<SEC-DOCUMENT>0001641172-25-012889.txt : 20250529
<SEC-HEADER>0001641172-25-012889.hdr.sgml : 20250529
<ACCEPTANCE-DATETIME>20250529170102
ACCESSION NUMBER:		0001641172-25-012889
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		124
CONFORMED PERIOD OF REPORT:	20250228
FILED AS OF DATE:		20250529
DATE AS OF CHANGE:		20250529

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			NextTrip, Inc.
		CENTRAL INDEX KEY:			0000788611
		STANDARD INDUSTRIAL CLASSIFICATION:	TRANSPORTATION SERVICES [4700]
		ORGANIZATION NAME:           	01 Energy & Transportation
		EIN:				820404220
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			0228

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38015
		FILM NUMBER:		251004469

	BUSINESS ADDRESS:	
		STREET 1:		3900 PASEO DEL SOL
		CITY:			SANTE FE
		STATE:			NM
		ZIP:			87507
		BUSINESS PHONE:		(954) 526-9688

	MAIL ADDRESS:	
		STREET 1:		3900 PASEO DEL SOL
		CITY:			SANTE FE
		STATE:			NM
		ZIP:			87507

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SIGMA ADDITIVE SOLUTIONS, INC.
		DATE OF NAME CHANGE:	20220812

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SIGMA LABS, INC.
		DATE OF NAME CHANGE:	20101014

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	FRAMEWAVES INC
		DATE OF NAME CHANGE:	20010130
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>form10-k.htm
<DESCRIPTION>10-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:us-types="http://fasb.org/us-types/2024" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:ecd="http://xbrl.sec.gov/ecd/2024" xmlns:country="http://xbrl.sec.gov/country/2024" xmlns:srt="http://fasb.org/srt/2024" xmlns:cyd="http://xbrl.sec.gov/cyd/2024" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:NTRP="http://nexttrip.com/20250228">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_076_XDX_form10%2Dk.xdx -->
<!-- Field: Set; Name: xdx; ID: xdx_029_US%2DGAAP%2D2024%2D(with%2DECD%2Dand%2DCYD) -->
<!-- Field: Set; Name: xdx; ID: xdx_039_NTRP_nexttrip.com_20250228 -->
<!-- Field: Set; Name: xdx; ID: xdx_045_20240301_20250228 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_05A_edei%2D%2DDocumentFiscalPeriodFocus_FY -->
<!-- Field: Set; Name: xdx; ID: xdx_05E_edei%2D%2DEntityCentralIndexKey_0000788611 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_069_Pure_4_xbrli%2D%2Dpure -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_sqft_0_utr%2D%2Dsqft -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="From2024-03-01to2025-02-28" id="Fact000004" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2024-03-01to2025-02-28" id="Fact000005" name="dei:DocumentFiscalPeriodFocus">FY</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2024-03-01to2025-02-28" id="Fact000006" name="dei:EntityCentralIndexKey">0000788611</ix:nonNumeric>
  <ix:nonFraction name="NTRP:PromissoryNoteReceivableNet" contextRef="AsOf2025-02-28" id="xdx2ixbrl0077" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:EquityMethodInvestments" contextRef="AsOf2024-02-29" id="xdx2ixbrl0105" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:PrepaidExpenseOtherNoncurrent" contextRef="AsOf2024-02-29" id="xdx2ixbrl0108" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NotesPayableCurrent" contextRef="AsOf2024-02-29_us-gaap_NonrelatedPartyMember" id="xdx2ixbrl0132" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CommitmentsAndContingencies" contextRef="AsOf2025-02-28" id="xdx2ixbrl0146" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CommitmentsAndContingencies" contextRef="AsOf2024-02-29" id="xdx2ixbrl0147" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2024-03-01to2025-02-28" id="xdx2ixbrl0276" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2023-03-012024-02-29" id="xdx2ixbrl0277" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncomeLossFromEquityMethodInvestments" contextRef="From2023-03-012024-02-29" id="xdx2ixbrl0283" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-02-28_us-gaap_PreferredStockMember" id="xdx2ixbrl0337" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2023-02-28_us-gaap_PreferredStockMember" id="xdx2ixbrl0343" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="NTRP:StockIssuedDuringPeriodValueOfPreferredShares" contextRef="From2023-03-012024-02-29_us-gaap_CommonStockMember" id="xdx2ixbrl0348" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="NTRP:StockIssuedDuringPeriodValueOfPreferredShares" contextRef="From2023-03-012024-02-29_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0350" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="NTRP:StockIssuedDuringPeriodShareOfPreferredShares" contextRef="From2023-03-012024-02-29_us-gaap_CommonStockMember" id="xdx2ixbrl0355" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="From2023-03-012024-02-29_us-gaap_PreferredStockMember" id="xdx2ixbrl0357" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="From2023-03-012024-02-29_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0360" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="NTRP:StockIssuedDuringPeriodValuePurchasesOfCommonShares" contextRef="From2023-03-012024-02-29_us-gaap_PreferredStockMember" id="xdx2ixbrl0365" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="NTRP:StockIssuedDuringPeriodValuePurchasesOfCommonShares" contextRef="From2023-03-012024-02-29_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0368" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2023-03-012024-02-29_us-gaap_PreferredStockMember" id="xdx2ixbrl0373" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2023-03-012024-02-29_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0376" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="NTRP:StockIssuedDuringPeriodValueReverseAcquisition" contextRef="From2023-03-012024-02-29_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0384" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2023-03-012024-02-29_us-gaap_PreferredStockMember" id="xdx2ixbrl0391" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2023-03-012024-02-29_us-gaap_CommonStockMember" id="xdx2ixbrl0392" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2023-03-012024-02-29_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0394" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DividendsPreferredStock" contextRef="From2023-03-012024-02-29_us-gaap_PreferredStockMember" id="xdx2ixbrl0397" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DividendsPreferredStock" contextRef="From2023-03-012024-02-29_us-gaap_CommonStockMember" id="xdx2ixbrl0398" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DividendsPreferredStock" contextRef="From2023-03-012024-02-29" id="xdx2ixbrl0401" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="NTRP:StockIssuedDuringPeriodValueOfPreferredSharesInPrivatePlacements" contextRef="From2024-03-012025-02-28_us-gaap_CommonStockMember" id="xdx2ixbrl0430" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="NTRP:StockIssuedDuringPeriodValueOfPreferredSharesInPrivatePlacements" contextRef="From2024-03-012025-02-28_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0432" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="NTRP:StockIssuedDuringPeriodSharesOfPreferredSharesInPrivatePlacements" contextRef="From2024-03-012025-02-28_us-gaap_CommonStockMember" id="xdx2ixbrl0437" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="NTRP:StockIssuedDuringPeriodValueConversionOfPreferredSharesToCommonShares" contextRef="From2024-03-012025-02-28_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0441" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="NTRP:StockIssuedDuringPeriodValueConversionOfPreferredSharesToCommonShares" contextRef="From2024-03-012025-02-28_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0442" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="NTRP:StockIssuedDuringPeriodValueConversionOfPreferredSharesToCommonShares" contextRef="From2024-03-01to2025-02-28" id="xdx2ixbrl0443" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="NTRP:StockIssuedDuringPeriodValueIssuanceOfPreferredSharesForDebtConversions" contextRef="From2024-03-012025-02-28_us-gaap_CommonStockMember" id="xdx2ixbrl0450" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="NTRP:StockIssuedDuringPeriodValueIssuanceOfPreferredSharesForDebtConversions" contextRef="From2024-03-012025-02-28_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0452" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="NTRP:StockIssuedDuringPeriodSharesIssuanceOfPreferredSharesForDebtConversions" contextRef="From2024-03-012025-02-28_us-gaap_CommonStockMember" id="xdx2ixbrl0457" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="NTRP:StockIssuedDuringPeriodValueIssuanceOfSecuritiesForServices" contextRef="From2024-03-012025-02-28_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0462" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="NTRP:StockIssuedDuringPeriodValueSecuritiesIssuedForEquityInvestments" contextRef="From2024-03-012025-02-28_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0472" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="NTRP:StockIssuedDuringPeriodValueIssuanceOfCommitmentSharesForEquityLineOfCredit" contextRef="From2024-03-012025-02-28_us-gaap_PreferredStockMember" id="xdx2ixbrl0479" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="NTRP:StockIssuedDuringPeriodValueIssuanceOfCommitmentSharesForEquityLineOfCredit" contextRef="From2024-03-012025-02-28_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0482" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="NTRP:StockIssuedDuringPeriodSharesIssuanceOfCommitmentSharesForEquityLineOfCredit" contextRef="From2024-03-012025-02-28_us-gaap_PreferredStockMember" id="xdx2ixbrl0485" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2024-03-012025-02-28_us-gaap_PreferredStockMember" id="xdx2ixbrl0489" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2024-03-012025-02-28_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0492" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="From2024-03-012025-02-28_us-gaap_PreferredStockMember" id="xdx2ixbrl0495" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2024-03-012025-02-28_us-gaap_PreferredStockMember" id="xdx2ixbrl0499" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2024-03-012025-02-28_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0502" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" contextRef="From2024-03-012025-02-28_us-gaap_PreferredStockMember" id="xdx2ixbrl0505" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DividendsPreferredStock" contextRef="From2024-03-012025-02-28_us-gaap_PreferredStockMember" id="xdx2ixbrl0509" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DividendsPreferredStock" contextRef="From2024-03-012025-02-28_us-gaap_CommonStockMember" id="xdx2ixbrl0510" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DividendsPreferredStock" contextRef="From2024-03-01to2025-02-28" id="xdx2ixbrl0513" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-03-012025-02-28_us-gaap_PreferredStockMember" id="xdx2ixbrl0515" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-03-012025-02-28_us-gaap_CommonStockMember" id="xdx2ixbrl0516" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-03-012025-02-28_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0517" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:AmortizationOfDebtDiscountPremium" contextRef="From2023-03-012024-02-29" id="xdx2ixbrl0559" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="NTRP:AmortizationOfPrepaidExpenses" contextRef="From2023-03-012024-02-29" id="xdx2ixbrl0562" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncomeLossFromEquityMethodInvestments" contextRef="From2023-03-012024-02-29" id="xdx2ixbrl0577" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="From2024-03-01to2025-02-28" id="xdx2ixbrl0609" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProceedsFromSaleOfProductiveAssets" contextRef="From2024-03-01to2025-02-28" id="xdx2ixbrl0615" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="NTRP:InvestmentInEquityMethodInvestee" contextRef="From2023-03-012024-02-29" id="xdx2ixbrl0619" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="NTRP:ProceedsFromAcquireBusinessesGross" contextRef="From2024-03-01to2025-02-28" id="xdx2ixbrl0621" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProceedsFromSaleOfOtherProductiveAssets" contextRef="From2023-03-012024-02-29" id="xdx2ixbrl0625" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProceedsFromNotesPayable" contextRef="From2023-03-012024-02-29" id="xdx2ixbrl0634" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProceedsFromConvertibleDebt" contextRef="From2024-03-01to2025-02-28" id="xdx2ixbrl0636" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfCommonStock" contextRef="From2024-03-01to2025-02-28" id="xdx2ixbrl0639" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfWarrants" contextRef="From2023-03-012024-02-29" id="xdx2ixbrl0646" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncomeTaxesPaidNet" contextRef="From2024-03-01to2025-02-28" id="xdx2ixbrl0669" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncomeTaxesPaidNet" contextRef="From2023-03-012024-02-29" id="xdx2ixbrl0670" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="NTRP:IssuanceOfCommonSharesAsCommitmentShares" contextRef="From2023-03-012024-02-29" id="xdx2ixbrl0682" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="NTRP:IssuanceOfCommonWarrantsForServices" contextRef="From2023-03-012024-02-29" id="xdx2ixbrl0685" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="NTRP:IssuanceOfCommonSharesForEquityInvestments" contextRef="From2023-03-012024-02-29" id="xdx2ixbrl0688" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="NTRP:IssuanceOfPreferredSharesForEquityInvestments" contextRef="From2023-03-012024-02-29" id="xdx2ixbrl0691" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="NTRP:IssuanceOfPreferredSharesForPerpetualSoftwareLicense" contextRef="From2024-03-01to2025-02-28" id="xdx2ixbrl0693" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="NTRP:ConversionOfConvertibleNotes" contextRef="From2024-03-01to2025-02-28" id="xdx2ixbrl0696" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold" contextRef="From2024-03-01to2025-02-28" id="xdx2ixbrl0856" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="NTRP:PrepaidOfferingCosts" contextRef="AsOf2024-02-29" id="xdx2ixbrl0966" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="NTRP:PrepaidConsultingContract" contextRef="AsOf2024-02-29" id="xdx2ixbrl0969" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:PrepaidAdvertising" contextRef="AsOf2025-02-28" id="xdx2ixbrl0977" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="From2024-03-01to2025-02-28" id="xdx2ixbrl1006" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="NTRP:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour" contextRef="AsOf2025-02-28" id="xdx2ixbrl1046" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DeferredTaxAssetsNet" contextRef="AsOf2025-02-28" id="xdx2ixbrl1140" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:DeferredTaxAssetsNet" contextRef="AsOf2024-02-29" id="xdx2ixbrl1141" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment" contextRef="From2024-03-01to2025-02-28" id="xdx2ixbrl1155" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="NTRP:IncomeTaxReconciliationNondeductibleExpenseLossOnNextPlayNoteReceivable" contextRef="From2023-03-012024-02-29" id="xdx2ixbrl1162" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2024-03-01to2025-02-28" id="xdx2ixbrl1179" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2023-03-012024-02-29" id="xdx2ixbrl1180" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" contextRef="AsOf2024-02-29" id="xdx2ixbrl1700" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" contextRef="From2024-03-01to2025-02-28" id="xdx2ixbrl1704" unitRef="USDPShares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" contextRef="From2024-03-01to2025-02-28" id="xdx2ixbrl1706" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="NTRP:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedorCancelledInPeriodTotalIntrinsicValue" contextRef="From2024-03-01to2025-02-28" id="xdx2ixbrl1712" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" contextRef="AsOf2025-02-28" id="xdx2ixbrl1720" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" contextRef="AsOf2025-02-28" id="xdx2ixbrl1728" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" contextRef="AsOf2025-02-28" id="xdx2ixbrl1736" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" contextRef="AsOf2025-02-28" id="xdx2ixbrl1744" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" contextRef="AsOf2024-02-29_custom_StockAppreciationRightsMember" id="xdx2ixbrl1784" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="From2024-03-012025-02-28_custom_StockAppreciationRightsMember" id="xdx2ixbrl1786" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" contextRef="From2024-03-012025-02-28_custom_StockAppreciationRightsMember" id="xdx2ixbrl1788" unitRef="USDPShares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" contextRef="From2024-03-012025-02-28_custom_StockAppreciationRightsMember" id="xdx2ixbrl1790" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="NTRP:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedorCancelledInPeriodTotalIntrinsicValue" contextRef="From2024-03-012025-02-28_custom_StockAppreciationRightsMember" id="xdx2ixbrl1796" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" contextRef="AsOf2025-02-28_custom_StockAppreciationRightsMember" id="xdx2ixbrl1804" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" contextRef="AsOf2025-02-28_custom_StockAppreciationRightsMember" id="xdx2ixbrl1812" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" contextRef="AsOf2025-02-28_custom_StockAppreciationRightsMember" id="xdx2ixbrl1820" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" contextRef="AsOf2025-02-28_custom_StockAppreciationRightsMember" id="xdx2ixbrl1828" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="NTRP:ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageWeightedAverageExercisePriceWarrantsForfeitedOrCancelled" contextRef="From2024-03-01to2025-02-28" id="xdx2ixbrl1884" unitRef="USDPShares" xs:nil="true"></ix:nonFraction>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="ntrp-20250228.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="From2024-03-01to2025-02-28">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-03-01</xbrli:startDate>
        <xbrli:endDate>2025-02-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-08-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-05-28">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-05-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-12-012025-02-28">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-12-01</xbrli:startDate>
        <xbrli:endDate>2025-02-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-02-28">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-02-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-02-29">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-02-29</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-02-28_us-gaap_NonrelatedPartyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:NonrelatedPartyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-02-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-02-29_us-gaap_NonrelatedPartyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:NonrelatedPartyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-02-29</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-02-28_us-gaap_RelatedPartyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-02-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-02-29_us-gaap_RelatedPartyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-02-29</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-12-292023-12-29_custom_NextTripGroupLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">NTRP:NextTripGroupLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-12-29</xbrli:startDate>
        <xbrli:endDate>2023-12-29</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-03-012024-02-29">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-03-01</xbrli:startDate>
        <xbrli:endDate>2024-02-29</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-02-28_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-02-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-02-28_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-02-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-02-28_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-02-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-02-28_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-02-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-02-28">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-02-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-02-29_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-02-29</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-02-29_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-02-29</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-02-29_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-02-29</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-02-29_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-02-29</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-03-012024-02-29_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-03-01</xbrli:startDate>
        <xbrli:endDate>2024-02-29</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-03-012024-02-29_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-03-01</xbrli:startDate>
        <xbrli:endDate>2024-02-29</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-03-012024-02-29_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-03-01</xbrli:startDate>
        <xbrli:endDate>2024-02-29</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-03-012024-02-29_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-03-01</xbrli:startDate>
        <xbrli:endDate>2024-02-29</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-03-012025-02-28_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-03-01</xbrli:startDate>
        <xbrli:endDate>2025-02-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-03-012025-02-28_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-03-01</xbrli:startDate>
        <xbrli:endDate>2025-02-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-03-012025-02-28_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-03-01</xbrli:startDate>
        <xbrli:endDate>2025-02-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-03-012025-02-28_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-03-01</xbrli:startDate>
        <xbrli:endDate>2025-02-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-02-28_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-02-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-02-28_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-02-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-02-28_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-02-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-02-28_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-02-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-252023-01-25_custom_NextPlayTechnologiesIncMember_custom_ShareExchangeAgreementMember_custom_MembershipUnitsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">NTRP:NextPlayTechnologiesIncMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:ShareExchangeAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">NTRP:MembershipUnitsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-25</xbrli:startDate>
        <xbrli:endDate>2023-01-25</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-252023-01-25_custom_NextPlayTechnologiesIncMember_custom_ShareExchangeAgreementMember_custom_PreferredUnitsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">NTRP:NextPlayTechnologiesIncMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:ShareExchangeAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">NTRP:PreferredUnitsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-25</xbrli:startDate>
        <xbrli:endDate>2023-01-25</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-01-25_custom_NextPlayTechnologiesIncMember_custom_ShareExchangeAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">NTRP:NextPlayTechnologiesIncMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:ShareExchangeAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-01-25</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-01-25_custom_NextTripGroupLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">NTRP:NextTripGroupLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-01-25</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-11-30_custom_NextInnovationLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">NTRP:NextInnovationLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-11-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-10-122023-10-12_custom_ShareExchangeAgreementMember_custom_NextTripGroupLLCMember_custom_ClosingSharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:ShareExchangeAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">NTRP:NextTripGroupLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:ClosingSharesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-10-12</xbrli:startDate>
        <xbrli:endDate>2023-10-12</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-10-122023-10-12_custom_ShareExchangeAgreementMember_custom_NextTripGroupLLCMember_custom_ContingentSharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:ShareExchangeAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">NTRP:NextTripGroupLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:ContingentSharesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-10-12</xbrli:startDate>
        <xbrli:endDate>2023-10-12</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-10-122023-10-12_custom_ShareExchangeAgreementMember_custom_NextTripGroupLLCMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:ShareExchangeAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">NTRP:NextTripGroupLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-10-12</xbrli:startDate>
        <xbrli:endDate>2023-10-12</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-10-122023-10-12_custom_ShareExchangeAgreementMember_custom_NextTripGroupLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:ShareExchangeAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">NTRP:NextTripGroupLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-10-12</xbrli:startDate>
        <xbrli:endDate>2023-10-12</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-03-012025-02-28_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-03-01</xbrli:startDate>
        <xbrli:endDate>2025-02-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-03-012024-02-29_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-03-01</xbrli:startDate>
        <xbrli:endDate>2024-02-29</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-03-012025-02-28_us-gaap_StockOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-03-01</xbrli:startDate>
        <xbrli:endDate>2025-02-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-03-012024-02-29_us-gaap_StockOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-03-01</xbrli:startDate>
        <xbrli:endDate>2024-02-29</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-03-012025-02-28_us-gaap_PreferredStockMember11842375">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-03-01</xbrli:startDate>
        <xbrli:endDate>2025-02-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-03-012024-02-29_us-gaap_PreferredStockMember11842375">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-03-01</xbrli:startDate>
        <xbrli:endDate>2024-02-29</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-02-28_custom_NextPlayTechnologiesIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">NTRP:NextPlayTechnologiesIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-02-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-02-29_custom_NextPlayTechnologiesIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">NTRP:NextPlayTechnologiesIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-02-29</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-25_custom_NextPlayTechnologiesIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">NTRP:NextPlayTechnologiesIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-25</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-01-27_custom_NextPlayTechnologiesIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">NTRP:NextPlayTechnologiesIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-01-27</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-02-28_us-gaap_FurnitureAndFixturesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-02-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-02-28_us-gaap_ComputerEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-02-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-02-28_custom_SoftwareMember_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">NTRP:SoftwareMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-02-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-02-28_custom_SoftwareMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">NTRP:SoftwareMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-02-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-02-28_custom_SoftwareLicensesMember_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">NTRP:SoftwareLicensesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-02-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-02-28_custom_SoftwareLicensesMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">NTRP:SoftwareLicensesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-02-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-10-062023-10-06_custom_AssetPurchaseAgreementMember_custom_DivergentTechnologiesIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:AssetPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">NTRP:DivergentTechnologiesIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-10-06</xbrli:startDate>
        <xbrli:endDate>2023-10-06</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-10-06_custom_AssetPurchaseAgreementMember_custom_DivergentTechnologiesIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:AssetPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">NTRP:DivergentTechnologiesIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-10-06</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-02-06_custom_MembershipPurchaseAgreementMember_custom_FSATravelLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:MembershipPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">NTRP:FSATravelLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-02-06</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-02-06_custom_MembershipPurchaseAgreementMember_custom_FSATravelLLCMember_custom_SeriesOPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:MembershipPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">NTRP:FSATravelLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesOPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-02-06</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-02-06_custom_MembershipPurchaseAgreementMember_custom_NextTripMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:MembershipPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">NTRP:NextTripMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-02-06</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-02-06_custom_MembershipPurchaseAgreementMember_custom_FSATravelLLCMember11843687">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:MembershipPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">NTRP:FSATravelLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-02-06</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-02-06_custom_MembershipPurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:MembershipPurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-02-06</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-02-06_custom_MembershipPurchaseAgreementMember_custom_SeriesOPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:MembershipPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesOPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-02-06</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-02-28_custom_MembershipPurchaseAgreementMember_custom_FSATravelLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:MembershipPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">NTRP:FSATravelLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-02-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-02-28_custom_MembershipPurchaseAgreementMember_custom_FSATravelLLCMember_custom_SeriesOPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:MembershipPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">NTRP:FSATravelLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesOPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-02-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-02-28_custom_MembershipPurchaseAgreementMember_custom_FSATravelLLCMember11843734">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:MembershipPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">NTRP:FSATravelLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-02-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-02-28_custom_MembershipPurchaseAgreementMember_custom_NextTripMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:MembershipPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">NTRP:NextTripMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-02-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-02-282025-02-28_custom_MembershipPurchaseAgreementMember_custom_NextTripMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:MembershipPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">NTRP:NextTripMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-02-28</xbrli:startDate>
        <xbrli:endDate>2025-02-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-02-282025-02-28_custom_MembershipPurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:MembershipPurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-02-28</xbrli:startDate>
        <xbrli:endDate>2025-02-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-02-28_custom_MembershipPurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:MembershipPurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-02-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-02-282025-02-28_custom_MembershipPurchaseAgreementMember_custom_NextTripMember11843750">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:MembershipPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">NTRP:NextTripMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-02-28</xbrli:startDate>
        <xbrli:endDate>2025-02-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_custom_FSATravelLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">NTRP:FSATravelLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_custom_FSATravelLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">NTRP:FSATravelLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-02-24_custom_ShareExchangeAgreementMember_custom_BlueFyshHoldingsIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:ShareExchangeAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">NTRP:BlueFyshHoldingsIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-02-24</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-02-242025-02-24_custom_ShareExchangeAgreementMember_custom_BlueFyshHoldingsIncMember_custom_SeriesNNonvotingConvertiblePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:ShareExchangeAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">NTRP:BlueFyshHoldingsIncMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesNNonvotingConvertiblePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-02-24</xbrli:startDate>
        <xbrli:endDate>2025-02-24</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-02-24_custom_ShareExchangeAgreementMember_custom_BlueFyshHoldingsIncMember_custom_SeriesNNonvotingConvertiblePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:ShareExchangeAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">NTRP:BlueFyshHoldingsIncMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesNNonvotingConvertiblePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-02-24</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-02-242025-02-24_custom_ShareExchangeAgreementMember_custom_BlueFyshHoldingsIncMember_us-gaap_RestrictedStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:ShareExchangeAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">NTRP:BlueFyshHoldingsIncMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-02-24</xbrli:startDate>
        <xbrli:endDate>2025-02-24</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-02-29_us-gaap_FurnitureAndFixturesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-02-29</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-02-29_us-gaap_ComputerEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-02-29</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-02-28_us-gaap_SoftwareDevelopmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-02-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-02-29_us-gaap_SoftwareDevelopmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-02-29</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-02-28_custom_SoftwareLicenseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">NTRP:SoftwareLicenseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-02-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-02-29_custom_SoftwareLicenseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">NTRP:SoftwareLicenseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-02-29</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-02-28_us-gaap_TrademarksMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-02-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-02-29_us-gaap_TrademarksMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-02-29</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-10-122023-10-12_custom_SigmaAdditiveSolutionsIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">NTRP:SigmaAdditiveSolutionsIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-10-12</xbrli:startDate>
        <xbrli:endDate>2023-10-12</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-10-12_custom_SigmaAdditiveSolutionsIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">NTRP:SigmaAdditiveSolutionsIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-10-12</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-10-12">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-10-12</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-10-12_us-gaap_SeriesEPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesEPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-10-12</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-10-122023-10-12_custom_NextTripHoldingsIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">NTRP:NextTripHoldingsIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-10-12</xbrli:startDate>
        <xbrli:endDate>2023-10-12</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-10-122023-10-12_custom_DivergentTechnologiesIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">NTRP:DivergentTechnologiesIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-10-12</xbrli:startDate>
        <xbrli:endDate>2023-10-12</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-10-122023-10-12">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-10-12</xbrli:startDate>
        <xbrli:endDate>2023-10-12</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-05-242024-05-24">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-05-24</xbrli:startDate>
        <xbrli:endDate>2024-05-24</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-05-24">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-05-24</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-02-282025-02-28">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-02-28</xbrli:startDate>
        <xbrli:endDate>2025-02-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-06-262024-06-26">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-06-26</xbrli:startDate>
        <xbrli:endDate>2024-06-26</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-26">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-26</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-19_custom_SecuritiesPurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-19</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-09-192024-09-19_custom_SecuritiesPurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-09-19</xbrli:startDate>
        <xbrli:endDate>2024-09-19</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-19_custom_SecuritiesPurchaseAgreementMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-19</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-09-192024-09-19">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-09-19</xbrli:startDate>
        <xbrli:endDate>2024-09-19</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-10-18_custom_NoteSecuritiesPurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:NoteSecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-10-18</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-10-18">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-10-18</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-11-01_custom_ShortTermPromissoryNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:ShortTermPromissoryNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-11-01</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-11-01">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-11-01</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-11-29">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-11-29</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-11-29_custom_ShortTermPromissoryNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:ShortTermPromissoryNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-11-29</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-11-292024-11-29">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-11-29</xbrli:startDate>
        <xbrli:endDate>2024-11-29</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-12-312024-12-31_custom_SeriesMNonvotingConvertiblePreferredStockMember_custom_DebtConversionAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesMNonvotingConvertiblePreferredStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:DebtConversionAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-12-31</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_custom_SeriesMNonvotingConvertiblePreferredStockMember_custom_DebtConversionAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesMNonvotingConvertiblePreferredStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:DebtConversionAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-11-08">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-11-08</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-11-08_custom_NoteSecuritiesPurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:NoteSecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-11-08</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-11-082024-11-08_custom_NoteTwoSecuritiesPurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:NoteTwoSecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-11-08</xbrli:startDate>
        <xbrli:endDate>2024-11-08</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-11-082024-11-08_custom_ShortTermPromissoryNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:ShortTermPromissoryNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-11-08</xbrli:startDate>
        <xbrli:endDate>2024-11-08</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-11-082024-11-08">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-11-08</xbrli:startDate>
        <xbrli:endDate>2024-11-08</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-02-28_custom_ShortTermPromissoryNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:ShortTermPromissoryNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-02-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_custom_ShortTermPromissoryNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:ShortTermPromissoryNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-12-312024-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-12-31</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_custom_OneMillionNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:OneMillionNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-02-26">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-02-26</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-02-262025-02-26_custom_SeriesPNonvotingConvertiblePreferredStockMember_custom_DebtExchangeAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesPNonvotingConvertiblePreferredStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:DebtExchangeAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-02-26</xbrli:startDate>
        <xbrli:endDate>2025-02-26</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-02-26_custom_SeriesPNonvotingConvertiblePreferredStockMember_custom_DebtExchangeAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesPNonvotingConvertiblePreferredStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:DebtExchangeAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-02-26</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-02-04">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-02-04</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-02-04_custom_SecuritiesPurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-02-04</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-02-04_custom_NoteSecuritiesPurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:NoteSecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-02-04</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-02-042025-02-04_custom_NoteTwoSecuritiesPurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:NoteTwoSecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-02-04</xbrli:startDate>
        <xbrli:endDate>2025-02-04</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-02-042025-02-04">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-02-04</xbrli:startDate>
        <xbrli:endDate>2025-02-04</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-03-132023-06-09_custom_SpecialPurposeAcquisitionCorporationMember_custom_SeveralInvestorsMember_custom_ConvertibleNotesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">NTRP:SpecialPurposeAcquisitionCorporationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">NTRP:SeveralInvestorsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">NTRP:ConvertibleNotesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-03-13</xbrli:startDate>
        <xbrli:endDate>2023-06-09</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-09_custom_SpecialPurposeAcquisitionCorporationMember_custom_SeveralInvestorsMember_custom_ConvertibleNotesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">NTRP:SpecialPurposeAcquisitionCorporationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">NTRP:SeveralInvestorsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">NTRP:ConvertibleNotesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-09</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-272023-02-21_custom_SpecialPurposeAcquisitionCorporationMember_custom_SeveralInvestorsMember_custom_ConvertibleNotesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">NTRP:SpecialPurposeAcquisitionCorporationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">NTRP:SeveralInvestorsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">NTRP:ConvertibleNotesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-27</xbrli:startDate>
        <xbrli:endDate>2023-02-21</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-02-21_custom_SpecialPurposeAcquisitionCorporationMember_custom_SeveralInvestorsMember_custom_ConvertibleNotesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">NTRP:SpecialPurposeAcquisitionCorporationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">NTRP:SeveralInvestorsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">NTRP:ConvertibleNotesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-02-21</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-29_custom_DebtAssignmentAndConversionAgreementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:DebtAssignmentAndConversionAgreementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-29</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-12-292023-12-29_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-12-29</xbrli:startDate>
        <xbrli:endDate>2023-12-29</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-12-292023-12-29_custom_ContingentSharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">NTRP:ContingentSharesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-12-29</xbrli:startDate>
        <xbrli:endDate>2023-12-29</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-08-102023-11-06_custom_SharePurchaseAgreementsMember_custom_SeveralInvestorsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:SharePurchaseAgreementsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">NTRP:SeveralInvestorsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-08-10</xbrli:startDate>
        <xbrli:endDate>2023-11-06</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-11-06_custom_SharePurchaseAgreementsMember_custom_SeveralInvestorsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:SharePurchaseAgreementsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">NTRP:SeveralInvestorsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-11-06</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-09-192022-09-19_custom_SoftwareAsAServiceAgreementMember_custom_ThirdPartyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:SoftwareAsAServiceAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">NTRP:ThirdPartyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-09-19</xbrli:startDate>
        <xbrli:endDate>2022-09-19</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-09-19_custom_SoftwareAsAServiceAgreementMember_custom_ThirdPartyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:SoftwareAsAServiceAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">NTRP:ThirdPartyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-09-19</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-12-292023-12-29_custom_SoftwareAsAServiceAgreementMember_us-gaap_CommonStockMember_custom_ThirdPartyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:SoftwareAsAServiceAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">NTRP:ThirdPartyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-12-29</xbrli:startDate>
        <xbrli:endDate>2023-12-29</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-12-292023-12-29_custom_ContingentSharesMember_custom_SoftwareAsAServiceAgreementMember_custom_ThirdPartyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">NTRP:ContingentSharesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:SoftwareAsAServiceAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">NTRP:ThirdPartyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-12-29</xbrli:startDate>
        <xbrli:endDate>2023-12-29</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-12-292023-12-29_us-gaap_CommonStockMember_custom_ThirdPartyConsultantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">NTRP:ThirdPartyConsultantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-12-29</xbrli:startDate>
        <xbrli:endDate>2023-12-29</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-12-292023-12-29_custom_ContingentSharesMember_custom_ThirdPartyConsultantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">NTRP:ContingentSharesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">NTRP:ThirdPartyConsultantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-12-29</xbrli:startDate>
        <xbrli:endDate>2023-12-29</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-12-282023-12-28_custom_ConsultingModificationAgreementMember_custom_ThirdPartyConsultantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:ConsultingModificationAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">NTRP:ThirdPartyConsultantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-12-28</xbrli:startDate>
        <xbrli:endDate>2023-12-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-12-292023-12-29_custom_ConsultingModificationAgreementMember_us-gaap_CommonStockMember_custom_ThirdPartyConsultantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:ConsultingModificationAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">NTRP:ThirdPartyConsultantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-12-29</xbrli:startDate>
        <xbrli:endDate>2023-12-29</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-12-292023-12-29_custom_ConsultingModificationAgreementMember_custom_ContingentSharesMember_custom_ThirdPartyConsultantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:ConsultingModificationAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">NTRP:ContingentSharesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">NTRP:ThirdPartyConsultantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-12-29</xbrli:startDate>
        <xbrli:endDate>2023-12-29</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-03-012025-02-28_custom_NextPlayTechnologiesIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">NTRP:NextPlayTechnologiesIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-03-01</xbrli:startDate>
        <xbrli:endDate>2025-02-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-09-212023-09-22">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-09-21</xbrli:startDate>
        <xbrli:endDate>2023-09-22</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-09-222023-09-22">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-09-22</xbrli:startDate>
        <xbrli:endDate>2023-09-22</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-03-152024-03-15_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-03-15</xbrli:startDate>
        <xbrli:endDate>2024-03-15</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-012024-08-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-01</xbrli:startDate>
        <xbrli:endDate>2024-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-09-192024-09-19_custom_AlumniCapitalLPMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">NTRP:AlumniCapitalLPMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-09-19</xbrli:startDate>
        <xbrli:endDate>2024-09-19</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-10-082024-10-08_custom_FSATravelLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">NTRP:FSATravelLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-10-08</xbrli:startDate>
        <xbrli:endDate>2024-10-08</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-12-162024-12-16_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-12-16</xbrli:startDate>
        <xbrli:endDate>2024-12-16</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-12-012025-01-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-12-01</xbrli:startDate>
        <xbrli:endDate>2025-01-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-072025-01-07_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-07</xbrli:startDate>
        <xbrli:endDate>2025-01-07</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-292025-01-29_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-29</xbrli:startDate>
        <xbrli:endDate>2025-01-29</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-02-262025-02-26_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-02-26</xbrli:startDate>
        <xbrli:endDate>2025-02-26</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-09-012023-09-30_custom_AtTheMarketIssuanceSalesAgreementMember_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">NTRP:AtTheMarketIssuanceSalesAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-09-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-10-012023-10-31_custom_AtTheMarketIssuanceSalesAgreementMember_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">NTRP:AtTheMarketIssuanceSalesAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-10-01</xbrli:startDate>
        <xbrli:endDate>2023-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-29_custom_NextTripHoldingsIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">NTRP:NextTripHoldingsIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-29</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-12-292023-12-29_custom_NextTripHoldingsIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">NTRP:NextTripHoldingsIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-12-29</xbrli:startDate>
        <xbrli:endDate>2023-12-29</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-12-292024-12-29_custom_NextTripHoldingsIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">NTRP:NextTripHoldingsIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-12-29</xbrli:startDate>
        <xbrli:endDate>2024-12-29</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-12-292023-12-29_custom_NextTripHoldingsIncMember_custom_DebtAssignmentAndConversionAgreementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">NTRP:NextTripHoldingsIncMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DeferredRevenueArrangementTypeAxis">NTRP:DebtAssignmentAndConversionAgreementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-12-29</xbrli:startDate>
        <xbrli:endDate>2023-12-29</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-12-292023-12-29_custom_NextTripHoldingsIncMember_custom_SharePurchaseAndExchangeAgreementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">NTRP:NextTripHoldingsIncMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DeferredRevenueArrangementTypeAxis">NTRP:SharePurchaseAndExchangeAgreementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-12-29</xbrli:startDate>
        <xbrli:endDate>2023-12-29</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-12-292023-12-29_custom_NextTripHoldingsIncMember_custom_ThirdPartyConsultantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">NTRP:NextTripHoldingsIncMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">NTRP:ThirdPartyConsultantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-12-29</xbrli:startDate>
        <xbrli:endDate>2023-12-29</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-02-28_custom_SeriesEConvertiblePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesEConvertiblePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-02-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-03-012025-02-28_custom_SeriesEConvertiblePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesEConvertiblePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-03-01</xbrli:startDate>
        <xbrli:endDate>2025-02-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-01-04_custom_SeriesFConvertiblePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesFConvertiblePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-01-04</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-02-28_custom_SeriesFConvertiblePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesFConvertiblePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-02-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-01-26_custom_SeriesGConvertiblePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesGConvertiblePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-01-26</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-03-012025-02-28_custom_SeriesGConvertiblePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesGConvertiblePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-03-01</xbrli:startDate>
        <xbrli:endDate>2025-02-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-02-28_custom_SeriesGConvertiblePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesGConvertiblePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-02-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-01-26_custom_SeriesHConvertiblePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesHConvertiblePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-01-26</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-02-28_custom_SeriesHConvertiblePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesHConvertiblePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-02-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-02-22_custom_SeriesIConvertiblePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesIConvertiblePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-02-22</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-02-25_custom_SeriesIConvertiblePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesIConvertiblePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-02-25</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-02-152024-02-15_custom_SeriesIConvertiblePreferredStockMember_custom_SecuritiesPurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesIConvertiblePreferredStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-02-15</xbrli:startDate>
        <xbrli:endDate>2024-02-15</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-02-15_custom_SeriesIConvertiblePreferredStockMember_custom_SecuritiesPurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesIConvertiblePreferredStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-02-15</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-08-152024-08-15_custom_SeriesIConvertiblePreferredStockMember_custom_SecuritiesPurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesIConvertiblePreferredStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-08-15</xbrli:startDate>
        <xbrli:endDate>2024-08-15</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-08-15_custom_SeriesIConvertiblePreferredStockMember_custom_SecuritiesPurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesIConvertiblePreferredStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-08-15</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-08-312024-08-31_custom_SeriesIConvertiblePreferredStockMember_custom_SecuritiesPurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesIConvertiblePreferredStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-08-31</xbrli:startDate>
        <xbrli:endDate>2024-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-08-31_custom_SeriesIConvertiblePreferredStockMember_custom_SecuritiesPurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesIConvertiblePreferredStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-10-012024-10-01_custom_SeriesIConvertiblePreferredStockMember_custom_SecuritiesPurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesIConvertiblePreferredStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-10-01</xbrli:startDate>
        <xbrli:endDate>2024-10-01</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-10-01_custom_SeriesIConvertiblePreferredStockMember_custom_SecuritiesPurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesIConvertiblePreferredStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-10-01</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-02-242025-02-24_custom_SeriesIConvertiblePreferredStockMember_custom_SeriesIPurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesIConvertiblePreferredStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:SeriesIPurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-02-24</xbrli:startDate>
        <xbrli:endDate>2025-02-24</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-02-24_custom_SeriesIConvertiblePreferredStockMember_custom_SecuritiesPurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesIConvertiblePreferredStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-02-24</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-02-242025-02-24_custom_SeriesIPreferredStockMember_custom_SeriesIPurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesIPreferredStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:SeriesIPurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-02-24</xbrli:startDate>
        <xbrli:endDate>2025-02-24</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-10-01_custom_SeriesIPreferredStockMember_custom_SecuritiesPurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesIPreferredStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-10-01</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-02-242025-02-24_custom_MillerDebtConversionAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:MillerDebtConversionAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-02-24</xbrli:startDate>
        <xbrli:endDate>2025-02-24</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-02-242025-02-24_custom_MillerDebtConversionAgreementMember_custom_SeriesIConvertiblePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:MillerDebtConversionAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesIConvertiblePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-02-24</xbrli:startDate>
        <xbrli:endDate>2025-02-24</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-02-24_custom_MillerDebtConversionAgreementMember_custom_SeriesIConvertiblePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:MillerDebtConversionAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesIConvertiblePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-02-24</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-02-28_custom_SeriesIConvertiblePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesIConvertiblePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-02-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-032025-01-03_custom_SeriesJNonvotingConvertiblePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesJNonvotingConvertiblePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-03</xbrli:startDate>
        <xbrli:endDate>2025-01-03</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-01-03_custom_SeriesJNonvotingConvertiblePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesJNonvotingConvertiblePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-01-03</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-12-312024-12-31_custom_SeriesJNonvotingConvertiblePreferredStockMember_custom_SecuritiesPurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesJNonvotingConvertiblePreferredStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-12-31</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_custom_SeriesJNonvotingConvertiblePreferredStockMember_custom_SecuritiesPurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesJNonvotingConvertiblePreferredStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-02-28_custom_SeriesJNonvotingConvertiblePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesJNonvotingConvertiblePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-02-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-032025-01-03_custom_SeriesKNonvotingConvertiblePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesKNonvotingConvertiblePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-03</xbrli:startDate>
        <xbrli:endDate>2025-01-03</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-01-03_custom_SeriesKNonvotingConvertiblePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesKNonvotingConvertiblePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-01-03</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-12-312024-12-31_custom_SeriesKNonvotingConvertiblePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesKNonvotingConvertiblePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-12-31</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_custom_SeriesKNonvotingConvertiblePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesKNonvotingConvertiblePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-02-28_custom_SeriesKNonvotingConvertiblePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesKNonvotingConvertiblePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-02-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-032025-01-03_custom_SeriesLNonvotingConvertiblePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesLNonvotingConvertiblePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-03</xbrli:startDate>
        <xbrli:endDate>2025-01-03</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-01-03_custom_SeriesLNonvotingConvertiblePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesLNonvotingConvertiblePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-01-03</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-02-25_custom_SeriesLNonvotingConvertiblePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesLNonvotingConvertiblePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-02-25</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-12-312024-12-31_custom_MessrsKerbyAndMonacoMember_custom_RelatedPartyDebtConversionAgreementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">NTRP:MessrsKerbyAndMonacoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:RelatedPartyDebtConversionAgreementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-12-31</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-12-312024-12-31_custom_MessrsKerbyAndMonacoMember_custom_SeriesLNonvotingConvertiblePreferredStockMember_custom_RelatedPartyDebtConversionAgreementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">NTRP:MessrsKerbyAndMonacoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesLNonvotingConvertiblePreferredStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:RelatedPartyDebtConversionAgreementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-12-31</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_custom_MessrsKerbyAndMonacoMember_custom_SeriesLNonvotingConvertiblePreferredStockMember_custom_RelatedPartyDebtConversionAgreementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">NTRP:MessrsKerbyAndMonacoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesLNonvotingConvertiblePreferredStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:RelatedPartyDebtConversionAgreementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-02-242025-02-24_custom_RelatedPartyDebtConversionAgreementsMember_custom_SeriesLNonvotingConvertiblePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:RelatedPartyDebtConversionAgreementsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesLNonvotingConvertiblePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-02-24</xbrli:startDate>
        <xbrli:endDate>2025-02-24</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-02-24_custom_SeriesLNonvotingConvertiblePreferredStockMember_custom_RelatedPartyDebtConversionAgreementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesLNonvotingConvertiblePreferredStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:RelatedPartyDebtConversionAgreementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-02-24</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-02-28_custom_SeriesLNonvotingConvertiblePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesLNonvotingConvertiblePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-02-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-032025-01-03_custom_SeriesMNonvotingConvertiblePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesMNonvotingConvertiblePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-03</xbrli:startDate>
        <xbrli:endDate>2025-01-03</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-01-03_custom_SeriesMNonvotingConvertiblePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesMNonvotingConvertiblePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-01-03</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-12-312024-12-31_custom_SecuritiesPurchaseAgreementMember_custom_SeriesMNonvotingConvertiblePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesMNonvotingConvertiblePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-12-31</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-12-31_custom_SecuritiesPurchaseAgreementMember_custom_SeriesMNonvotingConvertiblePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesMNonvotingConvertiblePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-12-312024-12-31_custom_SeriesMNonvotingConvertiblePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesMNonvotingConvertiblePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-12-31</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-02-28_custom_SeriesMNonvotingConvertiblePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesMNonvotingConvertiblePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-02-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-03-012025-02-28_custom_SeriesMNonvotingConvertiblePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesMNonvotingConvertiblePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-03-01</xbrli:startDate>
        <xbrli:endDate>2025-02-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-032025-01-03_custom_SeriesNNonvotingConvertiblePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesNNonvotingConvertiblePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-03</xbrli:startDate>
        <xbrli:endDate>2025-01-03</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-01-03_custom_SeriesNNonvotingConvertiblePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesNNonvotingConvertiblePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-01-03</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-282025-01-28_custom_SeriesNNonvotingConvertiblePreferredStockMember_custom_SecuritiesPurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesNNonvotingConvertiblePreferredStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-28</xbrli:startDate>
        <xbrli:endDate>2025-01-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-01-28_custom_SeriesNNonvotingConvertiblePreferredStockMember_custom_SecuritiesPurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesNNonvotingConvertiblePreferredStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-01-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-282025-01-28_custom_SeriesNNonvotingConvertiblePreferredStockMember_custom_ShareExchangeAgreementMember_custom_BlueFyshHoldingsIncMember_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesNNonvotingConvertiblePreferredStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:ShareExchangeAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">NTRP:BlueFyshHoldingsIncMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-28</xbrli:startDate>
        <xbrli:endDate>2025-01-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-01-28_custom_SeriesNNonvotingConvertiblePreferredStockMember_custom_ShareExchangeAgreementMember_custom_BlueFyshHoldingsIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesNNonvotingConvertiblePreferredStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:ShareExchangeAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">NTRP:BlueFyshHoldingsIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-01-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-01-282025-01-28_custom_SeriesNNonvotingConvertiblePreferredStockMember_custom_ShareExchangeAgreementMember_custom_BlueFyshHoldingsIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesNNonvotingConvertiblePreferredStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:ShareExchangeAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">NTRP:BlueFyshHoldingsIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-01-28</xbrli:startDate>
        <xbrli:endDate>2025-01-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-02-28_custom_SeriesNNonvotingConvertibleConvertiblePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesNNonvotingConvertibleConvertiblePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-02-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-02-062025-02-06_custom_SeriesONonvotingConvertiblePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesONonvotingConvertiblePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-02-06</xbrli:startDate>
        <xbrli:endDate>2025-02-06</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-02-06_custom_SeriesONonvotingConvertiblePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesONonvotingConvertiblePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-02-06</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-02-06_custom_FSATravelLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">NTRP:FSATravelLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-02-06</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-02-28_custom_SeriesONonvotingConvertiblePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesONonvotingConvertiblePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-02-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-02-252025-02-25_custom_SeriesPNonvotingConvertiblePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesPNonvotingConvertiblePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-02-25</xbrli:startDate>
        <xbrli:endDate>2025-02-25</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-02-25_custom_SeriesPNonvotingConvertiblePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesPNonvotingConvertiblePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-02-25</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-02-262025-02-26_custom_SeriesPNonvotingConvertiblePreferredStockMember_custom_EquityInvestmentAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesPNonvotingConvertiblePreferredStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:EquityInvestmentAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-02-26</xbrli:startDate>
        <xbrli:endDate>2025-02-26</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-02-26_custom_SeriesPNonvotingConvertiblePreferredStockMember_custom_EquityInvestmentAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesPNonvotingConvertiblePreferredStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:EquityInvestmentAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-02-26</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-02-28_custom_SeriesPNonvotingConvertiblePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesPNonvotingConvertiblePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-02-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-02-28_custom_TwoThousandTwentyThreeEquityIncentivePlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">NTRP:TwoThousandTwentyThreeEquityIncentivePlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-02-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-02-28_custom_TwoThousandThirteenEquityIncentivePlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">NTRP:TwoThousandThirteenEquityIncentivePlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-02-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-02-28_us-gaap_StockOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-02-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-03-012025-02-28_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-03-01</xbrli:startDate>
        <xbrli:endDate>2025-02-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-12-292024-02-29">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-12-29</xbrli:startDate>
        <xbrli:endDate>2024-02-29</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-29_custom_StockAppreciationRightsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">NTRP:StockAppreciationRightsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-29</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-12-292024-12-29_custom_StockAppreciationRightsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">NTRP:StockAppreciationRightsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-12-29</xbrli:startDate>
        <xbrli:endDate>2024-12-29</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-03-012025-02-28_custom_TwoThousandAndTwentyStockAppreciationRightsPlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">NTRP:TwoThousandAndTwentyStockAppreciationRightsPlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-03-01</xbrli:startDate>
        <xbrli:endDate>2025-02-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-02-28_custom_TwoThousandAndTwentyStockAppreciationRightsPlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">NTRP:TwoThousandAndTwentyStockAppreciationRightsPlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-02-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-02-28_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-02-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-02-28_us-gaap_WarrantMember_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-02-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-02-28_us-gaap_WarrantMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-02-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-03-012025-02-28_us-gaap_WarrantMember11853671">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-03-01</xbrli:startDate>
        <xbrli:endDate>2025-02-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-03-012025-02-28_custom_StockAppreciationRightsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">NTRP:StockAppreciationRightsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-03-01</xbrli:startDate>
        <xbrli:endDate>2025-02-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-02-29_custom_StockAppreciationRightsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">NTRP:StockAppreciationRightsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-02-29</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-03-012024-02-28_custom_StockAppreciationRightsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">NTRP:StockAppreciationRightsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-03-01</xbrli:startDate>
        <xbrli:endDate>2024-02-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-02-28_custom_StockAppreciationRightsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">NTRP:StockAppreciationRightsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-02-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-03-012025-02-28_custom_TwoThousandAndTwentyStockAppreciationRightsPlanMember_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">NTRP:TwoThousandAndTwentyStockAppreciationRightsPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-03-01</xbrli:startDate>
        <xbrli:endDate>2025-02-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-03-012025-02-28_custom_TwoThousandAndTwentyStockAppreciationRightsPlanMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">NTRP:TwoThousandAndTwentyStockAppreciationRightsPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-03-01</xbrli:startDate>
        <xbrli:endDate>2025-02-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-03-012025-02-28_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-03-01</xbrli:startDate>
        <xbrli:endDate>2025-02-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-06-102024-06-10_custom_ShareExchangeAgreementMember_custom_AchievedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:ShareExchangeAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">NTRP:AchievedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-06-10</xbrli:startDate>
        <xbrli:endDate>2024-06-10</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-06-102024-06-10_custom_ShareExchangeAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:ShareExchangeAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-06-10</xbrli:startDate>
        <xbrli:endDate>2024-06-10</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-02-28_us-gaap_EmployeeStockOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-02-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-03-012025-02-28_us-gaap_SeriesEPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesEPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-03-01</xbrli:startDate>
        <xbrli:endDate>2025-02-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-03-012025-02-28_us-gaap_SeriesHPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesHPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-03-01</xbrli:startDate>
        <xbrli:endDate>2025-02-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-03-012025-02-28_custom_SeriesIPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesIPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-03-01</xbrli:startDate>
        <xbrli:endDate>2025-02-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-03-012025-02-28_custom_SeriesJPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesJPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-03-01</xbrli:startDate>
        <xbrli:endDate>2025-02-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-03-012025-02-28_custom_SeriesKPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesKPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-03-01</xbrli:startDate>
        <xbrli:endDate>2025-02-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-03-012025-02-28_custom_SeriesLPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesLPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-03-01</xbrli:startDate>
        <xbrli:endDate>2025-02-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-03-012025-02-28_custom_SeriesMPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesMPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-03-01</xbrli:startDate>
        <xbrli:endDate>2025-02-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-03-012025-02-28_custom_SeriesNPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesNPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-03-01</xbrli:startDate>
        <xbrli:endDate>2025-02-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-03-012025-02-28_custom_SeriesOPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesOPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-03-01</xbrli:startDate>
        <xbrli:endDate>2025-02-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-03-012025-02-28_custom_SeriesOPreferredStockOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesOPreferredStockOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-03-01</xbrli:startDate>
        <xbrli:endDate>2025-02-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-06-102024-06-10_custom_AchievedMember_custom_LeisureTravelBookingPlatformMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">NTRP:AchievedMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">NTRP:LeisureTravelBookingPlatformMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-06-10</xbrli:startDate>
        <xbrli:endDate>2024-06-10</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-06-102024-06-10_custom_AchievedMember_custom_GroupTravelBookingPlatformMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">NTRP:AchievedMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">NTRP:GroupTravelBookingPlatformMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-06-10</xbrli:startDate>
        <xbrli:endDate>2024-06-10</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-06-102024-06-10_custom_AchievedMember_custom_FlexPayTechnologyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">NTRP:AchievedMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">NTRP:FlexPayTechnologyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-06-10</xbrli:startDate>
        <xbrli:endDate>2024-06-10</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-06-102024-06-10_custom_AchievedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">NTRP:AchievedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-06-10</xbrli:startDate>
        <xbrli:endDate>2024-06-10</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-06-102024-06-10_custom_NotAchievedMember_custom_TravelAgentPlatformMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">NTRP:NotAchievedMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">NTRP:TravelAgentPlatformMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-06-10</xbrli:startDate>
        <xbrli:endDate>2024-06-10</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-06-102024-06-10_custom_NotAchievedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">NTRP:NotAchievedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-06-10</xbrli:startDate>
        <xbrli:endDate>2024-06-10</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-06-102024-06-10">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-06-10</xbrli:startDate>
        <xbrli:endDate>2024-06-10</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-03-012025-02-28_us-gaap_CommonStockMember11856671">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-03-01</xbrli:startDate>
        <xbrli:endDate>2025-02-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-03-012025-02-28_custom_ContingentSharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:ContingentSharesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-03-01</xbrli:startDate>
        <xbrli:endDate>2025-02-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-03-012024-02-29_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">NTRP:CustomerMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-03-01</xbrli:startDate>
        <xbrli:endDate>2024-02-29</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-03-012025-02-28_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">NTRP:CustomerMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-03-01</xbrli:startDate>
        <xbrli:endDate>2025-02-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-03-012024-02-29_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">NTRP:CustomerMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-03-01</xbrli:startDate>
        <xbrli:endDate>2024-02-29</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-03-012025-02-28_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">NTRP:CustomerMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-03-01</xbrli:startDate>
        <xbrli:endDate>2025-02-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-03-012024-02-28">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-03-01</xbrli:startDate>
        <xbrli:endDate>2024-02-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-03-262025-03-26_custom_ExchangeAgreementMember_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:ExchangeAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-03-26</xbrli:startDate>
        <xbrli:endDate>2025-03-26</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-03-26_custom_ExchangeAgreementMember_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:ExchangeAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-03-26</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-05-052025-05-05_custom_ExchangeAgreementMember_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:ExchangeAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-05-05</xbrli:startDate>
        <xbrli:endDate>2025-05-05</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-04-01_custom_SecuritiesPurchaseAgreementMember_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-04-01</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-04-012025-04-01_custom_SecuritiesPurchaseAgreementMember_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-04-01</xbrli:startDate>
        <xbrli:endDate>2025-04-01</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-04-01_custom_SecuritiesPurchaseAgreementMember_srt_MaximumMember_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-04-01</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-04-012025-04-01_custom_AssetPurchaseAgreementMember_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:AssetPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-04-01</xbrli:startDate>
        <xbrli:endDate>2025-04-01</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-04-012025-04-01_custom_AssetPurchaseAgreementMember_us-gaap_CommonStockMember_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:AssetPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-04-01</xbrli:startDate>
        <xbrli:endDate>2025-04-01</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-04-09_custom_FSATravelLLCMember_custom_PurchaseAgreementMember_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">NTRP:FSATravelLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:PurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-04-09</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-04-092025-04-09_custom_FSATravelLLCMember_custom_PurchaseAgreementMember_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">NTRP:FSATravelLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:PurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-04-09</xbrli:startDate>
        <xbrli:endDate>2025-04-09</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-04-092025-04-09_custom_FSATravelLLCMember_us-gaap_PreferredStockMember_custom_SeriesOPreferredStockMember_custom_PurchaseAgreementMember_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">NTRP:FSATravelLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesOPreferredStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:PurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-04-09</xbrli:startDate>
        <xbrli:endDate>2025-04-09</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-04-282025-04-28_custom_FSATravelLLCMember_custom_PurchaseAgreementMember_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">NTRP:FSATravelLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:PurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-04-28</xbrli:startDate>
        <xbrli:endDate>2025-04-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-04-282025-04-28_custom_FSATravelLLCMember_us-gaap_PreferredStockMember_custom_SeriesOPreferredStockMember_custom_PurchaseAgreementMember_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">NTRP:FSATravelLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesOPreferredStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:PurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-04-28</xbrli:startDate>
        <xbrli:endDate>2025-04-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-04-282025-04-28_custom_FSATravelLLCMember_us-gaap_CommonStockMember_custom_PurchaseAgreementMember_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">NTRP:FSATravelLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:PurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-04-28</xbrli:startDate>
        <xbrli:endDate>2025-04-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-04-09_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-04-09</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-04-09_us-gaap_SubsequentEventMember_custom_NoteOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">NTRP:NoteOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-04-09</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-04-09_us-gaap_SubsequentEventMember_custom_NoteTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">NTRP:NoteTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-04-09</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-05-06_custom_LineOfCreditAgreementMember_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:LineOfCreditAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-05-06</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-05-062025-05-06_custom_LineOfCreditAgreementMember_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:LineOfCreditAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-05-06</xbrli:startDate>
        <xbrli:endDate>2025-05-06</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-04-09_custom_LineOfCreditAgreementMember_custom_TwoPromissoryNotesMember_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:LineOfCreditAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">NTRP:TwoPromissoryNotesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-04-09</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    <xbrli:unit id="Pure">
      <xbrli:measure>xbrli:pure</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="sqft">
      <xbrli:measure>utr:sqft</xbrli:measure>
    </xbrli:unit>
  <ix:relationship fromRefs="Fact000171" toRefs="Footnote000201"/>
  <ix:relationship fromRefs="Fact000172" toRefs="Footnote000201"/>
  <ix:relationship fromRefs="Fact000190" toRefs="Footnote000201"/>
  <ix:relationship fromRefs="Fact000191" toRefs="Footnote000201"/>
  <ix:relationship fromRefs="Fact000300" toRefs="Footnote000331"/>
  <ix:relationship fromRefs="Fact000302" toRefs="Footnote000331"/>
  <ix:relationship fromRefs="Fact000304" toRefs="Footnote000331"/>
  <ix:relationship fromRefs="Fact000306" toRefs="Footnote000331"/>
  <ix:relationship fromRefs="Fact000308" toRefs="Footnote000331"/>
  <ix:relationship fromRefs="Fact000310" toRefs="Footnote000331"/>
  <ix:relationship fromRefs="Fact000312" toRefs="Footnote000331"/>
  <ix:relationship fromRefs="Fact000314" toRefs="Footnote000331"/>
  <ix:relationship fromRefs="Fact000316" toRefs="Footnote000331"/>
  <ix:relationship fromRefs="Fact000318" toRefs="Footnote000331"/>
  <ix:relationship fromRefs="Fact000320" toRefs="Footnote000331"/>
  <ix:relationship fromRefs="Fact000322" toRefs="Footnote000331"/>
  <ix:relationship fromRefs="Fact000324" toRefs="Footnote000331"/>
  <ix:relationship fromRefs="Fact000326" toRefs="Footnote000331"/>
  <ix:relationship fromRefs="Fact000328" toRefs="Footnote000331"/>
  <ix:relationship fromRefs="Fact000330" toRefs="Footnote000331"/>
  <ix:relationship fromRefs="xdx2ixbrl0337" toRefs="Footnote000540"/>
  <ix:relationship fromRefs="Fact000338" toRefs="Footnote000540"/>
  <ix:relationship fromRefs="Fact000339" toRefs="Footnote000540"/>
  <ix:relationship fromRefs="Fact000340" toRefs="Footnote000540"/>
  <ix:relationship fromRefs="Fact000341" toRefs="Footnote000540"/>
  <ix:relationship fromRefs="xdx2ixbrl0343" toRefs="Footnote000540"/>
  <ix:relationship fromRefs="Fact000345" toRefs="Footnote000540"/>
  <ix:relationship fromRefs="Fact000409" toRefs="Footnote000540"/>
  <ix:relationship fromRefs="Fact000410" toRefs="Footnote000540"/>
  <ix:relationship fromRefs="Fact000411" toRefs="Footnote000540"/>
  <ix:relationship fromRefs="Fact000412" toRefs="Footnote000540"/>
  <ix:relationship fromRefs="Fact000413" toRefs="Footnote000540"/>
  <ix:relationship fromRefs="Fact000415" toRefs="Footnote000540"/>
  <ix:relationship fromRefs="Fact000417" toRefs="Footnote000540"/>
  <ix:relationship fromRefs="Fact000425" toRefs="Footnote000540"/>
  <ix:relationship fromRefs="Fact000427" toRefs="Footnote000540"/>
  <ix:relationship fromRefs="Fact000435" toRefs="Footnote000540"/>
  <ix:relationship fromRefs="xdx2ixbrl0437" toRefs="Footnote000540"/>
  <ix:relationship fromRefs="Fact000445" toRefs="Footnote000540"/>
  <ix:relationship fromRefs="Fact000447" toRefs="Footnote000540"/>
  <ix:relationship fromRefs="Fact000455" toRefs="Footnote000540"/>
  <ix:relationship fromRefs="xdx2ixbrl0457" toRefs="Footnote000540"/>
  <ix:relationship fromRefs="Fact000465" toRefs="Footnote000540"/>
  <ix:relationship fromRefs="Fact000467" toRefs="Footnote000540"/>
  <ix:relationship fromRefs="Fact000475" toRefs="Footnote000540"/>
  <ix:relationship fromRefs="Fact000477" toRefs="Footnote000540"/>
  <ix:relationship fromRefs="xdx2ixbrl0485" toRefs="Footnote000540"/>
  <ix:relationship fromRefs="Fact000487" toRefs="Footnote000540"/>
  <ix:relationship fromRefs="xdx2ixbrl0495" toRefs="Footnote000540"/>
  <ix:relationship fromRefs="Fact000497" toRefs="Footnote000540"/>
  <ix:relationship fromRefs="xdx2ixbrl0505" toRefs="Footnote000540"/>
  <ix:relationship fromRefs="Fact000507" toRefs="Footnote000540"/>
  <ix:relationship fromRefs="Fact000527" toRefs="Footnote000540"/>
  <ix:relationship fromRefs="Fact000529" toRefs="Footnote000540"/>
  <ix:relationship fromRefs="Fact000537" toRefs="Footnote000540"/>
  <ix:relationship fromRefs="Fact000539" toRefs="Footnote000540"/>
  </ix:resources>
 </ix:header>
</div>


<p style="font: bold 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Rule-Page --><div style="padding: 0pt; margin-top: 0pt; width: 100%; margin-right: 0pt; margin-bottom: 0pt"><div style="border-top: Black 4pt solid; margin-top: 0pt; font-size: 1pt; border-bottom: Black 1pt solid; padding: 0pt; margin-right: 0pt; margin-bottom: 0pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: bold 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 18pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>UNITED
STATES</b></span></p>

<p style="font: bold 18pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>SECURITIES
AND EXCHANGE COMMISSION</b></span></p>

<p style="font: bold 12pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 12pt"><b>WASHINGTON,
D.C. 20549</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 18pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>FORM
<span id="xdx_90B_edei--DocumentType_c20240301__20250228_zqCfKtb7o9ci"><ix:nonNumeric contextRef="From2024-03-01to2025-02-28" id="Fact000013" name="dei:DocumentType">10-K</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_edei--DocumentAnnualReport_c20240301__20250228_zVbUY2T9fTa9"><ix:nonNumeric contextRef="From2024-03-01to2025-02-28" format="ixt:booleantrue" id="Fact000014" name="dei:DocumentAnnualReport">&#9746;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ANNUAL
                                            REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For
    the fiscal year ended <span id="xdx_902_edei--DocumentPeriodEndDate_c20240301__20250228_zIMTQIuY1Go1"><ix:nonNumeric contextRef="From2024-03-01to2025-02-28" format="ixt:datemonthdayyearen" id="Fact000015" name="dei:DocumentPeriodEndDate"><span id="xdx_909_edei--CurrentFiscalYearEndDate_c20240301__20250228_z9vmQqsiQ8Hj"><ix:nonNumeric contextRef="From2024-03-01to2025-02-28" format="ixt:datemonthdayen" id="Fact000016" name="dei:CurrentFiscalYearEndDate">February 28</ix:nonNumeric></span>, <span id="xdx_904_edei--DocumentFiscalYearFocus_c20240301__20250228_zIdZRTsAQoD5"><ix:nonNumeric contextRef="From2024-03-01to2025-02-28" id="Fact000017" name="dei:DocumentFiscalYearFocus">2025</ix:nonNumeric></span></ix:nonNumeric></span></b></span></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>or</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_edei--DocumentTransitionReport_c20240301__20250228_zeamIuVyzfNf"><ix:nonNumeric contextRef="From2024-03-01to2025-02-28" format="ixt:booleanfalse" id="Fact000018" name="dei:DocumentTransitionReport">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>TRANSITION
                                            REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For
    the transition period from ______ to ______</b></span></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Commission
file number: <b><span id="xdx_901_edei--EntityFileNumber_c20240301__20250228_zuTppvcnUTwg"><ix:nonNumeric contextRef="From2024-03-01to2025-02-28" id="Fact000019" name="dei:EntityFileNumber">001-38015</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 18pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b><span id="xdx_902_edei--EntityRegistrantName_c20240301__20250228_zx88RWRBwn3e"><ix:nonNumeric contextRef="From2024-03-01to2025-02-28" id="Fact000020" name="dei:EntityRegistrantName">NEXTTRIP,
INC.</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Exact
name of registrant as specified in its charter)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_900_edei--EntityIncorporationStateCountryCode_c20240301__20250228_zNpBttKDwqv4"><ix:nonNumeric contextRef="From2024-03-01to2025-02-28" format="ixt-sec:stateprovnameen" id="Fact000021" name="dei:EntityIncorporationStateCountryCode">Nevada</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_903_edei--EntityTaxIdentificationNumber_c20240301__20250228_zjT3D159UMY9"><ix:nonNumeric contextRef="From2024-03-01to2025-02-28" id="Fact000022" name="dei:EntityTaxIdentificationNumber">27-1865814</ix:nonNumeric></span></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(State
    or other jurisdiction of</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(I.R.S.
    Employer</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">incorporation
    or organization)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Identification
    Number)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_901_edei--EntityAddressAddressLine1_c20240301__20250228_z0CbcJcblvGb"><ix:nonNumeric contextRef="From2024-03-01to2025-02-28" id="Fact000023" name="dei:EntityAddressAddressLine1">3900
Paseo del Sol</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_906_edei--EntityAddressCityOrTown_c20240301__20250228_zFMYuKDN4MTf"><ix:nonNumeric contextRef="From2024-03-01to2025-02-28" id="Fact000024" name="dei:EntityAddressCityOrTown">Santa
Fe</ix:nonNumeric></span>, <span id="xdx_908_edei--EntityAddressStateOrProvince_c20240301__20250228_zkmduj3rtlNb"><ix:nonNumeric contextRef="From2024-03-01to2025-02-28" format="ixt-sec:stateprovnameen" id="Fact000025" name="dei:EntityAddressStateOrProvince">New Mexico</ix:nonNumeric></span> <span id="xdx_905_edei--EntityAddressPostalZipCode_c20240301__20250228_zCVQADwh474h"><ix:nonNumeric contextRef="From2024-03-01to2025-02-28" id="Fact000026" name="dei:EntityAddressPostalZipCode">87507</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Address
of principal executive offices)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90C_edei--CityAreaCode_c20240301__20250228_zGHC9PtzEpoe"><ix:nonNumeric contextRef="From2024-03-01to2025-02-28" id="Fact000027" name="dei:CityAreaCode">(954)</ix:nonNumeric></span>
<span id="xdx_90E_edei--LocalPhoneNumber_c20240301__20250228_zbzxOpX4J3Ei"><ix:nonNumeric contextRef="From2024-03-01to2025-02-28" id="Fact000028" name="dei:LocalPhoneNumber">526-9688</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Registrant&#8217;s
telephone number, including area code):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities
registered pursuant to Section 12(b) of the Act:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 36%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
    of each class</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 20%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trading
    Symbol(s)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 1pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 40%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
    of each exchange on which registered</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_edei--Security12bTitle_c20240301__20250228_zq3xH2yuiqUb"><ix:nonNumeric contextRef="From2024-03-01to2025-02-28" id="Fact000029" name="dei:Security12bTitle">Common
    Stock, par value $0.001 per share</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_edei--TradingSymbol_c20240301__20250228_zQpqKIXeNaId"><ix:nonNumeric contextRef="From2024-03-01to2025-02-28" id="Fact000030" name="dei:TradingSymbol">NTRP</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_edei--SecurityExchangeName_c20240301__20250228_z01wqD8nnpyc"><ix:nonNumeric contextRef="From2024-03-01to2025-02-28" format="ixt-sec:exchnameen" id="Fact000031" name="dei:SecurityExchangeName">The
    NASDAQ Stock Market LLC</ix:nonNumeric></span></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities
registered pursuant to Section 12(g) of the Act: None.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes &#9744; <span id="xdx_90F_edei--EntityWellKnownSeasonedIssuer_c20240301__20250228_zRTXkoHIqAN3"><ix:nonNumeric contextRef="From2024-03-01to2025-02-28" id="Fact000032" name="dei:EntityWellKnownSeasonedIssuer">No</ix:nonNumeric></span> &#9746;.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes &#9744; <span id="xdx_909_edei--EntityVoluntaryFilers_c20240301__20250228_zKOHmIb4EHna"><ix:nonNumeric contextRef="From2024-03-01to2025-02-28" id="Fact000033" name="dei:EntityVoluntaryFilers">No</ix:nonNumeric></span> &#9746;.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 13.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange
Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)
has been subject to such filing requirements for the past 90 days. Yes &#9744;. <span id="xdx_908_edei--EntityCurrentReportingStatus_c20240301__20250228_zAhvEx1chd84"><ix:nonNumeric contextRef="From2024-03-01to2025-02-28" id="Fact000034" name="dei:EntityCurrentReportingStatus">No</ix:nonNumeric></span> &#9746;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule
405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_edei--EntityInteractiveDataCurrent_c20240301__20250228_zKwZKhUbVZti"><ix:nonNumeric contextRef="From2024-03-01to2025-02-28" id="Fact000035" name="dei:EntityInteractiveDataCurrent">Yes</ix:nonNumeric></span>
&#9746;. No &#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting
company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221;
&#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act. (Check one):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 13.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 60%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Large
    accelerated filer &#9744;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 40%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accelerated
    filer &#9744;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_edei--EntityFilerCategory_c20240301__20250228_z9yGKG7ugBIa"><ix:nonNumeric contextRef="From2024-03-01to2025-02-28" format="ixt-sec:entityfilercategoryen" id="Fact000036" name="dei:EntityFilerCategory">Non-accelerated
filer</ix:nonNumeric></span> &#9746;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Smaller
    reporting company <span id="xdx_908_edei--EntitySmallBusiness_c20240301__20250228_zAIZeXLCl6oj"><ix:nonNumeric contextRef="From2024-03-01to2025-02-28" format="ixt:booleantrue" id="Fact000037" name="dei:EntitySmallBusiness">&#9746;</ix:nonNumeric></span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging
    growth company <span id="xdx_90D_edei--EntityEmergingGrowthCompany_c20240301__20250228_ztb3M5TlJiga"><ix:nonNumeric contextRef="From2024-03-01to2025-02-28" format="ixt:booleanfalse" id="Fact000038" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></span></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 13.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant has filed a report on and attestation to its management&#8217;s assessment of the effectiveness
of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered
public accounting firm that prepared or issued its audit report.<span id="xdx_902_edei--IcfrAuditorAttestationFlag_c20240301__20250228_z9LjvYUFQl5g"> <ix:nonNumeric contextRef="From2024-03-01to2025-02-28" format="ixt:booleanfalse" id="Fact000039" name="dei:IcfrAuditorAttestationFlag">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant
included in the filing reflect the correction of an error to previously issued financial statements. <span id="xdx_90A_edei--DocumentFinStmtErrorCorrectionFlag_c20240301__20250228_zmJqYDBKfAx5"><ix:nonNumeric contextRef="From2024-03-01to2025-02-28" format="ixt:booleanfalse" id="Fact000040" name="dei:DocumentFinStmtErrorCorrectionFlag">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation
received by any of the registrant&#8217;s executive officers during the relevant recovery period pursuant to &#167;240.10D-1(b). &#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes &#9744;. No <span id="xdx_903_edei--EntityShellCompany_dbF_c20240301__20250228_znrHZMyC2frd"><ix:nonNumeric contextRef="From2024-03-01to2025-02-28" format="ixt:booleanfalse" id="Fact000041" name="dei:EntityShellCompany">&#9746;</ix:nonNumeric></span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 13.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
on the closing price of the registrant&#8217;s common stock as reported on the Nasdaq Capital Market, the aggregate market value of the
Registrant&#8217;s common stock held by non-affiliates on August 31, 2024 (the last business day of the registrant&#8217;s most recently
completed second fiscal quarter) was approximately $<span id="xdx_90B_edei--EntityPublicFloat_iI_c20240831_z14iQRO8TDek"><ix:nonFraction name="dei:EntityPublicFloat" contextRef="AsOf2024-08-31" id="Fact000042" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,817,106</ix:nonFraction></span>. Shares of common stock held by directors and executive officers and any
ten percent or greater stockholders and their respective affiliates have been excluded from this calculation, because such stockholders
may be deemed to be &#8220;affiliates&#8221; of the registrant. This is not necessarily determinative of affiliate status for other purposes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
number of outstanding shares of the registrant&#8217;s common stock as of May 28, 2025 was <span id="xdx_907_edei--EntityCommonStockSharesOutstanding_iI_c20250528_zRcX5N4QsNy8"><ix:nonFraction name="dei:EntityCommonStockSharesOutstanding" contextRef="AsOf2025-05-28" id="Fact000043" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">7,653,525</ix:nonFraction></span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Documents
incorporated by reference: <span id="xdx_902_edei--DocumentsIncorporatedByReferenceTextBlock_c20240301__20250228_zoMcImAB1wM1"><ix:nonNumeric contextRef="From2024-03-01to2025-02-28" escape="true" id="Fact000044" name="dei:DocumentsIncorporatedByReferenceTextBlock">None</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Rule-Page --><div style="padding: 0pt; margin-top: 0pt; width: 100%; margin-right: 0pt; margin-bottom: 0pt"><div style="border-top: Black 1pt solid; margin-top: 0pt; font-size: 1pt; border-bottom: Black 4pt solid; padding: 0pt; margin-right: 0pt; margin-bottom: 0pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NEXTTRIP,
INC.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FORM
10-K &#8212; FISCAL YEAR ENDED FEBRUARY 28, 2025</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>TABLE
OF CONTENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td colspan="3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_001">PART I</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 0.5in; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
    1.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_002">BUSINESS</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
    1A.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_003">RISK FACTORS</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">18</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
    1B.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_004">UNRESOLVED STAFF COMMENTS</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">31</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
    1C.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_005">CYBERSECURITY</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">31</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
    2.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_006">PROPERTIES</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">32</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
    3.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_007">LEGAL PROCEEDINGS</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">32</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
    4.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_008">MINE SAFETY DISCLOSURES</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">32</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td colspan="3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_009">PART II</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
    5.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_010">MARKET FOR REGISTRANT&#8217;S COMMON EQUITY, RELATED STOCKHOLDER MATTERS, AND ISSUER PURCHASES OF EQUITY SECURITIES</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">33</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
    6.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_011">[RESERVED]</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">33</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
    7.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_012">MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">33</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
    7A.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_013">QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">41</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
    8.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_014">FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">41</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
    9.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_015">CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">41</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
    9A.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_016">CONTROLS AND PROCEDURES</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">42</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
    9B.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_017">OTHER INFORMATION</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">43</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
    9C.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><a href="#a_018"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">43</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td colspan="3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_019">PART III</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
    10.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_020">DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">44</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
    11.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><a href="#a_021"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">EXECUTIVE COMPENSATION</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">51</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
    12.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_022">SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">64</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
    13.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_023">CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">69</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
    14.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_024">PRINCIPAL ACCOUNTING FEES AND SERVICES</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">71</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td colspan="3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_025">PART IV</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
    15.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_026">EXHIBITS, FINANCIAL STATEMENT SCHEDULES</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">72</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
    16.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_027">FORM 10-K SUMMARY</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">74</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td colspan="3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a_028">SIGNATURES</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">75</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


   <!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DISCLOSURE
REGARDING FORWARD-LOOKING STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Annual Report on Form 10-K (this &#8220;Report&#8221;), including any documents which may be incorporated by reference into this Report,
contains &#8220;forward-looking statements&#8221; within the meaning of Section 27A of the Securities Act of 1933, as amended (the &#8220;Securities
Act&#8221;), and Section 21E of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;). All statements other
than statements of historical fact are forward-looking statements for purposes of these provisions, including, but not limited to, statements
regarding our expectations about development and commercialization of our technology, any projections of revenues or statements regarding
our anticipated revenues or other financial items, any statements of the plans and objectives of management for future operations, any
statements concerning proposed new products or services, any statements regarding future economic conditions or performance, and any
statements of assumptions underlying any of the foregoing. All forward-looking statements included in this document are made as of the
date hereof and are based on information available to us as of such date. We assume no obligation to update any forward-looking statement.
In some cases, forward-looking statements can be identified by the use of terminology such as &#8220;may,&#8221; &#8220;will,&#8221;
&#8220;expects,&#8221; &#8220;plans,&#8221; &#8220;anticipates,&#8221; &#8220;intends,&#8221; &#8220;believes,&#8221; &#8220;estimates,&#8221;
&#8220;potential,&#8221; or &#8220;continue,&#8221; or the negative thereof or other comparable terminology. Although we believe that
the expectations reflected in the forward-looking statements contained herein are reasonable, there can be no assurance that such expectations
or any of the forward-looking statements will prove to be correct, and actual results could differ materially from those projected or
assumed in the forward-looking statements. Future financial condition and results of operations, as well as any forward-looking statements
are subject to inherent risks and uncertainties, including any other factors referred to in our press releases and reports filed with
the Securities and Exchange Commission (the &#8220;SEC&#8221;). All subsequent forward-looking statements attributable to the Company
or persons acting on its behalf are expressly qualified in their entirety by these cautionary statements. Certain factors that may have
a direct bearing on our operating results are described under &#8220;Risk Factors&#8221; and elsewhere in this Report.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 3; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_001"></span>PART
I</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="a_002"></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM
1. BUSINESS.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Overview</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NextTrip,
Inc. (the &#8220;Company,&#8221; &#8220;NextTrip,&#8221; &#8220;we,&#8221; &#8220;us&#8221; and &#8220;our&#8221;) is an early-stage,
technology-driven travel company developing an integrated travel booking and media platform designed to connect leisure, group and business
travelers to the world. Our travel booking platform is powered by our proprietary NXT2.0 booking engine, which offers extensive inventory,
supporting both travelers and distributors with a platform for curating personalized experiences and efficient trip planning and booking.
We market our travel services through several core brands including NextTrip Vacations (direct-to-consumer leisure travel), Five Star
Alliance (luxury and cruise bookings) and NextTrip Business (small-to-mid-sized corporate travel) and differentiate our platform through
specialty features, including specialized widgets for groups (the &#8220;Groups Platform&#8221;) and travel agents (the &#8220;Travel
Agent Platform&#8221;) and PayDlay, a delayed payment booking option. Complementing our booking engine are our media properties, including
Journy.tv, Compass.tv and Travel Magazine, which provide destination content that we believe will drive high-intention traffic into our
booking funnel and, over time, constitute a separate high-margin advertising revenue stream.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Because
we are at an early stage of commercial development and have only nominal revenues to date, our ability to implement our business plan
depends on our ability to successfully expand our supplier relationships, attract customers, and secure adequate capital to fund marketing
and future product development. There can be no assurance that we will be able to do so.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By
integrating our media properties with our travel booking platform, our ambition is to build a next-generation travel solution for consumers,
allowing them to better research and explore desired travel destinations. To accomplish this, we will be using content from ours and
others&#8217; media platforms featuring travel videos, blogs and articles along with access to curated travel products from our strategic
partnerships, all supported by our technology and call center agents. Upon full integration of our travel and media platforms, we believe
our offers will both inspire and empower consumers to make informed choices when booking. This contrasts with the existing online travel
agency (&#8220;OTA&#8221;) model that focuses on volume bookings with little to no service support.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NXT2.0
&#8211; Our Integrated Travel Booking Platform</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
the core of our business is our proprietary, direct-to-consumer NXT2.0 travel booking engine, which has been continually enhanced and
developed through a series of acquisitions of a variety of media and travel assets. NXT2.0 powers several websites, including our main
leisure site, nexttrip.com, and fivestaralliance.com, our widgets for The Groups and Travel Agent Platforms, as well as providing travel
booking solutions for our media hubs, Journy.tv, travelmagazine.com and Compass.tv. We serve both leisure and business travelers by offering
them access to travel blogs, videos and concierge assistance to aid in planning travel, coupled with our proprietary booking platform
for the direct purchase of flights, hotels, vacation homes, cruise, tours, and other travel products. Our content includes destination
guides, maps and travel tips, designed to help travelers plan memorable trips and book those trips on our travel platform.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Development
of the Platform</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prior
to the COVID-19 pandemic, NextTrip (then known as Monaker Group) ran its travel business, which included the sale of vacation rentals,
and in particular, alternative lodging rentals (&#8220;ALRs&#8221;), to consumers through its proprietary booking engine (NXT1.0). In
June 2022, NextTrip acquired the Bookit.com booking engine with a plan to integrate Bookit.com&#8217;s technology into NextTrip&#8217;s
existing booking platform to create NXT2.0. The acquisition of the Bookit.com asset included the Bookit.com booking engine, customer
lists, all content associated with hotel and destination product in the booking engine, including pictures, hotel descriptions, restaurant
descriptions, room descriptions, amenity descriptions, destination information, and source code related thereto, as well as all contracts
and agreements of Bookit.com. Previously, the acquired technology powered the Bookit.com business, a well-established online leisure
travel agent generating over $400 million in annual sales as recently as 2019 (pre-pandemic). As part of the acquisition of the assets
of Bookit.com, NextTrip was not only able to acquire a proven technology platform that could be integrated with its core travel sectors,
but it was also able to secure the Bookit.com database with millions of past travelers and opt-in consumers. The combination of technology
and infrastructure, travel contracts and property details and traveler data helped drastically accelerate NextTrip&#8217;s potential
capabilities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 4; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since
2022, we have been focused on the integration of Bookit.com into the NXT2.0 technology platform, which serves as a base for current and
future technology projects as well as proprietary system enhancements, as well as the development of additional specialized features
and core brands. One of the key areas of focus related to integrating application programming interfaces (&#8220;APIs&#8221;) into the
NXT2.0 technology platform. This process involves first identifying travel providers, negotiating relevant contracts, obtaining API keys
and agreeing to terms of use. NextTrip developers then write code to connect the APIs into the NXT2.0 platform, map and normalize the
relevant data and then complete the front-end user interface integration. As part of the acquisition of the Bookit.com assets, NextTrip
was afforded access to approximately 250 third-party travel suppliers with previously developed APIs that gave Bookit.com access to these
significant travel products. Although the relevant contracts were terminated when Bookit.com was closed during the COVID-19 pandemic,
NextTrip acquired all the data, tools and APIs to re-approach such travel providers for a seamless re-launch of previously existing product
offerings, which helped to accelerate NextTrip&#8217;s entry into a wide range of markets.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
launched our platform in May 2023 with limited listings. Since then, we have scaled by adding strategic product suppliers resulting in
over four million hotel properties, vacation rental homes and cruise products, giving NextTrip a comprehensive global leisure travel
inventory base.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Travel
Products and Services</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
with many OTAs or booking engines in the travel industry, a travel booking platform is the technological foundation of the business.
The key to operating and scaling the NXT2.0 booking engine is to add inventory and products to the platform to generate sales and revenues
to NextTrip. Inventory and product offerings are not all created equal and consist chiefly of (1) direct contracts, which are negotiated
directly with the travel provider and generally generate higher gross margins to the platform, and (2) third-party API content, which
is lower margin but can drastically broaden inventory and support the integration of specialty products and features which leads to cross-selling
and additional revenue to the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Our
Direct Contract Strategy</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
initial focus was to negotiate direct connectivity and fixed base pricing contracts with hotels and travel suppliers and to integrate
the products into the NXT2.0 booking engine. This allowed us to set our own pricing and control our margins for the leisure and vacation
travel products. This flexibility affords us the opportunity to run specials on travel offerings that are highly competitive but will
require additional funding to support comprehensive marketing and awareness campaigns to attract new customers. Until this happens, we
are working to target customers with low dollar marketing campaigns in the leisure travel space, as well as pursuing strategic partnerships
and specialized travel offerings (e.g. Groups Platform), while maintaining competitiveness within our marketplace through adjustment
of pricing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 3, 2025, we announced once such direct partnership with Intimate Hotels of Barbados (&#8220;IHB&#8221;), a collection of over 35
independent hotels and vacation rentals. NextTrip will serve as the official booking engine for IHB, providing a fully integrated travel
portal and customized packaging tools directly on the IHB website.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Our
Inventory Expansion and API Strategy</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
supplement the supply of higher margin direct inventory and to allow us to grow our specialized features, including business as well
as our Groups and Travel Agent platforms, we first started tapping into previously existing Bookit.com inventory and negotiated contracts
for travel products that can be imported to our NXT2.0 booking engine via API links over the last 12 to 15 months. This inventory can
come in many forms with differing pricing models. Major suppliers include Expedia (accessing their worldwide hotel product), Nuit&#233;e
(accessing both Hotel and Vacation Rental Homes), Global Distribution Systems (for access to luxury hotels and activities), and Signature
Vacations (via Five Star Alliance for access to all major cruise lines). These established suppliers provide us with significant additional
content and product in our booking engine. Although such products are not unique to NextTrip, we believe we have achieved the necessary
depth and breadth of travel market inventory (i.e. over four million hotels and vacation rental homes worldwide as well as cruise and
vacation activities products) through these major suppliers to better utilize our specialty features and develop a foundation upon which
to further obtain and launch higher-margin direct inventory.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
foundation of our inventory strategy began via the Bookit.com acquisition and access to Expedia&#8217;s worldwide hotel product and related
APIs. We continued that strategy recently with the announcement of a strategic partnership with Nuit&#233;e, a premier global hotel
API provider. Through this collaboration, we are strategically integrating Nuit&#233;e&#8217;s extensive lodging portfolio, featuring
up to 1.5 million properties, into our travel booking platform.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 5; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
further expanded our product offerings in the luxury travel and cruise industries with our recent acquisition of Five Star Alliance.
Founded in 2004, Five Star Alliance is a premier luxury travel agency known for its curated collection of over 5,000 five-star hotels
and resorts worldwide. Five Star Alliance offers personalized recommendations, high-end travel solutions, a proprietary booking engine
and established relationships with premium travel providers, resulting in an industry coveted 4.9-star Trustpilot rating. These combined
offers have resulted in monthly site visits from over 400,000 viewers and are expected to align seamlessly with NextTrip&#8217;s technology-driven
approach. See &#8220;<i>Recent Developments &#8211; Acquisition of Five Star Alliance</i>&#8221; for more details on the transaction.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Core
Product Offerings</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NextTrip&#8217;s
offerings include a mixture of direct contracts and third-party API content which span leisure and business travel, alternative lodging,
wellness travel, and media solutions, engaging customers throughout their travel journey with both individual and packaged options. One
of the key pillars of the NextTrip ecosystem is NextTrip Vacations, which is our core platform, powered by NXT2.0, delivering seamless
booking and customizable travel options across airlines, hotels, cruise, ground activities, and more. NextTrip has enhanced its offerings
to include luxury travel products and services with the acquisition of Five Star Alliance, providing travelers with curated packages
and detailed trip planning information through an intuitive booking system and/or its concierge help desk. Such additional product offering
highlights include:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NextTrip
    Leisure</b> &#8211; A robust booking engine providing customized vacation packages, flights, hotels, tours, wellness vacations, cruise
    and group travel options.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NextTrip
    Luxury &amp; Business</b> &#8211; Five Star Alliance provides access to over 5,000 luxury hotel properties worldwide featuring booking,
    expense reporting, concierge services, and 24/7 support.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NextTrip
    Cruises</b> &#8211; a fully integrated cruise booking engine providing access to over 10,000 sailings and 35 cruise partners. Travelers
    benefit from exclusive pricing, concierge service, and bundled packages that include transfers, pre- and post-cruise stays, and expert
    travel support.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NextTrip
    Solutions</b> &#8211; A suite for product management and white-label solutions, including property management, vacation rentals,
    and a portal to support travel agents &#8211; the Travel Agent Platform.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NextTrip
    Media</b> &#8211; Travel Magazine, Journy.tv and Compass.tv offering travelers inspiration and information through articles, videos,
    and immersive digital experiences. This will include personalized travel content for users to explore and share with friends and
    family.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>NXT2.0
Platform Features</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Existing
Features</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
marketplace at nexttrip.com offers tools for browsing and comparing flights, hotels, tours, cruises and activities. Additionally, we
allow travelers to defer payments on select vacation packages with our proprietary PayDlay program. PayDlay allows travelers to purchase
travel with a small deposit and make subsequent payments between purchase and the week before travel. Registered NextTrip travelers can
manage bookings, receive updates on special offers, and subscribe to newsletters with travel tips and destination highlights. Security
is a priority, with rigorous content screening and Payment Card Industry compliance to safeguard customer information.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NXT2.0
equips travelers with a seamlessly integrated planning and booking ecosystem that begins with inspiration and ends well after the trip
is complete. Within a personalized profile, users can explore a curated library of videos and editorial content tailored to their interests,
earmark preferred destinations and activities for future reference, and lean on a dedicated concierge team for travel planning support.
When it comes time to confirm arrangements, travelers may transact digitally through the platform&#8217;s intuitive booking engine or
speak directly with a call-center specialist, all while enjoying the flexibility of proprietary payment tools such as PayDlay, which
allows for manageable installments without compromising travel dates or inventory.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beyond
the individual traveler, NXT2.0 delivers distinct competitive advantages through exclusive supplier partnerships that unlock preferential
rates and targeted promotions. Its robust technology stack seamlessly supports group bookings for both corporate and leisure itineraries
and offers a specialized interface for professional travel agents via the Travel Agent Platform, ensuring efficient management of complex,
multi-passenger reservations. Comprehensive customer support persists from the moment of inquiry through the post-travel experience,
demonstrating NXT2.0&#8217;s commitment to end-to-end service excellence and sustained traveler satisfaction.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 6; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Travel Agent Platform has reached the minimum viable product stage of development by capitalizing on the former technology and relationships
from NextTrip&#8217;s Bookit.com booking engine acquisition as well as attracting significant new travel supplier partnerships through
Five Star Alliance. These combined purchases have given NextTrip the needed product breadth to be able to launch a competitive travel
agent program by mid-year 2025. The Company currently has over 150 travel agents helping with its beta testing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Groups Platform initial version has been launched. It provides users with a solution for more complex travel needs such as conferences,
conventions and destination weddings through our group&#8217;s widget. This is an underserved and emerging market. Initial results are
promising, as the Company completed several group bookings on the Groups Platform in the first 60 days from leads generated by Five Star
Alliance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Features
in Development</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
NextTrip executes its business model by increasing its inventory base and expanding key partnerships, it plans to launch a series of
additional features designed to benefit its users. We intend to further integrate NextTrip&#8217;s media features with its booking system,
bringing together travel content and itinerary management in one interface. The &#8220;My Journy&#8221; personalized travel-planning
magazine is intended to provide editorial features, destination information, and user-specific offers based on analysis of past searches
and bookings. By including this content in the booking process, NXT2.0 aims to turn browsing into bookings more efficiently and give
suppliers better opportunities to promote their products.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NextTrip
also plans to introduce a multi-level Rewards program that gives benefits for repeat bookings, using different channels, and social interactions
within the platform. A planned group chat and sharing feature will let families, friends, and corporate groups work together on itinerary
changes in real time. These developmental features are designed to encourage customer loyalty and keep users engaged with NXT2.0. An
AI-powered travel assistant is in development which is intended to provide recommendations, price alerts and support, offering services
usually found in premium travel agencies in a digital format.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following
the initial launch of the Travel Agent Platform, NextTrip is continuing development on new tools for travel agents. With new product
options like cruises, wellness retreats, and extra experiences, NXT2.0 aims to attract more leisure and business travelers. These updates
are intended to boost user engagement, speed up bookings, and increase customer value, while giving NextTrip a competitive edge through
technology and personalized data.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Technology
and Infrastructure</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
websites are hosted using cloud services distributed globally across multiple regions. Our system&#8217;s architecture has been designed
to manage increases in traffic through additional computing power without making software changes. Our cloud services provide our online
marketplace with scalable and redundant Internet connectivity and redundant power and cooling to its hosting environments. We use security
methods to ensure the integrity of our networks and protection of confidential data collected and stored on our servers. We have developed
and use internal policies and procedures to protect the personal information of our travelers using our websites that we collect and
use as part of our normal operations. Access to NextTrip&#8217;s networks, and the servers and databases on which confidential data is
stored, is protected by industry standard firewall and encryption technology. Physical access to our servers and related equipment is
secured by limiting access to the data center to operations personnel only.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NextTrip
Integrated Media Solutions</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition to the key features, robust inventory, and focus on underserved market opportunities like groups and travel agent bookings,
a key differentiator benefiting the growth and development of our NXT2.0 booking engine is our media strategy which, when fully integrated
with NXT2.0, is intended to offer a comprehensive travel and media ecosystem designed to guide and support consumers throughout their
travel experience from inspiration to booking, to travel to sharing the journey on social media.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 7; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding: 0pt; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p>


<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><img src="form10-k_001.jpg" alt=""/></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>




<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NextTrip
leverages its media brands&#8212;TravelMagazine.com, Compass.tv, and Journy.tv&#8212;as strategic tools to generate travel bookings by
integrating content, marketing, and booking technology as well as to generate advertising revenues for third-party content. The strategy
includes generating content marketing and inspiration, integrating booking opportunities into that content and generating feedback from
such advertising data to better target and identify travel interests and intent, which is intended to lead to growing brand trust and
authority and future partnerships and opportunities for sponsored advertising content.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By
combining engaging travel content with seamless booking technology and targeted marketing, NextTrip&#8217;s media brands serve as both
inspiration engines and direct booking channels. This holistic approach helps capture travelers at every stage of the decision-making
process, ultimately driving more bookings through the NXT2.0 platform and independent advertising revenue.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Key
Media Brands and Partnerships</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Travel
Magazine</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">TravelMagazine.com
is our media hub. It is an online travel publication that provides articles, guides, tips, and inspiration for travelers. The website
features content on destinations, travel experiences, hotel and restaurant recommendations, and general travel advice. Its audience includes
both casual vacationers and more seasoned travelers seeking ideas and information for their next trip. Coming soon is &#8220;My Bucket
List,&#8221; a platform where travelers can create and share personalized travel lists, supported by booking features and local insights.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Compass.tv
and Journy.tv</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Compass.tv
was launched in Fall 2024, as an AVOD (Advertising-based Video on Demand) platform designed to provide streaming television content,
often focusing on live and on-demand programming. Compass.tv offers over 1,200 hours of travel content including key travel influencers
with millions of followers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
April 2025, the Company acquired Journy.tv, a Free Ad-Supported Streaming TV (&#8220;FAST&#8221;) Channel that specializes in travel,
adventure, and culture-focused content. It is designed for viewers who are passionate about exploring the world, learning about different
cultures, and experiencing unique destinations through high-quality video programming. Journy.tv has contracts with key platforms including
Samsung TV Plus and Plex.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: center"><img src="form10-k_002.jpg" alt=""/></td>
    <td style="width: 2%"/>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: center"><img src="form10-k_003.jpg" alt=""/></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify">In combination, these platforms have 17 million viewers,
and will be combined with multiple influencers that have millions of additional followers on social media platforms. These influencers
are being offered a new way to engage their audiences by using NextTrip travel offerings that can be customized to be highly complementary
to their adventures. We will begin to target travel promotions on Journy.tv as well as destination centric vacation products on Compass.tv.
Additionally, the Company has launched Compass.tv Apps for iPhone and Android, as well as targeted expansion through dedicated CTV apps.
Using artificial intelligence, Compass.tv intends to personalize content, convert blogs into videos, and enable users to create their
own custom travel channels.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Promethean</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Promethean
is our proprietary interactive video overlay platform which is intended to drive ad revenue and facilitate content-to-commerce integration.
The Company purchased a perpetual license from Promethean TV, Inc. and is integrating this platform into Compass.tv and Travel Magazine&#8217;s
video content with interactive overlays that allow users to book travel directly from their screens.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Leap
Media</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
December 2024, NextTrip announced its collaboration with Leap Media Group, a respected leader with over 35 years in TV advertising, media
planning and buying, to support the launch of advertising on Compass.tv by delivering branded entertainment content and advertising seamlessly
across its platform, supported by targeted media strategy designed to optimize revenue well delivering high quality content to travel
enthusiasts.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Blue
Fysh</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
February 2025, the Company and Blue Fysh Holdings Inc. (&#8220;Blue Fysh&#8221;) entered into a share exchange agreement creating minority
ownership positions between the entities, as part of their mutual efforts to work together to expand each company&#8217;s business opportunities.
See &#8220;<i>Recent Developments &#8211; Blue Fysh Share Exchange</i>&#8221; for more details on the transaction.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Blue
Fysh is focused on creating and implementing digital and network solutions that connect people to brands in the places they live, love
and work. Blue Fysh has implemented thousands of digital installations in diverse environments, enabling media content clients to deliver
compelling marketing solutions that connect brands with consumers in high traffic environments.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 9; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
strategic partnership between NextTrip and Blue Fysh is intended to focus on:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 3%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 3%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 94%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expanded
    audience reach integrating NextTrip&#8217;s FAST Channel (Compass.tv), media platform (TravelMagazine.com), and travel products platform
    (NextTrip.com) with Blue Fysh&#8217;s expertise in digital OOH solutions throughout North America;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Increased
    advertising revenue by leveraging their combined media assets, to enhance their ability to broaden reach, deployment, and higher
    expected advertising fees, providing greater value to advertisers and stakeholders;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Enhanced
    sales efforts with NextTrip utilizing Blue Fysh&#8217;s strategic sales relationships to contribute advertising sales across NextTrip&#8217;s
    media platforms; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Increased
    Brand Awareness as a result of Blue Fysh&#8217;s media relationships and digital displays to help create flash marketing campaigns
    to raise awareness of NextTrip and highlight NextTrip&#8217;s travel products and services as well as its media properties, Compass.tv,
    Journy.tv and Travel Magazine.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Revenue
Strategy and Development of an Integrated Travel and Media Ecosystem</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NextTrip&#8217;s
revenue strategy and business model focuses on integrating its Media and Travel divisions, offering users a comprehensive ecosystem designed
to guide and support them throughout the travel experience. Presently, NextTrip generates revenue through two core methods: travel bookings
and advertising revenue.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Travel
Bookings and Related Services</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NextTrip,
like many OTAs and travel platforms, can generate revenue through a variety of channels. The specific
mix depends on the continued development of our platform, execution of our business model, partnerships, and the types of services we
offer at any given time.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Product
sales are generally structured either: (1) as a set commission on the sale of a travel product whereby the supplier or wholesaler controls
the pricing (as is the case with the majority of Five Star Alliance products), or (2) through a direct, negotiated contract between product
supplier and the Company (as is the case with the majority NextTrip&#8217;s products) which allows the Company to set its own retail
pricing based upon market forces and a need to maintain a markup above its fixed cost. Commission-based travel products are generally
lower margin than directly negotiated travel products.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
flexibility of directly negotiated contracts affords the Company the opportunity to both run specials that are highly competitive but
result in low margins, or to simply adjust pricing to maintain competitiveness within its market. Key factors that affect revenues and
profitability include competitive market pressures from other travel suppliers and distributors, variable contract terms, marketing budget
to create awareness, and seasonality.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leisure
travel bookings currently generate the majority of our nominal revenues. This includes the sale of travel products such as airline tickets,
hotel rooms, and cruises as well as travel services such as travel insurance and ground activities. While we believe this revenue can
be accelerated with an enhanced marketing budget, management has largely focused on supplements to its travel offerings by including
travel technology products such as our Travel Agent and Groups Platforms.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additionally,
offering concierge-level customer support, trip planning assistance or other premium features can provide peace of mind and added convenience
and may result in premium service fees added to the cost of booking, which represents direct revenue for NextTrip.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Advertising</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is building its own media and advertising ecosystem through Travel Magazine, Journy.tv and Compass.tv. These media platforms
are designed to allow users to explore and educate themselves on travel. The revenue strategy in the media division is two-pronged: (1)
as the number of viewers/users grows, it drives the advertising rates the Company can charge third-parties to promote travel products
and services to our audience and (2) outside of the direct advertising dollars generated from our media platforms which are expected
to become a key driver of higher margin revenue than those earned from travel product sales, but as the audience grows it will provide
additional opportunities for NextTrip to promote its own travel offerings to highly targeted viewers, thus lessening the need for spending
significant marketing dollars through other mediums to attract consumers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
drive this initiative, the Company has entered into partnerships with Travel Spike and Leap Media Group, respected leaders in the travel
category with decades of experience in TV advertising, media planning and buying. Compass.tv is now equipped to deliver branded entertainment
content and advertising seamlessly across its platform, supported by targeted media strategy designed to optimize revenue well delivering
high quality content to travel enthusiasts.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 10; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Development
of Integrated Revenue Model &#8211; Strategy and Current Status</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
the Company is still in the developmental phase of its commercial operations and has thus far realized only nominal revenues, the successful
execution of our business strategy is predicated upon our capacity to broaden and deepen our supplier base, cultivate and maintain a
robust customer network, and obtain adequate financing to underwrite our marketing initiatives and continued product development. There
can be no assurance that we will be able to accomplish any of these objectives.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NextTrip
is in the early stages of development and roll out of its comprehensive travel and media model. While the products introduced to date
(See above &#8220;<i>NXT2.0 Platform Features &#8211; Existing Features</i>&#8221;) are now functional and responsible for the current,
nominal revenue generation of the Company, the corresponding revenue streams are currently both small and unpredictable relative to the
established travel industry leaders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">While
our core marketing initiatives have been handicapped due to budget constraints, we have undertaken limited promotions focused on higher
margin products, in sought after vacation regions like Mexico and the Caribbean. Recognizing these marketing budget restraints, we focused
our efforts on expanding our product offering globally with major suppliers, including Expedia and Nuit&#233;e, among others. Management
believes this was a critical step to allow for the launch and promotion of specialty travel services like NextTrip&#8217;s Groups Platform
(i.e. destination weddings, conferences and conventions), NextTrip Travel Agents Platform and business-focused travel offerings. These
types of programs require unique technologies, broad global inventory offerings, and specialized servicing. Key to this development is
the fact that the platforms fall outside of the typical OTA business model, thereby justifying the supply of travel products from large
OTAs, which in turn supports our platforms while being mutually beneficial to both parties.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
ability to capitalize on existing travel technology platforms is severely restricted due to the lack of funding to drive marketing programs.
Enhancements to the existing platforms along with the introduction of new programs under development (See above &#8220;<i>NXT2.0 Platform
Features &#8211; Features in Development</i>&#8221;) are needed to complete the model. The timeline to complete these programs is dependent
upon our ability to raise capital; however, we believe that most programs can be delivered within 180 days of obtaining such necessary
funding. Once fully functioning, we believe the model will deliver accelerated growth as its &#8220;conversion technology&#8221; focuses
on underserved areas in the travel sector utilizing platforms (i.e. PayDlay, Groups bookings and Travel Agents) that are not well serviced
by the major travel industry leaders. Additionally, we have introduced engagement and media solutions (i.e. Journy.tv, Compass.tv and
Travel Magazine), allowing users to better plan future travel. We believe a natural extension of providing users with media solutions
to assist with travel planning will further the development and growth of a NextTrip ecosystem. This ecosystem is expected to assist
NextTrip in reducing external marketing expenditures while creating a new revenue channel from targeted and timely advertising designed
to assist users in their travel planning. Upon completion of the NextTrip model, the Company expects to drive revenues from travel solutions
outside of the focus of major travel competitors as highlighted in the table below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center; color: Red"><img src="form10-k_004.jpg" alt=""/></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center; color: Red"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 11; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Key
factors that affect revenues and profitability beyond securing access to inventory (whether wholesale, supplier-controlled or directly-negotiated)
include competitive market pressures from other travel suppliers and distributors, as well as the funding needed to enact a large enough
marketing budget to create awareness. While marketing budget constraints have delayed the launch of an aggressive advertising campaign
designed to scale travel sales, the Company&#8217;s management addressed the issue by shifting focus to building an audience through
media platforms it could control. This included the rebuilding of the Travel Magazine website as well as the launch of Compass.tv with
over 1,200 hours of travel content, both properties able to attract and harness content creators and influencers, each with several million
followers. Key to engaging with these travel influencers was the exclusive license of the Promethean platform, due to be implemented
in the Company&#8217;s second fiscal quarter of 2026, which allows for targeted advertisements to be inserted as overlays onto video
content. The advertising does not interfere with viewing but enables sales of travel products complementary to the viewers selected programs,
including the potential to immediately make a booking. This key feature means the Company, its influencers, viewers and advertisers all
benefit through a call to action, showcasing the right product at the right time.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
accelerate viewership and distribution, the Company acquired Journy.tv in April 2025 from Ovation LLC. The acquisition included original
travel shows, carrier agreements and a viewing audience of over 17 million travel enthusiasts in 2024. By combining Compass.tv, Journy.tv
and Travel Magazine, NextTrip&#8217;s media division has a critical audience in the lucrative North American market, large enough to
attract endemic and programmatic advertisers. Advertising revenue is expected to be further enhanced when the Promethean interactive
overlay technology is introduced, allowing users to transact on calls of action presented on the video stream.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
media team benefits from a range of partners and vendors engaged in driving its potential advertising revenues, from online behemoths
such as Magnite to travel industry experts such as Leap Media and Travel Spike, providing both programmatic and direct advertising sales
around our channels. As the number of viewers/users grows, it not only determines the CPMs (or advertising rates) the Company can charge,
but it should also provide additional opportunities for us to promote our own travel offerings to highly targeted viewers, thus lessening
the need for spending significant marketing dollars through other mediums to attract consumers. Management believes the development of
this ecosystem not only affords access to travelers but also opens up a higher margin advertising revenue stream not previously available.
The Company is also engaging Save Your Day Films, a London-based production company celebrated globally for award-winning factual programming
and captivating travel content, as an in-house production partner to deliver exclusive content as part of Media strategy, driving traffic,
cross-promotional opportunities and licensing revenues.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
order to capitalize on this recent acquisition, the team are engaging PR Firms like FINN, and marketing teams like Jungle Creations to
accelerate channel awareness and audience growth, while exploring opportunities for global distribution with other FAST channel providers
such as Vizio and Whale.tv.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Though
each division can independently drive revenue through their respective channels, we intend to create additional value by bringing the
divisions together to create an engaging consumer-focused ecosystem. Today, we have media and travel operations that largely run independently
but are working towards integrating the platforms to seamlessly move customers from one portion of the ecosystem to the next, with the
ultimate goal of influencing a travel purchase decision.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
such, the key initiative the Company intends to focus on for the balance of 2025 is to complete technological integration between our
media and travel divisions. While both divisions have reached a minimum critical mass levels to allow us to deploy programs, our ability
to grow our nominal revenues will be directly tied to leveraging our media audience through interactive technology, into our travel platforms
to deliver impactful and personalized travel solutions. To accomplish this, we will need to complete the build out of a personalized
social media platform linking the media and travel products which will be called &#8220;My Journy&#8221;. We believe this platform will
become the core of the NextTrip consumer base as it will provide users a platform where they can explore, share and seamlessly move from
one portion of the ecosystem to the next, with the ultimate goal of influencing a travel purchase decision.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
we move into the future, NextTrip intends to add additional revenue streams, including more diversified, exclusive products from around
the world, niche travel segments, technology licensing and enhanced media advertising opportunities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Competition</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
U.S. travel market is highly competitive and rapidly evolving. The markets are dominated by a few key distributors, which has caused
suppliers to look for viable alternatives that would diversify their business mix.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 12; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
competition, which is strong and increasing, includes online and offline travel companies that target leisure and corporate travelers,
including travel agencies, tour operators, travel supplier direct websites and their call centers, consolidators and wholesalers of travel
products and services, large online portals and search websites, certain travel metasearch websites, mobile travel applications, social
media websites, as well as traditional consumer eCommerce and group buying websites. These companies include Expedia, Booking.com, TripAdvisor,
Sabre Corp., TravelZoo and AirBnb. We are an early-stage company with nominal revenues. Though we do consider these companies competitors,
they are all much larger and more advanced in development than our current offerings and we may be unable to raise sufficient capital
or develop our technology at such a rate to compete for meaningful market share. In some cases, competitors are offering more favorable
terms and improved interfaces to suppliers and travelers, which makes competition increasingly difficult. Also, in some cases, we offer
larger, conglomerate wholesale product offerings like Expedia on our site for booking at a lower commission, which is common in the industry.
We also face competition for customer traffic on internet search engines and metasearch websites, which impacts our customer acquisition
and marketing costs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Seasonality</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
experience seasonal fluctuations in the demand for our travel products and services. For example, traditional leisure travel bookings
are generally the highest in the first three quarters as travelers plan and book their spring, summer and winter holiday travel. The
number of bookings typically decreases in the fourth quarter. Because revenue for most of our travel products is recognized when the
travel takes place rather than when it is booked, revenue typically lags bookings by several weeks to several months. As a result, although
travel bookings through NextTrip&#8217;s platforms tend to be highest from the period from January to June, moderate from July through
September and low from October through December, the majority of revenue is recognized in the summer months (June, July, and August),
and during the winter holidays (November and December).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Intellectual
Property</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
intellectual property includes the content of our websites, registered domain names, registered and unregistered trademarks, business
plan, business strategies and trade secrets, proprietary and acquired software platforms and related assets, licensed software platforms,
and customer and third-party supplier lists. We believe that our intellectual property is an essential asset of our business and that
our registered domain names and our technology infrastructure will give us a competitive advantage in the online market and arrangements
with attractions and tour operators. We rely on a combination of trademark, copyright and trade secret laws in the United States, as
well as contractual provisions, to protect our proprietary technology and our brands. We also rely on copyright laws to protect the appearance
and design of our sites and applications. We have registered numerous Internet domain names related to our business in order to protect
our proprietary interests.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
key proprietary software platforms and systems include our booking engine, NXT2.0, which we enhanced through our acquisition and subsequent
integration of the Bookit.com assets; the group travel booking platform, which allows for efficient and streamlined travel planning and
booking for travel groups of five or more; PayDlay technology, which allows travelers to book a trip for as little as $1.00 down and
pay over time with no interest; Travel Magazine, which offers tools to create personalized travel using video, blogs, reviews, tourism
boards and planned AI planner; and our FAST TV channels, Compass.tv and Journey.tv, which aim to inspire audiences by highlighting the
world&#8217;s best travel experiences and offering viewers a rich source of inspiration for planning their next journey.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Regulation</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
ability to provide our services and any future services is affected by legal regulations of governments and regulatory authorities around
the world, many of which are evolving and subject to revised interpretations. Violations of any laws or regulations could result in fines,
penalties, and criminal sanctions against us, our officers or employees, and prohibitions on how or where we conduct our business, which
could damage our reputation, brands, global expansion efforts, ability to attract and retain employees and business partners, business,
and operating results. Even if we comply with these laws and regulations, doing business in certain jurisdictions or violations of these
laws and regulations by the parties with which we conduct business runs the risk of harming our reputation and our brands. Regulations
that impact our business or our industry include:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
<i>Data Protection and Privacy</i>: We have policies and a global governance framework to comply with privacy laws that apply to our
business, meet evolving stakeholder expectations, and support business innovation and growth. In the European Union, the General Data
Protection Regulation (the &#8220;GDPR&#8221;) imposes significant compliance obligations and costs. In the United States, the California
Consumer Privacy Act (the &#8220;CCPA&#8221;) and the California Privacy Rights Act (&#8220;CPRA&#8221;) impose privacy requirements
and rights for consumers in California that will result in additional compliance complexity, risks, and costs. Other U.S. states and
jurisdictions globally have adopted or may adopt similar data protection regulations. Some data protection and privacy laws afford consumers
a private right of action against companies like ours for certain statutory violations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<br/></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
<i>Regulation of the Travel Industry</i>: Our business is impacted by travel-related regulations such as local regulation of the use
of alternative accommodations. Local jurisdictions around the world have instituted a variety of measures to address the issues of &#8220;overtourism&#8221;
and the impact of tourism on the climate. As our business evolves, we expect to become subject to existing and new regulations. For example,
some parts of our business are already subject to certain requirements of the US Department of Transportation (&#8220;DOT&#8221;), and
as our offerings continue to diversify and expand, we may become subject to additional requirements of regulatory agencies across the
world.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
<i>Payments</i>: As we expand our payments services to consumers and business partners, we are subject to additional regulations, such
as financial services regulations and license requirements, which has resulted in increased compliance costs and complexities, including
those associated with the implementation of new or advanced internal controls. We are also subject to payment card association rules
and obligations under our contracts with payment card processors, including the Payment Card Industry Data Security Standard, compliance
with which is complex and costly.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Organizational
History</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Reverse
Acquisition of NextTrip Holdings</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 12, 2023, the Company (formerly known as Sigma Additive Solutions, Inc.) entered into a Share Exchange Agreement with NextTrip
Holdings, Inc. (&#8220;NTH&#8221;), NextTrip Group, LLC (&#8220;NTG&#8221;) and William Kerby (the &#8220;NTH Representative&#8221;),
pursuant to which the Company acquired NTH (the &#8220;NextTrip Acquisition&#8221;) in exchange for shares of our common stock, which
we refer to as the Exchange Shares. The NextTrip Acquisition was consummated on December 29, 2023. As a result, NTH became a wholly owned
subsidiary of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
the closing of the NextTrip Acquisition, the shareholders of NTG (collectively, the &#8220;NTG Sellers&#8221;), were issued a number
of Exchange Shares equal to 19.99%, or 156,007 shares, of our issued and outstanding shares of common stock immediately prior to the
closing. Under the Share Exchange Agreement, the NTG Sellers were entitled to receive additional shares of our common stock, referred
to as the Contingent Shares, subject to NTH&#8217;s achievement of future business milestones (the &#8220;Milestone Events&#8221;) specified
in the Share Exchange Agreement as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 39%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Milestone
    Event</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date
    Earned</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Contingent
    Shares</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 22%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Status
    as of the date of this Prospectus</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Launch
    of NTH&#8217;s leisure travel booking platform by either (i) achieving $1,000,000 in cumulative sales under its historical &#8220;phase
    1&#8221; business, or (ii) commencement of its marketing program under its enhanced &#8220;phase 2&#8221; business.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
    of a date six months after the closing date</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,450,000
    Contingent Shares</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Achieved.
    Marketing program under &#8220;phase 2&#8221; has commenced.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Launch
    of NTH&#8217;s group travel booking platform and signing of at least five (5) entities to use the Groups Platform.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
    of a date nine months from the closing date (or earlier date six months after the closing date)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,450,000
    Contingent Shares</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Achieved.
    Five groups have been contracted to use the Groups Platform.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Launch
    of NTH&#8217;s Travel Agent Platform and signing up of at least 100 travel agents to the platform (which calculation includes individual
    agents of an agency that signs up on behalf of multiple agents).</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
    of a date 12 months from the closing date (or earlier date six months after the closing date)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,450,000
    Contingent Shares</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Achieved.
    The company has signed up more than 175 travel agents to its Travel Agent Platform.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Commercial
    launch of PayDlay technology in the NXT2.0 system.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
    of a date 15 months after the closing date (or earlier date six months after the closing date)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,650,000
    Contingent Shares, less the Exchange Shares issued at the closing of the Acquisition</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Achieved.
    PayDlay has been commercially launched.</span></td></tr>
  </table>

<p style="margin-top: 0; margin-bottom: 0"></p>
<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 14; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Alternatively,
independent of the aforementioned milestones, for each month during the fifteen month period following the closing date in which $1,000,000
or more in gross travel bookings were generated by the combined company, to the extent not previously issued, the Contingent Shares would
be issuable up to the maximum Contingent Shares issuable under the Share Exchange Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Contingent Shares, together with the shares of our common stock issued at the closing, was not to exceed 6,000,000 shares of our common
stock, or approximately 90.2% of our issued and outstanding shares of common stock immediately prior to closing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the NextTrip Acquisition, the Company and Nasdaq determined that the issuance of Contingent Shares upon achievement of
any one of the Milestone Events would result in a change in control of the Company under Nasdaq Listing Rule 5635(a). Pursuant to Nasdaq
Listing Rule 5110(a), the Company was required to submit an initial listing application with Nasdaq and to obtain Nasdaq approval of
the initial listing application prior to the issuance of the Contingent Shares; failure to obtain such approval in advance of the Contingent
Share issuance would have resulted in Nasdaq issuing the Company a delisting determination and commencing delisting proceedings with
respect to its common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 25, 2025, the Company received a letter from Nasdaq notifying the Company that it had approved the Company&#8217;s initial listing
application in connection with the issuance of the Contingent Shares. On March 26, 2025, the Company issued the NTG Sellers an aggregate
of 4,393,993 of the Contingent Shares in satisfaction of the Company&#8217;s obligations under the Share Exchange Agreement</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a result of Nasdaq&#8217;s approval of our initial listing application, the issuance of the Contingent Shares was completed in compliance
with Nasdaq Listing Rule 5110(a) and the Company&#8217;s shares of common stock continue to trade on the Nasdaq Capital Market under
the symbol &#8220;NTRP.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 5, 2025, as a result of the achievement of the fourth and final business milestone, the remaining 1,450,000 Contingent Shares were
issued to the NTG Sellers. No additional shares are issuable pursuant to the Share Exchange Agreement as of the date of this Annual Report.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Share Exchange Agreement provided that William Kerby, the Chief Executive Officer and co-founder of NTH, was appointed as Chief Executive
Officer of the Company and Donald P. Monaco was appointed as a director of the Company as of the closing of the NextTrip Acquisition.
The NTH Representative (Mr. Kerby) will be entitled to designate a replacement for one additional director of the Company upon achievement
of each of the milestones under the Share Exchange Agreement. No such additional appointments have occurred to date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Historical
Monaker Group Business</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NextTrip&#8217;s
travel business was the principal business of NextPlay Technologies, Inc. (then, Monaker Group, Inc. (&#8220;Monaker&#8221;)) until June
30, 2020, when Monaker entered into a share exchange transaction with HotPlay Enterprise Limited (&#8220;HotPlay&#8221;), resulting in
HotPlay becoming a wholly owned subsidiary of Monaker and HotPlay&#8217;s business becoming the principal business of Monaker. Prior
to this share exchange, the primary focus of Monaker had been its travel business, which included the sale of vacation rentals, and in
particular, alternative lodging rentals (&#8220;ALRs&#8221;), to consumers through its proprietary booking engine. To support its travel
offerings, Monaker introduced travelmagazine.com, featuring travel and lifestyle content to appeal to travelers researching destinations
and planning future vacations. In January 2023, NextPlay spun the NextTrip business out to its founders to separate it from NextPlay&#8217;s
primary business. This resulted in NTG operating the NextTrip business, which was held in its wholly-owned subsidiary, NTH.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Acquisition
of Bookit.com Asset</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following
NTH&#8217;s separation from NextPlay, NTH acquired a travel platform, Bookit.com, in June 2022 to help power NTH&#8217;s proprietary
NXT2.0 booking technology. Pursuant to the terms of its asset purchase agreement, in exchange for a cash payment of $600,000, NTH acquired
the Bookit.com booking engine, customer lists, all content associated to hotel and destination product in the booking engine, including
pictures, hotel descriptions, restaurant descriptions, room descriptions, amenity descriptions, and destination information, and source
code related thereto (the &#8220;Purchased Assets&#8221;). The Purchased Assets included: (i) all permits and licenses related to the
purchased assets; (ii) all contracts and agreements of Bookit.com (the &#8220;Assumed Contracts&#8221;); and (iii) any goodwill related
to the Purchased Assets. Further to the APA, NTH agreed to assume any obligation or liability of Bookit.com, and any related claims,
whether asserted prior to or following the Purchased Assets, with the exception of: (i) all tax obligations and liabilities of any nature
arising in connection with or related to Bookit.com and/or the Purchased Assets prior to the closing date, and (ii) any post-closing
payment or performance obligations arising under the Assumed Contracts.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 15; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Recent
Developments</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Acquisition
of Five Star Alliance</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 6, 2025, the Company entered into a Membership Interest Purchase Agreement (the &#8220;FSA Purchase Agreement&#8221;) with FSA
Travel, LLC (&#8220;FSA&#8221;), John McMahon, as Majority Member, and the other members of FSA included on the signature page thereto
(Mr. McMahon together with such other members, collectively the &#8220;FSA Members&#8221;). Pursuant to the FSA Purchase Agreement, on
February 10, 2025 (the &#8220;Initial Closing Date&#8221;), the Company purchased 9,608 membership units of FSA (equal to a 49% ownership
stake in FSA immediately after closing) (the &#8220;Initial Interests&#8221;) in exchange for the Company&#8217;s (i) payment of $500,000
in cash and (ii) issuance of 161,291 shares of newly designated Series O Nonvoting Convertible Preferred Stock of the Company (&#8220;Series
O Preferred&#8221;) to FSA. In connection with, and as a condition to, the Initial Closing, the Company entered into employment agreements
with Mr. McMahon and Courtney May, each of whom became employees of the Company as of the Initial Closing Date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, subject to satisfaction of the conditions discussed below, the FSA Purchase Agreement provided the Company with an option (the
&#8220;Option&#8221;), in its sole discretion, to purchase the remaining 51% of the membership units from the FSA Members within 60 days
of the Initial Closing Date (the &#8220;Final Closing Date&#8221;), in exchange for (i) the payment by the Company to the FSA Members
of an aggregate of $500,000 in cash and (ii) the issuance of an aggregate of 161,291 shares of Series O Preferred to the FSA Members
(the &#8220;Final Closing&#8221;). The Company&#8217;s Option was subject to, and contingent upon, satisfaction of the following conditions:
(i) the continued employment of Mr. McMahon and Ms. May by the Company, subject to limited exceptions, (ii) the completion of a $2,000,000
capital raise by the Company, and (iii) the continued operation of FSA by FSA&#8217;s existing management until the Final Closing Date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 9, 2025 (the &#8220;Final Closing Date&#8221;), upon FSA&#8217;s agreement to waive the capital raise condition to closing, the
Company exercised the Option and, in satisfaction of its obligations under the Purchase Agreement in connection with the Final Closing,
the Company paid the FSA Members an aggregate of $500,000 in cash and issued the FSA Members an aggregate of 161,291 shares of Series
O Preferred. As a result, as of the Final Closing Date, the Company acquired the remaining 51% of the membership units in FSA and FSA
became a wholly owned subsidiary of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition to the above consideration, the FSA Purchase Agreement provided that the Company shall make additional payments to the FSA Members
upon achievement of certain milestones, as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    payment of $100,000 in cash and the issuance of 32,258 shares of Series O Preferred at such time as FSA shall have Travel Bookings
    of Travel Products for five groups by FSA, the commissions to FSA for which are scheduled to be collected after the Final Closing;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    payment of $100,000 in cash and the issuance of 32,258 shares of Series O Preferred at such time as FSA shall have Travel Bookings
    of cruise related Travel Products, the gross cumulative cost of which to the customers is greater than or equal to $25,000 and the
    commissions for which are scheduled to collected after the Final Closing;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    payment of $100,000 in cash and issuance of 32,258 shares of Series O Preferred at such time as FSA shall deliver all necessary passcodes
    to allow NextTrip full remote access to the FSA booking engine for use by NextTrip; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    payment of $100,000 in cash and issuance 32,258 shares of Series O Preferred at such time as FSA shall have Travel Bookings for Travel
    Products, the cumulative gross cost of which to the customers is greater than or equal to $1 million and the commissions for which
    are scheduled to be collected after the Final Closing.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 28, 2025, the parties determined that each of the foregoing milestones had been achieved, and in satisfaction of its obligations
under the FSA Purchase Agreement, the Company paid the FSA Members an aggregate of $400,000 in cash and issued the FSA Members an aggregate
of 120,967 shares of Series O Preferred.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Blue
Fysh Share Exchange</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 24, 2025, the Company and Blue Fysh entered into a share exchange agreement (the &#8220;BF Share Exchange Agreement&#8221;)
whereby Blue Fysh agreed to issue 82 restricted shares of its common stock to the Company, representing a ten percent (10%) interest
in Blue Fysh, in exchange for 483,000 restricted shares of Series N Nonvoting Convertible Preferred Stock (the &#8220;Series N Preferred&#8221;)
of the Company at an issuance price of $5.00 per share (the &#8220;BF Share Exchange&#8221;). The BF Share Exchange closed on February
28, 2025. The parties entered into the BF Share Exchange Agreement, creating minority ownership positions between the entities, as part
of their mutual efforts to work together to expand each company&#8217;s business opportunities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 16; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Journy.tv
Asset Purchase</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 1, 2025, the Company entered into an asset purchase agreement (the &#8220;Journy.tv Purchase Agreement&#8221;) with Ovation LLC
(&#8220;Ovation&#8221;), pursuant to which the Company purchased assets, including without limitation trademarks, domains, apps and certain
agreements, and assumed certain liabilities related to Ovation&#8217;s Journy.tv business (the &#8220;Journy.tv Acquisition&#8221;). The Journy.tv
Acquisition closed on April 1, 2025.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the Journy.tv Purchase Agreement, as consideration for the Journy.tv Acquisition, the Company paid Ovation $300,000 in cash at closing
and issued Ovation 20,000 restricted shares of Company common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the Journy.tv Acquisition, on April 1, 2025, the Company and Ovation also entered into a License Agreement (the &#8220;License
Agreement&#8221;), pursuant to which Ovation granted the Company the non-exclusive right, throughout the territories and for the term
set forth therein, to exhibit, promote, market, advertise, publicize and/or otherwise exploit the programs listed in the License Agreement
in the media of (i) FAST via the Journy.tv Channel and (ii) Video On Demand via the Journy.tv Channel. Pursuant to the License Agreement,
Ovation shall not license any unaffiliated third party the right to exhibit certain of the programs subject to the License Agreement,
and shall not use certain of the programs subject to the License Agreement on its owned or operating streaming platforms (subject to
certain exceptions). As consideration for the rights granted under the License Agreement, the Company agreed to pay Ovation an aggregate
non-refundable license fee of $336,801, as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold">Payment Date</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 80%">April 30, 2025</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">47,709</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>July 31, 2025</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">59,709</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>October 31, 2025</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">47,709</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>January 31, 2026</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">22,709</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>April 30, 2026</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">22,709</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>July 31, 2026</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">22,709</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>October 31, 2026</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">22,709</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>January 31, 2027</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">22,709</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>April 30, 2027</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">22,709</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>July 31, 2027</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">22,709</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>October 31, 2027</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">22,709</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Strategic
Partnership with Intimate Hotels of Barbados (IHB) </i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 3, 2025, NextTrip entered into a strategic partnership with IHB, a collection of over 35 independent hotels and vacation rentals.
NextTrip will serve as the official booking engine for IHB, providing a fully integrated travel portal and customized packaging tools
directly on the IHB website.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>NextTrip
Cruise Launches, Offering Seamless Cruise Booking Experience</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 27, 2025, NextTrip unveiled NextTrip Cruise, a fully integrated cruise booking engine providing access to over 10,000 sailings
and 35 cruise partners. Travelers benefit from exclusive pricing, concierge service, and bundled packages that include transfers, pre-
and post-cruise stays, and expert travel support.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Facilities</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
principal executive offices are located at 3900 Paseo del Sol, Santa Fe, New Mexico 87507. The lease has a 6-month term, which ends on
June 30, 2025. The landlord can terminate the lease upon 30 days written notice and the Company can terminate the lease upon 45 days
written notice.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Human
Capital Resources</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of May 28, 2025, we had 16 full-time employees and 6 independent contractors. We use independent contractors and temporary personnel
to supplement our workforce, particularly in the software development and technology tasks. Our employees are not represented by a labor
union, and we consider our employee relations to be very good. Competition for qualified personnel in our industry has historically been
intense, particularly for software engineers, developers, and other technical staff. Our human capital resources objectives include,
as applicable, identifying, recruiting, retaining, incentivizing and integrating our existing and additional employees. We strive to
provide competitive compensation and benefits for our employees. Our benefit programs include bonuses, stock-based compensation awards,
a 401(k) plan with employer matching, healthcare and insurance benefits, flexible paid time off and other employee assistance programs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 17; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
principal purposes of our equity incentive plans are to attract, retain and motivate selected employees, consultants and directors, through
the granting of stock-based compensation awards and cash-based performance bonus awards.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
employees are responsible for upholding our Code of Ethics and Business Conduct, which is important in delivering on our strategy. We
maintain a compliance hotline for the confidential reporting of any suspected policy violations or unethical business conduct on the
part of our businesses, employees, officers, directors, suppliers, or customers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Corporate
Information</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company was initially incorporated as Messidor Limited in Nevada on December 23, 1985, and changed its name to Framewaves Inc. in 2001.
On September 27, 2010, the name was changed to Sigma Labs, Inc. On May 17, 2022, Sigma Labs, Inc. began doing business as Sigma Additive
Solutions, and on August 9, 2022, changed its name to Sigma Additive Solutions, Inc. On March 13, 2024, we changed the Company&#8217;s
name to NextTrip, Inc. in connection with our reverse acquisition of NTH.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
principal executive offices are located at 3900 Paseo del Sol, Santa Fe, New Mexico 87507, and our current telephone number at that address
is (954) 526-9688. Our website address is www.nexttrip.com. The Company&#8217;s annual reports, quarterly reports, current reports on
Form 8-K and amendments to such reports filed or furnished pursuant to section 13(a) or 15(d) of the Exchange Act and other information
related to the Company, are available, free of charge, on that website as soon as we electronically file those documents with, or otherwise
furnish them to, the SEC. The Company&#8217;s website and the information contained therein, or connected thereto, are not and are not
intended to be incorporated into this Report.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="a_003"></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM
1A. RISK FACTORS.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
business is subject to numerous risks. We caution you that the following important factors, among others, could cause our actual results
to differ materially from those expressed in statements made by us or on our behalf in filings with the SEC, press releases or communications
with investors and others. Any or all of our statements in this Report and in any other public statements we make may turn out to be
wrong. They can be affected by inaccurate assumptions or by known or unknown risks and uncertainties. The factors mentioned in the discussion
below will be important in determining future results. Consequently, actual future results may vary materially from those anticipated
in this Report or our other public statements. The occurrence of any of the events or developments described below could harm our financial
condition, results of operations, business and prospects. In such an event, the market price of our securities could decline. Additional
risks and uncertainties not presently known to us or that we currently deem immaterial also may have similar adverse effects on us.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
risks described below and in our filings with the SEC are not the only ones facing us. Our business is also subject to the risks that
affect many other companies, such as competition, labor relations, general economic conditions, inflation, supply chain constraints,
geopolitical changes, and international operations. We operate in a rapidly changing environment that involves a number of risks, some
of which are beyond our control. Additional risks not currently known to us or that we currently believe are immaterial also may impair
our business operations and our liquidity. The risks described below and in our filings with the SEC could cause our actual results to
differ materially from those contained in the forward-looking statements we have made in this prospectus, the information incorporated
herein by reference, and those forward-looking statements we may make from time to time. You should understand that it is not possible
to predict or identify all such factors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Risks
Related to Our Business</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our
revenue is derived from the global travel industry, and a prolonged or substantial decrease in global travel, particularly air travel,
could adversely affect our operating results.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
revenue is derived from the global travel industry and would be significantly impacted by declines in, or disruptions to, travel activity,
particularly air travel. Global factors over which we have no control, but which could impact our clients&#8217; ability or willingness
to travel and, depending on the scope and duration, cause a significant decline in travel volumes include, among other things:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
widespread health concerns, epidemics or pandemics, such as the COVID-19 pandemic, the Zika virus, H1N1 influenza, the Ebola virus, avian
flu, SARS or any other serious contagious diseases;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
global security concerns caused by terrorist attacks, the threat of terrorist attacks, or the precautions taken in anticipation of such
attacks, including elevated threat warnings or selective cancellation or redirection of travel;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; padding: 0pt; text-align: justify">&#160;</p>


<!-- Field: Page; Sequence: 18; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
cyber-terrorism, political unrest, the outbreak of hostilities or escalation or worsening of existing hostilities or war, such as Russia&#8217;s
invasion of Ukraine and the ongoing military conflict in Israel, resulting sanctions imposed by the U.S. and other countries and retaliatory
actions taken by sanctioned countries in response to such sanctions;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
natural disasters or severe weather conditions, such as hurricanes, flooding and earthquakes;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
climate change-related impact on travel destinations, such as extreme weather, natural disasters and disruptions, and actions taken by
governments, businesses and supplier partners to combat climate change;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
the occurrence of travel-related accidents or the grounding of aircraft due to safety concerns;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
the impact of macroeconomic conditions (including inflation) and labor shortages on the cost and availability of airline travel; and</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
adverse changes in visa and immigration policies or the imposition of travel restrictions or more restrictive security procedures.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
decrease in demand for consumer or business travel could materially and adversely affect our business, financial condition and results
of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
need additional capital, which may not be available on commercially acceptable terms, if at all, which raises questions about our ability
to continue as a going concern.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of February 28, 2025, we had $9,936,153 in total assets, $2,571,086 in total liabilities, negative working capital of $105,577 and a
total accumulated deficit of $34,349,823. We had a net loss of $10,198,684 for the fiscal year ended February 28, 2025 and $7,339,276
for the fiscal year ended February 29, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are subject to all the substantial risks inherent in the development of a new business enterprise within an extremely competitive industry.
Due to the absence of a long-standing operating history and the emerging nature of the markets in which we compete, we anticipate operating
losses until we can successfully implement our business strategy, which includes all associated revenue streams. Our revenue model is
new and evolving, and we cannot be certain that it will be successful. The potential profitability of this business model is unproven.
We may never achieve profitable operations or generate significant revenues. Our future operating results depend on many factors, including
demand for our products, the level of competition, and the ability of our officers to manage our business and growth. Additional development
expenses may delay or negatively impact our ability to generate profits. Accordingly, we cannot assure you that our business model will
be successful or that we can sustain revenue growth, achieve or sustain profitability, or continue as a going concern.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
believe that, in the aggregate, it could require several millions of dollars to support and expand the marketing and development of our
products, repay debt obligations, provide capital expenditures for additional equipment and development costs, payment obligations, office
space and systems for managing the business, and cover other operating costs until our planned revenue streams from all products are
fully implemented and begin to offset its operating costs. We estimate that we will need to raise a minimum of $5.5 million in net proceeds
to continue operations for the next twelve months.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the event the Company is unable to raise adequate funding in the future for its operations and to pay its outstanding debt obligations,
the Company may be forced to scale back its business plan and/or liquidate some or all of its assets or may be forced to seek bankruptcy
protection</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
light of the foregoing, there is substantial doubt about our ability to continue as a going concern, and the report of our registered
independent public accounting firm on our financial statements as of and for the year ended February 28, 2025, included in Item 15 of
this Report, contains a going concern qualification.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
are not profitable and may never become profitable.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have incurred losses in every reporting period since we commenced business operations in 2010 and expect to continue to incur significant
losses for the foreseeable future. Our net loss applicable to common stockholders for the years ended February 28, 2025 and February
29, 2024 was $10,198,684 and $7,339,276, respectively. As of February 28, 2025, our accumulated deficit was $34,349,823. There is no
assurance that any revenues we generate will be sufficient for us to become profitable or to maintain profitability. Our revenues for
the years ended February 28, 2025 and February 29, 2024 were $501,423 and $458,752, respectively, and our operating expenses for those
periods were $7,416,731 and $5,740,577, respectively. Our current revenues are not sufficient to fund our operations. We cannot predict
when, if ever, we might achieve profitability and we are not certain that we will be able to sustain profitability, if achieved. If we
fail to achieve or maintain profitability, the market price of our securities is likely to be adversely affected.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"></p>

<!-- Field: Page; Sequence: 19; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
have outstanding indebtedness, which could adversely affect our business and financial condition.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risks
relating to its indebtedness include:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">increasing
    our vulnerability to general adverse economic and industry conditions;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">requiring
    us to dedicate a portion of our cash flow from operations to principal and interest payments on our indebtedness, thereby reducing
    the availability of cash flow to fund working capital, capital expenditures, acquisitions and investments and other general corporate
    purposes;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">making
    it more difficult for us to optimally capitalize and manage the cash flow for our businesses;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">limiting
    our flexibility in planning for, or reacting to, changes in our businesses and the markets in which we operate;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">possibly
    placing us at a competitive disadvantage compared to our competitors that have less debt; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">limiting
    our ability to borrow additional funds or to borrow funds at rates or on other terms that we find acceptable.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>If
distributors are unable to drive customers to our websites and/or we are unable to drive visitors to our websites, from search engines
or otherwise, this could negatively impact transactions on the websites of our distributors as well as our own websites and consequently
cause our travel revenue to decrease.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Many
visitors find the distributors and NextTrip&#8217;s websites by searching for vacation information through Internet search engines. A
critical factor in attracting visitors to NextTrip&#8217;s websites, and those of our distributors, is how prominently our distributors
and NextTrip are displayed in response to search queries. Accordingly, we utilize search engine marketing (&#8220;SEM&#8221;) as a means
to provide a significant portion of our visitor acquisition. SEM includes both paid visitor acquisition (on a cost-per-click basis) and
unpaid visitor acquisition, which is often referred to as organic search.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
plan to employ search engine optimization (&#8220;SEO&#8221;) to acquire visitors. SEO involves developing our websites in order to rank
highly in relevant search queries. In addition to SEM and SEO, we may also utilize other forms of marketing to drive visitors to our
websites, including branded search, display advertising and email marketing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
various search engine providers, such as Google and Bing, employ proprietary algorithms and other methods for determining which websites
are displayed for a given search query and how highly websites rank. Search engine providers may change these methods in a way that may
negatively affect the number of visitors to our distributors&#8217; websites as well as our own websites and may do so without public
announcement or detailed explanation. Therefore, the success of our SEO and SEM strategy depends, in part, on our ability to anticipate
and respond to such changes in a timely and effective manner.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, websites must comply with search engine guidelines and policies. These guidelines and policies are complex and may change at
any time. If we or our distributors fail to follow such guidelines and policies properly, the search engine may cause our content to
rank lower in search results or could remove the content altogether. If we or our distributors fail to understand and comply with these
guidelines and policies and ensure their websites&#8217; compliance, our SEO and SEM strategy may not be successful.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Unfavorable
changes in, or interpretations of, government regulations or taxation of the evolving product offerings, Internet and e-commerce industries
could harm our travel division operating results</i>.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have contracted for products in markets throughout the world, including in jurisdictions which have various regulatory and taxation requirements
that can affect our travel division operations or regulate the activity of travel suppliers. Compliance with laws and regulations of
different jurisdictions imposing different standards and requirements is very burdensome because each region has different regulations
with respect to licensing and other requirements. Our online marketplaces are accessible by travelers in many states and foreign jurisdictions.
Compliance requirements that vary significantly from jurisdiction to jurisdiction impose added costs and increased liabilities for compliance
deficiencies. In addition, laws or regulations that may harm our business could be adopted, or interpreted in a manner that affects our
activities, including but not limited to the regulation of personal and consumer information and real estate licensing requirements.
Violations or new interpretations of these laws or regulations may result in penalties, negatively impact our operations and damage our
reputation and business.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 20; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, many of the fundamental statutes and regulations that impose taxes or other obligations on travel and lodging companies were
established before the growth of the Internet and e-commerce, which creates a risk of these laws being used, in ways not originally intended,
that could burden travel suppliers or otherwise harm our business. These and other similar new and newly interpreted regulations could
increase costs for, or otherwise discourage, suppliers from partnering with us, which could harm our business and operating results.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furthermore,
as we expand or change the products and services that we offer or the methods by which we offer them, we may become subject to additional
legal regulations, tax requirements or other risks. Regulators may seek to impose regulations and requirements on us even if we utilize
third parties to offer the products or services. These regulations and requirements may apply to payment processing, insurance products
or the various other products and services we may now or in the future offer or facilitate through our marketplace. Whether we comply
with or challenge these additional regulations, our costs may increase, and our business may otherwise be harmed.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>If
we are not able to maintain and enhance our NextTrip brand and the brands associated with each of our platforms, our reputation and business
may suffer.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">It
is important for us to maintain and enhance our brand identity in order to attract and retain travel suppliers and customers. The successful
promotion of our brands will depend largely on our marketing and public relations efforts. As discussed elsewhere in this Report, our
ability to expand our marketing efforts and capitalize on our existing travel technology platforms has been severely restricted due to
the lack of funding to drive marketing programs, which has negatively impacted our business. We expect that the promotion of our brands
will require us to make substantial investments, and, as our market becomes more competitive, these branding initiatives may become increasingly
difficult and expensive. In addition, we may not be able to successfully build our NextTrip brand identity without losing value associated
with, or decreasing the effectiveness of, our other brand identities. If we do not successfully maintain and enhance our brands, we could
lose traveler traffic, which could, in turn, cause suppliers to discontinue their distribution with us. In addition, our brand promotion
activities may not be successful or may not yield sufficient revenue to offset their cost, which could adversely affect our reputation
and business.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our
long-term success depends, in part, on our ability to expand traveler bases outside of the United States and, as a result, our business
is susceptible to risks associated with international operations.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have limited operating and e-commerce experience in many foreign jurisdictions and are making significant investments to build our international
operations. We plan to continue our efforts to expand globally, including potentially acquiring international businesses and conducting
business in jurisdictions where we do not currently operate. Managing a global organization is difficult, time-consuming and expensive
and any international expansion efforts that we undertake may not be profitable in the near or long term or otherwise be successful.
In addition, conducting international operations subjects the Company to risks that include:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    cost and resources required to localize its services, which requires the translation of our websites and their adaptation for local
    practices and legal and regulatory requirements;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">adjusting
    the products and services we provide in foreign jurisdictions, as needed, to better address the needs of local owners, managers,
    distributors and travelers, and the threats of local competitors;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">being
subject to foreign laws and regulations, including those laws governing Internet activities, email messaging, collection and use of personal
information, ownership of intellectual property, taxation and other activities important to our online business practices, which may
be less developed, less predictable, more restrictive, and less familiar, and which may adversely affect financial results in certain
regions;</span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">competition
    with companies that understand the local market better than we do or who have pre-existing relationships with suppliers, distributors
    and travelers in those markets;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">legal
    uncertainty regarding our liability for the transactions and content on our websites, including online bookings, property listings
    and other content provided by suppliers, including uncertainty resulting from unique local laws or a lack of clear precedent of applicable
    law;</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="margin: 0"></p>

<!-- Field: Page; Sequence: 21; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">lack
    of familiarity with and the burden of complying with a wide variety of other foreign laws, legal standards and foreign regulatory
    requirements, including invoicing, data collection and storage, financial reporting and tax compliance requirements, which are subject
    to unexpected changes;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">laws
    and business practices that favor local competitors or prohibit or limit foreign ownership of certain businesses;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">challenges
    associated with joint venture relationships and minority investments;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">adapting
    to variations in foreign payment forms;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">difficulties
    in managing and staffing international operations and establishing or maintaining operational efficiencies;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">difficulties
    in establishing and maintaining adequate internal controls and security over our data and systems;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">currency
    exchange restrictions and fluctuations in currency exchange rates;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">potentially
    adverse tax consequences, which may be difficult to predict, including the complexities of foreign value added tax systems and restrictions
    on the repatriation of earnings;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">political,
    social and economic instability abroad, war, terrorist attacks and security concerns in general;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    potential failure of financial institutions internationally;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">reduced
    or varied protection for intellectual property rights in some countries; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">higher
    telecommunications and Internet service provider costs.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating
in international markets also requires significant management attention and financial resources. We cannot guarantee that our international
expansion efforts in any or multiple territories will be successful. The investment and additional resources required to establish operations
and manage growth in other countries may not produce desired levels of revenue or profitability and could instead result in increased
costs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>The
market in which we participate is highly competitive, and we may be unable to compete successfully with our current or future competitors</i>.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
market to provide listing, search and marketing services for the travel industry is very competitive and dominated by key players, such
as Expedia and Booking.com. In addition, the barriers to entry are low and new competitors may enter. All of the services that we plan
to provide to travelers are provided separately or in combination by current or potential competitors. Our competitors may adopt aspects
of our business model, which could reduce our ability to differentiate our services. Additionally, current or new competitors may introduce
new business models or services that we may need to adopt or otherwise adapt to in order to compete, which could reduce our ability to
differentiate our business or services from those of our competitors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, most of our current or potential competitors are larger and have more resources than we do. Many of our current and potential
competitors enjoy substantial competitive advantages, such as greater name recognition in their markets, longer operating histories and
larger marketing budgets, as well as substantially greater financial, technical and other resources. In addition, our current or potential
competitors may have access to larger traveler bases. As a result, our competitors may be able to respond more quickly and effectively
than we can to new or changing opportunities, technologies, standards or distribution or traveler requirements. For all of these reasons,
we may not be able to compete successfully against our current and future competitors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>If
we are unable to introduce new or upgraded products, services or features that distributors, travelers or agents recognize as valuable,
we may fail to: drive additional travelers to our websites, retain existing distributors, and/or attract new distributors. Our efforts
to develop new and upgraded services and products could require us to incur significant costs.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
order to attract travelers to our distributors, as well as our own online marketplace, while retaining, and attracting new suppliers,
we will need to continue to invest in the development of new products, services and features that both add value for travelers and suppliers
and differentiate us from our competitors. The success of new products, services and features depends on several factors, including the
timely completion, introduction and market acceptance of the product, service or feature. If travelers, or suppliers do not recognize
the value of our new services or features, they may choose not to utilize our products or make their inventory available through our
channels.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>


<!-- Field: Page; Sequence: 22; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attempting
to develop and deliver these new or upgraded products, services or features involves inherent hazards and difficulties, and is costly.
Efforts to enhance and improve the ease of use, responsiveness, functionality and features of our existing websites have inherent risks,
and we may not be able to manage these product developments and enhancements successfully. We may not succeed in developing new or upgraded
products, services or features or new or upgraded products, services or features may not work as intended or provide value. In addition,
some new or upgraded products, services or features may be difficult for us to market and may also involve unfavorable pricing. Even
if we succeed, we cannot guarantee that our suppliers will respond favorably.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition to developing our own improvements, we may choose to license or otherwise integrate applications, content and data from third
parties. The introduction of these improvements imposes costs on the Company and creates a risk that we may be unable to continue to
access these technologies and content on commercially reasonable terms, or at all. In the event we fail to develop new or upgraded products,
services or features, the demand for our services and ultimately our results of operations may be adversely affected.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
are exposed to fluctuations in currency exchange rates.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Because
we plan to conduct a significant portion of our business outside the United States, but report our results in U.S. dollars, we face exposure
to adverse movements in currency exchange rates, which may cause our revenue and operating results to differ materially from expectations.
In addition, fluctuation in our mix of U.S. and foreign currency denominated transactions may contribute to this effect as exchange rates
vary. Moreover, as a result of these exchange rate fluctuations, revenue, cost of revenue, operating expenses and other operating results
may differ materially from expectations when translated from the local currency into U.S. dollars upon consolidation. For example, if
the U.S. dollar strengthens relative to foreign currencies our non-U.S. revenue would be adversely affected when translated into U.S.
dollars. Conversely, a decline in the U.S. dollar relative to foreign currencies would increase our non-U.S. revenue when translated
into U.S. dollars. We may enter into hedging arrangements in order to manage foreign currency exposure, but such activities may not completely
eliminate fluctuations in our operating results and may be costly.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>If
we fail to protect confidential information against security breaches, or if distributors or travelers are reluctant to use our online
marketplace because of privacy or security concerns, we might face additional costs, and activity on our websites could decline.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
collect and use personally identifiable information of distributors and travelers in the operation of our business. Our systems may be
vulnerable to computer viruses or physical or electronic break-ins that our security measures may not detect. Anyone that is able to
circumvent our security measures could misappropriate confidential or proprietary information, cause an interruption in our operations,
damage our computers or those of our users, or otherwise damage our reputation and business. We may need to expend significant resources
to protect against security breaches or to address problems caused by breaches. Security breaches of our systems, or the systems of third
parties we rely upon, such as credit card processors, could damage our reputation and expose us to litigation and possible liability
under various laws and regulations. Concern among distributors and travelers regarding our use of personal information collected on our
websites could keep them from using, or continuing to use, our online marketplace.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
are risks of security breaches both on our systems and on third party systems which store our information as we increase the types of
technology that we use to operate our marketplace, such as mobile applications. New and evolving technology systems and platforms may
involve security risks that are difficult to predict and adequately guard against. In addition, third parties that process credit card
transactions between us and travelers maintain personal information collected from them. Such information could be stolen or misappropriated,
and we could be subject to liability as a result. Our distributors and travelers may be harmed by such breaches, and we may in turn be
subject to costly litigation or regulatory compliance costs, and harm to our reputation and brand. Moreover, some distributors and travelers
may cease using our marketplace altogether.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
laws of some states and countries require businesses that maintain personal information about their residents in electronic databases
to implement reasonable measures to keep that information secure. Our practice is to encrypt all sensitive information, but we do not
know whether our current practice will be challenged under these laws. In addition, under certain of these laws, if there is a breach
of our computer systems and we know or suspect that unencrypted personal data has been stolen, we are required to inform any user whose
data was stolen, which could harm our reputation and business. Complying with the applicable notice requirements in the event of a security
breach could result in significant costs. We may also be subject to contractual claims, investigation and penalties by regulatory authorities,
and claims by persons whose information was disclosed.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 23; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Compounding
these legal risks, many states and countries have enacted different and often contradictory requirements for protecting personal information
collected and maintained electronically. Compliance with these numerous and contradictory requirements is particularly difficult for
us because we collect personal information from users in multiple jurisdictions. While we endeavor to comply fully with these laws, failure
to comply could result in legal liability, cause the Company to suffer adverse publicity and lose business, traffic and revenue. If we
were required to pay any significant amount of money in satisfaction of claims under these or similar laws, or if we were forced to cease
our business operations for any length of time as a result of our inability to comply fully, our business, operating results and financial
condition could be adversely affected.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Cyber-attacks
and system vulnerabilities could lead to sustained service outages, data loss, reduced revenue, increased costs, liability claims, or
harm to our competitive position</i>.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may experience targeted and organized malware, phishing, and account takeover attacks and other forms of attack such as ransomware, SQL
injection (where a third-party attempts to insert malicious code into its software through data entry fields in its websites in order
to gain control of the system) and attempts to use our websites as a platform to launch a denial-of-service attack on another party.
Our existing security measures may not be successful in preventing attacks on our systems. Our existing IT business continuity and disaster
recovery practices are less effective against certain types of attacks such as ransomware, which could result in our services being unavailable
for an extended period of time, nullify our data, expose our payment card and personal data, or expose us to an extortion attempt.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reductions
in the availability and response time of our online services could cause loss of substantial business volumes during the occurrence of
a cyber-attack on our systems and measures we may take to divert suspect traffic in the event of such an attack could result in the diversion
of bona fide customers. These issues are more difficult to manage during any expansion of the number of places where we operate and the
variety of services we offer, and as the tools and techniques used in such attacks become more advanced. We use sophisticated technology
to identify cybersecurity threats; however, a cyberattack may go undetected for a period of time resulting in harm to our computer systems
and the loss of data. This could result in financial penalties being imposed by the regulators and reputational harm. Our insurance policies
have coverage limits and may not be adequate to reimburse us for all losses caused by security breaches. Successful attacks could result
in significant interruptions in our operations, severe damage to our information technology infrastructure, negative publicity, damage
our reputation, and prevent consumers from using our services during the attack, any of which could cause consumers to use the services
of our competitors, which would have a negative effect on the value of our brands, market share, business, and results of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>If
our systems cannot cope with the level of demand required to service our consumers and accommodations, we could experience unanticipated
disruptions in service, slower response times, decreased customer service and customer satisfaction, and delays in the introduction of
new services.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
an online business, we are dependent on the Internet and maintaining connectivity between us and consumers, sources of Internet traffic,
such as Google, and our travel service providers. As consumers increasingly turn to mobile and other smart devices, we also depend on
consumers&#8217; access to the Internet through mobile carriers and their systems. Disruptions in internet access, especially if widespread
or prolonged, could materially adversely affect our business and results of operations. While we maintain redundant systems and hosting
services, it is possible that we could experience an interruption in our business, and we do not carry business interruption insurance
sufficient to compensate us for all losses that may occur. We do not have a comprehensive disaster recovery plan in every geographic region in which we conduct business, and
these systems and operations are vulnerable to damage or interruption from human error, misconduct, or catastrophic events. In the event
of any disruption of service at such facilities or the failure by such facilities to provide our required data communications capacity,
we may not be able to switch to back-up systems immediately and it could result in lengthy interruptions or delays in our services. We
have taken and continue to take steps to increase the reliability and redundancy of our systems. These steps are expensive, may reduce
our margins, and may not be successful in reducing the frequency or duration of unscheduled downtime.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Loss
or material modification of our credit card acceptance privileges could have a material adverse effect on our business and operating
results.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
loss of our credit card acceptance privileges could significantly limit the availability and desirability of our products and services.
Moreover, if we fail to fully perform our contractual obligations, we could be obligated to reimburse credit card companies for refunded
payments that have been contested by the cardholders. In addition, even when we are in compliance with these obligations, we bear other
expenses including those related to the acceptance of fraudulent credit cards. As a result of all of these risks, credit card companies
may require us to set aside additional cash reserves, may increase the transaction fees they charge us, or may even refuse to renew our
acceptance privileges.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 24; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, credit card networks, such as Visa, MasterCard and American Express, have adopted rules and regulations that apply to all merchants
who process and accept credit cards and include the Payment Card Industry Data Security Standards (the &#8220;PCI DSS&#8221;). Under
these rules, we are required to adopt and implement internal controls over the use, storage and security of card data. We assess our
compliance with the PCI DSS rules on a periodic basis and make necessary improvements to our internal controls. Failure to comply may
subject us to fines, penalties, damages and civil liability and could prevent us from processing or accepting credit cards. However,
we cannot guarantee that compliance with these rules will prevent illegal or improper use of our payment systems or the theft, loss or
misuse of the credit card data.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
loss of, or the significant modification of, the terms under which we obtain credit card acceptance privileges could have a material
adverse effect on our business, revenue and operating results.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
currently rely on a small number of third-party service providers to host and deliver a significant portion of our services, and any
interruptions or delays in services from these third parties could impair the delivery of our services and harm our business.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
rely on third-party service providers for numerous products and services, including payment processing services, data center services,
web hosting services, insurance products for customers and travelers and some customer service functions. We rely on these companies
to provide uninterrupted services and to provide their services in accordance with all applicable laws, rules and regulations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
use a combination of third-party data centers to host our websites and core services. We do not control the operation of any of the third-party
data center facilities we use. These facilities may be subject to break-ins, computer viruses, denial-of-service attacks, sabotage, acts
of vandalism and other misconduct. They are also vulnerable to damage or interruption from power loss, telecommunications failures, fires,
floods, earthquakes, hurricanes, tornadoes and similar events. We currently do not have a comprehensive disaster recovery plan in place
nor do our systems provide complete redundancy of data storage or processing. As a result, the occurrence of any of these events, a decision
by our third-party service providers to close their data center facilities without adequate notice or other unanticipated problems could
result in loss of data as well as a significant interruption in our services and harm to our reputation and brand.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
our third-party service providers experience difficulties and are not able to provide services in a reliable and secure manner, if they
do not operate in compliance with applicable laws, rules and regulations and, with respect to payment and card processing companies,
if they are unable to effectively combat the use of fraudulent payments on our websites, our results of operations and financial positions
could be materially and adversely affected. In addition, if such third-party service providers were to cease operations or face other
business disruption either temporarily or permanently, or otherwise face serious performance problems, we could suffer increased costs
and delays until we find or develop an equivalent replacement, any of which could have an adverse impact on our business and financial
performance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>If
we do not adequately protect our intellectual property, our ability to compete could be impaired.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
intellectual property includes the content of our websites, registered domain names, as well as registered and unregistered trademarks,
know-how and trade secrets. We believe that our intellectual property is an essential asset of our business and that our domain names
and our technology infrastructure currently give us a competitive advantage in the online market for travel. If we do not adequately
protect our intellectual property, our brand, reputation and perceived content value could be harmed, resulting in an impaired ability
to compete effectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
protect our intellectual property, we rely on a combination of copyright, trademark and trade secret laws, contractual provisions
and our user policy and restrictions on disclosure. Upon discovery of potential infringement of our intellectual property, we promptly
take action we deem appropriate to protect our rights. We also enter into confidentiality agreements with our employees and consultants
and seek to control access to and distribution of our proprietary information in a commercially prudent manner. The efforts we have taken
to protect our intellectual property may not be sufficient or effective, and, despite these precautions, it may be possible for other
parties to copy or otherwise obtain and use the content of our websites without authorization. We may be unable to prevent competitors
from acquiring domain names or trademarks that are similar to, infringe upon or diminish the value of our domain names, service marks
and our other proprietary rights. Even if we do detect violations and decide to enforce our intellectual property rights, litigation
may be necessary to enforce our rights, and any enforcement efforts we undertake could be time-consuming, expensive, distracting and
result in unfavorable outcomes. A failure to protect our intellectual property in a cost-effective and meaningful manner could have a
material adverse effect on our ability to compete.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 25; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective
trademark, copyright and trade secret protection may not be available in every country in which our offerings are available over the
Internet. In addition, the legal standards relating to the validity, enforceability and scope of protection of intellectual property
rights are uncertain and still evolving.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
may be subject to claims that we violated intellectual property rights of others, which are extremely costly to defend and could require
us to pay significant damages and limit our ability to operate.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Companies
in the Internet and technology industries, and other trademark holders seeking to profit from royalties in connection with
grants of licenses, own large numbers of copyrights, trademarks and trade secrets and frequently enter into litigation based
on allegations of infringement or other violations of intellectual property rights. There may be intellectual property rights held by
others, including issued or pending trademarks, that cover significant aspects of our technologies, content, branding or
business methods. Any intellectual property claims against us, regardless of merit, could be time-consuming and expensive to settle or
litigate and could divert management&#8217;s attention and other resources. These claims also could subject us to significant liability
for damages and could result in the Company having to stop using technology, content, branding or business methods found to be in violation
of another party&#8217;s rights. We might be required or may opt to seek a license for rights to intellectual property held by others,
which may not be available on commercially reasonable terms, or at all. If we cannot license or develop technology, content, branding
or business methods for any allegedly infringing aspect of our business, we may be unable to compete effectively. Even if a license is
available, we could be required to pay significant royalties, which could increase our operating expenses. We may also be required to
develop alternative non-infringing technology, content, branding or business methods, which could require significant effort and expense
and be inferior. Any of these results could harm our operating results.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>If
the businesses and/or assets that we have acquired or invested in do not perform as expected or we are unable to effectively integrate
acquired businesses, our operating results and prospects could be harmed.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
acquisition activity involves numerous risks, including the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">difficulties
    in integrating and managing the combined operations, technologies, technology platforms and products of the acquired businesses and
    realizing the anticipated economic, operational and other benefits in a timely manner, which could result in substantial costs and
    delays or other operational, technical or financial problems;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">legal
    or regulatory challenges or post-acquisition litigation, which could result in significant costs or require changes to the businesses
    or unwinding of the transaction;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">failure
    of the acquired company or assets to achieve anticipated revenue, earnings or cash flow;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">diversion
    of management&#8217;s attention or other resources from our existing business;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    inability to maintain key distributors and business relationships, and the reputations of acquired businesses;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">uncertainty
    resulting from entering markets in which we have limited or no prior experience or in which competitors have stronger market positions;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    dependence on unfamiliar affiliates and partners of acquired businesses;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">unanticipated
    costs associated with pursuing acquisitions;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">liabilities
    of acquired businesses, which may not be disclosed to us or which may exceed our estimates, including liabilities relating to non-compliance
    with applicable laws and regulations, such as data protection and privacy controls;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">difficulties
    in assigning or transferring to us or our subsidiaries intellectual property licensed to companies we acquired;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">potential
    loss of key employees of the acquired companies;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">difficulties
    in complying with antitrust and other government regulations;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 26; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">challenges
    in integrating and auditing the financial statements of acquired companies that have not historically prepared financial statements
    in accordance with U.S. generally accepted accounting principles; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">potential
    accounting charges to the extent intangibles recorded in connection with an acquisition, such as goodwill, trademarks, customer relationships
    or intellectual property, are later determined to be impaired and written down in value.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Moreover,
we rely heavily on the representations and warranties provided to us by the sellers of acquired companies and assets, including as they
relate to creation, ownership and rights in intellectual property, existence of open-source software and compliance with laws and contractual
requirements. If any of these representations and warranties are inaccurate or breached, such inaccuracy or breach could result in costly
litigation and assessment of liability for which there may not be adequate recourse against such sellers, in part due to contractual
time limitations and limitations of liability.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Failure
to obtain adequate insurance coverage could put us at risk for uninsured losses.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Some
or all of our customers may require insurance as a requirement to conduct business with us. <span style="text-transform: uppercase">A</span>lthough
we currently have product liability insurance, we may be unable to obtain or maintain adequate liability insurance on acceptable terms,
if at all, and there is a risk that our insurance will not provide adequate coverage against our potential losses. Additionally, there
are certain types of losses that may not be insurable at a cost that we can afford, and insurance may not be available at any cost with
respect to certain losses. Claims or losses in excess of any insurance coverage we may obtain, or the lack of insurance coverage, could
put us at risk of uninsured loss, which would have a material adverse effect on our business and financial condition.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
are dependent on key personnel, and the loss of any of these individuals could harm our business.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
depend on key industry and other personnel. The loss of any of these individuals could harm our business and significantly delay or prevent
the achievement of our business objectives. The success of our business will require that we attract, develop, motivate and retain experienced
and innovative executive officers and information technology professionals who have designed or implemented complex information technology
projects.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Innovative,
experienced and technically proficient individuals are in great demand and are likely to remain a limited resource. We may be unable
to continue to attract and retain desirable executive officers and technology professionals. Our inability to hire sufficient personnel
on a timely basis or the loss of significant numbers of executive officers and senior managers could adversely affect our business.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our
Bylaws contain provisions for indemnifying our officers and directors.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
amended and restated bylaws (&#8220;Bylaws&#8221;) contain provisions with respect to the indemnification of our officers and directors
against all costs, charges and expenses actually and reasonably incurred by an officer or director paid to settle an action or satisfy
a judgment in a civil, criminal or administrative action or proceeding to which he or she is made a party by reason of being or having
been one of our directors or officers. To the extent that our directors&#8217; and officers&#8217; insurance policy does not provide
reimbursement for such costs, charges, expenses and other amounts, we may incur substantial expenses in satisfying our indemnification
obligations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our
operating costs could be significantly higher than we expect, and this could reduce our future profitability.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition to general economic conditions, market fluctuations and international risks, significant increases in operating, development
and implementation costs could adversely affect us due to numerous factors, many of which are beyond our control.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 27; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Risks
Related to Our Securities</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>The
price of our securities is subject to volatility related or unrelated to our operations, which could result in substantial losses for
our stockholders.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Between
March 1, 2024 and February 28, 2025, the trading price of our common stock has ranged from a low of $1.50 to a high of $7.65, and could
be subject to wide fluctuations in the future in response to various factors, some of which are beyond our control. These factors include
those discussed previously in this &#8220;Risk Factors&#8221; section and others, such as:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">delays
    or failures in the commercialization of our current or future products and services; </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">quarterly
    variations in our results of operations or those of our competitors; </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes
    in our earnings estimates or recommendations by securities analysts or adverse publicity about us or our products or services;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">announcements
    by us or our competitors of new products and services, significant contracts, commercial relationships, acquisitions or capital commitments;
    </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">adverse
    developments with respect to our intellectual property rights; </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">commencement
    of litigation involving us or our competitors; </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
    major changes in our Board of Directors or management; </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">market
    conditions in our industry; </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Changes
    in laws and regulations applicable to our business; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">general
    economic conditions in the United States and abroad.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, the stock market, in general, has recently experienced, and may continue to experience, broad market fluctuations, which may
adversely affect the market price or liquidity of our securities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
could be subject to securities class action litigation.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
sudden decline in the market price of our securities could trigger securities class action lawsuits against us. If any of our stockholders
were to bring such a lawsuit against us, we could incur substantial costs defending the lawsuit and the time and attention of our management
would be diverted from our business and operations. We also could be subject to damages claims if we are found to be at fault in connection
with a decline in the market price of our securities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Historically,
there has been a limited trading market in our common stock, and you may therefore have difficulty selling your securities at a price
that you determine is satisfactory</i>.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
common stock is listed on the Nasdaq Capital Market. Historically, there has been a limited trading market for our common stock. There
is no assurance that our common stock will actively trade in the public market at or above a price that you consider acceptable. If an
active market for our common stock is not maintained, it may be difficult for you to sell your shares of common stock when you wish to
sell them or at a price that you consider satisfactory. An inactive trading market may also impair our ability to raise capital to continue
to fund operations by selling securities and may impair our ability to acquire other companies or technologies by using our securities
as consideration.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>If
we are unable to comply with the continued listing requirements of the Nasdaq Capital Market, our common stock could be delisted, which
could affect our common stock&#8217;s market price and liquidity and reduce our ability to raise capital.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
common stock is listed on the Nasdaq Capital Market (&#8220;Nasdaq&#8221;), a national securities exchange, which imposes continued listing
requirements with respect to issuers whose securities are listed on Nasdaq. If we fail to satisfy the continued listing standards, such
as, for example, Nasdaq&#8217;s minimum bid price requirement or stockholders equity requirements, Nasdaq may issue a non-compliance
letter or initiate delisting proceedings.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 28; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company received multiple notifications from Nasdaq staff (the &#8220;Staff&#8221;) in the year ended February 28, 2025 regarding non-compliance
with continued listing requirements, including as a result of our stockholders&#8217; equity falling below the $2,500,000 minimum requirement,
the untimely filing of our Annual Report on Form 10-K for the fiscal year ended February 24, 2024 and our Quarterly Report on Form 10-Q
for the first quarter ended May 31, 2024 and our failure to hold our annual meeting of stockholders within twelve months from the end
of our fiscal year ended February 29, 2024. Although we believe that we have regained compliance with all applicable continued listing
requirements, there can be no assurance that we will continue to maintain such compliance. If we are unable to maintain compliance with
the continued listing requirements of Nasdaq, our common stock could be delisted, making it could be more difficult to buy or sell our
securities and to obtain accurate quotations, and the price of our securities could suffer a material decline. Delisting could also impair
our ability to raise capital.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>You
may experience significant dilution as a result of future equity offerings or the conversion of outstanding shares of our convertible
preferred stock.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
order to raise additional capital, we may sell additional shares of our common stock, including pursuant to the Securities Purchase Agreement
we entered into with Alumni Capital LP (&#8220;Alumni&#8221;) on September 19, 2024, or other securities convertible into or exchangeable
for our common stock. The price per share at which we sell additional shares of our common stock, or securities convertible or exchangeable
into common stock, in future transactions may be lower than the price per share that you paid for our common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additionally,
as of May 28, 2025, there were 3,388,875 shares of our preferred stock are outstanding, consisting of 316 shares of Series E Preferred
Stock, 33,000 shares of Series H Preferred Stock, 500,442 shares of Series I Preferred Stock, 297,788 shares of Series J Preferred Stock,
60,595 shares of Series K Preferred Stock, 1,076,156 shares of Series L Preferred Stock, 133,278 shares of Series M Preferred Stock,
500,000 shares of Series N Preferred Stock, 443,549 shares of Series O Preferred Stock, and 343,750 shares of Series P Preferred Stock.
A significant number of such shares of preferred stock will automatically convert into shares of our common stock at such time, if ever,
we received stockholder approval of such conversions in accordance with applicable Nasdaq rules. Conversion of such shares of preferred
stock into shares of our common stock by the holders thereof will result in significant dilution to holders of shares of our common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our
outstanding warrants may result in further dilution to our stockholders</i>.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of May 28, 2025, there were warrants to purchase an aggregate of 3,122,772
shares of our common stock outstanding. Of such outstanding warrants, warrants to purchase an aggregate of 237,429 shares of our common stock contain so-called full-ratchet
anti-dilution adjustments in the event we sell or issue shares of common stock or common stock equivalents at an effective price less
than the exercise price of such warrants, subject to certain exceptions. Of these warrants, warrants with an aggregate exercise price
of $717,036 also provide for a ratable increase in the number of shares purchasable upon exercise of the warrants in the event the exercise
price per share of the warrants is reduced. The anti-dilution adjustments of the foregoing outstanding warrants would be triggered by future issuances
of shares of our common stock at a price per share below the then-exercise price of such warrants, which adjustments would have a further
dilutive effect on our stockholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
do not intend to pay dividends on our common stock, and your ability to achieve a return on your investment will depend on appreciation
in the market price of our securities.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
currently intend to invest our future earnings, if any, to fund our growth and not to pay any cash dividends on our common stock. Since
we do not intend to pay dividends, your ability to receive a return on your investment will depend on any future appreciation in the
market price of our securities. There is no assurance that our securities will appreciate in price.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>If
securities or industry analysts do not publish research or reports about us, or if they issue adverse or misleading opinions regarding
us or our securities, the market price of our securities and their trading volume could decline.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
we do not obtain and maintain research coverage by securities and industry analysts, the market price for our securities may be adversely
affected. The market price of our securities also may decline if any analyst who covers us issues an adverse or erroneous opinion regarding
us, our business model, our intellectual property or our performance. If one or more analysts cease coverage of us or fail to regularly
publish reports on us, we could lose visibility in the financial markets, which could cause the market price of our securities and their
trading volume to decline and possibly adversely affect our ability to engage in future financings.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 29; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Sales
of a substantial number of shares of our common stock in the public market could cause our stock price to fall.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of May 28, 2025, we had 7,653,525 outstanding shares of common stock. Future sales of a large number of our shares, or the issuance of
shares issuable upon exercise of our outstanding warrants and stock options or conversion of outstanding shares of our convertible preferred
stock, or the perception that a large number of shares may be sold, could have a material adverse effect on the trading price of our
common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>If
we fail to maintain effective internal control over financial reporting, the market price of our securities may be adversely affected.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a public reporting company, we are required to establish and maintain effective internal control over financial reporting. Failure to
establish such internal control, or any failure of such internal control once established, could adversely impact our public disclosures
regarding our business, financial condition or results of operations. Any failure of our internal control over financial reporting could
also prevent us from maintaining accurate accounting records and discovering accounting errors and financial frauds.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rules
adopted by the SEC pursuant to Section 404 of the Sarbanes-Oxley Act of 2002 require annual assessment of our internal control over financial
reporting. The standards that must be met for management to assess the internal control over financial reporting as effective are complex,
and require significant documentation, testing and possible remediation to meet the detailed standards. We may encounter problems or
delays in completing activities necessary to make an assessment of our internal control over financial reporting. If we cannot assess
our internal control over financial reporting as effective, investor confidence and share value may be negatively impacted. In addition,
management&#8217;s assessment of internal control over financial reporting may identify weaknesses and conditions that need to be addressed
in our internal control over financial reporting or other matters that may raise concerns for investors. Any actual or perceived weaknesses
and conditions that need to be addressed in our internal control over financial reporting (including those weaknesses identified in our
periodic reports), or disclosure of management&#8217;s assessment of our internal control over financial reporting may have an adverse
impact on the price of our securities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Provisions
in our Charter and Bylaws could discourage a takeover that stockholders may consider favorable and may lead to entrenchment of management.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
amended and restated articles of incorporation (&#8220;our Charter&#8221;) and Bylaws contain provisions that could delay or prevent
changes in control or changes in our management without the consent of our Board of Directors. These provisions include the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    classified Board of Directors with three-year staggered terms, which may delay the ability of stockholders to change the membership
    of a majority of our Board of Directors; </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">no
    cumulative voting in the election of directors, which limits the ability of minority stockholders to elect director candidates;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    exclusive right of our Board of Directors to elect a director to fill a vacancy created by the expansion of the Board of Directors
    or the resignation, death or removal of a director, which prevents stockholders from being able to fill vacancies on our Board of
    Directors; </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    ability of our Board of Directors to alter our Bylaws without obtaining stockholder approval; </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    required approval of the holders of at least two-thirds of the shares entitled to vote at an election of directors to adopt, amend
    or repeal our Bylaws or repeal the provisions of our Charter and Bylaws regarding the election and removal of directors; </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    prohibition on stockholder action by written consent, which forces stockholder action to be taken at an annual or special meeting
    of our stockholders; </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    requirement that a special meeting of stockholders may be called only by the chairman of the Board of Directors, the chief executive
    officer, the president (in the absence of a chief executive officer) or the Board of Directors, which may delay the ability of our
    stockholders to force consideration of a proposal or to take action, including the removal of directors; and </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">advance
    notice procedures that stockholders must comply with in order to nominate candidates to our Board of Directors or to propose matters
    to be acted upon at a stockholders&#8217; meeting, which may discourage or deter a potential acquirer from conducting a solicitation
    of proxies to elect the acquirer&#8217;s own slate of directors or otherwise attempting to obtain control of us. </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 30; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
provisions could inhibit or prevent possible transactions that some stockholders may consider attractive.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
could issue one or more additional series of shares of preferred stock with the effect of diluting existing stockholders and impairing
their voting and other rights.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Board of Directors is authorized to issue up to 10,000,000 shares of preferred stock and may determine the terms of future preferred
stock offerings without further action by our stockholders. If we issue preferred stock, it could affect your rights or reduce the value
of our outstanding common stock. In particular, specific rights granted to future holders of preferred stock may include voting rights,
preferences as to dividends and liquidation, conversion, and redemption rights, sinking fund provisions, and restrictions on our ability
to merge with or sell our assets to a third party. As of May 28, 2025, 3,388,875 shares of our preferred stock are outstanding, consisting
of 316 shares of Series E Preferred Stock, 33,000 shares of Series H Preferred Stock, 500,442 shares of Series I Preferred Stock, 297,788
shares of Series J Preferred Stock, 60,595 shares of Series K Preferred Stock, 1,076,156 shares of Series L Preferred Stock, 133,278
shares of Series M Preferred Stock, 500,000 shares of Series N Preferred Stock, 443,549 shares of Series O Preferred Stock, and 343,750
shares of Series P Preferred Stock. As a result, there is a possible negative effect on the market price of our common shares resulting
from the public sale or perceived sale of common shares issuable upon conversion or exercise of these securities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="a_004"></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM
1B. UNRESOLVED STAFF COMMENTS.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: -0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="a_005"></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM
1C. CYBERSECURITY.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p id="xdx_98D_ecyd--CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock_iB_c20240301__20250228_gBFCRMPFAIAMT-UUCRHTRA_zBZNRQbDPnql" class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"><ix:nonNumeric contextRef="From2024-03-01to2025-02-28" continuedAt="ConU000051-01" escape="true" id="Fact000051" name="cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Risk
Management and Strategy</i></b></span></ix:nonNumeric></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_C0F_gBFCRMPFAIAMT-UUCRHTRA_zLhQ1PbgYQ1k"><ix:continuation continuedAt="ConU000051-02" id="ConU000051-01"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></ix:continuation></span></p>

<div id="xdx_C0F_gBFCRMPFAIAMT-UUCRHTRA_zgYbkcMr4iX5"><ix:continuation continuedAt="ConU000051-03" id="ConU000051-02"><p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Due
to the size of our company, we have not yet developed robust policies and processes for assessing, identifying, and managing material
risk from cybersecurity threats. <span id="xdx_905_ecyd--CybersecurityRiskManagementProcessesIntegratedTextBlock_c20240301__20250228_zceUsl7Glt9" class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__"><ix:nonNumeric contextRef="From2024-03-01to2025-02-28" escape="true" id="Fact000052" name="cyd:CybersecurityRiskManagementProcessesIntegratedTextBlock">We have <span id="xdx_90F_ecyd--CybersecurityRiskManagementProcessesIntegratedFlag_dbT_c20240301__20250228_zTzF38pbzok1" class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__"><ix:nonNumeric contextRef="From2024-03-01to2025-02-28" format="ixt:booleantrue" id="Fact000053" name="cyd:CybersecurityRiskManagementProcessesIntegratedFlag">implemented</ix:nonNumeric></span> access controls with respect to our systems, which we monitor regularly and audit
annually. We currently rely heavily on products and services provided by <span id="xdx_90F_ecyd--CybersecurityRiskManagementThirdPartyEngagedFlag_dbT_c20240301__20250228_ztXsSs4RzLcb" class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__"><ix:nonNumeric contextRef="From2024-03-01to2025-02-28" format="ixt:booleantrue" id="Fact000054" name="cyd:CybersecurityRiskManagementThirdPartyEngagedFlag">third-party</ix:nonNumeric></span> suppliers to operate certain critical business systems,
including without limitation, cloud-based infrastructure, encryption and authentication technology, email, and other functions</ix:nonNumeric></span>. <span id="xdx_902_ecyd--CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag_dbT_c20240301__20250228_z1JBgml2CD19" class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__"><ix:nonNumeric contextRef="From2024-03-01to2025-02-28" format="ixt:booleantrue" id="Fact000055" name="cyd:CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag">We rely
on third party providers and outsourced IT services to monitor and address cybersecurity related risks, including installing software
for threat protection and malware</ix:nonNumeric></span>. Such third-party providers are tasked with notifying management of any material risks or cybersecurity
concerns that they identify, which management then assesses and may bring to our Board of Directors to discuss if deemed necessary or
appropriate. Based on the results of our risk assessments, if deemed necessary or appropriate, we take steps to re-design, implement,
and maintain reasonable safeguards to minimize identified risks; reasonably address any identified gaps in existing safeguards; and regularly
monitor the effectiveness of our safeguards.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
intend to work with outside counsel and third-party service providers to further develop our expertise, processes and procedures with
respect to cybersecurity protection and our response plan.</span></p>

</ix:continuation></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_C00_gBFCRMPFAIAMT-UUCRHTRA_zG7KdYHP0LHh"><ix:continuation continuedAt="ConU000051-04" id="ConU000051-03">&#160;</ix:continuation></span></span></p>


<!-- Field: Page; Sequence: 31; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0"><span id="xdx_C00_gBFCRMPFAIAMT-UUCRHTRA_zTlufbI0cJQa"><ix:continuation continuedAt="ConU000051-05" id="ConU000051-04"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></ix:continuation></span></p>

<div id="xdx_C0B_gBFCRMPFAIAMT-UUCRHTRA_zdzAaZjatclj"><ix:continuation continuedAt="ConU000051-06" id="ConU000051-05"><p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
date, we have <span id="xdx_908_ecyd--CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag_dbF_c20240301__20250228_z9TcUXskhocb" class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__"><ix:nonNumeric contextRef="From2024-03-01to2025-02-28" format="ixt:booleanfalse" id="Fact000056" name="cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag">not</ix:nonNumeric></span> (to our knowledge) encountered cybersecurity challenges that have materially impaired our operations or financial standing.
For additional information regarding risks from cybersecurity threats, please refer to Item 1A, &#8220;Risk Factors,&#8221; in this Report.</span></p>

</ix:continuation></div><p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_C03_gBFCRMPFAIAMT-UUCRHTRA_zgJwPYSiAgZ4"><ix:continuation id="ConU000051-06">&#160;</ix:continuation></span></span></p>

<p id="xdx_980_ecyd--CybersecurityRiskBoardOfDirectorsOversightTextBlock_c20240301__20250228_gBFCRBODOTB-FF_zYJL9y3qa0I3" class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; padding: 0pt; text-align: justify"><ix:nonNumeric contextRef="From2024-03-01to2025-02-28" continuedAt="ConU000060-01" escape="true" id="Fact000060" name="cyd:CybersecurityRiskBoardOfDirectorsOversightTextBlock"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Governance</i></b></span></ix:nonNumeric></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_C0E_gBFCRBODOTB-FF_zMtiqLp0FI8l"><ix:continuation continuedAt="ConU000060-02" id="ConU000060-01"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></ix:continuation></span></p>

<div id="xdx_C0B_gBFCRBODOTB-FF_zbLgQ6OO7mIl"><ix:continuation continuedAt="ConU000060-03" id="ConU000060-02"><p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_ecyd--CybersecurityRiskRoleOfManagementTextBlock_c20240301__20250228_z1UKx64iKHMi" class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__"><ix:nonNumeric contextRef="From2024-03-01to2025-02-28" escape="true" id="Fact000061" name="cyd:CybersecurityRiskRoleOfManagementTextBlock">Our
management team is primarily responsible for assessing and managing our strategic risk exposures, including material risks from cybersecurity
threats, with assistance from third-party service providers. Management oversees our cybersecurity process on a day-to-day basis, including
those described in &#8220;Risk Management and Strategy&#8221; above</ix:nonNumeric></span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Board of Directors does not have a standing risk management committee. Instead, <span id="xdx_905_ecyd--CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock_c20240301__20250228_zZm3ycTJbAPj" class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__"><ix:nonNumeric contextRef="From2024-03-01to2025-02-28" escape="true" id="Fact000062" name="cyd:CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock">our Board of Directors as a whole has oversight responsibility
for risk management, which it administers directly as well as with the assistance of standing committees of the Board of Directors that
will address risks inherent in their respective areas of oversight</ix:nonNumeric></span>. Throughout the year, the board and its committees engage with management
to discuss a wide range of enterprise risks, including cybersecurity.</span></p>

</ix:continuation></div><p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_C00_gBFCRBODOTB-FF_z8l4bKSPkYF3"><ix:continuation id="ConU000060-03">&#160;</ix:continuation></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="a_006"></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM
2. PROPERTIES.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
lease co-working space at 3900 Paseo del Sol, Santa Fe, New Mexico 87507, for a monthly rent expense of approximately $250. The lease
expires on June 30, 2025, and is cancelable at any time upon 45 days written notice. We believe that our facilities are suitable for
our current needs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="a_007"></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM
3. LEGAL PROCEEDINGS.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are not currently a party to any legal proceedings. However, from time to time, we may become subject to legal proceedings and claims
that arise in the ordinary course of our business, and an adverse outcome in litigation could materially adversely affect our business,
results of operations, financial condition, cash flows and price.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="a_008"></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM
4. MINE SAFETY DISCLOSURES.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
Applicable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 32; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="a_009"></span><b>PART
II</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="a_010"></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM
5. MARKET FOR REGISTRANT&#8217;S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Market
Information</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
common stock trades on the Nasdaq Capital Market under the symbol &#8220;NTRP.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Shareholders</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of May 28, 2025, there were approximately 649 holders of record of our common stock based on information provided by our transfer agent.
A substantially greater number of holders of our common stock are &#8220;street name&#8221; or beneficial holders, whose shares are held
by banks, brokers, and other financial institutions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Dividends</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have not paid any dividends on our common stock to date and do not anticipate that we will pay dividends in the foreseeable future. Any
payment of cash dividends on our common stock in the future will be dependent upon the amount of funds legally available, our earnings,
if any, our financial condition, restrictive covenants under outstanding preferred stock, our anticipated capital requirements, and other
factors that our Board of Directors deem relevant. We have paid dividends on certain series of our preferred stock pursuant to the respective
Certificates of Designation of such series of preferred stock and may do so in the future pursuant to future financing agreements, if
any.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Repurchases</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
did not purchase any shares of our common stock during the three months ended February 28, 2025.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_011"></span>ITEM
6. [RESERVED]</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="a_012"></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM
7. MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
should read the following discussion of our financial condition and results of operations in conjunction with the &#8220;Risk Factors&#8221;
included in Part I, Item 1A, &#8220;Risk Factors&#8221; of this Report and our Consolidated Financial Statements and related Notes thereto
included in Part II, Item 8, &#8220;Financial Statements and Supplementary Data&#8221; of this Report. See also the discussion of &#8220;Forward-Looking
Statements&#8221; immediately preceding Part I of this Report.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Business
Overview</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NextTrip
is an early-stage, technology-driven travel company developing an integrated travel booking and media platform designed to connect leisure,
group and business travelers to the world. Our travel booking platform is powered by our proprietary NXT2.0 booking engine, which offers
extensive inventory, supporting both travelers and distributors with a platform for curating personalized experiences and efficient trip
planning and booking. We market our travel services through several core brands including NextTrip Vacations (direct-to-consumer leisure
travel), Five Star Alliance (luxury and cruise bookings) and NextTrip Business (small-to-mid-sized corporate travel) and differentiate
our platform through specialty features, including specialized widgets for our Groups Platform and Travel Agent Platform, as well PayDlay,
a delayed payment booking option. Complementing our booking engine are our media properties, including Journy.tv, Compass.tv and Travel
Magazine, which provide destination content that we believe will drive high-intention traffic into our booking funnel and, over time,
constitute a separate high-margin advertising revenue stream.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
offerings include a mixture of direct contracts and third-party API content which span leisure and business travel, alternative lodging,
wellness travel, and media solutions, engaging customers throughout their travel journey with both individual and packaged options. One
of the key pillars of the NextTrip ecosystem is NextTrip Vacations, which is our core platform, powered by NXT2.0, delivering seamless
booking and customizable travel options across airlines, hotels, cruise, ground activities, and more. We have enhanced our offerings
to include luxury travel products and services with our recent acquisition of Five Star Alliance, providing travelers with curated packages
and detailed trip planning information through an intuitive booking system and/or its concierge help desk. Such additional product offering
highlights include:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NextTrip Leisure</b>
    &#8211; A robust booking engine providing customized vacation packages, flights, hotels, tours, wellness vacations, cruise and group
    travel options.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NextTrip Luxury &amp;
    Business</b> &#8211; Five Star Alliance provides access to over 5,000 luxury hotel properties worldwide featuring booking, expense
    reporting, concierge services, and 24/7 support.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NextTrip Cruises</b>
    &#8211; a fully integrated cruise booking engine providing access to over 10,000 sailings and 35 cruise partners. Travelers benefit
    from exclusive pricing, concierge service, and bundled packages that include transfers, pre- and post-cruise stays, and expert travel
    support.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NextTrip Solutions</b>
    &#8211; A suite for product management and white-label solutions, including property management, vacation rentals, and a portal to
    support travel agents &#8211; the Travel Agent Platform.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NextTrip Media</b> &#8211;
    Travel Magazine, Journy.tv and Compass.tv offering travelers inspiration and information through articles, videos, and immersive
    digital experiences. This will include personalized travel content for users to explore and share with friends and family.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
ambition is to build a next-generation travel solution for consumers, allowing them to better research and explore desired travel destinations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
revenue strategy and business model focuses on integrating our Media and Travel divisions, offering users a comprehensive ecosystem designed
to guide and support them throughout the travel experience. Presently, we generate revenue through two core methods: travel bookings
and advertising revenue. Leisure travel bookings currently generate the majority of our nominal revenues. This includes the sale of travel
products such as airline tickets, hotel rooms, and cruises as well as travel services such as travel insurance and ground activities.
We also currently generate nominal advertising revenues through our media and advertising ecosystem. Our advertising revenue strategy
is two-pronged: (1) as the number of viewers/users of Travel Magazine, Journy.tv and Compass.tv grows, it drives the advertising rates
we can charge third-parties to promote travel products and services to our audience and (2) outside of the direct advertising dollars
generated from our media platforms, which are expected to become a key driver of higher margin revenue than those earned from travel
product sales, growth in our audience will provide additional opportunities for us to promote our own travel offerings to highly targeted
viewers, thus lessening the need for spending significant marketing dollars through other mediums to attract consumers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are in the early stages of development and roll out of our comprehensive travel and media model. While the products we have introduced
to date (See above &#8220;<i>NXT2.0 Platform Features &#8211; Existing Features</i>&#8221;) are now functional and responsible for the
current, nominal revenue generation of the Company, the corresponding revenue streams are currently both small and unpredictable relative
to the established travel industry leaders. Our ability to capitalize on our existing travel technology platforms is severely restricted
due to the lack of funding to drive marketing programs. Enhancements to the existing platforms along with the introduction of new programs
under development (See above &#8220;<i>NXT2.0 Platform Features &#8211; Features in Development</i>&#8221;) are needed to complete the
model.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Because
we are at an early stage of commercial development and have only nominal revenues to date, our ability to implement our business plan
depends on our ability to successfully expand our supplier relationships, attract customers, and secure adequate capital to fund marketing
and future product development. There can be no assurance that we will be able to do so.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 33; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></td></tr></table></div>
    <div style="margin-bottom: 0pt; break-before: page; margin-top: 0pt"><p style="margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Critical
Accounting Policies and Estimates</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management
to make estimates and assumptions that affect the reported assets, liabilities, sales and expenses in the accompanying financial statements.
Critical accounting policies are those that require the most subjective and complex judgments, often employing the use of estimates about
the effect of matters that are inherently uncertain. By their nature, changes in these assumptions and estimates could significantly
affect our financial position or results of operations. Significant accounting estimates that may materially change in the near future
are revenue recognition, impairment of long-lived assets, values of stock compensation awards and stock equivalents granted as offering
costs, and allowance for bad debts. Such critical accounting policies, including the assumptions and judgments underlying them, are disclosed
in Note 1 &#8211; Business Description and Going Concern in the Notes to the Consolidated Financial Statements included in Part II, Item
8, &#8220;Financial Statements and Supplementary Data&#8221; of this Report. However, we do not believe that there are any alternative
methods of accounting for our operations that would have a material effect on our financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
critical accounting policies and estimates addressed below reflect our most significant judgements and estimates used in the preparation
of our financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Basis
of Presentation and Principles of Consolidation</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s financial statements and related disclosures are prepared pursuant to the rules and regulations of the SEC for annual
financial statements, as applicable. The Financial Statements have been prepared using the accrual basis of accounting in accordance
with U.S. generally accepted accounting principles (&#8220;GAAP&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
financial statements of the Company have been prepared on a consolidated basis with those of its wholly owned subsidiaries. All intercompany
transactions and balances have been eliminated in consolidation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Use
of Estimates</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect
the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the consolidated
financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from
those estimates. These differences could have a material effect on our future results of operations and financial position. Significant
items subject to estimates and assumptions include the carrying amounts of intangible assets, depreciation and amortization.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></p>

<!-- Field: Page; Sequence: 34; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></td></tr></table></div>
    <div style="margin-bottom: 0pt; break-before: page; margin-top: 0pt"><p style="margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Information
about key assumptions and estimation uncertainty that has a significant risk of resulting in a material adjustment to the carrying amounts
of our assets and liabilities within the next financial year is referenced in the notes to the financial statements as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    assessment of our ability to continue as a going concern;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    measurement and useful life of intangible assets and property and equipment; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recoverability
    of long-lived assets</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Receivables</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trade
accounts receivable are recorded at the invoiced amount and do not bear interest. The allowance for credit losses is the Company&#8217;s
best estimate of the amount of probable losses in its existing accounts receivable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company considers trade accounts receivable to be fully collectible; accordingly, no allowance for credit losses is required. If
amounts become uncollectible, they will be charged to operations when that determination is made.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trade
accounts receivable balances as of February 28, 2025 and February 29, 2024, were $22,567 and $34,082, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Receivables
from NextPlay under the promissory note, as described in Note 1 &#8211; Business Description and Going Concern in the Notes to the Consolidated
Financial Statements included in Part II, Item 8, &#8220;Financial Statements and Supplementary Data&#8221; of this Report, were $0 and
$1,000,000 at February 28, 2025 and February 29, 2024, respectively. Management has determined that, since NextPlay is in involuntary
bankruptcy proceedings and is in default under the terms of the promissory note, collectability of the entire related party receivable
as of February 28, 2025 is uncertain, and has therefore established an allowance for credit losses of $2,567,665.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Intangible
Assets</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company measures separately acquired intangible assets at cost less accumulated amortization and impairment losses. The Company recognizes
internally developed intangible assets when it has determined that the completion of such is technically feasible, and it has sufficient
resources to complete the development. Subsequent expenditures are capitalized when they increase the future economic benefits of the
associated asset. All other expenditures are recorded in profit or loss as incurred.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company assesses whether the life of intangible assets is finite or indefinite. The Company reviews the amortization method and period
of use of its intangible assets at least annually. Changes in the expected useful life or period of consumption of future economic benefits
associated with the asset are accounted for prospectively by changing the amortization method or period as a change in accounting estimates
in profit or loss. The Company has assessed the useful life of its trademarks as indefinite.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
estimated useful lives for the Company&#8217;s finite life intangible assets are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: justify">Category</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: justify">Method</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: justify">Estimated useful life</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Software</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Straight line</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">3 years</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Software licenses</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Straight line</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">0.5 - 4 years</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Software
Development Costs</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company capitalizes internal software development costs subsequent to establishing technological feasibility of a software application
in accordance with guidelines established by &#8220;ASC 985-20-25&#8221; Accounting for the Costs of Software to Be Sold, Leased, or
Otherwise Marketed, requiring certain software development costs to be capitalized upon the establishment of technological feasibility.
The establishment of technological feasibility and the ongoing assessment of the recoverability of these costs require considerable judgment
by management with respect to certain external factors such as anticipated future revenue, estimated economic life, and changes in software
and hardware technologies. Amortization of the capitalized software development costs begins when the product is available for general
release to customers. Capitalized costs are amortized based on the straight-line method over the remaining estimated economic life of
the product.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Investments
in Equity Method Investees</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company holds investments in certain entities that are accounted for under the equity method of accounting, as well as investments that
are accounted for under the fair value method pursuant to ASC 321, &#8220;Investments - Equity Securities.&#8221; Under the equity method,
investments in entities in which the Company has significant influence, but not control, are initially recognized at cost and adjusted
thereafter to recognize the Company&#8217;s share of the investees&#8217; earnings or losses and other comprehensive income.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 35; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></td></tr></table></div>
    <div style="margin-bottom: 0pt; break-before: page; margin-top: 0pt"><p style="margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company determines the existence of significant influence based on various factors, including representation on the investees&#8217;
board of directors, participation in policy-making processes, and material intercompany transactions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s equity method investments are evaluated periodically for impairment by assessing whether events or changes in circumstances
indicate that the carrying value of the investment may not be recoverable. When such indicators exist, the Company performs an impairment
test and recognizes an impairment loss to the extent that the carrying amount of the investment exceeds its fair value.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Distributions
received from equity method investees that exceed cumulative earnings recognized by the Company are considered a return of investment
and are recorded as a reduction in the carrying amount of the investment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Adjustments
resulting from changes in the Company&#8217;s ownership interest in equity method investees that do not result in a loss of significant
influence are accounted for prospectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Basis
Difference</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
accordance with ASC 323, &#8220;Investments - Equity Method and Joint Ventures,&#8221; the Company records a basis difference when the
carrying value of its equity method investment differs from its share of the investee&#8217;s fair value of net assets at the acquisition
date. This basis difference is allocated to the investee&#8217;s identifiable assets and liabilities based on their fair values. The
amortization of any basis difference related to depreciable assets, such as property, plant, and equipment, is recognized in the Company&#8217;s
share of the investee&#8217;s earnings or losses. Any basis difference related to non-depreciable assets, including goodwill, is generally
not amortized, but is subject to impairment testing as necessary.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company assesses the impact of any basis differences on its earnings and the carrying value of its equity method investments. If a basis
difference is determined to exist, the appropriate adjustments are made to reflect the amortization of such differences in the consolidated
financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Investments
in Equity Securities without Readily Determinable Fair Value</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
accordance with ASC 321-10-35-2, the Company holds certain investments in equity securities in which the Company does not have significant
influence or control, and for which fair value is not readily determinable. These investments are primarily accounted for at cost, less
any impairment. The carrying amount is periodically evaluated for impairment, and if necessary, an impairment loss is recognized in the
statement of operations. These investments are not adjusted for unrealized gains or losses unless an impairment is identified.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
investments in non-public entities where fair value is not determinable, the Company does not adjust the carrying value for changes in
fair value, except for impairment losses. The fair value of these investments is disclosed when it is practicable to determine.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Equity
in Earnings of Equity Method Investees</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s share of earnings or losses from equity method investees is recognized in the consolidated statement of operations within
&#8220;Equity in earnings of equity method investees,&#8221; net of any related income taxes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fair
Value Measurements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fair value of equity method investments is disclosed when available and practical to determine. However, for investments that are not
readily marketable, such as non-public entities, fair value is not typically recognized in the financial statements unless the investment
is impaired.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Impairment
of Intangible Assets</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
accordance with ASC 350-30-65 &#8220;Goodwill and Other Intangible Assets&#8221;, the Company assesses the impairment of identifiable
intangible assets whenever events or changes in circumstances indicate that the carrying value may not be recoverable. Factors it considers
important, which could trigger an impairment review include the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.
Significant underperformance compared to historical or projected future operating results;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<br/></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.
Significant changes in the manner or use of the acquired assets or the strategy for the overall business; and</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.
Significant negative industry or economic trends.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 36; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></td></tr></table></div>
    <div style="margin-bottom: 0pt; break-before: page; margin-top: 0pt"><p style="margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">When
the Company determines that the carrying value of an intangible asset may not be recoverable based upon the existence of one or more
of the above indicators of impairment and the carrying value of the asset cannot be recovered from projected undiscounted cash flows,
the Company records an impairment charge. The Company measures any impairment based on a projected discounted cash flow method using
a discount rate determined by management to be commensurate with the risk inherent to the current business model. Significant management
judgment is required in determining whether an indicator of impairment exists and in projecting cash flows. Intangible assets that have
finite useful lives are amortized over their useful lives.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Revenue
Recognition</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recognizes revenue in accordance with ASC 606 &#8220;Revenue from Contracts with Customers,&#8221; which involves identifying
the contracts with customers, identifying performance obligations in the contracts, determining transactions price, allocating transaction
price to the performance obligation, and recognizing revenue when the performance obligation is satisfied.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recognizes revenue when the customer has purchased the product, the occurrence of the earlier of date of travel or the date of
cancellation has expired, as satisfaction of the performance obligation, the sales price is fixed or determinable and collectability
is reasonably assured. Revenue for customer travel packages purchased directly from the Company is recorded gross (the amount paid to
the Company by the customer is shown as revenue and the cost of providing the respective travel package is recorded to cost of revenues).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company generates revenues from sales directly to customers as well as through other distribution channels of tours and activities at
destinations throughout the world.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company controls the specified travel product before it is transferred to the customer and is therefore a principal, including but not
limited to, the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company is primarily
    responsible for fulling the promise to provide such travel product.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has inventory
    risk before the specified travel product has been transferred to a customer or after transfer of control to a customer.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has discretion
    in establishing the price for the specified travel product.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Payments
for tours or activities received in advance of services being rendered are recorded as deferred revenue and recognized as revenue at
the earlier of the date of travel or the last date of cancellation (i.e., the customer&#8217;s refund privileges lapse).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
time to time, payments are made to suppliers in advance of customer bookings as required by hotels. These payments are recognized as
costs of goods at the earlier of the date of travel or the last date of cancellation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Stock-Based
Compensation</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
measure the compensation costs of stock-based compensation arrangements based on the grant-date fair value and recognize the costs in
the financial statements over the period during which employees are required to provide services. Stock-based compensation arrangements
may include stock options, grants of shares of common stock with and without restrictions, performance-based awards, share appreciation
rights and employee share purchase plans. Stock-based compensation is measured on the date of grant at its fair value.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: -0.9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equity
instruments issued to non-employees are recorded on the basis of the grant date fair value of the instruments. In general, the measurement
date is either (a) when a performance commitment, as defined, is reached or (b) the earlier of the date that (i) the non-employee performance
requirement is complete or (ii) the instruments are vested. The measured value related to the instruments is recognized over a period
based on the facts and circumstances of each particular grant.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
grant date fair value of stock-based compensation and other equity instruments is calculated using the Black Scholes valuation model,
and requires estimates of several inputs to the model, including risk-free interest rates, dividends, and expected volatility of our
stock price.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 37; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></td></tr></table></div>
    <div style="margin-bottom: 0pt; break-before: page; margin-top: 0pt"><p style="margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Results
of Operations</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Year
Ended February 28, 2025 Compared to the Year Ended February 29, 2024</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Revenue</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the year ended February 28, 2025, we recognized revenue of $501,423 as compared to $<span style="background-color: white">458,752 </span>in
the same period in 2024, an increase of $42,671, or 9%. The increase was a result of the continued implementation of our booking engine
and expanded product offerings.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Cost
of Revenue</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cost
of revenue for the year ended February 28, 2025, was $498,121 as compared to $<span style="background-color: white">397,532</span> for
the same period in 2024, an increase of $100,589, or 25%. The increase was attributable to the increase in revenue in the year ended
February 28, 2025, as compared to the same period in 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Operating
Expenses</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating
expenses totaled $7,416,731 for the year ended February 28, 2025, versus $5,740,577 for the year ended February 29, 2024. The increase
of $1,676,154, or 29%, was due to an increase in Salaries and Benefits of $1,026,176, an increase in technology expenses of $531,866,
an increase in professional service fees of $809,973, an increase in organization costs of $188,613, and an increase in other operating
expenses of $160,539. Partially offsetting these increases were a decrease in stock based compensation expenses of $48,638, a decrease
in general and administrative expenses of $56,765, a decrease in sales and marketing expenses of $177,084, and a decrease in depreciation
and amortization of $755,526.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Salaries
and Benefits</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Salaries
and benefits expenses were $2,630,663 for the year ended February 28, 2025, as compared to $1,604,487 for the same period in 2024. The
increase of $1,026,176 or 64% was the result of an increase in salary expense of $762,052 and payroll taxes of $138,669 due to an increase
in headcount, and increased benefits costs of $82,125 due to higher insurance premiums and an increase in the employer contribution toward
employee health plans, an increase in bonus expense of $40,000, and an increase in severance expense of $38,141. Partially offsetting
these increases was a decrease in SARs compensation of $34,926.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Stock
Based Compensation</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock
based compensation totaled $67,874 for the year ended February 28, 2025, versus $116,512 for the year ended February 29, 2024, a decrease
of 48,638, or 42%. The decrease of $75,368 was attributable to the accelerated vesting of employee stock options in connection
with the reverse acquisition in fiscal 2024; partially offset by $26,760 in stock granted to a former employee as part of a separation
agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Loss
on Promissory Note Receivable</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
loss of $1,000,000 on the NextPlay promissory note receivable for the year ended February 28, 2025 is attributable to reserving the
remaining balance on the outstanding promissory note receivable from NextPlay. Management has determined that, since NextPlay is in
involuntary bankruptcy proceedings and is also in default on the note repayment, collectability of the related party receivable as
of February 28, 2025 is uncertain.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>General
and Administrative Expense</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">General
and administrative expense for the year ended February 28, 2025 was $95,341, as compared to $152,106 for the year ended February 29,
2024, a decrease of $56,765. The decrease was primarily attributable to a reduction in travel expenses of $10,141, a decrease in rent
and utilities expenses of $4,257, a decrease in payroll expense of $24,925, and a decrease in office and other general expenses of $21,878.
Partially offsetting the decrease was an increase in license fees of $4,436.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Sales
and Marketing Expense</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sales
and marketing expenses were $307,166 for the year ended February 28, 2025, as compared to $484,250 for the same period in 2024. The decrease
of $177,084, or 37%, was primarily due to cost-cutting measures, including the absence of a Black Friday campaign in fiscal year 2025</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 38; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></td></tr></table></div>
    <div style="margin-bottom: 0pt; break-before: page; margin-top: 0pt"><p style="margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<br/></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Professional
Service Fees</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Professional
service fees were $2,228,481 for the year ended February 28, 2025, as compared to $1,421,508 for the same period in 2024. The increase
of $806,973, or 57%, was the result of an increase in investor relations expenses of $343,655, an increase in legal fees of $130,463,
an increase in accounting and audit fees of $158,744, and an increase in financial advisory fees of $299,289. Partially offsetting these
increases was a decrease in consulting fees of $125,178 due to the capitalization of development work related to Compass.tv.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Technology</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Technology
expenses for the year ended February 28, 2025 were $843,296, as compared to $311,430 for the year ended February 29, 2024. The increase
of $531,866, or 171%, was primarily attributable to an increase in dues and subscription expenses of $37,598 for external travel services
used in connection with our booking engine, an increase of $207,333 in cloud database and networking expenses related to hosting our
booking engine, an increase in Compass.tv expenses of $281,500 due to third party contracted services related to hosting and maintenance,
and an increase in information technology expenses of $5,435.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Organization
Costs</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Organization
costs were $213,613 for the year ended February 28, 2025, as compared to $25,000 for the year ended February 29, 2024. The increase was
primarily attributable to directors&#8217; compensation and shareholder services expenses, including transfer agent fees.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Depreciation
and Amortization</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation
and amortization expense for the year ended February 28, 2025, was $713,236 as compared to $1,468,762 for the same period in 2024, a
decrease of $755,526, or 51%. The decrease was primarily the result of no new equipment purchases and an increase in fully amortized
intangible assets as compared to the same period in 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Other
Expenses</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
expenses totaled $317,061 for the year ended February 28, 2025, as compared to $156,522 for the year ended February 29, 2024. The increase
of $160,539, or 103%, was primarily due to an increase in D&amp;O insurance premiums of $170,924, partially offset by a $10,386 decrease
in bank service charges as a result of a change in our merchant processor and lower processing rates.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Other
Expense</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
expense was $2,707,609 for the year ended February 28, 2025, as compared to other expense of $977,480 for the same period in 2024. The
increase of $1,730,129 was primarily due to an increase of loss on extinguishment of debt related to equity conversions of $1,301,469,
an increase in interest expense, primarily associated with bridge loans and the amortization of the debt discount of $540,419, and a
decrease in other income of $470,534, partially offset by a decrease in loss on disposal of assets of $14,628, and a decrease in the
loss on related party receivable of $567,665.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Net
Loss from Continuing Operations</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the year ended February 28, 2025, the net loss from continuing operations totaled $10,121,038 as compared to a net loss from continuing
operations of $6,656,837 for the year ended February 29, 2024. The operating loss component increased by $1,734,072 in 2025, and the
other loss component increased by $1,730,129.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Net
Gain from Discontinued Operations</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
net gain from discontinued operations of $8,344 for the year ended February 28, 2025 consisted primarily of the collection of an outstanding
receivable that was written off in the prior year and the reversal of an outstanding payable that was settled for a lower amount.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Net
Loss Applicable to Common Shareholders</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
net loss applicable to common shareholders totaled $10,198,684 for the year ended February 28, 2025, as compared to $7,339,276 for the
year ended February 29, 2024. Preferred dividends were $78,600 in 2025 and $7,125 in 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 39; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></td></tr></table></div>
    <div style="margin-bottom: 0pt; break-before: page; margin-top: 0pt"><p style="margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<br/></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Liquidity
and Capital Resources</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Due
to uncertainties regarding our ability to meet our current and future operating and capital expenses, there is substantial doubt about
our ability to continue as a going concern for 12 months from the date of filing of Annual Report, and the report of our registered independent
public accounting firm on our financial statements as of and for the year ended February 28, 2025 included in Item 15 of this Report
contains a going concern qualification.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of February 28, 2025, we had $1,062,367 in cash, an accumulated deficit of $34,349,823 and a working capital deficit of $105,577, compared
to $323,805 in cash, an accumulated deficit of $24,151,139 and a working capital deficit of $262,005 as of February 29, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Given
the lack of significant revenue since inception, NextTrip has financed its operations primarily through the issuance of short-term promissory
notes, advances from related parties, and private placements of its securities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 1, 2025, we entered into a securities purchase agreement (the &#8220;Alumni Purchase Agreement&#8221;) with Alumni for the sale
of a short-term promissory note (the &#8220;Alumni Note&#8221;) and warrants to purchase 80,000 shares of common stock to Alumni for
total consideration of $300,000.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Alumni Note is in the principal amount of $360,000 with an original issue discount of $60,000 and guaranteed interest on the principal
amount of ten percent (10%) per annum, which shall be due and payable on July 1, 2025. In the event of a failure to re-pay the Alumni
Note on or before the maturity date, the interest rate will increase to the lesser of twenty-two percent (22%) per annum or the maximum
amount permitted under law from the due date thereof until the same is paid.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Alumni Note is convertible into shares of common stock of the Company only upon an event of default.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 9, 2025, we entered into two promissory notes (together, the &#8220;Trust Notes&#8221;) with Donald P. Monaco Insurance
Trust (the &#8220;Trust&#8221;) under our $2.0 million line of credit. Donald Monaco, chairman of our Board, is the trustee of the Trust.
The first note had a principal balance of $500,000 and was issued in exchange for a new cash payment provided my Mr. Monaco. The second
note had a principal balance of $145,000 and was issued in exchange for cash advances previously made by Mr. Monaco to the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 6, 2025, we entered into a Line of Credit Agreement (the &#8220;MIP Line of Credit&#8221;) with Monaco Investment Partners
II, LP (&#8220;MIP&#8221;) providing the Company with a $3,000,000 revolving line of credit. The MIP Line of Credit allows the
Company to request advances thereunder from time to time until May 31, 2027, the maturity date. Advances made under the MIP Line of Credit
bear simple interest at a rate of 12% per annum, calculated from the date of each respective advance. Accrued interest shall be payable
on a monthly basis, no later than the 10th day of the subsequent month. The full outstanding principal balance, together with any accrued
and unpaid interest, shall be due and payable in full by the Company on the maturity date. The Company may, at its option, prepay any
borrowings under the MIP Line of Credit, in whole or in part, at any time prior to the maturity date, without penalty. Mr. Monaco controls
MIP.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
received an initial advance of $1,045,000 under the MIP Line of Credit, which was used to repay (i) a $400,000 cash advance
previously made by the Trust to the Company (ii) and all outstanding indebtedness under the terms of the
Trust Notes, totaling $645,000.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
will need to raise additional funds through equity or debt financings or other means to support our on-going operations, increase market
penetration of our products, expand the marketing and development of our travel and technology driven products, provide capital expenditures
for additional equipment and development costs, payment obligations, and systems for managing the business including covering other operating
costs and maintaining compliance with Nasdaq listing requirements until planned revenue streams are fully implemented and begin to offset
the our operating costs. The Company estimates that it will require a minimum of $5.5 million to continue operations for the next twelve
months.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
is no assurance as to the amount and availability of any required future financing or the terms thereof. Such financing, if in the form
of equity, may be highly dilutive to our existing stockholders and may otherwise include onerous terms. If in the form of debt, such
financing may include covenants and repayment obligations which may be difficult to meet and that could adversely affect our business
and operations. To the extent that funds are not available to us, we may be required to delay, limit, or terminate our business and operations
and lose our Nasdaq listing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 29.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Net
Cash Used in Operating Activities</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
cash used in operating activities from continuing operations during the year ended February 28, 2025, was $5,088,498 as compared to $5,056,095
during the same period in 2024, an increase of $32,403, or 0.6%.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 40; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></td></tr></table></div>
    <div style="margin-bottom: 0pt; break-before: page; margin-top: 0pt"><p style="margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the year ended February 28, 2025, the net cash used in operating activities from continuing operations was the result of a net loss of
$10,128,428, partially offset by changes in working capital of $1,537,714 and non-cash expenses of $3,502,216. The non-cash expenses
were primarily comprised of depreciation and amortization of $713,236, stock-based compensation of $67,874, amortization of prepaid expenses
of $236,112, amortization of debt discount of $342,935, a loss on debt extinguishment of $1,134,579, and the loss of $1,000,000 on the
NextPlay promissory note receivable. Changes in working capital were driven by a decrease in accounts receivable of $11,515, a decrease
in prepaid expenses of $159,343, a decrease in security deposits of $12,000, and an increase in accounts payable and accrued expenses
of $1,397,007, partially offset by a decrease in deferred revenue of $42,151.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
cash provided by operating activities from discontinued operations during the year ended February 28, 2025, was $8,344 as compared to
net cash used of $675,314 during the same period in 2024, which was primarily related to payments received on legacy Sigma contracts.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a result, total net cash used in operating activities decreased by $651,255 during the year ended February 28, 2025, to $5,080,154 as
compared to $5,731,409 during the same period in 2024, a decrease of 11.4%.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; color: #212529"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">During
the year ended February 29, 2024, the net cash used in operating activities from continuing operations was the result of a net loss of
$6,656,837, partially offset by changes in working capital of $1,400,025 and non-cash expenses of $3,000,767. The non-cash expenses were
primarily comprised of depreciation and amortization of $1,468,762 and the loss of $1,567,665 on the NextPlay promissory note receivable.
Changes in working capital were driven by an increase in accounts receivable of $662,939, an increase in prepaid expenses of $281,506,
an increase in security deposits of $27,167, and a decrease in accounts payable and accrued expenses of $531,367, partially offset by
an increase in deferred revenue of $102,954.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Net
Cash Provided by/(Used in) Investing Activities</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
cash used in investing activities during the year ended February 28, 2025, was $(1,033,751), which compares to net cash provided by investing
activities of $980,936 during the same period of 2024, an increase of $2,014,687. The primary uses of cash in investing activities for
the twelve months ended February 28, 2025 were $500,000 used to purchase the 49% interest in FSA, and capitalized software development
costs of $534,751. For the twelve months ended February 29, 2024, cash provided by investing activities was primarily a result of the
reverse acquisition, which provided cash of $417,122, and the subsequent sale of Sigma&#8217;s legacy assets to a third party, which
generated an additional $1,589,241 in cash, partially offset by capitalized software development costs of $1,016,175.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Net
Cash Provided by Financing Activities</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
raised $6,852,467 in net proceeds during the year ended February 28, 2025, consisting of $1,967,224 from the issuance of short-term promissory
notes, $2,450,000 from the issuance of preferred shares, $2,118,249 from related party advances, and $316,994 from the exercise of warrants.
We raised <span style="background-color: white">$4,791,804 in net proceeds during the year ended February 29, 2024, consisting of $735,0<span style="background-color: white">5</span>7
from the issuance of convertible notes, $1,905,970 from the issuance of common shares, $1,603,500 from the issuance of preferred shares,
and $547,277 from related party advances.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inflation,
changing prices and rising interest rates have had no material effect on NextTrip&#8217;s continuing operations over our two most recent
fiscal years.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have no off-balance sheet arrangements as defined in Item 303(a) of Regulation S-K.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span id="a_013"></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM
7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span id="a_014"></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM
8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Consolidated Financial Statements, the report thereon, the Notes thereto, and the supplementary data commencing on page F-1 of this Report
are incorporated herein by reference.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span id="a_015"></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM
9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">None.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 41; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></td></tr></table></div>
    <div style="margin-bottom: 0pt; break-before: page; margin-top: 0pt"><p style="margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="a_016"></span>&#160;<br/></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM
9A. CONTROLS AND PROCEDURES.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; color: #212529"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Evaluation
of Disclosure Controls and Procedures </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
maintain disclosure controls and procedures that are designed to ensure that information required to be disclosed in our periodic and
current reports that we file with the SEC is recorded, processed, summarized and reported within the time periods specified in the SEC&#8217;s
rules and forms; and that such information is accumulated and communicated to our management, including our principal executive officer
and principal financial officer, as appropriate, to allow timely decisions regarding required disclosure.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Chief Executive Officer and our Chief Financial Officer, after evaluating our &#8220;disclosure controls and procedures&#8221; (as defined
in Exchange Act Rules 13a 15(e) and 15d 15(e)) as of February 28, 2025 (the &#8220;Evaluation Date&#8221;), have concluded that as of
the Evaluation Date, our disclosure controls and procedures are effective to ensure that information we are required to disclose in reports
that we file or submit under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in SEC
rules and forms, and to ensure that information required to be disclosed by us in such reports is accumulated and communicated to our
management, including our Chief Executive Officer and Chief Financial Officer, where appropriate, to allow timely decisions regarding
required disclosure.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Changes
in Internal Controls Over Financial Reporting</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the first six months of the fiscal year, management implemented several enhancements to its control over financial reporting (as defined
in Rules 13a-15(f) and 15d-15(f) under the Exchange Act), including, but not limited to, establishing a monthly financial closing process,
implementing account reconciliations, ensuring proper segregation of duties, and implementing new financial control software. These enhancements
were completed by August 31, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
were no other changes in our internal control over financial reporting identified in management&#8217;s evaluation pursuant to Rules
13a-15(d) or 15d-15(d) of the Exchange Act during the period covered by this Report that materially affected, or are reasonably likely
to materially affect, our internal control over financial reporting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Management&#8217;s
Report on Internal Control Over Financial Reporting</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
management is responsible for establishing and maintaining adequate internal control over financial reporting (as defined in Exchange
Act Rules 13a-15(f) and 15d-15(f)). Internal control over financial reporting is designed to provide reasonable assurance regarding the
reliability of financial reporting and the preparation of financial statements for external purposes in accordance with GAAP. Our management,
with the participation of our Chief Executive Officer and Chief Financial Officer, conducted an evaluation of the effectiveness of our
control over financial reporting based on the framework in Internal Control-Integrated Framework issued by the Committee of Sponsoring
Organizations of the Treadway Commission. Based on its evaluation under the framework, management has concluded that our internal control
over financial reporting was effective as of February 28, 2025.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
continuously seek to improve and strengthen our control processes to ensure that our controls and procedures are adequate and effective.
Any failure to implement and maintain improvements in the controls over our financial reporting could cause us to fail to meet our reporting
obligations under the SEC&#8217;s rules and regulations. Any such failure could also cause investors to lose confidence in our reported
financial information, which could have a negative impact on the trading price of our common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Report does not include an attestation report of the Company&#8217;s registered independent public accounting firm regarding internal
control over financial reporting, which is not required for smaller reporting companies.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 42; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></td></tr></table></div>
    <div style="margin-bottom: 0pt; break-before: page; margin-top: 0pt"><p style="margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Inherent
Limitations on Effectiveness of Controls</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
management, including our Chief Executive Officer and our Chief Financial Officer, does not expect that our disclosure controls and procedures
or our internal control over financial reporting will prevent or detect all errors and all fraud. A control system, no matter how well-designed
and operated, can provide only reasonable, not absolute, assurance that the control system&#8217;s objectives will be met. The design
of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative
to their costs. Further, because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance
that misstatements due to error or fraud will not occur or that all control issues and instances of fraud, if any, have been detected.
The design of any system of controls is based in part on certain assumptions about the likelihood of future events, and there can be
no assurance that any design will succeed in achieving its stated goals under all potential future conditions. Projections of any evaluation
of the effectiveness of controls to future periods are subject to risks. Over time, controls may become inadequate because of changes
in conditions or deterioration in the degree of compliance with policies or procedures.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span id="a_017"></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM
9B. OTHER INFORMATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Rule
10b5-1 Trading Arrangements</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the three months ended February 28, 2025, no director or officer of the Company <span id="xdx_90F_eecd--Rule10b51ArrAdoptedFlag_dbF_c20241201__20250228_zVGHJVwA6KMg" class="xdx_phnt_RGlzY2xvc3VyZSAtIEluc2lkZXIgVHJhZGluZyBBcnJhbmdlbWVudHMA"><span id="xdx_90F_eecd--NonRule10b51ArrAdoptedFlag_dbF_c20241201__20250228_zNBmTJSAkt29" class="xdx_phnt_RGlzY2xvc3VyZSAtIEluc2lkZXIgVHJhZGluZyBBcnJhbmdlbWVudHMA"><ix:nonNumeric contextRef="From2024-12-012025-02-28" format="ixt:booleanfalse" id="Fact000063" name="ecd:Rule10b51ArrAdoptedFlag"><ix:nonNumeric contextRef="From2024-12-012025-02-28" format="ixt:booleanfalse" id="Fact000064" name="ecd:NonRule10b51ArrAdoptedFlag">adopted</ix:nonNumeric></ix:nonNumeric></span></span> or <span id="xdx_90D_eecd--Rule10b51ArrTrmntdFlag_dbF_c20241201__20250228_zdX9JOMYxHN" class="xdx_phnt_RGlzY2xvc3VyZSAtIEluc2lkZXIgVHJhZGluZyBBcnJhbmdlbWVudHMA"><span id="xdx_901_eecd--NonRule10b51ArrTrmntdFlag_dbF_c20241201__20250228_ztXT0kd4uu31" class="xdx_phnt_RGlzY2xvc3VyZSAtIEluc2lkZXIgVHJhZGluZyBBcnJhbmdlbWVudHMA"><ix:nonNumeric contextRef="From2024-12-012025-02-28" format="ixt:booleanfalse" id="Fact000065" name="ecd:Rule10b51ArrTrmntdFlag"><ix:nonNumeric contextRef="From2024-12-012025-02-28" format="ixt:booleanfalse" id="Fact000066" name="ecd:NonRule10b51ArrTrmntdFlag">terminated</ix:nonNumeric></ix:nonNumeric></span></span> any &#8220;Rule 10b5-1 trading
arrangement&#8221; or &#8220;non-Rule 10b5-1 trading arrangement&#8221; (as such terms are defined under Item 408(a) of Regulation S-K).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span id="a_018"></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM
9C. DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 43; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></td></tr></table></div>
    <div style="margin-bottom: 0pt; break-before: page; margin-top: 0pt"><p style="margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="a_019"></span><b>PART
III</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span id="a_020"></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM
10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Executive
Officers</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth the name, age and position of each of our executive officers as of May 28, 2025:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 93%; border-collapse: collapse; margin-left: 0.5in">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 27%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Age</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 58%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Position</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">William Kerby</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">67</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">John McMahon</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">61</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Operating Officer, Travel Division</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Frank Orzechowski</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">65</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Financial Officer, Treasurer and Corporate Secretary</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>William
Kerby</i></b> has served as our Chief Executive Officer since December 29, 2023. Mr. Kerby has over two decades of experience in the
travel and media industries, and approximately a decade of experience in the financial industry. He acted as the architect of the
NextTrip model, overseeing the development and operations of the Travel, Real Estate and Television Media divisions of the company.
From January 2023 to December 2023, Mr. Kerby served as the Chief Executive Officer of NextTrip Group, LLC. Mr. Kerby served as the
Co-Chief Executive Officer of NextPlay Technologies, Inc. (formerly Monaker Group, Inc.) from September 2021 to January 2023. From
July 2008 to September 2021, Mr. Kerby was the Chief Executive Officer of Monaker Group, Inc. During that time, Mr. Kerby also
served as Chief Executive Officer of NextPlay Media from 2009 through 2020 as well as the Chief Executive Officer of the
company&#8217;s real estate holding Verus International, Inc. (formerly Realbiz Media Group, Inc.) from October 2012 until August
2015 and on the board of directors until April 2016. From April 2002 to July 2008, Mr. Kerby served as the Chief Executive Officer
of various media and travel entities that ultimately became part of Extraordinary Vacations Group. Operations included Cruise &amp;
Vacation Shoppes, Maupintour Extraordinary Vacations, Attach&#233; Travel and the Travel Magazine - a TV series of 160 travel
shows. From February 1999 to April 2002, Mr. Kerby founded and managed Travelbyus, which was a publicly- traded company on the Toronto Stock Exchange
and Nasdaq Small Cap Market. The launch included an intellectually patented travel model that utilized technology-based marketing to
promote its travel services and products. Mr. Kerby negotiated the acquisition and financing of 21 companies encompassing multiple
tour operators, 2,100 travel agencies, media that included print, television, outdoor billboard and wireless applications and
leading-edge technology in order to build and complete the Travelbyus model. The company had over 500 employees, gross revenues
exceeding $3 billion and a market cap of over $900 million. From June 1989 to January 1999, Mr. Kerby founded and grew Leisure
Canada,  a company that included the Master Franchise for Thrifty Car Rental British Columbia, TravelPlus (a nationwide Travel
Agency), Bluebird Holidays (an international tour company with operations in the U.S., Canada, Great Britain, France, South Africa
and the South Pacific) and Canadian Traveler (a travel magazine). Leisure Canada was acquired in May 1998 by Wilton Properties, a
Canadian company developing hotel and resort properties in Cuba. From October 1980 through June 1989, Mr. Kerby worked in the
financial industry as an investment advisor. Mr. Kerby graduated from York University with a Specialized Honors Economics
degree.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>John
McMahon</i></b> has served as Chief Operating Officer, Travel Division since February 7, 2025. He brings 28 years of experience in consumer
and trade travel media. For the past seven years, Mr. McMahon served as the Chief Executive Officer and majority shareholder of Five Star Alliance,
a leading travel agency known for its curated collection of over 5,000 five-star hotels and more than 35 cruise lines. In 2018, he successfully
led a management buyout of Five Star Alliance from Questex Media and Shamrock Capital. From 1997 to 2018, Mr. McMahon held various leadership
roles over a 20-year tenure at Questex Media. As Executive Vice President of the Travel &amp; Hospitality Group, he oversaw global travel
media and event assets including Travel Agent Magazine, Luxury Travel Advisor, Premier Hotel &amp; Resorts, Travel Agent University,
Ultra Summit, Global Meeting &amp; Incentive Travel Exchange, Hotel Management, Hotel Design, and the International Hotel Investment
Forums. He was instrumental in transitioning traditional media and event properties into high-margin digital platforms. Earlier in his
career, from 1987 to 1997, Mr. McMahon worked at a trade media company, Putman Publishing. He has served on multiple advisory boards,
including the Starwood Hotels Luxury Board and Fairmont Hotels &amp; Resorts. Mr. McMahon served on the Cystic Fibrosis Board Directors-New
York Chapter from 2001 to 2019. Mr. McMahon holds a Bachelor of Science degree in Education (B.S.Ed.) from Rider University.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Frank
Orzechowski</i></b> has served as our Chief Financial Officer, Treasurer, principal accounting officer, principal financial officer,
and Corporate Secretary since July 1, 2019. Prior to joining the Company, Mr. Orzechowski served as the Chief Financial Officer of StormHarbour
Partners LP, an independent global markets and financial advisory firm since September 2013. From May 2013 to August 2013, Mr. Orzechowski
served as a contract Chief Financial Officer for Etouches Inc., a cloud-based event management software company, to assist with financial matters in connection
with that company&#8217;s planned equity financing. Prior to that, he served as President and Owner/Operator of Four-O Technologies Inc.
from August 2009 to December 2012, where he successfully launched and guided operations for two Cartridge World franchise units in Connecticut.
From February 2006 to July 2009, Mr. Orzechowski served as President and Chief Financial Officer of Nikko Americas Holding Company Inc.,
where he was responsible for managing all of the support and infrastructure for that company&#8217;s U.S. business, as well as investment
manager selection and due diligence functions for its World Series Platform. Mr. Orzechowski began his career at Coopers &amp; Lybrand
in 1982, received his CPA certification in 1984 and received his Bachelor of Science in Business Administration with a major in Accounting
from Georgetown University in 1982.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 44; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></td></tr></table></div>
    <div style="margin-bottom: 0pt; break-before: page; margin-top: 0pt"><p style="margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Board
of Directors and Corporate Governance</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth the names, ages as of May 28, 2025, and certain other information regarding our directors:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Directors</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Class</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Age</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Position</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Director<br/>

    Since</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Current
                                            Term</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Expires</b></span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Donald P. Monaco</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 7%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">I</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 8%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">72</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 21%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chairman of the Board and Director</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 15%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2028</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jacob Brunsberg</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">II</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">38</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2026</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Salvatore Battinelli(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">II</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">83</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2017</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2026</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dennis Duitch(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">III</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">80</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2017</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2027</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Kent Summers(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">III</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">66</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2018</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2027</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)
Member of our Audit Committee, Compensation Committee, and Nominating and Corporate Governance Committee.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Directors</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Donald
P. Monaco </i></b>has served as Chairman of our Board of Directors since December 29, 2023. Mr. Monaco has approximately three decades
of experience as an international information technology and business management consultant. Mr. Monaco founded and owned Monaco
Air Duluth, LLC, a full service, fixed-base operator aviation services business at Duluth International Airport in Duluth, Minnesota,
serving airline, military, and general aviation customers in November 2005, which he sold in April 2025. Since January 2009, he has been appointed and reappointed
by Minnesota Governors to serve as a Commissioner of the Metropolitan Airports Commission in Minneapolis-St. Paul, Minnesota, and currently
serves as Chairman of the Operations, Finance and Administration Committee. Mr. Monaco is also the President and Chairman of the Monaco
Air Foundation, Treasurer of Honor Flight Northland, Treasurer of the Duluth Aviation Institute, and a member of the Duluth Chamber of
Commerce Military Affairs Committee. Mr. Monaco previously worked as an international information technology and business management
consultant with Accenture in Chicago, Illinois for 28 years, and as a partner and senior executive for 18 of such years. From August
2011 to January 2023, Mr. Monaco served as a member of the board of directors of NextPlay (known as Monaker prior to June 2020), where
he served as chairman of the board of directors from August 2018 to June 2021 and as co-chairman of the board from June 2021 to December
2021. He previously served as a director at Republic Bank in Duluth, Minnesota from May 2015 until October 2019. He also served on the
Verus International, Inc., formerly RealBiz Media Group, Inc., board of directors from October 2012 until April 2016, serving as chairman
of the board from August 2015 to April 2016. Mr. Monaco holds Bachelor&#8217;s and Master&#8217;s degrees in Computer Science Engineering
from Northwestern University.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Board of Directors believes that Mr. Monaco is qualified to serve as a member of our Board on the basis of his deep understanding of
information technology, early-stage business growth strategies, and business acquisitions, as well as his background and extensive company
management and leadership experience.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Jacob
Brunsberg</i></b> was appointed to our Board of Directors on April 1, 2022. Previously, he was as appointed Senior Vice-President of
Product Management and Strategic Relationships of the Company on September 20, 2021; on February 16, 2022, he was named President
and Chief Operating Officer of the Company; and on April 1, 2022, he was named President and Chief Executive Officer of the Company,
a role that he held until December 29, 2023. Prior to joining the Company, Mr. Brunsberg was a P&amp;L leader for General
Electric&#8217;s Binder Jet Technology unit, with management responsibility for strategy, development, commercialization, and
overall business performance. From 2017 to 2019, he served as Sr. Managing Director of the Central Region, tasked with helping
establish the U.S. sales infrastructure for post-acquisition integration of several additive manufacturing technology companies
including Concept Laser, Arcam and GEonX into the newly formed GE Additive business entity. Prior to General Electric, Mr. Brunsberg
worked for the American Roller Company in sales leadership and product marketing positions, responsible for the development and
oversight of growth strategies, focused on advanced welding, cladding, thermal spray, and powder metallurgy technologies across a
number of industrial markets. Mr. Brunsberg holds a Bachelor of Science degree in Material Science and Engineering from the
University of Wisconsin-Madison.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Board of Directors believes that Mr. Brunsberg is qualified to serve as a member of the Board because of his experience in leading early-stage
growth companies.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 45; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --></td></tr></table></div>
    <div style="margin-bottom: 0pt; break-before: page; margin-top: 0pt"><p style="margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Salvatore
Battinelli</i></b> was appointed to our Board of Directors on August 16, 2017. Mr. Battinelli currently serves as the President and
Chief Executive Officer of Bello e Preciso Co., a manufacturer and wholesaler of Italian-made fashion watches and has served in
those roles since early 2017. Prior to joining Bello e Preciso Co., from 2011 to 2013, Mr. Battinelli served as Vice-President of
Development and Long-Term Strategy of North American Management Corporation, a wealth management firm based in Boston, Massachusetts
with over $2 billion in assets under management. From 1987 to 2011, Mr. Battinelli served as Executive Vice-President and acting
Chief Executive Officer and Chief Operating Officer of Faneuil Hall Associates, Inc., a concierge boutique family office devoted to
five interrelated ultra-high net-worth families. Mr. Battinelli&#8217;s primary responsibilities while at Faneuil Hall Associates
included providing planning and investment advice, the management of approximately 30 asset portfolios and more than 65 individual
business entities, and assisting the families in their various business ventures worldwide while working closely with law,
accounting and banking functions. During his tenure at Faneuil Hall Associates, Mr. Battinelli served as an executive officer or
director for certain of the family-owned entities and successfully managed several portfolio company IPOs, as well as serving as CEO
and COO for Designhouse International, a Scandinavian furniture company operating out of Atlanta, Georgia, which was previously
listed on Nasdaq in 1983.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
1970 to 1974, Mr. Battinelli served as Audit Manager for Deloitte &amp; Touche (formally Touche Ross), where he specialized in management
information systems. From 2002 to 2011, Mr. Battinelli also served as the Chairman of the Board of Directors of HealthLink Europe, BV,
a logistics and services company that serves the healthcare industry. Mr. Battinelli is a Certified Public Accountant and received a
BS in accounting and an MBA with an emphasis in international economics and accounting, both from Babson College.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Board of Directors believes that Mr. Battinelli is qualified to serve as a member of the Board on the basis of his deep understanding
of business acquisitions and sales, as well as his background and extensive company management and integration experience.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Dennis
Duitch</i></b> was appointed to our Board of Directors on August 8, 2017. Mr. Duitch has served as Managing Director of Duitch Consulting
Group, a private consulting company, since 2003. Prior to that time, he practiced public accounting, business management, mediation and
consultancy nationally, with expertise in strategic and operations management, finance, accounting, strategic planning and business operations
for a wide spectrum of companies, including technology, manufacturing and distribution, marketing, real estate, entertainment, and professional
practices. He has served in executive officer roles and as a director of public and private companies, not-for-profit organizations,
including as Vice-Chairman for Accountants Global Network, and as a top-level advisor for public companies, closely held businesses,
families and high-wealth individuals for over thirty years.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Duitch began his career with the international CPA firm Grant Thornton in its Chicago, San Francisco and Beverly Hills offices before
founding Duitch &amp; Franklin LLP, which evolved to become one of Southern California&#8217;s largest independent CPA/Business Management/Consultancy
practices, and which was acquired by a public company in 1998. He subsequently served as President for a consumer products company with
direct responsibility for marketing, retail, and fulfillment operations, until forming Duitch Consulting Group in 2003 to serve clients
in advisory, C-level, and board of director roles.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Duitch is a Certified Family Business and Estate Advisor, and mediator for matters including partner/shareholder agreements and disputes,
business and marital property dissolution, and dysfunctional executive teams and boards of directors. He has lectured extensively in
management, financial and accounting areas for the California CPA Foundation, business and professional groups, has instructed at several
colleges and universities, and has authored technical articles in management and taxation for regional and national publications.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Duitch earned a B.B.A degree in Accounting from the University of Iowa and a Master of Business Administration in Finance from Northwestern
University.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Board of Directors believes that Mr. Duitch is qualified to serve as a member of the Board because of his extensive public accounting
experience, which will assist the Board and the Audit Committee in addressing the numerous accounting-related issues, regulations and
SEC reporting requirements to which we are subject, as well as his expertise in business management, finance and strategic planning.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Kent
Summers</i></b> was appointed to our Board of Directors on January 18, 2018.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 46; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --></td></tr></table></div>
    <div style="margin-bottom: 0pt; break-before: page; margin-top: 0pt"><p style="margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Summers currently divides his time among a number of independent activities which focus on early-stage technology company formation and
development strategies, and sales planning and execution needs for emerging- and mid-market technology companies located primarily in
the Boston metropolitan area, including: management consultant to private and family-owned businesses; volunteer mentor and instructor
with the Massachusetts Institute of Technology Venture Mentoring Services program; regular lecturer on enterprise, business-to-business
sales to company founders and students enrolled at the Massachusetts Institute of Technology Sloan School of Management, the Harvard
MBA Program, the Wharton School at the University of Pennsylvania, and a number of domestic and international entrepreneurship support
organizations; and consultant to Fellows enrolled in the Harvard Advanced Leadership Initiative. Mr. Summers has served in those roles
at various times from 2003 to the present. From 2009 to the present, Mr. Summers has served as the non-executive Chairman of CADNexus,
Inc., and from 2017 to the present, as a director and Chairman of the Compensation Committee with iQ3 Connect, Inc. Mr. Summers also
currently serves as Chairman, Board of Managers at Massachusetts Materials Technologies LLC.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
2005 to 2017, Mr. Summers served as Managing Partner at Practical Computer Applications, Inc., a Boston-based database consulting and
engineering services firm, where he was responsible for sales planning and execution activities. Prior to Practical Computer Applications,
from 2001 to 2005, Mr. Summers provided independent merger &amp; acquisition advisory services to support the sale of privately-owned
companies. Over a prior 14-year period, Mr. Summers served in leadership roles at several software and internet start-ups, including:
Chairman and Chief Executive Officer of Collego Corporation (acquired by MRO Software), founder and Chief Executive Officer of MyHelpDesk, Inc. (acquired by Support.com), founder
of PCMovingVan.com (acquired by a PE firm), and Vice President of Marketing at Electronic Book Technologies, Inc. (acquired by INSO Corporation,
formerly listed on Nasdaq).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prior
to his work in the software industry, Mr. Summers served as Technology Analyst at Electronic Joint Venture Partners LLC and
Associate Program Trader on the Options Trading Desk at Bear Stearns &amp; Co. In 1986, Mr. Summers received a BA in English from
the University of Houston.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Board of Directors believes that Mr. Summers is qualified to serve as a member of our Board on the basis of his deep understanding of
early-stage business growth strategies, enterprise sales, business acquisitions, as well as his background and extensive company management
and leadership experience.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Director
Independence</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Board of Directors currently consists of five members. As a result of his previous service as our Chief Executive Officer, Mr.
Brunsberg is not considered an independent director. As a result of Mr. Monaco&#8217;s previous affiliation with NextTrip and certain other factors, Mr.
Monaco is not considered an independent director. Our Board of Directors has determined that our other directors, Salvatore
Battinelli, Dennis Duitch and Kent Summers, constituting a majority of our directors, are &#8220;independent&#8221; as that term is
defined under Rule 5605(a)(2) of the Nasdaq marketplace rules. Pursuant to Nasdaq rules, our board must consist of a majority of
independent directors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Nasdaq independence definition includes a series of objective tests, including that the director is not, and has not been for at least
three years, one of our employees and that neither the director nor any of his family members has engaged in various types of business
dealings with us. In addition, as required by Nasdaq rules, our Board of Directors has made a subjective determination as to Messrs.
Battinelli, Duitch and Summers, our independent directors, that no relationships exist, which, in the opinion of our Board of Directors,
would interfere with the exercise of independent judgment in carrying out the responsibilities of a director. In making these determinations,
our Board of Directors reviewed and discussed information provided by the directors and us with regard to each director&#8217;s business
and personal activities and relationships as they may relate to us and our management. There are no family relationships among any of
our directors or executive officers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Classified
Board of Directors</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
accordance with our Bylaws, our Board of Directors is divided into three classes with staggered, three-year terms.
At each annual meeting of stockholders, the successors to directors whose terms then expire will be elected to serve from the time of
election and qualification until the third annual meeting following election. Our directors are classified as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the Class I director is
    Donald P. Monaco, with his current term expiring at our 2028 annual meeting of stockholders;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    Class II directors are Salvatore Battinelli and Jacob Brunsberg, with their current terms expiring at our 2026 annual meeting of
    stockholders; and</span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the Class III directors
    are Dennis Duitch and Kent Summers, with their current terms expiring at our 2027 annual meeting of stockholders.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 47; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence --></td></tr></table></div>
    <div style="margin-bottom: 0pt; break-before: page; margin-top: 0pt"><p style="margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Bylaws provide that the authorized number of directors may be changed by resolution of the Board of Directors. Any
additional directorships resulting from an increase in the number of directors will be distributed among the three classes so that, as
nearly as possible, each class will consist of one-third of the directors. The division of our Board of Directors into three classes
with staggered three-year terms may delay or prevent a change of our management or a change in control of our Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Leadership
Structure of the Board</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
director, or our Board of Directors as a whole, may be removed with or without cause at any meeting of stockholders by the affirmative
vote of the holders of at least two-thirds of our outstanding voting stock entitled to vote in the election of directors. Our Bylaws provide our Board of Directors with flexibility in its discretion to combine or separate the positions of Chairman
of the Board and Chief Executive Officer. Our Board of Directors believes it is important to select the Company&#8217;s Chairman and
Chief Executive Officer in the manner it considers in the best interests of the Company at any given time. Our Board of Directors believes
that the Chairman and Chief Executive Officer positions may be filled by one individual or by two different individuals, as determined
by our Board of Directors based on circumstances then in existence.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.55in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Chairman of the Board presides at all meetings of our Board of Directors and exercises and performs such other powers and duties as may
be assigned to him from time to time by the Board or prescribed by our Bylaws.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.55in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Board of Directors has no established policy on whether it should be led by a Chairman who is also the Chief Executive Officer, and has
in the past combined the roles of Chairman and Chief Executive Officer. Our Board currently is committed to the separated roles given
the circumstances of our Company, with Donald P. Monaco serving as Chairman of the Board and Bill Kerby
serving as our Chief Executive Officer. However, our Board of Directors continually evaluates our leadership structure and could, in the future,
decide to combine the Chairman and Chief Executive Officer positions if it believes that doing so would serve the best interests of our
Company and our stockholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.55in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Board
Meetings and Committees</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
our fiscal year ended February 28, 2025, the Board of Directors held 7 formal meetings, and each director attended at least 75% of
the aggregate of (i) the total number of meetings of our Board of Directors held during the period he was a director and (ii) the
total number of meetings held by all committees of our Board of Directors on which he served during the periods that he
served. The Board of Directors also held various informal meetings and took various actions by written consent during the
year.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although
we do not have a formal policy regarding attendance by members of our Board of Directors at annual meetings of stockholders, we encourage,
but do not require, our directors to attend. Each of our then current directors attended our 2025 Annual Meeting of Stockholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Board of Directors has established three standing committees. Audit, Compensation, and Nominating and Corporate Governance, each of
which operates under a written charter that has been approved by our Board of Directors. Each committee charter has been posted on
the Investors section of our website at www.nexttrip.com. The reference to our website address does not constitute
incorporation by reference of the information contained at or available through our website, and you should not consider it to be a
part of this Report.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 48; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence --></td></tr></table></div>
    <div style="margin-bottom: 0pt; break-before: page; margin-top: 0pt"><p style="margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Audit
Committee</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Audit Committee&#8217;s responsibilities include:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">appointing, approving the
    compensation of, and assessing the independence of our registered public accounting firm; </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">overseeing the work of
    our registered public accounting firm, including through the receipt and consideration of reports from such firm; </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">reviewing and discussing
    with management and the registered public accounting firm our annual and quarterly financial statements and related disclosures;
    </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">monitoring our internal
    control over financial reporting, disclosure controls and procedures; </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">establishing procedures
    for the receipt, retention and treatment of accounting related complaints and concerns; </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">meeting independently with
    our registered public accounting firm and management; </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">reviewing and approving
    or ratifying any related person transactions; and </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">preparing the Audit Committee
    report required by SEC rules.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
members of our Audit Committee are Messrs. Duitch, Battinelli and Summers, and Mr. Duitch serves as the chairperson of the
committee. Our Board of Directors has determined that each of Messrs. Duitch, Battinelli and Summers is an independent director
under the applicable Nasdaq rules and under Rule 10A-3 of the Exchange Act. All members of our Audit Committee meet the requirements for financial
literacy under the applicable rules and regulations of the SEC and Nasdaq. Our Board of Directors has determined that each member of
our Audit Committee is an &#8220;audit committee financial expert&#8221; as defined by applicable SEC rules and has the requisite
financial sophistication as defined under the applicable Nasdaq rules and regulations. The Audit Committee held four formal meetings, held various informal meetings and took various
actions by written consent during our fiscal year ended February 28, 2025.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Compensation
Committee</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Compensation Committee&#8217;s responsibilities include:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">annually reviewing and
    approving corporate goals and objectives applicable to CEO compensation; </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">determining our CEO&#8217;s
    compensation; </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">reviewing and approving,
    or making recommendations to our Board of Directors with respect to the compensation of our other executive officers; </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">overseeing an evaluation
    of our senior executives; </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">overseeing and administering
    our equity incentive plans; </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">reviewing and making recommendations
    to our Board of Directors with respect to director compensation; and </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">reviewing
    and discussing annually with management our &#8220;Compensation Discussion and Analysis&#8221; if and when it is required by SEC
    rules to be included in our Proxy Statements. </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
members of our Compensation Committee are Messrs. Duitch, Battinelli and Summers, and Mr. Battinelli serves as the chairperson of
the committee. Our Board of Directors has determined that each of Messrs. Duitch, Battinelli and Summers is independent under the
applicable Nasdaq rules and regulations and is a &#8220;non-employee director&#8221; as defined in Rule 16b-3 promulgated under the
Exchange Act. The Compensation Committee held three formal meetings, held various informal meetings and took various actions by
written consent during our fiscal year ended February 28, 2025.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 49; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence --></td></tr></table></div>
    <div style="margin-bottom: 0pt; break-before: page; margin-top: 0pt"><p style="margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Nominating
and Corporate Governance Committee</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Nominating and Corporate Governance Committee&#8217;s responsibilities include:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">identifying individuals
    qualified to become board members;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">recommending
    to our Board of Directors the persons to be nominated for election as directors and to each of the Board&#8217;s committees;
    and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">overseeing an annual evaluation
    of the Board of Directors.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
members of our Nominating and Corporate Governance Committee are Messrs. Duitch, Battinelli and Summers, and Mr. Duitch serves as the
chairperson of the committee. Our Board of Directors has determined that each of Messrs. Duitch, Battinelli and Summers is independent
under the applicable Nasdaq rules and regulations. The Nominating and Corporate Governance Committee held one formal meeting and held various informal meetings during
our fiscal year ended February 28, 2025.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Code
of Ethics and Business Conduct</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has a code of ethics that applies to all employees, including the Company&#8217;s principal executive officer, principal
financial officer, and principal accounting officer, as well as to the members of the Board of Directors. The code of ethics is
available on our website at www.nexttrip.com. The Company intends to disclose any changes in, or waivers from, this code by posting
such information on the same website or by filing a Current Report on Form 8-K, in each case to the extent such disclosure is
required by the rules of the SEC or Nasdaq. The reference to our website address does not constitute incorporation by reference of
the information contained at or available through our website, and you should not consider it to be a part of this Report.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Considerations
in Evaluating Director Nominees</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Nominating and Corporate Governance Committee uses a variety of methods for identifying and evaluating director nominees. In its evaluation
of director candidates, our Nominating and Corporate Governance Committee will consider the current size and composition of our Board
of Directors and the needs of our Board of Directors and the respective committees of our Board of Directors. Some of the qualifications
that our Nominating and Corporate Governance Committee considers include, without limitation, issues of character, integrity, judgment,
diversity of experience, independence, area of expertise, corporate experience, length of service, potential conflicts of interest and
other commitments. Nominees must also have the ability to offer advice and guidance to our Chief Executive Officer based on past experience
in positions with a high degree of responsibility and leadership positions in the companies or institutions with which they are affiliated. Director
candidates must have sufficient time available in the judgment of our Nominating and Corporate Governance Committee to perform all Board
of Director and committee responsibilities. Members of our Board of Directors are expected to prepare for, attend, and participate in
all Board of Director and applicable committee meetings. Other than the foregoing, there are no stated minimum criteria for director
nominees, although our Nominating and Corporate Governance Committee may also consider such other factors as it may deem, from time to
time, are in our and our stockholders&#8217; best interests.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although
our Board of Directors does not maintain a specific policy with respect to board diversity, our Board of Directors believes that our
Board of Directors should be a diverse body, and our Nominating and Corporate Governance Committee considers a broad range of backgrounds
and experiences. In making determinations regarding nominations of directors, our Nominating and Corporate Governance Committee may take
into account the benefits of diverse viewpoints. Our Nominating and Corporate Governance Committee also will consider these and other
factors as it oversees the annual Board of Directors and committee evaluations. After completing its review and evaluation of director
candidates, our Nominating and Corporate Governance Committee recommends to our full Board of Directors the director nominees for selection.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Stockholder
Recommendations for Nominations to the Board of Directors</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Nominating and Corporate Governance Committee will consider candidates for director recommended by stockholders so long as such recommending
stockholder was a stockholder of record both at the time of giving notice and at the time of the annual meeting, and such recommendations
comply with our Charter and Bylaws and applicable laws, rules and regulations,
including those promulgated by the SEC. The Nominating and Corporate Governance Committee will evaluate such recommendations in accordance
with its charter, our Bylaws, our policies and procedures for director candidates, as well as the regular director
nominee criteria described above. This process is designed to ensure that our Board of Directors includes members with diverse backgrounds,
skills and experience, including appropriate financial and other expertise relevant to our business. Eligible stockholders wishing to
recommend a candidate for nomination should contact the Secretary in writing. Our Nominating and Corporate Governance Committee has discretion
to decide which individuals to recommend for nomination as directors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 50; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence --></td></tr></table></div>
    <div style="margin-bottom: 0pt; break-before: page; margin-top: 0pt"><p style="margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
nomination should be sent in writing to our Corporate Secretary at NextTrip, Inc., 3900 Paseo del Sol, Santa Fe, New Mexico 87507.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Role
of Board in Risk Oversight Process</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risk
assessment and oversight are an integral part of our governance and management processes. Our Board of Directors encourages management
to promote a culture that incorporates risk management into our corporate strategy and day-to-day business operations. Management discusses
strategic and operational risks at regular management meetings and conducts specific strategic planning and review sessions during the
year that include a focused discussion and analysis of the risks we face. Throughout the year, senior management reviews these risks
with the Board of Directors at regular board meetings as part of management presentations that focus on particular business functions,
operations or strategies, and presents the steps taken by management to mitigate or eliminate such risks. Our Board of Directors does
not have a standing risk management committee, but rather administers this oversight function directly through the Board of Directors
as a whole, as well as through standing committees of the Board of Directors that will address risks inherent in their respective areas
of oversight. In particular, our Audit Committee is responsible for overseeing our major financial risk exposures and the steps our management
has taken to monitor and control these exposures. The Audit Committee also monitors compliance with legal and regulatory requirements
and considers and approves or disapproves any related-person transactions. Our Nominating and Governance Committee monitors the effectiveness
of our corporate governance guidelines that we may adopt or amend from time to time. Our Compensation Committee assesses and monitors
whether any of our compensation policies and programs has the potential to encourage excessive risk-taking by our management.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Delinquent
Section 16(a) Reports</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
16(a) of the Exchange Act requires the Company&#8217;s executive officers and directors, and persons who own more than 10% of a registered
class of the Company&#8217;s equity securities, to file reports of ownership and changes in ownership with the SEC. Executive officers,
directors and greater than 10% stockholders are required by SEC regulations to furnish the Company with copies of all Section 16(a) forms
they file.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company believes that during the fiscal year ended February 28, 2025, its executive officers, directors and greater than 10% stockholders
timely filed all reports under Section 16(a), with the exceptions of Donald P. Monaco and William Kerby, who failed to file a Form 4
on a timely basis related to their December 2024 and February 2025 debt conversions. These transactions were subsequently filed by both
individuals on a Form 5 on March 28, 2025.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span id="a_021"></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM
11. EXECUTIVE COMPENSATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Processes
and Procedures for Compensation Decisions</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Compensation Committee is responsible for the executive compensation programs for our executive officers and reports to our Board of
Directors on its discussions, decisions and other actions. Typically, our Chief Executive Officer makes recommendations to our
Compensation Committee and is involved in the determination of compensation for the respective executive officers that report to
him. Our Chief Executive Officer does not determine his own compensation. Our Chief Executive Officer makes recommendations to our
Compensation Committee regarding short- and long-term compensation for all executive officers based on our operating results, an
individual executive officer&#8217;s contribution toward these results and performance toward individual goal achievement. Our
Compensation Committee then reviews the recommendations and other data and makes decisions (or makes recommendations to the Board)
as to total compensation for each executive officer as well as each individual compensation component.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth compensation for services rendered in all capacities to the Company: (i) for each person who served as the
Company&#8217;s Chief Executive Officer at any time during the past fiscal year, and (ii) for our two most highly compensated executive
officers, other than our Chief Executive Officer, who were employed with the Company on February 28, 2025 (the foregoing executives are
herein collectively referred to as the &#8220;named executive officers&#8221; or &#8220;NEOs&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 51; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->51<!-- Field: /Sequence --></td></tr></table></div>
    <div style="margin-bottom: 0pt; break-before: page; margin-top: 0pt"><p style="margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">Summary
Compensation Table</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif">Name and Principal Position</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fiscal</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Year</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Salary</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($) <sup>(1)</sup></b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Bonus</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($) <sup>(1)</sup></b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Stock Awards</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Option Awards</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($) <sup>(2)</sup></b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>All Other Compensation</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($) <sup>(1)</sup></b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Total</p>
                                                                               <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">($)</p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 37%; text-align: left">Bill Kerby &#8211; Chief Executive Officer</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 7%; text-align: center">2025</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: right">400,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: right">42,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;<sup>(3)</sup></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: right">442,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">2024</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">400,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">42,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;<sup>(3)</sup></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">442,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Frank Orzechowski - Chief Financial Officer</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">2025</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">200,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">200,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">2024</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">200,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">-</p></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">109,073</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;<sup>(4)</sup></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">309,073</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Lyndsey North - Former President</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">2025</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">169,697</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">26,760</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;<sup>(5)</sup></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">16,667</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;<sup>(5)</sup></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">213,124</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">2024</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">200,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">200,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Actual amounts paid or
    accrued.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
        option awards and stock appreciation rights awards (&#8220;SARs&#8221;). SARs awards are only payable in cash. As such, no shares
        of common stock were reserved in connection with the awards since no shares will be issued pursuant to exercise. The fair value
        of option and SARs awards are calculated in accordance with the Financial Accounting Standards Board (&#8220;FASB&#8221;) ASC 718,
&#8220;Compensation &#8211; Stock Compensation.&#8221; The amount recognized for all awards is calculated using the Black Scholes pricing
model. No options or SARs were awarded during the twelve months ended February 28, 2025 or February 29, 2024.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In fiscal years 2025 and
    2024, we paid Mr. Kerby $24,000 in connection with various personal financial guarantees, and a personal car allowance of $18,000
    pursuant to the terms of his employment agreement</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In fiscal year 2024, we
    paid Mr. Orzechowski a retention bonus of $109,073 pursuant to the terms of his Retention Bonus and Separation Agreement.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
    fiscal year 2025, we granted Ms. North 4,000 shares of common stock at $6.69 per share and paid cash severance of $16,667 pursuant
    to the terms of her separation agreement. Ms. North&#8217;s employment by the Company terminated on January 6, 2025.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Named
Executive Officer Employment Agreements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>William
Kerby</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with this appointment as Chief Executive Officer of the Company on December 29, 2023, the Company and Mr. Kerby entered
into an employment letter agreement, dated as of December 29, 2023. Under the employment agreement, Mr. Kerby will be entitled to
receive an annual base salary of $400,000, which is subject to increase (but not decrease) in the discretion of the Compensation
Committee of our Board of Directors based on an annual or special case assessment of his performance and other factors. At the
discretion of our Board of Directors, Mr. Kerby is also eligible to earn a discretionary, annual fiscal end-of-year incentive bonus
in an amount of up to 100% of his base annual salary. The exact amount of the incentive bonus will be dependent on the achievement
of Company milestones and profitability, and such other milestones as the Board deems appropriate. Mr. Kerby will have the option of
receiving some or all of his base annual salary and any incentive bonus in cash or in shares of our common stock valued for this
purpose as set forth in his employment agreement and will be eligible to receive equity compensation at the discretion and in an
amount to be determined by our Board of Directors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
his employment, Mr. Kerby will be entitled to an automobile allowance of $1,500 per month and to receive all benefits under any and
all deferred compensation plans, retirement plans, life, disability, health, accident and other insurance programs, and similar
employee benefit plans and programs, sick leave and vacation time that the Company elects, in its sole discretion, to provide from
time to time to its executive officers, and to earn four weeks of paid time off (&#8220;PTO&#8221;) in accordance with the
Company&#8217;s PTO policy.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 52; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->52<!-- Field: /Sequence --></td></tr></table></div>
    <div style="margin-bottom: 0pt; break-before: page; margin-top: 0pt"><p style="margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Kerby has entered into various personal guarantees with the Airline Reporting Commission, sellers of travel, merchant providers, financial
institutions, associations and service providers for the benefit of NextTrip, in consideration of which the Company agrees in his employment
agreement to pay him a $2,000 per month guarantee fee for so long as the employment agreement and the guarantees remain in place. In
the event Mr. Kerby resigns for &#8220;Good Reason&#8221; (as defined in the employment agreement), or his employment is terminated by
the Company for any reason, the Company will immediately eliminate any and all guarantees failing which, for each month the guarantees
remain in place, the monthly guarantee fee will rise to $10,000 per month after 30 days in the event the Company is unable to assume
the guarantees during such 30-day period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
term of Mr. Kerby&#8217;s employment under his employment agreement will continue from month-to-month until terminated by either party
with 30 days&#8217; prior written notice, unless sooner terminated in accordance with the terms thereof. Should the Company elect to terminate Mr. Kerby&#8217;s employment agreement (other than as a result of death, &#8220;Disability&#8221; or &#8220;Cause,&#8221;
as defined therein), he will be entitled to payment of an amount equal to 12 months of his base annual salary in a lump sum payment upon
termination and the continuation of his health care coverage, at the Company&#8217;s expense, for up to 12 months following the termination
(collectively, the &#8220;Kerby Severance Payments&#8221;). In addition, in the event that Mr. Kerby&#8217;s agreement is terminated
by the Company for any reason within 12 months from the date of closing of the Acquisition, Mr. Kerby will be entitled to receive the
Kerby Severance Payments and the Contingent Shares will automatically accelerate and be issuable in full if not yet earned or issued.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>John
McMahon</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 10, 2025, we entered into an employment letter agreement with John McMahon, pursuant to which Mr. McMahon agreed to serve as
Chief Operating Officer, Travel Division of the Company. Under the terms of Mr. McMahon&#8217;s employment agreement, he is entitled
to receive an annual base salary of $250,000. In addition, pursuant to the terms of his employment agreement, Mr. McMahon is entitled
to receive bonuses subject to the achievement of mutually agreed performance objectives. Such bonuses may be paid in cash or common shares
of the Company at the option of Mr. McMahon. Mr. McMahon is also entitled to receive an incentive bonus at the discretion of the Compensation
Committee of the Board of Directors. Mr. McMahon is eligible to participate in the Company&#8217;s equity incentive and group benefit
plans, including medical, dental, and vision plans, as well as a 401(k) plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Lyndsey
North</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 17, 2022, we entered into an &#8220;at will&#8221; employment agreement, with Lyndsey North under which she was engaged to serve
as Vice President of Marketing of the Company. As of September 28, 2022, Ms. North was appointed President of the Company. Under the
terms of Ms. North&#8217;s employment agreement, she was entitled to receive an annual base salary of $155,000, which was increased to
$200,000 effective September 28, 2022. Pursuant to the employment agreement, Ms. North was granted 4,000 SARs
at an exercise price of $7.00, which vested over a period of three years, with one-third of the award vesting each year on her employment
anniversary date. At the discretion of the Board of Directors, and subject to the achievement of certain performance goals, Ms. North
was also eligible for a performance bonus consisting of a cash award of up to 30% of base salary, which was increased to 50% of base salary,
and a SAR award of up to 25% of base salary. Ms. North was eligible to participate in the Company&#8217;s group benefit plans, including
medical, dental, and vision plans, as well as a 401(k) plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">On January 6, 2025 (the &#8220;Termination Date&#8221;), Ms. North&#8217;s
employment by the Company terminated. In connection with her departure, the Company paid Ms. North all deferred compensation owed to Ms.
North as of the Termination Date and, upon her execution and non-revocation of a waiver and release of claims agreement, Ms. North became
entitled to receive accrued interest on her deferred compensation through the Termination Date, plus severance in an amount equal to one
month of her base salary. In addition, Ms. North was granted 4,000 shares of Company common stock, at a price of $6.69 per share, upon
execution of her separation agreement.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Frank
D. Orzechowski</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 1, 2019, we entered into an &#8220;at will&#8221; employment agreement, with Frank Orzechowski under which he was engaged to serve
as our Chief Financial Officer, Treasurer, Principal Accounting Officer and Corporate Secretary of the Company. Under Mr. Orzechowski&#8217;s
employment agreement, he was entitled to receive an annual base salary of $135,000, which was increased to $155,000 effective March 1,
2020, to $180,000 on January 1, 2021, and to $200,000 on October 1, 2021. Pursuant to the employment
agreement, Mr. Orzechowski was granted (1) a stock option to purchase up to 250 shares of common stock of the Company, at an exercise
price equal to $14.00 per share, which was the closing market price of the Company&#8217;s common stock on July 1, 2019 (the &#8220;Effective
Date&#8221;), and (2) to purchase up to 6,000 shares of common stock of the Company, with an exercise price of $14.00, subject to vesting as follows: 387 shares vested and became exercisable on the one-year anniversary of the Effective Date, 900 shares vested
and became exercisable on the second-year anniversary of the Effective Date, 1,413 shares vested and became exercisable on the third-year
anniversary of the Effective Date, and 3,300 shares vested and became exercisable on the fourth-year anniversary of the Effective
Date. Further, Mr. Orzechowski
is eligible to participate in the Company&#8217;s equity incentive and group benefit plans, including medical, dental, and vision plans,
as well as a 401(k) plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><b>Compensation Recovery
Policy</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">On November 29, 2023, we
adopted a compensation recovery policy (the &#8220;Compensation Recovery Policy&#8221;) that is designed to comply with, and will be interpreted
in a manner consistent with, Section 10D and Rule 10D-1 of the Exchange Act and the applicable rules of the Nasdaq Stock Market, including
any interpretive guidance provided by Nasdaq. Under our Compensation Recovery Policy, in the event of an accounting restatement due to
the Company&#8217;s material noncompliance with any financial reporting requirement under the securities laws, including any required
accounting restatement to correct a material error in previously issued financial statements, or that would result in a material misstatement
if the error were corrected in the current period or left uncorrected in the current period, the Company must recover erroneously awarded
incentive-based compensation previously paid to the Company&#8217;s executive officers in accordance with the terms of such Compensation
Recovery Policy. Furthermore, under the Compensation Recovery Policy, the Company is prohibited from indemnifying any executive officer
or former executive officer against the loss of erroneously awarded incentive-based compensation and from paying or reimbursing an executive
officer for purchasing insurance to cover any such loss.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 53; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->53<!-- Field: /Sequence --></td></tr></table></div>
    <div style="margin-bottom: 0pt; break-before: page; margin-top: 0pt"><p style="margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Outstanding
Equity Awards at 2025 Fiscal Year-End</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth outstanding stock options granted under our 2013 Equity Incentive Plan (the &#8220;2013 Plan&#8221;) or
2023 Equity Incentive Plan (the &#8220;2023 Plan&#8221;) and SARs under our 2020 Stock Appreciation Rights Plan (the &#8220;2020
SARs Plan&#8221;) that are held by our named executive officers as of February 28, 2025:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Option Awards<sup>(1)</sup></b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif">Name</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Number of securities underlying unexercised options (#) exercisable</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Number of securities underlying unexercised options (#) unexercisable</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Option exercise price ($)</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Option</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>expiration date</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 41%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Frank Orzechowski<sup>(2)</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right">1,750</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right">50.00</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6/14/2025</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">902</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">52.60</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6/22/2025</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">2,429</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">68.40</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8/11/2026</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">2,429</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">68.40</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8/11/2026</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">717</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">80</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">50.00</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7/1/2027</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">2,339</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">270</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">50.00</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7/1/2027</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">3,113</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">361</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">50.00</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7/1/2027</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">4,852</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">26.00</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7/1/2027</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">3,711</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">11.60</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1/25/2028</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)
On June 23, 2020, we adopted the 2020 SARs Plan. The 2020 SARs Plan provides for incentive awards in the form of SARs payable in
cash. No shares of common stock were reserved in connection with the adoption of the 2020 SARs Plan since no shares will be issued
pursuant to the 2020 SARs Plan. Awards issued under the 2020 SARs Plan are included in the table.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">(2) On May 28, 2020, we granted Mr. Orzechowski an
option to purchase 1,750 shares of our common stock under the 2013 Plan in connection with his employment arrangement. The option has
an exercise price of $50.00, which as of February 28, 2025 was fully vested. On June 23, 2020, pursuant to our 2020 SARs Plan, we granted
Mr. Orzechowski 902 SARs. The SARs have an exercise price of $52.60 which as of February 28, 2025 were fully vested and exercisable. On
August 11, 2021, we granted Mr. Orzechowski an option to purchase 2,429 shares of our common stock under our 2013 Plan in connection with
his employment arrangement. The option has an exercise price of $68.40 and as of February 28, 2025, was fully vested. On August 11, 2021,
pursuant to our 2020 SARs Plan, we granted Mr. Orzechowski 2,429 SARs. The SARs have an exercise price of $68.40 and as of February 28,
2025, were fully vested and exercisable. On July 1, 2022, we granted Mr. Orzechowski: (i) an option to purchase up to 797 shares of our
common stock with an exercise price of $50.00, 717 of which were vested as of February 28, 2025 and the remaining 80 shares of which will
vest in equal monthly installments over the next five months; (ii) an option to purchase up to 2,609 shares of our common stock with an
exercise price of $50.00, 2,339 of which shares were fully vested as of February 28, 2025 and the remaining 270 shares will vest in equal
monthly installments over the next five months; (iii) 3,474 SARs with an exercise price of $50.00, 3,113 of which SARs were fully vested
and exercisable as of February 28, 2025, and the remaining 361 of which SARs will vest in equal monthly installments over the next five
months; and (iv) 4,852 SARs in connection with his employment retention agreement, which SARs have an exercise price of $26.00 and will
vest and become exercisable on March 15, 2025 if Mr. Orzechowski remains an employee of the Company on that date. On January 26, 2023,
we granted Mr. Orzechowski an option to purchase up to 3,711 shares of our common stock, with an exercise price of $11.60. As of February
28, 2025, the option was fully vested and exercisable.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Equity
Awards</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
offer stock options, stock appreciation rights, and stock awards to certain of our employees, including our executive officers, as the
long-term incentive component of our compensation program. We generally grant equity awards to new hires upon their commencing employment
with us. Our stock options allow employees to purchase shares of our common stock at a price per share equal to the fair market value
of our common stock on the date of grant and may or may not be intended to qualify as &#8220;incentive stock options&#8221; for U.S.
federal income tax purposes. Our stock appreciation rights allow employees to receive a cash payment for the difference between the market
price of our common stock on the date of exercise and the strike price. We sometimes also offer stock options, stock appreciation rights
and stock awards to our consultants in lieu of cash. Our stock options allow consultants to purchase shares of our common stock at a
price per share equal to the fair market value of our common stock on the date of grant and are not intended to qualify as &#8220;incentive
stock options&#8221; for U.S. federal income tax purposes. Our stock appreciation rights allow consultants to receive a cash payment
for the difference between the market price of our common stock on the date of exercise and the strike price. Stock options, stock appreciation
rights, and stock awards granted to our executive officers may be subject to accelerated vesting in certain circumstances.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 54; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->54<!-- Field: /Sequence --></td></tr></table></div>
    <div style="margin-bottom: 0pt; break-before: page; margin-top: 0pt"><p style="margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Retirement
Plans</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
maintain two qualified 401(k) plans, in which all eligible employees may participate. We make safe harbor contributions to both plans:
one plan matches 100% of each participant&#8217;s contribution up to 3% of salary, and 50% of the next 2% of salary contributed, and
the other plan makes a 3% non-elective contribution for all eligible participants. Safe harbor contributions are 100% vested. We may
also elect, on an annual basis, to make a discretionary contribution to the plan, but have not done so to date. Our elective matches
and elective contributions vest to participant accounts as follows: 20% after two years of service, and 20% per year thereafter until
the participant reaches 6 years of service, at which time, employer contributions vest 100%. As a tax-qualified retirement plan, contributions
to the 401(k) plans and earnings on those contributions are not taxable to the employees until distributed from the 401(k) plans.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>No
Tax Gross-Ups</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
do not make gross-up payments to cover our executive officers&#8217; personal income taxes that may pertain to any of the compensation
paid or provided by our Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2023
Equity Incentive Plan</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 19, 2023, our Board of Directors adopted the 2024 Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Board of Directors believes that the grant of options and other stock awards is an important incentive for the Company&#8217;s employees,
officers and directors. Previously, we issued options and stock awards pursuant to our 2013 Plan, which plan expired
according to its terms in March 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
summary of the material terms of the 2023 Plan is set forth below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><b>Plan</b> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Purpose</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Board of Directors adopted the 2023 Plan to (1) encourage selected employees, officers, directors, consultants and advisers to improve
our operations and increase our profitability, (2) encourage selected employees, officers, directors, consultants and advisers to accept
or continue employment or association with us, and (3) increase the interest of selected employees, officers, directors, consultants
and advisers in our welfare through participation in the growth in value of our common stock. All of our current employees, directors
and consultants are eligible to participate in the 2023 Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Administration</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
2023 Plan is to be administered by the Board of Directors or by a committee to which administration of the 2023 Plan, or of part of
thereof, is delegated by the Board of Directors. The 2023 Plan is currently administered by our Compensation Committee, which we
refer to below as the &#8220;Administrator.&#8221; The Administrator is responsible for selecting the officers, employees,
directors, consultants and advisers who will receive Options, Stock Appreciation Rights and Stock Awards (each as defined in the 2023 Plan). Subject to the
requirements imposed by the 2023 Plan, the Administrator is also responsible for determining the terms and conditions of each Option
and Stock Appreciation Right award, including the number of shares subject to the Option, the exercise price, expiration date and
vesting period of the Option and whether the option is an Incentive Option or a Non-Qualified Option. Subject to the requirements
imposed by the 2023 Plan, the Administrator is also responsible for determining the terms and conditions of each Stock Award,
including the number of shares granted, the purchase price (if any), and the vesting, transfer and other restrictions imposed on the
stock. The Administrator has the power, authority and discretion to make all other determinations deemed necessary or advisable for
the administration of the 2023 Plan or of any award under the 2023 Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
2023 Plan is not subject to the Employee Retirement Income Security Act of 1974 and is not a qualified pension, profit sharing or bonus
plan under Section 401(a) of the Internal Revenue Code.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Stock
Subject to the 2023 Plan</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
aggregate number of shares of common stock set aside and reserved for issuance under the 2023 Plan is 7,000,000 shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 55; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->55<!-- Field: /Sequence --></td></tr></table></div>
    <div style="margin-bottom: 0pt; break-before: page; margin-top: 0pt"><p style="margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
awards granted under the 2023 Plan expire or otherwise terminate or are cancelled without being exercised in full, the shares of common
stock not acquired pursuant to such awards will again become available for issuance under the 2023 Plan. If shares of common stock issued
pursuant to awards under the 2023 Plan are forfeited to or repurchased by us, the forfeited or repurchased stock will again become available
for issuance under the 2023 Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
shares of common stock subject to an award are not delivered to a participant because such shares are withheld for payment of taxes incurred
in connection with the exercise of an Option, or the issuance of shares under a Stock Award, or the award is exercised through a reduction
of shares subject to the award (&#8220;net exercised&#8221;), then the number of shares that are not delivered will not again be available
for issuance under the 2023 Plan. In addition, if the exercise price of any award is satisfied by the tender of shares of common stock
to us (whether by actual delivery or attestation), the shares tendered will not again be available for issuance under the 2023 Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Eligibility</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
directors, employees, consultants and advisors of the Company and its subsidiaries are eligible to receive awards under the 2023 Plan.
Incentive Options may only be granted under the 2023 Plan to a person who is a full-time officer or employee of the Company or a subsidiary.
The Administrator will determine from time-to-time which directors, employees, consultants and advisers will be granted awards under
the 2023 Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Terms
of Awards</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Maximum
Grant</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
maximum number of shares of Common Stock subject to a Stock Award granted during a single Fiscal Year to any Non-Employee Director (together
with any cash fees paid to such Non-Employee Director during the Fiscal Year) is not permitted to exceed a total value of $500,000. The
value of the Stock Award is based on the fair value for financial reporting purposes on the grant date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Written
Agreement</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
award under the 2023 Plan will be evidenced by an agreement in a form approved by the Administrator.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Exercise
Price; Base Value</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
exercise price for a Non-Qualified Option or an Incentive Option may not be less than 100% of the fair market value of the Common Stock
on the date of the grant of the Non-Qualified Option or Incentive Option. With respect to an Option holder who owns stock possessing
more than 10% of the total voting power of all classes of our stock, the exercise price for an Incentive Option may not be less than
110% of the fair market value of the Common Stock on the date of the grant of the Incentive Option. The base value of a Stock Appreciation
Right shall also be no less than 100% of the Common Stock on the date of the grant of the Stock Appreciation Right. The 2023 Plan does
not specify a minimum exercise price for Stock Awards.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Vesting</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
Option, Stock Appreciation Right or Stock Award will become exercisable or non-forfeitable (that is, &#8220;vest&#8221;) under conditions
specified by the Administrator at the time of grant. Vesting typically is based upon continued service as a director or employee but
may be based upon any performance criteria and other contingencies that are determined by the Administrator. Shares subject to Stock
Awards may be subject to specified restrictions concerning transferability, repurchase by the Company and forfeiture of the shares issued,
together with such other restrictions as may be determined by the Administrator.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Expiration
Date</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
Option or Stock Appreciation Right must be exercised by a date specified in the award agreement, which may not be more than ten years
after the grant date. Except as otherwise provided in the relevant agreement, an Option or Stock Appreciation Right ceases to be exercisable
ninety days after the termination of the holder&#8217;s employment with us.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Transfers
of Options</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
otherwise determined by the Administrator, Options are not transferable except by will or the laws of descent and distribution.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 56; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->56<!-- Field: /Sequence --></td></tr></table></div>
    <div style="margin-bottom: 0pt; break-before: page; margin-top: 0pt"><p style="margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Purchase
Price Payment</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
otherwise determined by the Administrator, the purchase price of Common Stock acquired under the 2023 Plan is payable by cash or check
at the time of an Option exercise or acquisition of a Stock Award. The Company does not charge participants any fees or commissions in
connection with their acquisition of Common Stock under the 2023 Plan. The Administrator also has the discretion to accept the following
types of payment from participants: shares of Common Stock, cash or a combination thereof.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Withholding
Taxes</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
the time of his or her exercise of an Option or Stock Appreciation Right, an employee is responsible for paying all applicable federal
and state withholding taxes. A holder of Stock Awards is responsible for paying all applicable federal and state withholding taxes once
the shares covered by the award cease to be forfeitable or at any other time required by applicable law.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Securities
Law Compliance</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares
of Common Stock will not be issued pursuant to the exercise of an Option or the receipt of a Stock Award unless the Administrator determines
that the exercise of the Option or receipt of the Stock Award and the issuance and delivery of such shares will comply with all relevant
provisions of law, including, without limitation, the Securities Act, applicable state and foreign securities laws and the requirements
of any stock exchange on which our Common Stock is traded.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Effects
of Change of Control</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
as otherwise provided in an Award Agreement, in the event of a Change in Control, all outstanding Options and Stock Appreciation Rights
shall become immediately exercisable with respect to 100% of the shares subject to such Options or Stock Appreciation Rights, and/or
the Restricted Period shall expire immediately with respect to 100% of the outstanding shares of Restricted Stock or Restricted Stock
Units.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">With
respect to Performance Share Awards and Cash Awards, in the event of a Change in Control, all Performance Goals or other vesting criteria
will be deemed achieved at 100% of target levels and all other terms and conditions will be deemed met.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
general, a &#8220;Change of Control&#8221; means:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A sale of all or substantially
    all of our assets;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our liquidation or dissolution;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A purchase or other acquisition
    of 51% or more of our Common Stock</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our merger or consolidation
    with or into another corporation.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Other
Adjustment Provisions</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the stock of the Company is changed by reason of a stock split, reverse stock split, stock dividend, recapitalization, combination or
reclassification, appropriate adjustments shall be made by the Administrator, in its discretion, in (1) the number and class of shares
of stock subject to the 2023 Plan and each Option and grant of Stock Awards outstanding under the 2023 Plan, and (2) the purchase price
of each outstanding Option and (if applicable) Stock Award. For example, if an Option is for 1,000 shares for $20.00 per share and there
is a 2-for-1 stock split, the Option would be adjusted to be exercisable for 2,000 shares at $10.00 per share.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Amendment
or Termination of the Plan</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board of Directors may at any time amend, discontinue or terminate the 2023 Plan. With specified exceptions, no amendment,
suspension or termination of the 2023 Plan may adversely affect outstanding Options or Stock Appreciation Rights or the terms that
are applicable to outstanding Stock Awards. No amendment, suspension or termination of the Plan requires stockholder approval unless
such approval is required under applicable law or under the rules of any stock exchange on which our Common Stock is traded. Unless
terminated earlier by the Board of Directors, the 2023 Plan will terminate on the tenth anniversary of the date of the Board&#8217;s
adoption of the 2023 Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 57; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->57<!-- Field: /Sequence --></td></tr></table></div>
    <div style="margin-bottom: 0pt; break-before: page; margin-top: 0pt"><p style="margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Federal
Income Tax Consequences</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>The
following discussion is a summary of the federal income tax provisions relating to the grant and exercise of awards under the 2023 Plan
and the subsequent sale of common stock acquired under the 2023 Plan. The tax effect of awards may vary depending upon the circumstances,
and the income tax laws and regulations change frequently. This summary is not intended to be exhaustive and does not constitute legal
or tax advice.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>General</i>.
A recipient of an award of Options or Stock Appreciation Rights under the 2023 Plan will realize no taxable income at the time of grant
if the exercise price is not less than the fair market value of our Common Stock on the date of the grant. The recipient generally will
realize no taxable income at the time of a grant of a Stock Award so long as the Stock Award is not vested (that is, remains subject
to forfeiture and is not transferable) and an election under Section 83(b) of the Internal Revenue Code is not made.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Non-Qualified
Options. </i>The holder of a Non-Qualified Option will recognize ordinary income at the time of the Non-Qualified Option exercise in
an amount equal to the excess of the fair market value of the shares on the date of exercise over the exercise price. This taxable income
will be subject to payroll tax withholding if the holder is an employee.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">When
a holder disposes of shares acquired upon the exercise of a Non-Qualified Option, any amount received in excess of the fair market value
of the shares on the date of exercise will be treated as long-term or short-term capital gain, depending upon the holding period of the
shares, and if the amount received is less than the fair market value of the shares on the date of exercise, the loss will be treated
as long-term or short-term capital loss, depending upon on the holding period of the shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Incentive
Options. </i>The holder of an Incentive Option will not recognize taxable income upon exercise of the Incentive Option. In order to retain
this tax benefit, the holder must make no disposition of the shares so received for at least one year from the date of exercise and for
at least two years from the date of grant of the Incentive Option. The holder&#8217;s compliance with the holding period requirement
and other applicable tax provisions will result in the realization of long-term capital gain or loss when he or she disposes of the shares,
measured by the difference between the exercise price and the amount received for the shares at the time of disposition.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
a holder disposes of shares acquired by exercise of an Incentive Option before the expiration of the required holding period, the gain,
if any, arising from such disqualifying disposition will be taxable as ordinary income in the year of disposition to the extent of the
lesser of (1) the excess of the fair market value of the shares over the exercise price on the date the Incentive Option was exercised
or (2) the excess of the amount realized over the exercise price upon such disposition. Any amount realized in excess of the fair market
value on the date of exercise is treated as long-term or short-term capital gain, depending upon the holding period of the shares. If
the amount realized upon such disposition is less than the exercise price, the loss will be treated as long-term or short-term capital
loss, depending upon the holding period of the shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
purposes of the alternative minimum tax, the holder will recognize as an addition to his or her tax base, upon the exercise of an Incentive
Option, an amount equal to the excess of the fair market value of the shares at the time of exercise over the exercise price. If the
holder makes a disqualifying disposition in the year of exercise, the holder will recognize taxable income for purposes of the regular
income tax and the holder&#8217;s alternative minimum tax base will not be additionally increased.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Stock
Appreciation Rights. </i>The holder of a Stock Appreciation Right will recognize ordinary income at the time that it is exercised in
an amount equal to the excess of the fair market value of the number of shares of Common Stock as to which it is exercised on the date
of exercise over their value at the date of grant. This taxable income will be subject to payroll tax withholding if the holder is an
employee.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Stock
Awards. </i>The recipient of a Stock Award will recognize ordinary income when the stock vests in an amount equal to the excess of the
fair market value of the shares at the time of vesting over the purchase price for the shares, if any, subject to payroll tax withholding
if the holder is an employee. When the recipient sells a Stock Award that has vested, any amount received in excess of the fair market
value of the shares on the date of vesting will be treated as long-term or short-term capital gain, depending upon the holding period
of the shares (after vesting has occurred), and if the amount received is less than the fair market value on the date of vesting, the
loss will be treated as long-term or short-term capital loss, depending on the holding period of the shares. Dividends paid on Stock
Awards that have not vested and that have not been the subject of an election under Section 83(b) of the Internal Revenue Code are treated
as compensation income, subject to payroll tax withholding with respect to an employee.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 58; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->58<!-- Field: /Sequence --></td></tr></table></div>
    <div style="margin-bottom: 0pt; break-before: page; margin-top: 0pt"><p style="margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
83(b) of the Internal Revenue Code permits the recipient to elect, not more than thirty days after the date of receipt of a Stock Award,
to include as ordinary income the difference between the fair market value of the Stock Award on the date of grant and its purchase price
(rather than being taxed as the shares vest). If such an election is made, the holding period for long-term capital gain or loss treatment
will commence on the day following the receipt of the Stock Award, dividends on the Stock Award will be treated as such and not as compensation,
and the tax basis of the shares will be their fair market value at the date of grant.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Deduction
for the Company. </i>The Company will be entitled to a deduction for federal income tax purposes at the same time and in the same amount
as the recipient of an award is considered to have realized ordinary income as a result of the award, assuming that the limitation under
Section 162(m) of the Internal Revenue Code is not applicable. Assuming that the holder of shares received on exercise of an Incentive
Option disposes of the shares after compliance with the holding period requirement described above, the Company will not be entitled
to a federal income tax deduction since the holder will not have realized any ordinary income in the transaction.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prior
to the Tax Cuts and Jobs Act of 2017 (&#8220;TCJA&#8221;), Section 162(m) of the Internal Revenue Code generally disallowed a tax deduction
to publicly held companies for compensation paid to certain executive officers in excess of $1 million per officer in any year that did
not qualify as performance-based. Under the TCJA, the performance-based exception has been repealed and the $1 million deduction limit
now applies to anyone serving as the chief executive officer or the chief financial officer at any time during the taxable year and the
top three other highest compensated executive officers serving at any fiscal year-end.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2013
Equity Incentive Plan</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Plan
Purpose</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Board of Directors adopted the 2013 Plan, which terminated on March 15, 2023, to (1) encourage selected employees, officers, directors,
consultants and advisers to improve our operations and increase our profitability, (2) encourage selected employees, officers, directors,
consultants and advisers to accept or continue employment or association with us, and (3) increase the interest of selected employees,
officers, directors, consultants and advisers in our welfare through participation in the growth in value of our common stock. All of
our current employees, officers, directors and consultants were eligible to participate in the 2013 Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Administration</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
2013 Plan is administered by the Board or by a committee to which administration of the Plan, or of part of thereof, is delegated by
the Board. The 2013 Plan is currently administered by our Compensation Committee, which we refer to below as the
&#8220;Administrator.&#8221; The Administrator is responsible for selecting the officers, employees, directors, consultants and
advisers who will receive Options, Stock Appreciation Rights and Stock Awards (each as defined in the 2013 Plan). Subject to the requirements imposed by the 2013
Plan, the Administrator is also responsible for determining the terms and conditions of each Option and Stock Appreciation Right
award, including the number of shares subject to the Option, the exercise price, expiration date and vesting period of the Option
and whether the option is an Incentive Option or a Non-Qualified Option. Subject to the requirements imposed by the 2013 Plan, the
Administrator is also responsible for determining the terms and conditions of each Stock Award, including the number of shares
granted, the purchase price (if any), and the vesting, transfer and other restrictions imposed on the stock. The Administrator has
the power, authority and discretion to make all other determinations deemed necessary or advisable for the administration of the
2013 Plan or of any award under the 2013 Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
2013 Plan is not subject to the Employee Retirement Income Security Act of 1974 and is not a qualified pension, profit sharing or bonus
plan under Section 401(a) of the Internal Revenue Code.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Stock
Subject to the 2013 Plan</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of May 28, 2024 there were no shares subject to outstanding awards under the 2013 Plan. The plan expired
on March 15, 2023 and therefore there are no shares available for future issuance under the 2013 Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 59; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->59<!-- Field: /Sequence --></td></tr></table></div>
    <div style="margin-bottom: 0pt; break-before: page; margin-top: 0pt"><p style="margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Vesting</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
Option, Stock Appreciation Right or Stock Award will become exercisable or non-forfeitable (that is, &#8220;vest&#8221;) under conditions
specified by the Administrator at the time of grant. Vesting typically is based upon continued service as a director or employee but
may be based upon any performance criteria and other contingencies that are determined by the Administrator. Shares subject to Stock
Awards may be subject to specified restrictions concerning transferability, repurchase by the Company and forfeiture of the shares issued,
together with such other restrictions as may be determined by the Administrator.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Expiration
Date</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
Option or Stock Appreciation Right must be exercised by a date specified in the award agreement, which may not be more than ten years
after the grant date. Except as otherwise provided in the relevant agreement, an Option or Stock Appreciation Right ceases to be exercisable
ninety days after the termination of the holder&#8217;s service with us.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Transfers
of Options</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
otherwise determined by the Administrator, Options are not transferable except by will or the laws of descent and distribution.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Purchase
Price Payment</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
otherwise determined by the Administrator, the purchase price of common stock acquired under the 2013 Plan is payable by cash or check
at the time of an Option exercise or acquisition of a Stock Award. The Company does not charge participants any fees or commissions in
connection with their acquisition of common stock under the 2013 Plan. The Administrator also has discretion to accept the following
types of payment from participants:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A secured or unsecured
    promissory note, provided that this method of payment is not available to a participant who is a director or an executive officer;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares of our Common Stock
    already owned by the Option or Stock Award holder as long as the surrendered shares have a fair market value that is equal to the
    acquired stock and have been owned by the participant for at least six months; </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The surrender of shares
    of Common Stock then issuable upon exercise of an Option; and </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A &#8220;cashless&#8221;
    option exercise in accordance with applicable regulations of the SEC and the Federal Reserve Board.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Withholding
Taxes</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
the time of his or her exercise of an Option or Stock Appreciation Right, an employee is responsible for paying all applicable federal
and state withholding taxes. A holder of Stock Awards is responsible for paying all applicable federal and state withholding taxes once
the shares covered by the award cease to be forfeitable or at any other time required by applicable law.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Securities
Law Compliance</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares
of common stock will not be issued pursuant to the exercise of an Option or the receipt of a Stock Award unless the Administrator determines
that the exercise of the Option or receipt of the Stock Award and the issuance and delivery of such shares will comply with all relevant
provisions of law, including, without limitation, the Securities Act, applicable state and
foreign securities laws and the requirements of any stock exchange on which our common stock is traded.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 60; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->60<!-- Field: /Sequence --></td></tr></table></div>
    <div style="margin-bottom: 0pt; break-before: page; margin-top: 0pt"><p style="margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Effects
of Certain Corporate Transactions</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
as otherwise determined by the Administrator, in the event of a &#8220;corporate transaction,&#8221; all previously unexercised Options
and Stock Appreciation Rights will terminate immediately prior to the consummation of the corporate transaction and all unvested Restricted
Stock awards will be forfeited immediately prior to the consummation of the corporate transaction. The Administrator, in its discretion,
may permit exercise of any Options or Stock Appreciation Rights prior to their termination, even if those awards would not otherwise
have been exercisable, or provide that outstanding awards will be assumed or an equivalent Option or Stock Appreciation Right substituted
by a successor corporation. The Administrator, in its discretion, may remove any restrictions as to any Restricted Stock awards or provide
that all outstanding Restricted Stock awards will participate in the corporate transaction with an equivalent stock substituted by the
successor corporation subject to the restrictions. In general, a &#8220;corporate transaction&#8221; means:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our liquidation or dissolution;
    </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our merger or consolidation
    with or into another corporation as a result of which we are not the surviving corporation;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A sale of all or substantially
    all of our assets; or</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A purchase or other acquisition
    of more than 50% of our outstanding stock by one person, or by more than one person acting in concert. </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Other
Adjustment Provisions</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the stock of the Company is changed by reason of a stock split, reverse stock split, stock dividend, recapitalization, combination or
reclassification, appropriate adjustments shall be made by the Administrator, in its discretion, in (1) the number and class of shares
of stock subject to the 2013 Plan and each Option and grant of Stock Awards outstanding under the 2013 Plan, and (2) the purchase price
of each outstanding Option and (if applicable) Stock Award.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Termination
of the Plan</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
2013 Plan terminated automatically on March 15, 2023, which was the tenth anniversary of the date of the 2013 Plan&#8217;s adoption by
our Board of Directors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2020
Stock Appreciation Rights Plan</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 23, 2020, our Board of Directors adopted the 2020 SARs Plan. The purposes of the 2020 SARs Plan are to: (i) enable the Company
to attract and retain the types of employees, consultants, and directors (collectively, &#8220;Service Providers&#8221;) who will
contribute to the Company&#8217;s long-range success; (ii) provide incentives that align the interests of Service Providers with
those of the shareholders of the Company; and (iii) promote the success of the Company&#8217;s business. The 2020 SARs Plan only
provides for incentive awards that are only made in the form of SARs payable in cash. No shares of common stock were reserved
in connection with the adoption of the 2020 SARs Plan since no shares will be issued pursuant to the 2020 SARs Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Governance
of the Plan</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
2020 SARs Plan will be administered by the Compensation Committee of the Board or, in the Board&#8217;s sole discretion, by the
Board. The Compensation Committee will have the authority to, among other things, (i) construe and interpret the 2020 SARs Plan and
apply its provisions; (ii) promulgate, amend, and rescind rules and regulations relating to the administration of the Plan; (iii)
delegate its authority to one or more persons who is an officer of the Company within the meaning of Section 16 of the Exchange Act
and the rules and regulations promulgated thereunder with respect to SARs that do not involve &#8220;insiders&#8221; within the
meaning of Section 16 of the Exchange Act; (iv) determine when SARs are to be granted under the 2020 SARs Plan and the applicable
grant date; (v) prescribe the terms and conditions of each SAR, including, without limitation, the exercise price and medium of
payment and vesting provisions, and to specify the provisions of the SAR Agreement relating to such grant; (vi) amend any
outstanding SARs, subject, in certain cases, to the participant&#8217;s consent; and (vii) make all other determinations which may
be necessary or advisable for the administration of the 2020 SARs Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 61; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->61<!-- Field: /Sequence --></td></tr></table></div>
    <div style="margin-bottom: 0pt; break-before: page; margin-top: 0pt"><p style="margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Eligible
Participants</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SARs
may be granted only to persons who are Service Providers, and those persons whom the Compensation Committee determines are
reasonably expected to become Service Providers following the grant date. The Compensation Committee may from time to time designate
those Service Providers, if any, to be granted SARs under the 2020 SARs Plan, the number of SARs which will be granted to each such
person, and any other terms or conditions relating to SARs as it may deem appropriate to the extent consistent with the provisions
of the 2020 SARs Plan. A participant who has been granted a SAR may, if otherwise eligible, be granted additional incentive awards
at any time.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Grant</i>.
The Compensation Committee may grant SARs to any Service Provider. A SAR is the right to receive an amount equal to the Spread with
respect to a share of the Company&#8217;s common stock upon the exercise of the SAR. The &#8220;Spread&#8221; is the difference
between the exercise price per share specified in a SAR agreement on the date of grant and the fair market value per share on the
date of exercise of the SAR.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>General
Provisions</i>. The terms and conditions of each SAR will be evidenced by a SAR agreement. The exercise price per share will not be
less than 100% of the fair market value of a Share on the date of grant of the SAR. The term of the SAR will be determined by the
Compensation Committee but may not be greater than ten years from the date of grant.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Exercise</i>.
SARs are exercisable subject to such terms and conditions as the Compensation Committee may specify in the SAR agreement for the
SAR. A SAR may be exercised by the delivery of a signed written notice of exercise to the Company, which must be received and
accepted by the Company as of a date set by the Company in advance of the effective date of the proposed exercise. The notice must
set forth the number of SARs being exercised, together with any additional documents the Company may require.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Settlement</i>.
Upon exercise of a SAR, the Grantee will receive an amount equal to the Spread. The Spread, less applicable withholdings, will be payable
only in cash. In no event may any SAR be settled in any manner other than by delivery of a cash payment from the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Form
of SAR Agreement</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
participant to whom a SAR is granted will be required to enter into a SAR agreement with the Company, in such a form as is provided
by the Compensation Committee. The SAR agreement will contain specific terms as determined by the Compensation Committee, in its
discretion, with respect to the participant&#8217;s particular SAR. Such terms need not be uniform among all participants or any
similarly situated participants. The SAR agreement may include, without limitation, vesting, forfeiture and other provisions
particular to the particular participant&#8217;s SAR, as well as, for example, provisions to the effect that the participant must
abide by all the terms and conditions of the Plan and such other terms and conditions as may be imposed by the Compensation
Committee. A SAR will include such terms and conditions as are determined by the Compensation Committee, in its discretion, to be
appropriate with respect to any participant.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Compensation Committee may specify in a SAR agreement that the participant&#8217;s rights, payments, and benefits with respect to a
SAR will be subject to forfeiture upon the occurrence of certain specified events, in addition to any otherwise applicable vesting
or performance conditions of the incentive award. Such events may include, but are not limited to, termination with cause or other
conduct by the participant that is detrimental to the business or reputation of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Termination
of Employment</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
otherwise expressly provided in the participant&#8217;s SAR agreement, if the participant&#8217;s employment is terminated for any reason
other than due to cause, death or disability, any non-vested portion of any outstanding SAR at the time of such termination will automatically
expire and terminate and no further vesting will occur after the termination date. In such event, except as otherwise expressly provided
in the SAR agreement, the participant will be entitled to exercise such participant&#8217;s rights only with respect to the portion of
the SAR that was vested as of the termination date for a period that will end on the earlier of (i) the expiration date set forth in
the SAR agreement or (ii) ninety days after the date of termination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Termination
for Cause</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
otherwise expressly provided in the participant&#8217;s SAR agreement, in the event of the termination of a participant&#8217;s employment
for cause, all vested and non-vested SARs granted to such participant will immediately expire, and will not be exercisable to any extent.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 62; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->62<!-- Field: /Sequence --></td></tr></table></div>
    <div style="margin-bottom: 0pt; break-before: page; margin-top: 0pt"><p style="margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Disability
or Death</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
otherwise expressly provided in the participant&#8217;s SAR agreement, upon termination of employment as a result of the participant&#8217;s
disability or death, (i) any non-vested portion of any outstanding SAR will immediately terminate upon termination and no further vesting
will occur, and (ii) any vested SAR will expire on the earlier of either (A) the expiration date set forth in the SAR agreement or (B)
12 months following the participant&#8217;s termination of employment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Continuation</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to the conditions and limitations of the 2020 SARs Plan and applicable law, in the event that a participant ceases to be an
employee, outside director or consultant, as applicable, for whatever reason, the Compensation Committee and participant may
mutually agree with respect to any outstanding SAR then held by the participant (i) for an acceleration or other adjustment in any
vesting schedule applicable to the SAR award; (ii) for a continuation of the exercise period following termination for a longer
period than is otherwise provided under such SAR; or (iii) to any other change in the terms and conditions of the SAR. In the event
of any such change to an outstanding SAR, a written amendment to the participant&#8217;s SAR agreement will be required. No
amendment to a participant&#8217;s SAR will be made to the extent compensation payable pursuant thereto as a result of such
amendment would be considered deferred compensation that is not excepted from taxation or penalties under Code Section 409A, unless
otherwise determined by the Compensation Committee.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SARs
granted under the 2020 SARs Plan are not transferable other than to a designated beneficiary upon the Participant&#8217;s death or
by will or the laws of descent and distribution.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Change
in Control</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
otherwise provided in a SAR Agreement, notwithstanding any contrary provision in the 2020 SARs Plan, in the event of a Change in
Control (as defined in the 2020 SARs Plan), all outstanding SARs will become 100% vested and immediately exercisable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Amendment</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board at any time, and from time to time, may amend or terminate the 2020 SARs Plan. The Compensation Committee at any time, and
from time to time, may amend the terms of any one or more SAR agreements, except that the Committee may not affect any amendment
which would otherwise constitute an impairment of the rights under any SAR unless the participant consents in writing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of May 28, 2025 there were 40,223 SARs outstanding under the 2020 SARs Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Director
Compensation</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
believe that a combination of cash and equity compensation is appropriate to attract and retain the individuals we desire to serve on
our Board of Directors. Our cash compensation policies are designed to encourage frequent and active interaction between directors and
our executives both during and between formal meetings as well as compensate our directors for their time and effort. Further, we believe
it is important to align the long-term interests of our non-employee directors (i.e., directors who are not employed by us as officers
or employees) with those of the Company and its stockholders, and that awarding equity compensation to, and thereby increasing ownership
of our common stock by, our non-employee directors is an appropriate means to achieve this alignment. Directors who are also employees
of our company do not receive compensation for their service on our Board of Directors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
our director compensation program for fiscal year 2025, each non-employee director received annual compensation of $35,000, and each
director has agreed to defer receipt of cash compensation until such time as the Company completes a public financing. All cash fees
are paid quarterly. Also, each non-employee director may be reimbursed for his reasonable expenses incurred in the performance of his
duties as a director as our Board of Directors determines from time to time. Our Compensation Committee intends to evaluate our director
compensation program and determine whether any changes should be recommended to the Board.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 63; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->63<!-- Field: /Sequence --></td></tr></table></div>
    <div style="margin-bottom: 0pt; break-before: page; margin-top: 0pt"><p style="margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth certain information concerning the compensation paid to non-employee directors in fiscal year 2025 for their
services as directors of the Company. Our non-employee directors do not receive fringe or other benefits.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fees
    Earned or<br/>
    Paid in Cash ($)<sup>(1)</sup></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Option
    <br/>
Awards ($)</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total
    ($)</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 49%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Donald P. Monaco <sup>(1)</sup></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 13%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">35,000</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 13%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 13%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">35,000</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jacob Brunsberg <sup>(2)</sup></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">35,000</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">35,000</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Salvatore Battinelli<sup>(3)</sup></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">35,000</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">35,000</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dennis Duitch<sup>(4)</sup></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">35,000</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">35,000</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Kent Summers<sup>(5)</sup></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">35,000</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">35,000</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The fees shown were paid
    to each of the respective individuals for services as director. </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span id="a_022"></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM
12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following tables set forth certain information regarding beneficial ownership of our common stock, and each series of our outstanding preferred stock
as of May 28, 2025 (a) by each person known by us to own beneficially 5% or more of the outstanding shares of each class of the outstanding
securities, (b) by our named executive officers and each of our directors (and director nominees) and (c) by all executive officers and
directors of the Company as a group.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
number of shares beneficially owned by each stockholder is determined in accordance with SEC rules. Under these rules, beneficial ownership
includes any shares as to which a person has sole or shared voting power or investment power. At the close of business on May 28, 2025,
there were 7,653,525 shares of Company common stock outstanding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">In addition to the foregoing, as of May 28, 2025,
there were (i) 316 shares of the Company&#8217;s Series E Preferred outstanding, which, including accrued dividends thereon, were convertible
into an aggregate of 3,380 shares of Company common stock; (ii) 33,000 shares of Series H Preferred outstanding; (iii) 500,442 shares
of Series I Preferred outstanding; (iii) 297,788 shares of Series J Preferred outstanding; (iv) 60,595 shares of Series K Preferred outstanding;
(v) 1,076,156 shares of Series L Preferred outstanding; (vi) 133,278 shares of Series M Preferred outstanding; (vii) 500,000 shares of
Series N Preferred outstanding; (viii) 443,549 shares of Series O Preferred outstanding; and (ix) 343,750 shares of Series P Preferred
outstanding.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
computing the number of shares of common stock beneficially owned by a person and the percentage ownership of that person, shares of
common stock subject to stock options, warrants, convertible preferred stock or other rights held by such person that are currently convertible
or exercisable or will become convertible or exercisable within 60 days of May 28, 2025 are considered outstanding, although these shares
are not considered outstanding for purposes of computing the percentage ownership of any other person.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
believe, based on information provided to us, that each of the stockholders listed below has sole voting and investment power with respect
to the shares beneficially owned by the stockholder unless noted otherwise, subject to community property laws where applicable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 64; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->64<!-- Field: /Sequence --></td></tr></table></div>
    <div style="margin-bottom: 0pt; break-before: page; margin-top: 0pt"><p style="margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Common
Stock</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif">Name of Beneficial Owner</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Number of Shares<br/>
 Beneficially Owned</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Percentage of<br/>
 Shares Beneficially<br/>
 Owned<sup>(1)</sup></b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Named Executive Officers and Directors:</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 60%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">William Kerby<sup>(2)</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">1,337,704</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">17.5</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">%</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Lyndsey North</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">4,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Frank Orzechowski</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">48</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Donald P. Monaco<sup>(3)</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">1,482,637</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">19.2</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jacob Brunsberg<sup>(4)</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">116,595</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">1.5</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Salvatore Battinelli<sup>(5)</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">85,978</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">1.1</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dennis Duitch<sup>(6)</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">85,664</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">1.1</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Kent J. Summers<sup>(7)</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">85,626</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">1.1</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All executive officers and directors as a group (7 persons)<sup>(8)</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">3,194,253</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">39.4</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif">5% Stockholders:</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">David Jiang <sup>(9)</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">621,414</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">9.9</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*Less
than 1%.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based on 7,653,525 shares outstanding at May 28, 2025.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;(2)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
    11,386 shares held by Travel and Media Tech, LLC (&#8220;TMT&#8221;). Mr. Kerby is a 50% member of TMT, and is deemed to
    beneficially own the shares held by TMT. Mr. Kerby disclaims beneficial ownership of all securities held by TMT in excess of his
    pecuniary interest, if any. Excludes 331,124 shares of common stock issuable upon conversion of shares of Series L Preferred stock,
    as conversion is contingent upon shareholder approval and subject to beneficial ownership limitations.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
    (i) 1,733 shares held by Monaco Investment Partners, LP (&#8220;MIP&#8221;); (ii) 1,049,446 shares held by the Donald P. Monaco
    Insurance Trust (the &#8220;Trust&#8221;); and (iii) 11,386 shares held by TMT. Mr. Monaco is the managing general partner of MI
    Partners, is the trustee of the Trust and is a 50% member of TMT, and as such is deemed to beneficially own the securities held by
    the MI Partners, Trust and TMT, respectively. Mr. Monaco disclaims beneficial ownership of all securities held by MIP, the Trust and
    TMT in excess of his pecuniary interest, if any. Excludes 745,032 shares of common stock issuable upon conversion of shares of
    Series L Preferred stock held by the Trust, as conversion is contingent upon shareholder approval and subject to beneficial
    ownership limitations.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes 116,500 shares
    issuable upon the exercise of stock options.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes (i) 85,000 shares
    issuable upon the exercise of stock options, (ii) 179 shares issuable upon the conversion of shares of the Company&#8217;s Series
    E Preferred Stock, and (iii) 122 shares issuable upon exercise of Class A Warrants.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes 85,000 shares
    issuable upon the exercise of stock options.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes 85,000 shares
    issuable upon the exercise of stock options.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(8)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes (i) 456,500 shares
    issuable upon the exercise of stock options, (ii) 179 shares issuable upon the conversion of the shares of the Company&#8217;s Series
    E Preferred Stock, and (iii) 122 shares issuable upon exercise of Class A Warrants. Excludes shares beneficially owned by Ms. North
    since her employment terminated on January 6, 2025.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(9)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes 197,500 shares
    issuable upon the conversion of Series I Preferred. Excludes 230,028 shares of common stock issuable upon conversion of shares
of additional Series I Preferred stock and 231,788 shares of common stock issuable upon conversion of shares of Series J Preferred stock,
as conversion is contingent upon shareholder approval and subject to beneficial ownership limitations.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 65; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->65<!-- Field: /Sequence --></td></tr></table></div>
    <div style="margin-bottom: 0pt; break-before: page; margin-top: 0pt"><p style="margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Series
H Preferred</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">None
of the Company&#8217;s officers or directors beneficially own any shares of the outstanding shares of Series H Preferred, and therefore
have been excluded from the following table.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif">Name of Beneficial Owner</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Number of Shares<br/>
 Beneficially Owned</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Percentage of<br/>
 Shares Beneficially<br/>
 Owned<sup>(1)</sup></b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">5% Beneficial Owners:</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left">Procopio Cory Hargreaves &amp; Savitch LLP <br/> c/o NextTrip, Inc.</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">33,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">100</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based on 33,000 shares
    of Series H Preferred outstanding at May 28, 2025.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Series
I Preferred</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">None
of the Company&#8217;s officers or directors beneficially own any shares of the outstanding shares of Series I Preferred, and therefore
have been excluded from the following table.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name of Beneficial Owner<sup>(1)</sup></b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Number of Shares<br/>
 Beneficially Owned</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Percentage of<br/>
 Shares Beneficially<br/>
 Owned<sup>(1)</sup></b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">5% Beneficial Owners:</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">David Jiang <i>c/o NextTrip, Inc.</i></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">427,528</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">85.4</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">%</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gregory Miller <i>c/o NextTrip, Inc.</i></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">33,113</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">6.6</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based on 500,442 shares
    of Series I Preferred outstanding at May 28, 2025.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Series
J Preferred</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">None
of the Company&#8217;s officers or directors beneficially own any shares of the outstanding shares of Series J Preferred, and therefore
have been excluded from the following table.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif">Name of Beneficial Owner</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Number of Shares<br/>
 Beneficially Owned</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Percentage of<br/>
 Shares Beneficially<br/>
 Owned<sup>(1)</sup></b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">5% Beneficial Owners:</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">David Jiang <i>c/o NextTrip, Inc.</i></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">231,788</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">77.8</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">%</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Market Makers <i>c/o NextTrip, Inc.</i></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">36,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">12.1</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based on 297,788 shares
    of Series J Preferred outstanding at May 28, 2025.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Series
K Preferred</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">None
of the Company&#8217;s officers or directors beneficially own any shares of the outstanding shares of Series K Preferred, and therefore
have been excluded from the following table.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif">Name of Beneficial Owner</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Number of Shares<br/>
 Beneficially Owned</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Percentage of<br/>
 Shares Beneficially<br/>
 Owned<sup>(1)</sup></b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">5% Beneficial Owners:</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Denis Suggs <i>c/o NextTrip, Inc<b>.</b></i></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">49,668</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">82.0</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">%</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SIS II <i>c/o NextTrip, Inc.</i></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">10,927</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">18.0</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based on 60,595 shares
    of Series K Preferred outstanding at May 28, 2025.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<!-- Field: Page; Sequence: 66; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->66<!-- Field: /Sequence --></td></tr></table></div>
    <div style="margin-bottom: 0pt; break-before: page; margin-top: 0pt"><p style="margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Series
L Preferred</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Other than Messrs. Kerby and Monaco, who serve as
our Chief Executive Officer and Chairman of our Board, respectively, there are no other 5% beneficial owners of shares of our Series L
Preferred.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif">Name of Beneficial Owner</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Number of Shares<br/>
 Beneficially Owned</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Percentage of<br/>
 Shares Beneficially<br/>
 Owned<sup>(1)</sup></b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Named Executive Officers and Directors:</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bill Kerby <i>c/o NextTrip, Inc.</i></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">331,124</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">30.8</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">%</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Donald
    P. Monaco <i>c/o NextTrip, Inc.</i><sup>(2)</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">745,032</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">69.2</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based on 1,076,156 shares
    of Series L Preferred outstanding at May 28, 2025.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">(2)</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Shares are held by the Trust. Mr. Monaco is the trustee of the Trust. Mr.
Monaco disclaims beneficial ownership of all securities held by the Trust in excess of his pecuniary interest.</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Series
M Preferred</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">None
of the Company&#8217;s officers or directors beneficially own any shares of the outstanding shares of Series M Preferred, and therefore
have been excluded from the following table.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
    of Beneficial Owner</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number
    of Shares<br/>
 Beneficially Owned</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Percentage
    of<br/>
 Shares Beneficially<br/>
 Owned<sup>(1)</sup></b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 60%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>5% Beneficial Owners:</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: italic 10pt Times New Roman, Times, Serif; text-align: left"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Marc
                                            Bern <i>c/o NextTrip, Inc.</i></span></p></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">133,278</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based on 133,278 shares
    of Series M Preferred outstanding at May 28, 2025.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Series
N Preferred</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">None
of the Company&#8217;s officers or directors beneficially own any shares of the outstanding shares of Series N Preferred, and therefore
have been excluded from the following table.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif">Name of Beneficial Owner</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Number of Shares<br/>
 Beneficially Owned</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Percentage of<br/>
 Shares Beneficially<br/>
 Owned<sup>(1)</sup></b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">5% Beneficial Owners:</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Blue
    Fysh Holdings, Inc. <i>c/o NextTrip, Inc.</i></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">483,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">96.6</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based on 500,000 shares
    of Series N Preferred outstanding at May 28, 2025.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Series
O Preferred</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">One
of the Company&#8217;s executive officers owns shares of the outstanding shares of Series O Preferred, as set forth below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif">Name of Beneficial Owner</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Number of Shares<br/>
 Beneficially Owned</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Percentage of<br/>
 Shares Beneficially<br/>
 Owned<sup>(1)</sup></b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">5% Beneficial Owners:</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">John
McMahon <i>c/o NextTrip, Inc.<sup>(2)</sup></i></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">168,416</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">38.0</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">%</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Priscilla Alexander <i>c/o NextTrip, Inc.</i></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">95,674</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">21,6</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">James Killen <i>c/o NextTrip, Inc.</i></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">39,875</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">9.0</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">LuxeLife Services LLC <i>c/o NextTrip, Inc.</i></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">39,875</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">9.0</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Valerie Wilson Travel, Inc. <i>c/o NextTrip, Inc.</i></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">39,875</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">9.0</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based on 443,549 shares
    of Series O Preferred outstanding at May 28, 2025.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
    McMahon serves as Chief Operating Officer of the Company&#8217;s Travel Division.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<!-- Field: Page; Sequence: 67; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->67<!-- Field: /Sequence --></td></tr></table></div>
    <div style="margin-bottom: 0pt; break-before: page; margin-top: 0pt"><p style="margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Series
P Preferred</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">None
of the Company&#8217;s officers or directors beneficially own any shares of the outstanding shares of Series P Preferred, and therefore
have been excluded from the following table.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif">Name of Beneficial Owner</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Number of Shares<br/>
 Beneficially Owned</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Percentage of<br/>
 Shares Beneficially<br/>
 Owned<sup>(1)</sup></b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">5% Beneficial Owners:</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Denis Suggs <i>c/o NextTrip, Inc.</i></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">343,750</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">100</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based on 343,750 shares
    of Series P Preferred outstanding at May 28, 2025.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Equity
Compensation Plan Information</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table provides certain information with respect to our equity compensation plans as of February 28, 2025.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">(a)</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">(b)</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">(c)</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif">Plan Category</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Number of Securities to be Issued Upon Exercise of Outstanding Options, Warrants and Rights</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted-</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>average</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exercise Price</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>of Outstanding Options,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Warrants and Rights</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Number of Securities Remaining Available for Future Issuance Under Equity Compensation Plans (Excluding Securities Reflected in Column (a))</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 46%; text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023 Equity Incentive Plan<sup>(1)</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right">7,000,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2013 Equity Incentive Plan<sup>(2)</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">76,342</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">52.69</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equity compensation plans not approved by security holders<sup>(3)</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">44.80</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-left: 0.25in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)
On November 19, 2023 the Company&#8217;s Board of Directors adopted the Company&#8217;s 2023 Plan, which was approved
by our stockholders on December 28, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 68; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->68<!-- Field: /Sequence --></td></tr></table></div>
    <div style="margin-bottom: 0pt; break-before: page; margin-top: 0pt"><p style="margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-left: 0.25in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)
On March 15, 2013, the Company&#8217;s Board of Directors adopted the Company&#8217;s 2013 Plan. The 2013 Plan was approved by our
stockholders on October 10, 2013. The 2013 Plan automatically expired on March 15, 2023, which was the tenth anniversary of the
adoption of the 2013 Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-left: 0.25in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">(3) On June 23, 2020, our Board of Directors adopted
the 2020 SARs Plan. No shares of common stock are reserved in connection with the adoption of the 2020 SARs Plan since no shares will
be issued pursuant to the 2020 SARs Plan. As of February 28, 2025, the Company had 40,223 SARs outstanding under the 2020 SARs Plan.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span id="a_023"></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM
13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
as described below in this section, since the beginning of our last fiscal year, there has not been, nor is there currently proposed,
any transaction or series of similar transactions to which we were a party other than equity and other compensation, termination, change
in control and other arrangements, which are described under &#8220;Executive Compensation&#8221; and &#8220;Director Compensation&#8221;
above:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in which the amount involved
    exceeds the lesser of $120,000 or 1% of the average of our total assets at year-end for the last two completed fiscal years; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in which any director,
    executive officer, or other stockholder of more than 5% of our common stock or any member of their immediate family had or will have
    a direct or indirect material interest.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Related
Party Loans to Company</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 29, 2024, NTH, a wholly owned subsidiary of the Company, issued an unsecured promissory
note, in the principal amount of $391,776.54, to William Kerby, to memorialize the terms and conditions of certain working capital advances
made by Mr. Kerby to NTH. The promissory note accrued interest at a rate equal to 7.5% simple interest per annum and was scheduled
to automatically mature and become due and payable in full on February 28, 2025, subject to certain limited exceptions. The promissory
note, or any portion thereof, could be prepaid by NTH without any penalty. Mr. Kerby serves as Chief Executive Officer of both the
Company and NTH. The promissory note was approved by the Board, including all independent members thereof. On December 31, 2024,
the full outstanding balance of the note ($321,257) was converted into shares of our Series L Preferred.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 18, 2024, NTH entered into an unsecured promissory note for a line of credit with Donald Monaco and William Kerby, the Company&#8217;s
Chairman of the Board and Chief Executive Officer, respectively, for the aggregate principal amount of $500,000 with an initial advance
of $125,000, provided that the aggregate principal amount of the note does not exceed $500,000 at any time. Under the terms of the note,
advances under the line of credit may be made at the Company&#8217;s request until August 31, 2024. The note bore an annual interest
rate of 7.5%, matured on February 28, 2025, and could be prepaid by the Company at any time prior to maturity without penalty. The promissory
note was approved by the Board, including the independent members thereof. On December 31, 2024, $453,743 of the outstanding principal
balance of $467,892 was converted into shares of Series L Preferred, and on February 24, 2025, the remaining balance was converted into
Series L Preferred. As of May 28, 2025 there is no outstanding principal balance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 23, 2024, the Board approved NTH to enter into a series of unsecured promissory notes with certain related parties, including
investors, directors, officers and employees, who may individually provide funds for the aggregate principal amount of $1,000,000.
The notes bear an annual interest rate of 7.5%, shall mature one year from the date of each note&#8217;s execution, and may be
prepaid by NTH at any time prior to maturity without penalty. On August 14, 2024, at a joint meeting of the Audit Committee and the
Board, the directors unanimously approved an increase in the principal amount of the related party line of credit to $2,000,000 on
the same terms and conditions as previously approved. On December 31, 2024, $570,000 of the outstanding principal balance of
$1,714,863 was converted into shares of Series L Preferred, and on February 24, 2025, an additional $1,000,000 of the principal
balance was converted into Series L Preferred Shares, and $100,000 of the principal balance was converted into Series I Preferred
Shares. On May 6, 2025, the remaining principal balance was paid by the MIP Line of Credit (as further discussed below) and as of
May 28, 2025 there is no remaining outstanding principal balance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 69; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->69<!-- Field: /Sequence --></td></tr></table></div>
    <div style="margin-bottom: 0pt; break-before: page; margin-top: 0pt"><p style="margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 21, 2024, NTH issued an unsecured promissory note, in the principal amount of $455,000, to Mr. Monaco. The promissory note accrued
interest at a rate equal to 7.5% simple interest per annum, and was scheduled to automatically mature and become due and payable in full
on February 28, 2025, subject to certain limited exceptions. The promissory note, or any portion thereof, could be prepaid by NTH
without any penalty. The promissory note was approved by the Board, including the independent members thereof. On December 31, 2024,
the full outstanding balance of the note ($405,000) was converted into shares of our Series L Preferred.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">On April 9, 2025, the Company entered into the two Trust Notes with the
Trust under our $2.0 million line of credit. The first note had a principal balance of $500,000 and was issued in exchange for a new cash
payment provided my Mr. Monaco. The second note had a principal balance of $145,000 and was issued in exchange for cash advances previously
made by Mr. Monaco to the Company.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">On May 6, 2025, the Company
entered into the MIP Line of Credit with MIP, providing the Company with a $3,000,000 revolving line of credit. The MIP Line of Credit
allows the Company to request advances thereunder from time to time until May 31, 2027, the maturity date. Advances made under the MIP
Line of Credit bear simple interest at a rate of 12% per annum, calculated from the date of each respective advance. Accrued interest
shall be payable on a monthly basis, no later than the 10th day of the subsequent month. The full outstanding principal balance, together
with any accrued and unpaid interest, shall be due and payable in full by the Company on the maturity date. The Company may, at its option,
prepay any borrowings under the MIP Line of Credit, in whole or in part, at any time prior to the maturity date, without penalty.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The Company received an initial advance of $1,045,000
under the MIP Line of Credit, which was used to repay (i) a $400,000 cash advance previously made by the Trust to the Company (ii) and
all outstanding indebtedness under the terms of the Trust Notes, totaling $645,000. Additional advances through May 28, 2025 totaled $441,575,
bringing the total amount advanced under the line to $1,486,575.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Donald
Monaco, Chairman of the Company&#8217;s Board of Directors, controls MIP. Mr. Monaco is also trustee of the Trust. The MIP Line of
Credit, including the use of proceeds from the initial advance made thereunder for the repayment of the cash advance and Trust
Notes, was approved by the Audit Committee of the Board and the full Board, including the independent members thereof.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
repayment of related party loans, to the extent not limited by any contractual terms, is subject to review and approval by the Audit
Committee which consists of independent directors which are not parties to the aforementioned related party loans.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Conversion
of Deferred Salary to Company Stock</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 26, 2025, $500,000 of deferred salary owed to Mr. Kerby was converted into 165,562 shares of Series L Preferred at a conversion
price of $3.02 per share.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Indemnification
Agreements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have entered into indemnification agreements with each of our directors and executive officers. These agreements, among other things,
require us to indemnify each director and executive officer to the fullest extent permitted by Nevada law, including indemnification
of expenses such as attorneys&#8217; fees, judgments, fines and settlement amounts incurred by the director or executive officer in any
action or proceeding, including any action or proceeding by or in the right of us, arising out of the person&#8217;s services as a director
or executive officer, including in connection with the Acquisition and related matters.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Policies
and Procedures for Related Person Transactions</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Audit Committee is responsible for reviewing and approving, as appropriate, all transactions with related persons (other than compensation-related
matters, which should be reviewed by our Compensation Committee), in accordance with its Charter and the Nasdaq marketplace rules. In
reviewing and approving any such transactions, our Audit Committee is tasked to consider all relevant facts and circumstances, including,
but not limited to, whether the transaction is on terms comparable to those that could be obtained in an arm&#8217;s length transaction
and the extent of the related person&#8217;s interest in the transaction.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 70; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->70<!-- Field: /Sequence --></td></tr></table></div>
    <div style="margin-bottom: 0pt; break-before: page; margin-top: 0pt"><p style="margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span id="a_024"></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM
14. PRINCIPAL ACCOUNTING FEES AND SERVICES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Audit
Fees</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth a summary of the fees billed to the Company by our current independent registered public account firm,
Haynie &amp; Company, for professional services rendered with respect to the years ended February 28, 2025 February 29, 2024, as
applicable, as well as by TPS Thayer. LLC (&#8220;TPS&#8221;), our predecessor auditor, for professional services rendered with respect to the
year ended February 29, 2024 (as noted in the footnotes to the following table):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 80%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2025</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2024</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 60%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Audit
    Fees<sup>(1)</sup></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">98,500</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">78,000</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Audit
    Related Fees<sup>(2)</sup></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">16,250</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tax
    Fees<sup>(3)</sup></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,283</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right">750</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; vertical-align: bottom">All other fees</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; vertical-align: bottom">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right">-</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; vertical-align: bottom">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; vertical-align: bottom">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">12,500</p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; vertical-align: bottom">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">122,033</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">91,250</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify">(1) In accordance with the SEC&#8217;s
definitions and rules, &#8220;audit fees&#8221; are fees that we paid for professional services for the audit of our financial statements
included in our Annual Reports on Form 10-K and review of the interim financial statements included in quarterly reports, and for services
that are normally provided by the registered public accounting firm in connection with statutory and regulatory filings or engagements.
In addition to the amounts included in the table above, the Company paid TPS, its predecessor auditor, $44,000 in audit fees for the February
29, 2024 audit.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify">(2) In accordance with the SEC&#8217;s
definitions and rules, &#8220;audit-related fees&#8221; are fees for assurance and related services that are reasonably related to the
performance of the audit or review of our financial statements; and &#8220;tax fees&#8221; are fees for tax compliance, tax advice and
tax planning.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify">(3) In accordance with the SEC&#8217;s
definitions and rules, tax fees&#8221; are fees for tax compliance, tax advice and tax planning.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Audit Committee&#8217;s pre-approval policies and procedures and other protocols are discussed in its written charter which can be found
at www.sigmaadditive.com under the tab &#8220;Investors.&#8221; Before our independent registered public accounting firm is engaged by
the Company to render audit or non-audit services, the Audit Committee must pre-approve the engagement. Audit Committee pre-approval
of audit and non-audit services are not required if the engagement for the services is entered into pursuant to pre-approval policies
and procedures established by the Audit Committee regarding the Company&#8217;s engagement of the independent registered public accounting
firm, provided the policies and procedures are detailed as to the particular service, the Audit Committee is informed of each service
provided and such policies and procedures do not include delegation of the Audit Committee&#8217;s responsibilities under the Exchange
Act to the Company&#8217;s management. The Audit Committee may delegate to one or more designated members of the Audit Committee the
authority to grant pre-approvals. If the Audit Committee elects to establish pre-approval policies and procedures regarding non-audit
services, the Audit Committee must be informed of each non-audit service provided by the independent registered public accounting firm.
Audit Committee pre-approval of non-audit services (other than review and attestation services) also will not be required if such services
fall within available exceptions established by the SEC. The Audit Committee may not engage the independent registered public accounting
firm to perform non-audit services prohibited by law or regulation. On an annual basis, our management reports to the Audit Committee
all audit services performed during the previous 12 months and all fees billed by our independent registered public accounting firm for
such services.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Auditor
Independence</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
our fiscal year ended February 28, 2025, Haynie &amp; Company provided no professional services other than those described above that would require our
Audit Committee to consider their compatibility with maintaining the independence of Haynie &amp; Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 71; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->71<!-- Field: /Sequence --></td></tr></table></div>
    <div style="margin-bottom: 0pt; break-before: page; margin-top: 0pt"><p style="margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span id="a_025"></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PART
IV</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span id="a_026"></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM
15. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
financial statements and related notes thereto are listed and included in this Report beginning on page F-1. The following documents
are furnished as exhibits to this Form 10-K.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; width: 0.75in"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibit</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number</b></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.1in; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1&#8224;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/788611/000149315223037109/ex2-1.htm" style="-sec-extract: exhibit">Share Exchange Agreement dated as of October 12, 2023 among Sigma Additive Solutions, Inc., NextTrip Holdings, Inc., NextTrip Group, LLC and the NextTrip Representative (filed as Exhibit 2.1 to the Company&#8217;s Current Report on Form 8-K filed on October 13, 2023, and incorporated by reference herein).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.2&#8224;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/788611/000149315225005803/ex2-1.htm" style="-sec-extract: exhibit">Membership Interest Purchase Agreement, by and among NextTrip, Inc., FSA Travel, LLC, John McMahon, as Majority Member, and the other Signatories thereto, dated February 6, 2025 (filed as Exhibit 2.1 to the Company&#8217;s Current Report on Form 8-K dated February 11, 2025, and incorporated herein by reference).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.3</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/788611/000149315225008467/ex10-1.htm" style="-sec-extract: exhibit">Share Exchange Agreement by and between the Company and Blue Fysh Holdings, Inc., dated February 24, 2025 (filed as Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed February 27, 2025 incorporated herein by reference).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.4</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/788611/000164117225002933/ex2-1.htm" style="-sec-extract: exhibit">Asset Purchase Agreement by and between the Company and Ovation, LLC, dated April 1, 2025 (filed as Exhibit 2.1 to the Company&#8217;s Current Report on Form 8-K dated April 7, 2025, and incorporated herein by reference).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/788611/000149315222007671/ex3-1.htm" style="-sec-extract: exhibit">Amended and Restated Articles of Incorporation of the Company, as amended (filed as Exhibit 3.1 to the Company&#8217;s Annual Report on Form 10-K filed on March 24, 2022, and incorporated herein by reference).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/788611/000149315222022379/ex3-1.htm" style="-sec-extract: exhibit">Certificate of Amendment to Amended and Restated Articles of Incorporation, as amended (filed as Exhibit 3.1 to the Company&#8217;s Current Report on Form 8-K filed August 12, 2022, and incorporated herein by reference).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.3</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/788611/000149315221006709/ex3-12.htm" style="-sec-extract: exhibit">Amended and Restated Bylaws of the Company, as amended. (filed by the Company as Exhibit 3.12 to the Company&#8217;s Form 10-K, filed on March 24, 2021, and incorporated herein by reference).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.4</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/788611/000149315222035735/ex3-1.htm" style="-sec-extract: exhibit">Amendment No. 3 to Amended and Restated Bylaws of Sigma Additive Solutions, Inc. (filed as Exhibit 3.1 to the Company&#8217;s Current Report on Form 8-K filed December 16, 2022, and incorporated herein by reference).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.5</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/788611/000149315223033449/ex3-1.htm">Certificate of Change Pursuant to NRS 78.209 (filed as Exhibit 3.1 to the Company&#8217;s Current Report on Form 8-K filed September 22, 2023 and incorporated herein by reference).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.6</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/788611/000149315224001847/ex3-1.htm" style="-sec-extract: exhibit">Certificate of Designation of Series F Convertible Preferred Stock (filed as Exhibit 3.1 to the Company&#8217;s Current Report on Form 8-K filed January 9, 2024 and incorporated herein by reference).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.7</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/788611/000149315224004337/ex3-1.htm" style="-sec-extract: exhibit">Certificate of Designation of Series G Convertible Preferred Stock (filed as Exhibit 3.1 to the Company&#8217;s Current Report on Form 8-K filed January 30, 2024 and incorporated herein by reference).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.8</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/788611/000149315224004337/ex3-2.htm" style="-sec-extract: exhibit">Certificate of Designation of Series H Convertible Preferred Stock (filed as Exhibit 3.2 to the Company&#8217;s Current Report on Form 8-K filed January 30, 2024 and incorporated herein by reference).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.9</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/788611/000149315224007564/ex3-1.htm" style="-sec-extract: exhibit">Certificate of Designation of Series I Convertible Preferred Stock (filed as Exhibit 3.1 to the Company&#8217;s Current Report on Form 8-K filed February 22, 2024 and incorporated herein by reference).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.10</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/788611/000149315224009634/ex3-1.htm" style="-sec-extract: exhibit">Certificate of Amendment, effective March 13, 2024 (filed as Exhibit 3.1 to the Company&#8217;s Current Report on Form 8-K filed March 12, 2024 and incorporated herein by reference).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.11</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/788611/000149315225000299/ex3-1.htm" style="-sec-extract: exhibit">Certificate of Designation of Series J Nonvoting Convertible Preferred Stock (filed as Exhibit 3.1 to the Company&#8217;s Current Report on Form 8-K filed January 3, 2025 and incorporated herein by reference).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.12</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/788611/000149315225000299/ex3-2.htm" style="-sec-extract: exhibit">Certificate of Designation of Series K Nonvoting Convertible Preferred Stock (filed as Exhibit 3.2 to the Company&#8217;s Current Report on Form 8-K filed January 3, 2025 and incorporated herein by reference).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.13</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/788611/000149315225000299/ex3-3.htm" style="-sec-extract: exhibit">Certificate of Designation of Series L Nonvoting Convertible Preferred Stock (filed as Exhibit 3.3 to the Company&#8217;s Current Report on Form 8-K filed January 3, 2025 and incorporated herein by reference).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.14</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/788611/000149315225000299/ex3-4.htm" style="-sec-extract: exhibit">Certificate of Designation of Series M Nonvoting Convertible Preferred Stock (filed as Exhibit 3.4 to the Company&#8217;s Current Report on Form 8-K filed January 3, 2025 and incorporated herein by reference).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.15</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/788611/000149315225004477/ex3-1.htm" style="-sec-extract: exhibit">Certificate of Designation of Series N Nonvoting Convertible Preferred Stock (filed as Exhibit 3.1 to the Company&#8217;s Current Report on Form 8-K filed January 31, 2025 and incorporated herein by reference).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.16</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/788611/000149315225005803/ex3-1.htm" style="-sec-extract: exhibit">Certificate of Designation of Series O Nonvoting Convertible Preferred Stock (filed as Exhibit 3.1 to the Company&#8217;s Current Report on Form 8-K filed February 11, 2025 and incorporated herein by reference).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.17</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/788611/000149315225008467/ex3-1.htm" style="-sec-extract: exhibit">Withdrawal of Certificate of Designation of Series A Preferred Stock (filed as Exhibit 3.1 to the Company&#8217;s Current Report on Form 8-K filed on February 27, 2025 and incorporated herein by reference).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.18</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/788611/000149315225008467/ex3-2.htm" style="-sec-extract: exhibit">Withdrawal of Certificate of Designation of Series B Preferred Stock (filed as Exhibit 3.2 to the Company&#8217;s Current Report on Form 8-K filed on February 27, 2025 and incorporated herein by reference).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.19</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/788611/000149315225008467/ex3-3.htm" style="-sec-extract: exhibit">Withdrawal of Certificate of Designation of Series C Preferred Stock (filed as Exhibit 3.3 to the Company&#8217;s Current Report on Form 8-K filed on February 27, 2025 and incorporated herein by reference).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.20</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/788611/000149315225008467/ex3-4.htm">Withdrawal of Certificate of Designation of Series D Preferred Stock (filed as Exhibit 3.4 to the Company&#8217;s Current Report on Form 8-K filed on February 27, 2025 and incorporated herein by reference).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.21</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/788611/000149315225008467/ex3-5.htm" style="-sec-extract: exhibit">Withdrawal of Certificate of Designation of Series G Preferred Stock (filed as Exhibit 3.5 to the Company&#8217;s Current Report on Form 8-K filed on February 27, 2025 and incorporated herein by reference).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.22</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/788611/000149315225008627/ex3-1.htm" style="-sec-extract: exhibit">Amendment to Certificate of Designation of Series I Convertible Preferred Stock (filed as Exhibit 3.1 to the Company&#8217;s Current Report on Form 8-K filed on February 28, 2025 and incorporated herein by reference).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.23</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/788611/000149315225008627/ex3-2.htm" style="-sec-extract: exhibit">Amendment to Certificate of Designation of Series L Nonvoting Convertible Preferred Stock (filed as Exhibit 3.2 to the Company&#8217;s Current Report on Form 8-K filed on February 28, 2025 and incorporated herein by reference).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.24</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/788611/000149315225008627/ex3-3.htm" style="-sec-extract: exhibit">Certificate of Designation of Series P Nonvoting Convertible Preferred Stock (filed as Exhibit 3.3 to the Company&#8217;s Current Report on Form 8-K filed on February 28, 2025 and incorporated herein by reference).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/788611/000149315220001399/ex10-4.htm" style="-sec-extract: exhibit">Form of Institutional Common Warrant (filed as Exhibit 10.4 to the Company&#8217;s Current Report on Form 8-K, filed January 30, 2020, and incorporated herein by reference).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/788611/000149315220001399/ex10-8.htm" style="-sec-extract: exhibit">Form of Class A Warrant (filed as Exhibit 10.8 to the Company&#8217;s Current Report on Form 8-K, filed January 30, 2020, and incorporated herein by reference).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/788611/000149315220005763/ex10-3.htm" style="-sec-extract: exhibit">Form of Series A Warrant to Purchase Common Stock (filed as Exhibit 10.3 to the Company&#8217;s Current Report on Form 8-K filed April 3, 2020, and incorporated herein by reference).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.4</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/788611/000149315221000848/ex4-1.htm" style="-sec-extract: exhibit">Form of Underwriter Common Stock Purchase Warrant (filed as Exhibit 4.1 to the Company&#8217;s Current Report on Form 8-K filed January 12, 2021, and incorporated herein by reference).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.5</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/788611/000149315221000848/ex4-2.htm" style="-sec-extract: exhibit">Form of Warrant to Purchase Common Stock (filed as Exhibit 4.2 to the Company&#8217;s Current Report on Form 8-K filed January 12, 2021, and incorporated herein by reference).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.6</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/788611/000149315221007229/ex4-1.htm" style="-sec-extract: exhibit">Form of Warrant to Purchase Common Stock (filed as Exhibit 4.1 to the Company&#8217;s Current Report on Form 8-K filed March 30, 2021, and incorporated herein by reference).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.7</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/788611/000149315221007229/ex4-2.htm" style="-sec-extract: exhibit">Form of Placement Agent Warrant (filed as Exhibit 4.2 to the Company&#8217;s Current Report on Form 8-K filed March 30, 2021, and incorporated herein by reference).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.8</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/788611/000149315223009743/ex4-15.htm" style="-sec-extract: exhibit">Warrant to Purchase Common Stock issued January 26, 2023 (filed as Exhibit 4.15 to the Company&#8217;s Annual Report on Form 10-K filed on March 30, 2023, and incorporated herein by reference).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.9</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/788611/000149315224007564/ex4-1.htm" style="-sec-extract: exhibit">Form of Warrant (filed as Exhibit 4.1 to the Company&#8217;s Current Report on Form 8-K dated February 22, 2024 and incorporated herein by reference).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.10</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/788611/000149315224038111/ex4-1.htm" style="-sec-extract: exhibit">Warrant by and between the Company and Alumni Capital LP, dated September 19, 2024 (filed as Exhibit 4.1 to the Company&#8217;s Current Report on Form 8-K dated September 25, 2024, and incorporated herein by reference).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.11*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex4-11.htm">Warrant to Purchase Common Stock, dated November 1, 2024.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.12*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex4-12.htm">Warrant to Purchase Common Stock, dated December 3, 2024.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.13*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex4-13.htm">Cash Warrant, dated December 31, 2024.</a></span></td></tr>
</table>

<p style="margin: 0">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<!-- Field: Page; Sequence: 72; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->72<!-- Field: /Sequence --></td></tr></table></div>
    <div style="margin-bottom: 0pt; break-before: page; margin-top: 0pt"><p style="margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.14*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex4-14.htm">Cashless Warrant, dated December 31, 2024.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.15*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex4-15.htm">Warrant to Purchase Common Stock, dated January 27, 2025.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.16*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex4-16.htm">Warrant to Purchase Common Stock, dated January 27, 2025.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.17*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex4-17.htm">Warrant to Purchase Common Stock, dated January 28, 2025.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.18</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/788611/000149315225008627/ex4-1.htm" style="-sec-extract: exhibit">Warrant to Purchase Common Stock issued to Greg Miller, dated as of February 24, 2025 (filed as Exhibit 4.1 to the Company&#8217;s Current Report on Form 8-K filed on February 28, 2025, and incorporated herein by reference).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.19</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/788611/000149315225008627/ex4-2.htm" style="-sec-extract: exhibit">Warrant to Purchase Common Stock (Cash) issued to AOS Holdings, LLC, dated as of February 26, 2025 (filed as Exhibit 4.2 to the Company&#8217;s Current Report on Form 8-K filed on February 28, 2025, and incorporated herein by reference).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.20</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/788611/000149315225008627/ex4-3.htm" style="-sec-extract: exhibit">Warrant to Purchase Common Stock (Cashless) issued to AOS Holdings, LLC, dated as of February 26, 2025 (filed as Exhibit 4.3 to the Company&#8217;s Current Report on Form 8-K filed on February 28, 2025, and incorporated herein by reference).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.21</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/788611/000149315225008627/ex4-4.htm" style="-sec-extract: exhibit">Warrant to Purchase Common Stock issued to AOS Holdings, LLC, dated as of February 26, 2025 (filed as Exhibit 4.4 to the Company&#8217;s Current Report on Form 8-K filed on February 28, 2025, and incorporated herein by reference).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.22</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/788611/000164117225002776/ex4-1.htm" style="-sec-extract: exhibit">Warrant by and between the Company and Alumni Capital LP, dated April 1, 2025 (filed as Exhibit 4.1 to the Company&#8217;s Current Report on Form 8-K filed on April 4, 2025, and incorporated herein by reference).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.23*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="ex4-23.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Description of Securities.</span></a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1#</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/788611/000149315219004380/ex10-4.htm" style="-sec-extract: exhibit">Form of Nonqualified Stock Option Agreement (previously filed by the Company as Exhibit 10.4 to the Company&#8217;s Form 10-K, filed on April 1, 2019, and incorporated herein by reference)</a> </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2#</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/788611/000114420414044763/v384543_ex4-3.htm" style="-sec-extract: exhibit">Form of Incentive Stock Option Agreement (previously filed by the Company as Exhibit 4.3 to the Company&#8217;s Form S-8 Registration Statement, filed on July 24, 2014, and incorporated herein by reference).</a> </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.3#</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/788611/000149315219004380/ex10-6.htm" style="-sec-extract: exhibit">Form of Restricted Stock Agreement (previously filed by the Company as Exhibit 10.6 to the Company&#8217;s Form 10-K, filed on April 1, 2019, and incorporated herein by reference).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.4#</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/788611/000107878216003155/s1_ex10z12.htm" style="-sec-extract: exhibit">Form of Indemnification Agreement for directors and officers of Sigma Labs, Inc. (filed as Exhibit 10.12 to the Company&#8217;s Registration Statement on Form S-1, filed on July 28, 2016, and incorporated herein by reference).</a> </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.5#</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/788611/000149315219012517/ex10-2.htm" style="-sec-extract: exhibit">Employment
    letter agreement, effective as of July 1, 2019, between the Company and Frank D. Orzechowski (filed as Exhibit 10.2 to the
    Company&#8217;s Quarterly Report on Form 10-Q filed August 14, 2019, and incorporated herein by reference).</a> </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.6</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/788611/000149315220001134/ex10-1.htm" style="-sec-extract: exhibit">Securities Purchase Agreement (Institutional Investors) (filed as Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K, filed January 27, 2020, and incorporated herein by reference).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.7</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/788611/000149315220001134/ex10-3.htm" style="-sec-extract: exhibit">Registration Rights Agreement (filed as Exhibit 10.3 to the Company&#8217;s Current Report on Form 8-K, filed January 27, 2020, and incorporated herein by reference).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.8</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/788611/000149315220001134/ex10-6.htm" style="-sec-extract: exhibit">Securities Purchase Agreement (Other Investors) (filed as Exhibit 10.6 to the Company&#8217;s Current Report on Form 8-K, filed January 27, 2020, and incorporated herein by reference).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.9</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/788611/000149315220005763/ex10-1.htm" style="-sec-extract: exhibit">Securities Purchase Agreement, dated as of April 2, 2020, between the Company and Purchasers (filed as Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed April 3, 2020, and incorporated herein by reference).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.10#</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/788611/000149315220012176/ex10-1.htm" style="-sec-extract: exhibit">Sigma Labs, Inc. 2020 Stock Appreciation Rights Plan (filed as Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed June 29, 2020 and incorporated herein by reference).</a> </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.11#</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/788611/000149315220012176/ex10-2.htm" style="-sec-extract: exhibit">Form of Stock Appreciation Rights Agreement (Employees; 2020 Stock Appreciation Rights Plan) (filed as Exhibit 10.2 to the Company&#8217;s Current Report on Form 8-K filed June 29, 2020 and incorporated herein by reference).</a> </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.12</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/788611/000149315220012176/ex10-3.htm" style="-sec-extract: exhibit">Form of Stock Appreciation Rights Agreement (Non-employee Directors; 2020 Stock Appreciation Rights Plan) (filed as Exhibit 10.3 to the Company&#8217;s Current Report on Form 8-K filed June 29, 2020 and incorporated herein by reference).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.13</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/788611/000149315221007229/ex10-1.htm" style="-sec-extract: exhibit">Form of Securities Purchase Agreement (filed as Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed March 30, 2021, and incorporated herein by reference).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.14#</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/788611/000149315222028882/ex99-1.htm" style="-sec-extract: exhibit">Sigma Additive Solutions, Inc. 2013 Equity Incentive Plan, as Amended (filed as Exhibit 99.1 to the Company&#8217;s Form S-8 Registration Statement, filed on October 19, 2022 and incorporated herein by reference).</a> </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.15#</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/788611/000149315221017084/ex10-2.htm" style="-sec-extract: exhibit">Sigma Labs, Inc. 2021 Employee Stock Purchase Plan (filed as Exhibit 10.2 to the Company&#8217;s Current Report on Form 8-K filed July 16, 2021 and incorporated herein by reference).</a> </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.16#</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/788611/000149315224035017/ex10-22.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Retention Bonus and Change in Control Agreement, dated as of January 26, 2023, entered into by Sigma Additive Solutions, Inc. and Jacob Brunsberg (filed as Exhibit 10.22 to the Company&#8217;s Annual Report on Form 10-K filed on September 4, 2024, and incorporated by reference herein).</span></a></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<!-- Field: Page; Sequence: 73; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->73<!-- Field: /Sequence --></td></tr></table></div>
    <div style="margin-bottom: 0pt; break-before: page; margin-top: 0pt"><p style="margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.17#</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.1in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/788611/000149315224035017/ex10-23.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Retention Bonus and Change in Control Agreement, dated as of January 26, 2023, entered into by Sigma Additive Solutions, Inc. and Frank Orzechowski (filed as Exhibit 10.23 to the Company&#8217;s Annual Report on Form 10-K filed on September 4, 2024, and incorporated by reference herein).</span></a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.18</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/788611/000149315223037110/ex10-1.htm" style="-sec-extract: exhibit">Asset Purchase Agreement dated as of October 6, 2023 between Sigma Additive Solutions, Inc. and Divergent Technologies, Inc. (filed as Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed on October 13, 2023 and incorporated by reference herein).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.19#</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/788611/000149315223042671/ex10-1.htm" style="-sec-extract: exhibit">Retention Bonus and Separation Agreement between Sigma Additive Solutions and Jacob Brunsberg, dated November 22, 2023 (filed as Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed on November 24, 2023 and incorporated by reference herein).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.20#</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/788611/000149315223042671/ex10-2.htm" style="-sec-extract: exhibit">Retention Bonus and Separation Agreement between Sigma Additive Solutions and Frank Orzechowski, dated November 22, 2023 (filed as Exhibit 10.2 to the Company&#8217;s Current Report on Form 8-K filed on November 24, 2023 and incorporated by reference herein).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.21#</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/788611/000149315223043301/formdef14a.htm#mj_017" style="-sec-extract: exhibit">2023 Equity Incentive Plan (filed as Annex D to the Company&#8217;s Definitive Proxy Statement on Schedule 14A filed on December 1, 2023 and incorporated herein by reference). #</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.22#</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/788611/000149315224000196/ex10-1.htm" style="-sec-extract: exhibit">Employment letter agreement dated December 29, 2023 between Sigma Additive Solutions, Inc. and William Kerby (filed by the Company as Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed on January 3, 2024 and incorporated by reference herein).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.23</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/788611/000149315224004337/ex10-1.htm" style="-sec-extract: exhibit">Perpetual License Agreement, by and among the Company, NextTrip Holdings, Inc. and Promethean TV, Inc., dated as of January 26, 2024. (filed as Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed January 30, 2024 and incorporated herein by reference).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.24</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/788611/000149315224007564/ex10-1.htm" style="-sec-extract: exhibit">Form of Securities Purchase Agreement, dated as of February 15, 2024 (filed as Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed February 22, 2024 and incorporated herein by reference).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.25*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex10-25.htm">Unsecured Promissory Note by and between the Company and Steve Kircher, dated October 18, 2024.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.26*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex10-26.htm">Promissory Note by and between the Company and Carmen Diges, dated October 18, 2024.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.27</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/788611/000149315224038111/ex10-1.htm" style="-sec-extract: exhibit">Securities Purchase Agreement by and between the Company and Alumni Capital LP, dated September 19, 2024 (filed as Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed September 25, 2024, and incorporated herein by reference).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.28</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/788611/000149315224038111/ex10-3.htm" style="-sec-extract: exhibit">Securities Purchase Agreement by and between the Company and Alumni Capital LP, dated September 19, 2024 (filed as Exhibit 10.3 to the Company&#8217;s Current Report on Form 8-K filed September 25, 2024 and incorporated herein by reference).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.29*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex10-29.htm">Promissory Note and Securities Purchase Agreement by and between the Company and 1800 Diagonal Lending LLC, dated October 18, 2024.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.30*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex10-30.htm">Securities Purchase Agreement by and between the Company and 1800 Diagonal Lending LLC, dated November 8, 2024.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.31*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex10-31.htm">Promissory Note by and between the Company and 1800 Diagonal Lending LLC, dated November 8, 2024.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.32</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/788611/000149315225000299/ex10-1.htm" style="-sec-extract: exhibit">Form of Series J Preferred Stock Securities Purchase Agreement, dated as of December 31, 2024 (filed as Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed January 3, 2025, and incorporated herein by reference).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.33</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/788611/000149315225000299/ex10-2.htm" style="-sec-extract: exhibit">Form of Series K Preferred Stock Securities Purchase Agreement, dated as of December 31, 2024 (filed as Exhibit 10.2 to the Company&#8217;s Current Report on Form 8-K filed January 3, 2025, and incorporated herein by reference).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.34</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/788611/000149315225000299/ex10-3.htm" style="-sec-extract: exhibit">Form of Series M Preferred Stock Securities Purchase Agreement, dated as of December 31, 2024 (filed as Exhibit 10.3 to the Company&#8217;s Current Report on Form 8-K filed January 3, 2025, and incorporated herein by reference).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.35</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/788611/000149315225000299/ex10-7.htm" style="-sec-extract: exhibit">Unsecured Promissory Note, dated as of December 31, 2024 (filed as Exhibit 10.7 to the Company&#8217;s Current Report on Form 8-K filed January 3, 2025, and incorporated herein by reference).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.36</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/788611/000149315225000299/ex10-8.htm" style="-sec-extract: exhibit">Registration Rights Agreement, dated as of December 31, 2024 (filed as Exhibit 10.8 to the Company&#8217;s Current Report on Form 8-K filed January 3, 2025, and incorporated herein by reference).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.37</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/788611/000149315225004477/ex10-2.htm" style="-sec-extract: exhibit">Form of Series N Preferred Stock Securities Purchase Agreement, dated as of January 28, 2025 (filed as Exhibit 10.2 to the Company&#8217;s Current Report on Form 8-K filed January 31, 2025, and incorporated herein by reference).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.38*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex10-38.htm">Securities Purchase Agreement by and between the Company and 1800 Diagonal Lending LLC, dated February 4, 2025.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.39*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex10-39.htm">Promissory Note by and between the Company and 1800 Diagonal Lending LLC, dated February 4, 2025.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.40</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/788611/000149315225008627/ex10-1.htm" style="-sec-extract: exhibit">Form of Series I Preferred Stock Securities Purchase Agreement, dated as of February 24, 2025 (filed as Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed on February 28, 2025 and incorporated herein by reference).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.41</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/788611/000149315225008627/ex10-2.htm" style="-sec-extract: exhibit">Debt Conversion Agreement, dated as of February 24, 2025, by and between the Company and Greg Miller (filed as Exhibit 10.2 to the Company&#8217;s Current Report on Form 8-K filed on February 28, 2025 and incorporated herein by reference).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.42</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/788611/000149315225008627/ex10-3.htm" style="-sec-extract: exhibit">Related Party Debt Conversion Agreement, dated as of February 24, 2025, by and between the Company and William Kerby (filed as Exhibit 10.3 to the Company&#8217;s Current Report on Form 8-K filed on February 28, 2025 and incorporated herein by reference).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.43</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/788611/000149315225008627/ex10-4.htm" style="-sec-extract: exhibit">Related Party Debt Conversion Agreement, dated as of February 24, 2025, by and between the Company and Donald P. Monaco (filed as Exhibit 10.4 to the Company&#8217;s Current Report on Form 8-K filed on February 28, 2025 and incorporated herein by reference).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.44</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/788611/000149315225008627/ex10-5.htm" style="-sec-extract: exhibit">Equity Investment Agreement, dated as of February 26, 2025, by and between AOS Holdings LLC and the Company (filed as Exhibit 10.5 to the Company&#8217;s Current Report on Form 8-K filed on February 28, 2025 and incorporated herein by reference).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.45</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/788611/000149315225008627/ex10-6.htm" style="-sec-extract: exhibit">Debt Exchange Agreement, dated as of February 26, 2025, by and between AOS Holdings LLC and the Company (filed as Exhibit 10.6 to the Company&#8217;s Current Report on Form 8-K filed on February 28, 2025 and incorporated herein by reference).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.46</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/788611/000149315225008627/ex10-7.htm" style="-sec-extract: exhibit">Consulting Agreement, dated as of February 26, 2025, by and between AOS Holdings LLC and the Company (filed as Exhibit 10.7 to the Company&#8217;s Current Report on Form 8-K filed on February 28, 2025 and incorporated herein by reference).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.47</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/788611/000164117225002776/ex10-1.htm" style="-sec-extract: exhibit">Securities Purchase Agreement by and between the Company and Alumni Capital LP, dated April 1, 2025 (filed as Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed on April 4, 2025 and incorporated herein by reference).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.48</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/788611/000164117225002776/ex10-2.htm" style="-sec-extract: exhibit">Promissory Note by and between the Company and Alumni Capital LP, dated April 1, 2025 (filed as Exhibit 10.2 to the Company&#8217;s Current Report on Form 8-K filed on April 4, 2025 and incorporated herein by reference).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.49</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/788611/000164117225002933/ex10-1.htm" style="-sec-extract: exhibit">License Agreement by and between the Company and Ovation, LLC, dated April 1, 2025 (filed as Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed on April 7, 2025 and incorporated herein by reference)</a>.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.50</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/788611/000164117225003841/ex10-1.htm" style="-sec-extract: exhibit">Unsecured Promissory Note ($500,000) by and between NextTrip Holdings, Inc. and Donald P. Monaco Insurance Trust, dated April 9, 2025 (filed as Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed on April 11, 2025 and incorporated herein by reference).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.51</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/788611/000164117225003841/ex10-2.htm" style="-sec-extract: exhibit">Unsecured Promissory Note ($145,000) by and between NextTrip Holdings, Inc. and Donald P. Monaco Insurance Trust, dated April 9, 2025 (filed as Exhibit 10.2 to the Company&#8217;s Current Report on Form 8-K filed on April 11, 2025 and incorporated herein by reference).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.52</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/788611/000164117225009176/ex10-1.htm" style="-sec-extract: exhibit">Line of Credit Agreement, dated May 6, 2025 (filed as Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed on May 8, 2025 and incorporated herein by reference).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">19.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/788611/000149315224035017/ex19-1.htm" style="-sec-extract: exhibit">NextTrip Inc&#8217;s Insider Trading Policy (filed as Exhibit 19.1 to the Company&#8217;s Annual Report on Form 10-K filed on September 4, 2024, and incorporated by reference herein).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">21.1*</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="ex21-1.htm">List of Subsidiaries.</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.1*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex23-1.htm">Consent of Haynie &amp; Company.</a> </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">31.1*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex31-1.htm">Certificate of principal executive officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</a> </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">31.2*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex31-2.htm">Certificate of principal financial officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</a> </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">32.1**</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex32-1.htm">Certificate of principal executive officer and principal financial officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</a> </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">97.1#</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/788611/000149315224035017/ex97-1.htm" style="-sec-extract: exhibit">NextTrip, Inc. Compensation Recovery Policy (filed as Exhibit 97.1 to the Company&#8217;s Annual Report on Form 10-K filed on September 4, 2024, and incorporated by reference herein).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.INS***</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline
    XBRL Instance Document.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.SCH***</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline
    XBRL Taxonomy Extension Schema with Embedded Linkbase Documents.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">104</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cover
    Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" border="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
  <td style="text-align: justify; width: 0.25in">#</td>
  <td style="text-align: justify">Indicates a management contract or compensatory plan or arrangement.</td></tr>

<tr style="vertical-align: top">
  <td style="text-align: justify; width: 0.25in">&#8224;</td>
  <td style="text-align: justify">Portions of the exhibit, marked by brackets, have been omitted because the omitted information (i) is not material and (ii) would likely
cause competitive harm if publicly disclosed.</td></tr>

<tr style="vertical-align: top">
  <td style="text-align: justify; width: 0.25in">*</td>
  <td style="text-align: justify">Filed herewith.</td></tr>

<tr style="vertical-align: top">
  <td style="text-align: justify; width: 0.25in">**</td>
  <td style="text-align: justify">Furnished herewith.</td></tr>
<tr style="vertical-align: top">
  <td style="text-align: justify">***</td>
  <td style="text-align: justify">The XBRL related information in Exhibit 101 shall not be deemed &#8220;filed&#8221;
for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to liability of that section and shall
not be incorporated by reference into any filing or other document pursuant to the Securities Act of 1933, as amended, except as shall
be expressly set forth by specific reference in such filing or document.</td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span id="a_027"></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM
16. FORM 10-K SUMMARY.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may voluntarily include a summary of information required by Form 10-K under this Item 16. We have elected not to include such summary
information.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 74; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->74<!-- Field: /Sequence --></td></tr></table></div>
    <div style="margin-bottom: 0pt; break-before: page; margin-top: 0pt"><p style="margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span id="a_028"></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SIGNATURES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this Report to be signed
on its behalf by the undersigned, thereunto duly authorized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NEXTTRIP, INC.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 50%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 47%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">May 29, 2025</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/ William
    Kerby</i></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">William Kerby</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
        Executive Officer</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Principal
    Executive Officer)</span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">May 29, 2025</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/ Frank
    Orzechowski</i></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Frank Orzechowski</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
        Financial Officer</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Principal
    Financial and Accounting Officer)</span></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Exchange Act of 1934, this Report has been signed below by the following persons on behalf of the
registrant in the capacities and on the dates indicated.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 30%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Signature</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 46%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 20%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    William Kerby</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer (Principal Executive Officer and Director)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">May 29, 2025</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">William Kerby</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    Frank Orzechowski</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Financial Officer</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">May 29, 2025</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Frank Orzechowski</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Principal Financial and Accounting Officer)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    Donald P. Monaco</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chairman, Director</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">May 29, 2025</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Donald P. Monaco</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    Salvatore Battinelli</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">May 29, 2025</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Salvatore Battinelli</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    Dennis Duitch</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">May 29, 2025</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dennis Duitch</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    Kent Summers</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">May 29, 2025</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Kent Summers</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    Jacob Brunsberg</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">May 29, 2025</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jacob Brunsberg</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 75; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->75<!-- Field: /Sequence --></td></tr></table></div>
    <div style="margin-bottom: 0pt; break-before: page; margin-top: 0pt"><p style="margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Index
to Financial Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Financial
    Statements:</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 0.5in; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#f_001">Report of Independent Registered Public Accounting Firm</a> PCAOB ID No. 00457</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-2</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#f_002">Balance Sheets</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-4</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#f_003">Statements of Operations</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-5</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#f_004">Statement of Stockholders&#8217; Equity</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-6</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#f_005">Statements of Cash Flows</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-7</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#f_006">Notes to Financial Statements</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-8</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 76; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><img src="form10-k_005.jpg" alt="" style="width: 680px"/></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="f_001"></span>REPORT
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
the Board of Directors and</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stockholders
of NextTrip, Inc.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Opinion
on the Financial Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have audited the accompanying consolidated balance sheets of NextTrip, Inc. (the Company) as of February 28, 2025 and February 29,
2024, and the related consolidated statements of operations, stockholders&#8217; equity, and cash flows for each of the years in the
two-year period ended February 28, 2025, and the related notes (collectively referred to as the consolidated financial statements).
In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the
Company as of February 28, 2025 and February 29, 2024, and the results of its operations and its cash flows for each of the years in
the two-year period ended February 28, 2025, in conformity with accounting principles generally accepted in the United States of
America.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Substantial
Doubt about the Company&#8217;s Ability to Continue as a Going Concern</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The accompanying consolidated financial statements
have been prepared assuming that the Company will continue as a going concern. As discussed in Note 1 of the financial statements, the
Company has suffered recurring losses from operations and has an accumulated deficit of ($34,349,823). The losses in conjunction with
uncertainty around the success of management&#8217;s future plans, raise substantial doubt about its ability to continue as a going concern.
Management&#8217;s plans are described in Note 1. The consolidated financial statements do not include any adjustments that might result
from the outcome of this uncertainty.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Basis
for Opinion</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
consolidated financial statements are the responsibility of the Company&#8217;s management. Our responsibility is to express an
opinion on the Company&#8217;s consolidated financial statements based on our audits. We are a public accounting firm registered
with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the
Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange
Commission and the PCAOB.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain
reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company
is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits,
we are required to obtain an understanding of internal control over financial reporting, but not for the purpose of expressing an opinion
on the effectiveness of the Company&#8217;s internal control over financial reporting. Accordingly, we express no such opinion.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
audits included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether
due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis,
evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the
accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the
consolidated financial statements. We believe that our audits provide a reasonable basis for our opinion.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 77; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Critical
Audit Matters</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
critical audit matters communicated below are matters arising from the current period audit of the consolidated financial statements
that were communicated or required to be communicated to the audit committee and that: (1) relate to accounts or disclosures that
are material to the consolidated financial statements and (2) involved our especially challenging, subjective, or complex judgments.
The communication of critical audit matters does not alter in any way our opinion on the financial statements, taken as a whole, and
we are not, by communicating the critical audit matters below, providing separate opinions on the critical audit matters or on the
accounts or disclosures to which they relate.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><i>Valuation and Allocation of Warrants Issued
with Debt</i></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><b><span style="text-decoration: underline">Description of the Matter</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">As described in Note 12 to the financial
statements, the Company issued promissory notes with warrants during the year ended February 28, 2025. The Company recorded these transactions
in accordance with ASC 470-20, Debt &#8211; Debt with Conversion and Other Options which requires the Company to value the instruments
and allocate the proceeds based on relative fair values. The valuation relies on management estimates and assumptions. These transactions
are complex in nature, require management judgment, and require a thorough understanding of the transactions and related accounting guidance.
As such, we considered this to be a CAM.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><b><span style="text-decoration: underline">How We Addressed the Matter</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">To address the CAM, we obtained and reviewed
all debt and warrant agreements; tested the inputs and assumptions used by management in the valuations of the warrants; performed an
independent recalculation of the fair value of the warrants; and recalculated and tied out the allocation of proceeds between the debt
and warrant instruments.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 50%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    Haynie &amp; Company</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 50%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_edei--AuditorName_c20240301__20250228_ziMPx89hb8Bj"><ix:nonNumeric contextRef="From2024-03-01to2025-02-28" id="Fact000067" name="dei:AuditorName">Haynie
    &amp; Company</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_edei--AuditorLocation_c20240301__20250228_zVXwSQWUVkk9"><ix:nonNumeric contextRef="From2024-03-01to2025-02-28" id="Fact000068" name="dei:AuditorLocation">Salt
    Lake City, Utah</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">May
    29, 2025</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PCAOB
    #<span id="xdx_903_edei--AuditorFirmId_c20240301__20250228_zoyNHpwRfpv1"><ix:nonNumeric contextRef="From2024-03-01to2025-02-28" id="Fact000069" name="dei:AuditorFirmId">457</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have served as the Company&#8217;s auditor since 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><img src="form10-k_006.jpg" alt=""/></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 78; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NEXTTRIP,
INC.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="f_002"></span>CONSOLIDATED
BALANCE SHEETS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As
of February 28, 2025 and February 29, 2024</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_30B_111_zLL9YDisI3Ci" summary="xdx: Statement - Consolidated Balance Sheets" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_491_20250228_zPUK7wAwIXud" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">2025</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_492_20240229_zVS9pG4mBeti" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">2024</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--AssetsAbstract_iB_zI0EspFmru8j" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif">ASSETS</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--CashAndCashEquivalentsAtCarryingValue_i01I_maCzKnn_z2o3d1pjqUj1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; width: 60%; text-align: left">Cash and cash equivalents</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="AsOf2025-02-28" id="Fact000074" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,062,367</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="AsOf2024-02-29" id="Fact000075" format="ixt:numdotdecimal" decimals="0" unitRef="USD">323,805</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_ecustom--PromissoryNoteReceivableNet_i01I_maCzKnn_zwaLArNE1hoi" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify">Promissory note receivable, net</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0077">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="NTRP:PromissoryNoteReceivableNet" contextRef="AsOf2024-02-29" id="Fact000078" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,000,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--AccountsReceivableNetCurrent_i01I_maCzKnn_zok1xuORUmt2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify">Accounts receivable, net</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:AccountsReceivableNetCurrent" contextRef="AsOf2025-02-28" id="Fact000080" format="ixt:numdotdecimal" decimals="0" unitRef="USD">22,567</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:AccountsReceivableNetCurrent" contextRef="AsOf2024-02-29" id="Fact000081" format="ixt:numdotdecimal" decimals="0" unitRef="USD">34,082</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_i01I_maCzKnn_zglO7v8XGbw6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 1pt">Prepaid expenses and other current assets</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="AsOf2025-02-28" id="Fact000083" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,380,575</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="AsOf2024-02-29" id="Fact000084" format="ixt:numdotdecimal" decimals="0" unitRef="USD">340,921</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--AssetsCurrent_i01TI_mtCzKnn_maCzZWh_zuSBAVLtAGD8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Total Current Assets</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="AsOf2025-02-28" id="Fact000086" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,465,509</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="AsOf2024-02-29" id="Fact000087" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,698,808</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--AssetsNoncurrentAbstract_i01B_ziYQu4FQ0Moa" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Non-Current assets</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--PropertyPlantAndEquipmentNet_i02I_maCzocv_zSaIX85ydzMa" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Property and equipment, net</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2025-02-28" id="Fact000092" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,119</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2024-02-29" id="Fact000093" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,642</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--IntangibleAssetsNetExcludingGoodwill_i02I_maCzocv_z90NB4MyYV72" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Intangible assets, net</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:IntangibleAssetsNetExcludingGoodwill" contextRef="AsOf2025-02-28" id="Fact000095" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,127,368</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:IntangibleAssetsNetExcludingGoodwill" contextRef="AsOf2024-02-29" id="Fact000096" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,173,420</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--SecurityDeposit_i02I_maCzocv_zqIX4FrDXt1g" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Security deposit</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:SecurityDeposit" contextRef="AsOf2025-02-28" id="Fact000098" format="ixt:numdotdecimal" decimals="0" unitRef="USD">30,167</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:SecurityDeposit" contextRef="AsOf2024-02-29" id="Fact000099" format="ixt:numdotdecimal" decimals="0" unitRef="USD">42,167</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--Goodwill_i02I_maCzocv_zMoqXVkrAl2l" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt">Goodwill</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:Goodwill" contextRef="AsOf2025-02-28" id="Fact000101" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,167,805</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:Goodwill" contextRef="AsOf2024-02-29" id="Fact000102" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,167,805</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--EquityMethodInvestments_i02I_maCzocv_zbejvGIApJH4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Equity investments</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:EquityMethodInvestments" contextRef="AsOf2025-02-28" id="Fact000104" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,407,610</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0105">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--PrepaidExpenseOtherNoncurrent_i02I_maCzocv_zXK9KRhHVTP1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 1pt">Other prepaid assets</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:PrepaidExpenseOtherNoncurrent" contextRef="AsOf2025-02-28" id="Fact000107" format="ixt:numdotdecimal" decimals="0" unitRef="USD">733,575</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0108">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--AssetsNoncurrent_i02TI_mtCzocv_maCzZWh_zzsCz5Emvt6h" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Total Non-Current Assets</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:AssetsNoncurrent" contextRef="AsOf2025-02-28" id="Fact000110" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,470,644</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:AssetsNoncurrent" contextRef="AsOf2024-02-29" id="Fact000111" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,390,034</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--Assets_i01TI_mtCzZWh_zb3xSQ8NnqVj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Total Assets</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2025-02-28" id="Fact000113" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,936,153</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2024-02-29" id="Fact000114" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,088,842</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--LiabilitiesAbstract_iB_zNVoo1EMsF1h" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif">LIABILITIES</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--LiabilitiesCurrentAbstract_i01B_zALnECqe0Zqi" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Current Liabilities</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--AccountsPayableCurrent_i02I_maCzquV_zjT7jG7Ew7R" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Accounts payable</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:AccountsPayableCurrent" contextRef="AsOf2025-02-28" id="Fact000122" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,184,404</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:AccountsPayableCurrent" contextRef="AsOf2024-02-29" id="Fact000123" format="ixt:numdotdecimal" decimals="0" unitRef="USD">531,847</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--AccruedLiabilitiesCurrent_i02I_maCzquV_zDSLMG8Sg0Tb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Accrued expenses</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:AccruedLiabilitiesCurrent" contextRef="AsOf2025-02-28" id="Fact000125" format="ixt:numdotdecimal" decimals="0" unitRef="USD">721,382</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:AccruedLiabilitiesCurrent" contextRef="AsOf2024-02-29" id="Fact000126" format="ixt:numdotdecimal" decimals="0" unitRef="USD">460,768</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--DeferredRevenueCurrent_i02I_maCzquV_zm9bCRNZxVFi" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Deferred revenue</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:DeferredRevenueCurrent" contextRef="AsOf2025-02-28" id="Fact000128" format="ixt:numdotdecimal" decimals="0" unitRef="USD">97,770</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:DeferredRevenueCurrent" contextRef="AsOf2024-02-29" id="Fact000129" format="ixt:numdotdecimal" decimals="0" unitRef="USD">139,921</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--NotesPayableCurrent_i02I_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--NonrelatedPartyMember_maCzquV_z8QxpDeRiFOf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Notes payable</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:NotesPayableCurrent" contextRef="AsOf2025-02-28_us-gaap_NonrelatedPartyMember" id="Fact000131" format="ixt:numdotdecimal" decimals="0" unitRef="USD">506,004</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0132">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--NotesPayableCurrent_i02I_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_maCzquV_zFsETNKnNvR" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 1pt">Notes payable - related parties</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:NotesPayableCurrent" contextRef="AsOf2025-02-28_us-gaap_RelatedPartyMember" id="Fact000134" format="ixt:numdotdecimal" decimals="0" unitRef="USD">61,526</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:NotesPayableCurrent" contextRef="AsOf2024-02-29_us-gaap_RelatedPartyMember" id="Fact000135" format="ixt:numdotdecimal" decimals="0" unitRef="USD">828,277</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--NotesPayableCurrent_i02I_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_maCzquV_zDuKokJc9hU2" style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 1pt">Notes payable</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:NotesPayableCurrent" contextRef="AsOf2025-02-28_us-gaap_RelatedPartyMember" id="Fact000137" format="ixt:numdotdecimal" decimals="0" unitRef="USD">61,526</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:NotesPayableCurrent" contextRef="AsOf2024-02-29_us-gaap_RelatedPartyMember" id="Fact000138" format="ixt:numdotdecimal" decimals="0" unitRef="USD">828,277</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr id="xdx_40D_eus-gaap--LiabilitiesCurrent_i02TI_mtCzquV_maCzadg_z63teXrHMLqd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Total Current Liabilities</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="AsOf2025-02-28" id="Fact000140" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,571,086</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="AsOf2024-02-29" id="Fact000141" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,960,813</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--Liabilities_i01TI_mtCzadg_maCz7jK_zhfLhqiusKwe" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Total Liabilities</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:Liabilities" contextRef="AsOf2025-02-28" id="Fact000143" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,571,086</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:Liabilities" contextRef="AsOf2024-02-29" id="Fact000144" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,960,813</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--CommitmentsAndContingencies_i01I_maCz7jK_zw8maCuWpvId" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Commitments and Contingencies</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0146">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0147">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--StockholdersEquityAbstract_i01B" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Stockholder&#8217;s Equity</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--PreferredStockValue_i02I_maCzton_zfshOEdPcxu2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Preferred Stock, $<span id="xdx_904_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_c20250228_zniOdaD5If8c" title="Preferred stock, par value"><span id="xdx_909_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_c20240229_zYgTXM8Igg19" title="Preferred stock, par value"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2025-02-28" id="Fact000155" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2024-02-29" id="Fact000157" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.001</ix:nonFraction></ix:nonFraction></span></span> par value; <span id="xdx_90E_eus-gaap--PreferredStockSharesAuthorized_iI_pid_c20250228_z93jVo2nvrXa" title="Preferred stock, shares authorized"><span id="xdx_90A_eus-gaap--PreferredStockSharesAuthorized_iI_pid_c20240229_zbxgzArK6INj" title="Preferred stock, shares authorized"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2025-02-28" id="Fact000159" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2024-02-29" id="Fact000161" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">10,000,000</ix:nonFraction></ix:nonFraction></span></span> shares authorized; <span id="xdx_900_eus-gaap--PreferredStockSharesIssued_iI_pid_c20250228_zm0WwVTqTrBi" title="Preferred stock, shares issued"><span id="xdx_906_eus-gaap--PreferredStockSharesOutstanding_iI_pid_c20250228_z4HIFK3UNXEf" title="Preferred stock, shares outstanding"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2025-02-28" id="Fact000163" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2025-02-28" id="Fact000165" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,106,616</ix:nonFraction></ix:nonFraction></span></span> and <span id="xdx_908_eus-gaap--PreferredStockSharesIssued_iI_pid_c20240229_zVwTd0NBNMhc" title="Preferred stock, shares issued"><span id="xdx_901_eus-gaap--PreferredStockSharesOutstanding_iI_pid_c20240229_zGBMsLhw0Im6" title="Preferred stock, shares outstanding"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2024-02-29" id="Fact000167" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2024-02-29" id="Fact000169" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">472,996</ix:nonFraction></ix:nonFraction></span></span> shares issued and outstanding, respectively</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:PreferredStockValue" contextRef="AsOf2025-02-28" id="Fact000152" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,107</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:PreferredStockValue" contextRef="AsOf2024-02-29" id="Fact000153" format="ixt:numdotdecimal" decimals="0" unitRef="USD">474</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--CommonStockValue_i02I_maCzton_zxVRWaOGhtth" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Common Stock, par value $<span id="xdx_907_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20250228_zMjoAOJgqCWc" title="Common stock, par shares"><span id="xdx_90F_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20240229_zmfngMnV7MMb" title="Common stock, par shares"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2025-02-28" id="Fact000174" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2024-02-29" id="Fact000176" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.001</ix:nonFraction></ix:nonFraction></span></span>,
    <span id="xdx_90E_eus-gaap--CommonStockSharesAuthorized_iI_pid_c20250228_zlaiGiLn4f09" title="Common stock, shares authorized"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2025-02-28" id="Fact000178" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">250,000,000</ix:nonFraction></span> and <span id="xdx_901_eus-gaap--CommonStockSharesAuthorized_iI_pid_c20240229_zBvOMgqFW8m4" title="Common stock, shares authorized"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2024-02-29" id="Fact000180" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,200,000</ix:nonFraction></span>
    shares authorized, <span id="xdx_90C_eus-gaap--CommonStockSharesIssued_iI_pid_c20250228_z0H13E6YYL1i" title="Common stock, shares issued"><span id="xdx_90A_eus-gaap--CommonStockSharesOutstanding_iI_pid_c20250228_z6yQ8fScwSRa" title="Common stock, shares outstanding"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2025-02-28" id="Fact000182" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2025-02-28" id="Fact000184" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,656,738</ix:nonFraction></ix:nonFraction></span></span> and <span id="xdx_90E_eus-gaap--CommonStockSharesIssued_iI_pid_c20240229_zoF2KyDQjxOl" title="Common stock, shares issued"><span id="xdx_905_eus-gaap--CommonStockSharesOutstanding_iI_pid_c20240229_zvB3UkEc5zOc" title="Common stock, shares outstanding"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2024-02-29" id="Fact000186" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2024-02-29" id="Fact000188" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">936,430</ix:nonFraction></ix:nonFraction></span></span>
    shares issued and outstanding, respectively <span id="xdx_F4D_zwRLwdYI9Wrj">(*)</span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2025-02-28" id="Fact000171" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,657</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2024-02-29" id="Fact000172" format="ixt:numdotdecimal" decimals="0" unitRef="USD">936</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--AdditionalPaidInCapital_i02I_maCzton_zWZ8MCt0qexh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Additional Paid in Capital (<span id="xdx_F40_zr0rJnFLysYh">*</span>)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:AdditionalPaidInCapital" contextRef="AsOf2025-02-28" id="Fact000190" format="ixt:numdotdecimal" decimals="0" unitRef="USD">41,710,126</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:AdditionalPaidInCapital" contextRef="AsOf2024-02-29" id="Fact000191" format="ixt:numdotdecimal" decimals="0" unitRef="USD">27,277,758</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--RetainedEarningsAccumulatedDeficit_i02I_maCzton_zagXA7O275Ei" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 1pt">Accumulated deficit</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2025-02-28" id="Fact000193" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">34,349,823</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2024-02-29" id="Fact000194" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">24,151,139</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_40D_eus-gaap--StockholdersEquity_i02TI_pp0p0_mtCzton_maCz7jK_zR44pb3ewpj6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Total Stockholders&#8217; Equity</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2025-02-28" id="Fact000196" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">7,365,067</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-02-29" id="Fact000197" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,128,029</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--LiabilitiesAndStockholdersEquity_i01TI_pp0p0_mtCz7jK_zbXQPgeFfRs3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Total Liabilities and Stockholders&#8217; Equity</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="AsOf2025-02-28" id="Fact000199" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">9,936,153</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="AsOf2024-02-29" id="Fact000200" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,088,842</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: right"><span id="xdx_F06_zHbIDIPKcBfj" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F1C_zJ7Xl9Cq1PZ8" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:footnote id="Footnote000201" xml:lang="en-US">On
    December 29, 2023, the Company (then known as Sigma Additive Solutions, Inc.) acquired NextTrip Holdings, Inc. (&#8220;NTH&#8221;)
    in a reverse acquisition. NextTrip Group, LLC (&#8220;NTG&#8221;) was issued <span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_pid_c20231229__20231229__us-gaap--BusinessAcquisitionAxis__custom--NextTripGroupLLCMember_zi92mxXMT2Ei" title="Number of shares acquired"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesAcquisitions" contextRef="From2023-12-292023-12-29_custom_NextTripGroupLLCMember" id="Fact000203" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">83,371</ix:nonFraction></span> shares of Company common stock in exchange for
    <span id="xdx_909_ecustom--PercentageForIssuedAndOutstandingCapitalStock_pid_dp_uPure_c20231229__20231229__us-gaap--BusinessAcquisitionAxis__custom--NextTripGroupLLCMember_zUXOGjE4ta79" title="Percentage for issued and outstanding capital stock"><ix:nonFraction name="NTRP:PercentageForIssuedAndOutstandingCapitalStock" contextRef="From2023-12-292023-12-29_custom_NextTripGroupLLCMember" id="Fact000205" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>% of the issued and outstanding capital stock of NTH at the time of the reverse acquisition. The Company has reflected this transaction
    retroactively in these financial statements.</ix:footnote></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">See
accompanying notes to financial statements</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 79; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NEXTTRIP,
INC.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="f_003"></span>CONSOLIDATED
STATEMENTS OF OPERATIONS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR
THE YEARS ENDED FEBRUARY 28, 2025 AND FEBRUARY 29, 2024</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" summary="xdx: Statement - Consolidated Statements of Operations" id="xdx_30B_113_zEaaHEd2LYxj" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49C_20240301__20250228_zXe6Vzjlv8xf" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">February 28, 2025</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_493_20230301__20240229_zZoCMHf3jCH6" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">February 29, 2024</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_maGPz6pe_z6Ye7hS9tG1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 60%">Revenue</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2024-03-01to2025-02-28" id="Fact000207" format="ixt:numdotdecimal" decimals="0" unitRef="USD">501,423</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2023-03-012024-02-29" id="Fact000208" format="ixt:numdotdecimal" decimals="0" unitRef="USD">458,752</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--CostOfRevenue_iN_di_msGPz6pe_zW7IgTKFC9B3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Cost of revenue (exclusive of depreciation and amortization, shown separately below)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:CostOfRevenue" contextRef="From2024-03-01to2025-02-28" id="Fact000210" format="ixt:numdotdecimal" decimals="0" unitRef="USD">498,121</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:CostOfRevenue" contextRef="From2023-03-012024-02-29" id="Fact000211" format="ixt:numdotdecimal" decimals="0" unitRef="USD">397,532</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_40A_eus-gaap--GrossProfit_iT_pp0p0_mtGPz6pe_maOILz4uP_zTf3h61BaV0g" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Gross profit</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:GrossProfit" contextRef="From2024-03-01to2025-02-28" id="Fact000213" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,302</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:GrossProfit" contextRef="From2023-03-012024-02-29" id="Fact000214" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">61,220</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--OperatingExpensesAbstract_iB" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Operating Expenses</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--LaborAndRelatedExpense_i01_pp0p0_maOEzGD1_zpiajjCoFoX3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Salaries and benefits</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:LaborAndRelatedExpense" contextRef="From2024-03-01to2025-02-28" id="Fact000219" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,630,663</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:LaborAndRelatedExpense" contextRef="From2023-03-012024-02-29" id="Fact000220" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,604,487</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--ShareBasedCompensation_i01_pp0p0_maOEzGD1_zmHeKSCy2Z6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Stock based compensation</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2024-03-01to2025-02-28" id="Fact000222" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">67,874</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2023-03-012024-02-29" id="Fact000223" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">116,512</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--GeneralAndAdministrativeExpense_i01_pp0p0_maOEzGD1_zvZSBGhTkzg3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">General and administrative</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:GeneralAndAdministrativeExpense" contextRef="From2024-03-01to2025-02-28" id="Fact000225" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">95,341</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:GeneralAndAdministrativeExpense" contextRef="From2023-03-012024-02-29" id="Fact000226" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">152,106</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--SellingAndMarketingExpense_i01_pp0p0_maOEzGD1_zX7vdjtEaFQ1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Sales and marketing</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:SellingAndMarketingExpense" contextRef="From2024-03-01to2025-02-28" id="Fact000228" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">307,166</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:SellingAndMarketingExpense" contextRef="From2023-03-012024-02-29" id="Fact000229" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">484,250</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--ProfessionalFees_i01_pp0p0_maOEzGD1_zLjTB2vNsXA7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Professional Service Fees</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ProfessionalFees" contextRef="From2024-03-01to2025-02-28" id="Fact000231" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,228,481</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ProfessionalFees" contextRef="From2023-03-012024-02-29" id="Fact000232" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,421,508</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_ecustom--Technology_i01_pp0p0_maOEzGD1_zVUTu5dgThVh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt">Technology</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="NTRP:Technology" contextRef="From2024-03-01to2025-02-28" id="Fact000234" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">843,296</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="NTRP:Technology" contextRef="From2023-03-012024-02-29" id="Fact000235" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">311,430</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_ecustom--OrganizationCosts_i01_pp0p0_maOEzGD1_zDyUEink2gw6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Organization Costs</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="NTRP:OrganizationCosts" contextRef="From2024-03-01to2025-02-28" id="Fact000237" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">213,613</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="NTRP:OrganizationCosts" contextRef="From2023-03-012024-02-29" id="Fact000238" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">25,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--DepreciationDepletionAndAmortization_i01_pp0p0_maOEzGD1_zOjBreRIMkk5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Depreciation and amortization</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:DepreciationDepletionAndAmortization" contextRef="From2024-03-01to2025-02-28" id="Fact000240" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">713,236</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:DepreciationDepletionAndAmortization" contextRef="From2023-03-012024-02-29" id="Fact000241" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,468,762</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--OtherExpenses_i01_pp0p0_maOEzGD1_zK1xx7IaftYc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 1pt">Other expenses</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:OtherExpenses" contextRef="From2024-03-01to2025-02-28" id="Fact000243" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">317,061</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:OtherExpenses" contextRef="From2023-03-012024-02-29" id="Fact000244" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">156,522</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--OperatingExpenses_i01T_pp0p0_mtOEzGD1_msOILz4uP_zo5TYKLb0Ru2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Total Operating Expenses</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:OperatingExpenses" contextRef="From2024-03-01to2025-02-28" id="Fact000246" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">7,416,731</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:OperatingExpenses" contextRef="From2023-03-012024-02-29" id="Fact000247" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,740,577</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--OperatingIncomeLoss_iT_pp0p0_mtOILz4uP_maILFCOzzCi_z4nVcvVeOxN7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Operating loss</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2024-03-01to2025-02-28" id="Fact000249" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">7,413,429</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2023-03-012024-02-29" id="Fact000250" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">5,679,357</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--NonoperatingIncomeExpenseAbstract_iB" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Other Income/(Expenses)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--GainLossOnDispositionOfAssets1_i01_pp0p0_maNIEz088_zaJ2TizOeEdl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Loss on disposal of assets</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:GainLossOnDispositionOfAssets1" contextRef="From2024-03-01to2025-02-28" id="Fact000255" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">90</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:GainLossOnDispositionOfAssets1" contextRef="From2023-03-012024-02-29" id="Fact000256" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">14,718</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr id="xdx_40C_eus-gaap--GainsLossesOnExtinguishmentOfDebt_i01_pp0p0_maNIEz088_zEqw9UiKq6qd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Gain (Loss) on extinguishment of liability</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:GainsLossesOnExtinguishmentOfDebt" contextRef="From2024-03-01to2025-02-28" id="Fact000258" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">1,134,579</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:GainsLossesOnExtinguishmentOfDebt" contextRef="From2023-03-012024-02-29" id="Fact000259" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">166,890</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_ecustom--LossOnRelatedPartyReceivable_i01N_pp0p0_di_msNIEz088_zQrWTiqORewb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Loss on promissory note receivable</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="NTRP:LossOnRelatedPartyReceivable" contextRef="From2024-03-01to2025-02-28" id="Fact000261" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,000,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="NTRP:LossOnRelatedPartyReceivable" contextRef="From2023-03-012024-02-29" id="Fact000262" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,567,665</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr id="xdx_40F_eus-gaap--InterestIncomeExpenseNonoperatingNet_i01_pp0p0_maNIEz088_zzWENtHpkxd6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Interest income (expense), net</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:InterestIncomeExpenseNonoperatingNet" contextRef="From2024-03-01to2025-02-28" id="Fact000264" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">589,039</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:InterestIncomeExpenseNonoperatingNet" contextRef="From2023-03-012024-02-29" id="Fact000265" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">48,620</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr id="xdx_402_eus-gaap--OtherNonoperatingIncomeExpense_i01_pp0p0_maNIEz088_zLOfDqYhh7ld" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 1pt">Other Income (expense)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:OtherNonoperatingIncomeExpense" contextRef="From2024-03-01to2025-02-28" id="Fact000267" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">16,099</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:OtherNonoperatingIncomeExpense" contextRef="From2023-03-012024-02-29" id="Fact000268" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">486,633</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--NonoperatingIncomeExpense_i01T_pp0p0_mtNIEz088_maILFCOzzCi_zXfvBB50sqgi" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Total other income (expense)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" contextRef="From2024-03-01to2025-02-28" id="Fact000270" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">2,707,609</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" contextRef="From2023-03-012024-02-29" id="Fact000271" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">977,480</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_408_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_iT_mtILFCOzzCi_maILFCOzZIn_zKYUprX5l7Pa" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Net loss from continuing operations before taxes</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2024-03-01to2025-02-28" id="Fact000273" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">10,121,038</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2023-03-012024-02-29" id="Fact000274" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">6,656,837</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr id="xdx_405_eus-gaap--IncomeTaxExpenseBenefit_iN_di_msILFCOzZIn_zcZD4b8kPNrl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Provision for income taxes</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0276">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0277">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_ecustom--IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestment_iT_mtILFCOzZIn_maILFCOzk6c_zEv2hlXIDxPg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Net loss from continuing operations before share of net income (loss) in equity method investee</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="NTRP:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestment" contextRef="From2024-03-01to2025-02-28" id="Fact000279" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">10,121,038</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="NTRP:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestment" contextRef="From2023-03-012024-02-29" id="Fact000280" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">6,656,837</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr id="xdx_40B_eus-gaap--IncomeLossFromEquityMethodInvestments_maILFCOzk6c_zfDIQ1inBtel" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Share of net loss of equity method investee</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromEquityMethodInvestments" contextRef="From2024-03-01to2025-02-28" id="Fact000282" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">7,390</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0283">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_iT_mtILFCOzk6c_maNILzJAN_z2huxYUscqme" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Net loss from continuing operations</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" contextRef="From2024-03-01to2025-02-28" id="Fact000285" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">10,128,428</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" contextRef="From2023-03-012024-02-29" id="Fact000286" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">6,656,837</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr id="xdx_407_eus-gaap--IncomeLossFromDiscontinuedOperationsNetOfTax_maNILzJAN_zVmT2fECV1z7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Net income (loss) from discontinued operations, net of taxes</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" contextRef="From2024-03-01to2025-02-28" id="Fact000288" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8,344</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" contextRef="From2023-03-012024-02-29" id="Fact000289" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">675,314</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_409_eus-gaap--NetIncomeLoss_iT_pp0p0_mtNILzJAN_maNILATzCnm_z2GuUUDQore1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Net loss</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-03-01to2025-02-28" id="Fact000291" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">10,120,084</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-03-012024-02-29" id="Fact000292" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">7,332,151</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)</td></tr>
  <tr id="xdx_40C_eus-gaap--PreferredStockDividendsIncomeStatementImpact_iN_pp0p0_di_msNILATzCnm_ziBmoTp89aef" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Preferred Dividends</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:PreferredStockDividendsIncomeStatementImpact" contextRef="From2024-03-01to2025-02-28" id="Fact000294" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">78,600</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:PreferredStockDividendsIncomeStatementImpact" contextRef="From2023-03-012024-02-29" id="Fact000295" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">7,125</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_404_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_iT_pp0p0_mtNILATzCnm_z5j6t10EfLel" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Net Loss Applicable to Common Stockholders</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="From2024-03-01to2025-02-28" id="Fact000297" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">10,198,684</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="From2023-03-012024-02-29" id="Fact000298" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">7,339,276</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Basic and diluted loss per common share from continuing operations(*)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_906_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_pid_c20240301__20250228_fKCop_zObDVjCXnkk6" title="Basic loss per common share from continuing operations" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uc29saWRhdGVkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucwA_"><span id="xdx_905_eus-gaap--IncomeLossFromContinuingOperationsPerDilutedShare_pid_c20240301__20250228_fKg_____zfEWV25obZT5" title="Diluted loss per common share from continuing operations" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uc29saWRhdGVkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucwA_">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" contextRef="From2024-03-01to2025-02-28" id="Fact000300" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" contextRef="From2024-03-01to2025-02-28" id="Fact000302" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">2.24</ix:nonFraction></ix:nonFraction></span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90A_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_pid_c20230301__20240229_fKCop_zB5FDRg1eIPl" title="Basic loss per common share from continuing operations" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uc29saWRhdGVkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucwA_"><span id="xdx_903_eus-gaap--IncomeLossFromContinuingOperationsPerDilutedShare_pid_c20230301__20240229_fKg_____zj07rhEJFHWh" title="Diluted loss per common share from continuing operations" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uc29saWRhdGVkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucwA_">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" contextRef="From2023-03-012024-02-29" id="Fact000304" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" contextRef="From2023-03-012024-02-29" id="Fact000306" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">29.16</ix:nonFraction></ix:nonFraction></span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Basic and diluted loss per common share from discontinued operations (*)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_908_eus-gaap--IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_pid_c20240301__20250228_fKg_____zT5shHkRUAHc" title="Basic loss per common share from discontinued operations" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uc29saWRhdGVkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucwA_"><span id="xdx_906_eus-gaap--IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_pid_c20240301__20250228_fKg_____zePJWAfs9Uef" title="Diluted loss per common share from discontinued operations" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uc29saWRhdGVkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucwA_"><ix:nonFraction name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" contextRef="From2024-03-01to2025-02-28" id="Fact000308" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" contextRef="From2024-03-01to2025-02-28" id="Fact000310" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.01</ix:nonFraction></ix:nonFraction></span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_901_eus-gaap--IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_pid_c20230301__20240229_fKg_____zR6ePDd4UvVi" title="Basic loss per common share from discontinued operations" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uc29saWRhdGVkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucwA_"><span id="xdx_908_eus-gaap--IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_pid_c20230301__20240229_fKg_____z5aJZuNqtR92" title="Diluted loss per common share from discontinued operations" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uc29saWRhdGVkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucwA_">(<ix:nonFraction name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" contextRef="From2023-03-012024-02-29" id="Fact000312" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares"><ix:nonFraction name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" contextRef="From2023-03-012024-02-29" id="Fact000314" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">2.96</ix:nonFraction></ix:nonFraction></span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Basic and diluted loss per common share (*)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_906_eus-gaap--EarningsPerShareBasic_pid_c20240301__20250228_fKg_____z3oplPAhcxQk" title="Loss per common share basic" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uc29saWRhdGVkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucwA_"><span id="xdx_904_eus-gaap--EarningsPerShareDiluted_pid_c20240301__20250228_fKg_____zKrCUyOmokmh" title="Loss per common share diluted" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uc29saWRhdGVkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucwA_">(<ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2024-03-01to2025-02-28" id="Fact000316" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2024-03-01to2025-02-28" id="Fact000318" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">2.23</ix:nonFraction></ix:nonFraction></span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_906_eus-gaap--EarningsPerShareBasic_pid_c20230301__20240229_fKg_____zsMACHgcbBi1" title="Loss per common share basic" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uc29saWRhdGVkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucwA_"><span id="xdx_907_eus-gaap--EarningsPerShareDiluted_pid_c20230301__20240229_fKg_____zsXyWFQe4Jhl" title="Loss per common share diluted" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uc29saWRhdGVkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucwA_">(<ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2023-03-012024-02-29" id="Fact000320" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2023-03-012024-02-29" id="Fact000322" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">32.12</ix:nonFraction></ix:nonFraction></span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">Basic and diluted weighted average number of common shares (*)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_909_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20240301__20250228_fKg_____zbnom1h7r6s4" title="Weighted average number of shares outstanding basic" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uc29saWRhdGVkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucwA_"><span id="xdx_902_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20240301__20250228_fKg_____znr9AKjb6rqa" title="Weighted nverage number of shares outstanding diluted" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uc29saWRhdGVkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucwA_"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2024-03-01to2025-02-28" id="Fact000324" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2024-03-01to2025-02-28" id="Fact000326" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">4,566,787</ix:nonFraction></ix:nonFraction></span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_908_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20230301__20240229_fKg_____zRktDIh5yGUd" title="Weighted average number of shares outstanding basic" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uc29saWRhdGVkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucwA_"><span id="xdx_906_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20230301__20240229_fKg_____zSlpbFboY1fh" title="Weighted nverage number of shares outstanding diluted" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uc29saWRhdGVkIFN0YXRlbWVudHMgb2YgT3BlcmF0aW9ucwA_"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2023-03-012024-02-29" id="Fact000328" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2023-03-012024-02-29" id="Fact000330" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">228,274</ix:nonFraction></ix:nonFraction></span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: right"><span id="xdx_F07_zmfO1Gt51RVd" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F1F_zrHgjKMV5sTg" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:footnote id="Footnote000331" xml:lang="en-US">On
    December 29, 2023, the Company (then known as Sigma Additive Solutions, Inc.) acquired NTH in a reverse acquisition. NTG was issued
    <span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_pid_c20231229__20231229__us-gaap--BusinessAcquisitionAxis__custom--NextTripGroupLLCMember_zMAWreRRiNcf" title="Number of shares acquired"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesAcquisitions" contextRef="From2023-12-292023-12-29_custom_NextTripGroupLLCMember" id="Fact000333" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">83,371</ix:nonFraction></span> shares of Company common stock in exchange for <span id="xdx_904_ecustom--PercentageForIssuedAndOutstandingCapitalStock_pid_dp_c20231229__20231229__us-gaap--BusinessAcquisitionAxis__custom--NextTripGroupLLCMember_zN7cXzVnhmg1" title="Percentage for issued and outstanding capital stock"><ix:nonFraction name="NTRP:PercentageForIssuedAndOutstandingCapitalStock" contextRef="From2023-12-292023-12-29_custom_NextTripGroupLLCMember" id="Fact000335" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>% of the issued and outstanding capital stock of NTH at the time of the
    reverse acquisition. The Company has reflected this transaction retroactively in these financial statements.</ix:footnote></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">See
accompanying notes to financial statements</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 80; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NEXTTRIP,
INC.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="f_004"></span>CONSOLIDATED
STATEMENTS OF STOCKHOLDERS&#8217; EQUITY</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR
THE YEARS ENDED FEBRUARY 28, 2025 AND FEBRUARY 29, 2024</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellpadding="0" cellspacing="0" summary="xdx: Statement - Consolidated Statements of Stockholders' Equity" id="xdx_304_114_zMIn653xHbr7" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Shares</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_4BC_us-gaap--StatementEquityComponentsAxis_us-gaap--PreferredStockMember_z9FueYEsSl6" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Amount</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Shares</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_4B6_us-gaap--StatementEquityComponentsAxis_us-gaap--CommonStockMember_zSXeHmyjLSh1" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Amount</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_4B9_us-gaap--StatementEquityComponentsAxis_us-gaap--AdditionalPaidInCapitalMember_zLQybHy8AZza" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Capital</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_4B3_us-gaap--StatementEquityComponentsAxis_us-gaap--RetainedEarningsMember_zT2SkdoCPcJ6" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Deficit</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_4B7_z0K31zDLvTY4" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Total</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Preferred</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Common</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center">Additional Paid in</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center">Accumulated</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Shares</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Amount</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Shares</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Amount</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Capital</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Deficit</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Total</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_434_c20230301__20240229_eus-gaap--StockholdersEquity_iS_zayaHzJFTKWg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 30%; padding-bottom: 1pt">Balance, February 28, 2023 <span id="xdx_F46_zvtwMH8zJ1W4">(*)</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--SharesOutstanding_iS_pid_c20230301__20240229__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_fKCop_z8VC8YIWLqmb" title="Beginning balance, shares" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0343">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0337">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--SharesOutstanding_iS_pid_c20230301__20240229__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_fKCop_zubJdSyWpUMi" title="Beginning balance, shares" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2023-02-28_us-gaap_CommonStockMember" id="Fact000345" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">83,371</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-02-28_us-gaap_CommonStockMember" id="Fact000338" format="ixt:numdotdecimal" decimals="0" unitRef="USD">83</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-02-28_us-gaap_AdditionalPaidInCapitalMember" id="Fact000339" format="ixt:numdotdecimal" decimals="0" unitRef="USD">17,295,890</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-02-28_us-gaap_RetainedEarningsMember" id="Fact000340" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">16,811,863</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-02-28" id="Fact000341" format="ixt:numdotdecimal" decimals="0" unitRef="USD">484,110</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_ecustom--StockIssuedDuringPeriodValueOfPreferredShares_zleRvUaxBJm6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">Issuance of Preferred Shares</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98C_ecustom--StockIssuedDuringPeriodShareOfPreferredShares_pid_c20230301__20240229__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_zhi3z72lTxCa" title="Issuance of Preferred Shares, Shares" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="NTRP:StockIssuedDuringPeriodShareOfPreferredShares" contextRef="From2023-03-012024-02-29_us-gaap_PreferredStockMember" id="Fact000353" format="ixt:numdotdecimal" decimals="INF" unitRef="USD">472,680</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="NTRP:StockIssuedDuringPeriodValueOfPreferredShares" contextRef="From2023-03-012024-02-29_us-gaap_PreferredStockMember" id="Fact000347" format="ixt:numdotdecimal" decimals="0" unitRef="USD">473</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_983_ecustom--StockIssuedDuringPeriodShareOfPreferredShares_pid_c20230301__20240229__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zl7pFCUxDuV7" title="Issuance of Preferred Shares, Shares" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0355">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0348">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="NTRP:StockIssuedDuringPeriodValueOfPreferredShares" contextRef="From2023-03-012024-02-29_us-gaap_AdditionalPaidInCapitalMember" id="Fact000349" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,603,027</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0350">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="NTRP:StockIssuedDuringPeriodValueOfPreferredShares" contextRef="From2023-03-012024-02-29" id="Fact000351" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,603,500</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_z1zZ34jIfJZj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Conversion of Convertible Notes</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0357">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_pid_c20230301__20240229__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zcBHm6zmkbib" title="Conversion of Convertible Notes, Shares" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" contextRef="From2023-03-012024-02-29_us-gaap_CommonStockMember" id="Fact000363" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">52,818</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="From2023-03-012024-02-29_us-gaap_CommonStockMember" id="Fact000358" format="ixt:numdotdecimal" decimals="0" unitRef="USD">53</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="From2023-03-012024-02-29_us-gaap_AdditionalPaidInCapitalMember" id="Fact000359" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,968,507</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0360">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="From2023-03-012024-02-29" id="Fact000361" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,968,560</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_ecustom--StockIssuedDuringPeriodValuePurchasesOfCommonShares_zkkXgAcgao3f" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">Purchases of Common Shares</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0365">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_982_ecustom--StockIssuedDuringPeriodSharesPurchasesOfCommonShares_pid_c20230301__20240229__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zlBTIkFRYQsg" title="Purchases of Common Shares, Sharers" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="NTRP:StockIssuedDuringPeriodSharesPurchasesOfCommonShares" contextRef="From2023-03-012024-02-29_us-gaap_CommonStockMember" id="Fact000371" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">15,481</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="NTRP:StockIssuedDuringPeriodValuePurchasesOfCommonShares" contextRef="From2023-03-012024-02-29_us-gaap_CommonStockMember" id="Fact000366" format="ixt:numdotdecimal" decimals="0" unitRef="USD">16</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="NTRP:StockIssuedDuringPeriodValuePurchasesOfCommonShares" contextRef="From2023-03-012024-02-29_us-gaap_AdditionalPaidInCapitalMember" id="Fact000367" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,905,954</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0368">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="NTRP:StockIssuedDuringPeriodValuePurchasesOfCommonShares" contextRef="From2023-03-012024-02-29" id="Fact000369" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,905,970</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_zMI2uIC2obmh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Issuance of Common Shares for Services</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0373">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_c20230301__20240229__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zEPmGovu0jCg" title="Issuance of Common Shares for Services, Shares" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" contextRef="From2023-03-012024-02-29_us-gaap_CommonStockMember" id="Fact000379" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">4,337</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2023-03-012024-02-29_us-gaap_CommonStockMember" id="Fact000374" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2023-03-012024-02-29_us-gaap_AdditionalPaidInCapitalMember" id="Fact000375" format="ixt:numdotdecimal" decimals="0" unitRef="USD">13,106</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0376">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2023-03-012024-02-29" id="Fact000377" format="ixt:numdotdecimal" decimals="0" unitRef="USD">13,110</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_ecustom--StockIssuedDuringPeriodValueReverseAcquisition_z4PDt1cwBbPl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Reverse Acquisition of Sigma Additive Solutions, Inc.</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_986_ecustom--StockIssuedDuringPeriodSharesReverseAcquisition_pid_c20230301__20240229__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_zh5EeZWB95nd" title="Reverse Acquisition of Sigma Additive Solutions, Inc., Shares" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="NTRP:StockIssuedDuringPeriodSharesReverseAcquisition" contextRef="From2023-03-012024-02-29_us-gaap_PreferredStockMember" id="Fact000387" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">316</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="NTRP:StockIssuedDuringPeriodValueReverseAcquisition" contextRef="From2023-03-012024-02-29_us-gaap_PreferredStockMember" id="Fact000381" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_988_ecustom--StockIssuedDuringPeriodSharesReverseAcquisition_pid_c20230301__20240229__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zfVOtGxZohE3" title="Reverse Acquisition of Sigma Additive Solutions, Inc., Shares" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="NTRP:StockIssuedDuringPeriodSharesReverseAcquisition" contextRef="From2023-03-012024-02-29_us-gaap_CommonStockMember" id="Fact000389" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">780,423</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="NTRP:StockIssuedDuringPeriodValueReverseAcquisition" contextRef="From2023-03-012024-02-29_us-gaap_CommonStockMember" id="Fact000382" format="ixt:numdotdecimal" decimals="0" unitRef="USD">780</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="NTRP:StockIssuedDuringPeriodValueReverseAcquisition" contextRef="From2023-03-012024-02-29_us-gaap_AdditionalPaidInCapitalMember" id="Fact000383" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,367,637</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0384">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="NTRP:StockIssuedDuringPeriodValueReverseAcquisition" contextRef="From2023-03-012024-02-29" id="Fact000385" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,368,418</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_zmZ9mCaDK9uj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Stock Compensation</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0391">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0392">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2023-03-012024-02-29_us-gaap_AdditionalPaidInCapitalMember" id="Fact000393" format="ixt:numdotdecimal" decimals="0" unitRef="USD">116,512</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0394">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2023-03-012024-02-29" id="Fact000395" format="ixt:numdotdecimal" decimals="0" unitRef="USD">116,512</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--DividendsPreferredStock_iN_di_z0nHDqOZWFgf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Preferred Stock Dividends</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0397">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0398">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:DividendsPreferredStock" contextRef="From2023-03-012024-02-29_us-gaap_AdditionalPaidInCapitalMember" id="Fact000399" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">7,125</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:DividendsPreferredStock" contextRef="From2023-03-012024-02-29_us-gaap_RetainedEarningsMember" id="Fact000400" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,125</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0401">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--NetIncomeLoss_zDIl2uMzohQk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Net Loss</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-03-012024-02-29_us-gaap_RetainedEarningsMember" id="Fact000406" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">7,332,151</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-03-012024-02-29" id="Fact000407" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">7,332,151</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_434_c20240301__20250228_eus-gaap--StockholdersEquity_iS_zQa6icRoSSHl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">Balance, February 29, 2024 <span id="xdx_F44_z7P6X7GKHVtk">(*)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><sup>&#160;</sup></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--SharesOutstanding_iS_pid_c20240301__20250228__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_fKCop_zq9kgig07JO7" title="Beginning balance, shares" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2024-02-29_us-gaap_PreferredStockMember" id="Fact000415" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">472,996</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-02-29_us-gaap_PreferredStockMember" id="Fact000409" format="ixt:numdotdecimal" decimals="0" unitRef="USD">474</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--SharesOutstanding_iS_pid_c20240301__20250228__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_fKCop_z2OMzPwbq06f" title="Beginning balance, shares" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2024-02-29_us-gaap_CommonStockMember" id="Fact000417" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">936,430</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-02-29_us-gaap_CommonStockMember" id="Fact000410" format="ixt:numdotdecimal" decimals="0" unitRef="USD">936</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-02-29_us-gaap_AdditionalPaidInCapitalMember" id="Fact000411" format="ixt:numdotdecimal" decimals="0" unitRef="USD">27,277,758</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-02-29_us-gaap_RetainedEarningsMember" id="Fact000412" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">24,151,139</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-02-29" id="Fact000413" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,128,029</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_439_c20240301__20250228_eus-gaap--StockholdersEquity_iS_zdq5qgSSNNy8" style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">Beginning balance</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><sup>&#160;</sup></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--SharesOutstanding_iS_pid_c20240301__20250228__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_fKCop_z5mGyVbIZrcd" title="Beginning balance, shares" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2024-02-29_us-gaap_PreferredStockMember" id="Fact000425" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">472,996</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-02-29_us-gaap_PreferredStockMember" id="Fact000419" format="ixt:numdotdecimal" decimals="0" unitRef="USD">474</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--SharesOutstanding_iS_pid_c20240301__20250228__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_fKCop_zH3L71mmELuf" title="Beginning balance, shares" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2024-02-29_us-gaap_CommonStockMember" id="Fact000427" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">936,430</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-02-29_us-gaap_CommonStockMember" id="Fact000420" format="ixt:numdotdecimal" decimals="0" unitRef="USD">936</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-02-29_us-gaap_AdditionalPaidInCapitalMember" id="Fact000421" format="ixt:numdotdecimal" decimals="0" unitRef="USD">27,277,758</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-02-29_us-gaap_RetainedEarningsMember" id="Fact000422" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">24,151,139</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-02-29" id="Fact000423" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,128,029</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr id="xdx_404_ecustom--StockIssuedDuringPeriodValueOfPreferredSharesInPrivatePlacements_zl6DSU5FtdAk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Issuance of Preferred Shares in Private Placements</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98F_ecustom--StockIssuedDuringPeriodSharesOfPreferredSharesInPrivatePlacements_pid_c20240301__20250228__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_fKCop_zP00QUEx4Zpd" title="Issuance of Preferred Shares in Private Placements, shares" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="NTRP:StockIssuedDuringPeriodSharesOfPreferredSharesInPrivatePlacements" contextRef="From2024-03-012025-02-28_us-gaap_PreferredStockMember" id="Fact000435" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">830,284</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="NTRP:StockIssuedDuringPeriodValueOfPreferredSharesInPrivatePlacements" contextRef="From2024-03-012025-02-28_us-gaap_PreferredStockMember" id="Fact000429" format="ixt:numdotdecimal" decimals="0" unitRef="USD">830</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_989_ecustom--StockIssuedDuringPeriodSharesOfPreferredSharesInPrivatePlacements_pid_c20240301__20250228__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_fKCop_zykMkHVpZ4x6" title="Issuance of Preferred Shares in Private Placements, shares" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0437">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0430">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="NTRP:StockIssuedDuringPeriodValueOfPreferredSharesInPrivatePlacements" contextRef="From2024-03-012025-02-28_us-gaap_AdditionalPaidInCapitalMember" id="Fact000431" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,872,104</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0432">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="NTRP:StockIssuedDuringPeriodValueOfPreferredSharesInPrivatePlacements" contextRef="From2024-03-01to2025-02-28" id="Fact000433" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,872,934</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_ecustom--StockIssuedDuringPeriodValueConversionOfPreferredSharesToCommonShares_zGcEAO6JMRi7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">Conversion of Preferred Shares to Common Shares</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98A_ecustom--StockIssuedDuringPeriodSharesConversionOfPreferredSharesToCommonShares_pid_c20240301__20250228__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_fKCop_zkpIxPSA1CMh" title="Conversion of Preferred Shares to Common Shares, shares" style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="NTRP:StockIssuedDuringPeriodSharesConversionOfPreferredSharesToCommonShares" contextRef="From2024-03-012025-02-28_us-gaap_PreferredStockMember" id="Fact000445" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="Shares">409,502</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="NTRP:StockIssuedDuringPeriodValueConversionOfPreferredSharesToCommonShares" contextRef="From2024-03-012025-02-28_us-gaap_PreferredStockMember" id="Fact000439" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">410</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_982_ecustom--StockIssuedDuringPeriodSharesConversionOfPreferredSharesToCommonShares_pid_c20240301__20250228__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_fKCop_zlgQVYk8pmN7" title="Conversion of Preferred Shares to Common Shares, shares" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="NTRP:StockIssuedDuringPeriodSharesConversionOfPreferredSharesToCommonShares" contextRef="From2024-03-012025-02-28_us-gaap_CommonStockMember" id="Fact000447" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">409,502</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="NTRP:StockIssuedDuringPeriodValueConversionOfPreferredSharesToCommonShares" contextRef="From2024-03-012025-02-28_us-gaap_CommonStockMember" id="Fact000440" format="ixt:numdotdecimal" decimals="0" unitRef="USD">410</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0441">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0442">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0443">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_ecustom--StockIssuedDuringPeriodValueIssuanceOfPreferredSharesForDebtConversions_zYzDuO3hqzM7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Issuance of Preferred Shares for Debt Conversions</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_985_ecustom--StockIssuedDuringPeriodSharesIssuanceOfPreferredSharesForDebtConversions_pid_c20240301__20250228__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_fKCop_zz2fBWohE1d4" title="Issuance of Preferred Shares for Debt Conversions, shares" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="NTRP:StockIssuedDuringPeriodSharesIssuanceOfPreferredSharesForDebtConversions" contextRef="From2024-03-012025-02-28_us-gaap_PreferredStockMember" id="Fact000455" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,459,434</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="NTRP:StockIssuedDuringPeriodValueIssuanceOfPreferredSharesForDebtConversions" contextRef="From2024-03-012025-02-28_us-gaap_PreferredStockMember" id="Fact000449" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,460</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_984_ecustom--StockIssuedDuringPeriodSharesIssuanceOfPreferredSharesForDebtConversions_pid_c20240301__20250228__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_fKCop_zMVUwU1YriB8" title="Issuance of Preferred Shares for Debt Conversions, shares" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0457">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0450">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="NTRP:StockIssuedDuringPeriodValueIssuanceOfPreferredSharesForDebtConversions" contextRef="From2024-03-012025-02-28_us-gaap_AdditionalPaidInCapitalMember" id="Fact000451" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,651,040</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0452">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="NTRP:StockIssuedDuringPeriodValueIssuanceOfPreferredSharesForDebtConversions" contextRef="From2024-03-01to2025-02-28" id="Fact000453" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,652,500</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_ecustom--StockIssuedDuringPeriodValueIssuanceOfSecuritiesForServices_zhz5MxFUFlPc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Issuance of Securities for Services</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98D_ecustom--StockIssuedDuringPeriodSharesIssuanceOfSecuritiesForServices_pid_c20240301__20250228__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_fKCop_zcESJUyGEM4j" title="Issuance of Securities for Services, shares" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="NTRP:StockIssuedDuringPeriodSharesIssuanceOfSecuritiesForServices" contextRef="From2024-03-012025-02-28_us-gaap_PreferredStockMember" id="Fact000465" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">109,113</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="NTRP:StockIssuedDuringPeriodValueIssuanceOfSecuritiesForServices" contextRef="From2024-03-012025-02-28_us-gaap_PreferredStockMember" id="Fact000459" format="ixt:numdotdecimal" decimals="0" unitRef="USD">109</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98F_ecustom--StockIssuedDuringPeriodSharesIssuanceOfSecuritiesForServices_pid_c20240301__20250228__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_fKCop_zYEfTmBG8CB" title="Issuance of Securities for Services, shares" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="NTRP:StockIssuedDuringPeriodSharesIssuanceOfSecuritiesForServices" contextRef="From2024-03-012025-02-28_us-gaap_CommonStockMember" id="Fact000467" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">160,990</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="NTRP:StockIssuedDuringPeriodValueIssuanceOfSecuritiesForServices" contextRef="From2024-03-012025-02-28_us-gaap_CommonStockMember" id="Fact000460" format="ixt:numdotdecimal" decimals="0" unitRef="USD">161</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="NTRP:StockIssuedDuringPeriodValueIssuanceOfSecuritiesForServices" contextRef="From2024-03-012025-02-28_us-gaap_AdditionalPaidInCapitalMember" id="Fact000461" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,407,193</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0462">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="NTRP:StockIssuedDuringPeriodValueIssuanceOfSecuritiesForServices" contextRef="From2024-03-01to2025-02-28" id="Fact000463" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,407,463</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_ecustom--StockIssuedDuringPeriodValueSecuritiesIssuedForEquityInvestments_zAbuCeYoDP38" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Securities Issued for Equity Investments</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_988_ecustom--StockIssuedDuringPeriodSharseSecuritiesIssuedForEquityInvestments_pid_c20240301__20250228__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_fKCop_zHPAcEvCjaWa" title="Securities Issued for Equity Investments, shares" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="NTRP:StockIssuedDuringPeriodSharseSecuritiesIssuedForEquityInvestments" contextRef="From2024-03-012025-02-28_us-gaap_PreferredStockMember" id="Fact000475" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">644,291</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="NTRP:StockIssuedDuringPeriodValueSecuritiesIssuedForEquityInvestments" contextRef="From2024-03-012025-02-28_us-gaap_PreferredStockMember" id="Fact000469" format="ixt:numdotdecimal" decimals="0" unitRef="USD">644</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_986_ecustom--StockIssuedDuringPeriodSharseSecuritiesIssuedForEquityInvestments_pid_c20240301__20250228__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_fKCop_zQLW5uvuxfb9" title="Securities Issued for Equity Investments, shares" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="NTRP:StockIssuedDuringPeriodSharseSecuritiesIssuedForEquityInvestments" contextRef="From2024-03-012025-02-28_us-gaap_CommonStockMember" id="Fact000477" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">8,065</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="NTRP:StockIssuedDuringPeriodValueSecuritiesIssuedForEquityInvestments" contextRef="From2024-03-012025-02-28_us-gaap_CommonStockMember" id="Fact000470" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="NTRP:StockIssuedDuringPeriodValueSecuritiesIssuedForEquityInvestments" contextRef="From2024-03-012025-02-28_us-gaap_AdditionalPaidInCapitalMember" id="Fact000471" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,938,704</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0472">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="NTRP:StockIssuedDuringPeriodValueSecuritiesIssuedForEquityInvestments" contextRef="From2024-03-01to2025-02-28" id="Fact000473" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,939,356</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_ecustom--StockIssuedDuringPeriodValueIssuanceOfCommitmentSharesForEquityLineOfCredit_zUdCJtOzu1Ph" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Issuance of Commitment Shares for Equity Line of Credit</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98E_ecustom--StockIssuedDuringPeriodSharesIssuanceOfCommitmentSharesForEquityLineOfCredit_pid_c20240301__20250228__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_fKCop_zM6LGDQnWpw1" title="Issuance of Commitment Shares for Equity Line of Credit, shares" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0485">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0479">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_982_ecustom--StockIssuedDuringPeriodSharesIssuanceOfCommitmentSharesForEquityLineOfCredit_pid_c20240301__20250228__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_fKCop_zHqk689l7pR" title="Issuance of Commitment Shares for Equity Line of Credit, shares" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="NTRP:StockIssuedDuringPeriodSharesIssuanceOfCommitmentSharesForEquityLineOfCredit" contextRef="From2024-03-012025-02-28_us-gaap_CommonStockMember" id="Fact000487" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">32,786</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="NTRP:StockIssuedDuringPeriodValueIssuanceOfCommitmentSharesForEquityLineOfCredit" contextRef="From2024-03-012025-02-28_us-gaap_CommonStockMember" id="Fact000480" format="ixt:numdotdecimal" decimals="0" unitRef="USD">33</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="NTRP:StockIssuedDuringPeriodValueIssuanceOfCommitmentSharesForEquityLineOfCredit" contextRef="From2024-03-012025-02-28_us-gaap_AdditionalPaidInCapitalMember" id="Fact000481" format="ixt:numdotdecimal" decimals="0" unitRef="USD">99,967</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0482">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="NTRP:StockIssuedDuringPeriodValueIssuanceOfCommitmentSharesForEquityLineOfCredit" contextRef="From2024-03-01to2025-02-28" id="Fact000483" format="ixt:numdotdecimal" decimals="0" unitRef="USD">100,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--StockIssuedDuringPeriodValueStockOptionsExercised_zB9gNMMqC8h2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Issuance of Common Shares for Warrant Exercises</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_pid_c20240301__20250228__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_fKCop_ziHFCb4rR0v5" title="Issuance of Common Shares for Warrant Exercises, shares" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0495">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0489">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_pid_c20240301__20250228__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_fKCop_zj18LUg8eMgl" title="Issuance of Common Shares for Warrant Exercises, shares" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="From2024-03-012025-02-28_us-gaap_CommonStockMember" id="Fact000497" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">104,965</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2024-03-012025-02-28_us-gaap_CommonStockMember" id="Fact000490" format="ixt:numdotdecimal" decimals="0" unitRef="USD">105</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2024-03-012025-02-28_us-gaap_AdditionalPaidInCapitalMember" id="Fact000491" format="ixt:numdotdecimal" decimals="0" unitRef="USD">316,890</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0492">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" contextRef="From2024-03-01to2025-02-28" id="Fact000493" format="ixt:numdotdecimal" decimals="0" unitRef="USD">316,995</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--StockIssuedDuringPeriodValueShareBasedCompensation_zIVp1C7Ygxbk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Stock Compensation</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensation_pid_c20240301__20250228__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_fKCop_zYTCIQOhXsrg" title="Stock Compensation, shares" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0505">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0499">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensation_pid_c20240301__20250228__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_fKCop_znRUwhNoE5S8" title="Stock Compensation, shares" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" contextRef="From2024-03-012025-02-28_us-gaap_CommonStockMember" id="Fact000507" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">4,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2024-03-012025-02-28_us-gaap_CommonStockMember" id="Fact000500" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2024-03-012025-02-28_us-gaap_AdditionalPaidInCapitalMember" id="Fact000501" format="ixt:numdotdecimal" decimals="0" unitRef="USD">67,870</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0502">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" contextRef="From2024-03-01to2025-02-28" id="Fact000503" format="ixt:numdotdecimal" decimals="0" unitRef="USD">67,874</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--DividendsPreferredStock_iN_di_z69YcMgsbSY1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Preferred Stock Dividends</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0509">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0510">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:DividendsPreferredStock" contextRef="From2024-03-012025-02-28_us-gaap_AdditionalPaidInCapitalMember" id="Fact000511" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">78,600</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:DividendsPreferredStock" contextRef="From2024-03-012025-02-28_us-gaap_RetainedEarningsMember" id="Fact000512" format="ixt:numdotdecimal" decimals="0" unitRef="USD">78,600</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0513">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--NetIncomeLoss_zSHKdmdvcPxi" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Net Loss</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0515">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0516">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0517">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-03-012025-02-28_us-gaap_RetainedEarningsMember" id="Fact000518" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">10,120,084</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-03-01to2025-02-28" id="Fact000519" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">10,120,084</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_433_c20240301__20250228_eus-gaap--StockholdersEquity_iE_zXQu0RxOu1t9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">Balance, February 28, 2025</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--SharesOutstanding_iE_pid_c20240301__20250228__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_fKCop_zexzg4mMZuW4" title="Ending balance, shares" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2025-02-28_us-gaap_PreferredStockMember" id="Fact000527" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,106,616</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2025-02-28_us-gaap_PreferredStockMember" id="Fact000521" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,107</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--SharesOutstanding_iE_pid_c20240301__20250228__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_fKCop_zQAufvTK1xI2" title="Ending balance, shares" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2025-02-28_us-gaap_CommonStockMember" id="Fact000529" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,656,738</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2025-02-28_us-gaap_CommonStockMember" id="Fact000522" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,657</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2025-02-28_us-gaap_AdditionalPaidInCapitalMember" id="Fact000523" format="ixt:numdotdecimal" decimals="0" unitRef="USD">41,710,126</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2025-02-28_us-gaap_RetainedEarningsMember" id="Fact000524" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">34,349,823</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2025-02-28" id="Fact000525" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,365,067</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_43A_c20240301__20250228_eus-gaap--StockholdersEquity_iE_ze6FcGcCRtg4" style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">Ending balance</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--SharesOutstanding_iE_pid_c20240301__20250228__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_fKCop_zGNwYEiLdtOi" title="Ending balance, shares" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2025-02-28_us-gaap_PreferredStockMember" id="Fact000537" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,106,616</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2025-02-28_us-gaap_PreferredStockMember" id="Fact000531" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,107</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--SharesOutstanding_iE_pid_c20240301__20250228__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_fKCop_z0yeLq3yTx1l" title="Ending balance, shares" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2025-02-28_us-gaap_CommonStockMember" id="Fact000539" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,656,738</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2025-02-28_us-gaap_CommonStockMember" id="Fact000532" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,657</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2025-02-28_us-gaap_AdditionalPaidInCapitalMember" id="Fact000533" format="ixt:numdotdecimal" decimals="0" unitRef="USD">41,710,126</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2025-02-28_us-gaap_RetainedEarningsMember" id="Fact000534" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">34,349,823</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2025-02-28" id="Fact000535" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,365,067</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td id="xdx_F04_z8fJbNoTIUQ3" style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F1A_zXusTjCOBCsb" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:footnote id="Footnote000540" xml:lang="en-US">On
    December 29, 2023, the Company (then known as Sigma Additive Solutions, Inc.) acquired NTH in a reverse acquisition. NTG was issued
    <span id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_pid_c20231229__20231229__us-gaap--BusinessAcquisitionAxis__custom--NextTripGroupLLCMember_znf0cL99Yexe" title="Number of shares acquired"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesAcquisitions" contextRef="From2023-12-292023-12-29_custom_NextTripGroupLLCMember" id="Fact000542" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">83,371</ix:nonFraction></span> shares of Company common stock in exchange for <span id="xdx_903_ecustom--PercentageForIssuedAndOutstandingCapitalStock_pid_dp_uPure_c20231229__20231229__us-gaap--BusinessAcquisitionAxis__custom--NextTripGroupLLCMember_zJ1ftypKOa1l" title="Percentage for issued and outstanding capital stock"><ix:nonFraction name="NTRP:PercentageForIssuedAndOutstandingCapitalStock" contextRef="From2023-12-292023-12-29_custom_NextTripGroupLLCMember" id="Fact000544" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>% of the issued and outstanding capital stock of NTH at the time of the
    reverse acquisition. The Company has reflected this transaction retroactively in these financial statements.</ix:footnote></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">See
accompanying notes to financial statements</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 81; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NEXTTRIP,
INC.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="f_005"></span>CONSOLIDATED
STATEMENTS OF CASH FLOWS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR
THE YEARS ENDED FEBRUARY 28, 2025 AND FEBRUARY 29, 2024</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_301_112_zfMxLsKfs902" summary="xdx: Statement - Consolidated Statements of Cash Flows" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_493_20240301__20250228_z6QEAjNjmB21" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">February 28, 2025</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49A_20230301__20240229_zPc3E4s6JPLi" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">February 29, 2024</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--NetCashProvidedByUsedInOperatingActivitiesAbstract_iB" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Cash Flows from Operating Activities:</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_i01_pp0p0_maNCPBUz5H1_zoYaYcpWI8Uj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left">Net Loss from continuing operations</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" contextRef="From2024-03-01to2025-02-28" id="Fact000549" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">10,128,428</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" contextRef="From2023-03-012024-02-29" id="Fact000550" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">6,656,837</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">)</td></tr>
  <tr id="xdx_403_eus-gaap--AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_i01B" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Adjustments to reconcile net loss to net cash used in operating activities:</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--DepreciationDepletionAndAmortization_i02_pp0p0_maNCPBUz5H1_zBc8r4DTNhYj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Depreciation and amortization &#8211; property and equipment and intangibles</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:DepreciationDepletionAndAmortization" contextRef="From2024-03-01to2025-02-28" id="Fact000555" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">713,236</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:DepreciationDepletionAndAmortization" contextRef="From2023-03-012024-02-29" id="Fact000556" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,468,762</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--AmortizationOfDebtDiscountPremium_i02_pp0p0_maNCPBUz5H1_zxSLP3Xpvig3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Amortization of Debt Discount</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:AmortizationOfDebtDiscountPremium" contextRef="From2024-03-01to2025-02-28" id="Fact000558" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">342,935</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0559">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_ecustom--AmortizationOfPrepaidExpenses_i02_pp0p0_maNCPBUz5H1_z4FuaT8diWIi" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Amortization of prepaid expenses</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="NTRP:AmortizationOfPrepaidExpenses" contextRef="From2024-03-01to2025-02-28" id="Fact000561" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">236,112</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0562">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_ecustom--LossOnRelatedPartyReceivable_i02_pp0p0_maNCPBUz5H1_zmP5b5ypRW58" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Loss on promissory note receivable</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="NTRP:LossOnRelatedPartyReceivable" contextRef="From2024-03-01to2025-02-28" id="Fact000564" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,000,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="NTRP:LossOnRelatedPartyReceivable" contextRef="From2023-03-012024-02-29" id="Fact000565" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,567,665</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--ShareBasedCompensation_i02_pp0p0_maNCPBUz5H1_zZ3QVx2CUFX" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Stock based compensation</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2024-03-01to2025-02-28" id="Fact000567" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">67,874</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2023-03-012024-02-29" id="Fact000568" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">116,512</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--GainsLossesOnExtinguishmentOfDebt_i02N_pp0p0_di_msNCPBUz5H1_zoXh38Begi7a" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">(Gain) loss on extinguishment of liability</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:GainsLossesOnExtinguishmentOfDebt" contextRef="From2024-03-01to2025-02-28" id="Fact000570" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">1,134,579</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:GainsLossesOnExtinguishmentOfDebt" contextRef="From2023-03-012024-02-29" id="Fact000571" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">166,890</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr id="xdx_40F_ecustom--LossOnDispositionOfAssets_i02_pp0p0_maNCPBUz5H1_zX8GksUQgKbi" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Loss on disposal of assets</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="NTRP:LossOnDispositionOfAssets" contextRef="From2024-03-01to2025-02-28" id="Fact000573" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">90</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="NTRP:LossOnDispositionOfAssets" contextRef="From2023-03-012024-02-29" id="Fact000574" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">14,718</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--IncomeLossFromEquityMethodInvestments_i02N_pp0p0_di_msNCPBUz5H1_zrviacktK2nb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Loss on share of net income in equity method investee</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:IncomeLossFromEquityMethodInvestments" contextRef="From2024-03-01to2025-02-28" id="Fact000576" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">7,390</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0577">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--IncreaseDecreaseInOperatingCapitalAbstract_i01B_z1KmhnzeL4bf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Changes in operating assets and liabilities:</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--IncreaseDecreaseInAccountsReceivable_i02N_pp0p0_di_msNCPBUz5H1_zcjq5muYXg23" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Accounts receivable</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsReceivable" contextRef="From2024-03-01to2025-02-28" id="Fact000582" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">11,515</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsReceivable" contextRef="From2023-03-012024-02-29" id="Fact000583" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">662,939</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr id="xdx_40E_eus-gaap--IncreaseDecreaseInPrepaidExpense_i02N_pp0p0_di_msNCPBUz5H1_zgdQiTRJgrOg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Prepaid expenses</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidExpense" contextRef="From2024-03-01to2025-02-28" id="Fact000585" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">159,343</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidExpense" contextRef="From2023-03-012024-02-29" id="Fact000586" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">281,506</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr id="xdx_405_eus-gaap--IncreaseDecreaseInSecurityDeposits_i02_maNCPBUz5H1_zb8rv8MdPgF6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Security deposit</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInSecurityDeposits" contextRef="From2024-03-01to2025-02-28" id="Fact000588" format="ixt:numdotdecimal" decimals="0" unitRef="USD">12,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInSecurityDeposits" contextRef="From2023-03-012024-02-29" id="Fact000589" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">27,167</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr id="xdx_40D_eus-gaap--IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_i02_maNCPBUz5H1_zgsSuSPFhfGk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Accounts payable and accrued expenses</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" contextRef="From2024-03-01to2025-02-28" id="Fact000591" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,397,007</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" contextRef="From2023-03-012024-02-29" id="Fact000592" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">531,367</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr id="xdx_40F_eus-gaap--IncreaseDecreaseInDeferredRevenue_i02_maNCPBUz5H1_z5tRmdkTRws1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Deferred revenue</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInDeferredRevenue" contextRef="From2024-03-01to2025-02-28" id="Fact000594" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">42,151</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInDeferredRevenue" contextRef="From2023-03-012024-02-29" id="Fact000595" format="ixt:numdotdecimal" decimals="0" unitRef="USD">102,954</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_i01T_mtNCPBUz5H1_maNCPBUz5Tw_z6aFEnmhMY8f" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Net cash used in operating activities from continuing operations</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" contextRef="From2024-03-01to2025-02-28" id="Fact000597" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">5,088,498</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" contextRef="From2023-03-012024-02-29" id="Fact000598" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">5,056,095</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr id="xdx_40D_eus-gaap--CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations_i01_maNCPBUz5Tw_zvDlAheBVdf8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Net cash provided (used) in operating activities from discontinued operations</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations" contextRef="From2024-03-01to2025-02-28" id="Fact000600" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8,344</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations" contextRef="From2023-03-012024-02-29" id="Fact000601" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">675,314</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_400_eus-gaap--NetCashProvidedByUsedInOperatingActivities_i01T_mtNCPBUz5Tw_maCCERCzqGy_zMJhem090lEc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Net cash used in operating activities</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2024-03-01to2025-02-28" id="Fact000603" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">5,080,154</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2023-03-012024-02-29" id="Fact000604" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">5,731,409</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--NetCashProvidedByUsedInInvestingActivitiesAbstract_iB_z1lJMOmWqVy8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Cash Flows from Investing activities:</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--PaymentsToAcquirePropertyPlantAndEquipment_i01N_di_msNCPBUz5Hq_zSEEN9A3eUMf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">Purchase of equipment</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0609">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="From2023-03-012024-02-29" id="Fact000610" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,253</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr id="xdx_404_eus-gaap--PaymentsForSoftware_i01N_di_msNCPBUz5Hq_zBdJfN64pmM7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Capitalized software development costs</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:PaymentsForSoftware" contextRef="From2024-03-01to2025-02-28" id="Fact000612" format="ixt:numdotdecimal" decimals="0" unitRef="USD">534,751</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:PaymentsForSoftware" contextRef="From2023-03-012024-02-29" id="Fact000613" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,016,175</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr id="xdx_400_eus-gaap--ProceedsFromSaleOfProductiveAssets_i01_maNCPBUz5Hq_z4ZahIqk0ll1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Sale of Sigma Additive Solutions, Inc. assets</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0615">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromSaleOfProductiveAssets" contextRef="From2023-03-012024-02-29" id="Fact000616" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,589,241</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_ecustom--InvestmentInEquityMethodInvestee_i01N_di_msNCPBUz5Hq_zdjQlRiBDg35" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Investment in equity method investee</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="NTRP:InvestmentInEquityMethodInvestee" contextRef="From2024-03-01to2025-02-28" id="Fact000618" format="ixt:numdotdecimal" decimals="0" unitRef="USD">500,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0619">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_ecustom--ProceedsFromAcquireBusinessesGross_i01N_di_msNCPBUz5Hq_zNqOqlX0MGl6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Reverse acquisition of Sigma Additive Solutions, Inc.</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0621">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="NTRP:ProceedsFromAcquireBusinessesGross" contextRef="From2023-03-012024-02-29" id="Fact000622" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">417,122</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--ProceedsFromSaleOfOtherProductiveAssets_i01_maNCPBUz5Hq_z8uUdLFBetx1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">Sale of assets</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromSaleOfOtherProductiveAssets" contextRef="From2024-03-01to2025-02-28" id="Fact000624" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0625">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--NetCashProvidedByUsedInInvestingActivities_i01T_mtNCPBUz5Hq_maCCERCzqGy_zQRenI3Z2jkk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Net cash provided (used) in investing activities</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="From2024-03-01to2025-02-28" id="Fact000627" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,033,751</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="From2023-03-012024-02-29" id="Fact000628" format="ixt:numdotdecimal" decimals="0" unitRef="USD">980,935</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--NetCashProvidedByUsedInFinancingActivitiesAbstract_iB_z28ZTc9zzwl9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Cash Flows from Financing Activities:</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--ProceedsFromNotesPayable_i01_maNCPBUzDrm_zUL0ZBCEk6R1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Notes payable</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromNotesPayable" contextRef="From2024-03-01to2025-02-28" id="Fact000633" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,967,224</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0634">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--ProceedsFromConvertibleDebt_i01_maNCPBUzDrm_z4MoNiE6wZKg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Issuance of convertible notes</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0636">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromConvertibleDebt" contextRef="From2023-03-012024-02-29" id="Fact000637" format="ixt:numdotdecimal" decimals="0" unitRef="USD">735,057</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--ProceedsFromIssuanceOfCommonStock_i01_maNCPBUzDrm_zVLiqLbLVayk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">Issuances of common shares</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0639">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfCommonStock" contextRef="From2023-03-012024-02-29" id="Fact000640" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,905,970</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--ProceedsFromIssuanceOfPreferredStockAndPreferenceStock_i01_maNCPBUzDrm_z5Fk0VPBPQS8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">Issuances of preferred shares</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" contextRef="From2024-03-01to2025-02-28" id="Fact000642" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,450,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" contextRef="From2023-03-012024-02-29" id="Fact000643" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,603,500</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--ProceedsFromIssuanceOfWarrants_i01_maNCPBUzDrm_zJW2ZsklbYd1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">Exercise of warrants</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfWarrants" contextRef="From2024-03-01to2025-02-28" id="Fact000645" format="ixt:numdotdecimal" decimals="0" unitRef="USD">316,994</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0646">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--ProceedsFromRelatedPartyDebt_i01_maNCPBUzDrm_zsB64aBJFAdd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Advances from related party, net</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromRelatedPartyDebt" contextRef="From2024-03-01to2025-02-28" id="Fact000648" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,118,249</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromRelatedPartyDebt" contextRef="From2023-03-012024-02-29" id="Fact000649" format="ixt:numdotdecimal" decimals="0" unitRef="USD">547,277</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--NetCashProvidedByUsedInFinancingActivities_i01T_mtNCPBUzDrm_maCCERCzqGy_zIySiflPBIZk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Net cash provided by financing activities</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="From2024-03-01to2025-02-28" id="Fact000651" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,852,467</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="From2023-03-012024-02-29" id="Fact000652" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,791,804</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_iT_pp0p0_mtCCERCzqGy_zuR6xtPj7Ggk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Increase in cash</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" contextRef="From2024-03-01to2025-02-28" id="Fact000654" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">738,562</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" contextRef="From2023-03-012024-02-29" id="Fact000655" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">41,330</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_iS_pp0p0_zNLi4c5EF323" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">Cash - beginning of the period</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="AsOf2024-02-29" id="Fact000657" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">323,805</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="AsOf2023-02-28" id="Fact000658" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">282,475</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_iE_pp0p0_zJx4LdlQzsze" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">Cash - end of the period</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="AsOf2025-02-28" id="Fact000660" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,062,367</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="AsOf2024-02-29" id="Fact000661" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">323,805</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--SupplementalCashFlowInformationAbstract_iB_zbqaR9JgjCYb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Supplemental cash flow information</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--InterestPaidNet_i01_zblXCvfzINg7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Cash paid for interest</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:InterestPaidNet" contextRef="From2024-03-01to2025-02-28" id="Fact000666" format="ixt:numdotdecimal" decimals="0" unitRef="USD">91,680</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:InterestPaidNet" contextRef="From2023-03-012024-02-29" id="Fact000667" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,381</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--IncomeTaxesPaidNet_i01_zfPR2X0d5C87" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Cash paid for taxes</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0669">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0670">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_iB_zlumpIiDKzf8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Non-Cash Financing Transactions</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_ecustom--IssuanceOfPreferredSharesForServices_i01_zsiU1QZz7Ede" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Issuance of preferred shares for services</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="NTRP:IssuanceOfPreferredSharesForServices" contextRef="From2024-03-01to2025-02-28" id="Fact000675" format="ixt:numdotdecimal" decimals="0" unitRef="USD">329,520</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="NTRP:IssuanceOfPreferredSharesForServices" contextRef="From2023-03-012024-02-29" id="Fact000676" format="ixt:numdotdecimal" decimals="0" unitRef="USD">569,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--IssuanceOfCommonSharesForServices_i01_zLX1ZvsIZanb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Issuance of common shares for services</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="NTRP:IssuanceOfCommonSharesForServices" contextRef="From2024-03-01to2025-02-28" id="Fact000678" format="ixt:numdotdecimal" decimals="0" unitRef="USD">706,870</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="NTRP:IssuanceOfCommonSharesForServices" contextRef="From2023-03-012024-02-29" id="Fact000679" format="ixt:numdotdecimal" decimals="0" unitRef="USD">13,106</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_ecustom--IssuanceOfCommonSharesAsCommitmentShares_i01_zP9vPoKB0Daa" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">Issuance of common shares as commitment shares</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="NTRP:IssuanceOfCommonSharesAsCommitmentShares" contextRef="From2024-03-01to2025-02-28" id="Fact000681" format="ixt:numdotdecimal" decimals="0" unitRef="USD">100,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0682">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_ecustom--IssuanceOfCommonWarrantsForServices_i01_ze3gldIfMeX2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Issuance of common warrants for services</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="NTRP:IssuanceOfCommonWarrantsForServices" contextRef="From2024-03-01to2025-02-28" id="Fact000684" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,371,072</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0685">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_ecustom--IssuanceOfCommonSharesForEquityInvestments_i01_zqwJBkKhfau9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Issuance of common shares for equity investments</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="NTRP:IssuanceOfCommonSharesForEquityInvestments" contextRef="From2024-03-01to2025-02-28" id="Fact000687" format="ixt:numdotdecimal" decimals="0" unitRef="USD">24,356</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0688">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_ecustom--IssuanceOfPreferredSharesForEquityInvestments_i01_zFDxkofR0xp8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Issuance of preferred shares for equity investments</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="NTRP:IssuanceOfPreferredSharesForEquityInvestments" contextRef="From2024-03-01to2025-02-28" id="Fact000690" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,915,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0691">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_ecustom--IssuanceOfPreferredSharesForPerpetualSoftwareLicense_i01_zXsx9FKgmPD6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Issuance of preferred shares for perpetual software license</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0693">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="NTRP:IssuanceOfPreferredSharesForPerpetualSoftwareLicense" contextRef="From2023-03-012024-02-29" id="Fact000694" format="ixt:numdotdecimal" decimals="0" unitRef="USD">362,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_ecustom--ConversionOfConvertibleNotes_i01_zcMC71JQhps5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Conversion of convertible notes</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0696">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="NTRP:ConversionOfConvertibleNotes" contextRef="From2023-03-012024-02-29" id="Fact000697" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,968,507</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_ecustom--PreferredStockDividends_i01_zv4wKTAFLOD2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Preferred stock dividends</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="NTRP:PreferredStockDividends" contextRef="From2024-03-01to2025-02-28" id="Fact000699" format="ixt:numdotdecimal" decimals="0" unitRef="USD">78,600</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="NTRP:PreferredStockDividends" contextRef="From2023-03-012024-02-29" id="Fact000700" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,125</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">See
accompanying notes to financial statements</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 82; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NEXTTRIP,
INC.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="f_006"></span>NOTES
TO THE CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FEBRUARY
28, 2025 AND FEBRUARY 29, 2024</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<ix:nonNumeric contextRef="From2024-03-01to2025-02-28" escape="true" id="Fact000702" name="us-gaap:SubstantialDoubtAboutGoingConcernTextBlock"><p id="xdx_800_eus-gaap--SubstantialDoubtAboutGoingConcernTextBlock_zN1FKlthmUk4" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
1 - <span id="xdx_828_z3J93tCm4t6c">Business Description and Going Concern</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sigma
Additive Solutions, Inc. (&#8220;Sigma&#8221;), the legal acquiror of NextTrip, was initially incorporated as Messidor Limited in Nevada
on December 23, 1985, and changed its name to Framewaves Inc. in 2001. On September 27, 2010, the name was changed to Sigma Labs, Inc.
On May 17, 2022, Sigma Labs, Inc. began doing business as Sigma Additive Solutions, and on August 9, 2022, changed its name to Sigma
Additive Solutions, Inc.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 11, 2024, Sigma filed a Certificate of Amendment to its Amended and Restated Articles of Incorporation, as amended to date, with
the Secretary of State of the State of Nevada, pursuant to which, effective as of 12:01 a.m. Pacific time on March 13, 2024, among other
things, Sigma&#8217;s corporate name was changed from Sigma Additive Solutions, Inc. to &#8220;NextTrip, Inc.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s corporate office is located at 3900 Paseo del Sol, Santa Fe NM 87507. The consolidated financial statements include
the accounts of the Company&#8217;s wholly owned subsidiaries, NextTrip Holdings Inc., incorporated on October 22, 2015, and
Extraordinary Vacations USA, Inc., incorporated on June 24, 2002.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prior
to the NextPlay Exchange Agreement, as described below, NextTrip Holdings, Inc. (&#8220;NTH&#8221;) was a wholly owned subsidiary of
NextTrip Group, LLC (&#8220;NTG&#8221;), which in turn, was a wholly owned subsidiary of NextPlay Technologies, Inc.
(&#8220;NextPlay&#8221;). All of the business operations of NTG were conducted through its subsidiaries. On January 25, 2023,
NextPlay and NTG entered into an Amended and Restated Separation Agreement, Amended and Restated Operating Agreement, and Exchange
Agreement (the &#8220;NextPlay Exchange Agreement&#8221;, whereby NextPlay transferred their interest in the travel business
to NTG. Pursuant to the NextPlay Exchange Agreement, NextPlay exchanged <span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230125__20230125__us-gaap--BusinessAcquisitionAxis__custom--NextPlayTechnologiesIncMember__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__us-gaap--StatementEquityComponentsAxis__custom--MembershipUnitsMember_zjos9diZi93h" title="Number of common stock issued"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2023-01-252023-01-25_custom_NextPlayTechnologiesIncMember_custom_ShareExchangeAgreementMember_custom_MembershipUnitsMember" id="Fact000704" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,000,000</ix:nonFraction></span>
Membership Units of NTG for <span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230125__20230125__us-gaap--BusinessAcquisitionAxis__custom--NextPlayTechnologiesIncMember__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__us-gaap--StatementEquityComponentsAxis__custom--PreferredUnitsMember_ztMgBBiMFbL4" title="Number of common stock issued"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2023-01-252023-01-25_custom_NextPlayTechnologiesIncMember_custom_ShareExchangeAgreementMember_custom_PreferredUnitsMember" id="Fact000706" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">400,000</ix:nonFraction></span>
Preferred Units of NTG, with a value of $<span id="xdx_905_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20230125__us-gaap--BusinessAcquisitionAxis__custom--NextPlayTechnologiesIncMember__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember_zELcOTaWmJIh" title="Share price per share"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2023-01-25_custom_NextPlayTechnologiesIncMember_custom_ShareExchangeAgreementMember" id="Fact000708" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">10</ix:nonFraction></span>
per unit. Prior to the exchange for Preferred Units, NTG had a payable due to NextPlay of $<span id="xdx_905_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pid_c20230125__20230125__us-gaap--BusinessAcquisitionAxis__custom--NextPlayTechnologiesIncMember__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__us-gaap--StatementEquityComponentsAxis__custom--PreferredUnitsMember_zI3yKNrROni" title="Number of common stock issued, value"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2023-01-252023-01-25_custom_NextPlayTechnologiesIncMember_custom_ShareExchangeAgreementMember_custom_PreferredUnitsMember" id="Fact000710" format="ixt:numdotdecimal" decimals="INF" unitRef="USD">17,295,873</ix:nonFraction></span>,
representing cash advances and payment of expenses by NextPlay on behalf of NTG, while NextPlay had obligations to provide ongoing
support to NTH. Such liability was settled by the issuance of the Preferred Units and the waiver of all of NextPlay&#8217;s
ongoing support obligations except for a $<span id="xdx_909_eus-gaap--Capital_iI_pn5n6_c20230125__us-gaap--BusinessAcquisitionAxis__custom--NextTripGroupLLCMember_zrZpt7552iM4" title="Contributed capital"><ix:nonFraction name="us-gaap:Capital" contextRef="AsOf2023-01-25_custom_NextTripGroupLLCMember" id="Fact000712" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">1.5</ix:nonFraction></span>
million advance remaining under a promissory note and, as such, NTH recorded the payable as contributed capital.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company provides travel technology solutions with sales originating in the United States, with a primary emphasis on hotels, air, and
all-inclusive travel packages. Our proprietary booking engine, branded as NextTrip 2.0, provides travel distributors access to a sizeable
inventory.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company owns <span id="xdx_908_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_dp_uPure_c20241130__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--NextInnovationLLCMember_zwBXrrGEDlol" title="Ownership percentage"><ix:nonFraction name="us-gaap:EquityMethodInvestmentOwnershipPercentage" contextRef="AsOf2024-11-30_custom_NextInnovationLLCMember" id="Fact000714" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">50</ix:nonFraction></span>%
of Next Innovation LLC, a Joint Venture (&#8220;Next Innovation&#8221;), which is dormant. No activities nor operations occurred
through Next Innovation in fiscal years 2024 or 2025 and the Company does not have control of Next Innovation and therefore no minority interest
was recorded.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Reverse
Acquisition</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 12, 2023, the Company (then known as Sigma) entered into a Share Exchange Agreement (as amended, the &#8220;Exchange
Agreement&#8221;) with NTH, NTG, and William Kerby (the &#8220;NextTrip Representative&#8221;). Under the terms of the Exchange
Agreement, the parties agreed that NTG would sell and transfer to the Company all of the issued and outstanding shares of NTH in
exchange for <span id="xdx_90E_eus-gaap--BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_pid_c20231012__20231012__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__us-gaap--BusinessAcquisitionAxis__custom--NextTripGroupLLCMember__us-gaap--StatementClassOfStockAxis__custom--ClosingSharesMember_z1dbqyxiBm58" title="Restricted shares issuable in reverse acquisition"><ix:nonFraction name="us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" contextRef="From2023-10-122023-10-12_custom_ShareExchangeAgreementMember_custom_NextTripGroupLLCMember_custom_ClosingSharesMember" id="Fact000716" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">156,007</ix:nonFraction></span>
restricted shares of Company common stock (the &#8220;Closing Shares&#8221;), issuable at closing, and the right to receive up to an
additional <span id="xdx_908_eus-gaap--BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_pid_c20231012__20231012__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__us-gaap--BusinessAcquisitionAxis__custom--NextTripGroupLLCMember__us-gaap--StatementClassOfStockAxis__custom--ContingentSharesMember_zFZ7ArmJ3rXl" title="Restricted shares issuable in reverse acquisition"><ix:nonFraction name="us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" contextRef="From2023-10-122023-10-12_custom_ShareExchangeAgreementMember_custom_NextTripGroupLLCMember_custom_ContingentSharesMember" id="Fact000718" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,843,993</ix:nonFraction></span>
restricted shares of Company common stock upon satisfaction of certain milestones set forth in the Exchange Agreement (the
&#8220;Contingent Shares,&#8221; and together with the Closing Shares, the &#8220;Restricted Shares&#8221;), which Restricted Shares
are issuable to the members of NTG, on a pro rata basis, under the terms of the Exchange Agreement, subject to certain closing
conditions (the &#8220;NextTrip Acquisition&#8221;). Upon the closing of the NextTrip Acquisition on December 29, 2023, NTH
became a wholly owned subsidiary of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Contingent Shares, together with the Closing Shares, will not exceed <span id="xdx_907_eus-gaap--BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_pid_c20231012__20231012__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__us-gaap--BusinessAcquisitionAxis__custom--NextTripGroupLLCMember__srt--RangeAxis__srt--MaximumMember_zUcGhlrNAGd9" title="Restricted shares issuable in reverse acquisition"><ix:nonFraction name="us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" contextRef="From2023-10-122023-10-12_custom_ShareExchangeAgreementMember_custom_NextTripGroupLLCMember_srt_MaximumMember" id="Fact000720" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,000,000</ix:nonFraction></span>
shares of Company common stock, or approximately <span id="xdx_90A_ecustom--PercentageForIssuedAndOutstandingCapitalStock_pid_dp_uPure_c20231012__20231012__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__us-gaap--BusinessAcquisitionAxis__custom--NextTripGroupLLCMember_zgpUt3q26oo1" title="Percentage for issued and outstanding capital stock"><ix:nonFraction name="NTRP:PercentageForIssuedAndOutstandingCapitalStock" contextRef="From2023-10-122023-10-12_custom_ShareExchangeAgreementMember_custom_NextTripGroupLLCMember" id="Fact000722" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">90.2</ix:nonFraction></span>%
of the issued and outstanding shares of Company common stock immediately prior to the closing. The NextTrip Acquisition will likely
result in a change of control, with the members of NTG receiving an aggregate number of shares that exceeds the number of shares
that held by the legacy shareholders of Sigma. As a result, the NextTrip Acquisition is accounted for as a reverse acquisition of
NTH by the Company, whereby the Company is treated as the legal acquirer and NTH is treated as the accounting acquirer. As a result,
the historical financial information for the periods prior to closing of the NextTrip Acquisition presented is that of
NTH.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 83; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
accordance with ASC <i>805</i>-<i>40</i>-<i>45</i>-<i>1,</i> the consolidated financial statements prepared following a reverse acquisition
are issued under the name of the legal parent (NextTrip, Inc., f/k/a Sigma Additive Solutions, Inc.) but described in the notes to the
financial statements as a continuation of the financial statements of the legal subsidiary (NTH), with <i>one</i> adjustment, which
is to retroactively adjust the accounting acquirer&#8217;s legal capital to reflect the legal capital of the accounting acquiree. That
adjustment is required to reflect the capital of the legal parent. Comparative information presented in the consolidated financial statements
also is retroactively adjusted to reflect the legal capital of the legal parent.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
ASC <i>805</i>-<i>40</i>-<i>45</i>-<i>2,</i> the consolidated financial statements represent the continuation of the legal subsidiary
except for the capital structure, as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    assets and liabilities of the legal subsidiary recognized and measured at their pre-combination carrying amounts;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    assets and liabilities of the legal parent recognized and measured in accordance with the guidance in this topic applicable to business
    combinations (ASC 805);</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    retained earnings and other equity balances of the legal subsidiary before the business combination;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    amount required to be recognized as issued equity interests in the consolidated financial statements determined by adding the issued
    equity interest of the legal subsidiary outstanding immediately before the business combination to the fair value of the legal parent
    determined in accordance with the guidance in ASC 805 applicable to business combinations. However, the equity structure reflects
    the equity structure of the legal parent, including the equity interests the legal parent issued to affect the combination. Accordingly,
    the equity structure of the legal subsidiary is restated using the exchange ratio established in the acquisition agreement to reflect
    the number of shares of the legal parent issued in the reverse acquisition.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
assets and liabilities of Sigma were recognized at fair value under ASC 805 as described in <b>NOTE 8 &#8211;
Goodwill</b>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Going
Concern</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of February 28, 2025, and February 29, 2024, the Company had an accumulated deficit of $<span id="xdx_90D_eus-gaap--RetainedEarningsAccumulatedDeficit_iNI_di_c20250228_zsUkhEI6Ady3" title="Accumulated deficit"><ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2025-02-28" id="Fact000724" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">34,349,823</ix:nonFraction></span> and $<span id="xdx_90F_eus-gaap--RetainedEarningsAccumulatedDeficit_iNI_di_c20240229_zUD6hNqCpqLc" title="Accumulated deficit"><ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2024-02-29" id="Fact000726" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">24,151,139</ix:nonFraction></span>, respectively, and
working capital deficit of $<span id="xdx_902_ecustom--WorkingCapitalDeficit_iI_c20250228_zg9XcvXLlAzd" title="Working capital deficit"><ix:nonFraction name="NTRP:WorkingCapitalDeficit" contextRef="AsOf2025-02-28" id="Fact000728" format="ixt:numdotdecimal" decimals="0" unitRef="USD">105,577</ix:nonFraction></span> and $<span id="xdx_90F_ecustom--WorkingCapitalDeficit_iI_c20240229_zf4PSoVY4I1j" title="Working capital deficit"><ix:nonFraction name="NTRP:WorkingCapitalDeficit" contextRef="AsOf2024-02-29" id="Fact000730" format="ixt:numdotdecimal" decimals="0" unitRef="USD">262,005</ix:nonFraction></span>, respectively, and has incurred losses since incorporation. The Company will need to
raise additional funds through equity or debt financings to support its on-going operations, increase market penetration of its products,
expand the marketing and development of its travel and technology driven products, provide capital expenditures for additional equipment
and development costs, payment obligations, and systems for managing the business including covering other operating costs until the
planned revenue streams are fully implemented and begin to offset the Company&#8217;s operating costs. In the event the Company is unable to raise adequate
funding in the future for its operations and to pay its outstanding debt obligations, the Company may be forced to scale back its business
plan and/or liquidate some or all of its assets or may be forced to seek bankruptcy protection.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
light of the foregoing, there is substantial doubt about the Company&#8217;s ability to continue as a going concern for 12 months from the date of the
filing of this Report.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-03-01to2025-02-28" escape="true" id="Fact000732" name="us-gaap:SignificantAccountingPoliciesTextBlock"><p id="xdx_806_eus-gaap--SignificantAccountingPoliciesTextBlock_z9EOl08QDmLe" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
2 &#8211; <span id="xdx_82D_zmWRpPg1HyL9">Summary of Significant Accounting Policies</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2024-03-01to2025-02-28" escape="true" id="Fact000734" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock"><p id="xdx_849_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zJ1BUaV0Gyzk" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86E_zh2Lg2wMOZjl">Basis
of Presentation and Principles of Consolidation</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying consolidated financial statements and related disclosures have been prepared pursuant to the rules and regulations of the
Securities and Exchange Commission (&#8220;SEC&#8221;). The Financial Statements have been prepared using the accrual basis of accounting
in accordance with Generally Accepted Accounting Principles (&#8220;GAAP&#8221;) of the United States.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
financial statements have been prepared on a consolidated basis with those of the Company&#8217;s wholly owned subsidiaries. All intercompany
transactions and balances have been eliminated in consolidation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-03-01to2025-02-28" escape="true" id="Fact000736" name="us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"><p id="xdx_849_eus-gaap--ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_zSHpdixYhZra" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86B_zRKXUvJqxDW9">Functional
and presentation currency</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
financial statements are presented in United States dollars (&#8220;USD&#8221;), which is the Company&#8217;s functional and reporting
currency. All financial information has been rounded to the nearest dollar except where otherwise indicated.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 84; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-03-01to2025-02-28" escape="true" id="Fact000738" name="us-gaap:UseOfEstimates"><p id="xdx_847_eus-gaap--UseOfEstimates_z92xxB7g9Hp6" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_868_zANkfF99EJc3">Use
of Estimates</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that
affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the consolidated
financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from
those estimates. These differences could have a material effect on the Company&#8217;s future results of operations and financial position.
Significant items subject to estimates and assumptions include the carrying amounts of intangible assets, depreciation and amortization.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Information
about key assumptions and estimation uncertainty that has a significant risk of resulting in a material adjustment to the carrying amounts
of the Company&#8217;s assets and liabilities within the next financial year are referenced in the notes to the financial statements
as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    assessment of the Company to continue as a going concern;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    assessment of the allowance on the related party promissory note receivable;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Estimates
    of purchase price allocation;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    measurement and useful life of intangible assets and property and equipment</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Estimates
    of fair value of equity instruments;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recoverability
    of long lived assets</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-03-01to2025-02-28" escape="true" id="Fact000740" name="us-gaap:EarningsPerSharePolicyTextBlock"><p id="xdx_84E_eus-gaap--EarningsPerSharePolicyTextBlock_z00E9Pa3SOu7" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86E_zssQN5TOOKRj">Loss
Per Share </span>&#8211; </b>The computation of loss per share is based on the weighted average number of shares outstanding during the period
in accordance with ASC Topic No. 260, &#8220;Earnings Per Share.&#8221; Shares underlying the Company&#8217;s outstanding warrants, options, preferred stock
or note conversion features were excluded due to the anti-dilutive effect they would have on the computation. At February 28, 2025 and
February 29, 2024, the Company had the following common shares underlying these instruments:</span></p>

<ix:nonNumeric contextRef="From2024-03-01to2025-02-28" escape="true" id="Fact000742" name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"><p id="xdx_892_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zvqrR8ZG98Q5" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B9_zfcl7inofrn9" style="display: none">Schedule of Anti-dilutive Securities Excluded
from Computation of Earnings Per Share</span></span></span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
  <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_490_20240301__20250228_zVHxnQOa9wwf" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">2025</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49B_20230301__20240229_zoPHw1J6jZFc" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">2024</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Year Ended February 28 and 29,</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">2025</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">2024</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zqkv5WKfeJ97" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 60%">Warrants</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2024-03-012025-02-28_us-gaap_WarrantMember" id="Fact000744" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,015,885</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2023-03-012024-02-29_us-gaap_WarrantMember" id="Fact000745" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">486,165</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--StockOptionMember_zAoWQGOKgK8b" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Stock Options</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2024-03-012025-02-28_us-gaap_StockOptionMember" id="Fact000747" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">76,342</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2023-03-012024-02-29_us-gaap_StockOptionMember" id="Fact000748" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">85,300</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--PreferredStockMember_zaluQv3R7uv5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Preferred Stock</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2024-03-012025-02-28_us-gaap_PreferredStockMember11842375" id="Fact000750" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,109,663</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2023-03-012024-02-29_us-gaap_PreferredStockMember11842375" id="Fact000751" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">475,835</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_z7EAhfi3Lt6d" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Total Underlying Common Shares</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2024-03-01to2025-02-28" id="Fact000753" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,201,890</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2023-03-012024-02-29" id="Fact000754" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,047,300</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A7_zrK2FIOrjfHj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-03-01to2025-02-28" escape="true" id="Fact000756" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock"><p id="xdx_84C_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zhjm7voHXbBg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86A_z9BMsv76wSO3">Cash
and Cash Equivalents</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash
consists of amounts denominated in USD. The Company has not experienced any losses on such accounts. The Company considers all
highly liquid investments with a maturity of three months or less when purchased to be cash equivalents. There were <span id="xdx_90B_eus-gaap--CashEquivalentsAtCarryingValue_iI_do_c20250228_zuNofbvNxerl" title="Cash equivalents"><span id="xdx_905_eus-gaap--CashEquivalentsAtCarryingValue_iI_do_c20240229_zQkXA1eQbURh" title="Cash equivalents"><ix:nonFraction name="us-gaap:CashEquivalentsAtCarryingValue" contextRef="AsOf2025-02-28" id="Fact000758" format="ixt-sec:numwordsen" decimals="0" unitRef="USD"><ix:nonFraction name="us-gaap:CashEquivalentsAtCarryingValue" contextRef="AsOf2024-02-29" id="Fact000760" format="ixt-sec:numwordsen" decimals="0" unitRef="USD">no</ix:nonFraction></ix:nonFraction></span></span> cash equivalents
as of February 28, 2025, or February 29, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-03-01to2025-02-28" escape="true" id="Fact000762" name="NTRP:PrepaidsPolicyTextBlock"><p id="xdx_840_ecustom--PrepaidsPolicyTextBlock_zwgSrGb0Idxj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_865_zDatv27VkZte">Prepaids</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company records cash paid in advance for goods and/or services to be received in the future as prepaid expenses. Prepaid expenses are
expensed over time according to the terms of the purchase. Other current assets are recognized when it is probable that the future economic
benefits will flow to the Company and the asset has a cost or value that can be measured reliably. It is then charged to expense over
the expected number of periods during which economic benefits will be realized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-03-01to2025-02-28" escape="true" id="Fact000764" name="us-gaap:TradeAndOtherAccountsReceivablePolicy"><p id="xdx_849_eus-gaap--TradeAndOtherAccountsReceivablePolicy_zqPgfmpOk2Yi" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_867_zSrcewP8Ripj">Accounts
Receivable</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trade
accounts receivable are recorded at the invoiced amount and do not bear interest. The allowance for credit losses is the Company&#8217;s
best estimate of the amount of probable losses in its existing accounts receivable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company considers accounts receivable to be fully collectible; accordingly, no allowance for credit losses is required. If amounts
become uncollectible, they will be charged to operations when that determination is made.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trade
accounts receivable balances as of February 28, 2025 and February 29, 2024, were $<span id="xdx_909_eus-gaap--AccountsReceivableNet_iI_c20250228_zUbjy98GiaXl" title="Accounts receivable"><ix:nonFraction name="us-gaap:AccountsReceivableNet" contextRef="AsOf2025-02-28" id="Fact000766" format="ixt:numdotdecimal" decimals="0" unitRef="USD">22,567</ix:nonFraction></span> and $<span id="xdx_900_eus-gaap--AccountsReceivableNet_iI_c20240229_zcmT867FEce8" title="Accounts receivable"><ix:nonFraction name="us-gaap:AccountsReceivableNet" contextRef="AsOf2024-02-29" id="Fact000768" format="ixt:numdotdecimal" decimals="0" unitRef="USD">34,092</ix:nonFraction></span>, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 85; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-03-01to2025-02-28" escape="true" id="Fact000770" name="us-gaap:EquityMethodInvestmentsPolicy"><p id="xdx_841_eus-gaap--EquityMethodInvestmentsPolicy_zabWDYnrzqte" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_863_zrlX5qfCtnlc">Investments
in Equity Method Investees</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company holds investments in certain entities that are accounted for under the equity method of accounting, as well as investments that
are accounted for under the fair value method pursuant to ASC 321, &#8220;Investments - Equity Securities.&#8221; Under the equity method,
investments in entities in which the Company has significant influence, but not control, are initially recognized at cost and adjusted
thereafter to recognize the Company&#8217;s share of the investees&#8217; earnings or losses and other comprehensive income.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company determines the existence of significant influence based on various factors, including representation on the investees&#8217;
board of directors, participation in policy-making processes, and material intercompany transactions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s equity method investments are evaluated periodically for impairment by assessing whether events or changes in circumstances
indicate that the carrying value of the investment may not be recoverable. When such indicators exist, the Company performs an impairment
test and recognizes an impairment loss to the extent that the carrying amount of the investment exceeds its fair value.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Distributions
received from equity method investees that exceed cumulative earnings recognized by the Company are considered a return of investment
and are recorded as a reduction in the carrying amount of the investment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Adjustments
resulting from changes in the Company&#8217;s ownership interest in equity method investees that do not result in a loss of significant
influence are accounted for prospectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-03-01to2025-02-28" escape="true" id="Fact000772" name="NTRP:BasisDifferencePolicyTextBlock"><p id="xdx_84F_ecustom--BasisDifferencePolicyTextBlock_zIre3wqhViVg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_862_zKhnwIT74bZ1">Basis
Difference</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
accordance with ASC 323, &#8220;Investments - Equity Method and Joint Ventures,&#8221; the Company records a basis difference when the
carrying value of its equity method investment differs from its share of the investee&#8217;s fair value of net assets at the acquisition
date. This basis difference is allocated to the investee&#8217;s identifiable assets and liabilities based on their fair values. The
amortization of any basis difference related to depreciable assets, such as property, plant, and equipment, is recognized in the Company&#8217;s
share of the investee&#8217;s earnings or losses. Any basis difference related to non-depreciable assets, including goodwill, is generally
not amortized, but is subject to impairment testing as necessary.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company assesses the impact of any basis differences on its earnings and the carrying value of its equity method investments. If a basis
difference is determined to exist, the appropriate adjustments are made to reflect the amortization of such differences in the consolidated
financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-03-01to2025-02-28" escape="true" id="Fact000774" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValuePolicyTextBlock"><p id="xdx_84B_eus-gaap--EquitySecuritiesWithoutReadilyDeterminableFairValuePolicyTextBlock_z70CbGD2sAsc" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_865_ziedsQLI2no4">Investments
in Equity Securities without Readily Determinable Fair Value</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
accordance with ASC 321-10-35-2, the Company holds certain investments in equity securities in which the Company does not have significant
influence or control, and for which fair value is not readily determinable. These investments are primarily accounted for at cost, less
any impairment. The carrying amount is periodically evaluated for impairment, and if necessary, an impairment loss is recognized in the
statement of operations. These investments are not adjusted for unrealized gains or losses unless an impairment is identified.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-03-01to2025-02-28" escape="true" id="Fact000776" name="us-gaap:EquityMethodInvestmentsIssuancesPolicy"><p id="xdx_84C_eus-gaap--EquityMethodInvestmentsIssuancesPolicy_zWGPIxaV2yFe" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_868_zE55pMyDrGlg">Equity
in Earnings of Equity Method Investees</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s share of earnings or losses from equity method investees is recognized in the consolidated statement of operations within
&#8220;Equity in share of loss of equity method investees,&#8221; net of any related income taxes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-03-01to2025-02-28" escape="true" id="Fact000778" name="us-gaap:FairValueMeasurementPolicyPolicyTextBlock"><p id="xdx_843_eus-gaap--FairValueMeasurementPolicyPolicyTextBlock_zPNgWiw9RGQh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_869_zAp1boL6zgRj">Fair
Value Measurements</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fair value of equity method investments is disclosed when available and practical to determine. However, for investments that are not
readily marketable, such as non-public entities, fair value is not typically recognized in the financial statements unless the investment
is impaired.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 86; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-03-01to2025-02-28" escape="true" id="Fact000780" name="NTRP:PromissoryNoteReceivablePolicyTextBlock"><p id="xdx_84C_ecustom--PromissoryNoteReceivablePolicyTextBlock_zpvsQAIGfJNc" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Promissory
Note Receivable</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Receivables
from NextPlay under the promissory note as described in <b>NOTE 1 &#8211; Business Description and Going Concern</b> were $<span id="xdx_903_eus-gaap--AccountsReceivableNet_iI_c20250228__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--NextPlayTechnologiesIncMember_z1qGJcY8kUE" title="Accounts receivable"><ix:nonFraction name="us-gaap:AccountsReceivableNet" contextRef="AsOf2025-02-28_custom_NextPlayTechnologiesIncMember" id="Fact000782" format="ixt:numdotdecimal" decimals="0" unitRef="USD">0</ix:nonFraction></span> and $<span id="xdx_903_eus-gaap--AccountsReceivableNet_iI_c20240229__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--NextPlayTechnologiesIncMember_zoFhIZVRI9Ab" title="Accounts receivable"><ix:nonFraction name="us-gaap:AccountsReceivableNet" contextRef="AsOf2024-02-29_custom_NextPlayTechnologiesIncMember" id="Fact000784" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,000,000</ix:nonFraction></span>
at February 28, 2025 and February 29, 2024, respectively. Pursuant to the terms of the Promissory Note (the &#8220;NextPlay Note&#8221;)
between NTH and NextPlay, the NextPlay Note was due and payable in full on the earlier of September 1, 2023 or the date the Company
completed a financing of $<span id="xdx_90E_eus-gaap--NotesPayable_iI_pn6n6_c20230925__us-gaap--BusinessAcquisitionAxis__custom--NextPlayTechnologiesIncMember_zGhg2DJpWydb" title="Notes payable"><ix:nonFraction name="us-gaap:NotesPayable" contextRef="AsOf2023-09-25_custom_NextPlayTechnologiesIncMember" id="Fact000786" format="ixt:numdotdecimal" decimals="-6" scale="6" unitRef="USD">10</ix:nonFraction></span> million or more. No payments have been made by NextPlay, and as such NextPlay is in default under the terms
of the NextPlay Note.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 27, 2025, as creditors of NextPlay, Donald P. Monaco, the Company&#8217;s Chairman, William Kerby, the Company&#8217;s Chief
Executive Officer, and Ian Sharpe, the Chief Operating Officer of the Company&#8217;s Media division, filed a petition to force NextPlay
into involuntary bankruptcy as a result of unpaid fees. The proceedings are ongoing and the outcome at this time is uncertain and cannot
be predicted. As a result, management has determined that the collectability of the NextPlay Note is uncertain and has therefore established
an allowance for doubtful accounts for the entire balance of $<span id="xdx_902_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iI_c20250127__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--NextPlayTechnologiesIncMember_z2SRuRsyeQXk" title="Allowance for doubtful accounts"><ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivable" contextRef="AsOf2025-01-27_custom_NextPlayTechnologiesIncMember" id="Fact000788" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,567,665</ix:nonFraction></span>. Of this amount, $<span id="xdx_908_ecustom--LossOnRelatedPartyReceivable_c20240301__20250228_z7jiBGEHH9Uc" title="Loss on promissory note receivable"><ix:nonFraction name="NTRP:LossOnRelatedPartyReceivable" contextRef="From2024-03-01to2025-02-28" id="Fact000790" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,000,000</ix:nonFraction></span> was recorded as of February 28, 2025,
and $<span id="xdx_900_ecustom--LossOnRelatedPartyReceivable_c20230301__20240229_zmIVjrNPV9Lb" title="Loss on promissory note receivable"><ix:nonFraction name="NTRP:LossOnRelatedPartyReceivable" contextRef="From2023-03-012024-02-29" id="Fact000792" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,567,665</ix:nonFraction></span> was recorded as of February 29, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-03-01to2025-02-28" escape="true" id="Fact000794" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock"><p id="xdx_84A_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_z8czT4zfswHh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86F_z6yCU0h8ggla">Property
and Equipment</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Recognition
and measurement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Items
of property and equipment are measured at cost, less accumulated depreciation and accumulated impairment losses. When parts of an item
of property and equipment have different estimated useful lives, they are accounted for as separate items within property and equipment.
The costs of the ongoing regular repairs and maintenance of property and equipment are recognized in the period in which they are incurred.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Depreciation</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation
is recognized in profit or loss over the estimated useful lives of each part of an item of property and equipment in a manner that most
closely reflects management&#8217;s estimated future consumption of the future economic benefits embodied in the asset. The estimated
useful lives for the Company&#8217;s property and equipment are as follows:</span></p>

<ix:nonNumeric contextRef="From2024-03-01to2025-02-28" escape="true" id="Fact000796" name="NTRP:ScheduleOfEstimatedUsefulLivesForPropertyAndEquipmentTableTextBlock"><p id="xdx_89A_ecustom--ScheduleOfEstimatedUsefulLivesForPropertyAndEquipmentTableTextBlock_z5CB4ZAtqjM7" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span style="display: none"><span id="xdx_8BB_zz2yIF2XvmHl">Schedule
of Estimated
Useful Lives for Property and Equipment</span></span></span></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Category</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Method</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Estimated
    useful life</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furniture
    &amp; Fixtures</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Straight
    line</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20250228__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zvTl2fGZ8Eof" title="Estimated useful life"><ix:nonNumeric contextRef="AsOf2025-02-28_us-gaap_FurnitureAndFixturesMember" format="ixt-sec:duryear" id="Fact000798" name="us-gaap:PropertyPlantAndEquipmentUsefulLife">5</ix:nonNumeric></span>
    years</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Computer
    &amp; Equipment</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Straight
    line</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20250228__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_zUaXzpeVFOQf" title="Estimated useful life"><ix:nonNumeric contextRef="AsOf2025-02-28_us-gaap_ComputerEquipmentMember" format="ixt-sec:duryear" id="Fact000800" name="us-gaap:PropertyPlantAndEquipmentUsefulLife">3</ix:nonNumeric></span>
    years</span></td></tr>
  </table>
</ix:nonNumeric><p id="xdx_8A6_zYReKKJGarnl" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-03-01to2025-02-28" escape="true" id="Fact000802" name="us-gaap:IntangibleAssetsFiniteLivedPolicy"><p id="xdx_84F_eus-gaap--IntangibleAssetsFiniteLivedPolicy_zDoeSolb4H5g" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86D_z5mvFUmsmmdh">Intangible
assets</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company measures separately acquired intangible assets at cost, less accumulated amortization and impairment losses. The Company recognizes
internally developed intangible assets when it has determined that the completion of such is technically feasible, and the Company has
sufficient resources to complete the development. Subsequent expenditures are capitalized when they increase the future economic benefits
of the associated asset. All other expenditures are recorded in profit or loss as incurred.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company assesses whether the life of intangible asset is finite or indefinite. The Company reviews the amortization method and period
of use of its intangible assets at least annually. Changes in the expected useful life or period of consumption of future economic benefits
associated with the asset are accounted for prospectively by changing the amortization method or period as a change in accounting estimates
in profit or loss. The Company has assessed the useful life of its trademarks as indefinite.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2024-03-01to2025-02-28" escape="true" id="Fact000804" name="NTRP:ScheduleOfEstimatedUsefulLivesForFiniteLifeIntangibleAssetsTableTextBlock"><p id="xdx_891_ecustom--ScheduleOfEstimatedUsefulLivesForFiniteLifeIntangibleAssetsTableTextBlock_zX9Gyyi62dK9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
estimated useful lives for the Company&#8217;s finite life intangible assets are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B8_zqdpJQVrfANf" style="display: none">Schedule
of Estimated
Useful Lives for Finite Life Intangible Assets</span></span></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Category</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Method</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Estimated
    useful life</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Software</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Straight
    line</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20250228__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SoftwareMember__srt--RangeAxis__srt--MinimumMember_zAPO9167w9ai" title="Estimated useful life"><ix:nonNumeric contextRef="AsOf2025-02-28_custom_SoftwareMember_srt_MinimumMember" format="ixt-sec:duryear" id="Fact000806" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife">1</ix:nonNumeric></span>
    - <span id="xdx_909_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20250228__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SoftwareMember__srt--RangeAxis__srt--MaximumMember_zv66dkLsEoxe" title="Estimated useful life"><ix:nonNumeric contextRef="AsOf2025-02-28_custom_SoftwareMember_srt_MaximumMember" format="ixt-sec:duryear" id="Fact000808" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife">3</ix:nonNumeric></span> years</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Software
    licenses</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Straight
    line</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20250228__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SoftwareLicensesMember__srt--RangeAxis__srt--MinimumMember_zfNu07ETVGUi" title="Estimated useful life"><ix:nonNumeric contextRef="AsOf2025-02-28_custom_SoftwareLicensesMember_srt_MinimumMember" format="ixt-sec:duryear" id="Fact000810" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife">0.5</ix:nonNumeric></span>
    - <span id="xdx_902_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20250228__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SoftwareLicensesMember__srt--RangeAxis__srt--MaximumMember_zPU8KANFDz6l" title="Estimated useful life"><ix:nonNumeric contextRef="AsOf2025-02-28_custom_SoftwareLicensesMember_srt_MaximumMember" format="ixt-sec:duryear" id="Fact000812" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife">4</ix:nonNumeric></span> years</span></td></tr>
  </table>
</ix:nonNumeric><p id="xdx_8AA_zrmr4KOowcch" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>


<ix:exclude><!-- Field: Page; Sequence: 87; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-03-01to2025-02-28" escape="true" id="Fact000814" name="us-gaap:InternalUseSoftwarePolicy"><p id="xdx_84F_eus-gaap--InternalUseSoftwarePolicy_zPKn11aVP3Sg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_864_zS1UUutOsNbd">Software
Development Costs</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company capitalizes internal software development costs subsequent to establishing technological feasibility of a software application
in accordance with guidelines established by &#8220;ASC 985-20-25&#8221; Accounting for the Costs of Software to Be Sold, Leased, or
Otherwise Marketed, requiring certain software development costs to be capitalized upon the establishment of technological feasibility.
The establishment of technological feasibility and the ongoing assessment of the recoverability of these costs require considerable judgment
by management with respect to certain external factors such as anticipated future revenue, estimated economic life, and changes in software
and hardware technologies. Amortization of the capitalized software development costs begins when the product is available for general
release to customers. Capitalized costs are amortized based on the straight-line method over the remaining estimated economic life of
the product.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-03-01to2025-02-28" escape="true" id="Fact000816" name="us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsPolicy"><p id="xdx_849_eus-gaap--GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_z6Yc1kBv10E4" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_863_zmgLD6BsuqJk">Impairment
of Intangible Assets</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
accordance with ASC 350-30-65 &#8220;Goodwill and Other Intangible Assets&#8221;, the Company assesses the impairment of identifiable
intangible assets whenever events or changes in circumstances indicate that the carrying value may not be recoverable. Factors the Company
considers important, which could trigger an impairment review include the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.
Significant underperformance compared to historical or projected future operating results.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.
Significant changes in the manner or use of the acquired assets or the strategy for the overall business, and</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.
Significant negative industry or economic trends.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">When
the Company determines that the carrying value of an intangible asset may not be recoverable based upon the existence of one or more
of the above indicators of impairment and the carrying value of the asset cannot be recovered from projected undiscounted cash flows,
the Company records an impairment charge. The Company measures any impairment based on a projected discounted cash flow method using
a discount rate determined by management to be commensurate with the risk inherent to the current business model. Significant management
judgment is required in determining whether an indicator of impairment exists and in projecting cash flows. Intangible assets that have
finite useful lives are amortized over their useful lives.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-03-01to2025-02-28" escape="true" id="Fact000818" name="us-gaap:LesseeLeasesPolicyTextBlock"><p id="xdx_84F_eus-gaap--LesseeLeasesPolicyTextBlock_zCLGhnMfxjwa" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86A_zflz7TQmjQ8k">Leases</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company adopted ASU 2016-02 (Topic ASC 842) Leases, which requires a lessee to recognize a lease asset and a leases liability for operating
leases arrangements greater than twelve (12) months.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
determine if an arrangement is a lease at inception. Operating leases are included in operating lease right-of-use (&#8220;ROU&#8221;)
assets, operating lease liabilities - current, and operating lease liabilities - noncurrent on the balance sheets.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ROU
assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease
payments arising from the lease. Operating lease ROU assets and liabilities are recognized at commencement date based on the present
value of lease payments over the lease term. As most of our leases do not provide an implicit rate, we generally use our incremental
borrowing rate based on the estimated rate of interest for collateralized borrowing over a similar term of the lease payments at commencement
date. The operating lease ROU asset also includes any lease payments made and excludes lease incentives. Our lease terms may include
options to extend or terminate the lease when it is reasonably certain that we will exercise that option. Lease expense for lease payments
is recognized on a straight-line basis over the lease term.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-03-01to2025-02-28" escape="true" id="Fact000820" name="us-gaap:PriorPeriodReclassificationAdjustmentDescription"><p id="xdx_845_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zs0xXffHlI4j" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_861_zQFg4hltGIxf">Reclassification</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
prior year amounts have been reclassified to conform to the current period presentation. These reclassifications had no impact on the
net earnings (loss) or financial position.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-03-01to2025-02-28" escape="true" id="Fact000822" name="us-gaap:FairValueOfFinancialInstrumentsPolicy"><p id="xdx_84C_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zYUEOLk4dVve" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_868_zgeN1xwJDHX">Fair
Value of Financial Instruments</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company follows accounting guidelines on fair value measurements for financial instruments measured on a recurring basis, as well as
for certain assets and liabilities that are initially recorded at their estimated fair values. Fair Value is defined as the exit price,
or the amount that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants
as the measurement date. The Company uses the following three-level hierarchy that maximizes the use of observable inputs and minimizes
the use of unobservable inputs to value its financial instruments:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    1: Observable inputs such as unadjusted quoted prices in active markets for identical instruments.</span></td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<ix:exclude><!-- Field: Page; Sequence: 88; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    2: Quoted prices for similar instruments that are directly or indirectly observable in the marketplace.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    3: Significant unobservable inputs which are supported by little or no market activity and that are financial instruments whose values
    are determined using pricing models, discounted cash flow methodologies, or similar techniques, as well as instruments for which
    the determination of fair value requires a significant judgment or estimation.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
instruments measured at fair value are classified in their entirety based on the lowest level of input that is significant to the fair
value measurement. The Company&#8217;s assessment of the significance of a particular input to the fair value measurement in its entirety
requires it to make judgments and consider factors specific to the asset or liability. The use of different assumptions and/or estimation
methodologies may have a material effect on estimated fair values. Accordingly, the fair value estimates disclosed, or initial amounts
recorded may not be indicative of the amount that the Company or holders of the instruments could realize in a current market exchange.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
carrying amounts of the Company&#8217;s financial instruments including cash, accounts receivable, accounts payable, accrued expenses,
convertible notes and notes payable are of approximately fair value due to the short-term maturities of these instruments.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-03-01to2025-02-28" escape="true" id="Fact000824" name="us-gaap:MarketRiskBenefitPolicyTextBlock"><p id="xdx_848_eus-gaap--MarketRiskBenefitPolicyTextBlock_zmy8rbwcLTdf" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_868_zxjb70IvPBf5">Concentration
of Credit Risk </span>-</b> The Company maintains its cash in bank deposit accounts, which, at times, may exceed federally insured limits. The
Company has not experienced any losses in such accounts and believes it is not exposed to any significant credit risk on its cash and
cash equivalents.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-03-01to2025-02-28" escape="true" id="Fact000826" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy"><p id="xdx_849_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_z3Mq8xR32Ov9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: -0.9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86A_zGMWX7TRgG6f">Stock
Based Compensation</span></b> &#8211; The Company recognizes compensation costs to employees under ASC Topic No. 718, &#8220;Compensation &#8211;
Stock Compensation.&#8221; Under ASC Topic No. 718, companies are required to measure the compensation costs of share-based compensation
arrangements based on the grant-date fair value and recognize the costs in the financial statements over the period during which employees
are required to provide services. Share based compensation arrangements may include stock options, grants of shares of common stock with
and without restrictions, performance-based awards, share appreciation rights and employee share purchase plans. As such, compensation
cost is measured on the date of grant at its fair value. Such compensation amounts, if any, are amortized over the respective vesting
periods of the option or stock grants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: -0.9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equity
instruments issued to non-employees are recorded on the basis of the fair value of the instruments, as required by ASC Topic No. 718.
In general, the measurement date is either (a) when a performance commitment, as defined, is reached or (b) the earlier of the date that
(i) the non-employee performance requirement is complete or (ii) the instruments are vested. The measured value related to the instruments
is recognized over a period based on the facts and circumstances of each particular grant as defined in the FASB Accounting Standards
Codification.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-03-01to2025-02-28" escape="true" id="Fact000828" name="us-gaap:RevenueFromContractWithCustomerPolicyTextBlock"><p id="xdx_844_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_zrdm3uMmNHhg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86E_z1a64sRD73ic">Revenue
Recognition</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recognizes revenue in accordance with ASC Topic No. 606. In May 2014, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued
Accounting Standards Update (&#8220;ASU&#8221;) No. 2014-09, <i>Revenue from Contracts with Customers</i>. ASU 2014-09 is a comprehensive revenue recognition
standard that superseded nearly all existing revenue recognition guidance under prior GAAP and replaced it with a principles-based
approach for determining revenue recognition. The core principle of the standard is the recognition of revenue upon the transfer of promised
goods or services to customers in an amount that reflects the consideration to which the company expects to be entitled in exchange for
those goods or services. In general, we determine revenue recognition by: (1) identifying the contract, or contracts, with our customer;
(2) identifying the performance obligations in the contract; (3) determining the transaction price; (4) allocating the transaction price
to performance obligations in the contract; and (5) recognizing revenue when, or as, we satisfy performance obligations by transferring
the promised goods or services.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recognizes revenue when the customer has purchased the product, the occurrence of the earlier of date of travel and the date of
cancellation has expired, as satisfaction of the performance obligation, the sales price is fixed or determinable and collectability
is reasonably assured. Revenue for customer travel packages purchased directly from the Company are recorded gross (the amount paid to
the Company by the customer is shown as revenue and the cost of providing the respective travel package is recorded to cost of revenues).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company generates revenues from sales directly to customers as well as through other distribution channels of tours and activities at
destinations throughout the world.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 89; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company controls the specified travel product before it is transferred to the customer and is therefore a principal, based on but not
limited to, the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Company is primarily responsible for fulling the promise to provide such travel product.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Company has inventory risk before the specified travel product has been transferred to a customer or after transfer of control to
    a customer.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Company has discretion in establishing the price for the specified travel product.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Payments
for tours or activities received in advance of services being rendered are recorded as deferred revenue and recognized as revenue at
the earlier of the date of travel or the last date of cancellation (i.e., the customer&#8217;s refund privileges lapse).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-03-01to2025-02-28" escape="true" id="Fact000830" name="us-gaap:SellingGeneralAndAdministrativeExpensesPolicyTextBlock"><p id="xdx_84D_eus-gaap--SellingGeneralAndAdministrativeExpensesPolicyTextBlock_zJTtpSias568" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86F_zQ3fcJCgU2ec">Sales
and Marketing</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Selling
and marketing expenses consist primarily of marketing and promotional expenses, expenses related to our participation in industry
conferences, and public relations expenses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sales
and marketing expenses are charged to expense as incurred and are included in selling and promotions expenses in the accompanying consolidated
financial statements. Sales and marketing expense for the years ended February 28, 2025 and February 29, 2024 was $<span id="xdx_907_eus-gaap--SellingAndMarketingExpense_c20240301__20250228_z6vgQuzeHCol" title="Sales and marketing expense"><ix:nonFraction name="us-gaap:SellingAndMarketingExpense" contextRef="From2024-03-01to2025-02-28" id="Fact000832" format="ixt:numdotdecimal" decimals="0" unitRef="USD">307,166</ix:nonFraction></span> and $<span id="xdx_905_eus-gaap--SellingAndMarketingExpense_c20230301__20240229_z4jYH9fDJYtb" title="Sales and marketing expense"><ix:nonFraction name="us-gaap:SellingAndMarketingExpense" contextRef="From2023-03-012024-02-29" id="Fact000834" format="ixt:numdotdecimal" decimals="0" unitRef="USD">484,250</ix:nonFraction></span>,
respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-03-01to2025-02-28" escape="true" id="Fact000836" name="us-gaap:IncomeTaxPolicyTextBlock"><p id="xdx_84B_eus-gaap--IncomeTaxPolicyTextBlock_zgwGOWd6ekvk" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86E_zNUHheJDSJmc">Income
Taxes</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for income taxes in accordance with ASC Topic No. 740, &#8220;Accounting for Income Taxes.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Income
taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences
attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective
tax bases and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected
to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred
tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. A valuation
allowance on deferred tax assets is established when management considers it is more likely than not that some portion or all of the
deferred tax assets will not be realized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tax
benefits from an uncertain tax position are only recognized if it is more likely than not that the tax position will be sustained on
examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in the consolidated
financial statements from such a position are measured based on the largest benefit that has a greater than fifty percent likelihood
of being realized upon ultimate resolution. Interest and penalties related to unrecognized tax benefits are recorded as incurred as a
component of income tax expense. The Company has not recognized any tax benefits from uncertain tax positions for any of the reporting
periods presented.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company had no tax positions at February 28, 2025 or 2024 for which the ultimate deductibility was highly uncertain but for which there
was uncertainty about the timing of such deductibility.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recognizes interest accrued related to unrecognized tax benefits in interest expense and penalties in operating expenses.
During the years ended February 28, 2025 and February 29, 2024, the Company recognized no interest and penalties. All tax returns
for years starting with 2021 and thereafter remain open for examination by the IRS.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-03-01to2025-02-28" escape="true" id="Fact000838" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock"><p id="xdx_849_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zAjDLPXRefc6" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86D_zo0lewsivXQl">Recently
adopted accounting pronouncements</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
July 2023, the FASB issued ASU 2023-03, Presentation of Financial Statements (Topic 205), Income Statement&#8212;Reporting Comprehensive
Income (Topic 220), Distinguishing Liabilities from Equity (Topic 480), Equity (Topic 505), and Compensation&#8212;Stock Compensation
(Topic 718). The FASB Issued this ASU to amend and align various SEC paragraphs within the Codification with interpretive guidance recently
issued by the Securities and Exchange Commission (SEC). Specifically, this update codifies the guidance from SEC Staff Accounting Bulletin
(SAB) No. 120, which clarifies the application of ASC 718 &#8211; Compensation&#8212;Stock Compensation to certain share-based payment
arrangements. SAB No. 120 was issued in response to concerns about so-called &#8220;spring-loaded&#8221; awards &#8212; share-based compensation
arrangements granted shortly before the release of material nonpublic information (MNPI) that is expected to significantly affect the
market price of the issuer&#8217;s stock. SAB No. 120 does not change the fundamental measurement principles of ASC 718, but it emphasizes
the requirement to include the impact of MNPI in estimating fair value at the grant date when it is reasonable to expect that such information
would be factored into the pricing by a market participant. Under ASC 718, entities must measure the grant-date fair value of equity-classified
awards using an option-pricing model and inputs that reflect assumptions a market participant would make. SAB No. 120 reinforces that
this includes: (i) adjusting expected volatility or stock price to reflect the anticipated impact of MNPI; (ii) documenting the rationale
for assumptions that do not reflect such information, if applicable; and (3) ensuring internal control processes capture relevant information
in determining grant-date fair value. The Company adopted ASU 2023-03 effective January 1, 2024. In conjunction with this adoption, the
Company reviewed its stock compensation grant practices and valuation procedures under ASC 718. While the Company has not historically
granted awards in close proximity to the release of MNPI, it has updated its internal controls to require additional documentation and
review for any future awards that may be subject to this scenario. The adoption of ASU 2023-03 did not result in any changes to the recognition
or measurement of share-based payment expense in the Company&#8217;s consolidated financial statements. However, the Company enhanced
its internal controls around the timing and valuation of equity awards to ensure compliance with the interpretive guidance of SAB No.
120 and ASC 718.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 90; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
November 2023, the FASB issued ASU 2023-07 to improve disclosures about a public entity&#8217;s reportable segments and address investor
feedback for greater transparency. The amendments are intended to enhance the usefulness of segment information, particularly regarding
expenses, by requiring more detailed disclosures and expanding the scope of interim disclosures. The Company adopted ASU 2023-07 for
its fiscal year beginning March 1, 2024 (i.e., for the fiscal year ending February 28, 2025), as required. The amendments require entities
to disclose, on an annual and interim basis: (i) significant segment expenses that are regularly provided to the chief operating decision
maker (&#8220;CODM&#8221;); (ii) an explanation of how reported segment profit or loss is measured, (ii) The title and position of the CODM; (iii)
a description of how the CODM uses reported measures in decision-making; and (iv) expanded disclosures of segment information in interim
periods, consistent with annual disclosures.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
manage the Company as one reportable segment, Travel Products and Services. Travel bookings are the source of our revenues and include
the sale of travel products such as airline tickets and hotel rooms as well as travel services such as travel insurance and ground activities.
The segment information aligns with how the Company&#8217;s CODM reviews and manages our
business. The Company&#8217;s CODM is the Company&#8217;s Chief Executive Officer.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
information and annual operating plans and forecasts are prepared and are reviewed by the CODM at a consolidated level. The CODM assesses
performance for the Travel Products and Services segment and decides how to allocate resources based on revenue and net income that is
reported on the Consolidated Statements of Operations. The Company&#8217;s objective in making resource allocation decisions is to optimize
the financial results. The accounting policies of our Travel Products and Services segment are the same as those described in the summary
of significant accounting policies herein.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
our single reportable segment-level financial information, total assets, and significant non-cash transactions, see the Financial Statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-03-01to2025-02-28" escape="true" id="Fact000840" name="NTRP:RecentlyIssuedAccountingPronouncementsNotYetAdoptedPolicyTextBlock"><p id="xdx_84D_ecustom--RecentlyIssuedAccountingPronouncementsNotYetAdoptedPolicyTextBlock_zTPCxbe6xR06" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_866_zgwQwVdwKsR9">Recently
issued accounting pronouncements not yet adopted</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
December 2023, the FASB issued ASU 2023-09, <i>Income Taxes (Topic 740): Improvements to Income
Tax Disclosures</i>, to enhance the transparency and decision-usefulness of income tax information provided to investors. The amendments
focus primarily on expanding the disclosures related to the effective tax rate reconciliation and income taxes paid. Key provisions of
the update include: (i) enhanced disclosure of the effective tax rate reconciliation, using both standardized categories and quantitative
disclosure of individual reconciling items that meet specified thresholds; (ii) required disaggregation of income taxes paid, by federal,
state, and significant foreign jurisdictions; (iii) additional qualitative disclosures about tax-related assumptions and estimation methodologies.
ASU 2023-09 is effective for public business entities for annual periods beginning after December 15, 2024. As a result, the Company
will adopt the standard for its fiscal year beginning March 1, 2025 (ending February 28, 2026). Early adoption is permitted; however,
the Company does not intend to early adopt. The Company is currently evaluating the impact of the new standard on its income tax footnote
disclosures. The adoption is not expected to have an impact on the Company&#8217;s consolidated financial position, results of operations,
or cash flows, but it will result in expanded and more detailed income tax disclosures beginning in fiscal 2026.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has considered all other recently issued accounting pronouncements and does not believe the adoption of such pronouncements will
have a material impact on its consolidated financial statements.</span></p>

</ix:nonNumeric><p id="xdx_85D_zmoLoCbHvlrb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>


<ix:exclude><!-- Field: Page; Sequence: 91; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-03-01to2025-02-28" escape="true" id="Fact000842" name="us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock"><p id="xdx_803_eus-gaap--DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_zc6Ec27lkNVg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
3 &#8211; <span id="xdx_820_zjAQlsGaqkYc">Discontinued Operations</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the fiscal year ended February 29, 2024, the Company completed the sale of certain legacy assets of Sigma,
which has been classified as discontinued operations in accordance with ASC 205-20, &#8220;Presentation of Financial Statements
&#8211; Discontinued Operations.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 6, 2023, the Company entered into a definitive asset purchase agreement (the &#8220;Divergent Agreement&#8221;) with Divergent Technologies,
Inc. (&#8220;Divergent&#8221;), pursuant to which the Company agreed to sell to Divergent, and Divergent agreed to purchase from
us, certain assets consisting primarily of patents, software code and other intellectual property for a purchase price of $<span id="xdx_907_eus-gaap--PaymentsToAcquireIntangibleAssets_c20231006__20231006__us-gaap--TypeOfArrangementAxis__custom--AssetPurchaseAgreementMember__dei--LegalEntityAxis__custom--DivergentTechnologiesIncMember_zoTShA3T5C7g" title="Purchase price"><ix:nonFraction name="us-gaap:PaymentsToAcquireIntangibleAssets" contextRef="From2023-10-062023-10-06_custom_AssetPurchaseAgreementMember_custom_DivergentTechnologiesIncMember" id="Fact000844" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,626,242</ix:nonFraction></span>,
including a $<span id="xdx_90B_ecustom--EarnestMoneyDeposit_iI_c20231006__us-gaap--TypeOfArrangementAxis__custom--AssetPurchaseAgreementMember__dei--LegalEntityAxis__custom--DivergentTechnologiesIncMember_zp3ut5lOt7ud" title="Earnest money deposit"><ix:nonFraction name="NTRP:EarnestMoneyDeposit" contextRef="AsOf2023-10-06_custom_AssetPurchaseAgreementMember_custom_DivergentTechnologiesIncMember" id="Fact000846" format="ixt:numdotdecimal" decimals="0" unitRef="USD">37,000</ix:nonFraction></span>
earnest-money deposit previously paid to us by Divergent. The closing under the Divergent Agreement occurred subsequent to the
closing of the reverse acquisition with NTH on January 12, 2024. The parties&#8217; respective obligations to close were
subject to the accuracy of the parties&#8217; respective representations and warranties and performance of their respective
covenants and satisfaction or waiver of other customary conditions specified in the Divergent Agreement. In the interim,
between the signing date and closing date or termination of the Divergent Agreement, the Company granted Divergent a non-exclusive,
nontransferable, non-sublicensable (except to Divergent customers and affiliates), limited, irrevocable (except in connection with
the termination of the Divergent Agreement), worldwide, royalty-free license to the &#8220;Licensed IP&#8221; (as defined therein) for
testing, evaluation, and commercialization purposes. A gain of $<span id="xdx_908_eus-gaap--GainLossOnDispositionOfAssets1_c20231006__20231006__us-gaap--TypeOfArrangementAxis__custom--AssetPurchaseAgreementMember__dei--LegalEntityAxis__custom--DivergentTechnologiesIncMember_z29KsoyPT2Yj" title="Loss on disposal of assets"><ix:nonFraction name="us-gaap:GainLossOnDispositionOfAssets1" contextRef="From2023-10-062023-10-06_custom_AssetPurchaseAgreementMember_custom_DivergentTechnologiesIncMember" id="Fact000848" format="ixt:numdotdecimal" decimals="0" unitRef="USD">30,515</ix:nonFraction> </span>was
recognized in the asset disposition transaction.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the year ended February 28, 2025, the Company recorded a gain of $<span id="xdx_90B_eus-gaap--IncomeLossFromDiscontinuedOperationsNetOfTax_c20240301__20250228_znCJ5QuEoQd4" title="Loss of discontinued operations"><ix:nonFraction name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" contextRef="From2024-03-01to2025-02-28" id="Fact000850" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8,344</ix:nonFraction></span> from discontinued operations as follows:</span></p>

<ix:nonNumeric contextRef="From2024-03-01to2025-02-28" escape="true" id="Fact000852" name="us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock"><p id="xdx_894_eus-gaap--ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_zFCh736E4fIa" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b><span id="xdx_8B1_zhPTT6uD6F5e" style="display: none">Schedule
of Discontinued Operations</span></span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_495_20240301__20250228_zIpCboDEeHp3" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">February 28,</p>
                                                                               <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">2025</p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--DisposalGroupIncludingDiscontinuedOperationRevenue_maDGIDOzv4w_zShvCX8ho5Rl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 78%">Revenue</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right"><ix:nonFraction name="us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue" contextRef="From2024-03-01to2025-02-28" id="Fact000854" format="ixt:numdotdecimal" decimals="0" unitRef="USD">14,731</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold_msDGIDOzv4w_zJf2TzTzn1Q3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">Cost of revenue</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0856">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss_iT_mtDGIDOzv4w_maDGIDOzv2d_zzYmXroHjHW2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Gross profit</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss" contextRef="From2024-03-01to2025-02-28" id="Fact000858" format="ixt:numdotdecimal" decimals="0" unitRef="USD">14,731</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_ecustom--DisposalGroupIncludingDiscontinuedOperationsProfessionalServices_maDGIDOzcGq_zZbST1Jw89Fh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Professional services</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="NTRP:DisposalGroupIncludingDiscontinuedOperationsProfessionalServices" contextRef="From2024-03-01to2025-02-28" id="Fact000860" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,163</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_ecustom--DisposalGroupIncludingDiscontinuedOperationsInvestorRelationsServices_maDGIDOzcGq_zTrEix5zyql" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Investor relations services</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="NTRP:DisposalGroupIncludingDiscontinuedOperationsInvestorRelationsServices" contextRef="From2024-03-01to2025-02-28" id="Fact000862" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,194</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--DisposalGroupIncludingDiscontinuedOperationsOtherIncome_maDGIDOzcGq_zF8I0kVGhYR6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Other income</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="NTRP:DisposalGroupIncludingDiscontinuedOperationsOtherIncome" contextRef="From2024-03-01to2025-02-28" id="Fact000864" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,970</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_409_eus-gaap--DisposalGroupIncludingDiscontinuedOperationOperatingExpense_iT_mtDGIDOzcGq_msDGIDOzv2d_zYuvubvD1yHg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Total Expenses</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingExpense" contextRef="From2024-03-01to2025-02-28" id="Fact000866" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,387</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--IncomeLossFromDiscontinuedOperationsNetOfTax_iT_mtDGIDOzv2d_zENYlBZnkdX8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Gain from Discontinued Operations</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" contextRef="From2024-03-01to2025-02-28" id="Fact000868" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8,344</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A5_zV0vEq8nfgE3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-03-01to2025-02-28" escape="true" id="Fact000870" name="us-gaap:EquityMethodInvestmentsDisclosureTextBlock"><p id="xdx_80D_eus-gaap--EquityMethodInvestmentsDisclosureTextBlock_zbW1I4veE0f2" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
4 - <span id="xdx_82A_zRyuxxMKdLBf">Investment in Equity Method Investee</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Membership
Purchase Agreement with FSA Travel, LLC</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 6, 2025, the Company entered into a Membership Purchase Agreement (the &#8220;FSA Purchase Agreement&#8221;) with FSA
Travel, LLC (&#8220;FSA&#8221;). Under the terms of the FSA Purchase Agreement, the Company acquired an initial <span id="xdx_90B_eus-gaap--EquityOwnershipPercentageExcludingConsolidatedEntityAndEquityMethodInvestee_iI_pid_dp_uPure_c20250206__us-gaap--TypeOfArrangementAxis__custom--MembershipPurchaseAgreementMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--FSATravelLLCMember_zEcBTYA2ex1a"><ix:nonFraction name="us-gaap:EquityOwnershipPercentageExcludingConsolidatedEntityAndEquityMethodInvestee" contextRef="AsOf2025-02-06_custom_MembershipPurchaseAgreementMember_custom_FSATravelLLCMember" id="Fact000871" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">49</ix:nonFraction></span>%
membership interest in FSA for a total of $<span id="xdx_90C_eus-gaap--BusinessAcquisitionPreacquisitionContingencyAmountOfSettlement_iI_c20250206__us-gaap--TypeOfArrangementAxis__custom--MembershipPurchaseAgreementMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--FSATravelLLCMember_zSsW0K191t04" title="Business acquisition amount"><ix:nonFraction name="us-gaap:BusinessAcquisitionPreacquisitionContingencyAmountOfSettlement" contextRef="AsOf2025-02-06_custom_MembershipPurchaseAgreementMember_custom_FSATravelLLCMember" id="Fact000873" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,000,000</ix:nonFraction></span>.
The acquisition consideration consisted of $<span id="xdx_90B_eus-gaap--BusinessCombinationContingentConsiderationAsset_iI_c20250206__us-gaap--TypeOfArrangementAxis__custom--MembershipPurchaseAgreementMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--FSATravelLLCMember_zzSu8xqvHChl" title="Business acquisition  consideration cash"><ix:nonFraction name="us-gaap:BusinessCombinationContingentConsiderationAsset" contextRef="AsOf2025-02-06_custom_MembershipPurchaseAgreementMember_custom_FSATravelLLCMember" id="Fact000875" format="ixt:numdotdecimal" decimals="0" unitRef="USD">500,000</ix:nonFraction></span>
in cash and $<span id="xdx_905_eus-gaap--BusinessCombinationContingentConsiderationAsset_iI_c20250206__us-gaap--TypeOfArrangementAxis__custom--MembershipPurchaseAgreementMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--FSATravelLLCMember__us-gaap--StatementClassOfStockAxis__custom--SeriesOPreferredStockMember_zIfy9t8SHmh9" title="Business acquisition  consideration cash"><ix:nonFraction name="us-gaap:BusinessCombinationContingentConsiderationAsset" contextRef="AsOf2025-02-06_custom_MembershipPurchaseAgreementMember_custom_FSATravelLLCMember_custom_SeriesOPreferredStockMember" id="Fact000877" format="ixt:numdotdecimal" decimals="0" unitRef="USD">500,000</ix:nonFraction></span>
of Series O Preferred shares (<span id="xdx_90E_eus-gaap--SharesIssued_iI_c20250206__us-gaap--TypeOfArrangementAxis__custom--MembershipPurchaseAgreementMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--FSATravelLLCMember__us-gaap--StatementClassOfStockAxis__custom--SeriesOPreferredStockMember_zIyezkG0RZt1" title="Business acquisition shares issued"><ix:nonFraction name="us-gaap:SharesIssued" contextRef="AsOf2025-02-06_custom_MembershipPurchaseAgreementMember_custom_FSATravelLLCMember_custom_SeriesOPreferredStockMember" id="Fact000879" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">161,291</ix:nonFraction></span>
shares at $<span id="xdx_909_eus-gaap--SharesIssuedPricePerShare_iI_c20250206__us-gaap--TypeOfArrangementAxis__custom--MembershipPurchaseAgreementMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--FSATravelLLCMember__us-gaap--StatementClassOfStockAxis__custom--SeriesOPreferredStockMember_zikqIxv9di4g" title="Business acquisition shares price per share"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2025-02-06_custom_MembershipPurchaseAgreementMember_custom_FSATravelLLCMember_custom_SeriesOPreferredStockMember" id="Fact000881" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">3.10</ix:nonFraction></span>
per share). The investment in FSA is accounted for using the equity method of accounting in accordance with ASC 323 because
the Company has significant influence over the investee due to its <span id="xdx_901_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20250206__us-gaap--TypeOfArrangementAxis__custom--MembershipPurchaseAgreementMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--NextTripMember_zQw3wG4WabA4"><ix:nonFraction name="us-gaap:EquityMethodInvestmentOwnershipPercentage" contextRef="AsOf2025-02-06_custom_MembershipPurchaseAgreementMember_custom_NextTripMember" id="Fact000882" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">49</ix:nonFraction></span>%
ownership interest.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the FSA Purchase Agreement, NextTrip was granted an option to acquire the remaining <span id="xdx_909_eus-gaap--InvestmentInterestRatePaidInCash_iI_pid_dp_uPure_c20250206__us-gaap--TypeOfArrangementAxis__custom--MembershipPurchaseAgreementMember__dei--LegalEntityAxis__custom--FSATravelLLCMember_zA8Z86vKyKSf"><ix:nonFraction name="us-gaap:InvestmentInterestRatePaidInCash" contextRef="AsOf2025-02-06_custom_MembershipPurchaseAgreementMember_custom_FSATravelLLCMember11843687" id="Fact000883" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">51</ix:nonFraction></span>%
membership interest in FSA for an additional $<span id="xdx_903_eus-gaap--BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCosts_iI_c20250206__us-gaap--TypeOfArrangementAxis__custom--MembershipPurchaseAgreementMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--FSATravelLLCMember_zYvOcwYUanbl" title="Business acquisition additional amount"><ix:nonFraction name="us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCosts" contextRef="AsOf2025-02-06_custom_MembershipPurchaseAgreementMember_custom_FSATravelLLCMember" id="Fact000885" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,000,000</ix:nonFraction></span>.
The option is exercisable within 60 days from the execution of the FSA Purchase Agreement, subject to the satisfaction of certain
conditions outlined in the FSA Purchase Agreement. The consideration for the remaining interest would consist of $<span id="xdx_90B_eus-gaap--BusinessCombinationContingentConsiderationAsset_iI_c20250206__us-gaap--TypeOfArrangementAxis__custom--MembershipPurchaseAgreementMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--FSATravelLLCMember_zDak6yi2AVzg" title="Business acquisition  consideration cash"><ix:nonFraction name="us-gaap:BusinessCombinationContingentConsiderationAsset" contextRef="AsOf2025-02-06_custom_MembershipPurchaseAgreementMember_custom_FSATravelLLCMember" id="Fact000887" format="ixt:numdotdecimal" decimals="0" unitRef="USD">500,000</ix:nonFraction></span>
in cash and $<span id="xdx_905_eus-gaap--BusinessCombinationContingentConsiderationAsset_iI_c20250206__us-gaap--TypeOfArrangementAxis__custom--MembershipPurchaseAgreementMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--FSATravelLLCMember__us-gaap--StatementClassOfStockAxis__custom--SeriesOPreferredStockMember_z7eHicJCV7Rg" title="Business acquisition  consideration cash"><ix:nonFraction name="us-gaap:BusinessCombinationContingentConsiderationAsset" contextRef="AsOf2025-02-06_custom_MembershipPurchaseAgreementMember_custom_FSATravelLLCMember_custom_SeriesOPreferredStockMember" id="Fact000889" format="ixt:numdotdecimal" decimals="0" unitRef="USD">500,000</ix:nonFraction> </span>of
Series O Preferred shares (<span id="xdx_90E_eus-gaap--SharesIssued_iI_c20250206__us-gaap--TypeOfArrangementAxis__custom--MembershipPurchaseAgreementMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--FSATravelLLCMember__us-gaap--StatementClassOfStockAxis__custom--SeriesOPreferredStockMember_zWCrdKGwd3Nl" title="Business acquisition shares issued"><ix:nonFraction name="us-gaap:SharesIssued" contextRef="AsOf2025-02-06_custom_MembershipPurchaseAgreementMember_custom_FSATravelLLCMember_custom_SeriesOPreferredStockMember" id="Fact000891" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">161,291</ix:nonFraction></span>
shares at $<span id="xdx_909_eus-gaap--SharesIssuedPricePerShare_iI_c20250206__us-gaap--TypeOfArrangementAxis__custom--MembershipPurchaseAgreementMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--FSATravelLLCMember__us-gaap--StatementClassOfStockAxis__custom--SeriesOPreferredStockMember_zeCwqzFwvc3b" title="Business acquisition shares price per share"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2025-02-06_custom_MembershipPurchaseAgreementMember_custom_FSATravelLLCMember_custom_SeriesOPreferredStockMember" id="Fact000893" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">3.10</ix:nonFraction></span>
per share).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the FSA Purchase Agreement, if the Company exercises its option to acquire the remaining <span id="xdx_904_eus-gaap--InvestmentInterestRatePaidInCash_iI_pid_dp_uPure_c20250206__us-gaap--TypeOfArrangementAxis__custom--MembershipPurchaseAgreementMember_z3aqMnqtD3p"><ix:nonFraction name="us-gaap:InvestmentInterestRatePaidInCash" contextRef="AsOf2025-02-06_custom_MembershipPurchaseAgreementMember" id="Fact000894" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">51</ix:nonFraction></span>%
interest, incremental consideration would include four business milestone payments, payable upon achievement of such milestones. The
achievement of each milestone would result in a payment of $<span id="xdx_904_eus-gaap--BusinessAcquisitionPreacquisitionContingencyAmountOfSettlement_iI_c20250206__us-gaap--TypeOfArrangementAxis__custom--MembershipPurchaseAgreementMember_zgE4X010ITMf" title="Business acquisition amount"><ix:nonFraction name="us-gaap:BusinessAcquisitionPreacquisitionContingencyAmountOfSettlement" contextRef="AsOf2025-02-06_custom_MembershipPurchaseAgreementMember" id="Fact000896" format="ixt:numdotdecimal" decimals="0" unitRef="USD">200,000</ix:nonFraction></span>,
consisting of $<span id="xdx_901_eus-gaap--BusinessCombinationContingentConsiderationAsset_iI_c20250206__us-gaap--TypeOfArrangementAxis__custom--MembershipPurchaseAgreementMember_zo2QpEl46jmd" title="Business acquisition  consideration cash"><ix:nonFraction name="us-gaap:BusinessCombinationContingentConsiderationAsset" contextRef="AsOf2025-02-06_custom_MembershipPurchaseAgreementMember" id="Fact000898" format="ixt:numdotdecimal" decimals="0" unitRef="USD">100,000</ix:nonFraction></span>
in cash and $<span id="xdx_90C_eus-gaap--BusinessCombinationContingentConsiderationAsset_iI_c20250206__us-gaap--TypeOfArrangementAxis__custom--MembershipPurchaseAgreementMember_zZaV1pfvSP4i" title="Business acquisition  consideration cash"><ix:nonFraction name="us-gaap:BusinessCombinationContingentConsiderationAsset" contextRef="AsOf2025-02-06_custom_MembershipPurchaseAgreementMember" id="Fact000900" format="ixt:numdotdecimal" decimals="0" unitRef="USD">100,000</ix:nonFraction></span>
in Series O Preferred shares (<span id="xdx_906_eus-gaap--SharesIssued_iI_c20250206__us-gaap--TypeOfArrangementAxis__custom--MembershipPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesOPreferredStockMember_zZJiCUG0YA02" title="Business acquisition shares issued"><ix:nonFraction name="us-gaap:SharesIssued" contextRef="AsOf2025-02-06_custom_MembershipPurchaseAgreementMember_custom_SeriesOPreferredStockMember" id="Fact000902" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">32,258</ix:nonFraction></span>
shares at $<span id="xdx_908_eus-gaap--SharesIssuedPricePerShare_iI_c20250206__us-gaap--TypeOfArrangementAxis__custom--MembershipPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesOPreferredStockMember_zJplSBKHtrDc" title="Business acquisition shares price per share"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2025-02-06_custom_MembershipPurchaseAgreementMember_custom_SeriesOPreferredStockMember" id="Fact000904" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">3.10</ix:nonFraction></span>
per share). These milestone payments are contingent upon the Company&#8217;s exercise of the option to acquire the remaining <span id="xdx_908_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20250206__us-gaap--TypeOfArrangementAxis__custom--MembershipPurchaseAgreementMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--FSATravelLLCMember_zng5Ri49qDA4"><ix:nonFraction name="us-gaap:EquityMethodInvestmentOwnershipPercentage" contextRef="AsOf2025-02-06_custom_MembershipPurchaseAgreementMember_custom_FSATravelLLCMember" id="Fact000905" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">51</ix:nonFraction></span>%
of FSA, and are triggered only if the conditions necessary to exercise the option are satisfied. The total milestone payments
are capped at $<span id="xdx_90B_ecustom--BusinessAcquisitionMilestonePayments_iI_c20250206__us-gaap--TypeOfArrangementAxis__custom--MembershipPurchaseAgreementMember__dei--LegalEntityAxis__custom--FSATravelLLCMember_zMhTirdjALPj" title="Milestone payments"><ix:nonFraction name="NTRP:BusinessAcquisitionMilestonePayments" contextRef="AsOf2025-02-06_custom_MembershipPurchaseAgreementMember_custom_FSATravelLLCMember11843687" id="Fact000907" format="ixt:numdotdecimal" decimals="0" unitRef="USD">800,000</ix:nonFraction></span>
(four milestones at $<span id="xdx_904_ecustom--BusinessAcquisitionPerMilestonePayments_iI_c20250206__us-gaap--TypeOfArrangementAxis__custom--MembershipPurchaseAgreementMember__dei--LegalEntityAxis__custom--FSATravelLLCMember_zbwuYGV0Ob12" title="Per milestone payments"><ix:nonFraction name="NTRP:BusinessAcquisitionPerMilestonePayments" contextRef="AsOf2025-02-06_custom_MembershipPurchaseAgreementMember_custom_FSATravelLLCMember11843687" id="Fact000909" format="ixt:numdotdecimal" decimals="0" unitRef="USD">200,000</ix:nonFraction></span>
per milestone). These milestone payments are considered performance-based contingent consideration and will be recognized in the
future if and when the related milestones are satisfied, and the payments are made.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 92; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of February 28, 2025, the Company recorded its initial <span id="xdx_905_eus-gaap--EquityOwnershipPercentageExcludingConsolidatedEntityAndEquityMethodInvestee_iI_pid_dp_uPure_c20250228__us-gaap--TypeOfArrangementAxis__custom--MembershipPurchaseAgreementMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--FSATravelLLCMember_zqCu082XJZSi"><ix:nonFraction name="us-gaap:EquityOwnershipPercentageExcludingConsolidatedEntityAndEquityMethodInvestee" contextRef="AsOf2025-02-28_custom_MembershipPurchaseAgreementMember_custom_FSATravelLLCMember" id="Fact000910" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">49</ix:nonFraction></span>% investment in FSA at $<span id="xdx_901_eus-gaap--BusinessAcquisitionPreacquisitionContingencyAmountOfSettlement_iI_c20250228__us-gaap--TypeOfArrangementAxis__custom--MembershipPurchaseAgreementMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--FSATravelLLCMember_zuhACkyCc3ci" title="Business acquisition amount"><ix:nonFraction name="us-gaap:BusinessAcquisitionPreacquisitionContingencyAmountOfSettlement" contextRef="AsOf2025-02-28_custom_MembershipPurchaseAgreementMember_custom_FSATravelLLCMember" id="Fact000912" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,000,000</ix:nonFraction></span>. This amount includes $<span id="xdx_903_eus-gaap--BusinessCombinationContingentConsiderationAsset_iI_c20250228__us-gaap--TypeOfArrangementAxis__custom--MembershipPurchaseAgreementMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--FSATravelLLCMember_zgSP8xRQODil" title="Business acquisition  consideration cash"><ix:nonFraction name="us-gaap:BusinessCombinationContingentConsiderationAsset" contextRef="AsOf2025-02-28_custom_MembershipPurchaseAgreementMember_custom_FSATravelLLCMember" id="Fact000914" format="ixt:numdotdecimal" decimals="0" unitRef="USD">500,000</ix:nonFraction></span> in cash
and $<span id="xdx_900_eus-gaap--BusinessCombinationContingentConsiderationAsset_iI_c20250228__us-gaap--TypeOfArrangementAxis__custom--MembershipPurchaseAgreementMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--FSATravelLLCMember__us-gaap--StatementClassOfStockAxis__custom--SeriesOPreferredStockMember_zl8ndLJ5AvNg" title="Business acquisition  consideration cash"><ix:nonFraction name="us-gaap:BusinessCombinationContingentConsiderationAsset" contextRef="AsOf2025-02-28_custom_MembershipPurchaseAgreementMember_custom_FSATravelLLCMember_custom_SeriesOPreferredStockMember" id="Fact000916" format="ixt:numdotdecimal" decimals="0" unitRef="USD">500,000</ix:nonFraction></span> in Series O Preferred shares. The carrying amount of the equity method investment will be adjusted based on the Company&#8217;s
share of FSA&#8217;s earnings or losses, in accordance with the equity method of accounting. The milestones and contingent consideration
payments, including the additional $<span id="xdx_909_eus-gaap--BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCosts_iI_c20250228__us-gaap--TypeOfArrangementAxis__custom--MembershipPurchaseAgreementMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--FSATravelLLCMember_zyHgXJuKdZ5f" title="Business acquisition additional amount"><ix:nonFraction name="us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCosts" contextRef="AsOf2025-02-28_custom_MembershipPurchaseAgreementMember_custom_FSATravelLLCMember" id="Fact000918" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,000,000</ix:nonFraction></span> to acquire the remaining <span id="xdx_90E_eus-gaap--InvestmentInterestRatePaidInCash_iI_pid_dp_uPure_c20250228__us-gaap--TypeOfArrangementAxis__custom--MembershipPurchaseAgreementMember__dei--LegalEntityAxis__custom--FSATravelLLCMember_zeSYLOpWPy02"><ix:nonFraction name="us-gaap:InvestmentInterestRatePaidInCash" contextRef="AsOf2025-02-28_custom_MembershipPurchaseAgreementMember_custom_FSATravelLLCMember11843734" id="Fact000919" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">51</ix:nonFraction></span>% interest, will be recognized in the future if, as, and when
the conditions for such payments are satisfied.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
total potential commitment for the Company under the FSA Purchase Agreement, assuming the satisfaction of all conditions and the
exercise of the option to acquire the remaining <span id="xdx_902_eus-gaap--InvestmentInterestRatePaidInCash_iI_pid_dp_uPure_c20250228__us-gaap--TypeOfArrangementAxis__custom--MembershipPurchaseAgreementMember__dei--LegalEntityAxis__custom--NextTripMember_zzhZ21BWDPSj"><ix:nonFraction name="us-gaap:InvestmentInterestRatePaidInCash" contextRef="AsOf2025-02-28_custom_MembershipPurchaseAgreementMember_custom_NextTripMember" id="Fact000920" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">51</ix:nonFraction></span>%
interest, is $<span id="xdx_90E_eus-gaap--PaymentsToAcquireBusinessesAndInterestInAffiliates_c20250228__20250228__us-gaap--TypeOfArrangementAxis__custom--MembershipPurchaseAgreementMember__dei--LegalEntityAxis__custom--NextTripMember_zEp6yDsJxHtb" title="Business acquisition additional amount"><ix:nonFraction name="us-gaap:PaymentsToAcquireBusinessesAndInterestInAffiliates" contextRef="From2025-02-282025-02-28_custom_MembershipPurchaseAgreementMember_custom_NextTripMember" id="Fact000922" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,800,000</ix:nonFraction></span>.
This includes $<span id="xdx_901_eus-gaap--PaymentsToAcquireBusinessesAndInterestInAffiliates_c20250228__20250228__us-gaap--TypeOfArrangementAxis__custom--MembershipPurchaseAgreementMember_z2jaaqCZkEuh" title="Business acquisition additional amount"><ix:nonFraction name="us-gaap:PaymentsToAcquireBusinessesAndInterestInAffiliates" contextRef="From2025-02-282025-02-28_custom_MembershipPurchaseAgreementMember" id="Fact000924" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,000,000</ix:nonFraction></span>
already paid for the <span id="xdx_90B_eus-gaap--EquityOwnershipPercentageExcludingConsolidatedEntityAndEquityMethodInvestee_iI_pid_dp_uPure_c20250228__us-gaap--TypeOfArrangementAxis__custom--MembershipPurchaseAgreementMember_zU2uuJy4lbGb"><ix:nonFraction name="us-gaap:EquityOwnershipPercentageExcludingConsolidatedEntityAndEquityMethodInvestee" contextRef="AsOf2025-02-28_custom_MembershipPurchaseAgreementMember" id="Fact000925" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">49</ix:nonFraction></span>%
interest in FSA, $<span id="xdx_901_eus-gaap--PaymentsToAcquireBusinessesAndInterestInAffiliates_c20250228__20250228__us-gaap--TypeOfArrangementAxis__custom--MembershipPurchaseAgreementMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--NextTripMember_zAakq6b8sXz4" title="Business acquisition additional amount"><ix:nonFraction name="us-gaap:PaymentsToAcquireBusinessesAndInterestInAffiliates" contextRef="From2025-02-282025-02-28_custom_MembershipPurchaseAgreementMember_custom_NextTripMember11843750" id="Fact000927" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,000,000</ix:nonFraction></span>
payable by the Company in the event that it exercises its option to acquire the remaining <span id="xdx_905_eus-gaap--InvestmentInterestRatePaidInCash_iI_pid_dp_uPure_c20250228__us-gaap--TypeOfArrangementAxis__custom--MembershipPurchaseAgreementMember__dei--LegalEntityAxis__custom--NextTripMember_zVwV0o3plrbj"><ix:nonFraction name="us-gaap:InvestmentInterestRatePaidInCash" contextRef="AsOf2025-02-28_custom_MembershipPurchaseAgreementMember_custom_NextTripMember" id="Fact000928" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">51</ix:nonFraction></span>%
of interests in FSA, and $<span id="xdx_90D_ecustom--BusinessAcquisitionMilestonePayments_iI_c20250228__us-gaap--TypeOfArrangementAxis__custom--MembershipPurchaseAgreementMember_z1wmXjB9Tgj5" title="Milestone payments"><ix:nonFraction name="NTRP:BusinessAcquisitionMilestonePayments" contextRef="AsOf2025-02-28_custom_MembershipPurchaseAgreementMember" id="Fact000930" format="ixt:numdotdecimal" decimals="0" unitRef="USD">800,000</ix:nonFraction></span>
for the milestone payments associated with the acquisition of the remaining interests.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Summarized
Financial Information for FSA Travel, LLC</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2024-03-01to2025-02-28" escape="true" id="Fact000932" name="us-gaap:EquityMethodInvestmentsTextBlock"><p id="xdx_89A_eus-gaap--EquityMethodInvestmentsTextBlock_zgVv5JxPm8S8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">FSA
Travel&#8217;s fiscal year ends on December 31. As of and for the year ended December 31, 2024, unaudited summarized financial
information for FSA is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BA_zlKZQgby6RVe" style="display: none">Schedule
of Unaudited Summarized Financial Information</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_493_20241231__dei--LegalEntityAxis__custom--FSATravelLLCMember_zB2Y60wOH5Vi" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">December 31,</p>
                                                                               <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">2024</p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--AssetsCurrent_iI_zCdkziM07QYb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 78%; text-align: left">Current assets</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right"><ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="AsOf2024-12-31_custom_FSATravelLLCMember" id="Fact000934" format="ixt:numdotdecimal" decimals="0" unitRef="USD">13,629</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--AssetsNoncurrent_iI_zNAqslBORhIk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Non-current assets</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:AssetsNoncurrent" contextRef="AsOf2024-12-31_custom_FSATravelLLCMember" id="Fact000936" format="ixt:numdotdecimal" decimals="0" unitRef="USD">577,776</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--LiabilitiesCurrent_iI_zSXOMmfed4H5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Current liabilities</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="AsOf2024-12-31_custom_FSATravelLLCMember" id="Fact000938" format="ixt:numdotdecimal" decimals="0" unitRef="USD">12,452</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--LiabilitiesNoncurrent_iI_zIq6Zjv4hvYa" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Non-current liabilities</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesNoncurrent" contextRef="AsOf2024-12-31_custom_FSATravelLLCMember" id="Fact000940" format="ixt:numdotdecimal" decimals="0" unitRef="USD">199,100</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--StockholdersEquity_iI_zZWVpEs6pGl4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Member&#8217;s equity</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-12-31_custom_FSATravelLLCMember" id="Fact000942" format="ixt:numdotdecimal" decimals="0" unitRef="USD">379,852</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Net revenues</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_907_eus-gaap--Revenues_c20240101__20241231__dei--LegalEntityAxis__custom--FSATravelLLCMember_zWL53lViRExk" title="Net revenues"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2024-01-012024-12-31_custom_FSATravelLLCMember" id="Fact000944" format="ixt:numdotdecimal" decimals="0" unitRef="USD">374,143</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Gross profit</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90C_eus-gaap--GrossProfit_c20240101__20241231__dei--LegalEntityAxis__custom--FSATravelLLCMember_z6tp6d7RJNI2" title="Gross profit"><ix:nonFraction name="us-gaap:GrossProfit" contextRef="From2024-01-012024-12-31_custom_FSATravelLLCMember" id="Fact000946" format="ixt:numdotdecimal" decimals="0" unitRef="USD">374,143</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Net loss</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_905_eus-gaap--NetIncomeLoss_c20240101__20241231__dei--LegalEntityAxis__custom--FSATravelLLCMember_zYKrNYjeG0ni" title="Net loss">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-01-012024-12-31_custom_FSATravelLLCMember" id="Fact000948" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">252,381</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A4_zNyhCz8xN6Mf" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-03-01to2025-02-28" escape="true" id="Fact000950" name="us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock"><p id="xdx_803_eus-gaap--InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_zk1spcvuT7k3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
5 - <span id="xdx_820_zRjrY1NKPcH9">Investment in Equity Securities</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Investment
in Blue Fysh Holdings Inc</i>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 24, 2025, the Company entered into a Share Exchange Agreement with Blue Fysh Holdings Inc. (&#8220;Blue Fysh&#8221;), under
which the Company acquired a <span id="xdx_90F_eus-gaap--EquityOwnershipPercentageExcludingConsolidatedEntityAndEquityMethodInvestee_iI_pid_dp_uPure_c20250224__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__dei--LegalEntityAxis__custom--BlueFyshHoldingsIncMember_zaWvJzjAQ25k"><ix:nonFraction name="us-gaap:EquityOwnershipPercentageExcludingConsolidatedEntityAndEquityMethodInvestee" contextRef="AsOf2025-02-24_custom_ShareExchangeAgreementMember_custom_BlueFyshHoldingsIncMember" id="Fact000951" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">10</ix:nonFraction></span>% ownership interest in Blue Fysh. As part of the transaction, the Company issued <span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20250224__20250224__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__dei--LegalEntityAxis__custom--BlueFyshHoldingsIncMember__us-gaap--StatementClassOfStockAxis__custom--SeriesNNonvotingConvertiblePreferredStockMember_zRCl6t2mIp1h" title="Number of shares issued"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2025-02-242025-02-24_custom_ShareExchangeAgreementMember_custom_BlueFyshHoldingsIncMember_custom_SeriesNNonvotingConvertiblePreferredStockMember" id="Fact000953" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">483,000</ix:nonFraction></span> shares of Series
N Nonvoting Preferred at an issuance price of $<span id="xdx_903_eus-gaap--SharesIssuedPricePerShare_iI_c20250224__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__dei--LegalEntityAxis__custom--BlueFyshHoldingsIncMember__us-gaap--StatementClassOfStockAxis__custom--SeriesNNonvotingConvertiblePreferredStockMember_zW6i30bGo65b" title="Shares issued price per share"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2025-02-24_custom_ShareExchangeAgreementMember_custom_BlueFyshHoldingsIncMember_custom_SeriesNNonvotingConvertiblePreferredStockMember" id="Fact000955" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">5.00</ix:nonFraction></span> per share, totaling $<span id="xdx_906_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20250224__20250224__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__dei--LegalEntityAxis__custom--BlueFyshHoldingsIncMember__us-gaap--StatementClassOfStockAxis__custom--SeriesNNonvotingConvertiblePreferredStockMember_zUrODtjF2Y3c" title="Shares issued value"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2025-02-242025-02-24_custom_ShareExchangeAgreementMember_custom_BlueFyshHoldingsIncMember_custom_SeriesNNonvotingConvertiblePreferredStockMember" id="Fact000957" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,415,000</ix:nonFraction></span>, in exchange for <span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20250224__20250224__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__dei--LegalEntityAxis__custom--BlueFyshHoldingsIncMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_z9hh8JaoSN83" title="Number of shares issued"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2025-02-242025-02-24_custom_ShareExchangeAgreementMember_custom_BlueFyshHoldingsIncMember_us-gaap_RestrictedStockMember" id="Fact000959" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">82</ix:nonFraction></span> restricted shares
of Blue Fysh common stock. The transaction closed on February 28, 2025.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s investment in Blue Fysh is accounted for under the cost method, as the Company does not have significant influence over
Blue Fysh. No board appointments are contemplated as part of this transaction; however, the Company has the right to appoint a representative
to the Blue Fysh Advisory Committee, which will allow the Company to receive financial updates as needed and to be informed of financial
events that could significantly impact the Company&#8217;s ownership position.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since
the Company&#8217;s ownership interest does not meet the criteria for significant influence pursuant to ASC 323, this investment is classified
as an equity security without a readily determinable fair value and is initially recorded at cost. The Company will assess the investment
for impairment in future periods and recognize any impairment losses as necessary.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-03-01to2025-02-28" escape="true" id="Fact000961" name="NTRP:PrepaidExpensesAndOtherCurrentAssetsTextBlock"><p id="xdx_80A_ecustom--PrepaidExpensesAndOtherCurrentAssetsTextBlock_z3tgxJoRgvZb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
6 - <span id="xdx_821_zMmrmVtuVkN3">Prepaid and Other Current Assets</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2024-03-01to2025-02-28" escape="true" id="Fact000963" name="us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock"><p id="xdx_895_eus-gaap--DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_zzd2qGLq0dEf" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prepaid
and other current assets consisted of the following as of February 28, 2025 and as of February 29, 2024:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span><span id="xdx_8B9_zZ9LwnoUVML1" style="display: none">Schedule
of Prepaid and Other Current Assets</span></span></span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_493_20250228_zaA7VLr6hEd7" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">February 28,</p>
                                                                               <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">2025</p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49E_20240229_z4C2EE7B1Xm" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">February 29,</p>
                                                                               <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">2024</p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--PrepaidOfferingCosts_iI_maPEAOAzw6s_znFtiZY5Fzd2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: justify">Offering costs</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><ix:nonFraction name="NTRP:PrepaidOfferingCosts" contextRef="AsOf2025-02-28" id="Fact000965" format="ixt:numdotdecimal" decimals="0" unitRef="USD">100,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0966">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_ecustom--PrepaidConsultingContract_iI_maPEAOAzw6s_zAVhaLKZoOG4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Current portion of two-year strategic consulting contract</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="NTRP:PrepaidConsultingContract" contextRef="AsOf2025-02-28" id="Fact000968" format="ixt:numdotdecimal" decimals="0" unitRef="USD">733,575</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0969">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_ecustom--PrepaidCostOfSales_iI_maPEAOAzw6s_z8dUu9C15iIl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Cost of sales</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="NTRP:PrepaidCostOfSales" contextRef="AsOf2025-02-28" id="Fact000971" format="ixt:numdotdecimal" decimals="0" unitRef="USD">121,588</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="NTRP:PrepaidCostOfSales" contextRef="AsOf2024-02-29" id="Fact000972" format="ixt:numdotdecimal" decimals="0" unitRef="USD">42,547</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--OtherPrepaidExpenseCurrent_iI_maPEAOAzw6s_zEO9vZ7unnL" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Other expenses</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:OtherPrepaidExpenseCurrent" contextRef="AsOf2025-02-28" id="Fact000974" format="ixt:numdotdecimal" decimals="0" unitRef="USD">425,412</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:OtherPrepaidExpenseCurrent" contextRef="AsOf2024-02-29" id="Fact000975" format="ixt:numdotdecimal" decimals="0" unitRef="USD">298,274</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--PrepaidAdvertising_iI_maPEAOAzw6s_zpQz10yOyLk8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 1pt">Marketing expenses</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0977">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:PrepaidAdvertising" contextRef="AsOf2024-02-29" id="Fact000978" format="ixt:numdotdecimal" decimals="0" unitRef="USD">100</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_iTI_mtPEAOAzw6s_z2yNbqhBQOy5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 2.5pt">Total</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="AsOf2025-02-28" id="Fact000980" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,380,575</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="AsOf2024-02-29" id="Fact000981" format="ixt:numdotdecimal" decimals="0" unitRef="USD">340,921</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A7_zgXt3pMmAJa4" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>


<ix:exclude><!-- Field: Page; Sequence: 93; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-03-01to2025-02-28" escape="true" id="Fact000983" name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock"><p id="xdx_80E_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_zMTpp6N84Goh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
7 - <span id="xdx_829_zPDHFk9aODM9">Property and Equipment</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2024-03-01to2025-02-28" escape="true" id="Fact000985" name="us-gaap:PropertyPlantAndEquipmentTextBlock"><p id="xdx_891_eus-gaap--PropertyPlantAndEquipmentTextBlock_z6SunUFoOwGj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property
and equipment as of February 28, 2025 and February 29, 2024 consisted of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BF_zEtJj1gNIcbg" style="display: none">Schedule
of Property and Equipment</span></span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_490_20250228_zWpUUeXWrJNb" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">February 28,</p>
                                                                               <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">2025</p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_497_20240229_zyYAsYQPn3A5" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">February 29,</p>
                                                                               <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">2024</p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zYTS5IqlbML3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left">Furniture and Fixtures</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2025-02-28_us-gaap_FurnitureAndFixturesMember" id="Fact000987" format="ixt:numdotdecimal" decimals="0" unitRef="USD">17,018</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2024-02-29_us-gaap_FurnitureAndFixturesMember" id="Fact000988" format="ixt:numdotdecimal" decimals="0" unitRef="USD">17,018</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_zXutqmKqqjGj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Computer and Equipment</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2025-02-28_us-gaap_ComputerEquipmentMember" id="Fact000990" format="ixt:numdotdecimal" decimals="0" unitRef="USD">80,786</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2024-02-29_us-gaap_ComputerEquipmentMember" id="Fact000991" format="ixt:numdotdecimal" decimals="0" unitRef="USD">82,492</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--PropertyPlantAndEquipmentGross_iI_maPPAENzyNw_zvY3v3iwVE74" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">Total</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2025-02-28" id="Fact000993" format="ixt:numdotdecimal" decimals="0" unitRef="USD">97,804</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2024-02-29" id="Fact000994" format="ixt:numdotdecimal" decimals="0" unitRef="USD">99,510</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_di_msPPAENzyNw_zMcYamBJ0cA6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Accumulated depreciation</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2025-02-28" id="Fact000996" format="ixt:numdotdecimal" decimals="0" unitRef="USD">93,685</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2024-02-29" id="Fact000997" format="ixt:numdotdecimal" decimals="0" unitRef="USD">92,868</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_40C_eus-gaap--PropertyPlantAndEquipmentNet_iTI_mtPPAENzyNw_zs6xEA8hJwX7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Property and Equipment, net of depreciation</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2025-02-28" id="Fact000999" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,119</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2024-02-29" id="Fact001000" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,642</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8AC_zp7QT4rzrdS7" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation
expense for the years ended February 28, 2025, and February 29, 2024 was $<span id="xdx_904_eus-gaap--Depreciation_c20240301__20250228_zvlqpnbQtuDk" title="Depreciation expense"><ix:nonFraction name="us-gaap:Depreciation" contextRef="From2024-03-01to2025-02-28" id="Fact001002" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,434</ix:nonFraction></span> and $<span id="xdx_906_eus-gaap--Depreciation_c20230301__20240229_z4CJhKlIg4hf" title="Depreciation expense"><ix:nonFraction name="us-gaap:Depreciation" contextRef="From2023-03-012024-02-29" id="Fact001004" format="ixt:numdotdecimal" decimals="0" unitRef="USD">18,838</ix:nonFraction></span>, respectively, and is recorded in operating
expenses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the years ended February 28, 2025 and February 29, 2024, the Company acquired property and equipment of $<span id="xdx_90D_eus-gaap--PaymentsToAcquirePropertyPlantAndEquipment_dxL_c20240301__20250228_z40WmMzunsv" title="Property and equipment::XDX::-"><span style="-sec-ix-hidden: xdx2ixbrl1006">0</span></span> and $<span id="xdx_908_eus-gaap--PaymentsToAcquirePropertyPlantAndEquipment_c20230301__20240229_zbTQ3DkdSAMe" title="Property and equipment"><ix:nonFraction name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="From2023-03-012024-02-29" id="Fact001008" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,253</ix:nonFraction></span>, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-03-01to2025-02-28" escape="true" id="Fact001010" name="us-gaap:IntangibleAssetsDisclosureTextBlock"><p id="xdx_808_eus-gaap--IntangibleAssetsDisclosureTextBlock_z4mPR0KbQZAf" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
8 - <span id="xdx_820_zTJZLaMb9ES1">Intangible Assets</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2024-03-01to2025-02-28" escape="true" id="Fact001012" name="us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"><p id="xdx_897_eus-gaap--ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_zMzuwzsxZmVb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangible
assets as of February 28, 2025, and February 29, 2024 consisted of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B9_zcVqzSqgiiBl" style="display: none">Schedule
of Intangible Assets</span></span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_491_20250228_zMGiNaZmXL5b" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">February 28,</p>
                                                                               <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">2025</p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_497_20240229_zetU7acUGT5k" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">February 29,</p>
                                                                               <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">2024</p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_hus-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareDevelopmentMember_zekzs3dSm5ml" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left">Software Development</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2025-02-28_us-gaap_SoftwareDevelopmentMember" id="Fact001014" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,267,778</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2024-02-29_us-gaap_SoftwareDevelopmentMember" id="Fact001015" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,602,028</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_hus-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SoftwareLicenseMember_zWrgLBaj59K" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Software Licenses</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2025-02-28_custom_SoftwareLicenseMember" id="Fact001017" format="ixt:numdotdecimal" decimals="0" unitRef="USD">789,576</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2024-02-29_custom_SoftwareLicenseMember" id="Fact001018" format="ixt:numdotdecimal" decimals="0" unitRef="USD">789,576</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_hus-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksMember_z50dLyO1uDDg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">Trademark</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2025-02-28_us-gaap_TrademarksMember" id="Fact001020" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,283</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2024-02-29_us-gaap_TrademarksMember" id="Fact001021" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,283</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_maIANEGzjZg_zeOpXEg4tvac" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">Total</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2025-02-28" id="Fact001023" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8,063,637</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2024-02-29" id="Fact001024" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,397,887</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iNI_di_msIANEGzjZg_zOR1s54bfor5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Accumulated amortization</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2025-02-28" id="Fact001026" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,936,269</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2024-02-29" id="Fact001027" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,224,467</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_40A_eus-gaap--IntangibleAssetsNetExcludingGoodwill_iTI_mtIANEGzjZg_zMNY8S7Av56d" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Intangible assets, net of amortization</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:IntangibleAssetsNetExcludingGoodwill" contextRef="AsOf2025-02-28" id="Fact001029" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,127,368</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:IntangibleAssetsNetExcludingGoodwill" contextRef="AsOf2024-02-29" id="Fact001030" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,173,420</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8AA_ztSc7ffpHbN1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amortization
expense for the years ended February 28, 2025 and February 29, 2024 was $<span id="xdx_901_eus-gaap--AmortizationOfIntangibleAssets_c20240301__20250228_z1z7BDzi649j" title="Amortization"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" contextRef="From2024-03-01to2025-02-28" id="Fact001032" format="ixt:numdotdecimal" decimals="0" unitRef="USD">711,802</ix:nonFraction></span>
and $<span id="xdx_90E_eus-gaap--AmortizationOfIntangibleAssets_c20230301__20240229_zBXe78p2Qr8b" title="Amortization"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" contextRef="From2023-03-012024-02-29" id="Fact001034" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,449,925</ix:nonFraction></span>,
respectively, and is recorded in operating expenses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the years ended February 28, 2025 and February 29, 2024, the Company recorded no impairment losses associated with the carrying value
exceeding its recoverable amount.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<ix:nonNumeric contextRef="From2024-03-01to2025-02-28" escape="true" id="Fact001036" name="us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"><p id="xdx_890_eus-gaap--ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_zxtda79nCq13" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
estimated aggregate amortization expense for each of the succeeding years ending February 28 is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b><span id="xdx_8BF_zK8DGd5XDLF7" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Schedule
of estimated aggregate amortization expense</span></span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%">
  <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td id="xdx_492_20250228_zvwRmE3Hy06d" style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr>
<tr id="xdx_400_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_iI_maFLIANzgGq_zmX8Le2zIXee" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 78%; text-align: left">2025</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" contextRef="AsOf2025-02-28" id="Fact001038" format="ixt:numdotdecimal" decimals="0" unitRef="USD">597,914</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_iI_maFLIANzgGq_zlGpJjXF1bSi" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">2026</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" contextRef="AsOf2025-02-28" id="Fact001040" format="ixt:numdotdecimal" decimals="0" unitRef="USD">623,882</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_iI_maFLIANzgGq_zIvT3DmfbQ46" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">2027</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" contextRef="AsOf2025-02-28" id="Fact001042" format="ixt:numdotdecimal" decimals="0" unitRef="USD">312,358</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_iI_maFLIANzgGq_zlLijaxGX7W3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">2028</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" contextRef="AsOf2025-02-28" id="Fact001044" format="ixt:numdotdecimal" decimals="0" unitRef="USD">528</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_ecustom--FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour_iI_maFLIANzgGq_zSd01zuCTb31" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Thereafter</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1046">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_mtFLIANzgGq_zLFRe29Qm969" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="AsOf2025-02-28" id="Fact001048" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,534,682</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A6_zTFjqqWrscsa" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-03-01to2025-02-28" escape="true" id="Fact001050" name="us-gaap:GoodwillDisclosureTextBlock"><p id="xdx_801_eus-gaap--GoodwillDisclosureTextBlock_zWPMFJypXXB3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
9 &#8211; <span id="xdx_829_zVVnxALhjXHc">Goodwill</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
discussed in <b>Note 1&#8211; Business Description and Going Concern</b>, the legal acquisition of NTH by the Company was determined to be a reverse acquisition, with NTH as the accounting acquirer, using the acquisition method of accounting
in accordance with ASC 805, Business Combinations. Under this method of accounting, the purchase price was allocated to the assets acquired
and liabilities assumed based upon their estimated fair values at the date of consummation of the transaction.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 94; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table presents the allocation of the $<span id="xdx_900_eus-gaap--BusinessCombinationConsiderationTransferred1_c20231012__20231012__us-gaap--BusinessAcquisitionAxis__custom--SigmaAdditiveSolutionsIncMember_zW6FAhvFKOug" title="Consideration transferred"><ix:nonFraction name="us-gaap:BusinessCombinationConsiderationTransferred1" contextRef="From2023-10-122023-10-12_custom_SigmaAdditiveSolutionsIncMember" id="Fact001052" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,368,418</ix:nonFraction></span>
consideration for the acquisition and summarizes the estimated fair values of the Sigma (the accounting acquiree) assets acquired
and liabilities assumed for NTH (the accounting acquirer). The estimated consideration of approximately $<span id="xdx_904_eus-gaap--BusinessCombinationConsiderationTransferred1_c20231012__20231012__us-gaap--BusinessAcquisitionAxis__custom--SigmaAdditiveSolutionsIncMember_zRSV2kBwEe62" title="Consideration transferred"><ix:nonFraction name="us-gaap:BusinessCombinationConsiderationTransferred1" contextRef="From2023-10-122023-10-12_custom_SigmaAdditiveSolutionsIncMember" id="Fact001054" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,368,418</ix:nonFraction></span>
is based on Sigma&#8217;s closing share price of $<span id="xdx_906_eus-gaap--BusinessAcquisitionSharePrice_iI_pid_c20231012__us-gaap--BusinessAcquisitionAxis__custom--SigmaAdditiveSolutionsIncMember_z8YJRkGf8PSb" title="Share price"><ix:nonFraction name="us-gaap:BusinessAcquisitionSharePrice" contextRef="AsOf2023-10-12_custom_SigmaAdditiveSolutionsIncMember" id="Fact001056" decimals="INF" unitRef="USDPShares">3.0229</ix:nonFraction>,</span>
as reported on Nasdaq on December 29, 2023 multiplied by the <span id="xdx_90A_eus-gaap--CommonStockSharesOutstanding_iI_c20231012_zPDW0LbjsEVg" title="Shares outstanding"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2023-10-12" id="Fact001058" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">780,423</ix:nonFraction></span>
shares outstanding as of that date and the fair value of Series E Preferred Stock (on an as converted basis) into <span id="xdx_904_eus-gaap--CommonStockSharesOutstanding_iI_c20231012__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesEPreferredStockMember_zBjDxbkcvl42" title="Shares outstanding"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2023-10-12_us-gaap_SeriesEPreferredStockMember" id="Fact001060" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,069</ix:nonFraction></span>
common shares.</span></p>

<ix:nonNumeric contextRef="From2024-03-01to2025-02-28" escape="true" id="Fact001062" name="us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"><p id="xdx_89C_eus-gaap--ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_zDnofmYiEA1d" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BB_zX19U9Pi4bTl" style="display: none">Schedule
of Fair Value of Assets Acquired</span></span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
  <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td>
    <td colspan="2" id="xdx_495_20231012__us-gaap--BusinessAcquisitionAxis__custom--SigmaAdditiveSolutionsIncMember_zzmncsXgk2P3" style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td colspan="5" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Fair Value of Net Assets Acquired:</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_iI_maBCRIAzMVe_zYkg02IIjFDb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 78%">Cash</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" contextRef="AsOf2023-10-12_custom_SigmaAdditiveSolutionsIncMember" id="Fact001064" format="ixt:numdotdecimal" decimals="0" unitRef="USD">417,121</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_iI_maBCRIAzMVe_z15YejLtQxk9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Accounts Receivable, net</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" contextRef="AsOf2023-10-12_custom_SigmaAdditiveSolutionsIncMember" id="Fact001066" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,900</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_iI_maBCRIAzMVe_zQWARQWVfXci" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">Inventory</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" contextRef="AsOf2023-10-12_custom_SigmaAdditiveSolutionsIncMember" id="Fact001068" format="ixt:numdotdecimal" decimals="0" unitRef="USD">257,873</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_iI_maBCRIAzMVe_zL1FXHlImNyg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Prepaid expenses and other current assets</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" contextRef="AsOf2023-10-12_custom_SigmaAdditiveSolutionsIncMember" id="Fact001070" format="ixt:numdotdecimal" decimals="0" unitRef="USD">50,802</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_iI_maBCRIAzMVe_z3g28zCwuAf4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Property and equipment</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" contextRef="AsOf2023-10-12_custom_SigmaAdditiveSolutionsIncMember" id="Fact001072" format="ixt:numdotdecimal" decimals="0" unitRef="USD">52,357</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_iI_maBCRIAzMVe_z6ftHVRcBZg7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Intangible assets</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" contextRef="AsOf2023-10-12_custom_SigmaAdditiveSolutionsIncMember" id="Fact001074" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,277,919</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_iNI_di_msBCRIAzMVe_zpye9vMBtYE1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Accounts payable</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" contextRef="AsOf2023-10-12_custom_SigmaAdditiveSolutionsIncMember" id="Fact001076" format="ixt:numdotdecimal" decimals="0" unitRef="USD">837,450</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr id="xdx_403_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses_iNI_di_msBCRIAzMVe_zV7kmVYEqlQ7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Accrued expenses</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="NTRP:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses" contextRef="AsOf2023-10-12_custom_SigmaAdditiveSolutionsIncMember" id="Fact001078" format="ixt:numdotdecimal" decimals="0" unitRef="USD">61,001</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr id="xdx_402_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_iNI_di_msBCRIAzMVe_zEkqA9FU2eYj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Deferred revenue</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" contextRef="AsOf2023-10-12_custom_SigmaAdditiveSolutionsIncMember" id="Fact001080" format="ixt:numdotdecimal" decimals="0" unitRef="USD">14,218</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iTI_mtBCRIAzMVe_maBCRIAzevg_z0KXangQ1Emi" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Total identifiable net assets acquired</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" contextRef="AsOf2023-10-12_custom_SigmaAdditiveSolutionsIncMember" id="Fact001082" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,148,303</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--Goodwill_iI_maBCRIAzevg_z0xwSYYEs4Je" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">Goodwill</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:Goodwill" contextRef="AsOf2023-10-12_custom_SigmaAdditiveSolutionsIncMember" id="Fact001084" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,220,115</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_iTI_mtBCRIAzevg_zXBJU8hxiP4e" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Total Fair Value of Net Assets Acquired</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" contextRef="AsOf2023-10-12_custom_SigmaAdditiveSolutionsIncMember" id="Fact001086" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,368,418</ix:nonFraction></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Total Purchase Consideration</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_985_eus-gaap--BusinessCombinationConsiderationTransferred1_c20231012__20231012__us-gaap--BusinessAcquisitionAxis__custom--SigmaAdditiveSolutionsIncMember_zcZftK0JDz8j" style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:BusinessCombinationConsiderationTransferred1" contextRef="From2023-10-122023-10-12_custom_SigmaAdditiveSolutionsIncMember" id="Fact001087" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,368,418</ix:nonFraction></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A0_zczo4MRxO5Hl" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to ASC 350-20, the Company assigned its goodwill to reporting units and is required to test each reporting unit&#8217;s goodwill for
impairment at least on an annual basis and between annual tests if an event occurs or circumstances change that would more likely
than not reduce the fair value of a reporting unit below its carrying amount. The goodwill resulting from the reverse acquisition is
primarily attributable to NTH&#8217;s objective to obtain access to public markets to provide funding wherewithal to fund business
growth. NTH&#8217;s benefit in paying for these synergies in the reverse acquisition transaction are to avoid the time and expense
of organizing and executing an Initial Public Offering transaction. In the reverse acquisition, $<span id="xdx_902_eus-gaap--GoodwillPeriodIncreaseDecrease_c20231012__20231012__us-gaap--BusinessAcquisitionAxis__custom--SigmaAdditiveSolutionsIncMember_zi5bC55rUBYa" title="Goodwill"><ix:nonFraction name="us-gaap:GoodwillPeriodIncreaseDecrease" contextRef="From2023-10-122023-10-12_custom_SigmaAdditiveSolutionsIncMember" id="Fact001089" format="ixt:numdotdecimal" decimals="0" unitRef="USD">52,310</ix:nonFraction></span>
of goodwill was allocated to the Sigma Reporting Unit (as defined below) and $<span id="xdx_90B_eus-gaap--GoodwillPeriodIncreaseDecrease_c20231012__20231012__us-gaap--BusinessAcquisitionAxis__custom--NextTripHoldingsIncMember_z6OXPWNwWl83" title="Goodwill"><ix:nonFraction name="us-gaap:GoodwillPeriodIncreaseDecrease" contextRef="From2023-10-122023-10-12_custom_NextTripHoldingsIncMember" id="Fact001091" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,167,805</ix:nonFraction></span>
of goodwill was allocated to the NTH Reporting Unit (as defined below) under the acquisition method of accounting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
combined Company consists of two reporting units, Sigma (the &#8220;Sigma Reporting Unit&#8221;) and NTH (the &#8220;NTH Reporting
Unit&#8221;). As the accounting acquirer in the reverse acquisition, NTH is considered to be an existing reporting unit and Sigma is
considered to be a new reporting unit in that it is not in the same business as NTH. Accordingly, the reverse acquisition creates a
new reporting unit which holds the Sigma business, constituting an asset held for sale as a result of the agreement for the sale of
certain legacy Sigma assets to Divergent for a sales price of $<span id="xdx_900_eus-gaap--PaymentsToAcquireIntangibleAssets_c20231012__20231012__dei--LegalEntityAxis__custom--DivergentTechnologiesIncMember_ziJtjLwFy6Zi" title="Purchase price"><ix:nonFraction name="us-gaap:PaymentsToAcquireIntangibleAssets" contextRef="From2023-10-122023-10-12_custom_DivergentTechnologiesIncMember" id="Fact001093" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,626,242</ix:nonFraction></span>.
As such, the fair value of the Sigma Reporting Unit is determined to be $<span id="xdx_900_eus-gaap--PaymentsToAcquireIntangibleAssets_c20231012__20231012__dei--LegalEntityAxis__custom--DivergentTechnologiesIncMember_zBatN4lIfTFe" title="Purchase price"><ix:nonFraction name="us-gaap:PaymentsToAcquireIntangibleAssets" contextRef="From2023-10-122023-10-12_custom_DivergentTechnologiesIncMember" id="Fact001095" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,626,242</ix:nonFraction></span>,
with the difference of $<span id="xdx_90C_eus-gaap--BusinessCombinationConsiderationTransferred1_c20231012__20231012__us-gaap--BusinessAcquisitionAxis__custom--NextTripHoldingsIncMember_zTcxU0mfMXnb" title="Purchase consideration"><ix:nonFraction name="us-gaap:BusinessCombinationConsiderationTransferred1" contextRef="From2023-10-122023-10-12_custom_NextTripHoldingsIncMember" id="Fact001097" format="ixt:numdotdecimal" decimals="0" unitRef="USD">742,176</ix:nonFraction></span>
from the purchase consideration being allocated to the NTH Reporting Unit. The assets sold to Divergent and the
liabilities relieved from the Divergent transaction are assigned to the Sigma Reporting unit with the difference between the
net fair value of those assets and liabilities and the Sigma Reporting Unit being assigned to goodwill. The goodwill being assigned
to the NTH Reporting Unit is determined by the difference between the purchase consideration assigned to the NTH Reporting
Unit and the net acquired Sigma assets and liabilities assumed that are assigned to the NTH Reporting Unit. A gain of $<span id="xdx_906_eus-gaap--GainLossOnDispositionOfAssets_c20231012__20231012_zEoTtbZ4IOCh" title="Gain on disposition transaction"><ix:nonFraction name="us-gaap:GainLossOnDispositionOfAssets" contextRef="From2023-10-122023-10-12" id="Fact001099" format="ixt:numdotdecimal" decimals="0" unitRef="USD">37,592</ix:nonFraction></span>
was recognized in the disposition transaction.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-03-01to2025-02-28" escape="true" id="Fact001101" name="us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock"><p id="xdx_80D_eus-gaap--AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_z7y9rYBML4o7" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
10 - <span id="xdx_825_zJ9fAe9YNBbf">Accounts Payable and Accrued Liabilities</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of February 28, 2025, the Company had accounts payable of $<span id="xdx_907_eus-gaap--AccountsPayableCurrentAndNoncurrent_iI_c20250228_zryYUIlMxoT8" title="Accounts payable"><ix:nonFraction name="us-gaap:AccountsPayableCurrentAndNoncurrent" contextRef="AsOf2025-02-28" id="Fact001103" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,184,404</ix:nonFraction></span> and accrued expenses of $<span id="xdx_90D_eus-gaap--AccruedLiabilitiesCurrentAndNoncurrent_iI_c20250228_zOPT2vJQ7Gq3" title="Accrued expenses"><ix:nonFraction name="us-gaap:AccruedLiabilitiesCurrentAndNoncurrent" contextRef="AsOf2025-02-28" id="Fact001105" format="ixt:numdotdecimal" decimals="0" unitRef="USD">721,382</ix:nonFraction></span>, compared to $<span id="xdx_905_eus-gaap--AccountsPayableCurrentAndNoncurrent_iI_c20240229_znbiVZ0aUmH2" title="Accounts payable"><ix:nonFraction name="us-gaap:AccountsPayableCurrentAndNoncurrent" contextRef="AsOf2024-02-29" id="Fact001107" format="ixt:numdotdecimal" decimals="0" unitRef="USD">531,847</ix:nonFraction></span> of accounts
payable and $<span id="xdx_90B_eus-gaap--AccruedLiabilitiesCurrentAndNoncurrent_iI_c20240229_z11rWuyggAGf" title="Accrued expenses"><ix:nonFraction name="us-gaap:AccruedLiabilitiesCurrentAndNoncurrent" contextRef="AsOf2024-02-29" id="Fact001109" format="ixt:numdotdecimal" decimals="0" unitRef="USD">460,768</ix:nonFraction></span> of accrued expenses for the year ended February 29, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-03-01to2025-02-28" escape="true" id="Fact001111" name="us-gaap:IncomeTaxDisclosureTextBlock"><p id="xdx_802_eus-gaap--IncomeTaxDisclosureTextBlock_zAMEfinEtRp8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
11 &#8211; <span id="xdx_821_zRvcjmT4d2N5">Income Taxes</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for income taxes in accordance with ASC Topic No. 740. This standard requires the Company to provide a net deferred
tax asset or liability equal to the expected future tax benefit or expense of temporary reporting differences between book and tax
accounting methods and any available net operating loss or tax credit carryforwards. Income tax returns open for examination by the
Internal Revenue Service consist of tax years ended February 28, 2021 through 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 95; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company had available at February 28, 2025 unused operating loss carryforwards of approximately $<span id="xdx_90A_eus-gaap--OperatingLossCarryforwards_iI_c20250228_zSA0W3b79QS8" title="Operating loss carryforwards"><ix:nonFraction name="us-gaap:OperatingLossCarryforwards" contextRef="AsOf2025-02-28" id="Fact001113" format="ixt:numdotdecimal" decimals="0" unitRef="USD">54,763,000</ix:nonFraction></span>, which may be applied against
future taxable income. Losses incurred between 2010 and 2017, which total $<span id="xdx_900_eus-gaap--OperatingLossCarryforwards_iI_c20171231_zmYP2WgUOpP6" title="Operating loss carryforwards"><ix:nonFraction name="us-gaap:OperatingLossCarryforwards" contextRef="AsOf2017-12-31" id="Fact001115" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,820,000</ix:nonFraction></span>, expire in various years through 2038, and the remainder
of the losses, which total $<span id="xdx_90A_ecustom--OperatingLossCarryforwardsRemainder_iI_c20250228_z5GAdPXg45Kc" title="Operating loss carryforwards remainder"><ix:nonFraction name="NTRP:OperatingLossCarryforwardsRemainder" contextRef="AsOf2025-02-28" id="Fact001117" format="ixt:numdotdecimal" decimals="0" unitRef="USD">44,943,000</ix:nonFraction></span>, can be carried forward indefinitely. Due to the change in ownership provisions of the Tax Reform
Act of 1986, net operating loss carryforwards for Federal income tax reported purposes are subject to annual limitations. Due to the
change in ownership as a result of the reverse acquisition, the Company&#8217;s net operating loss carryforwards may be limited as to
use in future years, and any such limitation will be determined on a year-to-year basis. The amount and ultimate realization of the
benefits from the operating loss carryforwards for income tax purposes is dependent, in part, upon the tax laws in effect, the future
earnings of the Company and other future events, the effects of which cannot be determined. Because of the uncertainty surrounding the
realization of the loss carryforwards, the Company has established a valuation allowance equal to the tax effect of the loss carryforwards
and other temporary differences of approximately $<span id="xdx_904_eus-gaap--DeferredTaxAssetsValuationAllowance_iI_c20250228_zXMxl7FIKd6h" title="Valuation allowance loss carryforwards"><ix:nonFraction name="us-gaap:DeferredTaxAssetsValuationAllowance" contextRef="AsOf2025-02-28" id="Fact001119" format="ixt:numdotdecimal" decimals="0" unitRef="USD">11,816,400</ix:nonFraction></span> and $<span id="xdx_900_eus-gaap--DeferredTaxAssetsValuationAllowance_iI_c20240229_zqO5bIbmUTp" title="Valuation allowance loss carryforwards"><ix:nonFraction name="us-gaap:DeferredTaxAssetsValuationAllowance" contextRef="AsOf2024-02-29" id="Fact001121" format="ixt:numdotdecimal" decimals="0" unitRef="USD">11,250,300</ix:nonFraction></span> at February 28, 2025, and February 29, 2024, respectively,
and, therefore, no deferred tax asset has been recognized for the loss carryforwards.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2024-03-01to2025-02-28" escape="true" id="Fact001123" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"><p id="xdx_89C_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zm5FVERFSJ79" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred
tax assets are comprised of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BA_zjS1RXDG8JMl" style="display: none">Schedule of Deferred Tax Assets</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_497_20250228_zMJ3N7S1jjIh" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">2025</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49C_20240229_zhx5HdvLifX5" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">2024</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Deferred tax assets:</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_pp0p0_maDTANzaXy_z7BPBcuMa4j6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left">NOL carryover</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" contextRef="AsOf2025-02-28" id="Fact001125" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">11,500,300</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><ix:nonFraction name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" contextRef="AsOf2024-02-29" id="Fact001126" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">9,226,100</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--DeferredTaxAssetDepreciation_iI_pp0p0_maDTANzaXy_zpGYk1ZOToF6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Related party accruals</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="NTRP:DeferredTaxAssetDepreciation" contextRef="AsOf2025-02-28" id="Fact001128" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">12,900</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="NTRP:DeferredTaxAssetDepreciation" contextRef="AsOf2024-02-29" id="Fact001129" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">173,900</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_ecustom--DeferredTaxAssetsPayrollAccruals_iI_pp0p0_maDTANzaXy_zwCIXWVDgPE9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Payroll accruals</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="NTRP:DeferredTaxAssetsPayrollAccruals" contextRef="AsOf2025-02-28" id="Fact001131" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">47,800</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="NTRP:DeferredTaxAssetsPayrollAccruals" contextRef="AsOf2024-02-29" id="Fact001132" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">77,800</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Deferred tax liabilities:</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_ecustom--DeferredTaxLiabilitiesDepreciation_iNI_di_msDTANzaXy_z3CrokXutTlk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">Depreciation</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="NTRP:DeferredTaxLiabilitiesDepreciation" contextRef="AsOf2025-02-28" id="Fact001134" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">255,400</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="NTRP:DeferredTaxLiabilitiesDepreciation" contextRef="AsOf2024-02-29" id="Fact001135" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,772,500</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_di_msDTANzaXy_zB3Dn34YPKJe" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Valuation allowance</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:DeferredTaxAssetsValuationAllowance" contextRef="AsOf2025-02-28" id="Fact001137" format="ixt:numdotdecimal" decimals="0" unitRef="USD">11,816,400</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:DeferredTaxAssetsValuationAllowance" contextRef="AsOf2024-02-29" id="Fact001138" format="ixt:numdotdecimal" decimals="0" unitRef="USD">11,250,300</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_40E_eus-gaap--DeferredTaxAssetsNet_iTI_pp0p0_mtDTANzaXy_zmyZXff2Z04a" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Net deferred tax asset (liability)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1140">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1141">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8AD_zLxZyXncLAHj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
reconciliation of the provision for income taxes computed at the U.S. federal statutory tax rate (<span id="xdx_90F_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pid_dp_uPure_c20240301__20250228_zTwd4Tos7Jcj" title="Federal statutory tax rate"><span id="xdx_908_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pid_dp_uPure_c20230301__20240229_zKEATpMRAFKj" title="Federal statutory tax rate"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" contextRef="From2024-03-01to2025-02-28" id="Fact001143" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" contextRef="From2023-03-012024-02-29" id="Fact001145" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">21</ix:nonFraction></ix:nonFraction></span></span>%) to the Company&#8217;s effective
tax rate for the years ended February 28, 2025, and February 29, 2024 is as follows:</span></p>

<ix:nonNumeric contextRef="From2024-03-01to2025-02-28" escape="true" id="Fact001147" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"><p id="xdx_894_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_z1nA8U21pNwd" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BE_zVTgBR51BTI" style="display: none">Schedule
of Reconciliation of Provision for Income Taxes</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49E_20240301__20250228_zGywL4iFe0Kh" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">2025</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_498_20230301__20240229_zF6BxogVbtue" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">2024</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_404_ecustom--EffectiveIncomeTaxRateReconciliationBookLoss_maITEBzMQv_zQlIL8hoKUDf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left">Book loss</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">(<ix:nonFraction name="NTRP:EffectiveIncomeTaxRateReconciliationBookLoss" contextRef="From2024-03-01to2025-02-28" id="Fact001149" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">2,141,700</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">(<ix:nonFraction name="NTRP:EffectiveIncomeTaxRateReconciliationBookLoss" contextRef="From2023-03-012024-02-29" id="Fact001150" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,541,200</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">)</td></tr>
  <tr id="xdx_40C_eus-gaap--IncomeTaxReconciliationNondeductibleExpenseDepreciation_maITEBzMQv_zfkiHKDQ2hk7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">Depreciation</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseDepreciation" contextRef="From2024-03-01to2025-02-28" id="Fact001152" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">197,100</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseDepreciation" contextRef="From2023-03-012024-02-29" id="Fact001153" format="ixt:numdotdecimal" decimals="0" unitRef="USD">270,100</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment_maITEBzMQv_zsvIGW2gXn6f" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Meals &amp; entertainment</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1155">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment" contextRef="From2023-03-012024-02-29" id="Fact001156" format="ixt:numdotdecimal" decimals="0" unitRef="USD">300</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_ecustom--IncomeTaxReconciliationNondeductibleExpensePreferredDividends_maITEBzMQv_z5S1j75qjE8g" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Preferred dividends</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="NTRP:IncomeTaxReconciliationNondeductibleExpensePreferredDividends" contextRef="From2024-03-01to2025-02-28" id="Fact001158" format="ixt:numdotdecimal" decimals="0" unitRef="USD">16,506</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="NTRP:IncomeTaxReconciliationNondeductibleExpensePreferredDividends" contextRef="From2023-03-012024-02-29" id="Fact001159" format="ixt:numdotdecimal" decimals="0" unitRef="USD">422,842</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_ecustom--IncomeTaxReconciliationNondeductibleExpenseLossOnNextPlayNoteReceivable_maITEBzMQv_zZHdbst94oE5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Loss on NextPlay note receivable</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><p style="margin: 0"><ix:nonFraction name="NTRP:IncomeTaxReconciliationNondeductibleExpenseLossOnNextPlayNoteReceivable" contextRef="From2024-03-01to2025-02-28" id="Fact001161" format="ixt:numdotdecimal" decimals="0" unitRef="USD">210,000</ix:nonFraction></p></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><p style="margin: 0"><span style="-sec-ix-hidden: xdx2ixbrl1162">-</span></p></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_maITEBzMQv_zBx7diM0508d" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Stock compensation</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" contextRef="From2024-03-01to2025-02-28" id="Fact001164" format="ixt:numdotdecimal" decimals="0" unitRef="USD">14,254</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" contextRef="From2023-03-012024-02-29" id="Fact001165" format="ixt:numdotdecimal" decimals="0" unitRef="USD">24,468</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_ecustom--IncomeTaxReconciliationNondeductibleExpenseLossOnAssetDisposal_maITEBzMQv_zIsiJttSawak" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Loss on asset disposal</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="NTRP:IncomeTaxReconciliationNondeductibleExpenseLossOnAssetDisposal" contextRef="From2024-03-01to2025-02-28" id="Fact001167" format="ixt:numdotdecimal" decimals="0" unitRef="USD">229</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="NTRP:IncomeTaxReconciliationNondeductibleExpenseLossOnAssetDisposal" contextRef="From2023-03-012024-02-29" id="Fact001168" format="ixt:numdotdecimal" decimals="0" unitRef="USD">67,274</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_ecustom--IncomeTaxReconciliationNondeductibleExpenseAccruedPayroll_maITEBzMQv_zl7vdpLM9dDb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Accrued payroll</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="NTRP:IncomeTaxReconciliationNondeductibleExpenseAccruedPayroll" contextRef="From2024-03-01to2025-02-28" id="Fact001170" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">29,991</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="NTRP:IncomeTaxReconciliationNondeductibleExpenseAccruedPayroll" contextRef="From2023-03-012024-02-29" id="Fact001171" format="ixt:numdotdecimal" decimals="0" unitRef="USD">51,857</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_ecustom--IncomeTaxReconciliationNondeductibleExpenseRelatedPartyAccruals_maITEBzMQv_zSajqfDyM3ac" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Related party accruals</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="NTRP:IncomeTaxReconciliationNondeductibleExpenseRelatedPartyAccruals" contextRef="From2024-03-01to2025-02-28" id="Fact001173" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">161,018</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="NTRP:IncomeTaxReconciliationNondeductibleExpenseRelatedPartyAccruals" contextRef="From2023-03-012024-02-29" id="Fact001174" format="ixt:numdotdecimal" decimals="0" unitRef="USD">114,928</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_maITEBzMQv_z8zXFDg5og7a" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Change in valuation allowance</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" contextRef="From2024-03-01to2025-02-28" id="Fact001176" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,288,820</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" contextRef="From2023-03-012024-02-29" id="Fact001177" format="ixt:numdotdecimal" decimals="0" unitRef="USD">589,431</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--IncomeTaxExpenseBenefit_iT_pp0p0_mtITEBzMQv_zCxHBGqrRx7a" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Provision for Income Taxes</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1179">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1180">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A9_zH8XhtFGojgd" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-03-01to2025-02-28" escape="true" id="Fact001182" name="us-gaap:DebtDisclosureTextBlock"><p id="xdx_80B_eus-gaap--DebtDisclosureTextBlock_zJycisDhM7kj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
12 &#8211; <span id="xdx_82A_zKmZC7DCvcz3">Notes Payable</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 24, 2024, the Company sold a short-term promissory note to a private investor in the aggregate principal amount of $<span id="xdx_90B_eus-gaap--ProceedsFromConvertibleDebt_c20240524__20240524_zBEAX7ZtzvLl" title="Proceeds from convertible debt"><ix:nonFraction name="us-gaap:ProceedsFromConvertibleDebt" contextRef="From2024-05-242024-05-24" id="Fact001184" format="ixt:numdotdecimal" decimals="0" unitRef="USD">100,000</ix:nonFraction></span>. The
note bears interest at <span id="xdx_907_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20240524_zrgztgDt5oV6" title="Interest rate"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="AsOf2024-05-24" id="Fact001186" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">7.5</ix:nonFraction>%</span> per annum and had a maturity date of the earlier of completion of a public financing or October 31, 2024.
The investor has consented to extend the maturity date on a month-to-month basis and continues to accrue interest. As of February 28,
2025, the full principal amount of $<span id="xdx_902_eus-gaap--ProceedsFromConvertibleDebt_c20250228__20250228_zJMqQv5AfXT5" title="Proceeds from convertible debt"><ix:nonFraction name="us-gaap:ProceedsFromConvertibleDebt" contextRef="From2025-02-282025-02-28" id="Fact001188" format="ixt:numdotdecimal" decimals="0" unitRef="USD">100,000</ix:nonFraction></span> was outstanding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 26, 2024, the Company sold a short-term promissory note to a private investor in the aggregate principal amount of $<span id="xdx_902_eus-gaap--ProceedsFromConvertibleDebt_c20240626__20240626_zI2ZfkH51vMd" title="Proceeds from convertible debt"><ix:nonFraction name="us-gaap:ProceedsFromConvertibleDebt" contextRef="From2024-06-262024-06-26" id="Fact001190" format="ixt:numdotdecimal" decimals="0" unitRef="USD">40,000</ix:nonFraction></span>. The
note bears interest at <span id="xdx_90E_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20240626_zgfW4BoE5CYb" title="Interest rate"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="AsOf2024-06-26" id="Fact001192" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">7.5</ix:nonFraction>%</span> per annum and has a maturity date of June 25, 2025, which may be extended by written consent of the investor.
As of February 28, 2025, the full principal amount of $<span id="xdx_901_eus-gaap--DebtInstrumentFaceAmount_iI_c20250228_zxsaPosbe7Y5" title="Proceeds from convertible debt"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2025-02-28" id="Fact001194" format="ixt:numdotdecimal" decimals="0" unitRef="USD">40,000</ix:nonFraction></span> was outstanding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 19, 2024, the Company sold a short-term promissory note and warrants to Alumni Capital for total consideration of $<span id="xdx_901_eus-gaap--NotesAndLoansPayableCurrent_iI_c20240919__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_z0C93Fxfrkh1"><ix:nonFraction name="us-gaap:NotesAndLoansPayableCurrent" contextRef="AsOf2024-09-19_custom_SecuritiesPurchaseAgreementMember" id="Fact001195" format="ixt:numdotdecimal" decimals="0" unitRef="USD">250,000</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.
After deducting commissions, net proceeds to the Company were $<span id="xdx_904_eus-gaap--ProceedsFromNotesPayable_c20240919__20240919__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_z4FHdwt6KMi2"><ix:nonFraction name="us-gaap:ProceedsFromNotesPayable" contextRef="From2024-09-192024-09-19_custom_SecuritiesPurchaseAgreementMember" id="Fact001196" format="ixt:numdotdecimal" decimals="0" unitRef="USD">230,000</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">. </span>The
Alumni Note is in the principal amount of $<span id="xdx_908_eus-gaap--DebtInstrumentFaceAmount_iI_c20240919__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zCWCosv8eXC2"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2024-09-19_custom_SecuritiesPurchaseAgreementMember" id="Fact001197" format="ixt:numdotdecimal" decimals="0" unitRef="USD">300,000</ix:nonFraction></span>
with an original issue discount of $<span id="xdx_90D_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_c20240919__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zeOR7C3q0v5g"><ix:nonFraction name="us-gaap:DebtInstrumentUnamortizedDiscount" contextRef="AsOf2024-09-19_custom_SecuritiesPurchaseAgreementMember" id="Fact001198" format="ixt:numdotdecimal" decimals="0" unitRef="USD">50,000</ix:nonFraction></span>
and guaranteed interest on the principal amount of <span id="xdx_908_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20240919__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zlVVaRo5Bd4k"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="AsOf2024-09-19_custom_SecuritiesPurchaseAgreementMember" id="Fact001199" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">10</ix:nonFraction>%</span>
per annum which shall be due and payable on <span id="xdx_909_eus-gaap--DebtInstrumentMaturityDate_c20240919__20240919__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_z9Ow7VXcrnO4"><ix:nonNumeric contextRef="From2024-09-192024-09-19_custom_SecuritiesPurchaseAgreementMember" format="ixt:datemonthdayyearen" id="Fact001200" name="us-gaap:DebtInstrumentMaturityDate">December
19, 2024</ix:nonNumeric></span>. In the event of a failure to re-pay the Alumni Note on or before December 19, 2024, the interest rate will increase
to the lesser of twenty-two percent (<span id="xdx_902_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20240919__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--RangeAxis__srt--MaximumMember_zAftHR1QEATh"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="AsOf2024-09-19_custom_SecuritiesPurchaseAgreementMember_srt_MaximumMember" id="Fact001201" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">22</ix:nonFraction>%</span>)
per annum or the maximum amount permitted under law from the due date thereof until the same is paid. The Alumni Note is convertible
into common stock of the Company only upon an event of default. In accordance with ASC 470-20-25-2, the proceeds of the short-term
promissory note was allocated to the note and the warrant based on the relative fair values of the note without the warrants and of
the warrant itself at time of issuance, with the portion of the proceeds allocated to the warrants accounted for as paid-in capital,
and the remainder of the proceeds allocated to the note. The relative fair value of the warrants at the time of issuance that was
allocated to additional paid-in capital was $<span id="xdx_90C_eus-gaap--AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_c20240919__20240919_zNOGirYXAju4" title="Warrants additional paid in capital"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" contextRef="From2024-09-192024-09-19" id="Fact001203" format="ixt:numdotdecimal" decimals="0" unitRef="USD">116,322</ix:nonFraction></span>. The Alumni note and accrued interest was repaid on December 19, 2024.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<ix:exclude><!-- Field: Page; Sequence: 96; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 18, 2024, the Company sold a short-term promissory note to 1800 Diagonal Lending LLC in the aggregate principal amount of $<span id="xdx_90B_eus-gaap--DebtInstrumentFaceAmount_iI_c20241018__us-gaap--TypeOfArrangementAxis__custom--NoteSecuritiesPurchaseAgreementMember_zWr2I6la4A2c" title="Principal amount"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2024-10-18_custom_NoteSecuritiesPurchaseAgreementMember" id="Fact001205" format="ixt:numdotdecimal" decimals="0" unitRef="USD">154,440</ix:nonFraction></span>.
The note includes an Original Issue Discount of $<span id="xdx_901_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_c20241018__us-gaap--TypeOfArrangementAxis__custom--NoteSecuritiesPurchaseAgreementMember_z51Qe94BOfR4" title="Original issue discount"><ix:nonFraction name="us-gaap:DebtInstrumentUnamortizedDiscount" contextRef="AsOf2024-10-18_custom_NoteSecuritiesPurchaseAgreementMember" id="Fact001207" format="ixt:numdotdecimal" decimals="0" unitRef="USD">22,440</ix:nonFraction></span>, and bears a one-time interest charge of <span id="xdx_903_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20241018__us-gaap--TypeOfArrangementAxis__custom--NoteSecuritiesPurchaseAgreementMember_zftE50q6jJ9g" title="Interest rate"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="AsOf2024-10-18_custom_NoteSecuritiesPurchaseAgreementMember" id="Fact001209" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">13</ix:nonFraction>%</span>, which was applied on the issuance
date to the principal. The note is payable in ten equal installments of $<span id="xdx_902_ecustom--ConvertibleNotesPayableOfInstallments_iI_c20241018_z3eNQ8RVoR6" title="Note payable equal installments"><ix:nonFraction name="NTRP:ConvertibleNotesPayableOfInstallments" contextRef="AsOf2024-10-18" id="Fact001211" format="ixt:numdotdecimal" decimals="0" unitRef="USD">17,452</ix:nonFraction></span> beginning on November 15, 2024, and may be prepaid at
any time with no prepayment penalty. Upon the event of default by the Company, any unpaid principal and interest may be converted to
common stock at the election of 1800 Diagonal Lending LLC. As of February 28, 2025, the balance on the note, net of the unamortized debt
discount, was $<span id="xdx_903_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_c20250228_zNLJLhdwZzW6" title="Unamortized debt discount"><ix:nonFraction name="us-gaap:DebtInstrumentUnamortizedDiscount" contextRef="AsOf2025-02-28" id="Fact001213" format="ixt:numdotdecimal" decimals="0" unitRef="USD">80,114</ix:nonFraction></span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 1, 2024, the Company sold a short-term promissory note to a private investor in the aggregate principal amount of $<span id="xdx_908_eus-gaap--NotesAndLoansPayableCurrent_iI_c20241101__us-gaap--TypeOfArrangementAxis__custom--ShortTermPromissoryNoteMember_z5xR8xUFqdCe" title="Total consideration"><ix:nonFraction name="us-gaap:NotesAndLoansPayableCurrent" contextRef="AsOf2024-11-01_custom_ShortTermPromissoryNoteMember" id="Fact001215" format="ixt:numdotdecimal" decimals="0" unitRef="USD">250,000</ix:nonFraction></span>.
The note bears guaranteed interest of <span id="xdx_909_eus-gaap--DebtInstrumentInterestRateEffectivePercentage_iI_c20241101_zIgqTZj01r95"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" contextRef="AsOf2024-11-01" id="Fact001216" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">15</ix:nonFraction>%</span>, or $<span id="xdx_900_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_c20241101__us-gaap--TypeOfArrangementAxis__custom--ShortTermPromissoryNoteMember_zqK0frNw2T2e" title="Original issue discount"><ix:nonFraction name="us-gaap:DebtInstrumentUnamortizedDiscount" contextRef="AsOf2024-11-01_custom_ShortTermPromissoryNoteMember" id="Fact001218" format="ixt:numdotdecimal" decimals="0" unitRef="USD">37,500</ix:nonFraction></span>, payable in full together with the principal on the maturity date of May 1, 2025.
On November 29, 2024, the Company sold an additional short-term promissory note to the same investor in the aggregate principal amount
of $<span id="xdx_901_eus-gaap--DebtInstrumentFaceAmount_iI_c20241129_zAEeeRAkVMC7" title="Principal amount"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2024-11-29" id="Fact001220" format="ixt:numdotdecimal" decimals="0" unitRef="USD">100,000</ix:nonFraction></span>. The note bears guaranteed interest of <span id="xdx_90C_eus-gaap--DebtInstrumentInterestRateEffectivePercentage_iI_c20241129_zrUST1p7cLU8"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" contextRef="AsOf2024-11-29" id="Fact001221" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">15</ix:nonFraction>%</span>, or $<span id="xdx_906_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_c20241129__us-gaap--TypeOfArrangementAxis__custom--ShortTermPromissoryNoteMember_zrDUCMfH9Q5l" title="Original issue discount"><ix:nonFraction name="us-gaap:DebtInstrumentUnamortizedDiscount" contextRef="AsOf2024-11-29_custom_ShortTermPromissoryNoteMember" id="Fact001223" format="ixt:numdotdecimal" decimals="0" unitRef="USD">15,000</ix:nonFraction></span>, payable in full together with the principal on the maturity date
of May 29, 2025. In connection with the promissory notes, the Company issued warrants to the investor to purchase up to <span id="xdx_900_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20241129_z8JLL4TcD549"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="AsOf2024-11-29" id="Fact001224" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">140,000</ix:nonFraction></span> shares
of common stock at an exercise price of $<span id="xdx_90C_eus-gaap--SaleOfStockPricePerShare_iI_c20241129_zmeaklvS04ci"><ix:nonFraction name="us-gaap:SaleOfStockPricePerShare" contextRef="AsOf2024-11-29" id="Fact001225" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">3.25</ix:nonFraction></span> per share with a three-year term. In accordance with ASC 470-20-25-2, the proceeds of the
short-term promissory notes were allocated to the notes and the warrants based on the relative fair values of the notes without the warrants
and of the warrants themselves at time of issuance, with the portion of the proceeds allocated to the warrants accounted for as paid-in
capital, and the remainder of the proceeds allocated to the note. The relative fair value of the warrants at the time of issuance that
was allocated to additional paid-in capital was $<span id="xdx_903_eus-gaap--AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_c20241129__20241129_zpAlDZeU6XUe" title="Warrants additional paid in capital"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" contextRef="From2024-11-292024-11-29" id="Fact001227" format="ixt:numdotdecimal" decimals="0" unitRef="USD">120,239</ix:nonFraction></span>. On December 31, 2024, the Company entered into a Debt Exchange Agreement with
the investor whereby the entire principal balance of $<span id="xdx_904_eus-gaap--DebtConversionConvertedInstrumentAmount1_c20241231__20241231__us-gaap--StatementClassOfStockAxis__custom--SeriesMNonvotingConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--DebtConversionAgreementMember_zgPVpvDII9Y1" title="Debt converted amount"><ix:nonFraction name="us-gaap:DebtConversionConvertedInstrumentAmount1" contextRef="From2024-12-312024-12-31_custom_SeriesMNonvotingConvertiblePreferredStockMember_custom_DebtConversionAgreementMember" id="Fact001229" format="ixt:numdotdecimal" decimals="0" unitRef="USD">350,000</ix:nonFraction></span> plus guaranteed interest of $<span id="xdx_903_ecustom--DebtConversionConvertedInstrumentOfGuaranteedInterest_c20241231__20241231__us-gaap--StatementClassOfStockAxis__custom--SeriesMNonvotingConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--DebtConversionAgreementMember_z81TaBNZutsd"><ix:nonFraction name="NTRP:DebtConversionConvertedInstrumentOfGuaranteedInterest" contextRef="From2024-12-312024-12-31_custom_SeriesMNonvotingConvertiblePreferredStockMember_custom_DebtConversionAgreementMember" id="Fact001230" format="ixt:numdotdecimal" decimals="0" unitRef="USD">52,500</ix:nonFraction></span> was converted into <span id="xdx_90E_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_c20241231__20241231__us-gaap--StatementClassOfStockAxis__custom--SeriesMNonvotingConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--DebtConversionAgreementMember_zIDXPkBPwtZi"><ix:nonFraction name="us-gaap:DebtConversionConvertedInstrumentSharesIssued1" contextRef="From2024-12-312024-12-31_custom_SeriesMNonvotingConvertiblePreferredStockMember_custom_DebtConversionAgreementMember" id="Fact001231" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">133,278</ix:nonFraction></span> shares of
the Company&#8217;s Series M Preferred Stock at a price of $<span id="xdx_908_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20241231__us-gaap--StatementClassOfStockAxis__custom--SeriesMNonvotingConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--DebtConversionAgreementMember_zb6cA43vRrt1"><ix:nonFraction name="us-gaap:DebtInstrumentConvertibleConversionPrice1" contextRef="AsOf2024-12-31_custom_SeriesMNonvotingConvertiblePreferredStockMember_custom_DebtConversionAgreementMember" id="Fact001232" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">3.02</ix:nonFraction></span> per share.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 8, 2024<b>, </b>the Company sold a short-term promissory note to 1800 Diagonal Lending LLC in the aggregate principal amount
of $<span id="xdx_90F_eus-gaap--NotesAndLoansPayableCurrent_iI_c20241108_zNG0R61hGIC" title="Total consideration"><ix:nonFraction name="us-gaap:NotesAndLoansPayableCurrent" contextRef="AsOf2024-11-08" id="Fact001234" format="ixt:numdotdecimal" decimals="0" unitRef="USD">125,190</ix:nonFraction></span>. The note includes an Original Issue Discount of $<span id="xdx_90F_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_c20241108_zv5cgFneuBe2"><ix:nonFraction name="us-gaap:DebtInstrumentUnamortizedDiscount" contextRef="AsOf2024-11-08" id="Fact001235" format="ixt:numdotdecimal" decimals="0" unitRef="USD">18,190</ix:nonFraction></span>, and bears a one-time interest charge of <span id="xdx_905_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20241108__us-gaap--TypeOfArrangementAxis__custom--NoteSecuritiesPurchaseAgreementMember_zsS0kZcQyHvc" title="Interest rate"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="AsOf2024-11-08_custom_NoteSecuritiesPurchaseAgreementMember" id="Fact001237" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">13</ix:nonFraction>%</span>, which was applied
on the issuance date to the principal. The note is payable in five installments, with the first payment in the amount of $<span id="xdx_900_eus-gaap--DebtInstrumentPeriodicPayment_c20241108__20241108__us-gaap--TypeOfArrangementAxis__custom--NoteTwoSecuritiesPurchaseAgreementMember_z1jKJ62U7ZIb" title="debt instrument periodic payment"><ix:nonFraction name="us-gaap:DebtInstrumentPeriodicPayment" contextRef="From2024-11-082024-11-08_custom_NoteTwoSecuritiesPurchaseAgreementMember" id="Fact001239" format="ixt:numdotdecimal" decimals="0" unitRef="USD">70,732</ix:nonFraction></span> due
on <span id="xdx_90B_eus-gaap--DebtInstrumentMaturityDate_c20241108__20241108__us-gaap--TypeOfArrangementAxis__custom--ShortTermPromissoryNoteMember_z4mym9CGrcP3" title="Maturity date"><ix:nonNumeric contextRef="From2024-11-082024-11-08_custom_ShortTermPromissoryNoteMember" format="ixt:datemonthdayyearen" id="Fact001241" name="us-gaap:DebtInstrumentMaturityDate">May 15, 2025</ix:nonNumeric></span>, and the remaining four equal installments of $<span id="xdx_90B_ecustom--DebtInstrumentPeriodicOfInstallments_c20241108__20241108_z6TC8sK7qk49"><ix:nonFraction name="NTRP:DebtInstrumentPeriodicOfInstallments" contextRef="From2024-11-082024-11-08" id="Fact001242" format="ixt:numdotdecimal" decimals="0" unitRef="USD">17,683</ix:nonFraction></span> are due on the 15<sup>th</sup> of each of the next four successive
months. The note may be prepaid at any time with no prepayment penalty. Upon the event of default by the Company, any unpaid principal
and interest may be converted to common stock at the election of 1800 Diagonal Lending LLC. As of February 28, 2025, the balance on the
note, net of the unamortized debt discount was $<span id="xdx_900_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_c20250228__us-gaap--TypeOfArrangementAxis__custom--ShortTermPromissoryNoteMember_zt9vJ0AhiUc5" title="Unamortized debt discount"><ix:nonFraction name="us-gaap:DebtInstrumentUnamortizedDiscount" contextRef="AsOf2025-02-28_custom_ShortTermPromissoryNoteMember" id="Fact001244" format="ixt:numdotdecimal" decimals="0" unitRef="USD">113,223</ix:nonFraction></span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 31, 2024, the Company sold a short-term promissory note to a private investor in the aggregate principal amount of $<span id="xdx_901_eus-gaap--DebtInstrumentFaceAmount_iI_c20241231_z5MqTZHU4mC1" title="Principal amount"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2024-12-31" id="Fact001246" format="ixt:numdotdecimal" decimals="0" unitRef="USD">220,000</ix:nonFraction></span>.
The note bears guaranteed interest of <span id="xdx_902_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20241231_zLvfBopacQ82" title="Prepaid interest percentage"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="AsOf2024-12-31" id="Fact001248" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">15</ix:nonFraction>%</span>, or $<span id="xdx_900_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_c20241231__us-gaap--TypeOfArrangementAxis__custom--ShortTermPromissoryNoteMember_z1wy7onjpcdi" title="Original issue discount"><ix:nonFraction name="us-gaap:DebtInstrumentUnamortizedDiscount" contextRef="AsOf2024-12-31_custom_ShortTermPromissoryNoteMember" id="Fact001250" format="ixt:numdotdecimal" decimals="0" unitRef="USD">33,000</ix:nonFraction></span>, payable in full on the issue date by the issuance of <span id="xdx_908_eus-gaap--SharesIssued_iI_c20241231_zfgQNQVk3Upd"><ix:nonFraction name="us-gaap:SharesIssued" contextRef="AsOf2024-12-31" id="Fact001251" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">10,927</ix:nonFraction></span> shares of the Company&#8217;s
Series K Preferred Stock. The note may be prepaid at any time without penalty. Additionally, the Company issued a warrant to the investor
to purchase up to <span id="xdx_901_eus-gaap--DebtInstrumentFaceAmount_iI_c20241231_zwI6QTrfbl39" title="Principal amount"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2024-12-31" id="Fact001253" format="ixt:numdotdecimal" decimals="0" unitRef="USD">220,000</ix:nonFraction></span> shares of common stock with an exercise price of $<span id="xdx_909_eus-gaap--SharesIssuedPricePerShare_iI_c20241231_zWwHNTyoZBO8"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2024-12-31" id="Fact001254" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">4.00</ix:nonFraction></span> per share and a three-year term. In accordance with
ASC 470-20-25-2, the proceeds of the short-term promissory note were allocated to the note and the warrant based on the relative fair
values of the note without the warrant and of the warrant itself at time of issuance, with the portion of the proceeds allocated to the
warrants accounted for as paid-in capital, and the remainder of the proceeds allocated to the note. The relative fair value of the warrant
at the time of issuance that was allocated to additional paid-in capital was $<span id="xdx_90A_eus-gaap--AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_c20241231__20241231_zr5av3hXuExh" title="Warrants additional paid in capital"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" contextRef="From2024-12-312024-12-31" id="Fact001256" format="ixt:numdotdecimal" decimals="0" unitRef="USD">179,913</ix:nonFraction></span>. As of February 28, 2025, the balance on the note,
net of the unamortized debt discount, was $<span id="xdx_900_ecustom--DebtInstrumentUnamortizedDebtDiscount_iI_c20250228__us-gaap--TypeOfArrangementAxis__custom--ShortTermPromissoryNoteMember_zJK8Q5c3qlr3" title="Unamortized debt discount"><ix:nonFraction name="NTRP:DebtInstrumentUnamortizedDebtDiscount" contextRef="AsOf2025-02-28_custom_ShortTermPromissoryNoteMember" id="Fact001258" format="ixt:numdotdecimal" decimals="0" unitRef="USD">41,504</ix:nonFraction></span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 31, 2024, <span id="xdx_901_eus-gaap--DebtInstrumentCovenantDescription_c20241231__20241231_zm6oP8foT3u1"><ix:nonNumeric contextRef="From2024-12-312024-12-31" id="Fact001259" name="us-gaap:DebtInstrumentCovenantDescription">the Company sold a short-term promissory note to a private investor for $<span id="xdx_90D_ecustom--DebtInstrumentOfInvestor_iI_c20241231_zFZUXAuF8mii" title="Principal amount"><ix:nonFraction name="NTRP:DebtInstrumentOfInvestor" contextRef="AsOf2024-12-31" id="Fact001261" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,000,000</ix:nonFraction></span>, with $<span id="xdx_904_ecustom--DebtInstrumentOfFunded_iI_c20241231_z7VzIGZ5keAe" title="Principal amount"><ix:nonFraction name="NTRP:DebtInstrumentOfFunded" contextRef="AsOf2024-12-31" id="Fact001263" format="ixt:numdotdecimal" decimals="0" unitRef="USD">500,000</ix:nonFraction></span> funded on December
15, 2024 and $<span id="xdx_904_ecustom--DebtInstrumentOfFunded_iI_c20241231_z2YtBzjQd928" title="Principal amount"><ix:nonFraction name="NTRP:DebtInstrumentOfFunded" contextRef="AsOf2024-12-31" id="Fact001265" format="ixt:numdotdecimal" decimals="0" unitRef="USD">500,000</ix:nonFraction></span> funded on January 15, 2025. The note bears prepaid interest of <span id="xdx_90D_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20241231__us-gaap--TypeOfArrangementAxis__custom--OneMillionNoteMember_zmX2kk62B8gk" title="Prepaid interest percentage"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="AsOf2024-12-31_custom_OneMillionNoteMember" id="Fact001267" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">15</ix:nonFraction>%</span>, payable in 49,668 shares of the Company&#8217;s
Series K Preferred Stock. In addition, the Company issued warrants to the investor to purchase up to <span id="xdx_90A_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20241231_ziblBpt8Seee"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="AsOf2024-12-31" id="Fact001268" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,000,000</ix:nonFraction></span> shares of the Company&#8217;s
common stock at an exercise price of $<span id="xdx_900_eus-gaap--SaleOfStockPricePerShare_iI_c20241231_z34O3oH0JLIk"><ix:nonFraction name="us-gaap:SaleOfStockPricePerShare" contextRef="AsOf2024-12-31" id="Fact001269" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">4.00</ix:nonFraction></span> per share with an expiration date of June 30, 2028. Up to 500,000 of the warrants may be exercised
on a cashless basis, at the election of the investor. In accordance with ASC 470-20-25-2, the proceeds of the short-term promissory note
were allocated to the note and the warrant based on the relative fair values of the note without the warrant and of the warrant itself
at time of issuance, with the portion of the proceeds allocated to the warrants accounted for as paid-in capital, and the remainder of
the proceeds allocated to the note.</ix:nonNumeric> </span>The relative fair value of the warrant at the time of issuance that was allocated to additional paid-in
capital was $<span id="xdx_901_ecustom--AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCost_c20241231__20241231_zBAf4ZOqGXS6" title="Warrants additional paid in capital"><ix:nonFraction name="NTRP:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCost" contextRef="From2024-12-312024-12-31" id="Fact001271" format="ixt:numdotdecimal" decimals="0" unitRef="USD">829,523</ix:nonFraction></span>. On February 26, 2025, the Company entered into a Debt Exchange Agreement with the investor whereby the entire principal
balance of $<span id="xdx_904_ecustom--DebtInstrumentOfInvestor_iI_c20250226_zRkWv1tOib47" title="Principal amount"><ix:nonFraction name="NTRP:DebtInstrumentOfInvestor" contextRef="AsOf2025-02-26" id="Fact001273" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,000,000</ix:nonFraction></span> was converted into <span id="xdx_90C_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20250226__20250226__us-gaap--StatementClassOfStockAxis__custom--SeriesPNonvotingConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--DebtExchangeAgreementMember_zkEL8xoqn4A8" title="Sale of stock, shares"><ix:nonFraction name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" contextRef="From2025-02-262025-02-26_custom_SeriesPNonvotingConvertiblePreferredStockMember_custom_DebtExchangeAgreementMember" id="Fact001275" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">250,000</ix:nonFraction></span> shares of the Company&#8217;s Series P Preferred Stock at a price of $<span id="xdx_909_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20250226__us-gaap--StatementClassOfStockAxis__custom--SeriesPNonvotingConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--DebtExchangeAgreementMember_zogRlktljk0g" title="Conversion price"><ix:nonFraction name="us-gaap:DebtInstrumentConvertibleConversionPrice1" contextRef="AsOf2025-02-26_custom_SeriesPNonvotingConvertiblePreferredStockMember_custom_DebtExchangeAgreementMember" id="Fact001277" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">4.00</ix:nonFraction></span> per share.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 4<b>, </b>2025, the Company sold a short-term promissory note to 1800 Diagonal Lending LLC in the aggregate principal amount
of $<span id="xdx_904_eus-gaap--DebtInstrumentFaceAmount_iI_c20250204_z1rwk3pZAuzj" title="Principal amount"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2025-02-04" id="Fact001279" format="ixt:numdotdecimal" decimals="0" unitRef="USD">152,100</ix:nonFraction></span>. The note includes an Original Issue Discount of $<span id="xdx_909_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_c20240204__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zlXNvH0LPtCh" title="Original issue discount"><ix:nonFraction name="us-gaap:DebtInstrumentUnamortizedDiscount" contextRef="AsOf2024-02-04_custom_SecuritiesPurchaseAgreementMember" id="Fact001281" format="ixt:numdotdecimal" decimals="0" unitRef="USD">22,100</ix:nonFraction></span>, and bears a one-time interest charge of <span id="xdx_905_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20250204__us-gaap--TypeOfArrangementAxis__custom--NoteSecuritiesPurchaseAgreementMember_ztGbj94eVLGd" title="Interest rate"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="AsOf2025-02-04_custom_NoteSecuritiesPurchaseAgreementMember" id="Fact001283" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">13</ix:nonFraction>%</span>, which was applied
on the issuance date to the principal. The note is payable in five installments, with the first payment in the amount of $<span id="xdx_901_eus-gaap--DebtInstrumentPeriodicPayment_c20250204__20250204__us-gaap--TypeOfArrangementAxis__custom--NoteTwoSecuritiesPurchaseAgreementMember_z04eXxeAYiqg" title="debt instrument periodic payment"><ix:nonFraction name="us-gaap:DebtInstrumentPeriodicPayment" contextRef="From2025-02-042025-02-04_custom_NoteTwoSecuritiesPurchaseAgreementMember" id="Fact001285" format="ixt:numdotdecimal" decimals="0" unitRef="USD">85,937</ix:nonFraction></span> due
on August 15, 2025, and the remaining four equal installments of $<span id="xdx_90E_ecustom--DebtInstrumentPeriodicOfInstallments_c20250204__20250204_zXNAmsgJYPcl"><ix:nonFraction name="NTRP:DebtInstrumentPeriodicOfInstallments" contextRef="From2025-02-042025-02-04" id="Fact001286" format="ixt:numdotdecimal" decimals="0" unitRef="USD">21,484</ix:nonFraction></span> are due on the 15<sup>th</sup> of each of the next four successive
months. The note may be prepaid at any time with no prepayment penalty. Upon the event of default by the Company, any unpaid principal
and interest may be converted to common stock at the election of 1800 Diagonal Lending LLC. As of February 28, 2025, the balance on the
note, net of the unamortized debt discount was $<span id="xdx_908_ecustom--DebtInstrumentUnamortizedDebtDiscount_iI_c20250228_zZv0YlQrZlqc" title="Unamortized debt discount"><ix:nonFraction name="NTRP:DebtInstrumentUnamortizedDebtDiscount" contextRef="AsOf2025-02-28" id="Fact001288" format="ixt:numdotdecimal" decimals="0" unitRef="USD">131,163</ix:nonFraction></span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-03-01to2025-02-28" escape="true" id="Fact001290" name="NTRP:ConvertibleDebtDisclosureTextBlock"><p id="xdx_806_ecustom--ConvertibleDebtDisclosureTextBlock_zcANo5qcnnHa" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
13 - <span id="xdx_825_za9lYQGopFr">Convertible Notes</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Between
March 13, 2023 and June 9, 2023, the Company issued $<span id="xdx_909_eus-gaap--ProceedsFromConvertibleDebt_c20230313__20230609__dei--LegalEntityAxis__custom--SpecialPurposeAcquisitionCorporationMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SeveralInvestorsMember__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesMember_z0TrXPn1tkdi" title="Convertible note issued"><ix:nonFraction name="us-gaap:ProceedsFromConvertibleDebt" contextRef="From2023-03-132023-06-09_custom_SpecialPurposeAcquisitionCorporationMember_custom_SeveralInvestorsMember_custom_ConvertibleNotesMember" id="Fact001292" format="ixt:numdotdecimal" decimals="0" unitRef="USD">650,000</ix:nonFraction></span> in convertible notes upon the receipt of proceeds from several investors.
The notes had an interest at a rate of <span id="xdx_906_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_c20230609__dei--LegalEntityAxis__custom--SpecialPurposeAcquisitionCorporationMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SeveralInvestorsMember__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesMember_z44HX4hk5tzf" title="Interest rate"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="AsOf2023-06-09_custom_SpecialPurposeAcquisitionCorporationMember_custom_SeveralInvestorsMember_custom_ConvertibleNotesMember" id="Fact001294" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">8</ix:nonFraction></span>% per annum and were convertible into shares and warrants in a new public company upon the completion
of a merger with a Special Purpose Acquisition Corporation (&#8220;SPAC&#8221;) at a conversion price of $<span id="xdx_906_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_pid_c20230609__dei--LegalEntityAxis__custom--SpecialPurposeAcquisitionCorporationMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SeveralInvestorsMember__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesMember_zf9jm3XdNhq5" title="Conversion price"><ix:nonFraction name="us-gaap:DebtInstrumentConvertibleConversionPrice1" contextRef="AsOf2023-06-09_custom_SpecialPurposeAcquisitionCorporationMember_custom_SeveralInvestorsMember_custom_ConvertibleNotesMember" id="Fact001296" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">3.00</ix:nonFraction></span> per common share, subject
to certain adjustments.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Between
July 27, 2022 and February 21, 2023, the Company issued a total principal amount of $<span id="xdx_902_eus-gaap--ProceedsFromConvertibleDebt_c20220727__20230221__dei--LegalEntityAxis__custom--SpecialPurposeAcquisitionCorporationMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SeveralInvestorsMember__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesMember_ztwdnKjl5qIg" title="Convertible note issued"><ix:nonFraction name="us-gaap:ProceedsFromConvertibleDebt" contextRef="From2022-07-272023-02-21_custom_SpecialPurposeAcquisitionCorporationMember_custom_SeveralInvestorsMember_custom_ConvertibleNotesMember" id="Fact001298" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,012,000</ix:nonFraction></span> in convertible notes upon the receipt
of proceeds from several investors. The notes had an interest at a rate of <span id="xdx_90E_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_c20230221__dei--LegalEntityAxis__custom--SpecialPurposeAcquisitionCorporationMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SeveralInvestorsMember__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesMember_zxrpswu6nIY1" title="Interest rate"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="AsOf2023-02-21_custom_SpecialPurposeAcquisitionCorporationMember_custom_SeveralInvestorsMember_custom_ConvertibleNotesMember" id="Fact001300" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">8</ix:nonFraction></span>% per annum and were convertible into shares and warrants
in a new public company upon the completion of a merger with a SPAC at a conversion
price of $<span id="xdx_905_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_pid_c20230221__dei--LegalEntityAxis__custom--SpecialPurposeAcquisitionCorporationMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SeveralInvestorsMember__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesMember_zo7R6X7v7QC7" title="Conversion price"><ix:nonFraction name="us-gaap:DebtInstrumentConvertibleConversionPrice1" contextRef="AsOf2023-02-21_custom_SpecialPurposeAcquisitionCorporationMember_custom_SeveralInvestorsMember_custom_ConvertibleNotesMember" id="Fact001302" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">3.00</ix:nonFraction></span> per common share, subject to certain adjustments.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 29, 2023, in connection with, and contingent upon the acquisition of NTH by the Company, each investor in a convertible
note entered into a Debt Assignment and Conversion Agreement with NTG and NTH, whereby the notes and the debt represented thereby
were assigned from NTH to NTG and converted into common units of NTG with the equivalent value on the terms and conditions as set
forth in the Debt Assignment and Conversion Agreements. In exchange for entering into the Debt Assignment and Conversion Agreements,
each investor received the right to receive a number of Restricted Shares, including both Closing Shares and Contingent
Shares, to be distributed by the Company to each such investor following the consummation of the NextTrip Acquisition. The shares were
issued at a price of $<span id="xdx_901_eus-gaap--SharePrice_iI_pid_c20231229__us-gaap--TypeOfArrangementAxis__custom--DebtAssignmentAndConversionAgreementsMember_zqd25b5TLGgf" title="Share price"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2023-12-29_custom_DebtAssignmentAndConversionAgreementsMember" id="Fact001304" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">3.00</ix:nonFraction></span>,
and include both principal and accrued interest thereon.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 97; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
NextTrip Acquisition closed on December 29, 2023, and as a result, the Company issued to the investors and aggregate of <span id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c20231229__20231229__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zqOOW0RWTYyb" title="Conversion of convertible notes, shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" contextRef="From2023-12-292023-12-29_us-gaap_CommonStockMember" id="Fact001306" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">52,818</ix:nonFraction></span>
Closing Shares, and the right to receive an aggregate of <span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c20231229__20231229__us-gaap--StatementEquityComponentsAxis__custom--ContingentSharesMember_zWexfYlJF83g" title="Conversion of convertible notes, shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" contextRef="From2023-12-292023-12-29_custom_ContingentSharesMember" id="Fact001308" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,978,598</ix:nonFraction></span>
Contingent Shares, if issued.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the years ended February 28, 2025 and February 29, 2024, the Company recorded interest expense of $<span id="xdx_90F_eus-gaap--InterestExpenseDebt_c20240301__20250228_zhEGTUfgQNWh" title="Interest expense"><ix:nonFraction name="us-gaap:InterestExpenseDebt" contextRef="From2024-03-01to2025-02-28" id="Fact001310" format="ixt:numdotdecimal" decimals="0" unitRef="USD">0</ix:nonFraction></span> and $<span id="xdx_90C_eus-gaap--InterestExpenseDebt_c20230301__20240229_zpmr2iYBE1Kl" title="Interest expense"><ix:nonFraction name="us-gaap:InterestExpenseDebt" contextRef="From2023-03-012024-02-29" id="Fact001312" format="ixt:numdotdecimal" decimals="0" unitRef="USD">234,213</ix:nonFraction></span>, respectively, related
to the notes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-03-01to2025-02-28" escape="true" id="Fact001314" name="NTRP:SharePurchaseAgreementsDisclosureTextBlock"><p id="xdx_80A_ecustom--SharePurchaseAgreementsDisclosureTextBlock_zQgD7zi8pgnc" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
14 &#8211; <span id="xdx_820_zxVVuh2q1wsk">Share Purchase Agreements</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Between
August 10, 2023 and November 6, 2023, NTH entered into Share Purchase Agreements with several investors to purchase convertible
shares in NTH in exchange for total proceeds of $<span id="xdx_905_eus-gaap--ProceedsFromConvertibleDebt_c20230810__20231106__us-gaap--TypeOfArrangementAxis__custom--SharePurchaseAgreementsMember__srt--TitleOfIndividualAxis__custom--SeveralInvestorsMember_zpjBX0R5bUbc" title="Proceeds from convertible shares"><ix:nonFraction name="us-gaap:ProceedsFromConvertibleDebt" contextRef="From2023-08-102023-11-06_custom_SharePurchaseAgreementsMember_custom_SeveralInvestorsMember" id="Fact001316" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,755,970</ix:nonFraction></span>.
Pursuant to the Share Purchase Agreements, the shares were initially convertible into the common shares of a public company with
which NTH completed a strategic transaction at a price of $<span id="xdx_909_eus-gaap--SharePrice_iI_c20231106__us-gaap--TypeOfArrangementAxis__custom--SharePurchaseAgreementsMember__srt--TitleOfIndividualAxis__custom--SeveralInvestorsMember_zR1y7oIRSJh4" title="Conversion share price"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2023-11-06_custom_SharePurchaseAgreementsMember_custom_SeveralInvestorsMember" id="Fact001318" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.15</ix:nonFraction></span>
per share. The Share Purchase Agreements further provided that contingent upon the consummation of the legal acquisition of NTH by
the Company, the investors would receive the same number of shares of Company common stock in lieu of NTH common
shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">On December 29, 2023, concurrent with the consummation
of the NextTrip Acquisition, each investor entered into an Exchange Agreement (the &#8220;Pre-Acquisition Exchange Agreements&#8221;)
with NTG and NTH, whereby such investors exchanged their rights to NTH shares for rights to common units of NTG of the same value, and
NTG distributed to the investors that number of Closing Shares as set forth in the Pre-Acquisition Exchange Agreements. Additionally,
upon the Company&#8217;s achievement of each of the milestones as set forth in the Exchange Agreement, if ever, NTG will further distribute
the number of Contingent Shares in accordance with the Pre-Acquisition Exchange Agreements.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 19, 2022, the Company entered into a Software as a Service Agreement with a third-party consultant, pursuant to which the Company received
a $<span id="xdx_90A_ecustom--ProceedsFromDownpaymentForContract_c20220919__20220919__us-gaap--TypeOfArrangementAxis__custom--SoftwareAsAServiceAgreementMember__srt--TitleOfIndividualAxis__custom--ThirdPartyMember_zRhEOz43wfSa" title="Proceeds from downpayment for contract"><ix:nonFraction name="NTRP:ProceedsFromDownpaymentForContract" contextRef="From2022-09-192022-09-19_custom_SoftwareAsAServiceAgreementMember_custom_ThirdPartyMember" id="Fact001320" format="ixt:numdotdecimal" decimals="0" unitRef="USD">150,000</ix:nonFraction></span> down payment upon signing of the contract. On December 31, 2022, the Company entered into an amended agreement with the counterparty,
pursuant which the down payment became a noninterest bearing share issuance obligation and which such amount will be converted to shares in
a new public company upon the completion of a merger at a conversion price of $<span id="xdx_908_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20220919__us-gaap--TypeOfArrangementAxis__custom--SoftwareAsAServiceAgreementMember__srt--TitleOfIndividualAxis__custom--ThirdPartyMember_zq7TiMeqVl1e" title="Conversion share price"><ix:nonFraction name="us-gaap:DebtInstrumentConvertibleConversionPrice1" contextRef="AsOf2022-09-19_custom_SoftwareAsAServiceAgreementMember_custom_ThirdPartyMember" id="Fact001322" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">3.00</ix:nonFraction></span> per common share, subject to adjustments. On December
29, 2023, upon the consummation of the NextTrip Acquisition, the counterparty received <span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c20231229__20231229__us-gaap--TypeOfArrangementAxis__custom--SoftwareAsAServiceAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--TitleOfIndividualAxis__custom--ThirdPartyMember_zySNcOwmPOB6" title="Conversion of convertible notes, shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" contextRef="From2023-12-292023-12-29_custom_SoftwareAsAServiceAgreementMember_us-gaap_CommonStockMember_custom_ThirdPartyMember" id="Fact001324" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,996</ix:nonFraction></span> Closing Shares and
the right to receive an additional <span id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c20231229__20231229__us-gaap--StatementEquityComponentsAxis__custom--ContingentSharesMember__us-gaap--TypeOfArrangementAxis__custom--SoftwareAsAServiceAgreementMember__srt--TitleOfIndividualAxis__custom--ThirdPartyMember_zGj6xEvHIh7" title="Conversion of convertible notes, shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" contextRef="From2023-12-292023-12-29_custom_ContingentSharesMember_custom_SoftwareAsAServiceAgreementMember_custom_ThirdPartyMember" id="Fact001326" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">74,786</ix:nonFraction></span> Contingent Shares, if issued.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
total number of Closing Shares issued to investors, inclusive the third-party consultant, on December 29, 2023 was <span id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c20231229__20231229__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--TitleOfIndividualAxis__custom--ThirdPartyConsultantMember_ztLhHtQNDYn6" title="Conversion of convertible notes, shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" contextRef="From2023-12-292023-12-29_us-gaap_CommonStockMember_custom_ThirdPartyConsultantMember" id="Fact001328" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">15,481</ix:nonFraction></span>
Closing Shares, and the Contingent Shares issuable, if ever, totaled an aggregate of <span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c20231229__20231229__us-gaap--StatementEquityComponentsAxis__custom--ContingentSharesMember__srt--TitleOfIndividualAxis__custom--ThirdPartyConsultantMember_zy8pL76pzPT7" title="Conversion of convertible notes, shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" contextRef="From2023-12-292023-12-29_custom_ContingentSharesMember_custom_ThirdPartyConsultantMember" id="Fact001330" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">579,954</ix:nonFraction></span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 28, 2023, the Company entered into a Consulting Modification Agreement with a third-party consultant, which provided for
the full settlement of $<span id="xdx_90F_ecustom--ConsultingFees_c20231228__20231228__us-gaap--TypeOfArrangementAxis__custom--ConsultingModificationAgreementMember__srt--TitleOfIndividualAxis__custom--ThirdPartyConsultantMember_zvTINfhiX9Bc" title="Consulting fees"><ix:nonFraction name="NTRP:ConsultingFees" contextRef="From2023-12-282023-12-28_custom_ConsultingModificationAgreementMember_custom_ThirdPartyConsultantMember" id="Fact001332" format="ixt:numdotdecimal" decimals="0" unitRef="USD">180,000</ix:nonFraction></span>
in consulting fees by issuing shares of Company common stock contingent upon the closing of the NextTrip acquisition. The NextTrip
Acquisition closed on December 29, 2023, pursuant to which the Company issued <span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c20231229__20231229__us-gaap--TypeOfArrangementAxis__custom--ConsultingModificationAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--TitleOfIndividualAxis__custom--ThirdPartyConsultantMember_z5TLUDwCfJFk" title="Conversion of convertible notes, shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" contextRef="From2023-12-292023-12-29_custom_ConsultingModificationAgreementMember_us-gaap_CommonStockMember_custom_ThirdPartyConsultantMember" id="Fact001334" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">4,337</ix:nonFraction></span>
Closing Shares to the consultant, and the right to receive <span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c20231229__20231229__us-gaap--TypeOfArrangementAxis__custom--ConsultingModificationAgreementMember__us-gaap--StatementEquityComponentsAxis__custom--ContingentSharesMember__srt--TitleOfIndividualAxis__custom--ThirdPartyConsultantMember_zeuqJbpGydkb" title="Conversion of convertible notes, shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" contextRef="From2023-12-292023-12-29_custom_ConsultingModificationAgreementMember_custom_ContingentSharesMember_custom_ThirdPartyConsultantMember" id="Fact001336" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">162,466</ix:nonFraction></span>
Contingent Shares, if issued.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-03-01to2025-02-28" escape="true" id="Fact001338" name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock"><p id="xdx_80E_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zYTv9TEZiO23" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
15 - <span id="xdx_82D_zLEG8HLsV2me">Related Party Transactions</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 28, 2023, the Company entered into an Asset Purchase Agreement with Travel and Media Tech, LLC (&#8220;TMT&#8221;),
pursuant to which it purchased the right, title and interest in the &#8220;Bookit&#8221; or &#8220;NextTrip 2.0&#8221; booking
engine, including customer lists, all current content associated with hotel and destination product in the booking engine (pictures,
hotel descriptions, restaurant descriptions, room descriptions, amenity descriptions, and destination information) and source code
related thereto. TMT is a related entity owned by Donald P. Monaco, the Company&#8217;s Chairman, and William Kerby, the
Company&#8217;s Chief Executive Officer.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amounts
due to related parties at February 28, 2025 and February 29, 2024 was $<span id="xdx_90B_eus-gaap--NotesPayableCurrent_iI_pp0p0_c20250228__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_z8Ao9EYP5eD1" title="Notes payable - related parties"><ix:nonFraction name="us-gaap:NotesPayableCurrent" contextRef="AsOf2025-02-28_us-gaap_RelatedPartyMember" id="Fact001340" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">61,526</ix:nonFraction></span> and $<span id="xdx_906_eus-gaap--NotesPayableCurrent_c20240229__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_pp0p0" title="Notes payable - related parties"><ix:nonFraction name="us-gaap:NotesPayableCurrent" contextRef="AsOf2024-02-29_us-gaap_RelatedPartyMember" id="Fact001342" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">828,277</ix:nonFraction></span>, respectively. The amounts due at February
28, 2025 are to Donald P. Monaco, William Kerby, and Gregory Miller, and at February 29, 2024 were to William Kerby and Donald P. Monaco.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recorded a loss of $<span id="xdx_907_ecustom--LossOnRelatedPartyReceivable_c20240301__20250228__us-gaap--BusinessAcquisitionAxis__custom--NextPlayTechnologiesIncMember_zEymAtR6JJIb" title="Loss on related party receivable"><ix:nonFraction name="NTRP:LossOnRelatedPartyReceivable" contextRef="From2024-03-012025-02-28_custom_NextPlayTechnologiesIncMember" id="Fact001344" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,000,000</ix:nonFraction></span> on the NextPlay related party receivable for the year ended February 28, 2025. The total amount
receivable from NextPlay was $<span id="xdx_909_eus-gaap--ReceivablesNetCurrent_iI_c20250228__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--NextPlayTechnologiesIncMember_z3YA7KBgwUFh" title="Accounts receivable"><ix:nonFraction name="us-gaap:ReceivablesNetCurrent" contextRef="AsOf2025-02-28_custom_NextPlayTechnologiesIncMember" id="Fact001346" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,567,665</ix:nonFraction></span> at February 28, 2025. NextPlay is in involuntary bankruptcy proceedings and is in default under
the terms of its promissory note and, as a result, the Company established an allowance for doubtful accounts of $<span id="xdx_90E_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iI_c20250228__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--NextPlayTechnologiesIncMember_zcQK8VpCTHw2" title="Allowance for doubtful accounts"><ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivable" contextRef="AsOf2025-02-28_custom_NextPlayTechnologiesIncMember" id="Fact001348" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,567,665</ix:nonFraction></span> as collectability
of the note is uncertain. As of February 29, 2024, $<span id="xdx_902_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iI_do_c20240229__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--NextPlayTechnologiesIncMember_zctRo65pvGYe" title="Allowance for doubtful accounts"><ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivable" contextRef="AsOf2024-02-29_custom_NextPlayTechnologiesIncMember" id="Fact001350" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,567,665</ix:nonFraction></span> allowance for credit losses was established.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-03-01to2025-02-28" escape="true" id="Fact001352" name="NTRP:DeferredRevenueTextBlock"><p id="xdx_803_ecustom--DeferredRevenueTextBlock_z2KWmrnN1kLd" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
16 - <span id="xdx_821_zKG1fsISYakd">Deferred Revenue</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred
revenue as of the years ended February 28, 2025, and February 29, 2024 was $<span id="xdx_905_eus-gaap--DeferredRevenueCurrent_iI_c20250228_zmue3OBk8KNd" title="Deferred revenue"><ix:nonFraction name="us-gaap:DeferredRevenueCurrent" contextRef="AsOf2025-02-28" id="Fact001354" format="ixt:numdotdecimal" decimals="0" unitRef="USD">97,770</ix:nonFraction></span> and $<span id="xdx_90B_eus-gaap--DeferredRevenueCurrent_iI_c20240229_zqpuCaLJE1d1" title="Deferred revenue"><ix:nonFraction name="us-gaap:DeferredRevenueCurrent" contextRef="AsOf2024-02-29" id="Fact001356" format="ixt:numdotdecimal" decimals="0" unitRef="USD">139,921</ix:nonFraction></span>, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 98; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred
revenue consists of travel deposits received from users in advance of revenue recognition. The deferred revenue balance for the years
ended February 28, 2025 and February 29, 2024 was driven by cash payments from customers in advance of satisfying our performance obligations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-03-01to2025-02-28" escape="true" id="Fact001358" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock"><p id="xdx_800_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zePe41COpDyf" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
17 - <span id="xdx_822_z0jGBGniifL5">Commitments and Contingencies</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is involved, from time to time, in litigation, other legal claims and proceedings involving matters associated with or incidental
to our business, including, among other things, matters involving breach of contract claims, intellectual property, employment issues,
and other related claims and vendor matters. The Company believes that the resolution of currently pending matters could, individually
or in the aggregate, have a material adverse effect on our financial condition or results of operations. However, assessment of the current
litigation or other legal claims could change considering the discovery of facts not presently known to the Company or by judges, juries
or other finders of fact, which are not in accord with management&#8217;s evaluation of the possible liability or outcome of such litigation
or claims.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-03-01to2025-02-28" escape="true" id="Fact001360" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock"><p id="xdx_80A_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zIUrNS1iB2Ig" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
18 &#8211; <span id="xdx_828_zLvcJElMeBJj">Stockholders&#8217; Equity</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Common
Stock</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has <span id="xdx_908_eus-gaap--CommonStockSharesAuthorized_iI_c20250228_zJY3vPkCUuU1" title="Common stock, shares authorized"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2025-02-28" id="Fact001362" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">250,000,000</ix:nonFraction></span> shares of common stock authorized. As of February 28, 2025 and February 29, 2024, the Company had
<span id="xdx_903_eus-gaap--CommonStockSharesOutstanding_iI_c20250228_zna4o60hVrV9" title="Common stock, shares outstanding"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2025-02-28" id="Fact001364" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,656,738</ix:nonFraction></span> and <span id="xdx_908_eus-gaap--CommonStockSharesOutstanding_iI_c20240229_zSbHcduuN7ej" title="Common stock, shares outstanding"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2024-02-29" id="Fact001366" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">936,430</ix:nonFraction></span> shares of common stock, par value $<span id="xdx_908_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20250228_z4zA75WQagXf" title="Common stock, par value"><span id="xdx_90B_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20240229_zndi6ZE0anr3" title="Common stock, par value"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2025-02-28" id="Fact001368" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2024-02-29" id="Fact001370" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.001</ix:nonFraction></ix:nonFraction></span></span> issued and outstanding, respectively. All shares have equal voting rights,
are fully-paid and non-assessable, and are entitled to one vote per share.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 22, 2023, we effected a <span id="xdx_905_eus-gaap--StockholdersEquityReverseStockSplit_c20230921__20230922_z2xDteU60Hu3" title="Reverse stock split"><ix:nonNumeric contextRef="From2023-09-212023-09-22" id="Fact001372" name="us-gaap:StockholdersEquityReverseStockSplit">1-for-20 reverse stock split</ix:nonNumeric></span> of the outstanding shares of our common stock and a corresponding decrease
in the number of shares of our common stock that we are authorized to issue. In connection with the reverse split, we issued <span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesReverseStockSplits_c20230922__20230922_zR9cE8RQxuWb" title="Reverse stock split issued common shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesReverseStockSplits" contextRef="From2023-09-222023-09-22" id="Fact001374" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">40,197</ix:nonFraction></span> common
shares to round-up fractional shares to the nearest whole share.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
effects of the reverse stock split have been retroactively reflected in all periods presented in this Report.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fiscal
Year Ended February 28, 2025</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 15, 2024, the Company issued <span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c20240315__20240315__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zoHQgPDk8x35" title="Conversion shares issued"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" contextRef="From2024-03-152024-03-15_us-gaap_CommonStockMember" id="Fact001376" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">409,502</ix:nonFraction></span> shares of common stock pursuant to automatic conversions of the Company&#8217;s Series G,
H, and I Convertible Preferred Stock upon receiving shareholder approval to increase the Company&#8217;s authorized common shares to
250 million.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
July 2024 and August 2024, the Company issued <span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20240701__20240831__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zdQhOExxWQea" title="Shares issued for services"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" contextRef="From2024-07-012024-08-31_us-gaap_CommonStockMember" id="Fact001378" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">42,709</ix:nonFraction></span>
shares of common stock to Dooya Media Group, Inc. as partial compensation for development work related to Compass.TV, the
Company&#8217;s Free-Ad Supported TV (&#8220;FAST&#8221;) channel.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 19, 2024, the Company issued <span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20240919__20240919__dei--LegalEntityAxis__custom--AlumniCapitalLPMember_zTXmv6NkWxtl" title="Number of common stock issued"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2024-09-192024-09-19_custom_AlumniCapitalLPMember" id="Fact001380" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">32,786</ix:nonFraction></span>
shares of common stock to Alumni Capital LP (&#8220;Alumni&#8221;) as commitment shares for a $<span id="xdx_907_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pn6n6_c20240919__20240919__dei--LegalEntityAxis__custom--AlumniCapitalLPMember_zFlkjOgy8Oia" title="Equity line of credit"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2024-09-192024-09-19_custom_AlumniCapitalLPMember" id="Fact001382" format="ixt:numdotdecimal" decimals="-6" scale="6" unitRef="USD">10</ix:nonFraction></span>
million equity line of credit.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 8, 2024, the Company issued <span id="xdx_90D_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_c20241008__20241008__dei--LegalEntityAxis__custom--FSATravelLLCMember_zwpHTsJDSii9" title="Stock deposit acquisition"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesAcquisitions" contextRef="From2024-10-082024-10-08_custom_FSATravelLLCMember" id="Fact001384" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">8,065</ix:nonFraction></span>
shares of common stock to FSA upon executing a non-binding letter of intent to acquire interests in FSA. Pursuant to the
terms of the agreement, the shares were to be credited towards the final purchase price if an acquisition occurs, and as a down
payment towards the acquisition price of FSA.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">On December 16, 2024, the Company issued <span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20241216__20241216__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z8KZe2l0kaE9" title="Issuance of shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2024-12-162024-12-16_us-gaap_CommonStockMember" id="Fact001386" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">28,281</ix:nonFraction></span> shares
of common stock to Out of the Box Capital as a prepayment for an Investor Relations consulting contract.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
December 2024 and January 2025, the Company issued <span id="xdx_907_ecustom--StockIssuedDuringPeriodSharesWarrantExercises_c20241201__20250131__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_ztS6QABvdmci" title="Issuance of shares warrant exercises">an
aggregate of <ix:nonFraction name="NTRP:StockIssuedDuringPeriodSharesWarrantExercises" contextRef="From2024-12-012025-01-31_us-gaap_CommonStockMember" id="Fact001388" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">104,965</ix:nonFraction></span> shares of common stock pursuant to warrant exercises, resulting in gross proceeds of $<span id="xdx_90E_eus-gaap--ProceedsFromWarrantExercises_c20241201__20250131__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z5FgNxiqzPL5" title="Gross proceeds of warrant exercises"><ix:nonFraction name="us-gaap:ProceedsFromWarrantExercises" contextRef="From2024-12-012025-01-31_us-gaap_CommonStockMember" id="Fact001390" format="ixt:numdotdecimal" decimals="0" unitRef="USD">316,995</ix:nonFraction></span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 7, 2025, the Company issued <span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20250107__20250107__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zSqjLW2Q6jhj" title="Issuance of shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2025-01-072025-01-07_us-gaap_CommonStockMember" id="Fact001392" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">30,000</ix:nonFraction></span> shares of common stock as a prepayment for a consulting contract with an investor relations
company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 29, 2025, the Company issued <span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20250129__20250129__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zSsKSEKezNie" title="Issuance of shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2025-01-292025-01-29_us-gaap_CommonStockMember" id="Fact001394" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">4,000</ix:nonFraction></span>
shares of common stock to Lyndsey North, the Company&#8217;s former President, in connection with her separation
agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 26, 2025, the Company issued <span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20250226__20250226__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zNOFulTCQf1h" title="Issuance of shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2025-02-262025-02-26_us-gaap_CommonStockMember" id="Fact001396" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">60,000</ix:nonFraction></span> shares of common stock to AOS Holdings, Inc. as a partial prepayment for a two-year consulting
contract to provide investor relations and strategic consulting services.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fiscal
Year Ended February 29, 2024</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
September 2023 and October 2023, the Company sold <span id="xdx_903_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20230901__20230930__us-gaap--SubsidiarySaleOfStockAxis__custom--AtTheMarketIssuanceSalesAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zyaF72bp2UW5" title="Share issued and sold during period, shares"><ix:nonFraction name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" contextRef="From2023-09-012023-09-30_custom_AtTheMarketIssuanceSalesAgreementMember_us-gaap_CommonStockMember" id="Fact001398" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">72,721</ix:nonFraction></span>
and <span id="xdx_905_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20231001__20231031__us-gaap--SubsidiarySaleOfStockAxis__custom--AtTheMarketIssuanceSalesAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zxYVWkKBw9U6" title="Share issued and sold during period, shares"><ix:nonFraction name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" contextRef="From2023-10-012023-10-31_custom_AtTheMarketIssuanceSalesAgreementMember_us-gaap_CommonStockMember" id="Fact001400" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">128,887</ix:nonFraction></span>
shares of common stock, respectively, through our ATM Agreement, resulting in net proceeds of $<span id="xdx_905_eus-gaap--ProceedsFromIssuanceOfCommonStock_c20230901__20230930__us-gaap--SubsidiarySaleOfStockAxis__custom--AtTheMarketIssuanceSalesAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zD8h2PXjJjG7" title="Net proceeds"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfCommonStock" contextRef="From2023-09-012023-09-30_custom_AtTheMarketIssuanceSalesAgreementMember_us-gaap_CommonStockMember" id="Fact001402" format="ixt:numdotdecimal" decimals="0" unitRef="USD">364,555</ix:nonFraction></span>
and $<span id="xdx_90F_eus-gaap--ProceedsFromIssuanceOfCommonStock_c20231001__20231031__us-gaap--SubsidiarySaleOfStockAxis__custom--AtTheMarketIssuanceSalesAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_ztTcgd3Usf24" title="Net proceeds"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfCommonStock" contextRef="From2023-10-012023-10-31_custom_AtTheMarketIssuanceSalesAgreementMember_us-gaap_CommonStockMember" id="Fact001404" format="ixt:numdotdecimal" decimals="0" unitRef="USD">772,468</ix:nonFraction></span>,
respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 99; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 29, 2023, the Company acquired <span id="xdx_903_eus-gaap--BusinessAcquisitionPercentageOfVotingInterestsAcquired_iI_pid_dp_uPure_c20231229__us-gaap--BusinessAcquisitionAxis__custom--NextTripHoldingsIncMember_zTCR7L3h4Si9" title="Equity interest acquired"><ix:nonFraction name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" contextRef="AsOf2023-12-29_custom_NextTripHoldingsIncMember" id="Fact001406" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%
of the outstanding equity interests of NTH pursuant to the Exchange Agreement in connection with the NextTrip Acquisition. As
consideration for the NextTrip Acquisition, at closing the Company issued <span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20231229__20231229__us-gaap--BusinessAcquisitionAxis__custom--NextTripHoldingsIncMember_z6XeUm1x8hha" title="Restricted shares issued in acquisitions"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross" contextRef="From2023-12-292023-12-29_custom_NextTripHoldingsIncMember" id="Fact001408" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">156,007</ix:nonFraction></span>
restricted shares of its common stock as Closing Shares, constituting <span id="xdx_908_eus-gaap--SaleOfStockPercentageOfOwnershipAfterTransaction_pid_dp_uPure_c20231229__20241229__us-gaap--BusinessAcquisitionAxis__custom--NextTripHoldingsIncMember_z8nwLdn84WU4" title="Percentage of issued and outstanding common shares"><ix:nonFraction name="us-gaap:SaleOfStockPercentageOfOwnershipAfterTransaction" contextRef="From2023-12-292024-12-29_custom_NextTripHoldingsIncMember" id="Fact001410" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">19.99</ix:nonFraction></span>%
of its issued and outstanding shares of common stock immediately prior to execution of the Exchange Agreement, and agreed to
issue up to an aggregate of <span id="xdx_90F_eus-gaap--BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_c20231229__20231229__us-gaap--BusinessAcquisitionAxis__custom--NextTripHoldingsIncMember_zBEYPX4hztel" title="Shares issuable for consideration"><ix:nonFraction name="us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" contextRef="From2023-12-292023-12-29_custom_NextTripHoldingsIncMember" id="Fact001412" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,843,993</ix:nonFraction></span>
Contingent Shares as further consideration upon NTH&#8217;s achievement of certain milestones set forth in the Exchange
Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Of
the <span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20231229__20231229__us-gaap--BusinessAcquisitionAxis__custom--NextTripHoldingsIncMember_ziKRiLvxb8vd" title="Restricted shares issued in acquisitions"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross" contextRef="From2023-12-292023-12-29_custom_NextTripHoldingsIncMember" id="Fact001414" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">156,007</ix:nonFraction></span>
restricted shares issued at closing, <span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_c20231229__20231229__us-gaap--BusinessAcquisitionAxis__custom--NextTripHoldingsIncMember__us-gaap--DeferredRevenueArrangementTypeAxis__custom--DebtAssignmentAndConversionAgreementsMember_zcVxde1Nxxm4" title="Shares issued in acquisitions"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesAcquisitions" contextRef="From2023-12-292023-12-29_custom_NextTripHoldingsIncMember_custom_DebtAssignmentAndConversionAgreementsMember" id="Fact001416" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">52,818</ix:nonFraction></span>
shares were issued pursuant to the Debt Assignment and Conversion agreements, <span id="xdx_908_eus-gaap--StockRepurchasedDuringPeriodShares_c20231229__20231229__us-gaap--BusinessAcquisitionAxis__custom--NextTripHoldingsIncMember__us-gaap--DeferredRevenueArrangementTypeAxis__custom--SharePurchaseAndExchangeAgreementsMember_zXmqO1j4HNF9" title="Purchase of shares issued"><ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodShares" contextRef="From2023-12-292023-12-29_custom_NextTripHoldingsIncMember_custom_SharePurchaseAndExchangeAgreementsMember" id="Fact001418" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">15,481</ix:nonFraction></span>
shares were issued pursuant to the Share Purchase and Pre-Acquisition Exchange Agreements, and <span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20231229__20231229__us-gaap--BusinessAcquisitionAxis__custom--NextTripHoldingsIncMember__us-gaap--RelatedPartyTransactionAxis__custom--ThirdPartyConsultantMember_zWAaO8cs85Il" title="Shares issued during period services"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" contextRef="From2023-12-292023-12-29_custom_NextTripHoldingsIncMember_custom_ThirdPartyConsultantMember" id="Fact001420" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">4,337</ix:nonFraction></span>
shares were issued to a third-party consultant. Pursuant to ASC 805-40-45-1, the remaining <span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_c20231229__20231229__us-gaap--BusinessAcquisitionAxis__custom--NextTripHoldingsIncMember_zKEQJKuWBoB9" title="Shares issued in acquisitions"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesAcquisitions" contextRef="From2023-12-292023-12-29_custom_NextTripHoldingsIncMember" id="Fact001422" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">83,371</ix:nonFraction></span>
Closing Shares are reflected as a retroactive adjustment to adjust the accounting acquirer&#8217;s legal capital to reflect the
legal capital of the accounting acquiree. That adjustment is required to reflect the capital of the legal parent.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Deferred
Compensation</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
discussed above, during the fiscal year ended February 28, 2025, the Company issued <span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20240301__20250228_zmoUsuE3c0p" title="Number of restricted common shares issued"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross" contextRef="From2024-03-01to2025-02-28" id="Fact001424" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">4,000</ix:nonFraction></span>
restricted shares of common stock at a price of $<span id="xdx_90B_eus-gaap--SharePrice_iI_c20250228_za5aZ7S8ciyg" title="Share price"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2025-02-28" id="Fact001426" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">6.69</ix:nonFraction></span>
to Lyndsey North, the Company&#8217;s former President, in connection with her separation agreement. The shares were fully vested on
January 29, 2025, which was the grant date. As a result, the Company recorded share based compensation expense of $<span id="xdx_904_eus-gaap--AllocatedShareBasedCompensationExpense_c20240301__20250228_zBXrJqKFWwKb" title="Share based compensation expense"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2024-03-01to2025-02-28" id="Fact001428" format="ixt:numdotdecimal" decimals="0" unitRef="USD">26,760</ix:nonFraction></span>.
The Company did not issue any shares of common stock to employees during the fiscal year ended February 29, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Preferred
Stock</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
our amended and restated articles of incorporation (our &#8220;Charter&#8221;), our board of directors has the authority, without further action by
stockholders, to designate one or more series of preferred stock and to fix the voting powers, designations, preferences,
limitations, restrictions and relative rights granted to or imposed upon the preferred stock, including dividend rights, conversion
rights, voting rights, rights and terms of redemption, liquidation preference and sinking fund terms, any or all of which may be
preferential to or greater than the rights of the common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
board of directors may authorize the issuance of preferred stock with voting or conversion rights that could adversely affect the voting
power or other rights of the holders of the common stock. The issuance of preferred stock, while providing flexibility in connection
with possible acquisitions and other corporate purposes, could, among other things, have the effect of delaying, deferring or preventing
a change in our control and may adversely affect the market price of the common stock and the voting and other rights of the holders
of common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is authorized to issue <span id="xdx_908_eus-gaap--PreferredStockSharesAuthorized_iI_pid_c20250228_zrlsHaHx2Kig" title="Preferred stock, shares authorized"><span id="xdx_90C_eus-gaap--PreferredStockSharesAuthorized_iI_pid_c20240229_zmn39j8t6sj9" title="Preferred stock, shares authorized"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2025-02-28" id="Fact001430" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2024-02-29" id="Fact001432" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">10,000,000</ix:nonFraction></ix:nonFraction></span></span> shares of preferred stock, $<span id="xdx_90A_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_c20250228_ztDddnKY9zf5" title="Preferred stock, par value"><span id="xdx_908_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_c20240229_z1pgoEkOJyXh" title="Preferred stock, par value"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2025-02-28" id="Fact001434" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2024-02-29" id="Fact001436" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.001</ix:nonFraction></ix:nonFraction></span></span> par value. <span id="xdx_907_eus-gaap--PreferredStockSharesIssued_iI_c20250228_zAhHboNAMuYh" title="Preferred stock, shares issued"><span id="xdx_903_eus-gaap--PreferredStockSharesOutstanding_iI_c20250228_zPBQUchr8fPd" title="Preferred stock, shares outstanding"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2025-02-28" id="Fact001438" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2025-02-28" id="Fact001440" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,106,616</ix:nonFraction></ix:nonFraction></span></span> and <span id="xdx_908_eus-gaap--PreferredStockSharesIssued_iI_c20240229_zNopltyXIZs" title="Preferred stock, shares issued"><span id="xdx_900_eus-gaap--PreferredStockSharesOutstanding_iI_c20240229_zxwtZ7Dqslcc" title="Preferred stock, shares outstanding"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2024-02-29" id="Fact001442" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2024-02-29" id="Fact001444" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">472,996</ix:nonFraction></ix:nonFraction></span></span> shares of preferred stock
were issued and outstanding at February 28, 2025 and February 29, 2024, Respectively, as discussed in additional detail below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Series
E Convertible Preferred Stock</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the Certificate of Designations of the Series E Preferred Stock, the shares of the Company&#8217;s preferred stock as Series E
Convertible Preferred Stock (the &#8220;Series E Preferred&#8221;) have an initial stated value of $<span id="xdx_906_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20250228__us-gaap--StatementClassOfStockAxis__custom--SeriesEConvertiblePreferredStockMember_zUdA0lJ5fYTi" title="Preferred stock, par value"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2025-02-28_custom_SeriesEConvertiblePreferredStockMember" id="Fact001446" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1,500</ix:nonFraction></span>
per share (the &#8220;Stated Value&#8221;). Dividends at the initial rate of <span id="xdx_90F_eus-gaap--PreferredStockDividendRatePercentage_pid_dp_uPure_c20240301__20250228__us-gaap--StatementClassOfStockAxis__custom--SeriesEConvertiblePreferredStockMember_zVPdL0kaOB6k" title="Dividends percentage"><ix:nonFraction name="us-gaap:PreferredStockDividendRatePercentage" contextRef="From2024-03-012025-02-28_custom_SeriesEConvertiblePreferredStockMember" id="Fact001448" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">9</ix:nonFraction></span>%
per annum will accrue and, on a monthly basis, shall be payable in kind by the increase of the Stated Value of the Series E
Preferred by said amount. The holders of shares of the Series E Preferred have the right at any time to convert all or a portion of
the Series E Preferred (including, without limitation, accrued and unpaid dividends and make-whole dividends through the third
anniversary of the closing date) into shares of the Company&#8217;s common stock at an initial conversion rate determined by
dividing the Conversion Amount by the conversion price ($<span id="xdx_900_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20250228__us-gaap--StatementClassOfStockAxis__custom--SeriesEConvertiblePreferredStockMember_zdEKRkCpfPYb" title="Conversion price per share"><ix:nonFraction name="us-gaap:DebtInstrumentConvertibleConversionPrice1" contextRef="AsOf2025-02-28_custom_SeriesEConvertiblePreferredStockMember" id="Fact001450" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.13</ix:nonFraction></span>
above the consolidated closing bid price for the trading day prior to the execution of the relates stock purchase agreement). The
Conversion Amount is the sum of the Stated Value of the shares of Series E Preferred then being converted plus any other
unpaid amounts payable with respect to the Series E Preferred being converted plus the &#8220;Make Whole Amount&#8221; (the
amount of any dividends that, but for the conversion, would have accrued at the dividend rate for the period through the third
anniversary of the initial issuance date). The Conversion Rate is also subject to adjustment for stock splits, dividends
recapitalizations and similar events.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
February 28, 2025, <span title="Preferred stock, shares issued"><span id="xdx_90B_eus-gaap--PreferredStockSharesOutstanding_iI_c20250228__us-gaap--StatementClassOfStockAxis__custom--SeriesEConvertiblePreferredStockMember_zfcxfpP5yLk8" title="Preferred stock, shares outstanding"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2025-02-28_custom_SeriesEConvertiblePreferredStockMember" id="Fact001452" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">316</ix:nonFraction></span></span> shares of Series E Preferred were outstanding, which if converted as of February
28, 2025, including the make-whole dividends, would have resulted in the issuance of <span id="xdx_906_eus-gaap--PreferredStockConvertibleSharesIssuable_iI_c20250228__us-gaap--StatementClassOfStockAxis__custom--SeriesEConvertiblePreferredStockMember_z3PGw85AlSk7" title="Common stock issuable upon conversion"><ix:nonFraction name="us-gaap:PreferredStockConvertibleSharesIssuable" contextRef="AsOf2025-02-28_custom_SeriesEConvertiblePreferredStockMember" id="Fact001454" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,362</ix:nonFraction></span> shares of common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 100; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Series
F Convertible Preferred Stock</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 4, 2024, the Company filed a Certificate of Designation of Series F Convertible Preferred Stock (the &#8220;Series F
Certificate of Designation&#8221;) with the Secretary of State of the State of Nevada, designating <span id="xdx_90B_eus-gaap--PreferredStockSharesAuthorized_iI_c20240104__us-gaap--StatementClassOfStockAxis__custom--SeriesFConvertiblePreferredStockMember_zwGeU0lsj9Yb" title="Preferred stock shares authorized"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2024-01-04_custom_SeriesFConvertiblePreferredStockMember" id="Fact001456" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,843,993</ix:nonFraction></span>
shares of the Company&#8217;s preferred stock as Series F Convertible Preferred Stock, par value $<span id="xdx_90B_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20240104__us-gaap--StatementClassOfStockAxis__custom--SeriesFConvertiblePreferredStockMember_zxN6eeocjlAg" title="Preferred stock, par value"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2024-01-04_custom_SeriesFConvertiblePreferredStockMember" id="Fact001458" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.001</ix:nonFraction></span>
per share (the &#8220;Series F Preferred&#8221;). The Series F Preferred was designated by the Company in connection with the NextTrip Acquisition, and, in the event that the Company does not have sufficient shares
of common stock available to fulfill its obligations pursuant to the Exchange Agreement governing the terms of the
NextTrip Acquisition, shares of Series F Preferred shall be issued to the previous equity holders of NTH in lieu of shares of Company
common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
terms and conditions set forth in the Series F Certificate of Designation are summarized below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Ranking</i></b><i>.
</i>The Series F Preferred rank pari passu to the Company&#8217;s common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Dividends</i></b><i>.
</i>Holders of Series F Preferred will be entitled to dividends, on an as-converted basis, equal to dividends actually paid, if any,
on shares of Company common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Voting</i></b>.
Except as provided by the Company&#8217;s Charter or as otherwise required by the Nevada Revised Statutes, holders of Series F
Preferred are entitled to vote with the holders of outstanding shares of Company common stock, voting together as a single class,
with respect to all matters presented to the Company&#8217;s stockholders for their action or consideration. In any such vote, each
holder is entitled to a number of votes equal to the number of shares of common stock into which the Series F Preferred held by such
holder is convertible. The Company may not, without the consent of holders of a majority of the outstanding shares of Series F
Preferred, (i) alter or change adversely the powers, preferences or rights given to the Series F Preferred or alter or amend the
Series F Certificate of Designation, (ii) amend its Charter or other charter documents in any manner that adversely effects any
rights of the holders of the Series F Preferred, or (c) enter into any agreement with respect to the foregoing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Conversion</i></b>.
On such date that the Company amends its Charter to increase the number of shares of common stock authorized for issuance
thereunder, to at least the extent required to convert all of the outstanding Series F Preferred, each outstanding share of Series F
Preferred shall automatically be converted into one share of Company common stock (subject to adjustment under certain limited
circumstances) (the &#8220;Series F Conversion Ratio&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Liquidation</i></b>.
In the event of any liquidation, dissolution or winding up of the Company, either voluntary or involuntary (each, a
&#8220;Liquidation&#8221;), holders of Series F Preferred will be entitled to participate, on an as-converted-to-common stock basis
calculate based on the Series F Conversion Ratio, with holders of Company common stock in any distribution of assets of the Company
to holders of the Company&#8217;s common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
February 28, 2025, <span id="xdx_901_eus-gaap--PreferredStockSharesOutstanding_iI_do_c20250228__us-gaap--StatementClassOfStockAxis__custom--SeriesFConvertiblePreferredStockMember_zAtQK5X3Ymz9" title="Preferred stock, shares outstanding"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2025-02-28_custom_SeriesFConvertiblePreferredStockMember" id="Fact001460" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares">no</ix:nonFraction></span> shares of the Series F Preferred were outstanding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Series
G Convertible Preferred Stock</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 26, 2024, the Company filed a Certificate of Designation of Series G Convertible Preferred Stock (the &#8220;Series G
Certificate of Designation&#8221;) with the Secretary of State of the State of Nevada, designating <span id="xdx_907_eus-gaap--PreferredStockSharesAuthorized_iI_c20240126__us-gaap--StatementClassOfStockAxis__custom--SeriesGConvertiblePreferredStockMember_zheNllniYYnf" title="Preferred stock shares authorized"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2024-01-26_custom_SeriesGConvertiblePreferredStockMember" id="Fact001462" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">100,000</ix:nonFraction></span>
shares of the Company&#8217;s preferred stock as Series G Convertible Preferred Stock, par value $<span id="xdx_906_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20240126__us-gaap--StatementClassOfStockAxis__custom--SeriesGConvertiblePreferredStockMember_zOSy2wUglqF5" title="Preferred stock, par value"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2024-01-26_custom_SeriesGConvertiblePreferredStockMember" id="Fact001464" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.001</ix:nonFraction></span>
per share (the &#8220;Series G Preferred&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
terms and conditions set forth in the Series G Certificate of Designation are summarized below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Ranking.
</i>The Series G Preferred rank pari passu to the Company&#8217;s common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Dividends.
</i>Holders of Series G Preferred will be entitled to dividends, on an as-converted basis, equal to dividends actually paid, if any,
on shares of Company common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Voting</i>.
Except as provided by the Company&#8217;s Charter or as otherwise required by the Nevada Revised Statutes, holders of Series G Preferred
are entitled to vote with the holders of outstanding shares of Company common stock, voting together as a single class, with respect
to all matters presented to the Company&#8217;s stockholders for their action or consideration. In any such vote, each holder is entitled
to a number of votes equal to the number of shares of common stock into which the Series G Preferred held by such holder is convertible.
The Company may not, without the consent of holders of a majority of the outstanding shares of Series G Preferred, (i) alter or change
adversely the powers, preferences or rights given to the Series G Preferred or alter or amend the Series G Certificate of Designation,
(ii) amend its Charter or other charter documents in any manner that adversely effects any rights of the holders of the Series G Preferred,
or (c) enter into any agreement with respect to the foregoing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 101; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Conversion</i>.
On such date that the Company amends its Charter to increase the number of shares of common stock authorized for issuance thereunder,
to at least the extent required to convert all of the outstanding Series G Preferred, each outstanding share of Series G Preferred shall
automatically be converted into one share of Company common stock (subject to adjustment under certain limited circumstances) (the &#8220;Series
G Conversion Ratio&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Liquidation</i>.
In the event of any liquidation, dissolution or winding up of the Company, either voluntary or involuntary, holders of Series G Preferred
will be entitled to participate, on an as-converted-to-common stock basis calculate based on the Series G Conversion Ratio, with holders
of Company common stock in any distribution of assets of the Company to holders of the Company&#8217;s common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Redemption
Right</i>. <span id="xdx_90E_eus-gaap--PreferredStockRedemptionTerms_c20240301__20250228__us-gaap--StatementClassOfStockAxis__custom--SeriesGConvertiblePreferredStockMember_z0OGLpnlv4G" title="Preferred stock redemption right, description"><ix:nonNumeric contextRef="From2024-03-012025-02-28_custom_SeriesGConvertiblePreferredStockMember" id="Fact001466" name="us-gaap:PreferredStockRedemptionTerms">The
Company shall have the right to redeem up to 50% of the Series G Preferred for an aggregate price of $1.00 in accordance with
the terms of the Perpetual License Agreement</ix:nonNumeric></span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company did not exercise its option to repurchase up to 50% of the Series G Preferred, and all such shares were converted to common
stock on March 15, 2024. At February 28, 2025, <span id="xdx_906_eus-gaap--PreferredStockSharesOutstanding_iI_do_c20250228__us-gaap--StatementClassOfStockAxis__custom--SeriesGConvertiblePreferredStockMember_zBnO2ylgM36b" title="Preferred stock, shares outstanding"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2025-02-28_custom_SeriesGConvertiblePreferredStockMember" id="Fact001468" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares">no</ix:nonFraction></span> shares of the issued Series G Preferred were outstanding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Series
H Convertible Preferred Stock</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 26, 2024, the Company filed a Certificate of Designation of Series H Convertible Preferred Stock (the &#8220;Series H
Certificate of Designation&#8221;) with the Secretary of State of the State of Nevada, designating <span id="xdx_905_eus-gaap--PreferredStockSharesAuthorized_iI_c20240126__us-gaap--StatementClassOfStockAxis__custom--SeriesHConvertiblePreferredStockMember_z6RcaBv2mAu1" title="Preferred stock, shares authorized"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2024-01-26_custom_SeriesHConvertiblePreferredStockMember" id="Fact001470" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">150,000</ix:nonFraction></span>
shares of the Company&#8217;s preferred stock as Series H Preferred Stock, par value $<span id="xdx_90C_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20240126__us-gaap--StatementClassOfStockAxis__custom--SeriesHConvertiblePreferredStockMember_zypY5Qw3AED5" title="Preferred stock, par value"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2024-01-26_custom_SeriesHConvertiblePreferredStockMember" id="Fact001472" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.001</ix:nonFraction></span>
per share (the &#8220;Series H Preferred&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
terms and conditions set forth in the Series H Certificate of Designation are summarized below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Ranking.
</i>The Series H Preferred rank pari passu to the Company&#8217;s common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Dividends.
</i>Holders of Series H Preferred will be entitled to dividends, on an as-converted basis, equal to dividends actually paid, if any,
on shares of Company common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Voting</i>.
Except as provided by the Company&#8217;s Charter or as otherwise required by the Nevada Revised Statutes, holders of Series H Preferred
are entitled to vote with the holders of outstanding shares of Company common stock, voting together as a single class, with respect
to all matters presented to the Company&#8217;s stockholders for their action or consideration. In any such vote, each holder is entitled
to a number of votes equal to the number of shares of common stock into which the Series H Preferred held by such holder is convertible.
The Company may not, without the consent of holders of a majority of the outstanding shares of Series H Preferred, (i) alter or change
adversely the powers, preferences or rights given to the Series H Preferred or alter or amend the Series H Certificate of Designation,
(ii) amend its Charter or other charter documents in any manner that adversely effects any rights of the holders of the Series H Preferred,
or (c) enter into any agreement with respect to the foregoing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Conversion</i>.
On such date that the Company amends its Charter to increase the number of shares of common stock authorized for issuance thereunder,
to at least the extent required to convert all of the outstanding Series H Preferred, each outstanding share of Series H Preferred shall
automatically be converted into one share of Company common stock (subject to adjustment under certain limited circumstances) (the &#8220;Series
H Conversion Ratio&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Liquidation</i>.
In the event of any liquidation, dissolution or winding up of the Company, either voluntary or involuntary, holders of Series H Preferred
will be entitled to participate, on an as-converted-to-common stock basis calculate based on the Series H Conversion Ratio, with holders
of Company common stock in any distribution of assets of the Company to holders of the Company&#8217;s common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
February 28, 2025, <span title="Preferred stock, shares issued"><span id="xdx_90A_eus-gaap--PreferredStockSharesOutstanding_iI_c20250228__us-gaap--StatementClassOfStockAxis__custom--SeriesHConvertiblePreferredStockMember_zPXkajWGz9i3" title="Preferred stock, shares outstanding"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2025-02-28_custom_SeriesHConvertiblePreferredStockMember" id="Fact001474" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">33,000</ix:nonFraction></span></span> shares of the issued Series H Preferred were outstanding, which if converted as of February
28, 2025, would have resulted in the issuance of <span id="xdx_905_eus-gaap--PreferredStockConvertibleSharesIssuable_iI_c20250228__us-gaap--StatementClassOfStockAxis__custom--SeriesHConvertiblePreferredStockMember_zMAiZCl9HXwa" title="Common stock issuable upon conversion"><ix:nonFraction name="us-gaap:PreferredStockConvertibleSharesIssuable" contextRef="AsOf2025-02-28_custom_SeriesHConvertiblePreferredStockMember" id="Fact001476" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">33,000</ix:nonFraction></span> shares of common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 102; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Series
I Convertible Preferred Stock</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 22, 2024, the Company filed a Certificate of Designation of Series I Convertible Preferred Stock (the &#8220;Initial Series
I Certificate of Designation&#8221;) with the Secretary of State of the State of Nevada, designating <span id="xdx_900_eus-gaap--PreferredStockSharesAuthorized_iI_c20240222__us-gaap--StatementClassOfStockAxis__custom--SeriesIConvertiblePreferredStockMember_zjIC8UIJlcK1"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2024-02-22_custom_SeriesIConvertiblePreferredStockMember" id="Fact001477" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">331,124</ix:nonFraction></span></span>
<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of the Company&#8217;s preferred stock as Series I Convertible
Preferred Stock, par value $<span id="xdx_904_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20240222__us-gaap--StatementClassOfStockAxis__custom--SeriesIConvertiblePreferredStockMember_zAw72DGiuhC1"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2024-02-22_custom_SeriesIConvertiblePreferredStockMember" id="Fact001478" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.001</ix:nonFraction></span></span>
<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share (the &#8220;Series I Preferred&#8221;). On February
25, 2025, the Company filed an amendment to the Certificate of Designation of Series I Convertible Preferred Stock (the &#8220;Amendment
to Series I Certificate of Designation,&#8221; and together with the Initial Series I Certificate of Designation, the &#8220;Series I
Certificate of Designation&#8221;) with the Secretary of State of the State of Nevada, to increase the number of shares of the Company&#8217;s
preferred stock designated as Series I Preferred to <span id="xdx_900_eus-gaap--PreferredStockSharesAuthorized_iI_c20250225__us-gaap--StatementClassOfStockAxis__custom--SeriesIConvertiblePreferredStockMember_zmfPDHYZIMUb"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2025-02-25_custom_SeriesIConvertiblePreferredStockMember" id="Fact001479" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">692,945</ix:nonFraction></span></span>
<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
terms and conditions set forth in the Series I Certificate of Designation are summarized below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Ranking.
</i>The Series I Preferred rank pari passu to the Company&#8217;s common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Dividends.
</i>Holders of Series I Preferred will be entitled to dividends, on an as-converted basis, equal to dividends actually paid, if any,
on shares of Company common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Voting</i>.
Except as provided by the Charter, or as otherwise required by the Nevada Revised Statutes, holders of Series I Preferred are entitled
to vote with the holders of outstanding shares of Company common stock, voting together as a single class, with respect to all matters
presented to the Company&#8217;s stockholders for their action or consideration. In any such vote, each holder is entitled to a number
of votes equal to the number of shares of common stock into which the Series I Preferred held by such holder is convertible. The Company
may not, without the consent of holders of a majority of the outstanding shares of Series I Preferred, (i) alter or change adversely
the powers, preferences or rights given to the Series I Preferred or alter or amend the Series I Certificate of Designation, (ii) amend
its Charter or other charter documents in any manner that adversely effects any rights of the holders of the Series I Preferred, or (c)
enter into any agreement with respect to the foregoing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Conversion</i>.
On such date that the Company amends its Charter to increase the number of shares of common stock authorized for issuance thereunder,
to at least the extent required to convert all of the outstanding shares of Series I Preferred, each outstanding share of Series I Preferred
shall automatically be converted into one share of Company common stock (subject to adjustment under certain limited circumstances) (the
&#8220;Series I Conversion Ratio&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Liquidation</i>.
In the event of any liquidation, dissolution or winding up of the Company, either voluntary or involuntary, holders of Series I Preferred
will be entitled to participate, on an as-converted-to-common stock basis calculated based on the Series I Conversion Ratio, with holders
of Company common stock in any distribution of assets of the Company to holders of the Company&#8217;s common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 15, 2024, the Company entered into a securities purchase agreement with certain accredited investors, pursuant to which the
Company issued and sold an aggregate of $<span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20240215__20240215__us-gaap--StatementClassOfStockAxis__custom--SeriesIConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zE4U5gt1etga" title="Issuance of shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2024-02-152024-02-15_custom_SeriesIConvertiblePreferredStockMember_custom_SecuritiesPurchaseAgreementMember" id="Fact001481" format="ixt:numdotdecimal" decimals="0" unitRef="USD">672,500</ix:nonFraction></span> of the Company&#8217;s securities, consisting of (i) <span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20240215__20240215__us-gaap--StatementClassOfStockAxis__custom--SeriesIConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zUhxlGTD5jKd" title="Issuance of shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2024-02-152024-02-15_custom_SeriesIConvertiblePreferredStockMember_custom_SecuritiesPurchaseAgreementMember" id="Fact001483" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">222,680</ix:nonFraction></span> restricted shares of Series I Preferred, and (ii) unregistered warrants
to purchase up to <span id="xdx_905_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20240215__us-gaap--StatementClassOfStockAxis__custom--SeriesIConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zYwR9dgXiJ33" title="Warrants to purchase common stock"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="AsOf2024-02-15_custom_SeriesIConvertiblePreferredStockMember_custom_SecuritiesPurchaseAgreementMember" id="Fact001485" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">111,340</ix:nonFraction></span> shares of Company common stock at a combined price of $<span id="xdx_907_eus-gaap--SharePrice_iI_c20240215__us-gaap--StatementClassOfStockAxis__custom--SeriesIConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zHGEKTXDd78i" title="Share price"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2024-02-15_custom_SeriesIConvertiblePreferredStockMember_custom_SecuritiesPurchaseAgreementMember" id="Fact001487" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">3.02</ix:nonFraction></span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 15, 2024, the Company entered into a securities purchase agreement with an investor for the sale of <span id="xdx_904_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20240815__20240815__us-gaap--StatementClassOfStockAxis__custom--SeriesIConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_z06NpsU1w4y6" title="Sale of stock, shares"><ix:nonFraction name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" contextRef="From2024-08-152024-08-15_custom_SeriesIConvertiblePreferredStockMember_custom_SecuritiesPurchaseAgreementMember" id="Fact001489" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">4,967</ix:nonFraction></span> shares of Series I Preferred, at $<span id="xdx_901_eus-gaap--SaleOfStockPricePerShare_iI_c20240815__us-gaap--StatementClassOfStockAxis__custom--SeriesIConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zDpKxUYtGCEa" title="Sale of stock, shares price"><ix:nonFraction name="us-gaap:SaleOfStockPricePerShare" contextRef="AsOf2024-08-15_custom_SeriesIConvertiblePreferredStockMember_custom_SecuritiesPurchaseAgreementMember" id="Fact001491" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">3.02</ix:nonFraction></span> per share, resulting in gross proceeds to the Company of $<span id="xdx_905_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_c20240815__20240815__us-gaap--StatementClassOfStockAxis__custom--SeriesIConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_z5x5E7G4Awf6" title="Sale of stock proceeds"><ix:nonFraction name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" contextRef="From2024-08-152024-08-15_custom_SeriesIConvertiblePreferredStockMember_custom_SecuritiesPurchaseAgreementMember" id="Fact001493" format="ixt:numdotdecimal" decimals="0" unitRef="USD">15,000</ix:nonFraction></span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 31, 2024, the Company entered into a securities purchase agreement with an investor for the sale of <span id="xdx_90E_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20240831__20240831__us-gaap--StatementClassOfStockAxis__custom--SeriesIConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zhY4QXaJPvW7" title="Sale of stock, shares"><ix:nonFraction name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" contextRef="From2024-08-312024-08-31_custom_SeriesIConvertiblePreferredStockMember_custom_SecuritiesPurchaseAgreementMember" id="Fact001495" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">24,834</ix:nonFraction></span> shares of Series I Preferred at $<span id="xdx_904_eus-gaap--SaleOfStockPricePerShare_iI_c20240831__us-gaap--StatementClassOfStockAxis__custom--SeriesIConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zI7UoZbvVzVl" title="Sale of stock, shares price"><ix:nonFraction name="us-gaap:SaleOfStockPricePerShare" contextRef="AsOf2024-08-31_custom_SeriesIConvertiblePreferredStockMember_custom_SecuritiesPurchaseAgreementMember" id="Fact001497" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">3.02</ix:nonFraction></span> per share, resulting in gross proceeds to the Company of $<span id="xdx_90D_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_c20240831__20240831__us-gaap--StatementClassOfStockAxis__custom--SeriesIConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zmJhDJJyyqN2" title="Sale of stock proceeds"><ix:nonFraction name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" contextRef="From2024-08-312024-08-31_custom_SeriesIConvertiblePreferredStockMember_custom_SecuritiesPurchaseAgreementMember" id="Fact001499" format="ixt:numdotdecimal" decimals="0" unitRef="USD">75,000</ix:nonFraction></span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 1, 2024, the Company entered into a securities purchase agreement with an investor for the sale of <span id="xdx_908_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20241001__20241001__us-gaap--StatementClassOfStockAxis__custom--SeriesIConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_z7uKfJAZlqKh" title="Sale of stock, shares"><ix:nonFraction name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" contextRef="From2024-10-012024-10-01_custom_SeriesIConvertiblePreferredStockMember_custom_SecuritiesPurchaseAgreementMember" id="Fact001501" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">66,225</ix:nonFraction></span> shares of Series I Preferred at $<span id="xdx_903_eus-gaap--SaleOfStockPricePerShare_iI_c20241001__us-gaap--StatementClassOfStockAxis__custom--SeriesIConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zfPCvEmQkxj" title="Sale of stock, shares price"><ix:nonFraction name="us-gaap:SaleOfStockPricePerShare" contextRef="AsOf2024-10-01_custom_SeriesIConvertiblePreferredStockMember_custom_SecuritiesPurchaseAgreementMember" id="Fact001503" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">3.02</ix:nonFraction></span> per share, resulting in gross proceeds to the Company of $<span id="xdx_90A_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_c20241001__20241001__us-gaap--StatementClassOfStockAxis__custom--SeriesIConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zOvdrEUweBq6" title="Sale of stock proceeds"><ix:nonFraction name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" contextRef="From2024-10-012024-10-01_custom_SeriesIConvertiblePreferredStockMember_custom_SecuritiesPurchaseAgreementMember" id="Fact001505" format="ixt:numdotdecimal" decimals="0" unitRef="USD">200,000</ix:nonFraction></span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 24, 2025, the Company entered into a securities purchase agreement (the &#8220;Series I Purchase Agreement&#8221;) with
certain accredited investors (the &#8220;Purchasers&#8221;), pursuant to which the Company issued and sold an aggregate of <span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20250224__20250224__us-gaap--StatementClassOfStockAxis__custom--SeriesIConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--SeriesIPurchaseAgreementMember_zUIhkjOBdwJ6" title="Restricted shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross" contextRef="From2025-02-242025-02-24_custom_SeriesIConvertiblePreferredStockMember_custom_SeriesIPurchaseAgreementMember" id="Fact001507" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">331,125</ix:nonFraction></span>
restricted shares of Series I Preferred Stock to the Purchasers at a purchase price of $<span id="xdx_904_eus-gaap--SaleOfStockPricePerShare_iI_c20250224__us-gaap--StatementClassOfStockAxis__custom--SeriesIConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zARw9a2FXOF2" title="Sale of stock, shares price"><ix:nonFraction name="us-gaap:SaleOfStockPricePerShare" contextRef="AsOf2025-02-24_custom_SeriesIConvertiblePreferredStockMember_custom_SecuritiesPurchaseAgreementMember" id="Fact001509" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">3.02</ix:nonFraction></span>
per share (the &#8220;Series I Offering&#8221;), resulting in aggregate gross proceeds to the Company of $<span id="xdx_90A_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_c20250224__20250224__us-gaap--StatementClassOfStockAxis__custom--SeriesIConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--SeriesIPurchaseAgreementMember_zwrMGrCZ65p6" title="Sale of stock proceeds"><ix:nonFraction name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" contextRef="From2025-02-242025-02-24_custom_SeriesIConvertiblePreferredStockMember_custom_SeriesIPurchaseAgreementMember" id="Fact001511" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,000,000</ix:nonFraction></span>.
In addition, the Company issued <span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20250224__20250224__us-gaap--StatementClassOfStockAxis__custom--SeriesIPreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--SeriesIPurchaseAgreementMember_zUW6n00Q1BVk" title="Issuance of shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2025-02-242025-02-24_custom_SeriesIPreferredStockMember_custom_SeriesIPurchaseAgreementMember" id="Fact001513" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">10,000</ix:nonFraction></span>
shares of Series I Preferred at $<span id="xdx_909_eus-gaap--SaleOfStockPricePerShare_iI_c20241001__us-gaap--StatementClassOfStockAxis__custom--SeriesIPreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zBybi1QSKXo8" title="Sale of stock, shares price"><ix:nonFraction name="us-gaap:SaleOfStockPricePerShare" contextRef="AsOf2024-10-01_custom_SeriesIPreferredStockMember_custom_SecuritiesPurchaseAgreementMember" id="Fact001515" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">3.02</ix:nonFraction></span>
per share to an outside contractor as payment for outstanding invoices.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 103; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 24 2025, the Company entered into a debt conversion agreement with Greg Miller, an independent contractor of the Company,
whereby Mr. Miller and the Company agreed to convert $<span id="xdx_902_eus-gaap--DebtConversionConvertedInstrumentAmount1_c20250224__20250224__us-gaap--TypeOfArrangementAxis__custom--MillerDebtConversionAgreementMember_zoUUqZLZ2R46" title="Converted amount"><ix:nonFraction name="us-gaap:DebtConversionConvertedInstrumentAmount1" contextRef="From2025-02-242025-02-24_custom_MillerDebtConversionAgreementMember" id="Fact001517" format="ixt:numdotdecimal" decimals="0" unitRef="USD">100,000</ix:nonFraction></span>
in deferred consulting fees owed to Mr. Miller into <span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20250224__20250224__us-gaap--TypeOfArrangementAxis__custom--MillerDebtConversionAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesIConvertiblePreferredStockMember_zF3KiLH3tJ11" title="Issuance of shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2025-02-242025-02-24_custom_MillerDebtConversionAgreementMember_custom_SeriesIConvertiblePreferredStockMember" id="Fact001519" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">33,113</ix:nonFraction></span>
shares of Series I Preferred, at a conversion price of $<span id="xdx_90B_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20250224__us-gaap--TypeOfArrangementAxis__custom--MillerDebtConversionAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesIConvertiblePreferredStockMember_zh6vvXLmh4J3" title="Debt conversion price"><ix:nonFraction name="us-gaap:DebtInstrumentConvertibleConversionPrice1" contextRef="AsOf2025-02-24_custom_MillerDebtConversionAgreementMember_custom_SeriesIConvertiblePreferredStockMember" id="Fact001521" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">3.02</ix:nonFraction></span>
per share, and a warrant to purchase <span id="xdx_904_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20250224__us-gaap--TypeOfArrangementAxis__custom--MillerDebtConversionAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesIConvertiblePreferredStockMember_zmwVL8rVnyV3" title="Warrants to purchase common stock"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="AsOf2025-02-24_custom_MillerDebtConversionAgreementMember_custom_SeriesIConvertiblePreferredStockMember" id="Fact001523" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">33,113</ix:nonFraction></span>
shares of common stock (the &#8220;Miller Warrant&#8221;). The Miller Warrant has an exercise price of $<span id="xdx_90A_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20250224__us-gaap--TypeOfArrangementAxis__custom--MillerDebtConversionAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesIConvertiblePreferredStockMember_z5GwVjqRpot7" title="Exercise price"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2025-02-24_custom_MillerDebtConversionAgreementMember_custom_SeriesIConvertiblePreferredStockMember" id="Fact001525" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">4.00</ix:nonFraction></span>
per share, becomes exercisable six months from the issuance date (subject to stockholder approval of removal of the Exchange Cap),
and shall expire three years from the initial exercise date (August 24, 2028).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Series I Preferred shall not be convertible and the Miller Warrant shall be not exercisable into shares of common stock until such date
that the Company obtains stockholder approval to remove the Exchange Cap (as described below).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
February 28, 2025, <span title="Preferred stock, shares issued"><span id="xdx_90E_eus-gaap--PreferredStockSharesOutstanding_iI_c20250228__us-gaap--StatementClassOfStockAxis__custom--SeriesIConvertiblePreferredStockMember_zUdgF5jSWgsc" title="Preferred stock, shares outstanding"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2025-02-28_custom_SeriesIConvertiblePreferredStockMember" id="Fact001527" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">500,442</ix:nonFraction></span></span> shares of the Series I Preferred were outstanding, which if converted as of February 28,
2025, would have resulted in the issuance of <span id="xdx_902_eus-gaap--PreferredStockConvertibleSharesIssuable_iI_c20250228__us-gaap--StatementClassOfStockAxis__custom--SeriesIConvertiblePreferredStockMember_zViR1ZgYSmd1" title="Converted issuance of shares of common stock"><ix:nonFraction name="us-gaap:PreferredStockConvertibleSharesIssuable" contextRef="AsOf2025-02-28_custom_SeriesIConvertiblePreferredStockMember" id="Fact001529" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">500,442</ix:nonFraction></span> shares of common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Series
J Nonvoting Convertible Preferred Stock</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 3, 2025, the Company filed a Certificate of Designation of Series J Nonvoting Convertible Preferred Stock (the &#8220;Series
J Certificate of Designation&#8221;) with the Secretary of State of the State of Nevada, designating <span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20250103__20250103__us-gaap--StatementClassOfStockAxis__custom--SeriesJNonvotingConvertiblePreferredStockMember_zqRBMkqSJcu5" title="Restricted shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross" contextRef="From2025-01-032025-01-03_custom_SeriesJNonvotingConvertiblePreferredStockMember" id="Fact001531" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">297,788</ix:nonFraction></span>
shares of the Company&#8217;s preferred stock as Series J Nonvoting Convertible Preferred Stock, par value $<span id="xdx_906_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20250103__us-gaap--StatementClassOfStockAxis__custom--SeriesJNonvotingConvertiblePreferredStockMember_zc2zlVEBbpFk" title="Preferred stock, par value"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2025-01-03_custom_SeriesJNonvotingConvertiblePreferredStockMember" id="Fact001533" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.001</ix:nonFraction></span>
per share (the &#8220;Series J Preferred&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
terms and conditions set forth in the Series J Certificate of Designation are summarized below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Ranking.
</i>The Series J Preferred rank pari passu to the Company&#8217;s common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Dividends.
</i>Holders of Series J Preferred will be entitled to dividends, on an as-converted basis, equal to dividends actually paid, if any,
on shares of Company common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Voting</i>.
Except as provided by the Charter, or as otherwise required by the Nevada Revised Statutes, holders of Series J Preferred are not entitled
to voting rights. However, the Company may not, without the consent of holders of a majority of the outstanding shares of Series J Preferred,
(i) alter or change adversely the powers, preferences or rights given to the Series J Preferred or alter or amend the Series J Certificate
of Designation, (ii) amend its Charter or other charter documents in any manner that adversely effects any rights of the holders of the
Series J Preferred, or (c) enter into any agreement with respect to the foregoing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Conversion</i>.
On the third business day after the date that the Company&#8217;s stockholders approve the conversion of Series J Preferred into shares
of Common Stock in accordance with the listing rules of Nasdaq, each outstanding share of Series J Preferred shall automatically be converted
into one share of Company common stock (subject to adjustment under certain limited circumstances) (the &#8220;Series J Conversion Ratio&#8221;),
subject to beneficial ownership limitations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Liquidation</i>.
In the event of any liquidation, dissolution or winding up of the Company, either voluntary or involuntary, holders of Series J Preferred
will be entitled to participate, on an as-converted-to-common stock basis calculated based on the Series J Conversion Ratio, with holders
of Company common stock in any distribution of assets of the Company to holders of the Company&#8217;s common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 31, 2024, the Company entered into a securities purchase agreement with certain accredited investors, pursuant to which the
Company issued and sold an aggregate of <span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20241231__20241231__us-gaap--StatementClassOfStockAxis__custom--SeriesJNonvotingConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zYp76RjrWlC2" title="Issuance of shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2024-12-312024-12-31_custom_SeriesJNonvotingConvertiblePreferredStockMember_custom_SecuritiesPurchaseAgreementMember" id="Fact001535" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">231,788</ix:nonFraction></span> restricted shares of Series J Preferred, at a purchase price of $<span id="xdx_909_eus-gaap--SharePrice_iI_c20241231__us-gaap--StatementClassOfStockAxis__custom--SeriesJNonvotingConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_z5jYfH7uczp6" title="Share price"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2024-12-31_custom_SeriesJNonvotingConvertiblePreferredStockMember_custom_SecuritiesPurchaseAgreementMember" id="Fact001537" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">3.02</ix:nonFraction></span> per share, resulting in gross proceeds to the Company
of $<span id="xdx_905_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_c20241231__20241231__us-gaap--StatementClassOfStockAxis__custom--SeriesJNonvotingConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zVAHvSTRWQCi" title="Sale of stock proceeds"><ix:nonFraction name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" contextRef="From2024-12-312024-12-31_custom_SeriesJNonvotingConvertiblePreferredStockMember_custom_SecuritiesPurchaseAgreementMember" id="Fact001539" format="ixt:numdotdecimal" decimals="0" unitRef="USD">700,000</ix:nonFraction></span>. In addition, the Company issued a total of <span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20241231__20241231__us-gaap--StatementClassOfStockAxis__custom--SeriesJNonvotingConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zETwHV1wAIUl" title="Issuance of shares for services"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" contextRef="From2024-12-312024-12-31_custom_SeriesJNonvotingConvertiblePreferredStockMember_custom_SecuritiesPurchaseAgreementMember" id="Fact001541" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">66,000</ix:nonFraction></span> shares of Series J Preferred to four consultants for investor relations
services.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Series J Preferred shall be convertible into the Company&#8217;s common stock on such date that the Company obtains stockholder approval
to remove the Exchange Cap.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
February 28, 2025, <span title="Preferred stock, shares issued"><span id="xdx_90F_eus-gaap--PreferredStockSharesOutstanding_iI_c20250228__us-gaap--StatementClassOfStockAxis__custom--SeriesJNonvotingConvertiblePreferredStockMember_z4EO1sdNnv8l" title="Preferred stock, shares outstanding"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2025-02-28_custom_SeriesJNonvotingConvertiblePreferredStockMember" id="Fact001543" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">297,788</ix:nonFraction></span></span> shares of the Series J Preferred were outstanding, which if converted as of February 28,
2025, would have resulted in the issuance of <span id="xdx_90D_eus-gaap--PreferredStockConvertibleSharesIssuable_iI_c20250228__us-gaap--StatementClassOfStockAxis__custom--SeriesJNonvotingConvertiblePreferredStockMember_zS4BPrzLX3F2" title="Common stock issuable upon conversion"><ix:nonFraction name="us-gaap:PreferredStockConvertibleSharesIssuable" contextRef="AsOf2025-02-28_custom_SeriesJNonvotingConvertiblePreferredStockMember" id="Fact001545" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">297,788</ix:nonFraction></span> shares of common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Series
K Nonvoting Convertible Preferred Stock</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 3, 2025, the Company filed a Certificate of Designation of Series K Nonvoting Convertible Preferred Stock (the &#8220;Series
K Certificate of Designation&#8221;) with the Secretary of State of the State of Nevada, designating <span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20250103__20250103__us-gaap--StatementClassOfStockAxis__custom--SeriesKNonvotingConvertiblePreferredStockMember_z8hCFKypgGIc" title="Restricted shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross" contextRef="From2025-01-032025-01-03_custom_SeriesKNonvotingConvertiblePreferredStockMember" id="Fact001547" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">60,595</ix:nonFraction></span>
shares of the Company&#8217;s preferred stock as Series K Nonvoting Convertible Preferred Stock, par value $<span id="xdx_90E_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20250103__us-gaap--StatementClassOfStockAxis__custom--SeriesKNonvotingConvertiblePreferredStockMember_zxciiO6flLPd" title="Preferred stock, par value"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2025-01-03_custom_SeriesKNonvotingConvertiblePreferredStockMember" id="Fact001549" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.001</ix:nonFraction></span>
per share (the &#8220;Series K Preferred&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
terms and conditions set forth in the Series K Certificate of Designation are summarized below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Ranking.
</i>The Series K Preferred rank pari passu to the Company&#8217;s common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 104; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Dividends.
</i>Holders of Series K Preferred will be entitled to dividends, on an as-converted basis, equal to dividends actually paid, if any,
on shares of Company common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Voting</i>.
Except as provided by the Charter, or as otherwise required by the Nevada Revised Statutes, holders of Series K Preferred are not entitled
to voting rights. However, the Company may not, without the consent of holders of a majority of the outstanding shares of Series K Preferred,
(i) alter or change adversely the powers, preferences or rights given to the Series K Preferred or alter or amend the Series K Certificate
of Designation, (ii) amend its Charter or other charter documents in any manner that adversely effects any rights of the holders of the
Series K Preferred, or (c) enter into any agreement with respect to the foregoing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Conversion</i>.
On the third business day after the date that the Company&#8217;s stockholders approve the conversion of Series K Preferred into shares
of Common Stock in accordance with the listing rules of Nasdaq, each outstanding share of Series K Preferred shall automatically be converted
into one share of Company common stock (subject to adjustment under certain limited circumstances) (the &#8220;Series K Conversion Ratio&#8221;),
subject to beneficial ownership limitations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Liquidation</i>.
In the event of any liquidation, dissolution or winding up of the Company, either voluntary or involuntary, holders of Series K Preferred
will be entitled to participate, on an as-converted-to-common stock basis calculated based on the Series K Conversion Ratio, with holders
of Company common stock in any distribution of assets of the Company to holders of the Company&#8217;s common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 31, 2024, the Company issued an aggregate of <span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20241231__20241231__us-gaap--StatementClassOfStockAxis__custom--SeriesKNonvotingConvertiblePreferredStockMember_zYVNUXGoXWxl" title="Issuance of shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2024-12-312024-12-31_custom_SeriesKNonvotingConvertiblePreferredStockMember" id="Fact001551" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">60,595</ix:nonFraction></span> shares of Series K Preferred to a series of investors
at a price of $<span id="xdx_901_eus-gaap--SharePrice_iI_c20241231__us-gaap--StatementClassOfStockAxis__custom--SeriesKNonvotingConvertiblePreferredStockMember_z2DyjOLX6OSf" title="Share price"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2024-12-31_custom_SeriesKNonvotingConvertiblePreferredStockMember" id="Fact001553" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">3.02</ix:nonFraction></span> per share as prepaid guaranteed interest in connection with the sale of an aggregate of $<span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20241231__20241231__us-gaap--StatementClassOfStockAxis__custom--SeriesKNonvotingConvertiblePreferredStockMember_z7pGBVoIMrCb" title="Issuance of shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2024-12-312024-12-31_custom_SeriesKNonvotingConvertiblePreferredStockMember" id="Fact001555" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,220,000</ix:nonFraction></span> in promissory
notes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Series K Preferred shall be convertible into the Company&#8217;s common stock on such date that the Company obtains stockholder approval
to remove the Exchange Cap.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
February 28, 2025, <span title="Preferred stock, shares issued"><span id="xdx_90D_eus-gaap--PreferredStockSharesOutstanding_iI_c20250228__us-gaap--StatementClassOfStockAxis__custom--SeriesKNonvotingConvertiblePreferredStockMember_zRtrgYW5oqO4" title="Preferred stock, shares outstanding"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2025-02-28_custom_SeriesKNonvotingConvertiblePreferredStockMember" id="Fact001557" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">60,595</ix:nonFraction></span></span> shares of the Series K Preferred were outstanding, which if converted as of February 28,
2025, would have resulted in the issuance of <span id="xdx_907_eus-gaap--PreferredStockConvertibleSharesIssuable_iI_c20250228__us-gaap--StatementClassOfStockAxis__custom--SeriesKNonvotingConvertiblePreferredStockMember_zGyKd0UC1YVg" title="Converted issuance of shares of common stock"><ix:nonFraction name="us-gaap:PreferredStockConvertibleSharesIssuable" contextRef="AsOf2025-02-28_custom_SeriesKNonvotingConvertiblePreferredStockMember" id="Fact001559" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">60,595</ix:nonFraction></span> shares of common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Series
L Nonvoting Convertible Preferred Stock</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 3, 2025, the Company filed a Certificate of Designation of Series L Nonvoting Convertible Preferred Stock (the
&#8220;Initial Series L Certificate of Designation&#8221;) with the Secretary of State of the State of Nevada, designating <span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20250103__20250103__us-gaap--StatementClassOfStockAxis__custom--SeriesLNonvotingConvertiblePreferredStockMember_zw5J948csBw6" title="Restricted shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross" contextRef="From2025-01-032025-01-03_custom_SeriesLNonvotingConvertiblePreferredStockMember" id="Fact001561" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">579,469</ix:nonFraction></span>
shares of the Company&#8217;s preferred stock as Series L Nonvoting Convertible Preferred Stock, par value $<span id="xdx_90C_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20250103__us-gaap--StatementClassOfStockAxis__custom--SeriesLNonvotingConvertiblePreferredStockMember_zxFdB69gfp9d" title="Preferred stock, par value"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2025-01-03_custom_SeriesLNonvotingConvertiblePreferredStockMember" id="Fact001563" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.001</ix:nonFraction></span>
per share(the &#8220;Series L Preferred&#8221;). On February 25, 2025, the Company filed an amendment to the Initial Series L Certificate of Designation (the &#8220;Series
L Preferred Amendment,&#8221; and together with the Initial Series L Certificate of Designation, the &#8220;Series L Certificate of Designation&#8221;)
with the Secretary of State of the State of Nevada, to increase the number of shares of the Company&#8217;s preferred stock designated
as Series L Preferred to <span id="xdx_904_eus-gaap--PreferredStockSharesAuthorized_iI_c20250225__us-gaap--StatementClassOfStockAxis__custom--SeriesLNonvotingConvertiblePreferredStockMember_zLBhtrDGaLPc" title="Preferred stock, shares authorized"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2025-02-25_custom_SeriesLNonvotingConvertiblePreferredStockMember" id="Fact001565" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,076,158</ix:nonFraction></span> shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
terms and conditions set forth in the Series L Certificate of Designation are summarized below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Ranking.
</i>The Series L Preferred rank pari passu to the Company&#8217;s common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Dividends.
</i>Holders of Series L Preferred will be entitled to dividends, if, as and when declared by the Board out of funds at the time legally
available therefor, dividends in the amount of <span id="xdx_90E_eus-gaap--PreferredStockDividendRatePercentage_pid_dp_uPure_c20250103__20250103__us-gaap--StatementClassOfStockAxis__custom--SeriesLNonvotingConvertiblePreferredStockMember_z602A2WHwORb" title="Dividend percentage"><ix:nonFraction name="us-gaap:PreferredStockDividendRatePercentage" contextRef="From2025-01-032025-01-03_custom_SeriesLNonvotingConvertiblePreferredStockMember" id="Fact001567" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">12</ix:nonFraction></span>% per annum per share of Preferred Stock (subject to appropriate adjustment in the event
of any stock dividend, stock split, combination or other similar recapitalization with respect to the Preferred Stock), and no more.
Dividends on the Preferred Stock shall be fully cumulative, shall accrue without interest and without compounding from the date of first
issuance, and shall, if declared by the Board, be payable quarterly in arrears on March 1, June 1, September 1 and December of each year.
All dividends on the Preferred Stock shall be payable (i) in shares of Common Stock of the Company at the Nasdaq Closing Price; provided,
however, that such prices shall not be less than $<span id="xdx_90F_eus-gaap--SaleOfStockPricePerShare_iI_c20250103__us-gaap--StatementClassOfStockAxis__custom--SeriesLNonvotingConvertiblePreferredStockMember_zG9MtSsxsPNg" title="Purchase price, per share"><ix:nonFraction name="us-gaap:SaleOfStockPricePerShare" contextRef="AsOf2025-01-03_custom_SeriesLNonvotingConvertiblePreferredStockMember" id="Fact001569" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">3.02</ix:nonFraction></span> per share, or (ii) cash, at the election of a majority of the independent directors.
Any dividend which shall not be paid on required dividend date on which it shall become due shall be deemed to be &#8220;past due&#8221;
until such dividend shall be paid or until the share of Preferred Stock with respect to which such dividend became due shall no longer
be outstanding, whichever is the earlier to occur. In the event that any dividend becomes &#8220;past due&#8221; the per annum rate shall
increase to 14%.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Voting</i>.
Except as provided by the Charter, or as otherwise required by the Nevada Revised Statutes, holders of Series L Preferred are not entitled
to voting rights However, the Company may not, without the consent of holders of a majority of the outstanding shares of Series L Preferred,
(i) alter or change adversely the powers, preferences or rights given to the Series L Preferred or alter or amend the Series L Certificate
of Designation, (ii) amend its Charter or other charter documents in any manner that adversely effects any rights of the holders of the
Series L Preferred, or (c) enter into any agreement with respect to the foregoing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>


<ix:exclude><!-- Field: Page; Sequence: 105; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Conversion</i>.
On the third business day after the date that the Company&#8217;s stockholders approve the conversion of Series L Preferred into shares
of Common Stock in accordance with the listing rules of Nasdaq, each outstanding share of Series L Preferred shall automatically be converted
into one share of Company common stock (subject to adjustment under certain limited circumstances) (the &#8220;Series L Conversion Ratio&#8221;),
subject to beneficial ownership limitations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Liquidation</i>.
In the event of any liquidation, dissolution or winding up of the Company, either voluntary or involuntary, holders of Series L Preferred
will be entitled to participate, on an as-converted-to-common stock basis calculated based on the Series L Conversion Ratio, with holders
of Company common stock in any distribution of assets of the Company to holders of the Company&#8217;s common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 31, 2024, the Company entered into debt conversion agreements with
its chief executive officer, William Kerby, and chairman of the board, Donald P. Monaco (the &#8220;Related Parties&#8221;), whereby
the Related Parties and the Company agreed to convert $<span id="xdx_909_eus-gaap--DebtConversionConvertedInstrumentAmount1_pn4n6_c20241231__20241231__srt--TitleOfIndividualAxis__custom--MessrsKerbyAndMonacoMember__us-gaap--TypeOfArrangementAxis__custom--RelatedPartyDebtConversionAgreementsMember_z0bWZk7HXdfh" title="Converted amount"><ix:nonFraction name="us-gaap:DebtConversionConvertedInstrumentAmount1" contextRef="From2024-12-312024-12-31_custom_MessrsKerbyAndMonacoMember_custom_RelatedPartyDebtConversionAgreementsMember" id="Fact001571" format="ixt:numdotdecimal" decimals="-4" scale="6" unitRef="USD">1.75</ix:nonFraction></span> million in existing unsecured promissory notes owed to the Related Parties
for monies advanced to the Company into an aggregate of <span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20241231__20241231__srt--TitleOfIndividualAxis__custom--MessrsKerbyAndMonacoMember__us-gaap--StatementClassOfStockAxis__custom--SeriesLNonvotingConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--RelatedPartyDebtConversionAgreementsMember_zs93oHrPKI0f" title="Restricted shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross" contextRef="From2024-12-312024-12-31_custom_MessrsKerbyAndMonacoMember_custom_SeriesLNonvotingConvertiblePreferredStockMember_custom_RelatedPartyDebtConversionAgreementsMember" id="Fact001573" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">579,469</ix:nonFraction></span> restricted shares of Series L Preferred, at a purchase price of $<span id="xdx_90D_eus-gaap--SaleOfStockPricePerShare_iI_c20241231__srt--TitleOfIndividualAxis__custom--MessrsKerbyAndMonacoMember__us-gaap--StatementClassOfStockAxis__custom--SeriesLNonvotingConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--RelatedPartyDebtConversionAgreementsMember_zoRaJYGTeIjb" title="Purchase price, per share"><ix:nonFraction name="us-gaap:SaleOfStockPricePerShare" contextRef="AsOf2024-12-31_custom_MessrsKerbyAndMonacoMember_custom_SeriesLNonvotingConvertiblePreferredStockMember_custom_RelatedPartyDebtConversionAgreementsMember" id="Fact001575" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">3.02</ix:nonFraction></span> per share.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 24, 2025, the Company entered into debt conversion agreements with
its chief executive officer, William Kerby, and chairman of the board, Donald P. Monaco, whereby
the Related Parties and the Company agreed to convert $<span id="xdx_90E_eus-gaap--DebtConversionConvertedInstrumentAmount1_c20250224__20250224__us-gaap--TypeOfArrangementAxis__custom--RelatedPartyDebtConversionAgreementsMember__us-gaap--StatementClassOfStockAxis__custom--SeriesLNonvotingConvertiblePreferredStockMember_ziHxJhrI8nZc" title="Converted amount"><ix:nonFraction name="us-gaap:DebtConversionConvertedInstrumentAmount1" contextRef="From2025-02-242025-02-24_custom_RelatedPartyDebtConversionAgreementsMember_custom_SeriesLNonvotingConvertiblePreferredStockMember" id="Fact001577" format="ixt:numdotdecimal" decimals="0" unitRef="USD">500,000</ix:nonFraction></span> in deferred salary (Mr. Kerby) and $<span id="xdx_90A_eus-gaap--ProceedsFromUnsecuredNotesPayable_pn5n6_c20250224__20250224__us-gaap--TypeOfArrangementAxis__custom--RelatedPartyDebtConversionAgreementsMember__us-gaap--StatementClassOfStockAxis__custom--SeriesLNonvotingConvertiblePreferredStockMember_zM611ZdNl5ll" title="Unsecured promissory notes"><ix:nonFraction name="us-gaap:ProceedsFromUnsecuredNotesPayable" contextRef="From2025-02-242025-02-24_custom_RelatedPartyDebtConversionAgreementsMember_custom_SeriesLNonvotingConvertiblePreferredStockMember" id="Fact001579" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">1.0</ix:nonFraction></span> million in existing unsecured
promissory notes owed for monies advanced to the Company (Mr. Monaco), respectively, into an aggregate of <span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20250224__20250224__us-gaap--TypeOfArrangementAxis__custom--RelatedPartyDebtConversionAgreementsMember__us-gaap--StatementClassOfStockAxis__custom--SeriesLNonvotingConvertiblePreferredStockMember_zfkF3xJox5Hg" title="Restricted shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross" contextRef="From2025-02-242025-02-24_custom_RelatedPartyDebtConversionAgreementsMember_custom_SeriesLNonvotingConvertiblePreferredStockMember" id="Fact001581" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">496,687</ix:nonFraction></span> restricted shares of
Series L Preferred at a conversion price of $<span id="xdx_902_eus-gaap--SaleOfStockPricePerShare_iI_c20250224__us-gaap--StatementClassOfStockAxis__custom--SeriesLNonvotingConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--RelatedPartyDebtConversionAgreementsMember_zEQYUFXzuhMk" title="Purchase price, per share"><ix:nonFraction name="us-gaap:SaleOfStockPricePerShare" contextRef="AsOf2025-02-24_custom_SeriesLNonvotingConvertiblePreferredStockMember_custom_RelatedPartyDebtConversionAgreementsMember" id="Fact001583" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">3.02</ix:nonFraction></span> per
share.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Series L Preferred shall be convertible into the Company&#8217;s common stock on such date that the Company obtains stockholder approval
to remove the Exchange Cap (as described below), subject to beneficial ownership limitations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
February 28, 2025, <span title="Preferred stock, shares issued"><span id="xdx_900_eus-gaap--PreferredStockSharesOutstanding_iI_c20250228__us-gaap--StatementClassOfStockAxis__custom--SeriesLNonvotingConvertiblePreferredStockMember_zf890FYnq3Vl" title="Preferred stock, shares outstanding"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2025-02-28_custom_SeriesLNonvotingConvertiblePreferredStockMember" id="Fact001585" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,076,156</ix:nonFraction></span></span> shares of the Series L Preferred were outstanding, which if converted as of February 28,
2025, would have resulted in the issuance of <span id="xdx_90F_eus-gaap--PreferredStockConvertibleSharesIssuable_iI_c20250228__us-gaap--StatementClassOfStockAxis__custom--SeriesLNonvotingConvertiblePreferredStockMember_zTTBPSqknx52" title="Converted issuance of shares of common stock"><ix:nonFraction name="us-gaap:PreferredStockConvertibleSharesIssuable" contextRef="AsOf2025-02-28_custom_SeriesLNonvotingConvertiblePreferredStockMember" id="Fact001587" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,076,156</ix:nonFraction></span> shares of common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Series
M Nonvoting Convertible Preferred Stock</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 3, 2025, the Company filed a Certificate of Designation of Series M Nonvoting Convertible Preferred Stock (the &#8220;Series
M Certificate of Designation&#8221;) with the Secretary of State of the State of Nevada, designating <span id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20250103__20250103__us-gaap--StatementClassOfStockAxis__custom--SeriesMNonvotingConvertiblePreferredStockMember_zOdtJ9ntlIge" title="Restricted shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross" contextRef="From2025-01-032025-01-03_custom_SeriesMNonvotingConvertiblePreferredStockMember" id="Fact001589" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">165,562</ix:nonFraction></span>
shares of the Company&#8217;s preferred stock as Series M Nonvoting Convertible Preferred Stock, par value $<span id="xdx_901_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20250103__us-gaap--StatementClassOfStockAxis__custom--SeriesMNonvotingConvertiblePreferredStockMember_z2NKN9bwu4Kg" title="Preferred stock, par value"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2025-01-03_custom_SeriesMNonvotingConvertiblePreferredStockMember" id="Fact001591" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.001</ix:nonFraction></span>
per share (the &#8220;Series M Preferred&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
terms and conditions set forth in the Series M Certificate of Designation are summarized below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Ranking.
</i>The Series M Preferred rank pari passu to the Company&#8217;s common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Dividends.
</i>Holders of Series M Preferred will be entitled to dividends, if, as and when declared by the Board out of funds at the time legally
available therefor, dividends in the amount of <span id="xdx_900_eus-gaap--PreferredStockDividendRatePercentage_pid_dp_uPure_c20250103__20250103__us-gaap--StatementClassOfStockAxis__custom--SeriesMNonvotingConvertiblePreferredStockMember_zZdJb3e6He6k" title="Dividend percentage"><ix:nonFraction name="us-gaap:PreferredStockDividendRatePercentage" contextRef="From2025-01-032025-01-03_custom_SeriesMNonvotingConvertiblePreferredStockMember" id="Fact001593" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">12</ix:nonFraction></span>% per annum per share of Preferred Stock (subject to appropriate adjustment in the event
of any stock dividend, stock split, combination or other similar recapitalization with respect to the Preferred Stock), and no more.
Dividends on the Preferred Stock shall be fully cumulative, shall accrue without interest and without compounding from the date of first
issuance, and shall, if declared by the Board, be payable quarterly in arrears on March 1, June 1, September 1 and December of each year.
All dividends on the Preferred Stock shall be payable (i) in shares of Common Stock of the Company at the Nasdaq Closing Price; provided,
however, that such prices shall not be less than $<span id="xdx_902_eus-gaap--SaleOfStockPricePerShare_iI_c20250103__us-gaap--StatementClassOfStockAxis__custom--SeriesMNonvotingConvertiblePreferredStockMember_zAOACmj362H2" title="Purchase price, per share"><ix:nonFraction name="us-gaap:SaleOfStockPricePerShare" contextRef="AsOf2025-01-03_custom_SeriesMNonvotingConvertiblePreferredStockMember" id="Fact001595" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">3.02</ix:nonFraction></span> per share, or (ii) cash, at the election of a majority of the independent directors.
Any dividend which shall not be paid on required dividend date on which it shall become due shall be deemed to be &#8220;past due&#8221;
until such dividend shall be paid or until the share of Preferred Stock with respect to which such dividend became due shall no longer
be outstanding, whichever is the earlier to occur. In the event that any dividend becomes &#8220;past due&#8221; the per annum rate shall
increase to 14%.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Voting</i>.
Except as provided by the Charter, or as otherwise required by the Nevada Revised Statutes, holders of Series M Preferred are not entitled
to voting rights. However, the Company may not, without the consent of holders of a majority of the outstanding shares of Series M Preferred,
(i) alter or change adversely the powers, preferences or rights given to the Series M Preferred or alter or amend the Series M Certificate
of Designation, (ii) amend its Charter or other charter documents in any manner that adversely effects any rights of the holders of the
Series M Preferred, or (c) enter into any agreement with respect to the foregoing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>


<ix:exclude><!-- Field: Page; Sequence: 106; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Conversion</i>.
On the third business day after the date that the Company&#8217;s stockholders approve the conversion of Series M Preferred into shares
of Common Stock in accordance with the listing rules of Nasdaq, each outstanding share of Series M Preferred shall automatically be converted
into one share of Company common stock (subject to adjustment under certain limited circumstances) (the &#8220;Series M Conversion Ratio&#8221;),
subject to beneficial ownership limitations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Liquidation</i>.
In the event of any liquidation, dissolution or winding up of the Company, either voluntary or involuntary, holders of Series M Preferred
will be entitled to participate, on an as-converted-to-common stock basis calculated based on the Series M Conversion Ratio, with holders
of Company common stock in any distribution of assets of the Company to holders of the Company&#8217;s common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 31, 2024, the Company entered into a securities purchase agreement with certain accredited investors, pursuant to which the
Company may issue and sell up to $<span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20241231__20241231__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesMNonvotingConvertiblePreferredStockMember_zZscwvrUyrn4" title="Restricted shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross" contextRef="From2024-12-312024-12-31_custom_SecuritiesPurchaseAgreementMember_custom_SeriesMNonvotingConvertiblePreferredStockMember" id="Fact001597" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">500,000</ix:nonFraction></span> of restricted shares of Series M Preferred, at a purchase price of $<span id="xdx_906_eus-gaap--SaleOfStockPricePerShare_iI_c20241231__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesMNonvotingConvertiblePreferredStockMember_zVwTLZ977Sw9" title="Purchase price, per share"><ix:nonFraction name="us-gaap:SaleOfStockPricePerShare" contextRef="AsOf2024-12-31_custom_SecuritiesPurchaseAgreementMember_custom_SeriesMNonvotingConvertiblePreferredStockMember" id="Fact001599" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">3.02</ix:nonFraction></span> per share.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, as part of the Series M Preferred offering, on December 31, 2024, the Company entered into a debt conversion agreement
with an existing lender whereby the lender and the Company agreed to convert $<span id="xdx_90E_eus-gaap--DebtConversionConvertedInstrumentAmount1_c20241231__20241231__us-gaap--StatementClassOfStockAxis__custom--SeriesMNonvotingConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--DebtConversionAgreementMember_zq7Jb0QNf96c" title="Debt converted amount"><ix:nonFraction name="us-gaap:DebtConversionConvertedInstrumentAmount1" contextRef="From2024-12-312024-12-31_custom_SeriesMNonvotingConvertiblePreferredStockMember_custom_DebtConversionAgreementMember" id="Fact001601" format="ixt:numdotdecimal" decimals="0" unitRef="USD">350,000</ix:nonFraction></span>
in existing unsecured promissory notes plus accrued interest owed to the lender for monies advanced to the Company into shares of
Series M Preferred.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Series M Preferred shall be convertible into the Company&#8217;s common stock on such date that the Company obtains stockholder approval
to remove the Exchange Cap.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 31, 2024, in connection with the foregoing, the Company issued <span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20241231__20241231__us-gaap--StatementClassOfStockAxis__custom--SeriesMNonvotingConvertiblePreferredStockMember_zXOhuFET6MJl" title="Issuance of shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2024-12-312024-12-31_custom_SeriesMNonvotingConvertiblePreferredStockMember" id="Fact001603" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">133,278</ix:nonFraction></span>
shares of Series M Preferred to an investor pursuant to a debt conversion agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At February 28, 2025, all <span id="xdx_901_eus-gaap--PreferredStockSharesIssued_iI_c20250228__us-gaap--StatementClassOfStockAxis__custom--SeriesMNonvotingConvertiblePreferredStockMember_z98tTMXOF478" title="Preferred stock, shares issued"><span id="xdx_90D_eus-gaap--PreferredStockSharesOutstanding_iI_c20250228__us-gaap--StatementClassOfStockAxis__custom--SeriesMNonvotingConvertiblePreferredStockMember_zBAAKrlUXXF4" title="Preferred stock, shares outstanding"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2025-02-28_custom_SeriesMNonvotingConvertiblePreferredStockMember" id="Fact001605" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2025-02-28_custom_SeriesMNonvotingConvertiblePreferredStockMember" id="Fact001607" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">133,278</ix:nonFraction></ix:nonFraction></span></span>
shares of the Series M Preferred were outstanding, which if converted as of February 28, 2025, would have resulted
in the issuance of <span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesConversionOfUnits_c20240301__20250228__us-gaap--StatementClassOfStockAxis__custom--SeriesMNonvotingConvertiblePreferredStockMember_zxIZ2glL7L3j" title="Common stock issuable upon conversion"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits" contextRef="From2024-03-012025-02-28_custom_SeriesMNonvotingConvertiblePreferredStockMember" id="Fact001609" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">133,278</ix:nonFraction></span>
shares of common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Series
N Nonvoting Convertible Preferred Stock</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 30, 2025, the Company filed a Certificate of Designation of Series N Convertible Preferred Stock (the &#8220;Series N
Certificate of Designation&#8221;) with the Secretary of State of the State of Nevada, designating <span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20250103__20250103__us-gaap--StatementClassOfStockAxis__custom--SeriesNNonvotingConvertiblePreferredStockMember_zOUglbwzLDQf" title="Restricted shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross" contextRef="From2025-01-032025-01-03_custom_SeriesNNonvotingConvertiblePreferredStockMember" id="Fact001611" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">500,000</ix:nonFraction></span>
shares of the Company&#8217;s preferred stock as Series N Convertible Preferred Stock, par value $<span id="xdx_90E_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20250103__us-gaap--StatementClassOfStockAxis__custom--SeriesNNonvotingConvertiblePreferredStockMember_zMFcuI5CZk1i" title="Preferred stock, par value"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2025-01-03_custom_SeriesNNonvotingConvertiblePreferredStockMember" id="Fact001613" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.001</ix:nonFraction></span>
per share (the &#8220;Series N Preferred&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
terms and conditions set forth in the Series N Certificate of Designation are summarized below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Ranking.
</i>The Series N Preferred rank pari passu to the Company&#8217;s common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Dividends.
</i>Holders of Series N Preferred will be entitled to dividends, on an as-converted basis, equal to dividends actually paid, if any,
on shares of Company common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Voting</i>.
Except as provided by the Series N Certificate of Designation, or as otherwise required by the Nevada Revised Statutes, holders of Series
N Preferred are not entitled to voting rights. However, the Company may not, without the consent of holders of a majority of the outstanding
shares of Series N Preferred, (i) alter or change adversely the powers, preferences or rights given to the Series N Preferred or alter
or amend the Series N Certificate of Designation, (ii) amend its amended and restated articles of incorporation, amended and restated
bylaws or other charter documents in any manner that adversely effects any rights of the holders of the Series N Preferred, or (c) enter
into any agreement with respect to the foregoing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Conversion</i>.
On the third business day after the date that the Company&#8217;s stockholders approve the conversion of Series N Preferred into shares
of common stock in accordance with the listing rules of Nasdaq, each outstanding share of Series N Preferred shall automatically be converted
into one share of Company common stock (subject to adjustment under certain limited circumstances) (the &#8220;Series N Conversion Ratio&#8221;),
subject to beneficial ownership limitations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Liquidation</i>.
In the event of any liquidation, dissolution or winding up of the Company, either voluntary or involuntary, holders of Series N Preferred
will be entitled to participate, on an as-converted-to-common stock basis calculated based on the Series N Conversion Ratio (as defined
in the Series N Certificate of Designation), with holders of Company common stock in any distribution of assets of the Company to holders
of the Company&#8217;s common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 28, 2025, the Company entered into a securities purchase agreement with an accredited
investor, pursuant to which the Company issued and sold the purchaser (i) <span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20250128__20250128__us-gaap--StatementClassOfStockAxis__custom--SeriesNNonvotingConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zqbnJZQtgAMi" title="Restricted shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross" contextRef="From2025-01-282025-01-28_custom_SeriesNNonvotingConvertiblePreferredStockMember_custom_SecuritiesPurchaseAgreementMember" id="Fact001615" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">17,000</ix:nonFraction></span> restricted shares of Series N Preferred and (ii) warrants to
purchase <span id="xdx_905_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20250128__us-gaap--StatementClassOfStockAxis__custom--SeriesNNonvotingConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zgmwKVtsXA2a" title="Warrants to purchase common stock"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="AsOf2025-01-28_custom_SeriesNNonvotingConvertiblePreferredStockMember_custom_SecuritiesPurchaseAgreementMember" id="Fact001617" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">17,000</ix:nonFraction></span> shares of Company common stock, at a combined purchase price of $<span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20250128__us-gaap--StatementClassOfStockAxis__custom--SeriesNNonvotingConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zXTcVmlFpkxf" title="Warrants purchase price"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2025-01-28_custom_SeriesNNonvotingConvertiblePreferredStockMember_custom_SecuritiesPurchaseAgreementMember" id="Fact001619" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">5.00</ix:nonFraction></span> per share and warrant,
resulting in gross proceeds to the Company of $<span id="xdx_906_eus-gaap--ProceedsFromIssuanceOfWarrants_c20250128__20250128__us-gaap--StatementClassOfStockAxis__custom--SeriesNNonvotingConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_z4pSYqAktbg6" title="Gross proceeds"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfWarrants" contextRef="From2025-01-282025-01-28_custom_SeriesNNonvotingConvertiblePreferredStockMember_custom_SecuritiesPurchaseAgreementMember" id="Fact001621" format="ixt:numdotdecimal" decimals="0" unitRef="USD">85,000</ix:nonFraction></span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 107; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 24, 2025, the Company and Blue Fysh Holdings Inc. (&#8220;Blue Fysh&#8221;) entered into a share exchange agreement (the &#8220;BF
Share Exchange Agreement&#8221;) whereby Blue Fysh agreed to issue <span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20250128__20250128__us-gaap--StatementClassOfStockAxis__custom--SeriesNNonvotingConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__dei--LegalEntityAxis__custom--BlueFyshHoldingsIncMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zISI3Wgnbwf9" title="Restricted shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross" contextRef="From2025-01-282025-01-28_custom_SeriesNNonvotingConvertiblePreferredStockMember_custom_ShareExchangeAgreementMember_custom_BlueFyshHoldingsIncMember_us-gaap_CommonStockMember" id="Fact001623" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">82</ix:nonFraction></span> restricted shares of its common stock to the Company, representing
a ten percent (<span id="xdx_90A_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20250128__us-gaap--StatementClassOfStockAxis__custom--SeriesNNonvotingConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__dei--LegalEntityAxis__custom--BlueFyshHoldingsIncMember_z8cLbTETA5c9" title="Interest rate"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="AsOf2025-01-28_custom_SeriesNNonvotingConvertiblePreferredStockMember_custom_ShareExchangeAgreementMember_custom_BlueFyshHoldingsIncMember" id="Fact001625" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">10</ix:nonFraction></span>%) interest in Blue Fysh, in exchange for <span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20250128__20250128__us-gaap--StatementClassOfStockAxis__custom--SeriesNNonvotingConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__dei--LegalEntityAxis__custom--BlueFyshHoldingsIncMember_z5vsJPbVCyY7" title="Restricted shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross" contextRef="From2025-01-282025-01-28_custom_SeriesNNonvotingConvertiblePreferredStockMember_custom_ShareExchangeAgreementMember_custom_BlueFyshHoldingsIncMember" id="Fact001627" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">483,000</ix:nonFraction></span> restricted shares of Series N Preferred at an issuance price of $<span id="xdx_909_eus-gaap--SharePrice_iI_pid_c20250128__us-gaap--StatementClassOfStockAxis__custom--SeriesNNonvotingConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__dei--LegalEntityAxis__custom--BlueFyshHoldingsIncMember_z6757XdqSBre" title="Share price"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2025-01-28_custom_SeriesNNonvotingConvertiblePreferredStockMember_custom_ShareExchangeAgreementMember_custom_BlueFyshHoldingsIncMember" id="Fact001629" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">5.00</ix:nonFraction></span> per share (the &#8220;BF Share Exchange&#8221;).
The BF Share Exchange closed on February 28, 2025.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Series N Preferred shall be convertible into the Company&#8217;s common stock on such date that the Company obtains stockholder approval
to remove the Exchange Cap.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
February 28, 2025, <span id="xdx_905_eus-gaap--PreferredStockSharesOutstanding_iI_c20250228__us-gaap--StatementClassOfStockAxis__custom--SeriesNNonvotingConvertibleConvertiblePreferredStockMember_ztaGf0VmnbGf" title="Preferred stock, shares outstanding"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2025-02-28_custom_SeriesNNonvotingConvertibleConvertiblePreferredStockMember" id="Fact001631" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">500,000</ix:nonFraction></span> shares of the Series N Preferred were outstanding, which if converted as of February 28,
2025, would have resulted in the issuance of <span id="xdx_90F_eus-gaap--PreferredStockConvertibleSharesIssuable_iI_c20250228__us-gaap--StatementClassOfStockAxis__custom--SeriesNNonvotingConvertibleConvertiblePreferredStockMember_z0HYZvaK6ky5" title="Converted issuance of shares of common stock"><ix:nonFraction name="us-gaap:PreferredStockConvertibleSharesIssuable" contextRef="AsOf2025-02-28_custom_SeriesNNonvotingConvertibleConvertiblePreferredStockMember" id="Fact001633" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">500,000</ix:nonFraction></span> shares of common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Series
O Nonvoting Convertible Preferred Stock</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 6, 2025, the Company filed a Certificate of Designation of Series O Nonvoting Convertible Preferred Stock (the
&#8220;Series O Certificate of Designation&#8221;) with the Secretary of State of the State of Nevada, designating <span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20250206__20250206__us-gaap--StatementClassOfStockAxis__custom--SeriesONonvotingConvertiblePreferredStockMember_zpajU4Nv96S" title="Restricted shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross" contextRef="From2025-02-062025-02-06_custom_SeriesONonvotingConvertiblePreferredStockMember" id="Fact001635" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">451,614</ix:nonFraction></span>
shares of the Company&#8217;s preferred stock as Series O Nonvoting Convertible Preferred Stock, par value $<span id="xdx_90D_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20250206__us-gaap--StatementClassOfStockAxis__custom--SeriesONonvotingConvertiblePreferredStockMember_ztKyiykfFosd" title="Preferred stock, par value"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2025-02-06_custom_SeriesONonvotingConvertiblePreferredStockMember" id="Fact001637" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.001</ix:nonFraction></span>
per share (the &#8220;Series O Preferred&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
terms and conditions set forth in the Series O Certificate of Designation are summarized below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Ranking.
</i>The Series O Preferred rank pari passu to the Company&#8217;s common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Dividends.
</i>Holders of Series O Preferred will be entitled to dividends, on an as-converted basis, equal to dividends actually paid, if any,
on shares of Company common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Voting</i>.
Except as provided by the Series O Certificate of Designation, or as otherwise required by the Nevada Revised Statutes, holders of Series
O Preferred are not entitled to voting rights. However, the Company may not, without the consent of holders of a majority of the outstanding
shares of Series O Preferred, (i) alter or change adversely the powers, preferences or rights given to the Series O Preferred or alter
or amend the Series O Certificate of Designation, (ii) amend its amended and restated articles of incorporation, amended and restated
bylaws or other charter documents in any manner that adversely effects any rights of the holders of the Series O Preferred, or (c) enter
into any agreement with respect to the foregoing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Conversion</i>.
On the third business day after the date that the Company&#8217;s stockholders approve the conversion of Series O Preferred into shares
of common stock in accordance with the listing rules of Nasdaq, each outstanding share of Series O Preferred shall automatically be converted
into one share of Company common stock (subject to adjustment under certain limited circumstances) (the &#8220;Series O Conversion Ratio&#8221;),
subject to beneficial ownership limitations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Liquidation</i>.
In the event of any liquidation, dissolution or winding up of the Company, either voluntary or involuntary, holders of Series O Preferred
will be entitled to participate, on an as-converted-to-common stock basis calculated based on the Series O Conversion Ratio (as defined
in the Series O Certificate of Designation), with holders of Company common stock in any distribution of assets of the Company to holders
of the Company&#8217;s common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 6, 2025, in connection with the initial <span id="xdx_90A_eus-gaap--BusinessAcquisitionPercentageOfVotingInterestsAcquired_iI_pid_dp_uPure_c20250206__us-gaap--BusinessAcquisitionAxis__custom--FSATravelLLCMember_zeI5BSCSrnVa"><ix:nonFraction name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" contextRef="AsOf2025-02-06_custom_FSATravelLLCMember" id="Fact001638" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">49</ix:nonFraction></span>%
acquisition of FSA, the Company issued <span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20250206__20250206__us-gaap--StatementClassOfStockAxis__custom--SeriesONonvotingConvertiblePreferredStockMember_zEyjzfmhhv7d" title="Shares issued"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2025-02-062025-02-06_custom_SeriesONonvotingConvertiblePreferredStockMember" id="Fact001640" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">161,291</ix:nonFraction></span>
shares of Series O Preferred to FSA.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
shares of Series O Preferred issued and issuable cannot be converted into shares of Company common stock unless and until the Company&#8217;s
stockholders approve the conversion of Series O Preferred into shares of common stock in accordance with the listing rules of Nasdaq.
Upon receipt of such approvals, the share of Series O Preferred outstanding as of such date shall automatically convert into shares of
Company common stock, subject to applicable beneficial ownership limitations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
February 28, 2025, <span id="xdx_906_eus-gaap--PreferredStockSharesOutstanding_iI_c20250228__us-gaap--StatementClassOfStockAxis__custom--SeriesONonvotingConvertiblePreferredStockMember_zQgI5WxaOB0l" title="Preferred stock, shares outstanding"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2025-02-28_custom_SeriesONonvotingConvertiblePreferredStockMember" id="Fact001642" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">161,291</ix:nonFraction></span> shares of the Series O Preferred were outstanding, which if converted as of February 28,
2025, would have resulted in the issuance of <span id="xdx_905_eus-gaap--PreferredStockConvertibleSharesIssuable_iI_c20250228__us-gaap--StatementClassOfStockAxis__custom--SeriesONonvotingConvertiblePreferredStockMember_zDEy67uEeA41" title="Common stock issuable upon conversion"><ix:nonFraction name="us-gaap:PreferredStockConvertibleSharesIssuable" contextRef="AsOf2025-02-28_custom_SeriesONonvotingConvertiblePreferredStockMember" id="Fact001644" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">161,291</ix:nonFraction></span> shares of common stock</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Series
P Nonvoting Convertible Preferred Stock</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 25, 2025, the Company filed a Certificate of Designation of Series P Nonvoting Convertible Preferred Stock (the
&#8220;Series P Certificate of Designation&#8221;) with the Secretary of State of the State of Nevada, designating <span id="xdx_90D_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20250225__20250225__us-gaap--StatementClassOfStockAxis__custom--SeriesPNonvotingConvertiblePreferredStockMember_zjRV5lYzrXP6" title="Restricted shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross" contextRef="From2025-02-252025-02-25_custom_SeriesPNonvotingConvertiblePreferredStockMember" id="Fact001646" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">343,750</ix:nonFraction></span>
shares of the Company&#8217;s preferred stock as Series P Nonvoting Convertible Preferred Stock, par value $<span id="xdx_90E_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20250225__us-gaap--StatementClassOfStockAxis__custom--SeriesPNonvotingConvertiblePreferredStockMember_zgBVASdwY4Dc" title="Preferred stock, par value"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2025-02-25_custom_SeriesPNonvotingConvertiblePreferredStockMember" id="Fact001648" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.001</ix:nonFraction></span>
per share (the &#8220;Series P Preferred&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 108; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
terms and conditions set forth in the Series P Certificate of Designation are summarized below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ranking.
The Series P Preferred rank pari passu to the Company&#8217;s common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dividends.
Holders of Series P Preferred will be entitled to dividends, on an as-converted basis, equal to dividends actually paid, if any, on shares
of Company common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Voting.
Except as provided by the Charter, or as otherwise required by the Nevada Revised Statutes, holders of Series P Preferred are not entitled
to voting rights. However, the Company may not, without the consent of holders of a majority of the outstanding shares of Series P Preferred,
(i) alter or change adversely the powers, preferences or rights given to the Series P Preferred or alter or amend the Series P Certificate
of Designation, (ii) amend its Charter or other charter documents in any manner that adversely effects any rights of the holders of the
Series P Preferred, or (c) enter into any agreement with respect to the foregoing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conversion.
On the third business day after the date that the Company&#8217;s stockholders approve the conversion of Series P Preferred into shares
of Common Stock in accordance with the listing rules of Nasdaq, each outstanding share of Series P Preferred shall automatically be converted
into one share of Company common stock (subject to adjustment under certain limited circumstances) (the &#8220;Series P Conversion Ratio&#8221;),
subject to beneficial ownership limitations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Liquidation.
In the event of any liquidation, dissolution or winding up of the Company, either voluntary or involuntary, holders of Series P Preferred
will be entitled to participate, on an as-converted-to-common stock basis calculated based on the Series P Conversion Ratio, with holders
of Company common stock in any distribution of assets of the Company to holders of the Company&#8217;s common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 26, 2025, the Company entered into an Equity Investment Agreement with AOS Holdings
LLC (&#8220;AOS&#8221;), pursuant to which the Company issued and sold to AOS (i) <span id="xdx_90F_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20250226__20250226__us-gaap--StatementClassOfStockAxis__custom--SeriesPNonvotingConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--EquityInvestmentAgreementMember_zI1HPWniz502" title="Sale of stock, shares"><ix:nonFraction name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" contextRef="From2025-02-262025-02-26_custom_SeriesPNonvotingConvertiblePreferredStockMember_custom_EquityInvestmentAgreementMember" id="Fact001650" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">93,750</ix:nonFraction></span> restricted shares of Series P Preferred, (ii) a warrant exercisable in cash to purchase up to <span id="xdx_903_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20250226__us-gaap--StatementClassOfStockAxis__custom--SeriesPNonvotingConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--EquityInvestmentAgreementMember_zEOhxa8c6Qlg" title="Warrants to purchase common stock"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="AsOf2025-02-26_custom_SeriesPNonvotingConvertiblePreferredStockMember_custom_EquityInvestmentAgreementMember" id="Fact001652" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">375,000</ix:nonFraction></span> shares
of common stock (the &#8220;Cash Warrant&#8221;), and (iii) a warrant exercisable in either cash or via cashless exercise (the &#8220;Cashless
Warrant&#8221;) to purchase up to <span id="xdx_909_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_iI_c20250226__us-gaap--StatementClassOfStockAxis__custom--SeriesPNonvotingConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--EquityInvestmentAgreementMember_z4V7Mi6lcV61" title="Warrants to purchase"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" contextRef="AsOf2025-02-26_custom_SeriesPNonvotingConvertiblePreferredStockMember_custom_EquityInvestmentAgreementMember" id="Fact001654" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">375,000</ix:nonFraction></span> shares of common stock, for a combined purchase price of $<span id="xdx_906_eus-gaap--SharePrice_iI_c20250226__us-gaap--StatementClassOfStockAxis__custom--SeriesPNonvotingConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--EquityInvestmentAgreementMember_zOaMfIoTxjdj" title="Share price"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2025-02-26_custom_SeriesPNonvotingConvertiblePreferredStockMember_custom_EquityInvestmentAgreementMember" id="Fact001656" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">4.00</ix:nonFraction></span> per share, resulting in gross
proceeds to the Company of $<span id="xdx_907_eus-gaap--ProceedsFromIssuanceOfWarrants_c20250226__20250226__us-gaap--StatementClassOfStockAxis__custom--SeriesPNonvotingConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--EquityInvestmentAgreementMember_z9Td9kHZ3iGb" title="Gross proceeds"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfWarrants" contextRef="From2025-02-262025-02-26_custom_SeriesPNonvotingConvertiblePreferredStockMember_custom_EquityInvestmentAgreementMember" id="Fact001658" format="ixt:numdotdecimal" decimals="0" unitRef="USD">375,000</ix:nonFraction></span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 26, 2025, the Company entered into a Debt Exchange Agreement with AOS whereby
AOS and the Company agreed to convert $<span id="xdx_90B_eus-gaap--DebtConversionConvertedInstrumentAmount1_c20250226__20250226__us-gaap--StatementClassOfStockAxis__custom--SeriesPNonvotingConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--DebtExchangeAgreementMember_zWYcQofGXV23" title="Converted amount"><ix:nonFraction name="us-gaap:DebtConversionConvertedInstrumentAmount1" contextRef="From2025-02-262025-02-26_custom_SeriesPNonvotingConvertiblePreferredStockMember_custom_DebtExchangeAgreementMember" id="Fact001660" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,000,000</ix:nonFraction></span> owed to AOS under an existing unsecured promissory note owed for monies advanced to
the Company into <span id="xdx_90C_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20250226__20250226__us-gaap--StatementClassOfStockAxis__custom--SeriesPNonvotingConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--DebtExchangeAgreementMember_zPyueLqYjVk2" title="Sale of stock, shares"><ix:nonFraction name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" contextRef="From2025-02-262025-02-26_custom_SeriesPNonvotingConvertiblePreferredStockMember_custom_DebtExchangeAgreementMember" id="Fact001662" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">250,000</ix:nonFraction></span> shares of Series P Preferred at a conversion price of $<span id="xdx_909_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20250226__us-gaap--StatementClassOfStockAxis__custom--SeriesPNonvotingConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--DebtExchangeAgreementMember_z6TKteeZ1gXg" title="Conversion price"><ix:nonFraction name="us-gaap:DebtInstrumentConvertibleConversionPrice1" contextRef="AsOf2025-02-26_custom_SeriesPNonvotingConvertiblePreferredStockMember_custom_DebtExchangeAgreementMember" id="Fact001664" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">4.00</ix:nonFraction></span> per share.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Series P Preferred shall be convertible into the Company&#8217;s common stock on such date that the Company obtains stockholder approval
to remove the Exchange Cap (as described below), subject to beneficial ownership limitations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
February 28, 2025, <span id="xdx_908_eus-gaap--PreferredStockSharesOutstanding_iI_c20250228__us-gaap--StatementClassOfStockAxis__custom--SeriesPNonvotingConvertiblePreferredStockMember_znU2pxliQcJh" title="Preferred stock, shares outstanding"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2025-02-28_custom_SeriesPNonvotingConvertiblePreferredStockMember" id="Fact001666" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">343,750</ix:nonFraction></span> shares of the Series P Preferred were outstanding, which if converted as of February 28,
2025, would have resulted in the issuance of <span id="xdx_90F_eus-gaap--PreferredStockConvertibleSharesIssuable_iI_c20250228__us-gaap--StatementClassOfStockAxis__custom--SeriesPNonvotingConvertiblePreferredStockMember_zDzHqs2vaAH6" title="Common stock issuable upon conversion"><ix:nonFraction name="us-gaap:PreferredStockConvertibleSharesIssuable" contextRef="AsOf2025-02-28_custom_SeriesPNonvotingConvertiblePreferredStockMember" id="Fact001668" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">343,750</ix:nonFraction></span> shares of common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Stock
Options</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 28, 2023, at the Annual Meeting of Stockholders of the Company, the Company&#8217;s stockholders approved the adoption of
the NextTrip 2023 Equity Incentive Plan (the &#8220;2023 Plan&#8221;). <span id="xdx_907_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_c20250228__us-gaap--PlanNameAxis__custom--TwoThousandTwentyThreeEquityIncentivePlanMember_zo3mmXkcbxo5" title="Common stock reserved for issuance"><ix:nonFraction name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" contextRef="AsOf2025-02-28_custom_TwoThousandTwentyThreeEquityIncentivePlanMember" id="Fact001670" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">7,000,000</ix:nonFraction></span>
shares of common stock have been reserved for issuance under the 2023 Plan, and as of February 28, 2025, all such shares are
available for issuance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of February 28, 2025, we had outstanding options under our 2013 Equity Incentive Plan (the &#8220;2012 Plan&#8221;) to purchase an
aggregate of <span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20250228__us-gaap--PlanNameAxis__custom--TwoThousandThirteenEquityIncentivePlanMember_z5lWraltrygh" title="Common stock shares option outstanding"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2025-02-28_custom_TwoThousandThirteenEquityIncentivePlanMember" id="Fact001672" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">76,342</ix:nonFraction></span>
shares of our common stock at a weighted-average exercise price of $<span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20250228__us-gaap--PlanNameAxis__custom--TwoThousandThirteenEquityIncentivePlanMember_zS36WPJG0okh" title="Weighted average exercise price"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2025-02-28_custom_TwoThousandThirteenEquityIncentivePlanMember" id="Fact001674" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">52.69</ix:nonFraction></span>
per share.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
fiscal year 2025, the Company did not grant any options. In fiscal year 2025, <span id="xdx_90B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_c20240301__20250228_zldPJCJcWiw1" title="Share based compensation arrangement by award options vested"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" contextRef="From2024-03-01to2025-02-28" id="Fact001676" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,101</ix:nonFraction></span> options vested and $<span id="xdx_906_eus-gaap--CompensationExpenseExcludingCostOfGoodAndServiceSold_c20240301__20250228_zuBpMRIgQca2" title="Compensation cost"><ix:nonFraction name="us-gaap:CompensationExpenseExcludingCostOfGoodAndServiceSold" contextRef="From2024-03-01to2025-02-28" id="Fact001678" format="ixt:numdotdecimal" decimals="0" unitRef="USD">41,114</ix:nonFraction></span> of compensation cost was
recognized during the year. At February 28, 2025, there are vested options exercisable for <span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20250228__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_z1aCqAmcHwO2" title="Stock issued during Stock options exercised"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" contextRef="AsOf2025-02-28_us-gaap_StockOptionMember" id="Fact001680" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">75,992</ix:nonFraction></span> shares of common stock. <span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_do_c20240301__20250228_zXpnLOlY10c5" title="Share based compensation arrangement by award options grants"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="From2024-03-01to2025-02-28" id="Fact001682" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares">No</ix:nonFraction></span> options
to purchase shares of common stock were exercised during the fiscal year ended February 28, 2025.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 109; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company generally grants stock options to employees, consultants and directors at exercise prices equal to the fair market value of the
Company&#8217;s stock on the dates of grant. Stock options are typically granted throughout the year and generally vest over three years
of service and expire five years from the date of the award, unless otherwise specified. The Company recognizes compensation expense
for the fair value of the stock options over the requisite service period for each stock option award.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
closing of the NextTrip Acquisition on December 29, 2023, the Company assumed options to purchase up to <span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20240301__20250228__srt--RangeAxis__srt--MaximumMember_zOz24DRBl19g" title="Options to purchase of common stock"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2024-03-012025-02-28_srt_MaximumMember" id="Fact001684" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">86,402</ix:nonFraction></span> shares of common
stock. Between December 29, 2023 and February 29, 2024, <span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_pid_c20231229__20240229_zlUILpQ5eShi" title="Options to forfeited or expired"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" contextRef="From2023-12-292024-02-29" id="Fact001686" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,342</ix:nonFraction></span> options were forfeited or expired and no options were issued or exercised.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
employee share-based compensation expense for the year ended February 28, 2025 was $<span id="xdx_90B_eus-gaap--ShareBasedCompensation_pp0p0_c20240301__20250228_zRSQ1hA9KgM4" title="Allocation share based compensation expense"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2024-03-01to2025-02-28" id="Fact001688" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">67,874</ix:nonFraction></span>, of which $<span id="xdx_904_eus-gaap--ProceedsFromStockOptionsExercised_pp0p0_c20240301__20250228_zgTHMbIBiPr9" title="Stock options"><ix:nonFraction name="us-gaap:ProceedsFromStockOptionsExercised" contextRef="From2024-03-01to2025-02-28" id="Fact001690" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">41,114</ix:nonFraction></span> was related to stock options.
There was no capitalized share-based compensation cost as of February 28, 2025, and there were no recognized tax benefits during the
fiscal year ended February 28, 2025.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
estimate the value of an option award, the Company uses the Black-Scholes option-pricing model. This model requires inputs such as
expected life, expected volatility and risk-free interest rate. The forfeiture rate also impacts the amount of aggregate
compensation. These inputs are subjective and generally require significant analysis and judgment to develop. While estimates of
expected life, volatility and forfeiture rate are derived primarily from the Company&#8217;s historical data, the risk-free rate is
based on the yield available on U.S. Treasury constant maturity rates with similar terms to the expected term of the stock option
awards. The fair value of outstanding stock option awards at February 28, 2025 was estimated using the Black-Scholes model with the
following weighted-average assumptions at the date of grant:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2024-03-01to2025-02-28" escape="true" id="Fact001692" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"><p id="xdx_895_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_z7fWqRBOsDU8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Option
activity for the year ended February 28, 2025 was as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8BC_zfQu3JsnJ59" style="display: none">Schedule of Stock Option Activity</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Weighted Average</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Weighted Average</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Exercise</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Remaining</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Aggregate</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Price</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Contractual</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Intrinsic</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Options</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">($)</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Life (Yrs.)</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Value ($)</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 44%; padding-bottom: 2.5pt">Options outstanding at February 29, 2024</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20240301__20250228_zPZHtTXqaegk" title="Number of Options Outstanding, Balance" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2024-02-29" id="Fact001694" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">85,300</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 2.5pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; width: 1%; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20240301__20250228_z9ijAU1jR6H5" title="Weighted Average Exercise Price Outstanding, Balance" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; width: 10%; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2024-02-29" id="Fact001696" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">60.50</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 2.5pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; width: 10%; text-align: right"><span id="xdx_90B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20230301__20240229_z7rh1Tw5VOCa" title="Weighted Average Remaining Contractual Life Years, Outstanding Balance"><ix:nonNumeric contextRef="From2023-03-012024-02-29" format="ixt-sec:duryear" id="Fact001698" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">2.52</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_pp0p0_c20240301__20250228_zzRgZC8N6fuf" title="Aggregate Intrinsic Value Outstanding" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right">&#160;&#160;&#160;&#160;<span style="-sec-ix-hidden: xdx2ixbrl1700">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">Exercised</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_pid_di0_c20240301__20250228_zgwFJ0vHjxqj" title="Number of Options, Exercised" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="From2024-03-01to2025-02-28" id="Fact001702" format="ixt:zerodash" decimals="INF" unitRef="Shares">-</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20240301__20250228_zb5XDJ5uwvna" title="Weighted Average Exercise Price, Exercised" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1704">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_pp0p0_c20240301__20250228_zMmgjk4Asvdf" title="Aggregate Intrinsic Value, Exercised" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1706">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Forfeited or cancelled</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_iN_pid_di_c20240301__20250228_zLqMInKaS8x7" title="Number of Options, Forfeited or cancelled" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" contextRef="From2024-03-01to2025-02-28" id="Fact001708" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">8,958</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_pid_c20240301__20250228_zRGsYFDGyqqa" title="Weighted Average Exercise Price, Forfeited or cancelled" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" contextRef="From2024-03-01to2025-02-28" id="Fact001710" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">125.65</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_980_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedorCancelledInPeriodTotalIntrinsicValue_pp0p0_c20240301__20250228_zGxxh3VyvZD6" title="Aggregate Intrinsic Value, Forfeited or cancelled" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1712">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">Options outstanding at February 28, 2025</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20240301__20250228_zxxWWJqIBdUc" title="Number of Options Outstanding, Balance" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2025-02-28" id="Fact001714" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">76,342</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20240301__20250228_zycMET3eH0s6" title="Weighted Average Exercise Price Outstanding, Balance" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2025-02-28" id="Fact001716" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">52.69</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span id="xdx_904_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20240301__20250228_z7pTiXutuxa4" title="Weighted Average Remaining Contractual Life Years, Outstanding Balance"><ix:nonNumeric contextRef="From2024-03-01to2025-02-28" format="ixt-sec:duryear" id="Fact001718" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">1.60</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iE_pp0p0_c20240301__20250228_zxoBHzrt13Sc" title="Aggregate Intrinsic Value Outstanding" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1720">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Options expected to vest in the future as of February 28, 2025</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iE_pid_c20240301__20250228_zRqlghxB8pGb" title="Number of Options, Expected to Vest in the Future Ending Balance" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" contextRef="AsOf2025-02-28" id="Fact001722" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">350</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_iE_pid_c20240301__20250228_zRmsLe0OoOx" title="Weighted Average Exercise Price, Expected to Vest" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" contextRef="AsOf2025-02-28" id="Fact001724" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">50.00</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_dtY_c20240301__20250228_zVtPqhUUH0Xg" title="Weighted Average Remaining Contractual Life Years, Expected to Vest"><ix:nonNumeric contextRef="From2024-03-01to2025-02-28" format="ixt-sec:duryear" id="Fact001726" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1">2.34</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_iE_pp0p0_c20240301__20250228_zVuiziQo3bue" title="Aggregate Intrinsic Value, Outstanding, Expected of  Vest" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1728">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">Options exercisable at February 28, 2025</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_pid_c20240301__20250228_zKfkfptkyge6" title="Number of Options, Exercisable" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" contextRef="AsOf2025-02-28" id="Fact001730" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">75,992</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20240301__20250228_z7d3SzvRF8i6" title="Weighted Average Exercise Price, Exercisable" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" contextRef="AsOf2025-02-28" id="Fact001732" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">52.71</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right"><span id="xdx_90D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20240301__20250228_zLUR4wKzojMi" title="Weighted Average Remaining Contractual Life Years, Exercisable"><ix:nonNumeric contextRef="From2024-03-01to2025-02-28" format="ixt-sec:duryear" id="Fact001734" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">1.59</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iE_pp0p0_c20240301__20250228_zup665Ufk8G" title="Aggregate Intrinsic Value, Outstanding, Exercisable" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1736">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Options vested, exercisable, and options expected to vest at February 28, 2025</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_iE_pid_c20230301__20250228_zLyRyLfYBXdb" title="Number of Options, Vested, Exercisable and Options Expected to Vest, Balance" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" contextRef="AsOf2025-02-28" id="Fact001738" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">76,342</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_iE_c20240301__20250228_zOaTHmRKbjRj" title="Weighted Average Exercise Price, Vested, Exercisable and Options Expected to Vest" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" contextRef="AsOf2025-02-28" id="Fact001740" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">52.69</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span id="xdx_904_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_dtY_c20240301__20250228_z3c1eUlHCHM8" title="Weighted Average Remaining Contractual Life (Yrs.), Vested, Exercisable and Options Expected to Vest"><ix:nonNumeric contextRef="From2024-03-01to2025-02-28" format="ixt-sec:duryear" id="Fact001742" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1">1.60</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_iE_pp0p0_c20240301__20250228_zetWwG7Azr31" title="Aggregate Intrinsic Value, Outstanding,Exercisable and Options Expected to Vest" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1744">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8AA_z4ubeUqz6YUc" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
aggregate intrinsic value is calculated as the difference between the exercise price of the underlying awards and the quoted price of
our common stock for those awards that have an exercise price below the $<span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20240301__20250228_zdDyM65zTIOd" title="Options exercise price"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="From2024-03-01to2025-02-28" id="Fact001746" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">3.98</ix:nonFraction></span> closing price of our Common Stock on February 28, 2025.
All of the outstanding option grants have an exercise price above $<span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20240301__20250228_z9fEYjzkqxFf" title="Options exercise price"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="From2024-03-01to2025-02-28" id="Fact001748" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">3.98</ix:nonFraction></span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
February 28, 2025, there was $<span id="xdx_906_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_iI_c20250228_zkNsCfHfwop5" title="Unrecognized stock-based compensation expense, stock option"><ix:nonFraction name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" contextRef="AsOf2025-02-28" id="Fact001750" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,260</ix:nonFraction></span> of unrecognized share-based compensation expense related to unvested stock options with a weighted
average remaining recognition period of <span id="xdx_901_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_dtY_c20240301__20250228_zyY6aVCYc9n7" title="Weighted average remaining recognition period"><ix:nonNumeric contextRef="From2024-03-01to2025-02-28" format="ixt-sec:duryear" id="Fact001752" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">0.34</ix:nonNumeric></span> years.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Stock
Appreciation Rights</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
purposes of the 2020 Stock Appreciation Rights Plan (the &#8220;2020 SARs Plan&#8221;) are to: (i) enable the Company to attract and
retain the types of employees, consultants, and directors (collectively, &#8220;Service Providers&#8221;) who will contribute to the
Company&#8217;s long-range success; (ii) provide incentives that align the interests of Service Providers with those of the
shareholders of the Company; and (iii) promote the success of the Company&#8217;s business. The 2020 SARs Plan provides for
incentive awards that are only made in the form of stock appreciation rights payable in cash (&#8220;SARs&#8221;). No shares of
common stock were reserved in connection with the adoption of the 2020 SARs Plan since no shares will be issued pursuant to the
2020 SARs Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 110; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SARs
may be granted to any Service Provider. A SAR is the right to receive an amount equal to the Spread with respect to a share of the
Company&#8217;s common stock (a &#8220;Share&#8221;) upon the exercise of the SAR. The &#8220;Spread&#8221; is the difference
between the exercise price per share specified in a SAR agreement on the date of grant and the fair market value per share on the
date of exercise of the SAR. The exercise price per share will not be less than 100% of the fair market value of a Share on the date
of grant of the SAR. The administrator of the 2020 SARs Plan will have the authority to, among other things, prescribe the terms and
conditions of each SAR, including, without limitation, the exercise price and medium of payment and vesting provisions, and to
specify the provisions of the SAR agreement relating to such grant.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
closing of the NextTrip Acquisition on December 29, 2023, the Company assumed <span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20231229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_z5PCbZEWw0re" title="Reverse acquisition shares outstanding"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2023-12-29_custom_StockAppreciationRightsMember" id="Fact001754" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">40,390</ix:nonFraction></span> outstanding SARs. Between December 29, 2023
and February 29, 2024, <span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_dn_c20241229__20241229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zHJ6bvYJEXWb" title="Shares forfeited or expired"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" contextRef="From2024-12-292024-12-29_custom_StockAppreciationRightsMember" id="Fact001756" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares">none</ix:nonFraction></span> were forfeited or expired and <span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_do_c20241229__20241229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_z98G3VLCaAd1" title="Shares issued or exercised"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="From2024-12-292024-12-29_custom_StockAppreciationRightsMember" id="Fact001758" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares">no</ix:nonFraction></span> SARs were issued or exercised.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recognizes compensation expense and a corresponding liability for the fair value of the SARs over the requisite service period
for each SAR award. The SAR&#8217;s are revalued at each reporting date in accordance with ASC 718 &#8220;Compensation-Stock Compensation&#8221;,
and any changes in fair value are reflected in income as of the applicable reporting date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2024-03-012025-02-28_custom_StockAppreciationRightsMember" escape="true" id="Fact001760" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"><p id="xdx_89B_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_hus-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_z2BXlDB1N7Lj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fair value of outstanding SAR awards was estimated using the Black-Scholes model with the following assumptions for the twelve months
ended February 28, 2025:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Assumptions:</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8BE_zRCuvey8r5x6" style="display: none">Schedule of Share Based Payments Award Stock Options Valuation Assumptions</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 75%; margin-right: auto">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">2025</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 78%; text-align: left">Dividend yield</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right"><span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_uPure_c20240301__20250228__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyStockAppreciationRightsPlanMember_zvTY0812C7Tb" title="Dividend yield"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" contextRef="From2024-03-012025-02-28_custom_TwoThousandAndTwentyStockAppreciationRightsPlanMember" id="Fact001762" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.0</ix:nonFraction></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">%</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Risk-free interest rate</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_dp_uPure_c20240301__20250228__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyStockAppreciationRightsPlanMember_zKHl8PAoQXla" title="Risk-free interest rate, minimum"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" contextRef="From2024-03-012025-02-28_custom_TwoThousandAndTwentyStockAppreciationRightsPlanMember" id="Fact001764" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">2.3</ix:nonFraction></span>%-<span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_dp_uPure_c20240301__20250228__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyStockAppreciationRightsPlanMember_zX9fO0EfkiO6" title="Risk-free interest rate, maximum"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" contextRef="From2024-03-012025-02-28_custom_TwoThousandAndTwentyStockAppreciationRightsPlanMember" id="Fact001766" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">5.25</ix:nonFraction></span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Expected volatility</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_dp_uPure_c20240301__20250228__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyStockAppreciationRightsPlanMember_zq5yRj9WdE3e" title="Expected volatility, minimum"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" contextRef="From2024-03-012025-02-28_custom_TwoThousandAndTwentyStockAppreciationRightsPlanMember" id="Fact001768" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">96.5</ix:nonFraction></span>%-<span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_dp_uPure_c20240301__20250228__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyStockAppreciationRightsPlanMember_zq9WsGGxTKmj" title="Expected volatility, maximum"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" contextRef="From2024-03-012025-02-28_custom_TwoThousandAndTwentyStockAppreciationRightsPlanMember" id="Fact001770" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">187.8</ix:nonFraction></span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Expected life (in years)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20240301__20250228__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyStockAppreciationRightsPlanMember__srt--RangeAxis__srt--MinimumMember_z86hD1Pm8OR" title="Expected life"><ix:nonNumeric contextRef="From2024-03-012025-02-28_custom_TwoThousandAndTwentyStockAppreciationRightsPlanMember_srt_MinimumMember" format="ixt-sec:duryear" id="Fact001772" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">0.16</ix:nonNumeric></span>-<span id="xdx_90B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20240301__20250228__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyStockAppreciationRightsPlanMember__srt--RangeAxis__srt--MaximumMember_z8xRrC63KiZ" title="Expected life"><ix:nonNumeric contextRef="From2024-03-012025-02-28_custom_TwoThousandAndTwentyStockAppreciationRightsPlanMember_srt_MaximumMember" format="ixt-sec:duryear" id="Fact001774" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">2.08</ix:nonNumeric></span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A2_zKoCi2YHf8pl" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2024-03-012025-02-28_custom_StockAppreciationRightsMember" escape="true" id="Fact001776" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"><p id="xdx_89B_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_hus-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zY6pvwKtnjEh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SARs
activity for the year ended February 28, 2025 was as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8BC_z9W7DSJJXzi3" style="display: none">Schedule of Stock Option Activity</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Weighted Average</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Weighted Average</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Exercise</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Remaining</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Aggregate</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Price</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Contractual</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Intrinsic</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">SARs</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">($)</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Life (Yrs.)</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Value ($)</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 44%; padding-bottom: 2.5pt">SARs outstanding at February 29, 2024</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20240301__20250228__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zjkCZZCRAwh8" title="Number of Options, Outstanding, Balance" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2024-02-29_custom_StockAppreciationRightsMember" id="Fact001778" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">40,390</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20240301__20250228__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zQ4n6w20TGg5" title="Weighted Average Exercise Price, Outstanding Balance" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2024-02-29_custom_StockAppreciationRightsMember" id="Fact001780" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">44.77</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right"><span id="xdx_90B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20230301__20240228__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zRRT7pE2pkti" title="Weighted Average Remaining Contractual Life, Outstanding Balance"><ix:nonNumeric contextRef="From2023-03-012024-02-28_custom_StockAppreciationRightsMember" format="ixt-sec:duryear" id="Fact001782" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">2.99</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_pp0p0_c20240301__20250228__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zsdfPy788FQj" title="Aggregate Intrinsic Value, Outstanding Balance" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;<span style="-sec-ix-hidden: xdx2ixbrl1784">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">Exercised</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_pid_di_c20240301__20250228__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_z4IaxQLm7lD8" title="Number of Options, Exercised" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1786">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20240301__20250228__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zSHJCbpGBwW8" title="Weighted Average Exercise Price, Exercised" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1788">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_pp0p0_c20240301__20250228__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zceVw30bzj7" title="Aggregate Intrinsic Value, Exercised" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1790">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Forfeited or cancelled</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_iN_pid_di_c20240301__20250228__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zYUiseWCIOyj" title="Number of Options, Forfeited or cancelled" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" contextRef="From2024-03-012025-02-28_custom_StockAppreciationRightsMember" id="Fact001792" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">167</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98B_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageForfeitedOrCancelled_pid_c20240301__20250228__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zKmYsp2iQrNe" title="Weighted Average Exercise Price, Forfeited or cancelled" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="NTRP:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageForfeitedOrCancelled" contextRef="From2024-03-012025-02-28_custom_StockAppreciationRightsMember" id="Fact001794" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">37.4</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_982_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedorCancelledInPeriodTotalIntrinsicValue_pp0p0_c20240301__20250228__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zbjkcFaAlHz8" title="Aggregate Intrinsic Value, Forfeited or cancelled" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1796">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">SARs outstanding February 28, 2025</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20240301__20250228__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zqxsOpD7OZwd" title="Number of Options, Outstanding, Balance" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2025-02-28_custom_StockAppreciationRightsMember" id="Fact001798" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">40,223</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20240301__20250228__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zC6dAbVaDPBg" title="Weighted Average Exercise Price, Outstanding Balance" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2025-02-28_custom_StockAppreciationRightsMember" id="Fact001800" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">44.80</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20240301__20250228__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zr4yQGUbcPJ7" title="Weighted Average Remaining Contractual Life, Outstanding Balance"><ix:nonNumeric contextRef="From2024-03-012025-02-28_custom_StockAppreciationRightsMember" format="ixt-sec:duryear" id="Fact001802" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">1.99</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iE_pp0p0_c20240301__20250228__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zGpRxO6pgOQf" title="Aggregate Intrinsic Value, Outstanding Balance" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1804">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">SARs expected to vest in the future as of February 28, 2025</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iE_pid_c20240301__20250228__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zGGSsgm4v6p9" title="Number of Options, Expected to vest in the future, Balance" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" contextRef="AsOf2025-02-28_custom_StockAppreciationRightsMember" id="Fact001806" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,213</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_iE_pid_c20240301__20250228__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zn7Hsp92P6K3" title="Weighted Average Exercise Price, Expected to Vest" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" contextRef="AsOf2025-02-28_custom_StockAppreciationRightsMember" id="Fact001808" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">27.66</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_dtY_c20240301__20250228__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zwFy3VfuD7Ta" title="Weighted Average Remaining Contractual Life, Expected to Vest"><ix:nonNumeric contextRef="From2024-03-012025-02-28_custom_StockAppreciationRightsMember" format="ixt-sec:duryear" id="Fact001810" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1">1.93</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_iE_pp0p0_c20240301__20250228__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zGQtOUP8Ukwd" title="Aggregate Intrinsic Value, Options expected to vest in the future" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1812">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">SARs exercisable at February 28, 2025</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_pid_c20240301__20250228__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zx1loO0OnAHd" title="Number of Options, Exercisable" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" contextRef="AsOf2025-02-28_custom_StockAppreciationRightsMember" id="Fact001814" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">35,010</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20240301__20250228__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zAMuaPcKE2H9" title="Weighted Average Exercise Price, Exercisable" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" contextRef="AsOf2025-02-28_custom_StockAppreciationRightsMember" id="Fact001816" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">47.35</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20240301__20250228__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zD33XKKplyh9" title="Weighted Average Remaining Contractual Life, Exercisable"><ix:nonNumeric contextRef="From2024-03-012025-02-28_custom_StockAppreciationRightsMember" format="ixt-sec:duryear" id="Fact001818" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">2.34</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iE_pp0p0_c20240301__20250228__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zJCSqvoC7hnd" title="Aggregate Intrinsic Value, Options exercisable" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1820">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">SARs vested, exercisable, and options expected to vest at February 28, 2025</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_iE_pid_c20240301__20250228__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_z0urZVBN5lfj" title="Number of Options, Vested, Exercisable and Options Expected to Vest Balance" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" contextRef="AsOf2025-02-28_custom_StockAppreciationRightsMember" id="Fact001822" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">40,223</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_iE_pid_c20240301__20250228__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zva9jgslCi35" title="Weighted Average Exercise Price, Vested, Exercisable and Options Expected to Vest" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" contextRef="AsOf2025-02-28_custom_StockAppreciationRightsMember" id="Fact001824" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">44.80</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_dtY_c20240301__20250228__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zf1jdG76Rzj6" title="Weighted Average Remaining Contractual Life, Vested, Exercisable and Options Expected to Vest"><ix:nonNumeric contextRef="From2024-03-012025-02-28_custom_StockAppreciationRightsMember" format="ixt-sec:duryear" id="Fact001826" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1">1.99</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_iE_pp0p0_c20240301__20250228__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zklpPrAoaHe4" title="Aggregate Intrinsic Value, Options vested, exercisable and options expected to vest" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1828">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A5_z19QDd2hIeyl" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
aggregate intrinsic value is calculated as the difference between the exercise price of the underlying awards and the quoted price of
our common stock for those awards that have an exercise price below the $<span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20240301__20250228__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyStockAppreciationRightsPlanMember_zhEqFikJSe5f" title="Options exercise price"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="From2024-03-012025-02-28_custom_TwoThousandAndTwentyStockAppreciationRightsPlanMember" id="Fact001830" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">3.98</ix:nonFraction></span> closing price of our common stock on February 28, 2025.
All the SARs have an exercise price above $<span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20240301__20250228__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyStockAppreciationRightsPlanMember_zZEZPtWnuHKk" title="Options exercise price"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="From2024-03-012025-02-28_custom_TwoThousandAndTwentyStockAppreciationRightsPlanMember" id="Fact001832" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">3.98</ix:nonFraction></span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the year ended February 28, 2025, $<span id="xdx_905_eus-gaap--AllocatedShareBasedCompensationExpense_c20240301__20250228__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyStockAppreciationRightsPlanMember_zf6X6c9CefPk" title="Share based compensation expense"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2024-03-012025-02-28_custom_TwoThousandAndTwentyStockAppreciationRightsPlanMember" id="Fact001834" format="ixt:numdotdecimal" decimals="0" unitRef="USD">67,874</ix:nonFraction></span> of share-based compensation expense was recognized, and at February 28, 2025, there was $<span id="xdx_900_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_iI_c20250228__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyStockAppreciationRightsPlanMember_zRDVDCFMfG3i" title="Unrecognized share based compensation cost"><ix:nonFraction name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" contextRef="AsOf2025-02-28_custom_TwoThousandAndTwentyStockAppreciationRightsPlanMember" id="Fact001836" format="ixt:numdotdecimal" decimals="0" unitRef="USD">119</ix:nonFraction></span>
of unrecognized share-based compensation expense related to unvested SARs with a weighted average remaining recognition period of <span id="xdx_90A_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardWeightedAverageRemainingRecognitionPeriod_dtY_c20240301__20250228__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyStockAppreciationRightsPlanMember_zpvquFCnh26a" title="Weighted average remaining recognition period"><ix:nonNumeric contextRef="From2024-03-012025-02-28_custom_TwoThousandAndTwentyStockAppreciationRightsPlanMember" format="ixt-sec:duryear" id="Fact001838" name="NTRP:SharebasedCompensationArrangementBySharebasedPaymentAwardWeightedAverageRemainingRecognitionPeriod">0.26</ix:nonNumeric></span>
years.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Warrants</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
February 28, 2025, the Company had outstanding warrants to purchase a total of <span id="xdx_909_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_iI_c20250228__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zpWoyYv4gsfi" title="Purchase of outstanding warrants"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" contextRef="AsOf2025-02-28_us-gaap_WarrantMember" id="Fact001840" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,015,885</ix:nonFraction></span> shares of common stock. The warrants have exercise
prices that range from $<span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20250228__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--RangeAxis__srt--MinimumMember_zUVFINpdY1be" title="Warrants exercise price"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2025-02-28_us-gaap_WarrantMember_srt_MinimumMember" id="Fact001842" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">3.02</ix:nonFraction></span> to $<span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20250228__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--RangeAxis__srt--MaximumMember_zbSbYTOWgPnl" title="Warrants exercise price"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2025-02-28_us-gaap_WarrantMember_srt_MaximumMember" id="Fact001844" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">350.00</ix:nonFraction></span>, which if not exercised, will <span id="xdx_904_ecustom--DescriptionForWarrantExpiration_c20240301__20250228__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zbpmzUCaixki" title="Warrant description"><ix:nonNumeric contextRef="From2024-03-012025-02-28_us-gaap_WarrantMember11853671" id="Fact001846" name="NTRP:DescriptionForWarrantExpiration">expire between July 26, 2025 and August 24, 2030</ix:nonNumeric></span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 111; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2024-03-01to2025-02-28" escape="true" id="Fact001848" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"><p id="xdx_893_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_zFI411ZI4oWh" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The fair value of warrants issued during the year
was estimated using the Black-Scholes model with the following assumptions for the twelve months ended February 28, 2025:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"><b>Assumptions:</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8B0_zjrLnBZbNBQh" style="display: none">Schedule of Share Based Payments Award Stock Options Valuation Assumptions</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2025</td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 80%; text-align: left">Dividend yield</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 18%; text-align: right"><span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_uPure_c20240301__20250228_zaeQiO9I5h47" title="Dividend yield"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" contextRef="From2024-03-01to2025-02-28" id="Fact001850" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.0</ix:nonFraction></span></td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Risk-free interest rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_pid_dp_uPure_c20240301__20250228__srt--RangeAxis__srt--MinimumMember_zhLnzXurenHb" title="Risk-free interest rate, minimum"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" contextRef="From2024-03-012025-02-28_srt_MinimumMember" id="Fact001852" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">3.5</ix:nonFraction>%</span>-<span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uPure_c20240301__20250228__srt--RangeAxis__srt--MaximumMember_zPhasS7VGCxb" title="Risk-free interest rate, maximum"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" contextRef="From2024-03-012025-02-28_srt_MaximumMember" id="Fact001854" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">4.3</ix:nonFraction></span></span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Expected volatility</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_dp_uPure_c20240301__20250228__srt--RangeAxis__srt--MinimumMember_zxTUefTGKlD5" title="Expected volatility, minimum"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" contextRef="From2024-03-012025-02-28_srt_MinimumMember" id="Fact001856" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">127.1</ix:nonFraction>%</span>-<span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_dp_uPure_c20240301__20250228__srt--RangeAxis__srt--MaximumMember_zjNy1QocRtUj" title="Expected volatility, maximum"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" contextRef="From2024-03-012025-02-28_srt_MaximumMember" id="Fact001858" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">159.4</ix:nonFraction></span></span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Expected life (in years)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20240301__20250228__srt--RangeAxis__srt--MinimumMember_zWEcePIp2eya" title="Expected life"><ix:nonNumeric contextRef="From2024-03-012025-02-28_srt_MinimumMember" format="ixt-sec:duryear" id="Fact001860" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">1.5</ix:nonNumeric></span>-<span id="xdx_90F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20240301__20250228__srt--RangeAxis__srt--MaximumMember_zE5VvcpgzZzb" title="Expected life"><ix:nonNumeric contextRef="From2024-03-012025-02-28_srt_MaximumMember" format="ixt-sec:duryear" id="Fact001862" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">5.0</ix:nonNumeric></span></span></td><td style="text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8AB_zOXeCzacRYT9" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2024-03-01to2025-02-28" escape="true" id="Fact001864" name="us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock"><p id="xdx_896_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zhpRYHcrbv0j" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrant
activity for the year ended February 28, 2025 was as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8BB_zjRXwdpkZ8oh" style="display: none">Schedule of Warranty Activity</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Weighted Average</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Average</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Exercise</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Remaining</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Price</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Contractual</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Warrants</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">($)</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Life (Yrs.)</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 46%; padding-bottom: 2.5pt">Warrants outstanding at February 29, 2024</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_pid_c20240301__20250228_zIpt1G5hP1Ph" title="Warrants Outstanding, Beginning Balance" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" contextRef="AsOf2024-02-29" id="Fact001866" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">486,165</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20240301__20250228_zgZUaZGSu2Ci" title="Weighted Average Exercise Price Outstanding, Beginning Balance" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><ix:nonFraction name="NTRP:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2024-02-29" id="Fact001868" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">9.94</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span id="xdx_90C_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonOutstandingWeightedAverageRemainingContractualTerm_dtY_c20230301__20240229_zw2bFLwpI3ri" title="Weighted Average Remaining Contractual Life Years, Beginning Balance"><ix:nonNumeric contextRef="From2023-03-012024-02-29" format="ixt-sec:duryear" id="Fact001870" name="NTRP:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonOutstandingWeightedAverageRemainingContractualTerm">1.96</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">Granted</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_pid_c20240301__20250228_zvn9T6oeWXu2" title="Warrants, Granted" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" contextRef="From2024-03-01to2025-02-28" id="Fact001872" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,637,887</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_980_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20240301__20250228_zFHGq4ni9MKc" title="Weighted Average Exercise Price Outstanding, Granted" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="NTRP:ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageExercisePrice" contextRef="From2024-03-01to2025-02-28" id="Fact001874" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">4.80</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_901_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonGrantsWeightedAverageRemainingContractualTerm_dtY_c20240301__20250228_zszdofnTORw5" title="Weighted Average Remaining Contractual Life Years, Granted"><ix:nonNumeric contextRef="From2024-03-01to2025-02-28" format="ixt-sec:duryear" id="Fact001876" name="NTRP:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonGrantsWeightedAverageRemainingContractualTerm">4.24</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">Exercised</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_iN_pid_di_c20240301__20250228_ztCL8aXqCXTc" title="Warrants,Exercised" style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" contextRef="From2024-03-01to2025-02-28" id="Fact001878" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">104,965</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98D_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageExercisePrice_pid_c20240301__20250228_zMCjplN3nB72" title="Weighted Average Exercise Price Outstanding,Exercised" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="NTRP:ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageExercisePrice" contextRef="From2024-03-01to2025-02-28" id="Fact001880" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">3.02</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Forfeited or cancelled</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_iN_pid_di_c20240301__20250228_zuGRbpcXSw46" title="Warrants, Forfeited or cancelled" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures" contextRef="From2024-03-01to2025-02-28" id="Fact001882" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,202</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98D_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageWeightedAverageExercisePriceWarrantsForfeitedOrCancelled_pid_c20240301__20250228_zSjC9Dr7s8jk" title="Weighted Average Exercise Price Outstanding, Forfeited or cancelled" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1884">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">Warrants outstanding at February 28, 2025</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_pid_c20240301__20250228_ziS5TaRvdfLk" title="Warrants Outstanding, Ending Balance" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" contextRef="AsOf2025-02-28" id="Fact001886" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,015,885</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_984_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20240301__20250228_zHwIq6VlvfIk" title="Weighted Average Exercise Price Outstanding, Ending Balance" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="NTRP:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2025-02-28" id="Fact001888" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">5.36</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90F_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonOutstandingWeightedAverageRemainingContractualTerm_dtY_c20240301__20250228_zoWs4z0IxTZb" title="Weighted Average Remaining Contractual Life Years, Ending Balance"><ix:nonNumeric contextRef="From2024-03-01to2025-02-28" format="ixt-sec:duryear" id="Fact001890" name="NTRP:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonOutstandingWeightedAverageRemainingContractualTerm">3.84</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A7_zppCWPjkWhq6" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
further information regarding the allocation of the relative fair values of warrants issued in connection with short-term promissory
notes, see <b>NOTE 12- Notes Payable.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-03-01to2025-02-28" escape="true" id="Fact001892" name="us-gaap:EarningsPerShareTextBlock"><p id="xdx_80B_eus-gaap--EarningsPerShareTextBlock_zDTtQmaqfTp9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
19 &#8211; <span id="xdx_82F_zpwl32m6pnoc">Loss Per Share</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2024-03-01to2025-02-28" escape="true" id="Fact001894" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"><p id="xdx_89C_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zzRn2OLe8J13" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following data show the amounts used in computing loss per share and the effect on income and the weighted average number of shares of
dilutive potential common stock for the years ended February 28, 2025 and February 29, 2024:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8B0_zB5oQ5B78MWg" style="display: none">Schedule of Earnings Per Share, Basic and Diluted</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
  <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_491_20240301__20250228_zIax3Wzc3cCl" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">2025</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_490_20230301__20240229_zea9HjiMcnW9" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">2024</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Year Ended February</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">2025</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">2024</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_zFrF7PIzwta" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left">Loss from continuing operations</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" contextRef="From2024-03-01to2025-02-28" id="Fact001896" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">10,128,428</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" contextRef="From2023-03-012024-02-29" id="Fact001897" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">6,656,837</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">)</td></tr>
  <tr id="xdx_405_eus-gaap--PreferredStockDividendsIncomeStatementImpact_iN_di_z9I9ynpTyyy9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Preferred dividends</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:PreferredStockDividendsIncomeStatementImpact" contextRef="From2024-03-01to2025-02-28" id="Fact001899" format="ixt:numdotdecimal" decimals="0" unitRef="USD">78,600</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:PreferredStockDividendsIncomeStatementImpact" contextRef="From2023-03-012024-02-29" id="Fact001900" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,125</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_40E_eus-gaap--IncomeLossFromContinuingOperations_z8bBw63pHCCg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Loss from continuing operations applicable to common stockholders</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperations" contextRef="From2024-03-01to2025-02-28" id="Fact001902" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">10,207,028</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperations" contextRef="From2023-03-012024-02-29" id="Fact001903" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">6,663,962</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr id="xdx_407_eus-gaap--IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_zhUfm67V8gu5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Gain (loss) from discontinued operations applicable to common stockholders</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" contextRef="From2024-03-01to2025-02-28" id="Fact001905" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8,344</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" contextRef="From2023-03-012024-02-29" id="Fact001906" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">675,314</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_40E_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_zPemkS9ty0b" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Net loss applicable to common stockholders</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="From2024-03-01to2025-02-28" id="Fact001908" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">10,198,684</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="From2023-03-012024-02-29" id="Fact001909" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">7,339,276</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_zfw2IISZJTAf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Weighted average number of common shares Outstanding used in loss per share during the Period (denominator)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2024-03-01to2025-02-28" id="Fact001911" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">4,566,787</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2023-03-012024-02-29" id="Fact001912" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">228,274</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A6_zMqJkahZJF4" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 10, 2024, the Company determined that three of the four business milestones per the Exchange Agreement had been achieved.
As a result, <span id="xdx_906_eus-gaap--IncrementalCommonSharesAttributableToContingentlyIssuableShares_c20240610__20240610__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__srt--StatementScenarioAxis__custom--AchievedMember_z28SKl9tP20a" title="Contingent shares issuable"><ix:nonFraction name="us-gaap:IncrementalCommonSharesAttributableToContingentlyIssuableShares" contextRef="From2024-06-102024-06-10_custom_ShareExchangeAgreementMember_custom_AchievedMember" id="Fact001914" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">4,393,993</ix:nonFraction></span> of the total Contingent Shares of <span id="xdx_905_eus-gaap--IncrementalCommonSharesAttributableToContingentlyIssuableShares_pid_c20240610__20240610__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember_zyiZR7FWQkR3" title="Contingent shares issuable"><ix:nonFraction name="us-gaap:IncrementalCommonSharesAttributableToContingentlyIssuableShares" contextRef="From2024-06-102024-06-10_custom_ShareExchangeAgreementMember" id="Fact001916" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,843,993</ix:nonFraction></span> became eligible for issuance. Pursuant to ASC 260, as there are no
circumstances under which the shares will not be issued, such eligible contingent shares are included in the computation of basic earnings
per share. The following table shows the business milestones and the issuable Contingent Shares:</span></p>

<ix:nonNumeric contextRef="From2024-03-01to2025-02-28" escape="true" id="Fact001918" name="us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock"><p id="xdx_89D_eus-gaap--ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock_zwEd4uQAvnFg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8BA_zJ94RHgNtRXe" style="display: none">Schedule
of Business Milestones and Issuable Contingent Shares</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify">Business Milestones</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Contingent Shares</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: italic 10pt Times New Roman, Times, Serif; text-align: justify">Achieved</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 78%; text-align: justify">Launch of leisure travel booking platform</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--IncrementalCommonSharesAttributableToContingentlyIssuableShares_c20240610__20240610__srt--StatementScenarioAxis__custom--AchievedMember__us-gaap--OtherCommitmentsAxis__custom--LeisureTravelBookingPlatformMember_zj7ToOtUlco7" title="Launch of leisure travel booking platform" style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right"><ix:nonFraction name="us-gaap:IncrementalCommonSharesAttributableToContingentlyIssuableShares" contextRef="From2024-06-102024-06-10_custom_AchievedMember_custom_LeisureTravelBookingPlatformMember" id="Fact001920" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,450,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Launch of group travel booking platform</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--IncrementalCommonSharesAttributableToContingentlyIssuableShares_c20240610__20240610__srt--StatementScenarioAxis__custom--AchievedMember__us-gaap--OtherCommitmentsAxis__custom--GroupTravelBookingPlatformMember_zUvg407RUbDg" title="Launch of group travel booking platform" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:IncrementalCommonSharesAttributableToContingentlyIssuableShares" contextRef="From2024-06-102024-06-10_custom_AchievedMember_custom_GroupTravelBookingPlatformMember" id="Fact001922" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,450,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 1pt">Launch of PayDlay technology</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--IncrementalCommonSharesAttributableToContingentlyIssuableShares_c20240610__20240610__srt--StatementScenarioAxis__custom--AchievedMember__us-gaap--OtherCommitmentsAxis__custom--FlexPayTechnologyMember_z8y6ZcZE9Lqb" title="Launch of FlexPay technology" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:IncrementalCommonSharesAttributableToContingentlyIssuableShares" contextRef="From2024-06-102024-06-10_custom_AchievedMember_custom_FlexPayTechnologyMember" id="Fact001924" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,493,993</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 1pt">Total contingent shares issuable on June 10, 2024</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--IncrementalCommonSharesAttributableToContingentlyIssuableShares_c20240610__20240610__srt--StatementScenarioAxis__custom--AchievedMember_zzmq5bWdIYRc" title="Total contingent shares issuable on June 10, 2024" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:IncrementalCommonSharesAttributableToContingentlyIssuableShares" contextRef="From2024-06-102024-06-10_custom_AchievedMember" id="Fact001926" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">4,393,993</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: italic 10pt Times New Roman, Times, Serif; text-align: justify">Not Achieved</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 1pt">Launch of travel agent platform</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--IncrementalCommonSharesAttributableToContingentlyIssuableShares_c20240610__20240610__srt--StatementScenarioAxis__custom--NotAchievedMember__us-gaap--OtherCommitmentsAxis__custom--TravelAgentPlatformMember_zis53YyOuZRh" title="Total contingent shares potentially issuable in future periods" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:IncrementalCommonSharesAttributableToContingentlyIssuableShares" contextRef="From2024-06-102024-06-10_custom_NotAchievedMember_custom_TravelAgentPlatformMember" id="Fact001928" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,450,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 1pt">Total contingent shares potentially issuable in future periods</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--IncrementalCommonSharesAttributableToContingentlyIssuableShares_c20240610__20240610__srt--StatementScenarioAxis__custom--NotAchievedMember_zMhks37wI6C4" title="Total contingent shares potentially issuable in future periods" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:IncrementalCommonSharesAttributableToContingentlyIssuableShares" contextRef="From2024-06-102024-06-10_custom_NotAchievedMember" id="Fact001930" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,450,000</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 2.5pt">Total contingent shares</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--IncrementalCommonSharesAttributableToContingentlyIssuableShares_c20240610__20240610_zwx7IksCC5M5" title="Total contingent shares" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:IncrementalCommonSharesAttributableToContingentlyIssuableShares" contextRef="From2024-06-102024-06-10" id="Fact001932" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,843,993</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A3_zmC9g7WtLdQa" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2024-03-01to2025-02-28" escape="true" id="Fact001934" name="us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock"><p id="xdx_899_eus-gaap--ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_zkFLoYttQsQb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table shows the reconciliation of the weighted average common shares outstanding for the twelve months ended February 28, 2025
to the weighted average common shares used in the computation of basic earnings per share:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8BD_zbSPJ2PEsGaf" style="display: none">Schedule
of Weighted Average Common Shares</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">February 28,</p>
                                                                               <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">2025</p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 78%"><span id="xdx_90D_eus-gaap--CommonStockSharesOutstanding_iI_c20250228_ziMjiQjhAeV9" title="Common stock, shares outstanding" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFdlaWdodGVkIEF2ZXJhZ2UgQ29tbW9uIFNoYXJlcyAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2025-02-28" id="Fact001936" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,656,738</ix:nonFraction></span> common shares outstanding</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20240301__20250228__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zoNFLk1YuaVc" title="1,656,738 common shares outstanding" style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2024-03-012025-02-28_us-gaap_CommonStockMember11856671" id="Fact001938" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,400,705</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span id="xdx_906_eus-gaap--IncrementalCommonSharesAttributableToContingentlyIssuableShares_c20240301__20250228_zKANRDcND0Yf" title="Contingent shares issuable" class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFdlaWdodGVkIEF2ZXJhZ2UgQ29tbW9uIFNoYXJlcyAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__"><ix:nonFraction name="us-gaap:IncrementalCommonSharesAttributableToContingentlyIssuableShares" contextRef="From2024-03-01to2025-02-28" id="Fact001940" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">4,393,993</ix:nonFraction></span> issuable contingent shares</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20240301__20250228__us-gaap--StatementClassOfStockAxis__custom--ContingentSharesMember_z5QbJx49MdH7" title="4,393,993 issuable contingent shares" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2024-03-012025-02-28_custom_ContingentSharesMember" id="Fact001942" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,166,083</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">Weighted average common shares outstanding</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20240301__20250228_zL6wAdzc4YJ" title="Weighted average common shares outstanding" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2024-03-01to2025-02-28" id="Fact001944" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">4,566,787</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A8_zIqBfyY49Km3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 112; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
issuable Contingent Shares are of the Company&#8217;s sole class of common stock, and as such have the same rights and privileges as
existing common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dilutive
loss per share was not presented as the Company&#8217;s outstanding common and preferred warrants, stock options and preferred stock
common equivalent shares for the periods presented would have had an anti-dilutive effect. At February 28, 2025, the Company had outstanding
warrants to purchase <span id="xdx_907_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20250228__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zC1uVTvVAj9i" title="Warrants outstanding to purchase common stock"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="AsOf2025-02-28_us-gaap_WarrantMember" id="Fact001946" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,105,885</ix:nonFraction></span> shares of common stock; stock options exercisable for <span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20250228__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zY4mdWRCA8R2" title="Shares issuable upon exercisable of options"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" contextRef="AsOf2025-02-28_us-gaap_EmployeeStockOptionMember" id="Fact001948" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">76,342</ix:nonFraction></span> shares of common stock; <span id="xdx_90C_eus-gaap--ConversionOfStockSharesConverted1_c20240301__20250228__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesEPreferredStockMember_zh5W9qUysmQh" title="Number of shares converted"><ix:nonFraction name="us-gaap:ConversionOfStockSharesConverted1" contextRef="From2024-03-012025-02-28_us-gaap_SeriesEPreferredStockMember" id="Fact001950" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">316</ix:nonFraction></span> shares of
Series E Preferred, which could be converted into <span id="xdx_90C_eus-gaap--ConversionOfStockSharesIssued1_c20240301__20250228__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesEPreferredStockMember_z5JhoCeB2Rb3" title="Common stock issuable upon conversion"><ix:nonFraction name="us-gaap:ConversionOfStockSharesIssued1" contextRef="From2024-03-012025-02-28_us-gaap_SeriesEPreferredStockMember" id="Fact001952" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,362</ix:nonFraction></span> shares of common stock; <span id="xdx_90D_eus-gaap--ConversionOfStockSharesConverted1_c20240301__20250228__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesHPreferredStockMember_zNLZxBa501d5" title="Number of shares converted"><ix:nonFraction name="us-gaap:ConversionOfStockSharesConverted1" contextRef="From2024-03-012025-02-28_us-gaap_SeriesHPreferredStockMember" id="Fact001954" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">33,000</ix:nonFraction></span> shares of Series H Preferred, convertible
into <span id="xdx_90F_eus-gaap--ConversionOfStockSharesIssued1_c20240301__20250228__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesHPreferredStockMember_zi4TX1YcKCk9" title="Common stock issuable upon conversion"><ix:nonFraction name="us-gaap:ConversionOfStockSharesIssued1" contextRef="From2024-03-012025-02-28_us-gaap_SeriesHPreferredStockMember" id="Fact001956" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">33,000</ix:nonFraction></span> shares of common stock; <span id="xdx_903_eus-gaap--ConversionOfStockSharesConverted1_c20240301__20250228__us-gaap--StatementClassOfStockAxis__custom--SeriesIPreferredStockMember_zrW6cm8FCER7" title="Number of shares converted"><ix:nonFraction name="us-gaap:ConversionOfStockSharesConverted1" contextRef="From2024-03-012025-02-28_custom_SeriesIPreferredStockMember" id="Fact001958" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">500,442</ix:nonFraction></span> shares of Series I Preferred, convertible into <span id="xdx_90E_eus-gaap--ConversionOfStockSharesIssued1_c20240301__20250228__us-gaap--StatementClassOfStockAxis__custom--SeriesIPreferredStockMember_zRhpP5XqF5p6" title="Common stock issuable upon conversion"><ix:nonFraction name="us-gaap:ConversionOfStockSharesIssued1" contextRef="From2024-03-012025-02-28_custom_SeriesIPreferredStockMember" id="Fact001960" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">500,442</ix:nonFraction></span> shares of common stock; <span id="xdx_905_eus-gaap--ConversionOfStockSharesConverted1_c20240301__20250228__us-gaap--StatementClassOfStockAxis__custom--SeriesJPreferredStockMember_zWRY8Z3kyK95" title="Number of shares converted"><ix:nonFraction name="us-gaap:ConversionOfStockSharesConverted1" contextRef="From2024-03-012025-02-28_custom_SeriesJPreferredStockMember" id="Fact001962" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">297,788</ix:nonFraction></span>
shares of Series J Preferred, convertible into <span id="xdx_90A_eus-gaap--ConversionOfStockSharesIssued1_c20240301__20250228__us-gaap--StatementClassOfStockAxis__custom--SeriesJPreferredStockMember_zGjMu8V3sE75" title="Common stock issuable upon conversion"><ix:nonFraction name="us-gaap:ConversionOfStockSharesIssued1" contextRef="From2024-03-012025-02-28_custom_SeriesJPreferredStockMember" id="Fact001964" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">297,788</ix:nonFraction></span> shares of common stock; <span id="xdx_905_eus-gaap--ConversionOfStockSharesConverted1_c20240301__20250228__us-gaap--StatementClassOfStockAxis__custom--SeriesKPreferredStockMember_z5OxjsaXehr9" title="Number of shares converted"><ix:nonFraction name="us-gaap:ConversionOfStockSharesConverted1" contextRef="From2024-03-012025-02-28_custom_SeriesKPreferredStockMember" id="Fact001966" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">60,595</ix:nonFraction></span> shares of Series K Stock, convertible
into <span id="xdx_90F_eus-gaap--ConversionOfStockSharesIssued1_c20240301__20250228__us-gaap--StatementClassOfStockAxis__custom--SeriesKPreferredStockMember_zuFEdBtf2MU3" title="Common stock issuable upon conversion"><ix:nonFraction name="us-gaap:ConversionOfStockSharesIssued1" contextRef="From2024-03-012025-02-28_custom_SeriesKPreferredStockMember" id="Fact001968" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">60,595</ix:nonFraction></span> shares of common stock; <span id="xdx_900_eus-gaap--ConversionOfStockSharesConverted1_c20240301__20250228__us-gaap--StatementClassOfStockAxis__custom--SeriesLPreferredStockMember_zljkXPA5OQV7" title="Number of shares converted"><ix:nonFraction name="us-gaap:ConversionOfStockSharesConverted1" contextRef="From2024-03-012025-02-28_custom_SeriesLPreferredStockMember" id="Fact001970" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,076,156</ix:nonFraction></span> shares of Series L Preferred, convertible into <span id="xdx_906_eus-gaap--ConversionOfStockSharesIssued1_c20240301__20250228__us-gaap--StatementClassOfStockAxis__custom--SeriesLPreferredStockMember_zgkaLd7XJ8V3" title="Common stock issuable upon conversion"><ix:nonFraction name="us-gaap:ConversionOfStockSharesIssued1" contextRef="From2024-03-012025-02-28_custom_SeriesLPreferredStockMember" id="Fact001972" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,076,156</ix:nonFraction></span> shares of common stock;
<span id="xdx_900_eus-gaap--ConversionOfStockSharesConverted1_c20240301__20250228__us-gaap--StatementClassOfStockAxis__custom--SeriesMPreferredStockMember_zwQrwAAxmBU6" title="Number of shares converted"><ix:nonFraction name="us-gaap:ConversionOfStockSharesConverted1" contextRef="From2024-03-012025-02-28_custom_SeriesMPreferredStockMember" id="Fact001974" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">133,278</ix:nonFraction></span> shares of Series M Preferred, convertible into <span id="xdx_904_eus-gaap--ConversionOfStockSharesIssued1_c20240301__20250228__us-gaap--StatementClassOfStockAxis__custom--SeriesMPreferredStockMember_zwsyCupL84Wl" title="Common stock issuable upon conversion"><ix:nonFraction name="us-gaap:ConversionOfStockSharesIssued1" contextRef="From2024-03-012025-02-28_custom_SeriesMPreferredStockMember" id="Fact001976" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">133,278</ix:nonFraction></span> shares of common stock; <span id="xdx_900_eus-gaap--ConversionOfStockSharesConverted1_c20240301__20250228__us-gaap--StatementClassOfStockAxis__custom--SeriesNPreferredStockMember_zIxkCjvTHMTi" title="Number of shares converted"><ix:nonFraction name="us-gaap:ConversionOfStockSharesConverted1" contextRef="From2024-03-012025-02-28_custom_SeriesNPreferredStockMember" id="Fact001978" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">500,000</ix:nonFraction></span> shares of Series N Preferred,
convertible into <span id="xdx_90A_eus-gaap--ConversionOfStockSharesIssued1_c20240301__20250228__us-gaap--StatementClassOfStockAxis__custom--SeriesNPreferredStockMember_z2OG52knENS7" title="Common stock issuable upon conversion"><ix:nonFraction name="us-gaap:ConversionOfStockSharesIssued1" contextRef="From2024-03-012025-02-28_custom_SeriesNPreferredStockMember" id="Fact001980" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">500,000</ix:nonFraction></span> shares of common stock; <span id="xdx_901_eus-gaap--ConversionOfStockSharesConverted1_c20240301__20250228__us-gaap--StatementClassOfStockAxis__custom--SeriesOPreferredStockMember_zWIrpBfIwWj9" title="Number of shares converted"><ix:nonFraction name="us-gaap:ConversionOfStockSharesConverted1" contextRef="From2024-03-012025-02-28_custom_SeriesOPreferredStockMember" id="Fact001982" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">161,291</ix:nonFraction></span> shares of Series O Preferred, convertible into <span id="xdx_90E_eus-gaap--ConversionOfStockSharesIssued1_c20240301__20250228__us-gaap--StatementClassOfStockAxis__custom--SeriesOPreferredStockMember_zqjL1H1CNWYc" title="Common stock issuable upon conversion"><ix:nonFraction name="us-gaap:ConversionOfStockSharesIssued1" contextRef="From2024-03-012025-02-28_custom_SeriesOPreferredStockMember" id="Fact001984" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">161,291</ix:nonFraction></span> shares of common
stock; and <span id="xdx_906_eus-gaap--ConversionOfStockSharesConverted1_c20240301__20250228__us-gaap--StatementClassOfStockAxis__custom--SeriesOPreferredStockOneMember_z4zt5soCOyWg" title="Number of shares converted"><ix:nonFraction name="us-gaap:ConversionOfStockSharesConverted1" contextRef="From2024-03-012025-02-28_custom_SeriesOPreferredStockOneMember" id="Fact001986" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">343,750</ix:nonFraction></span> shares of Series O Stock, convertible into <span id="xdx_909_eus-gaap--ConversionOfStockSharesIssued1_c20240301__20250228__us-gaap--StatementClassOfStockAxis__custom--SeriesOPreferredStockOneMember_zudvTBRY08c4" title="Common stock issuable upon conversion"><ix:nonFraction name="us-gaap:ConversionOfStockSharesIssued1" contextRef="From2024-03-012025-02-28_custom_SeriesOPreferredStockOneMember" id="Fact001988" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">343,750</ix:nonFraction></span> shares of common stock, resulting in a potential total
additional <span id="xdx_90C_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_c20240301__20250228__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zMwWi7Oo9q03" title="Potentially dilutive securities"><ix:nonFraction name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" contextRef="From2024-03-012025-02-28_us-gaap_CommonStockMember" id="Fact001990" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,109,663</ix:nonFraction></span> shares of common stock outstanding in the future. At February 29, 2024, the Company had <span id="xdx_902_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_c20230301__20240229__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zLQykkw5cWcf" title="Potentially dilutive securities"><ix:nonFraction name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" contextRef="From2023-03-012024-02-29_us-gaap_CommonStockMember" id="Fact001992" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,047,300</ix:nonFraction></span> outstanding potentially
dilutive securities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-03-01to2025-02-28" escape="true" id="Fact001994" name="us-gaap:ConcentrationRiskDisclosureTextBlock"><p id="xdx_806_eus-gaap--ConcentrationRiskDisclosureTextBlock_z4zPeoJ5B9ub" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
20 &#8211; <span id="xdx_827_zbuUqEC1BVk1">Concentrations</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Revenues
</b>&#8211; During the years ended February 28, 2025 and February 29, 2024, the Company did not have any significant customers who accounted
for more than <span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20230301__20240229__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerMember_zeDZHqbZWjC8" title="Concentration of risk percentage"><span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20240301__20250228__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerMember_zhl4YsKrD3Vi" title="Concentration of risk percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2023-03-012024-02-29_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerMember" id="Fact001996" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2024-03-012025-02-28_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerMember" id="Fact001998" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">10</ix:nonFraction></ix:nonFraction></span></span>% each of the Company&#8217;s revenue in at least one of the periods presented.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Accounts
Receivable</b> &#8211; The Company had no significant customers who accounted for more than <span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20230301__20240229__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerMember_zVjSBRAFYhH5" title="Concentration of risk percentage"><span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20240301__20250228__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerMember_zTgRhDTrrEtg" title="Concentration of risk percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2023-03-012024-02-29_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerMember" id="Fact002000" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2024-03-012025-02-28_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerMember" id="Fact002002" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">10</ix:nonFraction></ix:nonFraction></span></span>% each of the Company&#8217;s accounts
receivable balance at February 28, 2025 and February 29, 2024, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-03-01to2025-02-28" escape="true" id="Fact002004" name="us-gaap:CompensationAndEmployeeBenefitPlansTextBlock"><p id="xdx_80C_eus-gaap--CompensationAndEmployeeBenefitPlansTextBlock_zvEibmnE4U3h" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
21 - <span id="xdx_822_zfN3g2K8OFl6">Defined Contribution Plans</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has adopted two qualified 401(k) plans (the &#8220;401(k) Plans&#8221;), in which all employees over the age of 21 may
participate. Depending on the 401(k) Plan, <span id="xdx_90C_eus-gaap--DescriptionOfDefinedContributionPensionAndOtherPostretirementPlans_c20240301__20250228_zoaePQhxSIsj" title="Contribution plan description"><ix:nonNumeric contextRef="From2024-03-01to2025-02-28" id="Fact002006" name="us-gaap:DescriptionOfDefinedContributionPensionAndOtherPostretirementPlans">the
Company makes either a safe Harbor contribution match of 100% of each participant&#8217;s contribution up to 3% of salary, and 50%
of the next 2% of salary contributed, or a 3% non-elective contribution for all eligible participants</ix:nonNumeric></span>. The matching
contributions were $<span id="xdx_90D_eus-gaap--DefinedContributionPlanCostRecognized_c20240301__20250228_z0tS3FmyBaKb" title="Cost of contribution"><ix:nonFraction name="us-gaap:DefinedContributionPlanCostRecognized" contextRef="From2024-03-01to2025-02-28" id="Fact002008" format="ixt:numdotdecimal" decimals="0" unitRef="USD">23,628</ix:nonFraction></span>
in 2025 and $<span id="xdx_90F_eus-gaap--DefinedContributionPlanCostRecognized_c20230301__20240228_zYLUz8bt56ej" title="Cost of contribution"><ix:nonFraction name="us-gaap:DefinedContributionPlanCostRecognized" contextRef="From2023-03-012024-02-28" id="Fact002010" format="ixt:numdotdecimal" decimals="0" unitRef="USD">17,112</ix:nonFraction></span>
in 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-03-01to2025-02-28" escape="true" id="Fact002012" name="us-gaap:SubsequentEventsTextBlock"><p id="xdx_80B_eus-gaap--SubsequentEventsTextBlock_zxuIlZY5Qj77" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
22 &#8211; <span id="xdx_82B_zUTpgECwLQI3">Subsequent Events</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Nasdaq </i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 3, 2025, the Company received a notification letter from Nasdaq notifying the Company that, because the Company had not held
an annual meeting of shareholders within twelve months of the end of the Company&#8217;s fiscal year ended February 29, 2024,the
Company was out of compliance with Nasdaq Listing Rule 5620(a) (the &#8220;Annual Meeting Rule&#8221;). On March 3, 2025, the
Company also received a notification letter from the Listing Qualifications Staff of Nasdaq (the &#8220;Staff&#8221;) notifying the
Company that, based on the Current Report on Form 8-K filed by the Company with the SEC on February 18, 2024, the Staff had
determined the Company had regained compliance with the minimum stockholders&#8217; equity requirements set forth in Nasdaq Listing
Rule 5550(b)(1) (the &#8220;Equity Rule&#8221;). However, if the Company fails to evidence compliance with the Equity Rule upon
filing its next periodic report, the Company may be subject to delisting. At that time, Staff will provide written notification to
the Company, which may then appeal Staff&#8217;s determination to a Nasdaq Hearings Panel. The notification letters had no immediate effect on the listing of the Company&#8217;s securities on Nasdaq.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
Nasdaq Listing Rule 5810(c)(2)(G), the Company had until April 17, 2025 to provide Nasdaq with a plan to regain compliance with the Annual
Meeting Rule. </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 9, 2025, the Company held its 2025 Annual Meeting of the Stockholders (the &#8220;Annual Meeting&#8221;) in a virtual format. On
April 23, 2025, the Company received a letter from the Staff of Nasdaq notifying the Company that, based on the fact that the Company
held its Annual Meeting on April 9, 2025, Nasdaq had determined that the Company has regained compliance with the Annual Meeting Rule
and that the matter is now closed.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 113; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Contingent Shares Issuances and Change in Control
</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 26, 2025, the Company issued an aggregate of <span id="xdx_901_eus-gaap--IncrementalCommonSharesAttributableToContingentlyIssuableShares_pid_c20250326__20250326__us-gaap--TypeOfArrangementAxis__custom--ExchangeAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zJ6xP4rbZzpl" title="Number of contingent shares issued"><ix:nonFraction name="us-gaap:IncrementalCommonSharesAttributableToContingentlyIssuableShares" contextRef="From2025-03-262025-03-26_custom_ExchangeAgreementMember_us-gaap_SubsequentEventMember" id="Fact002014" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">4,393,993</ix:nonFraction></span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Contingent
Shares to the NextTrip Sellers in satisfaction of its obligations to issue Contingent Shares upon achievement of three of the four
Milestone Events under the Exchange Agreement. The Contingent Shares were issued after the Company received notice from Nasdaq, on
March 25, 2025, that Nasdaq has approved the Company&#8217;s initial listing application. </span>Following issuance of the
Contingent Shares, the Company had <span id="xdx_905_eus-gaap--CommonStockSharesIssued_iI_pid_c20250326__us-gaap--TypeOfArrangementAxis__custom--ExchangeAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zYxN3Ugjsf6e" title="Common sock, shares issued"><span id="xdx_906_eus-gaap--CommonStockSharesOutstanding_iI_pid_c20250326__us-gaap--TypeOfArrangementAxis__custom--ExchangeAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zHksYJ3TSVG9" title="Common sock, shares outstanding"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2025-03-26_custom_ExchangeAgreementMember_us-gaap_SubsequentEventMember" id="Fact002016" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2025-03-26_custom_ExchangeAgreementMember_us-gaap_SubsequentEventMember" id="Fact002018" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,163,525</ix:nonFraction></ix:nonFraction></span></span> shares of common stock issued and outstanding, <span id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20250326__20250326__us-gaap--TypeOfArrangementAxis__custom--ExchangeAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zK5XDanrfaMi" title="Issuance of shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2025-03-262025-03-26_custom_ExchangeAgreementMember_us-gaap_SubsequentEventMember" id="Fact002020" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">4,550,000</ix:nonFraction></span> of which (or <span id="xdx_902_ecustom--CommonStockIssuedPercentage_iI_pid_dp_uPure_c20250326__us-gaap--TypeOfArrangementAxis__custom--ExchangeAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z2UiBwdezCW2" title="Issued percentage"><ix:nonFraction name="NTRP:CommonStockIssuedPercentage" contextRef="AsOf2025-03-26_custom_ExchangeAgreementMember_us-gaap_SubsequentEventMember" id="Fact002022" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">73.8</ix:nonFraction></span>%) were held
by the NextTrip Sellers. As a result, the NextTrip Sellers collectively had ownership and voting control over the Company as of such
date, resulting in a change in control of the Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">As a result of the issuance of the Contingent Shares and pursuant to the Exchange Agreement, the NextTrip Representative
now has the right to designate a replacement for three directors of the Company.&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">On May 5, 2025, the Company
issued an aggregate of <span id="xdx_909_eus-gaap--IncrementalCommonSharesAttributableToContingentlyIssuableShares_pid_c20250505__20250505__us-gaap--TypeOfArrangementAxis__custom--ExchangeAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zTFe7Qz4Rr15" title="Number of contingent shares issued"><ix:nonFraction name="us-gaap:IncrementalCommonSharesAttributableToContingentlyIssuableShares" contextRef="From2025-05-052025-05-05_custom_ExchangeAgreementMember_us-gaap_SubsequentEventMember" id="Fact002024" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,450,000</ix:nonFraction></span> Contingent Shares to the NextTrip Sellers in satisfaction of its obligation to issue Contingent Shares
upon achievement of the fourth and final Milestone Event under the Exchange Agreement. Immediately following such issuance, all Contingent
Shares issuable pursuant to the Exchange Agreement have been issued, and the Company has no further commitments or obligations to issue
additional shares pursuant to the Exchange Agreement.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Alumni Agreements</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 1, 2025, the Company entered into a securities purchase agreement (the &#8220;Alumni Purchase Agreement&#8221;) with Alumni
for the sale of a short-term promissory note (the &#8220;Alumni Note&#8221;) and warrants (the &#8220;Alumni Warrants&#8221;) to
Alumni for total consideration of $<span id="xdx_90C_eus-gaap--NotesAndLoansPayableCurrent_iI_c20250401__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zCoMNQphumnj" title="Total consideration"><ix:nonFraction name="us-gaap:NotesAndLoansPayableCurrent" contextRef="AsOf2025-04-01_custom_SecuritiesPurchaseAgreementMember_us-gaap_SubsequentEventMember" id="Fact002026" format="ixt:numdotdecimal" decimals="0" unitRef="USD">300,000</ix:nonFraction></span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Alumni Note is in the principal amount of $<span id="xdx_90D_eus-gaap--DebtInstrumentFaceAmount_iI_c20250401__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zJveFiDgW6Fa" title="Principal amount"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2025-04-01_custom_SecuritiesPurchaseAgreementMember_us-gaap_SubsequentEventMember" id="Fact002028" format="ixt:numdotdecimal" decimals="0" unitRef="USD">360,000</ix:nonFraction></span>
with an original issue discount of $<span id="xdx_907_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_c20250401__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zNdmU5aLYUnd" title="Original issue discount"><ix:nonFraction name="us-gaap:DebtInstrumentUnamortizedDiscount" contextRef="AsOf2025-04-01_custom_SecuritiesPurchaseAgreementMember_us-gaap_SubsequentEventMember" id="Fact002030" format="ixt:numdotdecimal" decimals="0" unitRef="USD">60,000</ix:nonFraction></span>
and guaranteed interest on the principal amount of ten percent (<span id="xdx_909_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20250401__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zQ1cbaz7zEQe" title="Interest rate"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="AsOf2025-04-01_custom_SecuritiesPurchaseAgreementMember_us-gaap_SubsequentEventMember" id="Fact002032" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">10</ix:nonFraction></span>%)
per annum, which shall be due and payable on <span id="xdx_909_eus-gaap--DebtInstrumentMaturityDate_dd_c20250401__20250401__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zycytL4IV6rd" title="Maturity date"><ix:nonNumeric contextRef="From2025-04-012025-04-01_custom_SecuritiesPurchaseAgreementMember_us-gaap_SubsequentEventMember" format="ixt:datemonthdayyearen" id="Fact002034" name="us-gaap:DebtInstrumentMaturityDate">July
1, 2025</ix:nonNumeric></span>. In the event of a failure to re-pay the Alumni Note on or before the maturity date, the interest rate will increase
to the lesser of twenty-two percent (<span id="xdx_909_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20250401__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--RangeAxis__srt--MaximumMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zUSE8BnQJTK4" title="Interest rate"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="AsOf2025-04-01_custom_SecuritiesPurchaseAgreementMember_srt_MaximumMember_us-gaap_SubsequentEventMember" id="Fact002036" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">22</ix:nonFraction></span>%)
per annum or the maximum amount permitted under law from the due date thereof until the same is paid.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Alumni Note is convertible into shares of common stock of the Company only upon an event of default.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_eus-gaap--ClassOfWarrantOrRightReasonForIssuingToNonemployees_pid_c20250401__20250401__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zPmjiM1vQwx2" title="Warrant description"><ix:nonNumeric contextRef="From2025-04-012025-04-01_custom_SecuritiesPurchaseAgreementMember_us-gaap_SubsequentEventMember" id="Fact002038" name="us-gaap:ClassOfWarrantOrRightReasonForIssuingToNonemployees">In
conjunction with the issuance of the Alumni Note to Alumni, the Company also issued warrants to purchase <span id="xdx_90C_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20250401__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z6NY4ONNLD6e" title="Warrants outstanding to purchase common stock"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="AsOf2025-04-01_custom_SecuritiesPurchaseAgreementMember_us-gaap_SubsequentEventMember" id="Fact002040" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">80,000</ix:nonFraction></span>
shares of common stock at a price per share of $<span id="xdx_906_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20250401__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zpQswI5Itn5c" title="Shares issued price per share"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2025-04-01_custom_SecuritiesPurchaseAgreementMember_us-gaap_SubsequentEventMember" id="Fact002042" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">4.50</ix:nonFraction></span>,
which represents 100% warrant coverage on the principal amount of the Alumni Note. The Alumni Warrants are exercisable on or prior
to the five (5) year anniversary of the effective date.</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0"><i>Journy.tv Asset Purchase</i></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 1, 2025, the Company entered into an asset purchase agreement (the &#8220;Journy.tv Purchase Agreement&#8221;) with Ovation
LLC (&#8220;Ovation&#8221;), pursuant to which the Company purchased assets, including without limitation trademarks, domains, apps
and certain agreements, and assumed certain liabilities related to Ovation&#8217; Journy.tv business (the &#8220;Journy.tv
Acquisition&#8221;). The Journy.tv Acquisition closed on April 1, 2025.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the Purchase Agreement, as consideration for the Journy.tv Acquisition, the Company paid Ovation $<span id="xdx_900_eus-gaap--PaymentsToAcquireBusinessesGross_c20250401__20250401__us-gaap--TypeOfArrangementAxis__custom--AssetPurchaseAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_znitF9Zvx9f4" title="Payments to acquire businesses"><ix:nonFraction name="us-gaap:PaymentsToAcquireBusinessesGross" contextRef="From2025-04-012025-04-01_custom_AssetPurchaseAgreementMember_us-gaap_SubsequentEventMember" id="Fact002044" format="ixt:numdotdecimal" decimals="0" unitRef="USD">300,000</ix:nonFraction></span> in cash at closing and issued
Ovation <span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20250401__20250401__us-gaap--TypeOfArrangementAxis__custom--AssetPurchaseAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zSAOMC0wxs06" title="Restricted shares, issued"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross" contextRef="From2025-04-012025-04-01_custom_AssetPurchaseAgreementMember_us-gaap_CommonStockMember_us-gaap_SubsequentEventMember" id="Fact002046" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">20,000</ix:nonFraction></span> restricted shares of Company common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the Journy.tv Acquisition, on April 1, 2025, the Company and Ovation also entered into a License Agreement (the &#8220;License
Agreement&#8221;), pursuant to which Ovation granted the Company the non-exclusive right, throughout the territories and for the term
set forth therein, to exhibit, promote, market, advertise, publicize and/or otherwise exploit the programs listed in the License Agreement
in the media of (i) FAST via the Journy.tv Channel and (ii) Video On Demand via the Journy.tv Channel. Pursuant to the License Agreement, Ovation
shall not license any unaffiliated third party the right to exhibit certain of the programs subject to the License Agreement and shall
not use certain of the programs subject to the License Agreement on its owned or operating streaming platforms (subject to certain exceptions).
As consideration for the rights granted under the License Agreement, the Company agreed to pay Ovation an aggregate non-refundable license
fee of $<span id="xdx_904_eus-gaap--PaymentsForFees_c20250401__20250401__us-gaap--TypeOfArrangementAxis__custom--AssetPurchaseAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zpFgbhkGnCEh" title="License fee"><ix:nonFraction name="us-gaap:PaymentsForFees" contextRef="From2025-04-012025-04-01_custom_AssetPurchaseAgreementMember_us-gaap_SubsequentEventMember" id="Fact002048" format="ixt:numdotdecimal" decimals="0" unitRef="USD">336,801</ix:nonFraction></span> over thirty months.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>FSA Travel Final Closing and Milestone Payments</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 9, 2025 (the &#8220;Final Closing Date&#8221;), upon FSA&#8217;s agreement to waive the capital raise condition to closing,
the Company exercised its option to acquire the remaining <span id="xdx_90A_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20250409__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--FSATravelLLCMember__us-gaap--TypeOfArrangementAxis__custom--PurchaseAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zMUctIfatDld" title="Ownership percentage"><ix:nonFraction name="us-gaap:EquityMethodInvestmentOwnershipPercentage" contextRef="AsOf2025-04-09_custom_FSATravelLLCMember_custom_PurchaseAgreementMember_us-gaap_SubsequentEventMember" id="Fact002050" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">51</ix:nonFraction></span>%
of FSA outstanding membership units, in satisfaction of its obligations under the FSA Purchase Agreement. In connection with the
Final Closing, the Company paid the the members of FSA (the &#8220;FSA Members&#8221;) an aggregate of $<span id="xdx_902_eus-gaap--PaymentsToAcquireBusinessesGross_c20250409__20250409__dei--LegalEntityAxis__custom--FSATravelLLCMember__us-gaap--TypeOfArrangementAxis__custom--PurchaseAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zZ4QHlZsyZ96" title="Payments to acquire businesses"><ix:nonFraction name="us-gaap:PaymentsToAcquireBusinessesGross" contextRef="From2025-04-092025-04-09_custom_FSATravelLLCMember_custom_PurchaseAgreementMember_us-gaap_SubsequentEventMember" id="Fact002052" format="ixt:numdotdecimal" decimals="0" unitRef="USD">500,000</ix:nonFraction></span>
in cash and issued the FSA Members an aggregate of <span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20250409__20250409__dei--LegalEntityAxis__custom--FSATravelLLCMember__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember__us-gaap--StatementClassOfStockAxis__custom--SeriesOPreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--PurchaseAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zYC2BlGq4Snj" title="Shares issued"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2025-04-092025-04-09_custom_FSATravelLLCMember_us-gaap_PreferredStockMember_custom_SeriesOPreferredStockMember_custom_PurchaseAgreementMember_us-gaap_SubsequentEventMember" id="Fact002054" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">161,291</ix:nonFraction></span>
shares of Series O Preferred. As a result, as of the Final Closing Date, FSA became a wholly owned subsidiary of the
Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 28, 2025, upon achievement of each of the business milestones pursuant to the FSA Purchase Agreement, the Company made each of
the Milestone Payments to the FSA Members, including payment of $<span id="xdx_900_eus-gaap--PaymentsToAcquireBusinessesGross_c20250428__20250428__dei--LegalEntityAxis__custom--FSATravelLLCMember__us-gaap--TypeOfArrangementAxis__custom--PurchaseAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z4CF8Se9GgIj" title="Payments to acquire businesses"><ix:nonFraction name="us-gaap:PaymentsToAcquireBusinessesGross" contextRef="From2025-04-282025-04-28_custom_FSATravelLLCMember_custom_PurchaseAgreementMember_us-gaap_SubsequentEventMember" id="Fact002056" format="ixt:numdotdecimal" decimals="0" unitRef="USD">400,000</ix:nonFraction></span>
in cash and the issuance of an aggregate of <span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20250428__20250428__dei--LegalEntityAxis__custom--FSATravelLLCMember__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember__us-gaap--StatementClassOfStockAxis__custom--SeriesOPreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--PurchaseAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z0RrCw0Y065c" title="Shares issued"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2025-04-282025-04-28_custom_FSATravelLLCMember_us-gaap_PreferredStockMember_custom_SeriesOPreferredStockMember_custom_PurchaseAgreementMember_us-gaap_SubsequentEventMember" id="Fact002058" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">129,032</ix:nonFraction></span>
shares of Series O Preferred (the number of shares provided for above, less <span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20250428__20250428__dei--LegalEntityAxis__custom--FSATravelLLCMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--TypeOfArrangementAxis__custom--PurchaseAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z5zYKtv2Huid" title="Shares issued"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2025-04-282025-04-28_custom_FSATravelLLCMember_us-gaap_CommonStockMember_custom_PurchaseAgreementMember_us-gaap_SubsequentEventMember" id="Fact002060" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">8,065</ix:nonFraction></span>
shares of common stock previously issued to FSA by the Company as a deposit.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Related Party Notes</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On April 9, 2025, NTH and the Donald P. Monaco Insurance
Trust (the &#8220;Trust&#8221;) entered into two promissory notes (together, the &#8220;Trust Notes&#8221;) under the Company&#8217;s
$<span id="xdx_902_eus-gaap--LineOfCredit_iI_pn5n6_c20250409__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zmKe78yprE4d" title="Line of credit"><ix:nonFraction name="us-gaap:LineOfCredit" contextRef="AsOf2025-04-09_us-gaap_SubsequentEventMember" id="Fact002062" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">2.0</ix:nonFraction></span> million line of credit. Donald Monaco, chairman of the Company&#8217;s Board of Directors, is the trustee of the Trust. The first
note had a principal balance of $<span id="xdx_900_eus-gaap--DebtInstrumentFaceAmount_iI_c20250409__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--DebtInstrumentAxis__custom--NoteOneMember_zjQvZgFBKAC1" title="Principal amount"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2025-04-09_us-gaap_SubsequentEventMember_custom_NoteOneMember" id="Fact002064" format="ixt:numdotdecimal" decimals="0" unitRef="USD">500,000</ix:nonFraction></span> and was issued in exchange for a new cash payment provided my Mr. Monaco. The second note had
a principal balance of $<span id="xdx_90F_eus-gaap--DebtInstrumentFaceAmount_iI_c20250409__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--DebtInstrumentAxis__custom--NoteTwoMember_zkVBY5TC4mIl" title="Principal amount"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2025-04-09_us-gaap_SubsequentEventMember_custom_NoteTwoMember" id="Fact002066" format="ixt:numdotdecimal" decimals="0" unitRef="USD">145,000</ix:nonFraction></span> and was issued in exchange for cash advances previously made by Mr. Monaco to the Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 6, 2025, the Company entered into a Line of Credit Agreement (the &#8220;MIP Line of Credit&#8221;) with Monaco Investment
Partners II, LP (&#8220;MIP&#8221;) providing the Company with a $<span id="xdx_90E_eus-gaap--LineOfCredit_iI_c20250506__us-gaap--TypeOfArrangementAxis__custom--LineOfCreditAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zqdYGYbfhWjc" title="Line of credit"><ix:nonFraction name="us-gaap:LineOfCredit" contextRef="AsOf2025-05-06_custom_LineOfCreditAgreementMember_us-gaap_SubsequentEventMember" id="Fact002068" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,000,000</ix:nonFraction></span>
revolving line of credit. The MIP Line of Credit allows the Company to request advances thereunder from time to time until <span id="xdx_902_eus-gaap--LineOfCreditFacilityExpirationDate1_dd_c20250506__20250506__us-gaap--TypeOfArrangementAxis__custom--LineOfCreditAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zSQVIbLr1hG7" title="Line of credit maturity date"><ix:nonNumeric contextRef="From2025-05-062025-05-06_custom_LineOfCreditAgreementMember_us-gaap_SubsequentEventMember" format="ixt:datemonthdayyearen" id="Fact002070" name="us-gaap:LineOfCreditFacilityExpirationDate1">May
31, 2027</ix:nonNumeric></span>, the maturity date. Advances made under the MIP Line of Credit bear simple interest at a rate of <span id="xdx_908_eus-gaap--LineOfCreditFacilityInterestRateDuringPeriod_pid_dp_c20250506__20250506__us-gaap--TypeOfArrangementAxis__custom--LineOfCreditAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zxLWn1ou9Tq4" title="Line of credit, interest rate"><ix:nonFraction name="us-gaap:LineOfCreditFacilityInterestRateDuringPeriod" contextRef="From2025-05-062025-05-06_custom_LineOfCreditAgreementMember_us-gaap_SubsequentEventMember" id="Fact002072" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">12</ix:nonFraction></span>%
per annum, calculated from the date of each respective advance. Accrued interest shall be payable on a monthly basis, no later than
the 10th day of the subsequent month. The full outstanding principal balance, together with any accrued and unpaid interest, shall
be due and payable in full by the Company on the maturity date. The Company may, at its option, prepay any borrowings under the MIP
Line of Credit, in whole or in part, at any time prior to the maturity date, without penalty. Mr. Monaco controls MIP</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_eus-gaap--LineOfCreditFacilityDescription_c20250506__20250506__us-gaap--TypeOfArrangementAxis__custom--LineOfCreditAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zljfoUUl9AV6" title="Line of credit advance description"><ix:nonNumeric contextRef="From2025-05-062025-05-06_custom_LineOfCreditAgreementMember_us-gaap_SubsequentEventMember" id="Fact002074" name="us-gaap:LineOfCreditFacilityDescription">The
Company received an initial advance of $<span id="xdx_909_eus-gaap--ProceedsFromLinesOfCredit_dd_c20250506__20250506__us-gaap--TypeOfArrangementAxis__custom--LineOfCreditAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z7Y2FX0x9hr7" title="Initial advance of line of credit"><ix:nonFraction name="us-gaap:ProceedsFromLinesOfCredit" contextRef="From2025-05-062025-05-06_custom_LineOfCreditAgreementMember_us-gaap_SubsequentEventMember" id="Fact002076" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,045,000</ix:nonFraction></span>
under the MIP Line of Credit, which was used to repay (i) a $<span id="xdx_901_ecustom--CashAdvance_c20250506__20250506__us-gaap--TypeOfArrangementAxis__custom--LineOfCreditAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zw6gUi5lPRF7" title="Cash advance"><ix:nonFraction name="NTRP:CashAdvance" contextRef="From2025-05-062025-05-06_custom_LineOfCreditAgreementMember_us-gaap_SubsequentEventMember" id="Fact002078" format="ixt:numdotdecimal" decimals="0" unitRef="USD">400,000</ix:nonFraction></span>
cash advance previously made by the Trust to the Company (ii) and all outstanding
indebtedness under the terms of the Trust Notes, totaling $<span id="xdx_907_eus-gaap--DebtInstrumentCarryingAmount_iI_c20250409__us-gaap--TypeOfArrangementAxis__custom--LineOfCreditAgreementMember__us-gaap--DebtInstrumentAxis__custom--TwoPromissoryNotesMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z5Wg2rLyMCjc" title="Cash advance"><ix:nonFraction name="us-gaap:DebtInstrumentCarryingAmount" contextRef="AsOf2025-04-09_custom_LineOfCreditAgreementMember_custom_TwoPromissoryNotesMember_us-gaap_SubsequentEventMember" id="Fact002080" format="ixt:numdotdecimal" decimals="0" unitRef="USD">645,000</ix:nonFraction></span>.
Additional advances through May 28, 2025 totaled $<span id="xdx_90B_eus-gaap--LineOfCreditFacilityIncreaseDecreaseForPeriodNet_c20250506__20250506__us-gaap--TypeOfArrangementAxis__custom--LineOfCreditAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zw4plTy3cax" title="Aditional advances"><ix:nonFraction name="us-gaap:LineOfCreditFacilityIncreaseDecreaseForPeriodNet" contextRef="From2025-05-062025-05-06_custom_LineOfCreditAgreementMember_us-gaap_SubsequentEventMember" id="Fact002082" format="ixt:numdotdecimal" decimals="0" unitRef="USD">441,575</ix:nonFraction></span>,
bringing the total amount advanced under the line to $<span id="xdx_903_eus-gaap--LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod_dd_c20250506__20250506__us-gaap--TypeOfArrangementAxis__custom--LineOfCreditAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zHx7o3dgDMZf" title="Total advances of line of credit"><ix:nonFraction name="us-gaap:LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod" contextRef="From2025-05-062025-05-06_custom_LineOfCreditAgreementMember_us-gaap_SubsequentEventMember" id="Fact002084" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,486,575</ix:nonFraction></span>.</ix:nonNumeric></span></span></p>

</ix:nonNumeric><p id="xdx_81B_zvjB4zB5dRId" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>


<!-- Field: Page; Sequence: 114; Options: Last -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- 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
     gVGIf3gW7z/ii+jNsojYLIMYQ+D/+onzCA== -->
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.11
<SEQUENCE>2
<FILENAME>ex4-11.htm
<DESCRIPTION>EX-4.11
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Exhibit
4.11</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NEITHER
THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION
OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED
(THE &ldquo;SECURITIES ACT&rdquo;), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT
UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS
OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE
OF THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WARRANT</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 70%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrant
    Shares: 100,000</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 30%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issuance
    Date: November 1, 2024</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THIS
WARRANT (the &ldquo;<U>Warrant</U>&rdquo;) certifies that, for value received, Marc Bern or his assigns (the &ldquo;<U>Holder</U>&rdquo;)
is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after
the 1<SUP>st</SUP> of November, 2024 (the &ldquo;<U>Initial Issuance Date</U>&rdquo;) and on or prior to the close of business on the
three (3) year anniversary of the Initial Exercise Date (the &ldquo;<U>Termination Date</U>&rdquo;) but not thereafter, to subscribe
for and purchase from NextTrip, Inc., a Nevada corporation (the &ldquo;<U>Company</U>&rdquo;), up to 100,000 shares of the Company&rsquo;s
Common Stock (&ldquo;<U>Warrant Shares</U>&rdquo;). The purchase price of one Warrant Share under this Warrant shall be equal to the
Exercise Price, as defined in <U>Section 2(b)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
1. <U>Definitions</U>. Capitalized terms used are defined herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
purposes of this Warrant, the following terms shall have the following meanings:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Affiliate</U>&rdquo;
means, as applied to any Person, any other Person directly or indirectly </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">controlling,
controlled by, or under common control with, that Person. For the purposes of this definition, &ldquo;control&rdquo; (including, with
correlative meanings, the terms &ldquo;controlling,&rdquo; &ldquo;controlled by&rdquo; and &ldquo;under common control with&rdquo;),
as applied to any Person, means possession, directly or indirectly, of the power to direct or cause the direction of the management or
policies of a Person, whether through the ability to exercise voting power, by contract or otherwise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Approved
Stock Plan</U>&rdquo; means any employee benefit plan or agreement which has been approved by the board of directors of the Company prior
to or subsequent to the date hereof pursuant to which shares of Common Stock and Options may be issued to any employee, officer, consultant,
or director for services provided to the Company in their capacity as such.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Business
Day</U>&rdquo; means any day except any Saturday, any Sunday, any day which is a federal legal holiday in the United States, or any day
on which banking institutions in the State of New York are authorized or required by law or other governmental action to close.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1; Options: NewSection -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Common
Stock</U>&rdquo; means the Common Stock of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Convertible
Securities</U>&rdquo; means any stock or other security (other than Options) that is at any time and under any circumstances, directly
or indirectly, convertible into, exercisable or exchangeable for, or which otherwise entitles the holder thereof to acquire, any shares
of Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Excluded
Securities</U>&rdquo; means the issuance of (a) shares of Common Stock or options to employees, officers or directors of the Company
pursuant to any stock or option plan duly adopted for such purpose by a majority of the non-employee members of the Board of Directors
or a majority of the members of a committee of non-employee directors established for such purpose, (b) securities upon the exercise
or exchange of or conversion of any shares issued hereunder and/or other securities exercisable or exchangeable for or convertible into
shares of Common Stock issued and outstanding on the date of this Agreement, provided that such securities have not been amended since
the date of this Agreement to increase the number of such securities or to decrease the exercise price, exchange price or conversion
price of such securities or to extend the term of such securities, (c) securities issued in connection with the Company&rsquo;s pending
Registration Statement on Form S-1 (File No. 333-278562); and (d) securities issued pursuant to acquisitions or strategic transactions
approved by a majority of the disinterested directors of the Company, provided that such securities are issued as &ldquo;restricted securities&rdquo;
(as defined in Rule 144) and carry no registration rights that require or permit the filing of any registration statement in connection
therewith, and provided that any such issuance shall only be to a Person (or to the equity holders of a Person) which is, itself or through
its subsidiaries, an operating company or an owner of an asset in a business synergistic with the business of the Company and shall provide
to the Company additional benefits in addition to the investment of funds, but shall not include a transaction in which the Company is
issuing securities primarily for the purpose of raising capital or to an entity whose primary business is investing in securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Market
Price</U>&rdquo; means as applicable: (i) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise
if such Notice of Exercise is (1) both executed and delivered pursuant to Section 2(a) hereof on a day that is not a Trading Day or (2)
both executed and delivered pursuant to Section 2(a) hereof on a Trading Day prior to the opening of &ldquo;regular trading hours&rdquo;
(as defined in Rule 600(b) of Regulation NMS promulgated under the federal securities laws) on such Trading Day, (ii) at the option of
the Holder, either (y) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise or (z) the Bid
Price of the Common Stock on the principal Trading Market as reported by Bloomberg L.P. (&ldquo;Bloomberg&rdquo;) as of the time of the
Holder&rsquo;s execution of the applicable Notice of Exercise if such Notice of Exercise is executed during &ldquo;regular trading hours&rdquo;
on a Trading Day and is delivered within two (2) hours thereafter (including until two (2) hours after the close of &ldquo;regular trading
hours&rdquo; on a Trading Day) pursuant to Section 2(a) hereof or (iii) the VWAP on the date of the applicable Notice of Exercise if
the date of such Notice of Exercise is a Trading Day and such Notice of Exercise is both executed and delivered pursuant to Section 2(a)
hereof after the close of &ldquo;regular trading hours&rdquo; on such Trading Day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Options</U>&rdquo;
means any rights, warrants, or options to subscribe for, purchase, or otherwise acquire shares of Common Stock or Convertible Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Stockholder
Approval</U>&rdquo; means the approval required by the applicable rules and regulations of the NASDAQ Capital Market (or any successor
entity) from the stockholders of the Company of the provisions of <U>Section 3(b)</U> of this Warrant in order for such provisions to
become effective by their terms and to be in compliance with such applicable rules and regulations of the NASDAQ Capital Market (or any
successor entity).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Trading
Day</U>&rdquo; means a day on which the shares of Common Stock are traded on the Trading Market; provided, however, that in the event
that the shares of Common Stock are not listed or quoted on the Trading Market, then Trading Day shall mean any day except Saturday,
Sunday and any day which shall be a legal holiday or a day on which banking institutions in the State of New York or State of Delaware
are authorized or required by law or other government action to close.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Trading
Market</U>&rdquo; means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date
in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, the New York Stock
Exchange, or the OTC Markets QB Tier (or any successors to any of the foregoing).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
2. <U>Exercise</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>Exercise of Warrants</U>. Exercise of the purchase rights for Warrant Shares represented by this Warrant may be made, in whole or
in part, at any time or times on or after the Initial Issuance Date and on or before the Termination Date by delivery to the Company
(or such other office or agency of the Company as it may designate by notice in writing to the registered Holder at the address of the
Holder appearing on the books of the Company) of a duly executed Notice of Exercise in the form annexed hereto as Exhibit A (which may
be delivered in a .PDF format via electronic mail pursuant to the notice provisions set forth in the Purchase Agreement). Within two
(2) Trading Days of the date said Notice of Exercise is delivered to the Company (or within three (3) Trading Days of the date said Notice
of Exercise is delivered to the Company if the Notice of Exercise is received after 12 p.m. EST on such day), the Company shall have
received payment of the aggregate Exercise Price of the Warrant Shares thereby purchased by wire transfer or cashier&rsquo;s check drawn
on a United States bank, unless such exercise is made pursuant to the cashless exercise procedure specified in <U>Section 2(c)</U> below
(if available). No ink-original Notice of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee or
notarization) of any Notice of Exercise form be required. The Company shall be entitled to conclusively assume the genuineness of any
signature on any Notice of Exercise delivered to the Company pursuant to this <U>Section 2(a)</U>, the legal capacity and competency
of all natural persons signing any Notice of Exercise so delivered, the authenticity of any Notice of Exercise so delivered, the conformity
to an authentic original of any Notice of Exercise so delivered as certified, authenticated, conformed, photostatic, facsimile, or electronic
and the authenticity of the original of such Notice of Exercise. Notwithstanding anything herein to the contrary, the Holder shall not
be required to physically surrender this Warrant to the Company until the Holder has purchased all of the Warrant Shares available hereunder
and the Warrant has been exercised in full, in which case, the Holder shall surrender this Warrant to the Company for cancellation within
three (3) Trading Days of the date the final Notice of Exercise is delivered to the Company. Partial exercises of this Warrant resulting
in purchases of a portion of the total number of Warrant Shares available hereunder shall have the effect of lowering the outstanding
number of Warrant Shares purchasable hereunder in an amount equal to the applicable number of Warrant Shares purchased. The Holder and
the Company shall maintain records showing the number of Warrant Shares purchased and the date of such purchases, and the Company shall
be entitled to conclusively assume that its records of the number of Warrant Shares purchased and the date of such purchases are accurate,
absent actual notice to the contrary. The Company shall deliver any objection to any Notice of Exercise within two (2) Business Days
of receipt of such notice. The Holder and any assignee, by acceptance of this Warrant, acknowledge and agree that, by reason of the provisions
of this paragraph, following the purchase of a portion of the Warrant Shares hereunder, the number of Warrant Shares available for purchase
hereunder at any given time may be less than the amount stated on the face hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>Exercise Price</U>. The exercise price per Warrant Share shall be $3.25, subject to adjustment hereunder (the &ldquo;<U>Exercise Price</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>





<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 76.9pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 76.9pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Cashless Exercise</U>. If at any time ninety (90) days after the date of the Initial Issuance Date, there is no effective Registration
Statement registering, or no current prospectus available for, the resale of the Warrant Shares by the Holder, then this Warrant may
also be exercised, in whole or in part, at such time by means of a &ldquo;cashless exercise&rdquo; in which the Holder shall be entitled
to receive a number of Warrant Shares equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.35in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(A)
    =</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    Market Price (at the date of such calculation)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(B)
    =</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    Exercise Price of this Warrant, as adjusted hereunder; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(X)
    =</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    number of Warrant Shares that would be issuable upon exercise of this Warrant in accordance with the terms of this Warrant if such
    exercise were by means of a cash exercise rather than a cashless exercise.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 77pt; text-align: justify; text-indent: -31.0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assuming
(i) the Holder is not an Affiliate of the Company, and (ii) all of the applicable conditions of Rule 144 promulgated under the Securities
Act of 1933, as amended (the &ldquo;<U>Securities Act</U>&rdquo;) with respect to Holder and the Warrant Shares are met in the case of
such a cashless exercise, the Company agrees that the Company will use its best efforts to cause the removal of the legend from such
Warrant Shares (including by delivering an opinion of the Company&rsquo;s counsel to the Company&rsquo;s transfer agent at its own expense
to ensure the foregoing), and the Company agrees that the Holder is under no obligation to sell the Warrant Shares issuable upon the
exercise of the Warrant prior to removing the legend. The Company expressly acknowledges that Rule 144(d)(3)(ii), as currently in effect,
provides that Warrant Shares issued solely upon a cashless exercise shall be deemed to have been acquired at the same time as the Warrant.
The Company agrees not to take any position contrary to this <U>Section 2(c)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)
<U>Mechanics of Exercise</U>.</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 76.90pt; text-align: justify; text-indent: -31.60pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.
<U>Delivery of Warrant Shares Upon Exercise</U>. The Company shall cause the Warrant Shares purchased hereunder to be transmitted by
the Company&rsquo;s transfer agent (the &ldquo;<U>Transfer Agent</U>&rdquo;) to the Holder by crediting the account of the Holder&rsquo;s
or its designee&rsquo;s balance account with The Depository Trust Company through its Deposit or Withdrawal at Custodian system (&ldquo;<U>DWAC</U>&rdquo;)
if the Company is then a participant in such system and either (A) there is an effective registration statement permitting the issuance
of the Warrant Shares to or resale of the Warrant Shares by the Holder or (B) the Warrant Shares are eligible for resale by the Holder
pursuant to Rule 144, and otherwise by physical delivery of a certificate, registered in the Company&rsquo;s share register in the name
of the Holder or its designee, for the number of Warrant Shares to which the Holder is entitled pursuant to such exercise to the address
specified by the Holder in the Notice of Exercise by the date that is one (1) Trading Day after the later of (A) the delivery to the
Company of the Notice of Exercise provided that such Notice of Exercise is received by 12 p.m. EST and two (2) Trading Days for any Notice
of Exercise received after 12 p.m. EST, and (B) the Company&rsquo;s receipt of payment of the aggregate Exercise Price of the Warrant
Shares thereby purchased by wire transfer or cashier&rsquo;s check drawn on a United States bank, unless such exercise is made pursuant
to the cashless exercise procedure specified in <U>Section 2(c)</U> (such date, the &ldquo;<U>Warrant Share Delivery Date</U>&rdquo;).
The Warrant Shares shall be deemed to have been issued, and Holder or any other person so designated to be named therein shall be deemed
to have become a holder of record of such shares for all purposes, as of the date the Warrant has been exercised, with payment to the
Company of the Exercise Price (or by cashless exercise, if permitted) and all taxes required to be paid by the Holder, if any, pursuant
to <U>Section 2(d)(vi)</U> prior to the issuance of such Warrant Shares, having been paid. If the Company fails for any reason to deliver
to the Holder the Warrant Shares subject to a Notice of Exercise by the Warrant Share Delivery Date, the Company shall pay to the Holder,
in cash, as liquidated damages and not as a penalty, for each $1,000 of Warrant Shares subject to such exercise (based on the VWAP of
the Common Stock on the date of the applicable Notice of Exercise), $5 per Trading Day (increasing to $10 per Trading Day on the fifth
Trading Day after such liquidated damages begin to accrue) for each Trading Day after such Warrant Share Delivery Date until such Warrant
Shares are delivered or Holder rescinds such exercise. The Company agrees to maintain a transfer agent that is a participant in the FAST
program so long as this Warrant remains outstanding and exercisable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.
<U>Delivery of New Warrants Upon Exercise</U>. If this Warrant shall have been exercised in part, the Company shall, at the request of
a Holder and upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant
evidencing the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in
all other respects be identical with this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iii.
<U>Rescission Rights</U>. If the Holder fails to make payment of the aggregate Exercise Price of the Warrant Shares pursuant to a Notice
of Exercise within two (2) Trading Days of the date said Notice of Exercise is delivered to the Company (or within three (3) Trading
Days of the date said Notice of Exercise is delivered to the Company if the Notice of Exercise is received after 12 p.m. EST on such
day) by wire transfer or cashier&rsquo;s check drawn on a United States bank, then the Company will have the right to rescind such exercise,
unless such exercise is made pursuant to the cashless exercise procedure specified in <U>Section 2(c)</U>. If the Company fails to cause
the Transfer Agent to transmit to the Holder the Warrant Shares pursuant to <U>Section 2(d)(i)</U> by the Warrant Share Delivery Date,
then the Holder will have the right to rescind such exercise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iv.
<U>Compensation for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise</U>. In addition to any other rights available to
the Holder, if the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance with the provisions
of <U>Section 2(d)(i)</U> above pursuant to an exercise on or before the Warrant Share Delivery Date, and if after such date the Holder
is required by its broker to purchase (in an open market transaction or otherwise) or the Holder&rsquo;s brokerage firm otherwise purchases,
shares of Common Stock to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving
upon such exercise (a &ldquo;<U>Buy-In</U>&rdquo;), then the Company shall (A) pay in cash to the Holder the amount, if any, by which
(x) the Holder&rsquo;s total purchase price (including brokerage commissions, if any) for the shares of Common Stock so purchased exceeds
(y) the amount obtained by multiplying (1) the number of Warrant Shares that the Company was required to deliver to the Holder in connection
with the exercise at issue times (2) the price at which the sell order giving rise to such purchase obligation was executed, and (B)
at the option of the Holder, either reinstate the portion of the Warrant Shares for which such exercise was not honored (in which case
such exercise shall be deemed rescinded) or deliver to the Holder the number of shares of Common Stock that would have been issued had
the Company timely complied with its exercise and delivery obligations hereunder. For example, if the Holder purchases Common Stock having
a total purchase price of $11,000 to cover a Buy-In with respect to an attempted exercise of shares of Common Stock with an aggregate
sale price giving rise to such purchase obligation of $10,000, under clause (A) of the immediately preceding sentence the Company shall
be required to pay the Holder $1,000. The Holder shall provide the Company written notice indicating the amounts payable to the Holder
in respect of the Buy-In and, upon request of the Company, evidence of the amount of such loss. Nothing herein shall limit a Holder&rsquo;s
right to pursue any other remedies available to it hereunder, at law or in equity including, without limitation, a decree of specific
performance and/or injunctive relief with respect to the Company&rsquo;s failure to timely deliver shares of Common Stock upon exercise
of the Warrant as required pursuant to the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">v.
<U>No Fractional Shares or Scrip</U>. No fractional shares or scrip representing fractional shares shall be issued upon the exercise
of this Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company
shall, at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied
by the Exercise Price or round up to the next whole share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">vi.
<U>Charges, Taxes, and Expenses</U>. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer
tax or other incidental expense in respect of the issuance of Warrant Shares, all of which taxes and expenses shall be paid by the Company,
and such Warrant Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder; provided,
however, that in the event that Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when surrendered
for exercise shall be accompanied by the Assignment Form attached hereto duly executed by the Holder and the Company may require, as
a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto. The Company shall pay all
fees charged by the Transfer Agent, including any fees assessed to the Transfer Agent by Depository Trust Company (or another established
clearing corporation performing similar functions) required for same-day processing of any Notice of Exercise and for same-day electronic
delivery of the Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">vii.
<U>Closing of Books</U>. The Company will not close its stockholder books or records in any manner which prevents the timely exercise
of this Warrant, pursuant to the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)
<U>Holder&rsquo;s Exercise Limitations</U>. To the extent the exercise of any portion of this Warrant requires the Company to receive
the approval of the Company&rsquo;s stockholders pursuant to NASDAQ Capital Market Listing Rules, the Company shall not effect such exercise
of this Warrant, and a Holder shall not have the right to exercise any such portion of this Warrant, pursuant to <U>Section 2</U> or
otherwise, until such approval has been received by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
3. <U>Certain Adjustments</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>Stock Dividends and Splits</U>. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise
makes a distribution or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable in shares
of Common Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon exercise of this
Warrant), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way of reverse
stock split) outstanding shares of Common Stock into a smaller number of shares or (iv) issues by reclassification of shares of the Common
Stock any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which the
numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before such event
and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event, and the number of
Warrant Shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this
Warrant shall remain unchanged. Any adjustment made pursuant to this Section 3(a) shall become effective immediately after the record
date for the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after
the effective date in the case of a subdivision, combination or re-classification.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>Notice</U>. The Company shall notify the Holder, in writing, no later than the Trading Day following the issuance or deemed issuance
of any Common Stock or Common Stock Equivalents subject to <U>Section 3(a)</U>, indicating therein the applicable issuance price, or
applicable reset price, exchange price, conversion price and other pricing terms (such notice, the &ldquo;<U>Dilutive Issuance Notice</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Fundamental Transaction</U>. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or
more related transactions effects any merger or consolidation of the Company with or into another Person, (ii) the Company, directly
or indirectly, effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially all of
its assets in one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange offer
(whether by the Company or another Person) is completed pursuant to which holders of Common Stock are permitted to sell, tender or exchange
their shares for other securities, cash or property and has been accepted by the holders of more than 50% of the outstanding Common Stock
or more than 50% of the voting power of the common equity of the Company, (iv) the Company, directly or indirectly, in one or more related
transactions effects any reclassification, reorganization, or recapitalization of the Common Stock or any compulsory share exchange pursuant
to which the Common Stock is effectively converted into or exchanged for other securities, cash or property, or (v) the Company, directly
or indirectly, in one or more related transactions consummates a stock or share purchase agreement or other business combination (including,
without limitation, a reorganization, recapitalization, spin-off, merger or scheme of arrangement) with another Person or group of Persons
whereby such other Person or group acquires more than 50% of the outstanding shares of Common Stock or more than 50% of the voting power
of the common equity of the Company (not including any shares of Common Stock held by the other Person or other Persons making or party
to, or associated or affiliated with the other Persons making or party to, such stock or share purchase agreement or other business combination)
(each a &ldquo;<U>Fundamental Transaction</U>&rdquo;), then, the Company shall cause any successor entity in a Fundamental Transaction
in which the Company is not the survivor (the &ldquo;<U>Successor Entity</U>&rdquo;) to assume in writing all of the obligations of the
Company under this Warrant and the other Transaction Documents in accordance with the provisions of this <U>Section 3(e)</U> pursuant
to written agreements in form and substance reasonably satisfactory to the Holder and approved by the Holder (without unreasonable delay)
prior to such Fundamental Transaction and shall, at the option of the Holder, deliver to the Holder in exchange for this Warrant a security
of the Successor Entity evidenced by a written instrument substantially similar in form and substance to this Warrant which is exercisable
for a corresponding number of shares of capital stock of such Successor Entity (or its parent entity) equivalent to the shares of Common
Stock acquirable and receivable upon exercise of this Warrant (without regard to any limitations on the exercise of this Warrant) prior
to such Fundamental Transaction, and with an exercise price which applies the exercise price hereunder to such shares of capital stock
(but taking into account the relative value of the shares of Common Stock pursuant to such Fundamental Transaction and the value of such
shares of capital stock, such number of shares of capital stock and such exercise price being for the purpose of protecting the economic
value of this Warrant immediately prior to the consummation of such Fundamental Transaction), and which is reasonably satisfactory in
form and substance to the Holder. Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall succeed to, and
be substituted for (so that from and after the date of such Fundamental Transaction, the provisions of this Warrant and the other Transaction
Documents referring to the &ldquo;Company&rdquo; shall refer instead to the Successor Entity), and may exercise every right and power
of the Company and shall assume all of the obligations of the Company under this Warrant and the other Transaction Documents with the
same effect as if such Successor Entity had been named as the Company herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)
<U>Calculations</U>. All calculations under this <U>Section 3</U> shall be made to the nearest cent or the nearest 1/100th of a share,
as the case may be. For purposes of this <U>Section 3</U>, the number of shares of Common Stock deemed to be issued and outstanding as
of a given date shall be the sum of the number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)
<U>Notice to Holder</U>.</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 76.90pt; text-align: justify; text-indent: -31.60pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.
<U>Adjustment to Exercise Price</U>. Whenever the Exercise Price is adjusted pursuant to any provision of this <U>Section 3</U>, the
Company shall promptly mail or deliver via electronic mail to the Holder a notice setting forth the Exercise Price after such adjustment
and any resulting adjustment to the number of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.
<U>Notice to Allow Exercise by Holder</U>. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on
the Common Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C) the
Company shall authorize the granting to all holders of the Common Stock rights or warrants to subscribe for or purchase any shares of
capital stock of any class or of any rights, (D) the approval of any stockholders of the Company shall be required in connection with
any reclassification of the Common Stock, any consolidation or merger to which the Company is a party, any sale or transfer of all or
substantially all of the assets of the Company, or any compulsory share exchange whereby the Common Stock is converted into other securities,
cash or property, or </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">(E) the Company shall authorize the voluntary or
involuntary dissolution, liquidation or winding up of the affairs of the Company, then, in each case, the Company shall cause to be mailed
to the Holder at its last address as it shall appear upon the Warrant Register of the Company, at least 20 calendar days prior to the
applicable record or effective date hereinafter specified, a notice stating (x) the date on which a record is to be taken for the purpose
of such dividend, distribution, redemption, rights, or warrants, or if a record is not to be taken, the date as of which the holders
of the Common Stock of record to be entitled to such dividend, distributions, redemption, rights or warrants are to be determined or
(y) the date on which such reclassification, consolidation, merger, sale, transfer or share exchange is expected to become effective
or close, and the date as of which it is expected that holders of the Common Stock of record shall be entitled to exchange their shares
of the Common Stock for securities, cash or other property deliverable upon such reclassification, consolidation, merger, sale, transfer
or share exchange; provided that the failure to mail such notice or any defect therein or in the mailing thereof shall not affect the
validity of the corporate action required to be specified in such notice. To the extent that any notice provided in this Warrant constitutes,
or contains, material, non-public information regarding the Company, the Company shall simultaneously file such notice with the Commission
pursuant to a Current Report on Form 8-K. The Holder shall remain entitled to exercise this Warrant during the period commencing on the
date of such notice to the effective date of the event triggering such notice except as may otherwise be expressly set forth herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
4. <U>Transfer of Warrant</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>Transferability</U>. Subject to compliance with any applicable securities laws and the conditions set forth in <U>Section 4(d)</U>
hereof, this Warrant and all rights hereunder (including, without limitation, any registration rights) are transferable, in whole or
in part, upon surrender of this Warrant at the principal office of the Company or its designated agent, together with a written assignment
of this Warrant substantially in the form attached hereto duly executed by the Holder or its agent or attorney and funds sufficient to
pay any transfer taxes payable upon the making of such transfer. Upon such surrender and, if required, such payment, the Company shall
execute and deliver a new Warrant or Warrants in the name of the assignee or assignees, as applicable, and in the denomination or denominations
specified in such instrument of assignment and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not so
assigned, and this Warrant shall promptly be cancelled. Notwithstanding anything herein to the contrary, the Holder shall not be required
to physically surrender this Warrant to the Company unless the Holder has assigned this Warrant in full, in which case, the Holder shall
surrender this Warrant to the Company within three (3) Trading Days of the date the Holder delivers an assignment form to the Company
assigning this Warrant in full. The Warrant, if properly assigned in accordance herewith, may be exercised by a new holder for the purchase
of Warrant Shares without having a new Warrant issued.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>New Warrants</U>. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of
the Company, together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by
the Holder or its agent or attorney. Subject to compliance with <U>Section 4(a)</U>, as to any transfer which may be involved in such
division or combination, the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be
divided or combined in accordance with such notice. All Warrants issued on transfers or exchanges shall be dated the Initial Exercise
Date and shall be identical with this Warrant except as to the number of Warrant Shares issuable pursuant thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Warrant Register</U>. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the
&ldquo;<U>Warrant Register</U>&rdquo;), in the name of the record Holder hereof from time to time. The Company may deem and treat the
registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder,
and for all other purposes, absent actual notice to the contrary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)
<U>Transfer Restrictions</U>. Subject to any limitations imposed by applicable law, this Warrant may be offered for sale, sold, transferred,
or assigned without the consent of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)
<U>Representation by the Holder</U>. The Holder, by the acceptance hereof, represents and warrants that it is acquiring this Warrant
and, upon any exercise hereof, will acquire the Warrant Shares issuable upon such exercise, for its own account and not with a view to
or for distributing or reselling such Warrant Shares or any part thereof in violation of the Securities Act or any applicable state securities
law, except pursuant to sales registered or exempted under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
5. <U>Miscellaneous</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>No Rights as Stockholder Until Exercise</U>. This Warrant does not entitle the Holder to any voting rights, dividends or other rights
as a stockholder of the Company prior to the exercise hereof as set forth in <U>Section 2(d)(i)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>Loss, Theft, Destruction, or Mutilation of Warrant</U>. The Company covenants that upon receipt by the Company of evidence reasonably
satisfactory to it of the loss, theft, destruction, or mutilation of this Warrant or any stock certificate relating to the Warrant Shares,
and in case of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant,
shall not include the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the
Company will make and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant
or stock certificate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Saturdays, Sundays, Holidays, etc</U>. If the last or appointed day for the taking of any action or the expiration of any right required
or granted herein shall not be a Business Day, then, such action may be taken or such right may be exercised on the next succeeding Business
Day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)
<U>Authorized Shares</U>. The Company covenants that, during the period the Warrant is outstanding, it will reserve from its authorized
and unissued Common Stock a sufficient number of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase
rights under this Warrant (the &ldquo;<U>Required Reserve Amount</U>&rdquo;). The Company further covenants that its issuance of this
Warrant shall constitute full authority to its officers who are charged with the duty of issuing the necessary Warrant Shares upon the
exercise of the purchase rights under this Warrant. The Company will take all such reasonable action as may be necessary to assure that
such Warrant Shares may be issued as provided herein without violation of any applicable law or regulation, or of any requirements of
the Trading Market upon which the Common Stock may be listed. The Company covenants that all Warrant Shares which may be issued upon
the exercise of the purchase rights represented by this Warrant will, upon exercise of the purchase rights represented by this Warrant
and payment for such Warrant Shares in accordance herewith, be duly authorized, validly issued, fully paid, and nonassessable and free
from all taxes, liens, and charges created by the Company in respect of the issue thereof (other than taxes in respect of any transfer
occurring contemporaneously with such issue).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)
<U>Transfer Agent Instructions</U>. The Company covenants and agrees that it will, at all times during the period the Warrant is outstanding,
maintain a duly qualified independent Transfer Agent. The Company represents and covenants that, within one (1) day from the Initial
Exercise Date, it will either (i) issue irrevocable instructions to its current Transfer Agent (and each Transfer Agent appointed thereafter)
to issue certificates, registered in the name of the Holder or its nominee, for the Warrant Shares in such amounts as specified from
time to time by the Holder to the Company upon exercise of this Warrant in accordance with the terms thereof (the &ldquo;<U>Irrevocable
Transfer Agent Instructions</U>&rdquo;), or (ii) appoint a new Transfer Agent, at which time the Company (a) shall provide a copy of
its agreement with the new Transfer Agent to the Holder, and (b) issue Irrevocable Transfer Agent Instructions to the new Transfer Agent.
Such Irrevocable Transfer Agent Instructions shall be in a form acceptable to the Holder and shall include a provision to irrevocably
reserve the Required Reserve Amount. The Irrevocable Transfer Agent Instructions shall be signed by the Company&rsquo;s Transfer Agent
as of the date of the Initial Exercise Date or by the New Transfer Agent, as applicable, and by the Company. The Company warrants that,
(i) no instruction other than the Irrevocable Transfer Agent Instructions referred to in this Section 5(e), and stop transfer instructions
to give effect to Section 5(g) (prior to registration of the Warrant Shares under the Securities Act or the date on which the Warrant
Shares may be sold pursuant to Rule 144 without any restriction as to the number of Securities as of a particular date that can then
be immediately sold), will be given by the Company to its Transfer Agent and that the Warrant Shares shall otherwise be freely transferable
on the books and records of the Company as and to the extent provided in this Warrant and the Purchase Agreement, (ii) it will not direct
its Transfer Agent not to transfer or delay, impair, and/or hinder its Transfer Agent in transferring (or issuing)(electronically or
in certificated form) any certificate for Warrant Shares to be issued to the Holder upon exercise of or otherwise pursuant to this Warrant
as and when required by this Warrant and the Purchase Agreement, and (iii) it will not fail to remove (or direct its Transfer Agent not
to remove or impair, delay, and/or hinder its Transfer Agent from removing) any restrictive legend (or to withdraw any stop transfer
instructions in respect thereof) on any certificate for any Warrant Shares issued to the Holder upon exercise of or otherwise pursuant
to this Warrant as and when required by this Warrant and the Purchase Agreement. Nothing in this Section shall affect in any way the
Holder&rsquo;s obligations to comply with all applicable prospectus delivery requirements, if any, upon resale of the Warrant Shares.
If a Holder provides the Company, at the cost of the Holder, with an opinion of counsel in form, substance, and scope customary for opinions
in comparable transactions, to the effect that a public sale or transfer of such Warrant Shares may be made without registration under
the Securities Act and such sale or transfer is effected, the Company shall permit the transfer, and, in the case of the Warrant Shares,
promptly instruct its Transfer Agent to issue one or more certificates, free from restrictive legend, in such name and in such denominations
as specified by the Holder. The Company acknowledges that a breach by it of its obligations hereunder will cause irreparable harm to
the Holder, by vitiating the intent and purpose of the transactions contemplated hereby. Accordingly, the Company acknowledges that the
remedy at law for a breach of its obligations under this Section 5(e) may be inadequate and agrees, in the event of a breach or threatened
breach by the Company of the provisions of this Section, that the Holder shall be entitled, in addition to all other available remedies,
to an injunction restraining any breach and requiring immediate transfer, without the necessity of showing economic loss and without
any bond or other security being required.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f)
<U>Jurisdiction</U>. All questions concerning the construction, validity, enforcement, and interpretation of this Warrant shall be determined
in accordance with the provisions of the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">g)
<U>Restrictions</U>. The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, will
have restrictions upon resale imposed by state and federal securities laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">h)
<U>Nonwaiver and Expenses</U>. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall
operate as a waiver of such right or otherwise prejudice the Holder&rsquo;s rights, powers, or remedies, notwithstanding the fact that
all rights hereunder terminate on the Termination Date. If the Company willfully and knowingly fails to comply with any provision of
this Warrant, which results in any material damages to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient
to cover any costs and expenses including, but not limited to, reasonable attorneys&rsquo; fees, including those of appellate proceedings,
incurred by the Holder in collecting any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies
hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i)
<U>Notices</U>. Any notice, request or other document required or permitted to be given or delivered to the Holder by the Company shall
be delivered in accordance with the notice provisions of the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">j)
<U>Limitation of Liability</U>. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant
to purchase Warrant Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of
the Holder for the purchase price of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company
or by creditors of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">k)
<U>Remedies</U>. The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will
be entitled to specific performance of its rights under this Warrant. The Company agrees that monetary damages may not be adequate compensation
for any loss incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to assert the
defense in any action for specific performance that a remedy at law would be adequate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">l)
<U>Successors and Assigns</U>. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall
inure to the benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns
of Holder. The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall
be enforceable by the Holder or holder of Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">m)
<U>Amendment</U>. This Warrant (other than <U>Section 2(e)</U>) may be modified or amended or the provisions hereof waived with the written
consent of the Company and the Holder. No waiver shall be effective unless it is in writing and signed by an authorized representative
of the waiving party.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">n)
<U>Severability</U>. If any provision of this Warrant is prohibited by law or otherwise determined to be invalid or unenforceable by
a court of competent jurisdiction, the provision that would otherwise be prohibited, invalid or unenforceable shall be deemed amended
to apply to the broadest extent that it would be valid and enforceable, and the invalidity or unenforceability of such provision shall
not affect the validity of the remaining provisions of this Warrant so long as this Warrant as so modified continues to express, without
material change, the original intentions of the parties as to the subject matter hereof and the prohibited nature, invalidity or unenforceability
of the provision(s) in question does not substantially impair the respective expectations or reciprocal obligations of the parties or
the practical realization of the benefits that would otherwise be conferred upon the parties. The parties will endeavor in good faith
negotiations to replace the prohibited, invalid or unenforceable provision(s) with a valid provision(s), the effect of which comes as
close as possible to that of the prohibited, invalid or unenforceable provision(s).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">o)
<U>Headings</U>. This Warrant shall be deemed to be jointly drafted by the Company and the Holder and shall not be construed against
any Person as the drafter hereof. The headings of this Warrant are for convenience of reference and shall not form part of, or affect
the interpretation of, this Warrant. Terms used in this Warrant but defined in the other Transaction Documents shall have the meanings
ascribed to such terms on the Closing Date in such other Transaction Documents unless otherwise consented to in writing by the Holder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">p)
<U>Governing Law</U>. This Warrant shall be governed by and construed and enforced in accordance with, and all questions concerning the
construction, validity, interpretation, and performance of this Warrant shall be governed by, the internal laws of the State of Delaware,
without giving effect to any choice of law or conflict of law provision or rule (whether of the State of Delaware or any other jurisdictions)
that would cause the application of the laws of any jurisdictions other than the State of Delaware. The Company hereby irrevocably waives
personal service of process and consents to process being served in any such suit, action, or proceeding by mailing a copy thereof to
the Company at the address set forth in the Purchase Agreement and agrees that such service shall constitute good and sufficient service
of process and notice thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">q)
<U>Jurisdiction and Venue</U>. Each party hereby irrevocably submits that any dispute, controversy or claim arising out of or relating
to this Warrant, shall be submitted to the exclusive jurisdiction of the Chancery Court of the State of Delaware and the United States
District Court for the District of Delaware. Each party hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding,
any claim that it is not personally subject to the jurisdiction of any such court, that such suit, action or proceeding is brought in
an inconvenient forum or that the venue of such suit, action or proceeding is improper. Each party hereby irrevocably waives personal
service of process and consents to process being served in any such suit, action or proceeding by mailing a copy thereof to such party
at the address for such notices to it under the Purchase Agreement and agrees that such service shall constitute good and sufficient
service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any
manner permitted by law. EACH PARTY HEREBY IRREVOCABLY WAIVES ANY RIGHT IT MAY HAVE, AND AGREES NOT TO REQUEST, A JURY TRIAL FOR THE
ADJUDICATION OF ANY DISPUTE HEREUNDER OR IN CONNECTION HEREWITH OR </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">ARISING
OUT OF THIS WARRANT. The parties agree that all dispute resolution proceedings in accordance with this Section 5(o) may be conducted
in a virtual setting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>********************</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(Signature
Page Follows)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>


<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the Company has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above
indicated.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>NEXTTRIP, INC.</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Bill Kerby</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bill
    Kerby</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[Signature Page to Warrant]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">EXHIBIT
A</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTICE
OF EXERCISE</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">TO
BE EXECUTED BY THE REGISTERED HOLDER TO EXERCISE THIS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WARRANT
TO PURCHASE COMMON STOCK</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NEXTTRIP,
INC.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned holder hereby exercises the right to purchase  of the shares of Common Stock (&ldquo;<U>Warrant Shares</U>&rdquo;) of NextTrip,
Inc., a Nevada corporation (the &ldquo;Company&rdquo;), evidenced by the Warrant (the &ldquo;<U>Warrant</U>&rdquo;). Capitalized terms
used herein and not otherwise defined shall have the respective meanings set forth in the Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.
<U>Form of Exercise Price</U>. The Holder intends that payment of the Aggregate Exercise Price shall be made as:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">____________
<FONT STYLE="font-size: 10pt">a &ldquo;<U>Cash Exercise</U>&rdquo; with respect to ____________ Warrant Shares; and/or</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;____________
a &ldquo;<U>Cashless Exercise</U>&rdquo; with respect to ____________ Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.
<U>Payment of Exercise Price</U>. In the event that the Holder has elected a Cash Exercise with respect to some or all of the Warrant
Shares to be issued pursuant hereto, the Holder shall pay the Aggregate Exercise Price in the sum of $ ____________ to the Company in
accordance with the terms of the Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.
<U>Delivery of Warrant Shares</U>. The Company shall deliver to Holder, or its designee or agent as specified below, ____________ Warrant
Shares in accordance with the terms of the Warrant. Delivery shall be made to Holder, or for its benefit, as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;
Check here if requesting delivery as a certificate to the following name and to the following address:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="width: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issue to:</FONT></TD>
  <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 46pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;
&nbsp;&nbsp;&nbsp;Check here if requesting delivery by Deposit/Withdrawal at Custodian as follows:</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 46pt; text-align: justify; text-indent: -0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 46pt; text-align: justify; text-indent: 0pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="width: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">DTC Participant:</FONT></TD>
  <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">DTC Number:</FONT></TD>
  <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Account Number:</FONT></TD>
  <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 46pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Date:
___________ __,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 46pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Name
of Registered Holder</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 46pt; text-align: justify; text-indent: 0pt"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 46pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 46pt; text-align: justify; text-indent: 0pt"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 15%"><FONT STYLE="font-family: Times New Roman, Times, Serif">Tax
    ID:</FONT></TD>
    <TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left; width: 35%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Facsimile:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">E-mail
    Address:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 46pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">EXHIBIT
B</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASSIGNMENT
FORM</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<I>To
assign the foregoing Warrant, execute this form and supply required information. Do not use this form to purchase shares</I>.)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FOR
VALUE RECEIVED, the foregoing Warrant and all rights evidenced thereby are hereby assigned to</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif">Name:</FONT></TD>
    <TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif">(Please
    Print)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Address:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">(Please
    Print)</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated:
________ __,</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif">____</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s
Signature:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s
Address:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 14; Options: Last -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.12
<SEQUENCE>3
<FILENAME>ex4-12.htm
<DESCRIPTION>EX-4.12
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Exhibit
4.12</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NEITHER
THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION
OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED
(THE &ldquo;SECURITIES ACT&rdquo;), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT
UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS
OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE
OF THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WARRANT</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 70%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrant
    Shares: 40,000</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 30%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issuance
    Date: December 3, 2024</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THIS
WARRANT (the &ldquo;<U>Warrant</U>&rdquo;) certifies that, for value received, Marc Bern or his assigns (the &ldquo;<U>Holder</U>&rdquo;)
is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after
the 3<SUP>rd</SUP> of December, 2024 (the &ldquo;<U>Initial Issuance Date</U>&rdquo;) and on or prior to the close of business on the
three (3) year anniversary of the Initial Exercise Date (the &ldquo;<U>Termination Date</U>&rdquo;) but not thereafter, to subscribe
for and purchase from NextTrip, Inc., a Nevada corporation (the &ldquo;<U>Company</U>&rdquo;), up to 40,000 shares of the Company&rsquo;s
Common Stock (&ldquo;<U>Warrant Shares</U>&rdquo;). The purchase price of one Warrant Share under this Warrant shall be equal to the
Exercise Price, as defined in <U>Section 2(b)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
1. <U>Definitions</U>. Capitalized terms used are defined herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
purposes of this Warrant, the following terms shall have the following meanings:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Affiliate</U>&rdquo;
means, as applied to any Person, any other Person directly or indirectly </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">controlling,
controlled by, or under common control with, that Person. For the purposes of this definition, &ldquo;control&rdquo; (including, with
correlative meanings, the terms &ldquo;controlling,&rdquo; &ldquo;controlled by&rdquo; and &ldquo;under common control with&rdquo;),
as applied to any Person, means possession, directly or indirectly, of the power to direct or cause the direction of the management or
policies of a Person, whether through the ability to exercise voting power, by contract or otherwise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Approved
Stock Plan</U>&rdquo; means any employee benefit plan or agreement which has been approved by the board of directors of the Company prior
to or subsequent to the date hereof pursuant to which shares of Common Stock and Options may be issued to any employee, officer, consultant,
or director for services provided to the Company in their capacity as such.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Business
Day</U>&rdquo; means any day except any Saturday, any Sunday, any day which is a federal legal holiday in the United States, or any day
on which banking institutions in the State of New York are authorized or required by law or other governmental action to close.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1; Options: NewSection -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Common
Stock</U>&rdquo; means the Common Stock of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Convertible
Securities</U>&rdquo; means any stock or other security (other than Options) that is at any time and under any circumstances, directly
or indirectly, convertible into, exercisable or exchangeable for, or which otherwise entitles the holder thereof to acquire, any shares
of Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Excluded
Securities</U>&rdquo; means the issuance of (a) shares of Common Stock or options to employees, officers or directors of the Company
pursuant to any stock or option plan duly adopted for such purpose by a majority of the non-employee members of the Board of Directors
or a majority of the members of a committee of non-employee directors established for such purpose, (b) securities upon the exercise
or exchange of or conversion of any shares issued hereunder and/or other securities exercisable or exchangeable for or convertible into
shares of Common Stock issued and outstanding on the date of this Agreement, provided that such securities have not been amended since
the date of this Agreement to increase the number of such securities or to decrease the exercise price, exchange price or conversion
price of such securities or to extend the term of such securities, (c) securities issued in connection with the Company&rsquo;s pending
Registration Statement on Form S-1 (File No. 333-278562); and (d) securities issued pursuant to acquisitions or strategic transactions
approved by a majority of the disinterested directors of the Company, provided that such securities are issued as &ldquo;restricted securities&rdquo;
(as defined in Rule 144) and carry no registration rights that require or permit the filing of any registration statement in connection
therewith, and provided that any such issuance shall only be to a Person (or to the equity holders of a Person) which is, itself or through
its subsidiaries, an operating company or an owner of an asset in a business synergistic with the business of the Company and shall provide
to the Company additional benefits in addition to the investment of funds, but shall not include a transaction in which the Company is
issuing securities primarily for the purpose of raising capital or to an entity whose primary business is investing in securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Market
Price</U>&rdquo; means as applicable: (i) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise
if such Notice of Exercise is (1) both executed and delivered pursuant to Section 2(a) hereof on a day that is not a Trading Day or (2)
both executed and delivered pursuant to Section 2(a) hereof on a Trading Day prior to the opening of &ldquo;regular trading hours&rdquo;
(as defined in Rule 600(b) of Regulation NMS promulgated under the federal securities laws) on such Trading Day, (ii) at the option of
the Holder, either (y) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise or (z) the Bid
Price of the Common Stock on the principal Trading Market as reported by Bloomberg L.P. (&ldquo;Bloomberg&rdquo;) as of the time of the
Holder&rsquo;s execution of the applicable Notice of Exercise if such Notice of Exercise is executed during &ldquo;regular trading hours&rdquo;
on a Trading Day and is delivered within two (2) hours thereafter (including until two (2) hours after the close of &ldquo;regular trading
hours&rdquo; on a Trading Day) pursuant to Section 2(a) hereof or (iii) the VWAP on the date of the applicable Notice of Exercise if
the date of such Notice of Exercise is a Trading Day and such Notice of Exercise is both executed and delivered pursuant to Section 2(a)
hereof after the close of &ldquo;regular trading hours&rdquo; on such Trading Day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Options</U>&rdquo;
means any rights, warrants, or options to subscribe for, purchase, or otherwise acquire shares of Common Stock or Convertible Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Stockholder
Approval</U>&rdquo; means the approval required by the applicable rules and regulations of the NASDAQ Capital Market (or any successor
entity) from the stockholders of the Company of the provisions of <U>Section 3(b)</U> of this Warrant in order for such provisions to
become effective by their terms and to be in compliance with such applicable rules and regulations of the NASDAQ Capital Market (or any
successor entity).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Trading
Day</U>&rdquo; means a day on which the shares of Common Stock are traded on the Trading Market; provided, however, that in the event
that the shares of Common Stock are not listed or quoted on the Trading Market, then Trading Day shall mean any day except Saturday,
Sunday and any day which shall be a legal holiday or a day on which banking institutions in the State of New York or State of Delaware
are authorized or required by law or other government action to close.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Trading
Market</U>&rdquo; means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date
in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, the New York Stock
Exchange, or the OTC Markets QB Tier (or any successors to any of the foregoing).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
2. <U>Exercise</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>Exercise of Warrants</U>. Exercise of the purchase rights for Warrant Shares represented by this Warrant may be made, in whole or
in part, at any time or times on or after the Initial Issuance Date and on or before the Termination Date by delivery to the Company
(or such other office or agency of the Company as it may designate by notice in writing to the registered Holder at the address of the
Holder appearing on the books of the Company) of a duly executed Notice of Exercise in the form annexed hereto as Exhibit A (which may
be delivered in a .PDF format via electronic mail pursuant to the notice provisions set forth in the Purchase Agreement). Within two
(2) Trading Days of the date said Notice of Exercise is delivered to the Company (or within three (3) Trading Days of the date said Notice
of Exercise is delivered to the Company if the Notice of Exercise is received after 12 p.m. EST on such day), the Company shall have
received payment of the aggregate Exercise Price of the Warrant Shares thereby purchased by wire transfer or cashier&rsquo;s check drawn
on a United States bank, unless such exercise is made pursuant to the cashless exercise procedure specified in <U>Section 2(c)</U> below
(if available). No ink-original Notice of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee or
notarization) of any Notice of Exercise form be required. The Company shall be entitled to conclusively assume the genuineness of any
signature on any Notice of Exercise delivered to the Company pursuant to this <U>Section 2(a)</U>, the legal capacity and competency
of all natural persons signing any Notice of Exercise so delivered, the authenticity of any Notice of Exercise so delivered, the conformity
to an authentic original of any Notice of Exercise so delivered as certified, authenticated, conformed, photostatic, facsimile, or electronic
and the authenticity of the original of such Notice of Exercise. Notwithstanding anything herein to the contrary, the Holder shall not
be required to physically surrender this Warrant to the Company until the Holder has purchased all of the Warrant Shares available hereunder
and the Warrant has been exercised in full, in which case, the Holder shall surrender this Warrant to the Company for cancellation within
three (3) Trading Days of the date the final Notice of Exercise is delivered to the Company. Partial exercises of this Warrant resulting
in purchases of a portion of the total number of Warrant Shares available hereunder shall have the effect of lowering the outstanding
number of Warrant Shares purchasable hereunder in an amount equal to the applicable number of Warrant Shares purchased. The Holder and
the Company shall maintain records showing the number of Warrant Shares purchased and the date of such purchases, and the Company shall
be entitled to conclusively assume that its records of the number of Warrant Shares purchased and the date of such purchases are accurate,
absent actual notice to the contrary. The Company shall deliver any objection to any Notice of Exercise within two (2) Business Days
of receipt of such notice. The Holder and any assignee, by acceptance of this Warrant, acknowledge and agree that, by reason of the provisions
of this paragraph, following the purchase of a portion of the Warrant Shares hereunder, the number of Warrant Shares available for purchase
hereunder at any given time may be less than the amount stated on the face hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>Exercise Price</U>. The exercise price per Warrant Share shall be $3.25, subject to adjustment hereunder (the &ldquo;<U>Exercise Price</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>





<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 76.9pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 76.9pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Cashless Exercise</U>. If at any time ninety (90) days after the date of the Initial Issuance Date, there is no effective Registration
Statement registering, or no current prospectus available for, the resale of the Warrant Shares by the Holder, then this Warrant may
also be exercised, in whole or in part, at such time by means of a &ldquo;cashless exercise&rdquo; in which the Holder shall be entitled
to receive a number of Warrant Shares equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.35in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(A)
    =</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    Market Price (at the date of such calculation)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(B)
    =</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    Exercise Price of this Warrant, as adjusted hereunder; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(X)
    =</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    number of Warrant Shares that would be issuable upon exercise of this Warrant in accordance with the terms of this Warrant if such
    exercise were by means of a cash exercise rather than a cashless exercise.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 77pt; text-align: justify; text-indent: -31.0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assuming
(i) the Holder is not an Affiliate of the Company, and (ii) all of the applicable conditions of Rule 144 promulgated under the Securities
Act of 1933, as amended (the &ldquo;<U>Securities Act</U>&rdquo;) with respect to Holder and the Warrant Shares are met in the case of
such a cashless exercise, the Company agrees that the Company will use its best efforts to cause the removal of the legend from such
Warrant Shares (including by delivering an opinion of the Company&rsquo;s counsel to the Company&rsquo;s transfer agent at its own expense
to ensure the foregoing), and the Company agrees that the Holder is under no obligation to sell the Warrant Shares issuable upon the
exercise of the Warrant prior to removing the legend. The Company expressly acknowledges that Rule 144(d)(3)(ii), as currently in effect,
provides that Warrant Shares issued solely upon a cashless exercise shall be deemed to have been acquired at the same time as the Warrant.
The Company agrees not to take any position contrary to this <U>Section 2(c)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)
<U>Mechanics of Exercise</U>.</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 76.90pt; text-align: justify; text-indent: -31.60pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.
<U>Delivery of Warrant Shares Upon Exercise</U>. The Company shall cause the Warrant Shares purchased hereunder to be transmitted by
the Company&rsquo;s transfer agent (the &ldquo;<U>Transfer Agent</U>&rdquo;) to the Holder by crediting the account of the Holder&rsquo;s
or its designee&rsquo;s balance account with The Depository Trust Company through its Deposit or Withdrawal at Custodian system (&ldquo;<U>DWAC</U>&rdquo;)
if the Company is then a participant in such system and either (A) there is an effective registration statement permitting the issuance
of the Warrant Shares to or resale of the Warrant Shares by the Holder or (B) the Warrant Shares are eligible for resale by the Holder
pursuant to Rule 144, and otherwise by physical delivery of a certificate, registered in the Company&rsquo;s share register in the name
of the Holder or its designee, for the number of Warrant Shares to which the Holder is entitled pursuant to such exercise to the address
specified by the Holder in the Notice of Exercise by the date that is one (1) Trading Day after the later of (A) the delivery to the
Company of the Notice of Exercise provided that such Notice of Exercise is received by 12 p.m. EST and two (2) Trading Days for any Notice
of Exercise received after 12 p.m. EST, and (B) the Company&rsquo;s receipt of payment of the aggregate Exercise Price of the Warrant
Shares thereby purchased by wire transfer or cashier&rsquo;s check drawn on a United States bank, unless such exercise is made pursuant
to the cashless exercise procedure specified in <U>Section 2(c)</U> (such date, the &ldquo;<U>Warrant Share Delivery Date</U>&rdquo;).
The Warrant Shares shall be deemed to have been issued, and Holder or any other person so designated to be named therein shall be deemed
to have become a holder of record of such shares for all purposes, as of the date the Warrant has been exercised, with payment to the
Company of the Exercise Price (or by cashless exercise, if permitted) and all taxes required to be paid by the Holder, if any, pursuant
to <U>Section 2(d)(vi)</U> prior to the issuance of such Warrant Shares, having been paid. If the Company fails for any reason to deliver
to the Holder the Warrant Shares subject to a Notice of Exercise by the Warrant Share Delivery Date, the Company shall pay to the Holder,
in cash, as liquidated damages and not as a penalty, for each $1,000 of Warrant Shares subject to such exercise (based on the VWAP of
the Common Stock on the date of the applicable Notice of Exercise), $5 per Trading Day (increasing to $10 per Trading Day on the fifth
Trading Day after such liquidated damages begin to accrue) for each Trading Day after such Warrant Share Delivery Date until such Warrant
Shares are delivered or Holder rescinds such exercise. The Company agrees to maintain a transfer agent that is a participant in the FAST
program so long as this Warrant remains outstanding and exercisable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.
<U>Delivery of New Warrants Upon Exercise</U>. If this Warrant shall have been exercised in part, the Company shall, at the request of
a Holder and upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant
evidencing the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in
all other respects be identical with this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iii.
<U>Rescission Rights</U>. If the Holder fails to make payment of the aggregate Exercise Price of the Warrant Shares pursuant to a Notice
of Exercise within two (2) Trading Days of the date said Notice of Exercise is delivered to the Company (or within three (3) Trading
Days of the date said Notice of Exercise is delivered to the Company if the Notice of Exercise is received after 12 p.m. EST on such
day) by wire transfer or cashier&rsquo;s check drawn on a United States bank, then the Company will have the right to rescind such exercise,
unless such exercise is made pursuant to the cashless exercise procedure specified in <U>Section 2(c)</U>. If the Company fails to cause
the Transfer Agent to transmit to the Holder the Warrant Shares pursuant to <U>Section 2(d)(i)</U> by the Warrant Share Delivery Date,
then the Holder will have the right to rescind such exercise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iv.
<U>Compensation for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise</U>. In addition to any other rights available to
the Holder, if the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance with the provisions
of <U>Section 2(d)(i)</U> above pursuant to an exercise on or before the Warrant Share Delivery Date, and if after such date the Holder
is required by its broker to purchase (in an open market transaction or otherwise) or the Holder&rsquo;s brokerage firm otherwise purchases,
shares of Common Stock to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving
upon such exercise (a &ldquo;<U>Buy-In</U>&rdquo;), then the Company shall (A) pay in cash to the Holder the amount, if any, by which
(x) the Holder&rsquo;s total purchase price (including brokerage commissions, if any) for the shares of Common Stock so purchased exceeds
(y) the amount obtained by multiplying (1) the number of Warrant Shares that the Company was required to deliver to the Holder in connection
with the exercise at issue times (2) the price at which the sell order giving rise to such purchase obligation was executed, and (B)
at the option of the Holder, either reinstate the portion of the Warrant Shares for which such exercise was not honored (in which case
such exercise shall be deemed rescinded) or deliver to the Holder the number of shares of Common Stock that would have been issued had
the Company timely complied with its exercise and delivery obligations hereunder. For example, if the Holder purchases Common Stock having
a total purchase price of $11,000 to cover a Buy-In with respect to an attempted exercise of shares of Common Stock with an aggregate
sale price giving rise to such purchase obligation of $10,000, under clause (A) of the immediately preceding sentence the Company shall
be required to pay the Holder $1,000. The Holder shall provide the Company written notice indicating the amounts payable to the Holder
in respect of the Buy-In and, upon request of the Company, evidence of the amount of such loss. Nothing herein shall limit a Holder&rsquo;s
right to pursue any other remedies available to it hereunder, at law or in equity including, without limitation, a decree of specific
performance and/or injunctive relief with respect to the Company&rsquo;s failure to timely deliver shares of Common Stock upon exercise
of the Warrant as required pursuant to the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">v.
<U>No Fractional Shares or Scrip</U>. No fractional shares or scrip representing fractional shares shall be issued upon the exercise
of this Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company
shall, at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied
by the Exercise Price or round up to the next whole share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">vi.
<U>Charges, Taxes, and Expenses</U>. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer
tax or other incidental expense in respect of the issuance of Warrant Shares, all of which taxes and expenses shall be paid by the Company,
and such Warrant Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder; provided,
however, that in the event that Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when surrendered
for exercise shall be accompanied by the Assignment Form attached hereto duly executed by the Holder and the Company may require, as
a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto. The Company shall pay all
fees charged by the Transfer Agent, including any fees assessed to the Transfer Agent by Depository Trust Company (or another established
clearing corporation performing similar functions) required for same-day processing of any Notice of Exercise and for same-day electronic
delivery of the Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">vii.
<U>Closing of Books</U>. The Company will not close its stockholder books or records in any manner which prevents the timely exercise
of this Warrant, pursuant to the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)
<U>Holder&rsquo;s Exercise Limitations</U>. To the extent the exercise of any portion of this Warrant requires the Company to receive
the approval of the Company&rsquo;s stockholders pursuant to NASDAQ Capital Market Listing Rules, the Company shall not effect such exercise
of this Warrant, and a Holder shall not have the right to exercise any such portion of this Warrant, pursuant to <U>Section 2</U> or
otherwise, until such approval has been received by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
3. <U>Certain Adjustments</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>Stock Dividends and Splits</U>. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise
makes a distribution or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable in shares
of Common Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon exercise of this
Warrant), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way of reverse
stock split) outstanding shares of Common Stock into a smaller number of shares or (iv) issues by reclassification of shares of the Common
Stock any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which the
numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before such event
and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event, and the number of
Warrant Shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this
Warrant shall remain unchanged. Any adjustment made pursuant to this Section 3(a) shall become effective immediately after the record
date for the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after
the effective date in the case of a subdivision, combination or re-classification.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>Notice</U>. The Company shall notify the Holder, in writing, no later than the Trading Day following the issuance or deemed issuance
of any Common Stock or Common Stock Equivalents subject to <U>Section 3(a)</U>, indicating therein the applicable issuance price, or
applicable reset price, exchange price, conversion price and other pricing terms (such notice, the &ldquo;<U>Dilutive Issuance Notice</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Fundamental Transaction</U>. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or
more related transactions effects any merger or consolidation of the Company with or into another Person, (ii) the Company, directly
or indirectly, effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially all of
its assets in one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange offer
(whether by the Company or another Person) is completed pursuant to which holders of Common Stock are permitted to sell, tender or exchange
their shares for other securities, cash or property and has been accepted by the holders of more than 50% of the outstanding Common Stock
or more than 50% of the voting power of the common equity of the Company, (iv) the Company, directly or indirectly, in one or more related
transactions effects any reclassification, reorganization, or recapitalization of the Common Stock or any compulsory share exchange pursuant
to which the Common Stock is effectively converted into or exchanged for other securities, cash or property, or (v) the Company, directly
or indirectly, in one or more related transactions consummates a stock or share purchase agreement or other business combination (including,
without limitation, a reorganization, recapitalization, spin-off, merger or scheme of arrangement) with another Person or group of Persons
whereby such other Person or group acquires more than 50% of the outstanding shares of Common Stock or more than 50% of the voting power
of the common equity of the Company (not including any shares of Common Stock held by the other Person or other Persons making or party
to, or associated or affiliated with the other Persons making or party to, such stock or share purchase agreement or other business combination)
(each a &ldquo;<U>Fundamental Transaction</U>&rdquo;), then, the Company shall cause any successor entity in a Fundamental Transaction
in which the Company is not the survivor (the &ldquo;<U>Successor Entity</U>&rdquo;) to assume in writing all of the obligations of the
Company under this Warrant and the other Transaction Documents in accordance with the provisions of this <U>Section 3(e)</U> pursuant
to written agreements in form and substance reasonably satisfactory to the Holder and approved by the Holder (without unreasonable delay)
prior to such Fundamental Transaction and shall, at the option of the Holder, deliver to the Holder in exchange for this Warrant a security
of the Successor Entity evidenced by a written instrument substantially similar in form and substance to this Warrant which is exercisable
for a corresponding number of shares of capital stock of such Successor Entity (or its parent entity) equivalent to the shares of Common
Stock acquirable and receivable upon exercise of this Warrant (without regard to any limitations on the exercise of this Warrant) prior
to such Fundamental Transaction, and with an exercise price which applies the exercise price hereunder to such shares of capital stock
(but taking into account the relative value of the shares of Common Stock pursuant to such Fundamental Transaction and the value of such
shares of capital stock, such number of shares of capital stock and such exercise price being for the purpose of protecting the economic
value of this Warrant immediately prior to the consummation of such Fundamental Transaction), and which is reasonably satisfactory in
form and substance to the Holder. Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall succeed to, and
be substituted for (so that from and after the date of such Fundamental Transaction, the provisions of this Warrant and the other Transaction
Documents referring to the &ldquo;Company&rdquo; shall refer instead to the Successor Entity), and may exercise every right and power
of the Company and shall assume all of the obligations of the Company under this Warrant and the other Transaction Documents with the
same effect as if such Successor Entity had been named as the Company herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)
<U>Calculations</U>. All calculations under this <U>Section 3</U> shall be made to the nearest cent or the nearest 1/100th of a share,
as the case may be. For purposes of this <U>Section 3</U>, the number of shares of Common Stock deemed to be issued and outstanding as
of a given date shall be the sum of the number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)
<U>Notice to Holder</U>.</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 76.90pt; text-align: justify; text-indent: -31.60pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.
<U>Adjustment to Exercise Price</U>. Whenever the Exercise Price is adjusted pursuant to any provision of this <U>Section 3</U>, the
Company shall promptly mail or deliver via electronic mail to the Holder a notice setting forth the Exercise Price after such adjustment
and any resulting adjustment to the number of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.
<U>Notice to Allow Exercise by Holder</U>. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on
the Common Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C) the
Company shall authorize the granting to all holders of the Common Stock rights or warrants to subscribe for or purchase any shares of
capital stock of any class or of any rights, (D) the approval of any stockholders of the Company shall be required in connection with
any reclassification of the Common Stock, any consolidation or merger to which the Company is a party, any sale or transfer of all or
substantially all of the assets of the Company, or any compulsory share exchange whereby the Common Stock is converted into other securities,
cash or property, or </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">(E) the Company shall authorize the voluntary or
involuntary dissolution, liquidation or winding up of the affairs of the Company, then, in each case, the Company shall cause to be mailed
to the Holder at its last address as it shall appear upon the Warrant Register of the Company, at least 20 calendar days prior to the
applicable record or effective date hereinafter specified, a notice stating (x) the date on which a record is to be taken for the purpose
of such dividend, distribution, redemption, rights, or warrants, or if a record is not to be taken, the date as of which the holders
of the Common Stock of record to be entitled to such dividend, distributions, redemption, rights or warrants are to be determined or
(y) the date on which such reclassification, consolidation, merger, sale, transfer or share exchange is expected to become effective
or close, and the date as of which it is expected that holders of the Common Stock of record shall be entitled to exchange their shares
of the Common Stock for securities, cash or other property deliverable upon such reclassification, consolidation, merger, sale, transfer
or share exchange; provided that the failure to mail such notice or any defect therein or in the mailing thereof shall not affect the
validity of the corporate action required to be specified in such notice. To the extent that any notice provided in this Warrant constitutes,
or contains, material, non-public information regarding the Company, the Company shall simultaneously file such notice with the Commission
pursuant to a Current Report on Form 8-K. The Holder shall remain entitled to exercise this Warrant during the period commencing on the
date of such notice to the effective date of the event triggering such notice except as may otherwise be expressly set forth herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
4. <U>Transfer of Warrant</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>Transferability</U>. Subject to compliance with any applicable securities laws and the conditions set forth in <U>Section 4(d)</U>
hereof, this Warrant and all rights hereunder (including, without limitation, any registration rights) are transferable, in whole or
in part, upon surrender of this Warrant at the principal office of the Company or its designated agent, together with a written assignment
of this Warrant substantially in the form attached hereto duly executed by the Holder or its agent or attorney and funds sufficient to
pay any transfer taxes payable upon the making of such transfer. Upon such surrender and, if required, such payment, the Company shall
execute and deliver a new Warrant or Warrants in the name of the assignee or assignees, as applicable, and in the denomination or denominations
specified in such instrument of assignment and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not so
assigned, and this Warrant shall promptly be cancelled. Notwithstanding anything herein to the contrary, the Holder shall not be required
to physically surrender this Warrant to the Company unless the Holder has assigned this Warrant in full, in which case, the Holder shall
surrender this Warrant to the Company within three (3) Trading Days of the date the Holder delivers an assignment form to the Company
assigning this Warrant in full. The Warrant, if properly assigned in accordance herewith, may be exercised by a new holder for the purchase
of Warrant Shares without having a new Warrant issued.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>New Warrants</U>. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of
the Company, together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by
the Holder or its agent or attorney. Subject to compliance with <U>Section 4(a)</U>, as to any transfer which may be involved in such
division or combination, the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be
divided or combined in accordance with such notice. All Warrants issued on transfers or exchanges shall be dated the Initial Exercise
Date and shall be identical with this Warrant except as to the number of Warrant Shares issuable pursuant thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Warrant Register</U>. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the
&ldquo;<U>Warrant Register</U>&rdquo;), in the name of the record Holder hereof from time to time. The Company may deem and treat the
registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder,
and for all other purposes, absent actual notice to the contrary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)
<U>Transfer Restrictions</U>. Subject to any limitations imposed by applicable law, this Warrant may be offered for sale, sold, transferred,
or assigned without the consent of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)
<U>Representation by the Holder</U>. The Holder, by the acceptance hereof, represents and warrants that it is acquiring this Warrant
and, upon any exercise hereof, will acquire the Warrant Shares issuable upon such exercise, for its own account and not with a view to
or for distributing or reselling such Warrant Shares or any part thereof in violation of the Securities Act or any applicable state securities
law, except pursuant to sales registered or exempted under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
5. <U>Miscellaneous</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>No Rights as Stockholder Until Exercise</U>. This Warrant does not entitle the Holder to any voting rights, dividends or other rights
as a stockholder of the Company prior to the exercise hereof as set forth in <U>Section 2(d)(i)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>Loss, Theft, Destruction, or Mutilation of Warrant</U>. The Company covenants that upon receipt by the Company of evidence reasonably
satisfactory to it of the loss, theft, destruction, or mutilation of this Warrant or any stock certificate relating to the Warrant Shares,
and in case of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant,
shall not include the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the
Company will make and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant
or stock certificate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Saturdays, Sundays, Holidays, etc</U>. If the last or appointed day for the taking of any action or the expiration of any right required
or granted herein shall not be a Business Day, then, such action may be taken or such right may be exercised on the next succeeding Business
Day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)
<U>Authorized Shares</U>. The Company covenants that, during the period the Warrant is outstanding, it will reserve from its authorized
and unissued Common Stock a sufficient number of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase
rights under this Warrant (the &ldquo;<U>Required Reserve Amount</U>&rdquo;). The Company further covenants that its issuance of this
Warrant shall constitute full authority to its officers who are charged with the duty of issuing the necessary Warrant Shares upon the
exercise of the purchase rights under this Warrant. The Company will take all such reasonable action as may be necessary to assure that
such Warrant Shares may be issued as provided herein without violation of any applicable law or regulation, or of any requirements of
the Trading Market upon which the Common Stock may be listed. The Company covenants that all Warrant Shares which may be issued upon
the exercise of the purchase rights represented by this Warrant will, upon exercise of the purchase rights represented by this Warrant
and payment for such Warrant Shares in accordance herewith, be duly authorized, validly issued, fully paid, and nonassessable and free
from all taxes, liens, and charges created by the Company in respect of the issue thereof (other than taxes in respect of any transfer
occurring contemporaneously with such issue).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)
<U>Transfer Agent Instructions</U>. The Company covenants and agrees that it will, at all times during the period the Warrant is outstanding,
maintain a duly qualified independent Transfer Agent. The Company represents and covenants that, within one (1) day from the Initial
Exercise Date, it will either (i) issue irrevocable instructions to its current Transfer Agent (and each Transfer Agent appointed thereafter)
to issue certificates, registered in the name of the Holder or its nominee, for the Warrant Shares in such amounts as specified from
time to time by the Holder to the Company upon exercise of this Warrant in accordance with the terms thereof (the &ldquo;<U>Irrevocable
Transfer Agent Instructions</U>&rdquo;), or (ii) appoint a new Transfer Agent, at which time the Company (a) shall provide a copy of
its agreement with the new Transfer Agent to the Holder, and (b) issue Irrevocable Transfer Agent Instructions to the new Transfer Agent.
Such Irrevocable Transfer Agent Instructions shall be in a form acceptable to the Holder and shall include a provision to irrevocably
reserve the Required Reserve Amount. The Irrevocable Transfer Agent Instructions shall be signed by the Company&rsquo;s Transfer Agent
as of the date of the Initial Exercise Date or by the New Transfer Agent, as applicable, and by the Company. The Company warrants that,
(i) no instruction other than the Irrevocable Transfer Agent Instructions referred to in this Section 5(e), and stop transfer instructions
to give effect to Section 5(g) (prior to registration of the Warrant Shares under the Securities Act or the date on which the Warrant
Shares may be sold pursuant to Rule 144 without any restriction as to the number of Securities as of a particular date that can then
be immediately sold), will be given by the Company to its Transfer Agent and that the Warrant Shares shall otherwise be freely transferable
on the books and records of the Company as and to the extent provided in this Warrant and the Purchase Agreement, (ii) it will not direct
its Transfer Agent not to transfer or delay, impair, and/or hinder its Transfer Agent in transferring (or issuing)(electronically or
in certificated form) any certificate for Warrant Shares to be issued to the Holder upon exercise of or otherwise pursuant to this Warrant
as and when required by this Warrant and the Purchase Agreement, and (iii) it will not fail to remove (or direct its Transfer Agent not
to remove or impair, delay, and/or hinder its Transfer Agent from removing) any restrictive legend (or to withdraw any stop transfer
instructions in respect thereof) on any certificate for any Warrant Shares issued to the Holder upon exercise of or otherwise pursuant
to this Warrant as and when required by this Warrant and the Purchase Agreement. Nothing in this Section shall affect in any way the
Holder&rsquo;s obligations to comply with all applicable prospectus delivery requirements, if any, upon resale of the Warrant Shares.
If a Holder provides the Company, at the cost of the Holder, with an opinion of counsel in form, substance, and scope customary for opinions
in comparable transactions, to the effect that a public sale or transfer of such Warrant Shares may be made without registration under
the Securities Act and such sale or transfer is effected, the Company shall permit the transfer, and, in the case of the Warrant Shares,
promptly instruct its Transfer Agent to issue one or more certificates, free from restrictive legend, in such name and in such denominations
as specified by the Holder. The Company acknowledges that a breach by it of its obligations hereunder will cause irreparable harm to
the Holder, by vitiating the intent and purpose of the transactions contemplated hereby. Accordingly, the Company acknowledges that the
remedy at law for a breach of its obligations under this Section 5(e) may be inadequate and agrees, in the event of a breach or threatened
breach by the Company of the provisions of this Section, that the Holder shall be entitled, in addition to all other available remedies,
to an injunction restraining any breach and requiring immediate transfer, without the necessity of showing economic loss and without
any bond or other security being required.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f)
<U>Jurisdiction</U>. All questions concerning the construction, validity, enforcement, and interpretation of this Warrant shall be determined
in accordance with the provisions of the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">g)
<U>Restrictions</U>. The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, will
have restrictions upon resale imposed by state and federal securities laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">h)
<U>Nonwaiver and Expenses</U>. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall
operate as a waiver of such right or otherwise prejudice the Holder&rsquo;s rights, powers, or remedies, notwithstanding the fact that
all rights hereunder terminate on the Termination Date. If the Company willfully and knowingly fails to comply with any provision of
this Warrant, which results in any material damages to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient
to cover any costs and expenses including, but not limited to, reasonable attorneys&rsquo; fees, including those of appellate proceedings,
incurred by the Holder in collecting any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies
hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i)
<U>Notices</U>. Any notice, request or other document required or permitted to be given or delivered to the Holder by the Company shall
be delivered in accordance with the notice provisions of the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">j)
<U>Limitation of Liability</U>. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant
to purchase Warrant Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of
the Holder for the purchase price of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company
or by creditors of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">k)
<U>Remedies</U>. The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will
be entitled to specific performance of its rights under this Warrant. The Company agrees that monetary damages may not be adequate compensation
for any loss incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to assert the
defense in any action for specific performance that a remedy at law would be adequate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">l)
<U>Successors and Assigns</U>. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall
inure to the benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns
of Holder. The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall
be enforceable by the Holder or holder of Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">m)
<U>Amendment</U>. This Warrant (other than <U>Section 2(e)</U>) may be modified or amended or the provisions hereof waived with the written
consent of the Company and the Holder. No waiver shall be effective unless it is in writing and signed by an authorized representative
of the waiving party.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">n)
<U>Severability</U>. If any provision of this Warrant is prohibited by law or otherwise determined to be invalid or unenforceable by
a court of competent jurisdiction, the provision that would otherwise be prohibited, invalid or unenforceable shall be deemed amended
to apply to the broadest extent that it would be valid and enforceable, and the invalidity or unenforceability of such provision shall
not affect the validity of the remaining provisions of this Warrant so long as this Warrant as so modified continues to express, without
material change, the original intentions of the parties as to the subject matter hereof and the prohibited nature, invalidity or unenforceability
of the provision(s) in question does not substantially impair the respective expectations or reciprocal obligations of the parties or
the practical realization of the benefits that would otherwise be conferred upon the parties. The parties will endeavor in good faith
negotiations to replace the prohibited, invalid or unenforceable provision(s) with a valid provision(s), the effect of which comes as
close as possible to that of the prohibited, invalid or unenforceable provision(s).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">o)
<U>Headings</U>. This Warrant shall be deemed to be jointly drafted by the Company and the Holder and shall not be construed against
any Person as the drafter hereof. The headings of this Warrant are for convenience of reference and shall not form part of, or affect
the interpretation of, this Warrant. Terms used in this Warrant but defined in the other Transaction Documents shall have the meanings
ascribed to such terms on the Closing Date in such other Transaction Documents unless otherwise consented to in writing by the Holder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">p)
<U>Governing Law</U>. This Warrant shall be governed by and construed and enforced in accordance with, and all questions concerning the
construction, validity, interpretation, and performance of this Warrant shall be governed by, the internal laws of the State of Delaware,
without giving effect to any choice of law or conflict of law provision or rule (whether of the State of Delaware or any other jurisdictions)
that would cause the application of the laws of any jurisdictions other than the State of Delaware. The Company hereby irrevocably waives
personal service of process and consents to process being served in any such suit, action, or proceeding by mailing a copy thereof to
the Company at the address set forth in the Purchase Agreement and agrees that such service shall constitute good and sufficient service
of process and notice thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">q)
<U>Jurisdiction and Venue</U>. Each party hereby irrevocably submits that any dispute, controversy or claim arising out of or relating
to this Warrant, shall be submitted to the exclusive jurisdiction of the Chancery Court of the State of Delaware and the United States
District Court for the District of Delaware. Each party hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding,
any claim that it is not personally subject to the jurisdiction of any such court, that such suit, action or proceeding is brought in
an inconvenient forum or that the venue of such suit, action or proceeding is improper. Each party hereby irrevocably waives personal
service of process and consents to process being served in any such suit, action or proceeding by mailing a copy thereof to such party
at the address for such notices to it under the Purchase Agreement and agrees that such service shall constitute good and sufficient
service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any
manner permitted by law. EACH PARTY HEREBY IRREVOCABLY WAIVES ANY RIGHT IT MAY HAVE, AND AGREES NOT TO REQUEST, A JURY TRIAL FOR THE
ADJUDICATION OF ANY DISPUTE HEREUNDER OR IN CONNECTION HEREWITH OR </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">ARISING
OUT OF THIS WARRANT. The parties agree that all dispute resolution proceedings in accordance with this Section 5(o) may be conducted
in a virtual setting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>********************</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(Signature
Page Follows)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>


<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the Company has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above
indicated.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>NEXTTRIP, INC.</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Bill Kerby</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bill
    Kerby</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[Signature Page to Warrant]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">EXHIBIT
A</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTICE
OF EXERCISE</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">TO
BE EXECUTED BY THE REGISTERED HOLDER TO EXERCISE THIS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WARRANT
TO PURCHASE COMMON STOCK</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NEXTTRIP,
INC.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned holder hereby exercises the right to purchase  of the shares of Common Stock (&ldquo;<U>Warrant Shares</U>&rdquo;) of NextTrip,
Inc., a Nevada corporation (the &ldquo;Company&rdquo;), evidenced by the Warrant (the &ldquo;<U>Warrant</U>&rdquo;). Capitalized terms
used herein and not otherwise defined shall have the respective meanings set forth in the Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.
<U>Form of Exercise Price</U>. The Holder intends that payment of the Aggregate Exercise Price shall be made as:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">____________
<FONT STYLE="font-size: 10pt">a &ldquo;<U>Cash Exercise</U>&rdquo; with respect to ____________ Warrant Shares; and/or</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;____________
a &ldquo;<U>Cashless Exercise</U>&rdquo; with respect to ____________ Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.
<U>Payment of Exercise Price</U>. In the event that the Holder has elected a Cash Exercise with respect to some or all of the Warrant
Shares to be issued pursuant hereto, the Holder shall pay the Aggregate Exercise Price in the sum of $ ____________ to the Company in
accordance with the terms of the Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.
<U>Delivery of Warrant Shares</U>. The Company shall deliver to Holder, or its designee or agent as specified below, ____________ Warrant
Shares in accordance with the terms of the Warrant. Delivery shall be made to Holder, or for its benefit, as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;
Check here if requesting delivery as a certificate to the following name and to the following address:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="width: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issue to:</FONT></TD>
  <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 46pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;
&nbsp;&nbsp;&nbsp;Check here if requesting delivery by Deposit/Withdrawal at Custodian as follows:</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 46pt; text-align: justify; text-indent: -0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 46pt; text-align: justify; text-indent: 0pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="width: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">DTC Participant:</FONT></TD>
  <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">DTC Number:</FONT></TD>
  <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Account Number:</FONT></TD>
  <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 46pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Date:
___________ __,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 46pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Name
of Registered Holder</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 46pt; text-align: justify; text-indent: 0pt"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 46pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 46pt; text-align: justify; text-indent: 0pt"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 15%"><FONT STYLE="font-family: Times New Roman, Times, Serif">Tax
    ID:</FONT></TD>
    <TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left; width: 35%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Facsimile:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">E-mail
    Address:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 46pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">EXHIBIT
B</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASSIGNMENT
FORM</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<I>To
assign the foregoing Warrant, execute this form and supply required information. Do not use this form to purchase shares</I>.)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FOR
VALUE RECEIVED, the foregoing Warrant and all rights evidenced thereby are hereby assigned to</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif">Name:</FONT></TD>
    <TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif">(Please
    Print)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Address:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">(Please
    Print)</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated:
________ __,</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif">____</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s
Signature:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s
Address:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 14; Options: Last -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.13
<SEQUENCE>4
<FILENAME>ex4-13.htm
<DESCRIPTION>EX-4.13
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 4.13</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt">NEITHER THIS
SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR
THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE
&ldquo;SECURITIES ACT&rdquo;), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER
THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE
SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS
SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">COMMON STOCK PURCHASE WARRANT</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">NEXTTRIP, INC.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 223.4pt; text-indent: -73pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; font-size: 10pt; text-align: justify">Warrant Shares: 250,000</TD>
    <TD STYLE="width: 50%; font-size: 10pt; text-align: right">Issue Date: December 31, 2024</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in">THIS COMMON STOCK
PURCHASE WARRANT (the &ldquo;<U>Warrant</U>&rdquo;) certifies that, for value received, AOS Holdings LLC or its assigns (the &ldquo;<U>Holder</U>&rdquo;)
is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time or times
on or after the date that is six (6) months from the Issue Date (the &ldquo;<U>Initial Exercise Date</U>&rdquo;) and on or prior to 5:00
p.m. (New York City time) on June 30, 2028, the three (3) year anniversary of the Initial Exercise Date (the &ldquo;<U>Termination Date</U>&rdquo;),
but not thereafter, to subscribe for and purchase from NextTrip, Inc., a Nevada corporation (the &ldquo;<U>Company</U>&rdquo;), up to
250,000 shares (as subject to adjustment hereunder, the &ldquo;<U>Warrant Shares</U>&rdquo;) of Common Stock. The purchase price of one
share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 0.5in"><U>Section 1</U>.
<U>Definitions</U>. Capitalized terms used and not otherwise defined herein shall have the meanings set forth in that certain Securities
Purchase Agreement (the &ldquo;<U>Purchase Agreement</U>&rdquo;), dated December 30, 2024, among the Company and the purchasers signatory
thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt .5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt .5in"><U>Section 2</U>. <U>Exercise</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">a) <U>Exercise
of Warrant</U>. Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time or times
on or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company of a duly executed PDF copy
submitted by e-mail (or e-mail attachment) of the Notice of </FONT>Exercise in the form annexed hereto (the &ldquo;<U>Notice of
Exercise</U>&rdquo;). Within the earlier of (i) two (2) Trading Days and (ii) the number of Trading Days comprising the Standard
Settlement Period (as defined in Section 2(c)(i) herein) following the date of exercise as aforesaid, the Holder shall deliver the
aggregate Exercise Price for the Warrant Shares specified in the applicable Notice of Exercise by wire transfer or cashier&rsquo;s
check drawn on a United States bank. No ink-original Notice of Exercise shall be required, nor shall any medallion guarantee (or
other type of guarantee or notarization) of any Notice of Exercise be required. Notwithstanding anything herein to the contrary, the
Holder shall not be required to physically surrender this Warrant to the Company until the Holder has purchased all of the Warrant
Shares available hereunder and the Warrant has been exercised in full, in which case, the Holder shall surrender this Warrant to the
Company for cancellation as soon as reasonably practicable of the date on which the final Notice of Exercise is delivered to the
Company. Partial exercises of this Warrant resulting in purchases of a portion of the total number of Warrant Shares available
hereunder shall have the effect of lowering the outstanding number of Warrant Shares purchasable hereunder in an amount equal to the
applicable number of Warrant Shares purchased. The Holder and the Company shall maintain records showing the number of Warrant
Shares purchased and the date of such purchases. The Company shall deliver any objection to any Notice of Exercise within one (1)
Trading Day of receipt of such notice. <B>The Holder and any assignee, by acceptance of this Warrant, acknowledge and agree that, by
reason of the provisions of this paragraph, following the purchase of a portion of the Warrant Shares hereunder, the number of
Warrant Shares available for purchase hereunder at any given time may be less than the amount stated on the face hereof.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt .5in; text-indent: 35.95pt">b) <U>Exercise Price</U>. The
exercise price per share of Common Stock under this Warrant shall be $4.00, subject to adjustment hereunder (the &ldquo;<U>Exercise
Price</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 1in; margin-top: 0pt; margin-bottom: 0pt"> c) <U>Mechanics of Exercise</U>.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 29.6pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 29.6pt"><FONT STYLE="font-size: 10pt">i. <U>Delivery
of Warrant Shares Upon Exercise</U>. The Company shall cause the Warrant Shares purchased hereunder to be transmitted by the
Transfer Agent to the Holder by crediting the account of the Holder&rsquo;s or its designee&rsquo;s balance account with The
Depository Trust Company through its Deposit or Withdrawal at Custodian system (&ldquo;<U>DWAC</U>&rdquo;) if the Company is then a
participant in such system and either (A) there is an effective registration statement permitting the issuance of the Warrant Shares
to or resale of the Warrant Shares by the Holder or (B) the Warrant Shares are eligible for resale by the Holder without volume or
manner-of-sale limitations pursuant to Rule 144, and otherwise by physical delivery of a certificate, registered in the
Company&rsquo;s share register in the name of the Holder or its designee, for the number of Warrant Shares to which the Holder is
entitled pursuant to such exercise to the address specified by the Holder in the Notice of Exercise by the date that is the earliest
of (i) two (2) Trading Days after the delivery to the Company of the Notice of Exercise, (ii) one (1) </FONT>Trading Day after
delivery of the aggregate Exercise Price to the Company and (iii) the number of Trading Days comprising the Standard Settlement
Period after the delivery to the Company of the Notice of Exercise (such date, the &ldquo;<U>Warrant Share Delivery
Date</U>&rdquo;). Upon delivery of the Notice of Exercise, the Holder shall be deemed for all corporate purposes to have become the
holder of record of the Warrant Shares with respect to which this Warrant has been exercised, irrespective of the date of delivery
of the Warrant Shares, provided that payment of the aggregate Exercise Price is received by the Warrant Share Delivery Date. The
Company agrees to maintain a transfer agent that is a participant in the FAST program so long as this Warrant remains outstanding
and exercisable. As used herein, &ldquo;<U>Standard Settlement Period</U>&rdquo; means the standard settlement period, expressed in
a number of Trading Days, on the Company&rsquo;s primary Trading Market with respect to the Common Stock as in effect on the date of
delivery of the Notice of Exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 29.6pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 29.6pt">ii.&nbsp;<U>Delivery
of New Warrants Upon Exercise</U>. If this Warrant shall have been exercised in part, the Company shall, at the request of a Holder and
upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant evidencing
the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in all other respects
be identical with this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 29.6pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 29.6pt">iii.&nbsp;<U>Rescission
Rights</U>. If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant to Section 2(c)(i)
by the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 23.6pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 29.6pt">iv.&nbsp;<U>No
Fractional Shares or Scrip</U>. No fractional shares or scrip representing fractional shares shall be issued upon the exercise of this
Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company shall,
at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied by the
Exercise Price or round up to the next whole share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 27pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 29.6pt"><FONT STYLE="font-size: 10pt">v.&nbsp;<U>Charges,
Taxes and Expenses</U>. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax or other incidental
expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the Company, and such Warrant
Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder; <U>provided</U>, <U>however</U>,
that, in the event that Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when surrendered for
exercise shall be accompanied by the Assignment Form attached </FONT>hereto duly executed by the Holder and the Company may require, as
a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto. The Company shall pay all
Transfer Agent fees required for same-day processing of any Notice of Exercise and all fees to the Depository Trust Company (or another
established clearing corporation performing similar functions) required for same-day electronic delivery of the Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 29.6pt">&nbsp;</P>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 29.6pt">vi.&nbsp;<U>Closing
of Books</U>. The Company will not close its stockholder books or records in any manner which prevents the timely exercise of this Warrant,
pursuant to the terms hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 29.6pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 1in; margin-top: 0pt; margin-bottom: 0pt"> d) <U>Holder&rsquo;s Exercise Limitations</U>.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 157.55pt; text-align: justify; text-indent: 20.6pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 29.6pt"><FONT STYLE="font-size: 10pt">i.&nbsp;<U>Beneficial
Ownership Limitation</U>. The Company shall not effect any exercise of this Warrant, and a Holder shall not have the right to exercise
any portion of this Warrant, pursuant to Section 2 or otherwise, to the extent that after giving effect to such issuance after exercise
as set forth on the applicable Notice of Exercise, the Holder (together with the Holder&rsquo;s Affiliates, and any other Persons acting
as a group together with the Holder or any of the Holder&rsquo;s Affiliates (such Persons, &ldquo;<U>Attribution Parties</U>&rdquo;)),
would beneficially own in excess of the Beneficial Ownership Limitation (as defined below). For purposes of the foregoing sentence, the
number of shares of Common Stock beneficially owned by the Holder and its Affiliates and Attribution Parties shall include the number
of shares of Common Stock held by such Holder and all other Attribution Parties plus the number of shares of Common Stock issuable upon
exercise of this Warrant with respect to which such determination is being made, but shall exclude the number of shares of Common Stock
which would be issuable upon (i) exercise of the remaining, nonexercised portion of this Warrant beneficially owned by the Holder or any
of its Affiliates or Attribution Parties and (ii) exercise or conversion of the unexercised or nonconverted portion of any other securities
of the Company (including, without limitation, any other Common Stock Equivalents) subject to a limitation on conversion or exercise analogous
to the limitation contained herein beneficially owned by the Holder or any of its Affiliates or Attribution Parties. Except as set forth
in the preceding sentence, for purposes of this Section 2(d), beneficial ownership shall be calculated in accordance with Section 13(d)
of the Exchange Act and the rules and regulations promulgated thereunder, it being acknowledged by the Holder that the Company is not
representing to the Holder that such calculation is in compliance with Section 13(d) of the Exchange Act and the Holder is solely responsible
for any schedules required to be filed in accordance therewith. To the extent that the limitation contained in this Section 2(d) applies,
the determination of whether this Warrant is exercisable (in relation to </FONT>other securities owned by the Holder together with any
Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable shall be in the sole discretion of the Holder,
and the submission of a Notice of Exercise shall be deemed to be the Holder&rsquo;s determination of whether this Warrant is exercisable
(in relation to other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this
Warrant is exercisable, in each case subject to the Beneficial Ownership Limitation, and the Company shall have no obligation to verify
or confirm the accuracy of such determination. In addition, a determination as to any group status as contemplated above shall be determined
in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder. For purposes of this Section
2(d), in determining the number of outstanding shares of Common Stock, a Holder may rely on the number of outstanding shares of Common
Stock as reflected in (A) the Company&rsquo;s most recent periodic or annual report filed with the Commission, as the case may be, (B)
a more recent public announcement by the Company or (C) a more recent written notice by the Company or the Transfer Agent setting forth
the number of shares of Common Stock outstanding. Upon the written or oral request of a Holder, the Company shall within one Trading Day
confirm orally and in writing to the Holder the number of shares of Common Stock then outstanding. In any case, the number of outstanding
shares of Common Stock shall be determined after giving effect to the conversion or exercise of securities of the Company, including this
Warrant, by the Holder or its Affiliates or Attribution Parties since the date as of which such number of outstanding shares of Common
Stock was reported. The &ldquo;<U>Beneficial Ownership Limitation</U>&rdquo; shall be 4.99% (or, upon election by a Holder in compliance
with this Section 2(d) prior to the issuance of any Warrants, 9.99%) of the number of shares of the Common Stock outstanding immediately
after giving effect to the issuance of shares of Common Stock issuable upon exercise of this Warrant. The Holder, upon notice to the Company,
may increase or decrease the Beneficial Ownership Limitation provisions of this Section 2(d), provided that the Beneficial Ownership Limitation
in no event exceeds 9.99% of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares
of Common Stock upon exercise of this Warrant held by the Holder and the provisions of this Section 2(d) shall continue to apply. Any
increase in the Beneficial Ownership Limitation will not be effective until the 61<SUP>st</SUP> day after such notice is delivered to
the Company. The provisions of this paragraph shall be construed and implemented in a manner otherwise than in strict conformity with
the terms of this Section 2(d) to correct this paragraph (or any portion hereof) which may be defective or inconsistent with the intended
Beneficial Ownership Limitation herein contained or to make changes or supplements necessary or desirable to properly give effect to such
limitation. The limitations contained in this paragraph shall apply to a successor holder of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 29.6pt">&nbsp;</P>


<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><U>Section 3</U>. <U>Certain Adjustments</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt .5in; text-align: justify; text-indent: 0.5in">a)&nbsp;<U>Stock
Dividends and Splits</U>. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise makes
a distribution or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable in shares of
Common Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon exercise of this
Warrant), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way of reverse
stock split) outstanding shares of Common Stock into a smaller number of shares, or (iv) issues by reclassification of shares of the Common
Stock any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which the
numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before such event
and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event, and the number of
shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this Warrant
shall remain unchanged. Any adjustment made pursuant to this Section 3(a) shall become effective immediately after the record date for
the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after the effective
date in the case of a subdivision, combination or re-classification.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt .5in; text-align: justify; text-indent: 35.95pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 35.95pt">b)&nbsp;<U>Subsequent
Rights Offerings</U>. In addition to any adjustments pursuant to Section 3(a) above, if at any time the Company grants, issues or sells
any Common Stock Equivalents or rights to purchase stock, warrants, securities or other property pro rata to the record holders of any
class of shares of Common Stock (the &ldquo;<U>Purchase Rights</U>&rdquo;), then the Holder will be entitled to acquire, upon the terms
applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had held the number
of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise hereof) immediately
before the date on which a record is taken for the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the
date as of which the record holders of shares of Common Stock are to be determined for the grant, issue or sale of such Purchase Rights.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">c)&nbsp;<U>Pro
Rata Distributions</U>. During such time as this Warrant is outstanding, if the Company shall declare or make any dividend or other distribution
of its assets (or rights to acquire its assets) to holders of shares of Common Stock, by way of return of capital or otherwise (including,
without limitation, any distribution of cash, stock or other securities, property or options by way of a dividend, spin off, reclassification,
corporate rearrangement, scheme of arrangement or other similar transaction) (a &ldquo;<U>Distribution</U>&rdquo;), at any time after
the issuance of this Warrant, then, in each such case, the Holder shall be entitled to participate in such Distribution to the same extent
that the Holder would have participated therein if the Holder had held the number of shares of Common Stock </FONT>acquirable upon complete
exercise of this Warrant (without regard to any limitations on exercise hereof) immediately before the date of which a record is taken
for such Distribution, or, if no such record is taken, the date as of which the record holders of shares of Common Stock are to be determined
for the participation in such Distribution.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">d)&nbsp;<U>Fundamental
Transaction</U>. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or more related transactions
effects any merger or consolidation of the Company with or into another Person, (ii) the Company (or any Subsidiary), directly or indirectly,
effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially all of its assets in one
or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange offer (whether by the Company
or another Person) is completed pursuant to which holders of Common Stock are permitted to sell, tender or exchange their shares for other
securities, cash or property and has been accepted by the holders of more than 50% of the outstanding Common Stock or more than 50% of
the voting power of the common equity of the Company, (iv) the Company, directly or indirectly, in one or more related transactions effects
any reclassification, reorganization or recapitalization of the Common Stock or any compulsory share exchange pursuant to which the Common
Stock is effectively converted into or exchanged for other securities, cash or property, or </FONT>(v) the Company, directly or indirectly,
in one or more related transactions consummates a stock or share purchase agreement or other business combination (including, without
limitation, a reorganization, recapitalization, spin-off, merger or scheme of arrangement) with another Person or group of Persons whereby
such other Person or group acquires more than 50% of the outstanding shares of Common Stock or more than 50% of the voting power of the
common equity of the Company (each a &ldquo;<U>Fundamental Transaction</U>&rdquo;), then, upon any subsequent exercise of this Warrant,
the Holder shall have the right to receive, for each Warrant Share that would have been issuable upon such exercise immediately prior
to the occurrence of such Fundamental Transaction, at the option of the Holder (without regard to any limitation in Section 2(e) on the
exercise of this Warrant), the number of shares of Common Stock of the successor or acquiring corporation or of the Company, if it is
the surviving corporation, and any additional consideration (the &ldquo;<U>Alternate Consideration</U>&rdquo;) receivable as a result
of such Fundamental Transaction by a holder of the number of shares of Common Stock for which this Warrant is exercisable immediately
prior to such Fundamental Transaction (without regard to any limitation in Section 2(e) on the exercise of this Warrant). For purposes
of any such exercise, the determination of the Exercise Price shall be appropriately adjusted to apply to such Alternate Consideration
based on the amount of Alternate Consideration issuable in respect of one share of Common Stock in such Fundamental Transaction, and the
Company shall apportion the Exercise Price among the Alternate Consideration in a reasonable manner reflecting the relative value of any
different components of the Alternate Consideration. If holders of Common Stock are given any choice as to the securities, cash or property
to be received in a Fundamental Transaction, then the Holder shall be given the same choice as to the Alternate Consideration it receives
upon any exercise of this Warrant following such Fundamental Transaction. The Company shall cause any successor entity in a Fundamental
Transaction in which the Company is not the survivor (the &ldquo;<U>Successor Entity</U>&rdquo;) to assume in writing all of the obligations
of the Company under this Warrant and the other Transaction Documents in accordance with the provisions of this Section 3(d) pursuant
to written agreements in form and substance reasonably satisfactory to the Holder and approved by the Holder (without unreasonable delay)
prior to such Fundamental Transaction and shall, at the option of the Holder, deliver to the Holder in exchange for this Warrant a security
of the Successor Entity evidenced by a written instrument substantially similar in form and substance to this Warrant which is exercisable
for a corresponding number of shares of capital stock of such Successor Entity (or its parent entity) equivalent to the shares of Common
Stock acquirable and receivable upon exercise of this Warrant (without regard to any limitations on the exercise of this Warrant) prior
to such Fundamental Transaction, and with an exercise price which applies the exercise price hereunder to such shares of capital stock
(but taking into account the relative value of the shares of Common Stock pursuant to such Fundamental Transaction and the value of such
shares of capital stock, such number of shares of capital stock and such exercise price being for the purpose of protecting the economic
value of this Warrant immediately prior to the consummation of such Fundamental Transaction), and which is reasonably satisfactory in
form and substance to the Holder. Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall be added to the
term &ldquo;Company&rdquo; under this Warrant (so that from and after the occurrence or consummation of such Fundamental Transaction,
each and every provision of this Warrant and the other Transaction Documents referring to the &ldquo;Company&rdquo; shall refer instead
to each of the Company and the Successor Entity or Successor Entities, jointly and severally), and the Successor Entity or Successor Entities,
jointly and severally with the Company, may exercise every right and power of the Company prior thereto and the Successor Entity or Successor
Entities shall assume all of the obligations of the Company prior thereto under this Warrant and the other Transaction Documents with
the same effect as if the Company and such Successor Entity or Successor Entities, jointly and severally, had been named as the Company
herein. For the avoidance of doubt, the Holder shall be entitled to the benefits of the provisions of this Section 3(d) regardless of
(i) whether the Company has sufficient authorized shares of Common Stock for the issuance of Warrant Shares and/or (ii) whether a Fundamental
Transaction occurs prior to the Initial Exercise Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt .5in; text-align: justify; text-indent: 0.5in">e)&nbsp;<U>Calculations</U>.
All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share, as the case may be. For purposes
of this Section 3, the number of shares of Common Stock deemed to be issued and outstanding as of a given date shall be the sum of the
number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 1in; margin-top: 0pt; margin-bottom: 0pt"> f) <U>Notice to Holder</U>.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 143.95pt; text-align: justify; text-indent: 29.6pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 29.6pt">i.&nbsp;<U>Adjustment
to Exercise Price</U>. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company shall promptly
deliver to the Holder by email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment to the number
of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 143.95pt; text-align: justify; text-indent: 26.25pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 29.6pt">ii.&nbsp;<U>Notice
to Allow Exercise by Holder</U>. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on the Common
Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C) the Company shall
authorize the granting to all holders of the Common Stock rights or warrants to subscribe for or purchase any shares of capital stock
of any class or of any rights, (D) the approval of any stockholders of the Company shall be required in connection with any reclassification
of the Common Stock, any consolidation or merger to which the Company (or any of its Subsidiaries) is a party, any sale or transfer of
all or substantially all of its assets, or any compulsory share exchange whereby the Common Stock is converted into other securities,
cash or property, or (E) the Company shall authorize the voluntary or involuntary dissolution, liquidation or winding up of the affairs
of the Company, then, in each case, the Company shall cause to be delivered by email to the Holder at its last email address as it shall
appear upon the Warrant Register of the Company, at least 20 calendar days prior to the applicable record or effective date hereinafter
specified, a notice stating (x) the date on which a record is to be taken for the purpose of such dividend, distribution, redemption,
rights or warrants, or if a record is not to be taken, the date as of which the holders of the Common Stock of record to be entitled to
such dividend, distributions, redemption, rights or warrants are to be determined or (y) the date on which such reclassification, consolidation,
merger, sale, transfer or share exchange is expected to become effective or close, and the date as of which it is expected that holders
of the Common Stock of record shall be entitled to exchange their shares of the Common Stock for securities, cash or other property deliverable
upon such reclassification, consolidation, merger, sale, transfer or share exchange; provided that the failure to deliver such notice
or any defect therein or in the delivery thereof shall not affect the validity of the corporate action required to be specified in such
notice. To the extent that any notice provided in this Warrant constitutes, or contains, material, non-public information regarding the
Company or any of the Subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant to a Current Report
on Form 8-K. The Holder shall remain entitled to exercise this Warrant during the period commencing on the date of such notice to the
effective date of the event triggering such notice except as may otherwise be expressly set forth herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><U>Section 4</U>. <U>Transfer of Warrant</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">a) <U>Transferability</U>.
Subject to compliance with any applicable securities laws and the conditions set forth in Section 4(d) hereof and to the provisions
of Section 4.1 of the Purchase Agreement, this Warrant and all rights hereunder (including, without limitation, any registration
rights) are transferable, in whole or in part, upon surrender of this Warrant at the principal office of the Company or its
designated agent, together with a written assignment of this Warrant substantially in the form attached hereto duly </FONT>executed
by the Holder or its agent or attorney and funds sufficient to pay any transfer taxes payable upon the making of such transfer. Upon
such surrender and, if required, such payment, the Company shall execute and deliver a new Warrant or Warrants in the name of the
assignee or assignees, as applicable, and in the denomination or denominations specified in such instrument of assignment, and shall
issue to the assignor a new Warrant evidencing the portion of this Warrant not so assigned, and this Warrant shall promptly be
cancelled. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant to
the Company unless the Holder has assigned this Warrant in full, in which case, the Holder shall surrender this Warrant to the
Company within three (3) Trading Days of the date on which the Holder delivers an assignment form to the Company assigning this
Warrant in full. The Warrant, if properly assigned in accordance herewith, may be exercised by a new holder for the purchase of
Warrant Shares without having a new Warrant issued.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt .5in; text-align: justify; text-indent: 35.95pt">b) <U>New
Warrants</U>. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of the
Company, together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by the
Holder or its agent or attorney. Subject to compliance with Section 4(a), as to any transfer which may be involved in such division
or combination, the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be
divided or combined in accordance with such notice. All Warrants issued on transfers or exchanges shall be dated the Issue Date of
this Warrant and shall be identical with this Warrant except as to the number of Warrant Shares issuable pursuant thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">c) <U>Warrant
Register</U>. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the
&ldquo;<U>Warrant Register</U>&rdquo;), in the name of the record Holder hereof from time to time. The Company may deem and treat
the registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the
Holder, and for all other purposes, absent actual notice to the contrary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">d) <U>Transfer
Restrictions</U>. If, at the time of the surrender of this Warrant in connection with any transfer of this Warrant, the transfer of
this Warrant shall not be either (i) registered pursuant to an effective registration statement under the Securities Act and under
applicable state securities or blue sky laws or (ii) eligible for resale without volume or manner-of-sale restrictions or current
public information requirements pursuant to Rule 144, the Company may require, as a condition of allowing such transfer, that the
Holder or transferee of this Warrant, as the case may be, comply with the provisions of Section 5.7 of the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">e) <U>Representation
by the Holder</U>. The Holder, by the acceptance hereof, represents and warrants that it is acquiring this Warrant and, upon any
exercise hereof, will acquire the Warrant Shares issuable upon such exercise, for its own account and not with a view to or for
distributing or reselling such Warrant Shares or any part thereof in violation of the Securities Act or any applicable state
securities law, except pursuant to sales registered or exempted under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><U>Section 5</U>. <U>Miscellaneous</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">a) <U>No
Rights as Stockholder Until Exercise; No Settlement in Cash</U>. This Warrant does not entitle the Holder to any voting rights,
dividends or other rights as a stockholder of the Company prior to the exercise hereof as set forth in Section 2(c)(i), except as
expressly set forth in Section 3. In no event shall the Company be required to net cash settle an exercise of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">b)&nbsp;<U>Loss,
Theft, Destruction or Mutilation of Warrant</U>. The Company covenants that upon receipt by the Company of evidence reasonably satisfactory
to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares, and in case
of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant, shall not include
the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the Company will make
and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant or stock certificate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">c)&nbsp;<U>Saturdays,
Sundays, Holidays, etc</U>. If the last or appointed day for the taking of any action or the expiration of any right required or granted
herein shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding Business Day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">d)&nbsp;<U>Authorized
Shares</U>. The Company covenants that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued
Common Stock a sufficient number of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights
under this Warrant. The Company further covenants that its issuance of this Warrant shall constitute full authority to its officers who
are charged with the duty of issuing the necessary Warrant Shares upon the exercise of the purchase rights under this Warrant. The Company
will take all such reasonable action as may be necessary to assure that such Warrant Shares may be issued as provided herein without violation
of any applicable law or regulation, or of any requirements of the Trading Market upon which the Common Stock may be listed. The Company
covenants that all Warrant Shares which may be issued upon the exercise of the purchase rights represented by this Warrant will, upon
exercise of the purchase rights represented by this Warrant and payment for such Warrant Shares in accordance herewith, be duly authorized,
validly issued, fully paid and nonassessable and free from all taxes, liens and charges created by the Company in respect of the issue
thereof (other than taxes in respect of any transfer occurring contemporaneously with such issue).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">e)&nbsp;<U>Jurisdiction</U>.
All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be determined in accordance
with the provisions of the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">f)&nbsp;<U>Restrictions</U>.
The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, will have restrictions
upon resale imposed by state and federal securities laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt .5in; text-align: justify; text-indent: 0.5in">g)&nbsp;<U>Nonwaiver
and Expenses</U>. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall operate as
a waiver of such right or otherwise prejudice the Holder&rsquo;s rights, powers or remedies, notwithstanding the fact that the right to
exercise this Warrant terminates on the Termination Date. Without limiting any other provision of this Warrant or the Purchase Agreement,
if the Company willfully and knowingly fails to comply with any provision of this Warrant, which results in any material damages to the
Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover any costs and expenses including, but not limited
to, reasonable attorneys&rsquo; fees, including those of appellate proceedings, incurred by the Holder in collecting any amounts due pursuant
hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">h)&nbsp;<U>Notices</U>.
Any notice, request or other document required or permitted to be given or delivered to the Holder by the Company shall be delivered in
accordance with the notice provisions of the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">i)&nbsp;<U>Limitation
of Liability</U>. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant to purchase Warrant
Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder for the purchase
price of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company or by creditors of the
Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">j)&nbsp;<U>Remedies</U>.
The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will be entitled to specific
performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate compensation for any loss
incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to assert the defense in any
action for specific performance that a remedy at law would be adequate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">k)&nbsp;<U>Successors
and Assigns</U>. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall inure to the
benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns of Holder.
The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall be enforceable
by the Holder or holder of Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">l)&nbsp;<U>Amendment</U>.
This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company, on the one hand, and
the Holder of this Warrant, on the other hand.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">m)&nbsp;<U>Severability</U>.
Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid under applicable law,
but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall be ineffective to the
extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining provisions of this Warrant.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">n)&nbsp;<U>Headings</U>.
The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed a part of this Warrant.</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">********************</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><I>(Signature Page Follows)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0 0pt 0pt; text-indent: 0.5in">IN WITNESS WHEREOF, the Company has
caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above indicated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold">NEXTTRIP, INC.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; font-weight: bold">&nbsp;</TD>
    <TD STYLE="width: 5%; font-weight: bold">&nbsp;</TD>
    <TD STYLE="width: 45%; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>By:</TD>
    <TD STYLE="border-bottom: Black 1pt solid"><I>/s/ Bill Kerby</I></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Name: </TD>
    <TD>William Kerby</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Title: </TD>
    <TD>Chief Executive Officer</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 247.65pt">&nbsp;</P>


<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36.1pt; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">NOTICE OF EXERCISE</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34.2pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left">TO:</TD><TD STYLE="text-align: justify">NEXTTRIP, INC.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34.15pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 1in">(1) The
undersigned hereby elects to purchase _______ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only if exercised
in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34.15pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 1in"> (2) Payment shall take the form of lawful money of the United States.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34.15pt; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 1in">(3) Please
issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-left: 1in; margin-top: 0pt; margin-bottom: 0pt; width: 50%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in">The Warrant Shares shall be delivered to the following
DWAC Account Number:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-left: 1in; margin-top: 0pt; margin-bottom: 0pt; width: 50%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-left: 1in; margin-top: 0pt; margin-bottom: 0pt; width: 50%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-left: 1in; margin-top: 0pt; margin-bottom: 0pt; width: 50%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 1in">(4) <U>Accredited
Investor</U>. The undersigned is an &ldquo;accredited investor&rdquo; as defined in Regulation D promulgated under the Securities
Act of 1933, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify">[SIGNATURE OF HOLDER]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="white-space: nowrap; padding-bottom: 1pt; width: 10%; text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name of Investing Entity:</FONT>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 90%; text-align: justify; font-size: 10pt">&nbsp;</TD></TR>

</TABLE>

<P STYLE="margin: 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="white-space: nowrap; width: 20%; text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Signature of Authorized Signatory of Investing Entity:</I></FONT>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: justify; font-size: 10pt; width: 80%"></TD></TR>

</TABLE>

<P STYLE="margin: 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="white-space: nowrap; width: 12%; text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name of Authorized Signatory:</FONT>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: justify; font-size: 10pt; width: 88%">&nbsp;</TD></TR>

</TABLE>

<P STYLE="margin: 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="white-space: nowrap; width: 12%; text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title of Authorized Signatory:</FONT>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: justify; font-size: 10pt; width: 88%">&nbsp;</TD></TR>

</TABLE>

<P STYLE="margin: 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 3%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: justify; font-size: 10pt; width: 97%">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">EXHIBIT B</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">ASSIGNMENT FORM</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><I>&nbsp;</I></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-indent: 0.25in"><I>(To assign the foregoing Warrant,
execute this form and supply required information. Do not use this form to exercise the Warrant to purchase shares.)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 7.15pt; text-indent: 10.55pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0in; text-indent: 0.25in">FOR VALUE RECEIVED, the foregoing
Warrant and all rights evidenced thereby are hereby assigned to</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 7.15pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 45%">Name:</TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 53%; border-bottom: Black 1pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: left">(Please Print)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Address:</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left">(Please Print)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Phone Number:</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Email Address:</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Dated: _______________ , ________</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Holder&rsquo;s Signature:____________________</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Holder&rsquo;s Address: ____________________</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 11; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.14
<SEQUENCE>5
<FILENAME>ex4-14.htm
<DESCRIPTION>EX-4.14
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 4.14</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt">NEITHER THIS
SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR
THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE
&ldquo;SECURITIES ACT&rdquo;), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER
THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE
SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS
SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">COMMON STOCK PURCHASE WARRANT</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">NEXTTRIP, INC.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 223.4pt; text-indent: -73pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; font-size: 10pt; text-align: justify">Warrant Shares: 250,000</TD>
    <TD STYLE="width: 50%; font-size: 10pt; text-align: right">Issue Date: December 31, 2024</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in">THIS COMMON STOCK
PURCHASE WARRANT (the &ldquo;<U>Warrant</U>&rdquo;) certifies that, for value received, AOS Holdings LLC or its assigns (the &ldquo;<U>Holder</U>&rdquo;)
is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time or times
on or after the date that is six (6) months from the Issue Date (the &ldquo;<U>Initial Exercise Date</U>&rdquo;) and on or prior to 5:00
p.m. (New York City time) on June 30, 2028, the three (3) year anniversary of the Initial Exercise Date (the &ldquo;<U>Termination Date</U>&rdquo;),
but not thereafter, to subscribe for and purchase from NextTrip, Inc., a Nevada corporation (the &ldquo;<U>Company</U>&rdquo;), up to
250,000 shares (as subject to adjustment hereunder, the &ldquo;<U>Warrant Shares</U>&rdquo;) of Common Stock. The purchase price of one
share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 0.5in"><U>Section 1</U>.
<U>Definitions</U>. Capitalized terms used and not otherwise defined herein shall have the meanings set forth in that certain Securities
Purchase Agreement (the &ldquo;<U>Purchase Agreement</U>&rdquo;), dated December 30, 2024, among the Company and the purchasers signatory
thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><U>Section 2</U>.&#9;<U>Exercise</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">a)
<U>Exercise of Warrant</U>. Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time
or times on or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company of a duly executed PDF
copy submitted by e-mail (or e-mail attachment) of the Notice of </FONT>Exercise in the form annexed hereto (the &ldquo;<U>Notice of Exercise</U>&rdquo;).
Within the earlier of (i) two (2) Trading Days and (ii) the number of Trading Days comprising the Standard Settlement Period (as defined
in Section 2(c)(i) herein) following the date of exercise as aforesaid, the Holder shall deliver the aggregate Exercise Price for the
Warrant Shares specified in the applicable Notice of Exercise by wire transfer or cashier&rsquo;s check drawn on a United States bank
unless the cashless exercise procedure specified in Section 2(c) below is specified in the applicable Notice of Exercise. No ink-original
Notice of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of
Exercise be required. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant
to the Company until the Holder has purchased all of the Warrant Shares available hereunder and the Warrant has been exercised in full,
in which case, the Holder shall surrender this Warrant to the Company for cancellation as soon as reasonably practicable of the date on
which the final Notice of Exercise is delivered to the Company. Partial exercises of this Warrant resulting in purchases of a portion
of the total number of Warrant Shares available hereunder shall have the effect of lowering the outstanding number of Warrant Shares purchasable
hereunder in an amount equal to the applicable number of Warrant Shares purchased. The Holder and the Company shall maintain records showing
the number of Warrant Shares purchased and the date of such purchases. The Company shall deliver any objection to any Notice of Exercise
within one (1) Trading Day of receipt of such notice. <B>The Holder and any assignee, by acceptance of this Warrant, acknowledge and agree
that, by reason of the provisions of this paragraph, following the purchase of a portion of the Warrant Shares hereunder, the number of
Warrant Shares available for purchase hereunder at any given time may be less than the amount stated on the face hereof.</B></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 35.95pt">b)&nbsp;<U>Exercise
Price</U>. The exercise price per share of Common Stock under this Warrant shall be $4.00, subject to adjustment hereunder (the &ldquo;<U>Exercise
Price</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 35.95pt">c) <U>Cashless
Exercise</U>. Alternatively, this Warrant may be exercised, in whole or in part, at such time by means of a &ldquo;cashless exercise&rdquo;
in which the Holder shall be entitled to receive a number of Warrant Shares equal to the quotient obtained by dividing [(A-B) (X)] by
(A), where:</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 1in; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0in; text-align: justify; text-indent: 1.5in">(A) = as
applicable: (i) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise if such Notice of Exercise
is (1) both executed and delivered pursuant to Section 2(a) hereof on a day that is not a Trading Day or (2) both executed and delivered
pursuant to Section 2(a) hereof on a Trading Day prior to the opening of &ldquo;regular trading hours&rdquo; (as defined in Rule 600(b)
of Regulation NMS promulgated under the federal securities laws) on such Trading Day, (ii) the VWAP on the Trading Day immediately preceding
the date of the applicable Notice of Exercise of the applicable Notice of Exercise if such Notice of Exercise is executed during &ldquo;regular
trading hours&rdquo; on a Trading Day and is delivered within two (2) hours thereafter (including until two (2) hours after the close
of &ldquo;regular trading hours&rdquo; on a Trading Day) pursuant to Section 2(a) hereof or (iii) the VWAP on the date of the applicable
Notice of Exercise if the date of such Notice of Exercise is a Trading Day and such Notice of Exercise is both executed and delivered
pursuant to Section 2(a) hereof after the close of &ldquo;regular trading hours&rdquo; on such Trading Day;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 1in; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0in; text-align: justify; text-indent: 1.5in">(B) = the Exercise Price of this Warrant, as adjusted hereunder;
and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0in; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0in; text-align: justify; text-indent: 1.5in">(X) = the number
of Warrant Shares that would be issuable upon exercise of this Warrant in accordance with the terms of this Warrant if such exercise were
by means of a cash exercise rather than a cashless exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0in; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0in; text-align: justify; text-indent: 1in">If Warrant Shares
are issued in such a cashless exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9) of the Securities Act,
the Warrant Shares shall take on the registered characteristics of the Warrants being exercised. The Company agrees not to take any position
contrary to this Section 2(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 1in; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 1in; margin-top: 0pt; margin-bottom: 0pt">d) <U>Mechanics of Exercise</U>.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 29.6pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 29.6pt">i. <U>Delivery
of Warrant Shares Upon Exercise</U>. The Company shall cause the Warrant Shares purchased hereunder to be transmitted by the Transfer
Agent to the Holder by crediting the account of the Holder&rsquo;s or its designee&rsquo;s balance account with The Depository Trust Company
through its Deposit or Withdrawal at Custodian system (&ldquo;<U>DWAC</U>&rdquo;) if the Company is then a participant in such system
and either (A) there is an effective registration statement permitting the issuance of the Warrant Shares to or resale of the Warrant
Shares by the Holder or (B) the Warrant Shares are eligible for resale by the Holder without volume or manner-of-sale limitations pursuant
to Rule 144, and otherwise by physical delivery of a certificate, registered in the Company&rsquo;s share register in the name of the
Holder or its designee, for the number of Warrant Shares to which the Holder is entitled pursuant to such exercise to the address specified
by the Holder in the Notice of Exercise by the date that is the earliest of (i) two (2) Trading Days after the delivery to the Company
of the Notice of Exercise, (ii) one (1) Trading Day after delivery of the aggregate Exercise Price (other than in the case of a cashless
exercise) to the Company and (iii) the number of Trading Days comprising the Standard Settlement Period after the delivery to the Company
of the Notice of Exercise (such date, the &ldquo;<U>Warrant Share Delivery Date</U>&rdquo;). Upon delivery of the Notice of Exercise,
the Holder shall be deemed for all corporate purposes to have become the holder of record of the Warrant Shares with respect to which
this Warrant has been exercised, irrespective of the date of delivery of the Warrant Shares, provided that payment of the aggregate Exercise
Price is received by the Warrant Share Delivery Date. The Company agrees to maintain a transfer agent that is a participant in the FAST
program so long as this Warrant remains outstanding and exercisable. As used herein, &ldquo;<U>Standard Settlement Period</U>&rdquo; means
the standard settlement period, expressed in a number of Trading Days, on the Company&rsquo;s primary Trading Market with respect to the
Common Stock as in effect on the date of delivery of the Notice of Exercise.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 29.6pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 29.6pt"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Value: 2; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 29.6pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 29.6pt">ii.&nbsp;<U>Delivery
of New Warrants Upon Exercise</U>. If this Warrant shall have been exercised in part, the Company shall, at the request of a Holder and
upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant evidencing
the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in all other respects
be identical with this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 29.6pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 29.6pt">iii.&nbsp;<U>Rescission
Rights</U>. If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant to Section 2(c)(i)
by the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 23.6pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 29.6pt">iv.&nbsp;<U>No
Fractional Shares or Scrip</U>. No fractional shares or scrip representing fractional shares shall be issued upon the exercise of this
Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company shall,
at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied by the
Exercise Price or round up to the next whole share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 27pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 29.6pt"><FONT STYLE="font-size: 10pt">v.&nbsp;<U>Charges,
Taxes and Expenses</U>. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax or other incidental
expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the Company, and such Warrant
Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder; <U>provided</U>, <U>however</U>,
that, in the event that Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when surrendered for
exercise shall be accompanied by the Assignment Form attached </FONT>hereto duly executed by the Holder and the Company may require, as
a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto. The Company shall pay all
Transfer Agent fees required for same-day processing of any Notice of Exercise and all fees to the Depository Trust Company (or another
established clearing corporation performing similar functions) required for same-day electronic delivery of the Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 29.6pt">&nbsp;</P>


<!-- Field: Page; Sequence: 3; Options: NewSection; Value: 2 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Value: 3; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 29.6pt">vi.&nbsp;<U>Closing
of Books</U>. The Company will not close its stockholder books or records in any manner which prevents the timely exercise of this Warrant,
pursuant to the terms hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 29.6pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 1in; margin-top: 0pt; margin-bottom: 0pt"> e) <U>Holder&rsquo;s Exercise Limitations</U>.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 157.55pt; text-align: justify; text-indent: 20.6pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 29.6pt"><FONT STYLE="font-size: 10pt">i.&nbsp;<U>Beneficial
Ownership Limitation</U>. The Company shall not effect any exercise of this Warrant, and a Holder shall not have the right to exercise
any portion of this Warrant, pursuant to Section 2 or otherwise, to the extent that after giving effect to such issuance after exercise
as set forth on the applicable Notice of Exercise, the Holder (together with the Holder&rsquo;s Affiliates, and any other Persons acting
as a group together with the Holder or any of the Holder&rsquo;s Affiliates (such Persons, &ldquo;<U>Attribution Parties</U>&rdquo;)),
would beneficially own in excess of the Beneficial Ownership Limitation (as defined below). For purposes of the foregoing sentence, the
number of shares of Common Stock beneficially owned by the Holder and its Affiliates and Attribution Parties shall include the number
of shares of Common Stock held by such Holder and all other Attribution Parties plus the number of shares of Common Stock issuable upon
exercise of this Warrant with respect to which such determination is being made, but shall exclude the number of shares of Common Stock
which would be issuable upon (i) exercise of the remaining, nonexercised portion of this Warrant beneficially owned by the Holder or any
of its Affiliates or Attribution Parties and (ii) exercise or conversion of the unexercised or nonconverted portion of any other securities
of the Company (including, without limitation, any other Common Stock Equivalents) subject to a limitation on conversion or exercise analogous
to the limitation contained herein beneficially owned by the Holder or any of its Affiliates or Attribution Parties. Except as set forth
in the preceding sentence, for purposes of this Section 2(d), beneficial ownership shall be calculated in accordance with Section 13(d)
of the Exchange Act and the rules and regulations promulgated thereunder, it being acknowledged by the Holder that the Company is not
representing to the Holder that such calculation is in compliance with Section 13(d) of the Exchange Act and the Holder is solely responsible
for any schedules required to be filed in accordance therewith. To the extent that the limitation contained in this Section 2(d) applies,
the determination of whether this Warrant is exercisable (in relation to </FONT>other securities owned by the Holder together with any
Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable shall be in the sole discretion of the Holder,
and the submission of a Notice of Exercise shall be deemed to be the Holder&rsquo;s determination of whether this Warrant is exercisable
(in relation to other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this
Warrant is exercisable, in each case subject to the Beneficial Ownership Limitation, and the Company shall have no obligation to verify
or confirm the accuracy of such determination. In addition, a determination as to any group status as contemplated above shall be determined
in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder. For purposes of this Section
2(d), in determining the number of outstanding shares of Common Stock, a Holder may rely on the number of outstanding shares of Common
Stock as reflected in (A) the Company&rsquo;s most recent periodic or annual report filed with the Commission, as the case may be, (B)
a more recent public announcement by the Company or (C) a more recent written notice by the Company or the Transfer Agent setting forth
the number of shares of Common Stock outstanding. Upon the written or oral request of a Holder, the Company shall within one Trading Day
confirm orally and in writing to the Holder the number of shares of Common Stock then outstanding. In any case, the number of outstanding
shares of Common Stock shall be determined after giving effect to the conversion or exercise of securities of the Company, including this
Warrant, by the Holder or its Affiliates or Attribution Parties since the date as of which such number of outstanding shares of Common
Stock was reported. The &ldquo;<U>Beneficial Ownership Limitation</U>&rdquo; shall be 4.99% (or, upon election by a Holder in compliance
with this Section 2(d) prior to the issuance of any Warrants, 9.99%) of the number of shares of the Common Stock outstanding immediately
after giving effect to the issuance of shares of Common Stock issuable upon exercise of this Warrant. The Holder, upon notice to the Company,
may increase or decrease the Beneficial Ownership Limitation provisions of this Section 2(d), provided that the Beneficial Ownership Limitation
in no event exceeds 9.99% of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares
of Common Stock upon exercise of this Warrant held by the Holder and the provisions of this Section 2(d) shall continue to apply. Any
increase in the Beneficial Ownership Limitation will not be effective until the 61<SUP>st</SUP> day after such notice is delivered to
the Company. The provisions of this paragraph shall be construed and implemented in a manner otherwise than in strict conformity with
the terms of this Section 2(d) to correct this paragraph (or any portion hereof) which may be defective or inconsistent with the intended
Beneficial Ownership Limitation herein contained or to make changes or supplements necessary or desirable to properly give effect to such
limitation. The limitations contained in this paragraph shall apply to a successor holder of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 29.6pt">&nbsp;</P>


<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><U>Section 3</U>.&#9;<U>Certain Adjustments</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">a)&nbsp;<U>Stock
Dividends and Splits</U>. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise makes
a distribution or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable in shares of
Common Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon exercise of this
Warrant), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way of reverse
stock split) outstanding shares of Common Stock into a smaller number of shares, or (iv) issues by reclassification of shares of the Common
Stock any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which the
numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before such event
and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event, and the number of
shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this Warrant
shall remain unchanged. Any adjustment made pursuant to this Section 3(a) shall become effective immediately after the record date for
the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after the effective
date in the case of a subdivision, combination or re-classification.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 35.95pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 35.95pt">b)&nbsp;<U>Subsequent
Rights Offerings</U>. In addition to any adjustments pursuant to Section 3(a) above, if at any time the Company grants, issues or sells
any Common Stock Equivalents or rights to purchase stock, warrants, securities or other property pro rata to the record holders of any
class of shares of Common Stock (the &ldquo;<U>Purchase Rights</U>&rdquo;), then the Holder will be entitled to acquire, upon the terms
applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had held the number
of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise hereof) immediately
before the date on which a record is taken for the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the
date as of which the record holders of shares of Common Stock are to be determined for the grant, issue or sale of such Purchase Rights.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">c)&nbsp;<U>Pro
Rata Distributions</U>. During such time as this Warrant is outstanding, if the Company shall declare or make any dividend or other distribution
of its assets (or rights to acquire its assets) to holders of shares of Common Stock, by way of return of capital or otherwise (including,
without limitation, any distribution of cash, stock or other securities, property or options by way of a dividend, spin off, reclassification,
corporate rearrangement, scheme of arrangement or other similar transaction) (a &ldquo;<U>Distribution</U>&rdquo;), at any time after
the issuance of this Warrant, then, in each such case, the Holder shall be entitled to participate in such Distribution to the same extent
that the Holder would have participated therein if the Holder had held the number of shares of Common Stock </FONT>acquirable upon complete
exercise of this Warrant (without regard to any limitations on exercise hereof) immediately before the date of which a record is taken
for such Distribution, or, if no such record is taken, the date as of which the record holders of shares of Common Stock are to be determined
for the participation in such Distribution.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">d)&nbsp;<U>Fundamental
Transaction</U>. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or more related transactions
effects any merger or consolidation of the Company with or into another Person, (ii) the Company (or any Subsidiary), directly or indirectly,
effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially all of its assets in one
or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange offer (whether by the Company
or another Person) is completed pursuant to which holders of Common Stock are permitted to sell, tender or exchange their shares for other
securities, cash or property and has been accepted by the holders of more than 50% of the outstanding Common Stock or more than 50% of
the voting power of the common equity of the Company, (iv) the Company, directly or indirectly, in one or more related transactions effects
any reclassification, reorganization or recapitalization of the Common Stock or any compulsory share exchange pursuant to which the Common
Stock is effectively converted into or exchanged for other securities, cash or property, or </FONT>(v) the Company, directly or indirectly,
in one or more related transactions consummates a stock or share purchase agreement or other business combination (including, without
limitation, a reorganization, recapitalization, spin-off, merger or scheme of arrangement) with another Person or group of Persons whereby
such other Person or group acquires more than 50% of the outstanding shares of Common Stock or more than 50% of the voting power of the
common equity of the Company (each a &ldquo;<U>Fundamental Transaction</U>&rdquo;), then, upon any subsequent exercise of this Warrant,
the Holder shall have the right to receive, for each Warrant Share that would have been issuable upon such exercise immediately prior
to the occurrence of such Fundamental Transaction, at the option of the Holder (without regard to any limitation in Section 2(e) on the
exercise of this Warrant), the number of shares of Common Stock of the successor or acquiring corporation or of the Company, if it is
the surviving corporation, and any additional consideration (the &ldquo;<U>Alternate Consideration</U>&rdquo;) receivable as a result
of such Fundamental Transaction by a holder of the number of shares of Common Stock for which this Warrant is exercisable immediately
prior to such Fundamental Transaction (without regard to any limitation in Section 2(e) on the exercise of this Warrant). For purposes
of any such exercise, the determination of the Exercise Price shall be appropriately adjusted to apply to such Alternate Consideration
based on the amount of Alternate Consideration issuable in respect of one share of Common Stock in such Fundamental Transaction, and the
Company shall apportion the Exercise Price among the Alternate Consideration in a reasonable manner reflecting the relative value of any
different components of the Alternate Consideration. If holders of Common Stock are given any choice as to the securities, cash or property
to be received in a Fundamental Transaction, then the Holder shall be given the same choice as to the Alternate Consideration it receives
upon any exercise of this Warrant following such Fundamental Transaction. The Company shall cause any successor entity in a Fundamental
Transaction in which the Company is not the survivor (the &ldquo;<U>Successor Entity</U>&rdquo;) to assume in writing all of the obligations
of the Company under this Warrant and the other Transaction Documents in accordance with the provisions of this Section 3(d) pursuant
to written agreements in form and substance reasonably satisfactory to the Holder and approved by the Holder (without unreasonable delay)
prior to such Fundamental Transaction and shall, at the option of the Holder, deliver to the Holder in exchange for this Warrant a security
of the Successor Entity evidenced by a written instrument substantially similar in form and substance to this Warrant which is exercisable
for a corresponding number of shares of capital stock of such Successor Entity (or its parent entity) equivalent to the shares of Common
Stock acquirable and receivable upon exercise of this Warrant (without regard to any limitations on the exercise of this Warrant) prior
to such Fundamental Transaction, and with an exercise price which applies the exercise price hereunder to such shares of capital stock
(but taking into account the relative value of the shares of Common Stock pursuant to such Fundamental Transaction and the value of such
shares of capital stock, such number of shares of capital stock and such exercise price being for the purpose of protecting the economic
value of this Warrant immediately prior to the consummation of such Fundamental Transaction), and which is reasonably satisfactory in
form and substance to the Holder. Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall be added to the
term &ldquo;Company&rdquo; under this Warrant (so that from and after the occurrence or consummation of such Fundamental Transaction,
each and every provision of this Warrant and the other Transaction Documents referring to the &ldquo;Company&rdquo; shall refer instead
to each of the Company and the Successor Entity or Successor Entities, jointly and severally), and the Successor Entity or Successor Entities,
jointly and severally with the Company, may exercise every right and power of the Company prior thereto and the Successor Entity or Successor
Entities shall assume all of the obligations of the Company prior thereto under this Warrant and the other Transaction Documents with
the same effect as if the Company and such Successor Entity or Successor Entities, jointly and severally, had been named as the Company
herein. For the avoidance of doubt, the Holder shall be entitled to the benefits of the provisions of this Section 3(d) regardless of
(i) whether the Company has sufficient authorized shares of Common Stock for the issuance of Warrant Shares and/or (ii) whether a Fundamental
Transaction occurs prior to the Initial Exercise Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">e)&nbsp;<U>Calculations</U>.
All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share, as the case may be. For purposes
of this Section 3, the number of shares of Common Stock deemed to be issued and outstanding as of a given date shall be the sum of the
number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 1in; margin-top: 0pt; margin-bottom: 0pt"> f) <U>Notice to Holder</U>.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 143.95pt; text-align: justify; text-indent: 29.6pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 29.6pt">i.&nbsp;<U>Adjustment
to Exercise Price</U>. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company shall promptly
deliver to the Holder by email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment to the number
of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 143.95pt; text-align: justify; text-indent: 26.25pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 29.6pt">ii.&nbsp;<U>Notice
to Allow Exercise by Holder</U>. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on the Common
Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C) the Company shall
authorize the granting to all holders of the Common Stock rights or warrants to subscribe for or purchase any shares of capital stock
of any class or of any rights, (D) the approval of any stockholders of the Company shall be required in connection with any reclassification
of the Common Stock, any consolidation or merger to which the Company (or any of its Subsidiaries) is a party, any sale or transfer of
all or substantially all of its assets, or any compulsory share exchange whereby the Common Stock is converted into other securities,
cash or property, or (E) the Company shall authorize the voluntary or involuntary dissolution, liquidation or winding up of the affairs
of the Company, then, in each case, the Company shall cause to be delivered by email to the Holder at its last email address as it shall
appear upon the Warrant Register of the Company, at least 20 calendar days prior to the applicable record or effective date hereinafter
specified, a notice stating (x) the date on which a record is to be taken for the purpose of such dividend, distribution, redemption,
rights or warrants, or if a record is not to be taken, the date as of which the holders of the Common Stock of record to be entitled to
such dividend, distributions, redemption, rights or warrants are to be determined or (y) the date on which such reclassification, consolidation,
merger, sale, transfer or share exchange is expected to become effective or close, and the date as of which it is expected that holders
of the Common Stock of record shall be entitled to exchange their shares of the Common Stock for securities, cash or other property deliverable
upon such reclassification, consolidation, merger, sale, transfer or share exchange; provided that the failure to deliver such notice
or any defect therein or in the delivery thereof shall not affect the validity of the corporate action required to be specified in such
notice. To the extent that any notice provided in this Warrant constitutes, or contains, material, non-public information regarding the
Company or any of the Subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant to a Current Report
on Form 8-K. The Holder shall remain entitled to exercise this Warrant during the period commencing on the date of such notice to the
effective date of the event triggering such notice except as may otherwise be expressly set forth herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><U>Section 4</U>.&#9;<U>Transfer of Warrant</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">a)&nbsp;<U>Transferability</U>.
Subject to compliance with any applicable securities laws and the conditions set forth in Section 4(d) hereof and to the provisions of
Section 4.1 of the Purchase Agreement, this Warrant and all rights hereunder (including, without limitation, any registration rights)
are transferable, in whole or in part, upon surrender of this Warrant at the principal office of the Company or its designated agent,
together with a written assignment of this Warrant substantially in the form attached hereto duly </FONT>executed by the Holder or its
agent or attorney and funds sufficient to pay any transfer taxes payable upon the making of such transfer. Upon such surrender and, if
required, such payment, the Company shall execute and deliver a new Warrant or Warrants in the name of the assignee or assignees, as applicable,
and in the denomination or denominations specified in such instrument of assignment, and shall issue to the assignor a new Warrant evidencing
the portion of this Warrant not so assigned, and this Warrant shall promptly be cancelled. Notwithstanding anything herein to the contrary,
the Holder shall not be required to physically surrender this Warrant to the Company unless the Holder has assigned this Warrant in full,
in which case, the Holder shall surrender this Warrant to the Company within three (3) Trading Days of the date on which the Holder delivers
an assignment form to the Company assigning this Warrant in full. The Warrant, if properly assigned in accordance herewith, may be exercised
by a new holder for the purchase of Warrant Shares without having a new Warrant issued.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 35.95pt">b)&nbsp;<U>New
Warrants</U>. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of the Company,
together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by the Holder or
its agent or attorney. Subject to compliance with Section 4(a), as to any transfer which may be involved in such division or combination,
the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided or combined in accordance
with such notice. All Warrants issued on transfers or exchanges shall be dated the Issue Date of this Warrant and shall be identical with
this Warrant except as to the number of Warrant Shares issuable pursuant thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">c)&nbsp;<U>Warrant
Register</U>. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the &ldquo;<U>Warrant
Register</U>&rdquo;), in the name of the record Holder hereof from time to time. The Company may deem and treat the registered Holder
of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder, and for all other
purposes, absent actual notice to the contrary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">d)&nbsp;<U>Transfer
Restrictions</U>. If, at the time of the surrender of this Warrant in connection with any transfer of this Warrant, the transfer of this
Warrant shall not be either (i) registered pursuant to an effective registration statement under the Securities Act and under applicable
state securities or blue sky laws or (ii) eligible for resale without volume or manner-of-sale restrictions or current public information
requirements pursuant to Rule 144, the Company may require, as a condition of allowing such transfer, that the Holder or transferee of
this Warrant, as the case may be, comply with the provisions of Section 5.7 of the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">e)&nbsp;<U>Representation
by the Holder</U>. The Holder, by the acceptance hereof, represents and warrants that it is acquiring this Warrant and, upon any exercise
hereof, will acquire the Warrant Shares issuable upon such exercise, for its own account and not with a view to or for distributing or
reselling such Warrant Shares or any part thereof in violation of the Securities Act or any applicable state securities law, except pursuant
to sales registered or exempted under the Securities Act.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><U>Section 5</U>.&#9;<U>Miscellaneous</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">a) <U>No
Rights as Stockholder Until Exercise; No Settlement in Cash</U>. This Warrant does not entitle the Holder to any voting rights, dividends
or other rights as a stockholder of the Company prior to the exercise hereof as set forth in Section 2(c)(i), except as expressly set
forth in Section 3. Without limiting any rights of a Holder to receive Warrant Shares on a &ldquo;cashless exercise&rdquo; pursuant to
Section 2(c), in no event shall the Company be required to net cash settle an exercise of this Warrant.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">b)&nbsp;<U>Loss,
Theft, Destruction or Mutilation of Warrant</U>. The Company covenants that upon receipt by the Company of evidence reasonably satisfactory
to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares, and in case
of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant, shall not include
the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the Company will make
and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant or stock certificate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">c)&nbsp;<U>Saturdays,
Sundays, Holidays, etc</U>. If the last or appointed day for the taking of any action or the expiration of any right required or granted
herein shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding Business Day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">d)&nbsp;<U>Authorized
Shares</U>. The Company covenants that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued
Common Stock a sufficient number of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights
under this Warrant. The Company further covenants that its issuance of this Warrant shall constitute full authority to its officers who
are charged with the duty of issuing the necessary Warrant Shares upon the exercise of the purchase rights under this Warrant. The Company
will take all such reasonable action as may be necessary to assure that such Warrant Shares may be issued as provided herein without violation
of any applicable law or regulation, or of any requirements of the Trading Market upon which the Common Stock may be listed. The Company
covenants that all Warrant Shares which may be issued upon the exercise of the purchase rights represented by this Warrant will, upon
exercise of the purchase rights represented by this Warrant and payment for such Warrant Shares in accordance herewith, be duly authorized,
validly issued, fully paid and nonassessable and free from all taxes, liens and charges created by the Company in respect of the issue
thereof (other than taxes in respect of any transfer occurring contemporaneously with such issue).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">e)&nbsp;<U>Jurisdiction</U>.
All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be determined in accordance
with the provisions of the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">f)&nbsp;<U>Restrictions</U>.
The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, will have restrictions
upon resale imposed by state and federal securities laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">g)&nbsp;<U>Nonwaiver
and Expenses</U>. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall operate as
a waiver of such right or otherwise prejudice the Holder&rsquo;s rights, powers or remedies, notwithstanding the fact that the right to
exercise this Warrant terminates on the Termination Date. Without limiting any other provision of this Warrant or the Purchase Agreement,
if the Company willfully and knowingly fails to comply with any provision of this Warrant, which results in any material damages to the
Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover any costs and expenses including, but not limited
to, reasonable attorneys&rsquo; fees, including those of appellate proceedings, incurred by the Holder in collecting any amounts due pursuant
hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">h)&nbsp;<U>Notices</U>.
Any notice, request or other document required or permitted to be given or delivered to the Holder by the Company shall be delivered in
accordance with the notice provisions of the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">i)&nbsp;<U>Limitation
of Liability</U>. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant to purchase Warrant
Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder for the purchase
price of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company or by creditors of the
Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">j)&nbsp;<U>Remedies</U>.
The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will be entitled to specific
performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate compensation for any loss
incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to assert the defense in any
action for specific performance that a remedy at law would be adequate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">k)&nbsp;<U>Successors
and Assigns</U>. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall inure to the
benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns of Holder.
The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall be enforceable
by the Holder or holder of Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">l)&nbsp;<U>Amendment</U>.
This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company, on the one hand, and
the Holder of this Warrant, on the other hand.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">m)&nbsp;<U>Severability</U>.
Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid under applicable law,
but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall be ineffective to the
extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining provisions of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">n)&nbsp;<U>Headings</U>.
The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed a part of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">********************</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><I>(Signature Page Follows)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF, the Company has
caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above indicated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold">NEXTTRIP, INC.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; font-weight: bold">&nbsp;</TD>
    <TD STYLE="width: 5%; font-weight: bold">&nbsp;</TD>
    <TD STYLE="width: 45%; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>By:</TD>
    <TD STYLE="border-bottom: Black 1pt solid"><I>/s/ Bill Kerby</I></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Name: </TD>
    <TD>William Kerby</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Title: </TD>
    <TD>Chief Executive Officer</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 247.65pt">&nbsp;</P>


<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36.1pt; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">NOTICE OF EXERCISE</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34.2pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left">TO:</TD><TD STYLE="text-align: justify">NEXTTRIP, INC.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34.15pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 1in">(1)&nbsp;The
undersigned hereby elects to purchase _______ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only if exercised
in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34.15pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 1in"> (2) Payment shall take the form of (check applicable box):</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34.15pt; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9744;
</FONT>in lawful money of the United States; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 12.75pt 0pt 151.15pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9744;
</FONT>if permitted the cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection
2(c), to exercise this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure
set forth in subsection 2(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34.15pt; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 1in">(3)&nbsp;Please
issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-left: 1in; margin-top: 0pt; margin-bottom: 0pt; width: 50%"><DIV STYLE="border-top: Black 1pt solid; font-size: 1pt">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in">The Warrant Shares shall be delivered to the following
DWAC Account Number:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-left: 1in; margin-top: 0pt; margin-bottom: 0pt; width: 50%"><DIV STYLE="border-top: Black 1pt solid; font-size: 1pt">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-left: 1in; margin-top: 0pt; margin-bottom: 0pt; width: 50%"><DIV STYLE="border-top: Black 1pt solid; font-size: 1pt">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-left: 1in; margin-top: 0pt; margin-bottom: 0pt; width: 50%"><DIV STYLE="border-top: Black 1pt solid; font-size: 1pt">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 1in">(4)&nbsp;<U>Accredited
Investor</U>. The undersigned is an &ldquo;accredited investor&rdquo; as defined in Regulation D promulgated under the Securities Act
of 1933, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify">[SIGNATURE OF HOLDER]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="white-space: nowrap; padding-bottom: 1pt; width: 10%; text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name of Investing Entity:</FONT>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 90%; text-align: justify; font-size: 10pt">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I></I></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="white-space: nowrap; width: 20%; text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Signature of Authorized Signatory of Investing Entity:</I></FONT>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: justify; font-size: 10pt; width: 80%">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="white-space: nowrap; width: 12%; text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name of Authorized Signatory:</FONT>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: justify; font-size: 10pt; width: 88%">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="white-space: nowrap; width: 12%; text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title of Authorized Signatory:</FONT>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: justify; font-size: 10pt; width: 88%">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 3%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: justify; font-size: 10pt; width: 97%">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">EXHIBIT B</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36.1pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">ASSIGNMENT FORM</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 7.15pt; text-indent: 13.55pt"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0 0pt 0in; text-indent: 0.25in"><I>(To assign the foregoing Warrant,
execute this form and supply required information. Do not use this form to exercise the Warrant to purchase shares.)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 7.15pt; text-indent: 10.55pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0pt 0pt 0in; text-indent: 0.25in">FOR VALUE RECEIVED, the foregoing
Warrant and all rights evidenced thereby are hereby assigned to</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 7.15pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 45%">Name:</TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 53%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: left">(Please Print)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Address:</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left">(Please Print)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Phone Number:</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Email Address:</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Dated: _______________ , ________</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Holder&rsquo;s Signature:____________________</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Holder&rsquo;s Address: ____________________</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 12; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>



</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.15
<SEQUENCE>6
<FILENAME>ex4-15.htm
<DESCRIPTION>EX-4.15
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Exhibit
4.15</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NEITHER
THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION
OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED
(THE &ldquo;SECURITIES ACT&rdquo;), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT
UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS
OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE
OF THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WARRANT</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 70%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrant
    Shares: 5,000</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 30%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issuance
    Date: January 27, 2025</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THIS
WARRANT (the &ldquo;<U>Warrant</U>&rdquo;) certifies that, for value received, Gregory R. Traina or his assigns (the &ldquo;<U>Holder</U>&rdquo;)
is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after
the 27th of January 27, 2025 (the &ldquo;<U>Initial Issuance Date</U>&rdquo;) and on or prior to the close of business on the
five (5) year anniversary of the Initial Exercise Date (the &ldquo;<U>Termination Date</U>&rdquo;) but not thereafter, to subscribe
for and purchase from NextTrip, Inc., a Nevada corporation (the &ldquo;<U>Company</U>&rdquo;), up to 5,000 shares of the Company&rsquo;s
Common Stock (&ldquo;<U>Warrant Shares</U>&rdquo;). The purchase price of one Warrant Share under this Warrant shall be equal to the
Exercise Price, as defined in <U>Section 2(b)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
1. <U>Definitions</U>. Capitalized terms used are defined herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
purposes of this Warrant, the following terms shall have the following meanings:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Affiliate</U>&rdquo;
means, as applied to any Person, any other Person directly or indirectly </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">controlling,
controlled by, or under common control with, that Person. For the purposes of this definition, &ldquo;control&rdquo; (including, with
correlative meanings, the terms &ldquo;controlling,&rdquo; &ldquo;controlled by&rdquo; and &ldquo;under common control with&rdquo;),
as applied to any Person, means possession, directly or indirectly, of the power to direct or cause the direction of the management or
policies of a Person, whether through the ability to exercise voting power, by contract or otherwise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Approved
Stock Plan</U>&rdquo; means any employee benefit plan or agreement which has been approved by the board of directors of the Company prior
to or subsequent to the date hereof pursuant to which shares of Common Stock and Options may be issued to any employee, officer, consultant,
or director for services provided to the Company in their capacity as such.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Business
Day</U>&rdquo; means any day except any Saturday, any Sunday, any day which is a federal legal holiday in the United States, or any day
on which banking institutions in the State of New York are authorized or required by law or other governmental action to close.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1; Options: NewSection -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Common
Stock</U>&rdquo; means the Common Stock of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Convertible
Securities</U>&rdquo; means any stock or other security (other than Options) that is at any time and under any circumstances, directly
or indirectly, convertible into, exercisable or exchangeable for, or which otherwise entitles the holder thereof to acquire, any shares
of Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Excluded
Securities</U>&rdquo; means the issuance of (a) shares of Common Stock or options to employees, officers or directors of the Company
pursuant to any stock or option plan duly adopted for such purpose by a majority of the non-employee members of the Board of Directors
or a majority of the members of a committee of non-employee directors established for such purpose, (b) securities upon the exercise
or exchange of or conversion of any shares issued hereunder and/or other securities exercisable or exchangeable for or convertible into
shares of Common Stock issued and outstanding on the date of this Agreement, provided that such securities have not been amended since
the date of this Agreement to increase the number of such securities or to decrease the exercise price, exchange price or conversion
price of such securities or to extend the term of such securities, (c) securities issued in connection with the Company&rsquo;s pending
Registration Statement on Form S-1 (File No. 333-278562); and (d) securities issued pursuant to acquisitions or strategic transactions
approved by a majority of the disinterested directors of the Company, provided that such securities are issued as &ldquo;restricted securities&rdquo;
(as defined in Rule 144) and carry no registration rights that require or permit the filing of any registration statement in connection
therewith, and provided that any such issuance shall only be to a Person (or to the equity holders of a Person) which is, itself or through
its subsidiaries, an operating company or an owner of an asset in a business synergistic with the business of the Company and shall provide
to the Company additional benefits in addition to the investment of funds, but shall not include a transaction in which the Company is
issuing securities primarily for the purpose of raising capital or to an entity whose primary business is investing in securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Market
Price</U>&rdquo; means as applicable: (i) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise
if such Notice of Exercise is (1) both executed and delivered pursuant to Section 2(a) hereof on a day that is not a Trading Day or (2)
both executed and delivered pursuant to Section 2(a) hereof on a Trading Day prior to the opening of &ldquo;regular trading hours&rdquo;
(as defined in Rule 600(b) of Regulation NMS promulgated under the federal securities laws) on such Trading Day, (ii) at the option of
the Holder, either (y) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise or (z) the Bid
Price of the Common Stock on the principal Trading Market as reported by Bloomberg L.P. (&ldquo;Bloomberg&rdquo;) as of the time of the
Holder&rsquo;s execution of the applicable Notice of Exercise if such Notice of Exercise is executed during &ldquo;regular trading hours&rdquo;
on a Trading Day and is delivered within two (2) hours thereafter (including until two (2) hours after the close of &ldquo;regular trading
hours&rdquo; on a Trading Day) pursuant to Section 2(a) hereof or (iii) the VWAP on the date of the applicable Notice of Exercise if
the date of such Notice of Exercise is a Trading Day and such Notice of Exercise is both executed and delivered pursuant to Section 2(a)
hereof after the close of &ldquo;regular trading hours&rdquo; on such Trading Day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Options</U>&rdquo;
means any rights, warrants, or options to subscribe for, purchase, or otherwise acquire shares of Common Stock or Convertible Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Stockholder
Approval</U>&rdquo; means the approval required by the applicable rules and regulations of the NASDAQ Capital Market (or any successor
entity) from the stockholders of the Company of the provisions of <U>Section 3(b)</U> of this Warrant in order for such provisions to
become effective by their terms and to be in compliance with such applicable rules and regulations of the NASDAQ Capital Market (or any
successor entity).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Trading
Day</U>&rdquo; means a day on which the shares of Common Stock are traded on the Trading Market; provided, however, that in the event
that the shares of Common Stock are not listed or quoted on the Trading Market, then Trading Day shall mean any day except Saturday,
Sunday and any day which shall be a legal holiday or a day on which banking institutions in the State of New York or State of Delaware
are authorized or required by law or other government action to close.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Trading
Market</U>&rdquo; means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date
in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, the New York Stock
Exchange, or the OTC Markets QB Tier (or any successors to any of the foregoing).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
2. <U>Exercise</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>Exercise of Warrants</U>. Exercise of the purchase rights for Warrant Shares represented by this Warrant may be made, in whole or
in part, at any time or times on or after the Initial Issuance Date and on or before the Termination Date by delivery to the Company
(or such other office or agency of the Company as it may designate by notice in writing to the registered Holder at the address of the
Holder appearing on the books of the Company) of a duly executed Notice of Exercise in the form annexed hereto as Exhibit A (which may
be delivered in a .PDF format via electronic mail pursuant to the notice provisions set forth in the Purchase Agreement). Within two
(2) Trading Days of the date said Notice of Exercise is delivered to the Company (or within three (3) Trading Days of the date said Notice
of Exercise is delivered to the Company if the Notice of Exercise is received after 12 p.m. EST on such day), the Company shall have
received payment of the aggregate Exercise Price of the Warrant Shares thereby purchased by wire transfer or cashier&rsquo;s check drawn
on a United States bank, unless such exercise is made pursuant to the cashless exercise procedure specified in <U>Section 2(c)</U> below
(if available). No ink-original Notice of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee or
notarization) of any Notice of Exercise form be required. The Company shall be entitled to conclusively assume the genuineness of any
signature on any Notice of Exercise delivered to the Company pursuant to this <U>Section 2(a)</U>, the legal capacity and competency
of all natural persons signing any Notice of Exercise so delivered, the authenticity of any Notice of Exercise so delivered, the conformity
to an authentic original of any Notice of Exercise so delivered as certified, authenticated, conformed, photostatic, facsimile, or electronic
and the authenticity of the original of such Notice of Exercise. Notwithstanding anything herein to the contrary, the Holder shall not
be required to physically surrender this Warrant to the Company until the Holder has purchased all of the Warrant Shares available hereunder
and the Warrant has been exercised in full, in which case, the Holder shall surrender this Warrant to the Company for cancellation within
three (3) Trading Days of the date the final Notice of Exercise is delivered to the Company. Partial exercises of this Warrant resulting
in purchases of a portion of the total number of Warrant Shares available hereunder shall have the effect of lowering the outstanding
number of Warrant Shares purchasable hereunder in an amount equal to the applicable number of Warrant Shares purchased. The Holder and
the Company shall maintain records showing the number of Warrant Shares purchased and the date of such purchases, and the Company shall
be entitled to conclusively assume that its records of the number of Warrant Shares purchased and the date of such purchases are accurate,
absent actual notice to the contrary. The Company shall deliver any objection to any Notice of Exercise within two (2) Business Days
of receipt of such notice. The Holder and any assignee, by acceptance of this Warrant, acknowledge and agree that, by reason of the provisions
of this paragraph, following the purchase of a portion of the Warrant Shares hereunder, the number of Warrant Shares available for purchase
hereunder at any given time may be less than the amount stated on the face hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>Exercise Price</U>. The exercise price per Warrant Share shall be $3.02, subject to adjustment hereunder (the &ldquo;<U>Exercise Price</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>





<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 76.9pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 76.9pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Cashless Exercise</U>. If at any time ninety (90) days after the date of the Initial Issuance Date, there is no effective Registration
Statement registering, or no current prospectus available for, the resale of the Warrant Shares by the Holder, then this Warrant may
also be exercised, in whole or in part, at such time by means of a &ldquo;cashless exercise&rdquo; in which the Holder shall be entitled
to receive a number of Warrant Shares equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.35in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(A)
    =</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    Market Price (at the date of such calculation)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(B)
    =</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    Exercise Price of this Warrant, as adjusted hereunder; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(X)
    =</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    number of Warrant Shares that would be issuable upon exercise of this Warrant in accordance with the terms of this Warrant if such
    exercise were by means of a cash exercise rather than a cashless exercise.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 77pt; text-align: justify; text-indent: -31.0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assuming
(i) the Holder is not an Affiliate of the Company, and (ii) all of the applicable conditions of Rule 144 promulgated under the Securities
Act of 1933, as amended (the &ldquo;<U>Securities Act</U>&rdquo;) with respect to Holder and the Warrant Shares are met in the case of
such a cashless exercise, the Company agrees that the Company will use its best efforts to cause the removal of the legend from such
Warrant Shares (including by delivering an opinion of the Company&rsquo;s counsel to the Company&rsquo;s transfer agent at its own expense
to ensure the foregoing), and the Company agrees that the Holder is under no obligation to sell the Warrant Shares issuable upon the
exercise of the Warrant prior to removing the legend. The Company expressly acknowledges that Rule 144(d)(3)(ii), as currently in effect,
provides that Warrant Shares issued solely upon a cashless exercise shall be deemed to have been acquired at the same time as the Warrant.
The Company agrees not to take any position contrary to this <U>Section 2(c)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)
<U>Mechanics of Exercise</U>.</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 76.90pt; text-align: justify; text-indent: -31.60pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.
<U>Delivery of Warrant Shares Upon Exercise</U>. The Company shall cause the Warrant Shares purchased hereunder to be transmitted by
the Company&rsquo;s transfer agent (the &ldquo;<U>Transfer Agent</U>&rdquo;) to the Holder by crediting the account of the Holder&rsquo;s
or its designee&rsquo;s balance account with The Depository Trust Company through its Deposit or Withdrawal at Custodian system (&ldquo;<U>DWAC</U>&rdquo;)
if the Company is then a participant in such system and either (A) there is an effective registration statement permitting the issuance
of the Warrant Shares to or resale of the Warrant Shares by the Holder or (B) the Warrant Shares are eligible for resale by the Holder
pursuant to Rule 144, and otherwise by physical delivery of a certificate, registered in the Company&rsquo;s share register in the name
of the Holder or its designee, for the number of Warrant Shares to which the Holder is entitled pursuant to such exercise to the address
specified by the Holder in the Notice of Exercise by the date that is one (1) Trading Day after the later of (A) the delivery to the
Company of the Notice of Exercise provided that such Notice of Exercise is received by 12 p.m. EST and two (2) Trading Days for any Notice
of Exercise received after 12 p.m. EST, and (B) the Company&rsquo;s receipt of payment of the aggregate Exercise Price of the Warrant
Shares thereby purchased by wire transfer or cashier&rsquo;s check drawn on a United States bank, unless such exercise is made pursuant
to the cashless exercise procedure specified in <U>Section 2(c)</U> (such date, the &ldquo;<U>Warrant Share Delivery Date</U>&rdquo;).
The Warrant Shares shall be deemed to have been issued, and Holder or any other person so designated to be named therein shall be deemed
to have become a holder of record of such shares for all purposes, as of the date the Warrant has been exercised, with payment to the
Company of the Exercise Price (or by cashless exercise, if permitted) and all taxes required to be paid by the Holder, if any, pursuant
to <U>Section 2(d)(vi)</U> prior to the issuance of such Warrant Shares, having been paid. If the Company fails for any reason to deliver
to the Holder the Warrant Shares subject to a Notice of Exercise by the Warrant Share Delivery Date, the Company shall pay to the Holder,
in cash, as liquidated damages and not as a penalty, for each $1,000 of Warrant Shares subject to such exercise (based on the VWAP of
the Common Stock on the date of the applicable Notice of Exercise), $5 per Trading Day (increasing to $10 per Trading Day on the fifth
Trading Day after such liquidated damages begin to accrue) for each Trading Day after such Warrant Share Delivery Date until such Warrant
Shares are delivered or Holder rescinds such exercise. The Company agrees to maintain a transfer agent that is a participant in the FAST
program so long as this Warrant remains outstanding and exercisable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.
<U>Delivery of New Warrants Upon Exercise</U>. If this Warrant shall have been exercised in part, the Company shall, at the request of
a Holder and upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant
evidencing the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in
all other respects be identical with this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iii.
<U>Rescission Rights</U>. If the Holder fails to make payment of the aggregate Exercise Price of the Warrant Shares pursuant to a Notice
of Exercise within two (2) Trading Days of the date said Notice of Exercise is delivered to the Company (or within three (3) Trading
Days of the date said Notice of Exercise is delivered to the Company if the Notice of Exercise is received after 12 p.m. EST on such
day) by wire transfer or cashier&rsquo;s check drawn on a United States bank, then the Company will have the right to rescind such exercise,
unless such exercise is made pursuant to the cashless exercise procedure specified in <U>Section 2(c)</U>. If the Company fails to cause
the Transfer Agent to transmit to the Holder the Warrant Shares pursuant to <U>Section 2(d)(i)</U> by the Warrant Share Delivery Date,
then the Holder will have the right to rescind such exercise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iv.
<U>Compensation for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise</U>. In addition to any other rights available to
the Holder, if the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance with the provisions
of <U>Section 2(d)(i)</U> above pursuant to an exercise on or before the Warrant Share Delivery Date, and if after such date the Holder
is required by its broker to purchase (in an open market transaction or otherwise) or the Holder&rsquo;s brokerage firm otherwise purchases,
shares of Common Stock to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving
upon such exercise (a &ldquo;<U>Buy-In</U>&rdquo;), then the Company shall (A) pay in cash to the Holder the amount, if any, by which
(x) the Holder&rsquo;s total purchase price (including brokerage commissions, if any) for the shares of Common Stock so purchased exceeds
(y) the amount obtained by multiplying (1) the number of Warrant Shares that the Company was required to deliver to the Holder in connection
with the exercise at issue times (2) the price at which the sell order giving rise to such purchase obligation was executed, and (B)
at the option of the Holder, either reinstate the portion of the Warrant Shares for which such exercise was not honored (in which case
such exercise shall be deemed rescinded) or deliver to the Holder the number of shares of Common Stock that would have been issued had
the Company timely complied with its exercise and delivery obligations hereunder. For example, if the Holder purchases Common Stock having
a total purchase price of $11,000 to cover a Buy-In with respect to an attempted exercise of shares of Common Stock with an aggregate
sale price giving rise to such purchase obligation of $10,000, under clause (A) of the immediately preceding sentence the Company shall
be required to pay the Holder $1,000. The Holder shall provide the Company written notice indicating the amounts payable to the Holder
in respect of the Buy-In and, upon request of the Company, evidence of the amount of such loss. Nothing herein shall limit a Holder&rsquo;s
right to pursue any other remedies available to it hereunder, at law or in equity including, without limitation, a decree of specific
performance and/or injunctive relief with respect to the Company&rsquo;s failure to timely deliver shares of Common Stock upon exercise
of the Warrant as required pursuant to the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">v.
<U>No Fractional Shares or Scrip</U>. No fractional shares or scrip representing fractional shares shall be issued upon the exercise
of this Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company
shall, at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied
by the Exercise Price or round up to the next whole share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">vi.
<U>Charges, Taxes, and Expenses</U>. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer
tax or other incidental expense in respect of the issuance of Warrant Shares, all of which taxes and expenses shall be paid by the Company,
and such Warrant Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder; provided,
however, that in the event that Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when surrendered
for exercise shall be accompanied by the Assignment Form attached hereto duly executed by the Holder and the Company may require, as
a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto. The Company shall pay all
fees charged by the Transfer Agent, including any fees assessed to the Transfer Agent by Depository Trust Company (or another established
clearing corporation performing similar functions) required for same-day processing of any Notice of Exercise and for same-day electronic
delivery of the Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">vii.
<U>Closing of Books</U>. The Company will not close its stockholder books or records in any manner which prevents the timely exercise
of this Warrant, pursuant to the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)
<U>Holder&rsquo;s Exercise Limitations</U>. To the extent the exercise of any portion of this Warrant requires the Company to receive
the approval of the Company&rsquo;s stockholders pursuant to NASDAQ Capital Market Listing Rules, the Company shall not effect such exercise
of this Warrant, and a Holder shall not have the right to exercise any such portion of this Warrant, pursuant to <U>Section 2</U> or
otherwise, until such approval has been received by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
3. <U>Certain Adjustments</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>Stock Dividends and Splits</U>. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise
makes a distribution or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable in shares
of Common Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon exercise of this
Warrant), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way of reverse
stock split) outstanding shares of Common Stock into a smaller number of shares or (iv) issues by reclassification of shares of the Common
Stock any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which the
numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before such event
and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event, and the number of
Warrant Shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this
Warrant shall remain unchanged. Any adjustment made pursuant to this Section 3(a) shall become effective immediately after the record
date for the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after
the effective date in the case of a subdivision, combination or re-classification.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>Notice</U>. The Company shall notify the Holder, in writing, no later than the Trading Day following the issuance or deemed issuance
of any Common Stock or Common Stock Equivalents subject to <U>Section 3(a)</U>, indicating therein the applicable issuance price, or
applicable reset price, exchange price, conversion price and other pricing terms (such notice, the &ldquo;<U>Dilutive Issuance Notice</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Fundamental Transaction</U>. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or
more related transactions effects any merger or consolidation of the Company with or into another Person, (ii) the Company, directly
or indirectly, effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially all of
its assets in one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange offer
(whether by the Company or another Person) is completed pursuant to which holders of Common Stock are permitted to sell, tender or exchange
their shares for other securities, cash or property and has been accepted by the holders of more than 50% of the outstanding Common Stock
or more than 50% of the voting power of the common equity of the Company, (iv) the Company, directly or indirectly, in one or more related
transactions effects any reclassification, reorganization, or recapitalization of the Common Stock or any compulsory share exchange pursuant
to which the Common Stock is effectively converted into or exchanged for other securities, cash or property, or (v) the Company, directly
or indirectly, in one or more related transactions consummates a stock or share purchase agreement or other business combination (including,
without limitation, a reorganization, recapitalization, spin-off, merger or scheme of arrangement) with another Person or group of Persons
whereby such other Person or group acquires more than 50% of the outstanding shares of Common Stock or more than 50% of the voting power
of the common equity of the Company (not including any shares of Common Stock held by the other Person or other Persons making or party
to, or associated or affiliated with the other Persons making or party to, such stock or share purchase agreement or other business combination)
(each a &ldquo;<U>Fundamental Transaction</U>&rdquo;), then, the Company shall cause any successor entity in a Fundamental Transaction
in which the Company is not the survivor (the &ldquo;<U>Successor Entity</U>&rdquo;) to assume in writing all of the obligations of the
Company under this Warrant and the other Transaction Documents in accordance with the provisions of this <U>Section 3(e)</U> pursuant
to written agreements in form and substance reasonably satisfactory to the Holder and approved by the Holder (without unreasonable delay)
prior to such Fundamental Transaction and shall, at the option of the Holder, deliver to the Holder in exchange for this Warrant a security
of the Successor Entity evidenced by a written instrument substantially similar in form and substance to this Warrant which is exercisable
for a corresponding number of shares of capital stock of such Successor Entity (or its parent entity) equivalent to the shares of Common
Stock acquirable and receivable upon exercise of this Warrant (without regard to any limitations on the exercise of this Warrant) prior
to such Fundamental Transaction, and with an exercise price which applies the exercise price hereunder to such shares of capital stock
(but taking into account the relative value of the shares of Common Stock pursuant to such Fundamental Transaction and the value of such
shares of capital stock, such number of shares of capital stock and such exercise price being for the purpose of protecting the economic
value of this Warrant immediately prior to the consummation of such Fundamental Transaction), and which is reasonably satisfactory in
form and substance to the Holder. Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall succeed to, and
be substituted for (so that from and after the date of such Fundamental Transaction, the provisions of this Warrant and the other Transaction
Documents referring to the &ldquo;Company&rdquo; shall refer instead to the Successor Entity), and may exercise every right and power
of the Company and shall assume all of the obligations of the Company under this Warrant and the other Transaction Documents with the
same effect as if such Successor Entity had been named as the Company herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)
<U>Calculations</U>. All calculations under this <U>Section 3</U> shall be made to the nearest cent or the nearest 1/100th of a share,
as the case may be. For purposes of this <U>Section 3</U>, the number of shares of Common Stock deemed to be issued and outstanding as
of a given date shall be the sum of the number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)
<U>Notice to Holder</U>.</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 76.90pt; text-align: justify; text-indent: -31.60pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.
<U>Adjustment to Exercise Price</U>. Whenever the Exercise Price is adjusted pursuant to any provision of this <U>Section 3</U>, the
Company shall promptly mail or deliver via electronic mail to the Holder a notice setting forth the Exercise Price after such adjustment
and any resulting adjustment to the number of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.
<U>Notice to Allow Exercise by Holder</U>. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on
the Common Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C) the
Company shall authorize the granting to all holders of the Common Stock rights or warrants to subscribe for or purchase any shares of
capital stock of any class or of any rights, (D) the approval of any stockholders of the Company shall be required in connection with
any reclassification of the Common Stock, any consolidation or merger to which the Company is a party, any sale or transfer of all or
substantially all of the assets of the Company, or any compulsory share exchange whereby the Common Stock is converted into other securities,
cash or property, or </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">(E) the Company shall authorize the voluntary or
involuntary dissolution, liquidation or winding up of the affairs of the Company, then, in each case, the Company shall cause to be mailed
to the Holder at its last address as it shall appear upon the Warrant Register of the Company, at least 20 calendar days prior to the
applicable record or effective date hereinafter specified, a notice stating (x) the date on which a record is to be taken for the purpose
of such dividend, distribution, redemption, rights, or warrants, or if a record is not to be taken, the date as of which the holders
of the Common Stock of record to be entitled to such dividend, distributions, redemption, rights or warrants are to be determined or
(y) the date on which such reclassification, consolidation, merger, sale, transfer or share exchange is expected to become effective
or close, and the date as of which it is expected that holders of the Common Stock of record shall be entitled to exchange their shares
of the Common Stock for securities, cash or other property deliverable upon such reclassification, consolidation, merger, sale, transfer
or share exchange; provided that the failure to mail such notice or any defect therein or in the mailing thereof shall not affect the
validity of the corporate action required to be specified in such notice. To the extent that any notice provided in this Warrant constitutes,
or contains, material, non-public information regarding the Company, the Company shall simultaneously file such notice with the Commission
pursuant to a Current Report on Form 8-K. The Holder shall remain entitled to exercise this Warrant during the period commencing on the
date of such notice to the effective date of the event triggering such notice except as may otherwise be expressly set forth herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
4. <U>Transfer of Warrant</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>Transferability</U>. Subject to compliance with any applicable securities laws and the conditions set forth in <U>Section 4(d)</U>
hereof, this Warrant and all rights hereunder (including, without limitation, any registration rights) are transferable, in whole or
in part, upon surrender of this Warrant at the principal office of the Company or its designated agent, together with a written assignment
of this Warrant substantially in the form attached hereto duly executed by the Holder or its agent or attorney and funds sufficient to
pay any transfer taxes payable upon the making of such transfer. Upon such surrender and, if required, such payment, the Company shall
execute and deliver a new Warrant or Warrants in the name of the assignee or assignees, as applicable, and in the denomination or denominations
specified in such instrument of assignment and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not so
assigned, and this Warrant shall promptly be cancelled. Notwithstanding anything herein to the contrary, the Holder shall not be required
to physically surrender this Warrant to the Company unless the Holder has assigned this Warrant in full, in which case, the Holder shall
surrender this Warrant to the Company within three (3) Trading Days of the date the Holder delivers an assignment form to the Company
assigning this Warrant in full. The Warrant, if properly assigned in accordance herewith, may be exercised by a new holder for the purchase
of Warrant Shares without having a new Warrant issued.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>New Warrants</U>. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of
the Company, together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by
the Holder or its agent or attorney. Subject to compliance with <U>Section 4(a)</U>, as to any transfer which may be involved in such
division or combination, the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be
divided or combined in accordance with such notice. All Warrants issued on transfers or exchanges shall be dated the Initial Exercise
Date and shall be identical with this Warrant except as to the number of Warrant Shares issuable pursuant thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Warrant Register</U>. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the
&ldquo;<U>Warrant Register</U>&rdquo;), in the name of the record Holder hereof from time to time. The Company may deem and treat the
registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder,
and for all other purposes, absent actual notice to the contrary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)
<U>Transfer Restrictions</U>. Subject to any limitations imposed by applicable law, this Warrant may be offered for sale, sold, transferred,
or assigned without the consent of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)
<U>Representation by the Holder</U>. The Holder, by the acceptance hereof, represents and warrants that it is acquiring this Warrant
and, upon any exercise hereof, will acquire the Warrant Shares issuable upon such exercise, for its own account and not with a view to
or for distributing or reselling such Warrant Shares or any part thereof in violation of the Securities Act or any applicable state securities
law, except pursuant to sales registered or exempted under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
5. <U>Miscellaneous</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>No Rights as Stockholder Until Exercise</U>. This Warrant does not entitle the Holder to any voting rights, dividends or other rights
as a stockholder of the Company prior to the exercise hereof as set forth in <U>Section 2(d)(i)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>Loss, Theft, Destruction, or Mutilation of Warrant</U>. The Company covenants that upon receipt by the Company of evidence reasonably
satisfactory to it of the loss, theft, destruction, or mutilation of this Warrant or any stock certificate relating to the Warrant Shares,
and in case of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant,
shall not include the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the
Company will make and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant
or stock certificate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Saturdays, Sundays, Holidays, etc</U>. If the last or appointed day for the taking of any action or the expiration of any right required
or granted herein shall not be a Business Day, then, such action may be taken or such right may be exercised on the next succeeding Business
Day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)
<U>Authorized Shares</U>. The Company covenants that, during the period the Warrant is outstanding, it will reserve from its authorized
and unissued Common Stock a sufficient number of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase
rights under this Warrant (the &ldquo;<U>Required Reserve Amount</U>&rdquo;). The Company further covenants that its issuance of this
Warrant shall constitute full authority to its officers who are charged with the duty of issuing the necessary Warrant Shares upon the
exercise of the purchase rights under this Warrant. The Company will take all such reasonable action as may be necessary to assure that
such Warrant Shares may be issued as provided herein without violation of any applicable law or regulation, or of any requirements of
the Trading Market upon which the Common Stock may be listed. The Company covenants that all Warrant Shares which may be issued upon
the exercise of the purchase rights represented by this Warrant will, upon exercise of the purchase rights represented by this Warrant
and payment for such Warrant Shares in accordance herewith, be duly authorized, validly issued, fully paid, and nonassessable and free
from all taxes, liens, and charges created by the Company in respect of the issue thereof (other than taxes in respect of any transfer
occurring contemporaneously with such issue).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)
<U>Transfer Agent Instructions</U>. The Company covenants and agrees that it will, at all times during the period the Warrant is outstanding,
maintain a duly qualified independent Transfer Agent. The Company represents and covenants that, within one (1) day from the Initial
Exercise Date, it will either (i) issue irrevocable instructions to its current Transfer Agent (and each Transfer Agent appointed thereafter)
to issue certificates, registered in the name of the Holder or its nominee, for the Warrant Shares in such amounts as specified from
time to time by the Holder to the Company upon exercise of this Warrant in accordance with the terms thereof (the &ldquo;<U>Irrevocable
Transfer Agent Instructions</U>&rdquo;), or (ii) appoint a new Transfer Agent, at which time the Company (a) shall provide a copy of
its agreement with the new Transfer Agent to the Holder, and (b) issue Irrevocable Transfer Agent Instructions to the new Transfer Agent.
Such Irrevocable Transfer Agent Instructions shall be in a form acceptable to the Holder and shall include a provision to irrevocably
reserve the Required Reserve Amount. The Irrevocable Transfer Agent Instructions shall be signed by the Company&rsquo;s Transfer Agent
as of the date of the Initial Exercise Date or by the New Transfer Agent, as applicable, and by the Company. The Company warrants that,
(i) no instruction other than the Irrevocable Transfer Agent Instructions referred to in this Section 5(e), and stop transfer instructions
to give effect to Section 5(g) (prior to registration of the Warrant Shares under the Securities Act or the date on which the Warrant
Shares may be sold pursuant to Rule 144 without any restriction as to the number of Securities as of a particular date that can then
be immediately sold), will be given by the Company to its Transfer Agent and that the Warrant Shares shall otherwise be freely transferable
on the books and records of the Company as and to the extent provided in this Warrant and the Purchase Agreement, (ii) it will not direct
its Transfer Agent not to transfer or delay, impair, and/or hinder its Transfer Agent in transferring (or issuing)(electronically or
in certificated form) any certificate for Warrant Shares to be issued to the Holder upon exercise of or otherwise pursuant to this Warrant
as and when required by this Warrant and the Purchase Agreement, and (iii) it will not fail to remove (or direct its Transfer Agent not
to remove or impair, delay, and/or hinder its Transfer Agent from removing) any restrictive legend (or to withdraw any stop transfer
instructions in respect thereof) on any certificate for any Warrant Shares issued to the Holder upon exercise of or otherwise pursuant
to this Warrant as and when required by this Warrant and the Purchase Agreement. Nothing in this Section shall affect in any way the
Holder&rsquo;s obligations to comply with all applicable prospectus delivery requirements, if any, upon resale of the Warrant Shares.
If a Holder provides the Company, at the cost of the Holder, with an opinion of counsel in form, substance, and scope customary for opinions
in comparable transactions, to the effect that a public sale or transfer of such Warrant Shares may be made without registration under
the Securities Act and such sale or transfer is effected, the Company shall permit the transfer, and, in the case of the Warrant Shares,
promptly instruct its Transfer Agent to issue one or more certificates, free from restrictive legend, in such name and in such denominations
as specified by the Holder. The Company acknowledges that a breach by it of its obligations hereunder will cause irreparable harm to
the Holder, by vitiating the intent and purpose of the transactions contemplated hereby. Accordingly, the Company acknowledges that the
remedy at law for a breach of its obligations under this Section 5(e) may be inadequate and agrees, in the event of a breach or threatened
breach by the Company of the provisions of this Section, that the Holder shall be entitled, in addition to all other available remedies,
to an injunction restraining any breach and requiring immediate transfer, without the necessity of showing economic loss and without
any bond or other security being required.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f)
<U>Jurisdiction</U>. All questions concerning the construction, validity, enforcement, and interpretation of this Warrant shall be determined
in accordance with the provisions of the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">g)
<U>Restrictions</U>. The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, will
have restrictions upon resale imposed by state and federal securities laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">h)
<U>Nonwaiver and Expenses</U>. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall
operate as a waiver of such right or otherwise prejudice the Holder&rsquo;s rights, powers, or remedies, notwithstanding the fact that
all rights hereunder terminate on the Termination Date. If the Company willfully and knowingly fails to comply with any provision of
this Warrant, which results in any material damages to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient
to cover any costs and expenses including, but not limited to, reasonable attorneys&rsquo; fees, including those of appellate proceedings,
incurred by the Holder in collecting any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies
hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i)
<U>Notices</U>. Any notice, request or other document required or permitted to be given or delivered to the Holder by the Company shall
be delivered in accordance with the notice provisions of the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">j)
<U>Limitation of Liability</U>. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant
to purchase Warrant Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of
the Holder for the purchase price of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company
or by creditors of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">k)
<U>Remedies</U>. The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will
be entitled to specific performance of its rights under this Warrant. The Company agrees that monetary damages may not be adequate compensation
for any loss incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to assert the
defense in any action for specific performance that a remedy at law would be adequate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">l)
<U>Successors and Assigns</U>. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall
inure to the benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns
of Holder. The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall
be enforceable by the Holder or holder of Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">m)
<U>Amendment</U>. This Warrant (other than <U>Section 2(e)</U>) may be modified or amended or the provisions hereof waived with the written
consent of the Company and the Holder. No waiver shall be effective unless it is in writing and signed by an authorized representative
of the waiving party.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">n)
<U>Severability</U>. If any provision of this Warrant is prohibited by law or otherwise determined to be invalid or unenforceable by
a court of competent jurisdiction, the provision that would otherwise be prohibited, invalid or unenforceable shall be deemed amended
to apply to the broadest extent that it would be valid and enforceable, and the invalidity or unenforceability of such provision shall
not affect the validity of the remaining provisions of this Warrant so long as this Warrant as so modified continues to express, without
material change, the original intentions of the parties as to the subject matter hereof and the prohibited nature, invalidity or unenforceability
of the provision(s) in question does not substantially impair the respective expectations or reciprocal obligations of the parties or
the practical realization of the benefits that would otherwise be conferred upon the parties. The parties will endeavor in good faith
negotiations to replace the prohibited, invalid or unenforceable provision(s) with a valid provision(s), the effect of which comes as
close as possible to that of the prohibited, invalid or unenforceable provision(s).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">o)
<U>Headings</U>. This Warrant shall be deemed to be jointly drafted by the Company and the Holder and shall not be construed against
any Person as the drafter hereof. The headings of this Warrant are for convenience of reference and shall not form part of, or affect
the interpretation of, this Warrant. Terms used in this Warrant but defined in the other Transaction Documents shall have the meanings
ascribed to such terms on the Closing Date in such other Transaction Documents unless otherwise consented to in writing by the Holder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">p)
<U>Governing Law</U>. This Warrant shall be governed by and construed and enforced in accordance with, and all questions concerning the
construction, validity, interpretation, and performance of this Warrant shall be governed by, the internal laws of the State of Delaware,
without giving effect to any choice of law or conflict of law provision or rule (whether of the State of Delaware or any other jurisdictions)
that would cause the application of the laws of any jurisdictions other than the State of Delaware. The Company hereby irrevocably waives
personal service of process and consents to process being served in any such suit, action, or proceeding by mailing a copy thereof to
the Company at the address set forth in the Purchase Agreement and agrees that such service shall constitute good and sufficient service
of process and notice thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">q)
<U>Jurisdiction and Venue</U>. Each party hereby irrevocably submits that any dispute, controversy or claim arising out of or relating
to this Warrant, shall be submitted to the exclusive jurisdiction of the Chancery Court of the State of Delaware and the United States
District Court for the District of Delaware. Each party hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding,
any claim that it is not personally subject to the jurisdiction of any such court, that such suit, action or proceeding is brought in
an inconvenient forum or that the venue of such suit, action or proceeding is improper. Each party hereby irrevocably waives personal
service of process and consents to process being served in any such suit, action or proceeding by mailing a copy thereof to such party
at the address for such notices to it under the Purchase Agreement and agrees that such service shall constitute good and sufficient
service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any
manner permitted by law. EACH PARTY HEREBY IRREVOCABLY WAIVES ANY RIGHT IT MAY HAVE, AND AGREES NOT TO REQUEST, A JURY TRIAL FOR THE
ADJUDICATION OF ANY DISPUTE HEREUNDER OR IN CONNECTION HEREWITH OR </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">ARISING
OUT OF THIS WARRANT. The parties agree that all dispute resolution proceedings in accordance with this Section 5(o) may be conducted
in a virtual setting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>********************</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(Signature
Page Follows)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>


<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the Company has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above
indicated.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>NEXTTRIP, INC.</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Bill Kerby</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bill
    Kerby</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[Signature Page to Warrant]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">EXHIBIT
A</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTICE
OF EXERCISE</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">TO
BE EXECUTED BY THE REGISTERED HOLDER TO EXERCISE THIS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WARRANT
TO PURCHASE COMMON STOCK</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NEXTTRIP,
INC.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned holder hereby exercises the right to purchase  of the shares of Common Stock (&ldquo;<U>Warrant Shares</U>&rdquo;) of NextTrip,
Inc., a Nevada corporation (the &ldquo;Company&rdquo;), evidenced by the Warrant (the &ldquo;<U>Warrant</U>&rdquo;). Capitalized terms
used herein and not otherwise defined shall have the respective meanings set forth in the Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.
<U>Form of Exercise Price</U>. The Holder intends that payment of the Aggregate Exercise Price shall be made as:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">____________
<FONT STYLE="font-size: 10pt">a &ldquo;<U>Cash Exercise</U>&rdquo; with respect to ____________ Warrant Shares; and/or</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;____________
a &ldquo;<U>Cashless Exercise</U>&rdquo; with respect to ____________ Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.
<U>Payment of Exercise Price</U>. In the event that the Holder has elected a Cash Exercise with respect to some or all of the Warrant
Shares to be issued pursuant hereto, the Holder shall pay the Aggregate Exercise Price in the sum of $ ____________ to the Company in
accordance with the terms of the Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.
<U>Delivery of Warrant Shares</U>. The Company shall deliver to Holder, or its designee or agent as specified below, ____________ Warrant
Shares in accordance with the terms of the Warrant. Delivery shall be made to Holder, or for its benefit, as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;
&nbsp;&nbsp;&nbsp;Check here if requesting delivery as a certificate to the following name and to the following address:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="width: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issue to:</FONT></TD>
  <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 46pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;
Check here if requesting delivery by Deposit/Withdrawal at Custodian as follows:</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 46pt; text-align: justify; text-indent: -0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 46pt; text-align: justify; text-indent: 0pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="width: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">DTC Participant:</FONT></TD>
  <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">DTC Number:</FONT></TD>
  <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Account Number:</FONT></TD>
  <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 46pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Date:
___________ __,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 46pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Name
of Registered Holder</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 46pt; text-align: justify; text-indent: 0pt"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 46pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 46pt; text-align: justify; text-indent: 0pt"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 15%"><FONT STYLE="font-family: Times New Roman, Times, Serif">Tax
    ID:</FONT></TD>
    <TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left; width: 35%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Facsimile:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">E-mail
    Address:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 46pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">EXHIBIT
B</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASSIGNMENT
FORM</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<I>To
assign the foregoing Warrant, execute this form and supply required information. Do not use this form to purchase shares</I>.)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FOR
VALUE RECEIVED, the foregoing Warrant and all rights evidenced thereby are hereby assigned to</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif">Name:</FONT></TD>
    <TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif">(Please
    Print)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Address:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">(Please
    Print)</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated:
________ __,</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif">____</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s
Signature:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s
Address:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 14; Options: Last -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.16
<SEQUENCE>7
<FILENAME>ex4-16.htm
<DESCRIPTION>EX-4.16
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Exhibit
4.16</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NEITHER
THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION
OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED
(THE &ldquo;SECURITIES ACT&rdquo;), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT
UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS
OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE
OF THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WARRANT</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 70%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrant
    Shares: 1,000</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 30%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issuance
    Date: January 27, 2025</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THIS
WARRANT (the &ldquo;<U>Warrant</U>&rdquo;) certifies that, for value received, Enclave Capital LLC or its assigns (the &ldquo;<U>Holder</U>&rdquo;)
is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after
the 27th of January 27, 2025 (the &ldquo;<U>Initial Issuance Date</U>&rdquo;) and on or prior to the close of business on the
five (5) year anniversary of the Initial Exercise Date (the &ldquo;<U>Termination Date</U>&rdquo;) but not thereafter, to subscribe
for and purchase from NextTrip, Inc., a Nevada corporation (the &ldquo;<U>Company</U>&rdquo;), up to 1,000 shares of the Company&rsquo;s
Common Stock (&ldquo;<U>Warrant Shares</U>&rdquo;). The purchase price of one Warrant Share under this Warrant shall be equal to the
Exercise Price, as defined in <U>Section 2(b)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
1. <U>Definitions</U>. Capitalized terms used are defined herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
purposes of this Warrant, the following terms shall have the following meanings:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Affiliate</U>&rdquo;
means, as applied to any Person, any other Person directly or indirectly </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">controlling,
controlled by, or under common control with, that Person. For the purposes of this definition, &ldquo;control&rdquo; (including, with
correlative meanings, the terms &ldquo;controlling,&rdquo; &ldquo;controlled by&rdquo; and &ldquo;under common control with&rdquo;),
as applied to any Person, means possession, directly or indirectly, of the power to direct or cause the direction of the management or
policies of a Person, whether through the ability to exercise voting power, by contract or otherwise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Approved
Stock Plan</U>&rdquo; means any employee benefit plan or agreement which has been approved by the board of directors of the Company prior
to or subsequent to the date hereof pursuant to which shares of Common Stock and Options may be issued to any employee, officer, consultant,
or director for services provided to the Company in their capacity as such.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Business
Day</U>&rdquo; means any day except any Saturday, any Sunday, any day which is a federal legal holiday in the United States, or any day
on which banking institutions in the State of New York are authorized or required by law or other governmental action to close.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1; Options: NewSection -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Common
Stock</U>&rdquo; means the Common Stock of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Convertible
Securities</U>&rdquo; means any stock or other security (other than Options) that is at any time and under any circumstances, directly
or indirectly, convertible into, exercisable or exchangeable for, or which otherwise entitles the holder thereof to acquire, any shares
of Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Excluded
Securities</U>&rdquo; means the issuance of (a) shares of Common Stock or options to employees, officers or directors of the Company
pursuant to any stock or option plan duly adopted for such purpose by a majority of the non-employee members of the Board of Directors
or a majority of the members of a committee of non-employee directors established for such purpose, (b) securities upon the exercise
or exchange of or conversion of any shares issued hereunder and/or other securities exercisable or exchangeable for or convertible into
shares of Common Stock issued and outstanding on the date of this Agreement, provided that such securities have not been amended since
the date of this Agreement to increase the number of such securities or to decrease the exercise price, exchange price or conversion
price of such securities or to extend the term of such securities, (c) securities issued in connection with the Company&rsquo;s pending
Registration Statement on Form S-1 (File No. 333-278562); and (d) securities issued pursuant to acquisitions or strategic transactions
approved by a majority of the disinterested directors of the Company, provided that such securities are issued as &ldquo;restricted securities&rdquo;
(as defined in Rule 144) and carry no registration rights that require or permit the filing of any registration statement in connection
therewith, and provided that any such issuance shall only be to a Person (or to the equity holders of a Person) which is, itself or through
its subsidiaries, an operating company or an owner of an asset in a business synergistic with the business of the Company and shall provide
to the Company additional benefits in addition to the investment of funds, but shall not include a transaction in which the Company is
issuing securities primarily for the purpose of raising capital or to an entity whose primary business is investing in securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Market
Price</U>&rdquo; means as applicable: (i) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise
if such Notice of Exercise is (1) both executed and delivered pursuant to Section 2(a) hereof on a day that is not a Trading Day or (2)
both executed and delivered pursuant to Section 2(a) hereof on a Trading Day prior to the opening of &ldquo;regular trading hours&rdquo;
(as defined in Rule 600(b) of Regulation NMS promulgated under the federal securities laws) on such Trading Day, (ii) at the option of
the Holder, either (y) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise or (z) the Bid
Price of the Common Stock on the principal Trading Market as reported by Bloomberg L.P. (&ldquo;Bloomberg&rdquo;) as of the time of the
Holder&rsquo;s execution of the applicable Notice of Exercise if such Notice of Exercise is executed during &ldquo;regular trading hours&rdquo;
on a Trading Day and is delivered within two (2) hours thereafter (including until two (2) hours after the close of &ldquo;regular trading
hours&rdquo; on a Trading Day) pursuant to Section 2(a) hereof or (iii) the VWAP on the date of the applicable Notice of Exercise if
the date of such Notice of Exercise is a Trading Day and such Notice of Exercise is both executed and delivered pursuant to Section 2(a)
hereof after the close of &ldquo;regular trading hours&rdquo; on such Trading Day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Options</U>&rdquo;
means any rights, warrants, or options to subscribe for, purchase, or otherwise acquire shares of Common Stock or Convertible Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Stockholder
Approval</U>&rdquo; means the approval required by the applicable rules and regulations of the NASDAQ Capital Market (or any successor
entity) from the stockholders of the Company of the provisions of <U>Section 3(b)</U> of this Warrant in order for such provisions to
become effective by their terms and to be in compliance with such applicable rules and regulations of the NASDAQ Capital Market (or any
successor entity).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Trading
Day</U>&rdquo; means a day on which the shares of Common Stock are traded on the Trading Market; provided, however, that in the event
that the shares of Common Stock are not listed or quoted on the Trading Market, then Trading Day shall mean any day except Saturday,
Sunday and any day which shall be a legal holiday or a day on which banking institutions in the State of New York or State of Delaware
are authorized or required by law or other government action to close.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Trading
Market</U>&rdquo; means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date
in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, the New York Stock
Exchange, or the OTC Markets QB Tier (or any successors to any of the foregoing).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
2. <U>Exercise</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>Exercise of Warrants</U>. Exercise of the purchase rights for Warrant Shares represented by this Warrant may be made, in whole or
in part, at any time or times on or after the Initial Issuance Date and on or before the Termination Date by delivery to the Company
(or such other office or agency of the Company as it may designate by notice in writing to the registered Holder at the address of the
Holder appearing on the books of the Company) of a duly executed Notice of Exercise in the form annexed hereto as Exhibit A (which may
be delivered in a .PDF format via electronic mail pursuant to the notice provisions set forth in the Purchase Agreement). Within two
(2) Trading Days of the date said Notice of Exercise is delivered to the Company (or within three (3) Trading Days of the date said Notice
of Exercise is delivered to the Company if the Notice of Exercise is received after 12 p.m. EST on such day), the Company shall have
received payment of the aggregate Exercise Price of the Warrant Shares thereby purchased by wire transfer or cashier&rsquo;s check drawn
on a United States bank, unless such exercise is made pursuant to the cashless exercise procedure specified in <U>Section 2(c)</U> below
(if available). No ink-original Notice of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee or
notarization) of any Notice of Exercise form be required. The Company shall be entitled to conclusively assume the genuineness of any
signature on any Notice of Exercise delivered to the Company pursuant to this <U>Section 2(a)</U>, the legal capacity and competency
of all natural persons signing any Notice of Exercise so delivered, the authenticity of any Notice of Exercise so delivered, the conformity
to an authentic original of any Notice of Exercise so delivered as certified, authenticated, conformed, photostatic, facsimile, or electronic
and the authenticity of the original of such Notice of Exercise. Notwithstanding anything herein to the contrary, the Holder shall not
be required to physically surrender this Warrant to the Company until the Holder has purchased all of the Warrant Shares available hereunder
and the Warrant has been exercised in full, in which case, the Holder shall surrender this Warrant to the Company for cancellation within
three (3) Trading Days of the date the final Notice of Exercise is delivered to the Company. Partial exercises of this Warrant resulting
in purchases of a portion of the total number of Warrant Shares available hereunder shall have the effect of lowering the outstanding
number of Warrant Shares purchasable hereunder in an amount equal to the applicable number of Warrant Shares purchased. The Holder and
the Company shall maintain records showing the number of Warrant Shares purchased and the date of such purchases, and the Company shall
be entitled to conclusively assume that its records of the number of Warrant Shares purchased and the date of such purchases are accurate,
absent actual notice to the contrary. The Company shall deliver any objection to any Notice of Exercise within two (2) Business Days
of receipt of such notice. The Holder and any assignee, by acceptance of this Warrant, acknowledge and agree that, by reason of the provisions
of this paragraph, following the purchase of a portion of the Warrant Shares hereunder, the number of Warrant Shares available for purchase
hereunder at any given time may be less than the amount stated on the face hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>Exercise Price</U>. The exercise price per Warrant Share shall be $3.02, subject to adjustment hereunder (the &ldquo;<U>Exercise Price</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>





<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 76.9pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 76.9pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Cashless Exercise</U>. If at any time ninety (90) days after the date of the Initial Issuance Date, there is no effective Registration
Statement registering, or no current prospectus available for, the resale of the Warrant Shares by the Holder, then this Warrant may
also be exercised, in whole or in part, at such time by means of a &ldquo;cashless exercise&rdquo; in which the Holder shall be entitled
to receive a number of Warrant Shares equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.35in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(A)
    =</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    Market Price (at the date of such calculation)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(B)
    =</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    Exercise Price of this Warrant, as adjusted hereunder; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(X)
    =</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    number of Warrant Shares that would be issuable upon exercise of this Warrant in accordance with the terms of this Warrant if such
    exercise were by means of a cash exercise rather than a cashless exercise.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 77pt; text-align: justify; text-indent: -31.0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assuming
(i) the Holder is not an Affiliate of the Company, and (ii) all of the applicable conditions of Rule 144 promulgated under the Securities
Act of 1933, as amended (the &ldquo;<U>Securities Act</U>&rdquo;) with respect to Holder and the Warrant Shares are met in the case of
such a cashless exercise, the Company agrees that the Company will use its best efforts to cause the removal of the legend from such
Warrant Shares (including by delivering an opinion of the Company&rsquo;s counsel to the Company&rsquo;s transfer agent at its own expense
to ensure the foregoing), and the Company agrees that the Holder is under no obligation to sell the Warrant Shares issuable upon the
exercise of the Warrant prior to removing the legend. The Company expressly acknowledges that Rule 144(d)(3)(ii), as currently in effect,
provides that Warrant Shares issued solely upon a cashless exercise shall be deemed to have been acquired at the same time as the Warrant.
The Company agrees not to take any position contrary to this <U>Section 2(c)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)
<U>Mechanics of Exercise</U>.</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 76.90pt; text-align: justify; text-indent: -31.60pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.
<U>Delivery of Warrant Shares Upon Exercise</U>. The Company shall cause the Warrant Shares purchased hereunder to be transmitted by
the Company&rsquo;s transfer agent (the &ldquo;<U>Transfer Agent</U>&rdquo;) to the Holder by crediting the account of the Holder&rsquo;s
or its designee&rsquo;s balance account with The Depository Trust Company through its Deposit or Withdrawal at Custodian system (&ldquo;<U>DWAC</U>&rdquo;)
if the Company is then a participant in such system and either (A) there is an effective registration statement permitting the issuance
of the Warrant Shares to or resale of the Warrant Shares by the Holder or (B) the Warrant Shares are eligible for resale by the Holder
pursuant to Rule 144, and otherwise by physical delivery of a certificate, registered in the Company&rsquo;s share register in the name
of the Holder or its designee, for the number of Warrant Shares to which the Holder is entitled pursuant to such exercise to the address
specified by the Holder in the Notice of Exercise by the date that is one (1) Trading Day after the later of (A) the delivery to the
Company of the Notice of Exercise provided that such Notice of Exercise is received by 12 p.m. EST and two (2) Trading Days for any Notice
of Exercise received after 12 p.m. EST, and (B) the Company&rsquo;s receipt of payment of the aggregate Exercise Price of the Warrant
Shares thereby purchased by wire transfer or cashier&rsquo;s check drawn on a United States bank, unless such exercise is made pursuant
to the cashless exercise procedure specified in <U>Section 2(c)</U> (such date, the &ldquo;<U>Warrant Share Delivery Date</U>&rdquo;).
The Warrant Shares shall be deemed to have been issued, and Holder or any other person so designated to be named therein shall be deemed
to have become a holder of record of such shares for all purposes, as of the date the Warrant has been exercised, with payment to the
Company of the Exercise Price (or by cashless exercise, if permitted) and all taxes required to be paid by the Holder, if any, pursuant
to <U>Section 2(d)(vi)</U> prior to the issuance of such Warrant Shares, having been paid. If the Company fails for any reason to deliver
to the Holder the Warrant Shares subject to a Notice of Exercise by the Warrant Share Delivery Date, the Company shall pay to the Holder,
in cash, as liquidated damages and not as a penalty, for each $1,000 of Warrant Shares subject to such exercise (based on the VWAP of
the Common Stock on the date of the applicable Notice of Exercise), $5 per Trading Day (increasing to $10 per Trading Day on the fifth
Trading Day after such liquidated damages begin to accrue) for each Trading Day after such Warrant Share Delivery Date until such Warrant
Shares are delivered or Holder rescinds such exercise. The Company agrees to maintain a transfer agent that is a participant in the FAST
program so long as this Warrant remains outstanding and exercisable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.
<U>Delivery of New Warrants Upon Exercise</U>. If this Warrant shall have been exercised in part, the Company shall, at the request of
a Holder and upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant
evidencing the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in
all other respects be identical with this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iii.
<U>Rescission Rights</U>. If the Holder fails to make payment of the aggregate Exercise Price of the Warrant Shares pursuant to a Notice
of Exercise within two (2) Trading Days of the date said Notice of Exercise is delivered to the Company (or within three (3) Trading
Days of the date said Notice of Exercise is delivered to the Company if the Notice of Exercise is received after 12 p.m. EST on such
day) by wire transfer or cashier&rsquo;s check drawn on a United States bank, then the Company will have the right to rescind such exercise,
unless such exercise is made pursuant to the cashless exercise procedure specified in <U>Section 2(c)</U>. If the Company fails to cause
the Transfer Agent to transmit to the Holder the Warrant Shares pursuant to <U>Section 2(d)(i)</U> by the Warrant Share Delivery Date,
then the Holder will have the right to rescind such exercise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iv.
<U>Compensation for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise</U>. In addition to any other rights available to
the Holder, if the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance with the provisions
of <U>Section 2(d)(i)</U> above pursuant to an exercise on or before the Warrant Share Delivery Date, and if after such date the Holder
is required by its broker to purchase (in an open market transaction or otherwise) or the Holder&rsquo;s brokerage firm otherwise purchases,
shares of Common Stock to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving
upon such exercise (a &ldquo;<U>Buy-In</U>&rdquo;), then the Company shall (A) pay in cash to the Holder the amount, if any, by which
(x) the Holder&rsquo;s total purchase price (including brokerage commissions, if any) for the shares of Common Stock so purchased exceeds
(y) the amount obtained by multiplying (1) the number of Warrant Shares that the Company was required to deliver to the Holder in connection
with the exercise at issue times (2) the price at which the sell order giving rise to such purchase obligation was executed, and (B)
at the option of the Holder, either reinstate the portion of the Warrant Shares for which such exercise was not honored (in which case
such exercise shall be deemed rescinded) or deliver to the Holder the number of shares of Common Stock that would have been issued had
the Company timely complied with its exercise and delivery obligations hereunder. For example, if the Holder purchases Common Stock having
a total purchase price of $11,000 to cover a Buy-In with respect to an attempted exercise of shares of Common Stock with an aggregate
sale price giving rise to such purchase obligation of $10,000, under clause (A) of the immediately preceding sentence the Company shall
be required to pay the Holder $1,000. The Holder shall provide the Company written notice indicating the amounts payable to the Holder
in respect of the Buy-In and, upon request of the Company, evidence of the amount of such loss. Nothing herein shall limit a Holder&rsquo;s
right to pursue any other remedies available to it hereunder, at law or in equity including, without limitation, a decree of specific
performance and/or injunctive relief with respect to the Company&rsquo;s failure to timely deliver shares of Common Stock upon exercise
of the Warrant as required pursuant to the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">v.
<U>No Fractional Shares or Scrip</U>. No fractional shares or scrip representing fractional shares shall be issued upon the exercise
of this Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company
shall, at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied
by the Exercise Price or round up to the next whole share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">vi.
<U>Charges, Taxes, and Expenses</U>. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer
tax or other incidental expense in respect of the issuance of Warrant Shares, all of which taxes and expenses shall be paid by the Company,
and such Warrant Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder; provided,
however, that in the event that Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when surrendered
for exercise shall be accompanied by the Assignment Form attached hereto duly executed by the Holder and the Company may require, as
a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto. The Company shall pay all
fees charged by the Transfer Agent, including any fees assessed to the Transfer Agent by Depository Trust Company (or another established
clearing corporation performing similar functions) required for same-day processing of any Notice of Exercise and for same-day electronic
delivery of the Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">vii.
<U>Closing of Books</U>. The Company will not close its stockholder books or records in any manner which prevents the timely exercise
of this Warrant, pursuant to the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)
<U>Holder&rsquo;s Exercise Limitations</U>. To the extent the exercise of any portion of this Warrant requires the Company to receive
the approval of the Company&rsquo;s stockholders pursuant to NASDAQ Capital Market Listing Rules, the Company shall not effect such exercise
of this Warrant, and a Holder shall not have the right to exercise any such portion of this Warrant, pursuant to <U>Section 2</U> or
otherwise, until such approval has been received by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
3. <U>Certain Adjustments</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>Stock Dividends and Splits</U>. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise
makes a distribution or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable in shares
of Common Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon exercise of this
Warrant), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way of reverse
stock split) outstanding shares of Common Stock into a smaller number of shares or (iv) issues by reclassification of shares of the Common
Stock any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which the
numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before such event
and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event, and the number of
Warrant Shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this
Warrant shall remain unchanged. Any adjustment made pursuant to this Section 3(a) shall become effective immediately after the record
date for the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after
the effective date in the case of a subdivision, combination or re-classification.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>Notice</U>. The Company shall notify the Holder, in writing, no later than the Trading Day following the issuance or deemed issuance
of any Common Stock or Common Stock Equivalents subject to <U>Section 3(a)</U>, indicating therein the applicable issuance price, or
applicable reset price, exchange price, conversion price and other pricing terms (such notice, the &ldquo;<U>Dilutive Issuance Notice</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Fundamental Transaction</U>. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or
more related transactions effects any merger or consolidation of the Company with or into another Person, (ii) the Company, directly
or indirectly, effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially all of
its assets in one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange offer
(whether by the Company or another Person) is completed pursuant to which holders of Common Stock are permitted to sell, tender or exchange
their shares for other securities, cash or property and has been accepted by the holders of more than 50% of the outstanding Common Stock
or more than 50% of the voting power of the common equity of the Company, (iv) the Company, directly or indirectly, in one or more related
transactions effects any reclassification, reorganization, or recapitalization of the Common Stock or any compulsory share exchange pursuant
to which the Common Stock is effectively converted into or exchanged for other securities, cash or property, or (v) the Company, directly
or indirectly, in one or more related transactions consummates a stock or share purchase agreement or other business combination (including,
without limitation, a reorganization, recapitalization, spin-off, merger or scheme of arrangement) with another Person or group of Persons
whereby such other Person or group acquires more than 50% of the outstanding shares of Common Stock or more than 50% of the voting power
of the common equity of the Company (not including any shares of Common Stock held by the other Person or other Persons making or party
to, or associated or affiliated with the other Persons making or party to, such stock or share purchase agreement or other business combination)
(each a &ldquo;<U>Fundamental Transaction</U>&rdquo;), then, the Company shall cause any successor entity in a Fundamental Transaction
in which the Company is not the survivor (the &ldquo;<U>Successor Entity</U>&rdquo;) to assume in writing all of the obligations of the
Company under this Warrant and the other Transaction Documents in accordance with the provisions of this <U>Section 3(e)</U> pursuant
to written agreements in form and substance reasonably satisfactory to the Holder and approved by the Holder (without unreasonable delay)
prior to such Fundamental Transaction and shall, at the option of the Holder, deliver to the Holder in exchange for this Warrant a security
of the Successor Entity evidenced by a written instrument substantially similar in form and substance to this Warrant which is exercisable
for a corresponding number of shares of capital stock of such Successor Entity (or its parent entity) equivalent to the shares of Common
Stock acquirable and receivable upon exercise of this Warrant (without regard to any limitations on the exercise of this Warrant) prior
to such Fundamental Transaction, and with an exercise price which applies the exercise price hereunder to such shares of capital stock
(but taking into account the relative value of the shares of Common Stock pursuant to such Fundamental Transaction and the value of such
shares of capital stock, such number of shares of capital stock and such exercise price being for the purpose of protecting the economic
value of this Warrant immediately prior to the consummation of such Fundamental Transaction), and which is reasonably satisfactory in
form and substance to the Holder. Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall succeed to, and
be substituted for (so that from and after the date of such Fundamental Transaction, the provisions of this Warrant and the other Transaction
Documents referring to the &ldquo;Company&rdquo; shall refer instead to the Successor Entity), and may exercise every right and power
of the Company and shall assume all of the obligations of the Company under this Warrant and the other Transaction Documents with the
same effect as if such Successor Entity had been named as the Company herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)
<U>Calculations</U>. All calculations under this <U>Section 3</U> shall be made to the nearest cent or the nearest 1/100th of a share,
as the case may be. For purposes of this <U>Section 3</U>, the number of shares of Common Stock deemed to be issued and outstanding as
of a given date shall be the sum of the number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)
<U>Notice to Holder</U>.</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 76.90pt; text-align: justify; text-indent: -31.60pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.
<U>Adjustment to Exercise Price</U>. Whenever the Exercise Price is adjusted pursuant to any provision of this <U>Section 3</U>, the
Company shall promptly mail or deliver via electronic mail to the Holder a notice setting forth the Exercise Price after such adjustment
and any resulting adjustment to the number of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.
<U>Notice to Allow Exercise by Holder</U>. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on
the Common Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C) the
Company shall authorize the granting to all holders of the Common Stock rights or warrants to subscribe for or purchase any shares of
capital stock of any class or of any rights, (D) the approval of any stockholders of the Company shall be required in connection with
any reclassification of the Common Stock, any consolidation or merger to which the Company is a party, any sale or transfer of all or
substantially all of the assets of the Company, or any compulsory share exchange whereby the Common Stock is converted into other securities,
cash or property, or </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">(E) the Company shall authorize the voluntary or
involuntary dissolution, liquidation or winding up of the affairs of the Company, then, in each case, the Company shall cause to be mailed
to the Holder at its last address as it shall appear upon the Warrant Register of the Company, at least 20 calendar days prior to the
applicable record or effective date hereinafter specified, a notice stating (x) the date on which a record is to be taken for the purpose
of such dividend, distribution, redemption, rights, or warrants, or if a record is not to be taken, the date as of which the holders
of the Common Stock of record to be entitled to such dividend, distributions, redemption, rights or warrants are to be determined or
(y) the date on which such reclassification, consolidation, merger, sale, transfer or share exchange is expected to become effective
or close, and the date as of which it is expected that holders of the Common Stock of record shall be entitled to exchange their shares
of the Common Stock for securities, cash or other property deliverable upon such reclassification, consolidation, merger, sale, transfer
or share exchange; provided that the failure to mail such notice or any defect therein or in the mailing thereof shall not affect the
validity of the corporate action required to be specified in such notice. To the extent that any notice provided in this Warrant constitutes,
or contains, material, non-public information regarding the Company, the Company shall simultaneously file such notice with the Commission
pursuant to a Current Report on Form 8-K. The Holder shall remain entitled to exercise this Warrant during the period commencing on the
date of such notice to the effective date of the event triggering such notice except as may otherwise be expressly set forth herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
4. <U>Transfer of Warrant</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>Transferability</U>. Subject to compliance with any applicable securities laws and the conditions set forth in <U>Section 4(d)</U>
hereof, this Warrant and all rights hereunder (including, without limitation, any registration rights) are transferable, in whole or
in part, upon surrender of this Warrant at the principal office of the Company or its designated agent, together with a written assignment
of this Warrant substantially in the form attached hereto duly executed by the Holder or its agent or attorney and funds sufficient to
pay any transfer taxes payable upon the making of such transfer. Upon such surrender and, if required, such payment, the Company shall
execute and deliver a new Warrant or Warrants in the name of the assignee or assignees, as applicable, and in the denomination or denominations
specified in such instrument of assignment and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not so
assigned, and this Warrant shall promptly be cancelled. Notwithstanding anything herein to the contrary, the Holder shall not be required
to physically surrender this Warrant to the Company unless the Holder has assigned this Warrant in full, in which case, the Holder shall
surrender this Warrant to the Company within three (3) Trading Days of the date the Holder delivers an assignment form to the Company
assigning this Warrant in full. The Warrant, if properly assigned in accordance herewith, may be exercised by a new holder for the purchase
of Warrant Shares without having a new Warrant issued.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>New Warrants</U>. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of
the Company, together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by
the Holder or its agent or attorney. Subject to compliance with <U>Section 4(a)</U>, as to any transfer which may be involved in such
division or combination, the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be
divided or combined in accordance with such notice. All Warrants issued on transfers or exchanges shall be dated the Initial Exercise
Date and shall be identical with this Warrant except as to the number of Warrant Shares issuable pursuant thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Warrant Register</U>. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the
&ldquo;<U>Warrant Register</U>&rdquo;), in the name of the record Holder hereof from time to time. The Company may deem and treat the
registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder,
and for all other purposes, absent actual notice to the contrary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)
<U>Transfer Restrictions</U>. Subject to any limitations imposed by applicable law, this Warrant may be offered for sale, sold, transferred,
or assigned without the consent of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)
<U>Representation by the Holder</U>. The Holder, by the acceptance hereof, represents and warrants that it is acquiring this Warrant
and, upon any exercise hereof, will acquire the Warrant Shares issuable upon such exercise, for its own account and not with a view to
or for distributing or reselling such Warrant Shares or any part thereof in violation of the Securities Act or any applicable state securities
law, except pursuant to sales registered or exempted under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
5. <U>Miscellaneous</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>No Rights as Stockholder Until Exercise</U>. This Warrant does not entitle the Holder to any voting rights, dividends or other rights
as a stockholder of the Company prior to the exercise hereof as set forth in <U>Section 2(d)(i)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>Loss, Theft, Destruction, or Mutilation of Warrant</U>. The Company covenants that upon receipt by the Company of evidence reasonably
satisfactory to it of the loss, theft, destruction, or mutilation of this Warrant or any stock certificate relating to the Warrant Shares,
and in case of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant,
shall not include the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the
Company will make and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant
or stock certificate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Saturdays, Sundays, Holidays, etc</U>. If the last or appointed day for the taking of any action or the expiration of any right required
or granted herein shall not be a Business Day, then, such action may be taken or such right may be exercised on the next succeeding Business
Day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)
<U>Authorized Shares</U>. The Company covenants that, during the period the Warrant is outstanding, it will reserve from its authorized
and unissued Common Stock a sufficient number of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase
rights under this Warrant (the &ldquo;<U>Required Reserve Amount</U>&rdquo;). The Company further covenants that its issuance of this
Warrant shall constitute full authority to its officers who are charged with the duty of issuing the necessary Warrant Shares upon the
exercise of the purchase rights under this Warrant. The Company will take all such reasonable action as may be necessary to assure that
such Warrant Shares may be issued as provided herein without violation of any applicable law or regulation, or of any requirements of
the Trading Market upon which the Common Stock may be listed. The Company covenants that all Warrant Shares which may be issued upon
the exercise of the purchase rights represented by this Warrant will, upon exercise of the purchase rights represented by this Warrant
and payment for such Warrant Shares in accordance herewith, be duly authorized, validly issued, fully paid, and nonassessable and free
from all taxes, liens, and charges created by the Company in respect of the issue thereof (other than taxes in respect of any transfer
occurring contemporaneously with such issue).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)
<U>Transfer Agent Instructions</U>. The Company covenants and agrees that it will, at all times during the period the Warrant is outstanding,
maintain a duly qualified independent Transfer Agent. The Company represents and covenants that, within one (1) day from the Initial
Exercise Date, it will either (i) issue irrevocable instructions to its current Transfer Agent (and each Transfer Agent appointed thereafter)
to issue certificates, registered in the name of the Holder or its nominee, for the Warrant Shares in such amounts as specified from
time to time by the Holder to the Company upon exercise of this Warrant in accordance with the terms thereof (the &ldquo;<U>Irrevocable
Transfer Agent Instructions</U>&rdquo;), or (ii) appoint a new Transfer Agent, at which time the Company (a) shall provide a copy of
its agreement with the new Transfer Agent to the Holder, and (b) issue Irrevocable Transfer Agent Instructions to the new Transfer Agent.
Such Irrevocable Transfer Agent Instructions shall be in a form acceptable to the Holder and shall include a provision to irrevocably
reserve the Required Reserve Amount. The Irrevocable Transfer Agent Instructions shall be signed by the Company&rsquo;s Transfer Agent
as of the date of the Initial Exercise Date or by the New Transfer Agent, as applicable, and by the Company. The Company warrants that,
(i) no instruction other than the Irrevocable Transfer Agent Instructions referred to in this Section 5(e), and stop transfer instructions
to give effect to Section 5(g) (prior to registration of the Warrant Shares under the Securities Act or the date on which the Warrant
Shares may be sold pursuant to Rule 144 without any restriction as to the number of Securities as of a particular date that can then
be immediately sold), will be given by the Company to its Transfer Agent and that the Warrant Shares shall otherwise be freely transferable
on the books and records of the Company as and to the extent provided in this Warrant and the Purchase Agreement, (ii) it will not direct
its Transfer Agent not to transfer or delay, impair, and/or hinder its Transfer Agent in transferring (or issuing)(electronically or
in certificated form) any certificate for Warrant Shares to be issued to the Holder upon exercise of or otherwise pursuant to this Warrant
as and when required by this Warrant and the Purchase Agreement, and (iii) it will not fail to remove (or direct its Transfer Agent not
to remove or impair, delay, and/or hinder its Transfer Agent from removing) any restrictive legend (or to withdraw any stop transfer
instructions in respect thereof) on any certificate for any Warrant Shares issued to the Holder upon exercise of or otherwise pursuant
to this Warrant as and when required by this Warrant and the Purchase Agreement. Nothing in this Section shall affect in any way the
Holder&rsquo;s obligations to comply with all applicable prospectus delivery requirements, if any, upon resale of the Warrant Shares.
If a Holder provides the Company, at the cost of the Holder, with an opinion of counsel in form, substance, and scope customary for opinions
in comparable transactions, to the effect that a public sale or transfer of such Warrant Shares may be made without registration under
the Securities Act and such sale or transfer is effected, the Company shall permit the transfer, and, in the case of the Warrant Shares,
promptly instruct its Transfer Agent to issue one or more certificates, free from restrictive legend, in such name and in such denominations
as specified by the Holder. The Company acknowledges that a breach by it of its obligations hereunder will cause irreparable harm to
the Holder, by vitiating the intent and purpose of the transactions contemplated hereby. Accordingly, the Company acknowledges that the
remedy at law for a breach of its obligations under this Section 5(e) may be inadequate and agrees, in the event of a breach or threatened
breach by the Company of the provisions of this Section, that the Holder shall be entitled, in addition to all other available remedies,
to an injunction restraining any breach and requiring immediate transfer, without the necessity of showing economic loss and without
any bond or other security being required.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f)
<U>Jurisdiction</U>. All questions concerning the construction, validity, enforcement, and interpretation of this Warrant shall be determined
in accordance with the provisions of the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">g)
<U>Restrictions</U>. The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, will
have restrictions upon resale imposed by state and federal securities laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">h)
<U>Nonwaiver and Expenses</U>. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall
operate as a waiver of such right or otherwise prejudice the Holder&rsquo;s rights, powers, or remedies, notwithstanding the fact that
all rights hereunder terminate on the Termination Date. If the Company willfully and knowingly fails to comply with any provision of
this Warrant, which results in any material damages to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient
to cover any costs and expenses including, but not limited to, reasonable attorneys&rsquo; fees, including those of appellate proceedings,
incurred by the Holder in collecting any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies
hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i)
<U>Notices</U>. Any notice, request or other document required or permitted to be given or delivered to the Holder by the Company shall
be delivered in accordance with the notice provisions of the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">j)
<U>Limitation of Liability</U>. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant
to purchase Warrant Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of
the Holder for the purchase price of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company
or by creditors of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">k)
<U>Remedies</U>. The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will
be entitled to specific performance of its rights under this Warrant. The Company agrees that monetary damages may not be adequate compensation
for any loss incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to assert the
defense in any action for specific performance that a remedy at law would be adequate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">l)
<U>Successors and Assigns</U>. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall
inure to the benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns
of Holder. The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall
be enforceable by the Holder or holder of Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">m)
<U>Amendment</U>. This Warrant (other than <U>Section 2(e)</U>) may be modified or amended or the provisions hereof waived with the written
consent of the Company and the Holder. No waiver shall be effective unless it is in writing and signed by an authorized representative
of the waiving party.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">n)
<U>Severability</U>. If any provision of this Warrant is prohibited by law or otherwise determined to be invalid or unenforceable by
a court of competent jurisdiction, the provision that would otherwise be prohibited, invalid or unenforceable shall be deemed amended
to apply to the broadest extent that it would be valid and enforceable, and the invalidity or unenforceability of such provision shall
not affect the validity of the remaining provisions of this Warrant so long as this Warrant as so modified continues to express, without
material change, the original intentions of the parties as to the subject matter hereof and the prohibited nature, invalidity or unenforceability
of the provision(s) in question does not substantially impair the respective expectations or reciprocal obligations of the parties or
the practical realization of the benefits that would otherwise be conferred upon the parties. The parties will endeavor in good faith
negotiations to replace the prohibited, invalid or unenforceable provision(s) with a valid provision(s), the effect of which comes as
close as possible to that of the prohibited, invalid or unenforceable provision(s).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">o)
<U>Headings</U>. This Warrant shall be deemed to be jointly drafted by the Company and the Holder and shall not be construed against
any Person as the drafter hereof. The headings of this Warrant are for convenience of reference and shall not form part of, or affect
the interpretation of, this Warrant. Terms used in this Warrant but defined in the other Transaction Documents shall have the meanings
ascribed to such terms on the Closing Date in such other Transaction Documents unless otherwise consented to in writing by the Holder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">p)
<U>Governing Law</U>. This Warrant shall be governed by and construed and enforced in accordance with, and all questions concerning the
construction, validity, interpretation, and performance of this Warrant shall be governed by, the internal laws of the State of Delaware,
without giving effect to any choice of law or conflict of law provision or rule (whether of the State of Delaware or any other jurisdictions)
that would cause the application of the laws of any jurisdictions other than the State of Delaware. The Company hereby irrevocably waives
personal service of process and consents to process being served in any such suit, action, or proceeding by mailing a copy thereof to
the Company at the address set forth in the Purchase Agreement and agrees that such service shall constitute good and sufficient service
of process and notice thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">q)
<U>Jurisdiction and Venue</U>. Each party hereby irrevocably submits that any dispute, controversy or claim arising out of or relating
to this Warrant, shall be submitted to the exclusive jurisdiction of the Chancery Court of the State of Delaware and the United States
District Court for the District of Delaware. Each party hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding,
any claim that it is not personally subject to the jurisdiction of any such court, that such suit, action or proceeding is brought in
an inconvenient forum or that the venue of such suit, action or proceeding is improper. Each party hereby irrevocably waives personal
service of process and consents to process being served in any such suit, action or proceeding by mailing a copy thereof to such party
at the address for such notices to it under the Purchase Agreement and agrees that such service shall constitute good and sufficient
service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any
manner permitted by law. EACH PARTY HEREBY IRREVOCABLY WAIVES ANY RIGHT IT MAY HAVE, AND AGREES NOT TO REQUEST, A JURY TRIAL FOR THE
ADJUDICATION OF ANY DISPUTE HEREUNDER OR IN CONNECTION HEREWITH OR </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">ARISING
OUT OF THIS WARRANT. The parties agree that all dispute resolution proceedings in accordance with this Section 5(o) may be conducted
in a virtual setting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>********************</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(Signature
Page Follows)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>


<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the Company has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above
indicated.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>NEXTTRIP, INC.</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Bill Kerby</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bill
    Kerby</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[Signature Page to Warrant]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">EXHIBIT
A</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTICE
OF EXERCISE</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">TO
BE EXECUTED BY THE REGISTERED HOLDER TO EXERCISE THIS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WARRANT
TO PURCHASE COMMON STOCK</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NEXTTRIP,
INC.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned holder hereby exercises the right to purchase  of the shares of Common Stock (&ldquo;<U>Warrant Shares</U>&rdquo;) of NextTrip,
Inc., a Nevada corporation (the &ldquo;Company&rdquo;), evidenced by the Warrant (the &ldquo;<U>Warrant</U>&rdquo;). Capitalized terms
used herein and not otherwise defined shall have the respective meanings set forth in the Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.
<U>Form of Exercise Price</U>. The Holder intends that payment of the Aggregate Exercise Price shall be made as:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">____________
<FONT STYLE="font-size: 10pt">a &ldquo;<U>Cash Exercise</U>&rdquo; with respect to ____________ Warrant Shares; and/or</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;____________
a &ldquo;<U>Cashless Exercise</U>&rdquo; with respect to ____________ Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt .5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.
<U>Payment of Exercise Price</U>. In the event that the Holder has elected a Cash Exercise with respect to some or all of the Warrant
Shares to be issued pursuant hereto, the Holder shall pay the Aggregate Exercise Price in the sum of $ ____________ to the Company in
accordance with the terms of the Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.
<U>Delivery of Warrant Shares</U>. The Company shall deliver to Holder, or its designee or agent as specified below, ____________ Warrant
Shares in accordance with the terms of the Warrant. Delivery shall be made to Holder, or for its benefit, as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;
Check here if requesting delivery as a certificate to the following name and to the following address:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="width: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issue to:</FONT></TD>
  <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 46pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;
&nbsp;&nbsp;&nbsp;&nbsp;Check here if requesting delivery by Deposit/Withdrawal at Custodian as follows:</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 46pt; text-align: justify; text-indent: -0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 46pt; text-align: justify; text-indent: 0pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="width: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">DTC Participant:</FONT></TD>
  <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">DTC Number:</FONT></TD>
  <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Account Number:</FONT></TD>
  <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 46pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Date:
___________ __,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 46pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Name
of Registered Holder</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 46pt; text-align: justify; text-indent: 0pt"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 46pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 46pt; text-align: justify; text-indent: 0pt"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 15%"><FONT STYLE="font-family: Times New Roman, Times, Serif">Tax
    ID:</FONT></TD>
    <TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left; width: 35%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Facsimile:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">E-mail
    Address:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 46pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">EXHIBIT
B</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASSIGNMENT
FORM</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<I>To
assign the foregoing Warrant, execute this form and supply required information. Do not use this form to purchase shares</I>.)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FOR
VALUE RECEIVED, the foregoing Warrant and all rights evidenced thereby are hereby assigned to</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif">Name:</FONT></TD>
    <TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif">(Please
    Print)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Address:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">(Please
    Print)</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated:
________ __,</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif">____</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s
Signature:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s
Address:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 14; Options: Last -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.17
<SEQUENCE>8
<FILENAME>ex4-17.htm
<DESCRIPTION>EX-4.17
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 4.17</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt">NEITHER THIS
SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR
THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE
&ldquo;SECURITIES ACT&rdquo;), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER
THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE
SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS
SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES.</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">COMMON STOCK PURCHASE WARRANT</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">NEXTTRIP, INC.</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; font-size: 10pt; text-align: justify">Warrant Shares: 17,000</TD>
    <TD STYLE="width: 50%; font-size: 10pt; text-align: right">Issue Date: January 28, 2025</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 1in">THIS COMMON STOCK
PURCHASE WARRANT (the &ldquo;<U>Warrant</U>&rdquo;) certifies that, for value received, The Entrust Group, Inc. FBO Milburn Christopher Mabry Roth IRA Account 7230028478 or its assigns (the &ldquo;<U>Holder</U>&rdquo;)
is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time or times
on or after the date that is six (6) months from the Issue Date (the &ldquo;<U>Initial Exercise Date</U>&rdquo;) and on or prior to 5:00
p.m. (New York City time) on July 28, 2028, the three (3) year anniversary of the Initial Exercise Date (the &ldquo;<U>Termination Date</U>&rdquo;),
but not thereafter, to subscribe for and purchase from NextTrip, Inc., a Nevada corporation (the &ldquo;<U>Company</U>&rdquo;), up to
17,000 shares (as subject to adjustment hereunder, the &ldquo;<U>Warrant Shares</U>&rdquo;) of Common Stock. The purchase price of one
share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: 0.5in"><U>Section 1</U>.
<U>Definitions</U>. Capitalized terms used and not otherwise defined herein shall have the meanings set forth in that certain Securities
Purchase Agreement (the &ldquo;<U>Purchase Agreement</U>&rdquo;), dated January 28, 2025, among the Company and the purchasers signatory
thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt .5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt .5in"><U>Section 2</U>. <U>Exercise</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">a) <U>Exercise
of Warrant</U>. Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time or times
on or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company of a duly executed PDF copy
submitted by e-mail (or e-mail attachment) of the Notice of </FONT>Exercise in the form annexed hereto (the &ldquo;<U>Notice of
Exercise</U>&rdquo;). Within the earlier of (i) two (2) Trading Days and (ii) the number of Trading Days comprising the Standard
Settlement Period (as defined in Section 2(c)(i) herein) following the date of exercise as aforesaid, the Holder shall deliver the
aggregate Exercise Price for the Warrant Shares specified in the applicable Notice of Exercise by wire transfer or cashier&rsquo;s
check drawn on a United States bank. No ink-original Notice of Exercise shall be required, nor shall any medallion guarantee (or
other type of guarantee or notarization) of any Notice of Exercise be required. Notwithstanding anything herein to the contrary, the
Holder shall not be required to physically surrender this Warrant to the Company until the Holder has purchased all of the Warrant
Shares available hereunder and the Warrant has been exercised in full, in which case, the Holder shall surrender this Warrant to the
Company for cancellation as soon as reasonably practicable of the date on which the final Notice of Exercise is delivered to the
Company. Partial exercises of this Warrant resulting in purchases of a portion of the total number of Warrant Shares available
hereunder shall have the effect of lowering the outstanding number of Warrant Shares purchasable hereunder in an amount equal to the
applicable number of Warrant Shares purchased. The Holder and the Company shall maintain records showing the number of Warrant
Shares purchased and the date of such purchases. The Company shall deliver any objection to any Notice of Exercise within one (1)
Trading Day of receipt of such notice. <B>The Holder and any assignee, by acceptance of this Warrant, acknowledge and agree that, by
reason of the provisions of this paragraph, following the purchase of a portion of the Warrant Shares hereunder, the number of
Warrant Shares available for purchase hereunder at any given time may be less than the amount stated on the face hereof.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt .5in; text-indent: 35.95pt">b) <U>Exercise Price</U>. The
exercise price per share of Common Stock under this Warrant shall be $7.50, subject to adjustment hereunder (the &ldquo;<U>Exercise
Price</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 1in; margin-top: 0pt; margin-bottom: 0pt"> c) <U>Mechanics of Exercise</U>.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 29.6pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 29.6pt"><FONT STYLE="font-size: 10pt">i. <U>Delivery
of Warrant Shares Upon Exercise</U>. The Company shall cause the Warrant Shares purchased hereunder to be transmitted by the
Transfer Agent to the Holder by crediting the account of the Holder&rsquo;s or its designee&rsquo;s balance account with The
Depository Trust Company through its Deposit or Withdrawal at Custodian system (&ldquo;<U>DWAC</U>&rdquo;) if the Company is then a
participant in such system and either (A) there is an effective registration statement permitting the issuance of the Warrant Shares
to or resale of the Warrant Shares by the Holder or (B) the Warrant Shares are eligible for resale by the Holder without volume or
manner-of-sale limitations pursuant to Rule 144, and otherwise by physical delivery of a certificate, registered in the
Company&rsquo;s share register in the name of the Holder or its designee, for the number of Warrant Shares to which the Holder is
entitled pursuant to such exercise to the address specified by the Holder in the Notice of Exercise by the date that is the earliest
of (i) two (2) Trading Days after the delivery to the Company of the Notice of Exercise, (ii) one (1) </FONT>Trading Day after
delivery of the aggregate Exercise Price to the Company and (iii) the number of Trading Days comprising the Standard Settlement
Period after the delivery to the Company of the Notice of Exercise (such date, the &ldquo;<U>Warrant Share Delivery
Date</U>&rdquo;). Upon delivery of the Notice of Exercise, the Holder shall be deemed for all corporate purposes to have become the
holder of record of the Warrant Shares with respect to which this Warrant has been exercised, irrespective of the date of delivery
of the Warrant Shares, provided that payment of the aggregate Exercise Price is received by the Warrant Share Delivery Date. The
Company agrees to maintain a transfer agent that is a participant in the FAST program so long as this Warrant remains outstanding
and exercisable. As used herein, &ldquo;<U>Standard Settlement Period</U>&rdquo; means the standard settlement period, expressed in
a number of Trading Days, on the Company&rsquo;s primary Trading Market with respect to the Common Stock as in effect on the date of
delivery of the Notice of Exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 29.6pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 29.6pt">ii. <U>Delivery
of New Warrants Upon Exercise</U>. If this Warrant shall have been exercised in part, the Company shall, at the request of a Holder
and upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant
evidencing the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall
in all other respects be identical with this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 29.6pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 29.6pt">iii. <U>Rescission
Rights</U>. If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant to Section
2(c)(i) by the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 23.6pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 29.6pt">iv. <U>No
Fractional Shares or Scrip</U>. No fractional shares or scrip representing fractional shares shall be issued upon the exercise of
this Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company
shall, at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction
multiplied by the Exercise Price or round up to the next whole share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 27pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 29.6pt"><FONT STYLE="font-size: 10pt">v. <U>Charges,
Taxes and Expenses</U>. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax or other
incidental expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the Company,
and such Warrant Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder; <U>provided</U>, <U>however</U>,
that, in the event that Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when surrendered
for exercise shall be accompanied by the Assignment Form attached </FONT>hereto duly executed by the Holder and the Company may
require, as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto. The
Company shall pay all Transfer Agent fees required for same-day processing of any Notice of Exercise and all fees to the Depository
Trust Company (or another established clearing corporation performing similar functions) required for same-day electronic delivery
of the Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 29.6pt">&nbsp;</P>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 29.6pt">vi.&nbsp;<U>Closing
of Books</U>. The Company will not close its stockholder books or records in any manner which prevents the timely exercise of this Warrant,
pursuant to the terms hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 29.6pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 1in; margin-top: 0pt; margin-bottom: 0pt"> d) <U>Holder&rsquo;s Exercise Limitations</U>.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 157.55pt; text-align: justify; text-indent: 20.6pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 29.6pt"><FONT STYLE="font-size: 10pt">i.&nbsp;<U>Beneficial
Ownership Limitation</U>. The Company shall not effect any exercise of this Warrant, and a Holder shall not have the right to exercise
any portion of this Warrant, pursuant to Section 2 or otherwise, to the extent that after giving effect to such issuance after exercise
as set forth on the applicable Notice of Exercise, the Holder (together with the Holder&rsquo;s Affiliates, and any other Persons acting
as a group together with the Holder or any of the Holder&rsquo;s Affiliates (such Persons, &ldquo;<U>Attribution Parties</U>&rdquo;)),
would beneficially own in excess of the Beneficial Ownership Limitation (as defined below). For purposes of the foregoing sentence, the
number of shares of Common Stock beneficially owned by the Holder and its Affiliates and Attribution Parties shall include the number
of shares of Common Stock held by such Holder and all other Attribution Parties plus the number of shares of Common Stock issuable upon
exercise of this Warrant with respect to which such determination is being made, but shall exclude the number of shares of Common Stock
which would be issuable upon (i) exercise of the remaining, nonexercised portion of this Warrant beneficially owned by the Holder or any
of its Affiliates or Attribution Parties and (ii) exercise or conversion of the unexercised or nonconverted portion of any other securities
of the Company (including, without limitation, any other Common Stock Equivalents) subject to a limitation on conversion or exercise analogous
to the limitation contained herein beneficially owned by the Holder or any of its Affiliates or Attribution Parties. Except as set forth
in the preceding sentence, for purposes of this Section 2(d), beneficial ownership shall be calculated in accordance with Section 13(d)
of the Exchange Act and the rules and regulations promulgated thereunder, it being acknowledged by the Holder that the Company is not
representing to the Holder that such calculation is in compliance with Section 13(d) of the Exchange Act and the Holder is solely responsible
for any schedules required to be filed in accordance therewith. To the extent that the limitation contained in this Section 2(d) applies,
the determination of whether this Warrant is exercisable (in relation to </FONT>other securities owned by the Holder together with any
Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable shall be in the sole discretion of the Holder,
and the submission of a Notice of Exercise shall be deemed to be the Holder&rsquo;s determination of whether this Warrant is exercisable
(in relation to other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this
Warrant is exercisable, in each case subject to the Beneficial Ownership Limitation, and the Company shall have no obligation to verify
or confirm the accuracy of such determination. In addition, a determination as to any group status as contemplated above shall be determined
in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder. For purposes of this Section
2(d), in determining the number of outstanding shares of Common Stock, a Holder may rely on the number of outstanding shares of Common
Stock as reflected in (A) the Company&rsquo;s most recent periodic or annual report filed with the Commission, as the case may be, (B)
a more recent public announcement by the Company or (C) a more recent written notice by the Company or the Transfer Agent setting forth
the number of shares of Common Stock outstanding. Upon the written or oral request of a Holder, the Company shall within one Trading Day
confirm orally and in writing to the Holder the number of shares of Common Stock then outstanding. In any case, the number of outstanding
shares of Common Stock shall be determined after giving effect to the conversion or exercise of securities of the Company, including this
Warrant, by the Holder or its Affiliates or Attribution Parties since the date as of which such number of outstanding shares of Common
Stock was reported. The &ldquo;<U>Beneficial Ownership Limitation</U>&rdquo; shall be 4.99% (or, upon election by a Holder in compliance
with this Section 2(d) prior to the issuance of any Warrants, 9.99%) of the number of shares of the Common Stock outstanding immediately
after giving effect to the issuance of shares of Common Stock issuable upon exercise of this Warrant. The Holder, upon notice to the Company,
may increase or decrease the Beneficial Ownership Limitation provisions of this Section 2(d), provided that the Beneficial Ownership Limitation
in no event exceeds 9.99% of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares
of Common Stock upon exercise of this Warrant held by the Holder and the provisions of this Section 2(d) shall continue to apply. Any
increase in the Beneficial Ownership Limitation will not be effective until the 61<SUP>st</SUP> day after such notice is delivered to
the Company. The provisions of this paragraph shall be construed and implemented in a manner otherwise than in strict conformity with
the terms of this Section 2(d) to correct this paragraph (or any portion hereof) which may be defective or inconsistent with the intended
Beneficial Ownership Limitation herein contained or to make changes or supplements necessary or desirable to properly give effect to such
limitation. The limitations contained in this paragraph shall apply to a successor holder of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 29.6pt">&nbsp;</P>


<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><U>Section 3</U>. <U>Certain Adjustments</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt .5in; text-align: justify; text-indent: 0.5in">a)&nbsp;<U>Stock
Dividends and Splits</U>. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise makes
a distribution or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable in shares of
Common Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon exercise of this
Warrant), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way of reverse
stock split) outstanding shares of Common Stock into a smaller number of shares, or (iv) issues by reclassification of shares of the Common
Stock any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which the
numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before such event
and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event, and the number of
shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this Warrant
shall remain unchanged. Any adjustment made pursuant to this Section 3(a) shall become effective immediately after the record date for
the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after the effective
date in the case of a subdivision, combination or re classification.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt .5in; text-align: justify; text-indent: 35.95pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 35.95pt">b)&nbsp;<U>Subsequent
Rights Offerings</U>. In addition to any adjustments pursuant to Section 3(a) above, if at any time the Company grants, issues or sells
any Common Stock Equivalents or rights to purchase stock, warrants, securities or other property pro rata to the record holders of any
class of shares of Common Stock (the &ldquo;<U>Purchase Rights</U>&rdquo;), then the Holder will be entitled to acquire, upon the terms
applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had held the number
of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise hereof) immediately
before the date on which a record is taken for the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the
date as of which the record holders of shares of Common Stock are to be determined for the grant, issue or sale of such Purchase Rights.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">c)&nbsp;<U>Pro
Rata Distributions</U>. During such time as this Warrant is outstanding, if the Company shall declare or make any dividend or other distribution
of its assets (or rights to acquire its assets) to holders of shares of Common Stock, by way of return of capital or otherwise (including,
without limitation, any distribution of cash, stock or other securities, property or options by way of a dividend, spin off, reclassification,
corporate rearrangement, scheme of arrangement or other similar transaction) (a &ldquo;<U>Distribution</U>&rdquo;), at any time after
the issuance of this Warrant, then, in each such case, the Holder shall be entitled to participate in such Distribution to the same extent
that the Holder would have participated therein if the Holder had held the number of shares of Common Stock </FONT>acquirable upon complete
exercise of this Warrant (without regard to any limitations on exercise hereof) immediately before the date of which a record is taken
for such Distribution, or, if no such record is taken, the date as of which the record holders of shares of Common Stock are to be determined
for the participation in such Distribution.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">d)&nbsp;<U>Fundamental
Transaction</U>. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or more related transactions
effects any merger or consolidation of the Company with or into another Person, (ii) the Company (or any Subsidiary), directly or indirectly,
effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially all of its assets in one
or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange offer (whether by the Company
or another Person) is completed pursuant to which holders of Common Stock are permitted to sell, tender or exchange their shares for other
securities, cash or property and has been accepted by the holders of more than 50% of the outstanding Common Stock or more than 50% of
the voting power of the common equity of the Company, (iv) the Company, directly or indirectly, in one or more related transactions effects
any reclassification, reorganization or recapitalization of the Common Stock or any compulsory share exchange pursuant to which the Common
Stock is effectively converted into or exchanged for other securities, cash or property, or </FONT>(v) the Company, directly or indirectly,
in one or more related transactions consummates a stock or share purchase agreement or other business combination (including, without
limitation, a reorganization, recapitalization, spin-off, merger or scheme of arrangement) with another Person or group of Persons whereby
such other Person or group acquires more than 50% of the outstanding shares of Common Stock or more than 50% of the voting power of the
common equity of the Company (each a &ldquo;<U>Fundamental Transaction</U>&rdquo;), then, upon any subsequent exercise of this Warrant,
the Holder shall have the right to receive, for each Warrant Share that would have been issuable upon such exercise immediately prior
to the occurrence of such Fundamental Transaction, at the option of the Holder (without regard to any limitation in Section 2(e) on the
exercise of this Warrant), the number of shares of Common Stock of the successor or acquiring corporation or of the Company, if it is
the surviving corporation, and any additional consideration (the &ldquo;<U>Alternate Consideration</U>&rdquo;) receivable as a result
of such Fundamental Transaction by a holder of the number of shares of Common Stock for which this Warrant is exercisable immediately
prior to such Fundamental Transaction (without regard to any limitation in Section 2(e) on the exercise of this Warrant). For purposes
of any such exercise, the determination of the Exercise Price shall be appropriately adjusted to apply to such Alternate Consideration
based on the amount of Alternate Consideration issuable in respect of one share of Common Stock in such Fundamental Transaction, and the
Company shall apportion the Exercise Price among the Alternate Consideration in a reasonable manner reflecting the relative value of any
different components of the Alternate Consideration. If holders of Common Stock are given any choice as to the securities, cash or property
to be received in a Fundamental Transaction, then the Holder shall be given the same choice as to the Alternate Consideration it receives
upon any exercise of this Warrant following such Fundamental Transaction. The Company shall cause any successor entity in a Fundamental
Transaction in which the Company is not the survivor (the &ldquo;<U>Successor Entity</U>&rdquo;) to assume in writing all of the obligations
of the Company under this Warrant and the other Transaction Documents in accordance with the provisions of this Section 3(d) pursuant
to written agreements in form and substance reasonably satisfactory to the Holder and approved by the Holder (without unreasonable delay)
prior to such Fundamental Transaction and shall, at the option of the Holder, deliver to the Holder in exchange for this Warrant a security
of the Successor Entity evidenced by a written instrument substantially similar in form and substance to this Warrant which is exercisable
for a corresponding number of shares of capital stock of such Successor Entity (or its parent entity) equivalent to the shares of Common
Stock acquirable and receivable upon exercise of this Warrant (without regard to any limitations on the exercise of this Warrant) prior
to such Fundamental Transaction, and with an exercise price which applies the exercise price hereunder to such shares of capital stock
(but taking into account the relative value of the shares of Common Stock pursuant to such Fundamental Transaction and the value of such
shares of capital stock, such number of shares of capital stock and such exercise price being for the purpose of protecting the economic
value of this Warrant immediately prior to the consummation of such Fundamental Transaction), and which is reasonably satisfactory in
form and substance to the Holder. Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall be added to the
term &ldquo;Company&rdquo; under this Warrant (so that from and after the occurrence or consummation of such Fundamental Transaction,
each and every provision of this Warrant and the other Transaction Documents referring to the &ldquo;Company&rdquo; shall refer instead
to each of the Company and the Successor Entity or Successor Entities, jointly and severally), and the Successor Entity or Successor Entities,
jointly and severally with the Company, may exercise every right and power of the Company prior thereto and the Successor Entity or Successor
Entities shall assume all of the obligations of the Company prior thereto under this Warrant and the other Transaction Documents with
the same effect as if the Company and such Successor Entity or Successor Entities, jointly and severally, had been named as the Company
herein. For the avoidance of doubt, the Holder shall be entitled to the benefits of the provisions of this Section 3(d) regardless of
(i) whether the Company has sufficient authorized shares of Common Stock for the issuance of Warrant Shares and/or (ii) whether a Fundamental
Transaction occurs prior to the Initial Exercise Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt .5in; text-align: justify; text-indent: 0.5in">e) <U>Calculations</U>.
All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share, as the case may be. For
purposes of this Section 3, the number of shares of Common Stock deemed to be issued and outstanding as of a given date shall be the
sum of the number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 1in; margin-top: 0pt; margin-bottom: 0pt"> f) <U>Notice to Holder</U>.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 143.95pt; text-align: justify; text-indent: 29.6pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 29.6pt">i. <U>Adjustment
to Exercise Price</U>. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company shall
promptly deliver to the Holder by email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment
to the number of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 143.95pt; text-align: justify; text-indent: 26.25pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 29.6pt">ii.&nbsp;<U>Notice
to Allow Exercise by Holder</U>. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on the Common
Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C) the Company shall
authorize the granting to all holders of the Common Stock rights or warrants to subscribe for or purchase any shares of capital stock
of any class or of any rights, (D) the approval of any stockholders of the Company shall be required in connection with any reclassification
of the Common Stock, any consolidation or merger to which the Company (or any of its Subsidiaries) is a party, any sale or transfer of
all or substantially all of its assets, or any compulsory share exchange whereby the Common Stock is converted into other securities,
cash or property, or (E) the Company shall authorize the voluntary or involuntary dissolution, liquidation or winding up of the affairs
of the Company, then, in each case, the Company shall cause to be delivered by email to the Holder at its last email address as it shall
appear upon the Warrant Register of the Company, at least 20 calendar days prior to the applicable record or effective date hereinafter
specified, a notice stating (x) the date on which a record is to be taken for the purpose of such dividend, distribution, redemption,
rights or warrants, or if a record is not to be taken, the date as of which the holders of the Common Stock of record to be entitled to
such dividend, distributions, redemption, rights or warrants are to be determined or (y) the date on which such reclassification, consolidation,
merger, sale, transfer or share exchange is expected to become effective or close, and the date as of which it is expected that holders
of the Common Stock of record shall be entitled to exchange their shares of the Common Stock for securities, cash or other property deliverable
upon such reclassification, consolidation, merger, sale, transfer or share exchange; provided that the failure to deliver such notice
or any defect therein or in the delivery thereof shall not affect the validity of the corporate action required to be specified in such
notice. To the extent that any notice provided in this Warrant constitutes, or contains, material, non-public information regarding the
Company or any of the Subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant to a Current Report
on Form 8-K. The Holder shall remain entitled to exercise this Warrant during the period commencing on the date of such notice to the
effective date of the event triggering such notice except as may otherwise be expressly set forth herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><U>Section 4</U>. <U>Transfer of Warrant</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">a) <U>Transferability</U>.
Subject to compliance with any applicable securities laws and the conditions set forth in Section 4(d) hereof and to the provisions
of Section 4.1 of the Purchase Agreement, this Warrant and all rights hereunder (including, without limitation, any registration
rights) are transferable, in whole or in part, upon surrender of this Warrant at the principal office of the Company or its
designated agent, together with a written assignment of this Warrant substantially in the form attached hereto duly </FONT>executed
by the Holder or its agent or attorney and funds sufficient to pay any transfer taxes payable upon the making of such transfer. Upon
such surrender and, if required, such payment, the Company shall execute and deliver a new Warrant or Warrants in the name of the
assignee or assignees, as applicable, and in the denomination or denominations specified in such instrument of assignment, and shall
issue to the assignor a new Warrant evidencing the portion of this Warrant not so assigned, and this Warrant shall promptly be
cancelled. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant to
the Company unless the Holder has assigned this Warrant in full, in which case, the Holder shall surrender this Warrant to the
Company within three (3) Trading Days of the date on which the Holder delivers an assignment form to the Company assigning this
Warrant in full. The Warrant, if properly assigned in accordance herewith, may be exercised by a new holder for the purchase of
Warrant Shares without having a new Warrant issued.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt .5in; text-align: justify; text-indent: 35.95pt">b) <U>New
Warrants</U>. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of the
Company, together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by the
Holder or its agent or attorney. Subject to compliance with Section 4(a), as to any transfer which may be involved in such division
or combination, the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be
divided or combined in accordance with such notice. All Warrants issued on transfers or exchanges shall be dated the Issue Date of
this Warrant and shall be identical with this Warrant except as to the number of Warrant Shares issuable pursuant thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">c) <U>Warrant
Register</U>. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the
&ldquo;<U>Warrant Register</U>&rdquo;), in the name of the record Holder hereof from time to time. The Company may deem and treat
the registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the
Holder, and for all other purposes, absent actual notice to the contrary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">d)&nbsp;<U>Transfer
Restrictions</U>. If, at the time of the surrender of this Warrant in connection with any transfer of this Warrant, the transfer of this
Warrant shall not be either (i) registered pursuant to an effective registration statement under the Securities Act and under applicable
state securities or blue sky laws or (ii) eligible for resale without volume or manner-of-sale restrictions or current public information
requirements pursuant to Rule 144, the Company may require, as a condition of allowing such transfer, that the Holder or transferee of
this Warrant, as the case may be, comply with the provisions of Section 5.7 of the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">e)&nbsp;<U>Representation
by the Holder</U>. The Holder, by the acceptance hereof, represents and warrants that it is acquiring this Warrant and, upon any exercise
hereof, will acquire the Warrant Shares issuable upon such exercise, for its own account and not with a view to or for distributing or
reselling such Warrant Shares or any part thereof in violation of the Securities Act or any applicable state securities law, except pursuant
to sales registered or exempted under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><U>Section 5</U>. <U>Miscellaneous</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">a)&nbsp;<U>No
Rights as Stockholder Until Exercise; No Settlement in Cash</U>. This Warrant does not entitle the Holder to any voting rights, dividends
or other rights as a stockholder of the Company prior to the exercise hereof as set forth in Section 2(c)(i), except as expressly set
forth in Section 3. In no event shall the Company be required to net cash settle an exercise of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">b)&nbsp;<U>Loss,
Theft, Destruction or Mutilation of Warrant</U>. The Company covenants that upon receipt by the Company of evidence reasonably satisfactory
to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares, and in case
of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant, shall not include
the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the Company will make
and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant or stock certificate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">c)&nbsp;<U>Saturdays,
Sundays, Holidays, etc</U>. If the last or appointed day for the taking of any action or the expiration of any right required or granted
herein shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding Business Day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">d)&nbsp;<U>Authorized
Shares</U>. The Company covenants that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued
Common Stock a sufficient number of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights
under this Warrant. The Company further covenants that its issuance of this Warrant shall constitute full authority to its officers who
are charged with the duty of issuing the necessary Warrant Shares upon the exercise of the purchase rights under this Warrant. The Company
will take all such reasonable action as may be necessary to assure that such Warrant Shares may be issued as provided herein without violation
of any applicable law or regulation, or of any requirements of the Trading Market upon which the Common Stock may be listed. The Company
covenants that all Warrant Shares which may be issued upon the exercise of the purchase rights represented by this Warrant will, upon
exercise of the purchase rights represented by this Warrant and payment for such Warrant Shares in accordance herewith, be duly authorized,
validly issued, fully paid and nonassessable and free from all taxes, liens and charges created by the Company in respect of the issue
thereof (other than taxes in respect of any transfer occurring contemporaneously with such issue).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">e)&nbsp;<U>Jurisdiction</U>.
All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be determined in accordance
with the provisions of the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">f)&nbsp;<U>Restrictions</U>.
The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, will have restrictions
upon resale imposed by state and federal securities laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt .5in; text-align: justify; text-indent: 0.5in">g)&nbsp;<U>Nonwaiver
and Expenses</U>. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall operate as
a waiver of such right or otherwise prejudice the Holder&rsquo;s rights, powers or remedies, notwithstanding the fact that the right to
exercise this Warrant terminates on the Termination Date. Without limiting any other provision of this Warrant or the Purchase Agreement,
if the Company willfully and knowingly fails to comply with any provision of this Warrant, which results in any material damages to the
Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover any costs and expenses including, but not limited
to, reasonable attorneys&rsquo; fees, including those of appellate proceedings, incurred by the Holder in collecting any amounts due pursuant
hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">h)&nbsp;<U>Notices</U>.
Any notice, request or other document required or permitted to be given or delivered to the Holder by the Company shall be delivered in
accordance with the notice provisions of the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">i)&nbsp;<U>Limitation
of Liability</U>. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant to purchase Warrant
Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder for the purchase
price of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company or by creditors of the
Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">j)&nbsp;<U>Remedies</U>.
The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will be entitled to specific
performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate compensation for any loss
incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to assert the defense in any
action for specific performance that a remedy at law would be adequate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">k)&nbsp;<U>Successors
and Assigns</U>. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall inure to the
benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns of Holder.
The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall be enforceable
by the Holder or holder of Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">l) <U>Amendment</U>.
This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company, on the one hand,
and the Holder of this Warrant, on the other hand.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">m) <U>Severability</U>.
Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid under applicable
law, but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall be
ineffective to the extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining
provisions of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt .5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">n) <U>Headings</U>.
The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed a part of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">********************</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><I>(Signature Page Follows)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0 0pt 0pt; text-indent: 0.5in">IN WITNESS WHEREOF, the Company has
caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above indicated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold">NEXTTRIP, INC.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; font-weight: bold">&nbsp;</TD>
    <TD STYLE="width: 5%; font-weight: bold">&nbsp;</TD>
    <TD STYLE="width: 45%; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>By:</TD>
    <TD STYLE="border-bottom: Black 1pt solid"><I>/s/ William Kerby</I></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Name: </TD>
    <TD>William Kerby</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Title: </TD>
    <TD>Chief Executive Officer</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 247.65pt">&nbsp;</P>


<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36.1pt; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">NOTICE OF EXERCISE</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34.2pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left">TO:</TD><TD STYLE="text-align: justify">NEXTTRIP, INC.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34.15pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 1in">(1) The
undersigned hereby elects to purchase _______ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only if exercised
in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34.15pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 1in"> (2) Payment shall take the form of lawful money of the United States.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 34.15pt; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 1in">(3) Please
issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-left: 1in; margin-top: 0pt; margin-bottom: 0pt; width: 50%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in">The Warrant Shares shall be delivered to the following
DWAC Account Number:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-left: 1in; margin-top: 0pt; margin-bottom: 0pt; width: 50%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-left: 1in; margin-top: 0pt; margin-bottom: 0pt; width: 50%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-left: 1in; margin-top: 0pt; margin-bottom: 0pt; width: 50%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 1in">(4)&nbsp;<U>Accredited
Investor</U>. The undersigned is an &ldquo;accredited investor&rdquo; as defined in Regulation D promulgated under the Securities Act
of 1933, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify">[SIGNATURE OF HOLDER]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="white-space: nowrap; padding-bottom: 1pt; width: 13%; text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name of Investing Entity:</FONT>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 87%; text-align: justify; font-size: 10pt">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I></I></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="white-space: nowrap; width: 20%; text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Signature of Authorized Signatory of Investing Entity:</I></FONT>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: justify; font-size: 10pt; width: 80%">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="white-space: nowrap; width: 13%; text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name of Authorized Signatory:</FONT>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: justify; font-size: 10pt; width: 87%">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="white-space: nowrap; width: 13%; text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title of Authorized Signatory:</FONT>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: justify; font-size: 10pt; width: 87%">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 3%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: justify; font-size: 10pt; width: 97%">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">EXHIBIT B</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36.1pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">ASSIGNMENT FORM</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 7.15pt; text-indent: 13.55pt"><I>&nbsp;</I></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-indent: 0.25in"><I>(To assign the foregoing Warrant,
execute this form and supply required information. Do not use this form to exercise the Warrant to purchase shares.)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 7.15pt; text-indent: 10.55pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0in; text-indent: 0.25in">FOR VALUE RECEIVED, the foregoing
Warrant and all rights evidenced thereby are hereby assigned to</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 7.15pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 46%">Name:</TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 52%; border-bottom: Black 1pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: left">(Please Print)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Address:</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left">(Please Print)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Phone Number:</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Email Address:</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Dated: _______________ , ________</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Holder&rsquo;s Signature:____________________</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Holder&rsquo;s Address: ____________________</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 11; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.23
<SEQUENCE>9
<FILENAME>ex4-23.htm
<DESCRIPTION>EX-4.23
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
4.23</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>DESCRIPTION
OF SECURITIES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following is a summary of the material terms and provisions of the securities of NextTrip, Inc. (&ldquo;us,&rdquo; &ldquo;our,&rdquo;
&ldquo;we&rdquo; or the &ldquo;Company&rdquo;) that are registered under Section 12 of the Securities Exchange Act of 1934, as amended,
and certain provisions of our amended and restated articles of incorporation, as amended (our &ldquo;Charter&rdquo;), and amended and
restated bylaws, as amended (our &ldquo;Bylaws&rdquo;), that are currently in effect. This summary does not purport to be complete and
is qualified in its entirety by the provisions of our Charter and Bylaws, each of which have been previously filed with the Securities
and Exchange Commission (&ldquo;SEC&rdquo;) and are incorporated by reference as an exhibit to the Annual Report on Form 10-K of which
this Exhibit 4.23 is a part, as well as to the applicable provisions of the Nevada Revised Statutes (the &ldquo;NRS&rdquo;). We encourage
you to read our Charter, Bylaws and the applicable portions of the NRS carefully.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>General</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
authorized capital stock consists of 250,000,000 shares, all with a par value of $0.001 per share, of which:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">240,000,000
                                            shares are designated as common stock; and</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,000,000
                                            shares are designated as preferred stock.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Common
Stock</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
common stock is listed on the Nasdaq Capital Market under the symbol &ldquo;NTRP.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have one class of common stock. Holders of our common stock are entitled to one vote per share on all matters to be voted upon by stockholders
and do not have cumulative voting rights in the election of directors. Holders of shares of common stock are entitled to receive on a
pro rata basis such dividends, if any, as may be declared from time to time by our board of directors in its discretion from funds legally
available for that use, subject to any preferential dividend rights of outstanding preferred stock. They are also entitled to share on
a pro rata basis in any distribution to our common stockholders upon our liquidation, dissolution or winding up, subject to the prior
rights of any outstanding preferred stock. Common stockholders do not have preemptive rights to subscribe to any additional stock issuances
by us, and they do not have the right to require the redemption of their shares or the conversion of their shares into any other class
of our stock. The rights, preferences and privileges of holders of common stock are subject to, and may be adversely affected by, the
rights of the holders of any series of preferred stock that we may designate and issue in the future.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Anti-Takeover
Effects of Our Articles of Incorporation and Bylaws</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
provisions of our Charter and Bylaws contain provisions that could have the effect of delaying or discouraging another party from acquiring
control of us. These provisions, which are summarized below, are designed to discourage certain types of takeover proposals that are
considered coercive or inadequate. These provisions are also intended to encourage anyone seeking to acquire control of us to first negotiate
with our board of directors. We believe that protecting our ability to negotiate with any unsolicited and potentially unfriendly acquirer
outweigh the disadvantages of discouraging such proposals, including those that may be priced at a premium above the market price of
our common stock, because, among other reasons, we may be able to improve the terms of any such proposals by negotiation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Charter and Bylaws include the following provisions:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
                                            classified board of directors with three-year staggered terms, which may delay the ability
                                            of stockholders to change the membership of a majority of our board of directors;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">no
                                            cumulative voting in the election of directors, which limits the ability of minority stockholders
                                            to elect director candidates;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            exclusive right of our board of directors to elect a director to fill a vacancy created by
                                            the expansion of the board of directors or the resignation, death or removal of a director,
                                            which prevents stockholders from being able to fill vacancies on our board of directors;
                                            </FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            ability of our board of directors to authorize the issuance of shares of preferred stock
                                            and to determine the terms of those shares, including preferences and voting rights, without
                                            stockholder approval, which could adversely affect the rights of our common stockholders
                                            or be used to deter a possible acquisition of our company;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            ability of our board of directors to alter our Bylaws without obtaining stockholder approval;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            required approval of the holders of at least two-thirds of the shares entitled to vote at
                                            an election of directors to adopt, amend or repeal our Bylaws or repeal the provisions of
                                            our Charter and Bylaws regarding the election and removal of directors;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
                                            prohibition on stockholder action by written consent, which forces stockholder action to
                                            be taken at an annual or special meeting of our stockholders;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            requirement that a special meeting of stockholders may be called only by the chairman of
                                            the board of directors, the chief executive officer, the president or the board of directors,
                                            which may delay the ability of our stockholders to force consideration of a proposal or to
                                            take action, including the removal of directors; and</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">advance
                                            notice procedures that stockholders must comply with in order to nominate candidates to our
                                            board of directors or to propose matters to be acted upon at a stockholders&rsquo; meeting,
                                            which may discourage or deter a potential acquirer from conducting a solicitation of proxies
                                            to elect the acquirer&rsquo;s own slate of directors or otherwise attempting to obtain control
                                            of us.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Nasdaq
Capital Market Listing</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
common stock is listed on The Nasdaq Capital Market under the symbol &ldquo;NTRP&rdquo;.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.25
<SEQUENCE>10
<FILENAME>ex10-25.htm
<DESCRIPTION>EX-10.25
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">Exhibit
10.25</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">UNSECURED
PROMISSORY NOTE</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$100,000.00</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">May
    24, 2024</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sunrise,
    Florida</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
value received, NextTrip Holdings, Inc., a Florida corporation (the &ldquo;<U>Company</U>&rdquo;), promises to pay to Steve Kircher,
an individual (the &ldquo;<U>Holder</U>&rdquo;), the principal sum of $100,000.00. Interest shall accrue from the date of this Unsecured
Promissory Note (the &ldquo;<U>Note</U>&rdquo;) on the unpaid principal amount at a rate equal to 7.5% simple interest per annum<B>.
</B>The Holder and the Company are hereinafter sometimes referred to collectively as the &ldquo;<U>Parties</U>,&rdquo; and individually
as a &ldquo;<U>Party</U>.&rdquo; This Note is subject to the following terms and conditions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1. <B><U>Maturity</U>.
</B>This Note will automatically mature and be due and payable on the earlier date of the completion of a public financing or October
31, 2024, (the &ldquo;<U>Maturity Date</U>&rdquo;) unless extended by the written consent of the Holder. The Note can be prepaid at any
time by the Company without penalty. The entire unpaid principal sum of this Note shall become immediately due and payable upon (i) the
insolvency of the Company, (ii) the commission of any act of bankruptcy by the Company, (iii) the execution by the Company of a general
assignment for the benefit of creditors, (iv) the filing by or against the Company of a petition in bankruptcy or any petition for relief
under the federal bankruptcy act or the continuation of such petition without dismissal for a period of ninety (90) days or more, or
(v) the appointment of a receiver or trustee to take possession of the property or assets of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2. <B><U>Payment
and Proceeds</U>.</B> All payments shall be made in lawful money of the United States of America at such place as the Holder hereof may
from time to time designate in writing to the Company. Payment shall be credited first to the accrued interest then due and payable and
the remainder applied to principal. Prepayment of this Note may be made at any time without penalty. The Company may use the proceeds
of the Note for any lawful purpose.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3. <B><U>Transfer;
Successors and Assigns</U>.</B> The terms and conditions of this Note shall inure to the benefit of and be binding upon the respective
successors and assigns of the Parties. Notwithstanding the foregoing, the Holder may not assign, pledge, or otherwise transfer this Note
without the prior written consent of the Company. Subject to the preceding sentence, this Note may be transferred only upon surrender
of the original Note for registration of transfer, duly endorsed, or accompanied by a duly executed written instrument of transfer in
form satisfactory to the Holder. Thereupon, a new note for the same principal amount and interest will be issued to, and registered in
the name of, the transferee. Interest and principal are payable only to the registered holder of this Note.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4. <B><U>Governing
Law</U>.</B> This Note and all acts and transactions pursuant hereto and the rights and obligations of the Parties hereto shall be governed,
construed and interpreted in accordance with the laws of the State of Florida, without giving effect to principles of conflicts of law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5. <B><U>Notices</U>.
</B>Any notice required by this Note shall be in writing. Such notice shall be deemed sufficient upon delivery, when delivered personally
or by a nationally-recognized delivery service (such as Federal Express or UPS), or forty-eight (48) hours after being deposited in the
U.S. mail, as certified or registered mail, with postage prepaid, addressed to the Party to be notified at such Party&rsquo;s address
as set forth below or as subsequently modified by written notice.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6. <B><U>Amendments
and Waivers</U>. </B>Any term of this Note may be amended only with the written consent of the Company and the Holder. Any amendment
or waiver executed in accordance with this Section 6 shall be binding upon the Company, the Holder and each transferee of the Note.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.<B> <U>Officers
and Directors Not Liable</U>.</B> In no event shall any officer or director of the Company be liable for any amounts due or payable pursuant
to this Note.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8. <B><U>Action
to Collect on Note</U>.</B> If action is instituted to collect on this Note, the Company shall pay all costs and expenses, including
reasonable attorney&rsquo;s fees, incurred in connection with such action.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9. <B><U>Usury
Savings Clause</U></B>. It is the intention of the Parties hereto to comply with applicable state and federal usury laws from time to
time in effect. Accordingly, notwithstanding any provision to the contrary in this Note or any other documents related hereto, in any
event (including, but not limited to, prepayment or acceleration of the maturity of any obligation) will this Note or any such other
document require the payment or permit the collection or receipt of interest in excess of the highest lawful rate. If under any circumstance
whatsoever, any provision of the Note or of any other document pertaining hereto will provide for the payment, collection or receipt
of interest in excess of the highest lawful rate, then, ipso facto, the obligation to be fulfilled shall be reduced to the limit of such
validity, and if, from any such circumstances, the Holder will ever receive anything of value as interest (or anything of value deemed
interest by applicable law) under this Note, or any other document pertaining hereto, an amount that would exceed the highest lawful
rate, such amount that would exceed the highest lawful rate shall be applied to the reduction of the principal amount owning under this
Note or on account of any other indebtedness of the Company to the Holder, and not to the payment of interest, or if such excess interest
exceeds the unpaid principal balance of the Note and such other indebtedness, such excess shall be refunded to the Company. In determining
whether or not the interest paid or payable with respect to any indebtedness of the Company to the Holder, under any specified contingency,
exceeds the highest lawful rate, the Company and the Holder will, to the maximum extent permitted by applicable law, (i) characterize
any non-principal payment as an expense, fee or premium, rather than as interest, (ii) exclude voluntary prepayments and the effects
thereof, (iii) amortize, prorate, allocate and spread the total amount of interest throughout the full term of such indebtedness (including
any extension or renewal) so that interest thereon does not exceed the maximum amount permitted by applicable law, and/or (iv) allocate
interest between portions of such indebtedness, to the end that no such portion shall bear interest at a rate greater than that permitted
by applicable law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10. <B><U>Severability</U></B>. If
one or more provision of this Note is held to be unenforceable under applicable law, such provision(s) shall be excluded from this Note
and the balance of the Note shall be interpreted as if such provision(s) were so excluded and shall be enforceable in accordance with
its terms.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11. <B><U>Facsimile
and Counterparts</U></B>. This Note may be signed by facsimile and executed in any number of counterparts, each of which will be deemed
to be an original and all of which together will constitute a single agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>[Signature
Page Follows]</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>


<!-- Field: Page; Sequence: 2; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
parties have executed this Unsecured Promissory Note as of the date first set forth above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>COMPANY:</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">nEXTTRIP HOLDINGS, inc.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Bill Kerby</I> </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bill
    Kerby</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address:</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3900 Paseo Del Sol</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Santa Fe, NM 87507</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>AGREED
    TO AND ACCEPTED:</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>THE
    HOLDER:</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">steve
    kircher</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Steve Kircher</I></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps">Signature
Page to Unsecured Promissory Note</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3; Options: Last -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.26
<SEQUENCE>11
<FILENAME>ex10-26.htm
<DESCRIPTION>EX-10.26
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">Exhibit
10.26</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">UNSECURED
PROMISSORY NOTE</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$40,000.00</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">June 26, 2024</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sunrise,
    Florida</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
value received, NextTrip Holdings, Inc., a Florida corporation (the &ldquo;<U>Company</U>&rdquo;), promises to pay to Carmen Diges,
an individual (the &ldquo;<U>Holder</U>&rdquo;), the principal sum of $40,000.00. Interest shall accrue from the date of this Unsecured
Promissory Note (the &ldquo;<U>Note</U>&rdquo;) on the unpaid principal amount at a rate equal to 7.5% simple interest per annum<B>.
</B>The Holder and the Company are hereinafter sometimes referred to collectively as the &ldquo;<U>Parties</U>,&rdquo; and individually
as a &ldquo;<U>Party</U>.&rdquo; This Note is subject to the following terms and conditions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1. <B><U>Maturity</U>.
</B>This Note will automatically mature and be due and payable on June 25, 2025, (the &ldquo;<U>Maturity Date</U>&rdquo;) unless extended by the written consent of the Holder. The Note can be prepaid at any
time by the Company without penalty. The entire unpaid principal sum of this Note shall become immediately due and payable upon (i) the
insolvency of the Company, (ii) the commission of any act of bankruptcy by the Company, (iii) the execution by the Company of a general
assignment for the benefit of creditors, (iv) the filing by or against the Company of a petition in bankruptcy or any petition for relief
under the federal bankruptcy act or the continuation of such petition without dismissal for a period of ninety (90) days or more, or
(v) the appointment of a receiver or trustee to take possession of the property or assets of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2. <B><U>Payment
and Proceeds</U>.</B> All payments shall be made in lawful money of the United States of America at such place as the Holder hereof may
from time to time designate in writing to the Company. Payment shall be credited first to the accrued interest then due and payable and
the remainder applied to principal. Prepayment of this Note may be made at any time without penalty. The Company may use the proceeds
of the Note for any lawful purpose.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3. <B><U>Transfer;
Successors and Assigns</U>.</B> The terms and conditions of this Note shall inure to the benefit of and be binding upon the respective
successors and assigns of the Parties. Notwithstanding the foregoing, the Holder may not assign, pledge, or otherwise transfer this Note
without the prior written consent of the Company. Subject to the preceding sentence, this Note may be transferred only upon surrender
of the original Note for registration of transfer, duly endorsed, or accompanied by a duly executed written instrument of transfer in
form satisfactory to the Holder. Thereupon, a new note for the same principal amount and interest will be issued to, and registered in
the name of, the transferee. Interest and principal are payable only to the registered holder of this Note.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4. <B><U>Governing
Law</U>.</B> This Note and all acts and transactions pursuant hereto and the rights and obligations of the Parties hereto shall be governed,
construed and interpreted in accordance with the laws of the State of Florida, without giving effect to principles of conflicts of law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5. <B><U>Notices</U>.
</B>Any notice required by this Note shall be in writing. Such notice shall be deemed sufficient upon delivery, when delivered personally
or by a nationally-recognized delivery service (such as Federal Express or UPS), or forty-eight (48) hours after being deposited in the
U.S. mail, as certified or registered mail, with postage prepaid, addressed to the Party to be notified at such Party&rsquo;s address
as set forth below or as subsequently modified by written notice.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6. <B><U>Amendments
and Waivers</U>. </B>Any term of this Note may be amended only with the written consent of the Company and the Holder. Any amendment
or waiver executed in accordance with this Section 6 shall be binding upon the Company, the Holder and each transferee of the Note.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.<B> <U>Officers
and Directors Not Liable</U>.</B> In no event shall any officer or director of the Company be liable for any amounts due or payable pursuant
to this Note.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8. <B><U>Action
to Collect on Note</U>.</B> If action is instituted to collect on this Note, the Company shall pay all costs and expenses, including
reasonable attorney&rsquo;s fees, incurred in connection with such action.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9. <B><U>Usury
Savings Clause</U></B>. It is the intention of the Parties hereto to comply with applicable state and federal usury laws from time to
time in effect. Accordingly, notwithstanding any provision to the contrary in this Note or any other documents related hereto, in any
event (including, but not limited to, prepayment or acceleration of the maturity of any obligation) will this Note or any such other
document require the payment or permit the collection or receipt of interest in excess of the highest lawful rate. If under any circumstance
whatsoever, any provision of the Note or of any other document pertaining hereto will provide for the payment, collection or receipt
of interest in excess of the highest lawful rate, then, ipso facto, the obligation to be fulfilled shall be reduced to the limit of such
validity, and if, from any such circumstances, the Holder will ever receive anything of value as interest (or anything of value deemed
interest by applicable law) under this Note, or any other document pertaining hereto, an amount that would exceed the highest lawful
rate, such amount that would exceed the highest lawful rate shall be applied to the reduction of the principal amount owning under this
Note or on account of any other indebtedness of the Company to the Holder, and not to the payment of interest, or if such excess interest
exceeds the unpaid principal balance of the Note and such other indebtedness, such excess shall be refunded to the Company. In determining
whether or not the interest paid or payable with respect to any indebtedness of the Company to the Holder, under any specified contingency,
exceeds the highest lawful rate, the Company and the Holder will, to the maximum extent permitted by applicable law, (i) characterize
any non-principal payment as an expense, fee or premium, rather than as interest, (ii) exclude voluntary prepayments and the effects
thereof, (iii) amortize, prorate, allocate and spread the total amount of interest throughout the full term of such indebtedness (including
any extension or renewal) so that interest thereon does not exceed the maximum amount permitted by applicable law, and/or (iv) allocate
interest between portions of such indebtedness, to the end that no such portion shall bear interest at a rate greater than that permitted
by applicable law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10. <B><U>Severability</U></B>. If
one or more provision of this Note is held to be unenforceable under applicable law, such provision(s) shall be excluded from this Note
and the balance of the Note shall be interpreted as if such provision(s) were so excluded and shall be enforceable in accordance with
its terms.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11. <B><U>Facsimile
and Counterparts</U></B>. This Note may be signed by facsimile and executed in any number of counterparts, each of which will be deemed
to be an original and all of which together will constitute a single agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>[Signature
Page Follows]</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>


<!-- Field: Page; Sequence: 2; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
parties have executed this Unsecured Promissory Note as of the date first set forth above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>COMPANY:</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">nEXTTRIP HOLDINGS, inc.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Bill Kerby</I> </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bill
    Kerby</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address:</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3900 Paseo Del Sol</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Santa Fe, NM 87507</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>AGREED
    TO AND ACCEPTED:</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>THE
    HOLDER:</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"></FONT>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">CARMEN DIGES</P>
<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Carmen Diges</I></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps">Signature
Page to Unsecured Promissory Note</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3; Options: Last -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.29
<SEQUENCE>12
<FILENAME>ex10-29.htm
<DESCRIPTION>EX-10.29
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
10.29</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>THE
ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED,
OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF (A)
AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR (B) AN OPINION OF COUNSEL (WHICH
COUNSEL SHALL BE SELECTED BY THE HOLDER), IN A GENERALLY ACCEPTABLE FORM, THAT REGISTRATION IS NOT REQUIRED UNDER SAID ACT.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>THE
ISSUE PRICE OF THIS NOTE IS $154,440.00</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>THE
ORIGINAL ISSUE DISCOUNT IS $22,440.00</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 188.2pt; text-align: center"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 60%"><B>Principal
Amount: $154,440.00</B></TD>
  <TD STYLE="width: 40%"><B>Issue Date: October 18, 2024</B></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Purchase
Price: $132,000.00</B></FONT></TD>
  <TD>&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 188.2pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>PROMISSORY
NOTE</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>FOR
VALUE RECEIVED</B>, <B>NEXTTRIP, INC.</B>, a Nevada corporation (hereinafter called the &ldquo;Borrower&rdquo;), hereby promises to pay
to the order of <B>1800 DIAGONAL LENDING LLC</B>, a Virginia limited liability company, or registered assigns (the &ldquo;Holder&rdquo;)
the sum of $154,440.00 together with any interest as set forth herein, on August 15, 2025 (the &ldquo;Maturity Date&rdquo;), and to pay
interest on the unpaid principal balance hereof from the date hereof (the &ldquo;Issue Date&rdquo;) as set forth herein. This Note may
not be prepaid in whole or in part except as otherwise explicitly set forth herein. Any amount of principal or interest on this Note
which is not paid when due shall bear interest at the rate of twenty two percent (22%) per annum from the due date thereof until the
same is paid (&ldquo;Default Interest&rdquo;). All payments due hereunder (to the extent not converted into common stock, $0.001 par
value per share (the &ldquo;Common Stock&rdquo;) in accordance with the terms hereof) shall be made in lawful money of the United States
of America. All payments shall be made at such address as the Holder shall hereafter give to the Borrower by written notice made in accordance
with the provisions of this Note. Each capitalized term used herein, and not otherwise defined, shall have the meaning ascribed thereto
in that certain Securities Purchase Agreement dated the date hereof, pursuant to which this Note was originally issued (the &ldquo;Purchase
Agreement&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Note is free from all taxes, liens, claims and encumbrances with respect to the issue thereof and shall not be subject to preemptive
rights or other similar rights of shareholders of the Borrower and will not impose personal liability upon the holder thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following terms shall apply to this Note:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
I. GENERAL TERMS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.1 <U>Interest</U>.
A one-time interest charge of thirteen percent (13%) (the &ldquo;Interest Rate&rdquo;) shall be applied on the Issuance Date to the
Principal ($154,440.00 * thirteen percent (13%) =$20,077.00). Interest hereunder shall be paid as set forth herein to the Holder or
its assignee in whose name this Note is registered on the records of the Company regarding registration and transfers of Notes in
cash or, in the Event of Default, at the Option of the Holder, converted into share of Common Stock as set forth herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.2
<U>Mandatory Monthly Payments</U>. Accrued, unpaid Interest and outstanding principal, subject to adjustment, shall be paid in ten (10)
payments; each be in the amount of $17,451.70 (a total payback to the Holder of $174,517.00). The first payment shall be due November
15, 2024 with nine (9) subsequent payments on the 15th of each month thereafter. The Company shall have a five (5) business day grace
period with respect to each payment. The Company has right to accelerate payments or prepay in full at any time with no prepayment penalty.
All payments shall be made by bank wire transfer to the Holder&rsquo;s wire instructions, attached hereto as Exhibit A. For the avoidance
of doubt, a missed payment shall be considered an Event of Default.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.3
<U>Prepayment Discount</U>. Notwithstanding anything to the contrary contained in this Note, at any time during the period set forth
on the table immediately following this paragraph (the &ldquo;Prepayment Period&rdquo;) or as otherwise agreed to between the Borrower
and the Holder, the Borrower shall have the right, exercisable on not more than three (3) Trading Days prior written notice to the Holder
of the Note to prepay the outstanding Note (principal and accrued interest), in full, in accordance with this Section 1.3. Any notice
of prepayment hereunder (an &ldquo;Optional Prepayment Notice&rdquo;) shall be delivered to the Holder of the Note at its registered
addresses and shall state: (1) that the Borrower is exercising its right to prepay the Note, and (2) the date of prepayment which shall
be not more than three (3) Trading Days from the date of the Optional Prepayment Notice. On the date fixed for prepayment (the &ldquo;Optional
Prepayment Date&rdquo;), the Borrower shall make payment of the Optional Prepayment Amount (as defined below) to Holder, or upon the
direction of the Holder as specified by the Holder in a writing to the Borrower (which shall direction to be sent to Borrower by the
Holder at least one (1) business day prior to the Optional Prepayment Date). If the Borrower exercises its right to prepay the Note,
the Borrower shall make payment to the Holder of an amount in cash equal to the percentage (&ldquo;Prepayment Percentage&rdquo;) as set
forth in the table immediately following this paragraph opposite the Prepayment Period, multiplied by the sum of the then outstanding
principal amount of this Note <U>plus</U> any accrued and unpaid interest on the unpaid principal amount of this Note to the Optional
Prepayment Date (the &ldquo;Optional Prepayment Amount&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; font-weight: bold; border-bottom: Black 1pt solid; vertical-align: bottom">Prepayment Period</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: center; font-weight: bold">Prepayment Percentage</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 81%; text-align: left">1) The period beginning on the Issue Date and ending on the date which is thirty (30) days following the Issue Date.</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 16%; text-align: right">96</TD><TD STYLE="width: 1%; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">2) The period beginning on date which is thirty-one (31) days following the Issue Date and ending on the date which is sixty (60) days following the Issue Date.</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">97</TD><TD STYLE="text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">3) The period beginning on date which is sixty-one (61) days following the Issue Date and ending on the date which is one hundred twenty (120) days following the Issue Date.</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">98</TD><TD STYLE="text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">4) The period beginning on date which is one hundred twenty-one (121) days following the Issue Date and ending on the date which is one hundred eighty (180) days following the Issue Date.</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">99</TD><TD STYLE="text-align: left">%</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
II. CERTAIN COVENANTS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1
<U>Sale of Assets</U>. So long as the Borrower shall have any obligation under this Note, the Borrower shall not, without the Holder&rsquo;s
written consent, sell, lease or otherwise dispose of any significant portion of its assets outside the ordinary course of business. Any
consent to the disposition of any assets may be conditioned on a specified use of the proceeds of disposition.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
III. EVENTS OF DEFAULT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
any of the following events of default (each, an &ldquo;Event of Default&rdquo;) shall occur:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1
<U>Failure to Pay Principal and Interest</U>. The Borrower fails to pay the principal hereof or interest thereon when due on this Note,
whether at maturity, upon acceleration or otherwise and such breach continues for a period of five (5) days after written notice from
the Holder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2
<U>Conversion and the Shares</U>. The Borrower fails to issue shares of Common Stock to the Holder (or announces or threatens in writing
that it will not honor its obligation to do so) upon exercise by the Holder of the conversion rights of the Holder in accordance with
the terms of this Note (following an Event of Default other than this Section 3.2), fails to transfer or cause its transfer agent to
transfer (issue) (electronically or in certificated form) any certificate for shares of Common Stock issued to the Holder upon conversion
of or otherwise pursuant to this Note as and when required by this Note, the Borrower directs its transfer agent not to transfer or delays,
impairs, and/or hinders its transfer agent in transferring (or issuing) (electronically or in certificated form) any certificate for
shares of Common Stock to be issued to the Holder upon conversion of or otherwise pursuant to this Note as and when required by this
Note, or fails to remove (or directs its transfer agent not to remove or impairs, delays, and/or hinders its transfer agent from removing)
any restrictive legend (or to withdraw any stop transfer instructions in respect thereof) on any certificate for any shares of Common
Stock issued to the Holder upon conversion of or otherwise pursuant to this Note as and when required by this Note (or makes any written
announcement, statement or threat that it does not intend to honor the obligations described in this paragraph) and any such failure
shall continue uncured (or any written announcement, statement or threat not to honor its obligations shall not be rescinded in writing)
for three (3) business days after the Holder shall have delivered a Notice of Conversion. It is an obligation of the Borrower to remain
current in its obligations to its transfer agent. It shall be an event of default of this Note, if a conversion of this Note is delayed,
hindered or frustrated due to a balance owed by the Borrower to its transfer agent. If at the option of the Holder, the Holder advances
any funds to the Borrower&rsquo;s transfer agent in order to process a conversion, such advanced funds shall be paid by the Borrower
to the Holder within forty-eight (48) hours of a demand from the Holder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.3
<U>Breach of Covenants</U>. The Borrower breaches any material covenant or other material term or condition contained in this Note and
any collateral documents including but not limited to the Purchase Agreement and such breach continues for a period of twenty (20) days
after written notice thereof to the Borrower from the Holder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.4
<U>Breach of Representations and Warranties</U>. Any representation or warranty of the Borrower made herein or in any agreement, statement
or certificate given in writing pursuant hereto or in connection herewith (including, without limitation, the Purchase Agreement), shall
be false or misleading in any material respect when made and the breach of which has (or with the passage of time will have) a material
adverse effect on the rights of the Holder with respect to this Note or the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.5
<U>Receiver or Trustee</U>. The Borrower or any subsidiary of the Borrower shall make an assignment for the benefit of creditors, or
apply for or consent to the appointment of a receiver or trustee for it or for a substantial part of its property or business, or such
a receiver or trustee shall otherwise be appointed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.6
<U>Bankruptcy</U>. Bankruptcy, insolvency, reorganization or liquidation proceedings or other proceedings, voluntary or involuntary,
for relief under any bankruptcy law or any law for the relief of debtors shall be instituted by or against the Borrower or any subsidiary
of the Borrower.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.7
<U>Delisting of Common Stock</U>. The Borrower shall fail to maintain the listing of the Common Stock on the Nasdaq National Market,
the Nasdaq SmallCap Market, the New York Stock Exchange, or the NYSE American Stock Exchange (collectively, the &ldquo;Exchanges&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.8
<U>Failure to Comply with the Exchange Act</U>. The Borrower shall fail to comply with the reporting requirements of the Exchange Act;
and/or the Borrower shall cease to be subject to the reporting requirements of the Exchange Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.9
<U>Liquidation</U>. Any dissolution, liquidation, or winding up of Borrower or any substantial portion of its business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.10
<U>Cessation of Operations</U>. Any cessation of operations by Borrower or Borrower admits it is otherwise generally unable to pay its
debts as such debts become due, provided, however, that any disclosure of the Borrower&rsquo;s ability to continue as a &ldquo;going
concern&rdquo; shall not be an admission that the Borrower cannot pay its debts as they become due.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.11
<U>Financial Statement Restatement</U>. The restatement of any financial statements filed by the Borrower with the SEC at any time after
180 days after the Issuance Date for any date or period until this Note is no longer outstanding, if the result of such restatement would,
by comparison to the un-restated financial statement, have constituted a material adverse effect on the rights of the Holder with respect
to this Note or the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.12
<U>Replacement of Transfer Agent</U>. In the event that the Borrower proposes to replace its transfer agent, the Borrower fails to provide,
prior to the effective date of such replacement, a fully executed Irrevocable Transfer Agent Instructions in a form as initially delivered
pursuant to the Purchase Agreement (including but not limited to the provision to irrevocably reserve shares of Common Stock in the Reserved
Amount) signed by the successor transfer agent to Borrower and the Borrower.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.13
<U>Cross-Default</U>. Notwithstanding anything to the contrary contained in this Note or the other related or companion documents, a
breach or default by the Borrower of any covenant or other term or condition contained in any of the Other Agreements, after the passage
of all applicable notice and cure or grace periods, shall, at the option of the Holder, be considered a default under this Note and the
Other Agreements, in which event the Holder shall be entitled (but in no event required) to apply all rights and remedies of the Holder
under the terms of this Note and the Other Agreements by reason of a default under said Other Agreement or hereunder. &ldquo;Other Agreements&rdquo;
means, collectively, all agreements and instruments between, among or by: (1) the Borrower, and, or for the benefit of, (2) the Holder
and any affiliate of the Holder, including, without limitation, promissory notes; provided, however, the term &ldquo;Other Agreements&rdquo;
shall not include the related or companion documents to this Note. Each of the loan transactions will be cross-defaulted with each other
loan transaction and with all other existing and future debt of Borrower to the Holder. .</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
the occurrence and during the continuation of any Event of Default, the Note shall become immediately due and payable and the Borrower
shall pay to the Holder, in full satisfaction of its obligations hereunder, an amount equal to 200% (&ldquo;Default Percentage&rdquo;)
<U>times</U> the <U>sum</U> of (w) the then outstanding principal amount of this Note <U>plus</U> (x) accrued and unpaid interest on
the unpaid principal amount of this Note to the date of payment <U>plus</U> (y) Default Interest, if any, on the amounts referred to
in clauses (w) and/or (x) <U>plus </U>(z) any amounts owed to the Holder pursuant to Article IV hereof (the then outstanding principal
amount of this Note to the date of payment <U>plus </U>the amounts referred to in clauses (x), (y) and (z) shall collectively be known
as the &ldquo;Default Amount&rdquo;) and all other amounts payable hereunder shall immediately become due and payable, all without demand,
presentment or notice, all of which hereby are expressly waived, together with all costs, including, without limitation, legal fees and
expenses, of collection, and the Holder shall be entitled to exercise all other rights and remedies available at law or in equity. Notwithstanding
anything to the contrary contained herein, in the event that following an Event of Default (other than Section 3.2), a default pursuant
to Section 3.2 occurs, the Default Percentage shall be immediately adjusted to 225%.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the Borrower fails to pay the Default Amount within five (5) business days of written notice that such amount is due and payable, then
the Holder shall have the right at any time, to convert the balance owed pursuant to the note including the Default Amount into shares
of common stock of the Company as set forth herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
IV. CONVERSION RIGHTS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1
<U>Conversion Right</U>. After the occurrence of an Event of Default, at any time, the Holder shall have the right, to convert all or
any part of the outstanding and unpaid amount of this Note into fully paid and non-assessable shares of Common Stock, as such Common
Stock exists on the Issue Date, or any shares of capital stock or other securities of the Borrower into which such Common Stock shall
hereafter be changed or reclassified at the conversion price determined as provided herein (a &ldquo;Conversion&rdquo;); <U>provided</U>,
<U>however</U>, that in no event shall the Holder be entitled to convert any portion of this Note in excess of that portion of this Note
upon conversion of which the sum of (1) the number of shares of Common Stock beneficially owned by the Holder and its affiliates (other
than shares of Common Stock which may be deemed beneficially owned through the ownership of the unconverted portion of the Notes or the
unexercised or unconverted portion of any other security of the Borrower subject to a limitation on conversion or exercise analogous
to the limitations contained herein) and (2) the number of shares of Common Stock issuable upon the conversion of the portion of this
Note with respect to which the determination of this proviso is being made, would result in beneficial ownership by the Holder and its
affiliates of more than 4.99% of the outstanding shares of Common Stock. For purposes of the proviso to the immediately preceding sentence,
beneficial ownership shall be determined in accordance with Section 13(d) of the Securities Exchange Act of 1934, as amended (the &ldquo;Exchange
Act&rdquo;), and Regulations 13D-G thereunder, except as otherwise provided in clause (1) of such proviso. <U>The beneficial ownership
limitations on conversion as set forth in the section may NOT be waived by the Holder</U>. The number of shares of Common Stock to be
issued upon each conversion of this Note shall be determined by dividing the Conversion Amount (as defined below) by the applicable Conversion
Price then in effect on the date specified in the notice of conversion, in the form attached hereto as Exhibit B(the &ldquo;Notice of
Conversion&rdquo;), delivered to the Borrower by the Holder in accordance with Section 4.4 below; provided that the Notice of Conversion
is submitted by facsimile or e-mail (or by other means resulting in, or reasonably expected to result in, notice) to the Borrower before
6:00 p.m., New York, New York time on such conversion date (the &ldquo;Conversion Date&rdquo;); however, if the Notice of Conversion
is sent after 6:00pm, New York, New York time the Conversion Date shall be the next business day. The term &ldquo;Conversion Amount&rdquo;
means, with respect to any conversion of this Note, the sum of (1) the principal amount of this Note to be converted in such conversion
<U>plus</U> (2) at the Holder&rsquo;s option, accrued and unpaid interest, if any, on such principal amount at the interest rates provided
in this Note to the Conversion Date, <U>plus</U> (3) at the Holder&rsquo;s option, Default Interest, if any, on the amounts referred
to in the immediately preceding clauses (1) and/or (2) <U>plus</U> (4) at the Holder&rsquo;s option, any amounts owed to the Holder pursuant
to Sections 4.4 hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
anything in this Agreement to the contrary, and in addition to the limitations set forth herein, if the Borrower has not obtained Stockholder
Approval, the Borrower shall not issue a number of shares of Common Stock under this Agreement, which when aggregated with all other
securities that are required to be aggregated for purposes of Rule 5635(d), would exceed 19.99% of the shares of Common Stock outstanding
as of the date of definitive agreement with respect to the first of such aggregated transactions (the &ldquo;Conversion Limitation&rdquo;).
For purposes of this section, &ldquo;Stockholder Approval&rdquo; means such approval as may be required by the applicable rules and regulations
of the Nasdaq Stock Market LLC (or any successor entity) from the stockholders of the Company with respect to the issuance of the shares
under this Agreement that, when taken together with any other securities that are required to be aggregated with the issuance of the
shares issued under this Agreement for purposes of Rule 5635(d) of the Nasdaq Stock Market LLC (&ldquo;Rule 5635(d)&rdquo;), would exceed
19.99% of the issued and outstanding common stock as of the date of definitive agreement with respect to the first of such aggregated
transactions. &ldquo;Principal Market&rdquo; means the Exchanges, the quotation platforms maintained by the OTC Markets Group) or an
equivalent replacement exchange, and all rules and regulations relating to such exchange. Upon the occurrence of an Event of Default
pursuant to Section 3.7 hereof, the Conversion Limitation shall no longer apply to limit the issuance of shares in conversion of this
Note.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Holder shall be entitled to deduct $1,500.00 from the conversion amount in each Notice of Conversion to cover Holder&rsquo;s deposit
fees associated with each Notice of Conversion. Any additional expenses incurred by Holder with respect to the Borrower&rsquo;s transfer
agent, for the issuance of the Common Stock into which this Note is convertible into, shall immediately and automatically be added to
the balance of the Note at such time as the expenses are incurred by Holder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2 <U>Conversion
Price</U>. The conversion price (the &ldquo;Conversion Price&rdquo;) shall mean $3.02 (subject to equitable adjustments by the
Borrower relating to the Borrower&rsquo;s securities or the securities of any subsidiary of the Borrower, combinations,
recapitalization, reclassifications, extraordinary distributions and similar events).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3
<U>Authorized Shares</U>. The Borrower covenants that during the period that the Note is outstanding, the Borrower will reserve from
its authorized and unissued Common Stock a sufficient number of shares, free from preemptive rights, to provide for the issuance of Common
Stock upon the full conversion of this Note issued pursuant to the Purchase Agreement. The Borrower is required at all times to have
authorized and reserved four times the number of shares that is actually issuable upon full conversion of the Note (based on the Conversion
Price of the Note in effect from time to time initially 334,829 shares) (the &ldquo;Reserved Amount&rdquo;). The Reserved Amount shall
be adjusted from time to time in accordance with the Borrower&rsquo;s obligations hereunder and the reduction of the balance due to timely
payments. The Borrower represents that upon issuance, such shares will be duly and validly issued, fully paid and non-assessable. In
addition, if the Borrower shall issue any securities or make any change to its capital structure which would change the number of shares
of Common Stock into which the Notes shall be convertible at the then current Conversion Price, the Borrower shall at the same time make
proper provision so that thereafter there shall be a sufficient number of shares of Common Stock authorized and reserved, free from preemptive
rights, for conversion of the outstanding Note. The Borrower (i) acknowledges that it has irrevocably instructed its transfer agent to
issue certificates for the Common Stock issuable upon conversion of this Note, and (ii) agrees that its issuance of this Note shall constitute
full authority to its officers and agents who are charged with the duty of executing stock certificates to execute and issue the necessary
certificates for shares of Common Stock in accordance with the terms and conditions of this Note.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If,
at any time the Borrower does not maintain the Reserved Amount it will be considered an Event of Default under this Note.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.4
<U>Method of Conversion</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Mechanics of Conversion</U>. As set forth in Section 4.1 hereof, at any time following an Event of Default, the balance due pursuant
to this Note may be converted by the Holder in whole or in part at any time from time to time after the Issue Date, by (A) submitting
to the Borrower a Notice of Conversion (by facsimile, e-mail or other reasonable means of communication dispatched on the Conversion
Date prior to 6:00 p.m., New York, New York time) and (B) subject to Section 4.4(b), surrendering this Note at the principal office of
the Borrower (upon payment in full of any amounts owed hereunder).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Surrender of Note Upon Conversion</U>. Notwithstanding anything to the contrary set forth herein, upon conversion of this Note in
accordance with the terms hereof, the Holder shall not be required to physically surrender this Note to the Borrower unless the entire
unpaid principal amount of this Note is so converted. The Holder and the Borrower shall maintain records showing the principal amount
so converted and the dates of such conversions or shall use such other method, reasonably satisfactory to the Holder and the Borrower,
so as not to require physical surrender of this Note upon each such conversion.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Delivery of Common Stock Upon Conversion</U>. Upon receipt by the Borrower from the Holder of a facsimile transmission or e-mail (or
other reasonable means of communication) of a Notice of Conversion meeting the requirements for conversion as provided in this Section
4.4, the Borrower shall issue and deliver or cause to be issued and delivered to or upon the order of the Holder certificates for the
Common Stock issuable upon such conversion within three (3) business days after such receipt (the &ldquo;Deadline&rdquo;) (and, solely
in the case of conversion of the entire unpaid principal amount hereof, surrender of this Note) in accordance with the terms hereof and
the Purchase Agreement. Upon receipt by the Borrower of a Notice of Conversion, the Holder shall be deemed to be the holder of record
of the Common Stock issuable upon such conversion, the outstanding principal amount and the amount of accrued and unpaid interest on
this Note shall be reduced to reflect such conversion, and, unless the Borrower defaults on its obligations hereunder, all rights with
respect to the portion of this Note being so converted shall forthwith terminate except the right to receive the Common Stock or other
securities, cash or other assets, as herein provided, on such conversion. If the Holder shall have given a Notice of Conversion as provided
herein, the Borrower&rsquo;s obligation to issue and deliver the certificates for Common Stock shall be absolute and unconditional, irrespective
of the absence of any action by the Holder to enforce the same, any waiver or consent with respect to any provision thereof, the recovery
of any judgment against any person or any action to enforce the same, any failure or delay in the enforcement of any other obligation
of the Borrower to the holder of record, or any setoff, counterclaim, recoupment, limitation or termination, or any breach or alleged
breach by the Holder of any obligation to the Borrower, and irrespective of any other circumstance which might otherwise limit such obligation
of the Borrower to the Holder in connection with such conversion.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>Delivery of Common Stock by Electronic Transfer</U>. In lieu of delivering physical certificates representing the Common Stock issuable
upon conversion, provided the Borrower is participating in the Depository Trust Company (&ldquo;DTC&rdquo;) Fast Automated Securities
Transfer (&ldquo;FAST&rdquo;) program, upon request of the Holder and its compliance with the provisions set forth herein, the Borrower
shall use its best efforts to cause its transfer agent to electronically transmit the Common Stock issuable upon conversion to the Holder
by crediting the account of Holder&rsquo;s Prime Broker with DTC through its Deposit and Withdrawal at Custodian (&ldquo;DWAC&rdquo;)
system.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
<U>Failure to Deliver Common Stock Prior to Deadline</U>. Without in any way limiting the Holder&rsquo;s right to pursue other remedies,
including actual damages and/or equitable relief, the parties agree that if delivery of the Common Stock issuable upon conversion of
this Note is not delivered by the Deadline due to action and/or inaction of the Borrower, the Borrower shall pay to the Holder $2,000
per day in cash, for each day beyond the Deadline that the Borrower fails to deliver such Common Stock (the &ldquo;Fail to Deliver Fee&rdquo;);
provided; however that the Fail to Deliver Fee shall not be due if the failure is a result of a third party (i.e., transfer agent; and
not the result of any failure to pay such transfer agent) despite the best efforts of the Borrower to effect delivery of such Common
Stock. Such cash amount shall be paid to Holder by the fifth day of the month following the month in which it has accrued or, at the
option of the Holder (by written notice to the Borrower by the first day of the month following the month in which it has accrued), shall
be added to the principal amount of this Note, in which event interest shall accrue thereon in accordance with the terms of this Note
and such additional principal amount shall be convertible into Common Stock in accordance with the terms of this Note. The Borrower agrees
that the right to convert is a valuable right to the Holder. The damages resulting from a failure, attempt to frustrate, interference
with such conversion right are difficult if not impossible to qualify. Accordingly, the parties acknowledge that the liquidated damages
provision contained in this Section</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.4(e)
are justified.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.5
<U>Concerning the Shares</U>. The shares of Common Stock issuable upon conversion of this Note may not be sold or transferred unless:
(i) such shares are sold pursuant to an effective registration statement under the Act or (ii) the Borrower or its transfer agent shall
have been furnished with an opinion of counsel (which opinion shall be in form, substance and scope customary for opinions of counsel
in comparable transactions) to the effect that the shares to be sold or transferred may be sold or transferred pursuant to an exemption
from such registration (such as Rule 144 or a successor rule) (&ldquo;Rule 144&rdquo;); or (iii) such shares are transferred to an &ldquo;affiliate&rdquo;
(as defined in Rule 144) of the Borrower who agrees to sell or otherwise transfer the shares only in accordance with this Section 4.5
and who is an Accredited Investor (as defined in the Purchase Agreement).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
restrictive legend on certificates representing shares of Common Stock issuable upon conversion of this Note shall be removed and the
Borrower shall issue to the Holder a new certificate therefore free of any transfer legend if the Borrower or its transfer agent shall
have received an opinion of counsel from Holder&rsquo;s counsel, in form, substance and scope customary for opinions of counsel in comparable
transactions, to the effect that (i) a public sale or transfer of such Common Stock may be made without registration under the Act, which
opinion shall be accepted by the Company so that the sale or transfer is effected; or (ii) in the case of the Common Stock issuable upon
conversion of this Note, such security is registered for sale by the Holder under an effective registration statement filed under the
Act; or otherwise may be sold pursuant to an exemption from registration. In the event that the Company does not reasonably accept the
opinion of counsel provided by the Holder with respect to the transfer of Securities pursuant to an exemption from registration (such
as Rule 144), it will be considered an Event of Default pursuant to this Note.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.6
<U>Effect of Certain Events</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Effect of Merger, Consolidation, Etc</U>. At the option of the Holder, the sale, conveyance or disposition of all or substantially
all of the assets of the Borrower, the effectuation by the Borrower of a transaction or series of related transactions in which more
than 50% of the voting power of the Borrower is disposed of, or the consolidation, merger or other business combination of the Borrower
with or into any other Person (as defined below) or Persons when the Borrower is not the survivor shall be deemed to be an Event of Default
(as defined in Article III) pursuant to which the Borrower shall be required to pay to the Holder upon the consummation of and as a condition
to such transaction an amount equal to the Default Amount (as defined in Article III). &ldquo;Person&rdquo; shall mean any individual,
corporation, limited liability company, partnership, association, trust or other entity or organization.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Adjustment Due to Merger, Consolidation, Etc</U>. If, at any time when this Note is issued and outstanding and prior to conversion
of all of the Note, there shall be any merger, consolidation, exchange of shares, recapitalization, reorganization, or other similar
event, as a result of which shares of Common Stock of the Borrower shall be changed into the same or a different number of shares of
another class or classes of stock or securities of the Borrower or another entity, or in case of any sale or conveyance of all or substantially
all of the assets of the Borrower other than in connection with a plan of complete liquidation of the Borrower, then the Holder of this
Note shall thereafter have the right to receive upon conversion of this Note, upon the basis and upon the terms and conditions specified
herein and in lieu of the shares of Common Stock immediately theretofore issuable upon conversion, such stock, securities or assets which
the Holder would have been entitled to receive in such transaction had this Note been converted in full immediately prior to such transaction
(without regard to any limitations on conversion set forth herein), and in any such case appropriate provisions shall be made with respect
to the rights and interests of the Holder of this Note to the end that the provisions hereof (including, without limitation, provisions
for adjustment of the Conversion Price and of the number of shares issuable upon conversion of the Note) shall thereafter be applicable,
as nearly as may be practicable in relation to any securities or assets thereafter deliverable upon the conversion hereof. The Borrower
shall not affect any transaction described in this Section 4.6(b) unless (a) it first gives, to the extent practicable, ten (10) days
prior written notice (but in any event at least five (5) days prior written notice) of the record date of the special meeting of shareholders
to approve, or if there is no such record date, the consummation of, such merger, consolidation, exchange of shares, recapitalization,
reorganization or other similar event or sale of assets (during which time the Holder shall be entitled to convert this Note) and (b)
the resulting successor or acquiring entity (if not the Borrower) assumes by written instrument the obligations of this Note. The above
provisions shall similarly apply to successive consolidations, mergers, sales, transfers or share exchanges.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Adjustment Due to Distribution</U>. If the Borrower shall declare or make any distribution of its assets (or rights to acquire its
assets) to holders of Common Stock as a dividend, stock repurchase, by way of return of capital or otherwise (including any dividend
or distribution to the Borrower&rsquo;s shareholders in cash or shares (or rights to acquire shares) of capital stock of a subsidiary
(i.e., a spin-off)) (a &ldquo;Distribution&rdquo;), then the Holder of this Note shall be entitled, upon any conversion of this Note
after the date of record for determining shareholders entitled to such Distribution, to receive the amount of such assets which would
have been payable to the Holder with respect to the shares of Common Stock issuable upon such conversion had such Holder been the holder
of such shares of Common Stock on the record date for the determination of shareholders entitled to such Distribution.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>Adjustment Due to Market Price</U>. Notwithstanding anything contained herein to the contrary, if at any time the Market Price, as
determined on the date of each conversion, is less than the Conversion Price, then the Default Amount due pursuant to this Note shall
be increased immediately following each such conversion by the result of the Conversion Price minus the Market Price multiplied by the
amount of shares of common stock being issued with respect to such conversion. &ldquo;Market Price&rdquo; shall mean the lowest closing
bid price for the Common Stock during ten (10) Trading Days prior to the applicable date of conversion. &ldquo;Trading Day&rdquo; shall
mean any day on which the Common Stock is tradable for any period on the trading market, or on the principal securities exchange or other
securities market on which the Common Stock is then being traded. For example, the Conversion Price is $1.00 and if the Market Price
is $0.50 and the amount of shares issued upon conversion is 10,000 shares, then the Default Amount shall be increased by $5,000.00 ($1.00
- $0.50 = $0.50 multiplied by 10,000 = 5,000.00) immediately following such conversion.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
V. MISCELLANEOUS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1
<U>Failure or Indulgence Not Waiver</U>. No failure or delay on the part of the Holder in the exercise of any power, right or privilege
hereunder shall operate as a waiver thereof, nor shall any single or partial exercise of any such power, right or privilege preclude
other or further exercise thereof or of any other right, power or privileges. All rights and remedies existing hereunder are cumulative
to, and not exclusive of, any rights or remedies otherwise available.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.2
<U>Notices</U>. All notices, demands, requests, consents, approvals, and other communications required or permitted hereunder shall be
in writing and, unless otherwise specified herein, shall be (i) personally served, (ii) deposited in the mail, registered or certified,
return receipt requested, postage prepaid, (iii) delivered by reputable air courier service with charges prepaid, or (iv) transmitted
by hand delivery, telegram, or electronic mail, addressed as set forth below or to such other address as such party shall have specified
most recently by written notice. Any notice or other communication required or permitted to be given hereunder shall be deemed effective
(a) upon hand delivery or delivery by electronic mail, at the address or number designated below (if delivered on a business day during
normal business hours where such notice is to be received), or the first business day following such delivery (if delivered other than
on a business day during normal business hours where such notice is to be received) or (b) on the second business day following the date
of mailing by express courier service, fully prepaid, addressed to such address, or upon actual receipt of such mailing, whichever shall
first occur. The addresses for such communications shall be:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 132pt; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
to the Borrower, to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 132pt; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NEXTTRIP, INC.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3900
Paseo del Sol</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Santa
Fe, NM 87507</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attn:
William Kerby, Chief Executive Officer</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email:
bill.kerby@nexttrip.com</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
to the Holder:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1800
DIAGONAL LENDING LLC</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1800
Diagonal Road, Suite 623</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Alexandria
VA 22314</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attn:
Curt Kramer, President</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email:
ckramer6@bloomberg.net</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.3
<U>Amendments</U>. This Note and any provision hereof may only be amended by an instrument in writing signed by the Borrower and the
Holder. The term &ldquo;Note&rdquo; and all reference thereto, as used throughout this instrument, shall mean this instrument (and the
other Notes issued pursuant to the Purchase Agreement) as originally executed, or if later amended or supplemented, then as so amended
or supplemented.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.4
<U>Assignability</U>. This Note shall be binding upon the Borrower and its successors and assigns, and shall inure to be the benefit
of the Holder and its successors and assigns. Each transferee of this Note must be an &ldquo;accredited investor&rdquo; (as defined in
Rule 501(a) of the Securities and Exchange Commission). Notwithstanding anything in this Note to the contrary, this Note may be pledged
as collateral in connection with a <U>bona fide</U> margin account or other lending arrangement; and may be assigned by the Holder without
the consent of the Borrower.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.5
<U>Cost of Collection</U>. If default is made in the payment of this Note, the Borrower shall pay the Holder hereof costs of collection,
including reasonable attorneys&rsquo; fees.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.6
<U>Governing Law</U>. This Note shall be governed by and construed in accordance with the laws of the Commonwealth of Virginia without
regard to principles of conflicts of laws. Any action brought by either party against the other concerning the transactions contemplated
by this Note shall be brought only in the Circuit Court of Fairfax County, Virginia or in the Alexandria Division of the United States
District Court for the Eastern District of Virginia. The parties to this Note hereby irrevocably waive any objection to jurisdiction
and venue of any action instituted hereunder and shall not assert any defense based on lack of jurisdiction or venue or based upon <I>forum
non conveniens</I>. The Borrower and Holder waive trial by jury. The Holder shall be entitled to recover from the Borrower its reasonable
attorney&rsquo;s fees and costs. In the event that any provision of this Note or any other agreement delivered in connection herewith
is invalid or unenforceable under any applicable statute or rule of law, then such provision shall be deemed inoperative to the extent
that it may conflict therewith and shall be deemed modified to conform with such statute or rule of law. Any such provision which may
prove invalid or unenforceable under any law shall not affect the validity or enforceability of any other provision of any agreement.
Each party hereby irrevocably waives personal service of process and consents to process being served in any suit, action or proceeding
in connection with this Note, any agreement or any other document delivered in connection with this Note by mailing a copy thereof via
registered or certified mail or overnight delivery (with evidence of delivery) to such party at the address in effect for notices to
it under this Note and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained
herein shall be deemed to limit in any way any right to serve process in any other manner permitted by law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.7
<U>Purchase Agreement</U>. By its acceptance of this Note, each party agrees to be bound by the applicable terms of the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.8
<U>Remedies</U>. The Borrower acknowledges that a breach by it of its obligations hereunder will cause irreparable harm to the Holder,
by vitiating the intent and purpose of the transaction contemplated hereby. Accordingly, the Borrower acknowledges that the remedy at
law for a breach of its obligations under this Note will be inadequate and agrees, in the event of a breach or threatened breach by the
Borrower of the provisions of this Note, that the Holder shall be entitled, in addition to all other available remedies at law or in
equity, and in addition to the penalties assessable herein, to an injunction or injunctions restraining, preventing or curing any breach
of this Note and to enforce specifically the terms and provisions thereof, without the necessity of showing economic loss and without
any bond or other security being required.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, Borrower has caused this Note to be signed in its name by its duly authorized officer this on October 18, 2024</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NEXTTRIP, INC.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 47%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:
    </FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    William Kerby</I></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">William
    Kerby</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXHIBIT
A &ndash; WIRE INSTRUCTIONS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[to
be provided via email]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXHIBIT
B &mdash; NOTICE OF CONVERSION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 82.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned hereby elects to convert $_________________ principal amount of the Note (defined below) into that number of shares of Common Stock to be
issued pursuant to the conversion of the Note (&ldquo;Common Stock&rdquo;) as set forth below, of NEXTTRIP, INC., a Nevada corporation
(the &ldquo;Borrower&rdquo;) according to the conditions of the convertible note of the Borrower dated as of October 18, 2024 (the &ldquo;Note&rdquo;),
as of the date written below. No fee will be charged to the Holder for any conversion, except for transfer taxes, if any.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Box
Checked as to applicable instructions:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;] </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Borrower shall electronically transmit the Common Stock issuable pursuant to this Notice of Conversion to the account of the undersigned
    or its nominee with DTC through its Deposit Withdrawal Agent Commission system (&ldquo;DWAC Transfer&rdquo;).</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
    of DTC Prime Broker: Account Number:</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    undersigned hereby requests that the Borrower issue a certificate or certificates for the number of shares of Common Stock set forth
    below (which numbers are based on the Holder&rsquo;s calculation attached hereto) in the name(s) specified immediately below or,
    if additional space is necessary, on an attachment hereto:</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 75%; margin-left: 1.25in">
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 1pt">Date of conversion:</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1pt; width: 80%">Applicable Conversion Price:</TD><TD STYLE="padding-bottom: 1pt; width: 2%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></TD><TD STYLE="padding-bottom: 1pt; width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 1pt; text-align: left">Number of shares of common stock to be issued pursuant to conversion of the Notes:</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1pt; text-align: left">Amount of Principal Balance due remaining under the Note after this conversion:</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 82%; border-collapse: collapse; margin-left: 1.25in">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1800
    DIAGONAL LENDING LLC</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:
    </FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:
    </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Curt
    Kramer</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:
    </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">President</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 195.7pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECURITIES
PURCHASE AGREEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This <B>SECURITIES
PURCHASE AGREEMENT </B>(the &ldquo;Agreement&rdquo;), dated as of October 18, 2024, by and between <B>NEXTTRIP, INC.</B>, a Nevada
corporation, with its address at 3900 Paseo del Sol, Santa Fe, NM 87507 (the &ldquo;Company&rdquo;), and <B>1800 DIAGONAL LENDING
LLC</B>, a Virginia limited liability company, with its address at 1800 Diagonal Road, Suite 623, Alexandria, VA 22314 (the
&ldquo;Lender&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREAS</B>:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.
The Company and the Lender are executing and delivering this Agreement in reliance upon the exemption from securities registration afforded
by the rules and regulations as promulgated by the United States Securities and Exchange Commission (the &ldquo;SEC&rdquo;) under the
Securities Act of 1933, as amended (the &ldquo;1933 Act&rdquo;); and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.
Lender desires to purchase and the Company desires to issue and sell, upon the terms and conditions set forth in this Agreement a promissory
note of the Company, in the form attached hereto as Exhibit A, in the aggregate principal amount of $154,440.00 (together with any note(s)
issued in replacement thereof or as a dividend thereon or otherwise with respect thereto in accordance with the terms thereof, the &ldquo;Note&rdquo;)
which upon default is convertible into shares of common stock, $0.001 par value per share, of the Company (the &ldquo;Common Stock&rdquo;),
upon the terms and subject to the limitations and conditions set forth in such Note with additional tranches of financing of up to $775,000.00
during the next twelve (12) months subject to further agreement by and between the Company and the Lender.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOW
THEREFORE</B>, the Company and the Lender severally (and not jointly) hereby agree as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.
<U>Purchase and Sale of Note.</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a.
<U>Purchase of Note</U>. On the Closing Date (as defined below), the Company shall issue and sell to the Lender and the Lender agrees
to purchase from the Company such principal amount of Note as is set forth immediately below the Lender&rsquo;s name on the signature
pages hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b.
<U>Form of Payment</U>. On the Closing Date (as defined below), (i) the Lender shall pay the purchase price for the Note to be issued
and sold to it at the Closing (as defined below) (the &ldquo;Purchase Price&rdquo;) by wire transfer of immediately available funds to
the Company, in accordance with the Company&rsquo;s written wiring instructions, against delivery of the Note in the principal amount
equal to the Purchase Price as is set forth immediately below the Lender&rsquo;s name on the signature pages hereto, and (ii) the Company
shall deliver such duly executed Note on behalf of the Company, to the Lender, against delivery of such Purchase Price.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c.
<U>Closing Date</U>. Subject to the satisfaction (or written waiver) of the conditions thereto set forth in Section 6 and Section 7 below,
the date and time of the issuance and sale of the Note pursuant to this Agreement (the &ldquo;Closing Date&rdquo;) shall be 12:00 noon,
Eastern Standard Time on or about October 21, 2024, or such other mutually agreed upon time. The closing of the transactions contemplated
by this Agreement (the &ldquo;Closing&rdquo;) shall occur on the Closing Date at such location as may be agreed to by the parties.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.
<U>Lender&rsquo;s Representations and Warranties. </U>The Lender represents and warrants to the Company that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a.
<U>Investment Purpose</U>. As of the date hereof, the Lender is purchasing the Note and the shares of Common Stock issuable upon conversion
of or otherwise pursuant to the Note (such shares of Common Stock being collectively referred to herein as the &ldquo;Conversion Shares&rdquo;
and, collectively with the Note, the &ldquo;Securities&rdquo;) for its own account and not with a present view towards the public sale
or distribution thereof, except pursuant to sales registered or exempted from registration under the 1933 Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b.
<U>Accredited Investor Status</U>. The Lender is an &ldquo;accredited investor&rdquo; as that term is defined in Rule 501(a) of Regulation
D (an &ldquo;Accredited Investor&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c.
<U>Reliance on Exemptions</U>. The Lender understands that the Securities are being offered and sold to it in reliance upon specific
exemptions from the registration requirements of United States federal and state securities laws and that the Company is relying upon
the truth and accuracy of, and the Lender&rsquo;s compliance with, the representations, warranties, agreements, acknowledgments and understandings
of the Lender set forth herein in order to determine the availability of such exemptions and the eligibility of the Lender to acquire
the Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d.
<U>Information</U>. The Company has not disclosed to the Lender any material nonpublic information and will not disclose such information
unless such information is disclosed to the public prior to or promptly following such disclosure to the Lender.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e.
<U>Legends</U>. The Lender understands that the Note and, until such time as the Conversion Shares have been registered under the 1933
Act; or may be sold pursuant to an applicable exemption from registration, the Conversion Shares may bear a restrictive legend in substantially
the following form:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;THE
SECURITIES REPRESENTED BY THIS INSTRUMENT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE &ldquo;SECURITIES
ACT&rdquo;), OR UNDER ANY STATE SECURITIES LAWS, AND MAY NOT BE PLEDGED, SOLD, ASSIGNED, HYPOTHECATED OR OTHERWISE TRANSFERRED UNLESS
(1) A REGISTRATION STATEMENT WITH RESPECT THERETO IS EFFECTIVE UNDER THE SECURITIES ACT AND ANY APPLICABLE STATE SECURITIES LAWS OR (2)
THE ISSUER OF SUCH SECURITIES RECEIVES AN OPINION OF COUNSEL TO THE HOLDER OF SUCH SECURITIES, WHICH COUNSEL AND OPINION ARE REASONABLY
ACCEPTABLE TO THE ISSUER&rsquo;S TRANSFER AGENT, THAT SUCH SECURITIES MAY BE PLEDGED, SOLD, ASSIGNED, HYPOTHECATED OR OTHERWISE TRANSFERRED
WITHOUT AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT AND APPLICABLE STATE SECURITIES LAWS.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 132pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 132pt; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
legend set forth above shall be removed and the Company shall issue a certificate without such legend to the holder of any Security upon
which it is stamped, if, unless otherwise required by applicable state securities laws, (a) such Security is registered for sale under
an effective registration statement filed under the 1933 Act or otherwise may be sold pursuant to an exemption from registration without
any restriction as to the number of securities as of a particular date that can then be immediately sold, or (b) such holder provides
the Company with an opinion of counsel, in form, substance and scope customary for opinions of counsel in comparable transactions, to
the effect that a public sale or transfer of such Security may be made without registration under the 1933 Act, which opinion shall be
accepted by the Company so that the sale or transfer is effected. The Lender agrees to sell all Securities, including those represented
by a certificate(s) from which the legend has been removed, in compliance with applicable prospectus delivery requirements, if any. In
the event that the Company does not accept the opinion of counsel provided by the Lender with respect to the transfer of Securities pursuant
to an exemption from registration, such as Rule 144, at the Deadline, it will be considered an Event of Default pursuant to Section 3.2
of the Note.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f.
<U>Authorization; Enforcement</U>. This Agreement has been duly and validly authorized. This Agreement has been duly executed and delivered
on behalf of the Lender, and this Agreement constitutes a valid and binding agreement of the Lender enforceable in accordance with its
terms.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.
<U>Representations and Warranties of the Company</U>. The Company represents and warrants to the Lender that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a.
<U>Organization and Qualification</U>. The Company and each of its Subsidiaries (as defined below), if any, is a corporation duly organized,
validly existing and in good standing under the laws of the jurisdiction in which it is incorporated, with full power and authority (corporate
and other) to own, lease, use and operate its properties and to carry on its business as and where now owned, leased, used, operated
and conducted. &ldquo;Subsidiaries&rdquo; means any corporation or other organization, whether incorporated or unincorporated, in which
the Company owns, directly or indirectly, any equity or other ownership interest.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b.
<U>Authorization; Enforcement</U>. (i) The Company has all requisite corporate power and authority to enter into and perform this Agreement,
the Note and to consummate the transactions contemplated hereby and thereby and to issue the Securities, in accordance with the terms
hereof and thereof, (ii) the execution and delivery of this Agreement, the Note by the Company and the consummation by it of the transactions
contemplated hereby and thereby (including without limitation, the issuance of the Note and the issuance and reservation for issuance
of the Conversion Shares issuable upon conversion or exercise thereof) have been duly authorized by the Company&rsquo;s Board of Directors
and no further consent or authorization of the Company, its Board of Directors, or its shareholders is required, (iii) this Agreement
has been duly executed and delivered by the Company by its authorized representative, and such authorized representative is the true
and official representative with authority to sign this Agreement and the other documents executed in connection herewith and bind the
Company accordingly, and (iv) this Agreement constitutes, and upon execution and delivery by the Company of the Note, each of such instruments
will constitute, a legal, valid and binding obligation of the Company enforceable against the Company in accordance with its terms.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c.
<U>Capitalization</U>. As of the date hereof, the authorized common stock of the Company consists of 250,000,000 authorized shares of
Common Stock, $0.001 par value per share, of which 1,388,641 shares are issued and outstanding. All of such outstanding shares of capital
stock are, or upon issuance will be, duly authorized, validly issued, fully paid and non-assessable. .</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d.
<U>Issuance of Shares</U>. The Conversion Shares are duly authorized and reserved for issuance and, upon conversion of the Note in accordance
with its respective terms, will be validly issued, fully paid and non-assessable, and free from all taxes, liens, claims and encumbrances
with respect to the issue thereof and shall not be subject to preemptive rights or other similar rights of shareholders of the Company
and will not impose personal liability upon the holder thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e.
<U>No Conflicts</U>. The execution, delivery and performance of this Agreement, the Note by the Company and the consummation by the Company
of the transactions contemplated hereby and thereby (including, without limitation, the issuance and reservation for issuance of the
Conversion Shares) will not (i) conflict with or result in a violation of any provision of the Certificate of Incorporation or By-laws,
or (ii) violate or conflict with, or result in a breach of any provision of, or constitute a default (or an event which with notice or
lapse of time or both could become a default) under, or give to others any rights of termination, amendment, acceleration or cancellation
of, any agreement, indenture, patent, patent license or instrument to which the Company or any of its Subsidiaries is a party, or (iii)
result in a violation of any law, rule, regulation, order, judgment or decree (including federal and state securities laws and regulations
and regulations of any self-regulatory organizations to which the Company or its securities are subject) applicable to the Company or
any of its Subsidiaries or by which any property or asset of the Company or any of its Subsidiaries is bound or affected (except for
such conflicts, defaults, terminations, amendments, accelerations, cancellations and violations as would not, individually or in the
aggregate, have a Material Adverse Effect). The businesses of the Company and its Subsidiaries, if any, are not being conducted, and
shall not be conducted so long as the Lender owns any of the Securities, in violation of any law, ordinance or regulation of any governmental
entity. &ldquo;Material Adverse Effect&rdquo; means any material adverse effect on the business, operations, assets, financial condition
or prospects of the Company or its Subsidiaries, if any, taken as a whole, or on the transactions contemplated hereby or by the agreements
or instruments to be entered into in connection herewith.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f.
<U>SEC Documents: Financial Statements</U>. The Company has filed all reports, schedules, forms, statements and other documents required
to be filed by it with the SEC pursuant to the reporting requirements of the Securities Exchange Act of 1934, as amended (the &ldquo;1934
Act&rdquo;) (all of the foregoing filed prior to the date hereof and all exhibits included therein and financial statements and schedules
thereto and documents (other than exhibits to such documents) incorporated by reference therein, being hereinafter referred to herein
as the &ldquo;SEC Documents&rdquo;). The Company is subject to the filings requirements of the 1934 Act pursuant to Section 12 of the
1934 Act. Upon written request the Company will deliver to the Lender true and complete copies of the SEC Documents, except for such
exhibits and incorporated documents. As of their respective dates or if amended, as of the dates of the amendments, the SEC Documents
complied in all material respects with the requirements of the 1934 Act and the rules and regulations of the SEC promulgated thereunder
applicable to the SEC Documents, and none of the SEC Documents, at the time they were filed with the SEC, contained any untrue statement
of a material fact or omitted to state a material fact required to be stated therein or necessary in order to make the statements therein,
in light of the circumstances under which they were made, not misleading. None of the statements made in any such SEC Documents is, or
has been, required to be amended or updated under applicable law (except for such statements as have been amended or updated in subsequent
filings prior the date hereof). As of their respective dates or if amended, as of the dates of the amendments, the financial statements
of the Company included in the SEC Documents complied as to form in all material respects with applicable accounting requirements and
the published rules and regulations of the SEC with respect thereto. Such financial statements have been prepared in accordance with
United States generally accepted accounting principles, consistently applied, during the periods involved and fairly present in all material
respects the consolidated financial position of the Company and its consolidated Subsidiaries as of the dates thereof and the consolidated
results of their operations and cash flows for the periods then ended (subject, in the case of unaudited statements, to normal year-end
audit adjustments). The Company is subject to the reporting requirements of the 1934 Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">g.
<U>Absence of Certain Changes</U>. Since May 31, 2024, except as set forth in the SEC Documents, there has been no material adverse change
and no material adverse development in the assets, liabilities, business, properties, operations, financial condition, results of operations,
prospects or 1934 Act reporting status of the Company or any of its Subsidiaries.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">h.
<U>Absence of Litigation</U>. Except as set forth in the SEC Documents, there is no action, suit, claim, proceeding, inquiry or investigation
before or by any court, public board, government agency, self-regulatory organization or body pending or, to the knowledge of the Company
or any of its Subsidiaries, threatened against or affecting the Company or any of its Subsidiaries, or their officers or directors in
their capacity as such, that could have a Material Adverse Effect. The Company and its Subsidiaries are unaware of any facts or circumstances
which might give rise to any of the foregoing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.
<U>No Integrated Offering</U>. Neither the Company, nor any of its affiliates, nor any person acting on its or their behalf, has directly
or indirectly made any offers or sales in any security or solicited any offers to buy any security under circumstances that would require
registration under the 1933 Act of the issuance of the Securities to the Lender. The issuance of the Securities to the Lender will not
be integrated with any other issuance of the Company&rsquo;s securities (past, current or future) for purposes of any shareholder approval
provisions applicable to the Company or its securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 19; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">j.
<U>No Brokers</U>. Except for Enclave Capital, the Company has taken no action which would give rise to any claim by any person for brokerage
commissions, transaction fees or similar payments relating to this Agreement or the transactions contemplated hereby.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">k.
<U>No Investment Company</U>. The Company is not, and upon the issuance and sale of the Securities as contemplated by this Agreement
will not be an &ldquo;investment company&rdquo; required to be registered under the Investment Company Act of 1940 (an &ldquo;Investment
Company&rdquo;). The Company is not controlled by an Investment Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">l.
<U>Breach of Representations and Warranties by the Company</U>. If the Company breaches any of the representations or warranties set
forth in this Section 3, and in addition to any other remedies available to the Lender pursuant to this Agreement, it will be considered
an Event of default under Section 3.4 of the Note.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.
<U>COVENANTS</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a.
<U>Best Efforts</U>. The Company shall use its best efforts to satisfy timely each of the conditions described in Section 7 of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b.
<U>Form D; Blue Sky Laws</U>. The Company agrees to timely make any filings required by federal and state laws as a result of the closing
of the transactions contemplated by this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c.
<U>Use of Proceeds</U>. The Company shall use the proceeds for general working capital purposes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d.
<U>Expenses</U>. At the Closing, the Company&rsquo;s obligation with respect to the transactions contemplated by this Agreement is to
reimburse Lender&rsquo; expenses shall be $17,000.00 for Lender&rsquo;s legal fees and due diligence fee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e.
<U>Corporate Existence</U>. So long as the Lender beneficially owns any Note, the Company shall maintain its corporate existence and
shall not sell all or substantially all of the Company&rsquo;s assets, except with the prior written consent of the Lender.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f.
<U>Breach of Covenants</U>. If the Company breaches any of the covenants set forth in this Section 4, and in addition to any other remedies
available to the Lender pursuant to this Agreement, it will be considered an event of default under Section 3.4 of the Note.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">g.
<U>Failure to Comply with the 1934 Act</U>. So long as the Lender beneficially owns the Note, the Company shall comply with the reporting
requirements of the 1934 Act; and the Company shall continue to be subject to the reporting requirements of the 1934 Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 20; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">h.
<U>Trading Activities</U>. Neither the Lender nor its affiliates has an open short position in the common stock of the Company and the
Lender agrees that it shall not, and that it will cause its affiliates not to, engage in any short sales of or hedging transactions with
respect to the common stock of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.
<U>The Lender is Not a &ldquo;Dealer&rdquo;</U>. The Lender and the Company hereby acknowledge and agree that the Lender has not: (i)
acted as an underwriter; (ii) acted as a market maker or specialist; (iii) acted as &ldquo;de facto&rdquo; market maker; or (iv) conducted
any other professional market activities such as providing investment advice, extending credit and lending securities in connection;
and thus that the Lender is not a &ldquo;Dealer&rdquo; as such term is defined in the 1934 Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.
<U>Transfer Agent Instructions</U>. The Company shall issue irrevocable instructions to its transfer agent to issue certificates, registered
in the name of the Lender or its nominee, for the Conversion Shares in such amounts as specified from time to time by the Lender to the
Company upon conversion of the Note in accordance with the terms thereof (the &ldquo;Irrevocable Transfer Agent Instructions&rdquo;).
In the event that the Company proposes to replace its transfer agent, the Company shall provide, prior to the effective date of such
replacement, a fully executed Irrevocable Transfer Agent Instructions in a form as initially delivered pursuant to this Agreement (including
but not limited to the provision to irrevocably reserve shares of Common Stock in the Reserved Amount as such term is defined in the
Note) signed by the successor transfer agent to Company and the Company. Prior to registration of the Conversion Shares under the 1933
Act or the date on which the Conversion Shares may be sold pursuant to an exemption from registration, all such certificates shall bear
the restrictive legend specified in Section 2(e) of this Agreement. The Company warrants that: (i) no instruction other than the Irrevocable
Transfer Agent Instructions referred to in this Section 5, will be given by the Company to its transfer agent and that the Securities
shall otherwise be freely transferable on the books and records of the Company as and to the extent provided in this Agreement and the
Note; (ii) it will not direct its transfer agent not to transfer or delay, impair, and/or hinder its transfer agent in transferring (or
issuing)(electronically or in certificated form) any certificate for Conversion Shares to be issued to the Lender upon conversion of
or otherwise pursuant to the Note as and when required by the Note and this Agreement; and (iii) it will not fail to remove (or directs
its transfer agent not to remove or impairs, delays, and/or hinders its transfer agent from removing) any restrictive legend (or to withdraw
any stop transfer instructions in respect thereof) on any certificate for any Conversion Shares issued to the Lender upon conversion
of or otherwise pursuant to the Note as and when required by the Note and/or this Agreement. If the Lender provides the Company and the
Company&rsquo;s transfer agent, at the cost of the Lender, with an opinion of counsel in form, substance and scope customary for opinions
in comparable transactions, to the effect that a public sale or transfer of such Securities may be made without registration under the
1933 Act, the Company shall permit the transfer, and, in the case of the Conversion Shares, promptly instruct its transfer agent to issue
one or more certificates, free from restrictive legend, in such name and in such denominations as specified by the Lender. The Company
acknowledges that a breach by it of its obligations hereunder will cause irreparable harm to the Lender, by vitiating the intent and
purpose of the transactions contemplated hereby. Accordingly, the Company acknowledges that the remedy at law for a breach of its obligations
under this Section 5 may be inadequate and agrees, in the event of a breach or threatened breach by the Company of the provisions of
this Section, that the Lender shall be entitled, in addition to all other available remedies, to an injunction restraining any breach
and requiring immediate transfer, without the necessity of showing economic loss and without any bond or other security being required.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 21; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.
<U>Conditions to the Company&rsquo;s Obligation to Sell</U>. The obligation of the Company hereunder to issue and sell the Note to the
Lender at the Closing is subject to the satisfaction, at or before the Closing Date of each of the following conditions thereto, provided
that these conditions are for the Company&rsquo;s sole benefit and may be waived by the Company at any time in its sole discretion:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a.
The Lender shall have executed this Agreement and delivered the same to the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b.
The Lender shall have delivered the Purchase Price in accordance with Section 1(b) above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c.
The Lender shall have delivered a subordination agreement in a form acceptable to the Lender, the Company and the Company&rsquo;s primary
lender.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d.
The representations and warranties of the Lender shall be true and correct in all material respects as of the date when made and as of
the Closing Date as though made at that time (except for representations and warranties that speak as of a specific date), and the Lender
shall have performed, satisfied and complied in all material respects with the covenants, agreements and conditions required by this
Agreement to be performed, satisfied or complied with by the Lender at or prior to the Closing Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e.
No litigation, statute, rule, regulation, executive order, decree, ruling or injunction shall have been enacted, entered, promulgated
or endorsed by or in any court or governmental authority of competent jurisdiction or any self-regulatory organization having authority
over the matters contemplated hereby which prohibits the consummation of any of the transactions contemplated by this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.
<U>Conditions to The Lender&rsquo;s Obligation to Purchase</U>. The obligation of the Lender hereunder to purchase the Note at the Closing
is subject to the satisfaction, at or before the Closing Date of each of the following conditions, provided that these conditions are
for the Lender&rsquo;s sole benefit and may be waived by the Lender at any time in its sole discretion:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a.
The Company shall have executed this Agreement and delivered the same to the Lender.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b.
The Company shall have delivered to the Lender the duly executed Note (in such denominations as the Lender shall request) in accordance
with Section 1(b) above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 22; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c.
The Irrevocable Transfer Agent Instructions, in form and substance satisfactory to the Lender, shall have been delivered to and acknowledged
in writing by the Company&rsquo;s Transfer Agent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d.
The representations and warranties of the Company shall be true and correct in all material respects as of the date when made and as
of the Closing Date as though made at such time (except for representations and warranties that speak as of a specific date) and the
Company shall have performed, satisfied and complied in all material respects with the covenants, agreements and conditions required
by this Agreement to be performed, satisfied or complied with by the Company at or prior to the Closing Date. The Lender shall have received
a certificate or certificates, executed by the chief executive officer of the Company, dated as of the Closing Date, to the foregoing
effect and as to such other matters as may be reasonably requested by the Lender including, but not limited to certificates with respect
to the Board of Directors&rsquo; resolutions relating to the transactions contemplated hereby.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e.
No litigation, statute, rule, regulation, executive order, decree, ruling or injunction shall have been enacted, entered, promulgated
or endorsed by or in any court or governmental authority of competent jurisdiction or any self-regulatory organization having authority
over the matters contemplated hereby which prohibits the consummation of any of the transactions contemplated by this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f.
No event shall have occurred which could reasonably be expected to have a Material Adverse Effect on the Company including but not limited
to a change in the 1934 Act reporting status of the Company or the failure of the Company to be timely in its 1934 Act reporting obligations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.
<U>Governing Law; Miscellaneous</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a.
<U>Governing Law</U>. This Agreement shall be governed by and construed in accordance with the laws of the Commonwealth of Virginia without
regard to principles of conflicts of laws. Any action brought by either party against the other concerning the transactions contemplated
by this Agreement shall be brought only in the Circuit Court of Fairfax County, Virginia or in the Alexandria Division of the United
States District Court for the Eastern District of Virginia. The parties to this Agreement hereby irrevocably waive any objection to jurisdiction
and venue of any action instituted hereunder and shall not assert any objection or defense based on lack of jurisdiction or venue or
based upon <I>forum non conveniens</I>. The Company and Lender waive trial by jury. The Lender shall be entitled to recover from the
Company its reasonable attorney&rsquo;s fees and costs incurred in connection with or related to any Event of Default by the Company,
as defined in Article III of the Note. Each party hereby irrevocably waives personal service of process and consents to process being
served in any suit, action or proceeding in connection with this Agreement, the Note or any related document or agreement by mailing
a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery) to such party at the address in effect
for notices to it under this Agreement and agrees that such service shall constitute good and sufficient service of process and notice
thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any other manner permitted by law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 23; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b.
<U>Counterparts</U>. This Agreement may be executed in one or more counterparts, each of which shall be deemed an original but all of
which shall constitute one and the same agreement and shall become effective when counterparts have been signed by each party and delivered
to the other party.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c.
<U>Headings</U>. The headings of this Agreement are for convenience of reference only and shall not form part of, or affect the interpretation
of, this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d.
<U>Severability</U>. In the event that any provision of this Agreement is invalid or unenforceable under any applicable statute or rule
of law, then such provision shall be deemed inoperative to the extent that it may conflict therewith and shall be deemed modified to
conform with such statute or rule of law. Any provision hereof which may prove invalid or unenforceable under any law shall not affect
the validity or enforceability of any other provision hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e.
<U>Entire Agreement; Amendments</U>. This Agreement and the instruments referenced herein contain the entire understanding of the parties
with respect to the matters covered herein and therein and, except as specifically set forth herein or therein, neither the Company nor
the Lender makes any representation, warranty, covenant or undertaking with respect to such matters. No provision of this Agreement may
be waived or amended other than by an instrument in writing signed by the majority in interest of the Lender.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f. <U>Notices</U>.
All notices, demands, requests, consents, approvals, and other communications required or permitted hereunder shall be in writing
and, unless otherwise specified herein, shall be (i) personally served, (ii) deposited in the mail, registered or certified, return
receipt requested, postage prepaid, (iii) delivered by reputable air courier service with charges prepaid, or (iv) transmitted by
hand delivery, telegram, email or facsimile, addressed as set forth below or to such other address as such party shall have
specified most recently by written notice. Any notice or other communication required or permitted to be given hereunder shall be
deemed effective (a) upon hand delivery or delivery by facsimile, with accurate confirmation generated by the transmitting facsimile
machine, at the address or number designated below (if delivered on a business day during normal business hours where such notice is
to be received), or the first business day following such delivery (if delivered other than on a business day during normal business
hours where such notice is to be received) or (b) on the second business day following the date of mailing by express courier
service, fully prepaid, addressed to such address, or upon actual receipt of such mailing, whichever shall first occur. The
addresses for such communications shall be as set forth in the heading of this Agreement with a copy by fax only to (which copy
shall not constitute notice) to Naidich Wurman LLP, 111 Great Neck Road, Suite 214, Great Neck, NY 11021, Attn: Allison Naidich,
facsimile: 516-466-3555, e-mail: <U>allison@nwlaw.com</U>. Each party shall provide notice to the other party of any change in
address.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">g.
<U>Successors and Assigns</U>. This Agreement shall be binding upon and inure to the benefit of the parties and their successors and
assigns. Neither the Company nor the Lender shall assign this Agreement or any rights or obligations hereunder without the prior written
consent of the other. Notwithstanding the foregoing, the Lender may assign its rights hereunder to any person that purchases Securities
in a private transaction from the Lender or to any of its &ldquo;affiliates,&rdquo; as that term is defined under the 1934 Act, without
the consent of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 24; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">h.
<U>Survival</U>. The representations and warranties of the Company and the agreements and covenants set forth in this Agreement shall
survive the closing hereunder notwithstanding any due diligence investigation conducted by or on behalf of the Lender. The Company agrees
to indemnify and hold harmless the Lender and all their officers, directors, employees and agents for loss or damage arising as a result
of or related to any breach or alleged breach by the Company of any of its representations, warranties and covenants set forth in this
Agreement or any of its covenants and obligations under this Agreement, including advancement of expenses as they are incurred.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.
<U>Further Assurances</U>. Each party shall do and perform, or cause to be done and performed, all such further acts and things, and
shall execute and deliver all such other agreements, certificates, instruments and documents, as the other party may reasonably request
in order to carry out the intent and accomplish the purposes of this Agreement and the consummation of the transactions contemplated
hereby.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">j.
<U>No Strict Construction</U>. The language used in this Agreement will be deemed to be the language chosen by the parties to express
their mutual intent, and no rules of strict construction will be applied against any party.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">k.
<U>Remedies</U>. The Company acknowledges that a breach by it of its obligations hereunder will cause irreparable harm to the Lender
by vitiating the intent and purpose of the transaction contemplated hereby. Accordingly, the Company acknowledges that the remedy at
law for a breach of its obligations under this Agreement will be inadequate and agrees, in the event of a breach or threatened breach
by the Company of the provisions of this Agreement, that the Lender shall be entitled, in addition to all other available remedies at
law or in equity, and in addition to the penalties assessable herein, to an injunction or injunctions restraining, preventing or curing
any breach of this Agreement and to enforce specifically the terms and provisions hereof, without the necessity of showing economic loss
and without any bond or other security being required.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 25; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the undersigned Lender and the Company have caused this Agreement to be duly executed as of the date first above written.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0pt; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NEXTTRIP,
    INC.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 47%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:
    </FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    William Kerby</I></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">William
    Kerby</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>1800
    DIAGONAL LENDING LLC</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:
    </FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Kurt Cramer</I></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Kurt
    Cramer</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">President</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD>AGGREGATE SUBSCRIPTION AMOUNT:</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 80%">Aggregate Purchase Price:</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 16%; text-align: right">132,000.00</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Original Issue Discount:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">22,440.00</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Aggregate Principal Amount of Note:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">154,440.00</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 26; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.30
<SEQUENCE>13
<FILENAME>ex10-30.htm
<DESCRIPTION>EX-10.30
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt"><B>Exhibit 10.30</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-indent: 0pt; font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECURITIES
PURCHASE AGREEMENT</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
<B>SECURITIES PURCHASE AGREEMENT </B>(the &ldquo;Agreement&rdquo;), dated as of November 8, 2024, by and between <B>NEXTTRIP, INC.</B>,
a Nevada corporation, with its address at 3900 Paseo del Sol, Santa Fe, NM 87507 (the &ldquo;Company&rdquo;), and <B>1800 DIAGONAL LENDING
LLC</B>, a Virginia limited liability company, with its address at 1800 Diagonal Road, Suite 623, Alexandria, VA 22314 (the &ldquo;Lender&rdquo;).</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-indent: 0pt; font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHEREAS<FONT STYLE="font-weight: normal">:</FONT></FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A. The
Company and the Lender are executing and delivering this Agreement in reliance upon the exemption from securities registration afforded
by the rules and regulations as promulgated by the United States Securities and Exchange Commission (the &ldquo;SEC&rdquo;) under the
Securities Act of 1933, as amended (the &ldquo;1933 Act&rdquo;); and</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">B. Lender
desires to purchase and the Company desires to issue and sell, upon the terms and conditions set forth in this Agreement a promissory
note of the Company, in the form attached hereto as Exhibit A, in the aggregate principal amount of $125,190.00 (together with any note(s)
issued in replacement thereof or as a dividend thereon or otherwise with respect thereto in accordance with the terms thereof, the &ldquo;Note&rdquo;)
which upon default is convertible into shares of common stock, $0.001 par value per share, of the Company (the &ldquo;Common Stock&rdquo;),
upon the terms and subject to the limitations and conditions set forth in such Note with additional tranches of financing of up to $775,000.00
during the next twelve (12) months subject to further agreement by and between the Company and the Lender.</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOW
THEREFORE</B>, the Company and the Lender severally (and not jointly) hereby agree as follows:</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1. <U>Purchase
and Sale of Note.</U></FONT></P>



<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a. <U>Purchase
of Note</U>. On the Closing Date (as defined below), the Company shall issue and sell to the Lender and the Lender agrees to purchase
from the Company such principal amount of Note as is set forth immediately below the Lender&rsquo;s name on the signature pages hereto.</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b. <U>Form
of Payment</U>. On the Closing Date (as defined below), (i) the Lender shall pay the purchase price for the Note to be issued and sold
to it at the Closing (as defined below) (the &ldquo;Purchase Price&rdquo;) by wire transfer of immediately available funds to the Company,
in accordance with the Company&rsquo;s written wiring instructions, against delivery of the Note in the principal amount equal to the
Purchase Price as is set forth immediately below the Lender&rsquo;s name on the signature pages hereto, and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
the Company shall deliver such duly executed Note on behalf of the Company, to the Lender, against delivery of such Purchase Price.</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c. <U>Closing
Date</U>. Subject to the satisfaction (or written waiver) of the conditions thereto set forth in Section 6 and Section 7 below, the
date and time of the issuance and sale of the Note pursuant to this Agreement (the &ldquo;Closing Date&rdquo;) shall be 12:00 noon,
Eastern Standard Time on or about November 12, 2024, or such other mutually agreed upon time. The closing of the transactions
contemplated by this Agreement (the &ldquo;Closing&rdquo;) shall occur on the Closing Date at such location as may be agreed to by
the parties.</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2. <U>Lender&rsquo;s
Representations and Warranties.</U> The Lender represents and warrants to the Company that:</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a. <U>Investment
Purpose</U>. As of the date hereof, the Lender is purchasing the Note and the shares of Common Stock issuable upon conversion of or otherwise
pursuant to the Note (such shares of Common Stock being collectively referred to herein as the &ldquo;Conversion Shares&rdquo; and, collectively
with the Note, the &ldquo;Securities&rdquo;) for its own account and not with a present view towards the public sale or distribution
thereof, except pursuant to sales registered or exempted from registration under the 1933 Act.</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b. <U>Accredited
Investor Status</U>. The Lender is an &ldquo;accredited investor&rdquo; as that term is defined in Rule 501(a) of Regulation D (an &ldquo;Accredited
Investor&rdquo;).</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c. <U>Reliance
on Exemptions</U>. The Lender understands that the Securities are being offered and sold to it in reliance upon specific exemptions from
the registration requirements of United States federal and state securities laws and that the Company is relying upon the truth and accuracy
of, and the Lender&rsquo;s compliance with, the representations, warranties, agreements, acknowledgments and understandings of the Lender
set forth herein in order to determine the availability of such exemptions and the eligibility of the Lender to acquire the Securities.</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d. <U>Information</U>.
The Company has not disclosed to the Lender any material nonpublic information and will not disclose such information unless such information
is disclosed to the public prior to or promptly following such disclosure to the Lender.</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e. <U>Legends</U>.
The Lender understands that the Note and, until such time as the Conversion Shares have been registered under the 1933 Act; or may be
sold pursuant to an applicable exemption from registration, the Conversion Shares may bear a restrictive legend in substantially the
following form:</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1in; text-indent: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;THE
SECURITIES REPRESENTED BY THIS INSTRUMENT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE
&ldquo;SECURITIES ACT&rdquo;), OR UNDER ANY STATE SECURITIES LAWS, AND MAY NOT BE PLEDGED, SOLD, ASSIGNED, HYPOTHECATED OR OTHERWISE
TRANSFERRED UNLESS (1) A REGISTRATION STATEMENT WITH RESPECT THERETO IS EFFECTIVE UNDER THE SECURITIES ACT AND ANY APPLICABLE STATE
SECURITIES LAWS OR (2) THE ISSUER OF SUCH SECURITIES RECEIVES AN OPINION OF COUNSEL TO THE HOLDER OF SUCH SECURITIES, WHICH COUNSEL
AND OPINION ARE REASONABLY ACCEPTABLE TO THE ISSUER&rsquo;S TRANSFER AGENT, THAT SUCH SECURITIES MAY BE PLEDGED, SOLD, ASSIGNED,
HYPOTHECATED OR OTHERWISE TRANSFERRED WITHOUT AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT AND APPLICABLE STATE
SECURITIES LAWS.&rdquo;</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
legend set forth above shall be removed and the Company shall issue a certificate without such legend to the holder of any Security upon
which it is stamped, if, unless otherwise required by applicable state securities laws, (a) such Security is registered for sale under
an effective registration statement filed under the 1933 Act or otherwise may be sold pursuant to an exemption from registration without
any restriction as to the number of securities as of a particular date that can then be immediately sold, or (b) such holder provides
the Company with an opinion of counsel, in form, substance and scope customary for opinions of counsel in comparable transactions, to
the effect that a public sale or transfer of such Security may be made without registration under the 1933 Act, which opinion shall be
accepted by the Company so that the sale or transfer is effected. The Lender agrees to sell all Securities, including those represented
by a certificate(s) from which the legend has been removed, in compliance with applicable prospectus delivery requirements, if any. In
the event that the Company does not accept the opinion of counsel provided by the Lender with respect to the transfer of Securities pursuant
to an exemption from registration, such as Rule 144, at the Deadline, it will be considered an Event of Default pursuant to Section 3.2
of the Note.</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f. <U>Authorization;
Enforcement</U>. This Agreement has been duly and validly authorized. This Agreement has been duly executed and delivered on behalf of
the Lender, and this Agreement constitutes a valid and binding agreement of the Lender enforceable in accordance with its terms.</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3. <U>Representations
and Warranties of the Company</U>. The Company represents and warrants to the Lender that:</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a. <U>Organization
and Qualification</U>. The Company and each of its Subsidiaries (as defined below), if any, is a corporation duly organized, validly
existing and in good standing under the laws of the jurisdiction in which it is incorporated, with full power and authority (corporate
and other) to own, lease, use and operate its properties and to carry on its business as and where now owned, leased, used, operated
and conducted. &ldquo;Subsidiaries&rdquo; means any corporation or other organization, whether incorporated or unincorporated, in which
the Company owns, directly or indirectly, any equity or other ownership interest.</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b. <U>Authorization;
Enforcement</U>. (i) The Company has all requisite corporate power and authority to enter into and perform this Agreement, the Note
and to consummate the transactions contemplated hereby and thereby and to issue the Securities, in accordance with the terms hereof
and thereof, (ii) the execution and delivery of this Agreement, the Note by the Company and the consummation by it of the
transactions contemplated hereby and thereby (including without limitation, the issuance of the Note and the issuance and
reservation for issuance of the Conversion Shares issuable upon conversion or exercise thereof) have been duly authorized by the
Company&rsquo;s Board of Directors and no further consent or authorization of the Company, its Board of Directors, or its
shareholders is required, </FONT>(iii) this Agreement has been duly executed and delivered by the Company by its authorized
representative, and such authorized representative is the true and official representative with authority to sign this Agreement and
the other documents executed in connection herewith and bind the Company accordingly, and (iv) this Agreement constitutes, and upon
execution and delivery by the Company of the Note, each of such instruments will constitute, a legal, valid and binding obligation
of the Company enforceable against the Company in accordance with its terms.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.75in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.75in"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.75in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c. <U>Capitalization</U>.
As of the date hereof, the authorized common stock of the Company consists of 250,000,000 authorized shares of Common Stock, $0.001 par
value per share, of which 1,421,427 shares are issued and outstanding. All of such outstanding shares of capital stock are, or upon issuance
will be, duly authorized, validly issued, fully paid and non-assessable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d. <U>Issuance
of Shares</U>. The Conversion Shares are duly authorized and reserved for issuance and, upon conversion of the Note in accordance with
its respective terms, will be validly issued, fully paid and non-assessable, and free from all taxes, liens, claims and encumbrances
with respect to the issue thereof and shall not be subject to preemptive rights or other similar rights of shareholders of the Company
and will not impose personal liability upon the holder thereof.</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e. <U>No
Conflicts</U>. The execution, delivery and performance of this Agreement, the Note by the Company and the consummation by the Company
of the transactions contemplated hereby and thereby (including, without limitation, the issuance and reservation for issuance of the
Conversion Shares) will not (i) conflict with or result in a violation of any provision of the Certificate of Incorporation or By-laws,
or (ii) violate or conflict with, or result in a breach of any provision of, or constitute a default (or an event which with notice or
lapse of time or both could become a default) under, or give to others any rights of termination, amendment, acceleration or cancellation
of, any agreement, indenture, patent, patent license or instrument to which the Company or any of its Subsidiaries is a party, or (iii)
result in a violation of any law, rule, regulation, order, judgment or decree (including federal and state securities laws and regulations
and regulations of any self-regulatory organizations to which the Company or its securities are subject) applicable to the Company or
any of its Subsidiaries or by which any property or asset of the Company or any of its Subsidiaries is bound or affected (except for
such conflicts, defaults, terminations, amendments, accelerations, cancellations and violations as would not, individually or in the
aggregate, have a Material Adverse Effect). The businesses of the Company and its Subsidiaries, if any, are not being conducted, and
shall not be conducted so long as the Lender owns any of the Securities, in violation of any law, ordinance or regulation of any governmental
entity. &ldquo;Material Adverse Effect&rdquo; means any material adverse effect on the business, operations, assets, financial condition
or prospects of the Company or its Subsidiaries, if any, taken as a whole, or on the transactions contemplated hereby or by the agreements
or instruments to be entered into in connection herewith.</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f. <U>SEC
Documents: Financial Statements</U>. The Company has filed all reports, schedules, forms, statements and other documents required to
be filed by it with the SEC pursuant to the reporting requirements of the Securities Exchange Act of 1934, as amended (the
&ldquo;1934 Act&rdquo;) (all of the foregoing filed prior to the date hereof and all exhibits included therein and financial
statements and schedules thereto and documents (other than exhibits to such documents) incorporated by reference therein, being
hereinafter referred to herein as the &ldquo;SEC Documents&rdquo;). The Company is subject to the filings requirements of the 1934
Act pursuant to Section 12 of the 1934 Act. Upon written request the Company will deliver to the Lender true and complete copies of
the SEC Documents, except for such exhibits and incorporated documents. As of their respective dates or if amended, as of the dates
of the amendments, the SEC Documents complied in all material respects with the requirements of the 1934 Act and the rules and
regulations of the SEC promulgated thereunder applicable to the SEC Documents, and none of the SEC Documents, at the time they were
filed with the SEC, contained any untrue statement of a material fact or omitted to state a material fact required to be stated
therein or necessary in order to make the statements therein, in light of the circumstances under which they were made, not
misleading. None of the statements made in any such SEC Documents is, or has been, required to be amended or updated under
applicable law (except for such statements as have been amended or updated in subsequent filings prior the date hereof). As of their
respective dates or if amended, as of the dates of the amendments, the financial statements of the Company included in the SEC
Documents complied as to form in all material respects with applicable accounting requirements and the published rules and
regulations of the SEC with respect thereto. Such financial statements have been prepared in accordance with United States generally
accepted accounting principles, consistently applied, during the periods involved and fairly present in all material respects the
consolidated financial position of the Company and its consolidated Subsidiaries as of the dates thereof and the consolidated
results of their operations and cash flows for the periods then ended (subject, in the case of unaudited statements, to normal
year-end audit adjustments). The Company is subject to the reporting requirements of the 1934 Act.</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">g. <U>Absence
of Certain Changes</U>. Since August 31, 2024, except as set forth in the SEC Documents, there has been no material adverse change and
no material adverse development in the assets, liabilities, business, properties, operations, financial condition, results of operations,
prospects or 1934 Act reporting status of the Company or any of its Subsidiaries.</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">h. <U>Absence
of Litigation</U>. Except as set forth in the SEC Documents, there is no action, suit, claim, proceeding, inquiry or investigation before
or by any court, public board, government agency, self-regulatory organization or body pending or, to the knowledge of the Company or
any of its Subsidiaries, threatened against or affecting the Company or any of its Subsidiaries, or their officers or directors in their
capacity as such, that could have a Material Adverse Effect. The Company and its Subsidiaries are unaware of any facts or circumstances
which might give rise to any of the foregoing.</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i. <U>No
Integrated Offering</U>. Neither the Company, nor any of its affiliates, nor any person acting on its or their behalf, has directly or
indirectly made any offers or sales in any security or solicited any offers to buy any security under circumstances that would require
registration under the 1933 Act of the issuance of the Securities to the Lender. The issuance of the Securities to the Lender will not
be integrated with any other issuance of the Company&rsquo;s securities (past, current or future) for purposes of any shareholder approval
provisions applicable to the Company or its securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.75in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">j. <U>No
Brokers</U>. Except for Enclave Capital, the Company has taken no action which would give rise to any claim by any person for brokerage
commissions, transaction fees or similar payments relating to this Agreement or the transactions contemplated hereby.</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">k. <U>No
Investment Company</U>. The Company is not, and upon the issuance and sale of the Securities as contemplated by this Agreement will not
be an &ldquo;investment company&rdquo; required to be registered under the Investment Company Act of 1940 (an &ldquo;Investment Company&rdquo;).
The Company is not controlled by an Investment Company.</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">l. <U>Breach
of Representations and Warranties by the Company</U>. If the Company breaches any of the representations or warranties set forth in this
Section 3, and in addition to any other remedies available to the Lender pursuant to this Agreement, it will be considered an Event of
default under Section 3.4 of the Note.</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4. <U>COVENANTS</U>.</FONT></P>



<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a. <U>Best
Efforts</U>. The Company shall use its best efforts to satisfy timely each of the conditions described in Section 7 of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b. <U>Form
D; Blue Sky Laws</U>. The Company agrees to timely make any filings required by federal and state laws as a result of the closing of
the transactions contemplated by this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c. <U>Use
of Proceeds</U>. The Company shall use the proceeds for general working capital purposes.</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d. <U>Expenses</U>.
At the Closing, the Company&rsquo;s obligation with respect to the transactions contemplated by this Agreement is to reimburse Lender&rsquo;
expenses shall be $15,000.00 for Lender&rsquo;s legal fees and due diligence fee.</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e. <U>Corporate
Existence</U>. So long as the Lender beneficially owns any Note, the Company shall maintain its corporate existence and shall not sell
all or substantially all of the Company&rsquo;s assets, except with the prior written consent of the Lender.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f. <U>Breach
of Covenants</U>. If the Company breaches any of the covenants set forth in this Section 4, and in addition to any other remedies available
to the Lender pursuant to this Agreement, it will be considered an event of default under Section 3.4 of the Note.</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">g. <U>Failure
to Comply with the 1934 Act</U>. So long as the Lender beneficially owns the Note, the Company shall comply with the reporting requirements
of the 1934 Act; and the Company shall continue to be subject to the reporting requirements of the 1934 Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">h. <U>Trading
Activities</U>. Neither the Lender nor its affiliates has an open short position in the common stock of the Company and the Lender agrees
that it shall not, and that it will cause its affiliates not to, engage in any short sales of or hedging transactions with respect to
the common stock of the Company.</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i. <U>The
Lender is Not a &ldquo;Dealer&rdquo;</U>. The Lender and the Company hereby acknowledge and agree that the Lender has not: (i) acted
as an underwriter; (ii) acted as a market maker or specialist; (iii) acted as &ldquo;de facto&rdquo; market maker; or (iv) conducted
any other professional market activities such as providing investment advice, extending credit and lending securities in connection;
and thus that the Lender is not a &ldquo;Dealer&rdquo; as such term is defined in the 1934 Act.</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5. <U>Transfer
Agent Instructions</U>. The Company shall issue irrevocable instructions to its transfer agent to issue certificates, registered in
the name of the Lender or its nominee, for the Conversion Shares in such amounts as specified from time to time by the Lender to the
Company upon conversion of the Note in accordance with the terms thereof (the &ldquo;Irrevocable Transfer Agent
Instructions&rdquo;). In the event that the Company proposes to replace its transfer agent, the Company shall provide, prior to the
effective date of such replacement, a fully executed Irrevocable Transfer Agent Instructions in a form as initially delivered
pursuant to this Agreement (including but not limited to the provision to irrevocably reserve shares of Common Stock in the Reserved
Amount as such term is defined in the Note) signed by the successor transfer agent to Company and the Company. Prior to registration
of the Conversion Shares under the 1933 Act or the date on which the Conversion Shares may be sold pursuant to an exemption from
registration, all such certificates shall bear the restrictive legend specified in Section 2(e) of this Agreement. The Company
warrants that: (i) no instruction other than the Irrevocable Transfer Agent Instructions referred to in this Section 5, will be
given by the Company to its transfer agent and that the Securities shall otherwise be freely transferable on the books and records
of the Company as and to the extent provided in this Agreement and the Note; (ii) it will not direct its transfer agent not to
transfer or delay, impair, and/or hinder its transfer agent in transferring (or issuing)(electronically or in certificated form) any
certificate for Conversion Shares to be issued to the Lender upon conversion of or otherwise pursuant to the Note as and when
required by the Note and this Agreement; and (iii) it will not fail to remove (or directs its transfer agent not to remove or
impairs, delays, and/or hinders its transfer agent from removing) any restrictive legend (or to withdraw any stop transfer
instructions in respect thereof) on any certificate for any Conversion Shares issued to the Lender upon conversion of or otherwise
pursuant to the Note as and when required by the Note and/or this Agreement. If the Lender provides the Company and the
Company&rsquo;s transfer agent, at the cost of the Lender, with an opinion of counsel in form, substance and scope customary for
opinions in comparable transactions, to the effect that a public sale or transfer of such Securities may be made without
registration under the 1933 Act, the Company shall permit the transfer, and, in the case of the Conversion Shares, promptly instruct
its transfer agent to issue one or more certificates, free from restrictive legend, in such name and in such denominations as
specified by the Lender. The Company acknowledges that a breach by it of its obligations hereunder will cause irreparable harm to
the Lender, by vitiating the intent and purpose of the transactions contemplated hereby. Accordingly, the Company acknowledges that
the remedy at law for a breach of its obligations under this Section 5 may be inadequate and agrees, in the event of a breach or
threatened breach by the Company of the provisions of this Section, that the Lender shall be entitled, in addition to all other
available remedies, to an injunction restraining any breach and requiring immediate transfer, without the necessity of showing
economic loss and without any bond or other security being required.</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6. <U>Conditions
to the Company&rsquo;s Obligation to Sell</U>. The obligation of the Company hereunder to issue and sell the Note to the Lender at the
Closing is subject to the satisfaction, at or before the Closing Date of each of the following conditions thereto, provided that these
conditions are for the Company&rsquo;s sole benefit and may be waived by the Company at any time in its sole discretion:</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a.
The Lender shall have executed this Agreement and delivered the same</FONT> to the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.75in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b.
The Lender shall have delivered the Purchase Price in accordance with</FONT> Section 1(b) above.</P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c. The
Lender shall have delivered a subordination agreement in a form acceptable to the Lender, the Company and the Company&rsquo;s primary
lender.</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d. The
representations and warranties of the Lender shall be true and correct in all material respects as of the date when made and as of the
Closing Date as though made at that time (except for representations and warranties that speak as of a specific date), and the Lender
shall have performed, satisfied and complied in all material respects with the covenants, agreements and conditions required by this
Agreement to be performed, satisfied or complied with by the Lender at or prior to the Closing Date.</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e. No
litigation, statute, rule, regulation, executive order, decree, ruling or injunction shall have been enacted, entered, promulgated or
endorsed by or in any court or governmental authority of competent jurisdiction or any self-regulatory organization having authority
over the matters contemplated hereby which prohibits the consummation of any of the transactions contemplated by this Agreement.</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7. <U>Conditions
to The Lender&rsquo;s Obligation to Purchase</U>. The obligation of the Lender hereunder to purchase the Note at the Closing is subject
to the satisfaction, at or before the Closing Date of each of the following conditions, provided that these conditions are for the Lender&rsquo;s
sole benefit and may be waived by the Lender at any time in its sole discretion:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a.
The Company shall have executed this Agreement and delivered the</FONT> same to the Lender.</P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b. The
Company shall have delivered to the Lender the duly executed Note (in such denominations as the Lender shall request) in accordance with
Section 1(b) above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c. The
Irrevocable Transfer Agent Instructions, in form and substance satisfactory to the Lender, shall have been delivered to and acknowledged
in writing by the Company&rsquo;s Transfer Agent.</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d. The
representations and warranties of the Company shall be true and correct in all material respects as of the date when made and as of the
Closing Date as though made at such time (except for representations and warranties that speak as of a specific date) and the Company
shall have performed, satisfied and complied in all material respects with the covenants, agreements and conditions required by this
Agreement to be performed, satisfied or complied with by the Company at or prior to the Closing Date. The Lender shall have received
a certificate or certificates, executed by the chief executive officer of the Company, dated as of the Closing Date, to the foregoing
effect and as to such other matters as may be reasonably requested by the Lender including, but not limited to certificates with respect
to the Board of Directors&rsquo; resolutions relating to the transactions contemplated hereby.</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e. No
litigation, statute, rule, regulation, executive order, decree, ruling or injunction shall have been enacted, entered, promulgated or
endorsed by or in any court or governmental authority of competent jurisdiction or any self-regulatory organization having authority
over the matters contemplated hereby which prohibits the consummation of any of the transactions contemplated by this Agreement.</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f. No
event shall have occurred which could reasonably be expected to have a Material Adverse Effect on the Company including but not limited
to a change in the 1934 Act reporting status of the Company or the failure of the Company to be timely in its 1934 Act reporting obligations.</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.25in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Governing Law; Miscellaneous</U>.</FONT></P>



<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a. <U>Governing
Law</U>. This Agreement shall be governed by and construed in accordance with the laws of the Commonwealth of Virginia without regard
to principles of conflicts of laws. Any action brought by either party against the other concerning the transactions contemplated by
this Agreement shall be brought only in the Circuit Court of Fairfax County, Virginia or in the Alexandria Division of the United States
District Court for the Eastern District of Virginia. The parties to this Agreement hereby irrevocably waive any objection to jurisdiction
and venue of any action instituted hereunder and shall not assert any objection or defense based on lack of jurisdiction or venue or
based upon <I>forum non conveniens</I>. The Company and Lender waive trial by jury. The Lender shall be entitled to recover from the
Company its reasonable attorney&rsquo;s fees and costs incurred in connection with or related to any Event of Default by the Company,
as defined in Article III of the Note. Each party hereby irrevocably waives personal service of process and consents to process being
served in any suit, action or proceeding in connection with this Agreement, the Note or any related document or agreement by mailing
a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery) to such party at the address in effect
for notices to it under this Agreement and agrees that such service shall constitute good and sufficient service of process and notice
thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any other manner permitted by law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.75in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b. <U>Counterparts</U>.
This Agreement may be executed in one or more counterparts, each of which shall be deemed an original but all of which shall constitute
one and the same agreement and shall become effective when counterparts have been signed by each party and delivered to the other party.</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c. <U>Headings</U>.
The headings of this Agreement are for convenience of reference only and shall not form part of, or affect the interpretation of, this
Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d. <U>Severability</U>.
In the event that any provision of this Agreement is invalid or unenforceable under any applicable statute or rule of law, then such
provision shall be deemed inoperative to the extent that it may conflict therewith and shall be deemed modified to conform with such
statute or rule of law. Any provision hereof which may prove invalid or unenforceable under any law shall not affect the validity or
enforceability of any other provision hereof.</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e. <U>Entire
Agreement; Amendments</U>. This Agreement and the instruments referenced herein contain the entire understanding of the parties with
respect to the matters covered herein and therein and, except as specifically set forth herein or therein, neither the Company nor the
Lender makes any representation, warranty, covenant or undertaking with respect to such matters. No provision of this Agreement may be
waived or amended other than by an instrument in writing signed by the majority in interest of the Lender.</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f. <U>Notices</U>.
All notices, demands, requests, consents, approvals, and other communications required or permitted hereunder shall be in writing and,
unless otherwise specified herein, shall be (i) personally served, (ii) deposited in the mail, registered or certified, return receipt
requested, postage prepaid, (iii) delivered by reputable air courier service with charges prepaid, or (iv) transmitted by hand delivery,
telegram, email or facsimile, addressed as set forth below or to such other address as such party shall have specified most recently
by written notice. Any notice or other communication required or permitted to be given hereunder shall be deemed effective (a) upon hand
delivery or delivery by facsimile, with accurate confirmation generated by the transmitting facsimile machine, at the address or number
designated below (if delivered on a business day during normal business hours where such notice is to be received), or the first business
day following such delivery (if delivered other than on a business day during normal business hours where such notice is to be received)
or (b) on the second business day following the date of mailing by express courier service, fully prepaid, addressed to such address,
or upon actual receipt of such mailing, whichever shall first occur. The addresses for such communications shall be as set forth in the
heading of this Agreement with a copy by fax only to (which copy shall not constitute notice) to Naidich Wurman LLP, 111 Great Neck Road,
Suite 214, Great Neck, NY 11021, Attn: Allison Naidich, facsimile: 516-466-3555, e-mail: <U>allison@nwlaw.com</U>. Each party shall provide
notice to the other party of any change in address.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">g. <U>Successors
and Assigns</U>. This Agreement shall be binding upon and inure to the benefit of the parties and their successors and assigns.
Neither the Company nor the Lender shall assign this Agreement or any rights or obligations hereunder without the prior written
consent of the other. Notwithstanding the foregoing, the Lender may assign its rights hereunder to any person that purchases
Securities in a private transaction from the Lender or to any of its &ldquo;affiliates,&rdquo; as that term is defined under the
1934 Act, without the consent of the Company.</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">h. <U>Survival</U>.
The representations and warranties of the Company and the agreements and covenants set forth in this Agreement shall survive the closing
hereunder notwithstanding any due diligence investigation conducted by or on behalf of the Lender. The Company agrees to indemnify and
hold harmless the Lender and all their officers, directors, employees and agents for loss or damage arising as a result of or related
to any breach or alleged breach by the Company of any of its representations, warranties and covenants set forth in this Agreement or
any of its covenants and obligations under this Agreement, including advancement of expenses as they are incurred.</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i. <U>Further
Assurances</U>. Each party shall do and perform, or cause to be done and performed, all such further acts and things, and shall execute
and deliver all such other agreements, certificates, instruments and documents, as the other party may reasonably request in order to
carry out the intent and accomplish the purposes of this Agreement and the consummation of the transactions contemplated hereby.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">j. <U>No
Strict Construction</U>. The language used in this Agreement will be deemed to be the language chosen by the parties to express their
mutual intent, and no rules of strict construction will be applied against any party.</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">k. <U>Remedies</U>.
The Company acknowledges that a breach by it of its obligations hereunder will cause irreparable harm to the Lender by vitiating the
intent and purpose of the transaction contemplated hereby. Accordingly, the Company acknowledges that the remedy at law for a breach
of its obligations under this Agreement will be inadequate and agrees, in the event of a breach or threatened breach by the Company of
the provisions of this Agreement, that the Lender shall be entitled, in addition to all other available remedies at law or in equity,
and in addition to the penalties assessable herein, to an injunction or injunctions restraining, preventing or curing any breach of this
Agreement and to enforce specifically the terms and provisions hereof, without the necessity of showing economic loss and without any
bond or other security being required.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the undersigned Lender and the Company have caused this Agreement to be duly executed as of the date first above written.</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NEXTTRIP,
INC.</B></FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
                                                                                                                                      <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
                                                                                                                                      <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 47%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
                                            William Kerby</I></FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 50%"></TD></TR><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">William
                                            Kerby</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
                                <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
                                            Executive Officer</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>

<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
  <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>1800 DIAGONAL
  LENDING LLC</B></FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify">&nbsp;</TD>
  <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify; width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
  <TD STYLE="border-bottom: Black 1pt solid; text-align: justify; width: 47%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
  Curt Kramer</I></FONT></TD>
    <TD STYLE="width: 50%">&nbsp;</TD></TR>

<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Curt Kramer</FONT></TD>
    <TD>&nbsp;</TD></TR>

<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify">&nbsp;</TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">President</FONT></TD>
    <TD>&nbsp;</TD></TR>
</TABLE>


<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 80%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>AGGREGATE SUBSCRIPTION AMOUNT:</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 80%">Aggregate Purchase Price:</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 16%; text-align: right">107,000.00</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Original Issue Discount:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">18,190.00</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Aggregate Principal Amount of Note:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">125,190.00</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 12; Options: Last -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.31
<SEQUENCE>14
<FILENAME>ex10-31.htm
<DESCRIPTION>EX-10.31
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
10.31</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>THE
ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED,
OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF (A)
AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR (B) AN OPINION OF COUNSEL (WHICH
COUNSEL SHALL BE SELECTED BY THE HOLDER), IN A GENERALLY ACCEPTABLE FORM, THAT REGISTRATION IS NOT REQUIRED UNDER SAID ACT.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>THE
ISSUE PRICE OF THIS NOTE IS $125,190.00</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>THE ORIGINAL ISSUE DISCOUNT IS $18,190.00</B></FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Principal
    Amount: $125,190.00</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Issue
    Date: November 8, 2024</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Purchase
    Price: $107,000.00</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>PROMISSORY
NOTE</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>FOR
VALUE RECEIVED</B>, <B>NEXTTRIP, INC.</B>, a Nevada corporation (hereinafter called the &ldquo;Borrower&rdquo;), hereby promises to pay
to the order of <B>1800 DIAGONAL LENDING LLC</B>, a Virginia limited liability company, or registered assigns (the &ldquo;Holder&rdquo;)
the sum of $125,190.00 together with any interest as set forth herein, on September 15, 2025 (the &ldquo;Maturity Date&rdquo;), and to
pay interest on the unpaid principal balance hereof from the date hereof (the &ldquo;Issue Date&rdquo;) as set forth herein. This Note
may not be prepaid in whole or in part except as otherwise explicitly set forth herein. Any amount of principal or interest on this Note
which is not paid when due shall bear interest at the rate of twenty two percent (22%) per annum from the due date thereof until the
same is paid (&ldquo;Default Interest&rdquo;). All payments due hereunder (to the extent not converted into common stock, $0.001 par
value per share (the &ldquo;Common Stock&rdquo;) in accordance with the terms hereof) shall be made in lawful money of the United States
of America. All payments shall be made at such address as the Holder shall hereafter give to the Borrower by written notice made in accordance
with the provisions of this Note. Each capitalized term used herein, and not otherwise defined, shall have the meaning ascribed thereto
in that certain Securities Purchase Agreement dated the date hereof, pursuant to which this Note was originally issued (the &ldquo;Purchase
Agreement&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Note is free from all taxes, liens, claims and encumbrances with respect to the issue thereof and shall not be subject to preemptive
rights or other similar rights of shareholders of the Borrower and will not impose personal liability upon the holder thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following terms shall apply to this Note:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
I. GENERAL TERMS</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.1
<U>Interest</U>. A one-time interest charge of thirteen percent (13%) (the &ldquo;Interest Rate&rdquo;) shall be applied on the Issuance
Date to the Principal ($125,190.00 * thirteen percent (13%) = $16,274.00). Interest hereunder shall be paid as set forth herein to the
Holder or its assignee in whose name this Note is registered on the records of the Company regarding registration and transfers of Notes
in cash or, in the Event of Default, at the Option of the Holder, converted into share of Common Stock as set forth herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.2
<U>Mandatory Monthly Payments</U>. Accrued, unpaid interest and outstanding principal, subject to adjustment, shall be paid in five (5)
payments as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 60%; font: 10pt Times New Roman, Times, Serif; margin-left: 1in">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Payment Date</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amount
    of Payment</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">May 15, 2025</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="width: 46%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">70,732.00</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">June 15, 2025</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17,683.00</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">July 15, 2025</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17,683.00</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">August 15, 2025</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17,683.00</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">September 15, 2025</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17,683.00</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 71.95pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a
total payback to the Holder of $141464).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 71.95pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company shall have a five (5) day grace period with respect to each payment. The Company has right to prepay in full at any time with
no prepayment penalty. All payments shall be made by bank wire transfer to the Holder&rsquo;s wire instructions, attached hereto as Exhibit
A. For the avoidance of doubt, a missed payment shall be considered an Event of Default.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 71.95pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.3
<U>Prepayment Discount</U>. Notwithstanding anything to the contrary contained in this Note, at any time during the period set forth
on the table immediately following this paragraph (the &ldquo;Prepayment Period&rdquo;) or as otherwise agreed to between the Borrower
and the Holder, the Borrower shall have the right, exercisable on not more than three (3) Trading Days prior written notice to the Holder
of the Note to prepay the outstanding Note (principal and accrued interest), in full, in accordance with this Section 1.3. Any notice
of prepayment hereunder (an &ldquo;Optional Prepayment Notice&rdquo;) shall be delivered to the Holder of the Note at its registered
addresses and shall state: (1) that the Borrower is exercising its right to prepay the Note, and (2) the date of prepayment which shall
be not more than three (3) Trading Days from the date of the Optional Prepayment Notice. On the date fixed for prepayment (the &ldquo;Optional
Prepayment Date&rdquo;), the Borrower shall make payment of the Optional Prepayment Amount (as defined below) to Holder, or upon the
direction of the Holder as specified by the Holder in a writing to the Borrower (which shall direction to be sent to Borrower by the
Holder at least one (1) business day prior to the Optional Prepayment Date). If the Borrower exercises its right to prepay the Note,
the Borrower shall make payment to the Holder of an amount in cash equal to the percentage (&ldquo;Prepayment Percentage&rdquo;) as set
forth in the table immediately following this paragraph opposite the Prepayment Period, multiplied by the sum of the then outstanding
principal amount of this Note <U>plus</U> any accrued and unpaid interest on the unpaid principal amount of this Note to the Optional
Prepayment Date (the &ldquo;Optional Prepayment Amount&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prepayment
    Period</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prepayment
    Percentage</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 81%; text-align: left; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1)
    The period beginning on the Issue Date and ending on the date which is thirty (30) days following the Issue Date.</FONT></TD><TD STYLE="width: 2%; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1pt; width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">96</FONT></TD><TD STYLE="width: 1%; padding-bottom: 1pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2)
    The period beginning on date which is thirty-one (31) days following the Issue Date and ending on the date which is sixty (60) days
    following the Issue Date.</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">97</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3)
    The period beginning on date which is sixty-one (61) days following the Issue Date and ending on the date which is one hundred twenty
    (120) days following the Issue Date.</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">98</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4)
    The period beginning on date which is one hundred twenty-one (121) days following the Issue Date and ending on the date which
is one hundred eighty (180) days following the Issue Date.</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">99</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
II. CERTAIN COVENANTS</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1
<U>Sale of Assets</U>. So long as the Borrower shall have any obligation under this Note, the Borrower shall not, without the Holder&rsquo;s
written consent, sell, lease or otherwise dispose of any significant portion of its assets outside the ordinary course of business. Any
consent to the disposition of any assets may be conditioned on a specified use of the proceeds of disposition.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
III. EVENTS OF DEFAULT</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
any of the following events of default (each, an &ldquo;Event of Default&rdquo;) shall occur:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1
<U>Failure to Pay Principal and Interest</U>. The Borrower fails to pay the principal hereof or interest thereon when due on this Note,
whether at maturity, upon acceleration or otherwise and such breach continues for a period of five (5) days after written notice from
the Holder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2
<U>Conversion and the Shares</U>. The Borrower fails to issue shares of Common Stock to the Holder (or announces or threatens in writing
that it will not honor its obligation to do so) upon exercise by the Holder of the conversion rights of the Holder in accordance with
the terms of this Note (following an Event of Default other than this Section 3.2), fails to transfer or cause its transfer agent to
transfer (issue) (electronically or in certificated form) any certificate for shares of Common Stock issued to the Holder upon conversion
of or otherwise pursuant to this Note as and when required by this Note, the Borrower directs its transfer agent not to transfer or delays,
impairs, and/or hinders its transfer agent in transferring (or issuing) (electronically or in certificated form) any certificate for
shares of Common Stock to be issued to the Holder upon conversion of or otherwise pursuant to this Note as and when required by this
Note, or fails to remove (or directs its transfer agent not to remove or impairs, delays, and/or hinders its transfer agent from removing)
any restrictive legend (or to withdraw any stop transfer instructions in respect thereof) on any certificate for any shares of Common
Stock issued to the Holder upon conversion of or otherwise pursuant to this Note as and when required by this Note (or makes any written
announcement, statement or threat that it does not intend to honor the obligations described in this paragraph) and any such failure
shall continue uncured (or any written announcement, statement or threat not to honor its obligations shall not be rescinded in writing)
for three (3) business days after the Holder shall have delivered a Notice of Conversion. It is an obligation of the Borrower to remain
current in its obligations to its transfer agent. It shall be an event of default of this Note, if a conversion of this Note is delayed,
hindered or frustrated due to a balance owed by the Borrower to its transfer agent. If at the option of the Holder, the Holder advances
any funds to the Borrower&rsquo;s transfer agent in order to process a conversion, such advanced funds shall be paid by the Borrower
to the Holder within forty-eight (48) hours of a demand from the Holder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.3
<U>Breach of Covenants</U>. The Borrower breaches any material covenant or other material term or condition contained in this Note and
any collateral documents including but not limited to the Purchase Agreement and such breach continues for a period of twenty (20) days
after written notice thereof to the Borrower from the Holder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.4
<U>Breach of Representations and Warranties</U>. Any representation or warranty of the Borrower made herein or in any agreement, statement
or certificate given in writing pursuant hereto or in connection herewith (including, without limitation, the Purchase Agreement), shall
be false or misleading in any material respect when made and the breach of which has (or with the passage of time will have) a material
adverse effect on the rights of the Holder with respect to this Note or the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.5
<U>Receiver or Trustee</U>. The Borrower or any subsidiary of the Borrower shall make an assignment for the benefit of creditors, or
apply for or consent to the appointment of a receiver or trustee for it or for a substantial part of its property or business, or such
a receiver or trustee shall otherwise be appointed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.6
<U>Bankruptcy</U>. Bankruptcy, insolvency, reorganization or liquidation proceedings or other proceedings, voluntary or involuntary,
for relief under any bankruptcy law or any law for the relief of debtors shall be instituted by or against the Borrower or any subsidiary
of the Borrower.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.7
<U>Delisting of Common Stock</U>. The Borrower shall fail to maintain the listing of the Common Stock on the Nasdaq National Market,
the Nasdaq SmallCap Market, the New York Stock Exchange, or the NYSE American Stock Exchange (collectively, the &ldquo;Exchanges&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.8
<U>Failure to Comply with the Exchange Act</U>. The Borrower shall fail to comply with the reporting requirements of the Exchange Act;
and/or the Borrower shall cease to be subject to the reporting requirements of the Exchange Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.9
<U>Liquidation</U>. Any dissolution, liquidation, or winding up of Borrower or any substantial portion of its business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.10
<U>Cessation of Operations</U>. Any cessation of operations by Borrower or Borrower admits it is otherwise generally unable to pay its
debts as such debts become due, provided, however, that any disclosure of the Borrower&rsquo;s ability to continue as a &ldquo;going
concern&rdquo; shall not be an admission that the Borrower cannot pay its debts as they become due.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.11
<U>Financial Statement Restatement</U>.&#9;The restatement of any financial statements filed by the Borrower with the SEC at any time
after 180 days after the Issuance Date for any date or period until this Note is no longer outstanding, if the result of such restatement
would, by comparison to the un-restated financial statement, have constituted a material adverse effect on the rights of the Holder with
respect to this Note or the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.12
<U>Replacement of Transfer Agent</U>. In the event that the Borrower proposes to replace its transfer agent, the Borrower fails to provide,
prior to the effective date of such replacement, a fully executed Irrevocable Transfer Agent Instructions in a form as initially delivered
pursuant to the Purchase Agreement (including but not limited to the provision to irrevocably reserve shares of Common Stock in the Reserved
Amount) signed by the successor transfer agent to Borrower and the Borrower.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.13
<U>Cross-Default</U>. Notwithstanding anything to the contrary contained in this Note or the other related or companion documents, a
breach or default by the Borrower of any covenant or other term or condition contained in any of the Other Agreements, after the passage
of all applicable notice and cure or grace periods, shall, at the option of the Holder, be considered a default under this Note and the
Other Agreements, in which event the Holder shall be entitled (but in no event required) to apply all rights and remedies of the Holder
under the terms of this Note and the Other Agreements by reason of a default under said Other Agreement or hereunder. &ldquo;Other Agreements&rdquo;
means, collectively, all agreements and instruments between, among or by: (1) the Borrower, and, or for the benefit of, (2) the Holder
and any affiliate of the Holder, including, without limitation, promissory notes; provided, however, the term &ldquo;Other Agreements&rdquo;
shall not include the related or companion documents to this Note. Each of the loan transactions will be cross-defaulted with each other
loan transaction and with all other existing and future debt of Borrower to the Holder. .</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
the occurrence and during the continuation of any Event of Default, the Note shall become immediately due and payable and the Borrower
shall pay to the Holder, in full satisfaction of its obligations hereunder, an amount equal to 200% (&ldquo;Default Percentage&rdquo;)
<U>times</U> the <U>sum</U> of (w) the then outstanding principal amount of this Note <U>plus</U> (x) accrued and unpaid interest on
the unpaid principal amount of this Note to the date of payment <U>plus</U> (y) Default Interest, if any, on the amounts referred to
in clauses (w) and/or (x) <U>plus</U> (z) any amounts owed to the Holder pursuant to Article IV hereof (the then outstanding principal
amount of this Note to the date of payment <U>plus</U> the amounts referred to in clauses (x), (y) and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(z)
shall collectively be known as the &ldquo;Default Amount&rdquo;) and all other amounts payable hereunder shall immediately become due
and payable, all without demand, presentment or notice, all of which hereby are expressly waived, together with all costs, including,
without limitation, legal fees and expenses, of collection, and the Holder shall be entitled to exercise all other rights and remedies
available at law or in equity. Notwithstanding anything to the contrary contained herein, in the event that following an Event of Default
(other than Section 3.2), a default pursuant to Section 3.2 occurs, the Default Percentage shall be immediately adjusted to 225%.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the Borrower fails to pay the Default Amount within five (5) business days of written notice that such amount is due and payable, then
the Holder shall have the right at any time, to convert the balance owed pursuant to the note including the Default Amount into shares
of common stock of the Company as set forth herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
IV. CONVERSION RIGHTS</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1
<U>Conversion Right</U>. After the occurrence of an Event of Default, at any time, the Holder shall have the right, to convert all or
any part of the outstanding and unpaid amount of this Note into fully paid and non-assessable shares of Common Stock, as such Common
Stock exists on the Issue Date, or any shares of capital stock or other securities of the Borrower into which such Common Stock shall
hereafter be changed or reclassified at the conversion price determined as provided herein (a &ldquo;Conversion&rdquo;); <U>provided</U>,
<U>however</U>, that in no event shall the Holder be entitled to convert any portion of this Note in excess of that portion of this Note
upon conversion of which the sum of (1) the number of shares of Common Stock beneficially owned by the Holder and its affiliates (other
than shares of Common Stock which may be deemed beneficially owned through the ownership of the unconverted portion of the Notes or the
unexercised or unconverted portion of any other security of the Borrower subject to a limitation on conversion or exercise analogous
to the limitations contained herein) and (2) the number of shares of Common Stock issuable upon the conversion of the portion of this
Note with respect to which the determination of this proviso is being made, would result in beneficial ownership by the Holder and its
affiliates of more than 4.99% of the outstanding shares of Common Stock. For purposes of the proviso to the immediately preceding sentence,
beneficial ownership shall be determined in accordance with Section 13(d) of the Securities Exchange Act of 1934, as amended (the &ldquo;Exchange
Act&rdquo;), and Regulations 13D-G thereunder, except as otherwise provided in clause (1) of such proviso. <U>The beneficial ownership
limitations on conversion as set forth in the section may NOT be waived by the Holder</U>. The number of shares of Common Stock to be
issued upon each conversion of this Note shall be determined by dividing the Conversion Amount (as defined below) by the applicable Conversion
Price then in effect on the date specified in the notice of conversion, in the form attached hereto as Exhibit B(the &ldquo;Notice of
Conversion&rdquo;), delivered to the Borrower by the Holder in accordance with Section 4.4 below; provided that the Notice of Conversion
is submitted by facsimile or e-mail (or by other means resulting in, or reasonably expected to result in, notice) to the Borrower before
6:00 p.m., New York, New York time on such conversion date (the &ldquo;Conversion Date&rdquo;); however, if the Notice of Conversion
is sent after 6:00pm, New York, New York time the Conversion Date shall be the next business day. The term &ldquo;Conversion Amount&rdquo;
means, with respect to any conversion of this Note, the sum of (1) the principal amount of this Note to be converted in such conversion
<U>plus</U> (2) at the Holder&rsquo;s option, accrued and unpaid interest, if any, on such principal amount at the interest rates provided
in this Note to the Conversion Date, <U>plus</U> (3) at the Holder&rsquo;s option, Default Interest, if any, on the amounts referred
to in the immediately preceding clauses (1) and/or (2) <U>plus</U> (4) at the Holder&rsquo;s option, any amounts owed to the Holder pursuant
to Sections 4.4 hereof. Notwithstanding anything in this Agreement to the contrary, and in addition to the limitations set forth herein,
if the Borrower has not obtained Stockholder Approval, the Borrower shall not issue a number of shares of Common Stock under this Agreement,
which when aggregated with all other securities that are required to be aggregated for purposes of Rule 5635(d), would exceed 19.99%
of the shares of Common Stock outstanding as of the date of definitive agreement with respect to the first of such aggregated transactions
(the &ldquo;Conversion Limitation&rdquo;). For purposes of this section, &ldquo;Stockholder Approval&rdquo; means such approval as may
be required by the applicable rules and regulations of the Nasdaq Stock Market LLC (or any successor entity) from the stockholders of
the Company with respect to the issuance of the shares under this Agreement that, when taken together with any other securities that
are required to be aggregated with the issuance of the shares issued under this Agreement for purposes of Rule 5635(d) of the Nasdaq
Stock Market LLC (&ldquo;Rule 5635(d)&rdquo;), would exceed 19.99% of the issued and outstanding common stock as of the date of definitive
agreement with respect to the first of such aggregated transactions. &ldquo;Principal Market&rdquo; means the Exchanges, the quotation
platforms maintained by the OTC Markets Group) or an equivalent replacement exchange, and all rules and regulations relating to such
exchange. Upon the occurrence of an Event of Default pursuant to Section 3.7 hereof, the Conversion Limitation shall no longer apply
to limit the issuance of shares in conversion of this Note.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Holder shall be entitled to deduct $1,500.00 from the conversion amount in each Notice of Conversion to cover Holder&rsquo;s deposit
fees associated with each Notice of Conversion. Any additional expenses incurred by Holder with respect to the Borrower&rsquo;s transfer
agent, for the issuance of the Common Stock into which this Note is convertible into, shall immediately and automatically be added to
the balance of the Note at such time as the expenses are incurred by Holder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2 <U>Conversion
Price</U>. The conversion price (the &ldquo;Conversion Price&rdquo;) shall mean $3.02 (subject to equitable adjustments by the
Borrower relating to the Borrower&rsquo;s securities or the securities of any subsidiary of the Borrower, combinations,
recapitalization, reclassifications, extraordinary distributions and similar events).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3
<U>Authorized Shares</U>. The Borrower covenants that during the period that the Note is outstanding, the Borrower will reserve from
its authorized and unissued Common Stock a sufficient number of shares, free from preemptive rights, to provide for the issuance of Common
Stock upon the full conversion of this Note issued pursuant to the Purchase Agreement. The Borrower is required at all times to have
authorized and reserved four times the number of shares that is actually issuable upon full conversion of the Note (based on the Conversion
Price of the Note in effect from time to time initially 165,815 shares) (the &ldquo;Reserved Amount&rdquo;). The Reserved Amount shall
be adjusted from time to time in accordance with the Borrower&rsquo;s obligations hereunder and the reduction of the balance due to timely
payments. The Borrower represents that upon issuance, such shares will be duly and validly issued, fully paid and non-assessable. In
addition, if the Borrower shall issue any securities or make any change to its capital structure which would change the number of shares
of Common Stock into which the Notes shall be convertible at the then current Conversion Price, the Borrower shall at the same time make
proper provision so that thereafter there shall be a sufficient number of shares of Common Stock authorized and reserved, free from preemptive
rights, for conversion of the outstanding Note. The Borrower (i) acknowledges that it has irrevocably instructed its transfer agent to
issue certificates for the Common Stock issuable upon conversion of this Note, and (ii) agrees that its issuance of this Note shall constitute
full authority to its officers and agents who are charged with the duty of executing stock certificates to execute and issue the necessary
certificates for shares of Common Stock in accordance with the terms and conditions of this Note.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 71.95pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If,
at any time the Borrower does not maintain the Reserved Amount it will be considered an Event of Default under this Note.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 71.95pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.4</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Method of Conversion</U>.</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: -35.95pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Mechanics of Conversion</U>. As set forth in Section 4.1 hereof, at any time following an Event of Default, the balance due pursuant
to this Note may be converted by the Holder in whole or in part at any time from time to time after the Issue Date, by (A) submitting
to the Borrower a Notice of Conversion (by facsimile, e-mail or other reasonable means of communication dispatched on the Conversion
Date prior to 6:00 p.m., New York, New York time) and (B) subject to Section 4.4(b), surrendering this Note at the principal office of
the Borrower (upon payment in full of any amounts owed hereunder).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Surrender of Note Upon Conversion</U>. Notwithstanding anything to the contrary set forth herein, upon conversion of this Note in
accordance with the terms hereof, the Holder shall not be required to physically surrender this Note to the Borrower unless the entire
unpaid principal amount of this Note is so converted. The Holder and the Borrower shall maintain records showing the principal amount
so converted and the dates of such conversions or shall use such other method, reasonably satisfactory to the Holder and the Borrower,
so as not to require physical surrender of this Note upon each such conversion.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Delivery of Common Stock Upon Conversion</U>. Upon receipt by the Borrower from the Holder of a facsimile transmission or e-mail (or
other reasonable means of communication) of a Notice of Conversion meeting the requirements for conversion as provided in this Section
4.4, the Borrower shall issue and deliver or cause to be issued and delivered to or upon the order of the Holder certificates for the
Common Stock issuable upon such conversion within three (3) business days after such receipt (the &ldquo;Deadline&rdquo;) (and, solely
in the case of conversion of the entire unpaid principal amount hereof, surrender of this Note) in accordance with the terms hereof and
the Purchase Agreement. Upon receipt by the Borrower of a Notice of Conversion, the Holder shall be deemed to be the holder of record
of the Common Stock issuable upon such conversion, the outstanding principal amount and the amount of accrued and unpaid interest on
this Note shall be reduced to reflect such conversion, and, unless the Borrower defaults on its obligations hereunder, all rights with
respect to the portion of this Note being so converted shall forthwith terminate except the right to receive the Common Stock or other
securities, cash or other assets, as herein provided, on such conversion. If the Holder shall have given a Notice of Conversion as provided
herein, the Borrower&rsquo;s obligation to issue and deliver the certificates for Common Stock shall be absolute and unconditional, irrespective
of the absence of any action by the Holder to enforce the same, any waiver or consent with respect to any provision thereof, the recovery
of any judgment against any person or any action to enforce the same, any failure or delay in the enforcement of any other obligation
of the Borrower to the holder of record, or any setoff, counterclaim, recoupment, limitation or termination, or any breach or alleged
breach by the Holder of any obligation to the Borrower, and irrespective of any other circumstance which might otherwise limit such obligation
of the Borrower to the Holder in connection with such conversion.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>Delivery of Common Stock by Electronic Transfer</U>. In lieu of delivering physical certificates representing the Common Stock issuable
upon conversion, provided the Borrower is participating in the Depository Trust Company (&ldquo;DTC&rdquo;) Fast Automated Securities
Transfer (&ldquo;FAST&rdquo;) program, upon request of the Holder and its compliance with the provisions set forth herein, the Borrower
shall use its best efforts to cause its transfer agent to electronically transmit the Common Stock issuable upon conversion to the Holder
by crediting the account of Holder&rsquo;s Prime Broker with DTC through its Deposit and Withdrawal at Custodian (&ldquo;DWAC&rdquo;)
system.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e) <U>Failure
to Deliver Common Stock Prior to Deadline</U>. Without in any way limiting the Holder&rsquo;s right to pursue other remedies,
including actual damages and/or equitable relief, the parties agree that if delivery of the Common Stock issuable upon conversion of
this Note is not delivered by the Deadline due to action and/or inaction of the Borrower, the Borrower shall pay to the Holder
$2,000 per day in cash, for each day beyond the Deadline that the Borrower fails to deliver such Common Stock (the &ldquo;Fail to
Deliver Fee&rdquo;); provided; however that the Fail to Deliver Fee shall not be due if the failure is a result of a third party
(i.e., transfer agent; and not the result of any failure to pay such transfer agent) despite the best efforts of the Borrower to
effect delivery of such Common Stock. Such cash amount shall be paid to Holder by the fifth day of the month following the month in
which it has accrued or, at the option of the Holder (by written notice to the Borrower by the first day of the month following the
month in which it has accrued), shall be added to the principal amount of this Note, in which event interest shall accrue thereon in
accordance with the terms of this Note and such additional principal amount shall be convertible into Common Stock in accordance
with the terms of this Note. The Borrower agrees that the right to convert is a valuable right to the Holder. The damages resulting
from a failure, attempt to frustrate, interference with such conversion right are difficult if not impossible to qualify.
Accordingly, the parties acknowledge that the liquidated damages provision contained in this Section 4.4(e) are
justified.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.5
<U>Concerning the Shares</U>. The shares of Common Stock issuable upon conversion of this Note may not be sold or transferred unless:
(i) such shares are sold pursuant to an effective registration statement under the Act or (ii) the Borrower or its transfer agent shall
have been furnished with an opinion of counsel (which opinion shall be in form, substance and scope customary for opinions of counsel
in comparable transactions) to the effect that the shares to be sold or transferred may be sold or transferred pursuant to an exemption
from such registration (such as Rule 144 or a successor rule) (&ldquo;Rule 144&rdquo;); or (iii) such shares are transferred to an &ldquo;affiliate&rdquo;
(as defined in Rule 144) of the Borrower who agrees to sell or otherwise transfer the shares only in accordance with this Section 4.5
and who is an Accredited Investor (as defined in the Purchase Agreement).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
restrictive legend on certificates representing shares of Common Stock issuable upon conversion of this Note shall be removed and the
Borrower shall issue to the Holder a new certificate therefore free of any transfer legend if the Borrower or its transfer agent shall
have received an opinion of counsel from Holder&rsquo;s counsel, in form, substance and scope customary for opinions of counsel in comparable
transactions, to the effect that (i) a public sale or transfer of such Common Stock may be made without registration under the Act, which
opinion shall be accepted by the Company so that the sale or transfer is effected; or (ii) in the case of the Common Stock issuable upon
conversion of this Note, such security is registered for sale by the Holder under an effective registration statement filed under the
Act; or otherwise may be sold pursuant to an exemption from registration. In the event that the Company does not reasonably accept the
opinion of counsel provided by the Holder with respect to the transfer of Securities pursuant to an exemption from registration (such
as Rule 144), it will be considered an Event of Default pursuant to this Note.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.6</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Effect of Certain Events</U>.</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: -35.95pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Effect of Merger, Consolidation, Etc</U>. At the option of the Holder, the sale, conveyance or disposition of all or substantially
all of the assets of the Borrower, the effectuation by the Borrower of a transaction or series of related transactions in which more
than 50% of the voting power of the Borrower is disposed of, or the consolidation, merger or other business combination of the Borrower
with or into any other Person (as defined below) or Persons when the Borrower is not the survivor shall be deemed to be an Event of Default
(as defined in Article III) pursuant to which the Borrower shall be required to pay to the Holder upon the consummation of and as a condition
to such transaction an amount equal to the Default Amount (as defined in Article III). &ldquo;Person&rdquo; shall mean any individual,
corporation, limited liability company, partnership, association, trust or other entity or organization.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Adjustment Due to Merger, Consolidation, Etc</U>. If, at any time when this Note is issued and outstanding and prior to conversion
of all of the Note, there shall be any merger, consolidation, exchange of shares, recapitalization, reorganization, or other similar
event, as a result of which shares of Common Stock of the Borrower shall be changed into the same or a different number of shares of
another class or classes of stock or securities of the Borrower or another entity, or in case of any sale or conveyance of all or substantially
all of the assets of the Borrower other than in connection with a plan of complete liquidation of the Borrower, then the Holder of this
Note shall thereafter have the right to receive upon conversion of this Note, upon the basis and upon the terms and conditions specified
herein and in lieu of the shares of Common Stock immediately theretofore issuable upon conversion, such stock, securities or assets which
the Holder would have been entitled to receive in such transaction had this Note been converted in full immediately prior to such transaction
(without regard to any limitations on conversion set forth herein), and in any such case appropriate provisions shall be made with respect
to the rights and interests of the Holder of this Note to the end that the provisions hereof (including, without limitation, provisions
for adjustment of the Conversion Price and of the number of shares issuable upon conversion of the Note) shall thereafter be applicable,
as nearly as may be practicable in relation to any securities or assets thereafter deliverable upon the conversion hereof. The Borrower
shall not affect any transaction described in this Section 4.6(b) unless (a) it first gives, to the extent practicable, ten (10) days
prior written notice (but in any event at least five (5) days prior written notice) of the record date of the special meeting of shareholders
to approve, or if there is no such record date, the consummation of, such merger, consolidation, exchange of shares, recapitalization,
reorganization or other similar event or sale of assets (during which time the Holder shall be entitled to convert this Note) and (b)
the resulting successor or acquiring entity (if not the Borrower) assumes by written instrument the obligations of this Note. The above
provisions shall similarly apply to successive consolidations, mergers, sales, transfers or share exchanges.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Adjustment Due to Distribution</U>. If the Borrower shall declare or make any distribution of its assets (or rights to acquire its
assets) to holders of Common Stock as a dividend, stock repurchase, by way of return of capital or otherwise (including any dividend
or distribution to the Borrower&rsquo;s shareholders in cash or shares (or rights to acquire shares) of capital stock of a subsidiary
(i.e., a spin-off)) (a &ldquo;Distribution&rdquo;), then the Holder of this Note shall be entitled, upon any conversion of this Note
after the date of record for determining shareholders entitled to such Distribution, to receive the amount of such assets which would
have been payable to the Holder with respect to the shares of Common Stock issuable upon such conversion had such Holder been the holder
of such shares of Common Stock on the record date for the determination of shareholders entitled to such Distribution.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>Adjustment Due to Market Price</U>. Notwithstanding anything contained herein to the contrary, if at any time the Market Price, as
determined on the date of each conversion, is less than the Conversion Price, then the Default Amount due pursuant to this Note shall
be increased immediately following each such conversion by the result of the Conversion Price minus the Market Price multiplied by the
amount of shares of common stock being issued with respect to such conversion. &ldquo;Market Price&rdquo; shall mean the lowest closing
bid price for the Common Stock during ten (10) Trading Days prior to the applicable date of conversion. &ldquo;Trading Day&rdquo; shall
mean any day on which the Common Stock is tradable for any period on the trading market, or on the principal securities exchange or other
securities market on which the Common Stock is then being traded. For example, the Conversion Price is $1.00 and if the Market Price
is $0.50 and the amount of shares issued upon conversion is 10,000 shares, then the Default Amount shall be increased by $5,000.00 ($1.00
- $0.50 = $0.50 multiplied by 10,000 = 5,000.00) immediately following such conversion.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
V. MISCELLANEOUS</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1
<U>Failure or Indulgence Not Waiver</U>. No failure or delay on the part of the Holder in the exercise of any power, right or privilege
hereunder shall operate as a waiver thereof, nor shall any single or partial exercise of any such power, right or privilege preclude
other or further exercise thereof or of any other right, power or privileges. All rights and remedies existing hereunder are cumulative
to, and not exclusive of, any rights or remedies otherwise available.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.2
<U>Notices</U>. All notices, demands, requests, consents, approvals, and other communications required or permitted hereunder shall be
in writing and, unless otherwise specified herein, shall be (i) personally served, (ii) deposited in the mail, registered or certified,
return receipt requested, postage prepaid, (iii) delivered by reputable air courier service with charges prepaid, or (iv) transmitted
by hand delivery, telegram, or electronic mail, addressed as set forth below or to such other address as such party shall have specified
most recently by written notice. Any notice or other communication required or permitted to be given hereunder shall be deemed effective
(a) upon hand delivery or delivery by electronic mail, at the address or number designated below (if delivered on a business day during
normal business hours where such notice is to be received), or the first business day following such delivery (if delivered other than
on a business day during normal business hours where such notice is to be received) or (b) on the second business day following the date
of mailing by express courier service, fully prepaid, addressed to such address, or upon actual receipt of such mailing, whichever shall
first occur. The addresses for such communications shall be:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
to the Borrower, to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-indent: 0.75in; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NEXTTRIP,
INC.</FONT></P>

<P STYLE="text-indent: 0.75in; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3900
Paseo del Sol</FONT></P>

<P STYLE="text-indent: 0.75in; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Santa
Fe, NM 87507</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attn:
William Kerby, Chief Executive Officer</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email: bill.kerby@nexttrip.com</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: -0.05pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
to the Holder:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1800
DIAGONAL LENDING LLC</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1800
Diagonal Road, Suite 623</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Alexandria
VA 22314</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attn:
Curt Kramer, President</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email: ckramer6@bloomberg.net</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.3
<U>Amendments</U>. This Note and any provision hereof may only be amended by an instrument in writing signed by the Borrower and the
Holder. The term &ldquo;Note&rdquo; and all reference thereto, as used throughout this instrument, shall mean this instrument (and the
other Notes issued pursuant to the Purchase Agreement) as originally executed, or if later amended or supplemented, then as so amended
or supplemented.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.4
<U>Assignability</U>. This Note shall be binding upon the Borrower and its successors and assigns, and shall inure to be the benefit
of the Holder and its successors and assigns. Each transferee of this Note must be an &ldquo;accredited investor&rdquo; (as defined in
Rule 501(a) of the Securities and Exchange Commission). Notwithstanding anything in this Note to the contrary, this Note may be pledged
as collateral in connection with a <U>bona fide</U> margin account or other lending arrangement; and may be assigned by the Holder without
the consent of the Borrower.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.5
<U>Cost of Collection</U>. If default is made in the payment of this Note, the Borrower shall pay the Holder hereof costs of collection,
including reasonable attorneys&rsquo; fees.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.6
<U>Governing Law</U>. This Note shall be governed by and construed in accordance with the laws of the Commonwealth of Virginia without
regard to principles of conflicts of laws. Any action brought by either party against the other concerning the transactions contemplated
by this Note shall be brought only in the Circuit Court of Fairfax County, Virginia or in the Alexandria Division of the United States
District Court for the Eastern District of Virginia. The parties to this Note hereby irrevocably waive any objection to jurisdiction
and venue of any action instituted hereunder and shall not assert any defense based on lack of jurisdiction or venue or based upon <I>forum
non conveniens</I>. The Borrower and Holder waive trial by jury. The Holder shall be entitled to recover from the Borrower its reasonable
attorney&rsquo;s fees and costs. In the event that any provision of this Note or any other agreement delivered in connection herewith
is invalid or unenforceable under any applicable statute or rule of law, then such provision shall be deemed inoperative to the extent
that it may conflict therewith and shall be deemed modified to conform with such statute or rule of law. Any such provision which may
prove invalid or unenforceable under any law shall not affect the validity or enforceability of any other provision of any agreement.
Each party hereby irrevocably waives personal service of process and consents to process being served in any suit, action or proceeding
in connection with this Note, any agreement or any other document delivered in connection with this Note by mailing a copy thereof via
registered or certified mail or overnight delivery (with evidence of delivery) to such party at the address in effect for notices to
it under this Note and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained
herein shall be deemed to limit in any way any right to serve process in any other manner permitted by law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.7
<U>Purchase Agreement</U>. By its acceptance of this Note, each party agrees to be bound by the applicable terms of the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.8
<U>Remedies</U>. The Borrower acknowledges that a breach by it of its obligations hereunder will cause irreparable harm to the Holder,
by vitiating the intent and purpose of the transaction contemplated hereby. Accordingly, the Borrower acknowledges that the remedy at
law for a breach of its obligations under this Note will be inadequate and agrees, in the event of a breach or threatened breach by the
Borrower of the provisions of this Note, that the Holder shall be entitled, in addition to all other available remedies at law or in
equity, and in addition to the penalties assessable herein, to an injunction or injunctions restraining, preventing or curing any breach
of this Note and to enforce specifically the terms and provisions thereof, without the necessity of showing economic loss and without
any bond or other security being required.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, Borrower has caused this Note to be signed in its name by its duly authorized officer this on November 8, 2024</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NEXTTRIP,
INC.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 47%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    William Kerby</I></FONT></TD>
    <TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">William
    Kerby</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">EXHIBIT
A &ndash; WIRE INSTRUCTIONS</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[to
be provided via email]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">EXHIBIT
B &mdash; NOTICE OF CONVERSION</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned hereby elects to convert $_______________<U></U> principal amount of the Note (defined below) into that number of shares of Common Stock
to be issued pursuant to the conversion of the Note (&ldquo;Common Stock&rdquo;) as set forth below, of NEXTTRIP, INC., a Nevada corporation
(the &ldquo;Borrower&rdquo;) according to the conditions of the convertible note of the Borrower dated as of November 8, 2024 (the &ldquo;Note&rdquo;),
as of the date written below. No fee will be charged to the Holder for any conversion, except for transfer taxes, if any.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Box
Checked as to applicable instructions:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Borrower shall electronically transmit the Common Stock issuable pursuant to this Notice of Conversion to the account of the undersigned
    or its nominee with DTC through its Deposit Withdrawal Agent Commission system (&ldquo;DWAC Transfer&rdquo;).</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
    of DTC Prime Broker:</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Account
    Number:</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    undersigned hereby requests that the Borrower issue a certificate or certificates for the number of shares of Common Stock set forth
    below (which numbers are based on the Holder&rsquo;s calculation attached hereto) in the name(s) specified immediately below or,
    if additional space is necessary, on an attachment hereto:</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 80%; font: 10pt Times New Roman, Times, Serif; margin-left: 1in">
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 1pt">Date of conversion:</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 80%; padding-bottom: 1pt">Applicable Conversion Price:</TD><TD STYLE="width: 2%; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 1pt solid; text-align: left">$</TD><TD STYLE="width: 16%; border-bottom: Black 1pt solid; text-align: right"></TD><TD STYLE="width: 1%; padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Number of shares of common stock to be issued pursuant to conversion of the Notes:</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Amount of Principal Balance due remaining under the Note after this conversion:</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 85%; border-collapse: collapse; margin-left: 1in">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1800 DIAGONAL LENDING LLC</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Curt
    Kramer</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">President</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
    </FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 13; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.38
<SEQUENCE>15
<FILENAME>ex10-38.htm
<DESCRIPTION>EX-10.38
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt">&nbsp;</P>

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt"><B>Exhibit 10.38</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-indent: 0pt; font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECURITIES
PURCHASE AGREEMENT</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
<B>SECURITIES PURCHASE AGREEMENT </B>(the &ldquo;Agreement&rdquo;), dated as of February 4, 2025, by and between <B>NEXTTRIP, INC.</B>,
a Nevada corporation, with its address at 3900 Paseo del Sol, Santa Fe, NM 87507 (the &ldquo;Company&rdquo;), and <B>1800 DIAGONAL LENDING
LLC</B>, a Virginia limited liability company, with its address at 1800 Diagonal Road, Suite 623, Alexandria, VA 22314 (the &ldquo;Lender&rdquo;).</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-indent: 0pt; font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHEREAS<FONT STYLE="font-weight: normal">:</FONT></FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A. The
Company and the Lender are executing and delivering this Agreement in reliance upon the exemption from securities registration afforded
by the rules and regulations as promulgated by the United States Securities and Exchange Commission (the &ldquo;SEC&rdquo;) under the
Securities Act of 1933, as amended (the &ldquo;1933 Act&rdquo;); and</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">B. Lender
desires to purchase and the Company desires to issue and sell, upon the terms and conditions set forth in this Agreement a promissory
note of the Company, in the form attached hereto as Exhibit A, in the aggregate principal amount of $152,100.00 (together with any note(s)
issued in replacement thereof or as a dividend thereon or otherwise with respect thereto in accordance with the terms thereof, the &ldquo;Note&rdquo;)
which upon default is convertible into shares of common stock, $0.001 par value per share, of the Company (the &ldquo;Common Stock&rdquo;),
upon the terms and subject to the limitations and conditions set forth in such Note with additional tranches of financing of up to $775,000.00
during the next twelve (12) months subject to further agreement by and between the Company and the Lender.</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOW
THEREFORE</B>, the Company and the Lender severally (and not jointly) hereby agree as follows:</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1. <U>Purchase
and Sale of Note.</U></FONT></P>



<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a. <U>Purchase
of Note</U>. On the Closing Date (as defined below), the Company shall issue and sell to the Lender and the Lender agrees to purchase
from the Company such principal amount of Note as is set forth immediately below the Lender&rsquo;s name on the signature pages hereto.</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b. <U>Form
of Payment</U>. On the Closing Date (as defined below), (i) the Lender shall pay the purchase price for the Note to be issued and sold
to it at the Closing (as defined below) (the &ldquo;Purchase Price&rdquo;) by wire transfer of immediately available funds to the Company,
in accordance with the Company&rsquo;s written wiring instructions, against delivery of the Note in the principal amount equal to the
Purchase Price as is set forth immediately below the Lender&rsquo;s name on the signature pages hereto, and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
the Company shall deliver such duly executed Note on behalf of the Company, to the Lender, against delivery of such Purchase Price.</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c. <U>Closing
Date</U>. Subject to the satisfaction (or written waiver) of the conditions thereto set forth in Section 6 and Section 7 below, the
date and time of the issuance and sale of the Note pursuant to this Agreement (the &ldquo;Closing Date&rdquo;) shall be 12:00 noon,
Eastern Standard Time on or about February 4, 2025, or such other mutually agreed upon time. The closing of the transactions
contemplated by this Agreement (the &ldquo;Closing&rdquo;) shall occur on the Closing Date at such location as may be agreed to by
the parties.</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2. <U>Lender&rsquo;s
Representations and Warranties.</U> The Lender represents and warrants to the Company that:</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a. <U>Investment
Purpose</U>. As of the date hereof, the Lender is purchasing the Note and the shares of Common Stock issuable upon conversion of or otherwise
pursuant to the Note (such shares of Common Stock being collectively referred to herein as the &ldquo;Conversion Shares&rdquo; and, collectively
with the Note, the &ldquo;Securities&rdquo;) for its own account and not with a present view towards the public sale or distribution
thereof, except pursuant to sales registered or exempted from registration under the 1933 Act.</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b. <U>Accredited
Investor Status</U>. The Lender is an &ldquo;accredited investor&rdquo; as that term is defined in Rule 501(a) of Regulation D (an &ldquo;Accredited
Investor&rdquo;).</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c. <U>Reliance
on Exemptions</U>. The Lender understands that the Securities are being offered and sold to it in reliance upon specific exemptions from
the registration requirements of United States federal and state securities laws and that the Company is relying upon the truth and accuracy
of, and the Lender&rsquo;s compliance with, the representations, warranties, agreements, acknowledgments and understandings of the Lender
set forth herein in order to determine the availability of such exemptions and the eligibility of the Lender to acquire the Securities.</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d. <U>Information</U>.
The Company has not disclosed to the Lender any material nonpublic information and will not disclose such information unless such information
is disclosed to the public prior to or promptly following such disclosure to the Lender.</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e. <U>Legends</U>.
The Lender understands that the Note and, until such time as the Conversion Shares have been registered under the 1933 Act; or may be
sold pursuant to an applicable exemption from registration, the Conversion Shares may bear a restrictive legend in substantially the
following form:</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1in; text-indent: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;THE
SECURITIES REPRESENTED BY THIS INSTRUMENT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE
&ldquo;SECURITIES ACT&rdquo;), OR UNDER ANY STATE SECURITIES LAWS, AND MAY NOT BE PLEDGED, SOLD, ASSIGNED, HYPOTHECATED OR OTHERWISE
TRANSFERRED UNLESS (1) A REGISTRATION STATEMENT WITH RESPECT THERETO IS EFFECTIVE UNDER THE SECURITIES ACT AND ANY APPLICABLE STATE
SECURITIES LAWS OR (2) THE ISSUER OF SUCH SECURITIES RECEIVES AN OPINION OF COUNSEL TO THE HOLDER OF SUCH SECURITIES, WHICH COUNSEL
AND OPINION ARE REASONABLY ACCEPTABLE TO THE ISSUER&rsquo;S TRANSFER AGENT, THAT SUCH SECURITIES MAY BE PLEDGED, SOLD, ASSIGNED,
HYPOTHECATED OR OTHERWISE TRANSFERRED WITHOUT AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT AND APPLICABLE STATE
SECURITIES LAWS.&rdquo;</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
legend set forth above shall be removed and the Company shall issue a certificate without such legend to the holder of any Security upon
which it is stamped, if, unless otherwise required by applicable state securities laws, (a) such Security is registered for sale under
an effective registration statement filed under the 1933 Act or otherwise may be sold pursuant to an exemption from registration without
any restriction as to the number of securities as of a particular date that can then be immediately sold, or (b) such holder provides
the Company with an opinion of counsel, in form, substance and scope customary for opinions of counsel in comparable transactions, to
the effect that a public sale or transfer of such Security may be made without registration under the 1933 Act, which opinion shall be
accepted by the Company so that the sale or transfer is effected. The Lender agrees to sell all Securities, including those represented
by a certificate(s) from which the legend has been removed, in compliance with applicable prospectus delivery requirements, if any. In
the event that the Company does not accept the opinion of counsel provided by the Lender with respect to the transfer of Securities pursuant
to an exemption from registration, such as Rule 144, at the Deadline, it will be considered an Event of Default pursuant to Section 3.2
of the Note.</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f. <U>Authorization;
Enforcement</U>. This Agreement has been duly and validly authorized. This Agreement has been duly executed and delivered on behalf of
the Lender, and this Agreement constitutes a valid and binding agreement of the Lender enforceable in accordance with its terms.</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3. <U>Representations
and Warranties of the Company</U>. The Company represents and warrants to the Lender that:</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a. <U>Organization
and Qualification</U>. The Company and each of its Subsidiaries (as defined below), if any, is a corporation duly organized, validly
existing and in good standing under the laws of the jurisdiction in which it is incorporated, with full power and authority (corporate
and other) to own, lease, use and operate its properties and to carry on its business as and where now owned, leased, used, operated
and conducted. &ldquo;Subsidiaries&rdquo; means any corporation or other organization, whether incorporated or unincorporated, in which
the Company owns, directly or indirectly, any equity or other ownership interest.</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b. <U>Authorization;
Enforcement</U>. (i) The Company has all requisite corporate power and authority to enter into and perform this Agreement, the Note
and to consummate the transactions contemplated hereby and thereby and to issue the Securities, in accordance with the terms hereof
and thereof, (ii) the execution and delivery of this Agreement, the Note by the Company and the consummation by it of the
transactions contemplated hereby and thereby (including without limitation, the issuance of the Note and the issuance and
reservation for issuance of the Conversion Shares issuable upon conversion or exercise thereof) have been duly authorized by the
Company&rsquo;s Board of Directors and no further consent or authorization of the Company, its Board of Directors, or its
shareholders is required, </FONT>(iii) this Agreement has been duly executed and delivered by the Company by its authorized
representative, and such authorized representative is the true and official representative with authority to sign this Agreement and
the other documents executed in connection herewith and bind the Company accordingly, and (iv) this Agreement constitutes, and upon
execution and delivery by the Company of the Note, each of such instruments will constitute, a legal, valid and binding obligation
of the Company enforceable against the Company in accordance with its terms.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.75in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.75in"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.75in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c. <U>Capitalization</U>.
As of the date hereof, the authorized common stock of the Company consists of 250,000,000 authorized shares of Common Stock, $0.001 par
value per share, of which 1,592,738 shares are issued and outstanding. All of such outstanding shares of capital stock are, or upon issuance
will be, duly authorized, validly issued, fully paid and non-assessable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d. <U>Issuance
of Shares</U>. The Conversion Shares are duly authorized and reserved for issuance and, upon conversion of the Note in accordance with
its respective terms, will be validly issued, fully paid and non-assessable, and free from all taxes, liens, claims and encumbrances
with respect to the issue thereof and shall not be subject to preemptive rights or other similar rights of shareholders of the Company
and will not impose personal liability upon the holder thereof.</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e. <U>No
Conflicts</U>. The execution, delivery and performance of this Agreement, the Note by the Company and the consummation by the Company
of the transactions contemplated hereby and thereby (including, without limitation, the issuance and reservation for issuance of the
Conversion Shares) will not (i) conflict with or result in a violation of any provision of the Certificate of Incorporation or By-laws,
or (ii) violate or conflict with, or result in a breach of any provision of, or constitute a default (or an event which with notice or
lapse of time or both could become a default) under, or give to others any rights of termination, amendment, acceleration or cancellation
of, any agreement, indenture, patent, patent license or instrument to which the Company or any of its Subsidiaries is a party, or (iii)
result in a violation of any law, rule, regulation, order, judgment or decree (including federal and state securities laws and regulations
and regulations of any self-regulatory organizations to which the Company or its securities are subject) applicable to the Company or
any of its Subsidiaries or by which any property or asset of the Company or any of its Subsidiaries is bound or affected (except for
such conflicts, defaults, terminations, amendments, accelerations, cancellations and violations as would not, individually or in the
aggregate, have a Material Adverse Effect). The businesses of the Company and its Subsidiaries, if any, are not being conducted, and
shall not be conducted so long as the Lender owns any of the Securities, in violation of any law, ordinance or regulation of any governmental
entity. &ldquo;Material Adverse Effect&rdquo; means any material adverse effect on the business, operations, assets, financial condition
or prospects of the Company or its Subsidiaries, if any, taken as a whole, or on the transactions contemplated hereby or by the agreements
or instruments to be entered into in connection herewith.</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f. <U>SEC
Documents: Financial Statements</U>. The Company has filed all reports, schedules, forms, statements and other documents required to
be filed by it with the SEC pursuant to the reporting requirements of the Securities Exchange Act of 1934, as amended (the
&ldquo;1934 Act&rdquo;) (all of the foregoing filed prior to the date hereof and all exhibits included therein and financial
statements and schedules thereto and documents (other than exhibits to such documents) incorporated by reference therein, being
hereinafter referred to herein as the &ldquo;SEC Documents&rdquo;). The Company is subject to the filings requirements of the 1934
Act pursuant to Section 12 of the 1934 Act. Upon written request the Company will deliver to the Lender true and complete copies of
the SEC Documents, except for such exhibits and incorporated documents. As of their respective dates or if amended, as of the dates
of the amendments, the SEC Documents complied in all material respects with the requirements of the 1934 Act and the rules and
regulations of the SEC promulgated thereunder applicable to the SEC Documents, and none of the SEC Documents, at the time they were
filed with the SEC, contained any untrue statement of a material fact or omitted to state a material fact required to be stated
therein or necessary in order to make the statements therein, in light of the circumstances under which they were made, not
misleading. None of the statements made in any such SEC Documents is, or has been, required to be amended or updated under
applicable law (except for such statements as have been amended or updated in subsequent filings prior the date hereof). As of their
respective dates or if amended, as of the dates of the amendments, the financial statements of the Company included in the SEC
Documents complied as to form in all material respects with applicable accounting requirements and the published rules and
regulations of the SEC with respect thereto. Such financial statements have been prepared in accordance with United States generally
accepted accounting principles, consistently applied, during the periods involved and fairly present in all material respects the
consolidated financial position of the Company and its consolidated Subsidiaries as of the dates thereof and the consolidated
results of their operations and cash flows for the periods then ended (subject, in the case of unaudited statements, to normal
year-end audit adjustments). The Company is subject to the reporting requirements of the 1934 Act.</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">g. <U>Absence
of Certain Changes</U>. Since August 31, 2024, except as set forth in the SEC Documents, there has been no material adverse change and
no material adverse development in the assets, liabilities, business, properties, operations, financial condition, results of operations,
prospects or 1934 Act reporting status of the Company or any of its Subsidiaries.</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">h. <U>Absence
of Litigation</U>. Except as set forth in the SEC Documents, there is no action, suit, claim, proceeding, inquiry or investigation before
or by any court, public board, government agency, self-regulatory organization or body pending or, to the knowledge of the Company or
any of its Subsidiaries, threatened against or affecting the Company or any of its Subsidiaries, or their officers or directors in their
capacity as such, that could have a Material Adverse Effect. The Company and its Subsidiaries are unaware of any facts or circumstances
which might give rise to any of the foregoing.</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i. <U>No
Integrated Offering</U>. Neither the Company, nor any of its affiliates, nor any person acting on its or their behalf, has directly or
indirectly made any offers or sales in any security or solicited any offers to buy any security under circumstances that would require
registration under the 1933 Act of the issuance of the Securities to the Lender. The issuance of the Securities to the Lender will not
be integrated with any other issuance of the Company&rsquo;s securities (past, current or future) for purposes of any shareholder approval
provisions applicable to the Company or its securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.75in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">j. <U>No
Brokers</U>. Except for Enclave Capital, the Company has taken no action which would give rise to any claim by any person for brokerage
commissions, transaction fees or similar payments relating to this Agreement or the transactions contemplated hereby.</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">k. <U>No
Investment Company</U>. The Company is not, and upon the issuance and sale of the Securities as contemplated by this Agreement will not
be an &ldquo;investment company&rdquo; required to be registered under the Investment Company Act of 1940 (an &ldquo;Investment Company&rdquo;).
The Company is not controlled by an Investment Company.</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">l. <U>Breach
of Representations and Warranties by the Company</U>. If the Company breaches any of the representations or warranties set forth in this
Section 3, and in addition to any other remedies available to the Lender pursuant to this Agreement, it will be considered an Event of
default under Section 3.4 of the Note.</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4. <U>COVENANTS</U>.</FONT></P>



<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a. <U>Best
Efforts</U>. The Company shall use its best efforts to satisfy timely each of the conditions described in Section 7 of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b. <U>Form
D; Blue Sky Laws</U>. The Company agrees to timely make any filings required by federal and state laws as a result of the closing of
the transactions contemplated by this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c. <U>Use
of Proceeds</U>. The Company shall use the proceeds for general working capital purposes.</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d. <U>Expenses</U>.
At the Closing, the Company&rsquo;s obligation with respect to the transactions contemplated by this Agreement is to reimburse Lender&rsquo;
expenses shall be $15,000.00 for Lender&rsquo;s legal fees and due diligence fee.</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e. <U>Corporate
Existence</U>. So long as the Lender beneficially owns any Note, the Company shall maintain its corporate existence and shall not sell
all or substantially all of the Company&rsquo;s assets, except with the prior written consent of the Lender.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f. <U>Breach
of Covenants</U>. If the Company breaches any of the covenants set forth in this Section 4, and in addition to any other remedies available
to the Lender pursuant to this Agreement, it will be considered an event of default under Section 3.4 of the Note.</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">g. <U>Failure
to Comply with the 1934 Act</U>. So long as the Lender beneficially owns the Note, the Company shall comply with the reporting requirements
of the 1934 Act; and the Company shall continue to be subject to the reporting requirements of the 1934 Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">h. <U>Trading
Activities</U>. Neither the Lender nor its affiliates has an open short position in the common stock of the Company and the Lender agrees
that it shall not, and that it will cause its affiliates not to, engage in any short sales of or hedging transactions with respect to
the common stock of the Company.</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i. <U>The
Lender is Not a &ldquo;Dealer&rdquo;</U>. The Lender and the Company hereby acknowledge and agree that the Lender has not: (i) acted
as an underwriter; (ii) acted as a market maker or specialist; (iii) acted as &ldquo;de facto&rdquo; market maker; or (iv) conducted
any other professional market activities such as providing investment advice, extending credit and lending securities in connection;
and thus that the Lender is not a &ldquo;Dealer&rdquo; as such term is defined in the 1934 Act.</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5. <U>Transfer
Agent Instructions</U>. The Company shall issue irrevocable instructions to its transfer agent to issue certificates, registered in
the name of the Lender or its nominee, for the Conversion Shares in such amounts as specified from time to time by the Lender to the
Company upon conversion of the Note in accordance with the terms thereof (the &ldquo;Irrevocable Transfer Agent
Instructions&rdquo;). In the event that the Company proposes to replace its transfer agent, the Company shall provide, prior to the
effective date of such replacement, a fully executed Irrevocable Transfer Agent Instructions in a form as initially delivered
pursuant to this Agreement (including but not limited to the provision to irrevocably reserve shares of Common Stock in the Reserved
Amount as such term is defined in the Note) signed by the successor transfer agent to Company and the Company. Prior to registration
of the Conversion Shares under the 1933 Act or the date on which the Conversion Shares may be sold pursuant to an exemption from
registration, all such certificates shall bear the restrictive legend specified in Section 2(e) of this Agreement. The Company
warrants that: (i) no instruction other than the Irrevocable Transfer Agent Instructions referred to in this Section 5, will be
given by the Company to its transfer agent and that the Securities shall otherwise be freely transferable on the books and records
of the Company as and to the extent provided in this Agreement and the Note; (ii) it will not direct its transfer agent not to
transfer or delay, impair, and/or hinder its transfer agent in transferring (or issuing)(electronically or in certificated form) any
certificate for Conversion Shares to be issued to the Lender upon conversion of or otherwise pursuant to the Note as and when
required by the Note and this Agreement; and (iii) it will not fail to remove (or directs its transfer agent not to remove or
impairs, delays, and/or hinders its transfer agent from removing) any restrictive legend (or to withdraw any stop transfer
instructions in respect thereof) on any certificate for any Conversion Shares issued to the Lender upon conversion of or otherwise
pursuant to the Note as and when required by the Note and/or this Agreement. If the Lender provides the Company and the
Company&rsquo;s transfer agent, at the cost of the Lender, with an opinion of counsel in form, substance and scope customary for
opinions in comparable transactions, to the effect that a public sale or transfer of such Securities may be made without
registration under the 1933 Act, the Company shall permit the transfer, and, in the case of the Conversion Shares, promptly instruct
its transfer agent to issue one or more certificates, free from restrictive legend, in such name and in such denominations as
specified by the Lender. The Company acknowledges that a breach by it of its obligations hereunder will cause irreparable harm to
the Lender, by vitiating the intent and purpose of the transactions contemplated hereby. Accordingly, the Company acknowledges that
the remedy at law for a breach of its obligations under this Section 5 may be inadequate and agrees, in the event of a breach or
threatened breach by the Company of the provisions of this Section, that the Lender shall be entitled, in addition to all other
available remedies, to an injunction restraining any breach and requiring immediate transfer, without the necessity of showing
economic loss and without any bond or other security being required.</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6. <U>Conditions
to the Company&rsquo;s Obligation to Sell</U>. The obligation of the Company hereunder to issue and sell the Note to the Lender at the
Closing is subject to the satisfaction, at or before the Closing Date of each of the following conditions thereto, provided that these
conditions are for the Company&rsquo;s sole benefit and may be waived by the Company at any time in its sole discretion:</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a.
The Lender shall have executed this Agreement and delivered the same</FONT> to the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.75in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b.
The Lender shall have delivered the Purchase Price in accordance with</FONT> Section 1(b) above.</P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c. The
Lender shall have delivered a subordination agreement in a form acceptable to the Lender, the Company and the Company&rsquo;s primary
lender.</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d. The
representations and warranties of the Lender shall be true and correct in all material respects as of the date when made and as of the
Closing Date as though made at that time (except for representations and warranties that speak as of a specific date), and the Lender
shall have performed, satisfied and complied in all material respects with the covenants, agreements and conditions required by this
Agreement to be performed, satisfied or complied with by the Lender at or prior to the Closing Date.</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e. No
litigation, statute, rule, regulation, executive order, decree, ruling or injunction shall have been enacted, entered, promulgated or
endorsed by or in any court or governmental authority of competent jurisdiction or any self-regulatory organization having authority
over the matters contemplated hereby which prohibits the consummation of any of the transactions contemplated by this Agreement.</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7. <U>Conditions
to The Lender&rsquo;s Obligation to Purchase</U>. The obligation of the Lender hereunder to purchase the Note at the Closing is subject
to the satisfaction, at or before the Closing Date of each of the following conditions, provided that these conditions are for the Lender&rsquo;s
sole benefit and may be waived by the Lender at any time in its sole discretion:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a.
The Company shall have executed this Agreement and delivered the</FONT> same to the Lender.</P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b. The
Company shall have delivered to the Lender the duly executed Note (in such denominations as the Lender shall request) in accordance with
Section 1(b) above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c. The
Irrevocable Transfer Agent Instructions, in form and substance satisfactory to the Lender, shall have been delivered to and acknowledged
in writing by the Company&rsquo;s Transfer Agent.</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d. The
representations and warranties of the Company shall be true and correct in all material respects as of the date when made and as of the
Closing Date as though made at such time (except for representations and warranties that speak as of a specific date) and the Company
shall have performed, satisfied and complied in all material respects with the covenants, agreements and conditions required by this
Agreement to be performed, satisfied or complied with by the Company at or prior to the Closing Date. The Lender shall have received
a certificate or certificates, executed by the chief executive officer of the Company, dated as of the Closing Date, to the foregoing
effect and as to such other matters as may be reasonably requested by the Lender including, but not limited to certificates with respect
to the Board of Directors&rsquo; resolutions relating to the transactions contemplated hereby.</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e. No
litigation, statute, rule, regulation, executive order, decree, ruling or injunction shall have been enacted, entered, promulgated or
endorsed by or in any court or governmental authority of competent jurisdiction or any self-regulatory organization having authority
over the matters contemplated hereby which prohibits the consummation of any of the transactions contemplated by this Agreement.</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f. No
event shall have occurred which could reasonably be expected to have a Material Adverse Effect on the Company including but not limited
to a change in the 1934 Act reporting status of the Company or the failure of the Company to be timely in its 1934 Act reporting obligations.</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.25in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Governing Law; Miscellaneous</U>.</FONT></P>



<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a. <U>Governing
Law</U>. This Agreement shall be governed by and construed in accordance with the laws of the Commonwealth of Virginia without regard
to principles of conflicts of laws. Any action brought by either party against the other concerning the transactions contemplated by
this Agreement shall be brought only in the Circuit Court of Fairfax County, Virginia or in the Alexandria Division of the United States
District Court for the Eastern District of Virginia. The parties to this Agreement hereby irrevocably waive any objection to jurisdiction
and venue of any action instituted hereunder and shall not assert any objection or defense based on lack of jurisdiction or venue or
based upon <I>forum non conveniens</I>. The Company and Lender waive trial by jury. The Lender shall be entitled to recover from the
Company its reasonable attorney&rsquo;s fees and costs incurred in connection with or related to any Event of Default by the Company,
as defined in Article III of the Note. Each party hereby irrevocably waives personal service of process and consents to process being
served in any suit, action or proceeding in connection with this Agreement, the Note or any related document or agreement by mailing
a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery) to such party at the address in effect
for notices to it under this Agreement and agrees that such service shall constitute good and sufficient service of process and notice
thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any other manner permitted by law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.75in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b. <U>Counterparts</U>.
This Agreement may be executed in one or more counterparts, each of which shall be deemed an original but all of which shall constitute
one and the same agreement and shall become effective when counterparts have been signed by each party and delivered to the other party.</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c. <U>Headings</U>.
The headings of this Agreement are for convenience of reference only and shall not form part of, or affect the interpretation of, this
Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d. <U>Severability</U>.
In the event that any provision of this Agreement is invalid or unenforceable under any applicable statute or rule of law, then such
provision shall be deemed inoperative to the extent that it may conflict therewith and shall be deemed modified to conform with such
statute or rule of law. Any provision hereof which may prove invalid or unenforceable under any law shall not affect the validity or
enforceability of any other provision hereof.</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e. <U>Entire
Agreement; Amendments</U>. This Agreement and the instruments referenced herein contain the entire understanding of the parties with
respect to the matters covered herein and therein and, except as specifically set forth herein or therein, neither the Company nor the
Lender makes any representation, warranty, covenant or undertaking with respect to such matters. No provision of this Agreement may be
waived or amended other than by an instrument in writing signed by the majority in interest of the Lender.</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f. <U>Notices</U>.
All notices, demands, requests, consents, approvals, and other communications required or permitted hereunder shall be in writing and,
unless otherwise specified herein, shall be (i) personally served, (ii) deposited in the mail, registered or certified, return receipt
requested, postage prepaid, (iii) delivered by reputable air courier service with charges prepaid, or (iv) transmitted by hand delivery,
telegram, email or facsimile, addressed as set forth below or to such other address as such party shall have specified most recently
by written notice. Any notice or other communication required or permitted to be given hereunder shall be deemed effective (a) upon hand
delivery or delivery by facsimile, with accurate confirmation generated by the transmitting facsimile machine, at the address or number
designated below (if delivered on a business day during normal business hours where such notice is to be received), or the first business
day following such delivery (if delivered other than on a business day during normal business hours where such notice is to be received)
or (b) on the second business day following the date of mailing by express courier service, fully prepaid, addressed to such address,
or upon actual receipt of such mailing, whichever shall first occur. The addresses for such communications shall be as set forth in the
heading of this Agreement with a copy by fax only to (which copy shall not constitute notice) to Naidich Wurman LLP, 111 Great Neck Road,
Suite 214, Great Neck, NY 11021, Attn: Allison Naidich, facsimile: 516-466-3555, e-mail: <U>allison@nwlaw.com</U>. Each party shall provide
notice to the other party of any change in address.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">g. <U>Successors
and Assigns</U>. This Agreement shall be binding upon and inure to the benefit of the parties and their successors and assigns.
Neither the Company nor the Lender shall assign this Agreement or any rights or obligations hereunder without the prior written
consent of the other. Notwithstanding the foregoing, the Lender may assign its rights hereunder to any person that purchases
Securities in a private transaction from the Lender or to any of its &ldquo;affiliates,&rdquo; as that term is defined under the
1934 Act, without the consent of the Company.</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">h. <U>Survival</U>.
The representations and warranties of the Company and the agreements and covenants set forth in this Agreement shall survive the closing
hereunder notwithstanding any due diligence investigation conducted by or on behalf of the Lender. The Company agrees to indemnify and
hold harmless the Lender and all their officers, directors, employees and agents for loss or damage arising as a result of or related
to any breach or alleged breach by the Company of any of its representations, warranties and covenants set forth in this Agreement or
any of its covenants and obligations under this Agreement, including advancement of expenses as they are incurred.</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i. <U>Further
Assurances</U>. Each party shall do and perform, or cause to be done and performed, all such further acts and things, and shall execute
and deliver all such other agreements, certificates, instruments and documents, as the other party may reasonably request in order to
carry out the intent and accomplish the purposes of this Agreement and the consummation of the transactions contemplated hereby.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">j. <U>No
Strict Construction</U>. The language used in this Agreement will be deemed to be the language chosen by the parties to express their
mutual intent, and no rules of strict construction will be applied against any party.</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">k. <U>Remedies</U>.
The Company acknowledges that a breach by it of its obligations hereunder will cause irreparable harm to the Lender by vitiating the
intent and purpose of the transaction contemplated hereby. Accordingly, the Company acknowledges that the remedy at law for a breach
of its obligations under this Agreement will be inadequate and agrees, in the event of a breach or threatened breach by the Company of
the provisions of this Agreement, that the Lender shall be entitled, in addition to all other available remedies at law or in equity,
and in addition to the penalties assessable herein, to an injunction or injunctions restraining, preventing or curing any breach of this
Agreement and to enforce specifically the terms and provisions hereof, without the necessity of showing economic loss and without any
bond or other security being required.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the undersigned Lender and the Company have caused this Agreement to be duly executed as of the date first above written.</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NEXTTRIP,
INC.</B></FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
                                                                                                                                      <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
                                                                                                                                      <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 47%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
                                            William Kerby</I></FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 50%"></TD></TR><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">William
                                            Kerby</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
                                <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
                                            Executive Officer</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
                                <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
                                <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>1800
DIAGONAL LENDING LLC</B></FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>

<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
  <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify; width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
  <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: justify; width: 47%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
  Curt Kramer</I></FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>

<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
  <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Curt
  Kramer</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>

<TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: top">
  <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">President</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>


<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 80%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>AGGREGATE SUBSCRIPTION AMOUNT:</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 80%">Aggregate Purchase Price:</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 16%; text-align: right">130,000.00</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Original Issue Discount:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">22,100.00</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Aggregate Principal Amount of Note:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">152,100.00</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-indent: 0pt; font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 12; Options: Last -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.39
<SEQUENCE>16
<FILENAME>ex10-39.htm
<DESCRIPTION>EX-10.39
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
10.39</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>THE
ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED,
OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF (A)
AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR (B) AN OPINION OF COUNSEL (WHICH
COUNSEL SHALL BE SELECTED BY THE HOLDER), IN A GENERALLY ACCEPTABLE FORM, THAT REGISTRATION IS NOT REQUIRED UNDER SAID ACT.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>THE
ISSUE PRICE OF THIS NOTE IS $152,100.00</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>THE ORIGINAL ISSUE DISCOUNT IS $22,100.00</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Principal
    Amount: $152,100.00</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Issue
    Date: February 4, 2025</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Purchase
    Price: $130,000.00</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>PROMISSORY
NOTE</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>FOR
VALUE RECEIVED</B>, <B>NEXTTRIP, INC.</B>, a Nevada corporation (hereinafter called the &ldquo;Borrower&rdquo;), hereby promises to pay
to the order of <B>1800 DIAGONAL LENDING LLC</B>, a Virginia limited liability company, or registered assigns (the &ldquo;Holder&rdquo;)
the sum of $152,100.00 together with any interest as set forth herein, on December 15, 2025 (the &ldquo;Maturity Date&rdquo;), and to
pay interest on the unpaid principal balance hereof from the date hereof (the &ldquo;Issue Date&rdquo;) as set forth herein. This Note
may not be prepaid in whole or in part except as otherwise explicitly set forth herein. Any amount of principal or interest on this Note
which is not paid when due shall bear interest at the rate of twenty two percent (22%) per annum from the due date thereof until the
same is paid (&ldquo;Default Interest&rdquo;). All payments due hereunder (to the extent not converted into common stock, $0.001 par
value per share (the &ldquo;Common Stock&rdquo;) in accordance with the terms hereof) shall be made in lawful money of the United States
of America. All payments shall be made at such address as the Holder shall hereafter give to the Borrower by written notice made in accordance
with the provisions of this Note. Each capitalized term used herein, and not otherwise defined, shall have the meaning ascribed thereto
in that certain Securities Purchase Agreement dated the date hereof, pursuant to which this Note was originally issued (the &ldquo;Purchase
Agreement&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Note is free from all taxes, liens, claims and encumbrances with respect to the issue thereof and shall not be subject to preemptive
rights or other similar rights of shareholders of the Borrower and will not impose personal liability upon the holder thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following terms shall apply to this Note:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
I. GENERAL TERMS</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.1
<U>Interest</U>. A one-time interest charge of thirteen percent (13%) (the &ldquo;Interest Rate&rdquo;) shall be applied on the Issuance
Date to the Principal ($152,100.00 * thirteen percent (13%) = $19,773.00). Interest hereunder shall be paid as set forth herein to the
Holder or its assignee in whose name this Note is registered on the records of the Company regarding registration and transfers of Notes
in cash or, in the Event of Default, at the Option of the Holder, converted into share of Common Stock as set forth herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.2
<U>Mandatory Monthly Payments</U>. Accrued, unpaid interest and outstanding principal, subject to adjustment, shall be paid in five (5)
payments as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 60%; font: 10pt Times New Roman, Times, Serif; margin-left: 1in">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid">Payment Date</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid">Amount of Payment</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 50%">August 15, 2025</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 46%; text-align: right">85,936.50</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>September 15, 2025</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">21,484.13</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>October 15, 2025</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">21,484.13</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>November 15, 2025</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">21,484.13</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>December 15, 2025</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">21,484.11</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 71.95pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a
total payback to the Holder of $171,873.00).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 71.95pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company shall have a five (5) day grace period with respect to each payment. The Company has right to prepay in full at any time with
no prepayment penalty. All payments shall be made by bank wire transfer to the Holder&rsquo;s wire instructions, attached hereto as Exhibit
A. For the avoidance of doubt, a missed payment shall be considered an Event of Default.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 71.95pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.3
<U>Prepayment Discount</U>. Notwithstanding anything to the contrary contained in this Note, at any time during the period set forth
on the table immediately following this paragraph (the &ldquo;Prepayment Period&rdquo;) or as otherwise agreed to between the Borrower
and the Holder, the Borrower shall have the right, exercisable on not more than three (3) Trading Days prior written notice to the Holder
of the Note to prepay the outstanding Note (principal and accrued interest), in full, in accordance with this Section 1.3. Any notice
of prepayment hereunder (an &ldquo;Optional Prepayment Notice&rdquo;) shall be delivered to the Holder of the Note at its registered
addresses and shall state: (1) that the Borrower is exercising its right to prepay the Note, and (2) the date of prepayment which shall
be not more than three (3) Trading Days from the date of the Optional Prepayment Notice. On the date fixed for prepayment (the &ldquo;Optional
Prepayment Date&rdquo;), the Borrower shall make payment of the Optional Prepayment Amount (as defined below) to Holder, or upon the
direction of the Holder as specified by the Holder in a writing to the Borrower (which shall direction to be sent to Borrower by the
Holder at least one (1) business day prior to the Optional Prepayment Date). If the Borrower exercises its right to prepay the Note,
the Borrower shall make payment to the Holder of an amount in cash equal to the percentage (&ldquo;Prepayment Percentage&rdquo;) as set
forth in the table immediately following this paragraph opposite the Prepayment Period, multiplied by the sum of the then outstanding
principal amount of this Note <U>plus</U> any accrued and unpaid interest on the unpaid principal amount of this Note to the Optional
Prepayment Date (the &ldquo;Optional Prepayment Amount&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prepayment
    Period</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prepayment
    Percentage</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 81%; text-align: left; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1)
    The period beginning on the Issue Date and ending on the date which is thirty (30) days following the Issue Date.</FONT></TD><TD STYLE="width: 2%; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1pt; width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">96</FONT></TD><TD STYLE="width: 1%; padding-bottom: 1pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2)
    The period beginning on date which is thirty-one (31) days following the Issue Date and ending on the date which is sixty (60) days
    following the Issue Date.</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">97</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3)
    The period beginning on date which is sixty-one (61) days following the Issue Date and ending on the date which is one hundred twenty
    (120) days following the Issue Date.</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">98</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4)
    The period beginning on date which is one hundred twenty-one (121) days following the Issue Date and ending on the date which
is one hundred eighty (180) days following the Issue Date.</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">99</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
II. CERTAIN COVENANTS</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1
<U>Sale of Assets</U>. So long as the Borrower shall have any obligation under this Note, the Borrower shall not, without the Holder&rsquo;s
written consent, sell, lease or otherwise dispose of any significant portion of its assets outside the ordinary course of business. Any
consent to the disposition of any assets may be conditioned on a specified use of the proceeds of disposition.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
III. EVENTS OF DEFAULT</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
any of the following events of default (each, an &ldquo;Event of Default&rdquo;) shall occur:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1
<U>Failure to Pay Principal and Interest</U>. The Borrower fails to pay the principal hereof or interest thereon when due on this Note,
whether at maturity, upon acceleration or otherwise and such breach continues for a period of five (5) days after written notice from
the Holder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2
<U>Conversion and the Shares</U>. The Borrower fails to issue shares of Common Stock to the Holder (or announces or threatens in writing
that it will not honor its obligation to do so) upon exercise by the Holder of the conversion rights of the Holder in accordance with
the terms of this Note (following an Event of Default other than this Section 3.2), fails to transfer or cause its transfer agent to
transfer (issue) (electronically or in certificated form) any certificate for shares of Common Stock issued to the Holder upon conversion
of or otherwise pursuant to this Note as and when required by this Note, the Borrower directs its transfer agent not to transfer or delays,
impairs, and/or hinders its transfer agent in transferring (or issuing) (electronically or in certificated form) any certificate for
shares of Common Stock to be issued to the Holder upon conversion of or otherwise pursuant to this Note as and when required by this
Note, or fails to remove (or directs its transfer agent not to remove or impairs, delays, and/or hinders its transfer agent from removing)
any restrictive legend (or to withdraw any stop transfer instructions in respect thereof) on any certificate for any shares of Common
Stock issued to the Holder upon conversion of or otherwise pursuant to this Note as and when required by this Note (or makes any written
announcement, statement or threat that it does not intend to honor the obligations described in this paragraph) and any such failure
shall continue uncured (or any written announcement, statement or threat not to honor its obligations shall not be rescinded in writing)
for three (3) business days after the Holder shall have delivered a Notice of Conversion. It is an obligation of the Borrower to remain
current in its obligations to its transfer agent. It shall be an event of default of this Note, if a conversion of this Note is delayed,
hindered or frustrated due to a balance owed by the Borrower to its transfer agent. If at the option of the Holder, the Holder advances
any funds to the Borrower&rsquo;s transfer agent in order to process a conversion, such advanced funds shall be paid by the Borrower
to the Holder within forty-eight (48) hours of a demand from the Holder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.3
<U>Breach of Covenants</U>. The Borrower breaches any material covenant or other material term or condition contained in this Note and
any collateral documents including but not limited to the Purchase Agreement and such breach continues for a period of twenty (20) days
after written notice thereof to the Borrower from the Holder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.4
<U>Breach of Representations and Warranties</U>. Any representation or warranty of the Borrower made herein or in any agreement, statement
or certificate given in writing pursuant hereto or in connection herewith (including, without limitation, the Purchase Agreement), shall
be false or misleading in any material respect when made and the breach of which has (or with the passage of time will have) a material
adverse effect on the rights of the Holder with respect to this Note or the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.5
<U>Receiver or Trustee</U>. The Borrower or any subsidiary of the Borrower shall make an assignment for the benefit of creditors, or
apply for or consent to the appointment of a receiver or trustee for it or for a substantial part of its property or business, or such
a receiver or trustee shall otherwise be appointed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.6
<U>Bankruptcy</U>. Bankruptcy, insolvency, reorganization or liquidation proceedings or other proceedings, voluntary or involuntary,
for relief under any bankruptcy law or any law for the relief of debtors shall be instituted by or against the Borrower or any subsidiary
of the Borrower.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.7
<U>Delisting of Common Stock</U>. The Borrower shall fail to maintain the listing of the Common Stock on the Nasdaq National Market,
the Nasdaq SmallCap Market, the New York Stock Exchange, or the NYSE American Stock Exchange (collectively, the &ldquo;Exchanges&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.8
<U>Failure to Comply with the Exchange Act</U>. The Borrower shall fail to comply with the reporting requirements of the Exchange Act;
and/or the Borrower shall cease to be subject to the reporting requirements of the Exchange Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.9
<U>Liquidation</U>. Any dissolution, liquidation, or winding up of Borrower or any substantial portion of its business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.10
<U>Cessation of Operations</U>. Any cessation of operations by Borrower or Borrower admits it is otherwise generally unable to pay its
debts as such debts become due, provided, however, that any disclosure of the Borrower&rsquo;s ability to continue as a &ldquo;going
concern&rdquo; shall not be an admission that the Borrower cannot pay its debts as they become due.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.11
<U>Financial Statement Restatement</U>.&#9;The restatement of any financial statements filed by the Borrower with the SEC at any time
after 180 days after the Issuance Date for any date or period until this Note is no longer outstanding, if the result of such restatement
would, by comparison to the un-restated financial statement, have constituted a material adverse effect on the rights of the Holder with
respect to this Note or the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.12
<U>Replacement of Transfer Agent</U>. In the event that the Borrower proposes to replace its transfer agent, the Borrower fails to provide,
prior to the effective date of such replacement, a fully executed Irrevocable Transfer Agent Instructions in a form as initially delivered
pursuant to the Purchase Agreement (including but not limited to the provision to irrevocably reserve shares of Common Stock in the Reserved
Amount) signed by the successor transfer agent to Borrower and the Borrower.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.13
<U>Cross-Default</U>. Notwithstanding anything to the contrary contained in this Note or the other related or companion documents, a
breach or default by the Borrower of any covenant or other term or condition contained in any of the Other Agreements, after the passage
of all applicable notice and cure or grace periods, shall, at the option of the Holder, be considered a default under this Note and the
Other Agreements, in which event the Holder shall be entitled (but in no event required) to apply all rights and remedies of the Holder
under the terms of this Note and the Other Agreements by reason of a default under said Other Agreement or hereunder. &ldquo;Other Agreements&rdquo;
means, collectively, all agreements and instruments between, among or by: (1) the Borrower, and, or for the benefit of, (2) the Holder
and any affiliate of the Holder, including, without limitation, promissory notes; provided, however, the term &ldquo;Other Agreements&rdquo;
shall not include the related or companion documents to this Note. Each of the loan transactions will be cross-defaulted with each other
loan transaction and with all other existing and future debt of Borrower to the Holder. .</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
the occurrence and during the continuation of any Event of Default, the Note shall become immediately due and payable and the Borrower
shall pay to the Holder, in full satisfaction of its obligations hereunder, an amount equal to 200% (&ldquo;Default Percentage&rdquo;)
<U>times</U> the <U>sum</U> of (w) the then outstanding principal amount of this Note <U>plus</U> (x) accrued and unpaid interest on
the unpaid principal amount of this Note to the date of payment <U>plus</U> (y) Default Interest, if any, on the amounts referred to
in clauses (w) and/or (x) <U>plus</U> (z) any amounts owed to the Holder pursuant to Article IV hereof (the then outstanding principal
amount of this Note to the date of payment <U>plus</U> the amounts referred to in clauses (x), (y) and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(z)
shall collectively be known as the &ldquo;Default Amount&rdquo;) and all other amounts payable hereunder shall immediately become due
and payable, all without demand, presentment or notice, all of which hereby are expressly waived, together with all costs, including,
without limitation, legal fees and expenses, of collection, and the Holder shall be entitled to exercise all other rights and remedies
available at law or in equity. Notwithstanding anything to the contrary contained herein, in the event that following an Event of Default
(other than Section 3.2), a default pursuant to Section 3.2 occurs, the Default Percentage shall be immediately adjusted to 225%.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the Borrower fails to pay the Default Amount within five (5) business days of written notice that such amount is due and payable, then
the Holder shall have the right at any time, to convert the balance owed pursuant to the note including the Default Amount into shares
of common stock of the Company as set forth herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
IV. CONVERSION RIGHTS</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1
<U>Conversion Right</U>. After the occurrence of an Event of Default, at any time, the Holder shall have the right, to convert all or
any part of the outstanding and unpaid amount of this Note into fully paid and non-assessable shares of Common Stock, as such Common
Stock exists on the Issue Date, or any shares of capital stock or other securities of the Borrower into which such Common Stock shall
hereafter be changed or reclassified at the conversion price determined as provided herein (a &ldquo;Conversion&rdquo;); <U>provided</U>,
<U>however</U>, that in no event shall the Holder be entitled to convert any portion of this Note in excess of that portion of this Note
upon conversion of which the sum of (1) the number of shares of Common Stock beneficially owned by the Holder and its affiliates (other
than shares of Common Stock which may be deemed beneficially owned through the ownership of the unconverted portion of the Notes or the
unexercised or unconverted portion of any other security of the Borrower subject to a limitation on conversion or exercise analogous
to the limitations contained herein) and (2) the number of shares of Common Stock issuable upon the conversion of the portion of this
Note with respect to which the determination of this proviso is being made, would result in beneficial ownership by the Holder and its
affiliates of more than 4.99% of the outstanding shares of Common Stock. For purposes of the proviso to the immediately preceding sentence,
beneficial ownership shall be determined in accordance with Section 13(d) of the Securities Exchange Act of 1934, as amended (the &ldquo;Exchange
Act&rdquo;), and Regulations 13D-G thereunder, except as otherwise provided in clause (1) of such proviso. <U>The beneficial ownership
limitations on conversion as set forth in the section may NOT be waived by the Holder</U>. The number of shares of Common Stock to be
issued upon each conversion of this Note shall be determined by dividing the Conversion Amount (as defined below) by the applicable Conversion
Price then in effect on the date specified in the notice of conversion, in the form attached hereto as Exhibit B(the &ldquo;Notice of
Conversion&rdquo;), delivered to the Borrower by the Holder in accordance with Section 4.4 below; provided that the Notice of Conversion
is submitted by facsimile or e-mail (or by other means resulting in, or reasonably expected to result in, notice) to the Borrower before
6:00 p.m., New York, New York time on such conversion date (the &ldquo;Conversion Date&rdquo;); however, if the Notice of Conversion
is sent after 6:00pm, New York, New York time the Conversion Date shall be the next business day. The term &ldquo;Conversion Amount&rdquo;
means, with respect to any conversion of this Note, the sum of (1) the principal amount of this Note to be converted in such conversion
<U>plus</U> (2) at the Holder&rsquo;s option, accrued and unpaid interest, if any, on such principal amount at the interest rates provided
in this Note to the Conversion Date, <U>plus</U> (3) at the Holder&rsquo;s option, Default Interest, if any, on the amounts referred
to in the immediately preceding clauses (1) and/or (2) <U>plus</U> (4) at the Holder&rsquo;s option, any amounts owed to the Holder pursuant
to Sections 4.4 hereof. Notwithstanding anything in this Agreement to the contrary, and in addition to the limitations set forth herein,
if the Borrower has not obtained Stockholder Approval, the Borrower shall not issue a number of shares of Common Stock under this Agreement,
which when aggregated with all other securities that are required to be aggregated for purposes of Rule 5635(d), would exceed 19.99%
of the shares of Common Stock outstanding as of the date of definitive agreement with respect to the first of such aggregated transactions
(the &ldquo;Conversion Limitation&rdquo;). For purposes of this section, &ldquo;Stockholder Approval&rdquo; means such approval as may
be required by the applicable rules and regulations of the Nasdaq Stock Market LLC (or any successor entity) from the stockholders of
the Company with respect to the issuance of the shares under this Agreement that, when taken together with any other securities that
are required to be aggregated with the issuance of the shares issued under this Agreement for purposes of Rule 5635(d) of the Nasdaq
Stock Market LLC (&ldquo;Rule 5635(d)&rdquo;), would exceed 19.99% of the issued and outstanding common stock as of the date of definitive
agreement with respect to the first of such aggregated transactions. &ldquo;Principal Market&rdquo; means the Exchanges, the quotation
platforms maintained by the OTC Markets Group) or an equivalent replacement exchange, and all rules and regulations relating to such
exchange. Upon the occurrence of an Event of Default pursuant to Section 3.7 hereof, the Conversion Limitation shall no longer apply
to limit the issuance of shares in conversion of this Note.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Holder shall be entitled to deduct $1,500.00 from the conversion amount in each Notice of Conversion to cover Holder&rsquo;s deposit
fees associated with each Notice of Conversion. Any additional expenses incurred by Holder with respect to the Borrower&rsquo;s transfer
agent, for the issuance of the Common Stock into which this Note is convertible into, shall immediately and automatically be added to
the balance of the Note at such time as the expenses are incurred by Holder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2 <U>Conversion
Price</U>. The conversion price (the &ldquo;Conversion Price&rdquo;) shall mean $3.02 (subject to equitable adjustments by the
Borrower relating to the Borrower&rsquo;s securities or the securities of any subsidiary of the Borrower, combinations,
recapitalization, reclassifications, extraordinary distributions and similar events).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3
<U>Authorized Shares</U>. The Borrower covenants that during the period that the Note is outstanding, the Borrower will reserve from
its authorized and unissued Common Stock a sufficient number of shares, free from preemptive rights, to provide for the issuance of Common
Stock upon the full conversion of this Note issued pursuant to the Purchase Agreement. The Borrower is required at all times to have
authorized and reserved four times the number of shares that is actually issuable upon full conversion of the Note (based on the Conversion
Price of the Note in effect from time to time) (the &ldquo;Reserved Amount&rdquo;). The Reserved Amount shall
be adjusted from time to time in accordance with the Borrower&rsquo;s obligations hereunder and the reduction of the balance due to timely
payments. The Borrower represents that upon issuance, such shares will be duly and validly issued, fully paid and non-assessable. In
addition, if the Borrower shall issue any securities or make any change to its capital structure which would change the number of shares
of Common Stock into which the Notes shall be convertible at the then current Conversion Price, the Borrower shall at the same time make
proper provision so that thereafter there shall be a sufficient number of shares of Common Stock authorized and reserved, free from preemptive
rights, for conversion of the outstanding Note. The Borrower (i) acknowledges that it has irrevocably instructed its transfer agent to
issue certificates for the Common Stock issuable upon conversion of this Note, and (ii) agrees that its issuance of this Note shall constitute
full authority to its officers and agents who are charged with the duty of executing stock certificates to execute and issue the necessary
certificates for shares of Common Stock in accordance with the terms and conditions of this Note.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 71.95pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If,
at any time the Borrower does not maintain the Reserved Amount it will be considered an Event of Default under this Note.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 71.95pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.4</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Method of Conversion</U>.</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: -35.95pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Mechanics of Conversion</U>. As set forth in Section 4.1 hereof, at any time following an Event of Default, the balance due pursuant
to this Note may be converted by the Holder in whole or in part at any time from time to time after the Issue Date, by (A) submitting
to the Borrower a Notice of Conversion (by facsimile, e-mail or other reasonable means of communication dispatched on the Conversion
Date prior to 6:00 p.m., New York, New York time) and (B) subject to Section 4.4(b), surrendering this Note at the principal office of
the Borrower (upon payment in full of any amounts owed hereunder).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Surrender of Note Upon Conversion</U>. Notwithstanding anything to the contrary set forth herein, upon conversion of this Note in
accordance with the terms hereof, the Holder shall not be required to physically surrender this Note to the Borrower unless the entire
unpaid principal amount of this Note is so converted. The Holder and the Borrower shall maintain records showing the principal amount
so converted and the dates of such conversions or shall use such other method, reasonably satisfactory to the Holder and the Borrower,
so as not to require physical surrender of this Note upon each such conversion.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Delivery of Common Stock Upon Conversion</U>. Upon receipt by the Borrower from the Holder of a facsimile transmission or e-mail (or
other reasonable means of communication) of a Notice of Conversion meeting the requirements for conversion as provided in this Section
4.4, the Borrower shall issue and deliver or cause to be issued and delivered to or upon the order of the Holder certificates for the
Common Stock issuable upon such conversion within three (3) business days after such receipt (the &ldquo;Deadline&rdquo;) (and, solely
in the case of conversion of the entire unpaid principal amount hereof, surrender of this Note) in accordance with the terms hereof and
the Purchase Agreement. Upon receipt by the Borrower of a Notice of Conversion, the Holder shall be deemed to be the holder of record
of the Common Stock issuable upon such conversion, the outstanding principal amount and the amount of accrued and unpaid interest on
this Note shall be reduced to reflect such conversion, and, unless the Borrower defaults on its obligations hereunder, all rights with
respect to the portion of this Note being so converted shall forthwith terminate except the right to receive the Common Stock or other
securities, cash or other assets, as herein provided, on such conversion. If the Holder shall have given a Notice of Conversion as provided
herein, the Borrower&rsquo;s obligation to issue and deliver the certificates for Common Stock shall be absolute and unconditional, irrespective
of the absence of any action by the Holder to enforce the same, any waiver or consent with respect to any provision thereof, the recovery
of any judgment against any person or any action to enforce the same, any failure or delay in the enforcement of any other obligation
of the Borrower to the holder of record, or any setoff, counterclaim, recoupment, limitation or termination, or any breach or alleged
breach by the Holder of any obligation to the Borrower, and irrespective of any other circumstance which might otherwise limit such obligation
of the Borrower to the Holder in connection with such conversion.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>Delivery of Common Stock by Electronic Transfer</U>. In lieu of delivering physical certificates representing the Common Stock issuable
upon conversion, provided the Borrower is participating in the Depository Trust Company (&ldquo;DTC&rdquo;) Fast Automated Securities
Transfer (&ldquo;FAST&rdquo;) program, upon request of the Holder and its compliance with the provisions set forth herein, the Borrower
shall use its best efforts to cause its transfer agent to electronically transmit the Common Stock issuable upon conversion to the Holder
by crediting the account of Holder&rsquo;s Prime Broker with DTC through its Deposit and Withdrawal at Custodian (&ldquo;DWAC&rdquo;)
system.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e) <U>Failure
to Deliver Common Stock Prior to Deadline</U>. Without in any way limiting the Holder&rsquo;s right to pursue other remedies,
including actual damages and/or equitable relief, the parties agree that if delivery of the Common Stock issuable upon conversion of
this Note is not delivered by the Deadline due to action and/or inaction of the Borrower, the Borrower shall pay to the Holder
$2,000 per day in cash, for each day beyond the Deadline that the Borrower fails to deliver such Common Stock (the &ldquo;Fail to
Deliver Fee&rdquo;); provided; however that the Fail to Deliver Fee shall not be due if the failure is a result of a third party
(i.e., transfer agent; and not the result of any failure to pay such transfer agent) despite the best efforts of the Borrower to
effect delivery of such Common Stock. Such cash amount shall be paid to Holder by the fifth day of the month following the month in
which it has accrued or, at the option of the Holder (by written notice to the Borrower by the first day of the month following the
month in which it has accrued), shall be added to the principal amount of this Note, in which event interest shall accrue thereon in
accordance with the terms of this Note and such additional principal amount shall be convertible into Common Stock in accordance
with the terms of this Note. The Borrower agrees that the right to convert is a valuable right to the Holder. The damages resulting
from a failure, attempt to frustrate, interference with such conversion right are difficult if not impossible to qualify.
Accordingly, the parties acknowledge that the liquidated damages provision contained in this Section 4.4(e) are
justified.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.5
<U>Concerning the Shares</U>. The shares of Common Stock issuable upon conversion of this Note may not be sold or transferred unless:
(i) such shares are sold pursuant to an effective registration statement under the Act or (ii) the Borrower or its transfer agent shall
have been furnished with an opinion of counsel (which opinion shall be in form, substance and scope customary for opinions of counsel
in comparable transactions) to the effect that the shares to be sold or transferred may be sold or transferred pursuant to an exemption
from such registration (such as Rule 144 or a successor rule) (&ldquo;Rule 144&rdquo;); or (iii) such shares are transferred to an &ldquo;affiliate&rdquo;
(as defined in Rule 144) of the Borrower who agrees to sell or otherwise transfer the shares only in accordance with this Section 4.5
and who is an Accredited Investor (as defined in the Purchase Agreement).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
restrictive legend on certificates representing shares of Common Stock issuable upon conversion of this Note shall be removed and the
Borrower shall issue to the Holder a new certificate therefore free of any transfer legend if the Borrower or its transfer agent shall
have received an opinion of counsel from Holder&rsquo;s counsel, in form, substance and scope customary for opinions of counsel in comparable
transactions, to the effect that (i) a public sale or transfer of such Common Stock may be made without registration under the Act, which
opinion shall be accepted by the Company so that the sale or transfer is effected; or (ii) in the case of the Common Stock issuable upon
conversion of this Note, such security is registered for sale by the Holder under an effective registration statement filed under the
Act; or otherwise may be sold pursuant to an exemption from registration. In the event that the Company does not reasonably accept the
opinion of counsel provided by the Holder with respect to the transfer of Securities pursuant to an exemption from registration (such
as Rule 144), it will be considered an Event of Default pursuant to this Note.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.6</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Effect of Certain Events</U>.</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: -35.95pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Effect of Merger, Consolidation, Etc</U>. At the option of the Holder, the sale, conveyance or disposition of all or substantially
all of the assets of the Borrower, the effectuation by the Borrower of a transaction or series of related transactions in which more
than 50% of the voting power of the Borrower is disposed of, or the consolidation, merger or other business combination of the Borrower
with or into any other Person (as defined below) or Persons when the Borrower is not the survivor shall be deemed to be an Event of Default
(as defined in Article III) pursuant to which the Borrower shall be required to pay to the Holder upon the consummation of and as a condition
to such transaction an amount equal to the Default Amount (as defined in Article III). &ldquo;Person&rdquo; shall mean any individual,
corporation, limited liability company, partnership, association, trust or other entity or organization.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Adjustment Due to Merger, Consolidation, Etc</U>. If, at any time when this Note is issued and outstanding and prior to conversion
of all of the Note, there shall be any merger, consolidation, exchange of shares, recapitalization, reorganization, or other similar
event, as a result of which shares of Common Stock of the Borrower shall be changed into the same or a different number of shares of
another class or classes of stock or securities of the Borrower or another entity, or in case of any sale or conveyance of all or substantially
all of the assets of the Borrower other than in connection with a plan of complete liquidation of the Borrower, then the Holder of this
Note shall thereafter have the right to receive upon conversion of this Note, upon the basis and upon the terms and conditions specified
herein and in lieu of the shares of Common Stock immediately theretofore issuable upon conversion, such stock, securities or assets which
the Holder would have been entitled to receive in such transaction had this Note been converted in full immediately prior to such transaction
(without regard to any limitations on conversion set forth herein), and in any such case appropriate provisions shall be made with respect
to the rights and interests of the Holder of this Note to the end that the provisions hereof (including, without limitation, provisions
for adjustment of the Conversion Price and of the number of shares issuable upon conversion of the Note) shall thereafter be applicable,
as nearly as may be practicable in relation to any securities or assets thereafter deliverable upon the conversion hereof. The Borrower
shall not affect any transaction described in this Section 4.6(b) unless (a) it first gives, to the extent practicable, ten (10) days
prior written notice (but in any event at least five (5) days prior written notice) of the record date of the special meeting of shareholders
to approve, or if there is no such record date, the consummation of, such merger, consolidation, exchange of shares, recapitalization,
reorganization or other similar event or sale of assets (during which time the Holder shall be entitled to convert this Note) and (b)
the resulting successor or acquiring entity (if not the Borrower) assumes by written instrument the obligations of this Note. The above
provisions shall similarly apply to successive consolidations, mergers, sales, transfers or share exchanges.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Adjustment Due to Distribution</U>. If the Borrower shall declare or make any distribution of its assets (or rights to acquire its
assets) to holders of Common Stock as a dividend, stock repurchase, by way of return of capital or otherwise (including any dividend
or distribution to the Borrower&rsquo;s shareholders in cash or shares (or rights to acquire shares) of capital stock of a subsidiary
(i.e., a spin-off)) (a &ldquo;Distribution&rdquo;), then the Holder of this Note shall be entitled, upon any conversion of this Note
after the date of record for determining shareholders entitled to such Distribution, to receive the amount of such assets which would
have been payable to the Holder with respect to the shares of Common Stock issuable upon such conversion had such Holder been the holder
of such shares of Common Stock on the record date for the determination of shareholders entitled to such Distribution.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>Adjustment Due to Market Price</U>. Notwithstanding anything contained herein to the contrary, if at any time the Market Price, as
determined on the date of each conversion, is less than the Conversion Price, then the Default Amount due pursuant to this Note shall
be increased immediately following each such conversion by the result of the Conversion Price minus the Market Price multiplied by the
amount of shares of common stock being issued with respect to such conversion. &ldquo;Market Price&rdquo; shall mean the lowest closing
bid price for the Common Stock during ten (10) Trading Days prior to the applicable date of conversion. &ldquo;Trading Day&rdquo; shall
mean any day on which the Common Stock is tradable for any period on the trading market, or on the principal securities exchange or other
securities market on which the Common Stock is then being traded. For example, the Conversion Price is $1.00 and if the Market Price
is $0.50 and the amount of shares issued upon conversion is 10,000 shares, then the Default Amount shall be increased by $5,000.00 ($1.00
- $0.50 = $0.50 multiplied by 10,000 = 5,000.00) immediately following such conversion.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
V. MISCELLANEOUS</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1
<U>Failure or Indulgence Not Waiver</U>. No failure or delay on the part of the Holder in the exercise of any power, right or privilege
hereunder shall operate as a waiver thereof, nor shall any single or partial exercise of any such power, right or privilege preclude
other or further exercise thereof or of any other right, power or privileges. All rights and remedies existing hereunder are cumulative
to, and not exclusive of, any rights or remedies otherwise available.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.2
<U>Notices</U>. All notices, demands, requests, consents, approvals, and other communications required or permitted hereunder shall be
in writing and, unless otherwise specified herein, shall be (i) personally served, (ii) deposited in the mail, registered or certified,
return receipt requested, postage prepaid, (iii) delivered by reputable air courier service with charges prepaid, or (iv) transmitted
by hand delivery, telegram, or electronic mail, addressed as set forth below or to such other address as such party shall have specified
most recently by written notice. Any notice or other communication required or permitted to be given hereunder shall be deemed effective
(a) upon hand delivery or delivery by electronic mail, at the address or number designated below (if delivered on a business day during
normal business hours where such notice is to be received), or the first business day following such delivery (if delivered other than
on a business day during normal business hours where such notice is to be received) or (b) on the second business day following the date
of mailing by express courier service, fully prepaid, addressed to such address, or upon actual receipt of such mailing, whichever shall
first occur. The addresses for such communications shall be:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
to the Borrower, to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-indent: 0.75in; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NEXTTRIP,
INC.</FONT></P>

<P STYLE="text-indent: 0.75in; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3900
Paseo del Sol</FONT></P>

<P STYLE="text-indent: 0.75in; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Santa
Fe, NM 87507</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attn:
William Kerby, Chief Executive Officer</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email: bill.kerby@nexttrip.com</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: -0.05pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
to the Holder:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1800
DIAGONAL LENDING LLC</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1800
Diagonal Road, Suite 623</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Alexandria
VA 22314</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attn:
Curt Kramer, President</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email: ckramer6@bloomberg.net</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.3
<U>Amendments</U>. This Note and any provision hereof may only be amended by an instrument in writing signed by the Borrower and the
Holder. The term &ldquo;Note&rdquo; and all reference thereto, as used throughout this instrument, shall mean this instrument (and the
other Notes issued pursuant to the Purchase Agreement) as originally executed, or if later amended or supplemented, then as so amended
or supplemented.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.4
<U>Assignability</U>. This Note shall be binding upon the Borrower and its successors and assigns, and shall inure to be the benefit
of the Holder and its successors and assigns. Each transferee of this Note must be an &ldquo;accredited investor&rdquo; (as defined in
Rule 501(a) of the Securities and Exchange Commission). Notwithstanding anything in this Note to the contrary, this Note may be pledged
as collateral in connection with a <U>bona fide</U> margin account or other lending arrangement; and may be assigned by the Holder without
the consent of the Borrower.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.5
<U>Cost of Collection</U>. If default is made in the payment of this Note, the Borrower shall pay the Holder hereof costs of collection,
including reasonable attorneys&rsquo; fees.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.6
<U>Governing Law</U>. This Note shall be governed by and construed in accordance with the laws of the Commonwealth of Virginia without
regard to principles of conflicts of laws. Any action brought by either party against the other concerning the transactions contemplated
by this Note shall be brought only in the Circuit Court of Fairfax County, Virginia or in the Alexandria Division of the United States
District Court for the Eastern District of Virginia. The parties to this Note hereby irrevocably waive any objection to jurisdiction
and venue of any action instituted hereunder and shall not assert any defense based on lack of jurisdiction or venue or based upon <I>forum
non conveniens</I>. The Borrower and Holder waive trial by jury. The Holder shall be entitled to recover from the Borrower its reasonable
attorney&rsquo;s fees and costs. In the event that any provision of this Note or any other agreement delivered in connection herewith
is invalid or unenforceable under any applicable statute or rule of law, then such provision shall be deemed inoperative to the extent
that it may conflict therewith and shall be deemed modified to conform with such statute or rule of law. Any such provision which may
prove invalid or unenforceable under any law shall not affect the validity or enforceability of any other provision of any agreement.
Each party hereby irrevocably waives personal service of process and consents to process being served in any suit, action or proceeding
in connection with this Note, any agreement or any other document delivered in connection with this Note by mailing a copy thereof via
registered or certified mail or overnight delivery (with evidence of delivery) to such party at the address in effect for notices to
it under this Note and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained
herein shall be deemed to limit in any way any right to serve process in any other manner permitted by law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.7
<U>Purchase Agreement</U>. By its acceptance of this Note, each party agrees to be bound by the applicable terms of the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.8
<U>Remedies</U>. The Borrower acknowledges that a breach by it of its obligations hereunder will cause irreparable harm to the Holder,
by vitiating the intent and purpose of the transaction contemplated hereby. Accordingly, the Borrower acknowledges that the remedy at
law for a breach of its obligations under this Note will be inadequate and agrees, in the event of a breach or threatened breach by the
Borrower of the provisions of this Note, that the Holder shall be entitled, in addition to all other available remedies at law or in
equity, and in addition to the penalties assessable herein, to an injunction or injunctions restraining, preventing or curing any breach
of this Note and to enforce specifically the terms and provisions thereof, without the necessity of showing economic loss and without
any bond or other security being required.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, Borrower has caused this Note to be signed in its name by its duly authorized officer this on February 4, 2025</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NEXTTRIP,
INC.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 47%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    William Kerby</I></FONT></TD>
    <TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">William
    Kerby</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">EXHIBIT
A &ndash; WIRE INSTRUCTIONS</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[to
be provided via email]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">EXHIBIT
B &mdash; NOTICE OF CONVERSION</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned hereby elects to convert $<U>&#9;</U> principal amount of the Note (defined below) into that number of shares of Common Stock
to be issued pursuant to the conversion of the Note (&ldquo;Common Stock&rdquo;) as set forth below, of NEXTTRIP, INC., a Nevada corporation
(the &ldquo;Borrower&rdquo;) according to the conditions of the convertible note of the Borrower dated as of February 4, 2025 (the &ldquo;Note&rdquo;),
as of the date written below. No fee will be charged to the Holder for any conversion, except for transfer taxes, if any.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Box
Checked as to applicable instructions:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Borrower shall electronically transmit the Common Stock issuable pursuant to this Notice of Conversion to the account of the undersigned
    or its nominee with DTC through its Deposit Withdrawal Agent Commission system (&ldquo;DWAC Transfer&rdquo;).</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
    of DTC Prime Broker:</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Account
    Number:</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    undersigned hereby requests that the Borrower issue a certificate or certificates for the number of shares of Common Stock set forth
    below (which numbers are based on the Holder&rsquo;s calculation attached hereto) in the name(s) specified immediately below or,
    if additional space is necessary, on an attachment hereto:</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: -36.05pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 80%; font: 10pt Times New Roman, Times, Serif; margin-left: 1in">
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 1pt; width: 80%">Date of conversion:</TD><TD STYLE="padding-bottom: 1pt; width: 2%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 1%; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; width: 16%; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1pt">Applicable Conversion Price:</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
  <TD STYLE="padding-bottom: 1pt; text-align: left">Number of shares of common stock to be issued pursuant to conversion of the
  Notes:</TD>
  <TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
  <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD>
  <TD STYLE="border-bottom: Black 1pt solid; text-align: right">&nbsp;<BR>
&nbsp;</TD>
  <TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;<BR>
&nbsp;</TD>
</TR>
<TR STYLE="vertical-align: bottom; background-color: White">
  <TD STYLE="padding-bottom: 1pt; text-align: left">Amount of Principal Balance due remaining under the Note after this
  conversion:</TD>
  <TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
  <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD>
  <TD STYLE="border-bottom: Black 1pt solid; text-align: right">&nbsp;</TD>
  <TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;<BR>
&nbsp;</TD>
</TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 85%; border-collapse: collapse; margin-left: 1in">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1800 DIAGONAL LENDING LLC</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Curt
    Kramer</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">President</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
    </FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 13; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-21.1
<SEQUENCE>17
<FILENAME>ex21-1.htm
<DESCRIPTION>EX-21.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
21.1</B></FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>List
of Subsidiaries</B></FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 40%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Subsidiary</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; vertical-align: top; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 28%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Percentage</B></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Owned
    by NextTrip, Inc.</B></FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; vertical-align: top; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 28%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Jurisdiction
    of Incorporation</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NextTrip
    Holdings, Inc.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">100%</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Florida</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Extraordinary
    Vacations USA, Inc.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">100%</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Delaware</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FSA
    Travel, LLC</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">100%</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
    York</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>18
<FILENAME>ex23-1.htm
<DESCRIPTION>EX-23.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
23.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><IMG SRC="ex23-1_001.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CONSENT
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
consent to the incorporation by reference in Registration Statement Nos. 333-174897, 333-197616, 333-212612, 333-222369, 333-228628,
333-233348, 333-250181, 333-258683, 333-259523, and 333-267943 on Form S-8, of NextTrip, Inc. of our report dated May 29, 2025,
relating to our audit of the financial statements which appear in this Annual Report on Form 10-K of NextTrip, Inc. for the years
ended February 28, 2025 and February 29, 2024.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
Haynie &amp; Company</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Haynie
&amp; Company</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Salt
Lake City, Utah</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">May
29, 2025</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="ex23-1_002.jpg" ALT=""></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>19
<FILENAME>ex31-1.htm
<DESCRIPTION>EX-31.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
31.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Certification
of Principal Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I,
William Kerby, certify that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.
I have reviewed this Annual Report on Form 10-K of NextTrip, Inc.;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary
to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the
period covered by this report;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material
respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this
report;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.
The registrant&rsquo;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures
(as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act
Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision,
to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others
within those entities, particularly during the period in which this report is being prepared;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under
our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements
for external purposes in accordance with generally accepted accounting principles;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
Evaluated the effectiveness of the registrant&rsquo;s disclosure controls and procedures and presented in this report our conclusions
about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation;
and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
Disclosed in this report any change in the registrant&rsquo;s internal control over financial reporting that occurred during the registrant&rsquo;s
most recent fiscal quarter (the registrant&rsquo;s fourth fiscal quarter in the case of an annual report) that has materially affected,
or is reasonably likely to materially affect, the registrant&rsquo;s internal control over financial reporting; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.
The registrant&rsquo;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial
reporting, to the registrant&rsquo;s auditors and the audit committee of the registrant&rsquo;s board of directors (or persons performing
the equivalent functions):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are
reasonably likely to adversely affect the registrant&rsquo;s ability to record, process, summarize and report financial information;
and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&rsquo;s
internal control over financial reporting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
May 29, 2025</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    William Kerby</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:
    </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">William
    Kerby</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Principal
    Executive Officer)</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>20
<FILENAME>ex31-2.htm
<DESCRIPTION>EX-31.2
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
31.2</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Certification
of Principal Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I,
Frank Orzechowski, certify that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.
I have reviewed this Annual Report on Form 10-K of NextTrip, Inc.;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary
to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the
period covered by this report;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material
respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this
report;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.
The registrant&rsquo;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures
(as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act
Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision,
to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others
within those entities, particularly during the period in which this report is being prepared;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under
our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements
for external purposes in accordance with generally accepted accounting principles;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
Evaluated the effectiveness of the registrant&rsquo;s disclosure controls and procedures and presented in this report our conclusions
about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation;
and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
Disclosed in this report any change in the registrant&rsquo;s internal control over financial reporting that occurred during the registrant&rsquo;s
most recent fiscal quarter (the registrant&rsquo;s fourth fiscal quarter in the case of an annual report) that has materially affected,
or is reasonably likely to materially affect, the registrant&rsquo;s internal control over financial reporting; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.
The registrant&rsquo;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial
reporting, to the registrant&rsquo;s auditors and the audit committee of the registrant&rsquo;s board of directors (or persons performing
the equivalent functions):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are
reasonably likely to adversely affect the registrant&rsquo;s ability to record, process, summarize and report financial information;
and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&rsquo;s
internal control over financial reporting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
May 29, 2025</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Frank Orzechowski</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Frank
    Orzechowski</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Financial Officer, Treasurer</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Principal
    Financial and Accounting Officer)</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>21
<FILENAME>ex32-1.htm
<DESCRIPTION>EX-32.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
32.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CERTIFICATION
PURSUANT TO</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>18
U.S.C. SECTION 1350</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>AS
ADOPTED PURSUANT TO</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the accompanying Annual Report of NextTrip, Inc., (the &ldquo;Company&rdquo;) on Form 10-K for the period ended February
28, 2025 as filed with the Securities and Exchange Commission on the date hereof (the &ldquo;Report&rdquo;), the undersigned officers
of the Company certify, pursuant to 18 U.S.C. &sect; 1350, as adopted pursuant to &sect; 906 of the Sarbanes-Oxley Act of 2002, that
to their knowledge:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
The Report fully complies with the requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934,
as amended; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations
of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
    May 29, 2025</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    William Kerby</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">William
    Kerby</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
                                            Executive Officer (Principal</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Executive
    Officer)</FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
    May 29, 2025</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Frank Orzechowski</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Frank
    Orzechowski</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
                                            Financial Officer (Principal Financial and</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounting
    Officer)</FONT></P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>ex23-1_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex23-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" !^ D # 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#]4Z*** "B
MBB@ HHHH *:W&.2*&)!X-4M5U.#2;">\NYX[6TMXVEFGF8*D:@9+,3P * W=
MD6U?+8SDBGYKXE\,_M=7'QN_:X\)^&O#4TEKX'LY+H[QE6U.0028D8=HQ_"I
M^I[ ?4/QTN)K/X)_$"XMYI+>XB\/Z@\<L+E71A;N0RD<@@\@UC3JQJW<-EH>
MIC\MQ&6.G#$JTIQ4K=DV[7\]#N20**_-W_@GG^VQ\-/ ?[-FGZ3\2_B=%:^*
MEU&[D>/5Y9YYQ$S#R\MM;C'09JA_P3R_:+M_ 7P+^._Q#\;Z_J>LZ%HNO++$
M\\[W,K(RXCCB#MP69E ' YR<5L>6?IE17Q5X3_X*6P7?B?P3:>,_A%XL\!>'
MO&=PEMHGB'42LD%PTA41DJ%4A3O0Y!. P.".:]4^"O[86A_%WQK\4/"MWH=[
MX3UCX?RLNHQ:A*CB2)6D#2H5_A'EYY[,M 'T#2$XKXW3_@I3X>/[.%W\9I/
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M[2_V65LK"YG6V\26;2+! S^4H6W^]@?*!COZ5^A&X4O YH _.+6O 6K^-?\
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M;EP/F(QQD^[]*X[3;KP7I6H^'?L4FE6M]J=@+31Q%M62XLXT\T1P@<F-5^;
MX%6O#?Q,\*^+]8O]*T77K+4]1L"1<6]M*&9,-M8C^\ PVDC(!X/- '3T444
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M#=*\ V#6]M=^)[2X:6[N[2 CREV=20%7@JF2HR>N?8;[]D7Q%HW[8OP9\;Z
MED/A_P""/# T&0SW.+K*PW$:83'S?ZQ"3GN: /"_AI\3OVM/B%\2_B;\$+;X
MC^'H/$'@YS>7'BR?3$,LB<!((U";0KEE8LR[EP1D]*M:?^W7\5=2_P"">7B?
MXC27UG:>/_#WB*+0VU2.SC9+A/,BR[1$% VV0J< #C( KZ"^"/[.'C#P#^V#
M\;_B3JJV \->+X(X],:"YWS$KLSO3'R_=/<U\D?&']GGQ;^S?_P38^)>@>,D
ML5O[_P 8V^I0BPN/.3R7E@49.!@Y0\4 =C\5/CK^U;^S_P""O!GQP\5^(O#V
MK^#]5EM!J'@VSLE3[)%,FY 9-N[>R@Y8-\K$#!'%>@?M3?'WXF1?$S2K'2/B
MIX4^"/PWN-&AU*VUW5S;W5_J$LB*^T6I+2!1NV_= ^1CD\"N!U_]G3]IG]IW
MX8?#;X<^+-0\*6OPLMHK"_F\263LM]>VZP@Q+)$23YBHV, *I;!)KLO'/[)'
MQ6\'_M<ZS\2O OA;P7X^T+5M+MM.L8_&$QQH9BBBC5E3!)V^5D%,DAR.#S0!
MQOPV_;I^*/B7]BSXT^*[C6]/O?%W@?4+>TT_Q';V**EY%)*BAVA9=N=N[!VC
MAAD9%8WQ!_:*_:H^&_P/\ ?M ZIXS\.7'AK57LXI/",&G*-\4JDJ\DFW.Z0(
M2=K#9O&.F*Z;P?\ L*_%W0_V>?VAO >I_P!@7FN^-]2MM0TV^M;OR[>9EN-\
MNY-N8A@9 YZX[5Z-\>?V2?'WQ$_8(\ ?"/2$TP^+]%&FB[$]WLM_W$3K)MDV
M\\L,<<T"+W@3]IWQMH?[<?B#X;^-]4BE\#ZQX>_X2'PWOM8XG@3RUF9"Z@%]
MJK<*22?]7FNC_P""?WQJ^(?[1'ACQQX\\7:A%+X:NM<EM/#5E':QQ>3;1D[F
M+* 7^\BY.>8V]:^=/^"K'AU?#>@?"/Q#H.M6UE\2=,4^'O[/M;A3>3V]Q;LA
MVIU*A@ZY(P?--?>'[-WPH@^!_P #?!?@B%%632=-BCN2H^_<,-\S>^9&<T >
ME4444#"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M_AO_ +#B_P#HF2N3%_P)'T_#'_(XP_\ B_1GYK4 %B H+,3@ #))[ "@ EE
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M2Z:.Z0K,J[8]S[7E8L01SGSF4G'I6YX(\$VG@73)K&REDEBDE,Q$@ "D@#
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MU%%VQV"BBBD,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@"IJNG6^L:9=6-W'YUK<Q-#+&3C<K#!'Y&I
MH8EAB6-!M5 % ] .!4M)M H"[V#%(8U.?E'/M3J* $"@= *6BB@ HHHH ***
;* $P/2EHHH **** "BBB@ HHHH **** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>23
<FILENAME>ex23-1_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex23-1_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1"  0 D # 2(  A$! Q$!_\0
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-Y/I29[=*+B<(=D?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>24
<FILENAME>form10-k_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 form10-k_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" &4 R # 2(  A$! Q$!_\0
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MW)Y)[?R%  !@ >@Q1110 4444 %%%% !12$X]/Q_S_\ J'.#C!C,@W^6!E@
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MV: !FV_4@X&#R1^@'(R3^!'.8B6; 8@@'.,8YY'OZT=22>I_3V'L.![XYHH
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M!S0!UV[ 9B,#8_.,CD @G&>PY]^.M?-W[5_QBU_X!_LW_%SXQ^&--TO5=?\
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M=^BYFE",*& X&52I34I2P/%LL.N:7M&WST^*:D%/5<]K.,KIQBURK^B[P?\
M\%[/V>M4 3QK\*_B5X2F(S))8+IOB2U4DXVQM:SV]PZ $E]T*G(.&QD'Z/\
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M3[I]@ZWZI-)]KK=7NKK=.S<7JK,ZB>^AM4$DEQAI0K)&@9Y)%?()CB#Y0
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M?B5?II7PY^&_CWQ_J<F[R].\%^#O$7BB^D*J)&V6NAZ=?3D+$1*Q\L!8_G;
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M?"8:M\7OA3;^;>7/V"PDN/&/A.T,CE8M3TVU>XDU33+6(*5U>QA@0?.TT"@
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M^!CDC!/XC@^HX/%+10 4444 %%%% !1110 4444 %%%% !1110 4=U_WE_\
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MCBBA0RS22.-BQQP(=[[^Y1"Y)X!/!_8?]CC_ ((*?\%./VVSINI_#;]GO6/
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M;]D_PAXC\16T83_A(?B]J6M_$_4(VCC7-Q!:>*M0N='CFD<;W"Z;$ PVF,;
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M6Z'>S:3DU%OEBKMV5[)772_HDW9[#1]FG8DQO"S<J0",L>I#EPX&0WW&4 '
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M?;ZC:_&#]E3X%^.[/4[:6*XBUKX;>&5U.\1V7S9I]6LK"RU""YW$A)+>[BF
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M-"L5GKOB58F>WO;'X1P-&\FD:1*IEM)O&%W&NHZBJ/)IL4:,EV/R@_X+B?\
M!P-\8O\ @IQXGU?X-_!V?6OA-^Q9X<UJ]CT;PC;27&G>)OB^;6Y,=CXN^)TT
M<R>?93PVQOO#WA I#;Z.M[<1ZFEW?,OD?SP^#/!7B[XC>*="\#>!/#>M^,?%
M_B;4K?2?#WAGPUI]QJ^MZSJ5R0D-EI^GVD<EU=2%58CRXV1%#.[K&K. #*UO
M6]8\3:OJ/B'Q!J^I:[KFL7D^HZOK>MWUSJ6KZIJ-T[375]J-_>S7%W>75Q*S
MR2W$\TLLTF7=MS 5^Y__  2Q_P"#?K]LO_@I;/I?CO\ LQO@%^S0TS/>_''X
MAZ9?0QZ_#;7:V]W9?#GPUMAU+Q5?NOFQK?*EOHD#PYEOWXA?^DK_ ((N_P#!
MJYX:^'MMX3_:4_X*6:!;^*?'HETGQ'X+_9GDOK&Z\'>%64K<V]Q\7GM&O(O%
M&I(9+:1O"UI<#3].GCFM=3@OI@##_;SHV@:5H5CI^C:18V=AINCVEMIFDZ=9
M6T%EI>DV%JHBM;/3;&V6*VM+6W0;((8AA(U5"=HQ0!^.W_!/S_@C-^QO_P $
MY=)L&^"'PDTWQ#\07MK>SU_XV_$:TLM=^)&LLC&2>\M;VY26#PGIYF/F6=KX
M?@MFAC8Q2NS#S&_7B/3+:Q,(\/SZ5%=L,37%PS33*6R9%B(DD;RQ(0%5@&(Y
M9@>O,>)O$DMU-+I]J3%!&6BEF0@M<8."&. 8]I&%4 JX)QTS7%0.L<T8(>-5
MEC!*[C(5)RY4JPZ* <EL ]<B@#N/$,_B6WNHH9+MU22,&%[!#;I)(FXOYD8W
M.6'&78 '(P2.E2PT^YG6ZG\00W$@G"+#<NSF<S.1M,* _-M4G<6V[1DD@#-3
M/K+7%[&NER7$A?\ T<RW9S)Y48!:.VB7+*[?\M)'4A@1M1< T[Q=\3O"G@2R
M>Z\>:]I.@06\1EF:\E*W/EM'F..UM(]]W=74J$$>1$R%FV,J]: .EL]'TV&/
M&D7)61G*2.S$2S  .\*OR(2[K\_)5@"&8'"FS<:GJ>FPN;NW6:V59-Y098F4
M );0@J-RHF/-?< 6SU/!^"?%W[:_AV6ZN-*^#_A'5_&FIFW5+.Z:">VL8GF)
M\R>32XUEU2;<@/S&.)5?9EE4G/(_:OVZ?BNME(MG:?#[P[+YD22P_8]%N%M5
M4$RW6Z[NM5N2<EHO+2%P<AE( 0 'M/BOX^?#/P=XWN/!/C#4;CPSJ4UG9ZE9
MW]Y92-I=[;WK.@VW<>YHC'+$XE\Z&)(W3.XJI->T^&#%XJM(]2\-:SIFK:9*
MEN\5[9WMO<PF.YDCQ(S0-)T7Y<$=&(([5^8'C[]D'XD3^+/"-E<ZY=^-=8\7
M+?F_UFX>=;#P_:Z=)YKW%_>W\F9+0F>22V./WDNV-4!:OT:^!GP%\(?!3PU_
M9_AG57O=9U.WM7U36[J:1&N&B9_.:R3Y/LUFLBNL!P-P.X[E"@.,FG:,I1<U
M*DW%)R<:L*E*44Y)QCSQFX<\K1ASJ;:23#>ZLGV;=N1IP:J+57G3<>:"O:3]
MUIJ31\H_"GPG:?&+_@I%\;/$_BU&UG2OV2_A]X$\&?##1+_RGT[1O&'Q%TD:
MUXI\70VKB5#K-Q8E+*VU/;YMO;OB,(Z$FQ_P5W_;J^.'_!/CX%_"?XX_"?X<
M?#SXBZ'K?[0/PR^$GQ.M_'&M:QI=YHF@?$S7[+PSI.K^%;;28W34M3AU:Y9;
MB"\FA@M[=5F9I,&-LS7O&,7[(?[?.N?$?X@S6ND_ K]L+PKX1\(CQTQG.D^#
M_C#X$M'TW1['Q-=1I)!IEEXNTIQ;V=Y>%(S?Q*))HD#!OH+_ (*#_L1>%?\
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M5T6TVQ@_>2S1E)))BN @E+,-SCY0I;<_. <XK'OO%>I7#3P6[BUML*J[=B3
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M(A\4%?%GQ]\8:WXKU&[,!.F07-Q*#J6Y7E@FU*YED:ZA51AOL$%I;9!\L+M
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MQ$N%&0@V@4H:4D[6C8CJ!" 1GC)(=BO!/)&,$C(SD?G;_P $TOVRK/\ :Z^
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M;1?!OQ*T7PY?+J7@[Q'*J_V3KJO;7;W+Q6E^J"[*J9+BWDF(0AG% 'ZAR?\
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MI]E:1R3W$\\TRJB(A"+EFVQH2/\ 5(_X(B?\$=?!?_!+GX,VFN>--)TGQ?\
MMC_%32;:?XK^+VLX+A? 5I=Q0W%M\*?"%PYN'6UT5MR^(=3LIK8ZKJ?G)<PK
M9V\5N?RK_P"#8/\ X(XCX.>!/#__  4S_:)\*Q_\+#\>VCM^R[X5U:%9YO"'
MA"YB;[3\3[O3+B("W\0:_&QMO#PN?-FL-)Q?1_9YKYJ_LDL+M88KRX:.234;
MG?$MT[EUMTF/[]UW?,TI.X*Z*N=QV@]2 =1!)?ZY;RZ!<W^EVY@/GR"*U 1%
MA"'8+B,)%"T>2FU %3&. N:Y6>V%G+<PP2Q3/;K(5FA_?*TL:M*FQ!\LC!D!
MVNR*#U8?*I$EAA@;9-,M[+((DA3A3&5&4D8$;Q(=NY2<@#+8.:; 94$:6_RQ
MI.+F1BNZ:0C]XT1.-[#:C,JJRNP7:IYVEQG"#52;E%4E.K[2"YIQY5%6<->>
M$F[.*3;DMK(B:<H5HIQ?-"C3J0FW&"IUJ[I>U<ELZ<VKV][E>A\Y?\$G;#3$
M_92GUR&VA7Q#XJ^,OQHUOQE=Q^6U_=^(9/'^L6]R=2N #*UW#;0V\2QS.QAB
MC2 ;4&#_ #:?\%)?VB_VO_@K_P %4/'/B;P?\:/BCKVM^%OVKOV+/!/P6\'>
M /V@M"M?A1X2^"WQ3L=#T;XA?"+XB?LR1W*^)?%_C/QG=W^J>)8O$<>G36>G
M:>RZHUS&MN\C?N3X;\8>(_\ @G)\6_'>H^(O#>OZS^QG\=_&L_CMM9\-VMQK
MNI_ /XC:Y-*?%;>(]'CQ=P>"/$M[.FI+=V!N?[.:WN7:#]XRO]-7NH?\$POB
MKXZ\/?MEZO<_LK^+?B5X'L(U\._&S6IO"A\;>'X;5&@A4WU^8M4M[S3XV>TL
M3=VGVVPB)@MW@7*5]]QCE&99GGV+S_+,)BLTRSB6LL9@,?EN%Q.-2^LTL/)9
M3.&'PU>&!Q^!J0G0E@JL*484*%"I"I*%2*7YEP1GN3Y+D5'AC.,9A<GSCAFE
M4P.,P.98C"8-U'A:N+MG-.6(Q="IC<NQ\*E/$QQT)5:DJU>K3J4E*#<O;OVY
M/#WA+Q'^R)^TCIOC:6&U\._\*F\:7LUW.R1)97VF:9<ZGI%Y#(V/+NK;5K:Q
MFM77$GG[?+)<)CYD^&/QXL/AE^Q+^RK\2?B?I?B+Q#<^+/!7P\\/ZBUE"()%
MUW4M!*VVM>([^^DAM--MIK>QC7S;R1&N+F:-2^[<6\C^-'QN/_!1G5[+]F7]
MFW^V+S]GV]UG3KG]HOX_3:3<V'AB_P##.DW\.JR_#OP!-J"PW&OZGKDEG''J
M6I6UJ=/AT^66V6X._:WV[\:? /PA/PGATCQ5HBZIX#\!6-I<:3X9M-:NM(>2
M/1;%-,@M([BUO=.>YCCT\36U]:S2S13V]RHDMG2'>.7-,-5R/A/+<AS*$J&;
M8W-L3Q)++)N$JV4X&>$CE-#ZW34JD\%B\TJ4ZN+6%G4YY8>DJLJ-%R43HR'%
MT>(N-,WXCRJ7M,EP.4X7AM9A34HT,YS&&)GFE>6%FX4XXS"913KPP<<5"%EB
M,55I^VJQC&WEOAC]K/X+:S8?:[D^)=+O8]5UR!M%O?#6JW6KWEEH%S?6VJW>
MC0Z=;S1:_8:4NG75UJ6H:8\UI901LMP8FVO6W-^W%^S1<WNAI;>*KB^LM5$5
MGH-[8^'M;O7UC5R+8G3-#LX[ 3ZK-;)<J]\]N56QD#6TS;U9Z\$N_&O[$&OV
MT'PTU[PYKVG3:)X?\8^(?#&GQV'B/PW*?!5G!K^J^*-6\-:II>K6ETF@:D;3
M7;"X5[E%O/(N;>6V*#%<;8?%7_@G=X3\(^!?B7/X0UGPWX!\"W6I3>$_%VH>
M%?$L/ACPDT.HZAHB7MW?_P!IW-_]DUG4]"NM.TFZN;2X6\N+*62X$#/#(/BC
M](/MBU_:(^$FO7]MH'A'Q'=WUW)I/BCQ59O!I.IBQ\06?A71DU[Q##HU_P"0
MD.IZGHUE)$=0TZ _:(Y9HX1$78N/+_"'[<7P=UD^-I]5N/$?A23P?J^EZ9+?
M^,/#=]86.H_VIHFF:[:6>DSRQB&;4WM]4MXUTH2?VG.\B%+=$96?YA^"&N?L
M:>)?CCH'CSX9_$7Q??ZQXDE\1>#/!'PNN- U*"!(O'.EV-AXA>QM;:^O+66P
MM-$L[?4]2U&R2V_LVTN5O=4NY&$4%?2/PY^!GPT\667Q]\-:[\,-#'PVM?BK
MJOASPA:KK6OWFM:^-#TO1=$U7Q-JFJW&HRWD-R+RRBL]"FLY1-;V.GV\I8.K
M. #Z]\$_%#PE\0_"=IXZ\)7\6L^%=2A9]+U6!I"+YH+I[.8"&1$E@(N(I%E3
MYC"5\F1F;+#HVBTF9X[7:R$D:AY2D*6W;99&F.T [ 5&" 0,CN17+^"?#7AC
MX=^%O"_P^\)^'HM#\-Z/8FTTW28'DNX-/B:66[=7GNY[NZFN99Y)KF:6YN&:
M1Y)'W.Q&>C^TZ41=W^\Q%]UB\@W#;D&) FWA0WSDE<9 !/ S0!*+)9HKZ2TO
MLO?,%64MN\J")R@BWJ5)(0$KW"MM'"KAT,.H)-F.[;[+#9"&..0Y7SV!(WC(
M"'(^7A>6!YJ>UAMK%(;""0.40/MQESN =I6WX[-DG) P%;T&;)I]TJ7\D-VL
MDE]/NB8,?+CC0 ,5ZKO );@\<-[T .ACUK;IT;E7/G,;MC_RS4R.4C/W<Y 4
MKDG&2#R0!&UYK$5OJ$KQ#<ETD4'[L$^4[@2*J_Q)C<_S L#GG%63%J2ZE;LC
M#[(EI&DH+']],J<,%/RLVX9W' YQD]JOGZV+2-FA)N_M8."J%OL[-D%L+@94
M@G('!P<<B@"V][<IJ"VWV?,7V!)2^WF.0 ':)#_"W0C))) )QP<Z\UNYATRW
MO9++:H^U2W(\HYMXK>.6<NJA2"VV+B(O"9<D+("*GDU2ZBU&2!H!]FCMN'/_
M #U4 K%U'RE^JYP?3J#0EU>[N-.'FV"L]R\EO<VPA9@]K<1O!.B@E5Q+"[KY
MH>-H1^\C;(S0!\=V/[<7PPL-/NIO'>G^(?AO#)I-IXI\.W?B2P%[8:]X1OH]
M3NF\1VESHK7*16EA;Z5>/J0O5MVMO)*LZ!MP[1/VSO@0]A::U'XR5]!N([:.
M^U>'2-2N+'0;^]NH[#2[;Q'>6MM<6^EG4;]TCTXW9'VY'7RD^8-4FE?LN_ S
M3IM>TZV^&>GWMKJ>G7]M<+K6IZOK4LNE:AI]]IMUHJ/JFI7BII4UEJ=[8V^E
M0O!:V0GEN8HE8@MD6_[&'[/Z:-X<TH?# 2:9I$ZS'2SXE\5M;W,L>H1ZA83Z
MS;-K*Q:W-IL\*S6$FM)>BS(4VRQ!5"@%[1?VQ?@[XC9XM*\1W4EUI.I1Z=KG
M]I:%JVCVD%Q-;V.HI;M>7UJL0OCI%W_:T%D@DN)=+5;]%-O, E.__;$^!=I:
M:C<W_CVZLI=%FLK_ %&"Y\.>(4NM*\/:A-86UIXDU6R>SBN++PS=7.J64%IK
M4RKIUU)-A+M&1XZ]!_X9W^&L-OX@@A\!Z;'%J>LV>M2/'/>@7E_INC6WA>SG
M!^W$J\&@V=I:0LPW *-IVQD#R+XV_L,_#KXYS::DEW?^#87T?2=$\2-X>GD@
MO->T30)M)FTW1;BYENXRUK;S:)8[8+AKRP9!(39B01R$ \X^/]K/J'_!1+_@
MG_HVN00S^#3I_P ;?&6B&Z8O:#QK8>'=-@TME2>/RFO8["2X?3R$2YCR9(BK
M#Y?<_P#@IAJ?@?0/V-/BIJ_Q-_:O\2_L6?#K3TT:[\;?''P7<6EEXRLO#5OJ
MB3ZMX,\)7T\T%S9:_P"/($;PYIL^DF75UN+X1Z=!++(4/-?M@_ +QO\ $OP;
M\/\ QY\']<MM*^/G[./BB/XA?":?4IF72M;N+2+[/J_@?5Y90Q&G^+]&232S
M+/EXIY(III!-&'KBM'_:J_8I_;2\"/\  S]K3PIX)\/>+!>6O_"?_LY_M&Z/
M80VL'BG0+A3;7>E+KO\ Q(/$EA%=N+_0M3L;B5WM;A7;RY4P/N\QP.-XAX9X
M9QF2X7$8Z.08&MDF=X/!49UL7@,9'-,?F.'QM3!T85,1+"8W"XG#P>-IT*U-
M5<-.%94[TIO\ORW,\MX7XPXMPV?8RCET.(L=@L_R?,LPJT\/@,3A9Y;@<HK9
M52QU>5.A3QN#Q^6U'+ U<11YXXSVF'G4;JP7AG_! ;Q'\3_&'[%GBGQ3XZ^+
M'B?XG>"?$?Q]^(^O?L]V7Q$^)6G?%7XM> /V>]3_ +-E^&GA3XI^)K/4]7O+
M?Q.^GA]=.BZY)#JNEVFI6RW=I;/(%'K_ (%>;1O^"JG[3VC>$K@W&A^(?V?O
MA5XO^(%F@$=K9>-[?4;;1=.DE9"$-W>>'8U>5RQG4)$@.&8M</Q\_P""?'[
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M4%;BRN8CNANE1@%=0P_R'_\ @MQ_P2J\7_\ !+?]K+7/!VGV]]JO[//Q2O\
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MCOQGBG?)MW?*,C<H8\YR!@9X"\9X!ZG'84 ."< ^8O &%50C8(&!@Y)Q@ 9
MSMYYY (Q@=23@$$D@\\\<9Y^F#SVQ32?,3>J'/"AE;D$J P+C!)!&T9''&,D
MG#09BV" 4.=I&=Y/5<C /!Y/(X!Y/.0!5&6)0*CH>&VG#-GG(;[P&.".G7G-
M E"OB4A4"X&/XI.H* 'OGM]TG'U;E2R[G5B/DRAV\G: & P >2">O3'\(I[!
M1\JA<A@3QRN!_>.2,GISD GK0 A*N-IB=@1RS?* &!'3;G!P?3 P#@ $50[J
M&MU4"-6$8!&#M8@MCKN.._';).:EFDD"9\M\!2_F9&TG .WGJQ!R01C)//)S
M02=[AP.%=<@'(.['!Z9&,8"G R 1TS0!HAEVD,Q<G((4X /0;ADC:,#)]QTP
M,PONC(+-&L)YR"&;'4QG!Z 9&?8< 8H13&65AG<0&+8R0WRY&.@YXY!!![<4
MY8XT<L$4C:N5 W$E@,@AB023]XGGG.<<4 -\J"9(G\E6#*1@D@%01EOE .&.
M5QZ,6Z"O@+_@HK_P3J^!/_!1WX%ZI\(/B[IJ:;K]K'/=?#7XG:=:6;^*OAWX
ME:)GM;ZPNIE_TW2Y70VFJ:3=AK6\M;N9QY=VD$B??X81%4=B4Y"NH&$R20K
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MB?X<:QK>GW_A2^.MW?A^QD<2W[VIE O;=8EC:6XLAA%MI$:&>,'*;V%?4/\
M;%E%90W44#/&MT+%B HEA7(0C<,.5R22#D$G&&[5[V^OA<W$"JD CB6:UN.$
M5EEVN4\QS@[B07.TCKC@8IXK&XW'5HXC&XS$XRO&'LU6Q5:IB*O+TC[2M5K2
M45NH1<*:E[RAS:CP>#P>7T7A\#A,)A*#DY2H87#8?"TIMJS<Z>&H4(S;6G//
MGG;W>?E21X?\ /C7I_QV\*0)?36UCXR\-,EKXDT@,P-U'$@B75K2%U,T=M/(
MLL4P(8PW<4P8JI4U[Q(MIH@02QQWD,TGGVUN[&.:&0#S5*RLS+E01\N.O(Q@
M5^:/QN\'>*/@3\1?#/[1/PQMGMM%N9H4\;:+&'33A=7<KK<M)"<6\>G:G%-D
M#(1+T (%:137Z&^"=>T3XH^$="\9:=>_:]/U:Q6>&.("-=.NVA1;BUN(U#&.
MXM+@O!(CDG"H>,BN:[>[;?5NUWYNR5WYVZ(W225EHELND5T2[)=%T-^'Q#'=
MB2$VDL;3++Y3Q,#M&<Y<HHS(Q!&5ZXX_AK\Y/^"LG_!.OP-_P4__ &,O'/[/
MVOZ3%9>/=)M-3\9_ KQK=0627OA#XF65E,^D1Q/-Y<D&D>)75=$UJ*.>,7%O
M=6[R@&VS7Z+VV@R6]QL%TH4I'(LH0MM"'&".,Y( .%Y/<]3O?;KBS9FOXB8T
M5B+V 8B*PJS!)$!#JRE5!5\QN 8W#*10,_PE/BC\-/''P7^)'C?X3_$SP]?^
M$_'WP]\2ZMX2\7>'=3@DAN],US0[M[2^MY8YA&SQ&>$RVTH0Q7-M+'<0,\4D
M;-_=#_P:%_\ !4JYDD\4_P#!-+XP^(U=4AN_'O[+^HZSJ<,;)+:F6?QG\*K,
M7>QKLWCW$?B'PW90NKPJ-:LHXF22$Q\9_P '?G_!,6TT#Q!X6_X*:_"30[>#
M1/&-WH7PU_:1ATP[8H?%JP#3_ ?CO[%% ELD6NV%K!H.J7JW!>?48K!YD+R.
MR_Q7? ?XV>/?V;OC3\+?CS\+M8ET+XA?"/QSX<\>^%=4A".8=9\.ZE#J,4<R
M.C1RV=T(GL;^UD#1W5G<2Q2*T;T ?[L,198U>/'F$ \X(+% R@L.[#(VCD_,
M."2:?:S7+(5GBA:12S#[.9!$S$$ A&)Q*NX9 ;RVR=X/RX^0OV%?VM? W[<W
M[)'P/_:E\ R.NB?%[P3;:O>V4J10W>A>,=-N)='\9:->06\DD5M<:5XBM+V(
MQ*[;K-8)%4*6(^I+:*:S>6-IVF=OWB012'S)MY.YUW#[H&W."",@$9YI-735
MY1;C**E%VE!R5G.#L^6?+>*E9^ZVK:BLKIM)VG&:3U5XPG!*UU[MYJ=M_:0I
MRNN6S_DC_P""S/[+_P#PI_X^Q?&?P]H4VE^"/C=+]MO5'SVMCX_L;0IJT,2H
MJQ0KJMM!)JRQ8!>3SI0K,A)_/K]DKX^ZO^S-^T'\.?B_I<TD=EH.LPVOBF%
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MXBTJ/Q%8VD>AWMS<K>-;6L"OIL4&B+(H>=6+.E_?S+*C@,T4D<L9QE:]P3+
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M//3&"<G\.H]3^>#Q4+S! "J.Q;[ISDCIM)&,<9Z'^+OWJR1GK^' P/0XQ_\
M6]J:8P<Y Y[<@#KR,=2 0.V<#- #(]W&Y7W99BS$8ZL,+@9# ]3G/4C@FGC=
MG! (X .3G)(QU)P 2>G?D8Z4[&#U/?J2>I)[_A], 4O=?]Y?_0A0!E26TIER
MI^5MJ[L\A1AB.O&=F.<'+?05> C4C*X.=@)'!V@=,YQ]XC.,$$=,9I%D#NBC
M)*KYC'NS,"O?K][/48QCK4K;2"&& <9)^O'()[_YZT )C!R<%2"=OW1N(R&
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M]3S*"49"-D8RR8(8@,N>#][ P#UX!.* )I0K#9&I;!&.1@8 Y8]#DDYP1T'
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MYQFJ[1QMOE:.,F-!M)PI4 %=G &0$(!4''08!P:62:=>JQLKDE"%S+&I_B&
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M;2_LI53?#)$61@2=W^*'^TU^S]X\_97_ &@?C!^SO\2=+O-*\9?!_P >^)/
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MG-3[V8D+Y@53@GRSR^,!3SU(P>N0<>F*5BJ* P90<$_N^F.<@Y(ZC&0 <<T
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M\UQB<O<")VLX$2,D&0S&,1Q'Y2X4%QW^.?V)O!L^LW/C3]H+5]LFK^(]9O\
M3M&C:W>66,R@R:A<181O*$LLR6H=B4 B.&."*]!_;;NO$WB/X;^'O#OAKPYK
ME_:>)_$4=MX@O-+TY[Q;+3K40I9"]DA4D07$TWG3&3"[4Y;<L=>\_#;P5;_"
M;PUX4\*Z6\[V>D:#9"_;R4C-U>A"U_(PC^57>[#9$@,N$&YBK;0VFE%VE::O
M%\LDFN[YN2<'Y3I1;>FA2O).249132E*$X5%"3VC-TW*,9.SM%RN[/LSUM+X
MQ166G7\1GN[V-C,@ $2(2HW2X; (R=X)&,,,$57ETN*]OK*:&?<+:$C9"RYC
M=01&.%("Y;:5).68$,,;3#9Z[8WRRW#VIM(X \/VNYVN6$F=P0*H"D_,0#DA
MB I/016\$UI#'#I-SY[W<R-+*Z;2L857<#D@+O9<@#[V.N:0$O\ :NI:3#,^
ML6\DS3R^5;2%D<! P$@*Q]-J%7 _B+8SQ5CR].OE%A*!')._VL6T08+M7@ES
MM.1(&!/3 QC.!5BXU*&6:[LY[12MO;F2XFD57CW@8+1@C*ME2<C!(Y/"BLJ'
M[-!+-J=M*[V\B"V%PY;=:/GJRDDM&Q (<$#:,J,Y% &HUC,-0^VQW"_9[:W\
MN*W1L*Y164PE""#R<9XZ#M6-)<S+I#S:C;N"]VZQ18$3X+$1NK!BJA>A*C)!
M  YS5M(=3L=.A6V87<T]P\[MEF"1,W#*3R%P1DDG //&:NRW:->P:7<6X=VA
M,DCL4EC5U0.K(CAL$9/(^M &0HM+B)-)U2&-3,T,\.Q2/-&<AB5&Y7X*ECR<
M$]2IJU+I(DU.TGCO$$5C"D(M,EM@&0I9^2A4  ;]N??D4FS2M3FFN(9G6>R0
M0F5B(TA:/&'ZGG)P W!XQ@\50MX)['[:!(DEW>H6BEX59D(RK;@-V6'3/(/J
M: +,1U.U.I33[F*Q,;;#"7< Q(954\$[QA3ACC/(SB$ZK=6^DPSW4#RW$T^W
MRW'W8^@8KDD;N1@CH%ZYYDF;5K2PM(8E:YNFD 8G>Q1>"5))(;"YP"#GVX-/
MN+Q6OX-/>U)DE6.265@-J% H( <8 !)/<9!QZ* +=7MM)+:65Q;;Y+B,2Q(=
MIC24Y*C:/F W* 6 /5LA>:C_ - EU!VB"/>66T2$,1M558R' Z8X/!X].E1Q
MW%I/>2F)E^T62?+-. 2%C4@JGIECR<'KCHM5[1+%OMMW P+SQR)<3+*@,>XM
MO^5B.A+=.H[A: )(+2S1-0>TE1EN0ZS/N!$<G&T$D@Y+ #KU&X'! JC)I?D:
M8+.&\!<S[_,)(1TP#A6S@\#@Y!W8..U"V%M#I-Q"DYVW#K,)PA.TH2 N5;!)
M(R023DD<@8JA<6\DUI8P6]XB?9VWR%V)RHYVD;L') 4=<[L'DG(!-/:WFZQ$
M4[-%;*HE)8;G);D@9^=N-I)? &T\YY%^V'4Y)$??;A'5>R*Q R=I_BR,'D#/
MYBZK2-@'"IY<8+D[2Q7(8@'CG(/')X!YZ2;3%&?+!9F=@H/1F52W)ZY)[^W)
M% &5:B^,E])<EI$.3;[L#YQD@*H)P0<$9YZ?6FQ2ZJVGRF0N]X),A01NV*><
M L #@\C/ )Q[);'4W%WYX",C$VX!/+8)  P,X'8D\5''-J@L9)ID1;H!F &"
M?+/RM+C:!D+D [> 0< ] !9VU0V^G; XG#[KD*P+8!R1(<@ ;<G@-CG &<5>
MD_M!K^VD4XM1$"Z[E*A@06^4$D\$GD#/ ]0,.;5+U;:W:%ECN^!,"@**K,B8
M(QM.5 S_ !#)QUK9N)-1WV0M8XY$9%^V?*N%SSG)!QD<]1T!/0T 2VZ:FMS?
MM,SB"0,(6ZA2P<*5VG*@_+_">.HJ"2UNUT=X;B\,4RS*R%6?=.%?>L:$?.YP
M<\@#!ZXS4OVJ[M;Z:>9R^FK'@ !&RS?(%7!)!#L,DYQ@=!UAMK"^F2Y>\D;,
M@/V(.Y;RSG=O4C;ARK9QTX!QF@"W'IUQ=/97MY.(HH=H2W=0'?:J[=^7P 2/
MF)[D[@.M:MI86EO<70,A)U%55H/-0,%7:"4"YVX5>>#Q\H!)W#-;2[FXTZWM
M9[E1/'()&E&225*DAW)+Y)5BRY&<%L8!JZ]G;1WMC?R7D<4EN@3;+A1-(@"$
MCH"2#T(P<9Y(Y )8_P"R([.6-%6X@L7+$')E1T;[S<#=C ^ZF.Y).ZIWU:V1
MK&YAMVD2])@64LJ%-O"JQR2H&0 &.,#&>Y@A_LJ*ZO+6/<9[N-GDB;#1R [G
M95.<KUW<$$GC@$5''J-FEA<2VUONBT\X%O, .6)4,N[=N!ST(P<#UQ0!I>=>
M-J.I6(C6)! WV:X"E07&",,3AB<<LI(')SGKAZ[!/)IL$.KW$-O%';7(U2:X
M=%A.GR@+*))9"L:IY#RN6DX/W>-HKI+>Y-U;07Z?()2S*O5HU?Y6"D@X7<#P
M,#GC'<U73;.^LFCND@NH9E,,D%U EU!/%*K1F&XBD63?#*'*X9753RN'^:@#
M\C?A7\:_#7[,WQ4^)7AD7K^)_ NI&:70FT*Z2Z66_$LES8M&X985;RO]#NV;
ME%VGYF^6OUP\+:O)XF\-:%XDD@?3_P"VM)L=6_L]G$LMHE] L\<$LBJ$,BJZ
M!MI!RQ/0 U^:_P ;OV(X-/UC3_&?PYC#Z-_:VFMK_A."-B^GPW%]"9[S39"<
MO; 2M]I@D7?"BY1EXQ^F,$L.GZ796L".UO9:?9VUNL65C-O9V<,&%8DJK*8P
MC!0"VW.2Q-)M<BFE4<7/DNJ-9IRO9QBX0JJ<KII1BXR?1)Z(ZV;@G:_\2&BW
MN[NFT[;I0G9Z7EN]A%'E!A@,S-DC@$$%OF!'/?KC&3D9K\IO^"VO['-E^V__
M ,$R_P!J'X26V@-KOCSPYX#U7XL?">VMW6*Z'Q%^'%E<Z]H\4&[:'-_;P7NE
M+ 61IS>M$7*D5^IEG?"XMDE6&:-6.53RBX&,\A@I[;>3R><9'729+.\ADM[J
M&2:"ZM[BWN8WA<K+!-"UO+$ RD%G@ED#+]T[PQ&_D-Z.S3BVKJ,HN$K=^25I
M)>J#9V?*GO93A)V[\L7S)>;25]-V?X(\MO+;32V\Z20SV\CPW$,J-')#+&3'
M-'(K %'AD!C=6 (?C!K_ %>O^#7?]JY?VGO^"4GPY\(:T6D\3_LK^*;SX%ZI
M(\KSRW6@:?!;:]X/O)2Y9@ZZ#J(LD:3AC9+'D!:_SI_^"OG[,47['?\ P4F_
M:W^ MCY[:!X9^*VJZYX7EG@-L+CPQXYM[/QIHQ6$D[8H+771:*"6#"SZD<U_
M0U_P9E?M*MX+_:Q_:,_9?U?7IX-(^-OPLL?&?A?09;B0VMUXW^'-W<+?3VMI
MDQ-?W7AW5YXY)XPLDD-C LIE$41A /\ 1YEB8 /'\FQE)Q][R& RAVMC[N&.
M"0I.SD@D^/\ [3'PNA^,_P"SQ\8?AG/:6VH-XL\"Z]8:;#*$#?VC%92W.E2H
MS<"2&]@BDA&5(DV_-G%>N13*47,<VTKLRT3@L,!7+85L,Q4EL'@G<OI51-;C
M2YBTA(':259/*><A5-NA)DWJ?FW@!B ".0,X%88O#0QM"OA*D5.CC*$\/73^
M)J5*=*/)?2Z4M+M)66MM5V99C\1E.9X#-L-4]EB<LS'!9K0JQ;36)P%7#SI<
M[6OL_9T%!VULVDC_ #E[_3[O2+Z]T?45:WO]%O;[3;^WE4L]M?:=<&TNE<$J
M6FMKB(J&#  ,20X&!_7/_P $//C!)XW_ &3M5^'5Z[+??"'QW?:%:\R332:'
MKEO9:_9Y&XG:MQ-?0B8X!*L0JX K^=/]O_X62?!_]L7X\>#",VDWC.X\4Z8X
M4HKV'BV-=>B"J"?EBDO98>I#[!GH /T4_P""#/Q)NM#_ &A/B3\+Y;G&F>._
M $NNQ6C,BQMJ_A*X+-(J$D%FT[4)$<_+Q'SN"*1_+/A]7KY#X@0RJJHP5;$8
MG*ZE/GBH2A]9J5:;?.XMR:IP2T;;YK)K5_ZO?2(P6&\0_H[5^(\+*GB:F593
MPYQU@ZL*E.5=2E2PU/.(N$9\_*J&*JRJ6;BO9KF5]%_5=* 7@4>6$Q*K;P7N
M%D'\3'C .2,'/4=CFA;5%VM]JG3<VUL,?+4,#M+@*1L)[<=1SV,11(I5E5?]
M8V3DEMV8QN."Q')'&W' & <X&FFUT**O+H%('\0*L?X>N3M;(Y R<@9K^K.L
MF[<SG-2CUC:3BHOH_=2::;336O0_R6?+9<MK+F@TMHN$G[OK&-2*>ZO>S:,6
MZMGLI+:X>3*F4*^Q/W.2PX !R,Y!.#@@@Y Z]"V7&Y'4[3N!R%RN<G*L#N '
M'RGD=^<U3O(U>V:WE8@NRLCX# ,@W,H![!1@G&1D9[5/#"#';O!\B+'E]H/F
M.3@C<@.QE.>A7G'S#U8@9U4LSAN<$NN#@C &!GG(XR>QS@ Y+&&Y[9PV &8L
M&!'\(R#QG !ST.3ZD"AXR[ L#( 1M*L05(&!OC';J,<C(SC)R4FDBE9(8Y<L
M&_>$!0ZY##!]2Y 4^F!CKF@"QA7*%B#M)#D'JTAS&1ZXSP!T/7T-CDG)P.A
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M^,+SPCX&TX3^*/&,WARQ2?5;B-/+N);S7-9NE^V7E_<&X>'S+B6;S8H3GZ[
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M"!45 $/D09?,0^8L05W!N2WS<#J01C//'S#)-1/;Q@ @RC+<#S6'')P3R<
MX'OSZ"W374L  <8.<XSV(]O6@#/E201,8Y)FD"G:I 8YQQMZ@]3QN^O -9>=
M2DTJY:9"+O<%VA%4F(E067'\0(.1G..?4GH/*/=P1Z%>/T8']:J7WGQ6LKVY
M9Y$"E%P7.2V,*-P+$@$8R>IZT <:1=&%5$>V7Y 5V$OD'[Q&.,@*<]#G(((-
M;=W<ZC8VMBZ;S&J@7("*<;N0G!+9;H,#.,=.M.:ZNQIKWGV55N2RB42+PJ G
M:QRF03M)QR,<9(S56>35+Q+&XCM@T D4; 7(:0.I+2#&"F<[6(P%P.1F@"]
MM_>:A#<3P,EK@_+\N(P /GP&)+9(!VY^^<8YQT\:8(4YVD\;CD@?,2H(R<#
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M8QKZ#JC6,MW&\.V:]T]E8P@;?-17=WW!2!^Z:3S.!G! /R *)8;R*YOYXTA
M-B'E2=\-WQ(0N<[1SUPQQP"/O26=MIMTUQ?63KYTI:.:0OE5_O9& 5&X8QC.
M>>>E $%M:+)?RZI'<M*KP81.5 =N#'QUQD'G)^;CA<"M;0:E;0:A<W WRAI9
M;<$EF((8J O4@CG'4X&#G.(;2SO-.&I6T$PDNKB+S[4J0$)# -Y?(*R#')?
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M5"\2,P)S"/4.6.<C.00 I'7 SCG&",5"J2*7+$2IO&T]R!W?CG@CH, X]!@
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M%7COZA #T!+D_I@9_P :9L?)+;58\AE!Z]"3C..V<D _-GJ< #@KJJXP8R2
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M@;6+.A+G:3R-N,87 P.@R#CJ0#CBFA"5990DNXDY91@#&!COD9/&0IZX!ZO
MQSDDX Y]LX_GCZ 4M %%D=)2D+$':3L/*E>/E49XY/Y_48CB+[5\Z!HQ^\5@
M"7!5B&/S$[L\[1D8!/(&.;&=W)(R0.G! _#Z_P J"JXVD KSN7M\W#'D]<#(
M_'UH S[:[,\> I9XCY6"I 8*3M<EN<A6VGY2>-W4BK9AWN3)M8 !0B\1],G=
MSEN3R<]3TQU2WBCA,\<:!,@2$ DDH-Q*%CGGG[WI@ >DPP1P0-PR,< 9'&._
MOZ]Z (&/*)P0JK.W ^Z$*A,8 VY(*C^$@<G'-.'RC*J,/DMKBX9L@-DAD"GU
M&=V>?3^+%7$<,99=IV%C$G/1(AECUQAFPH'(&5/4"L^W=8KN_$IR[/MVA<Y,
MV]C@=!T7W'MV +-TQ8AL*X4HN"O#CS&"D 8VY4#..O4FI^A'(P&&">,A?F]^
MH4X_/CH*DDZ$,?*E50R(VY<9\O&,< <E6SSCD'..">=!*%)E*Y(()0X89&5&
M<@%@#@YSC')/- '.VT"'5Y&D23RUF<P@L0IF0K-N..ZH'4=_GW$G!4_Y2/\
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MVVN(%NI9I6BNF(=L!64 -R5.2258YP 1G&:V/(TN]U)6\\M=6*I\O7*G&%X
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M'WY5N61R>FP-O!.=PP, C(^:?V'=.2S_ &0_V;4E4ET^#_@J=A(@7;G2(W
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M4MO/#_HFR0J%YVC)"NK8&7R,#)X P..:I:=?"74[T>64#+N1B/G009 QU!.
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M8)((YP>G:LSPYID6A^'O#NAV:87PYH>CZ0D7*HL6GZ=:VK1*W0^6L2 -]WC
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M@#/7./<#N: *(>/?@<.I D4*<$YZ GUP!C !QCBIV>;<2IVHN2%;NS'&.I'
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M@XRHZYQ*5W#!S]XD>V2< ^H .#ZU#$6W>65ZC<LF<*W1B,$;@2$)R1@Y)[T
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MU,=KO\TFJ17+,"Y>,XCE <<_X<=Q:SVEU/9W,3)<6MQ+;3Q-E&2:&1HI(VR
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M)XW6 >)M(TN&POFM[G[5&RVJB.U?[2Z(9)#;+"LN!@2J4#$@&J/QT^-?@O\
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M'T/%2>6G]T'ZY)_,FHXARYR1N"E@, '.<CIT('./YT 2$N0"HVG/\6<<9X!
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MB9<<B$*9 $."<.$!XZ8(K16\U)]8B7+BU*;7AGD2.51D X4GYG!)QAB"-I+
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MXK:"*)2L2QH/PC_X*._\%Q_B!X2_X*?? +]FWX(?&SPU\'?@9\#_ -K?X7_
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MU&X9R/?H,X&",T Y6#J&! W8RN06X.X<=?R&0,Y'HA;D8!(5P2<'^(,&.<=
M3G^1P:C8 %I%&-A(;G&XC@X'09SQR,G@X!J,R>:H*ET((/SD<]1C\QT/![T
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M"ULI)"Y3/$<B'YPV.5).05ZD\=NN< 9]^'G>"RF(\V642L@P=T<' E3! !;
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ME>:2Q]3"24HTH8O!XK"I5YMSES0PU6E;$24:7/%5;KZG!8_B#$TLTH2K\E?
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M(<YP0-W;N-I"XZY.0H.1CYCQDBK3.4CD!!)0E?NAL@G<#@C)"GY >=N %YR
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M@@[E^7 '- $5BWG1R2N$+W,A.0=VY< 1A"&(&U?OAB"&.-I'1DD$J-M &/,
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M\IFA6-Q)_7U^PCJO[5NM_LJ?"34_VV]&TGP_^T[>:;JDOQ0TG18]+BT^QO\
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MUK3M0CEC;3+B$S+*)",B,*/,A<X5A-%M=6 ;(P17YZ^*OV4_BA\,=>N/B%\
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M@>MB\]X9IXG.>$W*=2</8NIF604W*[^O4Z3E'%8&CS.$,PH=(I8FC3JQE?\
MJWP/^DWD/'M' \/<73H9'Q;R0ITZ\JRAEO$%912BL%4JQB\+C:UN>6!K72;;
MH5JE-JW\$?\ P3/_ ."M_P"UY_P2U^)4'BSX">,6U7X=ZW>VLWQ&^"'BJ1]1
M^'?CC3XY56\\S3Y'=_#VO/:++%;^(M(^SWEO*89;I;Z&&*W3_3D_X):_\%SO
MV,/^"H?AG3-&\#^)H?A5^T/!9QR^*/V??'M]:6/B07NYXI)/ E^\R6?C?2'
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M7B"XBN?$_P 4_$&ES 3Z/-XCM;33;?0[&Z5[F+3I'8&/,@;]0(U2--K%FD8
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M5;E>F.H&?<FING7KMVG'&5[#/H .YY&3US2;-S#<B2[@5C5P"$Q@9Y&0,]L
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M%.C[1CEC,-55*E6IR5&2J>UE%R56BY23C5H<Z4)U8*ZC";]G)2DI--)GF?Q
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M .A"BCNO^\O_ *$* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M*K)3E%1;_O BC6)$C567:-S;NI9MN2/7@]^,<X! (EW =_7L>W\J_DC^'O\
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M1K86G6INW2I"+>JZ.W['HJF5W(P  J$]@1EMK'GG([DC(P00,/D4,5(;:ZX
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MCL&TISX=EU0:@DT#274[7061-T,H$?E+@L>  <FO8LD]3TX'L/2E#,. Q ]
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ME]&3^?-_V[?7X_$?0;SB,E]7\0,LJ1;DW*KDF8PJ-77+S*CC*FN^]O*^MO\
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MS3 @6!%_@5CUW,,DMDX))RQ[=_7T%3\]3C/MTP/0?CGZDT44 %%%% !1110
M4444 %%%% !1110 4H!)4XRI.?P&""?8]0,9.!G&:0 L<?P@_,?ISCWSW[ 5
M/CG\OTSC'IU(/J.* %HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ H[K_O+_P"A"BCNO^\O_H0H D\I?5O^^C1Y2^K?
M]]&BB@ \I?5O^^C1Y2^K?]]&BB@ \I?5O^^C1Y2^K?\ ?1HHH /*7U;_ +Z-
M'E+ZM_WT:** #RE]6_[Z-'E+ZM_WT:** #RE]6_[Z-'E+ZM_WT:** #RE]6_
M[Z-'E+ZM_P!]&BB@ \I?5O\ OHT>4OJW_?1HHH /*7U;_OHT>4OJW_?1HHH
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/,;N>>>1W_/ZC-%% '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>25
<FILENAME>form10-k_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 form10-k_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" 'N 9 # 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#^_"BBB@ H
MHHH **** "BBB@ HI"<?D3^7_P"O_P"O4#W*(0&5_FQM 4DG/MV Z'G@\=:5
MTMVE9Q7SD^6*]92T7=@KMQ23;E+EBDMY6<K+SY8N731-W,/Q'XBT#PIHU_K_
M (EUG2- T?3HGN+_ %76+N*PT^S@5BK37=U<-'!!$&!#.[JI8'DYJUI5_8:G
M96=_IMQ9WNG7<,=S97EE(DEM<Q2J&2>UE1F26*1"&1T)5E8%#@C'Y2?\%1C>
M?&[]G_XN?!SX0^,8Y?B-\-[;0_'OCWP;I3+<:UJ'@^0WK/I!MT+[S?+:-.\,
MB,8XP692 !7!?\$>/VMY/BS\+9/@!XK+CQW\&M)LEL;J6X\QM>\'![2*UN;9
M69Y7CT::>"SN7=W=G=5<J<U\Q+BG#TN):7#]2G?ZQE\L50QFGL:F,C7E1G@X
M5+\KKPI)RE3NIQ49-Z:'ZE2\+,?B/"_&>(N%Q-2O5RO.:&"SW(JL'&67Y5B\
M/#$Y=GD822J8M8GGI<M6,'2HX>4:BJ2Y';]K2[;B !@''/4\ YXS^'J#SBF=
M,D^Y/X\FHC* 6)#DJV'PC,P;' VJ">1@J%W$K@@'FG*XDW!,D@E3C!(('/ )
M((ZX(!]0*^GNNZ/RQ-.]G?E=I>3[/S]+^H[([\?4C_&HS(V2 %(&.23Z ]OK
M5<HZL%+-O(R  0S= % 8*22<D!<X^;<0 *56X8!@Y0D%@<J2">%89!P1M/N/
M3%,+K77;<F\Q_1?S/^%'F-P<#C^Z2#Z<9QZ_ETYJ!GW*=N"003\R_)CYAO.0
M@)QP"P.,YQC%,WRYP%8Y#$?NV_A.''.,,AQO!Q@%2I8$4KK7RW"ZM>ZMWZ?D
M6.I)Z9.<>@Z ?@ /QICL5(  .<]<]L>GUJ$R2!2V054@%@K%3D*00P&-N&!+
M$J ,GH":3>3\S?PJ['C&U5<HQ8\K]]0!AB>5R!N%,+J]KZDGF/Z+^9_PH\Q_
M1?S/^%1ALY^5N%W'Y6Z9 XR!D\[L#^$%N@I<D=0 ?3//!QCZ^@[\D<4KKO\
MU]P^MNKZ#_,?T7\S_A1YC^B_F?\ "F$D9W(RC++E@0"RMM*#@G</O8QS'\XR
M*&)4X(R<J,*=V-Y 4GIA22,$X[DX"DTWIOIK;YO9 2"3KOPO3'7GKG\N/SJ6
MJW4<@X)*Y[$C(9?JI!5NV00">M(9&7C=G.<#!9S@ DA5!)4 C)QQF@"U1].Q
M!_(Y_I5=7D?&SYL]"J[@> 3M*E@< @M@_*.O((IIF8#=N&.><9X'?Y=W4\!?
MOLW"H3C*YE:]U;^O(-M^FY<\Q_1?S/\ A1YC^B_F?\*J>9)D D G& VU68$$
M@A&82=B""@8-P0.2%+RC@A@>< QG)VLR,% RS%2A)50S!06Q@'!S1[K7;^K"
M33U6I:\Q_1?S/^%'F/Z+^9_PJIYC^HZ9QMP<>N#SZ8! /.&"GBIE8[4W8RY8
M*#PS!0&+*O\ ="LN2<8_FUKMKZ#)?,?T7\S_ (4>8V1D+@D \GN<>E1Y;&?+
MDP0"&V-MP1D'=C&!T;&<'BE^8IN 904W E6&%)(R<KP0>H.,=S0!8R#T(/XT
MM40,A6\Q]K %6( X8X!(.&4=\L NWG.,4@RQ4*[MO5F7: P(0D-@C*G:1A@"
M<;D_O"E=*S[[>8?KL7^001U!R/R(Y_ TX2G^[D\]",<'!Z\UGX;!(=V Q]P%
MSR2H("@MAF5E4D %D8< $U)&=KG+,2#M(P#T!!Y!(P2,Y[%2..0'Y==P+OF'
M^X?S'^-'F'^X?S'^-,YY!&".WU (_0C\:* '&5N,+W[D$=#Z=/KT[=ZD5@W0
M^F1W&>Q]ZAI,9_\ K$C^5 %FBJ_(Z,P'IG_$$T9;^^WYC_"@"Q14*OM&&R1V
M/4@>A[X]S]#VS-0 4444 %%%% !1110 4444 %%%% !112$X!)Z $_E0!%(Y
M4_=+ *"<>[ 'MSQV/'\Z\<^//Q@\,? ?X5>-/BIXMNDM]+\+Z1/=B!B@DO[]
M8I#96=HCD>==W$NT11*5+ $GH<>QLZG'!R>HXR,<@$G.,\],9'>OQA_X+<?%
MWX+?!O\ 9G\+^)OVAO#'QP\1?".;QY;6.OM\%DTM[G3;]K)Y-$G\3OJFH:9%
M'IUQ=F5+0Q3NWG6TGFAHV$8\_,_KOU'%K+J4*V-G0J4L/"I5C1I\U6/)SRJ3
MC.,71NZL/=]Z44KQ;N>UPS#)ZG$&40X@KU\/DG]H4)YM4PU&>(KSR^%2G5K4
M*-*G.G)U*JHN@IQE&488B<KVBT_B;_@E&/BG^TA^V5\;/VJ-<U&\D\*Z]HFH
MV7BJ QJ^C:C>:[-/!IFA0!F,$LFC:7;J[_9FD2)[R1%PVXMX7\=M&\3?\$O?
MV]['XG>%+.?3OACXNU5-0T"+SECT+4? >IW*GQ9X8)1V=)-!NI+6Z6TE6.68
MP)<J9X[5@?VG_P""2/Q%_9>^+'[&7@GQA^R?!K>F> KR_P!4BUC2O%;:7_PF
M^E>*;63;J$?BJ/3IKF$Z@S/%.AB+1B*;RT\PJS'P#_@N-\9?V,?@U^SUX"US
M]KO2/'7B*TU#XBVMCX*T7X62Z,/',]XNB:]->7UO#JM]I]O+H5G%#)%JK-<3
M11O-;N<';7Y[4X'S"'#6#P\,2ZW$F"Q3SBGC*M=14\9*KSU,%+$N,K8>5.[<
MVN5S;3ALS^E<+XX9#+Q1SV6*REP\*\[X:CP#4R2CA']=H\-9;A/JN38YTHS4
M:N8X2]6$YN^(G0G!>UYHIG["^"_&VA^/O!7AGQ_H%]'-X;\3Z#I^NV%\90D#
M:9?Q&X2XF=I%$8ABE,DS-(DD8A*G'0?Q[_MC_P#!>O\ :\^.O[3NK?LE?\$N
M_AS/XON_#_B.^\,S^*;'0UU_Q5XIU#09Y(=7N=+M+^?3M,T32[.\M[JUCOIK
M](+Q'BD5Y.5'[9?LD>.M)^)'_!)[QQXR^!'ASXN^%O#.I_!;XR2?"/3OBVNF
MQ>-I4MO#&KQ:7>VG]FW-\B:;-J:.NDR%S]HMQ%/;A5P3^(O_  :@K\-XM4_:
MBA\1+HG_  T"^H::)EOA&/$DVAVAE75S8&\07)\O5A=2W;VBL20YN=J,N[].
MR^6(6$P_UJE%5X82E&NHRYXK$KE]HHR27-%/FM/1/LNG\R9G1RZAF>92RQU,
M7@:.+QM+*ZE:#H3CE=;$NKAE7I2E)O$4J:ITGS-O24KZM'DFN?\ !8#_ (+(
M?\$]/&'AK4/V\?@]J<O@'Q9JR0V&G^,_#6D:<NLZ5:30+=3:5XDT'7==MM,U
M?R[N18].N;>W:Z>)8C<3+%(MM_7)\+OVVO@#\5_V3;']LWP[XF>W^"K>"Y/&
M6M:AJ$+0:IH,=E;POJ>BZA92N3!J]C=3QZ<+:>>-99FB$4IA<2UYY_P4D/[#
M"?LZZO\ \/ KKPYI_P %I=2M[87NMF\354U:X5DMY/#1TI9]<BO4C9XV?3(6
MD0,K,V&V5^-G[63_ +)Z?\$#_P!I:'_@F]K>LZE^STDM_%<7T+^)FE2>/Q9X
M=E\5;CKME::C'IL=VEAYN8T@=9PD*J,O71)>TY4X\EI735]7;;=KSN^WR.%J
M,N1\O*Y22:M[MK;)_+MZ'P#\0_\ @MY_P50_;O\ C1XP\(?\$N_@IJFJ_#7P
MK<23V9L/#5C?^*;K24FDBMM9U[4M9U70K73H;U4CD&D&>>[5)#Y7FQ[)&[G]
MFG_@NY^W/^RG^TMX6_9W_P""K_PJE\%>'=>U2+3[SQCJ.APV/B7PK'?#=H^H
MZA=Z3?:M9^)-,-PRFZGCO_\ 1XE(3]]$D$GZB_\ !L['\*%_X)E^!F\!0Z+%
MXX/C'Q@?BG]GCTY/$G]K'6YGT=_$26K&XCBDT9(9-(>\\S_05/#.25^:O^#I
MJU^"[?LP?":Z\2R:!!\9K7QPMUX&F T^7Q$-$M8Q=:TMS:S31WSZ7/;+</:K
M,!;)?3O;J[3HC+?N-J$HV233:5[OOZ>9ISQ<W0=&R2^+EMKWOITUWT\]CZ<_
MX+8_\%&OC)^P/H7[%GQ]^!5M'XY^&/BWQAXR3XD:2!<'0O%?A"YT?PM=:%YV
MII"TEA<7%O?7<NDS")GN)E>%(VPRG]1/V4?VV?@/^U]^SEH?[2_PY\8Z1:^#
M+G0FU7QA#JMW%;7G@#4M.T]9-:TSQ+;S.4LI-'E2:1+B1O+N$*%)6G;RE_$+
MX@_M0? ?X0_\$]/^";'P1_;O^'\7B_X(?M7>$O$7@WQSXKUMKIM<^'.HZ-I^
MD2>#?$MA"D4<D1@;68Y9;N&1KJTC@MUM6>-I&?\ !?X^?\$M?VY/V=?CI=?L
MT?LQ^(_BWXY_9S_:8U#1YOA7XB\!W<D/@[Q9X(U>>WOX+'XCSP-!;:;<^'["
M\BGN7F#K<VB-*(Y+@N2.*\G;9^72_GY="(PBTHR3B^9KGMH];6;TV^X_=KPS
M_P %GOB)^U+_ ,%7/V=OV=OV=[*ZTG]E6+XC>(_#?BCQG<P^5)\6I-.\*:W<
MO=67V^Y@G31[+4+ "W>"SN7N8R@(M6.*^6?CS\7/^#F73_CE\:;#X4? ?QUJ
M7PK@^)GBZV^%^I6FG^#I;:[\#6VN7P\.7<?G^+!<&&XTC[&(3<E)Y /,F6-R
M8T^&_P!A/P+XK^!G_!8+]D3]G+QEJ5CKWB#X-?&CQ5X:OO$43$O<31_#KQ-'
M<V6FLKLDMDLP,=U)>F*\FDA$L<;-P?.['Q?_ ,%&OVOOVYOVM_V<_@3^T_\
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MG3? 5Q\0O#4/C75]5L?!,*IX+DUVS.NW%U%;^++BYMQ!IINF98X99&0 Q@C
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M!U'[-?\ P0B_;V_:D_:CT/\ :)_X*T^,HM<\.VE]#KVO^"Y?'>E>,;_Q-]C
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M;IKFT>[AN8;C]]"'AWM& BJ$K^MO ]!^0]O\!^0]*:P4XW D<=0AZ #C=V&
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MD:=IT4=M806=C;K'MM[>$F...1F>1A][S9)6.,C'<X&<X'X  <  8   X4=
M.GN<K14^\Y-MW36WGW;$%%)D>_X G^0HR/?\C_A3 6CGL2,]<8YQG';W-)D>
M_P"1_P *,CW_ "/^% "Y;^^WYC_"C+?WV_,?X4F1[_D?\*,CW_(_X4 2QDD'
M))PV.?H#_6I*CCZ-_O=QC^%?6I* "BBB@!&Z'Z'^512#YV';M^#OCCI@>G3M
MC%2MT/T/\JBD/SD\X.>@)_C?TH GDD'.&&P 9.0!R2#EF(  '))(P.<BH]Z
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M7\O&,[0F<[L].>PR13M&Z7M-7?MT^12FGOI^/Y#-HXXZGKWQ@GZ9X].GO2,
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MB>T\#Z9;7KS"&YGD@<36\BOM9;:$[S(&YWN3\O &.:_8#P[J>E:G\/O%VDK
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MFD6MW9QI \&M)K=UIFDQ[WFF=#<2>0LA,3ED.T*PR*^D_ '_  38T/PCX?\
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MQT!-26D&QG4("0@PRCC@#@9!'YD#@#/&3O\ D)]GA(7<-NTC&3UQW(..,_\
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M=S8Z9:E)EUK4M2GMXX[?4$D3</++8.!DR,2HQ@BOCCQ!^SM\5?C1)\,?B/\
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M*?7G''!P""3QQ4,>TJ=P)RP(P"1G"Y)(Z$'N<8Y&<9%78%8[3\I+8.0><#D
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MO[(WB3XUWUW>>//%FJM8+J?V#1-'LKV:WT6*V@C>2.]DA@,;7=]Y<2--NFA
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M;->R?M+?$:\^'VHZE8ZG:B0Z_--,VN+/)9JMN7S#:P1(1 XD5L@?ZQ> X5B
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MD^A]1TX.>0>@M96:-7/WR=I5CPRA>P)P<Y/09Y."!TY9R4G.VEETZ=//7O\
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M16K^.M6N;J_T:+5XY'L-,O;J\:0I%<QRR2(;J1B6,D,9)8C:I.T<5^S)\./
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M@DL QS@9!-?45O\ 'CPAXSA5O#^HI<VX!5X1)$TT*N-J*L:(,H-P!>1"A'&
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MJI<DG>*=T_-JVS]?FK(T4DHM:Z];KR\O(ZN*9ADE@"64\,<CN>0 2<X!!/4
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MK?M%>"8O&OC^YU;1K^YL;-]?FG39-% WF>8"\,JS%0P+-N7(.[?@?=Y[K4/
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MSEX]_:9OO$NLRV-EHVG>%G@GDCU&ST=Y%DM[0PL(-\#R.20\4I1E8E?G!/S
M'TK7OBUI'A;PZ+>6UO;MHK<I_:=](EW?R[8R/GDEFC:0$$E@>G4@\U\O>%-/
M^$OQ1U35]2MWU"R\3O\ :0MI=Z4D=O>NB2,@BG264R[RQQC9\K#;O+$+ZLJF
M"S/,'EF QE7!X;F=>K@:RE3;K6<Y-15ER1:;4+JUMWL_KL'4CF<ZF'P599?E
MTKU:D(-0OSIM<L/=;;=DWKI<],TJYU_6=(MM1N[W6-.TX*;BQU6^0-;ZW*<%
M;6)PZRPLF5)+@0GS"!EE?'H?ASQ+#H,DUW!9V6CM=V#R7EX(P&>>W5D$FT.4
MDGE#%=WE\ACMZ UQT>D7T&E6^D>(1*VF:1/(=*LK23^SK2"(!"OF>1YHG^97
M&'",3\H((&>6\8^*M'M-(N!:6AOKI$>.)I7,,=N,#. ^!*1DD,2<YPN*>>87
M)E@YX#$SH5;J*E4FF_9V:O)*[ES->[>^S=^Q\3F.#PJQ6*P-"?M%%WC5D_>=
M7FLY-ZIIQ<ERWO=WO9:]E:?M#6%Q)<Z1HME<1^*+6X>6;4-^PR*,$20RX0JP
M5=PV[G!QC)&#ROB+XN>$-=CN/#7Q3L(+^SU1BD,D\;SSQW$C +*C>2/*FW!"
MDN4(?:6<#)KXLU'1O%.N-/KVB7S:9.KG*P7;I=12QD,OED I)G"DH< @D/M'
M(H6VN:YXGTY])\:(T6L:<TAM=8M)H[>:=("2JW0ER 2$.YD^7.6.!DCBPO#>
M+<*&)RI4GEL94W&,FGK&-G%05I2YU>2_EV=VTS&GD.84K8FG3C[!2A"SDI0U
M5Y*4?M.3UOI9::W/MGX?>&="\":U9V^A^+[JXT?5;A+K3K>\E$$]C#E2T$DB
M^:DZ(F3R<XQR2#GZP^+WC*VNM&TG3='DBO$N8XK6XU:*47,4*B)5D#QJJ[3Q
MU5.@)SG /XD1>,]4>XCMM+\2SP:EI-PD4<=],DT4@W[087A(1E)P&VL%*DYP
M>:_4/X8^+X=0\#6$?B[0Q=7=O%$T6K:8T:VTLQ4<R^6TD>W/#Y<8R5//7]*X
M=HU\!]:YL*J$\0HN;<.2BXI:-<VSDKW=[-V>I^G\/Y;/!T)5X86%"<H<UH6]
MG=Z\]K:.5DVKW6W9GN7AN9?!?A 7EMJ=C$_DM*SL@*R)Y3%2J@@HQ9MI+ Y8
MYY(S7YG_ !G^*GBS5]<U1I-+DDL SJ\IE0))!YK[_(*.TC+)@. 1N (  [?<
MOB#5+37]-FL(WT^S@:!D"Q3#=GD+NQDJ,YW':%#9VG  KX^\2_#&.=YX9+Z&
M3[0[MYL&H,C1JSY&0V 1T!( 4\X&*Z<ZXBQ^!]E3I4:$J?)%+V4HSDDEIS<J
M=WW.',<TS.A4GR3IRO*5Y*223N]&G=KY;'P;IFEV?B3XBQW42PVP0P7$=O>(
M^()C)DDS'<4/IYA<# 7;@@5]%>,O'+6&@SV$>A0W<5I;S1J]A;I-/&D2+&UP
M[G:59PQVA5P1\P&0,Y_B[1_"OP_MI)+*2&;62CK.S3I/YN<':LBA=N#T., ]
M@#Q\J7?Q'U.WNK^*XNF6UN5.\3N<F)]VY(V"C<%& ,G((7@<"O'P_B3C,+>E
MC:%.$W9*HTE!-R5FTX726V_5>9Y=#.Z].I%8EJ51NW-3J*<(W4M9-)V7J^N[
M/ASXQ^(=;UK7+Q(K6^B8O*EO#-#*@9?,DV!99(R@90</N?\ B7EB"1_HV_\
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MQJQ'>?%W]C#XH_#?QIJ7A?P+>:'^T)I6E+917?C?X)RWGB?PG;ZG?:?+J/\
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M:MO*$!S6+8?MQ_!W6/!7PH;XI?LQV7C_ .+?P7^%UA\*/"'B^;QSJUGX<O\
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M8L'@,<$[AT6O.;[QS##=6=\UW<VL-S<26UW&KMLBEDD<KP&)6+)W9R  =N,
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MP_R_=4X&%Z8)P<'!X!R#SV)Z'D';S2^__(LZ?IKWUY%;MN@C=AYDK,0L:MC
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M3Y+F2_2-X(WVPK(/,DDP-N00QV\=.I))#+T&.^RW7:C^=*3M>1<E8R0<[2,
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MP3>4']A7]E\$<?\ "J_#^!SC_4R?-UR2?7.TX!QR<_Y7I59(9[<C87@<Q/\
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MCH'A[P+XNU+0/%^K:JFGZ+?-IL^HZ-IL-S>ES$DL96TN98(UB9VP&61G!&2
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MTO\ 9O\ $\M@MYKJV6CV,40*27$DHB\N18629I9SD B0 LR*,ALL 0&^'_\
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MH5IS<_>7Q.]K=K]?ZT1^C/[#VC7!^&&GW"P3-$<[IPY*2+@8;9N*   A2.>
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M\KPQ>'9&C6,,[[Y1L38>0&%<CJ7QM^"GB'Q9%KVO_!3XR:'K/BN>+3UUB_\
M%\%A:"\EM##'(X/AA5E!$ DN(EEMWVO$Y+F0X\*G^(OQK^!WB?Q=:_#SQYX4
MDTSXE6-H-8U&RA_M5IM,:SCB33KJ>>-'C!4JDUN4$;!L$ 9%9/C'X_\ QX^*
MUOX=\.?$7Q#HFI:#X<UVRUU84TZ"SEEN(%2V>4RH@+LT44(8GG"J!Q7JJC&.
M'LH1:FUS1:O&?-)*2DM;MIZWW1S0O+$Q;YF_:4XWB[24.:TDG_*XW4ELXW6S
M/TJ_X)M^(]5T#3_VCK#PUK][I5OK-[X8:Z$5\Z%[.WEO8XUN)(C&)V10REV1
M2S%CMQC/]&W[#'P8UK]JGQEK&B:GXPO[/X=^&]&M[_6[59IIX-9U<SV<5K:3
M6HFC:2-XI;E7?)")(&QD<?R5_LD?%;POX"L?C')XFU^TT5M<CTV;389&D7[9
M]EEDE,-OLC8; DIQZG>"O7/]7W_!)C]LK]@7X8?#FY^(/Q(_:/\ "7@+XC:M
M>:AI-UX4\0:AJT(_LVWN(/L6HB**Q>&7<@9-P9_W:A2<*H'Y;Q;D^*C5QN;4
M:%2<E[:[H2<*D9/#\D:CE&SO%*,$^BLEL?U1P[Q3E. \'<NPBQ.!>,Q%+V<:
M=6C3E5C5^OUJGM'.47)23IP]^,HR]U6EI8^X?VR_A59_LO>!](TCX2ZF?A_I
M6LV<^I:E=:/"8(KB_MY3:R02;FF_?30Q+.'#*PB8 <8(_-'P3HGQ7G_9YU7X
MY^(_BAK\@\6^++A/"%H]P9OM>EV]T--M[ERY(24WY:-8PA&&WG(3(_0;]NC_
M (*%?\$\_B]\+TT/1/VH?A7K6JV;7S00QR7LWE-/IOE1S*)K& 9B8J4^21>%
MX;@'\K_"O[6W[*-C^S7^SI\,M9_:(\"75WHWQ M'\5V2WFI2'3]%U'QA=R.U
MVGV)RL<6G-;3A2I00231XV.YK\B> S.A5QF#PM#%JK7SG#+$.I1^M2IX*K@X
M3JU*<IN]-QG)Z1TE)N36J/M^$^*LE?"F Q&-S+*_[1P^*S&6)GB,/2K8K$4Z
M5-RI4?;5(U)NE'E7N-VYK/H?L%X;_9"^(6C?!OPQXEOO'/CK2/%5SX9NM8UR
M6PNH8HM3DOK>6X$$Y4"0(L(C*C"JFPXY.3^)^A?$OXX:Y?WG@[0OB#XJ74/L
MNN-)>0WA,UE%ID4T\MS/( -N3$\()/RM+'QE%!_I7;_@J]_P33D\)-HG_#77
MPGEA3PX^D1P"\U.2-&33&MH%R-*Q$6.2V=B[U!SGK_+U^S-^TE^R?IGQ@_:/
MM_'_ ,;/".EZ=>_#OQEI/P\\0_:[^/2[_6KG4[&2T=+E+=Y$GNK59%5@8Y'\
MY\@[S7TO#_#F:X#^V\0G4Q5&%6E*@\1#DDE;F34%\.NSO[UKV5CYW(?$3)LP
MHYUB<XIY53HT*,GAW+!X>3G*>)<*-36GNH?"UJEHCX\\8?M%Z/X6\;'P+XQ\
M">+_ (AW^OZ#)J?BR_T5DCUF:RNV>-YY)Q8W3SGSY(U+8./+)/4Y[K3/^"J&
ML>!O@<WP1^&_PT^*O@GP#IEO-I]KJ/\ ;C+@:AJ=S:W<VKW*>'U80SR22Z6I
M\XM'+'M0JR@#P7XF:Y:6/Q>;XC_ G]HSX+V,UQX)L-"DN->>[>YM4WI=36]J
M\M@R0[RQ!:+:TNQ&D);%?-/C#XK?'&^\/7/P\UWXX_"W5/"&K3VJ:K;Z5$(X
M6LK?7IO$:LURFG!K=4U&X>^>92&FB9&=B6!K](P]"CB<%3J8AXA8GDC.>'52
M3I2J2BG.7))M-MZM_P":/SOBOBS,<?G>(PN%K8.IEF&G-8.AA5EE*,*2:5-^
MSE"ZFXNSYH\]]]=3PGQG>^(]!_:&\=7MW>3^(]=::6XOK^:[,L]W'JEI:7MO
MOEGW22"WMY6AY8GI@G KY<\9^!_$.K^*-=UJ.XMTBU34;BZ,+2*?+,I1Y Q3
M@AF5?[O&X9P<U]&?$SQ-H6L_'/Q;KUEJMO<:+=P6<4&H0J!'>11Z;86DQMRH
M<Q 7%M* $' 9@#@D#DY='\-W=VTEIKC?9KG=(+59YE5-Y!=;@)"-ZC.<,"I
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M'O\ R.6D?]=4_P#0C7VL.GXM_,U\4_#W_D<M(_ZZI_Z$:^UAT_%OYFMN*/\
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M/<#)&#VR.,<=*0=_J>F<>W4D^YYY.30,#R#CK@XST_&F_*IWE22&4G! RNX
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MU\4_#W_D<M(_ZZI_Z$:^UAT_%OYFM>*/]_A_UXA^2,.%/]QG_P!?'^<A;O\
MX]KC_KWN/_1$E?XT?_!1/'_#<G[3V>G_  M;Q-^E\YS[8QG/:O\ 9<N_^/:X
M_P"O>X_]$25_C1?\%%"!^W'^T\2<8^*OB;G&>?MSXXR.]?*U-X^C/L,/\4O\
M+/C!EQRF P.1ECWZX!//W1D#U  .:LAUN (Y!LGVX5UYR!G@\$9ZYR,DD#D5
MK0V6BMH_GO?N=4:)F6#@#<S9VMSD=#@ CZ$\5@8;:1PI(09ZD.J@E@0 02
M1GKDY[&#I%VYWJ1M?HXYR.,#.<]1S@<<XZYJ:WDV-Y4F3&PP3R5.=HQCG'7
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M#]HKP99?VCK/CCP\MBK7"W$UE=VVHK;7$$>ZYM)I+%;B-;V!MK2PEE*JK<$
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M\.*F(C3K<<U</2:E.59XOA24X\EY2AR2S5Q56T7&U3FBJBM.,HJ2E\"^ _\
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M&YLM,MK9([6Z^V27!1F4D?NV(Y 4'KZ<[LD\^IV]5^:"U].Z:_\ )9',3_\
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M \=ZD3C/<L[$#U"XSCDG&:'_ ."IG_!1D2/Y?[:7[0"[7Y+>.M1<X7"G:"X
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MA$8\R-O,B9E(VY)08/W@<#H1T)Z8'I1_P/S14?B7S_\ 29"3.ES$XSY-PL;
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MGF 3FY.1O*PD <D4 >1J"A!3Y",8()SQGJ?X@<D $C QWJ8-'-GSGV2@?+(
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MQ2W L+>QC9@QSD^8H(Y*]*_TNO#OQ(7R4C:YA\O=\A*+OQ\J\KNR ,MDXX(
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M9NL7@.%I_P!G9+'*G3I3R2=3ZP\3B*F*;]K5Q%*FZ3JQG:,(4ZE)0_CNMO\
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M8R ,X YR?YEO^#D75+*[^$'[,\-IY'[KXV6#RB(HQ5/[.U>,L5!(X:5< '&
M3C'7Q^[_ ."P7P7EDDC;XG>,LK(R$V_A;6&!8.5^7&0=^"4 ;)!R^W.!^<?_
M  4?_:G\*_M+?"?X>^(/!_BWQ!XCTGPE\4=-@O8]:L)--:QO[JPU7R/+CO\
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MD9X'-?97PO\ %-G>7FGSZXUW-=:8\<^G3F\=Q!(BJ T9DF+Q[N2B)Y848 4
M"OVO)JU>O1HQ4O905&FHWDE[JBDMW?Y.WIN?8/B2GA).G]5NJ;Y%)ZN7+9<S
MW=W?J?LS\</C];>'[GPQHRVMW>7]YXAAN[K2],T9-3TW^P]';S;TW7VV/SEO
M6C.VV6';$[, 5&<U[SX!^+/@;5=9T[QG?Z/X@\-#Q-I=I';Z+<6=Q9I90V;O
M!;W5_## +<RW*C>KL4>%>&SD5^*OCOXA:#K=CJ-U)>3Q>(+*T>]TO4([ZX%S
M;S(A4OLWB.1&F57:-U*M]UMV=U?8?PN^.?B/5OA]H>H^,;>#3]:FTJWADDA5
M$DNDCA6$7+HP1EFGBC#28/E-D#9NYKZ/#86M6K5*7MDW%72YEO\ ?;N*CQ/S
MNMS4X<GM%.',XVE;O'5[]+7\C]?)O&'A"\02P:C:D.C(L?F*6) $F05R.!GD
MG.X@ 8-?&OQC\3Z'\0_B/X0\)>#IY6\0>"=3LO$>N>);349[.#P_9[V+:9=-
M;!HM0?48$D$MA=!D17CE4!SD_GG\4OVS/#'PU&W4;RX:_GW7%A:KY>&6-A&%
MF6,J%1RW4 8.,E@M?GOIO[<NO:-J'BJXTG6/L%YXAU";4Y[QHEDE,K,%M5)E
M9E=8+=1"0>3@8V+P>7,9X/#25&MCH)I7E!2:DI1U2T6RUO;RV.JKQ+*JH1CA
MZ4H)Q;Y(\MK.ZU:6E];=?4_>WXU_$3P[_P )'H_AR*\N+324,M_K TR\GAE-
MG?,UIID47EW(G,GVPAGG50@7YL<8/S#^T+XE\/3_  L\76UM<+++_8-RD;S/
MOE(95A57=OF:0E#YA)RQRQ.6)K\5]3_:Q\876MW'B"/Q+,FL7$<D-QJ0C$TD
MT."((MDTLB1QPR*LRK"L7SYQAB36'>_M&^/O'LL6DWGB66:RNG:WO8DBA5KF
M*1D/^K!9N?F&T%F;(P<U\CC\SPWL:U-8BI)2C444IN2;=&O"/-%-MIRG%*RT
M;[78IYXJBY?JR2<H)R5N:*][6+^R^K;]%L?TU?\ !&]+Y_V8673?,+O\0/'3
M,%*J/+$IP&9^!^]4;>,'(VD$*1^NZZ5X@CM')M;R.25X0[O<2>6[.F/FC1QN
M4RO(>-JY"MCM7XF_\$OKKQ1:?L@R7'A9)(=63XD>+  LD<,@CDNH\[EG$9R5
MWY&QNO!4@&OOB3Q'\>9+>,R7-PQ=(R$%S:J$56"AC@G)#E6!*X.,8& 1_1'!
M.:8K!<+9'1_LZABDLMP\;.@Y.$U'E=VHVNM-F^^MU?\ S,\7> <FXFX_SK,*
MF<9U@,3ALWHUHTZ&:U<-AYO"SE7IWI4JL8RE*5:<74<=8Q4&_=27UBF@:W]G
M$^J:;=7 M)I4N99O)F?8V5B56?;*8^5V@$X1>>1BN<N(=*M,65W&+>0O)(SI
MM;<LW6,$]X^& '&XD=!S\\'7_CLNQSJ%])Y:IN26]M&CD'4Y!ZX/3(.,]ZD@
M7XN:E(+J\U:WLF8$E)DMIC\QR" JA0 .=VXDY& O0?68;B#,HQ5-Y7A'[._(
MY823D^9N5K^S:5KVWM9'YKFGA#D6(Q5:I1XGXEP\L57CBZZPO$^*P]*ABH)3
MG5^J\M6.(E6BW0C%5J4:BJ5I5VG3HR?O%Q/IDUO((EMHV6VDBA)7[\I.(][Q
M$9;&/,+ D-NR#S7Z"_!WPC\1/AQ^SSJ7Q1^ VEZ!-\>M;L[^UTJ[\427U_HI
MTE];LY6CDT*&&^M'E>V5Y(Y4TR-@  A^8D?ESH6FZ[:B-]>UV6_E<R(]NB6T
M%H?-RWF JC/N4'J6W-U.&)K]9M';XEV'P^\,GX/^-?!GBRX;0M%M9?#&DZ]I
M/]KZ3<3:=*+PW%G++#?1O&XBC=)HE"R@.6!.VOBO$C,JF:9)##8NK#*'BZ6)
MOB,)3JPJ/V5.JDDJ$'5C)<EHM1YE)+E]Y11^M>"?#.$X)S#-LUPU'/>)<'@Z
M%/,ZF%E*>=8K!U:V*^JJ5+ZQ5JU<1A+O]^Y1G*AAU-PC:FCQ76M)_;$_:#C\
M(ZS\8/BOJFCWO@_4I]2M8/AE9Z-HEKHNL03?9'N5GU1=,DNY8;<;#9W04-(L
MD(3"DCY%_:7\%?&/P5K5Q:^)/C/X]^)I\4>!_$MI)I_C7QAJ%II=E9:I9RR3
MW\OAKP_<3:-->0-;L^GRN1Y+DQQGYVV^W^%8/VL?V8_',?@2]T?Q9\2?"GQ0
MU_7?$ZS3VAUJ7P[>W\,^L7L6L:FK/:6MA]LFFM[*!&#PQO'M,NUE'E'QX\6Z
MIX[\?>([K5],?2-4\+?#N'PUJFD.L:26.LH]Y=S?*6C^66PNHSNR2 V2NTY/
MX?P3PWD.,K+'S>+KXS"5:BG2>-Q%>?LZ-.M)XVI0E*33FE?DG%5(MWY$XZ?U
MYXF9[G.14(8;!T?88;,\/E6(A6GE\(X>%7,</A[X"=:C&2IU*=&M-N,G%QE%
M1ERZH_!;_@CU^VEK'[&GBC]J2XTBW@:;QQKNC:=<ZO*K2S:1;:=/J2B6WC5#
M]I(E961;M7# D'D$G]OV_;F^-'[6-UX0^!?@?QYJOB#XA^-G@6^O])M8;+3/
M#.AV]NXNIRD$*M]LFMW*RW+ ^4S1  [AC^:C]ASX.:'\5]5_:0BO]2U;3-2T
M3Q'I;Z9/I%O+=Q&>6\U5GMKTP0R95GB95CWJ<MN/;=_3;_P2>\)? 3]G5?&/
MBGXJWEKIOCF[\4Z7H?A>\U6WO(M<339M(U*YFM[.&9MZ?;;RWM&Q% P\F-V.
M2,5_-_%ZI8G&8W+<1FD<#AE7K49TJ^->&;3Q>):IQC&:G-N$XR4$GH[OWE8_
M:N&<[I</SPF</!X+'8M8*C]1>(IJKA74GAL*IU5#EFX5*;C4Y'.,6FKKHSZ8
M\)?LO>+?A9H%]I_A6_T[5-1\/VM]J^OK-97G]I:X\,"76H^:UQ9I#-</.+GR
MY0=TH;AP#Q\7>'?C#XDUOQAXH69/$=GX;T/SD@O)]%;3(28IB;LLEG%'8L(&
M#1B6;S)F09)+E5K^D&"QT&[L(]2\,)I&L7'B#2TO=16?6[*QN(;2^5D>%K5W
M)7_0VCNC-(X1PY22)-I<?)?QU^%'P_T[P/J/AW0O#FG16NLZ?XBOM4:RO(+N
M\TR^T^T:\BNIFT]Y%CMKB[\LPH[F-YMD3OME+I^5^(/AUDRX5S3%8#%SP=6G
ME\I1QE#$XJ56;=I<R:KT)^P;TJ2490YG9R3:3_?_  ;\0\72XXR3#8O+,#G6
M&S'-Z*Q53,*F*C]5IUM:CH0A2G1Q%:BY6P]"N^7V<4HQY4V?BEXO\(Z#\5-2
MM/#_ (FG?286VW&F^(="T5[B]-I(TQ:ZO[RSB+0IE]PEE>($#+ ';7VQ\%?^
M">?P[^&TGPN^(UIJ.KZEXGT+7H]8L-=&I7JV]S:26\D<<T]O]J,"1FUEGW&2
M-,/M')(8?,>M^-8/@WXD\4:MK'AG1;?X4^!=1T&V\<>*;C5Y+?4M/T6_7+2"
MT2Y_XFEWY7FNEM%;[?*+#EH]Q^N;K_@K/^P1,NLZ$OQK@A\.:7X<DTWP\EEH
MNJ0FYO D4-G%=JDP80VT4;+."(WD=SM*A26Y_ C)\;#(8U<SIX?&TJ5=/ U*
M=*:G.G"$J=:JYUI3DYJ3CSR<[3E[T+Q39]Q]*OBVO1XLGDV2X[$87 /+\*Z^
M$IXETG!UZ:K4U5C0E&%6-:,7*.&FG##Q7LY1IN3B^QB^%R^$?CQXF^,GCKXB
MW8TJ$NNCZ5%JTBR7-@C-Y@F:2<1&WAE2"+R8C.X *A5"[:Z/Q7^U'IKH=,\+
MBXF-Z\T5I#I5K(D5ZT<"D,=1$"W!>10'RKJ78YV@<5\06'[;'_!.OQ;8:E-X
MT^.%E9W<EP)H8XM*\27T*LLA,<]LDC.D,@B"(\:.P)#!QO!KL/!?[5?[$/Q3
M\>^$?AW\-OC_ *-;:[K6K:=H/A;1AX5U2T.H:O).EK;QSW=Y&$6:_#0B28':
MCR,WEN!@_M6%P6)P=.=#!4)8>G6Q-6M.:E!MJ<Y2YFE+6][[7[G\F8_-*F-=
M*I6G2KRI0A",94G%I1C&.J45".VT79=#^.+]N7Q]XS\/?MS?M ^*_#6JZOX4
M\0WWBNY26XT^^N;6^BMY;"V2>%IHV20+(LD8.<#@Y(Q@_EWJNK>(/%OC^[?6
M];U:^OM<\11QWE_++J&H7$S74L:27#6\;W%Y=211EF\FV1IY0K+"C2%$/ZN_
M\%)?"MW%_P %"/VC?"EM>6U[=VGCRZMTO9F:);@BPTZ2)2\BHI:922$8H%V$
M;V(%?E;KG@GX@Z3K,^M'PSKUC)%>?;(+RTM;@/9E)R(;A+R-?)@E5HOM%G.)
M=ZE8[F-051Z^^H9GD5/*\'A,=CL!_:[:E6<Z&"A4<=;M3DE#==*C?;>QS4LA
MS?'TJV8X/+<9CL%"?LXRPN&K8JG2JVT35&G4=M?B4;:[GK?B3X<ZS\/_ !CJ
MG@;5O$2O<:=9Q7<%Y92R2)+'+%%>1V\T4^;FRO8HGS=V5R(KF$RQ1W$,<H*C
M_4Z_X)M@_P##"W[,#EV??\*M"8N^=[$JWS,#G!8;2<<9-?Y+4'_"7ZAK"7K6
MVMZAXB\1ZDMO'*8;N]U'7]6O)G5H&N'#7-]J-W,TDL8E>5GD9E,S;\K_ *X'
M_!/_ ,+>(O!7[%G[-7AKQ7IL^D>(--^$_A8:EIET0+JRFNM.ANXX+E 3Y4XM
MY8FFB)#0R,T+ E"S>MPS]7=?&2PN(IUJ4VW:G#"I-Q:NU*B^?W7>]E9]3\_X
MMPE7 /#4<316&K.5Y4JE*=*LOB>M.<(R2UN[I6Z]$?>GP]_Y&S3/^N[_ /H-
M?:R]!]!_*OBGX>_\C7I>,_ZYNHP?N^F3CGWK[67H/H/Y4N)?]]I>5""_+_,W
MX4TP,_\ K[+_ -*8FT,""=V1@XXX_#OS7Y[_ +7W_!+;]A?]N;6M-\6?M+_
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MY/A6^_\ 9U)_IV/CP_L6_ ':P_X1JY"LP.?MS,00.,$QG.<$'.3SP<XQ3?\
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MCRT_N1_]^Q_C4E%&O\T__!DQ>SC_ "T__!4/\B/RT_N1_P#?L?XT>6G]R/\
M[]C_ !J2BC7^:?\ X,F'LX_RT_\ P5#_ "("@SPB$>T:_0]CWI-@_P">:_\
M?M?_ (FI\#T'Y48'H/R%/7^:?_@<A\B_EI?^"HC/+0_P1_\ ?L?XT>6G]R/_
M +]C_&I**6O\T_\ P9,/9Q_EI_\ @J'^1'Y:?W(_^_8_QIK*@.-B'([(H_F#
M_G'OF:BFFT[\TO\ P.3_  8>SCUA3:[*$8_BE?\ S&*JX'  ]  !Z=!U]L]!
?^)+QP /2BBCJWU>[NVWVW[:_>4E;1:+HELO3;\C_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>26
<FILENAME>form10-k_003.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 form10-k_003.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" '> 7P# 2(  A$! Q$!_\0
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MZ>-Q:FE?[#>7?$]->KNW8_TRO^$^\ XR?''@L<8P/$FBD<8)!_TK/'/H23^
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MX]\!D\^._!Q8<@CQ/H8Z9_Z>ATP>#DC&<@9%(?'W@7C'COP:V#T;Q+H/)/\
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M#,;FYQ@95B%+!CO4MM!"L6(SR3GCD0LD<A90H4AB"HQMY!#$9^8+@X&"<G
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MZ7!'#J&H1VD$I(LX9I@/.E<",)""1NDW<1KT\S8K8&36K?W&I>&/#&J^+/\
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M@AN#A6(7 'S#)Q4<$LUA*LT3;9 1Y60 I^7*AMO).2W(X."/3'336A"*><Y
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M5-J<?N[F-T7&1L*AB0"#P< L2#G@9ZJ#FD:U!(CD;YL9!9<<9.,8S@DC.<Y
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M"G(#;?X(>/[Z4'2]#NKGYA@1Q3JV-V=RJD;Y(SGEEY!.#R!^]?P]\&_!R_\
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M 8Y&E=^3N+D@L<$#G"@,0/IG  Z5P>L6/@"Z8FXMHQ) &V,[;4(R,]"-PQR
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MP.:XWX'_ !FU?QKX0\*W7Q-\&7?AOQ)+)#9WMZ-D%M.D1>&(Q,L:J]RP5<R
M>9N8@9PK5]'_ !(^./A'X&_#SQ+XYU&[NYE\/64UZ-*O'2*YNMLJI':V[SCR
MC)(654QD<C=C.3^_OB3B*AC*E5XMXCFYN2FY7C!Z6=W=+SZ=K:'R%#!</XG"
M*E"C'+H1C:IHYSJ0ZQO%Z.222;?=GSQ#^S'-]GGF-Y>7^H>8@9'VQ1J3G?F8
MN3\S!"/DX"DGJ6J&3]E_4W^T.+YHDMD&-J!\RL01&Y$H.Q.<O_$0 !U%=5^S
MQ_P4*^"'[3K'2+FV7P!XFB$"'2-4DBAEO;C$JHD$\8CBG)E"@)"'+!C\N,U]
MS+?Z&HCM8;BRFM@'&<('?:$5/M*[B^6=VVK@G"AN@"CIK>('$D(QA&$Y..\H
M4Y3BMF_>BN7:RO9)W^2SH\#<-8J-27M8OF3::DD_*T;W?S>SV36OY/>(/@AX
MZT:9D739;JT*H8[J'(C8-E3AL$XV]R2!U^7K7I?PN_9$UCXDO#;W_B:U\-QN
M%>7[2))98QDK@*B, 1@$Y:-@6^X>#7W/\0?B=X7\$>'IM3\1WVB:/H6GQB2^
MU34I(+:VA1, QIY^W>6# 8RNX=>N&^&->_;I_99T34X'7XDQ>=<RH9+K0+";
M4-."3D!8Y)H(]L9W. Q(C1%!(RHPO?B/$G/<;@/8QJ+ 8I.FJ56%.G6FI1E=
M3E"HN5J.G,I*Z3]V[>OFX?PYX>PN+57$5JDZ*DY>RI5H1G-)+12D[):7=]7\
M-V]#ZZMO^"1GB;6=,-]X?^,'AVZ8(9(()UF+.0NX(?)MI9$R> Q &3C(SFOS
MM^//[.OB?]GF'Q1?>/M;\/:?IOA:PFU2YFEOXQ<7=O&PC!MH@H#S3D@P0D!V
M& P4X4>C^+/^"H?PU^%\*IX/^*$]S)>E%M[RUMIKC2+0L,[[NXA58HY+=3O:
M-V). NTU^#G[;'[8MY^T!XTOH?!NN7GC72KVWN+/7?%FIZBPGDO-0D!,EOI<
M<EO!]BLYE"6*BV>6"/:))I6)->/D_'?B%EM?$U<^S_(LRP,HR]C[#+L/ALPA
M[T?9PG*"4YT[<RJ13?,U3>JCH<1</<!XF,*>7Y3FGU].,%5G63H-<L^=\T6E
MS[<KOJN9=K_1/B;]JOX4:?H<DF@Z_'JGBJ6XCM-$\*JR+J&K7,ZHL4L"$NBV
MT#R*;@2@&(JY"L!7SC\#6\?>-/'?B_7[C2_$?C[7VMKBYM?#.G?:9HM*N1,J
M0)=6S>5'9VD*2RRI<OE7%NL:H&G5D^1_A7X(T_3]1/B 37MW<V]KJ-_J%]?1
MB> WXM'@@M[%9;<,U].XVQM#(C0 HY21E.?VT_88\:^)--^#?Q'\3(;Y]5\2
M?$+PQ::U<3V]C!JT6B6.C6\*Z0;Y;))X;-KVRM+R<J,NT30,"LS2#\R\;/&_
M..$N#<3Q3CJ,\QEA<33H9?EM'$5\/AZE3%0=&B\=]6<7/#RE)0=.5U&?+4=T
MFSZ#PO\ ## <0\3X3(,,_88>O3J5\;7J4:-:=.-)J551AB4^>4(WE%TO>E:R
MW9X)\,_@G^TQ)K'C/Q#-X6U7POXKGMKF47-UIT$EO;A9;AXXM%N TAENT\P+
MMPJ2;2PD8-D=#X1TG]HWPE\4?#GC[5? /BOQ*FLQ)H/BM)=.\C4(+&"Z\N:6
MWA3?"@G12Q.<D2$_,!7Z$7'B+5-"=$U'7-1N]6U&)]01;9(%^9&Q!).$MYE6
M)'^7R5SE.6E. S/GU77]3TAELM:U2>=[BTGGCMVM(B!/=Q+)A5LC($21&3(
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MF=G'S%BH^53DW%S=Z3XD%_>3WS-_9M[<07,MS%<12&;<4NT^4"(LKJI"[=H
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MQ\$>#=.O$$=U8>%=#M+J-&D*QW=OIUO%<1HS(A*)(I"X8Y'.%[]:88AUW?\
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ME:%Y17-91UDGOK9^=37K?Q+KRQ^%V6*STVR$T@PRQ2W*SNSR(8U*B25#PK2
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M[V>I\O?$>VDU?4CI&GWJ3V]TDTMW;Q1%+>8Q2?98Y1$RA6E6!F0Y^54)8 L
M:Z#X8?#W5-(E@G5$CFC0M#$PP@CC4J@*K@\@Y"\9)!X'%9'PVTE]5U(:QKUR
MYVV]PEE&01CS6=G5@<*S%R,%L@ ;05&37T19VL^EJVJQVUU<V]R0 L+(D\)C
MX_=C);$G! P,@=3D$>M4Q%6-%8>-1Q=N7FA9VNDN:.R;BDU=I.S;[$N,5)RW
M7IK_ %9VZZW(]5T^2VDM[6:R$HG!FO)1LWG QL*2?>CR>5/N1ZU2U#Q'XTT2
M"&#PKK-[H&E>49_M5M*DBF9&5S90VN66*-EC97 7(#[A@G-:5UK-W"K7KLEU
M<N0D*2Q9F@AVEI(9W(($K*,*24('S#<3@<[XJAU6STJ6:2,&Y-F+ZWMK5<E3
M=R[[18A@ ,UNX64@\[22H(!;T\ASK-<EQ-*OE&*J8"M";G>G.<X8B2C)-5:=
MXQ2:O>-I)M_,X<?AL/BZ4H5:"J1DDI+VCHR:YHN\:BC-Q::3T2YDG'3FTZ;Q
M9^V+X=^&O@J'Q5XU?4(D!2V-G'!-)+<7 Q&S[P&6+S6!DRV !G/K5?X#?\%(
M/@!\6?&UMX GN9O#NLW<_E:*VKO'';ZVR6K7D\4$Y(1&2.WFCC9CAID9/X2:
M\5\>^"]-\5>%Y3K<"3V5O9S7-W:74:>7'<PQ1L(6AYRQ)8L0,G)! P"?R\\>
M?L]GQ7XGTB[\),GA5-%:6[L9-'C%K?0%&U!Q.DBA,0Q.2S(V&<O-SY; 5_9?
MAGX\91FF'P^6<<87V&(C;#0SC#2EA,-!-**6)HTI/F]JVX.O*#5'E<WHV?B'
M&_"'$^#?]H\-8RIC<$HNK+)I4TZ\Y)2:G3K-/F="SJ*#E!3YE&ZL?T]^-OB1
MI>C64YTC2)K^8HSF>&)C&-J [XV *M&7+;<$@KANAY^.=0\>:]XDNI+A;,0"
M/=^Z9GCE49&TJ?4 X7(!)(R".OY##]L#]K_X;R:1X$@T:3QQX=\.6UA%!KEU
M9>5>ZY;0PA+B-[@(YNKDHJARXR"P8,2V!]K_  1_:S^)_BV7Q39Z?\&O#MIJ
MR6.G3W+^(99;VYMYII,W:P6PA'V>3RP/+1U.W[V&R!7]X\$X?AW%9=#$Y/AZ
M.94*JC*&-HXJECZ-2,DG:,J,ZJC?2ZJNE46J<&FVOY,XJXPS:ACI4\TGB<NQ
M$?<J86K"M"I3Y79J:?+!M\NCA5J)I/WKW1]'7][XEU*'[-<?)$R[2R%BV<$C
M(Y^4(<'G[^.V*R;#PUJ4<A=HV!WAPX7.5'W<C&0<$9YP/F.<5KV_Q.T31M3N
MM5^)FJ7%G+/:0SM86?AZ"T\/60"QNPM]1MY7EG(C&TQR1(Q8$'@9;8U']L+]
MF_3_ !7X;\)PFZ-EXDM&:V\4_95BT6SOWA+6L4\TGF!X?-'[]VVA1GITKZ;,
M,RQ67VHTLFE&-1N,9^QC&FI6W4U)N*5^L-MKM6,,MQ>68U+%8G/J='124*E5
MNI*2;E)<BY^CO9M?+6\5O8ZHKH'4[7!*[8V!90<'YB-W!52#VVY Y.>M@756
MMQ'!%(LB1J=P#<EP0<8'S8)X'4X&>,BJ?[-GQ?\ @SJ'B[5? GQ?^.G@/5?'
M/B==3M_ VF:,(4M+;[,)+N*.>0#RI99+=[:&RR=M[,75L$@#WC4OVN/V3/A1
M\0['X+>)(KWQ-X\73&O-5D\/Z?#=V5G+&ZQ6ED7-R U[J#LLGV<!!""4\P [
MQ\CFE;-^5?5,HEC*SE&52EAK5)1YO>I**:IW;7-HM$MWT/H,KSSA;$8EPKY[
M'#<D90C4K0E"FW'W9-SYI:)V2;5]>FB/&=.T_P 4/+(S+.Z\C:L9#$B/)4GM
MGUZ*6/'&:VAX1\5:I(5@M+B1& V*4)9B,<$@$[0>#SP!S@YKW:X_:M^ &C1Z
M'J.I_#CQ=IMQX@U6:PA\/V>FQW&KVMHK%8]9O;9Y1#;V&,2S2F>8119;!P<_
M*WQ8_P""LGP&\#:9=6O@?P5JEYXG>XN+?37U*"V33XFM+F2UD>YDBFDV!GBW
MMLBD(4D$8.5^2Q;XQQ.*G!<)XG#-0YO:XVG3H4=(WLY\U1J5D[+E>GGJ?;X?
M/.!\+AH59\68:MRU.1TL-*5:M+^]&G[EX+9RYU[]TUU/2!\+?'S1%/LMR&XX
M"/\ *&X4*""01G'(^O(!KT#1?AAX^6&UA>TO JSVX+!6!PDZJW(!ZC<>.<DG
M& *\D_9O_P""T7[/OCZ2WT7XO_#VZ\#W48%O_P )%HP75M"9H7$=Q>ZA-//;
MR6\ 90S(D16(9))'(_</X$?M&_L9_&VTN7^'OQ8\":Q]BN7B>%[^VLY)G@*F
M1H#=1K&Y5ADIN.YB0C'J/QWC+B'BS)^:.9</SH0?+"EBHTJM7"/VE9X=1C5I
M8>J_:<TDY1=.*47S<[V/T_(\TX0Q&$C4P.>T,754U5]@IQCBHPC0G#WZ+J74
M7*I%1;DT_?VY7?\ 5OP*DD'@CP7%* )(?">@QR!<[O,73;=7!R<DK(N#GMVK
MJC+C@!E]CS_.L/2Q NG::MLXDMC8PM:R(RE'MO+40R1M'C*.A4IM4QX(*$YY
MT @/\3_]]G'X<\_YX'2O@(352$:J3C[;]]))?;K7E*UTG;F3>L4^Z3T/RBOR
M/$5N5N455JV>B;_>3?FFM5^G=YWC2>.S\%^-+X '[)X5\1WD>,*6\C2+R0 $
M^HCX/0>F*_S"?CI^TMJOQPU>[TC1M3U#2A8W_B"W%U-,6%N\FH75LT,4C8B-
MOO0N0 K;>A[5_IW^.X7D\%^+H$ *OX6\3QA3C:=VF:C&(SN(7#;@N"5 &>PK
M_*^^(WPNCTSQ3XNL_#UG_P (_K,6M:U?SVKW!F$4RZM=%)4C7,<UO>%CM6%V
M,8<_+D8K\U\0O&'BGPPI8'+^&,YJY%/B1_7L9BZ=*C4G.ME$Z6%PE.O.H^>%
M-T\6XUG33:C.I*+YHPYO7R3P_I<7T\;F-?"K,:.2U:&$]A).5>7]J*KC(UJ-
MTZ7LL-#!S59U&I<W)[-.*FU^>OCCX/\ Q0L_B/%HFM7HNM0U:V74+6Z6Y63R
M]/\ F>+8^?E=PJG:^<<!>:L7/P;\::Q=6=H_BF$R7Q\B\C56C;3K)<JT2C"E
MF9A\S ;F)+'))-?7?B[X7>/K;Q1X<U3Q%#)>7&H6-N\5]9&5H4LH64E)-@+1
M,%R#TV8Y^4@U)XM\-S+XCM+HL=,@T^.$NPD3[/Y#Q[P\SAE\_P W&_ +?-SG
M )KQJ7TG>*<UJ9+A<JKX+$NOE=3%YEC9*I*K7QE&<Z591G!-2@JD92:OS.,D
MN7FYD?,YEX;87+*N+^L8&K2K3K.MA\).DZ=>6%3N\1%2BH2PZBTW54E34;2:
MU1\ER? KQ%H.DQQ:SJ&E'PU;W_FW-W%*!JETLQ,2)Y?WF>%,[1C<@<L"*]:\
M,_#R7Q)X\L)O$GBBV2QTS3[8:=:_9CMGLT:,PQR,JA);@)@9(+!054@8KO\
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M+H[-M+R6A\06"7EKINB>.?#VKW47B/2=7N+W2=45W+PW-O%'-I2AP?-$5O)
MC(K93^ Y5BIZWX6_M!^-?"/QNB^*NJE?%'B:]C4ZM<ZFX9[N9D)G$K2#AUG
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MM)3;MV3+$R*C+APQ3!! KT75]%MKK2YS>22O=2AOMMW*^VU;SE9;>&-<X4L
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M/1R?EE@L/2C2PKH>SPKP.&3BI8*G!4[2IN48R<I>]>DM6KH_E',\+F-3VO\
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MR7+JE<_2"PO/"'CN7Q-IWB_0-"U&XN+5YM+GO;*2[\^.V3SH?WSA<E%0A)6
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M8BFN[.]MS<PWS$!B&&,I^\ <*I((SSVK:7XL>'-3\,Z?I?C$@^*]/UATN%$
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M[TZ2V=MAU.QVPOME$8-_;+@DC(W8XP#A1CZOO+>U"I'"B%-\8P[!F#L>9 V
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MMEA[*&R"22.<&E'_  =@?\$F5# >(?C^=VWYO^%23%@>IV_\3KC.0#QMPO\
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M<#/4C^V\?@1STIX_X.NO^"3* '_A(/VA1MQ\S?"60DXR>3_;1R!P3CDDX (
MJWG.-DK.G%KI>;T7;9:;]"_['P2E=R:?2T6E\USM?IZG\,4__! #_@L6\CE?
MV,/'&V&4^6HU+0\M^/V_)'IW&3G@5U6A_P#!O-_P5DOCIC:S^R+XZT_R]0L9
M7 U'1F"K'?02DN1>':@0.[,1P.!D@9_MU/\ P=@_\$F?^AB_:".><'X1RC(
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M]%EE^RW^S<GA72@?V?OA&;C^Q(0S'P58%VF:!B6/S'KL!(!V!CM4#%?P@_\
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M,;B/QQWH6%I>\U!.T5:ZDK:-:>\V]7>W1KS!5JO/&]6JTW>WM):V<;I:^?\
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M3WM<^??"Z:CH7B3PQJ-G8O?7::G:?9(K9/.\RZ2Z0Q6JQ %YFD8?>CV[@Q&
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M8M)12=T[WU[+3\SXJAA5.C3D[^]!25[M6=^5Q:5K-:IIM?D<FVGD))'&,LP
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MBIY<TJ6/D-.=P92%9@Q;&1DD\]59]G]S_P A_5E_3_X)_ !X8@N?!&O7"ZE
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MKVUOU,=S=PDBW,1Y+F9R8^!V+@L< E<-63IUOXBT#6D;3X+RZF-PT4<_F+'
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M75C=7D-NLLUDZ9GARKQ(Q+F%!N#LP"X#Q!]AQT.TMZ&7GNM,TJPGTFP-UI,
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M@G'!!K\WG\17,P"3W4TN"-BO,^ I.0&4Y!!R.>-PQT))+K?4802[[% /\*@
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M:-2#JV:=Y.:LK:*UI-WN^J\NIV?P^U2)$NYKV-Q(D@2/S%P$(XV@$$(I89!
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M-M<].ZU:<TK=5N[?EH>X-K4*8+2;%#'+;MQ^88&.YYYY(XR*S-0\5PVL>4N
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M\K[]2XYO4DK*W:SNG9+HN;16^_4^@(M>.TGS2"[*P4H,#!Y0KT/^\<@;L'
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ML8UF73I9CNLUED,6W=D_I;%_P0,_X*-JBK+X/\&,"5 _XJFR8KSA^0?3(/<
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M4#>&8 D<[L8R!VR.YQDJV=I E:]N6\EBX))YW<9.21SMR,XQG&>I&:_=A_\
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M>Q" @ ^I&!V/6G6O_! W_@J'!+;R77PH\%I"MU:7$CKX_P!+8I'%/&S@8_B
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M &5HEO&D_P""@$$2V$\=M>>9X:T_$-Q+N$<;,2"&D*G;C:3@Y'2J_MW+-?\
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M8&<D'I7'F2E++<PC13G4G@,=&E%?%*K+!XR%.,79ZRJ2IQC=/WI)M-:.J?\
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M^8JN<8X(SU]7\._%K3/'6J7NI^(-1\0VFK^'";*74H+S4()K&.6Y1;.Z6(R
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M]5\,Z7X4U.QN+G6H[5=1L]3OKQI6F:$G[5'Y5M($4E!(BALX(6OPO\'?ME^
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MLKS4!O\ +NI=+LFDBWQB-B@:W:(9"QG_ %?'EKC&2:XGQ%^T1\3_ !,YEO\
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MT2D=_P"Q-).2?;[!C ]#]>M+_P 1,/\ P5=!'_%\82JDLH.@:.?G/<DV +*
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MY==E':)]CD.=X.O*='"XF^*FY2TY9+EES.VS[M:KK>^[</\ P<[?#Z\\._\
M!.7XE>*#<07-GJOQ=^$MBGV25KB.SEL-(\0P3AV'R_Z69PN<X&  ,IQ\\?\
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M"G@O1?C;9>(;FQN5T";4]<TDV-KJ$T#(DMVL/F220+)CS%4 N#D %!N^/_\
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M?B;\<I7\3R3?!_Q?\2=)\,1:?## ?$NO3S:S-=$(MS+(]M,T4>6#/$8V4!&
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M\7-J?P=\=_%K2]%>TBMKC_A)_%-W/JCO9(MI;F*>VG7-K):QHYBD4,A^7@#
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MNZ>C6KZ/OW\O(S22V27DMK^1YE\5I-_PD^)W PWPS\=N&Z*5;P_J>.3T]><
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M'RR[/^OF?YL]%?Z2$O\ P:7?\$OHP,>/_P!K<ECCYO'_ ,/B,8))X^'*G/
M^I]*@/\ P:9_\$P0,_\ "??M:<?]3]X _P#G=FCZM6>B2?ES+]0Y9=G_ %\S
M_-VHK_2('_!IG_P3"(!_X3W]K/G_ *G_ , ?_.ZIA_X--?\ @F$>GC[]K0?]
MS]X /_O.J?U6O_+_ .3+_,.679_U\S_-ZHK_ $A/^(37_@F%_P!#_P#M:?\
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/Z=MM%RV_%-_B/FCW1__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>27
<FILENAME>form10-k_004.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 form10-k_004.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" %8 C\# 2(  A$! Q$!_\0
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MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#]4MU&?:D
MYIU !1110 4444 %%%% # 17S5^UY\??$WP/NO"YT!+5X;UI#=)<Q;BZK@X4
MY&#R:^E.Y]:^/?VX(3<_$#X4*T#7$1U+8\?EET(9U&&'H>AKV,HA1GBXQQ$>
M:&MT_0\+.IUJ>#D\.VIZ6MZHV?B[^U)>Z=\+_ _BWP2UH5UR]6"X2[0R>6<?
M,F 1A@:]'^(O[3/@KX4O86.N7DUQJUS LQL;" S2@$ EBH^Z.M?&W[2'PKU;
MX0^,+71[,3S>"=4U*/4K&)$+""XSAXP><8!X/H?:NB^*$5]\-OVAM4\1:Q?Z
MCH&EZI91&RU>QTY;L,/+4&+:P(!&#S7T2RW U(4VGHU*6CU>UD]]MCY%9MCZ
M+J<T;-.*VT7=KR9]27'[3_@C_A7<GC:RGN=2T2*017)M;<M);$_\]4ZCZ]*E
MNOVGO!"7OA>TM+NXU.Z\11B6S@LXC(P0]W'\/?KZ5\[_  <OO#_PX^%/Q%\;
MZC:ZS=:+K ,*6FK6B1B_F.X9CC3)P2<'C Y]*Y3]F&W'P;^+6BR^,M DLH?$
MMB?[)O7#,EJ&;(4_W<YQS@C(]:XO[,PG+5DFWR;:KWM-OD>A_:N+YJ479.>^
MC]W7]3UOP=^VB=;^,VL>&;N!8]#GF^QZ/(EL_G?:,[<2\D!<YYQTQ6%XP^,G
MQ\\"^.M$\*Z@OAL:CKCD60CC+J?FP-QSQ5;PYK-C\,?VS?%']N:1<I:ZZT4.
MG2QVA>,NS+AL@8 X.373?M)1/_PU/\'62*1EW,/,5"P7YQU(Z5NHX:G7C"-.
M/*X7UUUM?_ASGE4Q=7#2J.H^>,[:::-Z^JML>@2_'6X^$/A[P];?%V6&W\1:
MI)*,Z5$7MU53U)[8!&:\[^+/Q@T3X@:C\/-7\-^/M5T#39]6>S6.TM6*7KJR
MYW<@XYP,\')XJO\ MQZ:FL>//A/92VK75K-?-',@4E2I9<AL= >:B_:W\,6'
MAOQG\&[+2--CL+*+5"1#9PXC4[DY( X/N:Y\+A\+*5*;5I3YKVM;2]K'1B\1
MB8JM33O"#CNFV[VZGJOBK]KSX?>!_$NL:#J=W>1:EI9"RQBV+"1L X0CJ<&N
MS^%'QK\*_&C29K[PW=M,8&VSV\Z%)8CVW*?YU\=R>.M"^'/[7WCS6O$>BS:M
MI<>Y6:"W\\VS%4PY7'0]/QKM_P!C2QNO$'Q=^('C?3M+GT;PG?GRK6"2,HKL
M7!X'3@ YQZT\5EF'I89U%=-1B[MJS;Z6*P6;8FMB5"34ES-62=TEUO\ @=!\
M5?C7\3[?]H"?X>^!5T@DV:W,0OXN^TEOFR,#CTKH?@1^T5K?BC7_ !7X8\>V
M5EI&M^&T,UW=6CXM_+'7.2<''->-_&KP3J/CS]L/4M*TR_O-'O9-'\VVOK3*
MXD2)BJ%O1CP:S/A%X73Q7\!?BAX>L=/N8?B<Q9=1-P7,MVJ-G"ENV0173+#8
M.>#AHE*T;VW3;^)OJK=.YQ+%XV&.J6<K)RLNC2Z)='<^B-*_;2^&&K^(XM*A
MU&ZC$TOD0W\]JR6\CYP '/;WKL=*^./AK6/BE>?#Z.2Y@\06L7VC$L.(IDQN
MRC=#P:^!+&YLO%G@GP_X'N;WQ+=ZA'*L?_"/6>CQH;60,<MYIPQ'/K7N'[2N
MBWWP9\6_#?XBZ=#<7DMA:KIE]M!+OB/"[\9[9!K.KE.$52-&,G>2:6O5;/9:
M,VHYSCG3E6J15HM75NCZ==4?0.B?M#>#]:\2^*-&@NY(SX;C:34;R:/;;Q '
M!&_H3FN;\-_MG?#+Q+XBM]'@U*[MGNI/*M[JZM6CMYFSC"N?ZUX-X.^$&NZW
M^R)XTU2VMY9_$/BFZ;47@VD22PJY.SUYYXKS6PET_P"('A_PGX.>_P#$VHZG
M%.B+I%II$<?V"53R3(0"0/7-%/*L%/GO)Z.V_9:O9Z7"IG&/@Z:4%JK[/9O1
M>MC[/\;?M7> O 'B[4?#FLW-W%J%BBR2!+<LK[AD*F.IQ5_PK^TOX&\9^"=:
M\4Z5>3RV6C(9+RW>$K/$!ZH:\-\)Z#%-^W3JMKJ%I]M2VT:) \\.Y2XB W$G
MC=UZ5RWA/PI<:G\1OVBM$TFR='FL72WA2/8C-G.U>V:Y_J&#<4HMIJ,6W=6U
M:3LCI>9XZ,G)I-7:M;565]SZD/[0WA./X0CXD;[H>'",@F ^:?FV_=^M0^)?
MVD_ _A/P5HOB;5+Z:*TU>,2V5JD):YE!]$'-?&,GQCL9?V1I_AK_ &1JG_"0
MVA*7"M:,(XT#Y)9L?A5WQ]HVJ:+:_!CQC/\ ;[70+;1HK>2_M;7SVLG!)W&-
MACGWK?\ LB@I?O&TN:26JU26GWG-//,0XWII2]U-Z/23?7T/M#X4?'WPC\93
M=1>'[J4WEK_K[*[C,4T8]2A[5Q?[1G[0U_\ #+5='\)^%M)76_&6M#_1X'R8
MXES@,P'))]/:O*_V6M%M?%_QOU7QG87GB#45@MVAN-6O;"*UMKS/155<'(^E
M:O[3^BZ[\/\ XV^$?BU9:3-K>C6$0MKV&!2[P 9YP/4$X/J*Y(X+#4\?[*+N
MN6Z3>G-;:YVO'8RKEWMFK-RLVE]GJ[%W0?C9\8? /C'2M+^)'A&.^TC4G 6_
MT2%I3;9(&6QD;03R.U4'_:CN? 7[1/C73/%NN,GA"QBQ96<5N'<R8!PNT9/>
MMK2_VN]2^)/C/1M"^'?@^ZU"WG93?7NJQM"ELI//W<C@9Z]ZYWX9Z+::G^W)
M\0OM]BEQ'%:G:9H=R _+]W(QG%=4:-.TYXFDH^ZW9/7?1];,Y'5K7IQPE5R2
MDE=WLM/Q1[WX&^/O@KX@^$=0\2Z?JBQ:?IX+7C7:^6]N ,Y937 +^W1\+)(;
MR47M\J6_W=UHP^T#.,Q^M?.>C>"]2\0V'[1&BZ#:2K*9U>*VB0A9$20DJGK]
M!6/XO^)WA?Q#^S38^#M-\(W</B;3?+^UW7V0A;8@_,Y?&26Z8K2GE&$<VU>2
M;2T:NDTG=_D9U,ZQL8I2M%I/=-\VMK(^R?%'[57@7P7-X?&KW-U:QZY:"^M9
M?LY($7^UZ'VJ?X=?M,> _BOJ=_8Z+?3B\M$:<V]U 8FDC7JR@]17S'XOTY-2
M^*7[/$-U:-<6QTR 2(\9*GYOXAC'YUVGBS1X-,_;DM%L;(6T<F@RES#'M1CY
M;#G QFN667X114;OF:;WT5G^IT1S3'<SEHXJ26SOJOT.^D_;G^&$-E+.]UJ&
M^&8Q/"MFV\8."3Z+[UZ'JGQZ\$:5\.[?QK=:Y$OA^< Q3*"6=O[BKU+>U?+7
M[+7AS3[_ ."/Q6EO-,CGG,]RL;7$'SX",1@D9//I7G#^%=9U3]E'P%JUG9W<
M]CH^M7,UY&D6Z2)"XQ)L(^;;[UK++<%.K[.#:M))MM:Z=#!9OCX4>><5*\6[
M6:MK;4^TOAM^T[X'^*VLR:-HMW=6FJ[&DBMM0@,#R@#JH/7CG%>;?L]_M :I
MJ;?$[4O'6N))I&@7I6*5HE001Y(Q\HY/ KR[X9PV/Q2^.7AO5-.U?Q'KUUHZ
M"4ZH^EQ6MM @4YC<C!/7'>L_X7:59W_@GX\6^K:%JNKV,FHAGM-,4+<;-Q.^
M/=@':>?I5O X:G"I%:W4=]U=VTV)CF.-JRA+9IR]'I=:>3/J+X?_ +5G@+XC
M^)8]!L+F[L]2N%+6J7]LT(NE]8V/!KH?BC\;?#OPAN]$B\0FY2/6)_L]O-%$
M7C5L@8<C[O6OC_X*>+[F3XM^!='T.>;QQHRKAX]7TGRKG1%YZ2X[>QQS7TQ^
MU[\/'^(/P4UA;6-FU+3"+^T(&6RG) ^HS7F5\%AZ&*A2O>,O\SU\/F&)KX&I
M65E./E]YT_C'XY^'/!7C#P]X6OFN9]8UQ@+:*TC\P $\,_/ KDM=_;'^&WA[
MQ)<Z1<WUU(MM/]GGU"&V9[6*3IAI!P,>M>(?LOS7_P ;_C6/'&KV4D</AO1H
MK*WCF0C=/MVY!(ZXS^=>:^+=<L/ NI>*X?#+ZSHVJ3WY>?P9KNEBZM[]RQR4
M;! 7ZX]J[H97AU5="=W))7L]+OY=#SZN<XJ5*->%E&4GHUK9+_,_2:PO8-1L
MX;NV=9K>=!)'*AR&4C((_"O)OVBOCTGP0\,VLUM8'5-<U&;[/860/WW/\1]O
M:LO0/C]::!X@\">!M4\.WMAK.LZ?%+LM(/\ 1K4[>4SV [^E<E^VIX$US5+;
MPCXRT*QDU2?PS>BXGLT4LS)D-N"CJ..:\C"X:/UR,*_PN_X'NXO&3>#E4P[]
MY6,,?&OX]_#R73M8\8^#+74] O7 E@TJ-GN+8'GHN2#CL17M'Q!_:*\&_"S2
MM*N]>O)8)M4B$UMI\4!:X92.Z?PXSW[UY!>?MPS^)5TK2_ ?@G4=6\2W3JLU
MK?1,D<(/!.Y<GKZ]JY3XTRWOPX_:5\/>/_&6A2ZCX=GTZ.)FMX?/CMI@N'4?
M1N1ZUZOU2-:I&->FJ;UT3UEV6M['A_7:F%I2>'JNHM-6G:-]WY^G0^B?!7[2
M/@?QUX3U?7M)U"22WTF)I[RU:(K/"H'/R'GM7')^W5\+'AL9/[0OE2X.&S:,
M?(.<8?T)KP?P?#+XW\:?%SX@:!HMUI/A"?0[B!$FA,7VB0KCY5Z=BWMFM#P5
MX7TR7]@75;N;2XSJ1660SFW_ 'P(EP#TSD"M?[.P5)^^WJXJR:TNM;^A,<UQ
M]56@EHI.[3UL^GJ>]7_[9'PNTSQ)!H\FN-*966/[;#"S6RLW(4OT[_A6QX^_
M:?\  WPS\16NBZW=S17%S;"[2>&$R1&,_=)8>O:OFSXB>$]-@_8+\/WL.EQQ
MZCMMY?-B@_>[F8ACP,\^]<_\1]9M-!^,GPFU35='DUBTM- M99K&.,O(X"GD
M+_%MZ_A3HY5@Z]2U/F=N:^JUMLUZDULWQM&#]IRIM1:T>E]T_0^N/A5^TQX%
M^,%]>6.B:A)'J%JI=K2[C,3L@_C7/45SFJ_MI_##2?$,VE2ZE<S)%+Y,M]!:
ML]LC9Q]_I7@'AV3_ (7U^TA?>(/ FCW6D:1!H\\$MX]OY&Z5HRHR,8R2<?AF
MO+_#UTOACP+JW@KQ!>:_8:C)=O%+X>L=(24W!)X82.,UI3RG!RDW)O9-J^JO
MW=NAG//,9&,5&*M=J]G9V_(^H_V@?VM6^&OB[PO8:#]GN[*Z1+S4)Y(&D!M6
M(PT6",MC/YU'XR^(MIXB^-GPNU.P\;ZMHVG:I9"YAT)+5C%=IAF^?L,@'KTP
M/6O+OC7X,N?ASX$^"U_-IVHW6FZ-+OO'GAWSQIN5E24+GMD8Z5TGC_7;;Q=^
MTY\%-:TRTGCTR]M%EA1X"FQ2'X88^4@=J(X;"0A!Q6EIW=UK;;0SGBL74=15
M7I>.B6U^IU/PH_;*/C7XPZIX;U.%4TJ[NC!HC06S"7[Q!\[)P.!UXKN_&'[8
M_P -O!/B6;0[S4KB[N[=_+N9+2 R16[9QAV'2O$_AWJ<'P]_:I\?:+J^EW-O
M<>()VBTF9;4F)2=Q1]W\(P>M<+X$\9Z-\$_#'Q#\&^-?"EW<^)K^>=;>46?F
M_: P*J=W;#'.:)Y;A*M6\%=6B[)K6^[OY=32&98VC3:J2UO+5J]K;*WF?87C
M']I#P1X(\-:#KM[?2W.DZY*(K2YM(_,4YQDMZ 9YS6;+^U9\/(_"=[XD35)9
M-+M[TZ>ACA+/<3  D1KU;@CFOCKQ;X%UCPO^SW\,],UZRGC:[\0O*+-E9FC@
MD*C:>/EXS^=?07[4?@OPAX<^'GAF'^P-3TZPMKE98M2\.0J?L4NT /*G\0([
M]?EKCEEV"IRA"[;E)K=;)G0LUQU6$ZB27*D]4];GLOPE^/OA+XPW%[;:#<31
MW]D ;BPO(3%-&#T.T]C7I>?YU\>_LC^+]5\2?%?Q#"QC\3:/!:CR_%3Z;]DG
MD.1B-CC)X]?2OL$'GIBO&Q^'AAJ[A3VW/I<LQ,\7AU4J;WMV)-U&ZFT5YYZP
M[=0#FFTX=* %HHI#TH :>M<G\1=7N]&T!+FR;RY_-50<9R,&NM'>N+^*-E<7
MWAN..WADGD\Y3MC&3C!K2E_$5S"M=0=CMJ***S-PHHHH *0G%(V<<4W)[T .
M;/:D&32;J-WI0 I.*JW%E;7$BO+;Q3,O(9T!P?;-6"<TE.]B6K]"M<64%YM\
M^WBEV<C>@.#Z\U'=Z;;:A&([JVAN4!X66,,/R/%7<8II4_6CF<=F2Z<9)W6Y
M3DT^V,2Q26T+PJ?D0Q@JON!C J-UTVX$+.EK*C';"6VD9]%]^.@]*N3H1;2[
M1EMC8'J<5\D:)X/\:^$M/\!V.EZ7?W-K/>WFIP^>2QTR[V2_NY<G/E,2&7T/
M%:1NV_>%*,7JOR/K)K6"65)'MXW=?NL\8)![$''%0WSZ=;G[3>?9D, #F6?:
M#&"< Y/3GO7RCX>OOB5)HFJ/9WFJR:Q]BAVVTD4K ZMO'RN9 %6,_,&5,KMQ
M75?#_0KK4/B/<7WB"WUNXDU;PPL<D>HHQMVND9_.1DQM&T_=!ZC&*;C;7F!1
MB]+'T LVEZLGGQO:7H@YWJRR!#UZ]J6%]/UZUM[N+[/?PGYH9EQ(N,_>!Y[@
M_E7S[X#\$ZO8^&?AKI=O#J6@V@M+ZXU.*Q40^;*H;RA*0.YQ@?A7)R:_K[SW
MVGWU[XIM-9M-(MI-,T[2(B(Q=L\G^L &,GY<AL#%-1UNI/0C2]G%:O\ +N=Y
MX&^!.N>'_P!HSQIXSU!K*;P]K,92&!27DZ+]]2,8XSUKVN36=#\.G[)+>6>G
M>5"UQY#.L>R)>KD<84$]:\L^*5[KL<7@]=;FU:QT.6V8ZS-X>5C.+P1@HOR@
ML$+;NG7@=*\RU+P!XB\7Z1K^H:];ZQ+J=SX?MK888H\D7VHE58+TD,>TL/SK
M:I6J8AKVKV5ODM$<^&PM+#)^SCNV_OU9]70I97@BOXHX9O,4%+E%!+*1P0WI
MBGI96L,K21VT<<KCYG1 &;ZG&:^9=1;XAZ?\4KBQANKR!;:^AATZ,)+) ^G*
M@R64+Y9SR&9CN!QBJWB-/%GA_P '^%K^35?%5[>W1FN+JR0.K2RF0A$5U!V,
M%^ZC#81U-<_+I;F_,Z[*]^7\CZ5"Z19ZO&@CM(M3NE8H BK+*%ZD'J<5<NX;
M:X0)<QQ2 D "8 C/08SWKQ[XV'Q,T6EOH46H03OI5QNDM8@TT$K!<<]FZ^U<
M/XS\):YINL?V?=W?B74O#6E:UI.II<!W>9-V1/M9?F9 <$KSMS0DWRMRU^9*
MBES)1T^1].10QQ*J1H(XT& JKA?RJ&#2[*VN7NH[2&&=^#*D0#L/KC-?+L6J
M_%)?&>I/!=W,6M)/>,+2996MFM I\C&0(UXP0V<YX(K./B'7KFXGTSP[KOBZ
M6YO?#;SS_P!H*V^.\,\:L\.1G(!8#&5 Q5*F^DM]]P:CI>.WH?70L8/.:X6&
M,2L.90HW$?6HX+.U6:66&.(2L<.\:C)/H3_C7S-\23XE\.W?B"T34?%S:E9)
M:+X=&FH98;B/Y?,:4XPSD[BV[''2J>JV/BGP['XOBTLZQ$;CQ2MSJLDSRE?[
M/>-2'@902 6&&V#(QTJ4KK67D)QC>W+YGT^^F:;$9Y)+2V0N"TKO$HW =V..
M12Q1V6JZ=&L45O=6,JC;M"M&R_[.."*^6WN?%LV@01^*M0\2G1GTZ[.E2:-!
M()II\D(DW&YAL^[OQGOS75:C:ZYH_P"S?X(MX9-5T6ZMX8/ML%O"_FE0I)CE
M9 7BR<?,H.#UXH?->W-^8*,.B_(^@[2Q@L8%CMX$AC7HD2!5'X"F0W-OJ,<P
MBEBNHU8QR!"& 8=5.._L:^8=3USQ9<16DMT?%FFZB=/MG\-VL"LXEGW$2"Z(
M&TMTSOQ\O/6KVBZUXG\ :M?W5_8:I%IM[_:6^+3[=I4-\0I1@,$\X(5NAI<M
MVY-C7*DHI'T&QT?PU!-,_P!CTR%2/,?Y8U!)P-WU/2KPLK9)S<+#$)GX:0*
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M6VD2J;.(3M<"92)%.=N%!SVKS7X=>%_BHMSI>H^)-0TKS;"&2W^R3)ND920
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MNE:/9@D/N]#M(^N!WKZ'^R,D_F_$^:_MS//Y5]Q[K_P\EU+_ *)W'_X,U_\
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MXN&A33[8LMJMWN%PI5@Q^5 >FXX(Q537O@-J'A'2-*O?$>HVVER7FHI836Z
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MWZG-6XDSC#_Q4H^J/K?_ (>2ZE_T3Q/_  9K_P#$T?\ #R74O^B>)_X,U_\
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MDVSSR,TY!*LV?F6+!"C@]^:[X?$7PEG(\3:5GU^UI_C4@^(_@]0/^*ETH?\
M;VG^-+FL%F>;0ZI\6CI;I%;1R7+PS7$4]VD:-E794A*C@.ZE6R 0,'UI^EP_
M$.]\*Z]<:KYZZK+IOEVHB(5BX=B/E& 'VGT&1BO1F^)WA$\?\)-I)^MTG^-1
MM\2O"C'_ )&?2?\ P*3_ !HY_(=F>9:9>_%'3].LX+>"::8EF@^V %')?E9R
M261=OW<$G/6FFX^*-Y<Z9,8+D6JNT=T75$GP8_F 0':RA\ -UQSUKTT_$CPE
MSGQ/I7O_ *6G^-.'Q)\)XX\3Z3_X%)_C3Y_(+,\XO-6^(GAG1)+RZF$5NJ^7
M)&RQG[+&"N'0DDLY^;&XD9ZXHTF]\:?$3P9X?EMM3FLI6U*X2>^=1$QMEW"-
MV52,GIQT)ZUZ'+\0_"$B,DGB32)(V!!5[J,@@]1C-(GQ#\(11K&GB32$11A4
M6ZC 4>@&>*7/Y!9GF<Z_%&"22QMGO-K3LD4RB-U>$[]TCL>4?(3:HZ ]Z+*U
M^)6D2W%U&VH77VN2,+YZQLZE8EPK+T5"^[<1S7J$?Q'\)A^?$VD_^!2?XU*_
MQ,\*#IXETH#WNT_QI\[Z(+,X1K?XG7&)#J1M9&<,8H[>)E0-( 0,@\*F2"3D
MGK7H7@T:O_8,"ZXQ?44>1'? 'F*'(1B!QDK@\5"OQ+\(8P/$NDYZ<7:?XT[_
M (69X1SG_A)=+S_U]I_C4N5QK0Z,)S2A=M<W_P +,\)_]#+I?_@6G^-'_"S?
M"7_0RZ7_ .!:?XU(SI::V<\5SG_"S?"7_0RZ7_X%I_C1_P +-\)?]#+I?_@6
MG^- '%_'(9U;P#G_ *"[_P#HAZH>495V*VUF!4'L 1@U1^-7Q \,W6J^!&B\
M1::RQZNQ<+=)T\E_>J3>._#+(P'B+2QN# %;M.21CUKU\*[4V>-C5=O2^A\K
MCX<>/_&?B2\M?#5R^A^$-/U"6TNM2CNO+6'9\TDTQSDGG*YXZ5Z=\ KS1=9\
M=>*)-$O[G5K72H8K)=4NN'O=W5SV/(.#R<&L6^^$VEZS::G;W'Q1LM+342$O
M_P"R[E0E\@Y7S5)QN'3(//?-=1\)_"WASX6:A(MOXLT-]*\@QK$MRIEDD)!,
MLA)'3' %>Y6Q%&IAE#[DEMYM]?*Q\'AL'5A6IM4M&VVV]$^ECVH#D<5QW@=2
M/$GCS_L+)_Z)6M/_ (3[PSGCQ%I7_@4G^-<GX*\;>'$\1^.V;7]-1'U5-A:Z
M7D>2N<<UYZ:[GVIZ/G%(?6L7_A.?#/\ T,>E_P#@6G^-*?'?AK'_ ",>E_\
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M\QK4:]52I.]MVE:__ 1RY30KX>DU7^2;O8Z-22O)KSKXYG_BF='_ .P]9?\
MH=="OQ(\)J#GQ/I/_@5'_C7 ?&OX@>%[GPQI(@\1Z6[+K=FQVW4?3>?>O,CN
M>X]CNI_]?)_O&F5B3^/_  L)Y/\ BI=)Y;('VM,X_.H_^$_\+?\ 0RZ5_P"!
MB?XUZ+V1YO5F_16!_P )_P"%O^AETK_P,3_&C_A/_"W_ $,NE?\ @8G^-,#?
MHK _X3_PM_T,NE?^!B?XT?\ "?\ A8?\S+I7_@8G^-*XR/XDD_\ "NO$_/\
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M]<#CK2Q_&;Q$L963041]B[S+%(/L/0>;.N/NMDD!>12Y&',CT[_A#_#_ /T
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M *(>J&_I7KX/X+GDXEM5-.QG_P#"+:)_T!-._P# 1/\ "D/A;1#_ ,P/3O\
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M2_AP-A;C76]_[8N/_BZ!G>E96).T_3'2E$$AZ@BN$_X4GX>(YN-< ]]9N/\
MXND_X4GX;)P+K76/H-8N/_BZ ,KXWQD:KX &"W_$X?C'_3!ZK&&4$_NF'L0:
MY;XQ?"/0K+4_ Z)<:SB75F4L=5G8@>2Y[M[52_X5+H )Q+K1'_87N/\ XJO8
MPC_=_,\K%:S1VOV:4_\ +-OR-'D2?W&_(UQ7_"IM!_Y^-9'_ '%[C_XJF_\
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MK":UTNT@:$PB*,1B)>0@' &>^!BN>^*$$H\&S JP'VNU]?\ GLM4Q\)]!/\
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M*UO)_P \V_(UPY^#OA[/^NUK_P '%Q_\71_PI[P]_P ]M;_\'-Q_\776<IW
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MXA_"/P];> /$DRSZUO2PE;YM6N".G3&ZNP\-?!OP]+X<TF1I];W-9PG"ZO<
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MK@'_ &&+C_XJC_A3GAT=)M;/UUBX_P#BZ] X#N?*E_YYM^1H\J3^X?UKAO\
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MMGO[TT\'%04CS7XWS9U7P"0,9UAQ_P"0'J@6).<FK7QKS_:?@#@D_P!LN?\
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M79^&&QX7T?\ Z\8/_0!7%_$H%?AUXFX)_P")?+@@>U=MX9C)\+Z-SS]AA_\
M0!7+6W1TTNIJ0]Z8S$MBG1'9G(QFD9"3E2#FN8Z!.!1N%&QAV%)M- %F*$%2
MS&O+48#XU^* >G]CV7_H3UZ8LA"E2>,5YB ?^%U^*" 3G1[+M_MO5T?B,ZGP
MG4-STH!.*-N&.3C%+Q7H' &\4;@:,BE\Q12&.7[P^M8?PF(_M7Q_S_S'6_\
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M30NX@8&WOQ19:^8=K]#CCX8\:B'GQXO_ (*(\_SI8?#'C4G'_">KQW_LB/\
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M(W+Q6ULD"LPPQ"#&3GU[9K%^)W_(G3?]?=K_ .CEJ'^VO'?_ $*6DC_N+_\
MV%<U\1]7\<2>$Y1)X6TJ-3=6QRFJ;N?-7C[M8<T_9^^[NSN[6U9UQY7-*GHM
M+?D?6-T!Y\F3CFHE?R^5QGU(KB)/$?Q%:1O^*-T<\]]8(_\ 9*9_PD'Q$/\
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M_L,__84KC.T69BP[\UB?"2<IJWC]F3(_MUAC_MFM8PU[XAY&/!VC#G_H,_\
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M.!Z4AD . ,"@9YI\:RHU/X?JHR#K+YSW_</5)WPK;N2 <>_&>U6_C4?^)GX
M_P"PR_\ Z(:J8?RW9S\VP;BOJ!SBO7PG\-GC8W2_HCPC5OVK-/\ "UW]DUK2
M7>^8Y%KITF]X5)X+D@ $X^Z,GFN^\"_$B\\8ZU):3Z0VFVXMOM"M+E9D?@[)
M(V V$@Y'4&O"[77O"OA>_P!>\3W?@B?Q1K[7TE]HM]"&EA9V^7R[A?X3$1D
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MO^$>\3\X'_()?_&N[\^4 '>WYG%2M(\=JH,C&1SG.3P*!71YY_PM[3O^A?\
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MMT=(O^UTI"23@=.U<X_Q.\&$8'B_0<?]A*'_ .*H7XF>##][Q?H./^PE#_\
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M]\"C^S[3_GWB_P"^!5K<?3]*-Q_N_I6_LZ7\OY')[:HOM/[RH=.M#_R[Q?\
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M09//^?6C_6+,UM/\$'^K&5_R?BSX!7]@+XG*N!J7AGGL)Y?\*>?^"?\ \4B
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M(_M'PS@]O/E_PI3^P)\3LD_VGX:SU'[^7K^5?H&3Q30"Q &<GIBA<1YE_/\
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MZD\/^%M/75H%OM'C:)M2:(O)M9MQ" DC';YL]C6O_P +8M_^A4\5Y_[!I_\
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ML:'XKMO ^JZYXRDE75O$5^;_ .SRC:T:8P,K_#NP,+Z 5UQ^)]N[(&\*>)I
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M%0XMHF4]&V=3Z?7VKW?]45_S^/G?]=G_ ,^']_\ P#]:F^,7@'/_ ".WA_\
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MU[&-Z^4HRO///'%?!_V6V/\ RZP?]\"C[);?\^UO^""G_JV_^?GX,K_6U?\
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MD?G7YM"TMATMH1_P 4W[%:J<BV@&>IV 4X\(<KO[7\&)\;\RM['\3]31\6_
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M)F[JJU]Y*RS.E%Q]E%_<9\/Q7^$MK<787PK<7,,UI<)NELH]Z2R-N4#G&%'
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MS+_A4/B++U_R\_!EKAC,W_R[_%'S51CWKZ8/_!/CXD)R=>\,J?<R_P"%1_\
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M=_BCYPHQ[U],/_P3Z^)"KG^WO#6/K+_A3%_X)_?$<M_R'O#/_?4M3_K'E_\
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M:<RFVN 2'R'Y;G&[+\$#C XJ5/@?+%!"\NO'4+J(Y<7L):*X4']VDB@C*JH
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M1_TY0?\ H KEK=#IH]36N&_<@$_I4$28<'I4EV.0*;#U%<MCI)[S_58/4U!
MVTC\NM273[D''M44/+?2BP#KG)8<G\Z\TB 'QK\3=<_V/8]_]IZ]+G&.:\TB
MY^-7B?\ [ ]C_P"A/6M+XC.K\)U3L-IZ_G3 1[_G2OTIHZ5WLX"?AE[C\:B(
MVYXS^-2(<**&(- #$&YAUZ^M<_\ "U-NI>/CR5_MUO\ T6M=%$N7'/>LGX3Q
M"35?'Z_]1U__ $6E8U6TC:CO9HB^,-I?WG@V'^SM-N=4GM]1M+DVUHH>5T20
M%RH) X^M22_%"5I'QX)\68)S_P >*>N?[]%%<1VC#\2ICG_BB?%O/7_04_\
MBZ>OQ*F49/@CQ8?^W!/_ (NBBE8=V'_"SIL?\B1XM'O]@3_XND/Q,E/3P3XM
M/_;BG7U^_P!:**90W_A9,K-_R)7BWW_T%.?_ !^I5^)3J,_\(3XLS_UX)_\
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M,<+(&/\ 'Z"BBHE7FXM,J%&"=SU]_BA(!(?^$(\6 L?^?%#_ .SU /B5,?\
MF2?%G_@ G_Q=%%>=U/0)8?B9(F2?!/BSC_IQ3_XNHF^)<S,3_P (3XLP?^G%
M/_BZ**8$D'Q,D16)\$^+2W8FQ3C_ ,?IG_"S)MV?^$)\6'_MQ3_XNBB@":/X
MH21(H'@KQ:.?^?!/_BZ\_P#AUX@U;PYX5AL+[P+XJ6Y2XGE(6S0C:TA*G._K
M@]***U@^78RG%2W.D?QY>%ACP-XK_P# )/\ XNG#QU=!<GP/XK^GV-/_ (NB
MBM>>1G[.(C>/KQ\ >!_%@'_7DG_Q=!\=W2_\R/XL_P# )#_[/112]I(/9Q%_
MX3Z\_P"A%\6'_MR3_P"+IO\ PG]YG_D1O%@_[<D_^+HHHYY![.)CZ=XFU2#X
MF3ZW)X&\5?8&T5+(-]C0L9!*6/&_T-=HGQ'<=?!GBT^WV%/_ (NBBL'J]3=*
MT=!P^)^SIX&\6?\ @"G/_C]-;XIRX&WP/XLQZ_8$R/I\]%%24,/Q.G88/@KQ
M:1V'V!/_ (NF+\2I@>/!/BS_ , $_P#BZ**5A6L31?$MX5+'P1XL8_\ 7BG_
M ,77&_$_Q?J?BK0["VL? OBMI(=4MKMP]DBXC1B6_C]***J.X/8VF\>W+R2-
M_P (/XLR6)'^A)_\741\>W9)_P"*'\6?^ 2?_%T45T>TD<_LXB+X[O"__(C>
M+ /^O)/_ (NI9/'EX%_Y$?Q6?^W-/_BZ**.>0<D2,^/+O(_XH;Q9_P" 2?\
MQ=/_ .$\O57CP-XK_P# -/\ XNBBCVD@Y(F'XS\5:EKG@_7-.M/ _BIKJ[M)
M(HPUD@&YAQSOKJ/#_P 1+BQT;3[>?P1XK66&UBB<"Q0@%5 /\=%%9S;EN:02
M6Q:G^)TKM_R)/BW'_7BG_P 72Q_$R0$?\43XM_\  %/_ (NBBLC4=<?$^1@
M/!/BW_P!3_XNHX?B9(CY/@GQ;_X I_\ %T44 /G^)KE,?\(3XM_\ 4_^+KB(
M?$NJGXEZ[K'_  @WBDV-SI]M;1L;- 2R,V[^/W%%%5#34SGKH;K^.[P+_P B
M/XK)_P"O)/\ XNF_\)Y=]/\ A!O%G_@$G_Q=%%="G(RY(DP\=W>W_D1_%?\
MX!)_\74?_">W?_0C^+,_]>2?_%T44O:2#DB2)X\O%(/_  @_BOK_ ,^2?_%U
K=^$9U&+_ (2S4+W1[W2?[1U=[BWM[] )FCV* Q4$\<&BBDY.6XTE%Z'_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>28
<FILENAME>form10-k_005.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 form10-k_005.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" #P!&@# 2(  A$! Q$!_\0
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MRN]8#7$3%9$@B>3:1U!*C&?QH [:BN(T?XN>"M;O8[.UU@)<2,%1)XGCW$]
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MG1K/5-1"JTD4/FSL3\B ;4'N0-H]S0(^SXW$D22 $!@#@]1FG4=**!A1110
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MN.Y R1@'FJGANQ\#Z9#HAU;POJ-K.XB$>J74;I%)-P<\/QD],@4 >V$@ DG
M'<T!E9=P((/<&H;VUCOK"XM)1F.>-HV'L1@UY7I>LS^'_@E=V[[FO[.:;3(P
M.K2&0JN/H&S^% 'K2NKKN1@P]0<T!@W0@]N*X'P1'!X*TK6M"N)2XTH+=LWJ
MCQ!CC_@:O4'A_P 3'1O#6A6L=A+?ZSK?FWJVT3!,!V,A9F/  # 4 >C45S5A
MXL=_$+:%JVFOIU\8#<1$2B6.9!UVL #D>A JG;>,M5U#25U?3_#,EWI[D^7Y
M5VOGLH8C/EXQVZ;LT =CFBO-K_4M9/QFT^&.S5H1IC-'"]V5!4OS(1M.&[8Y
MZ=:[_4H;FXTN[@LYEANI(72&5NB.00&_ \T 3B6,OL#J6_NYYI6=4&68*/4G
M%>5^)_ WA[PKX;74+-[B+7HWC6UN_/8RW$^1A2,X()ZC'2MGQ=X:TZXO;O7_
M !7>SW.C6T*K!80JX$;' +':<LQ/3@8_"@#O::LL;,55U+#J >:\T\#V^IZU
M\-]1M+/5'CAN)I(]/FDEWS00$CAB#PV,X'49%,UKP?I?A&31+KPY'+%KDE_%
M"KF9F:Y0_P"L#@G!&W))QQ0!Z<SJ@R[!1ZDXIP((R.17FUQIUMXZ^).KZ;JZ
MO-I6C6\2QVN]E5I9 27.".0 15WP")M)U[Q)X6-Q+/::=+%+:F5RS)'*I.S)
M[#'ZT =X2 ,GI34D23.QU;'7!S7"_$_S!8Z6T\>H2:*MT3J*6&?,*;3MSCG;
MGK6#H5GX2OM4L;OP!K$>G7L,H-S9R-(!<Q_Q*R/R3Z$<4 >M45SMYXCO/[=F
MTC2-)^WS6T227,CW(ACB+9VKG!)) )X'I6;/\0/LGA_7+Z[T>>"]T=D6XLWE
M7YMY&TJX!!!SUQVH [2C/..]<UXA\7)H'ANRUAK)IQ=20QB(2;=OF=\X.<5C
MVE[JA^,.IP+:K);+80 [KDCRT+-\X7;U)[<=.M '>*P894@CU%+7F'@[Q#J^
MG^ (Y[7PZ]U:69F+R-=K&T@$C%BBX.0/<CH:] T758=<T2RU2W5DBNH5E57Z
MJ".AH OT444 %%%% !1110 4444 %%%% !1110 4444 %%%% !113)98X(GE
ME=4C0%F9C@ #N: $N+B&TMY+BXD6*&-2SNQP% [FO!OB'X_7Q04T_3T>/3X7
M+%V.#,>QQV YXJQ\0_B*GB&%M)TM66P#YDF;@S8Z8'9<\_E7G-<5:K?W8['U
MN5Y;[.U:LO>Z+M_P?R"BBBN8^@-3PU_R-.D?]?L/_H8KZGKY8\-?\C3I'_7[
M#_Z&*^IZ[,-LSY3/OXD/1_F%>*^,_@CJ7BCQG?:Y#K%K!%<.K")XV)&% ZCZ
M5[5174?.D<$9AMXHR<E$"Y^@KRSXF_"6^\>>(+?4K;4[:U2*W$)25&8D@DYX
M^M>KT4 <I#X*AF^&T/A#4IA(@M%MWEC&.5Y##/H0#^%>16OP#\7Z7=2/IGB:
MSMU?Y3)')+&S+[@#],U]$44 > WO[.4SVMM]EUZ-KOYFN99HCAR<8V@'Z]>N
M:]H\,:=>:/X9T[3+Z:*:>T@6 R1 A6"C .#WP!6M6%XRTS4=8\(ZCI^D7'V>
M_FC"PRERFT[@>HY' - 'S7\;])M=-^)5RUI*KF\C6YEC7K&[9!!^N,_C7T#\
M,/#)\*^ ["RD&+F5?M$_^^^#C\!@?A7E?ASX$>(?^$HM-3\17]G+;Q3K-,HE
M>22;!SCD#KCDDU]"4 <9\3?!5QX\\,P:5;7D5J\=VMP7E4L" KKCC_>_2G_#
M;P;<>!_##:3<W<5TYG:7S(U(&"!QS]*["B@#RCXF_"6^\>>(;?4K;4[:U2*W
M$)25&8DAB<\?6NF\4^#;CQ!\.4\,17<44RPPQ^<RDK\FW)QUYQ78T4 >>_"S
MX=7?P^M]3CNK^&[-XT;*8D*[=H;KG_>K&^(_P63Q?K1UC2KV&QNY% N$E0E)
M6'1LCH<<'CM7K=% 'S@/V=_$TS(ESKVG^2G PTC[1[ J/YU[/X"\%6O@7PXN
MEV\QN)6<RSSE=ID<\=.P   KJ** "O#_ !S\![C7?$5[K&BZG;0_:Y#*]O<*
MP"N?O89<]3D].]>X44 ?-L'[/7BF[D7^T-:L(T7@$/)*P'L"!_.M?4/V=9X]
M1CGT37DAC148>?&2ZR#&2"/<9]J][HH IZ4FH1:9;QZI+#+>H@662$$*Y'?!
MZ9]*N444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '.>%?^
M/C7_ /L*2_R6NCKG/"O_ !\:_P#]A27^2UT=3'8WQ'\1_+\D%%%%48%#7$:3
M0-11%+,UK* H&23M-8?PXAFM/AWH\5Q#)%+' =T;J58<GJ#S75T4 <+\-;*X
M>+6M?OH)(;O5;^1PDJ%62)3A%Y_&H-1N)O"GC[4=<U#3[Z_LK^VBAMI;.#SF
M@V9W(5Z@$D'/0UZ#10!YIH=MX@CF\3^(M#T=+(7S1-9V%\NPRE =[%5(VEL\
M9/7K47B/5KWX@:$WANR\/:G:7D\D9N)KV'RXK8*P8G=GYNF!CUKU"B@!D2&.
M%$+%BJ@9/?%>57.D7UW\3/[#%I,ND+J?]LR3E#L8^4OR9Z9W@FO6** /*OB3
MIFK#Q &TNWEE37;$:7,Z(6$)$@.]L=MK,*=XZ\(-%JNC:I'9W]YI=C:?8YH-
M.E*3QJ/NNN,9'8BO4Z* /+O!FB:;<^)4U33]&UZ.*UC8)>:M<LN6(P56-LD_
M7BN<U6PB@OKM] TOQ5HWB$R-BWLUW6K29Z[CA=AZ]OI7NE% 'FNLS7NB_$G0
MM:OK"\N(&TK[)+):0F0+,6R<@=!S7>ZMJ']E:1=W_D2W!MXFD$,2DM(0.% '
M<GBKM% 'B^E^(H+O6T\0>*=.UV[OXO\ CTM(=,?R+3_=S]YO]HUW.J>*]5T#
M6)3?Z+<7>C3(K6MQI\)DD1L?,LJY]>A'_P"KKZ* /,='?4?#\7BSQ@-$N8;:
M^:)[/20O[UF VEV5<[=Q.?7&:S?#OB. :Z==U^SUZ\U>0>5"J:8ZP6B'JJ _
MJQKV"B@#SN\EN/!?CS5=<ETV]O-+UB"++V<7F-%+&",,HYP0>M7O!%G?7.M:
M_P")KVSELEU5XEM[:?B18XU(!8=LYZ>U=M10!SOB>^UG29['4M.LYK^RBWK>
MV<&WS&4@;77/4J0> >=U<+X@:+QY<6<>@^&=0LM6BN$E.IW5M]G%L 03ENKD
M^@S7KE% '!7.HR>"_%6K7=WINH7MGJOE2QSV4'F^6R+M*,!R.Q!]ZS-1TS5O
M%WAWQ=?1:7/9MJ4,$5G;7.%DD$)+;B/X<Y( /I7J%% 'C/B;6+_Q%X,TW3;7
MPYJ\3V=Q;?:7G@VA2I"X7NWKD# %=5)=R:1\79I)["]>WU&Q@MX9X8"\:N';
M.YA]WK7>44 <9X5MIX?A:+>2"1)O(N1Y;(0V2\F..O>K_@"&6W\ Z)#/$\4J
M6J!D=2K*?0@]*Z2B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***0D
M*"20 .230 .RHC.[!549))P *\/^(?Q&&MQS:-I8Q8!QYEQGF;'8>BY_/%6?
MB%\2A?)=:'H^TVK?)-= \R>H7V[9[UY97'6JW]V)]5E>6<MJU9:]%^H4445R
MGT84444 :GAK_D:=(_Z_8?\ T,5]3U\L>&O^1ITC_K]A_P#0Q7U/79AMF?*9
M]_$AZ/\ ,*\K^*?Q<;P3>1Z1IEI%<:D\7F.\Q.R$'IP.23C/4=J]4KX\\6S3
M>,OB]>PDE3=:D+./_90,(Q^@S74?.FK;:A\6/&N_4K";5YX&8X:W;RHA[+R!
MQ[58TSXO>.O!FHOINMAKSR2%DMK]<2+]''/YYKZ:TG3+;1=(M-,LTV6UK$L4
M8]@,<^]<?\0/A;IGCZXM+F>ZDLKFW4H98D#&13T!SZ=OJ: .NT75;?7=%L]4
MM&S!=0K*O/3(Z'W'3\*O5R_A;0+;X?>#VL9=1DN+.T\R8S3*%V)]XCCL.3^-
M>#ZC\4_'?CS7!I7ATO:)*Q$5O:##E?5W/(XZX(% 'U!17RYJ&H_%?X=2PWVI
M7EX;9G S-*)X7/\ =/7&?P]J]O\ A]X^@\>>&YKU81;7MN2EQ &R%.,AA['^
MAH [2BOE#3/BKX^;Q-';V^I37\CS-%%:.B[78Y50< '@D'KVJSXJN?BSX6>+
M6=:U*]@260*KQSJ8P^"0I5>!P#QC'% 'U-17S;;_ ! ^(OQ*L4T;0H%@GMXP
M]W=6S^69.>,L>%SZ#K].*R/#WQ+\8>"/%OV#7[FZN88Y?*N[2Z?<5SCYE;J"
M.H[&@#ZIHKS7XV^(M6\->#K.\T:]>TN'OEC9T )*E'..0>X%>3Z!XW^)GC&P
MET31KJ>YNPYFFNP41ECP %W8 49R?4_A0!]145\J?\)I\1OAOKZP:Q<7$C,
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MGAMC$\#!206&X@J<8[<D5A>+SI&L^+[#PWKUB84F@,VGZG',4D64'YD4XX.
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M<?C6_;_\>T7^X/Y5P>F7%S>3:_>::NC:=8B^ECN9KU7FED=0 S-EP%'H.@%
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M'<GBK7=;AUCQ!ITD-S>6ZO%'' RA8@2%X.2.A///- 'L?Q"_Y-QTG_KTL/\
MT%*J_LW1(-%UV4*/,-Q&I;O@*2!^IJ?QJ[7_ .S?I1@CD9A;V<90*<ADVJPQ
M]0:/V<X)H- UL2Q/&3=)@.I&?EH&8/[28']K: <<^1-S_P "6N]T?1(O$/P
MM-,E3?YNEYC]G7+(?^^@*X?]HZWGGU70###)(!!-G8I./F7TKU?X:HR?#70$
M=2K"S4%6&#0!X'\#_%1\/^);^SF<+;W=I(Y#?WXE+C] U5?A-HLGC#XH1WUY
MF1+>1M0N&]7W97_Q\C\JR_B3H#^#?B#?VMIOB@D)FMR/^><@.0/IEE_"O;O@
M)X872/!;:O+&1=:F^[)[1+POYG)_$4"/5Z***!A1110 4444 %%%% !1110
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MJFHHH KFQLS<?:#:P&;_ )Z>6-WY]:F**Q^90?J*=10 FU=NW:,>F* JK]T
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M,DQG,\]H( \8C;,2'^/.1QZ#-:7A:VM]>\;>,;O4K>*[\BYCM(5G0.(T53D
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MB72)"'TV6YCSA9+4>8#^ Y'XBNR^%O@S5+'6FUC4K22UCCB9(5E&&9FX)QU
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M<"[NFN'5A+*OW5CQU&<G/^3Z310 4444 %%%% !1110 4444 %%%% !1110
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MH **** "BBB@ HHHH **** "BBB@#G/"O_'QK_\ V%)?Y+71USGA7_CXU_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MR$CH"3CID8/K7F5Z-&OO#<FD6'B+6+YY4:&P\//'M>WE.0JRD#D(>>3C@=:
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MW'7([UZQ#!%;0K#!$D42#"HBA5'T ID=G:Q3331VT*2SX\UU0!I,# W'O^-
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MBVAU>_V.RWD+9%BI&-Q..OM6?HOC7PWI_P /!IEY=PV]]9VC6D]@_$K2@%2
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MT2/2I)Y%D+O-C<%4(HQZ*.E&@:FI1112&%%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 <]X65EN->W*1G4Y2,CJ,+70T8Q122LK%U)\\N;^N@4444R
MJA?Z)I6ID&^TZVN&'1I(@3^?6K]% U)Q=T[%*QT?3=,S]AL+:V)ZF*(*3^(J
M[110#;;NV%%%% @HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
F**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>29
<FILENAME>form10-k_006.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 form10-k_006.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1"  0 D # 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#Y5TR,'2]/
MX.3:P]S_ '!5GRE[Y_[Z-5],Q_9.G_\ 7I#_ .@"K6?:OD9;L_JC#1@Z$-%L
MOR&^4GHW_?1H\I?1O^^C_C3\D]J,GTJ3JY(=AGE+Z-_WT:7RU]#_ -]&G9/I
M1D^E.X<D.R&&)/0_]]&CRD]&_P"^C3\GTHY]*0<D.R&>6OH?^^C1Y2^A_P"^
MC3^?2C)]*=PY(=D,\I?0_P#?1H\I?1O^^C_C3\GTHR?2D'+#LAGE+Z'_ +Z-
M'E+Z'_OHT_)]*,GTH#DAV0SRT'8_]]&CRE]#_P!]&G\^E&3Z4!R0[(9Y2^A_
M[Z/^-'E+Z'_OH_XT_)]*,GTH#EAV&>4OH?\ OHT>6GH?^^C3\GTHY]* Y8=D
M,\I?0_\ ?1H\M?0_]]&GY/I1D^E <D.PSRE]#_WT:/*7T/\ WT:?D^E&3Z4[
MARP[(9Y2^A_,T>4OO_WT:?D^E&3Z4@Y(=D,$:^__ 'T:/*7T/_?1I_X49/I3
MN')3[(9Y2^A_[Z-'EKZ'_OHT_)]*,GTI!R0[(9Y:^A_[Z-'E+Z'_ +Z-/R?2
MC)]*=PY(=D,,2^C?]]&CRU]&_P"^C3\GTHR?2D'+#LAGE+Z'_OHT>4OHW_?1
MI^3Z49/I0'+#LAGEIGH?^^C1Y:^A_P"^C3_PHR?2G<.2'9#/*7G@\^YH\I,]
M#_WT:?D^E&3Z47#DAV0SRD]#_P!]'_&CR5]#_P!]&GY/I1D^E(.6'9#/*7T/
M_?1H\I?1O^^C3\GTHR?2@.6'89Y:^A_[Z-'E)Z'_ +Z-/_"C)]*8<L.R&>4O
MO_WT:#$OH?\ OHT_)]*.?2D')#LAGE+Z'_OH_P"-'E+Z-_WT:?D^E&3Z4!R0
M[(9Y2Y_B_P"^C_C1Y:^C?]]&GY/I1SZ4!R0[#/*7T/\ WT?\:/*7T/\ WT:?
MD^E&3Z4!R0[(9Y2^_P#WT?\ &CRU]&_[Z-/Y]*,GTH#DAV0SRU]&_P"^C1Y2
M^A_[Z-/R?2C)]* Y8=D,\I?0_P#?1_QH\I?0_P#?1I^3Z49/I0'+#LAGE+Z'
M_OH_XT>4OH?^^C3\GTHR?2G<.2'9#/+7T/\ WT:/*7T;_OHT_P#"C)]*0<L.
MR&>4N>A_,_XT>2OO_P!]'_&GY/I1D^E <L.R&>4I[-_WT:/*7_:_[Z-/R?2C
M)]* Y8=D,\I??_OHT>6I]?\ OH_XT_)]*.?2@.6'9##$OH?^^C08E'8_]]&G
-Y/I29[=*+B<(=D?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>30
<FILENAME>ntrp-20250228.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.0c -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: 96Mps7xRiXgen8uDanwsWaKM+bP9z5Z8SekhvWB2bWk6Hykt6gMRViWMM6fm0boJ -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:us-types="http://fasb.org/us-types/2024" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:ecd="http://xbrl.sec.gov/ecd/2024" xmlns:country="http://xbrl.sec.gov/country/2024" xmlns:srt="http://fasb.org/srt/2024" xmlns:cyd="http://xbrl.sec.gov/cyd/2024" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:NTRP="http://nexttrip.com/20250228" elementFormDefault="qualified" targetNamespace="http://nexttrip.com/20250228">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://nexttrip.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://nexttrip.com/role/BalanceSheets" id="BalanceSheets">
          <link:definition>00000002 - Statement - Consolidated Balance Sheets</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://nexttrip.com/role/BalanceSheetsParenthetical" id="BalanceSheetsParenthetical">
          <link:definition>00000003 - Statement - Consolidated Balance Sheets (Parenthetical)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://nexttrip.com/role/StatementsOfOperations" id="StatementsOfOperations">
          <link:definition>00000004 - Statement - Consolidated Statements of Operations</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://nexttrip.com/role/StatementsOfOperationsParenthetical" id="StatementsOfOperationsParenthetical">
          <link:definition>00000005 - Statement - Consolidated Statements of Operations (Parenthetical)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://nexttrip.com/role/StatementsOfStockholdersEquity" id="StatementsOfStockholdersEquity">
          <link:definition>00000006 - Statement - Consolidated Statements of Stockholders' Equity</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://nexttrip.com/role/StatementsOfStockholdersEquityParenthetical" id="StatementsOfStockholdersEquityParenthetical">
          <link:definition>00000007 - Statement - Consolidated Statements of Stockholders' Equity (Parenthetical)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://nexttrip.com/role/StatementsOfCashFlows" id="StatementsOfCashFlows">
          <link:definition>00000008 - Statement - Consolidated Statements of Cash Flows</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://nexttrip.com/role/BusinessDescriptionAndGoingConcern" id="BusinessDescriptionAndGoingConcern">
          <link:definition>999016 - Disclosure - Business Description and Going Concern</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://nexttrip.com/role/SummaryOfSignificantAccountingPolicies" id="SummaryOfSignificantAccountingPolicies">
          <link:definition>999017 - Disclosure - Summary of Significant Accounting Policies</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://nexttrip.com/role/DiscontinuedOperations" id="DiscontinuedOperations">
          <link:definition>999018 - Disclosure - Discontinued Operations</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://nexttrip.com/role/InvestmentInEquityMethodInvestee" id="InvestmentInEquityMethodInvestee">
          <link:definition>999019 - Disclosure - Investment in Equity Method Investee</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://nexttrip.com/role/InvestmentInEquitySecurities" id="InvestmentInEquitySecurities">
          <link:definition>999020 - Disclosure - Investment in Equity Securities</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://nexttrip.com/role/PrepaidAndOtherCurrentAssets" id="PrepaidAndOtherCurrentAssets">
          <link:definition>999021 - Disclosure - Prepaid and Other Current Assets</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://nexttrip.com/role/PropertyAndEquipment" id="PropertyAndEquipment">
          <link:definition>999022 - Disclosure - Property and Equipment</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://nexttrip.com/role/IntangibleAssets" id="IntangibleAssets">
          <link:definition>999023 - Disclosure - Intangible Assets</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://nexttrip.com/role/Goodwill" id="Goodwill">
          <link:definition>999024 - Disclosure - Goodwill</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://nexttrip.com/role/AccountsPayableAndAccruedLiabilities" id="AccountsPayableAndAccruedLiabilities">
          <link:definition>999025 - Disclosure - Accounts Payable and Accrued Liabilities</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://nexttrip.com/role/IncomeTaxes" id="IncomeTaxes">
          <link:definition>999026 - Disclosure - Income Taxes</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://nexttrip.com/role/NotesPayable" id="NotesPayable">
          <link:definition>999027 - Disclosure - Notes Payable</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://nexttrip.com/role/ConvertibleNotes" id="ConvertibleNotes">
          <link:definition>999028 - Disclosure - Convertible Notes</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://nexttrip.com/role/SharePurchaseAgreements" id="SharePurchaseAgreements">
          <link:definition>999029 - Disclosure - Share Purchase Agreements</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://nexttrip.com/role/RelatedPartyTransactions" id="RelatedPartyTransactions">
          <link:definition>999030 - Disclosure - Related Party Transactions</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://nexttrip.com/role/DeferredRevenue" id="DeferredRevenue">
          <link:definition>999031 - Disclosure - Deferred Revenue</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://nexttrip.com/role/CommitmentsAndContingencies" id="CommitmentsAndContingencies">
          <link:definition>999032 - Disclosure - Commitments and Contingencies</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://nexttrip.com/role/StockholdersEquity" id="StockholdersEquity">
          <link:definition>999033 - Disclosure - Stockholders&#8217; Equity</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://nexttrip.com/role/LossPerShare" id="LossPerShare">
          <link:definition>999034 - Disclosure - Loss Per Share</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://nexttrip.com/role/Concentrations" id="Concentrations">
          <link:definition>999035 - Disclosure - Concentrations</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://nexttrip.com/role/DefinedContributionPlans" id="DefinedContributionPlans">
          <link:definition>999036 - Disclosure - Defined Contribution Plans</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://nexttrip.com/role/SubsequentEvents" id="SubsequentEvents">
          <link:definition>999037 - Disclosure - Subsequent Events</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesPolicies" id="SummaryOfSignificantAccountingPoliciesPolicies">
          <link:definition>999038 - Disclosure - Summary of Significant Accounting Policies (Policies)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesTables" id="SummaryOfSignificantAccountingPoliciesTables">
          <link:definition>999039 - Disclosure - Summary of Significant Accounting Policies (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://nexttrip.com/role/DiscontinuedOperationsTables" id="DiscontinuedOperationsTables">
          <link:definition>999040 - Disclosure - Discontinued Operations (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://nexttrip.com/role/InvestmentInEquityMethodInvesteeTables" id="InvestmentInEquityMethodInvesteeTables">
          <link:definition>999041 - Disclosure - Investment in Equity Method Investee (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://nexttrip.com/role/PrepaidAndOtherCurrentAssetsTables" id="PrepaidAndOtherCurrentAssetsTables">
          <link:definition>999042 - Disclosure - Prepaid and Other Current Assets (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://nexttrip.com/role/PropertyAndEquipmentTables" id="PropertyAndEquipmentTables">
          <link:definition>999043 - Disclosure - Property and Equipment (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://nexttrip.com/role/IntangibleAssetsTables" id="IntangibleAssetsTables">
          <link:definition>999044 - Disclosure - Intangible Assets (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://nexttrip.com/role/GoodwillTables" id="GoodwillTables">
          <link:definition>999045 - Disclosure - Goodwill (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://nexttrip.com/role/IncomeTaxesTables" id="IncomeTaxesTables">
          <link:definition>999046 - Disclosure - Income Taxes (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://nexttrip.com/role/StockholdersEquityTables" id="StockholdersEquityTables">
          <link:definition>999047 - Disclosure - Stockholders&#8217; Equity (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://nexttrip.com/role/LossPerShareTables" id="LossPerShareTables">
          <link:definition>999048 - Disclosure - Loss Per Share (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://nexttrip.com/role/BusinessDescriptionAndGoingConcernDetailsNarrative" id="BusinessDescriptionAndGoingConcernDetailsNarrative">
          <link:definition>999049 - Disclosure - Business Description and Going Concern (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://nexttrip.com/role/ScheduleOfAnti-dilutiveSecuritiesExcludedFromComputationOfEarningsPerShareDetails" id="ScheduleOfAnti-dilutiveSecuritiesExcludedFromComputationOfEarningsPerShareDetails">
          <link:definition>999050 - Disclosure - Schedule of Anti-dilutive Securities Excluded from Computation of Earnings Per Share (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://nexttrip.com/role/ScheduleOfEstimatedUsefulLivesForPropertyAndEquipmentDetails" id="ScheduleOfEstimatedUsefulLivesForPropertyAndEquipmentDetails">
          <link:definition>999051 - Disclosure - Schedule of Estimated Useful Lives for Property and Equipment (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://nexttrip.com/role/ScheduleOfEstimatedUsefulLivesForFiniteLifeIntangibleAssetsDetails" id="ScheduleOfEstimatedUsefulLivesForFiniteLifeIntangibleAssetsDetails">
          <link:definition>999052 - Disclosure - Schedule of Estimated Useful Lives for Finite Life Intangible Assets (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" id="SummaryOfSignificantAccountingPoliciesDetailsNarrative">
          <link:definition>999053 - Disclosure - Summary of Significant Accounting Policies (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://nexttrip.com/role/ScheduleOfDiscontinuedOperationsDetails" id="ScheduleOfDiscontinuedOperationsDetails">
          <link:definition>999054 - Disclosure - Schedule of Discontinued Operations (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://nexttrip.com/role/DiscontinuedOperationsDetailsNarrative" id="DiscontinuedOperationsDetailsNarrative">
          <link:definition>999055 - Disclosure - Discontinued Operations (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://nexttrip.com/role/ScheduleOfUnauditedSummarizedFinancialInformationDetails" id="ScheduleOfUnauditedSummarizedFinancialInformationDetails">
          <link:definition>999056 - Disclosure - Schedule of Unaudited Summarized Financial Information (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://nexttrip.com/role/InvestmentInEquityMethodInvesteeDetailsNarrative" id="InvestmentInEquityMethodInvesteeDetailsNarrative">
          <link:definition>999057 - Disclosure - Investment in Equity Method Investee (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://nexttrip.com/role/InvestmentInEquitySecuritiesDetailsNarrative" id="InvestmentInEquitySecuritiesDetailsNarrative">
          <link:definition>999058 - Disclosure - Investment in Equity Securities (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://nexttrip.com/role/ScheduleOfPrepaidAndOtherCurrentAssetsDetails" id="ScheduleOfPrepaidAndOtherCurrentAssetsDetails">
          <link:definition>999059 - Disclosure - Schedule of Prepaid and Other Current Assets (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://nexttrip.com/role/ScheduleOfPropertyAndEquipmentDetails" id="ScheduleOfPropertyAndEquipmentDetails">
          <link:definition>999060 - Disclosure - Schedule of Property and Equipment (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://nexttrip.com/role/PropertyAndEquipmentDetailsNarrative" id="PropertyAndEquipmentDetailsNarrative">
          <link:definition>999061 - Disclosure - Property and Equipment (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://nexttrip.com/role/ScheduleOfIntangibleAssetsDetails" id="ScheduleOfIntangibleAssetsDetails">
          <link:definition>999062 - Disclosure - Schedule of Intangible Assets (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://nexttrip.com/role/ScheduleOfEstimatedAggregateAmortizationExpenseDetails" id="ScheduleOfEstimatedAggregateAmortizationExpenseDetails">
          <link:definition>999063 - Disclosure - Schedule of estimated aggregate amortization expense (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://nexttrip.com/role/IntangibleAssetsDetailsNarrative" id="IntangibleAssetsDetailsNarrative">
          <link:definition>999064 - Disclosure - Intangible Assets (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://nexttrip.com/role/ScheduleOfFairValueOfAssetsAcquiredDetails" id="ScheduleOfFairValueOfAssetsAcquiredDetails">
          <link:definition>999065 - Disclosure - Schedule of Fair Value of Assets Acquired (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://nexttrip.com/role/GoodwillDetailsNarrative" id="GoodwillDetailsNarrative">
          <link:definition>999066 - Disclosure - Goodwill (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://nexttrip.com/role/AccountsPayableAndAccruedLiabilitiesDetailsNarrative" id="AccountsPayableAndAccruedLiabilitiesDetailsNarrative">
          <link:definition>999067 - Disclosure - Accounts Payable and Accrued Liabilities (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://nexttrip.com/role/ScheduleOfDeferredTaxAssetsDetails" id="ScheduleOfDeferredTaxAssetsDetails">
          <link:definition>999068 - Disclosure - Schedule of Deferred Tax Assets (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://nexttrip.com/role/ScheduleOfReconciliationOfProvisionForIncomeTaxesDetails" id="ScheduleOfReconciliationOfProvisionForIncomeTaxesDetails">
          <link:definition>999069 - Disclosure - Schedule of Reconciliation of Provision for Income Taxes (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://nexttrip.com/role/IncomeTaxesDetailsNarrative" id="IncomeTaxesDetailsNarrative">
          <link:definition>999070 - Disclosure - Income Taxes (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://nexttrip.com/role/NotesPayableDetailsNarrative" id="NotesPayableDetailsNarrative">
          <link:definition>999071 - Disclosure - Notes Payable (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://nexttrip.com/role/ConvertibleNotesDetailsNarrative" id="ConvertibleNotesDetailsNarrative">
          <link:definition>999072 - Disclosure - Convertible Notes (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://nexttrip.com/role/SharePurchaseAgreementsDetailsNarrative" id="SharePurchaseAgreementsDetailsNarrative">
          <link:definition>999073 - Disclosure - Share Purchase Agreements (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://nexttrip.com/role/RelatedPartyTransactionsDetailsNarrative" id="RelatedPartyTransactionsDetailsNarrative">
          <link:definition>999074 - Disclosure - Related Party Transactions (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://nexttrip.com/role/DeferredRevenueDetailsNarrative" id="DeferredRevenueDetailsNarrative">
          <link:definition>999075 - Disclosure - Deferred Revenue (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://nexttrip.com/role/ScheduleOfStockOptionActivityDetails" id="ScheduleOfStockOptionActivityDetails">
          <link:definition>999076 - Disclosure - Schedule of Stock Option Activity (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://nexttrip.com/role/ScheduleOfShareBasedPaymentsAwardStockOptionsValuationAssumptionsDetails" id="ScheduleOfShareBasedPaymentsAwardStockOptionsValuationAssumptionsDetails">
          <link:definition>999077 - Disclosure - Schedule of Share Based Payments Award Stock Options Valuation Assumptions (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://nexttrip.com/role/ScheduleOfWarrantyActivityDetails" id="ScheduleOfWarrantyActivityDetails">
          <link:definition>999078 - Disclosure - Schedule of Warranty Activity (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://nexttrip.com/role/StockholdersEquityDetailsNarrative" id="StockholdersEquityDetailsNarrative">
          <link:definition>999079 - Disclosure - Stockholders&#8217; Equity (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://nexttrip.com/role/ScheduleOfEarningsPerShareBasicAndDilutedDetails" id="ScheduleOfEarningsPerShareBasicAndDilutedDetails">
          <link:definition>999080 - Disclosure - Schedule of Earnings Per Share, Basic and Diluted (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://nexttrip.com/role/ScheduleOfBusinessMilestonesAndIssuableContingentSharesDetails" id="ScheduleOfBusinessMilestonesAndIssuableContingentSharesDetails">
          <link:definition>999081 - Disclosure - Schedule of Business Milestones and Issuable Contingent Shares (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://nexttrip.com/role/ScheduleOfWeightedAverageCommonSharesDetailsParenthetical" id="ScheduleOfWeightedAverageCommonSharesDetailsParenthetical">
          <link:definition>999082 - Disclosure - Schedule of Weighted Average Common Shares (Details) (Parenthetical)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://nexttrip.com/role/ScheduleOfWeightedAverageCommonSharesDetails" id="ScheduleOfWeightedAverageCommonSharesDetails">
          <link:definition>999083 - Disclosure - Schedule of Weighted Average Common Shares (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://nexttrip.com/role/LossPerShareDetailsNarrative" id="LossPerShareDetailsNarrative">
          <link:definition>999084 - Disclosure - Loss Per Share (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://nexttrip.com/role/ConcentrationsDetailsNarrative" id="ConcentrationsDetailsNarrative">
          <link:definition>999085 - Disclosure - Concentrations (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://nexttrip.com/role/DefinedContributionPlansDetailsNarrative" id="DefinedContributionPlansDetailsNarrative">
          <link:definition>999086 - Disclosure - Defined Contribution Plans (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://nexttrip.com/role/SubsequentEventsDetailsNarrative" id="SubsequentEventsDetailsNarrative">
          <link:definition>999087 - Disclosure - Subsequent Events (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="ntrp-20250228_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="ntrp-20250228_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="ntrp-20250228_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Calculation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="ntrp-20250228_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2024" schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd" />
    <import namespace="http://fasb.org/us-gaap/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd" />
    <import namespace="http://fasb.org/us-types/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/ecd/2024" schemaLocation="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2024" schemaLocation="https://xbrl.sec.gov/country/2024/country-2024.xsd" />
    <import namespace="http://fasb.org/srt/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd" />
    <import namespace="http://xbrl.sec.gov/cyd/2024" schemaLocation="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd" />
    <element id="NTRP_NextTripGroupLLCMember" name="NextTripGroupLLCMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_NextPlayTechnologiesIncMember" name="NextPlayTechnologiesIncMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_ShareExchangeAgreementMember" name="ShareExchangeAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_MembershipUnitsMember" name="MembershipUnitsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_PreferredUnitsMember" name="PreferredUnitsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_NextInnovationLLCMember" name="NextInnovationLLCMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_ClosingSharesMember" name="ClosingSharesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_ContingentSharesMember" name="ContingentSharesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_SoftwareMember" name="SoftwareMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_SoftwareLicensesMember" name="SoftwareLicensesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_AssetPurchaseAgreementMember" name="AssetPurchaseAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_DivergentTechnologiesIncMember" name="DivergentTechnologiesIncMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_MembershipPurchaseAgreementMember" name="MembershipPurchaseAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_FSATravelLLCMember" name="FSATravelLLCMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_SeriesOPreferredStockMember" name="SeriesOPreferredStockMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_NextTripMember" name="NextTripMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_BlueFyshHoldingsIncMember" name="BlueFyshHoldingsIncMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_SeriesNNonvotingConvertiblePreferredStockMember" name="SeriesNNonvotingConvertiblePreferredStockMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_SoftwareLicenseMember" name="SoftwareLicenseMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_SigmaAdditiveSolutionsIncMember" name="SigmaAdditiveSolutionsIncMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_NextTripHoldingsIncMember" name="NextTripHoldingsIncMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_SecuritiesPurchaseAgreementMember" name="SecuritiesPurchaseAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_NoteSecuritiesPurchaseAgreementMember" name="NoteSecuritiesPurchaseAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_ShortTermPromissoryNoteMember" name="ShortTermPromissoryNoteMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_SeriesMNonvotingConvertiblePreferredStockMember" name="SeriesMNonvotingConvertiblePreferredStockMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_DebtConversionAgreementMember" name="DebtConversionAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_NoteTwoSecuritiesPurchaseAgreementMember" name="NoteTwoSecuritiesPurchaseAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_OneMillionNoteMember" name="OneMillionNoteMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_SeriesPNonvotingConvertiblePreferredStockMember" name="SeriesPNonvotingConvertiblePreferredStockMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_DebtExchangeAgreementMember" name="DebtExchangeAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_SpecialPurposeAcquisitionCorporationMember" name="SpecialPurposeAcquisitionCorporationMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_SeveralInvestorsMember" name="SeveralInvestorsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_ConvertibleNotesMember" name="ConvertibleNotesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_DebtAssignmentAndConversionAgreementsMember" name="DebtAssignmentAndConversionAgreementsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_SharePurchaseAgreementsMember" name="SharePurchaseAgreementsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_SoftwareAsAServiceAgreementMember" name="SoftwareAsAServiceAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_ThirdPartyMember" name="ThirdPartyMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_ThirdPartyConsultantMember" name="ThirdPartyConsultantMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_ConsultingModificationAgreementMember" name="ConsultingModificationAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_AlumniCapitalLPMember" name="AlumniCapitalLPMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_AtTheMarketIssuanceSalesAgreementMember" name="AtTheMarketIssuanceSalesAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_SharePurchaseAndExchangeAgreementsMember" name="SharePurchaseAndExchangeAgreementsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_SeriesEConvertiblePreferredStockMember" name="SeriesEConvertiblePreferredStockMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_SeriesFConvertiblePreferredStockMember" name="SeriesFConvertiblePreferredStockMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_SeriesGConvertiblePreferredStockMember" name="SeriesGConvertiblePreferredStockMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_SeriesHConvertiblePreferredStockMember" name="SeriesHConvertiblePreferredStockMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_SeriesIConvertiblePreferredStockMember" name="SeriesIConvertiblePreferredStockMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_SeriesIPurchaseAgreementMember" name="SeriesIPurchaseAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_SeriesIPreferredStockMember" name="SeriesIPreferredStockMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_MillerDebtConversionAgreementMember" name="MillerDebtConversionAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_SeriesJNonvotingConvertiblePreferredStockMember" name="SeriesJNonvotingConvertiblePreferredStockMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_SeriesKNonvotingConvertiblePreferredStockMember" name="SeriesKNonvotingConvertiblePreferredStockMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_SeriesLNonvotingConvertiblePreferredStockMember" name="SeriesLNonvotingConvertiblePreferredStockMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_MessrsKerbyAndMonacoMember" name="MessrsKerbyAndMonacoMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_RelatedPartyDebtConversionAgreementsMember" name="RelatedPartyDebtConversionAgreementsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_SeriesNNonvotingConvertibleConvertiblePreferredStockMember" name="SeriesNNonvotingConvertibleConvertiblePreferredStockMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_SeriesONonvotingConvertiblePreferredStockMember" name="SeriesONonvotingConvertiblePreferredStockMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_EquityInvestmentAgreementMember" name="EquityInvestmentAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_TwoThousandTwentyThreeEquityIncentivePlanMember" name="TwoThousandTwentyThreeEquityIncentivePlanMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_TwoThousandThirteenEquityIncentivePlanMember" name="TwoThousandThirteenEquityIncentivePlanMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_StockAppreciationRightsMember" name="StockAppreciationRightsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_TwoThousandAndTwentyStockAppreciationRightsPlanMember" name="TwoThousandAndTwentyStockAppreciationRightsPlanMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_AchievedMember" name="AchievedMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_SeriesJPreferredStockMember" name="SeriesJPreferredStockMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_SeriesKPreferredStockMember" name="SeriesKPreferredStockMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_SeriesLPreferredStockMember" name="SeriesLPreferredStockMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_SeriesMPreferredStockMember" name="SeriesMPreferredStockMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_SeriesNPreferredStockMember" name="SeriesNPreferredStockMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_SeriesOPreferredStockOneMember" name="SeriesOPreferredStockOneMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_LeisureTravelBookingPlatformMember" name="LeisureTravelBookingPlatformMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_GroupTravelBookingPlatformMember" name="GroupTravelBookingPlatformMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_FlexPayTechnologyMember" name="FlexPayTechnologyMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_NotAchievedMember" name="NotAchievedMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_TravelAgentPlatformMember" name="TravelAgentPlatformMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_CustomerMember" name="CustomerMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_ExchangeAgreementMember" name="ExchangeAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_PurchaseAgreementMember" name="PurchaseAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_NoteOneMember" name="NoteOneMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_NoteTwoMember" name="NoteTwoMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_LineOfCreditAgreementMember" name="LineOfCreditAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_TwoPromissoryNotesMember" name="TwoPromissoryNotesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_PromissoryNoteReceivableNet" name="PromissoryNoteReceivableNet" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_PercentageForIssuedAndOutstandingCapitalStock" name="PercentageForIssuedAndOutstandingCapitalStock" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_Technology" name="Technology" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_OrganizationCosts" name="OrganizationCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_LossOnRelatedPartyReceivable" name="LossOnRelatedPartyReceivable" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestment" name="IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestment" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_StockIssuedDuringPeriodValueOfPreferredShares" name="StockIssuedDuringPeriodValueOfPreferredShares" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_StockIssuedDuringPeriodShareOfPreferredShares" name="StockIssuedDuringPeriodShareOfPreferredShares" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_StockIssuedDuringPeriodValuePurchasesOfCommonShares" name="StockIssuedDuringPeriodValuePurchasesOfCommonShares" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_StockIssuedDuringPeriodSharesPurchasesOfCommonShares" name="StockIssuedDuringPeriodSharesPurchasesOfCommonShares" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_StockIssuedDuringPeriodValueReverseAcquisition" name="StockIssuedDuringPeriodValueReverseAcquisition" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_StockIssuedDuringPeriodSharesReverseAcquisition" name="StockIssuedDuringPeriodSharesReverseAcquisition" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_StockIssuedDuringPeriodValueOfPreferredSharesInPrivatePlacements" name="StockIssuedDuringPeriodValueOfPreferredSharesInPrivatePlacements" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_StockIssuedDuringPeriodSharesOfPreferredSharesInPrivatePlacements" name="StockIssuedDuringPeriodSharesOfPreferredSharesInPrivatePlacements" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_StockIssuedDuringPeriodValueConversionOfPreferredSharesToCommonShares" name="StockIssuedDuringPeriodValueConversionOfPreferredSharesToCommonShares" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_StockIssuedDuringPeriodSharesConversionOfPreferredSharesToCommonShares" name="StockIssuedDuringPeriodSharesConversionOfPreferredSharesToCommonShares" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_StockIssuedDuringPeriodValueIssuanceOfPreferredSharesForDebtConversions" name="StockIssuedDuringPeriodValueIssuanceOfPreferredSharesForDebtConversions" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_StockIssuedDuringPeriodSharesIssuanceOfPreferredSharesForDebtConversions" name="StockIssuedDuringPeriodSharesIssuanceOfPreferredSharesForDebtConversions" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_StockIssuedDuringPeriodValueIssuanceOfSecuritiesForServices" name="StockIssuedDuringPeriodValueIssuanceOfSecuritiesForServices" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_StockIssuedDuringPeriodSharesIssuanceOfSecuritiesForServices" name="StockIssuedDuringPeriodSharesIssuanceOfSecuritiesForServices" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_StockIssuedDuringPeriodValueSecuritiesIssuedForEquityInvestments" name="StockIssuedDuringPeriodValueSecuritiesIssuedForEquityInvestments" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_StockIssuedDuringPeriodSharseSecuritiesIssuedForEquityInvestments" name="StockIssuedDuringPeriodSharseSecuritiesIssuedForEquityInvestments" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_StockIssuedDuringPeriodValueIssuanceOfCommitmentSharesForEquityLineOfCredit" name="StockIssuedDuringPeriodValueIssuanceOfCommitmentSharesForEquityLineOfCredit" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_StockIssuedDuringPeriodSharesIssuanceOfCommitmentSharesForEquityLineOfCredit" name="StockIssuedDuringPeriodSharesIssuanceOfCommitmentSharesForEquityLineOfCredit" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_AmortizationOfPrepaidExpenses" name="AmortizationOfPrepaidExpenses" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_LossOnDispositionOfAssets" name="LossOnDispositionOfAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_InvestmentInEquityMethodInvestee" name="InvestmentInEquityMethodInvestee" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_ProceedsFromAcquireBusinessesGross" name="ProceedsFromAcquireBusinessesGross" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_IssuanceOfPreferredSharesForServices" name="IssuanceOfPreferredSharesForServices" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_IssuanceOfCommonSharesForServices" name="IssuanceOfCommonSharesForServices" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_IssuanceOfCommonSharesAsCommitmentShares" name="IssuanceOfCommonSharesAsCommitmentShares" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_IssuanceOfCommonWarrantsForServices" name="IssuanceOfCommonWarrantsForServices" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_IssuanceOfCommonSharesForEquityInvestments" name="IssuanceOfCommonSharesForEquityInvestments" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_IssuanceOfPreferredSharesForEquityInvestments" name="IssuanceOfPreferredSharesForEquityInvestments" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_IssuanceOfPreferredSharesForPerpetualSoftwareLicense" name="IssuanceOfPreferredSharesForPerpetualSoftwareLicense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_ConversionOfConvertibleNotes" name="ConversionOfConvertibleNotes" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_PreferredStockDividends" name="PreferredStockDividends" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_DisclosurePrepaidAndOtherCurrentAssetsAbstract" name="DisclosurePrepaidAndOtherCurrentAssetsAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_PrepaidExpensesAndOtherCurrentAssetsTextBlock" name="PrepaidExpensesAndOtherCurrentAssetsTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_DisclosureConvertibleNotesAbstract" name="DisclosureConvertibleNotesAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_ConvertibleDebtDisclosureTextBlock" name="ConvertibleDebtDisclosureTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_DisclosureSharePurchaseAgreementsAbstract" name="DisclosureSharePurchaseAgreementsAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_SharePurchaseAgreementsDisclosureTextBlock" name="SharePurchaseAgreementsDisclosureTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_DisclosureDeferredRevenueAbstract" name="DisclosureDeferredRevenueAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_DeferredRevenueTextBlock" name="DeferredRevenueTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_PrepaidsPolicyTextBlock" name="PrepaidsPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_BasisDifferencePolicyTextBlock" name="BasisDifferencePolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_PromissoryNoteReceivablePolicyTextBlock" name="PromissoryNoteReceivablePolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_RecentlyIssuedAccountingPronouncementsNotYetAdoptedPolicyTextBlock" name="RecentlyIssuedAccountingPronouncementsNotYetAdoptedPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_ScheduleOfEstimatedUsefulLivesForPropertyAndEquipmentTableTextBlock" name="ScheduleOfEstimatedUsefulLivesForPropertyAndEquipmentTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_ScheduleOfEstimatedUsefulLivesForFiniteLifeIntangibleAssetsTableTextBlock" name="ScheduleOfEstimatedUsefulLivesForFiniteLifeIntangibleAssetsTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_WorkingCapitalDeficit" name="WorkingCapitalDeficit" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_DisposalGroupIncludingDiscontinuedOperationsProfessionalServices" name="DisposalGroupIncludingDiscontinuedOperationsProfessionalServices" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_DisposalGroupIncludingDiscontinuedOperationsInvestorRelationsServices" name="DisposalGroupIncludingDiscontinuedOperationsInvestorRelationsServices" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_DisposalGroupIncludingDiscontinuedOperationsOtherIncome" name="DisposalGroupIncludingDiscontinuedOperationsOtherIncome" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_EarnestMoneyDeposit" name="EarnestMoneyDeposit" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_BusinessAcquisitionMilestonePayments" name="BusinessAcquisitionMilestonePayments" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_BusinessAcquisitionPerMilestonePayments" name="BusinessAcquisitionPerMilestonePayments" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_PrepaidOfferingCosts" name="PrepaidOfferingCosts" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_PrepaidConsultingContract" name="PrepaidConsultingContract" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_PrepaidCostOfSales" name="PrepaidCostOfSales" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour" name="FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_DeferredTaxAssetDepreciation" name="DeferredTaxAssetDepreciation" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_DeferredTaxAssetsPayrollAccruals" name="DeferredTaxAssetsPayrollAccruals" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_DeferredTaxLiabilitiesDepreciation" name="DeferredTaxLiabilitiesDepreciation" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_EffectiveIncomeTaxRateReconciliationBookLoss" name="EffectiveIncomeTaxRateReconciliationBookLoss" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_IncomeTaxReconciliationNondeductibleExpensePreferredDividends" name="IncomeTaxReconciliationNondeductibleExpensePreferredDividends" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_IncomeTaxReconciliationNondeductibleExpenseLossOnNextPlayNoteReceivable" name="IncomeTaxReconciliationNondeductibleExpenseLossOnNextPlayNoteReceivable" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_IncomeTaxReconciliationNondeductibleExpenseLossOnAssetDisposal" name="IncomeTaxReconciliationNondeductibleExpenseLossOnAssetDisposal" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_IncomeTaxReconciliationNondeductibleExpenseAccruedPayroll" name="IncomeTaxReconciliationNondeductibleExpenseAccruedPayroll" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_IncomeTaxReconciliationNondeductibleExpenseRelatedPartyAccruals" name="IncomeTaxReconciliationNondeductibleExpenseRelatedPartyAccruals" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_OperatingLossCarryforwardsRemainder" name="OperatingLossCarryforwardsRemainder" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_ConvertibleNotesPayableOfInstallments" name="ConvertibleNotesPayableOfInstallments" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_DebtConversionConvertedInstrumentOfGuaranteedInterest" name="DebtConversionConvertedInstrumentOfGuaranteedInterest" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_DebtInstrumentPeriodicOfInstallments" name="DebtInstrumentPeriodicOfInstallments" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_DebtInstrumentUnamortizedDebtDiscount" name="DebtInstrumentUnamortizedDebtDiscount" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_DebtInstrumentOfInvestor" name="DebtInstrumentOfInvestor" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_DebtInstrumentOfFunded" name="DebtInstrumentOfFunded" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCost" name="AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCost" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_ProceedsFromDownpaymentForContract" name="ProceedsFromDownpaymentForContract" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_ConsultingFees" name="ConsultingFees" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedorCancelledInPeriodTotalIntrinsicValue" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedorCancelledInPeriodTotalIntrinsicValue" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageForfeitedOrCancelled" name="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageForfeitedOrCancelled" nillable="true" xbrli:periodType="duration" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice" nillable="true" xbrli:periodType="instant" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonOutstandingWeightedAverageRemainingContractualTerm" name="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonOutstandingWeightedAverageRemainingContractualTerm" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageExercisePrice" name="ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageExercisePrice" nillable="true" xbrli:periodType="duration" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonGrantsWeightedAverageRemainingContractualTerm" name="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonGrantsWeightedAverageRemainingContractualTerm" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageExercisePrice" name="ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageExercisePrice" nillable="true" xbrli:periodType="duration" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageWeightedAverageExercisePriceWarrantsForfeitedOrCancelled" name="ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageWeightedAverageExercisePriceWarrantsForfeitedOrCancelled" nillable="true" xbrli:periodType="duration" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_StockIssuedDuringPeriodSharesWarrantExercises" name="StockIssuedDuringPeriodSharesWarrantExercises" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardWeightedAverageRemainingRecognitionPeriod" name="SharebasedCompensationArrangementBySharebasedPaymentAwardWeightedAverageRemainingRecognitionPeriod" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_DescriptionForWarrantExpiration" name="DescriptionForWarrantExpiration" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_CommonStockIssuedPercentage" name="CommonStockIssuedPercentage" nillable="true" xbrli:periodType="instant" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_CashAdvance" name="CashAdvance" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_FirstPromissoryNoteMember" name="FirstPromissoryNoteMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_SecondPromissoryNoteMember" name="SecondPromissoryNoteMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_BoardOfDirectorsAndChiefExecutiveOfficerMember" name="BoardOfDirectorsAndChiefExecutiveOfficerMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>31
<FILENAME>ntrp-20250228_cal.xml
<DESCRIPTION>XBRL CALCULATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.0c -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://nexttrip.com/role/Cover" xlink:href="ntrp-20250228.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/BalanceSheets" xlink:href="ntrp-20250228.xsd#BalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/BalanceSheetsParenthetical" xlink:href="ntrp-20250228.xsd#BalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/StatementsOfOperations" xlink:href="ntrp-20250228.xsd#StatementsOfOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/StatementsOfOperationsParenthetical" xlink:href="ntrp-20250228.xsd#StatementsOfOperationsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/StatementsOfStockholdersEquity" xlink:href="ntrp-20250228.xsd#StatementsOfStockholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/StatementsOfStockholdersEquityParenthetical" xlink:href="ntrp-20250228.xsd#StatementsOfStockholdersEquityParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/StatementsOfCashFlows" xlink:href="ntrp-20250228.xsd#StatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#CybersecurityRiskManagementAndStrategyDisclosure" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/cyd/role/MaterialCybersecurityIncidentDisclosure" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#MaterialCybersecurityIncidentDisclosure" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/BusinessDescriptionAndGoingConcern" xlink:href="ntrp-20250228.xsd#BusinessDescriptionAndGoingConcern" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="ntrp-20250228.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/DiscontinuedOperations" xlink:href="ntrp-20250228.xsd#DiscontinuedOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/InvestmentInEquityMethodInvestee" xlink:href="ntrp-20250228.xsd#InvestmentInEquityMethodInvestee" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/InvestmentInEquitySecurities" xlink:href="ntrp-20250228.xsd#InvestmentInEquitySecurities" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/PrepaidAndOtherCurrentAssets" xlink:href="ntrp-20250228.xsd#PrepaidAndOtherCurrentAssets" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/PropertyAndEquipment" xlink:href="ntrp-20250228.xsd#PropertyAndEquipment" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/IntangibleAssets" xlink:href="ntrp-20250228.xsd#IntangibleAssets" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/Goodwill" xlink:href="ntrp-20250228.xsd#Goodwill" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/AccountsPayableAndAccruedLiabilities" xlink:href="ntrp-20250228.xsd#AccountsPayableAndAccruedLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/IncomeTaxes" xlink:href="ntrp-20250228.xsd#IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/NotesPayable" xlink:href="ntrp-20250228.xsd#NotesPayable" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/ConvertibleNotes" xlink:href="ntrp-20250228.xsd#ConvertibleNotes" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/SharePurchaseAgreements" xlink:href="ntrp-20250228.xsd#SharePurchaseAgreements" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/RelatedPartyTransactions" xlink:href="ntrp-20250228.xsd#RelatedPartyTransactions" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/DeferredRevenue" xlink:href="ntrp-20250228.xsd#DeferredRevenue" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/CommitmentsAndContingencies" xlink:href="ntrp-20250228.xsd#CommitmentsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/StockholdersEquity" xlink:href="ntrp-20250228.xsd#StockholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/LossPerShare" xlink:href="ntrp-20250228.xsd#LossPerShare" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/Concentrations" xlink:href="ntrp-20250228.xsd#Concentrations" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/DefinedContributionPlans" xlink:href="ntrp-20250228.xsd#DefinedContributionPlans" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/SubsequentEvents" xlink:href="ntrp-20250228.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="ntrp-20250228.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:href="ntrp-20250228.xsd#SummaryOfSignificantAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/DiscontinuedOperationsTables" xlink:href="ntrp-20250228.xsd#DiscontinuedOperationsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/InvestmentInEquityMethodInvesteeTables" xlink:href="ntrp-20250228.xsd#InvestmentInEquityMethodInvesteeTables" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/PrepaidAndOtherCurrentAssetsTables" xlink:href="ntrp-20250228.xsd#PrepaidAndOtherCurrentAssetsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/PropertyAndEquipmentTables" xlink:href="ntrp-20250228.xsd#PropertyAndEquipmentTables" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/IntangibleAssetsTables" xlink:href="ntrp-20250228.xsd#IntangibleAssetsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/GoodwillTables" xlink:href="ntrp-20250228.xsd#GoodwillTables" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/IncomeTaxesTables" xlink:href="ntrp-20250228.xsd#IncomeTaxesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/StockholdersEquityTables" xlink:href="ntrp-20250228.xsd#StockholdersEquityTables" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/LossPerShareTables" xlink:href="ntrp-20250228.xsd#LossPerShareTables" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/BusinessDescriptionAndGoingConcernDetailsNarrative" xlink:href="ntrp-20250228.xsd#BusinessDescriptionAndGoingConcernDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/ScheduleOfAnti-dilutiveSecuritiesExcludedFromComputationOfEarningsPerShareDetails" xlink:href="ntrp-20250228.xsd#ScheduleOfAnti-dilutiveSecuritiesExcludedFromComputationOfEarningsPerShareDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/ScheduleOfEstimatedUsefulLivesForPropertyAndEquipmentDetails" xlink:href="ntrp-20250228.xsd#ScheduleOfEstimatedUsefulLivesForPropertyAndEquipmentDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/ScheduleOfEstimatedUsefulLivesForFiniteLifeIntangibleAssetsDetails" xlink:href="ntrp-20250228.xsd#ScheduleOfEstimatedUsefulLivesForFiniteLifeIntangibleAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:href="ntrp-20250228.xsd#SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/ScheduleOfDiscontinuedOperationsDetails" xlink:href="ntrp-20250228.xsd#ScheduleOfDiscontinuedOperationsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/DiscontinuedOperationsDetailsNarrative" xlink:href="ntrp-20250228.xsd#DiscontinuedOperationsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/ScheduleOfUnauditedSummarizedFinancialInformationDetails" xlink:href="ntrp-20250228.xsd#ScheduleOfUnauditedSummarizedFinancialInformationDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/InvestmentInEquityMethodInvesteeDetailsNarrative" xlink:href="ntrp-20250228.xsd#InvestmentInEquityMethodInvesteeDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/InvestmentInEquitySecuritiesDetailsNarrative" xlink:href="ntrp-20250228.xsd#InvestmentInEquitySecuritiesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/ScheduleOfPrepaidAndOtherCurrentAssetsDetails" xlink:href="ntrp-20250228.xsd#ScheduleOfPrepaidAndOtherCurrentAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/ScheduleOfPropertyAndEquipmentDetails" xlink:href="ntrp-20250228.xsd#ScheduleOfPropertyAndEquipmentDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/PropertyAndEquipmentDetailsNarrative" xlink:href="ntrp-20250228.xsd#PropertyAndEquipmentDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/ScheduleOfIntangibleAssetsDetails" xlink:href="ntrp-20250228.xsd#ScheduleOfIntangibleAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/ScheduleOfEstimatedAggregateAmortizationExpenseDetails" xlink:href="ntrp-20250228.xsd#ScheduleOfEstimatedAggregateAmortizationExpenseDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/IntangibleAssetsDetailsNarrative" xlink:href="ntrp-20250228.xsd#IntangibleAssetsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/ScheduleOfFairValueOfAssetsAcquiredDetails" xlink:href="ntrp-20250228.xsd#ScheduleOfFairValueOfAssetsAcquiredDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/GoodwillDetailsNarrative" xlink:href="ntrp-20250228.xsd#GoodwillDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/AccountsPayableAndAccruedLiabilitiesDetailsNarrative" xlink:href="ntrp-20250228.xsd#AccountsPayableAndAccruedLiabilitiesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/ScheduleOfDeferredTaxAssetsDetails" xlink:href="ntrp-20250228.xsd#ScheduleOfDeferredTaxAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/ScheduleOfReconciliationOfProvisionForIncomeTaxesDetails" xlink:href="ntrp-20250228.xsd#ScheduleOfReconciliationOfProvisionForIncomeTaxesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/IncomeTaxesDetailsNarrative" xlink:href="ntrp-20250228.xsd#IncomeTaxesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/NotesPayableDetailsNarrative" xlink:href="ntrp-20250228.xsd#NotesPayableDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/ConvertibleNotesDetailsNarrative" xlink:href="ntrp-20250228.xsd#ConvertibleNotesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/SharePurchaseAgreementsDetailsNarrative" xlink:href="ntrp-20250228.xsd#SharePurchaseAgreementsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:href="ntrp-20250228.xsd#RelatedPartyTransactionsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/DeferredRevenueDetailsNarrative" xlink:href="ntrp-20250228.xsd#DeferredRevenueDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/ScheduleOfStockOptionActivityDetails" xlink:href="ntrp-20250228.xsd#ScheduleOfStockOptionActivityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/ScheduleOfShareBasedPaymentsAwardStockOptionsValuationAssumptionsDetails" xlink:href="ntrp-20250228.xsd#ScheduleOfShareBasedPaymentsAwardStockOptionsValuationAssumptionsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/ScheduleOfWarrantyActivityDetails" xlink:href="ntrp-20250228.xsd#ScheduleOfWarrantyActivityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/StockholdersEquityDetailsNarrative" xlink:href="ntrp-20250228.xsd#StockholdersEquityDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/ScheduleOfEarningsPerShareBasicAndDilutedDetails" xlink:href="ntrp-20250228.xsd#ScheduleOfEarningsPerShareBasicAndDilutedDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/ScheduleOfBusinessMilestonesAndIssuableContingentSharesDetails" xlink:href="ntrp-20250228.xsd#ScheduleOfBusinessMilestonesAndIssuableContingentSharesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/ScheduleOfWeightedAverageCommonSharesDetailsParenthetical" xlink:href="ntrp-20250228.xsd#ScheduleOfWeightedAverageCommonSharesDetailsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/ScheduleOfWeightedAverageCommonSharesDetails" xlink:href="ntrp-20250228.xsd#ScheduleOfWeightedAverageCommonSharesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/LossPerShareDetailsNarrative" xlink:href="ntrp-20250228.xsd#LossPerShareDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/ConcentrationsDetailsNarrative" xlink:href="ntrp-20250228.xsd#ConcentrationsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/DefinedContributionPlansDetailsNarrative" xlink:href="ntrp-20250228.xsd#DefinedContributionPlansDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/SubsequentEventsDetailsNarrative" xlink:href="ntrp-20250228.xsd#SubsequentEventsDetailsNarrative" xlink:type="simple" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/Cover" xlink:title="00000001 - Document - Cover" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/BalanceSheets" xlink:title="00000002 - Statement - Consolidated Balance Sheets">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_PromissoryNoteReceivableNet" xlink:label="loc_NTRPPromissoryNoteReceivableNet" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_NTRPPromissoryNoteReceivableNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaapAccountsReceivableNetCurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapAccountsReceivableNetCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsNoncurrent" xlink:label="loc_us-gaapAssetsNoncurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsNoncurrent" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsNoncurrent" xlink:to="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SecurityDeposit" xlink:label="loc_us-gaapSecurityDeposit" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsNoncurrent" xlink:to="loc_us-gaapSecurityDeposit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsNoncurrent" xlink:to="loc_us-gaapGoodwill" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestments" xlink:label="loc_us-gaapEquityMethodInvestments" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsNoncurrent" xlink:to="loc_us-gaapEquityMethodInvestments" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseOtherNoncurrent" xlink:label="loc_us-gaapPrepaidExpenseOtherNoncurrent" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsNoncurrent" xlink:to="loc_us-gaapPrepaidExpenseOtherNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapAssetsNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccountsPayableCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccruedLiabilitiesCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccruedLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="loc_us-gaapDeferredRevenueCurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapDeferredRevenueCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesPayableCurrent" xlink:label="loc_us-gaapNotesPayableCurrent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapNotesPayableCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapPreferredStockValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaapCommitmentsAndContingencies" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapCommitmentsAndContingencies" xlink:type="arc" weight="1" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Consolidated Balance Sheets (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/StatementsOfOperations" xlink:title="00000004 - Statement - Consolidated Statements of Operations">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaapGrossProfit" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapGrossProfit" xlink:to="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfRevenue" xlink:label="loc_us-gaapCostOfRevenue" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapGrossProfit" xlink:to="loc_us-gaapCostOfRevenue" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaapOperatingExpenses" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LaborAndRelatedExpense" xlink:label="loc_us-gaapLaborAndRelatedExpense" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapLaborAndRelatedExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaapGeneralAndAdministrativeExpense" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapGeneralAndAdministrativeExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingAndMarketingExpense" xlink:label="loc_us-gaapSellingAndMarketingExpense" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapSellingAndMarketingExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfessionalFees" xlink:label="loc_us-gaapProfessionalFees" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapProfessionalFees" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_Technology" xlink:label="loc_NTRPTechnology" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_NTRPTechnology" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_OrganizationCosts" xlink:label="loc_NTRPOrganizationCosts" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_NTRPOrganizationCosts" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="loc_us-gaapDepreciationDepletionAndAmortization" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapDepreciationDepletionAndAmortization" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherExpenses" xlink:label="loc_us-gaapOtherExpenses" />
      <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapOtherExpenses" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapGrossProfit" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapOperatingExpenses" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaapNonoperatingIncomeExpense" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossOnDispositionOfAssets1" xlink:label="loc_us-gaapGainLossOnDispositionOfAssets1" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapGainLossOnDispositionOfAssets1" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaapGainsLossesOnExtinguishmentOfDebt" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapGainsLossesOnExtinguishmentOfDebt" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_LossOnRelatedPartyReceivable" xlink:label="loc_NTRPLossOnRelatedPartyReceivable" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_NTRPLossOnRelatedPartyReceivable" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:label="loc_us-gaapInterestIncomeExpenseNonoperatingNet" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapInterestIncomeExpenseNonoperatingNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="loc_us-gaapOtherNonoperatingIncomeExpense" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapOtherNonoperatingIncomeExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapNonoperatingIncomeExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestment" xlink:label="loc_NTRPIncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestment" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_NTRPIncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestment" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_NTRPIncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestment" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:to="loc_NTRPIncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestment" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromEquityMethodInvestments" xlink:label="loc_us-gaapIncomeLossFromEquityMethodInvestments" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:to="loc_us-gaapIncomeLossFromEquityMethodInvestments" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:label="loc_us-gaapIncomeLossFromDiscontinuedOperationsNetOfTax" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapIncomeLossFromDiscontinuedOperationsNetOfTax" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasic" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockDividendsIncomeStatementImpact" xlink:label="loc_us-gaapPreferredStockDividendsIncomeStatementImpact" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="loc_us-gaapPreferredStockDividendsIncomeStatementImpact" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/StatementsOfOperationsParenthetical" xlink:title="00000005 - Statement - Consolidated Statements of Operations (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/StatementsOfStockholdersEquity" xlink:title="00000006 - Statement - Consolidated Statements of Stockholders&apos; Equity" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/StatementsOfStockholdersEquityParenthetical" xlink:title="00000007 - Statement - Consolidated Statements of Stockholders&apos; Equity (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/StatementsOfCashFlows" xlink:title="00000008 - Statement - Consolidated Statements of Cash Flows">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="loc_us-gaapDepreciationDepletionAndAmortization" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaapDepreciationDepletionAndAmortization" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfDebtDiscountPremium" xlink:label="loc_us-gaapAmortizationOfDebtDiscountPremium" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaapAmortizationOfDebtDiscountPremium" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_AmortizationOfPrepaidExpenses" xlink:label="loc_NTRPAmortizationOfPrepaidExpenses" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_NTRPAmortizationOfPrepaidExpenses" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_LossOnRelatedPartyReceivable" xlink:label="loc_NTRPLossOnRelatedPartyReceivable" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_NTRPLossOnRelatedPartyReceivable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaapGainsLossesOnExtinguishmentOfDebt" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaapGainsLossesOnExtinguishmentOfDebt" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_LossOnDispositionOfAssets" xlink:label="loc_NTRPLossOnDispositionOfAssets" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_NTRPLossOnDispositionOfAssets" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromEquityMethodInvestments" xlink:label="loc_us-gaapIncomeLossFromEquityMethodInvestments" />
      <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaapIncomeLossFromEquityMethodInvestments" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsReceivable" />
      <link:calculationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsReceivable" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidExpense" />
      <link:calculationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidExpense" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInSecurityDeposits" xlink:label="loc_us-gaapIncreaseDecreaseInSecurityDeposits" />
      <link:calculationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaapIncreaseDecreaseInSecurityDeposits" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
      <link:calculationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:label="loc_us-gaapIncreaseDecreaseInDeferredRevenue" />
      <link:calculationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaapIncreaseDecreaseInDeferredRevenue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations" xlink:label="loc_us-gaapCashProvidedByUsedInOperatingActivitiesDiscontinuedOperations" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapCashProvidedByUsedInOperatingActivitiesDiscontinuedOperations" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForSoftware" xlink:label="loc_us-gaapPaymentsForSoftware" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapPaymentsForSoftware" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromSaleOfProductiveAssets" xlink:label="loc_us-gaapProceedsFromSaleOfProductiveAssets" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapProceedsFromSaleOfProductiveAssets" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_InvestmentInEquityMethodInvestee" xlink:label="loc_NTRPInvestmentInEquityMethodInvestee" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_NTRPInvestmentInEquityMethodInvestee" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_ProceedsFromAcquireBusinessesGross" xlink:label="loc_NTRPProceedsFromAcquireBusinessesGross" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_NTRPProceedsFromAcquireBusinessesGross" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromSaleOfOtherProductiveAssets" xlink:label="loc_us-gaapProceedsFromSaleOfOtherProductiveAssets" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapProceedsFromSaleOfOtherProductiveAssets" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromNotesPayable" xlink:label="loc_us-gaapProceedsFromNotesPayable" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromNotesPayable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromConvertibleDebt" xlink:label="loc_us-gaapProceedsFromConvertibleDebt" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromConvertibleDebt" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfCommonStock" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromIssuanceOfCommonStock" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfPreferredStockAndPreferenceStock" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromIssuanceOfPreferredStockAndPreferenceStock" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfWarrants" xlink:label="loc_us-gaapProceedsFromIssuanceOfWarrants" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromIssuanceOfWarrants" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromRelatedPartyDebt" xlink:label="loc_us-gaapProceedsFromRelatedPartyDebt" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromRelatedPartyDebt" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure" xlink:title="00000014 - Disclosure - Cybersecurity Risk Management and Strategy Disclosure" />
    <link:calculationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cyd/role/MaterialCybersecurityIncidentDisclosure" xlink:title="00000015 - Disclosure - Material Cybersecurity Incident Disclosure" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/BusinessDescriptionAndGoingConcern" xlink:title="999016 - Disclosure - Business Description and Going Concern" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/SummaryOfSignificantAccountingPolicies" xlink:title="999017 - Disclosure - Summary of Significant Accounting Policies" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/DiscontinuedOperations" xlink:title="999018 - Disclosure - Discontinued Operations" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/InvestmentInEquityMethodInvestee" xlink:title="999019 - Disclosure - Investment in Equity Method Investee" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/InvestmentInEquitySecurities" xlink:title="999020 - Disclosure - Investment in Equity Securities" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/PrepaidAndOtherCurrentAssets" xlink:title="999021 - Disclosure - Prepaid and Other Current Assets" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/PropertyAndEquipment" xlink:title="999022 - Disclosure - Property and Equipment" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/IntangibleAssets" xlink:title="999023 - Disclosure - Intangible Assets" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/Goodwill" xlink:title="999024 - Disclosure - Goodwill" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/AccountsPayableAndAccruedLiabilities" xlink:title="999025 - Disclosure - Accounts Payable and Accrued Liabilities" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/IncomeTaxes" xlink:title="999026 - Disclosure - Income Taxes" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/NotesPayable" xlink:title="999027 - Disclosure - Notes Payable" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/ConvertibleNotes" xlink:title="999028 - Disclosure - Convertible Notes" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/SharePurchaseAgreements" xlink:title="999029 - Disclosure - Share Purchase Agreements" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/RelatedPartyTransactions" xlink:title="999030 - Disclosure - Related Party Transactions" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/DeferredRevenue" xlink:title="999031 - Disclosure - Deferred Revenue" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/CommitmentsAndContingencies" xlink:title="999032 - Disclosure - Commitments and Contingencies" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/StockholdersEquity" xlink:title="999033 - Disclosure - Stockholders&#8217; Equity" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/LossPerShare" xlink:title="999034 - Disclosure - Loss Per Share" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/Concentrations" xlink:title="999035 - Disclosure - Concentrations" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/DefinedContributionPlans" xlink:title="999036 - Disclosure - Defined Contribution Plans" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/SubsequentEvents" xlink:title="999037 - Disclosure - Subsequent Events" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="999038 - Disclosure - Summary of Significant Accounting Policies (Policies)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:title="999039 - Disclosure - Summary of Significant Accounting Policies (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/DiscontinuedOperationsTables" xlink:title="999040 - Disclosure - Discontinued Operations (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/InvestmentInEquityMethodInvesteeTables" xlink:title="999041 - Disclosure - Investment in Equity Method Investee (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/PrepaidAndOtherCurrentAssetsTables" xlink:title="999042 - Disclosure - Prepaid and Other Current Assets (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/PropertyAndEquipmentTables" xlink:title="999043 - Disclosure - Property and Equipment (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/IntangibleAssetsTables" xlink:title="999044 - Disclosure - Intangible Assets (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/GoodwillTables" xlink:title="999045 - Disclosure - Goodwill (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/IncomeTaxesTables" xlink:title="999046 - Disclosure - Income Taxes (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/StockholdersEquityTables" xlink:title="999047 - Disclosure - Stockholders&#8217; Equity (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/LossPerShareTables" xlink:title="999048 - Disclosure - Loss Per Share (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/BusinessDescriptionAndGoingConcernDetailsNarrative" xlink:title="999049 - Disclosure - Business Description and Going Concern (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/ScheduleOfAnti-dilutiveSecuritiesExcludedFromComputationOfEarningsPerShareDetails" xlink:title="999050 - Disclosure - Schedule of Anti-dilutive Securities Excluded from Computation of Earnings Per Share (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/ScheduleOfEstimatedUsefulLivesForPropertyAndEquipmentDetails" xlink:title="999051 - Disclosure - Schedule of Estimated Useful Lives for Property and Equipment (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/ScheduleOfEstimatedUsefulLivesForFiniteLifeIntangibleAssetsDetails" xlink:title="999052 - Disclosure - Schedule of Estimated Useful Lives for Finite Life Intangible Assets (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="999053 - Disclosure - Summary of Significant Accounting Policies (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/ScheduleOfDiscontinuedOperationsDetails" xlink:title="999054 - Disclosure - Schedule of Discontinued Operations (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss" xlink:label="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationGrossProfitLoss" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue" xlink:label="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationRevenue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationGrossProfitLoss" xlink:to="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationRevenue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold" xlink:label="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationGrossProfitLoss" xlink:to="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense" xlink:label="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationOperatingExpense" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_DisposalGroupIncludingDiscontinuedOperationsProfessionalServices" xlink:label="loc_NTRPDisposalGroupIncludingDiscontinuedOperationsProfessionalServices" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationOperatingExpense" xlink:to="loc_NTRPDisposalGroupIncludingDiscontinuedOperationsProfessionalServices" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_DisposalGroupIncludingDiscontinuedOperationsInvestorRelationsServices" xlink:label="loc_NTRPDisposalGroupIncludingDiscontinuedOperationsInvestorRelationsServices" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationOperatingExpense" xlink:to="loc_NTRPDisposalGroupIncludingDiscontinuedOperationsInvestorRelationsServices" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_DisposalGroupIncludingDiscontinuedOperationsOtherIncome" xlink:label="loc_NTRPDisposalGroupIncludingDiscontinuedOperationsOtherIncome" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationOperatingExpense" xlink:to="loc_NTRPDisposalGroupIncludingDiscontinuedOperationsOtherIncome" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:label="loc_us-gaapIncomeLossFromDiscontinuedOperationsNetOfTax" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromDiscontinuedOperationsNetOfTax" xlink:to="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationGrossProfitLoss" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromDiscontinuedOperationsNetOfTax" xlink:to="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationOperatingExpense" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/DiscontinuedOperationsDetailsNarrative" xlink:title="999055 - Disclosure - Discontinued Operations (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/ScheduleOfUnauditedSummarizedFinancialInformationDetails" xlink:title="999056 - Disclosure - Schedule of Unaudited Summarized Financial Information (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/InvestmentInEquityMethodInvesteeDetailsNarrative" xlink:title="999057 - Disclosure - Investment in Equity Method Investee (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/InvestmentInEquitySecuritiesDetailsNarrative" xlink:title="999058 - Disclosure - Investment in Equity Securities (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/ScheduleOfPrepaidAndOtherCurrentAssetsDetails" xlink:title="999059 - Disclosure - Schedule of Prepaid and Other Current Assets (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_PrepaidOfferingCosts" xlink:label="loc_NTRPPrepaidOfferingCosts" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" xlink:to="loc_NTRPPrepaidOfferingCosts" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_PrepaidConsultingContract" xlink:label="loc_NTRPPrepaidConsultingContract" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" xlink:to="loc_NTRPPrepaidConsultingContract" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_PrepaidCostOfSales" xlink:label="loc_NTRPPrepaidCostOfSales" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" xlink:to="loc_NTRPPrepaidCostOfSales" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherPrepaidExpenseCurrent" xlink:label="loc_us-gaapOtherPrepaidExpenseCurrent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" xlink:to="loc_us-gaapOtherPrepaidExpenseCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidAdvertising" xlink:label="loc_us-gaapPrepaidAdvertising" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" xlink:to="loc_us-gaapPrepaidAdvertising" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/ScheduleOfPropertyAndEquipmentDetails" xlink:title="999060 - Disclosure - Schedule of Property and Equipment (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaapPropertyPlantAndEquipmentGross" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:to="loc_us-gaapPropertyPlantAndEquipmentGross" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:to="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/PropertyAndEquipmentDetailsNarrative" xlink:title="999061 - Disclosure - Property and Equipment (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/ScheduleOfIntangibleAssetsDetails" xlink:title="999062 - Disclosure - Schedule of Intangible Assets (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsGross" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsGross" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/ScheduleOfEstimatedAggregateAmortizationExpenseDetails" xlink:title="999063 - Disclosure - Schedule of estimated aggregate amortization expense (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsNet" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsNet" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsNet" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearThree" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsNet" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearFour" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsNet" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour" xlink:label="loc_NTRPFiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsNet" xlink:to="loc_NTRPFiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/IntangibleAssetsDetailsNarrative" xlink:title="999064 - Disclosure - Intangible Assets (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/ScheduleOfFairValueOfAssetsAcquiredDetails" xlink:title="999065 - Disclosure - Schedule of Fair Value of Assets Acquired (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses" xlink:label="loc_NTRPBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:to="loc_NTRPBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" />
      <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:to="loc_us-gaapGoodwill" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/GoodwillDetailsNarrative" xlink:title="999066 - Disclosure - Goodwill (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/AccountsPayableAndAccruedLiabilitiesDetailsNarrative" xlink:title="999067 - Disclosure - Accounts Payable and Accrued Liabilities (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/ScheduleOfDeferredTaxAssetsDetails" xlink:title="999068 - Disclosure - Schedule of Deferred Tax Assets (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="loc_us-gaapDeferredTaxAssetsNet" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwards" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsNet" xlink:to="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwards" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_DeferredTaxAssetDepreciation" xlink:label="loc_NTRPDeferredTaxAssetDepreciation" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsNet" xlink:to="loc_NTRPDeferredTaxAssetDepreciation" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_DeferredTaxAssetsPayrollAccruals" xlink:label="loc_NTRPDeferredTaxAssetsPayrollAccruals" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsNet" xlink:to="loc_NTRPDeferredTaxAssetsPayrollAccruals" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_DeferredTaxLiabilitiesDepreciation" xlink:label="loc_NTRPDeferredTaxLiabilitiesDepreciation" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsNet" xlink:to="loc_NTRPDeferredTaxLiabilitiesDepreciation" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapDeferredTaxAssetsValuationAllowance" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsNet" xlink:to="loc_us-gaapDeferredTaxAssetsValuationAllowance" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/ScheduleOfReconciliationOfProvisionForIncomeTaxesDetails" xlink:title="999069 - Disclosure - Schedule of Reconciliation of Provision for Income Taxes (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_EffectiveIncomeTaxRateReconciliationBookLoss" xlink:label="loc_NTRPEffectiveIncomeTaxRateReconciliationBookLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeTaxExpenseBenefit" xlink:to="loc_NTRPEffectiveIncomeTaxRateReconciliationBookLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseDepreciation" xlink:label="loc_us-gaapIncomeTaxReconciliationNondeductibleExpenseDepreciation" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeTaxExpenseBenefit" xlink:to="loc_us-gaapIncomeTaxReconciliationNondeductibleExpenseDepreciation" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment" xlink:label="loc_us-gaapIncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeTaxExpenseBenefit" xlink:to="loc_us-gaapIncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_IncomeTaxReconciliationNondeductibleExpensePreferredDividends" xlink:label="loc_NTRPIncomeTaxReconciliationNondeductibleExpensePreferredDividends" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeTaxExpenseBenefit" xlink:to="loc_NTRPIncomeTaxReconciliationNondeductibleExpensePreferredDividends" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_IncomeTaxReconciliationNondeductibleExpenseLossOnNextPlayNoteReceivable" xlink:label="loc_NTRPIncomeTaxReconciliationNondeductibleExpenseLossOnNextPlayNoteReceivable" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeTaxExpenseBenefit" xlink:to="loc_NTRPIncomeTaxReconciliationNondeductibleExpenseLossOnNextPlayNoteReceivable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:label="loc_us-gaapIncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeTaxExpenseBenefit" xlink:to="loc_us-gaapIncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_IncomeTaxReconciliationNondeductibleExpenseLossOnAssetDisposal" xlink:label="loc_NTRPIncomeTaxReconciliationNondeductibleExpenseLossOnAssetDisposal" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeTaxExpenseBenefit" xlink:to="loc_NTRPIncomeTaxReconciliationNondeductibleExpenseLossOnAssetDisposal" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_IncomeTaxReconciliationNondeductibleExpenseAccruedPayroll" xlink:label="loc_NTRPIncomeTaxReconciliationNondeductibleExpenseAccruedPayroll" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeTaxExpenseBenefit" xlink:to="loc_NTRPIncomeTaxReconciliationNondeductibleExpenseAccruedPayroll" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_IncomeTaxReconciliationNondeductibleExpenseRelatedPartyAccruals" xlink:label="loc_NTRPIncomeTaxReconciliationNondeductibleExpenseRelatedPartyAccruals" />
      <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeTaxExpenseBenefit" xlink:to="loc_NTRPIncomeTaxReconciliationNondeductibleExpenseRelatedPartyAccruals" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapIncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" />
      <link:calculationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeTaxExpenseBenefit" xlink:to="loc_us-gaapIncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/IncomeTaxesDetailsNarrative" xlink:title="999070 - Disclosure - Income Taxes (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/NotesPayableDetailsNarrative" xlink:title="999071 - Disclosure - Notes Payable (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/ConvertibleNotesDetailsNarrative" xlink:title="999072 - Disclosure - Convertible Notes (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/SharePurchaseAgreementsDetailsNarrative" xlink:title="999073 - Disclosure - Share Purchase Agreements (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:title="999074 - Disclosure - Related Party Transactions (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/DeferredRevenueDetailsNarrative" xlink:title="999075 - Disclosure - Deferred Revenue (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/ScheduleOfStockOptionActivityDetails" xlink:title="999076 - Disclosure - Schedule of Stock Option Activity (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/ScheduleOfShareBasedPaymentsAwardStockOptionsValuationAssumptionsDetails" xlink:title="999077 - Disclosure - Schedule of Share Based Payments Award Stock Options Valuation Assumptions (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/ScheduleOfWarrantyActivityDetails" xlink:title="999078 - Disclosure - Schedule of Warranty Activity (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/StockholdersEquityDetailsNarrative" xlink:title="999079 - Disclosure - Stockholders&#8217; Equity (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/ScheduleOfEarningsPerShareBasicAndDilutedDetails" xlink:title="999080 - Disclosure - Schedule of Earnings Per Share, Basic and Diluted (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/ScheduleOfBusinessMilestonesAndIssuableContingentSharesDetails" xlink:title="999081 - Disclosure - Schedule of Business Milestones and Issuable Contingent Shares (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/ScheduleOfWeightedAverageCommonSharesDetailsParenthetical" xlink:title="999082 - Disclosure - Schedule of Weighted Average Common Shares (Details) (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/ScheduleOfWeightedAverageCommonSharesDetails" xlink:title="999083 - Disclosure - Schedule of Weighted Average Common Shares (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/LossPerShareDetailsNarrative" xlink:title="999084 - Disclosure - Loss Per Share (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/ConcentrationsDetailsNarrative" xlink:title="999085 - Disclosure - Concentrations (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/DefinedContributionPlansDetailsNarrative" xlink:title="999086 - Disclosure - Defined Contribution Plans (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/SubsequentEventsDetailsNarrative" xlink:title="999087 - Disclosure - Subsequent Events (Details Narrative)" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>32
<FILENAME>ntrp-20250228_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.0c -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://nexttrip.com/role/Cover" xlink:href="ntrp-20250228.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/BalanceSheets" xlink:href="ntrp-20250228.xsd#BalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/BalanceSheetsParenthetical" xlink:href="ntrp-20250228.xsd#BalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/StatementsOfOperations" xlink:href="ntrp-20250228.xsd#StatementsOfOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/StatementsOfOperationsParenthetical" xlink:href="ntrp-20250228.xsd#StatementsOfOperationsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/StatementsOfStockholdersEquity" xlink:href="ntrp-20250228.xsd#StatementsOfStockholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/StatementsOfStockholdersEquityParenthetical" xlink:href="ntrp-20250228.xsd#StatementsOfStockholdersEquityParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/StatementsOfCashFlows" xlink:href="ntrp-20250228.xsd#StatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#CybersecurityRiskManagementAndStrategyDisclosure" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/cyd/role/MaterialCybersecurityIncidentDisclosure" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#MaterialCybersecurityIncidentDisclosure" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/BusinessDescriptionAndGoingConcern" xlink:href="ntrp-20250228.xsd#BusinessDescriptionAndGoingConcern" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="ntrp-20250228.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/DiscontinuedOperations" xlink:href="ntrp-20250228.xsd#DiscontinuedOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/InvestmentInEquityMethodInvestee" xlink:href="ntrp-20250228.xsd#InvestmentInEquityMethodInvestee" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/InvestmentInEquitySecurities" xlink:href="ntrp-20250228.xsd#InvestmentInEquitySecurities" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/PrepaidAndOtherCurrentAssets" xlink:href="ntrp-20250228.xsd#PrepaidAndOtherCurrentAssets" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/PropertyAndEquipment" xlink:href="ntrp-20250228.xsd#PropertyAndEquipment" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/IntangibleAssets" xlink:href="ntrp-20250228.xsd#IntangibleAssets" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/Goodwill" xlink:href="ntrp-20250228.xsd#Goodwill" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/AccountsPayableAndAccruedLiabilities" xlink:href="ntrp-20250228.xsd#AccountsPayableAndAccruedLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/IncomeTaxes" xlink:href="ntrp-20250228.xsd#IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/NotesPayable" xlink:href="ntrp-20250228.xsd#NotesPayable" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/ConvertibleNotes" xlink:href="ntrp-20250228.xsd#ConvertibleNotes" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/SharePurchaseAgreements" xlink:href="ntrp-20250228.xsd#SharePurchaseAgreements" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/RelatedPartyTransactions" xlink:href="ntrp-20250228.xsd#RelatedPartyTransactions" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/DeferredRevenue" xlink:href="ntrp-20250228.xsd#DeferredRevenue" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/CommitmentsAndContingencies" xlink:href="ntrp-20250228.xsd#CommitmentsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/StockholdersEquity" xlink:href="ntrp-20250228.xsd#StockholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/LossPerShare" xlink:href="ntrp-20250228.xsd#LossPerShare" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/Concentrations" xlink:href="ntrp-20250228.xsd#Concentrations" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/DefinedContributionPlans" xlink:href="ntrp-20250228.xsd#DefinedContributionPlans" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/SubsequentEvents" xlink:href="ntrp-20250228.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="ntrp-20250228.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:href="ntrp-20250228.xsd#SummaryOfSignificantAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/DiscontinuedOperationsTables" xlink:href="ntrp-20250228.xsd#DiscontinuedOperationsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/InvestmentInEquityMethodInvesteeTables" xlink:href="ntrp-20250228.xsd#InvestmentInEquityMethodInvesteeTables" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/PrepaidAndOtherCurrentAssetsTables" xlink:href="ntrp-20250228.xsd#PrepaidAndOtherCurrentAssetsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/PropertyAndEquipmentTables" xlink:href="ntrp-20250228.xsd#PropertyAndEquipmentTables" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/IntangibleAssetsTables" xlink:href="ntrp-20250228.xsd#IntangibleAssetsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/GoodwillTables" xlink:href="ntrp-20250228.xsd#GoodwillTables" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/IncomeTaxesTables" xlink:href="ntrp-20250228.xsd#IncomeTaxesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/StockholdersEquityTables" xlink:href="ntrp-20250228.xsd#StockholdersEquityTables" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/LossPerShareTables" xlink:href="ntrp-20250228.xsd#LossPerShareTables" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/BusinessDescriptionAndGoingConcernDetailsNarrative" xlink:href="ntrp-20250228.xsd#BusinessDescriptionAndGoingConcernDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/ScheduleOfAnti-dilutiveSecuritiesExcludedFromComputationOfEarningsPerShareDetails" xlink:href="ntrp-20250228.xsd#ScheduleOfAnti-dilutiveSecuritiesExcludedFromComputationOfEarningsPerShareDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/ScheduleOfEstimatedUsefulLivesForPropertyAndEquipmentDetails" xlink:href="ntrp-20250228.xsd#ScheduleOfEstimatedUsefulLivesForPropertyAndEquipmentDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/ScheduleOfEstimatedUsefulLivesForFiniteLifeIntangibleAssetsDetails" xlink:href="ntrp-20250228.xsd#ScheduleOfEstimatedUsefulLivesForFiniteLifeIntangibleAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:href="ntrp-20250228.xsd#SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/ScheduleOfDiscontinuedOperationsDetails" xlink:href="ntrp-20250228.xsd#ScheduleOfDiscontinuedOperationsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/DiscontinuedOperationsDetailsNarrative" xlink:href="ntrp-20250228.xsd#DiscontinuedOperationsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/ScheduleOfUnauditedSummarizedFinancialInformationDetails" xlink:href="ntrp-20250228.xsd#ScheduleOfUnauditedSummarizedFinancialInformationDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/InvestmentInEquityMethodInvesteeDetailsNarrative" xlink:href="ntrp-20250228.xsd#InvestmentInEquityMethodInvesteeDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/InvestmentInEquitySecuritiesDetailsNarrative" xlink:href="ntrp-20250228.xsd#InvestmentInEquitySecuritiesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/ScheduleOfPrepaidAndOtherCurrentAssetsDetails" xlink:href="ntrp-20250228.xsd#ScheduleOfPrepaidAndOtherCurrentAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/ScheduleOfPropertyAndEquipmentDetails" xlink:href="ntrp-20250228.xsd#ScheduleOfPropertyAndEquipmentDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/PropertyAndEquipmentDetailsNarrative" xlink:href="ntrp-20250228.xsd#PropertyAndEquipmentDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/ScheduleOfIntangibleAssetsDetails" xlink:href="ntrp-20250228.xsd#ScheduleOfIntangibleAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/ScheduleOfEstimatedAggregateAmortizationExpenseDetails" xlink:href="ntrp-20250228.xsd#ScheduleOfEstimatedAggregateAmortizationExpenseDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/IntangibleAssetsDetailsNarrative" xlink:href="ntrp-20250228.xsd#IntangibleAssetsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/ScheduleOfFairValueOfAssetsAcquiredDetails" xlink:href="ntrp-20250228.xsd#ScheduleOfFairValueOfAssetsAcquiredDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/GoodwillDetailsNarrative" xlink:href="ntrp-20250228.xsd#GoodwillDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/AccountsPayableAndAccruedLiabilitiesDetailsNarrative" xlink:href="ntrp-20250228.xsd#AccountsPayableAndAccruedLiabilitiesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/ScheduleOfDeferredTaxAssetsDetails" xlink:href="ntrp-20250228.xsd#ScheduleOfDeferredTaxAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/ScheduleOfReconciliationOfProvisionForIncomeTaxesDetails" xlink:href="ntrp-20250228.xsd#ScheduleOfReconciliationOfProvisionForIncomeTaxesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/IncomeTaxesDetailsNarrative" xlink:href="ntrp-20250228.xsd#IncomeTaxesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/NotesPayableDetailsNarrative" xlink:href="ntrp-20250228.xsd#NotesPayableDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/ConvertibleNotesDetailsNarrative" xlink:href="ntrp-20250228.xsd#ConvertibleNotesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/SharePurchaseAgreementsDetailsNarrative" xlink:href="ntrp-20250228.xsd#SharePurchaseAgreementsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:href="ntrp-20250228.xsd#RelatedPartyTransactionsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/DeferredRevenueDetailsNarrative" xlink:href="ntrp-20250228.xsd#DeferredRevenueDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/ScheduleOfStockOptionActivityDetails" xlink:href="ntrp-20250228.xsd#ScheduleOfStockOptionActivityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/ScheduleOfShareBasedPaymentsAwardStockOptionsValuationAssumptionsDetails" xlink:href="ntrp-20250228.xsd#ScheduleOfShareBasedPaymentsAwardStockOptionsValuationAssumptionsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/ScheduleOfWarrantyActivityDetails" xlink:href="ntrp-20250228.xsd#ScheduleOfWarrantyActivityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/StockholdersEquityDetailsNarrative" xlink:href="ntrp-20250228.xsd#StockholdersEquityDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/ScheduleOfEarningsPerShareBasicAndDilutedDetails" xlink:href="ntrp-20250228.xsd#ScheduleOfEarningsPerShareBasicAndDilutedDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/ScheduleOfBusinessMilestonesAndIssuableContingentSharesDetails" xlink:href="ntrp-20250228.xsd#ScheduleOfBusinessMilestonesAndIssuableContingentSharesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/ScheduleOfWeightedAverageCommonSharesDetailsParenthetical" xlink:href="ntrp-20250228.xsd#ScheduleOfWeightedAverageCommonSharesDetailsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/ScheduleOfWeightedAverageCommonSharesDetails" xlink:href="ntrp-20250228.xsd#ScheduleOfWeightedAverageCommonSharesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/LossPerShareDetailsNarrative" xlink:href="ntrp-20250228.xsd#LossPerShareDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/ConcentrationsDetailsNarrative" xlink:href="ntrp-20250228.xsd#ConcentrationsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/DefinedContributionPlansDetailsNarrative" xlink:href="ntrp-20250228.xsd#DefinedContributionPlansDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/SubsequentEventsDetailsNarrative" xlink:href="ntrp-20250228.xsd#SubsequentEventsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpDisclosureWithAdditionalMeasures" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpDisclosureWithAdditionalMeasures" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpTable" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpTable" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpAdjustmentsToCompensation" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpAdjustmentsToCompensation" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/TabularListsByExecutiveCategory" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#TabularListsByExecutiveCategory" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/TabularListMeasures" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#TabularListMeasures" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpMeasures" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpMeasures" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpExecutiveCategoriesOnly" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpExecutiveCategoriesOnly" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpAdjustmentsOnly" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpAdjustmentsOnly" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/IndividualsOnly" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#IndividualsOnly" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/AwardTypeOnly" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#AwardTypeOnly" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/TradingArrangementsOnly" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#TradingArrangmentsOnly" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/ForgoneRecoveries" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ForgoneRecoveries" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/OutstandingRecoveries" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#OutstandingRecoveries" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/AwardsCloseToMnpiDisc" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#AwardsCloseToMnpiDisc" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangementsByInd" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#InsiderTradingArrangemenstByInd" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/Defaults" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#Defaults" xlink:type="simple" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nexttrip.com/role/Cover" xlink:title="00000001 - Document - Cover" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nexttrip.com/role/BalanceSheets" xlink:title="00000002 - Statement - Consolidated Balance Sheets">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:label="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:label="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonrelatedPartyMember" xlink:label="loc_us-gaapNonrelatedPartyMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_us-gaapNonrelatedPartyMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyMember" xlink:label="loc_us-gaapRelatedPartyMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_us-gaapRelatedPartyMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaapAssetsAbstract_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapAssetsAbstract_70" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsAbstract_70" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue_70" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_PromissoryNoteReceivableNet" xlink:label="loc_NTRPPromissoryNoteReceivableNet_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsAbstract_70" xlink:to="loc_NTRPPromissoryNoteReceivableNet_70" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaapAccountsReceivableNetCurrent_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsAbstract_70" xlink:to="loc_us-gaapAccountsReceivableNetCurrent_70" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsAbstract_70" xlink:to="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent_70" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsAbstract_70" xlink:to="loc_us-gaapAssetsCurrent_70" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsNoncurrentAbstract" xlink:label="loc_us-gaapAssetsNoncurrentAbstract_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsAbstract_70" xlink:to="loc_us-gaapAssetsNoncurrentAbstract_70" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsNoncurrentAbstract_70" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet_70" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaapIntangibleAssetsNetExcludingGoodwill_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsNoncurrentAbstract_70" xlink:to="loc_us-gaapIntangibleAssetsNetExcludingGoodwill_70" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SecurityDeposit" xlink:label="loc_us-gaapSecurityDeposit_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsNoncurrentAbstract_70" xlink:to="loc_us-gaapSecurityDeposit_70" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsNoncurrentAbstract_70" xlink:to="loc_us-gaapGoodwill_70" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestments" xlink:label="loc_us-gaapEquityMethodInvestments_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsNoncurrentAbstract_70" xlink:to="loc_us-gaapEquityMethodInvestments_70" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseOtherNoncurrent" xlink:label="loc_us-gaapPrepaidExpenseOtherNoncurrent_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsNoncurrentAbstract_70" xlink:to="loc_us-gaapPrepaidExpenseOtherNoncurrent_70" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsNoncurrent" xlink:label="loc_us-gaapAssetsNoncurrent_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsNoncurrentAbstract_70" xlink:to="loc_us-gaapAssetsNoncurrent_70" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsAbstract_70" xlink:to="loc_us-gaapAssets_70" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAbstract" xlink:label="loc_us-gaapLiabilitiesAbstract_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapLiabilitiesAbstract_70" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaapLiabilitiesCurrentAbstract_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAbstract_70" xlink:to="loc_us-gaapLiabilitiesCurrentAbstract_70" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_70" xlink:to="loc_us-gaapAccountsPayableCurrent_70" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccruedLiabilitiesCurrent_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_70" xlink:to="loc_us-gaapAccruedLiabilitiesCurrent_70" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="loc_us-gaapDeferredRevenueCurrent_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_70" xlink:to="loc_us-gaapDeferredRevenueCurrent_70" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesPayableCurrent" xlink:label="loc_us-gaapNotesPayableCurrent_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_70" xlink:to="loc_us-gaapNotesPayableCurrent_70" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_70" xlink:to="loc_us-gaapLiabilitiesCurrent_70" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAbstract_70" xlink:to="loc_us-gaapLiabilities_70" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaapCommitmentsAndContingencies_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAbstract_70" xlink:to="loc_us-gaapCommitmentsAndContingencies_70" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaapStockholdersEquityAbstract_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAbstract_70" xlink:to="loc_us-gaapStockholdersEquityAbstract_70" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_70" xlink:to="loc_us-gaapPreferredStockValue_70" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_70" xlink:to="loc_us-gaapCommonStockValue_70" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_70" xlink:to="loc_us-gaapAdditionalPaidInCapital_70" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_70" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit_70" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_70" xlink:to="loc_us-gaapStockholdersEquity_70" xlink:type="arc" order="29" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAbstract_70" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquity_70" xlink:type="arc" order="30" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://nexttrip.com/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Consolidated Balance Sheets (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="loc_us-gaapRestructuringCostAndReserveLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_NextTripGroupLLCMember" xlink:label="loc_NTRPNextTripGroupLLCMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_NTRPNextTripGroupLLCMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare_40" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaapPreferredStockSharesAuthorized_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapPreferredStockSharesAuthorized_40" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaapPreferredStockSharesIssued_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapPreferredStockSharesIssued_40" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaapPreferredStockSharesOutstanding_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapPreferredStockSharesOutstanding_40" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare_40" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapCommonStockSharesAuthorized_40" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapCommonStockSharesIssued_40" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding_40" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesAcquisitions_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesAcquisitions_40" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_PercentageForIssuedAndOutstandingCapitalStock" xlink:label="loc_NTRPPercentageForIssuedAndOutstandingCapitalStock_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_NTRPPercentageForIssuedAndOutstandingCapitalStock_40" xlink:type="arc" order="9" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://nexttrip.com/role/StatementsOfOperations" xlink:title="00000004 - Statement - Consolidated Statements of Operations" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nexttrip.com/role/StatementsOfOperationsParenthetical" xlink:title="00000005 - Statement - Consolidated Statements of Operations (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="loc_us-gaapRestructuringCostAndReserveLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_NextTripGroupLLCMember" xlink:label="loc_NTRPNextTripGroupLLCMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_NTRPNextTripGroupLLCMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesAcquisitions_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesAcquisitions_20" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_PercentageForIssuedAndOutstandingCapitalStock" xlink:label="loc_NTRPPercentageForIssuedAndOutstandingCapitalStock_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_NTRPPercentageForIssuedAndOutstandingCapitalStock_20" xlink:type="arc" order="1" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://nexttrip.com/role/StatementsOfStockholdersEquity" xlink:title="00000006 - Statement - Consolidated Statements of Stockholders&apos; Equity">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockMember" xlink:label="loc_us-gaapPreferredStockMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapPreferredStockMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaapAdditionalPaidInCapitalMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapAdditionalPaidInCapitalMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapRetainedEarningsMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity_60" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding_60" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_StockIssuedDuringPeriodValueOfPreferredShares" xlink:label="loc_NTRPStockIssuedDuringPeriodValueOfPreferredShares_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_NTRPStockIssuedDuringPeriodValueOfPreferredShares_60" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_StockIssuedDuringPeriodShareOfPreferredShares" xlink:label="loc_NTRPStockIssuedDuringPeriodShareOfPreferredShares_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_NTRPStockIssuedDuringPeriodShareOfPreferredShares_60" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueConversionOfConvertibleSecurities_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueConversionOfConvertibleSecurities_60" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_60" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_StockIssuedDuringPeriodValuePurchasesOfCommonShares" xlink:label="loc_NTRPStockIssuedDuringPeriodValuePurchasesOfCommonShares_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_NTRPStockIssuedDuringPeriodValuePurchasesOfCommonShares_60" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_StockIssuedDuringPeriodSharesPurchasesOfCommonShares" xlink:label="loc_NTRPStockIssuedDuringPeriodSharesPurchasesOfCommonShares_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_NTRPStockIssuedDuringPeriodSharesPurchasesOfCommonShares_60" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices_60" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices_60" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_StockIssuedDuringPeriodValueReverseAcquisition" xlink:label="loc_NTRPStockIssuedDuringPeriodValueReverseAcquisition_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_NTRPStockIssuedDuringPeriodValueReverseAcquisition_60" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_StockIssuedDuringPeriodSharesReverseAcquisition" xlink:label="loc_NTRPStockIssuedDuringPeriodSharesReverseAcquisition_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_NTRPStockIssuedDuringPeriodSharesReverseAcquisition_60" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_60" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DividendsPreferredStock" xlink:label="loc_us-gaapDividendsPreferredStock_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDividendsPreferredStock_60" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss_60" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_StockIssuedDuringPeriodValueOfPreferredSharesInPrivatePlacements" xlink:label="loc_NTRPStockIssuedDuringPeriodValueOfPreferredSharesInPrivatePlacements_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_NTRPStockIssuedDuringPeriodValueOfPreferredSharesInPrivatePlacements_60" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_StockIssuedDuringPeriodSharesOfPreferredSharesInPrivatePlacements" xlink:label="loc_NTRPStockIssuedDuringPeriodSharesOfPreferredSharesInPrivatePlacements_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_NTRPStockIssuedDuringPeriodSharesOfPreferredSharesInPrivatePlacements_60" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_StockIssuedDuringPeriodValueConversionOfPreferredSharesToCommonShares" xlink:label="loc_NTRPStockIssuedDuringPeriodValueConversionOfPreferredSharesToCommonShares_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_NTRPStockIssuedDuringPeriodValueConversionOfPreferredSharesToCommonShares_60" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_StockIssuedDuringPeriodSharesConversionOfPreferredSharesToCommonShares" xlink:label="loc_NTRPStockIssuedDuringPeriodSharesConversionOfPreferredSharesToCommonShares_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_NTRPStockIssuedDuringPeriodSharesConversionOfPreferredSharesToCommonShares_60" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_StockIssuedDuringPeriodValueIssuanceOfPreferredSharesForDebtConversions" xlink:label="loc_NTRPStockIssuedDuringPeriodValueIssuanceOfPreferredSharesForDebtConversions_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_NTRPStockIssuedDuringPeriodValueIssuanceOfPreferredSharesForDebtConversions_60" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_StockIssuedDuringPeriodSharesIssuanceOfPreferredSharesForDebtConversions" xlink:label="loc_NTRPStockIssuedDuringPeriodSharesIssuanceOfPreferredSharesForDebtConversions_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_NTRPStockIssuedDuringPeriodSharesIssuanceOfPreferredSharesForDebtConversions_60" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_StockIssuedDuringPeriodValueIssuanceOfSecuritiesForServices" xlink:label="loc_NTRPStockIssuedDuringPeriodValueIssuanceOfSecuritiesForServices_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_NTRPStockIssuedDuringPeriodValueIssuanceOfSecuritiesForServices_60" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_StockIssuedDuringPeriodSharesIssuanceOfSecuritiesForServices" xlink:label="loc_NTRPStockIssuedDuringPeriodSharesIssuanceOfSecuritiesForServices_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_NTRPStockIssuedDuringPeriodSharesIssuanceOfSecuritiesForServices_60" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_StockIssuedDuringPeriodValueSecuritiesIssuedForEquityInvestments" xlink:label="loc_NTRPStockIssuedDuringPeriodValueSecuritiesIssuedForEquityInvestments_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_NTRPStockIssuedDuringPeriodValueSecuritiesIssuedForEquityInvestments_60" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_StockIssuedDuringPeriodSharseSecuritiesIssuedForEquityInvestments" xlink:label="loc_NTRPStockIssuedDuringPeriodSharseSecuritiesIssuedForEquityInvestments_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_NTRPStockIssuedDuringPeriodSharseSecuritiesIssuedForEquityInvestments_60" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_StockIssuedDuringPeriodValueIssuanceOfCommitmentSharesForEquityLineOfCredit" xlink:label="loc_NTRPStockIssuedDuringPeriodValueIssuanceOfCommitmentSharesForEquityLineOfCredit_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_NTRPStockIssuedDuringPeriodValueIssuanceOfCommitmentSharesForEquityLineOfCredit_60" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_StockIssuedDuringPeriodSharesIssuanceOfCommitmentSharesForEquityLineOfCredit" xlink:label="loc_NTRPStockIssuedDuringPeriodSharesIssuanceOfCommitmentSharesForEquityLineOfCredit_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_NTRPStockIssuedDuringPeriodSharesIssuanceOfCommitmentSharesForEquityLineOfCredit_60" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueStockOptionsExercised_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueStockOptionsExercised_60" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised_60" xlink:type="arc" order="29" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueShareBasedCompensation_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueShareBasedCompensation_60" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesShareBasedCompensation_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesShareBasedCompensation_60" xlink:type="arc" order="31" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://nexttrip.com/role/StatementsOfStockholdersEquityParenthetical" xlink:title="00000007 - Statement - Consolidated Statements of Stockholders&apos; Equity (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="loc_us-gaapRestructuringCostAndReserveLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_NextTripGroupLLCMember" xlink:label="loc_NTRPNextTripGroupLLCMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_NTRPNextTripGroupLLCMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesAcquisitions_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesAcquisitions_20" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_PercentageForIssuedAndOutstandingCapitalStock" xlink:label="loc_NTRPPercentageForIssuedAndOutstandingCapitalStock_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_NTRPPercentageForIssuedAndOutstandingCapitalStock_20" xlink:type="arc" order="1" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://nexttrip.com/role/StatementsOfCashFlows" xlink:title="00000008 - Statement - Consolidated Statements of Cash Flows" />
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure" xlink:title="00000014 - Disclosure - Cybersecurity Risk Management and Strategy Disclosure" />
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cyd/role/MaterialCybersecurityIncidentDisclosure" xlink:title="00000015 - Disclosure - Material Cybersecurity Incident Disclosure" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nexttrip.com/role/BusinessDescriptionAndGoingConcern" xlink:title="999016 - Disclosure - Business Description and Going Concern" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nexttrip.com/role/SummaryOfSignificantAccountingPolicies" xlink:title="999017 - Disclosure - Summary of Significant Accounting Policies" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nexttrip.com/role/DiscontinuedOperations" xlink:title="999018 - Disclosure - Discontinued Operations" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nexttrip.com/role/InvestmentInEquityMethodInvestee" xlink:title="999019 - Disclosure - Investment in Equity Method Investee" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nexttrip.com/role/InvestmentInEquitySecurities" xlink:title="999020 - Disclosure - Investment in Equity Securities" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nexttrip.com/role/PrepaidAndOtherCurrentAssets" xlink:title="999021 - Disclosure - Prepaid and Other Current Assets" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nexttrip.com/role/PropertyAndEquipment" xlink:title="999022 - Disclosure - Property and Equipment" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nexttrip.com/role/IntangibleAssets" xlink:title="999023 - Disclosure - Intangible Assets" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nexttrip.com/role/Goodwill" xlink:title="999024 - Disclosure - Goodwill" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nexttrip.com/role/AccountsPayableAndAccruedLiabilities" xlink:title="999025 - Disclosure - Accounts Payable and Accrued Liabilities" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nexttrip.com/role/IncomeTaxes" xlink:title="999026 - Disclosure - Income Taxes" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nexttrip.com/role/NotesPayable" xlink:title="999027 - Disclosure - Notes Payable" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nexttrip.com/role/ConvertibleNotes" xlink:title="999028 - Disclosure - Convertible Notes" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nexttrip.com/role/SharePurchaseAgreements" xlink:title="999029 - Disclosure - Share Purchase Agreements" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nexttrip.com/role/RelatedPartyTransactions" xlink:title="999030 - Disclosure - Related Party Transactions" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nexttrip.com/role/DeferredRevenue" xlink:title="999031 - Disclosure - Deferred Revenue" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nexttrip.com/role/CommitmentsAndContingencies" xlink:title="999032 - Disclosure - Commitments and Contingencies" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nexttrip.com/role/StockholdersEquity" xlink:title="999033 - Disclosure - Stockholders&#8217; Equity" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nexttrip.com/role/LossPerShare" xlink:title="999034 - Disclosure - Loss Per Share" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nexttrip.com/role/Concentrations" xlink:title="999035 - Disclosure - Concentrations" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nexttrip.com/role/DefinedContributionPlans" xlink:title="999036 - Disclosure - Defined Contribution Plans" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nexttrip.com/role/SubsequentEvents" xlink:title="999037 - Disclosure - Subsequent Events" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="999038 - Disclosure - Summary of Significant Accounting Policies (Policies)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:title="999039 - Disclosure - Summary of Significant Accounting Policies (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nexttrip.com/role/DiscontinuedOperationsTables" xlink:title="999040 - Disclosure - Discontinued Operations (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nexttrip.com/role/InvestmentInEquityMethodInvesteeTables" xlink:title="999041 - Disclosure - Investment in Equity Method Investee (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nexttrip.com/role/PrepaidAndOtherCurrentAssetsTables" xlink:title="999042 - Disclosure - Prepaid and Other Current Assets (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nexttrip.com/role/PropertyAndEquipmentTables" xlink:title="999043 - Disclosure - Property and Equipment (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nexttrip.com/role/IntangibleAssetsTables" xlink:title="999044 - Disclosure - Intangible Assets (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nexttrip.com/role/GoodwillTables" xlink:title="999045 - Disclosure - Goodwill (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nexttrip.com/role/IncomeTaxesTables" xlink:title="999046 - Disclosure - Income Taxes (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nexttrip.com/role/StockholdersEquityTables" xlink:title="999047 - Disclosure - Stockholders&#8217; Equity (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapAwardTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_StockAppreciationRightsMember" xlink:label="loc_NTRPStockAppreciationRightsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_NTRPStockAppreciationRightsMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_30" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="loc_us-gaapScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_30" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:label="loc_us-gaapScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_30" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://nexttrip.com/role/LossPerShareTables" xlink:title="999048 - Disclosure - Loss Per Share (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nexttrip.com/role/BusinessDescriptionAndGoingConcernDetailsNarrative" xlink:title="999049 - Disclosure - Business Description and Going Concern (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_NextPlayTechnologiesIncMember" xlink:label="loc_NTRPNextPlayTechnologiesIncMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_NTRPNextPlayTechnologiesIncMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_NextTripGroupLLCMember" xlink:label="loc_NTRPNextTripGroupLLCMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_NTRPNextTripGroupLLCMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_ShareExchangeAgreementMember" xlink:label="loc_NTRPShareExchangeAgreementMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_NTRPShareExchangeAgreementMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_MembershipUnitsMember" xlink:label="loc_NTRPMembershipUnitsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_NTRPMembershipUnitsMember_0" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_PreferredUnitsMember" xlink:label="loc_NTRPPreferredUnitsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_NTRPPreferredUnitsMember_10" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:label="loc_srtScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_srtScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="loc_srtEquityMethodInvesteeNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="loc_srtEquityMethodInvesteeNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="loc_srtEquityMethodInvesteeNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="loc_srtEquityMethodInvesteeNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_NextInnovationLLCMember" xlink:label="loc_NTRPNextInnovationLLCMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtEquityMethodInvesteeNameDomain" xlink:to="loc_NTRPNextInnovationLLCMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_ClosingSharesMember" xlink:label="loc_NTRPClosingSharesMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_NTRPClosingSharesMember_50" xlink:type="arc" order="53" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_ContingentSharesMember" xlink:label="loc_NTRPContingentSharesMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_NTRPContingentSharesMember_60" xlink:type="arc" order="63" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_srtRangeAxis" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember_70" xlink:type="arc" order="73" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_120" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaapSharesIssuedPricePerShare_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapSharesIssuedPricePerShare_120" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_120" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Capital" xlink:label="loc_us-gaapCapital_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapCapital_120" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="loc_us-gaapEquityMethodInvestmentOwnershipPercentage_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapEquityMethodInvestmentOwnershipPercentage_120" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:label="loc_us-gaapBusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapBusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_120" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_PercentageForIssuedAndOutstandingCapitalStock" xlink:label="loc_NTRPPercentageForIssuedAndOutstandingCapitalStock_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_NTRPPercentageForIssuedAndOutstandingCapitalStock_120" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit_120" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_WorkingCapitalDeficit" xlink:label="loc_NTRPWorkingCapitalDeficit_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_NTRPWorkingCapitalDeficit_120" xlink:type="arc" order="8" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://nexttrip.com/role/ScheduleOfAnti-dilutiveSecuritiesExcludedFromComputationOfEarningsPerShareDetails" xlink:title="999050 - Disclosure - Schedule of Anti-dilutive Securities Excluded from Computation of Earnings Per Share (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="loc_us-gaapScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="loc_us-gaapScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="loc_us-gaapAntidilutiveSecuritiesNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="loc_us-gaapAntidilutiveSecuritiesNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="loc_us-gaapAntidilutiveSecuritiesNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:to="loc_us-gaapWarrantMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockOptionMember" xlink:label="loc_us-gaapStockOptionMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:to="loc_us-gaapStockOptionMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockMember" xlink:label="loc_us-gaapPreferredStockMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:to="loc_us-gaapPreferredStockMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_90" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://nexttrip.com/role/ScheduleOfEstimatedUsefulLivesForPropertyAndEquipmentDetails" xlink:title="999051 - Disclosure - Schedule of Estimated Useful Lives for Property and Equipment (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaapPropertyPlantAndEquipmentLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="loc_us-gaapFurnitureAndFixturesMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapFurnitureAndFixturesMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComputerEquipmentMember" xlink:label="loc_us-gaapComputerEquipmentMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapComputerEquipmentMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="loc_us-gaapPropertyPlantAndEquipmentUsefulLife_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentUsefulLife_30" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://nexttrip.com/role/ScheduleOfEstimatedUsefulLivesForFiniteLifeIntangibleAssetsDetails" xlink:title="999052 - Disclosure - Schedule of Estimated Useful Lives for Finite Life Intangible Assets (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaapPropertyPlantAndEquipmentLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_SoftwareMember" xlink:label="loc_NTRPSoftwareMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_NTRPSoftwareMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_SoftwareLicensesMember" xlink:label="loc_NTRPSoftwareLicensesMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_NTRPSoftwareLicensesMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_srtRangeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetUsefulLife_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetUsefulLife_50" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="999053 - Disclosure - Summary of Significant Accounting Policies (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:label="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:label="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_NextPlayTechnologiesIncMember" xlink:label="loc_NTRPNextPlayTechnologiesIncMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_NTRPNextPlayTechnologiesIncMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_NextPlayTechnologiesIncMember" xlink:label="loc_NTRPNextPlayTechnologiesIncMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_NTRPNextPlayTechnologiesIncMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashEquivalentsAtCarryingValue_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapCashEquivalentsAtCarryingValue_90" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableNet" xlink:label="loc_us-gaapAccountsReceivableNet_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapAccountsReceivableNet_90" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesPayable" xlink:label="loc_us-gaapNotesPayable_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapNotesPayable_90" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:label="loc_us-gaapAllowanceForDoubtfulAccountsReceivable_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapAllowanceForDoubtfulAccountsReceivable_90" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_LossOnRelatedPartyReceivable" xlink:label="loc_NTRPLossOnRelatedPartyReceivable_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_NTRPLossOnRelatedPartyReceivable_90" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingAndMarketingExpense" xlink:label="loc_us-gaapSellingAndMarketingExpense_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapSellingAndMarketingExpense_90" xlink:type="arc" order="5" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://nexttrip.com/role/ScheduleOfDiscontinuedOperationsDetails" xlink:title="999054 - Disclosure - Schedule of Discontinued Operations (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nexttrip.com/role/DiscontinuedOperationsDetailsNarrative" xlink:title="999055 - Disclosure - Discontinued Operations (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_AssetPurchaseAgreementMember" xlink:label="loc_NTRPAssetPurchaseAgreementMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_NTRPAssetPurchaseAgreementMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_DivergentTechnologiesIncMember" xlink:label="loc_NTRPDivergentTechnologiesIncMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_NTRPDivergentTechnologiesIncMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireIntangibleAssets" xlink:label="loc_us-gaapPaymentsToAcquireIntangibleAssets_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapPaymentsToAcquireIntangibleAssets_40" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_EarnestMoneyDeposit" xlink:label="loc_NTRPEarnestMoneyDeposit_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_NTRPEarnestMoneyDeposit_40" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossOnDispositionOfAssets1" xlink:label="loc_us-gaapGainLossOnDispositionOfAssets1_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapGainLossOnDispositionOfAssets1_40" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:label="loc_us-gaapIncomeLossFromDiscontinuedOperationsNetOfTax_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapIncomeLossFromDiscontinuedOperationsNetOfTax_40" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://nexttrip.com/role/ScheduleOfUnauditedSummarizedFinancialInformationDetails" xlink:title="999056 - Disclosure - Schedule of Unaudited Summarized Financial Information (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_FSATravelLLCMember" xlink:label="loc_NTRPFSATravelLLCMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_NTRPFSATravelLLCMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAssetsCurrent_30" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsNoncurrent" xlink:label="loc_us-gaapAssetsNoncurrent_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAssetsNoncurrent_30" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLiabilitiesCurrent_30" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="loc_us-gaapLiabilitiesNoncurrent_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLiabilitiesNoncurrent_30" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity_30" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRevenues_30" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaapGrossProfit_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapGrossProfit_30" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss_30" xlink:type="arc" order="7" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://nexttrip.com/role/InvestmentInEquityMethodInvesteeDetailsNarrative" xlink:title="999057 - Disclosure - Investment in Equity Method Investee (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:label="loc_us-gaapScheduleOfEquityMethodInvestmentsLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:label="loc_us-gaapScheduleOfEquityMethodInvestmentsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapScheduleOfEquityMethodInvestmentsLineItems" xlink:to="loc_us-gaapScheduleOfEquityMethodInvestmentsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfEquityMethodInvestmentsTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_MembershipPurchaseAgreementMember" xlink:label="loc_NTRPMembershipPurchaseAgreementMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_NTRPMembershipPurchaseAgreementMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:label="loc_srtScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfEquityMethodInvestmentsTable" xlink:to="loc_srtScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="loc_srtEquityMethodInvesteeNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="loc_srtEquityMethodInvesteeNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="loc_srtEquityMethodInvesteeNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="loc_srtEquityMethodInvesteeNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_FSATravelLLCMember" xlink:label="loc_NTRPFSATravelLLCMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtEquityMethodInvesteeNameDomain" xlink:to="loc_NTRPFSATravelLLCMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_NextTripMember" xlink:label="loc_NTRPNextTripMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtEquityMethodInvesteeNameDomain" xlink:to="loc_NTRPNextTripMember_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfEquityMethodInvestmentsTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_SeriesOPreferredStockMember" xlink:label="loc_NTRPSeriesOPreferredStockMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_NTRPSeriesOPreferredStockMember_10" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfEquityMethodInvestmentsTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_FSATravelLLCMember" xlink:label="loc_NTRPFSATravelLLCMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_NTRPFSATravelLLCMember_30" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_NextTripMember" xlink:label="loc_NTRPNextTripMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_NTRPNextTripMember_90" xlink:type="arc" order="92" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityOwnershipPercentageExcludingConsolidatedEntityAndEquityMethodInvestee" xlink:label="loc_us-gaapEquityOwnershipPercentageExcludingConsolidatedEntityAndEquityMethodInvestee_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfEquityMethodInvestmentsLineItems" xlink:to="loc_us-gaapEquityOwnershipPercentageExcludingConsolidatedEntityAndEquityMethodInvestee_150" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionPreacquisitionContingencyAmountOfSettlement" xlink:label="loc_us-gaapBusinessAcquisitionPreacquisitionContingencyAmountOfSettlement_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfEquityMethodInvestmentsLineItems" xlink:to="loc_us-gaapBusinessAcquisitionPreacquisitionContingencyAmountOfSettlement_150" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationContingentConsiderationAsset" xlink:label="loc_us-gaapBusinessCombinationContingentConsiderationAsset_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfEquityMethodInvestmentsLineItems" xlink:to="loc_us-gaapBusinessCombinationContingentConsiderationAsset_150" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesIssued" xlink:label="loc_us-gaapSharesIssued_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfEquityMethodInvestmentsLineItems" xlink:to="loc_us-gaapSharesIssued_150" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaapSharesIssuedPricePerShare_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfEquityMethodInvestmentsLineItems" xlink:to="loc_us-gaapSharesIssuedPricePerShare_150" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="loc_us-gaapEquityMethodInvestmentOwnershipPercentage_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfEquityMethodInvestmentsLineItems" xlink:to="loc_us-gaapEquityMethodInvestmentOwnershipPercentage_150" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentInterestRatePaidInCash" xlink:label="loc_us-gaapInvestmentInterestRatePaidInCash_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfEquityMethodInvestmentsLineItems" xlink:to="loc_us-gaapInvestmentInterestRatePaidInCash_150" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCosts" xlink:label="loc_us-gaapBusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCosts_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfEquityMethodInvestmentsLineItems" xlink:to="loc_us-gaapBusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCosts_150" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_BusinessAcquisitionMilestonePayments" xlink:label="loc_NTRPBusinessAcquisitionMilestonePayments_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfEquityMethodInvestmentsLineItems" xlink:to="loc_NTRPBusinessAcquisitionMilestonePayments_150" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_BusinessAcquisitionPerMilestonePayments" xlink:label="loc_NTRPBusinessAcquisitionPerMilestonePayments_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfEquityMethodInvestmentsLineItems" xlink:to="loc_NTRPBusinessAcquisitionPerMilestonePayments_150" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireBusinessesAndInterestInAffiliates" xlink:label="loc_us-gaapPaymentsToAcquireBusinessesAndInterestInAffiliates_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScheduleOfEquityMethodInvestmentsLineItems" xlink:to="loc_us-gaapPaymentsToAcquireBusinessesAndInterestInAffiliates_150" xlink:type="arc" order="10" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://nexttrip.com/role/InvestmentInEquitySecuritiesDetailsNarrative" xlink:title="999058 - Disclosure - Investment in Equity Securities (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_ShareExchangeAgreementMember" xlink:label="loc_NTRPShareExchangeAgreementMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_NTRPShareExchangeAgreementMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_BlueFyshHoldingsIncMember" xlink:label="loc_NTRPBlueFyshHoldingsIncMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_NTRPBlueFyshHoldingsIncMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_SeriesNNonvotingConvertiblePreferredStockMember" xlink:label="loc_NTRPSeriesNNonvotingConvertiblePreferredStockMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_NTRPSeriesNNonvotingConvertiblePreferredStockMember_10" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapAwardTypeAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockMember" xlink:label="loc_us-gaapRestrictedStockMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapRestrictedStockMember_30" xlink:type="arc" order="33" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityOwnershipPercentageExcludingConsolidatedEntityAndEquityMethodInvestee" xlink:label="loc_us-gaapEquityOwnershipPercentageExcludingConsolidatedEntityAndEquityMethodInvestee_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEquityOwnershipPercentageExcludingConsolidatedEntityAndEquityMethodInvestee_50" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_50" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaapSharesIssuedPricePerShare_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesIssuedPricePerShare_50" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_50" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://nexttrip.com/role/ScheduleOfPrepaidAndOtherCurrentAssetsDetails" xlink:title="999059 - Disclosure - Schedule of Prepaid and Other Current Assets (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nexttrip.com/role/ScheduleOfPropertyAndEquipmentDetails" xlink:title="999060 - Disclosure - Schedule of Property and Equipment (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaapPropertyPlantAndEquipmentLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="loc_us-gaapFurnitureAndFixturesMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapFurnitureAndFixturesMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComputerEquipmentMember" xlink:label="loc_us-gaapComputerEquipmentMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapComputerEquipmentMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaapPropertyPlantAndEquipmentGross_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentGross_70" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_70" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet_70" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://nexttrip.com/role/PropertyAndEquipmentDetailsNarrative" xlink:title="999061 - Disclosure - Property and Equipment (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nexttrip.com/role/ScheduleOfIntangibleAssetsDetails" xlink:title="999062 - Disclosure - Schedule of Intangible Assets (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SoftwareDevelopmentMember" xlink:label="loc_us-gaapSoftwareDevelopmentMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapSoftwareDevelopmentMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_SoftwareLicenseMember" xlink:label="loc_NTRPSoftwareLicenseMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_NTRPSoftwareLicenseMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TrademarksMember" xlink:label="loc_us-gaapTrademarksMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapTrademarksMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsGross_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsGross_90" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization_90" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaapIntangibleAssetsNetExcludingGoodwill_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapIntangibleAssetsNetExcludingGoodwill_90" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://nexttrip.com/role/ScheduleOfEstimatedAggregateAmortizationExpenseDetails" xlink:title="999063 - Disclosure - Schedule of estimated aggregate amortization expense (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nexttrip.com/role/IntangibleAssetsDetailsNarrative" xlink:title="999064 - Disclosure - Intangible Assets (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nexttrip.com/role/ScheduleOfFairValueOfAssetsAcquiredDetails" xlink:title="999065 - Disclosure - Schedule of Fair Value of Assets Acquired (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="loc_us-gaapRestructuringCostAndReserveLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_SigmaAdditiveSolutionsIncMember" xlink:label="loc_NTRPSigmaAdditiveSolutionsIncMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_NTRPSigmaAdditiveSolutionsIncMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_30" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_30" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_30" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_30" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_30" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_30" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_30" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses" xlink:label="loc_NTRPBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_NTRPBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses_30" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_30" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_30" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapGoodwill_30" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_30" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="loc_us-gaapBusinessCombinationConsiderationTransferred1_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapBusinessCombinationConsiderationTransferred1_30" xlink:type="arc" order="12" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://nexttrip.com/role/GoodwillDetailsNarrative" xlink:title="999066 - Disclosure - Goodwill (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_SigmaAdditiveSolutionsIncMember" xlink:label="loc_NTRPSigmaAdditiveSolutionsIncMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_NTRPSigmaAdditiveSolutionsIncMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_NextTripHoldingsIncMember" xlink:label="loc_NTRPNextTripHoldingsIncMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_NTRPNextTripHoldingsIncMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeriesEPreferredStockMember" xlink:label="loc_us-gaapSeriesEPreferredStockMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesEPreferredStockMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_DivergentTechnologiesIncMember" xlink:label="loc_NTRPDivergentTechnologiesIncMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_NTRPDivergentTechnologiesIncMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="loc_us-gaapBusinessCombinationConsiderationTransferred1_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapBusinessCombinationConsiderationTransferred1_80" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionSharePrice" xlink:label="loc_us-gaapBusinessAcquisitionSharePrice_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapBusinessAcquisitionSharePrice_80" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding_80" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillPeriodIncreaseDecrease" xlink:label="loc_us-gaapGoodwillPeriodIncreaseDecrease_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapGoodwillPeriodIncreaseDecrease_80" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireIntangibleAssets" xlink:label="loc_us-gaapPaymentsToAcquireIntangibleAssets_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPaymentsToAcquireIntangibleAssets_80" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossOnDispositionOfAssets" xlink:label="loc_us-gaapGainLossOnDispositionOfAssets_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapGainLossOnDispositionOfAssets_80" xlink:type="arc" order="5" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://nexttrip.com/role/AccountsPayableAndAccruedLiabilitiesDetailsNarrative" xlink:title="999067 - Disclosure - Accounts Payable and Accrued Liabilities (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nexttrip.com/role/ScheduleOfDeferredTaxAssetsDetails" xlink:title="999068 - Disclosure - Schedule of Deferred Tax Assets (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nexttrip.com/role/ScheduleOfReconciliationOfProvisionForIncomeTaxesDetails" xlink:title="999069 - Disclosure - Schedule of Reconciliation of Provision for Income Taxes (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nexttrip.com/role/IncomeTaxesDetailsNarrative" xlink:title="999070 - Disclosure - Income Taxes (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nexttrip.com/role/NotesPayableDetailsNarrative" xlink:title="999071 - Disclosure - Notes Payable (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaapDebtInstrumentLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaapDebtInstrumentTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_SecuritiesPurchaseAgreementMember" xlink:label="loc_NTRPSecuritiesPurchaseAgreementMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_NTRPSecuritiesPurchaseAgreementMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_NoteSecuritiesPurchaseAgreementMember" xlink:label="loc_NTRPNoteSecuritiesPurchaseAgreementMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_NTRPNoteSecuritiesPurchaseAgreementMember_100" xlink:type="arc" order="101" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_ShortTermPromissoryNoteMember" xlink:label="loc_NTRPShortTermPromissoryNoteMember_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_NTRPShortTermPromissoryNoteMember_120" xlink:type="arc" order="121" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_DebtConversionAgreementMember" xlink:label="loc_NTRPDebtConversionAgreementMember_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_NTRPDebtConversionAgreementMember_170" xlink:type="arc" order="172" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_NoteTwoSecuritiesPurchaseAgreementMember" xlink:label="loc_NTRPNoteTwoSecuritiesPurchaseAgreementMember_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_NTRPNoteTwoSecuritiesPurchaseAgreementMember_210" xlink:type="arc" order="211" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_OneMillionNoteMember" xlink:label="loc_NTRPOneMillionNoteMember_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_NTRPOneMillionNoteMember_280" xlink:type="arc" order="281" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_DebtExchangeAgreementMember" xlink:label="loc_NTRPDebtExchangeAgreementMember_300" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_NTRPDebtExchangeAgreementMember_300" xlink:type="arc" order="302" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_srtRangeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember_80" xlink:type="arc" order="82" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_SeriesMNonvotingConvertiblePreferredStockMember" xlink:label="loc_NTRPSeriesMNonvotingConvertiblePreferredStockMember_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_NTRPSeriesMNonvotingConvertiblePreferredStockMember_170" xlink:type="arc" order="171" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_SeriesPNonvotingConvertiblePreferredStockMember" xlink:label="loc_NTRPSeriesPNonvotingConvertiblePreferredStockMember_300" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_NTRPSeriesPNonvotingConvertiblePreferredStockMember_300" xlink:type="arc" order="301" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromConvertibleDebt" xlink:label="loc_us-gaapProceedsFromConvertibleDebt_380" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapProceedsFromConvertibleDebt_380" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaapDebtInstrumentInterestRateStatedPercentage_380" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateStatedPercentage_380" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaapDebtInstrumentFaceAmount_380" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentFaceAmount_380" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesAndLoansPayableCurrent" xlink:label="loc_us-gaapNotesAndLoansPayableCurrent_380" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapNotesAndLoansPayableCurrent_380" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromNotesPayable" xlink:label="loc_us-gaapProceedsFromNotesPayable_380" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapProceedsFromNotesPayable_380" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentUnamortizedDiscount" xlink:label="loc_us-gaapDebtInstrumentUnamortizedDiscount_380" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentUnamortizedDiscount_380" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="loc_us-gaapDebtInstrumentMaturityDate_380" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentMaturityDate_380" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:label="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_380" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_380" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_ConvertibleNotesPayableOfInstallments" xlink:label="loc_NTRPConvertibleNotesPayableOfInstallments_380" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_NTRPConvertibleNotesPayableOfInstallments_380" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:label="loc_us-gaapDebtInstrumentInterestRateEffectivePercentage_380" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateEffectivePercentage_380" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_380" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_380" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="loc_us-gaapSaleOfStockPricePerShare_380" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapSaleOfStockPricePerShare_380" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:label="loc_us-gaapDebtConversionConvertedInstrumentAmount1_380" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtConversionConvertedInstrumentAmount1_380" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_DebtConversionConvertedInstrumentOfGuaranteedInterest" xlink:label="loc_NTRPDebtConversionConvertedInstrumentOfGuaranteedInterest_380" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_NTRPDebtConversionConvertedInstrumentOfGuaranteedInterest_380" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:label="loc_us-gaapDebtConversionConvertedInstrumentSharesIssued1_380" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtConversionConvertedInstrumentSharesIssued1_380" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:label="loc_us-gaapDebtInstrumentConvertibleConversionPrice1_380" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentConvertibleConversionPrice1_380" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentPeriodicPayment" xlink:label="loc_us-gaapDebtInstrumentPeriodicPayment_380" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentPeriodicPayment_380" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_DebtInstrumentPeriodicOfInstallments" xlink:label="loc_NTRPDebtInstrumentPeriodicOfInstallments_380" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_NTRPDebtInstrumentPeriodicOfInstallments_380" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesIssued" xlink:label="loc_us-gaapSharesIssued_380" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapSharesIssued_380" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaapSharesIssuedPricePerShare_380" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapSharesIssuedPricePerShare_380" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_DebtInstrumentUnamortizedDebtDiscount" xlink:label="loc_NTRPDebtInstrumentUnamortizedDebtDiscount_380" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_NTRPDebtInstrumentUnamortizedDebtDiscount_380" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentCovenantDescription" xlink:label="loc_us-gaapDebtInstrumentCovenantDescription_380" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentCovenantDescription_380" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_DebtInstrumentOfInvestor" xlink:label="loc_NTRPDebtInstrumentOfInvestor_380" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_NTRPDebtInstrumentOfInvestor_380" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_DebtInstrumentOfFunded" xlink:label="loc_NTRPDebtInstrumentOfFunded_380" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_NTRPDebtInstrumentOfFunded_380" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCost" xlink:label="loc_NTRPAdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCost_380" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_NTRPAdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCost_380" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction_380" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction_380" xlink:type="arc" order="25" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://nexttrip.com/role/ConvertibleNotesDetailsNarrative" xlink:title="999072 - Disclosure - Convertible Notes (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_SpecialPurposeAcquisitionCorporationMember" xlink:label="loc_NTRPSpecialPurposeAcquisitionCorporationMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_NTRPSpecialPurposeAcquisitionCorporationMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_SeveralInvestorsMember" xlink:label="loc_NTRPSeveralInvestorsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_NTRPSeveralInvestorsMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaapDebtInstrumentAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapDebtInstrumentAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_ConvertibleNotesMember" xlink:label="loc_NTRPConvertibleNotesMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_NTRPConvertibleNotesMember_0" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_DebtAssignmentAndConversionAgreementsMember" xlink:label="loc_NTRPDebtAssignmentAndConversionAgreementsMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_NTRPDebtAssignmentAndConversionAgreementsMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_ContingentSharesMember" xlink:label="loc_NTRPContingentSharesMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_NTRPContingentSharesMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromConvertibleDebt" xlink:label="loc_us-gaapProceedsFromConvertibleDebt_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProceedsFromConvertibleDebt_100" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaapDebtInstrumentInterestRateStatedPercentage_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateStatedPercentage_100" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:label="loc_us-gaapDebtInstrumentConvertibleConversionPrice1_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentConvertibleConversionPrice1_100" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaapSharePrice_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharePrice_100" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_100" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpenseDebt" xlink:label="loc_us-gaapInterestExpenseDebt_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapInterestExpenseDebt_100" xlink:type="arc" order="5" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://nexttrip.com/role/SharePurchaseAgreementsDetailsNarrative" xlink:title="999073 - Disclosure - Share Purchase Agreements (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_SharePurchaseAgreementsMember" xlink:label="loc_NTRPSharePurchaseAgreementsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_NTRPSharePurchaseAgreementsMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_SoftwareAsAServiceAgreementMember" xlink:label="loc_NTRPSoftwareAsAServiceAgreementMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_NTRPSoftwareAsAServiceAgreementMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_ConsultingModificationAgreementMember" xlink:label="loc_NTRPConsultingModificationAgreementMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_NTRPConsultingModificationAgreementMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtTitleOfIndividualAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_SeveralInvestorsMember" xlink:label="loc_NTRPSeveralInvestorsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_NTRPSeveralInvestorsMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_ThirdPartyMember" xlink:label="loc_NTRPThirdPartyMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_NTRPThirdPartyMember_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_ThirdPartyConsultantMember" xlink:label="loc_NTRPThirdPartyConsultantMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_NTRPThirdPartyConsultantMember_60" xlink:type="arc" order="62" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember_40" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_ContingentSharesMember" xlink:label="loc_NTRPContingentSharesMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_NTRPContingentSharesMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromConvertibleDebt" xlink:label="loc_us-gaapProceedsFromConvertibleDebt_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProceedsFromConvertibleDebt_120" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaapSharePrice_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharePrice_120" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_ProceedsFromDownpaymentForContract" xlink:label="loc_NTRPProceedsFromDownpaymentForContract_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_NTRPProceedsFromDownpaymentForContract_120" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:label="loc_us-gaapDebtInstrumentConvertibleConversionPrice1_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentConvertibleConversionPrice1_120" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_120" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_ConsultingFees" xlink:label="loc_NTRPConsultingFees_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_NTRPConsultingFees_120" xlink:type="arc" order="5" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://nexttrip.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:title="999074 - Disclosure - Related Party Transactions (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="loc_us-gaapRelatedPartyTransactionLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyMember" xlink:label="loc_us-gaapRelatedPartyMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_us-gaapRelatedPartyMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_NextPlayTechnologiesIncMember" xlink:label="loc_NTRPNextPlayTechnologiesIncMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_NTRPNextPlayTechnologiesIncMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_NextPlayTechnologiesIncMember" xlink:label="loc_NTRPNextPlayTechnologiesIncMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_NTRPNextPlayTechnologiesIncMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesPayableCurrent" xlink:label="loc_us-gaapNotesPayableCurrent_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapNotesPayableCurrent_60" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_LossOnRelatedPartyReceivable" xlink:label="loc_NTRPLossOnRelatedPartyReceivable_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_NTRPLossOnRelatedPartyReceivable_60" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReceivablesNetCurrent" xlink:label="loc_us-gaapReceivablesNetCurrent_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapReceivablesNetCurrent_60" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:label="loc_us-gaapAllowanceForDoubtfulAccountsReceivable_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapAllowanceForDoubtfulAccountsReceivable_60" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://nexttrip.com/role/DeferredRevenueDetailsNarrative" xlink:title="999075 - Disclosure - Deferred Revenue (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nexttrip.com/role/ScheduleOfStockOptionActivityDetails" xlink:title="999076 - Disclosure - Schedule of Stock Option Activity (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapAwardTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_StockAppreciationRightsMember" xlink:label="loc_NTRPStockAppreciationRightsMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_NTRPStockAppreciationRightsMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_90" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_90" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_90" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_90" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised_90" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_90" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_90" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_90" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_90" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedorCancelledInPeriodTotalIntrinsicValue" xlink:label="loc_NTRPShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedorCancelledInPeriodTotalIntrinsicValue_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_NTRPShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedorCancelledInPeriodTotalIntrinsicValue_90" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_90" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_90" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_90" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_90" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_90" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_90" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_90" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_90" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_90" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_90" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_90" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_90" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageForfeitedOrCancelled" xlink:label="loc_NTRPShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageForfeitedOrCancelled_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_NTRPShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageForfeitedOrCancelled_90" xlink:type="arc" order="25" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://nexttrip.com/role/ScheduleOfShareBasedPaymentsAwardStockOptionsValuationAssumptionsDetails" xlink:title="999077 - Disclosure - Schedule of Share Based Payments Award Stock Options Valuation Assumptions (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapPlanNameAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_TwoThousandAndTwentyStockAppreciationRightsPlanMember" xlink:label="loc_NTRPTwoThousandAndTwentyStockAppreciationRightsPlanMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_NTRPTwoThousandAndTwentyStockAppreciationRightsPlanMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_srtRangeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_70" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_70" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_70" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_70" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_70" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_70" xlink:type="arc" order="5" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://nexttrip.com/role/ScheduleOfWarrantyActivityDetails" xlink:title="999078 - Disclosure - Schedule of Warranty Activity (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nexttrip.com/role/StockholdersEquityDetailsNarrative" xlink:title="999079 - Disclosure - Stockholders&#8217; Equity (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember_1040" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapWarrantMember_1040" xlink:type="arc" order="1041" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_AlumniCapitalLPMember" xlink:label="loc_NTRPAlumniCapitalLPMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_NTRPAlumniCapitalLPMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_FSATravelLLCMember" xlink:label="loc_NTRPFSATravelLLCMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_NTRPFSATravelLLCMember_70" xlink:type="arc" order="71" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_BlueFyshHoldingsIncMember" xlink:label="loc_NTRPBlueFyshHoldingsIncMember_800" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_NTRPBlueFyshHoldingsIncMember_800" xlink:type="arc" order="803" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_AtTheMarketIssuanceSalesAgreementMember" xlink:label="loc_NTRPAtTheMarketIssuanceSalesAgreementMember_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_NTRPAtTheMarketIssuanceSalesAgreementMember_130" xlink:type="arc" order="131" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_NextTripHoldingsIncMember" xlink:label="loc_NTRPNextTripHoldingsIncMember_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_NTRPNextTripHoldingsIncMember_150" xlink:type="arc" order="151" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_FSATravelLLCMember" xlink:label="loc_NTRPFSATravelLLCMember_860" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_NTRPFSATravelLLCMember_860" xlink:type="arc" order="861" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredRevenueArrangementTypeAxis" xlink:label="loc_us-gaapDeferredRevenueArrangementTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" xlink:to="loc_us-gaapDeferredRevenueArrangementTypeAxis" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredRevenueArrangementTypeDomain" xlink:label="loc_us-gaapDeferredRevenueArrangementTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapDeferredRevenueArrangementTypeAxis" xlink:to="loc_us-gaapDeferredRevenueArrangementTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredRevenueArrangementTypeDomain" xlink:label="loc_us-gaapDeferredRevenueArrangementTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDeferredRevenueArrangementTypeAxis" xlink:to="loc_us-gaapDeferredRevenueArrangementTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_DebtAssignmentAndConversionAgreementsMember" xlink:label="loc_NTRPDebtAssignmentAndConversionAgreementsMember_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDeferredRevenueArrangementTypeDomain" xlink:to="loc_NTRPDebtAssignmentAndConversionAgreementsMember_180" xlink:type="arc" order="182" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_SharePurchaseAndExchangeAgreementsMember" xlink:label="loc_NTRPSharePurchaseAndExchangeAgreementsMember_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDeferredRevenueArrangementTypeDomain" xlink:to="loc_NTRPSharePurchaseAndExchangeAgreementsMember_190" xlink:type="arc" order="192" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:label="loc_us-gaapRelatedPartyTransactionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" xlink:to="loc_us-gaapRelatedPartyTransactionAxis" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="loc_us-gaapRelatedPartyTransactionDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionAxis" xlink:to="loc_us-gaapRelatedPartyTransactionDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="loc_us-gaapRelatedPartyTransactionDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionAxis" xlink:to="loc_us-gaapRelatedPartyTransactionDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_ThirdPartyConsultantMember" xlink:label="loc_NTRPThirdPartyConsultantMember_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionDomain" xlink:to="loc_NTRPThirdPartyConsultantMember_200" xlink:type="arc" order="202" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_SeriesEConvertiblePreferredStockMember" xlink:label="loc_NTRPSeriesEConvertiblePreferredStockMember_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_NTRPSeriesEConvertiblePreferredStockMember_220" xlink:type="arc" order="221" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_SeriesFConvertiblePreferredStockMember" xlink:label="loc_NTRPSeriesFConvertiblePreferredStockMember_240" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_NTRPSeriesFConvertiblePreferredStockMember_240" xlink:type="arc" order="241" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_SeriesGConvertiblePreferredStockMember" xlink:label="loc_NTRPSeriesGConvertiblePreferredStockMember_260" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_NTRPSeriesGConvertiblePreferredStockMember_260" xlink:type="arc" order="261" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_SeriesHConvertiblePreferredStockMember" xlink:label="loc_NTRPSeriesHConvertiblePreferredStockMember_290" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_NTRPSeriesHConvertiblePreferredStockMember_290" xlink:type="arc" order="291" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_SeriesIConvertiblePreferredStockMember" xlink:label="loc_NTRPSeriesIConvertiblePreferredStockMember_310" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_NTRPSeriesIConvertiblePreferredStockMember_310" xlink:type="arc" order="311" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_SeriesIPreferredStockMember" xlink:label="loc_NTRPSeriesIPreferredStockMember_430" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_NTRPSeriesIPreferredStockMember_430" xlink:type="arc" order="431" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_SeriesJNonvotingConvertiblePreferredStockMember" xlink:label="loc_NTRPSeriesJNonvotingConvertiblePreferredStockMember_490" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_NTRPSeriesJNonvotingConvertiblePreferredStockMember_490" xlink:type="arc" order="491" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_SeriesKNonvotingConvertiblePreferredStockMember" xlink:label="loc_NTRPSeriesKNonvotingConvertiblePreferredStockMember_540" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_NTRPSeriesKNonvotingConvertiblePreferredStockMember_540" xlink:type="arc" order="541" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_SeriesLNonvotingConvertiblePreferredStockMember" xlink:label="loc_NTRPSeriesLNonvotingConvertiblePreferredStockMember_590" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_NTRPSeriesLNonvotingConvertiblePreferredStockMember_590" xlink:type="arc" order="591" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_SeriesMNonvotingConvertiblePreferredStockMember" xlink:label="loc_NTRPSeriesMNonvotingConvertiblePreferredStockMember_680" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_NTRPSeriesMNonvotingConvertiblePreferredStockMember_680" xlink:type="arc" order="681" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_SeriesNNonvotingConvertiblePreferredStockMember" xlink:label="loc_NTRPSeriesNNonvotingConvertiblePreferredStockMember_760" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_NTRPSeriesNNonvotingConvertiblePreferredStockMember_760" xlink:type="arc" order="761" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_SeriesNNonvotingConvertibleConvertiblePreferredStockMember" xlink:label="loc_NTRPSeriesNNonvotingConvertibleConvertiblePreferredStockMember_830" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_NTRPSeriesNNonvotingConvertibleConvertiblePreferredStockMember_830" xlink:type="arc" order="831" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_SeriesONonvotingConvertiblePreferredStockMember" xlink:label="loc_NTRPSeriesONonvotingConvertiblePreferredStockMember_840" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_NTRPSeriesONonvotingConvertiblePreferredStockMember_840" xlink:type="arc" order="841" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_SeriesPNonvotingConvertiblePreferredStockMember" xlink:label="loc_NTRPSeriesPNonvotingConvertiblePreferredStockMember_880" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_NTRPSeriesPNonvotingConvertiblePreferredStockMember_880" xlink:type="arc" order="881" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_SecuritiesPurchaseAgreementMember" xlink:label="loc_NTRPSecuritiesPurchaseAgreementMember_330" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_NTRPSecuritiesPurchaseAgreementMember_330" xlink:type="arc" order="332" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_SeriesIPurchaseAgreementMember" xlink:label="loc_NTRPSeriesIPurchaseAgreementMember_410" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_NTRPSeriesIPurchaseAgreementMember_410" xlink:type="arc" order="412" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_MillerDebtConversionAgreementMember" xlink:label="loc_NTRPMillerDebtConversionAgreementMember_450" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_NTRPMillerDebtConversionAgreementMember_450" xlink:type="arc" order="451" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_RelatedPartyDebtConversionAgreementsMember" xlink:label="loc_NTRPRelatedPartyDebtConversionAgreementsMember_620" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_NTRPRelatedPartyDebtConversionAgreementsMember_620" xlink:type="arc" order="622" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_DebtConversionAgreementMember" xlink:label="loc_NTRPDebtConversionAgreementMember_720" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_NTRPDebtConversionAgreementMember_720" xlink:type="arc" order="722" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_ShareExchangeAgreementMember" xlink:label="loc_NTRPShareExchangeAgreementMember_800" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_NTRPShareExchangeAgreementMember_800" xlink:type="arc" order="802" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_EquityInvestmentAgreementMember" xlink:label="loc_NTRPEquityInvestmentAgreementMember_900" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_NTRPEquityInvestmentAgreementMember_900" xlink:type="arc" order="902" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_DebtExchangeAgreementMember" xlink:label="loc_NTRPDebtExchangeAgreementMember_920" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_NTRPDebtExchangeAgreementMember_920" xlink:type="arc" order="922" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" xlink:to="loc_srtTitleOfIndividualAxis" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_MessrsKerbyAndMonacoMember" xlink:label="loc_NTRPMessrsKerbyAndMonacoMember_620" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_NTRPMessrsKerbyAndMonacoMember_620" xlink:type="arc" order="621" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" xlink:to="loc_us-gaapPlanNameAxis" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_TwoThousandTwentyThreeEquityIncentivePlanMember" xlink:label="loc_NTRPTwoThousandTwentyThreeEquityIncentivePlanMember_950" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_NTRPTwoThousandTwentyThreeEquityIncentivePlanMember_950" xlink:type="arc" order="951" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_TwoThousandThirteenEquityIncentivePlanMember" xlink:label="loc_NTRPTwoThousandThirteenEquityIncentivePlanMember_960" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_NTRPTwoThousandThirteenEquityIncentivePlanMember_960" xlink:type="arc" order="961" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_TwoThousandAndTwentyStockAppreciationRightsPlanMember" xlink:label="loc_NTRPTwoThousandAndTwentyStockAppreciationRightsPlanMember_1020" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_NTRPTwoThousandAndTwentyStockAppreciationRightsPlanMember_1020" xlink:type="arc" order="1021" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" xlink:to="loc_us-gaapAwardTypeAxis" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockOptionMember" xlink:label="loc_us-gaapStockOptionMember_970" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapStockOptionMember_970" xlink:type="arc" order="971" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_StockAppreciationRightsMember" xlink:label="loc_NTRPStockAppreciationRightsMember_1000" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_NTRPStockAppreciationRightsMember_1000" xlink:type="arc" order="1001" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" xlink:to="loc_srtRangeAxis" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember_980" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember_980" xlink:type="arc" order="981" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember_1050" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember_1050" xlink:type="arc" order="1052" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized_1090" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapCommonStockSharesAuthorized_1090" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding_1090" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding_1090" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare_1090" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare_1090" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityReverseStockSplit" xlink:label="loc_us-gaapStockholdersEquityReverseStockSplit_1090" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapStockholdersEquityReverseStockSplit_1090" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesReverseStockSplits_1090" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesReverseStockSplits_1090" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_1090" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_1090" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices_1090" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices_1090" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_1090" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_1090" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_1090" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_1090" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesAcquisitions_1090" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesAcquisitions_1090" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_StockIssuedDuringPeriodSharesWarrantExercises" xlink:label="loc_NTRPStockIssuedDuringPeriodSharesWarrantExercises_1090" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_NTRPStockIssuedDuringPeriodSharesWarrantExercises_1090" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:label="loc_us-gaapProceedsFromWarrantExercises_1090" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapProceedsFromWarrantExercises_1090" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction_1090" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction_1090" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfCommonStock_1090" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOfCommonStock_1090" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:label="loc_us-gaapBusinessAcquisitionPercentageOfVotingInterestsAcquired_1090" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapBusinessAcquisitionPercentageOfVotingInterestsAcquired_1090" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesRestrictedStockAwardGross_1090" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesRestrictedStockAwardGross_1090" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction" xlink:label="loc_us-gaapSaleOfStockPercentageOfOwnershipAfterTransaction_1090" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapSaleOfStockPercentageOfOwnershipAfterTransaction_1090" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:label="loc_us-gaapBusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_1090" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapBusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_1090" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockRepurchasedDuringPeriodShares" xlink:label="loc_us-gaapStockRepurchasedDuringPeriodShares_1090" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapStockRepurchasedDuringPeriodShares_1090" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaapSharePrice_1090" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapSharePrice_1090" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaapAllocatedShareBasedCompensationExpense_1090" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapAllocatedShareBasedCompensationExpense_1090" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaapPreferredStockSharesAuthorized_1090" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapPreferredStockSharesAuthorized_1090" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare_1090" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare_1090" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaapPreferredStockSharesIssued_1090" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapPreferredStockSharesIssued_1090" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaapPreferredStockSharesOutstanding_1090" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapPreferredStockSharesOutstanding_1090" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockDividendRatePercentage" xlink:label="loc_us-gaapPreferredStockDividendRatePercentage_1090" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapPreferredStockDividendRatePercentage_1090" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:label="loc_us-gaapDebtInstrumentConvertibleConversionPrice1_1090" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapDebtInstrumentConvertibleConversionPrice1_1090" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockConvertibleSharesIssuable" xlink:label="loc_us-gaapPreferredStockConvertibleSharesIssuable_1090" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapPreferredStockConvertibleSharesIssuable_1090" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockRedemptionTerms" xlink:label="loc_us-gaapPreferredStockRedemptionTerms_1090" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapPreferredStockRedemptionTerms_1090" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_1090" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_1090" xlink:type="arc" order="29" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="loc_us-gaapSaleOfStockPricePerShare_1090" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapSaleOfStockPricePerShare_1090" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:label="loc_us-gaapSaleOfStockConsiderationReceivedOnTransaction_1090" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapSaleOfStockConsiderationReceivedOnTransaction_1090" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:label="loc_us-gaapDebtConversionConvertedInstrumentAmount1_1090" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapDebtConversionConvertedInstrumentAmount1_1090" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_1090" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_1090" xlink:type="arc" order="33" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromUnsecuredNotesPayable" xlink:label="loc_us-gaapProceedsFromUnsecuredNotesPayable_1090" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapProceedsFromUnsecuredNotesPayable_1090" xlink:type="arc" order="34" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfUnits_1090" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfUnits_1090" xlink:type="arc" order="35" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfWarrants" xlink:label="loc_us-gaapProceedsFromIssuanceOfWarrants_1090" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOfWarrants_1090" xlink:type="arc" order="36" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaapDebtInstrumentInterestRateStatedPercentage_1090" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateStatedPercentage_1090" xlink:type="arc" order="37" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:label="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_1090" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_1090" xlink:type="arc" order="38" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="loc_us-gaapCommonStockCapitalSharesReservedForFutureIssuance_1090" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapCommonStockCapitalSharesReservedForFutureIssuance_1090" xlink:type="arc" order="39" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_1090" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_1090" xlink:type="arc" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_1090" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_1090" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_1090" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_1090" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CompensationExpenseExcludingCostOfGoodAndServiceSold" xlink:label="loc_us-gaapCompensationExpenseExcludingCostOfGoodAndServiceSold_1090" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapCompensationExpenseExcludingCostOfGoodAndServiceSold_1090" xlink:type="arc" order="43" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_1090" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_1090" xlink:type="arc" order="44" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised_1090" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised_1090" xlink:type="arc" order="45" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_1090" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_1090" xlink:type="arc" order="46" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_1090" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_1090" xlink:type="arc" order="47" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation_1090" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapShareBasedCompensation_1090" xlink:type="arc" order="48" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="loc_us-gaapProceedsFromStockOptionsExercised_1090" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapProceedsFromStockOptionsExercised_1090" xlink:type="arc" order="49" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1090" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1090" xlink:type="arc" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:label="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_1090" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_1090" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_1090" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_1090" xlink:type="arc" order="52" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_1090" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_1090" xlink:type="arc" order="53" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardWeightedAverageRemainingRecognitionPeriod" xlink:label="loc_NTRPSharebasedCompensationArrangementBySharebasedPaymentAwardWeightedAverageRemainingRecognitionPeriod_1090" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_NTRPSharebasedCompensationArrangementBySharebasedPaymentAwardWeightedAverageRemainingRecognitionPeriod_1090" xlink:type="arc" order="54" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_DescriptionForWarrantExpiration" xlink:label="loc_NTRPDescriptionForWarrantExpiration_1090" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_NTRPDescriptionForWarrantExpiration_1090" xlink:type="arc" order="55" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://nexttrip.com/role/ScheduleOfEarningsPerShareBasicAndDilutedDetails" xlink:title="999080 - Disclosure - Schedule of Earnings Per Share, Basic and Diluted (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nexttrip.com/role/ScheduleOfBusinessMilestonesAndIssuableContingentSharesDetails" xlink:title="999081 - Disclosure - Schedule of Business Milestones and Issuable Contingent Shares (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementScenarioAxis" xlink:label="loc_srtStatementScenarioAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtStatementScenarioAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_AchievedMember" xlink:label="loc_NTRPAchievedMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_NTRPAchievedMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_NotAchievedMember" xlink:label="loc_NTRPNotAchievedMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_NTRPNotAchievedMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherCommitmentsAxis" xlink:label="loc_us-gaapOtherCommitmentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapOtherCommitmentsAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherCommitmentsDomain" xlink:label="loc_us-gaapOtherCommitmentsDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapOtherCommitmentsAxis" xlink:to="loc_us-gaapOtherCommitmentsDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherCommitmentsDomain" xlink:label="loc_us-gaapOtherCommitmentsDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapOtherCommitmentsAxis" xlink:to="loc_us-gaapOtherCommitmentsDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_LeisureTravelBookingPlatformMember" xlink:label="loc_NTRPLeisureTravelBookingPlatformMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOtherCommitmentsDomain" xlink:to="loc_NTRPLeisureTravelBookingPlatformMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_GroupTravelBookingPlatformMember" xlink:label="loc_NTRPGroupTravelBookingPlatformMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOtherCommitmentsDomain" xlink:to="loc_NTRPGroupTravelBookingPlatformMember_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_FlexPayTechnologyMember" xlink:label="loc_NTRPFlexPayTechnologyMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOtherCommitmentsDomain" xlink:to="loc_NTRPFlexPayTechnologyMember_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_TravelAgentPlatformMember" xlink:label="loc_NTRPTravelAgentPlatformMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOtherCommitmentsDomain" xlink:to="loc_NTRPTravelAgentPlatformMember_40" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncrementalCommonSharesAttributableToContingentlyIssuableShares" xlink:label="loc_us-gaapIncrementalCommonSharesAttributableToContingentlyIssuableShares_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncrementalCommonSharesAttributableToContingentlyIssuableShares_80" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://nexttrip.com/role/ScheduleOfWeightedAverageCommonSharesDetailsParenthetical" xlink:title="999082 - Disclosure - Schedule of Weighted Average Common Shares (Details) (Parenthetical)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nexttrip.com/role/ScheduleOfWeightedAverageCommonSharesDetails" xlink:title="999083 - Disclosure - Schedule of Weighted Average Common Shares (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasicLineItems" xlink:label="loc_us-gaapEarningsPerShareBasicLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:label="loc_us-gaapScheduleOfEarningsPerShareBasicByCommonClassTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapEarningsPerShareBasicLineItems" xlink:to="loc_us-gaapScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonStockMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_ContingentSharesMember" xlink:label="loc_NTRPContingentSharesMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_NTRPContingentSharesMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEarningsPerShareBasicLineItems" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic_40" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://nexttrip.com/role/LossPerShareDetailsNarrative" xlink:title="999084 - Disclosure - Loss Per Share (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasicLineItems" xlink:label="loc_us-gaapEarningsPerShareBasicLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:label="loc_us-gaapScheduleOfEarningsPerShareBasicByCommonClassTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapEarningsPerShareBasicLineItems" xlink:to="loc_us-gaapScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_ShareExchangeAgreementMember" xlink:label="loc_NTRPShareExchangeAgreementMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_NTRPShareExchangeAgreementMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementScenarioAxis" xlink:label="loc_srtStatementScenarioAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:to="loc_srtStatementScenarioAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_AchievedMember" xlink:label="loc_NTRPAchievedMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_NTRPAchievedMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapWarrantMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember_140" xlink:type="arc" order="141" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:to="loc_us-gaapAwardTypeAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaapEmployeeStockOptionMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapEmployeeStockOptionMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeriesEPreferredStockMember" xlink:label="loc_us-gaapSeriesEPreferredStockMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesEPreferredStockMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeriesHPreferredStockMember" xlink:label="loc_us-gaapSeriesHPreferredStockMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesHPreferredStockMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_SeriesIPreferredStockMember" xlink:label="loc_NTRPSeriesIPreferredStockMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_NTRPSeriesIPreferredStockMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_SeriesJPreferredStockMember" xlink:label="loc_NTRPSeriesJPreferredStockMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_NTRPSeriesJPreferredStockMember_70" xlink:type="arc" order="71" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_SeriesKPreferredStockMember" xlink:label="loc_NTRPSeriesKPreferredStockMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_NTRPSeriesKPreferredStockMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_SeriesLPreferredStockMember" xlink:label="loc_NTRPSeriesLPreferredStockMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_NTRPSeriesLPreferredStockMember_90" xlink:type="arc" order="91" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_SeriesMPreferredStockMember" xlink:label="loc_NTRPSeriesMPreferredStockMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_NTRPSeriesMPreferredStockMember_100" xlink:type="arc" order="101" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_SeriesNPreferredStockMember" xlink:label="loc_NTRPSeriesNPreferredStockMember_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_NTRPSeriesNPreferredStockMember_110" xlink:type="arc" order="111" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_SeriesOPreferredStockMember" xlink:label="loc_NTRPSeriesOPreferredStockMember_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_NTRPSeriesOPreferredStockMember_120" xlink:type="arc" order="121" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_SeriesOPreferredStockOneMember" xlink:label="loc_NTRPSeriesOPreferredStockOneMember_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_NTRPSeriesOPreferredStockOneMember_130" xlink:type="arc" order="131" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncrementalCommonSharesAttributableToContingentlyIssuableShares" xlink:label="loc_us-gaapIncrementalCommonSharesAttributableToContingentlyIssuableShares_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEarningsPerShareBasicLineItems" xlink:to="loc_us-gaapIncrementalCommonSharesAttributableToContingentlyIssuableShares_170" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEarningsPerShareBasicLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_170" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEarningsPerShareBasicLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_170" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConversionOfStockSharesConverted1" xlink:label="loc_us-gaapConversionOfStockSharesConverted1_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEarningsPerShareBasicLineItems" xlink:to="loc_us-gaapConversionOfStockSharesConverted1_170" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConversionOfStockSharesIssued1" xlink:label="loc_us-gaapConversionOfStockSharesIssued1_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEarningsPerShareBasicLineItems" xlink:to="loc_us-gaapConversionOfStockSharesIssued1_170" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:label="loc_us-gaapWeightedAverageNumberDilutedSharesOutstandingAdjustment_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEarningsPerShareBasicLineItems" xlink:to="loc_us-gaapWeightedAverageNumberDilutedSharesOutstandingAdjustment_170" xlink:type="arc" order="5" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://nexttrip.com/role/ConcentrationsDetailsNarrative" xlink:title="999085 - Disclosure - Concentrations (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskLineItems" xlink:label="loc_us-gaapConcentrationRiskLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskTable" xlink:label="loc_us-gaapConcentrationRiskTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapConcentrationRiskLineItems" xlink:to="loc_us-gaapConcentrationRiskTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="loc_us-gaapConcentrationRiskByBenchmarkAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapConcentrationRiskTable" xlink:to="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaapConcentrationRiskBenchmarkDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:to="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaapConcentrationRiskBenchmarkDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:to="loc_us-gaapConcentrationRiskBenchmarkDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SalesRevenueNetMember" xlink:label="loc_us-gaapSalesRevenueNetMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_us-gaapSalesRevenueNetMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableMember" xlink:label="loc_us-gaapAccountsReceivableMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_us-gaapAccountsReceivableMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="loc_us-gaapConcentrationRiskByTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapConcentrationRiskTable" xlink:to="loc_us-gaapConcentrationRiskByTypeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaapConcentrationRiskTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapConcentrationRiskByTypeAxis" xlink:to="loc_us-gaapConcentrationRiskTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaapConcentrationRiskTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapConcentrationRiskByTypeAxis" xlink:to="loc_us-gaapConcentrationRiskTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:label="loc_us-gaapCustomerConcentrationRiskMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskTypeDomain" xlink:to="loc_us-gaapCustomerConcentrationRiskMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MajorCustomersAxis" xlink:label="loc_srtMajorCustomersAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapConcentrationRiskTable" xlink:to="loc_srtMajorCustomersAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_NameOfMajorCustomerDomain" xlink:label="loc_srtNameOfMajorCustomerDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtMajorCustomersAxis" xlink:to="loc_srtNameOfMajorCustomerDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_NameOfMajorCustomerDomain" xlink:label="loc_srtNameOfMajorCustomerDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtMajorCustomersAxis" xlink:to="loc_srtNameOfMajorCustomerDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_CustomerMember" xlink:label="loc_NTRPCustomerMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_NTRPCustomerMember_0" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaapConcentrationRiskPercentage1_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskLineItems" xlink:to="loc_us-gaapConcentrationRiskPercentage1_50" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://nexttrip.com/role/DefinedContributionPlansDetailsNarrative" xlink:title="999086 - Disclosure - Defined Contribution Plans (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nexttrip.com/role/SubsequentEventsDetailsNarrative" xlink:title="999087 - Disclosure - Subsequent Events (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_ExchangeAgreementMember" xlink:label="loc_NTRPExchangeAgreementMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_NTRPExchangeAgreementMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_SecuritiesPurchaseAgreementMember" xlink:label="loc_NTRPSecuritiesPurchaseAgreementMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_NTRPSecuritiesPurchaseAgreementMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_AssetPurchaseAgreementMember" xlink:label="loc_NTRPAssetPurchaseAgreementMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_NTRPAssetPurchaseAgreementMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_PurchaseAgreementMember" xlink:label="loc_NTRPPurchaseAgreementMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_NTRPPurchaseAgreementMember_80" xlink:type="arc" order="82" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_LineOfCreditAgreementMember" xlink:label="loc_NTRPLineOfCreditAgreementMember_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_NTRPLineOfCreditAgreementMember_170" xlink:type="arc" order="171" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtRangeAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember_50" xlink:type="arc" order="52" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember_70" xlink:type="arc" order="72" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockMember" xlink:label="loc_us-gaapPreferredStockMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapPreferredStockMember_100" xlink:type="arc" order="102" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:label="loc_srtScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="loc_srtEquityMethodInvesteeNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="loc_srtEquityMethodInvesteeNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="loc_srtEquityMethodInvesteeNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="loc_srtEquityMethodInvesteeNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_FSATravelLLCMember" xlink:label="loc_NTRPFSATravelLLCMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtEquityMethodInvesteeNameDomain" xlink:to="loc_NTRPFSATravelLLCMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_FSATravelLLCMember" xlink:label="loc_NTRPFSATravelLLCMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_NTRPFSATravelLLCMember_90" xlink:type="arc" order="91" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_SeriesOPreferredStockMember" xlink:label="loc_NTRPSeriesOPreferredStockMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_NTRPSeriesOPreferredStockMember_100" xlink:type="arc" order="103" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaapDebtInstrumentAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapDebtInstrumentAxis" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_NoteOneMember" xlink:label="loc_NTRPNoteOneMember_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_NTRPNoteOneMember_150" xlink:type="arc" order="152" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_NoteTwoMember" xlink:label="loc_NTRPNoteTwoMember_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_NTRPNoteTwoMember_160" xlink:type="arc" order="162" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_TwoPromissoryNotesMember" xlink:label="loc_NTRPTwoPromissoryNotesMember_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_NTRPTwoPromissoryNotesMember_190" xlink:type="arc" order="192" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncrementalCommonSharesAttributableToContingentlyIssuableShares" xlink:label="loc_us-gaapIncrementalCommonSharesAttributableToContingentlyIssuableShares_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncrementalCommonSharesAttributableToContingentlyIssuableShares_210" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesIssued_210" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding_210" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_210" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_CommonStockIssuedPercentage" xlink:label="loc_NTRPCommonStockIssuedPercentage_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_NTRPCommonStockIssuedPercentage_210" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesAndLoansPayableCurrent" xlink:label="loc_us-gaapNotesAndLoansPayableCurrent_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNotesAndLoansPayableCurrent_210" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaapDebtInstrumentFaceAmount_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentFaceAmount_210" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentUnamortizedDiscount" xlink:label="loc_us-gaapDebtInstrumentUnamortizedDiscount_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentUnamortizedDiscount_210" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaapDebtInstrumentInterestRateStatedPercentage_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateStatedPercentage_210" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="loc_us-gaapDebtInstrumentMaturityDate_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentMaturityDate_210" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightReasonForIssuingToNonemployees" xlink:label="loc_us-gaapClassOfWarrantOrRightReasonForIssuingToNonemployees_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightReasonForIssuingToNonemployees_210" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_210" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaapSharesIssuedPricePerShare_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesIssuedPricePerShare_210" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireBusinessesGross" xlink:label="loc_us-gaapPaymentsToAcquireBusinessesGross_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPaymentsToAcquireBusinessesGross_210" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesRestrictedStockAwardGross_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesRestrictedStockAwardGross_210" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForFees" xlink:label="loc_us-gaapPaymentsForFees_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPaymentsForFees_210" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="loc_us-gaapEquityMethodInvestmentOwnershipPercentage_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEquityMethodInvestmentOwnershipPercentage_210" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCredit" xlink:label="loc_us-gaapLineOfCredit_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLineOfCredit_210" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityExpirationDate1" xlink:label="loc_us-gaapLineOfCreditFacilityExpirationDate1_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLineOfCreditFacilityExpirationDate1_210" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityInterestRateDuringPeriod" xlink:label="loc_us-gaapLineOfCreditFacilityInterestRateDuringPeriod_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLineOfCreditFacilityInterestRateDuringPeriod_210" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityDescription" xlink:label="loc_us-gaapLineOfCreditFacilityDescription_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLineOfCreditFacilityDescription_210" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromLinesOfCredit" xlink:label="loc_us-gaapProceedsFromLinesOfCredit_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProceedsFromLinesOfCredit_210" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_CashAdvance" xlink:label="loc_NTRPCashAdvance_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_NTRPCashAdvance_210" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentCarryingAmount" xlink:label="loc_us-gaapDebtInstrumentCarryingAmount_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentCarryingAmount_210" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet" xlink:label="loc_us-gaapLineOfCreditFacilityIncreaseDecreaseForPeriodNet_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLineOfCreditFacilityIncreaseDecreaseForPeriodNet_210" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod" xlink:label="loc_us-gaapLineOfCreditFacilityMaximumAmountOutstandingDuringPeriod_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLineOfCreditFacilityMaximumAmountOutstandingDuringPeriod_210" xlink:type="arc" order="25" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/PvpExecutiveCategoriesOnly" />
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/PvpAdjustmentsOnly" />
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/IndividualsOnly" />
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/AwardTypeOnly">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockOptionMember" xlink:label="loc_us-gaapStockOptionMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapStockOptionMember" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_StockAppreciationRightsMember" xlink:label="loc_NTRPStockAppreciationRightsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_NTRPStockAppreciationRightsMember" xlink:type="arc" order="10" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/TradingArrangementsOnly" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>33
<FILENAME>ntrp-20250228_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.0c -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" xml:lang="en-US">Related and Nonrelated Parties [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonrelatedPartyMember" xlink:label="us-gaap_NonrelatedPartyMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonrelatedPartyMember" xlink:to="us-gaap_NonrelatedPartyMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NonrelatedPartyMember_lbl" xml:lang="en-US">Nonrelated Party [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyMember" xlink:label="us-gaap_RelatedPartyMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyMember" xlink:to="us-gaap_RelatedPartyMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyMember_lbl" xml:lang="en-US">Related Party [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionAxis_lbl" xml:lang="en-US">Business Acquisition [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_NextTripGroupLLCMember" xlink:label="NTRP_NextTripGroupLLCMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_NextTripGroupLLCMember" xlink:to="NTRP_NextTripGroupLLCMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_NextTripGroupLLCMember_lbl" xml:lang="en-US">NextTrip Holdings, Inc. [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xml:lang="en-US">Equity Components [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockMember" xlink:label="us-gaap_PreferredStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockMember" xlink:to="us-gaap_PreferredStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockMember_lbl" xml:lang="en-US">Preferred Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockMember_lbl" xml:lang="en-US">Common Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsMember_lbl" xml:lang="en-US">Retained Earnings [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_NextPlayTechnologiesIncMember" xlink:label="NTRP_NextPlayTechnologiesIncMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_NextPlayTechnologiesIncMember" xlink:to="NTRP_NextPlayTechnologiesIncMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_NextPlayTechnologiesIncMember_lbl" xml:lang="en-US">Next Play Technologies Inc [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_TypeOfArrangementAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TypeOfArrangementAxis_lbl" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_ShareExchangeAgreementMember" xlink:label="NTRP_ShareExchangeAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_ShareExchangeAgreementMember" xlink:to="NTRP_ShareExchangeAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_ShareExchangeAgreementMember_lbl" xml:lang="en-US">Share Exchange Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_MembershipUnitsMember" xlink:label="NTRP_MembershipUnitsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_MembershipUnitsMember" xlink:to="NTRP_MembershipUnitsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_MembershipUnitsMember_lbl" xml:lang="en-US">Membership Units [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_PreferredUnitsMember" xlink:label="NTRP_PreferredUnitsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_PreferredUnitsMember" xlink:to="NTRP_PreferredUnitsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_PreferredUnitsMember_lbl" xml:lang="en-US">Preferred Units [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:label="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_lbl" xml:lang="en-US">Investment, Name [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_NextInnovationLLCMember" xlink:label="NTRP_NextInnovationLLCMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_NextInnovationLLCMember" xlink:to="NTRP_NextInnovationLLCMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_NextInnovationLLCMember_lbl" xml:lang="en-US">Next Innovation LLC [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xml:lang="en-US">Class of Stock [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_ClosingSharesMember" xlink:label="NTRP_ClosingSharesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_ClosingSharesMember" xlink:to="NTRP_ClosingSharesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_ClosingSharesMember_lbl" xml:lang="en-US">Closing Shares [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_ContingentSharesMember" xlink:label="NTRP_ContingentSharesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_ContingentSharesMember" xlink:to="NTRP_ContingentSharesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_ContingentSharesMember_lbl" xml:lang="en-US">Contingent Shares [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RangeAxis" xlink:to="srt_RangeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_RangeAxis_lbl" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MaximumMember" xlink:to="srt_MaximumMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MaximumMember_lbl" xml:lang="en-US">Maximum [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantMember" xlink:to="us-gaap_WarrantMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WarrantMember_lbl" xml:lang="en-US">Warrant [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockOptionMember" xlink:label="us-gaap_StockOptionMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockOptionMember" xlink:to="us-gaap_StockOptionMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockOptionMember_lbl" xml:lang="en-US">Equity Option [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="us-gaap_FurnitureAndFixturesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FurnitureAndFixturesMember" xlink:to="us-gaap_FurnitureAndFixturesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FurnitureAndFixturesMember_lbl" xml:lang="en-US">Furniture and Fixtures [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComputerEquipmentMember" xlink:label="us-gaap_ComputerEquipmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComputerEquipmentMember" xlink:to="us-gaap_ComputerEquipmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ComputerEquipmentMember_lbl" xml:lang="en-US">Computer Equipment [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_SoftwareMember" xlink:label="NTRP_SoftwareMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_SoftwareMember" xlink:to="NTRP_SoftwareMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_SoftwareMember_lbl" xml:lang="en-US">Software [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MinimumMember" xlink:to="srt_MinimumMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MinimumMember_lbl" xml:lang="en-US">Minimum [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_SoftwareLicensesMember" xlink:label="NTRP_SoftwareLicensesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_SoftwareLicensesMember" xlink:to="NTRP_SoftwareLicensesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_SoftwareLicensesMember_lbl" xml:lang="en-US">Software Licenses [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_AssetPurchaseAgreementMember" xlink:label="NTRP_AssetPurchaseAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_AssetPurchaseAgreementMember" xlink:to="NTRP_AssetPurchaseAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_AssetPurchaseAgreementMember_lbl" xml:lang="en-US">Asset Purchase Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LegalEntityAxis" xlink:to="dei_LegalEntityAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LegalEntityAxis_lbl" xml:lang="en-US">Legal Entity [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_DivergentTechnologiesIncMember" xlink:label="NTRP_DivergentTechnologiesIncMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_DivergentTechnologiesIncMember" xlink:to="NTRP_DivergentTechnologiesIncMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_DivergentTechnologiesIncMember_lbl" xml:lang="en-US">Divergent Technologies, Inc. [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_MembershipPurchaseAgreementMember" xlink:label="NTRP_MembershipPurchaseAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_MembershipPurchaseAgreementMember" xlink:to="NTRP_MembershipPurchaseAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_MembershipPurchaseAgreementMember_lbl" xml:lang="en-US">Membership Purchase Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_FSATravelLLCMember" xlink:label="NTRP_FSATravelLLCMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_FSATravelLLCMember" xlink:to="NTRP_FSATravelLLCMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_FSATravelLLCMember_lbl" xml:lang="en-US">FSA Travel LLC [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_SeriesOPreferredStockMember" xlink:label="NTRP_SeriesOPreferredStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_SeriesOPreferredStockMember" xlink:to="NTRP_SeriesOPreferredStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_SeriesOPreferredStockMember_lbl" xml:lang="en-US">Series O Preferred Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_NextTripMember" xlink:label="NTRP_NextTripMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_NextTripMember" xlink:to="NTRP_NextTripMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_NextTripMember_lbl" xml:lang="en-US">Next Trip [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_BlueFyshHoldingsIncMember" xlink:label="NTRP_BlueFyshHoldingsIncMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_BlueFyshHoldingsIncMember" xlink:to="NTRP_BlueFyshHoldingsIncMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_BlueFyshHoldingsIncMember_lbl" xml:lang="en-US">Blue Fysh Holdings Inc [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_SeriesNNonvotingConvertiblePreferredStockMember" xlink:label="NTRP_SeriesNNonvotingConvertiblePreferredStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_SeriesNNonvotingConvertiblePreferredStockMember" xlink:to="NTRP_SeriesNNonvotingConvertiblePreferredStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_SeriesNNonvotingConvertiblePreferredStockMember_lbl" xml:lang="en-US">Series N Nonvoting Convertible Preferred Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_AwardTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AwardTypeAxis_lbl" xml:lang="en-US">Award Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockMember" xlink:label="us-gaap_RestrictedStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedStockMember" xlink:to="us-gaap_RestrictedStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RestrictedStockMember_lbl" xml:lang="en-US">Restricted Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SoftwareDevelopmentMember" xlink:label="us-gaap_SoftwareDevelopmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SoftwareDevelopmentMember" xlink:to="us-gaap_SoftwareDevelopmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SoftwareDevelopmentMember_lbl" xml:lang="en-US">Software Development [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_SoftwareLicenseMember" xlink:label="NTRP_SoftwareLicenseMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_SoftwareLicenseMember" xlink:to="NTRP_SoftwareLicenseMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_SoftwareLicenseMember_lbl" xml:lang="en-US">Software License [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TrademarksMember" xlink:label="us-gaap_TrademarksMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TrademarksMember" xlink:to="us-gaap_TrademarksMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TrademarksMember_lbl" xml:lang="en-US">Trademarks [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_SigmaAdditiveSolutionsIncMember" xlink:label="NTRP_SigmaAdditiveSolutionsIncMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_SigmaAdditiveSolutionsIncMember" xlink:to="NTRP_SigmaAdditiveSolutionsIncMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_SigmaAdditiveSolutionsIncMember_lbl" xml:lang="en-US">Sigma Additive Solutions Inc. [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeriesEPreferredStockMember" xlink:label="us-gaap_SeriesEPreferredStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeriesEPreferredStockMember" xlink:to="us-gaap_SeriesEPreferredStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SeriesEPreferredStockMember_lbl" xml:lang="en-US">Series E Preferred Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_NextTripHoldingsIncMember" xlink:label="NTRP_NextTripHoldingsIncMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_NextTripHoldingsIncMember" xlink:to="NTRP_NextTripHoldingsIncMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_NextTripHoldingsIncMember_lbl" xml:lang="en-US">Next Trip Holdings Inc [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_SecuritiesPurchaseAgreementMember" xlink:label="NTRP_SecuritiesPurchaseAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_SecuritiesPurchaseAgreementMember" xlink:to="NTRP_SecuritiesPurchaseAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_SecuritiesPurchaseAgreementMember_lbl" xml:lang="en-US">Securities Purchase Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_NoteSecuritiesPurchaseAgreementMember" xlink:label="NTRP_NoteSecuritiesPurchaseAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_NoteSecuritiesPurchaseAgreementMember" xlink:to="NTRP_NoteSecuritiesPurchaseAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_NoteSecuritiesPurchaseAgreementMember_lbl" xml:lang="en-US">Note Securities Purchase Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_ShortTermPromissoryNoteMember" xlink:label="NTRP_ShortTermPromissoryNoteMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_ShortTermPromissoryNoteMember" xlink:to="NTRP_ShortTermPromissoryNoteMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_ShortTermPromissoryNoteMember_lbl" xml:lang="en-US">Short Term Promissory Note [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_SeriesMNonvotingConvertiblePreferredStockMember" xlink:label="NTRP_SeriesMNonvotingConvertiblePreferredStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_SeriesMNonvotingConvertiblePreferredStockMember" xlink:to="NTRP_SeriesMNonvotingConvertiblePreferredStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_SeriesMNonvotingConvertiblePreferredStockMember_lbl" xml:lang="en-US">Series M Nonvoting Convertible Preferred Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_DebtConversionAgreementMember" xlink:label="NTRP_DebtConversionAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_DebtConversionAgreementMember" xlink:to="NTRP_DebtConversionAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_DebtConversionAgreementMember_lbl" xml:lang="en-US">Debt Conversion Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_NoteTwoSecuritiesPurchaseAgreementMember" xlink:label="NTRP_NoteTwoSecuritiesPurchaseAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_NoteTwoSecuritiesPurchaseAgreementMember" xlink:to="NTRP_NoteTwoSecuritiesPurchaseAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_NoteTwoSecuritiesPurchaseAgreementMember_lbl" xml:lang="en-US">Note Two Securities Purchase Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_OneMillionNoteMember" xlink:label="NTRP_OneMillionNoteMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_OneMillionNoteMember" xlink:to="NTRP_OneMillionNoteMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_OneMillionNoteMember_lbl" xml:lang="en-US">One Million Note [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_SeriesPNonvotingConvertiblePreferredStockMember" xlink:label="NTRP_SeriesPNonvotingConvertiblePreferredStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_SeriesPNonvotingConvertiblePreferredStockMember" xlink:to="NTRP_SeriesPNonvotingConvertiblePreferredStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_SeriesPNonvotingConvertiblePreferredStockMember_lbl" xml:lang="en-US">Series P Nonvoting Convertible Preferred Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_DebtExchangeAgreementMember" xlink:label="NTRP_DebtExchangeAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_DebtExchangeAgreementMember" xlink:to="NTRP_DebtExchangeAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_DebtExchangeAgreementMember_lbl" xml:lang="en-US">Debt Exchange Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_SpecialPurposeAcquisitionCorporationMember" xlink:label="NTRP_SpecialPurposeAcquisitionCorporationMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_SpecialPurposeAcquisitionCorporationMember" xlink:to="NTRP_SpecialPurposeAcquisitionCorporationMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_SpecialPurposeAcquisitionCorporationMember_lbl" xml:lang="en-US">Special Purpose Acquisition Corporation [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_SeveralInvestorsMember" xlink:label="NTRP_SeveralInvestorsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_SeveralInvestorsMember" xlink:to="NTRP_SeveralInvestorsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_SeveralInvestorsMember_lbl" xml:lang="en-US">Several Investors [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentAxis_lbl" xml:lang="en-US">Debt Instrument [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_ConvertibleNotesMember" xlink:label="NTRP_ConvertibleNotesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_ConvertibleNotesMember" xlink:to="NTRP_ConvertibleNotesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_ConvertibleNotesMember_lbl" xml:lang="en-US">Convertible Notes [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_DebtAssignmentAndConversionAgreementsMember" xlink:label="NTRP_DebtAssignmentAndConversionAgreementsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_DebtAssignmentAndConversionAgreementsMember" xlink:to="NTRP_DebtAssignmentAndConversionAgreementsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_DebtAssignmentAndConversionAgreementsMember_lbl" xml:lang="en-US">Debt Assignment and Conversion Agreements [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_SharePurchaseAgreementsMember" xlink:label="NTRP_SharePurchaseAgreementsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_SharePurchaseAgreementsMember" xlink:to="NTRP_SharePurchaseAgreementsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_SharePurchaseAgreementsMember_lbl" xml:lang="en-US">Share Purchase Agreements [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualAxis" xlink:label="srt_TitleOfIndividualAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_TitleOfIndividualAxis_lbl" xml:lang="en-US">Title and Position [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_SoftwareAsAServiceAgreementMember" xlink:label="NTRP_SoftwareAsAServiceAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_SoftwareAsAServiceAgreementMember" xlink:to="NTRP_SoftwareAsAServiceAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_SoftwareAsAServiceAgreementMember_lbl" xml:lang="en-US">Software as a Service Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_ThirdPartyMember" xlink:label="NTRP_ThirdPartyMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_ThirdPartyMember" xlink:to="NTRP_ThirdPartyMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_ThirdPartyMember_lbl" xml:lang="en-US">Third Party [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_ThirdPartyConsultantMember" xlink:label="NTRP_ThirdPartyConsultantMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_ThirdPartyConsultantMember" xlink:to="NTRP_ThirdPartyConsultantMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_ThirdPartyConsultantMember_lbl" xml:lang="en-US">Third Party Consultant [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_ConsultingModificationAgreementMember" xlink:label="NTRP_ConsultingModificationAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_ConsultingModificationAgreementMember" xlink:to="NTRP_ConsultingModificationAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_ConsultingModificationAgreementMember_lbl" xml:lang="en-US">Consulting Modification Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_AlumniCapitalLPMember" xlink:label="NTRP_AlumniCapitalLPMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_AlumniCapitalLPMember" xlink:to="NTRP_AlumniCapitalLPMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_AlumniCapitalLPMember_lbl" xml:lang="en-US">Alumni Capital LP [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SubsidiarySaleOfStockAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsidiarySaleOfStockAxis_lbl" xml:lang="en-US">Sale of Stock [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_AtTheMarketIssuanceSalesAgreementMember" xlink:label="NTRP_AtTheMarketIssuanceSalesAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_AtTheMarketIssuanceSalesAgreementMember" xlink:to="NTRP_AtTheMarketIssuanceSalesAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_AtTheMarketIssuanceSalesAgreementMember_lbl" xml:lang="en-US">At-The-Market Issuance Sales Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredRevenueArrangementTypeAxis" xlink:label="us-gaap_DeferredRevenueArrangementTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredRevenueArrangementTypeAxis" xlink:to="us-gaap_DeferredRevenueArrangementTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredRevenueArrangementTypeAxis_lbl" xml:lang="en-US">Deferred Revenue Arrangement Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_SharePurchaseAndExchangeAgreementsMember" xlink:label="NTRP_SharePurchaseAndExchangeAgreementsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_SharePurchaseAndExchangeAgreementsMember" xlink:to="NTRP_SharePurchaseAndExchangeAgreementsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_SharePurchaseAndExchangeAgreementsMember_lbl" xml:lang="en-US">Share Purchase And Exchange Agreements [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:label="us-gaap_RelatedPartyTransactionAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionAxis_lbl" xml:lang="en-US">Related Party Transaction [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_SeriesEConvertiblePreferredStockMember" xlink:label="NTRP_SeriesEConvertiblePreferredStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_SeriesEConvertiblePreferredStockMember" xlink:to="NTRP_SeriesEConvertiblePreferredStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_SeriesEConvertiblePreferredStockMember_lbl" xml:lang="en-US">Series E Convertible Preferred Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_SeriesFConvertiblePreferredStockMember" xlink:label="NTRP_SeriesFConvertiblePreferredStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_SeriesFConvertiblePreferredStockMember" xlink:to="NTRP_SeriesFConvertiblePreferredStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_SeriesFConvertiblePreferredStockMember_lbl" xml:lang="en-US">Series F Convertible Preferred Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_SeriesGConvertiblePreferredStockMember" xlink:label="NTRP_SeriesGConvertiblePreferredStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_SeriesGConvertiblePreferredStockMember" xlink:to="NTRP_SeriesGConvertiblePreferredStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_SeriesGConvertiblePreferredStockMember_lbl" xml:lang="en-US">Series G Convertible Preferred Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_SeriesHConvertiblePreferredStockMember" xlink:label="NTRP_SeriesHConvertiblePreferredStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_SeriesHConvertiblePreferredStockMember" xlink:to="NTRP_SeriesHConvertiblePreferredStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_SeriesHConvertiblePreferredStockMember_lbl" xml:lang="en-US">Series H Convertible Preferred Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_SeriesIConvertiblePreferredStockMember" xlink:label="NTRP_SeriesIConvertiblePreferredStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_SeriesIConvertiblePreferredStockMember" xlink:to="NTRP_SeriesIConvertiblePreferredStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_SeriesIConvertiblePreferredStockMember_lbl" xml:lang="en-US">Series I Convertible Preferred Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_SeriesIPurchaseAgreementMember" xlink:label="NTRP_SeriesIPurchaseAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_SeriesIPurchaseAgreementMember" xlink:to="NTRP_SeriesIPurchaseAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_SeriesIPurchaseAgreementMember_lbl" xml:lang="en-US">Series I Purchase Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_SeriesIPreferredStockMember" xlink:label="NTRP_SeriesIPreferredStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_SeriesIPreferredStockMember" xlink:to="NTRP_SeriesIPreferredStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_SeriesIPreferredStockMember_lbl" xml:lang="en-US">Series I Preferred Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_MillerDebtConversionAgreementMember" xlink:label="NTRP_MillerDebtConversionAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_MillerDebtConversionAgreementMember" xlink:to="NTRP_MillerDebtConversionAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_MillerDebtConversionAgreementMember_lbl" xml:lang="en-US">Miller Debt Conversion Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_SeriesJNonvotingConvertiblePreferredStockMember" xlink:label="NTRP_SeriesJNonvotingConvertiblePreferredStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_SeriesJNonvotingConvertiblePreferredStockMember" xlink:to="NTRP_SeriesJNonvotingConvertiblePreferredStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_SeriesJNonvotingConvertiblePreferredStockMember_lbl" xml:lang="en-US">Series J Nonvoting Convertible Preferred Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_SeriesKNonvotingConvertiblePreferredStockMember" xlink:label="NTRP_SeriesKNonvotingConvertiblePreferredStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_SeriesKNonvotingConvertiblePreferredStockMember" xlink:to="NTRP_SeriesKNonvotingConvertiblePreferredStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_SeriesKNonvotingConvertiblePreferredStockMember_lbl" xml:lang="en-US">Series K Nonvoting Convertible Preferred Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_SeriesLNonvotingConvertiblePreferredStockMember" xlink:label="NTRP_SeriesLNonvotingConvertiblePreferredStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_SeriesLNonvotingConvertiblePreferredStockMember" xlink:to="NTRP_SeriesLNonvotingConvertiblePreferredStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_SeriesLNonvotingConvertiblePreferredStockMember_lbl" xml:lang="en-US">Series L Nonvoting Convertible Preferred Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_MessrsKerbyAndMonacoMember" xlink:label="NTRP_MessrsKerbyAndMonacoMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_MessrsKerbyAndMonacoMember" xlink:to="NTRP_MessrsKerbyAndMonacoMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_MessrsKerbyAndMonacoMember_lbl" xml:lang="en-US">Messrs Kerby And Monaco [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_RelatedPartyDebtConversionAgreementsMember" xlink:label="NTRP_RelatedPartyDebtConversionAgreementsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_RelatedPartyDebtConversionAgreementsMember" xlink:to="NTRP_RelatedPartyDebtConversionAgreementsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_RelatedPartyDebtConversionAgreementsMember_lbl" xml:lang="en-US">Related Party Debt Conversion Agreements [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_SeriesNNonvotingConvertibleConvertiblePreferredStockMember" xlink:label="NTRP_SeriesNNonvotingConvertibleConvertiblePreferredStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_SeriesNNonvotingConvertibleConvertiblePreferredStockMember" xlink:to="NTRP_SeriesNNonvotingConvertibleConvertiblePreferredStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_SeriesNNonvotingConvertibleConvertiblePreferredStockMember_lbl" xml:lang="en-US">Series N Nonvoting Convertible Convertible Preferred Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_SeriesONonvotingConvertiblePreferredStockMember" xlink:label="NTRP_SeriesONonvotingConvertiblePreferredStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_SeriesONonvotingConvertiblePreferredStockMember" xlink:to="NTRP_SeriesONonvotingConvertiblePreferredStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_SeriesONonvotingConvertiblePreferredStockMember_lbl" xml:lang="en-US">Series O Nonvoting Convertible Preferred Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_EquityInvestmentAgreementMember" xlink:label="NTRP_EquityInvestmentAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_EquityInvestmentAgreementMember" xlink:to="NTRP_EquityInvestmentAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_EquityInvestmentAgreementMember_lbl" xml:lang="en-US">Equity Investment Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PlanNameAxis_lbl" xml:lang="en-US">Plan Name [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_TwoThousandTwentyThreeEquityIncentivePlanMember" xlink:label="NTRP_TwoThousandTwentyThreeEquityIncentivePlanMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_TwoThousandTwentyThreeEquityIncentivePlanMember" xlink:to="NTRP_TwoThousandTwentyThreeEquityIncentivePlanMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_TwoThousandTwentyThreeEquityIncentivePlanMember_lbl" xml:lang="en-US">2023 Equity Incentive Plan [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_TwoThousandThirteenEquityIncentivePlanMember" xlink:label="NTRP_TwoThousandThirteenEquityIncentivePlanMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_TwoThousandThirteenEquityIncentivePlanMember" xlink:to="NTRP_TwoThousandThirteenEquityIncentivePlanMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_TwoThousandThirteenEquityIncentivePlanMember_lbl" xml:lang="en-US">2013 Equity Incentive Plan [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_StockAppreciationRightsMember" xlink:label="NTRP_StockAppreciationRightsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_StockAppreciationRightsMember" xlink:to="NTRP_StockAppreciationRightsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_StockAppreciationRightsMember_lbl" xml:lang="en-US">Stock Appreciation Rights [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_TwoThousandAndTwentyStockAppreciationRightsPlanMember" xlink:label="NTRP_TwoThousandAndTwentyStockAppreciationRightsPlanMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_TwoThousandAndTwentyStockAppreciationRightsPlanMember" xlink:to="NTRP_TwoThousandAndTwentyStockAppreciationRightsPlanMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_TwoThousandAndTwentyStockAppreciationRightsPlanMember_lbl" xml:lang="en-US">2020 Stock Appreciation Rights Plan [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementScenarioAxis" xlink:label="srt_StatementScenarioAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_StatementScenarioAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_StatementScenarioAxis_lbl" xml:lang="en-US">Scenario [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_AchievedMember" xlink:label="NTRP_AchievedMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_AchievedMember" xlink:to="NTRP_AchievedMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_AchievedMember_lbl" xml:lang="en-US">Achieved [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeStockOptionMember" xlink:to="us-gaap_EmployeeStockOptionMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeStockOptionMember_lbl" xml:lang="en-US">Share-Based Payment Arrangement, Option [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeriesHPreferredStockMember" xlink:label="us-gaap_SeriesHPreferredStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeriesHPreferredStockMember" xlink:to="us-gaap_SeriesHPreferredStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SeriesHPreferredStockMember_lbl" xml:lang="en-US">Series H Preferred Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_SeriesJPreferredStockMember" xlink:label="NTRP_SeriesJPreferredStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_SeriesJPreferredStockMember" xlink:to="NTRP_SeriesJPreferredStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_SeriesJPreferredStockMember_lbl" xml:lang="en-US">Series J Preferred Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_SeriesKPreferredStockMember" xlink:label="NTRP_SeriesKPreferredStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_SeriesKPreferredStockMember" xlink:to="NTRP_SeriesKPreferredStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_SeriesKPreferredStockMember_lbl" xml:lang="en-US">Series K Preferred Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_SeriesLPreferredStockMember" xlink:label="NTRP_SeriesLPreferredStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_SeriesLPreferredStockMember" xlink:to="NTRP_SeriesLPreferredStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_SeriesLPreferredStockMember_lbl" xml:lang="en-US">Series L Preferred Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_SeriesMPreferredStockMember" xlink:label="NTRP_SeriesMPreferredStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_SeriesMPreferredStockMember" xlink:to="NTRP_SeriesMPreferredStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_SeriesMPreferredStockMember_lbl" xml:lang="en-US">Series M Preferred Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_SeriesNPreferredStockMember" xlink:label="NTRP_SeriesNPreferredStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_SeriesNPreferredStockMember" xlink:to="NTRP_SeriesNPreferredStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_SeriesNPreferredStockMember_lbl" xml:lang="en-US">Series N Preferred Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_SeriesOPreferredStockOneMember" xlink:label="NTRP_SeriesOPreferredStockOneMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_SeriesOPreferredStockOneMember" xlink:to="NTRP_SeriesOPreferredStockOneMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_SeriesOPreferredStockOneMember_lbl" xml:lang="en-US">Series O Preferred Stock One [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherCommitmentsAxis" xlink:label="us-gaap_OtherCommitmentsAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherCommitmentsAxis" xlink:to="us-gaap_OtherCommitmentsAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherCommitmentsAxis_lbl" xml:lang="en-US">Other Commitments [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_LeisureTravelBookingPlatformMember" xlink:label="NTRP_LeisureTravelBookingPlatformMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_LeisureTravelBookingPlatformMember" xlink:to="NTRP_LeisureTravelBookingPlatformMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_LeisureTravelBookingPlatformMember_lbl" xml:lang="en-US">Leisure Travel Booking Platform [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_GroupTravelBookingPlatformMember" xlink:label="NTRP_GroupTravelBookingPlatformMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_GroupTravelBookingPlatformMember" xlink:to="NTRP_GroupTravelBookingPlatformMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_GroupTravelBookingPlatformMember_lbl" xml:lang="en-US">Group Travel Booking Platform [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_FlexPayTechnologyMember" xlink:label="NTRP_FlexPayTechnologyMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_FlexPayTechnologyMember" xlink:to="NTRP_FlexPayTechnologyMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_FlexPayTechnologyMember_lbl" xml:lang="en-US">Flex Pay Technology [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_NotAchievedMember" xlink:label="NTRP_NotAchievedMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_NotAchievedMember" xlink:to="NTRP_NotAchievedMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_NotAchievedMember_lbl" xml:lang="en-US">Not Achieved [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_TravelAgentPlatformMember" xlink:label="NTRP_TravelAgentPlatformMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_TravelAgentPlatformMember" xlink:to="NTRP_TravelAgentPlatformMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_TravelAgentPlatformMember_lbl" xml:lang="en-US">Travel Agent Platform [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_ConcentrationRiskByBenchmarkAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis_lbl" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SalesRevenueNetMember" xlink:label="us-gaap_SalesRevenueNetMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SalesRevenueNetMember" xlink:to="us-gaap_SalesRevenueNetMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SalesRevenueNetMember_lbl" xml:lang="en-US">Revenue Benchmark [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="us-gaap_ConcentrationRiskByTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskByTypeAxis" xlink:to="us-gaap_ConcentrationRiskByTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskByTypeAxis_lbl" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:label="us-gaap_CustomerConcentrationRiskMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CustomerConcentrationRiskMember" xlink:to="us-gaap_CustomerConcentrationRiskMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CustomerConcentrationRiskMember_lbl" xml:lang="en-US">Customer Concentration Risk [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MajorCustomersAxis" xlink:label="srt_MajorCustomersAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MajorCustomersAxis" xlink:to="srt_MajorCustomersAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MajorCustomersAxis_lbl" xml:lang="en-US">Customer [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_CustomerMember" xlink:label="NTRP_CustomerMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_CustomerMember" xlink:to="NTRP_CustomerMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_CustomerMember_lbl" xml:lang="en-US">Customer [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableMember" xlink:label="us-gaap_AccountsReceivableMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableMember" xlink:to="us-gaap_AccountsReceivableMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsReceivableMember_lbl" xml:lang="en-US">Accounts Receivable [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_ExchangeAgreementMember" xlink:label="NTRP_ExchangeAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_ExchangeAgreementMember" xlink:to="NTRP_ExchangeAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_ExchangeAgreementMember_lbl" xml:lang="en-US">Exchange Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventTypeAxis_lbl" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventMember" xlink:to="us-gaap_SubsequentEventMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventMember_lbl" xml:lang="en-US">Subsequent Event [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_PurchaseAgreementMember" xlink:label="NTRP_PurchaseAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_PurchaseAgreementMember" xlink:to="NTRP_PurchaseAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_PurchaseAgreementMember_lbl" xml:lang="en-US">Purchase Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_NoteOneMember" xlink:label="NTRP_NoteOneMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_NoteOneMember" xlink:to="NTRP_NoteOneMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_NoteOneMember_lbl" xml:lang="en-US">Note One [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_NoteTwoMember" xlink:label="NTRP_NoteTwoMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_NoteTwoMember" xlink:to="NTRP_NoteTwoMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_NoteTwoMember_lbl" xml:lang="en-US">Note Two [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_LineOfCreditAgreementMember" xlink:label="NTRP_LineOfCreditAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_LineOfCreditAgreementMember" xlink:to="NTRP_LineOfCreditAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_LineOfCreditAgreementMember_lbl" xml:lang="en-US">Line of Credit Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_TwoPromissoryNotesMember" xlink:label="NTRP_TwoPromissoryNotesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_TwoPromissoryNotesMember" xlink:to="NTRP_TwoPromissoryNotesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_TwoPromissoryNotesMember_lbl" xml:lang="en-US">Two Promissory Notes [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_IcfrAuditorAttestationFlag" xlink:label="dei_IcfrAuditorAttestationFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_IcfrAuditorAttestationFlag" xlink:to="dei_IcfrAuditorAttestationFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_IcfrAuditorAttestationFlag_lbl" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFinStmtErrorCorrectionFlag" xlink:label="dei_DocumentFinStmtErrorCorrectionFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFinStmtErrorCorrectionFlag" xlink:to="dei_DocumentFinStmtErrorCorrectionFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFinStmtErrorCorrectionFlag_lbl" xml:lang="en-US">Document Financial Statement Error Correction [Flag]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorName" xlink:label="dei_AuditorName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorName" xlink:to="dei_AuditorName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditorName_lbl" xml:lang="en-US">Auditor Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorLocation" xlink:label="dei_AuditorLocation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorLocation" xlink:to="dei_AuditorLocation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditorLocation_lbl" xml:lang="en-US">Auditor Location</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorFirmId" xlink:label="dei_AuditorFirmId" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorFirmId" xlink:to="dei_AuditorFirmId_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditorFirmId_lbl" xml:lang="en-US">Auditor Firm ID</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:label="us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_lbl" xml:lang="en-US">Defined Benefit Plan [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:label="us-gaap_DefinedBenefitPlanDisclosureLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:to="us-gaap_DefinedBenefitPlanDisclosureLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DefinedBenefitPlanDisclosureLineItems_lbl" xml:lang="en-US">Defined Benefit Plan Disclosure [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsAbstract_lbl" xml:lang="en-US">ASSETS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xml:lang="en-US">Cash and cash equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_PromissoryNoteReceivableNet" xlink:label="NTRP_PromissoryNoteReceivableNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_PromissoryNoteReceivableNet" xlink:to="NTRP_PromissoryNoteReceivableNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_PromissoryNoteReceivableNet_lbl" xml:lang="en-US">Promissory note receivable, net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="us-gaap_AccountsReceivableNetCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableNetCurrent" xlink:to="us-gaap_AccountsReceivableNetCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsReceivableNetCurrent_lbl" xml:lang="en-US">Accounts receivable, net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AssetsCurrent_lbl" xml:lang="en-US">Total Current Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsNoncurrentAbstract" xlink:label="us-gaap_AssetsNoncurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsNoncurrentAbstract" xlink:to="us-gaap_AssetsNoncurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsNoncurrentAbstract_lbl" xml:lang="en-US">Non-Current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xml:lang="en-US">Property and equipment, net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl" xml:lang="en-US">Intangible assets, net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SecurityDeposit" xlink:label="us-gaap_SecurityDeposit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SecurityDeposit" xlink:to="us-gaap_SecurityDeposit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SecurityDeposit_lbl" xml:lang="en-US">Security deposit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Goodwill" xlink:label="us-gaap_Goodwill" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Goodwill" xlink:to="us-gaap_Goodwill_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Goodwill_lbl" xml:lang="en-US">Goodwill</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestments" xlink:label="us-gaap_EquityMethodInvestments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityMethodInvestments" xlink:to="us-gaap_EquityMethodInvestments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityMethodInvestments_lbl" xml:lang="en-US">Equity investments</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseOtherNoncurrent" xlink:label="us-gaap_PrepaidExpenseOtherNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseOtherNoncurrent" xlink:to="us-gaap_PrepaidExpenseOtherNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrepaidExpenseOtherNoncurrent_lbl" xml:lang="en-US">Other prepaid assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsNoncurrent" xlink:label="us-gaap_AssetsNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsNoncurrent" xlink:to="us-gaap_AssetsNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AssetsNoncurrent_lbl" xml:lang="en-US">Total Non-Current Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Assets_lbl" xml:lang="en-US">Total Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAbstract" xlink:label="us-gaap_LiabilitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAbstract" xlink:to="us-gaap_LiabilitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAbstract_lbl" xml:lang="en-US">LIABILITIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xml:lang="en-US">Current Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableCurrent" xlink:to="us-gaap_AccountsPayableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xml:lang="en-US">Accounts payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedLiabilitiesCurrent_lbl" xml:lang="en-US">Accrued expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="us-gaap_DeferredRevenueCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredRevenueCurrent" xlink:to="us-gaap_DeferredRevenueCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredRevenueCurrent_lbl" xml:lang="en-US">Deferred revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesPayableCurrent" xlink:label="us-gaap_NotesPayableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotesPayableCurrent" xlink:to="us-gaap_NotesPayableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NotesPayableCurrent_lbl" xml:lang="en-US">Notes payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xml:lang="en-US">Total Current Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Liabilities_lbl" xml:lang="en-US">Total Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingencies" xlink:to="us-gaap_CommitmentsAndContingencies_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingencies_lbl" xml:lang="en-US">Commitments and Contingencies</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xml:lang="en-US">Stockholder&#8217;s Equity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockValue" xlink:to="us-gaap_PreferredStockValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockValue_lbl" xml:lang="en-US">Preferred Stock, $0.001 par value; 10,000,000 shares authorized; 3,106,616 and 472,996 shares issued and outstanding, respectively</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockValue_lbl" xml:lang="en-US">Common Stock, par value $0.001, 250,000,000 and 1,200,000 shares authorized, 1,656,738 and 936,430 shares issued and outstanding, respectively</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="us-gaap_AdditionalPaidInCapital" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapital" xlink:to="us-gaap_AdditionalPaidInCapital_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapital_lbl" xml:lang="en-US">Additional Paid in Capital ()</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xml:lang="en-US">Accumulated deficit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_StockholdersEquity_lbl" xml:lang="en-US">Total Stockholders&#8217; Equity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xml:lang="en-US">Total Liabilities and Stockholders&#8217; Equity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:to="us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_lbl" xml:lang="en-US">Restructuring Cost [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="us-gaap_RestructuringCostAndReserveLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestructuringCostAndReserveLineItems" xlink:to="us-gaap_RestructuringCostAndReserveLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RestructuringCostAndReserveLineItems_lbl" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Preferred stock, par value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xml:lang="en-US">Preferred stock, shares authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesIssued" xlink:to="us-gaap_PreferredStockSharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xml:lang="en-US">Preferred stock, shares issued</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesOutstanding" xlink:to="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xml:lang="en-US">Preferred stock, shares outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Common stock, par shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xml:lang="en-US">Common stock, shares authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xml:lang="en-US">Common stock, shares issued</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xml:lang="en-US">Common stock, shares outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:label="us-gaap_StockIssuedDuringPeriodSharesAcquisitions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:to="us-gaap_StockIssuedDuringPeriodSharesAcquisitions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesAcquisitions_lbl" xml:lang="en-US">Number of shares acquired</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_PercentageForIssuedAndOutstandingCapitalStock" xlink:label="NTRP_PercentageForIssuedAndOutstandingCapitalStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_PercentageForIssuedAndOutstandingCapitalStock" xlink:to="NTRP_PercentageForIssuedAndOutstandingCapitalStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_PercentageForIssuedAndOutstandingCapitalStock_lbl" xml:lang="en-US">Percentage for issued and outstanding capital stock</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeStatementAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementAbstract_lbl" xml:lang="en-US">Income Statement [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl" xml:lang="en-US">Revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfRevenue" xlink:label="us-gaap_CostOfRevenue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfRevenue" xlink:to="us-gaap_CostOfRevenue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_CostOfRevenue_lbl" xml:lang="en-US">Cost of revenue (exclusive of depreciation and amortization, shown separately below)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GrossProfit" xlink:label="us-gaap_GrossProfit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GrossProfit" xlink:to="us-gaap_GrossProfit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_GrossProfit_lbl" xml:lang="en-US">Gross profit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="us-gaap_OperatingExpensesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpensesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingExpensesAbstract_lbl" xml:lang="en-US">Operating Expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LaborAndRelatedExpense" xlink:label="us-gaap_LaborAndRelatedExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LaborAndRelatedExpense" xlink:to="us-gaap_LaborAndRelatedExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LaborAndRelatedExpense_lbl" xml:lang="en-US">Salaries and benefits</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensation_lbl" xml:lang="en-US">Stock based compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpense" xlink:to="us-gaap_GeneralAndAdministrativeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl" xml:lang="en-US">General and administrative</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingAndMarketingExpense" xlink:label="us-gaap_SellingAndMarketingExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SellingAndMarketingExpense" xlink:to="us-gaap_SellingAndMarketingExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SellingAndMarketingExpense_lbl" xml:lang="en-US">Sales and marketing</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfessionalFees" xlink:label="us-gaap_ProfessionalFees" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfessionalFees" xlink:to="us-gaap_ProfessionalFees_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProfessionalFees_lbl" xml:lang="en-US">Professional Service Fees</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_Technology" xlink:label="NTRP_Technology" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_Technology" xlink:to="NTRP_Technology_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_Technology_lbl" xml:lang="en-US">Technology</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_OrganizationCosts" xlink:label="NTRP_OrganizationCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_OrganizationCosts" xlink:to="NTRP_OrganizationCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_OrganizationCosts_lbl" xml:lang="en-US">Organization Costs</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="us-gaap_DepreciationDepletionAndAmortization" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepreciationDepletionAndAmortization" xlink:to="us-gaap_DepreciationDepletionAndAmortization_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DepreciationDepletionAndAmortization_lbl" xml:lang="en-US">Depreciation and amortization</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherExpenses" xlink:label="us-gaap_OtherExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherExpenses" xlink:to="us-gaap_OtherExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherExpenses_lbl" xml:lang="en-US">Other expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingExpenses_lbl" xml:lang="en-US">Total Operating Expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xml:lang="en-US">Operating loss</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_NonoperatingIncomeExpenseAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract_lbl" xml:lang="en-US">Other Income/(Expenses)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossOnDispositionOfAssets1" xlink:label="us-gaap_GainLossOnDispositionOfAssets1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnDispositionOfAssets1" xlink:to="us-gaap_GainLossOnDispositionOfAssets1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GainLossOnDispositionOfAssets1_lbl" xml:lang="en-US">Loss on disposal of assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="us-gaap_GainsLossesOnExtinguishmentOfDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt_lbl" xml:lang="en-US">Gain (Loss) on extinguishment of liability</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_LossOnRelatedPartyReceivable" xlink:label="NTRP_LossOnRelatedPartyReceivable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_LossOnRelatedPartyReceivable" xlink:to="NTRP_LossOnRelatedPartyReceivable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="NTRP_LossOnRelatedPartyReceivable_lbl" xml:lang="en-US">Loss on promissory note receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:label="us-gaap_InterestIncomeExpenseNonoperatingNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:to="us-gaap_InterestIncomeExpenseNonoperatingNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestIncomeExpenseNonoperatingNet_lbl" xml:lang="en-US">Interest income (expense), net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="us-gaap_OtherNonoperatingIncomeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNonoperatingIncomeExpense" xlink:to="us-gaap_OtherNonoperatingIncomeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherNonoperatingIncomeExpense_lbl" xml:lang="en-US">Other Income (expense)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="us-gaap_NonoperatingIncomeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_NonoperatingIncomeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NonoperatingIncomeExpense_lbl" xml:lang="en-US">Total other income (expense)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xml:lang="en-US">Net loss from continuing operations before taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Provision for income taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestment" xlink:label="NTRP_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestment" xlink:to="NTRP_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="NTRP_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestment_lbl" xml:lang="en-US">Net loss from continuing operations before share of net income (loss) in equity method investee</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromEquityMethodInvestments" xlink:label="us-gaap_IncomeLossFromEquityMethodInvestments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromEquityMethodInvestments" xlink:to="us-gaap_IncomeLossFromEquityMethodInvestments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromEquityMethodInvestments_lbl" xml:lang="en-US">Share of net loss of equity method investee</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_lbl" xml:lang="en-US">Net loss from continuing operations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:label="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:to="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_lbl" xml:lang="en-US">Net income (loss) from discontinued operations, net of taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetIncomeLoss_lbl" xml:lang="en-US">Net loss</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockDividendsIncomeStatementImpact" xlink:label="us-gaap_PreferredStockDividendsIncomeStatementImpact" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockDividendsIncomeStatementImpact" xlink:to="us-gaap_PreferredStockDividendsIncomeStatementImpact_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PreferredStockDividendsIncomeStatementImpact_lbl" xml:lang="en-US">Preferred Dividends</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl" xml:lang="en-US">Net Loss Applicable to Common Stockholders</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:label="us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:to="us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_lbl" xml:lang="en-US">Basic loss per common share from continuing operations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:label="us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:to="us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_lbl" xml:lang="en-US">Diluted loss per common share from continuing operations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:label="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:to="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_lbl" xml:lang="en-US">Basic loss per common share from discontinued operations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" xlink:label="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" xlink:to="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_lbl" xml:lang="en-US">Diluted loss per common share from discontinued operations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasic" xlink:label="us-gaap_EarningsPerShareBasic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasic" xlink:to="us-gaap_EarningsPerShareBasic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareBasic_lbl" xml:lang="en-US">Loss per common share basic</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="us-gaap_EarningsPerShareDiluted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareDiluted" xlink:to="us-gaap_EarningsPerShareDiluted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareDiluted_lbl" xml:lang="en-US">Loss per common share diluted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xml:lang="en-US">Weighted average number of shares outstanding basic</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xml:lang="en-US">Weighted nverage number of shares outstanding diluted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US">Statement [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_StockholdersEquity_2_lbl" xml:lang="en-US">Beginning balance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesOutstanding" xlink:label="us-gaap_SharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_SharesOutstanding_lbl" xml:lang="en-US">Beginning balance, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_StockIssuedDuringPeriodValueOfPreferredShares" xlink:label="NTRP_StockIssuedDuringPeriodValueOfPreferredShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_StockIssuedDuringPeriodValueOfPreferredShares" xlink:to="NTRP_StockIssuedDuringPeriodValueOfPreferredShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_StockIssuedDuringPeriodValueOfPreferredShares_lbl" xml:lang="en-US">Issuance of Preferred Shares</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_StockIssuedDuringPeriodShareOfPreferredShares" xlink:label="NTRP_StockIssuedDuringPeriodShareOfPreferredShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_StockIssuedDuringPeriodShareOfPreferredShares" xlink:to="NTRP_StockIssuedDuringPeriodShareOfPreferredShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_StockIssuedDuringPeriodShareOfPreferredShares_lbl" xml:lang="en-US">Issuance of Preferred Shares, Shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:to="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_lbl" xml:lang="en-US">Conversion of Convertible Notes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_lbl" xml:lang="en-US">Conversion of Convertible Notes, Shares</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_StockIssuedDuringPeriodValuePurchasesOfCommonShares" xlink:label="NTRP_StockIssuedDuringPeriodValuePurchasesOfCommonShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_StockIssuedDuringPeriodValuePurchasesOfCommonShares" xlink:to="NTRP_StockIssuedDuringPeriodValuePurchasesOfCommonShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_StockIssuedDuringPeriodValuePurchasesOfCommonShares_lbl" xml:lang="en-US">Purchases of Common Shares</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_StockIssuedDuringPeriodSharesPurchasesOfCommonShares" xlink:label="NTRP_StockIssuedDuringPeriodSharesPurchasesOfCommonShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_StockIssuedDuringPeriodSharesPurchasesOfCommonShares" xlink:to="NTRP_StockIssuedDuringPeriodSharesPurchasesOfCommonShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_StockIssuedDuringPeriodSharesPurchasesOfCommonShares_lbl" xml:lang="en-US">Purchases of Common Shares, Sharers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:label="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:to="us-gaap_StockIssuedDuringPeriodValueIssuedForServices_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueIssuedForServices_lbl" xml:lang="en-US">Issuance of Common Shares for Services</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:to="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl" xml:lang="en-US">Issuance of Common Shares for Services, Shares</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_StockIssuedDuringPeriodValueReverseAcquisition" xlink:label="NTRP_StockIssuedDuringPeriodValueReverseAcquisition" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_StockIssuedDuringPeriodValueReverseAcquisition" xlink:to="NTRP_StockIssuedDuringPeriodValueReverseAcquisition_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_StockIssuedDuringPeriodValueReverseAcquisition_lbl" xml:lang="en-US">Reverse Acquisition of Sigma Additive Solutions, Inc.</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_StockIssuedDuringPeriodSharesReverseAcquisition" xlink:label="NTRP_StockIssuedDuringPeriodSharesReverseAcquisition" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_StockIssuedDuringPeriodSharesReverseAcquisition" xlink:to="NTRP_StockIssuedDuringPeriodSharesReverseAcquisition_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_StockIssuedDuringPeriodSharesReverseAcquisition_lbl" xml:lang="en-US">Reverse Acquisition of Sigma Additive Solutions, Inc., Shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" xml:lang="en-US">Stock Compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DividendsPreferredStock" xlink:label="us-gaap_DividendsPreferredStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DividendsPreferredStock" xlink:to="us-gaap_DividendsPreferredStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DividendsPreferredStock_lbl" xml:lang="en-US">Preferred Stock Dividends</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLoss_2_lbl" xml:lang="en-US">Net Loss</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_StockIssuedDuringPeriodValueOfPreferredSharesInPrivatePlacements" xlink:label="NTRP_StockIssuedDuringPeriodValueOfPreferredSharesInPrivatePlacements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_StockIssuedDuringPeriodValueOfPreferredSharesInPrivatePlacements" xlink:to="NTRP_StockIssuedDuringPeriodValueOfPreferredSharesInPrivatePlacements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_StockIssuedDuringPeriodValueOfPreferredSharesInPrivatePlacements_lbl" xml:lang="en-US">Issuance of Preferred Shares in Private Placements</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_StockIssuedDuringPeriodSharesOfPreferredSharesInPrivatePlacements" xlink:label="NTRP_StockIssuedDuringPeriodSharesOfPreferredSharesInPrivatePlacements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_StockIssuedDuringPeriodSharesOfPreferredSharesInPrivatePlacements" xlink:to="NTRP_StockIssuedDuringPeriodSharesOfPreferredSharesInPrivatePlacements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_StockIssuedDuringPeriodSharesOfPreferredSharesInPrivatePlacements_lbl" xml:lang="en-US">Issuance of Preferred Shares in Private Placements, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_StockIssuedDuringPeriodValueConversionOfPreferredSharesToCommonShares" xlink:label="NTRP_StockIssuedDuringPeriodValueConversionOfPreferredSharesToCommonShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_StockIssuedDuringPeriodValueConversionOfPreferredSharesToCommonShares" xlink:to="NTRP_StockIssuedDuringPeriodValueConversionOfPreferredSharesToCommonShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_StockIssuedDuringPeriodValueConversionOfPreferredSharesToCommonShares_lbl" xml:lang="en-US">Conversion of Preferred Shares to Common Shares</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_StockIssuedDuringPeriodSharesConversionOfPreferredSharesToCommonShares" xlink:label="NTRP_StockIssuedDuringPeriodSharesConversionOfPreferredSharesToCommonShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_StockIssuedDuringPeriodSharesConversionOfPreferredSharesToCommonShares" xlink:to="NTRP_StockIssuedDuringPeriodSharesConversionOfPreferredSharesToCommonShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_StockIssuedDuringPeriodSharesConversionOfPreferredSharesToCommonShares_lbl" xml:lang="en-US">Conversion of Preferred Shares to Common Shares, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_StockIssuedDuringPeriodValueIssuanceOfPreferredSharesForDebtConversions" xlink:label="NTRP_StockIssuedDuringPeriodValueIssuanceOfPreferredSharesForDebtConversions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_StockIssuedDuringPeriodValueIssuanceOfPreferredSharesForDebtConversions" xlink:to="NTRP_StockIssuedDuringPeriodValueIssuanceOfPreferredSharesForDebtConversions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_StockIssuedDuringPeriodValueIssuanceOfPreferredSharesForDebtConversions_lbl" xml:lang="en-US">Issuance of Preferred Shares for Debt Conversions</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_StockIssuedDuringPeriodSharesIssuanceOfPreferredSharesForDebtConversions" xlink:label="NTRP_StockIssuedDuringPeriodSharesIssuanceOfPreferredSharesForDebtConversions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_StockIssuedDuringPeriodSharesIssuanceOfPreferredSharesForDebtConversions" xlink:to="NTRP_StockIssuedDuringPeriodSharesIssuanceOfPreferredSharesForDebtConversions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_StockIssuedDuringPeriodSharesIssuanceOfPreferredSharesForDebtConversions_lbl" xml:lang="en-US">Issuance of Preferred Shares for Debt Conversions, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_StockIssuedDuringPeriodValueIssuanceOfSecuritiesForServices" xlink:label="NTRP_StockIssuedDuringPeriodValueIssuanceOfSecuritiesForServices" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_StockIssuedDuringPeriodValueIssuanceOfSecuritiesForServices" xlink:to="NTRP_StockIssuedDuringPeriodValueIssuanceOfSecuritiesForServices_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_StockIssuedDuringPeriodValueIssuanceOfSecuritiesForServices_lbl" xml:lang="en-US">Issuance of Securities for Services</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_StockIssuedDuringPeriodSharesIssuanceOfSecuritiesForServices" xlink:label="NTRP_StockIssuedDuringPeriodSharesIssuanceOfSecuritiesForServices" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_StockIssuedDuringPeriodSharesIssuanceOfSecuritiesForServices" xlink:to="NTRP_StockIssuedDuringPeriodSharesIssuanceOfSecuritiesForServices_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_StockIssuedDuringPeriodSharesIssuanceOfSecuritiesForServices_lbl" xml:lang="en-US">Issuance of Securities for Services, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_StockIssuedDuringPeriodValueSecuritiesIssuedForEquityInvestments" xlink:label="NTRP_StockIssuedDuringPeriodValueSecuritiesIssuedForEquityInvestments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_StockIssuedDuringPeriodValueSecuritiesIssuedForEquityInvestments" xlink:to="NTRP_StockIssuedDuringPeriodValueSecuritiesIssuedForEquityInvestments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_StockIssuedDuringPeriodValueSecuritiesIssuedForEquityInvestments_lbl" xml:lang="en-US">Securities Issued for Equity Investments</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_StockIssuedDuringPeriodSharseSecuritiesIssuedForEquityInvestments" xlink:label="NTRP_StockIssuedDuringPeriodSharseSecuritiesIssuedForEquityInvestments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_StockIssuedDuringPeriodSharseSecuritiesIssuedForEquityInvestments" xlink:to="NTRP_StockIssuedDuringPeriodSharseSecuritiesIssuedForEquityInvestments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_StockIssuedDuringPeriodSharseSecuritiesIssuedForEquityInvestments_lbl" xml:lang="en-US">Securities Issued for Equity Investments, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_StockIssuedDuringPeriodValueIssuanceOfCommitmentSharesForEquityLineOfCredit" xlink:label="NTRP_StockIssuedDuringPeriodValueIssuanceOfCommitmentSharesForEquityLineOfCredit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_StockIssuedDuringPeriodValueIssuanceOfCommitmentSharesForEquityLineOfCredit" xlink:to="NTRP_StockIssuedDuringPeriodValueIssuanceOfCommitmentSharesForEquityLineOfCredit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_StockIssuedDuringPeriodValueIssuanceOfCommitmentSharesForEquityLineOfCredit_lbl" xml:lang="en-US">Issuance of Commitment Shares for Equity Line of Credit</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_StockIssuedDuringPeriodSharesIssuanceOfCommitmentSharesForEquityLineOfCredit" xlink:label="NTRP_StockIssuedDuringPeriodSharesIssuanceOfCommitmentSharesForEquityLineOfCredit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_StockIssuedDuringPeriodSharesIssuanceOfCommitmentSharesForEquityLineOfCredit" xlink:to="NTRP_StockIssuedDuringPeriodSharesIssuanceOfCommitmentSharesForEquityLineOfCredit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_StockIssuedDuringPeriodSharesIssuanceOfCommitmentSharesForEquityLineOfCredit_lbl" xml:lang="en-US">Issuance of Commitment Shares for Equity Line of Credit, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl" xml:lang="en-US">Issuance of Common Shares for Warrant Exercises</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xml:lang="en-US">Issuance of Common Shares for Warrant Exercises, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:label="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:to="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_lbl" xml:lang="en-US">Stock Compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:label="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:to="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_lbl" xml:lang="en-US">Stock Compensation, shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_StockholdersEquity_3_lbl" xml:lang="en-US">Ending balance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_SharesOutstanding_2_lbl" xml:lang="en-US">Ending balance, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Cash Flows from Operating Activities:</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_2_lbl" xml:lang="en-US">Net Loss from continuing operations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Adjustments to reconcile net loss to net cash used in operating activities:</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepreciationDepletionAndAmortization" xlink:to="us-gaap_DepreciationDepletionAndAmortization_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DepreciationDepletionAndAmortization_2_lbl" xml:lang="en-US">Depreciation and amortization &#8211; property and equipment and intangibles</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfDebtDiscountPremium" xlink:label="us-gaap_AmortizationOfDebtDiscountPremium" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfDebtDiscountPremium" xlink:to="us-gaap_AmortizationOfDebtDiscountPremium_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AmortizationOfDebtDiscountPremium_lbl" xml:lang="en-US">Amortization of Debt Discount</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_AmortizationOfPrepaidExpenses" xlink:label="NTRP_AmortizationOfPrepaidExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_AmortizationOfPrepaidExpenses" xlink:to="NTRP_AmortizationOfPrepaidExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_AmortizationOfPrepaidExpenses_lbl" xml:lang="en-US">Amortization of prepaid expenses</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_LossOnRelatedPartyReceivable" xlink:to="NTRP_LossOnRelatedPartyReceivable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_LossOnRelatedPartyReceivable_2_lbl" xml:lang="en-US">Loss on promissory note receivable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="us-gaap_GainsLossesOnExtinguishmentOfDebt_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt_2_lbl" xml:lang="en-US">(Gain) loss on extinguishment of liability</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_LossOnDispositionOfAssets" xlink:label="NTRP_LossOnDispositionOfAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_LossOnDispositionOfAssets" xlink:to="NTRP_LossOnDispositionOfAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="NTRP_LossOnDispositionOfAssets_lbl" xml:lang="en-US">Loss on disposal of assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromEquityMethodInvestments" xlink:to="us-gaap_IncomeLossFromEquityMethodInvestments_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncomeLossFromEquityMethodInvestments_2_lbl" xml:lang="en-US">Loss on share of net income in equity method investee</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xml:lang="en-US">Changes in operating assets and liabilities:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xml:lang="en-US">Accounts receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:to="us-gaap_IncreaseDecreaseInPrepaidExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpense_lbl" xml:lang="en-US">Prepaid expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInSecurityDeposits" xlink:label="us-gaap_IncreaseDecreaseInSecurityDeposits" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInSecurityDeposits" xlink:to="us-gaap_IncreaseDecreaseInSecurityDeposits_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInSecurityDeposits_lbl" xml:lang="en-US">Security deposit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl" xml:lang="en-US">Accounts payable and accrued expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:label="us-gaap_IncreaseDecreaseInDeferredRevenue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:to="us-gaap_IncreaseDecreaseInDeferredRevenue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInDeferredRevenue_lbl" xml:lang="en-US">Deferred revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_lbl" xml:lang="en-US">Net cash used in operating activities from continuing operations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations" xlink:label="us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations" xlink:to="us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations_lbl" xml:lang="en-US">Net cash provided (used) in operating activities from discontinued operations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xml:lang="en-US">Net cash used in operating activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xml:lang="en-US">Cash Flows from Investing activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xml:lang="en-US">Purchase of equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForSoftware" xlink:label="us-gaap_PaymentsForSoftware" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForSoftware" xlink:to="us-gaap_PaymentsForSoftware_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsForSoftware_lbl" xml:lang="en-US">Capitalized software development costs</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromSaleOfProductiveAssets" xlink:label="us-gaap_ProceedsFromSaleOfProductiveAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromSaleOfProductiveAssets" xlink:to="us-gaap_ProceedsFromSaleOfProductiveAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromSaleOfProductiveAssets_lbl" xml:lang="en-US">Sale of Sigma Additive Solutions, Inc. assets</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_InvestmentInEquityMethodInvestee" xlink:label="NTRP_InvestmentInEquityMethodInvestee" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_InvestmentInEquityMethodInvestee" xlink:to="NTRP_InvestmentInEquityMethodInvestee_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="NTRP_InvestmentInEquityMethodInvestee_lbl" xml:lang="en-US">Investment in equity method investee</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_ProceedsFromAcquireBusinessesGross" xlink:label="NTRP_ProceedsFromAcquireBusinessesGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_ProceedsFromAcquireBusinessesGross" xlink:to="NTRP_ProceedsFromAcquireBusinessesGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="NTRP_ProceedsFromAcquireBusinessesGross_lbl" xml:lang="en-US">Reverse acquisition of Sigma Additive Solutions, Inc.</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromSaleOfOtherProductiveAssets" xlink:label="us-gaap_ProceedsFromSaleOfOtherProductiveAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromSaleOfOtherProductiveAssets" xlink:to="us-gaap_ProceedsFromSaleOfOtherProductiveAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromSaleOfOtherProductiveAssets_lbl" xml:lang="en-US">Sale of assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xml:lang="en-US">Net cash provided (used) in investing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xml:lang="en-US">Cash Flows from Financing Activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromNotesPayable" xlink:label="us-gaap_ProceedsFromNotesPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromNotesPayable" xlink:to="us-gaap_ProceedsFromNotesPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ProceedsFromNotesPayable_lbl" xml:lang="en-US">Notes payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromConvertibleDebt" xlink:label="us-gaap_ProceedsFromConvertibleDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromConvertibleDebt" xlink:to="us-gaap_ProceedsFromConvertibleDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromConvertibleDebt_lbl" xml:lang="en-US">Issuance of convertible notes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xml:lang="en-US">Issuances of common shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" xlink:label="us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" xlink:to="us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock_lbl" xml:lang="en-US">Issuances of preferred shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfWarrants" xlink:label="us-gaap_ProceedsFromIssuanceOfWarrants" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfWarrants" xlink:to="us-gaap_ProceedsFromIssuanceOfWarrants_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfWarrants_lbl" xml:lang="en-US">Exercise of warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromRelatedPartyDebt" xlink:label="us-gaap_ProceedsFromRelatedPartyDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromRelatedPartyDebt" xlink:to="us-gaap_ProceedsFromRelatedPartyDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromRelatedPartyDebt_lbl" xml:lang="en-US">Advances from related party, net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xml:lang="en-US">Net cash provided by financing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xml:lang="en-US">Increase in cash</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl" xml:lang="en-US">Cash - beginning of the period</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_2_lbl" xml:lang="en-US">Cash - end of the period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xml:lang="en-US">Supplemental cash flow information</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestPaidNet" xlink:label="us-gaap_InterestPaidNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPaidNet" xlink:to="us-gaap_InterestPaidNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestPaidNet_lbl" xml:lang="en-US">Cash paid for interest</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxesPaidNet" xlink:label="us-gaap_IncomeTaxesPaidNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxesPaidNet" xlink:to="us-gaap_IncomeTaxesPaidNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxesPaidNet_lbl" xml:lang="en-US">Cash paid for taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl" xml:lang="en-US">Non-Cash Financing Transactions</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_IssuanceOfPreferredSharesForServices" xlink:label="NTRP_IssuanceOfPreferredSharesForServices" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_IssuanceOfPreferredSharesForServices" xlink:to="NTRP_IssuanceOfPreferredSharesForServices_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_IssuanceOfPreferredSharesForServices_lbl" xml:lang="en-US">Issuance of preferred shares for services</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_IssuanceOfCommonSharesForServices" xlink:label="NTRP_IssuanceOfCommonSharesForServices" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_IssuanceOfCommonSharesForServices" xlink:to="NTRP_IssuanceOfCommonSharesForServices_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_IssuanceOfCommonSharesForServices_lbl" xml:lang="en-US">Issuance of common shares for services</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_IssuanceOfCommonSharesAsCommitmentShares" xlink:label="NTRP_IssuanceOfCommonSharesAsCommitmentShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_IssuanceOfCommonSharesAsCommitmentShares" xlink:to="NTRP_IssuanceOfCommonSharesAsCommitmentShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_IssuanceOfCommonSharesAsCommitmentShares_lbl" xml:lang="en-US">Issuance of common shares as commitment shares</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_IssuanceOfCommonWarrantsForServices" xlink:label="NTRP_IssuanceOfCommonWarrantsForServices" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_IssuanceOfCommonWarrantsForServices" xlink:to="NTRP_IssuanceOfCommonWarrantsForServices_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_IssuanceOfCommonWarrantsForServices_lbl" xml:lang="en-US">Issuance of common warrants for services</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_IssuanceOfCommonSharesForEquityInvestments" xlink:label="NTRP_IssuanceOfCommonSharesForEquityInvestments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_IssuanceOfCommonSharesForEquityInvestments" xlink:to="NTRP_IssuanceOfCommonSharesForEquityInvestments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_IssuanceOfCommonSharesForEquityInvestments_lbl" xml:lang="en-US">Issuance of common shares for equity investments</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_IssuanceOfPreferredSharesForEquityInvestments" xlink:label="NTRP_IssuanceOfPreferredSharesForEquityInvestments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_IssuanceOfPreferredSharesForEquityInvestments" xlink:to="NTRP_IssuanceOfPreferredSharesForEquityInvestments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_IssuanceOfPreferredSharesForEquityInvestments_lbl" xml:lang="en-US">Issuance of preferred shares for equity investments</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_IssuanceOfPreferredSharesForPerpetualSoftwareLicense" xlink:label="NTRP_IssuanceOfPreferredSharesForPerpetualSoftwareLicense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_IssuanceOfPreferredSharesForPerpetualSoftwareLicense" xlink:to="NTRP_IssuanceOfPreferredSharesForPerpetualSoftwareLicense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_IssuanceOfPreferredSharesForPerpetualSoftwareLicense_lbl" xml:lang="en-US">Issuance of preferred shares for perpetual software license</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_ConversionOfConvertibleNotes" xlink:label="NTRP_ConversionOfConvertibleNotes" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_ConversionOfConvertibleNotes" xlink:to="NTRP_ConversionOfConvertibleNotes_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_ConversionOfConvertibleNotes_lbl" xml:lang="en-US">Conversion of convertible notes</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_PreferredStockDividends" xlink:label="NTRP_PreferredStockDividends" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_PreferredStockDividends" xlink:to="NTRP_PreferredStockDividends_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_PreferredStockDividends_lbl" xml:lang="en-US">Preferred stock dividends</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PvpTable" xlink:label="ecd_PvpTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PvpTable" xlink:to="ecd_PvpTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PvpTable_lbl" xml:lang="en-US">Pay vs Performance Disclosure [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ExecutiveCategoryAxis" xlink:label="ecd_ExecutiveCategoryAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ExecutiveCategoryAxis" xlink:to="ecd_ExecutiveCategoryAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ExecutiveCategoryAxis_lbl" xml:lang="en-US">Executive Category [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_IndividualAxis" xlink:label="ecd_IndividualAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_IndividualAxis" xlink:to="ecd_IndividualAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_IndividualAxis_lbl" xml:lang="en-US">Individual [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToCompAxis" xlink:label="ecd_AdjToCompAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AdjToCompAxis" xlink:to="ecd_AdjToCompAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AdjToCompAxis_lbl" xml:lang="en-US">Adjustment to Compensation [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MeasureAxis" xlink:label="ecd_MeasureAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_MeasureAxis" xlink:to="ecd_MeasureAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_MeasureAxis_lbl" xml:lang="en-US">Measure [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PvpTableTextBlock" xlink:label="ecd_PvpTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PvpTableTextBlock" xlink:to="ecd_PvpTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PvpTableTextBlock_lbl" xml:lang="en-US">Pay vs Performance Disclosure, Table</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CoSelectedMeasureName" xlink:label="ecd_CoSelectedMeasureName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_CoSelectedMeasureName" xlink:to="ecd_CoSelectedMeasureName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_CoSelectedMeasureName_lbl" xml:lang="en-US">Company Selected Measure Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NamedExecutiveOfficersFnTextBlock" xlink:label="ecd_NamedExecutiveOfficersFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_NamedExecutiveOfficersFnTextBlock" xlink:to="ecd_NamedExecutiveOfficersFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_NamedExecutiveOfficersFnTextBlock_lbl" xml:lang="en-US">Named Executive Officers, Footnote</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeerGroupIssuersFnTextBlock" xlink:label="ecd_PeerGroupIssuersFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PeerGroupIssuersFnTextBlock" xlink:to="ecd_PeerGroupIssuersFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PeerGroupIssuersFnTextBlock_lbl" xml:lang="en-US">Peer Group Issuers, Footnote</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ChangedPeerGroupFnTextBlock" xlink:label="ecd_ChangedPeerGroupFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ChangedPeerGroupFnTextBlock" xlink:to="ecd_ChangedPeerGroupFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ChangedPeerGroupFnTextBlock_lbl" xml:lang="en-US">Changed Peer Group, Footnote</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoTotalCompAmt" xlink:label="ecd_PeoTotalCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PeoTotalCompAmt" xlink:to="ecd_PeoTotalCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PeoTotalCompAmt_lbl" xml:lang="en-US">PEO Total Compensation Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoActuallyPaidCompAmt" xlink:label="ecd_PeoActuallyPaidCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PeoActuallyPaidCompAmt" xlink:to="ecd_PeoActuallyPaidCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PeoActuallyPaidCompAmt_lbl" xml:lang="en-US">PEO Actually Paid Compensation Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToPeoCompFnTextBlock" xlink:label="ecd_AdjToPeoCompFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AdjToPeoCompFnTextBlock" xlink:to="ecd_AdjToPeoCompFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AdjToPeoCompFnTextBlock_lbl" xml:lang="en-US">Adjustment To PEO Compensation, Footnote</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonPeoNeoAvgTotalCompAmt" xlink:label="ecd_NonPeoNeoAvgTotalCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_NonPeoNeoAvgTotalCompAmt" xlink:to="ecd_NonPeoNeoAvgTotalCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_NonPeoNeoAvgTotalCompAmt_lbl" xml:lang="en-US">Non-PEO NEO Average Total Compensation Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:label="ecd_NonPeoNeoAvgCompActuallyPaidAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:to="ecd_NonPeoNeoAvgCompActuallyPaidAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_NonPeoNeoAvgCompActuallyPaidAmt_lbl" xml:lang="en-US">Non-PEO NEO Average Compensation Actually Paid Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:label="ecd_AdjToNonPeoNeoCompFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:to="ecd_AdjToNonPeoNeoCompFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AdjToNonPeoNeoCompFnTextBlock_lbl" xml:lang="en-US">Adjustment to Non-PEO NEO Compensation Footnote</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:label="ecd_EquityValuationAssumptionDifferenceFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:to="ecd_EquityValuationAssumptionDifferenceFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_EquityValuationAssumptionDifferenceFnTextBlock_lbl" xml:lang="en-US">Equity Valuation Assumption Difference, Footnote</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:label="ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:to="ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock_lbl" xml:lang="en-US">Compensation Actually Paid vs. Total Shareholder Return</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:label="ecd_CompActuallyPaidVsNetIncomeTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:to="ecd_CompActuallyPaidVsNetIncomeTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_CompActuallyPaidVsNetIncomeTextBlock_lbl" xml:lang="en-US">Compensation Actually Paid vs. Net Income</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:label="ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:to="ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock_lbl" xml:lang="en-US">Compensation Actually Paid vs. Company Selected Measure</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:label="ecd_TotalShareholderRtnVsPeerGroupTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:to="ecd_TotalShareholderRtnVsPeerGroupTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TotalShareholderRtnVsPeerGroupTextBlock_lbl" xml:lang="en-US">Total Shareholder Return Vs Peer Group</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:label="ecd_CompActuallyPaidVsOtherMeasureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:to="ecd_CompActuallyPaidVsOtherMeasureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_CompActuallyPaidVsOtherMeasureTextBlock_lbl" xml:lang="en-US">Compensation Actually Paid vs. Other Measure</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TabularListTableTextBlock" xlink:label="ecd_TabularListTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TabularListTableTextBlock" xlink:to="ecd_TabularListTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TabularListTableTextBlock_lbl" xml:lang="en-US">Tabular List, Table</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TotalShareholderRtnAmt" xlink:label="ecd_TotalShareholderRtnAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TotalShareholderRtnAmt" xlink:to="ecd_TotalShareholderRtnAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TotalShareholderRtnAmt_lbl" xml:lang="en-US">Total Shareholder Return Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeerGroupTotalShareholderRtnAmt" xlink:label="ecd_PeerGroupTotalShareholderRtnAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PeerGroupTotalShareholderRtnAmt" xlink:to="ecd_PeerGroupTotalShareholderRtnAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PeerGroupTotalShareholderRtnAmt_lbl" xml:lang="en-US">Peer Group Total Shareholder Return Amount</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_NetIncomeLoss_3_lbl" xml:lang="en-US">Net Income (Loss)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CoSelectedMeasureAmt" xlink:label="ecd_CoSelectedMeasureAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_CoSelectedMeasureAmt" xlink:to="ecd_CoSelectedMeasureAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_CoSelectedMeasureAmt_lbl" xml:lang="en-US">Company Selected Measure Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OtherPerfMeasureAmt" xlink:label="ecd_OtherPerfMeasureAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_OtherPerfMeasureAmt" xlink:to="ecd_OtherPerfMeasureAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_OtherPerfMeasureAmt_lbl" xml:lang="en-US">Other Performance Measure, Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToCompAmt" xlink:label="ecd_AdjToCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AdjToCompAmt" xlink:to="ecd_AdjToCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AdjToCompAmt_lbl" xml:lang="en-US">Adjustment to Compensation, Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoName" xlink:label="ecd_PeoName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PeoName" xlink:to="ecd_PeoName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PeoName_lbl" xml:lang="en-US">PEO Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MeasureName" xlink:label="ecd_MeasureName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_MeasureName" xlink:to="ecd_MeasureName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_MeasureName_lbl" xml:lang="en-US">Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonGaapMeasureDescriptionTextBlock" xlink:label="ecd_NonGaapMeasureDescriptionTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_NonGaapMeasureDescriptionTextBlock" xlink:to="ecd_NonGaapMeasureDescriptionTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_NonGaapMeasureDescriptionTextBlock_lbl" xml:lang="en-US">Non-GAAP Measure Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Additional402vDisclosureTextBlock" xlink:label="ecd_Additional402vDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_Additional402vDisclosureTextBlock" xlink:to="ecd_Additional402vDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_Additional402vDisclosureTextBlock_lbl" xml:lang="en-US">Additional 402(v) Disclosure</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PnsnBnftsAdjFnTextBlock" xlink:label="ecd_PnsnBnftsAdjFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PnsnBnftsAdjFnTextBlock" xlink:to="ecd_PnsnBnftsAdjFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PnsnBnftsAdjFnTextBlock_lbl" xml:lang="en-US">Pension Benefits Adjustments, Footnote</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ErrCompRecoveryTable" xlink:label="ecd_ErrCompRecoveryTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ErrCompRecoveryTable" xlink:to="ecd_ErrCompRecoveryTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ErrCompRecoveryTable_lbl" xml:lang="en-US">Erroneously Awarded Compensation Recovery [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDateAxis" xlink:label="ecd_RestatementDateAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_RestatementDateAxis" xlink:to="ecd_RestatementDateAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_RestatementDateAxis_lbl" xml:lang="en-US">Restatement Determination Date [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDeterminationDate" xlink:label="ecd_RestatementDeterminationDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_RestatementDeterminationDate" xlink:to="ecd_RestatementDeterminationDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_RestatementDeterminationDate_lbl" xml:lang="en-US">Restatement Determination Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtErrCompAmt" xlink:label="ecd_AggtErrCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AggtErrCompAmt" xlink:to="ecd_AggtErrCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AggtErrCompAmt_lbl" xml:lang="en-US">Aggregate Erroneous Compensation Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ErrCompAnalysisTextBlock" xlink:label="ecd_ErrCompAnalysisTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ErrCompAnalysisTextBlock" xlink:to="ecd_ErrCompAnalysisTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ErrCompAnalysisTextBlock_lbl" xml:lang="en-US">Erroneous Compensation Analysis</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:label="ecd_StkPrcOrTsrEstimationMethodTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:to="ecd_StkPrcOrTsrEstimationMethodTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_StkPrcOrTsrEstimationMethodTextBlock_lbl" xml:lang="en-US">Stock Price or TSR Estimation Method</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingAggtErrCompAmt" xlink:label="ecd_OutstandingAggtErrCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_OutstandingAggtErrCompAmt" xlink:to="ecd_OutstandingAggtErrCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_OutstandingAggtErrCompAmt_lbl" xml:lang="en-US">Outstanding Aggregate Erroneous Compensation Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:label="ecd_AggtErrCompNotYetDeterminedTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:to="ecd_AggtErrCompNotYetDeterminedTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AggtErrCompNotYetDeterminedTextBlock_lbl" xml:lang="en-US">Aggregate Erroneous Compensation Not Yet Determined</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryIndName" xlink:label="ecd_ForgoneRecoveryIndName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ForgoneRecoveryIndName" xlink:to="ecd_ForgoneRecoveryIndName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ecd_ForgoneRecoveryIndName_lbl" xml:lang="en-US">Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:label="ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:to="ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt_lbl" xml:lang="en-US">Forgone Recovery due to Expense of Enforcement, Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:label="ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:to="ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt_lbl" xml:lang="en-US">Forgone Recovery due to Violation of Home Country Law, Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:label="ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:to="ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt_lbl" xml:lang="en-US">Forgone Recovery due to Disqualification of Tax Benefits, Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:label="ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:to="ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock_lbl" xml:lang="en-US">Forgone Recovery, Explanation of Impracticability</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingRecoveryIndName" xlink:label="ecd_OutstandingRecoveryIndName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_OutstandingRecoveryIndName" xlink:to="ecd_OutstandingRecoveryIndName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ecd_OutstandingRecoveryIndName_lbl" xml:lang="en-US">Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingRecoveryCompAmt" xlink:label="ecd_OutstandingRecoveryCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_OutstandingRecoveryCompAmt" xlink:to="ecd_OutstandingRecoveryCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_OutstandingRecoveryCompAmt_lbl" xml:lang="en-US">Compensation Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:label="ecd_RestatementDoesNotRequireRecoveryTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:to="ecd_RestatementDoesNotRequireRecoveryTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_RestatementDoesNotRequireRecoveryTextBlock_lbl" xml:lang="en-US">Restatement does not require Recovery</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscTable" xlink:label="ecd_AwardsCloseToMnpiDiscTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardsCloseToMnpiDiscTable" xlink:to="ecd_AwardsCloseToMnpiDiscTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardsCloseToMnpiDiscTable_lbl" xml:lang="en-US">Awards Close in Time to MNPI Disclosures [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMnpiDiscTextBlock" xlink:label="ecd_AwardTmgMnpiDiscTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardTmgMnpiDiscTextBlock" xlink:to="ecd_AwardTmgMnpiDiscTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardTmgMnpiDiscTextBlock_lbl" xml:lang="en-US">Award Timing MNPI Disclosure</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMethodTextBlock" xlink:label="ecd_AwardTmgMethodTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardTmgMethodTextBlock" xlink:to="ecd_AwardTmgMethodTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardTmgMethodTextBlock_lbl" xml:lang="en-US">Award Timing Method</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgPredtrmndFlag" xlink:label="ecd_AwardTmgPredtrmndFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardTmgPredtrmndFlag" xlink:to="ecd_AwardTmgPredtrmndFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardTmgPredtrmndFlag_lbl" xml:lang="en-US">Award Timing Predetermined</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMnpiCnsdrdFlag" xlink:label="ecd_AwardTmgMnpiCnsdrdFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardTmgMnpiCnsdrdFlag" xlink:to="ecd_AwardTmgMnpiCnsdrdFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardTmgMnpiCnsdrdFlag_lbl" xml:lang="en-US">Award Timing MNPI Considered</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:label="ecd_AwardTmgHowMnpiCnsdrdTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:to="ecd_AwardTmgHowMnpiCnsdrdTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardTmgHowMnpiCnsdrdTextBlock_lbl" xml:lang="en-US">Award Timing, How MNPI Considered</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MnpiDiscTimedForCompValFlag" xlink:label="ecd_MnpiDiscTimedForCompValFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_MnpiDiscTimedForCompValFlag" xlink:to="ecd_MnpiDiscTimedForCompValFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_MnpiDiscTimedForCompValFlag_lbl" xml:lang="en-US">MNPI Disclosure Timed for Compensation Value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:label="ecd_AwardsCloseToMnpiDiscTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:to="ecd_AwardsCloseToMnpiDiscTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardsCloseToMnpiDiscTableTextBlock_lbl" xml:lang="en-US">Awards Close in Time to MNPI Disclosures, Table</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscIndName" xlink:label="ecd_AwardsCloseToMnpiDiscIndName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardsCloseToMnpiDiscIndName" xlink:to="ecd_AwardsCloseToMnpiDiscIndName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ecd_AwardsCloseToMnpiDiscIndName_lbl" xml:lang="en-US">Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardUndrlygSecuritiesAmt" xlink:label="ecd_AwardUndrlygSecuritiesAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardUndrlygSecuritiesAmt" xlink:to="ecd_AwardUndrlygSecuritiesAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardUndrlygSecuritiesAmt_lbl" xml:lang="en-US">Underlying Securities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardExrcPrice" xlink:label="ecd_AwardExrcPrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardExrcPrice" xlink:to="ecd_AwardExrcPrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardExrcPrice_lbl" xml:lang="en-US">Exercise Price</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardGrantDateFairValue" xlink:label="ecd_AwardGrantDateFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardGrantDateFairValue" xlink:to="ecd_AwardGrantDateFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardGrantDateFairValue_lbl" xml:lang="en-US">Fair Value as of Grant Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_UndrlygSecurityMktPriceChngPct" xlink:label="ecd_UndrlygSecurityMktPriceChngPct" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_UndrlygSecurityMktPriceChngPct" xlink:to="ecd_UndrlygSecurityMktPriceChngPct_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_UndrlygSecurityMktPriceChngPct_lbl" xml:lang="en-US">Underlying Security Market Price Change</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTradingArrLineItems" xlink:label="ecd_InsiderTradingArrLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_InsiderTradingArrLineItems" xlink:to="ecd_InsiderTradingArrLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_InsiderTradingArrLineItems_lbl" xml:lang="en-US">Insider Trading Arrangements [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MtrlTermsOfTrdArrTextBlock" xlink:label="ecd_MtrlTermsOfTrdArrTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_MtrlTermsOfTrdArrTextBlock" xlink:to="ecd_MtrlTermsOfTrdArrTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_MtrlTermsOfTrdArrTextBlock_lbl" xml:lang="en-US">Material Terms of Trading Arrangement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrIndName" xlink:label="ecd_TrdArrIndName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrIndName" xlink:to="ecd_TrdArrIndName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ecd_TrdArrIndName_lbl" xml:lang="en-US">Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrIndTitle" xlink:label="ecd_TrdArrIndTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrIndTitle" xlink:to="ecd_TrdArrIndTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TrdArrIndTitle_lbl" xml:lang="en-US">Title</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Rule10b51ArrAdoptedFlag" xlink:label="ecd_Rule10b51ArrAdoptedFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_Rule10b51ArrAdoptedFlag" xlink:to="ecd_Rule10b51ArrAdoptedFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_Rule10b51ArrAdoptedFlag_lbl" xml:lang="en-US">Rule 10b5-1 Arrangement Adopted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonRule10b51ArrAdoptedFlag" xlink:label="ecd_NonRule10b51ArrAdoptedFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_NonRule10b51ArrAdoptedFlag" xlink:to="ecd_NonRule10b51ArrAdoptedFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_NonRule10b51ArrAdoptedFlag_lbl" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Adopted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrAdoptionDate" xlink:label="ecd_TrdArrAdoptionDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrAdoptionDate" xlink:to="ecd_TrdArrAdoptionDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TrdArrAdoptionDate_lbl" xml:lang="en-US">Adoption Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Rule10b51ArrTrmntdFlag" xlink:label="ecd_Rule10b51ArrTrmntdFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_Rule10b51ArrTrmntdFlag" xlink:to="ecd_Rule10b51ArrTrmntdFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_Rule10b51ArrTrmntdFlag_lbl" xml:lang="en-US">Rule 10b5-1 Arrangement Terminated</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonRule10b51ArrTrmntdFlag" xlink:label="ecd_NonRule10b51ArrTrmntdFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_NonRule10b51ArrTrmntdFlag" xlink:to="ecd_NonRule10b51ArrTrmntdFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_NonRule10b51ArrTrmntdFlag_lbl" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Terminated</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrTerminationDate" xlink:label="ecd_TrdArrTerminationDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrTerminationDate" xlink:to="ecd_TrdArrTerminationDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TrdArrTerminationDate_lbl" xml:lang="en-US">Termination Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrExpirationDate" xlink:label="ecd_TrdArrExpirationDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrExpirationDate" xlink:to="ecd_TrdArrExpirationDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TrdArrExpirationDate_lbl" xml:lang="en-US">Expiration Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrDuration" xlink:label="ecd_TrdArrDuration" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrDuration" xlink:to="ecd_TrdArrDuration_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TrdArrDuration_lbl" xml:lang="en-US">Arrangement Duration</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTradingPoliciesProcLineItems" xlink:label="ecd_InsiderTradingPoliciesProcLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_InsiderTradingPoliciesProcLineItems" xlink:to="ecd_InsiderTradingPoliciesProcLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_InsiderTradingPoliciesProcLineItems_lbl" xml:lang="en-US">Insider Trading Policies and Procedures [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:label="ecd_InsiderTrdPoliciesProcAdoptedFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:to="ecd_InsiderTrdPoliciesProcAdoptedFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_InsiderTrdPoliciesProcAdoptedFlag_lbl" xml:lang="en-US">Insider Trading Policies and Procedures Adopted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:label="ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:to="ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock_lbl" xml:lang="en-US">Insider Trading Policies and Procedures Not Adopted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract" xlink:to="cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract_lbl" xml:lang="en-US">Cybersecurity Risk Management, Strategy, and Governance [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:label="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock_lbl" xml:lang="en-US">Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementProcessesIntegratedFlag" xlink:label="cyd_CybersecurityRiskManagementProcessesIntegratedFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementProcessesIntegratedFlag" xlink:to="cyd_CybersecurityRiskManagementProcessesIntegratedFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskManagementProcessesIntegratedFlag_lbl" xml:lang="en-US">Cybersecurity Risk Management Processes Integrated [Flag]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock" xlink:label="cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock" xlink:to="cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock_lbl" xml:lang="en-US">Cybersecurity Risk Management Processes Integrated [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementThirdPartyEngagedFlag" xlink:label="cyd_CybersecurityRiskManagementThirdPartyEngagedFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementThirdPartyEngagedFlag" xlink:to="cyd_CybersecurityRiskManagementThirdPartyEngagedFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskManagementThirdPartyEngagedFlag_lbl" xml:lang="en-US">Cybersecurity Risk Management Third Party Engaged [Flag]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag" xlink:label="cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag" xlink:to="cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag_lbl" xml:lang="en-US">Cybersecurity Risk Third Party Oversight and Identification Processes [Flag]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" xlink:label="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" xlink:to="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag_lbl" xml:lang="en-US">Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock" xlink:label="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock" xlink:to="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock_lbl" xml:lang="en-US">Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:label="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock_lbl" xml:lang="en-US">Cybersecurity Risk Board of Directors Oversight [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" xlink:label="cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" xlink:to="cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock_lbl" xml:lang="en-US">Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" xlink:label="cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" xlink:to="cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock_lbl" xml:lang="en-US">Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskRoleOfManagementTextBlock" xlink:label="cyd_CybersecurityRiskRoleOfManagementTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskRoleOfManagementTextBlock" xlink:to="cyd_CybersecurityRiskRoleOfManagementTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskRoleOfManagementTextBlock_lbl" xml:lang="en-US">Cybersecurity Risk Role of Management [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag" xlink:to="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag_lbl" xml:lang="en-US">Cybersecurity Risk Management Positions or Committees Responsible [Flag]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock" xlink:to="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock_lbl" xml:lang="en-US">Cybersecurity Risk Management Positions or Committees Responsible [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_MaterialCybersecurityIncidentAbstract" xlink:label="cyd_MaterialCybersecurityIncidentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_MaterialCybersecurityIncidentAbstract" xlink:to="cyd_MaterialCybersecurityIncidentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_MaterialCybersecurityIncidentAbstract_lbl" xml:lang="en-US">Material Cybersecurity Incident [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_MaterialCybersecurityIncidentNatureTextBlock" xlink:label="cyd_MaterialCybersecurityIncidentNatureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_MaterialCybersecurityIncidentNatureTextBlock" xlink:to="cyd_MaterialCybersecurityIncidentNatureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_MaterialCybersecurityIncidentNatureTextBlock_lbl" xml:lang="en-US">Material Cybersecurity Incident Nature [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_MaterialCybersecurityIncidentScopeTextBlock" xlink:label="cyd_MaterialCybersecurityIncidentScopeTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_MaterialCybersecurityIncidentScopeTextBlock" xlink:to="cyd_MaterialCybersecurityIncidentScopeTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_MaterialCybersecurityIncidentScopeTextBlock_lbl" xml:lang="en-US">Material Cybersecurity Incident Scope [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_MaterialCybersecurityIncidentTimingTextBlock" xlink:label="cyd_MaterialCybersecurityIncidentTimingTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_MaterialCybersecurityIncidentTimingTextBlock" xlink:to="cyd_MaterialCybersecurityIncidentTimingTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_MaterialCybersecurityIncidentTimingTextBlock_lbl" xml:lang="en-US">Material Cybersecurity Incident Timing [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_MaterialCybersecurityIncidentMaterialImpactOrReasonablyLikelyMaterialImpactTextBlock" xlink:label="cyd_MaterialCybersecurityIncidentMaterialImpactOrReasonablyLikelyMaterialImpactTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_MaterialCybersecurityIncidentMaterialImpactOrReasonablyLikelyMaterialImpactTextBlock" xlink:to="cyd_MaterialCybersecurityIncidentMaterialImpactOrReasonablyLikelyMaterialImpactTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_MaterialCybersecurityIncidentMaterialImpactOrReasonablyLikelyMaterialImpactTextBlock_lbl" xml:lang="en-US">Material Cybersecurity Incident Material Impact or Reasonably Likely Material Impact [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_MaterialCybersecurityIncidentInformationNotAvailableOrUndeterminedTextBlock" xlink:label="cyd_MaterialCybersecurityIncidentInformationNotAvailableOrUndeterminedTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_MaterialCybersecurityIncidentInformationNotAvailableOrUndeterminedTextBlock" xlink:to="cyd_MaterialCybersecurityIncidentInformationNotAvailableOrUndeterminedTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cyd_MaterialCybersecurityIncidentInformationNotAvailableOrUndeterminedTextBlock_lbl" xml:lang="en-US">Material Cybersecurity Incident Information Not Available or Undetermined [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubstantialDoubtAboutGoingConcernTextBlock" xlink:label="us-gaap_SubstantialDoubtAboutGoingConcernTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubstantialDoubtAboutGoingConcernTextBlock" xlink:to="us-gaap_SubstantialDoubtAboutGoingConcernTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubstantialDoubtAboutGoingConcernTextBlock_lbl" xml:lang="en-US">Business Description and Going Concern</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountingPoliciesAbstract_lbl" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xml:lang="en-US">Summary of Significant Accounting Policies</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:label="us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:to="us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_lbl" xml:lang="en-US">Discontinued Operations and Disposal Groups [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:label="us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:to="us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_lbl" xml:lang="en-US">Discontinued Operations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:label="us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:to="us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_lbl" xml:lang="en-US">Equity Method Investments and Joint Ventures [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestmentsDisclosureTextBlock" xlink:label="us-gaap_EquityMethodInvestmentsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityMethodInvestmentsDisclosureTextBlock" xlink:to="us-gaap_EquityMethodInvestmentsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityMethodInvestmentsDisclosureTextBlock_lbl" xml:lang="en-US">Investment in Equity Method Investee</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:label="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_lbl" xml:lang="en-US">Investments, Debt and Equity Securities [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:label="us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:to="us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_lbl" xml:lang="en-US">Investment in Equity Securities</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_DisclosurePrepaidAndOtherCurrentAssetsAbstract" xlink:label="NTRP_DisclosurePrepaidAndOtherCurrentAssetsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_DisclosurePrepaidAndOtherCurrentAssetsAbstract" xlink:to="NTRP_DisclosurePrepaidAndOtherCurrentAssetsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_DisclosurePrepaidAndOtherCurrentAssetsAbstract_lbl" xml:lang="en-US">Prepaid And Other Current Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_PrepaidExpensesAndOtherCurrentAssetsTextBlock" xlink:label="NTRP_PrepaidExpensesAndOtherCurrentAssetsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_PrepaidExpensesAndOtherCurrentAssetsTextBlock" xlink:to="NTRP_PrepaidExpensesAndOtherCurrentAssetsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_PrepaidExpensesAndOtherCurrentAssetsTextBlock_lbl" xml:lang="en-US">Prepaid and Other Current Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract_lbl" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl" xml:lang="en-US">Property and Equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_lbl" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:label="us-gaap_IntangibleAssetsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:to="us-gaap_IntangibleAssetsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IntangibleAssetsDisclosureTextBlock_lbl" xml:lang="en-US">Intangible Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillDisclosureTextBlock" xlink:label="us-gaap_GoodwillDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillDisclosureTextBlock" xlink:to="us-gaap_GoodwillDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_GoodwillDisclosureTextBlock_lbl" xml:lang="en-US">Goodwill</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="us-gaap_PayablesAndAccrualsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_PayablesAndAccrualsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PayablesAndAccrualsAbstract_lbl" xml:lang="en-US">Payables and Accruals [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl" xml:lang="en-US">Accounts Payable and Accrued Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureAbstract_lbl" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xml:lang="en-US">Income Taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="us-gaap_DebtDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_DebtDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtDisclosureAbstract_lbl" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="us-gaap_DebtDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtDisclosureTextBlock" xlink:to="us-gaap_DebtDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtDisclosureTextBlock_lbl" xml:lang="en-US">Notes Payable</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_DisclosureConvertibleNotesAbstract" xlink:label="NTRP_DisclosureConvertibleNotesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_DisclosureConvertibleNotesAbstract" xlink:to="NTRP_DisclosureConvertibleNotesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_DisclosureConvertibleNotesAbstract_lbl" xml:lang="en-US">Convertible Notes</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_ConvertibleDebtDisclosureTextBlock" xlink:label="NTRP_ConvertibleDebtDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_ConvertibleDebtDisclosureTextBlock" xlink:to="NTRP_ConvertibleDebtDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="NTRP_ConvertibleDebtDisclosureTextBlock_lbl" xml:lang="en-US">Convertible Notes</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_DisclosureSharePurchaseAgreementsAbstract" xlink:label="NTRP_DisclosureSharePurchaseAgreementsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_DisclosureSharePurchaseAgreementsAbstract" xlink:to="NTRP_DisclosureSharePurchaseAgreementsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_DisclosureSharePurchaseAgreementsAbstract_lbl" xml:lang="en-US">Share Purchase Agreements</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_SharePurchaseAgreementsDisclosureTextBlock" xlink:label="NTRP_SharePurchaseAgreementsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_SharePurchaseAgreementsDisclosureTextBlock" xlink:to="NTRP_SharePurchaseAgreementsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="NTRP_SharePurchaseAgreementsDisclosureTextBlock_lbl" xml:lang="en-US">Share Purchase Agreements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="us-gaap_RelatedPartyTransactionsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_RelatedPartyTransactionsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsAbstract_lbl" xml:lang="en-US">Related Party Transactions [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xml:lang="en-US">Related Party Transactions</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_DisclosureDeferredRevenueAbstract" xlink:label="NTRP_DisclosureDeferredRevenueAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_DisclosureDeferredRevenueAbstract" xlink:to="NTRP_DisclosureDeferredRevenueAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_DisclosureDeferredRevenueAbstract_lbl" xml:lang="en-US">Deferred Revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_DeferredRevenueTextBlock" xlink:label="NTRP_DeferredRevenueTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_DeferredRevenueTextBlock" xlink:to="NTRP_DeferredRevenueTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="NTRP_DeferredRevenueTextBlock_lbl" xml:lang="en-US">Deferred Revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xml:lang="en-US">Commitments and Contingencies</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract" xlink:label="us-gaap_EquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_EquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityAbstract_lbl" xml:lang="en-US">Equity [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xml:lang="en-US">Stockholders&#8217; Equity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareAbstract_lbl" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="us-gaap_EarningsPerShareTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareTextBlock" xlink:to="us-gaap_EarningsPerShareTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareTextBlock_lbl" xml:lang="en-US">Loss Per Share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RisksAndUncertaintiesAbstract" xlink:label="us-gaap_RisksAndUncertaintiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RisksAndUncertaintiesAbstract" xlink:to="us-gaap_RisksAndUncertaintiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RisksAndUncertaintiesAbstract_lbl" xml:lang="en-US">Risks and Uncertainties [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:label="us-gaap_ConcentrationRiskDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:to="us-gaap_ConcentrationRiskDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskDisclosureTextBlock_lbl" xml:lang="en-US">Concentrations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:label="us-gaap_CompensationAndRetirementDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="us-gaap_CompensationAndRetirementDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CompensationAndRetirementDisclosureAbstract_lbl" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CompensationAndEmployeeBenefitPlansTextBlock" xlink:label="us-gaap_CompensationAndEmployeeBenefitPlansTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CompensationAndEmployeeBenefitPlansTextBlock" xlink:to="us-gaap_CompensationAndEmployeeBenefitPlansTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CompensationAndEmployeeBenefitPlansTextBlock_lbl" xml:lang="en-US">Defined Contribution Plans</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="us-gaap_SubsequentEventsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsAbstract_lbl" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="us-gaap_SubsequentEventsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl" xml:lang="en-US">Subsequent Events</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xml:lang="en-US">Basis of Presentation and Principles of Consolidation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:to="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_lbl" xml:lang="en-US">Functional and presentation currency</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UseOfEstimates" xlink:label="us-gaap_UseOfEstimates" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UseOfEstimates_lbl" xml:lang="en-US">Use of Estimates</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xml:lang="en-US">Loss Per Share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xml:lang="en-US">Cash and Cash Equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_PrepaidsPolicyTextBlock" xlink:label="NTRP_PrepaidsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_PrepaidsPolicyTextBlock" xlink:to="NTRP_PrepaidsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_PrepaidsPolicyTextBlock_lbl" xml:lang="en-US">Prepaids</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:label="us-gaap_TradeAndOtherAccountsReceivablePolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:to="us-gaap_TradeAndOtherAccountsReceivablePolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TradeAndOtherAccountsReceivablePolicy_lbl" xml:lang="en-US">Accounts Receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestmentsPolicy" xlink:label="us-gaap_EquityMethodInvestmentsPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityMethodInvestmentsPolicy" xlink:to="us-gaap_EquityMethodInvestmentsPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityMethodInvestmentsPolicy_lbl" xml:lang="en-US">Investments in Equity Method Investees</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_BasisDifferencePolicyTextBlock" xlink:label="NTRP_BasisDifferencePolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_BasisDifferencePolicyTextBlock" xlink:to="NTRP_BasisDifferencePolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_BasisDifferencePolicyTextBlock_lbl" xml:lang="en-US">Basis Difference</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValuePolicyTextBlock" xlink:label="us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValuePolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValuePolicyTextBlock" xlink:to="us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValuePolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValuePolicyTextBlock_lbl" xml:lang="en-US">Investments in Equity Securities without Readily Determinable Fair Value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestmentsIssuancesPolicy" xlink:label="us-gaap_EquityMethodInvestmentsIssuancesPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityMethodInvestmentsIssuancesPolicy" xlink:to="us-gaap_EquityMethodInvestmentsIssuancesPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityMethodInvestmentsIssuancesPolicy_lbl" xml:lang="en-US">Equity in Earnings of Equity Method Investees</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:label="us-gaap_FairValueMeasurementPolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:to="us-gaap_FairValueMeasurementPolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueMeasurementPolicyPolicyTextBlock_lbl" xml:lang="en-US">Fair Value Measurements</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_PromissoryNoteReceivablePolicyTextBlock" xlink:label="NTRP_PromissoryNoteReceivablePolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_PromissoryNoteReceivablePolicyTextBlock" xlink:to="NTRP_PromissoryNoteReceivablePolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_PromissoryNoteReceivablePolicyTextBlock_lbl" xml:lang="en-US">Promissory Note Receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" xml:lang="en-US">Property and Equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:label="us-gaap_IntangibleAssetsFiniteLivedPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:to="us-gaap_IntangibleAssetsFiniteLivedPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IntangibleAssetsFiniteLivedPolicy_lbl" xml:lang="en-US">Intangible assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InternalUseSoftwarePolicy" xlink:label="us-gaap_InternalUseSoftwarePolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InternalUseSoftwarePolicy" xlink:to="us-gaap_InternalUseSoftwarePolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InternalUseSoftwarePolicy_lbl" xml:lang="en-US">Software Development Costs</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:label="us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:to="us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_lbl" xml:lang="en-US">Impairment of Intangible Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeLeasesPolicyTextBlock" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeLeasesPolicyTextBlock" xlink:to="us-gaap_LesseeLeasesPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock_lbl" xml:lang="en-US">Leases</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:label="us-gaap_PriorPeriodReclassificationAdjustmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:to="us-gaap_PriorPeriodReclassificationAdjustmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PriorPeriodReclassificationAdjustmentDescription_lbl" xml:lang="en-US">Reclassification</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:to="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" xml:lang="en-US">Fair Value of Financial Instruments</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketRiskBenefitPolicyTextBlock" xlink:label="us-gaap_MarketRiskBenefitPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketRiskBenefitPolicyTextBlock" xlink:to="us-gaap_MarketRiskBenefitPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MarketRiskBenefitPolicyTextBlock_lbl" xml:lang="en-US">Concentration of Credit Risk</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl" xml:lang="en-US">Stock Based Compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:label="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:to="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_lbl" xml:lang="en-US">Revenue Recognition</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock_lbl" xml:lang="en-US">Sales and Marketing</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="us-gaap_IncomeTaxPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl" xml:lang="en-US">Income Taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xml:lang="en-US">Recently adopted accounting pronouncements</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_RecentlyIssuedAccountingPronouncementsNotYetAdoptedPolicyTextBlock" xlink:label="NTRP_RecentlyIssuedAccountingPronouncementsNotYetAdoptedPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_RecentlyIssuedAccountingPronouncementsNotYetAdoptedPolicyTextBlock" xlink:to="NTRP_RecentlyIssuedAccountingPronouncementsNotYetAdoptedPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_RecentlyIssuedAccountingPronouncementsNotYetAdoptedPolicyTextBlock_lbl" xml:lang="en-US">Recently issued accounting pronouncements not yet adopted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl" xml:lang="en-US">Schedule of Anti-dilutive Securities Excluded from Computation of Earnings Per Share</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_ScheduleOfEstimatedUsefulLivesForPropertyAndEquipmentTableTextBlock" xlink:label="NTRP_ScheduleOfEstimatedUsefulLivesForPropertyAndEquipmentTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_ScheduleOfEstimatedUsefulLivesForPropertyAndEquipmentTableTextBlock" xlink:to="NTRP_ScheduleOfEstimatedUsefulLivesForPropertyAndEquipmentTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_ScheduleOfEstimatedUsefulLivesForPropertyAndEquipmentTableTextBlock_lbl" xml:lang="en-US">Schedule of Estimated Useful Lives for Property and Equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_ScheduleOfEstimatedUsefulLivesForFiniteLifeIntangibleAssetsTableTextBlock" xlink:label="NTRP_ScheduleOfEstimatedUsefulLivesForFiniteLifeIntangibleAssetsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_ScheduleOfEstimatedUsefulLivesForFiniteLifeIntangibleAssetsTableTextBlock" xlink:to="NTRP_ScheduleOfEstimatedUsefulLivesForFiniteLifeIntangibleAssetsTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_ScheduleOfEstimatedUsefulLivesForFiniteLifeIntangibleAssetsTableTextBlock_lbl" xml:lang="en-US">Schedule of Estimated Useful Lives for Finite Life Intangible Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:label="us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:to="us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_lbl" xml:lang="en-US">Schedule of Discontinued Operations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestmentsTextBlock" xlink:label="us-gaap_EquityMethodInvestmentsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityMethodInvestmentsTextBlock" xlink:to="us-gaap_EquityMethodInvestmentsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityMethodInvestmentsTextBlock_lbl" xml:lang="en-US">Schedule of Unaudited Summarized Financial Information</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" xlink:label="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" xlink:to="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_lbl" xml:lang="en-US">Schedule of Prepaid and Other Current Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xml:lang="en-US">Schedule of Property and Equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:to="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_lbl" xml:lang="en-US">Schedule of Intangible Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:label="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:to="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_lbl" xml:lang="en-US">Schedule of estimated aggregate amortization expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:label="us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:to="us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_lbl" xml:lang="en-US">Schedule of Fair Value of Assets Acquired</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xml:lang="en-US">Schedule of Deferred Tax Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xml:lang="en-US">Schedule of Reconciliation of Provision for Income Taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" xml:lang="en-US">Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" xml:lang="en-US">Schedule of Stock Option Activity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" xml:lang="en-US">Schedule of Share Based Payments Award Stock Options Valuation Assumptions</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:label="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:to="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_lbl" xml:lang="en-US">Schedule of Warranty Activity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock" xlink:to="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock_lbl" xml:lang="en-US">Schedule of Business Milestones and Issuable Contingent Shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:label="us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:to="us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_lbl" xml:lang="en-US">Schedule of Weighted Average Common Shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_lbl" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_lbl" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xml:lang="en-US">Number of common stock issued</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="us-gaap_SharesIssuedPricePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssuedPricePerShare" xlink:to="us-gaap_SharesIssuedPricePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharesIssuedPricePerShare_lbl" xml:lang="en-US">Share price per share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xml:lang="en-US">Number of common stock issued, value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Capital" xlink:label="us-gaap_Capital" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Capital" xlink:to="us-gaap_Capital_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Capital_lbl" xml:lang="en-US">Contributed capital</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:to="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl" xml:lang="en-US">Ownership percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:label="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:to="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_lbl" xml:lang="en-US">Restricted shares issuable in reverse acquisition</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_2_lbl" xml:lang="en-US">Accumulated deficit</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_WorkingCapitalDeficit" xlink:label="NTRP_WorkingCapitalDeficit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_WorkingCapitalDeficit" xlink:to="NTRP_WorkingCapitalDeficit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_WorkingCapitalDeficit_lbl" xml:lang="en-US">Working capital deficit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_lbl" xml:lang="en-US">Antidilutive Security, Excluded EPS Calculation [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_lbl" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xml:lang="en-US">Total Underlying Common Shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl" xml:lang="en-US">Estimated useful life</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="us-gaap_FiniteLivedIntangibleAssetUsefulLife_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife_lbl" xml:lang="en-US">Estimated useful life</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashEquivalentsAtCarryingValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashEquivalentsAtCarryingValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashEquivalentsAtCarryingValue_lbl" xml:lang="en-US">Cash equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableNet" xlink:label="us-gaap_AccountsReceivableNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableNet" xlink:to="us-gaap_AccountsReceivableNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsReceivableNet_lbl" xml:lang="en-US">Accounts receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesPayable" xlink:label="us-gaap_NotesPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotesPayable" xlink:to="us-gaap_NotesPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_NotesPayable_lbl" xml:lang="en-US">Notes payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:to="us-gaap_AllowanceForDoubtfulAccountsReceivable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivable_lbl" xml:lang="en-US">Allowance for doubtful accounts</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SellingAndMarketingExpense" xlink:to="us-gaap_SellingAndMarketingExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SellingAndMarketingExpense_2_lbl" xml:lang="en-US">Sales and marketing expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue_lbl" xml:lang="en-US">Revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold_lbl" xml:lang="en-US">Cost of revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss_lbl" xml:lang="en-US">Gross profit</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_DisposalGroupIncludingDiscontinuedOperationsProfessionalServices" xlink:label="NTRP_DisposalGroupIncludingDiscontinuedOperationsProfessionalServices" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_DisposalGroupIncludingDiscontinuedOperationsProfessionalServices" xlink:to="NTRP_DisposalGroupIncludingDiscontinuedOperationsProfessionalServices_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_DisposalGroupIncludingDiscontinuedOperationsProfessionalServices_lbl" xml:lang="en-US">Professional services</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_DisposalGroupIncludingDiscontinuedOperationsInvestorRelationsServices" xlink:label="NTRP_DisposalGroupIncludingDiscontinuedOperationsInvestorRelationsServices" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_DisposalGroupIncludingDiscontinuedOperationsInvestorRelationsServices" xlink:to="NTRP_DisposalGroupIncludingDiscontinuedOperationsInvestorRelationsServices_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_DisposalGroupIncludingDiscontinuedOperationsInvestorRelationsServices_lbl" xml:lang="en-US">Investor relations services</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_DisposalGroupIncludingDiscontinuedOperationsOtherIncome" xlink:label="NTRP_DisposalGroupIncludingDiscontinuedOperationsOtherIncome" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_DisposalGroupIncludingDiscontinuedOperationsOtherIncome" xlink:to="NTRP_DisposalGroupIncludingDiscontinuedOperationsOtherIncome_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_DisposalGroupIncludingDiscontinuedOperationsOtherIncome_lbl" xml:lang="en-US">Other income</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense_lbl" xml:lang="en-US">Total Expenses</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:to="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_2_lbl" xml:lang="en-US">Gain from Discontinued Operations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireIntangibleAssets" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireIntangibleAssets" xlink:to="us-gaap_PaymentsToAcquireIntangibleAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets_lbl" xml:lang="en-US">Purchase price</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_EarnestMoneyDeposit" xlink:label="NTRP_EarnestMoneyDeposit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_EarnestMoneyDeposit" xlink:to="NTRP_EarnestMoneyDeposit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_EarnestMoneyDeposit_lbl" xml:lang="en-US">Earnest money deposit</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:to="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_3_lbl" xml:lang="en-US">Loss of discontinued operations</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrent_2_lbl" xml:lang="en-US">Current assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsNoncurrent" xlink:to="us-gaap_AssetsNoncurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsNoncurrent_2_lbl" xml:lang="en-US">Non-current assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrent_2_lbl" xml:lang="en-US">Current liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="us-gaap_LiabilitiesNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesNoncurrent" xlink:to="us-gaap_LiabilitiesNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesNoncurrent_lbl" xml:lang="en-US">Non-current liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquity_4_lbl" xml:lang="en-US">Member&#8217;s equity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Revenues" xlink:label="us-gaap_Revenues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Revenues" xlink:to="us-gaap_Revenues_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Revenues_lbl" xml:lang="en-US">Net revenues</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GrossProfit" xlink:to="us-gaap_GrossProfit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GrossProfit_2_lbl" xml:lang="en-US">Gross profit</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NetIncomeLoss_4_lbl" xml:lang="en-US">Net loss</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:label="us-gaap_ScheduleOfEquityMethodInvestmentsTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:to="us-gaap_ScheduleOfEquityMethodInvestmentsTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEquityMethodInvestmentsTable_lbl" xml:lang="en-US">Equity Method Investment [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:label="us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:to="us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_lbl" xml:lang="en-US">Schedule of Equity Method Investments [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityOwnershipPercentageExcludingConsolidatedEntityAndEquityMethodInvestee" xlink:label="us-gaap_EquityOwnershipPercentageExcludingConsolidatedEntityAndEquityMethodInvestee" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityOwnershipPercentageExcludingConsolidatedEntityAndEquityMethodInvestee" xlink:to="us-gaap_EquityOwnershipPercentageExcludingConsolidatedEntityAndEquityMethodInvestee_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityOwnershipPercentageExcludingConsolidatedEntityAndEquityMethodInvestee_lbl" xml:lang="en-US">Equity Ownership, Excluding Consolidated Entity and Equity Method Investee, Percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionPreacquisitionContingencyAmountOfSettlement" xlink:label="us-gaap_BusinessAcquisitionPreacquisitionContingencyAmountOfSettlement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionPreacquisitionContingencyAmountOfSettlement" xlink:to="us-gaap_BusinessAcquisitionPreacquisitionContingencyAmountOfSettlement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionPreacquisitionContingencyAmountOfSettlement_lbl" xml:lang="en-US">Business acquisition amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationContingentConsiderationAsset" xlink:label="us-gaap_BusinessCombinationContingentConsiderationAsset" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationContingentConsiderationAsset" xlink:to="us-gaap_BusinessCombinationContingentConsiderationAsset_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationContingentConsiderationAsset_lbl" xml:lang="en-US">Business acquisition consideration cash</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesIssued" xlink:label="us-gaap_SharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssued" xlink:to="us-gaap_SharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharesIssued_lbl" xml:lang="en-US">Business acquisition shares issued</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssuedPricePerShare" xlink:to="us-gaap_SharesIssuedPricePerShare_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SharesIssuedPricePerShare_2_lbl" xml:lang="en-US">Business acquisition shares price per share</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:to="us-gaap_EquityMethodInvestmentOwnershipPercentage_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage_2_lbl" xml:lang="en-US">Equity Method Investment, Ownership Percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentInterestRatePaidInCash" xlink:label="us-gaap_InvestmentInterestRatePaidInCash" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentInterestRatePaidInCash" xlink:to="us-gaap_InvestmentInterestRatePaidInCash_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentInterestRatePaidInCash_lbl" xml:lang="en-US">Investment, Interest Rate, Paid in Cash</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCosts" xlink:label="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCosts" xlink:to="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCosts_lbl" xml:lang="en-US">Business acquisition additional amount</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_BusinessAcquisitionMilestonePayments" xlink:label="NTRP_BusinessAcquisitionMilestonePayments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_BusinessAcquisitionMilestonePayments" xlink:to="NTRP_BusinessAcquisitionMilestonePayments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_BusinessAcquisitionMilestonePayments_lbl" xml:lang="en-US">Milestone payments</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_BusinessAcquisitionPerMilestonePayments" xlink:label="NTRP_BusinessAcquisitionPerMilestonePayments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_BusinessAcquisitionPerMilestonePayments" xlink:to="NTRP_BusinessAcquisitionPerMilestonePayments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_BusinessAcquisitionPerMilestonePayments_lbl" xml:lang="en-US">Per milestone payments</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireBusinessesAndInterestInAffiliates" xlink:label="us-gaap_PaymentsToAcquireBusinessesAndInterestInAffiliates" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireBusinessesAndInterestInAffiliates" xlink:to="us-gaap_PaymentsToAcquireBusinessesAndInterestInAffiliates_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PaymentsToAcquireBusinessesAndInterestInAffiliates_lbl" xml:lang="en-US">Business acquisition additional amount</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_2_lbl" xml:lang="en-US">Number of shares issued</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssuedPricePerShare" xlink:to="us-gaap_SharesIssuedPricePerShare_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SharesIssuedPricePerShare_3_lbl" xml:lang="en-US">Shares issued price per share</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_2_lbl" xml:lang="en-US">Shares issued value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_DisclosurePrepaidAndOtherCurrentAssetsAbstract" xlink:to="NTRP_DisclosurePrepaidAndOtherCurrentAssetsAbstract_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="NTRP_DisclosurePrepaidAndOtherCurrentAssetsAbstract_2_lbl" xml:lang="en-US">Schedule Of Prepaid And Other Current Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_PrepaidOfferingCosts" xlink:label="NTRP_PrepaidOfferingCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_PrepaidOfferingCosts" xlink:to="NTRP_PrepaidOfferingCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_PrepaidOfferingCosts_lbl" xml:lang="en-US">Offering costs</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_PrepaidConsultingContract" xlink:label="NTRP_PrepaidConsultingContract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_PrepaidConsultingContract" xlink:to="NTRP_PrepaidConsultingContract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_PrepaidConsultingContract_lbl" xml:lang="en-US">Current portion of two-year strategic consulting contract</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_PrepaidCostOfSales" xlink:label="NTRP_PrepaidCostOfSales" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_PrepaidCostOfSales" xlink:to="NTRP_PrepaidCostOfSales_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_PrepaidCostOfSales_lbl" xml:lang="en-US">Cost of sales</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherPrepaidExpenseCurrent" xlink:label="us-gaap_OtherPrepaidExpenseCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherPrepaidExpenseCurrent" xlink:to="us-gaap_OtherPrepaidExpenseCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OtherPrepaidExpenseCurrent_lbl" xml:lang="en-US">Other expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidAdvertising" xlink:label="us-gaap_PrepaidAdvertising" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidAdvertising" xlink:to="us-gaap_PrepaidAdvertising_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrepaidAdvertising_lbl" xml:lang="en-US">Marketing expenses</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_2_lbl" xml:lang="en-US">Total</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="us-gaap_PropertyPlantAndEquipmentGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentGross" xlink:to="us-gaap_PropertyPlantAndEquipmentGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl" xml:lang="en-US">Total</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xml:lang="en-US">Accumulated depreciation</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_2_lbl" xml:lang="en-US">Property and Equipment, net of depreciation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Depreciation" xlink:label="us-gaap_Depreciation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Depreciation" xlink:to="us-gaap_Depreciation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Depreciation_lbl" xml:lang="en-US">Depreciation expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_2_lbl" xml:lang="en-US">Property and equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_lbl" xml:lang="en-US">Intangible Asset, Finite-Lived [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="us-gaap_FiniteLivedIntangibleAssetsLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsLineItems_lbl" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="us-gaap_FiniteLivedIntangibleAssetsGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross_lbl" xml:lang="en-US">Total</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl" xml:lang="en-US">Accumulated amortization</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill_2_lbl" xml:lang="en-US">Intangible assets, net of amortization</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_lbl" xml:lang="en-US">2025</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_lbl" xml:lang="en-US">2026</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_lbl" xml:lang="en-US">2027</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_lbl" xml:lang="en-US">2028</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour" xlink:label="NTRP_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour" xlink:to="NTRP_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour_lbl" xml:lang="en-US">Thereafter</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet_lbl" xml:lang="en-US">Total</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="us-gaap_AmortizationOfIntangibleAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfIntangibleAssets" xlink:to="us-gaap_AmortizationOfIntangibleAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AmortizationOfIntangibleAssets_lbl" xml:lang="en-US">Amortization</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_lbl" xml:lang="en-US">Cash</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_lbl" xml:lang="en-US">Accounts Receivable, net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_lbl" xml:lang="en-US">Inventory</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_lbl" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_lbl" xml:lang="en-US">Property and equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_lbl" xml:lang="en-US">Intangible assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_lbl" xml:lang="en-US">Accounts payable</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses" xlink:label="NTRP_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses" xlink:to="NTRP_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="NTRP_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses_lbl" xml:lang="en-US">Accrued expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_lbl" xml:lang="en-US">Deferred revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_lbl" xml:lang="en-US">Total identifiable net assets acquired</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_lbl" xml:lang="en-US">Total Fair Value of Net Assets Acquired</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="us-gaap_BusinessCombinationConsiderationTransferred1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationConsiderationTransferred1" xlink:to="us-gaap_BusinessCombinationConsiderationTransferred1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationConsiderationTransferred1_lbl" xml:lang="en-US">Business Combination, Consideration Transferred</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationConsiderationTransferred1" xlink:to="us-gaap_BusinessCombinationConsiderationTransferred1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_BusinessCombinationConsiderationTransferred1_2_lbl" xml:lang="en-US">Purchase consideration</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionSharePrice" xlink:label="us-gaap_BusinessAcquisitionSharePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionSharePrice" xlink:to="us-gaap_BusinessAcquisitionSharePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionSharePrice_lbl" xml:lang="en-US">Share price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CommonStockSharesOutstanding_2_lbl" xml:lang="en-US">Shares outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillPeriodIncreaseDecrease" xlink:label="us-gaap_GoodwillPeriodIncreaseDecrease" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillPeriodIncreaseDecrease" xlink:to="us-gaap_GoodwillPeriodIncreaseDecrease_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_GoodwillPeriodIncreaseDecrease_lbl" xml:lang="en-US">Goodwill</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossOnDispositionOfAssets" xlink:label="us-gaap_GainLossOnDispositionOfAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnDispositionOfAssets" xlink:to="us-gaap_GainLossOnDispositionOfAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GainLossOnDispositionOfAssets_lbl" xml:lang="en-US">Gain on disposition transaction</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableCurrentAndNoncurrent" xlink:label="us-gaap_AccountsPayableCurrentAndNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableCurrentAndNoncurrent" xlink:to="us-gaap_AccountsPayableCurrentAndNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AccountsPayableCurrentAndNoncurrent_lbl" xml:lang="en-US">Accounts payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedLiabilitiesCurrentAndNoncurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrentAndNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedLiabilitiesCurrentAndNoncurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrentAndNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AccruedLiabilitiesCurrentAndNoncurrent_lbl" xml:lang="en-US">Accrued expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" xml:lang="en-US">NOL carryover</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_DeferredTaxAssetDepreciation" xlink:label="NTRP_DeferredTaxAssetDepreciation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_DeferredTaxAssetDepreciation" xlink:to="NTRP_DeferredTaxAssetDepreciation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_DeferredTaxAssetDepreciation_lbl" xml:lang="en-US">Related party accruals</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_DeferredTaxAssetsPayrollAccruals" xlink:label="NTRP_DeferredTaxAssetsPayrollAccruals" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_DeferredTaxAssetsPayrollAccruals" xlink:to="NTRP_DeferredTaxAssetsPayrollAccruals_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_DeferredTaxAssetsPayrollAccruals_lbl" xml:lang="en-US">Payroll accruals</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_DeferredTaxLiabilitiesDepreciation" xlink:label="NTRP_DeferredTaxLiabilitiesDepreciation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_DeferredTaxLiabilitiesDepreciation" xlink:to="NTRP_DeferredTaxLiabilitiesDepreciation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="NTRP_DeferredTaxLiabilitiesDepreciation_lbl" xml:lang="en-US">Depreciation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xml:lang="en-US">Valuation allowance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="us-gaap_DeferredTaxAssetsNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_DeferredTaxAssetsNet_lbl" xml:lang="en-US">Net deferred tax asset (liability)</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_EffectiveIncomeTaxRateReconciliationBookLoss" xlink:label="NTRP_EffectiveIncomeTaxRateReconciliationBookLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_EffectiveIncomeTaxRateReconciliationBookLoss" xlink:to="NTRP_EffectiveIncomeTaxRateReconciliationBookLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_EffectiveIncomeTaxRateReconciliationBookLoss_lbl" xml:lang="en-US">Book loss</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseDepreciation" xlink:label="us-gaap_IncomeTaxReconciliationNondeductibleExpenseDepreciation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationNondeductibleExpenseDepreciation" xlink:to="us-gaap_IncomeTaxReconciliationNondeductibleExpenseDepreciation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationNondeductibleExpenseDepreciation_lbl" xml:lang="en-US">Depreciation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment" xlink:label="us-gaap_IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment" xlink:to="us-gaap_IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment_lbl" xml:lang="en-US">Meals &amp; entertainment</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_IncomeTaxReconciliationNondeductibleExpensePreferredDividends" xlink:label="NTRP_IncomeTaxReconciliationNondeductibleExpensePreferredDividends" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_IncomeTaxReconciliationNondeductibleExpensePreferredDividends" xlink:to="NTRP_IncomeTaxReconciliationNondeductibleExpensePreferredDividends_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_IncomeTaxReconciliationNondeductibleExpensePreferredDividends_lbl" xml:lang="en-US">Preferred dividends</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_IncomeTaxReconciliationNondeductibleExpenseLossOnNextPlayNoteReceivable" xlink:label="NTRP_IncomeTaxReconciliationNondeductibleExpenseLossOnNextPlayNoteReceivable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_IncomeTaxReconciliationNondeductibleExpenseLossOnNextPlayNoteReceivable" xlink:to="NTRP_IncomeTaxReconciliationNondeductibleExpenseLossOnNextPlayNoteReceivable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_IncomeTaxReconciliationNondeductibleExpenseLossOnNextPlayNoteReceivable_lbl" xml:lang="en-US">Loss on NextPlay note receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:label="us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:to="us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_lbl" xml:lang="en-US">Stock compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_IncomeTaxReconciliationNondeductibleExpenseLossOnAssetDisposal" xlink:label="NTRP_IncomeTaxReconciliationNondeductibleExpenseLossOnAssetDisposal" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_IncomeTaxReconciliationNondeductibleExpenseLossOnAssetDisposal" xlink:to="NTRP_IncomeTaxReconciliationNondeductibleExpenseLossOnAssetDisposal_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_IncomeTaxReconciliationNondeductibleExpenseLossOnAssetDisposal_lbl" xml:lang="en-US">Loss on asset disposal</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_IncomeTaxReconciliationNondeductibleExpenseAccruedPayroll" xlink:label="NTRP_IncomeTaxReconciliationNondeductibleExpenseAccruedPayroll" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_IncomeTaxReconciliationNondeductibleExpenseAccruedPayroll" xlink:to="NTRP_IncomeTaxReconciliationNondeductibleExpenseAccruedPayroll_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_IncomeTaxReconciliationNondeductibleExpenseAccruedPayroll_lbl" xml:lang="en-US">Accrued payroll</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_IncomeTaxReconciliationNondeductibleExpenseRelatedPartyAccruals" xlink:label="NTRP_IncomeTaxReconciliationNondeductibleExpenseRelatedPartyAccruals" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_IncomeTaxReconciliationNondeductibleExpenseRelatedPartyAccruals" xlink:to="NTRP_IncomeTaxReconciliationNondeductibleExpenseRelatedPartyAccruals_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="NTRP_IncomeTaxReconciliationNondeductibleExpenseRelatedPartyAccruals_lbl" xml:lang="en-US">Related party accruals</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xml:lang="en-US">Change in valuation allowance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_IncomeTaxExpenseBenefit_2_lbl" xml:lang="en-US">Provision for Income Taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="us-gaap_OperatingLossCarryforwards" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLossCarryforwards" xlink:to="us-gaap_OperatingLossCarryforwards_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLossCarryforwards_lbl" xml:lang="en-US">Operating loss carryforwards</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_OperatingLossCarryforwardsRemainder" xlink:label="NTRP_OperatingLossCarryforwardsRemainder" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_OperatingLossCarryforwardsRemainder" xlink:to="NTRP_OperatingLossCarryforwardsRemainder_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_OperatingLossCarryforwardsRemainder_lbl" xml:lang="en-US">Operating loss carryforwards remainder</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_2_lbl" xml:lang="en-US">Valuation allowance loss carryforwards</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl" xml:lang="en-US">Federal statutory tax rate</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTable" xlink:label="us-gaap_DebtInstrumentTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentTable_lbl" xml:lang="en-US">Schedule of Long-Term Debt Instruments [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="us-gaap_DebtInstrumentLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentLineItems_lbl" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromConvertibleDebt" xlink:to="us-gaap_ProceedsFromConvertibleDebt_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ProceedsFromConvertibleDebt_2_lbl" xml:lang="en-US">Proceeds from convertible debt</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl" xml:lang="en-US">Interest rate</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="us-gaap_DebtInstrumentFaceAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentFaceAmount" xlink:to="us-gaap_DebtInstrumentFaceAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentFaceAmount_lbl" xml:lang="en-US">Principal amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesAndLoansPayableCurrent" xlink:label="us-gaap_NotesAndLoansPayableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotesAndLoansPayableCurrent" xlink:to="us-gaap_NotesAndLoansPayableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NotesAndLoansPayableCurrent_lbl" xml:lang="en-US">Total consideration</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromNotesPayable" xlink:to="us-gaap_ProceedsFromNotesPayable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromNotesPayable_2_lbl" xml:lang="en-US">Proceeds from Notes Payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentUnamortizedDiscount" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentUnamortizedDiscount" xlink:to="us-gaap_DebtInstrumentUnamortizedDiscount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscount_lbl" xml:lang="en-US">Original issue discount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="us-gaap_DebtInstrumentMaturityDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentMaturityDate" xlink:to="us-gaap_DebtInstrumentMaturityDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentMaturityDate_lbl" xml:lang="en-US">Maturity date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_lbl" xml:lang="en-US">Warrants additional paid in capital</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_ConvertibleNotesPayableOfInstallments" xlink:label="NTRP_ConvertibleNotesPayableOfInstallments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_ConvertibleNotesPayableOfInstallments" xlink:to="NTRP_ConvertibleNotesPayableOfInstallments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_ConvertibleNotesPayableOfInstallments_lbl" xml:lang="en-US">Note payable equal installments</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:label="us-gaap_DebtInstrumentInterestRateEffectivePercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:to="us-gaap_DebtInstrumentInterestRateEffectivePercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentInterestRateEffectivePercentage_lbl" xml:lang="en-US">Debt Instrument, Interest Rate, Effective Percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl" xml:lang="en-US">Class of Warrant or Right, Number of Securities Called by Warrants or Rights</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="us-gaap_SaleOfStockPricePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockPricePerShare" xlink:to="us-gaap_SaleOfStockPricePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SaleOfStockPricePerShare_lbl" xml:lang="en-US">Sale of Stock, Price Per Share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:label="us-gaap_DebtConversionConvertedInstrumentAmount1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:to="us-gaap_DebtConversionConvertedInstrumentAmount1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtConversionConvertedInstrumentAmount1_lbl" xml:lang="en-US">Debt converted amount</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_DebtConversionConvertedInstrumentOfGuaranteedInterest" xlink:label="NTRP_DebtConversionConvertedInstrumentOfGuaranteedInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_DebtConversionConvertedInstrumentOfGuaranteedInterest" xlink:to="NTRP_DebtConversionConvertedInstrumentOfGuaranteedInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_DebtConversionConvertedInstrumentOfGuaranteedInterest_lbl" xml:lang="en-US">[custom:DebtConversionConvertedInstrumentOfGuaranteedInterest]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:label="us-gaap_DebtConversionConvertedInstrumentSharesIssued1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:to="us-gaap_DebtConversionConvertedInstrumentSharesIssued1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtConversionConvertedInstrumentSharesIssued1_lbl" xml:lang="en-US">Debt Conversion, Converted Instrument, Shares Issued</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:label="us-gaap_DebtInstrumentConvertibleConversionPrice1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:to="us-gaap_DebtInstrumentConvertibleConversionPrice1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentConvertibleConversionPrice1_lbl" xml:lang="en-US">Conversion price</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentPeriodicPayment" xlink:label="us-gaap_DebtInstrumentPeriodicPayment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentPeriodicPayment" xlink:to="us-gaap_DebtInstrumentPeriodicPayment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentPeriodicPayment_lbl" xml:lang="en-US">debt instrument periodic payment</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_DebtInstrumentPeriodicOfInstallments" xlink:label="NTRP_DebtInstrumentPeriodicOfInstallments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_DebtInstrumentPeriodicOfInstallments" xlink:to="NTRP_DebtInstrumentPeriodicOfInstallments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_DebtInstrumentPeriodicOfInstallments_lbl" xml:lang="en-US">[custom:DebtInstrumentPeriodicOfInstallments]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssued" xlink:to="us-gaap_SharesIssued_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SharesIssued_2_lbl" xml:lang="en-US">Shares, Issued</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_DebtInstrumentUnamortizedDebtDiscount" xlink:label="NTRP_DebtInstrumentUnamortizedDebtDiscount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_DebtInstrumentUnamortizedDebtDiscount" xlink:to="NTRP_DebtInstrumentUnamortizedDebtDiscount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_DebtInstrumentUnamortizedDebtDiscount_lbl" xml:lang="en-US">Unamortized debt discount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentCovenantDescription" xlink:label="us-gaap_DebtInstrumentCovenantDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentCovenantDescription" xlink:to="us-gaap_DebtInstrumentCovenantDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentCovenantDescription_lbl" xml:lang="en-US">Debt Instrument, Covenant Description</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_DebtInstrumentOfInvestor" xlink:label="NTRP_DebtInstrumentOfInvestor" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_DebtInstrumentOfInvestor" xlink:to="NTRP_DebtInstrumentOfInvestor_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="NTRP_DebtInstrumentOfInvestor_lbl" xml:lang="en-US">Principal amount</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_DebtInstrumentOfFunded" xlink:label="NTRP_DebtInstrumentOfFunded" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_DebtInstrumentOfFunded" xlink:to="NTRP_DebtInstrumentOfFunded_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="NTRP_DebtInstrumentOfFunded_lbl" xml:lang="en-US">Principal amount</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCost" xlink:label="NTRP_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCost" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCost" xlink:to="NTRP_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCost_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="NTRP_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCost_lbl" xml:lang="en-US">Warrants additional paid in capital</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl" xml:lang="en-US">Sale of stock, shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromConvertibleDebt" xlink:to="us-gaap_ProceedsFromConvertibleDebt_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProceedsFromConvertibleDebt_3_lbl" xml:lang="en-US">Convertible note issued</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharePrice" xlink:label="us-gaap_SharePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharePrice" xlink:to="us-gaap_SharePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SharePrice_lbl" xml:lang="en-US">Share price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_2_lbl" xml:lang="en-US">Conversion of convertible notes, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpenseDebt" xlink:label="us-gaap_InterestExpenseDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpenseDebt" xlink:to="us-gaap_InterestExpenseDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestExpenseDebt_lbl" xml:lang="en-US">Interest expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharePrice" xlink:to="us-gaap_SharePrice_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharePrice_2_lbl" xml:lang="en-US">Conversion share price</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_ProceedsFromDownpaymentForContract" xlink:label="NTRP_ProceedsFromDownpaymentForContract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_ProceedsFromDownpaymentForContract" xlink:to="NTRP_ProceedsFromDownpaymentForContract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_ProceedsFromDownpaymentForContract_lbl" xml:lang="en-US">Proceeds from downpayment for contract</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:to="us-gaap_DebtInstrumentConvertibleConversionPrice1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DebtInstrumentConvertibleConversionPrice1_2_lbl" xml:lang="en-US">Conversion share price</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_ConsultingFees" xlink:label="NTRP_ConsultingFees" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_ConsultingFees" xlink:to="NTRP_ConsultingFees_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_ConsultingFees_lbl" xml:lang="en-US">Consulting fees</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_lbl" xml:lang="en-US">Related Party Transaction [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="us-gaap_RelatedPartyTransactionLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_RelatedPartyTransactionLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionLineItems_lbl" xml:lang="en-US">Related Party Transaction [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotesPayableCurrent" xlink:to="us-gaap_NotesPayableCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_NotesPayableCurrent_2_lbl" xml:lang="en-US">Notes payable - related parties</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_LossOnRelatedPartyReceivable" xlink:to="NTRP_LossOnRelatedPartyReceivable_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="NTRP_LossOnRelatedPartyReceivable_3_lbl" xml:lang="en-US">Loss on related party receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReceivablesNetCurrent" xlink:label="us-gaap_ReceivablesNetCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ReceivablesNetCurrent" xlink:to="us-gaap_ReceivablesNetCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ReceivablesNetCurrent_lbl" xml:lang="en-US">Accounts receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xml:lang="en-US">Number of Options, Outstanding, Balance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted Average Exercise Price, Outstanding Balance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xml:lang="en-US">Weighted Average Remaining Contractual Life, Outstanding Balance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xml:lang="en-US">Aggregate Intrinsic Value, Outstanding Balance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_2_lbl" xml:lang="en-US">Number of Options, Exercised</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted Average Exercise Price, Exercised</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_lbl" xml:lang="en-US">Aggregate Intrinsic Value, Exercised</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_lbl" xml:lang="en-US">Number of Options, Forfeited or cancelled</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted Average Exercise Price, Forfeited or cancelled</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedorCancelledInPeriodTotalIntrinsicValue" xlink:label="NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedorCancelledInPeriodTotalIntrinsicValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedorCancelledInPeriodTotalIntrinsicValue" xlink:to="NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedorCancelledInPeriodTotalIntrinsicValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedorCancelledInPeriodTotalIntrinsicValue_lbl" xml:lang="en-US">Aggregate Intrinsic Value, Forfeited or cancelled</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2_lbl" xml:lang="en-US">Number of Options, Outstanding, Balance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2_lbl" xml:lang="en-US">Weighted Average Exercise Price, Outstanding Balance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_2_lbl" xml:lang="en-US">Aggregate Intrinsic Value, Outstanding Balance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_lbl" xml:lang="en-US">Number of Options, Expected to vest in the future, Balance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted Average Exercise Price, Expected to Vest</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_lbl" xml:lang="en-US">Weighted Average Remaining Contractual Life, Expected to Vest</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_lbl" xml:lang="en-US">Aggregate Intrinsic Value, Options expected to vest in the future</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" xml:lang="en-US">Number of Options, Exercisable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted Average Exercise Price, Exercisable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl" xml:lang="en-US">Weighted Average Remaining Contractual Life, Exercisable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl" xml:lang="en-US">Aggregate Intrinsic Value, Options exercisable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_lbl" xml:lang="en-US">Number of Options, Vested, Exercisable and Options Expected to Vest Balance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted Average Exercise Price, Vested, Exercisable and Options Expected to Vest</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_lbl" xml:lang="en-US">Weighted Average Remaining Contractual Life, Vested, Exercisable and Options Expected to Vest</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_lbl" xml:lang="en-US">Aggregate Intrinsic Value, Options vested, exercisable and options expected to vest</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageForfeitedOrCancelled" xlink:label="NTRP_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageForfeitedOrCancelled" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageForfeitedOrCancelled" xlink:to="NTRP_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageForfeitedOrCancelled_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="NTRP_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageForfeitedOrCancelled_lbl" xml:lang="en-US">Weighted Average Exercise Price, Forfeited or cancelled</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xml:lang="en-US">Dividend yield</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_lbl" xml:lang="en-US">Risk-free interest rate, minimum</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_lbl" xml:lang="en-US">Risk-free interest rate, maximum</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_lbl" xml:lang="en-US">Expected volatility, minimum</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_lbl" xml:lang="en-US">Expected volatility, maximum</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xml:lang="en-US">Expected life</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_lbl" xml:lang="en-US">Warrants Outstanding, Beginning Balance</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice" xlink:label="NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice" xlink:to="NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted Average Exercise Price Outstanding, Beginning Balance</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonOutstandingWeightedAverageRemainingContractualTerm" xlink:label="NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonOutstandingWeightedAverageRemainingContractualTerm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonOutstandingWeightedAverageRemainingContractualTerm" xlink:to="NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonOutstandingWeightedAverageRemainingContractualTerm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonOutstandingWeightedAverageRemainingContractualTerm_lbl" xml:lang="en-US">Weighted Average Remaining Contractual Life Years, Ending Balance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_lbl" xml:lang="en-US">Warrants, Granted</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="NTRP_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="NTRP_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted Average Exercise Price Outstanding, Granted</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonGrantsWeightedAverageRemainingContractualTerm" xlink:label="NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonGrantsWeightedAverageRemainingContractualTerm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonGrantsWeightedAverageRemainingContractualTerm" xlink:to="NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonGrantsWeightedAverageRemainingContractualTerm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonGrantsWeightedAverageRemainingContractualTerm_lbl" xml:lang="en-US">Weighted Average Remaining Contractual Life Years, Granted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_lbl" xml:lang="en-US">Warrants,Exercised</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageExercisePrice" xlink:label="NTRP_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageExercisePrice" xlink:to="NTRP_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted Average Exercise Price Outstanding,Exercised</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_lbl" xml:lang="en-US">Warrants, Forfeited or cancelled</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageWeightedAverageExercisePriceWarrantsForfeitedOrCancelled" xlink:label="NTRP_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageWeightedAverageExercisePriceWarrantsForfeitedOrCancelled" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageWeightedAverageExercisePriceWarrantsForfeitedOrCancelled" xlink:to="NTRP_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageWeightedAverageExercisePriceWarrantsForfeitedOrCancelled_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageWeightedAverageExercisePriceWarrantsForfeitedOrCancelled_lbl" xml:lang="en-US">Weighted Average Exercise Price Outstanding, Forfeited or cancelled</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_2_lbl" xml:lang="en-US">Warrants Outstanding, Ending Balance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice" xlink:to="NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice_2_lbl" xml:lang="en-US">Weighted Average Exercise Price Outstanding, Ending Balance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_lbl" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_lbl" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_2_lbl" xml:lang="en-US">Common stock, par value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityReverseStockSplit" xlink:label="us-gaap_StockholdersEquityReverseStockSplit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityReverseStockSplit" xlink:to="us-gaap_StockholdersEquityReverseStockSplit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityReverseStockSplit_lbl" xml:lang="en-US">Reverse stock split</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits" xlink:label="us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits" xlink:to="us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits_lbl" xml:lang="en-US">Reverse stock split issued common shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_3_lbl" xml:lang="en-US">Conversion shares issued</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:to="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_2_lbl" xml:lang="en-US">Issuance of shares for services</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_3_lbl" xml:lang="en-US">Shares issued</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_3_lbl" xml:lang="en-US">Issuance of shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:to="us-gaap_StockIssuedDuringPeriodSharesAcquisitions_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesAcquisitions_2_lbl" xml:lang="en-US">Shares issued in acquisitions</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_StockIssuedDuringPeriodSharesWarrantExercises" xlink:label="NTRP_StockIssuedDuringPeriodSharesWarrantExercises" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_StockIssuedDuringPeriodSharesWarrantExercises" xlink:to="NTRP_StockIssuedDuringPeriodSharesWarrantExercises_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_StockIssuedDuringPeriodSharesWarrantExercises_lbl" xml:lang="en-US">Issuance of shares warrant exercises</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:label="us-gaap_ProceedsFromWarrantExercises" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromWarrantExercises" xlink:to="us-gaap_ProceedsFromWarrantExercises_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromWarrantExercises_lbl" xml:lang="en-US">Gross proceeds of warrant exercises</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_2_lbl" xml:lang="en-US">Net proceeds</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:label="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:to="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_lbl" xml:lang="en-US">Equity interest acquired</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:to="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_lbl" xml:lang="en-US">Restricted shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction" xlink:label="us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction" xlink:to="us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction_lbl" xml:lang="en-US">Percentage of issued and outstanding common shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:to="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_2_lbl" xml:lang="en-US">Shares issuable for consideration</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockRepurchasedDuringPeriodShares" xlink:label="us-gaap_StockRepurchasedDuringPeriodShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRepurchasedDuringPeriodShares" xlink:to="us-gaap_StockRepurchasedDuringPeriodShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockRepurchasedDuringPeriodShares_lbl" xml:lang="en-US">Purchase of shares issued</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xml:lang="en-US">Share based compensation expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockDividendRatePercentage" xlink:label="us-gaap_PreferredStockDividendRatePercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockDividendRatePercentage" xlink:to="us-gaap_PreferredStockDividendRatePercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockDividendRatePercentage_lbl" xml:lang="en-US">Dividend percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockConvertibleSharesIssuable" xlink:label="us-gaap_PreferredStockConvertibleSharesIssuable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockConvertibleSharesIssuable" xlink:to="us-gaap_PreferredStockConvertibleSharesIssuable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockConvertibleSharesIssuable_lbl" xml:lang="en-US">Common stock issuable upon conversion</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockRedemptionTerms" xlink:label="us-gaap_PreferredStockRedemptionTerms" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockRedemptionTerms" xlink:to="us-gaap_PreferredStockRedemptionTerms_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockRedemptionTerms_lbl" xml:lang="en-US">Preferred stock redemption right, description</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_2_lbl" xml:lang="en-US">Warrants to purchase common stock</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockPricePerShare" xlink:to="us-gaap_SaleOfStockPricePerShare_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SaleOfStockPricePerShare_2_lbl" xml:lang="en-US">Purchase price, per share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:label="us-gaap_SaleOfStockConsiderationReceivedOnTransaction" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:to="us-gaap_SaleOfStockConsiderationReceivedOnTransaction_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SaleOfStockConsiderationReceivedOnTransaction_lbl" xml:lang="en-US">Sale of stock proceeds</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:to="us-gaap_DebtConversionConvertedInstrumentAmount1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DebtConversionConvertedInstrumentAmount1_2_lbl" xml:lang="en-US">Converted amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xml:lang="en-US">Warrants exercise price</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromUnsecuredNotesPayable" xlink:label="us-gaap_ProceedsFromUnsecuredNotesPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromUnsecuredNotesPayable" xlink:to="us-gaap_ProceedsFromUnsecuredNotesPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromUnsecuredNotesPayable_lbl" xml:lang="en-US">Unsecured promissory notes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits_lbl" xml:lang="en-US">Common stock issuable upon conversion</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfWarrants" xlink:to="us-gaap_ProceedsFromIssuanceOfWarrants_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ProceedsFromIssuanceOfWarrants_2_lbl" xml:lang="en-US">Gross proceeds</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_lbl" xml:lang="en-US">Purchase of outstanding warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl" xml:lang="en-US">Common stock reserved for issuance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_3_lbl" xml:lang="en-US">Reverse acquisition shares outstanding</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_3_lbl" xml:lang="en-US">Weighted average exercise price</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_lbl" xml:lang="en-US">Share based compensation arrangement by award options vested</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CompensationExpenseExcludingCostOfGoodAndServiceSold" xlink:label="us-gaap_CompensationExpenseExcludingCostOfGoodAndServiceSold" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CompensationExpenseExcludingCostOfGoodAndServiceSold" xlink:to="us-gaap_CompensationExpenseExcludingCostOfGoodAndServiceSold_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CompensationExpenseExcludingCostOfGoodAndServiceSold_lbl" xml:lang="en-US">Compensation cost</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_2_lbl" xml:lang="en-US">Stock issued during Stock options exercised</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_3_lbl" xml:lang="en-US">Shares issued or exercised</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xml:lang="en-US">Options to purchase of common stock</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_2_lbl" xml:lang="en-US">Shares forfeited or expired</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensation_2_lbl" xml:lang="en-US">Allocation share based compensation expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="us-gaap_ProceedsFromStockOptionsExercised" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromStockOptionsExercised" xlink:to="us-gaap_ProceedsFromStockOptionsExercised_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromStockOptionsExercised_lbl" xml:lang="en-US">Stock options</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US">Options exercise price</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_lbl" xml:lang="en-US">Unrecognized stock-based compensation expense, stock option</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl" xml:lang="en-US">Weighted average remaining recognition period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_lbl" xml:lang="en-US">Unrecognized share based compensation cost</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardWeightedAverageRemainingRecognitionPeriod" xlink:label="NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardWeightedAverageRemainingRecognitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardWeightedAverageRemainingRecognitionPeriod" xlink:to="NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardWeightedAverageRemainingRecognitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardWeightedAverageRemainingRecognitionPeriod_lbl" xml:lang="en-US">Weighted average remaining recognition period</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_DescriptionForWarrantExpiration" xlink:label="NTRP_DescriptionForWarrantExpiration" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_DescriptionForWarrantExpiration" xlink:to="NTRP_DescriptionForWarrantExpiration_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_DescriptionForWarrantExpiration_lbl" xml:lang="en-US">Warrant description</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_3_lbl" xml:lang="en-US">Loss from continuing operations</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockDividendsIncomeStatementImpact" xlink:to="us-gaap_PreferredStockDividendsIncomeStatementImpact_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="us-gaap_PreferredStockDividendsIncomeStatementImpact_2_lbl" xml:lang="en-US">Preferred dividends</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperations" xlink:label="us-gaap_IncomeLossFromContinuingOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperations" xlink:to="us-gaap_IncomeLossFromContinuingOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperations_lbl" xml:lang="en-US">Loss from continuing operations applicable to common stockholders</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" xlink:label="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" xlink:to="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_lbl" xml:lang="en-US">Gain (loss) from discontinued operations applicable to common stockholders</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_2_lbl" xml:lang="en-US">Net loss applicable to common stockholders</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_2_lbl" xml:lang="en-US">Weighted average number of common shares Outstanding used in loss per share during the Period (denominator)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncrementalCommonSharesAttributableToContingentlyIssuableShares" xlink:label="us-gaap_IncrementalCommonSharesAttributableToContingentlyIssuableShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncrementalCommonSharesAttributableToContingentlyIssuableShares" xlink:to="us-gaap_IncrementalCommonSharesAttributableToContingentlyIssuableShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncrementalCommonSharesAttributableToContingentlyIssuableShares_lbl" xml:lang="en-US">Total contingent shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncrementalCommonSharesAttributableToContingentlyIssuableShares" xlink:to="us-gaap_IncrementalCommonSharesAttributableToContingentlyIssuableShares_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncrementalCommonSharesAttributableToContingentlyIssuableShares_2_lbl" xml:lang="en-US">Contingent shares issuable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_lbl" xml:lang="en-US">Earnings Per Share, Basic, by Common Class, Including Two-Class Method [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasicLineItems" xlink:label="us-gaap_EarningsPerShareBasicLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasicLineItems" xlink:to="us-gaap_EarningsPerShareBasicLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareBasicLineItems_lbl" xml:lang="en-US">Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_3_lbl" xml:lang="en-US">Weighted average common shares outstanding</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_3_lbl" xml:lang="en-US">Warrants outstanding to purchase common stock</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_3_lbl" xml:lang="en-US">Shares issuable upon exercisable of options</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConversionOfStockSharesConverted1" xlink:label="us-gaap_ConversionOfStockSharesConverted1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConversionOfStockSharesConverted1" xlink:to="us-gaap_ConversionOfStockSharesConverted1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConversionOfStockSharesConverted1_lbl" xml:lang="en-US">Number of shares converted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConversionOfStockSharesIssued1" xlink:label="us-gaap_ConversionOfStockSharesIssued1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConversionOfStockSharesIssued1" xlink:to="us-gaap_ConversionOfStockSharesIssued1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ConversionOfStockSharesIssued1_lbl" xml:lang="en-US">Common stock issuable upon conversion</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:label="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:to="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_lbl" xml:lang="en-US">Potentially dilutive securities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskTable" xlink:label="us-gaap_ConcentrationRiskTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskTable" xlink:to="us-gaap_ConcentrationRiskTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskTable_lbl" xml:lang="en-US">Concentration Risk [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskLineItems" xlink:label="us-gaap_ConcentrationRiskLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskLineItems" xlink:to="us-gaap_ConcentrationRiskLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskLineItems_lbl" xml:lang="en-US">Concentration Risk [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="us-gaap_ConcentrationRiskPercentage1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskPercentage1" xlink:to="us-gaap_ConcentrationRiskPercentage1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskPercentage1_lbl" xml:lang="en-US">Concentration of risk percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DescriptionOfDefinedContributionPensionAndOtherPostretirementPlans" xlink:label="us-gaap_DescriptionOfDefinedContributionPensionAndOtherPostretirementPlans" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DescriptionOfDefinedContributionPensionAndOtherPostretirementPlans" xlink:to="us-gaap_DescriptionOfDefinedContributionPensionAndOtherPostretirementPlans_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DescriptionOfDefinedContributionPensionAndOtherPostretirementPlans_lbl" xml:lang="en-US">Contribution plan description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedContributionPlanCostRecognized" xlink:label="us-gaap_DefinedContributionPlanCostRecognized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedContributionPlanCostRecognized" xlink:to="us-gaap_DefinedContributionPlanCostRecognized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DefinedContributionPlanCostRecognized_lbl" xml:lang="en-US">Cost of contribution</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncrementalCommonSharesAttributableToContingentlyIssuableShares" xlink:to="us-gaap_IncrementalCommonSharesAttributableToContingentlyIssuableShares_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncrementalCommonSharesAttributableToContingentlyIssuableShares_3_lbl" xml:lang="en-US">Number of contingent shares issued</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CommonStockSharesIssued_2_lbl" xml:lang="en-US">Common sock, shares issued</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockSharesOutstanding_3_lbl" xml:lang="en-US">Common sock, shares outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_CommonStockIssuedPercentage" xlink:label="NTRP_CommonStockIssuedPercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_CommonStockIssuedPercentage" xlink:to="NTRP_CommonStockIssuedPercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_CommonStockIssuedPercentage_lbl" xml:lang="en-US">Issued percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightReasonForIssuingToNonemployees" xlink:label="us-gaap_ClassOfWarrantOrRightReasonForIssuingToNonemployees" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightReasonForIssuingToNonemployees" xlink:to="us-gaap_ClassOfWarrantOrRightReasonForIssuingToNonemployees_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ClassOfWarrantOrRightReasonForIssuingToNonemployees_lbl" xml:lang="en-US">Warrant description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireBusinessesGross" xlink:label="us-gaap_PaymentsToAcquireBusinessesGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireBusinessesGross" xlink:to="us-gaap_PaymentsToAcquireBusinessesGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquireBusinessesGross_lbl" xml:lang="en-US">Payments to acquire businesses</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:to="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_2_lbl" xml:lang="en-US">Restricted shares, issued</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForFees" xlink:label="us-gaap_PaymentsForFees" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForFees" xlink:to="us-gaap_PaymentsForFees_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsForFees_lbl" xml:lang="en-US">License fee</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCredit" xlink:label="us-gaap_LineOfCredit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCredit" xlink:to="us-gaap_LineOfCredit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LineOfCredit_lbl" xml:lang="en-US">Line of credit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityExpirationDate1" xlink:label="us-gaap_LineOfCreditFacilityExpirationDate1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityExpirationDate1" xlink:to="us-gaap_LineOfCreditFacilityExpirationDate1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LineOfCreditFacilityExpirationDate1_lbl" xml:lang="en-US">Line of credit maturity date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityInterestRateDuringPeriod" xlink:label="us-gaap_LineOfCreditFacilityInterestRateDuringPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityInterestRateDuringPeriod" xlink:to="us-gaap_LineOfCreditFacilityInterestRateDuringPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LineOfCreditFacilityInterestRateDuringPeriod_lbl" xml:lang="en-US">Line of credit, interest rate</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityDescription" xlink:label="us-gaap_LineOfCreditFacilityDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityDescription" xlink:to="us-gaap_LineOfCreditFacilityDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LineOfCreditFacilityDescription_lbl" xml:lang="en-US">Line of credit advance description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromLinesOfCredit" xlink:label="us-gaap_ProceedsFromLinesOfCredit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromLinesOfCredit" xlink:to="us-gaap_ProceedsFromLinesOfCredit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromLinesOfCredit_lbl" xml:lang="en-US">Initial advance of line of credit</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_CashAdvance" xlink:label="NTRP_CashAdvance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_CashAdvance" xlink:to="NTRP_CashAdvance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_CashAdvance_lbl" xml:lang="en-US">Cash advance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentCarryingAmount" xlink:label="us-gaap_DebtInstrumentCarryingAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentCarryingAmount" xlink:to="us-gaap_DebtInstrumentCarryingAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DebtInstrumentCarryingAmount_lbl" xml:lang="en-US">Cash advance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet" xlink:label="us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet" xlink:to="us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet_lbl" xml:lang="en-US">Aditional advances</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod" xlink:label="us-gaap_LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod" xlink:to="us-gaap_LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod_lbl" xml:lang="en-US">Total advances of line of credit</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_PromissoryNoteReceivableNet" xlink:to="NTRP_PromissoryNoteReceivableNet_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_PromissoryNoteReceivableNet_doc" xml:lang="en-US">Promissory note receivable net.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_NextTripGroupLLCMember" xlink:to="NTRP_NextTripGroupLLCMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_NextTripGroupLLCMember_doc" xml:lang="en-US">NextTrip Holdings, Inc. [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_PercentageForIssuedAndOutstandingCapitalStock" xlink:to="NTRP_PercentageForIssuedAndOutstandingCapitalStock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_PercentageForIssuedAndOutstandingCapitalStock_doc" xml:lang="en-US">Percentage for issued and outstanding, capital stock.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_Technology" xlink:to="NTRP_Technology_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_Technology_doc" xml:lang="en-US">Technology.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_OrganizationCosts" xlink:to="NTRP_OrganizationCosts_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_OrganizationCosts_doc" xml:lang="en-US">Organization costs.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_LossOnRelatedPartyReceivable" xlink:to="NTRP_LossOnRelatedPartyReceivable_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_LossOnRelatedPartyReceivable_doc" xml:lang="en-US">Loss on related party receivable.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_StockIssuedDuringPeriodValueOfPreferredShares" xlink:to="NTRP_StockIssuedDuringPeriodValueOfPreferredShares_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_StockIssuedDuringPeriodValueOfPreferredShares_doc" xml:lang="en-US">Stock issued during period value of preferred shares.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_StockIssuedDuringPeriodValuePurchasesOfCommonShares" xlink:to="NTRP_StockIssuedDuringPeriodValuePurchasesOfCommonShares_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_StockIssuedDuringPeriodValuePurchasesOfCommonShares_doc" xml:lang="en-US">Stock issued during period value purchases of common shares.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_StockIssuedDuringPeriodValueReverseAcquisition" xlink:to="NTRP_StockIssuedDuringPeriodValueReverseAcquisition_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_StockIssuedDuringPeriodValueReverseAcquisition_doc" xml:lang="en-US">Stock issued during period value reverse acquisition.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_StockIssuedDuringPeriodValueOfPreferredSharesInPrivatePlacements" xlink:to="NTRP_StockIssuedDuringPeriodValueOfPreferredSharesInPrivatePlacements_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_StockIssuedDuringPeriodValueOfPreferredSharesInPrivatePlacements_doc" xml:lang="en-US">Stock issued during period value of preferred shares in private placements.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_ProceedsFromAcquireBusinessesGross" xlink:to="NTRP_ProceedsFromAcquireBusinessesGross_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_ProceedsFromAcquireBusinessesGross_doc" xml:lang="en-US">Proceeds from acquire businesses gross.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_IssuanceOfPreferredSharesForServices" xlink:to="NTRP_IssuanceOfPreferredSharesForServices_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_IssuanceOfPreferredSharesForServices_doc" xml:lang="en-US">Issuance of preferred shares for services.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_IssuanceOfPreferredSharesForPerpetualSoftwareLicense" xlink:to="NTRP_IssuanceOfPreferredSharesForPerpetualSoftwareLicense_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_IssuanceOfPreferredSharesForPerpetualSoftwareLicense_doc" xml:lang="en-US">Issuance of preferred shares for perpetual software license.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_ConversionOfConvertibleNotes" xlink:to="NTRP_ConversionOfConvertibleNotes_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_ConversionOfConvertibleNotes_doc" xml:lang="en-US">Conversion of convertible notes.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_PreferredStockDividends" xlink:to="NTRP_PreferredStockDividends_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_PreferredStockDividends_doc" xml:lang="en-US">Preferred stock dividends.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_IssuanceOfCommonSharesForServices" xlink:to="NTRP_IssuanceOfCommonSharesForServices_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_IssuanceOfCommonSharesForServices_doc" xml:lang="en-US">Issuance of common shares for services.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_IssuanceOfCommonSharesAsCommitmentShares" xlink:to="NTRP_IssuanceOfCommonSharesAsCommitmentShares_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_IssuanceOfCommonSharesAsCommitmentShares_doc" xml:lang="en-US">Issuance of common shares as commitment shares.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_IssuanceOfCommonWarrantsForServices" xlink:to="NTRP_IssuanceOfCommonWarrantsForServices_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_IssuanceOfCommonWarrantsForServices_doc" xml:lang="en-US">Issuance of common warrants for services.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_IssuanceOfCommonSharesForEquityInvestments" xlink:to="NTRP_IssuanceOfCommonSharesForEquityInvestments_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_IssuanceOfCommonSharesForEquityInvestments_doc" xml:lang="en-US">Issuance of common shares for equity investments.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_IssuanceOfPreferredSharesForEquityInvestments" xlink:to="NTRP_IssuanceOfPreferredSharesForEquityInvestments_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_IssuanceOfPreferredSharesForEquityInvestments_doc" xml:lang="en-US">Issuance of preferred shares for equity investments.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_AmortizationOfPrepaidExpenses" xlink:to="NTRP_AmortizationOfPrepaidExpenses_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_AmortizationOfPrepaidExpenses_doc" xml:lang="en-US">Amortization of prepaid expenses.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_InvestmentInEquityMethodInvestee" xlink:to="NTRP_InvestmentInEquityMethodInvestee_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_InvestmentInEquityMethodInvestee_doc" xml:lang="en-US">Investment in equity method investee.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_NextPlayTechnologiesIncMember" xlink:to="NTRP_NextPlayTechnologiesIncMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_NextPlayTechnologiesIncMember_doc" xml:lang="en-US">Next Play Technologies Inc [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_ShareExchangeAgreementMember" xlink:to="NTRP_ShareExchangeAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_ShareExchangeAgreementMember_doc" xml:lang="en-US">Share Exchange Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_MembershipUnitsMember" xlink:to="NTRP_MembershipUnitsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_MembershipUnitsMember_doc" xml:lang="en-US">Membership Units [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_PreferredUnitsMember" xlink:to="NTRP_PreferredUnitsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_PreferredUnitsMember_doc" xml:lang="en-US">Preferred Units [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_NextInnovationLLCMember" xlink:to="NTRP_NextInnovationLLCMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_NextInnovationLLCMember_doc" xml:lang="en-US">Next Innovation LLC [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_ClosingSharesMember" xlink:to="NTRP_ClosingSharesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_ClosingSharesMember_doc" xml:lang="en-US">Closing Shares [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_ContingentSharesMember" xlink:to="NTRP_ContingentSharesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_ContingentSharesMember_doc" xml:lang="en-US">Contingent Shares [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_WorkingCapitalDeficit" xlink:to="NTRP_WorkingCapitalDeficit_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_WorkingCapitalDeficit_doc" xml:lang="en-US">Working capital deficit.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_PrepaidsPolicyTextBlock" xlink:to="NTRP_PrepaidsPolicyTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_PrepaidsPolicyTextBlock_doc" xml:lang="en-US">Prepaids [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_BasisDifferencePolicyTextBlock" xlink:to="NTRP_BasisDifferencePolicyTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_BasisDifferencePolicyTextBlock_doc" xml:lang="en-US">Basis Difference [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_PromissoryNoteReceivablePolicyTextBlock" xlink:to="NTRP_PromissoryNoteReceivablePolicyTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_PromissoryNoteReceivablePolicyTextBlock_doc" xml:lang="en-US">Promissory Note Receivable [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_ScheduleOfEstimatedUsefulLivesForPropertyAndEquipmentTableTextBlock" xlink:to="NTRP_ScheduleOfEstimatedUsefulLivesForPropertyAndEquipmentTableTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_ScheduleOfEstimatedUsefulLivesForPropertyAndEquipmentTableTextBlock_doc" xml:lang="en-US">Schedule Of Estimated Useful Lives For Property And Equipment [Table Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_ScheduleOfEstimatedUsefulLivesForFiniteLifeIntangibleAssetsTableTextBlock" xlink:to="NTRP_ScheduleOfEstimatedUsefulLivesForFiniteLifeIntangibleAssetsTableTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_ScheduleOfEstimatedUsefulLivesForFiniteLifeIntangibleAssetsTableTextBlock_doc" xml:lang="en-US">Schedule of Estimated Useful Lives for Finite Life Intangible Assets [Table Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_SoftwareMember" xlink:to="NTRP_SoftwareMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_SoftwareMember_doc" xml:lang="en-US">Software [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_SoftwareLicensesMember" xlink:to="NTRP_SoftwareLicensesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_SoftwareLicensesMember_doc" xml:lang="en-US">Software Licenses [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_RecentlyIssuedAccountingPronouncementsNotYetAdoptedPolicyTextBlock" xlink:to="NTRP_RecentlyIssuedAccountingPronouncementsNotYetAdoptedPolicyTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_RecentlyIssuedAccountingPronouncementsNotYetAdoptedPolicyTextBlock_doc" xml:lang="en-US">Recently Issued Accounting Pronouncements Not Yet Adopted [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_AssetPurchaseAgreementMember" xlink:to="NTRP_AssetPurchaseAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_AssetPurchaseAgreementMember_doc" xml:lang="en-US">Asset Purchase Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_DivergentTechnologiesIncMember" xlink:to="NTRP_DivergentTechnologiesIncMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_DivergentTechnologiesIncMember_doc" xml:lang="en-US">Divergent Technologies, Inc. [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_EarnestMoneyDeposit" xlink:to="NTRP_EarnestMoneyDeposit_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_EarnestMoneyDeposit_doc" xml:lang="en-US">Earnest-money deposit</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_DisposalGroupIncludingDiscontinuedOperationsOtherIncome" xlink:to="NTRP_DisposalGroupIncludingDiscontinuedOperationsOtherIncome_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_DisposalGroupIncludingDiscontinuedOperationsOtherIncome_doc" xml:lang="en-US">Disposal group including discontinued operations other income</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_DisposalGroupIncludingDiscontinuedOperationsProfessionalServices" xlink:to="NTRP_DisposalGroupIncludingDiscontinuedOperationsProfessionalServices_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_DisposalGroupIncludingDiscontinuedOperationsProfessionalServices_doc" xml:lang="en-US">Disposal group including discontinued operations professional services.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_DisposalGroupIncludingDiscontinuedOperationsInvestorRelationsServices" xlink:to="NTRP_DisposalGroupIncludingDiscontinuedOperationsInvestorRelationsServices_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_DisposalGroupIncludingDiscontinuedOperationsInvestorRelationsServices_doc" xml:lang="en-US">Disposal group including discontinued operations investor relations services.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_StockIssuedDuringPeriodValueConversionOfPreferredSharesToCommonShares" xlink:to="NTRP_StockIssuedDuringPeriodValueConversionOfPreferredSharesToCommonShares_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_StockIssuedDuringPeriodValueConversionOfPreferredSharesToCommonShares_doc" xml:lang="en-US">Stock issued during period value conversion of preferred shares to common shares.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_StockIssuedDuringPeriodValueIssuanceOfPreferredSharesForDebtConversions" xlink:to="NTRP_StockIssuedDuringPeriodValueIssuanceOfPreferredSharesForDebtConversions_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_StockIssuedDuringPeriodValueIssuanceOfPreferredSharesForDebtConversions_doc" xml:lang="en-US">Stock issued during period value issuance of preferred shares for debt conversion.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_StockIssuedDuringPeriodValueIssuanceOfSecuritiesForServices" xlink:to="NTRP_StockIssuedDuringPeriodValueIssuanceOfSecuritiesForServices_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_StockIssuedDuringPeriodValueIssuanceOfSecuritiesForServices_doc" xml:lang="en-US">Stock issued during period value issuance of securities for services.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_StockIssuedDuringPeriodValueSecuritiesIssuedForEquityInvestments" xlink:to="NTRP_StockIssuedDuringPeriodValueSecuritiesIssuedForEquityInvestments_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_StockIssuedDuringPeriodValueSecuritiesIssuedForEquityInvestments_doc" xml:lang="en-US">Stock issued during period value securities issued for equity investments.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_StockIssuedDuringPeriodValueIssuanceOfCommitmentSharesForEquityLineOfCredit" xlink:to="NTRP_StockIssuedDuringPeriodValueIssuanceOfCommitmentSharesForEquityLineOfCredit_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_StockIssuedDuringPeriodValueIssuanceOfCommitmentSharesForEquityLineOfCredit_doc" xml:lang="en-US">Stock issued during period value issuance of commitment shares for equity line of credit.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_StockIssuedDuringPeriodShareOfPreferredShares" xlink:to="NTRP_StockIssuedDuringPeriodShareOfPreferredShares_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_StockIssuedDuringPeriodShareOfPreferredShares_doc" xml:lang="en-US">Stock issued during period share of preferred shares.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_StockIssuedDuringPeriodSharesReverseAcquisition" xlink:to="NTRP_StockIssuedDuringPeriodSharesReverseAcquisition_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_StockIssuedDuringPeriodSharesReverseAcquisition_doc" xml:lang="en-US">Stock issued during period shares reverse acquisition.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_StockIssuedDuringPeriodSharesPurchasesOfCommonShares" xlink:to="NTRP_StockIssuedDuringPeriodSharesPurchasesOfCommonShares_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_StockIssuedDuringPeriodSharesPurchasesOfCommonShares_doc" xml:lang="en-US">Stock issued during period shares purchases of common shares.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_StockIssuedDuringPeriodSharesOfPreferredSharesInPrivatePlacements" xlink:to="NTRP_StockIssuedDuringPeriodSharesOfPreferredSharesInPrivatePlacements_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_StockIssuedDuringPeriodSharesOfPreferredSharesInPrivatePlacements_doc" xml:lang="en-US">Stock issued during period shares of preferred shares in private placement.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_StockIssuedDuringPeriodSharesConversionOfPreferredSharesToCommonShares" xlink:to="NTRP_StockIssuedDuringPeriodSharesConversionOfPreferredSharesToCommonShares_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_StockIssuedDuringPeriodSharesConversionOfPreferredSharesToCommonShares_doc" xml:lang="en-US">Stock issued during period shares conversion of preferred shares to common shares.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_StockIssuedDuringPeriodSharesIssuanceOfPreferredSharesForDebtConversions" xlink:to="NTRP_StockIssuedDuringPeriodSharesIssuanceOfPreferredSharesForDebtConversions_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_StockIssuedDuringPeriodSharesIssuanceOfPreferredSharesForDebtConversions_doc" xml:lang="en-US">Stock issued during period shares issuance of preferred shares for debt conversion.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_StockIssuedDuringPeriodSharesIssuanceOfSecuritiesForServices" xlink:to="NTRP_StockIssuedDuringPeriodSharesIssuanceOfSecuritiesForServices_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_StockIssuedDuringPeriodSharesIssuanceOfSecuritiesForServices_doc" xml:lang="en-US">Stock issued during period shares issuance of securities for services.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_StockIssuedDuringPeriodSharseSecuritiesIssuedForEquityInvestments" xlink:to="NTRP_StockIssuedDuringPeriodSharseSecuritiesIssuedForEquityInvestments_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_StockIssuedDuringPeriodSharseSecuritiesIssuedForEquityInvestments_doc" xml:lang="en-US">Stock issued during period shares securities issued for equity investments.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_StockIssuedDuringPeriodSharesIssuanceOfCommitmentSharesForEquityLineOfCredit" xlink:to="NTRP_StockIssuedDuringPeriodSharesIssuanceOfCommitmentSharesForEquityLineOfCredit_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_StockIssuedDuringPeriodSharesIssuanceOfCommitmentSharesForEquityLineOfCredit_doc" xml:lang="en-US">Stock issued during period shares issuance of commitment shares for equity line of credit.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_MembershipPurchaseAgreementMember" xlink:to="NTRP_MembershipPurchaseAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_MembershipPurchaseAgreementMember_doc" xml:lang="en-US">Membership Purchase Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_FSATravelLLCMember" xlink:to="NTRP_FSATravelLLCMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_FSATravelLLCMember_doc" xml:lang="en-US">FSA Travel LLC [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_NextTripMember" xlink:to="NTRP_NextTripMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_NextTripMember_doc" xml:lang="en-US">Next Trip [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_SeriesOPreferredStockMember" xlink:to="NTRP_SeriesOPreferredStockMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_SeriesOPreferredStockMember_doc" xml:lang="en-US">Series O Preferred Stock [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_BusinessAcquisitionMilestonePayments" xlink:to="NTRP_BusinessAcquisitionMilestonePayments_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_BusinessAcquisitionMilestonePayments_doc" xml:lang="en-US">Business acquisition milestone payments.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_BusinessAcquisitionPerMilestonePayments" xlink:to="NTRP_BusinessAcquisitionPerMilestonePayments_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_BusinessAcquisitionPerMilestonePayments_doc" xml:lang="en-US">Business acquisition per milestone payments.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_BlueFyshHoldingsIncMember" xlink:to="NTRP_BlueFyshHoldingsIncMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_BlueFyshHoldingsIncMember_doc" xml:lang="en-US">Blue Fysh Holdings Inc [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_SeriesNNonvotingConvertiblePreferredStockMember" xlink:to="NTRP_SeriesNNonvotingConvertiblePreferredStockMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_SeriesNNonvotingConvertiblePreferredStockMember_doc" xml:lang="en-US">Series N Nonvoting Convertible Preferred Stock [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_LossOnDispositionOfAssets" xlink:to="NTRP_LossOnDispositionOfAssets_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_LossOnDispositionOfAssets_doc" xml:lang="en-US">Loss on disposition of assets.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestment" xlink:to="NTRP_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestment_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestment_doc" xml:lang="en-US">Income loss from continuing operations before income taxes minority interest and income loss from equity method investment.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_PrepaidExpensesAndOtherCurrentAssetsTextBlock" xlink:to="NTRP_PrepaidExpensesAndOtherCurrentAssetsTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_PrepaidExpensesAndOtherCurrentAssetsTextBlock_doc" xml:lang="en-US">Prepaid Expenses and Other Current Assets [Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_PrepaidCostOfSales" xlink:to="NTRP_PrepaidCostOfSales_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_PrepaidCostOfSales_doc" xml:lang="en-US">Prepaid cost of sales.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_PrepaidOfferingCosts" xlink:to="NTRP_PrepaidOfferingCosts_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_PrepaidOfferingCosts_doc" xml:lang="en-US">Prepaid offering costs.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour" xlink:to="NTRP_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour_doc" xml:lang="en-US">Finite lived intangible assets amortization expense after year four.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_SigmaAdditiveSolutionsIncMember" xlink:to="NTRP_SigmaAdditiveSolutionsIncMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_SigmaAdditiveSolutionsIncMember_doc" xml:lang="en-US">Sigma Additive Solutions Inc. [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses" xlink:to="NTRP_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses_doc" xml:lang="en-US">Business combination recognized identifiable assets acquired and liabilities assumed current liabilities accrued expenses.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_NextTripHoldingsIncMember" xlink:to="NTRP_NextTripHoldingsIncMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_NextTripHoldingsIncMember_doc" xml:lang="en-US">Next Trip Holdings Inc [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_OperatingLossCarryforwardsRemainder" xlink:to="NTRP_OperatingLossCarryforwardsRemainder_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_OperatingLossCarryforwardsRemainder_doc" xml:lang="en-US">Operating loss carryforwards remainder.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_DeferredTaxAssetDepreciation" xlink:to="NTRP_DeferredTaxAssetDepreciation_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_DeferredTaxAssetDepreciation_doc" xml:lang="en-US">Deferred tax asset depreciation.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_DeferredTaxAssetsPayrollAccruals" xlink:to="NTRP_DeferredTaxAssetsPayrollAccruals_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_DeferredTaxAssetsPayrollAccruals_doc" xml:lang="en-US">Deferred tax assets payroll accruals.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_DeferredTaxLiabilitiesDepreciation" xlink:to="NTRP_DeferredTaxLiabilitiesDepreciation_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_DeferredTaxLiabilitiesDepreciation_doc" xml:lang="en-US">Deferred tax liabilities depreciation.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_EffectiveIncomeTaxRateReconciliationBookLoss" xlink:to="NTRP_EffectiveIncomeTaxRateReconciliationBookLoss_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_EffectiveIncomeTaxRateReconciliationBookLoss_doc" xml:lang="en-US">Effective income tax rate reconciliation book loss.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_IncomeTaxReconciliationNondeductibleExpensePreferredDividends" xlink:to="NTRP_IncomeTaxReconciliationNondeductibleExpensePreferredDividends_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_IncomeTaxReconciliationNondeductibleExpensePreferredDividends_doc" xml:lang="en-US">Income tax reconciliation nondeductible expense preferred dividends.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_IncomeTaxReconciliationNondeductibleExpenseLossOnAssetDisposal" xlink:to="NTRP_IncomeTaxReconciliationNondeductibleExpenseLossOnAssetDisposal_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_IncomeTaxReconciliationNondeductibleExpenseLossOnAssetDisposal_doc" xml:lang="en-US">Income tax reconciliation nondeductible expense loss on asset disposal.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_IncomeTaxReconciliationNondeductibleExpenseAccruedPayroll" xlink:to="NTRP_IncomeTaxReconciliationNondeductibleExpenseAccruedPayroll_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_IncomeTaxReconciliationNondeductibleExpenseAccruedPayroll_doc" xml:lang="en-US">Income tax reconciliation nondeductible expense accrued payroll.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_IncomeTaxReconciliationNondeductibleExpenseRelatedPartyAccruals" xlink:to="NTRP_IncomeTaxReconciliationNondeductibleExpenseRelatedPartyAccruals_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_IncomeTaxReconciliationNondeductibleExpenseRelatedPartyAccruals_doc" xml:lang="en-US">Income tax reconciliation nondeductible expense related party accruals.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_SpecialPurposeAcquisitionCorporationMember" xlink:to="NTRP_SpecialPurposeAcquisitionCorporationMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_SpecialPurposeAcquisitionCorporationMember_doc" xml:lang="en-US">Special Purpose Acquisition Corporation [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_SeveralInvestorsMember" xlink:to="NTRP_SeveralInvestorsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_SeveralInvestorsMember_doc" xml:lang="en-US">Several Investors [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_ConvertibleNotesMember" xlink:to="NTRP_ConvertibleNotesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_ConvertibleNotesMember_doc" xml:lang="en-US">Convertible Notes [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_DebtAssignmentAndConversionAgreementsMember" xlink:to="NTRP_DebtAssignmentAndConversionAgreementsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_DebtAssignmentAndConversionAgreementsMember_doc" xml:lang="en-US">Debt Assignment and Conversion Agreements [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_SharePurchaseAgreementsDisclosureTextBlock" xlink:to="NTRP_SharePurchaseAgreementsDisclosureTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_SharePurchaseAgreementsDisclosureTextBlock_doc" xml:lang="en-US">Share Purchase Agreements Disclosure [Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_SharePurchaseAgreementsMember" xlink:to="NTRP_SharePurchaseAgreementsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_SharePurchaseAgreementsMember_doc" xml:lang="en-US">Share Purchase Agreements [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_ProceedsFromDownpaymentForContract" xlink:to="NTRP_ProceedsFromDownpaymentForContract_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_ProceedsFromDownpaymentForContract_doc" xml:lang="en-US">Proceeds from down-payment for contract.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_SoftwareAsAServiceAgreementMember" xlink:to="NTRP_SoftwareAsAServiceAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_SoftwareAsAServiceAgreementMember_doc" xml:lang="en-US">Software as a Service Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_ThirdPartyMember" xlink:to="NTRP_ThirdPartyMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_ThirdPartyMember_doc" xml:lang="en-US">Third Party [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_ThirdPartyConsultantMember" xlink:to="NTRP_ThirdPartyConsultantMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_ThirdPartyConsultantMember_doc" xml:lang="en-US">Third Party Consultant [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_ConsultingFees" xlink:to="NTRP_ConsultingFees_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_ConsultingFees_doc" xml:lang="en-US">Consulting fees.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_ConsultingModificationAgreementMember" xlink:to="NTRP_ConsultingModificationAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_ConsultingModificationAgreementMember_doc" xml:lang="en-US">Consulting Modification Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_AtTheMarketIssuanceSalesAgreementMember" xlink:to="NTRP_AtTheMarketIssuanceSalesAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_AtTheMarketIssuanceSalesAgreementMember_doc" xml:lang="en-US">At-The-Market Issuance Sales Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_SharePurchaseAndExchangeAgreementsMember" xlink:to="NTRP_SharePurchaseAndExchangeAgreementsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_SharePurchaseAndExchangeAgreementsMember_doc" xml:lang="en-US">Share Purchase And Exchange Agreements [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_SeriesEConvertiblePreferredStockMember" xlink:to="NTRP_SeriesEConvertiblePreferredStockMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_SeriesEConvertiblePreferredStockMember_doc" xml:lang="en-US">Series E Convertible Preferred Stock [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_SeriesFConvertiblePreferredStockMember" xlink:to="NTRP_SeriesFConvertiblePreferredStockMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_SeriesFConvertiblePreferredStockMember_doc" xml:lang="en-US">Series F Convertible Preferred Stock [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_SeriesGConvertiblePreferredStockMember" xlink:to="NTRP_SeriesGConvertiblePreferredStockMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_SeriesGConvertiblePreferredStockMember_doc" xml:lang="en-US">Series G Convertible Preferred Stock [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_SeriesHConvertiblePreferredStockMember" xlink:to="NTRP_SeriesHConvertiblePreferredStockMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_SeriesHConvertiblePreferredStockMember_doc" xml:lang="en-US">Series H Convertible Preferred Stock [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_SeriesIConvertiblePreferredStockMember" xlink:to="NTRP_SeriesIConvertiblePreferredStockMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_SeriesIConvertiblePreferredStockMember_doc" xml:lang="en-US">Series I Convertible Preferred Stock [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_SecuritiesPurchaseAgreementMember" xlink:to="NTRP_SecuritiesPurchaseAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_SecuritiesPurchaseAgreementMember_doc" xml:lang="en-US">Securities Purchase Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_SeriesIPurchaseAgreementMember" xlink:to="NTRP_SeriesIPurchaseAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_SeriesIPurchaseAgreementMember_doc" xml:lang="en-US">Series I Purchase Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_SeriesIPreferredStockMember" xlink:to="NTRP_SeriesIPreferredStockMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_SeriesIPreferredStockMember_doc" xml:lang="en-US">Series I Preferred Stock [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_DebtConversionAgreementMember" xlink:to="NTRP_DebtConversionAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_DebtConversionAgreementMember_doc" xml:lang="en-US">Debt Conversion Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_SeriesJPreferredStockMember" xlink:to="NTRP_SeriesJPreferredStockMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_SeriesJPreferredStockMember_doc" xml:lang="en-US">Series J Preferred Stock [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_RelatedPartyDebtConversionAgreementsMember" xlink:to="NTRP_RelatedPartyDebtConversionAgreementsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_RelatedPartyDebtConversionAgreementsMember_doc" xml:lang="en-US">Related Party Debt Conversion Agreements [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_MessrsKerbyAndMonacoMember" xlink:to="NTRP_MessrsKerbyAndMonacoMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_MessrsKerbyAndMonacoMember_doc" xml:lang="en-US">Messrs Kerby And Monaco [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_SeriesMNonvotingConvertiblePreferredStockMember" xlink:to="NTRP_SeriesMNonvotingConvertiblePreferredStockMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_SeriesMNonvotingConvertiblePreferredStockMember_doc" xml:lang="en-US">Series M Nonvoting Convertible Preferred Stock [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_SeriesMPreferredStockMember" xlink:to="NTRP_SeriesMPreferredStockMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_SeriesMPreferredStockMember_doc" xml:lang="en-US">Series M Preferred Stock [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_SeriesNNonvotingConvertibleConvertiblePreferredStockMember" xlink:to="NTRP_SeriesNNonvotingConvertibleConvertiblePreferredStockMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_SeriesNNonvotingConvertibleConvertiblePreferredStockMember_doc" xml:lang="en-US">Series N Nonvoting Convertible Convertible Preferred Stock [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_StockAppreciationRightsMember" xlink:to="NTRP_StockAppreciationRightsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_StockAppreciationRightsMember_doc" xml:lang="en-US">Stock Appreciation Rights [Member].</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_TwoThousandAndTwentyStockAppreciationRightsPlanMember" xlink:to="NTRP_TwoThousandAndTwentyStockAppreciationRightsPlanMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_TwoThousandAndTwentyStockAppreciationRightsPlanMember_doc" xml:lang="en-US">2020 Stock Appreciation Rights Plan [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedorCancelledInPeriodTotalIntrinsicValue" xlink:to="NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedorCancelledInPeriodTotalIntrinsicValue_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedorCancelledInPeriodTotalIntrinsicValue_doc" xml:lang="en-US">Share based compensation arrangement by share based payment award options for feited or cancelled in period total intrinsic value.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_TwoThousandTwentyThreeEquityIncentivePlanMember" xlink:to="NTRP_TwoThousandTwentyThreeEquityIncentivePlanMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_TwoThousandTwentyThreeEquityIncentivePlanMember_doc" xml:lang="en-US">2023 Equity Incentive Plan [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_TwoThousandThirteenEquityIncentivePlanMember" xlink:to="NTRP_TwoThousandThirteenEquityIncentivePlanMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_TwoThousandThirteenEquityIncentivePlanMember_doc" xml:lang="en-US">2013 Equity Incentive Plan [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardWeightedAverageRemainingRecognitionPeriod" xlink:to="NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardWeightedAverageRemainingRecognitionPeriod_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardWeightedAverageRemainingRecognitionPeriod_doc" xml:lang="en-US">Weighted average remaining recognition period.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_DescriptionForWarrantExpiration" xlink:to="NTRP_DescriptionForWarrantExpiration_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_DescriptionForWarrantExpiration_doc" xml:lang="en-US">Description for warrant expiration.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice" xlink:to="NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice_doc" xml:lang="en-US">Weighted average exercise price, warrants outstanding.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="NTRP_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageExercisePrice_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageExercisePrice_doc" xml:lang="en-US">Weighted average exercise price, warrants grants.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageExercisePrice" xlink:to="NTRP_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageExercisePrice_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageExercisePrice_doc" xml:lang="en-US">Weighted average exercise price, warrants exercised.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageWeightedAverageExercisePriceWarrantsForfeitedOrCancelled" xlink:to="NTRP_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageWeightedAverageExercisePriceWarrantsForfeitedOrCancelled_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageWeightedAverageExercisePriceWarrantsForfeitedOrCancelled_doc" xml:lang="en-US">Weighted average exercise price, warrants forfeited or cancelled.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonOutstandingWeightedAverageRemainingContractualTerm" xlink:to="NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonOutstandingWeightedAverageRemainingContractualTerm_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonOutstandingWeightedAverageRemainingContractualTerm_doc" xml:lang="en-US">Weighted average remaining contractual life (years), warrants outstanding, beginning balance.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonGrantsWeightedAverageRemainingContractualTerm" xlink:to="NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonGrantsWeightedAverageRemainingContractualTerm_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonGrantsWeightedAverageRemainingContractualTerm_doc" xml:lang="en-US">Share based compensation arrangement by share based payment award options non grants weighted average remaining contractual term.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_AchievedMember" xlink:to="NTRP_AchievedMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_AchievedMember_doc" xml:lang="en-US">Achieved [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_LeisureTravelBookingPlatformMember" xlink:to="NTRP_LeisureTravelBookingPlatformMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_LeisureTravelBookingPlatformMember_doc" xml:lang="en-US">Leisure Travel Booking Platform [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_GroupTravelBookingPlatformMember" xlink:to="NTRP_GroupTravelBookingPlatformMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_GroupTravelBookingPlatformMember_doc" xml:lang="en-US">Group Travel Booking Platform [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_FlexPayTechnologyMember" xlink:to="NTRP_FlexPayTechnologyMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_FlexPayTechnologyMember_doc" xml:lang="en-US">Flex Pay Technology [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_NotAchievedMember" xlink:to="NTRP_NotAchievedMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_NotAchievedMember_doc" xml:lang="en-US">Not Achieved [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_TravelAgentPlatformMember" xlink:to="NTRP_TravelAgentPlatformMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_TravelAgentPlatformMember_doc" xml:lang="en-US">Travel Agent Platform [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_SeriesKPreferredStockMember" xlink:to="NTRP_SeriesKPreferredStockMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_SeriesKPreferredStockMember_doc" xml:lang="en-US">Series K Preferred Stock [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_SeriesLPreferredStockMember" xlink:to="NTRP_SeriesLPreferredStockMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_SeriesLPreferredStockMember_doc" xml:lang="en-US">Series L Preferred Stock [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_SeriesNPreferredStockMember" xlink:to="NTRP_SeriesNPreferredStockMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_SeriesNPreferredStockMember_doc" xml:lang="en-US">Series N Preferred Stock [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_SeriesOPreferredStockOneMember" xlink:to="NTRP_SeriesOPreferredStockOneMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_SeriesOPreferredStockOneMember_doc" xml:lang="en-US">Series O Preferred Stock One [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_PrepaidConsultingContract" xlink:to="NTRP_PrepaidConsultingContract_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_PrepaidConsultingContract_doc" xml:lang="en-US">Prepaid consulting contract.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_DeferredRevenueTextBlock" xlink:to="NTRP_DeferredRevenueTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_DeferredRevenueTextBlock_doc" xml:lang="en-US">Deferred Revenue [Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_AlumniCapitalLPMember" xlink:to="NTRP_AlumniCapitalLPMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_AlumniCapitalLPMember_doc" xml:lang="en-US">Alumni Capital LP [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_StockIssuedDuringPeriodSharesWarrantExercises" xlink:to="NTRP_StockIssuedDuringPeriodSharesWarrantExercises_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_StockIssuedDuringPeriodSharesWarrantExercises_doc" xml:lang="en-US">Shares of warrant exercises.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_MillerDebtConversionAgreementMember" xlink:to="NTRP_MillerDebtConversionAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_MillerDebtConversionAgreementMember_doc" xml:lang="en-US">Miller Debt Conversion Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_SeriesKNonvotingConvertiblePreferredStockMember" xlink:to="NTRP_SeriesKNonvotingConvertiblePreferredStockMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_SeriesKNonvotingConvertiblePreferredStockMember_doc" xml:lang="en-US">Series K Nonvoting Convertible Preferred Stock [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_SeriesJNonvotingConvertiblePreferredStockMember" xlink:to="NTRP_SeriesJNonvotingConvertiblePreferredStockMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_SeriesJNonvotingConvertiblePreferredStockMember_doc" xml:lang="en-US">Series J Nonvoting Convertible Preferred Stock [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_SeriesLNonvotingConvertiblePreferredStockMember" xlink:to="NTRP_SeriesLNonvotingConvertiblePreferredStockMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_SeriesLNonvotingConvertiblePreferredStockMember_doc" xml:lang="en-US">Series L Nonvoting Convertible Preferred Stock [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_SeriesONonvotingConvertiblePreferredStockMember" xlink:to="NTRP_SeriesONonvotingConvertiblePreferredStockMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_SeriesONonvotingConvertiblePreferredStockMember_doc" xml:lang="en-US">Series O Nonvoting Convertible Preferred Stock [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_SeriesPNonvotingConvertiblePreferredStockMember" xlink:to="NTRP_SeriesPNonvotingConvertiblePreferredStockMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_SeriesPNonvotingConvertiblePreferredStockMember_doc" xml:lang="en-US">Series P Nonvoting Convertible Preferred Stock [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_DebtExchangeAgreementMember" xlink:to="NTRP_DebtExchangeAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_DebtExchangeAgreementMember_doc" xml:lang="en-US">Debt Exchange Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_EquityInvestmentAgreementMember" xlink:to="NTRP_EquityInvestmentAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_EquityInvestmentAgreementMember_doc" xml:lang="en-US">Equity Investment Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageForfeitedOrCancelled" xlink:to="NTRP_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageForfeitedOrCancelled_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageForfeitedOrCancelled_doc" xml:lang="en-US">Forfeited or cancelled.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_CustomerMember" xlink:to="NTRP_CustomerMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_CustomerMember_doc" xml:lang="en-US">Customer [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_TwoPromissoryNotesMember" xlink:to="NTRP_TwoPromissoryNotesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_TwoPromissoryNotesMember_doc" xml:lang="en-US">Two Promissory Notes [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_FirstPromissoryNoteMember" xlink:label="NTRP_FirstPromissoryNoteMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_FirstPromissoryNoteMember" xlink:to="NTRP_FirstPromissoryNoteMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_FirstPromissoryNoteMember_doc" xml:lang="en-US">First Promissory Note [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_SecondPromissoryNoteMember" xlink:label="NTRP_SecondPromissoryNoteMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_SecondPromissoryNoteMember" xlink:to="NTRP_SecondPromissoryNoteMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_SecondPromissoryNoteMember_doc" xml:lang="en-US">Second Promissory Note [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_PurchaseAgreementMember" xlink:to="NTRP_PurchaseAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_PurchaseAgreementMember_doc" xml:lang="en-US">Purchase Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_ExchangeAgreementMember" xlink:to="NTRP_ExchangeAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_ExchangeAgreementMember_doc" xml:lang="en-US">Exchange Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_LineOfCreditAgreementMember" xlink:to="NTRP_LineOfCreditAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_LineOfCreditAgreementMember_doc" xml:lang="en-US">Line of Credit Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_SoftwareLicenseMember" xlink:to="NTRP_SoftwareLicenseMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_SoftwareLicenseMember_doc" xml:lang="en-US">Software License [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_CashAdvance" xlink:to="NTRP_CashAdvance_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_CashAdvance_doc" xml:lang="en-US">Cash advance.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_CommonStockIssuedPercentage" xlink:to="NTRP_CommonStockIssuedPercentage_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_CommonStockIssuedPercentage_doc" xml:lang="en-US">Common stock issued percentage.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_NoteOneMember" xlink:to="NTRP_NoteOneMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_NoteOneMember_doc" xml:lang="en-US">Note One [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_NoteTwoMember" xlink:to="NTRP_NoteTwoMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_NoteTwoMember_doc" xml:lang="en-US">Note Two [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_NoteSecuritiesPurchaseAgreementMember" xlink:to="NTRP_NoteSecuritiesPurchaseAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_NoteSecuritiesPurchaseAgreementMember_doc" xml:lang="en-US">Note Securities Purchase Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_ShortTermPromissoryNoteMember" xlink:to="NTRP_ShortTermPromissoryNoteMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_ShortTermPromissoryNoteMember_doc" xml:lang="en-US">Short Term Promissory Note [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_BoardOfDirectorsAndChiefExecutiveOfficerMember" xlink:label="NTRP_BoardOfDirectorsAndChiefExecutiveOfficerMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_BoardOfDirectorsAndChiefExecutiveOfficerMember" xlink:to="NTRP_BoardOfDirectorsAndChiefExecutiveOfficerMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_BoardOfDirectorsAndChiefExecutiveOfficerMember_doc" xml:lang="en-US">Board of Directors and Chief Executive Officer [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_NoteTwoSecuritiesPurchaseAgreementMember" xlink:to="NTRP_NoteTwoSecuritiesPurchaseAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_NoteTwoSecuritiesPurchaseAgreementMember_doc" xml:lang="en-US">Note Two Securities Purchase Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_OneMillionNoteMember" xlink:to="NTRP_OneMillionNoteMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_OneMillionNoteMember_doc" xml:lang="en-US">One Million Note [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Assets_2_lbl" xml:lang="en-US">Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Liabilities_2_lbl" xml:lang="en-US">Liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_2_lbl" xml:lang="en-US">Liabilities and Equity</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfRevenue" xlink:to="us-gaap_CostOfRevenue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostOfRevenue_2_lbl" xml:lang="en-US">Cost of Revenue</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingExpenses_2_lbl" xml:lang="en-US">Operating Expenses [Default Label]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingIncomeLoss_2_lbl" xml:lang="en-US">Operating Income (Loss)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_NonoperatingIncomeExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NonoperatingIncomeExpense_2_lbl" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_lbl" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxExpenseBenefit_3_lbl" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestment" xlink:to="NTRP_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestment_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestment_3_lbl" xml:lang="en-US">IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockDividendsIncomeStatementImpact" xlink:to="us-gaap_PreferredStockDividendsIncomeStatementImpact_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockDividendsIncomeStatementImpact_3_lbl" xml:lang="en-US">Preferred Stock Dividends, Income Statement Impact</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharesOutstanding_3_lbl" xml:lang="en-US">Shares, Outstanding</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DividendsPreferredStock" xlink:to="us-gaap_DividendsPreferredStock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DividendsPreferredStock_2_lbl" xml:lang="en-US">Dividends, Preferred Stock</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:to="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_2_lbl" xml:lang="en-US">Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_LossOnDispositionOfAssets" xlink:to="NTRP_LossOnDispositionOfAssets_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_LossOnDispositionOfAssets_3_lbl" xml:lang="en-US">LossOnDispositionOfAssets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_2_lbl" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:to="us-gaap_IncreaseDecreaseInPrepaidExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpense_2_lbl" xml:lang="en-US">Increase (Decrease) in Prepaid Expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInSecurityDeposits" xlink:to="us-gaap_IncreaseDecreaseInSecurityDeposits_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInSecurityDeposits_2_lbl" xml:lang="en-US">Increase (Decrease) in Security Deposits</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:to="us-gaap_IncreaseDecreaseInDeferredRevenue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInDeferredRevenue_2_lbl" xml:lang="en-US">Increase (Decrease) in Deferred Revenue</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities, Continuing Operations</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForSoftware" xlink:to="us-gaap_PaymentsForSoftware_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsForSoftware_2_lbl" xml:lang="en-US">Payments for Software</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_InvestmentInEquityMethodInvestee" xlink:to="NTRP_InvestmentInEquityMethodInvestee_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_InvestmentInEquityMethodInvestee_3_lbl" xml:lang="en-US">InvestmentInEquityMethodInvestee</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_ProceedsFromAcquireBusinessesGross" xlink:to="NTRP_ProceedsFromAcquireBusinessesGross_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_ProceedsFromAcquireBusinessesGross_3_lbl" xml:lang="en-US">ProceedsFromAcquireBusinessesGross</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_lbl" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_3_lbl" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ForgoneRecoveryIndName" xlink:to="ecd_ForgoneRecoveryIndName_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ForgoneRecoveryIndName_2_lbl" xml:lang="en-US">Forgone Recovery, Individual Name</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_OutstandingRecoveryIndName" xlink:to="ecd_OutstandingRecoveryIndName_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_OutstandingRecoveryIndName_2_lbl" xml:lang="en-US">Outstanding Recovery, Individual Name</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardsCloseToMnpiDiscIndName" xlink:to="ecd_AwardsCloseToMnpiDiscIndName_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardsCloseToMnpiDiscIndName_2_lbl" xml:lang="en-US">Awards Close in Time to MNPI Disclosures, Individual Name</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrIndName" xlink:to="ecd_TrdArrIndName_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TrdArrIndName_2_lbl" xml:lang="en-US">Trading Arrangement, Individual Name</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillDisclosureTextBlock" xlink:to="us-gaap_GoodwillDisclosureTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GoodwillDisclosureTextBlock_2_lbl" xml:lang="en-US">Goodwill Disclosure [Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_ConvertibleDebtDisclosureTextBlock" xlink:to="NTRP_ConvertibleDebtDisclosureTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_ConvertibleDebtDisclosureTextBlock_2_lbl" xml:lang="en-US">ConvertibleDebtDisclosureTextBlock</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_SharePurchaseAgreementsDisclosureTextBlock" xlink:to="NTRP_SharePurchaseAgreementsDisclosureTextBlock_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_SharePurchaseAgreementsDisclosureTextBlock_3_lbl" xml:lang="en-US">Share Purchase Agreements Disclosure [Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_DeferredRevenueTextBlock" xlink:to="NTRP_DeferredRevenueTextBlock_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_DeferredRevenueTextBlock_3_lbl" xml:lang="en-US">Deferred Revenue [Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_2_lbl" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_2_lbl" xml:lang="en-US">Earnings Per Share, Policy [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_2_lbl" xml:lang="en-US">Property, Plant and Equipment, Policy [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_2_lbl" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="us-gaap_FiniteLivedIntangibleAssetUsefulLife_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife_2_lbl" xml:lang="en-US">Finite-Lived Intangible Asset, Useful Life</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotesPayable" xlink:to="us-gaap_NotesPayable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NotesPayable_2_lbl" xml:lang="en-US">Notes Payable [Default Label]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue_2_lbl" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Revenue</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss_2_lbl" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Gross Profit (Loss)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense_2_lbl" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Operating Expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireBusinessesAndInterestInAffiliates" xlink:to="us-gaap_PaymentsToAcquireBusinessesAndInterestInAffiliates_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquireBusinessesAndInterestInAffiliates_2_lbl" xml:lang="en-US">Payments to Acquire Businesses and Interest in Affiliates</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherPrepaidExpenseCurrent" xlink:to="us-gaap_OtherPrepaidExpenseCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherPrepaidExpenseCurrent_2_lbl" xml:lang="en-US">Other Prepaid Expense, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_2_lbl" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="us-gaap_FiniteLivedIntangibleAssetsGross_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross_2_lbl" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_2_lbl" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet_2_lbl" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_2_lbl" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_2_lbl" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_2_lbl" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_2_lbl" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses" xlink:to="NTRP_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses_3_lbl" xml:lang="en-US">BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_2_lbl" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Deferred Revenue</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_2_lbl" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_2_lbl" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillPeriodIncreaseDecrease" xlink:to="us-gaap_GoodwillPeriodIncreaseDecrease_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GoodwillPeriodIncreaseDecrease_2_lbl" xml:lang="en-US">Goodwill, Period Increase (Decrease)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableCurrentAndNoncurrent" xlink:to="us-gaap_AccountsPayableCurrentAndNoncurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableCurrentAndNoncurrent_2_lbl" xml:lang="en-US">Accounts Payable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedLiabilitiesCurrentAndNoncurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrentAndNoncurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedLiabilitiesCurrentAndNoncurrent_2_lbl" xml:lang="en-US">Accrued Liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_DeferredTaxLiabilitiesDepreciation" xlink:to="NTRP_DeferredTaxLiabilitiesDepreciation_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_DeferredTaxLiabilitiesDepreciation_3_lbl" xml:lang="en-US">Deferred tax liabilities depreciation</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsNet_2_lbl" xml:lang="en-US">Deferred Tax Assets, Net of Valuation Allowance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_IncomeTaxReconciliationNondeductibleExpenseRelatedPartyAccruals" xlink:to="NTRP_IncomeTaxReconciliationNondeductibleExpenseRelatedPartyAccruals_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_IncomeTaxReconciliationNondeductibleExpenseRelatedPartyAccruals_3_lbl" xml:lang="en-US">IncomeTaxReconciliationNondeductibleExpenseRelatedPartyAccruals</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_DebtInstrumentOfInvestor" xlink:to="NTRP_DebtInstrumentOfInvestor_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_DebtInstrumentOfInvestor_2_lbl" xml:lang="en-US">DebtInstrumentOfInvestor</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_DebtInstrumentOfFunded" xlink:to="NTRP_DebtInstrumentOfFunded_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_DebtInstrumentOfFunded_2_lbl" xml:lang="en-US">DebtInstrumentOfFunded</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCost" xlink:to="NTRP_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCost_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCost_2_lbl" xml:lang="en-US">AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCost</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ReceivablesNetCurrent" xlink:to="us-gaap_ReceivablesNetCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ReceivablesNetCurrent_2_lbl" xml:lang="en-US">Receivables, Net, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_3_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_2_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_2_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_2_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_2_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_2_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_2_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_2_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_2_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageForfeitedOrCancelled" xlink:to="NTRP_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageForfeitedOrCancelled_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageForfeitedOrCancelled_3_lbl" xml:lang="en-US">ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageForfeitedOrCancelled</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_3_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice" xlink:to="NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice_4_lbl" xml:lang="en-US">ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_2_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Exercised</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_2_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Forfeitures</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits_2_lbl" xml:lang="en-US">Stock Issued During Period, Shares, Conversion of Units</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardWeightedAverageRemainingRecognitionPeriod" xlink:to="NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardWeightedAverageRemainingRecognitionPeriod_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardWeightedAverageRemainingRecognitionPeriod_3_lbl" xml:lang="en-US">SharebasedCompensationArrangementBySharebasedPaymentAwardWeightedAverageRemainingRecognitionPeriod</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConversionOfStockSharesIssued1" xlink:to="us-gaap_ConversionOfStockSharesIssued1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConversionOfStockSharesIssued1_2_lbl" xml:lang="en-US">Conversion of Stock, Shares Issued</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightReasonForIssuingToNonemployees" xlink:to="us-gaap_ClassOfWarrantOrRightReasonForIssuingToNonemployees_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightReasonForIssuingToNonemployees_2_lbl" xml:lang="en-US">Warrant or Right, Reason for Issuance, Description</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentCarryingAmount" xlink:to="us-gaap_DebtInstrumentCarryingAmount_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentCarryingAmount_2_lbl" xml:lang="en-US">Long-Term Debt, Gross</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>34
<FILENAME>ntrp-20250228_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.0c -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://nexttrip.com/role/Cover" xlink:href="ntrp-20250228.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/BalanceSheets" xlink:href="ntrp-20250228.xsd#BalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/BalanceSheetsParenthetical" xlink:href="ntrp-20250228.xsd#BalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/StatementsOfOperations" xlink:href="ntrp-20250228.xsd#StatementsOfOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/StatementsOfOperationsParenthetical" xlink:href="ntrp-20250228.xsd#StatementsOfOperationsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/StatementsOfStockholdersEquity" xlink:href="ntrp-20250228.xsd#StatementsOfStockholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/StatementsOfStockholdersEquityParenthetical" xlink:href="ntrp-20250228.xsd#StatementsOfStockholdersEquityParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/StatementsOfCashFlows" xlink:href="ntrp-20250228.xsd#StatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#CybersecurityRiskManagementAndStrategyDisclosure" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/cyd/role/MaterialCybersecurityIncidentDisclosure" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#MaterialCybersecurityIncidentDisclosure" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/BusinessDescriptionAndGoingConcern" xlink:href="ntrp-20250228.xsd#BusinessDescriptionAndGoingConcern" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="ntrp-20250228.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/DiscontinuedOperations" xlink:href="ntrp-20250228.xsd#DiscontinuedOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/InvestmentInEquityMethodInvestee" xlink:href="ntrp-20250228.xsd#InvestmentInEquityMethodInvestee" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/InvestmentInEquitySecurities" xlink:href="ntrp-20250228.xsd#InvestmentInEquitySecurities" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/PrepaidAndOtherCurrentAssets" xlink:href="ntrp-20250228.xsd#PrepaidAndOtherCurrentAssets" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/PropertyAndEquipment" xlink:href="ntrp-20250228.xsd#PropertyAndEquipment" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/IntangibleAssets" xlink:href="ntrp-20250228.xsd#IntangibleAssets" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/Goodwill" xlink:href="ntrp-20250228.xsd#Goodwill" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/AccountsPayableAndAccruedLiabilities" xlink:href="ntrp-20250228.xsd#AccountsPayableAndAccruedLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/IncomeTaxes" xlink:href="ntrp-20250228.xsd#IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/NotesPayable" xlink:href="ntrp-20250228.xsd#NotesPayable" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/ConvertibleNotes" xlink:href="ntrp-20250228.xsd#ConvertibleNotes" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/SharePurchaseAgreements" xlink:href="ntrp-20250228.xsd#SharePurchaseAgreements" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/RelatedPartyTransactions" xlink:href="ntrp-20250228.xsd#RelatedPartyTransactions" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/DeferredRevenue" xlink:href="ntrp-20250228.xsd#DeferredRevenue" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/CommitmentsAndContingencies" xlink:href="ntrp-20250228.xsd#CommitmentsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/StockholdersEquity" xlink:href="ntrp-20250228.xsd#StockholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/LossPerShare" xlink:href="ntrp-20250228.xsd#LossPerShare" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/Concentrations" xlink:href="ntrp-20250228.xsd#Concentrations" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/DefinedContributionPlans" xlink:href="ntrp-20250228.xsd#DefinedContributionPlans" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/SubsequentEvents" xlink:href="ntrp-20250228.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="ntrp-20250228.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:href="ntrp-20250228.xsd#SummaryOfSignificantAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/DiscontinuedOperationsTables" xlink:href="ntrp-20250228.xsd#DiscontinuedOperationsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/InvestmentInEquityMethodInvesteeTables" xlink:href="ntrp-20250228.xsd#InvestmentInEquityMethodInvesteeTables" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/PrepaidAndOtherCurrentAssetsTables" xlink:href="ntrp-20250228.xsd#PrepaidAndOtherCurrentAssetsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/PropertyAndEquipmentTables" xlink:href="ntrp-20250228.xsd#PropertyAndEquipmentTables" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/IntangibleAssetsTables" xlink:href="ntrp-20250228.xsd#IntangibleAssetsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/GoodwillTables" xlink:href="ntrp-20250228.xsd#GoodwillTables" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/IncomeTaxesTables" xlink:href="ntrp-20250228.xsd#IncomeTaxesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/StockholdersEquityTables" xlink:href="ntrp-20250228.xsd#StockholdersEquityTables" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/LossPerShareTables" xlink:href="ntrp-20250228.xsd#LossPerShareTables" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/BusinessDescriptionAndGoingConcernDetailsNarrative" xlink:href="ntrp-20250228.xsd#BusinessDescriptionAndGoingConcernDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/ScheduleOfAnti-dilutiveSecuritiesExcludedFromComputationOfEarningsPerShareDetails" xlink:href="ntrp-20250228.xsd#ScheduleOfAnti-dilutiveSecuritiesExcludedFromComputationOfEarningsPerShareDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/ScheduleOfEstimatedUsefulLivesForPropertyAndEquipmentDetails" xlink:href="ntrp-20250228.xsd#ScheduleOfEstimatedUsefulLivesForPropertyAndEquipmentDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/ScheduleOfEstimatedUsefulLivesForFiniteLifeIntangibleAssetsDetails" xlink:href="ntrp-20250228.xsd#ScheduleOfEstimatedUsefulLivesForFiniteLifeIntangibleAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:href="ntrp-20250228.xsd#SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/ScheduleOfDiscontinuedOperationsDetails" xlink:href="ntrp-20250228.xsd#ScheduleOfDiscontinuedOperationsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/DiscontinuedOperationsDetailsNarrative" xlink:href="ntrp-20250228.xsd#DiscontinuedOperationsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/ScheduleOfUnauditedSummarizedFinancialInformationDetails" xlink:href="ntrp-20250228.xsd#ScheduleOfUnauditedSummarizedFinancialInformationDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/InvestmentInEquityMethodInvesteeDetailsNarrative" xlink:href="ntrp-20250228.xsd#InvestmentInEquityMethodInvesteeDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/InvestmentInEquitySecuritiesDetailsNarrative" xlink:href="ntrp-20250228.xsd#InvestmentInEquitySecuritiesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/ScheduleOfPrepaidAndOtherCurrentAssetsDetails" xlink:href="ntrp-20250228.xsd#ScheduleOfPrepaidAndOtherCurrentAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/ScheduleOfPropertyAndEquipmentDetails" xlink:href="ntrp-20250228.xsd#ScheduleOfPropertyAndEquipmentDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/PropertyAndEquipmentDetailsNarrative" xlink:href="ntrp-20250228.xsd#PropertyAndEquipmentDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/ScheduleOfIntangibleAssetsDetails" xlink:href="ntrp-20250228.xsd#ScheduleOfIntangibleAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/ScheduleOfEstimatedAggregateAmortizationExpenseDetails" xlink:href="ntrp-20250228.xsd#ScheduleOfEstimatedAggregateAmortizationExpenseDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/IntangibleAssetsDetailsNarrative" xlink:href="ntrp-20250228.xsd#IntangibleAssetsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/ScheduleOfFairValueOfAssetsAcquiredDetails" xlink:href="ntrp-20250228.xsd#ScheduleOfFairValueOfAssetsAcquiredDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/GoodwillDetailsNarrative" xlink:href="ntrp-20250228.xsd#GoodwillDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/AccountsPayableAndAccruedLiabilitiesDetailsNarrative" xlink:href="ntrp-20250228.xsd#AccountsPayableAndAccruedLiabilitiesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/ScheduleOfDeferredTaxAssetsDetails" xlink:href="ntrp-20250228.xsd#ScheduleOfDeferredTaxAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/ScheduleOfReconciliationOfProvisionForIncomeTaxesDetails" xlink:href="ntrp-20250228.xsd#ScheduleOfReconciliationOfProvisionForIncomeTaxesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/IncomeTaxesDetailsNarrative" xlink:href="ntrp-20250228.xsd#IncomeTaxesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/NotesPayableDetailsNarrative" xlink:href="ntrp-20250228.xsd#NotesPayableDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/ConvertibleNotesDetailsNarrative" xlink:href="ntrp-20250228.xsd#ConvertibleNotesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/SharePurchaseAgreementsDetailsNarrative" xlink:href="ntrp-20250228.xsd#SharePurchaseAgreementsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:href="ntrp-20250228.xsd#RelatedPartyTransactionsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/DeferredRevenueDetailsNarrative" xlink:href="ntrp-20250228.xsd#DeferredRevenueDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/ScheduleOfStockOptionActivityDetails" xlink:href="ntrp-20250228.xsd#ScheduleOfStockOptionActivityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/ScheduleOfShareBasedPaymentsAwardStockOptionsValuationAssumptionsDetails" xlink:href="ntrp-20250228.xsd#ScheduleOfShareBasedPaymentsAwardStockOptionsValuationAssumptionsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/ScheduleOfWarrantyActivityDetails" xlink:href="ntrp-20250228.xsd#ScheduleOfWarrantyActivityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/StockholdersEquityDetailsNarrative" xlink:href="ntrp-20250228.xsd#StockholdersEquityDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/ScheduleOfEarningsPerShareBasicAndDilutedDetails" xlink:href="ntrp-20250228.xsd#ScheduleOfEarningsPerShareBasicAndDilutedDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/ScheduleOfBusinessMilestonesAndIssuableContingentSharesDetails" xlink:href="ntrp-20250228.xsd#ScheduleOfBusinessMilestonesAndIssuableContingentSharesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/ScheduleOfWeightedAverageCommonSharesDetailsParenthetical" xlink:href="ntrp-20250228.xsd#ScheduleOfWeightedAverageCommonSharesDetailsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/ScheduleOfWeightedAverageCommonSharesDetails" xlink:href="ntrp-20250228.xsd#ScheduleOfWeightedAverageCommonSharesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/LossPerShareDetailsNarrative" xlink:href="ntrp-20250228.xsd#LossPerShareDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/ConcentrationsDetailsNarrative" xlink:href="ntrp-20250228.xsd#ConcentrationsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/DefinedContributionPlansDetailsNarrative" xlink:href="ntrp-20250228.xsd#DefinedContributionPlansDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/SubsequentEventsDetailsNarrative" xlink:href="ntrp-20250228.xsd#SubsequentEventsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpDisclosure" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ErrCompDisclosure" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#AwardTimingDisclosure" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#InsiderTradingArrangements" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#InsiderTradingPoliciesProc" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_IcfrAuditorAttestationFlag" xlink:label="loc_deiIcfrAuditorAttestationFlag" />
      <link:presentationArc order="580" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiIcfrAuditorAttestationFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFinStmtErrorCorrectionFlag" xlink:label="loc_deiDocumentFinStmtErrorCorrectionFlag" />
      <link:presentationArc order="590" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFinStmtErrorCorrectionFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorName" xlink:label="loc_deiAuditorName" />
      <link:presentationArc order="600" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditorName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorLocation" xlink:label="loc_deiAuditorLocation" />
      <link:presentationArc order="610" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditorLocation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorFirmId" xlink:label="loc_deiAuditorFirmId" />
      <link:presentationArc order="620" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditorFirmId" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/BalanceSheets" xlink:title="00000002 - Statement - Consolidated Balance Sheets">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:label="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:label="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonrelatedPartyMember" xlink:label="loc_us-gaapNonrelatedPartyMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_us-gaapNonrelatedPartyMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyMember" xlink:label="loc_us-gaapRelatedPartyMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_us-gaapRelatedPartyMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaapAssetsAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapAssetsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_PromissoryNoteReceivableNet" xlink:label="loc_NTRPPromissoryNoteReceivableNet" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_NTRPPromissoryNoteReceivableNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaapAccountsReceivableNetCurrent" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapAccountsReceivableNetCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsNoncurrentAbstract" xlink:label="loc_us-gaapAssetsNoncurrentAbstract" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapAssetsNoncurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsNoncurrentAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsNoncurrentAbstract" xlink:to="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SecurityDeposit" xlink:label="loc_us-gaapSecurityDeposit" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsNoncurrentAbstract" xlink:to="loc_us-gaapSecurityDeposit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsNoncurrentAbstract" xlink:to="loc_us-gaapGoodwill" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestments" xlink:label="loc_us-gaapEquityMethodInvestments" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsNoncurrentAbstract" xlink:to="loc_us-gaapEquityMethodInvestments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseOtherNoncurrent" xlink:label="loc_us-gaapPrepaidExpenseOtherNoncurrent" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsNoncurrentAbstract" xlink:to="loc_us-gaapPrepaidExpenseOtherNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsNoncurrent" xlink:label="loc_us-gaapAssetsNoncurrent" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsNoncurrentAbstract" xlink:to="loc_us-gaapAssetsNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAbstract" xlink:label="loc_us-gaapLiabilitiesAbstract" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapLiabilitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaapLiabilitiesCurrentAbstract" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAbstract" xlink:to="loc_us-gaapLiabilitiesCurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapAccountsPayableCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccruedLiabilitiesCurrent" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapAccruedLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="loc_us-gaapDeferredRevenueCurrent" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapDeferredRevenueCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesPayableCurrent" xlink:label="loc_us-gaapNotesPayableCurrent" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapNotesPayableCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAbstract" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaapCommitmentsAndContingencies" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAbstract" xlink:to="loc_us-gaapCommitmentsAndContingencies" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaapStockholdersEquityAbstract" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAbstract" xlink:to="loc_us-gaapStockholdersEquityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapPreferredStockValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAbstract" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Consolidated Balance Sheets (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="loc_us-gaapRestructuringCostAndReserveLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapRestructuringCostAndReserveLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_NextTripGroupLLCMember" xlink:label="loc_NTRPNextTripGroupLLCMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_NTRPNextTripGroupLLCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaapPreferredStockSharesAuthorized" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapPreferredStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaapPreferredStockSharesIssued" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapPreferredStockSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaapPreferredStockSharesOutstanding" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapPreferredStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapCommonStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapCommonStockSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesAcquisitions" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesAcquisitions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_PercentageForIssuedAndOutstandingCapitalStock" xlink:label="loc_NTRPPercentageForIssuedAndOutstandingCapitalStock" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_NTRPPercentageForIssuedAndOutstandingCapitalStock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/StatementsOfOperations" xlink:title="00000004 - Statement - Consolidated Statements of Operations">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaapIncomeStatementAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfRevenue" xlink:label="loc_us-gaapCostOfRevenue" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapCostOfRevenue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaapGrossProfit" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapGrossProfit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="loc_us-gaapOperatingExpensesAbstract" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapOperatingExpensesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LaborAndRelatedExpense" xlink:label="loc_us-gaapLaborAndRelatedExpense" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapLaborAndRelatedExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaapGeneralAndAdministrativeExpense" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapGeneralAndAdministrativeExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingAndMarketingExpense" xlink:label="loc_us-gaapSellingAndMarketingExpense" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapSellingAndMarketingExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfessionalFees" xlink:label="loc_us-gaapProfessionalFees" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapProfessionalFees" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_Technology" xlink:label="loc_NTRPTechnology" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_NTRPTechnology" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_OrganizationCosts" xlink:label="loc_NTRPOrganizationCosts" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_NTRPOrganizationCosts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="loc_us-gaapDepreciationDepletionAndAmortization" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapDepreciationDepletionAndAmortization" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherExpenses" xlink:label="loc_us-gaapOtherExpenses" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapOtherExpenses" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaapOperatingExpenses" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapOperatingExpenses" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="loc_us-gaapNonoperatingIncomeExpenseAbstract" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossOnDispositionOfAssets1" xlink:label="loc_us-gaapGainLossOnDispositionOfAssets1" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapGainLossOnDispositionOfAssets1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaapGainsLossesOnExtinguishmentOfDebt" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapGainsLossesOnExtinguishmentOfDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_LossOnRelatedPartyReceivable" xlink:label="loc_NTRPLossOnRelatedPartyReceivable" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_NTRPLossOnRelatedPartyReceivable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:label="loc_us-gaapInterestIncomeExpenseNonoperatingNet" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapInterestIncomeExpenseNonoperatingNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="loc_us-gaapOtherNonoperatingIncomeExpense" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapOtherNonoperatingIncomeExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaapNonoperatingIncomeExpense" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapNonoperatingIncomeExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestment" xlink:label="loc_NTRPIncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestment" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_NTRPIncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestment" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromEquityMethodInvestments" xlink:label="loc_us-gaapIncomeLossFromEquityMethodInvestments" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapIncomeLossFromEquityMethodInvestments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:label="loc_us-gaapIncomeLossFromDiscontinuedOperationsNetOfTax" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapIncomeLossFromDiscontinuedOperationsNetOfTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockDividendsIncomeStatementImpact" xlink:label="loc_us-gaapPreferredStockDividendsIncomeStatementImpact" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapPreferredStockDividendsIncomeStatementImpact" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasic" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasic" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsPerBasicShare" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsPerBasicShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsPerDilutedShare" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsPerDilutedShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:label="loc_us-gaapIncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapIncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" xlink:label="loc_us-gaapIncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapIncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaapEarningsPerShareBasic" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapEarningsPerShareBasic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaapEarningsPerShareDiluted" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapEarningsPerShareDiluted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/StatementsOfOperationsParenthetical" xlink:title="00000005 - Statement - Consolidated Statements of Operations (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaapIncomeStatementAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="loc_us-gaapRestructuringCostAndReserveLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapRestructuringCostAndReserveLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_NextTripGroupLLCMember" xlink:label="loc_NTRPNextTripGroupLLCMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_NTRPNextTripGroupLLCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesAcquisitions" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesAcquisitions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_PercentageForIssuedAndOutstandingCapitalStock" xlink:label="loc_NTRPPercentageForIssuedAndOutstandingCapitalStock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_NTRPPercentageForIssuedAndOutstandingCapitalStock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/StatementsOfStockholdersEquity" xlink:title="00000006 - Statement - Consolidated Statements of Stockholders&apos; Equity">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="loc_us-gaapStatementOfStockholdersEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfStockholdersEquityAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockMember" xlink:label="loc_us-gaapPreferredStockMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaapAdditionalPaidInCapitalMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapAdditionalPaidInCapitalMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapRetainedEarningsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_StockIssuedDuringPeriodValueOfPreferredShares" xlink:label="loc_NTRPStockIssuedDuringPeriodValueOfPreferredShares" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_NTRPStockIssuedDuringPeriodValueOfPreferredShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_StockIssuedDuringPeriodShareOfPreferredShares" xlink:label="loc_NTRPStockIssuedDuringPeriodShareOfPreferredShares" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_NTRPStockIssuedDuringPeriodShareOfPreferredShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueConversionOfConvertibleSecurities" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_StockIssuedDuringPeriodValuePurchasesOfCommonShares" xlink:label="loc_NTRPStockIssuedDuringPeriodValuePurchasesOfCommonShares" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_NTRPStockIssuedDuringPeriodValuePurchasesOfCommonShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_StockIssuedDuringPeriodSharesPurchasesOfCommonShares" xlink:label="loc_NTRPStockIssuedDuringPeriodSharesPurchasesOfCommonShares" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_NTRPStockIssuedDuringPeriodSharesPurchasesOfCommonShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_StockIssuedDuringPeriodValueReverseAcquisition" xlink:label="loc_NTRPStockIssuedDuringPeriodValueReverseAcquisition" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_NTRPStockIssuedDuringPeriodValueReverseAcquisition" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_StockIssuedDuringPeriodSharesReverseAcquisition" xlink:label="loc_NTRPStockIssuedDuringPeriodSharesReverseAcquisition" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_NTRPStockIssuedDuringPeriodSharesReverseAcquisition" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DividendsPreferredStock" xlink:label="loc_us-gaapDividendsPreferredStock" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDividendsPreferredStock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_StockIssuedDuringPeriodValueOfPreferredSharesInPrivatePlacements" xlink:label="loc_NTRPStockIssuedDuringPeriodValueOfPreferredSharesInPrivatePlacements" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_NTRPStockIssuedDuringPeriodValueOfPreferredSharesInPrivatePlacements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_StockIssuedDuringPeriodSharesOfPreferredSharesInPrivatePlacements" xlink:label="loc_NTRPStockIssuedDuringPeriodSharesOfPreferredSharesInPrivatePlacements" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_NTRPStockIssuedDuringPeriodSharesOfPreferredSharesInPrivatePlacements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_StockIssuedDuringPeriodValueConversionOfPreferredSharesToCommonShares" xlink:label="loc_NTRPStockIssuedDuringPeriodValueConversionOfPreferredSharesToCommonShares" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_NTRPStockIssuedDuringPeriodValueConversionOfPreferredSharesToCommonShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_StockIssuedDuringPeriodSharesConversionOfPreferredSharesToCommonShares" xlink:label="loc_NTRPStockIssuedDuringPeriodSharesConversionOfPreferredSharesToCommonShares" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_NTRPStockIssuedDuringPeriodSharesConversionOfPreferredSharesToCommonShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_StockIssuedDuringPeriodValueIssuanceOfPreferredSharesForDebtConversions" xlink:label="loc_NTRPStockIssuedDuringPeriodValueIssuanceOfPreferredSharesForDebtConversions" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_NTRPStockIssuedDuringPeriodValueIssuanceOfPreferredSharesForDebtConversions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_StockIssuedDuringPeriodSharesIssuanceOfPreferredSharesForDebtConversions" xlink:label="loc_NTRPStockIssuedDuringPeriodSharesIssuanceOfPreferredSharesForDebtConversions" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_NTRPStockIssuedDuringPeriodSharesIssuanceOfPreferredSharesForDebtConversions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_StockIssuedDuringPeriodValueIssuanceOfSecuritiesForServices" xlink:label="loc_NTRPStockIssuedDuringPeriodValueIssuanceOfSecuritiesForServices" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_NTRPStockIssuedDuringPeriodValueIssuanceOfSecuritiesForServices" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_StockIssuedDuringPeriodSharesIssuanceOfSecuritiesForServices" xlink:label="loc_NTRPStockIssuedDuringPeriodSharesIssuanceOfSecuritiesForServices" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_NTRPStockIssuedDuringPeriodSharesIssuanceOfSecuritiesForServices" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_StockIssuedDuringPeriodValueSecuritiesIssuedForEquityInvestments" xlink:label="loc_NTRPStockIssuedDuringPeriodValueSecuritiesIssuedForEquityInvestments" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_NTRPStockIssuedDuringPeriodValueSecuritiesIssuedForEquityInvestments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_StockIssuedDuringPeriodSharseSecuritiesIssuedForEquityInvestments" xlink:label="loc_NTRPStockIssuedDuringPeriodSharseSecuritiesIssuedForEquityInvestments" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_NTRPStockIssuedDuringPeriodSharseSecuritiesIssuedForEquityInvestments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_StockIssuedDuringPeriodValueIssuanceOfCommitmentSharesForEquityLineOfCredit" xlink:label="loc_NTRPStockIssuedDuringPeriodValueIssuanceOfCommitmentSharesForEquityLineOfCredit" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_NTRPStockIssuedDuringPeriodValueIssuanceOfCommitmentSharesForEquityLineOfCredit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_StockIssuedDuringPeriodSharesIssuanceOfCommitmentSharesForEquityLineOfCredit" xlink:label="loc_NTRPStockIssuedDuringPeriodSharesIssuanceOfCommitmentSharesForEquityLineOfCredit" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_NTRPStockIssuedDuringPeriodSharesIssuanceOfCommitmentSharesForEquityLineOfCredit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueStockOptionsExercised" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueShareBasedCompensation" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueShareBasedCompensation" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesShareBasedCompensation" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesShareBasedCompensation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_2" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding_2" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/StatementsOfStockholdersEquityParenthetical" xlink:title="00000007 - Statement - Consolidated Statements of Stockholders&apos; Equity (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="loc_us-gaapStatementOfStockholdersEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfStockholdersEquityAbstract" xlink:to="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="loc_us-gaapRestructuringCostAndReserveLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapRestructuringCostAndReserveLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_NextTripGroupLLCMember" xlink:label="loc_NTRPNextTripGroupLLCMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_NTRPNextTripGroupLLCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesAcquisitions" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesAcquisitions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_PercentageForIssuedAndOutstandingCapitalStock" xlink:label="loc_NTRPPercentageForIssuedAndOutstandingCapitalStock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_NTRPPercentageForIssuedAndOutstandingCapitalStock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/StatementsOfCashFlows" xlink:title="00000008 - Statement - Consolidated Statements of Cash Flows">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaapStatementOfCashFlowsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="loc_us-gaapDepreciationDepletionAndAmortization" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapDepreciationDepletionAndAmortization" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfDebtDiscountPremium" xlink:label="loc_us-gaapAmortizationOfDebtDiscountPremium" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapAmortizationOfDebtDiscountPremium" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_AmortizationOfPrepaidExpenses" xlink:label="loc_NTRPAmortizationOfPrepaidExpenses" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_NTRPAmortizationOfPrepaidExpenses" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_LossOnRelatedPartyReceivable" xlink:label="loc_NTRPLossOnRelatedPartyReceivable" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_NTRPLossOnRelatedPartyReceivable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaapGainsLossesOnExtinguishmentOfDebt" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapGainsLossesOnExtinguishmentOfDebt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_LossOnDispositionOfAssets" xlink:label="loc_NTRPLossOnDispositionOfAssets" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_NTRPLossOnDispositionOfAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromEquityMethodInvestments" xlink:label="loc_us-gaapIncomeLossFromEquityMethodInvestments" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapIncomeLossFromEquityMethodInvestments" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsReceivable" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsReceivable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidExpense" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInSecurityDeposits" xlink:label="loc_us-gaapIncreaseDecreaseInSecurityDeposits" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInSecurityDeposits" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:label="loc_us-gaapIncreaseDecreaseInDeferredRevenue" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInDeferredRevenue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations" xlink:label="loc_us-gaapCashProvidedByUsedInOperatingActivitiesDiscontinuedOperations" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapCashProvidedByUsedInOperatingActivitiesDiscontinuedOperations" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForSoftware" xlink:label="loc_us-gaapPaymentsForSoftware" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsForSoftware" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromSaleOfProductiveAssets" xlink:label="loc_us-gaapProceedsFromSaleOfProductiveAssets" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromSaleOfProductiveAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_InvestmentInEquityMethodInvestee" xlink:label="loc_NTRPInvestmentInEquityMethodInvestee" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_NTRPInvestmentInEquityMethodInvestee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_ProceedsFromAcquireBusinessesGross" xlink:label="loc_NTRPProceedsFromAcquireBusinessesGross" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_NTRPProceedsFromAcquireBusinessesGross" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromSaleOfOtherProductiveAssets" xlink:label="loc_us-gaapProceedsFromSaleOfOtherProductiveAssets" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromSaleOfOtherProductiveAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromNotesPayable" xlink:label="loc_us-gaapProceedsFromNotesPayable" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromNotesPayable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromConvertibleDebt" xlink:label="loc_us-gaapProceedsFromConvertibleDebt" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromConvertibleDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfCommonStock" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromIssuanceOfCommonStock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfPreferredStockAndPreferenceStock" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromIssuanceOfPreferredStockAndPreferenceStock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfWarrants" xlink:label="loc_us-gaapProceedsFromIssuanceOfWarrants" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromIssuanceOfWarrants" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromRelatedPartyDebt" xlink:label="loc_us-gaapProceedsFromRelatedPartyDebt" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromRelatedPartyDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_2" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="loc_us-gaapSupplementalCashFlowInformationAbstract" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapSupplementalCashFlowInformationAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestPaidNet" xlink:label="loc_us-gaapInterestPaidNet" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplementalCashFlowInformationAbstract" xlink:to="loc_us-gaapInterestPaidNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxesPaidNet" xlink:label="loc_us-gaapIncomeTaxesPaidNet" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplementalCashFlowInformationAbstract" xlink:to="loc_us-gaapIncomeTaxesPaidNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:label="loc_us-gaapCashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_IssuanceOfPreferredSharesForServices" xlink:label="loc_NTRPIssuanceOfPreferredSharesForServices" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="loc_NTRPIssuanceOfPreferredSharesForServices" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_IssuanceOfCommonSharesForServices" xlink:label="loc_NTRPIssuanceOfCommonSharesForServices" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="loc_NTRPIssuanceOfCommonSharesForServices" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_IssuanceOfCommonSharesAsCommitmentShares" xlink:label="loc_NTRPIssuanceOfCommonSharesAsCommitmentShares" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="loc_NTRPIssuanceOfCommonSharesAsCommitmentShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_IssuanceOfCommonWarrantsForServices" xlink:label="loc_NTRPIssuanceOfCommonWarrantsForServices" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="loc_NTRPIssuanceOfCommonWarrantsForServices" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_IssuanceOfCommonSharesForEquityInvestments" xlink:label="loc_NTRPIssuanceOfCommonSharesForEquityInvestments" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="loc_NTRPIssuanceOfCommonSharesForEquityInvestments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_IssuanceOfPreferredSharesForEquityInvestments" xlink:label="loc_NTRPIssuanceOfPreferredSharesForEquityInvestments" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="loc_NTRPIssuanceOfPreferredSharesForEquityInvestments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_IssuanceOfPreferredSharesForPerpetualSoftwareLicense" xlink:label="loc_NTRPIssuanceOfPreferredSharesForPerpetualSoftwareLicense" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="loc_NTRPIssuanceOfPreferredSharesForPerpetualSoftwareLicense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_ConversionOfConvertibleNotes" xlink:label="loc_NTRPConversionOfConvertibleNotes" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="loc_NTRPConversionOfConvertibleNotes" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_PreferredStockDividends" xlink:label="loc_NTRPPreferredStockDividends" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="loc_NTRPPreferredStockDividends" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:title="995410 - Disclosure - Pay vs Performance Disclosure">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PayVsPerformanceDisclosureLineItems" xlink:label="loc_ecdPayVsPerformanceDisclosureLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PvpTable" xlink:label="loc_ecdPvpTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPayVsPerformanceDisclosureLineItems" xlink:to="loc_ecdPvpTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ExecutiveCategoryAxis" xlink:label="loc_ecdExecutiveCategoryAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPvpTable" xlink:to="loc_ecdExecutiveCategoryAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllExecutiveCategoriesMember" xlink:label="loc_ecdAllExecutiveCategoriesMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdExecutiveCategoryAxis" xlink:to="loc_ecdAllExecutiveCategoriesMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_IndividualAxis" xlink:label="loc_ecdIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPvpTable" xlink:to="loc_ecdIndividualAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllIndividualsMember" xlink:label="loc_ecdAllIndividualsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdIndividualAxis" xlink:to="loc_ecdAllIndividualsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToCompAxis" xlink:label="loc_ecdAdjToCompAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPvpTable" xlink:to="loc_ecdAdjToCompAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllAdjToCompMember" xlink:label="loc_ecdAllAdjToCompMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAdjToCompAxis" xlink:to="loc_ecdAllAdjToCompMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MeasureAxis" xlink:label="loc_ecdMeasureAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPvpTable" xlink:to="loc_ecdMeasureAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PvpTableTextBlock" xlink:label="loc_ecdPvpTableTextBlock" />
      <link:presentationArc order="2000" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPayVsPerformanceDisclosureLineItems" xlink:to="loc_ecdPvpTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CoSelectedMeasureName" xlink:label="loc_ecdCoSelectedMeasureName" />
      <link:presentationArc order="2010" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPvpTableTextBlock" xlink:to="loc_ecdCoSelectedMeasureName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NamedExecutiveOfficersFnTextBlock" xlink:label="loc_ecdNamedExecutiveOfficersFnTextBlock" />
      <link:presentationArc order="2020" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdNamedExecutiveOfficersFnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeerGroupIssuersFnTextBlock" xlink:label="loc_ecdPeerGroupIssuersFnTextBlock" />
      <link:presentationArc order="2030" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdPeerGroupIssuersFnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ChangedPeerGroupFnTextBlock" xlink:label="loc_ecdChangedPeerGroupFnTextBlock" />
      <link:presentationArc order="2040" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdChangedPeerGroupFnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoTotalCompAmt" xlink:label="loc_ecdPeoTotalCompAmt" />
      <link:presentationArc order="2050" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdPeoTotalCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoActuallyPaidCompAmt" xlink:label="loc_ecdPeoActuallyPaidCompAmt" />
      <link:presentationArc order="2060" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdPeoActuallyPaidCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToPeoCompFnTextBlock" xlink:label="loc_ecdAdjToPeoCompFnTextBlock" />
      <link:presentationArc order="2070" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdAdjToPeoCompFnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonPeoNeoAvgTotalCompAmt" xlink:label="loc_ecdNonPeoNeoAvgTotalCompAmt" />
      <link:presentationArc order="2080" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPvpTableTextBlock" xlink:to="loc_ecdNonPeoNeoAvgTotalCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:label="loc_ecdNonPeoNeoAvgCompActuallyPaidAmt" />
      <link:presentationArc order="2090" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPvpTableTextBlock" xlink:to="loc_ecdNonPeoNeoAvgCompActuallyPaidAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:label="loc_ecdAdjToNonPeoNeoCompFnTextBlock" />
      <link:presentationArc order="2100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdNonPeoNeoAvgCompActuallyPaidAmt" xlink:to="loc_ecdAdjToNonPeoNeoCompFnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:label="loc_ecdEquityValuationAssumptionDifferenceFnTextBlock" />
      <link:presentationArc order="2110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdNonPeoNeoAvgCompActuallyPaidAmt" xlink:to="loc_ecdEquityValuationAssumptionDifferenceFnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:label="loc_ecdCompActuallyPaidVsTotalShareholderRtnTextBlock" />
      <link:presentationArc order="2120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdNonPeoNeoAvgCompActuallyPaidAmt" xlink:to="loc_ecdCompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:label="loc_ecdCompActuallyPaidVsNetIncomeTextBlock" />
      <link:presentationArc order="2130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdNonPeoNeoAvgCompActuallyPaidAmt" xlink:to="loc_ecdCompActuallyPaidVsNetIncomeTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:label="loc_ecdCompActuallyPaidVsCoSelectedMeasureTextBlock" />
      <link:presentationArc order="2140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdNonPeoNeoAvgCompActuallyPaidAmt" xlink:to="loc_ecdCompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:label="loc_ecdTotalShareholderRtnVsPeerGroupTextBlock" />
      <link:presentationArc order="2150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdNonPeoNeoAvgCompActuallyPaidAmt" xlink:to="loc_ecdTotalShareholderRtnVsPeerGroupTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:label="loc_ecdCompActuallyPaidVsOtherMeasureTextBlock" />
      <link:presentationArc order="2160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdNonPeoNeoAvgCompActuallyPaidAmt" xlink:to="loc_ecdCompActuallyPaidVsOtherMeasureTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TabularListTableTextBlock" xlink:label="loc_ecdTabularListTableTextBlock" />
      <link:presentationArc order="2170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdNonPeoNeoAvgCompActuallyPaidAmt" xlink:to="loc_ecdTabularListTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TotalShareholderRtnAmt" xlink:label="loc_ecdTotalShareholderRtnAmt" />
      <link:presentationArc order="2180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdNonPeoNeoAvgCompActuallyPaidAmt" xlink:to="loc_ecdTotalShareholderRtnAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeerGroupTotalShareholderRtnAmt" xlink:label="loc_ecdPeerGroupTotalShareholderRtnAmt" />
      <link:presentationArc order="2190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdNonPeoNeoAvgCompActuallyPaidAmt" xlink:to="loc_ecdPeerGroupTotalShareholderRtnAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="2200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPvpTableTextBlock" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CoSelectedMeasureAmt" xlink:label="loc_ecdCoSelectedMeasureAmt" />
      <link:presentationArc order="2210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_ecdCoSelectedMeasureAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OtherPerfMeasureAmt" xlink:label="loc_ecdOtherPerfMeasureAmt" />
      <link:presentationArc order="2220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_ecdOtherPerfMeasureAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToCompAmt" xlink:label="loc_ecdAdjToCompAmt" />
      <link:presentationArc order="2230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_ecdAdjToCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoName" xlink:label="loc_ecdPeoName" />
      <link:presentationArc order="2240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_ecdPeoName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MeasureName" xlink:label="loc_ecdMeasureName" />
      <link:presentationArc order="2250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPayVsPerformanceDisclosureLineItems" xlink:to="loc_ecdMeasureName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonGaapMeasureDescriptionTextBlock" xlink:label="loc_ecdNonGaapMeasureDescriptionTextBlock" />
      <link:presentationArc order="2260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdMeasureName" xlink:to="loc_ecdNonGaapMeasureDescriptionTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Additional402vDisclosureTextBlock" xlink:label="loc_ecdAdditional402vDisclosureTextBlock" />
      <link:presentationArc order="2270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPayVsPerformanceDisclosureLineItems" xlink:to="loc_ecdAdditional402vDisclosureTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PnsnBnftsAdjFnTextBlock" xlink:label="loc_ecdPnsnBnftsAdjFnTextBlock" />
      <link:presentationArc order="2280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPayVsPerformanceDisclosureLineItems" xlink:to="loc_ecdPnsnBnftsAdjFnTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" xlink:title="995440 - Disclosure - Recovery of Erroneously Awarded Compensation">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RecoveryOfErrCompDisclosureLineItems" xlink:label="loc_ecdRecoveryOfErrCompDisclosureLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ErrCompRecoveryTable" xlink:label="loc_ecdErrCompRecoveryTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdRecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecdErrCompRecoveryTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDateAxis" xlink:label="loc_ecdRestatementDateAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdErrCompRecoveryTable" xlink:to="loc_ecdRestatementDateAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_IndividualAxis" xlink:label="loc_ecdIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdErrCompRecoveryTable" xlink:to="loc_ecdIndividualAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllIndividualsMember" xlink:label="loc_ecdAllIndividualsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdIndividualAxis" xlink:to="loc_ecdAllIndividualsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDeterminationDate" xlink:label="loc_ecdRestatementDeterminationDate" />
      <link:presentationArc order="2000" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdRecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecdRestatementDeterminationDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtErrCompAmt" xlink:label="loc_ecdAggtErrCompAmt" />
      <link:presentationArc order="2010" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdRestatementDeterminationDate" xlink:to="loc_ecdAggtErrCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ErrCompAnalysisTextBlock" xlink:label="loc_ecdErrCompAnalysisTextBlock" />
      <link:presentationArc order="2020" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAggtErrCompAmt" xlink:to="loc_ecdErrCompAnalysisTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:label="loc_ecdStkPrcOrTsrEstimationMethodTextBlock" />
      <link:presentationArc order="2030" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAggtErrCompAmt" xlink:to="loc_ecdStkPrcOrTsrEstimationMethodTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingAggtErrCompAmt" xlink:label="loc_ecdOutstandingAggtErrCompAmt" />
      <link:presentationArc order="2040" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAggtErrCompAmt" xlink:to="loc_ecdOutstandingAggtErrCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:label="loc_ecdAggtErrCompNotYetDeterminedTextBlock" />
      <link:presentationArc order="2050" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAggtErrCompAmt" xlink:to="loc_ecdAggtErrCompNotYetDeterminedTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryIndName" xlink:label="loc_ecdForgoneRecoveryIndName" />
      <link:presentationArc order="2060" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAggtErrCompAmt" xlink:to="loc_ecdForgoneRecoveryIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:label="loc_ecdForgoneRecoveryDueToExpenseOfEnforcementAmt" />
      <link:presentationArc order="2070" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAggtErrCompAmt" xlink:to="loc_ecdForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:label="loc_ecdForgoneRecoveryDueToViolationOfHomeCountryLawAmt" />
      <link:presentationArc order="2080" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdRestatementDeterminationDate" xlink:to="loc_ecdForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:label="loc_ecdForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" />
      <link:presentationArc order="2090" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdRestatementDeterminationDate" xlink:to="loc_ecdForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:label="loc_ecdForgoneRecoveryExplanationOfImpracticabilityTextBlock" />
      <link:presentationArc order="2100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:to="loc_ecdForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingRecoveryIndName" xlink:label="loc_ecdOutstandingRecoveryIndName" />
      <link:presentationArc order="2110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:to="loc_ecdOutstandingRecoveryIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingRecoveryCompAmt" xlink:label="loc_ecdOutstandingRecoveryCompAmt" />
      <link:presentationArc order="2120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:to="loc_ecdOutstandingRecoveryCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:label="loc_ecdRestatementDoesNotRequireRecoveryTextBlock" />
      <link:presentationArc order="2130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:to="loc_ecdRestatementDoesNotRequireRecoveryTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" xlink:title="995443 - Disclosure - Award Timing Disclosure">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgDiscLineItems" xlink:label="loc_ecdAwardTmgDiscLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscTable" xlink:label="loc_ecdAwardsCloseToMnpiDiscTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardsCloseToMnpiDiscTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_IndividualAxis" xlink:label="loc_ecdIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardsCloseToMnpiDiscTable" xlink:to="loc_ecdIndividualAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllIndividualsMember" xlink:label="loc_ecdAllIndividualsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdIndividualAxis" xlink:to="loc_ecdAllIndividualsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardsCloseToMnpiDiscTable" xlink:to="loc_us-gaapAwardTypeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMnpiDiscTextBlock" xlink:label="loc_ecdAwardTmgMnpiDiscTextBlock" />
      <link:presentationArc order="2000" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardTmgMnpiDiscTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMethodTextBlock" xlink:label="loc_ecdAwardTmgMethodTextBlock" />
      <link:presentationArc order="2010" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardTmgMethodTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgPredtrmndFlag" xlink:label="loc_ecdAwardTmgPredtrmndFlag" />
      <link:presentationArc order="2020" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardTmgPredtrmndFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMnpiCnsdrdFlag" xlink:label="loc_ecdAwardTmgMnpiCnsdrdFlag" />
      <link:presentationArc order="2030" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardTmgMnpiCnsdrdFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:label="loc_ecdAwardTmgHowMnpiCnsdrdTextBlock" />
      <link:presentationArc order="2040" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardTmgHowMnpiCnsdrdTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MnpiDiscTimedForCompValFlag" xlink:label="loc_ecdMnpiDiscTimedForCompValFlag" />
      <link:presentationArc order="2050" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdMnpiDiscTimedForCompValFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:label="loc_ecdAwardsCloseToMnpiDiscTableTextBlock" />
      <link:presentationArc order="2060" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardsCloseToMnpiDiscTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscIndName" xlink:label="loc_ecdAwardsCloseToMnpiDiscIndName" />
      <link:presentationArc order="2070" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardsCloseToMnpiDiscIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardUndrlygSecuritiesAmt" xlink:label="loc_ecdAwardUndrlygSecuritiesAmt" />
      <link:presentationArc order="2080" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardUndrlygSecuritiesAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardExrcPrice" xlink:label="loc_ecdAwardExrcPrice" />
      <link:presentationArc order="2090" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardExrcPrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardGrantDateFairValue" xlink:label="loc_ecdAwardGrantDateFairValue" />
      <link:presentationArc order="2100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardGrantDateFairValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_UndrlygSecurityMktPriceChngPct" xlink:label="loc_ecdUndrlygSecurityMktPriceChngPct" />
      <link:presentationArc order="2110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdUndrlygSecurityMktPriceChngPct" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:title="995445 - Disclosure - Insider Trading Arrangements">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTradingArrLineItems" xlink:label="loc_ecdInsiderTradingArrLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MtrlTermsOfTrdArrTextBlock" xlink:label="loc_ecdMtrlTermsOfTrdArrTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdMtrlTermsOfTrdArrTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrIndName" xlink:label="loc_ecdTrdArrIndName" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTrdArrIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrIndTitle" xlink:label="loc_ecdTrdArrIndTitle" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTrdArrIndTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Rule10b51ArrAdoptedFlag" xlink:label="loc_ecdRule10b51ArrAdoptedFlag" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdRule10b51ArrAdoptedFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonRule10b51ArrAdoptedFlag" xlink:label="loc_ecdNonRule10b51ArrAdoptedFlag" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdNonRule10b51ArrAdoptedFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrAdoptionDate" xlink:label="loc_ecdTrdArrAdoptionDate" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTrdArrAdoptionDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Rule10b51ArrTrmntdFlag" xlink:label="loc_ecdRule10b51ArrTrmntdFlag" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdRule10b51ArrTrmntdFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonRule10b51ArrTrmntdFlag" xlink:label="loc_ecdNonRule10b51ArrTrmntdFlag" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdNonRule10b51ArrTrmntdFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrTerminationDate" xlink:label="loc_ecdTrdArrTerminationDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTrdArrTerminationDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrExpirationDate" xlink:label="loc_ecdTrdArrExpirationDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTrdArrExpirationDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrDuration" xlink:label="loc_ecdTrdArrDuration" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTrdArrDuration" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" xlink:title="995447 - Disclosure - Insider Trading Policies and Procedures">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTradingPoliciesProcLineItems" xlink:label="loc_ecdInsiderTradingPoliciesProcLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:label="loc_ecdInsiderTrdPoliciesProcAdoptedFlag" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingPoliciesProcLineItems" xlink:to="loc_ecdInsiderTrdPoliciesProcAdoptedFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:label="loc_ecdInsiderTrdPoliciesProcNotAdoptedTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingPoliciesProcLineItems" xlink:to="loc_ecdInsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure" xlink:title="00000014 - Disclosure - Cybersecurity Risk Management and Strategy Disclosure">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract" xlink:label="loc_cydCybersecurityRiskManagementStrategyAndGovernanceAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:label="loc_cydCybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cydCybersecurityRiskManagementStrategyAndGovernanceAbstract" xlink:to="loc_cydCybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementProcessesIntegratedFlag" xlink:label="loc_cydCybersecurityRiskManagementProcessesIntegratedFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cydCybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="loc_cydCybersecurityRiskManagementProcessesIntegratedFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock" xlink:label="loc_cydCybersecurityRiskManagementProcessesIntegratedTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cydCybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="loc_cydCybersecurityRiskManagementProcessesIntegratedTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementThirdPartyEngagedFlag" xlink:label="loc_cydCybersecurityRiskManagementThirdPartyEngagedFlag" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cydCybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="loc_cydCybersecurityRiskManagementThirdPartyEngagedFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag" xlink:label="loc_cydCybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cydCybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="loc_cydCybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" xlink:label="loc_cydCybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cydCybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="loc_cydCybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock" xlink:label="loc_cydCybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cydCybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="loc_cydCybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:label="loc_cydCybersecurityRiskBoardOfDirectorsOversightTextBlock" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cydCybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="loc_cydCybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" xlink:label="loc_cydCybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cydCybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="loc_cydCybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" xlink:label="loc_cydCybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cydCybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="loc_cydCybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskRoleOfManagementTextBlock" xlink:label="loc_cydCybersecurityRiskRoleOfManagementTextBlock" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cydCybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="loc_cydCybersecurityRiskRoleOfManagementTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag" xlink:label="loc_cydCybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cydCybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="loc_cydCybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock" xlink:label="loc_cydCybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cydCybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="loc_cydCybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cyd/role/MaterialCybersecurityIncidentDisclosure" xlink:title="00000015 - Disclosure - Material Cybersecurity Incident Disclosure">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_MaterialCybersecurityIncidentAbstract" xlink:label="loc_cydMaterialCybersecurityIncidentAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_MaterialCybersecurityIncidentNatureTextBlock" xlink:label="loc_cydMaterialCybersecurityIncidentNatureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cydMaterialCybersecurityIncidentAbstract" xlink:to="loc_cydMaterialCybersecurityIncidentNatureTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_MaterialCybersecurityIncidentScopeTextBlock" xlink:label="loc_cydMaterialCybersecurityIncidentScopeTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cydMaterialCybersecurityIncidentAbstract" xlink:to="loc_cydMaterialCybersecurityIncidentScopeTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_MaterialCybersecurityIncidentTimingTextBlock" xlink:label="loc_cydMaterialCybersecurityIncidentTimingTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cydMaterialCybersecurityIncidentAbstract" xlink:to="loc_cydMaterialCybersecurityIncidentTimingTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_MaterialCybersecurityIncidentMaterialImpactOrReasonablyLikelyMaterialImpactTextBlock" xlink:label="loc_cydMaterialCybersecurityIncidentMaterialImpactOrReasonablyLikelyMaterialImpactTextBlock" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cydMaterialCybersecurityIncidentAbstract" xlink:to="loc_cydMaterialCybersecurityIncidentMaterialImpactOrReasonablyLikelyMaterialImpactTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd#cyd_MaterialCybersecurityIncidentInformationNotAvailableOrUndeterminedTextBlock" xlink:label="loc_cydMaterialCybersecurityIncidentInformationNotAvailableOrUndeterminedTextBlock" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cydMaterialCybersecurityIncidentAbstract" xlink:to="loc_cydMaterialCybersecurityIncidentInformationNotAvailableOrUndeterminedTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/BusinessDescriptionAndGoingConcern" xlink:title="999016 - Disclosure - Business Description and Going Concern">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubstantialDoubtAboutGoingConcernTextBlock" xlink:label="loc_us-gaapSubstantialDoubtAboutGoingConcernTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapSubstantialDoubtAboutGoingConcernTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/SummaryOfSignificantAccountingPolicies" xlink:title="999017 - Disclosure - Summary of Significant Accounting Policies">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="loc_us-gaapSignificantAccountingPoliciesTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapSignificantAccountingPoliciesTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/DiscontinuedOperations" xlink:title="999018 - Disclosure - Discontinued Operations">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:label="loc_us-gaapDiscontinuedOperationsAndDisposalGroupsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:label="loc_us-gaapDisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDiscontinuedOperationsAndDisposalGroupsAbstract" xlink:to="loc_us-gaapDisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/InvestmentInEquityMethodInvestee" xlink:title="999019 - Disclosure - Investment in Equity Method Investee">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:label="loc_us-gaapEquityMethodInvestmentsAndJointVenturesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestmentsDisclosureTextBlock" xlink:label="loc_us-gaapEquityMethodInvestmentsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityMethodInvestmentsAndJointVenturesAbstract" xlink:to="loc_us-gaapEquityMethodInvestmentsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/InvestmentInEquitySecurities" xlink:title="999020 - Disclosure - Investment in Equity Securities">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:label="loc_us-gaapInvestmentsDebtAndEquitySecuritiesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:label="loc_us-gaapInvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="loc_us-gaapInvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/PrepaidAndOtherCurrentAssets" xlink:title="999021 - Disclosure - Prepaid and Other Current Assets">
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_DisclosurePrepaidAndOtherCurrentAssetsAbstract" xlink:label="loc_NTRPDisclosurePrepaidAndOtherCurrentAssetsAbstract" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_PrepaidExpensesAndOtherCurrentAssetsTextBlock" xlink:label="loc_NTRPPrepaidExpensesAndOtherCurrentAssetsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_NTRPDisclosurePrepaidAndOtherCurrentAssetsAbstract" xlink:to="loc_NTRPPrepaidExpensesAndOtherCurrentAssetsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/PropertyAndEquipment" xlink:title="999022 - Disclosure - Property and Equipment">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="loc_us-gaapPropertyPlantAndEquipmentDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/IntangibleAssets" xlink:title="999023 - Disclosure - Intangible Assets">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:label="loc_us-gaapIntangibleAssetsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapIntangibleAssetsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/Goodwill" xlink:title="999024 - Disclosure - Goodwill">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillDisclosureTextBlock" xlink:label="loc_us-gaapGoodwillDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapGoodwillDisclosureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/AccountsPayableAndAccruedLiabilities" xlink:title="999025 - Disclosure - Accounts Payable and Accrued Liabilities">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="loc_us-gaapPayablesAndAccrualsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/IncomeTaxes" xlink:title="999026 - Disclosure - Income Taxes">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="loc_us-gaapIncomeTaxDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/NotesPayable" xlink:title="999027 - Disclosure - Notes Payable">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="loc_us-gaapDebtDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapDebtDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/ConvertibleNotes" xlink:title="999028 - Disclosure - Convertible Notes">
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_DisclosureConvertibleNotesAbstract" xlink:label="loc_NTRPDisclosureConvertibleNotesAbstract" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_ConvertibleDebtDisclosureTextBlock" xlink:label="loc_NTRPConvertibleDebtDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_NTRPDisclosureConvertibleNotesAbstract" xlink:to="loc_NTRPConvertibleDebtDisclosureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/SharePurchaseAgreements" xlink:title="999029 - Disclosure - Share Purchase Agreements">
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_DisclosureSharePurchaseAgreementsAbstract" xlink:label="loc_NTRPDisclosureSharePurchaseAgreementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_SharePurchaseAgreementsDisclosureTextBlock" xlink:label="loc_NTRPSharePurchaseAgreementsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_NTRPDisclosureSharePurchaseAgreementsAbstract" xlink:to="loc_NTRPSharePurchaseAgreementsDisclosureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/RelatedPartyTransactions" xlink:title="999030 - Disclosure - Related Party Transactions">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaapRelatedPartyTransactionsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="loc_us-gaapRelatedPartyTransactionsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract" xlink:to="loc_us-gaapRelatedPartyTransactionsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/DeferredRevenue" xlink:title="999031 - Disclosure - Deferred Revenue">
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_DisclosureDeferredRevenueAbstract" xlink:label="loc_NTRPDisclosureDeferredRevenueAbstract" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_DeferredRevenueTextBlock" xlink:label="loc_NTRPDeferredRevenueTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_NTRPDisclosureDeferredRevenueAbstract" xlink:to="loc_NTRPDeferredRevenueTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/CommitmentsAndContingencies" xlink:title="999032 - Disclosure - Commitments and Contingencies">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapCommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/StockholdersEquity" xlink:title="999033 - Disclosure - Stockholders&#8217; Equity">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="loc_us-gaapStockholdersEquityNoteDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapStockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/LossPerShare" xlink:title="999034 - Disclosure - Loss Per Share">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaapEarningsPerShareAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="loc_us-gaapEarningsPerShareTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract" xlink:to="loc_us-gaapEarningsPerShareTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/Concentrations" xlink:title="999035 - Disclosure - Concentrations">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RisksAndUncertaintiesAbstract" xlink:label="loc_us-gaapRisksAndUncertaintiesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:label="loc_us-gaapConcentrationRiskDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRisksAndUncertaintiesAbstract" xlink:to="loc_us-gaapConcentrationRiskDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/DefinedContributionPlans" xlink:title="999036 - Disclosure - Defined Contribution Plans">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:label="loc_us-gaapCompensationAndRetirementDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CompensationAndEmployeeBenefitPlansTextBlock" xlink:label="loc_us-gaapCompensationAndEmployeeBenefitPlansTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCompensationAndRetirementDisclosureAbstract" xlink:to="loc_us-gaapCompensationAndEmployeeBenefitPlansTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/SubsequentEvents" xlink:title="999037 - Disclosure - Subsequent Events">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaapSubsequentEventsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="loc_us-gaapSubsequentEventsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventsAbstract" xlink:to="loc_us-gaapSubsequentEventsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="999038 - Disclosure - Summary of Significant Accounting Policies (Policies)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="loc_us-gaapBasisOfAccountingPolicyPolicyTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapBasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:label="loc_us-gaapForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UseOfEstimates" xlink:label="loc_us-gaapUseOfEstimates" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapUseOfEstimates" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="loc_us-gaapEarningsPerSharePolicyTextBlock" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapEarningsPerSharePolicyTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="loc_us-gaapCashAndCashEquivalentsPolicyTextBlock" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_PrepaidsPolicyTextBlock" xlink:label="loc_NTRPPrepaidsPolicyTextBlock" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_NTRPPrepaidsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:label="loc_us-gaapTradeAndOtherAccountsReceivablePolicy" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapTradeAndOtherAccountsReceivablePolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestmentsPolicy" xlink:label="loc_us-gaapEquityMethodInvestmentsPolicy" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapEquityMethodInvestmentsPolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_BasisDifferencePolicyTextBlock" xlink:label="loc_NTRPBasisDifferencePolicyTextBlock" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_NTRPBasisDifferencePolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValuePolicyTextBlock" xlink:label="loc_us-gaapEquitySecuritiesWithoutReadilyDeterminableFairValuePolicyTextBlock" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapEquitySecuritiesWithoutReadilyDeterminableFairValuePolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestmentsIssuancesPolicy" xlink:label="loc_us-gaapEquityMethodInvestmentsIssuancesPolicy" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapEquityMethodInvestmentsIssuancesPolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:label="loc_us-gaapFairValueMeasurementPolicyPolicyTextBlock" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapFairValueMeasurementPolicyPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_PromissoryNoteReceivablePolicyTextBlock" xlink:label="loc_NTRPPromissoryNoteReceivablePolicyTextBlock" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_NTRPPromissoryNoteReceivablePolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="loc_us-gaapPropertyPlantAndEquipmentPolicyTextBlock" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentPolicyTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:label="loc_us-gaapIntangibleAssetsFiniteLivedPolicy" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapIntangibleAssetsFiniteLivedPolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InternalUseSoftwarePolicy" xlink:label="loc_us-gaapInternalUseSoftwarePolicy" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapInternalUseSoftwarePolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsIntangibleAssetsPolicy" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapGoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeLeasesPolicyTextBlock" xlink:label="loc_us-gaapLesseeLeasesPolicyTextBlock" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapLesseeLeasesPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:label="loc_us-gaapPriorPeriodReclassificationAdjustmentDescription" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapPriorPeriodReclassificationAdjustmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="loc_us-gaapFairValueOfFinancialInstrumentsPolicy" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapFairValueOfFinancialInstrumentsPolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketRiskBenefitPolicyTextBlock" xlink:label="loc_us-gaapMarketRiskBenefitPolicyTextBlock" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapMarketRiskBenefitPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="loc_us-gaapShareBasedCompensationOptionAndIncentivePlansPolicy" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:label="loc_us-gaapRevenueFromContractWithCustomerPolicyTextBlock" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapRevenueFromContractWithCustomerPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock" xlink:label="loc_us-gaapSellingGeneralAndAdministrativeExpensesPolicyTextBlock" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapSellingGeneralAndAdministrativeExpensesPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="loc_us-gaapIncomeTaxPolicyTextBlock" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapIncomeTaxPolicyTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="loc_us-gaapNewAccountingPronouncementsPolicyPolicyTextBlock" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapNewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_RecentlyIssuedAccountingPronouncementsNotYetAdoptedPolicyTextBlock" xlink:label="loc_NTRPRecentlyIssuedAccountingPronouncementsNotYetAdoptedPolicyTextBlock" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_NTRPRecentlyIssuedAccountingPronouncementsNotYetAdoptedPolicyTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:title="999039 - Disclosure - Summary of Significant Accounting Policies (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:label="loc_us-gaapScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_ScheduleOfEstimatedUsefulLivesForPropertyAndEquipmentTableTextBlock" xlink:label="loc_NTRPScheduleOfEstimatedUsefulLivesForPropertyAndEquipmentTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_NTRPScheduleOfEstimatedUsefulLivesForPropertyAndEquipmentTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_ScheduleOfEstimatedUsefulLivesForFiniteLifeIntangibleAssetsTableTextBlock" xlink:label="loc_NTRPScheduleOfEstimatedUsefulLivesForFiniteLifeIntangibleAssetsTableTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_NTRPScheduleOfEstimatedUsefulLivesForFiniteLifeIntangibleAssetsTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/DiscontinuedOperationsTables" xlink:title="999040 - Disclosure - Discontinued Operations (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:label="loc_us-gaapDiscontinuedOperationsAndDisposalGroupsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:label="loc_us-gaapScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDiscontinuedOperationsAndDisposalGroupsAbstract" xlink:to="loc_us-gaapScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/InvestmentInEquityMethodInvesteeTables" xlink:title="999041 - Disclosure - Investment in Equity Method Investee (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:label="loc_us-gaapEquityMethodInvestmentsAndJointVenturesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestmentsTextBlock" xlink:label="loc_us-gaapEquityMethodInvestmentsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityMethodInvestmentsAndJointVenturesAbstract" xlink:to="loc_us-gaapEquityMethodInvestmentsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/PrepaidAndOtherCurrentAssetsTables" xlink:title="999042 - Disclosure - Prepaid and Other Current Assets (Tables)">
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_DisclosurePrepaidAndOtherCurrentAssetsAbstract" xlink:label="loc_NTRPDisclosurePrepaidAndOtherCurrentAssetsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" xlink:label="loc_us-gaapDeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_NTRPDisclosurePrepaidAndOtherCurrentAssetsAbstract" xlink:to="loc_us-gaapDeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/PropertyAndEquipmentTables" xlink:title="999043 - Disclosure - Property and Equipment (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/IntangibleAssetsTables" xlink:title="999044 - Disclosure - Intangible Assets (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:label="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:label="loc_us-gaapScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/GoodwillTables" xlink:title="999045 - Disclosure - Goodwill (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:label="loc_us-gaapScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/IncomeTaxesTables" xlink:title="999046 - Disclosure - Income Taxes (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="loc_us-gaapScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="loc_us-gaapScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/StockholdersEquityTables" xlink:title="999047 - Disclosure - Stockholders&#8217; Equity (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapAwardTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_StockAppreciationRightsMember" xlink:label="loc_NTRPStockAppreciationRightsMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_NTRPStockAppreciationRightsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="loc_us-gaapScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:label="loc_us-gaapScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/LossPerShareTables" xlink:title="999048 - Disclosure - Loss Per Share (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaapEarningsPerShareAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="loc_us-gaapScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract" xlink:to="loc_us-gaapScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock" xlink:label="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract" xlink:to="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:label="loc_us-gaapScheduleOfWeightedAverageNumberOfSharesTableTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract" xlink:to="loc_us-gaapScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/BusinessDescriptionAndGoingConcernDetailsNarrative" xlink:title="999049 - Disclosure - Business Description and Going Concern (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_NextPlayTechnologiesIncMember" xlink:label="loc_NTRPNextPlayTechnologiesIncMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_NTRPNextPlayTechnologiesIncMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_NextTripGroupLLCMember" xlink:label="loc_NTRPNextTripGroupLLCMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_NTRPNextTripGroupLLCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_ShareExchangeAgreementMember" xlink:label="loc_NTRPShareExchangeAgreementMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_NTRPShareExchangeAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_MembershipUnitsMember" xlink:label="loc_NTRPMembershipUnitsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_NTRPMembershipUnitsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_PreferredUnitsMember" xlink:label="loc_NTRPPreferredUnitsMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_NTRPPreferredUnitsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:label="loc_srtScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_srtScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="loc_srtEquityMethodInvesteeNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="loc_srtEquityMethodInvesteeNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_NextInnovationLLCMember" xlink:label="loc_NTRPNextInnovationLLCMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtEquityMethodInvesteeNameDomain" xlink:to="loc_NTRPNextInnovationLLCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_ClosingSharesMember" xlink:label="loc_NTRPClosingSharesMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_NTRPClosingSharesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_ContingentSharesMember" xlink:label="loc_NTRPContingentSharesMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_NTRPContingentSharesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_srtRangeAxis" order="60" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaapSharesIssuedPricePerShare" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapSharesIssuedPricePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Capital" xlink:label="loc_us-gaapCapital" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapCapital" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="loc_us-gaapEquityMethodInvestmentOwnershipPercentage" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapEquityMethodInvestmentOwnershipPercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:label="loc_us-gaapBusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapBusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_PercentageForIssuedAndOutstandingCapitalStock" xlink:label="loc_NTRPPercentageForIssuedAndOutstandingCapitalStock" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_NTRPPercentageForIssuedAndOutstandingCapitalStock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_WorkingCapitalDeficit" xlink:label="loc_NTRPWorkingCapitalDeficit" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_NTRPWorkingCapitalDeficit" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/ScheduleOfAnti-dilutiveSecuritiesExcludedFromComputationOfEarningsPerShareDetails" xlink:title="999050 - Disclosure - Schedule of Anti-dilutive Securities Excluded from Computation of Earnings Per Share (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="loc_us-gaapScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="loc_us-gaapAntidilutiveSecuritiesNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="loc_us-gaapAntidilutiveSecuritiesNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:to="loc_us-gaapWarrantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockOptionMember" xlink:label="loc_us-gaapStockOptionMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:to="loc_us-gaapStockOptionMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockMember" xlink:label="loc_us-gaapPreferredStockMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:to="loc_us-gaapPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/ScheduleOfEstimatedUsefulLivesForPropertyAndEquipmentDetails" xlink:title="999051 - Disclosure - Schedule of Estimated Useful Lives for Property and Equipment (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaapPropertyPlantAndEquipmentLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="loc_us-gaapFurnitureAndFixturesMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapFurnitureAndFixturesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComputerEquipmentMember" xlink:label="loc_us-gaapComputerEquipmentMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapComputerEquipmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="loc_us-gaapPropertyPlantAndEquipmentUsefulLife" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentUsefulLife" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/ScheduleOfEstimatedUsefulLivesForFiniteLifeIntangibleAssetsDetails" xlink:title="999052 - Disclosure - Schedule of Estimated Useful Lives for Finite Life Intangible Assets (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaapPropertyPlantAndEquipmentLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_SoftwareMember" xlink:label="loc_NTRPSoftwareMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_NTRPSoftwareMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_SoftwareLicensesMember" xlink:label="loc_NTRPSoftwareLicensesMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_NTRPSoftwareLicensesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_srtRangeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetUsefulLife" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetUsefulLife" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="999053 - Disclosure - Summary of Significant Accounting Policies (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:label="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:label="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_NextPlayTechnologiesIncMember" xlink:label="loc_NTRPNextPlayTechnologiesIncMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_NTRPNextPlayTechnologiesIncMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_NextPlayTechnologiesIncMember" xlink:label="loc_NTRPNextPlayTechnologiesIncMember_2" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_NTRPNextPlayTechnologiesIncMember_2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashEquivalentsAtCarryingValue" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapCashEquivalentsAtCarryingValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableNet" xlink:label="loc_us-gaapAccountsReceivableNet" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapAccountsReceivableNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesPayable" xlink:label="loc_us-gaapNotesPayable" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapNotesPayable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:label="loc_us-gaapAllowanceForDoubtfulAccountsReceivable" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapAllowanceForDoubtfulAccountsReceivable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_LossOnRelatedPartyReceivable" xlink:label="loc_NTRPLossOnRelatedPartyReceivable" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_NTRPLossOnRelatedPartyReceivable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingAndMarketingExpense" xlink:label="loc_us-gaapSellingAndMarketingExpense" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapSellingAndMarketingExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/ScheduleOfDiscontinuedOperationsDetails" xlink:title="999054 - Disclosure - Schedule of Discontinued Operations (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:label="loc_us-gaapDiscontinuedOperationsAndDisposalGroupsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue" xlink:label="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationRevenue" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDiscontinuedOperationsAndDisposalGroupsAbstract" xlink:to="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationRevenue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold" xlink:label="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDiscontinuedOperationsAndDisposalGroupsAbstract" xlink:to="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss" xlink:label="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationGrossProfitLoss" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDiscontinuedOperationsAndDisposalGroupsAbstract" xlink:to="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationGrossProfitLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_DisposalGroupIncludingDiscontinuedOperationsProfessionalServices" xlink:label="loc_NTRPDisposalGroupIncludingDiscontinuedOperationsProfessionalServices" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDiscontinuedOperationsAndDisposalGroupsAbstract" xlink:to="loc_NTRPDisposalGroupIncludingDiscontinuedOperationsProfessionalServices" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_DisposalGroupIncludingDiscontinuedOperationsInvestorRelationsServices" xlink:label="loc_NTRPDisposalGroupIncludingDiscontinuedOperationsInvestorRelationsServices" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDiscontinuedOperationsAndDisposalGroupsAbstract" xlink:to="loc_NTRPDisposalGroupIncludingDiscontinuedOperationsInvestorRelationsServices" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_DisposalGroupIncludingDiscontinuedOperationsOtherIncome" xlink:label="loc_NTRPDisposalGroupIncludingDiscontinuedOperationsOtherIncome" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDiscontinuedOperationsAndDisposalGroupsAbstract" xlink:to="loc_NTRPDisposalGroupIncludingDiscontinuedOperationsOtherIncome" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense" xlink:label="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationOperatingExpense" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDiscontinuedOperationsAndDisposalGroupsAbstract" xlink:to="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationOperatingExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:label="loc_us-gaapIncomeLossFromDiscontinuedOperationsNetOfTax" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDiscontinuedOperationsAndDisposalGroupsAbstract" xlink:to="loc_us-gaapIncomeLossFromDiscontinuedOperationsNetOfTax" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/DiscontinuedOperationsDetailsNarrative" xlink:title="999055 - Disclosure - Discontinued Operations (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:label="loc_us-gaapDiscontinuedOperationsAndDisposalGroupsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDiscontinuedOperationsAndDisposalGroupsAbstract" xlink:to="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_AssetPurchaseAgreementMember" xlink:label="loc_NTRPAssetPurchaseAgreementMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_NTRPAssetPurchaseAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_deiLegalEntityAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_DivergentTechnologiesIncMember" xlink:label="loc_NTRPDivergentTechnologiesIncMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_NTRPDivergentTechnologiesIncMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireIntangibleAssets" xlink:label="loc_us-gaapPaymentsToAcquireIntangibleAssets" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapPaymentsToAcquireIntangibleAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_EarnestMoneyDeposit" xlink:label="loc_NTRPEarnestMoneyDeposit" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_NTRPEarnestMoneyDeposit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossOnDispositionOfAssets1" xlink:label="loc_us-gaapGainLossOnDispositionOfAssets1" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapGainLossOnDispositionOfAssets1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:label="loc_us-gaapIncomeLossFromDiscontinuedOperationsNetOfTax" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapIncomeLossFromDiscontinuedOperationsNetOfTax" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/ScheduleOfUnauditedSummarizedFinancialInformationDetails" xlink:title="999056 - Disclosure - Schedule of Unaudited Summarized Financial Information (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:label="loc_us-gaapEquityMethodInvestmentsAndJointVenturesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityMethodInvestmentsAndJointVenturesAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_FSATravelLLCMember" xlink:label="loc_NTRPFSATravelLLCMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_NTRPFSATravelLLCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsNoncurrent" xlink:label="loc_us-gaapAssetsNoncurrent" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAssetsNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="loc_us-gaapLiabilitiesNoncurrent" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLiabilitiesNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRevenues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaapGrossProfit" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapGrossProfit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/InvestmentInEquityMethodInvesteeDetailsNarrative" xlink:title="999057 - Disclosure - Investment in Equity Method Investee (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:label="loc_us-gaapEquityMethodInvestmentsAndJointVenturesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:label="loc_us-gaapScheduleOfEquityMethodInvestmentsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityMethodInvestmentsAndJointVenturesAbstract" xlink:to="loc_us-gaapScheduleOfEquityMethodInvestmentsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:label="loc_us-gaapScheduleOfEquityMethodInvestmentsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfEquityMethodInvestmentsTable" xlink:to="loc_us-gaapScheduleOfEquityMethodInvestmentsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfEquityMethodInvestmentsTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_MembershipPurchaseAgreementMember" xlink:label="loc_NTRPMembershipPurchaseAgreementMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_NTRPMembershipPurchaseAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:label="loc_srtScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfEquityMethodInvestmentsTable" xlink:to="loc_srtScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="loc_srtEquityMethodInvesteeNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="loc_srtEquityMethodInvesteeNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_FSATravelLLCMember" xlink:label="loc_NTRPFSATravelLLCMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtEquityMethodInvesteeNameDomain" xlink:to="loc_NTRPFSATravelLLCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_NextTripMember" xlink:label="loc_NTRPNextTripMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtEquityMethodInvesteeNameDomain" xlink:to="loc_NTRPNextTripMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfEquityMethodInvestmentsTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_SeriesOPreferredStockMember" xlink:label="loc_NTRPSeriesOPreferredStockMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_NTRPSeriesOPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfEquityMethodInvestmentsTable" xlink:to="loc_deiLegalEntityAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_FSATravelLLCMember" xlink:label="loc_NTRPFSATravelLLCMember_2" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_NTRPFSATravelLLCMember_2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_NextTripMember" xlink:label="loc_NTRPNextTripMember_2" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_NTRPNextTripMember_2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityOwnershipPercentageExcludingConsolidatedEntityAndEquityMethodInvestee" xlink:label="loc_us-gaapEquityOwnershipPercentageExcludingConsolidatedEntityAndEquityMethodInvestee" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfEquityMethodInvestmentsLineItems" xlink:to="loc_us-gaapEquityOwnershipPercentageExcludingConsolidatedEntityAndEquityMethodInvestee" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionPreacquisitionContingencyAmountOfSettlement" xlink:label="loc_us-gaapBusinessAcquisitionPreacquisitionContingencyAmountOfSettlement" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfEquityMethodInvestmentsLineItems" xlink:to="loc_us-gaapBusinessAcquisitionPreacquisitionContingencyAmountOfSettlement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationContingentConsiderationAsset" xlink:label="loc_us-gaapBusinessCombinationContingentConsiderationAsset" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfEquityMethodInvestmentsLineItems" xlink:to="loc_us-gaapBusinessCombinationContingentConsiderationAsset" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesIssued" xlink:label="loc_us-gaapSharesIssued" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfEquityMethodInvestmentsLineItems" xlink:to="loc_us-gaapSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaapSharesIssuedPricePerShare" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfEquityMethodInvestmentsLineItems" xlink:to="loc_us-gaapSharesIssuedPricePerShare" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="loc_us-gaapEquityMethodInvestmentOwnershipPercentage" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfEquityMethodInvestmentsLineItems" xlink:to="loc_us-gaapEquityMethodInvestmentOwnershipPercentage" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentInterestRatePaidInCash" xlink:label="loc_us-gaapInvestmentInterestRatePaidInCash" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfEquityMethodInvestmentsLineItems" xlink:to="loc_us-gaapInvestmentInterestRatePaidInCash" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCosts" xlink:label="loc_us-gaapBusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCosts" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfEquityMethodInvestmentsLineItems" xlink:to="loc_us-gaapBusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCosts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_BusinessAcquisitionMilestonePayments" xlink:label="loc_NTRPBusinessAcquisitionMilestonePayments" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfEquityMethodInvestmentsLineItems" xlink:to="loc_NTRPBusinessAcquisitionMilestonePayments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_BusinessAcquisitionPerMilestonePayments" xlink:label="loc_NTRPBusinessAcquisitionPerMilestonePayments" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfEquityMethodInvestmentsLineItems" xlink:to="loc_NTRPBusinessAcquisitionPerMilestonePayments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireBusinessesAndInterestInAffiliates" xlink:label="loc_us-gaapPaymentsToAcquireBusinessesAndInterestInAffiliates" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfEquityMethodInvestmentsLineItems" xlink:to="loc_us-gaapPaymentsToAcquireBusinessesAndInterestInAffiliates" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/InvestmentInEquitySecuritiesDetailsNarrative" xlink:title="999058 - Disclosure - Investment in Equity Securities (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:label="loc_us-gaapInvestmentsDebtAndEquitySecuritiesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_ShareExchangeAgreementMember" xlink:label="loc_NTRPShareExchangeAgreementMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_NTRPShareExchangeAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_BlueFyshHoldingsIncMember" xlink:label="loc_NTRPBlueFyshHoldingsIncMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_NTRPBlueFyshHoldingsIncMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_SeriesNNonvotingConvertiblePreferredStockMember" xlink:label="loc_NTRPSeriesNNonvotingConvertiblePreferredStockMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_NTRPSeriesNNonvotingConvertiblePreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapAwardTypeAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockMember" xlink:label="loc_us-gaapRestrictedStockMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapRestrictedStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityOwnershipPercentageExcludingConsolidatedEntityAndEquityMethodInvestee" xlink:label="loc_us-gaapEquityOwnershipPercentageExcludingConsolidatedEntityAndEquityMethodInvestee" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEquityOwnershipPercentageExcludingConsolidatedEntityAndEquityMethodInvestee" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaapSharesIssuedPricePerShare" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesIssuedPricePerShare" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/ScheduleOfPrepaidAndOtherCurrentAssetsDetails" xlink:title="999059 - Disclosure - Schedule of Prepaid and Other Current Assets (Details)">
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_DisclosurePrepaidAndOtherCurrentAssetsAbstract" xlink:label="loc_NTRPDisclosurePrepaidAndOtherCurrentAssetsAbstract" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_PrepaidOfferingCosts" xlink:label="loc_NTRPPrepaidOfferingCosts" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_NTRPDisclosurePrepaidAndOtherCurrentAssetsAbstract" xlink:to="loc_NTRPPrepaidOfferingCosts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_PrepaidConsultingContract" xlink:label="loc_NTRPPrepaidConsultingContract" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_NTRPDisclosurePrepaidAndOtherCurrentAssetsAbstract" xlink:to="loc_NTRPPrepaidConsultingContract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_PrepaidCostOfSales" xlink:label="loc_NTRPPrepaidCostOfSales" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_NTRPDisclosurePrepaidAndOtherCurrentAssetsAbstract" xlink:to="loc_NTRPPrepaidCostOfSales" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherPrepaidExpenseCurrent" xlink:label="loc_us-gaapOtherPrepaidExpenseCurrent" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_NTRPDisclosurePrepaidAndOtherCurrentAssetsAbstract" xlink:to="loc_us-gaapOtherPrepaidExpenseCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidAdvertising" xlink:label="loc_us-gaapPrepaidAdvertising" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_NTRPDisclosurePrepaidAndOtherCurrentAssetsAbstract" xlink:to="loc_us-gaapPrepaidAdvertising" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_NTRPDisclosurePrepaidAndOtherCurrentAssetsAbstract" xlink:to="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/ScheduleOfPropertyAndEquipmentDetails" xlink:title="999060 - Disclosure - Schedule of Property and Equipment (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaapPropertyPlantAndEquipmentLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="loc_us-gaapFurnitureAndFixturesMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapFurnitureAndFixturesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComputerEquipmentMember" xlink:label="loc_us-gaapComputerEquipmentMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapComputerEquipmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaapPropertyPlantAndEquipmentGross" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/PropertyAndEquipmentDetailsNarrative" xlink:title="999061 - Disclosure - Property and Equipment (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaapDepreciation" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapDepreciation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/ScheduleOfIntangibleAssetsDetails" xlink:title="999062 - Disclosure - Schedule of Intangible Assets (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SoftwareDevelopmentMember" xlink:label="loc_us-gaapSoftwareDevelopmentMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapSoftwareDevelopmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_SoftwareLicenseMember" xlink:label="loc_NTRPSoftwareLicenseMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_NTRPSoftwareLicenseMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TrademarksMember" xlink:label="loc_us-gaapTrademarksMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapTrademarksMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsGross" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsGross" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/ScheduleOfEstimatedAggregateAmortizationExpenseDetails" xlink:title="999063 - Disclosure - Schedule of estimated aggregate amortization expense (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearThree" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearFour" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour" xlink:label="loc_NTRPFiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_NTRPFiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsNet" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/IntangibleAssetsDetailsNarrative" xlink:title="999064 - Disclosure - Intangible Assets (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="loc_us-gaapAmortizationOfIntangibleAssets" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapAmortizationOfIntangibleAssets" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/ScheduleOfFairValueOfAssetsAcquiredDetails" xlink:title="999065 - Disclosure - Schedule of Fair Value of Assets Acquired (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="loc_us-gaapRestructuringCostAndReserveLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapRestructuringCostAndReserveLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_SigmaAdditiveSolutionsIncMember" xlink:label="loc_NTRPSigmaAdditiveSolutionsIncMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_NTRPSigmaAdditiveSolutionsIncMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses" xlink:label="loc_NTRPBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_NTRPBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapGoodwill" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="loc_us-gaapBusinessCombinationConsiderationTransferred1" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapBusinessCombinationConsiderationTransferred1" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/GoodwillDetailsNarrative" xlink:title="999066 - Disclosure - Goodwill (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_SigmaAdditiveSolutionsIncMember" xlink:label="loc_NTRPSigmaAdditiveSolutionsIncMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_NTRPSigmaAdditiveSolutionsIncMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_NextTripHoldingsIncMember" xlink:label="loc_NTRPNextTripHoldingsIncMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_NTRPNextTripHoldingsIncMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeriesEPreferredStockMember" xlink:label="loc_us-gaapSeriesEPreferredStockMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesEPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_DivergentTechnologiesIncMember" xlink:label="loc_NTRPDivergentTechnologiesIncMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_NTRPDivergentTechnologiesIncMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="loc_us-gaapBusinessCombinationConsiderationTransferred1" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapBusinessCombinationConsiderationTransferred1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionSharePrice" xlink:label="loc_us-gaapBusinessAcquisitionSharePrice" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapBusinessAcquisitionSharePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillPeriodIncreaseDecrease" xlink:label="loc_us-gaapGoodwillPeriodIncreaseDecrease" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapGoodwillPeriodIncreaseDecrease" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireIntangibleAssets" xlink:label="loc_us-gaapPaymentsToAcquireIntangibleAssets" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPaymentsToAcquireIntangibleAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossOnDispositionOfAssets" xlink:label="loc_us-gaapGainLossOnDispositionOfAssets" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapGainLossOnDispositionOfAssets" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/AccountsPayableAndAccruedLiabilitiesDetailsNarrative" xlink:title="999067 - Disclosure - Accounts Payable and Accrued Liabilities (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="loc_us-gaapPayablesAndAccrualsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableCurrentAndNoncurrent" xlink:label="loc_us-gaapAccountsPayableCurrentAndNoncurrent" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapAccountsPayableCurrentAndNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedLiabilitiesCurrentAndNoncurrent" xlink:label="loc_us-gaapAccruedLiabilitiesCurrentAndNoncurrent" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapAccruedLiabilitiesCurrentAndNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/ScheduleOfDeferredTaxAssetsDetails" xlink:title="999068 - Disclosure - Schedule of Deferred Tax Assets (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwards" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwards" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_DeferredTaxAssetDepreciation" xlink:label="loc_NTRPDeferredTaxAssetDepreciation" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_NTRPDeferredTaxAssetDepreciation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_DeferredTaxAssetsPayrollAccruals" xlink:label="loc_NTRPDeferredTaxAssetsPayrollAccruals" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_NTRPDeferredTaxAssetsPayrollAccruals" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_DeferredTaxLiabilitiesDepreciation" xlink:label="loc_NTRPDeferredTaxLiabilitiesDepreciation" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_NTRPDeferredTaxLiabilitiesDepreciation" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapDeferredTaxAssetsValuationAllowance" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsValuationAllowance" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="loc_us-gaapDeferredTaxAssetsNet" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/ScheduleOfReconciliationOfProvisionForIncomeTaxesDetails" xlink:title="999069 - Disclosure - Schedule of Reconciliation of Provision for Income Taxes (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_EffectiveIncomeTaxRateReconciliationBookLoss" xlink:label="loc_NTRPEffectiveIncomeTaxRateReconciliationBookLoss" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_NTRPEffectiveIncomeTaxRateReconciliationBookLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseDepreciation" xlink:label="loc_us-gaapIncomeTaxReconciliationNondeductibleExpenseDepreciation" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxReconciliationNondeductibleExpenseDepreciation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment" xlink:label="loc_us-gaapIncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_IncomeTaxReconciliationNondeductibleExpensePreferredDividends" xlink:label="loc_NTRPIncomeTaxReconciliationNondeductibleExpensePreferredDividends" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_NTRPIncomeTaxReconciliationNondeductibleExpensePreferredDividends" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_IncomeTaxReconciliationNondeductibleExpenseLossOnNextPlayNoteReceivable" xlink:label="loc_NTRPIncomeTaxReconciliationNondeductibleExpenseLossOnNextPlayNoteReceivable" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_NTRPIncomeTaxReconciliationNondeductibleExpenseLossOnNextPlayNoteReceivable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:label="loc_us-gaapIncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_IncomeTaxReconciliationNondeductibleExpenseLossOnAssetDisposal" xlink:label="loc_NTRPIncomeTaxReconciliationNondeductibleExpenseLossOnAssetDisposal" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_NTRPIncomeTaxReconciliationNondeductibleExpenseLossOnAssetDisposal" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_IncomeTaxReconciliationNondeductibleExpenseAccruedPayroll" xlink:label="loc_NTRPIncomeTaxReconciliationNondeductibleExpenseAccruedPayroll" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_NTRPIncomeTaxReconciliationNondeductibleExpenseAccruedPayroll" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_IncomeTaxReconciliationNondeductibleExpenseRelatedPartyAccruals" xlink:label="loc_NTRPIncomeTaxReconciliationNondeductibleExpenseRelatedPartyAccruals" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_NTRPIncomeTaxReconciliationNondeductibleExpenseRelatedPartyAccruals" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapIncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/IncomeTaxesDetailsNarrative" xlink:title="999070 - Disclosure - Income Taxes (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="loc_us-gaapOperatingLossCarryforwards" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapOperatingLossCarryforwards" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_OperatingLossCarryforwardsRemainder" xlink:label="loc_NTRPOperatingLossCarryforwardsRemainder" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_NTRPOperatingLossCarryforwardsRemainder" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapDeferredTaxAssetsValuationAllowance" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsValuationAllowance" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/NotesPayableDetailsNarrative" xlink:title="999071 - Disclosure - Notes Payable (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaapDebtInstrumentTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapDebtInstrumentTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaapDebtInstrumentLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_us-gaapDebtInstrumentLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_SecuritiesPurchaseAgreementMember" xlink:label="loc_NTRPSecuritiesPurchaseAgreementMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_NTRPSecuritiesPurchaseAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_NoteSecuritiesPurchaseAgreementMember" xlink:label="loc_NTRPNoteSecuritiesPurchaseAgreementMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_NTRPNoteSecuritiesPurchaseAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_ShortTermPromissoryNoteMember" xlink:label="loc_NTRPShortTermPromissoryNoteMember" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_NTRPShortTermPromissoryNoteMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_DebtConversionAgreementMember" xlink:label="loc_NTRPDebtConversionAgreementMember" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_NTRPDebtConversionAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_NoteTwoSecuritiesPurchaseAgreementMember" xlink:label="loc_NTRPNoteTwoSecuritiesPurchaseAgreementMember" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_NTRPNoteTwoSecuritiesPurchaseAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_OneMillionNoteMember" xlink:label="loc_NTRPOneMillionNoteMember" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_NTRPOneMillionNoteMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_DebtExchangeAgreementMember" xlink:label="loc_NTRPDebtExchangeAgreementMember" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_NTRPDebtExchangeAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_srtRangeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_SeriesMNonvotingConvertiblePreferredStockMember" xlink:label="loc_NTRPSeriesMNonvotingConvertiblePreferredStockMember" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_NTRPSeriesMNonvotingConvertiblePreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_SeriesPNonvotingConvertiblePreferredStockMember" xlink:label="loc_NTRPSeriesPNonvotingConvertiblePreferredStockMember" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_NTRPSeriesPNonvotingConvertiblePreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromConvertibleDebt" xlink:label="loc_us-gaapProceedsFromConvertibleDebt" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapProceedsFromConvertibleDebt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaapDebtInstrumentInterestRateStatedPercentage" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateStatedPercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaapDebtInstrumentFaceAmount" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentFaceAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesAndLoansPayableCurrent" xlink:label="loc_us-gaapNotesAndLoansPayableCurrent" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapNotesAndLoansPayableCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromNotesPayable" xlink:label="loc_us-gaapProceedsFromNotesPayable" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapProceedsFromNotesPayable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentUnamortizedDiscount" xlink:label="loc_us-gaapDebtInstrumentUnamortizedDiscount" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentUnamortizedDiscount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="loc_us-gaapDebtInstrumentMaturityDate" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentMaturityDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:label="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_ConvertibleNotesPayableOfInstallments" xlink:label="loc_NTRPConvertibleNotesPayableOfInstallments" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_NTRPConvertibleNotesPayableOfInstallments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:label="loc_us-gaapDebtInstrumentInterestRateEffectivePercentage" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateEffectivePercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="loc_us-gaapSaleOfStockPricePerShare" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapSaleOfStockPricePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:label="loc_us-gaapDebtConversionConvertedInstrumentAmount1" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtConversionConvertedInstrumentAmount1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_DebtConversionConvertedInstrumentOfGuaranteedInterest" xlink:label="loc_NTRPDebtConversionConvertedInstrumentOfGuaranteedInterest" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_NTRPDebtConversionConvertedInstrumentOfGuaranteedInterest" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:label="loc_us-gaapDebtConversionConvertedInstrumentSharesIssued1" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtConversionConvertedInstrumentSharesIssued1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:label="loc_us-gaapDebtInstrumentConvertibleConversionPrice1" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentConvertibleConversionPrice1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentPeriodicPayment" xlink:label="loc_us-gaapDebtInstrumentPeriodicPayment" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentPeriodicPayment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_DebtInstrumentPeriodicOfInstallments" xlink:label="loc_NTRPDebtInstrumentPeriodicOfInstallments" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_NTRPDebtInstrumentPeriodicOfInstallments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesIssued" xlink:label="loc_us-gaapSharesIssued" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapSharesIssued" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaapSharesIssuedPricePerShare" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapSharesIssuedPricePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_DebtInstrumentUnamortizedDebtDiscount" xlink:label="loc_NTRPDebtInstrumentUnamortizedDebtDiscount" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_NTRPDebtInstrumentUnamortizedDebtDiscount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentCovenantDescription" xlink:label="loc_us-gaapDebtInstrumentCovenantDescription" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapDebtInstrumentCovenantDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_DebtInstrumentOfInvestor" xlink:label="loc_NTRPDebtInstrumentOfInvestor" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_NTRPDebtInstrumentOfInvestor" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_DebtInstrumentOfFunded" xlink:label="loc_NTRPDebtInstrumentOfFunded" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_NTRPDebtInstrumentOfFunded" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCost" xlink:label="loc_NTRPAdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCost" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_NTRPAdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCost" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentLineItems" xlink:to="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/ConvertibleNotesDetailsNarrative" xlink:title="999072 - Disclosure - Convertible Notes (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_DisclosureConvertibleNotesAbstract" xlink:label="loc_NTRPDisclosureConvertibleNotesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_NTRPDisclosureConvertibleNotesAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_SpecialPurposeAcquisitionCorporationMember" xlink:label="loc_NTRPSpecialPurposeAcquisitionCorporationMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_NTRPSpecialPurposeAcquisitionCorporationMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_SeveralInvestorsMember" xlink:label="loc_NTRPSeveralInvestorsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_NTRPSeveralInvestorsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaapDebtInstrumentAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapDebtInstrumentAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_ConvertibleNotesMember" xlink:label="loc_NTRPConvertibleNotesMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_NTRPConvertibleNotesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_DebtAssignmentAndConversionAgreementsMember" xlink:label="loc_NTRPDebtAssignmentAndConversionAgreementsMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_NTRPDebtAssignmentAndConversionAgreementsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_ContingentSharesMember" xlink:label="loc_NTRPContingentSharesMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_NTRPContingentSharesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromConvertibleDebt" xlink:label="loc_us-gaapProceedsFromConvertibleDebt" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProceedsFromConvertibleDebt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaapDebtInstrumentInterestRateStatedPercentage" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateStatedPercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:label="loc_us-gaapDebtInstrumentConvertibleConversionPrice1" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentConvertibleConversionPrice1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaapSharePrice" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpenseDebt" xlink:label="loc_us-gaapInterestExpenseDebt" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapInterestExpenseDebt" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/SharePurchaseAgreementsDetailsNarrative" xlink:title="999073 - Disclosure - Share Purchase Agreements (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_DisclosureSharePurchaseAgreementsAbstract" xlink:label="loc_NTRPDisclosureSharePurchaseAgreementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_NTRPDisclosureSharePurchaseAgreementsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_SharePurchaseAgreementsMember" xlink:label="loc_NTRPSharePurchaseAgreementsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_NTRPSharePurchaseAgreementsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_SoftwareAsAServiceAgreementMember" xlink:label="loc_NTRPSoftwareAsAServiceAgreementMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_NTRPSoftwareAsAServiceAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_ConsultingModificationAgreementMember" xlink:label="loc_NTRPConsultingModificationAgreementMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_NTRPConsultingModificationAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtTitleOfIndividualAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_SeveralInvestorsMember" xlink:label="loc_NTRPSeveralInvestorsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_NTRPSeveralInvestorsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_ThirdPartyMember" xlink:label="loc_NTRPThirdPartyMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_NTRPThirdPartyMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_ThirdPartyConsultantMember" xlink:label="loc_NTRPThirdPartyConsultantMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_NTRPThirdPartyConsultantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_ContingentSharesMember" xlink:label="loc_NTRPContingentSharesMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_NTRPContingentSharesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromConvertibleDebt" xlink:label="loc_us-gaapProceedsFromConvertibleDebt" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProceedsFromConvertibleDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaapSharePrice" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_ProceedsFromDownpaymentForContract" xlink:label="loc_NTRPProceedsFromDownpaymentForContract" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_NTRPProceedsFromDownpaymentForContract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:label="loc_us-gaapDebtInstrumentConvertibleConversionPrice1" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentConvertibleConversionPrice1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_ConsultingFees" xlink:label="loc_NTRPConsultingFees" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_NTRPConsultingFees" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:title="999074 - Disclosure - Related Party Transactions (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaapRelatedPartyTransactionsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract" xlink:to="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="loc_us-gaapRelatedPartyTransactionLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_us-gaapRelatedPartyTransactionLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyMember" xlink:label="loc_us-gaapRelatedPartyMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_us-gaapRelatedPartyMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_NextPlayTechnologiesIncMember" xlink:label="loc_NTRPNextPlayTechnologiesIncMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_NTRPNextPlayTechnologiesIncMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_NextPlayTechnologiesIncMember" xlink:label="loc_NTRPNextPlayTechnologiesIncMember_2" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_NTRPNextPlayTechnologiesIncMember_2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesPayableCurrent" xlink:label="loc_us-gaapNotesPayableCurrent" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapNotesPayableCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_LossOnRelatedPartyReceivable" xlink:label="loc_NTRPLossOnRelatedPartyReceivable" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_NTRPLossOnRelatedPartyReceivable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReceivablesNetCurrent" xlink:label="loc_us-gaapReceivablesNetCurrent" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapReceivablesNetCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:label="loc_us-gaapAllowanceForDoubtfulAccountsReceivable" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapAllowanceForDoubtfulAccountsReceivable" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/DeferredRevenueDetailsNarrative" xlink:title="999075 - Disclosure - Deferred Revenue (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_DisclosureDeferredRevenueAbstract" xlink:label="loc_NTRPDisclosureDeferredRevenueAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="loc_us-gaapDeferredRevenueCurrent" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_NTRPDisclosureDeferredRevenueAbstract" xlink:to="loc_us-gaapDeferredRevenueCurrent" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/ScheduleOfStockOptionActivityDetails" xlink:title="999076 - Disclosure - Schedule of Stock Option Activity (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapAwardTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_StockAppreciationRightsMember" xlink:label="loc_NTRPStockAppreciationRightsMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_NTRPStockAppreciationRightsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedorCancelledInPeriodTotalIntrinsicValue" xlink:label="loc_NTRPShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedorCancelledInPeriodTotalIntrinsicValue" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_NTRPShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedorCancelledInPeriodTotalIntrinsicValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_2" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageForfeitedOrCancelled" xlink:label="loc_NTRPShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageForfeitedOrCancelled" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_NTRPShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageForfeitedOrCancelled" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/ScheduleOfShareBasedPaymentsAwardStockOptionsValuationAssumptionsDetails" xlink:title="999077 - Disclosure - Schedule of Share Based Payments Award Stock Options Valuation Assumptions (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapPlanNameAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_TwoThousandAndTwentyStockAppreciationRightsPlanMember" xlink:label="loc_NTRPTwoThousandAndTwentyStockAppreciationRightsPlanMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_NTRPTwoThousandAndTwentyStockAppreciationRightsPlanMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_srtRangeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/ScheduleOfWarrantyActivityDetails" xlink:title="999078 - Disclosure - Schedule of Warranty Activity (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_NTRPShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_NTRPShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonOutstandingWeightedAverageRemainingContractualTerm" xlink:label="loc_NTRPSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonOutstandingWeightedAverageRemainingContractualTerm" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_NTRPSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonOutstandingWeightedAverageRemainingContractualTerm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_NTRPShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_NTRPShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonGrantsWeightedAverageRemainingContractualTerm" xlink:label="loc_NTRPSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonGrantsWeightedAverageRemainingContractualTerm" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_NTRPSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonGrantsWeightedAverageRemainingContractualTerm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageExercisePrice" xlink:label="loc_NTRPShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_NTRPShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageWeightedAverageExercisePriceWarrantsForfeitedOrCancelled" xlink:label="loc_NTRPShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageWeightedAverageExercisePriceWarrantsForfeitedOrCancelled" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_NTRPShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageWeightedAverageExercisePriceWarrantsForfeitedOrCancelled" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_2" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_NTRPShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice_2" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_NTRPShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/StockholdersEquityDetailsNarrative" xlink:title="999079 - Disclosure - Stockholders&#8217; Equity (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember" />
      <link:presentationArc order="1050" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapWarrantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" xlink:to="loc_deiLegalEntityAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_AlumniCapitalLPMember" xlink:label="loc_NTRPAlumniCapitalLPMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_NTRPAlumniCapitalLPMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_FSATravelLLCMember" xlink:label="loc_NTRPFSATravelLLCMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_NTRPFSATravelLLCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_BlueFyshHoldingsIncMember" xlink:label="loc_NTRPBlueFyshHoldingsIncMember" />
      <link:presentationArc order="810" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_NTRPBlueFyshHoldingsIncMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_AtTheMarketIssuanceSalesAgreementMember" xlink:label="loc_NTRPAtTheMarketIssuanceSalesAgreementMember" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_NTRPAtTheMarketIssuanceSalesAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_NextTripHoldingsIncMember" xlink:label="loc_NTRPNextTripHoldingsIncMember" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_NTRPNextTripHoldingsIncMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_FSATravelLLCMember" xlink:label="loc_NTRPFSATravelLLCMember_2" />
      <link:presentationArc order="870" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_NTRPFSATravelLLCMember_2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredRevenueArrangementTypeAxis" xlink:label="loc_us-gaapDeferredRevenueArrangementTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" xlink:to="loc_us-gaapDeferredRevenueArrangementTypeAxis" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredRevenueArrangementTypeDomain" xlink:label="loc_us-gaapDeferredRevenueArrangementTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredRevenueArrangementTypeAxis" xlink:to="loc_us-gaapDeferredRevenueArrangementTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_DebtAssignmentAndConversionAgreementsMember" xlink:label="loc_NTRPDebtAssignmentAndConversionAgreementsMember" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredRevenueArrangementTypeDomain" xlink:to="loc_NTRPDebtAssignmentAndConversionAgreementsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_SharePurchaseAndExchangeAgreementsMember" xlink:label="loc_NTRPSharePurchaseAndExchangeAgreementsMember" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredRevenueArrangementTypeDomain" xlink:to="loc_NTRPSharePurchaseAndExchangeAgreementsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:label="loc_us-gaapRelatedPartyTransactionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" xlink:to="loc_us-gaapRelatedPartyTransactionAxis" order="60" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="loc_us-gaapRelatedPartyTransactionDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionAxis" xlink:to="loc_us-gaapRelatedPartyTransactionDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_ThirdPartyConsultantMember" xlink:label="loc_NTRPThirdPartyConsultantMember" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionDomain" xlink:to="loc_NTRPThirdPartyConsultantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="70" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_SeriesEConvertiblePreferredStockMember" xlink:label="loc_NTRPSeriesEConvertiblePreferredStockMember" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_NTRPSeriesEConvertiblePreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_SeriesFConvertiblePreferredStockMember" xlink:label="loc_NTRPSeriesFConvertiblePreferredStockMember" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_NTRPSeriesFConvertiblePreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_SeriesGConvertiblePreferredStockMember" xlink:label="loc_NTRPSeriesGConvertiblePreferredStockMember" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_NTRPSeriesGConvertiblePreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_SeriesHConvertiblePreferredStockMember" xlink:label="loc_NTRPSeriesHConvertiblePreferredStockMember" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_NTRPSeriesHConvertiblePreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_SeriesIConvertiblePreferredStockMember" xlink:label="loc_NTRPSeriesIConvertiblePreferredStockMember" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_NTRPSeriesIConvertiblePreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_SeriesIPreferredStockMember" xlink:label="loc_NTRPSeriesIPreferredStockMember" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_NTRPSeriesIPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_SeriesJNonvotingConvertiblePreferredStockMember" xlink:label="loc_NTRPSeriesJNonvotingConvertiblePreferredStockMember" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_NTRPSeriesJNonvotingConvertiblePreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_SeriesKNonvotingConvertiblePreferredStockMember" xlink:label="loc_NTRPSeriesKNonvotingConvertiblePreferredStockMember" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_NTRPSeriesKNonvotingConvertiblePreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_SeriesLNonvotingConvertiblePreferredStockMember" xlink:label="loc_NTRPSeriesLNonvotingConvertiblePreferredStockMember" />
      <link:presentationArc order="600" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_NTRPSeriesLNonvotingConvertiblePreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_SeriesMNonvotingConvertiblePreferredStockMember" xlink:label="loc_NTRPSeriesMNonvotingConvertiblePreferredStockMember" />
      <link:presentationArc order="690" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_NTRPSeriesMNonvotingConvertiblePreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_SeriesNNonvotingConvertiblePreferredStockMember" xlink:label="loc_NTRPSeriesNNonvotingConvertiblePreferredStockMember" />
      <link:presentationArc order="770" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_NTRPSeriesNNonvotingConvertiblePreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_SeriesNNonvotingConvertibleConvertiblePreferredStockMember" xlink:label="loc_NTRPSeriesNNonvotingConvertibleConvertiblePreferredStockMember" />
      <link:presentationArc order="840" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_NTRPSeriesNNonvotingConvertibleConvertiblePreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_SeriesONonvotingConvertiblePreferredStockMember" xlink:label="loc_NTRPSeriesONonvotingConvertiblePreferredStockMember" />
      <link:presentationArc order="850" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_NTRPSeriesONonvotingConvertiblePreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_SeriesPNonvotingConvertiblePreferredStockMember" xlink:label="loc_NTRPSeriesPNonvotingConvertiblePreferredStockMember" />
      <link:presentationArc order="890" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_NTRPSeriesPNonvotingConvertiblePreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" order="80" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_SecuritiesPurchaseAgreementMember" xlink:label="loc_NTRPSecuritiesPurchaseAgreementMember" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_NTRPSecuritiesPurchaseAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_SeriesIPurchaseAgreementMember" xlink:label="loc_NTRPSeriesIPurchaseAgreementMember" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_NTRPSeriesIPurchaseAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_MillerDebtConversionAgreementMember" xlink:label="loc_NTRPMillerDebtConversionAgreementMember" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_NTRPMillerDebtConversionAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_RelatedPartyDebtConversionAgreementsMember" xlink:label="loc_NTRPRelatedPartyDebtConversionAgreementsMember" />
      <link:presentationArc order="630" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_NTRPRelatedPartyDebtConversionAgreementsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_DebtConversionAgreementMember" xlink:label="loc_NTRPDebtConversionAgreementMember" />
      <link:presentationArc order="730" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_NTRPDebtConversionAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_ShareExchangeAgreementMember" xlink:label="loc_NTRPShareExchangeAgreementMember" />
      <link:presentationArc order="810" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_NTRPShareExchangeAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_EquityInvestmentAgreementMember" xlink:label="loc_NTRPEquityInvestmentAgreementMember" />
      <link:presentationArc order="910" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_NTRPEquityInvestmentAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_DebtExchangeAgreementMember" xlink:label="loc_NTRPDebtExchangeAgreementMember" />
      <link:presentationArc order="930" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_NTRPDebtExchangeAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" xlink:to="loc_srtTitleOfIndividualAxis" order="90" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_MessrsKerbyAndMonacoMember" xlink:label="loc_NTRPMessrsKerbyAndMonacoMember" />
      <link:presentationArc order="630" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_NTRPMessrsKerbyAndMonacoMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" xlink:to="loc_us-gaapPlanNameAxis" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_TwoThousandTwentyThreeEquityIncentivePlanMember" xlink:label="loc_NTRPTwoThousandTwentyThreeEquityIncentivePlanMember" />
      <link:presentationArc order="960" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_NTRPTwoThousandTwentyThreeEquityIncentivePlanMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_TwoThousandThirteenEquityIncentivePlanMember" xlink:label="loc_NTRPTwoThousandThirteenEquityIncentivePlanMember" />
      <link:presentationArc order="970" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_NTRPTwoThousandThirteenEquityIncentivePlanMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_TwoThousandAndTwentyStockAppreciationRightsPlanMember" xlink:label="loc_NTRPTwoThousandAndTwentyStockAppreciationRightsPlanMember" />
      <link:presentationArc order="1030" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_NTRPTwoThousandAndTwentyStockAppreciationRightsPlanMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" xlink:to="loc_us-gaapAwardTypeAxis" order="110" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockOptionMember" xlink:label="loc_us-gaapStockOptionMember" />
      <link:presentationArc order="980" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapStockOptionMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_StockAppreciationRightsMember" xlink:label="loc_NTRPStockAppreciationRightsMember" />
      <link:presentationArc order="1010" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_NTRPStockAppreciationRightsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossTable" xlink:to="loc_srtRangeAxis" order="120" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember" />
      <link:presentationArc order="990" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember" />
      <link:presentationArc order="1060" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapCommonStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityReverseStockSplit" xlink:label="loc_us-gaapStockholdersEquityReverseStockSplit" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapStockholdersEquityReverseStockSplit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesReverseStockSplits" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesReverseStockSplits" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesAcquisitions" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesAcquisitions" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_StockIssuedDuringPeriodSharesWarrantExercises" xlink:label="loc_NTRPStockIssuedDuringPeriodSharesWarrantExercises" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_NTRPStockIssuedDuringPeriodSharesWarrantExercises" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:label="loc_us-gaapProceedsFromWarrantExercises" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapProceedsFromWarrantExercises" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfCommonStock" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOfCommonStock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:label="loc_us-gaapBusinessAcquisitionPercentageOfVotingInterestsAcquired" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapBusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesRestrictedStockAwardGross" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction" xlink:label="loc_us-gaapSaleOfStockPercentageOfOwnershipAfterTransaction" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapSaleOfStockPercentageOfOwnershipAfterTransaction" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:label="loc_us-gaapBusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapBusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockRepurchasedDuringPeriodShares" xlink:label="loc_us-gaapStockRepurchasedDuringPeriodShares" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapStockRepurchasedDuringPeriodShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaapSharePrice" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapSharePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaapAllocatedShareBasedCompensationExpense" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapAllocatedShareBasedCompensationExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaapPreferredStockSharesAuthorized" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapPreferredStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaapPreferredStockSharesIssued" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapPreferredStockSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaapPreferredStockSharesOutstanding" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapPreferredStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockDividendRatePercentage" xlink:label="loc_us-gaapPreferredStockDividendRatePercentage" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapPreferredStockDividendRatePercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:label="loc_us-gaapDebtInstrumentConvertibleConversionPrice1" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapDebtInstrumentConvertibleConversionPrice1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockConvertibleSharesIssuable" xlink:label="loc_us-gaapPreferredStockConvertibleSharesIssuable" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapPreferredStockConvertibleSharesIssuable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockRedemptionTerms" xlink:label="loc_us-gaapPreferredStockRedemptionTerms" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapPreferredStockRedemptionTerms" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="loc_us-gaapSaleOfStockPricePerShare" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapSaleOfStockPricePerShare" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:label="loc_us-gaapSaleOfStockConsiderationReceivedOnTransaction" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapSaleOfStockConsiderationReceivedOnTransaction" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:label="loc_us-gaapDebtConversionConvertedInstrumentAmount1" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapDebtConversionConvertedInstrumentAmount1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromUnsecuredNotesPayable" xlink:label="loc_us-gaapProceedsFromUnsecuredNotesPayable" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapProceedsFromUnsecuredNotesPayable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfUnits" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfUnits" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfWarrants" xlink:label="loc_us-gaapProceedsFromIssuanceOfWarrants" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOfWarrants" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaapDebtInstrumentInterestRateStatedPercentage" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateStatedPercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:label="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="loc_us-gaapCommonStockCapitalSharesReservedForFutureIssuance" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapCommonStockCapitalSharesReservedForFutureIssuance" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CompensationExpenseExcludingCostOfGoodAndServiceSold" xlink:label="loc_us-gaapCompensationExpenseExcludingCostOfGoodAndServiceSold" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapCompensationExpenseExcludingCostOfGoodAndServiceSold" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="loc_us-gaapProceedsFromStockOptionsExercised" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapProceedsFromStockOptionsExercised" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:label="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardWeightedAverageRemainingRecognitionPeriod" xlink:label="loc_NTRPSharebasedCompensationArrangementBySharebasedPaymentAwardWeightedAverageRemainingRecognitionPeriod" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_NTRPSharebasedCompensationArrangementBySharebasedPaymentAwardWeightedAverageRemainingRecognitionPeriod" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_DescriptionForWarrantExpiration" xlink:label="loc_NTRPDescriptionForWarrantExpiration" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="loc_NTRPDescriptionForWarrantExpiration" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/ScheduleOfEarningsPerShareBasicAndDilutedDetails" xlink:title="999080 - Disclosure - Schedule of Earnings Per Share, Basic and Diluted (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaapEarningsPerShareAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockDividendsIncomeStatementImpact" xlink:label="loc_us-gaapPreferredStockDividendsIncomeStatementImpact" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract" xlink:to="loc_us-gaapPreferredStockDividendsIncomeStatementImpact" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperations" xlink:label="loc_us-gaapIncomeLossFromContinuingOperations" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract" xlink:to="loc_us-gaapIncomeLossFromContinuingOperations" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" xlink:label="loc_us-gaapIncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract" xlink:to="loc_us-gaapIncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasic" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract" xlink:to="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/ScheduleOfBusinessMilestonesAndIssuableContingentSharesDetails" xlink:title="999081 - Disclosure - Schedule of Business Milestones and Issuable Contingent Shares (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaapEarningsPerShareAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementScenarioAxis" xlink:label="loc_srtStatementScenarioAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtStatementScenarioAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_AchievedMember" xlink:label="loc_NTRPAchievedMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_NTRPAchievedMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_NotAchievedMember" xlink:label="loc_NTRPNotAchievedMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_NTRPNotAchievedMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherCommitmentsAxis" xlink:label="loc_us-gaapOtherCommitmentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapOtherCommitmentsAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherCommitmentsDomain" xlink:label="loc_us-gaapOtherCommitmentsDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherCommitmentsAxis" xlink:to="loc_us-gaapOtherCommitmentsDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_LeisureTravelBookingPlatformMember" xlink:label="loc_NTRPLeisureTravelBookingPlatformMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherCommitmentsDomain" xlink:to="loc_NTRPLeisureTravelBookingPlatformMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_GroupTravelBookingPlatformMember" xlink:label="loc_NTRPGroupTravelBookingPlatformMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherCommitmentsDomain" xlink:to="loc_NTRPGroupTravelBookingPlatformMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_FlexPayTechnologyMember" xlink:label="loc_NTRPFlexPayTechnologyMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherCommitmentsDomain" xlink:to="loc_NTRPFlexPayTechnologyMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_TravelAgentPlatformMember" xlink:label="loc_NTRPTravelAgentPlatformMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherCommitmentsDomain" xlink:to="loc_NTRPTravelAgentPlatformMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncrementalCommonSharesAttributableToContingentlyIssuableShares" xlink:label="loc_us-gaapIncrementalCommonSharesAttributableToContingentlyIssuableShares" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncrementalCommonSharesAttributableToContingentlyIssuableShares" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/ScheduleOfWeightedAverageCommonSharesDetailsParenthetical" xlink:title="999082 - Disclosure - Schedule of Weighted Average Common Shares (Details) (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaapEarningsPerShareAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract" xlink:to="loc_us-gaapCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncrementalCommonSharesAttributableToContingentlyIssuableShares" xlink:label="loc_us-gaapIncrementalCommonSharesAttributableToContingentlyIssuableShares" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract" xlink:to="loc_us-gaapIncrementalCommonSharesAttributableToContingentlyIssuableShares" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/ScheduleOfWeightedAverageCommonSharesDetails" xlink:title="999083 - Disclosure - Schedule of Weighted Average Common Shares (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaapEarningsPerShareAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:label="loc_us-gaapScheduleOfEarningsPerShareBasicByCommonClassTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract" xlink:to="loc_us-gaapScheduleOfEarningsPerShareBasicByCommonClassTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasicLineItems" xlink:label="loc_us-gaapEarningsPerShareBasicLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:to="loc_us-gaapEarningsPerShareBasicLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_ContingentSharesMember" xlink:label="loc_NTRPContingentSharesMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_NTRPContingentSharesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareBasicLineItems" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/LossPerShareDetailsNarrative" xlink:title="999084 - Disclosure - Loss Per Share (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaapEarningsPerShareAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:label="loc_us-gaapScheduleOfEarningsPerShareBasicByCommonClassTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract" xlink:to="loc_us-gaapScheduleOfEarningsPerShareBasicByCommonClassTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasicLineItems" xlink:label="loc_us-gaapEarningsPerShareBasicLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:to="loc_us-gaapEarningsPerShareBasicLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_ShareExchangeAgreementMember" xlink:label="loc_NTRPShareExchangeAgreementMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_NTRPShareExchangeAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementScenarioAxis" xlink:label="loc_srtStatementScenarioAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:to="loc_srtStatementScenarioAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_AchievedMember" xlink:label="loc_NTRPAchievedMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_NTRPAchievedMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapWarrantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:to="loc_us-gaapAwardTypeAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaapEmployeeStockOptionMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapEmployeeStockOptionMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeriesEPreferredStockMember" xlink:label="loc_us-gaapSeriesEPreferredStockMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesEPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeriesHPreferredStockMember" xlink:label="loc_us-gaapSeriesHPreferredStockMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesHPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_SeriesIPreferredStockMember" xlink:label="loc_NTRPSeriesIPreferredStockMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_NTRPSeriesIPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_SeriesJPreferredStockMember" xlink:label="loc_NTRPSeriesJPreferredStockMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_NTRPSeriesJPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_SeriesKPreferredStockMember" xlink:label="loc_NTRPSeriesKPreferredStockMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_NTRPSeriesKPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_SeriesLPreferredStockMember" xlink:label="loc_NTRPSeriesLPreferredStockMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_NTRPSeriesLPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_SeriesMPreferredStockMember" xlink:label="loc_NTRPSeriesMPreferredStockMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_NTRPSeriesMPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_SeriesNPreferredStockMember" xlink:label="loc_NTRPSeriesNPreferredStockMember" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_NTRPSeriesNPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_SeriesOPreferredStockMember" xlink:label="loc_NTRPSeriesOPreferredStockMember" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_NTRPSeriesOPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_SeriesOPreferredStockOneMember" xlink:label="loc_NTRPSeriesOPreferredStockOneMember" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_NTRPSeriesOPreferredStockOneMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncrementalCommonSharesAttributableToContingentlyIssuableShares" xlink:label="loc_us-gaapIncrementalCommonSharesAttributableToContingentlyIssuableShares" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareBasicLineItems" xlink:to="loc_us-gaapIncrementalCommonSharesAttributableToContingentlyIssuableShares" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareBasicLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareBasicLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConversionOfStockSharesConverted1" xlink:label="loc_us-gaapConversionOfStockSharesConverted1" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareBasicLineItems" xlink:to="loc_us-gaapConversionOfStockSharesConverted1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConversionOfStockSharesIssued1" xlink:label="loc_us-gaapConversionOfStockSharesIssued1" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareBasicLineItems" xlink:to="loc_us-gaapConversionOfStockSharesIssued1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:label="loc_us-gaapWeightedAverageNumberDilutedSharesOutstandingAdjustment" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareBasicLineItems" xlink:to="loc_us-gaapWeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/ConcentrationsDetailsNarrative" xlink:title="999085 - Disclosure - Concentrations (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RisksAndUncertaintiesAbstract" xlink:label="loc_us-gaapRisksAndUncertaintiesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskTable" xlink:label="loc_us-gaapConcentrationRiskTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRisksAndUncertaintiesAbstract" xlink:to="loc_us-gaapConcentrationRiskTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskLineItems" xlink:label="loc_us-gaapConcentrationRiskLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskTable" xlink:to="loc_us-gaapConcentrationRiskLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="loc_us-gaapConcentrationRiskByBenchmarkAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskTable" xlink:to="loc_us-gaapConcentrationRiskByBenchmarkAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaapConcentrationRiskBenchmarkDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:to="loc_us-gaapConcentrationRiskBenchmarkDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SalesRevenueNetMember" xlink:label="loc_us-gaapSalesRevenueNetMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_us-gaapSalesRevenueNetMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableMember" xlink:label="loc_us-gaapAccountsReceivableMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_us-gaapAccountsReceivableMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="loc_us-gaapConcentrationRiskByTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskTable" xlink:to="loc_us-gaapConcentrationRiskByTypeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaapConcentrationRiskTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskByTypeAxis" xlink:to="loc_us-gaapConcentrationRiskTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:label="loc_us-gaapCustomerConcentrationRiskMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskTypeDomain" xlink:to="loc_us-gaapCustomerConcentrationRiskMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MajorCustomersAxis" xlink:label="loc_srtMajorCustomersAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskTable" xlink:to="loc_srtMajorCustomersAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_NameOfMajorCustomerDomain" xlink:label="loc_srtNameOfMajorCustomerDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtMajorCustomersAxis" xlink:to="loc_srtNameOfMajorCustomerDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_CustomerMember" xlink:label="loc_NTRPCustomerMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_NTRPCustomerMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaapConcentrationRiskPercentage1" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskLineItems" xlink:to="loc_us-gaapConcentrationRiskPercentage1" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/DefinedContributionPlansDetailsNarrative" xlink:title="999086 - Disclosure - Defined Contribution Plans (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:label="loc_us-gaapCompensationAndRetirementDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DescriptionOfDefinedContributionPensionAndOtherPostretirementPlans" xlink:label="loc_us-gaapDescriptionOfDefinedContributionPensionAndOtherPostretirementPlans" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCompensationAndRetirementDisclosureAbstract" xlink:to="loc_us-gaapDescriptionOfDefinedContributionPensionAndOtherPostretirementPlans" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedContributionPlanCostRecognized" xlink:label="loc_us-gaapDefinedContributionPlanCostRecognized" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCompensationAndRetirementDisclosureAbstract" xlink:to="loc_us-gaapDefinedContributionPlanCostRecognized" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/SubsequentEventsDetailsNarrative" xlink:title="999087 - Disclosure - Subsequent Events (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaapSubsequentEventsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_ExchangeAgreementMember" xlink:label="loc_NTRPExchangeAgreementMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_NTRPExchangeAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_SecuritiesPurchaseAgreementMember" xlink:label="loc_NTRPSecuritiesPurchaseAgreementMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_NTRPSecuritiesPurchaseAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_AssetPurchaseAgreementMember" xlink:label="loc_NTRPAssetPurchaseAgreementMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_NTRPAssetPurchaseAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_PurchaseAgreementMember" xlink:label="loc_NTRPPurchaseAgreementMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_NTRPPurchaseAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_LineOfCreditAgreementMember" xlink:label="loc_NTRPLineOfCreditAgreementMember" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_NTRPLineOfCreditAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtRangeAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockMember" xlink:label="loc_us-gaapPreferredStockMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:label="loc_srtScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="loc_srtEquityMethodInvesteeNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="loc_srtEquityMethodInvesteeNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_FSATravelLLCMember" xlink:label="loc_NTRPFSATravelLLCMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtEquityMethodInvesteeNameDomain" xlink:to="loc_NTRPFSATravelLLCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" order="60" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_FSATravelLLCMember" xlink:label="loc_NTRPFSATravelLLCMember_2" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_NTRPFSATravelLLCMember_2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="70" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_SeriesOPreferredStockMember" xlink:label="loc_NTRPSeriesOPreferredStockMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_NTRPSeriesOPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaapDebtInstrumentAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapDebtInstrumentAxis" order="80" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_NoteOneMember" xlink:label="loc_NTRPNoteOneMember" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_NTRPNoteOneMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_NoteTwoMember" xlink:label="loc_NTRPNoteTwoMember" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_NTRPNoteTwoMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_TwoPromissoryNotesMember" xlink:label="loc_NTRPTwoPromissoryNotesMember" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_NTRPTwoPromissoryNotesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncrementalCommonSharesAttributableToContingentlyIssuableShares" xlink:label="loc_us-gaapIncrementalCommonSharesAttributableToContingentlyIssuableShares" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncrementalCommonSharesAttributableToContingentlyIssuableShares" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesIssued" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_CommonStockIssuedPercentage" xlink:label="loc_NTRPCommonStockIssuedPercentage" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_NTRPCommonStockIssuedPercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesAndLoansPayableCurrent" xlink:label="loc_us-gaapNotesAndLoansPayableCurrent" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNotesAndLoansPayableCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaapDebtInstrumentFaceAmount" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentFaceAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentUnamortizedDiscount" xlink:label="loc_us-gaapDebtInstrumentUnamortizedDiscount" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentUnamortizedDiscount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaapDebtInstrumentInterestRateStatedPercentage" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateStatedPercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="loc_us-gaapDebtInstrumentMaturityDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentMaturityDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightReasonForIssuingToNonemployees" xlink:label="loc_us-gaapClassOfWarrantOrRightReasonForIssuingToNonemployees" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightReasonForIssuingToNonemployees" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaapSharesIssuedPricePerShare" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesIssuedPricePerShare" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireBusinessesGross" xlink:label="loc_us-gaapPaymentsToAcquireBusinessesGross" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPaymentsToAcquireBusinessesGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesRestrictedStockAwardGross" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForFees" xlink:label="loc_us-gaapPaymentsForFees" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPaymentsForFees" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="loc_us-gaapEquityMethodInvestmentOwnershipPercentage" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEquityMethodInvestmentOwnershipPercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCredit" xlink:label="loc_us-gaapLineOfCredit" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLineOfCredit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityExpirationDate1" xlink:label="loc_us-gaapLineOfCreditFacilityExpirationDate1" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLineOfCreditFacilityExpirationDate1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityInterestRateDuringPeriod" xlink:label="loc_us-gaapLineOfCreditFacilityInterestRateDuringPeriod" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLineOfCreditFacilityInterestRateDuringPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityDescription" xlink:label="loc_us-gaapLineOfCreditFacilityDescription" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLineOfCreditFacilityDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromLinesOfCredit" xlink:label="loc_us-gaapProceedsFromLinesOfCredit" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProceedsFromLinesOfCredit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20250228.xsd#NTRP_CashAdvance" xlink:label="loc_NTRPCashAdvance" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_NTRPCashAdvance" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentCarryingAmount" xlink:label="loc_us-gaapDebtInstrumentCarryingAmount" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentCarryingAmount" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet" xlink:label="loc_us-gaapLineOfCreditFacilityIncreaseDecreaseForPeriodNet" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLineOfCreditFacilityIncreaseDecreaseForPeriodNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod" xlink:label="loc_us-gaapLineOfCreditFacilityMaximumAmountOutstandingDuringPeriod" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLineOfCreditFacilityMaximumAmountOutstandingDuringPeriod" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover - USD ($)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Feb. 28, 2025</div></th>
<th class="th"><div>May 28, 2025</div></th>
<th class="th"><div>Aug. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Feb. 28,  2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--02-28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-38015<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">NEXTTRIP,
INC.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000788611<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">27-1865814<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">NV<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">3900
Paseo del Sol<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Santa
Fe<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NM<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">87507<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(954)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">526-9688<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common
    Stock, par value $0.001 per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">NTRP<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,817,106<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,653,525<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentsIncorporatedByReferenceTextBlock', window );">Documents Incorporated by Reference [Text Block]</a></td>
<td class="text">None<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFinStmtErrorCorrectionFlag', window );">Document Financial Statement Error Correction [Flag]</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorName', window );">Auditor Name</a></td>
<td class="text">Haynie
    & Company<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorLocation', window );">Auditor Location</a></td>
<td class="text">Salt
    Lake City, Utah<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorFirmId', window );">Auditor Firm ID</a></td>
<td class="text">457<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorFirmId">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>PCAOB issued Audit Firm Identifier</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorFirmId</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:nonemptySequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorLocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorLocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFinStmtErrorCorrectionFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates whether any of the financial statement period in the filing include a restatement due to error correction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection w<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFinStmtErrorCorrectionFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentsIncorporatedByReferenceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Documents incorporated by reference.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentsIncorporatedByReferenceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="2" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets - USD ($)<br></strong></div></th>
<th class="th"><div>Feb. 28, 2025</div></th>
<th class="th" colspan="2"><div>Feb. 29, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>ASSETS</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 1,062,367<span></span>
</td>
<td class="nump">$ 323,805<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_PromissoryNoteReceivableNet', window );">Promissory note receivable, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">22,567<span></span>
</td>
<td class="nump">34,082<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,380,575<span></span>
</td>
<td class="nump">340,921<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total Current Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,465,509<span></span>
</td>
<td class="nump">1,698,808<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsNoncurrentAbstract', window );"><strong>Non-Current assets</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">4,119<span></span>
</td>
<td class="nump">6,642<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,127,368<span></span>
</td>
<td class="nump">2,173,420<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SecurityDeposit', window );">Security deposit</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">30,167<span></span>
</td>
<td class="nump">42,167<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,167,805<span></span>
</td>
<td class="nump">1,167,805<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Equity investments</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3,407,610<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseOtherNoncurrent', window );">Other prepaid assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">733,575<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsNoncurrent', window );">Total Non-Current Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">7,470,644<span></span>
</td>
<td class="nump">3,390,034<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">9,936,153<span></span>
</td>
<td class="nump">5,088,842<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current Liabilities</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,184,404<span></span>
</td>
<td class="nump">531,847<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">721,382<span></span>
</td>
<td class="nump">460,768<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredRevenueCurrent', window );">Deferred revenue</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">97,770<span></span>
</td>
<td class="nump">139,921<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total Current Liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,571,086<span></span>
</td>
<td class="nump">1,960,813<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total Liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,571,086<span></span>
</td>
<td class="nump">1,960,813<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and Contingencies</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholder&#8217;s Equity</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred Stock, $0.001 par value; 10,000,000 shares authorized; 3,106,616 and 472,996 shares issued and outstanding, respectively</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3,107<span></span>
</td>
<td class="nump">474<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common Stock, par value $0.001, 250,000,000 and 1,200,000 shares authorized, 1,656,738 and 936,430 shares issued and outstanding, respectively</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">1,657<span></span>
</td>
<td class="nump">936<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional Paid in Capital ()</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">41,710,126<span></span>
</td>
<td class="nump">27,277,758<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(34,349,823)<span></span>
</td>
<td class="num">(24,151,139)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total Stockholders&#8217; Equity</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">7,365,067<span></span>
</td>
<td class="nump">3,128,029<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total Liabilities and Stockholders&#8217; Equity</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">9,936,153<span></span>
</td>
<td class="nump">5,088,842<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_NonrelatedPartyMember', window );">Nonrelated Party [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current Liabilities</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesPayableCurrent', window );">Notes payable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">506,004<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember', window );">Related Party [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current Liabilities</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesPayableCurrent', window );">Notes payable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 61,526<span></span>
</td>
<td class="nump">$ 828,277<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">On
    December 29, 2023, the Company (then known as Sigma Additive Solutions, Inc.) acquired NextTrip Holdings, Inc. (&#8220;NTH&#8221;)
    in a reverse acquisition. NextTrip Group, LLC (&#8220;NTG&#8221;) was issued <span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_pid_c20231229__20231229__us-gaap--BusinessAcquisitionAxis__custom--NextTripGroupLLCMember_zi92mxXMT2Ei" title="Number of shares acquired">83,371</span> shares of Company common stock in exchange for
    <span id="xdx_909_ecustom--PercentageForIssuedAndOutstandingCapitalStock_pid_dp_uPure_c20231229__20231229__us-gaap--BusinessAcquisitionAxis__custom--NextTripGroupLLCMember_zUXOGjE4ta79" title="Percentage for issued and outstanding capital stock">100</span>% of the issued and outstanding capital stock of NTH at the time of the reverse acquisition. The Company has reflected this transaction
    retroactively in these financial statements.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">On
    December 29, 2023, the Company (then known as Sigma Additive Solutions, Inc.) acquired NTH in a reverse acquisition. NTG was issued
    <span id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_pid_c20231229__20231229__us-gaap--BusinessAcquisitionAxis__custom--NextTripGroupLLCMember_znf0cL99Yexe" title="Number of shares acquired">83,371</span> shares of Company common stock in exchange for <span id="xdx_903_ecustom--PercentageForIssuedAndOutstandingCapitalStock_pid_dp_uPure_c20231229__20231229__us-gaap--BusinessAcquisitionAxis__custom--NextTripGroupLLCMember_zJ1ftypKOa1l" title="Percentage for issued and outstanding capital stock">100</span>% of the issued and outstanding capital stock of NTH at the time of the
    reverse acquisition. The Company has reflected this transaction retroactively in these financial statements.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_PromissoryNoteReceivableNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Promissory note receivable net.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_PromissoryNoteReceivableNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481990/310-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized for present right to economic benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 12: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 30: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized for present right to economic benefit, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481664/323-10-45-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated impairment loss, of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482598/350-20-45-1<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482686/350-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 28: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 29: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-5<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 21: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseOtherNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of amounts paid in advance which will be charged against earnings in periods after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseOtherNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478451/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SecurityDeposit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of an asset, typically cash, provided to a counterparty to provide certain assurance of performance by the entity pursuant to the terms of a written or oral agreement, such as a lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SecurityDeposit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_NonrelatedPartyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_NonrelatedPartyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Dec. 29, 2023</div></th>
<th class="th"><div>Feb. 28, 2025</div></th>
<th class="th"><div>Feb. 29, 2024</div></th>
<th class="th"><div>Oct. 12, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,106,616<span></span>
</td>
<td class="nump">472,996<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,106,616<span></span>
</td>
<td class="nump">472,996<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">250,000,000<span></span>
</td>
<td class="nump">1,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,656,738<span></span>
</td>
<td class="nump">936,430<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,656,738<span></span>
</td>
<td class="nump">936,430<span></span>
</td>
<td class="nump">780,423<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=NTRP_NextTripGroupLLCMember', window );">NextTrip Holdings, Inc. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions', window );">Number of shares acquired</a></td>
<td class="nump">83,371<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_PercentageForIssuedAndOutstandingCapitalStock', window );">Percentage for issued and outstanding capital stock</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_PercentageForIssuedAndOutstandingCapitalStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage for issued and outstanding, capital stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_PercentageForIssuedAndOutstandingCapitalStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4.d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479823/420-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4.b.1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479823/420-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4.b.2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479823/420-10-S99-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482017/420-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482017/420-10-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482017/420-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482017/420-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued during the period pursuant to acquisitions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=NTRP_NextTripGroupLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=NTRP_NextTripGroupLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Operations - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Feb. 28, 2025</div></th>
<th class="th"><div>Feb. 29, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 501,423<span></span>
</td>
<td class="nump">$ 458,752<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Cost of revenue (exclusive of depreciation and amortization, shown separately below)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(498,121)<span></span>
</td>
<td class="num">(397,532)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3,302<span></span>
</td>
<td class="nump">61,220<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating Expenses</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LaborAndRelatedExpense', window );">Salaries and benefits</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,630,663<span></span>
</td>
<td class="nump">1,604,487<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock based compensation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">67,874<span></span>
</td>
<td class="nump">116,512<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">95,341<span></span>
</td>
<td class="nump">152,106<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingAndMarketingExpense', window );">Sales and marketing</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">307,166<span></span>
</td>
<td class="nump">484,250<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfessionalFees', window );">Professional Service Fees</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,228,481<span></span>
</td>
<td class="nump">1,421,508<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_Technology', window );">Technology</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">843,296<span></span>
</td>
<td class="nump">311,430<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_OrganizationCosts', window );">Organization Costs</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">213,613<span></span>
</td>
<td class="nump">25,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">713,236<span></span>
</td>
<td class="nump">1,468,762<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherExpenses', window );">Other expenses</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">317,061<span></span>
</td>
<td class="nump">156,522<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total Operating Expenses</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">7,416,731<span></span>
</td>
<td class="nump">5,740,577<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating loss</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(7,413,429)<span></span>
</td>
<td class="num">(5,679,357)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other Income/(Expenses)</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnDispositionOfAssets1', window );">Loss on disposal of assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(90)<span></span>
</td>
<td class="num">(14,718)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Gain (Loss) on extinguishment of liability</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(1,134,579)<span></span>
</td>
<td class="nump">166,890<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_LossOnRelatedPartyReceivable', window );">Loss on promissory note receivable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(1,000,000)<span></span>
</td>
<td class="num">(1,567,665)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNonoperatingNet', window );">Interest income (expense), net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(589,039)<span></span>
</td>
<td class="num">(48,620)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other Income (expense)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">16,099<span></span>
</td>
<td class="nump">486,633<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total other income (expense)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(2,707,609)<span></span>
</td>
<td class="num">(977,480)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Net loss from continuing operations before taxes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(10,121,038)<span></span>
</td>
<td class="num">(6,656,837)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestment', window );">Net loss from continuing operations before share of net income (loss) in equity method investee</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(10,121,038)<span></span>
</td>
<td class="num">(6,656,837)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Share of net loss of equity method investee</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(7,390)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest', window );">Net loss from continuing operations</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(10,128,428)<span></span>
</td>
<td class="num">(6,656,837)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax', window );">Net income (loss) from discontinued operations, net of taxes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">8,344<span></span>
</td>
<td class="num">(675,314)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(10,120,084)<span></span>
</td>
<td class="num">(7,332,151)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockDividendsIncomeStatementImpact', window );">Preferred Dividends</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(78,600)<span></span>
</td>
<td class="num">(7,125)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net Loss Applicable to Common Stockholders</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (10,198,684)<span></span>
</td>
<td class="num">$ (7,339,276)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare', window );">Basic loss per common share from continuing operations</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">$ (2.24)<span></span>
</td>
<td class="num">$ (29.16)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare', window );">Diluted loss per common share from continuing operations</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(2.24)<span></span>
</td>
<td class="num">(29.16)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare', window );">Basic loss per common share from discontinued operations</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">0.01<span></span>
</td>
<td class="num">(2.96)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare', window );">Diluted loss per common share from discontinued operations</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">0.01<span></span>
</td>
<td class="num">(2.96)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Loss per common share basic</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(2.23)<span></span>
</td>
<td class="num">(32.12)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Loss per common share diluted</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">$ (2.23)<span></span>
</td>
<td class="num">$ (32.12)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average number of shares outstanding basic</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">4,566,787<span></span>
</td>
<td class="nump">228,274<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted nverage number of shares outstanding diluted</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">4,566,787<span></span>
</td>
<td class="nump">228,274<span></span>
</td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">On
    December 29, 2023, the Company (then known as Sigma Additive Solutions, Inc.) acquired NTH in a reverse acquisition. NTG was issued
    <span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_pid_c20231229__20231229__us-gaap--BusinessAcquisitionAxis__custom--NextTripGroupLLCMember_zMAWreRRiNcf" title="Number of shares acquired">83,371</span> shares of Company common stock in exchange for <span id="xdx_904_ecustom--PercentageForIssuedAndOutstandingCapitalStock_pid_dp_c20231229__20231229__us-gaap--BusinessAcquisitionAxis__custom--NextTripGroupLLCMember_zN7cXzVnhmg1" title="Percentage for issued and outstanding capital stock">100</span>% of the issued and outstanding capital stock of NTH at the time of the
    reverse acquisition. The Company has reflected this transaction retroactively in these financial statements.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income loss from continuing operations before income taxes minority interest and income loss from equity method investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_LossOnRelatedPartyReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loss on related party receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_LossOnRelatedPartyReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_OrganizationCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Organization costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_OrganizationCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_Technology">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Technology.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_Technology</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate cost of goods produced and sold and services rendered during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnDispositionOfAssets1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of assets, including but not limited to property plant and equipment, intangible assets and equity in securities of subsidiaries or equity method investee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnDispositionOfAssets1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481303/470-50-40-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481303/470-50-40-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from continuing operations including portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-19<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br><br>Reference 17: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerBasicShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 270<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477349/740-270-45-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-3A<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5C<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-3B<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-4<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-1<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per basic share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per diluted share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 5.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479836/810-10-S99-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481664/323-10-45-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482659/740-20-45-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeExpenseNonoperatingNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest income (expense) classified as nonoperating.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeExpenseNonoperatingNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LaborAndRelatedExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for salary, wage, profit sharing; incentive and equity-based compensation; and other employee benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LaborAndRelatedExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 6.B)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-5<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockDividendsIncomeStatementImpact">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of preferred stock dividends that is an adjustment to net income apportioned to common stockholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockDividendsIncomeStatementImpact</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfessionalFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (k)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-3<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfessionalFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479941/924-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingAndMarketingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total amount of expenses directly related to the marketing or selling of products or services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingAndMarketingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statements of Operations (Parenthetical) - NextTrip Holdings, Inc. [Member]<br></strong></div></th>
<th class="th">
<div>Dec. 29, 2023 </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions', window );">Number of shares acquired</a></td>
<td class="nump">83,371<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_PercentageForIssuedAndOutstandingCapitalStock', window );">Percentage for issued and outstanding capital stock</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_PercentageForIssuedAndOutstandingCapitalStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage for issued and outstanding, capital stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_PercentageForIssuedAndOutstandingCapitalStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4.d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479823/420-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4.b.1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479823/420-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4.b.2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479823/420-10-S99-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482017/420-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482017/420-10-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482017/420-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482017/420-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued during the period pursuant to acquisitions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=NTRP_NextTripGroupLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=NTRP_NextTripGroupLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="2" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statements of Stockholders' Equity - USD ($)<br></strong></div></th>
<th class="th" colspan="2"><div>Preferred Stock [Member]</div></th>
<th class="th" colspan="2"><div>Common Stock [Member]</div></th>
<th class="th"><div>Additional Paid-in Capital [Member]</div></th>
<th class="th"><div>Retained Earnings [Member]</div></th>
<th class="th"><div>Total</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Feb. 28, 2023</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 83<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 17,295,890<span></span>
</td>
<td class="num">$ (16,811,863)<span></span>
</td>
<td class="nump">$ 484,110<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance, shares at Feb. 28, 2023</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">83,371<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_StockIssuedDuringPeriodValueOfPreferredShares', window );">Issuance of Preferred Shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 473<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,603,027<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">1,603,500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_StockIssuedDuringPeriodShareOfPreferredShares', window );">Issuance of Preferred Shares, Shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">472,680<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities', window );">Conversion of Convertible Notes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 53<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">3,968,507<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">3,968,560<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Conversion of Convertible Notes, Shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">52,818<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_StockIssuedDuringPeriodValuePurchasesOfCommonShares', window );">Purchases of Common Shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 16<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,905,954<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">1,905,970<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_StockIssuedDuringPeriodSharesPurchasesOfCommonShares', window );">Purchases of Common Shares, Sharers</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">15,481<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices', window );">Issuance of Common Shares for Services</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 4<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">13,106<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">13,110<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Issuance of Common Shares for Services, Shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">4,337<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_StockIssuedDuringPeriodValueReverseAcquisition', window );">Reverse Acquisition of Sigma Additive Solutions, Inc.</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 1<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 780<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,367,637<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">2,368,418<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_StockIssuedDuringPeriodSharesReverseAcquisition', window );">Reverse Acquisition of Sigma Additive Solutions, Inc., Shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">316<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">780,423<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock Compensation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">116,512<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">116,512<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsPreferredStock', window );">Preferred Stock Dividends</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">7,125<span></span>
</td>
<td class="num">(7,125)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Loss</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7,332,151)<span></span>
</td>
<td class="num">(7,332,151)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Feb. 29, 2024</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 474<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 936<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">27,277,758<span></span>
</td>
<td class="num">(24,151,139)<span></span>
</td>
<td class="nump">3,128,029<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance, shares at Feb. 29, 2024</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">472,996<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">936,430<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsPreferredStock', window );">Preferred Stock Dividends</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">78,600<span></span>
</td>
<td class="num">(78,600)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Loss</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="num">(10,120,084)<span></span>
</td>
<td class="num">(10,120,084)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_StockIssuedDuringPeriodValueOfPreferredSharesInPrivatePlacements', window );">Issuance of Preferred Shares in Private Placements</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 830<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">3,872,104<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">3,872,934<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_StockIssuedDuringPeriodSharesOfPreferredSharesInPrivatePlacements', window );">Issuance of Preferred Shares in Private Placements, shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">830,284<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_StockIssuedDuringPeriodValueConversionOfPreferredSharesToCommonShares', window );">Conversion of Preferred Shares to Common Shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (410)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 410<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_StockIssuedDuringPeriodSharesConversionOfPreferredSharesToCommonShares', window );">Conversion of Preferred Shares to Common Shares, shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(409,502)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">409,502<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_StockIssuedDuringPeriodValueIssuanceOfPreferredSharesForDebtConversions', window );">Issuance of Preferred Shares for Debt Conversions</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 1,460<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">4,651,040<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">4,652,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_StockIssuedDuringPeriodSharesIssuanceOfPreferredSharesForDebtConversions', window );">Issuance of Preferred Shares for Debt Conversions, shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">1,459,434<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_StockIssuedDuringPeriodValueIssuanceOfSecuritiesForServices', window );">Issuance of Securities for Services</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 109<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 161<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,407,193<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">2,407,463<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_StockIssuedDuringPeriodSharesIssuanceOfSecuritiesForServices', window );">Issuance of Securities for Services, shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">109,113<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">160,990<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_StockIssuedDuringPeriodValueSecuritiesIssuedForEquityInvestments', window );">Securities Issued for Equity Investments</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 644<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 8<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,938,704<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">2,939,356<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_StockIssuedDuringPeriodSharseSecuritiesIssuedForEquityInvestments', window );">Securities Issued for Equity Investments, shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">644,291<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">8,065<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_StockIssuedDuringPeriodValueIssuanceOfCommitmentSharesForEquityLineOfCredit', window );">Issuance of Commitment Shares for Equity Line of Credit</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 33<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">99,967<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">100,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_StockIssuedDuringPeriodSharesIssuanceOfCommitmentSharesForEquityLineOfCredit', window );">Issuance of Commitment Shares for Equity Line of Credit, shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">32,786<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of Common Shares for Warrant Exercises</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 105<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">316,890<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 316,995<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Issuance of Common Shares for Warrant Exercises, shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">104,965<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Stock Compensation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 4<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">67,870<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 67,874<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Stock Compensation, shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">4,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Feb. 28, 2025</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 3,107<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 1,657<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 41,710,126<span></span>
</td>
<td class="num">$ (34,349,823)<span></span>
</td>
<td class="nump">$ 7,365,067<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance, shares at Feb. 28, 2025</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">3,106,616<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,656,738<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="8"></td></tr>
<tr><td colspan="8"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">On
    December 29, 2023, the Company (then known as Sigma Additive Solutions, Inc.) acquired NTH in a reverse acquisition. NTG was issued
    <span id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_pid_c20231229__20231229__us-gaap--BusinessAcquisitionAxis__custom--NextTripGroupLLCMember_znf0cL99Yexe" title="Number of shares acquired">83,371</span> shares of Company common stock in exchange for <span id="xdx_903_ecustom--PercentageForIssuedAndOutstandingCapitalStock_pid_dp_uPure_c20231229__20231229__us-gaap--BusinessAcquisitionAxis__custom--NextTripGroupLLCMember_zJ1ftypKOa1l" title="Percentage for issued and outstanding capital stock">100</span>% of the issued and outstanding capital stock of NTH at the time of the
    reverse acquisition. The Company has reflected this transaction retroactively in these financial statements.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_StockIssuedDuringPeriodShareOfPreferredShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period share of preferred shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_StockIssuedDuringPeriodShareOfPreferredShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_StockIssuedDuringPeriodSharesConversionOfPreferredSharesToCommonShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period shares conversion of preferred shares to common shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_StockIssuedDuringPeriodSharesConversionOfPreferredSharesToCommonShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_StockIssuedDuringPeriodSharesIssuanceOfCommitmentSharesForEquityLineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period shares issuance of commitment shares for equity line of credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_StockIssuedDuringPeriodSharesIssuanceOfCommitmentSharesForEquityLineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_StockIssuedDuringPeriodSharesIssuanceOfPreferredSharesForDebtConversions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period shares issuance of preferred shares for debt conversion.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_StockIssuedDuringPeriodSharesIssuanceOfPreferredSharesForDebtConversions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_StockIssuedDuringPeriodSharesIssuanceOfSecuritiesForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period shares issuance of securities for services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_StockIssuedDuringPeriodSharesIssuanceOfSecuritiesForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_StockIssuedDuringPeriodSharesOfPreferredSharesInPrivatePlacements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period shares of preferred shares in private placement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_StockIssuedDuringPeriodSharesOfPreferredSharesInPrivatePlacements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_StockIssuedDuringPeriodSharesPurchasesOfCommonShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period shares purchases of common shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_StockIssuedDuringPeriodSharesPurchasesOfCommonShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_StockIssuedDuringPeriodSharesReverseAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period shares reverse acquisition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_StockIssuedDuringPeriodSharesReverseAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_StockIssuedDuringPeriodSharseSecuritiesIssuedForEquityInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period shares securities issued for equity investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_StockIssuedDuringPeriodSharseSecuritiesIssuedForEquityInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_StockIssuedDuringPeriodValueConversionOfPreferredSharesToCommonShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period value conversion of preferred shares to common shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_StockIssuedDuringPeriodValueConversionOfPreferredSharesToCommonShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_StockIssuedDuringPeriodValueIssuanceOfCommitmentSharesForEquityLineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period value issuance of commitment shares for equity line of credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_StockIssuedDuringPeriodValueIssuanceOfCommitmentSharesForEquityLineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_StockIssuedDuringPeriodValueIssuanceOfPreferredSharesForDebtConversions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period value issuance of preferred shares for debt conversion.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_StockIssuedDuringPeriodValueIssuanceOfPreferredSharesForDebtConversions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_StockIssuedDuringPeriodValueIssuanceOfSecuritiesForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period value issuance of securities for services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_StockIssuedDuringPeriodValueIssuanceOfSecuritiesForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_StockIssuedDuringPeriodValueOfPreferredShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period value of preferred shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_StockIssuedDuringPeriodValueOfPreferredShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_StockIssuedDuringPeriodValueOfPreferredSharesInPrivatePlacements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period value of preferred shares in private placements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_StockIssuedDuringPeriodValueOfPreferredSharesInPrivatePlacements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_StockIssuedDuringPeriodValuePurchasesOfCommonShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period value purchases of common shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_StockIssuedDuringPeriodValuePurchasesOfCommonShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_StockIssuedDuringPeriodValueReverseAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period value reverse acquisition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_StockIssuedDuringPeriodValueReverseAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_StockIssuedDuringPeriodValueSecuritiesIssuedForEquityInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period value securities issued for equity investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_StockIssuedDuringPeriodValueSecuritiesIssuedForEquityInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481089/718-20-55-13<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481089/718-20-55-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsPreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid preferred stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -SubTopic 405<br> -Topic 942<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477787/942-405-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsPreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The gross value of stock issued during the period upon the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statements of Stockholders' Equity (Parenthetical) - NextTrip Holdings, Inc. [Member]<br></strong></div></th>
<th class="th">
<div>Dec. 29, 2023 </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions', window );">Number of shares acquired</a></td>
<td class="nump">83,371<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_PercentageForIssuedAndOutstandingCapitalStock', window );">Percentage for issued and outstanding capital stock</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_PercentageForIssuedAndOutstandingCapitalStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage for issued and outstanding, capital stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_PercentageForIssuedAndOutstandingCapitalStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4.d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479823/420-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4.b.1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479823/420-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4.b.2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479823/420-10-S99-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482017/420-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482017/420-10-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482017/420-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482017/420-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued during the period pursuant to acquisitions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=NTRP_NextTripGroupLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=NTRP_NextTripGroupLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Cash Flows - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Feb. 28, 2025</div></th>
<th class="th"><div>Feb. 29, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash Flows from Operating Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest', window );">Net Loss from continuing operations</a></td>
<td class="num">$ (10,128,428)<span></span>
</td>
<td class="num">$ (6,656,837)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization &#8211; property and equipment and intangibles</a></td>
<td class="nump">713,236<span></span>
</td>
<td class="nump">1,468,762<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfDebtDiscountPremium', window );">Amortization of Debt Discount</a></td>
<td class="nump">342,935<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_AmortizationOfPrepaidExpenses', window );">Amortization of prepaid expenses</a></td>
<td class="nump">236,112<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_LossOnRelatedPartyReceivable', window );">Loss on promissory note receivable</a></td>
<td class="nump">1,000,000<span></span>
</td>
<td class="nump">1,567,665<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock based compensation</a></td>
<td class="nump">67,874<span></span>
</td>
<td class="nump">116,512<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">(Gain) loss on extinguishment of liability</a></td>
<td class="nump">1,134,579<span></span>
</td>
<td class="num">(166,890)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_LossOnDispositionOfAssets', window );">Loss on disposal of assets</a></td>
<td class="nump">90<span></span>
</td>
<td class="nump">14,718<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Loss on share of net income in equity method investee</a></td>
<td class="nump">7,390<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="nump">11,515<span></span>
</td>
<td class="num">(662,939)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidExpense', window );">Prepaid expenses</a></td>
<td class="nump">159,343<span></span>
</td>
<td class="num">(281,506)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInSecurityDeposits', window );">Security deposit</a></td>
<td class="nump">12,000<span></span>
</td>
<td class="num">(27,167)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Accounts payable and accrued expenses</a></td>
<td class="nump">1,397,007<span></span>
</td>
<td class="num">(531,367)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredRevenue', window );">Deferred revenue</a></td>
<td class="num">(42,151)<span></span>
</td>
<td class="nump">102,954<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations', window );">Net cash used in operating activities from continuing operations</a></td>
<td class="num">(5,088,498)<span></span>
</td>
<td class="num">(5,056,095)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations', window );">Net cash provided (used) in operating activities from discontinued operations</a></td>
<td class="nump">8,344<span></span>
</td>
<td class="num">(675,314)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(5,080,154)<span></span>
</td>
<td class="num">(5,731,409)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash Flows from Investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchase of equipment</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(9,253)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForSoftware', window );">Capitalized software development costs</a></td>
<td class="num">(534,751)<span></span>
</td>
<td class="num">(1,016,175)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfProductiveAssets', window );">Sale of Sigma Additive Solutions, Inc. assets</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">1,589,241<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_InvestmentInEquityMethodInvestee', window );">Investment in equity method investee</a></td>
<td class="num">(500,000)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_ProceedsFromAcquireBusinessesGross', window );">Reverse acquisition of Sigma Additive Solutions, Inc.</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">417,122<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfOtherProductiveAssets', window );">Sale of assets</a></td>
<td class="nump">1,000<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash provided (used) in investing activities</a></td>
<td class="num">(1,033,751)<span></span>
</td>
<td class="nump">980,935<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash Flows from Financing Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromNotesPayable', window );">Notes payable</a></td>
<td class="nump">1,967,224<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Issuance of convertible notes</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">735,057<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Issuances of common shares</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">1,905,970<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock', window );">Issuances of preferred shares</a></td>
<td class="nump">2,450,000<span></span>
</td>
<td class="nump">1,603,500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfWarrants', window );">Exercise of warrants</a></td>
<td class="nump">316,994<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromRelatedPartyDebt', window );">Advances from related party, net</a></td>
<td class="nump">2,118,249<span></span>
</td>
<td class="nump">547,277<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="nump">6,852,467<span></span>
</td>
<td class="nump">4,791,804<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Increase in cash</a></td>
<td class="nump">738,562<span></span>
</td>
<td class="nump">41,330<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">Cash - beginning of the period</a></td>
<td class="nump">323,805<span></span>
</td>
<td class="nump">282,475<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">Cash - end of the period</a></td>
<td class="nump">1,062,367<span></span>
</td>
<td class="nump">323,805<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental cash flow information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Cash paid for interest</a></td>
<td class="nump">91,680<span></span>
</td>
<td class="nump">4,381<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaidNet', window );">Cash paid for taxes</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract', window );"><strong>Non-Cash Financing Transactions</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_IssuanceOfPreferredSharesForServices', window );">Issuance of preferred shares for services</a></td>
<td class="nump">329,520<span></span>
</td>
<td class="nump">569,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_IssuanceOfCommonSharesForServices', window );">Issuance of common shares for services</a></td>
<td class="nump">706,870<span></span>
</td>
<td class="nump">13,106<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_IssuanceOfCommonSharesAsCommitmentShares', window );">Issuance of common shares as commitment shares</a></td>
<td class="nump">100,000<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_IssuanceOfCommonWarrantsForServices', window );">Issuance of common warrants for services</a></td>
<td class="nump">1,371,072<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_IssuanceOfCommonSharesForEquityInvestments', window );">Issuance of common shares for equity investments</a></td>
<td class="nump">24,356<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_IssuanceOfPreferredSharesForEquityInvestments', window );">Issuance of preferred shares for equity investments</a></td>
<td class="nump">2,915,000<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_IssuanceOfPreferredSharesForPerpetualSoftwareLicense', window );">Issuance of preferred shares for perpetual software license</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">362,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_ConversionOfConvertibleNotes', window );">Conversion of convertible notes</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">3,968,507<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_PreferredStockDividends', window );">Preferred stock dividends</a></td>
<td class="nump">$ 78,600<span></span>
</td>
<td class="nump">$ 7,125<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_AmortizationOfPrepaidExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortization of prepaid expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_AmortizationOfPrepaidExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_ConversionOfConvertibleNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Conversion of convertible notes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_ConversionOfConvertibleNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_InvestmentInEquityMethodInvestee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Investment in equity method investee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_InvestmentInEquityMethodInvestee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_IssuanceOfCommonSharesAsCommitmentShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance of common shares as commitment shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_IssuanceOfCommonSharesAsCommitmentShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_IssuanceOfCommonSharesForEquityInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance of common shares for equity investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_IssuanceOfCommonSharesForEquityInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_IssuanceOfCommonSharesForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance of common shares for services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_IssuanceOfCommonSharesForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_IssuanceOfCommonWarrantsForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance of common warrants for services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_IssuanceOfCommonWarrantsForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_IssuanceOfPreferredSharesForEquityInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance of preferred shares for equity investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_IssuanceOfPreferredSharesForEquityInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_IssuanceOfPreferredSharesForPerpetualSoftwareLicense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance of preferred shares for perpetual software license.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_IssuanceOfPreferredSharesForPerpetualSoftwareLicense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_IssuanceOfPreferredSharesForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance of preferred shares for services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_IssuanceOfPreferredSharesForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_LossOnDispositionOfAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loss on disposition of assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_LossOnDispositionOfAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_LossOnRelatedPartyReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loss on related party receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_LossOnRelatedPartyReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_PreferredStockDividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Preferred stock dividends.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_PreferredStockDividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_ProceedsFromAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds from acquire businesses gross.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_ProceedsFromAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfDebtDiscountPremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfDebtDiscountPremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -SubTopic 230<br> -Topic 830<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477401/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) of operating activities of discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481303/470-50-40-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481303/470-50-40-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from continuing operations including portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-19<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481664/323-10-45-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after refund, of cash paid to foreign, federal, state, and local jurisdictions as income tax.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-2A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 23<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-22<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInSecurityDeposits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in security deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInSecurityDeposits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, excluding discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForSoftware">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the development, modification or acquisition of software programs or applications for internal use (that is, not to be sold, leased or otherwise marketed to others) that qualify for capitalization.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForSoftware</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds from issuance of capital stock which provides for a specific dividend that is paid to the shareholders before any dividends to common stockholders and which takes precedence over common stockholders in the event of liquidation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a borrowing supported by a written promise to pay an obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRelatedPartyDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRelatedPartyDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfOtherProductiveAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from the sale of tangible or intangible assets used to produce goods or deliver services, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfOtherProductiveAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfProductiveAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the sale of property, plant and equipment (capital expenditures), software, and other intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfProductiveAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pay vs Performance Disclosure - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Feb. 28, 2025</div></th>
<th class="th"><div>Feb. 29, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income (Loss)</a></td>
<td class="num">$ (10,120,084)<span></span>
</td>
<td class="num">$ (7,332,151)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PvpTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PvpTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Insider Trading Arrangements<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Feb. 28, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_InsiderTradingArrLineItems', window );"><strong>Insider Trading Arrangements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Rule10b51ArrAdoptedFlag', window );">Rule 10b5-1 Arrangement Adopted</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonRule10b51ArrAdoptedFlag', window );">Non-Rule 10b5-1 Arrangement Adopted</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Rule10b51ArrTrmntdFlag', window );">Rule 10b5-1 Arrangement Terminated</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonRule10b51ArrTrmntdFlag', window );">Non-Rule 10b5-1 Arrangement Terminated</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_InsiderTradingArrLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_InsiderTradingArrLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonRule10b51ArrAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonRule10b51ArrAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonRule10b51ArrTrmntdFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonRule10b51ArrTrmntdFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_Rule10b51ArrAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_Rule10b51ArrAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_Rule10b51ArrTrmntdFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_Rule10b51ArrTrmntdFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cybersecurity Risk Management and Strategy Disclosure<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Feb. 28, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract', window );"><strong>Cybersecurity Risk Management, Strategy, and Governance [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock', window );">Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]</a></td>
<td class="text"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Risk
Management and Strategy</i></b></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Due
to the size of our company, we have not yet developed robust policies and processes for assessing, identifying, and managing material
risk from cybersecurity threats. <span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_905_ecyd--CybersecurityRiskManagementProcessesIntegratedTextBlock_c20240301__20250228_zceUsl7Glt9">We have <span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_90F_ecyd--CybersecurityRiskManagementProcessesIntegratedFlag_dbT_c20240301__20250228_zTzF38pbzok1">implemented</span> access controls with respect to our systems, which we monitor regularly and audit
annually. We currently rely heavily on products and services provided by <span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_90F_ecyd--CybersecurityRiskManagementThirdPartyEngagedFlag_dbT_c20240301__20250228_ztXsSs4RzLcb">third-party</span> suppliers to operate certain critical business systems,
including without limitation, cloud-based infrastructure, encryption and authentication technology, email, and other functions</span>. <span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_902_ecyd--CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag_dbT_c20240301__20250228_z1JBgml2CD19">We rely
on third party providers and outsourced IT services to monitor and address cybersecurity related risks, including installing software
for threat protection and malware</span>. Such third-party providers are tasked with notifying management of any material risks or cybersecurity
concerns that they identify, which management then assesses and may bring to our Board of Directors to discuss if deemed necessary or
appropriate. Based on the results of our risk assessments, if deemed necessary or appropriate, we take steps to re-design, implement,
and maintain reasonable safeguards to minimize identified risks; reasonably address any identified gaps in existing safeguards; and regularly
monitor the effectiveness of our safeguards.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
intend to work with outside counsel and third-party service providers to further develop our expertise, processes and procedures with
respect to cybersecurity protection and our response plan.</span></p>

&#160;<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
date, we have <span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_908_ecyd--CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag_dbF_c20240301__20250228_z9TcUXskhocb">not</span> (to our knowledge) encountered cybersecurity challenges that have materially impaired our operations or financial standing.
For additional information regarding risks from cybersecurity threats, please refer to Item 1A, &#8220;Risk Factors,&#8221; in this Report.</span></p>

&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementProcessesIntegratedFlag', window );">Cybersecurity Risk Management Processes Integrated [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock', window );">Cybersecurity Risk Management Processes Integrated [Text Block]</a></td>
<td class="text">We have <span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_90F_ecyd--CybersecurityRiskManagementProcessesIntegratedFlag_dbT_c20240301__20250228_zTzF38pbzok1">implemented</span> access controls with respect to our systems, which we monitor regularly and audit
annually. We currently rely heavily on products and services provided by <span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_90F_ecyd--CybersecurityRiskManagementThirdPartyEngagedFlag_dbT_c20240301__20250228_ztXsSs4RzLcb">third-party</span> suppliers to operate certain critical business systems,
including without limitation, cloud-based infrastructure, encryption and authentication technology, email, and other functions<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementThirdPartyEngagedFlag', window );">Cybersecurity Risk Management Third Party Engaged [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag', window );">Cybersecurity Risk Third Party Oversight and Identification Processes [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag', window );">Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock', window );">Cybersecurity Risk Board of Directors Oversight [Text Block]</a></td>
<td class="text"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Governance</i></b></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_905_ecyd--CybersecurityRiskRoleOfManagementTextBlock_c20240301__20250228_z1UKx64iKHMi">Our
management team is primarily responsible for assessing and managing our strategic risk exposures, including material risks from cybersecurity
threats, with assistance from third-party service providers. Management oversees our cybersecurity process on a day-to-day basis, including
those described in &#8220;Risk Management and Strategy&#8221; above</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Board of Directors does not have a standing risk management committee. Instead, <span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_905_ecyd--CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock_c20240301__20250228_zZm3ycTJbAPj">our Board of Directors as a whole has oversight responsibility
for risk management, which it administers directly as well as with the assistance of standing committees of the Board of Directors that
will address risks inherent in their respective areas of oversight</span>. Throughout the year, the board and its committees engage with management
to discuss a wide range of enterprise risks, including cybersecurity.</span></p>

&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock', window );">Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block]</a></td>
<td class="text">our Board of Directors as a whole has oversight responsibility
for risk management, which it administers directly as well as with the assistance of standing committees of the Board of Directors that
will address risks inherent in their respective areas of oversight<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskRoleOfManagementTextBlock', window );">Cybersecurity Risk Role of Management [Text Block]</a></td>
<td class="text">Our
management team is primarily responsible for assessing and managing our strategic risk exposures, including material risks from cybersecurity
threats, with assistance from third-party service providers. Management oversees our cybersecurity process on a day-to-day basis, including
those described in &#8220;Risk Management and Strategy&#8221; above<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementProcessesIntegratedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph i<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementProcessesIntegratedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph i<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementThirdPartyEngagedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph ii<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementThirdPartyEngagedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 2<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskRoleOfManagementTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskRoleOfManagementTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph iii<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph iii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Description and Going Concern<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Feb. 28, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubstantialDoubtAboutGoingConcernTextBlock', window );">Business Description and Going Concern</a></td>
<td class="text"><p id="xdx_800_eus-gaap--SubstantialDoubtAboutGoingConcernTextBlock_zN1FKlthmUk4" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
1 - <span id="xdx_828_z3J93tCm4t6c">Business Description and Going Concern</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sigma
Additive Solutions, Inc. (&#8220;Sigma&#8221;), the legal acquiror of NextTrip, was initially incorporated as Messidor Limited in Nevada
on December 23, 1985, and changed its name to Framewaves Inc. in 2001. On September 27, 2010, the name was changed to Sigma Labs, Inc.
On May 17, 2022, Sigma Labs, Inc. began doing business as Sigma Additive Solutions, and on August 9, 2022, changed its name to Sigma
Additive Solutions, Inc.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 11, 2024, Sigma filed a Certificate of Amendment to its Amended and Restated Articles of Incorporation, as amended to date, with
the Secretary of State of the State of Nevada, pursuant to which, effective as of 12:01 a.m. Pacific time on March 13, 2024, among other
things, Sigma&#8217;s corporate name was changed from Sigma Additive Solutions, Inc. to &#8220;NextTrip, Inc.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s corporate office is located at 3900 Paseo del Sol, Santa Fe NM 87507. The consolidated financial statements include
the accounts of the Company&#8217;s wholly owned subsidiaries, NextTrip Holdings Inc., incorporated on October 22, 2015, and
Extraordinary Vacations USA, Inc., incorporated on June 24, 2002.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prior
to the NextPlay Exchange Agreement, as described below, NextTrip Holdings, Inc. (&#8220;NTH&#8221;) was a wholly owned subsidiary of
NextTrip Group, LLC (&#8220;NTG&#8221;), which in turn, was a wholly owned subsidiary of NextPlay Technologies, Inc.
(&#8220;NextPlay&#8221;). All of the business operations of NTG were conducted through its subsidiaries. On January 25, 2023,
NextPlay and NTG entered into an Amended and Restated Separation Agreement, Amended and Restated Operating Agreement, and Exchange
Agreement (the &#8220;NextPlay Exchange Agreement&#8221;, whereby NextPlay transferred their interest in the travel business
to NTG. Pursuant to the NextPlay Exchange Agreement, NextPlay exchanged <span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230125__20230125__us-gaap--BusinessAcquisitionAxis__custom--NextPlayTechnologiesIncMember__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__us-gaap--StatementEquityComponentsAxis__custom--MembershipUnitsMember_zjos9diZi93h" title="Number of common stock issued">1,000,000</span>
Membership Units of NTG for <span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230125__20230125__us-gaap--BusinessAcquisitionAxis__custom--NextPlayTechnologiesIncMember__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__us-gaap--StatementEquityComponentsAxis__custom--PreferredUnitsMember_ztMgBBiMFbL4" title="Number of common stock issued">400,000</span>
Preferred Units of NTG, with a value of $<span id="xdx_905_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20230125__us-gaap--BusinessAcquisitionAxis__custom--NextPlayTechnologiesIncMember__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember_zELcOTaWmJIh" title="Share price per share">10</span>
per unit. Prior to the exchange for Preferred Units, NTG had a payable due to NextPlay of $<span id="xdx_905_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pid_c20230125__20230125__us-gaap--BusinessAcquisitionAxis__custom--NextPlayTechnologiesIncMember__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__us-gaap--StatementEquityComponentsAxis__custom--PreferredUnitsMember_zI3yKNrROni" title="Number of common stock issued, value">17,295,873</span>,
representing cash advances and payment of expenses by NextPlay on behalf of NTG, while NextPlay had obligations to provide ongoing
support to NTH. Such liability was settled by the issuance of the Preferred Units and the waiver of all of NextPlay&#8217;s
ongoing support obligations except for a $<span id="xdx_909_eus-gaap--Capital_iI_pn5n6_c20230125__us-gaap--BusinessAcquisitionAxis__custom--NextTripGroupLLCMember_zrZpt7552iM4" title="Contributed capital">1.5</span>
million advance remaining under a promissory note and, as such, NTH recorded the payable as contributed capital.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company provides travel technology solutions with sales originating in the United States, with a primary emphasis on hotels, air, and
all-inclusive travel packages. Our proprietary booking engine, branded as NextTrip 2.0, provides travel distributors access to a sizeable
inventory.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company owns <span id="xdx_908_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_dp_uPure_c20241130__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--NextInnovationLLCMember_zwBXrrGEDlol" title="Ownership percentage">50</span>%
of Next Innovation LLC, a Joint Venture (&#8220;Next Innovation&#8221;), which is dormant. No activities nor operations occurred
through Next Innovation in fiscal years 2024 or 2025 and the Company does not have control of Next Innovation and therefore no minority interest
was recorded.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Reverse
Acquisition</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 12, 2023, the Company (then known as Sigma) entered into a Share Exchange Agreement (as amended, the &#8220;Exchange
Agreement&#8221;) with NTH, NTG, and William Kerby (the &#8220;NextTrip Representative&#8221;). Under the terms of the Exchange
Agreement, the parties agreed that NTG would sell and transfer to the Company all of the issued and outstanding shares of NTH in
exchange for <span id="xdx_90E_eus-gaap--BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_pid_c20231012__20231012__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__us-gaap--BusinessAcquisitionAxis__custom--NextTripGroupLLCMember__us-gaap--StatementClassOfStockAxis__custom--ClosingSharesMember_z1dbqyxiBm58" title="Restricted shares issuable in reverse acquisition">156,007</span>
restricted shares of Company common stock (the &#8220;Closing Shares&#8221;), issuable at closing, and the right to receive up to an
additional <span id="xdx_908_eus-gaap--BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_pid_c20231012__20231012__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__us-gaap--BusinessAcquisitionAxis__custom--NextTripGroupLLCMember__us-gaap--StatementClassOfStockAxis__custom--ContingentSharesMember_zFZ7ArmJ3rXl" title="Restricted shares issuable in reverse acquisition">5,843,993</span>
restricted shares of Company common stock upon satisfaction of certain milestones set forth in the Exchange Agreement (the
&#8220;Contingent Shares,&#8221; and together with the Closing Shares, the &#8220;Restricted Shares&#8221;), which Restricted Shares
are issuable to the members of NTG, on a pro rata basis, under the terms of the Exchange Agreement, subject to certain closing
conditions (the &#8220;NextTrip Acquisition&#8221;). Upon the closing of the NextTrip Acquisition on December 29, 2023, NTH
became a wholly owned subsidiary of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Contingent Shares, together with the Closing Shares, will not exceed <span id="xdx_907_eus-gaap--BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_pid_c20231012__20231012__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__us-gaap--BusinessAcquisitionAxis__custom--NextTripGroupLLCMember__srt--RangeAxis__srt--MaximumMember_zUcGhlrNAGd9" title="Restricted shares issuable in reverse acquisition">6,000,000</span>
shares of Company common stock, or approximately <span id="xdx_90A_ecustom--PercentageForIssuedAndOutstandingCapitalStock_pid_dp_uPure_c20231012__20231012__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__us-gaap--BusinessAcquisitionAxis__custom--NextTripGroupLLCMember_zgpUt3q26oo1" title="Percentage for issued and outstanding capital stock">90.2</span>%
of the issued and outstanding shares of Company common stock immediately prior to the closing. The NextTrip Acquisition will likely
result in a change of control, with the members of NTG receiving an aggregate number of shares that exceeds the number of shares
that held by the legacy shareholders of Sigma. As a result, the NextTrip Acquisition is accounted for as a reverse acquisition of
NTH by the Company, whereby the Company is treated as the legal acquirer and NTH is treated as the accounting acquirer. As a result,
the historical financial information for the periods prior to closing of the NextTrip Acquisition presented is that of
NTH.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
accordance with ASC <i>805</i>-<i>40</i>-<i>45</i>-<i>1,</i> the consolidated financial statements prepared following a reverse acquisition
are issued under the name of the legal parent (NextTrip, Inc., f/k/a Sigma Additive Solutions, Inc.) but described in the notes to the
financial statements as a continuation of the financial statements of the legal subsidiary (NTH), with <i>one</i> adjustment, which
is to retroactively adjust the accounting acquirer&#8217;s legal capital to reflect the legal capital of the accounting acquiree. That
adjustment is required to reflect the capital of the legal parent. Comparative information presented in the consolidated financial statements
also is retroactively adjusted to reflect the legal capital of the legal parent.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
ASC <i>805</i>-<i>40</i>-<i>45</i>-<i>2,</i> the consolidated financial statements represent the continuation of the legal subsidiary
except for the capital structure, as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    assets and liabilities of the legal subsidiary recognized and measured at their pre-combination carrying amounts;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    assets and liabilities of the legal parent recognized and measured in accordance with the guidance in this topic applicable to business
    combinations (ASC 805);</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    retained earnings and other equity balances of the legal subsidiary before the business combination;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    amount required to be recognized as issued equity interests in the consolidated financial statements determined by adding the issued
    equity interest of the legal subsidiary outstanding immediately before the business combination to the fair value of the legal parent
    determined in accordance with the guidance in ASC 805 applicable to business combinations. However, the equity structure reflects
    the equity structure of the legal parent, including the equity interests the legal parent issued to affect the combination. Accordingly,
    the equity structure of the legal subsidiary is restated using the exchange ratio established in the acquisition agreement to reflect
    the number of shares of the legal parent issued in the reverse acquisition.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
assets and liabilities of Sigma were recognized at fair value under ASC 805 as described in <b>NOTE 8 &#8211;
Goodwill</b>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Going
Concern</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of February 28, 2025, and February 29, 2024, the Company had an accumulated deficit of $<span id="xdx_90D_eus-gaap--RetainedEarningsAccumulatedDeficit_iNI_di_c20250228_zsUkhEI6Ady3" title="Accumulated deficit">34,349,823</span> and $<span id="xdx_90F_eus-gaap--RetainedEarningsAccumulatedDeficit_iNI_di_c20240229_zUD6hNqCpqLc" title="Accumulated deficit">24,151,139</span>, respectively, and
working capital deficit of $<span id="xdx_902_ecustom--WorkingCapitalDeficit_iI_c20250228_zg9XcvXLlAzd" title="Working capital deficit">105,577</span> and $<span id="xdx_90F_ecustom--WorkingCapitalDeficit_iI_c20240229_zf4PSoVY4I1j" title="Working capital deficit">262,005</span>, respectively, and has incurred losses since incorporation. The Company will need to
raise additional funds through equity or debt financings to support its on-going operations, increase market penetration of its products,
expand the marketing and development of its travel and technology driven products, provide capital expenditures for additional equipment
and development costs, payment obligations, and systems for managing the business including covering other operating costs until the
planned revenue streams are fully implemented and begin to offset the Company&#8217;s operating costs. In the event the Company is unable to raise adequate
funding in the future for its operations and to pay its outstanding debt obligations, the Company may be forced to scale back its business
plan and/or liquidate some or all of its assets or may be forced to seek bankruptcy protection.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
light of the foregoing, there is substantial doubt about the Company&#8217;s ability to continue as a going concern for 12 months from the date of the
filing of this Report.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubstantialDoubtAboutGoingConcernTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure when substantial doubt is raised about the ability to continue as a going concern. Includes, but is not limited to, principal conditions or events that raised substantial doubt about the ability to continue as a going concern, management's evaluation of the significance of those conditions or events in relation to the ability to meet its obligations, and management's plans that alleviated or are intended to mitigate the conditions or events that raise substantial doubt about the ability to continue as a going concern.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/205-40/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubstantialDoubtAboutGoingConcernTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Feb. 28, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Summary of Significant Accounting Policies</a></td>
<td class="text"><p id="xdx_806_eus-gaap--SignificantAccountingPoliciesTextBlock_z9EOl08QDmLe" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
2 &#8211; <span id="xdx_82D_zmWRpPg1HyL9">Summary of Significant Accounting Policies</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_849_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zJ1BUaV0Gyzk" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86E_zh2Lg2wMOZjl">Basis
of Presentation and Principles of Consolidation</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying consolidated financial statements and related disclosures have been prepared pursuant to the rules and regulations of the
Securities and Exchange Commission (&#8220;SEC&#8221;). The Financial Statements have been prepared using the accrual basis of accounting
in accordance with Generally Accepted Accounting Principles (&#8220;GAAP&#8221;) of the United States.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
financial statements have been prepared on a consolidated basis with those of the Company&#8217;s wholly owned subsidiaries. All intercompany
transactions and balances have been eliminated in consolidation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p id="xdx_849_eus-gaap--ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_zSHpdixYhZra" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86B_zRKXUvJqxDW9">Functional
and presentation currency</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
financial statements are presented in United States dollars (&#8220;USD&#8221;), which is the Company&#8217;s functional and reporting
currency. All financial information has been rounded to the nearest dollar except where otherwise indicated.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p id="xdx_847_eus-gaap--UseOfEstimates_z92xxB7g9Hp6" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_868_zANkfF99EJc3">Use
of Estimates</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that
affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the consolidated
financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from
those estimates. These differences could have a material effect on the Company&#8217;s future results of operations and financial position.
Significant items subject to estimates and assumptions include the carrying amounts of intangible assets, depreciation and amortization.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Information
about key assumptions and estimation uncertainty that has a significant risk of resulting in a material adjustment to the carrying amounts
of the Company&#8217;s assets and liabilities within the next financial year are referenced in the notes to the financial statements
as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    assessment of the Company to continue as a going concern;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    assessment of the allowance on the related party promissory note receivable;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Estimates
    of purchase price allocation;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    measurement and useful life of intangible assets and property and equipment</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Estimates
    of fair value of equity instruments;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recoverability
    of long lived assets</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84E_eus-gaap--EarningsPerSharePolicyTextBlock_z00E9Pa3SOu7" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86E_zssQN5TOOKRj">Loss
Per Share </span>&#8211; </b>The computation of loss per share is based on the weighted average number of shares outstanding during the period
in accordance with ASC Topic No. 260, &#8220;Earnings Per Share.&#8221; Shares underlying the Company&#8217;s outstanding warrants, options, preferred stock
or note conversion features were excluded due to the anti-dilutive effect they would have on the computation. At February 28, 2025 and
February 29, 2024, the Company had the following common shares underlying these instruments:</span></p>

<p id="xdx_892_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zvqrR8ZG98Q5" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B9_zfcl7inofrn9" style="display: none">Schedule of Anti-dilutive Securities Excluded
from Computation of Earnings Per Share</span></span></span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
  <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_490_20240301__20250228_zVHxnQOa9wwf" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">2025</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49B_20230301__20240229_zoPHw1J6jZFc" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">2024</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Year Ended February 28 and 29,</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">2025</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">2024</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zqkv5WKfeJ97" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 60%">Warrants</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">3,015,885</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">486,165</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--StockOptionMember_zAoWQGOKgK8b" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Stock Options</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">76,342</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">85,300</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--PreferredStockMember_zaluQv3R7uv5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Preferred Stock</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">3,109,663</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">475,835</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_z7EAhfi3Lt6d" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Total Underlying Common Shares</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">6,201,890</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">1,047,300</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A7_zrK2FIOrjfHj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p id="xdx_84C_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zhjm7voHXbBg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86A_z9BMsv76wSO3">Cash
and Cash Equivalents</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash
consists of amounts denominated in USD. The Company has not experienced any losses on such accounts. The Company considers all
highly liquid investments with a maturity of three months or less when purchased to be cash equivalents. There were <span id="xdx_90B_eus-gaap--CashEquivalentsAtCarryingValue_iI_do_c20250228_zuNofbvNxerl" title="Cash equivalents"><span id="xdx_905_eus-gaap--CashEquivalentsAtCarryingValue_iI_do_c20240229_zQkXA1eQbURh" title="Cash equivalents">no</span></span> cash equivalents
as of February 28, 2025, or February 29, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_840_ecustom--PrepaidsPolicyTextBlock_zwgSrGb0Idxj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_865_zDatv27VkZte">Prepaids</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company records cash paid in advance for goods and/or services to be received in the future as prepaid expenses. Prepaid expenses are
expensed over time according to the terms of the purchase. Other current assets are recognized when it is probable that the future economic
benefits will flow to the Company and the asset has a cost or value that can be measured reliably. It is then charged to expense over
the expected number of periods during which economic benefits will be realized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_849_eus-gaap--TradeAndOtherAccountsReceivablePolicy_zqPgfmpOk2Yi" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_867_zSrcewP8Ripj">Accounts
Receivable</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trade
accounts receivable are recorded at the invoiced amount and do not bear interest. The allowance for credit losses is the Company&#8217;s
best estimate of the amount of probable losses in its existing accounts receivable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company considers accounts receivable to be fully collectible; accordingly, no allowance for credit losses is required. If amounts
become uncollectible, they will be charged to operations when that determination is made.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trade
accounts receivable balances as of February 28, 2025 and February 29, 2024, were $<span id="xdx_909_eus-gaap--AccountsReceivableNet_iI_c20250228_zUbjy98GiaXl" title="Accounts receivable">22,567</span> and $<span id="xdx_900_eus-gaap--AccountsReceivableNet_iI_c20240229_zcmT867FEce8" title="Accounts receivable">34,092</span>, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_841_eus-gaap--EquityMethodInvestmentsPolicy_zabWDYnrzqte" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_863_zrlX5qfCtnlc">Investments
in Equity Method Investees</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company holds investments in certain entities that are accounted for under the equity method of accounting, as well as investments that
are accounted for under the fair value method pursuant to ASC 321, &#8220;Investments - Equity Securities.&#8221; Under the equity method,
investments in entities in which the Company has significant influence, but not control, are initially recognized at cost and adjusted
thereafter to recognize the Company&#8217;s share of the investees&#8217; earnings or losses and other comprehensive income.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company determines the existence of significant influence based on various factors, including representation on the investees&#8217;
board of directors, participation in policy-making processes, and material intercompany transactions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s equity method investments are evaluated periodically for impairment by assessing whether events or changes in circumstances
indicate that the carrying value of the investment may not be recoverable. When such indicators exist, the Company performs an impairment
test and recognizes an impairment loss to the extent that the carrying amount of the investment exceeds its fair value.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Distributions
received from equity method investees that exceed cumulative earnings recognized by the Company are considered a return of investment
and are recorded as a reduction in the carrying amount of the investment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Adjustments
resulting from changes in the Company&#8217;s ownership interest in equity method investees that do not result in a loss of significant
influence are accounted for prospectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84F_ecustom--BasisDifferencePolicyTextBlock_zIre3wqhViVg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_862_zKhnwIT74bZ1">Basis
Difference</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
accordance with ASC 323, &#8220;Investments - Equity Method and Joint Ventures,&#8221; the Company records a basis difference when the
carrying value of its equity method investment differs from its share of the investee&#8217;s fair value of net assets at the acquisition
date. This basis difference is allocated to the investee&#8217;s identifiable assets and liabilities based on their fair values. The
amortization of any basis difference related to depreciable assets, such as property, plant, and equipment, is recognized in the Company&#8217;s
share of the investee&#8217;s earnings or losses. Any basis difference related to non-depreciable assets, including goodwill, is generally
not amortized, but is subject to impairment testing as necessary.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company assesses the impact of any basis differences on its earnings and the carrying value of its equity method investments. If a basis
difference is determined to exist, the appropriate adjustments are made to reflect the amortization of such differences in the consolidated
financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84B_eus-gaap--EquitySecuritiesWithoutReadilyDeterminableFairValuePolicyTextBlock_z70CbGD2sAsc" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_865_ziedsQLI2no4">Investments
in Equity Securities without Readily Determinable Fair Value</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
accordance with ASC 321-10-35-2, the Company holds certain investments in equity securities in which the Company does not have significant
influence or control, and for which fair value is not readily determinable. These investments are primarily accounted for at cost, less
any impairment. The carrying amount is periodically evaluated for impairment, and if necessary, an impairment loss is recognized in the
statement of operations. These investments are not adjusted for unrealized gains or losses unless an impairment is identified.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84C_eus-gaap--EquityMethodInvestmentsIssuancesPolicy_zWGPIxaV2yFe" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_868_zE55pMyDrGlg">Equity
in Earnings of Equity Method Investees</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s share of earnings or losses from equity method investees is recognized in the consolidated statement of operations within
&#8220;Equity in share of loss of equity method investees,&#8221; net of any related income taxes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_843_eus-gaap--FairValueMeasurementPolicyPolicyTextBlock_zPNgWiw9RGQh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_869_zAp1boL6zgRj">Fair
Value Measurements</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fair value of equity method investments is disclosed when available and practical to determine. However, for investments that are not
readily marketable, such as non-public entities, fair value is not typically recognized in the financial statements unless the investment
is impaired.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p id="xdx_84C_ecustom--PromissoryNoteReceivablePolicyTextBlock_zpvsQAIGfJNc" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Promissory
Note Receivable</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Receivables
from NextPlay under the promissory note as described in <b>NOTE 1 &#8211; Business Description and Going Concern</b> were $<span id="xdx_903_eus-gaap--AccountsReceivableNet_iI_c20250228__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--NextPlayTechnologiesIncMember_z1qGJcY8kUE" title="Accounts receivable">0</span> and $<span id="xdx_903_eus-gaap--AccountsReceivableNet_iI_c20240229__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--NextPlayTechnologiesIncMember_zoFhIZVRI9Ab" title="Accounts receivable">1,000,000</span>
at February 28, 2025 and February 29, 2024, respectively. Pursuant to the terms of the Promissory Note (the &#8220;NextPlay Note&#8221;)
between NTH and NextPlay, the NextPlay Note was due and payable in full on the earlier of September 1, 2023 or the date the Company
completed a financing of $<span id="xdx_90E_eus-gaap--NotesPayable_iI_pn6n6_c20230925__us-gaap--BusinessAcquisitionAxis__custom--NextPlayTechnologiesIncMember_zGhg2DJpWydb" title="Notes payable">10</span> million or more. No payments have been made by NextPlay, and as such NextPlay is in default under the terms
of the NextPlay Note.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 27, 2025, as creditors of NextPlay, Donald P. Monaco, the Company&#8217;s Chairman, William Kerby, the Company&#8217;s Chief
Executive Officer, and Ian Sharpe, the Chief Operating Officer of the Company&#8217;s Media division, filed a petition to force NextPlay
into involuntary bankruptcy as a result of unpaid fees. The proceedings are ongoing and the outcome at this time is uncertain and cannot
be predicted. As a result, management has determined that the collectability of the NextPlay Note is uncertain and has therefore established
an allowance for doubtful accounts for the entire balance of $<span id="xdx_902_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iI_c20250127__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--NextPlayTechnologiesIncMember_z2SRuRsyeQXk" title="Allowance for doubtful accounts">2,567,665</span>. Of this amount, $<span id="xdx_908_ecustom--LossOnRelatedPartyReceivable_c20240301__20250228_z7jiBGEHH9Uc" title="Loss on promissory note receivable">1,000,000</span> was recorded as of February 28, 2025,
and $<span id="xdx_900_ecustom--LossOnRelatedPartyReceivable_c20230301__20240229_zmIVjrNPV9Lb" title="Loss on promissory note receivable">1,567,665</span> was recorded as of February 29, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p id="xdx_84A_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_z8czT4zfswHh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86F_z6yCU0h8ggla">Property
and Equipment</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Recognition
and measurement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Items
of property and equipment are measured at cost, less accumulated depreciation and accumulated impairment losses. When parts of an item
of property and equipment have different estimated useful lives, they are accounted for as separate items within property and equipment.
The costs of the ongoing regular repairs and maintenance of property and equipment are recognized in the period in which they are incurred.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Depreciation</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation
is recognized in profit or loss over the estimated useful lives of each part of an item of property and equipment in a manner that most
closely reflects management&#8217;s estimated future consumption of the future economic benefits embodied in the asset. The estimated
useful lives for the Company&#8217;s property and equipment are as follows:</span></p>

<p id="xdx_89A_ecustom--ScheduleOfEstimatedUsefulLivesForPropertyAndEquipmentTableTextBlock_z5CB4ZAtqjM7" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span style="display: none"><span id="xdx_8BB_zz2yIF2XvmHl">Schedule
of Estimated
Useful Lives for Property and Equipment</span></span></span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Category</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Method</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Estimated
    useful life</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furniture
    &amp; Fixtures</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Straight
    line</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20250228__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zvTl2fGZ8Eof" title="Estimated useful life">5</span>
    years</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Computer
    &amp; Equipment</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Straight
    line</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20250228__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_zUaXzpeVFOQf" title="Estimated useful life">3</span>
    years</span></td></tr>
  </table>
<p id="xdx_8A6_zYReKKJGarnl" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84F_eus-gaap--IntangibleAssetsFiniteLivedPolicy_zDoeSolb4H5g" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86D_z5mvFUmsmmdh">Intangible
assets</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company measures separately acquired intangible assets at cost, less accumulated amortization and impairment losses. The Company recognizes
internally developed intangible assets when it has determined that the completion of such is technically feasible, and the Company has
sufficient resources to complete the development. Subsequent expenditures are capitalized when they increase the future economic benefits
of the associated asset. All other expenditures are recorded in profit or loss as incurred.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company assesses whether the life of intangible asset is finite or indefinite. The Company reviews the amortization method and period
of use of its intangible assets at least annually. Changes in the expected useful life or period of consumption of future economic benefits
associated with the asset are accounted for prospectively by changing the amortization method or period as a change in accounting estimates
in profit or loss. The Company has assessed the useful life of its trademarks as indefinite.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_891_ecustom--ScheduleOfEstimatedUsefulLivesForFiniteLifeIntangibleAssetsTableTextBlock_zX9Gyyi62dK9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
estimated useful lives for the Company&#8217;s finite life intangible assets are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B8_zqdpJQVrfANf" style="display: none">Schedule
of Estimated
Useful Lives for Finite Life Intangible Assets</span></span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Category</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Method</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Estimated
    useful life</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Software</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Straight
    line</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20250228__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SoftwareMember__srt--RangeAxis__srt--MinimumMember_zAPO9167w9ai" title="Estimated useful life">1</span>
    - <span id="xdx_909_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20250228__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SoftwareMember__srt--RangeAxis__srt--MaximumMember_zv66dkLsEoxe" title="Estimated useful life">3</span> years</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Software
    licenses</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Straight
    line</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20250228__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SoftwareLicensesMember__srt--RangeAxis__srt--MinimumMember_zfNu07ETVGUi" title="Estimated useful life">0.5</span>
    - <span id="xdx_902_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20250228__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SoftwareLicensesMember__srt--RangeAxis__srt--MaximumMember_zPU8KANFDz6l" title="Estimated useful life">4</span> years</span></td></tr>
  </table>
<p id="xdx_8AA_zrmr4KOowcch" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p id="xdx_84F_eus-gaap--InternalUseSoftwarePolicy_zPKn11aVP3Sg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_864_zS1UUutOsNbd">Software
Development Costs</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company capitalizes internal software development costs subsequent to establishing technological feasibility of a software application
in accordance with guidelines established by &#8220;ASC 985-20-25&#8221; Accounting for the Costs of Software to Be Sold, Leased, or
Otherwise Marketed, requiring certain software development costs to be capitalized upon the establishment of technological feasibility.
The establishment of technological feasibility and the ongoing assessment of the recoverability of these costs require considerable judgment
by management with respect to certain external factors such as anticipated future revenue, estimated economic life, and changes in software
and hardware technologies. Amortization of the capitalized software development costs begins when the product is available for general
release to customers. Capitalized costs are amortized based on the straight-line method over the remaining estimated economic life of
the product.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_849_eus-gaap--GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_z6Yc1kBv10E4" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_863_zmgLD6BsuqJk">Impairment
of Intangible Assets</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
accordance with ASC 350-30-65 &#8220;Goodwill and Other Intangible Assets&#8221;, the Company assesses the impairment of identifiable
intangible assets whenever events or changes in circumstances indicate that the carrying value may not be recoverable. Factors the Company
considers important, which could trigger an impairment review include the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.
Significant underperformance compared to historical or projected future operating results.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.
Significant changes in the manner or use of the acquired assets or the strategy for the overall business, and</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.
Significant negative industry or economic trends.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">When
the Company determines that the carrying value of an intangible asset may not be recoverable based upon the existence of one or more
of the above indicators of impairment and the carrying value of the asset cannot be recovered from projected undiscounted cash flows,
the Company records an impairment charge. The Company measures any impairment based on a projected discounted cash flow method using
a discount rate determined by management to be commensurate with the risk inherent to the current business model. Significant management
judgment is required in determining whether an indicator of impairment exists and in projecting cash flows. Intangible assets that have
finite useful lives are amortized over their useful lives.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84F_eus-gaap--LesseeLeasesPolicyTextBlock_zCLGhnMfxjwa" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86A_zflz7TQmjQ8k">Leases</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company adopted ASU 2016-02 (Topic ASC 842) Leases, which requires a lessee to recognize a lease asset and a leases liability for operating
leases arrangements greater than twelve (12) months.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
determine if an arrangement is a lease at inception. Operating leases are included in operating lease right-of-use (&#8220;ROU&#8221;)
assets, operating lease liabilities - current, and operating lease liabilities - noncurrent on the balance sheets.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ROU
assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease
payments arising from the lease. Operating lease ROU assets and liabilities are recognized at commencement date based on the present
value of lease payments over the lease term. As most of our leases do not provide an implicit rate, we generally use our incremental
borrowing rate based on the estimated rate of interest for collateralized borrowing over a similar term of the lease payments at commencement
date. The operating lease ROU asset also includes any lease payments made and excludes lease incentives. Our lease terms may include
options to extend or terminate the lease when it is reasonably certain that we will exercise that option. Lease expense for lease payments
is recognized on a straight-line basis over the lease term.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p id="xdx_845_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zs0xXffHlI4j" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_861_zQFg4hltGIxf">Reclassification</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
prior year amounts have been reclassified to conform to the current period presentation. These reclassifications had no impact on the
net earnings (loss) or financial position.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84C_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zYUEOLk4dVve" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_868_zgeN1xwJDHX">Fair
Value of Financial Instruments</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company follows accounting guidelines on fair value measurements for financial instruments measured on a recurring basis, as well as
for certain assets and liabilities that are initially recorded at their estimated fair values. Fair Value is defined as the exit price,
or the amount that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants
as the measurement date. The Company uses the following three-level hierarchy that maximizes the use of observable inputs and minimizes
the use of unobservable inputs to value its financial instruments:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    1: Observable inputs such as unadjusted quoted prices in active markets for identical instruments.</span></td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    2: Quoted prices for similar instruments that are directly or indirectly observable in the marketplace.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    3: Significant unobservable inputs which are supported by little or no market activity and that are financial instruments whose values
    are determined using pricing models, discounted cash flow methodologies, or similar techniques, as well as instruments for which
    the determination of fair value requires a significant judgment or estimation.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
instruments measured at fair value are classified in their entirety based on the lowest level of input that is significant to the fair
value measurement. The Company&#8217;s assessment of the significance of a particular input to the fair value measurement in its entirety
requires it to make judgments and consider factors specific to the asset or liability. The use of different assumptions and/or estimation
methodologies may have a material effect on estimated fair values. Accordingly, the fair value estimates disclosed, or initial amounts
recorded may not be indicative of the amount that the Company or holders of the instruments could realize in a current market exchange.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
carrying amounts of the Company&#8217;s financial instruments including cash, accounts receivable, accounts payable, accrued expenses,
convertible notes and notes payable are of approximately fair value due to the short-term maturities of these instruments.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_848_eus-gaap--MarketRiskBenefitPolicyTextBlock_zmy8rbwcLTdf" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_868_zxjb70IvPBf5">Concentration
of Credit Risk </span>-</b> The Company maintains its cash in bank deposit accounts, which, at times, may exceed federally insured limits. The
Company has not experienced any losses in such accounts and believes it is not exposed to any significant credit risk on its cash and
cash equivalents.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_849_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_z3Mq8xR32Ov9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: -0.9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86A_zGMWX7TRgG6f">Stock
Based Compensation</span></b> &#8211; The Company recognizes compensation costs to employees under ASC Topic No. 718, &#8220;Compensation &#8211;
Stock Compensation.&#8221; Under ASC Topic No. 718, companies are required to measure the compensation costs of share-based compensation
arrangements based on the grant-date fair value and recognize the costs in the financial statements over the period during which employees
are required to provide services. Share based compensation arrangements may include stock options, grants of shares of common stock with
and without restrictions, performance-based awards, share appreciation rights and employee share purchase plans. As such, compensation
cost is measured on the date of grant at its fair value. Such compensation amounts, if any, are amortized over the respective vesting
periods of the option or stock grants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: -0.9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equity
instruments issued to non-employees are recorded on the basis of the fair value of the instruments, as required by ASC Topic No. 718.
In general, the measurement date is either (a) when a performance commitment, as defined, is reached or (b) the earlier of the date that
(i) the non-employee performance requirement is complete or (ii) the instruments are vested. The measured value related to the instruments
is recognized over a period based on the facts and circumstances of each particular grant as defined in the FASB Accounting Standards
Codification.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p id="xdx_844_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_zrdm3uMmNHhg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86E_z1a64sRD73ic">Revenue
Recognition</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recognizes revenue in accordance with ASC Topic No. 606. In May 2014, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued
Accounting Standards Update (&#8220;ASU&#8221;) No. 2014-09, <i>Revenue from Contracts with Customers</i>. ASU 2014-09 is a comprehensive revenue recognition
standard that superseded nearly all existing revenue recognition guidance under prior GAAP and replaced it with a principles-based
approach for determining revenue recognition. The core principle of the standard is the recognition of revenue upon the transfer of promised
goods or services to customers in an amount that reflects the consideration to which the company expects to be entitled in exchange for
those goods or services. In general, we determine revenue recognition by: (1) identifying the contract, or contracts, with our customer;
(2) identifying the performance obligations in the contract; (3) determining the transaction price; (4) allocating the transaction price
to performance obligations in the contract; and (5) recognizing revenue when, or as, we satisfy performance obligations by transferring
the promised goods or services.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recognizes revenue when the customer has purchased the product, the occurrence of the earlier of date of travel and the date of
cancellation has expired, as satisfaction of the performance obligation, the sales price is fixed or determinable and collectability
is reasonably assured. Revenue for customer travel packages purchased directly from the Company are recorded gross (the amount paid to
the Company by the customer is shown as revenue and the cost of providing the respective travel package is recorded to cost of revenues).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company generates revenues from sales directly to customers as well as through other distribution channels of tours and activities at
destinations throughout the world.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company controls the specified travel product before it is transferred to the customer and is therefore a principal, based on but not
limited to, the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Company is primarily responsible for fulling the promise to provide such travel product.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Company has inventory risk before the specified travel product has been transferred to a customer or after transfer of control to
    a customer.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Company has discretion in establishing the price for the specified travel product.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Payments
for tours or activities received in advance of services being rendered are recorded as deferred revenue and recognized as revenue at
the earlier of the date of travel or the last date of cancellation (i.e., the customer&#8217;s refund privileges lapse).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84D_eus-gaap--SellingGeneralAndAdministrativeExpensesPolicyTextBlock_zJTtpSias568" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86F_zQ3fcJCgU2ec">Sales
and Marketing</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Selling
and marketing expenses consist primarily of marketing and promotional expenses, expenses related to our participation in industry
conferences, and public relations expenses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sales
and marketing expenses are charged to expense as incurred and are included in selling and promotions expenses in the accompanying consolidated
financial statements. Sales and marketing expense for the years ended February 28, 2025 and February 29, 2024 was $<span id="xdx_907_eus-gaap--SellingAndMarketingExpense_c20240301__20250228_z6vgQuzeHCol" title="Sales and marketing expense">307,166</span> and $<span id="xdx_905_eus-gaap--SellingAndMarketingExpense_c20230301__20240229_z4jYH9fDJYtb" title="Sales and marketing expense">484,250</span>,
respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84B_eus-gaap--IncomeTaxPolicyTextBlock_zgwGOWd6ekvk" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86E_zNUHheJDSJmc">Income
Taxes</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for income taxes in accordance with ASC Topic No. 740, &#8220;Accounting for Income Taxes.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Income
taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences
attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective
tax bases and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected
to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred
tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. A valuation
allowance on deferred tax assets is established when management considers it is more likely than not that some portion or all of the
deferred tax assets will not be realized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tax
benefits from an uncertain tax position are only recognized if it is more likely than not that the tax position will be sustained on
examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in the consolidated
financial statements from such a position are measured based on the largest benefit that has a greater than fifty percent likelihood
of being realized upon ultimate resolution. Interest and penalties related to unrecognized tax benefits are recorded as incurred as a
component of income tax expense. The Company has not recognized any tax benefits from uncertain tax positions for any of the reporting
periods presented.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company had no tax positions at February 28, 2025 or 2024 for which the ultimate deductibility was highly uncertain but for which there
was uncertainty about the timing of such deductibility.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recognizes interest accrued related to unrecognized tax benefits in interest expense and penalties in operating expenses.
During the years ended February 28, 2025 and February 29, 2024, the Company recognized no interest and penalties. All tax returns
for years starting with 2021 and thereafter remain open for examination by the IRS.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_849_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zAjDLPXRefc6" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86D_zo0lewsivXQl">Recently
adopted accounting pronouncements</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
July 2023, the FASB issued ASU 2023-03, Presentation of Financial Statements (Topic 205), Income Statement&#8212;Reporting Comprehensive
Income (Topic 220), Distinguishing Liabilities from Equity (Topic 480), Equity (Topic 505), and Compensation&#8212;Stock Compensation
(Topic 718). The FASB Issued this ASU to amend and align various SEC paragraphs within the Codification with interpretive guidance recently
issued by the Securities and Exchange Commission (SEC). Specifically, this update codifies the guidance from SEC Staff Accounting Bulletin
(SAB) No. 120, which clarifies the application of ASC 718 &#8211; Compensation&#8212;Stock Compensation to certain share-based payment
arrangements. SAB No. 120 was issued in response to concerns about so-called &#8220;spring-loaded&#8221; awards &#8212; share-based compensation
arrangements granted shortly before the release of material nonpublic information (MNPI) that is expected to significantly affect the
market price of the issuer&#8217;s stock. SAB No. 120 does not change the fundamental measurement principles of ASC 718, but it emphasizes
the requirement to include the impact of MNPI in estimating fair value at the grant date when it is reasonable to expect that such information
would be factored into the pricing by a market participant. Under ASC 718, entities must measure the grant-date fair value of equity-classified
awards using an option-pricing model and inputs that reflect assumptions a market participant would make. SAB No. 120 reinforces that
this includes: (i) adjusting expected volatility or stock price to reflect the anticipated impact of MNPI; (ii) documenting the rationale
for assumptions that do not reflect such information, if applicable; and (3) ensuring internal control processes capture relevant information
in determining grant-date fair value. The Company adopted ASU 2023-03 effective January 1, 2024. In conjunction with this adoption, the
Company reviewed its stock compensation grant practices and valuation procedures under ASC 718. While the Company has not historically
granted awards in close proximity to the release of MNPI, it has updated its internal controls to require additional documentation and
review for any future awards that may be subject to this scenario. The adoption of ASU 2023-03 did not result in any changes to the recognition
or measurement of share-based payment expense in the Company&#8217;s consolidated financial statements. However, the Company enhanced
its internal controls around the timing and valuation of equity awards to ensure compliance with the interpretive guidance of SAB No.
120 and ASC 718.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
November 2023, the FASB issued ASU 2023-07 to improve disclosures about a public entity&#8217;s reportable segments and address investor
feedback for greater transparency. The amendments are intended to enhance the usefulness of segment information, particularly regarding
expenses, by requiring more detailed disclosures and expanding the scope of interim disclosures. The Company adopted ASU 2023-07 for
its fiscal year beginning March 1, 2024 (i.e., for the fiscal year ending February 28, 2025), as required. The amendments require entities
to disclose, on an annual and interim basis: (i) significant segment expenses that are regularly provided to the chief operating decision
maker (&#8220;CODM&#8221;); (ii) an explanation of how reported segment profit or loss is measured, (ii) The title and position of the CODM; (iii)
a description of how the CODM uses reported measures in decision-making; and (iv) expanded disclosures of segment information in interim
periods, consistent with annual disclosures.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
manage the Company as one reportable segment, Travel Products and Services. Travel bookings are the source of our revenues and include
the sale of travel products such as airline tickets and hotel rooms as well as travel services such as travel insurance and ground activities.
The segment information aligns with how the Company&#8217;s CODM reviews and manages our
business. The Company&#8217;s CODM is the Company&#8217;s Chief Executive Officer.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
information and annual operating plans and forecasts are prepared and are reviewed by the CODM at a consolidated level. The CODM assesses
performance for the Travel Products and Services segment and decides how to allocate resources based on revenue and net income that is
reported on the Consolidated Statements of Operations. The Company&#8217;s objective in making resource allocation decisions is to optimize
the financial results. The accounting policies of our Travel Products and Services segment are the same as those described in the summary
of significant accounting policies herein.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
our single reportable segment-level financial information, total assets, and significant non-cash transactions, see the Financial Statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84D_ecustom--RecentlyIssuedAccountingPronouncementsNotYetAdoptedPolicyTextBlock_zTPCxbe6xR06" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_866_zgwQwVdwKsR9">Recently
issued accounting pronouncements not yet adopted</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
December 2023, the FASB issued ASU 2023-09, <i>Income Taxes (Topic 740): Improvements to Income
Tax Disclosures</i>, to enhance the transparency and decision-usefulness of income tax information provided to investors. The amendments
focus primarily on expanding the disclosures related to the effective tax rate reconciliation and income taxes paid. Key provisions of
the update include: (i) enhanced disclosure of the effective tax rate reconciliation, using both standardized categories and quantitative
disclosure of individual reconciling items that meet specified thresholds; (ii) required disaggregation of income taxes paid, by federal,
state, and significant foreign jurisdictions; (iii) additional qualitative disclosures about tax-related assumptions and estimation methodologies.
ASU 2023-09 is effective for public business entities for annual periods beginning after December 15, 2024. As a result, the Company
will adopt the standard for its fiscal year beginning March 1, 2025 (ending February 28, 2026). Early adoption is permitted; however,
the Company does not intend to early adopt. The Company is currently evaluating the impact of the new standard on its income tax footnote
disclosures. The adoption is not expected to have an impact on the Company&#8217;s consolidated financial position, results of operations,
or cash flows, but it will result in expanded and more detailed income tax disclosures beginning in fiscal 2026.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has considered all other recently issued accounting pronouncements and does not believe the adoption of such pronouncements will
have a material impact on its consolidated financial statements.</span></p>

<p id="xdx_85D_zmoLoCbHvlrb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 235<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/235/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Discontinued Operations<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Feb. 28, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract', window );"><strong>Discontinued Operations and Disposal Groups [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock', window );">Discontinued Operations</a></td>
<td class="text"><p id="xdx_803_eus-gaap--DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_zc6Ec27lkNVg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
3 &#8211; <span id="xdx_820_zjAQlsGaqkYc">Discontinued Operations</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the fiscal year ended February 29, 2024, the Company completed the sale of certain legacy assets of Sigma,
which has been classified as discontinued operations in accordance with ASC 205-20, &#8220;Presentation of Financial Statements
&#8211; Discontinued Operations.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 6, 2023, the Company entered into a definitive asset purchase agreement (the &#8220;Divergent Agreement&#8221;) with Divergent Technologies,
Inc. (&#8220;Divergent&#8221;), pursuant to which the Company agreed to sell to Divergent, and Divergent agreed to purchase from
us, certain assets consisting primarily of patents, software code and other intellectual property for a purchase price of $<span id="xdx_907_eus-gaap--PaymentsToAcquireIntangibleAssets_c20231006__20231006__us-gaap--TypeOfArrangementAxis__custom--AssetPurchaseAgreementMember__dei--LegalEntityAxis__custom--DivergentTechnologiesIncMember_zoTShA3T5C7g" title="Purchase price">1,626,242</span>,
including a $<span id="xdx_90B_ecustom--EarnestMoneyDeposit_iI_c20231006__us-gaap--TypeOfArrangementAxis__custom--AssetPurchaseAgreementMember__dei--LegalEntityAxis__custom--DivergentTechnologiesIncMember_zp3ut5lOt7ud" title="Earnest money deposit">37,000</span>
earnest-money deposit previously paid to us by Divergent. The closing under the Divergent Agreement occurred subsequent to the
closing of the reverse acquisition with NTH on January 12, 2024. The parties&#8217; respective obligations to close were
subject to the accuracy of the parties&#8217; respective representations and warranties and performance of their respective
covenants and satisfaction or waiver of other customary conditions specified in the Divergent Agreement. In the interim,
between the signing date and closing date or termination of the Divergent Agreement, the Company granted Divergent a non-exclusive,
nontransferable, non-sublicensable (except to Divergent customers and affiliates), limited, irrevocable (except in connection with
the termination of the Divergent Agreement), worldwide, royalty-free license to the &#8220;Licensed IP&#8221; (as defined therein) for
testing, evaluation, and commercialization purposes. A gain of $<span id="xdx_908_eus-gaap--GainLossOnDispositionOfAssets1_c20231006__20231006__us-gaap--TypeOfArrangementAxis__custom--AssetPurchaseAgreementMember__dei--LegalEntityAxis__custom--DivergentTechnologiesIncMember_z29KsoyPT2Yj" title="Loss on disposal of assets">30,515 </span>was
recognized in the asset disposition transaction.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the year ended February 28, 2025, the Company recorded a gain of $<span id="xdx_90B_eus-gaap--IncomeLossFromDiscontinuedOperationsNetOfTax_c20240301__20250228_znCJ5QuEoQd4" title="Loss of discontinued operations">8,344</span> from discontinued operations as follows:</span></p>

<p id="xdx_894_eus-gaap--ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_zFCh736E4fIa" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b><span id="xdx_8B1_zhPTT6uD6F5e" style="display: none">Schedule
of Discontinued Operations</span></span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_495_20240301__20250228_zIpCboDEeHp3" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">February 28,</p>
                                                                               <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">2025</p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--DisposalGroupIncludingDiscontinuedOperationRevenue_maDGIDOzv4w_zShvCX8ho5Rl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 78%">Revenue</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right">14,731</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold_msDGIDOzv4w_zJf2TzTzn1Q3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">Cost of revenue</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0856">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss_iT_mtDGIDOzv4w_maDGIDOzv2d_zzYmXroHjHW2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Gross profit</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">14,731</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_ecustom--DisposalGroupIncludingDiscontinuedOperationsProfessionalServices_maDGIDOzcGq_zZbST1Jw89Fh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Professional services</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">4,163</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_ecustom--DisposalGroupIncludingDiscontinuedOperationsInvestorRelationsServices_maDGIDOzcGq_zTrEix5zyql" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Investor relations services</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">4,194</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--DisposalGroupIncludingDiscontinuedOperationsOtherIncome_maDGIDOzcGq_zF8I0kVGhYR6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Other income</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(1,970</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_409_eus-gaap--DisposalGroupIncludingDiscontinuedOperationOperatingExpense_iT_mtDGIDOzcGq_msDGIDOzv2d_zYuvubvD1yHg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Total Expenses</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">6,387</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--IncomeLossFromDiscontinuedOperationsNetOfTax_iT_mtDGIDOzv2d_zENYlBZnkdX8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Gain from Discontinued Operations</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">8,344</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A5_zV0vEq8nfgE3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/205-20/tableOfContent<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/360/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investment in Equity Method Investee<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Feb. 28, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract', window );"><strong>Equity Method Investments and Joint Ventures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsDisclosureTextBlock', window );">Investment in Equity Method Investee</a></td>
<td class="text"><p id="xdx_80D_eus-gaap--EquityMethodInvestmentsDisclosureTextBlock_zbW1I4veE0f2" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
4 - <span id="xdx_82A_zRyuxxMKdLBf">Investment in Equity Method Investee</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Membership
Purchase Agreement with FSA Travel, LLC</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 6, 2025, the Company entered into a Membership Purchase Agreement (the &#8220;FSA Purchase Agreement&#8221;) with FSA
Travel, LLC (&#8220;FSA&#8221;). Under the terms of the FSA Purchase Agreement, the Company acquired an initial <span id="xdx_90B_eus-gaap--EquityOwnershipPercentageExcludingConsolidatedEntityAndEquityMethodInvestee_iI_pid_dp_uPure_c20250206__us-gaap--TypeOfArrangementAxis__custom--MembershipPurchaseAgreementMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--FSATravelLLCMember_zEcBTYA2ex1a">49</span>%
membership interest in FSA for a total of $<span id="xdx_90C_eus-gaap--BusinessAcquisitionPreacquisitionContingencyAmountOfSettlement_iI_c20250206__us-gaap--TypeOfArrangementAxis__custom--MembershipPurchaseAgreementMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--FSATravelLLCMember_zSsW0K191t04" title="Business acquisition amount">1,000,000</span>.
The acquisition consideration consisted of $<span id="xdx_90B_eus-gaap--BusinessCombinationContingentConsiderationAsset_iI_c20250206__us-gaap--TypeOfArrangementAxis__custom--MembershipPurchaseAgreementMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--FSATravelLLCMember_zzSu8xqvHChl" title="Business acquisition  consideration cash">500,000</span>
in cash and $<span id="xdx_905_eus-gaap--BusinessCombinationContingentConsiderationAsset_iI_c20250206__us-gaap--TypeOfArrangementAxis__custom--MembershipPurchaseAgreementMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--FSATravelLLCMember__us-gaap--StatementClassOfStockAxis__custom--SeriesOPreferredStockMember_zIfy9t8SHmh9" title="Business acquisition  consideration cash">500,000</span>
of Series O Preferred shares (<span id="xdx_90E_eus-gaap--SharesIssued_iI_c20250206__us-gaap--TypeOfArrangementAxis__custom--MembershipPurchaseAgreementMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--FSATravelLLCMember__us-gaap--StatementClassOfStockAxis__custom--SeriesOPreferredStockMember_zIyezkG0RZt1" title="Business acquisition shares issued">161,291</span>
shares at $<span id="xdx_909_eus-gaap--SharesIssuedPricePerShare_iI_c20250206__us-gaap--TypeOfArrangementAxis__custom--MembershipPurchaseAgreementMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--FSATravelLLCMember__us-gaap--StatementClassOfStockAxis__custom--SeriesOPreferredStockMember_zikqIxv9di4g" title="Business acquisition shares price per share">3.10</span>
per share). The investment in FSA is accounted for using the equity method of accounting in accordance with ASC 323 because
the Company has significant influence over the investee due to its <span id="xdx_901_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20250206__us-gaap--TypeOfArrangementAxis__custom--MembershipPurchaseAgreementMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--NextTripMember_zQw3wG4WabA4">49</span>%
ownership interest.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the FSA Purchase Agreement, NextTrip was granted an option to acquire the remaining <span id="xdx_909_eus-gaap--InvestmentInterestRatePaidInCash_iI_pid_dp_uPure_c20250206__us-gaap--TypeOfArrangementAxis__custom--MembershipPurchaseAgreementMember__dei--LegalEntityAxis__custom--FSATravelLLCMember_zA8Z86vKyKSf">51</span>%
membership interest in FSA for an additional $<span id="xdx_903_eus-gaap--BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCosts_iI_c20250206__us-gaap--TypeOfArrangementAxis__custom--MembershipPurchaseAgreementMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--FSATravelLLCMember_zYvOcwYUanbl" title="Business acquisition additional amount">1,000,000</span>.
The option is exercisable within 60 days from the execution of the FSA Purchase Agreement, subject to the satisfaction of certain
conditions outlined in the FSA Purchase Agreement. The consideration for the remaining interest would consist of $<span id="xdx_90B_eus-gaap--BusinessCombinationContingentConsiderationAsset_iI_c20250206__us-gaap--TypeOfArrangementAxis__custom--MembershipPurchaseAgreementMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--FSATravelLLCMember_zDak6yi2AVzg" title="Business acquisition  consideration cash">500,000</span>
in cash and $<span id="xdx_905_eus-gaap--BusinessCombinationContingentConsiderationAsset_iI_c20250206__us-gaap--TypeOfArrangementAxis__custom--MembershipPurchaseAgreementMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--FSATravelLLCMember__us-gaap--StatementClassOfStockAxis__custom--SeriesOPreferredStockMember_z7eHicJCV7Rg" title="Business acquisition  consideration cash">500,000 </span>of
Series O Preferred shares (<span id="xdx_90E_eus-gaap--SharesIssued_iI_c20250206__us-gaap--TypeOfArrangementAxis__custom--MembershipPurchaseAgreementMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--FSATravelLLCMember__us-gaap--StatementClassOfStockAxis__custom--SeriesOPreferredStockMember_zWCrdKGwd3Nl" title="Business acquisition shares issued">161,291</span>
shares at $<span id="xdx_909_eus-gaap--SharesIssuedPricePerShare_iI_c20250206__us-gaap--TypeOfArrangementAxis__custom--MembershipPurchaseAgreementMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--FSATravelLLCMember__us-gaap--StatementClassOfStockAxis__custom--SeriesOPreferredStockMember_zeCwqzFwvc3b" title="Business acquisition shares price per share">3.10</span>
per share).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the FSA Purchase Agreement, if the Company exercises its option to acquire the remaining <span id="xdx_904_eus-gaap--InvestmentInterestRatePaidInCash_iI_pid_dp_uPure_c20250206__us-gaap--TypeOfArrangementAxis__custom--MembershipPurchaseAgreementMember_z3aqMnqtD3p">51</span>%
interest, incremental consideration would include four business milestone payments, payable upon achievement of such milestones. The
achievement of each milestone would result in a payment of $<span id="xdx_904_eus-gaap--BusinessAcquisitionPreacquisitionContingencyAmountOfSettlement_iI_c20250206__us-gaap--TypeOfArrangementAxis__custom--MembershipPurchaseAgreementMember_zgE4X010ITMf" title="Business acquisition amount">200,000</span>,
consisting of $<span id="xdx_901_eus-gaap--BusinessCombinationContingentConsiderationAsset_iI_c20250206__us-gaap--TypeOfArrangementAxis__custom--MembershipPurchaseAgreementMember_zo2QpEl46jmd" title="Business acquisition  consideration cash">100,000</span>
in cash and $<span id="xdx_90C_eus-gaap--BusinessCombinationContingentConsiderationAsset_iI_c20250206__us-gaap--TypeOfArrangementAxis__custom--MembershipPurchaseAgreementMember_zZaV1pfvSP4i" title="Business acquisition  consideration cash">100,000</span>
in Series O Preferred shares (<span id="xdx_906_eus-gaap--SharesIssued_iI_c20250206__us-gaap--TypeOfArrangementAxis__custom--MembershipPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesOPreferredStockMember_zZJiCUG0YA02" title="Business acquisition shares issued">32,258</span>
shares at $<span id="xdx_908_eus-gaap--SharesIssuedPricePerShare_iI_c20250206__us-gaap--TypeOfArrangementAxis__custom--MembershipPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesOPreferredStockMember_zJplSBKHtrDc" title="Business acquisition shares price per share">3.10</span>
per share). These milestone payments are contingent upon the Company&#8217;s exercise of the option to acquire the remaining <span id="xdx_908_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20250206__us-gaap--TypeOfArrangementAxis__custom--MembershipPurchaseAgreementMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--FSATravelLLCMember_zng5Ri49qDA4">51</span>%
of FSA, and are triggered only if the conditions necessary to exercise the option are satisfied. The total milestone payments
are capped at $<span id="xdx_90B_ecustom--BusinessAcquisitionMilestonePayments_iI_c20250206__us-gaap--TypeOfArrangementAxis__custom--MembershipPurchaseAgreementMember__dei--LegalEntityAxis__custom--FSATravelLLCMember_zMhTirdjALPj" title="Milestone payments">800,000</span>
(four milestones at $<span id="xdx_904_ecustom--BusinessAcquisitionPerMilestonePayments_iI_c20250206__us-gaap--TypeOfArrangementAxis__custom--MembershipPurchaseAgreementMember__dei--LegalEntityAxis__custom--FSATravelLLCMember_zbwuYGV0Ob12" title="Per milestone payments">200,000</span>
per milestone). These milestone payments are considered performance-based contingent consideration and will be recognized in the
future if and when the related milestones are satisfied, and the payments are made.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of February 28, 2025, the Company recorded its initial <span id="xdx_905_eus-gaap--EquityOwnershipPercentageExcludingConsolidatedEntityAndEquityMethodInvestee_iI_pid_dp_uPure_c20250228__us-gaap--TypeOfArrangementAxis__custom--MembershipPurchaseAgreementMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--FSATravelLLCMember_zqCu082XJZSi">49</span>% investment in FSA at $<span id="xdx_901_eus-gaap--BusinessAcquisitionPreacquisitionContingencyAmountOfSettlement_iI_c20250228__us-gaap--TypeOfArrangementAxis__custom--MembershipPurchaseAgreementMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--FSATravelLLCMember_zuhACkyCc3ci" title="Business acquisition amount">1,000,000</span>. This amount includes $<span id="xdx_903_eus-gaap--BusinessCombinationContingentConsiderationAsset_iI_c20250228__us-gaap--TypeOfArrangementAxis__custom--MembershipPurchaseAgreementMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--FSATravelLLCMember_zgSP8xRQODil" title="Business acquisition  consideration cash">500,000</span> in cash
and $<span id="xdx_900_eus-gaap--BusinessCombinationContingentConsiderationAsset_iI_c20250228__us-gaap--TypeOfArrangementAxis__custom--MembershipPurchaseAgreementMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--FSATravelLLCMember__us-gaap--StatementClassOfStockAxis__custom--SeriesOPreferredStockMember_zl8ndLJ5AvNg" title="Business acquisition  consideration cash">500,000</span> in Series O Preferred shares. The carrying amount of the equity method investment will be adjusted based on the Company&#8217;s
share of FSA&#8217;s earnings or losses, in accordance with the equity method of accounting. The milestones and contingent consideration
payments, including the additional $<span id="xdx_909_eus-gaap--BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCosts_iI_c20250228__us-gaap--TypeOfArrangementAxis__custom--MembershipPurchaseAgreementMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--FSATravelLLCMember_zyHgXJuKdZ5f" title="Business acquisition additional amount">1,000,000</span> to acquire the remaining <span id="xdx_90E_eus-gaap--InvestmentInterestRatePaidInCash_iI_pid_dp_uPure_c20250228__us-gaap--TypeOfArrangementAxis__custom--MembershipPurchaseAgreementMember__dei--LegalEntityAxis__custom--FSATravelLLCMember_zeSYLOpWPy02">51</span>% interest, will be recognized in the future if, as, and when
the conditions for such payments are satisfied.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
total potential commitment for the Company under the FSA Purchase Agreement, assuming the satisfaction of all conditions and the
exercise of the option to acquire the remaining <span id="xdx_902_eus-gaap--InvestmentInterestRatePaidInCash_iI_pid_dp_uPure_c20250228__us-gaap--TypeOfArrangementAxis__custom--MembershipPurchaseAgreementMember__dei--LegalEntityAxis__custom--NextTripMember_zzhZ21BWDPSj">51</span>%
interest, is $<span id="xdx_90E_eus-gaap--PaymentsToAcquireBusinessesAndInterestInAffiliates_c20250228__20250228__us-gaap--TypeOfArrangementAxis__custom--MembershipPurchaseAgreementMember__dei--LegalEntityAxis__custom--NextTripMember_zEp6yDsJxHtb" title="Business acquisition additional amount">2,800,000</span>.
This includes $<span id="xdx_901_eus-gaap--PaymentsToAcquireBusinessesAndInterestInAffiliates_c20250228__20250228__us-gaap--TypeOfArrangementAxis__custom--MembershipPurchaseAgreementMember_z2jaaqCZkEuh" title="Business acquisition additional amount">1,000,000</span>
already paid for the <span id="xdx_90B_eus-gaap--EquityOwnershipPercentageExcludingConsolidatedEntityAndEquityMethodInvestee_iI_pid_dp_uPure_c20250228__us-gaap--TypeOfArrangementAxis__custom--MembershipPurchaseAgreementMember_zU2uuJy4lbGb">49</span>%
interest in FSA, $<span id="xdx_901_eus-gaap--PaymentsToAcquireBusinessesAndInterestInAffiliates_c20250228__20250228__us-gaap--TypeOfArrangementAxis__custom--MembershipPurchaseAgreementMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--NextTripMember_zAakq6b8sXz4" title="Business acquisition additional amount">1,000,000</span>
payable by the Company in the event that it exercises its option to acquire the remaining <span id="xdx_905_eus-gaap--InvestmentInterestRatePaidInCash_iI_pid_dp_uPure_c20250228__us-gaap--TypeOfArrangementAxis__custom--MembershipPurchaseAgreementMember__dei--LegalEntityAxis__custom--NextTripMember_zVwV0o3plrbj">51</span>%
of interests in FSA, and $<span id="xdx_90D_ecustom--BusinessAcquisitionMilestonePayments_iI_c20250228__us-gaap--TypeOfArrangementAxis__custom--MembershipPurchaseAgreementMember_z1wmXjB9Tgj5" title="Milestone payments">800,000</span>
for the milestone payments associated with the acquisition of the remaining interests.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Summarized
Financial Information for FSA Travel, LLC</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_89A_eus-gaap--EquityMethodInvestmentsTextBlock_zgVv5JxPm8S8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">FSA
Travel&#8217;s fiscal year ends on December 31. As of and for the year ended December 31, 2024, unaudited summarized financial
information for FSA is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BA_zlKZQgby6RVe" style="display: none">Schedule
of Unaudited Summarized Financial Information</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_493_20241231__dei--LegalEntityAxis__custom--FSATravelLLCMember_zB2Y60wOH5Vi" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">December 31,</p>
                                                                               <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">2024</p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--AssetsCurrent_iI_zCdkziM07QYb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 78%; text-align: left">Current assets</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right">13,629</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--AssetsNoncurrent_iI_zNAqslBORhIk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Non-current assets</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">577,776</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--LiabilitiesCurrent_iI_zSXOMmfed4H5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Current liabilities</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">12,452</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--LiabilitiesNoncurrent_iI_zIq6Zjv4hvYa" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Non-current liabilities</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">199,100</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--StockholdersEquity_iI_zZWVpEs6pGl4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Member&#8217;s equity</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">379,852</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Net revenues</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_907_eus-gaap--Revenues_c20240101__20241231__dei--LegalEntityAxis__custom--FSATravelLLCMember_zWL53lViRExk" title="Net revenues">374,143</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Gross profit</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90C_eus-gaap--GrossProfit_c20240101__20241231__dei--LegalEntityAxis__custom--FSATravelLLCMember_z6tp6d7RJNI2" title="Gross profit">374,143</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Net loss</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_905_eus-gaap--NetIncomeLoss_c20240101__20241231__dei--LegalEntityAxis__custom--FSATravelLLCMember_zYKrNYjeG0ni" title="Net loss">(252,381</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  </table>

<p id="xdx_8A4_zNyhCz8xN6Mf" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for equity method investments and joint ventures. Equity method investments are investments that give the investor the ability to exercise significant influence over the operating and financial policies of an investee. Joint ventures are entities owned and operated by a small group of businesses as a separate and specific business or project for the mutual benefit of the members of the group.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478156/740-323-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Topic 323<br> -Publisher FASB<br> -URI https://asc.fasb.org/323/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investment in Equity Securities<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Feb. 28, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock', window );">Investment in Equity Securities</a></td>
<td class="text"><p id="xdx_803_eus-gaap--InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_zk1spcvuT7k3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
5 - <span id="xdx_820_zRjrY1NKPcH9">Investment in Equity Securities</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Investment
in Blue Fysh Holdings Inc</i>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 24, 2025, the Company entered into a Share Exchange Agreement with Blue Fysh Holdings Inc. (&#8220;Blue Fysh&#8221;), under
which the Company acquired a <span id="xdx_90F_eus-gaap--EquityOwnershipPercentageExcludingConsolidatedEntityAndEquityMethodInvestee_iI_pid_dp_uPure_c20250224__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__dei--LegalEntityAxis__custom--BlueFyshHoldingsIncMember_zaWvJzjAQ25k">10</span>% ownership interest in Blue Fysh. As part of the transaction, the Company issued <span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20250224__20250224__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__dei--LegalEntityAxis__custom--BlueFyshHoldingsIncMember__us-gaap--StatementClassOfStockAxis__custom--SeriesNNonvotingConvertiblePreferredStockMember_zRCl6t2mIp1h" title="Number of shares issued">483,000</span> shares of Series
N Nonvoting Preferred at an issuance price of $<span id="xdx_903_eus-gaap--SharesIssuedPricePerShare_iI_c20250224__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__dei--LegalEntityAxis__custom--BlueFyshHoldingsIncMember__us-gaap--StatementClassOfStockAxis__custom--SeriesNNonvotingConvertiblePreferredStockMember_zW6i30bGo65b" title="Shares issued price per share">5.00</span> per share, totaling $<span id="xdx_906_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20250224__20250224__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__dei--LegalEntityAxis__custom--BlueFyshHoldingsIncMember__us-gaap--StatementClassOfStockAxis__custom--SeriesNNonvotingConvertiblePreferredStockMember_zUrODtjF2Y3c" title="Shares issued value">2,415,000</span>, in exchange for <span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20250224__20250224__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__dei--LegalEntityAxis__custom--BlueFyshHoldingsIncMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_z9hh8JaoSN83" title="Number of shares issued">82</span> restricted shares
of Blue Fysh common stock. The transaction closed on February 28, 2025.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s investment in Blue Fysh is accounted for under the cost method, as the Company does not have significant influence over
Blue Fysh. No board appointments are contemplated as part of this transaction; however, the Company has the right to appoint a representative
to the Blue Fysh Advisory Committee, which will allow the Company to receive financial updates as needed and to be informed of financial
events that could significantly impact the Company&#8217;s ownership position.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since
the Company&#8217;s ownership interest does not meet the criteria for significant influence pursuant to ASC 323, this investment is classified
as an equity security without a readily determinable fair value and is initially recorded at cost. The Company will assess the investment
for impairment in future periods and recognize any impairment losses as necessary.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for investments in certain debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 940<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/940-320/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Regulation S-K (SK)<br> -Number 229<br> -Section 1403<br> -Paragraph b<br> -Publisher SEC<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/320/tableOfContent<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-10<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6B<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6B<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/942-320/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Prepaid and Other Current Assets<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Feb. 28, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_DisclosurePrepaidAndOtherCurrentAssetsAbstract', window );"><strong>Prepaid And Other Current Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_PrepaidExpensesAndOtherCurrentAssetsTextBlock', window );">Prepaid and Other Current Assets</a></td>
<td class="text"><p id="xdx_80A_ecustom--PrepaidExpensesAndOtherCurrentAssetsTextBlock_z3tgxJoRgvZb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
6 - <span id="xdx_821_zMmrmVtuVkN3">Prepaid and Other Current Assets</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_895_eus-gaap--DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_zzd2qGLq0dEf" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prepaid
and other current assets consisted of the following as of February 28, 2025 and as of February 29, 2024:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span><span id="xdx_8B9_zZ9LwnoUVML1" style="display: none">Schedule
of Prepaid and Other Current Assets</span></span></span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_493_20250228_zaA7VLr6hEd7" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">February 28,</p>
                                                                               <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">2025</p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49E_20240229_z4C2EE7B1Xm" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">February 29,</p>
                                                                               <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">2024</p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--PrepaidOfferingCosts_iI_maPEAOAzw6s_znFtiZY5Fzd2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: justify">Offering costs</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">100,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0966">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_ecustom--PrepaidConsultingContract_iI_maPEAOAzw6s_zAVhaLKZoOG4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Current portion of two-year strategic consulting contract</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">733,575</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0969">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_ecustom--PrepaidCostOfSales_iI_maPEAOAzw6s_z8dUu9C15iIl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Cost of sales</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">121,588</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">42,547</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--OtherPrepaidExpenseCurrent_iI_maPEAOAzw6s_zEO9vZ7unnL" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Other expenses</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">425,412</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">298,274</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--PrepaidAdvertising_iI_maPEAOAzw6s_zpQz10yOyLk8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 1pt">Marketing expenses</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0977">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">100</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_iTI_mtPEAOAzw6s_z2yNbqhBQOy5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 2.5pt">Total</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">1,380,575</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">340,921</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A7_zgXt3pMmAJa4" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_DisclosurePrepaidAndOtherCurrentAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_DisclosurePrepaidAndOtherCurrentAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_PrepaidExpensesAndOtherCurrentAssetsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Prepaid Expenses and Other Current Assets [Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_PrepaidExpensesAndOtherCurrentAssetsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Feb. 28, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">Property and Equipment</a></td>
<td class="text"><p id="xdx_80E_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_zMTpp6N84Goh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
7 - <span id="xdx_829_zPDHFk9aODM9">Property and Equipment</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_891_eus-gaap--PropertyPlantAndEquipmentTextBlock_z6SunUFoOwGj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property
and equipment as of February 28, 2025 and February 29, 2024 consisted of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BF_zEtJj1gNIcbg" style="display: none">Schedule
of Property and Equipment</span></span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_490_20250228_zWpUUeXWrJNb" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">February 28,</p>
                                                                               <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">2025</p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_497_20240229_zyYAsYQPn3A5" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">February 29,</p>
                                                                               <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">2024</p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zYTS5IqlbML3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left">Furniture and Fixtures</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">17,018</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">17,018</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_zXutqmKqqjGj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Computer and Equipment</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">80,786</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">82,492</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--PropertyPlantAndEquipmentGross_iI_maPPAENzyNw_zvY3v3iwVE74" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">Total</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">97,804</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">99,510</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_di_msPPAENzyNw_zMcYamBJ0cA6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Accumulated depreciation</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(93,685</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(92,868</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_40C_eus-gaap--PropertyPlantAndEquipmentNet_iTI_mtPPAENzyNw_zs6xEA8hJwX7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Property and Equipment, net of depreciation</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">4,119</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">6,642</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8AC_zp7QT4rzrdS7" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation
expense for the years ended February 28, 2025, and February 29, 2024 was $<span id="xdx_904_eus-gaap--Depreciation_c20240301__20250228_zvlqpnbQtuDk" title="Depreciation expense">1,434</span> and $<span id="xdx_906_eus-gaap--Depreciation_c20230301__20240229_z4CJhKlIg4hf" title="Depreciation expense">18,838</span>, respectively, and is recorded in operating
expenses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the years ended February 28, 2025 and February 29, 2024, the Company acquired property and equipment of $<span id="xdx_90D_eus-gaap--PaymentsToAcquirePropertyPlantAndEquipment_dxL_c20240301__20250228_z40WmMzunsv" title="Property and equipment::XDX::-"><span style="-sec-ix-hidden: xdx2ixbrl1006">0</span></span> and $<span id="xdx_908_eus-gaap--PaymentsToAcquirePropertyPlantAndEquipment_c20230301__20240229_zbTQ3DkdSAMe" title="Property and equipment">9,253</span>, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/360/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477798/958-360-50-6<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477798/958-360-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477798/958-360-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Feb. 28, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsDisclosureTextBlock', window );">Intangible Assets</a></td>
<td class="text"><p id="xdx_808_eus-gaap--IntangibleAssetsDisclosureTextBlock_z4mPR0KbQZAf" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
8 - <span id="xdx_820_zTJZLaMb9ES1">Intangible Assets</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_897_eus-gaap--ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_zMzuwzsxZmVb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangible
assets as of February 28, 2025, and February 29, 2024 consisted of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B9_zcVqzSqgiiBl" style="display: none">Schedule
of Intangible Assets</span></span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_491_20250228_zMGiNaZmXL5b" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">February 28,</p>
                                                                               <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">2025</p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_497_20240229_zetU7acUGT5k" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">February 29,</p>
                                                                               <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">2024</p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_hus-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareDevelopmentMember_zekzs3dSm5ml" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left">Software Development</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">7,267,778</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">6,602,028</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_hus-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SoftwareLicenseMember_zWrgLBaj59K" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Software Licenses</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">789,576</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">789,576</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_hus-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksMember_z50dLyO1uDDg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">Trademark</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">6,283</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">6,283</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_maIANEGzjZg_zeOpXEg4tvac" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">Total</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">8,063,637</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">7,397,887</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iNI_di_msIANEGzjZg_zOR1s54bfor5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Accumulated amortization</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(5,936,269</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(5,224,467</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_40A_eus-gaap--IntangibleAssetsNetExcludingGoodwill_iTI_mtIANEGzjZg_zMNY8S7Av56d" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Intangible assets, net of amortization</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">2,127,368</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">2,173,420</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8AA_ztSc7ffpHbN1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amortization
expense for the years ended February 28, 2025 and February 29, 2024 was $<span id="xdx_901_eus-gaap--AmortizationOfIntangibleAssets_c20240301__20250228_z1z7BDzi649j" title="Amortization">711,802</span>
and $<span id="xdx_90E_eus-gaap--AmortizationOfIntangibleAssets_c20230301__20240229_zBXe78p2Qr8b" title="Amortization">1,449,925</span>,
respectively, and is recorded in operating expenses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the years ended February 28, 2025 and February 29, 2024, the Company recorded no impairment losses associated with the carrying value
exceeding its recoverable amount.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p id="xdx_890_eus-gaap--ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_zxtda79nCq13" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
estimated aggregate amortization expense for each of the succeeding years ending February 28 is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b><span id="xdx_8BF_zK8DGd5XDLF7" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Schedule
of estimated aggregate amortization expense</span></span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%">
  <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td id="xdx_492_20250228_zvwRmE3Hy06d" style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr>
<tr id="xdx_400_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_iI_maFLIANzgGq_zmX8Le2zIXee" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 78%; text-align: left">2025</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right">597,914</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_iI_maFLIANzgGq_zlGpJjXF1bSi" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">2026</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">623,882</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_iI_maFLIANzgGq_zIvT3DmfbQ46" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">2027</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">312,358</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_iI_maFLIANzgGq_zlLijaxGX7W3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">2028</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">528</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_ecustom--FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour_iI_maFLIANzgGq_zSd01zuCTb31" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Thereafter</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1046">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_mtFLIANzgGq_zLFRe29Qm969" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">1,534,682</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A6_zTFjqqWrscsa" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all or part of the information related to intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/350-30/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/985-20/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Feb. 28, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillDisclosureTextBlock', window );">Goodwill</a></td>
<td class="text"><p id="xdx_801_eus-gaap--GoodwillDisclosureTextBlock_zWPMFJypXXB3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
9 &#8211; <span id="xdx_829_zVVnxALhjXHc">Goodwill</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
discussed in <b>Note 1&#8211; Business Description and Going Concern</b>, the legal acquisition of NTH by the Company was determined to be a reverse acquisition, with NTH as the accounting acquirer, using the acquisition method of accounting
in accordance with ASC 805, Business Combinations. Under this method of accounting, the purchase price was allocated to the assets acquired
and liabilities assumed based upon their estimated fair values at the date of consummation of the transaction.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table presents the allocation of the $<span id="xdx_900_eus-gaap--BusinessCombinationConsiderationTransferred1_c20231012__20231012__us-gaap--BusinessAcquisitionAxis__custom--SigmaAdditiveSolutionsIncMember_zW6FAhvFKOug" title="Consideration transferred">2,368,418</span>
consideration for the acquisition and summarizes the estimated fair values of the Sigma (the accounting acquiree) assets acquired
and liabilities assumed for NTH (the accounting acquirer). The estimated consideration of approximately $<span id="xdx_904_eus-gaap--BusinessCombinationConsiderationTransferred1_c20231012__20231012__us-gaap--BusinessAcquisitionAxis__custom--SigmaAdditiveSolutionsIncMember_zRSV2kBwEe62" title="Consideration transferred">2,368,418</span>
is based on Sigma&#8217;s closing share price of $<span id="xdx_906_eus-gaap--BusinessAcquisitionSharePrice_iI_pid_c20231012__us-gaap--BusinessAcquisitionAxis__custom--SigmaAdditiveSolutionsIncMember_z8YJRkGf8PSb" title="Share price">3.0229,</span>
as reported on Nasdaq on December 29, 2023 multiplied by the <span id="xdx_90A_eus-gaap--CommonStockSharesOutstanding_iI_c20231012_zPDW0LbjsEVg" title="Shares outstanding">780,423</span>
shares outstanding as of that date and the fair value of Series E Preferred Stock (on an as converted basis) into <span id="xdx_904_eus-gaap--CommonStockSharesOutstanding_iI_c20231012__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesEPreferredStockMember_zBjDxbkcvl42" title="Shares outstanding">3,069</span>
common shares.</span></p>

<p id="xdx_89C_eus-gaap--ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_zDnofmYiEA1d" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BB_zX19U9Pi4bTl" style="display: none">Schedule
of Fair Value of Assets Acquired</span></span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
  <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td>
    <td colspan="2" id="xdx_495_20231012__us-gaap--BusinessAcquisitionAxis__custom--SigmaAdditiveSolutionsIncMember_zzmncsXgk2P3" style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td colspan="5" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Fair Value of Net Assets Acquired:</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_iI_maBCRIAzMVe_zYkg02IIjFDb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 78%">Cash</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right">417,121</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_iI_maBCRIAzMVe_z15YejLtQxk9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Accounts Receivable, net</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">4,900</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_iI_maBCRIAzMVe_zQWARQWVfXci" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">Inventory</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">257,873</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_iI_maBCRIAzMVe_zL1FXHlImNyg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Prepaid expenses and other current assets</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">50,802</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_iI_maBCRIAzMVe_z3g28zCwuAf4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Property and equipment</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">52,357</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_iI_maBCRIAzMVe_z6ftHVRcBZg7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Intangible assets</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">1,277,919</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_iNI_di_msBCRIAzMVe_zpye9vMBtYE1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Accounts payable</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(837,450</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr id="xdx_403_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses_iNI_di_msBCRIAzMVe_zV7kmVYEqlQ7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Accrued expenses</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(61,001</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr id="xdx_402_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_iNI_di_msBCRIAzMVe_zEkqA9FU2eYj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Deferred revenue</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(14,218</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iTI_mtBCRIAzMVe_maBCRIAzevg_z0KXangQ1Emi" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Total identifiable net assets acquired</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">1,148,303</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--Goodwill_iI_maBCRIAzevg_z0xwSYYEs4Je" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">Goodwill</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">1,220,115</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_iTI_mtBCRIAzevg_zXBJU8hxiP4e" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Total Fair Value of Net Assets Acquired</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right">2,368,418</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Total Purchase Consideration</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_985_eus-gaap--BusinessCombinationConsiderationTransferred1_c20231012__20231012__us-gaap--BusinessAcquisitionAxis__custom--SigmaAdditiveSolutionsIncMember_zcZftK0JDz8j" style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right">2,368,418</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A0_zczo4MRxO5Hl" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to ASC 350-20, the Company assigned its goodwill to reporting units and is required to test each reporting unit&#8217;s goodwill for
impairment at least on an annual basis and between annual tests if an event occurs or circumstances change that would more likely
than not reduce the fair value of a reporting unit below its carrying amount. The goodwill resulting from the reverse acquisition is
primarily attributable to NTH&#8217;s objective to obtain access to public markets to provide funding wherewithal to fund business
growth. NTH&#8217;s benefit in paying for these synergies in the reverse acquisition transaction are to avoid the time and expense
of organizing and executing an Initial Public Offering transaction. In the reverse acquisition, $<span id="xdx_902_eus-gaap--GoodwillPeriodIncreaseDecrease_c20231012__20231012__us-gaap--BusinessAcquisitionAxis__custom--SigmaAdditiveSolutionsIncMember_zi5bC55rUBYa" title="Goodwill">52,310</span>
of goodwill was allocated to the Sigma Reporting Unit (as defined below) and $<span id="xdx_90B_eus-gaap--GoodwillPeriodIncreaseDecrease_c20231012__20231012__us-gaap--BusinessAcquisitionAxis__custom--NextTripHoldingsIncMember_z6OXPWNwWl83" title="Goodwill">1,167,805</span>
of goodwill was allocated to the NTH Reporting Unit (as defined below) under the acquisition method of accounting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
combined Company consists of two reporting units, Sigma (the &#8220;Sigma Reporting Unit&#8221;) and NTH (the &#8220;NTH Reporting
Unit&#8221;). As the accounting acquirer in the reverse acquisition, NTH is considered to be an existing reporting unit and Sigma is
considered to be a new reporting unit in that it is not in the same business as NTH. Accordingly, the reverse acquisition creates a
new reporting unit which holds the Sigma business, constituting an asset held for sale as a result of the agreement for the sale of
certain legacy Sigma assets to Divergent for a sales price of $<span id="xdx_900_eus-gaap--PaymentsToAcquireIntangibleAssets_c20231012__20231012__dei--LegalEntityAxis__custom--DivergentTechnologiesIncMember_ziJtjLwFy6Zi" title="Purchase price">1,626,242</span>.
As such, the fair value of the Sigma Reporting Unit is determined to be $<span id="xdx_900_eus-gaap--PaymentsToAcquireIntangibleAssets_c20231012__20231012__dei--LegalEntityAxis__custom--DivergentTechnologiesIncMember_zBatN4lIfTFe" title="Purchase price">1,626,242</span>,
with the difference of $<span id="xdx_90C_eus-gaap--BusinessCombinationConsiderationTransferred1_c20231012__20231012__us-gaap--BusinessAcquisitionAxis__custom--NextTripHoldingsIncMember_zTcxU0mfMXnb" title="Purchase consideration">742,176</span>
from the purchase consideration being allocated to the NTH Reporting Unit. The assets sold to Divergent and the
liabilities relieved from the Divergent transaction are assigned to the Sigma Reporting unit with the difference between the
net fair value of those assets and liabilities and the Sigma Reporting Unit being assigned to goodwill. The goodwill being assigned
to the NTH Reporting Unit is determined by the difference between the purchase consideration assigned to the NTH Reporting
Unit and the net acquired Sigma assets and liabilities assumed that are assigned to the NTH Reporting Unit. A gain of $<span id="xdx_906_eus-gaap--GainLossOnDispositionOfAssets_c20231012__20231012_zEoTtbZ4IOCh" title="Gain on disposition transaction">37,592</span>
was recognized in the disposition transaction.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482548/350-20-55-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/350-20/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accounts Payable and Accrued Liabilities<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Feb. 28, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock', window );">Accounts Payable and Accrued Liabilities</a></td>
<td class="text"><p id="xdx_80D_eus-gaap--AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_z7y9rYBML4o7" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
10 - <span id="xdx_825_zJ9fAe9YNBbf">Accounts Payable and Accrued Liabilities</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of February 28, 2025, the Company had accounts payable of $<span id="xdx_907_eus-gaap--AccountsPayableCurrentAndNoncurrent_iI_c20250228_zryYUIlMxoT8" title="Accounts payable">1,184,404</span> and accrued expenses of $<span id="xdx_90D_eus-gaap--AccruedLiabilitiesCurrentAndNoncurrent_iI_c20250228_zOPT2vJQ7Gq3" title="Accrued expenses">721,382</span>, compared to $<span id="xdx_905_eus-gaap--AccountsPayableCurrentAndNoncurrent_iI_c20240229_znbiVZ0aUmH2" title="Accounts payable">531,847</span> of accounts
payable and $<span id="xdx_90B_eus-gaap--AccruedLiabilitiesCurrentAndNoncurrent_iI_c20240229_z11rWuyggAGf" title="Accrued expenses">460,768</span> of accrued expenses for the year ended February 29, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 720<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483384/720-30-45-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Feb. 28, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text"><p id="xdx_802_eus-gaap--IncomeTaxDisclosureTextBlock_zAMEfinEtRp8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
11 &#8211; <span id="xdx_821_zRvcjmT4d2N5">Income Taxes</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for income taxes in accordance with ASC Topic No. 740. This standard requires the Company to provide a net deferred
tax asset or liability equal to the expected future tax benefit or expense of temporary reporting differences between book and tax
accounting methods and any available net operating loss or tax credit carryforwards. Income tax returns open for examination by the
Internal Revenue Service consist of tax years ended February 28, 2021 through 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company had available at February 28, 2025 unused operating loss carryforwards of approximately $<span id="xdx_90A_eus-gaap--OperatingLossCarryforwards_iI_c20250228_zSA0W3b79QS8" title="Operating loss carryforwards">54,763,000</span>, which may be applied against
future taxable income. Losses incurred between 2010 and 2017, which total $<span id="xdx_900_eus-gaap--OperatingLossCarryforwards_iI_c20171231_zmYP2WgUOpP6" title="Operating loss carryforwards">9,820,000</span>, expire in various years through 2038, and the remainder
of the losses, which total $<span id="xdx_90A_ecustom--OperatingLossCarryforwardsRemainder_iI_c20250228_z5GAdPXg45Kc" title="Operating loss carryforwards remainder">44,943,000</span>, can be carried forward indefinitely. Due to the change in ownership provisions of the Tax Reform
Act of 1986, net operating loss carryforwards for Federal income tax reported purposes are subject to annual limitations. Due to the
change in ownership as a result of the reverse acquisition, the Company&#8217;s net operating loss carryforwards may be limited as to
use in future years, and any such limitation will be determined on a year-to-year basis. The amount and ultimate realization of the
benefits from the operating loss carryforwards for income tax purposes is dependent, in part, upon the tax laws in effect, the future
earnings of the Company and other future events, the effects of which cannot be determined. Because of the uncertainty surrounding the
realization of the loss carryforwards, the Company has established a valuation allowance equal to the tax effect of the loss carryforwards
and other temporary differences of approximately $<span id="xdx_904_eus-gaap--DeferredTaxAssetsValuationAllowance_iI_c20250228_zXMxl7FIKd6h" title="Valuation allowance loss carryforwards">11,816,400</span> and $<span id="xdx_900_eus-gaap--DeferredTaxAssetsValuationAllowance_iI_c20240229_zqO5bIbmUTp" title="Valuation allowance loss carryforwards">11,250,300</span> at February 28, 2025, and February 29, 2024, respectively,
and, therefore, no deferred tax asset has been recognized for the loss carryforwards.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_89C_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zm5FVERFSJ79" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred
tax assets are comprised of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BA_zjS1RXDG8JMl" style="display: none">Schedule of Deferred Tax Assets</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_497_20250228_zMJ3N7S1jjIh" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">2025</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49C_20240229_zhx5HdvLifX5" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">2024</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Deferred tax assets:</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_pp0p0_maDTANzaXy_z7BPBcuMa4j6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left">NOL carryover</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">11,500,300</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">9,226,100</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--DeferredTaxAssetDepreciation_iI_pp0p0_maDTANzaXy_zpGYk1ZOToF6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Related party accruals</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">12,900</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">173,900</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_ecustom--DeferredTaxAssetsPayrollAccruals_iI_pp0p0_maDTANzaXy_zwCIXWVDgPE9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Payroll accruals</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">47,800</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">77,800</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Deferred tax liabilities:</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_ecustom--DeferredTaxLiabilitiesDepreciation_iNI_di_msDTANzaXy_z3CrokXutTlk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">Depreciation</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">255,400</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">1,772,500</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_di_msDTANzaXy_zB3Dn34YPKJe" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Valuation allowance</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(11,816,400</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(11,250,300</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_40E_eus-gaap--DeferredTaxAssetsNet_iTI_pp0p0_mtDTANzaXy_zmyZXff2Z04a" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Net deferred tax asset (liability)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1140">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1141">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8AD_zLxZyXncLAHj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
reconciliation of the provision for income taxes computed at the U.S. federal statutory tax rate (<span id="xdx_90F_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pid_dp_uPure_c20240301__20250228_zTwd4Tos7Jcj" title="Federal statutory tax rate"><span id="xdx_908_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pid_dp_uPure_c20230301__20240229_zKEATpMRAFKj" title="Federal statutory tax rate">21</span></span>%) to the Company&#8217;s effective
tax rate for the years ended February 28, 2025, and February 29, 2024 is as follows:</span></p>

<p id="xdx_894_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_z1nA8U21pNwd" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BE_zVTgBR51BTI" style="display: none">Schedule
of Reconciliation of Provision for Income Taxes</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49E_20240301__20250228_zGywL4iFe0Kh" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">2025</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_498_20230301__20240229_zF6BxogVbtue" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">2024</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_404_ecustom--EffectiveIncomeTaxRateReconciliationBookLoss_maITEBzMQv_zQlIL8hoKUDf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left">Book loss</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">(2,141,700</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">(1,541,200</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">)</td></tr>
  <tr id="xdx_40C_eus-gaap--IncomeTaxReconciliationNondeductibleExpenseDepreciation_maITEBzMQv_zfkiHKDQ2hk7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">Depreciation</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(197,100</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">270,100</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment_maITEBzMQv_zsvIGW2gXn6f" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Meals &amp; entertainment</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1155">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">300</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_ecustom--IncomeTaxReconciliationNondeductibleExpensePreferredDividends_maITEBzMQv_z5S1j75qjE8g" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Preferred dividends</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">16,506</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">422,842</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_ecustom--IncomeTaxReconciliationNondeductibleExpenseLossOnNextPlayNoteReceivable_maITEBzMQv_zZHdbst94oE5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Loss on NextPlay note receivable</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><p style="margin: 0">210,000</p></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><p style="margin: 0"><span style="-sec-ix-hidden: xdx2ixbrl1162">-</span></p></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_maITEBzMQv_zBx7diM0508d" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Stock compensation</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">14,254</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">24,468</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_ecustom--IncomeTaxReconciliationNondeductibleExpenseLossOnAssetDisposal_maITEBzMQv_zIsiJttSawak" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Loss on asset disposal</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">229</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">67,274</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_ecustom--IncomeTaxReconciliationNondeductibleExpenseAccruedPayroll_maITEBzMQv_zl7vdpLM9dDb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Accrued payroll</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(29,991</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">51,857</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_ecustom--IncomeTaxReconciliationNondeductibleExpenseRelatedPartyAccruals_maITEBzMQv_zSajqfDyM3ac" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Related party accruals</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(161,018</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">114,928</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_maITEBzMQv_z8zXFDg5og7a" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Change in valuation allowance</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">2,288,820</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">589,431</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--IncomeTaxExpenseBenefit_iT_pp0p0_mtITEBzMQv_zCxHBGqrRx7a" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Provision for Income Taxes</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1179">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1180">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A9_zH8XhtFGojgd" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income tax.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12C<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12B<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 270<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477891/740-270-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.5.Q1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-13<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/740/tableOfContent<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-14<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-21<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-17<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482603/740-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Notes Payable<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Feb. 28, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Notes Payable</a></td>
<td class="text"><p id="xdx_80B_eus-gaap--DebtDisclosureTextBlock_zJycisDhM7kj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
12 &#8211; <span id="xdx_82A_zKmZC7DCvcz3">Notes Payable</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 24, 2024, the Company sold a short-term promissory note to a private investor in the aggregate principal amount of $<span id="xdx_90B_eus-gaap--ProceedsFromConvertibleDebt_c20240524__20240524_zBEAX7ZtzvLl" title="Proceeds from convertible debt">100,000</span>. The
note bears interest at <span id="xdx_907_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20240524_zrgztgDt5oV6" title="Interest rate">7.5%</span> per annum and had a maturity date of the earlier of completion of a public financing or October 31, 2024.
The investor has consented to extend the maturity date on a month-to-month basis and continues to accrue interest. As of February 28,
2025, the full principal amount of $<span id="xdx_902_eus-gaap--ProceedsFromConvertibleDebt_c20250228__20250228_zJMqQv5AfXT5" title="Proceeds from convertible debt">100,000</span> was outstanding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 26, 2024, the Company sold a short-term promissory note to a private investor in the aggregate principal amount of $<span id="xdx_902_eus-gaap--ProceedsFromConvertibleDebt_c20240626__20240626_zI2ZfkH51vMd" title="Proceeds from convertible debt">40,000</span>. The
note bears interest at <span id="xdx_90E_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20240626_zgfW4BoE5CYb" title="Interest rate">7.5%</span> per annum and has a maturity date of June 25, 2025, which may be extended by written consent of the investor.
As of February 28, 2025, the full principal amount of $<span id="xdx_901_eus-gaap--DebtInstrumentFaceAmount_iI_c20250228_zxsaPosbe7Y5" title="Proceeds from convertible debt">40,000</span> was outstanding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 19, 2024, the Company sold a short-term promissory note and warrants to Alumni Capital for total consideration of $<span id="xdx_901_eus-gaap--NotesAndLoansPayableCurrent_iI_c20240919__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_z0C93Fxfrkh1">250,000</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.
After deducting commissions, net proceeds to the Company were $<span id="xdx_904_eus-gaap--ProceedsFromNotesPayable_c20240919__20240919__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_z4FHdwt6KMi2">230,000</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">. </span>The
Alumni Note is in the principal amount of $<span id="xdx_908_eus-gaap--DebtInstrumentFaceAmount_iI_c20240919__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zCWCosv8eXC2">300,000</span>
with an original issue discount of $<span id="xdx_90D_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_c20240919__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zeOR7C3q0v5g">50,000</span>
and guaranteed interest on the principal amount of <span id="xdx_908_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20240919__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zlVVaRo5Bd4k">10%</span>
per annum which shall be due and payable on <span id="xdx_909_eus-gaap--DebtInstrumentMaturityDate_c20240919__20240919__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_z9Ow7VXcrnO4">December
19, 2024</span>. In the event of a failure to re-pay the Alumni Note on or before December 19, 2024, the interest rate will increase
to the lesser of twenty-two percent (<span id="xdx_902_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20240919__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--RangeAxis__srt--MaximumMember_zAftHR1QEATh">22%</span>)
per annum or the maximum amount permitted under law from the due date thereof until the same is paid. The Alumni Note is convertible
into common stock of the Company only upon an event of default. In accordance with ASC 470-20-25-2, the proceeds of the short-term
promissory note was allocated to the note and the warrant based on the relative fair values of the note without the warrants and of
the warrant itself at time of issuance, with the portion of the proceeds allocated to the warrants accounted for as paid-in capital,
and the remainder of the proceeds allocated to the note. The relative fair value of the warrants at the time of issuance that was
allocated to additional paid-in capital was $<span id="xdx_90C_eus-gaap--AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_c20240919__20240919_zNOGirYXAju4" title="Warrants additional paid in capital">116,322</span>. The Alumni note and accrued interest was repaid on December 19, 2024.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 18, 2024, the Company sold a short-term promissory note to 1800 Diagonal Lending LLC in the aggregate principal amount of $<span id="xdx_90B_eus-gaap--DebtInstrumentFaceAmount_iI_c20241018__us-gaap--TypeOfArrangementAxis__custom--NoteSecuritiesPurchaseAgreementMember_zWr2I6la4A2c" title="Principal amount">154,440</span>.
The note includes an Original Issue Discount of $<span id="xdx_901_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_c20241018__us-gaap--TypeOfArrangementAxis__custom--NoteSecuritiesPurchaseAgreementMember_z51Qe94BOfR4" title="Original issue discount">22,440</span>, and bears a one-time interest charge of <span id="xdx_903_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20241018__us-gaap--TypeOfArrangementAxis__custom--NoteSecuritiesPurchaseAgreementMember_zftE50q6jJ9g" title="Interest rate">13%</span>, which was applied on the issuance
date to the principal. The note is payable in ten equal installments of $<span id="xdx_902_ecustom--ConvertibleNotesPayableOfInstallments_iI_c20241018_z3eNQ8RVoR6" title="Note payable equal installments">17,452</span> beginning on November 15, 2024, and may be prepaid at
any time with no prepayment penalty. Upon the event of default by the Company, any unpaid principal and interest may be converted to
common stock at the election of 1800 Diagonal Lending LLC. As of February 28, 2025, the balance on the note, net of the unamortized debt
discount, was $<span id="xdx_903_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_c20250228_zNLJLhdwZzW6" title="Unamortized debt discount">80,114</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 1, 2024, the Company sold a short-term promissory note to a private investor in the aggregate principal amount of $<span id="xdx_908_eus-gaap--NotesAndLoansPayableCurrent_iI_c20241101__us-gaap--TypeOfArrangementAxis__custom--ShortTermPromissoryNoteMember_z5xR8xUFqdCe" title="Total consideration">250,000</span>.
The note bears guaranteed interest of <span id="xdx_909_eus-gaap--DebtInstrumentInterestRateEffectivePercentage_iI_c20241101_zIgqTZj01r95">15%</span>, or $<span id="xdx_900_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_c20241101__us-gaap--TypeOfArrangementAxis__custom--ShortTermPromissoryNoteMember_zqK0frNw2T2e" title="Original issue discount">37,500</span>, payable in full together with the principal on the maturity date of May 1, 2025.
On November 29, 2024, the Company sold an additional short-term promissory note to the same investor in the aggregate principal amount
of $<span id="xdx_901_eus-gaap--DebtInstrumentFaceAmount_iI_c20241129_zAEeeRAkVMC7" title="Principal amount">100,000</span>. The note bears guaranteed interest of <span id="xdx_90C_eus-gaap--DebtInstrumentInterestRateEffectivePercentage_iI_c20241129_zrUST1p7cLU8">15%</span>, or $<span id="xdx_906_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_c20241129__us-gaap--TypeOfArrangementAxis__custom--ShortTermPromissoryNoteMember_zrDUCMfH9Q5l" title="Original issue discount">15,000</span>, payable in full together with the principal on the maturity date
of May 29, 2025. In connection with the promissory notes, the Company issued warrants to the investor to purchase up to <span id="xdx_900_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20241129_z8JLL4TcD549">140,000</span> shares
of common stock at an exercise price of $<span id="xdx_90C_eus-gaap--SaleOfStockPricePerShare_iI_c20241129_zmeaklvS04ci">3.25</span> per share with a three-year term. In accordance with ASC 470-20-25-2, the proceeds of the
short-term promissory notes were allocated to the notes and the warrants based on the relative fair values of the notes without the warrants
and of the warrants themselves at time of issuance, with the portion of the proceeds allocated to the warrants accounted for as paid-in
capital, and the remainder of the proceeds allocated to the note. The relative fair value of the warrants at the time of issuance that
was allocated to additional paid-in capital was $<span id="xdx_903_eus-gaap--AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_c20241129__20241129_zpAlDZeU6XUe" title="Warrants additional paid in capital">120,239</span>. On December 31, 2024, the Company entered into a Debt Exchange Agreement with
the investor whereby the entire principal balance of $<span id="xdx_904_eus-gaap--DebtConversionConvertedInstrumentAmount1_c20241231__20241231__us-gaap--StatementClassOfStockAxis__custom--SeriesMNonvotingConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--DebtConversionAgreementMember_zgPVpvDII9Y1" title="Debt converted amount">350,000</span> plus guaranteed interest of $<span id="xdx_903_ecustom--DebtConversionConvertedInstrumentOfGuaranteedInterest_c20241231__20241231__us-gaap--StatementClassOfStockAxis__custom--SeriesMNonvotingConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--DebtConversionAgreementMember_z81TaBNZutsd">52,500</span> was converted into <span id="xdx_90E_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_c20241231__20241231__us-gaap--StatementClassOfStockAxis__custom--SeriesMNonvotingConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--DebtConversionAgreementMember_zIDXPkBPwtZi">133,278</span> shares of
the Company&#8217;s Series M Preferred Stock at a price of $<span id="xdx_908_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20241231__us-gaap--StatementClassOfStockAxis__custom--SeriesMNonvotingConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--DebtConversionAgreementMember_zb6cA43vRrt1">3.02</span> per share.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 8, 2024<b>, </b>the Company sold a short-term promissory note to 1800 Diagonal Lending LLC in the aggregate principal amount
of $<span id="xdx_90F_eus-gaap--NotesAndLoansPayableCurrent_iI_c20241108_zNG0R61hGIC" title="Total consideration">125,190</span>. The note includes an Original Issue Discount of $<span id="xdx_90F_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_c20241108_zv5cgFneuBe2">18,190</span>, and bears a one-time interest charge of <span id="xdx_905_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20241108__us-gaap--TypeOfArrangementAxis__custom--NoteSecuritiesPurchaseAgreementMember_zsS0kZcQyHvc" title="Interest rate">13%</span>, which was applied
on the issuance date to the principal. The note is payable in five installments, with the first payment in the amount of $<span id="xdx_900_eus-gaap--DebtInstrumentPeriodicPayment_c20241108__20241108__us-gaap--TypeOfArrangementAxis__custom--NoteTwoSecuritiesPurchaseAgreementMember_z1jKJ62U7ZIb" title="debt instrument periodic payment">70,732</span> due
on <span id="xdx_90B_eus-gaap--DebtInstrumentMaturityDate_c20241108__20241108__us-gaap--TypeOfArrangementAxis__custom--ShortTermPromissoryNoteMember_z4mym9CGrcP3" title="Maturity date">May 15, 2025</span>, and the remaining four equal installments of $<span id="xdx_90B_ecustom--DebtInstrumentPeriodicOfInstallments_c20241108__20241108_z6TC8sK7qk49">17,683</span> are due on the 15<sup>th</sup> of each of the next four successive
months. The note may be prepaid at any time with no prepayment penalty. Upon the event of default by the Company, any unpaid principal
and interest may be converted to common stock at the election of 1800 Diagonal Lending LLC. As of February 28, 2025, the balance on the
note, net of the unamortized debt discount was $<span id="xdx_900_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_c20250228__us-gaap--TypeOfArrangementAxis__custom--ShortTermPromissoryNoteMember_zt9vJ0AhiUc5" title="Unamortized debt discount">113,223</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 31, 2024, the Company sold a short-term promissory note to a private investor in the aggregate principal amount of $<span id="xdx_901_eus-gaap--DebtInstrumentFaceAmount_iI_c20241231_z5MqTZHU4mC1" title="Principal amount">220,000</span>.
The note bears guaranteed interest of <span id="xdx_902_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20241231_zLvfBopacQ82" title="Prepaid interest percentage">15%</span>, or $<span id="xdx_900_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_c20241231__us-gaap--TypeOfArrangementAxis__custom--ShortTermPromissoryNoteMember_z1wy7onjpcdi" title="Original issue discount">33,000</span>, payable in full on the issue date by the issuance of <span id="xdx_908_eus-gaap--SharesIssued_iI_c20241231_zfgQNQVk3Upd">10,927</span> shares of the Company&#8217;s
Series K Preferred Stock. The note may be prepaid at any time without penalty. Additionally, the Company issued a warrant to the investor
to purchase up to <span id="xdx_901_eus-gaap--DebtInstrumentFaceAmount_iI_c20241231_zwI6QTrfbl39" title="Principal amount">220,000</span> shares of common stock with an exercise price of $<span id="xdx_909_eus-gaap--SharesIssuedPricePerShare_iI_c20241231_zWwHNTyoZBO8">4.00</span> per share and a three-year term. In accordance with
ASC 470-20-25-2, the proceeds of the short-term promissory note were allocated to the note and the warrant based on the relative fair
values of the note without the warrant and of the warrant itself at time of issuance, with the portion of the proceeds allocated to the
warrants accounted for as paid-in capital, and the remainder of the proceeds allocated to the note. The relative fair value of the warrant
at the time of issuance that was allocated to additional paid-in capital was $<span id="xdx_90A_eus-gaap--AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_c20241231__20241231_zr5av3hXuExh" title="Warrants additional paid in capital">179,913</span>. As of February 28, 2025, the balance on the note,
net of the unamortized debt discount, was $<span id="xdx_900_ecustom--DebtInstrumentUnamortizedDebtDiscount_iI_c20250228__us-gaap--TypeOfArrangementAxis__custom--ShortTermPromissoryNoteMember_zJK8Q5c3qlr3" title="Unamortized debt discount">41,504</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 31, 2024, <span id="xdx_901_eus-gaap--DebtInstrumentCovenantDescription_c20241231__20241231_zm6oP8foT3u1">the Company sold a short-term promissory note to a private investor for $<span id="xdx_90D_ecustom--DebtInstrumentOfInvestor_iI_c20241231_zFZUXAuF8mii" title="Principal amount">1,000,000</span>, with $<span id="xdx_904_ecustom--DebtInstrumentOfFunded_iI_c20241231_z7VzIGZ5keAe" title="Principal amount">500,000</span> funded on December
15, 2024 and $<span id="xdx_904_ecustom--DebtInstrumentOfFunded_iI_c20241231_z2YtBzjQd928" title="Principal amount">500,000</span> funded on January 15, 2025. The note bears prepaid interest of <span id="xdx_90D_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20241231__us-gaap--TypeOfArrangementAxis__custom--OneMillionNoteMember_zmX2kk62B8gk" title="Prepaid interest percentage">15%</span>, payable in 49,668 shares of the Company&#8217;s
Series K Preferred Stock. In addition, the Company issued warrants to the investor to purchase up to <span id="xdx_90A_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20241231_ziblBpt8Seee">1,000,000</span> shares of the Company&#8217;s
common stock at an exercise price of $<span id="xdx_900_eus-gaap--SaleOfStockPricePerShare_iI_c20241231_z34O3oH0JLIk">4.00</span> per share with an expiration date of June 30, 2028. Up to 500,000 of the warrants may be exercised
on a cashless basis, at the election of the investor. In accordance with ASC 470-20-25-2, the proceeds of the short-term promissory note
were allocated to the note and the warrant based on the relative fair values of the note without the warrant and of the warrant itself
at time of issuance, with the portion of the proceeds allocated to the warrants accounted for as paid-in capital, and the remainder of
the proceeds allocated to the note. </span>The relative fair value of the warrant at the time of issuance that was allocated to additional paid-in
capital was $<span id="xdx_901_ecustom--AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCost_c20241231__20241231_zBAf4ZOqGXS6" title="Warrants additional paid in capital">829,523</span>. On February 26, 2025, the Company entered into a Debt Exchange Agreement with the investor whereby the entire principal
balance of $<span id="xdx_904_ecustom--DebtInstrumentOfInvestor_iI_c20250226_zRkWv1tOib47" title="Principal amount">1,000,000</span> was converted into <span id="xdx_90C_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20250226__20250226__us-gaap--StatementClassOfStockAxis__custom--SeriesPNonvotingConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--DebtExchangeAgreementMember_zkEL8xoqn4A8" title="Sale of stock, shares">250,000</span> shares of the Company&#8217;s Series P Preferred Stock at a price of $<span id="xdx_909_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20250226__us-gaap--StatementClassOfStockAxis__custom--SeriesPNonvotingConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--DebtExchangeAgreementMember_zogRlktljk0g" title="Conversion price">4.00</span> per share.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 4<b>, </b>2025, the Company sold a short-term promissory note to 1800 Diagonal Lending LLC in the aggregate principal amount
of $<span id="xdx_904_eus-gaap--DebtInstrumentFaceAmount_iI_c20250204_z1rwk3pZAuzj" title="Principal amount">152,100</span>. The note includes an Original Issue Discount of $<span id="xdx_909_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_c20240204__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zlXNvH0LPtCh" title="Original issue discount">22,100</span>, and bears a one-time interest charge of <span id="xdx_905_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20250204__us-gaap--TypeOfArrangementAxis__custom--NoteSecuritiesPurchaseAgreementMember_ztGbj94eVLGd" title="Interest rate">13%</span>, which was applied
on the issuance date to the principal. The note is payable in five installments, with the first payment in the amount of $<span id="xdx_901_eus-gaap--DebtInstrumentPeriodicPayment_c20250204__20250204__us-gaap--TypeOfArrangementAxis__custom--NoteTwoSecuritiesPurchaseAgreementMember_z04eXxeAYiqg" title="debt instrument periodic payment">85,937</span> due
on August 15, 2025, and the remaining four equal installments of $<span id="xdx_90E_ecustom--DebtInstrumentPeriodicOfInstallments_c20250204__20250204_zXNAmsgJYPcl">21,484</span> are due on the 15<sup>th</sup> of each of the next four successive
months. The note may be prepaid at any time with no prepayment penalty. Upon the event of default by the Company, any unpaid principal
and interest may be converted to common stock at the election of 1800 Diagonal Lending LLC. As of February 28, 2025, the balance on the
note, net of the unamortized debt discount was $<span id="xdx_908_ecustom--DebtInstrumentUnamortizedDebtDiscount_iI_c20250228_zZv0YlQrZlqc" title="Unamortized debt discount">131,163</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-6<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 470<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/470/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1C<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1C<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1C<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Convertible Notes<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Feb. 28, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_DisclosureConvertibleNotesAbstract', window );"><strong>Convertible Notes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_ConvertibleDebtDisclosureTextBlock', window );">Convertible Notes</a></td>
<td class="text"><p id="xdx_806_ecustom--ConvertibleDebtDisclosureTextBlock_zcANo5qcnnHa" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
13 - <span id="xdx_825_za9lYQGopFr">Convertible Notes</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Between
March 13, 2023 and June 9, 2023, the Company issued $<span id="xdx_909_eus-gaap--ProceedsFromConvertibleDebt_c20230313__20230609__dei--LegalEntityAxis__custom--SpecialPurposeAcquisitionCorporationMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SeveralInvestorsMember__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesMember_z0TrXPn1tkdi" title="Convertible note issued">650,000</span> in convertible notes upon the receipt of proceeds from several investors.
The notes had an interest at a rate of <span id="xdx_906_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_c20230609__dei--LegalEntityAxis__custom--SpecialPurposeAcquisitionCorporationMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SeveralInvestorsMember__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesMember_z44HX4hk5tzf" title="Interest rate">8</span>% per annum and were convertible into shares and warrants in a new public company upon the completion
of a merger with a Special Purpose Acquisition Corporation (&#8220;SPAC&#8221;) at a conversion price of $<span id="xdx_906_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_pid_c20230609__dei--LegalEntityAxis__custom--SpecialPurposeAcquisitionCorporationMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SeveralInvestorsMember__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesMember_zf9jm3XdNhq5" title="Conversion price">3.00</span> per common share, subject
to certain adjustments.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Between
July 27, 2022 and February 21, 2023, the Company issued a total principal amount of $<span id="xdx_902_eus-gaap--ProceedsFromConvertibleDebt_c20220727__20230221__dei--LegalEntityAxis__custom--SpecialPurposeAcquisitionCorporationMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SeveralInvestorsMember__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesMember_ztwdnKjl5qIg" title="Convertible note issued">3,012,000</span> in convertible notes upon the receipt
of proceeds from several investors. The notes had an interest at a rate of <span id="xdx_90E_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_c20230221__dei--LegalEntityAxis__custom--SpecialPurposeAcquisitionCorporationMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SeveralInvestorsMember__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesMember_zxrpswu6nIY1" title="Interest rate">8</span>% per annum and were convertible into shares and warrants
in a new public company upon the completion of a merger with a SPAC at a conversion
price of $<span id="xdx_905_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_pid_c20230221__dei--LegalEntityAxis__custom--SpecialPurposeAcquisitionCorporationMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SeveralInvestorsMember__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesMember_zo7R6X7v7QC7" title="Conversion price">3.00</span> per common share, subject to certain adjustments.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 29, 2023, in connection with, and contingent upon the acquisition of NTH by the Company, each investor in a convertible
note entered into a Debt Assignment and Conversion Agreement with NTG and NTH, whereby the notes and the debt represented thereby
were assigned from NTH to NTG and converted into common units of NTG with the equivalent value on the terms and conditions as set
forth in the Debt Assignment and Conversion Agreements. In exchange for entering into the Debt Assignment and Conversion Agreements,
each investor received the right to receive a number of Restricted Shares, including both Closing Shares and Contingent
Shares, to be distributed by the Company to each such investor following the consummation of the NextTrip Acquisition. The shares were
issued at a price of $<span id="xdx_901_eus-gaap--SharePrice_iI_pid_c20231229__us-gaap--TypeOfArrangementAxis__custom--DebtAssignmentAndConversionAgreementsMember_zqd25b5TLGgf" title="Share price">3.00</span>,
and include both principal and accrued interest thereon.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
NextTrip Acquisition closed on December 29, 2023, and as a result, the Company issued to the investors and aggregate of <span id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c20231229__20231229__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zqOOW0RWTYyb" title="Conversion of convertible notes, shares">52,818</span>
Closing Shares, and the right to receive an aggregate of <span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c20231229__20231229__us-gaap--StatementEquityComponentsAxis__custom--ContingentSharesMember_zWexfYlJF83g" title="Conversion of convertible notes, shares">1,978,598</span>
Contingent Shares, if issued.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the years ended February 28, 2025 and February 29, 2024, the Company recorded interest expense of $<span id="xdx_90F_eus-gaap--InterestExpenseDebt_c20240301__20250228_zhEGTUfgQNWh" title="Interest expense">0</span> and $<span id="xdx_90C_eus-gaap--InterestExpenseDebt_c20230301__20240229_zpmr2iYBE1Kl" title="Interest expense">234,213</span>, respectively, related
to the notes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_ConvertibleDebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_ConvertibleDebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_DisclosureConvertibleNotesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_DisclosureConvertibleNotesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share Purchase Agreements<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Feb. 28, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_DisclosureSharePurchaseAgreementsAbstract', window );"><strong>Share Purchase Agreements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_SharePurchaseAgreementsDisclosureTextBlock', window );">Share Purchase Agreements</a></td>
<td class="text"><p id="xdx_80A_ecustom--SharePurchaseAgreementsDisclosureTextBlock_zQgD7zi8pgnc" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
14 &#8211; <span id="xdx_820_zxVVuh2q1wsk">Share Purchase Agreements</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Between
August 10, 2023 and November 6, 2023, NTH entered into Share Purchase Agreements with several investors to purchase convertible
shares in NTH in exchange for total proceeds of $<span id="xdx_905_eus-gaap--ProceedsFromConvertibleDebt_c20230810__20231106__us-gaap--TypeOfArrangementAxis__custom--SharePurchaseAgreementsMember__srt--TitleOfIndividualAxis__custom--SeveralInvestorsMember_zpjBX0R5bUbc" title="Proceeds from convertible shares">1,755,970</span>.
Pursuant to the Share Purchase Agreements, the shares were initially convertible into the common shares of a public company with
which NTH completed a strategic transaction at a price of $<span id="xdx_909_eus-gaap--SharePrice_iI_c20231106__us-gaap--TypeOfArrangementAxis__custom--SharePurchaseAgreementsMember__srt--TitleOfIndividualAxis__custom--SeveralInvestorsMember_zR1y7oIRSJh4" title="Conversion share price">0.15</span>
per share. The Share Purchase Agreements further provided that contingent upon the consummation of the legal acquisition of NTH by
the Company, the investors would receive the same number of shares of Company common stock in lieu of NTH common
shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">On December 29, 2023, concurrent with the consummation
of the NextTrip Acquisition, each investor entered into an Exchange Agreement (the &#8220;Pre-Acquisition Exchange Agreements&#8221;)
with NTG and NTH, whereby such investors exchanged their rights to NTH shares for rights to common units of NTG of the same value, and
NTG distributed to the investors that number of Closing Shares as set forth in the Pre-Acquisition Exchange Agreements. Additionally,
upon the Company&#8217;s achievement of each of the milestones as set forth in the Exchange Agreement, if ever, NTG will further distribute
the number of Contingent Shares in accordance with the Pre-Acquisition Exchange Agreements.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 19, 2022, the Company entered into a Software as a Service Agreement with a third-party consultant, pursuant to which the Company received
a $<span id="xdx_90A_ecustom--ProceedsFromDownpaymentForContract_c20220919__20220919__us-gaap--TypeOfArrangementAxis__custom--SoftwareAsAServiceAgreementMember__srt--TitleOfIndividualAxis__custom--ThirdPartyMember_zRhEOz43wfSa" title="Proceeds from downpayment for contract">150,000</span> down payment upon signing of the contract. On December 31, 2022, the Company entered into an amended agreement with the counterparty,
pursuant which the down payment became a noninterest bearing share issuance obligation and which such amount will be converted to shares in
a new public company upon the completion of a merger at a conversion price of $<span id="xdx_908_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20220919__us-gaap--TypeOfArrangementAxis__custom--SoftwareAsAServiceAgreementMember__srt--TitleOfIndividualAxis__custom--ThirdPartyMember_zq7TiMeqVl1e" title="Conversion share price">3.00</span> per common share, subject to adjustments. On December
29, 2023, upon the consummation of the NextTrip Acquisition, the counterparty received <span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c20231229__20231229__us-gaap--TypeOfArrangementAxis__custom--SoftwareAsAServiceAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--TitleOfIndividualAxis__custom--ThirdPartyMember_zySNcOwmPOB6" title="Conversion of convertible notes, shares">1,996</span> Closing Shares and
the right to receive an additional <span id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c20231229__20231229__us-gaap--StatementEquityComponentsAxis__custom--ContingentSharesMember__us-gaap--TypeOfArrangementAxis__custom--SoftwareAsAServiceAgreementMember__srt--TitleOfIndividualAxis__custom--ThirdPartyMember_zGj6xEvHIh7" title="Conversion of convertible notes, shares">74,786</span> Contingent Shares, if issued.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
total number of Closing Shares issued to investors, inclusive the third-party consultant, on December 29, 2023 was <span id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c20231229__20231229__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--TitleOfIndividualAxis__custom--ThirdPartyConsultantMember_ztLhHtQNDYn6" title="Conversion of convertible notes, shares">15,481</span>
Closing Shares, and the Contingent Shares issuable, if ever, totaled an aggregate of <span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c20231229__20231229__us-gaap--StatementEquityComponentsAxis__custom--ContingentSharesMember__srt--TitleOfIndividualAxis__custom--ThirdPartyConsultantMember_zy8pL76pzPT7" title="Conversion of convertible notes, shares">579,954</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 28, 2023, the Company entered into a Consulting Modification Agreement with a third-party consultant, which provided for
the full settlement of $<span id="xdx_90F_ecustom--ConsultingFees_c20231228__20231228__us-gaap--TypeOfArrangementAxis__custom--ConsultingModificationAgreementMember__srt--TitleOfIndividualAxis__custom--ThirdPartyConsultantMember_zvTINfhiX9Bc" title="Consulting fees">180,000</span>
in consulting fees by issuing shares of Company common stock contingent upon the closing of the NextTrip acquisition. The NextTrip
Acquisition closed on December 29, 2023, pursuant to which the Company issued <span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c20231229__20231229__us-gaap--TypeOfArrangementAxis__custom--ConsultingModificationAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--TitleOfIndividualAxis__custom--ThirdPartyConsultantMember_z5TLUDwCfJFk" title="Conversion of convertible notes, shares">4,337</span>
Closing Shares to the consultant, and the right to receive <span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c20231229__20231229__us-gaap--TypeOfArrangementAxis__custom--ConsultingModificationAgreementMember__us-gaap--StatementEquityComponentsAxis__custom--ContingentSharesMember__srt--TitleOfIndividualAxis__custom--ThirdPartyConsultantMember_zeuqJbpGydkb" title="Conversion of convertible notes, shares">162,466</span>
Contingent Shares, if issued.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_DisclosureSharePurchaseAgreementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_DisclosureSharePurchaseAgreementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_SharePurchaseAgreementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share Purchase Agreements Disclosure [Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_SharePurchaseAgreementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Transactions<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Feb. 28, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">Related Party Transactions</a></td>
<td class="text"><p id="xdx_80E_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zYTv9TEZiO23" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
15 - <span id="xdx_82D_zLEG8HLsV2me">Related Party Transactions</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 28, 2023, the Company entered into an Asset Purchase Agreement with Travel and Media Tech, LLC (&#8220;TMT&#8221;),
pursuant to which it purchased the right, title and interest in the &#8220;Bookit&#8221; or &#8220;NextTrip 2.0&#8221; booking
engine, including customer lists, all current content associated with hotel and destination product in the booking engine (pictures,
hotel descriptions, restaurant descriptions, room descriptions, amenity descriptions, and destination information) and source code
related thereto. TMT is a related entity owned by Donald P. Monaco, the Company&#8217;s Chairman, and William Kerby, the
Company&#8217;s Chief Executive Officer.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amounts
due to related parties at February 28, 2025 and February 29, 2024 was $<span id="xdx_90B_eus-gaap--NotesPayableCurrent_iI_pp0p0_c20250228__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_z8Ao9EYP5eD1" title="Notes payable - related parties">61,526</span> and $<span id="xdx_906_eus-gaap--NotesPayableCurrent_c20240229__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_pp0p0" title="Notes payable - related parties">828,277</span>, respectively. The amounts due at February
28, 2025 are to Donald P. Monaco, William Kerby, and Gregory Miller, and at February 29, 2024 were to William Kerby and Donald P. Monaco.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recorded a loss of $<span id="xdx_907_ecustom--LossOnRelatedPartyReceivable_c20240301__20250228__us-gaap--BusinessAcquisitionAxis__custom--NextPlayTechnologiesIncMember_zEymAtR6JJIb" title="Loss on related party receivable">1,000,000</span> on the NextPlay related party receivable for the year ended February 28, 2025. The total amount
receivable from NextPlay was $<span id="xdx_909_eus-gaap--ReceivablesNetCurrent_iI_c20250228__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--NextPlayTechnologiesIncMember_z3YA7KBgwUFh" title="Accounts receivable">2,567,665</span> at February 28, 2025. NextPlay is in involuntary bankruptcy proceedings and is in default under
the terms of its promissory note and, as a result, the Company established an allowance for doubtful accounts of $<span id="xdx_90E_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iI_c20250228__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--NextPlayTechnologiesIncMember_zcQK8VpCTHw2" title="Allowance for doubtful accounts">2,567,665</span> as collectability
of the note is uncertain. As of February 29, 2024, $<span id="xdx_902_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iI_do_c20240229__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--NextPlayTechnologiesIncMember_zctRo65pvGYe" title="Allowance for doubtful accounts">1,567,665</span> allowance for credit losses was established.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(g)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(e))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/850/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-6<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Deferred Revenue<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Feb. 28, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_DisclosureDeferredRevenueAbstract', window );"><strong>Deferred Revenue</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_DeferredRevenueTextBlock', window );">Deferred Revenue</a></td>
<td class="text"><p id="xdx_803_ecustom--DeferredRevenueTextBlock_z2KWmrnN1kLd" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
16 - <span id="xdx_821_zKG1fsISYakd">Deferred Revenue</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred
revenue as of the years ended February 28, 2025, and February 29, 2024 was $<span id="xdx_905_eus-gaap--DeferredRevenueCurrent_iI_c20250228_zmue3OBk8KNd" title="Deferred revenue">97,770</span> and $<span id="xdx_90B_eus-gaap--DeferredRevenueCurrent_iI_c20240229_zqpuCaLJE1d1" title="Deferred revenue">139,921</span>, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred
revenue consists of travel deposits received from users in advance of revenue recognition. The deferred revenue balance for the years
ended February 28, 2025 and February 29, 2024 was driven by cash payments from customers in advance of satisfying our performance obligations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_DeferredRevenueTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Revenue [Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_DeferredRevenueTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_DisclosureDeferredRevenueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_DisclosureDeferredRevenueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Feb. 28, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text"><p id="xdx_800_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zePe41COpDyf" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
17 - <span id="xdx_822_z0jGBGniifL5">Commitments and Contingencies</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is involved, from time to time, in litigation, other legal claims and proceedings involving matters associated with or incidental
to our business, including, among other things, matters involving breach of contract claims, intellectual property, employment issues,
and other related claims and vendor matters. The Company believes that the resolution of currently pending matters could, individually
or in the aggregate, have a material adverse effect on our financial condition or results of operations. However, assessment of the current
litigation or other legal claims could change considering the discovery of facts not presently known to the Company or by judges, juries
or other finders of fact, which are not in accord with management&#8217;s evaluation of the possible liability or outcome of such litigation
or claims.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 405<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/405-30/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482648/440-10-50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/450/tableOfContent<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 440<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478522/954-440-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482648/440-10-50-4<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 440<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/440/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders&#8217; Equity<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Feb. 28, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Stockholders&#8217; Equity</a></td>
<td class="text"><p id="xdx_80A_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zIUrNS1iB2Ig" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
18 &#8211; <span id="xdx_828_zLvcJElMeBJj">Stockholders&#8217; Equity</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Common
Stock</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has <span id="xdx_908_eus-gaap--CommonStockSharesAuthorized_iI_c20250228_zJY3vPkCUuU1" title="Common stock, shares authorized">250,000,000</span> shares of common stock authorized. As of February 28, 2025 and February 29, 2024, the Company had
<span id="xdx_903_eus-gaap--CommonStockSharesOutstanding_iI_c20250228_zna4o60hVrV9" title="Common stock, shares outstanding">1,656,738</span> and <span id="xdx_908_eus-gaap--CommonStockSharesOutstanding_iI_c20240229_zSbHcduuN7ej" title="Common stock, shares outstanding">936,430</span> shares of common stock, par value $<span id="xdx_908_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20250228_z4zA75WQagXf" title="Common stock, par value"><span id="xdx_90B_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20240229_zndi6ZE0anr3" title="Common stock, par value">0.001</span></span> issued and outstanding, respectively. All shares have equal voting rights,
are fully-paid and non-assessable, and are entitled to one vote per share.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 22, 2023, we effected a <span id="xdx_905_eus-gaap--StockholdersEquityReverseStockSplit_c20230921__20230922_z2xDteU60Hu3" title="Reverse stock split">1-for-20 reverse stock split</span> of the outstanding shares of our common stock and a corresponding decrease
in the number of shares of our common stock that we are authorized to issue. In connection with the reverse split, we issued <span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesReverseStockSplits_c20230922__20230922_zR9cE8RQxuWb" title="Reverse stock split issued common shares">40,197</span> common
shares to round-up fractional shares to the nearest whole share.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
effects of the reverse stock split have been retroactively reflected in all periods presented in this Report.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fiscal
Year Ended February 28, 2025</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 15, 2024, the Company issued <span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c20240315__20240315__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zoHQgPDk8x35" title="Conversion shares issued">409,502</span> shares of common stock pursuant to automatic conversions of the Company&#8217;s Series G,
H, and I Convertible Preferred Stock upon receiving shareholder approval to increase the Company&#8217;s authorized common shares to
250 million.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
July 2024 and August 2024, the Company issued <span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20240701__20240831__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zdQhOExxWQea" title="Shares issued for services">42,709</span>
shares of common stock to Dooya Media Group, Inc. as partial compensation for development work related to Compass.TV, the
Company&#8217;s Free-Ad Supported TV (&#8220;FAST&#8221;) channel.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 19, 2024, the Company issued <span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20240919__20240919__dei--LegalEntityAxis__custom--AlumniCapitalLPMember_zTXmv6NkWxtl" title="Number of common stock issued">32,786</span>
shares of common stock to Alumni Capital LP (&#8220;Alumni&#8221;) as commitment shares for a $<span id="xdx_907_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pn6n6_c20240919__20240919__dei--LegalEntityAxis__custom--AlumniCapitalLPMember_zFlkjOgy8Oia" title="Equity line of credit">10</span>
million equity line of credit.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 8, 2024, the Company issued <span id="xdx_90D_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_c20241008__20241008__dei--LegalEntityAxis__custom--FSATravelLLCMember_zwpHTsJDSii9" title="Stock deposit acquisition">8,065</span>
shares of common stock to FSA upon executing a non-binding letter of intent to acquire interests in FSA. Pursuant to the
terms of the agreement, the shares were to be credited towards the final purchase price if an acquisition occurs, and as a down
payment towards the acquisition price of FSA.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">On December 16, 2024, the Company issued <span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20241216__20241216__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z8KZe2l0kaE9" title="Issuance of shares">28,281</span> shares
of common stock to Out of the Box Capital as a prepayment for an Investor Relations consulting contract.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
December 2024 and January 2025, the Company issued <span id="xdx_907_ecustom--StockIssuedDuringPeriodSharesWarrantExercises_c20241201__20250131__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_ztS6QABvdmci" title="Issuance of shares warrant exercises">an
aggregate of 104,965</span> shares of common stock pursuant to warrant exercises, resulting in gross proceeds of $<span id="xdx_90E_eus-gaap--ProceedsFromWarrantExercises_c20241201__20250131__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z5FgNxiqzPL5" title="Gross proceeds of warrant exercises">316,995</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 7, 2025, the Company issued <span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20250107__20250107__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zSqjLW2Q6jhj" title="Issuance of shares">30,000</span> shares of common stock as a prepayment for a consulting contract with an investor relations
company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 29, 2025, the Company issued <span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20250129__20250129__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zSsKSEKezNie" title="Issuance of shares">4,000</span>
shares of common stock to Lyndsey North, the Company&#8217;s former President, in connection with her separation
agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 26, 2025, the Company issued <span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20250226__20250226__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zNOFulTCQf1h" title="Issuance of shares">60,000</span> shares of common stock to AOS Holdings, Inc. as a partial prepayment for a two-year consulting
contract to provide investor relations and strategic consulting services.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fiscal
Year Ended February 29, 2024</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
September 2023 and October 2023, the Company sold <span id="xdx_903_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20230901__20230930__us-gaap--SubsidiarySaleOfStockAxis__custom--AtTheMarketIssuanceSalesAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zyaF72bp2UW5" title="Share issued and sold during period, shares">72,721</span>
and <span id="xdx_905_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20231001__20231031__us-gaap--SubsidiarySaleOfStockAxis__custom--AtTheMarketIssuanceSalesAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zxYVWkKBw9U6" title="Share issued and sold during period, shares">128,887</span>
shares of common stock, respectively, through our ATM Agreement, resulting in net proceeds of $<span id="xdx_905_eus-gaap--ProceedsFromIssuanceOfCommonStock_c20230901__20230930__us-gaap--SubsidiarySaleOfStockAxis__custom--AtTheMarketIssuanceSalesAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zD8h2PXjJjG7" title="Net proceeds">364,555</span>
and $<span id="xdx_90F_eus-gaap--ProceedsFromIssuanceOfCommonStock_c20231001__20231031__us-gaap--SubsidiarySaleOfStockAxis__custom--AtTheMarketIssuanceSalesAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_ztTcgd3Usf24" title="Net proceeds">772,468</span>,
respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 29, 2023, the Company acquired <span id="xdx_903_eus-gaap--BusinessAcquisitionPercentageOfVotingInterestsAcquired_iI_pid_dp_uPure_c20231229__us-gaap--BusinessAcquisitionAxis__custom--NextTripHoldingsIncMember_zTCR7L3h4Si9" title="Equity interest acquired">100</span>%
of the outstanding equity interests of NTH pursuant to the Exchange Agreement in connection with the NextTrip Acquisition. As
consideration for the NextTrip Acquisition, at closing the Company issued <span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20231229__20231229__us-gaap--BusinessAcquisitionAxis__custom--NextTripHoldingsIncMember_z6XeUm1x8hha" title="Restricted shares issued in acquisitions">156,007</span>
restricted shares of its common stock as Closing Shares, constituting <span id="xdx_908_eus-gaap--SaleOfStockPercentageOfOwnershipAfterTransaction_pid_dp_uPure_c20231229__20241229__us-gaap--BusinessAcquisitionAxis__custom--NextTripHoldingsIncMember_z8nwLdn84WU4" title="Percentage of issued and outstanding common shares">19.99</span>%
of its issued and outstanding shares of common stock immediately prior to execution of the Exchange Agreement, and agreed to
issue up to an aggregate of <span id="xdx_90F_eus-gaap--BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_c20231229__20231229__us-gaap--BusinessAcquisitionAxis__custom--NextTripHoldingsIncMember_zBEYPX4hztel" title="Shares issuable for consideration">5,843,993</span>
Contingent Shares as further consideration upon NTH&#8217;s achievement of certain milestones set forth in the Exchange
Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Of
the <span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20231229__20231229__us-gaap--BusinessAcquisitionAxis__custom--NextTripHoldingsIncMember_ziKRiLvxb8vd" title="Restricted shares issued in acquisitions">156,007</span>
restricted shares issued at closing, <span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_c20231229__20231229__us-gaap--BusinessAcquisitionAxis__custom--NextTripHoldingsIncMember__us-gaap--DeferredRevenueArrangementTypeAxis__custom--DebtAssignmentAndConversionAgreementsMember_zcVxde1Nxxm4" title="Shares issued in acquisitions">52,818</span>
shares were issued pursuant to the Debt Assignment and Conversion agreements, <span id="xdx_908_eus-gaap--StockRepurchasedDuringPeriodShares_c20231229__20231229__us-gaap--BusinessAcquisitionAxis__custom--NextTripHoldingsIncMember__us-gaap--DeferredRevenueArrangementTypeAxis__custom--SharePurchaseAndExchangeAgreementsMember_zXmqO1j4HNF9" title="Purchase of shares issued">15,481</span>
shares were issued pursuant to the Share Purchase and Pre-Acquisition Exchange Agreements, and <span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20231229__20231229__us-gaap--BusinessAcquisitionAxis__custom--NextTripHoldingsIncMember__us-gaap--RelatedPartyTransactionAxis__custom--ThirdPartyConsultantMember_zWAaO8cs85Il" title="Shares issued during period services">4,337</span>
shares were issued to a third-party consultant. Pursuant to ASC 805-40-45-1, the remaining <span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_c20231229__20231229__us-gaap--BusinessAcquisitionAxis__custom--NextTripHoldingsIncMember_zKEQJKuWBoB9" title="Shares issued in acquisitions">83,371</span>
Closing Shares are reflected as a retroactive adjustment to adjust the accounting acquirer&#8217;s legal capital to reflect the
legal capital of the accounting acquiree. That adjustment is required to reflect the capital of the legal parent.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Deferred
Compensation</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
discussed above, during the fiscal year ended February 28, 2025, the Company issued <span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20240301__20250228_zmoUsuE3c0p" title="Number of restricted common shares issued">4,000</span>
restricted shares of common stock at a price of $<span id="xdx_90B_eus-gaap--SharePrice_iI_c20250228_za5aZ7S8ciyg" title="Share price">6.69</span>
to Lyndsey North, the Company&#8217;s former President, in connection with her separation agreement. The shares were fully vested on
January 29, 2025, which was the grant date. As a result, the Company recorded share based compensation expense of $<span id="xdx_904_eus-gaap--AllocatedShareBasedCompensationExpense_c20240301__20250228_zBXrJqKFWwKb" title="Share based compensation expense">26,760</span>.
The Company did not issue any shares of common stock to employees during the fiscal year ended February 29, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Preferred
Stock</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
our amended and restated articles of incorporation (our &#8220;Charter&#8221;), our board of directors has the authority, without further action by
stockholders, to designate one or more series of preferred stock and to fix the voting powers, designations, preferences,
limitations, restrictions and relative rights granted to or imposed upon the preferred stock, including dividend rights, conversion
rights, voting rights, rights and terms of redemption, liquidation preference and sinking fund terms, any or all of which may be
preferential to or greater than the rights of the common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
board of directors may authorize the issuance of preferred stock with voting or conversion rights that could adversely affect the voting
power or other rights of the holders of the common stock. The issuance of preferred stock, while providing flexibility in connection
with possible acquisitions and other corporate purposes, could, among other things, have the effect of delaying, deferring or preventing
a change in our control and may adversely affect the market price of the common stock and the voting and other rights of the holders
of common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is authorized to issue <span id="xdx_908_eus-gaap--PreferredStockSharesAuthorized_iI_pid_c20250228_zrlsHaHx2Kig" title="Preferred stock, shares authorized"><span id="xdx_90C_eus-gaap--PreferredStockSharesAuthorized_iI_pid_c20240229_zmn39j8t6sj9" title="Preferred stock, shares authorized">10,000,000</span></span> shares of preferred stock, $<span id="xdx_90A_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_c20250228_ztDddnKY9zf5" title="Preferred stock, par value"><span id="xdx_908_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_c20240229_z1pgoEkOJyXh" title="Preferred stock, par value">0.001</span></span> par value. <span id="xdx_907_eus-gaap--PreferredStockSharesIssued_iI_c20250228_zAhHboNAMuYh" title="Preferred stock, shares issued"><span id="xdx_903_eus-gaap--PreferredStockSharesOutstanding_iI_c20250228_zPBQUchr8fPd" title="Preferred stock, shares outstanding">3,106,616</span></span> and <span id="xdx_908_eus-gaap--PreferredStockSharesIssued_iI_c20240229_zNopltyXIZs" title="Preferred stock, shares issued"><span id="xdx_900_eus-gaap--PreferredStockSharesOutstanding_iI_c20240229_zxwtZ7Dqslcc" title="Preferred stock, shares outstanding">472,996</span></span> shares of preferred stock
were issued and outstanding at February 28, 2025 and February 29, 2024, Respectively, as discussed in additional detail below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Series
E Convertible Preferred Stock</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the Certificate of Designations of the Series E Preferred Stock, the shares of the Company&#8217;s preferred stock as Series E
Convertible Preferred Stock (the &#8220;Series E Preferred&#8221;) have an initial stated value of $<span id="xdx_906_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20250228__us-gaap--StatementClassOfStockAxis__custom--SeriesEConvertiblePreferredStockMember_zUdA0lJ5fYTi" title="Preferred stock, par value">1,500</span>
per share (the &#8220;Stated Value&#8221;). Dividends at the initial rate of <span id="xdx_90F_eus-gaap--PreferredStockDividendRatePercentage_pid_dp_uPure_c20240301__20250228__us-gaap--StatementClassOfStockAxis__custom--SeriesEConvertiblePreferredStockMember_zVPdL0kaOB6k" title="Dividends percentage">9</span>%
per annum will accrue and, on a monthly basis, shall be payable in kind by the increase of the Stated Value of the Series E
Preferred by said amount. The holders of shares of the Series E Preferred have the right at any time to convert all or a portion of
the Series E Preferred (including, without limitation, accrued and unpaid dividends and make-whole dividends through the third
anniversary of the closing date) into shares of the Company&#8217;s common stock at an initial conversion rate determined by
dividing the Conversion Amount by the conversion price ($<span id="xdx_900_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20250228__us-gaap--StatementClassOfStockAxis__custom--SeriesEConvertiblePreferredStockMember_zdEKRkCpfPYb" title="Conversion price per share">0.13</span>
above the consolidated closing bid price for the trading day prior to the execution of the relates stock purchase agreement). The
Conversion Amount is the sum of the Stated Value of the shares of Series E Preferred then being converted plus any other
unpaid amounts payable with respect to the Series E Preferred being converted plus the &#8220;Make Whole Amount&#8221; (the
amount of any dividends that, but for the conversion, would have accrued at the dividend rate for the period through the third
anniversary of the initial issuance date). The Conversion Rate is also subject to adjustment for stock splits, dividends
recapitalizations and similar events.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
February 28, 2025, <span title="Preferred stock, shares issued"><span id="xdx_90B_eus-gaap--PreferredStockSharesOutstanding_iI_c20250228__us-gaap--StatementClassOfStockAxis__custom--SeriesEConvertiblePreferredStockMember_zfcxfpP5yLk8" title="Preferred stock, shares outstanding">316</span></span> shares of Series E Preferred were outstanding, which if converted as of February
28, 2025, including the make-whole dividends, would have resulted in the issuance of <span id="xdx_906_eus-gaap--PreferredStockConvertibleSharesIssuable_iI_c20250228__us-gaap--StatementClassOfStockAxis__custom--SeriesEConvertiblePreferredStockMember_z3PGw85AlSk7" title="Common stock issuable upon conversion">3,362</span> shares of common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Series
F Convertible Preferred Stock</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 4, 2024, the Company filed a Certificate of Designation of Series F Convertible Preferred Stock (the &#8220;Series F
Certificate of Designation&#8221;) with the Secretary of State of the State of Nevada, designating <span id="xdx_90B_eus-gaap--PreferredStockSharesAuthorized_iI_c20240104__us-gaap--StatementClassOfStockAxis__custom--SeriesFConvertiblePreferredStockMember_zwGeU0lsj9Yb" title="Preferred stock shares authorized">5,843,993</span>
shares of the Company&#8217;s preferred stock as Series F Convertible Preferred Stock, par value $<span id="xdx_90B_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20240104__us-gaap--StatementClassOfStockAxis__custom--SeriesFConvertiblePreferredStockMember_zxN6eeocjlAg" title="Preferred stock, par value">0.001</span>
per share (the &#8220;Series F Preferred&#8221;). The Series F Preferred was designated by the Company in connection with the NextTrip Acquisition, and, in the event that the Company does not have sufficient shares
of common stock available to fulfill its obligations pursuant to the Exchange Agreement governing the terms of the
NextTrip Acquisition, shares of Series F Preferred shall be issued to the previous equity holders of NTH in lieu of shares of Company
common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
terms and conditions set forth in the Series F Certificate of Designation are summarized below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Ranking</i></b><i>.
</i>The Series F Preferred rank pari passu to the Company&#8217;s common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Dividends</i></b><i>.
</i>Holders of Series F Preferred will be entitled to dividends, on an as-converted basis, equal to dividends actually paid, if any,
on shares of Company common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Voting</i></b>.
Except as provided by the Company&#8217;s Charter or as otherwise required by the Nevada Revised Statutes, holders of Series F
Preferred are entitled to vote with the holders of outstanding shares of Company common stock, voting together as a single class,
with respect to all matters presented to the Company&#8217;s stockholders for their action or consideration. In any such vote, each
holder is entitled to a number of votes equal to the number of shares of common stock into which the Series F Preferred held by such
holder is convertible. The Company may not, without the consent of holders of a majority of the outstanding shares of Series F
Preferred, (i) alter or change adversely the powers, preferences or rights given to the Series F Preferred or alter or amend the
Series F Certificate of Designation, (ii) amend its Charter or other charter documents in any manner that adversely effects any
rights of the holders of the Series F Preferred, or (c) enter into any agreement with respect to the foregoing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Conversion</i></b>.
On such date that the Company amends its Charter to increase the number of shares of common stock authorized for issuance
thereunder, to at least the extent required to convert all of the outstanding Series F Preferred, each outstanding share of Series F
Preferred shall automatically be converted into one share of Company common stock (subject to adjustment under certain limited
circumstances) (the &#8220;Series F Conversion Ratio&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Liquidation</i></b>.
In the event of any liquidation, dissolution or winding up of the Company, either voluntary or involuntary (each, a
&#8220;Liquidation&#8221;), holders of Series F Preferred will be entitled to participate, on an as-converted-to-common stock basis
calculate based on the Series F Conversion Ratio, with holders of Company common stock in any distribution of assets of the Company
to holders of the Company&#8217;s common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
February 28, 2025, <span id="xdx_901_eus-gaap--PreferredStockSharesOutstanding_iI_do_c20250228__us-gaap--StatementClassOfStockAxis__custom--SeriesFConvertiblePreferredStockMember_zAtQK5X3Ymz9" title="Preferred stock, shares outstanding">no</span> shares of the Series F Preferred were outstanding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Series
G Convertible Preferred Stock</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 26, 2024, the Company filed a Certificate of Designation of Series G Convertible Preferred Stock (the &#8220;Series G
Certificate of Designation&#8221;) with the Secretary of State of the State of Nevada, designating <span id="xdx_907_eus-gaap--PreferredStockSharesAuthorized_iI_c20240126__us-gaap--StatementClassOfStockAxis__custom--SeriesGConvertiblePreferredStockMember_zheNllniYYnf" title="Preferred stock shares authorized">100,000</span>
shares of the Company&#8217;s preferred stock as Series G Convertible Preferred Stock, par value $<span id="xdx_906_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20240126__us-gaap--StatementClassOfStockAxis__custom--SeriesGConvertiblePreferredStockMember_zOSy2wUglqF5" title="Preferred stock, par value">0.001</span>
per share (the &#8220;Series G Preferred&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
terms and conditions set forth in the Series G Certificate of Designation are summarized below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Ranking.
</i>The Series G Preferred rank pari passu to the Company&#8217;s common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Dividends.
</i>Holders of Series G Preferred will be entitled to dividends, on an as-converted basis, equal to dividends actually paid, if any,
on shares of Company common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Voting</i>.
Except as provided by the Company&#8217;s Charter or as otherwise required by the Nevada Revised Statutes, holders of Series G Preferred
are entitled to vote with the holders of outstanding shares of Company common stock, voting together as a single class, with respect
to all matters presented to the Company&#8217;s stockholders for their action or consideration. In any such vote, each holder is entitled
to a number of votes equal to the number of shares of common stock into which the Series G Preferred held by such holder is convertible.
The Company may not, without the consent of holders of a majority of the outstanding shares of Series G Preferred, (i) alter or change
adversely the powers, preferences or rights given to the Series G Preferred or alter or amend the Series G Certificate of Designation,
(ii) amend its Charter or other charter documents in any manner that adversely effects any rights of the holders of the Series G Preferred,
or (c) enter into any agreement with respect to the foregoing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Conversion</i>.
On such date that the Company amends its Charter to increase the number of shares of common stock authorized for issuance thereunder,
to at least the extent required to convert all of the outstanding Series G Preferred, each outstanding share of Series G Preferred shall
automatically be converted into one share of Company common stock (subject to adjustment under certain limited circumstances) (the &#8220;Series
G Conversion Ratio&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Liquidation</i>.
In the event of any liquidation, dissolution or winding up of the Company, either voluntary or involuntary, holders of Series G Preferred
will be entitled to participate, on an as-converted-to-common stock basis calculate based on the Series G Conversion Ratio, with holders
of Company common stock in any distribution of assets of the Company to holders of the Company&#8217;s common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Redemption
Right</i>. <span id="xdx_90E_eus-gaap--PreferredStockRedemptionTerms_c20240301__20250228__us-gaap--StatementClassOfStockAxis__custom--SeriesGConvertiblePreferredStockMember_z0OGLpnlv4G" title="Preferred stock redemption right, description">The
Company shall have the right to redeem up to 50% of the Series G Preferred for an aggregate price of $1.00 in accordance with
the terms of the Perpetual License Agreement</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company did not exercise its option to repurchase up to 50% of the Series G Preferred, and all such shares were converted to common
stock on March 15, 2024. At February 28, 2025, <span id="xdx_906_eus-gaap--PreferredStockSharesOutstanding_iI_do_c20250228__us-gaap--StatementClassOfStockAxis__custom--SeriesGConvertiblePreferredStockMember_zBnO2ylgM36b" title="Preferred stock, shares outstanding">no</span> shares of the issued Series G Preferred were outstanding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Series
H Convertible Preferred Stock</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 26, 2024, the Company filed a Certificate of Designation of Series H Convertible Preferred Stock (the &#8220;Series H
Certificate of Designation&#8221;) with the Secretary of State of the State of Nevada, designating <span id="xdx_905_eus-gaap--PreferredStockSharesAuthorized_iI_c20240126__us-gaap--StatementClassOfStockAxis__custom--SeriesHConvertiblePreferredStockMember_z6RcaBv2mAu1" title="Preferred stock, shares authorized">150,000</span>
shares of the Company&#8217;s preferred stock as Series H Preferred Stock, par value $<span id="xdx_90C_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20240126__us-gaap--StatementClassOfStockAxis__custom--SeriesHConvertiblePreferredStockMember_zypY5Qw3AED5" title="Preferred stock, par value">0.001</span>
per share (the &#8220;Series H Preferred&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
terms and conditions set forth in the Series H Certificate of Designation are summarized below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Ranking.
</i>The Series H Preferred rank pari passu to the Company&#8217;s common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Dividends.
</i>Holders of Series H Preferred will be entitled to dividends, on an as-converted basis, equal to dividends actually paid, if any,
on shares of Company common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Voting</i>.
Except as provided by the Company&#8217;s Charter or as otherwise required by the Nevada Revised Statutes, holders of Series H Preferred
are entitled to vote with the holders of outstanding shares of Company common stock, voting together as a single class, with respect
to all matters presented to the Company&#8217;s stockholders for their action or consideration. In any such vote, each holder is entitled
to a number of votes equal to the number of shares of common stock into which the Series H Preferred held by such holder is convertible.
The Company may not, without the consent of holders of a majority of the outstanding shares of Series H Preferred, (i) alter or change
adversely the powers, preferences or rights given to the Series H Preferred or alter or amend the Series H Certificate of Designation,
(ii) amend its Charter or other charter documents in any manner that adversely effects any rights of the holders of the Series H Preferred,
or (c) enter into any agreement with respect to the foregoing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Conversion</i>.
On such date that the Company amends its Charter to increase the number of shares of common stock authorized for issuance thereunder,
to at least the extent required to convert all of the outstanding Series H Preferred, each outstanding share of Series H Preferred shall
automatically be converted into one share of Company common stock (subject to adjustment under certain limited circumstances) (the &#8220;Series
H Conversion Ratio&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Liquidation</i>.
In the event of any liquidation, dissolution or winding up of the Company, either voluntary or involuntary, holders of Series H Preferred
will be entitled to participate, on an as-converted-to-common stock basis calculate based on the Series H Conversion Ratio, with holders
of Company common stock in any distribution of assets of the Company to holders of the Company&#8217;s common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
February 28, 2025, <span title="Preferred stock, shares issued"><span id="xdx_90A_eus-gaap--PreferredStockSharesOutstanding_iI_c20250228__us-gaap--StatementClassOfStockAxis__custom--SeriesHConvertiblePreferredStockMember_zPXkajWGz9i3" title="Preferred stock, shares outstanding">33,000</span></span> shares of the issued Series H Preferred were outstanding, which if converted as of February
28, 2025, would have resulted in the issuance of <span id="xdx_905_eus-gaap--PreferredStockConvertibleSharesIssuable_iI_c20250228__us-gaap--StatementClassOfStockAxis__custom--SeriesHConvertiblePreferredStockMember_zMAiZCl9HXwa" title="Common stock issuable upon conversion">33,000</span> shares of common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Series
I Convertible Preferred Stock</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 22, 2024, the Company filed a Certificate of Designation of Series I Convertible Preferred Stock (the &#8220;Initial Series
I Certificate of Designation&#8221;) with the Secretary of State of the State of Nevada, designating <span id="xdx_900_eus-gaap--PreferredStockSharesAuthorized_iI_c20240222__us-gaap--StatementClassOfStockAxis__custom--SeriesIConvertiblePreferredStockMember_zjIC8UIJlcK1">331,124</span></span>
<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of the Company&#8217;s preferred stock as Series I Convertible
Preferred Stock, par value $<span id="xdx_904_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20240222__us-gaap--StatementClassOfStockAxis__custom--SeriesIConvertiblePreferredStockMember_zAw72DGiuhC1">0.001</span></span>
<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share (the &#8220;Series I Preferred&#8221;). On February
25, 2025, the Company filed an amendment to the Certificate of Designation of Series I Convertible Preferred Stock (the &#8220;Amendment
to Series I Certificate of Designation,&#8221; and together with the Initial Series I Certificate of Designation, the &#8220;Series I
Certificate of Designation&#8221;) with the Secretary of State of the State of Nevada, to increase the number of shares of the Company&#8217;s
preferred stock designated as Series I Preferred to <span id="xdx_900_eus-gaap--PreferredStockSharesAuthorized_iI_c20250225__us-gaap--StatementClassOfStockAxis__custom--SeriesIConvertiblePreferredStockMember_zmfPDHYZIMUb">692,945</span></span>
<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
terms and conditions set forth in the Series I Certificate of Designation are summarized below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Ranking.
</i>The Series I Preferred rank pari passu to the Company&#8217;s common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Dividends.
</i>Holders of Series I Preferred will be entitled to dividends, on an as-converted basis, equal to dividends actually paid, if any,
on shares of Company common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Voting</i>.
Except as provided by the Charter, or as otherwise required by the Nevada Revised Statutes, holders of Series I Preferred are entitled
to vote with the holders of outstanding shares of Company common stock, voting together as a single class, with respect to all matters
presented to the Company&#8217;s stockholders for their action or consideration. In any such vote, each holder is entitled to a number
of votes equal to the number of shares of common stock into which the Series I Preferred held by such holder is convertible. The Company
may not, without the consent of holders of a majority of the outstanding shares of Series I Preferred, (i) alter or change adversely
the powers, preferences or rights given to the Series I Preferred or alter or amend the Series I Certificate of Designation, (ii) amend
its Charter or other charter documents in any manner that adversely effects any rights of the holders of the Series I Preferred, or (c)
enter into any agreement with respect to the foregoing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Conversion</i>.
On such date that the Company amends its Charter to increase the number of shares of common stock authorized for issuance thereunder,
to at least the extent required to convert all of the outstanding shares of Series I Preferred, each outstanding share of Series I Preferred
shall automatically be converted into one share of Company common stock (subject to adjustment under certain limited circumstances) (the
&#8220;Series I Conversion Ratio&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Liquidation</i>.
In the event of any liquidation, dissolution or winding up of the Company, either voluntary or involuntary, holders of Series I Preferred
will be entitled to participate, on an as-converted-to-common stock basis calculated based on the Series I Conversion Ratio, with holders
of Company common stock in any distribution of assets of the Company to holders of the Company&#8217;s common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 15, 2024, the Company entered into a securities purchase agreement with certain accredited investors, pursuant to which the
Company issued and sold an aggregate of $<span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20240215__20240215__us-gaap--StatementClassOfStockAxis__custom--SeriesIConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zE4U5gt1etga" title="Issuance of shares">672,500</span> of the Company&#8217;s securities, consisting of (i) <span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20240215__20240215__us-gaap--StatementClassOfStockAxis__custom--SeriesIConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zUhxlGTD5jKd" title="Issuance of shares">222,680</span> restricted shares of Series I Preferred, and (ii) unregistered warrants
to purchase up to <span id="xdx_905_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20240215__us-gaap--StatementClassOfStockAxis__custom--SeriesIConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zYwR9dgXiJ33" title="Warrants to purchase common stock">111,340</span> shares of Company common stock at a combined price of $<span id="xdx_907_eus-gaap--SharePrice_iI_c20240215__us-gaap--StatementClassOfStockAxis__custom--SeriesIConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zHGEKTXDd78i" title="Share price">3.02</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 15, 2024, the Company entered into a securities purchase agreement with an investor for the sale of <span id="xdx_904_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20240815__20240815__us-gaap--StatementClassOfStockAxis__custom--SeriesIConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_z06NpsU1w4y6" title="Sale of stock, shares">4,967</span> shares of Series I Preferred, at $<span id="xdx_901_eus-gaap--SaleOfStockPricePerShare_iI_c20240815__us-gaap--StatementClassOfStockAxis__custom--SeriesIConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zDpKxUYtGCEa" title="Sale of stock, shares price">3.02</span> per share, resulting in gross proceeds to the Company of $<span id="xdx_905_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_c20240815__20240815__us-gaap--StatementClassOfStockAxis__custom--SeriesIConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_z5x5E7G4Awf6" title="Sale of stock proceeds">15,000</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 31, 2024, the Company entered into a securities purchase agreement with an investor for the sale of <span id="xdx_90E_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20240831__20240831__us-gaap--StatementClassOfStockAxis__custom--SeriesIConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zhY4QXaJPvW7" title="Sale of stock, shares">24,834</span> shares of Series I Preferred at $<span id="xdx_904_eus-gaap--SaleOfStockPricePerShare_iI_c20240831__us-gaap--StatementClassOfStockAxis__custom--SeriesIConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zI7UoZbvVzVl" title="Sale of stock, shares price">3.02</span> per share, resulting in gross proceeds to the Company of $<span id="xdx_90D_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_c20240831__20240831__us-gaap--StatementClassOfStockAxis__custom--SeriesIConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zmJhDJJyyqN2" title="Sale of stock proceeds">75,000</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 1, 2024, the Company entered into a securities purchase agreement with an investor for the sale of <span id="xdx_908_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20241001__20241001__us-gaap--StatementClassOfStockAxis__custom--SeriesIConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_z7uKfJAZlqKh" title="Sale of stock, shares">66,225</span> shares of Series I Preferred at $<span id="xdx_903_eus-gaap--SaleOfStockPricePerShare_iI_c20241001__us-gaap--StatementClassOfStockAxis__custom--SeriesIConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zfPCvEmQkxj" title="Sale of stock, shares price">3.02</span> per share, resulting in gross proceeds to the Company of $<span id="xdx_90A_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_c20241001__20241001__us-gaap--StatementClassOfStockAxis__custom--SeriesIConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zOvdrEUweBq6" title="Sale of stock proceeds">200,000</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 24, 2025, the Company entered into a securities purchase agreement (the &#8220;Series I Purchase Agreement&#8221;) with
certain accredited investors (the &#8220;Purchasers&#8221;), pursuant to which the Company issued and sold an aggregate of <span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20250224__20250224__us-gaap--StatementClassOfStockAxis__custom--SeriesIConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--SeriesIPurchaseAgreementMember_zUIhkjOBdwJ6" title="Restricted shares">331,125</span>
restricted shares of Series I Preferred Stock to the Purchasers at a purchase price of $<span id="xdx_904_eus-gaap--SaleOfStockPricePerShare_iI_c20250224__us-gaap--StatementClassOfStockAxis__custom--SeriesIConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zARw9a2FXOF2" title="Sale of stock, shares price">3.02</span>
per share (the &#8220;Series I Offering&#8221;), resulting in aggregate gross proceeds to the Company of $<span id="xdx_90A_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_c20250224__20250224__us-gaap--StatementClassOfStockAxis__custom--SeriesIConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--SeriesIPurchaseAgreementMember_zwrMGrCZ65p6" title="Sale of stock proceeds">1,000,000</span>.
In addition, the Company issued <span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20250224__20250224__us-gaap--StatementClassOfStockAxis__custom--SeriesIPreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--SeriesIPurchaseAgreementMember_zUW6n00Q1BVk" title="Issuance of shares">10,000</span>
shares of Series I Preferred at $<span id="xdx_909_eus-gaap--SaleOfStockPricePerShare_iI_c20241001__us-gaap--StatementClassOfStockAxis__custom--SeriesIPreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zBybi1QSKXo8" title="Sale of stock, shares price">3.02</span>
per share to an outside contractor as payment for outstanding invoices.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 24 2025, the Company entered into a debt conversion agreement with Greg Miller, an independent contractor of the Company,
whereby Mr. Miller and the Company agreed to convert $<span id="xdx_902_eus-gaap--DebtConversionConvertedInstrumentAmount1_c20250224__20250224__us-gaap--TypeOfArrangementAxis__custom--MillerDebtConversionAgreementMember_zoUUqZLZ2R46" title="Converted amount">100,000</span>
in deferred consulting fees owed to Mr. Miller into <span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20250224__20250224__us-gaap--TypeOfArrangementAxis__custom--MillerDebtConversionAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesIConvertiblePreferredStockMember_zF3KiLH3tJ11" title="Issuance of shares">33,113</span>
shares of Series I Preferred, at a conversion price of $<span id="xdx_90B_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20250224__us-gaap--TypeOfArrangementAxis__custom--MillerDebtConversionAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesIConvertiblePreferredStockMember_zh6vvXLmh4J3" title="Debt conversion price">3.02</span>
per share, and a warrant to purchase <span id="xdx_904_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20250224__us-gaap--TypeOfArrangementAxis__custom--MillerDebtConversionAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesIConvertiblePreferredStockMember_zmwVL8rVnyV3" title="Warrants to purchase common stock">33,113</span>
shares of common stock (the &#8220;Miller Warrant&#8221;). The Miller Warrant has an exercise price of $<span id="xdx_90A_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20250224__us-gaap--TypeOfArrangementAxis__custom--MillerDebtConversionAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesIConvertiblePreferredStockMember_z5GwVjqRpot7" title="Exercise price">4.00</span>
per share, becomes exercisable six months from the issuance date (subject to stockholder approval of removal of the Exchange Cap),
and shall expire three years from the initial exercise date (August 24, 2028).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Series I Preferred shall not be convertible and the Miller Warrant shall be not exercisable into shares of common stock until such date
that the Company obtains stockholder approval to remove the Exchange Cap (as described below).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
February 28, 2025, <span title="Preferred stock, shares issued"><span id="xdx_90E_eus-gaap--PreferredStockSharesOutstanding_iI_c20250228__us-gaap--StatementClassOfStockAxis__custom--SeriesIConvertiblePreferredStockMember_zUdgF5jSWgsc" title="Preferred stock, shares outstanding">500,442</span></span> shares of the Series I Preferred were outstanding, which if converted as of February 28,
2025, would have resulted in the issuance of <span id="xdx_902_eus-gaap--PreferredStockConvertibleSharesIssuable_iI_c20250228__us-gaap--StatementClassOfStockAxis__custom--SeriesIConvertiblePreferredStockMember_zViR1ZgYSmd1" title="Converted issuance of shares of common stock">500,442</span> shares of common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Series
J Nonvoting Convertible Preferred Stock</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 3, 2025, the Company filed a Certificate of Designation of Series J Nonvoting Convertible Preferred Stock (the &#8220;Series
J Certificate of Designation&#8221;) with the Secretary of State of the State of Nevada, designating <span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20250103__20250103__us-gaap--StatementClassOfStockAxis__custom--SeriesJNonvotingConvertiblePreferredStockMember_zqRBMkqSJcu5" title="Restricted shares">297,788</span>
shares of the Company&#8217;s preferred stock as Series J Nonvoting Convertible Preferred Stock, par value $<span id="xdx_906_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20250103__us-gaap--StatementClassOfStockAxis__custom--SeriesJNonvotingConvertiblePreferredStockMember_zc2zlVEBbpFk" title="Preferred stock, par value">0.001</span>
per share (the &#8220;Series J Preferred&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
terms and conditions set forth in the Series J Certificate of Designation are summarized below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Ranking.
</i>The Series J Preferred rank pari passu to the Company&#8217;s common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Dividends.
</i>Holders of Series J Preferred will be entitled to dividends, on an as-converted basis, equal to dividends actually paid, if any,
on shares of Company common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Voting</i>.
Except as provided by the Charter, or as otherwise required by the Nevada Revised Statutes, holders of Series J Preferred are not entitled
to voting rights. However, the Company may not, without the consent of holders of a majority of the outstanding shares of Series J Preferred,
(i) alter or change adversely the powers, preferences or rights given to the Series J Preferred or alter or amend the Series J Certificate
of Designation, (ii) amend its Charter or other charter documents in any manner that adversely effects any rights of the holders of the
Series J Preferred, or (c) enter into any agreement with respect to the foregoing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Conversion</i>.
On the third business day after the date that the Company&#8217;s stockholders approve the conversion of Series J Preferred into shares
of Common Stock in accordance with the listing rules of Nasdaq, each outstanding share of Series J Preferred shall automatically be converted
into one share of Company common stock (subject to adjustment under certain limited circumstances) (the &#8220;Series J Conversion Ratio&#8221;),
subject to beneficial ownership limitations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Liquidation</i>.
In the event of any liquidation, dissolution or winding up of the Company, either voluntary or involuntary, holders of Series J Preferred
will be entitled to participate, on an as-converted-to-common stock basis calculated based on the Series J Conversion Ratio, with holders
of Company common stock in any distribution of assets of the Company to holders of the Company&#8217;s common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 31, 2024, the Company entered into a securities purchase agreement with certain accredited investors, pursuant to which the
Company issued and sold an aggregate of <span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20241231__20241231__us-gaap--StatementClassOfStockAxis__custom--SeriesJNonvotingConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zYp76RjrWlC2" title="Issuance of shares">231,788</span> restricted shares of Series J Preferred, at a purchase price of $<span id="xdx_909_eus-gaap--SharePrice_iI_c20241231__us-gaap--StatementClassOfStockAxis__custom--SeriesJNonvotingConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_z5jYfH7uczp6" title="Share price">3.02</span> per share, resulting in gross proceeds to the Company
of $<span id="xdx_905_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_c20241231__20241231__us-gaap--StatementClassOfStockAxis__custom--SeriesJNonvotingConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zVAHvSTRWQCi" title="Sale of stock proceeds">700,000</span>. In addition, the Company issued a total of <span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20241231__20241231__us-gaap--StatementClassOfStockAxis__custom--SeriesJNonvotingConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zETwHV1wAIUl" title="Issuance of shares for services">66,000</span> shares of Series J Preferred to four consultants for investor relations
services.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Series J Preferred shall be convertible into the Company&#8217;s common stock on such date that the Company obtains stockholder approval
to remove the Exchange Cap.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
February 28, 2025, <span title="Preferred stock, shares issued"><span id="xdx_90F_eus-gaap--PreferredStockSharesOutstanding_iI_c20250228__us-gaap--StatementClassOfStockAxis__custom--SeriesJNonvotingConvertiblePreferredStockMember_z4EO1sdNnv8l" title="Preferred stock, shares outstanding">297,788</span></span> shares of the Series J Preferred were outstanding, which if converted as of February 28,
2025, would have resulted in the issuance of <span id="xdx_90D_eus-gaap--PreferredStockConvertibleSharesIssuable_iI_c20250228__us-gaap--StatementClassOfStockAxis__custom--SeriesJNonvotingConvertiblePreferredStockMember_zS4BPrzLX3F2" title="Common stock issuable upon conversion">297,788</span> shares of common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Series
K Nonvoting Convertible Preferred Stock</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 3, 2025, the Company filed a Certificate of Designation of Series K Nonvoting Convertible Preferred Stock (the &#8220;Series
K Certificate of Designation&#8221;) with the Secretary of State of the State of Nevada, designating <span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20250103__20250103__us-gaap--StatementClassOfStockAxis__custom--SeriesKNonvotingConvertiblePreferredStockMember_z8hCFKypgGIc" title="Restricted shares">60,595</span>
shares of the Company&#8217;s preferred stock as Series K Nonvoting Convertible Preferred Stock, par value $<span id="xdx_90E_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20250103__us-gaap--StatementClassOfStockAxis__custom--SeriesKNonvotingConvertiblePreferredStockMember_zxciiO6flLPd" title="Preferred stock, par value">0.001</span>
per share (the &#8220;Series K Preferred&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
terms and conditions set forth in the Series K Certificate of Designation are summarized below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Ranking.
</i>The Series K Preferred rank pari passu to the Company&#8217;s common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Dividends.
</i>Holders of Series K Preferred will be entitled to dividends, on an as-converted basis, equal to dividends actually paid, if any,
on shares of Company common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Voting</i>.
Except as provided by the Charter, or as otherwise required by the Nevada Revised Statutes, holders of Series K Preferred are not entitled
to voting rights. However, the Company may not, without the consent of holders of a majority of the outstanding shares of Series K Preferred,
(i) alter or change adversely the powers, preferences or rights given to the Series K Preferred or alter or amend the Series K Certificate
of Designation, (ii) amend its Charter or other charter documents in any manner that adversely effects any rights of the holders of the
Series K Preferred, or (c) enter into any agreement with respect to the foregoing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Conversion</i>.
On the third business day after the date that the Company&#8217;s stockholders approve the conversion of Series K Preferred into shares
of Common Stock in accordance with the listing rules of Nasdaq, each outstanding share of Series K Preferred shall automatically be converted
into one share of Company common stock (subject to adjustment under certain limited circumstances) (the &#8220;Series K Conversion Ratio&#8221;),
subject to beneficial ownership limitations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Liquidation</i>.
In the event of any liquidation, dissolution or winding up of the Company, either voluntary or involuntary, holders of Series K Preferred
will be entitled to participate, on an as-converted-to-common stock basis calculated based on the Series K Conversion Ratio, with holders
of Company common stock in any distribution of assets of the Company to holders of the Company&#8217;s common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 31, 2024, the Company issued an aggregate of <span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20241231__20241231__us-gaap--StatementClassOfStockAxis__custom--SeriesKNonvotingConvertiblePreferredStockMember_zYVNUXGoXWxl" title="Issuance of shares">60,595</span> shares of Series K Preferred to a series of investors
at a price of $<span id="xdx_901_eus-gaap--SharePrice_iI_c20241231__us-gaap--StatementClassOfStockAxis__custom--SeriesKNonvotingConvertiblePreferredStockMember_z2DyjOLX6OSf" title="Share price">3.02</span> per share as prepaid guaranteed interest in connection with the sale of an aggregate of $<span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20241231__20241231__us-gaap--StatementClassOfStockAxis__custom--SeriesKNonvotingConvertiblePreferredStockMember_z7pGBVoIMrCb" title="Issuance of shares">1,220,000</span> in promissory
notes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Series K Preferred shall be convertible into the Company&#8217;s common stock on such date that the Company obtains stockholder approval
to remove the Exchange Cap.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
February 28, 2025, <span title="Preferred stock, shares issued"><span id="xdx_90D_eus-gaap--PreferredStockSharesOutstanding_iI_c20250228__us-gaap--StatementClassOfStockAxis__custom--SeriesKNonvotingConvertiblePreferredStockMember_zRtrgYW5oqO4" title="Preferred stock, shares outstanding">60,595</span></span> shares of the Series K Preferred were outstanding, which if converted as of February 28,
2025, would have resulted in the issuance of <span id="xdx_907_eus-gaap--PreferredStockConvertibleSharesIssuable_iI_c20250228__us-gaap--StatementClassOfStockAxis__custom--SeriesKNonvotingConvertiblePreferredStockMember_zGyKd0UC1YVg" title="Converted issuance of shares of common stock">60,595</span> shares of common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Series
L Nonvoting Convertible Preferred Stock</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 3, 2025, the Company filed a Certificate of Designation of Series L Nonvoting Convertible Preferred Stock (the
&#8220;Initial Series L Certificate of Designation&#8221;) with the Secretary of State of the State of Nevada, designating <span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20250103__20250103__us-gaap--StatementClassOfStockAxis__custom--SeriesLNonvotingConvertiblePreferredStockMember_zw5J948csBw6" title="Restricted shares">579,469</span>
shares of the Company&#8217;s preferred stock as Series L Nonvoting Convertible Preferred Stock, par value $<span id="xdx_90C_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20250103__us-gaap--StatementClassOfStockAxis__custom--SeriesLNonvotingConvertiblePreferredStockMember_zxFdB69gfp9d" title="Preferred stock, par value">0.001</span>
per share(the &#8220;Series L Preferred&#8221;). On February 25, 2025, the Company filed an amendment to the Initial Series L Certificate of Designation (the &#8220;Series
L Preferred Amendment,&#8221; and together with the Initial Series L Certificate of Designation, the &#8220;Series L Certificate of Designation&#8221;)
with the Secretary of State of the State of Nevada, to increase the number of shares of the Company&#8217;s preferred stock designated
as Series L Preferred to <span id="xdx_904_eus-gaap--PreferredStockSharesAuthorized_iI_c20250225__us-gaap--StatementClassOfStockAxis__custom--SeriesLNonvotingConvertiblePreferredStockMember_zLBhtrDGaLPc" title="Preferred stock, shares authorized">1,076,158</span> shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
terms and conditions set forth in the Series L Certificate of Designation are summarized below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Ranking.
</i>The Series L Preferred rank pari passu to the Company&#8217;s common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Dividends.
</i>Holders of Series L Preferred will be entitled to dividends, if, as and when declared by the Board out of funds at the time legally
available therefor, dividends in the amount of <span id="xdx_90E_eus-gaap--PreferredStockDividendRatePercentage_pid_dp_uPure_c20250103__20250103__us-gaap--StatementClassOfStockAxis__custom--SeriesLNonvotingConvertiblePreferredStockMember_z602A2WHwORb" title="Dividend percentage">12</span>% per annum per share of Preferred Stock (subject to appropriate adjustment in the event
of any stock dividend, stock split, combination or other similar recapitalization with respect to the Preferred Stock), and no more.
Dividends on the Preferred Stock shall be fully cumulative, shall accrue without interest and without compounding from the date of first
issuance, and shall, if declared by the Board, be payable quarterly in arrears on March 1, June 1, September 1 and December of each year.
All dividends on the Preferred Stock shall be payable (i) in shares of Common Stock of the Company at the Nasdaq Closing Price; provided,
however, that such prices shall not be less than $<span id="xdx_90F_eus-gaap--SaleOfStockPricePerShare_iI_c20250103__us-gaap--StatementClassOfStockAxis__custom--SeriesLNonvotingConvertiblePreferredStockMember_zG9MtSsxsPNg" title="Purchase price, per share">3.02</span> per share, or (ii) cash, at the election of a majority of the independent directors.
Any dividend which shall not be paid on required dividend date on which it shall become due shall be deemed to be &#8220;past due&#8221;
until such dividend shall be paid or until the share of Preferred Stock with respect to which such dividend became due shall no longer
be outstanding, whichever is the earlier to occur. In the event that any dividend becomes &#8220;past due&#8221; the per annum rate shall
increase to 14%.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Voting</i>.
Except as provided by the Charter, or as otherwise required by the Nevada Revised Statutes, holders of Series L Preferred are not entitled
to voting rights However, the Company may not, without the consent of holders of a majority of the outstanding shares of Series L Preferred,
(i) alter or change adversely the powers, preferences or rights given to the Series L Preferred or alter or amend the Series L Certificate
of Designation, (ii) amend its Charter or other charter documents in any manner that adversely effects any rights of the holders of the
Series L Preferred, or (c) enter into any agreement with respect to the foregoing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Conversion</i>.
On the third business day after the date that the Company&#8217;s stockholders approve the conversion of Series L Preferred into shares
of Common Stock in accordance with the listing rules of Nasdaq, each outstanding share of Series L Preferred shall automatically be converted
into one share of Company common stock (subject to adjustment under certain limited circumstances) (the &#8220;Series L Conversion Ratio&#8221;),
subject to beneficial ownership limitations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Liquidation</i>.
In the event of any liquidation, dissolution or winding up of the Company, either voluntary or involuntary, holders of Series L Preferred
will be entitled to participate, on an as-converted-to-common stock basis calculated based on the Series L Conversion Ratio, with holders
of Company common stock in any distribution of assets of the Company to holders of the Company&#8217;s common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 31, 2024, the Company entered into debt conversion agreements with
its chief executive officer, William Kerby, and chairman of the board, Donald P. Monaco (the &#8220;Related Parties&#8221;), whereby
the Related Parties and the Company agreed to convert $<span id="xdx_909_eus-gaap--DebtConversionConvertedInstrumentAmount1_pn4n6_c20241231__20241231__srt--TitleOfIndividualAxis__custom--MessrsKerbyAndMonacoMember__us-gaap--TypeOfArrangementAxis__custom--RelatedPartyDebtConversionAgreementsMember_z0bWZk7HXdfh" title="Converted amount">1.75</span> million in existing unsecured promissory notes owed to the Related Parties
for monies advanced to the Company into an aggregate of <span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20241231__20241231__srt--TitleOfIndividualAxis__custom--MessrsKerbyAndMonacoMember__us-gaap--StatementClassOfStockAxis__custom--SeriesLNonvotingConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--RelatedPartyDebtConversionAgreementsMember_zs93oHrPKI0f" title="Restricted shares">579,469</span> restricted shares of Series L Preferred, at a purchase price of $<span id="xdx_90D_eus-gaap--SaleOfStockPricePerShare_iI_c20241231__srt--TitleOfIndividualAxis__custom--MessrsKerbyAndMonacoMember__us-gaap--StatementClassOfStockAxis__custom--SeriesLNonvotingConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--RelatedPartyDebtConversionAgreementsMember_zoRaJYGTeIjb" title="Purchase price, per share">3.02</span> per share.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 24, 2025, the Company entered into debt conversion agreements with
its chief executive officer, William Kerby, and chairman of the board, Donald P. Monaco, whereby
the Related Parties and the Company agreed to convert $<span id="xdx_90E_eus-gaap--DebtConversionConvertedInstrumentAmount1_c20250224__20250224__us-gaap--TypeOfArrangementAxis__custom--RelatedPartyDebtConversionAgreementsMember__us-gaap--StatementClassOfStockAxis__custom--SeriesLNonvotingConvertiblePreferredStockMember_ziHxJhrI8nZc" title="Converted amount">500,000</span> in deferred salary (Mr. Kerby) and $<span id="xdx_90A_eus-gaap--ProceedsFromUnsecuredNotesPayable_pn5n6_c20250224__20250224__us-gaap--TypeOfArrangementAxis__custom--RelatedPartyDebtConversionAgreementsMember__us-gaap--StatementClassOfStockAxis__custom--SeriesLNonvotingConvertiblePreferredStockMember_zM611ZdNl5ll" title="Unsecured promissory notes">1.0</span> million in existing unsecured
promissory notes owed for monies advanced to the Company (Mr. Monaco), respectively, into an aggregate of <span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20250224__20250224__us-gaap--TypeOfArrangementAxis__custom--RelatedPartyDebtConversionAgreementsMember__us-gaap--StatementClassOfStockAxis__custom--SeriesLNonvotingConvertiblePreferredStockMember_zfkF3xJox5Hg" title="Restricted shares">496,687</span> restricted shares of
Series L Preferred at a conversion price of $<span id="xdx_902_eus-gaap--SaleOfStockPricePerShare_iI_c20250224__us-gaap--StatementClassOfStockAxis__custom--SeriesLNonvotingConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--RelatedPartyDebtConversionAgreementsMember_zEQYUFXzuhMk" title="Purchase price, per share">3.02</span> per
share.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Series L Preferred shall be convertible into the Company&#8217;s common stock on such date that the Company obtains stockholder approval
to remove the Exchange Cap (as described below), subject to beneficial ownership limitations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
February 28, 2025, <span title="Preferred stock, shares issued"><span id="xdx_900_eus-gaap--PreferredStockSharesOutstanding_iI_c20250228__us-gaap--StatementClassOfStockAxis__custom--SeriesLNonvotingConvertiblePreferredStockMember_zf890FYnq3Vl" title="Preferred stock, shares outstanding">1,076,156</span></span> shares of the Series L Preferred were outstanding, which if converted as of February 28,
2025, would have resulted in the issuance of <span id="xdx_90F_eus-gaap--PreferredStockConvertibleSharesIssuable_iI_c20250228__us-gaap--StatementClassOfStockAxis__custom--SeriesLNonvotingConvertiblePreferredStockMember_zTTBPSqknx52" title="Converted issuance of shares of common stock">1,076,156</span> shares of common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Series
M Nonvoting Convertible Preferred Stock</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 3, 2025, the Company filed a Certificate of Designation of Series M Nonvoting Convertible Preferred Stock (the &#8220;Series
M Certificate of Designation&#8221;) with the Secretary of State of the State of Nevada, designating <span id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20250103__20250103__us-gaap--StatementClassOfStockAxis__custom--SeriesMNonvotingConvertiblePreferredStockMember_zOdtJ9ntlIge" title="Restricted shares">165,562</span>
shares of the Company&#8217;s preferred stock as Series M Nonvoting Convertible Preferred Stock, par value $<span id="xdx_901_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20250103__us-gaap--StatementClassOfStockAxis__custom--SeriesMNonvotingConvertiblePreferredStockMember_z2NKN9bwu4Kg" title="Preferred stock, par value">0.001</span>
per share (the &#8220;Series M Preferred&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
terms and conditions set forth in the Series M Certificate of Designation are summarized below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Ranking.
</i>The Series M Preferred rank pari passu to the Company&#8217;s common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Dividends.
</i>Holders of Series M Preferred will be entitled to dividends, if, as and when declared by the Board out of funds at the time legally
available therefor, dividends in the amount of <span id="xdx_900_eus-gaap--PreferredStockDividendRatePercentage_pid_dp_uPure_c20250103__20250103__us-gaap--StatementClassOfStockAxis__custom--SeriesMNonvotingConvertiblePreferredStockMember_zZdJb3e6He6k" title="Dividend percentage">12</span>% per annum per share of Preferred Stock (subject to appropriate adjustment in the event
of any stock dividend, stock split, combination or other similar recapitalization with respect to the Preferred Stock), and no more.
Dividends on the Preferred Stock shall be fully cumulative, shall accrue without interest and without compounding from the date of first
issuance, and shall, if declared by the Board, be payable quarterly in arrears on March 1, June 1, September 1 and December of each year.
All dividends on the Preferred Stock shall be payable (i) in shares of Common Stock of the Company at the Nasdaq Closing Price; provided,
however, that such prices shall not be less than $<span id="xdx_902_eus-gaap--SaleOfStockPricePerShare_iI_c20250103__us-gaap--StatementClassOfStockAxis__custom--SeriesMNonvotingConvertiblePreferredStockMember_zAOACmj362H2" title="Purchase price, per share">3.02</span> per share, or (ii) cash, at the election of a majority of the independent directors.
Any dividend which shall not be paid on required dividend date on which it shall become due shall be deemed to be &#8220;past due&#8221;
until such dividend shall be paid or until the share of Preferred Stock with respect to which such dividend became due shall no longer
be outstanding, whichever is the earlier to occur. In the event that any dividend becomes &#8220;past due&#8221; the per annum rate shall
increase to 14%.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Voting</i>.
Except as provided by the Charter, or as otherwise required by the Nevada Revised Statutes, holders of Series M Preferred are not entitled
to voting rights. However, the Company may not, without the consent of holders of a majority of the outstanding shares of Series M Preferred,
(i) alter or change adversely the powers, preferences or rights given to the Series M Preferred or alter or amend the Series M Certificate
of Designation, (ii) amend its Charter or other charter documents in any manner that adversely effects any rights of the holders of the
Series M Preferred, or (c) enter into any agreement with respect to the foregoing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Conversion</i>.
On the third business day after the date that the Company&#8217;s stockholders approve the conversion of Series M Preferred into shares
of Common Stock in accordance with the listing rules of Nasdaq, each outstanding share of Series M Preferred shall automatically be converted
into one share of Company common stock (subject to adjustment under certain limited circumstances) (the &#8220;Series M Conversion Ratio&#8221;),
subject to beneficial ownership limitations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Liquidation</i>.
In the event of any liquidation, dissolution or winding up of the Company, either voluntary or involuntary, holders of Series M Preferred
will be entitled to participate, on an as-converted-to-common stock basis calculated based on the Series M Conversion Ratio, with holders
of Company common stock in any distribution of assets of the Company to holders of the Company&#8217;s common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 31, 2024, the Company entered into a securities purchase agreement with certain accredited investors, pursuant to which the
Company may issue and sell up to $<span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20241231__20241231__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesMNonvotingConvertiblePreferredStockMember_zZscwvrUyrn4" title="Restricted shares">500,000</span> of restricted shares of Series M Preferred, at a purchase price of $<span id="xdx_906_eus-gaap--SaleOfStockPricePerShare_iI_c20241231__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesMNonvotingConvertiblePreferredStockMember_zVwTLZ977Sw9" title="Purchase price, per share">3.02</span> per share.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, as part of the Series M Preferred offering, on December 31, 2024, the Company entered into a debt conversion agreement
with an existing lender whereby the lender and the Company agreed to convert $<span id="xdx_90E_eus-gaap--DebtConversionConvertedInstrumentAmount1_c20241231__20241231__us-gaap--StatementClassOfStockAxis__custom--SeriesMNonvotingConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--DebtConversionAgreementMember_zq7Jb0QNf96c" title="Debt converted amount">350,000</span>
in existing unsecured promissory notes plus accrued interest owed to the lender for monies advanced to the Company into shares of
Series M Preferred.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Series M Preferred shall be convertible into the Company&#8217;s common stock on such date that the Company obtains stockholder approval
to remove the Exchange Cap.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 31, 2024, in connection with the foregoing, the Company issued <span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20241231__20241231__us-gaap--StatementClassOfStockAxis__custom--SeriesMNonvotingConvertiblePreferredStockMember_zXOhuFET6MJl" title="Issuance of shares">133,278</span>
shares of Series M Preferred to an investor pursuant to a debt conversion agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At February 28, 2025, all <span id="xdx_901_eus-gaap--PreferredStockSharesIssued_iI_c20250228__us-gaap--StatementClassOfStockAxis__custom--SeriesMNonvotingConvertiblePreferredStockMember_z98tTMXOF478" title="Preferred stock, shares issued"><span id="xdx_90D_eus-gaap--PreferredStockSharesOutstanding_iI_c20250228__us-gaap--StatementClassOfStockAxis__custom--SeriesMNonvotingConvertiblePreferredStockMember_zBAAKrlUXXF4" title="Preferred stock, shares outstanding">133,278</span></span>
shares of the Series M Preferred were outstanding, which if converted as of February 28, 2025, would have resulted
in the issuance of <span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesConversionOfUnits_c20240301__20250228__us-gaap--StatementClassOfStockAxis__custom--SeriesMNonvotingConvertiblePreferredStockMember_zxIZ2glL7L3j" title="Common stock issuable upon conversion">133,278</span>
shares of common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Series
N Nonvoting Convertible Preferred Stock</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 30, 2025, the Company filed a Certificate of Designation of Series N Convertible Preferred Stock (the &#8220;Series N
Certificate of Designation&#8221;) with the Secretary of State of the State of Nevada, designating <span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20250103__20250103__us-gaap--StatementClassOfStockAxis__custom--SeriesNNonvotingConvertiblePreferredStockMember_zOUglbwzLDQf" title="Restricted shares">500,000</span>
shares of the Company&#8217;s preferred stock as Series N Convertible Preferred Stock, par value $<span id="xdx_90E_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20250103__us-gaap--StatementClassOfStockAxis__custom--SeriesNNonvotingConvertiblePreferredStockMember_zMFcuI5CZk1i" title="Preferred stock, par value">0.001</span>
per share (the &#8220;Series N Preferred&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
terms and conditions set forth in the Series N Certificate of Designation are summarized below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Ranking.
</i>The Series N Preferred rank pari passu to the Company&#8217;s common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Dividends.
</i>Holders of Series N Preferred will be entitled to dividends, on an as-converted basis, equal to dividends actually paid, if any,
on shares of Company common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Voting</i>.
Except as provided by the Series N Certificate of Designation, or as otherwise required by the Nevada Revised Statutes, holders of Series
N Preferred are not entitled to voting rights. However, the Company may not, without the consent of holders of a majority of the outstanding
shares of Series N Preferred, (i) alter or change adversely the powers, preferences or rights given to the Series N Preferred or alter
or amend the Series N Certificate of Designation, (ii) amend its amended and restated articles of incorporation, amended and restated
bylaws or other charter documents in any manner that adversely effects any rights of the holders of the Series N Preferred, or (c) enter
into any agreement with respect to the foregoing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Conversion</i>.
On the third business day after the date that the Company&#8217;s stockholders approve the conversion of Series N Preferred into shares
of common stock in accordance with the listing rules of Nasdaq, each outstanding share of Series N Preferred shall automatically be converted
into one share of Company common stock (subject to adjustment under certain limited circumstances) (the &#8220;Series N Conversion Ratio&#8221;),
subject to beneficial ownership limitations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Liquidation</i>.
In the event of any liquidation, dissolution or winding up of the Company, either voluntary or involuntary, holders of Series N Preferred
will be entitled to participate, on an as-converted-to-common stock basis calculated based on the Series N Conversion Ratio (as defined
in the Series N Certificate of Designation), with holders of Company common stock in any distribution of assets of the Company to holders
of the Company&#8217;s common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 28, 2025, the Company entered into a securities purchase agreement with an accredited
investor, pursuant to which the Company issued and sold the purchaser (i) <span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20250128__20250128__us-gaap--StatementClassOfStockAxis__custom--SeriesNNonvotingConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zqbnJZQtgAMi" title="Restricted shares">17,000</span> restricted shares of Series N Preferred and (ii) warrants to
purchase <span id="xdx_905_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20250128__us-gaap--StatementClassOfStockAxis__custom--SeriesNNonvotingConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zgmwKVtsXA2a" title="Warrants to purchase common stock">17,000</span> shares of Company common stock, at a combined purchase price of $<span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20250128__us-gaap--StatementClassOfStockAxis__custom--SeriesNNonvotingConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zXTcVmlFpkxf" title="Warrants purchase price">5.00</span> per share and warrant,
resulting in gross proceeds to the Company of $<span id="xdx_906_eus-gaap--ProceedsFromIssuanceOfWarrants_c20250128__20250128__us-gaap--StatementClassOfStockAxis__custom--SeriesNNonvotingConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_z4pSYqAktbg6" title="Gross proceeds">85,000</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 24, 2025, the Company and Blue Fysh Holdings Inc. (&#8220;Blue Fysh&#8221;) entered into a share exchange agreement (the &#8220;BF
Share Exchange Agreement&#8221;) whereby Blue Fysh agreed to issue <span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20250128__20250128__us-gaap--StatementClassOfStockAxis__custom--SeriesNNonvotingConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__dei--LegalEntityAxis__custom--BlueFyshHoldingsIncMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zISI3Wgnbwf9" title="Restricted shares">82</span> restricted shares of its common stock to the Company, representing
a ten percent (<span id="xdx_90A_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20250128__us-gaap--StatementClassOfStockAxis__custom--SeriesNNonvotingConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__dei--LegalEntityAxis__custom--BlueFyshHoldingsIncMember_z8cLbTETA5c9" title="Interest rate">10</span>%) interest in Blue Fysh, in exchange for <span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20250128__20250128__us-gaap--StatementClassOfStockAxis__custom--SeriesNNonvotingConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__dei--LegalEntityAxis__custom--BlueFyshHoldingsIncMember_z5vsJPbVCyY7" title="Restricted shares">483,000</span> restricted shares of Series N Preferred at an issuance price of $<span id="xdx_909_eus-gaap--SharePrice_iI_pid_c20250128__us-gaap--StatementClassOfStockAxis__custom--SeriesNNonvotingConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__dei--LegalEntityAxis__custom--BlueFyshHoldingsIncMember_z6757XdqSBre" title="Share price">5.00</span> per share (the &#8220;BF Share Exchange&#8221;).
The BF Share Exchange closed on February 28, 2025.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Series N Preferred shall be convertible into the Company&#8217;s common stock on such date that the Company obtains stockholder approval
to remove the Exchange Cap.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
February 28, 2025, <span id="xdx_905_eus-gaap--PreferredStockSharesOutstanding_iI_c20250228__us-gaap--StatementClassOfStockAxis__custom--SeriesNNonvotingConvertibleConvertiblePreferredStockMember_ztaGf0VmnbGf" title="Preferred stock, shares outstanding">500,000</span> shares of the Series N Preferred were outstanding, which if converted as of February 28,
2025, would have resulted in the issuance of <span id="xdx_90F_eus-gaap--PreferredStockConvertibleSharesIssuable_iI_c20250228__us-gaap--StatementClassOfStockAxis__custom--SeriesNNonvotingConvertibleConvertiblePreferredStockMember_z0HYZvaK6ky5" title="Converted issuance of shares of common stock">500,000</span> shares of common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Series
O Nonvoting Convertible Preferred Stock</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 6, 2025, the Company filed a Certificate of Designation of Series O Nonvoting Convertible Preferred Stock (the
&#8220;Series O Certificate of Designation&#8221;) with the Secretary of State of the State of Nevada, designating <span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20250206__20250206__us-gaap--StatementClassOfStockAxis__custom--SeriesONonvotingConvertiblePreferredStockMember_zpajU4Nv96S" title="Restricted shares">451,614</span>
shares of the Company&#8217;s preferred stock as Series O Nonvoting Convertible Preferred Stock, par value $<span id="xdx_90D_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20250206__us-gaap--StatementClassOfStockAxis__custom--SeriesONonvotingConvertiblePreferredStockMember_ztKyiykfFosd" title="Preferred stock, par value">0.001</span>
per share (the &#8220;Series O Preferred&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
terms and conditions set forth in the Series O Certificate of Designation are summarized below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Ranking.
</i>The Series O Preferred rank pari passu to the Company&#8217;s common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Dividends.
</i>Holders of Series O Preferred will be entitled to dividends, on an as-converted basis, equal to dividends actually paid, if any,
on shares of Company common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Voting</i>.
Except as provided by the Series O Certificate of Designation, or as otherwise required by the Nevada Revised Statutes, holders of Series
O Preferred are not entitled to voting rights. However, the Company may not, without the consent of holders of a majority of the outstanding
shares of Series O Preferred, (i) alter or change adversely the powers, preferences or rights given to the Series O Preferred or alter
or amend the Series O Certificate of Designation, (ii) amend its amended and restated articles of incorporation, amended and restated
bylaws or other charter documents in any manner that adversely effects any rights of the holders of the Series O Preferred, or (c) enter
into any agreement with respect to the foregoing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Conversion</i>.
On the third business day after the date that the Company&#8217;s stockholders approve the conversion of Series O Preferred into shares
of common stock in accordance with the listing rules of Nasdaq, each outstanding share of Series O Preferred shall automatically be converted
into one share of Company common stock (subject to adjustment under certain limited circumstances) (the &#8220;Series O Conversion Ratio&#8221;),
subject to beneficial ownership limitations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Liquidation</i>.
In the event of any liquidation, dissolution or winding up of the Company, either voluntary or involuntary, holders of Series O Preferred
will be entitled to participate, on an as-converted-to-common stock basis calculated based on the Series O Conversion Ratio (as defined
in the Series O Certificate of Designation), with holders of Company common stock in any distribution of assets of the Company to holders
of the Company&#8217;s common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 6, 2025, in connection with the initial <span id="xdx_90A_eus-gaap--BusinessAcquisitionPercentageOfVotingInterestsAcquired_iI_pid_dp_uPure_c20250206__us-gaap--BusinessAcquisitionAxis__custom--FSATravelLLCMember_zeI5BSCSrnVa">49</span>%
acquisition of FSA, the Company issued <span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20250206__20250206__us-gaap--StatementClassOfStockAxis__custom--SeriesONonvotingConvertiblePreferredStockMember_zEyjzfmhhv7d" title="Shares issued">161,291</span>
shares of Series O Preferred to FSA.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
shares of Series O Preferred issued and issuable cannot be converted into shares of Company common stock unless and until the Company&#8217;s
stockholders approve the conversion of Series O Preferred into shares of common stock in accordance with the listing rules of Nasdaq.
Upon receipt of such approvals, the share of Series O Preferred outstanding as of such date shall automatically convert into shares of
Company common stock, subject to applicable beneficial ownership limitations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
February 28, 2025, <span id="xdx_906_eus-gaap--PreferredStockSharesOutstanding_iI_c20250228__us-gaap--StatementClassOfStockAxis__custom--SeriesONonvotingConvertiblePreferredStockMember_zQgI5WxaOB0l" title="Preferred stock, shares outstanding">161,291</span> shares of the Series O Preferred were outstanding, which if converted as of February 28,
2025, would have resulted in the issuance of <span id="xdx_905_eus-gaap--PreferredStockConvertibleSharesIssuable_iI_c20250228__us-gaap--StatementClassOfStockAxis__custom--SeriesONonvotingConvertiblePreferredStockMember_zDEy67uEeA41" title="Common stock issuable upon conversion">161,291</span> shares of common stock</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Series
P Nonvoting Convertible Preferred Stock</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 25, 2025, the Company filed a Certificate of Designation of Series P Nonvoting Convertible Preferred Stock (the
&#8220;Series P Certificate of Designation&#8221;) with the Secretary of State of the State of Nevada, designating <span id="xdx_90D_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20250225__20250225__us-gaap--StatementClassOfStockAxis__custom--SeriesPNonvotingConvertiblePreferredStockMember_zjRV5lYzrXP6" title="Restricted shares">343,750</span>
shares of the Company&#8217;s preferred stock as Series P Nonvoting Convertible Preferred Stock, par value $<span id="xdx_90E_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20250225__us-gaap--StatementClassOfStockAxis__custom--SeriesPNonvotingConvertiblePreferredStockMember_zgBVASdwY4Dc" title="Preferred stock, par value">0.001</span>
per share (the &#8220;Series P Preferred&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
terms and conditions set forth in the Series P Certificate of Designation are summarized below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ranking.
The Series P Preferred rank pari passu to the Company&#8217;s common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dividends.
Holders of Series P Preferred will be entitled to dividends, on an as-converted basis, equal to dividends actually paid, if any, on shares
of Company common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Voting.
Except as provided by the Charter, or as otherwise required by the Nevada Revised Statutes, holders of Series P Preferred are not entitled
to voting rights. However, the Company may not, without the consent of holders of a majority of the outstanding shares of Series P Preferred,
(i) alter or change adversely the powers, preferences or rights given to the Series P Preferred or alter or amend the Series P Certificate
of Designation, (ii) amend its Charter or other charter documents in any manner that adversely effects any rights of the holders of the
Series P Preferred, or (c) enter into any agreement with respect to the foregoing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conversion.
On the third business day after the date that the Company&#8217;s stockholders approve the conversion of Series P Preferred into shares
of Common Stock in accordance with the listing rules of Nasdaq, each outstanding share of Series P Preferred shall automatically be converted
into one share of Company common stock (subject to adjustment under certain limited circumstances) (the &#8220;Series P Conversion Ratio&#8221;),
subject to beneficial ownership limitations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Liquidation.
In the event of any liquidation, dissolution or winding up of the Company, either voluntary or involuntary, holders of Series P Preferred
will be entitled to participate, on an as-converted-to-common stock basis calculated based on the Series P Conversion Ratio, with holders
of Company common stock in any distribution of assets of the Company to holders of the Company&#8217;s common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 26, 2025, the Company entered into an Equity Investment Agreement with AOS Holdings
LLC (&#8220;AOS&#8221;), pursuant to which the Company issued and sold to AOS (i) <span id="xdx_90F_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20250226__20250226__us-gaap--StatementClassOfStockAxis__custom--SeriesPNonvotingConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--EquityInvestmentAgreementMember_zI1HPWniz502" title="Sale of stock, shares">93,750</span> restricted shares of Series P Preferred, (ii) a warrant exercisable in cash to purchase up to <span id="xdx_903_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20250226__us-gaap--StatementClassOfStockAxis__custom--SeriesPNonvotingConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--EquityInvestmentAgreementMember_zEOhxa8c6Qlg" title="Warrants to purchase common stock">375,000</span> shares
of common stock (the &#8220;Cash Warrant&#8221;), and (iii) a warrant exercisable in either cash or via cashless exercise (the &#8220;Cashless
Warrant&#8221;) to purchase up to <span id="xdx_909_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_iI_c20250226__us-gaap--StatementClassOfStockAxis__custom--SeriesPNonvotingConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--EquityInvestmentAgreementMember_z4V7Mi6lcV61" title="Warrants to purchase">375,000</span> shares of common stock, for a combined purchase price of $<span id="xdx_906_eus-gaap--SharePrice_iI_c20250226__us-gaap--StatementClassOfStockAxis__custom--SeriesPNonvotingConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--EquityInvestmentAgreementMember_zOaMfIoTxjdj" title="Share price">4.00</span> per share, resulting in gross
proceeds to the Company of $<span id="xdx_907_eus-gaap--ProceedsFromIssuanceOfWarrants_c20250226__20250226__us-gaap--StatementClassOfStockAxis__custom--SeriesPNonvotingConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--EquityInvestmentAgreementMember_z9Td9kHZ3iGb" title="Gross proceeds">375,000</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 26, 2025, the Company entered into a Debt Exchange Agreement with AOS whereby
AOS and the Company agreed to convert $<span id="xdx_90B_eus-gaap--DebtConversionConvertedInstrumentAmount1_c20250226__20250226__us-gaap--StatementClassOfStockAxis__custom--SeriesPNonvotingConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--DebtExchangeAgreementMember_zWYcQofGXV23" title="Converted amount">1,000,000</span> owed to AOS under an existing unsecured promissory note owed for monies advanced to
the Company into <span id="xdx_90C_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20250226__20250226__us-gaap--StatementClassOfStockAxis__custom--SeriesPNonvotingConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--DebtExchangeAgreementMember_zPyueLqYjVk2" title="Sale of stock, shares">250,000</span> shares of Series P Preferred at a conversion price of $<span id="xdx_909_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20250226__us-gaap--StatementClassOfStockAxis__custom--SeriesPNonvotingConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--DebtExchangeAgreementMember_z6TKteeZ1gXg" title="Conversion price">4.00</span> per share.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Series P Preferred shall be convertible into the Company&#8217;s common stock on such date that the Company obtains stockholder approval
to remove the Exchange Cap (as described below), subject to beneficial ownership limitations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
February 28, 2025, <span id="xdx_908_eus-gaap--PreferredStockSharesOutstanding_iI_c20250228__us-gaap--StatementClassOfStockAxis__custom--SeriesPNonvotingConvertiblePreferredStockMember_znU2pxliQcJh" title="Preferred stock, shares outstanding">343,750</span> shares of the Series P Preferred were outstanding, which if converted as of February 28,
2025, would have resulted in the issuance of <span id="xdx_90F_eus-gaap--PreferredStockConvertibleSharesIssuable_iI_c20250228__us-gaap--StatementClassOfStockAxis__custom--SeriesPNonvotingConvertiblePreferredStockMember_zDzHqs2vaAH6" title="Common stock issuable upon conversion">343,750</span> shares of common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Stock
Options</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 28, 2023, at the Annual Meeting of Stockholders of the Company, the Company&#8217;s stockholders approved the adoption of
the NextTrip 2023 Equity Incentive Plan (the &#8220;2023 Plan&#8221;). <span id="xdx_907_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_c20250228__us-gaap--PlanNameAxis__custom--TwoThousandTwentyThreeEquityIncentivePlanMember_zo3mmXkcbxo5" title="Common stock reserved for issuance">7,000,000</span>
shares of common stock have been reserved for issuance under the 2023 Plan, and as of February 28, 2025, all such shares are
available for issuance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of February 28, 2025, we had outstanding options under our 2013 Equity Incentive Plan (the &#8220;2012 Plan&#8221;) to purchase an
aggregate of <span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20250228__us-gaap--PlanNameAxis__custom--TwoThousandThirteenEquityIncentivePlanMember_z5lWraltrygh" title="Common stock shares option outstanding">76,342</span>
shares of our common stock at a weighted-average exercise price of $<span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20250228__us-gaap--PlanNameAxis__custom--TwoThousandThirteenEquityIncentivePlanMember_zS36WPJG0okh" title="Weighted average exercise price">52.69</span>
per share.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
fiscal year 2025, the Company did not grant any options. In fiscal year 2025, <span id="xdx_90B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_c20240301__20250228_zldPJCJcWiw1" title="Share based compensation arrangement by award options vested">3,101</span> options vested and $<span id="xdx_906_eus-gaap--CompensationExpenseExcludingCostOfGoodAndServiceSold_c20240301__20250228_zuBpMRIgQca2" title="Compensation cost">41,114</span> of compensation cost was
recognized during the year. At February 28, 2025, there are vested options exercisable for <span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20250228__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_z1aCqAmcHwO2" title="Stock issued during Stock options exercised">75,992</span> shares of common stock. <span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_do_c20240301__20250228_zXpnLOlY10c5" title="Share based compensation arrangement by award options grants">No</span> options
to purchase shares of common stock were exercised during the fiscal year ended February 28, 2025.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company generally grants stock options to employees, consultants and directors at exercise prices equal to the fair market value of the
Company&#8217;s stock on the dates of grant. Stock options are typically granted throughout the year and generally vest over three years
of service and expire five years from the date of the award, unless otherwise specified. The Company recognizes compensation expense
for the fair value of the stock options over the requisite service period for each stock option award.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
closing of the NextTrip Acquisition on December 29, 2023, the Company assumed options to purchase up to <span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20240301__20250228__srt--RangeAxis__srt--MaximumMember_zOz24DRBl19g" title="Options to purchase of common stock">86,402</span> shares of common
stock. Between December 29, 2023 and February 29, 2024, <span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_pid_c20231229__20240229_zlUILpQ5eShi" title="Options to forfeited or expired">1,342</span> options were forfeited or expired and no options were issued or exercised.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
employee share-based compensation expense for the year ended February 28, 2025 was $<span id="xdx_90B_eus-gaap--ShareBasedCompensation_pp0p0_c20240301__20250228_zRSQ1hA9KgM4" title="Allocation share based compensation expense">67,874</span>, of which $<span id="xdx_904_eus-gaap--ProceedsFromStockOptionsExercised_pp0p0_c20240301__20250228_zgTHMbIBiPr9" title="Stock options">41,114</span> was related to stock options.
There was no capitalized share-based compensation cost as of February 28, 2025, and there were no recognized tax benefits during the
fiscal year ended February 28, 2025.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
estimate the value of an option award, the Company uses the Black-Scholes option-pricing model. This model requires inputs such as
expected life, expected volatility and risk-free interest rate. The forfeiture rate also impacts the amount of aggregate
compensation. These inputs are subjective and generally require significant analysis and judgment to develop. While estimates of
expected life, volatility and forfeiture rate are derived primarily from the Company&#8217;s historical data, the risk-free rate is
based on the yield available on U.S. Treasury constant maturity rates with similar terms to the expected term of the stock option
awards. The fair value of outstanding stock option awards at February 28, 2025 was estimated using the Black-Scholes model with the
following weighted-average assumptions at the date of grant:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_895_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_z7fWqRBOsDU8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Option
activity for the year ended February 28, 2025 was as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8BC_zfQu3JsnJ59" style="display: none">Schedule of Stock Option Activity</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Weighted Average</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Weighted Average</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Exercise</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Remaining</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Aggregate</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Price</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Contractual</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Intrinsic</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Options</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">($)</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Life (Yrs.)</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Value ($)</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 44%; padding-bottom: 2.5pt">Options outstanding at February 29, 2024</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20240301__20250228_zPZHtTXqaegk" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Number of Options Outstanding, Balance">85,300</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 2.5pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; width: 1%; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20240301__20250228_z9ijAU1jR6H5" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; width: 10%; text-align: right" title="Weighted Average Exercise Price Outstanding, Balance">60.50</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 2.5pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; width: 10%; text-align: right"><span id="xdx_90B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20230301__20240229_z7rh1Tw5VOCa" title="Weighted Average Remaining Contractual Life Years, Outstanding Balance">2.52</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_pp0p0_c20240301__20250228_zzRgZC8N6fuf" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Aggregate Intrinsic Value Outstanding">&#160;&#160;&#160;&#160;<span style="-sec-ix-hidden: xdx2ixbrl1700">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">Exercised</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_pid_di0_c20240301__20250228_zgwFJ0vHjxqj" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options, Exercised">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20240301__20250228_zb5XDJ5uwvna" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl1704">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_pp0p0_c20240301__20250228_zMmgjk4Asvdf" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl1706">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Forfeited or cancelled</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_iN_pid_di_c20240301__20250228_zLqMInKaS8x7" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options, Forfeited or cancelled">(8,958</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_pid_c20240301__20250228_zRGsYFDGyqqa" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right" title="Weighted Average Exercise Price, Forfeited or cancelled">125.65</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_980_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedorCancelledInPeriodTotalIntrinsicValue_pp0p0_c20240301__20250228_zGxxh3VyvZD6" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Forfeited or cancelled"><span style="-sec-ix-hidden: xdx2ixbrl1712">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">Options outstanding at February 28, 2025</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20240301__20250228_zxxWWJqIBdUc" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options Outstanding, Balance">76,342</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20240301__20250228_zycMET3eH0s6" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price Outstanding, Balance">52.69</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span id="xdx_904_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20240301__20250228_z7pTiXutuxa4" title="Weighted Average Remaining Contractual Life Years, Outstanding Balance">1.60</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iE_pp0p0_c20240301__20250228_zxoBHzrt13Sc" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value Outstanding"><span style="-sec-ix-hidden: xdx2ixbrl1720">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Options expected to vest in the future as of February 28, 2025</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iE_pid_c20240301__20250228_zRqlghxB8pGb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options, Expected to Vest in the Future Ending Balance">350</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_iE_pid_c20240301__20250228_zRmsLe0OoOx" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Expected to Vest">50.00</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_dtY_c20240301__20250228_zVtPqhUUH0Xg" title="Weighted Average Remaining Contractual Life Years, Expected to Vest">2.34</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_iE_pp0p0_c20240301__20250228_zVuiziQo3bue" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Outstanding, Expected of  Vest"><span style="-sec-ix-hidden: xdx2ixbrl1728">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">Options exercisable at February 28, 2025</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_pid_c20240301__20250228_zKfkfptkyge6" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options, Exercisable">75,992</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20240301__20250228_z7d3SzvRF8i6" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right" title="Weighted Average Exercise Price, Exercisable">52.71</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right"><span id="xdx_90D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20240301__20250228_zLUR4wKzojMi" title="Weighted Average Remaining Contractual Life Years, Exercisable">1.59</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iE_pp0p0_c20240301__20250228_zup665Ufk8G" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Outstanding, Exercisable"><span style="-sec-ix-hidden: xdx2ixbrl1736">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Options vested, exercisable, and options expected to vest at February 28, 2025</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_iE_pid_c20230301__20250228_zLyRyLfYBXdb" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options, Vested, Exercisable and Options Expected to Vest, Balance">76,342</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_iE_c20240301__20250228_zOaTHmRKbjRj" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price, Vested, Exercisable and Options Expected to Vest">52.69</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span id="xdx_904_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_dtY_c20240301__20250228_z3c1eUlHCHM8" title="Weighted Average Remaining Contractual Life (Yrs.), Vested, Exercisable and Options Expected to Vest">1.60</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_iE_pp0p0_c20240301__20250228_zetWwG7Azr31" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Outstanding,Exercisable and Options Expected to Vest"><span style="-sec-ix-hidden: xdx2ixbrl1744">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8AA_z4ubeUqz6YUc" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
aggregate intrinsic value is calculated as the difference between the exercise price of the underlying awards and the quoted price of
our common stock for those awards that have an exercise price below the $<span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20240301__20250228_zdDyM65zTIOd" title="Options exercise price">3.98</span> closing price of our Common Stock on February 28, 2025.
All of the outstanding option grants have an exercise price above $<span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20240301__20250228_z9fEYjzkqxFf" title="Options exercise price">3.98</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
February 28, 2025, there was $<span id="xdx_906_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_iI_c20250228_zkNsCfHfwop5" title="Unrecognized stock-based compensation expense, stock option">5,260</span> of unrecognized share-based compensation expense related to unvested stock options with a weighted
average remaining recognition period of <span id="xdx_901_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_dtY_c20240301__20250228_zyY6aVCYc9n7" title="Weighted average remaining recognition period">0.34</span> years.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Stock
Appreciation Rights</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
purposes of the 2020 Stock Appreciation Rights Plan (the &#8220;2020 SARs Plan&#8221;) are to: (i) enable the Company to attract and
retain the types of employees, consultants, and directors (collectively, &#8220;Service Providers&#8221;) who will contribute to the
Company&#8217;s long-range success; (ii) provide incentives that align the interests of Service Providers with those of the
shareholders of the Company; and (iii) promote the success of the Company&#8217;s business. The 2020 SARs Plan provides for
incentive awards that are only made in the form of stock appreciation rights payable in cash (&#8220;SARs&#8221;). No shares of
common stock were reserved in connection with the adoption of the 2020 SARs Plan since no shares will be issued pursuant to the
2020 SARs Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SARs
may be granted to any Service Provider. A SAR is the right to receive an amount equal to the Spread with respect to a share of the
Company&#8217;s common stock (a &#8220;Share&#8221;) upon the exercise of the SAR. The &#8220;Spread&#8221; is the difference
between the exercise price per share specified in a SAR agreement on the date of grant and the fair market value per share on the
date of exercise of the SAR. The exercise price per share will not be less than 100% of the fair market value of a Share on the date
of grant of the SAR. The administrator of the 2020 SARs Plan will have the authority to, among other things, prescribe the terms and
conditions of each SAR, including, without limitation, the exercise price and medium of payment and vesting provisions, and to
specify the provisions of the SAR agreement relating to such grant.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
closing of the NextTrip Acquisition on December 29, 2023, the Company assumed <span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20231229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_z5PCbZEWw0re" title="Reverse acquisition shares outstanding">40,390</span> outstanding SARs. Between December 29, 2023
and February 29, 2024, <span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_dn_c20241229__20241229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zHJ6bvYJEXWb" title="Shares forfeited or expired">none</span> were forfeited or expired and <span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_do_c20241229__20241229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_z98G3VLCaAd1" title="Shares issued or exercised">no</span> SARs were issued or exercised.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recognizes compensation expense and a corresponding liability for the fair value of the SARs over the requisite service period
for each SAR award. The SAR&#8217;s are revalued at each reporting date in accordance with ASC 718 &#8220;Compensation-Stock Compensation&#8221;,
and any changes in fair value are reflected in income as of the applicable reporting date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_89B_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_hus-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_z2BXlDB1N7Lj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fair value of outstanding SAR awards was estimated using the Black-Scholes model with the following assumptions for the twelve months
ended February 28, 2025:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Assumptions:</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8BE_zRCuvey8r5x6" style="display: none">Schedule of Share Based Payments Award Stock Options Valuation Assumptions</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 75%; margin-right: auto">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">2025</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 78%; text-align: left">Dividend yield</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right"><span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_uPure_c20240301__20250228__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyStockAppreciationRightsPlanMember_zvTY0812C7Tb" title="Dividend yield">0.0</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">%</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Risk-free interest rate</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_dp_uPure_c20240301__20250228__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyStockAppreciationRightsPlanMember_zKHl8PAoQXla" title="Risk-free interest rate, minimum">2.3</span>%-<span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_dp_uPure_c20240301__20250228__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyStockAppreciationRightsPlanMember_zX9fO0EfkiO6" title="Risk-free interest rate, maximum">5.25</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Expected volatility</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_dp_uPure_c20240301__20250228__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyStockAppreciationRightsPlanMember_zq5yRj9WdE3e" title="Expected volatility, minimum">96.5</span>%-<span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_dp_uPure_c20240301__20250228__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyStockAppreciationRightsPlanMember_zq9WsGGxTKmj" title="Expected volatility, maximum">187.8</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Expected life (in years)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20240301__20250228__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyStockAppreciationRightsPlanMember__srt--RangeAxis__srt--MinimumMember_z86hD1Pm8OR" title="Expected life">0.16</span>-<span id="xdx_90B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20240301__20250228__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyStockAppreciationRightsPlanMember__srt--RangeAxis__srt--MaximumMember_z8xRrC63KiZ" title="Expected life">2.08</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A2_zKoCi2YHf8pl" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_89B_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_hus-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zY6pvwKtnjEh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SARs
activity for the year ended February 28, 2025 was as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8BC_z9W7DSJJXzi3" style="display: none">Schedule of Stock Option Activity</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Weighted Average</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Weighted Average</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Exercise</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Remaining</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Aggregate</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Price</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Contractual</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Intrinsic</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">SARs</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">($)</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Life (Yrs.)</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Value ($)</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 44%; padding-bottom: 2.5pt">SARs outstanding at February 29, 2024</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20240301__20250228__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zjkCZZCRAwh8" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Number of Options, Outstanding, Balance">40,390</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20240301__20250228__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zQ4n6w20TGg5" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Weighted Average Exercise Price, Outstanding Balance">44.77</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right"><span id="xdx_90B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20230301__20240228__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zRRT7pE2pkti" title="Weighted Average Remaining Contractual Life, Outstanding Balance">2.99</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_pp0p0_c20240301__20250228__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zsdfPy788FQj" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Aggregate Intrinsic Value, Outstanding Balance">&#160;&#160;&#160;&#160;&#160;&#160;<span style="-sec-ix-hidden: xdx2ixbrl1784">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">Exercised</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_pid_di_c20240301__20250228__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_z4IaxQLm7lD8" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl1786">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20240301__20250228__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zSHJCbpGBwW8" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl1788">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_pp0p0_c20240301__20250228__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zceVw30bzj7" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl1790">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Forfeited or cancelled</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_iN_pid_di_c20240301__20250228__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zYUiseWCIOyj" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options, Forfeited or cancelled">(167</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98B_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageForfeitedOrCancelled_pid_c20240301__20250228__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zKmYsp2iQrNe" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Forfeited or cancelled">37.4</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_982_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedorCancelledInPeriodTotalIntrinsicValue_pp0p0_c20240301__20250228__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zbjkcFaAlHz8" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Forfeited or cancelled"><span style="-sec-ix-hidden: xdx2ixbrl1796">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">SARs outstanding February 28, 2025</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20240301__20250228__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zqxsOpD7OZwd" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options, Outstanding, Balance">40,223</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20240301__20250228__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zC6dAbVaDPBg" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Outstanding Balance">44.80</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20240301__20250228__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zr4yQGUbcPJ7" title="Weighted Average Remaining Contractual Life, Outstanding Balance">1.99</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iE_pp0p0_c20240301__20250228__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zGpRxO6pgOQf" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Outstanding Balance"><span style="-sec-ix-hidden: xdx2ixbrl1804">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">SARs expected to vest in the future as of February 28, 2025</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iE_pid_c20240301__20250228__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zGGSsgm4v6p9" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options, Expected to vest in the future, Balance">5,213</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_iE_pid_c20240301__20250228__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zn7Hsp92P6K3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Expected to Vest">27.66</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_dtY_c20240301__20250228__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zwFy3VfuD7Ta" title="Weighted Average Remaining Contractual Life, Expected to Vest">1.93</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_iE_pp0p0_c20240301__20250228__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zGQtOUP8Ukwd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Options expected to vest in the future"><span style="-sec-ix-hidden: xdx2ixbrl1812">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">SARs exercisable at February 28, 2025</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_pid_c20240301__20250228__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zx1loO0OnAHd" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options, Exercisable">35,010</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20240301__20250228__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zAMuaPcKE2H9" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Exercisable">47.35</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20240301__20250228__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zD33XKKplyh9" title="Weighted Average Remaining Contractual Life, Exercisable">2.34</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iE_pp0p0_c20240301__20250228__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zJCSqvoC7hnd" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Options exercisable"><span style="-sec-ix-hidden: xdx2ixbrl1820">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">SARs vested, exercisable, and options expected to vest at February 28, 2025</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_iE_pid_c20240301__20250228__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_z0urZVBN5lfj" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options, Vested, Exercisable and Options Expected to Vest Balance">40,223</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_iE_pid_c20240301__20250228__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zva9jgslCi35" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Vested, Exercisable and Options Expected to Vest">44.80</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_dtY_c20240301__20250228__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zf1jdG76Rzj6" title="Weighted Average Remaining Contractual Life, Vested, Exercisable and Options Expected to Vest">1.99</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_iE_pp0p0_c20240301__20250228__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zklpPrAoaHe4" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Options vested, exercisable and options expected to vest"><span style="-sec-ix-hidden: xdx2ixbrl1828">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A5_z19QDd2hIeyl" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
aggregate intrinsic value is calculated as the difference between the exercise price of the underlying awards and the quoted price of
our common stock for those awards that have an exercise price below the $<span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20240301__20250228__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyStockAppreciationRightsPlanMember_zhEqFikJSe5f" title="Options exercise price">3.98</span> closing price of our common stock on February 28, 2025.
All the SARs have an exercise price above $<span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20240301__20250228__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyStockAppreciationRightsPlanMember_zZEZPtWnuHKk" title="Options exercise price">3.98</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the year ended February 28, 2025, $<span id="xdx_905_eus-gaap--AllocatedShareBasedCompensationExpense_c20240301__20250228__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyStockAppreciationRightsPlanMember_zf6X6c9CefPk" title="Share based compensation expense">67,874</span> of share-based compensation expense was recognized, and at February 28, 2025, there was $<span id="xdx_900_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_iI_c20250228__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyStockAppreciationRightsPlanMember_zRDVDCFMfG3i" title="Unrecognized share based compensation cost">119</span>
of unrecognized share-based compensation expense related to unvested SARs with a weighted average remaining recognition period of <span id="xdx_90A_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardWeightedAverageRemainingRecognitionPeriod_dtY_c20240301__20250228__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyStockAppreciationRightsPlanMember_zpvquFCnh26a" title="Weighted average remaining recognition period">0.26</span>
years.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Warrants</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
February 28, 2025, the Company had outstanding warrants to purchase a total of <span id="xdx_909_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_iI_c20250228__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zpWoyYv4gsfi" title="Purchase of outstanding warrants">3,015,885</span> shares of common stock. The warrants have exercise
prices that range from $<span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20250228__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--RangeAxis__srt--MinimumMember_zUVFINpdY1be" title="Warrants exercise price">3.02</span> to $<span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20250228__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--RangeAxis__srt--MaximumMember_zbSbYTOWgPnl" title="Warrants exercise price">350.00</span>, which if not exercised, will <span id="xdx_904_ecustom--DescriptionForWarrantExpiration_c20240301__20250228__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zbpmzUCaixki" title="Warrant description">expire between July 26, 2025 and August 24, 2030</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_893_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_zFI411ZI4oWh" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The fair value of warrants issued during the year
was estimated using the Black-Scholes model with the following assumptions for the twelve months ended February 28, 2025:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"><b>Assumptions:</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8B0_zjrLnBZbNBQh" style="display: none">Schedule of Share Based Payments Award Stock Options Valuation Assumptions</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2025</td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 80%; text-align: left">Dividend yield</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 18%; text-align: right"><span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_uPure_c20240301__20250228_zaeQiO9I5h47" title="Dividend yield">0.0</span></td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Risk-free interest rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_pid_dp_uPure_c20240301__20250228__srt--RangeAxis__srt--MinimumMember_zhLnzXurenHb" title="Risk-free interest rate, minimum">3.5%</span>-<span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uPure_c20240301__20250228__srt--RangeAxis__srt--MaximumMember_zPhasS7VGCxb" title="Risk-free interest rate, maximum">4.3</span></span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Expected volatility</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_dp_uPure_c20240301__20250228__srt--RangeAxis__srt--MinimumMember_zxTUefTGKlD5" title="Expected volatility, minimum">127.1%</span>-<span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_dp_uPure_c20240301__20250228__srt--RangeAxis__srt--MaximumMember_zjNy1QocRtUj" title="Expected volatility, maximum">159.4</span></span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Expected life (in years)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20240301__20250228__srt--RangeAxis__srt--MinimumMember_zWEcePIp2eya" title="Expected life">1.5</span>-<span id="xdx_90F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20240301__20250228__srt--RangeAxis__srt--MaximumMember_zE5VvcpgzZzb" title="Expected life">5.0</span></span></td><td style="text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8AB_zOXeCzacRYT9" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p id="xdx_896_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zhpRYHcrbv0j" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrant
activity for the year ended February 28, 2025 was as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8BB_zjRXwdpkZ8oh" style="display: none">Schedule of Warranty Activity</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Weighted Average</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Average</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Exercise</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Remaining</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Price</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Contractual</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Warrants</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">($)</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Life (Yrs.)</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 46%; padding-bottom: 2.5pt">Warrants outstanding at February 29, 2024</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_pid_c20240301__20250228_zIpt1G5hP1Ph" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right" title="Warrants Outstanding, Beginning Balance">486,165</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20240301__20250228_zgZUaZGSu2Ci" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right" title="Weighted Average Exercise Price Outstanding, Beginning Balance">9.94</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span id="xdx_90C_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonOutstandingWeightedAverageRemainingContractualTerm_dtY_c20230301__20240229_zw2bFLwpI3ri" title="Weighted Average Remaining Contractual Life Years, Beginning Balance">1.96</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">Granted</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_pid_c20240301__20250228_zvn9T6oeWXu2" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants, Granted">2,637,887</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_980_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20240301__20250228_zFHGq4ni9MKc" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price Outstanding, Granted">4.80</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_901_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonGrantsWeightedAverageRemainingContractualTerm_dtY_c20240301__20250228_zszdofnTORw5" title="Weighted Average Remaining Contractual Life Years, Granted">4.24</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">Exercised</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_iN_pid_di_c20240301__20250228_ztCL8aXqCXTc" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants,Exercised">(104,965</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98D_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageExercisePrice_pid_c20240301__20250228_zMCjplN3nB72" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price Outstanding,Exercised">3.02</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Forfeited or cancelled</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_iN_pid_di_c20240301__20250228_zuGRbpcXSw46" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants, Forfeited or cancelled">(3,202</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98D_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageWeightedAverageExercisePriceWarrantsForfeitedOrCancelled_pid_c20240301__20250228_zSjC9Dr7s8jk" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price Outstanding, Forfeited or cancelled"><span style="-sec-ix-hidden: xdx2ixbrl1884">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">Warrants outstanding at February 28, 2025</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_pid_c20240301__20250228_ziS5TaRvdfLk" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants Outstanding, Ending Balance">3,015,885</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_984_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20240301__20250228_zHwIq6VlvfIk" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price Outstanding, Ending Balance">5.36</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90F_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonOutstandingWeightedAverageRemainingContractualTerm_dtY_c20240301__20250228_zoWs4z0IxTZb" title="Weighted Average Remaining Contractual Life Years, Ending Balance">3.84</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A7_zppCWPjkWhq6" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
further information regarding the allocation of the relative fair values of warrants issued in connection with short-term promissory
notes, see <b>NOTE 12- Notes Payable.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-6<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480237/815-40-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/505/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-16<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Loss Per Share<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Feb. 28, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Loss Per Share</a></td>
<td class="text"><p id="xdx_80B_eus-gaap--EarningsPerShareTextBlock_zDTtQmaqfTp9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
19 &#8211; <span id="xdx_82F_zpwl32m6pnoc">Loss Per Share</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_89C_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zzRn2OLe8J13" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following data show the amounts used in computing loss per share and the effect on income and the weighted average number of shares of
dilutive potential common stock for the years ended February 28, 2025 and February 29, 2024:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8B0_zB5oQ5B78MWg" style="display: none">Schedule of Earnings Per Share, Basic and Diluted</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
  <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_491_20240301__20250228_zIax3Wzc3cCl" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">2025</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_490_20230301__20240229_zea9HjiMcnW9" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">2024</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Year Ended February</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">2025</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">2024</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_zFrF7PIzwta" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left">Loss from continuing operations</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">(10,128,428</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">(6,656,837</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">)</td></tr>
  <tr id="xdx_405_eus-gaap--PreferredStockDividendsIncomeStatementImpact_iN_di_z9I9ynpTyyy9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Preferred dividends</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(78,600</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(7,125</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_40E_eus-gaap--IncomeLossFromContinuingOperations_z8bBw63pHCCg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Loss from continuing operations applicable to common stockholders</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(10,207,028</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(6,663,962</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr id="xdx_407_eus-gaap--IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_zhUfm67V8gu5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Gain (loss) from discontinued operations applicable to common stockholders</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">8,344</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(675,314</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_40E_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_zPemkS9ty0b" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Net loss applicable to common stockholders</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(10,198,684</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(7,339,276</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_zfw2IISZJTAf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Weighted average number of common shares Outstanding used in loss per share during the Period (denominator)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">4,566,787</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">228,274</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A6_zMqJkahZJF4" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 10, 2024, the Company determined that three of the four business milestones per the Exchange Agreement had been achieved.
As a result, <span id="xdx_906_eus-gaap--IncrementalCommonSharesAttributableToContingentlyIssuableShares_c20240610__20240610__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__srt--StatementScenarioAxis__custom--AchievedMember_z28SKl9tP20a" title="Contingent shares issuable">4,393,993</span> of the total Contingent Shares of <span id="xdx_905_eus-gaap--IncrementalCommonSharesAttributableToContingentlyIssuableShares_pid_c20240610__20240610__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember_zyiZR7FWQkR3" title="Contingent shares issuable">5,843,993</span> became eligible for issuance. Pursuant to ASC 260, as there are no
circumstances under which the shares will not be issued, such eligible contingent shares are included in the computation of basic earnings
per share. The following table shows the business milestones and the issuable Contingent Shares:</span></p>

<p id="xdx_89D_eus-gaap--ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock_zwEd4uQAvnFg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8BA_zJ94RHgNtRXe" style="display: none">Schedule
of Business Milestones and Issuable Contingent Shares</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify">Business Milestones</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Contingent Shares</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: italic 10pt Times New Roman, Times, Serif; text-align: justify">Achieved</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 78%; text-align: justify">Launch of leisure travel booking platform</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--IncrementalCommonSharesAttributableToContingentlyIssuableShares_c20240610__20240610__srt--StatementScenarioAxis__custom--AchievedMember__us-gaap--OtherCommitmentsAxis__custom--LeisureTravelBookingPlatformMember_zj7ToOtUlco7" style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right" title="Launch of leisure travel booking platform">1,450,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Launch of group travel booking platform</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--IncrementalCommonSharesAttributableToContingentlyIssuableShares_c20240610__20240610__srt--StatementScenarioAxis__custom--AchievedMember__us-gaap--OtherCommitmentsAxis__custom--GroupTravelBookingPlatformMember_zUvg407RUbDg" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Launch of group travel booking platform">1,450,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 1pt">Launch of PayDlay technology</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--IncrementalCommonSharesAttributableToContingentlyIssuableShares_c20240610__20240610__srt--StatementScenarioAxis__custom--AchievedMember__us-gaap--OtherCommitmentsAxis__custom--FlexPayTechnologyMember_z8y6ZcZE9Lqb" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Launch of FlexPay technology">1,493,993</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 1pt">Total contingent shares issuable on June 10, 2024</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--IncrementalCommonSharesAttributableToContingentlyIssuableShares_c20240610__20240610__srt--StatementScenarioAxis__custom--AchievedMember_zzmq5bWdIYRc" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total contingent shares issuable on June 10, 2024">4,393,993</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: italic 10pt Times New Roman, Times, Serif; text-align: justify">Not Achieved</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 1pt">Launch of travel agent platform</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--IncrementalCommonSharesAttributableToContingentlyIssuableShares_c20240610__20240610__srt--StatementScenarioAxis__custom--NotAchievedMember__us-gaap--OtherCommitmentsAxis__custom--TravelAgentPlatformMember_zis53YyOuZRh" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total contingent shares potentially issuable in future periods">1,450,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 1pt">Total contingent shares potentially issuable in future periods</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--IncrementalCommonSharesAttributableToContingentlyIssuableShares_c20240610__20240610__srt--StatementScenarioAxis__custom--NotAchievedMember_zMhks37wI6C4" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total contingent shares potentially issuable in future periods">1,450,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 2.5pt">Total contingent shares</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--IncrementalCommonSharesAttributableToContingentlyIssuableShares_c20240610__20240610_zwx7IksCC5M5" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total contingent shares">5,843,993</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A3_zmC9g7WtLdQa" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_899_eus-gaap--ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_zkFLoYttQsQb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table shows the reconciliation of the weighted average common shares outstanding for the twelve months ended February 28, 2025
to the weighted average common shares used in the computation of basic earnings per share:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8BD_zbSPJ2PEsGaf" style="display: none">Schedule
of Weighted Average Common Shares</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">February 28,</p>
                                                                               <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">2025</p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 78%"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFdlaWdodGVkIEF2ZXJhZ2UgQ29tbW9uIFNoYXJlcyAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_90D_eus-gaap--CommonStockSharesOutstanding_iI_c20250228_ziMjiQjhAeV9" title="Common stock, shares outstanding">1,656,738</span> common shares outstanding</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20240301__20250228__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zoNFLk1YuaVc" style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right" title="1,656,738 common shares outstanding">1,400,705</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFdlaWdodGVkIEF2ZXJhZ2UgQ29tbW9uIFNoYXJlcyAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_906_eus-gaap--IncrementalCommonSharesAttributableToContingentlyIssuableShares_c20240301__20250228_zKANRDcND0Yf" title="Contingent shares issuable">4,393,993</span> issuable contingent shares</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20240301__20250228__us-gaap--StatementClassOfStockAxis__custom--ContingentSharesMember_z5QbJx49MdH7" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="4,393,993 issuable contingent shares">3,166,083</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">Weighted average common shares outstanding</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20240301__20250228_zL6wAdzc4YJ" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average common shares outstanding">4,566,787</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A8_zIqBfyY49Km3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
issuable Contingent Shares are of the Company&#8217;s sole class of common stock, and as such have the same rights and privileges as
existing common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dilutive
loss per share was not presented as the Company&#8217;s outstanding common and preferred warrants, stock options and preferred stock
common equivalent shares for the periods presented would have had an anti-dilutive effect. At February 28, 2025, the Company had outstanding
warrants to purchase <span id="xdx_907_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20250228__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zC1uVTvVAj9i" title="Warrants outstanding to purchase common stock">3,105,885</span> shares of common stock; stock options exercisable for <span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20250228__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zY4mdWRCA8R2" title="Shares issuable upon exercisable of options">76,342</span> shares of common stock; <span id="xdx_90C_eus-gaap--ConversionOfStockSharesConverted1_c20240301__20250228__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesEPreferredStockMember_zh5W9qUysmQh" title="Number of shares converted">316</span> shares of
Series E Preferred, which could be converted into <span id="xdx_90C_eus-gaap--ConversionOfStockSharesIssued1_c20240301__20250228__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesEPreferredStockMember_z5JhoCeB2Rb3" title="Common stock issuable upon conversion">3,362</span> shares of common stock; <span id="xdx_90D_eus-gaap--ConversionOfStockSharesConverted1_c20240301__20250228__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesHPreferredStockMember_zNLZxBa501d5" title="Number of shares converted">33,000</span> shares of Series H Preferred, convertible
into <span id="xdx_90F_eus-gaap--ConversionOfStockSharesIssued1_c20240301__20250228__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesHPreferredStockMember_zi4TX1YcKCk9" title="Common stock issuable upon conversion">33,000</span> shares of common stock; <span id="xdx_903_eus-gaap--ConversionOfStockSharesConverted1_c20240301__20250228__us-gaap--StatementClassOfStockAxis__custom--SeriesIPreferredStockMember_zrW6cm8FCER7" title="Number of shares converted">500,442</span> shares of Series I Preferred, convertible into <span id="xdx_90E_eus-gaap--ConversionOfStockSharesIssued1_c20240301__20250228__us-gaap--StatementClassOfStockAxis__custom--SeriesIPreferredStockMember_zRhpP5XqF5p6" title="Common stock issuable upon conversion">500,442</span> shares of common stock; <span id="xdx_905_eus-gaap--ConversionOfStockSharesConverted1_c20240301__20250228__us-gaap--StatementClassOfStockAxis__custom--SeriesJPreferredStockMember_zWRY8Z3kyK95" title="Number of shares converted">297,788</span>
shares of Series J Preferred, convertible into <span id="xdx_90A_eus-gaap--ConversionOfStockSharesIssued1_c20240301__20250228__us-gaap--StatementClassOfStockAxis__custom--SeriesJPreferredStockMember_zGjMu8V3sE75" title="Common stock issuable upon conversion">297,788</span> shares of common stock; <span id="xdx_905_eus-gaap--ConversionOfStockSharesConverted1_c20240301__20250228__us-gaap--StatementClassOfStockAxis__custom--SeriesKPreferredStockMember_z5OxjsaXehr9" title="Number of shares converted">60,595</span> shares of Series K Stock, convertible
into <span id="xdx_90F_eus-gaap--ConversionOfStockSharesIssued1_c20240301__20250228__us-gaap--StatementClassOfStockAxis__custom--SeriesKPreferredStockMember_zuFEdBtf2MU3" title="Common stock issuable upon conversion">60,595</span> shares of common stock; <span id="xdx_900_eus-gaap--ConversionOfStockSharesConverted1_c20240301__20250228__us-gaap--StatementClassOfStockAxis__custom--SeriesLPreferredStockMember_zljkXPA5OQV7" title="Number of shares converted">1,076,156</span> shares of Series L Preferred, convertible into <span id="xdx_906_eus-gaap--ConversionOfStockSharesIssued1_c20240301__20250228__us-gaap--StatementClassOfStockAxis__custom--SeriesLPreferredStockMember_zgkaLd7XJ8V3" title="Common stock issuable upon conversion">1,076,156</span> shares of common stock;
<span id="xdx_900_eus-gaap--ConversionOfStockSharesConverted1_c20240301__20250228__us-gaap--StatementClassOfStockAxis__custom--SeriesMPreferredStockMember_zwQrwAAxmBU6" title="Number of shares converted">133,278</span> shares of Series M Preferred, convertible into <span id="xdx_904_eus-gaap--ConversionOfStockSharesIssued1_c20240301__20250228__us-gaap--StatementClassOfStockAxis__custom--SeriesMPreferredStockMember_zwsyCupL84Wl" title="Common stock issuable upon conversion">133,278</span> shares of common stock; <span id="xdx_900_eus-gaap--ConversionOfStockSharesConverted1_c20240301__20250228__us-gaap--StatementClassOfStockAxis__custom--SeriesNPreferredStockMember_zIxkCjvTHMTi" title="Number of shares converted">500,000</span> shares of Series N Preferred,
convertible into <span id="xdx_90A_eus-gaap--ConversionOfStockSharesIssued1_c20240301__20250228__us-gaap--StatementClassOfStockAxis__custom--SeriesNPreferredStockMember_z2OG52knENS7" title="Common stock issuable upon conversion">500,000</span> shares of common stock; <span id="xdx_901_eus-gaap--ConversionOfStockSharesConverted1_c20240301__20250228__us-gaap--StatementClassOfStockAxis__custom--SeriesOPreferredStockMember_zWIrpBfIwWj9" title="Number of shares converted">161,291</span> shares of Series O Preferred, convertible into <span id="xdx_90E_eus-gaap--ConversionOfStockSharesIssued1_c20240301__20250228__us-gaap--StatementClassOfStockAxis__custom--SeriesOPreferredStockMember_zqjL1H1CNWYc" title="Common stock issuable upon conversion">161,291</span> shares of common
stock; and <span id="xdx_906_eus-gaap--ConversionOfStockSharesConverted1_c20240301__20250228__us-gaap--StatementClassOfStockAxis__custom--SeriesOPreferredStockOneMember_z4zt5soCOyWg" title="Number of shares converted">343,750</span> shares of Series O Stock, convertible into <span id="xdx_909_eus-gaap--ConversionOfStockSharesIssued1_c20240301__20250228__us-gaap--StatementClassOfStockAxis__custom--SeriesOPreferredStockOneMember_zudvTBRY08c4" title="Common stock issuable upon conversion">343,750</span> shares of common stock, resulting in a potential total
additional <span id="xdx_90C_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_c20240301__20250228__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zMwWi7Oo9q03" title="Potentially dilutive securities">3,109,663</span> shares of common stock outstanding in the future. At February 29, 2024, the Company had <span id="xdx_902_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_c20230301__20240229__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zLQykkw5cWcf" title="Potentially dilutive securities">1,047,300</span> outstanding potentially
dilutive securities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/260/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Concentrations<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Feb. 28, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RisksAndUncertaintiesAbstract', window );"><strong>Risks and Uncertainties [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskDisclosureTextBlock', window );">Concentrations</a></td>
<td class="text"><p id="xdx_806_eus-gaap--ConcentrationRiskDisclosureTextBlock_z4zPeoJ5B9ub" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
20 &#8211; <span id="xdx_827_zbuUqEC1BVk1">Concentrations</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Revenues
</b>&#8211; During the years ended February 28, 2025 and February 29, 2024, the Company did not have any significant customers who accounted
for more than <span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20230301__20240229__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerMember_zeDZHqbZWjC8" title="Concentration of risk percentage"><span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20240301__20250228__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerMember_zhl4YsKrD3Vi" title="Concentration of risk percentage">10</span></span>% each of the Company&#8217;s revenue in at least one of the periods presented.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Accounts
Receivable</b> &#8211; The Company had no significant customers who accounted for more than <span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20230301__20240229__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerMember_zVjSBRAFYhH5" title="Concentration of risk percentage"><span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20240301__20250228__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerMember_zTgRhDTrrEtg" title="Concentration of risk percentage">10</span></span>% each of the Company&#8217;s accounts
receivable balance at February 28, 2025 and February 29, 2024, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 275<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/275/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RisksAndUncertaintiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RisksAndUncertaintiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Defined Contribution Plans<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Feb. 28, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock', window );">Defined Contribution Plans</a></td>
<td class="text"><p id="xdx_80C_eus-gaap--CompensationAndEmployeeBenefitPlansTextBlock_zvEibmnE4U3h" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
21 - <span id="xdx_822_zfN3g2K8OFl6">Defined Contribution Plans</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has adopted two qualified 401(k) plans (the &#8220;401(k) Plans&#8221;), in which all employees over the age of 21 may
participate. Depending on the 401(k) Plan, <span id="xdx_90C_eus-gaap--DescriptionOfDefinedContributionPensionAndOtherPostretirementPlans_c20240301__20250228_zoaePQhxSIsj" title="Contribution plan description">the
Company makes either a safe Harbor contribution match of 100% of each participant&#8217;s contribution up to 3% of salary, and 50%
of the next 2% of salary contributed, or a 3% non-elective contribution for all eligible participants</span>. The matching
contributions were $<span id="xdx_90D_eus-gaap--DefinedContributionPlanCostRecognized_c20240301__20250228_z0tS3FmyBaKb" title="Cost of contribution">23,628</span>
in 2025 and $<span id="xdx_90F_eus-gaap--DefinedContributionPlanCostRecognized_c20230301__20240228_zYLUz8bt56ej" title="Cost of contribution">17,112</span>
in 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for an entity's employee compensation and benefit plans, including, but not limited to, postemployment and postretirement benefit plans, defined benefit pension plans, defined contribution plans, non-qualified and supplemental benefit plans, deferred compensation, share-based compensation, life insurance, severance, health care, unemployment and other benefit plans.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 710<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/710/tableOfContent<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 712<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/712/tableOfContent<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 715<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/715/tableOfContent<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/718/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndEmployeeBenefitPlansTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Feb. 28, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Subsequent Events</a></td>
<td class="text"><p id="xdx_80B_eus-gaap--SubsequentEventsTextBlock_zxuIlZY5Qj77" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
22 &#8211; <span id="xdx_82B_zUTpgECwLQI3">Subsequent Events</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Nasdaq </i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 3, 2025, the Company received a notification letter from Nasdaq notifying the Company that, because the Company had not held
an annual meeting of shareholders within twelve months of the end of the Company&#8217;s fiscal year ended February 29, 2024,the
Company was out of compliance with Nasdaq Listing Rule 5620(a) (the &#8220;Annual Meeting Rule&#8221;). On March 3, 2025, the
Company also received a notification letter from the Listing Qualifications Staff of Nasdaq (the &#8220;Staff&#8221;) notifying the
Company that, based on the Current Report on Form 8-K filed by the Company with the SEC on February 18, 2024, the Staff had
determined the Company had regained compliance with the minimum stockholders&#8217; equity requirements set forth in Nasdaq Listing
Rule 5550(b)(1) (the &#8220;Equity Rule&#8221;). However, if the Company fails to evidence compliance with the Equity Rule upon
filing its next periodic report, the Company may be subject to delisting. At that time, Staff will provide written notification to
the Company, which may then appeal Staff&#8217;s determination to a Nasdaq Hearings Panel. The notification letters had no immediate effect on the listing of the Company&#8217;s securities on Nasdaq.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
Nasdaq Listing Rule 5810(c)(2)(G), the Company had until April 17, 2025 to provide Nasdaq with a plan to regain compliance with the Annual
Meeting Rule. </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 9, 2025, the Company held its 2025 Annual Meeting of the Stockholders (the &#8220;Annual Meeting&#8221;) in a virtual format. On
April 23, 2025, the Company received a letter from the Staff of Nasdaq notifying the Company that, based on the fact that the Company
held its Annual Meeting on April 9, 2025, Nasdaq had determined that the Company has regained compliance with the Annual Meeting Rule
and that the matter is now closed.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Contingent Shares Issuances and Change in Control
</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 26, 2025, the Company issued an aggregate of <span id="xdx_901_eus-gaap--IncrementalCommonSharesAttributableToContingentlyIssuableShares_pid_c20250326__20250326__us-gaap--TypeOfArrangementAxis__custom--ExchangeAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zJ6xP4rbZzpl" title="Number of contingent shares issued">4,393,993</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Contingent
Shares to the NextTrip Sellers in satisfaction of its obligations to issue Contingent Shares upon achievement of three of the four
Milestone Events under the Exchange Agreement. The Contingent Shares were issued after the Company received notice from Nasdaq, on
March 25, 2025, that Nasdaq has approved the Company&#8217;s initial listing application. </span>Following issuance of the
Contingent Shares, the Company had <span id="xdx_905_eus-gaap--CommonStockSharesIssued_iI_pid_c20250326__us-gaap--TypeOfArrangementAxis__custom--ExchangeAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zYxN3Ugjsf6e" title="Common sock, shares issued"><span id="xdx_906_eus-gaap--CommonStockSharesOutstanding_iI_pid_c20250326__us-gaap--TypeOfArrangementAxis__custom--ExchangeAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zHksYJ3TSVG9" title="Common sock, shares outstanding">6,163,525</span></span> shares of common stock issued and outstanding, <span id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20250326__20250326__us-gaap--TypeOfArrangementAxis__custom--ExchangeAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zK5XDanrfaMi" title="Issuance of shares">4,550,000</span> of which (or <span id="xdx_902_ecustom--CommonStockIssuedPercentage_iI_pid_dp_uPure_c20250326__us-gaap--TypeOfArrangementAxis__custom--ExchangeAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z2UiBwdezCW2" title="Issued percentage">73.8</span>%) were held
by the NextTrip Sellers. As a result, the NextTrip Sellers collectively had ownership and voting control over the Company as of such
date, resulting in a change in control of the Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">As a result of the issuance of the Contingent Shares and pursuant to the Exchange Agreement, the NextTrip Representative
now has the right to designate a replacement for three directors of the Company.&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">On May 5, 2025, the Company
issued an aggregate of <span id="xdx_909_eus-gaap--IncrementalCommonSharesAttributableToContingentlyIssuableShares_pid_c20250505__20250505__us-gaap--TypeOfArrangementAxis__custom--ExchangeAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zTFe7Qz4Rr15" title="Number of contingent shares issued">1,450,000</span> Contingent Shares to the NextTrip Sellers in satisfaction of its obligation to issue Contingent Shares
upon achievement of the fourth and final Milestone Event under the Exchange Agreement. Immediately following such issuance, all Contingent
Shares issuable pursuant to the Exchange Agreement have been issued, and the Company has no further commitments or obligations to issue
additional shares pursuant to the Exchange Agreement.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Alumni Agreements</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 1, 2025, the Company entered into a securities purchase agreement (the &#8220;Alumni Purchase Agreement&#8221;) with Alumni
for the sale of a short-term promissory note (the &#8220;Alumni Note&#8221;) and warrants (the &#8220;Alumni Warrants&#8221;) to
Alumni for total consideration of $<span id="xdx_90C_eus-gaap--NotesAndLoansPayableCurrent_iI_c20250401__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zCoMNQphumnj" title="Total consideration">300,000</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Alumni Note is in the principal amount of $<span id="xdx_90D_eus-gaap--DebtInstrumentFaceAmount_iI_c20250401__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zJveFiDgW6Fa" title="Principal amount">360,000</span>
with an original issue discount of $<span id="xdx_907_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_c20250401__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zNdmU5aLYUnd" title="Original issue discount">60,000</span>
and guaranteed interest on the principal amount of ten percent (<span id="xdx_909_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20250401__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zQ1cbaz7zEQe" title="Interest rate">10</span>%)
per annum, which shall be due and payable on <span id="xdx_909_eus-gaap--DebtInstrumentMaturityDate_dd_c20250401__20250401__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zycytL4IV6rd" title="Maturity date">July
1, 2025</span>. In the event of a failure to re-pay the Alumni Note on or before the maturity date, the interest rate will increase
to the lesser of twenty-two percent (<span id="xdx_909_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20250401__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--RangeAxis__srt--MaximumMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zUSE8BnQJTK4" title="Interest rate">22</span>%)
per annum or the maximum amount permitted under law from the due date thereof until the same is paid.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Alumni Note is convertible into shares of common stock of the Company only upon an event of default.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_eus-gaap--ClassOfWarrantOrRightReasonForIssuingToNonemployees_pid_c20250401__20250401__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zPmjiM1vQwx2" title="Warrant description">In
conjunction with the issuance of the Alumni Note to Alumni, the Company also issued warrants to purchase <span id="xdx_90C_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20250401__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z6NY4ONNLD6e" title="Warrants outstanding to purchase common stock">80,000</span>
shares of common stock at a price per share of $<span id="xdx_906_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20250401__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zpQswI5Itn5c" title="Shares issued price per share">4.50</span>,
which represents 100% warrant coverage on the principal amount of the Alumni Note. The Alumni Warrants are exercisable on or prior
to the five (5) year anniversary of the effective date.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0"><i>Journy.tv Asset Purchase</i></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 1, 2025, the Company entered into an asset purchase agreement (the &#8220;Journy.tv Purchase Agreement&#8221;) with Ovation
LLC (&#8220;Ovation&#8221;), pursuant to which the Company purchased assets, including without limitation trademarks, domains, apps
and certain agreements, and assumed certain liabilities related to Ovation&#8217; Journy.tv business (the &#8220;Journy.tv
Acquisition&#8221;). The Journy.tv Acquisition closed on April 1, 2025.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the Purchase Agreement, as consideration for the Journy.tv Acquisition, the Company paid Ovation $<span id="xdx_900_eus-gaap--PaymentsToAcquireBusinessesGross_c20250401__20250401__us-gaap--TypeOfArrangementAxis__custom--AssetPurchaseAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_znitF9Zvx9f4" title="Payments to acquire businesses">300,000</span> in cash at closing and issued
Ovation <span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20250401__20250401__us-gaap--TypeOfArrangementAxis__custom--AssetPurchaseAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zSAOMC0wxs06" title="Restricted shares, issued">20,000</span> restricted shares of Company common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the Journy.tv Acquisition, on April 1, 2025, the Company and Ovation also entered into a License Agreement (the &#8220;License
Agreement&#8221;), pursuant to which Ovation granted the Company the non-exclusive right, throughout the territories and for the term
set forth therein, to exhibit, promote, market, advertise, publicize and/or otherwise exploit the programs listed in the License Agreement
in the media of (i) FAST via the Journy.tv Channel and (ii) Video On Demand via the Journy.tv Channel. Pursuant to the License Agreement, Ovation
shall not license any unaffiliated third party the right to exhibit certain of the programs subject to the License Agreement and shall
not use certain of the programs subject to the License Agreement on its owned or operating streaming platforms (subject to certain exceptions).
As consideration for the rights granted under the License Agreement, the Company agreed to pay Ovation an aggregate non-refundable license
fee of $<span id="xdx_904_eus-gaap--PaymentsForFees_c20250401__20250401__us-gaap--TypeOfArrangementAxis__custom--AssetPurchaseAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zpFgbhkGnCEh" title="License fee">336,801</span> over thirty months.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>FSA Travel Final Closing and Milestone Payments</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 9, 2025 (the &#8220;Final Closing Date&#8221;), upon FSA&#8217;s agreement to waive the capital raise condition to closing,
the Company exercised its option to acquire the remaining <span id="xdx_90A_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20250409__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--FSATravelLLCMember__us-gaap--TypeOfArrangementAxis__custom--PurchaseAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zMUctIfatDld" title="Ownership percentage">51</span>%
of FSA outstanding membership units, in satisfaction of its obligations under the FSA Purchase Agreement. In connection with the
Final Closing, the Company paid the the members of FSA (the &#8220;FSA Members&#8221;) an aggregate of $<span id="xdx_902_eus-gaap--PaymentsToAcquireBusinessesGross_c20250409__20250409__dei--LegalEntityAxis__custom--FSATravelLLCMember__us-gaap--TypeOfArrangementAxis__custom--PurchaseAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zZ4QHlZsyZ96" title="Payments to acquire businesses">500,000</span>
in cash and issued the FSA Members an aggregate of <span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20250409__20250409__dei--LegalEntityAxis__custom--FSATravelLLCMember__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember__us-gaap--StatementClassOfStockAxis__custom--SeriesOPreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--PurchaseAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zYC2BlGq4Snj" title="Shares issued">161,291</span>
shares of Series O Preferred. As a result, as of the Final Closing Date, FSA became a wholly owned subsidiary of the
Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 28, 2025, upon achievement of each of the business milestones pursuant to the FSA Purchase Agreement, the Company made each of
the Milestone Payments to the FSA Members, including payment of $<span id="xdx_900_eus-gaap--PaymentsToAcquireBusinessesGross_c20250428__20250428__dei--LegalEntityAxis__custom--FSATravelLLCMember__us-gaap--TypeOfArrangementAxis__custom--PurchaseAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z4CF8Se9GgIj" title="Payments to acquire businesses">400,000</span>
in cash and the issuance of an aggregate of <span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20250428__20250428__dei--LegalEntityAxis__custom--FSATravelLLCMember__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember__us-gaap--StatementClassOfStockAxis__custom--SeriesOPreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--PurchaseAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z0RrCw0Y065c" title="Shares issued">129,032</span>
shares of Series O Preferred (the number of shares provided for above, less <span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20250428__20250428__dei--LegalEntityAxis__custom--FSATravelLLCMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--TypeOfArrangementAxis__custom--PurchaseAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z5zYKtv2Huid" title="Shares issued">8,065</span>
shares of common stock previously issued to FSA by the Company as a deposit.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Related Party Notes</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On April 9, 2025, NTH and the Donald P. Monaco Insurance
Trust (the &#8220;Trust&#8221;) entered into two promissory notes (together, the &#8220;Trust Notes&#8221;) under the Company&#8217;s
$<span id="xdx_902_eus-gaap--LineOfCredit_iI_pn5n6_c20250409__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zmKe78yprE4d" title="Line of credit">2.0</span> million line of credit. Donald Monaco, chairman of the Company&#8217;s Board of Directors, is the trustee of the Trust. The first
note had a principal balance of $<span id="xdx_900_eus-gaap--DebtInstrumentFaceAmount_iI_c20250409__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--DebtInstrumentAxis__custom--NoteOneMember_zjQvZgFBKAC1" title="Principal amount">500,000</span> and was issued in exchange for a new cash payment provided my Mr. Monaco. The second note had
a principal balance of $<span id="xdx_90F_eus-gaap--DebtInstrumentFaceAmount_iI_c20250409__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--DebtInstrumentAxis__custom--NoteTwoMember_zkVBY5TC4mIl" title="Principal amount">145,000</span> and was issued in exchange for cash advances previously made by Mr. Monaco to the Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 6, 2025, the Company entered into a Line of Credit Agreement (the &#8220;MIP Line of Credit&#8221;) with Monaco Investment
Partners II, LP (&#8220;MIP&#8221;) providing the Company with a $<span id="xdx_90E_eus-gaap--LineOfCredit_iI_c20250506__us-gaap--TypeOfArrangementAxis__custom--LineOfCreditAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zqdYGYbfhWjc" title="Line of credit">3,000,000</span>
revolving line of credit. The MIP Line of Credit allows the Company to request advances thereunder from time to time until <span id="xdx_902_eus-gaap--LineOfCreditFacilityExpirationDate1_dd_c20250506__20250506__us-gaap--TypeOfArrangementAxis__custom--LineOfCreditAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zSQVIbLr1hG7" title="Line of credit maturity date">May
31, 2027</span>, the maturity date. Advances made under the MIP Line of Credit bear simple interest at a rate of <span id="xdx_908_eus-gaap--LineOfCreditFacilityInterestRateDuringPeriod_pid_dp_c20250506__20250506__us-gaap--TypeOfArrangementAxis__custom--LineOfCreditAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zxLWn1ou9Tq4" title="Line of credit, interest rate">12</span>%
per annum, calculated from the date of each respective advance. Accrued interest shall be payable on a monthly basis, no later than
the 10th day of the subsequent month. The full outstanding principal balance, together with any accrued and unpaid interest, shall
be due and payable in full by the Company on the maturity date. The Company may, at its option, prepay any borrowings under the MIP
Line of Credit, in whole or in part, at any time prior to the maturity date, without penalty. Mr. Monaco controls MIP</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_eus-gaap--LineOfCreditFacilityDescription_c20250506__20250506__us-gaap--TypeOfArrangementAxis__custom--LineOfCreditAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zljfoUUl9AV6" title="Line of credit advance description">The
Company received an initial advance of $<span id="xdx_909_eus-gaap--ProceedsFromLinesOfCredit_dd_c20250506__20250506__us-gaap--TypeOfArrangementAxis__custom--LineOfCreditAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z7Y2FX0x9hr7" title="Initial advance of line of credit">1,045,000</span>
under the MIP Line of Credit, which was used to repay (i) a $<span id="xdx_901_ecustom--CashAdvance_c20250506__20250506__us-gaap--TypeOfArrangementAxis__custom--LineOfCreditAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zw6gUi5lPRF7" title="Cash advance">400,000</span>
cash advance previously made by the Trust to the Company (ii) and all outstanding
indebtedness under the terms of the Trust Notes, totaling $<span id="xdx_907_eus-gaap--DebtInstrumentCarryingAmount_iI_c20250409__us-gaap--TypeOfArrangementAxis__custom--LineOfCreditAgreementMember__us-gaap--DebtInstrumentAxis__custom--TwoPromissoryNotesMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z5Wg2rLyMCjc" title="Cash advance">645,000</span>.
Additional advances through May 28, 2025 totaled $<span id="xdx_90B_eus-gaap--LineOfCreditFacilityIncreaseDecreaseForPeriodNet_c20250506__20250506__us-gaap--TypeOfArrangementAxis__custom--LineOfCreditAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zw4plTy3cax" title="Aditional advances">441,575</span>,
bringing the total amount advanced under the line to $<span id="xdx_903_eus-gaap--LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod_dd_c20250506__20250506__us-gaap--TypeOfArrangementAxis__custom--LineOfCreditAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zHx7o3dgDMZf" title="Total advances of line of credit">1,486,575</span>.</span></span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/855/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483399/855-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Feb. 28, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation and Principles of Consolidation</a></td>
<td class="text"><p id="xdx_849_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zJ1BUaV0Gyzk" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86E_zh2Lg2wMOZjl">Basis
of Presentation and Principles of Consolidation</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying consolidated financial statements and related disclosures have been prepared pursuant to the rules and regulations of the
Securities and Exchange Commission (&#8220;SEC&#8221;). The Financial Statements have been prepared using the accrual basis of accounting
in accordance with Generally Accepted Accounting Principles (&#8220;GAAP&#8221;) of the United States.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
financial statements have been prepared on a consolidated basis with those of the Company&#8217;s wholly owned subsidiaries. All intercompany
transactions and balances have been eliminated in consolidation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock', window );">Functional and presentation currency</a></td>
<td class="text"><p id="xdx_849_eus-gaap--ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_zSHpdixYhZra" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86B_zRKXUvJqxDW9">Functional
and presentation currency</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
financial statements are presented in United States dollars (&#8220;USD&#8221;), which is the Company&#8217;s functional and reporting
currency. All financial information has been rounded to the nearest dollar except where otherwise indicated.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><p id="xdx_847_eus-gaap--UseOfEstimates_z92xxB7g9Hp6" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_868_zANkfF99EJc3">Use
of Estimates</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that
affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the consolidated
financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from
those estimates. These differences could have a material effect on the Company&#8217;s future results of operations and financial position.
Significant items subject to estimates and assumptions include the carrying amounts of intangible assets, depreciation and amortization.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Information
about key assumptions and estimation uncertainty that has a significant risk of resulting in a material adjustment to the carrying amounts
of the Company&#8217;s assets and liabilities within the next financial year are referenced in the notes to the financial statements
as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    assessment of the Company to continue as a going concern;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    assessment of the allowance on the related party promissory note receivable;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Estimates
    of purchase price allocation;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    measurement and useful life of intangible assets and property and equipment</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Estimates
    of fair value of equity instruments;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recoverability
    of long lived assets</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Loss Per Share</a></td>
<td class="text"><p id="xdx_84E_eus-gaap--EarningsPerSharePolicyTextBlock_z00E9Pa3SOu7" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86E_zssQN5TOOKRj">Loss
Per Share </span>&#8211; </b>The computation of loss per share is based on the weighted average number of shares outstanding during the period
in accordance with ASC Topic No. 260, &#8220;Earnings Per Share.&#8221; Shares underlying the Company&#8217;s outstanding warrants, options, preferred stock
or note conversion features were excluded due to the anti-dilutive effect they would have on the computation. At February 28, 2025 and
February 29, 2024, the Company had the following common shares underlying these instruments:</span></p>

<p id="xdx_892_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zvqrR8ZG98Q5" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B9_zfcl7inofrn9" style="display: none">Schedule of Anti-dilutive Securities Excluded
from Computation of Earnings Per Share</span></span></span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
  <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_490_20240301__20250228_zVHxnQOa9wwf" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">2025</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49B_20230301__20240229_zoPHw1J6jZFc" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">2024</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Year Ended February 28 and 29,</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">2025</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">2024</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zqkv5WKfeJ97" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 60%">Warrants</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">3,015,885</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">486,165</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--StockOptionMember_zAoWQGOKgK8b" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Stock Options</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">76,342</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">85,300</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--PreferredStockMember_zaluQv3R7uv5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Preferred Stock</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">3,109,663</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">475,835</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_z7EAhfi3Lt6d" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Total Underlying Common Shares</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">6,201,890</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">1,047,300</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A7_zrK2FIOrjfHj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents</a></td>
<td class="text"><p id="xdx_84C_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zhjm7voHXbBg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86A_z9BMsv76wSO3">Cash
and Cash Equivalents</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash
consists of amounts denominated in USD. The Company has not experienced any losses on such accounts. The Company considers all
highly liquid investments with a maturity of three months or less when purchased to be cash equivalents. There were <span id="xdx_90B_eus-gaap--CashEquivalentsAtCarryingValue_iI_do_c20250228_zuNofbvNxerl" title="Cash equivalents"><span id="xdx_905_eus-gaap--CashEquivalentsAtCarryingValue_iI_do_c20240229_zQkXA1eQbURh" title="Cash equivalents">no</span></span> cash equivalents
as of February 28, 2025, or February 29, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_PrepaidsPolicyTextBlock', window );">Prepaids</a></td>
<td class="text"><p id="xdx_840_ecustom--PrepaidsPolicyTextBlock_zwgSrGb0Idxj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_865_zDatv27VkZte">Prepaids</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company records cash paid in advance for goods and/or services to be received in the future as prepaid expenses. Prepaid expenses are
expensed over time according to the terms of the purchase. Other current assets are recognized when it is probable that the future economic
benefits will flow to the Company and the asset has a cost or value that can be measured reliably. It is then charged to expense over
the expected number of periods during which economic benefits will be realized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TradeAndOtherAccountsReceivablePolicy', window );">Accounts Receivable</a></td>
<td class="text"><p id="xdx_849_eus-gaap--TradeAndOtherAccountsReceivablePolicy_zqPgfmpOk2Yi" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_867_zSrcewP8Ripj">Accounts
Receivable</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trade
accounts receivable are recorded at the invoiced amount and do not bear interest. The allowance for credit losses is the Company&#8217;s
best estimate of the amount of probable losses in its existing accounts receivable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company considers accounts receivable to be fully collectible; accordingly, no allowance for credit losses is required. If amounts
become uncollectible, they will be charged to operations when that determination is made.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trade
accounts receivable balances as of February 28, 2025 and February 29, 2024, were $<span id="xdx_909_eus-gaap--AccountsReceivableNet_iI_c20250228_zUbjy98GiaXl" title="Accounts receivable">22,567</span> and $<span id="xdx_900_eus-gaap--AccountsReceivableNet_iI_c20240229_zcmT867FEce8" title="Accounts receivable">34,092</span>, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsPolicy', window );">Investments in Equity Method Investees</a></td>
<td class="text"><p id="xdx_841_eus-gaap--EquityMethodInvestmentsPolicy_zabWDYnrzqte" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_863_zrlX5qfCtnlc">Investments
in Equity Method Investees</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company holds investments in certain entities that are accounted for under the equity method of accounting, as well as investments that
are accounted for under the fair value method pursuant to ASC 321, &#8220;Investments - Equity Securities.&#8221; Under the equity method,
investments in entities in which the Company has significant influence, but not control, are initially recognized at cost and adjusted
thereafter to recognize the Company&#8217;s share of the investees&#8217; earnings or losses and other comprehensive income.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company determines the existence of significant influence based on various factors, including representation on the investees&#8217;
board of directors, participation in policy-making processes, and material intercompany transactions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s equity method investments are evaluated periodically for impairment by assessing whether events or changes in circumstances
indicate that the carrying value of the investment may not be recoverable. When such indicators exist, the Company performs an impairment
test and recognizes an impairment loss to the extent that the carrying amount of the investment exceeds its fair value.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Distributions
received from equity method investees that exceed cumulative earnings recognized by the Company are considered a return of investment
and are recorded as a reduction in the carrying amount of the investment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Adjustments
resulting from changes in the Company&#8217;s ownership interest in equity method investees that do not result in a loss of significant
influence are accounted for prospectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_BasisDifferencePolicyTextBlock', window );">Basis Difference</a></td>
<td class="text"><p id="xdx_84F_ecustom--BasisDifferencePolicyTextBlock_zIre3wqhViVg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_862_zKhnwIT74bZ1">Basis
Difference</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
accordance with ASC 323, &#8220;Investments - Equity Method and Joint Ventures,&#8221; the Company records a basis difference when the
carrying value of its equity method investment differs from its share of the investee&#8217;s fair value of net assets at the acquisition
date. This basis difference is allocated to the investee&#8217;s identifiable assets and liabilities based on their fair values. The
amortization of any basis difference related to depreciable assets, such as property, plant, and equipment, is recognized in the Company&#8217;s
share of the investee&#8217;s earnings or losses. Any basis difference related to non-depreciable assets, including goodwill, is generally
not amortized, but is subject to impairment testing as necessary.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company assesses the impact of any basis differences on its earnings and the carrying value of its equity method investments. If a basis
difference is determined to exist, the appropriate adjustments are made to reflect the amortization of such differences in the consolidated
financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValuePolicyTextBlock', window );">Investments in Equity Securities without Readily Determinable Fair Value</a></td>
<td class="text"><p id="xdx_84B_eus-gaap--EquitySecuritiesWithoutReadilyDeterminableFairValuePolicyTextBlock_z70CbGD2sAsc" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_865_ziedsQLI2no4">Investments
in Equity Securities without Readily Determinable Fair Value</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
accordance with ASC 321-10-35-2, the Company holds certain investments in equity securities in which the Company does not have significant
influence or control, and for which fair value is not readily determinable. These investments are primarily accounted for at cost, less
any impairment. The carrying amount is periodically evaluated for impairment, and if necessary, an impairment loss is recognized in the
statement of operations. These investments are not adjusted for unrealized gains or losses unless an impairment is identified.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsIssuancesPolicy', window );">Equity in Earnings of Equity Method Investees</a></td>
<td class="text"><p id="xdx_84C_eus-gaap--EquityMethodInvestmentsIssuancesPolicy_zWGPIxaV2yFe" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_868_zE55pMyDrGlg">Equity
in Earnings of Equity Method Investees</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s share of earnings or losses from equity method investees is recognized in the consolidated statement of operations within
&#8220;Equity in share of loss of equity method investees,&#8221; net of any related income taxes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock', window );">Fair Value Measurements</a></td>
<td class="text"><p id="xdx_843_eus-gaap--FairValueMeasurementPolicyPolicyTextBlock_zPNgWiw9RGQh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_869_zAp1boL6zgRj">Fair
Value Measurements</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fair value of equity method investments is disclosed when available and practical to determine. However, for investments that are not
readily marketable, such as non-public entities, fair value is not typically recognized in the financial statements unless the investment
is impaired.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_PromissoryNoteReceivablePolicyTextBlock', window );">Promissory Note Receivable</a></td>
<td class="text"><p id="xdx_84C_ecustom--PromissoryNoteReceivablePolicyTextBlock_zpvsQAIGfJNc" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Promissory
Note Receivable</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Receivables
from NextPlay under the promissory note as described in <b>NOTE 1 &#8211; Business Description and Going Concern</b> were $<span id="xdx_903_eus-gaap--AccountsReceivableNet_iI_c20250228__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--NextPlayTechnologiesIncMember_z1qGJcY8kUE" title="Accounts receivable">0</span> and $<span id="xdx_903_eus-gaap--AccountsReceivableNet_iI_c20240229__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--NextPlayTechnologiesIncMember_zoFhIZVRI9Ab" title="Accounts receivable">1,000,000</span>
at February 28, 2025 and February 29, 2024, respectively. Pursuant to the terms of the Promissory Note (the &#8220;NextPlay Note&#8221;)
between NTH and NextPlay, the NextPlay Note was due and payable in full on the earlier of September 1, 2023 or the date the Company
completed a financing of $<span id="xdx_90E_eus-gaap--NotesPayable_iI_pn6n6_c20230925__us-gaap--BusinessAcquisitionAxis__custom--NextPlayTechnologiesIncMember_zGhg2DJpWydb" title="Notes payable">10</span> million or more. No payments have been made by NextPlay, and as such NextPlay is in default under the terms
of the NextPlay Note.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 27, 2025, as creditors of NextPlay, Donald P. Monaco, the Company&#8217;s Chairman, William Kerby, the Company&#8217;s Chief
Executive Officer, and Ian Sharpe, the Chief Operating Officer of the Company&#8217;s Media division, filed a petition to force NextPlay
into involuntary bankruptcy as a result of unpaid fees. The proceedings are ongoing and the outcome at this time is uncertain and cannot
be predicted. As a result, management has determined that the collectability of the NextPlay Note is uncertain and has therefore established
an allowance for doubtful accounts for the entire balance of $<span id="xdx_902_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iI_c20250127__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--NextPlayTechnologiesIncMember_z2SRuRsyeQXk" title="Allowance for doubtful accounts">2,567,665</span>. Of this amount, $<span id="xdx_908_ecustom--LossOnRelatedPartyReceivable_c20240301__20250228_z7jiBGEHH9Uc" title="Loss on promissory note receivable">1,000,000</span> was recorded as of February 28, 2025,
and $<span id="xdx_900_ecustom--LossOnRelatedPartyReceivable_c20230301__20240229_zmIVjrNPV9Lb" title="Loss on promissory note receivable">1,567,665</span> was recorded as of February 29, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property and Equipment</a></td>
<td class="text"><p id="xdx_84A_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_z8czT4zfswHh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86F_z6yCU0h8ggla">Property
and Equipment</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Recognition
and measurement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Items
of property and equipment are measured at cost, less accumulated depreciation and accumulated impairment losses. When parts of an item
of property and equipment have different estimated useful lives, they are accounted for as separate items within property and equipment.
The costs of the ongoing regular repairs and maintenance of property and equipment are recognized in the period in which they are incurred.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Depreciation</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation
is recognized in profit or loss over the estimated useful lives of each part of an item of property and equipment in a manner that most
closely reflects management&#8217;s estimated future consumption of the future economic benefits embodied in the asset. The estimated
useful lives for the Company&#8217;s property and equipment are as follows:</span></p>

<p id="xdx_89A_ecustom--ScheduleOfEstimatedUsefulLivesForPropertyAndEquipmentTableTextBlock_z5CB4ZAtqjM7" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span style="display: none"><span id="xdx_8BB_zz2yIF2XvmHl">Schedule
of Estimated
Useful Lives for Property and Equipment</span></span></span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Category</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Method</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Estimated
    useful life</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furniture
    &amp; Fixtures</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Straight
    line</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20250228__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zvTl2fGZ8Eof" title="Estimated useful life">5</span>
    years</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Computer
    &amp; Equipment</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Straight
    line</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20250228__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_zUaXzpeVFOQf" title="Estimated useful life">3</span>
    years</span></td></tr>
  </table>
<p id="xdx_8A6_zYReKKJGarnl" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsFiniteLivedPolicy', window );">Intangible assets</a></td>
<td class="text"><p id="xdx_84F_eus-gaap--IntangibleAssetsFiniteLivedPolicy_zDoeSolb4H5g" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86D_z5mvFUmsmmdh">Intangible
assets</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company measures separately acquired intangible assets at cost, less accumulated amortization and impairment losses. The Company recognizes
internally developed intangible assets when it has determined that the completion of such is technically feasible, and the Company has
sufficient resources to complete the development. Subsequent expenditures are capitalized when they increase the future economic benefits
of the associated asset. All other expenditures are recorded in profit or loss as incurred.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company assesses whether the life of intangible asset is finite or indefinite. The Company reviews the amortization method and period
of use of its intangible assets at least annually. Changes in the expected useful life or period of consumption of future economic benefits
associated with the asset are accounted for prospectively by changing the amortization method or period as a change in accounting estimates
in profit or loss. The Company has assessed the useful life of its trademarks as indefinite.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_891_ecustom--ScheduleOfEstimatedUsefulLivesForFiniteLifeIntangibleAssetsTableTextBlock_zX9Gyyi62dK9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
estimated useful lives for the Company&#8217;s finite life intangible assets are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B8_zqdpJQVrfANf" style="display: none">Schedule
of Estimated
Useful Lives for Finite Life Intangible Assets</span></span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Category</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Method</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Estimated
    useful life</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Software</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Straight
    line</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20250228__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SoftwareMember__srt--RangeAxis__srt--MinimumMember_zAPO9167w9ai" title="Estimated useful life">1</span>
    - <span id="xdx_909_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20250228__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SoftwareMember__srt--RangeAxis__srt--MaximumMember_zv66dkLsEoxe" title="Estimated useful life">3</span> years</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Software
    licenses</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Straight
    line</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20250228__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SoftwareLicensesMember__srt--RangeAxis__srt--MinimumMember_zfNu07ETVGUi" title="Estimated useful life">0.5</span>
    - <span id="xdx_902_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20250228__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SoftwareLicensesMember__srt--RangeAxis__srt--MaximumMember_zPU8KANFDz6l" title="Estimated useful life">4</span> years</span></td></tr>
  </table>
<p id="xdx_8AA_zrmr4KOowcch" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InternalUseSoftwarePolicy', window );">Software Development Costs</a></td>
<td class="text"><p id="xdx_84F_eus-gaap--InternalUseSoftwarePolicy_zPKn11aVP3Sg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_864_zS1UUutOsNbd">Software
Development Costs</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company capitalizes internal software development costs subsequent to establishing technological feasibility of a software application
in accordance with guidelines established by &#8220;ASC 985-20-25&#8221; Accounting for the Costs of Software to Be Sold, Leased, or
Otherwise Marketed, requiring certain software development costs to be capitalized upon the establishment of technological feasibility.
The establishment of technological feasibility and the ongoing assessment of the recoverability of these costs require considerable judgment
by management with respect to certain external factors such as anticipated future revenue, estimated economic life, and changes in software
and hardware technologies. Amortization of the capitalized software development costs begins when the product is available for general
release to customers. Capitalized costs are amortized based on the straight-line method over the remaining estimated economic life of
the product.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy', window );">Impairment of Intangible Assets</a></td>
<td class="text"><p id="xdx_849_eus-gaap--GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_z6Yc1kBv10E4" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_863_zmgLD6BsuqJk">Impairment
of Intangible Assets</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
accordance with ASC 350-30-65 &#8220;Goodwill and Other Intangible Assets&#8221;, the Company assesses the impairment of identifiable
intangible assets whenever events or changes in circumstances indicate that the carrying value may not be recoverable. Factors the Company
considers important, which could trigger an impairment review include the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.
Significant underperformance compared to historical or projected future operating results.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.
Significant changes in the manner or use of the acquired assets or the strategy for the overall business, and</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.
Significant negative industry or economic trends.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">When
the Company determines that the carrying value of an intangible asset may not be recoverable based upon the existence of one or more
of the above indicators of impairment and the carrying value of the asset cannot be recovered from projected undiscounted cash flows,
the Company records an impairment charge. The Company measures any impairment based on a projected discounted cash flow method using
a discount rate determined by management to be commensurate with the risk inherent to the current business model. Significant management
judgment is required in determining whether an indicator of impairment exists and in projecting cash flows. Intangible assets that have
finite useful lives are amortized over their useful lives.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeasesPolicyTextBlock', window );">Leases</a></td>
<td class="text"><p id="xdx_84F_eus-gaap--LesseeLeasesPolicyTextBlock_zCLGhnMfxjwa" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86A_zflz7TQmjQ8k">Leases</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company adopted ASU 2016-02 (Topic ASC 842) Leases, which requires a lessee to recognize a lease asset and a leases liability for operating
leases arrangements greater than twelve (12) months.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
determine if an arrangement is a lease at inception. Operating leases are included in operating lease right-of-use (&#8220;ROU&#8221;)
assets, operating lease liabilities - current, and operating lease liabilities - noncurrent on the balance sheets.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ROU
assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease
payments arising from the lease. Operating lease ROU assets and liabilities are recognized at commencement date based on the present
value of lease payments over the lease term. As most of our leases do not provide an implicit rate, we generally use our incremental
borrowing rate based on the estimated rate of interest for collateralized borrowing over a similar term of the lease payments at commencement
date. The operating lease ROU asset also includes any lease payments made and excludes lease incentives. Our lease terms may include
options to extend or terminate the lease when it is reasonably certain that we will exercise that option. Lease expense for lease payments
is recognized on a straight-line basis over the lease term.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription', window );">Reclassification</a></td>
<td class="text"><p id="xdx_845_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zs0xXffHlI4j" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_861_zQFg4hltGIxf">Reclassification</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
prior year amounts have been reclassified to conform to the current period presentation. These reclassifications had no impact on the
net earnings (loss) or financial position.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy', window );">Fair Value of Financial Instruments</a></td>
<td class="text"><p id="xdx_84C_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zYUEOLk4dVve" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_868_zgeN1xwJDHX">Fair
Value of Financial Instruments</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company follows accounting guidelines on fair value measurements for financial instruments measured on a recurring basis, as well as
for certain assets and liabilities that are initially recorded at their estimated fair values. Fair Value is defined as the exit price,
or the amount that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants
as the measurement date. The Company uses the following three-level hierarchy that maximizes the use of observable inputs and minimizes
the use of unobservable inputs to value its financial instruments:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    1: Observable inputs such as unadjusted quoted prices in active markets for identical instruments.</span></td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    2: Quoted prices for similar instruments that are directly or indirectly observable in the marketplace.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    3: Significant unobservable inputs which are supported by little or no market activity and that are financial instruments whose values
    are determined using pricing models, discounted cash flow methodologies, or similar techniques, as well as instruments for which
    the determination of fair value requires a significant judgment or estimation.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
instruments measured at fair value are classified in their entirety based on the lowest level of input that is significant to the fair
value measurement. The Company&#8217;s assessment of the significance of a particular input to the fair value measurement in its entirety
requires it to make judgments and consider factors specific to the asset or liability. The use of different assumptions and/or estimation
methodologies may have a material effect on estimated fair values. Accordingly, the fair value estimates disclosed, or initial amounts
recorded may not be indicative of the amount that the Company or holders of the instruments could realize in a current market exchange.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
carrying amounts of the Company&#8217;s financial instruments including cash, accounts receivable, accounts payable, accrued expenses,
convertible notes and notes payable are of approximately fair value due to the short-term maturities of these instruments.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketRiskBenefitPolicyTextBlock', window );">Concentration of Credit Risk</a></td>
<td class="text"><p id="xdx_848_eus-gaap--MarketRiskBenefitPolicyTextBlock_zmy8rbwcLTdf" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_868_zxjb70IvPBf5">Concentration
of Credit Risk </span>-</b> The Company maintains its cash in bank deposit accounts, which, at times, may exceed federally insured limits. The
Company has not experienced any losses in such accounts and believes it is not exposed to any significant credit risk on its cash and
cash equivalents.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Stock Based Compensation</a></td>
<td class="text"><p id="xdx_849_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_z3Mq8xR32Ov9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: -0.9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86A_zGMWX7TRgG6f">Stock
Based Compensation</span></b> &#8211; The Company recognizes compensation costs to employees under ASC Topic No. 718, &#8220;Compensation &#8211;
Stock Compensation.&#8221; Under ASC Topic No. 718, companies are required to measure the compensation costs of share-based compensation
arrangements based on the grant-date fair value and recognize the costs in the financial statements over the period during which employees
are required to provide services. Share based compensation arrangements may include stock options, grants of shares of common stock with
and without restrictions, performance-based awards, share appreciation rights and employee share purchase plans. As such, compensation
cost is measured on the date of grant at its fair value. Such compensation amounts, if any, are amortized over the respective vesting
periods of the option or stock grants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: -0.9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equity
instruments issued to non-employees are recorded on the basis of the fair value of the instruments, as required by ASC Topic No. 718.
In general, the measurement date is either (a) when a performance commitment, as defined, is reached or (b) the earlier of the date that
(i) the non-employee performance requirement is complete or (ii) the instruments are vested. The measured value related to the instruments
is recognized over a period based on the facts and circumstances of each particular grant as defined in the FASB Accounting Standards
Codification.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock', window );">Revenue Recognition</a></td>
<td class="text"><p id="xdx_844_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_zrdm3uMmNHhg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86E_z1a64sRD73ic">Revenue
Recognition</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recognizes revenue in accordance with ASC Topic No. 606. In May 2014, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued
Accounting Standards Update (&#8220;ASU&#8221;) No. 2014-09, <i>Revenue from Contracts with Customers</i>. ASU 2014-09 is a comprehensive revenue recognition
standard that superseded nearly all existing revenue recognition guidance under prior GAAP and replaced it with a principles-based
approach for determining revenue recognition. The core principle of the standard is the recognition of revenue upon the transfer of promised
goods or services to customers in an amount that reflects the consideration to which the company expects to be entitled in exchange for
those goods or services. In general, we determine revenue recognition by: (1) identifying the contract, or contracts, with our customer;
(2) identifying the performance obligations in the contract; (3) determining the transaction price; (4) allocating the transaction price
to performance obligations in the contract; and (5) recognizing revenue when, or as, we satisfy performance obligations by transferring
the promised goods or services.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recognizes revenue when the customer has purchased the product, the occurrence of the earlier of date of travel and the date of
cancellation has expired, as satisfaction of the performance obligation, the sales price is fixed or determinable and collectability
is reasonably assured. Revenue for customer travel packages purchased directly from the Company are recorded gross (the amount paid to
the Company by the customer is shown as revenue and the cost of providing the respective travel package is recorded to cost of revenues).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company generates revenues from sales directly to customers as well as through other distribution channels of tours and activities at
destinations throughout the world.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company controls the specified travel product before it is transferred to the customer and is therefore a principal, based on but not
limited to, the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Company is primarily responsible for fulling the promise to provide such travel product.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Company has inventory risk before the specified travel product has been transferred to a customer or after transfer of control to
    a customer.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Company has discretion in establishing the price for the specified travel product.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Payments
for tours or activities received in advance of services being rendered are recorded as deferred revenue and recognized as revenue at
the earlier of the date of travel or the last date of cancellation (i.e., the customer&#8217;s refund privileges lapse).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock', window );">Sales and Marketing</a></td>
<td class="text"><p id="xdx_84D_eus-gaap--SellingGeneralAndAdministrativeExpensesPolicyTextBlock_zJTtpSias568" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86F_zQ3fcJCgU2ec">Sales
and Marketing</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Selling
and marketing expenses consist primarily of marketing and promotional expenses, expenses related to our participation in industry
conferences, and public relations expenses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sales
and marketing expenses are charged to expense as incurred and are included in selling and promotions expenses in the accompanying consolidated
financial statements. Sales and marketing expense for the years ended February 28, 2025 and February 29, 2024 was $<span id="xdx_907_eus-gaap--SellingAndMarketingExpense_c20240301__20250228_z6vgQuzeHCol" title="Sales and marketing expense">307,166</span> and $<span id="xdx_905_eus-gaap--SellingAndMarketingExpense_c20230301__20240229_z4jYH9fDJYtb" title="Sales and marketing expense">484,250</span>,
respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"><p id="xdx_84B_eus-gaap--IncomeTaxPolicyTextBlock_zgwGOWd6ekvk" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86E_zNUHheJDSJmc">Income
Taxes</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for income taxes in accordance with ASC Topic No. 740, &#8220;Accounting for Income Taxes.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Income
taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences
attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective
tax bases and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected
to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred
tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. A valuation
allowance on deferred tax assets is established when management considers it is more likely than not that some portion or all of the
deferred tax assets will not be realized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tax
benefits from an uncertain tax position are only recognized if it is more likely than not that the tax position will be sustained on
examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in the consolidated
financial statements from such a position are measured based on the largest benefit that has a greater than fifty percent likelihood
of being realized upon ultimate resolution. Interest and penalties related to unrecognized tax benefits are recorded as incurred as a
component of income tax expense. The Company has not recognized any tax benefits from uncertain tax positions for any of the reporting
periods presented.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company had no tax positions at February 28, 2025 or 2024 for which the ultimate deductibility was highly uncertain but for which there
was uncertainty about the timing of such deductibility.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recognizes interest accrued related to unrecognized tax benefits in interest expense and penalties in operating expenses.
During the years ended February 28, 2025 and February 29, 2024, the Company recognized no interest and penalties. All tax returns
for years starting with 2021 and thereafter remain open for examination by the IRS.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recently adopted accounting pronouncements</a></td>
<td class="text"><p id="xdx_849_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zAjDLPXRefc6" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86D_zo0lewsivXQl">Recently
adopted accounting pronouncements</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
July 2023, the FASB issued ASU 2023-03, Presentation of Financial Statements (Topic 205), Income Statement&#8212;Reporting Comprehensive
Income (Topic 220), Distinguishing Liabilities from Equity (Topic 480), Equity (Topic 505), and Compensation&#8212;Stock Compensation
(Topic 718). The FASB Issued this ASU to amend and align various SEC paragraphs within the Codification with interpretive guidance recently
issued by the Securities and Exchange Commission (SEC). Specifically, this update codifies the guidance from SEC Staff Accounting Bulletin
(SAB) No. 120, which clarifies the application of ASC 718 &#8211; Compensation&#8212;Stock Compensation to certain share-based payment
arrangements. SAB No. 120 was issued in response to concerns about so-called &#8220;spring-loaded&#8221; awards &#8212; share-based compensation
arrangements granted shortly before the release of material nonpublic information (MNPI) that is expected to significantly affect the
market price of the issuer&#8217;s stock. SAB No. 120 does not change the fundamental measurement principles of ASC 718, but it emphasizes
the requirement to include the impact of MNPI in estimating fair value at the grant date when it is reasonable to expect that such information
would be factored into the pricing by a market participant. Under ASC 718, entities must measure the grant-date fair value of equity-classified
awards using an option-pricing model and inputs that reflect assumptions a market participant would make. SAB No. 120 reinforces that
this includes: (i) adjusting expected volatility or stock price to reflect the anticipated impact of MNPI; (ii) documenting the rationale
for assumptions that do not reflect such information, if applicable; and (3) ensuring internal control processes capture relevant information
in determining grant-date fair value. The Company adopted ASU 2023-03 effective January 1, 2024. In conjunction with this adoption, the
Company reviewed its stock compensation grant practices and valuation procedures under ASC 718. While the Company has not historically
granted awards in close proximity to the release of MNPI, it has updated its internal controls to require additional documentation and
review for any future awards that may be subject to this scenario. The adoption of ASU 2023-03 did not result in any changes to the recognition
or measurement of share-based payment expense in the Company&#8217;s consolidated financial statements. However, the Company enhanced
its internal controls around the timing and valuation of equity awards to ensure compliance with the interpretive guidance of SAB No.
120 and ASC 718.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
November 2023, the FASB issued ASU 2023-07 to improve disclosures about a public entity&#8217;s reportable segments and address investor
feedback for greater transparency. The amendments are intended to enhance the usefulness of segment information, particularly regarding
expenses, by requiring more detailed disclosures and expanding the scope of interim disclosures. The Company adopted ASU 2023-07 for
its fiscal year beginning March 1, 2024 (i.e., for the fiscal year ending February 28, 2025), as required. The amendments require entities
to disclose, on an annual and interim basis: (i) significant segment expenses that are regularly provided to the chief operating decision
maker (&#8220;CODM&#8221;); (ii) an explanation of how reported segment profit or loss is measured, (ii) The title and position of the CODM; (iii)
a description of how the CODM uses reported measures in decision-making; and (iv) expanded disclosures of segment information in interim
periods, consistent with annual disclosures.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
manage the Company as one reportable segment, Travel Products and Services. Travel bookings are the source of our revenues and include
the sale of travel products such as airline tickets and hotel rooms as well as travel services such as travel insurance and ground activities.
The segment information aligns with how the Company&#8217;s CODM reviews and manages our
business. The Company&#8217;s CODM is the Company&#8217;s Chief Executive Officer.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
information and annual operating plans and forecasts are prepared and are reviewed by the CODM at a consolidated level. The CODM assesses
performance for the Travel Products and Services segment and decides how to allocate resources based on revenue and net income that is
reported on the Consolidated Statements of Operations. The Company&#8217;s objective in making resource allocation decisions is to optimize
the financial results. The accounting policies of our Travel Products and Services segment are the same as those described in the summary
of significant accounting policies herein.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
our single reportable segment-level financial information, total assets, and significant non-cash transactions, see the Financial Statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_RecentlyIssuedAccountingPronouncementsNotYetAdoptedPolicyTextBlock', window );">Recently issued accounting pronouncements not yet adopted</a></td>
<td class="text"><p id="xdx_84D_ecustom--RecentlyIssuedAccountingPronouncementsNotYetAdoptedPolicyTextBlock_zTPCxbe6xR06" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_866_zgwQwVdwKsR9">Recently
issued accounting pronouncements not yet adopted</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
December 2023, the FASB issued ASU 2023-09, <i>Income Taxes (Topic 740): Improvements to Income
Tax Disclosures</i>, to enhance the transparency and decision-usefulness of income tax information provided to investors. The amendments
focus primarily on expanding the disclosures related to the effective tax rate reconciliation and income taxes paid. Key provisions of
the update include: (i) enhanced disclosure of the effective tax rate reconciliation, using both standardized categories and quantitative
disclosure of individual reconciling items that meet specified thresholds; (ii) required disaggregation of income taxes paid, by federal,
state, and significant foreign jurisdictions; (iii) additional qualitative disclosures about tax-related assumptions and estimation methodologies.
ASU 2023-09 is effective for public business entities for annual periods beginning after December 15, 2024. As a result, the Company
will adopt the standard for its fiscal year beginning March 1, 2025 (ending February 28, 2026). Early adoption is permitted; however,
the Company does not intend to early adopt. The Company is currently evaluating the impact of the new standard on its income tax footnote
disclosures. The adoption is not expected to have an impact on the Company&#8217;s consolidated financial position, results of operations,
or cash flows, but it will result in expanded and more detailed income tax disclosures beginning in fiscal 2026.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has considered all other recently issued accounting pronouncements and does not believe the adoption of such pronouncements will
have a material impact on its consolidated financial statements.</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_BasisDifferencePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Basis Difference [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_BasisDifferencePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_PrepaidsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Prepaids [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_PrepaidsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_PromissoryNoteReceivablePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Promissory Note Receivable [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_PromissoryNoteReceivablePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_RecentlyIssuedAccountingPronouncementsNotYetAdoptedPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Recently Issued Accounting Pronouncements Not Yet Adopted [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_RecentlyIssuedAccountingPronouncementsNotYetAdoptedPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsIssuancesPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income statement treatment of issuances of stock by an equity method investee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -SubTopic 10<br> -Topic 323<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsIssuancesPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for equity method of accounting for investments and other interests. Investment includes, but is not limited to, unconsolidated subsidiary, corporate joint venture, noncontrolling interest in real estate venture, limited partnership, and limited liability company. Information includes, but is not limited to, ownership percentage, reason equity method is or is not considered appropriate, and accounting policy election for distribution received.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 21D<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-21D<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValuePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for investment in equity security without readily determinable fair value, which does not qualify for practical expedient to estimate fair value using net asset value per share. Includes, but is not limited to, information considered for determining upward and downward adjustment from observable price change.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 321<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479536/321-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValuePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfFinancialInstrumentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the fair value of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 825<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfFinancialInstrumentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/830/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for intangible assets. This accounting policy may address both intangible assets subject to amortization and those that are not. The following also may be disclosed: (1) a description of intangible assets (2) the estimated useful lives of those assets (3) the amortization method used (4) how the entity assesses and measures impairment of such assets (5) how future cash flows are estimated (6) how the fair values of such asset are determined.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/350-30/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-20<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-19<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-25<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(h)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-17<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-28<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsFiniteLivedPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for finite-lived intangible assets. This accounting policy also might address: (1) the amortization method used; (2) the useful lives of such assets; and (3) how the entity assesses and measures impairment of such assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-4<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/350-30/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483154/926-20-50-5<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 920<br> -SubTopic 350<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478609/920-350-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 920<br> -SubTopic 350<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478609/920-350-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 920<br> -SubTopic 350<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478609/920-350-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsFiniteLivedPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InternalUseSoftwarePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs incurred when both (1) the software is acquired, internally developed, or modified solely to meet the entity's internal needs, and (2) during the software's development or modification, no substantive plan exists or is being developed to market the software externally.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/350-40/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InternalUseSoftwarePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeasesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for leasing arrangement entered into by lessee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeasesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketRiskBenefitPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for contract or contract feature in long-duration contract issued by insurance entity that both protects contract holder from other-than-nominal capital market risk and exposes insurance entity to other-than-nominal capital market risk. Includes, but is not limited to, input, judgment, assumption and method used in measuring market risk benefit, and change in input, judgment, and assumption.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7C<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480081/944-40-50-7C<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7C<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480081/944-40-50-7C<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketRiskBenefitPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 205<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483504/205-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PriorPeriodReclassificationAdjustmentDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477798/958-360-50-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477798/958-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue from contract with customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-19<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-18<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-18<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-20<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-20<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-20<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-20<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-4<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Topic 606<br> -Publisher FASB<br> -URI https://asc.fasb.org/606/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for inclusion of significant items in the selling, general and administrative (or similar) expense report caption.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 720<br> -SubTopic 35<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483406/720-35-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.C.Q3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.1.Q5)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.3.Q2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2.Q6)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/718/tableOfContent<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TradeAndOtherAccountsReceivablePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-6<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481569/310-20-50-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-15<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-11B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TradeAndOtherAccountsReceivablePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-9<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-12<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Feb. 28, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Schedule of Anti-dilutive Securities Excluded from Computation of Earnings Per Share</a></td>
<td class="text"><p id="xdx_892_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zvqrR8ZG98Q5" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B9_zfcl7inofrn9" style="display: none">Schedule of Anti-dilutive Securities Excluded
from Computation of Earnings Per Share</span></span></span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
  <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_490_20240301__20250228_zVHxnQOa9wwf" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">2025</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49B_20230301__20240229_zoPHw1J6jZFc" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">2024</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Year Ended February 28 and 29,</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">2025</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">2024</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zqkv5WKfeJ97" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 60%">Warrants</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">3,015,885</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">486,165</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--StockOptionMember_zAoWQGOKgK8b" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Stock Options</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">76,342</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">85,300</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--PreferredStockMember_zaluQv3R7uv5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Preferred Stock</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">3,109,663</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">475,835</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_z7EAhfi3Lt6d" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Total Underlying Common Shares</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">6,201,890</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">1,047,300</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_ScheduleOfEstimatedUsefulLivesForPropertyAndEquipmentTableTextBlock', window );">Schedule of Estimated Useful Lives for Property and Equipment</a></td>
<td class="text"><p id="xdx_89A_ecustom--ScheduleOfEstimatedUsefulLivesForPropertyAndEquipmentTableTextBlock_z5CB4ZAtqjM7" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span style="display: none"><span id="xdx_8BB_zz2yIF2XvmHl">Schedule
of Estimated
Useful Lives for Property and Equipment</span></span></span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Category</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Method</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Estimated
    useful life</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furniture
    &amp; Fixtures</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Straight
    line</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20250228__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zvTl2fGZ8Eof" title="Estimated useful life">5</span>
    years</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Computer
    &amp; Equipment</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Straight
    line</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20250228__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_zUaXzpeVFOQf" title="Estimated useful life">3</span>
    years</span></td></tr>
  </table>
<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_ScheduleOfEstimatedUsefulLivesForFiniteLifeIntangibleAssetsTableTextBlock', window );">Schedule of Estimated Useful Lives for Finite Life Intangible Assets</a></td>
<td class="text"><p id="xdx_891_ecustom--ScheduleOfEstimatedUsefulLivesForFiniteLifeIntangibleAssetsTableTextBlock_zX9Gyyi62dK9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
estimated useful lives for the Company&#8217;s finite life intangible assets are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B8_zqdpJQVrfANf" style="display: none">Schedule
of Estimated
Useful Lives for Finite Life Intangible Assets</span></span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Category</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Method</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Estimated
    useful life</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Software</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Straight
    line</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20250228__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SoftwareMember__srt--RangeAxis__srt--MinimumMember_zAPO9167w9ai" title="Estimated useful life">1</span>
    - <span id="xdx_909_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20250228__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SoftwareMember__srt--RangeAxis__srt--MaximumMember_zv66dkLsEoxe" title="Estimated useful life">3</span> years</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Software
    licenses</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Straight
    line</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20250228__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SoftwareLicensesMember__srt--RangeAxis__srt--MinimumMember_zfNu07ETVGUi" title="Estimated useful life">0.5</span>
    - <span id="xdx_902_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20250228__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SoftwareLicensesMember__srt--RangeAxis__srt--MaximumMember_zPU8KANFDz6l" title="Estimated useful life">4</span> years</span></td></tr>
  </table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_ScheduleOfEstimatedUsefulLivesForFiniteLifeIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule of Estimated Useful Lives for Finite Life Intangible Assets [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_ScheduleOfEstimatedUsefulLivesForFiniteLifeIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_ScheduleOfEstimatedUsefulLivesForPropertyAndEquipmentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule Of Estimated Useful Lives For Property And Equipment [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_ScheduleOfEstimatedUsefulLivesForPropertyAndEquipmentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Discontinued Operations (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Feb. 28, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract', window );"><strong>Discontinued Operations and Disposal Groups [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock', window );">Schedule of Discontinued Operations</a></td>
<td class="text"><p id="xdx_894_eus-gaap--ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_zFCh736E4fIa" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b><span id="xdx_8B1_zhPTT6uD6F5e" style="display: none">Schedule
of Discontinued Operations</span></span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_495_20240301__20250228_zIpCboDEeHp3" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">February 28,</p>
                                                                               <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">2025</p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--DisposalGroupIncludingDiscontinuedOperationRevenue_maDGIDOzv4w_zShvCX8ho5Rl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 78%">Revenue</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right">14,731</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold_msDGIDOzv4w_zJf2TzTzn1Q3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">Cost of revenue</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0856">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss_iT_mtDGIDOzv4w_maDGIDOzv2d_zzYmXroHjHW2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Gross profit</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">14,731</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_ecustom--DisposalGroupIncludingDiscontinuedOperationsProfessionalServices_maDGIDOzcGq_zZbST1Jw89Fh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Professional services</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">4,163</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_ecustom--DisposalGroupIncludingDiscontinuedOperationsInvestorRelationsServices_maDGIDOzcGq_zTrEix5zyql" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Investor relations services</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">4,194</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--DisposalGroupIncludingDiscontinuedOperationsOtherIncome_maDGIDOzcGq_zF8I0kVGhYR6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Other income</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(1,970</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_409_eus-gaap--DisposalGroupIncludingDiscontinuedOperationOperatingExpense_iT_mtDGIDOzcGq_msDGIDOzv2d_zYuvubvD1yHg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Total Expenses</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">6,387</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--IncomeLossFromDiscontinuedOperationsNetOfTax_iT_mtDGIDOzv2d_zENYlBZnkdX8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Gain from Discontinued Operations</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">8,344</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-11<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-3A<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-4A<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-4B<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5A<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5B<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5C<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5D<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5D<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-3A<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 20<br> -Topic 205<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-1<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investment in Equity Method Investee (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Feb. 28, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract', window );"><strong>Equity Method Investments and Joint Ventures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsTextBlock', window );">Schedule of Unaudited Summarized Financial Information</a></td>
<td class="text"><p id="xdx_89A_eus-gaap--EquityMethodInvestmentsTextBlock_zgVv5JxPm8S8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">FSA
Travel&#8217;s fiscal year ends on December 31. As of and for the year ended December 31, 2024, unaudited summarized financial
information for FSA is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BA_zlKZQgby6RVe" style="display: none">Schedule
of Unaudited Summarized Financial Information</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_493_20241231__dei--LegalEntityAxis__custom--FSATravelLLCMember_zB2Y60wOH5Vi" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">December 31,</p>
                                                                               <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">2024</p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--AssetsCurrent_iI_zCdkziM07QYb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 78%; text-align: left">Current assets</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right">13,629</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--AssetsNoncurrent_iI_zNAqslBORhIk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Non-current assets</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">577,776</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--LiabilitiesCurrent_iI_zSXOMmfed4H5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Current liabilities</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">12,452</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--LiabilitiesNoncurrent_iI_zIq6Zjv4hvYa" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Non-current liabilities</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">199,100</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--StockholdersEquity_iI_zZWVpEs6pGl4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Member&#8217;s equity</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">379,852</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Net revenues</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_907_eus-gaap--Revenues_c20240101__20241231__dei--LegalEntityAxis__custom--FSATravelLLCMember_zWL53lViRExk" title="Net revenues">374,143</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Gross profit</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90C_eus-gaap--GrossProfit_c20240101__20241231__dei--LegalEntityAxis__custom--FSATravelLLCMember_z6tp6d7RJNI2" title="Gross profit">374,143</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Net loss</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_905_eus-gaap--NetIncomeLoss_c20240101__20241231__dei--LegalEntityAxis__custom--FSATravelLLCMember_zYKrNYjeG0ni" title="Net loss">(252,381</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of equity method investments including, but not limited to, name of each investee or group of investments, percentage ownership, difference between recorded amount of an investment and the value of the underlying equity in the net assets, and summarized financial information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Prepaid and Other Current Assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Feb. 28, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_DisclosurePrepaidAndOtherCurrentAssetsAbstract', window );"><strong>Prepaid And Other Current Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock', window );">Schedule of Prepaid and Other Current Assets</a></td>
<td class="text"><p id="xdx_895_eus-gaap--DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_zzd2qGLq0dEf" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prepaid
and other current assets consisted of the following as of February 28, 2025 and as of February 29, 2024:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span><span id="xdx_8B9_zZ9LwnoUVML1" style="display: none">Schedule
of Prepaid and Other Current Assets</span></span></span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_493_20250228_zaA7VLr6hEd7" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">February 28,</p>
                                                                               <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">2025</p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49E_20240229_z4C2EE7B1Xm" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">February 29,</p>
                                                                               <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">2024</p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--PrepaidOfferingCosts_iI_maPEAOAzw6s_znFtiZY5Fzd2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: justify">Offering costs</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">100,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0966">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_ecustom--PrepaidConsultingContract_iI_maPEAOAzw6s_zAVhaLKZoOG4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Current portion of two-year strategic consulting contract</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">733,575</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0969">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_ecustom--PrepaidCostOfSales_iI_maPEAOAzw6s_z8dUu9C15iIl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Cost of sales</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">121,588</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">42,547</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--OtherPrepaidExpenseCurrent_iI_maPEAOAzw6s_zEO9vZ7unnL" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Other expenses</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">425,412</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">298,274</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--PrepaidAdvertising_iI_maPEAOAzw6s_zpQz10yOyLk8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 1pt">Marketing expenses</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0977">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">100</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_iTI_mtPEAOAzw6s_z2yNbqhBQOy5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 2.5pt">Total</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">1,380,575</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">340,921</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_DisclosurePrepaidAndOtherCurrentAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_DisclosurePrepaidAndOtherCurrentAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amounts paid in advance for capitalized costs that will be expensed with the passage of time or the occurrence of a triggering event, and will be charged against earnings within one year or the normal operating cycle, if longer; the aggregate carrying amount of current assets, not separately presented elsewhere in the balance sheet; and other deferred costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Feb. 28, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of Property and Equipment</a></td>
<td class="text"><p id="xdx_891_eus-gaap--PropertyPlantAndEquipmentTextBlock_z6SunUFoOwGj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property
and equipment as of February 28, 2025 and February 29, 2024 consisted of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BF_zEtJj1gNIcbg" style="display: none">Schedule
of Property and Equipment</span></span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_490_20250228_zWpUUeXWrJNb" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">February 28,</p>
                                                                               <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">2025</p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_497_20240229_zyYAsYQPn3A5" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">February 29,</p>
                                                                               <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">2024</p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zYTS5IqlbML3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left">Furniture and Fixtures</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">17,018</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">17,018</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_zXutqmKqqjGj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Computer and Equipment</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">80,786</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">82,492</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--PropertyPlantAndEquipmentGross_iI_maPPAENzyNw_zvY3v3iwVE74" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">Total</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">97,804</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">99,510</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_di_msPPAENzyNw_zMcYamBJ0cA6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Accumulated depreciation</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(93,685</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(92,868</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_40C_eus-gaap--PropertyPlantAndEquipmentNet_iTI_mtPPAENzyNw_zs6xEA8hJwX7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Property and Equipment, net of depreciation</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">4,119</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">6,642</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Feb. 28, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock', window );">Schedule of Intangible Assets</a></td>
<td class="text"><p id="xdx_897_eus-gaap--ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_zMzuwzsxZmVb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangible
assets as of February 28, 2025, and February 29, 2024 consisted of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B9_zcVqzSqgiiBl" style="display: none">Schedule
of Intangible Assets</span></span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_491_20250228_zMGiNaZmXL5b" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">February 28,</p>
                                                                               <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">2025</p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_497_20240229_zetU7acUGT5k" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">February 29,</p>
                                                                               <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">2024</p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_hus-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareDevelopmentMember_zekzs3dSm5ml" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left">Software Development</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">7,267,778</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">6,602,028</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_hus-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SoftwareLicenseMember_zWrgLBaj59K" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Software Licenses</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">789,576</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">789,576</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_hus-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksMember_z50dLyO1uDDg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">Trademark</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">6,283</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">6,283</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_maIANEGzjZg_zeOpXEg4tvac" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">Total</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">8,063,637</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">7,397,887</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iNI_di_msIANEGzjZg_zOR1s54bfor5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Accumulated amortization</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(5,936,269</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(5,224,467</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_40A_eus-gaap--IntangibleAssetsNetExcludingGoodwill_iTI_mtIANEGzjZg_zMNY8S7Av56d" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Intangible assets, net of amortization</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">2,127,368</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">2,173,420</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock', window );">Schedule of estimated aggregate amortization expense</a></td>
<td class="text"><p id="xdx_890_eus-gaap--ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_zxtda79nCq13" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
estimated aggregate amortization expense for each of the succeeding years ending February 28 is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b><span id="xdx_8BF_zK8DGd5XDLF7" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Schedule
of estimated aggregate amortization expense</span></span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%">
  <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td id="xdx_492_20250228_zvwRmE3Hy06d" style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr>
<tr id="xdx_400_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_iI_maFLIANzgGq_zmX8Le2zIXee" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 78%; text-align: left">2025</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right">597,914</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_iI_maFLIANzgGq_zlGpJjXF1bSi" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">2026</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">623,882</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_iI_maFLIANzgGq_zIvT3DmfbQ46" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">2027</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">312,358</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_iI_maFLIANzgGq_zlLijaxGX7W3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">2028</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">528</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_ecustom--FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour_iI_maFLIANzgGq_zSd01zuCTb31" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Thereafter</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1046">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_mtFLIANzgGq_zLFRe29Qm969" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">1,534,682</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Feb. 28, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock', window );">Schedule of Fair Value of Assets Acquired</a></td>
<td class="text"><p id="xdx_89C_eus-gaap--ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_zDnofmYiEA1d" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BB_zX19U9Pi4bTl" style="display: none">Schedule
of Fair Value of Assets Acquired</span></span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
  <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td>
    <td colspan="2" id="xdx_495_20231012__us-gaap--BusinessAcquisitionAxis__custom--SigmaAdditiveSolutionsIncMember_zzmncsXgk2P3" style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td colspan="5" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Fair Value of Net Assets Acquired:</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_iI_maBCRIAzMVe_zYkg02IIjFDb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 78%">Cash</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right">417,121</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_iI_maBCRIAzMVe_z15YejLtQxk9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Accounts Receivable, net</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">4,900</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_iI_maBCRIAzMVe_zQWARQWVfXci" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">Inventory</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">257,873</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_iI_maBCRIAzMVe_zL1FXHlImNyg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Prepaid expenses and other current assets</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">50,802</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_iI_maBCRIAzMVe_z3g28zCwuAf4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Property and equipment</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">52,357</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_iI_maBCRIAzMVe_z6ftHVRcBZg7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Intangible assets</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">1,277,919</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_iNI_di_msBCRIAzMVe_zpye9vMBtYE1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Accounts payable</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(837,450</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr id="xdx_403_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses_iNI_di_msBCRIAzMVe_zV7kmVYEqlQ7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Accrued expenses</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(61,001</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr id="xdx_402_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_iNI_di_msBCRIAzMVe_zEkqA9FU2eYj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Deferred revenue</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(14,218</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iTI_mtBCRIAzMVe_maBCRIAzevg_z0KXangQ1Emi" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Total identifiable net assets acquired</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">1,148,303</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--Goodwill_iI_maBCRIAzevg_z0xwSYYEs4Je" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">Goodwill</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">1,220,115</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_iTI_mtBCRIAzevg_zXBJU8hxiP4e" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Total Fair Value of Net Assets Acquired</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right">2,368,418</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Total Purchase Consideration</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_985_eus-gaap--BusinessCombinationConsiderationTransferred1_c20231012__20231012__us-gaap--BusinessAcquisitionAxis__custom--SigmaAdditiveSolutionsIncMember_zcZftK0JDz8j" style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right">2,368,418</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Paragraph 1<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Feb. 28, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Schedule of Deferred Tax Assets</a></td>
<td class="text"><p id="xdx_89C_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zm5FVERFSJ79" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred
tax assets are comprised of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BA_zjS1RXDG8JMl" style="display: none">Schedule of Deferred Tax Assets</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_497_20250228_zMJ3N7S1jjIh" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">2025</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49C_20240229_zhx5HdvLifX5" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">2024</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Deferred tax assets:</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_pp0p0_maDTANzaXy_z7BPBcuMa4j6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left">NOL carryover</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">11,500,300</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">9,226,100</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--DeferredTaxAssetDepreciation_iI_pp0p0_maDTANzaXy_zpGYk1ZOToF6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Related party accruals</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">12,900</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">173,900</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_ecustom--DeferredTaxAssetsPayrollAccruals_iI_pp0p0_maDTANzaXy_zwCIXWVDgPE9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Payroll accruals</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">47,800</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">77,800</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Deferred tax liabilities:</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_ecustom--DeferredTaxLiabilitiesDepreciation_iNI_di_msDTANzaXy_z3CrokXutTlk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">Depreciation</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">255,400</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">1,772,500</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_di_msDTANzaXy_zB3Dn34YPKJe" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Valuation allowance</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(11,816,400</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(11,250,300</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_40E_eus-gaap--DeferredTaxAssetsNet_iTI_pp0p0_mtDTANzaXy_zmyZXff2Z04a" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Net deferred tax asset (liability)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1140">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1141">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Schedule of Reconciliation of Provision for Income Taxes</a></td>
<td class="text"><p id="xdx_894_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_z1nA8U21pNwd" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BE_zVTgBR51BTI" style="display: none">Schedule
of Reconciliation of Provision for Income Taxes</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49E_20240301__20250228_zGywL4iFe0Kh" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">2025</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_498_20230301__20240229_zF6BxogVbtue" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">2024</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_404_ecustom--EffectiveIncomeTaxRateReconciliationBookLoss_maITEBzMQv_zQlIL8hoKUDf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left">Book loss</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">(2,141,700</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">(1,541,200</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">)</td></tr>
  <tr id="xdx_40C_eus-gaap--IncomeTaxReconciliationNondeductibleExpenseDepreciation_maITEBzMQv_zfkiHKDQ2hk7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">Depreciation</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(197,100</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">270,100</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment_maITEBzMQv_zsvIGW2gXn6f" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Meals &amp; entertainment</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1155">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">300</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_ecustom--IncomeTaxReconciliationNondeductibleExpensePreferredDividends_maITEBzMQv_z5S1j75qjE8g" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Preferred dividends</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">16,506</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">422,842</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_ecustom--IncomeTaxReconciliationNondeductibleExpenseLossOnNextPlayNoteReceivable_maITEBzMQv_zZHdbst94oE5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Loss on NextPlay note receivable</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><p style="margin: 0">210,000</p></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><p style="margin: 0"><span style="-sec-ix-hidden: xdx2ixbrl1162">-</span></p></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_maITEBzMQv_zBx7diM0508d" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Stock compensation</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">14,254</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">24,468</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_ecustom--IncomeTaxReconciliationNondeductibleExpenseLossOnAssetDisposal_maITEBzMQv_zIsiJttSawak" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Loss on asset disposal</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">229</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">67,274</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_ecustom--IncomeTaxReconciliationNondeductibleExpenseAccruedPayroll_maITEBzMQv_zl7vdpLM9dDb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Accrued payroll</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(29,991</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">51,857</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_ecustom--IncomeTaxReconciliationNondeductibleExpenseRelatedPartyAccruals_maITEBzMQv_zSajqfDyM3ac" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Related party accruals</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(161,018</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">114,928</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_maITEBzMQv_z8zXFDg5og7a" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Change in valuation allowance</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">2,288,820</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">589,431</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--IncomeTaxExpenseBenefit_iT_pp0p0_mtITEBzMQv_zCxHBGqrRx7a" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Provision for Income Taxes</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1179">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1180">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders&#8217; Equity (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Feb. 28, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Schedule of Stock Option Activity</a></td>
<td class="text"><p id="xdx_895_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_z7fWqRBOsDU8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Option
activity for the year ended February 28, 2025 was as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8BC_zfQu3JsnJ59" style="display: none">Schedule of Stock Option Activity</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Weighted Average</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Weighted Average</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Exercise</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Remaining</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Aggregate</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Price</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Contractual</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Intrinsic</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Options</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">($)</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Life (Yrs.)</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Value ($)</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 44%; padding-bottom: 2.5pt">Options outstanding at February 29, 2024</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20240301__20250228_zPZHtTXqaegk" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Number of Options Outstanding, Balance">85,300</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 2.5pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; width: 1%; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20240301__20250228_z9ijAU1jR6H5" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; width: 10%; text-align: right" title="Weighted Average Exercise Price Outstanding, Balance">60.50</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 2.5pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; width: 10%; text-align: right"><span id="xdx_90B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20230301__20240229_z7rh1Tw5VOCa" title="Weighted Average Remaining Contractual Life Years, Outstanding Balance">2.52</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_pp0p0_c20240301__20250228_zzRgZC8N6fuf" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Aggregate Intrinsic Value Outstanding">&#160;&#160;&#160;&#160;<span style="-sec-ix-hidden: xdx2ixbrl1700">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">Exercised</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_pid_di0_c20240301__20250228_zgwFJ0vHjxqj" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options, Exercised">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20240301__20250228_zb5XDJ5uwvna" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl1704">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_pp0p0_c20240301__20250228_zMmgjk4Asvdf" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl1706">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Forfeited or cancelled</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_iN_pid_di_c20240301__20250228_zLqMInKaS8x7" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options, Forfeited or cancelled">(8,958</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_pid_c20240301__20250228_zRGsYFDGyqqa" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right" title="Weighted Average Exercise Price, Forfeited or cancelled">125.65</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_980_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedorCancelledInPeriodTotalIntrinsicValue_pp0p0_c20240301__20250228_zGxxh3VyvZD6" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Forfeited or cancelled"><span style="-sec-ix-hidden: xdx2ixbrl1712">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">Options outstanding at February 28, 2025</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20240301__20250228_zxxWWJqIBdUc" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options Outstanding, Balance">76,342</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20240301__20250228_zycMET3eH0s6" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price Outstanding, Balance">52.69</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span id="xdx_904_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20240301__20250228_z7pTiXutuxa4" title="Weighted Average Remaining Contractual Life Years, Outstanding Balance">1.60</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iE_pp0p0_c20240301__20250228_zxoBHzrt13Sc" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value Outstanding"><span style="-sec-ix-hidden: xdx2ixbrl1720">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Options expected to vest in the future as of February 28, 2025</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iE_pid_c20240301__20250228_zRqlghxB8pGb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options, Expected to Vest in the Future Ending Balance">350</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_iE_pid_c20240301__20250228_zRmsLe0OoOx" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Expected to Vest">50.00</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_dtY_c20240301__20250228_zVtPqhUUH0Xg" title="Weighted Average Remaining Contractual Life Years, Expected to Vest">2.34</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_iE_pp0p0_c20240301__20250228_zVuiziQo3bue" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Outstanding, Expected of  Vest"><span style="-sec-ix-hidden: xdx2ixbrl1728">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">Options exercisable at February 28, 2025</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_pid_c20240301__20250228_zKfkfptkyge6" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options, Exercisable">75,992</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20240301__20250228_z7d3SzvRF8i6" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right" title="Weighted Average Exercise Price, Exercisable">52.71</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right"><span id="xdx_90D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20240301__20250228_zLUR4wKzojMi" title="Weighted Average Remaining Contractual Life Years, Exercisable">1.59</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iE_pp0p0_c20240301__20250228_zup665Ufk8G" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Outstanding, Exercisable"><span style="-sec-ix-hidden: xdx2ixbrl1736">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Options vested, exercisable, and options expected to vest at February 28, 2025</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_iE_pid_c20230301__20250228_zLyRyLfYBXdb" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options, Vested, Exercisable and Options Expected to Vest, Balance">76,342</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_iE_c20240301__20250228_zOaTHmRKbjRj" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price, Vested, Exercisable and Options Expected to Vest">52.69</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"><span id="xdx_904_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_dtY_c20240301__20250228_z3c1eUlHCHM8" title="Weighted Average Remaining Contractual Life (Yrs.), Vested, Exercisable and Options Expected to Vest">1.60</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_iE_pp0p0_c20240301__20250228_zetWwG7Azr31" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Outstanding,Exercisable and Options Expected to Vest"><span style="-sec-ix-hidden: xdx2ixbrl1744">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Schedule of Share Based Payments Award Stock Options Valuation Assumptions</a></td>
<td class="text"><p id="xdx_893_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_zFI411ZI4oWh" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The fair value of warrants issued during the year
was estimated using the Black-Scholes model with the following assumptions for the twelve months ended February 28, 2025:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"><b>Assumptions:</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8B0_zjrLnBZbNBQh" style="display: none">Schedule of Share Based Payments Award Stock Options Valuation Assumptions</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2025</td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 80%; text-align: left">Dividend yield</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 18%; text-align: right"><span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_uPure_c20240301__20250228_zaeQiO9I5h47" title="Dividend yield">0.0</span></td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Risk-free interest rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_pid_dp_uPure_c20240301__20250228__srt--RangeAxis__srt--MinimumMember_zhLnzXurenHb" title="Risk-free interest rate, minimum">3.5%</span>-<span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uPure_c20240301__20250228__srt--RangeAxis__srt--MaximumMember_zPhasS7VGCxb" title="Risk-free interest rate, maximum">4.3</span></span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Expected volatility</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_dp_uPure_c20240301__20250228__srt--RangeAxis__srt--MinimumMember_zxTUefTGKlD5" title="Expected volatility, minimum">127.1%</span>-<span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_dp_uPure_c20240301__20250228__srt--RangeAxis__srt--MaximumMember_zjNy1QocRtUj" title="Expected volatility, maximum">159.4</span></span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Expected life (in years)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20240301__20250228__srt--RangeAxis__srt--MinimumMember_zWEcePIp2eya" title="Expected life">1.5</span>-<span id="xdx_90F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20240301__20250228__srt--RangeAxis__srt--MaximumMember_zE5VvcpgzZzb" title="Expected life">5.0</span></span></td><td style="text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock', window );">Schedule of Warranty Activity</a></td>
<td class="text"><p id="xdx_896_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zhpRYHcrbv0j" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrant
activity for the year ended February 28, 2025 was as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8BB_zjRXwdpkZ8oh" style="display: none">Schedule of Warranty Activity</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Weighted Average</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Average</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Exercise</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Remaining</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Price</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Contractual</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Warrants</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">($)</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Life (Yrs.)</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 46%; padding-bottom: 2.5pt">Warrants outstanding at February 29, 2024</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_pid_c20240301__20250228_zIpt1G5hP1Ph" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right" title="Warrants Outstanding, Beginning Balance">486,165</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20240301__20250228_zgZUaZGSu2Ci" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right" title="Weighted Average Exercise Price Outstanding, Beginning Balance">9.94</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span id="xdx_90C_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonOutstandingWeightedAverageRemainingContractualTerm_dtY_c20230301__20240229_zw2bFLwpI3ri" title="Weighted Average Remaining Contractual Life Years, Beginning Balance">1.96</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">Granted</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_pid_c20240301__20250228_zvn9T6oeWXu2" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants, Granted">2,637,887</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_980_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20240301__20250228_zFHGq4ni9MKc" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price Outstanding, Granted">4.80</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_901_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonGrantsWeightedAverageRemainingContractualTerm_dtY_c20240301__20250228_zszdofnTORw5" title="Weighted Average Remaining Contractual Life Years, Granted">4.24</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">Exercised</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_iN_pid_di_c20240301__20250228_ztCL8aXqCXTc" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants,Exercised">(104,965</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98D_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageExercisePrice_pid_c20240301__20250228_zMCjplN3nB72" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price Outstanding,Exercised">3.02</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Forfeited or cancelled</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_iN_pid_di_c20240301__20250228_zuGRbpcXSw46" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants, Forfeited or cancelled">(3,202</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98D_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageWeightedAverageExercisePriceWarrantsForfeitedOrCancelled_pid_c20240301__20250228_zSjC9Dr7s8jk" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price Outstanding, Forfeited or cancelled"><span style="-sec-ix-hidden: xdx2ixbrl1884">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">Warrants outstanding at February 28, 2025</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_pid_c20240301__20250228_ziS5TaRvdfLk" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants Outstanding, Ending Balance">3,015,885</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_984_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20240301__20250228_zHwIq6VlvfIk" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price Outstanding, Ending Balance">5.36</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90F_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonOutstandingWeightedAverageRemainingContractualTerm_dtY_c20240301__20250228_zoWs4z0IxTZb" title="Weighted Average Remaining Contractual Life Years, Ending Balance">3.84</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=NTRP_StockAppreciationRightsMember', window );">Stock Appreciation Rights [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Schedule of Stock Option Activity</a></td>
<td class="text"><p id="xdx_89B_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_hus-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zY6pvwKtnjEh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SARs
activity for the year ended February 28, 2025 was as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8BC_z9W7DSJJXzi3" style="display: none">Schedule of Stock Option Activity</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Weighted Average</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Weighted Average</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Exercise</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Remaining</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Aggregate</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Price</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Contractual</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Intrinsic</td><td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">SARs</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">($)</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Life (Yrs.)</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Value ($)</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 44%; padding-bottom: 2.5pt">SARs outstanding at February 29, 2024</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20240301__20250228__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zjkCZZCRAwh8" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Number of Options, Outstanding, Balance">40,390</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20240301__20250228__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zQ4n6w20TGg5" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Weighted Average Exercise Price, Outstanding Balance">44.77</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right"><span id="xdx_90B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20230301__20240228__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zRRT7pE2pkti" title="Weighted Average Remaining Contractual Life, Outstanding Balance">2.99</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_pp0p0_c20240301__20250228__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zsdfPy788FQj" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Aggregate Intrinsic Value, Outstanding Balance">&#160;&#160;&#160;&#160;&#160;&#160;<span style="-sec-ix-hidden: xdx2ixbrl1784">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">Exercised</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_pid_di_c20240301__20250228__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_z4IaxQLm7lD8" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl1786">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20240301__20250228__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zSHJCbpGBwW8" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl1788">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_pp0p0_c20240301__20250228__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zceVw30bzj7" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl1790">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Forfeited or cancelled</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_iN_pid_di_c20240301__20250228__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zYUiseWCIOyj" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options, Forfeited or cancelled">(167</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98B_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageForfeitedOrCancelled_pid_c20240301__20250228__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zKmYsp2iQrNe" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Forfeited or cancelled">37.4</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_982_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedorCancelledInPeriodTotalIntrinsicValue_pp0p0_c20240301__20250228__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zbjkcFaAlHz8" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Forfeited or cancelled"><span style="-sec-ix-hidden: xdx2ixbrl1796">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">SARs outstanding February 28, 2025</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20240301__20250228__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zqxsOpD7OZwd" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options, Outstanding, Balance">40,223</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20240301__20250228__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zC6dAbVaDPBg" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Outstanding Balance">44.80</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20240301__20250228__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zr4yQGUbcPJ7" title="Weighted Average Remaining Contractual Life, Outstanding Balance">1.99</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iE_pp0p0_c20240301__20250228__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zGpRxO6pgOQf" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Outstanding Balance"><span style="-sec-ix-hidden: xdx2ixbrl1804">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">SARs expected to vest in the future as of February 28, 2025</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iE_pid_c20240301__20250228__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zGGSsgm4v6p9" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options, Expected to vest in the future, Balance">5,213</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_iE_pid_c20240301__20250228__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zn7Hsp92P6K3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Expected to Vest">27.66</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_dtY_c20240301__20250228__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zwFy3VfuD7Ta" title="Weighted Average Remaining Contractual Life, Expected to Vest">1.93</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_iE_pp0p0_c20240301__20250228__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zGQtOUP8Ukwd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Options expected to vest in the future"><span style="-sec-ix-hidden: xdx2ixbrl1812">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">SARs exercisable at February 28, 2025</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_pid_c20240301__20250228__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zx1loO0OnAHd" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options, Exercisable">35,010</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20240301__20250228__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zAMuaPcKE2H9" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Exercisable">47.35</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20240301__20250228__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zD33XKKplyh9" title="Weighted Average Remaining Contractual Life, Exercisable">2.34</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iE_pp0p0_c20240301__20250228__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zJCSqvoC7hnd" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Options exercisable"><span style="-sec-ix-hidden: xdx2ixbrl1820">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">SARs vested, exercisable, and options expected to vest at February 28, 2025</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_iE_pid_c20240301__20250228__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_z0urZVBN5lfj" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options, Vested, Exercisable and Options Expected to Vest Balance">40,223</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_iE_pid_c20240301__20250228__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zva9jgslCi35" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Vested, Exercisable and Options Expected to Vest">44.80</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_dtY_c20240301__20250228__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zf1jdG76Rzj6" title="Weighted Average Remaining Contractual Life, Vested, Exercisable and Options Expected to Vest">1.99</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_iE_pp0p0_c20240301__20250228__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zklpPrAoaHe4" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Options vested, exercisable and options expected to vest"><span style="-sec-ix-hidden: xdx2ixbrl1828">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Schedule of Share Based Payments Award Stock Options Valuation Assumptions</a></td>
<td class="text"><p id="xdx_89B_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_hus-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_z2BXlDB1N7Lj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fair value of outstanding SAR awards was estimated using the Black-Scholes model with the following assumptions for the twelve months
ended February 28, 2025:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Assumptions:</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8BE_zRCuvey8r5x6" style="display: none">Schedule of Share Based Payments Award Stock Options Valuation Assumptions</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 75%; margin-right: auto">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">2025</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 78%; text-align: left">Dividend yield</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right"><span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_uPure_c20240301__20250228__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyStockAppreciationRightsPlanMember_zvTY0812C7Tb" title="Dividend yield">0.0</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">%</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Risk-free interest rate</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_dp_uPure_c20240301__20250228__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyStockAppreciationRightsPlanMember_zKHl8PAoQXla" title="Risk-free interest rate, minimum">2.3</span>%-<span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_dp_uPure_c20240301__20250228__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyStockAppreciationRightsPlanMember_zX9fO0EfkiO6" title="Risk-free interest rate, maximum">5.25</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Expected volatility</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_dp_uPure_c20240301__20250228__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyStockAppreciationRightsPlanMember_zq5yRj9WdE3e" title="Expected volatility, minimum">96.5</span>%-<span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_dp_uPure_c20240301__20250228__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyStockAppreciationRightsPlanMember_zq9WsGGxTKmj" title="Expected volatility, maximum">187.8</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Expected life (in years)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20240301__20250228__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyStockAppreciationRightsPlanMember__srt--RangeAxis__srt--MinimumMember_z86hD1Pm8OR" title="Expected life">0.16</span>-<span id="xdx_90B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20240301__20250228__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyStockAppreciationRightsPlanMember__srt--RangeAxis__srt--MaximumMember_z8xRrC63KiZ" title="Expected life">2.08</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (f)(2)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=NTRP_StockAppreciationRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=NTRP_StockAppreciationRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Loss Per Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Feb. 28, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Earnings Per Share, Basic and Diluted</a></td>
<td class="text"><p id="xdx_89C_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zzRn2OLe8J13" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following data show the amounts used in computing loss per share and the effect on income and the weighted average number of shares of
dilutive potential common stock for the years ended February 28, 2025 and February 29, 2024:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8B0_zB5oQ5B78MWg" style="display: none">Schedule of Earnings Per Share, Basic and Diluted</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
  <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_491_20240301__20250228_zIax3Wzc3cCl" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">2025</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_490_20230301__20240229_zea9HjiMcnW9" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">2024</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Year Ended February</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">2025</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">2024</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_zFrF7PIzwta" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left">Loss from continuing operations</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">(10,128,428</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">(6,656,837</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">)</td></tr>
  <tr id="xdx_405_eus-gaap--PreferredStockDividendsIncomeStatementImpact_iN_di_z9I9ynpTyyy9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Preferred dividends</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(78,600</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(7,125</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_40E_eus-gaap--IncomeLossFromContinuingOperations_z8bBw63pHCCg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Loss from continuing operations applicable to common stockholders</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(10,207,028</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(6,663,962</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr>
  <tr id="xdx_407_eus-gaap--IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_zhUfm67V8gu5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Gain (loss) from discontinued operations applicable to common stockholders</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">8,344</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(675,314</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_40E_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_zPemkS9ty0b" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Net loss applicable to common stockholders</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(10,198,684</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(7,339,276</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_zfw2IISZJTAf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Weighted average number of common shares Outstanding used in loss per share during the Period (denominator)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">4,566,787</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">228,274</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock', window );">Schedule of Business Milestones and Issuable Contingent Shares</a></td>
<td class="text"><p id="xdx_89D_eus-gaap--ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock_zwEd4uQAvnFg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8BA_zJ94RHgNtRXe" style="display: none">Schedule
of Business Milestones and Issuable Contingent Shares</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify">Business Milestones</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Contingent Shares</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: italic 10pt Times New Roman, Times, Serif; text-align: justify">Achieved</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 78%; text-align: justify">Launch of leisure travel booking platform</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--IncrementalCommonSharesAttributableToContingentlyIssuableShares_c20240610__20240610__srt--StatementScenarioAxis__custom--AchievedMember__us-gaap--OtherCommitmentsAxis__custom--LeisureTravelBookingPlatformMember_zj7ToOtUlco7" style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right" title="Launch of leisure travel booking platform">1,450,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Launch of group travel booking platform</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--IncrementalCommonSharesAttributableToContingentlyIssuableShares_c20240610__20240610__srt--StatementScenarioAxis__custom--AchievedMember__us-gaap--OtherCommitmentsAxis__custom--GroupTravelBookingPlatformMember_zUvg407RUbDg" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Launch of group travel booking platform">1,450,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 1pt">Launch of PayDlay technology</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--IncrementalCommonSharesAttributableToContingentlyIssuableShares_c20240610__20240610__srt--StatementScenarioAxis__custom--AchievedMember__us-gaap--OtherCommitmentsAxis__custom--FlexPayTechnologyMember_z8y6ZcZE9Lqb" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Launch of FlexPay technology">1,493,993</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 1pt">Total contingent shares issuable on June 10, 2024</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--IncrementalCommonSharesAttributableToContingentlyIssuableShares_c20240610__20240610__srt--StatementScenarioAxis__custom--AchievedMember_zzmq5bWdIYRc" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total contingent shares issuable on June 10, 2024">4,393,993</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: italic 10pt Times New Roman, Times, Serif; text-align: justify">Not Achieved</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 1pt">Launch of travel agent platform</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--IncrementalCommonSharesAttributableToContingentlyIssuableShares_c20240610__20240610__srt--StatementScenarioAxis__custom--NotAchievedMember__us-gaap--OtherCommitmentsAxis__custom--TravelAgentPlatformMember_zis53YyOuZRh" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total contingent shares potentially issuable in future periods">1,450,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 1pt">Total contingent shares potentially issuable in future periods</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--IncrementalCommonSharesAttributableToContingentlyIssuableShares_c20240610__20240610__srt--StatementScenarioAxis__custom--NotAchievedMember_zMhks37wI6C4" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total contingent shares potentially issuable in future periods">1,450,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 2.5pt">Total contingent shares</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--IncrementalCommonSharesAttributableToContingentlyIssuableShares_c20240610__20240610_zwx7IksCC5M5" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total contingent shares">5,843,993</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock', window );">Schedule of Weighted Average Common Shares</a></td>
<td class="text"><p id="xdx_899_eus-gaap--ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_zkFLoYttQsQb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table shows the reconciliation of the weighted average common shares outstanding for the twelve months ended February 28, 2025
to the weighted average common shares used in the computation of basic earnings per share:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8BD_zbSPJ2PEsGaf" style="display: none">Schedule
of Weighted Average Common Shares</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">February 28,</p>
                                                                               <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">2025</p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 78%"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFdlaWdodGVkIEF2ZXJhZ2UgQ29tbW9uIFNoYXJlcyAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_90D_eus-gaap--CommonStockSharesOutstanding_iI_c20250228_ziMjiQjhAeV9" title="Common stock, shares outstanding">1,656,738</span> common shares outstanding</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20240301__20250228__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zoNFLk1YuaVc" style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right" title="1,656,738 common shares outstanding">1,400,705</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFdlaWdodGVkIEF2ZXJhZ2UgQ29tbW9uIFNoYXJlcyAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_906_eus-gaap--IncrementalCommonSharesAttributableToContingentlyIssuableShares_c20240301__20250228_zKANRDcND0Yf" title="Contingent shares issuable">4,393,993</span> issuable contingent shares</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20240301__20250228__us-gaap--StatementClassOfStockAxis__custom--ContingentSharesMember_z5QbJx49MdH7" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="4,393,993 issuable contingent shares">3,166,083</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">Weighted average common shares outstanding</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20240301__20250228_zL6wAdzc4YJ" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average common shares outstanding">4,566,787</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of contingent payment arrangements including the terms that will result in payment and the accounting treatment that will be followed if such contingencies occur, including the potential impact on earnings per share if contingencies are to be settled in common stock of the entity. The description also may include the period over which amounts are expected to be paid, and changes in the amount since the previous reporting period. This also includes contingent options and commitments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the weighted average number of shares used in calculating basic net earnings per share (or unit) and diluted earnings per share (or unit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Business Description and Going Concern (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 29, 2023</div></th>
<th class="th"><div>Oct. 12, 2023</div></th>
<th class="th"><div>Jan. 25, 2023</div></th>
<th class="th"><div>Feb. 28, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Nov. 30, 2024</div></th>
<th class="th"><div>Feb. 29, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Share price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 34,349,823<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 24,151,139<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_WorkingCapitalDeficit', window );">Working capital deficit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 105,577<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 262,005<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=NTRP_NextInnovationLLCMember', window );">Next Innovation LLC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Ownership percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=NTRP_NextPlayTechnologiesIncMember', window );">Next Play Technologies Inc [Member] | Share Exchange Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Share price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=NTRP_NextPlayTechnologiesIncMember', window );">Next Play Technologies Inc [Member] | Share Exchange Agreement [Member] | Membership Units [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Number of common stock issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=NTRP_NextPlayTechnologiesIncMember', window );">Next Play Technologies Inc [Member] | Share Exchange Agreement [Member] | Preferred Units [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Number of common stock issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Number of common stock issued, value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17,295,873<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=NTRP_NextTripGroupLLCMember', window );">NextTrip Holdings, Inc. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Capital', window );">Contributed capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_PercentageForIssuedAndOutstandingCapitalStock', window );">Percentage for issued and outstanding capital stock</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=NTRP_NextTripGroupLLCMember', window );">NextTrip Holdings, Inc. [Member] | Share Exchange Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_PercentageForIssuedAndOutstandingCapitalStock', window );">Percentage for issued and outstanding capital stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">90.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=NTRP_NextTripGroupLLCMember', window );">NextTrip Holdings, Inc. [Member] | Share Exchange Agreement [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued', window );">Restricted shares issuable in reverse acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=NTRP_NextTripGroupLLCMember', window );">NextTrip Holdings, Inc. [Member] | Share Exchange Agreement [Member] | Closing Shares [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued', window );">Restricted shares issuable in reverse acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">156,007<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=NTRP_NextTripGroupLLCMember', window );">NextTrip Holdings, Inc. [Member] | Share Exchange Agreement [Member] | Contingent Shares [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued', window );">Restricted shares issuable in reverse acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,843,993<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_PercentageForIssuedAndOutstandingCapitalStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage for issued and outstanding, capital stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_PercentageForIssuedAndOutstandingCapitalStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_WorkingCapitalDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Working capital deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_WorkingCapitalDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of equity interests issued or issuable to acquire entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Capital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of total capital as defined by regulatory framework.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477270/942-505-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Capital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 808<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479402/808-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-4<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=NTRP_NextInnovationLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=NTRP_NextInnovationLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=NTRP_NextPlayTechnologiesIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=NTRP_NextPlayTechnologiesIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=NTRP_ShareExchangeAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=NTRP_ShareExchangeAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=NTRP_MembershipUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=NTRP_MembershipUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=NTRP_PreferredUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=NTRP_PreferredUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=NTRP_NextTripGroupLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=NTRP_NextTripGroupLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=NTRP_ClosingSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=NTRP_ClosingSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=NTRP_ContingentSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=NTRP_ContingentSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule of Anti-dilutive Securities Excluded from Computation of Earnings Per Share (Details) - shares<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Feb. 28, 2025</div></th>
<th class="th"><div>Feb. 29, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total Underlying Common Shares</a></td>
<td class="nump">6,201,890<span></span>
</td>
<td class="nump">1,047,300<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember', window );">Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total Underlying Common Shares</a></td>
<td class="nump">3,015,885<span></span>
</td>
<td class="nump">486,165<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_StockOptionMember', window );">Equity Option [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total Underlying Common Shares</a></td>
<td class="nump">76,342<span></span>
</td>
<td class="nump">85,300<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_PreferredStockMember', window );">Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total Underlying Common Shares</a></td>
<td class="nump">3,109,663<span></span>
</td>
<td class="nump">475,835<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_StockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_StockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_PreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_PreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Schedule of Estimated Useful Lives for Property and Equipment (Details)<br></strong></div></th>
<th class="th"><div>Feb. 28, 2025</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and Fixtures [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful life</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember', window );">Computer Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful life</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Schedule of Estimated Useful Lives for Finite Life Intangible Assets (Details)<br></strong></div></th>
<th class="th"><div>Feb. 28, 2025</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=NTRP_SoftwareMember', window );">Software [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Estimated useful life</a></td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=NTRP_SoftwareMember', window );">Software [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Estimated useful life</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=NTRP_SoftwareLicensesMember', window );">Software Licenses [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Estimated useful life</a></td>
<td class="text">6 months<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=NTRP_SoftwareLicensesMember', window );">Software Licenses [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Estimated useful life</a></td>
<td class="text">4 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=NTRP_SoftwareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=NTRP_SoftwareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=NTRP_SoftwareLicensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=NTRP_SoftwareLicensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Feb. 28, 2025</div></th>
<th class="th"><div>Feb. 29, 2024</div></th>
<th class="th"><div>Jan. 27, 2025</div></th>
<th class="th"><div>Sep. 25, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashEquivalentsAtCarryingValue', window );">Cash equivalents</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNet', window );">Accounts receivable</a></td>
<td class="nump">22,567<span></span>
</td>
<td class="nump">34,092<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_LossOnRelatedPartyReceivable', window );">Loss on promissory note receivable</a></td>
<td class="nump">1,000,000<span></span>
</td>
<td class="nump">1,567,665<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingAndMarketingExpense', window );">Sales and marketing expense</a></td>
<td class="nump">307,166<span></span>
</td>
<td class="nump">484,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=NTRP_NextPlayTechnologiesIncMember', window );">Next Play Technologies Inc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_LossOnRelatedPartyReceivable', window );">Loss on promissory note receivable</a></td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=NTRP_NextPlayTechnologiesIncMember', window );">Next Play Technologies Inc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNet', window );">Accounts receivable</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Allowance for doubtful accounts</a></td>
<td class="nump">$ 2,567,665<span></span>
</td>
<td class="nump">$ 1,567,665<span></span>
</td>
<td class="nump">$ 2,567,665<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_LossOnRelatedPartyReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loss on related party receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_LossOnRelatedPartyReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 310<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477802/946-310-45-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(5)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 310<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479196/954-310-45-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479344/326-20-45-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479319/326-20-50-13<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479319/326-20-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingAndMarketingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total amount of expenses directly related to the marketing or selling of products or services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingAndMarketingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=NTRP_NextPlayTechnologiesIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=NTRP_NextPlayTechnologiesIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=NTRP_NextPlayTechnologiesIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=NTRP_NextPlayTechnologiesIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule of Discontinued Operations (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Feb. 28, 2025</div></th>
<th class="th"><div>Feb. 29, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract', window );"><strong>Discontinued Operations and Disposal Groups [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue', window );">Revenue</a></td>
<td class="nump">$ 14,731<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold', window );">Cost of revenue</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss', window );">Gross profit</a></td>
<td class="nump">14,731<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_DisposalGroupIncludingDiscontinuedOperationsProfessionalServices', window );">Professional services</a></td>
<td class="nump">4,163<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_DisposalGroupIncludingDiscontinuedOperationsInvestorRelationsServices', window );">Investor relations services</a></td>
<td class="nump">4,194<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_DisposalGroupIncludingDiscontinuedOperationsOtherIncome', window );">Other income</a></td>
<td class="num">(1,970)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense', window );">Total Expenses</a></td>
<td class="nump">6,387<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax', window );">Gain from Discontinued Operations</a></td>
<td class="nump">$ 8,344<span></span>
</td>
<td class="num">$ (675,314)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_DisposalGroupIncludingDiscontinuedOperationsInvestorRelationsServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal group including discontinued operations investor relations services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_DisposalGroupIncludingDiscontinuedOperationsInvestorRelationsServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_DisposalGroupIncludingDiscontinuedOperationsOtherIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal group including discontinued operations other income</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_DisposalGroupIncludingDiscontinuedOperationsOtherIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_DisposalGroupIncludingDiscontinuedOperationsProfessionalServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal group including discontinued operations professional services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_DisposalGroupIncludingDiscontinuedOperationsProfessionalServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of costs of goods sold attributable to disposal group, including, but not limited to, discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gross profit attributable to disposal group, including, but not limited to, discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating expense attributable to disposal group, including, but not limited to, discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue attributable to disposal group, including, but not limited to, discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 270<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477349/740-270-45-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-3A<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5C<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-3B<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-4<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-1<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Discontinued Operations (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 12, 2023</div></th>
<th class="th"><div>Oct. 06, 2023</div></th>
<th class="th"><div>Feb. 28, 2025</div></th>
<th class="th"><div>Feb. 29, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnDispositionOfAssets1', window );">Loss on disposal of assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (90)<span></span>
</td>
<td class="num">$ (14,718)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax', window );">Loss of discontinued operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,344<span></span>
</td>
<td class="num">$ (675,314)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=NTRP_DivergentTechnologiesIncMember', window );">Divergent Technologies, Inc. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireIntangibleAssets', window );">Purchase price</a></td>
<td class="nump">$ 1,626,242<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=NTRP_AssetPurchaseAgreementMember', window );">Asset Purchase Agreement [Member] | Divergent Technologies, Inc. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireIntangibleAssets', window );">Purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,626,242<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_EarnestMoneyDeposit', window );">Earnest money deposit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnDispositionOfAssets1', window );">Loss on disposal of assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30,515<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_EarnestMoneyDeposit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Earnest-money deposit</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_EarnestMoneyDeposit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 808<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479402/808-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnDispositionOfAssets1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of assets, including but not limited to property plant and equipment, intangible assets and equity in securities of subsidiaries or equity method investee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnDispositionOfAssets1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 270<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477349/740-270-45-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-3A<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5C<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-3B<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-4<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-1<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=NTRP_DivergentTechnologiesIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=NTRP_DivergentTechnologiesIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=NTRP_AssetPurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=NTRP_AssetPurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule of Unaudited Summarized Financial Information (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="4">12 Months Ended</th>
<th class="th" colspan="2"></th>
</tr>
<tr>
<th class="th"><div>Feb. 28, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th" colspan="2"><div>Feb. 29, 2024</div></th>
<th class="th"><div>Feb. 28, 2023</div></th>
<th class="th"><sup>[1]</sup></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Current assets</a></td>
<td class="nump">$ 2,465,509<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,698,808<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsNoncurrent', window );">Non-current assets</a></td>
<td class="nump">7,470,644<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,390,034<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Current liabilities</a></td>
<td class="nump">2,571,086<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,960,813<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Member&#8217;s equity</a></td>
<td class="nump">7,365,067<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,128,029<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td colspan="2" class="nump">$ 484,110<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">3,302<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">61,220<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (10,120,084)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (7,332,151)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=NTRP_FSATravelLLCMember', window );">FSA Travel LLC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,629<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsNoncurrent', window );">Non-current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">577,776<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,452<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrent', window );">Non-current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">199,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Member&#8217;s equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">379,852<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">374,143<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">374,143<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (252,381)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="7"></td></tr>
<tr><td colspan="7"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">On
    December 29, 2023, the Company (then known as Sigma Additive Solutions, Inc.) acquired NTH in a reverse acquisition. NTG was issued
    <span id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_pid_c20231229__20231229__us-gaap--BusinessAcquisitionAxis__custom--NextTripGroupLLCMember_znf0cL99Yexe" title="Number of shares acquired">83,371</span> shares of Company common stock in exchange for <span id="xdx_903_ecustom--PercentageForIssuedAndOutstandingCapitalStock_pid_dp_uPure_c20231229__20231229__us-gaap--BusinessAcquisitionAxis__custom--NextTripGroupLLCMember_zJ1ftypKOa1l" title="Percentage for issued and outstanding capital stock">100</span>% of the issued and outstanding capital stock of NTH at the time of the
    reverse acquisition. The Company has reflected this transaction retroactively in these financial statements.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized for present right to economic benefit, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-5<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 21: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=NTRP_FSATravelLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=NTRP_FSATravelLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Investment in Equity Method Investee (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th"><div>Feb. 28, 2025</div></th>
<th class="th"><div>Feb. 06, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Business acquisition shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,927<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Business acquisition shares price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.00<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=NTRP_MembershipPurchaseAgreementMember', window );">Membership Purchase Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityOwnershipPercentageExcludingConsolidatedEntityAndEquityMethodInvestee', window );">Equity Ownership, Excluding Consolidated Entity and Equity Method Investee, Percentage</a></td>
<td class="nump">49.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPreacquisitionContingencyAmountOfSettlement', window );">Business acquisition amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationAsset', window );">Business acquisition consideration cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentInterestRatePaidInCash', window );">Investment, Interest Rate, Paid in Cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">51.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_BusinessAcquisitionMilestonePayments', window );">Milestone payments</a></td>
<td class="nump">$ 800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesAndInterestInAffiliates', window );">Business acquisition additional amount</a></td>
<td class="nump">$ 1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=NTRP_MembershipPurchaseAgreementMember', window );">Membership Purchase Agreement [Member] | FSA Travel LLC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentInterestRatePaidInCash', window );">Investment, Interest Rate, Paid in Cash</a></td>
<td class="nump">51.00%<span></span>
</td>
<td class="nump">51.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_BusinessAcquisitionMilestonePayments', window );">Milestone payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_BusinessAcquisitionPerMilestonePayments', window );">Per milestone payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=NTRP_MembershipPurchaseAgreementMember', window );">Membership Purchase Agreement [Member] | Next Trip [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentInterestRatePaidInCash', window );">Investment, Interest Rate, Paid in Cash</a></td>
<td class="nump">51.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesAndInterestInAffiliates', window );">Business acquisition additional amount</a></td>
<td class="nump">$ 2,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=NTRP_MembershipPurchaseAgreementMember', window );">Membership Purchase Agreement [Member] | Series O Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Business acquisition shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32,258<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Business acquisition shares price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=NTRP_MembershipPurchaseAgreementMember', window );">Membership Purchase Agreement [Member] | FSA Travel LLC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityOwnershipPercentageExcludingConsolidatedEntityAndEquityMethodInvestee', window );">Equity Ownership, Excluding Consolidated Entity and Equity Method Investee, Percentage</a></td>
<td class="nump">49.00%<span></span>
</td>
<td class="nump">49.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPreacquisitionContingencyAmountOfSettlement', window );">Business acquisition amount</a></td>
<td class="nump">$ 1,000,000<span></span>
</td>
<td class="nump">$ 1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationAsset', window );">Business acquisition consideration cash</a></td>
<td class="nump">500,000<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Equity Method Investment, Ownership Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">51.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCosts', window );">Business acquisition additional amount</a></td>
<td class="nump">1,000,000<span></span>
</td>
<td class="nump">$ 1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=NTRP_MembershipPurchaseAgreementMember', window );">Membership Purchase Agreement [Member] | FSA Travel LLC [Member] | Series O Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationAsset', window );">Business acquisition consideration cash</a></td>
<td class="nump">500,000<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Business acquisition shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">161,291<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Business acquisition shares price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=NTRP_MembershipPurchaseAgreementMember', window );">Membership Purchase Agreement [Member] | Next Trip [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Equity Method Investment, Ownership Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesAndInterestInAffiliates', window );">Business acquisition additional amount</a></td>
<td class="nump">$ 1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_BusinessAcquisitionMilestonePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business acquisition milestone payments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_BusinessAcquisitionMilestonePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_BusinessAcquisitionPerMilestonePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business acquisition per milestone payments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_BusinessAcquisitionPerMilestonePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPreacquisitionContingencyAmountOfSettlement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount paid or received to resolve the preacquisition contingency.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 340<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 2.A.6)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480341/340-10-S99-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionPreacquisitionContingencyAmountOfSettlement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479613/805-30-35-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479668/805-30-25-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For transactions that are recognized separately from the acquisition of assets and assumptions of liabilities in the business combination, such as related to pre-existing relationships with the acquiree, this element represents the disclosure of the amount of acquisition related costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityOwnershipPercentageExcludingConsolidatedEntityAndEquityMethodInvestee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of ownership of equity interest excluding interest in entity that is consolidated and equity method investee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 321<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479536/321-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityOwnershipPercentageExcludingConsolidatedEntityAndEquityMethodInvestee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentInterestRatePaidInCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Rate of interest paid in cash on investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column A)(Footnote 4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.12-12A(Column A)(Footnote 3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column A)(Footnote 3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A)(Footnote 3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentInterestRatePaidInCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesAndInterestInAffiliates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a controlling interest in another entity or an entity that is related to it but not strictly controlled (for example, an unconsolidated subsidiary, affiliate, joint venture or equity method investment).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesAndInterestInAffiliates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEquityMethodInvestmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=NTRP_MembershipPurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=NTRP_MembershipPurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=NTRP_FSATravelLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=NTRP_FSATravelLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=NTRP_NextTripMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=NTRP_NextTripMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=NTRP_SeriesOPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=NTRP_SeriesOPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=NTRP_FSATravelLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=NTRP_FSATravelLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=NTRP_NextTripMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=NTRP_NextTripMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Investment in Equity Securities (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th"><div>Feb. 24, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Shares issued price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.00<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=NTRP_ShareExchangeAgreementMember', window );">Share Exchange Agreement [Member] | Blue Fysh Holdings Inc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityOwnershipPercentageExcludingConsolidatedEntityAndEquityMethodInvestee', window );">Equity Ownership, Excluding Consolidated Entity and Equity Method Investee, Percentage</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=NTRP_ShareExchangeAgreementMember', window );">Share Exchange Agreement [Member] | Blue Fysh Holdings Inc [Member] | Restricted Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Number of shares issued</a></td>
<td class="nump">82<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=NTRP_ShareExchangeAgreementMember', window );">Share Exchange Agreement [Member] | Blue Fysh Holdings Inc [Member] | Series N Nonvoting Convertible Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Number of shares issued</a></td>
<td class="nump">483,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Shares issued price per share</a></td>
<td class="nump">$ 5.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Shares issued value</a></td>
<td class="nump">$ 2,415,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityOwnershipPercentageExcludingConsolidatedEntityAndEquityMethodInvestee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of ownership of equity interest excluding interest in entity that is consolidated and equity method investee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 321<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479536/321-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityOwnershipPercentageExcludingConsolidatedEntityAndEquityMethodInvestee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-4<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=NTRP_ShareExchangeAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=NTRP_ShareExchangeAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=NTRP_BlueFyshHoldingsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=NTRP_BlueFyshHoldingsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=NTRP_SeriesNNonvotingConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=NTRP_SeriesNNonvotingConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Schedule of Prepaid and Other Current Assets (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Feb. 28, 2025</div></th>
<th class="th"><div>Feb. 29, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_DisclosurePrepaidAndOtherCurrentAssetsAbstract', window );"><strong>Prepaid And Other Current Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_PrepaidOfferingCosts', window );">Offering costs</a></td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_PrepaidConsultingContract', window );">Current portion of two-year strategic consulting contract</a></td>
<td class="nump">733,575<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_PrepaidCostOfSales', window );">Cost of sales</a></td>
<td class="nump">121,588<span></span>
</td>
<td class="nump">42,547<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherPrepaidExpenseCurrent', window );">Other expenses</a></td>
<td class="nump">425,412<span></span>
</td>
<td class="nump">298,274<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidAdvertising', window );">Marketing expenses</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">100<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Total</a></td>
<td class="nump">$ 1,380,575<span></span>
</td>
<td class="nump">$ 340,921<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_DisclosurePrepaidAndOtherCurrentAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_DisclosurePrepaidAndOtherCurrentAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_PrepaidConsultingContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Prepaid consulting contract.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_PrepaidConsultingContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_PrepaidCostOfSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Prepaid cost of sales.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_PrepaidCostOfSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_PrepaidOfferingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Prepaid offering costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_PrepaidOfferingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherPrepaidExpenseCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for other costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 340<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483032/340-10-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherPrepaidExpenseCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidAdvertising">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration paid in advance for advertising that provides economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 340<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483032/340-10-45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 340<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 5<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482955/340-10-05-5<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)(6)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidAdvertising</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Schedule of Property and Equipment (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Feb. 28, 2025</div></th>
<th class="th"><div>Feb. 29, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total</a></td>
<td class="nump">$ 97,804<span></span>
</td>
<td class="nump">$ 99,510<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Accumulated depreciation</a></td>
<td class="num">(93,685)<span></span>
</td>
<td class="num">(92,868)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and Equipment, net of depreciation</a></td>
<td class="nump">4,119<span></span>
</td>
<td class="nump">6,642<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and Fixtures [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total</a></td>
<td class="nump">17,018<span></span>
</td>
<td class="nump">17,018<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember', window );">Computer Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total</a></td>
<td class="nump">$ 80,786<span></span>
</td>
<td class="nump">$ 82,492<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478451/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Feb. 28, 2025</div></th>
<th class="th"><div>Feb. 29, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation expense</a></td>
<td class="nump">$ 1,434<span></span>
</td>
<td class="nump">$ 18,838<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Property and equipment</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 9,253<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Schedule of Intangible Assets (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Feb. 28, 2025</div></th>
<th class="th"><div>Feb. 29, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Total</a></td>
<td class="nump">$ 8,063,637<span></span>
</td>
<td class="nump">$ 7,397,887<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization</a></td>
<td class="num">(5,936,269)<span></span>
</td>
<td class="num">(5,224,467)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net of amortization</a></td>
<td class="nump">2,127,368<span></span>
</td>
<td class="nump">2,173,420<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_SoftwareDevelopmentMember', window );">Software Development [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Total</a></td>
<td class="nump">7,267,778<span></span>
</td>
<td class="nump">6,602,028<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=NTRP_SoftwareLicenseMember', window );">Software License [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Total</a></td>
<td class="nump">789,576<span></span>
</td>
<td class="nump">789,576<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember', window );">Trademarks [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Total</a></td>
<td class="nump">$ 6,283<span></span>
</td>
<td class="nump">$ 6,283<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480265/350-10-S45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480265/350-10-S45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 928<br> -SubTopic 340<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478859/928-340-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482686/350-30-45-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483154/926-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482686/350-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_SoftwareDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_SoftwareDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=NTRP_SoftwareLicenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=NTRP_SoftwareLicenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Schedule of estimated aggregate amortization expense (Details)<br></strong></div></th>
<th class="th">
<div>Feb. 28, 2025 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">2025</a></td>
<td class="nump">$ 597,914<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">2026</a></td>
<td class="nump">623,882<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">2027</a></td>
<td class="nump">312,358<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">2028</a></td>
<td class="nump">528<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour', window );">Thereafter</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Total</a></td>
<td class="nump">$ 1,534,682<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Finite lived intangible assets amortization expense after year four.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483154/926-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Feb. 28, 2025</div></th>
<th class="th"><div>Feb. 29, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization</a></td>
<td class="nump">$ 711,802<span></span>
</td>
<td class="nump">$ 1,449,925<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482686/350-30-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Schedule of Fair Value of Assets Acquired (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Oct. 12, 2023</div></th>
<th class="th"><div>Feb. 28, 2025</div></th>
<th class="th"><div>Feb. 29, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,167,805<span></span>
</td>
<td class="nump">$ 1,167,805<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=NTRP_SigmaAdditiveSolutionsIncMember', window );">Sigma Additive Solutions Inc. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents', window );">Cash</a></td>
<td class="nump">$ 417,121<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables', window );">Accounts Receivable, net</a></td>
<td class="nump">4,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory', window );">Inventory</a></td>
<td class="nump">257,873<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">50,802<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property and equipment</a></td>
<td class="nump">52,357<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Intangible assets</a></td>
<td class="nump">1,277,919<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable', window );">Accounts payable</a></td>
<td class="num">(837,450)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses', window );">Accrued expenses</a></td>
<td class="num">(61,001)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue', window );">Deferred revenue</a></td>
<td class="num">(14,218)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet', window );">Total identifiable net assets acquired</a></td>
<td class="nump">1,148,303<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">1,220,115<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Total Fair Value of Net Assets Acquired</a></td>
<td class="nump">2,368,418<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Business Combination, Consideration Transferred</a></td>
<td class="nump">$ 2,368,418<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business combination recognized identifiable assets acquired and liabilities assumed current liabilities accrued expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 8<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479637/805-30-30-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 7<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479637/805-30-30-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred revenue expected to be recognized as such within one year or the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of intangible assets, excluding goodwill, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of inventory recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479303/805-10-55-37<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479303/805-10-55-37<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of property, plant, and equipment recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479303/805-10-55-37<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated impairment loss, of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482598/350-20-45-1<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4.d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479823/420-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4.b.1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479823/420-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4.b.2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479823/420-10-S99-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482017/420-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482017/420-10-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482017/420-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482017/420-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=NTRP_SigmaAdditiveSolutionsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=NTRP_SigmaAdditiveSolutionsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Goodwill (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th"><div>Oct. 12, 2023</div></th>
<th class="th"><div>Feb. 28, 2025</div></th>
<th class="th"><div>Feb. 29, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Shares outstanding</a></td>
<td class="nump">780,423<span></span>
</td>
<td class="nump">1,656,738<span></span>
</td>
<td class="nump">936,430<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnDispositionOfAssets', window );">Gain on disposition transaction</a></td>
<td class="nump">$ 37,592<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=NTRP_DivergentTechnologiesIncMember', window );">Divergent Technologies, Inc. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireIntangibleAssets', window );">Purchase price</a></td>
<td class="nump">$ 1,626,242<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesEPreferredStockMember', window );">Series E Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Shares outstanding</a></td>
<td class="nump">3,069<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=NTRP_SigmaAdditiveSolutionsIncMember', window );">Sigma Additive Solutions Inc. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Purchase consideration</a></td>
<td class="nump">$ 2,368,418<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionSharePrice', window );">Share price</a></td>
<td class="nump">$ 3.0229<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillPeriodIncreaseDecrease', window );">Goodwill</a></td>
<td class="nump">$ 52,310<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=NTRP_NextTripHoldingsIncMember', window );">Next Trip Holdings Inc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Purchase consideration</a></td>
<td class="nump">742,176<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillPeriodIncreaseDecrease', window );">Goodwill</a></td>
<td class="nump">$ 1,167,805<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionSharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks paid or offered to be paid in a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionSharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 8<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479637/805-30-30-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 7<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479637/805-30-30-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnDispositionOfAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of property, plant and equipment assets, excluding oil and gas property and timber property.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482130/360-10-45-5<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnDispositionOfAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=NTRP_DivergentTechnologiesIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=NTRP_DivergentTechnologiesIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesEPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesEPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=NTRP_SigmaAdditiveSolutionsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=NTRP_SigmaAdditiveSolutionsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=NTRP_NextTripHoldingsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=NTRP_NextTripHoldingsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Accounts Payable and Accrued Liabilities (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th"><div>Feb. 28, 2025</div></th>
<th class="th"><div>Feb. 29, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrentAndNoncurrent', window );">Accounts payable</a></td>
<td class="nump">$ 1,184,404<span></span>
</td>
<td class="nump">$ 531,847<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrentAndNoncurrent', window );">Accrued expenses</a></td>
<td class="nump">$ 721,382<span></span>
</td>
<td class="nump">$ 460,768<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Schedule of Deferred Tax Assets (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Feb. 28, 2025</div></th>
<th class="th"><div>Feb. 29, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">NOL carryover</a></td>
<td class="nump">$ 11,500,300<span></span>
</td>
<td class="nump">$ 9,226,100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_DeferredTaxAssetDepreciation', window );">Related party accruals</a></td>
<td class="nump">12,900<span></span>
</td>
<td class="nump">173,900<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_DeferredTaxAssetsPayrollAccruals', window );">Payroll accruals</a></td>
<td class="nump">47,800<span></span>
</td>
<td class="nump">77,800<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_DeferredTaxLiabilitiesDepreciation', window );">Depreciation</a></td>
<td class="nump">255,400<span></span>
</td>
<td class="nump">1,772,500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="num">(11,816,400)<span></span>
</td>
<td class="num">(11,250,300)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNet', window );">Net deferred tax asset (liability)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_DeferredTaxAssetDepreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred tax asset depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_DeferredTaxAssetDepreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_DeferredTaxAssetsPayrollAccruals">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred tax assets payroll accruals.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_DeferredTaxAssetsPayrollAccruals</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_DeferredTaxLiabilitiesDepreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred tax liabilities depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_DeferredTaxLiabilitiesDepreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule of Reconciliation of Provision for Income Taxes (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Feb. 28, 2025</div></th>
<th class="th"><div>Feb. 29, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_EffectiveIncomeTaxRateReconciliationBookLoss', window );">Book loss</a></td>
<td class="num">$ (2,141,700)<span></span>
</td>
<td class="num">$ (1,541,200)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseDepreciation', window );">Depreciation</a></td>
<td class="num">(197,100)<span></span>
</td>
<td class="nump">270,100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment', window );">Meals &amp; entertainment</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">300<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_IncomeTaxReconciliationNondeductibleExpensePreferredDividends', window );">Preferred dividends</a></td>
<td class="nump">16,506<span></span>
</td>
<td class="nump">422,842<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_IncomeTaxReconciliationNondeductibleExpenseLossOnNextPlayNoteReceivable', window );">Loss on NextPlay note receivable</a></td>
<td class="nump">210,000<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost', window );">Stock compensation</a></td>
<td class="nump">14,254<span></span>
</td>
<td class="nump">24,468<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_IncomeTaxReconciliationNondeductibleExpenseLossOnAssetDisposal', window );">Loss on asset disposal</a></td>
<td class="nump">229<span></span>
</td>
<td class="nump">67,274<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_IncomeTaxReconciliationNondeductibleExpenseAccruedPayroll', window );">Accrued payroll</a></td>
<td class="num">(29,991)<span></span>
</td>
<td class="nump">51,857<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_IncomeTaxReconciliationNondeductibleExpenseRelatedPartyAccruals', window );">Related party accruals</a></td>
<td class="num">(161,018)<span></span>
</td>
<td class="nump">114,928<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Change in valuation allowance</a></td>
<td class="nump">2,288,820<span></span>
</td>
<td class="nump">589,431<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for Income Taxes</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_EffectiveIncomeTaxRateReconciliationBookLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective income tax rate reconciliation book loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_EffectiveIncomeTaxRateReconciliationBookLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_IncomeTaxReconciliationNondeductibleExpenseAccruedPayroll">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income tax reconciliation nondeductible expense accrued payroll.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_IncomeTaxReconciliationNondeductibleExpenseAccruedPayroll</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_IncomeTaxReconciliationNondeductibleExpenseLossOnAssetDisposal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income tax reconciliation nondeductible expense loss on asset disposal.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_IncomeTaxReconciliationNondeductibleExpenseLossOnAssetDisposal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_IncomeTaxReconciliationNondeductibleExpenseLossOnNextPlayNoteReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_IncomeTaxReconciliationNondeductibleExpenseLossOnNextPlayNoteReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_IncomeTaxReconciliationNondeductibleExpensePreferredDividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income tax reconciliation nondeductible expense preferred dividends.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_IncomeTaxReconciliationNondeductibleExpensePreferredDividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_IncomeTaxReconciliationNondeductibleExpenseRelatedPartyAccruals">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income tax reconciliation nondeductible expense related party accruals.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_IncomeTaxReconciliationNondeductibleExpenseRelatedPartyAccruals</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482659/740-20-45-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (a)(6)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseDepreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationNondeductibleExpenseDepreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible meals and entertainment expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of reported income tax expense (benefit) in excess of (less than) expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for award under share-based payment arrangement. Includes, but is not limited to, expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Feb. 28, 2025</div></th>
<th class="th"><div>Feb. 29, 2024</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating loss carryforwards</a></td>
<td class="nump">$ 54,763,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,820,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_OperatingLossCarryforwardsRemainder', window );">Operating loss carryforwards remainder</a></td>
<td class="nump">44,943,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance loss carryforwards</a></td>
<td class="nump">$ 11,816,400<span></span>
</td>
<td class="nump">$ 11,250,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Federal statutory tax rate</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_OperatingLossCarryforwardsRemainder">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Operating loss carryforwards remainder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_OperatingLossCarryforwardsRemainder</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.1.Q1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Notes Payable (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Feb. 28, 2025</div></th>
<th class="th"><div>Feb. 26, 2025</div></th>
<th class="th"><div>Feb. 04, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Nov. 29, 2024</div></th>
<th class="th"><div>Nov. 08, 2024</div></th>
<th class="th"><div>Sep. 19, 2024</div></th>
<th class="th"><div>Jun. 26, 2024</div></th>
<th class="th"><div>May 24, 2024</div></th>
<th class="th"><div>Feb. 28, 2025</div></th>
<th class="th"><div>Feb. 29, 2024</div></th>
<th class="th"><div>Jan. 03, 2025</div></th>
<th class="th"><div>Nov. 01, 2024</div></th>
<th class="th"><div>Oct. 18, 2024</div></th>
<th class="th"><div>Feb. 04, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Proceeds from convertible debt</a></td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 40,000<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 735,057<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.50%<span></span>
</td>
<td class="nump">7.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal amount</a></td>
<td class="nump">40,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 152,100<span></span>
</td>
<td class="nump">$ 220,000<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesAndLoansPayableCurrent', window );">Total consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 125,190<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromNotesPayable', window );">Proceeds from Notes Payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,967,224<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Original issue discount</a></td>
<td class="nump">80,114<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,190<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">80,114<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts', window );">Warrants additional paid in capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 179,913<span></span>
</td>
<td class="nump">$ 120,239<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 116,322<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_ConvertibleNotesPayableOfInstallments', window );">Note payable equal installments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17,452<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Debt Instrument, Interest Rate, Effective Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Class of Warrant or Right, Number of Securities Called by Warrants or Rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="nump">140,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Sale of Stock, Price Per Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.00<span></span>
</td>
<td class="nump">$ 3.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_DebtInstrumentPeriodicOfInstallments', window );">[custom:DebtInstrumentPeriodicOfInstallments]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 21,484<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17,683<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Shares, Issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,927<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Share price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_DebtInstrumentUnamortizedDebtDiscount', window );">Unamortized debt discount</a></td>
<td class="nump">131,163<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">131,163<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCovenantDescription', window );">Debt Instrument, Covenant Description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">the Company sold a short-term promissory note to a private investor for $1,000,000, with $500,000 funded on December
15, 2024 and $500,000 funded on January 15, 2025. The note bears prepaid interest of 15%, payable in 49,668 shares of the Company&#8217;s
Series K Preferred Stock. In addition, the Company issued warrants to the investor to purchase up to 1,000,000 shares of the Company&#8217;s
common stock at an exercise price of $4.00 per share with an expiration date of June 30, 2028. Up to 500,000 of the warrants may be exercised
on a cashless basis, at the election of the investor. In accordance with ASC 470-20-25-2, the proceeds of the short-term promissory note
were allocated to the note and the warrant based on the relative fair values of the note without the warrant and of the warrant itself
at time of issuance, with the portion of the proceeds allocated to the warrants accounted for as paid-in capital, and the remainder of
the proceeds allocated to the note.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_DebtInstrumentOfInvestor', window );">Principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_DebtInstrumentOfFunded', window );">Principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCost', window );">Warrants additional paid in capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 829,523<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=NTRP_SeriesMNonvotingConvertiblePreferredStockMember', window );">Series M Nonvoting Convertible Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Sale of Stock, Price Per Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.02<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=NTRP_SecuritiesPurchaseAgreementMember', window );">Securities Purchase Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesAndLoansPayableCurrent', window );">Total consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromNotesPayable', window );">Proceeds from Notes Payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">230,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Original issue discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 22,100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Maturity date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Dec. 19,  2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=NTRP_SecuritiesPurchaseAgreementMember', window );">Securities Purchase Agreement [Member] | Series M Nonvoting Convertible Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Sale of Stock, Price Per Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.02<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=NTRP_SecuritiesPurchaseAgreementMember', window );">Securities Purchase Agreement [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=NTRP_NoteSecuritiesPurchaseAgreementMember', window );">Note Securities Purchase Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 154,440<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Original issue discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 22,440<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=NTRP_ShortTermPromissoryNoteMember', window );">Short Term Promissory Note [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesAndLoansPayableCurrent', window );">Total consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Original issue discount</a></td>
<td class="nump">113,223<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 33,000<span></span>
</td>
<td class="nump">$ 15,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">113,223<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 37,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Maturity date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">May 15,  2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_DebtInstrumentUnamortizedDebtDiscount', window );">Unamortized debt discount</a></td>
<td class="nump">$ 41,504<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 41,504<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=NTRP_DebtConversionAgreementMember', window );">Debt Conversion Agreement [Member] | Series M Nonvoting Convertible Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentAmount1', window );">Debt converted amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">350,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_DebtConversionConvertedInstrumentOfGuaranteedInterest', window );">[custom:DebtConversionConvertedInstrumentOfGuaranteedInterest]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 52,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentSharesIssued1', window );">Debt Conversion, Converted Instrument, Shares Issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">133,278<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Conversion price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.02<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=NTRP_NoteTwoSecuritiesPurchaseAgreementMember', window );">Note Two Securities Purchase Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPayment', window );">debt instrument periodic payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 85,937<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 70,732<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=NTRP_OneMillionNoteMember', window );">One Million Note [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=NTRP_DebtExchangeAgreementMember', window );">Debt Exchange Agreement [Member] | Series P Nonvoting Convertible Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentAmount1', window );">Debt converted amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Conversion price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Sale of stock, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_ConvertibleNotesPayableOfInstallments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_ConvertibleNotesPayableOfInstallments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_DebtConversionConvertedInstrumentOfGuaranteedInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_DebtConversionConvertedInstrumentOfGuaranteedInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_DebtInstrumentOfFunded">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_DebtInstrumentOfFunded</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_DebtInstrumentOfInvestor">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_DebtInstrumentOfInvestor</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_DebtInstrumentPeriodicOfInstallments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_DebtInstrumentPeriodicOfInstallments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_DebtInstrumentUnamortizedDebtDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_DebtInstrumentUnamortizedDebtDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing stock. Includes, but is not limited to, legal and accounting fees and direct costs associated with stock issues under a shelf registration.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionConvertedInstrumentAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The value of the financial instrument(s) that the original debt is being converted into in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionConvertedInstrumentAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionConvertedInstrumentSharesIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionConvertedInstrumentSharesIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionPrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The price per share of the conversion feature embedded in the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionPrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCovenantDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of minimum financial levels (for example, tangible net worth and working capital) and achievement of certain financial ratios (for example, working capital ratio and debt service coverage ratio), and adherence to certain clauses which generally require or restrict certain actions (for example, entering into a debt arrangement with equal or greater seniority, and selling or discontinuing a certain business segment or material subsidiary) to be in compliance with the covenant clauses of the debt agreement. May also include a discussion of the adverse consequences that would result if the entity violates or fails to satisfy the covenants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477734/942-470-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCovenantDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateEffectivePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69E<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69F<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br><br>Reference 26: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 27: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentPeriodicPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the required periodic payments including both interest and principal payments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477734/942-470-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentPeriodicPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-1A<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesAndLoansPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of the portions of all long-term notes and loans payable due within one year or the operating cycle if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesAndLoansPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a borrowing supported by a written promise to pay an obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=NTRP_SeriesMNonvotingConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=NTRP_SeriesMNonvotingConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=NTRP_SecuritiesPurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=NTRP_SecuritiesPurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=NTRP_NoteSecuritiesPurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=NTRP_NoteSecuritiesPurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=NTRP_ShortTermPromissoryNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=NTRP_ShortTermPromissoryNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=NTRP_DebtConversionAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=NTRP_DebtConversionAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=NTRP_NoteTwoSecuritiesPurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=NTRP_NoteTwoSecuritiesPurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=NTRP_OneMillionNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=NTRP_OneMillionNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=NTRP_DebtExchangeAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=NTRP_DebtExchangeAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=NTRP_SeriesPNonvotingConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=NTRP_SeriesPNonvotingConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Convertible Notes (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">7 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Feb. 28, 2025</div></th>
<th class="th"><div>Jun. 26, 2024</div></th>
<th class="th"><div>May 24, 2024</div></th>
<th class="th"><div>Mar. 15, 2024</div></th>
<th class="th"><div>Dec. 29, 2023</div></th>
<th class="th"><div>Jun. 09, 2023</div></th>
<th class="th"><div>Feb. 21, 2023</div></th>
<th class="th"><div>Feb. 28, 2025</div></th>
<th class="th"><div>Feb. 29, 2024</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Convertible note issued</a></td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="nump">$ 40,000<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 735,057<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.50%<span></span>
</td>
<td class="nump">7.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price</a></td>
<td class="nump">$ 6.69<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6.69<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 234,213<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Conversion of convertible notes, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">409,502<span></span>
</td>
<td class="nump">52,818<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">52,818<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=NTRP_ContingentSharesMember', window );">Contingent Shares [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Conversion of convertible notes, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,978,598<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=NTRP_DebtAssignmentAndConversionAgreementsMember', window );">Debt Assignment and Conversion Agreements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=NTRP_SpecialPurposeAcquisitionCorporationMember', window );">Special Purpose Acquisition Corporation [Member] | Several Investors [Member] | Convertible Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Convertible note issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 650,000<span></span>
</td>
<td class="nump">$ 3,012,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Conversion price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.00<span></span>
</td>
<td class="nump">$ 3.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionPrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The price per share of the conversion feature embedded in the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionPrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense for debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69E<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69F<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=NTRP_ContingentSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=NTRP_ContingentSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=NTRP_DebtAssignmentAndConversionAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=NTRP_DebtAssignmentAndConversionAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=NTRP_SpecialPurposeAcquisitionCorporationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=NTRP_SpecialPurposeAcquisitionCorporationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=NTRP_SeveralInvestorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=NTRP_SeveralInvestorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=NTRP_ConvertibleNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=NTRP_ConvertibleNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>104
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share Purchase Agreements (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Feb. 28, 2025</div></th>
<th class="th"><div>Jun. 26, 2024</div></th>
<th class="th"><div>May 24, 2024</div></th>
<th class="th"><div>Mar. 15, 2024</div></th>
<th class="th"><div>Dec. 29, 2023</div></th>
<th class="th"><div>Dec. 28, 2023</div></th>
<th class="th"><div>Sep. 19, 2022</div></th>
<th class="th"><div>Nov. 06, 2023</div></th>
<th class="th"><div>Feb. 28, 2025</div></th>
<th class="th"><div>Feb. 29, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Issuance of convertible notes</a></td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="nump">$ 40,000<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 735,057<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Conversion share price</a></td>
<td class="nump">$ 6.69<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6.69<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Conversion of convertible notes, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">409,502<span></span>
</td>
<td class="nump">52,818<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">52,818<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=NTRP_ContingentSharesMember', window );">Contingent Shares [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Conversion of convertible notes, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,978,598<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=NTRP_ThirdPartyConsultantMember', window );">Third Party Consultant [Member] | Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Conversion of convertible notes, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,481<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=NTRP_ThirdPartyConsultantMember', window );">Third Party Consultant [Member] | Contingent Shares [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Conversion of convertible notes, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">579,954<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=NTRP_SharePurchaseAgreementsMember', window );">Share Purchase Agreements [Member] | Several Investors [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Issuance of convertible notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,755,970<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Conversion share price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=NTRP_SoftwareAsAServiceAgreementMember', window );">Software as a Service Agreement [Member] | Third Party [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_ProceedsFromDownpaymentForContract', window );">Proceeds from downpayment for contract</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 150,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Conversion share price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=NTRP_SoftwareAsAServiceAgreementMember', window );">Software as a Service Agreement [Member] | Third Party [Member] | Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Conversion of convertible notes, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,996<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=NTRP_SoftwareAsAServiceAgreementMember', window );">Software as a Service Agreement [Member] | Third Party [Member] | Contingent Shares [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Conversion of convertible notes, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">74,786<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=NTRP_ConsultingModificationAgreementMember', window );">Consulting Modification Agreement [Member] | Third Party Consultant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_ConsultingFees', window );">Consulting fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 180,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=NTRP_ConsultingModificationAgreementMember', window );">Consulting Modification Agreement [Member] | Third Party Consultant [Member] | Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Conversion of convertible notes, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,337<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=NTRP_ConsultingModificationAgreementMember', window );">Consulting Modification Agreement [Member] | Third Party Consultant [Member] | Contingent Shares [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Conversion of convertible notes, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">162,466<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_ConsultingFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Consulting fees.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_ConsultingFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_ProceedsFromDownpaymentForContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds from down-payment for contract.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_ProceedsFromDownpaymentForContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionPrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The price per share of the conversion feature embedded in the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionPrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=NTRP_ContingentSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=NTRP_ContingentSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=NTRP_ThirdPartyConsultantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=NTRP_ThirdPartyConsultantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=NTRP_SharePurchaseAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=NTRP_SharePurchaseAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=NTRP_SeveralInvestorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=NTRP_SeveralInvestorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=NTRP_SoftwareAsAServiceAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=NTRP_SoftwareAsAServiceAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=NTRP_ThirdPartyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=NTRP_ThirdPartyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=NTRP_ConsultingModificationAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=NTRP_ConsultingModificationAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>105
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Transactions (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Feb. 28, 2025</div></th>
<th class="th"><div>Feb. 29, 2024</div></th>
<th class="th"><div>Jan. 27, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_LossOnRelatedPartyReceivable', window );">Loss on related party receivable</a></td>
<td class="nump">$ 1,000,000<span></span>
</td>
<td class="nump">$ 1,567,665<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=NTRP_NextPlayTechnologiesIncMember', window );">Next Play Technologies Inc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_LossOnRelatedPartyReceivable', window );">Loss on related party receivable</a></td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember', window );">Related Party [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesPayableCurrent', window );">Notes payable - related parties</a></td>
<td class="nump">61,526<span></span>
</td>
<td class="nump">828,277<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=NTRP_NextPlayTechnologiesIncMember', window );">Next Play Technologies Inc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesNetCurrent', window );">Accounts receivable</a></td>
<td class="nump">2,567,665<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Allowance for doubtful accounts</a></td>
<td class="nump">$ 2,567,665<span></span>
</td>
<td class="nump">$ 1,567,665<span></span>
</td>
<td class="nump">$ 2,567,665<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_LossOnRelatedPartyReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loss on related party receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_LossOnRelatedPartyReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479344/326-20-45-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479319/326-20-50-13<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479319/326-20-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount due to the entity within one year of the balance sheet date (or one operating cycle, if longer) from outside sources, including trade accounts receivable, notes and loans receivable, as well as any other types of receivables, net of allowances established for the purpose of reducing such receivables to an amount that approximates their net realizable value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481990/310-10-45-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c)(2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c)(2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(g)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=NTRP_NextPlayTechnologiesIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=NTRP_NextPlayTechnologiesIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=NTRP_NextPlayTechnologiesIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=NTRP_NextPlayTechnologiesIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>106
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Deferred Revenue (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th"><div>Feb. 28, 2025</div></th>
<th class="th"><div>Feb. 29, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_DisclosureDeferredRevenueAbstract', window );"><strong>Deferred Revenue</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredRevenueCurrent', window );">Deferred revenue</a></td>
<td class="nump">$ 97,770<span></span>
</td>
<td class="nump">$ 139,921<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_DisclosureDeferredRevenueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_DisclosureDeferredRevenueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>107
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule of Stock Option Activity (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">2 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 29, 2024</div></th>
<th class="th"><div>Feb. 29, 2024</div></th>
<th class="th"><div>Feb. 28, 2025</div></th>
<th class="th"><div>Feb. 29, 2024</div></th>
<th class="th"><div>Feb. 28, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Number of Options, Outstanding, Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Outstanding Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 60.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted Average Remaining Contractual Life, Outstanding Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year 7 months 6 days<span></span>
</td>
<td class="text">2 years 6 months 7 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate Intrinsic Value, Outstanding Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Number of Options, Exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue', window );">Aggregate Intrinsic Value, Exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod', window );">Number of Options, Forfeited or cancelled</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,342)<span></span>
</td>
<td class="num">(8,958)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Forfeited or cancelled</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 125.65<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedorCancelledInPeriodTotalIntrinsicValue', window );">Aggregate Intrinsic Value, Forfeited or cancelled</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Number of Options, Outstanding, Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85,300<span></span>
</td>
<td class="nump">76,342<span></span>
</td>
<td class="nump">85,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Outstanding Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 60.50<span></span>
</td>
<td class="nump">$ 52.69<span></span>
</td>
<td class="nump">$ 60.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate Intrinsic Value, Outstanding Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Number of Options, Expected to vest in the future, Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">350<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Expected to Vest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1', window );">Weighted Average Remaining Contractual Life, Expected to Vest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years 4 months 2 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue', window );">Aggregate Intrinsic Value, Options expected to vest in the future</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Number of Options, Exercisable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75,992<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Exercisable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 52.71<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Weighted Average Remaining Contractual Life, Exercisable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year 7 months 2 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Aggregate Intrinsic Value, Options exercisable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber', window );">Number of Options, Vested, Exercisable and Options Expected to Vest Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">76,342<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Vested, Exercisable and Options Expected to Vest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 52.69<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1', window );">Weighted Average Remaining Contractual Life, Vested, Exercisable and Options Expected to Vest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year 7 months 6 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue', window );">Aggregate Intrinsic Value, Options vested, exercisable and options expected to vest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=NTRP_StockAppreciationRightsMember', window );">Stock Appreciation Rights [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Number of Options, Outstanding, Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40,390<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Outstanding Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 44.77<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted Average Remaining Contractual Life, Outstanding Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year 11 months 26 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years 11 months 26 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate Intrinsic Value, Outstanding Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Number of Options, Exercised</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue', window );">Aggregate Intrinsic Value, Exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod', window );">Number of Options, Forfeited or cancelled</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(167)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedorCancelledInPeriodTotalIntrinsicValue', window );">Aggregate Intrinsic Value, Forfeited or cancelled</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Number of Options, Outstanding, Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40,390<span></span>
</td>
<td class="nump">40,223<span></span>
</td>
<td class="nump">40,390<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Outstanding Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 44.77<span></span>
</td>
<td class="nump">$ 44.80<span></span>
</td>
<td class="nump">$ 44.77<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate Intrinsic Value, Outstanding Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Number of Options, Expected to vest in the future, Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,213<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Expected to Vest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 27.66<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1', window );">Weighted Average Remaining Contractual Life, Expected to Vest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year 11 months 4 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue', window );">Aggregate Intrinsic Value, Options expected to vest in the future</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Number of Options, Exercisable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35,010<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Exercisable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 47.35<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Weighted Average Remaining Contractual Life, Exercisable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years 4 months 2 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Aggregate Intrinsic Value, Options exercisable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber', window );">Number of Options, Vested, Exercisable and Options Expected to Vest Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40,223<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Vested, Exercisable and Options Expected to Vest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 44.80<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1', window );">Weighted Average Remaining Contractual Life, Vested, Exercisable and Options Expected to Vest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year 11 months 26 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue', window );">Aggregate Intrinsic Value, Options vested, exercisable and options expected to vest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageForfeitedOrCancelled', window );">Weighted Average Exercise Price, Forfeited or cancelled</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 37.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedorCancelledInPeriodTotalIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share based compensation arrangement by share based payment award options for feited or cancelled in period total intrinsic value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedorCancelledInPeriodTotalIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageForfeitedOrCancelled">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Forfeited or cancelled.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageForfeitedOrCancelled</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price of options that were either forfeited or expired.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest exercisable options that may be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (e)(1)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for fully vested and expected to vest exercisable or convertible options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=NTRP_StockAppreciationRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=NTRP_StockAppreciationRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>108
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule of Share Based Payments Award Stock Options Valuation Assumptions (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Feb. 28, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum', window );">Risk-free interest rate, minimum</a></td>
<td class="nump">3.50%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum', window );">Expected volatility, minimum</a></td>
<td class="nump">127.10%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected life</a></td>
<td class="text">1 year 6 months<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum', window );">Risk-free interest rate, maximum</a></td>
<td class="nump">4.30%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum', window );">Expected volatility, maximum</a></td>
<td class="nump">159.40%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected life</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=NTRP_TwoThousandAndTwentyStockAppreciationRightsPlanMember', window );">2020 Stock Appreciation Rights Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum', window );">Risk-free interest rate, minimum</a></td>
<td class="nump">2.30%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum', window );">Risk-free interest rate, maximum</a></td>
<td class="nump">5.25%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum', window );">Expected volatility, minimum</a></td>
<td class="nump">96.50%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum', window );">Expected volatility, maximum</a></td>
<td class="nump">187.80%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=NTRP_TwoThousandAndTwentyStockAppreciationRightsPlanMember', window );">2020 Stock Appreciation Rights Plan [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected life</a></td>
<td class="text">1 month 28 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=NTRP_TwoThousandAndTwentyStockAppreciationRightsPlanMember', window );">2020 Stock Appreciation Rights Plan [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected life</a></td>
<td class="text">2 years 29 days<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The minimum risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=NTRP_TwoThousandAndTwentyStockAppreciationRightsPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=NTRP_TwoThousandAndTwentyStockAppreciationRightsPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>109
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule of Warranty Activity (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Feb. 28, 2025</div></th>
<th class="th"><div>Feb. 29, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber', window );">Warrants Outstanding, Beginning Balance</a></td>
<td class="nump">486,165<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted Average Exercise Price Outstanding, Beginning Balance</a></td>
<td class="nump">$ 9.94<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonOutstandingWeightedAverageRemainingContractualTerm', window );">Weighted Average Remaining Contractual Life Years, Ending Balance</a></td>
<td class="text">3 years 10 months 2 days<span></span>
</td>
<td class="text">1 year 11 months 15 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted', window );">Warrants, Granted</a></td>
<td class="nump">2,637,887<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Weighted Average Exercise Price Outstanding, Granted</a></td>
<td class="nump">$ 4.80<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonGrantsWeightedAverageRemainingContractualTerm', window );">Weighted Average Remaining Contractual Life Years, Granted</a></td>
<td class="text">4 years 2 months 26 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised', window );">Warrants,Exercised</a></td>
<td class="num">(104,965)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageExercisePrice', window );">Weighted Average Exercise Price Outstanding,Exercised</a></td>
<td class="nump">$ 3.02<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures', window );">Warrants, Forfeited or cancelled</a></td>
<td class="num">(3,202)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageWeightedAverageExercisePriceWarrantsForfeitedOrCancelled', window );">Weighted Average Exercise Price Outstanding, Forfeited or cancelled</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber', window );">Warrants Outstanding, Ending Balance</a></td>
<td class="nump">3,015,885<span></span>
</td>
<td class="nump">486,165<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted Average Exercise Price Outstanding, Ending Balance</a></td>
<td class="nump">$ 5.36<span></span>
</td>
<td class="nump">$ 9.94<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average exercise price, warrants outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average exercise price, warrants exercised.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageWeightedAverageExercisePriceWarrantsForfeitedOrCancelled">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average exercise price, warrants forfeited or cancelled.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageWeightedAverageExercisePriceWarrantsForfeitedOrCancelled</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average exercise price, warrants grants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonGrantsWeightedAverageRemainingContractualTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share based compensation arrangement by share based payment award options non grants weighted average remaining contractual term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonGrantsWeightedAverageRemainingContractualTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonOutstandingWeightedAverageRemainingContractualTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual life (years), warrants outstanding, beginning balance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonOutstandingWeightedAverageRemainingContractualTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of non-option equity instruments exercised by participants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares under non-option equity instrument agreements that were cancelled as a result of occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net number of non-option equity instruments granted to participants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of equity instruments other than options outstanding, including both vested and non-vested instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>110
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Stockholders&#8217; Equity (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="3">2 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Feb. 26, 2025</div></th>
<th class="th"><div>Feb. 25, 2025</div></th>
<th class="th"><div>Feb. 24, 2025</div></th>
<th class="th"><div>Feb. 06, 2025</div></th>
<th class="th"><div>Jan. 29, 2025</div></th>
<th class="th"><div>Jan. 28, 2025</div></th>
<th class="th"><div>Jan. 07, 2025</div></th>
<th class="th"><div>Jan. 03, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 29, 2024</div></th>
<th class="th"><div>Dec. 16, 2024</div></th>
<th class="th"><div>Oct. 08, 2024</div></th>
<th class="th"><div>Oct. 01, 2024</div></th>
<th class="th"><div>Sep. 19, 2024</div></th>
<th class="th"><div>Aug. 31, 2024</div></th>
<th class="th"><div>Aug. 15, 2024</div></th>
<th class="th"><div>Mar. 15, 2024</div></th>
<th class="th"><div>Feb. 15, 2024</div></th>
<th class="th"><div>Dec. 29, 2023</div></th>
<th class="th"><div>Sep. 22, 2023</div></th>
<th class="th"><div>Sep. 22, 2023</div></th>
<th class="th"><div>Oct. 31, 2023</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Jan. 31, 2025</div></th>
<th class="th"><div>Aug. 31, 2024</div></th>
<th class="th"><div>Feb. 29, 2024</div></th>
<th class="th"><div>Feb. 28, 2025</div></th>
<th class="th"><div>Dec. 29, 2024</div></th>
<th class="th"><div>Feb. 29, 2024</div></th>
<th class="th"><div>Nov. 29, 2024</div></th>
<th class="th"><div>Jun. 26, 2024</div></th>
<th class="th"><div>May 24, 2024</div></th>
<th class="th"><div>Feb. 22, 2024</div></th>
<th class="th"><div>Jan. 26, 2024</div></th>
<th class="th"><div>Jan. 04, 2024</div></th>
<th class="th"><div>Oct. 12, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,200,000<span></span>
</td>
<td class="nump">250,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">936,430<span></span>
</td>
<td class="nump">1,656,738<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">936,430<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">780,423<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityReverseStockSplit', window );">Reverse stock split</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1-for-20 reverse stock split<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits', window );">Reverse stock split issued common shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40,197<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Net proceeds</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,905,970<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross', window );">Restricted shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6.69<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share based compensation expense</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 26,760<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">472,996<span></span>
</td>
<td class="nump">3,106,616<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">472,996<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">472,996<span></span>
</td>
<td class="nump">3,106,616<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">472,996<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants to purchase common stock</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">140,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Purchase price, per share</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfWarrants', window );">Gross proceeds</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 316,994<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.50%<span></span>
</td>
<td class="nump">7.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Reverse acquisition shares outstanding</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85,300<span></span>
</td>
<td class="nump">76,342<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted average exercise price</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 60.50<span></span>
</td>
<td class="nump">$ 52.69<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 60.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares', window );">Share based compensation arrangement by award options vested</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,101<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationExpenseExcludingCostOfGoodAndServiceSold', window );">Compensation cost</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 41,114<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Stock issued during Stock options exercised</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75,992<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Shares issued or exercised</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod', window );">Shares forfeited or expired</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,342<span></span>
</td>
<td class="nump">8,958<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Allocation share based compensation expense</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 67,874<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 116,512<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Stock options</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 41,114<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Options exercise price</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.98<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions', window );">Unrecognized stock-based compensation expense, stock option</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,260<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Weighted average remaining recognition period</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 months 2 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Options to purchase of common stock</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">86,402<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_StockOptionMember', window );">Equity Option [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Stock issued during Stock options exercised</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75,992<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=NTRP_StockAppreciationRightsMember', window );">Stock Appreciation Rights [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Reverse acquisition shares outstanding</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40,390<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40,390<span></span>
</td>
<td class="nump">40,223<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40,390<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted average exercise price</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 44.77<span></span>
</td>
<td class="nump">$ 44.80<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 44.77<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Stock issued during Stock options exercised</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35,010<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Shares issued or exercised</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod', window );">Shares forfeited or expired</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">167<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=NTRP_TwoThousandTwentyThreeEquityIncentivePlanMember', window );">2023 Equity Incentive Plan [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Common stock reserved for issuance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=NTRP_TwoThousandThirteenEquityIncentivePlanMember', window );">2013 Equity Incentive Plan [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Reverse acquisition shares outstanding</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">76,342<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted average exercise price</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 52.69<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=NTRP_TwoThousandAndTwentyStockAppreciationRightsPlanMember', window );">2020 Stock Appreciation Rights Plan [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share based compensation expense</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 67,874<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Options exercise price</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.98<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Unrecognized share based compensation cost</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 119<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardWeightedAverageRemainingRecognitionPeriod', window );">Weighted average remaining recognition period</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 months 3 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=NTRP_SecuritiesPurchaseAgreementMember', window );">Securities Purchase Agreement [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=NTRP_SecuritiesPurchaseAgreementMember', window );">Securities Purchase Agreement [Member] | Maximum [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=NTRP_MillerDebtConversionAgreementMember', window );">Miller Debt Conversion Agreement [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentAmount1', window );">Converted amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=NTRP_RelatedPartyDebtConversionAgreementsMember', window );">Related Party Debt Conversion Agreements [Member] | Messrs Kerby And Monaco [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentAmount1', window );">Converted amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=NTRP_SeriesEConvertiblePreferredStockMember', window );">Series E Convertible Preferred Stock [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">316<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockDividendRatePercentage', window );">Dividend percentage</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Conversion price</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockConvertibleSharesIssuable', window );">Common stock issuable upon conversion</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,362<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=NTRP_SeriesFConvertiblePreferredStockMember', window );">Series F Convertible Preferred Stock [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,843,993<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=NTRP_SeriesGConvertiblePreferredStockMember', window );">Series G Convertible Preferred Stock [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockRedemptionTerms', window );">Preferred stock redemption right, description</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">The
Company shall have the right to redeem up to 50% of the Series G Preferred for an aggregate price of $1.00 in accordance with
the terms of the Perpetual License Agreement<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=NTRP_SeriesHConvertiblePreferredStockMember', window );">Series H Convertible Preferred Stock [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">150,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockConvertibleSharesIssuable', window );">Common stock issuable upon conversion</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=NTRP_SeriesIConvertiblePreferredStockMember', window );">Series I Convertible Preferred Stock [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">692,945<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">331,124<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,442<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockConvertibleSharesIssuable', window );">Common stock issuable upon conversion</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,442<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=NTRP_SeriesIConvertiblePreferredStockMember', window );">Series I Convertible Preferred Stock [Member] | Securities Purchase Agreement [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Shares issued</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">222,680<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 672,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Sale of stock, shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">66,225<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,834<span></span>
</td>
<td class="nump">4,967<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.02<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants to purchase common stock</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">111,340<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Purchase price, per share</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.02<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.02<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.02<span></span>
</td>
<td class="nump">$ 3.02<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.02<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Sale of stock proceeds</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 75,000<span></span>
</td>
<td class="nump">$ 15,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=NTRP_SeriesIConvertiblePreferredStockMember', window );">Series I Convertible Preferred Stock [Member] | Series I Purchase Agreement [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross', window );">Restricted shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">331,125<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Sale of stock proceeds</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=NTRP_SeriesIConvertiblePreferredStockMember', window );">Series I Convertible Preferred Stock [Member] | Miller Debt Conversion Agreement [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Shares issued</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33,113<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Conversion price</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.02<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants to purchase common stock</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33,113<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrants exercise price</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=NTRP_SeriesIPreferredStockMember', window );">Series I Preferred Stock [Member] | Securities Purchase Agreement [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Purchase price, per share</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.02<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=NTRP_SeriesIPreferredStockMember', window );">Series I Preferred Stock [Member] | Series I Purchase Agreement [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Shares issued</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=NTRP_SeriesJNonvotingConvertiblePreferredStockMember', window );">Series J Nonvoting Convertible Preferred Stock [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross', window );">Restricted shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">297,788<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">297,788<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockConvertibleSharesIssuable', window );">Common stock issuable upon conversion</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">297,788<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=NTRP_SeriesJNonvotingConvertiblePreferredStockMember', window );">Series J Nonvoting Convertible Preferred Stock [Member] | Securities Purchase Agreement [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Issuance of shares for services</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">66,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Shares issued</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">231,788<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.02<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Sale of stock proceeds</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=NTRP_SeriesKNonvotingConvertiblePreferredStockMember', window );">Series K Nonvoting Convertible Preferred Stock [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Shares issued</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60,595<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,220,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross', window );">Restricted shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60,595<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.02<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60,595<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockConvertibleSharesIssuable', window );">Common stock issuable upon conversion</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60,595<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=NTRP_SeriesLNonvotingConvertiblePreferredStockMember', window );">Series L Nonvoting Convertible Preferred Stock [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross', window );">Restricted shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">579,469<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,076,158<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,076,156<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockDividendRatePercentage', window );">Dividend percentage</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockConvertibleSharesIssuable', window );">Common stock issuable upon conversion</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,076,156<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Purchase price, per share</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.02<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=NTRP_SeriesLNonvotingConvertiblePreferredStockMember', window );">Series L Nonvoting Convertible Preferred Stock [Member] | Related Party Debt Conversion Agreements [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross', window );">Restricted shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">496,687<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Purchase price, per share</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.02<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentAmount1', window );">Converted amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromUnsecuredNotesPayable', window );">Unsecured promissory notes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=NTRP_SeriesLNonvotingConvertiblePreferredStockMember', window );">Series L Nonvoting Convertible Preferred Stock [Member] | Related Party Debt Conversion Agreements [Member] | Messrs Kerby And Monaco [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross', window );">Restricted shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">579,469<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Purchase price, per share</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.02<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=NTRP_SeriesMNonvotingConvertiblePreferredStockMember', window );">Series M Nonvoting Convertible Preferred Stock [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Shares issued</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">133,278<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross', window );">Restricted shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">165,562<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">133,278<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">133,278<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockDividendRatePercentage', window );">Dividend percentage</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Purchase price, per share</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.02<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits', window );">Common stock issuable upon conversion</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">133,278<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=NTRP_SeriesMNonvotingConvertiblePreferredStockMember', window );">Series M Nonvoting Convertible Preferred Stock [Member] | Securities Purchase Agreement [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross', window );">Restricted shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Purchase price, per share</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.02<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=NTRP_SeriesMNonvotingConvertiblePreferredStockMember', window );">Series M Nonvoting Convertible Preferred Stock [Member] | Debt Conversion Agreement [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Conversion price</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.02<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentAmount1', window );">Converted amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 350,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=NTRP_SeriesNNonvotingConvertiblePreferredStockMember', window );">Series N Nonvoting Convertible Preferred Stock [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross', window );">Restricted shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=NTRP_SeriesNNonvotingConvertiblePreferredStockMember', window );">Series N Nonvoting Convertible Preferred Stock [Member] | Securities Purchase Agreement [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross', window );">Restricted shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants to purchase common stock</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrants exercise price</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfWarrants', window );">Gross proceeds</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 85,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=NTRP_SeriesNNonvotingConvertibleConvertiblePreferredStockMember', window );">Series N Nonvoting Convertible Convertible Preferred Stock [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockConvertibleSharesIssuable', window );">Common stock issuable upon conversion</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=NTRP_SeriesONonvotingConvertiblePreferredStockMember', window );">Series O Nonvoting Convertible Preferred Stock [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Shares issued</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">161,291<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross', window );">Restricted shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">451,614<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">161,291<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockConvertibleSharesIssuable', window );">Common stock issuable upon conversion</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">161,291<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=NTRP_SeriesPNonvotingConvertiblePreferredStockMember', window );">Series P Nonvoting Convertible Preferred Stock [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross', window );">Restricted shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">343,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">343,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockConvertibleSharesIssuable', window );">Common stock issuable upon conversion</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">343,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=NTRP_SeriesPNonvotingConvertiblePreferredStockMember', window );">Series P Nonvoting Convertible Preferred Stock [Member] | Equity Investment Agreement [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Sale of stock, shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">93,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 4.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants to purchase common stock</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">375,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfWarrants', window );">Gross proceeds</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 375,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight', window );">Purchase of outstanding warrants</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">375,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=NTRP_SeriesPNonvotingConvertiblePreferredStockMember', window );">Series P Nonvoting Convertible Preferred Stock [Member] | Debt Exchange Agreement [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Sale of stock, shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Conversion price</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 4.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentAmount1', window );">Converted amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=NTRP_NextTripHoldingsIncMember', window );">Next Trip Holdings Inc [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions', window );">Shares issued in acquisitions</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">83,371<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Equity interest acquired</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross', window );">Restricted shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">156,007<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction', window );">Percentage of issued and outstanding common shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19.99%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued', window );">Shares issuable for consideration</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,843,993<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=NTRP_NextTripHoldingsIncMember', window );">Next Trip Holdings Inc [Member] | Third Party Consultant [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Issuance of shares for services</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,337<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=NTRP_NextTripHoldingsIncMember', window );">Next Trip Holdings Inc [Member] | Debt Assignment and Conversion Agreements [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions', window );">Shares issued in acquisitions</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">52,818<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=NTRP_NextTripHoldingsIncMember', window );">Next Trip Holdings Inc [Member] | Share Purchase And Exchange Agreements [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Purchase of shares issued</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,481<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=NTRP_FSATravelLLCMember', window );">FSA Travel LLC [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Equity interest acquired</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=NTRP_AlumniCapitalLPMember', window );">Alumni Capital LP [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Shares issued</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32,786<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=NTRP_FSATravelLLCMember', window );">FSA Travel LLC [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions', window );">Shares issued in acquisitions</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,065<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=NTRP_BlueFyshHoldingsIncMember', window );">Blue Fysh Holdings Inc [Member] | Series N Nonvoting Convertible Preferred Stock [Member] | Share Exchange Agreement [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Shares issued</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">483,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,415,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross', window );">Restricted shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">483,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Conversion shares issued</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">409,502<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">52,818<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">52,818<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Issuance of shares for services</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42,709<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,337<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Shares issued</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">60,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28,281<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_StockIssuedDuringPeriodSharesWarrantExercises', window );">Issuance of shares warrant exercises</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">104,965<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromWarrantExercises', window );">Gross proceeds of warrant exercises</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 316,995<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Shares issued or exercised</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">104,965<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock [Member] | At-The-Market Issuance Sales Agreement [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Sale of stock, shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">128,887<span></span>
</td>
<td class="nump">72,721<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Net proceeds</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 772,468<span></span>
</td>
<td class="nump">$ 364,555<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock [Member] | Blue Fysh Holdings Inc [Member] | Series N Nonvoting Convertible Preferred Stock [Member] | Share Exchange Agreement [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross', window );">Restricted shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">82<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember', window );">Warrant [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants to purchase common stock</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,105,885<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight', window );">Purchase of outstanding warrants</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,015,885<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_DescriptionForWarrantExpiration', window );">Warrant description</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">expire between July 26, 2025 and August 24, 2030<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember', window );">Warrant [Member] | Maximum [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrants exercise price</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 350.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember', window );">Warrant [Member] | Minimum [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrants exercise price</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.02<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="37"></td></tr>
<tr><td colspan="37"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">On
    December 29, 2023, the Company (then known as Sigma Additive Solutions, Inc.) acquired NTH in a reverse acquisition. NTG was issued
    <span id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_pid_c20231229__20231229__us-gaap--BusinessAcquisitionAxis__custom--NextTripGroupLLCMember_znf0cL99Yexe" title="Number of shares acquired">83,371</span> shares of Company common stock in exchange for <span id="xdx_903_ecustom--PercentageForIssuedAndOutstandingCapitalStock_pid_dp_uPure_c20231229__20231229__us-gaap--BusinessAcquisitionAxis__custom--NextTripGroupLLCMember_zJ1ftypKOa1l" title="Percentage for issued and outstanding capital stock">100</span>% of the issued and outstanding capital stock of NTH at the time of the
    reverse acquisition. The Company has reflected this transaction retroactively in these financial statements.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_DescriptionForWarrantExpiration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description for warrant expiration.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_DescriptionForWarrantExpiration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardWeightedAverageRemainingRecognitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining recognition period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardWeightedAverageRemainingRecognitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_StockIssuedDuringPeriodSharesWarrantExercises">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Shares of warrant exercises.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_StockIssuedDuringPeriodSharesWarrantExercises</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-4<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481674/830-30-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-17<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-20<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-20<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-20<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-20<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of equity interests issued or issuable to acquire entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of voting equity interests acquired at the acquisition date in the business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationExpenseExcludingCostOfGoodAndServiceSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for salary, wage, profit sharing; incentive and equity-based compensation; and other employee benefit. Other employee benefit expense includes, but is not limited to, service component of net periodic benefit cost for defined benefit plan. Excludes compensation cost in cost of good and service sold.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationExpenseExcludingCostOfGoodAndServiceSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionConvertedInstrumentAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The value of the financial instrument(s) that the original debt is being converted into in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionConvertedInstrumentAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionPrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The price per share of the conversion feature embedded in the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionPrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockConvertibleSharesIssuable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of common shares issuable upon conversion of preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockConvertibleSharesIssuable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockDividendRatePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage rate used to calculate dividend payments on preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.12-12A(Column A)(Footnote 3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column A)(Footnote 4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column A)(Footnote 3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A)(Footnote 3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockDividendRatePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockRedemptionTerms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The redemption terms of preferred stock of an entity that has priority over common stock in the distribution of dividends and in the event of liquidation of the entity. The redemption features of this capital stock are solely within the control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockRedemptionTerms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromUnsecuredNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from borrowings supported by a written promise to pay an obligation that is uncollateralized (where debt is not backed by the pledge of collateral).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromUnsecuredNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromWarrantExercises">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from holders exercising their stock warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromWarrantExercises</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash received on stock transaction after deduction of issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockConsiderationReceivedOnTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of subsidiary's or equity investee's stock owned by parent company after stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options vested.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued during the period pursuant to acquisitions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued during the period upon the conversion of units. An example of a convertible unit is an umbrella partnership real estate investment trust unit (UPREIT unit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reduction in the number of shares during the period as a result of a reverse stock split.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-4<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityReverseStockSplit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of the reverse stock split arrangement. Also provide the retroactive effect given by the reverse split that occurs after the balance sheet date but before the release of financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SAB Topic 4.C)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityReverseStockSplit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_StockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_StockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=NTRP_StockAppreciationRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=NTRP_StockAppreciationRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=NTRP_TwoThousandTwentyThreeEquityIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=NTRP_TwoThousandTwentyThreeEquityIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=NTRP_TwoThousandThirteenEquityIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=NTRP_TwoThousandThirteenEquityIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=NTRP_TwoThousandAndTwentyStockAppreciationRightsPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=NTRP_TwoThousandAndTwentyStockAppreciationRightsPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=NTRP_SecuritiesPurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=NTRP_SecuritiesPurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=NTRP_MillerDebtConversionAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=NTRP_MillerDebtConversionAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=NTRP_RelatedPartyDebtConversionAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=NTRP_RelatedPartyDebtConversionAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=NTRP_MessrsKerbyAndMonacoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=NTRP_MessrsKerbyAndMonacoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=NTRP_SeriesEConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=NTRP_SeriesEConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=NTRP_SeriesFConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=NTRP_SeriesFConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=NTRP_SeriesGConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=NTRP_SeriesGConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=NTRP_SeriesHConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=NTRP_SeriesHConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=NTRP_SeriesIConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=NTRP_SeriesIConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=NTRP_SeriesIPurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=NTRP_SeriesIPurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=NTRP_SeriesIPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=NTRP_SeriesIPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=NTRP_SeriesJNonvotingConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=NTRP_SeriesJNonvotingConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=NTRP_SeriesKNonvotingConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=NTRP_SeriesKNonvotingConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=NTRP_SeriesLNonvotingConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=NTRP_SeriesLNonvotingConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=NTRP_SeriesMNonvotingConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=NTRP_SeriesMNonvotingConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=NTRP_DebtConversionAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=NTRP_DebtConversionAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=NTRP_SeriesNNonvotingConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=NTRP_SeriesNNonvotingConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=NTRP_SeriesNNonvotingConvertibleConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=NTRP_SeriesNNonvotingConvertibleConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=NTRP_SeriesONonvotingConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=NTRP_SeriesONonvotingConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=NTRP_SeriesPNonvotingConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=NTRP_SeriesPNonvotingConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=NTRP_EquityInvestmentAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=NTRP_EquityInvestmentAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=NTRP_DebtExchangeAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=NTRP_DebtExchangeAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=NTRP_NextTripHoldingsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=NTRP_NextTripHoldingsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=NTRP_ThirdPartyConsultantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=NTRP_ThirdPartyConsultantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueArrangementTypeAxis=NTRP_DebtAssignmentAndConversionAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueArrangementTypeAxis=NTRP_DebtAssignmentAndConversionAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueArrangementTypeAxis=NTRP_SharePurchaseAndExchangeAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueArrangementTypeAxis=NTRP_SharePurchaseAndExchangeAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=NTRP_FSATravelLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=NTRP_FSATravelLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=NTRP_AlumniCapitalLPMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=NTRP_AlumniCapitalLPMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=NTRP_FSATravelLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=NTRP_FSATravelLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=NTRP_BlueFyshHoldingsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=NTRP_BlueFyshHoldingsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=NTRP_ShareExchangeAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=NTRP_ShareExchangeAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=NTRP_AtTheMarketIssuanceSalesAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=NTRP_AtTheMarketIssuanceSalesAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>111
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Schedule of Earnings Per Share, Basic and Diluted (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Feb. 28, 2025</div></th>
<th class="th"><div>Feb. 29, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest', window );">Loss from continuing operations</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (10,128,428)<span></span>
</td>
<td class="num">$ (6,656,837)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockDividendsIncomeStatementImpact', window );">Preferred dividends</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(78,600)<span></span>
</td>
<td class="num">(7,125)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperations', window );">Loss from continuing operations applicable to common stockholders</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(10,207,028)<span></span>
</td>
<td class="num">(6,663,962)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity', window );">Gain (loss) from discontinued operations applicable to common stockholders</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">8,344<span></span>
</td>
<td class="num">(675,314)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net loss applicable to common stockholders</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (10,198,684)<span></span>
</td>
<td class="num">$ (7,339,276)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average number of common shares Outstanding used in loss per share during the Period (denominator)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">4,566,787<span></span>
</td>
<td class="nump">228,274<span></span>
</td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">On
    December 29, 2023, the Company (then known as Sigma Additive Solutions, Inc.) acquired NTH in a reverse acquisition. NTG was issued
    <span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_pid_c20231229__20231229__us-gaap--BusinessAcquisitionAxis__custom--NextTripGroupLLCMember_zMAWreRRiNcf" title="Number of shares acquired">83,371</span> shares of Company common stock in exchange for <span id="xdx_904_ecustom--PercentageForIssuedAndOutstandingCapitalStock_pid_dp_c20231229__20231229__us-gaap--BusinessAcquisitionAxis__custom--NextTripGroupLLCMember_zN7cXzVnhmg1" title="Percentage for issued and outstanding capital stock">100</span>% of the issued and outstanding capital stock of NTH at the time of the
    reverse acquisition. The Company has reflected this transaction retroactively in these financial statements.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from continuing operations attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from continuing operations including portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-19<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from a discontinued operation attributable to the parent. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-19<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-3A<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5B<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5C<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-3B<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-4<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 6.B)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-5<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockDividendsIncomeStatementImpact">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of preferred stock dividends that is an adjustment to net income apportioned to common stockholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockDividendsIncomeStatementImpact</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>112
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule of Business Milestones and Issuable Contingent Shares (Details) - shares<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 10, 2024</div></th>
<th class="th"><div>Feb. 28, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToContingentlyIssuableShares', window );">Total contingent shares</a></td>
<td class="nump">5,843,993<span></span>
</td>
<td class="nump">4,393,993<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementScenarioAxis=NTRP_AchievedMember', window );">Achieved [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToContingentlyIssuableShares', window );">Total contingent shares</a></td>
<td class="nump">4,393,993<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementScenarioAxis=NTRP_AchievedMember', window );">Achieved [Member] | Leisure Travel Booking Platform [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToContingentlyIssuableShares', window );">Total contingent shares</a></td>
<td class="nump">1,450,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementScenarioAxis=NTRP_AchievedMember', window );">Achieved [Member] | Group Travel Booking Platform [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToContingentlyIssuableShares', window );">Total contingent shares</a></td>
<td class="nump">1,450,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementScenarioAxis=NTRP_AchievedMember', window );">Achieved [Member] | Flex Pay Technology [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToContingentlyIssuableShares', window );">Total contingent shares</a></td>
<td class="nump">1,493,993<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementScenarioAxis=NTRP_NotAchievedMember', window );">Not Achieved [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToContingentlyIssuableShares', window );">Total contingent shares</a></td>
<td class="nump">1,450,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementScenarioAxis=NTRP_NotAchievedMember', window );">Not Achieved [Member] | Travel Agent Platform [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToContingentlyIssuableShares', window );">Total contingent shares</a></td>
<td class="nump">1,450,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToContingentlyIssuableShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of contingently issuable shares. Contingently issuable shares are those shares that are issuable for little or no cash contingent on certain conditions being met.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 26<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-26<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 44<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-44<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 51<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-51<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-52<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-53<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 54<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-54<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 48<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-48<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 48<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-48<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToContingentlyIssuableShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=NTRP_AchievedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=NTRP_AchievedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCommitmentsAxis=NTRP_LeisureTravelBookingPlatformMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCommitmentsAxis=NTRP_LeisureTravelBookingPlatformMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCommitmentsAxis=NTRP_GroupTravelBookingPlatformMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCommitmentsAxis=NTRP_GroupTravelBookingPlatformMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCommitmentsAxis=NTRP_FlexPayTechnologyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCommitmentsAxis=NTRP_FlexPayTechnologyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=NTRP_NotAchievedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=NTRP_NotAchievedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCommitmentsAxis=NTRP_TravelAgentPlatformMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCommitmentsAxis=NTRP_TravelAgentPlatformMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>113
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule of Weighted Average Common Shares (Details) (Parenthetical) - shares<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 10, 2024</div></th>
<th class="th"><div>Feb. 28, 2025</div></th>
<th class="th"><div>Feb. 29, 2024</div></th>
<th class="th"><div>Oct. 12, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,656,738<span></span>
</td>
<td class="nump">936,430<span></span>
</td>
<td class="nump">780,423<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToContingentlyIssuableShares', window );">Contingent shares issuable</a></td>
<td class="nump">5,843,993<span></span>
</td>
<td class="nump">4,393,993<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToContingentlyIssuableShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of contingently issuable shares. Contingently issuable shares are those shares that are issuable for little or no cash contingent on certain conditions being met.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 26<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-26<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 44<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-44<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 51<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-51<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-52<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-53<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 54<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-54<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 48<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-48<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 48<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-48<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToContingentlyIssuableShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>114
<FILENAME>R79.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Schedule of Weighted Average Common Shares (Details) - shares<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Feb. 28, 2025</div></th>
<th class="th"><div>Feb. 29, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicLineItems', window );"><strong>Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average common shares outstanding</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">4,566,787<span></span>
</td>
<td class="nump">228,274<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicLineItems', window );"><strong>Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average common shares outstanding</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,400,705<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=NTRP_ContingentSharesMember', window );">Contingent Shares [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicLineItems', window );"><strong>Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average common shares outstanding</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3,166,083<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">On
    December 29, 2023, the Company (then known as Sigma Additive Solutions, Inc.) acquired NTH in a reverse acquisition. NTG was issued
    <span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_pid_c20231229__20231229__us-gaap--BusinessAcquisitionAxis__custom--NextTripGroupLLCMember_zMAWreRRiNcf" title="Number of shares acquired">83,371</span> shares of Company common stock in exchange for <span id="xdx_904_ecustom--PercentageForIssuedAndOutstandingCapitalStock_pid_dp_c20231229__20231229__us-gaap--BusinessAcquisitionAxis__custom--NextTripGroupLLCMember_zN7cXzVnhmg1" title="Percentage for issued and outstanding capital stock">100</span>% of the issued and outstanding capital stock of NTH at the time of the
    reverse acquisition. The Company has reflected this transaction retroactively in these financial statements.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=NTRP_ContingentSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=NTRP_ContingentSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>115
<FILENAME>R80.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Loss Per Share (Details Narrative) - shares<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 10, 2024</div></th>
<th class="th"><div>Feb. 28, 2025</div></th>
<th class="th"><div>Feb. 29, 2024</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Nov. 29, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicLineItems', window );"><strong>Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToContingentlyIssuableShares', window );">Contingent shares issuable</a></td>
<td class="nump">5,843,993<span></span>
</td>
<td class="nump">4,393,993<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants outstanding to purchase common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="nump">140,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Shares issuable upon exercisable of options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75,992<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesEPreferredStockMember', window );">Series E Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicLineItems', window );"><strong>Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesConverted1', window );">Number of shares converted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">316<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesIssued1', window );">Common stock issuable upon conversion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,362<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesHPreferredStockMember', window );">Series H Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicLineItems', window );"><strong>Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesConverted1', window );">Number of shares converted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesIssued1', window );">Common stock issuable upon conversion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=NTRP_SeriesIPreferredStockMember', window );">Series I Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicLineItems', window );"><strong>Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesConverted1', window );">Number of shares converted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,442<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesIssued1', window );">Common stock issuable upon conversion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,442<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=NTRP_SeriesJPreferredStockMember', window );">Series J Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicLineItems', window );"><strong>Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesConverted1', window );">Number of shares converted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">297,788<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesIssued1', window );">Common stock issuable upon conversion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">297,788<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=NTRP_SeriesKPreferredStockMember', window );">Series K Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicLineItems', window );"><strong>Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesConverted1', window );">Number of shares converted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60,595<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesIssued1', window );">Common stock issuable upon conversion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60,595<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=NTRP_SeriesLPreferredStockMember', window );">Series L Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicLineItems', window );"><strong>Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesConverted1', window );">Number of shares converted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,076,156<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesIssued1', window );">Common stock issuable upon conversion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,076,156<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=NTRP_SeriesMPreferredStockMember', window );">Series M Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicLineItems', window );"><strong>Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesConverted1', window );">Number of shares converted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">133,278<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesIssued1', window );">Common stock issuable upon conversion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">133,278<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=NTRP_SeriesNPreferredStockMember', window );">Series N Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicLineItems', window );"><strong>Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesConverted1', window );">Number of shares converted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesIssued1', window );">Common stock issuable upon conversion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=NTRP_SeriesOPreferredStockMember', window );">Series O Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicLineItems', window );"><strong>Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesConverted1', window );">Number of shares converted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">161,291<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesIssued1', window );">Common stock issuable upon conversion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">161,291<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=NTRP_SeriesOPreferredStockOneMember', window );">Series O Preferred Stock One [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicLineItems', window );"><strong>Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesConverted1', window );">Number of shares converted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">343,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesIssued1', window );">Common stock issuable upon conversion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">343,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Share-Based Payment Arrangement, Option [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicLineItems', window );"><strong>Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Shares issuable upon exercisable of options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">76,342<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember', window );">Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicLineItems', window );"><strong>Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants outstanding to purchase common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,105,885<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicLineItems', window );"><strong>Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment', window );">Potentially dilutive securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,109,663<span></span>
</td>
<td class="nump">1,047,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementScenarioAxis=NTRP_AchievedMember', window );">Achieved [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicLineItems', window );"><strong>Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToContingentlyIssuableShares', window );">Contingent shares issuable</a></td>
<td class="nump">4,393,993<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=NTRP_ShareExchangeAgreementMember', window );">Share Exchange Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicLineItems', window );"><strong>Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToContingentlyIssuableShares', window );">Contingent shares issuable</a></td>
<td class="nump">5,843,993<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=NTRP_ShareExchangeAgreementMember', window );">Share Exchange Agreement [Member] | Achieved [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicLineItems', window );"><strong>Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToContingentlyIssuableShares', window );">Contingent shares issuable</a></td>
<td class="nump">4,393,993<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockSharesConverted1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockSharesConverted1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockSharesIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of new shares issued in the conversion of stock in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockSharesIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToContingentlyIssuableShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of contingently issuable shares. Contingently issuable shares are those shares that are issuable for little or no cash contingent on certain conditions being met.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 26<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-26<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 44<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-44<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 51<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-51<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-52<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-53<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 54<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-54<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 48<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-48<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 48<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-48<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToContingentlyIssuableShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesEPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesEPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesHPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesHPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=NTRP_SeriesIPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=NTRP_SeriesIPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=NTRP_SeriesJPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=NTRP_SeriesJPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=NTRP_SeriesKPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=NTRP_SeriesKPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=NTRP_SeriesLPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=NTRP_SeriesLPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=NTRP_SeriesMPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=NTRP_SeriesMPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=NTRP_SeriesNPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=NTRP_SeriesNPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=NTRP_SeriesOPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=NTRP_SeriesOPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=NTRP_SeriesOPreferredStockOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=NTRP_SeriesOPreferredStockOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=NTRP_AchievedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=NTRP_AchievedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=NTRP_ShareExchangeAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=NTRP_ShareExchangeAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>116
<FILENAME>R81.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Concentrations (Details Narrative) - Customer Concentration Risk [Member] - Customer [Member]<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Feb. 28, 2025</div></th>
<th class="th"><div>Feb. 29, 2024</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember', window );">Revenue Benchmark [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration of risk percentage</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember', window );">Accounts Receivable [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration of risk percentage</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 310<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478785/954-310-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-21<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-20<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-18<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-20<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=NTRP_CustomerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=NTRP_CustomerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>117
<FILENAME>R82.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Defined Contribution Plans (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Feb. 28, 2025</div></th>
<th class="th"><div>Feb. 28, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DescriptionOfDefinedContributionPensionAndOtherPostretirementPlans', window );">Contribution plan description</a></td>
<td class="text">the
Company makes either a safe Harbor contribution match of 100% of each participant&#8217;s contribution up to 3% of salary, and 50%
of the next 2% of salary contributed, or a 3% non-elective contribution for all eligible participants<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanCostRecognized', window );">Cost of contribution</a></td>
<td class="nump">$ 23,628<span></span>
</td>
<td class="nump">$ 17,112<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanCostRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost for defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 70<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480794/715-70-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanCostRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DescriptionOfDefinedContributionPensionAndOtherPostretirementPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of defined contribution pension and other postretirement plans.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DescriptionOfDefinedContributionPensionAndOtherPostretirementPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>118
<FILENAME>R83.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>May 06, 2025</div></th>
<th class="th"><div>May 05, 2025</div></th>
<th class="th"><div>Apr. 28, 2025</div></th>
<th class="th"><div>Apr. 09, 2025</div></th>
<th class="th"><div>Apr. 01, 2025</div></th>
<th class="th"><div>Mar. 26, 2025</div></th>
<th class="th"><div>Feb. 26, 2025</div></th>
<th class="th"><div>Jan. 29, 2025</div></th>
<th class="th"><div>Jan. 07, 2025</div></th>
<th class="th"><div>Dec. 16, 2024</div></th>
<th class="th"><div>Sep. 19, 2024</div></th>
<th class="th"><div>Jun. 10, 2024</div></th>
<th class="th"><div>Feb. 28, 2025</div></th>
<th class="th"><div>Feb. 04, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Nov. 29, 2024</div></th>
<th class="th"><div>Nov. 08, 2024</div></th>
<th class="th"><div>Jun. 26, 2024</div></th>
<th class="th"><div>May 24, 2024</div></th>
<th class="th"><div>Feb. 29, 2024</div></th>
<th class="th"><div>Feb. 04, 2024</div></th>
<th class="th"><div>Oct. 12, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToContingentlyIssuableShares', window );">Number of contingent shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,843,993<span></span>
</td>
<td class="nump">4,393,993<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common sock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,656,738<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">936,430<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common sock, shares outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,656,738<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">936,430<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">780,423<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesAndLoansPayableCurrent', window );">Total consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 125,190<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 40,000<span></span>
</td>
<td class="nump">$ 152,100<span></span>
</td>
<td class="nump">$ 220,000<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Original issue discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 80,114<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18,190<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.50%<span></span>
</td>
<td class="nump">7.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants outstanding to purchase common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="nump">140,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Shares issued price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross', window );">Restricted shares, issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60,000<span></span>
</td>
<td class="nump">4,000<span></span>
</td>
<td class="nump">30,000<span></span>
</td>
<td class="nump">28,281<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Line of credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Note One [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Note Two [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">145,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=NTRP_ExchangeAgreementMember', window );">Exchange Agreement [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToContingentlyIssuableShares', window );">Number of contingent shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,450,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,393,993<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common sock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,163,525<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common sock, shares outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,163,525<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,550,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_CommonStockIssuedPercentage', window );">Issued percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">73.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=NTRP_SecuritiesPurchaseAgreementMember', window );">Securities Purchase Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesAndLoansPayableCurrent', window );">Total consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Original issue discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 22,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Maturity date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Dec. 19,  2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=NTRP_SecuritiesPurchaseAgreementMember', window );">Securities Purchase Agreement [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=NTRP_SecuritiesPurchaseAgreementMember', window );">Securities Purchase Agreement [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesAndLoansPayableCurrent', window );">Total consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">360,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Original issue discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 60,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Maturity date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Jul.  01,  2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightReasonForIssuingToNonemployees', window );">Warrant description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">In
conjunction with the issuance of the Alumni Note to Alumni, the Company also issued warrants to purchase 80,000
shares of common stock at a price per share of $4.50,
which represents 100% warrant coverage on the principal amount of the Alumni Note. The Alumni Warrants are exercisable on or prior
to the five (5) year anniversary of the effective date.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants outstanding to purchase common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">80,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Shares issued price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=NTRP_SecuritiesPurchaseAgreementMember', window );">Securities Purchase Agreement [Member] | Subsequent Event [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=NTRP_AssetPurchaseAgreementMember', window );">Asset Purchase Agreement [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Payments to acquire businesses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForFees', window );">License fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 336,801<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=NTRP_AssetPurchaseAgreementMember', window );">Asset Purchase Agreement [Member] | Subsequent Event [Member] | Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross', window );">Restricted shares, issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=NTRP_PurchaseAgreementMember', window );">Purchase Agreement [Member] | Subsequent Event [Member] | FSA Travel LLC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Payments to acquire businesses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400,000<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=NTRP_PurchaseAgreementMember', window );">Purchase Agreement [Member] | Subsequent Event [Member] | FSA Travel LLC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Ownership percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">51.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=NTRP_PurchaseAgreementMember', window );">Purchase Agreement [Member] | Subsequent Event [Member] | Common Stock [Member] | FSA Travel LLC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,065<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=NTRP_PurchaseAgreementMember', window );">Purchase Agreement [Member] | Subsequent Event [Member] | Preferred Stock [Member] | FSA Travel LLC [Member] | Series O Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">129,032<span></span>
</td>
<td class="nump">161,291<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=NTRP_LineOfCreditAgreementMember', window );">Line of Credit Agreement [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Line of credit</a></td>
<td class="nump">$ 3,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityExpirationDate1', window );">Line of credit maturity date</a></td>
<td class="text">May 31,  2027<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod', window );">Line of credit, interest rate</a></td>
<td class="nump">12.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityDescription', window );">Line of credit advance description</a></td>
<td class="text">The
Company received an initial advance of $1,045,000
under the MIP Line of Credit, which was used to repay (i) a $400,000
cash advance previously made by the Trust to the Company (ii) and all outstanding
indebtedness under the terms of the Trust Notes, totaling $645,000.
Additional advances through May 28, 2025 totaled $441,575,
bringing the total amount advanced under the line to $1,486,575.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromLinesOfCredit', window );">Initial advance of line of credit</a></td>
<td class="nump">$ 1,045,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_CashAdvance', window );">Cash advance</a></td>
<td class="nump">400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet', window );">Aditional advances</a></td>
<td class="nump">441,575<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod', window );">Total advances of line of credit</a></td>
<td class="nump">$ 1,486,575<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=NTRP_LineOfCreditAgreementMember', window );">Line of Credit Agreement [Member] | Subsequent Event [Member] | Two Promissory Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Cash advance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 645,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_CashAdvance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash advance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_CashAdvance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_CommonStockIssuedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Common stock issued percentage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_CommonStockIssuedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightReasonForIssuingToNonemployees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of reason for issuing warrant or right.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightReasonForIssuingToNonemployees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-1A<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToContingentlyIssuableShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of contingently issuable shares. Contingently issuable shares are those shares that are issuable for little or no cash contingent on certain conditions being met.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 26<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-26<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 44<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-44<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 51<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-51<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-52<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-53<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 54<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-54<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 48<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-48<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 48<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-48<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToContingentlyIssuableShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of the terms of a credit facility arrangement. Terms typically include interest rate, collateral required, guarantees required, repayment requirements, and restrictions on use of assets and activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityExpirationDate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Date the credit facility terminates, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityExpirationDate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) of the credit facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The effective interest rate during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityInterestRateDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum amount borrowed under the credit facility at any time during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesAndLoansPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of the portions of all long-term notes and loans payable due within one year or the operating cycle if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesAndLoansPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for fees classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (g)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=NTRP_NoteOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=NTRP_NoteOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=NTRP_NoteTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=NTRP_NoteTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=NTRP_ExchangeAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=NTRP_ExchangeAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=NTRP_SecuritiesPurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=NTRP_SecuritiesPurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=NTRP_AssetPurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=NTRP_AssetPurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=NTRP_PurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=NTRP_PurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=NTRP_FSATravelLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=NTRP_FSATravelLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=NTRP_FSATravelLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=NTRP_FSATravelLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_PreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_PreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=NTRP_SeriesOPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=NTRP_SeriesOPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=NTRP_LineOfCreditAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=NTRP_LineOfCreditAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=NTRP_TwoPromissoryNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=NTRP_TwoPromissoryNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>119
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>120
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>122
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>307</ContextCount>
  <ElementCount>460</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>115</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>5</UnitCount>
  <MyReports>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nexttrip.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>00000002 - Statement - Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nexttrip.com/role/BalanceSheets</Role>
      <ShortName>Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>00000003 - Statement - Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nexttrip.com/role/BalanceSheetsParenthetical</Role>
      <ShortName>Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>00000004 - Statement - Consolidated Statements of Operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nexttrip.com/role/StatementsOfOperations</Role>
      <ShortName>Consolidated Statements of Operations</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>00000005 - Statement - Consolidated Statements of Operations (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nexttrip.com/role/StatementsOfOperationsParenthetical</Role>
      <ShortName>Consolidated Statements of Operations (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>00000006 - Statement - Consolidated Statements of Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nexttrip.com/role/StatementsOfStockholdersEquity</Role>
      <ShortName>Consolidated Statements of Stockholders' Equity</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>00000007 - Statement - Consolidated Statements of Stockholders' Equity (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nexttrip.com/role/StatementsOfStockholdersEquityParenthetical</Role>
      <ShortName>Consolidated Statements of Stockholders' Equity (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>00000008 - Statement - Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nexttrip.com/role/StatementsOfCashFlows</Role>
      <ShortName>Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>995410 - Disclosure - Pay vs Performance Disclosure</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/PvpDisclosure</Role>
      <ShortName>Pay vs Performance Disclosure</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>995445 - Disclosure - Insider Trading Arrangements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements</Role>
      <ShortName>Insider Trading Arrangements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>995550 - Disclosure - Cybersecurity Risk Management and Strategy Disclosure</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure</Role>
      <ShortName>Cybersecurity Risk Management and Strategy Disclosure</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>999016 - Disclosure - Business Description and Going Concern</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nexttrip.com/role/BusinessDescriptionAndGoingConcern</Role>
      <ShortName>Business Description and Going Concern</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>999017 - Disclosure - Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nexttrip.com/role/SummaryOfSignificantAccountingPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>999018 - Disclosure - Discontinued Operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nexttrip.com/role/DiscontinuedOperations</Role>
      <ShortName>Discontinued Operations</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>999019 - Disclosure - Investment in Equity Method Investee</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nexttrip.com/role/InvestmentInEquityMethodInvestee</Role>
      <ShortName>Investment in Equity Method Investee</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>999020 - Disclosure - Investment in Equity Securities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nexttrip.com/role/InvestmentInEquitySecurities</Role>
      <ShortName>Investment in Equity Securities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>999021 - Disclosure - Prepaid and Other Current Assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nexttrip.com/role/PrepaidAndOtherCurrentAssets</Role>
      <ShortName>Prepaid and Other Current Assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>999022 - Disclosure - Property and Equipment</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nexttrip.com/role/PropertyAndEquipment</Role>
      <ShortName>Property and Equipment</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>999023 - Disclosure - Intangible Assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nexttrip.com/role/IntangibleAssets</Role>
      <ShortName>Intangible Assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>999024 - Disclosure - Goodwill</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nexttrip.com/role/Goodwill</Role>
      <ShortName>Goodwill</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>999025 - Disclosure - Accounts Payable and Accrued Liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nexttrip.com/role/AccountsPayableAndAccruedLiabilities</Role>
      <ShortName>Accounts Payable and Accrued Liabilities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>999026 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nexttrip.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>999027 - Disclosure - Notes Payable</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://nexttrip.com/role/NotesPayable</Role>
      <ShortName>Notes Payable</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>999028 - Disclosure - Convertible Notes</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://nexttrip.com/role/ConvertibleNotes</Role>
      <ShortName>Convertible Notes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>999029 - Disclosure - Share Purchase Agreements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nexttrip.com/role/SharePurchaseAgreements</Role>
      <ShortName>Share Purchase Agreements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>999030 - Disclosure - Related Party Transactions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nexttrip.com/role/RelatedPartyTransactions</Role>
      <ShortName>Related Party Transactions</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>999031 - Disclosure - Deferred Revenue</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nexttrip.com/role/DeferredRevenue</Role>
      <ShortName>Deferred Revenue</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>999032 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nexttrip.com/role/CommitmentsAndContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>28</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>999033 - Disclosure - Stockholders??? Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nexttrip.com/role/StockholdersEquity</Role>
      <ShortName>Stockholders??? Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>29</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>999034 - Disclosure - Loss Per Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nexttrip.com/role/LossPerShare</Role>
      <ShortName>Loss Per Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>30</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>999035 - Disclosure - Concentrations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nexttrip.com/role/Concentrations</Role>
      <ShortName>Concentrations</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>31</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>999036 - Disclosure - Defined Contribution Plans</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nexttrip.com/role/DefinedContributionPlans</Role>
      <ShortName>Defined Contribution Plans</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>32</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>999037 - Disclosure - Subsequent Events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nexttrip.com/role/SubsequentEvents</Role>
      <ShortName>Subsequent Events</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>33</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>999038 - Disclosure - Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://nexttrip.com/role/SummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>999039 - Disclosure - Summary of Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesTables</Role>
      <ShortName>Summary of Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://nexttrip.com/role/SummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>999040 - Disclosure - Discontinued Operations (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nexttrip.com/role/DiscontinuedOperationsTables</Role>
      <ShortName>Discontinued Operations (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://nexttrip.com/role/DiscontinuedOperations</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>999041 - Disclosure - Investment in Equity Method Investee (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nexttrip.com/role/InvestmentInEquityMethodInvesteeTables</Role>
      <ShortName>Investment in Equity Method Investee (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://nexttrip.com/role/InvestmentInEquityMethodInvestee</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>999042 - Disclosure - Prepaid and Other Current Assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nexttrip.com/role/PrepaidAndOtherCurrentAssetsTables</Role>
      <ShortName>Prepaid and Other Current Assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://nexttrip.com/role/PrepaidAndOtherCurrentAssets</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>999043 - Disclosure - Property and Equipment (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nexttrip.com/role/PropertyAndEquipmentTables</Role>
      <ShortName>Property and Equipment (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://nexttrip.com/role/PropertyAndEquipment</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>999044 - Disclosure - Intangible Assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nexttrip.com/role/IntangibleAssetsTables</Role>
      <ShortName>Intangible Assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://nexttrip.com/role/IntangibleAssets</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>999045 - Disclosure - Goodwill (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nexttrip.com/role/GoodwillTables</Role>
      <ShortName>Goodwill (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://nexttrip.com/role/Goodwill</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>999046 - Disclosure - Income Taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nexttrip.com/role/IncomeTaxesTables</Role>
      <ShortName>Income Taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://nexttrip.com/role/IncomeTaxes</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>999047 - Disclosure - Stockholders??? Equity (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nexttrip.com/role/StockholdersEquityTables</Role>
      <ShortName>Stockholders??? Equity (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://nexttrip.com/role/StockholdersEquity</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>999048 - Disclosure - Loss Per Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nexttrip.com/role/LossPerShareTables</Role>
      <ShortName>Loss Per Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://nexttrip.com/role/LossPerShare</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>999049 - Disclosure - Business Description and Going Concern (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nexttrip.com/role/BusinessDescriptionAndGoingConcernDetailsNarrative</Role>
      <ShortName>Business Description and Going Concern (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://nexttrip.com/role/BusinessDescriptionAndGoingConcern</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>999050 - Disclosure - Schedule of Anti-dilutive Securities Excluded from Computation of Earnings Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nexttrip.com/role/ScheduleOfAnti-dilutiveSecuritiesExcludedFromComputationOfEarningsPerShareDetails</Role>
      <ShortName>Schedule of Anti-dilutive Securities Excluded from Computation of Earnings Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>999051 - Disclosure - Schedule of Estimated Useful Lives for Property and Equipment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nexttrip.com/role/ScheduleOfEstimatedUsefulLivesForPropertyAndEquipmentDetails</Role>
      <ShortName>Schedule of Estimated Useful Lives for Property and Equipment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>999052 - Disclosure - Schedule of Estimated Useful Lives for Finite Life Intangible Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nexttrip.com/role/ScheduleOfEstimatedUsefulLivesForFiniteLifeIntangibleAssetsDetails</Role>
      <ShortName>Schedule of Estimated Useful Lives for Finite Life Intangible Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>999053 - Disclosure - Summary of Significant Accounting Policies (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative</Role>
      <ShortName>Summary of Significant Accounting Policies (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesTables</ParentRole>
      <Position>49</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>999054 - Disclosure - Schedule of Discontinued Operations (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nexttrip.com/role/ScheduleOfDiscontinuedOperationsDetails</Role>
      <ShortName>Schedule of Discontinued Operations (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>999055 - Disclosure - Discontinued Operations (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nexttrip.com/role/DiscontinuedOperationsDetailsNarrative</Role>
      <ShortName>Discontinued Operations (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://nexttrip.com/role/DiscontinuedOperationsTables</ParentRole>
      <Position>51</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>999056 - Disclosure - Schedule of Unaudited Summarized Financial Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nexttrip.com/role/ScheduleOfUnauditedSummarizedFinancialInformationDetails</Role>
      <ShortName>Schedule of Unaudited Summarized Financial Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>999057 - Disclosure - Investment in Equity Method Investee (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nexttrip.com/role/InvestmentInEquityMethodInvesteeDetailsNarrative</Role>
      <ShortName>Investment in Equity Method Investee (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://nexttrip.com/role/InvestmentInEquityMethodInvesteeTables</ParentRole>
      <Position>53</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>999058 - Disclosure - Investment in Equity Securities (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nexttrip.com/role/InvestmentInEquitySecuritiesDetailsNarrative</Role>
      <ShortName>Investment in Equity Securities (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://nexttrip.com/role/InvestmentInEquitySecurities</ParentRole>
      <Position>54</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>999059 - Disclosure - Schedule of Prepaid and Other Current Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nexttrip.com/role/ScheduleOfPrepaidAndOtherCurrentAssetsDetails</Role>
      <ShortName>Schedule of Prepaid and Other Current Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>999060 - Disclosure - Schedule of Property and Equipment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nexttrip.com/role/ScheduleOfPropertyAndEquipmentDetails</Role>
      <ShortName>Schedule of Property and Equipment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>999061 - Disclosure - Property and Equipment (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nexttrip.com/role/PropertyAndEquipmentDetailsNarrative</Role>
      <ShortName>Property and Equipment (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://nexttrip.com/role/PropertyAndEquipmentTables</ParentRole>
      <Position>57</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>999062 - Disclosure - Schedule of Intangible Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nexttrip.com/role/ScheduleOfIntangibleAssetsDetails</Role>
      <ShortName>Schedule of Intangible Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>999063 - Disclosure - Schedule of estimated aggregate amortization expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nexttrip.com/role/ScheduleOfEstimatedAggregateAmortizationExpenseDetails</Role>
      <ShortName>Schedule of estimated aggregate amortization expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>999064 - Disclosure - Intangible Assets (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nexttrip.com/role/IntangibleAssetsDetailsNarrative</Role>
      <ShortName>Intangible Assets (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://nexttrip.com/role/IntangibleAssetsTables</ParentRole>
      <Position>60</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>999065 - Disclosure - Schedule of Fair Value of Assets Acquired (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nexttrip.com/role/ScheduleOfFairValueOfAssetsAcquiredDetails</Role>
      <ShortName>Schedule of Fair Value of Assets Acquired (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>999066 - Disclosure - Goodwill (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nexttrip.com/role/GoodwillDetailsNarrative</Role>
      <ShortName>Goodwill (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://nexttrip.com/role/GoodwillTables</ParentRole>
      <Position>62</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>999067 - Disclosure - Accounts Payable and Accrued Liabilities (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nexttrip.com/role/AccountsPayableAndAccruedLiabilitiesDetailsNarrative</Role>
      <ShortName>Accounts Payable and Accrued Liabilities (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://nexttrip.com/role/AccountsPayableAndAccruedLiabilities</ParentRole>
      <Position>63</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>999068 - Disclosure - Schedule of Deferred Tax Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nexttrip.com/role/ScheduleOfDeferredTaxAssetsDetails</Role>
      <ShortName>Schedule of Deferred Tax Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>999069 - Disclosure - Schedule of Reconciliation of Provision for Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nexttrip.com/role/ScheduleOfReconciliationOfProvisionForIncomeTaxesDetails</Role>
      <ShortName>Schedule of Reconciliation of Provision for Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>999070 - Disclosure - Income Taxes (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nexttrip.com/role/IncomeTaxesDetailsNarrative</Role>
      <ShortName>Income Taxes (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://nexttrip.com/role/IncomeTaxesTables</ParentRole>
      <Position>66</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>999071 - Disclosure - Notes Payable (Details Narrative)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://nexttrip.com/role/NotesPayableDetailsNarrative</Role>
      <ShortName>Notes Payable (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://nexttrip.com/role/NotesPayable</ParentRole>
      <Position>67</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>999072 - Disclosure - Convertible Notes (Details Narrative)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://nexttrip.com/role/ConvertibleNotesDetailsNarrative</Role>
      <ShortName>Convertible Notes (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://nexttrip.com/role/ConvertibleNotes</ParentRole>
      <Position>68</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>999073 - Disclosure - Share Purchase Agreements (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nexttrip.com/role/SharePurchaseAgreementsDetailsNarrative</Role>
      <ShortName>Share Purchase Agreements (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://nexttrip.com/role/SharePurchaseAgreements</ParentRole>
      <Position>69</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>999074 - Disclosure - Related Party Transactions (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nexttrip.com/role/RelatedPartyTransactionsDetailsNarrative</Role>
      <ShortName>Related Party Transactions (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://nexttrip.com/role/RelatedPartyTransactions</ParentRole>
      <Position>70</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>999075 - Disclosure - Deferred Revenue (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nexttrip.com/role/DeferredRevenueDetailsNarrative</Role>
      <ShortName>Deferred Revenue (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://nexttrip.com/role/DeferredRevenue</ParentRole>
      <Position>71</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>999076 - Disclosure - Schedule of Stock Option Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nexttrip.com/role/ScheduleOfStockOptionActivityDetails</Role>
      <ShortName>Schedule of Stock Option Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>72</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>999077 - Disclosure - Schedule of Share Based Payments Award Stock Options Valuation Assumptions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nexttrip.com/role/ScheduleOfShareBasedPaymentsAwardStockOptionsValuationAssumptionsDetails</Role>
      <ShortName>Schedule of Share Based Payments Award Stock Options Valuation Assumptions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>73</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>999078 - Disclosure - Schedule of Warranty Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nexttrip.com/role/ScheduleOfWarrantyActivityDetails</Role>
      <ShortName>Schedule of Warranty Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>74</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>999079 - Disclosure - Stockholders??? Equity (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nexttrip.com/role/StockholdersEquityDetailsNarrative</Role>
      <ShortName>Stockholders??? Equity (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://nexttrip.com/role/StockholdersEquityTables</ParentRole>
      <Position>75</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>999080 - Disclosure - Schedule of Earnings Per Share, Basic and Diluted (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nexttrip.com/role/ScheduleOfEarningsPerShareBasicAndDilutedDetails</Role>
      <ShortName>Schedule of Earnings Per Share, Basic and Diluted (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>76</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>999081 - Disclosure - Schedule of Business Milestones and Issuable Contingent Shares (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nexttrip.com/role/ScheduleOfBusinessMilestonesAndIssuableContingentSharesDetails</Role>
      <ShortName>Schedule of Business Milestones and Issuable Contingent Shares (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>77</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>999082 - Disclosure - Schedule of Weighted Average Common Shares (Details) (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nexttrip.com/role/ScheduleOfWeightedAverageCommonSharesDetailsParenthetical</Role>
      <ShortName>Schedule of Weighted Average Common Shares (Details) (Parenthetical)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>78</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R79.htm</HtmlFileName>
      <LongName>999083 - Disclosure - Schedule of Weighted Average Common Shares (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nexttrip.com/role/ScheduleOfWeightedAverageCommonSharesDetails</Role>
      <ShortName>Schedule of Weighted Average Common Shares (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>79</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R80.htm</HtmlFileName>
      <LongName>999084 - Disclosure - Loss Per Share (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nexttrip.com/role/LossPerShareDetailsNarrative</Role>
      <ShortName>Loss Per Share (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://nexttrip.com/role/LossPerShareTables</ParentRole>
      <Position>80</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R81.htm</HtmlFileName>
      <LongName>999085 - Disclosure - Concentrations (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nexttrip.com/role/ConcentrationsDetailsNarrative</Role>
      <ShortName>Concentrations (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://nexttrip.com/role/Concentrations</ParentRole>
      <Position>81</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R82.htm</HtmlFileName>
      <LongName>999086 - Disclosure - Defined Contribution Plans (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nexttrip.com/role/DefinedContributionPlansDetailsNarrative</Role>
      <ShortName>Defined Contribution Plans (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://nexttrip.com/role/DefinedContributionPlans</ParentRole>
      <Position>82</Position>
    </Report>
    <Report instance="form10-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R83.htm</HtmlFileName>
      <LongName>999087 - Disclosure - Subsequent Events (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nexttrip.com/role/SubsequentEventsDetailsNarrative</Role>
      <ShortName>Subsequent Events (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://nexttrip.com/role/SubsequentEvents</ParentRole>
      <Position>83</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-K" isDefinitelyFs="true" isUsgaap="true" original="form10-k.htm">form10-k.htm</File>
    <File>ntrp-20250228.xsd</File>
    <File>ntrp-20250228_cal.xml</File>
    <File>ntrp-20250228_def.xml</File>
    <File>ntrp-20250228_lab.xml</File>
    <File>ntrp-20250228_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>form10-k_001.jpg</File>
    <File>form10-k_002.jpg</File>
    <File>form10-k_003.jpg</File>
    <File>form10-k_004.jpg</File>
    <File>form10-k_005.jpg</File>
    <File>form10-k_006.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="938">http://fasb.org/us-gaap/2024</BaseTaxonomy>
    <BaseTaxonomy items="9">http://xbrl.sec.gov/cyd/2024</BaseTaxonomy>
    <BaseTaxonomy items="38">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
    <BaseTaxonomy items="4">http://xbrl.sec.gov/ecd/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>124
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "form10-k.htm": {
   "nsprefix": "NTRP",
   "nsuri": "http://nexttrip.com/20250228",
   "dts": {
    "inline": {
     "local": [
      "form10-k.htm"
     ]
    },
    "schema": {
     "local": [
      "ntrp-20250228.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd",
      "https://xbrl.sec.gov/country/2024/country-2024.xsd",
      "https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd",
      "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"
     ]
    },
    "calculationLink": {
     "local": [
      "ntrp-20250228_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "ntrp-20250228_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "ntrp-20250228_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "ntrp-20250228_pre.xml"
     ]
    }
   },
   "keyStandard": 369,
   "keyCustom": 91,
   "axisStandard": 24,
   "axisCustom": 0,
   "memberStandard": 22,
   "memberCustom": 81,
   "hidden": {
    "total": 106,
    "http://fasb.org/us-gaap/2024": 66,
    "http://nexttrip.com/20250228": 37,
    "http://xbrl.sec.gov/dei/2024": 3
   },
   "contextCount": 307,
   "entityCount": 1,
   "segmentCount": 115,
   "elementCount": 794,
   "unitCount": 5,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2024": 938,
    "http://xbrl.sec.gov/dei/2024": 38,
    "http://xbrl.sec.gov/cyd/2024": 9,
    "http://xbrl.sec.gov/ecd/2024": 4
   },
   "report": {
    "R1": {
     "role": "http://nexttrip.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "From2024-03-01to2025-02-28",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-03-01to2025-02-28",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://nexttrip.com/role/BalanceSheets",
     "longName": "00000002 - Statement - Consolidated Balance Sheets",
     "shortName": "Consolidated Balance Sheets",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "2",
     "firstAnchor": {
      "contextRef": "AsOf2025-02-28",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-02-28",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R3": {
     "role": "http://nexttrip.com/role/BalanceSheetsParenthetical",
     "longName": "00000003 - Statement - Consolidated Balance Sheets (Parenthetical)",
     "shortName": "Consolidated Balance Sheets (Parenthetical)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "3",
     "firstAnchor": {
      "contextRef": "AsOf2025-02-28",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "unitRef": "USDPShares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R4": {
     "role": "http://nexttrip.com/role/StatementsOfOperations",
     "longName": "00000004 - Statement - Consolidated Statements of Operations",
     "shortName": "Consolidated Statements of Operations",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "4",
     "firstAnchor": {
      "contextRef": "From2024-03-01to2025-02-28",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-03-01to2025-02-28",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R5": {
     "role": "http://nexttrip.com/role/StatementsOfOperationsParenthetical",
     "longName": "00000005 - Statement - Consolidated Statements of Operations (Parenthetical)",
     "shortName": "Consolidated Statements of Operations (Parenthetical)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "5",
     "firstAnchor": {
      "contextRef": "From2023-12-292023-12-29_custom_NextTripGroupLLCMember",
      "name": "us-gaap:StockIssuedDuringPeriodSharesAcquisitions",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "link:footnote",
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R6": {
     "role": "http://nexttrip.com/role/StatementsOfStockholdersEquity",
     "longName": "00000006 - Statement - Consolidated Statements of Stockholders' Equity",
     "shortName": "Consolidated Statements of Stockholders' Equity",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "6",
     "firstAnchor": {
      "contextRef": "AsOf2023-02-28_us-gaap_CommonStockMember",
      "name": "us-gaap:StockholdersEquity",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-02-28_us-gaap_CommonStockMember",
      "name": "us-gaap:StockholdersEquity",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R7": {
     "role": "http://nexttrip.com/role/StatementsOfStockholdersEquityParenthetical",
     "longName": "00000007 - Statement - Consolidated Statements of Stockholders' Equity (Parenthetical)",
     "shortName": "Consolidated Statements of Stockholders' Equity (Parenthetical)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "7",
     "firstAnchor": {
      "contextRef": "From2023-12-292023-12-29_custom_NextTripGroupLLCMember",
      "name": "us-gaap:StockIssuedDuringPeriodSharesAcquisitions",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "link:footnote",
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R8": {
     "role": "http://nexttrip.com/role/StatementsOfCashFlows",
     "longName": "00000008 - Statement - Consolidated Statements of Cash Flows",
     "shortName": "Consolidated Statements of Cash Flows",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "8",
     "firstAnchor": {
      "contextRef": "From2024-03-01to2025-02-28",
      "name": "us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-03-01to2025-02-28",
      "name": "us-gaap:AmortizationOfDebtDiscountPremium",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "unique": true
     }
    },
    "R9": {
     "role": "http://xbrl.sec.gov/ecd/role/PvpDisclosure",
     "longName": "995410 - Disclosure - Pay vs Performance Disclosure",
     "shortName": "Pay vs Performance Disclosure",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "9",
     "firstAnchor": {
      "contextRef": "From2024-03-01to2025-02-28",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R10": {
     "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
     "longName": "995445 - Disclosure - Insider Trading Arrangements",
     "shortName": "Insider Trading Arrangements",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "10",
     "firstAnchor": {
      "contextRef": "From2024-12-012025-02-28",
      "name": "ecd:Rule10b51ArrAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-12-012025-02-28",
      "name": "ecd:Rule10b51ArrAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R11": {
     "role": "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure",
     "longName": "995550 - Disclosure - Cybersecurity Risk Management and Strategy Disclosure",
     "shortName": "Cybersecurity Risk Management and Strategy Disclosure",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "11",
     "firstAnchor": {
      "contextRef": "From2024-03-01to2025-02-28",
      "name": "cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-03-01to2025-02-28",
      "name": "cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R12": {
     "role": "http://nexttrip.com/role/BusinessDescriptionAndGoingConcern",
     "longName": "999016 - Disclosure - Business Description and Going Concern",
     "shortName": "Business Description and Going Concern",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "12",
     "firstAnchor": {
      "contextRef": "From2024-03-01to2025-02-28",
      "name": "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-03-01to2025-02-28",
      "name": "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R13": {
     "role": "http://nexttrip.com/role/SummaryOfSignificantAccountingPolicies",
     "longName": "999017 - Disclosure - Summary of Significant Accounting Policies",
     "shortName": "Summary of Significant Accounting Policies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "13",
     "firstAnchor": {
      "contextRef": "From2024-03-01to2025-02-28",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-03-01to2025-02-28",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R14": {
     "role": "http://nexttrip.com/role/DiscontinuedOperations",
     "longName": "999018 - Disclosure - Discontinued Operations",
     "shortName": "Discontinued Operations",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "14",
     "firstAnchor": {
      "contextRef": "From2024-03-01to2025-02-28",
      "name": "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-03-01to2025-02-28",
      "name": "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R15": {
     "role": "http://nexttrip.com/role/InvestmentInEquityMethodInvestee",
     "longName": "999019 - Disclosure - Investment in Equity Method Investee",
     "shortName": "Investment in Equity Method Investee",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "15",
     "firstAnchor": {
      "contextRef": "From2024-03-01to2025-02-28",
      "name": "us-gaap:EquityMethodInvestmentsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-03-01to2025-02-28",
      "name": "us-gaap:EquityMethodInvestmentsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R16": {
     "role": "http://nexttrip.com/role/InvestmentInEquitySecurities",
     "longName": "999020 - Disclosure - Investment in Equity Securities",
     "shortName": "Investment in Equity Securities",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "16",
     "firstAnchor": {
      "contextRef": "From2024-03-01to2025-02-28",
      "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-03-01to2025-02-28",
      "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R17": {
     "role": "http://nexttrip.com/role/PrepaidAndOtherCurrentAssets",
     "longName": "999021 - Disclosure - Prepaid and Other Current Assets",
     "shortName": "Prepaid and Other Current Assets",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "17",
     "firstAnchor": {
      "contextRef": "From2024-03-01to2025-02-28",
      "name": "NTRP:PrepaidExpensesAndOtherCurrentAssetsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-03-01to2025-02-28",
      "name": "NTRP:PrepaidExpensesAndOtherCurrentAssetsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R18": {
     "role": "http://nexttrip.com/role/PropertyAndEquipment",
     "longName": "999022 - Disclosure - Property and Equipment",
     "shortName": "Property and Equipment",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "18",
     "firstAnchor": {
      "contextRef": "From2024-03-01to2025-02-28",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-03-01to2025-02-28",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R19": {
     "role": "http://nexttrip.com/role/IntangibleAssets",
     "longName": "999023 - Disclosure - Intangible Assets",
     "shortName": "Intangible Assets",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "19",
     "firstAnchor": {
      "contextRef": "From2024-03-01to2025-02-28",
      "name": "us-gaap:IntangibleAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-03-01to2025-02-28",
      "name": "us-gaap:IntangibleAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R20": {
     "role": "http://nexttrip.com/role/Goodwill",
     "longName": "999024 - Disclosure - Goodwill",
     "shortName": "Goodwill",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "20",
     "firstAnchor": {
      "contextRef": "From2024-03-01to2025-02-28",
      "name": "us-gaap:GoodwillDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-03-01to2025-02-28",
      "name": "us-gaap:GoodwillDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R21": {
     "role": "http://nexttrip.com/role/AccountsPayableAndAccruedLiabilities",
     "longName": "999025 - Disclosure - Accounts Payable and Accrued Liabilities",
     "shortName": "Accounts Payable and Accrued Liabilities",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "21",
     "firstAnchor": {
      "contextRef": "From2024-03-01to2025-02-28",
      "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-03-01to2025-02-28",
      "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R22": {
     "role": "http://nexttrip.com/role/IncomeTaxes",
     "longName": "999026 - Disclosure - Income Taxes",
     "shortName": "Income Taxes",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "22",
     "firstAnchor": {
      "contextRef": "From2024-03-01to2025-02-28",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-03-01to2025-02-28",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R23": {
     "role": "http://nexttrip.com/role/NotesPayable",
     "longName": "999027 - Disclosure - Notes Payable",
     "shortName": "Notes Payable",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "23",
     "firstAnchor": {
      "contextRef": "From2024-03-01to2025-02-28",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-03-01to2025-02-28",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R24": {
     "role": "http://nexttrip.com/role/ConvertibleNotes",
     "longName": "999028 - Disclosure - Convertible Notes",
     "shortName": "Convertible Notes",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "24",
     "firstAnchor": {
      "contextRef": "From2024-03-01to2025-02-28",
      "name": "NTRP:ConvertibleDebtDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-03-01to2025-02-28",
      "name": "NTRP:ConvertibleDebtDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R25": {
     "role": "http://nexttrip.com/role/SharePurchaseAgreements",
     "longName": "999029 - Disclosure - Share Purchase Agreements",
     "shortName": "Share Purchase Agreements",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "25",
     "firstAnchor": {
      "contextRef": "From2024-03-01to2025-02-28",
      "name": "NTRP:SharePurchaseAgreementsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-03-01to2025-02-28",
      "name": "NTRP:SharePurchaseAgreementsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R26": {
     "role": "http://nexttrip.com/role/RelatedPartyTransactions",
     "longName": "999030 - Disclosure - Related Party Transactions",
     "shortName": "Related Party Transactions",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "26",
     "firstAnchor": {
      "contextRef": "From2024-03-01to2025-02-28",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-03-01to2025-02-28",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R27": {
     "role": "http://nexttrip.com/role/DeferredRevenue",
     "longName": "999031 - Disclosure - Deferred Revenue",
     "shortName": "Deferred Revenue",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "27",
     "firstAnchor": {
      "contextRef": "From2024-03-01to2025-02-28",
      "name": "NTRP:DeferredRevenueTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-03-01to2025-02-28",
      "name": "NTRP:DeferredRevenueTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R28": {
     "role": "http://nexttrip.com/role/CommitmentsAndContingencies",
     "longName": "999032 - Disclosure - Commitments and Contingencies",
     "shortName": "Commitments and Contingencies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "28",
     "firstAnchor": {
      "contextRef": "From2024-03-01to2025-02-28",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-03-01to2025-02-28",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R29": {
     "role": "http://nexttrip.com/role/StockholdersEquity",
     "longName": "999033 - Disclosure - Stockholders\u2019 Equity",
     "shortName": "Stockholders\u2019 Equity",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "29",
     "firstAnchor": {
      "contextRef": "From2024-03-01to2025-02-28",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-03-01to2025-02-28",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R30": {
     "role": "http://nexttrip.com/role/LossPerShare",
     "longName": "999034 - Disclosure - Loss Per Share",
     "shortName": "Loss Per Share",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "30",
     "firstAnchor": {
      "contextRef": "From2024-03-01to2025-02-28",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-03-01to2025-02-28",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R31": {
     "role": "http://nexttrip.com/role/Concentrations",
     "longName": "999035 - Disclosure - Concentrations",
     "shortName": "Concentrations",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "31",
     "firstAnchor": {
      "contextRef": "From2024-03-01to2025-02-28",
      "name": "us-gaap:ConcentrationRiskDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-03-01to2025-02-28",
      "name": "us-gaap:ConcentrationRiskDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R32": {
     "role": "http://nexttrip.com/role/DefinedContributionPlans",
     "longName": "999036 - Disclosure - Defined Contribution Plans",
     "shortName": "Defined Contribution Plans",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "32",
     "firstAnchor": {
      "contextRef": "From2024-03-01to2025-02-28",
      "name": "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-03-01to2025-02-28",
      "name": "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R33": {
     "role": "http://nexttrip.com/role/SubsequentEvents",
     "longName": "999037 - Disclosure - Subsequent Events",
     "shortName": "Subsequent Events",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "33",
     "firstAnchor": {
      "contextRef": "From2024-03-01to2025-02-28",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-03-01to2025-02-28",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R34": {
     "role": "http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesPolicies",
     "longName": "999038 - Disclosure - Summary of Significant Accounting Policies (Policies)",
     "shortName": "Summary of Significant Accounting Policies (Policies)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "policies",
     "menuCat": "Policies",
     "order": "34",
     "firstAnchor": {
      "contextRef": "From2024-03-01to2025-02-28",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-03-01to2025-02-28",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R35": {
     "role": "http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesTables",
     "longName": "999039 - Disclosure - Summary of Significant Accounting Policies (Tables)",
     "shortName": "Summary of Significant Accounting Policies (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "35",
     "firstAnchor": {
      "contextRef": "From2024-03-01to2025-02-28",
      "name": "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:EarningsPerSharePolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-03-01to2025-02-28",
      "name": "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:EarningsPerSharePolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R36": {
     "role": "http://nexttrip.com/role/DiscontinuedOperationsTables",
     "longName": "999040 - Disclosure - Discontinued Operations (Tables)",
     "shortName": "Discontinued Operations (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "36",
     "firstAnchor": {
      "contextRef": "From2024-03-01to2025-02-28",
      "name": "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-03-01to2025-02-28",
      "name": "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R37": {
     "role": "http://nexttrip.com/role/InvestmentInEquityMethodInvesteeTables",
     "longName": "999041 - Disclosure - Investment in Equity Method Investee (Tables)",
     "shortName": "Investment in Equity Method Investee (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "37",
     "firstAnchor": {
      "contextRef": "From2024-03-01to2025-02-28",
      "name": "us-gaap:EquityMethodInvestmentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:EquityMethodInvestmentsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-03-01to2025-02-28",
      "name": "us-gaap:EquityMethodInvestmentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:EquityMethodInvestmentsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R38": {
     "role": "http://nexttrip.com/role/PrepaidAndOtherCurrentAssetsTables",
     "longName": "999042 - Disclosure - Prepaid and Other Current Assets (Tables)",
     "shortName": "Prepaid and Other Current Assets (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "38",
     "firstAnchor": {
      "contextRef": "From2024-03-01to2025-02-28",
      "name": "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "NTRP:PrepaidExpensesAndOtherCurrentAssetsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-03-01to2025-02-28",
      "name": "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "NTRP:PrepaidExpensesAndOtherCurrentAssetsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R39": {
     "role": "http://nexttrip.com/role/PropertyAndEquipmentTables",
     "longName": "999043 - Disclosure - Property and Equipment (Tables)",
     "shortName": "Property and Equipment (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "39",
     "firstAnchor": {
      "contextRef": "From2024-03-01to2025-02-28",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-03-01to2025-02-28",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R40": {
     "role": "http://nexttrip.com/role/IntangibleAssetsTables",
     "longName": "999044 - Disclosure - Intangible Assets (Tables)",
     "shortName": "Intangible Assets (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "40",
     "firstAnchor": {
      "contextRef": "From2024-03-01to2025-02-28",
      "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-03-01to2025-02-28",
      "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R41": {
     "role": "http://nexttrip.com/role/GoodwillTables",
     "longName": "999045 - Disclosure - Goodwill (Tables)",
     "shortName": "Goodwill (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "41",
     "firstAnchor": {
      "contextRef": "From2024-03-01to2025-02-28",
      "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:GoodwillDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-03-01to2025-02-28",
      "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:GoodwillDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R42": {
     "role": "http://nexttrip.com/role/IncomeTaxesTables",
     "longName": "999046 - Disclosure - Income Taxes (Tables)",
     "shortName": "Income Taxes (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "42",
     "firstAnchor": {
      "contextRef": "From2024-03-01to2025-02-28",
      "name": "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-03-01to2025-02-28",
      "name": "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R43": {
     "role": "http://nexttrip.com/role/StockholdersEquityTables",
     "longName": "999047 - Disclosure - Stockholders\u2019 Equity (Tables)",
     "shortName": "Stockholders\u2019 Equity (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "43",
     "firstAnchor": {
      "contextRef": "From2024-03-01to2025-02-28",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-03-01to2025-02-28",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R44": {
     "role": "http://nexttrip.com/role/LossPerShareTables",
     "longName": "999048 - Disclosure - Loss Per Share (Tables)",
     "shortName": "Loss Per Share (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "44",
     "firstAnchor": {
      "contextRef": "From2024-03-01to2025-02-28",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:EarningsPerShareTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-03-01to2025-02-28",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:EarningsPerShareTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R45": {
     "role": "http://nexttrip.com/role/BusinessDescriptionAndGoingConcernDetailsNarrative",
     "longName": "999049 - Disclosure - Business Description and Going Concern (Details Narrative)",
     "shortName": "Business Description and Going Concern (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "45",
     "firstAnchor": {
      "contextRef": "AsOf2024-12-31",
      "name": "us-gaap:SharesIssuedPricePerShare",
      "unitRef": "USDPShares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:DebtDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-02-28",
      "name": "NTRP:WorkingCapitalDeficit",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "unique": true
     }
    },
    "R46": {
     "role": "http://nexttrip.com/role/ScheduleOfAnti-dilutiveSecuritiesExcludedFromComputationOfEarningsPerShareDetails",
     "longName": "999050 - Disclosure - Schedule of Anti-dilutive Securities Excluded from Computation of Earnings Per Share (Details)",
     "shortName": "Schedule of Anti-dilutive Securities Excluded from Computation of Earnings Per Share (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "46",
     "firstAnchor": {
      "contextRef": "From2024-03-01to2025-02-28",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "us-gaap:EarningsPerSharePolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-03-01to2025-02-28",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "us-gaap:EarningsPerSharePolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R47": {
     "role": "http://nexttrip.com/role/ScheduleOfEstimatedUsefulLivesForPropertyAndEquipmentDetails",
     "longName": "999051 - Disclosure - Schedule of Estimated Useful Lives for Property and Equipment (Details)",
     "shortName": "Schedule of Estimated Useful Lives for Property and Equipment (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "47",
     "firstAnchor": {
      "contextRef": "AsOf2025-02-28_us-gaap_FurnitureAndFixturesMember",
      "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "NTRP:ScheduleOfEstimatedUsefulLivesForPropertyAndEquipmentTableTextBlock",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-02-28_us-gaap_FurnitureAndFixturesMember",
      "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "NTRP:ScheduleOfEstimatedUsefulLivesForPropertyAndEquipmentTableTextBlock",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R48": {
     "role": "http://nexttrip.com/role/ScheduleOfEstimatedUsefulLivesForFiniteLifeIntangibleAssetsDetails",
     "longName": "999052 - Disclosure - Schedule of Estimated Useful Lives for Finite Life Intangible Assets (Details)",
     "shortName": "Schedule of Estimated Useful Lives for Finite Life Intangible Assets (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "48",
     "firstAnchor": {
      "contextRef": "AsOf2025-02-28_custom_SoftwareMember_srt_MinimumMember",
      "name": "us-gaap:FiniteLivedIntangibleAssetUsefulLife",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "NTRP:ScheduleOfEstimatedUsefulLivesForFiniteLifeIntangibleAssetsTableTextBlock",
       "us-gaap:IntangibleAssetsFiniteLivedPolicy",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-02-28_custom_SoftwareMember_srt_MinimumMember",
      "name": "us-gaap:FiniteLivedIntangibleAssetUsefulLife",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "NTRP:ScheduleOfEstimatedUsefulLivesForFiniteLifeIntangibleAssetsTableTextBlock",
       "us-gaap:IntangibleAssetsFiniteLivedPolicy",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R49": {
     "role": "http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative",
     "longName": "999053 - Disclosure - Summary of Significant Accounting Policies (Details Narrative)",
     "shortName": "Summary of Significant Accounting Policies (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "49",
     "firstAnchor": {
      "contextRef": "AsOf2025-02-28",
      "name": "us-gaap:CashEquivalentsAtCarryingValue",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "span",
       "p",
       "us-gaap:CashAndCashEquivalentsPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-02-28",
      "name": "us-gaap:CashEquivalentsAtCarryingValue",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "span",
       "p",
       "us-gaap:CashAndCashEquivalentsPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R50": {
     "role": "http://nexttrip.com/role/ScheduleOfDiscontinuedOperationsDetails",
     "longName": "999054 - Disclosure - Schedule of Discontinued Operations (Details)",
     "shortName": "Schedule of Discontinued Operations (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "50",
     "firstAnchor": {
      "contextRef": "From2024-03-01to2025-02-28",
      "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
       "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-03-01to2025-02-28",
      "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
       "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R51": {
     "role": "http://nexttrip.com/role/DiscontinuedOperationsDetailsNarrative",
     "longName": "999055 - Disclosure - Discontinued Operations (Details Narrative)",
     "shortName": "Discontinued Operations (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "51",
     "firstAnchor": {
      "contextRef": "From2024-03-01to2025-02-28",
      "name": "us-gaap:GainLossOnDispositionOfAssets1",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-10-062023-10-06_custom_AssetPurchaseAgreementMember_custom_DivergentTechnologiesIncMember",
      "name": "us-gaap:PaymentsToAcquireIntangibleAssets",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "unique": true
     }
    },
    "R52": {
     "role": "http://nexttrip.com/role/ScheduleOfUnauditedSummarizedFinancialInformationDetails",
     "longName": "999056 - Disclosure - Schedule of Unaudited Summarized Financial Information (Details)",
     "shortName": "Schedule of Unaudited Summarized Financial Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "52",
     "firstAnchor": {
      "contextRef": "AsOf2025-02-28",
      "name": "us-gaap:AssetsCurrent",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-12-31_custom_FSATravelLLCMember",
      "name": "us-gaap:AssetsCurrent",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:EquityMethodInvestmentsTextBlock",
       "us-gaap:EquityMethodInvestmentsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "unique": true
     }
    },
    "R53": {
     "role": "http://nexttrip.com/role/InvestmentInEquityMethodInvesteeDetailsNarrative",
     "longName": "999057 - Disclosure - Investment in Equity Method Investee (Details Narrative)",
     "shortName": "Investment in Equity Method Investee (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "53",
     "firstAnchor": {
      "contextRef": "AsOf2024-12-31",
      "name": "us-gaap:SharesIssued",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:DebtDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-02-28_custom_MembershipPurchaseAgreementMember",
      "name": "us-gaap:EquityOwnershipPercentageExcludingConsolidatedEntityAndEquityMethodInvestee",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:EquityMethodInvestmentsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "unique": true
     }
    },
    "R54": {
     "role": "http://nexttrip.com/role/InvestmentInEquitySecuritiesDetailsNarrative",
     "longName": "999058 - Disclosure - Investment in Equity Securities (Details Narrative)",
     "shortName": "Investment in Equity Securities (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "54",
     "firstAnchor": {
      "contextRef": "AsOf2024-12-31",
      "name": "us-gaap:SharesIssuedPricePerShare",
      "unitRef": "USDPShares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:DebtDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-02-24_custom_ShareExchangeAgreementMember_custom_BlueFyshHoldingsIncMember",
      "name": "us-gaap:EquityOwnershipPercentageExcludingConsolidatedEntityAndEquityMethodInvestee",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "unique": true
     }
    },
    "R55": {
     "role": "http://nexttrip.com/role/ScheduleOfPrepaidAndOtherCurrentAssetsDetails",
     "longName": "999059 - Disclosure - Schedule of Prepaid and Other Current Assets (Details)",
     "shortName": "Schedule of Prepaid and Other Current Assets (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "55",
     "firstAnchor": {
      "contextRef": "AsOf2025-02-28",
      "name": "NTRP:PrepaidOfferingCosts",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock",
       "NTRP:PrepaidExpensesAndOtherCurrentAssetsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-02-28",
      "name": "NTRP:PrepaidOfferingCosts",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock",
       "NTRP:PrepaidExpensesAndOtherCurrentAssetsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R56": {
     "role": "http://nexttrip.com/role/ScheduleOfPropertyAndEquipmentDetails",
     "longName": "999060 - Disclosure - Schedule of Property and Equipment (Details)",
     "shortName": "Schedule of Property and Equipment (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "56",
     "firstAnchor": {
      "contextRef": "AsOf2025-02-28",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-02-28",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R57": {
     "role": "http://nexttrip.com/role/PropertyAndEquipmentDetailsNarrative",
     "longName": "999061 - Disclosure - Property and Equipment (Details Narrative)",
     "shortName": "Property and Equipment (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "57",
     "firstAnchor": {
      "contextRef": "From2024-03-01to2025-02-28",
      "name": "us-gaap:Depreciation",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-03-01to2025-02-28",
      "name": "us-gaap:Depreciation",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R58": {
     "role": "http://nexttrip.com/role/ScheduleOfIntangibleAssetsDetails",
     "longName": "999062 - Disclosure - Schedule of Intangible Assets (Details)",
     "shortName": "Schedule of Intangible Assets (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "58",
     "firstAnchor": {
      "contextRef": "AsOf2025-02-28",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-02-28",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R59": {
     "role": "http://nexttrip.com/role/ScheduleOfEstimatedAggregateAmortizationExpenseDetails",
     "longName": "999063 - Disclosure - Schedule of estimated aggregate amortization expense (Details)",
     "shortName": "Schedule of estimated aggregate amortization expense (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "59",
     "firstAnchor": {
      "contextRef": "AsOf2025-02-28",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-02-28",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R60": {
     "role": "http://nexttrip.com/role/IntangibleAssetsDetailsNarrative",
     "longName": "999064 - Disclosure - Intangible Assets (Details Narrative)",
     "shortName": "Intangible Assets (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "60",
     "firstAnchor": {
      "contextRef": "From2024-03-01to2025-02-28",
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-03-01to2025-02-28",
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R61": {
     "role": "http://nexttrip.com/role/ScheduleOfFairValueOfAssetsAcquiredDetails",
     "longName": "999065 - Disclosure - Schedule of Fair Value of Assets Acquired (Details)",
     "shortName": "Schedule of Fair Value of Assets Acquired (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "61",
     "firstAnchor": {
      "contextRef": "AsOf2025-02-28",
      "name": "us-gaap:Goodwill",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-10-12_custom_SigmaAdditiveSolutionsIncMember",
      "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
       "us-gaap:GoodwillDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "unique": true
     }
    },
    "R62": {
     "role": "http://nexttrip.com/role/GoodwillDetailsNarrative",
     "longName": "999066 - Disclosure - Goodwill (Details Narrative)",
     "shortName": "Goodwill (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "62",
     "firstAnchor": {
      "contextRef": "AsOf2023-10-12",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:GoodwillDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-10-122023-10-12",
      "name": "us-gaap:GainLossOnDispositionOfAssets",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:GoodwillDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "unique": true
     }
    },
    "R63": {
     "role": "http://nexttrip.com/role/AccountsPayableAndAccruedLiabilitiesDetailsNarrative",
     "longName": "999067 - Disclosure - Accounts Payable and Accrued Liabilities (Details Narrative)",
     "shortName": "Accounts Payable and Accrued Liabilities (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "63",
     "firstAnchor": {
      "contextRef": "AsOf2025-02-28",
      "name": "us-gaap:AccountsPayableCurrentAndNoncurrent",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-02-28",
      "name": "us-gaap:AccountsPayableCurrentAndNoncurrent",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R64": {
     "role": "http://nexttrip.com/role/ScheduleOfDeferredTaxAssetsDetails",
     "longName": "999068 - Disclosure - Schedule of Deferred Tax Assets (Details)",
     "shortName": "Schedule of Deferred Tax Assets (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "64",
     "firstAnchor": {
      "contextRef": "AsOf2025-02-28",
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-02-28",
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R65": {
     "role": "http://nexttrip.com/role/ScheduleOfReconciliationOfProvisionForIncomeTaxesDetails",
     "longName": "999069 - Disclosure - Schedule of Reconciliation of Provision for Income Taxes (Details)",
     "shortName": "Schedule of Reconciliation of Provision for Income Taxes (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "65",
     "firstAnchor": {
      "contextRef": "From2024-03-01to2025-02-28",
      "name": "NTRP:EffectiveIncomeTaxRateReconciliationBookLoss",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-03-01to2025-02-28",
      "name": "NTRP:EffectiveIncomeTaxRateReconciliationBookLoss",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R66": {
     "role": "http://nexttrip.com/role/IncomeTaxesDetailsNarrative",
     "longName": "999070 - Disclosure - Income Taxes (Details Narrative)",
     "shortName": "Income Taxes (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "66",
     "firstAnchor": {
      "contextRef": "AsOf2025-02-28",
      "name": "us-gaap:OperatingLossCarryforwards",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-02-28",
      "name": "us-gaap:OperatingLossCarryforwards",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R67": {
     "role": "http://nexttrip.com/role/NotesPayableDetailsNarrative",
     "longName": "999071 - Disclosure - Notes Payable (Details Narrative)",
     "shortName": "Notes Payable (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "67",
     "firstAnchor": {
      "contextRef": "From2025-02-282025-02-28",
      "name": "us-gaap:ProceedsFromConvertibleDebt",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:DebtDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-12-312024-12-31",
      "name": "us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:DebtDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "unique": true
     }
    },
    "R68": {
     "role": "http://nexttrip.com/role/ConvertibleNotesDetailsNarrative",
     "longName": "999072 - Disclosure - Convertible Notes (Details Narrative)",
     "shortName": "Convertible Notes (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "68",
     "firstAnchor": {
      "contextRef": "From2025-02-282025-02-28",
      "name": "us-gaap:ProceedsFromConvertibleDebt",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:DebtDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-03-01to2025-02-28",
      "name": "us-gaap:InterestExpenseDebt",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "NTRP:ConvertibleDebtDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "unique": true
     }
    },
    "R69": {
     "role": "http://nexttrip.com/role/SharePurchaseAgreementsDetailsNarrative",
     "longName": "999073 - Disclosure - Share Purchase Agreements (Details Narrative)",
     "shortName": "Share Purchase Agreements (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "69",
     "firstAnchor": {
      "contextRef": "From2025-02-282025-02-28",
      "name": "us-gaap:ProceedsFromConvertibleDebt",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:DebtDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-12-292023-12-29_us-gaap_CommonStockMember_custom_ThirdPartyConsultantMember",
      "name": "us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "p",
       "NTRP:SharePurchaseAgreementsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "unique": true
     }
    },
    "R70": {
     "role": "http://nexttrip.com/role/RelatedPartyTransactionsDetailsNarrative",
     "longName": "999074 - Disclosure - Related Party Transactions (Details Narrative)",
     "shortName": "Related Party Transactions (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "70",
     "firstAnchor": {
      "contextRef": "From2024-03-01to2025-02-28",
      "name": "NTRP:LossOnRelatedPartyReceivable",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-02-28_custom_NextPlayTechnologiesIncMember",
      "name": "us-gaap:ReceivablesNetCurrent",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "unique": true
     }
    },
    "R71": {
     "role": "http://nexttrip.com/role/DeferredRevenueDetailsNarrative",
     "longName": "999075 - Disclosure - Deferred Revenue (Details Narrative)",
     "shortName": "Deferred Revenue (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "71",
     "firstAnchor": {
      "contextRef": "AsOf2025-02-28",
      "name": "us-gaap:DeferredRevenueCurrent",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R72": {
     "role": "http://nexttrip.com/role/ScheduleOfStockOptionActivityDetails",
     "longName": "999076 - Disclosure - Schedule of Stock Option Activity (Details)",
     "shortName": "Schedule of Stock Option Activity (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "72",
     "firstAnchor": {
      "contextRef": "AsOf2024-02-29",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-03-01to2025-02-28",
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "unique": true
     }
    },
    "R73": {
     "role": "http://nexttrip.com/role/ScheduleOfShareBasedPaymentsAwardStockOptionsValuationAssumptionsDetails",
     "longName": "999077 - Disclosure - Schedule of Share Based Payments Award Stock Options Valuation Assumptions (Details)",
     "shortName": "Schedule of Share Based Payments Award Stock Options Valuation Assumptions (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "73",
     "firstAnchor": {
      "contextRef": "From2024-03-01to2025-02-28",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-03-01to2025-02-28",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R74": {
     "role": "http://nexttrip.com/role/ScheduleOfWarrantyActivityDetails",
     "longName": "999078 - Disclosure - Schedule of Warranty Activity (Details)",
     "shortName": "Schedule of Warranty Activity (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "74",
     "firstAnchor": {
      "contextRef": "AsOf2024-02-29",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-03-01to2025-02-28",
      "name": "NTRP:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonOutstandingWeightedAverageRemainingContractualTerm",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "unique": true
     }
    },
    "R75": {
     "role": "http://nexttrip.com/role/StockholdersEquityDetailsNarrative",
     "longName": "999079 - Disclosure - Stockholders\u2019 Equity (Details Narrative)",
     "shortName": "Stockholders\u2019 Equity (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "75",
     "firstAnchor": {
      "contextRef": "AsOf2024-02-29",
      "name": "us-gaap:CommonStockSharesAuthorized",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-09-212023-09-22",
      "name": "us-gaap:StockholdersEquityReverseStockSplit",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "unique": true
     }
    },
    "R76": {
     "role": "http://nexttrip.com/role/ScheduleOfEarningsPerShareBasicAndDilutedDetails",
     "longName": "999080 - Disclosure - Schedule of Earnings Per Share, Basic and Diluted (Details)",
     "shortName": "Schedule of Earnings Per Share, Basic and Diluted (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "76",
     "firstAnchor": {
      "contextRef": "From2024-03-01to2025-02-28",
      "name": "us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-03-01to2025-02-28",
      "name": "us-gaap:IncomeLossFromContinuingOperations",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "us-gaap:EarningsPerShareTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "unique": true
     }
    },
    "R77": {
     "role": "http://nexttrip.com/role/ScheduleOfBusinessMilestonesAndIssuableContingentSharesDetails",
     "longName": "999081 - Disclosure - Schedule of Business Milestones and Issuable Contingent Shares (Details)",
     "shortName": "Schedule of Business Milestones and Issuable Contingent Shares (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "77",
     "firstAnchor": {
      "contextRef": "From2024-06-102024-06-10",
      "name": "us-gaap:IncrementalCommonSharesAttributableToContingentlyIssuableShares",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock",
       "us-gaap:EarningsPerShareTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-06-102024-06-10_custom_AchievedMember_custom_LeisureTravelBookingPlatformMember",
      "name": "us-gaap:IncrementalCommonSharesAttributableToContingentlyIssuableShares",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock",
       "us-gaap:EarningsPerShareTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "unique": true
     }
    },
    "R78": {
     "role": "http://nexttrip.com/role/ScheduleOfWeightedAverageCommonSharesDetailsParenthetical",
     "longName": "999082 - Disclosure - Schedule of Weighted Average Common Shares (Details) (Parenthetical)",
     "shortName": "Schedule of Weighted Average Common Shares (Details) (Parenthetical)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "parenthetical",
     "menuCat": "Details",
     "order": "78",
     "firstAnchor": {
      "contextRef": "AsOf2025-02-28",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "us-gaap:CommonStockSharesIssued",
       "span",
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R79": {
     "role": "http://nexttrip.com/role/ScheduleOfWeightedAverageCommonSharesDetails",
     "longName": "999083 - Disclosure - Schedule of Weighted Average Common Shares (Details)",
     "shortName": "Schedule of Weighted Average Common Shares (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "79",
     "firstAnchor": {
      "contextRef": "From2024-03-01to2025-02-28",
      "name": "us-gaap:WeightedAverageNumberOfSharesOutstandingBasic",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-03-012025-02-28_us-gaap_CommonStockMember11856671",
      "name": "us-gaap:WeightedAverageNumberOfSharesOutstandingBasic",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock",
       "us-gaap:EarningsPerShareTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "unique": true
     }
    },
    "R80": {
     "role": "http://nexttrip.com/role/LossPerShareDetailsNarrative",
     "longName": "999084 - Disclosure - Loss Per Share (Details Narrative)",
     "shortName": "Loss Per Share (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "80",
     "firstAnchor": {
      "contextRef": "From2024-06-102024-06-10",
      "name": "us-gaap:IncrementalCommonSharesAttributableToContingentlyIssuableShares",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock",
       "us-gaap:EarningsPerShareTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-03-012025-02-28_us-gaap_SeriesEPreferredStockMember",
      "name": "us-gaap:ConversionOfStockSharesConverted1",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:EarningsPerShareTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "unique": true
     }
    },
    "R81": {
     "role": "http://nexttrip.com/role/ConcentrationsDetailsNarrative",
     "longName": "999085 - Disclosure - Concentrations (Details Narrative)",
     "shortName": "Concentrations (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "81",
     "firstAnchor": {
      "contextRef": "From2024-03-012025-02-28_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerMember",
      "name": "us-gaap:ConcentrationRiskPercentage1",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "us-gaap:ConcentrationRiskPercentage1",
       "span",
       "span",
       "span",
       "p",
       "us-gaap:ConcentrationRiskDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-03-012025-02-28_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerMember",
      "name": "us-gaap:ConcentrationRiskPercentage1",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "us-gaap:ConcentrationRiskPercentage1",
       "span",
       "span",
       "span",
       "p",
       "us-gaap:ConcentrationRiskDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R82": {
     "role": "http://nexttrip.com/role/DefinedContributionPlansDetailsNarrative",
     "longName": "999086 - Disclosure - Defined Contribution Plans (Details Narrative)",
     "shortName": "Defined Contribution Plans (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "82",
     "firstAnchor": {
      "contextRef": "From2024-03-01to2025-02-28",
      "name": "us-gaap:DescriptionOfDefinedContributionPensionAndOtherPostretirementPlans",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-03-01to2025-02-28",
      "name": "us-gaap:DescriptionOfDefinedContributionPensionAndOtherPostretirementPlans",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true,
      "unique": true
     }
    },
    "R83": {
     "role": "http://nexttrip.com/role/SubsequentEventsDetailsNarrative",
     "longName": "999087 - Disclosure - Subsequent Events (Details Narrative)",
     "shortName": "Subsequent Events (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "83",
     "firstAnchor": {
      "contextRef": "From2024-06-102024-06-10",
      "name": "us-gaap:IncrementalCommonSharesAttributableToContingentlyIssuableShares",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock",
       "us-gaap:EarningsPerShareTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-04-09_us-gaap_SubsequentEventMember",
      "name": "us-gaap:LineOfCredit",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "span",
       "p",
       "us-gaap:SubsequentEventsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form10-k.htm",
      "unique": true
     }
    }
   },
   "tag": {
    "us-gaap_AccountingPoliciesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountingPoliciesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
     "presentation": [
      "http://nexttrip.com/role/AccountsPayableAndAccruedLiabilities"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts Payable and Accrued Liabilities",
        "documentation": "The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period."
       }
      }
     },
     "auth_ref": [
      "r98",
      "r101",
      "r106",
      "r962"
     ]
    },
    "us-gaap_AccountsPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsPayableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://nexttrip.com/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts payable",
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r98",
      "r731"
     ]
    },
    "us-gaap_AccountsPayableCurrentAndNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsPayableCurrentAndNoncurrent",
     "crdr": "credit",
     "presentation": [
      "http://nexttrip.com/role/AccountsPayableAndAccruedLiabilitiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Accounts payable",
        "label": "Accounts Payable",
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business."
       }
      }
     },
     "auth_ref": [
      "r166",
      "r992"
     ]
    },
    "us-gaap_AccountsReceivableMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsReceivableMember",
     "presentation": [
      "http://nexttrip.com/role/ConcentrationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts Receivable [Member]",
        "documentation": "Due from customers or clients for goods or services that have been delivered or sold."
       }
      }
     },
     "auth_ref": [
      "r694"
     ]
    },
    "us-gaap_AccountsReceivableNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsReceivableNet",
     "crdr": "debit",
     "presentation": [
      "http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts receivable",
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business."
       }
      }
     },
     "auth_ref": [
      "r634",
      "r693",
      "r738",
      "r996",
      "r997"
     ]
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsReceivableNetCurrent",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/BalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts receivable, net",
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current."
       }
      }
     },
     "auth_ref": [
      "r897"
     ]
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccruedLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://nexttrip.com/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued expenses",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r101"
     ]
    },
    "us-gaap_AccruedLiabilitiesCurrentAndNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccruedLiabilitiesCurrentAndNoncurrent",
     "crdr": "credit",
     "presentation": [
      "http://nexttrip.com/role/AccountsPayableAndAccruedLiabilitiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Accrued expenses",
        "label": "Accrued Liabilities",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities."
       }
      }
     },
     "auth_ref": [
      "r166"
     ]
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "crdr": "credit",
     "calculation": {
      "http://nexttrip.com/role/ScheduleOfPropertyAndEquipmentDetails": {
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfPropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Accumulated depreciation",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services."
       }
      }
     },
     "auth_ref": [
      "r45",
      "r201",
      "r573"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems",
     "presentation": [
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r214",
      "r215",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccumulatedOtherComprehensiveIncomeLossTable",
     "presentation": [
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accumulated Other Comprehensive Income (Loss) [Table]",
        "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss)."
       }
      }
     },
     "auth_ref": [
      "r214",
      "r215",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530"
     ]
    },
    "NTRP_AchievedMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "AchievedMember",
     "presentation": [
      "http://nexttrip.com/role/LossPerShareDetailsNarrative",
      "http://nexttrip.com/role/ScheduleOfBusinessMilestonesAndIssuableContingentSharesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Achieved [Member]",
        "documentation": "Achieved [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_Additional402vDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Additional402vDisclosureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional 402(v) Disclosure"
       }
      }
     },
     "auth_ref": [
      "r806"
     ]
    },
    "us-gaap_AdditionalPaidInCapital": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdditionalPaidInCapital",
     "crdr": "credit",
     "calculation": {
      "http://nexttrip.com/role/BalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Paid in Capital ()",
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock."
       }
      }
     },
     "auth_ref": [
      "r111",
      "r731",
      "r1028"
     ]
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdditionalPaidInCapitalMember",
     "presentation": [
      "http://nexttrip.com/role/StatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Paid-in Capital [Member]",
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders."
       }
      }
     },
     "auth_ref": [
      "r604",
      "r884",
      "r885",
      "r886",
      "r888",
      "r972",
      "r1031"
     ]
    },
    "ecd_AdjToCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation, Amount"
       }
      }
     },
     "auth_ref": [
      "r812"
     ]
    },
    "ecd_AdjToCompAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToCompAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation [Axis]"
       }
      }
     },
     "auth_ref": [
      "r812"
     ]
    },
    "ecd_AdjToNonPeoNeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToNonPeoNeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Non-PEO NEO Compensation Footnote"
       }
      }
     },
     "auth_ref": [
      "r812"
     ]
    },
    "ecd_AdjToPeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToPeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment To PEO Compensation, Footnote"
       }
      }
     },
     "auth_ref": [
      "r812"
     ]
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "crdr": "credit",
     "presentation": [
      "http://nexttrip.com/role/StatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Compensation",
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r58",
      "r59",
      "r427"
     ]
    },
    "NTRP_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCost",
     "crdr": "debit",
     "presentation": [
      "http://nexttrip.com/role/NotesPayableDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Warrants additional paid in capital",
        "label": "AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCost"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts",
     "crdr": "debit",
     "presentation": [
      "http://nexttrip.com/role/NotesPayableDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants additional paid in capital",
        "documentation": "Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing stock. Includes, but is not limited to, legal and accounting fees and direct costs associated with stock issues under a shelf registration."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r146"
     ]
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://nexttrip.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to reconcile net loss to net cash used in operating activities:"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r773",
      "r784",
      "r798",
      "r824"
     ]
    },
    "ecd_AggtErrCompNotYetDeterminedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtErrCompNotYetDeterminedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Not Yet Determined"
       }
      }
     },
     "auth_ref": [
      "r776",
      "r787",
      "r801",
      "r827"
     ]
    },
    "ecd_AllAdjToCompMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllAdjToCompMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "auth_ref": [
      "r812"
     ]
    },
    "ecd_AllExecutiveCategoriesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllExecutiveCategoriesMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "auth_ref": [
      "r819"
     ]
    },
    "ecd_AllIndividualsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllIndividualsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "auth_ref": [
      "r777",
      "r788",
      "r802",
      "r819",
      "r828",
      "r832",
      "r840"
     ]
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AllocatedShareBasedCompensationExpense",
     "crdr": "debit",
     "presentation": [
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share based compensation expense",
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized."
       }
      }
     },
     "auth_ref": [
      "r458",
      "r464"
     ]
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AllowanceForDoubtfulAccountsReceivable",
     "crdr": "credit",
     "presentation": [
      "http://nexttrip.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Allowance for doubtful accounts",
        "documentation": "Amount of allowance for credit loss on accounts receivable."
       }
      }
     },
     "auth_ref": [
      "r209",
      "r292",
      "r306",
      "r307",
      "r308",
      "r997"
     ]
    },
    "NTRP_AlumniCapitalLPMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "AlumniCapitalLPMember",
     "presentation": [
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Alumni Capital LP [Member]",
        "documentation": "Alumni Capital LP [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://nexttrip.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://nexttrip.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AmortizationOfDebtDiscountPremium": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AmortizationOfDebtDiscountPremium",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amortization of Debt Discount",
        "documentation": "Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r126",
      "r385",
      "r978"
     ]
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AmortizationOfIntangibleAssets",
     "crdr": "debit",
     "presentation": [
      "http://nexttrip.com/role/IntangibleAssetsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amortization",
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r316",
      "r323",
      "r713"
     ]
    },
    "NTRP_AmortizationOfPrepaidExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "AmortizationOfPrepaidExpenses",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amortization of prepaid expenses",
        "documentation": "Amortization of prepaid expenses."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://nexttrip.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r780"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfAnti-dilutiveSecuritiesExcludedFromComputationOfEarningsPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Underlying Common Shares",
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented."
       }
      }
     },
     "auth_ref": [
      "r269"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfAnti-dilutiveSecuritiesExcludedFromComputationOfEarningsPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Antidilutive Securities [Axis]",
        "documentation": "Information by type of antidilutive security."
       }
      }
     },
     "auth_ref": [
      "r34"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfAnti-dilutiveSecuritiesExcludedFromComputationOfEarningsPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AntidilutiveSecuritiesNameDomain",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfAnti-dilutiveSecuritiesExcludedFromComputationOfEarningsPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented."
       }
      }
     },
     "auth_ref": [
      "r34"
     ]
    },
    "us-gaap_ArrangementsAndNonarrangementTransactionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ArrangementsAndNonarrangementTransactionsMember",
     "presentation": [
      "http://nexttrip.com/role/BusinessDescriptionAndGoingConcernDetailsNarrative",
      "http://nexttrip.com/role/ConvertibleNotesDetailsNarrative",
      "http://nexttrip.com/role/DiscontinuedOperationsDetailsNarrative",
      "http://nexttrip.com/role/InvestmentInEquityMethodInvesteeDetailsNarrative",
      "http://nexttrip.com/role/InvestmentInEquitySecuritiesDetailsNarrative",
      "http://nexttrip.com/role/LossPerShareDetailsNarrative",
      "http://nexttrip.com/role/NotesPayableDetailsNarrative",
      "http://nexttrip.com/role/SharePurchaseAgreementsDetailsNarrative",
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative",
      "http://nexttrip.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations."
       }
      }
     },
     "auth_ref": [
      "r505"
     ]
    },
    "NTRP_AssetPurchaseAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "AssetPurchaseAgreementMember",
     "presentation": [
      "http://nexttrip.com/role/DiscontinuedOperationsDetailsNarrative",
      "http://nexttrip.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Asset Purchase Agreement [Member]",
        "documentation": "Asset Purchase Agreement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_Assets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Assets",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/BalanceSheets": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://nexttrip.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Assets",
        "label": "Assets",
        "documentation": "Amount of asset recognized for present right to economic benefit."
       }
      }
     },
     "auth_ref": [
      "r164",
      "r178",
      "r204",
      "r229",
      "r274",
      "r278",
      "r286",
      "r287",
      "r302",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r506",
      "r508",
      "r523",
      "r564",
      "r639",
      "r708",
      "r709",
      "r731",
      "r745",
      "r929",
      "r930",
      "r982"
     ]
    },
    "us-gaap_AssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsAbstract",
     "presentation": [
      "http://nexttrip.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ASSETS"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/BalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/BalanceSheets",
      "http://nexttrip.com/role/ScheduleOfUnauditedSummarizedFinancialInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Current Assets",
        "label": "Current assets",
        "documentation": "Amount of asset recognized for present right to economic benefit, classified as current."
       }
      }
     },
     "auth_ref": [
      "r197",
      "r210",
      "r229",
      "r302",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r506",
      "r508",
      "r523",
      "r731",
      "r929",
      "r930",
      "r982"
     ]
    },
    "us-gaap_AssetsNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/BalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/BalanceSheets",
      "http://nexttrip.com/role/ScheduleOfUnauditedSummarizedFinancialInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Non-Current Assets",
        "label": "Non-current assets",
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r229",
      "r302",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r506",
      "r508",
      "r523",
      "r929",
      "r930",
      "r982"
     ]
    },
    "us-gaap_AssetsNoncurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsNoncurrentAbstract",
     "presentation": [
      "http://nexttrip.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Current assets"
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_AtTheMarketIssuanceSalesAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "AtTheMarketIssuanceSalesAgreementMember",
     "presentation": [
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "At-The-Market Issuance Sales Agreement [Member]",
        "documentation": "At-The-Market Issuance Sales Agreement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://nexttrip.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r780"
     ]
    },
    "dei_AuditorFirmId": {
     "xbrltype": "nonemptySequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorFirmId",
     "presentation": [
      "http://nexttrip.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Firm ID",
        "documentation": "PCAOB issued Audit Firm Identifier"
       }
      }
     },
     "auth_ref": [
      "r757",
      "r759",
      "r780"
     ]
    },
    "dei_AuditorLocation": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorLocation",
     "presentation": [
      "http://nexttrip.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Location"
       }
      }
     },
     "auth_ref": [
      "r757",
      "r759",
      "r780"
     ]
    },
    "dei_AuditorName": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorName",
     "presentation": [
      "http://nexttrip.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Name"
       }
      }
     },
     "auth_ref": [
      "r757",
      "r759",
      "r780"
     ]
    },
    "ecd_AwardExrcPrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardExrcPrice",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise Price"
       }
      }
     },
     "auth_ref": [
      "r835"
     ]
    },
    "ecd_AwardGrantDateFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardGrantDateFairValue",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value as of Grant Date"
       }
      }
     },
     "auth_ref": [
      "r836"
     ]
    },
    "ecd_AwardTmgDiscLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgDiscLineItems",
     "auth_ref": [
      "r831"
     ]
    },
    "ecd_AwardTmgHowMnpiCnsdrdTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgHowMnpiCnsdrdTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing, How MNPI Considered"
       }
      }
     },
     "auth_ref": [
      "r831"
     ]
    },
    "ecd_AwardTmgMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Method"
       }
      }
     },
     "auth_ref": [
      "r831"
     ]
    },
    "ecd_AwardTmgMnpiCnsdrdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMnpiCnsdrdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing MNPI Considered"
       }
      }
     },
     "auth_ref": [
      "r831"
     ]
    },
    "ecd_AwardTmgMnpiDiscTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMnpiDiscTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing MNPI Disclosure"
       }
      }
     },
     "auth_ref": [
      "r831"
     ]
    },
    "ecd_AwardTmgPredtrmndFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgPredtrmndFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Predetermined"
       }
      }
     },
     "auth_ref": [
      "r831"
     ]
    },
    "us-gaap_AwardTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AwardTypeAxis",
     "presentation": [
      "http://nexttrip.com/role/InvestmentInEquitySecuritiesDetailsNarrative",
      "http://nexttrip.com/role/LossPerShareDetailsNarrative",
      "http://nexttrip.com/role/ScheduleOfStockOptionActivityDetails",
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative",
      "http://nexttrip.com/role/StockholdersEquityTables",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Type [Axis]",
        "documentation": "Information by type of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r429",
      "r430",
      "r431",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457"
     ]
    },
    "ecd_AwardUndrlygSecuritiesAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardUndrlygSecuritiesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Underlying Securities"
       }
      }
     },
     "auth_ref": [
      "r834"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Name",
        "label": "Awards Close in Time to MNPI Disclosures, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r833"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures [Table]"
       }
      }
     },
     "auth_ref": [
      "r832"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures, Table"
       }
      }
     },
     "auth_ref": [
      "r832"
     ]
    },
    "NTRP_BasisDifferencePolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "BasisDifferencePolicyTextBlock",
     "presentation": [
      "http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Basis Difference",
        "documentation": "Basis Difference [Policy Text Block]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "presentation": [
      "http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Basis of Presentation and Principles of Consolidation",
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)."
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_BlueFyshHoldingsIncMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "BlueFyshHoldingsIncMember",
     "presentation": [
      "http://nexttrip.com/role/InvestmentInEquitySecuritiesDetailsNarrative",
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Blue Fysh Holdings Inc [Member]",
        "documentation": "Blue Fysh Holdings Inc [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessAcquisitionAcquireeDomain",
     "presentation": [
      "http://nexttrip.com/role/BalanceSheetsParenthetical",
      "http://nexttrip.com/role/BusinessDescriptionAndGoingConcernDetailsNarrative",
      "http://nexttrip.com/role/GoodwillDetailsNarrative",
      "http://nexttrip.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://nexttrip.com/role/ScheduleOfFairValueOfAssetsAcquiredDetails",
      "http://nexttrip.com/role/StatementsOfOperationsParenthetical",
      "http://nexttrip.com/role/StatementsOfStockholdersEquityParenthetical",
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative",
      "http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree."
       }
      }
     },
     "auth_ref": [
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r500",
      "r721",
      "r722"
     ]
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessAcquisitionAxis",
     "presentation": [
      "http://nexttrip.com/role/BalanceSheetsParenthetical",
      "http://nexttrip.com/role/BusinessDescriptionAndGoingConcernDetailsNarrative",
      "http://nexttrip.com/role/GoodwillDetailsNarrative",
      "http://nexttrip.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://nexttrip.com/role/ScheduleOfFairValueOfAssetsAcquiredDetails",
      "http://nexttrip.com/role/StatementsOfOperationsParenthetical",
      "http://nexttrip.com/role/StatementsOfStockholdersEquityParenthetical",
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative",
      "http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Acquisition [Axis]",
        "documentation": "Information by business combination or series of individually immaterial business combinations."
       }
      }
     },
     "auth_ref": [
      "r60",
      "r63",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r500",
      "r721",
      "r722"
     ]
    },
    "us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued",
     "presentation": [
      "http://nexttrip.com/role/BusinessDescriptionAndGoingConcernDetailsNarrative",
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restricted shares issuable in reverse acquisition",
        "verboseLabel": "Shares issuable for consideration",
        "documentation": "Number of shares of equity interests issued or issuable to acquire entity."
       }
      }
     },
     "auth_ref": [
      "r160"
     ]
    },
    "NTRP_BusinessAcquisitionMilestonePayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "BusinessAcquisitionMilestonePayments",
     "crdr": "debit",
     "presentation": [
      "http://nexttrip.com/role/InvestmentInEquityMethodInvesteeDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Milestone payments",
        "documentation": "Business acquisition milestone payments."
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_BusinessAcquisitionPerMilestonePayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "BusinessAcquisitionPerMilestonePayments",
     "crdr": "debit",
     "presentation": [
      "http://nexttrip.com/role/InvestmentInEquityMethodInvesteeDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Per milestone payments",
        "documentation": "Business acquisition per milestone payments."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessAcquisitionPercentageOfVotingInterestsAcquired",
     "presentation": [
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity interest acquired",
        "documentation": "Percentage of voting equity interests acquired at the acquisition date in the business combination."
       }
      }
     },
     "auth_ref": [
      "r61"
     ]
    },
    "us-gaap_BusinessAcquisitionPreacquisitionContingencyAmountOfSettlement": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessAcquisitionPreacquisitionContingencyAmountOfSettlement",
     "crdr": "credit",
     "presentation": [
      "http://nexttrip.com/role/InvestmentInEquityMethodInvesteeDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business acquisition amount",
        "documentation": "Amount paid or received to resolve the preacquisition contingency."
       }
      }
     },
     "auth_ref": [
      "r66",
      "r904"
     ]
    },
    "us-gaap_BusinessAcquisitionSharePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessAcquisitionSharePrice",
     "presentation": [
      "http://nexttrip.com/role/GoodwillDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share price",
        "documentation": "Price of a single share of a number of saleable stocks paid or offered to be paid in a business combination."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessCombinationConsiderationTransferred1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationConsiderationTransferred1",
     "crdr": "credit",
     "presentation": [
      "http://nexttrip.com/role/GoodwillDetailsNarrative",
      "http://nexttrip.com/role/ScheduleOfFairValueOfAssetsAcquiredDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination, Consideration Transferred",
        "verboseLabel": "Purchase consideration",
        "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r1",
      "r13"
     ]
    },
    "us-gaap_BusinessCombinationContingentConsiderationAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationContingentConsiderationAsset",
     "crdr": "debit",
     "presentation": [
      "http://nexttrip.com/role/InvestmentInEquityMethodInvesteeDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business acquisition consideration cash",
        "documentation": "Amount of asset recognized arising from contingent consideration in a business combination."
       }
      }
     },
     "auth_ref": [
      "r68",
      "r159",
      "r502"
     ]
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/ScheduleOfFairValueOfAssetsAcquiredDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfFairValueOfAssetsAcquiredDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash",
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/ScheduleOfFairValueOfAssetsAcquiredDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfFairValueOfAssetsAcquiredDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Prepaid expenses and other current assets",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets",
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date."
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/ScheduleOfFairValueOfAssetsAcquiredDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfFairValueOfAssetsAcquiredDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts Receivable, net",
        "documentation": "Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date."
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable",
     "crdr": "credit",
     "calculation": {
      "http://nexttrip.com/role/ScheduleOfFairValueOfAssetsAcquiredDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": -1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfFairValueOfAssetsAcquiredDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Accounts payable",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable",
        "documentation": "Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date."
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "NTRP_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses",
     "crdr": "credit",
     "calculation": {
      "http://nexttrip.com/role/ScheduleOfFairValueOfAssetsAcquiredDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": -1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfFairValueOfAssetsAcquiredDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Accrued expenses",
        "documentation": "Business combination recognized identifiable assets acquired and liabilities assumed current liabilities accrued expenses.",
        "label": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue",
     "crdr": "credit",
     "calculation": {
      "http://nexttrip.com/role/ScheduleOfFairValueOfAssetsAcquiredDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": -1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfFairValueOfAssetsAcquiredDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Deferred revenue",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Deferred Revenue",
        "documentation": "Amount of deferred revenue expected to be recognized as such within one year or the normal operating cycle, if longer, assumed at the acquisition date."
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/ScheduleOfFairValueOfAssetsAcquiredDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfFairValueOfAssetsAcquiredDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Intangible assets",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill",
        "documentation": "Amount of intangible assets, excluding goodwill, acquired at the acquisition date."
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/ScheduleOfFairValueOfAssetsAcquiredDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfFairValueOfAssetsAcquiredDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory",
        "documentation": "The amount of inventory recognized as of the acquisition date."
       }
      }
     },
     "auth_ref": [
      "r64",
      "r65"
     ]
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/ScheduleOfFairValueOfAssetsAcquiredDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfFairValueOfAssetsAcquiredDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total identifiable net assets acquired",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net",
        "documentation": "Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed."
       }
      }
     },
     "auth_ref": [
      "r64",
      "r65"
     ]
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/ScheduleOfFairValueOfAssetsAcquiredDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfFairValueOfAssetsAcquiredDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Property and equipment",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment",
        "documentation": "The amount of property, plant, and equipment recognized as of the acquisition date."
       }
      }
     },
     "auth_ref": [
      "r64",
      "r65"
     ]
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/ScheduleOfFairValueOfAssetsAcquiredDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfFairValueOfAssetsAcquiredDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Fair Value of Net Assets Acquired",
        "label": "Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net",
        "documentation": "Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed."
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCosts",
     "crdr": "debit",
     "presentation": [
      "http://nexttrip.com/role/InvestmentInEquityMethodInvesteeDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business acquisition additional amount",
        "documentation": "For transactions that are recognized separately from the acquisition of assets and assumptions of liabilities in the business combination, such as related to pre-existing relationships with the acquiree, this element represents the disclosure of the amount of acquisition related costs."
       }
      }
     },
     "auth_ref": [
      "r62"
     ]
    },
    "us-gaap_Capital": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Capital",
     "crdr": "credit",
     "presentation": [
      "http://nexttrip.com/role/BusinessDescriptionAndGoingConcernDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contributed capital",
        "documentation": "Amount of total capital as defined by regulatory framework."
       }
      }
     },
     "auth_ref": [
      "r563"
     ]
    },
    "NTRP_CashAdvance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "CashAdvance",
     "crdr": "debit",
     "presentation": [
      "http://nexttrip.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash advance",
        "documentation": "Cash advance."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/BalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and cash equivalents",
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r26",
      "r199",
      "r702"
     ]
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "presentation": [
      "http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and Cash Equivalents",
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value."
       }
      }
     },
     "auth_ref": [
      "r27"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations",
     "crdr": "debit",
     "presentation": [
      "http://nexttrip.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Cash - beginning of the period",
        "periodEndLabel": "Cash - end of the period",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations",
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r26",
      "r130",
      "r225"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/StatementsOfCashFlows": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://nexttrip.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Increase in cash",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r2",
      "r130"
     ]
    },
    "us-gaap_CashEquivalentsAtCarryingValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashEquivalentsAtCarryingValue",
     "crdr": "debit",
     "presentation": [
      "http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash equivalents",
        "documentation": "Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r867",
      "r995"
     ]
    },
    "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract",
     "presentation": [
      "http://nexttrip.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Cash Financing Transactions"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net cash provided (used) in operating activities from discontinued operations",
        "documentation": "Amount of cash inflow (outflow) of operating activities of discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities."
       }
      }
     },
     "auth_ref": [
      "r92",
      "r130"
     ]
    },
    "ecd_ChangedPeerGroupFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ChangedPeerGroupFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changed Peer Group, Footnote"
       }
      }
     },
     "auth_ref": [
      "r810"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://nexttrip.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfStockDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfStockDomain",
     "presentation": [
      "http://nexttrip.com/role/BusinessDescriptionAndGoingConcernDetailsNarrative",
      "http://nexttrip.com/role/GoodwillDetailsNarrative",
      "http://nexttrip.com/role/InvestmentInEquityMethodInvesteeDetailsNarrative",
      "http://nexttrip.com/role/InvestmentInEquitySecuritiesDetailsNarrative",
      "http://nexttrip.com/role/LossPerShareDetailsNarrative",
      "http://nexttrip.com/role/NotesPayableDetailsNarrative",
      "http://nexttrip.com/role/ScheduleOfWeightedAverageCommonSharesDetails",
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative",
      "http://nexttrip.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock."
       }
      }
     },
     "auth_ref": [
      "r193",
      "r206",
      "r207",
      "r208",
      "r229",
      "r253",
      "r256",
      "r266",
      "r268",
      "r276",
      "r277",
      "r302",
      "r354",
      "r356",
      "r357",
      "r358",
      "r361",
      "r362",
      "r394",
      "r395",
      "r398",
      "r401",
      "r407",
      "r523",
      "r595",
      "r596",
      "r597",
      "r598",
      "r604",
      "r605",
      "r606",
      "r607",
      "r608",
      "r609",
      "r610",
      "r611",
      "r612",
      "r613",
      "r614",
      "r615",
      "r626",
      "r648",
      "r670",
      "r687",
      "r688",
      "r689",
      "r690",
      "r691",
      "r857",
      "r879",
      "r889"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
     "presentation": [
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants exercise price",
        "documentation": "Exercise price per share or per unit of warrants or rights outstanding."
       }
      }
     },
     "auth_ref": [
      "r408"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight",
     "presentation": [
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Purchase of outstanding warrants",
        "documentation": "Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights",
     "presentation": [
      "http://nexttrip.com/role/LossPerShareDetailsNarrative",
      "http://nexttrip.com/role/NotesPayableDetailsNarrative",
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative",
      "http://nexttrip.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Warrant or Right, Number of Securities Called by Warrants or Rights",
        "verboseLabel": "Warrants to purchase common stock",
        "terseLabel": "Warrants outstanding to purchase common stock",
        "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares."
       }
      }
     },
     "auth_ref": [
      "r408"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightReasonForIssuingToNonemployees": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfWarrantOrRightReasonForIssuingToNonemployees",
     "presentation": [
      "http://nexttrip.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Warrant description",
        "label": "Warrant or Right, Reason for Issuance, Description",
        "documentation": "Description of reason for issuing warrant or right."
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_ClosingSharesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "ClosingSharesMember",
     "presentation": [
      "http://nexttrip.com/role/BusinessDescriptionAndGoingConcernDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Closing Shares [Member]",
        "documentation": "Closing Shares [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_CoSelectedMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CoSelectedMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Amount"
       }
      }
     },
     "auth_ref": [
      "r811"
     ]
    },
    "ecd_CoSelectedMeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CoSelectedMeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Name"
       }
      }
     },
     "auth_ref": [
      "r811"
     ]
    },
    "us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems",
     "presentation": [
      "http://nexttrip.com/role/BusinessDescriptionAndGoingConcernDetailsNarrative",
      "http://nexttrip.com/role/DiscontinuedOperationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r505"
     ]
    },
    "us-gaap_CommitmentsAndContingencies": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommitmentsAndContingencies",
     "crdr": "credit",
     "calculation": {
      "http://nexttrip.com/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies",
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur."
       }
      }
     },
     "auth_ref": [
      "r107",
      "r168",
      "r566",
      "r625"
     ]
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "presentation": [
      "http://nexttrip.com/role/CommitmentsAndContingencies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Commitments and Contingencies",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "documentation": "The entire disclosure for commitments and contingencies."
       }
      }
     },
     "auth_ref": [
      "r140",
      "r346",
      "r347",
      "r695",
      "r923",
      "r928"
     ]
    },
    "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockCapitalSharesReservedForFutureIssuance",
     "presentation": [
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock reserved for issuance",
        "documentation": "Aggregate number of common shares reserved for future issuance."
       }
      }
     },
     "auth_ref": [
      "r110"
     ]
    },
    "NTRP_CommonStockIssuedPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "CommonStockIssuedPercentage",
     "presentation": [
      "http://nexttrip.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issued percentage",
        "documentation": "Common stock issued percentage."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockMember",
     "presentation": [
      "http://nexttrip.com/role/ConvertibleNotesDetailsNarrative",
      "http://nexttrip.com/role/LossPerShareDetailsNarrative",
      "http://nexttrip.com/role/ScheduleOfWeightedAverageCommonSharesDetails",
      "http://nexttrip.com/role/SharePurchaseAgreementsDetailsNarrative",
      "http://nexttrip.com/role/StatementsOfStockholdersEquity",
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative",
      "http://nexttrip.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock [Member]",
        "documentation": "Stock that is subordinate to all other stock of the issuer."
       }
      }
     },
     "auth_ref": [
      "r735",
      "r736",
      "r737",
      "r739",
      "r740",
      "r741",
      "r742",
      "r884",
      "r885",
      "r888",
      "r972",
      "r1027",
      "r1031"
     ]
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockParOrStatedValuePerShare",
     "presentation": [
      "http://nexttrip.com/role/BalanceSheetsParenthetical",
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock, par shares",
        "verboseLabel": "Common stock, par value",
        "documentation": "Face amount or stated value per share of common stock."
       }
      }
     },
     "auth_ref": [
      "r110"
     ]
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockSharesAuthorized",
     "presentation": [
      "http://nexttrip.com/role/BalanceSheetsParenthetical",
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock, shares authorized",
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r110",
      "r626"
     ]
    },
    "us-gaap_CommonStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockSharesIssued",
     "presentation": [
      "http://nexttrip.com/role/BalanceSheetsParenthetical",
      "http://nexttrip.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock, shares issued",
        "verboseLabel": "Common sock, shares issued",
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury."
       }
      }
     },
     "auth_ref": [
      "r110"
     ]
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockSharesOutstanding",
     "presentation": [
      "http://nexttrip.com/role/BalanceSheetsParenthetical",
      "http://nexttrip.com/role/GoodwillDetailsNarrative",
      "http://nexttrip.com/role/ScheduleOfWeightedAverageCommonSharesDetailsParenthetical",
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative",
      "http://nexttrip.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock, shares outstanding",
        "verboseLabel": "Shares outstanding",
        "terseLabel": "Common sock, shares outstanding",
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r110",
      "r626",
      "r645",
      "r1031",
      "r1032"
     ]
    },
    "us-gaap_CommonStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockValue",
     "crdr": "credit",
     "calculation": {
      "http://nexttrip.com/role/BalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock, par value $0.001, 250,000,000 and 1,200,000 shares authorized, 1,656,738 and 936,430 shares issued and outstanding, respectively",
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r110",
      "r568",
      "r731"
     ]
    },
    "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Company Selected Measure"
       }
      }
     },
     "auth_ref": [
      "r816"
     ]
    },
    "ecd_CompActuallyPaidVsNetIncomeTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsNetIncomeTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Net Income"
       }
      }
     },
     "auth_ref": [
      "r815"
     ]
    },
    "ecd_CompActuallyPaidVsOtherMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsOtherMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Other Measure"
       }
      }
     },
     "auth_ref": [
      "r817"
     ]
    },
    "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Total Shareholder Return"
       }
      }
     },
     "auth_ref": [
      "r814"
     ]
    },
    "us-gaap_CompensationAndEmployeeBenefitPlansTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CompensationAndEmployeeBenefitPlansTextBlock",
     "presentation": [
      "http://nexttrip.com/role/DefinedContributionPlans"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Defined Contribution Plans",
        "documentation": "The entire disclosure for an entity's employee compensation and benefit plans, including, but not limited to, postemployment and postretirement benefit plans, defined benefit pension plans, defined contribution plans, non-qualified and supplemental benefit plans, deferred compensation, share-based compensation, life insurance, severance, health care, unemployment and other benefit plans."
       }
      }
     },
     "auth_ref": [
      "r148",
      "r149",
      "r150",
      "r151"
     ]
    },
    "us-gaap_CompensationAndRetirementDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CompensationAndRetirementDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Retirement Benefits [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CompensationExpenseExcludingCostOfGoodAndServiceSold": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CompensationExpenseExcludingCostOfGoodAndServiceSold",
     "crdr": "debit",
     "presentation": [
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation cost",
        "documentation": "Amount of expense for salary, wage, profit sharing; incentive and equity-based compensation; and other employee benefit. Other employee benefit expense includes, but is not limited to, service component of net periodic benefit cost for defined benefit plan. Excludes compensation cost in cost of good and service sold."
       }
      }
     },
     "auth_ref": [
      "r708",
      "r875"
     ]
    },
    "us-gaap_ComputerEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ComputerEquipmentMember",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfEstimatedUsefulLivesForPropertyAndEquipmentDetails",
      "http://nexttrip.com/role/ScheduleOfPropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Computer Equipment [Member]",
        "documentation": "Long lived, depreciable assets that are used in the creation, maintenance and utilization of information systems."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConcentrationRiskBenchmarkDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConcentrationRiskBenchmarkDomain",
     "presentation": [
      "http://nexttrip.com/role/ConcentrationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The denominator in a calculation of a disclosed concentration risk percentage."
       }
      }
     },
     "auth_ref": [
      "r38",
      "r39",
      "r70",
      "r71",
      "r290",
      "r694"
     ]
    },
    "us-gaap_ConcentrationRiskByBenchmarkAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConcentrationRiskByBenchmarkAxis",
     "presentation": [
      "http://nexttrip.com/role/ConcentrationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Concentration Risk Benchmark [Axis]",
        "documentation": "Information by benchmark of concentration risk."
       }
      }
     },
     "auth_ref": [
      "r38",
      "r39",
      "r70",
      "r71",
      "r290",
      "r592",
      "r694"
     ]
    },
    "us-gaap_ConcentrationRiskByTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConcentrationRiskByTypeAxis",
     "presentation": [
      "http://nexttrip.com/role/ConcentrationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Concentration Risk Type [Axis]",
        "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender."
       }
      }
     },
     "auth_ref": [
      "r38",
      "r39",
      "r70",
      "r71",
      "r290",
      "r694",
      "r865"
     ]
    },
    "us-gaap_ConcentrationRiskDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConcentrationRiskDisclosureTextBlock",
     "presentation": [
      "http://nexttrip.com/role/Concentrations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Concentrations",
        "documentation": "The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date."
       }
      }
     },
     "auth_ref": [
      "r134"
     ]
    },
    "us-gaap_ConcentrationRiskLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConcentrationRiskLineItems",
     "presentation": [
      "http://nexttrip.com/role/ConcentrationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Concentration Risk [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r694"
     ]
    },
    "us-gaap_ConcentrationRiskPercentage1": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConcentrationRiskPercentage1",
     "presentation": [
      "http://nexttrip.com/role/ConcentrationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Concentration of risk percentage",
        "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division."
       }
      }
     },
     "auth_ref": [
      "r38",
      "r39",
      "r70",
      "r71",
      "r290"
     ]
    },
    "us-gaap_ConcentrationRiskTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConcentrationRiskTable",
     "presentation": [
      "http://nexttrip.com/role/ConcentrationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Concentration Risk [Table]",
        "documentation": "Disclosure of information about concentration risk. Includes, but is not limited to, percentage of concentration risk and benchmark serving as denominator in calculation of percentage of concentration risk."
       }
      }
     },
     "auth_ref": [
      "r37",
      "r38",
      "r39",
      "r40",
      "r70",
      "r163",
      "r694"
     ]
    },
    "us-gaap_ConcentrationRiskTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConcentrationRiskTypeDomain",
     "presentation": [
      "http://nexttrip.com/role/ConcentrationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration."
       }
      }
     },
     "auth_ref": [
      "r38",
      "r39",
      "r70",
      "r71",
      "r290",
      "r694"
     ]
    },
    "NTRP_ConsultingFees": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "ConsultingFees",
     "crdr": "debit",
     "presentation": [
      "http://nexttrip.com/role/SharePurchaseAgreementsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consulting fees",
        "documentation": "Consulting fees."
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_ConsultingModificationAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "ConsultingModificationAgreementMember",
     "presentation": [
      "http://nexttrip.com/role/SharePurchaseAgreementsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consulting Modification Agreement [Member]",
        "documentation": "Consulting Modification Agreement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_ContingentSharesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "ContingentSharesMember",
     "presentation": [
      "http://nexttrip.com/role/BusinessDescriptionAndGoingConcernDetailsNarrative",
      "http://nexttrip.com/role/ConvertibleNotesDetailsNarrative",
      "http://nexttrip.com/role/ScheduleOfWeightedAverageCommonSharesDetails",
      "http://nexttrip.com/role/SharePurchaseAgreementsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contingent Shares [Member]",
        "documentation": "Contingent Shares [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_ConversionOfConvertibleNotes": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "ConversionOfConvertibleNotes",
     "crdr": "credit",
     "presentation": [
      "http://nexttrip.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Conversion of convertible notes",
        "documentation": "Conversion of convertible notes."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConversionOfStockSharesConverted1": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConversionOfStockSharesConverted1",
     "presentation": [
      "http://nexttrip.com/role/LossPerShareDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of shares converted",
        "documentation": "The number of shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period."
       }
      }
     },
     "auth_ref": [
      "r29",
      "r30",
      "r31"
     ]
    },
    "us-gaap_ConversionOfStockSharesIssued1": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConversionOfStockSharesIssued1",
     "presentation": [
      "http://nexttrip.com/role/LossPerShareDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Common stock issuable upon conversion",
        "label": "Conversion of Stock, Shares Issued",
        "documentation": "The number of new shares issued in the conversion of stock in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period."
       }
      }
     },
     "auth_ref": [
      "r29",
      "r30",
      "r31"
     ]
    },
    "NTRP_ConvertibleDebtDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "ConvertibleDebtDisclosureTextBlock",
     "presentation": [
      "http://nexttrip.com/role/ConvertibleNotes"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Convertible Notes",
        "label": "ConvertibleDebtDisclosureTextBlock"
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_ConvertibleNotesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "ConvertibleNotesMember",
     "presentation": [
      "http://nexttrip.com/role/ConvertibleNotesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Convertible Notes [Member]",
        "documentation": "Convertible Notes [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_ConvertibleNotesPayableOfInstallments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "ConvertibleNotesPayableOfInstallments",
     "crdr": "credit",
     "presentation": [
      "http://nexttrip.com/role/NotesPayableDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Note payable equal installments"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CostOfRevenue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CostOfRevenue",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Cost of revenue (exclusive of depreciation and amortization, shown separately below)",
        "label": "Cost of Revenue",
        "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r121",
      "r229",
      "r302",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r523",
      "r708",
      "r929"
     ]
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CountryRegion",
     "presentation": [
      "http://nexttrip.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://nexttrip.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CustomerConcentrationRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CustomerConcentrationRiskMember",
     "presentation": [
      "http://nexttrip.com/role/ConcentrationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer Concentration Risk [Member]",
        "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer."
       }
      }
     },
     "auth_ref": [
      "r135",
      "r290"
     ]
    },
    "NTRP_CustomerMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "CustomerMember",
     "presentation": [
      "http://nexttrip.com/role/ConcentrationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer [Member]",
        "documentation": "Customer [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r767",
      "r850"
     ]
    },
    "cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskBoardOfDirectorsOversightTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Board of Directors Oversight [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r767",
      "r850"
     ]
    },
    "cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Positions or Committees Responsible [Flag]"
       }
      }
     },
     "auth_ref": [
      "r769",
      "r852"
     ]
    },
    "cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Positions or Committees Responsible [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r769",
      "r852"
     ]
    },
    "cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r762",
      "r845"
     ]
    },
    "cyd_CybersecurityRiskManagementProcessesIntegratedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementProcessesIntegratedFlag",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Processes Integrated [Flag]"
       }
      }
     },
     "auth_ref": [
      "r763",
      "r846"
     ]
    },
    "cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementProcessesIntegratedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Processes Integrated [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r763",
      "r846"
     ]
    },
    "cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementStrategyAndGovernanceAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management, Strategy, and Governance [Abstract]"
       }
      }
     },
     "auth_ref": [
      "r761",
      "r844"
     ]
    },
    "cyd_CybersecurityRiskManagementThirdPartyEngagedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementThirdPartyEngagedFlag",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Third Party Engaged [Flag]"
       }
      }
     },
     "auth_ref": [
      "r764",
      "r847"
     ]
    },
    "cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]"
       }
      }
     },
     "auth_ref": [
      "r766",
      "r849"
     ]
    },
    "cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r766",
      "r849"
     ]
    },
    "cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r767",
      "r850"
     ]
    },
    "cyd_CybersecurityRiskRoleOfManagementTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskRoleOfManagementTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Role of Management [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r768",
      "r851"
     ]
    },
    "cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Third Party Oversight and Identification Processes [Flag]"
       }
      }
     },
     "auth_ref": [
      "r765",
      "r848"
     ]
    },
    "NTRP_DebtAssignmentAndConversionAgreementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "DebtAssignmentAndConversionAgreementsMember",
     "presentation": [
      "http://nexttrip.com/role/ConvertibleNotesDetailsNarrative",
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Assignment and Conversion Agreements [Member]",
        "documentation": "Debt Assignment and Conversion Agreements [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_DebtConversionAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "DebtConversionAgreementMember",
     "presentation": [
      "http://nexttrip.com/role/NotesPayableDetailsNarrative",
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Conversion Agreement [Member]",
        "documentation": "Debt Conversion Agreement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtConversionConvertedInstrumentAmount1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtConversionConvertedInstrumentAmount1",
     "crdr": "credit",
     "presentation": [
      "http://nexttrip.com/role/NotesPayableDetailsNarrative",
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt converted amount",
        "verboseLabel": "Converted amount",
        "documentation": "The value of the financial instrument(s) that the original debt is being converted into in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period."
       }
      }
     },
     "auth_ref": [
      "r29",
      "r31"
     ]
    },
    "NTRP_DebtConversionConvertedInstrumentOfGuaranteedInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "DebtConversionConvertedInstrumentOfGuaranteedInterest",
     "crdr": "credit",
     "presentation": [
      "http://nexttrip.com/role/NotesPayableDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:DebtConversionConvertedInstrumentOfGuaranteedInterest]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtConversionConvertedInstrumentSharesIssued1": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtConversionConvertedInstrumentSharesIssued1",
     "presentation": [
      "http://nexttrip.com/role/NotesPayableDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Conversion, Converted Instrument, Shares Issued",
        "documentation": "The number of shares issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or payments in the period."
       }
      }
     },
     "auth_ref": [
      "r29",
      "r31"
     ]
    },
    "us-gaap_DebtDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtDisclosureTextBlock",
     "presentation": [
      "http://nexttrip.com/role/NotesPayable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Notes Payable",
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants."
       }
      }
     },
     "auth_ref": [
      "r141",
      "r227",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r352",
      "r353",
      "r363",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r379",
      "r386",
      "r387",
      "r389",
      "r532"
     ]
    },
    "NTRP_DebtExchangeAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "DebtExchangeAgreementMember",
     "presentation": [
      "http://nexttrip.com/role/NotesPayableDetailsNarrative",
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Exchange Agreement [Member]",
        "documentation": "Debt Exchange Agreement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentAxis",
     "presentation": [
      "http://nexttrip.com/role/ConvertibleNotesDetailsNarrative",
      "http://nexttrip.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument [Axis]",
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities."
       }
      }
     },
     "auth_ref": [
      "r22",
      "r100",
      "r101",
      "r165",
      "r167",
      "r233",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r370",
      "r375",
      "r376",
      "r377",
      "r378",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r714",
      "r715",
      "r716",
      "r717",
      "r718",
      "r730",
      "r880",
      "r924",
      "r925",
      "r926",
      "r977",
      "r979"
     ]
    },
    "us-gaap_DebtInstrumentCarryingAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentCarryingAmount",
     "crdr": "credit",
     "presentation": [
      "http://nexttrip.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Cash advance",
        "label": "Long-Term Debt, Gross",
        "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt."
       }
      }
     },
     "auth_ref": [
      "r22",
      "r167",
      "r390"
     ]
    },
    "us-gaap_DebtInstrumentConvertibleConversionPrice1": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentConvertibleConversionPrice1",
     "presentation": [
      "http://nexttrip.com/role/ConvertibleNotesDetailsNarrative",
      "http://nexttrip.com/role/NotesPayableDetailsNarrative",
      "http://nexttrip.com/role/SharePurchaseAgreementsDetailsNarrative",
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Conversion price",
        "verboseLabel": "Conversion share price",
        "documentation": "The price per share of the conversion feature embedded in the debt instrument."
       }
      }
     },
     "auth_ref": [
      "r142",
      "r366"
     ]
    },
    "us-gaap_DebtInstrumentCovenantDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentCovenantDescription",
     "presentation": [
      "http://nexttrip.com/role/NotesPayableDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument, Covenant Description",
        "documentation": "Description of minimum financial levels (for example, tangible net worth and working capital) and achievement of certain financial ratios (for example, working capital ratio and debt service coverage ratio), and adherence to certain clauses which generally require or restrict certain actions (for example, entering into a debt arrangement with equal or greater seniority, and selling or discontinuing a certain business segment or material subsidiary) to be in compliance with the covenant clauses of the debt agreement. May also include a discussion of the adverse consequences that would result if the entity violates or fails to satisfy the covenants."
       }
      }
     },
     "auth_ref": [
      "r22",
      "r77"
     ]
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentFaceAmount",
     "crdr": "credit",
     "presentation": [
      "http://nexttrip.com/role/NotesPayableDetailsNarrative",
      "http://nexttrip.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Principal amount",
        "documentation": "Face (par) amount of debt instrument at time of issuance."
       }
      }
     },
     "auth_ref": [
      "r364",
      "r532",
      "r533",
      "r715",
      "r716",
      "r730"
     ]
    },
    "us-gaap_DebtInstrumentInterestRateEffectivePercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentInterestRateEffectivePercentage",
     "presentation": [
      "http://nexttrip.com/role/NotesPayableDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument, Interest Rate, Effective Percentage",
        "documentation": "Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium."
       }
      }
     },
     "auth_ref": [
      "r103",
      "r391",
      "r532",
      "r533",
      "r730"
     ]
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "presentation": [
      "http://nexttrip.com/role/ConvertibleNotesDetailsNarrative",
      "http://nexttrip.com/role/NotesPayableDetailsNarrative",
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative",
      "http://nexttrip.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest rate",
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement."
       }
      }
     },
     "auth_ref": [
      "r103",
      "r365"
     ]
    },
    "us-gaap_DebtInstrumentLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentLineItems",
     "presentation": [
      "http://nexttrip.com/role/NotesPayableDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r233",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r370",
      "r375",
      "r376",
      "r377",
      "r378",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r388",
      "r714",
      "r715",
      "r716",
      "r717",
      "r718",
      "r730",
      "r880",
      "r977",
      "r979"
     ]
    },
    "us-gaap_DebtInstrumentMaturityDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentMaturityDate",
     "presentation": [
      "http://nexttrip.com/role/NotesPayableDetailsNarrative",
      "http://nexttrip.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maturity date",
        "documentation": "Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": [
      "r205",
      "r714",
      "r973",
      "r974"
     ]
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentNameDomain",
     "presentation": [
      "http://nexttrip.com/role/ConvertibleNotesDetailsNarrative",
      "http://nexttrip.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities."
       }
      }
     },
     "auth_ref": [
      "r22",
      "r233",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r370",
      "r375",
      "r376",
      "r377",
      "r378",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r714",
      "r715",
      "r716",
      "r717",
      "r718",
      "r730",
      "r880",
      "r924",
      "r925",
      "r926",
      "r977",
      "r979"
     ]
    },
    "NTRP_DebtInstrumentOfFunded": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "DebtInstrumentOfFunded",
     "crdr": "credit",
     "presentation": [
      "http://nexttrip.com/role/NotesPayableDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Principal amount",
        "label": "DebtInstrumentOfFunded"
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_DebtInstrumentOfInvestor": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "DebtInstrumentOfInvestor",
     "crdr": "credit",
     "presentation": [
      "http://nexttrip.com/role/NotesPayableDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Principal amount",
        "label": "DebtInstrumentOfInvestor"
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_DebtInstrumentPeriodicOfInstallments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "DebtInstrumentPeriodicOfInstallments",
     "crdr": "debit",
     "presentation": [
      "http://nexttrip.com/role/NotesPayableDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:DebtInstrumentPeriodicOfInstallments]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentPeriodicPayment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentPeriodicPayment",
     "crdr": "debit",
     "presentation": [
      "http://nexttrip.com/role/NotesPayableDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "debt instrument periodic payment",
        "documentation": "Amount of the required periodic payments including both interest and principal payments."
       }
      }
     },
     "auth_ref": [
      "r22",
      "r76"
     ]
    },
    "us-gaap_DebtInstrumentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentTable",
     "presentation": [
      "http://nexttrip.com/role/NotesPayableDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Long-Term Debt Instruments [Table]",
        "documentation": "Disclosure of information about long-term debt instrument or arrangement."
       }
      }
     },
     "auth_ref": [
      "r22",
      "r49",
      "r50",
      "r75",
      "r144",
      "r145",
      "r233",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r370",
      "r375",
      "r376",
      "r377",
      "r378",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r388",
      "r714",
      "r715",
      "r716",
      "r717",
      "r718",
      "r730",
      "r880",
      "r977",
      "r979"
     ]
    },
    "NTRP_DebtInstrumentUnamortizedDebtDiscount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "DebtInstrumentUnamortizedDebtDiscount",
     "crdr": "debit",
     "presentation": [
      "http://nexttrip.com/role/NotesPayableDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Unamortized debt discount"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentUnamortizedDiscount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentUnamortizedDiscount",
     "crdr": "debit",
     "presentation": [
      "http://nexttrip.com/role/NotesPayableDetailsNarrative",
      "http://nexttrip.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Original issue discount",
        "documentation": "Amount, after accumulated amortization, of debt discount."
       }
      }
     },
     "auth_ref": [
      "r932",
      "r976",
      "r977",
      "r979"
     ]
    },
    "us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock",
     "presentation": [
      "http://nexttrip.com/role/PrepaidAndOtherCurrentAssetsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Prepaid and Other Current Assets",
        "documentation": "Tabular disclosure of the amounts paid in advance for capitalized costs that will be expensed with the passage of time or the occurrence of a triggering event, and will be charged against earnings within one year or the normal operating cycle, if longer; the aggregate carrying amount of current assets, not separately presented elsewhere in the balance sheet; and other deferred costs."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredRevenueArrangementTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredRevenueArrangementTypeAxis",
     "presentation": [
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Revenue Arrangement Type [Axis]",
        "documentation": "Information by type of deferred revenue arrangement."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredRevenueArrangementTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredRevenueArrangementTypeDomain",
     "presentation": [
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Category of obligation arising when an entity receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredRevenueCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredRevenueCurrent",
     "crdr": "credit",
     "calculation": {
      "http://nexttrip.com/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/BalanceSheets",
      "http://nexttrip.com/role/DeferredRevenueDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred revenue",
        "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current."
       }
      }
     },
     "auth_ref": [
      "r870"
     ]
    },
    "NTRP_DeferredRevenueTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "DeferredRevenueTextBlock",
     "presentation": [
      "http://nexttrip.com/role/DeferredRevenue"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Deferred Revenue",
        "documentation": "Deferred Revenue [Text Block]",
        "label": "Deferred Revenue [Text Block]"
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_DeferredTaxAssetDepreciation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "DeferredTaxAssetDepreciation",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/ScheduleOfDeferredTaxAssetsDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfDeferredTaxAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related party accruals",
        "documentation": "Deferred tax asset depreciation."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxAssetsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsNet",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/ScheduleOfDeferredTaxAssetsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfDeferredTaxAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net deferred tax asset (liability)",
        "label": "Deferred Tax Assets, Net of Valuation Allowance",
        "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards."
       }
      }
     },
     "auth_ref": [
      "r966"
     ]
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsOperatingLossCarryforwards",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/ScheduleOfDeferredTaxAssetsDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfDeferredTaxAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "NOL carryover",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards."
       }
      }
     },
     "auth_ref": [
      "r967"
     ]
    },
    "NTRP_DeferredTaxAssetsPayrollAccruals": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "DeferredTaxAssetsPayrollAccruals",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/ScheduleOfDeferredTaxAssetsDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfDeferredTaxAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payroll accruals",
        "documentation": "Deferred tax assets payroll accruals."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsValuationAllowance",
     "crdr": "credit",
     "calculation": {
      "http://nexttrip.com/role/ScheduleOfDeferredTaxAssetsDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": -1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/IncomeTaxesDetailsNarrative",
      "http://nexttrip.com/role/ScheduleOfDeferredTaxAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Valuation allowance",
        "label": "Valuation allowance loss carryforwards",
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized."
       }
      }
     },
     "auth_ref": [
      "r478"
     ]
    },
    "NTRP_DeferredTaxLiabilitiesDepreciation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "DeferredTaxLiabilitiesDepreciation",
     "crdr": "credit",
     "calculation": {
      "http://nexttrip.com/role/ScheduleOfDeferredTaxAssetsDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfDeferredTaxAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Depreciation",
        "documentation": "Deferred tax liabilities depreciation.",
        "label": "Deferred tax liabilities depreciation"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DefinedBenefitPlanDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DefinedBenefitPlanDisclosureLineItems",
     "presentation": [
      "http://nexttrip.com/role/BalanceSheets",
      "http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Defined Benefit Plan Disclosure [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DefinedContributionPlanCostRecognized": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DefinedContributionPlanCostRecognized",
     "crdr": "debit",
     "presentation": [
      "http://nexttrip.com/role/DefinedContributionPlansDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cost of contribution",
        "documentation": "Amount of cost for defined contribution plan."
       }
      }
     },
     "auth_ref": [
      "r422"
     ]
    },
    "us-gaap_Depreciation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Depreciation",
     "crdr": "debit",
     "presentation": [
      "http://nexttrip.com/role/PropertyAndEquipmentDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Depreciation expense",
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r44"
     ]
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DepreciationDepletionAndAmortization",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations",
       "weight": 1.0,
       "order": 2.0
      },
      "http://nexttrip.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/StatementsOfCashFlows",
      "http://nexttrip.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Depreciation and amortization",
        "verboseLabel": "Depreciation and amortization \u2013 property and equipment and intangibles",
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r274",
      "r281",
      "r287",
      "r708",
      "r709"
     ]
    },
    "NTRP_DescriptionForWarrantExpiration": {
     "xbrltype": "stringItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "DescriptionForWarrantExpiration",
     "presentation": [
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrant description",
        "documentation": "Description for warrant expiration."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DescriptionOfDefinedContributionPensionAndOtherPostretirementPlans": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DescriptionOfDefinedContributionPensionAndOtherPostretirementPlans",
     "presentation": [
      "http://nexttrip.com/role/DefinedContributionPlansDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contribution plan description",
        "documentation": "Description of defined contribution pension and other postretirement plans."
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_DisclosureConvertibleNotesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "DisclosureConvertibleNotesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Convertible Notes"
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_DisclosureDeferredRevenueAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "DisclosureDeferredRevenueAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Revenue"
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_DisclosurePrepaidAndOtherCurrentAssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "DisclosurePrepaidAndOtherCurrentAssetsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Prepaid And Other Current Assets",
        "verboseLabel": "Schedule Of Prepaid And Other Current Assets"
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_DisclosureSharePurchaseAgreementsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "DisclosureSharePurchaseAgreementsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Purchase Agreements"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DiscontinuedOperationsAndDisposalGroupsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Discontinued Operations and Disposal Groups [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/ScheduleOfDiscontinuedOperationsDetails": {
       "parentTag": "us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfDiscontinuedOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cost of revenue",
        "documentation": "Amount of costs of goods sold attributable to disposal group, including, but not limited to, discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r91",
      "r196"
     ]
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss",
     "crdr": "credit",
     "calculation": {
      "http://nexttrip.com/role/ScheduleOfDiscontinuedOperationsDetails": {
       "parentTag": "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfDiscontinuedOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Gross profit",
        "label": "Disposal Group, Including Discontinued Operation, Gross Profit (Loss)",
        "documentation": "Amount of gross profit attributable to disposal group, including, but not limited to, discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r91",
      "r196"
     ]
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DisposalGroupIncludingDiscontinuedOperationOperatingExpense",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/ScheduleOfDiscontinuedOperationsDetails": {
       "parentTag": "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfDiscontinuedOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Expenses",
        "label": "Disposal Group, Including Discontinued Operation, Operating Expense",
        "documentation": "Amount of operating expense attributable to disposal group, including, but not limited to, discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r91"
     ]
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DisposalGroupIncludingDiscontinuedOperationRevenue",
     "crdr": "credit",
     "calculation": {
      "http://nexttrip.com/role/ScheduleOfDiscontinuedOperationsDetails": {
       "parentTag": "us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfDiscontinuedOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Revenue",
        "label": "Disposal Group, Including Discontinued Operation, Revenue",
        "documentation": "Amount of revenue attributable to disposal group, including, but not limited to, discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r91",
      "r196"
     ]
    },
    "NTRP_DisposalGroupIncludingDiscontinuedOperationsInvestorRelationsServices": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "DisposalGroupIncludingDiscontinuedOperationsInvestorRelationsServices",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/ScheduleOfDiscontinuedOperationsDetails": {
       "parentTag": "us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfDiscontinuedOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investor relations services",
        "documentation": "Disposal group including discontinued operations investor relations services."
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_DisposalGroupIncludingDiscontinuedOperationsOtherIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "DisposalGroupIncludingDiscontinuedOperationsOtherIncome",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/ScheduleOfDiscontinuedOperationsDetails": {
       "parentTag": "us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfDiscontinuedOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other income",
        "documentation": "Disposal group including discontinued operations other income"
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_DisposalGroupIncludingDiscontinuedOperationsProfessionalServices": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "DisposalGroupIncludingDiscontinuedOperationsProfessionalServices",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/ScheduleOfDiscontinuedOperationsDetails": {
       "parentTag": "us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfDiscontinuedOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Professional services",
        "documentation": "Disposal group including discontinued operations professional services."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
     "presentation": [
      "http://nexttrip.com/role/DiscontinuedOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Discontinued Operations",
        "documentation": "The entire disclosure related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component."
       }
      }
     },
     "auth_ref": [
      "r78",
      "r137"
     ]
    },
    "NTRP_DivergentTechnologiesIncMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "DivergentTechnologiesIncMember",
     "presentation": [
      "http://nexttrip.com/role/DiscontinuedOperationsDetailsNarrative",
      "http://nexttrip.com/role/GoodwillDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Divergent Technologies, Inc. [Member]",
        "documentation": "Divergent Technologies, Inc. [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DividendsPreferredStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DividendsPreferredStock",
     "crdr": "debit",
     "presentation": [
      "http://nexttrip.com/role/StatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Preferred Stock Dividends",
        "label": "Dividends, Preferred Stock",
        "documentation": "Amount of paid and unpaid preferred stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK)."
       }
      }
     },
     "auth_ref": [
      "r4",
      "r146"
     ]
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://nexttrip.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r759"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://nexttrip.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r757",
      "r759",
      "r780"
     ]
    },
    "dei_DocumentFinStmtErrorCorrectionFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFinStmtErrorCorrectionFlag",
     "presentation": [
      "http://nexttrip.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Financial Statement Error Correction [Flag]",
        "documentation": "Indicates whether any of the financial statement period in the filing include a restatement due to error correction."
       }
      }
     },
     "auth_ref": [
      "r757",
      "r759",
      "r780",
      "r820"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://nexttrip.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://nexttrip.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://nexttrip.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://nexttrip.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://nexttrip.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r758"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://nexttrip.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r746"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://nexttrip.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r759"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://nexttrip.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r759"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://nexttrip.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r805"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://nexttrip.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://nexttrip.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r749"
     ]
    },
    "NTRP_EarnestMoneyDeposit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "EarnestMoneyDeposit",
     "crdr": "credit",
     "presentation": [
      "http://nexttrip.com/role/DiscontinuedOperationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnest money deposit",
        "documentation": "Earnest-money deposit"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerShareAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerShareBasic": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareBasic",
     "presentation": [
      "http://nexttrip.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loss per common share basic",
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r218",
      "r239",
      "r240",
      "r241",
      "r242",
      "r243",
      "r244",
      "r250",
      "r253",
      "r266",
      "r267",
      "r268",
      "r273",
      "r498",
      "r504",
      "r518",
      "r519",
      "r560",
      "r580",
      "r705"
     ]
    },
    "us-gaap_EarningsPerShareBasicLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareBasicLineItems",
     "presentation": [
      "http://nexttrip.com/role/LossPerShareDetailsNarrative",
      "http://nexttrip.com/role/ScheduleOfWeightedAverageCommonSharesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r253",
      "r256",
      "r266"
     ]
    },
    "us-gaap_EarningsPerShareDiluted": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareDiluted",
     "presentation": [
      "http://nexttrip.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loss per common share diluted",
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r218",
      "r239",
      "r240",
      "r241",
      "r242",
      "r243",
      "r244",
      "r253",
      "r266",
      "r267",
      "r268",
      "r273",
      "r498",
      "r504",
      "r518",
      "r519",
      "r560",
      "r580",
      "r705"
     ]
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerSharePolicyTextBlock",
     "presentation": [
      "http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Loss Per Share",
        "label": "Earnings Per Share, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements."
       }
      }
     },
     "auth_ref": [
      "r34",
      "r35",
      "r270"
     ]
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareTextBlock",
     "presentation": [
      "http://nexttrip.com/role/LossPerShare"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loss Per Share",
        "documentation": "The entire disclosure for earnings per share."
       }
      }
     },
     "auth_ref": [
      "r249",
      "r269",
      "r271",
      "r272"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
     "presentation": [
      "http://nexttrip.com/role/IncomeTaxesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Federal statutory tax rate",
        "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss)."
       }
      }
     },
     "auth_ref": [
      "r230",
      "r470",
      "r487",
      "r724"
     ]
    },
    "NTRP_EffectiveIncomeTaxRateReconciliationBookLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "EffectiveIncomeTaxRateReconciliationBookLoss",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/ScheduleOfReconciliationOfProvisionForIncomeTaxesDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfReconciliationOfProvisionForIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Book loss",
        "documentation": "Effective income tax rate reconciliation book loss."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
     "crdr": "debit",
     "presentation": [
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Unrecognized share based compensation cost",
        "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r459"
     ]
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "presentation": [
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted average remaining recognition period",
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r459"
     ]
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions",
     "crdr": "debit",
     "presentation": [
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Unrecognized stock-based compensation expense, stock option",
        "documentation": "Amount of cost to be recognized for option under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r961"
     ]
    },
    "us-gaap_EmployeeStockOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeStockOptionMember",
     "presentation": [
      "http://nexttrip.com/role/LossPerShareDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement, Option [Member]",
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://nexttrip.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://nexttrip.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://nexttrip.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://nexttrip.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://nexttrip.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://nexttrip.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://nexttrip.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://nexttrip.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r752"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://nexttrip.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r748"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://nexttrip.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://nexttrip.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityDomain",
     "presentation": [
      "http://nexttrip.com/role/ConvertibleNotesDetailsNarrative",
      "http://nexttrip.com/role/DiscontinuedOperationsDetailsNarrative",
      "http://nexttrip.com/role/GoodwillDetailsNarrative",
      "http://nexttrip.com/role/InvestmentInEquityMethodInvesteeDetailsNarrative",
      "http://nexttrip.com/role/InvestmentInEquitySecuritiesDetailsNarrative",
      "http://nexttrip.com/role/ScheduleOfUnauditedSummarizedFinancialInformationDetails",
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative",
      "http://nexttrip.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://nexttrip.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r748"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://nexttrip.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r856"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://nexttrip.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://nexttrip.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r748"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://nexttrip.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://nexttrip.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r853"
     ]
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://nexttrip.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r780"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://nexttrip.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://nexttrip.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r748"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://nexttrip.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r748"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://nexttrip.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r748"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://nexttrip.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r748"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://nexttrip.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://nexttrip.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r854"
     ]
    },
    "us-gaap_EquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EquityComponentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquityComponentDomain",
     "presentation": [
      "http://nexttrip.com/role/BusinessDescriptionAndGoingConcernDetailsNarrative",
      "http://nexttrip.com/role/ConvertibleNotesDetailsNarrative",
      "http://nexttrip.com/role/LossPerShareDetailsNarrative",
      "http://nexttrip.com/role/SharePurchaseAgreementsDetailsNarrative",
      "http://nexttrip.com/role/StatementsOfStockholdersEquity",
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative",
      "http://nexttrip.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r195",
      "r214",
      "r215",
      "r216",
      "r234",
      "r235",
      "r236",
      "r238",
      "r243",
      "r245",
      "r247",
      "r275",
      "r304",
      "r305",
      "r333",
      "r409",
      "r485",
      "r486",
      "r495",
      "r496",
      "r497",
      "r499",
      "r503",
      "r504",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r517",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r534",
      "r535",
      "r538",
      "r579",
      "r586",
      "r587",
      "r588",
      "r604",
      "r670"
     ]
    },
    "NTRP_EquityInvestmentAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "EquityInvestmentAgreementMember",
     "presentation": [
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Investment Agreement [Member]",
        "documentation": "Equity Investment Agreement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_EquityMethodInvesteeNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "EquityMethodInvesteeNameDomain",
     "presentation": [
      "http://nexttrip.com/role/BusinessDescriptionAndGoingConcernDetailsNarrative",
      "http://nexttrip.com/role/InvestmentInEquityMethodInvesteeDetailsNarrative",
      "http://nexttrip.com/role/SubsequentEventsDetailsNarrative"
     ],
     "auth_ref": [
      "r298",
      "r299",
      "r301",
      "r494",
      "r859",
      "r860",
      "r861",
      "r968",
      "r969",
      "r970",
      "r971"
     ]
    },
    "us-gaap_EquityMethodInvestmentOwnershipPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquityMethodInvestmentOwnershipPercentage",
     "presentation": [
      "http://nexttrip.com/role/BusinessDescriptionAndGoingConcernDetailsNarrative",
      "http://nexttrip.com/role/InvestmentInEquityMethodInvesteeDetailsNarrative",
      "http://nexttrip.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ownership percentage",
        "verboseLabel": "Equity Method Investment, Ownership Percentage",
        "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting."
       }
      }
     },
     "auth_ref": [
      "r298"
     ]
    },
    "us-gaap_EquityMethodInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquityMethodInvestments",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/BalanceSheets": {
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity investments",
        "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized."
       }
      }
     },
     "auth_ref": [
      "r274",
      "r284",
      "r287",
      "r296",
      "r868",
      "r901"
     ]
    },
    "us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquityMethodInvestmentsAndJointVenturesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Method Investments and Joint Ventures [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EquityMethodInvestmentsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquityMethodInvestmentsDisclosureTextBlock",
     "presentation": [
      "http://nexttrip.com/role/InvestmentInEquityMethodInvestee"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment in Equity Method Investee",
        "documentation": "The entire disclosure for equity method investments and joint ventures. Equity method investments are investments that give the investor the ability to exercise significant influence over the operating and financial policies of an investee. Joint ventures are entities owned and operated by a small group of businesses as a separate and specific business or project for the mutual benefit of the members of the group."
       }
      }
     },
     "auth_ref": [
      "r191",
      "r300",
      "r303",
      "r861"
     ]
    },
    "us-gaap_EquityMethodInvestmentsIssuancesPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquityMethodInvestmentsIssuancesPolicy",
     "presentation": [
      "http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity in Earnings of Equity Method Investees",
        "documentation": "Disclosure of accounting policy for income statement treatment of issuances of stock by an equity method investee."
       }
      }
     },
     "auth_ref": [
      "r20"
     ]
    },
    "us-gaap_EquityMethodInvestmentsPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquityMethodInvestmentsPolicy",
     "presentation": [
      "http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments in Equity Method Investees",
        "documentation": "Disclosure of accounting policy for equity method of accounting for investments and other interests. Investment includes, but is not limited to, unconsolidated subsidiary, corporate joint venture, noncontrolling interest in real estate venture, limited partnership, and limited liability company. Information includes, but is not limited to, ownership percentage, reason equity method is or is not considered appropriate, and accounting policy election for distribution received."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r72",
      "r299"
     ]
    },
    "us-gaap_EquityMethodInvestmentsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquityMethodInvestmentsTextBlock",
     "presentation": [
      "http://nexttrip.com/role/InvestmentInEquityMethodInvesteeTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Unaudited Summarized Financial Information",
        "documentation": "Tabular disclosure of equity method investments including, but not limited to, name of each investee or group of investments, percentage ownership, difference between recorded amount of an investment and the value of the underlying equity in the net assets, and summarized financial information."
       }
      }
     },
     "auth_ref": [
      "r297"
     ]
    },
    "us-gaap_EquityOwnershipPercentageExcludingConsolidatedEntityAndEquityMethodInvestee": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquityOwnershipPercentageExcludingConsolidatedEntityAndEquityMethodInvestee",
     "presentation": [
      "http://nexttrip.com/role/InvestmentInEquityMethodInvesteeDetailsNarrative",
      "http://nexttrip.com/role/InvestmentInEquitySecuritiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Ownership, Excluding Consolidated Entity and Equity Method Investee, Percentage",
        "documentation": "Percentage of ownership of equity interest excluding interest in entity that is consolidated and equity method investee."
       }
      }
     },
     "auth_ref": [
      "r863"
     ]
    },
    "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValuePolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValuePolicyTextBlock",
     "presentation": [
      "http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments in Equity Securities without Readily Determinable Fair Value",
        "documentation": "Disclosure of accounting policy for investment in equity security without readily determinable fair value, which does not qualify for practical expedient to estimate fair value using net asset value per share. Includes, but is not limited to, information considered for determining upward and downward adjustment from observable price change."
       }
      }
     },
     "auth_ref": [
      "r295"
     ]
    },
    "ecd_EquityValuationAssumptionDifferenceFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EquityValuationAssumptionDifferenceFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Valuation Assumption Difference, Footnote"
       }
      }
     },
     "auth_ref": [
      "r813"
     ]
    },
    "ecd_ErrCompAnalysisTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ErrCompAnalysisTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneous Compensation Analysis"
       }
      }
     },
     "auth_ref": [
      "r773",
      "r784",
      "r798",
      "r824"
     ]
    },
    "ecd_ErrCompRecoveryTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ErrCompRecoveryTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneously Awarded Compensation Recovery [Table]"
       }
      }
     },
     "auth_ref": [
      "r770",
      "r781",
      "r795",
      "r821"
     ]
    },
    "NTRP_ExchangeAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "ExchangeAgreementMember",
     "presentation": [
      "http://nexttrip.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exchange Agreement [Member]",
        "documentation": "Exchange Agreement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ExecutiveCategoryAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ExecutiveCategoryAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Executive Category [Axis]"
       }
      }
     },
     "auth_ref": [
      "r819"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Extension",
     "presentation": [
      "http://nexttrip.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_FSATravelLLCMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "FSATravelLLCMember",
     "presentation": [
      "http://nexttrip.com/role/InvestmentInEquityMethodInvesteeDetailsNarrative",
      "http://nexttrip.com/role/ScheduleOfUnauditedSummarizedFinancialInformationDetails",
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative",
      "http://nexttrip.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "FSA Travel LLC [Member]",
        "documentation": "FSA Travel LLC [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueMeasurementPolicyPolicyTextBlock",
     "presentation": [
      "http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Measurements",
        "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueOfFinancialInstrumentsPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueOfFinancialInstrumentsPolicy",
     "presentation": [
      "http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value of Financial Instruments",
        "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetUsefulLife": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetUsefulLife",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfEstimatedUsefulLivesForFiniteLifeIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Estimated useful life",
        "label": "Finite-Lived Intangible Asset, Useful Life",
        "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "crdr": "credit",
     "calculation": {
      "http://nexttrip.com/role/ScheduleOfIntangibleAssetsDetails": {
       "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Accumulated amortization",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life."
       }
      }
     },
     "auth_ref": [
      "r203",
      "r309",
      "r322",
      "r713"
     ]
    },
    "NTRP_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/ScheduleOfEstimatedAggregateAmortizationExpenseDetails": {
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfEstimatedAggregateAmortizationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Thereafter",
        "documentation": "Finite lived intangible assets amortization expense after year four."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/ScheduleOfEstimatedAggregateAmortizationExpenseDetails": {
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfEstimatedAggregateAmortizationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "2025",
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r324",
      "r699",
      "r713"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/ScheduleOfEstimatedAggregateAmortizationExpenseDetails": {
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfEstimatedAggregateAmortizationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "2028",
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r324",
      "r699",
      "r713"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/ScheduleOfEstimatedAggregateAmortizationExpenseDetails": {
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfEstimatedAggregateAmortizationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "2027",
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r324",
      "r699",
      "r713"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/ScheduleOfEstimatedAggregateAmortizationExpenseDetails": {
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfEstimatedAggregateAmortizationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "2026",
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r324",
      "r699",
      "r713"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfEstimatedUsefulLivesForFiniteLifeIntangibleAssetsDetails",
      "http://nexttrip.com/role/ScheduleOfIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "documentation": "Information by major type or class of finite-lived intangible assets."
       }
      }
     },
     "auth_ref": [
      "r315",
      "r317",
      "r318",
      "r319",
      "r321",
      "r322",
      "r325",
      "r326",
      "r557",
      "r558",
      "r699"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsGross",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/ScheduleOfIntangibleAssetsDetails": {
       "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Total",
        "label": "Finite-Lived Intangible Assets, Gross",
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life."
       }
      }
     },
     "auth_ref": [
      "r309",
      "r322",
      "r558",
      "r713"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsLineItems",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Assets [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r315",
      "r322",
      "r325",
      "r326",
      "r329",
      "r557",
      "r699",
      "r713"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfEstimatedUsefulLivesForFiniteLifeIntangibleAssetsDetails",
      "http://nexttrip.com/role/ScheduleOfIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company."
       }
      }
     },
     "auth_ref": [
      "r315",
      "r317",
      "r318",
      "r319",
      "r321",
      "r322",
      "r325",
      "r326",
      "r699"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsNet",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/ScheduleOfEstimatedAggregateAmortizationExpenseDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfEstimatedAggregateAmortizationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Total",
        "label": "Finite-Lived Intangible Assets, Net",
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life."
       }
      }
     },
     "auth_ref": [
      "r557",
      "r916"
     ]
    },
    "NTRP_FlexPayTechnologyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "FlexPayTechnologyMember",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfBusinessMilestonesAndIssuableContingentSharesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Flex Pay Technology [Member]",
        "documentation": "Flex Pay Technology [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock",
     "presentation": [
      "http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Functional and presentation currency",
        "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy."
       }
      }
     },
     "auth_ref": [
      "r524"
     ]
    },
    "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount"
       }
      }
     },
     "auth_ref": [
      "r777",
      "r788",
      "r802",
      "r828"
     ]
    },
    "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Expense of Enforcement, Amount"
       }
      }
     },
     "auth_ref": [
      "r777",
      "r788",
      "r802",
      "r828"
     ]
    },
    "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Violation of Home Country Law, Amount"
       }
      }
     },
     "auth_ref": [
      "r777",
      "r788",
      "r802",
      "r828"
     ]
    },
    "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery, Explanation of Impracticability"
       }
      }
     },
     "auth_ref": [
      "r777",
      "r788",
      "r802",
      "r828"
     ]
    },
    "ecd_ForgoneRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Name",
        "label": "Forgone Recovery, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r777",
      "r788",
      "r802",
      "r828"
     ]
    },
    "us-gaap_FurnitureAndFixturesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FurnitureAndFixturesMember",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfEstimatedUsefulLivesForPropertyAndEquipmentDetails",
      "http://nexttrip.com/role/ScheduleOfPropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Furniture and Fixtures [Member]",
        "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GainLossOnDispositionOfAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GainLossOnDispositionOfAssets",
     "crdr": "credit",
     "presentation": [
      "http://nexttrip.com/role/GoodwillDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Gain on disposition transaction",
        "documentation": "Amount of gain (loss) on sale or disposal of property, plant and equipment assets, excluding oil and gas property and timber property."
       }
      }
     },
     "auth_ref": [
      "r878",
      "r921",
      "r922"
     ]
    },
    "us-gaap_GainLossOnDispositionOfAssets1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GainLossOnDispositionOfAssets1",
     "crdr": "credit",
     "calculation": {
      "http://nexttrip.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/DiscontinuedOperationsDetailsNarrative",
      "http://nexttrip.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loss on disposal of assets",
        "documentation": "Amount of gain (loss) on sale or disposal of assets, including but not limited to property plant and equipment, intangible assets and equity in securities of subsidiaries or equity method investee."
       }
      }
     },
     "auth_ref": [
      "r878"
     ]
    },
    "us-gaap_GainsLossesOnExtinguishmentOfDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GainsLossesOnExtinguishmentOfDebt",
     "crdr": "credit",
     "calculation": {
      "http://nexttrip.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 2.0
      },
      "http://nexttrip.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations",
       "weight": -1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/StatementsOfCashFlows",
      "http://nexttrip.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Gain (Loss) on extinguishment of liability",
        "negatedLabel": "(Gain) loss on extinguishment of liability",
        "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r46",
      "r47"
     ]
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GeneralAndAdministrativeExpense",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General and administrative",
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line."
       }
      }
     },
     "auth_ref": [
      "r123",
      "r650"
     ]
    },
    "us-gaap_Goodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Goodwill",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/ScheduleOfFairValueOfAssetsAcquiredDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0,
       "order": 2.0
      },
      "http://nexttrip.com/role/BalanceSheets": {
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/BalanceSheets",
      "http://nexttrip.com/role/ScheduleOfFairValueOfAssetsAcquiredDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill",
        "documentation": "Amount, after accumulated impairment loss, of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized."
       }
      }
     },
     "auth_ref": [
      "r202",
      "r311",
      "r559",
      "r709",
      "r712",
      "r725",
      "r731",
      "r906",
      "r907"
     ]
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GoodwillAndIntangibleAssetsIntangibleAssetsPolicy",
     "presentation": [
      "http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Impairment of Intangible Assets",
        "documentation": "Disclosure of accounting policy for intangible assets. This accounting policy may address both intangible assets subject to amortization and those that are not. The following also may be disclosed: (1) a description of intangible assets (2) the estimated useful lives of those assets (3) the amortization method used (4) how the entity assesses and measures impairment of such assets (5) how future cash flows are estimated (6) how the fair values of such asset are determined."
       }
      }
     },
     "auth_ref": [
      "r314",
      "r328",
      "r331"
     ]
    },
    "us-gaap_GoodwillDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GoodwillDisclosureTextBlock",
     "presentation": [
      "http://nexttrip.com/role/Goodwill"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Goodwill",
        "label": "Goodwill Disclosure [Text Block]",
        "documentation": "The entire disclosure for goodwill."
       }
      }
     },
     "auth_ref": [
      "r310",
      "r312",
      "r313",
      "r712"
     ]
    },
    "us-gaap_GoodwillPeriodIncreaseDecrease": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GoodwillPeriodIncreaseDecrease",
     "presentation": [
      "http://nexttrip.com/role/GoodwillDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Goodwill",
        "label": "Goodwill, Period Increase (Decrease)",
        "documentation": "Amount of increase (decrease) of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized."
       }
      }
     },
     "auth_ref": [
      "r905"
     ]
    },
    "us-gaap_GrossProfit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GrossProfit",
     "crdr": "credit",
     "calculation": {
      "http://nexttrip.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfUnauditedSummarizedFinancialInformationDetails",
      "http://nexttrip.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Gross profit",
        "label": "Gross profit",
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity."
       }
      }
     },
     "auth_ref": [
      "r116",
      "r121",
      "r177",
      "r229",
      "r302",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r523",
      "r707",
      "r708",
      "r891",
      "r892",
      "r893",
      "r894",
      "r895",
      "r929"
     ]
    },
    "NTRP_GroupTravelBookingPlatformMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "GroupTravelBookingPlatformMember",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfBusinessMilestonesAndIssuableContingentSharesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Group Travel Booking Platform [Member]",
        "documentation": "Group Travel Booking Platform [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_IcfrAuditorAttestationFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "IcfrAuditorAttestationFlag",
     "presentation": [
      "http://nexttrip.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "auth_ref": [
      "r757",
      "r759",
      "r780"
     ]
    },
    "us-gaap_IncomeLossFromContinuingOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeLossFromContinuingOperations",
     "crdr": "credit",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfEarningsPerShareBasicAndDilutedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loss from continuing operations applicable to common stockholders",
        "documentation": "Amount after tax of income (loss) from continuing operations attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r69",
      "r119",
      "r132",
      "r239",
      "r240",
      "r241",
      "r242",
      "r243",
      "r264",
      "r268",
      "r504"
     ]
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "crdr": "credit",
     "calculation": {
      "http://nexttrip.com/role/StatementsOfOperations": {
       "parentTag": "NTRP_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestment",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net loss from continuing operations before taxes",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r117",
      "r171",
      "r177",
      "r561",
      "r576",
      "r707",
      "r708",
      "r891",
      "r892",
      "r893",
      "r894",
      "r895"
     ]
    },
    "NTRP_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestment",
     "crdr": "credit",
     "calculation": {
      "http://nexttrip.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net loss from continuing operations before share of net income (loss) in equity method investee",
        "documentation": "Income loss from continuing operations before income taxes minority interest and income loss from equity method investment.",
        "label": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestment"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest",
     "crdr": "credit",
     "calculation": {
      "http://nexttrip.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 1.0
      },
      "http://nexttrip.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfEarningsPerShareBasicAndDilutedDetails",
      "http://nexttrip.com/role/StatementsOfCashFlows",
      "http://nexttrip.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net loss from continuing operations",
        "label": "Net Loss from continuing operations",
        "verboseLabel": "Loss from continuing operations",
        "documentation": "Amount after tax of income (loss) from continuing operations including portion attributable to the noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r161",
      "r177",
      "r229",
      "r237",
      "r243",
      "r302",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r498",
      "r504",
      "r519",
      "r523",
      "r576",
      "r707",
      "r891",
      "r892",
      "r893",
      "r894",
      "r895",
      "r929"
     ]
    },
    "us-gaap_IncomeLossFromContinuingOperationsPerBasicShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeLossFromContinuingOperationsPerBasicShare",
     "presentation": [
      "http://nexttrip.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Basic loss per common share from continuing operations",
        "documentation": "The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r119",
      "r172",
      "r218",
      "r237",
      "r239",
      "r240",
      "r241",
      "r242",
      "r243",
      "r253",
      "r266",
      "r267",
      "r498",
      "r504",
      "r519",
      "r560",
      "r998"
     ]
    },
    "us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeLossFromContinuingOperationsPerDilutedShare",
     "presentation": [
      "http://nexttrip.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Diluted loss per common share from continuing operations",
        "documentation": "The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r119",
      "r218",
      "r237",
      "r239",
      "r240",
      "r241",
      "r242",
      "r243",
      "r253",
      "r266",
      "r267",
      "r268",
      "r504",
      "r519",
      "r560",
      "r998"
     ]
    },
    "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeLossFromDiscontinuedOperationsNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://nexttrip.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 2.0
      },
      "http://nexttrip.com/role/ScheduleOfDiscontinuedOperationsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://nexttrip.com/role/DiscontinuedOperationsDetailsNarrative",
      "http://nexttrip.com/role/ScheduleOfDiscontinuedOperationsDetails",
      "http://nexttrip.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net income (loss) from discontinued operations, net of taxes",
        "totalLabel": "Gain from Discontinued Operations",
        "verboseLabel": "Loss of discontinued operations",
        "documentation": "Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal."
       }
      }
     },
     "auth_ref": [
      "r80",
      "r81",
      "r82",
      "r83",
      "r84",
      "r94",
      "r196",
      "r491",
      "r577"
     ]
    },
    "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity",
     "crdr": "credit",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfEarningsPerShareBasicAndDilutedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Gain (loss) from discontinued operations applicable to common stockholders",
        "documentation": "Amount after tax of income (loss) from a discontinued operation attributable to the parent. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal."
       }
      }
     },
     "auth_ref": [
      "r80",
      "r81",
      "r82",
      "r83",
      "r84",
      "r90",
      "r94",
      "r161"
     ]
    },
    "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare",
     "presentation": [
      "http://nexttrip.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Basic loss per common share from discontinued operations",
        "documentation": "Per basic share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r120",
      "r218",
      "r256",
      "r266",
      "r267",
      "r991",
      "r998"
     ]
    },
    "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare",
     "presentation": [
      "http://nexttrip.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Diluted loss per common share from discontinued operations",
        "documentation": "Per diluted share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r162",
      "r256",
      "r266",
      "r267"
     ]
    },
    "us-gaap_IncomeLossFromEquityMethodInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeLossFromEquityMethodInvestments",
     "crdr": "credit",
     "calculation": {
      "http://nexttrip.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0,
       "order": 2.0
      },
      "http://nexttrip.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations",
       "weight": -1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/StatementsOfCashFlows",
      "http://nexttrip.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share of net loss of equity method investee",
        "negatedLabel": "Loss on share of net income in equity method investee",
        "documentation": "Amount of income (loss) for proportionate share of equity method investee's income (loss)."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r118",
      "r170",
      "r274",
      "r282",
      "r287",
      "r296",
      "r575"
     ]
    },
    "us-gaap_IncomeStatementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeStatementAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxDisclosureTextBlock",
     "presentation": [
      "http://nexttrip.com/role/IncomeTaxes"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Taxes",
        "documentation": "The entire disclosure for income tax."
       }
      }
     },
     "auth_ref": [
      "r230",
      "r466",
      "r470",
      "r473",
      "r474",
      "r475",
      "r476",
      "r480",
      "r488",
      "r490",
      "r492",
      "r493",
      "r600",
      "r724"
     ]
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/StatementsOfOperations": {
       "parentTag": "NTRP_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestment",
       "weight": -1.0,
       "order": 2.0
      },
      "http://nexttrip.com/role/ScheduleOfReconciliationOfProvisionForIncomeTaxesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfReconciliationOfProvisionForIncomeTaxesDetails",
      "http://nexttrip.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Provision for income taxes",
        "totalLabel": "Provision for Income Taxes",
        "label": "Income Tax Expense (Benefit)",
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations."
       }
      }
     },
     "auth_ref": [
      "r182",
      "r190",
      "r246",
      "r247",
      "r274",
      "r283",
      "r287",
      "r469",
      "r470",
      "r489",
      "r581",
      "r724"
     ]
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxPolicyTextBlock",
     "presentation": [
      "http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Income Taxes",
        "label": "Income Tax, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements."
       }
      }
     },
     "auth_ref": [
      "r213",
      "r467",
      "r468",
      "r476",
      "r477",
      "r479",
      "r484",
      "r594"
     ]
    },
    "us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/ScheduleOfReconciliationOfProvisionForIncomeTaxesDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfReconciliationOfProvisionForIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in valuation allowance",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets."
       }
      }
     },
     "auth_ref": [
      "r472",
      "r724",
      "r964"
     ]
    },
    "NTRP_IncomeTaxReconciliationNondeductibleExpenseAccruedPayroll": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "IncomeTaxReconciliationNondeductibleExpenseAccruedPayroll",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/ScheduleOfReconciliationOfProvisionForIncomeTaxesDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfReconciliationOfProvisionForIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued payroll",
        "documentation": "Income tax reconciliation nondeductible expense accrued payroll."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxReconciliationNondeductibleExpenseDepreciation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxReconciliationNondeductibleExpenseDepreciation",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/ScheduleOfReconciliationOfProvisionForIncomeTaxesDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfReconciliationOfProvisionForIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Depreciation",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible depreciation."
       }
      }
     },
     "auth_ref": [
      "r964",
      "r965"
     ]
    },
    "NTRP_IncomeTaxReconciliationNondeductibleExpenseLossOnAssetDisposal": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "IncomeTaxReconciliationNondeductibleExpenseLossOnAssetDisposal",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/ScheduleOfReconciliationOfProvisionForIncomeTaxesDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfReconciliationOfProvisionForIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loss on asset disposal",
        "documentation": "Income tax reconciliation nondeductible expense loss on asset disposal."
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_IncomeTaxReconciliationNondeductibleExpenseLossOnNextPlayNoteReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "IncomeTaxReconciliationNondeductibleExpenseLossOnNextPlayNoteReceivable",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/ScheduleOfReconciliationOfProvisionForIncomeTaxesDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfReconciliationOfProvisionForIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loss on NextPlay note receivable"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/ScheduleOfReconciliationOfProvisionForIncomeTaxesDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfReconciliationOfProvisionForIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Meals &amp; entertainment",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible meals and entertainment expense."
       }
      }
     },
     "auth_ref": [
      "r964",
      "r965"
     ]
    },
    "NTRP_IncomeTaxReconciliationNondeductibleExpensePreferredDividends": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "IncomeTaxReconciliationNondeductibleExpensePreferredDividends",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/ScheduleOfReconciliationOfProvisionForIncomeTaxesDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfReconciliationOfProvisionForIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred dividends",
        "documentation": "Income tax reconciliation nondeductible expense preferred dividends."
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_IncomeTaxReconciliationNondeductibleExpenseRelatedPartyAccruals": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "IncomeTaxReconciliationNondeductibleExpenseRelatedPartyAccruals",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/ScheduleOfReconciliationOfProvisionForIncomeTaxesDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfReconciliationOfProvisionForIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Related party accruals",
        "documentation": "Income tax reconciliation nondeductible expense related party accruals.",
        "label": "IncomeTaxReconciliationNondeductibleExpenseRelatedPartyAccruals"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/ScheduleOfReconciliationOfProvisionForIncomeTaxesDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfReconciliationOfProvisionForIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock compensation",
        "documentation": "Amount of reported income tax expense (benefit) in excess of (less than) expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for award under share-based payment arrangement. Includes, but is not limited to, expense determined to be nondeductible upon grant or after for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r724",
      "r964",
      "r965"
     ]
    },
    "us-gaap_IncomeTaxesPaidNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxesPaidNet",
     "crdr": "credit",
     "presentation": [
      "http://nexttrip.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash paid for taxes",
        "documentation": "Amount, after refund, of cash paid to foreign, federal, state, and local jurisdictions as income tax."
       }
      }
     },
     "auth_ref": [
      "r28",
      "r224",
      "r481",
      "r482"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations",
       "weight": 1.0,
       "order": 13.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts payable and accrued expenses",
        "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "crdr": "credit",
     "calculation": {
      "http://nexttrip.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations",
       "weight": -1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Accounts receivable",
        "label": "Increase (Decrease) in Accounts Receivable",
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "us-gaap_IncreaseDecreaseInDeferredRevenue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInDeferredRevenue",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations",
       "weight": 1.0,
       "order": 14.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Deferred revenue",
        "label": "Increase (Decrease) in Deferred Revenue",
        "documentation": "Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable."
       }
      }
     },
     "auth_ref": [
      "r700"
     ]
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "presentation": [
      "http://nexttrip.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changes in operating assets and liabilities:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInPrepaidExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInPrepaidExpense",
     "crdr": "credit",
     "calculation": {
      "http://nexttrip.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations",
       "weight": -1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Prepaid expenses",
        "label": "Increase (Decrease) in Prepaid Expense",
        "documentation": "The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "us-gaap_IncreaseDecreaseInSecurityDeposits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInSecurityDeposits",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations",
       "weight": 1.0,
       "order": 12.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Security deposit",
        "label": "Increase (Decrease) in Security Deposits",
        "documentation": "The increase (decrease) during the reporting period in security deposits."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "us-gaap_IncrementalCommonSharesAttributableToContingentlyIssuableShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncrementalCommonSharesAttributableToContingentlyIssuableShares",
     "presentation": [
      "http://nexttrip.com/role/LossPerShareDetailsNarrative",
      "http://nexttrip.com/role/ScheduleOfBusinessMilestonesAndIssuableContingentSharesDetails",
      "http://nexttrip.com/role/ScheduleOfWeightedAverageCommonSharesDetailsParenthetical",
      "http://nexttrip.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total contingent shares",
        "verboseLabel": "Contingent shares issuable",
        "terseLabel": "Number of contingent shares issued",
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of contingently issuable shares. Contingently issuable shares are those shares that are issuable for little or no cash contingent on certain conditions being met."
       }
      }
     },
     "auth_ref": [
      "r254",
      "r255",
      "r257",
      "r258",
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r268"
     ]
    },
    "ecd_IndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "IndividualAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Individual [Axis]"
       }
      }
     },
     "auth_ref": [
      "r777",
      "r788",
      "r802",
      "r819",
      "r828",
      "r832",
      "r840"
     ]
    },
    "ecd_InsiderTradingArrLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTradingArrLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Arrangements [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r838"
     ]
    },
    "ecd_InsiderTradingPoliciesProcLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTradingPoliciesProcLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r760",
      "r843"
     ]
    },
    "ecd_InsiderTrdPoliciesProcAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTrdPoliciesProcAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures Adopted"
       }
      }
     },
     "auth_ref": [
      "r760",
      "r843"
     ]
    },
    "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures Not Adopted"
       }
      }
     },
     "auth_ref": [
      "r760",
      "r843"
     ]
    },
    "us-gaap_IntangibleAssetsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IntangibleAssetsDisclosureTextBlock",
     "presentation": [
      "http://nexttrip.com/role/IntangibleAssets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Intangible Assets",
        "documentation": "The entire disclosure for all or part of the information related to intangible assets."
       }
      }
     },
     "auth_ref": [
      "r314",
      "r327",
      "r330",
      "r698",
      "r699"
     ]
    },
    "us-gaap_IntangibleAssetsFiniteLivedPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IntangibleAssetsFiniteLivedPolicy",
     "presentation": [
      "http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Intangible assets",
        "documentation": "Disclosure of accounting policy for finite-lived intangible assets. This accounting policy also might address: (1) the amortization method used; (2) the useful lives of such assets; and (3) how the entity assesses and measures impairment of such assets."
       }
      }
     },
     "auth_ref": [
      "r553",
      "r554",
      "r555",
      "r557",
      "r704",
      "r908"
     ]
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/BalanceSheets": {
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0,
       "order": 2.0
      },
      "http://nexttrip.com/role/ScheduleOfIntangibleAssetsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://nexttrip.com/role/BalanceSheets",
      "http://nexttrip.com/role/ScheduleOfIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Intangible assets, net",
        "totalLabel": "Intangible assets, net of amortization",
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges."
       }
      }
     },
     "auth_ref": [
      "r315",
      "r916",
      "r918"
     ]
    },
    "us-gaap_InterestExpenseDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InterestExpenseDebt",
     "crdr": "debit",
     "presentation": [
      "http://nexttrip.com/role/ConvertibleNotesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest expense",
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt."
       }
      }
     },
     "auth_ref": [
      "r126",
      "r383",
      "r392",
      "r717",
      "r718"
     ]
    },
    "us-gaap_InterestIncomeExpenseNonoperatingNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InterestIncomeExpenseNonoperatingNet",
     "crdr": "credit",
     "calculation": {
      "http://nexttrip.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest income (expense), net",
        "documentation": "Amount of interest income (expense) classified as nonoperating."
       }
      }
     },
     "auth_ref": [
      "r708",
      "r876",
      "r892"
     ]
    },
    "us-gaap_InterestPaidNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InterestPaidNet",
     "crdr": "credit",
     "presentation": [
      "http://nexttrip.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash paid for interest",
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount."
       }
      }
     },
     "auth_ref": [
      "r220",
      "r222",
      "r223"
     ]
    },
    "us-gaap_InternalUseSoftwarePolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InternalUseSoftwarePolicy",
     "presentation": [
      "http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Software Development Costs",
        "documentation": "Disclosure of accounting policy for costs incurred when both (1) the software is acquired, internally developed, or modified solely to meet the entity's internal needs, and (2) during the software's development or modification, no substantive plan exists or is being developed to market the software externally."
       }
      }
     },
     "auth_ref": [
      "r332"
     ]
    },
    "NTRP_InvestmentInEquityMethodInvestee": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "InvestmentInEquityMethodInvestee",
     "crdr": "credit",
     "calculation": {
      "http://nexttrip.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Investment in equity method investee",
        "documentation": "Investment in equity method investee.",
        "label": "InvestmentInEquityMethodInvestee"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InvestmentInterestRatePaidInCash": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InvestmentInterestRatePaidInCash",
     "presentation": [
      "http://nexttrip.com/role/InvestmentInEquityMethodInvesteeDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment, Interest Rate, Paid in Cash",
        "documentation": "Rate of interest paid in cash on investment."
       }
      }
     },
     "auth_ref": [
      "r1033",
      "r1034",
      "r1035",
      "r1036"
     ]
    },
    "us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InvestmentsDebtAndEquitySecuritiesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments, Debt and Equity Securities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
     "presentation": [
      "http://nexttrip.com/role/InvestmentInEquitySecurities"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment in Equity Securities",
        "documentation": "The entire disclosure for investments in certain debt and equity securities."
       }
      }
     },
     "auth_ref": [
      "r174",
      "r194",
      "r293",
      "r294",
      "r521",
      "r522",
      "r990"
     ]
    },
    "NTRP_IssuanceOfCommonSharesAsCommitmentShares": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "IssuanceOfCommonSharesAsCommitmentShares",
     "crdr": "credit",
     "presentation": [
      "http://nexttrip.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of common shares as commitment shares",
        "documentation": "Issuance of common shares as commitment shares."
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_IssuanceOfCommonSharesForEquityInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "IssuanceOfCommonSharesForEquityInvestments",
     "crdr": "credit",
     "presentation": [
      "http://nexttrip.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of common shares for equity investments",
        "documentation": "Issuance of common shares for equity investments."
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_IssuanceOfCommonSharesForServices": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "IssuanceOfCommonSharesForServices",
     "crdr": "credit",
     "presentation": [
      "http://nexttrip.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of common shares for services",
        "documentation": "Issuance of common shares for services."
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_IssuanceOfCommonWarrantsForServices": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "IssuanceOfCommonWarrantsForServices",
     "crdr": "credit",
     "presentation": [
      "http://nexttrip.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of common warrants for services",
        "documentation": "Issuance of common warrants for services."
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_IssuanceOfPreferredSharesForEquityInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "IssuanceOfPreferredSharesForEquityInvestments",
     "crdr": "credit",
     "presentation": [
      "http://nexttrip.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of preferred shares for equity investments",
        "documentation": "Issuance of preferred shares for equity investments."
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_IssuanceOfPreferredSharesForPerpetualSoftwareLicense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "IssuanceOfPreferredSharesForPerpetualSoftwareLicense",
     "crdr": "debit",
     "presentation": [
      "http://nexttrip.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of preferred shares for perpetual software license",
        "documentation": "Issuance of preferred shares for perpetual software license."
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_IssuanceOfPreferredSharesForServices": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "IssuanceOfPreferredSharesForServices",
     "crdr": "credit",
     "presentation": [
      "http://nexttrip.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of preferred shares for services",
        "documentation": "Issuance of preferred shares for services."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LaborAndRelatedExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LaborAndRelatedExpense",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Salaries and benefits",
        "documentation": "Amount of expense for salary, wage, profit sharing; incentive and equity-based compensation; and other employee benefit."
       }
      }
     },
     "auth_ref": [
      "r875"
     ]
    },
    "dei_LegalEntityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LegalEntityAxis",
     "presentation": [
      "http://nexttrip.com/role/ConvertibleNotesDetailsNarrative",
      "http://nexttrip.com/role/DiscontinuedOperationsDetailsNarrative",
      "http://nexttrip.com/role/GoodwillDetailsNarrative",
      "http://nexttrip.com/role/InvestmentInEquityMethodInvesteeDetailsNarrative",
      "http://nexttrip.com/role/InvestmentInEquitySecuritiesDetailsNarrative",
      "http://nexttrip.com/role/ScheduleOfUnauditedSummarizedFinancialInformationDetails",
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative",
      "http://nexttrip.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Legal Entity [Axis]",
        "documentation": "The set of legal entities associated with a report."
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_LeisureTravelBookingPlatformMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "LeisureTravelBookingPlatformMember",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfBusinessMilestonesAndIssuableContingentSharesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leisure Travel Booking Platform [Member]",
        "documentation": "Leisure Travel Booking Platform [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LesseeLeasesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeLeasesPolicyTextBlock",
     "presentation": [
      "http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases",
        "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee."
       }
      }
     },
     "auth_ref": [
      "r536"
     ]
    },
    "us-gaap_Liabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Liabilities",
     "crdr": "credit",
     "calculation": {
      "http://nexttrip.com/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Liabilities",
        "label": "Liabilities",
        "documentation": "Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others."
       }
      }
     },
     "auth_ref": [
      "r22",
      "r100",
      "r101",
      "r102",
      "r105",
      "r106",
      "r107",
      "r108",
      "r229",
      "r302",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r507",
      "r508",
      "r509",
      "r523",
      "r624",
      "r706",
      "r745",
      "r929",
      "r982",
      "r983"
     ]
    },
    "us-gaap_LiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesAbstract",
     "presentation": [
      "http://nexttrip.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "LIABILITIES"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesAndStockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://nexttrip.com/role/BalanceSheets": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://nexttrip.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Liabilities and Stockholders\u2019 Equity",
        "label": "Liabilities and Equity",
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any."
       }
      }
     },
     "auth_ref": [
      "r115",
      "r169",
      "r570",
      "r731",
      "r881",
      "r902",
      "r975"
     ]
    },
    "us-gaap_LiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://nexttrip.com/role/BalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/BalanceSheets",
      "http://nexttrip.com/role/ScheduleOfUnauditedSummarizedFinancialInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Current Liabilities",
        "label": "Current liabilities",
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r102",
      "r198",
      "r229",
      "r302",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r507",
      "r508",
      "r509",
      "r523",
      "r731",
      "r929",
      "r982",
      "r983"
     ]
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesCurrentAbstract",
     "presentation": [
      "http://nexttrip.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesNoncurrent",
     "crdr": "credit",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfUnauditedSummarizedFinancialInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-current liabilities",
        "documentation": "Amount of obligation due after one year or beyond the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r22",
      "r105",
      "r106",
      "r107",
      "r108",
      "r229",
      "r302",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r507",
      "r508",
      "r509",
      "r523",
      "r929",
      "r982",
      "r983"
     ]
    },
    "us-gaap_LineOfCredit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LineOfCredit",
     "crdr": "credit",
     "presentation": [
      "http://nexttrip.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Line of credit",
        "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement."
       }
      }
     },
     "auth_ref": [
      "r22",
      "r167",
      "r993"
     ]
    },
    "NTRP_LineOfCreditAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "LineOfCreditAgreementMember",
     "presentation": [
      "http://nexttrip.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Line of Credit Agreement [Member]",
        "documentation": "Line of Credit Agreement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LineOfCreditFacilityDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LineOfCreditFacilityDescription",
     "presentation": [
      "http://nexttrip.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Line of credit advance description",
        "documentation": "Description of the terms of a credit facility arrangement. Terms typically include interest rate, collateral required, guarantees required, repayment requirements, and restrictions on use of assets and activities of the entity."
       }
      }
     },
     "auth_ref": [
      "r99",
      "r104",
      "r353"
     ]
    },
    "us-gaap_LineOfCreditFacilityExpirationDate1": {
     "xbrltype": "dateItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LineOfCreditFacilityExpirationDate1",
     "presentation": [
      "http://nexttrip.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Line of credit maturity date",
        "documentation": "Date the credit facility terminates, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": [
      "r99",
      "r104"
     ]
    },
    "us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LineOfCreditFacilityIncreaseDecreaseForPeriodNet",
     "crdr": "credit",
     "presentation": [
      "http://nexttrip.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aditional advances",
        "documentation": "Amount of increase (decrease) of the credit facility."
       }
      }
     },
     "auth_ref": [
      "r880"
     ]
    },
    "us-gaap_LineOfCreditFacilityInterestRateDuringPeriod": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LineOfCreditFacilityInterestRateDuringPeriod",
     "presentation": [
      "http://nexttrip.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Line of credit, interest rate",
        "documentation": "The effective interest rate during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r99",
      "r104"
     ]
    },
    "us-gaap_LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod",
     "crdr": "credit",
     "presentation": [
      "http://nexttrip.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total advances of line of credit",
        "documentation": "Maximum amount borrowed under the credit facility at any time during the period."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://nexttrip.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_LossOnDispositionOfAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "LossOnDispositionOfAssets",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Loss on disposal of assets",
        "documentation": "Loss on disposition of assets.",
        "label": "LossOnDispositionOfAssets"
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_LossOnRelatedPartyReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "LossOnRelatedPartyReceivable",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": -1.0,
       "order": 3.0
      },
      "http://nexttrip.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://nexttrip.com/role/StatementsOfCashFlows",
      "http://nexttrip.com/role/StatementsOfOperations",
      "http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Loss on promissory note receivable",
        "label": "Loss on promissory note receivable",
        "verboseLabel": "Loss on related party receivable",
        "documentation": "Loss on related party receivable."
       }
      }
     },
     "auth_ref": []
    },
    "srt_MajorCustomersAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "MajorCustomersAxis",
     "presentation": [
      "http://nexttrip.com/role/ConcentrationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer [Axis]"
       }
      }
     },
     "auth_ref": [
      "r290",
      "r720",
      "r732",
      "r734",
      "r934",
      "r999",
      "r1000",
      "r1001",
      "r1002",
      "r1003",
      "r1004",
      "r1005",
      "r1006",
      "r1007",
      "r1008",
      "r1009",
      "r1010",
      "r1011",
      "r1012",
      "r1013",
      "r1014",
      "r1015",
      "r1016",
      "r1017",
      "r1018",
      "r1019",
      "r1020",
      "r1021",
      "r1022",
      "r1023",
      "r1024",
      "r1025",
      "r1026"
     ]
    },
    "us-gaap_MarketRiskBenefitPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MarketRiskBenefitPolicyTextBlock",
     "presentation": [
      "http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Concentration of Credit Risk",
        "documentation": "Disclosure of accounting policy for contract or contract feature in long-duration contract issued by insurance entity that both protects contract holder from other-than-nominal capital market risk and exposes insurance entity to other-than-nominal capital market risk. Includes, but is not limited to, input, judgment, assumption and method used in measuring market risk benefit, and change in input, judgment, and assumption."
       }
      }
     },
     "auth_ref": [
      "r584",
      "r585"
     ]
    },
    "cyd_MaterialCybersecurityIncidentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "MaterialCybersecurityIncidentAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Cybersecurity Incident [Abstract]"
       }
      }
     },
     "auth_ref": [
      "r791",
      "r792"
     ]
    },
    "cyd_MaterialCybersecurityIncidentInformationNotAvailableOrUndeterminedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "MaterialCybersecurityIncidentInformationNotAvailableOrUndeterminedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/MaterialCybersecurityIncidentDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Cybersecurity Incident Information Not Available or Undetermined [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r791",
      "r793"
     ]
    },
    "cyd_MaterialCybersecurityIncidentMaterialImpactOrReasonablyLikelyMaterialImpactTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "MaterialCybersecurityIncidentMaterialImpactOrReasonablyLikelyMaterialImpactTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/MaterialCybersecurityIncidentDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Cybersecurity Incident Material Impact or Reasonably Likely Material Impact [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r791",
      "r794"
     ]
    },
    "cyd_MaterialCybersecurityIncidentNatureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "MaterialCybersecurityIncidentNatureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/MaterialCybersecurityIncidentDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Cybersecurity Incident Nature [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r791",
      "r794"
     ]
    },
    "cyd_MaterialCybersecurityIncidentScopeTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "MaterialCybersecurityIncidentScopeTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/MaterialCybersecurityIncidentDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Cybersecurity Incident Scope [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r791",
      "r794"
     ]
    },
    "cyd_MaterialCybersecurityIncidentTimingTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "MaterialCybersecurityIncidentTimingTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/MaterialCybersecurityIncidentDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Cybersecurity Incident Timing [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r791",
      "r794"
     ]
    },
    "srt_MaximumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "MaximumMember",
     "presentation": [
      "http://nexttrip.com/role/BusinessDescriptionAndGoingConcernDetailsNarrative",
      "http://nexttrip.com/role/NotesPayableDetailsNarrative",
      "http://nexttrip.com/role/ScheduleOfEstimatedUsefulLivesForFiniteLifeIntangibleAssetsDetails",
      "http://nexttrip.com/role/ScheduleOfShareBasedPaymentsAwardStockOptionsValuationAssumptionsDetails",
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative",
      "http://nexttrip.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]"
       }
      }
     },
     "auth_ref": [
      "r348",
      "r349",
      "r350",
      "r351",
      "r423",
      "r465",
      "r520",
      "r552",
      "r582",
      "r583",
      "r591",
      "r616",
      "r617",
      "r678",
      "r680",
      "r683",
      "r684",
      "r685",
      "r696",
      "r697",
      "r710",
      "r719",
      "r723",
      "r726",
      "r727",
      "r728",
      "r729",
      "r733",
      "r931",
      "r984",
      "r985",
      "r986",
      "r987",
      "r988",
      "r989"
     ]
    },
    "ecd_MeasureAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MeasureAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measure [Axis]"
       }
      }
     },
     "auth_ref": [
      "r811"
     ]
    },
    "ecd_MeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Name"
       }
      }
     },
     "auth_ref": [
      "r811"
     ]
    },
    "NTRP_MembershipPurchaseAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "MembershipPurchaseAgreementMember",
     "presentation": [
      "http://nexttrip.com/role/InvestmentInEquityMethodInvesteeDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Membership Purchase Agreement [Member]",
        "documentation": "Membership Purchase Agreement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_MembershipUnitsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "MembershipUnitsMember",
     "presentation": [
      "http://nexttrip.com/role/BusinessDescriptionAndGoingConcernDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Membership Units [Member]",
        "documentation": "Membership Units [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_MessrsKerbyAndMonacoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "MessrsKerbyAndMonacoMember",
     "presentation": [
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Messrs Kerby And Monaco [Member]",
        "documentation": "Messrs Kerby And Monaco [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_MillerDebtConversionAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "MillerDebtConversionAgreementMember",
     "presentation": [
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Miller Debt Conversion Agreement [Member]",
        "documentation": "Miller Debt Conversion Agreement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_MinimumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "MinimumMember",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfEstimatedUsefulLivesForFiniteLifeIntangibleAssetsDetails",
      "http://nexttrip.com/role/ScheduleOfShareBasedPaymentsAwardStockOptionsValuationAssumptionsDetails",
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]"
       }
      }
     },
     "auth_ref": [
      "r348",
      "r349",
      "r350",
      "r351",
      "r423",
      "r465",
      "r520",
      "r552",
      "r582",
      "r583",
      "r591",
      "r616",
      "r617",
      "r678",
      "r680",
      "r683",
      "r684",
      "r685",
      "r696",
      "r697",
      "r710",
      "r719",
      "r723",
      "r726",
      "r727",
      "r728",
      "r733",
      "r931",
      "r984",
      "r985",
      "r986",
      "r987",
      "r988",
      "r989"
     ]
    },
    "ecd_MnpiDiscTimedForCompValFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MnpiDiscTimedForCompValFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "MNPI Disclosure Timed for Compensation Value"
       }
      }
     },
     "auth_ref": [
      "r831"
     ]
    },
    "ecd_MtrlTermsOfTrdArrTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MtrlTermsOfTrdArrTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Terms of Trading Arrangement"
       }
      }
     },
     "auth_ref": [
      "r839"
     ]
    },
    "srt_NameOfMajorCustomerDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "NameOfMajorCustomerDomain",
     "presentation": [
      "http://nexttrip.com/role/ConcentrationsDetailsNarrative"
     ],
     "auth_ref": [
      "r290",
      "r720",
      "r732",
      "r734",
      "r934",
      "r999",
      "r1000",
      "r1001",
      "r1002",
      "r1003",
      "r1004",
      "r1005",
      "r1006",
      "r1007",
      "r1008",
      "r1009",
      "r1010",
      "r1011",
      "r1012",
      "r1013",
      "r1014",
      "r1015",
      "r1016",
      "r1017",
      "r1018",
      "r1019",
      "r1020",
      "r1021",
      "r1022",
      "r1023",
      "r1024",
      "r1025",
      "r1026"
     ]
    },
    "ecd_NamedExecutiveOfficersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NamedExecutiveOfficersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Named Executive Officers, Footnote"
       }
      }
     },
     "auth_ref": [
      "r812"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash provided by financing activities",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit."
       }
      }
     },
     "auth_ref": [
      "r221"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "presentation": [
      "http://nexttrip.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Flows from Financing Activities:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash provided (used) in investing activities",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets."
       }
      }
     },
     "auth_ref": [
      "r221"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "presentation": [
      "http://nexttrip.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Flows from Investing activities:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "calculation": {
      "http://nexttrip.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash used in operating activities",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities."
       }
      }
     },
     "auth_ref": [
      "r130",
      "r131",
      "r132"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://nexttrip.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Flows from Operating Activities:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInOperatingActivitiesContinuingOperations",
     "calculation": {
      "http://nexttrip.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash used in operating activities from continuing operations",
        "label": "Net Cash Provided by (Used in) Operating Activities, Continuing Operations",
        "documentation": "Amount of cash inflow (outflow) from operating activities, excluding discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities."
       }
      }
     },
     "auth_ref": [
      "r130",
      "r131",
      "r132"
     ]
    },
    "us-gaap_NetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://nexttrip.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfUnauditedSummarizedFinancialInformationDetails",
      "http://nexttrip.com/role/StatementsOfOperations",
      "http://nexttrip.com/role/StatementsOfStockholdersEquity",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net loss",
        "label": "Net Loss",
        "verboseLabel": "Net Income (Loss)",
        "terseLabel": "Net loss",
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r122",
      "r132",
      "r173",
      "r196",
      "r211",
      "r212",
      "r216",
      "r229",
      "r237",
      "r239",
      "r240",
      "r241",
      "r242",
      "r243",
      "r246",
      "r247",
      "r264",
      "r302",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r498",
      "r504",
      "r519",
      "r523",
      "r578",
      "r647",
      "r668",
      "r669",
      "r743",
      "r929"
     ]
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetIncomeLossAvailableToCommonStockholdersBasic",
     "crdr": "credit",
     "calculation": {
      "http://nexttrip.com/role/StatementsOfOperations": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfEarningsPerShareBasicAndDilutedDetails",
      "http://nexttrip.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net Loss Applicable to Common Stockholders",
        "label": "Net loss applicable to common stockholders",
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders."
       }
      }
     },
     "auth_ref": [
      "r219",
      "r239",
      "r240",
      "r241",
      "r242",
      "r250",
      "r251",
      "r265",
      "r268",
      "r504"
     ]
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "presentation": [
      "http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Recently adopted accounting pronouncements",
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact."
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_NextInnovationLLCMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "NextInnovationLLCMember",
     "presentation": [
      "http://nexttrip.com/role/BusinessDescriptionAndGoingConcernDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Next Innovation LLC [Member]",
        "documentation": "Next Innovation LLC [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_NextPlayTechnologiesIncMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "NextPlayTechnologiesIncMember",
     "presentation": [
      "http://nexttrip.com/role/BusinessDescriptionAndGoingConcernDetailsNarrative",
      "http://nexttrip.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Next Play Technologies Inc [Member]",
        "documentation": "Next Play Technologies Inc [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_NextTripGroupLLCMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "NextTripGroupLLCMember",
     "presentation": [
      "http://nexttrip.com/role/BalanceSheetsParenthetical",
      "http://nexttrip.com/role/BusinessDescriptionAndGoingConcernDetailsNarrative",
      "http://nexttrip.com/role/StatementsOfOperationsParenthetical",
      "http://nexttrip.com/role/StatementsOfStockholdersEquityParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "NextTrip Holdings, Inc. [Member]",
        "documentation": "NextTrip Holdings, Inc. [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_NextTripHoldingsIncMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "NextTripHoldingsIncMember",
     "presentation": [
      "http://nexttrip.com/role/GoodwillDetailsNarrative",
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Next Trip Holdings Inc [Member]",
        "documentation": "Next Trip Holdings Inc [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_NextTripMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "NextTripMember",
     "presentation": [
      "http://nexttrip.com/role/InvestmentInEquityMethodInvesteeDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Next Trip [Member]",
        "documentation": "Next Trip [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://nexttrip.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_NonGaapMeasureDescriptionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonGaapMeasureDescriptionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-GAAP Measure Description"
       }
      }
     },
     "auth_ref": [
      "r811"
     ]
    },
    "ecd_NonPeoNeoAvgCompActuallyPaidAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoAvgCompActuallyPaidAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Compensation Actually Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r809"
     ]
    },
    "ecd_NonPeoNeoAvgTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoAvgTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r808"
     ]
    },
    "ecd_NonRule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonRule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Rule 10b5-1 Arrangement Adopted"
       }
      }
     },
     "auth_ref": [
      "r839"
     ]
    },
    "ecd_NonRule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonRule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Rule 10b5-1 Arrangement Terminated"
       }
      }
     },
     "auth_ref": [
      "r839"
     ]
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NonoperatingIncomeExpense",
     "crdr": "credit",
     "calculation": {
      "http://nexttrip.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total other income (expense)",
        "label": "Nonoperating Income (Expense)",
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business)."
       }
      }
     },
     "auth_ref": [
      "r125"
     ]
    },
    "us-gaap_NonoperatingIncomeExpenseAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NonoperatingIncomeExpenseAbstract",
     "presentation": [
      "http://nexttrip.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Income/(Expenses)"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NonrelatedPartyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NonrelatedPartyMember",
     "presentation": [
      "http://nexttrip.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Nonrelated Party [Member]",
        "documentation": "Party not related to reporting entity."
       }
      }
     },
     "auth_ref": [
      "r882",
      "r883"
     ]
    },
    "NTRP_NotAchievedMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "NotAchievedMember",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfBusinessMilestonesAndIssuableContingentSharesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Not Achieved [Member]",
        "documentation": "Not Achieved [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_NoteOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "NoteOneMember",
     "presentation": [
      "http://nexttrip.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Note One [Member]",
        "documentation": "Note One [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_NoteSecuritiesPurchaseAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "NoteSecuritiesPurchaseAgreementMember",
     "presentation": [
      "http://nexttrip.com/role/NotesPayableDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Note Securities Purchase Agreement [Member]",
        "documentation": "Note Securities Purchase Agreement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_NoteTwoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "NoteTwoMember",
     "presentation": [
      "http://nexttrip.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Note Two [Member]",
        "documentation": "Note Two [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_NoteTwoSecuritiesPurchaseAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "NoteTwoSecuritiesPurchaseAgreementMember",
     "presentation": [
      "http://nexttrip.com/role/NotesPayableDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Note Two Securities Purchase Agreement [Member]",
        "documentation": "Note Two Securities Purchase Agreement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NotesAndLoansPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NotesAndLoansPayableCurrent",
     "crdr": "credit",
     "presentation": [
      "http://nexttrip.com/role/NotesPayableDetailsNarrative",
      "http://nexttrip.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total consideration",
        "documentation": "Sum of the carrying values as of the balance sheet date of the portions of all long-term notes and loans payable due within one year or the operating cycle if longer."
       }
      }
     },
     "auth_ref": [
      "r100",
      "r101"
     ]
    },
    "us-gaap_NotesPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NotesPayable",
     "crdr": "credit",
     "presentation": [
      "http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Notes payable",
        "label": "Notes Payable [Default Label]",
        "documentation": "Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r22",
      "r167",
      "r993",
      "r994"
     ]
    },
    "us-gaap_NotesPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NotesPayableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://nexttrip.com/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/BalanceSheets",
      "http://nexttrip.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Notes payable",
        "verboseLabel": "Notes payable - related parties",
        "documentation": "Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer."
       }
      }
     },
     "auth_ref": [
      "r100",
      "r101"
     ]
    },
    "NTRP_OneMillionNoteMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "OneMillionNoteMember",
     "presentation": [
      "http://nexttrip.com/role/NotesPayableDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "One Million Note [Member]",
        "documentation": "One Million Note [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingExpenses",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Operating Expenses",
        "label": "Operating Expenses [Default Label]",
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingExpensesAbstract",
     "presentation": [
      "http://nexttrip.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://nexttrip.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Operating loss",
        "label": "Operating Income (Loss)",
        "documentation": "The net result for the period of deducting operating expenses from operating revenues."
       }
      }
     },
     "auth_ref": [
      "r177",
      "r707",
      "r891",
      "r892",
      "r893",
      "r894",
      "r895"
     ]
    },
    "us-gaap_OperatingLossCarryforwards": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLossCarryforwards",
     "crdr": "debit",
     "presentation": [
      "http://nexttrip.com/role/IncomeTaxesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating loss carryforwards",
        "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws."
       }
      }
     },
     "auth_ref": [
      "r483"
     ]
    },
    "NTRP_OperatingLossCarryforwardsRemainder": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "OperatingLossCarryforwardsRemainder",
     "crdr": "debit",
     "presentation": [
      "http://nexttrip.com/role/IncomeTaxesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating loss carryforwards remainder",
        "documentation": "Operating loss carryforwards remainder."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_OrganizationCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "OrganizationCosts",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization Costs",
        "documentation": "Organization costs."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherCommitmentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherCommitmentsAxis",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfBusinessMilestonesAndIssuableContingentSharesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Commitments [Axis]",
        "documentation": "Information by type of other commitment."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherCommitmentsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherCommitmentsDomain",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfBusinessMilestonesAndIssuableContingentSharesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other future obligation."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherExpenses",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other expenses",
        "documentation": "Amount of expense classified as other."
       }
      }
     },
     "auth_ref": [
      "r123",
      "r124"
     ]
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherNonoperatingIncomeExpense",
     "crdr": "credit",
     "calculation": {
      "http://nexttrip.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Income (expense)",
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other."
       }
      }
     },
     "auth_ref": [
      "r127"
     ]
    },
    "ecd_OtherPerfMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OtherPerfMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Performance Measure, Amount"
       }
      }
     },
     "auth_ref": [
      "r811"
     ]
    },
    "us-gaap_OtherPrepaidExpenseCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherPrepaidExpenseCurrent",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/ScheduleOfPrepaidAndOtherCurrentAssetsDetails": {
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfPrepaidAndOtherCurrentAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Other expenses",
        "label": "Other Prepaid Expense, Current",
        "documentation": "Amount of asset related to consideration paid in advance for other costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r873",
      "r903"
     ]
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://nexttrip.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r759"
     ]
    },
    "ecd_OutstandingAggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingAggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r775",
      "r786",
      "r800",
      "r826"
     ]
    },
    "ecd_OutstandingRecoveryCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingRecoveryCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r778",
      "r789",
      "r803",
      "r829"
     ]
    },
    "ecd_OutstandingRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Name",
        "label": "Outstanding Recovery, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r778",
      "r789",
      "r803",
      "r829"
     ]
    },
    "ecd_PayVsPerformanceDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PayVsPerformanceDisclosureLineItems",
     "auth_ref": [
      "r807"
     ]
    },
    "us-gaap_PayablesAndAccrualsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PayablesAndAccrualsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Payables and Accruals [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PaymentsForFees": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsForFees",
     "crdr": "credit",
     "presentation": [
      "http://nexttrip.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "License fee",
        "documentation": "Amount of cash outflow for fees classified as other."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "us-gaap_PaymentsForSoftware": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsForSoftware",
     "crdr": "credit",
     "calculation": {
      "http://nexttrip.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Capitalized software development costs",
        "label": "Payments for Software",
        "documentation": "The cash outflow associated with the development, modification or acquisition of software programs or applications for internal use (that is, not to be sold, leased or otherwise marketed to others) that qualify for capitalization."
       }
      }
     },
     "auth_ref": [
      "r129"
     ]
    },
    "us-gaap_PaymentsToAcquireBusinessesAndInterestInAffiliates": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsToAcquireBusinessesAndInterestInAffiliates",
     "crdr": "credit",
     "presentation": [
      "http://nexttrip.com/role/InvestmentInEquityMethodInvesteeDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Business acquisition additional amount",
        "label": "Payments to Acquire Businesses and Interest in Affiliates",
        "documentation": "The cash outflow associated with the acquisition of a controlling interest in another entity or an entity that is related to it but not strictly controlled (for example, an unconsolidated subsidiary, affiliate, joint venture or equity method investment)."
       }
      }
     },
     "auth_ref": [
      "r24"
     ]
    },
    "us-gaap_PaymentsToAcquireBusinessesGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsToAcquireBusinessesGross",
     "crdr": "credit",
     "presentation": [
      "http://nexttrip.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payments to acquire businesses",
        "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price."
       }
      }
     },
     "auth_ref": [
      "r24",
      "r501"
     ]
    },
    "us-gaap_PaymentsToAcquireIntangibleAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsToAcquireIntangibleAssets",
     "crdr": "credit",
     "presentation": [
      "http://nexttrip.com/role/DiscontinuedOperationsDetailsNarrative",
      "http://nexttrip.com/role/GoodwillDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Purchase price",
        "documentation": "The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill."
       }
      }
     },
     "auth_ref": [
      "r129"
     ]
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "crdr": "credit",
     "calculation": {
      "http://nexttrip.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/PropertyAndEquipmentDetailsNarrative",
      "http://nexttrip.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Purchase of equipment",
        "label": "Property and equipment",
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets."
       }
      }
     },
     "auth_ref": [
      "r129"
     ]
    },
    "ecd_PeerGroupIssuersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeerGroupIssuersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Issuers, Footnote"
       }
      }
     },
     "auth_ref": [
      "r810"
     ]
    },
    "ecd_PeerGroupTotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeerGroupTotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r810"
     ]
    },
    "ecd_PeoActuallyPaidCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoActuallyPaidCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Actually Paid Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r809"
     ]
    },
    "ecd_PeoName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Name"
       }
      }
     },
     "auth_ref": [
      "r812"
     ]
    },
    "ecd_PeoTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r808"
     ]
    },
    "NTRP_PercentageForIssuedAndOutstandingCapitalStock": {
     "xbrltype": "percentItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "PercentageForIssuedAndOutstandingCapitalStock",
     "presentation": [
      "http://nexttrip.com/role/BalanceSheetsParenthetical",
      "http://nexttrip.com/role/BusinessDescriptionAndGoingConcernDetailsNarrative",
      "http://nexttrip.com/role/StatementsOfOperationsParenthetical",
      "http://nexttrip.com/role/StatementsOfStockholdersEquityParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Percentage for issued and outstanding capital stock",
        "documentation": "Percentage for issued and outstanding, capital stock."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PlanNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PlanNameAxis",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfShareBasedPaymentsAwardStockOptionsValuationAssumptionsDetails",
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Plan Name [Axis]",
        "documentation": "Information by plan name for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r935",
      "r936",
      "r937",
      "r938",
      "r939",
      "r940",
      "r941",
      "r942",
      "r943",
      "r944",
      "r945",
      "r946",
      "r947",
      "r948",
      "r949",
      "r950",
      "r951",
      "r952",
      "r953",
      "r954",
      "r955",
      "r956",
      "r957",
      "r958",
      "r959",
      "r960"
     ]
    },
    "us-gaap_PlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PlanNameDomain",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfShareBasedPaymentsAwardStockOptionsValuationAssumptionsDetails",
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r935",
      "r936",
      "r937",
      "r938",
      "r939",
      "r940",
      "r941",
      "r942",
      "r943",
      "r944",
      "r945",
      "r946",
      "r947",
      "r948",
      "r949",
      "r950",
      "r951",
      "r952",
      "r953",
      "r954",
      "r955",
      "r956",
      "r957",
      "r958",
      "r959",
      "r960"
     ]
    },
    "ecd_PnsnBnftsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PnsnBnftsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pension Benefits Adjustments, Footnote"
       }
      }
     },
     "auth_ref": [
      "r809"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://nexttrip.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r753"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://nexttrip.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r755"
     ]
    },
    "us-gaap_PreferredStockConvertibleSharesIssuable": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockConvertibleSharesIssuable",
     "presentation": [
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock issuable upon conversion",
        "documentation": "Number of common shares issuable upon conversion of preferred stock."
       }
      }
     },
     "auth_ref": [
      "r396"
     ]
    },
    "us-gaap_PreferredStockDividendRatePercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockDividendRatePercentage",
     "presentation": [
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividend percentage",
        "documentation": "The percentage rate used to calculate dividend payments on preferred stock."
       }
      }
     },
     "auth_ref": [
      "r395",
      "r679",
      "r681",
      "r682",
      "r686"
     ]
    },
    "NTRP_PreferredStockDividends": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "PreferredStockDividends",
     "crdr": "credit",
     "presentation": [
      "http://nexttrip.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred stock dividends",
        "documentation": "Preferred stock dividends."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PreferredStockDividendsIncomeStatementImpact": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockDividendsIncomeStatementImpact",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfEarningsPerShareBasicAndDilutedDetails",
      "http://nexttrip.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Preferred Dividends",
        "negatedTerseLabel": "Preferred dividends",
        "label": "Preferred Stock Dividends, Income Statement Impact",
        "documentation": "The amount of preferred stock dividends that is an adjustment to net income apportioned to common stockholders."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockMember",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfAnti-dilutiveSecuritiesExcludedFromComputationOfEarningsPerShareDetails",
      "http://nexttrip.com/role/StatementsOfStockholdersEquity",
      "http://nexttrip.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock [Member]",
        "documentation": "Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company."
       }
      }
     },
     "auth_ref": [
      "r735",
      "r736",
      "r739",
      "r740",
      "r741",
      "r742",
      "r1027",
      "r1031"
     ]
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockParOrStatedValuePerShare",
     "presentation": [
      "http://nexttrip.com/role/BalanceSheetsParenthetical",
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred stock, par value",
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer."
       }
      }
     },
     "auth_ref": [
      "r109",
      "r394"
     ]
    },
    "us-gaap_PreferredStockRedemptionTerms": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockRedemptionTerms",
     "presentation": [
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred stock redemption right, description",
        "documentation": "The redemption terms of preferred stock of an entity that has priority over common stock in the distribution of dividends and in the event of liquidation of the entity. The redemption features of this capital stock are solely within the control of the issuer."
       }
      }
     },
     "auth_ref": [
      "r48",
      "r49"
     ]
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockSharesAuthorized",
     "presentation": [
      "http://nexttrip.com/role/BalanceSheetsParenthetical",
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred stock, shares authorized",
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r109",
      "r626"
     ]
    },
    "us-gaap_PreferredStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockSharesIssued",
     "presentation": [
      "http://nexttrip.com/role/BalanceSheetsParenthetical",
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred stock, shares issued",
        "documentation": "Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt."
       }
      }
     },
     "auth_ref": [
      "r109",
      "r394"
     ]
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockSharesOutstanding",
     "presentation": [
      "http://nexttrip.com/role/BalanceSheetsParenthetical",
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred stock, shares outstanding",
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased."
       }
      }
     },
     "auth_ref": [
      "r109",
      "r626",
      "r645",
      "r1031",
      "r1032"
     ]
    },
    "us-gaap_PreferredStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockValue",
     "crdr": "credit",
     "calculation": {
      "http://nexttrip.com/role/BalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock, $0.001 par value; 10,000,000 shares authorized; 3,106,616 and 472,996 shares issued and outstanding, respectively",
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r109",
      "r567",
      "r731"
     ]
    },
    "NTRP_PreferredUnitsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "PreferredUnitsMember",
     "presentation": [
      "http://nexttrip.com/role/BusinessDescriptionAndGoingConcernDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Units [Member]",
        "documentation": "Preferred Units [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PrepaidAdvertising": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PrepaidAdvertising",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/ScheduleOfPrepaidAndOtherCurrentAssetsDetails": {
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfPrepaidAndOtherCurrentAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Marketing expenses",
        "documentation": "Amount of consideration paid in advance for advertising that provides economic benefits within a future period of one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r703",
      "r711",
      "r903"
     ]
    },
    "NTRP_PrepaidConsultingContract": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "PrepaidConsultingContract",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/ScheduleOfPrepaidAndOtherCurrentAssetsDetails": {
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfPrepaidAndOtherCurrentAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current portion of two-year strategic consulting contract",
        "documentation": "Prepaid consulting contract."
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_PrepaidCostOfSales": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "PrepaidCostOfSales",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/ScheduleOfPrepaidAndOtherCurrentAssetsDetails": {
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfPrepaidAndOtherCurrentAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cost of sales",
        "documentation": "Prepaid cost of sales."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/BalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 4.0
      },
      "http://nexttrip.com/role/ScheduleOfPrepaidAndOtherCurrentAssetsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://nexttrip.com/role/BalanceSheets",
      "http://nexttrip.com/role/ScheduleOfPrepaidAndOtherCurrentAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prepaid expenses and other current assets",
        "totalLabel": "Total",
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r874"
     ]
    },
    "us-gaap_PrepaidExpenseOtherNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PrepaidExpenseOtherNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/BalanceSheets": {
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other prepaid assets",
        "documentation": "Carrying amount as of the balance sheet date of amounts paid in advance which will be charged against earnings in periods after one year or beyond the operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r869"
     ]
    },
    "NTRP_PrepaidExpensesAndOtherCurrentAssetsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "PrepaidExpensesAndOtherCurrentAssetsTextBlock",
     "presentation": [
      "http://nexttrip.com/role/PrepaidAndOtherCurrentAssets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prepaid and Other Current Assets",
        "documentation": "Prepaid Expenses and Other Current Assets [Text Block]"
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_PrepaidOfferingCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "PrepaidOfferingCosts",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/ScheduleOfPrepaidAndOtherCurrentAssetsDetails": {
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfPrepaidAndOtherCurrentAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering costs",
        "documentation": "Prepaid offering costs."
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_PrepaidsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "PrepaidsPolicyTextBlock",
     "presentation": [
      "http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prepaids",
        "documentation": "Prepaids [Policy Text Block]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PriorPeriodReclassificationAdjustmentDescription": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PriorPeriodReclassificationAdjustmentDescription",
     "presentation": [
      "http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reclassification",
        "documentation": "Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error."
       }
      }
     },
     "auth_ref": [
      "r866"
     ]
    },
    "NTRP_ProceedsFromAcquireBusinessesGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "ProceedsFromAcquireBusinessesGross",
     "crdr": "credit",
     "calculation": {
      "http://nexttrip.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Reverse acquisition of Sigma Additive Solutions, Inc.",
        "documentation": "Proceeds from acquire businesses gross.",
        "label": "ProceedsFromAcquireBusinessesGross"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromConvertibleDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromConvertibleDebt",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/ConvertibleNotesDetailsNarrative",
      "http://nexttrip.com/role/NotesPayableDetailsNarrative",
      "http://nexttrip.com/role/SharePurchaseAgreementsDetailsNarrative",
      "http://nexttrip.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of convertible notes",
        "verboseLabel": "Proceeds from convertible debt",
        "terseLabel": "Convertible note issued",
        "documentation": "The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder."
       }
      }
     },
     "auth_ref": [
      "r25"
     ]
    },
    "NTRP_ProceedsFromDownpaymentForContract": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "ProceedsFromDownpaymentForContract",
     "crdr": "debit",
     "presentation": [
      "http://nexttrip.com/role/SharePurchaseAgreementsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from downpayment for contract",
        "documentation": "Proceeds from down-payment for contract."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromIssuanceOfCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromIssuanceOfCommonStock",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/StatementsOfCashFlows",
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuances of common shares",
        "verboseLabel": "Net proceeds",
        "documentation": "The cash inflow from the additional capital contribution to the entity."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromIssuanceOfPreferredStockAndPreferenceStock",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuances of preferred shares",
        "documentation": "Proceeds from issuance of capital stock which provides for a specific dividend that is paid to the shareholders before any dividends to common stockholders and which takes precedence over common stockholders in the event of liquidation."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "us-gaap_ProceedsFromIssuanceOfWarrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromIssuanceOfWarrants",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/StatementsOfCashFlows",
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise of warrants",
        "verboseLabel": "Gross proceeds",
        "documentation": "The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt)."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "us-gaap_ProceedsFromLinesOfCredit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromLinesOfCredit",
     "crdr": "debit",
     "presentation": [
      "http://nexttrip.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Initial advance of line of credit",
        "documentation": "Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements."
       }
      }
     },
     "auth_ref": [
      "r25",
      "r880"
     ]
    },
    "us-gaap_ProceedsFromNotesPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromNotesPayable",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/NotesPayableDetailsNarrative",
      "http://nexttrip.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Notes payable",
        "label": "Proceeds from Notes Payable",
        "documentation": "The cash inflow from a borrowing supported by a written promise to pay an obligation."
       }
      }
     },
     "auth_ref": [
      "r25"
     ]
    },
    "us-gaap_ProceedsFromRelatedPartyDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromRelatedPartyDebt",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Advances from related party, net",
        "documentation": "The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates."
       }
      }
     },
     "auth_ref": [
      "r25"
     ]
    },
    "us-gaap_ProceedsFromSaleOfOtherProductiveAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromSaleOfOtherProductiveAssets",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sale of assets",
        "documentation": "Amount of cash inflow from the sale of tangible or intangible assets used to produce goods or deliver services, classified as other."
       }
      }
     },
     "auth_ref": [
      "r128"
     ]
    },
    "us-gaap_ProceedsFromSaleOfProductiveAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromSaleOfProductiveAssets",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sale of Sigma Additive Solutions, Inc. assets",
        "documentation": "The cash inflow from the sale of property, plant and equipment (capital expenditures), software, and other intangible assets."
       }
      }
     },
     "auth_ref": [
      "r128"
     ]
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromStockOptionsExercised",
     "crdr": "debit",
     "presentation": [
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock options",
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r3",
      "r19"
     ]
    },
    "us-gaap_ProceedsFromUnsecuredNotesPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromUnsecuredNotesPayable",
     "crdr": "debit",
     "presentation": [
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Unsecured promissory notes",
        "documentation": "The cash inflow from borrowings supported by a written promise to pay an obligation that is uncollateralized (where debt is not backed by the pledge of collateral)."
       }
      }
     },
     "auth_ref": [
      "r25"
     ]
    },
    "us-gaap_ProceedsFromWarrantExercises": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromWarrantExercises",
     "crdr": "debit",
     "presentation": [
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Gross proceeds of warrant exercises",
        "documentation": "The cash inflow associated with the amount received from holders exercising their stock warrants."
       }
      }
     },
     "auth_ref": [
      "r877"
     ]
    },
    "us-gaap_ProfessionalFees": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProfessionalFees",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Professional Service Fees",
        "documentation": "A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer."
       }
      }
     },
     "auth_ref": [
      "r708",
      "r743",
      "r1029",
      "r1030"
     ]
    },
    "NTRP_PromissoryNoteReceivableNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "PromissoryNoteReceivableNet",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/BalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Promissory note receivable, net",
        "documentation": "Promissory note receivable net."
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_PromissoryNoteReceivablePolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "PromissoryNoteReceivablePolicyTextBlock",
     "presentation": [
      "http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Promissory Note Receivable",
        "documentation": "Promissory Note Receivable [Policy Text Block]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfEstimatedUsefulLivesForPropertyAndEquipmentDetails",
      "http://nexttrip.com/role/ScheduleOfPropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Lived Tangible Asset [Axis]",
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r537"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentDisclosureTextBlock",
     "presentation": [
      "http://nexttrip.com/role/PropertyAndEquipment"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property and Equipment",
        "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections."
       }
      }
     },
     "auth_ref": [
      "r137",
      "r185",
      "r188",
      "r189"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentGross",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/ScheduleOfPropertyAndEquipmentDetails": {
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfPropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total",
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": [
      "r138",
      "r200",
      "r574"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentLineItems",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfEstimatedUsefulLivesForFiniteLifeIntangibleAssetsDetails",
      "http://nexttrip.com/role/ScheduleOfEstimatedUsefulLivesForPropertyAndEquipmentDetails",
      "http://nexttrip.com/role/ScheduleOfPropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r537"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentNet",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/BalanceSheets": {
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0,
       "order": 1.0
      },
      "http://nexttrip.com/role/ScheduleOfPropertyAndEquipmentDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://nexttrip.com/role/BalanceSheets",
      "http://nexttrip.com/role/ScheduleOfPropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property and equipment, net",
        "totalLabel": "Property and Equipment, net of depreciation",
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r537",
      "r562",
      "r574",
      "r731"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "presentation": [
      "http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Property and Equipment",
        "label": "Property, Plant and Equipment, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r185",
      "r188",
      "r572"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "presentation": [
      "http://nexttrip.com/role/PropertyAndEquipmentTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Property and Equipment",
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfEstimatedUsefulLivesForPropertyAndEquipmentDetails",
      "http://nexttrip.com/role/ScheduleOfPropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software."
       }
      }
     },
     "auth_ref": [
      "r138",
      "r537"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfEstimatedUsefulLivesForPropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Estimated useful life",
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment."
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_PurchaseAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "PurchaseAgreementMember",
     "presentation": [
      "http://nexttrip.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Purchase Agreement [Member]",
        "documentation": "Purchase Agreement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PvpTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PvpTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Table]"
       }
      }
     },
     "auth_ref": [
      "r807"
     ]
    },
    "ecd_PvpTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PvpTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure, Table"
       }
      }
     },
     "auth_ref": [
      "r807"
     ]
    },
    "srt_RangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "RangeAxis",
     "presentation": [
      "http://nexttrip.com/role/BusinessDescriptionAndGoingConcernDetailsNarrative",
      "http://nexttrip.com/role/NotesPayableDetailsNarrative",
      "http://nexttrip.com/role/ScheduleOfEstimatedUsefulLivesForFiniteLifeIntangibleAssetsDetails",
      "http://nexttrip.com/role/ScheduleOfShareBasedPaymentsAwardStockOptionsValuationAssumptionsDetails",
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative",
      "http://nexttrip.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]"
       }
      }
     },
     "auth_ref": [
      "r348",
      "r349",
      "r350",
      "r351",
      "r420",
      "r423",
      "r454",
      "r455",
      "r456",
      "r465",
      "r520",
      "r550",
      "r551",
      "r552",
      "r582",
      "r583",
      "r591",
      "r616",
      "r617",
      "r678",
      "r680",
      "r683",
      "r684",
      "r685",
      "r696",
      "r697",
      "r710",
      "r719",
      "r723",
      "r726",
      "r727",
      "r728",
      "r729",
      "r733",
      "r737",
      "r927",
      "r931",
      "r973",
      "r985",
      "r986",
      "r987",
      "r988",
      "r989"
     ]
    },
    "srt_RangeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "RangeMember",
     "presentation": [
      "http://nexttrip.com/role/BusinessDescriptionAndGoingConcernDetailsNarrative",
      "http://nexttrip.com/role/NotesPayableDetailsNarrative",
      "http://nexttrip.com/role/ScheduleOfEstimatedUsefulLivesForFiniteLifeIntangibleAssetsDetails",
      "http://nexttrip.com/role/ScheduleOfShareBasedPaymentsAwardStockOptionsValuationAssumptionsDetails",
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative",
      "http://nexttrip.com/role/SubsequentEventsDetailsNarrative"
     ],
     "auth_ref": [
      "r348",
      "r349",
      "r350",
      "r351",
      "r420",
      "r423",
      "r454",
      "r455",
      "r456",
      "r465",
      "r520",
      "r550",
      "r551",
      "r552",
      "r582",
      "r583",
      "r591",
      "r616",
      "r617",
      "r678",
      "r680",
      "r683",
      "r684",
      "r685",
      "r696",
      "r697",
      "r710",
      "r719",
      "r723",
      "r726",
      "r727",
      "r728",
      "r729",
      "r733",
      "r737",
      "r927",
      "r931",
      "r973",
      "r985",
      "r986",
      "r987",
      "r988",
      "r989"
     ]
    },
    "us-gaap_ReceivablesNetCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ReceivablesNetCurrent",
     "crdr": "debit",
     "presentation": [
      "http://nexttrip.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Accounts receivable",
        "label": "Receivables, Net, Current",
        "documentation": "The total amount due to the entity within one year of the balance sheet date (or one operating cycle, if longer) from outside sources, including trade accounts receivable, notes and loans receivable, as well as any other types of receivables, net of allowances established for the purpose of reducing such receivables to an amount that approximates their net realizable value."
       }
      }
     },
     "auth_ref": [
      "r731"
     ]
    },
    "NTRP_RecentlyIssuedAccountingPronouncementsNotYetAdoptedPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "RecentlyIssuedAccountingPronouncementsNotYetAdoptedPolicyTextBlock",
     "presentation": [
      "http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Recently issued accounting pronouncements not yet adopted",
        "documentation": "Recently Issued Accounting Pronouncements Not Yet Adopted [Policy Text Block]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_RecoveryOfErrCompDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RecoveryOfErrCompDisclosureLineItems",
     "auth_ref": [
      "r770",
      "r781",
      "r795",
      "r821"
     ]
    },
    "NTRP_RelatedPartyDebtConversionAgreementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "RelatedPartyDebtConversionAgreementsMember",
     "presentation": [
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Debt Conversion Agreements [Member]",
        "documentation": "Related Party Debt Conversion Agreements [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyDomain",
     "presentation": [
      "http://nexttrip.com/role/BalanceSheets",
      "http://nexttrip.com/role/ConvertibleNotesDetailsNarrative",
      "http://nexttrip.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related and nonrelated parties. Related party includes, but is not limited to, affiliate, other entity for which investment is accounted for under equity method, trust for benefit of employee, principal owner, management, and member of immediate family, and other party that may be prevented from pursuing separate interests because of control, significant influence, or ownership interest."
       }
      }
     },
     "auth_ref": [
      "r291",
      "r421",
      "r542",
      "r543",
      "r565",
      "r571",
      "r619",
      "r620",
      "r621",
      "r622",
      "r623",
      "r644",
      "r646",
      "r677"
     ]
    },
    "us-gaap_RelatedPartyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyMember",
     "presentation": [
      "http://nexttrip.com/role/BalanceSheets",
      "http://nexttrip.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party [Member]",
        "documentation": "Party related to reporting entity. Includes, but is not limited to, affiliate, entity for which investment is accounted for by equity method, trust for benefit of employees, and principal owner, management, and members of immediate family."
       }
      }
     },
     "auth_ref": [
      "r231",
      "r232",
      "r542",
      "r543",
      "r544",
      "r545",
      "r565",
      "r571",
      "r619",
      "r620",
      "r621",
      "r622",
      "r623",
      "r644",
      "r646",
      "r677"
     ]
    },
    "us-gaap_RelatedPartyTransactionAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyTransactionAxis",
     "presentation": [
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transaction [Axis]",
        "documentation": "Information by type of related party transaction."
       }
      }
     },
     "auth_ref": [
      "r542",
      "r543",
      "r981"
     ]
    },
    "us-gaap_RelatedPartyTransactionDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyTransactionDomain",
     "presentation": [
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Transaction between related party."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyTransactionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyTransactionLineItems",
     "presentation": [
      "http://nexttrip.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transaction [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r291",
      "r651",
      "r652",
      "r655"
     ]
    },
    "us-gaap_RelatedPartyTransactionsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyTransactionsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transactions [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "presentation": [
      "http://nexttrip.com/role/BalanceSheets",
      "http://nexttrip.com/role/ConvertibleNotesDetailsNarrative",
      "http://nexttrip.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related and Nonrelated Parties [Axis]",
        "documentation": "Information by related and nonrelated parties. Related party includes, but is not limited to, affiliate, other entity for which investment is accounted for under equity method, trust for benefit of employee, principal owner, management, and member of immediate family, and other party that may be prevented from pursuing separate interests because of control, significant influence, or ownership interest."
       }
      }
     },
     "auth_ref": [
      "r291",
      "r421",
      "r542",
      "r543",
      "r565",
      "r571",
      "r619",
      "r620",
      "r621",
      "r622",
      "r623",
      "r644",
      "r646",
      "r677",
      "r981"
     ]
    },
    "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyTransactionsDisclosureTextBlock",
     "presentation": [
      "http://nexttrip.com/role/RelatedPartyTransactions"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transactions",
        "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates."
       }
      }
     },
     "auth_ref": [
      "r539",
      "r540",
      "r541",
      "r543",
      "r546",
      "r601",
      "r602",
      "r603",
      "r653",
      "r654",
      "r655",
      "r674",
      "r676"
     ]
    },
    "ecd_RestatementDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDateAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date [Axis]"
       }
      }
     },
     "auth_ref": [
      "r771",
      "r782",
      "r796",
      "r822"
     ]
    },
    "ecd_RestatementDeterminationDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDeterminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date"
       }
      }
     },
     "auth_ref": [
      "r772",
      "r783",
      "r797",
      "r823"
     ]
    },
    "ecd_RestatementDoesNotRequireRecoveryTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDoesNotRequireRecoveryTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement does not require Recovery"
       }
      }
     },
     "auth_ref": [
      "r779",
      "r790",
      "r804",
      "r830"
     ]
    },
    "us-gaap_RestrictedStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RestrictedStockMember",
     "presentation": [
      "http://nexttrip.com/role/InvestmentInEquitySecuritiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restricted Stock [Member]",
        "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met."
       }
      }
     },
     "auth_ref": [
      "r34"
     ]
    },
    "us-gaap_RestructuringCostAndReserveLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RestructuringCostAndReserveLineItems",
     "presentation": [
      "http://nexttrip.com/role/BalanceSheetsParenthetical",
      "http://nexttrip.com/role/ScheduleOfFairValueOfAssetsAcquiredDetails",
      "http://nexttrip.com/role/StatementsOfOperationsParenthetical",
      "http://nexttrip.com/role/StatementsOfStockholdersEquityParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restructuring Cost and Reserve [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345"
     ]
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RetainedEarningsAccumulatedDeficit",
     "crdr": "credit",
     "calculation": {
      "http://nexttrip.com/role/BalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/BalanceSheets",
      "http://nexttrip.com/role/BusinessDescriptionAndGoingConcernDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accumulated deficit",
        "negatedLabel": "Accumulated deficit",
        "documentation": "Amount of accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r112",
      "r146",
      "r569",
      "r589",
      "r590",
      "r599",
      "r627",
      "r731"
     ]
    },
    "us-gaap_RetainedEarningsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RetainedEarningsMember",
     "presentation": [
      "http://nexttrip.com/role/StatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Retained Earnings [Member]",
        "documentation": "Accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r195",
      "r234",
      "r235",
      "r236",
      "r238",
      "r243",
      "r245",
      "r247",
      "r304",
      "r305",
      "r333",
      "r485",
      "r486",
      "r495",
      "r496",
      "r497",
      "r499",
      "r503",
      "r504",
      "r510",
      "r512",
      "r513",
      "r515",
      "r517",
      "r534",
      "r535",
      "r586",
      "r588",
      "r604",
      "r1031"
     ]
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "crdr": "credit",
     "calculation": {
      "http://nexttrip.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue",
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise."
       }
      }
     },
     "auth_ref": [
      "r175",
      "r176",
      "r274",
      "r279",
      "r280",
      "r285",
      "r287",
      "r288",
      "r289",
      "r290",
      "r418",
      "r419",
      "r556"
     ]
    },
    "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RevenueFromContractWithCustomerPolicyTextBlock",
     "presentation": [
      "http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue Recognition",
        "documentation": "Disclosure of accounting policy for revenue from contract with customer."
       }
      }
     },
     "auth_ref": [
      "r192",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r701"
     ]
    },
    "us-gaap_Revenues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Revenues",
     "crdr": "credit",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfUnauditedSummarizedFinancialInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net revenues",
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss)."
       }
      }
     },
     "auth_ref": [
      "r175",
      "r176",
      "r217",
      "r229",
      "r274",
      "r279",
      "r280",
      "r285",
      "r287",
      "r288",
      "r289",
      "r290",
      "r302",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r523",
      "r561",
      "r708",
      "r929"
     ]
    },
    "us-gaap_RisksAndUncertaintiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RisksAndUncertaintiesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Risks and Uncertainties [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_Rule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Rule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Adopted"
       }
      }
     },
     "auth_ref": [
      "r839"
     ]
    },
    "ecd_Rule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Rule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Terminated"
       }
      }
     },
     "auth_ref": [
      "r839"
     ]
    },
    "us-gaap_SaleOfStockConsiderationReceivedOnTransaction": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SaleOfStockConsiderationReceivedOnTransaction",
     "crdr": "debit",
     "presentation": [
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sale of stock proceeds",
        "documentation": "Cash received on stock transaction after deduction of issuance costs."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockNameOfTransactionDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SaleOfStockNameOfTransactionDomain",
     "presentation": [
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SaleOfStockNumberOfSharesIssuedInTransaction",
     "presentation": [
      "http://nexttrip.com/role/NotesPayableDetailsNarrative",
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sale of stock, shares",
        "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SaleOfStockPercentageOfOwnershipAfterTransaction",
     "presentation": [
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Percentage of issued and outstanding common shares",
        "documentation": "Percentage of subsidiary's or equity investee's stock owned by parent company after stock transaction."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockPricePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SaleOfStockPricePerShare",
     "presentation": [
      "http://nexttrip.com/role/NotesPayableDetailsNarrative",
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sale of Stock, Price Per Share",
        "verboseLabel": "Purchase price, per share",
        "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SalesRevenueNetMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SalesRevenueNetMember",
     "presentation": [
      "http://nexttrip.com/role/ConcentrationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue Benchmark [Member]",
        "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation."
       }
      }
     },
     "auth_ref": [
      "r290",
      "r864"
     ]
    },
    "srt_ScenarioUnspecifiedDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ScenarioUnspecifiedDomain",
     "presentation": [
      "http://nexttrip.com/role/LossPerShareDetailsNarrative",
      "http://nexttrip.com/role/ScheduleOfBusinessMilestonesAndIssuableContingentSharesDetails"
     ],
     "auth_ref": [
      "r248",
      "r424",
      "r858",
      "r887"
     ]
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfAnti-dilutiveSecuritiesExcludedFromComputationOfEarningsPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Antidilutive Security, Excluded EPS Calculation [Table]",
        "documentation": "Disclosure of information about security that could potentially dilute basic earnings per share (EPS) in future that was not included in calculation of diluted EPS."
       }
      }
     },
     "auth_ref": [
      "r34"
     ]
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
     "presentation": [
      "http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Anti-dilutive Securities Excluded from Computation of Earnings Per Share",
        "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities."
       }
      }
     },
     "auth_ref": [
      "r34"
     ]
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock",
     "presentation": [
      "http://nexttrip.com/role/LossPerShareTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Business Milestones and Issuable Contingent Shares",
        "documentation": "Tabular disclosure of contingent payment arrangements including the terms that will result in payment and the accounting treatment that will be followed if such contingencies occur, including the potential impact on earnings per share if contingencies are to be settled in common stock of the entity. The description also may include the period over which amounts are expected to be paid, and changes in the amount since the previous reporting period. This also includes contingent options and commitments."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable",
     "presentation": [
      "http://nexttrip.com/role/BusinessDescriptionAndGoingConcernDetailsNarrative",
      "http://nexttrip.com/role/DiscontinuedOperationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Table]",
        "documentation": "Disclosure of information about collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations."
       }
      }
     },
     "auth_ref": [
      "r505"
     ]
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "presentation": [
      "http://nexttrip.com/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Deferred Tax Assets",
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets."
       }
      }
     },
     "auth_ref": [
      "r966"
     ]
    },
    "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTable",
     "presentation": [
      "http://nexttrip.com/role/BalanceSheets",
      "http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Defined Benefit Plan [Table]",
        "documentation": "Disclosure of information about individual defined benefit pension plan or other postretirement defined benefit plan. It may be appropriate to group certain similar plans. Also includes schedule for fair value of plan assets by major categories of plan assets by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), Significant other observable inputs (Level 2), and significant unobservable inputs (Level 3)."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r51",
      "r52",
      "r53",
      "r54"
     ]
    },
    "us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
     "presentation": [
      "http://nexttrip.com/role/DiscontinuedOperationsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Discontinued Operations",
        "documentation": "Tabular disclosure of information related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r21",
      "r23",
      "r79",
      "r85",
      "r86",
      "r87",
      "r88",
      "r89",
      "r93",
      "r95",
      "r96",
      "r139"
     ]
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "presentation": [
      "http://nexttrip.com/role/LossPerShareTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Earnings Per Share, Basic and Diluted",
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r890"
     ]
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfEarningsPerShareBasicByCommonClassTable",
     "presentation": [
      "http://nexttrip.com/role/LossPerShareDetailsNarrative",
      "http://nexttrip.com/role/ScheduleOfWeightedAverageCommonSharesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Basic, by Common Class, Including Two-Class Method [Table]",
        "documentation": "Disclosure of information about basic earnings per share by class of stock. Includes, but is not limited to, two-class method."
       }
      }
     },
     "auth_ref": [
      "r33",
      "r36",
      "r253",
      "r256",
      "r266"
     ]
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "presentation": [
      "http://nexttrip.com/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Reconciliation of Provision for Income Taxes",
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r471",
      "r724",
      "r964"
     ]
    },
    "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis",
     "presentation": [
      "http://nexttrip.com/role/BusinessDescriptionAndGoingConcernDetailsNarrative",
      "http://nexttrip.com/role/InvestmentInEquityMethodInvesteeDetailsNarrative",
      "http://nexttrip.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment, Name [Axis]"
       }
      }
     },
     "auth_ref": [
      "r298",
      "r299",
      "r301",
      "r494",
      "r859",
      "r860",
      "r861",
      "r968",
      "r969",
      "r970",
      "r971"
     ]
    },
    "us-gaap_ScheduleOfEquityMethodInvestmentsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfEquityMethodInvestmentsLineItems",
     "presentation": [
      "http://nexttrip.com/role/InvestmentInEquityMethodInvesteeDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Equity Method Investments [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r229",
      "r298",
      "r299",
      "r301",
      "r302",
      "r523"
     ]
    },
    "us-gaap_ScheduleOfEquityMethodInvestmentsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfEquityMethodInvestmentsTable",
     "presentation": [
      "http://nexttrip.com/role/InvestmentInEquityMethodInvesteeDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Method Investment [Table]",
        "documentation": "Disclosure of information about equity method investment. Includes, but is not limited to, name of investee or group of investees, percentage ownership, difference between investment and value of underlying equity in net assets."
       }
      }
     },
     "auth_ref": [
      "r196",
      "r229",
      "r298",
      "r299",
      "r301",
      "r302",
      "r523"
     ]
    },
    "NTRP_ScheduleOfEstimatedUsefulLivesForFiniteLifeIntangibleAssetsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "ScheduleOfEstimatedUsefulLivesForFiniteLifeIntangibleAssetsTableTextBlock",
     "presentation": [
      "http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Estimated Useful Lives for Finite Life Intangible Assets",
        "documentation": "Schedule of Estimated Useful Lives for Finite Life Intangible Assets [Table Text Block]"
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_ScheduleOfEstimatedUsefulLivesForPropertyAndEquipmentTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "ScheduleOfEstimatedUsefulLivesForPropertyAndEquipmentTableTextBlock",
     "presentation": [
      "http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Estimated Useful Lives for Property and Equipment",
        "documentation": "Schedule Of Estimated Useful Lives For Property And Equipment [Table Text Block]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Intangible Asset, Finite-Lived [Table]",
        "documentation": "Disclosure of information about finite-lived intangible asset. Excludes indefinite-lived intangible asset."
       }
      }
     },
     "auth_ref": [
      "r315",
      "r322",
      "r325",
      "r326",
      "r329",
      "r557",
      "r699",
      "r713"
     ]
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
     "presentation": [
      "http://nexttrip.com/role/IntangibleAssetsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Intangible Assets",
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment."
       }
      }
     },
     "auth_ref": [
      "r713",
      "r915"
     ]
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfEstimatedUsefulLivesForFiniteLifeIntangibleAssetsDetails",
      "http://nexttrip.com/role/ScheduleOfEstimatedUsefulLivesForPropertyAndEquipmentDetails",
      "http://nexttrip.com/role/ScheduleOfPropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Table]",
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r537"
     ]
    },
    "us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
     "presentation": [
      "http://nexttrip.com/role/GoodwillTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Fair Value of Assets Acquired",
        "documentation": "Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree."
       }
      }
     },
     "auth_ref": [
      "r158"
     ]
    },
    "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable",
     "presentation": [
      "http://nexttrip.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transaction [Table]",
        "documentation": "Disclosure of information about related party transaction."
       }
      }
     },
     "auth_ref": [
      "r73",
      "r74",
      "r651",
      "r652",
      "r655"
     ]
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfRestructuringAndRelatedCostsTable",
     "presentation": [
      "http://nexttrip.com/role/BalanceSheetsParenthetical",
      "http://nexttrip.com/role/ScheduleOfFairValueOfAssetsAcquiredDetails",
      "http://nexttrip.com/role/StatementsOfOperationsParenthetical",
      "http://nexttrip.com/role/StatementsOfStockholdersEquityParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restructuring Cost [Table]",
        "documentation": "Disclosure of information about restructuring cost. Includes, but is not limited to, expected cost, cost incurred, statement of income caption that includes restructuring cost recognized, and amount of restructuring reserve."
       }
      }
     },
     "auth_ref": [
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfShareBasedPaymentsAwardStockOptionsValuationAssumptionsDetails",
      "http://nexttrip.com/role/ScheduleOfStockOptionActivityDetails",
      "http://nexttrip.com/role/StockholdersEquityTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]",
        "documentation": "Disclosure of information about share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r426",
      "r428",
      "r429",
      "r430",
      "r431",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "presentation": [
      "http://nexttrip.com/role/StockholdersEquityTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Stock Option Activity",
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value."
       }
      }
     },
     "auth_ref": [
      "r17",
      "r18",
      "r152"
     ]
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "presentation": [
      "http://nexttrip.com/role/StockholdersEquityTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Share Based Payments Award Stock Options Valuation Assumptions",
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions."
       }
      }
     },
     "auth_ref": [
      "r157"
     ]
    },
    "us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
     "presentation": [
      "http://nexttrip.com/role/StockholdersEquityTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Warranty Activity",
        "documentation": "Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable."
       }
      }
     },
     "auth_ref": [
      "r55"
     ]
    },
    "us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfWeightedAverageNumberOfSharesTableTextBlock",
     "presentation": [
      "http://nexttrip.com/role/LossPerShareTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Weighted Average Common Shares",
        "documentation": "Tabular disclosure of the weighted average number of shares used in calculating basic net earnings per share (or unit) and diluted earnings per share (or unit)."
       }
      }
     },
     "auth_ref": [
      "r32"
     ]
    },
    "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
     "presentation": [
      "http://nexttrip.com/role/IntangibleAssetsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of estimated aggregate amortization expense",
        "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets."
       }
      }
     },
     "auth_ref": [
      "r713",
      "r917"
     ]
    },
    "NTRP_SecuritiesPurchaseAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "SecuritiesPurchaseAgreementMember",
     "presentation": [
      "http://nexttrip.com/role/NotesPayableDetailsNarrative",
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative",
      "http://nexttrip.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities Purchase Agreement [Member]",
        "documentation": "Securities Purchase Agreement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://nexttrip.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r747"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12gTitle",
     "presentation": [
      "http://nexttrip.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r751"
     ]
    },
    "us-gaap_SecurityDeposit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SecurityDeposit",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/BalanceSheets": {
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security deposit",
        "documentation": "The amount of an asset, typically cash, provided to a counterparty to provide certain assurance of performance by the entity pursuant to the terms of a written or oral agreement, such as a lease."
       }
      }
     },
     "auth_ref": [
      "r869"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://nexttrip.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r750"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://nexttrip.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r756"
     ]
    },
    "us-gaap_SellingAndMarketingExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SellingAndMarketingExpense",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/StatementsOfOperations",
      "http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sales and marketing",
        "verboseLabel": "Sales and marketing expense",
        "documentation": "The aggregate total amount of expenses directly related to the marketing or selling of products or services."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SellingGeneralAndAdministrativeExpensesPolicyTextBlock",
     "presentation": [
      "http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sales and Marketing",
        "documentation": "Disclosure of accounting policy for inclusion of significant items in the selling, general and administrative (or similar) expense report caption."
       }
      }
     },
     "auth_ref": [
      "r963"
     ]
    },
    "NTRP_SeriesEConvertiblePreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "SeriesEConvertiblePreferredStockMember",
     "presentation": [
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series E Convertible Preferred Stock [Member]",
        "documentation": "Series E Convertible Preferred Stock [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SeriesEPreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SeriesEPreferredStockMember",
     "presentation": [
      "http://nexttrip.com/role/GoodwillDetailsNarrative",
      "http://nexttrip.com/role/LossPerShareDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series E Preferred Stock [Member]",
        "documentation": "Series E preferred stock."
       }
      }
     },
     "auth_ref": [
      "r871",
      "r872",
      "r933"
     ]
    },
    "NTRP_SeriesFConvertiblePreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "SeriesFConvertiblePreferredStockMember",
     "presentation": [
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series F Convertible Preferred Stock [Member]",
        "documentation": "Series F Convertible Preferred Stock [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_SeriesGConvertiblePreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "SeriesGConvertiblePreferredStockMember",
     "presentation": [
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series G Convertible Preferred Stock [Member]",
        "documentation": "Series G Convertible Preferred Stock [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_SeriesHConvertiblePreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "SeriesHConvertiblePreferredStockMember",
     "presentation": [
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series H Convertible Preferred Stock [Member]",
        "documentation": "Series H Convertible Preferred Stock [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SeriesHPreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SeriesHPreferredStockMember",
     "presentation": [
      "http://nexttrip.com/role/LossPerShareDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series H Preferred Stock [Member]",
        "documentation": "Series H preferred stock."
       }
      }
     },
     "auth_ref": [
      "r871",
      "r872",
      "r933"
     ]
    },
    "NTRP_SeriesIConvertiblePreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "SeriesIConvertiblePreferredStockMember",
     "presentation": [
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series I Convertible Preferred Stock [Member]",
        "documentation": "Series I Convertible Preferred Stock [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_SeriesIPreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "SeriesIPreferredStockMember",
     "presentation": [
      "http://nexttrip.com/role/LossPerShareDetailsNarrative",
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series I Preferred Stock [Member]",
        "documentation": "Series I Preferred Stock [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_SeriesIPurchaseAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "SeriesIPurchaseAgreementMember",
     "presentation": [
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series I Purchase Agreement [Member]",
        "documentation": "Series I Purchase Agreement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_SeriesJNonvotingConvertiblePreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "SeriesJNonvotingConvertiblePreferredStockMember",
     "presentation": [
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series J Nonvoting Convertible Preferred Stock [Member]",
        "documentation": "Series J Nonvoting Convertible Preferred Stock [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_SeriesJPreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "SeriesJPreferredStockMember",
     "presentation": [
      "http://nexttrip.com/role/LossPerShareDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series J Preferred Stock [Member]",
        "documentation": "Series J Preferred Stock [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_SeriesKNonvotingConvertiblePreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "SeriesKNonvotingConvertiblePreferredStockMember",
     "presentation": [
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series K Nonvoting Convertible Preferred Stock [Member]",
        "documentation": "Series K Nonvoting Convertible Preferred Stock [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_SeriesKPreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "SeriesKPreferredStockMember",
     "presentation": [
      "http://nexttrip.com/role/LossPerShareDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series K Preferred Stock [Member]",
        "documentation": "Series K Preferred Stock [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_SeriesLNonvotingConvertiblePreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "SeriesLNonvotingConvertiblePreferredStockMember",
     "presentation": [
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series L Nonvoting Convertible Preferred Stock [Member]",
        "documentation": "Series L Nonvoting Convertible Preferred Stock [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_SeriesLPreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "SeriesLPreferredStockMember",
     "presentation": [
      "http://nexttrip.com/role/LossPerShareDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series L Preferred Stock [Member]",
        "documentation": "Series L Preferred Stock [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_SeriesMNonvotingConvertiblePreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "SeriesMNonvotingConvertiblePreferredStockMember",
     "presentation": [
      "http://nexttrip.com/role/NotesPayableDetailsNarrative",
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series M Nonvoting Convertible Preferred Stock [Member]",
        "documentation": "Series M Nonvoting Convertible Preferred Stock [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_SeriesMPreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "SeriesMPreferredStockMember",
     "presentation": [
      "http://nexttrip.com/role/LossPerShareDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series M Preferred Stock [Member]",
        "documentation": "Series M Preferred Stock [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_SeriesNNonvotingConvertibleConvertiblePreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "SeriesNNonvotingConvertibleConvertiblePreferredStockMember",
     "presentation": [
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series N Nonvoting Convertible Convertible Preferred Stock [Member]",
        "documentation": "Series N Nonvoting Convertible Convertible Preferred Stock [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_SeriesNNonvotingConvertiblePreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "SeriesNNonvotingConvertiblePreferredStockMember",
     "presentation": [
      "http://nexttrip.com/role/InvestmentInEquitySecuritiesDetailsNarrative",
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series N Nonvoting Convertible Preferred Stock [Member]",
        "documentation": "Series N Nonvoting Convertible Preferred Stock [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_SeriesNPreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "SeriesNPreferredStockMember",
     "presentation": [
      "http://nexttrip.com/role/LossPerShareDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series N Preferred Stock [Member]",
        "documentation": "Series N Preferred Stock [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_SeriesONonvotingConvertiblePreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "SeriesONonvotingConvertiblePreferredStockMember",
     "presentation": [
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series O Nonvoting Convertible Preferred Stock [Member]",
        "documentation": "Series O Nonvoting Convertible Preferred Stock [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_SeriesOPreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "SeriesOPreferredStockMember",
     "presentation": [
      "http://nexttrip.com/role/InvestmentInEquityMethodInvesteeDetailsNarrative",
      "http://nexttrip.com/role/LossPerShareDetailsNarrative",
      "http://nexttrip.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series O Preferred Stock [Member]",
        "documentation": "Series O Preferred Stock [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_SeriesOPreferredStockOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "SeriesOPreferredStockOneMember",
     "presentation": [
      "http://nexttrip.com/role/LossPerShareDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series O Preferred Stock One [Member]",
        "documentation": "Series O Preferred Stock One [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_SeriesPNonvotingConvertiblePreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "SeriesPNonvotingConvertiblePreferredStockMember",
     "presentation": [
      "http://nexttrip.com/role/NotesPayableDetailsNarrative",
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series P Nonvoting Convertible Preferred Stock [Member]",
        "documentation": "Series P Nonvoting Convertible Preferred Stock [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_SeveralInvestorsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "SeveralInvestorsMember",
     "presentation": [
      "http://nexttrip.com/role/ConvertibleNotesDetailsNarrative",
      "http://nexttrip.com/role/SharePurchaseAgreementsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Several Investors [Member]",
        "documentation": "Several Investors [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensation",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 2.0
      },
      "http://nexttrip.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/StatementsOfCashFlows",
      "http://nexttrip.com/role/StatementsOfOperations",
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock based compensation",
        "verboseLabel": "Allocation share based compensation expense",
        "documentation": "Amount of noncash expense for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfShareBasedPaymentsAwardStockOptionsValuationAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividend yield",
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term."
       }
      }
     },
     "auth_ref": [
      "r455"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfShareBasedPaymentsAwardStockOptionsValuationAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expected volatility, maximum",
        "documentation": "The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfShareBasedPaymentsAwardStockOptionsValuationAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expected volatility, minimum",
        "documentation": "The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfShareBasedPaymentsAwardStockOptionsValuationAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Risk-free interest rate, maximum",
        "documentation": "The maximum risk-free interest rate assumption that is used in valuing an option on its own shares."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfShareBasedPaymentsAwardStockOptionsValuationAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Risk-free interest rate, minimum",
        "documentation": "The minimum risk-free interest rate assumption that is used in valuing an option on its own shares."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfShareBasedPaymentsAwardStockOptionsValuationAssumptionsDetails",
      "http://nexttrip.com/role/ScheduleOfStockOptionActivityDetails",
      "http://nexttrip.com/role/StockholdersEquityTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r426",
      "r428",
      "r429",
      "r430",
      "r431",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfWarrantyActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Warrants,Exercised",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Exercised",
        "documentation": "Number of non-option equity instruments exercised by participants."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfWarrantyActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Warrants, Forfeited or cancelled",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Forfeitures",
        "documentation": "Number of shares under non-option equity instrument agreements that were cancelled as a result of occurrence of a terminating event."
       }
      }
     },
     "auth_ref": [
      "r155"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfWarrantyActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants, Granted",
        "documentation": "Net number of non-option equity instruments granted to participants."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfWarrantyActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Warrants Outstanding, Beginning Balance",
        "periodEndLabel": "Warrants Outstanding, Ending Balance",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number",
        "documentation": "Number of equity instruments other than options outstanding, including both vested and non-vested instruments."
       }
      }
     },
     "auth_ref": [
      "r153",
      "r154"
     ]
    },
    "NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfWarrantyActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Weighted Average Exercise Price Outstanding, Beginning Balance",
        "periodEndLabel": "Weighted Average Exercise Price Outstanding, Ending Balance",
        "documentation": "Weighted average exercise price, warrants outstanding.",
        "label": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "presentation": [
      "http://nexttrip.com/role/LossPerShareDetailsNarrative",
      "http://nexttrip.com/role/ScheduleOfStockOptionActivityDetails",
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Number of Options, Exercisable",
        "label": "Stock issued during Stock options exercised",
        "verboseLabel": "Shares issuable upon exercisable of options",
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan."
       }
      }
     },
     "auth_ref": [
      "r435"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Weighted Average Exercise Price, Exercisable",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r435"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue",
     "crdr": "debit",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Intrinsic Value, Exercised",
        "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares."
       }
      }
     },
     "auth_ref": [
      "r448"
     ]
    },
    "NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedorCancelledInPeriodTotalIntrinsicValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedorCancelledInPeriodTotalIntrinsicValue",
     "crdr": "debit",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Intrinsic Value, Forfeited or cancelled",
        "documentation": "Share based compensation arrangement by share based payment award options for feited or cancelled in period total intrinsic value."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfStockOptionActivityDetails",
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Number of Options, Forfeited or cancelled",
        "label": "Shares forfeited or expired",
        "documentation": "For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired."
       }
      }
     },
     "auth_ref": [
      "r941"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Exercise Price, Forfeited or cancelled",
        "documentation": "Weighted average price of options that were either forfeited or expired."
       }
      }
     },
     "auth_ref": [
      "r941"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "presentation": [
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Options to purchase of common stock",
        "documentation": "Gross number of share options (or share units) granted during the period."
       }
      }
     },
     "auth_ref": [
      "r437"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Options exercise price",
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology."
       }
      }
     },
     "auth_ref": [
      "r447"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "crdr": "debit",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Aggregate Intrinsic Value, Outstanding Balance",
        "periodEndLabel": "Aggregate Intrinsic Value, Outstanding Balance",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value",
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding."
       }
      }
     },
     "auth_ref": [
      "r56"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfStockOptionActivityDetails",
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Number of Options, Outstanding, Balance",
        "periodEndLabel": "Number of Options, Outstanding, Balance",
        "label": "Reverse acquisition shares outstanding",
        "documentation": "Number of options outstanding, including both vested and non-vested options."
       }
      }
     },
     "auth_ref": [
      "r433",
      "r434"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfStockOptionActivityDetails",
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Weighted Average Exercise Price, Outstanding Balance",
        "periodEndLabel": "Weighted Average Exercise Price, Outstanding Balance",
        "label": "Weighted average exercise price",
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r433",
      "r434"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue",
     "crdr": "debit",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Aggregate Intrinsic Value, Options vested, exercisable and options expected to vest",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value",
        "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r450"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Number of Options, Vested, Exercisable and Options Expected to Vest Balance",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number",
        "documentation": "Number of fully vested and expected to vest exercisable options that may be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r450"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Weighted Average Exercise Price, Vested, Exercisable and Options Expected to Vest",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price",
        "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r450"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue",
     "crdr": "debit",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Aggregate Intrinsic Value, Options expected to vest in the future",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value",
        "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r449"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Number of Options, Expected to vest in the future, Balance",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number",
        "documentation": "Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r449"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Weighted Average Exercise Price, Expected to Vest",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price",
        "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r449"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "presentation": [
      "http://nexttrip.com/role/InvestmentInEquitySecuritiesDetailsNarrative",
      "http://nexttrip.com/role/LossPerShareDetailsNarrative",
      "http://nexttrip.com/role/ScheduleOfStockOptionActivityDetails",
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative",
      "http://nexttrip.com/role/StockholdersEquityTables",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r429",
      "r430",
      "r431",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457"
     ]
    },
    "NTRP_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfWarrantyActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Exercise Price Outstanding,Exercised",
        "documentation": "Weighted average exercise price, warrants exercised."
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageWeightedAverageExercisePriceWarrantsForfeitedOrCancelled": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageWeightedAverageExercisePriceWarrantsForfeitedOrCancelled",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfWarrantyActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Exercise Price Outstanding, Forfeited or cancelled",
        "documentation": "Weighted average exercise price, warrants forfeited or cancelled."
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfWarrantyActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Exercise Price Outstanding, Granted",
        "documentation": "Weighted average exercise price, warrants grants."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Exercise Price, Exercised",
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares."
       }
      }
     },
     "auth_ref": [
      "r438"
     ]
    },
    "NTRP_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageForfeitedOrCancelled": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageForfeitedOrCancelled",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Weighted Average Exercise Price, Forfeited or cancelled",
        "documentation": "Forfeited or cancelled.",
        "label": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageForfeitedOrCancelled"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "presentation": [
      "http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Based Compensation",
        "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost."
       }
      }
     },
     "auth_ref": [
      "r425",
      "r432",
      "r451",
      "r452",
      "r453",
      "r454",
      "r457",
      "r460",
      "r461",
      "r462",
      "r463"
     ]
    },
    "NTRP_ShareExchangeAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "ShareExchangeAgreementMember",
     "presentation": [
      "http://nexttrip.com/role/BusinessDescriptionAndGoingConcernDetailsNarrative",
      "http://nexttrip.com/role/InvestmentInEquitySecuritiesDetailsNarrative",
      "http://nexttrip.com/role/LossPerShareDetailsNarrative",
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Exchange Agreement [Member]",
        "documentation": "Share Exchange Agreement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharePrice",
     "presentation": [
      "http://nexttrip.com/role/ConvertibleNotesDetailsNarrative",
      "http://nexttrip.com/role/SharePurchaseAgreementsDetailsNarrative",
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Share price",
        "label": "Conversion share price",
        "documentation": "Price of a single share of a number of saleable stocks of a company."
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_SharePurchaseAgreementsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "SharePurchaseAgreementsDisclosureTextBlock",
     "presentation": [
      "http://nexttrip.com/role/SharePurchaseAgreements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Share Purchase Agreements",
        "documentation": "Share Purchase Agreements Disclosure [Text Block]",
        "label": "Share Purchase Agreements Disclosure [Text Block]"
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_SharePurchaseAgreementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "SharePurchaseAgreementsMember",
     "presentation": [
      "http://nexttrip.com/role/SharePurchaseAgreementsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Purchase Agreements [Member]",
        "documentation": "Share Purchase Agreements [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_SharePurchaseAndExchangeAgreementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "SharePurchaseAndExchangeAgreementsMember",
     "presentation": [
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Purchase And Exchange Agreements [Member]",
        "documentation": "Share Purchase And Exchange Agreements [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfShareBasedPaymentsAwardStockOptionsValuationAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expected life",
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r453"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1",
     "crdr": "debit",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Aggregate Intrinsic Value, Options exercisable",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value",
        "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable."
       }
      }
     },
     "auth_ref": [
      "r56"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Remaining Contractual Life, Exercisable",
        "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r56"
     ]
    },
    "NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonGrantsWeightedAverageRemainingContractualTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonGrantsWeightedAverageRemainingContractualTerm",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfWarrantyActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Remaining Contractual Life Years, Granted",
        "documentation": "Share based compensation arrangement by share based payment award options non grants weighted average remaining contractual term."
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonOutstandingWeightedAverageRemainingContractualTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonOutstandingWeightedAverageRemainingContractualTerm",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfWarrantyActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Remaining Contractual Life Years, Ending Balance",
        "documentation": "Weighted average remaining contractual life (years), warrants outstanding, beginning balance."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Remaining Contractual Life, Outstanding Balance",
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r156"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Remaining Contractual Life, Vested, Exercisable and Options Expected to Vest",
        "documentation": "Weighted average remaining contractual term for fully vested and expected to vest exercisable or convertible options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r450"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Remaining Contractual Life, Expected to Vest",
        "documentation": "Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r449"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares",
     "presentation": [
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share based compensation arrangement by award options vested",
        "documentation": "Number of options vested."
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardWeightedAverageRemainingRecognitionPeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardWeightedAverageRemainingRecognitionPeriod",
     "presentation": [
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Weighted average remaining recognition period",
        "documentation": "Weighted average remaining recognition period.",
        "label": "SharebasedCompensationArrangementBySharebasedPaymentAwardWeightedAverageRemainingRecognitionPeriod"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharesIssued",
     "presentation": [
      "http://nexttrip.com/role/InvestmentInEquityMethodInvesteeDetailsNarrative",
      "http://nexttrip.com/role/NotesPayableDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business acquisition shares issued",
        "verboseLabel": "Shares, Issued",
        "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "us-gaap_SharesIssuedPricePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharesIssuedPricePerShare",
     "presentation": [
      "http://nexttrip.com/role/BusinessDescriptionAndGoingConcernDetailsNarrative",
      "http://nexttrip.com/role/InvestmentInEquityMethodInvesteeDetailsNarrative",
      "http://nexttrip.com/role/InvestmentInEquitySecuritiesDetailsNarrative",
      "http://nexttrip.com/role/NotesPayableDetailsNarrative",
      "http://nexttrip.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share price per share",
        "verboseLabel": "Business acquisition shares price per share",
        "terseLabel": "Shares issued price per share",
        "documentation": "Per share or per unit amount of equity securities issued."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharesOutstanding",
     "presentation": [
      "http://nexttrip.com/role/StatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Beginning balance, shares",
        "periodEndLabel": "Ending balance, shares",
        "label": "Shares, Outstanding",
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury."
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_ShortTermPromissoryNoteMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "ShortTermPromissoryNoteMember",
     "presentation": [
      "http://nexttrip.com/role/NotesPayableDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Short Term Promissory Note [Member]",
        "documentation": "Short Term Promissory Note [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_SigmaAdditiveSolutionsIncMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "SigmaAdditiveSolutionsIncMember",
     "presentation": [
      "http://nexttrip.com/role/GoodwillDetailsNarrative",
      "http://nexttrip.com/role/ScheduleOfFairValueOfAssetsAcquiredDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sigma Additive Solutions Inc. [Member]",
        "documentation": "Sigma Additive Solutions Inc. [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SignificantAccountingPoliciesTextBlock",
     "presentation": [
      "http://nexttrip.com/role/SummaryOfSignificantAccountingPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Summary of Significant Accounting Policies",
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity."
       }
      }
     },
     "auth_ref": [
      "r133",
      "r226"
     ]
    },
    "NTRP_SoftwareAsAServiceAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "SoftwareAsAServiceAgreementMember",
     "presentation": [
      "http://nexttrip.com/role/SharePurchaseAgreementsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Software as a Service Agreement [Member]",
        "documentation": "Software as a Service Agreement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SoftwareDevelopmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SoftwareDevelopmentMember",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Software Development [Member]",
        "documentation": "Internally developed software for sale, licensing or long-term internal use."
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_SoftwareLicenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "SoftwareLicenseMember",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Software License [Member]",
        "documentation": "Software License [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_SoftwareLicensesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "SoftwareLicensesMember",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfEstimatedUsefulLivesForFiniteLifeIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Software Licenses [Member]",
        "documentation": "Software Licenses [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_SoftwareMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "SoftwareMember",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfEstimatedUsefulLivesForFiniteLifeIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Software [Member]",
        "documentation": "Software [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://nexttrip.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r754"
     ]
    },
    "NTRP_SpecialPurposeAcquisitionCorporationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "SpecialPurposeAcquisitionCorporationMember",
     "presentation": [
      "http://nexttrip.com/role/ConvertibleNotesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Special Purpose Acquisition Corporation [Member]",
        "documentation": "Special Purpose Acquisition Corporation [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementClassOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementClassOfStockAxis",
     "presentation": [
      "http://nexttrip.com/role/BusinessDescriptionAndGoingConcernDetailsNarrative",
      "http://nexttrip.com/role/GoodwillDetailsNarrative",
      "http://nexttrip.com/role/InvestmentInEquityMethodInvesteeDetailsNarrative",
      "http://nexttrip.com/role/InvestmentInEquitySecuritiesDetailsNarrative",
      "http://nexttrip.com/role/LossPerShareDetailsNarrative",
      "http://nexttrip.com/role/NotesPayableDetailsNarrative",
      "http://nexttrip.com/role/ScheduleOfWeightedAverageCommonSharesDetails",
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative",
      "http://nexttrip.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]",
        "documentation": "Information by the different classes of stock of the entity."
       }
      }
     },
     "auth_ref": [
      "r193",
      "r206",
      "r207",
      "r208",
      "r229",
      "r253",
      "r256",
      "r266",
      "r268",
      "r276",
      "r277",
      "r302",
      "r354",
      "r356",
      "r357",
      "r358",
      "r361",
      "r362",
      "r394",
      "r395",
      "r398",
      "r401",
      "r407",
      "r523",
      "r595",
      "r596",
      "r597",
      "r598",
      "r604",
      "r605",
      "r606",
      "r607",
      "r608",
      "r609",
      "r610",
      "r611",
      "r612",
      "r613",
      "r614",
      "r615",
      "r626",
      "r648",
      "r670",
      "r687",
      "r688",
      "r689",
      "r690",
      "r691",
      "r857",
      "r879",
      "r889"
     ]
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementEquityComponentsAxis",
     "presentation": [
      "http://nexttrip.com/role/BusinessDescriptionAndGoingConcernDetailsNarrative",
      "http://nexttrip.com/role/ConvertibleNotesDetailsNarrative",
      "http://nexttrip.com/role/LossPerShareDetailsNarrative",
      "http://nexttrip.com/role/SharePurchaseAgreementsDetailsNarrative",
      "http://nexttrip.com/role/StatementsOfStockholdersEquity",
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative",
      "http://nexttrip.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Components [Axis]",
        "documentation": "Information by component of equity."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r110",
      "r113",
      "r114",
      "r195",
      "r214",
      "r215",
      "r216",
      "r234",
      "r235",
      "r236",
      "r238",
      "r243",
      "r245",
      "r247",
      "r275",
      "r304",
      "r305",
      "r333",
      "r409",
      "r485",
      "r486",
      "r495",
      "r496",
      "r497",
      "r499",
      "r503",
      "r504",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r517",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r534",
      "r535",
      "r538",
      "r579",
      "r586",
      "r587",
      "r588",
      "r604",
      "r670"
     ]
    },
    "us-gaap_StatementLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementLineItems",
     "presentation": [
      "http://nexttrip.com/role/ConvertibleNotesDetailsNarrative",
      "http://nexttrip.com/role/GoodwillDetailsNarrative",
      "http://nexttrip.com/role/InvestmentInEquitySecuritiesDetailsNarrative",
      "http://nexttrip.com/role/ScheduleOfBusinessMilestonesAndIssuableContingentSharesDetails",
      "http://nexttrip.com/role/ScheduleOfUnauditedSummarizedFinancialInformationDetails",
      "http://nexttrip.com/role/SharePurchaseAgreementsDetailsNarrative",
      "http://nexttrip.com/role/StatementsOfStockholdersEquity",
      "http://nexttrip.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r234",
      "r235",
      "r236",
      "r275",
      "r535",
      "r556",
      "r593",
      "r615",
      "r618",
      "r619",
      "r620",
      "r621",
      "r622",
      "r623",
      "r626",
      "r629",
      "r630",
      "r631",
      "r632",
      "r633",
      "r635",
      "r636",
      "r637",
      "r638",
      "r640",
      "r641",
      "r642",
      "r643",
      "r644",
      "r646",
      "r649",
      "r650",
      "r656",
      "r657",
      "r658",
      "r659",
      "r660",
      "r661",
      "r662",
      "r663",
      "r664",
      "r665",
      "r666",
      "r667",
      "r670",
      "r738"
     ]
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementOfCashFlowsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementOfFinancialPositionAbstract",
     "auth_ref": []
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementOfStockholdersEquityAbstract",
     "auth_ref": []
    },
    "srt_StatementScenarioAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "StatementScenarioAxis",
     "presentation": [
      "http://nexttrip.com/role/LossPerShareDetailsNarrative",
      "http://nexttrip.com/role/ScheduleOfBusinessMilestonesAndIssuableContingentSharesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Axis]"
       }
      }
     },
     "auth_ref": [
      "r248",
      "r424",
      "r858",
      "r862",
      "r887"
     ]
    },
    "us-gaap_StatementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementTable",
     "presentation": [
      "http://nexttrip.com/role/ConvertibleNotesDetailsNarrative",
      "http://nexttrip.com/role/GoodwillDetailsNarrative",
      "http://nexttrip.com/role/InvestmentInEquitySecuritiesDetailsNarrative",
      "http://nexttrip.com/role/ScheduleOfBusinessMilestonesAndIssuableContingentSharesDetails",
      "http://nexttrip.com/role/ScheduleOfUnauditedSummarizedFinancialInformationDetails",
      "http://nexttrip.com/role/SharePurchaseAgreementsDetailsNarrative",
      "http://nexttrip.com/role/StatementsOfStockholdersEquity",
      "http://nexttrip.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Table]",
        "documentation": "Disclosure of information about statement of comprehensive income, income, other comprehensive income, financial position, cash flows, and shareholders' equity."
       }
      }
     },
     "auth_ref": [
      "r234",
      "r235",
      "r236",
      "r275",
      "r291",
      "r535",
      "r556",
      "r593",
      "r615",
      "r618",
      "r619",
      "r620",
      "r621",
      "r622",
      "r623",
      "r626",
      "r629",
      "r630",
      "r631",
      "r632",
      "r633",
      "r635",
      "r636",
      "r637",
      "r638",
      "r640",
      "r641",
      "r642",
      "r643",
      "r644",
      "r646",
      "r649",
      "r650",
      "r656",
      "r657",
      "r658",
      "r659",
      "r660",
      "r661",
      "r662",
      "r663",
      "r664",
      "r665",
      "r666",
      "r667",
      "r670",
      "r738"
     ]
    },
    "ecd_StkPrcOrTsrEstimationMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "StkPrcOrTsrEstimationMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Price or TSR Estimation Method"
       }
      }
     },
     "auth_ref": [
      "r774",
      "r785",
      "r799",
      "r825"
     ]
    },
    "NTRP_StockAppreciationRightsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "StockAppreciationRightsMember",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfStockOptionActivityDetails",
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative",
      "http://nexttrip.com/role/StockholdersEquityTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Appreciation Rights [Member]",
        "documentation": "Stock Appreciation Rights [Member]."
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_StockIssuedDuringPeriodShareOfPreferredShares": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "StockIssuedDuringPeriodShareOfPreferredShares",
     "crdr": "credit",
     "presentation": [
      "http://nexttrip.com/role/StatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of Preferred Shares, Shares",
        "documentation": "Stock issued during period share of preferred shares."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesAcquisitions": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesAcquisitions",
     "presentation": [
      "http://nexttrip.com/role/BalanceSheetsParenthetical",
      "http://nexttrip.com/role/StatementsOfOperationsParenthetical",
      "http://nexttrip.com/role/StatementsOfStockholdersEquityParenthetical",
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of shares acquired",
        "verboseLabel": "Shares issued in acquisitions",
        "documentation": "Number of shares of stock issued during the period pursuant to acquisitions."
       }
      }
     },
     "auth_ref": [
      "r109",
      "r110",
      "r146"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities",
     "presentation": [
      "http://nexttrip.com/role/ConvertibleNotesDetailsNarrative",
      "http://nexttrip.com/role/SharePurchaseAgreementsDetailsNarrative",
      "http://nexttrip.com/role/StatementsOfStockholdersEquity",
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Conversion of Convertible Notes, Shares",
        "verboseLabel": "Conversion of convertible notes, shares",
        "terseLabel": "Conversion shares issued",
        "documentation": "Number of shares issued during the period as a result of the conversion of convertible securities."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r49",
      "r110",
      "r113",
      "r146",
      "r380"
     ]
    },
    "NTRP_StockIssuedDuringPeriodSharesConversionOfPreferredSharesToCommonShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "StockIssuedDuringPeriodSharesConversionOfPreferredSharesToCommonShares",
     "presentation": [
      "http://nexttrip.com/role/StatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Conversion of Preferred Shares to Common Shares, shares",
        "documentation": "Stock issued during period shares conversion of preferred shares to common shares."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesConversionOfUnits",
     "presentation": [
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Common stock issuable upon conversion",
        "label": "Stock Issued During Period, Shares, Conversion of Units",
        "documentation": "The number of shares issued during the period upon the conversion of units. An example of a convertible unit is an umbrella partnership real estate investment trust unit (UPREIT unit)."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r49",
      "r109",
      "r110",
      "r146"
     ]
    },
    "NTRP_StockIssuedDuringPeriodSharesIssuanceOfCommitmentSharesForEquityLineOfCredit": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "StockIssuedDuringPeriodSharesIssuanceOfCommitmentSharesForEquityLineOfCredit",
     "presentation": [
      "http://nexttrip.com/role/StatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of Commitment Shares for Equity Line of Credit, shares",
        "documentation": "Stock issued during period shares issuance of commitment shares for equity line of credit."
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_StockIssuedDuringPeriodSharesIssuanceOfPreferredSharesForDebtConversions": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "StockIssuedDuringPeriodSharesIssuanceOfPreferredSharesForDebtConversions",
     "presentation": [
      "http://nexttrip.com/role/StatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of Preferred Shares for Debt Conversions, shares",
        "documentation": "Stock issued during period shares issuance of preferred shares for debt conversion."
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_StockIssuedDuringPeriodSharesIssuanceOfSecuritiesForServices": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "StockIssuedDuringPeriodSharesIssuanceOfSecuritiesForServices",
     "presentation": [
      "http://nexttrip.com/role/StatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of Securities for Services, shares",
        "documentation": "Stock issued during period shares issuance of securities for services."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesIssuedForServices": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesIssuedForServices",
     "presentation": [
      "http://nexttrip.com/role/StatementsOfStockholdersEquity",
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of Common Shares for Services, Shares",
        "verboseLabel": "Issuance of shares for services",
        "documentation": "Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "presentation": [
      "http://nexttrip.com/role/BusinessDescriptionAndGoingConcernDetailsNarrative",
      "http://nexttrip.com/role/InvestmentInEquitySecuritiesDetailsNarrative",
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative",
      "http://nexttrip.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of common stock issued",
        "verboseLabel": "Number of shares issued",
        "terseLabel": "Shares issued",
        "documentation": "Number of new stock issued during the period."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r109",
      "r110",
      "r146",
      "r595",
      "r670",
      "r688"
     ]
    },
    "NTRP_StockIssuedDuringPeriodSharesOfPreferredSharesInPrivatePlacements": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "StockIssuedDuringPeriodSharesOfPreferredSharesInPrivatePlacements",
     "presentation": [
      "http://nexttrip.com/role/StatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of Preferred Shares in Private Placements, shares",
        "documentation": "Stock issued during period shares of preferred shares in private placement."
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_StockIssuedDuringPeriodSharesPurchasesOfCommonShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "StockIssuedDuringPeriodSharesPurchasesOfCommonShares",
     "presentation": [
      "http://nexttrip.com/role/StatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Purchases of Common Shares, Sharers",
        "documentation": "Stock issued during period shares purchases of common shares."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardGross",
     "presentation": [
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative",
      "http://nexttrip.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restricted shares",
        "verboseLabel": "Restricted shares, issued",
        "documentation": "Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r146"
     ]
    },
    "NTRP_StockIssuedDuringPeriodSharesReverseAcquisition": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "StockIssuedDuringPeriodSharesReverseAcquisition",
     "presentation": [
      "http://nexttrip.com/role/StatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reverse Acquisition of Sigma Additive Solutions, Inc., Shares",
        "documentation": "Stock issued during period shares reverse acquisition."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesReverseStockSplits",
     "presentation": [
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reverse stock split issued common shares",
        "documentation": "Reduction in the number of shares during the period as a result of a reverse stock split."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation",
     "presentation": [
      "http://nexttrip.com/role/StatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Compensation, shares",
        "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP)."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r109",
      "r110",
      "r146"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfStockOptionActivityDetails",
      "http://nexttrip.com/role/StatementsOfStockholdersEquity",
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of Common Shares for Warrant Exercises, shares",
        "negatedLabel": "Number of Options, Exercised",
        "verboseLabel": "Shares issued or exercised",
        "documentation": "Number of share options (or share units) exercised during the current period."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r109",
      "r110",
      "r146",
      "r438"
     ]
    },
    "NTRP_StockIssuedDuringPeriodSharesWarrantExercises": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "StockIssuedDuringPeriodSharesWarrantExercises",
     "presentation": [
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of shares warrant exercises",
        "documentation": "Shares of warrant exercises."
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_StockIssuedDuringPeriodSharseSecuritiesIssuedForEquityInvestments": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "StockIssuedDuringPeriodSharseSecuritiesIssuedForEquityInvestments",
     "presentation": [
      "http://nexttrip.com/role/StatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities Issued for Equity Investments, shares",
        "documentation": "Stock issued during period shares securities issued for equity investments."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodValueConversionOfConvertibleSecurities",
     "crdr": "credit",
     "presentation": [
      "http://nexttrip.com/role/StatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Conversion of Convertible Notes",
        "documentation": "The gross value of stock issued during the period upon the conversion of convertible securities."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r110",
      "r113",
      "r114",
      "r146"
     ]
    },
    "NTRP_StockIssuedDuringPeriodValueConversionOfPreferredSharesToCommonShares": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "StockIssuedDuringPeriodValueConversionOfPreferredSharesToCommonShares",
     "crdr": "credit",
     "presentation": [
      "http://nexttrip.com/role/StatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Conversion of Preferred Shares to Common Shares",
        "documentation": "Stock issued during period value conversion of preferred shares to common shares."
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_StockIssuedDuringPeriodValueIssuanceOfCommitmentSharesForEquityLineOfCredit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "StockIssuedDuringPeriodValueIssuanceOfCommitmentSharesForEquityLineOfCredit",
     "crdr": "credit",
     "presentation": [
      "http://nexttrip.com/role/StatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of Commitment Shares for Equity Line of Credit",
        "documentation": "Stock issued during period value issuance of commitment shares for equity line of credit."
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_StockIssuedDuringPeriodValueIssuanceOfPreferredSharesForDebtConversions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "StockIssuedDuringPeriodValueIssuanceOfPreferredSharesForDebtConversions",
     "crdr": "credit",
     "presentation": [
      "http://nexttrip.com/role/StatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of Preferred Shares for Debt Conversions",
        "documentation": "Stock issued during period value issuance of preferred shares for debt conversion."
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_StockIssuedDuringPeriodValueIssuanceOfSecuritiesForServices": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "StockIssuedDuringPeriodValueIssuanceOfSecuritiesForServices",
     "crdr": "credit",
     "presentation": [
      "http://nexttrip.com/role/StatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of Securities for Services",
        "documentation": "Stock issued during period value issuance of securities for services."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodValueIssuedForServices": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodValueIssuedForServices",
     "crdr": "credit",
     "presentation": [
      "http://nexttrip.com/role/StatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of Common Shares for Services",
        "documentation": "Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "crdr": "credit",
     "presentation": [
      "http://nexttrip.com/role/BusinessDescriptionAndGoingConcernDetailsNarrative",
      "http://nexttrip.com/role/InvestmentInEquitySecuritiesDetailsNarrative",
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of common stock issued, value",
        "verboseLabel": "Shares issued value",
        "terseLabel": "Issuance of shares",
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r109",
      "r110",
      "r146",
      "r604",
      "r670",
      "r688",
      "r744"
     ]
    },
    "NTRP_StockIssuedDuringPeriodValueOfPreferredShares": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "StockIssuedDuringPeriodValueOfPreferredShares",
     "crdr": "credit",
     "presentation": [
      "http://nexttrip.com/role/StatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of Preferred Shares",
        "documentation": "Stock issued during period value of preferred shares."
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_StockIssuedDuringPeriodValueOfPreferredSharesInPrivatePlacements": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "StockIssuedDuringPeriodValueOfPreferredSharesInPrivatePlacements",
     "crdr": "credit",
     "presentation": [
      "http://nexttrip.com/role/StatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of Preferred Shares in Private Placements",
        "documentation": "Stock issued during period value of preferred shares in private placements."
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_StockIssuedDuringPeriodValuePurchasesOfCommonShares": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "StockIssuedDuringPeriodValuePurchasesOfCommonShares",
     "crdr": "credit",
     "presentation": [
      "http://nexttrip.com/role/StatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Purchases of Common Shares",
        "documentation": "Stock issued during period value purchases of common shares."
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_StockIssuedDuringPeriodValueReverseAcquisition": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "StockIssuedDuringPeriodValueReverseAcquisition",
     "crdr": "credit",
     "presentation": [
      "http://nexttrip.com/role/StatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reverse Acquisition of Sigma Additive Solutions, Inc.",
        "documentation": "Stock issued during period value reverse acquisition."
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_StockIssuedDuringPeriodValueSecuritiesIssuedForEquityInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "StockIssuedDuringPeriodValueSecuritiesIssuedForEquityInvestments",
     "crdr": "credit",
     "presentation": [
      "http://nexttrip.com/role/StatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities Issued for Equity Investments",
        "documentation": "Stock issued during period value securities issued for equity investments."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensation",
     "crdr": "credit",
     "presentation": [
      "http://nexttrip.com/role/StatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Stock Compensation",
        "label": "Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture",
        "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP)."
       }
      }
     },
     "auth_ref": [
      "r57",
      "r109",
      "r110",
      "r146"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "crdr": "credit",
     "presentation": [
      "http://nexttrip.com/role/StatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of Common Shares for Warrant Exercises",
        "documentation": "Value of stock issued as a result of the exercise of stock options."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r110",
      "r113",
      "r114",
      "r146"
     ]
    },
    "us-gaap_StockOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockOptionMember",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfAnti-dilutiveSecuritiesExcludedFromComputationOfEarningsPerShareDetails",
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Option [Member]",
        "documentation": "Contracts conveying rights, but not obligations, to buy or sell a specific quantity of stock at a specified price during a specified period (an American option) or at a specified date (a European option)."
       }
      }
     },
     "auth_ref": [
      "r737"
     ]
    },
    "us-gaap_StockRepurchasedDuringPeriodShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockRepurchasedDuringPeriodShares",
     "presentation": [
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Purchase of shares issued",
        "documentation": "Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r109",
      "r110",
      "r146",
      "r598",
      "r670",
      "r690"
     ]
    },
    "us-gaap_StockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://nexttrip.com/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/BalanceSheets",
      "http://nexttrip.com/role/ScheduleOfUnauditedSummarizedFinancialInformationDetails",
      "http://nexttrip.com/role/StatementsOfStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Stockholders\u2019 Equity",
        "periodStartLabel": "Beginning balance",
        "periodEndLabel": "Ending balance",
        "label": "Member\u2019s equity",
        "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r110",
      "r113",
      "r114",
      "r136",
      "r628",
      "r645",
      "r671",
      "r672",
      "r731",
      "r745",
      "r881",
      "r902",
      "r975",
      "r1031"
     ]
    },
    "us-gaap_StockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockholdersEquityAbstract",
     "presentation": [
      "http://nexttrip.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholder\u2019s Equity"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "presentation": [
      "http://nexttrip.com/role/StockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders\u2019 Equity",
        "documentation": "The entire disclosure for equity."
       }
      }
     },
     "auth_ref": [
      "r143",
      "r228",
      "r393",
      "r395",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r409",
      "r516",
      "r673",
      "r675",
      "r692"
     ]
    },
    "us-gaap_StockholdersEquityReverseStockSplit": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockholdersEquityReverseStockSplit",
     "presentation": [
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reverse stock split",
        "documentation": "Description of the reverse stock split arrangement. Also provide the retroactive effect given by the reverse split that occurs after the balance sheet date but before the release of financial statements."
       }
      }
     },
     "auth_ref": [
      "r147"
     ]
    },
    "us-gaap_SubsequentEventMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventMember",
     "presentation": [
      "http://nexttrip.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event [Member]",
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r531",
      "r548"
     ]
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventTypeAxis",
     "presentation": [
      "http://nexttrip.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event Type [Axis]",
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r531",
      "r548"
     ]
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventTypeDomain",
     "presentation": [
      "http://nexttrip.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r531",
      "r548"
     ]
    },
    "us-gaap_SubsequentEventsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventsTextBlock",
     "presentation": [
      "http://nexttrip.com/role/SubsequentEvents"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events",
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business."
       }
      }
     },
     "auth_ref": [
      "r547",
      "r549"
     ]
    },
    "us-gaap_SubsidiarySaleOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsidiarySaleOfStockAxis",
     "presentation": [
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sale of Stock [Axis]",
        "documentation": "Information by type of sale of the entity's stock."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubstantialDoubtAboutGoingConcernTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubstantialDoubtAboutGoingConcernTextBlock",
     "presentation": [
      "http://nexttrip.com/role/BusinessDescriptionAndGoingConcern"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Description and Going Concern",
        "documentation": "The entire disclosure when substantial doubt is raised about the ability to continue as a going concern. Includes, but is not limited to, principal conditions or events that raised substantial doubt about the ability to continue as a going concern, management's evaluation of the significance of those conditions or events in relation to the ability to meet its obligations, and management's plans that alleviated or are intended to mitigate the conditions or events that raise substantial doubt about the ability to continue as a going concern."
       }
      }
     },
     "auth_ref": [
      "r97"
     ]
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SupplementalCashFlowInformationAbstract",
     "presentation": [
      "http://nexttrip.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental cash flow information"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TabularListTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TabularListTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tabular List, Table"
       }
      }
     },
     "auth_ref": [
      "r818"
     ]
    },
    "NTRP_Technology": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "Technology",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Technology",
        "documentation": "Technology."
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_ThirdPartyConsultantMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "ThirdPartyConsultantMember",
     "presentation": [
      "http://nexttrip.com/role/SharePurchaseAgreementsDetailsNarrative",
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Third Party Consultant [Member]",
        "documentation": "Third Party Consultant [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_ThirdPartyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "ThirdPartyMember",
     "presentation": [
      "http://nexttrip.com/role/SharePurchaseAgreementsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Third Party [Member]",
        "documentation": "Third Party [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_TitleOfIndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "TitleOfIndividualAxis",
     "presentation": [
      "http://nexttrip.com/role/SharePurchaseAgreementsDetailsNarrative",
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title and Position [Axis]"
       }
      }
     },
     "auth_ref": [
      "r896",
      "r980"
     ]
    },
    "srt_TitleOfIndividualWithRelationshipToEntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "TitleOfIndividualWithRelationshipToEntityDomain",
     "presentation": [
      "http://nexttrip.com/role/SharePurchaseAgreementsDetailsNarrative",
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "auth_ref": []
    },
    "ecd_TotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r810"
     ]
    },
    "ecd_TotalShareholderRtnVsPeerGroupTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TotalShareholderRtnVsPeerGroupTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Vs Peer Group"
       }
      }
     },
     "auth_ref": [
      "r817"
     ]
    },
    "us-gaap_TradeAndOtherAccountsReceivablePolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TradeAndOtherAccountsReceivablePolicy",
     "presentation": [
      "http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts Receivable",
        "documentation": "Disclosure of accounting policy for accounts receivable."
       }
      }
     },
     "auth_ref": [
      "r179",
      "r180",
      "r181",
      "r898",
      "r899",
      "r900"
     ]
    },
    "us-gaap_TrademarksMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TrademarksMember",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trademarks [Member]",
        "documentation": "Rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style."
       }
      }
     },
     "auth_ref": [
      "r67",
      "r713",
      "r909",
      "r910",
      "r911",
      "r912",
      "r913",
      "r914",
      "r916",
      "r918",
      "r919",
      "r920"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://nexttrip.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_TravelAgentPlatformMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "TravelAgentPlatformMember",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfBusinessMilestonesAndIssuableContingentSharesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Travel Agent Platform [Member]",
        "documentation": "Travel Agent Platform [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TrdArrAdoptionDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrAdoptionDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adoption Date"
       }
      }
     },
     "auth_ref": [
      "r841"
     ]
    },
    "ecd_TrdArrDuration": {
     "xbrltype": "durationItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrDuration",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Arrangement Duration"
       }
      }
     },
     "auth_ref": [
      "r842"
     ]
    },
    "ecd_TrdArrExpirationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrExpirationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expiration Date"
       }
      }
     },
     "auth_ref": [
      "r842"
     ]
    },
    "ecd_TrdArrIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Name",
        "label": "Trading Arrangement, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r840"
     ]
    },
    "ecd_TrdArrIndTitle": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrIndTitle",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title"
       }
      }
     },
     "auth_ref": [
      "r840"
     ]
    },
    "ecd_TrdArrTerminationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrTerminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Termination Date"
       }
      }
     },
     "auth_ref": [
      "r841"
     ]
    },
    "NTRP_TwoPromissoryNotesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "TwoPromissoryNotesMember",
     "presentation": [
      "http://nexttrip.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Two Promissory Notes [Member]",
        "documentation": "Two Promissory Notes [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_TwoThousandAndTwentyStockAppreciationRightsPlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "TwoThousandAndTwentyStockAppreciationRightsPlanMember",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfShareBasedPaymentsAwardStockOptionsValuationAssumptionsDetails",
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "2020 Stock Appreciation Rights Plan [Member]",
        "documentation": "2020 Stock Appreciation Rights Plan [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_TwoThousandThirteenEquityIncentivePlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "TwoThousandThirteenEquityIncentivePlanMember",
     "presentation": [
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "2013 Equity Incentive Plan [Member]",
        "documentation": "2013 Equity Incentive Plan [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_TwoThousandTwentyThreeEquityIncentivePlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "TwoThousandTwentyThreeEquityIncentivePlanMember",
     "presentation": [
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "2023 Equity Incentive Plan [Member]",
        "documentation": "2023 Equity Incentive Plan [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TypeOfArrangementAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TypeOfArrangementAxis",
     "presentation": [
      "http://nexttrip.com/role/BusinessDescriptionAndGoingConcernDetailsNarrative",
      "http://nexttrip.com/role/ConvertibleNotesDetailsNarrative",
      "http://nexttrip.com/role/DiscontinuedOperationsDetailsNarrative",
      "http://nexttrip.com/role/InvestmentInEquityMethodInvesteeDetailsNarrative",
      "http://nexttrip.com/role/InvestmentInEquitySecuritiesDetailsNarrative",
      "http://nexttrip.com/role/LossPerShareDetailsNarrative",
      "http://nexttrip.com/role/NotesPayableDetailsNarrative",
      "http://nexttrip.com/role/SharePurchaseAgreementsDetailsNarrative",
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative",
      "http://nexttrip.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]",
        "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations."
       }
      }
     },
     "auth_ref": [
      "r505"
     ]
    },
    "ecd_UndrlygSecurityMktPriceChngPct": {
     "xbrltype": "pureItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "UndrlygSecurityMktPriceChngPct",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Underlying Security Market Price Change"
       }
      }
     },
     "auth_ref": [
      "r837"
     ]
    },
    "us-gaap_UseOfEstimates": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "UseOfEstimates",
     "presentation": [
      "http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Use of Estimates",
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles."
       }
      }
     },
     "auth_ref": [
      "r41",
      "r42",
      "r43",
      "r183",
      "r184",
      "r186",
      "r187"
     ]
    },
    "us-gaap_WarrantMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WarrantMember",
     "presentation": [
      "http://nexttrip.com/role/LossPerShareDetailsNarrative",
      "http://nexttrip.com/role/ScheduleOfAnti-dilutiveSecuritiesExcludedFromComputationOfEarningsPerShareDetails",
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrant [Member]",
        "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount."
       }
      }
     },
     "auth_ref": [
      "r735",
      "r736",
      "r739",
      "r740",
      "r741",
      "r742"
     ]
    },
    "us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WeightedAverageNumberDilutedSharesOutstandingAdjustment",
     "presentation": [
      "http://nexttrip.com/role/LossPerShareDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Potentially dilutive securities",
        "documentation": "The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation."
       }
      }
     },
     "auth_ref": [
      "r890"
     ]
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "presentation": [
      "http://nexttrip.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted nverage number of shares outstanding diluted",
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period."
       }
      }
     },
     "auth_ref": [
      "r252",
      "r268"
     ]
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfEarningsPerShareBasicAndDilutedDetails",
      "http://nexttrip.com/role/ScheduleOfWeightedAverageCommonSharesDetails",
      "http://nexttrip.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted average number of shares outstanding basic",
        "verboseLabel": "Weighted average number of common shares Outstanding used in loss per share during the Period (denominator)",
        "terseLabel": "Weighted average common shares outstanding",
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period."
       }
      }
     },
     "auth_ref": [
      "r250",
      "r268"
     ]
    },
    "NTRP_WorkingCapitalDeficit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://nexttrip.com/20250228",
     "localname": "WorkingCapitalDeficit",
     "crdr": "credit",
     "presentation": [
      "http://nexttrip.com/role/BusinessDescriptionAndGoingConcernDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Working capital deficit",
        "documentation": "Working capital deficit."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://nexttrip.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r855"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "30",
   "Paragraph": "7",
   "SubTopic": "30",
   "Topic": "805",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479637/805-30-30-7"
  },
  "r1": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "30",
   "Paragraph": "8",
   "SubTopic": "30",
   "Topic": "805",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479637/805-30-30-8"
  },
  "r2": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "SubTopic": "230",
   "Topic": "830",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477401/830-230-45-1"
  },
  "r3": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14"
  },
  "r4": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "SubTopic": "405",
   "Topic": "942",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477787/942-405-45-2"
  },
  "r5": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "21D",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-21D"
  },
  "r6": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(g)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25"
  },
  "r7": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r8": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r9": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r10": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "825",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-1"
  },
  "r11": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "20",
   "Topic": "205",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-1"
  },
  "r12": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "20",
   "Topic": "715",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r13": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "SubTopic": "30",
   "Topic": "805",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r14": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "SubTopic": "10",
   "Topic": "505",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2"
  },
  "r15": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r16": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r17": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r18": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r19": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2A",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2A"
  },
  "r20": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "SubTopic": "10",
   "Topic": "323",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r21": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3"
  },
  "r22": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22))",
   "SubTopic": "10",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r23": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "205",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-3"
  },
  "r24": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13"
  },
  "r25": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14"
  },
  "r26": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-4"
  },
  "r27": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-1"
  },
  "r28": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2"
  },
  "r29": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-3"
  },
  "r30": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-4"
  },
  "r31": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-5"
  },
  "r32": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r33": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r34": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r35": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-2"
  },
  "r36": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "52",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-52"
  },
  "r37": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-16"
  },
  "r38": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-18"
  },
  "r39": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-20"
  },
  "r40": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-21"
  },
  "r41": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-4"
  },
  "r42": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-8"
  },
  "r43": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-9"
  },
  "r44": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r45": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r46": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "50",
   "Section": "40",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481303/470-50-40-2"
  },
  "r47": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "50",
   "Section": "40",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481303/470-50-40-4"
  },
  "r48": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-11"
  },
  "r49": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3"
  },
  "r50": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-8"
  },
  "r51": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "715",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-2"
  },
  "r52": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "715",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-3"
  },
  "r53": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "715",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-4"
  },
  "r54": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "715",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480482/715-20-55-17"
  },
  "r55": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-1"
  },
  "r56": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r57": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r58": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481089/718-20-55-12"
  },
  "r59": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481089/718-20-55-13"
  },
  "r60": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r61": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r62": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r63": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-3"
  },
  "r64": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "37",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479303/805-10-55-37"
  },
  "r65": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1"
  },
  "r66": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1"
  },
  "r67": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-14"
  },
  "r68": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "30",
   "Section": "25",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479668/805-30-25-7"
  },
  "r69": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-18"
  },
  "r70": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "825",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-20"
  },
  "r71": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "825",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-21"
  },
  "r72": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "825",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r73": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "850",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r74": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "850",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3"
  },
  "r75": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "470",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477734/942-470-50-3"
  },
  "r76": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "470",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477734/942-470-50-3"
  },
  "r77": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "470",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477734/942-470-50-3"
  },
  "r78": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/205-20/tableOfContent"
  },
  "r79": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483475/205-20-45-11"
  },
  "r80": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483475/205-20-45-3"
  },
  "r81": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483475/205-20-45-3A"
  },
  "r82": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483475/205-20-45-3B"
  },
  "r83": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483475/205-20-45-4"
  },
  "r84": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-1"
  },
  "r85": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-3A"
  },
  "r86": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-4A"
  },
  "r87": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-4B"
  },
  "r88": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-5A"
  },
  "r89": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-5B"
  },
  "r90": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-5B"
  },
  "r91": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-5B"
  },
  "r92": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-5B"
  },
  "r93": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-5C"
  },
  "r94": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5C",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-5C"
  },
  "r95": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-5D"
  },
  "r96": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-7"
  },
  "r97": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/205-40/tableOfContent"
  },
  "r98": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r99": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r100": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r101": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r102": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r103": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r104": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r105": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r106": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r107": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r108": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(26))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r109": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r110": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r111": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r112": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r113": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r114": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(31))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r115": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(32))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r116": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r117": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r118": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r119": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r120": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r121": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r122": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r123": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r124": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r125": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r126": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r127": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r128": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "12",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-12"
  },
  "r129": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13"
  },
  "r130": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24"
  },
  "r131": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25"
  },
  "r132": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r133": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "235",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/235/tableOfContent"
  },
  "r134": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "275",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/275/tableOfContent"
  },
  "r135": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-18"
  },
  "r136": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 4.E)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480418/310-10-S99-2"
  },
  "r137": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/360/tableOfContent"
  },
  "r138": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r139": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3A"
  },
  "r140": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "440",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/440/tableOfContent"
  },
  "r141": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "470",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/470/tableOfContent"
  },
  "r142": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-5"
  },
  "r143": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/505/tableOfContent"
  },
  "r144": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-6"
  },
  "r145": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-7"
  },
  "r146": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1"
  },
  "r147": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "4",
   "Subparagraph": "(SAB Topic 4.C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-4"
  },
  "r148": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "710",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/710/tableOfContent"
  },
  "r149": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "712",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/712/tableOfContent"
  },
  "r150": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "715",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/715/tableOfContent"
  },
  "r151": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/718/tableOfContent"
  },
  "r152": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r153": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r154": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r155": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r156": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r157": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r158": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1"
  },
  "r159": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479613/805-30-35-1"
  },
  "r160": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r161": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-19"
  },
  "r162": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SAB Topic 5.E)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479836/810-10-S99-5"
  },
  "r163": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-21"
  },
  "r164": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r165": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r166": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(15)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r167": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r168": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r169": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r170": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(13)(f))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r171": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r172": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r173": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r174": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/942-320/tableOfContent"
  },
  "r175": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r176": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r177": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r178": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r179": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-11B"
  },
  "r180": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-15"
  },
  "r181": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-6"
  },
  "r182": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "SubTopic": "20",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482659/740-20-45-2"
  },
  "r183": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1"
  },
  "r184": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1"
  },
  "r185": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477798/958-360-50-1"
  },
  "r186": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-11"
  },
  "r187": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-12"
  },
  "r188": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477798/958-360-50-6"
  },
  "r189": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477798/958-360-50-7"
  },
  "r190": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h))",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r191": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Topic": "323",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/323/tableOfContent"
  },
  "r192": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Topic": "606",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/606/tableOfContent"
  },
  "r193": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "a",
   "Publisher": "SEC"
  },
  "r194": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1403",
   "Paragraph": "b",
   "Publisher": "SEC"
  },
  "r195": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6"
  },
  "r196": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-7"
  },
  "r197": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r198": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-5"
  },
  "r199": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r200": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r201": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r202": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r203": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r204": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r205": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r206": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r207": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r208": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r209": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r210": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r211": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A"
  },
  "r212": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B"
  },
  "r213": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-1"
  },
  "r214": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-4"
  },
  "r215": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-5"
  },
  "r216": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6"
  },
  "r217": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r218": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r219": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SAB Topic 6.B)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-5"
  },
  "r220": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-17"
  },
  "r221": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24"
  },
  "r222": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25"
  },
  "r223": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2"
  },
  "r224": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2A"
  },
  "r225": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-8"
  },
  "r226": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-1"
  },
  "r227": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r228": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r229": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r230": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r231": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(k)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r232": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(k)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r233": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-04(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-3"
  },
  "r234": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23"
  },
  "r235": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24"
  },
  "r236": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5"
  },
  "r237": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r238": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r239": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r240": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r241": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-3"
  },
  "r242": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-4"
  },
  "r243": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r244": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r245": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r246": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-8"
  },
  "r247": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-9"
  },
  "r248": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480530/250-10-S99-5"
  },
  "r249": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/260/tableOfContent"
  },
  "r250": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-10"
  },
  "r251": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-11"
  },
  "r252": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-16"
  },
  "r253": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-2"
  },
  "r254": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-23"
  },
  "r255": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "26",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-26"
  },
  "r256": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-3"
  },
  "r257": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "44",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-44"
  },
  "r258": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "48",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-48"
  },
  "r259": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "48",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-48"
  },
  "r260": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "51",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-51"
  },
  "r261": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "52",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-52"
  },
  "r262": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "53",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-53"
  },
  "r263": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "54",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-54"
  },
  "r264": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r265": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r266": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r267": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-7"
  },
  "r268": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r269": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r270": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r271": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-2"
  },
  "r272": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-3"
  },
  "r273": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-15"
  },
  "r274": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "270",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1"
  },
  "r275": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-1"
  },
  "r276": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482987/272-10-50-1"
  },
  "r277": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482987/272-10-50-3"
  },
  "r278": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r279": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r280": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r281": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r282": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r283": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r284": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-25"
  },
  "r285": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r286": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r287": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(ee)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r288": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "40",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-40"
  },
  "r289": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r290": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "42",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-42"
  },
  "r291": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-13"
  },
  "r292": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-4"
  },
  "r293": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/320/tableOfContent"
  },
  "r294": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-10"
  },
  "r295": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479536/321-10-50-3"
  },
  "r296": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481664/323-10-45-1"
  },
  "r297": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r298": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r299": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r300": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r301": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r302": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r303": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r304": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4"
  },
  "r305": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-5"
  },
  "r306": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479344/326-20-45-1"
  },
  "r307": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-13"
  },
  "r308": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-13"
  },
  "r309": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480265/350-10-S45-1"
  },
  "r310": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/350-20/tableOfContent"
  },
  "r311": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482598/350-20-45-1"
  },
  "r312": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r313": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-2"
  },
  "r314": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/350-30/tableOfContent"
  },
  "r315": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482686/350-30-45-1"
  },
  "r316": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482686/350-30-45-2"
  },
  "r317": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r318": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r319": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r320": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r321": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r322": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r323": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r324": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r325": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r326": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r327": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-3"
  },
  "r328": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-3"
  },
  "r329": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-3"
  },
  "r330": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-4"
  },
  "r331": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-5"
  },
  "r332": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/350-40/tableOfContent"
  },
  "r333": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476166/350-60-65-1"
  },
  "r334": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r335": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r336": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r337": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r338": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r339": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1"
  },
  "r340": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1"
  },
  "r341": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1"
  },
  "r342": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1"
  },
  "r343": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.P.4.b.1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-2"
  },
  "r344": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.P.4.b.2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-2"
  },
  "r345": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.P.4.d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-2"
  },
  "r346": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4"
  },
  "r347": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4"
  },
  "r348": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-4"
  },
  "r349": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9"
  },
  "r350": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r351": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r352": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6"
  },
  "r353": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6"
  },
  "r354": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r355": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r356": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r357": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r358": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r359": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r360": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r361": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r362": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r363": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r364": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r365": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r366": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r367": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r368": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r369": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r370": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r371": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r372": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1C"
  },
  "r373": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1C"
  },
  "r374": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1C"
  },
  "r375": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r376": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r377": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r378": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r379": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r380": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r381": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r382": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r383": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r384": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r385": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r386": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r387": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r388": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r389": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r390": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-4"
  },
  "r391": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-6"
  },
  "r392": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-6"
  },
  "r393": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r394": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r395": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r396": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r397": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r398": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r399": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r400": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r401": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r402": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r403": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "16",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-16"
  },
  "r404": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r405": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r406": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r407": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2"
  },
  "r408": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3"
  },
  "r409": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1"
  },
  "r410": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-17"
  },
  "r411": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-18"
  },
  "r412": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-18"
  },
  "r413": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-19"
  },
  "r414": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-20"
  },
  "r415": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-20"
  },
  "r416": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-20"
  },
  "r417": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-20"
  },
  "r418": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-4"
  },
  "r419": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-5"
  },
  "r420": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r421": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(n)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r422": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "70",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480794/715-70-50-1"
  },
  "r423": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-5"
  },
  "r424": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-5"
  },
  "r425": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/718/tableOfContent"
  },
  "r426": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-1D"
  },
  "r427": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-2"
  },
  "r428": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-3"
  },
  "r429": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r430": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r431": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r432": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r433": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r434": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r435": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r436": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r437": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r438": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r439": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r440": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r441": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r442": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r443": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r444": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r445": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r446": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r447": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r448": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r449": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r450": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r451": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r452": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r453": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r454": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r455": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r456": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r457": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r458": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r459": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r460": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.C.Q3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r461": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.D.1.Q5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r462": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.D.2.Q6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r463": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.D.3.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r464": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.F)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r465": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "720",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483359/720-20-50-1"
  },
  "r466": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/740/tableOfContent"
  },
  "r467": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-25"
  },
  "r468": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-28"
  },
  "r469": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-10"
  },
  "r470": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12"
  },
  "r471": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r472": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Subparagraph": "(a)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r473": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12B"
  },
  "r474": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12C"
  },
  "r475": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-14"
  },
  "r476": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-17"
  },
  "r477": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-19"
  },
  "r478": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2"
  },
  "r479": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-20"
  },
  "r480": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-21"
  },
  "r481": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-22"
  },
  "r482": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-23"
  },
  "r483": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-3"
  },
  "r484": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r485": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8"
  },
  "r486": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8"
  },
  "r487": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.1.Q1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r488": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.5.Q1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r489": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r490": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 11.C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-2"
  },
  "r491": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "270",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477349/740-270-45-3"
  },
  "r492": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "270",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477891/740-270-50-1"
  },
  "r493": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482603/740-30-50-2"
  },
  "r494": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478758/740-323-25-1"
  },
  "r495": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r496": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r497": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r498": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r499": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r500": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-5"
  },
  "r501": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r502": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r503": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r504": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r505": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "808",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479402/808-10-50-1"
  },
  "r506": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25"
  },
  "r507": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25"
  },
  "r508": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3"
  },
  "r509": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3"
  },
  "r510": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r511": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r512": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r513": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r514": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r515": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(i)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r516": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480237/815-40-50-6"
  },
  "r517": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r518": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r519": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r520": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r521": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6B"
  },
  "r522": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6B"
  },
  "r523": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r524": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/830/tableOfContent"
  },
  "r525": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-17"
  },
  "r526": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r527": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r528": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r529": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r530": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-1"
  },
  "r531": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-2"
  },
  "r532": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-2"
  },
  "r533": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482900/835-30-50-1"
  },
  "r534": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479832/842-10-65-8"
  },
  "r535": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "12A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479165/842-20-35-12A"
  },
  "r536": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-1"
  },
  "r537": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-7A"
  },
  "r538": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2"
  },
  "r539": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/850/tableOfContent"
  },
  "r540": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r541": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r542": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r543": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r544": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-2"
  },
  "r545": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3"
  },
  "r546": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-6"
  },
  "r547": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/855/tableOfContent"
  },
  "r548": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-2"
  },
  "r549": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-2"
  },
  "r550": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r551": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-7"
  },
  "r552": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "910",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482546/910-10-50-6"
  },
  "r553": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "920",
   "SubTopic": "350",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478609/920-350-50-1"
  },
  "r554": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "920",
   "SubTopic": "350",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478609/920-350-50-1"
  },
  "r555": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "920",
   "SubTopic": "350",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478609/920-350-50-4"
  },
  "r556": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "924",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 11.L)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479941/924-10-S99-1"
  },
  "r557": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "926",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483154/926-20-50-5"
  },
  "r558": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "928",
   "SubTopic": "340",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478859/928-340-50-1"
  },
  "r559": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r560": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(27))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r561": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-1"
  },
  "r562": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478451/942-360-50-1"
  },
  "r563": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477270/942-505-50-1"
  },
  "r564": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r565": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r566": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r567": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r568": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r569": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r570": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r571": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r572": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r573": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r574": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r575": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r576": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r577": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r578": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r579": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r580": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r581": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r582": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r583": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r584": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7C",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7C"
  },
  "r585": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7C",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7C"
  },
  "r586": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r587": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r588": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r589": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r590": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r591": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.W.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479583/944-40-S99-1"
  },
  "r592": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "825",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477351/944-825-50-1B"
  },
  "r593": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r594": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(h)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r595": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r596": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r597": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r598": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r599": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-11"
  },
  "r600": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-13"
  },
  "r601": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-2"
  },
  "r602": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-5"
  },
  "r603": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-6"
  },
  "r604": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4"
  },
  "r605": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-2"
  },
  "r606": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "27",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-27"
  },
  "r607": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r608": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r609": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r610": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r611": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r612": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r613": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r614": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r615": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477796/946-210-45-4"
  },
  "r616": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r617": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r618": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r619": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r620": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r621": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r622": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r623": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r624": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r625": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r626": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(16)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r627": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r628": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r629": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r630": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r631": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r632": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r633": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r634": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(5)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r635": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r636": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r637": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r638": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r639": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r640": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r641": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r642": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r643": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r644": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2"
  },
  "r645": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2"
  },
  "r646": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-3"
  },
  "r647": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-7"
  },
  "r648": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478297/946-220-50-3"
  },
  "r649": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r650": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r651": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(c)(2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r652": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(c)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r653": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r654": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r655": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(g)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r656": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r657": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r658": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r659": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r660": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r661": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r662": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r663": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r664": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r665": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r666": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r667": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r668": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r669": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(1)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r670": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r671": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r672": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r673": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r674": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r675": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r676": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r677": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1"
  },
  "r678": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r679": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r680": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r681": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r682": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r683": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r684": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r685": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r686": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r687": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-1"
  },
  "r688": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r689": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r690": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r691": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r692": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-6"
  },
  "r693": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479196/954-310-45-1"
  },
  "r694": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478785/954-310-50-2"
  },
  "r695": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "440",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478522/954-440-50-1"
  },
  "r696": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "976",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477332/976-310-50-1"
  },
  "r697": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "978",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479230/978-310-50-1"
  },
  "r698": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "985",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/985-20/tableOfContent"
  },
  "r699": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "985",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481283/985-20-50-2"
  },
  "r700": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r701": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4"
  },
  "r702": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r703": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(g)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r704": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4"
  },
  "r705": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "52",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-52"
  },
  "r706": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r707": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31"
  },
  "r708": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "48",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-48"
  },
  "r709": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "49",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-49"
  },
  "r710": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481933/310-10-55-12A"
  },
  "r711": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "340",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482955/340-10-05-5"
  },
  "r712": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482548/350-20-55-24"
  },
  "r713": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "40",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482640/350-30-55-40"
  },
  "r714": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r715": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69B"
  },
  "r716": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69C"
  },
  "r717": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69E"
  },
  "r718": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69F"
  },
  "r719": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r720": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r721": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-11"
  },
  "r722": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-6"
  },
  "r723": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480547/715-80-55-8"
  },
  "r724": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "231",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482663/740-10-55-231"
  },
  "r725": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "100",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-100"
  },
  "r726": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "103",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-103"
  },
  "r727": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r728": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r729": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r730": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482949/835-30-55-8"
  },
  "r731": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481372/852-10-55-10"
  },
  "r732": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13H"
  },
  "r733": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-29F"
  },
  "r734": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9C",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C"
  },
  "r735": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r736": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r737": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477439/946-210-55-1"
  },
  "r738": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1"
  },
  "r739": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r740": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r741": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r742": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r743": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-10"
  },
  "r744": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-11"
  },
  "r745": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-12"
  },
  "r746": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r747": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r748": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r749": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r750": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r751": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r752": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r753": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r754": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r755": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r756": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r757": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r758": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r759": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r760": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16",
   "Subsection": "J",
   "Paragraph": "a"
  },
  "r761": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K"
  },
  "r762": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r763": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r764": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r765": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r766": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "2"
  },
  "r767": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "1"
  },
  "r768": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "2"
  },
  "r769": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "i"
  },
  "r770": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1"
  },
  "r771": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r772": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r773": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r774": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r775": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r776": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r777": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r778": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r779": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "2"
  },
  "r780": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r781": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a"
  },
  "r782": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r783": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r784": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r785": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r786": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r787": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r788": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r789": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r790": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "b"
  },
  "r791": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 6-K",
   "Section": "General Instruction",
   "Subsection": "B"
  },
  "r792": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 8-K",
   "Section": "1.05"
  },
  "r793": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 8-K",
   "Section": "1.05",
   "Subsection": "Instruction",
   "Paragraph": "2"
  },
  "r794": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 8-K",
   "Section": "1.05",
   "Subsection": "a"
  },
  "r795": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a"
  },
  "r796": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r797": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r798": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r799": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r800": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r801": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r802": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r803": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r804": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "b"
  },
  "r805": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r806": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v"
  },
  "r807": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "1"
  },
  "r808": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r809": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r810": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iv"
  },
  "r811": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "vi"
  },
  "r812": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "3"
  },
  "r813": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "4"
  },
  "r814": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "i"
  },
  "r815": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "ii"
  },
  "r816": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iii"
  },
  "r817": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iv"
  },
  "r818": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6"
  },
  "r819": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6",
   "Subparagraph": "i"
  },
  "r820": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w"
  },
  "r821": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1"
  },
  "r822": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r823": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r824": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r825": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r826": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r827": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r828": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r829": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r830": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "2"
  },
  "r831": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "1"
  },
  "r832": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2"
  },
  "r833": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "A"
  },
  "r834": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "C"
  },
  "r835": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "D"
  },
  "r836": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "E"
  },
  "r837": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "F"
  },
  "r838": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a"
  },
  "r839": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "1"
  },
  "r840": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "A"
  },
  "r841": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "B"
  },
  "r842": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "C"
  },
  "r843": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r844": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106"
  },
  "r845": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r846": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r847": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r848": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r849": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "2"
  },
  "r850": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "1"
  },
  "r851": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "2"
  },
  "r852": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "i"
  },
  "r853": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r854": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r855": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r856": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  },
  "r857": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-3"
  },
  "r858": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-10"
  },
  "r859": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-2"
  },
  "r860": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-2"
  },
  "r861": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-2"
  },
  "r862": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-3"
  },
  "r863": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "321",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479536/321-10-50-1"
  },
  "r864": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-18"
  },
  "r865": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "SubTopic": "825",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477351/944-825-50-1B"
  },
  "r866": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "205",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483504/205-10-50-1"
  },
  "r867": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r868": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r869": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r870": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r871": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r872": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r873": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r874": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r875": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r876": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r877": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14"
  },
  "r878": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r879": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r880": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(f))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r881": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r882": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(k)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r883": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(k)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r884": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23"
  },
  "r885": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24"
  },
  "r886": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5"
  },
  "r887": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-4"
  },
  "r888": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r889": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "55",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-55"
  },
  "r890": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r891": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "270",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1"
  },
  "r892": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r893": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r894": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(ee)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r895": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r896": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-13"
  },
  "r897": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-2"
  },
  "r898": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-2"
  },
  "r899": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-2"
  },
  "r900": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481569/310-20-50-1"
  },
  "r901": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r902": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r903": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "340",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483032/340-10-45-1"
  },
  "r904": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "340",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 2.A.6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480341/340-10-S99-2"
  },
  "r905": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r906": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r907": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r908": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/350-30/tableOfContent"
  },
  "r909": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482686/350-30-45-1"
  },
  "r910": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r911": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r912": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r913": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r914": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r915": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r916": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r917": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r918": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r919": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r920": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r921": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482130/360-10-45-5"
  },
  "r922": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3"
  },
  "r923": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/405-30/tableOfContent"
  },
  "r924": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r925": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r926": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r927": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "410",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481931/410-30-50-10"
  },
  "r928": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/450/tableOfContent"
  },
  "r929": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r930": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r931": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r932": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r933": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2"
  },
  "r934": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-5"
  },
  "r935": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r936": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r937": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r938": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r939": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r940": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r941": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r942": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r943": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r944": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r945": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r946": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r947": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r948": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r949": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r950": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r951": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r952": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r953": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r954": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r955": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r956": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r957": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r958": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r959": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r960": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r961": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r962": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "720",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483384/720-30-45-1"
  },
  "r963": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "720",
   "SubTopic": "35",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483406/720-35-50-1"
  },
  "r964": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12"
  },
  "r965": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r966": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2"
  },
  "r967": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-6"
  },
  "r968": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-1A"
  },
  "r969": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-1A"
  },
  "r970": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-1A"
  },
  "r971": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-1A"
  },
  "r972": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r973": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r974": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r975": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r976": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-1A"
  },
  "r977": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-2"
  },
  "r978": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-3"
  },
  "r979": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482900/835-30-50-1"
  },
  "r980": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-2"
  },
  "r981": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3"
  },
  "r982": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7"
  },
  "r983": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7"
  },
  "r984": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r985": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r986": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r987": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r988": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r989": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r990": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "940",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/940-320/tableOfContent"
  },
  "r991": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(27))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r992": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(15)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r993": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r994": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r995": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r996": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r997": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r998": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r999": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479432/944-30-50-2B"
  },
  "r1000": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B"
  },
  "r1001": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B"
  },
  "r1002": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4D"
  },
  "r1003": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4G",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4G"
  },
  "r1004": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1005": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1006": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1007": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1008": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1009": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1010": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1011": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1012": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1013": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1014": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1015": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1016": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1017": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1018": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1019": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1020": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1021": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1022": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r1023": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r1024": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r1025": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2"
  },
  "r1026": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2"
  },
  "r1027": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4"
  },
  "r1028": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r1029": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(k)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-3"
  },
  "r1030": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r1031": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r1032": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r1033": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r1034": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r1035": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r1036": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>125
<FILENAME>0001641172-25-012889-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001641172-25-012889-xbrl.zip
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M_O7!49&5,K_=W[D^^-[PPZV>*$V103 LM$J4\I9^#"MUH\3?M(FFRD!B9"Z
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MI[H[/A;;VZ&C<WSZ]P"E0WF[*DI&.]!@>UQ459'MBA_IF6]BAF>OD-^]$\]
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M$SM],C6N?4RP1-H  ")W1#7SJ:QL <J8W@+ENVTCY\KNTIJ K:2F2EX0&"8
MGQ*WQ62/7F\Y1EPR_R24V!A"'71I"\'E;6<>6T[X\@ V) "(JB@AKH.9JZ.V
MF,"L#XUR'B/3,7CK2MDZZ3E1;IC8I9Z="P49<2)DZ(73)D@"37LDPHVG2=OB
MN>ED8V&%J_G0"(1?1E6<5NE @RT11@$:S[!4#^[RAG *A?P*?!>SHDYCIK:*
MEY :GH-I[3S O[_/S8DU!.\T/ET-'_2OYH8!%IH,Q8R!;M%<7VNDT,7OM1\[
M:) FBSJ&!N<=N0F^<J[MX?A*.A]Z/FWW-="<":K]Z(27Q? 9K BC;9=/RXUE
MRIE%5WGHPM8 S(':F[NC(Z))S=G08H_ZE,I]E$-I5SR?316?"7@9I6EW$H\@
MZ\24;+]]XTYPS?SV4\C6&A ZP57)W*S)A 9U>O.$^9#.?B!U8^7IA2LS^5YG
M=>;&FRIO$"O?")O3A1[/#$53:6 #X!/_5!2_4P$VWVZ9$EA,,X!Y")%Z%/HP
M?8S*=)WU",@I"QQIB>U( \\< 3MX#25NBA321ZZH=12V0<=Y.,M=+YI("#-'
MD&RXU3\5#Y$Z:H#7111<J,5ATAU1%55'%9+NH($IZDG3X01=TR:?9C&:X^9F
M)P DDC Q;6-X<S63Z9:PA=/H[C0#X(:8%8@!2*8Z6A[XXF'[*%^ U XNXKFH
M@&G7JJEJII#8ET06WZ*Y@T,C$(JI*\E7^Q$0MZW1&&E:#-I)U0EH6@6.\OX&
MY/6U.S _!;>/'*5G@Q#=#LG-RK%._2RG#VH3!!*Y"@-KBZ%,9[QWJM+8!PAU
MKG)$*9%R8XCMI$Y'EIW(A=,V[59KJ;U5B,,\=C.+$ S",H?0Z0"U_46R.,F2
MJV:0:E+3YB8V%\W]'>#OUK:@<+!-/ 3R)-V/'*5GS93R:QE9!*6IEZ(C,K80
M$^1EMA7VT6(!E69EG"E.PGY?$>B4/LDUUMG8S4U$G8-[KHJ)I[.IQB]AM".$
MHTY99-Y.M80&?;.E*B8N&.&]W$CGB@:LL:54#[_ ("OREP\KC(]8\#[<&!LT
M[WO>VSN7^Z<'_SODN<C:0-:XH_*:WW2P_[>_<WKP,$P*[:!Y[5JM;@'3P+@[
M:'V\Z_G\J<%YKPW.YT\-SL_>X%SNV0+ 7X-O'=$@2AD*F_)&M5YQ_K4YL?C6
MG&S28GZ]QTV"MX,D<ES<?!-MF:_S7?:N5K9O(Q]=$)+GOVX\_V2,5NJT7AT<
M7;P%(+_O4LCW4.^(WP--%FW?EP/YBK^ZPPT)% ;^IRY+92))PIV?_,]H='5Z
M*=Y<G)$J#;D?UW\HAB^XMY<+WFH%7ZBPTN]]6.GW"'@(7]PWB \O]I_1<+VZ
MW?TH>SX>#;L#']S8GA[LV!T'ZBO*7_^FS/B6T@7QS?*18_65*-I*I0O<<8!X
M%GVCW!GI*GV$[#F:\MO*!,F)>\<:T;8?KOK">+7R4[[1X&?CX-!-X>]^P3'L
M"M_E_&4P$)>(_ IQK%(Q+-(GLM"W+LF\DN*UZHGSM^+GGUX.?GJHKUQZRIZ_
M[&^"0Z)\^-O5"7UW($$VNA"'Y\?B\.CHY')T<GPG>7YT\#]LNO"5^\%'FN-#
M1D=O3AR4E.:?7*U.+K\E67R4=80G!JQ86RQ]JYX#\IW[:KTG/CTB3!\I6 _!
M@,=>NYK[/LJY;O>7P+<5Q/:?=:+BJYH.66E3\[Z_&9T?W$BC)0%G,YFFVQ&R
M'^25"Q,N5?'A=N\<SE\HW_["J_T_=%[M/Y.V^L8G7;Z4N8W'J^V?$? =^F<\
MW+_K0?_\Q_\#4$L#!!0    ( !V(O5JD+#K06!   !QE   +    97@Q,"TR
M-BYH=&WM76M3&T?6_DX5_Z&7>I."*B%DK^TD0%2%08[9Q4 A>7=36^^'UDQ+
MZLW<TCV#3'[]/N=T]\Q(R-YU5A"P23D6C/IR[G?)AV]'[\[ZFQN';P=')W@5
M]-_AZ'1T-N@?[KE7O+OGWSY\?7'RLQB.?CX;_+@UR;-R7SSK%:48Z519<:[F
MXBI/9=9Q#SIBJ(R>;&$CMEXN[AOG2?Q?;#X0J313G>T+6EK_?R!*]:'<E8F>
MXJU(9:4R6_W#-Q?GH_8UNQ.9ZN1F_S_=P6NM_DTY?/SIL8IR(TN=XXHLS]16
M_]ML;(N#PSVZ!_2YO'/,C)[.RGM ;/!AIL>ZW-QXUNL^?W6/"'ZYK%LW9EO]
M]^?#P?'[J\')YL;EU<6[T^'PXNIG<7XQ&OP'M'XW1NN$?C4#1D>OSP;B>'!V
M-KP\.CX]_^G'K=X6_WYY='(2?O]L;.8Z+F>TM/?- ;AJ8F5VHSQ)9&$!4/AI
MBRW>X>CJ\R^X5J;4D4P"M\N\V/+V\W!T\KL!?MG[9ITT_[\7O4ZOU^OV>C7=
M1R?K ?-.[=16_R]5IL3S5QWQO/?\11MX_'7U4-AVA^KQO['I3EDSK#*CK>HX
M^-XDN=&Q7,VB/5;O_AHMTB)N_ZILJ2<W=V^F[A1\_U!GL:+#>]V7.ELG2F]R
ML[EQ+9-*":,BI:]5W,'V#^7(Z$*\A<_3V13[3[.HVQ$RL!1FTA3>BXKM<J;$
MMTG\:Y4?'+[O'^=I(;.;P[WW_6\-/]SIB,+D*03#0JM$(6_HY5B:5&7B1$\!
MX.:&S 2PU-<ZKF2R?"8!HLSBD;2B,#J+=($-MDI%/A&-5>L"9CA994MA9S))
MA(PB S0G@(3WQK)4M*6<:2O>9U9%E5$Q_">#:G-S(\YS+%D"A9ZU 1&@ *VH
MLD+JN 613/,J*X7$'V'H+O4K80;,O^N^_$98G1:) LX>R$(9(;.L2@]?][L4
M5[_NCW"LPQSOQ'R+)ZZ01HD9-NI,3G" L'FJ2N:]41-E@ A=1,Y,126XFF"+
M%8N87$H8/&4)F8['AN]IV)#<@"\6\"]N8MYVPY81T8\IA5=;C?^%&^ERNFP"
M /(Y1 AB;%++QT<YSB?!L=TO2I6^0.OPK"L@C>#Z.UE61GO&!^$,;)]KTJZJ
MQ)'L0"%K*:U7S.XQ-*UR/T+QY1@R#XUQ/OPE^W#\O:1CX3IQ(I>4K<H29:T
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MNQ *,N)$R- +ITV0!) &I[OA,FD;/+>=;"RM<#4?&H'PRZB*TR@=:+ CPBA
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M8R'-!$ONX&:%67##/@90F<UP=IH;'H'.X5/%E,25ZB0M68+.,;1;=Z?K%9R
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M>CD=?ZQ_J[_*X<-)0P12"^?S_H&#)$+AC79KY^5V-;SK0N>I,#Y#,&0J9*)
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M1!@L2HZ=$" +/::2E)=T":+44/L>^E+%J,QTLO7%OK<%W)^6:)[5A; AH3-
M;$PQ<Z>S2528 -.B2'M225ZU^K3HID$*9:72:L[*[EX.+:)9]3#(8\;5T!\U
M0FWH]A4J'UOA'JN<1ML?6W6S65!_!?>R(/_7(O>;\HEPKRD75D<.0=P[MIN
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MSMECNREY$7RCE!+* MTD4_TPE?)=^JW=.KB*1E^98KB-T43WE,)B!4YSN3>
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M"I83&;1R,+#A(. E86VP:1JR[8!]'? W2.+T-*OM[D3%6<&^"C-#,4VDLW?
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M"O)BD^?RU_-<GO_9/)>'GXGRHW)0GKX[.?P==:"G'R\^';W]_P%02P,$%
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M##PY:ZED-3[;?9XT:/V4UFSNX;"YD-B<\))^#UD9\[AQ77W+077+9YHH5VT
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M*2$;_!\C8A8%R&;L>T;29!,MOXM&ZMK2UYCX<##1B,)X!B>3>UAXU?UAM8(
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MQ"-D'0%+4OT>_ZEG!543NJ9@"YZ'PQA7<J*&'U'>+-,.(*-4^Z[C0JCW>WA
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M^<0[NL&'#R?##X/3H1I_>C?>.SDX/CTX&JG!;T>?1J>O[;W=?>-ZEV#CGN_
MB&]<^^?SJ#!/5G*L7Y!C#<[.L-!:T6S/^+HI=LA+._^\6H2PML1_=ODP_K%B
MT.V?&X]3+/F3M]M;KX*MK:UG6UNK7NR<YLX >,7A=S$/GOW(U@<YH"Z[^U%.
MI3RNP8>5P[5@U@6G7X+M7[O =(^P685<[2D]%.,Z?EC%=(XP03L^5O:Z5]CL
MO/QKP/&X\8_"B^]Z&]\KP']G5QTMR/'_6AWJO%C[A>_!+[SSK7[ANXRYOS+I
MY/X)YJ=W1_M_D&CV\?2WP[?_'U!+ P04    "  =B+U:-\+59)1!  "QF $
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M0HR/0'<GN4A*6T\CZ*<PPD?&P=5H-O:@N>B:)A$>^9309CLK8(+R9@,^[4Q
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MLC@8* %(WQ'R<);1HQ=Z(^G07K,AP<DB&(Q!2B>3*(R#(H(+G(66N""<7Q;
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M034;EF[2 '.#48'C9SJ>40"7C@JENW!/EL.X\W#W=>V6%KBR46JW4W43W!%
M]\%%> W*X[;T$7<1T)717T6X^QB =]> .B,1DFY'FV#.#;^F=_<8%'Y 4RHJ
M[/8QXYIN/U '7RF:^*(NG'CG8K35YO[TC7$^ .LKH60*"P[)V4H"@@^M+\EL
MT2E!!(6\!J-HDZ[/N7/6V"UMS%EQ'=I>A0U4*WY*+]YY%/KELYO#S[4]O$MW
MXR]W%W^I\Y;JV_ ="\/V#=N@3LJ?D)6YLW6#I-^X9_+X*VZ99[)EN"/?NF]6
M=+/<[09Y_BW'Q@/9%;<X,.YC@^Q\TP8AD>;]\>R[]P<V<P$S1*X#RA[EKK2V
MMO_N*?./W"TO'N%N6:4S9/>;MDA5JGF_;&U_UX9I-DIMDYT,Q\O6B_5F^8;-
M\G+%-\M##^TNSGK9?BW^F_P5ODA<U*^]/S#='K[^9R7%U'%^.8DR]E2J27SM
M]:^G\/Y.%@SBX6OO*)A$/-%'*4[?MI/;HI[";]8)-__,'-C>!G%==GI'WO[Q
M']VCSE%_G0A[;R':;4F$/0O&%$7JY'FDTIW.4F^<$MG%W# E>M33 ?0WH/@)
M1^ZL^&S-<TE:^!073&=%#8Z@V5!12PST<ZY4A(%%#+E$FKR 63KBG%@(*,9Q
M[6&V:CP"I8?HAC13X2))98V0XF!6('9 D0_%"<>69QDWHN(X%*!L-J0#RM7/
M;XM5LQ1,X&:1-(>1"2%]S<FP@16:FN4Z1C?-TF$4<8*LU>0C33M]"%O9TDV@
MG+J@D_IGR MZT'W?^738?X C>B3*J3="P(2F(C(WBNB2P$JX@X2*J84@*8RT
MJY!;&1A40@JDP^$L>Y0,&*N_K#MRYKP/XO$LHU#J"6C0$P=CXC(S].US9 3/
M*2XY4:GJ26'$L5G%F'\F,>QA-LV8CSQCS/06%# MS-'F,_(@& ZC<21$!<[!
M0Q@1Y+="TQ3II6"(<3*+<L)4!.I>CAQM%LH/CB&BNRK!<A#)P5%]/@G_(2?!
MZ@]C1]+"]XE)(M=T%;!29\@FD2^23:9H(M:)O$([X4(T6BE1TJ4SXGLB4"2(
M%4A(3LP;#&%!"2'<DN%@ND@38>JP3#!H.DSAVMEF&5:HDA(X1C3JT(S,D$"5
M,#0NF(L%E8F%'#Q$RVCG&EBF,$X)H,F"@\$<MWTS:QICFB+!)%I-.#S]*=S4
MR!Z#7JB/6C31;3@ QM!DEB9XZ1U?"UDALK&125@PWFG2)KO-^IAV[)QE$HXU
M=[5H6LW$$8#-40XVB9N9GX"19:2%,K@&QYF"M]0;RPQ*RNO&CVM?FJLP&H-^
M 6T63Z9!G.6$.7L*7US@WLAJFT'@CGQ"P$D40QPQ_/O[IK/9F"_V@^A6L^I]
M_Z0RZQKAR+1X9=$D17V<WF9^Y<<X<C6I,LVWF%R"YU$+.)ULQN!QE,5#)&.#
MVPS\+*2>(-<?[*PP"Z[X&E.D4].<C:C&)="X<,7B2%JI*M*"-W>6H=FXO5PO
M805$,4 KB$_+J4MR]N&$L,(3.@R$6C)L4*D_3^F[,(V8!!2/=*)+%<U'MSBM
M^1!+J%@9%4A88\[:C%O%.<%C>\26!PDJ*%-U?,/]%:S"*!2-; @H;^ZLR$R=
M2LY=<CY8D2'*36@I]S:!Z2RHIXTH5&9#E4 3;^ &[QH(U)/76ZWCAM<K,!
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MNFS\'1M5=B 0ODOA+JJRW *DO-7]+;B_]&A,EAI;0=C- C4()>QGA8I,PO4
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METI7:J%D!#J;#]AAULLYKRT!KVQ4D^.J420V)/R7<$UB;::^-HO(#2K]ITD
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MUX53S/M,U!;JP*X22R@]9Y7=-HP([$&4<K\2-IERA((C#5@Y*X.+!,)0.23
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M#:V],6U,>0/158%G"A/&A<K5K2T*RO2N4N\I0QP>4WQ<!'#H.K$]GPS@R[A
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M)N5D@Z((AA<RCB)MJ]0*1+:V\K9%VVY70U&TY#[W IULDL: :9#3@*FI.1&
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M1"5,GN/EES;)0Q/JPGA9ONSWT@PN/L J9]J 7XIPA#G<F*4.SP'-SJ,\@H4
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MT^^1^.T-B]=0E]A 5Q.L*?;NK?D\FL:P7& EM$AGOG_D!=Z2A4I!-%9R318
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M#]3GCP?PC3S?[^'RS#B#DZ'"</:C$2P35KRW-SQF:[ ,R\L2J7"L#!35X ,
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MD)BI*7P+S[A*Z2CKG 2*_;=PP)J2)*_.$4T(G5G#;#[C,"$R(Y8<V61H%88
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MZ/9STD.PZ8C]2'H5SS(3*N"BKD;7,CG5^ /(BF%<BD(J+Z!^52W]9UGA\Y5
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MKN#04G5X>!RH[>UM]0%+<L&E$'Z!6T$C:QU7P _5SO:+P/DQ4*/?X?FMG>U
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MHES'[-Q#S,[.M\;LW&4^U)4)@?=/,#^].]K_G42SCZ>_'K[]_U!+ P04
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M L\IMA91J>I)23JWB3LXQ3LQ!!TVDX>/5![,I1(4,"U,@^(S\B 8CZ-I)+F
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MK&.:=-!%S*CY<HX+W'08:D/01:EI_-FCG[PG(P,;ZPP!@%71D9/#N8!"+%_
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M5X7H30V;WE6<96EYREW'3[+\+)XK42D34\G<F0KV? F;!<Y(HBY<)!T+GJ.
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M2'86A381MR"'1(Y$;%9ICHQR:M$9^P8/A*X#@$7)I0=LF'206$50LN@TIOU
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MKHZPV8)I<^8=K-P(+"-O L<JKII(DV%25F&8:22=RC+L^4RSELI+>5X;&6=
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M@>\YMJ6VXJSU>-IN]=Q;, AN?>_<&-&8UT&MFG 0X"E*P16:@6LZA7%%':B
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MI5#>P##K5BGX/FB66*#;IK)'HBNM: \QS:&ZB, 99.B]5G)GT%38 @8?$*D
MWV_O1>+V2&.'NMW&@^%,8;NE[&Y]\5K92,;YQUG9;D_R2EV,%'!],$W0P8A$
M== 7*^>&,/QQC^)0&C1 +\GN]G7@PY0#T]12<;LW&DUA"/=9+B7_O'H3()[F
M:,MSL^)<[?E:<'4@5AB<K7)]ZNQK%[?+XB5HE%GD-;#D^BFG6GI:=K8E(J&#
MLA1*2\92Q6N'<K]>F99\W:'>?\C7)+\ 4$L#!!0    ( !V(O5HF]Q>950,
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M\;9_3&^/M*%?IN1O5_1+F*]02P,$%     @ '8B]6LPZ^V"L!P  #3(   H
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MD2+I*:P<?J#D2P0^X51,#=.I]-77MUMKD(E(6,O-M%I!FY0_"%^7YT8MKL5
M@S$5K?*SPAU)$Q4IFF7H#R@Q:OUD)*,1LP7]6?2?""-*(^1!*JT2/);9D$VD
M&\%#FV-=((2P6ZWD *=C.#I&OY@-ILL3L;N!WG&>?GB.IX(E,@,1B%2+P-=
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M<,$K;0\P/G80M )\SB0"\#69*?^-D#W:[SNWB=!IW]F-H3<QJO^J#[FBPX9
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M!   #R4   H   !E>#,R+3$N:'1M[5IM;^(X$/Z.Q'^80]JJE7CO=M5"%BE
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M 1UC,#!'>J=_\>UKH5J(KT=ZMYM=OUK%6^;(F9I:_=2$B2_P,"C9ON>1($1
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M1W5:P.CP;/)'4L9IE="C^'U<Y).4OYXE99+FT13&"JJDQIG7LS"(:GAX%=1
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M_L5WP3OC /Z25VRGP6FQ72[-8S.!(5 AA], CZP[^U?Q!1J3BM^TMQ3'A,W
M<<VCVB'=<R-^ITN@Q-[SYQSBC:.R7 &C@4UJ$9&PK1PY5\8J18(Q-EMS>"+-
MB,?Y]#D_KO0..!M);%LF[&"F$*VS4#K$2S+11<)R0*3(,W(;X3XHAWG/Q*-Q
M<D!COJ4=/^J.-OG#(*VK)"/)(3[5;@<^(B=7.DFCDI@1'6JPPHB<JK&XD\C^
M#XK+G \1_#VJ,"@/2XM,#+Q:P?=( N )S:\F0N[ZV0@=0&L3"I#/S7EBPEB
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M!>EQ,8FU=CS[#2[!5]#C%ABFB)/)$OVBBR3&F@+-S.F8+>]Q @H4< F0/+H
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MSGY(_&V&J:TJXF]A*T&TK1M?)N>] 14&A%$6P"%.?0S;<WG5F$HP*I4HGW"
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M"F"I>F7U'2^LQ.C004T!.)[.QD3BJ6Z YK(>OAX]D;,B+Y!*/:?"@<"+UJ)
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MWQ3*$&[!""@\F\! 1(DT$9>;$)%(XE+19-,'&LQK%: A9=5"TRE).TG(CZI
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M:K#"D)RJD;B3R/X/BHN<#Q'\/:PP)@]+"TT(O%K!]T@"X G-KR9 [OK9"!Q
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MSYWO!W-$LXS%@8=IC0'Z?$'[I!VM$4C7+#R(D7-D$SI9!"<'2%PQCFY2Y8[
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MJ[L&8AW7QP&=;!Q[O$9/A5;;;]B"S,6<K;1&RK&.J^0:]0P!7%E\6HGGARQ
M[%3Z?(VD3B=4L57E5S&IM^+VJL5R!Z "I@EF<O9U7A0KQ.>P$1@11%.4W.7H
M@+\"8Q,-S>91 ]$:F\/&9BH)W<@,MJ-]4%5%,EX22BFWSZTPP4(:MNO'FFB
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MPNYKG;)7'0!2Z]6@G$3< F+?+_MH(Q?=@LQ#!A>X:B\WJR+X.ISPRI**,>B
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M.HH?O=T.4%X7O6"947#0&AQC@6I57NX#F!%+S%C2:6<M1:.M<[L*B+14K6;
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MK\Z.?D<</WXS>GMR\/\!4$L#!!0    ( !V(O5HK1 [MHSH  *HO 0 *
M97@T+3$T+FAT;>U]>U/;6+;O_Z[R=]#)N=,%MPP)D'1W'D.5 \Z$F02X0#H]
M=>K4E&S)6!-9\D@RQ//I[WKMIR1C$I.0'KJJ$V+DO;?67GL]?VOM5V\OWK_;
M[W9>O1WT#^'O /][=7%T\6ZP_^HQ_PV_?2R_?O7ZY/#OP?G%W]\-_OQHG&?5
MBV#GR:P*+I)I7 ;'\75PED_#K,<?](+SN$C&C^"+\-73VW[O93 -B\LD>Q'@
MHT\>[?^4#<O9RU>/3]<SX,N@BC]76V&:7,)'17(YJ1[MOWJ]/_@\289)%3S=
MWGGZZO'K_;5-N.8W<-?_SWE9)>.%?)AD48Q#PF./]H\'1Q=O!V?!Q=NC\V[G
M?'#PX>SHXN_!\0E^- CD@Z/!>? &/OKX]NC@+3T;Z$?AY\'O@[.#H_/^ZW>#
MX&W_MT'P>C X#LX&?SDZOQB<#0Z#CS")/U[_^!"^>/"V?_R707!P\O[]T?GY
MT<EQ<'+6[7B/VK]] U]$-NM?#((CG.3=4?_X8!!\.(7?]H]Q+>]/+_#1-V<G
M[V419WWZY,/QX:#V7OV#"QQUY_G>7B_HP[_?#^"QPV #GNMV?DJC?\WSE^[S
M/Q7TX68/7P+^.#@X.3L\.O[+N[_W@O=]I-X%D !&?4-O#X0[/WE';SLXO0A.
M/YR=?^@?7P07)[1@>.K@X@BHYJR5WA"6<L&KKM&$EGWF#];_K7_TCO;!I4,/
MGP5R]0,8__@<OHR_P76>?WC]5Y@?OM\CRCB+.!O\OP]'9[2,<R02D<1;!.XC
MCDQ$H*V@W>Z?GKX[.J"E\&997WO7_WB^[;$1#N.](FSY!QJ ]E:8;,#K<+@5
M:0[T/GTW./S+@%9S<')\/."7Y-4$KT^.^\&;H\,!/'WV%UGPAV,BX@D=@7<G
M0$ :$\9X#3SV 7C=+&?[FYWU89Y&MQAUJ\IG<NCE@V%>5?FT01",X.#'Q:-]
M/%#$8R<'?T,6@E,(A/W8/P/FN+@C(:KF?O7F!*ANC;QU':-\?1%D>3$-4T,=
M?+!5PMX]D8X'OU]<G!V=]H"A#EIW_Y;K$-+0G[N[>]M/]>Q*+&_]LH>"V6.1
M"SH(!X-W[\Y/^P<@:_[\Z,DC^O=I__!0_?O6^W6=1-4$'WWRIY?P*D44%UNC
M/$W#61D#)>2G1Z3]7UV<J0FNXJ)*1F&J2 ;$?206PJN+0_64#/X,QZ:-+I-_
MQ[RN1OWT:/]C6!1A5@7GD["(RQ?![K,GO2=/GH"U<?@5PXOZ/BK+>1P<AA4\
M=!B/XNDP+H*]G5ZP^V3W*4T!?YSQJSXF>N^OX1#PGZUOO&:[9>EL'J/M)-FC
M?1+"MCCH=GQY$&Q4DS@01?CJ@]JD5X\_["M%"&<&&&*<P#JK25CU8#^*X"I,
M@=X%4#JYBB-0DR?GP5LX+4EV60;OWAT$\$Q2E4%8EK#*TI\&'XT+>Y9N)RD#
M6'I2I3C>?)9G 7X'3NL4ALFBH)P/_QF/*N!'^D6:3),JK)(<1H=GX\]Q,4K*
MF![%WX_R+$KXUY.XB),L',-801E7^ +5I!>$%3R\""J@."X7_RZ['1@+_L$/
MXS@1\!2]>  ++)//P<;/F\$4=G!2!N,BG])#AOW\-SW*8!%A&@S4^O AA[RX
M8)YT5B2XCCQX]N+)DVYGMCW=#C:0-_Z>%Y^"@Z3BQ6[BXW^=9W&P]X08_-<>
MDVI2Q##_WF:PB$-XA2R#O2G*L%@$^9B7V;08?\470'&@%I*NMMA>MS.<5R#,
M*QROB(E,/5PR[$XY*I)A3.R![S2;%Z-)"),0E8Z!.R^*9 8"-QMM _'ADZLP
M"F&?BEE>\'3>2@[RZ0QVR%D < 9,U^V(] A*DB;!1EC:#!)&>"RFP$^T^7,X
M%043J<;J(H^<+0%RP=RPR<%YE8\^@3D#W]3O ]LTBO&9/(N['5J _XV 9H0)
M@6?4//!@F@9 H/A?<]@#86.]%:<X*M"E#*)XG&1Q%"0P&+P/$F9W8[BY/AOE
M-H+DR?8S%"7?493)"F#'%#5V<+.V81D?]@^15GS,Z</@()R!6$A!6T0B.^8E
M_(@,B5R;(]M>([T5E5DXR.Y,PJN8MF4:AQG),BTO<#M(#* X#'EOY@5,C4+C
M5/%&_Q+.(/&=Q\OU)URV1C$36:J+3_938 A@JDM:DQP'+>$40Q8HER[AQ.;%
MHMNA<UGEZ^:6.V2#VO[NTE;^]-_/D7#J@-!G=S#S]SX$MUQ#W<(VEA'\=KE=
M?1^6&&[2P=5R#R2G971L!_8O;"YG2Z\$FV,&XAK-^"@8+EP1.PT7*&"G8022
M%([H]21/2;?#S[.PJ!R=#ZI>E'[@Z_QF/6D4]3 &D<""PM>6N*8H3E'S+I2,
M5P<7WB@,HGFZ0&ME-,<W.#U\T^V,\MD"M1<8-/)6\=8T3-)@ ^:2'\.J"D<3
ME!N;BC+'>26*2+9=+S=AVPD6.44S &9C.0?K\<22&<,^9THL@8S]F "%>3@P
M*M($* 0/;R2;074-H^UN!A=%B&8?O/V"#;6-!'\+7\CF),O@>>>9$9"C2,I$
MQ-IY!5\*BP@8L +CCX3G*?!B'I%6%SD-]J&M#D>;N 26W9OPHFF:7ZL!R6*#
M28U)".O"#2O#)&(K@.U/$?JR7?2+\!+$\R4.X"IFLFK@ 2"(8S8$Y2P>H7$<
M*:*'LUD*[M,PM3=(#P9[>YT@Z\ 8Y1B)4P2CL)P 77\J2B0ZT&<2@P41%>%U
MAOP6!A^ '6$"(%0%,P[#[%.W,\_2N"S9TH7OTS_T"\^*?!1'<YC'69Y-/N!A
M(!G9M+=Z@VWX#![\M)7#>03&3[N=AM?4MDX!Q@Z\+Y ]RQ6]\2A,XPA^Q,5<
MSD.D)UJN\ 3IYZ!:S&@\\SOX%:COL$C^34>-S@".H^?N=@R-S;2XVNH:6+A$
M)D,&@2\A0U\JO2]'%+P%V))BT< >:#980^(W9I-%B2YRBL>V*.*:L0=JV#WZ
M<_!L4GML$&E:M(%Y O/(J?;X*[R"TT][H0U9;0"H1W&L81P;)XBV<CQ/TQX=
MF^M),IH@F\0-K]?\ K[H&A.?9J,X35G6H;V=\]_@!I1Y!FM< ..%HTIX1]Z'
M3V/6[? J2"XAWS2=CJ14AY'I;*U@.S@% 8Y"6;UDR3-8:P9ZS=,*-Q?EO1"W
M9+$+/@:N&X0^+ZL";DHM";4"V3T3,1Z/T=N [\)! GDETB>?5YK96H>7Q>$$
MW8Z9 98=9FCQ ;NX;H)U)F\:%+G^PNRR8A:UD_P6H%,RLF+!A<^+"#9S0@*4
M[,<5IM##*F%;SF%S-<UY!>Z42LR2)B1/#?D(G37['&MF (9AU0->5K"QX^@9
M?(YB#[-*SYW1"-O!J]?[WMN3S4QQB!@. $C@<#2*9Q5RL\]"8"",/F7Y=1I'
MEZSP0S37D2H8^8#O,K-KXZ3(KT"340Q"1@([ [X3SB8]3RUI0\;FQY93[SFM
M>C]JZL?P*9Y0/84E*]C@N0329QSJ$"-)U$<H,I]YKJS(#9'8RS@<\5#Y>-LD
MQ+Z34?E:F]\F,P>+^:^MK>!-$J?1"Q 0E_%+F/%?\QBV%A86;&VIR.+AT6]J
MU1()52'BUREL>; #2RKS-(EJ(>2?R:[6[VR]B>T0O'H,,S1-!OSR:8OMQ1?
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M.V\(@)@COE!V"([B^:A(9LP-H/+&YI%2/X*U2S.#+4>3L/Z<]E@D *R+U/P
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M0WY.VX26[&([Z*,-J3=(;+V;]D7'K8>Q5;9B&G/]O//J_,/I?EF]>HQ_4P,
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MAVX8Z5C\'CXDB#,;(%0>LW[D9"_+1MZ4.)+W>K[Z>S4F,->7/&MAYE>8F+2
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MC1:++,5S6M!U?0QW80'CX]\+O+_DDR!.01^ILQ7>M#!M]2]%J\_U+8(>49?
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MD>00GVJW Q^1DRN-TZ@D9D2'&JPP(J?J1-Q)9/\'Q47.APC^'E48B8>E128
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M53RQ;W 1H.>)^E_@L4=OH;)9\)!%SBK@#/2>[70[UWZ-/:@#P $IE8OPU1?
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M/JB.739R<ZJ*DJ%UZ=:,6%)UFM@MIV)'D1HXK52?E.ACDOM>4C(]''1@Z,C
MT))(H3[(EK2@?Z!E8;U/^C6I=X9F>ES8WAPR.?2VL\T*:.J"^3R8#6S<,.6J
M;<Z.@#/IU I)2=%'4V?*)26]JQG;=Z2("A:'@EFQBYEZ9YI")PO.$*=9N)!+
M"J-3[J7!Q39HE];N,.BIW23E#2FU/+6IJ>=F(S[:-X4RA%LP @K/)C 042)-
MQ.4Z1"22N%0TV?2!!O-:!6A(6;70=$K2Q@GY417(K]"=3/ '&O['YK6 \*.I
M^@F%#=+8"IBKO&Q,ER<IYC5(< K!6M-IYD *VDMFJ]=&L[/+< .YV$V/\ITA
M69@= QN!&(H2+AZ$6>:/%LLQ"!CX/=7VD;EA1$O%0FQ9ZLG-*D7(>I0GQ1)[
MRTT1>V;34D=R]W6!-[=Y3A3L<YLY$)2(PJ92BQCJ^.NC_VHI\R2@:I<A54,:
M>_7QLE33!RY+BYA@#%(UO)"V>DYT(M<*8]U$+<LF2MD%D!-GB;$.Y)=8@FY1
MJ^(.;ND7W7T/L9]L@7P=-_N]MQYN)7WL>TH?&UEJFO#1-GWL#KKK)'U,;5<T
M!GG,$);=X-3 M[FDGP&44&3.*%-6)E86753Z K6:N)K#ZA;GQDZ9^+INAZ\
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M*EA'>IM0FGM;U6Y?FV!UYW=,L8)K)RXQ;:V1:NTJZ59FD3B@!.=%'5>P59?
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MX%%/$"Y,3%W2=$?W-*<^!9A0M1L<%)37M*SL7]D)7I6 6X>O=W?N,0'O/0?
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MUG)KQTF&2!5/[!M<!.AYHOX7>.S16ZAL%CQDD;,*. .]9SO=SK5?8P_J '!
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M((%?%GDZ@5^DF>-+9? +3<2R?71*M9K1L>(I#:C8V0U^TSYOV)5G.[;^IPE
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MK3DFE=*Y * .K^2F*X-]Y/C(@!A3P.P>>>F:37[MR9CTFA;;21S92D%G.4E
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M?]\G32UXC&>ZVZ$S*SJ7DU4%Q[0*K#N)]#YI J/@T/X;MV?RCH5G= #J!PI
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MU3[\;K=SBCMWU8$,U D/&:<C<#P3?]FL 2HH>-5FQRJ@@6RI7[I"F B;0CC
M&ON(C^HG3U4#Z>SMT<T*W2$H-F #P>7O/OJ+SC:RB(QZV,8:S4P#K_&?:^[8
M45\09B@H\L*6#'XKXJM2@HO\<=:?RG94(8L?>HGX3BNXG@T4T!9()$.P=I*J
MD@?_-+\_VPEZ.F#B9.&L,:37!%F5W\I-#+8& %9U;#?$6CBQ76P@&3S]_GMM
MNTG=$X7_: 7?69/@K>=*!"D6R2I5,@"<\@D3/:=BCG8=2YS&CD3:X2NN,>69
M"B+1?8&=6YFUK?VRG61(M%>RE9//!&8#LP(WC95"K 0:\XLK2J*6DQ.[-@=6
MY70=*XNNKV25=!I0EQJZ"KD>.<LT;X62I6YG:E.AWQ"1-E'*\NPQ?#I+B2M:
MAD@-2)-T 2I<RXZ(G9ZIG4,9*)+395UTL105(>7#<L=/#:Q44=PI(>9*LL:5
MI"**M#6-9D3&QA4\QRRQTI9]@WH3K4G:IS[!IU(FJ$SFH)\01:0S0OL6T/F5
MAY%Z0GK9B4MW@#0<^CG2W#U4,&*6G*D:+UC< XY>7$87*O"TL$Q<1\FQ;&&Y
MMK'T2^M&X6<MN)7/W"8I4.'B#Z^S391:->/BOZYPE0H7+#2EC3,V:B/WF-?-
MUZYPJB#<8OE+F0SE=8)32W1;5H%N&FX[FU0=.HTBY7(JK6W%NYWAU#3,%7G@
M%#;5%;8G156[ZF&HBRL7BS07B8\PH2K)5*WKT%3>E6L&=" 8#&P4L#)*#F7(
MSRL^O?A>KFK@-@)Q,LS%\Q5($GY;Q9@-;C\J:6@5HC9W%MU.["7SKB==&[GQ
M+MT&0L*%?N-[Z@7":FJIFJEP1N3:V*>)Q.IL/G5ZVHZHUO'M=A"NOH^WASK*
M_N$-3>T$M $D^,OU/]PD2$>S=]1X5YF))A_RXB)+XC-EX&'A,+):X%<<V2;G
ML\7U)M^7)!V7ED$=4;$#D&1.8#.;!6&X<]3-= UJ-('DO%J884U]JR\&>MFX
M8P:7 -J%?<;+$T;*O*H-S?4(MAGT@!65I &1QR7:99DM"[0<WK;Z91(N@"O!
M9)6L K:.-9-P"0723]0;<"QR3>88"C'D]< &9#TWZT3+%$*C@CC)GE;Y$II#
M%'-VMRIXQ;IH= YWD=38096(6);P./";/Y:Y*MF!YRO-5:\+F2JK*PK7J'4J
MZY38<%GV[TMED&K&C<Q4P7%"*.AZ[_ 3KE>%T  #_]'(!"YGKD3]-^%-O>^+
MFK*WZ1^P@56<6IV\,+'GWTM@,'6J0>SE2A90\$LC551IF1 X&\[JQ%*R4&B4
MBS*IVX$T)A](%S.BN^HJW3=:588'MCN?X<#_V]:!?_,._+]M'?A;!_Y5%W6F
MDAC\!!F3M-"N]S2JQ$[$9FK%2+B);6":H EKO,_L.>EV9M%Y8CMK*L=ZL1)S
M&.M/ =P$IHB%,=V*--^$<+WOBYHI0'A^$3&&$C9T\'&!#2B%#0_1"@:CG5NW
M)U$F.25<9"Z+"&UJ%:333&>P;L:D$,:D5!,8SJT>@D4XI/Q?%,A\E ') [F>
MA#+Y8QE3@J ^*=J.5_!SZG%224-"48V1]9T:+/A[A,4*4*6U^)'J1)VH-8RL
MUM3HAM9801LXP_ ')"H>8+)HB%9-YX)7UAJM*_O LAN6JT=7RHFA"N$%<32/
MSI+*CU*T&,&1WR*L$3'2_GJ-VR)3 F-PJH9K)7&Y1!@EL I#81,F%"V4SR?-
M=VR\D"3*5[)3(#W8NM+5_&<JO72Q(!@NJ7*"4T2S!AY=EJ5O]W*MW"R3+DAD
M+,JBXJ7E')1B35P.T? 2:Z+JEV(TNCQDLQ!7SB+&V(JY>["HU&XMH+IPZ"*4
M(=F@265U3HRE09%Q1&)Q8;N;K(XQF#KR#4^HYP00,4?VB_K!&NO%KHZY-6+N
M_Z+^D!07G>2,^_DV=6K_'1;6#: R1U6'=LR+-RW1L'TH%3L]UPC,1C"_M; H
M%PM3/.1Y.06@!\(0>%\<L:I\K!0DT!6&%V5ZGJ+;LO*=T7R!4)RR3+DJ->=W
MRV(U"/-->\4LZ74G*VUT"]Z<,X87)1>'H7O-O#3EIM=E$T!( 'SX: +',87+
MR8_9;<_7/5C4!V5$\?W<S/KV7*?L>FRMPVMI?RHM [B#$IF-EH+A78KXH$[,
MRI>RH/SRW>RGG^#M016*Y1@;!>-2!+8-T(+#D'!Y>5'YT&NM,D64WQH52U#,
M(D[.5;$[\LW:VA.K98XS6T<%UGBK[3"<%.Q7LRM89=>IZ0S_3DKQT6,]ZKQ*
ME.HJ4HL@QVT4DF"%Z]F_*);8AMFL='LV[\&B,DFX4HT<V7;H4RV.EEH@:TO<
MMI2IM>XDZO)E17E,<V#5DIRUKS07.Y7P&DF>3%.!@1-GC75G!C'S*G?:1@?D
M8B)-A(=,Z[+?46%(.V:WZ;25$D^+M>ZI;DUG!2M]I_HU@EH/L-%'Q1%/5&]4
MKC47K1>U?F!\^B /WUS2Q,!2B-%::,GIMQ,DG"QZ;E"N Z/S(N: ,]XG<V9&
MI;L9WA7L)]T%5O*2%.GK=MK+[>ACHT[$8:$\0"8.JFO:2_%:+LEBMWE'IM8P
M0RP4:[+C2JM(S'FB.S[@2_"GU/9FR]'W8%&Y7"?)N5<[?3A=TQS. JK#E[-T
MG!JESG4I6DU2!(>64[02GUKFKI3L=B)RC-8,MP&-BP /?UBA4:\Y-"LUK,0X
MD$(SJW#]&ZW@)_7:E"/(<?X%.A+5I586$98&<%INI+71GO@%Y, SXYL6+#(#
MJ2-@34*9;U(U7"]+[A&WA4C@=Q#AWA=TUM;?=%4!:BKU"FU@P^ K+8$0-0(7
M.:N=TITB-)@#[1?E0I*\#2 '@(>C3) IME.%D*:,/!4:5J*0P$BU*8*G*&1Q
M48YIY$EX"=&TN-%+[U4[*+E4R-P45O$*SA-(4.A'<#/"_U(W'%%TR"TY2=%)
MBB7QFQVZU>H* 50M2E2^\>$2O?G_<5#"HD]4:WD52"\P9JTBR0M$C9&W<;(%
M<&ATSL[6LZ*(T?>-3<SRY*P@L)# [$ X9Y$X\J]T&!PZJB)8]*C]36@CU71'
M(6Q"5%$W6NH]1%FG8!JE&CH?V1;0I\WEF[A!-B,*GC[90@IN'E+P],D64[#%
M%%QU407K2&\22G-OJ]KM:Q.L[OR!*59P[<0EIJTU4JU=)=W*+!('E."\J.,*
MMNH2^-]Q4E:2]H&))24W^N,[E2^-F4RTU?*=<O.O\R1/E0^<4FGH'^X<*!-*
M@LO<<Y)D/]][#7"9ZU#8I8AN%2RKEDP,C&K&<#'F)D^/K::1 ;,&!Q(T4D%4
MPE+@H_,D0L6'@+O4:]0T]N.,.;E(]^$^XCX8=:*AOYO>(X:0N:#%NM))1LHR
M<C'"#XS;'^017O 1_@7=S*0UOXTN-IWC,WI06;ZQ?1:-HM\6;PQUPZ=U^$TV
MVML G.Z1"I6GR_9SMP,XK=F&&BY>HG9.S:Q4P=%:<O\.$O@89$'8[2@L\AG;
M[285CJ )LT)B1V+:H;::I:S]X4>6<0AJ,R:J]53 :-T[%=:%SZ%MWE68UFO4
M9&G".DN4#]/6J]6R<"1G##^;L/%^-Q8@SDPK9Y/])"!;%B1F"8A5G@L9"#I1
M59HC$JG?KS[G. AE=\;*-2]-HU+$Y)KZ=@:$@1RFFDA*+JVD#NFL 'UA2$\'
M:3CK%&QLCV8W,M)Y-K*B1BT=,BHX)417&9*'R>:RUZ^JB<O%\\#DQ8,4@O]N
MPLUI*W]-P/AG:3B(J(,9=F)M.1M@3<^U-2N5Z1=+K = U>11"E5DL4^R*)V#
MNI'2!8P"AA/75(G&1KI::".EQ@87PKC+2;:LT%*WC[IV><Y0-I88VQ;O4;O<
M4=K6^YP\#?0 %FA+&9PI/U>! /VQ(SHV4X<E1VB?.3=RIR6"$0:N+ A9PV/J
M676R<1@ECW@;5'P'Y^I314L=\J>%]L%?^V9\R[@LE@@+3'.<!L8VE9I(=%G.
M ]62@1Q2R#3:?;5YY'3./<&N1D&]U&[GIF7O)XA>U<RO1'^3)WEU:2<6@E+<
MPDH"OPU)O)8:GB36B9O2XM<OA.A8*80KM+,X#<P424!U"M2[^"GT!^;8RL+$
MX-CW"YO;WW\3'/=/1K\';P8G@[W?@^')R>#7HWTPHW\/?NL/?QV<!OW#WX.3
MX2]O1L%P%+SKPZ/]7P<A?'P0]'\Y&< 3AT>C8'04G S^^7YP.H*O@G^\/_D]
M&)T,^V^#UT<GP>C-H-OI'_SC_<%POS\:'AT&1Z]IW(/AZ?'[T8#>_O[P8' 2
MP-/#PV#_Z/!PL$]/XE>_#4=O\)OK=K3OGPQ/AX>_=#M'[T<XA=&;X2DL\^2D
M?SARW7>T\8&N:R9B$YV0TM/>1F6VH]B<_+I"AY&P0>D2DS0Y=2<X3TMJ]@'*
M 0K:F[N7U[N:&M>9]LS<U>OXJZ[EY?#5_VOYW\O'PU</9H&]4VH6NRQ!;R2?
MU>LBRXJ+:N=!K5)Q96-)E[ATGVY=NK?@TGVZ=>G>BDMW$Z/?=XMH>-CM@#9P
M.#B%BQM5@Z/7;IX'MO$E3X37Q)<=O'9_:JOJ+*MBRURUL;9P$UXAIFE:5J 2
MC O$4"!6BLJ[7'9IC[%&T&>3^BOU^C!RR99#OISZ9&YR9,E:<?8=G3Q+:%W]
M!2WB[3MUCE&L?*[RZ%$)AM*#@KZ*1#K\^W?//H,B+:+W<^?X<N_5X>!?(]"\
MCT/0H_>!,?=>V5,FH7I+I/5NBQ^>_/D:*]E$[6M36'/A#Y\_Q<O/T2W-^?O;
MGO1M\L@=98B;).C>ZL7&66Y6"'G K[\*4"(>5X]Y\GN(9?FOI!RO'(UBRRK7
M)3*IQ/=@GGN4V8%3$R[8<L -47:$B3+W@07V9VDRY;D-2(E&]_X1J\_M_""6
MV[WU%SPD%]9_:_<.&>!H#8EA]#\/8X&? ]1[MO7JM'MU*)Q@:/J ?3%-IKP2
M-W]Q,?.)#H2O>A0'_WHSW!N.NIW^ UK4@]NEPZ/1<'_0[1R]#@;_&ISL#T\'
M#VAU#^GN'AUU.WL#W*7]]Z/!0;#W.\93@Y/!+\/3T> $/GES]!9#IZ,CO944
MV7P8RY?P;+<#RSM^?[+_I@_+VS]Z]^[H$,8_VO^OA[',AR=@E!^RVV%'Y(-9
MV8.$FHT0YTIX&,D@E;1G ?VH\A"5R3D/[%(J*D@BC0WA7T[EDIYI@^(F4=O-
M3O!7A[#(49DND&ORR6X81/#1>10CVJ?$9F2$I[ [J^A.&JICBLE\%]3WFO:'
M5A-ET^YP/UJD-6:%8?P(L>E E,H <E1Q!SMEDE'Q'N3=RE93Z/<F_%,A[Q\8
M*SW(\_%TEZ"8KS'# OA4=V YQFH]C8*57*U @&.JOZ <D?[969F<83#1'<2@
MO:@N?%2]N%D2/CQ>P,G>;'#TNU?_:_T/9MH8QEY<9$F3_:B:Z0VU9 JCP72/
MB2*P7^!5E/A9NF!H<MT3JJW==Y>8/KDH=^>:)+LMV?D%B?3 !.4S%I3'1NBU
MR<JAW4[ +_V/& [JJ8/XB\ Y60W>J(HYIZB Z'2;5^A&34Y+':\29NC4 C4U
M0C?)Z515QJ&;X$\N>WIMY B:O;93G#OAK1YP#Q;UG-G[0+6\:90%:K:;9+:2
MFI?((*HHF_0UC!-2N9F-N267T]\DR8J+L%4(:A;?V(_0X[) S]U5.-R)365R
M4A"!^LA-&1-ZPWK)5]_2!\FG?_F_?_OI^^]_[G;V9PD88"CML.JY5'K%; /=
MM8EJ2MK=KD2&\7;CH[H?3^,;2;#X-ECB:C&=O:.3@\&)'=YQ BU7<F!<E6H8
M+-\< UJ/S[H>T=;%V%OB2S>, .7NYD4C:'YEB,V-KEGBW5?>A%N@]RUNX9:0
M]Y>0&G]QDP+Y^Q_72.2[?B%_W4N85]3\[^67\W@%^MJBJ-+Z\6_2U#+*,+%\
M'WL7QFF4;]#,OLC.>T1\]#7BX[>]*%[35@^XEAYPS?<<C/:#XP@7EH)956_O
M_^M?6TC20^I!O:7F]:F);3N78+W?28K> !KS.J+SAA;TY52!:\T:"UB]Z'9L
MC\W__F]X)^ZP;VLC$&!/A7!.=*<W<7+=MY7<:37H(24(>EK+ \]B^YKI2C>2
MT;9-8+MNSNB=3$+:;NMUZ7<W,XLV[ZOELMIJ1]O;^6'<SD^O=;N-HH\\J>'!
MYL.\P/Y>^9F^J)]^BO]HP_2?;R_GKR@M7T>3*H4G[YLDW^[MY?,:/,):ACR7
MOA]'OS.S_';NZTO219]OTT6_]731.Y!\\BG%O>Y34HW.&MU[0(MZ2&F(_=/3
MX2^'[P:8BO?ZZ.3=ET)\W?E=N1IB[287T ,A,"JPFP8"1P615R9G!2('='UN
MJ77'9?"H,PB7)Z9>:;JO>YI3MP),J]H-#@K*;EI6]J_L-*]*(*[#5[L[]YB
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MDV()E/%L9_?1HYU?GCS[)8!.TKH*HJJ":5;^.-_ :4Q*>YC]7EH%,/>TSG!
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MX1-U-.B#V^_U&U/_#8?0U-"-0O5@+]JT%PQDV#2P-(%MPV5$#FA>1MI7!8K
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M\2QSNJ';'3_@U'7G<N7M:]SO;6#Z=!U]Y'MN*(K#-=C;!47;J@J[;Y3%7G4
M2*U7C3*(N&.(H9_VT44NN@29MQB<X*J]W*R*X.MPPFM+*B:@ Q;S=-+O6;.U
MU2M?Y[;29M@"5""4%9/?E(U5QZ2+(Z4<)V@];HH76)E-KM:O-:Q5 K-YK(QV
M%<?6E4FHEBD!HO/-."VFA>=O5 6;,W0%*;%2C9:Q1UG>:-G0MT86'9:DHQJ>
M6D T]FD=J0,*45*65II6^_P4UFE*C!=4S"BFDTMC\>2?ZK:QK%@+T_V,5)Y_
M%7#<)&VLPCDAM]T,;]I.O]?:D)/=QZ81YACHH\&+R 8JW1QK.Z'4E(3*I=[<
M6@/K]]3(E$++^D2[$K&ZP\_4*$RB!H<BI?9+Y0?!-;_XHAT+*4I)!CO6!(Q5
M!J7V?G)DD^T@,C9:(*[7Q5[Q>ZX?8#3RZS0D%E$9ESK!Q.=-*T/:K,*,KO'5
M)?ZB)0BXDNYR76%\^B%FOXQB'C\D *K5YPI5EMA"Y?+4UJLK?Z#XX]/[^./7
MC#\^O8\__E#QQX1JJNV;VB"57# ]()O8?&P+ <W>O"JZNI@Q,I^:Z$BEDJO/
M'C\$6J]G@LE%+M66ZDY,FLK@M1=RV5W3@^F4KI",!(*16R[P2&Z29 \%X3IL
M,#DZVN=K.P37@;RWC^.[8JE?LZK?=#,P]P;#3K'XO:L2?D]V"=S\XY7XI^PM
MD[5%VF_;Q7H?9J">R.W#+=>\: ^M;22RQN>K\=YA<]QEZ&*!OU$):_>.X)W3
M?,^T2B1VJD>T.E5-\H65OJ!"!.82V,A=!/=<-A4@K^,H&)=I,K5N_Y*SC0:?
MJE2D'8BFK]O.D+L)(?Z\O7-G:0&?<X>*!J7PJ:5M&*#CU;D_RSK(Z)SV*J5X
MT%>#[=1(CR;JE7VML&](;VB4;UI7[!BO4JAO6^OJB^X#PXN"B[Q$/QT'M-#U
M;6"W?(4[$$2<S!VWH(N8Q=(J+<=#J^_T)4&SQ<BEP*1QU#?"]NKJE5)G*; ?
M9XR7-(S9UUA8=\*N2 _341[)4"B53Z(4R/K& 0^>G:Q1IGT6=O:.9QIJX:B+
M>G%N>R[L0I=F\H$,MJ/:+LQ#& 4')U2J<+D/3'"00(*WT8 @JO6D[YBZ"C7X
MQRG9CR;8>A">\'H$A03CFYM(L!H7*N$C(_J]5FC$QK"-=%URPGL P7HK!2=A
M_H3# NLH,-8LA?TQ2WJ9LK[#< +:]>DT2LM& ,&')AM4<EO$1,%858D(S?@]
M5S[?Q $$42O!('?SH3] 7P$$A B*HDEL4>S\5-TOZ \5VD5D5QWL/$)U-<$[
MN["2A6?%6IDQZLJVTLHI(ZV/_0."W=8W!H:6!$/7,JS@QB?>HA69)%PKS<DG
ML?R=3NY;Z+"XT&(X0")-9D!$@JJDU1V%FDR7*Q#*JQA/H:^SX[8LOX>@3=J'
M7#EC;N-?K6DK2.M7;0NI0-<>"LKA$5BSAEA$*/ ^<[Y+_Y!2#&3!%;MH%%Y"
M(7I L;*W\?@UEBZMW5;0K2I+V<K5K+5L=2.UH^/:&B*(>DM\ULM4D_/'01X#
M4[EN%8-U%_%%2Q$?O$9JR3NK=$"K<(R@#:^DE K[$M-<;A=AG(&Z+I)Q_%9^
M>315[V!L KB[ 1:9W YQ6GFU)<U5GQ+Y[_?4%?(M=25Q@'*Z]015=11]]QI6
MKDGK92WIW%)'I4)'+E S2 \J0[LEI=A2*E03R=C0]2=Q#8,P*)RRR[8 :^.S
M58IYVE&>%,L*Y!36C',J]+24CW.U^V"?G/W(11'3 #N3\WTFOVS]W2X2I;WL
ME%'LTJNZ5]5>F)B3GXBY\5V@" 636^0*YWY"9\ JGN'Q7UD.N10&V,AY8A1Q
M>371Y6#14>!>%,67,F+\1A?@%I?O#U+<HEFWXXFNVS$R^HM:_S]QW8[5J/AH
MTUZ1:)QF I_8!@/ %.KTR]M2J,'H 5;F;Q9=5IKYZ^MX[$KN%MKJ"?KTA6/1
M.X47!2")H)_>?JP(6Z=@#A0ZPKNI2-7Z%@EJW5V_1NEG^VIKI3=LLN35"R5E
M3?F>,6;$?&'E-;=/"L,'C2K'M"34DZ>Z)(%3-3)%%#-?\<P%1L]YFF[=5H,3
M,1<L^7VZRKF(C*ES"Y-]_9(@BM4M3/U>:]%#OHP6V6]=%V6>< AINL1Z,.[U
M2G0KDG>CDE5%12NH<P[8*PZG'N>(L*A-9F$CU)W2J999$E*7JY[:F+],B,:I
MI*QS=2?=M:X4K>:E7G@/ %^X3=.6WRN^>DH?AE#5S&2Y+&4U5&4:Z^^J*5]M
MP H>"2NO0@-L^CW.2E;:.#U3^#/Q[B#M*H&,"D)5J+G$2FUKU-S0'JHQ@I21
M#^"=I'@)8HUD:!S ^166%3U7==H,F !VL[QJ"0I*43U;\U"WJ:/XT=OM#,JK
MG1<L<PH)6HUC!%#-RD,\@!FQ1)R2!IMUI(IV]NTJ(%)(M9X!(PHV=KW;RPO[
MSNF\61- Z!!9IGV"Z7"ZI27EZT9-4C4AUCYT2FPZ->7M]$*XN#15)3Q4E?I,
M@7U"42$]S<RU?6)XJ>P9,X S<T4W<M-91.!DEQ[94?]=.>97QSI_OH]U?LU8
MY\_WL<X?(]9I5;2A6%-RJ1F!ON_+XI;ZDDNV!\GDH^)A@@-DVUL+7=(%Y (&
M4_"SF"JU*<)MJO"R3D=MTMRX6SU2?B<2N5>Z[CE?QDD*@2V9M6RP>%CS)DU0
M.9BOLH+4[UVC(6T'*U1JHQ-'FZ%5=%YK34Y15?)47EB:@RK()+7O=?+5K2A"
M'C@W:7V.5@8!]\VM;L%#6Y;H-@8\K/XXIHM*H4R]LI/CK.M78U5F@2ZG93A-
MX%^<[-2_6G7]N6407Q<*TYD3QC<@MX+^Q]>"F1!;T(75E+.YZR*S4CFCW8(>
MQ ?4)8!\Y-"1(C5WO4*(3)11K=W"&W0837J [_EV\^-:;N\5?Z/2)9D%$?:3
M*VH5]-.=#QY,Q$BP"@U2I68=5<TPT>TU3$+67*,QQ1L2ODE']]IT>3M9&_*8
M<A V:Y<HKL2Z/8'6]1U8"A028N<4(9[42XKEV;7-E?9^3]Q6#0'E,D$2Y[K:
MII*15!# M2-ZT<E_74Z!CJB?%6CSS@<U[7UK%'+'LI)KVA$J:9&B"UFP//BV
M[\,*["O$4H)R2OEZU#4E_*4Q@;'T)V%_G()P8\2?5Q^OV$6DH)0@?L[QJB.B
M3)3MF;E!'(-Q<RGEA"E?6\5TBQXHK24G02-.V:;;6%\0W2R==[J$EAX_>>)*
M2+[2I/U.Z8(J%E@Y4:;8@5\3R J3)DV9U'XE"6D$5UWI0DH_>+K]K-L+=G]$
M$W-$3Q-;D_3<6$8@*?8H7W.)!&T@%U062QIB5=%@"684BJ5 N<[E]74/*_7:
M7&VI6J:2A*K$F*U8^8I&,UV:\ZX).WV9ZP07'!\>?-%^+U)8:2XN@$\;\8!^
MMA(/!Q:;T/3L]2Y"!?V:.K $K.HB+3(GH=5C"?*:[1_VV0&P@%#I6T[6&Q[O
MRF94I/EA0#2).YG0C^*Y;P8EGNJ@Q+NT0J<:AZ;N(!SQ QYEJ^+X4:%KI0+G
M/+.NC'Y/=W HK-2+X AKHM8U7_Z U+H?5;,6PS0N$@[V2VS.9MYB>4F%!@7P
M41'[BDPL5J!*/:;(N<BZ/05$Q4Q=U2WJ"([L;$PV06J'EEWBQ.4HE\I]99=J
MQ^K;7E@/L ?B>5ISZ)>BX!4MF9.5Y^D<]^1HE?!]6U0(.@+I,059?H#:R'*B
M?/SO@+T:_F@'&!U[85+ 'ADQHBR>)%TT;QV;Z@37KMPZ8IZI!F!F.$#\#<<7
MN^.;.^-SQ)5P;DX]G*#KD- .*F?29):Y@D*'/%"=H9"=U;_<NJ)&$!(P#%9V
MGDM6DLKN797(G-:ZHKY7C=H:34M5?3;!P,:I);)$AP 4.LE)\X)U^)%$-]P,
M/FN!&HM#OG995/0)V3M'\AWKD'+)]4YG2W/%<1'3CUB.F(([>2S>#H;22(E+
M,U):ERQ-EFL-^?XP6T5ISZ)Z62+,+<20=TZ_H21(^;>DGCB76A#LKB!S!U/G
MDI@N>U)F>JUCF*0"Z4/'C'^1EIJN-';4<&0J.A3E%'.5 )ICRD7!*U5>Z2!2
M-Q0PMIH[$N<@@^4*P1!Q)XT0CP1=<U@<+M/ U__:/=R3B67P#W02(9 )L;WK
M>'K8@NJQF6>CGG'-_ *5\A),<7(XD2/9Y"^RN<TN4N_*D<@.NS>R:_BZ*Y0B
MK<F.+;:'CLO;*@%I,\KL9.VGWVOFM+K+,EV6I"UY(B\59V];35]S?YO@Q2C&
MJ5:B%J%021B@Q%I>H"*B@QZ&5I[;-X'&2T:\85?:[Z_O!%MGTD[D4U2^:^:,
MA9Q1]Z(2U!1,)@BAKJZAJ@94ZF":$4F]$E5!J\TP4T$ R7ZJ#.!.V(;VH"A3
M3</7+:L,C# N@*>NE0UM6+OM-I$U4)'M=U'Y,1&5Q2]V)\0H(\S0C(N]E?'(
M(#+.?QU*=D(=/,NU=T9;Z\I3;%?R2#'ROR0\R9>T0]GEC#0)=.5CWW;O"+9C
MX )A-N94AU2=(8T1G".!):1VM+S36$SZ'('T5:7+>TS1K\3E"(C./B'? P4@
M9Q\%GX(JP&L.ZZ;+W*WXI)@!JTMDE&RP?4-%ZQBNX[[BNB<G.N^#;T0N2@VQ
M-,$>ZF'S7J98'JJ_@7RHXM04G^5<4;K 5]5A!.ZFKVF6BQ]%D59P7M!1T.$I
M-Q:S*EXG)5!OW:[FM]V@ZU"KOMZUF9%_[W5L&\/4]CIZX0"R$W7NQN1C7EQF
M27R>5,9I[&?:J=M!.GB>[4BFXNJUY3$3IR*57+3]Y()E%Q=[.L? #_$%=LX1
M3TFP5ECFPSE_(-3.LWO4SM=$[3R[1^W\.#SMAD,XM[VO^66$C@OV8@P_+;#N
MM]@_1PAE69;,F^(DRCBV(/DJ640^'BN_1;,R8P ;=+:P.XHX0',.'A/!C)Q,
MA'<^\H"TMX,;4G[92RZ4E?QK&:<3V[7[E[+"J'^EG;I4(HAON,+R!I0VDGN@
M5D)+1Y/:\&M5 ]=2(EV,J!3]3'3IM)%5!I2JO@0?;/"Y8&=-*E)'&2BQW%K@
M[_V>5PD(I0!KD;AG*'6@$\QY@:VH- #IRD2;.WL-11_GM'%6;"E2RAD[01S-
MH_.D:N -FL C1(*[N8SLO:!2I>1&UZJ)"R%'DT$ED%82ADN$# ,+T8]UWU <
MTJ(F5-<J=,PN06)50@@@\JB<A+[&$O9$#-W%@GQKI &)<X2?1&^A7T*1 OB9
M*D=*=I;,*5XF5H1+8/:<+V!(E?4W302<.=M-HN; W&M>,YM-(6I%%UW1Z6@A
M&;-)994ICZ6PEN-[<XKPZSJK11G8E[;;N^X9599:K9['BG=ME4#M/+E[Y?J:
M,:16X$5GZI!#XVUJ9RRA*#),3(78)5Y  "=323 "[D(0D0OMBW%/=&>FGGT%
MHH:YV7$0#+_)-:]J'*D.E9N,WD697J19<FZ2517?9#JB.^G+E-/"N2"G3-9]
MOH'-IY*M9J:->PQ6QRI#7=R,6+/I-.5<_K+%FU#049@ P:? 7M5\-"CWGH+_
M99N'S,,;IB%1JGWM)Y?X;$T=M3+;)&" &T"@"B/*$,1(.<&HE[&(#EOOP)0T
MI D03E(2<DH.BI%"U[D[N4JQ6+1 ;@F74!#%@"\!4$&,&%@NRE74/T" \RF9
MBL:(@4.\HL)(69;>7%<*U7X@2OC4A#I;2@;:7CJI*J'&5[#BJ'$R[&Q-&.!"
M^=5YE8B&@ZQ;#TXM4F"O$?LO62Y?4?V$Z%)F:\WTGOX_VK??2@W*BHV) >4F
MB2UAP>.[LTM;,CTMSDJEP*QBG*8RM% "<]<T%W.$&)64H0PD#17V;JPK?(@"
MKRN9<Q=&5^#DJD9I%S6L==Z3RK?,#5;1,]Y#F=/%0$I'4<S?F<&5%@T^9+GU
MB%AE%<B-R!#.1M*G$1>NN^J>O#/"O ] 6XM18].LO9D',R]B3OA$=C?GC53B
MV^R[^.")4UF!+)7*@EY@J]B6%MRJ;'*>!#,$'O(!LS?1M^O4&R3O\9W[O9S3
M7IY1)5PG&_X#[@I:H0L042DE^I(PZC;63=*)<L=;^3IRB46DTAL, ALWC5S[
M+;AJ$O%HY*;3U3:[Z1P>F:7C5'0$+G+4VCKK#YQ$K9M5S:!,-D.LG>H?R@>C
M>A+(@_1# 0H5CY3/(NO6#LSKB"U/CLW_2NL9>(,JY74PQ[NCW#6)M)7";HMR
MO3'D1*1O$@K'VJKD3#X*EE5+]164'TI@4$FM/%4V$94#YS]R50U:04]"K9U)
MO@C',+D>:*2==7>S&[=83G-5\<QVG_C_M/SWYYC9R\.]C3.J+(%Z$/F[7]-]
M+]7FRX>'>]]D3#<)]/QR'^CYFH&>7^X#/>L<:#A5;H;VEYVD5I'2(BCT@?+$
MQ.%1\.%P=#0\.PL^O!F>#H]?NT[Y&892J/2@5R-#5!(I ,/VML9:<2K(,E?E
M8FQTFEOP8IJ6%4B=<7&1T!64"#V]]1H079/WF*LYVO91]H_ZC0?DG/1.CO"
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M@>$I.%+IY)2Z(2E0?$]"MIACF6X,M75>Y&J$6@A[=3N,+"XO+QCL!_M:L0;
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M-8@@DX4#)=5?-6;7H.+SS#78Y!+$<5[HF1KR$S4NUUJZ4?DB<K6_#4DL$<H
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M?RQ?K$;%VDG73MK\M++#QYVSGA!D!ZD.B>:/(!=./E:D(@_0I:+:3.<+"%5
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MNC=[XCV_Y^!VQ3DA&NLANT\.V3W*&-SC&](V_4-FX5\VHW\ [;]02P,$%
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M.D^:I@1-":5W2SV1'OHFD+;$J++^3#/7UM5HM=YH]9JV[A-SC#6JK#>J9(<
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M2#_7?Y*7S;R@(BZ8@D\"$#\)52=Q\0Q8Y9721U!O]+8;4AF4&B WD-Z=T &
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MOPO0C[@Y!2D'J%_!DP)\;2NZA<TQ=NM5 ]'>>(<O<S#=J2><HICT],B:1EY
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M\''[_/+R5_P[*7K>Y &5)47'[M .*BW7C4S'N&9CSP\-SS7./'_$C8EW(5Q
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M4"3\847]D"^%^7=VGTT#DVRL>!&#QWDCNX^/M6RQ+W"0S =H +8^XUB9 0(
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MB+ARP&4"!6+4YG_J4(4XN$B-%R,1_Y4=!_B9P:,^2"4E+NNGBG:+!3] M-&
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ME2XS\C%,,I6?D2A[20V9A1$;7O!F1A;WX4C]L\)KV$Q,U8B+^*7WG(00R.+
M4^NK4)@RDH^P?E-J?TF,0HR/MWUJ6T#EP51:QD-+F"X3*'EUGZ(^2/#*.1:?
MRNPZ,Y%N]T.6DJQ8-8Q!KE!M*9/7C09%->R'<'!Q;[^4ZZDICH[7IR!+P,OL
M-P+U-XB*:2:-- ,K*2MP8YCNYO4P48[L'EB$K*_ N/091O4:M4:3JA#@?:W?
M+D^-=ZU$;=WFJ:V_8?T_\L93!J^TWB=,0?5ERSAT@ D_(VXK..R.%.W8Q*]X
M@Q ][!@L$#55#I4;HU7I;EOT IFIB _9F6JW)<N"JHU:#7AQ)(;)I(V7)+\6
M@PBQG3QPR"/I\TQ%.:>2'C"@M"H4$1MQ[AO$>#INI37V;<+5O6JJ7(;JYM#K
M$+,BG$1WYC-FM*SMFUCDW,0XV?W->"=DWEGKIBL$W7OCA%N88G9K7!HN$SAP
M>E(%#3H7Y95(1P5K$?[8)F06L\+)O\15F9@V4 S+T7'W0X_25!"C,04$I6</
M0SR\ 8<,T5#;]RIZ:WS>)(2NB6-A%?'J.*M.:"=XJ1@<G>JS(:U6FM_W-R@8
MZ."AKAYI4DOZW UYY9084$7$0M4(<MYZ0F"5&W,41'QGKYQ(V$X.>WB;\:1#
M'4]:7CSI<+/C2?,5?)>:=^OY5T^ VSSZ1UYP:D9PK)$-CN4T6A4/;OP#+GAE
M\'9SP-/=0Y<EU#JN*-L7(:B0LM\3D4SICO6#>/JZT#FJ9*M1;4U/*?SG"K#,
M>E548ZX"T<-4_5BM+92J<C:%) %&YN:K*C?J/3U&6C_I,=@;'"L)[K'-EB=R
M](7#0KI',%8H4BLSK0"52<X\R ;'W&/JF#'>H8 :]\G":BKY\2>5N%=9K-+Q
MC%&Q2[<V3WWB(;=D-*-H683+5EH")R%)M780"<6W^TH_1CG:$3XG-LU.)=WM
M4=5NAZK!IIA!K?&81]WLJR&62N+YMES+]VRKFHJ0RN ,E90&:@?BI(W:">AM
M)CQPI_*-MZX$+H?%@Z*T"Q#@EO=A4P#@$46>*)MX?)(X+I79^Z'1<[Q;$0@5
MC8Y%%BE)@+@UL7 C\2PG''C-#S&VZ63PAXAN@Q3)LG+"G^WC*R &K+HSW8WQ
ME&S0 26G(QWM:IO N&+SC@DC$!TJU PV<?;FY [0P'+@F#*8R5,$0(,#<Q+I
M5Y _M@DC7[C?9TF:A.?N5-1&+[+OC,6;4XY9B'YOQ^[3-#-*;$Q6 ;9EU>BX
M_1WNX@Y2V1=40#U.&F$ I JKPALR_=SC.<U\\:EXM[HW8E>$?.$]>&.>A1[L
MN">B[.@HV[&!8.%=7[4S:=V6 KSKG)GCBNCZKWG7NBVEXU9.69^->LP7SNFD
MYM)UO2B>IDT67<\343ZB7CQ946) #7+0&0BJW9B7MV#NDZBQXB[DW3T#VU"1
MCP^UH,3Q7>7Z;"7=I3>:R,3J>) -<+2D\E9-^$@I>:C$*@/)*1,&U3)D-M@S
MD9+6U2PQ]4E)"\R*J%7#U2?#SU.!M20?)YW>KCKJL6(7->28CY.^J,"'*K,A
MW81QGU^93EZ!OX:@DIN!#M*MW5* O7T"@ZMR-@F&FKNMWU* NYVQGA^A'I83
MS@#2Q^,S\/B,+Y[#&Y*1YB.C%O'O<>B"V AO8NMA.R"*Q+,'7C-JF+>@B' &
M@V86I;39+N5XHJW%$YP,:N%/MJWLU(]P89II2'TXE))%KM^,(E+8V&! /7GA
MS>EF''SB#%E[)A4AT@KCE,"XFC^52KI3N6%QJQ] Y6N&5K3:_2J9%I;LTPTM
MN"T6C%@OTQ?B#G$6PS;E<?<TV=1[D]O2EG4I,?M"/5^&UCPWP5X^)DDX<WB#
M&MZO!'\0U;')Y+HX QOKF\'2\,:\8:7(1DV:U?2I8)=-*!Y=-1S0$+CC#!ZW
MHV ;.F7BUU-742\*Z%G8/E2 (MJIB_ ;]GFA5MLL52Q=Y8X0HDB2UE+4]AV;
M4)W&?)!4KE"S"8=?&R>ESUBD6!KI.4DYF<UG6,35Z*FR[3<9JCO2H;KEA>J.
M=*A.\_-9[5^3VB"EE"36-!3[3E5_,MXG65_\<2-V1<=%GP!W]Q^O?08OFEGY
MFE O<=2F /NH63S<;;(&&)\R&6<_4V_VE#MWJGH(T[3B]*QWB5/E?343=#3>
M32>:OZ^J+0;B$)R\A8!Y)U])-W"]*65E$1A\CKM-,<U8S[N\_)+2PN**_0LP
M:H9&"S0O((TU'4M;*@+3H,X&5:/4>H):GIG('=&O3'#GZ<)%:M'$*\=%CJKM
M)[DDG _C+",:H(:Y'$,^S) G68AQ961V>Z;%7,[WL=GRV/$FO"\C\FFT4,':
M12"0W_(>7PHT X:KX)GF^/<M90Z(5HW4/E)<+ MGP S_P8:>@RUI-,VL/1Z6
MB6;:',<YR02F S=+;RCO%R3-&M .Q 29::TBL8SX$U)C9,2,0M&S,!T4HJM%
M/"BK,A%$F82LGY <- &L.U*5B0#20H,JIXT6MJLDQSZ6%(FA)^@9G49]CJ!I
MA.>E_URWMNQ@S-,O/"KOEVEB \<,AHH7M&^"10!KY&@/%_LF:NEF# F\/>5B
MB$?Y3ML:63O!=)5&FTIF7=(Z!1-KD!APHY0N*02+DB,XG86RDTN,.DEV;9;R
M<^_XFBL_E1L91L=S/$TWFH.W*?T-NTG?-YZ'T)9]WW3[@/5;RI3@E-INH!YX
M9H@+CTE1+%'U6R!+X$>N$#M.7PUX/7C<E9^GD&4;!D[W!ZSD]@<$C7J4:0TX
M7:2^8USA/%$<_Z&DS\AN24&LU,?=3.Y1T?"9(;KU?LQV;*IDDU)T/Y/U7(IH
M9<X3=3[)KC5X>M>B >^-$&>ZI<EZ+D62:[5"?5)'F!=RV6VE6J7&6GV5RA[B
M-FA9NC;!,,:L7VJSK?908H8<8E09V0\&[UD4IT>(T1 LMZEJDGC&)UTIS;#3
MC+*:F5TEVU6'DS$CI2Q6K.Y91711Q>RWB1A"&<(^:?ZR9DNY$E,_A/T)(D/T
M.,$!W7)8@F4P&Y. /AKOZN^Y(1!0D_G1R*:R9XEH^!32H3**-V\V@NF,0V78
MN.=C^32\%X?><,/8<P*:@H+#<% LO3-I+B,A,5@FW!"GN:_F7Y[L-S\]%356
M^-]7\2WO&N\5$N+9W57#9;<>=B$6E=XTI42&,.4PE!A6B>PRL^MIP*9LD1@F
MD8U/">CI:9&8B<KX.#<LF_$IRZDB-X,W;XC&L-FB#S/0+1DR+B^]XH'5D0EJ
MC$F3?_"R:(S5YG>,GCJP'VBY04A]&,3QB;804\:2B@T5JA 36(KY*6Z2)J_L
M9.89FM[7;"D8O1\X[,$6+ES*<9H^QJ15@(DN,"N#IO YR?/C?F!L=N1'KFRU
M((LL_%3!GAROTXO"BG E #)A'0;?C8#(%:D ,[) 6[=P"V)NH"*W\C@246)2
M&1GR8E+KK]CE'!;AR1I(6 OF4\4-1;%!)F#JP ZE1ULT;TH!*V@-=/L@H-Y&
M5!7BJ3,0DTE\W.$AQI+ BZLDL7DB@&0R(2-)GW@\>A&.H:TDE7.QKT-,9J-&
M492^K0EJS99RSD=:53(&EC+X.NF:FY%;?%;(R'9IFC#'23F+6#:Q5:5JEC_+
MB<BF[?,.:S8V_ JJ%=[0S/>\D4 @,<8K54LJ,%?J;/)A<6N= /N@];FQBLW]
M4<;PB3(V%=?2%*U[K  &S,<.^0BW5%A!BZW@-/%^'YN+$4OATYY=&4JRIO"_
MJ@X-Y:6R_BVC*7=QTB@1&AO);$JD]JGJX9XRC5,>B]+E=&K[\!A2\]5PQ9EY
MS%J0K=M24E76E=@9 TRV#XSXEHE9F?'PMWB:(G;-,Y(Z(#&_$1 =) ]GZG*8
M8M)-T'3C;EACAD.8@!J!;BU1VV-QB0FH3]X:<JZ,S(F1B#CY2$%N%/<4-XJ1
M'*B3X6/C<0]<2?39F'M^ ME"5Y(8YL+'B2X;<:0;A)W<;:-T7M/>F?5<"NK#
M4JVUL8S%IAJ=V 0;Q1Y@U5N:.'>E69D)!E4SL2*E/X1HI)$)YU:RPVHSY<F\
MG9@8* [R2^@3HX Y=]QWS24==P9-N;U%601_J71BDP%[[VT#:W-OF476?<7D
M.H<;4<$F,"31=>0#!P7[S <TMYRJQ_G%*4>R&;*TM4"-18<HRY7N_=D!U6G5
MII**TXGI8W&.(?Z()KT7A0$-RA--P#E_3+7<QV18/QX%@+W;2'>/.]4FS5:$
M34Z55CQ1I4+]1L 2P/G+-+H(5TQ[PM-:I#&<>.E,W&8/RT),WY5OR[A"R-/R
M_]C[MB:WS6O+=_P*5":9LJJ@/NK6Q5:<294LVXERK,ACV7'-O$R!)$@B @$&
MEVXQOW[VVI?O I(MV9%M-H6'<V(U2>"[[OM>*X,+E.I:NXGQXF)M&;9$-4Y(
M K^/T^]!5/QBVMG=QU5IS!ES;:6&*9.B!31%6VI1&V@=!Q2$#*!@ OL$QQ-!
MQCSB4K!5MKL@6A0+/,0<L*YY9=)7)S:5[YM$T"!Z\3[ 0=QSW]08OR9J3HR(
M)-C 5SGX>HM8-R[J?@OWN(';-6UI.S)DVZII=_+ 13'/%Q)?#HBRCC5XIP<:
MO"/$49I=37*560NW"H,A+5F'N[B3=W=QI[].%W=R>Q=W^C%T<=_:_G7Y8.K_
M^G#]7Y</I@:P#^X0A%C49^(+R,2"&AKRQ<,"&BVY25]RK84U>T<%.,\E5(84
M3C],>>P3G<HSR<P%SA*]HJI,>0>993 Q PH*.EN 71@\JHPXD:5RCRU@,CR7
M>8L2<N$9 /_O7F TT]PALPDOARHYGJWV7@^2;@X8CQ-G^.(\A^2.Z]>%<11I
M<V$ZMKP?,F,9(T.7UT:-X!-LB5*GNBB3MJM+U+69R;<6)#NYT)$F5%LB@UE5
M;]JR%Z)O;TU[XZM3EFY+WIL'$2PUNWMMD2A88MT@H*6!6V.K-J1(5F2PQN>,
MG5AV:T[.B_>$W9K]DRG#B_.U'^[J5!S97^F,9?(P*V7!$J2"H+*#J4S(\H"'
M'%S"V^ALN<+#HOJ2@=<P>8FT//VG&LMTD)-/@.HA266/[:'L618Q3[^VZ*G)
M_*_>ED(P;Y\$R![WV/.&9;X<ZKEZN\K( B:Z$F=7Z4\LM9(E(QGAN/A$)@32
M*M,0:RN/6X2-,$)O(-ENG[3A?&:WR2L9QE"+(!%K4&J<KPN-W29@C9GA0OD$
MN.-=5Q]GNE(G-A4^Z0FK RZ4/"A_&31WAH*0-9T"TB/L,RZD-4FR5AS4H$TO
M&0"$Q"W_AJ4[6I5 A[$I>Y'>!C<;)+2T04HC27;I0$=)7LF FO9\*0U1BCK;
M%BM^!A>3O2S>EO/&%Z?D;3F;%7E]06;7O%G5TJ4BXGV<;F.RHV#<.BA>$NM[
M 8D?M_DR IK 3K(*<OF65=7,N%A(X(>1W?39\"R@[?B*G'<+I?Y]*/O_^3^N
M'C[\',P+FP8/1\RHNTA?NA1@HHG%3F(2-UQV-">%">>(CD"Q]6%2DPP*W::4
M([+<7)DF10G];B_MR<NX5ZHSROXEGY07Q46$!GQ3\!'N&!N721SF7E\#@AB;
M="\HU@TSC/[)43VR(YX8!^XT9IRX2CLE>4"^E?DRC"3"I3FY?8%M&]TAS^[N
M'ZO%!8X;PT*N'#-!\02+-V:^\+JE%#-PR84,L# 4;D?#J,M<U$X8F*5A\YZ]
M^O[97DEAKX5A>L,M],A':'<HZ<TA5<X,)ZBB=+2HI!6'MK:P2Q>5-G)TMS*P
M:D&Z@HQG[GFV2ZV"14/3D[0^L:F\&MHDZ#HE08R6(D3+6$2I87$@V>_Y34"N
M=DV'K=J)Y"LY!*FR7(3'_ T3!PTB[QQ"KI><=N\N$FT6=)4(;)+9./Q;\PK"
MS14'FBUE<JFF!7!WF75&=-?>Q\Y*]NPL]X>R#GM;]JVMHM#\LV"I6X6*6()(
M(Z%B5RI+XN]TA1\UBP=E2$V<BQ7LE71OZ8Y]GJZ;&VQ#%I>.D!S9-%SII8]5
MAT;#GUH^0A.Z_.P!V: [EH+B7W$P%J4<=0'7$&CPNH,7Z2OX0>0LHHA$[4K)
MK8?OUBF+GV3!X+!R!6F9?FUM8KH3 HDN&.SNO'F<.FXI2>A#WE7(570^H[TN
MCG;3H42!6M!3Z@^/:)UO\]V754XFK"JE6=@$$&F5>[[FKFYZB1^KHELD6GPK
M&OJ8D9K&V/5FS00N@(#Z.R]#X]D.,4.&') WQ<C-R2A-"C0/*'#?1N/YL1')
M-\)JRVW^Z/<M3VL<<T 6ONT+ <,7S:BMY/(\,4OB42*Q)W4?>C-=$;ZD#O@@
M+(=6*OSBV(:50^% <*&S4_ N)ZPE7#Y'7':^^=V].G$_Y PBK2XGEFDN+5P:
M+W/P4SK.<J5%CWGH/)8@KNA*,54DZV@I!S8.<9%W<6HTZ$K2Q9 5D^-9MN-E
MN4A_V#:UR8' QW(3\2K=18EDWIV7I9[,/4B-^IT960Z*$;6,CZT59Z*ND^Z3
M:_\4%CR^6^RFT5%I;B95_HZI2"@^_(,E0!Z,,?XLN3 G8=?^D7R,Q1'>F$=C
MWIA3&O!OEZ"ZG!)4'S!!=3DEJ.Z&A/FUA278W]]5]Y_&=?^S8M=PR=%\X+!&
MSFD&+C%V?O,G-VN!0G9-2YD+==S7[J4*49W6M53<]RT5]Y)?H+<@K.>&NE3/
MQ5OV10T_/1>'F?Z%D%*R%PDZT'A@H>"][P;A+C$.2>?GNV(QALZOTWRUPK2$
M8\0;'@;OD(3%#]T<->XV8ZF0"NP(CS'A*\3IH.'Q^N:2UH]!C;IUN>3QBNW
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M(M>(58@FAX<[Y K-QAD+3EMC-^2R%HA+JSPY>(=U"!PJZO10Z6.#=$\2YW
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MHEL%)4PW-7?SSKIR4>:ML87:6DPJ],2F HJ61.)$C0 KC-!*GHWAU_@<2OJ
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M3MKXQ*9"VC@P%F&@!3R@S\ #.NGBD]NTKRT+GH1M,WKOF6LSO/8"%NJ 4/.
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M4WG&H'5 7/.=6#<%]U-=/F%SYC[YUR%X).[QD\B],J:!!I;)CP4G[X]\+E*
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M\G2^\(S%3=/Q'A\WTW.%EZ3#O(3B-ZD^8,%3@6YO3Y!+^1J$O2T!BLR3D<Z
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M5+2C"^3&9 :>_(F^TT.=CM1I#O4N"?0;;]'O1X(E:,-00OO9PE3P7M;EK&2
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M!TOJ<%1]720,2MGO) 6E:XZOP=I7;=))PJ@Q@B\!*?@7!L@Y8)CG/'65*C,
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M4"H#R6 E:ZKAP;%IU,4-D+!>8/=XM1 X &B9Y'M'@MW"EEJX:20=5CH4?",
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M#H?Q6A\@\.3F3/I3@HH'1XP!@HMMCF\?>IP+8(RXOGZX>'V1K@KP'#&%!A-
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MBTN8AZ;.G=#:_#A/W;IC$OA3?\PKA'BQT8A "V'"H[1,%+& #TK5U_#GBO+
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MB.3R= OU-E9PE7&\E?G%<!(B84\1;1DG,,#5Y="&A/F(M%:;KYC2H)S'B@J
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MR<;@_8[F&I0SJTKNW6>LY.YLNQ>7YQ='E]<G1W]>%T5S"3\J'\@!J6&ZA>E
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M8U6;E8#=+#8C!0B40XMXEN-$L-:8 EWAPJ$;MX7=848R;M PR9DA#V&+<$]
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M8H,Z9&R;93#=QXOO) P'3UOCZ0#V2LV0\!'FX!A,&89GB@CURGH9E'E$I\M
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MZ:V3]["=JQ7=J@[SQQG@W(M>-;Z=JKIEM='SNJ#=[K/%36K"Z#$+7DCB&>K
MX<.9^V X=Z^B\=37P-5-$&_=IM+/'05*)XF=!U[+2A\Q#LENK^UU>KV'BZDX
M@_MP0?=04IT%-W&OVP9_[^!>T:R2*;;;VSN-:_@T\3&I.OF?3KO3ZQP\W=3N
M*&VYSWK4U.E_CO6H47]^I_%(*5OIA5]E/*+EL+>[M\)X)$/'^=W&H\'OK3')
M!,/L$5S0V\XC3+(5AM""3;:[BP;FP1(Y0JU5QLP(NTMH=?5F60<9"O?J8-X>
M9)6YBLVBNUN__XNCJ#7*VN ;'/2:OJIUF\I"2/O"V&;_?"WQ[3=2L;8N >YF
M0Q\5X8[TYME&RZ.LZ->(&M?U]GKM-\H&%BN%<ISZ K(M>_U:QWHM(8*"J7/0
MW5UET,!'ZN/>X%PB8.6^7!%\%\QQFEQ,CP-8-5UJ8,),*N7155?VW<1 JCI9
M%2'IKBE\T,[!/TSM(+SU^*KOV5WEB,/NYNFHN,74HE4[(64-K%-W<$FWW6.5
MY[US=/K.7[W4]I07V(:LRQWC#@R#!0I_^&L9Y1%7^_'.ZB?3>\BA;B-^3<?$
M,ZPJ1VQ0PP^1>R.$&;GR>01KE"IH+?H>>9/#A-A<=6$7GN"=O'_@=7;:IN^W
MUNZX9ZU=L]8@P.U=K[W7()6NVU167T#NL2XB:*Z==9\*UG_Z9)"#M[#?ZX#!
M32 !>#<09GL8/.+6$5Q @<B TWL MF>GLV,JO!_<G0WWQDZ/-7GMEV<:R(L;
ML^@;[?8^J)^#Y8[NN:Z+9VWXJ@MJY># &ECX)<R&$=]9JNEVV_DQ=&5Y*DN^
MT@%\!5?#0=O;;^T\>A'-/5%=Q+UNSVL][.V*X'O/J5TRNZ5-K3)L4:OG'>RM
M6&4;O(T_OMOJ$KO;PS:%:F=>]79 "O;V[MH6H]\WX%!MD'XX24;,&.LY%"Z0
M+@CL":%:L"CG"FRK]39W)_X-]W E*38*P*.Q+%4*O1(-[J#-COKP!A:8<HWL
M+3PFQ:>'F&5V+%K[)AZ[;E.!"X6V/Z$RW"W5N9=/J H0]>K80!HALDMBH11U
M6]W7_AO4))?AN&3!<Z^VOF]V^0FG$@7_]Y7_J=7NFIJ7I[0*3ZZ/3IV]_K;[
MGX_]L^N3Z_[UR0]';O_L'?[B@_KYW<G5X8?SJX^71U=N_^WYQVOWM'_Y_=&U
M>WERA=O=6(KK-I6SM' ,LFMS(I_A1.X\XXG<WW:/3\[Z9X<G_0_N%9S"H].C
ML^LK.IA7'R\N/M#/_<N?W'?]ZWYS M=P*M?4\9M0%2&9T,<:*?!*(P5Z-@PA
M]QXD_#MJ?N-?%:D=%)I)&PVZ(<@5359_**T,"97*N<=;[44 08S:(+]-!C_1
M</#)$25/R W JKW-4!,;,8DU.0A*U_6>4=<=;+N'W_;/WH-M<7)&&@[,C?[[
MRR/1>3^>7'_K]@\/SS^"QL-?G)^I'T_.WM,7C*XTEDJC%-=P*F=ILB%:9H,V
MY>&U].VFEOXY:^G;32W]6IV+RA6XJP_*!B*V\T7<AYOX_.SZ\OP#>QH7E^>'
M1^_0ZV\NTR>:RO,5NM$^'MV >J9 ')9Y(P=8G.;8[HS,A CK0H[$!68Y D0C
M<)M]7;^I_!@Z"HR!"K1E"X?V%L[,%E*'-2?E$:U9.%@3^@ZC)"38.\[A6;O!
M>A"JQTM%(^)B4'T(PMTG@:/0_=D_E3?=8N]\+, 0Z))>'1TB6%T6#O$J#CS%
M'HW_S,LIUD;\)I@/_""A<I6^]B+292FYBQA2T2CB\<C#5>+!R<I8$ADXG_QK
MTZ:.W?"5:<)X; !SJAD!-[E,$"A?6'1+@<T@;]JSP#(8'T1A1X5?PB%W]*?8
M)A]FCF!-R]\- 8#\G6B/_!FL GR(\4Y3A@&CN2)& $R2>7$-PX+>&+/CC:'\
M8J#MRLPYG$3AR#W2TG+.TL#P!"!1_'<3!#K7TC)"L+-0-+?(GT#4W7_\!<'.
M?6T2--AG=*30%?O#PKVD@]/N^FZ[]SID6*9V+^"?WBRA\ZL*+1MUSUPL[CO?
MH%Y[G#U$,@IFL&!E1 7-^.V%KWDTMP?H-%1GG((4*(U5^@RT$7ZV@ALA.@U5
MB&@NIZ*YT@QKJZ918<%/5=;K?FWF_0YU!JIL485)7.]WJ.L!UN11-7))X'NL
MH!^F]IS5:N\N(5XIP+?$Z/)8C><T&N\%:SRP-:4Z'[7-"7K 6%2HS<QS+ <P
MLL)!:-CUO]3>_%-6YN^P^U;G#*,0Y]$755$K&)U6V8=GV5D5&+ <ZV/1Q$HF
M6'; A0:@.K"G0FX&KBLQ-E:F!&GQPM-WW!;<:B-]Q\E/]8K^C:7^/'=0$IHR
M PZ1LO00;\P?Q%$^H;I?C51JQH.*BZMLZ);P'#T_KA3FYF:\3>#S,7?/(.@<
MZGOY'J*LYN$8%:-NC2X-JTGE@8C1;+U<UDB5Y5+-=AY6UI,;P@G0+2SXXNB7
M8X17%"S9O[!;I#F/3XJ-1CN-E3R$\6?UB^'-'BD5?>_!0I[50ELMYNCJ K#0
M&'6S,L-Z0D(.HQ/HR D,WJ"9)0<P>*.T0L7,LFHLI2V!8 I92*W<)9M%JC1-
MHY"A%898BF3^^7F:P$F=P^G]# 8'TEHM?<%[W$(TQLB:305LCM,E:71$1M)E
M*V0]C9 G7I$-HZ8^K[@G[(GE,ZRQQIP0PG56K^0%X%(_ *<"$0(?KNY>5RL;
ME89R*HYSG5'Q9MM(W/U*-:^$YQ1"K%9<H85I:8)"W$0$9H/!LJQ[N"H.H396
M@W-;2TU)2_A%A@WJ>Y;F?$F@K9(%!O/U?;]_L>V>5Z-DCH[Z4:L01L!L5-W?
MY3XBD40YE 8EZVZ1*T.' 0CLD5_DW+O>C%PCS<:CS)^&V$'LUO@J6_B+,=?$
M')L/,D^%P7<G&B%NPD)Q3,D /L_&?B(MT-KRO89-#6[].7\K1[=WVWVKQH.V
MK35)8YCJ05;,Y0FA:E2B*W67F+-R(;!#S4125H1ZU@88LT'4OC,M(*7W#,&>
MAR'1QX&# -J$V\H1=CD9@SBQT:>.B8IAY8NQ)NM#M3$XK4_Q;UJ,MIU^,K=Y
MP+2/4E'(:F2L>"0^IM^F&P;JI)9Q9X=^"=Y,2:/&MU6HA_6''1O8UIPG*W/@
MFK!;IBO5\VT79T'Q,S45@;N-\U3>S4V?:49#H* BC'^$%C(Q8%H# 2_43,0*
MX9E67GPT14L1]P''"_^$%?*'FLRMR'Q%7,$=.KP]AK^J,4G7;"K7X*4H"S1(
MPYP"" J(&?MMX=+ RY=CN8ILVN)),"):2S[MKB"?-B:"N@GNO1*5($8\2(.'
MC>'P*;A)858Y@#B\329,O;O2J=-4.CUGI5.GJ71:\^.Q<3$RK')*,$Z6%,X'
M#/$JJQU\OD470Z4Q-L:MWJ K]_QW)S#OS,+KVQL1F8:%,8_OSU8[:?;($"N1
MELPR81Q%SIL"WPF7L!MF62H$$?@C>(5E ):JB?43ZXLGS;I8.3!);]U;N#*V
M5(#!8F3 &.G03W2\@0A/3=#!8SZ& 5Q:):9M30R"IF_9Z_)>;:ZD@U_XR.0\
MF4$(EKFPX/$XF%"[^G5W6E)C\"CF)0:OUU=K77 6F:*Y.2SGD-X-#@UZ$[GI
M@!G *1T)ZI;>$'KN(-3,V82+%9.-[3 _2)0I/IGC,F,VT$'(1KY89)%H!TX
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MBS>?I$'J9]3?H I$<_7Y60;_"Q_?Y3W3OVAU:%/5#CY:7K$YX<;/HA1FR9J
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M>;J]-<#[RXB SOAU=5)!U>4ET/X"P#M"MPD&)W7PY'&59"R]5Y#;YD5%-S.
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MQ"XP2FE8AQ,91*O5>1GP=>AM_Z;M6G$8-:SC3E-[$E06K1K!O4*T _=&W$=
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M\F4F\5N$"1-%1SA\N(=0(:KZTF+<>6!:OZ+L4".MSC=*%L*DOH"U[AFU@7Y
M1[O';E4ODB/'7"ZIO)0THR+,/X[OA>&>U^_?QJ?ZXOL#*_,N&_;U\@^3S5^8
MZJ.RJ\:8I[*-^[15?DCDL[Q[_KI %N6_DAQ?-G^5Q.]>,F7=%UZ+*'$<)F$3
MM=NR.]HU*?$K<J X%,7'!E/KFM2K-Z=O&VG8D<-C:"=3WN_=&CO ))EQ1'1K
MH;LC5<#J(.X>V:S ==PST,].2!U:5G6+L/X!QXC3.)7'LLADWNC2F*W*%G\H
MN>A8,[S>SL59AT\Y0$GW!6]X!CYQ6L/?72EK>E[L$\TBA?=1<[8^-S$FU9!6
M^#(_XRI><,-H51?\HP!>4E]+N0L4?&6'MB6&6\/:N"JFAC>B; ;BS2!LA.G(
M/<+&KBPE0$$D&\DJ7:V&X3W_V=KS6\-_O*7)]?E5S<R#ZZZ$RY#J>P*>0[H9
M60J6L]CJ%*M1X^Z#%ZU1(UG,18TJ\;P0!Q,I?"7#\C54>6M<K[S<@Q$%Q5TZ
MEX1>EFFN*%O:0#G[4"J>@ZL>0JI5C.3+HI22I,BC&UUU5F^[0R=P.8P-L<U9
M"L\8\W1LB[S3Y7 @QVRUY',0-WJM\*1#*/D!SXP]3JP6$Q7]NRA5%<!;@O&A
M$6&#C@Y^#A; GQS^+.X0>)=0TYA6T=A,>+YB#KQ?D#%T_.C@^%YR_][1?>O2
MT-HC\3R2K4>'7BXRMNH69;507Y$^Q=\,>%:27C5#-K*2&)?$A;./NC:Y3\#:
M!;;R86HB5Y7FI4+,)&7Q9+B$$O>X@G1G#E-PC%JRG8CI-/*DI^KX=!XVN9@^
M:PBWE&$])P+Q1QI$54>"P*K(BYI9"0(TLWE6+(WF(?'HN4GY1C;>DK,O;VE9
MG!:E*A?D]YK\C$L)B8LX5^5R+@MRKN6QH=W.SRIA08N*=7T!S^'$K\I&[]E2
M7;TO:]@*5T\G-KB/C;.,1D,-[-1X33.@F]/D*IZ=.$Z"%W5>NH%N4!&7#8 J
M\XDNKB9 #*SQ5<SIC(L-6+J#Z*)89.K@F,"#Y ( YA-@DR0%(YS)OQ?C,XX^
MT#M&25DN;;TD?K12O\N<Q+/E5T@9^ZAY%E5KBV@V:_87 L1<*#CL.*U&BTIJ
MLWTDQSF<ALL&U6ARFYYV:<XP.!V$26C+[4-.5#DBX6PZ.@E)8/.!)JE0"S=>
M7-=0FI?RC<'P"WD4ZPEKP#^PEP[,GPY0";@UG(2\F,RCAM"(&YBD6B+0Y]!M
MVU)(#W^>(?D(=F&'1G=GL#'NT)F]RKF2OAQS=I4@.X 3+;/D8CW7AP&?6B\W
MAZ @WT8X?*/\!D;\&335@7PK7FGP/)(!)[5PH23/%\#],N).!:1;78P^2C)S
M)9%'K9A7Y&O/$RXX0,<#XCFN'$R9C0/<CK@X_&>A?\+E;'* '=X&/*&Q<.O0
M$"^_9O3SP].4,^@:$YT4"#LR )2.(7IWP'I+W0]QDG!&,X<J?_H:9'/;Q.[S
M@L(\H':>T+57UD@36IM.]+<;:]I%6_CY;;G<= _VCT@)_]I,YXO:QGSMF3]]
M]/CI+72\N86Y<H0<]S9^%2KY/%_IXQ"[/@Y:VLGE7>*K$+.5&9&&A\! CPZ.
MGES"ZAJ;<Z.-Z;Z0QG>(J/NIKI]J3U+;.=6=8HP\-V6.KUJZCO,:-J!92*]B
MX&N/PCEP9G9:-KAFU<4V'ZVR39Y$@W7B-5VT'FTML5L2O?GS_BHCRP9OZ>ZV
ME)L=XBRW.O.=8C2.R01<AN<+3G-9).(Z_.7Q)6K9?J<,[;L??NE24*RP_9;O
MKEGJS?ENJAYZW%</W6;UT..^>FB+G%4[RJ4Y*X+=L#;"X\./@DW &(I!@853
MR!&0&1JTX,K/)"Y4&HOOL!X3<3\^R9>1#0>24'0#<GA&$AU<\3OG'XR U6!L
MS*UK*M8;ZS"DX SE0(\X5T._<26(7 A$1KD@*P-MM*@XG7L@+F-^6(8-8O9%
M;O;$4ZO+"T I/O"?YVFU,1[8X<B.FH[L%3\V[_/8H%<= *!*<\ZU6;KO]E5!
MU9* TLBWB"'2D9=2A\,)*I*#UH>UMFPIOPQ_]=5#T:GK4!->I#[5;#?.$AS.
MLH8![N,:9L"YK(P5/[#<M#2SXMQV,RH$R@O!?T%K2&J.7*^Q(VQH'FE@'+8_
M-Q&0Q"T-V<>0,Z Y(W%]40A+JRR#H+>Y9%GZ-9?"X"6",)U)K(N'58;L EQ-
ME)ZW+L#G),N:;>"U3C+SR8)C*2 9$A%*(RWQN%!QF"*IA10Q,T^X?3@7I=FF
M1%P!TNH'Z9$IUB3FK<UD<WG):8U 9#I#D8?F>%6\Y+ [ETMP"$M5UB+(Z\;1
M8ZAB2GW&G44OI[<SXAD) *,9B6%W-"6#,QHSYSCCI:N(G%"_4BV-WU,E2P"2
MB8Q'7I%'$,1I@.HN$#.=(,&%$U<<P""G^_B$0#0;7D,$4IB%%LAI.5K,0()<
MIX28*V,WHFSEF^9%KS+ G@-NRHKKQL>>2XT3UX(EF?.)5!MT)BVGXVPIQ>&2
M9G*5] N6Y-)Y<6'+E\<+R25B\HV&AK%JSG)A7=-TID%Z!.BAC>%?99WZ=M:S
MB/FD0R5ZQ\MZ\ML%\EN3ZRVID[%K#@B,@")+1]QO\F)JF(Z('5=33MHCPLEL
MM9XC9A+7C7[B:Q.^-5<S4HX^3SC_EV68X"1)260@M*XJIWS*>LI8DUQ;/;9%
MVE8XCO4%+"6X=JK)69OV@'HTV\'G1B>(SOO,\*"PD_[+E,-E%#R_(1U^/_Z#
M;NLYMFG-G8?5DL)I2JLTYTFV0/\,?CBHEO%]'*5FGP[-I69.%OAB$(W-B(U:
MKT!\AA1,)R"+9JG2N&#5J(@EPU.R?[IE-TT[<K);LQ:['< ]4]E>ID(6&A-J
M]-J*+"8>BVUP=Q(/::'VV.[(BJ1)#Z?[3LBH(+V5_2O(N![[CL)'#/9U=#Q8
MU\Z#,;8?"[R-UUR$U3?RG6/ J/+@SM!Z?/QWQ)79/CL[0YZT&&;WTOOBI"J
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MU^]L+&%7E_++\-?GQ=A$1)\OZVDZ$G)ZMJB(,JN*2"0?+T9U[PW=OJ58\ ?
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M<_5H2-A^$%EW@P0YV;'0D8^<N,E>MN8[<7'N$ ^P:K_-[(]>D&3OF?CN'&#
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MW-^7G*4\ECZ^1;LSXY,']X:;&S/:4>&)N[-J_*XNA2YJ YI1,6;(V,7%_>"
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MR)L]-V"OMX3OY?;Z*^%[5BDC?4PPO]?QW!9#;5HBW3O5TB<9\:2U_^+W+J/
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M,>T8P"Q_V.$M/03!)4@4H=,+Z3I6WD@TO WJ@1NLGCVH8ZPX"2N4!#Q<<7R
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M81P);?BBIO\9E\X@@+L^-[C371&11SM8%$QH+ !7X+X-%)9"7@.'(\H0*&4
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M';NCDZ'C-WXL(!^F%<I?O.M QS9[,RV\=7W-%*0L3W(I:<-MK&5Y8_R-#E:
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MG+OL?;('WPL>^R*'S\<U@H*-[1)/\T4V@,?C[>/0@70-P B22/< $Y> @9
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MA?K\:[W/ 9W>A *KNE47J[HAX=$V=%1V4+Z8W9M ;FBM"3!$"\*R@IP,BJ4
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ML$D#LQ#^!/4]FF5W)^E/?/UC\B=A!_V+ _F3X/$GY+1J:7= 16$S;1%:;W=
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M+G4-\P>(0;L1[A+OR=_J3:4FO/[ZMMU:]-L]]&N8YA0J"-AS+GE3IC2T!S.
M^@ J9(=[NQ( 2WLOB5. W\ 1M=2JC4<U=W978C72J/%3QMFNK<&E/A[K6L?2
MI:=5WO3C1GF^Z=_\$&<'7;#88S\FX3]H2J0%8L9[_+PG2[C9&>\)W&%).% ^
M<9H-U$&9 ETN[JZ2_D8FF4>AMF&7O<1$JF@R^0+ 'T,84Z'^Q/QH7[2_=PZC
MXM?&/&KB3/DCL:D$FR<*&LGLNGSB!!V.SA>V']&9,=34,1'%9=]AZ0L,3Q=V
MB(B$FMZ#:!BBMA2PA;GIUP?NE_FD]A_E@W9_??I2>P.&I)"4ZE=[.MDN6;_<
M"3EDXBK2/"O0Y7+F]]JM:I_?@5MA(^WN#JBB!>2V:*!.0D&.+_-"R(L77^L5
M63X2'2YVF%)%?B&:'CX[,P@IX*60%C2E@<15(++XD-B,<!E_"=E@XI@0CF99
MB+?\'JJ09>&DAX2Q*,5S@TYI2ZEE^2+-%=-T,*85VAJC@&I *,5B:"L2$0NA
MK8U91QFH[8O&KSWZ(K<?S]J?40,WUB(+9-U/1&$ .I/)CT+B'FT"72IP=#[5
M3ER9_#AZQ$5(DT)BQU:>+I99NL0<3ON?HS )/I(MFH7"'2KM K4P=JGA"OH/
ME41X$554^N@.F):A2%!_13]4-'GQ"]^5;3@$5$%AN5F9I$[1]JZ]22-1&X([
MJ O7!@. @F&[O<F$F3!0F_-I<-,[X<UJ_RY>#8]1@T/U-\C,4;(14MH^ FZC
M6T[L#E8)5;!-*HI#?(' 6(X271!VEYN=86JOF(I2LC;PC8<A*L_2/+_G(R,A
M+0'ATK>JF!/=%-4KR(\G\(ZP!EX=6SS,FS=*7BK4ZCS''X0/.+9T"+1Q<-+$
M&=4'0T73<&/% 66- #7!J,P,JL/C%QLB=Y%;5,S6()1';)+ &L(CX*: !MF>
MTPHSO)X:7OE +6F3%I,A>.5*')U/M:)I6@[I\MXD7<V1=%_?\C>R^GUNSL$1
M&#_+A.?."SX!!S1Y6Z+-?M&FS +?1LGZM*^"]_&+_XG%*M)XWW%PBT";2M@@
M)C6,6[ T(W TOU4'-UZF74BX#+8'!MM I4S8I&'EWI2R6*#-_.2'Z]_(_.2'
M2KM(Y; SG4Q4@,H'BRKB2J@"0D,C/ /N\H5J#_UG\:[\=?C[\K%_!!K=*F'\
M<R5!" ,X6TKQIIL!+MNL![99_6G6#2CU#:A$M$5%;@(283KOJS\O7P;S1G.X
MW48]VTVGQH;6!,X+Z2MP2Y*)'ARF5K3.+:J42ZN=[#!(2-S_H,S20NE#9OT<
MVB)'G,X(B3.V\S1?VG-["WZ!O4GZ&'3%-U3$Q,?A!NT[[B<C%RY+1]B*S,_6
M+#2U4X=[S/P-X6.E9N^'R$5FITDR1Z%]'"Q$CDY?S6B7LC#,+YW:(&.\J6O(
M5/5*OFIR0.@L<A2JNCDUP(+%KD['DX92_38?'&<G<#CY,U*8T<T0Z!JB9A)-
MY?!$Z='!,*-=^N:ZVZXM('\?E[Y /3B!\:)() 6H-S>5>_;[KWFQ)F_WJ'1W
M%=&6JWU@]=>T)WUPT-N%P4>:M<6 1#([OY@\?9TKTP4N,_0/<MTC3/]B8N].
M02COM*A+6$>0569I5X\*YI0W/]E?+V;CEZCM\0CB_>QQH6!;QAN7]D@( A(R
MQL0)[45&H$L[K"66+7K<18_BBHDSS%F>9AEAOTR1C6**%1/]I>">K^0;PAO;
MY9>V_NV"J8KBD6B1ZYBB:.(OR#0/M6;<GO?)*A*2\<A2XJ1M=@?=?C\&CXSI
MT2UQ>RI[5 YG2T[AK15M#?!#56X,;L%/[@2T-:?^6J:O!;*D !0DY$;OZ&;)
M%UF:*7[(O,4]\:-46DPFX$?%&+8C"K&U9L1UCF2DS9:>7[]>/'T;#<3I870M
MVH8]"?#4[1:1>.ZG#M@$1L8*/A(RK,0!&%R>Y@N[LS=.=_'C<JO2(6E/J[[
M$(95K[X]Z8,[YFVRQV.\+1T*9(PJGILX)5Y53EQ<GZ/+;"$S]G;)KLKLGMA5
M/AZ[:@-C JRIJ';T@07-(W #M7[-)/WFYC_-MW+]VW#<K@HGHF8%,K")0P3*
MM*E J80,&8H)BODLTF_7TB)L9R9QIY<3V^.\P.W_D+'J\3+2'LN$0T"F@-LJ
M"[=-)#Q+NKTLLE^_CR9FX=@T+6]RQ]&2;D_,Z&-UH]L9,UJWM1(QG<0V-4^7
MA1)=8/;<B,X7"+;8OJ6JH#JHFFQSG)?\Z[=NI7[3JF[71[Y=+:GM:49HCI3L
M3/+C[HB054]HMB4^TBZ6:"&SV0YFI=>SO2*3V#POTBR79I&&>"SO;POUFOZ2
MR_T[V?P58]$8*MJ9I4_^H1A4 <+^PJD+P2Q7A8 JK 6,)6&/WG<V$,>*.OLG
MZHWX6E.9 S) ^*2^.ZW^%U<MF!SOA#H Y$1)TL?P@3,4+X^5/\K2G2+[R$ZU
M1 O8KK;CG[&S?KZ9Y/[]K[,SJJX 5?Z':HM#\!G>_3Q%_=+^H4K<9^J'J$[1
M ZBS,YOE0('EC":J5%K4G 4,++PQX'15U2YW@O<L^AL.5'+^7GPE%-6J.#'A
MR)Q/GZE71;9&:*[,'T'X];*NEE4!.+Z@7>QC!JOKLO"Z3U_J9WY".B3\3'5G
M$SB"BB'V%>DSU82<D)"YJ2."%OTW_>W<A7[Q>(?#./[]&Q(^8 D,(#Z=]0%D
MA?#1$[R"?K(+P5"#LW,Q3'ZUOW8P,EEXH7^8:/@8#2>T#8YT)I G-VL_N]V[
M1IO.-9J7YZ?"F^'$R,.0Q!_TH%KWR9E7L]6M=7+=%M6]KE&7K6:G==.H5KJU
M*E5O-"O-RT;EANITX1>WM6:W<T($J=<N[NXK=X\YKD132/NE*DTX:?M;BBOC
M;_,G-.,P?8-H;LWI&-XJQ382@"F)$\3+C2E84B6A/;E8:Z S[4/1KUE0!ZCJ
MT[Y5Z>M3ZTJ'L@A:[!(PM"Y\XX6*&HHB1NK8LJ6%]D;Q']*;-]GZ-]4:C>^?
M\@ELVXV7ZS>TMY7!+&U>!+=F#FH*E+=W,56X4F_.?RWSUN4X;PG2IR\74U/1
M@&E25;@HAC+!9H*HR12F#F63QUWT?0!Z"Q3:E]S9PE0ZRG LYBI06[.4%T!U
M='6*TTQIJJ%)Y]2?__O?)8YC/N/+\&?V\U\T+@JJ@B'4JT7I>:H8NH'\KTTX
MU"X$ 4V]BB:E0%,-;A@5G7-+NC'1#=P?$?YR"P&CR/">&V6LH.\4#=[[(LIB
M#J*G"B0P[@.#XGB:8LNE HT!16JZPVLM$V]QI-Y#DV\,7L47.&,\6O@<CF'8
M<ZJEP0E/+/LY1<1/688,&]^+QN<\$#X'SXZZ$?OVM'/P_EMQ1K'X3HZC5ZY
MY;_A"L@8Y7UG$\"GD@N#Z(DF :=7F0[A*E)EY\E!\UJ_*">!NQ/:0BTM=RL:
MTHAB62*X';@,%!4!GKI$5LH VBD6/E&M0#-4QA'^<*G1LN,OT)40(:A>)MXG
M%639J #WD6^X&PBB@$8P$^U;X!-D>#G<<8HURB%\=U [!$LT9NC&CF6_$__B
M_$'V&DU-I@8Z3</C>!TITHBF .Z7@$ GXC>SW#\,2XGGXW-H[$AH$I0%J8&
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M4+WB9(O]/;$P5U"35Y0WW2==B5"5)-]@X=5(/9%R?:"!@8)5!56E!JK^ZHS
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ML# \&XM/N(F)H4,;TT330ZAS>S/X&VA2_@::&?H.;"H^]+D<9Y'1^UDFXD0
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M3VYO;,6V<N(;U,?EC2C1!A1:,L^1CR.ED6 VTAY>\A?>*Q($:<4_Q@H<P<W
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M$'O:)%K/HU9O!L.%H&@@62:"AR2\CBI!<HM&^)P@2\&W8GH!-"A?)?D(?UH
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M3Z83<DTP@)9H/R!AVK),<5N3.ACV!?+<8RAMU;!=\,HUA.;!?;2E6P ^6.T
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M[-]'8HL+D5ME6S\[+53[%RM<!KL06IT[GJZD3KC/0,YC,W.L$4%SW0'$O9F
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M9\9N+*;5YYJK-KZD?CQN^#_2Z(1S21186-38U=P Y<0/,22B;$&!^R?V*6/
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MXU@]5"8G=B. &BL>5=O]H^^7O5908!M9#17>=#G3W*AY=C:F]E;)[BAJ^%.
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M4+<9$8#<-2R3J#<]=+O#S\<]TB#4,<:QH+HO@5AY. )>#K5X<;GE>.%@DSA
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M<):W7^3V[&;&3!LQ$B?'7KO=;#=;ZV@'M]6+H78_J U+>U=[C=ZYEG\LKO;
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MCC5PW YS?JO->Z$_[?[GPZ^WHF VJ_GMJ(C')*U_8&GG5!0AQ(-!"Y#"".V
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M,>.#,^SCM%40>!^[(H'IW"T@VT^NA;#P=1RIWO2YXX"$^$:*1[6P9$A*I /
M*LQ[$0(D.)%\ S] :@L/([#*'XKXKGW=%RN2.FV5X^Z88?G2FMS^Y4,[ZL99
MPO)^*:P#V0(AO(9$_D4DS*:B[ '.BX=C/S=XA(LW'2P"88_$25A!_(B5#4!B
M12)(.((@\=\7_>/#4K0OQ5H:C(1S8"3\2F$D7 B]DQ5&4IXKC(0<GMX.&[:T
MHU_*8^WE45ES& G>L;%[-W>*0R@5"Z5R%,L]M0X[#"RD'!E'P>EW8BU"O 3L
M /[X6R+TA&Z@'@LYYSO QH!5HQ%2=(5JL@>K&YN,4*65@.%$0M 6[L)!PZ:>
M)4(L;8&^_U)9H.\??_(T,J0FX')Z7.&W$X1!FNB<NKI&CS"@CH8)?+N]ZO#/
M'%!D6AO-/X500J9_\S3\.FJWFZ^"*Z-XD;T8<7HO),U2Q4E@::\L>)\\=&6V
M9:$_2YQT0+IS]_ K)P>#^*$VBG5XHC11]!N+6,E.[]2]J^.H;*X$-H0'\>#Z
MU\BVY,144*YE63=I*^?VM*NEI$ +/MZ\+8NUY;2"],3%)%87.4$V6+VUCUYN
MW@]NQO:OJ49NMB59.\'*%&<(^R?E<J%4C^)G9OT3![U,#V=,OU7_V^+)]/@K
MWFM4?._Z+PE>2WS%$;- W@)@WT/PW)B-D<)N36I5RE]WICVUT#CU,L3Y7DL6
MNTSL#S%^73$^K^[Z=;N,YA(SFA1]^+_N/P4>V.:6"4*,C*R?9,]O0M;_M'A7
M$P:G[</EYR4#B?YR?F:V4K4@---$V/," D_RIL[0$G]5I?Z)KHP.E(R5T=ER
M6L'5S ^O;"0M9G[0775>H#M8U7F#[JS[XOLOZ79R]B6M"G0'[W &T%TY;0AB
MKJ [+@"ZX[.![GH0VF*1;DPLKJ>::.T=K)>C%.,!'O'I;;3VJB&KT@VY%RM&
M^03J86RDD"GA[>*\5GJL_VI[7%081:6Z(X/#&P_-F6<V,0M,+#YR56Q$RUB:
MB03$+'<LH%XLU,OQ9HP\4KB(@NQX;'VX(#OO*YV2HZM\3#Z:AZ>F=%-VW^,5
MFV]*5Z(=\QJF9-RRE&=7A"SEV1@R0*G 8BJS@\%KL%!ZQLA,"Y0]\$=LPH(;
MP,E&O<6?VL-AP[JH?[['I[K<X,>T)Z3;(8%536N_1P%B:XVP.G4D'E(Q4#=,
M5:A0_9\U&B)#$GV/_A<65!&1MG52'FC49/&MD20IEH54)X>EP6+4:PA RR\!
M0,M- ]"&,G:+ =!R4P&T'C]+9*XC%T**\J7.2=G8S:_S8FN@/DK5%<-P<T "
M*C,TORH72J78O;)S;1?OVD[),BT7K9L-)P91KI_JU>?#K[/'RL>AL#2<&$22
M EL@/^]8:2' V?R4)6&.5;+0EU^] V,H2K?0:L%=:(6F:.E(AIZ_LW#/*>(M
MI 5KK@G&UA^FG>T$$<:3NJ&_#25971FDS!=A37]^5'.G?LKE;) RQFVE/BLU
M=%Q'=@K[%YOI""BB7O_V^O;IO?PXC,W6N:@AYB[II;LZ8R*C6&B6HAK]!O(8
M?$0>@Z-YC(M@'B.]#0J('=?P]+ 9VB02?2>Z/# !^!TW'7Z7XQ 9MVNW#V:O
MJX&?N[)#I)H;6CGE$&%>KL\D=]@,4\#HFC&;( 9'AU?U>7QV_3 Q?AUTIF*,
M8V^98?7RX1#9A$ME/PFTX +I,*5+&AP=EY&$*61;Q</H,K P<>E8F/@PA&Z^
M)$Q<>A*F1:/GN&D<3+.!YUKS!<_YT04_9E7\*@]>1L??@W4'S_ES_H']FMMD
M%NK-0C,B8.TF?C)7WW)I@@<QU;?%N&@7:SC1SF*+"R"<7S1NJU+Y4S/+^0,(
M$0&UF$G,.8)0S5UE51$*U>*NVG>] @CI+;)#XPO9A+I]I%B2J0[AW44KO8^:
M<=/H&0_ED9 R[IZH>YK)(?.(8?V1/=<?$1;I17F/1W$:!*+8Y(<!R^KDU^-+
M:W32^%#5S/9JQ";WGI/>W*KE)XP 4S79;\.V113^.&Z=3H"<,^B1U9]^VJ>_
MJN]*2YG/*I&G9%BCW 9]=4J'JAX>"4L>R#F4&MAVFGGM2J_VP<_;K=P$8H:5
MK%UN)$/ZM3L7=6P@./FP4%'F,!C?B@@/Q-.[YXRTI38).KIRI6H:FAMK"7R\
ME-[?:Z6#1O]]?>)TCDT0->3 >Y\7H"$IAL?$A2K-0JW6R!W^:'O5U/,N(VPM
MHHP0;VZUJQT,[<:]HDQ]_0LJ(XS8[YEBM^'HUK1#9<H;SE=<6,Q47(C7OESI
ME(VSXOEE>RIE?];BPHA%S43)-4M,Q LE#57:V<C7?:Q<Q"JV 4EG$':JI$-5
M;6Y7,K+V&&DD(A?6&@!E.VF@68C*);.;:QZ$V$&#CIM++"8E(W9\+(9;.B%V
M9"R&2Q&+":)+F(8W*4(T4VFRIX5HN,00C>#90S,$/J)]E8-6K_*K\WGZ<E^;
M1X &FU,S##)/<*:>V[IOE)J%:D)*'RH;O<A,C8W,Y*AL])^I296-W)3*QK0>
M&(1M:K]_[MZ?OP2[HW8KV>E)LGM@)+)2"[RC_$P,4P_+%$53,87UKFW 1/3;
M^@,2?HL\@UG%W]ZG[,4J-XLI5G$$+83K?#^^;'P;GWJEY7E$,&\0*&PV%*B)
MD>%8G[I8"7V1:]XG?U5+^H5AJEIBIAV0N'Q<!8XI,84C+-E"<TJI;K*64L53
MB*4HI=H8Z33Z=]J[K;V]%SWZ6&]29'D66V&U;%G,Y"?.8-KN8LB+CR&[!H%7
M614V"U927Q7D/)C2JAA=_R.8X_?R\%=K]/.V'# !WGG%2F!_Y$;L"]5204C%
M7):WKBI>)2=V1(35G6OWO)?KK[/BY8U].%@59 J_N'Q-]4J-W#9Z*?$%K[S6
MJYKM3:>L];)/NV_-BO)T>2JOI-:KZG_9.6J]&FD-_FVM]8K/(T;5>E$QRB=0
MZ6J]BA7EY5MIO:J?_176>E')BI:Q[+5>C=R9ET:UT"S'0PQIK5=KU$?#<Y,N
MLU8;'>>H-@J*QL_+=>O#ZI^_WDC)89C<U4:A=Q18\_SX<:%0:<0"(';51FM7
M;=28"2_T\^NK^*K=FK^T3VG50)^ ".?&\ AEH2#4MK@**%AFF::S;WFO*-@&
MN]@*.M&'T(3-'"G^I6^Z#7J#K4&<5ZD9%CKZ']!C#C2T/7#7,T<D&\"(&]'9
M).:WOW^DUK51_91T_4S\(^_+B&^&MY0V@-U_KCL/QYQ0YO<"5FRC5/W](S:U
MU]M38WAB_O$/LR*X=ZOEOMON/W.2S-4NQEQ#!JN=RH%BCQ5%YZY$9.?P0AFK
M\3(V,' 6DC #ER,S]8E>Z@U-=<'^#&P1K)S+Q;)0Q@9%N5A#O_PM*^K>WJ72
M%[5C'6GI2< Y'2)M*&K('!L:R!J3/D>JA3,ZAP;Z"\F?AL*#=Y S0VZ&:-H3
M)D1L'4S8;X)>,!JJJ#G)!2MT4_\AX/]QL,60:_4^F"\WNF"_,Z5&["ZA7@"N
M;IEB[":L:Z0950;%*)3)I]I>T6.P3K^BKK<=N33TV^BY!]1N[A+QVI1(N*JS
M[:$I[^UHZ&:4)44=8OO#3<'BEM06F9*;$+.\ZD&+'XB8^]\UH7#8W*0Y^O0<
MZ2E!3=*_8RM4*F<OE<%[U?[IK22HL Z[(%/=37Q4(I9B[S^\UZ,=-#D&8K#;
M Z<G:?((7^#DVE7 CNCH]!B.NAJVM(C&=W<2_$%3X&$0_!5Y9)#U'<)YD:>K
MR=/EY)GUY)D%Y?^$'%6I^/?]3>L0?Q3^_HML+RF0@8ET8./WVI0$%6RU?\D^
MZS7?/LHO\O7@L[JB]-8Z[+1,+83B* 634UZ.$PW7%WAKU'U##C0474IH=")L
M* ^(,B_';&?^SMG\/1]I$[Y4Q\9N":M$+[0A))C (F]C%L!47 VE#.9QJ5@O
MU:EYC-3C=NLJ>RSK%V]:];,=3,4OW#PN[17K>Z4Z45>EO9*P4G65OW56 ?U\
M=@.92V$@\SD-Y"!E=$X#>>LWP[<YM,:CFMYF6/27;""O>!^4BVGI+99N(',9
M#&0^RD!&!F_0T.7B#=WX]'!J0W?K]XM1OZN]U+_JMTS;NZ4;NBO?,7/ASLYA
MZ/([0W<CIL*6'9?<H*X::O=&<LL@Y*K>AZ2CJ]A$QI='NNKZX2R4A<2)49;0
M3&25*LX#1D+56Y:%YHUSG_!T9O<&L.O7#Z?X"O3P@@^[[N^3A3-ZIC)$<JW@
M0@V;7$HK4O#3H'P##!R8!QJ)<^< A)O*/&P8B\SZU -C*&A!OM#9@T9'ZS'(
M2@'2SG+N1NH.+*@3L12;0YO4'CC C;23MW!YCN( ^J'L!"\C9&/Q,#/=K,#Y
MWQ.V_;X4BBB (C18$/I7..TPY!IF?X=^@-0@K [1&@4*:(.!(&D>\(>:8<$_
M[KVC\]"5)<[Y$;I]%R/%T-VZ([B=7Y+@ CQ&:\0.M&=HFC&&VY.#5K=&'Q\B
M6[USC3;1@ZD.V< 3,5CI60X"P#F^6S(*6@CR]^ 3P'>X0L>?;&AD[_VT=#FB
M+X)[JGW*I6JW^G!YVO?"I'@4Z0XT;\ Q)Y908II99AA9X-B9G4$HZ=@I4 @#
MQDP2 6,<;> 4DB1SQ/+ZX8V.WOE6Z.R(XX>#UXX4 2S(/__[?WM[_(FJ:/)_
M^1MDSO^-[O0Y4G0)W:%9_YM_ J6$;L;O[?W#\>C__B>K7\[(NH8I*Z8[GP--
ME-YY 2V,96BJ/'T!:C@K;&/0FJ1HVA#*M/0^]DWAWVC0DO-O_R,EM(W%H85&
MYGSZ&^E4V1[ O(O_B4H^VZ9S#WR8((/?678T/O][T)0>_H7L_(+]4L)JT_>X
M/_XYV6,7TEG"OWG8SO_E6Z;85:6_^6NTO\@R7QNPH*42^ZO_<WX&7_WO_VP9
M_F/"?V"!T/^BE8]X!Z8BON]U%;2%T+V'^!6RZUZ+%CR,1:"W8( :GL ,?0]D
MAPGC)T-DY&BK=LBF3@4=4ES4\<4#FL1/7,$8<%@) N@8:;^19D?&* -U].14
M]D#]$:$:'W6=5R)Y- *+@T#XB/KVSHE.CW%3//@D>TY&G)AN<= QFJ\]@8$;
M.APVY.3TBOFQ&<86O_Q\=CK/Q;OGA]=)-\KMP\1]@7!7ZG*SF:8<DX7'!RYS
M]-*'_0Y-+7#"YLM@.*=KM51H"+%A$,YOKC&XTI 5J"=+3&--)(8)%E"CDSS6
MD9IGY;OWJIV?-,J115]K+S5>2"!B>@')F94>HEEO%*K-!.'QG$37&^A1I;.U
M!MBF3H6()"8AF. Z%053^H0 O('<5S.*X1PI!;#D&+-;^1XJNA7M1[$MH9Q@
M]#&YWLUV58KEHN 6-S=^_PR.3Q\>@1_X>1 .@M.G3=N0$0^+*>R/@(ZR.TG(
MS;8<'U"+I)PZ3+%497>I*L42[@S]89;4UX-CX4);^%*5R5(YA5B![LY(5^?&
MY)<KA5(\064![)LAA*F^%. _-DF(F6.[I&^OREDP&+HL5'Q@:!(["-:]6--!
MT2T/%)W^'K]_;OM']1^U,>SKTJ:#HRL\+KX7_@Y!I(N_?[Z?GD:#TJ<PMM#"
MD5B.LT),=&Z'E5[;J3A@$:<<J\B I=U^ES7'-8/ LB_8'?O*240YE&GW$9ZQ
M<70:RU1U_ PU$!EV "D>35-B6G$Z3KLA%*DI+A1K6>AW(U6 D_.S3!O= HXK
MJ 63U2]5'HE:JGSAS_#MX*5X5^T^=B6F7IR%+;!6?#KS/0>NNK$G%(EM+NP5
M/1J'Q'DG9OP":CD_W7.A7JTB^SVA1PH:(!2GNMT"8H6S0%F^W/ Y$CCDL4 ?
M@G#&G"; W32A17+@@5PY)GHG5;,@P#1CCM%4E@T(ASZZV/9RREGX2OR1>FFM
MQ/9.F-2-]MW]^: 2Y7Q:\PSO+T8B\[F4;+B_N!]!,^EXE!Z#",[9Q"O,WLB$
M2#]H.?0"<.H*R4A4UC(J2Z0!$"(ZG\GY\IG^L-G8&&FR&Q'!NP*]%"8]YHF\
MXRGY"BR1HM949>0\C'Q'E?GV&J\;.I453J(3&>E%@BR13M%> IH5;BXA!1K,
MS/MS\'H45=R?<"^*TK\QE3TV(AV^W') _%Q\FMZ7R[5<FP4''%63A!PMDHH_
M<[82V#/>%U')>(>%$G8B3L+C("8'7['YY5 ,'"L,;^L&\]8X6<_[DO4I5B'0
MIH=SM5"0F0N]#17IVP]:U<T6E"-QA2'J,:,(/Q5'W4!Y%R@Z0=-<_>@M 59L
MS'R#L3N,U@CP?Z:=-=XDF[K1MTAG=73N7AG:1',(1'.4$HDB[XV>/<8->B"'
MA.[[!396 '0#C7M44]X; J"/Z!S-%D'PAHP12>RY0)@0XTHX,;+?BV,ML8;W
MD3'6*0O"B6&"D(*)0 'Q38&D!.BGU 8=G6/+:M$)!DE)4AEU#[ &&-/HFG.#
MX\Y/I3SNW8LQ7HCL30>K,HE.*)%D8/IZQ '9FWM"T_OD&G93YT\O#,[0;_N5
M<@=!A2FEF[!*+J4-5IF 1 %M3%6BLVR8"378/"-1P)%.^R"!;C%,@DI8?$TL
MU@7.E65/D'T#ZRH2G#$BCZ;@QKV!\@D&2DQWKR4><G?ZQ.3$X&%\1WS^T>H0
MK*2#;!RN6\_E0ABG+Y]KS,+ON"Z[[[/^H%XIGT^:H,SH3,T&_EW0;ELEGI?%
M\;);CO.LT43_*MH$#6XY#W>85-ZYT&3R[+([!R1#3OF?W%]+G?''3>>@MLF9
M[.EK' N42+F3\D$4F31XLQ:[C<)P5RX6/N&QF*\KW&8*>&+U.O_TK?9]_'76
M'D16>FR*R,<L[YP/D-EP0_5*H=Y(D/L=]&-SI@+(0I(4BHUW>$A!-T)"H?V6
M$^N,\P&C<(F8QFU=M=S\CN)#=QG<0N;+P9E]>WWTJF_FH9SAK U./J!^9@2?
M50N5AI 9MA@1U0*7#*T$$R3#6T&1IT(:RVLBK]-.Y5EE=M(87M9KPY^;ART^
M5=/*;3E3Y7$8;@M]=JL+;ZZZ.QH74179B.+Y" 1,J?2 \KDR9+6G2L3S31TR
M);$@-V^)9 U[#+V1ID&P'^T^)RD0!:1D= $=QHG"Z)>&JU\RM$GV[L7.:$:+
M/:QFOA[:U[V!^M(\D%@UXZQF3XE7)PY%)S/E!-W0\#XQNB'%%+.JBMQ@1Z&1
M&!#E2%4NNS)0'PE'F1MKC,\R1R;!Z7D9C,^(P2I)YQLN=0%*<@J VI5)?1I7
M&>!)*?KK8%E6'RX?C\:'O?.3]PT_I5.L^-S,T/)LP9]*H1Q/SAZP0GD7_N0I
M^]ARFG_)AEBTZ:J,/L^[P].)_+Z9-6!YCJ<YV;FSA8>$6JE0J<7&A_ZEI4&+
MQNF7&W\$I#2.A&<Z5I]EX\IPE]\_KP]?S8?C7VJG5-YTM'XU@LK\Z/?/Y?%I
MX^S2>BI]*'_\0]>&QXO#LZNS;4!]M"R.4&_)C-@V:6F\.QWH4Q0[ G%*O#KT
M]K\40CQQI<BJR#\HTJ" 6Z4YA+8/5P\.%(Z!%+BVL6J[B'[&,BB0LXOW]>N@
M>"]ZWP/#>%=M>FO>,)V_NZ9\:;_H?-N%:_4^I^AHP166HH4<$LA^UU0+D-TB
M<CH=4"%63T ;8UF&I&*9QY,>H%.3S%E&PU)UXN\B!U8>2>XHZ2-Y\DC^SZ$J
MV2-0^QSY.?JIA$:)]PVNY;+%$6Y9'/C" -",[T^ WT"61?"O@>&H.CG,T.>_
M\)>6@989C#%9X6BQ&.$&L0WDZ5P]0,LET2DCPYUOT3.,L4ZH:(X@38?V_#YR
M\G51,@J1(+[#@:B:6 [AB<^JIJGB!W^AF%T"'>;"/U"5'G_\C<P$W,FYTT-G
MO6)N[X&XH5,AC0,M#KH 8:.=2 D$<Z"?JFBG+9N-;F=SP!R]F-#MAO3^.B0[
M$3,,#8O#(M/#)A_M7N2/'-NYT3*:QZ\W5>7(HYG$HW%;D>T%9S[-9HZ83%(S
M'-?-"P_/;_=4,D#/*!EDN'^ 4*B6XA.:D>6XM2DO2G*+<.?_?K $+/O%T*+>
M]"\F0P@L[L4TT!8JU6.];'_E+XE2$1"=A;MT,9N1\S:CB3=N6(T'E#2\]5-3
MZ4,[U"OT%:2',#F*';67%7)7WSWPY<'G[!3ZFDWEP3N,/?("D4>^371]9-V+
MM%^B:SHZNQ'N< P'ME(D=8&WJP]&%C*&+(N)I0:Z)J)9WVCB!,Q(W=",/MK*
M;5UR-/3QY*-EW]7.S]M>=.,2#UGW*0 '20=#2@RA)\TEB1F!4=E.F\2DD0=T
M1-H07$058[&8C!RFX6UG-+&K0NIB*?5%'/,%T2T$*$';&[-WP%R1SH,BS_6F
MSZ5V?FE=*S9SLL]ZIJ>4G?)KJWYQT!\_GGC\&2U)(GISNKAX\86(:22>Z3D$
M)'\CQT*U5B_4:K$%A9&FVK[W&E5<]J+J7X:&%@8NZHKZNSD:VM+$J:!&;@UA
MS"(7.PT81TB(2.J.L'TB-0)52<'^VNB'A7B"+O"#NL@7&U X M!;8@ YR*ML
MC+IV;Z3ALIQ10B]/5XY:SN]/#/.(_MIYZ8S66IX42K<7C:?AX</9N.1)8?(D
MITEDNCG.6T1S\_*G$%$+TR B"T?LJAIR0YU"/J<S\$BG_,KAIILN.T]BJXGT
M8B$;,]NT:27#OC-JU>'7Z:NR!I+AV+W9):.:ORIFNF3XUD,RD2ZRL<T"A?A(
M;!CML;T6YZ)CZM72'_X.KST%'7+R'73<'<5&S\ML1]KH7_S^*5T\?YCZM?!^
M*6]ZI+P6$2D7?O]<G H]JWW_*K[+?_SC+ 1/5V+;XN-;Y \YKPH9N/A5P2%$
M3YU$<KA"EC"7OW>%;Y-$VL,_'R.EW#EX;UQ<R^Z9X H5'>GT6JZH!Z5NR5RN
MYO96FO5"/9YP)3K =)!ZB2C7V^=P="A>GA\+LK",)8HD>:OFIZ4I-PO-4BRL
M-Q#JV8J=-A.%=V-'X;U8"N_RCL)['7?(IDXE=*P"%@PRK?AP)<EC61D:ENH&
M89PN)"-+,0D'A_Q%2LA[CC['$<N^SJ TY8#&Y[NBYOH)[B'.96)XQ6>X;*(1
MZ9 !E41KX)2^.Y1J-'D<'*8EVJK5FV!\Z<B$RF)\.OCKX+>8X&CA'DH(]0.P
M2)749Y->'01K)2$W=3KPI\C8'-EN]/M'N5$JPF%G>#3I;;I'4X_P:$J_?XIO
MIP>GNJKV+JM__,,LC[^3#2S0SKU9VZFPZ1X<M?TR-*1I"T2/V>C'&*R+_K=
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M]XN#<?.QMJ8"!FE=P?F$UG(A E8ISH;1$4J-0J,1WWPUKJB8K=0$K6<:H_X
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M69NNATC[)=%J62!<)0_ U?/^+YTJ^M#=%&@XA2Q09@ J-$BD.07_38.W(\]
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MY"':S39QGH FLD : QO(8(#?R<C;D6S#M'![/>PJ$9YIZ.@+1X<QLMW$'=6
MW0EG,1U9"J 99 6BIC@7#$R%)O]A(+UJ$9IL])RARXAMN;U4T,]ZZC=^*.UC
M-#3&^(;.W< %+M#? IK0*G":^H$\,?J-8UJXU7^D%A#YE:0C$CF=:),CDU<_
MA@8H>IQRQ'UJ_:-BVB3SN'VP K<DO9485G#.^9._^Y+S3#PUA\(-W1LI30(,
MTE3D7,HBY5!SYD1J,U3]'6[5&SD_+O"T<R^TC@#B%7SJ?HC0&YES?HTK*,G<
MT(D.G8RAMPR9&QV-TWZ8T>0[;;QF4^F,3"YB1\++=EG?\5M4F5+CX(["=AZ5
M2 )5</(65!)PUR'279KVND:&GDBZ77M[D,-[T.M-[1<CNN4CI0J;D@DCQ):C
MIM "7BSMFO*MTO[0/J.5PY-QNTBSH37>ZRGN:#P% N:PL_$NQ>V_HWJ<XT8M
M,&JGPS=::Z0N)CC_*..ATK4;0I\7'"WB1*<3MZK3/DZZ;1H:'@5^/U$K^8'K
M SR/)KA41$5X:H]IDQZUVD'FN-W^7;.IL%UJ52NJI5=BOM"UQ.Z]GIK^WK4
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M_UFAD]EX?/S\=?FK=%>I,1T5W*X2>!S3CN.TT\EFV*48?N <3AM."7L"R7X
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M/9_*Y3N>5UG@IN^&WOM)^?O<^*Z>]=?"95N7G=&8K3BQTJP5:HUZ)H<L B5
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MF)M'(%&N$]D#XIO8+XP]((-079U(HW;U\->[H*XA>T!>&9J=S7$&]H#K'7O
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M+[L\6Q65R!90<0X,*:9^*HAAP\532)Z(<4J?8&)#-ACMK<\MLP"I;._3(H/
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M0H#C.=%GO;/*,C^RG."W7UJ)2#I,HUS/^/_L/6EWJDB;W_T5S)VWY]P^,8F
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MC=M=YK^YSK'@O'PN_%DG"UT;%][AEX7=S_]X1.2^0;</=([),-\@/ V$*+:
M70$'/U_RFNG$"X?_\AQ&8U2".RHZUZ9*FEU'?"AX^?!I.,>4RJP&XVP%,_WM
MV5/W;.U_;I^,X2C5Z:1JB=D@MFLFY=K<V8N.F[0=RA[51#?0-2B,0ENG-.^(
MGC>(TK-KD ^%+U>;=O792=V7--1M?-L]GO)R#. E+%(S(M3(]2.'3[ATK/O/
MX 9'3[$\G4?$SA]U&0X_1*/?;.(#V,1'T, E\JKV4H#7,$;"3KA:C;\.^\*H
M:K5&5,X0\DCC3YFKZ<ZT#LBT(NV4EO!1*2T'Y4_%?!^K><*1P<2J>-SW^9G?
M7.-XY2)T&>5B<X!F?<< S7/I5&5[U44T%LN^#(^<O_FAJH1Q)+O_?>@XSI@O
MXSC/I9]/D<Z_"L>>W"[C6MGZ*RH]L^4E7T;:/,M?A/[">7K^4AI'A?1.B][1
MJ=+W,H1=I$'Y01I^"X[KHU#F&$:O[N'TUEEZS55<-R8O94G6GPJIKIQ+SEH[
M!I]O6I(?A8:Q/QD-_8#T_9\'MLO,0=\B7C2R;D-CNYRZQG#-&1GJ+H?10[2U
M#R+7>.CRY/KYPC:;^_&(366=G;P9J& +PNG:UA%QOJ-B>Q\I7\]N=W]9C:[]
M"BBNE<I7%L-=&IW[.5^X4:!)R#]OL]'^:<5(3@=-_*B^95L1&YSRTP_K0GEN
M1'%RW?,GH>WD.V=3SJ559YNH*DK*(JF+:=#%<5N5"?Y%*7.':] ?2?;N5%]N
MU*K[2?X2)W,Y-G#:N)>UB?+1A_#U><'56M->GR%< \'/L'*^#VC%L8DC./9A
MJ@#'2BNR_QC+J3L<,5DZ(3PM8X>83A_*IP^ULWSQSIV ^9_"5WUX<MQ6?;-_
MP+QR&.N#G"(N.7"9BZE=D[E:D=/12F?&WD8.W(WFO9VA/IV=]T80;BU1?26J
M:TCGVZ7>"TV=W)W6=CF:3E%LHMNDT]5D_P;3VCY5*MO)9!\+^9+*%O,SX_6;
M\B^8J79 =IHO3>5\R$[SF]\HX<5+[K7+5 O1JV:GG>K<."0[+1:ZC>PT_!+9
M:=^,P,U*OT;R6>:"-GE.KLTKE-ROO/1N*OGL=)L\%O(EF>R&,\@NVX8=V>:<
MU5Y1D\#"5 W._$1C!7484S+G?OIFM-]X-M$>RFT"^'"L$68SFB]*\*NK6N2Y
M7%WMC\-32H[OSF';=:S;1OH-*^B'0MUO#?VH,1%;AGDD2.!^VN6?/S/(E\%
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M1[:7 Q=J7JUWT(]I *HLS2MFFXV]UE=5H,4R$,WK;*XQDQH#25<!L "/;<S
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MDO@'H.6A5@  W@K&B2G-"P;X4HCA.@<WHGR,]V65&X_J<6T1ZGY:B\ S_1X
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M3 0SD>$>L*JNP(\:=.,FZBF,H !_I%6(5;!8%/R_* 487F'T,=0"& !P8/L
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MV/M)MP+.ML9-.5'GU  \'^N TX#=P H4((X6'*UX-CM$)LX>.<;R+*I80J5
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MN#Z-?M@\#G@AN(4?ZV,C4\S$%//H49]-#6(P^*^AX:N8RFE0O0!W U1:/\^
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M,@;J F*2"!DV9*W))>H.<;!#--N"$.6?3WE%@S\:YB>4U.8RB'V:T:9@WI3
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M\ _JH>D&"4VQGH$:<S"T8,$=K&_]( 2NA^Y@K3N</S(HWK;VNA^_L_=.<%J
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M=10:EPHEN2R/1(YAIK4*J:=ZQ'S:3$6R^4X-C\S8;#1;RL1)K=>8TKG! /
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M%J;>H6:*$RSZ="".62U=NR_[J/XA2>069Y"Y#BDJ/1J26SN0W]G*_M'2ZY^
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MX_9%FW?"G['K1"VZG,SQB;'_VU32&P?[YBISFQ6HI-=9^OS#8W=W4=9)'B7
M'\%N(_S3&6W)2M54[:F+^E=@UBPO=OW'27DC5+XR"70\HCC[K_BU\22C*Q'/
M)F^-8&W?=VBO53) DH^%R117],8/;>I"-BH=1LP&="18"@P4Y IZ RKQ?+L[
M6-RJP:(5V55O0RYP:>/8&HQ_?D]2_> 8QKZGJQ/^5(4SO+5G-YX:IMCX^57B
MJ\0AHFD&?050H/5:DA$,C-,[990KKR*Q4M\>*<<P;.'FEA_I0((K8R"FC?LR
M5(($K[#+TL6Q5/Z)F%[S4*!V<7;YTGBHBA/!C0VKF:DALP<V6-*&$,=-;.A%
M @VP-K*=G=LR,;LM2F9L]SB!SXV)9GT?C[6R9BRQA?P4[$@CSD)INQFGI>H?
MGQ0^MQG\ 3AF@;JI)N%=G@.-V?= =MS:D)+KQC68CRE4(,%-:+: OJOQC<PT
M27_X5RTP/TT*T[]A]B L\A[I'A%N=^Z. E:B0B=&*;##U&OP#M6PJRRU[@[F
M 0@UR*,'D.8&X8BA)%SW>[9KRBE'8#L[V61*)2Y!)$%$TMB N@)_[1UH"%]F
MYU0@+L]4U2U)4?,:':0*J<JHKJKB,S%T0Q4[Z:.2N^)K&MXH8!)P? O^+W%K
M>1UVY>?5>[Z=S; >"2^9EJ4"86%(D":>"^MR(@$260!C"<LU)-MC^/3\/#/X
M__;L_Y=(5M^.WP,%!!S_ND_XT)\Y@&_1_T,!Q;D0=\G2X[.:G2T";@$"F9\)
M@_+.;G9NDE55/K!"28!A;5QV]L/](^FR?(QHCO^'/(_KX542'P+$)@/N7NS)
M+.6#LISGPD+"1AGSP=!D).FD!5L6Z,M#NJ?92SPY5-)6.0C2-#\28T#^B0;X
M<>6B_\MJ*1W#8%JFN(P+UKM? MD[<41X%](?03U4^U KC.'\J3,:<?::/P6"
MH2LL3R==]OZ%B_?23DE=,KX05/3.QW Y3I6;PXP=9N<>#L>5JF&/4QD2=V$"
MS7[$2@!!O  &' F!O2XY6H $1#Y@S?+S0P\]RU-95J^IB>0#HO4<\?Z!-V7<
MLJR B@LXN!!*!#!9YA^':-KT)16ZXF(!&F)33!B^ELVNR_D?6)ZNI8=E)P@<
MAA^XCF*6TKM\Q)"=CJ/^B%NB&Y)\MZ6(=Z#I'\R)*;Y*1A_#-,I;H3Q*PR$
M!=LDG][D"FDQ"EJ&NR5:/;<@VL?A5VI2WF,'@Z @G;)7UY8@11K.:NY ?0#5
M*LX.=I]=$09Z21W7S062 JWI##/.YLK^X0WQ\RNZ]7Y)9'EEQ%P1%BI+KXG[
MP]=%VDWR+)-!N5![BEL9Q$(7XA*TIOT^EWBM][8CP?65W8N=<.V?(!J+8"Y
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MF([GSJP)J]Z5_2[JA-6$TYK5?Z?5**;;61/&P>G1B+&XN'BZX(.1,5E.6<^
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MV?NBBR2V-^AR+_KLYH4WSPI=JEEGJ%$U=TD0&#2OP09%:0]+C^QVXEOANMQ
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M]6!U89GXT\%-APX?/&?:7/VYVY%X27, S5+?BGQ;\G=\ZQE"J3_'<]5&)W*
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M7&=R/L^R(^-WT]-\;;XF)X48$A2GYP#5C8QY,N<)2>7T.+P)[4E.Q0IV\3G
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M,_S0'(&AA+1W7F<7[#<H,E22211/DNJJ8S?365AV;NOC%IM5\E26TC>A=DK
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M9N?O_1Q%ZDV>7 (<D:^C_1CG-!$P1-:O>4@KLV<;4P[%DZZ1)5JW(FK^) /
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M!&@:,BSN2V^5(O(6M=Q#7?SAJSC:KJ>60IH(,PXV$:J@%92/@B,!N$M[X+D
M/!+5V&;7EK,<E6 ?9XDY:4=[!O2'5L='BN%(?QFC8 X?^X0R!G9&=LVA9?S?
MTS;"N788E!.C,J\"'SF(/)1'!>3&YE V3M13FWSN"3Q35X )WC+L%YL+=O^G
MI*WXK+K,[-V_V<8R$4HS#13-;/HK@6&8WPQ&)6W(;KJZ96A!Q^SDJ=_8.WS:
ML:3RTG>329VT-GN3<]YHJ$GJ@K-2C7.:: I6 (XP  W_C-R,5)3[ MU' $Z<
M+\!-(9"V%>VCDO7$'44ES:@ZN=A_$JBA>5?XK&6621[H**!_HV)(!?]S]VMZ
MPJE#W=#\*9^R[<ZS@AZ\L<I;\9IEWQR#EC;+(Y[1W@Z=#@4LW,/ZZ=2ASR&H
M%.+]1_'="VC!/IMJ[ 0;HVN2V!"2$ (-M/W+ @GB$*%/,?)$;_70OF_+HGS[
M%NQA)#O!G$>&FQR<@9(ID.MHS]R:2'KA8LU?Q&:I</"M^>J@^2UW> @FJI2A
MPQ"C,M&OB(Q4PL4#P'>/7PJ8DECT(4JSDX.[B_)$'[H_'I#A)OEO$8#=5_,2
MB/,[T0Z.>E3W><?Z(OJ:_@WV48&_(.#[T]30G<&^5R?$CNLK\<(/47'S,[^D
MBFH^Q3&G[6LOU1WANY:<B!!*/17Y"XDTC+#[> %N7$G]LH>D\6"7[7O/ *HS
M8\4H$!NT5N2?"1PC%B0?Y%IJMRZ27K8A?'%9#*G8ZB&[;<M:/ET0G. @3S3;
MQXE3>@;(S"*X79$TBM6('%>2X*D^V,>@0%W86*2E8R+^Z$ZK$"=I0?>>7FS!
M]NT8%(A+/5%B3U29->]*83;:E?2CXLJ^42$AV_(J_ D[]AF @0K^\N*!\OP*
M#1"B,)\@1ZCHN1%TVN%6BGI09-[4?IL5T>OL\M%'F@>1+^3)5F@-$AE]&-HF
M8,?M36IO)SRU]P5/'D! TC@P@_A>)K_R=S#14)!H+6)LY(EUL?:Z$-_/=L@X
M:+2^]DPB<P(+-ZNP?%V196DQ4B_F:M]*'N?RC*HY!*?6U609I%9]*LT 1Z^O
M=.PZ:O27+JX^"]BZF2FM/LU)7&A9,5A/?#Q?(??--B!JGN >_JO*-6^]U<Y'
M^E#XXIP;GP'AP7U.?0AVIWN+I&= ,_4N^?G<@N VTAT176;QGK8/MW5]8VL-
M+ Y;7O7F);7HNFNLO2KMC44=^N:Z$V-QK_(" <\S8*"Z@ H1Z R56==Y>F/T
MW011/O;#C&TX&/OQVT%O8Q?,-])(97-C$VP>J- 3/T*51LE=XHIM;(HKHUX@
M7NLMQEL&&'KL^6\=/;/(\.1>)-72]G/9?[=9ZS;IY48F<M:E)R)D58RMS0M.
MSEF<CJHF7M3T40P1B7I8Z_RR=$D[,(U9!)/HN>O_/ F8=Z+>C1Y4$QV6(3!?
MWYZU0&S J>8GS1"I-4W\:8&3)AL96?A8)T>61T;KB&!LFR@1?I7SH2G7E9CK
M24=B3!CR7M? B5]X9$AH@=WI&QDC<VI/(P.*7L@7<1N,>OX]5R)5;Z&NH$I^
M.4J[TF^8W.[A812[%+>ID9IO.MAH!$UU\1JG*1CV];+X5"X%2-EX=*OQXE F
MG%!7&$,DDPEF]TP"*XK2+I:8$RC,!W"[E!E=>(\41,4_CYJ%8#"A)65R"3U\
M6SZ%$+QWI\]C'/(X/_(43&T9#$%NZ.:/M%U0,H<(ZD@WK9 WUF6S#$<^ WY/
MM=L*^&N%&$O:97/5[5S-*VI3$+:2 Q9ZS."2@P5H38'UM([KZJ&O>Q2,<JZT
MVZ5-%+_NM[8D!VTM+5;(T7[X&)EKR7'S'2]K5G'A<S*5_(01Y2^E\V%5/H#D
M8/UX1'?][(0^(.J36]GT:'GE24-G=[M1;:;5MJ9U; 8@:RZLV..'Y710/]FL
MS@"";62GK2_:NJMCOA<?H6@ +RMS7N*ZS,&ZJ/GB'_N7+5TUT7J)=3,$.2J6
M:6%CI)MW)>/PV!7,69L1;VL/>QAJNDME;GA,EN\PT=/\V&Y2=]EJDN9AS,O-
MX.9!J80"P&A!U.\?#\E@^&WO#TCS+;J !"O5;&TKC7:VC936S2Y^GDG@MKM?
MVB5X#.]92%"DB7Z\Y"A9:4%\&MFK5KKAQ764L*DM4\GZ0WJ1?_%SBE7R&]-P
MPIQ0/OGA  U%F*3!$49RGQ5=+#&B>5#$0.)P)]$[F9S[KF_9A=:[ ?98E\^6
M\X_\7_N5C>H[VS15R^1MU39A6>,^A5YT\&M8]( &+L068:L7N&6KT]X:I&/2
ME?/!,2JV<,:1^4YZVJ:)LP8#U4TRZ? -:D*.3T(IN3"'V@@;&U5#I8J6NO(H
M")X;#:JE\*QL2_LHVM44E.MS8#]0%:_GO^!^%/:SY'$Y)UWQE\P;,)L]//[I
MC3R\>?B)6V'9JWZ-%_HO%$0)&_K0=U6H_KOG,YQ<F6HE#FR&6QVK>29*QL)5
MVRK5Z_RS>X\O*2*7#F8 V:C>CT82[^]:#$*29+">@& 0(K[H#-*"/\0;44A<
MBW2O=:0R.XK]#OZX<MXC6'+Z1-HV;^FUV"KF[9AE$L/+&H4=Z&WTK60@L5GX
M#\7( \/3CL3Q,"1&T/A$YE6?$^\;A.(@T]A'6PF-\"<^!-'OZRW:L>$5K9(4
M^RQSGOD\D[5M<Y*$G>$?RC]D!WK#7I)&^-.P.>G+.C9XEDJF_Z?O'E[EKA35
M[-[.H$9\VQ,K;"D_JM[3VQLV-A+@&^\DU*HFFZO0O&P^S7W8K<.>)([V&XL2
M6W35/:Z6'7;+DPUJ^N;6]C[J5Y7F4678T'NL,%U^A##IY!O#+LJ<D:" ^ 3.
M'GG%F.K9-]=EP;[]Z4/:SP C-\-HS&/"O4N&$9NOX/=:PXOWEY^Y]$V,"VC!
M2YR'\,E2A23TYMPBA4QVZ'\*;S(Z>SO@?T*0['#'_IP_H2#_[_:]]+#L1)",
M>^G9O4CI&U,CTPT''\<>$F_+7HROPCV[S',2S(T3?3X00<AN+BT37+T8AC]2
MB">\Y1"DJOM8("V,.-[5.6O/QG?WK+0+?MW3UCTW]4^4;<HW6OYGU'3,.&$_
M21JZQN8SH,7V@ACVY]8,H5>-E(??5@/=[464+:$7;S8I6Y\!%(B,C?-YD&21
MO?O1L6;?8GFLEF5;G)*E#M,TLWM%P)WO+09"LA;,]YA?HS%<;9+/N><[RDN"
M6-FW'79^.XUM:K]^G'R8M>?,:G01/LBRT)+<(#^<-IY6DMHR3U"5 ]7[*(-R
M7&B2<3)$76"E-5ZYE+AEZD-+F>ET1AH=^6&)2PI810)#;,J+C9(ZZ YI'1=P
M)-!S617%PMF8C+R5- C#H.=[('D3?"WU+#KN*7<C%SJFP;U-^DRPWL<@D#,8
MCZKF&,1LO\<I-H2E_?'>51&>'=VCDDR6#:<;_'<DTZ[H#0RF;WI0_-H,2&T1
MF$I <\+\4N4VV>+#U+5 W]/11BTL5O8 \CEG3M+ULR)(,R%ZI3EZ.F3/EN>!
M@=[+OB3SF3?,MX972(/(;^7=HLM%W25#YI]:7CW0K4V'D[*S*]/KE"P]'K=H
M^P,4<W_R\WKX!O1<L&]P)]&7*D-@E?+BVOZ/[;S\,$'G*_FH>^5K*.-KG$%;
MAG$0J1@=<;E:5X 7DBLX82G79*TU2+C9X=Z^MKXLYZ0T>=YV?O7;ZY'__+*4
MM3_X:$:Z*'ZCW?-)@3=0O[*B1:'WU'MA6FY"!KDJ-6 H8$8OU2J4QHJ:2BYE
MR&XC1.(@= )Y $G>:7$=8O\1O3<VU XGRW#^G-\J)3)7NSFWFI+LD7WOU*Y/
M:Z_'-:]*HM6KO"Z8>OD_I=@=9T/-Q;.V.7\:_QU8WQJ*+UGHD7.9=# +&_X8
MD*'B=) 8X[QQ$+G'TAZ&#F ZD2/MP3K<4G)E2@*-<7<+^O-_(S\_K]B0XQ.A
M,7&?N+.B][ .-VE.U'_=-+T@5%&"$FO]*3*=JS3[@B-N>I0PXWSF2)ARL<6>
M*<Y,@J'"2,B>BSRK3/SBJ*7;VNXP28GV0Q;%)"=78$05WBU7E0-UJ/"9XN')
M$1TC] MW8F1H,K_ITXG<>FG2/)]!RDC4;UGR^MH+L$7QJ3%YW#6NJ!'LJ-:>
MI?0IMO:D+: LOL)0/9GT,*JTU&R,.Q.IC<6\0S)GW=XH4!G4BBR$#.A =I?H
MUL)OO[7#,48*5^/.AG::QD:K0[RQ^Z+G1SSZ4'NL!;B:S#!;'F1$_@Y(U)7R
M*TLOE0Z(I+A0&?'4T">N^\E4.]H)VZ=:JL(=#UK"/F3)X[\>YFY]DR5FQZIG
MWNE\QS*8WS++L[YM[7AGK2M*F7AQ0,QJ9-CRP<7-DJ>H6$$G&L!O+:F$@4A^
M6I9I;+]@>" "ZRT^X3[-/P.P>^1@LZ,Y;@(F/-4N\W8%C OM$S2]K=#$8%()
M\^X2\Y@<$Y-N]IU_\F@G)*5971:KW;=_'LO[=E_D&=GU3H),,\;PHV^_.7,[
MNW/=?_!-J9UPI'TIY6[6\3LX),HJY21G.]?+&?K.-O["#1,YJ?J52A'U,:K/
M26-UX?;+XT]I@E,ZU&> O484E>TP+Y:%\?;[[Z?:BC31"2#<((DJ&LL!<V9#
M\S]#ZUME3%D8\H%&E&@Z<HR@D&= #AV23/()%_;X0V;WVWU9)=P1NFF\,D:W
M^@S06NS;4X/S# [8P&6&KGN(9EV+P%J_6V[^UA0LB]G$/Q%UFX@)44_'S.=B
M62D= )Y.^G83GP$P"YFUH:<WA=^-P5)P(OL^5!G'(,9IC9A@ H?[TJ83:;$K
M;9'.E2=2AX5<?^%<8F_F;9]0MW"+A0.B=+0V9YRQ?W?,AHO6W_[1##'E684/
M'-.'O2G0#4_A1%*"&%X, 0E2!JX>ON_ZVB_:$):= .*N,CHSIX&+A%;,ECE2
M\53;OLV:U5RXP38B<@S\:J2W;&=ZJ6GIWIJ??"\!&7AQC+L'%_BW5<^ "-5;
MV<=ND-H/A.)M7-R8QIPT!=BN+_'Z#Q[8)0L%-[\@>F\C\<KPOSXBJQC4QW)/
M[JC4/9/0PV'+16!U",2JZ&JDZ56[7&H>\$)L? #MX J_:.8UN/O!Z&E\!UO&
M<2=J)1@#$5DZ@E?K"FSRDQG-@M\%[(3?3'R_VEODJO.H6:X5Z.<Y1[3G "8/
M[DJM9#Y&=$'-4E6@;B@4G_CD=L+X//@&#&GQU(0&SQ.:*$V"\5#SB$<!&X79
M3"D!23WNIJL]M-1TD=6A(]"*/5A'S(QPPU(QN7J?1,!BEV^&-(?'[X%!D9^I
M)]:4,\XI-GX?CUE&OS3XEZ'74JU*(!RV1VLE,FPIY=X%[VG]KGSGZ>7POH#T
M\UMU-0A@IV7E?!K.=JN-**Y"\B(R+9N.-J56HI'RML"=U0+.WRQI1LZM^1SV
MGBVF[^IX:M85.UIS6)4-HSX&8)QK/5@CY1X3@]G7_8:&1,D#"D-O8KT>>&-Z
M7SMFDTG3SRT'76UNC X/H'>7F?1,EUDP\H<IF]':)$;-GNO<]C^F2@.?5BTP
M;_"CGP3;5:5\QI4K$-2C/BFC7861PN-1EGZ';V;NK>=LHK6;F'ZEK2NF4!Q@
MTS_1]XJ#"1"1#Y+(CR]<TA<; ,K1[X,^K.U%:>,$!+>6-*MP@Q5+-D</>;B$
ML>VT3X65"V0MSN>Y/!./[QSC_32$=W'.\'.M$#DW;H+U$G<NGTIY3+G,3O4&
M;;1;M,.5YXJI>BI'JAUJ(-4ODK=U$**$AS75(9G Y^\-?M)E"M\#5G4EV!_[
MB<EK1OFGO<_QS'=@5VGE DGE79T'8:V7P(0KER#;.P/UB;2XC]][J1&V>]F#
M%\8[>K#Z6*?]SJB#3,%5<\4NR0O6>T(&/HO53?8P/VO9$U;6B$E,>\7*H!P%
MRF_@8Q ECXT]UL&UGEEUF.25WZBL^--;F=U<F?:DU@=:L(8:V_"*@4$A:H^W
M/TU?HE>TX&9;:, ?''Z_%96VF!0>9Z5 DU4"I7;]T-DT&UI/B$,O[4H+A.2_
M'(-8L%2%B4,73[NE8\5)3F9"F*/D).=7?3N;,%U):P5%'#>2.B@U[NG43H^;
M!CG4KYPCTM@]$A2,QQ_U.<Q3\]:YHM0XZ=(P(#VCG'*K4GG:8NM_S#?8 ^8I
M"(N.*PUS)4R&.LW7&O<(YJM$5&H/?]I2J2N@)O;K^YPT6/' )4^I_$N%;WC@
M5[XUB^,Y4PK9MK#XMF5BN->YACJ? /\"4[K>O.37D@*A#B\.94.31[D$F@'P
MH&]X:@>XVT-B7[C.Q$6,.>O-$ @(3^%? =@RW] D?IAS8?F;C6,@?I!?F_:R
M4]XNG@2.^^UR6]**R=H6N%#O>!&I:M[69R)9?2==W8BFK7Y%EL)!,;,B+T9/
M.G-1 I#=5)9R\\#0,OXU$/4>_20-B_Y0CH+YE0*?@(*Z^+'PAQI/%Q?2>'H>
M66HQ^CH,-C\ T(L)A,?^)66,:8B>,P'->@)W1A%XGX>')R!^)DO^WX\X0.+?
MOY;U=(N0FR3)(#7P_H,)#\1V-B;DWT*- 9H+AD1M@0"*.;I$&";I=:"7ZX]G
M@*"%>/#R,5WSGV&=D_*39\"]5VN]9Z1_W[(YG:;RM.TW\.??[=JM;_)ZUEOR
ME4;7I?6\TD'@>_-9EFF62_N0*0YSWT/U3" 7XX;Y55A"H0Q/K5FM-E^/*\SA
M;+@+(^R)$2S9^Y+_#/:.HWH$?VS:W9?VKG*#=$@"S.(W$)XC4<(:[2>^M#K&
MY;G/ -HS\?6Q$) _3PFBYM^V%,PU$S9T6X@PP=*@0@0?+FC,(Y52% ;W/RY3
MKND8S]5=_%!L[\U0I<D;)4G=?R7JV@Z6\GQ='_ZRA(#(LK)Z*>:9.[LZ4[]$
M;6_3T"YMV[.F_) GXJ29)T]VP#EF(KU;@P<.&2=?:.V9088AN,0:L.S('HPR
M!PF7<CBG3M:Q:ALB5F (V/1?6[O(!:K%?_R3@"C5NT:GIN%Q*GVMY-]BDC2Q
M4XV(/#SGI.)LZTX;7LIW(,6DDL:OIMTH\5/5ORN'OFZ"> UD)OY6?8V%-MS9
M_H&ON?! 3+\W++*KZ_:JQKAYP0S!W&!2K"_N2PQ1E:"J? ,LW4H@-T?JE)MP
M,=;\H V%X2^]LQ6M^S9.+,JY2G:##.*3Z_K87J;'6E6$J=D0[!A:&-D"=X>'
M[:WHA]'8FBPZQV8%42M\ ZH^ S"+[,Q<A%F4BCO:!-Y9V5";>"HNF-S&!+JB
M(O#6+=">)I]P4T[^;IWP/P.L=Q /V@LTNB=9K#1QO<!"KPM/'_!.VP4'L[3-
M\EW QN +2I+<&1#<:]<W8*D.A/ONF1FY_MR/Q=)6&8)+KB-<EI\E^M94^T.^
M:IB&K0I&.(E<O2ZWC'U*O:A@%=A*(D@8/UKHD0%$N:>!-D(6O4>'HN:*6[J<
M*!4WYK2PNAZ*;69/CH^J9NT3-RG$(_KYRF1K[Q<_%$Q4/X10\>*GX%&JJ7HC
M++,XI<[R15QPRD.['K0@,'6B$PDJ%\RIC?AE'PB44H(VOLDM3!^ZL<[?*]<0
MKCO[/:SX<5"]%<>"0+O88$WUM0)%G*&Q(5<WWH)W0T,^1\>]5[DV>)$UXV>N
M_%Q+(;Z]2 !M9+GQB;%\9(_^K8B(.S._R1!1I.&2EJ768$)*.?-A["<UYU$L
MNK?]:.5L:=\O3L)7?:4T&EB%9@0@>(I,S.%C  (%\C1RM/2<'"Z<>G$N0]M>
M?[%[(!SQK[[?EBTNNZU:NXY1C^TF5KVYXEC_IT:P7UR5LZY?7+I'IK)N;K:@
M_8CQY,U7Q;6%1(HMG;+'7SYQ$40JA%J)PA0*;PB3F2TO1T&5(IF;+5KR F'_
MK]^;_3_:_Q;7B/O?>1% 0I9E!Y2T 1WK6(R.$SXCR1.L.12BQNKA,_;/@*5Q
MCC"]_708FG&EZ)+!Z3) P>:.(S8(6Z,/P9K%R$-N]\]773!?H_C/J%^4?.Y&
MCKE34/S7%X+F0#XU"&LL<O*B=.^Y[M=G3D&7]+K^&DG3)#X.=!D'%9J[*8OW
MHRWY&4+SQU_O,,V%& 7L@\#EO>*CRB-&H&38/PHIP=44]P()SSA 3?=O(*M>
MQH5V2::'''W*SW'ZXS1%T-^4"=97YV\/,YKSFI("ZNG8)^YB1I7.<B)S+%KX
MY*>L]P_P<F5Q"PKRO)$<5TT-GZHH</+@*>KB]/G#KY0>.OJ1_50Q ">"WXV;
M8Y0X_8]'H##),'4%#+G^M!]OR!F47X=_5AZK/#D)3W /S4,.A4]KY0^S PGD
M!D#A+;L'!^YY[GG[#:]4=@GR7NT"U+$&Q"05S5$F+8&6;(T!F6*CF#A5^%^*
M,A7PO1D4Q8^!"\"*+(%^@JI+=3EJ60J,S8*=!:%1O8T4=>5^5&9@&CK*?OLO
M=0F<O1"*8S0"O^TA\8O6P81[J[>T#^XS[#2#C927;B2):YOOX(N\J!@_"KY.
M5)2D\*_3O'-V/J;CHR?K1X,TA\C-:KHI"6WX:QO^4TBX+.:1LY#U\.6C/^P<
M<Y/=G4/+ZZ:9\H!^K33/]24#7F.@!?#-3L;I4* T'5A9>KIA=(!P?Z&BA(]B
M[MH"HY-!_KO/@*B"-W"Z88L8::;Y'I;=0DQ[JJ3N/0O",U'WU9-[A>3/:.E;
M6Z:F'W7)E/:MHBAZ)HX*E!BCQ*GDS+D?V)Y6^IH++^IAO73_\TVGQK"4S)YH
M&%YUT ^S36;R+I_Z$H<<IUZ]D;+6'P[\<E7V"?O.(]U;)HJD2RV50D1B8@ Z
M96M+ECFAD@^GPXU6-"I9$_26"%7?75M4_E\K)E_>ZOI;H4^Z?>A@:'>CE*/V
MS'-#E]TU(AS)^B22K97:'9I'.C[C$7QU3%^'_X[S('E#]';W,?\9\ D2*2)#
M^6),DDD=>O%A9$5[/R4'-!T"1*.%Z8@V)_=PM=<O+P=_GWLUL@QR-1C./+G+
M4:53%5!< .[/K?934W13Z<3'T#[[C?[/U0^?QN80;/F<TA3B$Z4]QB3C1;,E
MU5G?3X>(;7["(F(RLMCW3?X<I\<J;O("98*N1.2V$85QK]M7>H A/$3Y59^5
MC&U?P@X>Q+X^0@9?QHXN/.?BMA.VL1<5!WJ_>V&BN< C%+]QP7GQ+\"MX%BM
M)Y&G1M5TU31"-1)G/#0$9T\ Y=+H9OP^3.(:&#IQ77:)!B38I$69$*-!EUS9
MS8Z3V3WD13#_"P/K[<F@(Y+W\8=-U ('"QB7D=RU"L'XB"Z_VAL(OH.!A'XU
MT&/$91M,]D]_'@4D5YQ&7T\K1Q^<%CSV#&AO/Z]^\$-(&L +SSOA!LJ(U'*$
MSR4G'=$)Y/.B$#X)PL<_1=EI?2Q:.,99F--$M67(:"?&JKD;]R'V8(@ Y98<
M9R3F>"[!N7\,%962II^28I^BF$EL?/QB\>E]3J+AKHM:>!%+QMM)2T]R-U)=
M\)0BQ:4)X,DW>)8.IL>[6G];_E@FS18\0??ZB=&1EA'Q&Y;#2Z2V%R3];S"@
M+15ZUH%DJ9'[X1>!\!PVCE#^7/L,L#D5Y1]B6_MU%\.2)3!!'8)RSYWZ!)F]
M \Z_PG^'/[>2"O9&0'?QUR9W_PWC)Q42UWD[0J+[<(0HP6I[#_7X__TK8%ZZ
M$++CX;ZP[6[]?;V8=8DP:9WR_)A2F29IE>.CF2H.-#C/?S &8S^V!>/8T=%!
M;#5(I_?QH[89>Q>]JB4?ICG^OE]R%C9C/:GEO;XPD5]DC'L&J'='R=8V0=^T
M:"O2I[SJ!P31G[]KFU,> . <B[&%H1P#KF?%2)BB-)4I!V9=\F$![A/GXO4Q
MP>B0@?<OW/L,6)>Y34#\?N &,\!%8Y&J<(M;B$DQ7)YND*JW$$I#Y"CUCH;'
M41)"LE428/VX8#[5\"YK:E*0:PKH[T2>\]@)V2TO;,) $A<]T<D]Z" 6AK>)
MT_<2:!D+!^E@20A>8_B7K2%HK!?".ZJ+ZJ- 4,S@>FDU?0=J0+9E2QDFQD[5
M2'X2_B_3L;R4N_%!VOTB:L^3I+*O'G)F4X:)6QZG<J-\2DP^BA,[  ]WBV@Z
MG+[=?3H$B^U(7TPP&D)OUR*^D$ 8GQ+\'JX?OUN/;60*?@O7SW?TWJ,CV,:5
M46WK[NF(9&B.<TRKLOF6Q:*()QJF].B"@,/KH<?G.[#H/=$QC7B)R,M,V!^H
M8O0?I-8^MZ+:0IUW_)D9G;J526Z\FL@4=?P8+R/FWKL$9<DP2S34I<&+3%U@
M=4)W0LJ4:-#^7.JB"^B3)67%L0=E,9JS#J4'_@[: 0, V=WY^AD0@KOYBG.X
MS^8%9%&HXH4M3+)_IT5F@.9EP[ %MC33VHX%0L=HL27PXM7M[8[ZLJN79%;G
M_ WF?E>S]:+70X3A$39S2D2F[B5';Q^A<NDW55+^ZBHEPR/EDO>=OY!#3A_.
MS34PQ-!#V)*V)1.;?VG;$/$#.*!QC_-UGJU?T+ZC_DE1HN.O?>7'[+D"]#[8
M1]UI.&XXJE[OSYI3?-/WM:HD6TK593(]SY<^B9-X9)L7UA>"Y-[CI?9;,5L
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MJ=(9U)0.X 4F3'_?.Z1;Q<SV[[I!].J;;64\D5+3^CQQ5J971M 55F#"#*2
M6E$4,[2'SN@-S'D=#M+D$!?."L#CF[+3]SC(=TX8T:DS7?U>J9].S$)&9-14
M3,VK-"I2\#-^.-N#)H71O;I-F;LT+,W.QLDY-VA89-,"F\+MA0%;$S<KK^[\
M<Z19]'>4^:@,:3Q\A^#7JD&V2M0CQZF1F3-8\,H3^.VI^\/!S[N(:M7@VF ^
MPY"_%FY7;M8^[H<R&'E,+D **$=;ZIAY0^:8>8PY*>:%76O*YLAN7W2 \&H
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M@PZE[BL!Y\-6+F$3Y\@1<Q2G3QB:==<\V@.E:(C8"8(2>55J[,G3.K!0(_G
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MOFAO[6KIBGZ1O:U*;QV=HD1<Q)2<Q22@9A+X+!"A(_CCZN;Z->I?Y8F,7-X
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MD=X/G)<OT6/>4O2 T 2T;8S/1)O/I(@DE]6L.RXNA&@4@E<Y9O&*E* ?;(G
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MB?X<:QK>GW_A2^.MW?A^QD<2W[VIE O;=8EC:6XLAA%MI$:&>,'*;V%?4/\
M;%E%90W44#/&MT+%B HEA7(0C<,.5R22#D$G&&[5[V^OA<W$"JD CB6:UN.$
M5EEVN4\QS@[B07.TCKC@8IXK&XW'5HXC&XS$XRO&'LU6Q5:IB*O+TC[2M5K2
M45NH1<*:E[RAS:CP>#P>7T7A\#A,)A*#DY2H87#8?"TIMJS<Z>&H4(S;6G//
MGG;W>?E21X?\ /C7I_QV\*0)?36UCXR\-,EKXDT@,P-U'$@B75K2%U,T=M/(
MLL4P(8PW<4P8JI4U[Q(MIH@02QQWD,TGGVUN[&.:&0#S5*RLS+E01\N.O(Q@
M5^:/QN\'>*/@3\1?#/[1/PQMGMM%N9H4\;:+&'33A=7<KK<M)"<6\>G:G%-D
M#(1+T (%:137Z&^"=>T3XH^$="\9:=>_:]/U:Q6>&.("-=.NVA1;BUN(U#&.
MXM+@O!(CDG"H>,BN:[>[;?5NUWYNR5WYVZ(W225EHELND5T2[)=%T-^'Q#'=
MB2$VDL;3++Y3Q,#M&<Y<HHS(Q!&5ZXX_AK\Y/^"LG_!.OP-_P4__ &,O'/[/
MVOZ3%9>/=)M-3\9_ KQK=0627OA#XF65E,^D1Q/-Y<D&D>)75=$UJ*.>,7%O
M=6[R@&VS7Z+VV@R6]QL%TH4I'(LH0MM"'&".,Y( .%Y/<]3O?;KBS9FOXB8T
M5B+V 8B*PJS!)$!#JRE5!5\QN 8W#*10,_PE/BC\-/''P7^)'C?X3_$SP]?^
M$_'WP]\2ZMX2\7>'=3@DAN],US0[M[2^MY8YA&SQ&>$RVTH0Q7-M+'<0,\4D
M;-_=#_P:%_\ !4JYDD\4_P#!-+XP^(U=4AN_'O[+^HZSJ<,;)+:F6?QG\*K,
M7>QKLWCW$?B'PW90NKPJ-:LHXF22$Q\9_P '?G_!,6TT#Q!X6_X*:_"30[>#
M1/&-WH7PU_:1ATP[8H?%JP#3_ ?CO[%% ELD6NV%K!H.J7JW!>?48K!YD+R.
MR_Q7? ?XV>/?V;OC3\+?CS\+M8ET+XA?"/QSX<\>^%=4A".8=9\.ZE#J,4<R
M.C1RV=T(GL;^UD#1W5G<2Q2*T;T ?[L,198U>/'F$ \X(+% R@L.[#(VCD_,
M."2:?:S7+(5GBA:12S#[.9!$S$$ A&)Q*NX9 ;RVR=X/RX^0OV%?VM? W[<W
M[)'P/_:E\ R.NB?%[P3;:O>V4J10W>A>,=-N)='\9:->06\DD5M<:5XBM+V(
MQ*[;K-8)%4*6(^I+:*:S>6-IVF=OWB012'S)MY.YUW#[H&W."",@$9YI-735
MY1;C**E%VE!R5G.#L^6?+>*E9^ZVK:BLKIM)VG&:3U5XPG!*UU[MYJ=M_:0I
MRNN6S_DC_P""S/[+_P#PI_X^Q?&?P]H4VE^"/C=+]MO5'SVMCX_L;0IJT,2H
MJQ0KJMM!)JRQ8!>3SI0K,A)_/K]DKX^ZO^S-^T'\.?B_I<TD=EH.LPVOBF%
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MXBTJ/Q%8VD>AWMS<K>-;6L"OIL4&B+(H>=6+.E_?S+*C@,T4D<L9QE:]P3+
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M//3&"<G\.H]3^>#Q4+S! "J.Q;[ISDCIM)&,<9Z'^+OWJR1GK^' P/0XQ_\
M6]J:8P<Y Y[<@#KR,=2 0.V<#- #(]W&Y7W99BS$8ZL,+@9# ]3G/4C@FGC=
MG! (X .3G)(QU)P 2>G?D8Z4[&#U/?J2>I)[_A], 4O=?]Y?_0A0!E26TIER
MI^5MJ[L\A1AB.O&=F.<'+?05> C4C*X.=@)'!V@=,YQ]XC.,$$=,9I%D#NBC
M)*KYC'NS,"O?K][/48QCK4K;2"&& <9)^O'()[_YZT )C!R<%2"=OW1N(R&
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M]3S*"49"-D8RR8(8@,N>#][ P#UX!.* )I0K#9&I;!&.1@8 Y8]#DDYP1T'
M%-\LAXMP5V7+OD8 W !2.F0NXYYSD'-/)$FPI^[W#Y5Z#Y1DD\\$^_44JMO,
MC DDL4)&<[0#MVYZ\@G@C!P>] #M@P5!VLW*L,Y\Q65D(]#N7(Y&" 1R :J_
MODEW;@5<A0HR,ON+;GR<%\LQR<DL2220")U#[N2VT DD\>F".>,'O@_KBB4>
M8"A!)?D/_==065E/0#.%]AC@\T 1RS*9_+<LLC(O!;EMK9&6 Y(R67'*OAA@
MKD&U!U[J%^J@  $]^ %RV2P 4D@ "%G$Q4MRZ$8?&,2]QTY4]2W(^O%,:9E<
M>8-N,Y4D!6YQRH'R@E@=Q[@#/4T 23NL:9=#*O"F/ R1DL,*PQMW,20%(.XY
M^7(J92&*OG+@$JV3O0-C(#$EUR%4$ @':.!TJNK1EBWSNQ&3P651G 5"<#@?
M>QQG&*=(>,^4PZ8.[9GICD=L#CGM@=30 \E$503G *@[1G!.2&( )R6R0^?F
MYQFJ[1QMOE:.,F-!M)PI4 %=G &0$(!4''08!P:62:=>JQLKDE"%S+&I_B&
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M;2_LI53?#)$61@2=W^*'^TU^S]X\_97_ &@?C!^SO\2=+O-*\9?!_P >^)/
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MG-3[V8D+Y@53@GRSR^,!3SU(P>N0<>F*5BJ* P90<$_N^F.<@Y(ZC&0 <<T
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M\UQB<O<")VLX$2,D&0S&,1Q'Y2X4%QW^.?V)O!L^LW/C3]H+5]LFK^(]9O\
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M  2A%"D!V7L%'(/)YQC(!]=W<D8R *<1G+$[ <'&6(R. <>V2,^H.0,5;VA
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MHFHVY07N@Z]I%VD=[I.JZ>\A2YLKY([A6)P&5H\_&?\ P33_ ."K%C_P4/\
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M1(O"H"=K'*9!.TG'(QQDC-59Y-4O$L;B.V#0"11L!<AI ZDM(,8*9SM8C 7
MY&: +T"W]YJ$-Q/ R6N#\ORXC  ^? 8DMD@';G[YQCG'3QI@A3G:3QN.2!\Q
M*@C)P, @@9Y)QNIJ[AY@) #-]U<C&%3<@Y/'S#D 8V<@]I$R&'\0!ZX/ P0=
MQZ<#OG)/&!UH BO+5[FVF@21HV8(0P)&Y54*P(^]QC&,<@G&3C-:;28I;2QC
MGNFWV)+-+P4?+!E3+ ,"5<=<8P0Q!'/E7Q<^/_PK^"=QX>LOB5XF7PU)XK/E
MZ3<RV\DEM&LNJZ9H*W%[*AS;6ZZGK.G(7*NR0237LJ1V=K-.O*:)^TE^SKK6
MGVVG6GQT\ :DVMZEK5K8W-MK<,]L\_AJP-]K3M=?-%!9V%DK7/VZY,-K=6[P
MSV4T\<R-0!](2VMA%?0WKS*EPP5(29/,23< A8!2Q.XDK@$#Y0.>:LQS:9!=
MW6G)"HFDC\Z9-A\J;!W; ,8;MD#YL$YYKYM/[47[+TVB^&M0?XX^"#INJM-_
M9.H'4"MO,+*\CL)A?2+#YFC-]MFBM[9-52U:_>:,Z<+F(-(M#6?VS_V6-$LH
M_$H^)VFZI;&/12USH^FZSJ30V>OZA#INFW.(-.?S5,MQ;2W4=L;B\2UGBN#:
M&%S(H!]2Z7?QW\5RBPM;B!VB,7(4GY2I (P#GH2>.X -:(=I;=8I H=+F-.1
MT*L2%!48V[59R<E0BNY(5&(^7M"_;)_9GU?QA<>!++XJ>#H=<ENH(=.8:G!+
M;:S%<VMK??VG%/;"2*PTV(WEO8W%UK#Z<8=1+V;+YL2[_3O#OQJ^&?C/1?%O
MB7P/XJT[Q=IG@H7=SKJZ4+A9K2YL-+U#44@DCNH+60I>VUI<BUN4!M+RW=I[
M66:-EJJ<)5:M.E"+<I<D5'3FJU*V(HX:E3I-V7-&57VE2]_<B_ALY&5>M"A1
MJ5ZC2A24W4?_ #[A'#UJOMI_].J3HMU=O=G!)Q>K\I_:/_:V\!_ W6="^&-M
MX>\4?%WXV^.81-X1^#/PZM5OO%&I6"R;?[:U:Y=H].\/:)!Y<V-4U>5(6\MA
M'N;%>%P_%O\ X*<Q:=%XCA_8N^#L?AJ,-=0>"+GXVVR_$A]($@E6UF?R;C11
MX@DM_D:V%P8EG)CRHZ;?_!,SP!<^)/AMKW[8/Q!@M=5^,G[4/B#5_&=WKMTA
MN[WPU\/TOYM.\&^ M+NKHO/;:-I=E9&X^RVXM(&N[UY7MB\0+^4^,/\ @K+X
MA^'W[?/PP_8J^(/[&?Q1\+>&_C)\5-8^$OPM^-]SXZ\&7NH>*;W1-(.JS?$.
M/X*V,$WCO3_@\[+):+\1+V6'0EFAD5I&=6C3[C'XG).&,97R7#Y%E_$F-P"E
MALTS7-*F93^LXNG&^*I9?@\#C\NHX' X:LYX.&*G[?%5IX>5=54IJ!^:9=A.
M)N+L)#/L3Q)F7#> S!1Q.3Y1DL<MHNAETIVHU<SS'%Y?F.8XW%XF@H8R>&4<
M+E]"E7C2<91@IOZM_9W_ &QO _QP\0:W\*M=\*^)_@Q\=O"L$UUXB^#/Q$L8
M]/U^*QC W:UX>O+5[G2?$V@B-U5+_1[R<( K311AC7V$K%2"O)&4)SW0A,<X
M8'*E>1E>00,Y'YY_\%,?AN;/X1VO[4W@2V@TGXU_LMZMIGQ$\-^(;-'LM1UG
MP?87D*^.? NI7MN%FNM"US0KBX:>SF%Q:+)"A$$CJ6K[J\'^(X_&7A'PIXOA
MC-O%XK\+Z#XGC@.,P+KVE6>IBW! 7 B:[,2DC(" $=<^5G. RZ>7Y=Q#E-&6
M#PN/KXO+L;EM6M+$U,NS;!0H8FK2I8F;YZN"Q6$Q5+$X53YJE)1G3J5*LDI/
MW>',SSBGF>:\+Y_B:>88[+*&"S++LTI8:&&>/R7'.K0I/%TE=T<PPV+H5*->
M,9NE6IRHXF$*+JNC3_SA_P#@\V^ MKX/_;?^ GQ^TG2/LT7QO^"*:-XCU*&,
M+#?>*?AQK5QH\7FNJ &Z.B7=G'F61Y98K99.F2/PZ_X(=_'JQ_9L_P""K'[%
M/Q,UJ\:Q\.R?&?P]X'\1W"LX5-'^(OF^#)FE\I78Q07&LVMQ*FTD"(%E(!%?
MZ>?_  5;_P""1OP1_P""NO@GX/\ @?XM?$/Q;\/+7X+>.=5\51:OX&T;1KWQ
M!J]MJFBR:1=^'9;O6'CCT[3Y':*]>2&.Y+7,2L+=9!YH^+/V;?\ @U:_X)4?
M +Q1X=\>77AOXM?&#Q9X7U;2-=T6]^(GCR>'2[+6M#OXM0L-2AT3PW;Z5;2&
MUNH+:=8KF:= T,8#;2X?YH^S/Z.[B[TK28[AM3U>PTVVB>3RKB^O+>RADB8M
M(A62YD16PA56<,58X(X=0?&M=_:'_9]T[QCX8\ S_%[X<-X\\2ZI%I>A^&H?
M$FFWFN7][>;W2RM[>QGN&BF>..7RC,T2.ZA Q)P?P>_X.%M/U/2M"_9S\6:/
MK&LZ=:OJ_BCPE=6EAJ^JV=E=Q#2H]0T][B"UN(X)[JWELY5A:9)7$6,N7WLW
M\[_[,GB9?"7[2'P&\8278MY-"^+?@'49[F=I (XXO$%C%([7#R.RQ;)6)5B^
MW  8'##^G_#[Z/-#C/@*7&\N(\93J+ 9MBZ64X?+,,N:OELL335!XV>-FVG.
MC"I4MAU5=%R<::E9K^1/$KZ3>+X&\1Y< 0X6P%6A0Q^2X;%YUB\TQ4XRPN;?
M5JDJM#!X/"TE"I1I5G3DJ^(E3A7252IR\UOZ1/\ @J=_P3L^/W[07[3/ACX@
M? OP=!XFL?%/@S3=)\5:E?ZSIFC6.CZSH4CVD#7TU_,&#7=JWG%K>UG7$?S.
MC%=S?V#?^"4G[3W[//Q\^'7QT\2^-OAYI-EX9FU>'7] TNZU#6-1U/2=2TN\
MTV]TR*9((;)&>>=)2YRF;;( # 5_1/;7MK<3QLK*Z-%%+%*5642I.HDC97.)
M&_=M'AFDD!!RH&X Z!V,X>%T2106;[P60@\G8"$0$\_Q=<D\G/\ $<O#OAYY
M_4SV:Q;S".,CB%'VD84J6)HQ?-*G'V"J*TG)24JCO=J_4_TTI?22\0X^'N!\
M-L.LC_U=I9%/*ZD\3D^'QN-Q&78^G5A&G6Q&)JU(>T]CB&J56G2@X*G3:5T[
MTYE8^2'885W(.W##N!QC!!.>/E!P,_PU.DS$_P"M"C</,CZE2,@G X((!&1D
M\#IS39+F/[1;APP;,N4*-]XC/!*X]2-P&<#\02-OVK'N,C$AY8\,,_W<;MP
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M%$DB( &XR 0,$\9&#P,<<$C/M5*Y)8A4CE7"YVIE,98YZ!B">22?; [E;=)
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MN1G/9&5B4P>-Z$CTZ#J0,].2 >O!QFG!<.6SU&,8Z?=[Y_V?2G^GL0?R(/\
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M2Q"$_>"EBISP-P S@_[59\NF-;:E'>2RR-:#&V1 S21/D%5E/:)<'>5! /<
M8(!M3H613T5,DCN. /3L,@8 '()]:K>6GOST^9OTYJXC;P4;:2P)4@8#C)&Y
M=^ W&W"]2<\$5!(F'.T9'!P",Y(#$8!QC.&[<@]0#0!5PP.,$D=<8Z=CVZX/
MTP:,,.3D ] <<$=1QSSUY)_#O/D D'@C@@X!_P#U=QCCFD;:1@X/IR.#Z@]L
M>O:@"&J=].]O;2S1KND1047!(^\,L2.FT8(&1D^O%:&V/'W1] "3^0R>._I5
M&\G%LJB)%::9A'&& *;&'[QSST5/N9/W@!QC@ YJXO[RXL@PMV0$QM<;0[*
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M\'KQ@B@"ZLD>?E95VD9QR<]#E^2V,'GC)YST(4 $%MP.S*L=S E^K$8Q@X&
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MV9T</.TR.B$):_V+&2M]_?]\DE#M#ZFQG4SGEGOT2R?S7I;./0B\/A;VXKG
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M(4*008B]=VCFD[[4[Q/>(:+9G;Y?*5FU7$C!,H*!@  %G*3<0/[P0Y5^_(B
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M#R\O[HF_Q!V95[[L8Q)O,=ACK6)M9<4WGK&!QD$/]&'0!HM6Z?[QLW724?U
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MU?]GE>G_EB6M 4SEP5G:?VR=,FV 7:PC'*,J,SV/5H#* 9-'S+V('/'7!$[
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M>^N=8'SLP7P23,>]X"5!UH&D5R5GYPPUEX;WT6LMIR/O U6/:AHJN XU55:
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M4P;/1YY"Z5(O%QF$"YF0#TOI+S.C+<>.ZB"7J__B$V;B\+;4=I4! ^]K!35
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M2\T/4Y6-L"!'P><E@^.@P0R1:<0@@=2!*(8=;(NVS <(_D]3YV3_ P=34^&
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ML=3F-":5Z*+YNOB:ADOX/]LX!0\"O +[&Y5'0%1@F%5JU", H16VNOY 0(K
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M5>@?"?OM-Y:>@?(WDD$8?ZY!1T,"N?<'PI03:<><[I'E9K3: <HC"1NVS_$
ML3O"Q2HG)O9L$<_?X/MP5B[E2V'[I$#BWY^>/;3>S6.^,1X>MD^N=@EDVACG
M_Q8W'T1)]5[E#OAS):BQ9R EX@X#VIU?<]&^@"3U,V/36Y$+/0MV.Y?(:9A;
ME4_XOW^(Q]DF<O\2&S\^2C3L3&H[YWB[X?S=F%ISN#C.!C]3'&CX2=J3Q5)X
M4B?&@7XH_I>6).^KNA%+$X'MNS_ZW?)4WF_%!8)WAK$ZOAE301%6:J:C3X:?
M5J;%/W9P=#"F^ZP_68DY_?,;N5J"3K3>2MF.3A/<8J84%[F;.B2$]'']5<?
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MO>#X)NSN$'!C,%UT"#M&;$BOE;#O(2M#22)R5[FND]J#,(<0Y12&YKC4HIB
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M.OMG"1+@F<=/)Y <TBBNUE6PN5YO&BJM3[M6FP]UK->I6VW74!&\JIC^68!
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M?QUX5_HH&T,G3]@"VLA+F%L)+6A [;C_&S6BN$2JWELD6OY\\43[(NG8IE=
M:JS HVRX,TT?#W* #1?L?2>M ERF^VGQT/#PI[M]M*;0$P$+?JL=U>P:@AJ
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M[M3',.&D>C+MW?%&;\B,3DZ;=H2.*H6N^N[EY[IR[O/[M/&D/J^@R?VWT0
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M9XR"957WF\ W\(M57 M*+32+A#O20+&18<I!!<$0%:;M$GDP^G,<3'8?X[G
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MEGR?R[E]/?]8NC;8*'3@U>],X-7OOWZ;D<*47&_[?"'=[7>8NHGS4YPO%OQ
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M%DKOWGTI;;*;XP%CWR8Q&-YH,J@>5QD;FI@4VW=W%<-$H&W?7#0I*K-A[#X
MEE6,YT'2B":]N8_&1^;J<X0-FW[2]7]X=^QC7?PJEF4]7.S8K%_M_UY:P^RS
M+BNM I+W"E>FM#P HG".)(.5B3@-6S&Q)=Q+A;=WW)4W>W PG:4Y/U%M:6#M
MY4A,,\@L6+>HX,P)5:AF*BCMWBHD0@GS[4%#AF1O;(-$BV5^&4@CXJHLQJJ9
M!'?]T&7%=@.] 8*'Z@)H5,/(\JGP&I_OWC&#<_VS^2$^ >81/;/9%'&:50J=
M/-_Y1\GYD42E?A_FP]:H1O2T[,LS8Q1+Y!CPI0A3*6=32CDN625T&E(*'DG#
M1[^R-HZL%<4O$B-W(>6F:Q]P$8,'K]N0J=^&X"XQOB)!Y7N=HO/.E;R%,YEJ
M\ZJ(UTD3OC_D.+D\).1%'@#U3/*9[QQ]B2+N-"KN)$Z%NP+;/WV2*OGF\#=9
M-+#=P5_SZ>AM)5&8O[PGB1RM> %3G=TB\76N8Z0\_1G>UTL&4B2G\JG-4-BQ
MIVBK/B(]JOQ.__M3GU#[Y=C8AOER=G<JAO$(FU58M]/JZ]AV=&Y(46^K**Q>
MXH0($CSM?#&& '7GCV;@;BXOI#<F5]HT=M:F/C?V2Y%(G?9(+2]&7-D$5<7V
MOSMUSE;6[M% H_Y<_KK'*D\%"P_2SNR(60/,@-@8O4T5AT3J>1;/O2TA^W.K
M(&;%-Z_+H5LRHIE4<F1#P:P7DY(<:T2[]]KS764^;I<M,SN[T(SMESN9TX".
MT@,P8FAS_+0J^B0O^J _X"5'W3*$L:\.".:M?,I4,U)E/O"Y/L;P1?=/9TJ.
M%QZ;,VI>7<^E7B#UM5J1LW USMYEVQ"G^O>(]R5<;MV+OA)C4.Y;Q4_OSTS7
M38Y;DOT=R;)K H,[OR,8^HYP-A<2;O2B72I_MV;]VF\=K/*XNG<Q:F4<(]W/
MB/DVXCK="_J<@A7'/\HVB<,+1<#&X \ 8LBBXNDZS%^X&%)*QR)IMJB4K"RB
M14?_8VEYA'IM[Z] ?OT;'&P]VH\O3@<RK7T6I*B<Q3V*3Z=$^A:K0GL70_HL
MJLD0R(9+7_ZRV+[-&O7XAE '_=)LY89"'I7IX"8%4HK@;_O38:DX\J^S[4LY
M&GS;1]4]=Q4)HDHBLCOFU6&IS&2%Y:M?=EN?)Q::V]]X%L]"/V2+%;2&+?PU
M6W#65PY7,K71[=0NFZ1?DQ$1N.923MLJKH N^\E*O4(Z6%AK6O,C_W9KQ[>;
M%- SUEMZ,[3GR:RJ"_CR0.CJ&0A!LF0(-=:!JDCM<I(A1CG&/_0Z8S0X'PHM
M\D^(55L4SY9H[)A-2-0\<WBFPYORF>,,U];?SK@$\^%/7E%H3A(!,20HO'#T
M?@WB96\FJE?*YM@D=[=JC?/-6Z8:6*R#&(T)GDALUN%[/E'7CE'F#\.LMR?6
M3R0=&$P3Y>WG*+6'[9?(B\_&2GLI3V?[?MS1Y"P3?M*T+ )&II5LIDCQW^>S
MG/6(#_5VD*I8Q%'RA,$E/#6G</X&/N.'G0\Q?XPG5  YW8JO'BY_A(:+7R98
M)#=(U]9#LCP2$_C0<]3=!3A7"G_ 6N-A/*/08:AR7;66TOU)HJTW_<*@ &ZS
M,]*T>6K<;B&#*+T8J7XR!OB30;<3! HX.=);2 R=ZEJ*HIP$#P'032#.A 4%
MU4=-\0;?=V@&V7]?GH.5S<?L2GG.[&X7%G4BXF_UZ^\CZA;V3_8%O_Z=-4H"
M2TL<9DH%(!D*S2#2&U-Q^;-5'X\8=,RI_-5S^K06&-XGVY2L.GB[[B6O"19$
M<J59.<_8T*D<OZ0YSI*45ENTJ&^2)JGGC5NN[-3"FO,TQX<DT4P0P@^_[VW/
M.-733(@X?!)7?)^V+&AM'4T11A4^D_^GC0AC3Q"I;82H;+/!0L57F4."&F@X
M0YE9&^>/CWD*M:P^>C*!:13^'# Y!\N_'#WZ[=1)LF^D2FP(\8"GQU^8BJP)
MA<\,@NN=WG.J0*:U:!Q\A-4$'$*;@LG/X/I)^A@GP[LT_C\1OT7"*1C[+$K\
M_*6,@RJ4"Y\LYC]1\!3$#^#090VJ,L>OH:T=6%+3#=[YJV5W3D$;0#4_J.[)
MSCY7@E<R8OEJSNIUK,@"(P&[LD@6]95@WUR1!'N+X5F.RO?&S&)(OA(B.SX>
MQ?R'6J^>I^*2 1=R<FNEOMA 91E55.^"APS^+=H2!\>UE/-T;BJO,\XG'R%)
M>@!$FSV1(FM'VM(G;IE'+B @F7"6Q,U[0^.!Y>SNENEC)][E#REMQ\&*J12.
MC=W@ZLU&ZBM3B4V>G-;C9+@&*21]@%YT08BJH.W'>C^%U[<A<&L:1:-?FZ2@
M>EU]HW$??NW [BCS3SQR77[8Q1H70BIY"P>QO9SR-T%E\U,  XF=NZ&X@KY.
M4[#!*Q^,_"A&W<3)<8!).%-B]$(NOE69]74J2)T>5I/JIN.P,YNG5TF:_A0/
MZ=/J4:(H7$'+&##:;BOWU.ACB_5.@'V##LZ77B",,]:N53,TU19?A)Q=)X5#
M0=C*']/ZVJ0$; 9:+/(3.4:9G3X (OTE$(L#XHHA_IRG&/UV6Q/VR[+,ZS'^
M^I]*D1Z]U*!KXU@7G?H64GFIKU>]>M..OS"3)BW3U!I7_GZ L&X1)FY4/;>#
M$MW)G;Z:&EJFB/IEB8B/94U[/N<D[ .PJR<B&:'E6RDU4;VMSUS0]:(,VB:@
M3KS@#>VD@9CWZGG_,%I^ -B;V;?&3E:4'X@ORWTJW6_ZJ_6%WJ\L/:;@!9-(
M]==G*RO%46^3.QN$U[$@YOT9"OEY]C<L7SR_VZ?5&9F^=JQ(C%9M\QYZ]6J$
M#'%7*PMRI*<B _9A!,?CNS%3SXSS&:QV81@)Q*JRF'-<-[)R]&UN<<Z/K=KK
M5T0,Z P9>7*^-X@FZ;?85\]R'>E-=M(;=Q6V4R$RBN-I+\25A2>-[8WH):GG
M,*H*<^QI);EOAYXPLV3X,?#YRRS2N\09544T..1&BU)CI3]& ZW9B_4(IP 2
M@M>?S+6"SXYO#TGE7HH2OY+IM+-XJ:7/H?9VX;+K*02JTC;_KN&^U"II9LTP
M+VEY1:^9#TS)I&39VO+\[ GJ/;]IF7%K. DCO#,>D=O[BZ'7MV>QXE+-16>>
MIL_()8Q@K<R;[*PSL<#,9,UNCW$(7\'04I2;5/G:CIP\CC)!\F7^>ZVPR1E*
MVN=:HNBXE)8%L&WT)\,T(9X5[(@<NZC"+W!^RE9*1SVI3JO(WMF*<(,[,S3X
M7L_;D(GBWQ"Q>1U6ZL2"O<V]WFSJN8V]N2LM"VW!OEX=N]E\CI_V.HB$%)]?
MK'H5'(FI1C.Z?/.5.\XV[QN,3)?H%1$,QJ<4D2BJ#]0GT<(TG_2UYF+O?JQU
M3W\Q5S4^B*R?F]-[ F]4,Y/0>3,WLX0)_ECY9?5[1WB+!A925 E!'T(4(21=
M#[65]2PV4^ I(!EEGJMZW]5"T_MUZ2HF"H^@BR-!;,#3\^I:@8$T=!1!:6*C
MJ$\>T3N=;U96=O1+.65KC/W63-G_[DI+/]I-3;;ES&-J=$"=W T8G9):,E>A
MY6J:S]XB[T]VI;Z.Z;52QO8M^D(5/9KMZW^0?R\:CY:HNAU[ .3A 1[;_;<2
M-G<\O').'Q&2A3;DO+3;-:>- ]K>"!HJNCZY* -.7>]+$C5AG!6;OMX)>I&S
MFLHZ&^BJ8973%0L0^5]U_YLD!"H\&1:J?XOE7AZ3QB'3#9QTZ\99/9]BF K%
M)Y+3LXMK"U=P1QLD%/A$Z&>-!XB.?L)8S @B5#3KB#HD( / ! I(O'+;<0*^
M_)T$8&!Z7 J;SC>YDK'L6.8#2.^/HL* H#,^,$'PZGP&GR06R[=E9W[WF':Q
M5'AV1ENTG9KA'N[YZZMT7@'5+PH":LK\6=8MUD63%QVST=HPG=EY964](Z-E
M>N;3MBL_)/^M E+]H =*Y8^U^0"@_9-./&I!75B,FIEEAHR[^!78_W@ ]/>I
MML7\=6<>*&O\^P8_D,?\^NM]9==&,/19.Z-(X1;O$F]_-?(!\/K78S[?6W>J
M.V: [)W$CFQ/_- Z]N;*:#F"H_%J,7QR>W"4VF>5!%J>ICDRQ-JZY:V>A9#=
MA=FRBO4(8Q97-61]7GKJ:$V3.!^$KYQP-,S*,79N>WQ)?B.*#BD9[*2W?,D5
M(EK!U3&OZR;&(J7KYJ/.8C+2M:J<7Q+F9.IG0J>LFRZ2-<H7=6T;F4/@RA#U
MV6XH\BP2:J>0RT(CV7VV>5ZJ"7.B]N0WR6I>YE<&??9W$D^Q8AOXGJ+;-8$S
M)(5V&M_'^\P<:0QG#?NW>B1DKD:.$D^]QK.])E^U&<GV*IIZ8E-96N_G:Y8)
MZ2+Q0N[/^%E?54">PO7[X\/$CXIB JB1*P-FZ*=8^:!&\:HP3[\)CB/#.,,:
MIU=#KDG5_=,3^(FJ9#YAD=T/@#=3L="Z]![I9=Z^J<UUV . \$YBJT/LB*6I
M,5.[+NS2B?<(H'"V)]ZO68C*=GO67[*SZO@Z)K('KPBA>!7[  CQ!TG[_O5=
M/VPY53]72'R5N(E@Z!]24QX%)X!9$RW@#IS&*C_3]-A>B:=VC+L>]Q>]$$,-
M;S(4_$5WDWI.I4&SD[RY/_^IM%^1YG6.7=_/UGD2[1*\SLE*3J+7_I-SYZJ@
MK:=2]C5UB7><@X\7&_\,J=4V@202BB![VZ?C68WH@^_;M&L$Y='9O8TEA+P=
MT"U8[#!&B]1.,IG^5OG-'WHK\0#H\7D V/%&Y/Y<%ATR)_@ I?47=N(SGC H
MH*<_;>VN(0O_P,O]]1,+"HZSNK[G]6,8'];KE4P#=0S AO;825N:P[RN1&Y.
M8)X:(3E,;6D2=A?0J.?L#M9U=9\7QT[I0IO$K1.*Y"3[^H+E1LALA>^R_3WN
M Z$.ZTLS?X9.I3?B8RQF\YO\$N$:A HYO(@QN8XD,(T.XMQLR*D^\&>[L199
M\'0@N"I..6DR'M>'/+K=':.##CPJ9.M@_2ZX')MHU*>[*F_B#@_AT:\L. [T
MG.F>&QC0"9<..:<%5<^4"*T+=,M;UN:\N:S DGNJ*_F\HOEN0>4B_'2HCTN-
MMBPR/W+\94@2K+939/0 I/R]8H+2JH:D;VLV&ORZH$Q?S\TM1GGJ7M"?<\L<
M![(V=:O1$\"!.(EQI!?.YKF3J-A;GGM)"1/,E&AQ!=A8RJJ&F[ Q8@2X@!CJ
MWH0JK];]C7NFQ"P[-0E^KR6[L373-4'1P_ ,Y(V8U0DQ1G[:DB:%\.J%N*ET
MX3OXIL4(1 RSK=MF6YVM<*=""N2&L61W+YYNZM^1KU^=(U5(C0W\3:1$9PV2
M/IY$44M610?S;]2+%M\$Y#.,\A%7YCR7*9]VQFR"&SX II]&_E%PWYQD'_$
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MM?'_1*2F#,Z_4 OZ_VT NS:91/TD_K8<GVWO.U3^8T.&AZ7_ 5!+ P04
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M0VMO;>Z#IBOTK.-8WWN5#Q5(LC9%?DY.?SQFEC,QIC54=GC#W4"F\..Z^9#
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M0/_#Q^#F_BZLY^CMUR^.SS55I8^6Z V^& 4I)?_6"2+S2O"N+A#+\#RM @Y
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M/(6-O HPAJ] P*J"18?LKF'07]:82!)S1$6$7@**A/&@2T"\01^,4%Q$O$[
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MF;YYY&W98R%K3 %H>7<)&4M,9D/].2/<Q9(,4'@/Z;&_!#0P^U\"N$DF<0.
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M(8<%UPJXZB44U.L3AX79AL$M:'COJ "4'<8)WK:=SNX+:;Y1M*)279S<6^Z
M]PD,++SU^GJ_3X[KSJ@797,W_0LCEAA[K4STC?'\(O:OY_#P;>\HTOR"JA!I
MVPP?;JE\T?RBE6BPNY2*6,X!U3%U,U&#D=TKU,GMPOB0WADM8:S[ZW9F?!F1
M%<C0%I_<<'%CZ5ZV44,]IJXUK.WLHLRF'O[1F^* (UWYBG9RT0:(D4042A%
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M1U2JBK"F/KO!M0X6]]!?WIU2*L"M:?D_ [ZY,ZF3MII+-_?NI9L2]IP6ZIQ
M[Q8JB3.K$'R.<BHJ?@*VRG0X+,%*)=31XRK>U1[8]YB<Z^;5_B;N_9Q R=*=
MK\D66;353D-]"O4W ELT57?D]=3U-\--',Y?GK*7%IQ%@=X-%Z6J%;1A8Z(^
MHB?*VH0!M]3""LQ\EF9^**X?LK\;&S 48EH8* E9CEFN?N"M%:]R"7@6(T)K
M9/Z%1O#9+"UIVG5?%6*; (3EK=*O[7HL&N>'UV2>U>"!F.[UV.:-M6PS,X.-
M2(C<E>JPV#38_9<G)_NF?]IA%9< 7MU,[\\25(#Y0N/V2']HRR8>&\-P2QU.
MTR2T&C?PE/II"_@L^0S=8%ZA__,0(HMW;K93=3C9GZF]IM?9L0$7(WCD6M=N
M%##*F_G>=R>LO$_P?Y,"1XN1_6$V[%?W<Q*P_B22JE[SZ]?/\OT.MR[C 1YY
MMSNL<JDJ(JR:*NR%8NX6&0Z*=CB[LG88.%#O>&9=Z'%:/>I[)X6K0)FHV7VT
MW_Z6 4_-EW9V\)VAOG:IB0C)H!5I]^XPT?C7SZ;C\E&2+=ZRCEA* N,56YOY
MQYFI*Q<G1M?[]@0M62EY+*"9M'FQ]>_=A/+K.),9Z5Q\]A0&R 4"^Q3FJJM*
M/&]M6M^V#JM.^NIA];E/_8+?1*(I1I[;,-U^B'YZ^/ )!I4GUWEJJ+AF*E%F
M)1<6/EYG[-C>XOUG_('GK9"_<X=U/HOVH2]"G%@)(+1L/*G;*XW&GSC>Q$JQ
M>"#3[6>7/.W>S >8N6C(.1B$J/=L\_^P_?7,M0OQ_L\ (%<29<9M'/ T=B6E
M9>XBQZLDO]5P2-B 0E8D4>CVJY[<J8</,XVL%C9AFI/[+]N>>H4>0]F]<O*'
MJ])MJGK72J9Z?R+U:;OY3#2[#1?-66L_"GQ@* HAYQER1T4_$/"R$;G;::EX
M'L,IKZUAH+4FPFC&0_E]AD,N3[8D0F.A,6#.LCKKZ/3DNKR%Z<.&#/BHT\'D
ML3A!&MWTM%$">_W/:) 'P\;L:&(F_2U3@7>_]L%?8-<5E*/VJ"*_-X"8P)<
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MSH*F>P$;GK$2 %9Y?54QD=7U=[-@\/>TRFW=M1<<$S7RGTVZM!&MI[KQ;GX
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MT^JK<*-+):L;X#%WS5W,_XB]X7FA_%MAO\_@]_)ZN0TRC8R2*\'IU8R6%S-
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MCAE5"8C#=2HZR*V42,\9-?L-<?$GPMX7CCT'PEH5Q9JE]=SVS>>Z06UU&QN
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MXW__  4&&?VX/VG000H^*OB;=@_>/VYQG]>"<\9& "*^*S*4?94M5\2?XO\
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MB6#@MTVD#C^\R\YSZD^^!SCI7-"4N>ZE;3_/[Q/1V=T]]NGKM^/Z&Q:6B *
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M7KT>I^&/#WAVY6RN(;0&VM]5U02B6ULIMO\ K]/ WQ^5@DIMR :I^)[3QU\
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MD \X'XU_L:W/_'M=D=?L5U^D38K_ !R_^"@:_P#&;G[3'4A_BMXEWY/3-^2
M2.I//0Y&>O7'PV9Q:I4KVT:O;YGT%7^''Y?G<^1%X0^C$8&.GW>2>F,8)P.,
M]ZO0,!+G!)"@#H 05"GUYQQP< @D\<5#'M*G<"<L", D9PN22.A![G&.1G&1
M5V!6.T_*2V#D'G Y ('<8S[< ] *\2$E>=TVFU_6Z['*YI-K5V[6_P SH+9=
MRM@[<X8G&[G+# Z'G&5[]>:Z"Q):-49<,2!D#G@# []3G/3&?<8QK)" 22BG
M .W<!@@NN!^)SVZ>XKJK&,,JN "%*@X'"G(W $]1SG(YS@].1$JB::UMK:_2
M_P#P+?H*2YXJW7OYKRN:>D1.58  [7/8C/WAR=V"<'C '. <UUUK8R&-67<3
MR<D=<'('&#@'!(Z]#D=!DZ. /,4#@2/A0,G&&. .?RX!&1G!->BV,*M"NT%F
MP<J>?EW#/)ZX.,#CKN.!G.$IN,D];6;\^NQ32>C2MWZ_+^N_<I6EE(K1R9(8
M;?X1M(Z8Q@G'&/O>V:[JSLRIW#8?F4Y/'7J.,8'WN<Y.<9[U'I]F'95? S@[
M< X(]^O &3DDXVCKP>SMK+&!A3N V_*N2PR!U&1R>,CG &>F5'%QBW>5MM+V
M:]=]]]S6$(.FX1;U5O>>U[[[Z7;M;35W&62-N.Y5P5V\#KU(((. ,#K@\#Y1
M@\:Z8\E B[V!+$8Z]3@ 8[#H1][H3@@S)8.H4G8 HP03@9(([$#'!&!C&.RU
M#)%=S2B&PT^ZNY20O^CL."2%7D$* =W7'3/7%7];I7:E/3E;O=66C=GKTZ[:
M)F^$P4ZTU3I4W4GHK05];I67J]%?K;U/FC]J>Z6T^"_C,,R!K]=,@B5U.=T=
MW#*=A# ?>4#Y@V 2!SR/R+\-:Y>:/?1S0_O(Y=L<\!&X,KG9N5"Z#>I'&YL;
MF;*X(Q^L_P"V3X,\7:9\&+[5-2TV6PT]+ZRP)9MS[GE7#;=Q8[@!GDJNT'C<
M17Y0^%$$>I)>FUAN_L^'AAN4W6TDPD^7S%(V.0"3'&X"LQQG(-?19/[&OETU
M.U6$YRY;--*5G*,G=JW*U&6G:YZ$,'7RW%QI34J%634VFG>SM>-FK-R^%)_:
M:N]+GV)X._9W^(7Q,DTOQ!H6GQ:4T5S83VUV)Y+=[MY)P(H(T52_G!&:6-07
MAE'FK))%E77^R7]DC]BOXW_LX>#(1_PD.E_&'X._%#P[;W6N26#V]GK7@K4]
M0T>9[>Z.E_;K]9]/6Y5+2^E6:-CL)18FS7X#_L&_ O\ :$^/EO<ZYX""0ZIH
M]N$LHYOM6G0BWE6-?L=D(4%M YPN1;RY*,3N_>N#^YFD?!G]OSX:_#1=$E7Q
MAX5@LX8=4T[QWX3DCU&'2;FQ598[#5[=-035[NQE*"%EL=/O]BL0 K;JO+,X
MP67XSZOFU.->+YE',(W=2$'=*A57NQ5':;>KYH1T=V?<9KP%_;&68?&T,55P
MF+J0C55*K'EJ58I-<B4%->])J2UV5VULN7_9<_9 ^%/@_P#:7\'?'"ZCUJR\
M>-XMOO#UOIC7#PZ.U\-:6U_M!;*6$,9&MY,EED(R 1D=?Z/OV8M1>R\4>.[&
M755U&TU#QWJUI&LCL7LU2[EM8[?9@#F5(L=,."_"C8?P?^&'Q3U/Q[)\+=!\
M<>,?"&H?%3P-\0M.USQ?XDACE\)2V\+ZE%<SMJ]IK=EI,O[Q8%6\F4Y^V.$4
M#>5/ZW?"Q/$$6O\ B?Q'H5S;:CI<GC.3Q"D^F74$\%[ILU^UZ?L5Q!(T;*<C
M+!UE=-P5Q(01^FY!CUB,$Z6&4)813J2P]2,DX2C)MMIWO=.R>FY^.YYDF.R?
M&..,PTX64:?M+2_>3TY8-R4;5)*[BMK;O0_6^3PAJ+,^Q6\L@-G:2VYMWR[M
MNTC:,CY<@_CB.'P[>Q,5\J4MN##*@8V\'L.#QT_ '//S;H?[4^K_  V\73>$
M?B>JR^'[U[6YT7Q#(!;O;Z=.OF.TL"J[SK&94A\S>\NY4QC+$_:O@CXD>!/'
MD,-WX7\1:5J(F)5(O/1+KY1P3:2ND_SKR-J%0!SC&*BMCL72]K:FY0BVE9+6
MUT_^'U/)I1P5:JZ:J0A7VG2FTIQGUB^5OWM=?7<R]-TR]MFC!BD)WAB #P2<
MC! STSUSP !UKT;27U*,LI1TC_N@,O3IG)8#H < \9P,GGJ4>( ;Q&"#P-J]
M5(Y!"YP3G!)X!S@GFKL-S%&KL51(NH^51E5(W=B?FY)!)X(P.HKYC$X_VTN6
M="'-*_,Y76KW4K7U[VO8^DPN"=*,6J\OA7NQ5TM-M;7T/DS]HGQ/XG\/V@.@
MV%QKMO+8VEQJNGA4OX;5HI2]O<1:23"&@GG.QYC(G[G*",,=Y_)+XQ>+/#::
M?JL=MX>L]1U:Z@AL?$+76H7.B:2+I59I839-IT\,"_OQ'.(7G+ ?+@DN/T8_
M:"^(4]YJ&KZ+J(\1^"-4M;2R?1M=T6T:YM]26\OB-.9;NS)"QVS1232/<R(Z
M!CN3:,#\=?VM_$NNZK=67AC6/%^KW\"V$-[?6.F6RP>(H+B]@#([ZE;!("RI
M 982+QR262;IBN+-,RJ83*XNE^[M+DG447:#:MS6:NTO/OY'@9E".(Q-U5EN
MM/>Y6NSLMOZZF1\(O#]A\1K;6M,U#PIX8CLO#DUDEQ!H>E--JHN$EB%A!I&I
M><OVJ--P1([B)7*%B6=B37K_ .T/X96VFU30-1U+6;&+_A#M/CM;&%U_L.SF
M33DC6UO8(FFCANV 4RM*J+&Y0><VTQK\B?LQWVL^#Y/&2Z/=^,)[;6M+_M2Y
MFO;^"RNM)_LN:*47.ID7@-W*L0,UL(%N)I=TJC:&&[W#XO>.T\1:DTFG^.=;
MOK;Q3X$6?5&DL9]+TR]CC@;?)-;7"VXN9H<9=FB7<I202.6(7Q<?GN'P'"]3
M$4Z=*OBZL)4H2M+GC5K-TX2E%+1*33;2;WTV.NG3AA\/%Q4YU)2BHN%FES7W
MNTU\E]_7\DO$>@:_:^*-#O4N-)ET^RU;3=%M$TZ:>YD:2XN\275[M@,+SSL3
M9_*%;A6#;0!79:SX*7PIXA\5ZO8R^((-10QWMEJ,B!-(673H!.UM9QR;)#<H
M\KI%=#_1B'6*2W>0&0QW_C^QTWQ)::#X5UZQG33)/M-S ME=36SW+P-)')*_
MV-HHKB *98_(>3:S"127!8=KX9\4Z;\0M/\ $Z>,%U>32KN'4-VJ63))/?GR
MK=/L>DF1TFLW28*THC$6!\X&0:_"LLQ6=RIT)8BK]6I8C,<8IJ32A+DAB*=2
MRMSM-?#>*;5KI'#16(A2:DHM3Q$U4C*_,XIIQY;JU[MWZ;6V,SXBQ67B7X0>
M'=1F%K=KJEIXGL+NTTN\Q?W%_?:WI=X\$,ZQ221WLGD/F(P(B@,=TB@!H_AS
MKGAWX):UI<NN>$+V'4+G3_.T_P /7&II-=2/>7B^4R61!1R-Y$C[1EC&9%SD
MUZCIGP\TF\;X:RZ1HMY>V=EK,J7ZP&=EU.UC1Y$EO+.W63S;NT")/<.%PXA>
M1LX+#?\ VI/A+9^*SX;\46'AG1[CQ+I5H1X;U[1KVXTM(K-'2,C78--B^V.T
M\TD=T5FMV3.U$V1X6O>XAP6$S!X7ZS6KPR^CP]'".HW&&$E7J4JLHT_9*,:D
MJBE-2G+VD8^SE!13DF?=PRW#/"0Q6*G.G16%A!46DE.=Y-23NM6I);].^IZK
M?>-/$>NZ-XUDTZ.'P[<R: ITS6;.US)H4;P(LJ75HESY=W<(K .\-S&5FRZQ
MHF83QW[/?@[2$U.359/$EXGB#3;26:XU75'BN+?5Q<J'G:\FN'BBMW5HD\BT
M19@-[*X9P"LW@#P'XK\-Z'IEYXJ?4YM<\416FG#1]'N&BT67[3L22\BLF9<L
M(6+R2RQ)([#S2JMS7T'J_P #] _XD=_=ZIJFE'2;()9:9+)<0:7?(VR2[O[E
MHV$;W*RH(XF;E<D@;LL?S3*^',5#+Z,IRA1P.$E+GQ:P?-5GAXU:K^KT%6G.
M]&:6LJE12YG*RY5$\R64T?9.HH/"X:,)5'AY2D_KT+RD[VO9M>[H[62U//O#
M'AKQMJ_Q/'B?Q!JNK:AI$=E) MGI:F#24=21$S-*^8650H".)'4 *[LP+5H?
M$;QI/8>'I/">B:=:PZF)9EMKP(WFI))<%5BO;E55X]^0& $Z;5QNW'(WOB/\
M3AH.B6\&G+ EO>9L99_-C%ZMPH\I;L23E'N9)'DAD89WEAF0%BP/'_"7XA^"
MO#5UXBT3Q*#>>*-1LK?4K;5O$C$6%OI]J6 %JUZ&ALY'EEA:,XC6<KB(8)S]
M!EG]D8[ZYE6%:PF5T;3]O-*ESN>N(BY-VA"5ZT9<LFHP<K:1B9TZ>68G#K#X
M3"RPM.%2$JU1*-N3FBZJ;J27-3C%5.=7UA&6]R_\%/!NO>)M%\66_BC5?#AU
MBPL[J'1-0O?]&TFP%TCH9IGGRYECEE9870Q@-G<').>#\._L^>&+31_$MKX@
MTNST_P#M+47LKOQ%8JMS?ZK';&)YI;:[D1"EO-*0860A6.<J0*X"Z\+>.OB_
M\9=-C\#ZQ++I>Z"R\6II>H?9]!C U%YX)9[42QPB98&3S$50K@<*</G[Q\7?
M"6ZFL+?2/^$ST_4;K2(46WT:*;[,TD^5#F18V"2HI4F, JBD-G.X!=\XP65Y
MIAL,LN]A@\)A)4\-2Q52G:EBJ].<$HQ]NH/$1<HJTXJ4=>9-VU]K!8&&,E5G
MAI9=3H8:C*-*IB<#2A>4(/EFE6Y*==74>1TY3M-QD]$SP7Q9J4B>'5^'O@3P
MR&\.Z9I,FFPZG>2!+B3>H,L\SP+%+-/AVVA'5$/EE@P+ ^.^$/A/K/@#PM;Z
M+I.L:/IYT^^EU%M+LY5U/5KK3KQ?MLT<[1_95,DKQ_O455,+D%]R?*/L'Q1\
M,99/#$6D6'B.'3=8;3ECEN(79Y1/*^!#:O!&\2/O4'>\H+8V$ #+?#/PE_9U
M\=6OBKQMHTOC7QAXOFU+409KN6_OM+&DI),'VV[S2H@A$F()&BDA63S"K97B
MOC\=DO$.+Q%:6+E4I8' QC&<Z5:E'+ZE&#C)NK3BU*G%TXMJ2C=RM32;EJ8/
M+<^QU?#.OCUBZ4':<Z,:-+V-!5(J25"BVFK:)0YI=+6NSM?A]X_N_&7B/4_"
M]SH4<*V,8OY;W4)-]\!YP@M;:6W*"**1DA#K\SELY"[2%KW7P[8ZK%XFGT#P
M]HEQI]_J\MJMQK"V4@2'[1+' [GRF3S(XH7DDC0%2957S)/*WJW3VO[//AOP
MO:2ZIJEYI_AGQ=H?E3ZUI=Y>!M0U.2VA6>UU"*0L8+I9XF9H$=]GGKM#+U7U
MSP3%JEM:->Z1?)J]_KMO%!8I+]F\R*2</'*0X?,7V%"TV^ .X"9!W ,/L>#\
M[RG,\SI8?AW'U8T,+2]AB:2P>(PU!58I\].$Z]&E4JNHXR<*BBX2CM/57^]S
M%T:.'6"P%6:HPIJ4UR4TYR5E-UDI>UIRO?D4XQ<HML_-_P"(W[-O[4?P9\7>
M,M5\"?M"_P#"P[&_A@UJ?2]5FCMG4W,Q9].@TKS[Q)6L$7$8$\0*AB4Y#5^A
M?P.^&_A'0_!A\=RZ=:WWC77=+BG\3ZE);P:;;S:I=11B]0^6I$<%L6D"\JPQ
M\Y?J/G?QSX?.EZUXMOK[5%F\11S6]NDUS=M.MFL))=[2+4/)FEV'>K& R,P8
M_>C!KU;PEXDU&;PKJ ?4+K4].TVRD>&;:\6GW<\D*HT<EJI"+&7)41L K$;M
MN1FON</CLRPF+QT*N'C4PL^90FYIRI:/6JKWBF]8J/-=/OH?-U\OQ3GA:V%E
M3JN;C[6E"4GR1NDI335ES*[=KK0\Y\'^$/"?Q*^.?Q&\=ZXDPT_P?IKZ#H-M
M8Q-'IHN4B#3WRP^8RW31R1LHN%V*S<A23D^7Z9X)\#^.?C+%+I\^JZM!X?NT
MB?37FD2U-_@B.>[*0M$! X9T2-8BD@^<R8P'?"[XJ7]YXB\?6Z:'+)%;QW.A
MPWUK]GMH)Y)VD,DB0^?&))$8LH.W< O!QD5L>%/$'AKP;KMMX<NY[OPSK7B?
M5A'$)K:_AO[]V+,;YKBV@D@M[)B3(9IYD3##YL$5M1PF"Q-7#8JKAX3KQ:JK
MV4Y\DHRNTY*2C:75Z->=CT%A*4Y8AU:%#GM[/F;E\4;)OX=K[6UMT2/JB]\2
M:Q\,HEO=>U>QMO!,-TLNM7\LDH>TLR0ZQATCFN MO"&/,);.0<Y-=UX0^*'P
M>\=VLNH>!O%&D:N]S=)()['48YKHH9#L9[3:EQ&6C#;86197?)$J %3XCXB\
M;_"_^PM<T'Q9J^BV^A)I]Q!JNH7BZ1J#W$42,L@N626;8)8RVYY&R!G#"OR8
M^,/B'X&6=W;S_L9:] WQ=E@FD%MX(TBUGLKYH-T<*:K<1M:""/<T>\Q$MG!9
MS@M7IU<8U.5127LJ<FFI/EO[L[N\K022;UDX_D1AL)1]FJ:<E.S47;E@W9VN
MW;3?4^U/VZKCP%9_\(]JZ:[I?AGQK#?QW]QJKVHO;ZYM;82[+>\2WN;:1//1
M8E=90S-L&TIM;=^V/[-6JQZW\"OAMK N(9AJ'A^WN#<PQ&%9]Y8[EB9Y?+0D
M[55F=E&S+.Q)K^:?2/A=\1?B!X&TC6/B[HUG#XMNH0VI7>J75O/+<3B,K*8T
MCD80)&"%5#\_SMDDKFOZ8_V:?#L>C? SX::8KQ^59^&[2$+"=\8"EC\A &1Q
MG!)ZCD9X]'PJSVGF'%6?8&C6A4HX;+<,U&$E+DESIN[BY15FVGK_ )+\NX\M
M&IA(<[DTY72NUI=73V_'TN?3_P /;GR?%^D>4N\M(@&Y@0%'3A0IW9&<ENF!
MCK7VBIOYF&6P/G/W<$'L1D\@COZ?7-?'WPYACC\8:3M5"/-!W;0>A^8X8=L9
MQC&>0,U]N =_J.@'&>.@!/ &,Y]J_4N)U;'4T]U1C^6WZG/PK_N53_KZ_P V
M17!Q;79STL[K_P!%-_@?R/I7^.-_P4%5C^V[^TMU4'XL>*#GY@H_TUN.PZ_S
M%?[&5WGR+L#K]FN$Q[>0['/ODDYSVZ]<_P".U_P4'!/[:W[3@ R?^%L>)C@=
M<&_D /ODHPP,D8R0!@U\+FDW[&F[+[^USZ"OI"*\[7Z]K_B?(D0)! !&>>A_
MNC X'<_3C.#GIHVD?,; C&TK@]CM;C')X)SVP!C!(%5H2<;<$!LY)4G&% YP
M#UP1@=1R.Q.E:DJ0H )50N2 <G#%B2<]OO=S[\ _/J5KZ;^?J<2I+FYG)];*
MRW>RU??Y^IT=C!D<')P20P!'WGP<GT& 2. .G4,.MT^/,7RG[K9/<': 6YZ8
M/L.@R 0>.:L#G+D!2-J'LJ\_,!T!]25R03D BNKL!M 1'!4L.,@=2HZ'GD#T
MSTYP37/*;?E97T;\U;\"XW6CZ;/N=%I*NN]B ,GC"<G/IUSQDD#)QGYJZJRN
M)Q(J*VW:.6.X @.F1ST/3U_4BN=TO)\SD?*,#!SP%(&"#C/('K@9(R:ZB")7
M*L""%YSD'HX"CKN(&.3]TD9Y)K!U=&G9.SUYNZ:ZFBE96LGUU_X9_F=C9793
M&Y@20,G(&#SG'?&2,#/IGCKZ'8W*.@DX)_=X QT!.0",]^OKWYS7D<<$Y"%3
M@#G)P#@D DEB&Y.>N,\X^6NYTJXDB0HQW D!<C&TMDY&0&XW ],\9&0.>.K%
M7<KWND^GI^@HMN=[VN[66RT^5[]CNIYLQ813N)SC&2,[LC&"?O<9 ')Y_P!K
MIO!>K1V-S,TT(W[@1C'R@$'//IG)/3WXKE+#?+OSE@(P >IR"AR%SG@X.> W
MYUR>MZY?Z'J0CMH9")& 9A$YWH<$CY5)SC(QU[' )%1&*DU3DDDVKROKRO=6
MTTLVKWW/I^'\5#"8Q3;3G+E4(M>[SMQ47?5Z2<;Z=&M2I^V_XML/''P:'A:Q
M=VU2\UG3;+RUV9#-<(J[=X *9*AB.BG@C(KS#]CG_@G/%^TI\7=&\*12:AX9
M\&Z/%;3>+M2_=7?]J:M:RAIK+3-C(J6$NPQR^:6E#.0 &7!]E^)UKX9@\ ^'
M_&_B+2YG-AKMI=>7#%_KKB&6%H4ECQO,9<+OXY]<U^S_ /P2OT73AKUOXEOK
M:/2[>^9[Y1##Y,;->SB?+IM .P'YFQMZDD#&/5PV*JX; NAAYPI7J349SFXQ
MU3NV^FE[6WE9=6?M&0Y%@\ZQ=;&9C2A.6&H>W48I2YO81=94U>VM1T^1))N\
ME9-Z'ZD?L^:!^SE^R/<Z-\-8;WPQX5NH=/M[:QTR^U73=*O=15$CCFGMTO"'
MN7E,:[1%F7S2RH.4S]_:1^T5\._$^BZSIW@C7[34SI4LFG:IIDL,G]IV%Q(K
M!TO+.5C-'&8U:2.2<!&0&12!T^*_VXOV9_A=^TGI/A[2['6? Q\:1Q))IZ7U
MX;#4GNH%4JMO<Z9?6-Y%)"T;ESO<2R20DQE8R:^2_$H\,_\ !,SX)Z3J'Q U
M^7QU\8_'$UII=I%,P:9](M/+(N-0N5 (AM;9YHY=2N/F,3?-,\FXGR?KM2AA
M\30=\15JJ:G5E",H2A*Z=.$KNS4FI*2?-96MK<^TQ>!H5*F&S6K?#8-T:%3
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M'4_%ES')I!^T1:EJES+.UAK&L >3?,DD[V5M&/G6&*U0QJFW/EYEPSB<KQF
MPO#$JF&H+$QEB:E7ZM6E:4DY*56;I5E&FG*-.$(3BHZ.7-:_IX7#)8:I4HP;
M5>/[S$8R;C5JZ-<[E=\_*FXJZC:Z6M[KE_C_ /&?QE\5/%>E^+O#?@RXTVT\
M.N\R2P(TS:E'+(Q+,J703+(_R>>&!4;0,$$>T_#'XG21?#K4_">L1:IX>U+Q
M(WF:-<7%U87MW=)J#_*K69>5X4MRSG# %54%<#!K[%@\%^&_^$-TGQ58Z%;:
M=H5Q;"2XN+@1P6]M:LO[I[Q408'E@?ZPA"2<G=M%?'DGPL\#>*?B-!\2;/Q?
MH_BE?"MX]NGA[0YIR^G3#(BW102F&09Z,%, (.6YS5U\FQF"JXW$U,U=:=:O
MAE-WY8<BLN10G).UKIM*TNE[73P. E*&+K8>N^:G2]^I.484VHJ2Y8-2?P[7
M6KWW/K'0?V?[#P+\++>7P_/;'6[R"'5-3U>\@CD D=FN)=0V1VS2+,&=D\D3
M$N1\J@8%9'@'PWI?Q"OM8M_%EA::["EG/I\GB8:;>:9=1V4,7E_Z/&S+)YAV
MY$RK&S'<Q"G<*]5\0^+-2L/AU=:UIEHAM(-.5;RRGNH0J6@!>Y>2%XYLS*!(
MZ1,58#"Q@C&>2^%_B33'@&N06]Q=:;J6GL-.DM[?$5@5AE.;K8JQR",NBL""
MQ.<+P=OV^'J48U(TJ>%K)4L/3<JKBE3J-05W!QW@WK%]4T?/SK5W3<W4Y*2K
M3ISJ0;F[QDUS0YK<R;U3>Z/.-:^%OPXNM'OK&&V\-C3M+M[S3;S3$@A%[J<$
MC/'&=2EE)W&--REWW-('."3Q7YO>$M$^''P;\0ZM!X8\'Z)X;E&K7<B7M@8K
M626TFE+Y-W"BS2Y?!,2.02 O;->R?M+?$:\^'VHZE8ZG:B0Z_--,VN+/)9JM
MN7S#:P1(1 XD5L@?ZQ> X5B /S@@^+GB_P *^(4\0R^$%UNSU&Z4:!8ZW;->
M6DOEMS=-"$+B(L-YEDV@CD!@0:_(N,L\QV:5,5E.7R^IT*D9JI*=Z6(E&4;.
M,%%)*5K)-2OO8SQV98B4%1A-2HM-5*B7LZG(T[N*BG9Z*UG_ ,'[7\5^-?%&
MO6RQ>"](EUB&625=06W:Y15>1&WMYDA+(H ."NQ=_.<&OZ2?V98[J'X#_#**
M^@>VNT\.V_G0R.9'1RTI*EV^9P,X#G.>@.  /Y"+WQQ\8?%#ZGJUG(VCF[(,
MEIH<!L()B#F*WM+:!5,D4.YU# ;F#<DX^7^N/]DDZBW[.?PD;5PXU-_"=JU\
M9-^\S^9(&+[R27( W'."?0Y%?=_1YX:KY)G.?5ZM:-7ZWEN%E*\W4J)N2M[S
M;=M6W>W1'YIQ)3QJHX>=5WP[J>[SJ]2[<^1\[][O?OZ'U[\/>?&.D=_WJ_\
MH7-?:PZ?BW\S7Q/\/./&.DD]#<*!]=W2OM<,H')&,GG<OJ>HSD?B!^HS_0'$
MTN;'4WM>A#3Y(ZN%/]QG_P!?'^<BI=D>3=MT'D7!_P#)=P?R/7Z&O\=S_@H
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MY2><8[]QP<< ]QVZ5QMLV2SDY&X+@C:.%V\]QC)R!CU %=%"!Y>X9^Z , ]
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M[)-\1B'[U.2 Q" ?>8$8J))(M-U*"+4;-KNSU)E6V>*W:.2,/@^5< ,\;#&
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M -F']DSQAX4N18>.O%=EIVC:C:7"_P!FWD4DNJRZK(X:]GO)KD^7!/<*5\T
M,!Y4>R0[B1]@:GX?NET-M=ENH]$O[W36N=&UZ2QC=+4K&7M98Y9(O+F=-Q52
MJMM5_.&"F:^5_B/\7/$-YIC:N_BGQ#XJU+1[.RMKV71K2[6WU34!((I;F,)
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M9Y."!TY9R4G.VEETZ=//7O\ \ #LM.@9V!"J,XR=PR.#Z+QD@CCKSQV'=:=
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MJ[:1!HVO6]S8:CI,CS:C=)9F,&)H9@71XIH_*PORR*,$@$XVM+M?$N@>.H?
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M2."2N/O\C@ ?K=\++M-7^&/A"^B/RSZ8LR,  0BSSKD$= 0H!Z<<'IFOZO\
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M9LD+,A*X.W-=T>(L'B,[P^$R?#K 8:G*E#'\GQ3QJ2Y\3LOW5:+45*_V $5
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MTOA9\5/!DV@6O@/Q#9:UX?TI==&MAHYS+9:9?!X[A+=P[*XA+_NP%!38V<Y
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MGG_@( .2<Y)'-=18SHJQ@E00AQGTP,<GIG(/'?/0YKDX6ZLK X"@MR03TST
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MM>VB][9WU6Z/E)_!6KV6LB_LKBZ73XY1))IZ2,-\F1N*QLW.0 !M0@X[\"O
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M4\PQR<%0H3?C@MS7%?%C5=>M6D:VNK^WSO/EQ3OY3PAB%:21#G<R@9506R<
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MO!OCB]^(/Q0U;5M0L/#1\/76CLNF3/;RK'K,%U<">UU.2:">VTR-M.B=89I
M?/E0B_B26VN_IY"Y8]OZ^\^&?AI^Q/\ M+?$KQ?X+\-P?#+Q/X;TWQSXCT;P
MOI?BGQ+I\NG^'+74M>N[:QTL7VH@S106]Y<74,,-V2+:YN7$%O*\F%//:]^R
MI^T)H%[-!_PJ;QIJ]A_PFNH^ =(US1]*>]TOQ%XCTW56T@VNBRA_/N$GO898
M;>2:W@AN)QY5L\K0W)C_ %Q7_@KE\)_A)J?A#4/A/\+-=\::C'\/?V>_#6MW
MGB;Q;<6FEP#X1:MX8\5S6UEH<=K>6@U2_P!3T2XTF6\4F<17"7C2EV\M>3\-
M_P#!9FTT#QKIGQ0A^!(F\:?V_P"%Y-7LYO&VHR^$Y-%\(>-O%_C#2AIFCMIK
M1Q:Y/-XNN[&2\$"LD5MYWF,2F(>'A%.TEJM=%M]U^H.":=E9K^O^'/REUK]F
MO]H3P]HGB7Q-KWP:^(&D^'_!TDT'BG4[[P_/;VNB7-L@-Q!=R,2IEB?AXXU=
MXE>'S_+\Q:^XOA]_P28^//Q)^ ?A+XX^'_'?PFA;QUX0\6>._!_PYU3Q!?V/
MC[Q%X>\%R1Q:[>:9I/\ 9$EO)]D=FWI<7\&^,+)%Y@4K7M&K_P#!9?QCXC_9
MD\<? 76?A=I]WK7BI_BG;V/CE]?NY-333OBA>65S>V.I(VEQ_:9='&G1"&22
M0F\6;!<!60[WP3_X+(#X._L_?!WX/GX.WGB:3X0^!/'O@9=.E\?:EI?@CQW%
MX]FCGDU'Q3H-I8307-UI++$^GV]S%Y*W$,D@D5VP<H4L,Y25T[:O5^?]Y]C/
MDEKUU\M--O->9\$_##]@#]IOXHW.D:7I?@"_T;Q#XFU;P]I?A'P_XBAET[4?
M$<7B34K73+;5K"-HY(VTFVDN&NKF]:9/^)>$NH895D5'D\6_L&?M'^$&TNPM
MO!=YXL\37T_B2'5O"_A..ZU/6/#"^%M2N=+OKO7(V@@M[>RFNK1X[2XCN)?,
MVR;L, H^FD_X*N^*4^)UW\14\"&X0>(/V?-6T71)/$5W%%HUE\"O^$77^RM/
MF6P8VMGXD_X1A?M?E"/[%;WS/&)'R:]O\%?\%HM+\+:E;PVOP+@N?#\-SXGO
M;_2]7U^;6+35O^$G\5ZKXGDMM;L;ZV2*[%O<:M+9V$SH7L8T\^$JTA(J-*ER
MJTDEK;?N^M[AR2[?D?FK\1/V3/CQ\-?A]X'^)NM>#M3O/!'C+P+I_CXZ_I-N
M]_9>'=,U'4]3TE+;Q!-"/]"O(KK2+Z*;(:WA9%5[G!+'Z;\ _P#!.+XJ^)/A
M#H7Q7F^(WP<\-:YXO\'3^/? OP<\2^-X-*^*WC3P?;P_:9-?T3P^UO+%+97-
MK)#<Z=+)>1&\B24QCY!G:^(O_!4'4OB%HGB_PO%\,[30O#'B']FW5/@#IWAV
MWU^YN=+T*YN]9OM8C\8V%O+:LKW%B]_+%%9,3&K;RA <UBV'[<?P=UCP5\*&
M^*7[,=EX_P#BW\%_A=8?"CPAXOF\<ZM9^'+_ $O1+:.WT#5M;\.0Z8UI)<:5
M9I/ ;, )=FX3SI"5!KCKX>A*_,TUK?O:SN]]TKVOZ&;@M=-=>^^OGW.J_9=_
M9=^.?B?5],\/P_#^_P##5SX_TO7]5\)^(?&%N=+\/7-CX7\/7/B35I?M<RNS
MW$>F64\UM ( 9BT3!A&X)XGQ-X&^.VBW>I^%K;P-XLU;6;:ZL(KO2K'16-X+
MK7%C.B0M;@))$^K)*SV+%BTD8#;0&&?M/X=?\%A=+\ VUUXLM?@J@U;4=!72
M/%RW_C34)]*2>#X9R_#:P'A*U&G&/3A+!)!JES"B1K(5=)%.XFO1O@Q_P4R\
M.^-_&6O?%&/]GZ'0/$'B=_AK=>(M1F\57MY:WMS\-K.RL;*YTBUEL8X;;^U#
MI\4DSHJLGVF4$$*<XY=PYAL3BHXCWYM2?L^>-HIR4HINUN^E[ZG?3<</0YI+
MWY1]R5W=>>]MF][^ESRO]EG]CCXW?#^*?Q3X[^'/BC3?&/B^[TBU-[X@TV:*
MU\,Z7?R2QV+37 %Q':6ZS"Y2>YCVJ#$RS,CNBGFOVA?V?OCUXS^)'C;P%JGA
MQ_"VC?!SPKKOB:QO]>5[73_'LND:AI6FZF/"S6_VAM2U*:\U2T^QVTPBN8D;
M C!-?;WQ4_X++:U\.?#OANP?X=0ZUJ<GPQU'X>6\5WXDN8_/FF\0ZAX@E\27
M,BZ?*8[R%=1M+*.*3C;:C:5P2WSOH7_!9_3O"\GC&X\/? =I6\?GQ5JVL+XE
M\;WVJRZ?XD\3^)O"WB S6'G:;*T%C:OHTL+Q0E$E-T2$S&,>]G%6DL/'*54Y
M%126(BE;VCY79-KWDM=DTGU5T>8H<\Y59^\KNU[Z-Z^G_#]#XOT#X.?%[0M?
M\$:!XV^'GB#P9>_$'Q-H7@[PW=^*[-M,TZXUSQ%=VUIIMO)<S86V.+E+BY28
M)+' "^S ./<_&_P.^./PG\3^-?#^O?"KQ1=P>%=6U32;G7=.TR6;1;M=*U";
M3)+ZUN]H!M_.@:0DJID1X3$#YR$U_CE_P4GT#XNZOX1U32_A9>>'7T3]I#1/
MVC=874/%=UKD-UJUBT$ESX:TD3VV;#0,QDHL(C$#R#9%\F*^P_A?_P %</AS
M=?&&/QUXJ\)ZKX.\)V7C#XD_%3Q7X>O]:E\9CQMKGB_P[?:%I_@JWAO(=NG:
M*G-_$P(CMYSNCB$S*3\[0PU*',W7J1MRJ/LTK*,4_P"[96\]^KZGH4ZCARI-
MJZ6FGWKS/$O@O^S!X_\ VD;WQ%\.[7XA_"OX->.O#:6FMW7@SXM:_=>&?$FH
M:#96PU#5-6T^RCT^Z9M+L;&6UN+FZEE0+'.HQN90?0+'X-_'/PCK,FC>#=%D
M^)6DZ1<SQZ9XS\"O_:WA+Q1#82!)[[1[V:.%IM+"%HQ<W"I'YH12P8C/YO>%
M_P!MS5_"_P"U;X\^.VJ>'9?$][XP\(_$OPY;V#W3V\VD0^.HH;+3'BN%3YGT
M:RM[&!8AM5HUD.<GG] _V?\ _@JMK7PW\#Z!X(\1^ ;G6?"R?"S6_AAK-G'X
MGO-(O;V6^U>QO(O$-A=06DS6NHV\ELKJ%EC>6,2KDAVQW4Y8=1E3=;$1G&\E
M75T_>U2LO=]W_#UU+J3;:FGJU:Z\EII_P+GNVFZ9\5;C1X-1UWX=ZW#JMYJR
MZ+9>#K73IO\ A,(O-MWO$U1H @\C3_+C+3%G)8 NJ[,FOEC]HF^U;1+FPL/%
M'AB_\,ZO \=Q)9:U:M9ZW;-]E!MV6.095;D 2+,@\JXSYBNRG)^F/$__  6$
MT_Q)KNJS'X4/I-S>Z'9Z=92Q:[>74]C<6GAC4O#:7)O);.-W<MJ"SB<#<3&&
MR2@(^"/VIOVN(_VC?B+H>NQ^%XM)NM&\!^"/ [O+>SW<5\_@_0++0SJT\\BH
M2UY]C\\@KG+$G+<GQL[G*> J4HXFIB7)*.K49.*V3Y%!W2Z_B>?B\17]BU3<
MI5-H.[T72RLUU[,YJY^($MJMOJ$]A>"SB'E%5<&;YRNV655!8!.&*KN+ ,*Z
M.U\7Z:5-U'=Z=>VDTBW,\C(7FCN]I/GRN7W(L6=K0HA"G&.*^?+;Q)<WT=Q+
M-+;Q HBX3;,@B9RH."-QDV\[V')YR.<<?]@@TJ99/[5U.2"Y+7,\3L((/.)9
MB(RA(5&!4%<;>?QK\[CE_-3K\\E&;K)*T8IWUTV2Z:Z?H>!*$ZSM4DTW:RV;
M?37_ "9];WGC"&34=/U*?5[Q;>:-;9;*U9;F"X*DLLR[4<6\9SAU;:SJ%!.%
MQ7'>/39ZY;PZO-=03QK=8CM8CF9$M2LKLT2MLC)#  8R#R< BOG%-:DL?F@U
M0)&L3_N;9IY9))0V2A905A8*5 )^]N; &*T['6=>OVMI(8991<'=-'OCD>(L
M?+W2(0%VLD8)W9<G/L*6%RI.M"I%J4H5(J3:3T;:?>VV^_9FM#!352*BVF[I
MW=[Q:]Y==]-59KNNO2IXNOM-DU#5[>UE-F\L0MXO.#-+;L=KHD>U&\Q6W.S-
MO95'0BN'E\56&NZX]C-J=]IE[>1O,L43*]F,$K:N["-D@DC<%26(4JQ=R%'.
M)XZ\166FK::>T\MI=RW CEEC;?%9J68O(R1X8"1<J=PX.=ORUX3J6O:CIM_?
M2^&[B.\9KAQ<+Y+!&@0KM*RMN8"0L5EB4_*#N(SBOI*.5\RKS7LU-2:I*HWJ
M]>91;>]N6Z[6)G@I-3C&]XU9)-W;LK:7;=U\SV2?3-?G\02^!$O+J\U#6))-
MK1Q%XQ'YB!(C(T1\M9(SN>>/:.B@,A.?IZQ^#4NAZ9':K90-+!83P7.GZD1<
MM=S1SX8P*T@#(I?<CM@HZH5&>#X'\/?B7;>)8;>.98+?QEHSVTYN[L!)KVV,
M16_2*Y0*\44?RK#"0$XVY )S] 7WCN=[TO;:?.;Q;47R,\_G/,)&$D\%N Q1
MVC(:0J_12#@D 5XN9SS7EI8>$51A3FERPJS@IJ_QOEFG*^JU;T6MSOI/%4XT
MZ5%0233J3FTI7TNO2R6W=L\-T".;P[X[M/#QL[W3;V[UY;B[N([AX]]B&+R6
MDJ.RI(@C&#YB$MT! KW76_$G@GPQ)=IIMC>S7FHM?BQN+&^6."65!OF1@2T,
M3;LK(LJDR."8R.E>2:GKW_"?:K+XCU%IK2>&-H+:=XE@E409C\L.H5R_RE=P
MR0,XZ8KP7Q'J,RZBEO;BZNEAE,OV-=[BZD) 9F.XE25'S$'DD9!&:RKY?2G-
MSKJK)UJ*GBJ*E.=.4XQY59N3:]V$?A<5>]];M^CR04IJ48\LZ+G746U&<K6N
MFFFK))>ZXZI^9]*:I^T&WB'15\"R^&(= NY]'N+>VU/4+B.U6^"2M';20W;+
ME)IY 3(4D0X)DV]J\R\>CQ9X>\BX\&:IJ5WJT:PR:Y%I]X]W'+&Q&-_E,T<8
M0$D%2=P)W8[>;?$ KXALM*O(-+O]-%M'!:W-K(\3PVUU+!(!-"QG$T<3.@<?
M*!&W923CF_"&L>)?#5YJ$=K?7$MI=PV\#--(SM(\1P0-ZMC=G!VD9)R>P'?E
MF34OJL*V7?5XTX3_ 'F%K[Q@FO:N"DY-R<>=I-M7LCC664)VQ%)QC123<%&+
M=TKM)R4FWNEK?F^\^\_@%XPUG4+N&3Q1=V4=U!%&4A54BE,2/AS*H^9G0J,N
M5^5B03GFONF^^+FF:'I&])(F14#2-$@W$*3@,%YD+ D*2 000/O$5^1O@77;
MFT\4Q7/FRE[V!82BME8%,_S%L#@G;DX7G/.2./J2_P!6MM2LFCM9D:80^6W[
MPLCRC.=RG@&/!V\ \MU!%=2H4HU:JCAJ:]HXPG44;6CS*R6J44W:/N\MUN[7
M1WTG1PM*^&I2C4FNL(M2OO=M-K1M]/*RU/IS2?'5OXH>XE759=+CDC:[M'F+
MQHK(,NKECR6 7:3D$8X..=6#XH3VMM/,;JVN&4I#- 9(_,8)CR[@%&R^#A@=
M@ /!]:^$[;Q;KNC6DR[4N(HY"J.6!:/')5EQB6+!X#'!.X=%KSF^\<PPW5G?
M-=W-K#<W$EM=QJ[;(I9)'*\!B5BR=V<@ ';C  '%_J_B,5B*LHN]*F_<BTGR
MQ>KL]6GTO>_2]KDTZ>(D[PI22GS>T?--WC9OJW;5)KEMVT6C_46P^,,UX53S
M/+E='B68!71@%)RZ+SD# !(/08SBDF^(WB2V*2+';:G;QS;'GC\IY8XY#@EX
MI-SIC=E0H..,D 9'PCI/BV:V$?D3Q3QS$/;7]M.-X) SO&3M"D9(]..IS6K>
M?$74WNC'-*L1D4(;A7VA@/[X0 !GV@$\DD\G!-;X3!U<%BW&%XNSO+XK):?:
MYE_6GEKA<?5PU*4G4JNI"HU"-E*FM])N496=UWV[GUKK_CWPD)&U*_;R=5<
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MDHP)**V.A".Q7& 3SQ@9/.*XHZ[J-]>&?S8Q;J59B#E)U4<A&Y&YOXEY)(&
M37"6^MKK<CQ2VUI/;*-S75N5RY)V_*N!V/3H>N2>1/JNMZ?I%FLD29CC8B.V
MW^6R;1RP&>3D9.3@[L\<$O$Y72K-XF4%)14I1IN_O-4YZ;WUOWZ')F<Y5<0Y
MQDYI)MM]%9KI9+3;3;0W_$7Q+N?#=K);PK"K2P'9"H7=$7D3>PC?>DA^5"-R
M C) /.*_NR_8?U*2_P#V0_@1=KEI[KP+IK,_EH,!VD<_*J[$8EB,+C@*>YK_
M #Q/%UY:^)[>:\L;AXM12-CY+R?*JAHP, G&"0=H R>A&,5_H5?\$^[>6/\
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M8?$)?$T-QJ<7]F7&GWCV&G'-I;MJ:V(!M]3N)X;I3:7 7>D9:2)6! [T2?\
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M)SP!P,'OR3@,QW$TJ_(?W<CQC=O;9(4+R*<Q.S!MY,/)0Y#*Q^5E7@)PB_\
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MU>02N?O9] ?KC.!_J'?\$Y-P_8=_9E\P;6_X59H(8,>A\MFRQR< YZ^O:O\
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MCA><],DUBH2RALG)X #$ '=@'DGT[Y[TXJ#D$9!Z@]#C@9'0GWQDGDDGFE
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M:I\7-=NF\-_$/QM;?%7P[JOC^VUS0;[PG9VMC!X";0+NU\,V*:HUQJ7]J_\
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M7?U;_"B)@I;+*>8O8PS0ZC':8VNZ%/9.C)1MN!@B-?_,S-B&24F0VQ&1+;$
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MZP'A8Z0X^H8)CZ9HGT]_3CR\D;/C?MTU911BI&-%2XMJCO3I7^-F+2JCD8B
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MLXTRJ-RF.H019F?-IFDM]P".5?E3F V=#$S7WH-UKVMQ,5F2-36YF./6 7;
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M;SZAHE>><4:<#KH6NV_.KC/K]2+]Y,J0AP.W1$>#\!1>(I0,/'KO1][4D9^
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M[#Y741WP%]X3X!C]R:8_>.9^\)W^Y7^MJF1R"*)0E-P&;_BUS^I"N#MG.OZ
MB\G^0>Q^YM*MG6V#2")W<:X&@9[F>JNQ \/X9O-743BW1I^IQ"^M.RTDD;5Y
MGN&P"]?9V.:8RAK>1H.H35ZSK69TG1;;^0@-6(1D<G,_@Q&!G?I$K7 B<I'<
M3\F\C+LYWJB=U3!5==K3_(NX85T!)T@T<)>-MSW<Z?=N8%YBI-6Y5%T;O!%%
MN@VR,EQ&EL(8@C_.,#;-.AY=W'/8UD761\@[2.9D'# G5_ 8E.^U>.<%X7.'
M0!5;5O9&ONMWFIN(;&64^E9DAAEV]JA9=$=;Y/_SB(,N>XWVK/$UMM0EFKR[
MWTL7+!WE1,*:X^+7#K[^TGBF'^5-'Q8@R'T:ZIZ)8T?_K(TQ^^ ,.EBP:K*\
MN&IHMF22I%6K-.J11#Q>=# @R$;IJF0J[SPO348^JEHSO=R]1I?,=9K??%Y8
MEV'[O"[)V=0_;L^^(,.J#_WYF0 1CY[H@"S@CN-8>B.Y04\+7Q&Y7MHCV.#&
M'&'CLCA<I/KE7":55XA3M89[)Y'3J%Z?F6>?(1S.#P*>C@7..BVKGP?T+"R
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MH^ACD^;*C.#5,SVNL^$H/)J:**RNE14'&@+K'Z)YT[X7)U#41Z-*T_N ^T<
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M0HM")("QI$*T::))@$5#DEW#%)(UHH.T[#B@XOTT7W>FNPQO,4$"(@98!:'
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MDCQ@'SX"B KG@*\W[NW[6SJ"RPY(5[J=_-T*_R6>*;U6#0G<C%=:Q#A_X4Y
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MBJ'U(!+JYRK2F$M>T2?F".$8P3AUT";5U'$Z*\FR(HT#_F8@)MO]<V3CG4;
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MX76/N>79LU(XCY,9B38IXH+68"0J5_<E'[&+SLOB$CLA'7/RQHA?D/8UG;*
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M)%QNHTU0OBE(]QA1VC%VPLE0)<OH2$,[S>PR_+9>O@SR;7_P)(J_J&E<M0_
ME%#\%E-(7Z@QG4#7CJ:E3'E7IB$;%46G81XW(5BF1&,A]I'?)Y'A^V&4=:;F
M=-UIG?T=M:A3H7Y;./Q%::L#9A4#Y-L5YAZMS#C.\X9KSTOE^X5(4F4IRWC[
MDIDSFVSGSC:"O =X"&8ES0^5($5I'K<,6!9K"!KX$2"[?[.7.0/-CT[\)'P&
M**?@QMB&B:XVBF(&3SHR@6\HA:@Y*[&4KKO-UV<2XM]*N,WG%PT7P+"W4O1^
MTB;,W<>,[XAX+-<Z>4PG/4!\_<I$;!X!A_?BUF*4UUVYF-^9[C7.MH+\#?B&
M!PR,*"8*S4QS*46/!(\%(Y='E2L9%V/?EVTF3]9B84(8TD)$83&:PY1YV2_*
MDC@\/2)=]'Q;Y?-2#^8J5#5]!W@?5F,> 6^^@A_VI+/HIW/]LV>K7@,L8M&&
M@;&*CMBN_A,6Z@HK>)0'BF+'E]N/@#AHDLVV.TZ%@F]"]_%L3.&'+RG*GG?+
MJ&64HW3O9,H%*"^]^74B"Q.BCH<0A]ZL@E!<QPNG:$SY-:D\/MS$(,</U=IP
MUA9E[HHG*G8\X?V-R]&=$E-WTZ3/:-43\X+55O('\'*<#VP;J(=!0>,OFO<,
MVQ6GD?+![WP?FO%O:@@A):+0K^]#<@@6N_HG>R3/C+:W?$EF<T$?FP?8=DZK
MNCQQF:CL+!</F]JQC";)2_Q(0J(N\'H#+-!]UQ87<C%N0Z9W>N80H$8F4\+0
MDN2)]3".=GCN\-\VI\$%R@FF.1ETUU5<XWB!'R4R%WLG49Y,L'RGPQ3:JP0'
MQT8ZPQ#][3B8NSE3O ,#?Y!?3>D/C_,F4E=7>T(A6WK,0&*3:2F!P+.-P(PR
M(PJ4V]J/FO.[]9OXO@\?DWMBA-^SD][R>(.,?[CB4([[/ O%C')>W,CXU;Q]
MYTASN2=I>\P0-RSSWB5SU;JY6TOIGV] VJPE! /08/;Y$[V Y?V6+Q8K?8@K
M%MI(>JJ>"]+(26/0++U;C@\:V=[XECWJK?$/:MIK K*%69>4ZK!-9B-28X)X
MES0/LS^^) F'P>-XY2%3)\>"N[.AB7KXC.+;0T5=_&R][A\]XK&5*1G<@2AO
M#HJT#%F@Y4;<0@<  #)]2U0I H7"?HA]Y=)/6&^L>@)UM'WUG-B,I6Y)T7&?
M[3N+&.,]&E<;-%OTUO0P[-UQ\6V"FCWP1B7]_;>Y>PF562%FR/&\9.)=U-_Q
M$O1?F(&3)Y2T:/1O*8=V6[8H+/^(?N7=+L; "/D"PY&4%65,(_9)^[\ FD!E
MO] $)2"$J&'G."I!/^K!XPI*CU R.<]S@U(TL>,M:1MV*QDKD,<'  '*@YSG
MH/S@!!Y!^7. #R<DCDGUR>1CJ>O<N(S_ )X_$=Z )ECAE7=;R*K 9,3#'.<$
M$^H_,X]!4#JR@AU ]<C(ZG) Y&%QDY]0?3,]M9S7DHMK4*)61V4E@H7&"3D]
M> 1CMU["O5?ACX0\*>*=<UG1/''BNU\'VVGV375MJ-T 8[N<W$%LME$[$)Y@
M$YN3D;RL) ')% 'D:@H04^0C&""<\9ZG^(') !(P,=ZF#1S9\Y]DH'RR  C#
M<88G[K<8(YP=QZ9)^N_$O[-'PYTG3EU+1OVD_A[KF;RTADTR&UO4O8([EU$I
M9S,8W>W7<9"HV[F !P%(X/Q/\)OAWHGC:?PWIGQ5T?5=)M/ OB'Q+<>(XT+V
M5UK>CZ3>W]EX>M(U8,;C4KBW2U5W/R-* %)&2 ?/S12J>5W*>C+RAXSD,,C!
MYSV''7!RR.1D<>4R _*'#C*L.I&TC;][.,<CD<$D%L4DT;(JL%#LH,((95+'
M&,] ,D*3SCJ,]*Z&ZT&YM[:*\N45%=OO1,A 5QN4L,]@""5&03P/4W^]?FBH
M[KY_^DR.?NGMYH',H:)C&P+QCY1D8)V'"\9_'H, <?ZIO_!-X*/V%OV82K;E
M;X6Z"P/^]%(2,9XYSQQQR1DFO\J^YB<0RE0LD)5L2H2<X*DX0Y.1D=>.>QR*
M_P!5#_@FX!_PPG^RZ1W^%F@\XQG$3]AP/R'T'2OJ.&%:MBTMD]/_  %'Q7&7
M^[9;_BJ?J?H3X )_X3+2%["93]<DYS^)SU[>YK[+GNH;95,S;0[[>.O+8)''
M.,^GUXKXS\  _P#"9Z0W8S+^.#_CR#W ('K7V+=0B=%$J@JC!DVC)R#P,]<9
M ('W>.,<5KQ1_O\ #_KQ#\D9<*_[C4_Z^/\ -E^Z51;7. !FVN < #(\B3@X
MZ]!7^,[_ ,%$>?VY/VG@#C_BZOB? ]S>OT'!!QZ8/%?[,5YS:70];6Y'_D"3
MI7^-'_P430#]N;]I\@\CXL>)@0>HW7CLOTR,D'N,^E?*U-XOU/L,/\4O\+/C
M>WGGCQ#YKR1L2IC+$QD/@8*$[2K$8.1MR,]1SM>&O#.J^+/%>D>$='5#JVOZ
MI::9I<<D@B22[O)4@@1W59'6+=(O2)E&W"Y(('/L/F![ '/_ 'TA_D#^5>\_
MLW0K<_M%?!Z @L)OB#X7B.!G"R:A;CGN-W;'H>^*4$I3BG>S:6F_];G73C&5
M2G&7PRG&+_[>=EN?88_X)0?MBF$PC3O#!E$DAG)\42(THE4^:)5:Q5FWODRJ
M^=[LQ(8'-36__!)/]LEQ(QTKPT[F(PC=XJ./F#(VT-",*R.4;@*8_E(QD5_9
MY;?#>,-)^YW;F79DG<0!@' R..W3.<GC%=9I?PP:ZEAM8;1I9F9E0(P))7:6
M4#83E58;LC[O;.*]A8/ N6OM.:R<DF]+]7&^V]M+/OI8^M7#^"<>?V=2KS13
MO%S44TKNS6EU?5)MI6;LK'\4>G_\$C_VTH6/E:9X9CC1#&D2^+BBA6&Q8DQ
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M:Y_G:^%/AWXH\=.5\+V+7VT%YI6S;PV^&V[7DW%/F(R ?F7)W#.:]*A_9?\
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M$/'5:<JF1TLOP<J=2M4<HRJ.G@JN*BZ493E3:C6C3E&4E*2J1I*4VE34FO\
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MM1;;LC]SH8RK.C@W!WQ6(C25.DDIRJ8BJHKD4$I2:M.Z2@_LM+57_P F]/\
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MZYJZKXD&HV$>GWDMLL8=&F\LQQNPB7:N?XF++][/!YSGK7\[_P (?VJ?B?\
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MVG!MOS=]+_J?CL__  0V_P""<$TSSR?!2=Y)%:-F;6KL_*S[RI4QE< GA3D
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M3JS*R%K^LYX-HR7;_YB,Z^Q,7YW\L3L[['!(W4SYR-AQ"?+@3U!+ P04
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M7@CFI]AK5?Q5_8V3'KQK&XX+1;+\IL4FR>VU7VX_FS:\A9 IY+^5HL7<(UX
MA^40EP4N^PS0SR-A*4VM,I<;:O=R1RVSBGV7\)(SQ/&)S.]Y@@?LY$&CJRA[
M5F%GK*E&PC9+@QKKZ,Q0VXZI][U3=FN5*L:[C0H"/>UA<+1>%HB_)Q0O6$B"
MZ4\DSPC-D:0UDIL0Y9M ,Y8\6![H;7_]W4%?$6NV]> #<Y_0KH]@=.Z/,93X
M,EGA9^% CN>I'L"I&+(GM)K+&$Y5&EMUBLSQ=]%3L+751HL/F@M'%N4F0U=X
MVD*C!S^S@4KE%SR,[:Y4PG3@G]3ZV$8 [0M-4440_H!NJW?':;H @"J:EQP3
M4W)X=ZP>-4<^NXGQB-[QI_L#E>(O0=A0E]L;;U<GK$]Q.J6-E"RO9>P[?M$0
M"WH4A#)%ZB%BWQD4VY325.RG9D,]G73Y0R'@I@8-5[_AR76:HW"QH"V&G6>"
M6K0W*BYBVB6[-X=<??1F(?>4VU4C.STH\CPD8 3=!^''7/HYXR<TI<5D\!;5
M.@[:NY@7 *\>'9S9YH.QJJEUSHY>H;*I#A<=WU>I_5LF'U( -6B$*<%AS@,W
M5H*P+EEC?9L">.W6?VL0_PO\YQ?V>*@]A+1[5E9%#@7W(H##.;^& E=HMGS;
MA)H@2X'K5!'S,G4VKCB31<+>OGBA)NE2R]]Q:/[ /H+'TUP%1V/O-Y.VM+//
M,$A13=EG7J.A'EQS]AP?-O2,ESK.%.///B5Y3V T=[L%^9FJ]&N0.C@I;$KD
M_8?D$6JT9@[*;CY8-G91:.TV!^O'4B WYE)P.0I->NDZ.RYJSQ0Y3700WBD7
M! &J-(T\1\/!F+]&W: +@ U\K#H%Z')LEJB\]95M@[?HPQT[O7Q'OI\Z<>H0
MQSLJBJZK<$CITVM$NYF(!F=E?N'C0YHVBND/DL;^5DLZ$ >[MF68/"-6_SR.
M)3.UW4"F(&>\GAY@(!@HO,4@I9FF&36@$VL[-_2M&%/##HC-(!MG/W5\D<GB
M)G 10/- E$<-PFM(H+@3A1@^RRI3_EH+5/O<+8Z*-"W:[3@"0'L!]/ML$8P@
M&)]Q^EX Y0F2]/'"^VX*#[D!/K575FSEU:L<&X4U56:.R59UY<%QV8X,SMP
M.G07)#):;/B?ZO,)N?HPM<5=+Z$8\VJ[_#DZ6L$'$\E1*M .!$1T5)NO9:25
M%_TI.W.19_1HA:NBTUW<CX.K^-2';22S?E\-NL9>2'QO=85YD1?TD+X.9/+S
M$5?]YPU\+X;M_@(@F@YK&Z,%%?[W[U!NA2>4&\-QS;P%E>M.%?'V!2!=&AH
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M#G7+=(TX[@KR2A<SHGM.F]S91$J>CD=0ZKFAPR4B1:R?<[]_H<:1'W9#E?D
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M-7YBT Q" P=T[(V@>8G>\E?;!E17-4>*.YNLWYQ\> %\R%%WD5A"#XBX"'0
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MI4=\^L?I*XS)54:@!%/3]S(^.-%5>K8N:U*9#E@>8S86'9(-))(UA3XZNKU
M6UM3RE<B']CA7VAJJMK$]L *4'TF./,5/4FJN%-Y-)FU-E9<E:G//2O-':;2
M&U2?"5?[I9<>$J':!:WA@J/U2S!-N^I34T39PW)I, :UKRC3JNSW/S5,.VK0
MZ Q!;76R&:2%]< BE9C_4MG%10B+28MM^@-)WN]N4-Y5#Y!Y4M,.NIP31-<)
M=39P]A[X6!Q![7;="W4(K[")C$3#S0W?FG"[%!I/=>8HIC+NIF;!$^YDG*8C
M_W$1FWQFR$GKH4SXZNQ*(!VT+\<.-ZI>+YJ@,+S755/&>!M%_T'YB/'A@&(
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MH>T#)<1&!.%;&E/<&C_W'ZRBGC._TFBJK$[I#?YA\Q^Q&">4GZ0Q;9B]NE-
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M\/?BI,B^+M M+_3B&R-B0O%R/G+QE6).1@C! ^?N-WY:^'OCU<:;"G[N6*9
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MD^)6MW_A70+C^Q_!4!1/$GBJ"54EU62V)\_2=(:-@4\T?)-*F&8-\IZU]R_
M3X?3:#\&K6UU'P;#JGP9EUW4-*AOM#BA?Q5X'\0BW1D\1&( W5W:7#-;"]64
M28AANI(AY^XCY]@\0>!8+--!L88M/TW3Q!%!:P+&+F>2%-CWADC._P R=\N9
M)"SM]X^_T?X:\7ZMX6^&OP_U?PAJU]I$VG>,]8FO[2[/^B^(+$V%K(^F7)(:
M&Y6XMGN$1IAD2S%XN02?HN'*].,<8\15Q%++H99.AB%.DE6KU'B*=+2+JO\
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M"':6DAG<@@2LHPI)0@?,-Q.!SOBJ'5;/2I9I(P;DV8OK>VM5R5-W+OM%B&
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M)^!=UX_MKVXL=!MK+5M.N);O1?$[0W23S&U+7"V;M#B&2.1OW;&;,#[R%(+
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M/L72M4\-ZU\.;?Q%8:7+-XNT2[@BU2WAN5A3[#'$B-))%*RD+'R/W:_>5OF
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MQ7F?CKX>^+- ^,\7BCP39V[Z1;:->76K:1&6(CD1(! \*\I++.&FDP2 IC.
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MW,";$4#(A=!M)V= 57'0;B.OPOXR\6>-_#&IO%<R1R6KQXA,41>&)&=F4[P
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MK<_BWP';-JVAR1P7VIPV%VQU"RENE+74 B\WR3% A2)#&OFD( ^&!KI_A?\
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M.<9ZD#@$\=,9K_(6^*FG^(M)\1W\<%_-=S:MK.M/''9J4:$R:U?"5!<!0SE
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M)'MO%392F!&ZLGE*%O-NW?;5%+&G:S ,K ]-F11$9#^85+>23IUL0FW^]-@
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ME%>")Q 9KT$B@0K+*BP>(&FVC2> \L!)";7)7)/]P$YJ<$;.A2":&:O8GZ-
M_6WQN=EQ:'X)8E#A]AGF/0'5F;3EG_YA>NNT&V=Q?A)^U%TWVP=_6ND-0_UO
MC^UTK",,U+=^2-0_3LBAYMDE :T9D8JR53GC!1ETVX+QYS/9>M*>#;N/!<=S
MC]5_%!# @G\TW>]9\SU"2<=$  <*FYZC?POS/<,"Q'K_][>'@UVL[VGR,?L
MPK3Z"R);3U/$J3")?[*M/4I3^"-;J65GQS/%JG<@VZ2!5UJ1&71.YZTJT.#I
M#&3HC("L,LQYOM/RK1PEG1MB7MZT\\4ZSZSCV@EZ=5G_^QT:Q0B_4^\K>"I/
MC-(U:LSH-T!,]75C_*4K3AQ:R)[5F9$3+S&R-)7]QC-$\-,^-B[7[5W<I?:L
M?,<]9(]S77P<I330YI@8S U/IGVOX"+#F2!&Q#IHPFO9>Q6X_FZQXNN<JTD
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M($M7[[XI9L!86ZS"E"+2!(!<(*+0J%O<NXPN@ L3"2K:E_FC H&;OW%9WWF
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M-FD,-O&Q):0 XW%?O!NG)X JQ;^"Y;32X/$5W]DF3SWLX[%V1KF2<?,SM#C
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MT>NM[Z]%^YOVR1B<,I"D<@G/0C@D?7+$'!(Y/2HY=3:  W$T<0)')=(XVYP
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MFW+G22C%*UDE;1Z6TL?:XO9" RL-K,%Y^;(.2,@X7DCK@>QSD5$UY<;N"NW
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M@*VU&S>^TG4?$.GP7]K'&Y:>V:ZB,D1=$81OLWG8P#!<-QDX_O8^%L%O\,/
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M8B80L$NHIY3"?.DD3RC(2,Y#5\^^./AS\+/$/@,>,/ >BV^C:E+:&[O=(\R
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M9()XP.& '!Y Y'.1FI+93?*1M8<[MV,X88P&)!W9Y)X!P..PCDU63 <L"QX
M*@C;@Y;N W"CC# =>N!#_:TCYP4)&#@JHX&1D' [':.<=<="*T66UWTDO6-O
M_;CJMA[;Q?F^33_R4\6^-OA>UOM!CU!0\6I64X"311%I'@X)20H""AP.-W Z
M]*^)%\.3/=K.%>60R,X 4;)&5RT9V\;3'A-V[;QV(YK]-+NYM[V-XIHHV?!1
M1(%:%BV 0Z,=K?*."0  #R1FOF7Q9HD&B:EJ=Q!I(FM;FW(CE0D16LSNWF%
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ME?IW[ZDM8=IK1MV5O=L[I+MZ_P">A[;X.L-3DM1-?PI!F:W13!(K&2,6[E5
M!..A!9P !@A\#-?"'[%OPEA^*?[67[>&G1:4-5ET[6M$DAW#,D5JUW<?:0,D
M,3A3@J#R3T'3[D\.:]]JEC9%F@4>4WD^8R1^8$DC<A< !5+'CHP4X!SS\S_\
M$SM76U_;:_;IDS<2W4NH:,$CMY6@C8K=3@JRHP+<<KV;:-P^88Y\1E]6E&G)
M<\7)I3=G>*N[NUTTU9;:M-)WNFL*SH0S3 ."A4YL?6K02^&5-8:-)S3M?DYH
MRA)V5FK6V:_2+X4>&KOX4:/KG@S7[6YLK&35Q=:?:SM*BI:R[0$!*R(4(RS!
M6&,<XZ5]%Z1XI^&G@>4:OJ6G:=<37 >2V26*%Q,R_<9RT;,Z0ONSC!"R%B-I
M!/B_QUUR>.XLK^\N(Y$:R:!6AE8S1S*S$I.[EE&U""HR">>P"U\_Z/J6D^/]
M:\/Z+X@U-X='C58ID>55%V(GWK&D@(9=P;YBO7>-YPH%?/UL@JUISJNO7Y8W
MERM.[U=MWOIS.]U9.^NA^FX/.HQP\,*H48J;47RNS35I7V6EXWZ)VTL[W^@-
M5U7X?>)?%&N:CX?\-W^JW>N(3J>D>$+22>6Q5\8NI[FWA>(,H7$<,<A!0D,H
M8;:MV_AS5/#MUIWBNU^&OCK1[#08U$6M:O833 )&\ESYT5EY3"WF;SPNX@91
M0Q.0X&5XHO?B+X-TTZ/\"K2V\.:>[".XNK*TMA=W,!4 ))?./.8'J)"YVCIC
M%8GA2/\ :.FO;:7QE\0[Z]M,+//92ZPUQ#)&S?+:O:K,8W8!<.-H;8P &!D9
M4<#+V-1^TJU'!J+C*[5I-QN][-/HUOT[>OB)X:'LOK#4ZLH\T*T=7&"LW"^K
M2DFD[=K/J>HR_'QO%TOV2_M97$4K1I-+#()Y=B8598V,:HZD9*A=N"H&0<U\
MO_$1K+Q;J$D5W$XT]K@6]PZQM&"HRS//""3(@#*H\H.#G'#GCMOCIXOL]$@T
MUA:6FG:O%/M::VV0?:<(RDR+&%&6).)'&6'7.,5X=\.7U+QSKMOIQNY([2:Y
M-S>3,=X6"W?S;IMW0[4W*G #C(!& :[\'DLYP=7DFG??ELG?IK^5KZ[ZH^?Q
MV/HRFJ=/GFHZN^L=$TVW>Z:3ZZV;\T_T9^'7PWT7[/I%M UKINE1Z9;+;FS(
M0N[01,&,1"LBMR2'5>23P3BO7KC1O#GAR_5=+UB9[Z,PS)B7[/'N &]IE/SD
M<@MP>"<#IGRJ/4=)LM$OFTW55M;K3].@:T1<LDNS; A"*!AW4H6!.<[B>AQ8
M\)?#WQAXQM[G4?M4]OJ<NQX9I(',,T3#*Q@DA ,8QCKSD'(KOEEE:$$US.+N
MOAMS.U[*V_5WLM&D?/N="KB6Y\\8OF]^+B[-[-O1\NNFFZZ'K_B#7K75- N+
M.[NI;^86:78D-RK)!=6MP+F!1$K;Q^\P!\I"X.>/F'B::5X2U^*75=8ELHKF
M4P1W4-[:R7L0,2'9)$GF.JM))\N !C(+$#FO8--^ WB2&TCN-4U.V>WM4$\M
MI I6ZN9,MF-PK9"9.=O R>6SU\4\=_#6ZT^>>]T47+6\LA^U6:@LUN1GYO+4
MABH'(8$*2 ,< 5X6.P-9.-3V%6-G-7<&DTW'KKII^+W/KN&L13HPJ4(574O-
M-1DTVD^=)Q5[ZZ-ZKYZGE7CB/PKI+?V5X<M;..XU"Y%M?7]E!(AOH6V"UQ:&
M8!5CF 5LH <ENF,_>6@7^EVOA_2M/L&@2]MM)TZ&63[(4D ^RP3S$,VZ(.'W
M @!MX!VY)!KYC^'_ ,*EGN%U[5+.269G%MI5M*I9Q),P07KHV3&\+E7C#C!X
MQ@ D_0VL?!7QA/\ 9=4T'6;.*62%1-93AQ<1J#Y:*K A0OD@<GC(V @[LZY;
M@*L)RE!2BJD')M1?Q=%MNTNFMMK:VCB6M@JBITJ[?,I\S4&K1C=IJ:Z/K;\"
MYK'BFU\*:7)J2I;K=W*.D4H66)Y<KG9O\["LP! 4PA3_ !,H!->)KKKZK<QZ
M]J&K06UU<FV>"SG@W2)%)/&!N(4C+!>,G<H(! SBO0M5^$7Q#U/3+G3YVL9G
MCC)LY&"ED94PRH)2!ER..3M'(P<FO*;W1-=^'EE;_P#"7^&&NKNYO+6-;J5@
MZK EQ"MN$*;MH(8L5 !4*#UQ7OK 8E1I^[43Y4E[LE=^\[+WNBWOWN?'SE@T
MJRI/3EJ6YI*[]WXK-:Q[.Z7R1_5C\/)_,\(>$OFW%_#.@LG!19 =-MB&7=M"
M8SNP"1TX."*W+NYVSNN3P2!@-CJ<XYY ;('7CWR!QO@24#P9X+G2,Q^;X3\/
M2K%D%HE.F6ZJ@7G;LZ@G/; -=1C>2[@,S$GYAR 3P.<D<<D$D[B222:PMRMQ
M<E)IM-KOU7K%Z/L]#\,Q34L5B6E9?6*VVFU21TGBAE/AKQ/SUT+Q"1T( %C<
M9/)R0,9!QR#D5_&!=YNI-<+8<MK&I21'(Y!OK@9X'&,$G/..G)K^S;Q5QX5\
M5.1MQX<\1G '((L;H9/S8&.#GK@ 'IQ_$_8:[!&^HM-,,)K.IQ$E@"RF_NAN
MRP!!ZG:#D\=0<GULKP-'&5ZCK6Y8)QNWM*RLM;N[?+LFNK9^C>'V.>#IYQ&$
MFG*O@G&RWC3HU(5&M=X3DETO=6O8[?PY:_9V#CYBKC"GG'S;MI)[!6SD\9&#
MC'%?XMZU<3>$[SP[82_9KW5X6CFE20HR60'[]OEY&Z$N,<?,<=<@XUKXCLX&
M=DF9L[F/0J2<\ !3SD+E3QAB,C[U>>:]<7UVUU>3N9;F8&&*,N4CCA<E8UP<
M]1]_G!!/&,5]$\#AJ%)0PZC5KVLNO*VK)MV6VMU=NV^Y]_#'5L2W[>:4(IOF
MYGJK6\W^"Z]D?%UU;6\5Q;Z-IEN5M;26.WCD*8\YX)=S2N0,L;AG)9S\Q*=,
M=/M;3[=_^$4TJVARJ7X@F:,J -]O&0&;'\9(RH(_G@?+DUFEMXGM8ID2!#>;
M&4;6BC8-A,8.2Q+L2=V3EE&-M?2B:H+2UT^*1@%ME2.,'&T%ITC+ 8 ^XS=V
M91U.:Y<7DM2M3C_#YI+WERI.^CT=DKW5EK;775Z:+,H4F^1N<8MZ1<E=;*UT
MD]5=7T44][V/LCP1KGD^"9XLEF^QHI57*.60D/P.2N% .2""0<U\N^-?!$6M
M>)P]EXAO='N=;N 42*=HXXI?+W$[-V-H&Y=Q VDJ,=AZUX5UB*VL9;99 RA#
MN4]'\S;N&&)^7!&TY.#\Q!Y%>+_%^.XT[Q)IE_:73VUO<A520.-BLZ[VV$J0
MKC(PV3E25 (Q79AN':D,-1E^[ER74H\J;2FE%7TZ.ZNKZWOHSYC'XW#8C$8A
MU%5BI<CYE.[<HROHU+2[5KOI9-+I0E^'_P 0O"6I-)8_$6]3[/'OA6>=R7W*
M,':#@JWW2>O![9JK-XJ^,-HI+:Q8ZBI900\.^20%@KDNR[CNR<=E7:03FKFK
M:SXF.H)-87*WC-8VI>-]H156(  E@>7&"V%(QDD=S0;QEX@MC&+O28Y 6A:1
M0 2=S8*@K@C:0<,1M ;C.6*:SR6I%J$:5.TFGLDKWTO?7:37;2VQY4882;G4
ME6Q-K.*BZC<>FNC>UNBNKV\R%/BGX[M97@N]$^VW,6X VKX0;2 I9%RZ< D>
MP[]:ZWPYX\:^UC5KV72[C2WNM.6.6W+']_+;V1#&,D?,QD0M\F<@9YKYK\.>
M.)E^*?B:>Z$\4);BT5F,:L56-$=)-S<XW';MP#C:"*]8'BTZG=V7EV6VZMI5
MF@$"C)3:5=&\M5&UUX7?D1LP+$J#7//+*-#$IXBG%J2Y9*G%)I--J4N7=:)6
MBW9VNETY<UX8QN=Y4Y87$8>O+ UJ>88.E6DX3EB\,XSHQC)\L>9N-M90BK-R
MDCLK7XXZ#(;B&:VO;5Y\@-<Q21H=S_>W'@]<DC()Y'')]Q^&/Q6\.S:E)(=<
MM5*0*(S)(%12,*RD \LO08!^[[\?.\G]@W)%OJFCVUNXMXYB\Z."0\:.=CA0
MK$9)(4 'CY<UX3J^OV2ZE<V^CV\5I!'<K$/LL>V650VW)ZD!FZ@@]3D$G%<-
M; X7#Q4J.&FI>TJ2ASZMIJ.JLW9Z-RU5_P #Z?)\IQ\Y5J4ZV$P\<3"C6KU:
M4IOEK.DI5U-3U]VHZBBX*2;O)-QY6_T3^.'Q TVZ\-116.HPRO-(?* N F8T
M!.YCG+X!8D=&!('0"OR5_:H>/4O@3\:Y)'AE>/X>>))%4* PVV8YW@Y8YP>>
M<D>@(^E]9T73M0\,Z4=<:[34%DFD3;/(NV-AF,&,L=Q5LE>0. <<E:^*/VF]
M)MK/X)?&+[+J%ZS?\(%XB&#+F(H;,CRY 1RI]00<C@[>:VCEGUNA+$)>QE3I
MSYH)+WDH^UE)I:>Y!7WOT2N['SW$^6XOV?LJ&-]I2H-_[1"\>:TDY*SY)-75
MOA?XZT?^"<]SL_8S^#6X8WZ3J38)Q\PUBY4D<Y'\1.>,9(&#BOMQ+L!6YZY
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MG;3O[+M;_5=3G%O',IMX96"@&$KB15R<9E&5& ?FZ\ U\HZ'X<O)IU2VMGP
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M>9);JS26NOWV7X['M%IK&YA&S $KA,#!QC< ._0@GI@'<>HQNV6NK:O& Y!
M4F,C@?,0<,?O$CJ._3/(KPR/67@;(#9;_5JPQ(44,&P/-WD*, -]X@C*DJ,[
M2:WN:.5O+PHVMN<;^2-Q*K)^Z'8;BS;AV8@4?V70]WWXWDVH632NG:_P[-KR
MOOU+CF]22LK=K.Z=DNBYM%;[]3Z BUX[2?-(+LK!2@P,'E"O0_[QR!NP< "K
M]CKWE$Q>86CD8EXW.[?N/(4G...N.,<#DX'B%MXC:-D4Y6*4!1P,L'(!#,7)
M"D8)(.X$<E05#:K:QY9+J6 #KM.<#+9SWY.0<88#.<A0I(<LH335HW:Y>BZ)
M76K?GMY)$O-Y23U6UMV]M';7S\^_>WJ-]>"UG,T'-O),I55)^5U;=N4]\.%R
M!@8W >@^1OV'].M/$'[5?[6S3%H=2CO=,ETR^C<QF*Y%Y.Q8A2 ROG!R?0GB
MO>K;51>&2S>3>)=S1@DC9(BLZA<D Y*$#&<XSGD[/E#]B#QKI/A3]JO]I.36
M4)@U'4[* 3F5X+>/9=7(+3RG)0G  !)!R1MSS7S^>9'2Q.(R>@JB@L5G.(BY
M3DH<L:6'@JGQ):II6N^:2>EC2CGM2C66(A#VDL/2O""3?-.*?+'1WM+F<=K7
M7R/V:UF_U6W5/#UIJ$#7UV(3-)-<?*S@ 2(&=L*KX.2Q"ACP:YJT\>Z%)%>:
M3J]_!%JFG[X;K29 )]T41*>;#*/D</AF"KP><\8KR?5/&?A'Q0^L_:O$-GIZ
M02;].:VN%FGD>.4JH3RI#)+G&-A?&"<8)%>4^--&BL]-A\9Z%K\>J?8KBSAU
M"UAC>'5D#IYLK26X3 MSOV@MN9E));!WG]6K<)9=6RK"4)1]A45-*%9P7-4:
M2=X.[<U*S5ULM;.SO\YA>)\=3Q^)KS<GS3NJ#ERJTF[I)I7Y4V]+M6_PGNNJ
M7&G2B6XLDA92'DC1 NUT(RI)'S!\<.O5#P.*R]-F6\&Z=(X$#?ZMT .Y,'<K
M8SAA\HP/X<C.!7GVJZSX<LO#FG>)O#VH.LVH)$+K2)G=_P#2U55N&B4G?$0Q
MVE6EP?0\$\_;?$%[U5M("3/DQS*R8\IPJGDY!,14@$I@*Q/))Y_/<3PQCL)B
M'"FZE2$JBC%JFY7YW:%W9<NN[>V^J5S[7!<4X3$TVY0C2E",I3E.2C\*4FE>
M3YFUHN6UW=::(^CK76-/TX22O(L:QJN=BKN=2"#SU! SENG(/:L_6/''A_4M
M*MX;.-Y-8M[Z20M*Q:%K4+NV8Y^\HR<9).1R<5\[:CJ<^IV#"UU!1<0S^3=Q
MAC(&>9E&(]C.55/F))9SSV(P.\\2Z/H'@#P]HFH)KT,^L:A&;B>W9T<*5B!"
M(ZA#NP.5=>,%3@BOMLCX3A@ZN#JX^M[.O4FE:45."4J4YW=32$7[NS2TUM9,
M^7SGBBMCHU:&#G>BI)W3]FW)22LHRO+E:YFI/35*VQ]G?"/XIWIBW-)Y5F-J
M26@)18G54151& V [5)7!Y.[KR?J&P\<V=]'O6?80H)5F'' )&?;G\L5^8GP
MM\=3>)--N+Z>WCL4:58X_*BV+.8U"^8A<ON9]GW@0"#PFX,:]HL_%,T1 $C*
MNS#%B57"G')W+CKD<=\D <U^4XZI/"YYFU*DUB*'URI&+Y+0IN,I7<9-6DVM
M++=;]S["E6]OEF"3D_:1HQ4FENU&*WV^[\TS[F7Q-$I!%V@QC[Q"DD$ Y'0?
M-G/8<=*0^*D^;=<P')P-LZ'/4'C/&2#@8.3[$5\5_P#"7S7#KNN9E#Y/#8YS
MGY<Y+ @'<5WXRC*0<X='XBMP'S*Y^=64%V4X!^\ 3DD^NT C 4EL@=U.K&:5
MX6=E=.RY;VTUNWY^;[&$/:6:<DFE?64=-6E]^EUOU9]F#Q9;F2-%NE+.&&%D
M5F1AT! ///7I]<9JROB%3R)6]NF#C &,,,<@Y'L><U\96/CBQL[N 172)*TJ
M*R,<GRWD4,QWDM\HR0PVJ <L".:]/'B:78$1P5*JP88CVAAU9B-@()(!'&2!
M][=CT\)A'B%*3I_#)1OI;92;N[=NJ=^C./%8RIAI146FI1YI-NRNI.-MUT^_
M[CH/CE\2)O#/PS\3ZC;W#1W?]G26\# D,LTXVC:5(P0.<\]1Q7XLW/B9KJ\@
MEEN'>22]L7E+L2[R-?1>9(Y'+.6'S9S@-[FOOS]J'6[B[^%]_!$"4BU"WGED
MCE4EH?* P5S\T88$L5! /+'(./R?@UHM>0Y!,0O[,J6&3^\U"-B-RD8*X'!S
MC)SN&,=W]GKEE>-KU*48RM:\O98BFDE9M+GE&TG_ 'I:J+.*IF<I*SE%<R2=
MG?2S2?S[=+6=C_5$^"<,C_"'X0R[CS\,_ Y.<;6!\.Z>X'4@;0<>X!)ZUZ$U
MK-(\C;%?+MDDXP1QC&?Q_'H.@\_^"]U%!\$/A!<R%DB7X7^ BI.#C?X:T[DJ
MH.>HS@@8(!]1ZK%(KQJ\,+2Q.-Z/E?F##)X+*1\Q.!C@8Y-?RW625?$):6Q&
M(7S5>LG^*>OZ-''>^KW>K^9RGCY?^*&\=9(&?"'BK.>?OZ#=2$GIP#GT],'D
MC_,UTCQ!<:=K>L:?+,TMH=>UM(G5R6 ?69P0V78;B?X@BG^O^F1X_8_\(#XY
MSDX\&^*B1ZD>';D_CD$@= /Y_P"6_P"&M3TX^-KVW\1W%[;Z/-XMUG^TI[4H
M;J.S_MFX,ALS)B,7"+S$&.TMD-U('ZGX68=57F\Y+F5*ME_,[7MR87$OFLDW
M)?N)NUKR=DM792\5["E*,I<KKM.GKHK6?O-O3Y<R?S/KZ/Q$L,8\D21J@C^;
MY67&#\S9&>P "[5^4,02!C*O_&U[!:3WSL);9=PCB:5(7)4'DR$<E1RH"\<@
MC& /H;Q-^RZ=;T71Y_@3>>)/&DEUX4@\=:[/XAN-%T6QT;PQ<7;:;9I)-<7D
M#2ZA/JD3P)#%DL@!SGK\]^/OV5_VD;;2;&&Y^%^KII6JV+ZEI^HP7MI<*ELD
MHM[JZDBMIYRT=G,R)*<%%1MSXP#7[/A,9EF(C1BL72H3E*HO]HDZ.E#2:7.N
M:[WBK:MZM,\>MCIWY5SR75TTFU==$Y):6O\ U<^9O$WQ#U+4-9TZU>_G:UEO
M6D2W9A,(Q%+"P;<<*NTE!G:NX-MXR*[_ ,.W\]YJSW<DJ$Q!H8D  8@Y?=*<
MDNF&;"C8%8*,G'/IGPU_X)W_ +0WB7Q[\,XO'7A'4_"OPY\6>//#7@K5/%-O
M<6=U<:<?%EW;VFGW]K"'=Y;>YGCEEAD9-ACBE!8%5!Z7Q3^RI\2/@S<6&M^+
MM*EL/ OB#XB:GX&T3Q1-=VLGV^TL=?N-+BOC#%([PEK.SDNY#(H"EL;N>>"M
M3RJMF-;"4\51JUHP552ISC.G-73:@U[[FDFW%15N5N_NM+LH9G6A@)T_:6Y)
M<R<GJXRE%)6ONF[.UEYO8ETKQ''IZW"I*<E;1% ;&YQ$5^4#IM8*QY&!SCC%
M=/%XD*1Q0,ZF6>3=&=Y9D?J"I##:1P",$C .2, ?2>F?\$]?%5QID>LP>,[<
M3ZM\1--\/Z+HLD9%]>^$;V*ZN)/&2I@DZ786\-L+B[4+$AN8R6RU<YX(_8X\
M9^,['0_&NE7S0>!+Z3PU93ZGJE_I]MJ>HKK_ (H?PW+>Z%8M.CBQM;E&$<TB
MJT@A')!:NR.9Y!AH^RJXR$73DH2;4N6,G>,8NR<M91:6C;?D>95Q>)DW4M-Q
MNM8W:;;26M[6OYV_(_,;]H2&R@\<:-K,'F17=W;[[N82;5,ULWRJR;<OYB E
MCOW.<$!<8/&6_C*V5MK)/%YDD;F5FXP!EL*0,E<A2=S*">,#(K[5_:T_9,\>
M?#OXL^$/ACXTMY--TOQAXP;2_!GBU+FSU&+5-)CU Z<;M7LY6,3J[[98Y" K
M@AJ\P^('[$.H^)_#OQ'U+]G#QAJ?CS6/@]\5/#7P=\>^%M:@MK/4O^$F\6_:
M3I-UHDJ>5;/IC?V?>&9IY1(BA"&.X4GB<JQ$:%:%11510K*510A:E*56%W>5
MFG*.UW:+332T-H8_$TDO>NT]8J3;MY_"M'UNS'\*:Y;W6ER7,,OF-,WE1R*V
M)$P<@J27 ;(Z 8R!Q1<:MK$URL-R9I;(NK1S#=(ZN6W /EL%\\DA5 )) 'RX
M]<^$/[#7[1>FOI6C^.?"<WASPY8^(=,T?Q1XAN-2TZ!K"ZU&X2/?81RW&=0,
M8E!:.$2>7C;R00.ZU+]D#]H[1KYK[2? &HZIX6UCQ9K'A+P?JDL]O#-K#Z0F
MH7#:I/;N0UG9/9Z9<3+<2Q)'/(PACE+;:\2H\!3Q=6G.M1=%_O/:0DIPO*2B
ME=-ZMO5V2MUN>FLZQ"HQE%>\FXZVWY+MM+9)ON[M[6.'T$Q&*#[3-<0FUF#*
MC959WCRNP@J<,=N6(/WN0 .GHD^H*UI+$TJF.88C1%!:!3DD(&#;"#G).3\I
MR *\7UJ'Q+X/;0E\3:1>:3+KOAZR\4:-!>[8)[G1M1>X:WU"XA=C+;2O#Y.;
M=R65<EMS<F-_%A:*5E8)G(^4]<^G<9[$9X.2<9-?;X+)<!*A"5)PK0J14E*%
MW%65TM;=7;KK??K\YC,[Q$Z\7*IR3BW:S2B[V3[/IYJU^A\]_%2ZD/Q N-%A
MD?9+]@53R"5G19),X."22<,JJHRQ W &M'XQZI::-^S[\3]*1]D#> -<CW@X
M+3O98*-R3D9..,Y&-PZUS?BJ_L3\0M1U:\NK<7"65E]GAEGCWI*;?ED3/S,!
M]W'0C<!@J3P'QIUO[;\'OB2C$R)+X1UG8=O1OLF%."?ESWSC/&<_+7BYIE7L
M<'CW&G:FL-C%=)WUPDK:6MM]WKOZ"SJ<U056?.Y7IIP:?O2L_>NXV25FWJ?/
MO[+FJRVWP%\ Q&7Y4L;WY/EW-G4&C4*&#@MEU"(48/($ *L0Z_O#^S]\(?!=
M[X!_9RDLO@-I7QETSXM^*/&&E?&#Q]<6-^T_@/2])6%+26RO=/N([;P[J%F+
MAIKJYUV&]M)EBQ#"O(K^=7]G/5H[7X-^#XY'8QQV%\)41]K>6;R9I0#_  GR
M5;D88$A@<CC]VOV=/V6?C7XY_9C^%?Q5^''QT\0>$O!/Q0^+6K?##XG:#I>K
MW=GIO@32HKI((_%5W!!*B'3[E#*^H7#@(F^(2,-RBO/K82A0X7R7$5<<LLM1
MP\8XBHVH)>RC>*<(SES^?+;;5ZGGO%REBZ])4W4]C-W;>BN_AMI=JZWMI+NK
MFO\ M'?L<?#[X1_"W5O'_A+XT67B#6CX0\%?$BV\!_V5.!!X0^(OCN]\&:0H
MUE939SO:W5D[N(9 \8A\YQY;;1]#? ']DC]EKQ9\$?A5\2-<\07U[=^//"OB
MM?$>KW^E7=QI?AK4M*\0KI-M?6TL7DH=2LXV6-[1Y;F2Z ::/R47:/C?XN_L
M._'^SU&_\#_#[5/&'CS3[/Q)XC^'L>NZWXCL=*\"W.@>$-,L]<T^"TGU.[@C
ML[:RN=7>]T]+^3:LT]Q<VZ[ANKQ[]IKX(?'3]G;X0>!M>TGQKXNE^&^IPS?V
M]GQ$+7P[H_BM+A3+H^CK;3)!?&65I)VO+(R13N-YD? 8YTJ?UJEA,)AN)HNO
MB*E?ZO6GAU4G5]G)NI&$Y*]H:1BGRZ:=67/$14IR=!P2ITVU>U^:.FBDWKUO
MY:Z'V9XV_P""9]QHWPS^(GQ8A^,&AZSHGA27Q+=>&X;/3;I+J?3- 1'1]9BD
MGD^R7-]'.K0IE<!,@9 8;W[ '[-WP+^,_P"S5JGC'XA:5\/+OQ5'XV^)6FF3
M5M/U"_\ &^I:)H/@FWU?1[?P;);:A!;PSP:K))?:M)=6UT$M]_EPQEQ(/!#^
MQU\;=5_9]LO%7AGXH?%2_N_&OA3P_KKZ5J&NM%X4\4ZEXH21K?PMIP\]I;G6
M;E8O)59%*2D#>"H)'S59?L=?MR>$->'@K2]"UGPX^B^'#XX2_L/'&EZ=X7T3
M3=<1M)F:?6;?4UTN#4=3^SS:5>6K70N9Q 8IH@I"G/V%7&X#%X:7%-)8C#8A
M>PK5Z%&DZBHRY:L)VDY-QFIPC:+4E%.]GH_KJHTXITH25KJSNW=W6O-'9NV]
MFUNS]"?$7_!)R718?!.L7'QAT[^QO%"6.I7MM8Z%J6K:S!INN:9+K5C::!8"
M4W&L:C808M;NWA4EIQE5C#"O.3_P3=T[4_AAX[^(NB?%>]MYM$T/XK^*O#VF
M>(_!.M:/:MH_PATZ+5=9T_Q+J=QY=OI'B+7+5]FD:7<&&9[D-$@F)&/G3]J[
MX-_M/_LR6G@3Q5)\2OB+>^%;/2O"\FD^([SQI*LFG>)]9TB*\N=-T!5OQ)=0
M:>SR6Z:A9*]O;PA8_,+%5'PW>_M!?%_5=-US1M0^*GCJZT3Q-=RWVNZ9+XEU
M-M/U2YNT*SSW5F]P4E^WQE1="0-]HC"1S%L 5ZF$RC.<?AX5<-GL94THP;6%
MI\L6DHO7WDXW3=TVUO971A+-XQDDZ*BY1<U>ZCRV=^KM+3379;[G[A_"W_@G
MC\'6\=6::E\5+CXF:/X;LM*M?%F@Z7X*URYM(/%7B'P7:^,H+:]>V_?6VAV5
MG=Q6YU.0M:F]8J9 $(;YW_9V_9 \)_M)^+OC190?%;0?A5;_  S^($EA-I6L
M0O(MEX%!O([CQ$I$A>6WL=0BM=.,6=Z_:E#,W.?S T'X[?%7PQ<:E<:!\2_&
MFD3ZY:PV6KR:?K^IVTFHVT-O%:6L%])#,OVE(K.&"% YPD"A!A"16)I7C_Q%
MI5WJ-W;>(-6LY]9AEL]<FM;^>"76+::=+F>"_:.1#=133HLLB2EMTBJ['<*]
M*/#.;QCB%/-HRE.A&-*2PE-I55&SG*_*TG*\E))MWV6IA_:T7K^\LW>-N6VN
MVMWHEMY>I^_WP\_X)]_##2?%%_\ #WXE?$+0]9N-*6[C\2ZGH&DWTWB?1_%8
MC-Q:^'[0&YEM[J*2UEM9F(MFRMP I0'%>?\ [07[(GPOT;X&WWQ.^&?BJUT;
MQ+\/]*FN/%_A&YTB[MKW5M,&M/I-M>RW4K21B^8^6\D"1J5^\R@ 8_'F+XQ?
M$*SU5]9M?'GB>#4KJ];4;G4(M=OOMD]ZPC075Q<^9YDEQY<4,8=R6V(%!VC%
M5-0^*_CG44U"WU#QEXEOK35 5U.VN=9O)(+]3/YY6ZB>5EE4W ,F&&-Q+ 9P
M:RH<*YU"K0E6SN4J=-+F@L)"\FK-J*O'1N\4T]$TTN8F6;K[#J7]+:]=;V\M
M.AW$6OR,T(\UO+*KN!9@1Q_#R HX#<[@#P00,5TMKKK3PEC-NVNI*EG)^0@<
M@DAE!//7'08!Q7SZ-:+C(;:!ARHQDYP1U&1PI&,>O?IHZ=K;1LRM(2,!@-PY
M8G#<]\8''7/ ZU],LK=TU"*U5MWVZV5_TWN)9LDT[RWU:LW;K9.6KTTV]>WT
M&NN$W,;,Y4 $Y4D8VJY('S9  '.<D>FWFOGC]CRXM+S]H;]I^.^BCE@O;ZT0
MJR))Y>+R=28O,5U1FYW, 6*XP5)&.FBUDM)'([@G<%90V,!_W>T#DY(<\D?=
M8;B",GP?]E+6FMOCA\?;ABH%Q=64Q8D@E/.=V;CIN9BV.!EN. !7PO&.6PC4
MX=Y93@YYMF2;IWYE>C#5:)IIV>_5ZJ^OHY;F;4ZN(BHS]G[\(3=HW33M.S=D
MU)WWU6B[?H/XK^'&A2^==Z7'/ \;)(;>-BJ=6#%,$%'Y8EMQ&22 "*S_  ]J
M%U=R2:!;^(FT59[1UD6_>-8)!:+M5 9$DED>14\LL\VW^)0"V!]*_L^>%_AM
M\5=>UCPYXZ\2^)=#O;/P]K?B*T?1H+6:!M-\/Z=-J=\S&4$EC;Q,L0. 9""<
M#('">-_^">?[3WB'QG9P^ ?!=VUCXF\+#Q[X,L-5U?3_ .W[SP7+$+J/4=0L
M[>YW6LMW')%/##(%WPR(R!@"1ZG#>=3RW$5\ISG%U,5245*C7Q3C'ZO!VE%8
M>4II2E9*G)2Y;1E)IMI1>F<UOK<*>)PN'ITJRC>;B^57;Y9;*3=T[;+=:]OG
MS6M2LSY<,#C3;RRN)?M< D\^SU$AES<VD.5,>X?>Q(5+-DC-=)X=U_05L=3M
M-8M8XY-12*Q757F(-E'NCE+I@C8")6(+;V5GD);& (M<_9P_:BO[_3O!'_"B
M]:L->LET O=*T&X+X@EECTV99Q*WVB*Z-M<&1^8[9,&0H2,==\:_V7/%OP&_
M9=U#XJ_%"#5/#_Q&T3]H>Y^!^O>"9GAN;&VM(_AG%X^368KJ'S1=23/?V]KB
M.1PJ12@,&C95_1XYOD-2-'#?6L*ZN(G&&'4)4YU9XCEJU*-"*4FW.JZ4XQV2
MDK.44]/D6LS7/*/+*FE>I#FG&Z35].5)\J6UU?KI8\O>2]CUE]+\*:A#)IL*
ML%OH9I'GN-P&9Y"3L8L<'[H&5)*@\GU70_ ^F7%JESXEU:XU&\96DC7[2H^S
MDKARJR%U4  DC8-V,GTK[0^#?_!)?5/'3? 36T^*FFZ9X1^,WP07XFG67N#$
MFGZ]#HD>J'PE.VZ,0W=XUP!9 JK7"JVP, <?,D'["W[3UT?#U[IW@R2\T#Q?
MK.I:5X5U*WUX+_:$6GW4]O\ ;9V>Y$=@LCPEREVL2DD[?EQGXK%YQE^-Q=6"
MS6DEAZ.&JRA.3IRH5,3[>-/#RYDH_6::HU%6IQ;C%N-JC6WK4J\*-!25)0E.
M-V[IR=WK>/,W:^^N_P!YM^'KO3]$@EM-+NDNK-"6 +(QA9%5=I1 BJ"<\?,1
MC.0>:Z:'Q*^W>6? 48 ;:>G&/O$<XX[=.PKQ+QI\,OB1^SEXRUWX=?%.Q;2-
M=L#9W$B&>UFB>&]MUFC9+FWDDAF*!AN$4C(W&3G<!@OXI)(99LG ^;S.",=1
MSC!'0XP>2/2OC*F3+VM:=.,9T:E252%9N,I5)R5I-N,F[<KOKIT5T?5T,[J4
MZ-&FYII4H\MI:].ON^NE_0^EI?$:R!66657&,#< "VT#/?JVW<3Z9![+4N?%
M3,())9<./F;+-G@9R,.O/3'8= *^<3XKD0%?-8$X&XR>A]\<]\]?6JUYXM>2
M:(>;$-JG< ^?F )!&>,$XX( &<<#)I3RJ4$I\D/=3VO>S[V7E^I?]L5&[N3L
M^S3T_O:Q6WJF[GTHGB:T,L=PRHKC:5E!VEF#9&X G.1P ,#<0>H '9GXB7C%
M7MW21!& (S(%W8&",,Q!(()8<Y(/&:^-HO%<F_#R @]MPVK]W)"\8(!8YSP<
M8Q6G!XF9&PL@PHW#YPO/)Y.2V.01T_6NW!4\72E94X).2;NY7LERK[.M^EEH
M]-S#%9C1Q%.SG)3BERZQ6CU=W>^C[:>=M_9?B9\3GNO#U[HUS&99=2MC (6Y
M5"!\LI8KP1M&>@/'' (_/RVG>ZU&VL(7A68:A:K()9%B ,5]$757) W9+ +@
MY X8XQ7U3=:]8:C&5U"&.7*X&W ?/. IZ@D]\XZDCM7R]\1_ MQ8W\?B#0)F
MGMKC4M+>:U)"S6\CWT(8*@)&U5)&[@Y]<&OKZ6'C6IWG%*494$TDM&JE1W_I
M7Z>9XE;'*GR)3<DI)RUTLW:RL[Z6N^EN]S_59^!\8NO@Y\&X'*O;Q?"OP*+C
MYMZAQX:TZ,8;[I&3C. .H '->C++=VA>"'S?)1V\K:1C8<$9W G.<_A@]Z\\
M_9^B^S_ ?X+H_P"[E/PJ^'WF;CD MX:TQL<?>;=DDMG &.U>P2P^:P8A&.T
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MW(P9,^-M-7:JA,$$@$-N5,8((5<@\<J/^#;G_@J %C \ ^ R0P(QXWTTA0.
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MB;OJK*)]ZD7HT>65P:+OE8>"J_.CSG85'G61KZ)/Z+H^#'6OEFSV3/6!8M@
MB5B[*P4[[T6$PWHO)?<.0?!QQ!F\+\CRKC!(%E&N!B\<1N)M#J.?3Y15JAZ7
M$(,&=(P9HN:2V$_3U?O$GYD\$<(GHMS-I]/0UHJSXA[3AI+%V7"KZB],QYD6
M.3O3F9@\NLEKC,?.%'X7<M+%@5:9E2&\?2T>W\7H!X:E-2<TJ!L%<V&CA%17
MUA;Q"V1#'J5#,S7F68?NXB9]'(UXIDM>,?OB8H")DKM+7$*U$(8AN ^$4 =%
M,;.C;)Q_!O^Y.;H!#6KB.T&K4YPK45-]YHPMB*EH&3IGV>)&B\W8M0_RKHYM
MNY6Q[OF*N\ &AVO!R@3:Q;\5X-YRJ&J_C53P#+0R>6UIQ30;%:C.1YDR%#?F
M\UXL:OQ$[Z/OD$%V2NP?[)W&3',1ZZ103VU($+?]5$2EE1$=8/3M+M[*\]J/
M'8"_RIP2-13$ ZW4 N0(OT^+A"84=!YCKW1T%V[.5'@XQF9<3&O II\[*!SZ
MZE7,C+,SP0&+4W9SZ,DYL(4 BC/B.V)\()@_8PM3N"Z'<N ,J0[Z#&, ,:%4
M]X,42OPV##MGI]#/ C))V3ZTSO"=KWP7M6X4_IQ N")I2\9>/IR..#E2N25"
M;?1TTW2Q.X!H!(* \).(#5HTV0_U_(,\,C03:10(OA?=(6SA778 =4EQK]=!
M/CI.;_>EJBQ0C;!N?-?J_\2?G^9B80-#_#+BV%I- !IPJ?;MPZ\$$*F#^\GX
ML0&1S1K-MQ)[)0/[;5WK'6@M/Q@V.Z$XHUD_?BM_0*'!__/+MPZ@M9[6RJ=P
MLB)]P<JBF)&_P4KQK?MJ0IOKS"-<VL.[1N%<%N6+NMPMHMQMIY#" @YT]H55
M>:SCRHI.MT"?I;!4(_?',@V/(@V]%\79]%JQ*2H-*3ZQ,QO2G.#H("4L?!:P
M#.NT@1:]^XE6011<)N<-2MT#^ED(44!CA) 3D"+HT0\'Z-W=9(;(.M^L\U$C
M':RKNV5:E.L([OEPG'?:=)5+5U!9J5_N\5WT/<#.E0K+?8(8KN Y+#?1BZA3
M7"9B;09!@S,+/ PCB-@&0C'X+-;/^(*$19!^,;MWKG*+7?\8))\;7H8_HQ.^
M76-!T\O;<2F$7F;/;[89'6^Z \,;"AC)1<RMUYW4)&(,M;HTA>TM?Y>S?;(L
M[,"2]]M_FZ?_6.\*+^BJBJ%(2L1E[E%I)5$%6_TC(=P1PN83R@=1DM7A W3O
M_+</1UO?4%W_3"U53'M71&P@4L,^T[A6>6)G%6+)+:G!B"R1TI/-,=335E=1
MRUA;-LFJVFG^CI*\E0V>!/TJ&>A^B*9K0\4C*0;6<1<[-#W=\LA%'8(,?F#/
M[) \['MIJ#_^'J+756^K_20K3'UK[Z]*30T:ZT)P+[#]-3_8?]14>_O^8+1\
M+>@S"&]E26E+X,D^QK?/;[,;<CA$ 5H?N6RR7(8UD*^8CKQH$]K]D]Y3,W-+
MBA*1=1W#>K_&Q_F4==)\;361Y]> >*,HE=/^T:0O#PC2B-0\2&75N]%T&R4:
M,^_ CCE:'*\EL-[029V[=0E&<_;@#EKAT@=+C]J."PTWYQFQH)7Z-I":6O0B
MGZOA9Y;/7DQ,@.S)Y\JJ L-RLC*N(??RK7\M19SM:\[ES;;S-_^Z\SKM, 03
M,#,E^$+-%FDDF%R&N/K (/?)G(P"K)-3%[6,V%+KF&L$$:/ZC>L6JD2)Y4[T
MFMMG;#0)C59 #OKBEW]&2U=5OI']J3" 8)&A +9Q_9I7KY=WU.J-L!L. $97
M=_&CF<&TZ->(M)KX(.FM3IT>9N[F.>=*VU^+C=V$&^N&)CEJ=VP&O^J^Y[?5
MUD)M-?G^Y/W$>KS*#80R@ROJA=T@Z&L>T18JRQ=) H[5,GY_Y;FOW\3YWJ0=
M;A\52^?M&Y^:,2J]*+F=!#;N(+X'//XYNHDUR'YJ0QDL#8H5A:24* ,-Y(.O
M>_TWGUZ9J%48O?7_-'2@SW:T,,[/']8N=*MLWK\Z;L>X0J#$\"75R>)0.\UP
M3*=$XT^\AH;=!/N,ZZ2F[DKC:$5,@:KNCCC'$XB;JJ"+Z9C,<:.-_>G1JO/O
M8Y^I+<%^:E[YZ^]1'#[_)/>>2##FZGG0_"B$;JRY_+##*_L+9+D'Z('-C#?0
M#.!;:92G]OSY9Y/+O7AO9_H#-89#-4U20S,5JB.!.L.QE>N8UT'A-I9AS R/
M.W V!=!/"^#BX1?.>.J(DF%P5)=4PJ4#L*'F?./1_J'KHS RR70U6V&+[4>&
MEAI??/<86U:G7HZGG1'-\O>N-5*!Z")C4Q('T@X$PD5N#VM70OHMS\3',V#N
M2\N!-Q:_&E^>EO(TRRF/#LKZFU6]*'+^CAZ%G>4*+LHJ2O2>[R4$(N=BS IS
MO]WA[8++:O9UWF"A3A\DL,"O+=DEB;H'O(WP:FUK[ISO8+"B?&ID_$O%.CMZ
ME%G+FN@UH]B;7S5FTV#8.C $>OY\<^IR:::8CV'D$NE G><8QTG:Q;E\)<G[
M@ G_<*YG5]+'%CKN2<1LP5$104JFT0!9:W80:5B8"31;+C27?I0P;M_79?%E
M^&/97%88,QN!>6:*ND)C@..^RFF[^4K>6&3:"^$&F#<;+E$V2=B%#"FFMCC5
M8BXP6"[R3P)6H*?>@I;$L$'N\>\@CD6OD J'[B;&1>I;]UTF4K78B22)>/UU
MR:(XU;?-;&Y]1/'##YM$3E"B&?URSSND0!'=CJTG%\I5$[^A_M,-;]W*ZMU?
M2/QK?LS&88";Y+\_5:^)HU]^MZ8JY%L7V9#8H.EBI"#NP%]^#_"0<;PNQB%:
M=;(D3TNI*P*]N]2\,KE:K$6[?;QA0=S<Z(2YK)8+XI4PU<?=?G$C^"LD'+=X
M"0##%MJ7^.,;NADZM%A-,IK%]=<99Z!"3YE.66_E.;2^ABY&/]9X+7K=> ]X
M9(@=AI0AN%>L P\&I#-$F[:BXM9%%YS/H[T.<_A7-"&#18TM+:G*ES.U=M$P
M7:]GKP5&#[@MW6A_LU,>?DBU/''@I&$2<=GOI-'7H!'KL2IOHS5]YZ2OTFV9
M6J U*"W)-:%PNE8A;;06U(T_]DOFJV OT2N_H\!;DKO(HA>DBW^Q60R(Z7X+
MFL<[PKIZW$=WV1@I-"[* !EI=M?DC.:H0-WV&6MTEON9W#Y> !T1KBF0K!#8
M)I%/M>*/LB<OONCL<T6)55Q:-C7G'H!7%KA@3?8+MJXD2UPZ@GIQZ;VTMLX%
M]@"(!!WM=7FV?,I,=MD4DXH&:;I65UG5;'V@=$U&BMRN#-7@/*6-9L199E(9
MOEZ)Q$>>28H2;;)L#KHA$B'MN)0.$Y.J66 B(*'_F6'B!P*TQ,%G)9?S+I/<
MJ#W,0W!?]R^5;MC*QK+&LJ40EKQ>'S]7:4HU0,Q'VQ))[-&MI/S)ML.+VZU7
M0C/DWSY_6G4/(,6OE[.!S_Y))%Y*$Q\<<')Y)9%4SSJL/H"3J;5)5*XQ/3!8
M'?]IX0K5=';*;THZB##(([7]\W?N%VU6R7*1^N'.$N:M&/#*!',-A,OKTX[]
MFGK_57BVA/&"Y=L%U5W _@;"Q?<HMOS[HT@T)3WT[\I:5=B0 (G1JYC]D14<
M0&$T/GOB92)G@I<U5AF=[P$V]NG(0BP,OLB3+VDR->Y]AU<!GZZJM2@Q"+)&
M))6MQ!?"MKW*,6OCHO< >XVUC'O IW<M/+%LS YN&,<"IXT#B:Q@D8P]C!(2
M&3HZ3#?\2^[[/4"V?B&.T6NX=0NQEW@(6OH$1#C;'?6ZD[7&7EY&'T,4HXM
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MAL3.D$/SP"K4VT&?9$<A,]#?A5=LC8-IYQZ#&;7Z3YJ:$#]#&%/:?V5(LKK
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M+D@7S=WHN]('O4)VB-^XQ K]Q5K^A#?)#K4K%8.N?%OCY(I)UQZ4PI!#ML=
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MFYST[P%369M[ UBVI[_JOP=$F#]%"=>@ILR0+K_JU_V&3HQ7G#RM*M\EC;I
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M#]7S]"QZJ\.J.2F5(+.%?)NGG5VSR_^.)BN:@ CVC92&<HCS7B%;?<?LHUN
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M:[RI 1"J#!OL^GV8I+V*OZKGT)//9BR0[=&L/?]:Y)?O/,(_M]OHNEB[!YA
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M5M>DW-"B=MGU^<UL09[ZOD_)LOSOW3OXU%G%L $/1JY?!:BNQ<9W<>X7LG?
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MI#5S5-)S@')%M.-4B,9T37,NE)RG'.6O.YFTGC*1XR@'VI?0#8Y?CY(:)1E
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M)V G>OX6X+2:9);Y:L79_'W[B.0SI*:<]*A*((!*3Y&QCC62*DEP2$8P1;Q
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M;0]<RX,TDC:58BGK4.X)(:J!OK7F3B3T@XR46L0>D7U2!7!W0>(!4H.TCO!
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MXC%//#?:]%MIU>'R5E<=E?NC5;-OY%^-RA+=@#?*/2.Z$<.#S2/]>>2<!MB
MF]:)79->Y_*,X4:QBR:.)TQ^)4-F1QTG"N+[;K]_.W6]661E6JK7/W.4@Q*6
M/LF]HE4!)WF8\WH$9.6_8= LS2J^G/)-?WW^5&\-(427Z_7Q[OEWJK-&*FM]
M3=,+UCACJSXKZ9GI+J23C1%9WS-S%M'[Y#,NIS/ZPTP./]9X"ZGON9;7X%VZ
MQP/>V/70",Q+XLEZ4;]CI5-::A:,O%=E;L$E;SSGPYM($[;9U?%3"ZH/?4YW
M?.1^XIV<PEQ@<.Q*,.6H+[_DC 05-I<RJNP)@_?K^S=%KX6T^BZ)C22\/\I[
M_TZS,\/5L5EC?\/A7IA[]\C5._V2I32M[A6UG"6^,>[4XA C6F3Q@(_! >7/
M928A2W5YO&/=G\L_N+(0-6\H&$R8+-,7QS27)G,RX30Y(VJ+/>KB5Y0)WERU
M7*7W<)5R![W_LL5LA.8-U5N\S\X)Z>#SFA#RS@6M \F$E$]I;^ JRX.SV>4;
M%3E5B)>$LU;IMGTY9OQ:B9%G!F9O6Y278<L#>RMQXQ-1=-KDFEBS'Q*1KZ-P
M'M'__F433 :A'T/JX0Z2O&[3I"]R.*$]_.)'90!?'B;J1N2JU_^PT,<@+7(Q
MOY4HK*U*UKYP;./F0)[0,YN-PZH9M0.4.6+7$"P>+NC\<#U,EC&D<O^&P2L5
MQ;>'QFP3M0/Y-D(RM.3-H"3YZ2+3!EAL@_8K'-=Z4*H5A]L!X-;=YW&/#876
ML#H"HS%=Z4\GTEQYG(IEMLD;@6BI[SE)_?EFMPINQ$L8D;&%'KS$D?A_1AY5
M&BFJHO-<8%QLX %W\?VIJ[LF1I[6@P/?.UV#!=->\/X<N;=2]5H9D/%+>TAD
MA$R2P[5/1;0$3/"][&Y6';8WZ>+[\2BV,DNT.ZF;5_SI;4VEG.QGRB;[=1KQ
MZWNQ].2]]_=(DHPNVLF+Q$#OF$U?]7N_)$J,I+ W)C/&+[W+I&?N9>4>*T.Y
M,^*^[XY$, IM[K56CV((TPD=/X%-@0WU115:\43V^)? +^,50Z2E^5]_RG8$
M-8_)3+E/GG7.?T <P26-VG\?]I[!K%QC'8,,^J=B&'++] :1P=9- IR?>4JL
M5"A)-77%FN15RG]"$!%P)KZLAB>\6DCNP'0/&Z D!%?,5BUS4WG#^MHF1IN7
M2]LT*^\\53&A;X?7N'[KN/V5#V,!;S*/"5-EVM%^8BY$3D-?L2[0Q##2-*=O
MN1X[$UDA"(69PSVC/^@;-VF:/1_ZE:\60$.DRV="6ZGF]$*& ,4\2DR$2HQQ
MW7NOH-)UI'<J!<;!Z-Z]U&Q3I78J^81)92/>.<A30<(?R6^*Y;+;HGUC$EOP
M/$J:?LUO-1,A\3DO,B :=B\\OAOI7V%<(7@8]YEV)WQ?CT,EU@5HO9U3LJT>
M)N 6OJ<F?IDB!1>&(:U7O/*W-F2+/SK]E*D8NJ P=-#(M0H[J] WQXL-,'0Y
M4F?A.!RF;..E_-@$SKN4BL^N=JF\D?A(P>>IP,^!HU;,JAB=]_B;X3ZOS0 \
M10O]*#.*5Z:>HX5,B/SC69+:F?K/M79?3=J"AYR;_ZL#@9UB_?(& J.UQDZ]
ML\>K4@F8PXR*78>@-5O:G2KB$6TYYGWJ?.0%!?&W;L'DN"?<[XI49.56W)&7
M3]T\"GDA\W8G<J&"P<DTCO?4.-.@T-QHM[O$(]?I,E295U'N_<F4]+N.>U?_
M7+Q%NDUGD5>*>:@HJ=;;#NY V*J#]?KNMOH%A9@.;PJNKJ[EE?9N\MPX(Y'P
M("1Z965"5[1>HI. KSJR[_Q5/W@S9W2]QA21)#R-;Q-<W13NG8+Q!VW9G;X;
MC&M3E*B/F<G%?>@^*WL@^OJ]MK$SG"(SP_,Y80-PPK6+?K3"*=W'1?P8 0_*
M<TG<$S: 2<3Y7S74]%07L4DQF":><EB\C3S)DAX2'WK0X&GL:#_!6M72Q<=R
M'>RM/1$=5RPAJV<[#X1 %M9RAJ-\J):B+>K+ 6J0##321;V>"!0XYYJ5\ D[
MI1OSMFA\5WH\:^5HNKKMB50)_3W_Y&Q?@9'EG)7&TQS%2))%8L-:4*$VO:PW
M<V*M$?\K:K*B:ID-4,FZM+#HW"#+*4VG$Z51-C3KR,+NA\5H3\E3E^K: R2:
M4>]/QHFV2X4C?V.>H;EF&%"QK,GQJVT[\QA"EZ5%/$N.YOC'9MC>?X[4J_B^
MLD89>D%(JB+J>QRV=<(=0A9@!9OOFH?U8,4-P";F7Q$/U[3\M-K!X36TJTLZ
MM&^?WO,>G]OMNQ:L'NKS6:8;XY_T.3WTY-G!JE7@F,.*G10@0A'9:IHC*D^9
M'T(93N7'-\^QI)TW1,KY,!F*!Y^U49#FB\>M/EGEF@FD.>+4+&0$<CRZ==NU
M/V:=\WIQ/U?(($5Q8JNDN->N6.OD,*ROVVR@0CBZ1&) P3/'S4D_YCKV@&]\
M>^=$Y#:I[IK:8Z5>77R7-T,>88=?UJ6%K"#,U0I<O>GN]6]E:ZSY$"Y>'&5I
MO$FW].;ER(Q@- E/CY>3FO9NP:2N(5J#OU*HNC!W3M&PN].)HX*-M%,K'+3"
MUAVMGY%3F3%.:L-_0GH*0O(6&\0'O#U+$-;D:(GJ:NSY\!QLC=>^#@IS_LB>
M8+D8=.IFCE9QJ_HC<[KUE0QEVV#;IWUQ@UHB$FH'4LO+8@.#ES?5V0 !.KCH
M3$I6,/)S5*FKW:HO&MT(AI:#9)KQF&V8,[A\%1PMI(==[W=?D17,"=]?8_G2
M:Y_(L7T: EL@X[Q/5A2:'-R'=R)[XDXAU6*N_Q/P3*AM.3MNI@[("8<$LWS#
MCJ+L&,*3,$Z#/,8J)-; J6+@9F\[I2M@U*QWS=/DA/6D#%8MYL;=HVU1H@;B
MI[>$V( [?,1=<=FU_P^1=(B;*W[<_A>CMK/KI4#;05S3V-.R;X1[W(DS=*6/
M^*6[KJAA7I0J5$!]<B9G>7MIN/D&SOZQL:5'7&*:J^"9W*N%A:U^RA<KE'?X
MQQ9GWQ1:1<P5WH9:X^P'%J^>^3ALG1B+ZKNUA2L9SR!ZH!NO/:!5Q6KNHV@\
M&5=X=-ZS8O1=5J1JM,506Z.)V4S4W7#!A^*;0IR8GU_VVRFL$MXY*Z565XC*
M(%Z'?S!"AO#4&C<*,N."NF_N#SY3$M6*%B:Z9!YW3[3]!ED1_42H.NWR6[9N
MRE-V9I0[I,ZEWL&?S_B5:WET:F_,QPX$X19,@ TX+P7V2Q(8/C1L4/$3<X(C
MW#$HZJ;)-H$-E/\LW,_M+O7"_.B:2+:>:I*5C"T'YDW;XPG$.\LWI>^23OM]
MG+]!E);/WWS:EZYQMOU$3:GF2F.^494 YP^\U,)GU+7G7VLO/Z[VZ,DU*]:\
M&9I[12E.YM2/Z5-ZW]>]NDP<!=[M_4!IT."Q8*Q?: <JHZ_?8:"(Q:4R]+S
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MEMH:I&JQRXHD>T^SA=B(*O=+[7/*&D>"[JMQ) ZD-'X>K)#_8F-ZZDKDV,A
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M_(,-J-7*[XECF*>]_YIS<K:S@0H\ZQ01P@:VQWM@E'XT0Y9+' )E#=7O,#9
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MP1!;P6X%=L@+)SP' ?#"&89^-\N01C49SY] NIKJ&L;LWS,K6_1E%L>&B2<
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M_;GN^LR[-M)/#K-7K3-)4\:RC_:AT?"6&UI?G*$.@<5]I:&QW#6C:D*D)1Y
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M^'P,$7!#0L/E.16I0#BSK;F_;?C9^/'D<07\D\=5B=,V;LSGB_6055_F90*
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M4U0/PL\Z*4W%%\HCQVLJ'O*O7H$'-VSSNJ>F<L5"S7\;2-7+Y.Y&#E;OZ4@
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M)GQ=)]9?!]/OV3"1;SV>QLOVX1[_39$K:K+Z^?IN34 V*_7LYGT2[>)0"2W
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MVRJ.(7BUCR%B=W@,_$+6N=Q.V;RL6E$YVFI\2'W346+]8JA/W,;4R\G#:7K
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M<(.I]Y/&))*69M I]L8AY S[/P_21W?M*^M_/!SX/B[_+OF)^*%P=798'67
MY\/8=,_GP$_KC8.6(:JOZK[=V& )W.07WMLS<KJ $Q 9S"RE/_22&+)7)TJ(
M=]%SILTEJM5N#JKI\V05ER:E>EU?"/:QU_A$Y?C3WR)L;.(J)!5[XTWE%:.^
MGZH=YI?%9RYUO5+ZXVM1W,"R''B8KY0B/1SENS< NT7(#WU1)"&R,?T>YQG4
M+5)*?V!O;#XJY'ZW. PO^7/GO>#K)@%/MLPS$KVG-/+O+@6,_I%:4518%]>7
M[?8X]\U\P4#;_=<6XEE@3<#[8D3H5XF*]WD_\VD5"L2@$X:-OY\:LGRGQ!,_
ME +:7]CLBE7>?B7[\E6DQR?=:.%/L L2U+CO_51]S?4I;B^F6V(XN4_BZ$?O
M\6FS6 G[D=L+P:'N[45AW$!Z%YO.+^*)$+3F98XW35U]-W)*\&*FJ Y90SQ4
MQ6D$)42YF/>!1[5 +"UX@_5R6FIDDIS:.T5UA;)P"(XU'55*OU_W;FW +:!O
MXJ5%3<1%P4!:!O(4Z0_'S);V!6^C&9JA=%%08+P.UU+V>8K1LN7H[^"G&<@/
M][@O^_M9FOEDBC:79A^?+W)N)CO:\5Z;&NMM%2.\1,8_E[^DJZ-G:AB6T*B-
MS$U%7Z*1!A\VEM<DJT0390)Q\^*6A)3\Z5 E\^D2]<5A[&!=S$T &N)8,'+7
MP=T=[<&"51/N6S,/FXZ*W B_E,.9X_P9Z<5LY_P0L35J69*[%:I7WN7_S7,^
M1-@P^LJNQGU'E?-RYDRZAN,DL=8F^^>C4-?/[XX6C:L=EOAN?CIN3/B@0)1K
ML" =Z7$DS%'>69\-^K;)T[$O-';5_@&1*ZHRC8X>5CEA8ZZRM8O@T;OI< E2
M')#TCM?SSM;,W(>^!IZE02%:WO9D@^*YBFJ;Z.2KW5*4DZ\>'9F^LB5\56#Y
M^FT#1=^_QDJG.+T+!"0$E,>=,W&^E4,BYKZ8CA\#.;TYQ.='>\Y$+@6;?5&T
M5!=['7V5$]*4XY*.<I=5@<<LY8HO*V;NTEK_2J/D/&?"?=8[0BP:$_3IY\.8
MCX9_@84E^LL#:J4+7+6YJN23"+$>)4T>(3GZ-7Z 25C2"I49D!-VM!3K?KOU
MMS/6B_U>R#O9)Y(A1TAK\=GN#63%MI=X@64S:\1'U0Q/A8;>HHN63F&</R7N
MJY[BU/_'O675?YT=L&= ["G:4\^D*7H-0_T.CRM[H]_P!^RA:I_3>7D$(=NK
M=C$KA"_N:9/G*0J[<<76I#:AT3Q2"^U^@NG?H^@8#4)PN-Q$X;5GK1T?I;JV
M?GB$X'\&V.&C6HB%1G5G-2OG0L(POW>G#==MTYZA9YQ!K?H<U.HWBOP_[\8,
M5BNR,""=OTA3!R<4Z;'6FY@RS0G<8'RZD6R1AV']1'M'L- ,_8*,SHE,7NQ6
MK3GFX$GYWR$%BOHJV:EQ>P^LN+EO\H/;F5^YZO9PC4KBB_3-?C,@8/4FW4Z;
M:PA\OZ6M>[7G[K1973C'66)&9I_!-<[76YC _B3N>=_0+JO0UK['APVPO+**
MD,"2"P <'ZX00].Q0R_,E5A6@&[!6F^41*DS(,_1'K4EHVN-H(2Y*=KC-B:*
M&;=%\RP:QO?SECE_U TW"=#N^8<!L:S6!O+/Q<SWI]$<G;.[9S^+E84G],SM
M%'!5&^@\9"7=2$@^"O$=/8['R?R$7B O@=$EV<=(['WGV-XJT>KGQ"=8R8T#
MGB!9)W4'W[AZ(SMHL2^LO-F<J+5(E4CEYU#*Z@F^D&\H9](\S?FG]:SS3Y%L
MMYLOCD[(>3@8_>Y-5$XV+]=SLW2J$#XT<7:)E+-OIO+S'[ZP.ZN)94DM^)2L
M+YISX0)\'[U>GT(\F*SR2G 3)^=C>N8T5]_XC,VK3+UK<W22>+S643=/>CC?
M4@/O3J'5.F(/5@82B2&BHD.\G=K=YX@JS4NNFP1/2>F#CMR'AO/DDILK&+5"
MX0@$5-YCP97/V'_1X*X!<M_\$/M6-XS6E%WVXKA61DY^2K)!CHLVA4\-!:-<
M@FYQ9>Q9N1(&)PCUHL'H]\SO!=A).E)4[$GJ/XTX&E9QHWBLI?<=2BUW1_<1
M)X(*L5+PZ!O0__SY.(_>H_M*?6X-I*J4GYY_E3?8)"UNI]I#MC^_K]CHF(=>
M7DC][9>0*%6)047.:Q^]+HF1X/\I_:WPI*L\3MYG0?;QDS>JXZ8FD.LGOW?
M?H8JQ6V>+)+NP)\FK:&=[ODQ(*'+?^,A/],\<-^V2L!F+7V(B$:L,(]^+RU2
M]2QT>'.XY3A2!K._/1?AZ&W7G4M!TGE2["-:Y*X)%[J,9LS*[N9M0@_*'F'(
M_UP^(GN\Q9/JSD*P33Y?2('DM*(]*QNI/ZP7=)]@9N\VLHXT5L#0&V!7X<.
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M05<NI(28RL.)6(H&GG8-2W6OV9R!L6IX[JFX.JF^.M7OE51S>)SSSZ'Y(:A
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M.%UF&""%*CF7N4,>X6T.\]J%=NA^^Q0!FK"0E036>0JNMZIA#(#P@^6S;]Z
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M4UPGO2$1H7#=IZOR!MVDUHL/)_Y[C\X'-TC^TR^1P4^C_0+ F :-Y?[[ZS.
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M';=",N2P?5#X7N"7Y^%L^N6E$.2OL\C":;/^[CD";*/)<7'1&34W"*RO17)
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M=W]BZ:C>;$8/M6%+./R$!?S4'?3IE].+^09/_RP6('"VK4/($X+33?:EFS4
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M\=Y!C&#'-OE'MT>"=&>O>8;]ND$%Y!*GTJ]J^I#7E!T>X@\-C%?MYL+DQ7'
MG I^XZ#[(X2;O^6YQH468N_3;U.*0:S?P &/U6R7E+?;_HF75_0B]58@HKH
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MN/OJWZENDSCDI4[1W>@N*"<>7>\3D!SML=S9I917:*\F^+K Z=U=Z^(W#E.
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M'$%2H@PB"@/=81E+4.%P3W J>HE6/2]18?\J;>A,LM.G*^_]BHJL?IG[SOA
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M%AQ"X^[2N#3TY3?GSMR9[XR<[]PYSW=V/^N/VEU/5;V[:JWUKJJU-^P/; W
M>2\C+P/ P<$!QL\_ +8(2 (H2$C(2(@HR,C(J*@H:!CXF!CHZ!@D>"^Q\2E(
MJ2@I2,G)J>G8&*A?L="2DS/ROF%YR\'-S4W%P"_,QRG$QL7-^5<C<"BHJ!CH
M&,28F,2<-.0TG'_W!>L$<%& ,P1+>+A7P M<.'A<.%@O0 4 <(AP_W0!_^\%
M]P(> 1$)&045#?VY0AT.\ (.'OX% CPB(@+"\[_>S_\#"+B(>#0<XD@O54R0
M7SG@<_K'_42AE:CJ(E"=/*/C^N08@(I&2$1,0DK_FH'Q#1,WSSM>/GX!22EI
M&5DY^?=JZAJ:6MHZNJ9FYI\M+*VLG9Q=7-U [AZ!WX*"0T+#PN,3OB<F)?](
M2<W)S<LO*"PJ_E5=4UM7W]#8U-S=T]O7/S X-#PU/3,[-_]G ;R^L;FUO;.[
MMW\ .;^XO+J^N;V[_PL7'  /]\_7OXL+]QG7"P0$> 3DOW#!O7#[JP(N B(-
M!Q*>N JRB</+5YS^*/@2<3^KNE!IN53/"#XY3J(1TG&OTT/^@O9/R/[7@ 7\
M;R'[%V#_'RXP@ $/]SQY\+B *'!SSYCCA_8?RJ_4S$*+W/WS5:/?E8N]G*.^
ML13C=?#R0PM?Y)W<[<Q"Y[D&\ 8/28ELOWSZ"ER]+JQ FO/ZO,(*.8G80HY1
M:F@-E8CJ,FTU#[UZ2CSE27^=[TGQHY2N<C)$Y%RKP;C<4QDR'U1;)J& _N@Z
MO'+""=]#]\.<SLSB@F!B?M"($ 9LE1U278%%'^%L)$/O(=H"P6J)M-31&U4N
M,<0@3[%F/3L][;J:C&2/O/$ K?G+,@7V6T@##"A7@);LC(-IGV33J.XA1H^H
M1?#[@LR+=C+#9"/\\396WX4<:0;-A?N4]!MZ[.]>KU#"@ I&&)"H.N?#"F*7
M:(\?/M7&='A)$$<=M@6657X?:0')Q@*';W#[1F2BS9V:UM3-O="7ZU)A"-M<
M4A)#)7ZT4>LU%#S;#6++J9^[HJH>X72/"WQ9:9+NHBP-.#MK4-!J5<[7-KJP
M<JY_87V-,$"-8(&,'#BXI<G6!GG9W4XRTU%SY:UA5UZ/? XM_(*MU(R2C943
MWCL+-?BY)T#?7E6\\IC9OYWX*3''J;$Z"1XP^XJMHN,F^A)*8Y/=5R9?\K,Z
M59)<2N9A.43_-:_#8:0RLI%ZG8%NC]3T"@Q0:XX&SW'"*S"()_CKKX;X,-[*
M]I&&3E\N*_%^X(Q3?"EC]+C<@_#@4@!5KZGJ.$.\:L\O9DNS'J,\3 K+0[_
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ME/C3+I^G3GE:0!4$]=4XO6\N69#@[E/W)N>DM&0P(N$TU6)ER]S=OAWSH%<
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M'W,)V65\N'VC6B5H*"'5-9[2(Q&]\F/:6KT!O&ZCLLC4#6.TYQ%ZXJ."!@P
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M&BQ"N:=SIH_IGN:"%6P66+\4?J*+YT15^A';M.OO;Y@F#;@?W7BL1E8XMY!
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MN1@(V'RSJ+=9]&7]C,;I>K$_!KA\UZ+*N8WYZ ?*/-E4[G@0R0*-"!I6?X^
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M&IM ^-U>D("0Q;CB 1\3U",BJ_BRY9(4A<.*I6%KZB(TP__6-9+_S^]\^C\
M4$L#!!0    ( !V(O5I769E%_@,   <&   0    9F]R;3$P+6M?,# V+FIP
M9_M_X_\#!@$O-T\W!D9&1H8$(&3X?YO!F8&9B0F$@( %B%@Y6%E96%BYV-G9
M.'BX>'BXN;BY>?F$!'CY!/FXN07$! 2%141%17GXQ27$1"2$1$1%0(8P,@/U
ML+!RLK)RBO!R\XJ0#/X?8!#D8!!@<F!F5&)@$F1D%F3\?X1!GH&!D941#!B@
M@)$)Z$8V=@Y.+FZ@@JT"#$R,S,Q,+,P@5P-E:X'R#"R"K$**AHYLPH&)[$J%
M(D:-$Q=R*#MM/"@:=/&#BG%241,GEYBXA*24JIJZAJ:6B:F9N86EE;.+JYN[
MAZ=7<$AH6'A$9%1R2FI:>D9F5G%):5EY1655<TMK6WM'9]>DR5.F3IL^8^:L
M18N7+%VV?,7*59LV;]FZ;?N.G;L.'3YR]-CQ$R=/7;I\Y>JUZS=NWGKXZ/&3
MI\^>OWCYZN.GSU^^?OO^X^<OD+\8&9@980"KOP2!_F)B86%F80?YBY&I'*1
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M'T19@2+QJSV562)%C:2O%2E*20-8H6/0?S$GZSV>P>D/7Z:$,=N= [#*B&>
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M;\([A8]@VN',: U ?%,%,6$M1\N<N9=S]U+V Y#-0(KF)**I8EY'91.AR3,
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MWED;<+.8$9N?5]-$'1D2&Z!8=^SHWF8;T#1'4_<B6S.<QM0&>-;\.OKWW 9
M+0*+RL^Y:2**.H@,X*N'$E7>@!M Z[/+D->DQNIV"#?^-8HVFAU%"Z4!?*VQ
M09*UIWA[*?-AFV"!HIB:COFLQ(?*C7K-[Q[0H  9$XY.J1;?B<?+57$8K2&]
M'3<#:ZC?UBM:@YQG9?U>*H G)2@9"O,R(;R"%(/9F)O-%S%0XFC3T?-U9 9
MMSJ(4KY#E]_B JUF'=Q-9X!>W>73<JEVF'U['&17;M;Q00_Y(QR<BDMQVI,Q
MPU+= +]M#12J7[3[7T]6)?WT265#ES5'.[TJ>X5"R"+"?W+0+OC4)5PYV4NY
MD6QJW=S<BX>!);3>O\ON^.:U2AM(Z\V?^8V4H0RSL,TL#-%\(0)2UI"".11/
M*!-< K#I0[:]BQL80VOD4EJ?EU3HJ1IKP ^?MGU\0[#'W@3NUA F4[@'>+L?
MTVA>J[52&,#7\=;TL#*S.B,H/!2M/2%HHS$ K.-]Z@$P*^]CXZO46C>D&;4!
MB!9O6@^ 6LR&E1>M=9?+.Z@, .Q^!_O_/6[BOSO X V<>0\R)>)D'W<86J[$
M1\!4VH+"V<<=;O2KW</]PU?[AX=O_\'5?O&P#%,244,&^OW]_8N'.QJ^('2^
M=[B_?Z20K[944G'* E"_QN7^2/(XX'CN22K.1-Z00)#MI<*G#"(4B>*30C6>
MJ(<OJO8>4?,0W-EJSHO \ E5OA3\GT)7;J"VNE9L^HDT/LEK>0J]>>^RU;O<
M(9]([=.LDKK6'_; :H7PC"0I_&^,B>H':1)7G-#(PV )V0KX;4HAS"+ 5RT[
M'N.;A26X)+YDU5)$_+6;EML52;L'A[M'!R\>6)!+:B-$W@QV0J3E>@@AN3'H
MOYB3-0<5<:Z'+YOK9SIR\4,8TTO32F> W4D58K8[!V!E4FECF3T81BQ-Z2V"
MZ"9L>QDD&RLA2G &$=T3+ 33PUV.X]&!7IRNDO)OULL(H!_8&$%*+GY8*5_B
M(@.GZ<:FXF*1](]^)L!H9(5^2J^0YW]MH??&JK%3<O&CJ5(80G6/743J36\F
M_[CF"](I7Y!^HB1>75Z>7,'E':0[4BQ.HLM%82C\H!]W(BH^<R=D0._Y8(U(
M,)5S2A"KS=V.I^88;H+*_M\'9 D0OHC@4E!RO?@JE _G<OL@Z_FXH]@A3M(E
M.M]N;*;07V 2DCF?*"ZP7]>@C<@%1:37XNS!7P \SV.XRGITT+B@AA*&+=#J
M,Y^365E^7:8+@O,5LHJL:9!;D^>"V,*T+_B29JT6ETU]MSG;!>%/^"X4X;ER
MJI8%;\YR0NC*<5-%;EVN"Z+?DEETSZ6JC"K55)=$O42^N"K,FD6NY;H@NKST
M4XO&+2O00>."&J=H#:DPY-:IM9/*!57R>:<#%A-"%Q0ZOQU-*5C#L#;@-^:X
M(/(MKPZR<3:5RJ":2J]N)7%!B70IW+Q =DK4XS"&YQNV^(6$@8AGJ?7<-@(7
M%%#6<'U-\)I$ZOGV]#I)MQ'9%'-"V?*$UCK;N24XFB_!* B0?%6=A))#W=BZ
MR5Q0)NW(VC[31N"" OE[=!T3G0FA"PJ)>V/&2ID2NZ#8[8)0OF:BRPDE2\08
MH1LA?G6_WT[DA")RO+WJ-TS;%'-!V5-X%RE)Q1UOC1EV$;F@B#"CZ3VQZEJ&
M]"ZH-\;PBLO!B]4[E2;/!;%5IYCTZTLVQ5Q05G23#G]G.XD+2MRNH'C(F?>&
M%>&=03RCQ.11Y GA*:KZ"E@V)9Q0$8H0R%"]?TMHU1.CRW5!].JU]IJKKCG7
M!=&%Z8\80W,LTD<X:)A16+VWF!=Q04G-O?6&0X\6(B<4279H(S;B@_&:[]-T
MZVX#0A<4FBX051?0R_(WI+LE+K=Y%H<1J#9\*X4+*B1B\>G[B@3R8RZ1?HEI
M2NR"8J,P7F)T E8H N'EI.('UV0Z(7@T7< K0+_"2%[YP3Z\!2%D.I>^,;D+
MRI5'51S4EEFMHW KO1/JR27QF=4"VH#:'=7.K50SH'9'M4]6JAE0NZ/:+U:J
M&5"[H]J%E6H&U ZIUNE,[:!R295N:!S&0SAN(#7RPIF1NJ"4:O:_]O/ZV!1S
M1]E?^REK4\P=92_[*6M3S 5EKR!CE/T*Z9WX!,@5P< GU>B*%@H75"@^O*89
M.2K+8JL2+JC8<CR^_0'[\S#4),RD7Z^T*>:"LNJ=FOSC99K9LIO,!66F]V2Z
M(#$#.)C>\YS-=,'%3&47EXG1&HK+IQ7?CW4QUY1=(!I!B*TT-2CC@IJRRXQ6
M*RJ.143I&_'R0M7[T$'D@B*%MA^EAJ:1NQ4XJ\(N*#[R%PBN85!QAU5371 U
M63,;+*L='M*3M;#!<MEY)2X-EL'.*W%E$.?BO!+7!DL^YY6HA Z+2(_N .,B
ME0NJ7$(DGF904=S'A'SE:TT^YD?B2]%E=8PH75!)$ALH9$#G@CKG(7R8%&X3
M5LY(]=DN"']-HN8)NRG#!8&5/8S$'9-FJVDC<$&!DYA%9 EIY0BWFNJ"J!WQ
M6&['8G5XZ=UVSXL(I-I\54UT15"^6VD,#W5*T$N$X7AVPJ=YI/-ZM).XH 1O
MU'+L=V5CW)+O@OAEV6Z@#]%:"'4-HZQ;MI)T*J%>5HG2K#L0BL +K@R\0U&J
MF<I;$@PC0#>/H1>DPI\"YE!\6(RQ&,H/TL>1$$;<#$DB6N0",]/4LM 6 *Y4
M58]A@-DJ)C.Y8HJ%C-\4H#&= YQ\;OB$L(AET=\-&:XJ(5ZT'./B$4/>/;(A
MK)W&5=74I]>$\.>\_ZM+\S'O F,NFWH/\ACRA1PL?/+M"F%"I2LS@A0R$>!:
MYJ(\G5<P6I @]V2G#?5-:^S?[+Z<C)ZLW>78HL:>TYB*#984*OGB<+XQEF\7
ME+RO%H6>F_92<%OMM86>F_82QG1QS/ARJ/"<LHD%Z(L^MY90@O=KBJZRUI.Y
MHF"R_!.#+SXE14MW44QP;RSU/"&W;H"68BX#71NN+O"$\K5")(X%?16MT&O0
M;^;S/(WA$1K)BI'+!I.'L]24F1+;B<*&V?,TG<=J+GMN+AM1>ANBI@7?!I=C
MIHS,R([=\S2DQVNR/OR>AS'E=]&Y$LEE.DL#TK%X[D;3IVE,>;AL'+G,BH!+
M7@UL,[(00S[/T4S88S22%2.7#28W=S&?(BES-C J98IG!':CBRG+YVA&Q9'B
M,9JN+\_O;5RC):%1XDZ6D^L*H.#L825?I<Q"X3J(7'72*M_R*6(KHK:WXYE\
MMS)3K(W 5:7RP>D"U_VW,'.L&] YVW$GE/@0!M)'+;T3%*8?,X2,<V(9@D:4
MSNK9MJRM+GL,:9^!KL6M7ZNB>L)GIN6(5>>#=F4;Z9^-SLD'HDVP;29]-II6
MYO:&!:A5B6>@=WWL,5#=K-"SU)ZO_E8PBD%8>>/4I!%:RKJZ^"BZ]*K/3V6!
M@>TTSL)<CJH^16L40!P45AJZ;&<URK^3EZS91;A.M(#T)*;B&[]JK3OBW"GP
MLQV.;2F0_$KU[[VGB<1VZG& +&Y0&L6?PH?H."P&-UD6VB*X*4K9/"K$U:ZF
MAU5/Z1R4!5&%FS?7H8:?$:5SH&G>AM-CUUG .0@U$K= :57".4A/DVE"'*[C
M&.JAU!(Z!V%%TAI@+?F.P).,[FQ"0N1O=(-_0[8C\A\#AG@'F/%VAGSEH%&C
MD\H1;70ATUIT3,D=T4^(B*-PD\1(^_*S?<)53 GF/Y/0":[,WV$T"LA*1+XV
MJ_XHG!QIE5M_ 8,XY%NA,\Y@*>)]/S,XB\-+M%;[(?6E5/&VBM@?KD3QJ9"\
M/D,\"JOGTB[GXNNP?',X@Q<X G@NUCC)@K1?ZU@P=*2-OA#Z-;]@(#Z8Z^='
M,KK,WG<OGGY;MB(,A++0!?;#6%R>$ L#%=0-@SRFFQOR##*QF09AU9GV"'Q<
M]3/8J)8^W2WO$(B$;=JIC=F/T%AR4ZLN ?1IGG)Q5QOD#%#,4;SB'#>G4)[M
M93= &[-<'2G2HZQ"A.X5"H6!8C@!FY*[U9#6T0MI#=)/(+515D/NJ+[)CF,L
MUNKR+:["%2]-GMN:Y"]ZBZM)Q1UO&X'K.K%H/)./8->4*>8XJD6ZS%O#H+K.
M*T9T)"[/T2R"].\0T',2YT]!;,7"T79)!X\3LKQ#6+U,!7TRQ^@/KF; :=$,
M@5Q1%58@W."7/!F%,F2,Y\5+&"3^X6*&[W-M:S$TW[I25Z>TU%<T!0]24SX)
M9^^#5?U)&AI'S:HJ->.S$"5A*+$!(=-IUT#GOH8%V^M 4$_IJHF>\8G7%V\-
M9E=I;X#T.Q'L<TVD^.)YG\M"'))E&5=7SKGT)<FO"0Y@$/OR>"499++ST-I)
MZ;9,?H#&48&%XFN;DQ!4W)8]FJF#W0_38&JT3_:CO=NIRN4':)YD?D]FBAXM
M4V/P S1*\=&(ZB2[/1M7&RAQQN"Y,/830.EF1N@]H &[@>+5FZ#PI4@C4D<7
M&]4H!6ZZ0LSQ[$*($X8E?X IL:M+CO(=MD0;L>=B7%!!.IY]BH$(E81R)R:?
M\\@76_T*NQNWQ!7*I5<7+)#?C+PAK:N]N2S^9ZZ3W%7S!5$2Q"(._)IUU1,[
MVJ/+X@N(E*^]6;U2OLO]MBCR>2SF%YU"6:ZKZHR"?\9)0.Z4J*_=BP.C"4!\
MW"B^[J7.H]/@5N$-R^X*;<7"U6Y:O&9R2N[Q2CF8SPFM>SL-*%U5,_?1GL-2
M0&\YU57Q9>#8,6 P."%+L;:30HS$%8.Y)#W>Y"3)&<%(K(?&*WFZQ4&:05Y)
MP,$2\H:AF"_5G#(ED?A*L BI8LB7-R5+\6K?M-IG"P#K:(JS!TA]Q.13(U*=
M+U!\,P &(_&59OGPH&JJ<=Y4QC \4>7;/7,H)?J>ML^W1(G^A9<<*YJG+3.A
MR-_>[/O4:#YC/G4;WW5K?*<Q,*&X5F.U)2L<C_%]Z!329:FYOT/E/8-/T]3O
M.JKDEO9)7C/3=.Q^YOW8M3HTCFQG9DKK;V_>MO7^&):=FE'PK8W;MF*'[/N)
M-6]KB,*-UR=8R7P3&1T!LNTACD2#;$67M:QEH>_]/$?O45$W"B8Q!TG %%=C
MZ_'7IJ;O/^*>0N93)+L(M^X,\15*ZTT]-UUDW_M.3G*=/+?G2?8Z>[YO;R/9
M:D7]2(^SGP"V& 5K,;9D0I>27-WHGB/*HO*]E,HW=%H(7/BPP:TX%@O:-&BE
M<$&%8R)6?[-31*$?$2JN[)XL$)SQ\=N/12C&>#;CDUGELS76I;ZMJA_VF+_@
M0RC_^2]02P,$%     @ '8B]6DT*ZY]3'   ?'T! !4   !N=')P+3(P,C4P
M,C(X7V-A;"YX;6SM/6MOW#B2WP_8_Z#S (LY8!W'R21Q,C.W</P(#,2Q83LS
M=Y\&M,3N)J*F/)1DN^?7+TE)W90H/J261'9V%[L['EM5K!=9562Q^,L_GY=Q
M\ A)BA+\Z][ABY=[ <1A$B$\_W7OZ^W^\>W)Q<5>D&8 1R!.,/QU#R=[__S?
MO_U70/_SRW_O[P?G",;1A^ T"?<O\"SY.?@"EO!#\ EB2$"6D)^#WT"<L]\D
MYRB&)#A)E@\QS"#]0S'PA^#MBY=AL+]O@?8WB*.$?+VY6*-=9-E#^N'@X.GI
MZ05.'L%30KZE+\)D:8?P-@-9GJZQO7Q^6?ZG /\E1OC;!_9_]R"% 1473C\\
MI^C7/39N.>S3ZQ<)F1^\>OGR\.#_+C_?A@NX!/L(,[&%<*^"8EC:X [?OW]_
MP/]:?2I]^7Q/XFJ,UP<5.6O,]*](\[U 28H^I)R\STD(,JYUXS"!\@OV;_O5
M9_OL5_N'K_9?'[YX3J.]2OA<@B2)X0V<!>R?5'OK43%\SC*"'IC"#M@?#TX2
M:H^44@ZV('!&32XC#Q3[JS<O7[TZ8KA_J'V4K1ZH7::(F=5><-!SW(\@9C*Z
M74"8I:;Q6S\>@8YK0"#.%C!#(8@[$=4*.0R%;,K )<6>7LVN'M@LIW9D%)D>
M:DS*.@FQ XKA:;[-DO#;(HDCNC">_9FC;-6%7#7T%)3VEK(EJN%Y. 'IXCQ.
MGCJ9K@34ARZ^BJ8P?#%/'@_"552N?*M[*@(8YH3*X :EWRX!!G,^\#&.;C-J
MBW"^.D5I&"=I3F"=[,H/2K@I*S^Q'QA//Q6K9\^!AF/UDHY $(AKE%S@$$64
MA@$X[(A_H)4[3Q&&:7H*TY#^@2T<5)R?$AI,G21T82;8N();8QAH-N3+)2 K
M.@?1'*,9G6[4 L(PR7%&A[Q.8A0B:)X>G; ,0SG38<+PYS"R]T%ZJ&$HN\"/
M,,W87+K Q7)V";-%$A6_A]!$HRW\6-3>%K/%0N\VL,-0>4W@ T 1G0M7U"V0
MDYPP!W&<IA:AF@WL4%0FU*:R%1V*B>.!2<9,G1IF* W3V'^.[F-H)R_5]\-0
M\RE)HB<4&P.$YG?#C%ZN2C2<6P'&(([H;PA=##XC<(]B*ZOO@F,H#=(?X1UX
MMIF2TJ?#T/ ER6#%LHF(MF^'H8(Z09KW9<PX^2#F-+']^X&\YX+&J=<Y"1<T
M^SV>$UC$B$9WJ0<;AK8;&-,0***1=+:Z(P"G(+3RD":X@;PWG$&Z#$<W\!%2
M7VQTV^V?#V53RR7B7BRE<_F$AP=SB&T"'PO0H;*6[GGAN+G@YR1-KR'AMFRB
MI>W;P=:#D$K?,OIK_WHPBZ:1.[<!@NYS-L)U#"PB4@/<4''^?0K_S"GS9X]6
M2Y3B^RFSCF&SCW&R$+NQ[Y@C'(B/.JXQ<RD[JFU@I\FK[.CMAF7\[,6.:GL,
MXV4RMI2:(,?):FRUKX,:-L.QHZC]Z\'S!EOQ* #&BF(L5T8#W/ 1C1U=:HBI
M]A-/8090G'X!A"V\C\9(K#_&@2P@7, HC^'5[)CZC/T(Q3D;9+-M=/8<QGD$
MHW.2+-DY<9YQAW(U.P,$4RK7\B[I-)K.6 ,.+8^S-$-+EGE]3>$LCS]3(M/S
MA+0MIYU9[X][(B[/$489_(QFL+E #\6K]0A3QH5=9^]V6(?697ODUUEA5FC&
MC'.[:J$;EJ&E_A6#/**F'!7&@/ZB2Q?" (<(Q*RLA2PY/9W5T _O-)%]5PWU
MQ3?^B<KVG)AQ#6UQNMRCLYEU0#8\'P.XTLE\IF8@:^OI@F-H:6_MR*?QTW+<
M<#R?$SBG/QTO$Y*AO_BR=_;\ '':/>CL@W6<_+C[RF,'/[0>S@$BO!231NQ\
MX..0FBZ!46?9VV(:-NOO*F<3W'3GGETIWP;GX+%H>4!T!YY[+C<F#$-3? -I
M$!E2,97I)EVK'Q$KAJ;)BK -TYF/?G@'WV_JOMP808<_Q^Y*I WL..?<72FU
MA1_U'+QS>ML-S;CGY%V)[XIGE'/TSJFL'?C0:Q_?S[TJ=A^IE!YI6M-YG3/C
M&)QJ9IX?J6E2):^*,_\G0"*!D)2%&WS=I2XD7S[TVQ 99IRAN?^=&06FN41?
MA1D0C'7"T'D1LL8P> ;2V'"F)H!"&E6=LCWK'O%O-WQ#<U.=-%RB&*990G^D
M0U]0<V7.<UTIDW'*NL^1;; //C,@FB]8BD<]+IA#5A.4X-K(W6Y&;(MX>OZ&
M9&F\,[VN*X$-[!A53#UB/0OH<:N<>@0>G?",4P75_?S%#EY'+9VH81YS77VF
M_UZ#H 1#',&HPL.(MKTHF:&,?5S>73T,]ME%UYR%#_3'\LO1*&F_#5FCZ!4E
M8WV-BI.$TR1&$0N:@Q(^*!&49%:$QDE8(RYF-U>3QA71VMV@&4CO^275/-V?
M _!07!""<996O]G<%"I_\4>1]9<;TA7N&-S#F(_X1_E=X[,#)[2R.VBLX)3^
M@\4HCR#F86)V0BUQ15T?W_92\V )WN1-,)AC$@8)H3'2KWN'U3B A#4SD6\+
MEU\<I.R(B:'91]0>*O@9298Z49=B3?JP(JJ$4K$7/'%'Q*GOI<*6S8&[F^L_
MKBD/*$T3LF)I]PT,(26))>&PS:08B!;"3@.OW&C 2/W@0M]^CI=;EC5"S5->
M"V6GH]=.9XD-WS[IJ3PE+,]'JL-"RQ7:"MA.:S\YU5H'*?BDO(+ +S0JM?.E
MXI>NS*TX)V4A:"8>EK8OVVOUZ*#\<)ZR%B0;,[/NDW$UCR4IF44%'_7US2N#
MLLKLH/WPND;5=1&%3RHL*UA6I_ A29%F@DD?^N%JC8I1,.B3#LQ3I>MT&-M5
M&J7NL\G+16BU&Y^R])4 =LIXXUH9!H9]TDT]RN(AEDWL8@"ST]-;UWJR8MXG
M;=5;$JA"2E_"+U4ZUC^$=Q.+:/GPVV"$8B1CYMCVK=N-BK+8Q'J+HOF]ZVF@
MEKYBAZ*=89\,2BYRL]&."L3U_.ZB(#W;/NFH4==B5)#J>]<)A[5V] S[I!JQ
MALZHE]:/7><CUDK1L.J31EK:%FE=HU=>12'ZW5BFU#U:6C9#6KYUEC 5BPTG
MR7#4V/JQ:_O1],:1TB,5JS[945E&8Z$.^4O7 8BU+E1,^J2(XRA"C&407].L
M^@*?@ >4 <TNFQ+ =>1AK18#RSYIYX:5ZV 85861-*3-ESDOVV;U2*%N+]H&
MUG5@8JTS>T'XI#[!I_,FQ?:^TPSIVB/9\J8.<WS4F$5[O'87I01R[:UZZLFZ
M3V"_[;])$M N_)J:#ZK8_.6@R>5G^N^35"VVEU+72AA?VY<P!C_6\/W/B+67
MAF<5:AS\I.-@@RA(9H& RLT))6'EUR29Z;QR[2-7007?<2G:![$J[##['66+
MDSS-DB4DZQ-YME=._\ONE^JBC![(7/NN%DU)\49O&?GESM*,7;"M]:!M<V"U
MSUR[++-Z6OEJ$?R^,\F7BQ&>EP>5FO"AY5-'X2JX3PAUFN7%T)(<39"J^-[U
M]%;*OAF+:OGU:1YO+EBRAF^42BX%S=:;XGO7,]M6,WI^?=),\69<S%I)1$N$
M49H5%VN,D\<(Z#J0MM65I01\4MHMC&/FO'%T"<@W*#"IF5(:&-?;*-;3RLBW
M3UIB$0 -KOA.W3G4>5#Y2]=%9[8:4?$X_KV?.Q@N<!(G\[9=*/:%^('KVC"C
M.)L$3R7%*S('N.R-Q8+2-B-E'[9\9R?3=VYEJN3/IX7B%#X0&!;M@^C/,2R;
M!(N-RW25%#;0=MHZ<KZ@=)&%3SKDA9P6N5+],SNMO'>NE5;NO!)_Q4C1U8HU
M$K!(6,6/O4GZ9 Z: 6O+]H*7E:SV+*GMT*<]D2\)3NHL&:-N#8BC? \@S!1Q
MA4]1RB_+\)YU15WQH9H1$YSKZ6/437,26<G!IR6.49PRDB$E^NR9,9JC=,&.
M#U@OQ7O=IKT9U/5:T4=_5M(8/X8NS$CL1K>Y]*T(I_4@KG=.K'5A9L7#5?P"
M9Y# -*MQ)K*LO8)L!^UZ0Z7K;.HB$Y_6Q.KZ5%>W;()SO?W257]V<O!)<YN0
ML#JC1#BGA&\.P3_"64*@T*66KO($4-$C#,CJ@HJ/WX-BIYL)WQ:LC%@W>4<<
MU'4$-(%$55%[2WSO94(RO8BFG).*\*0'TY<()^PZ?<4<Z_18P])^V5@1[$Q)
M@+-).#6C"C<^OGU[YT,H&^6<^@@QU!8O*0&<+4P>F8U2CIY%[R9AT2^*VJ9K
MMF-,%9@5#2]90G*7#!\R]!O/_VAA&SF*":(#\_9NC=+3K=FJM@3W/[ :PIJZ
MR<0_6Z!)M,WQ1.,SURM%*]6= X^M].^1#NN<MC],2"5V-=-6'7?#XGIV=[<
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MH X^7@2C*,\6")4<40432,7L(UCH<HF*&X%T92JJB><0*Z+$UY+_$>#Y>M3
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M2Y/&T6Z[U+Q2+'\JB)'(&O/IMY^WQNJZ2&<<)>LDN .._60!\!Q>X*TV4X?
M;;G9\]*U>0S(LG_E$/(^JZZ"X)W42+EU$W6:*@$66E<E$3:T2VU%.8)UZ<.T
MQ)\DF+?:IB-S,FP8D)J)"DA*9B:NTV"QZW5.P@6-7X_G!$*VF6'%B]QYCS^$
M7B$+-M@FYDE<W>\(H/%XR-!:,25U&RF1!1Q;(**;F*M&J:<-,_+;4E4)38G$
M65'0;9:$WZX>^-K*MN!1ME*?$;W3/B#%404%KJ!"-O%;])L,D"Y%W.2/676(
MP*7@2UCIW8-HD&TL2W5>-9;Y1./C!=6  1^Q)HTT6 \:"*-.+)O?F65A%F<9
M]:PM_ZKP3*QC)L]%$M- )BT>M;*9>/*AIH#F[S\<O3I\]W/U1I:K*7@&"$9X
MGEY#4IDO"H]Q=(KB/-.U,#K2/L50H0THWL)0_Q%PU+PPL40^L0E6I;.7*&9O
MK=(?*9\7=$:PJ.&$/[8WIW.(4ZN9E$=2^"$R7@T2;$;A+%?C!)N!"KE,/A%Y
MH JC8QIP@#GE>[E,<(UGZN,H=0N8H5#8TQ $H.V%7N$/R@&"8@2)V>#'VCB^
M,-_&K[:YL"V_(_+'MJ*J^6NQ+AU)T0U#L)FITP?0(61/;ME&9T=20%-',7U$
M1F=\Q)\-0_<Y0\GNM5MQ(H4T);) Q!9P=%-[B/P^A7_F5*IGCY:IP)$<K:R1
M! 46-1-ELLS^[YY&-/0W_P)02P,$%     @ '8B]6M9.ZGN250  S.H% !4
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M>_)H1MV+W.+EC+5HC\/+&7?<OH>7,T._G %]M/1YR!4QC)]QQC*'T&-[1J.
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MZH:Y%\%EGX&FH_1%P>R N%A%Y=<P6S 3AFK=(GRZQY)TICP&98,,['>28B#
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MP!3>X&.7*HC[-D\(,:EJ7G59/UO)<4QD5U?B#9PBAA&:IBG*], 1=;'U?-T
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M?P/T$^2EZ!05_R5GNV('O$:*UK;*2.[CV8XC$&-KW@<>'V6.O$(Y:W%B[8U
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M?4V*[3Q<S6LNYFC_DCUW".H/14$J7!V)$5P6>Q)C)YX,_9W](1K(VXR:8(-
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M9DW/=+-U94(WDQHDNEEB5=#M/\+3[7HVW<R:GNEFZ\J$;B8U2'2SQ*J@VS4
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MX2WD?:X*&&$/EPB4PL&98XM0>DCXW<>HY#M'AWIAJ3^;?H9J&W!HUIQY<+X
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M"YJQQR0;G#"6 ,7Z1JT&RJD*(IW.&<KQLEMNL_JN.@^J'/DBWQ2V4_':KUF
M'_5R&OG@!', *?2 C0HX=MT3O(O2Y/++#N<EIG&6YTK5O;J>9%::/KGFX,J0
M<A9J8)AGCU52Q8UI(ERKEKQ7+'A>7-P</HNXF>",M.%>0)89^12..5511=F-
M<;"N)\H3,](=2%Q!XL0M_3HU+JN9G$S</U/4H$72B+)@(H\!H%@:+G]W#BNN
MT''>#I/JP!8J*AHZV61BQW;PQ,&YG8K?OLT,?MRIJ>7!<,H"I&2PSE5X]X5;
M>1A#J>N\HE!3.K1K&@NN+K_$V9[E4_U0%,GG-%.]"3M5GX1S<69(/!L], 1T
M "MDG'2J37R#P<&VRM8%WA5EJHIK@I37+2 YQ-$FSU@$#%_DN)25SI):+#@I
M#,$G3(#1!1%P@<(0#-J?@W]IUH-6AT^X>BF2Z_P5EY6L;IE1VB</#)"'M%"(
M@F&)'I^0B<VE4=H+!J?/>'F!KRWT(WZK)0E!)]P"D *^>NEGH@"&5C8HY2<>
M=\VB#Y 9V'0.:3G5##MKMYFM0USE,5*D7N@93M1!+?9HG0M!"341('Y^[4<'
M\J%OTN@YS=(JQ:;4#*FD3PIHH [Y(!$#TXVHL0F7"UZO/E[?7#]=7X;/V1B@
M/K=:^]4I!&*, KB"..= 5X"-$(7DBZ9;&2@&IU.[#WL?'=@>K-TV^E0XQ :Z
M'+!LZWPL"88^6GC*[?)=+0V!-V2/$[$-J+U5R7MFCQ[VA$!R84@<TB*4T(C)
M=YO>P6ETP<ZU$IP\X%><[PWA1R7L.1%: WB2^2R1!$,=+3Q);C,71J26#LX;
MELMFUV=))7TR1@-U2!>)&!BNJ+&)V]Q4$DPG9=T[A>Z6[/JCP!V1<:)MW0V-
M4VH@#8<'6,Q.!N.(@1Q@6:&E R0:L&HP:;T'P3+M"UYU$>>QFA9:#:^'(,S0
M1T<?U.)@NA\S1F&FW6OPQ)B13G!V\2)#+T668%+6FUZ&)1R=@M=,!2/P4=*"
M4AH,LXP0A52&7N&?_^E/'][_ZU]*5"L&9]4]:0;I'*/NZ)94TO.^I KJ9#=R
M*@:&.6ILDD3S9O+4%!?[O[_]^MMOW]-!,D&O3.\OZ/VW9]]^R_]_5-:5QZ)]
M]5*0]!\X^0OZ[NS]MW\\^^/[/_)0]B__^N'L^^__V JF[,:EI$Y>[ZN5G=&)
M6KG#_/*++#PU!V79M$<*!3'?':<,Y+2W',J H:,"F*Q?[*O<=0QL*'F&/ORA
M9R*CU/NS#RI>GM$?__B'/Y[]ZW=_XJ+??_?'LW_Y[MLWQ<M5DO :[%%V'Z7)
M=7X>[5(Z%%4MMJFDO2Y@ZB&/EB_EHF XJ\<G+%UVTHB)HS1'C0+ZW>^#,^D!
M5Q$[_7\9D9R5*EW%\7Z[SUCY/E87(%9FGMHH^N27O2-#JIFUP+#.&JID[;P5
M1$DM&9QVXOC5>J ;>N9@-V. M92AQ"=?T1B*-[,%*).%8>Y#GEC3R*P6*@=%
MYX0J(46F XMPEFB-"VI\' :8CGTYJ =,Y]_[N-H3&IRISP^81]SSHJPL2WQ9
M6 A3X,O:-7EY+Z,ZF"[6'?.4P",]Q,3!%/8:06/(N%LE)J_&NEYVJGY'>_;.
MC,=[9CTP='0 :\%#%DD;;5@EO<8K4O<1N2.\)F_"%P3N,>%%[:V6L]3*X58)
M30ZI%PY5FF (Z@17O;Q83E9U@#&ROE-AU2T@6;T,42D< U4.J)DWU0#*. 5,
M(].$-4&0C+OF*Y$.+Z)5",VT,7 3RVIIT P;0;1E5[V0#))9ZFM_K+5"<TQQ
M\8^E"FBVF:_^45&N.-&U/T=NG3D.Z:PT VVPN0SF+-3 \- >JV)G;C"&J\D(
MB8"6(SBM1B#"V8S=-.(0"68Y:AL3"]Z03?!(.UY32@?EE7JDIA"%RR?M&$W*
M)2 #-(=+&>U4@C+*,"X#?1VC T@K@D$:CG%OZC9RP1<%:;>>%DD3B^._[].2
M9RFHEH =]+UOS[JX)>S:VBB#8:8K8N&4"[\@'17KKC]E.N3X**BJHHZI\WD5
M;?!506K<K-1MWRZ:3!CNU\3G.0;\55J?XUA?>]U%.SCY9D,6IJV=#;0NB"+3
M#L5-<A2/I<'C)KO/=(N[.P(-^>Y*:;\%'[60QS4>I:+!*6>'3ZSDR*0'%SK^
MW"J$W^1J3JM>T2_%SG0P4']-JY?S/:7Y%I.N6"4KZ$+_O^0I^J+<%9QAR>_>
M[&Q7QUNUSF; \'8^=G$C%\:Y9;:%S-(B.!KEN'DDXW<>(H$WGG@,!/SPY/N:
M)SG>L+4T7;:4#)PXPR@K-G!K#K*CWV%&HC)]Q>RO"=X1'*?U5<FL1XVV!:G2
M?_ _L E)\9G.3O N8A=S9P=$'U]\#I]]_ ,IRO*>%&MEFO%(PFM54Q':J+!I
M_S.LS#L1F%#CE$F@'1<)SH"['::4I*&P*8IHJA^FD??)#B/L(5>4PF#Z*Q-"
MH2AE*X\NH11DH6VB('VF7H-+X:]*V&L2L!;P*/57*@F&/%IXPCG4*(M(F]C[
M7-\X&9X\? 'E8U2R#,\M@R^[G]LD['7=2PMXM,@EE01#'BT\Z2%F],RD43P0
M#\Z?'RB129311K!*MFF>LN#)C@KJHY!1R^MXQ\Z%T1A(KP*&8W8XA6%2K56/
MID=ZP>GVB+.LSDO_%)%?\:#C5K4RC8+?&R-,P,>71ZBDP5#+"%'2_S6=W[95
M"$XG-EO 9<G/J%YA9:484<SSO4E2D).[DD8R8&BB ":Y$ZD30X^8O*8Q1DS^
M1-LS3SA^R8NLV$R/S0F_>MM8$2%UNR;]3\&_JQR/<)JM$SC1][LCFRAO%GGX
MT2093(F0MZ^I!-A]5$$"QK=5P1(FP@,Y?LPF_%SF8K 42/^=8?8/-O89K @J
MPI2=JM^JI?;.C&N8FO6",VT&6+&^J6;=-S@5^=TE[0J1:NEI+.-U$4\&;[1P
M-Q0 0Q<9*OFM,6"J)0OKB[;KD(%7=:U6<V&M_ZO@R8_: US([2#5V_DW16ED
MRU R"%]$J%+&]&) .2, 5"_\9U0H.%=NB[P88V\O5-?O(EGH^:VT;>G&N.ZV
M00E,AV6+5-Z)U1K?_*X-4 !VK:,T9VWD+K](2WXQ*!ULW:WKNYC>JQ8A#4I>
MUWJM'!@M]6HUP##-"J9P21+;#J?#YX2KT$ZQ6$.Y9X_Y4S)\F+IT^84UH'U:
MOK#DMKOU!7Y69DV8]7SSS<J-*>6T2J!89X-4V&&@>NAW3/'WC']XI,E8F#6%
MD$ZU?E0WE6;?]CXBU>$!QSA]E90KLI#WMJID [M;8-()0\D#LP6JBEP[^F[2
MLBS( >5%A1'I%(-'L.N\PO1M5:-^?S@@N,7J9&H;5;^9U?;.C-.LS7I@HID#
M6#$!NU9%:9V)_;MF >+W9RC' '+-F@MWY8-1W6J+1LG[@I71 6$%2ZD!AG-6
M,'73@YYJP5GF2C @W'*B%0Q&&=<U7!E5KXD5G%?3$!:<5_W:3'NL(,WWU+%F
M2:;(RX]X71!<RSU%7W!)QZ(D*DB2YA$Y\&IO["YI=B"AX&D+;;Q6]@0G?*+_
M$U$G?77BJ:J3/ Y6^SJ]H\(!5ESQE4?$/C"*NR>BHGLD>N;/1!5[')!62UUO
M(L_'.N55^T(ETOY;BQ*RR'1!%,J\R@ZF) OG-65)./4IU;H?6(1-BFGXC&;T
M*<T+DE:'MKFL\F1LI:Z/_ E7+P7]Y96*;,5;!+T_W=L2@?]7VBTX^'LTC,X@
MC--'= R\] %;7J-STFZ8E_%5N#1'F#\5;?ECZ1_8<S&$=13SJU'MDUKJAAN1
M&=Q1CZT4BF#FM2YHA4SA(4TYM>F_WP0[9<V?2M1'GN]9?E*1KZJ*I,_[BBU2
M/A4+3TOF/0S6C.28%^8V&9GS)!A=CQ<?9_0TP-KC15HV,''2OQ+JQ]U:76;"
MS42XMF/GG+I%Z/6!]B16H&7$'0]W.(.3@:T!A_F2/>MR8,RC*7AC/MA$QNOJ
MJ0S>:,5T*  K>LJ@J8)><!Z,"R9?I*]I@O.DG!0*NM[NU,E?;B;"%;JV<TY=
M]5JO#VV-9@9V=5GL3CTX7T>-:_4:I5D]Y!C4F&QNMOH8E6ELTT1MK 2+??8N
M*J.CV03@^&D-7A9A>3[':K?+TIB90%6!S@<7WS96@G/:/-R^QX3[JBOS[FP%
MUOQ,ZJ+;Q&MD NA(TQ;WE,Y<H)XG43U6K8'7Q^5K&F]FXJ1P_B+-]K0W.YK<
M8SO@Z"USTYG@0R-OB^(2Y,+INUKDK=-</YMTC^5.]J"N'#C&=P=C0)N!NP?.
M,5^QU/#6FH-S_'>T"+A)N/4)3N;>:K-8II^ VC3:V^;;6X!TLU2%K$\Z:^$.
MB2H5!$-!'3KI(0"!5,], QQ[FH9@Z74G'9)!$\@Z#C6B8%DTQF?'HZ36"<ZD
MO^)T\T*!K%YI:-S@^B*+N[5P/XLN/CG:\,FZ6>X-N>AD  Q#YZ">\K:U@:+:
M",JGEYP,;Y> $1<5?@^'$A;70#E; <!HDXL6G%:9@,YJ VXEKW,;7D.)T]U.
MS9/D$*E*R.^-43* XVNAAA)@6"6%)5;([>X^X6+A+S[I$-VD.>8)_R;_!H)!
MB"$ E9*CDX)'D"DT#4F8*.*R6J:<]+7W.UMU@J3\M4^E?OG@]<7OZHO6JHA4
MNKU #4YAM0QOTCROQR3TASA\%J?MN"/PR,)J[!!V=&#+%LNA@$"5LX4N658<
M2%%<,\BO@[Y;]YD:',/$MSD&O!T+F>58=[+#23MXMS ;LG"JGZHSTK&19Y]B
M\QB @/R9QQ!092 T ?6.F0@HUP9-0"UD%P*>+43$!<:YZI9V7K Y7,EK4=7_
MKE(Z.'_$,96L4F4YS"-M KB(U\U]B\MY[0P&Y_Z27H@WP;5ZK$$,--%M4<%M
M"74[7;@I6!L%T!8<7X#U3=5OOC6XN>'8');J(&8,E>_INWN)6%6X=9,+.FO
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M[4[QM2>_^_K84ECMMQ[]".)3RQ")YYC^MF_*Q%4%8L)T;E!?<AWDRW_"$=]
MEG_WT:^^OKH$4OO-!S^!^.(BGNGW;B3"?-QV2/*$OU0?,_%TN$+&][!.@#<=
MWW4"(#ZZ"I73B.\,/2U>/,5,B//B$6>8)1<WO+R-MK(AOD+.%S&T,%MR2(5
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ME<&0SQ6QL' WT/_G?_K3A_?_^I?F)'9P@EY&)*?QL[S'A"\OFF*74MQK%#.
M'L4SA2P8<AD "C&N$4=4'M4KPH#BW=098^TBM7Q(0NDK$ZF$P5+*%)]NBG+
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MHVI)M&6B**EE_W?H/;Z#MH\R"_WT<S)UMK:<#'N/PJKW..7&.P\YYWM"L.)
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M:=T.O(TU!"S4H)4,<H$LK?<$H!TK;@?C1^64;NN50-S@-G+ ZO(VK@&HW5O
MA$FJ51SOM^Q&<IQ<X!W!<<HWB.F_,\S3-/-DM67#Y7]$=6ZRPE/%FUG.O.?K
MD19]*9,;E1:Q[8?\W]?DS_&& =;%UX7]DES?U)IGE9,Z^\'Z305\Q3U:.GEX
M/:4%5M6=J./+4,]0COG4RO:3^:D1.@"C> =C$:]5/"7@1F4Y![^#Z0 EH*8$
M&8K87*#C<ZO9*8#;:P.JN# #M+:%XU8\>&/N3_6J+RVUK!U@-A#F?+:M8_+S
MV29M,!QUABRF!+>R]3;/&:H-O>.6P%04T'AW8Z@E8*<*XU9D??T &STPS'0
M.^7DB(%3@@(K%J!Q4[?$8%8#0DCE,H-)!]J*M"5>F"L.&O"#2=YPKNC^%I2&
M@##1X*@E-Q56H*T,S/9 MP80#<2#E5 >.T.GQUVQ"G8OW><TRV1?U$8/VIJ
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MXQ5>'OQ;;O*N)^N GNM8=N S7LCC<>_I)<JG:7HG'7P9,;S5]FW]>D\W;#<
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MHH*O9,Q4 29K%"B%=<Q:RB-G1BD0UO%%J16"-P879,Q1J$!)>7&#J[O6!=[
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MTHF@U13K98$22@ H!KJ4#JYW=&P<<;'@#&+)62S7]J:(\DEI$87'6@V?/+*
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MM" 8A^D$:8C51\YO IM$M'\]<!;5&&JR. AI6']]I3-TZ2"%Y:?/>C:?\)4
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MSMY4P#UY[S3[$L9)RJ-).66CFF_BH$E%+8$*@ZCH>+E/XS*:Q>56Z\X"*HG
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MM/ZF?[GOXS(T-\+K\PZ>X1M0_ZKD@W@5(X3Y^UD-KL@(]H ;D@AV>'ZP8(A
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M7>&[,=:AU#JC0Q7(<!WIJG#W+I/]<QC+P(.?O,3A'TS$@*WZX2[T:I;+O<2
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ME3=>IUJ""NBI'?NHA51PS(6=9%G>0Y$_AG'"'ERJ%78>!X>MB)^DD2SRI^P
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M3*):YTG\0HT_SSU7_IR'=/-^3WQ:,@]5B4X'-HO]K(+9)#D4/E>5H%35\;4
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MJ_R_A^?;/<>QI"WT!RW&&<A*I'K?+GHAZ6.2$=RK84K='D=#U(VA/VPQDAV
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MV9NSK)N[OR*_?@B%[%#W#R08]WU8/;*7K\0OV*V@<R\GZR3=2MX-I64E11W
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MZA^>Z<4!_V=4[KW S YH$BTY<%^V!\.'K@"_9F2QNLSR<.,U(N"ZK+;+H64
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MH9UB8IF&/J%3#O\=C)96%?18R3$Y$L)QU&\<B$$1K#9,XWZ$3: '<HZS&#.
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M#.7(%8^%7& '&1IP(BBA<5"+4*ZQ?1>#!<57B#&/ G8'&8V5U77<N,\&.AX
MM +5#T?\('T@<B 15OOT&9(,ZWT[&5:CD2HQUE@)L623S>[K[?XK4EYQHPVH
MB'R=2I/VJET.^;(.%%3QF&G)@I_U:M>CSG!7,''C6JXKL2[)P+^QE>$J(_[7
MZ^3EFX"$)?;TASWD]!]_W)"U%UW&U+AL)3<'::E.H6, 6=3O41-6Z<$M/RV]
M $B+')9 AE6$6 ?3PQY;NM[WS)Y0BY9%^IRPIQC^68196#Z?0G^3<CS4M\4,
M&D"[>M(!L[OJ-0<"W773?%JAF6/A;'OPZ(+REK))&\=@BGJ(92?_04\>=5>8
M167=X,5<&Q6<V;[3_,(2]]:.)GG*PO+:J+@P]CTZN=8<7GI5B8INP@ZWG6I3
M)2KKANJ#3)*H^^C9$PX[=>MMB,X R6NXP85<HY1\- 6Q8W3:VT6ET9$5QC8Z
M.GU1Q?H[9GK>4GIAD %29Q;^_I19^)19V.3\:YYEX9J_LDP[(L@YJ39P1BU@
MWPP=*;N=(6+H%G)G52[I9CC?LL=5DYAC $M\):[FQJ S\QJ*)6FH'=+3+X?=
MTBW=),4=(T2E;.UG6L0"64G!9T +[= FB=6)ENKK4]VBV->KE4K5OOTED]3>
M95J6N8G4P?.Z-;2P,/;59A# *@$<F1[>7%XJ^7G8A"FI<KHH."6DFG)/"Z;]
MZ'-1.7*;QUK084\FC^$>#Y\!>)\4"^]&&>R\5& JNH(==_#8/C#NHDCI[%U>
M<BDG\+UV+58-I=M?DU=MJH:UBYT)"ZX/HP!XU#I4SRS5\]GJ!96P,+;#!,RV
M0E0'X@5+V]1^F ,4-OA=.VR0MS6K&YOM6YLN?% B#CB*4%O_%$S8.Y@0R,TI
MIM!![^"-K9C"T['6X&.MTX.9IV,M@W?^A$98\\Z?L@ZV<V.49_X J-AZT2!9
MY9_IY^?9_)ZD+W27"'S"5%\/>X<\!C-0=.RYX[,B8C[JCTD0KD*_! _$$+ N
M=C+$$5@R0LF.HTGS?M0#V[BPB[=!^!(&A1?)GSN3%'5CRE&O%^2]1WD!K=.7
MW\/\B0=U,G5Z"I\?DDOUI0:10+I&D(F2<Z#G2B?:*588AC=,SZ8+(I8 __ 4
MIF5TLQ+R;C&TB7T<L&5R6X>YFJ<\S<2MJH!VM#XV]#(L\,^!3C%9D)@LO(CZ
M4TS6EQN39>T\Y123Y4+0VRDF2\X,^DFB64S6FPKBP(^,4@9QC&ELFBQ?))_C
MYS*'ZU62LH&I.,6$5'0_? DJB2/Z[F3T&7[(TY#HL^.+9CE%1 TUKD<?$:4]
M/K@B0J8/O>=E(>RE.,Q(BT5S(*1)EJ4!$M/T?3NFJ6ILQEN;-9L;+:C)6I(4
M1=13555?$\F@^D\D*)BO"Y9R0Q<6U:\Y-SP44';;)K6?S/CA59+N=FP16)MO
MG N]&J+=L"Q -R[%:WVA29SLLZS*]807%7;*]205#=M%W.R3SD<L*HOMK=$G
MA%)TWJK7YI8N0Y>1MWT@_E.<1,F:[DNN8U_I*=;4P=Z]P;)O@01'=].<%1F=
M$;.LD?10/=](*[AAG<:<7*2BHF<-%/6,_9@2;0XO0%4WF-1H)H"KEEAV8H1&
MMV]_O,=W9X+U"VSPF%2.F+SFX^/G1<K@D \786'D<S'H1K U1!1R.^@@O$FR
M;!$W1;TC/@E?) X-5D==Q:4E&H0UO43XW(VP[J[%R6Y)KAV-DN+8AW<]!Z12
M^*.F=1Y%R6?V,,Q5DEXDQ6.^*J*YSQ\_RY3#N(Z\!];'GB=[$F\&CP,G!Q>5
M MZ1%Q(7!')@\$/[P*!N8U8U,MW=YU;OP7>>I?6P3M0/NJ,UEK+R6*L7(+B2
M8W.5[ Z,D/V^DQ_9+I[+-3/5:A9U7"JZ:)C\V,D54#4T2U8SWM2L;&M6-[8;
M-TB':F6XG/X(K5T.^\",GYF?>1D)6*@?H;:Z5/C]':^S[;Y,]4#T_+.7!N!#
MM,&?<&/G+698>HPV6&K\HS6M"#().C.])*AO8-MNZ,7H8TD423@0*?Q#O5),
M^@&U'[55[,M@N"4T^HE<?RGWDL3!,O)BR/,)=K[FAN8(M=YT?/>2W]+53[;T
MFC]3,/V0=_,N7#_ITD&HZZ!'KUE4]H,;HQ#HT+W O2>;<CF>+8H\R[TX".-U
M^0RJA16 _%/8-S-&6R^-M030L=+;G?9<!MSF7IKCAE*/A\SOA U($LS9S>XU
MN7PEJ1]FH,LI4W0 VU%_#,H-H?!MJ/RC'J]'8[SN")N\Z._K:S.%%SV0=/->
MH_Y3=P;[8,/N4,"A]BVM/*ZIB&&<A?YO7E1,8[O;G\0^@CD&:RVFZ?CML^IR
M4L,-GM734Z#0T!YM8<<!VE.]WL":Z]0OI4[%9,U.,O'G^UX;U!8<V75<(F9I
MI3MR/YQW#%@SH58(/?H)OB/U0Y*S#%S3S/6PKV,G[7!VVC<A[^@U]2I)5R3,
M"TK^/ XN7Y_#M$RY50MO3TT!G\9^[,M9'073]K:7$T-1PO&C#>P6<%#\?!H4
M?>BVE0I['-E(D*3G+.XPBDA@MKC8)0.?LA?8":#'UU44&-_(8@/SQ,W@4@X/
M8SH2=;0)URA.KLOXN-<0QW+J9J+?IX,W!8@GK7?LA,)$LX_T',T6;"==I@C]
M1C(VW/F.@/CTQX>$_6K"Q0B\!U ]__(.XTQ9/"F]!BZ<U<S0?D$'R!$>&3K!
M^%L8-@.B4HQ!E 6K*)+BNM1'Z' ZTI-+1U!^(^X;/23S]3KEYP93;1H&= FJ
M^E_> >A@GM_")#+\ )G=HK*]LQ!\"JK77]ZAJ927D[[6N.!L"L =@.KVEW?V
M:<CA6]#X 8L[.5H(Z_E>G8&.A",Z6<6$TZ45^CBR'Z[,IE'?SC?!MU^^9"V5
M,/463/3XFY )U];P'D#5_,L[=S5E\:3T&KB<\MJ/O6Y__^4=WX[#^%L8-N/[
M:IU:Y8_91^AP.M)38D=0=FE/8-7"N.*UAW0)JOJG\U]CGG$GD;YQ\T,O(.YB
ML1?[6.R^T?-V^@)5^2,ZHT5$<Z"NBW-S(^:J;2.4<8B:5\S9("^QS;)B4_Y.
MD<_V)V4^6_:Y&?_>K/[@C'_Q(-5M-MM]=-;XZBGQ[2GQ[2GQK2/+PXYQ/B6^
M_=(3W]:9(=5Y;P]+?1G\'LJ,GO46FJ_6S4RS(C63X&TW1>S#Y^3A*2DR+V;[
MIH?/M.M;2>Y3UB%EZMB>;6&G2M0G@QT$DAWO29;FC5%"_[4?(?0??]RQH2ZQ
M8?3OC3^[,1ZL&:]#8>V\>0CA0CIPZ@Y"1X-E/@[Q$F-9=]7*>[<:,#^&<;@I
M-BHX6T70TD^VX>J *90%Q5Q\]%ZUJ!X60<N8J$=5),OQNK"OO##E/LJ&$Z%V
M;UZ$+V% XN#.RVVXJN&?/F7R'LC:V]+/NS#[=)42YF0G5!-R)FEE["924V4/
ML!><QZ&N !*_ *TM)Q-,K:U[\+;3:$](XMO2VGI6^2V):#-1F&^GM[::/IRR
M:X]&Y!>ANY/:7$T?WFYZ[LF)=$-W^T16J42V%3,'^.;;3KEME2BG'MO]W6.2
MY5O 2[L_JR(3ZG9.K^Q..[7=)G$9\U'*<1U3.0KNJIXBP9+1UY$=-;#8A EY
MP'Z^9.Q4N3L(!B1M')3>M4<'L-TQ:J6<&@WW]7) ;#K#PSA[C$I%I^\+MAL&
MJ*U8)+FQR!]W]OC 5E7*=Y\L?A/;>8(U9;= Q\I)+XTVV)MVWM.^[RD,"P/O
MUPELG\8($ZX56FSJV#![7,J"/E\:=@/;/S')5-F+FK<X2T+>1[3Z5>S7O+!F
M2J?>3[0XS^[D1)YJ#?N!_8#7-+-M+W+>HAELO, TJ2$\^"[V^UA8IE  _A=J
M#%7#KSHGR":Y]SM%E[&?V'+#Q ZE_"U:8\<.8)QX@<N90QA7GF<Y'<(X\7*6
M2^<P%E5S\C@#=E'M*8DH>UD)<144<,OFA#Q\V2_'&X$&OW0"#1K-_.N__/S^
MW4__/BN;VT49S'8MGN(- +V=^WZQ*2*VR%SD3R1E.IV2)ZK6%,'KF!)(;I(L
MT^0O,&O%C=M^H!G(3##\+ 3 _M[H<PZ8M^0&K7T4NA_I-RZE#+BG.//9IU1K
MUN4D9@L>=0X!3;4W0ZE&3O1$ JUNZ?()2(J[01=(%5O\2 2R<KG7@!;:H4T2
M\U6']%IJ5590U(VC)XE2M0B02HJ^(:^\!CK\6\7 &UPGT!?*."KR&?&_7B<O
MWP0D+$&G/^RQIO_XXX:LO>@RSMFB2#QGT%*=0FZ8G"$SA$BJ45,TZ*$O/RTU
M^K3(80EDT$6(=3 ][+&=O#'SJ-C$X;GW'.9>=+-4YH61E$4[&.M U/4T*,6S
M%"=R=3]_2+T7$MW<G"OQ%!5$._$!@"D7S!*29U%!KK;9T]^3B#EZ,FJ&E( J
MRD-Q'=\K!@!6*R?Z"N*^>,S"(/32[;W'L_OPK$GJ?9&\RO'/>'H9&_&<2)3M
M>\2R8BU6=.S&F><SD'6;(TA=-TC4*F:;,8!DEF;:_.&)?/323R2_SK*"G=JQ
MSF3S=4KX7D\]]T)KX[\J#=:[@XG:#!UT@WA69&%,LFSNTSU*%G)TE>906L&-
M<32",91*V(A#=H<L]B-5+9TE!%1U@T"-0@*X:HEEQPK>DM?\(0V?H4LZ17GT
M5X_!:M4T=%H W-N5&)PJ_VPM_+$7V&)9')E"+JI3Z#OR0N*"-(Z_'^A7U;,)
MI*X;=FF$B04B;,,1["*;NFD&5ML-1N%Z:\2CW7GG@CSF\RP+US$/)HF#\R1^
M(6G&D*N7F)G2+AJU@/ZFK8DZ-BUF#YQL7K=:%JG_Y&6$OP5$?V(9;6%TP:NC
MO^S:ERM3A-!GO#O"YX&EE^;;QJY0/=4I*[EA$4>8XY12-FX\.46<;E;35'.#
M/(!2PKBRG.#_*4S+3U*+G!51KCK0Y<GN%1707_D%*=1!ZGZM^.C6;1>T<1YY
M60;SD<NKN#$XQHP;ZLK8.!E$"DYI=$EGS$1EW2!)JWCM0!6!)':,UCU)0Y)=
MEFO(/*1*LJQCK]4107QY ZR,_H2L7(L.5FM&6-A:5/-.7 TA1%\9_95'$T*@
M6%@EY,,00O25H818<]Z9$ +%PBHA?Q]"B+XR.!F0"X1 L;!*R/400O25H818
M2P=F0@@4"[N$F+,P"/KOK1U8&T&/AO=_W5+2D[S,1=-[)!BT @Z]=H$78W2L
M<O7?HW!ET J4*R=67,;H6.7J9A2N#%H!IS=R@2MC=*QR]7$4K@Q:@7)E[1C'
MA"MC=*QR=3L*5P:M0,/0G=CD&*,S/5>CTS86@S\[L1(<@IE5,A>C##R#5J"T
M.;'X,$;'*E?+4;@R: 7*E1,3FC$ZZ$= [+Q^L6H<X*N/?R3%W3A5&.'H1R)?
MXPX34HJ'1KZN><RRRGB-F(O]<:0\PJ3&R+0A-ZA5JFD[DX.IB+9.DOPB#7-F
M%>J %]"]"4 ]J._/VK*CISH>&DP@/)9]@H;<J"M!/8/6G+*C$ ,!QA(K'\,H
M(BD+Z1-$\2FI =6$\F,M '\$?@P@LD12,Q1&T@]UI*-) U"'AK6S\A$H,P?,
M$G-]!M8X0^HGE_G!'$P\)+83!ZL/%)96P;LW/N(<! #%$A]U\M 7DN5\H0FB
M1%L+FBC895: T%BT76;C1%D#2HCK=LOR*!'O7+,T;^Q:Z;_V.U;ZCS\>6#K/
MQ>HZ#L*7,"B\2.)4H&4E1=W8=0YQ*,AE:^0$1Z3D]S!_XNL2IF)/X?-#<JE.
M2"022-<(,HUR#O1<Z42SXS3X2+(LS?Z;I(];:A,^4IO@)^IMCZ("WM*Y#Z""
MG8X6#'3WZ3+R8I8S0NTU/2QU_+9-*!9^'MRZ/[JX^'8Y-P@1J9($<,OW=CXG
M#T])D7EQ\/"9]GO[0(N3>O'GT]]0#6%=45_F,6T%NB"SYIL1J\_!E9Y^R%A:
M$#=[\Q2F.2'Q$)+T34 9LA:O8,80%!/[],QK?2GON3Q3X/R0PW;''@+(3'@R
M:0N<#]7:)L>(,7.8T.=__L:#/OE%JY@;$\X82=,/Y6H^U.'H0S[2UX[VHL0!
M="%AYVN.:(=(LTV?ZNDE/W;^;VY]RD=;=*?I@J+02=+:"W@VAT#GHJP$*5N^
M<O&\H':6J^N ITAKCMDI^ ( @>@NO./^2ZF+L/%G1TSC,+=@0YY:N\;).6Z$
MMW30U#UT) #H$# QF",%\O0"\Z/W&FZ*C0K.5A'H##%^1&,;KPZ:0F%0;,+'
M,-;">E@$;,G'=R#H<15)@[YY:3S_P2>8;%[D3TD:_JEZ25U9"<B!M2.UG@]A
MR9]%D>'B'G>-YP4-R#NH!1Y!1T:? !J7^%MZZ2+E&5&"W[RH($N2\GZ#:)17
M!B>).QHV=4 U2'TV>C#SA:2/24:&O.0ZSJ[SX+%,EEPOS4BIR,]1J'A6$E09
MG,+!;84P  I]E/,NL>SP)+@H4FI_RN>S2[/4Z;8R[99A0]!(UV,@VQQ MXG?
MAQHN5HU[0ON(^)YZ &@7G"+AB-4"#&_O^2)G:H<_6\@ *']_E:3W)'T)_=[Z
M)&@'G K@B/5'"M_QKR]D(M^2S_Q/?36E41\:#W[,&M*!Z^U9$K[ [J\6[>K0
MH/3CU HQ6&]/*2IOR/X]B[[VXK )J$/T.)5##AKF?*(Z89/)4#U8>_E*4C_,
MA%9A=] $;P/L=7*5_AXR.[)+6::)3TB075%( .36,3W*6E Z7?<B0K!!)[#Y
M<EW!SA;H/QIKV.NX<8]$8:J-6H$2[+ICL0]VZ(0WM;)^=9#M<G<^4MBPE52%
M4NNZBQ",TE'OZ 3OB]%9AX6Y>FLJ[F\\#\UU3%>3),NSZNDQQ<E>W_:@6N.Z
MKW$8GNBF0>,JS?(T]/,J"1&/'/J04E!ZNYRE[4'5X:A]C%H\\=5A/[TUM7CQ
M.::[RZ?P>;ZBBFRZ/ "V!%4!Y]V$/3%$)U]@RNIK$)7Y*A5[D?+I\3$BHB60
MT531JWVHHKCN+1P7[Z->E?#1<D>>J_1! MNIF7(T=:$J<Q2N1!!.Z-:D?+6/
M3G>*D)1F&2A%SCOT.G(?]<B<1[Q=$H@CSB]?V8\*BJ'UP8%'CM-OAA?Z*#U,
M,PH/Z-350W]Y;S2G  0?QV@TCPV$UH?2ZKH;SPPOQ^B%K;95=="?DK,X.J6K
M8G>H T5=:RM"273=@P9$R#$F+UB"&A('=U3\_38?2J>L-OJ3@E8X56.%3BQ+
MB'8=9WE:\,=%V\\<L)A OIY_)V?7H DHQ:Z[N8Q10^?Y4"F;09Z[B:-Y^5(W
MAA4-0#EVW4-EB)AC#-^1@&SX/?,'DFZ4L0G*:E V77<>@=!!Y[!Z.:.*GEBD
M_,+YSO&Y"\<^]Z*(!&?;JEQ6%52P/+AAJ!ZX[J$:">&C=FLU#VG8+*7?(LMK
M@*](.:X7.DS>"N%T'LOH>C0M\UD0GU"4@H5QU!.D&:AJN.X&ZX4>^E1RF*&]
M6KZP(*UZU3K?)$6<:];UL!:@3+ON&3/%[*B-@G FK ,VN0W<_7$W_2FTI6=S
M4-5QW1LW"$UT8]$,__LUSM@RB 2W24ZRI;?5[0NU5?$?7QH_2%*)$CJ?X-N>
MO\;]+U$+VH$R[;H+KQ]^1ST=B". :Y,%&_^B>E"5<-WE!\/GJ%7@T*M9!V(Q
MQW5Y/@AQ]9NT 54-USV%YKBA3Q"&;I!+SW\Z+#N:JTG4-%0Q7'<ZCH8ROK[L
M;X*<>\]A[D6[J&Z2OO"[_U=%3M=#M6E4Z(=Y4U!]<-[YV!=%=/ZU*5=E&5?+
M7+?-,^U2_S5QD>-^"IS:QW']L<;"6]*OWPFSG"28TR45G7(/]N"3:)VZ U!=
M=-XK.BUC;FCHHU[>1XF\O]$E(0D.+S%HU''TKT%USW4_K4TNT!5-$#%]^>I'
M!1LIYTF6+U8?DH2]_%$E6[I/(D4D9+_6H(KBO%=V );HBC#4PE9V=']WRM[L
M)_@45(5<=_I:8P%?OU1.SL9#%;4(JH#K/FU!->2HG<5*'(_:6SAT8'S@CM/K
MN$1+=[7>QL>@"NBZ:]HB$_A&:J!L5TFZ(B'SJ; GH^D:("R#-W;BVM,YP*>A
M&NBZ!WPREAS51U,E@C/ONHM;C<=13W#-$S_#Y1"@*E0!7/=I@U%R=.CVG29;
M3BO^QPL*YI47IOPBY52+&4!'P#G,'=<U) ;1-?=R\QPE6T)J+X40AEL6EL+\
M6ESB["')O:CY=^;ON$WR_R'Y'?&3=<SN<#<'K%Q?)_H\5$M=]XQ/RM;;U<UR
MD-*58?4K5DX1?SIU/Z#:ZKHO'8>_MZNV"!H*5T;7_?766;'US&[? ZG6&N2.
ML+=HPWC=&#-2-P7/HCW!AZ'*Y:PG?RJ@\/>\$O6\()F?AGSA0.WQ+C=W[661
MZ):V%E0QG'7@@Z24&H[_^*8C-?W2I_JOPC\>M$9><Q('>^-T $U,_YK3CGU-
MI2CUX]Y_(D'![J)=>BE3P:R^I$A-9.C/X^ BC J*Q07)O3#:2QOFK-U??OGE
MVY^_G7TUNP@S/TJR(B7T'W6CLV0UJYN=T79GO.'_:\:;GGEQ,*L:G_VU:O[?
M_H(S<;=DGS]F>>KYBH!4>0V<I<=>,9G/Y#R)\S N: <7SV3G]:S.J)=)R@<3
MTX3'(F>'B \)G?]\6HGJ1-1(KRR7W];WD)^NU2E":VEA%_4C=W2*$M9D)6(\
MA)W'M6^>E</,K!7LEW,-M:</1.8Z\4NI$S%9LRGM ?U1(_V8&6)U\!_<'=V$
M.+.]/>PJF_'+WM*%TJZSMR1?K!Z\UT,[=T>>F?F+UY>T0KZ%$CSH$]CO[ [2
M@Q' 15<7VMN]4/,7NKPK^]NXL%"]'\S7@W*E,&X(^]5=0^I[ H5.<&L7>QCZ
MV@C%UM!KV SVV[F&Y/8":>25']ZFLL[(_S&,Z,(VB7DH1IWEK)SLUO2K)1J*
M+>8[U1:S_LAL_Q6^N:R_,]M_J-R!9J?]YO XSVIY^J#.Y- NIQN]'?UW80RW
MA6B^A8@,?\<-I:"@4=8-&L1*) ._T?UF[OH1"<C2O $^_=<>>/J//>CW/HF]
M-$SFKZ$(=UI64O088)?WOK%]GA#TJ@N_QMDS\<-52(*+A+G+)<#+BR.#+\>U
MB[]<B+W_:TQ?_ISVF;R0X".17.E@I=J%T+PM:H2ZWGBQ=)9.[6Z3'(2FH!S:
MRM844*F,Z%N2^L1F$^9LG&42"UT5%Y<^!B.M%*#AX7*#!:G!EHCAB,56@@SB
MPZ[5OB$AVPT]I-X+B<Z2Y!,[9HB\?)6D&Z7M@53$]J6K=:AIC> P6#+Y']*D
M>#9G05\-VY4-YP *@24&KB+RNO2V#\1_BI,H66^5P$M+8[N,X7AK!+8$<TGP
MG#E20!JN*(_MQ8-#K14:?=%S'?LI7RKPD#7F,BY?U3HX)=C[P*)M[1C3)8P8
MW##R:;[<2](]?!D#0:?B>5J.YZ9<E?-SR3%\(GGH>Y'(Z_I>Y76MVY]5'YB5
M7^AX6&=_/?C.R>,Z/%N:P:-7ZEK'%6T#0>!DC(<:8U>B8\:WR<=]E*:WYR(3
M_MT8)OQDLGN>TJB#:\^V)=X\HZ?N',V\*3>\)Z9';>9RXI_&";O:67/J];5=
MSPT&>VMQ^QZ.1EI+AWI]3E6K'+M\J:%V(2NJO"WV%(+:.1<T61HWNJ3S-8O*
M.L*43OO$B: /)!GH:!YSDR+U#'57\Z[XG.5Z)-^)3.)X:T=**;UNLL+8WF0]
MNJK>.[*]<SKF<:J=FWA]@QKXF ON-4R]5V/ANS5$U=;IEEW]R\.7_:S:V)M]
MW]Z;L0;V]^1V^Z_9KI733NRT$SOMQ$X[L3>_$WN@;2]6C9OTZEV8I/C;8DTB
M)/KNJ]$C%MU_F\3>_C>-5TSEJ]:J)>.&W.!7J:LM#HU%M!,YQ+7O\M5_8I^>
MKU/"OZ_<5:BK8._<>NI@)YF'!A,[VX\O)>Q\J!W41J:/'/%XBDSOXG^*3'<_
M,GT\/_CE/XLP9^/R.8GUX=2::F_$"L&$;80*(NV$#KNE<XM+BCO"&40?VWL<
ML4#8#O(J%Y1N*=PJAAV8JE2FMM]/)"&Z29OF8,+>I7,# JP=3@S?*;+<=VR[
MI)Y'6L4<L4$CS1LMX1JI*!Q-8)[)\E_O)8F#9>3%M]Z&Z*89.U]S0T.$VFV:
M;+R7_-B3VB[#ZCZ7M,[(*JI@9V^Q.2)DJ6EEP*&;[%-(S)"0F!].(3%??$C,
M/4E#DET>)OO3F4=E)>R[4^ P&8#H^ :.]_'O?>B15 +28^T!.$-ZE*+;2FW.
MOWP-!)U[YU4U@(A;>_ ,%MD$$-HJW/]E#+>D!A!N:Z^,F<"M%-HJW/]M#+>D
M!A!N:V]ZF<"M%-HJW#?&<$MJ@ \/7,!;*;55O#\:XRVI <4;,>I7*\,$>-\:
MXRVI <4;.0X8(+55O!?&>$MJ0/&VYKPWP5LI]91X+V)B#GFC$A1U:UZD :AW
M9$??)!W]I6:G(N/=O-F,XI^J#@L7Z1V[++"[(T#\(@US.C+.O2@BP=FV*I=5
M!14:-;AA[%"V7BHU$IRC7K]P[!Q+\XQK];0P&V8E;@,.L<P_A7TWJY?268/\
MN"T;>TDPS:B U>Q?6NWRUSD)%,^- JJB1X+TLDY02- 7.I*>L@FX#W.[>MAG
MFF/2U@+CJ >K\))B]2A=YZ;B//A'D?%T<8K K;X-8A_JC'?'$PZ? _G2J([[
MM*WJ@1W(K<T?VK<V#YMPY];F79A]8I<A?J7=2VF78K8"U%_=U%1#L\M[C%D/
M-9<T9>7=.-8&,=,UQD*)\.]<=GK6L1H ?FY<NVNIUC@=.3<N7:;L].YL>T9B
M_VGCI9I0'GW-MT!61RCT*Y7=+M8=U,;R:&LZRIA$)[7<M<5##_?Q(I+=D1<2
M%^26: /])<6QG5!0!6Q[!%3"HV_NYKZ?%'%..^B3\(59".V-9&D-['UX3X)T
M$*!S)+ +^@L#RDJ.VCO#&:IS8P#O=8^N*/1CQO-2LY*C%'553[LF;PB%/1&=
MT\UVLF%)[EN=U-Y_TE5T;G+J*F";*!@6*-?[/WK_2-*Z@[(;MK2@J)RC T=V
M>U\D@IV+LAK,V<6,Q>J@.ZJK^XKB^%?WY?K30%XA@9U[^_57U)D*6X4P[^UK
M5>(@2:%0.O<63TN2LE]X:Z(^NU#40@ZPT#N7='.R  ,'_,X79$4%"5B4!P_Z
MH$VR&V,@#_2/;0]TU=BLV=J,-^>.-_K@B#@.[D@>ED$P>TGTOFFC1G#&X 7)
M?,ITSD_-1"S3_I>]YT\0+1/:W9T8G#.Y^&.TC3Z>C=6@-<#' QC=7DN,P#GM
M,MV@)^LX_'-O4$3J *J.OUP?3KD!3@X8]_OB,2/_+&ASER^$/2X&,.H_=1[J
MV#4R*UMQQY:WY=,;;GD-Y&O-1_E\O0[_T_/UT]#@V//U!@2\J?RJ$!I.R5-/
MR5-'<FV8Y4U]RRE3+6=+E=X7JL/9ET5*.Y!!,]CJZV&':8Z1QA:*CB5VYEE&
M<C-BU%6P+_>/P D$$TMTF#$QE 1K=]!'( $'?[;J6ZS.4Q*$_W][U[:<-@Q$
M_ZB=Z4N?*0F=S!#*4/J<48PF\0Q8J61(^/M*-FEDK,O*X.R:X247T-K:/;JL
MUNNS)0R#H 1TT^B->^$,0 !,@AZ9.3IAQ5,0O (TW"S84<6G WK*@:-G4:9!
MOP@12,)#+(X-E42#HZY%,][<S;'=X>@0"P-"()%@4;GBWOP!ZVLB$R"X)C5[
MC)(E4-W?.YS?.TCD/-VTE]N69SH7=TQS><LWVTW(G$=-T'C4CLW5,J93%WR?
MY9)9^Y-"K4%*?CRJY2LE/TE*_D^AAN_M0'89S/!I])M$B<12H/A\3M1H-:/_
MI,B5&O>\?!:KNV+'ZW=VVY]R;G+F L6H3KHBL67.6Y#J)"7[H8F.(.WK4B@#
M-B:#[_R>8_Q:N,84[N?1TN3W:"G9CJ^GTW$P2.AJB!:C!9BK'07TJWK6Y4_Q
M[,N3V'U=\;R>$_J/C^F@_WF8\B>VOBU*W7_/6J9;M1H-87ER]=LZ-'V&<>M;
M>U<6W:39 MFL+HNU;-KL,;F%X.$;)H=MRSZ0F6^Z3,01O<AZ%TF'9V\QB^_7
M8A9#+V9!B_&6!*-SKXRW9\@0?RSO"E7*;3Q)S]66V,@/+4"N[EO!$PKVAU0X
M\TO0P,(_HH)X]'_VF8F2QUB?C]I %YK>2JW$AH>]W#CUZRGKQ-QK^2JBMK3:
M0&W96YY5JBU;^O5D2WV?N>YKKI20>W-C?RJN:>]O#N9XI6#AF-;H.^.5DCRV
MV4Z)TY#C<T9;ST-L:E/0\Y^F 'KV"A3TB,J#)G-MZ6:1CR9@VI#")N;N#JQ#
M^0%/U4JQ>JS>;*76::Y/;^) ,COCK]57P2 -3!Z;UPN,=YI!\)#W\8-\#-=:
MB0^:!H]C%93 ?G$C#EM4!2)^5>7KC8K55+!"S=G>;/CCK30V\,^NH! VLS5X
M2@%41X>GZ<-/6,9'&\/H!PU(V!)H"7:IP,24)H;*GX)MA"P-*8%YHS\%'J<H
M]AM0'7$*F($88'>%WN:X*A=:STK9\&[DU#9\#>PLL8X00@Q##,M[5IKW'_<W
MNK=0[)HRV.^Z=<3*I3@Z-LZZ5 O.E"@F0AHG2'NN2S$3!=^\K,6>AWSX3A?#
M>Q2>?(+K;JMA']L'7PJ.0%CG6O_-BF;-99[Q]T(V@9B 7P2*/'[<)ZKW@#$]
MU(Q32S'*_FYSR7]LE3:'4ES]E$(%IGY<$HHP?J0':@7TS3X8DEIH-U(/S_*0
M9U'5 8R V/5Z4&@1HT$G:G@!N_[[J-:NS23H];4:0N'%#RAY=$2?J.X,^5^O
MA5[QG_,7R.$WX1+H61I@O)+M@H[DU.+2\(/5;(6>Z0'&PZ4=*9-/6):O]9"Y
M?7O):\9I<_H.<&V#A-%)7CH!%+$%2=SL^):] :<!Z+\*%$G\6%(7ZY"$U**'
M3D.Q(8B>JW42< X;H&,UER+C?*4F6E/39Q7?M@(B4'SP(S-1O7M*6QPS]3Q:
M[5B1>1^HVRV@!D4,>+3Z3&1D-\/P8R;EWE0[3GHL>RP%A0,_.@'1?M '5??.
MF$G.%+_A]6]]P*NWQAD'NN&P*T&' 7XDHZN5T&>OJ^,'?I]Z$%MY=-U=1-@5
MH7#C1S9.M9H#=G^1AL,WYL>C'D;ZDW]02P$"% ,4    "  =B+U:@$Y%HV80
M   %9   "P              @ $     97@Q,"TR-2YH=&U02P$"% ,4
M"  =B+U:I"PZT%@0   <90  "P              @ &/$   97@Q,"TR-BYH
M=&U02P$"% ,4    "  =B+U:]HJ9[L5O  !*Q@( "P              @ $0
M(0  97@Q,"TR.2YH=&U02P$"% ,4    "  =B+U:G ^"+$4S  #:-P$ "P
M            @ '^D   97@Q,"TS,"YH=&U02P$"% ,4    "  =B+U:-\+5
M9)1!  "QF $ "P              @ %LQ   97@Q,"TS,2YH=&U02P$"% ,4
M    "  =B+U:DFTY.3XS  !U/0$ "P              @ $I!@$ 97@Q,"TS
M."YH=&U02P$"% ,4    "  =B+U:+3]GV'Y!  #NCP$ "P
M@ &0.0$ 97@Q,"TS.2YH=&U02P$"% ,4    "  =B+U:@&1\]=\"   M&0
M"@              @ $W>P$ 97@R,2TQ+FAT;5!+ 0(4 Q0    ( !V(O5HF
M]Q>950,  (L1   *              "  3Y^ 0!E>#(S+3$N:'1M4$L! A0#
M%     @ '8B]6LPZ^V"L!P  #3(   H              ( !NX$! &5X,S$M
M,2YH=&U02P$"% ,4    "  =B+U:]0"\XK('   M,@  "@
M@ &/B0$ 97@S,2TR+FAT;5!+ 0(4 Q0    ( !V(O5J5'?@3X 0   \E   *
M              "  6F1 0!E>#,R+3$N:'1M4$L! A0#%     @ '8B]6JB-
M'U%L1P  S+P!  H              ( !<98! &5X-"TQ,2YH=&U02P$"% ,4
M    "  =B+U:\H8 NFU'  #*O $ "@              @ $%W@$ 97@T+3$R
M+FAT;5!+ 0(4 Q0    ( !V(O5H&,6EH5S<  /(8 0 *              "
M 9HE @!E>#0M,3,N:'1M4$L! A0#%     @ '8B]6BM$#NVC.@  JB\!  H
M             ( !&5T" &5X-"TQ-"YH=&U02P$"% ,4    "  =B+U:8'[F
M,FY'  #-O $ "@              @ 'DEP( 97@T+3$U+FAT;5!+ 0(4 Q0
M   ( !V(O5KKD"%^;$<  #N] 0 *              "  7K? @!E>#0M,38N
M:'1M4$L! A0#%     @ '8B]6O'VENYW-P  BQD!  H              ( !
M#B<# &5X-"TQ-RYH=&U02P$"% ,4    "  =B+U:?UF B2X,   '30  "@
M            @ &M7@, 97@T+3(S+FAT;5!+ 0(4 Q0    ( !V(O5J& UV5
M[=$# )KS)0 ,              "  0-K P!F;W)M,3 M:RYH=&U02P$"% ,4
M    "  =B+U::E[?@0I! @#&1@( $               @ $:/0< 9F]R;3$P
M+6M?,# Q+FIP9U!+ 0(4 Q0    ( !V(O5JW),6QF H" -0, @ 0
M      "  5)^"0!F;W)M,3 M:U\P,#(N:G!G4$L! A0#%     @ '8B]6L2L
M'X$N'@( 1R " !               ( !&(D+ &9O<FTQ,"UK7S P,RYJ<&=0
M2P$"% ,4    "  =B+U:QCSPA%K;  ""Y   $               @ %TIPT
M9F]R;3$P+6M?,# T+FIP9U!+ 0(4 Q0    ( !V(O5JYYRMZ>%,  "YA   0
M              "  ?R"#@!F;W)M,3 M:U\P,#4N:G!G4$L! A0#%     @
M'8B]6E=9F47^ P  !P8  !               ( !HM8. &9O<FTQ,"UK7S P
M-BYJ<&=02P$"% ,4    "  =B+U:)-!WGP49   E/ $ $0
M@ '.V@X ;G1R<"TR,#(U,#(R."YX<V102P$"% ,4    "  =B+U:30KKGU,<
M  !\?0$ %0              @ $"] X ;G1R<"TR,#(U,#(R.%]C86PN>&UL
M4$L! A0#%     @ '8B]6M9.ZGN250  S.H% !4              ( !B! /
M &YT<G M,C R-3 R,CA?9&5F+GAM;%!+ 0(4 Q0    ( !V(O5K^L)Z<#ZD
M "@Q"@ 5              "  4UF#P!N=')P+3(P,C4P,C(X7VQA8BYX;6Q0
M2P$"% ,4    "  =B+U:*_)NRA%^  "1?0@ %0              @ &/#Q
K;G1R<"TR,#(U,#(R.%]P<F4N>&UL4$L%!@     @ "  8 <  -.-$     $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>126
<FILENAME>form10-k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:NTRP="http://nexttrip.com/20250228"
  xmlns:cyd="http://xbrl.sec.gov/cyd/2024"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:ecd="http://xbrl.sec.gov/ecd/2024"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2024"
  xmlns:us-gaap="http://fasb.org/us-gaap/2024"
  xmlns:utr="http://www.xbrl.org/2009/utr"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xhtml="http://www.w3.org/1999/xhtml"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="ntrp-20250228.xsd" xlink:type="simple"/>
    <context id="From2024-03-01to2025-02-28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
        </entity>
        <period>
            <startDate>2024-03-01</startDate>
            <endDate>2025-02-28</endDate>
        </period>
    </context>
    <context id="AsOf2024-08-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
        </entity>
        <period>
            <instant>2024-08-31</instant>
        </period>
    </context>
    <context id="AsOf2025-05-28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
        </entity>
        <period>
            <instant>2025-05-28</instant>
        </period>
    </context>
    <context id="From2024-12-012025-02-28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
        </entity>
        <period>
            <startDate>2024-12-01</startDate>
            <endDate>2025-02-28</endDate>
        </period>
    </context>
    <context id="AsOf2025-02-28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
        </entity>
        <period>
            <instant>2025-02-28</instant>
        </period>
    </context>
    <context id="AsOf2024-02-29">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
        </entity>
        <period>
            <instant>2024-02-29</instant>
        </period>
    </context>
    <context id="AsOf2025-02-28_us-gaap_NonrelatedPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:NonrelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-28</instant>
        </period>
    </context>
    <context id="AsOf2024-02-29_us-gaap_NonrelatedPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:NonrelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-02-29</instant>
        </period>
    </context>
    <context id="AsOf2025-02-28_us-gaap_RelatedPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-28</instant>
        </period>
    </context>
    <context id="AsOf2024-02-29_us-gaap_RelatedPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-02-29</instant>
        </period>
    </context>
    <context id="From2023-12-292023-12-29_custom_NextTripGroupLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">NTRP:NextTripGroupLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-29</startDate>
            <endDate>2023-12-29</endDate>
        </period>
    </context>
    <context id="From2023-03-012024-02-29">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
        </entity>
        <period>
            <startDate>2023-03-01</startDate>
            <endDate>2024-02-29</endDate>
        </period>
    </context>
    <context id="AsOf2023-02-28_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-02-28</instant>
        </period>
    </context>
    <context id="AsOf2023-02-28_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-02-28</instant>
        </period>
    </context>
    <context id="AsOf2023-02-28_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-02-28</instant>
        </period>
    </context>
    <context id="AsOf2023-02-28_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-02-28</instant>
        </period>
    </context>
    <context id="AsOf2023-02-28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
        </entity>
        <period>
            <instant>2023-02-28</instant>
        </period>
    </context>
    <context id="AsOf2024-02-29_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-02-29</instant>
        </period>
    </context>
    <context id="AsOf2024-02-29_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-02-29</instant>
        </period>
    </context>
    <context id="AsOf2024-02-29_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-02-29</instant>
        </period>
    </context>
    <context id="AsOf2024-02-29_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-02-29</instant>
        </period>
    </context>
    <context id="From2023-03-012024-02-29_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-01</startDate>
            <endDate>2024-02-29</endDate>
        </period>
    </context>
    <context id="From2023-03-012024-02-29_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-01</startDate>
            <endDate>2024-02-29</endDate>
        </period>
    </context>
    <context id="From2023-03-012024-02-29_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-01</startDate>
            <endDate>2024-02-29</endDate>
        </period>
    </context>
    <context id="From2023-03-012024-02-29_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-01</startDate>
            <endDate>2024-02-29</endDate>
        </period>
    </context>
    <context id="From2024-03-012025-02-28_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-03-01</startDate>
            <endDate>2025-02-28</endDate>
        </period>
    </context>
    <context id="From2024-03-012025-02-28_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-03-01</startDate>
            <endDate>2025-02-28</endDate>
        </period>
    </context>
    <context id="From2024-03-012025-02-28_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-03-01</startDate>
            <endDate>2025-02-28</endDate>
        </period>
    </context>
    <context id="From2024-03-012025-02-28_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-03-01</startDate>
            <endDate>2025-02-28</endDate>
        </period>
    </context>
    <context id="AsOf2025-02-28_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-28</instant>
        </period>
    </context>
    <context id="AsOf2025-02-28_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-28</instant>
        </period>
    </context>
    <context id="AsOf2025-02-28_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-28</instant>
        </period>
    </context>
    <context id="AsOf2025-02-28_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-28</instant>
        </period>
    </context>
    <context id="From2023-01-252023-01-25_custom_NextPlayTechnologiesIncMember_custom_ShareExchangeAgreementMember_custom_MembershipUnitsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">NTRP:NextPlayTechnologiesIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">NTRP:MembershipUnitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:ShareExchangeAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-25</startDate>
            <endDate>2023-01-25</endDate>
        </period>
    </context>
    <context id="From2023-01-252023-01-25_custom_NextPlayTechnologiesIncMember_custom_ShareExchangeAgreementMember_custom_PreferredUnitsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">NTRP:NextPlayTechnologiesIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">NTRP:PreferredUnitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:ShareExchangeAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-25</startDate>
            <endDate>2023-01-25</endDate>
        </period>
    </context>
    <context id="AsOf2023-01-25_custom_NextPlayTechnologiesIncMember_custom_ShareExchangeAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">NTRP:NextPlayTechnologiesIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:ShareExchangeAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-25</instant>
        </period>
    </context>
    <context id="AsOf2023-01-25_custom_NextTripGroupLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">NTRP:NextTripGroupLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-25</instant>
        </period>
    </context>
    <context id="AsOf2024-11-30_custom_NextInnovationLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">NTRP:NextInnovationLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-11-30</instant>
        </period>
    </context>
    <context id="From2023-10-122023-10-12_custom_ShareExchangeAgreementMember_custom_NextTripGroupLLCMember_custom_ClosingSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">NTRP:NextTripGroupLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:ClosingSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:ShareExchangeAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-10-12</startDate>
            <endDate>2023-10-12</endDate>
        </period>
    </context>
    <context id="From2023-10-122023-10-12_custom_ShareExchangeAgreementMember_custom_NextTripGroupLLCMember_custom_ContingentSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">NTRP:NextTripGroupLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:ContingentSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:ShareExchangeAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-10-12</startDate>
            <endDate>2023-10-12</endDate>
        </period>
    </context>
    <context id="From2023-10-122023-10-12_custom_ShareExchangeAgreementMember_custom_NextTripGroupLLCMember_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">NTRP:NextTripGroupLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:ShareExchangeAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-10-12</startDate>
            <endDate>2023-10-12</endDate>
        </period>
    </context>
    <context id="From2023-10-122023-10-12_custom_ShareExchangeAgreementMember_custom_NextTripGroupLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">NTRP:NextTripGroupLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:ShareExchangeAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-10-12</startDate>
            <endDate>2023-10-12</endDate>
        </period>
    </context>
    <context id="From2024-03-012025-02-28_us-gaap_WarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-03-01</startDate>
            <endDate>2025-02-28</endDate>
        </period>
    </context>
    <context id="From2023-03-012024-02-29_us-gaap_WarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-01</startDate>
            <endDate>2024-02-29</endDate>
        </period>
    </context>
    <context id="From2024-03-012025-02-28_us-gaap_StockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-03-01</startDate>
            <endDate>2025-02-28</endDate>
        </period>
    </context>
    <context id="From2023-03-012024-02-29_us-gaap_StockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-01</startDate>
            <endDate>2024-02-29</endDate>
        </period>
    </context>
    <context id="From2024-03-012025-02-28_us-gaap_PreferredStockMember11842375">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-03-01</startDate>
            <endDate>2025-02-28</endDate>
        </period>
    </context>
    <context id="From2023-03-012024-02-29_us-gaap_PreferredStockMember11842375">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-01</startDate>
            <endDate>2024-02-29</endDate>
        </period>
    </context>
    <context id="AsOf2025-02-28_custom_NextPlayTechnologiesIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">NTRP:NextPlayTechnologiesIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-28</instant>
        </period>
    </context>
    <context id="AsOf2024-02-29_custom_NextPlayTechnologiesIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">NTRP:NextPlayTechnologiesIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-02-29</instant>
        </period>
    </context>
    <context id="AsOf2023-09-25_custom_NextPlayTechnologiesIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">NTRP:NextPlayTechnologiesIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-25</instant>
        </period>
    </context>
    <context id="AsOf2025-01-27_custom_NextPlayTechnologiesIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">NTRP:NextPlayTechnologiesIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-01-27</instant>
        </period>
    </context>
    <context id="AsOf2025-02-28_us-gaap_FurnitureAndFixturesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-28</instant>
        </period>
    </context>
    <context id="AsOf2025-02-28_us-gaap_ComputerEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-28</instant>
        </period>
    </context>
    <context id="AsOf2025-02-28_custom_SoftwareMember_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">NTRP:SoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-28</instant>
        </period>
    </context>
    <context id="AsOf2025-02-28_custom_SoftwareMember_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">NTRP:SoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-28</instant>
        </period>
    </context>
    <context id="AsOf2025-02-28_custom_SoftwareLicensesMember_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">NTRP:SoftwareLicensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-28</instant>
        </period>
    </context>
    <context id="AsOf2025-02-28_custom_SoftwareLicensesMember_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">NTRP:SoftwareLicensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-28</instant>
        </period>
    </context>
    <context id="From2023-10-062023-10-06_custom_AssetPurchaseAgreementMember_custom_DivergentTechnologiesIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:AssetPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">NTRP:DivergentTechnologiesIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-10-06</startDate>
            <endDate>2023-10-06</endDate>
        </period>
    </context>
    <context id="AsOf2023-10-06_custom_AssetPurchaseAgreementMember_custom_DivergentTechnologiesIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:AssetPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">NTRP:DivergentTechnologiesIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-10-06</instant>
        </period>
    </context>
    <context id="AsOf2025-02-06_custom_MembershipPurchaseAgreementMember_custom_FSATravelLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">NTRP:FSATravelLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:MembershipPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-06</instant>
        </period>
    </context>
    <context id="AsOf2025-02-06_custom_MembershipPurchaseAgreementMember_custom_FSATravelLLCMember_custom_SeriesOPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">NTRP:FSATravelLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesOPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:MembershipPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-06</instant>
        </period>
    </context>
    <context id="AsOf2025-02-06_custom_MembershipPurchaseAgreementMember_custom_NextTripMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">NTRP:NextTripMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:MembershipPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-06</instant>
        </period>
    </context>
    <context id="AsOf2025-02-06_custom_MembershipPurchaseAgreementMember_custom_FSATravelLLCMember11843687">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:MembershipPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">NTRP:FSATravelLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-06</instant>
        </period>
    </context>
    <context id="AsOf2025-02-06_custom_MembershipPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:MembershipPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-06</instant>
        </period>
    </context>
    <context id="AsOf2025-02-06_custom_MembershipPurchaseAgreementMember_custom_SeriesOPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesOPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:MembershipPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-06</instant>
        </period>
    </context>
    <context id="AsOf2025-02-28_custom_MembershipPurchaseAgreementMember_custom_FSATravelLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">NTRP:FSATravelLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:MembershipPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-28</instant>
        </period>
    </context>
    <context id="AsOf2025-02-28_custom_MembershipPurchaseAgreementMember_custom_FSATravelLLCMember_custom_SeriesOPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">NTRP:FSATravelLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesOPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:MembershipPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-28</instant>
        </period>
    </context>
    <context id="AsOf2025-02-28_custom_MembershipPurchaseAgreementMember_custom_FSATravelLLCMember11843734">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:MembershipPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">NTRP:FSATravelLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-28</instant>
        </period>
    </context>
    <context id="AsOf2025-02-28_custom_MembershipPurchaseAgreementMember_custom_NextTripMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:MembershipPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">NTRP:NextTripMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-28</instant>
        </period>
    </context>
    <context id="From2025-02-282025-02-28_custom_MembershipPurchaseAgreementMember_custom_NextTripMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:MembershipPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">NTRP:NextTripMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-02-28</startDate>
            <endDate>2025-02-28</endDate>
        </period>
    </context>
    <context id="From2025-02-282025-02-28_custom_MembershipPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:MembershipPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-02-28</startDate>
            <endDate>2025-02-28</endDate>
        </period>
    </context>
    <context id="AsOf2025-02-28_custom_MembershipPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:MembershipPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-28</instant>
        </period>
    </context>
    <context id="From2025-02-282025-02-28_custom_MembershipPurchaseAgreementMember_custom_NextTripMember11843750">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">NTRP:NextTripMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:MembershipPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-02-28</startDate>
            <endDate>2025-02-28</endDate>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_FSATravelLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">NTRP:FSATravelLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_FSATravelLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">NTRP:FSATravelLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-02-24_custom_ShareExchangeAgreementMember_custom_BlueFyshHoldingsIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:ShareExchangeAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">NTRP:BlueFyshHoldingsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-24</instant>
        </period>
    </context>
    <context id="From2025-02-242025-02-24_custom_ShareExchangeAgreementMember_custom_BlueFyshHoldingsIncMember_custom_SeriesNNonvotingConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesNNonvotingConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:ShareExchangeAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">NTRP:BlueFyshHoldingsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-02-24</startDate>
            <endDate>2025-02-24</endDate>
        </period>
    </context>
    <context id="AsOf2025-02-24_custom_ShareExchangeAgreementMember_custom_BlueFyshHoldingsIncMember_custom_SeriesNNonvotingConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesNNonvotingConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:ShareExchangeAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">NTRP:BlueFyshHoldingsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-24</instant>
        </period>
    </context>
    <context id="From2025-02-242025-02-24_custom_ShareExchangeAgreementMember_custom_BlueFyshHoldingsIncMember_us-gaap_RestrictedStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:ShareExchangeAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">NTRP:BlueFyshHoldingsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-02-24</startDate>
            <endDate>2025-02-24</endDate>
        </period>
    </context>
    <context id="AsOf2024-02-29_us-gaap_FurnitureAndFixturesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-02-29</instant>
        </period>
    </context>
    <context id="AsOf2024-02-29_us-gaap_ComputerEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-02-29</instant>
        </period>
    </context>
    <context id="AsOf2025-02-28_us-gaap_SoftwareDevelopmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-28</instant>
        </period>
    </context>
    <context id="AsOf2024-02-29_us-gaap_SoftwareDevelopmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-02-29</instant>
        </period>
    </context>
    <context id="AsOf2025-02-28_custom_SoftwareLicenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">NTRP:SoftwareLicenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-28</instant>
        </period>
    </context>
    <context id="AsOf2024-02-29_custom_SoftwareLicenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">NTRP:SoftwareLicenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-02-29</instant>
        </period>
    </context>
    <context id="AsOf2025-02-28_us-gaap_TrademarksMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-28</instant>
        </period>
    </context>
    <context id="AsOf2024-02-29_us-gaap_TrademarksMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-02-29</instant>
        </period>
    </context>
    <context id="From2023-10-122023-10-12_custom_SigmaAdditiveSolutionsIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">NTRP:SigmaAdditiveSolutionsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-10-12</startDate>
            <endDate>2023-10-12</endDate>
        </period>
    </context>
    <context id="AsOf2023-10-12_custom_SigmaAdditiveSolutionsIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">NTRP:SigmaAdditiveSolutionsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-10-12</instant>
        </period>
    </context>
    <context id="AsOf2023-10-12">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
        </entity>
        <period>
            <instant>2023-10-12</instant>
        </period>
    </context>
    <context id="AsOf2023-10-12_us-gaap_SeriesEPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesEPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-10-12</instant>
        </period>
    </context>
    <context id="From2023-10-122023-10-12_custom_NextTripHoldingsIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">NTRP:NextTripHoldingsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-10-12</startDate>
            <endDate>2023-10-12</endDate>
        </period>
    </context>
    <context id="From2023-10-122023-10-12_custom_DivergentTechnologiesIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">NTRP:DivergentTechnologiesIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-10-12</startDate>
            <endDate>2023-10-12</endDate>
        </period>
    </context>
    <context id="From2023-10-122023-10-12">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
        </entity>
        <period>
            <startDate>2023-10-12</startDate>
            <endDate>2023-10-12</endDate>
        </period>
    </context>
    <context id="AsOf2017-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="From2024-05-242024-05-24">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
        </entity>
        <period>
            <startDate>2024-05-24</startDate>
            <endDate>2024-05-24</endDate>
        </period>
    </context>
    <context id="AsOf2024-05-24">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
        </entity>
        <period>
            <instant>2024-05-24</instant>
        </period>
    </context>
    <context id="From2025-02-282025-02-28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
        </entity>
        <period>
            <startDate>2025-02-28</startDate>
            <endDate>2025-02-28</endDate>
        </period>
    </context>
    <context id="From2024-06-262024-06-26">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
        </entity>
        <period>
            <startDate>2024-06-26</startDate>
            <endDate>2024-06-26</endDate>
        </period>
    </context>
    <context id="AsOf2024-06-26">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
        </entity>
        <period>
            <instant>2024-06-26</instant>
        </period>
    </context>
    <context id="AsOf2024-09-19_custom_SecuritiesPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-19</instant>
        </period>
    </context>
    <context id="From2024-09-192024-09-19_custom_SecuritiesPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-09-19</startDate>
            <endDate>2024-09-19</endDate>
        </period>
    </context>
    <context id="AsOf2024-09-19_custom_SecuritiesPurchaseAgreementMember_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-19</instant>
        </period>
    </context>
    <context id="From2024-09-192024-09-19">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
        </entity>
        <period>
            <startDate>2024-09-19</startDate>
            <endDate>2024-09-19</endDate>
        </period>
    </context>
    <context id="AsOf2024-10-18_custom_NoteSecuritiesPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:NoteSecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-10-18</instant>
        </period>
    </context>
    <context id="AsOf2024-10-18">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
        </entity>
        <period>
            <instant>2024-10-18</instant>
        </period>
    </context>
    <context id="AsOf2024-11-01_custom_ShortTermPromissoryNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:ShortTermPromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-11-01</instant>
        </period>
    </context>
    <context id="AsOf2024-11-01">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
        </entity>
        <period>
            <instant>2024-11-01</instant>
        </period>
    </context>
    <context id="AsOf2024-11-29">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
        </entity>
        <period>
            <instant>2024-11-29</instant>
        </period>
    </context>
    <context id="AsOf2024-11-29_custom_ShortTermPromissoryNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:ShortTermPromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-11-29</instant>
        </period>
    </context>
    <context id="From2024-11-292024-11-29">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
        </entity>
        <period>
            <startDate>2024-11-29</startDate>
            <endDate>2024-11-29</endDate>
        </period>
    </context>
    <context id="From2024-12-312024-12-31_custom_SeriesMNonvotingConvertiblePreferredStockMember_custom_DebtConversionAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesMNonvotingConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:DebtConversionAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-12-31</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_SeriesMNonvotingConvertiblePreferredStockMember_custom_DebtConversionAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesMNonvotingConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:DebtConversionAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-11-08">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
        </entity>
        <period>
            <instant>2024-11-08</instant>
        </period>
    </context>
    <context id="AsOf2024-11-08_custom_NoteSecuritiesPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:NoteSecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-11-08</instant>
        </period>
    </context>
    <context id="From2024-11-082024-11-08_custom_NoteTwoSecuritiesPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:NoteTwoSecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-11-08</startDate>
            <endDate>2024-11-08</endDate>
        </period>
    </context>
    <context id="From2024-11-082024-11-08_custom_ShortTermPromissoryNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:ShortTermPromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-11-08</startDate>
            <endDate>2024-11-08</endDate>
        </period>
    </context>
    <context id="From2024-11-082024-11-08">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
        </entity>
        <period>
            <startDate>2024-11-08</startDate>
            <endDate>2024-11-08</endDate>
        </period>
    </context>
    <context id="AsOf2025-02-28_custom_ShortTermPromissoryNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:ShortTermPromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-28</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_ShortTermPromissoryNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:ShortTermPromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2024-12-312024-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
        </entity>
        <period>
            <startDate>2024-12-31</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_OneMillionNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:OneMillionNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-02-26">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
        </entity>
        <period>
            <instant>2025-02-26</instant>
        </period>
    </context>
    <context id="From2025-02-262025-02-26_custom_SeriesPNonvotingConvertiblePreferredStockMember_custom_DebtExchangeAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesPNonvotingConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:DebtExchangeAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-02-26</startDate>
            <endDate>2025-02-26</endDate>
        </period>
    </context>
    <context id="AsOf2025-02-26_custom_SeriesPNonvotingConvertiblePreferredStockMember_custom_DebtExchangeAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesPNonvotingConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:DebtExchangeAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-26</instant>
        </period>
    </context>
    <context id="AsOf2025-02-04">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
        </entity>
        <period>
            <instant>2025-02-04</instant>
        </period>
    </context>
    <context id="AsOf2024-02-04_custom_SecuritiesPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-02-04</instant>
        </period>
    </context>
    <context id="AsOf2025-02-04_custom_NoteSecuritiesPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:NoteSecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-04</instant>
        </period>
    </context>
    <context id="From2025-02-042025-02-04_custom_NoteTwoSecuritiesPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:NoteTwoSecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-02-04</startDate>
            <endDate>2025-02-04</endDate>
        </period>
    </context>
    <context id="From2025-02-042025-02-04">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
        </entity>
        <period>
            <startDate>2025-02-04</startDate>
            <endDate>2025-02-04</endDate>
        </period>
    </context>
    <context id="From2023-03-132023-06-09_custom_SpecialPurposeAcquisitionCorporationMember_custom_SeveralInvestorsMember_custom_ConvertibleNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">NTRP:ConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">NTRP:SeveralInvestorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">NTRP:SpecialPurposeAcquisitionCorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-13</startDate>
            <endDate>2023-06-09</endDate>
        </period>
    </context>
    <context id="AsOf2023-06-09_custom_SpecialPurposeAcquisitionCorporationMember_custom_SeveralInvestorsMember_custom_ConvertibleNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">NTRP:ConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">NTRP:SeveralInvestorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">NTRP:SpecialPurposeAcquisitionCorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-09</instant>
        </period>
    </context>
    <context id="From2022-07-272023-02-21_custom_SpecialPurposeAcquisitionCorporationMember_custom_SeveralInvestorsMember_custom_ConvertibleNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">NTRP:ConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">NTRP:SeveralInvestorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">NTRP:SpecialPurposeAcquisitionCorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-27</startDate>
            <endDate>2023-02-21</endDate>
        </period>
    </context>
    <context id="AsOf2023-02-21_custom_SpecialPurposeAcquisitionCorporationMember_custom_SeveralInvestorsMember_custom_ConvertibleNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">NTRP:ConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">NTRP:SeveralInvestorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">NTRP:SpecialPurposeAcquisitionCorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-02-21</instant>
        </period>
    </context>
    <context id="AsOf2023-12-29_custom_DebtAssignmentAndConversionAgreementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:DebtAssignmentAndConversionAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-29</instant>
        </period>
    </context>
    <context id="From2023-12-292023-12-29_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-29</startDate>
            <endDate>2023-12-29</endDate>
        </period>
    </context>
    <context id="From2023-12-292023-12-29_custom_ContingentSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">NTRP:ContingentSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-29</startDate>
            <endDate>2023-12-29</endDate>
        </period>
    </context>
    <context id="From2023-08-102023-11-06_custom_SharePurchaseAgreementsMember_custom_SeveralInvestorsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">NTRP:SeveralInvestorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:SharePurchaseAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-08-10</startDate>
            <endDate>2023-11-06</endDate>
        </period>
    </context>
    <context id="AsOf2023-11-06_custom_SharePurchaseAgreementsMember_custom_SeveralInvestorsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">NTRP:SeveralInvestorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:SharePurchaseAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-11-06</instant>
        </period>
    </context>
    <context id="From2022-09-192022-09-19_custom_SoftwareAsAServiceAgreementMember_custom_ThirdPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">NTRP:ThirdPartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:SoftwareAsAServiceAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-19</startDate>
            <endDate>2022-09-19</endDate>
        </period>
    </context>
    <context id="AsOf2022-09-19_custom_SoftwareAsAServiceAgreementMember_custom_ThirdPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">NTRP:ThirdPartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:SoftwareAsAServiceAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-19</instant>
        </period>
    </context>
    <context id="From2023-12-292023-12-29_custom_SoftwareAsAServiceAgreementMember_us-gaap_CommonStockMember_custom_ThirdPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">NTRP:ThirdPartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:SoftwareAsAServiceAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-29</startDate>
            <endDate>2023-12-29</endDate>
        </period>
    </context>
    <context id="From2023-12-292023-12-29_custom_ContingentSharesMember_custom_SoftwareAsAServiceAgreementMember_custom_ThirdPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">NTRP:ThirdPartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">NTRP:ContingentSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:SoftwareAsAServiceAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-29</startDate>
            <endDate>2023-12-29</endDate>
        </period>
    </context>
    <context id="From2023-12-292023-12-29_us-gaap_CommonStockMember_custom_ThirdPartyConsultantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">NTRP:ThirdPartyConsultantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-29</startDate>
            <endDate>2023-12-29</endDate>
        </period>
    </context>
    <context id="From2023-12-292023-12-29_custom_ContingentSharesMember_custom_ThirdPartyConsultantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">NTRP:ThirdPartyConsultantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">NTRP:ContingentSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-29</startDate>
            <endDate>2023-12-29</endDate>
        </period>
    </context>
    <context id="From2023-12-282023-12-28_custom_ConsultingModificationAgreementMember_custom_ThirdPartyConsultantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">NTRP:ThirdPartyConsultantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:ConsultingModificationAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-28</startDate>
            <endDate>2023-12-28</endDate>
        </period>
    </context>
    <context id="From2023-12-292023-12-29_custom_ConsultingModificationAgreementMember_us-gaap_CommonStockMember_custom_ThirdPartyConsultantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">NTRP:ThirdPartyConsultantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:ConsultingModificationAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-29</startDate>
            <endDate>2023-12-29</endDate>
        </period>
    </context>
    <context id="From2023-12-292023-12-29_custom_ConsultingModificationAgreementMember_custom_ContingentSharesMember_custom_ThirdPartyConsultantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">NTRP:ThirdPartyConsultantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">NTRP:ContingentSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:ConsultingModificationAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-29</startDate>
            <endDate>2023-12-29</endDate>
        </period>
    </context>
    <context id="From2024-03-012025-02-28_custom_NextPlayTechnologiesIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">NTRP:NextPlayTechnologiesIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-03-01</startDate>
            <endDate>2025-02-28</endDate>
        </period>
    </context>
    <context id="From2023-09-212023-09-22">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
        </entity>
        <period>
            <startDate>2023-09-21</startDate>
            <endDate>2023-09-22</endDate>
        </period>
    </context>
    <context id="From2023-09-222023-09-22">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
        </entity>
        <period>
            <startDate>2023-09-22</startDate>
            <endDate>2023-09-22</endDate>
        </period>
    </context>
    <context id="From2024-03-152024-03-15_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-03-15</startDate>
            <endDate>2024-03-15</endDate>
        </period>
    </context>
    <context id="From2024-07-012024-08-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-08-31</endDate>
        </period>
    </context>
    <context id="From2024-09-192024-09-19_custom_AlumniCapitalLPMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">NTRP:AlumniCapitalLPMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-09-19</startDate>
            <endDate>2024-09-19</endDate>
        </period>
    </context>
    <context id="From2024-10-082024-10-08_custom_FSATravelLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">NTRP:FSATravelLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-10-08</startDate>
            <endDate>2024-10-08</endDate>
        </period>
    </context>
    <context id="From2024-12-162024-12-16_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-12-16</startDate>
            <endDate>2024-12-16</endDate>
        </period>
    </context>
    <context id="From2024-12-012025-01-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-12-01</startDate>
            <endDate>2025-01-31</endDate>
        </period>
    </context>
    <context id="From2025-01-072025-01-07_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-07</startDate>
            <endDate>2025-01-07</endDate>
        </period>
    </context>
    <context id="From2025-01-292025-01-29_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-29</startDate>
            <endDate>2025-01-29</endDate>
        </period>
    </context>
    <context id="From2025-02-262025-02-26_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-02-26</startDate>
            <endDate>2025-02-26</endDate>
        </period>
    </context>
    <context id="From2023-09-012023-09-30_custom_AtTheMarketIssuanceSalesAgreementMember_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">NTRP:AtTheMarketIssuanceSalesAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-09-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2023-10-012023-10-31_custom_AtTheMarketIssuanceSalesAgreementMember_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">NTRP:AtTheMarketIssuanceSalesAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-10-01</startDate>
            <endDate>2023-10-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-29_custom_NextTripHoldingsIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">NTRP:NextTripHoldingsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-29</instant>
        </period>
    </context>
    <context id="From2023-12-292023-12-29_custom_NextTripHoldingsIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">NTRP:NextTripHoldingsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-29</startDate>
            <endDate>2023-12-29</endDate>
        </period>
    </context>
    <context id="From2023-12-292024-12-29_custom_NextTripHoldingsIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">NTRP:NextTripHoldingsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-29</startDate>
            <endDate>2024-12-29</endDate>
        </period>
    </context>
    <context id="From2023-12-292023-12-29_custom_NextTripHoldingsIncMember_custom_DebtAssignmentAndConversionAgreementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">NTRP:NextTripHoldingsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DeferredRevenueArrangementTypeAxis">NTRP:DebtAssignmentAndConversionAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-29</startDate>
            <endDate>2023-12-29</endDate>
        </period>
    </context>
    <context id="From2023-12-292023-12-29_custom_NextTripHoldingsIncMember_custom_SharePurchaseAndExchangeAgreementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">NTRP:NextTripHoldingsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DeferredRevenueArrangementTypeAxis">NTRP:SharePurchaseAndExchangeAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-29</startDate>
            <endDate>2023-12-29</endDate>
        </period>
    </context>
    <context id="From2023-12-292023-12-29_custom_NextTripHoldingsIncMember_custom_ThirdPartyConsultantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">NTRP:NextTripHoldingsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">NTRP:ThirdPartyConsultantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-29</startDate>
            <endDate>2023-12-29</endDate>
        </period>
    </context>
    <context id="AsOf2025-02-28_custom_SeriesEConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesEConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-28</instant>
        </period>
    </context>
    <context id="From2024-03-012025-02-28_custom_SeriesEConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesEConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-03-01</startDate>
            <endDate>2025-02-28</endDate>
        </period>
    </context>
    <context id="AsOf2024-01-04_custom_SeriesFConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesFConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-01-04</instant>
        </period>
    </context>
    <context id="AsOf2025-02-28_custom_SeriesFConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesFConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-28</instant>
        </period>
    </context>
    <context id="AsOf2024-01-26_custom_SeriesGConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesGConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-01-26</instant>
        </period>
    </context>
    <context id="From2024-03-012025-02-28_custom_SeriesGConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesGConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-03-01</startDate>
            <endDate>2025-02-28</endDate>
        </period>
    </context>
    <context id="AsOf2025-02-28_custom_SeriesGConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesGConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-28</instant>
        </period>
    </context>
    <context id="AsOf2024-01-26_custom_SeriesHConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesHConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-01-26</instant>
        </period>
    </context>
    <context id="AsOf2025-02-28_custom_SeriesHConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesHConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-28</instant>
        </period>
    </context>
    <context id="AsOf2024-02-22_custom_SeriesIConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesIConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-02-22</instant>
        </period>
    </context>
    <context id="AsOf2025-02-25_custom_SeriesIConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesIConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-25</instant>
        </period>
    </context>
    <context id="From2024-02-152024-02-15_custom_SeriesIConvertiblePreferredStockMember_custom_SecuritiesPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesIConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-02-15</startDate>
            <endDate>2024-02-15</endDate>
        </period>
    </context>
    <context id="AsOf2024-02-15_custom_SeriesIConvertiblePreferredStockMember_custom_SecuritiesPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesIConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-02-15</instant>
        </period>
    </context>
    <context id="From2024-08-152024-08-15_custom_SeriesIConvertiblePreferredStockMember_custom_SecuritiesPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesIConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-08-15</startDate>
            <endDate>2024-08-15</endDate>
        </period>
    </context>
    <context id="AsOf2024-08-15_custom_SeriesIConvertiblePreferredStockMember_custom_SecuritiesPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesIConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-08-15</instant>
        </period>
    </context>
    <context id="From2024-08-312024-08-31_custom_SeriesIConvertiblePreferredStockMember_custom_SecuritiesPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesIConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-08-31</startDate>
            <endDate>2024-08-31</endDate>
        </period>
    </context>
    <context id="AsOf2024-08-31_custom_SeriesIConvertiblePreferredStockMember_custom_SecuritiesPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesIConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-08-31</instant>
        </period>
    </context>
    <context id="From2024-10-012024-10-01_custom_SeriesIConvertiblePreferredStockMember_custom_SecuritiesPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesIConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-10-01</startDate>
            <endDate>2024-10-01</endDate>
        </period>
    </context>
    <context id="AsOf2024-10-01_custom_SeriesIConvertiblePreferredStockMember_custom_SecuritiesPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesIConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-10-01</instant>
        </period>
    </context>
    <context id="From2025-02-242025-02-24_custom_SeriesIConvertiblePreferredStockMember_custom_SeriesIPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesIConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:SeriesIPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-02-24</startDate>
            <endDate>2025-02-24</endDate>
        </period>
    </context>
    <context id="AsOf2025-02-24_custom_SeriesIConvertiblePreferredStockMember_custom_SecuritiesPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesIConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-24</instant>
        </period>
    </context>
    <context id="From2025-02-242025-02-24_custom_SeriesIPreferredStockMember_custom_SeriesIPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesIPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:SeriesIPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-02-24</startDate>
            <endDate>2025-02-24</endDate>
        </period>
    </context>
    <context id="AsOf2024-10-01_custom_SeriesIPreferredStockMember_custom_SecuritiesPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesIPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-10-01</instant>
        </period>
    </context>
    <context id="From2025-02-242025-02-24_custom_MillerDebtConversionAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:MillerDebtConversionAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-02-24</startDate>
            <endDate>2025-02-24</endDate>
        </period>
    </context>
    <context id="From2025-02-242025-02-24_custom_MillerDebtConversionAgreementMember_custom_SeriesIConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesIConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:MillerDebtConversionAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-02-24</startDate>
            <endDate>2025-02-24</endDate>
        </period>
    </context>
    <context id="AsOf2025-02-24_custom_MillerDebtConversionAgreementMember_custom_SeriesIConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesIConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:MillerDebtConversionAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-24</instant>
        </period>
    </context>
    <context id="AsOf2025-02-28_custom_SeriesIConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesIConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-28</instant>
        </period>
    </context>
    <context id="From2025-01-032025-01-03_custom_SeriesJNonvotingConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesJNonvotingConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-03</startDate>
            <endDate>2025-01-03</endDate>
        </period>
    </context>
    <context id="AsOf2025-01-03_custom_SeriesJNonvotingConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesJNonvotingConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-01-03</instant>
        </period>
    </context>
    <context id="From2024-12-312024-12-31_custom_SeriesJNonvotingConvertiblePreferredStockMember_custom_SecuritiesPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesJNonvotingConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-12-31</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_SeriesJNonvotingConvertiblePreferredStockMember_custom_SecuritiesPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesJNonvotingConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-02-28_custom_SeriesJNonvotingConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesJNonvotingConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-28</instant>
        </period>
    </context>
    <context id="From2025-01-032025-01-03_custom_SeriesKNonvotingConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesKNonvotingConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-03</startDate>
            <endDate>2025-01-03</endDate>
        </period>
    </context>
    <context id="AsOf2025-01-03_custom_SeriesKNonvotingConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesKNonvotingConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-01-03</instant>
        </period>
    </context>
    <context id="From2024-12-312024-12-31_custom_SeriesKNonvotingConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesKNonvotingConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-12-31</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_SeriesKNonvotingConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesKNonvotingConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-02-28_custom_SeriesKNonvotingConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesKNonvotingConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-28</instant>
        </period>
    </context>
    <context id="From2025-01-032025-01-03_custom_SeriesLNonvotingConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesLNonvotingConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-03</startDate>
            <endDate>2025-01-03</endDate>
        </period>
    </context>
    <context id="AsOf2025-01-03_custom_SeriesLNonvotingConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesLNonvotingConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-01-03</instant>
        </period>
    </context>
    <context id="AsOf2025-02-25_custom_SeriesLNonvotingConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesLNonvotingConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-25</instant>
        </period>
    </context>
    <context id="From2024-12-312024-12-31_custom_MessrsKerbyAndMonacoMember_custom_RelatedPartyDebtConversionAgreementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">NTRP:MessrsKerbyAndMonacoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:RelatedPartyDebtConversionAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-12-31</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-12-312024-12-31_custom_MessrsKerbyAndMonacoMember_custom_SeriesLNonvotingConvertiblePreferredStockMember_custom_RelatedPartyDebtConversionAgreementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">NTRP:MessrsKerbyAndMonacoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesLNonvotingConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:RelatedPartyDebtConversionAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-12-31</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_MessrsKerbyAndMonacoMember_custom_SeriesLNonvotingConvertiblePreferredStockMember_custom_RelatedPartyDebtConversionAgreementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">NTRP:MessrsKerbyAndMonacoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesLNonvotingConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:RelatedPartyDebtConversionAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2025-02-242025-02-24_custom_RelatedPartyDebtConversionAgreementsMember_custom_SeriesLNonvotingConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesLNonvotingConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:RelatedPartyDebtConversionAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-02-24</startDate>
            <endDate>2025-02-24</endDate>
        </period>
    </context>
    <context id="AsOf2025-02-24_custom_SeriesLNonvotingConvertiblePreferredStockMember_custom_RelatedPartyDebtConversionAgreementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesLNonvotingConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:RelatedPartyDebtConversionAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-24</instant>
        </period>
    </context>
    <context id="AsOf2025-02-28_custom_SeriesLNonvotingConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesLNonvotingConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-28</instant>
        </period>
    </context>
    <context id="From2025-01-032025-01-03_custom_SeriesMNonvotingConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesMNonvotingConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-03</startDate>
            <endDate>2025-01-03</endDate>
        </period>
    </context>
    <context id="AsOf2025-01-03_custom_SeriesMNonvotingConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesMNonvotingConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-01-03</instant>
        </period>
    </context>
    <context id="From2024-12-312024-12-31_custom_SecuritiesPurchaseAgreementMember_custom_SeriesMNonvotingConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesMNonvotingConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-12-31</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2024-12-31_custom_SecuritiesPurchaseAgreementMember_custom_SeriesMNonvotingConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesMNonvotingConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="From2024-12-312024-12-31_custom_SeriesMNonvotingConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesMNonvotingConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-12-31</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-02-28_custom_SeriesMNonvotingConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesMNonvotingConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-28</instant>
        </period>
    </context>
    <context id="From2024-03-012025-02-28_custom_SeriesMNonvotingConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesMNonvotingConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-03-01</startDate>
            <endDate>2025-02-28</endDate>
        </period>
    </context>
    <context id="From2025-01-032025-01-03_custom_SeriesNNonvotingConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesNNonvotingConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-03</startDate>
            <endDate>2025-01-03</endDate>
        </period>
    </context>
    <context id="AsOf2025-01-03_custom_SeriesNNonvotingConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesNNonvotingConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-01-03</instant>
        </period>
    </context>
    <context id="From2025-01-282025-01-28_custom_SeriesNNonvotingConvertiblePreferredStockMember_custom_SecuritiesPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesNNonvotingConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-28</startDate>
            <endDate>2025-01-28</endDate>
        </period>
    </context>
    <context id="AsOf2025-01-28_custom_SeriesNNonvotingConvertiblePreferredStockMember_custom_SecuritiesPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesNNonvotingConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-01-28</instant>
        </period>
    </context>
    <context id="From2025-01-282025-01-28_custom_SeriesNNonvotingConvertiblePreferredStockMember_custom_ShareExchangeAgreementMember_custom_BlueFyshHoldingsIncMember_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesNNonvotingConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:ShareExchangeAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">NTRP:BlueFyshHoldingsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-28</startDate>
            <endDate>2025-01-28</endDate>
        </period>
    </context>
    <context id="AsOf2025-01-28_custom_SeriesNNonvotingConvertiblePreferredStockMember_custom_ShareExchangeAgreementMember_custom_BlueFyshHoldingsIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesNNonvotingConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:ShareExchangeAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">NTRP:BlueFyshHoldingsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-01-28</instant>
        </period>
    </context>
    <context id="From2025-01-282025-01-28_custom_SeriesNNonvotingConvertiblePreferredStockMember_custom_ShareExchangeAgreementMember_custom_BlueFyshHoldingsIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesNNonvotingConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:ShareExchangeAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">NTRP:BlueFyshHoldingsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-28</startDate>
            <endDate>2025-01-28</endDate>
        </period>
    </context>
    <context id="AsOf2025-02-28_custom_SeriesNNonvotingConvertibleConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesNNonvotingConvertibleConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-28</instant>
        </period>
    </context>
    <context id="From2025-02-062025-02-06_custom_SeriesONonvotingConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesONonvotingConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-02-06</startDate>
            <endDate>2025-02-06</endDate>
        </period>
    </context>
    <context id="AsOf2025-02-06_custom_SeriesONonvotingConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesONonvotingConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-06</instant>
        </period>
    </context>
    <context id="AsOf2025-02-06_custom_FSATravelLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">NTRP:FSATravelLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-06</instant>
        </period>
    </context>
    <context id="AsOf2025-02-28_custom_SeriesONonvotingConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesONonvotingConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-28</instant>
        </period>
    </context>
    <context id="From2025-02-252025-02-25_custom_SeriesPNonvotingConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesPNonvotingConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-02-25</startDate>
            <endDate>2025-02-25</endDate>
        </period>
    </context>
    <context id="AsOf2025-02-25_custom_SeriesPNonvotingConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesPNonvotingConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-25</instant>
        </period>
    </context>
    <context id="From2025-02-262025-02-26_custom_SeriesPNonvotingConvertiblePreferredStockMember_custom_EquityInvestmentAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesPNonvotingConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:EquityInvestmentAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-02-26</startDate>
            <endDate>2025-02-26</endDate>
        </period>
    </context>
    <context id="AsOf2025-02-26_custom_SeriesPNonvotingConvertiblePreferredStockMember_custom_EquityInvestmentAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesPNonvotingConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:EquityInvestmentAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-26</instant>
        </period>
    </context>
    <context id="AsOf2025-02-28_custom_SeriesPNonvotingConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesPNonvotingConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-28</instant>
        </period>
    </context>
    <context id="AsOf2025-02-28_custom_TwoThousandTwentyThreeEquityIncentivePlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">NTRP:TwoThousandTwentyThreeEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-28</instant>
        </period>
    </context>
    <context id="AsOf2025-02-28_custom_TwoThousandThirteenEquityIncentivePlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">NTRP:TwoThousandThirteenEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-28</instant>
        </period>
    </context>
    <context id="AsOf2025-02-28_us-gaap_StockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-28</instant>
        </period>
    </context>
    <context id="From2024-03-012025-02-28_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-03-01</startDate>
            <endDate>2025-02-28</endDate>
        </period>
    </context>
    <context id="From2023-12-292024-02-29">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
        </entity>
        <period>
            <startDate>2023-12-29</startDate>
            <endDate>2024-02-29</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-29_custom_StockAppreciationRightsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">NTRP:StockAppreciationRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-29</instant>
        </period>
    </context>
    <context id="From2024-12-292024-12-29_custom_StockAppreciationRightsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">NTRP:StockAppreciationRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-12-29</startDate>
            <endDate>2024-12-29</endDate>
        </period>
    </context>
    <context id="From2024-03-012025-02-28_custom_TwoThousandAndTwentyStockAppreciationRightsPlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">NTRP:TwoThousandAndTwentyStockAppreciationRightsPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-03-01</startDate>
            <endDate>2025-02-28</endDate>
        </period>
    </context>
    <context id="AsOf2025-02-28_custom_TwoThousandAndTwentyStockAppreciationRightsPlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">NTRP:TwoThousandAndTwentyStockAppreciationRightsPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-28</instant>
        </period>
    </context>
    <context id="AsOf2025-02-28_us-gaap_WarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-28</instant>
        </period>
    </context>
    <context id="AsOf2025-02-28_us-gaap_WarrantMember_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-28</instant>
        </period>
    </context>
    <context id="AsOf2025-02-28_us-gaap_WarrantMember_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-28</instant>
        </period>
    </context>
    <context id="From2024-03-012025-02-28_us-gaap_WarrantMember11853671">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-03-01</startDate>
            <endDate>2025-02-28</endDate>
        </period>
    </context>
    <context id="From2024-03-012025-02-28_custom_StockAppreciationRightsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">NTRP:StockAppreciationRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-03-01</startDate>
            <endDate>2025-02-28</endDate>
        </period>
    </context>
    <context id="AsOf2024-02-29_custom_StockAppreciationRightsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">NTRP:StockAppreciationRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-02-29</instant>
        </period>
    </context>
    <context id="From2023-03-012024-02-28_custom_StockAppreciationRightsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">NTRP:StockAppreciationRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-01</startDate>
            <endDate>2024-02-28</endDate>
        </period>
    </context>
    <context id="AsOf2025-02-28_custom_StockAppreciationRightsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">NTRP:StockAppreciationRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-28</instant>
        </period>
    </context>
    <context id="From2024-03-012025-02-28_custom_TwoThousandAndTwentyStockAppreciationRightsPlanMember_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">NTRP:TwoThousandAndTwentyStockAppreciationRightsPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-03-01</startDate>
            <endDate>2025-02-28</endDate>
        </period>
    </context>
    <context id="From2024-03-012025-02-28_custom_TwoThousandAndTwentyStockAppreciationRightsPlanMember_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">NTRP:TwoThousandAndTwentyStockAppreciationRightsPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-03-01</startDate>
            <endDate>2025-02-28</endDate>
        </period>
    </context>
    <context id="From2024-03-012025-02-28_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-03-01</startDate>
            <endDate>2025-02-28</endDate>
        </period>
    </context>
    <context id="From2024-06-102024-06-10_custom_ShareExchangeAgreementMember_custom_AchievedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">NTRP:AchievedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:ShareExchangeAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-06-10</startDate>
            <endDate>2024-06-10</endDate>
        </period>
    </context>
    <context id="From2024-06-102024-06-10_custom_ShareExchangeAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:ShareExchangeAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-06-10</startDate>
            <endDate>2024-06-10</endDate>
        </period>
    </context>
    <context id="AsOf2025-02-28_us-gaap_EmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-28</instant>
        </period>
    </context>
    <context id="From2024-03-012025-02-28_us-gaap_SeriesEPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesEPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-03-01</startDate>
            <endDate>2025-02-28</endDate>
        </period>
    </context>
    <context id="From2024-03-012025-02-28_us-gaap_SeriesHPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesHPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-03-01</startDate>
            <endDate>2025-02-28</endDate>
        </period>
    </context>
    <context id="From2024-03-012025-02-28_custom_SeriesIPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesIPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-03-01</startDate>
            <endDate>2025-02-28</endDate>
        </period>
    </context>
    <context id="From2024-03-012025-02-28_custom_SeriesJPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesJPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-03-01</startDate>
            <endDate>2025-02-28</endDate>
        </period>
    </context>
    <context id="From2024-03-012025-02-28_custom_SeriesKPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesKPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-03-01</startDate>
            <endDate>2025-02-28</endDate>
        </period>
    </context>
    <context id="From2024-03-012025-02-28_custom_SeriesLPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesLPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-03-01</startDate>
            <endDate>2025-02-28</endDate>
        </period>
    </context>
    <context id="From2024-03-012025-02-28_custom_SeriesMPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesMPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-03-01</startDate>
            <endDate>2025-02-28</endDate>
        </period>
    </context>
    <context id="From2024-03-012025-02-28_custom_SeriesNPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesNPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-03-01</startDate>
            <endDate>2025-02-28</endDate>
        </period>
    </context>
    <context id="From2024-03-012025-02-28_custom_SeriesOPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesOPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-03-01</startDate>
            <endDate>2025-02-28</endDate>
        </period>
    </context>
    <context id="From2024-03-012025-02-28_custom_SeriesOPreferredStockOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesOPreferredStockOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-03-01</startDate>
            <endDate>2025-02-28</endDate>
        </period>
    </context>
    <context id="From2024-06-102024-06-10_custom_AchievedMember_custom_LeisureTravelBookingPlatformMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">NTRP:AchievedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">NTRP:LeisureTravelBookingPlatformMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-06-10</startDate>
            <endDate>2024-06-10</endDate>
        </period>
    </context>
    <context id="From2024-06-102024-06-10_custom_AchievedMember_custom_GroupTravelBookingPlatformMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">NTRP:AchievedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">NTRP:GroupTravelBookingPlatformMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-06-10</startDate>
            <endDate>2024-06-10</endDate>
        </period>
    </context>
    <context id="From2024-06-102024-06-10_custom_AchievedMember_custom_FlexPayTechnologyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">NTRP:AchievedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">NTRP:FlexPayTechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-06-10</startDate>
            <endDate>2024-06-10</endDate>
        </period>
    </context>
    <context id="From2024-06-102024-06-10_custom_AchievedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">NTRP:AchievedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-06-10</startDate>
            <endDate>2024-06-10</endDate>
        </period>
    </context>
    <context id="From2024-06-102024-06-10_custom_NotAchievedMember_custom_TravelAgentPlatformMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">NTRP:NotAchievedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">NTRP:TravelAgentPlatformMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-06-10</startDate>
            <endDate>2024-06-10</endDate>
        </period>
    </context>
    <context id="From2024-06-102024-06-10_custom_NotAchievedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">NTRP:NotAchievedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-06-10</startDate>
            <endDate>2024-06-10</endDate>
        </period>
    </context>
    <context id="From2024-06-102024-06-10">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
        </entity>
        <period>
            <startDate>2024-06-10</startDate>
            <endDate>2024-06-10</endDate>
        </period>
    </context>
    <context id="From2024-03-012025-02-28_us-gaap_CommonStockMember11856671">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-03-01</startDate>
            <endDate>2025-02-28</endDate>
        </period>
    </context>
    <context id="From2024-03-012025-02-28_custom_ContingentSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:ContingentSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-03-01</startDate>
            <endDate>2025-02-28</endDate>
        </period>
    </context>
    <context id="From2023-03-012024-02-29_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">NTRP:CustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-01</startDate>
            <endDate>2024-02-29</endDate>
        </period>
    </context>
    <context id="From2024-03-012025-02-28_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">NTRP:CustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-03-01</startDate>
            <endDate>2025-02-28</endDate>
        </period>
    </context>
    <context id="From2023-03-012024-02-29_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">NTRP:CustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-01</startDate>
            <endDate>2024-02-29</endDate>
        </period>
    </context>
    <context id="From2024-03-012025-02-28_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">NTRP:CustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-03-01</startDate>
            <endDate>2025-02-28</endDate>
        </period>
    </context>
    <context id="From2023-03-012024-02-28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
        </entity>
        <period>
            <startDate>2023-03-01</startDate>
            <endDate>2024-02-28</endDate>
        </period>
    </context>
    <context id="From2025-03-262025-03-26_custom_ExchangeAgreementMember_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:ExchangeAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-03-26</startDate>
            <endDate>2025-03-26</endDate>
        </period>
    </context>
    <context id="AsOf2025-03-26_custom_ExchangeAgreementMember_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:ExchangeAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-26</instant>
        </period>
    </context>
    <context id="From2025-05-052025-05-05_custom_ExchangeAgreementMember_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:ExchangeAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-05</startDate>
            <endDate>2025-05-05</endDate>
        </period>
    </context>
    <context id="AsOf2025-04-01_custom_SecuritiesPurchaseAgreementMember_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-04-01</instant>
        </period>
    </context>
    <context id="From2025-04-012025-04-01_custom_SecuritiesPurchaseAgreementMember_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-04-01</endDate>
        </period>
    </context>
    <context id="AsOf2025-04-01_custom_SecuritiesPurchaseAgreementMember_srt_MaximumMember_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-04-01</instant>
        </period>
    </context>
    <context id="From2025-04-012025-04-01_custom_AssetPurchaseAgreementMember_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:AssetPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-04-01</endDate>
        </period>
    </context>
    <context id="From2025-04-012025-04-01_custom_AssetPurchaseAgreementMember_us-gaap_CommonStockMember_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:AssetPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-04-01</endDate>
        </period>
    </context>
    <context id="AsOf2025-04-09_custom_FSATravelLLCMember_custom_PurchaseAgreementMember_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">NTRP:FSATravelLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:PurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-04-09</instant>
        </period>
    </context>
    <context id="From2025-04-092025-04-09_custom_FSATravelLLCMember_custom_PurchaseAgreementMember_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:PurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">NTRP:FSATravelLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-09</startDate>
            <endDate>2025-04-09</endDate>
        </period>
    </context>
    <context id="From2025-04-092025-04-09_custom_FSATravelLLCMember_us-gaap_PreferredStockMember_custom_SeriesOPreferredStockMember_custom_PurchaseAgreementMember_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesOPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:PurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">NTRP:FSATravelLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-09</startDate>
            <endDate>2025-04-09</endDate>
        </period>
    </context>
    <context id="From2025-04-282025-04-28_custom_FSATravelLLCMember_custom_PurchaseAgreementMember_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:PurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">NTRP:FSATravelLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-28</startDate>
            <endDate>2025-04-28</endDate>
        </period>
    </context>
    <context id="From2025-04-282025-04-28_custom_FSATravelLLCMember_us-gaap_PreferredStockMember_custom_SeriesOPreferredStockMember_custom_PurchaseAgreementMember_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesOPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:PurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">NTRP:FSATravelLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-28</startDate>
            <endDate>2025-04-28</endDate>
        </period>
    </context>
    <context id="From2025-04-282025-04-28_custom_FSATravelLLCMember_us-gaap_CommonStockMember_custom_PurchaseAgreementMember_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:PurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">NTRP:FSATravelLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-28</startDate>
            <endDate>2025-04-28</endDate>
        </period>
    </context>
    <context id="AsOf2025-04-09_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-04-09</instant>
        </period>
    </context>
    <context id="AsOf2025-04-09_us-gaap_SubsequentEventMember_custom_NoteOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">NTRP:NoteOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-04-09</instant>
        </period>
    </context>
    <context id="AsOf2025-04-09_us-gaap_SubsequentEventMember_custom_NoteTwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">NTRP:NoteTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-04-09</instant>
        </period>
    </context>
    <context id="AsOf2025-05-06_custom_LineOfCreditAgreementMember_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:LineOfCreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-05-06</instant>
        </period>
    </context>
    <context id="From2025-05-062025-05-06_custom_LineOfCreditAgreementMember_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:LineOfCreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-06</startDate>
            <endDate>2025-05-06</endDate>
        </period>
    </context>
    <context id="AsOf2025-04-09_custom_LineOfCreditAgreementMember_custom_TwoPromissoryNotesMember_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">NTRP:TwoPromissoryNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:LineOfCreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-04-09</instant>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="Pure">
        <measure>pure</measure>
    </unit>
    <unit id="sqft">
        <measure>utr:sqft</measure>
    </unit>
    <dei:AmendmentFlag contextRef="From2024-03-01to2025-02-28" id="Fact000004">false</dei:AmendmentFlag>
    <dei:DocumentFiscalPeriodFocus contextRef="From2024-03-01to2025-02-28" id="Fact000005">FY</dei:DocumentFiscalPeriodFocus>
    <dei:EntityCentralIndexKey contextRef="From2024-03-01to2025-02-28" id="Fact000006">0000788611</dei:EntityCentralIndexKey>
    <NTRP:PromissoryNoteReceivableNet
      contextRef="AsOf2025-02-28"
      id="xdx2ixbrl0077"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:EquityMethodInvestments
      contextRef="AsOf2024-02-29"
      id="xdx2ixbrl0105"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PrepaidExpenseOtherNoncurrent
      contextRef="AsOf2024-02-29"
      id="xdx2ixbrl0108"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NotesPayableCurrent
      contextRef="AsOf2024-02-29_us-gaap_NonrelatedPartyMember"
      id="xdx2ixbrl0132"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="AsOf2025-02-28"
      id="xdx2ixbrl0146"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="AsOf2024-02-29"
      id="xdx2ixbrl0147"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2024-03-01to2025-02-28"
      id="xdx2ixbrl0276"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2023-03-012024-02-29"
      id="xdx2ixbrl0277"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="From2023-03-012024-02-29"
      id="xdx2ixbrl0283"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-02-28_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0337"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-02-28_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0343"
      unitRef="Shares"
      xsi:nil="true"/>
    <NTRP:StockIssuedDuringPeriodValueOfPreferredShares
      contextRef="From2023-03-012024-02-29_us-gaap_CommonStockMember"
      id="xdx2ixbrl0348"
      unitRef="USD"
      xsi:nil="true"/>
    <NTRP:StockIssuedDuringPeriodValueOfPreferredShares
      contextRef="From2023-03-012024-02-29_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0350"
      unitRef="USD"
      xsi:nil="true"/>
    <NTRP:StockIssuedDuringPeriodShareOfPreferredShares
      contextRef="From2023-03-012024-02-29_us-gaap_CommonStockMember"
      id="xdx2ixbrl0355"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2023-03-012024-02-29_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0357"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2023-03-012024-02-29_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0360"
      unitRef="USD"
      xsi:nil="true"/>
    <NTRP:StockIssuedDuringPeriodValuePurchasesOfCommonShares
      contextRef="From2023-03-012024-02-29_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0365"
      unitRef="USD"
      xsi:nil="true"/>
    <NTRP:StockIssuedDuringPeriodValuePurchasesOfCommonShares
      contextRef="From2023-03-012024-02-29_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0368"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2023-03-012024-02-29_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0373"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2023-03-012024-02-29_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0376"
      unitRef="USD"
      xsi:nil="true"/>
    <NTRP:StockIssuedDuringPeriodValueReverseAcquisition
      contextRef="From2023-03-012024-02-29_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0384"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2023-03-012024-02-29_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0391"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2023-03-012024-02-29_us-gaap_CommonStockMember"
      id="xdx2ixbrl0392"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2023-03-012024-02-29_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0394"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DividendsPreferredStock
      contextRef="From2023-03-012024-02-29_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0397"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DividendsPreferredStock
      contextRef="From2023-03-012024-02-29_us-gaap_CommonStockMember"
      id="xdx2ixbrl0398"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DividendsPreferredStock
      contextRef="From2023-03-012024-02-29"
      id="xdx2ixbrl0401"
      unitRef="USD"
      xsi:nil="true"/>
    <NTRP:StockIssuedDuringPeriodValueOfPreferredSharesInPrivatePlacements
      contextRef="From2024-03-012025-02-28_us-gaap_CommonStockMember"
      id="xdx2ixbrl0430"
      unitRef="USD"
      xsi:nil="true"/>
    <NTRP:StockIssuedDuringPeriodValueOfPreferredSharesInPrivatePlacements
      contextRef="From2024-03-012025-02-28_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0432"
      unitRef="USD"
      xsi:nil="true"/>
    <NTRP:StockIssuedDuringPeriodSharesOfPreferredSharesInPrivatePlacements
      contextRef="From2024-03-012025-02-28_us-gaap_CommonStockMember"
      id="xdx2ixbrl0437"
      unitRef="Shares"
      xsi:nil="true"/>
    <NTRP:StockIssuedDuringPeriodValueConversionOfPreferredSharesToCommonShares
      contextRef="From2024-03-012025-02-28_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0441"
      unitRef="USD"
      xsi:nil="true"/>
    <NTRP:StockIssuedDuringPeriodValueConversionOfPreferredSharesToCommonShares
      contextRef="From2024-03-012025-02-28_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0442"
      unitRef="USD"
      xsi:nil="true"/>
    <NTRP:StockIssuedDuringPeriodValueConversionOfPreferredSharesToCommonShares
      contextRef="From2024-03-01to2025-02-28"
      id="xdx2ixbrl0443"
      unitRef="USD"
      xsi:nil="true"/>
    <NTRP:StockIssuedDuringPeriodValueIssuanceOfPreferredSharesForDebtConversions
      contextRef="From2024-03-012025-02-28_us-gaap_CommonStockMember"
      id="xdx2ixbrl0450"
      unitRef="USD"
      xsi:nil="true"/>
    <NTRP:StockIssuedDuringPeriodValueIssuanceOfPreferredSharesForDebtConversions
      contextRef="From2024-03-012025-02-28_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0452"
      unitRef="USD"
      xsi:nil="true"/>
    <NTRP:StockIssuedDuringPeriodSharesIssuanceOfPreferredSharesForDebtConversions
      contextRef="From2024-03-012025-02-28_us-gaap_CommonStockMember"
      id="xdx2ixbrl0457"
      unitRef="Shares"
      xsi:nil="true"/>
    <NTRP:StockIssuedDuringPeriodValueIssuanceOfSecuritiesForServices
      contextRef="From2024-03-012025-02-28_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0462"
      unitRef="USD"
      xsi:nil="true"/>
    <NTRP:StockIssuedDuringPeriodValueSecuritiesIssuedForEquityInvestments
      contextRef="From2024-03-012025-02-28_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0472"
      unitRef="USD"
      xsi:nil="true"/>
    <NTRP:StockIssuedDuringPeriodValueIssuanceOfCommitmentSharesForEquityLineOfCredit
      contextRef="From2024-03-012025-02-28_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0479"
      unitRef="USD"
      xsi:nil="true"/>
    <NTRP:StockIssuedDuringPeriodValueIssuanceOfCommitmentSharesForEquityLineOfCredit
      contextRef="From2024-03-012025-02-28_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0482"
      unitRef="USD"
      xsi:nil="true"/>
    <NTRP:StockIssuedDuringPeriodSharesIssuanceOfCommitmentSharesForEquityLineOfCredit
      contextRef="From2024-03-012025-02-28_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0485"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2024-03-012025-02-28_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0489"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2024-03-012025-02-28_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0492"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="From2024-03-012025-02-28_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0495"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2024-03-012025-02-28_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0499"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2024-03-012025-02-28_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0502"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="From2024-03-012025-02-28_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0505"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:DividendsPreferredStock
      contextRef="From2024-03-012025-02-28_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0509"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DividendsPreferredStock
      contextRef="From2024-03-012025-02-28_us-gaap_CommonStockMember"
      id="xdx2ixbrl0510"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DividendsPreferredStock
      contextRef="From2024-03-01to2025-02-28"
      id="xdx2ixbrl0513"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-03-012025-02-28_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0515"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-03-012025-02-28_us-gaap_CommonStockMember"
      id="xdx2ixbrl0516"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-03-012025-02-28_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0517"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="From2023-03-012024-02-29"
      id="xdx2ixbrl0559"
      unitRef="USD"
      xsi:nil="true"/>
    <NTRP:AmortizationOfPrepaidExpenses
      contextRef="From2023-03-012024-02-29"
      id="xdx2ixbrl0562"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="From2023-03-012024-02-29"
      id="xdx2ixbrl0577"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="From2024-03-01to2025-02-28"
      id="xdx2ixbrl0609"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromSaleOfProductiveAssets
      contextRef="From2024-03-01to2025-02-28"
      id="xdx2ixbrl0615"
      unitRef="USD"
      xsi:nil="true"/>
    <NTRP:InvestmentInEquityMethodInvestee
      contextRef="From2023-03-012024-02-29"
      id="xdx2ixbrl0619"
      unitRef="USD"
      xsi:nil="true"/>
    <NTRP:ProceedsFromAcquireBusinessesGross
      contextRef="From2024-03-01to2025-02-28"
      id="xdx2ixbrl0621"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromSaleOfOtherProductiveAssets
      contextRef="From2023-03-012024-02-29"
      id="xdx2ixbrl0625"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromNotesPayable
      contextRef="From2023-03-012024-02-29"
      id="xdx2ixbrl0634"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="From2024-03-01to2025-02-28"
      id="xdx2ixbrl0636"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="From2024-03-01to2025-02-28"
      id="xdx2ixbrl0639"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromIssuanceOfWarrants
      contextRef="From2023-03-012024-02-29"
      id="xdx2ixbrl0646"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="From2024-03-01to2025-02-28"
      id="xdx2ixbrl0669"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="From2023-03-012024-02-29"
      id="xdx2ixbrl0670"
      unitRef="USD"
      xsi:nil="true"/>
    <NTRP:IssuanceOfCommonSharesAsCommitmentShares
      contextRef="From2023-03-012024-02-29"
      id="xdx2ixbrl0682"
      unitRef="USD"
      xsi:nil="true"/>
    <NTRP:IssuanceOfCommonWarrantsForServices
      contextRef="From2023-03-012024-02-29"
      id="xdx2ixbrl0685"
      unitRef="USD"
      xsi:nil="true"/>
    <NTRP:IssuanceOfCommonSharesForEquityInvestments
      contextRef="From2023-03-012024-02-29"
      id="xdx2ixbrl0688"
      unitRef="USD"
      xsi:nil="true"/>
    <NTRP:IssuanceOfPreferredSharesForEquityInvestments
      contextRef="From2023-03-012024-02-29"
      id="xdx2ixbrl0691"
      unitRef="USD"
      xsi:nil="true"/>
    <NTRP:IssuanceOfPreferredSharesForPerpetualSoftwareLicense
      contextRef="From2024-03-01to2025-02-28"
      id="xdx2ixbrl0693"
      unitRef="USD"
      xsi:nil="true"/>
    <NTRP:ConversionOfConvertibleNotes
      contextRef="From2024-03-01to2025-02-28"
      id="xdx2ixbrl0696"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold
      contextRef="From2024-03-01to2025-02-28"
      id="xdx2ixbrl0856"
      unitRef="USD"
      xsi:nil="true"/>
    <NTRP:PrepaidOfferingCosts
      contextRef="AsOf2024-02-29"
      id="xdx2ixbrl0966"
      unitRef="USD"
      xsi:nil="true"/>
    <NTRP:PrepaidConsultingContract
      contextRef="AsOf2024-02-29"
      id="xdx2ixbrl0969"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PrepaidAdvertising
      contextRef="AsOf2025-02-28"
      id="xdx2ixbrl0977"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="From2024-03-01to2025-02-28"
      id="xdx2ixbrl1006"
      unitRef="USD"
      xsi:nil="true"/>
    <NTRP:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour
      contextRef="AsOf2025-02-28"
      id="xdx2ixbrl1046"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="AsOf2025-02-28"
      id="xdx2ixbrl1140"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="AsOf2024-02-29"
      id="xdx2ixbrl1141"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment
      contextRef="From2024-03-01to2025-02-28"
      id="xdx2ixbrl1155"
      unitRef="USD"
      xsi:nil="true"/>
    <NTRP:IncomeTaxReconciliationNondeductibleExpenseLossOnNextPlayNoteReceivable
      contextRef="From2023-03-012024-02-29"
      id="xdx2ixbrl1162"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2024-03-01to2025-02-28"
      id="xdx2ixbrl1179"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2023-03-012024-02-29"
      id="xdx2ixbrl1180"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="AsOf2024-02-29"
      id="xdx2ixbrl1700"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="From2024-03-01to2025-02-28"
      id="xdx2ixbrl1704"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="From2024-03-01to2025-02-28"
      id="xdx2ixbrl1706"
      unitRef="USD"
      xsi:nil="true"/>
    <NTRP:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedorCancelledInPeriodTotalIntrinsicValue
      contextRef="From2024-03-01to2025-02-28"
      id="xdx2ixbrl1712"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="AsOf2025-02-28"
      id="xdx2ixbrl1720"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
      contextRef="AsOf2025-02-28"
      id="xdx2ixbrl1728"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="AsOf2025-02-28"
      id="xdx2ixbrl1736"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
      contextRef="AsOf2025-02-28"
      id="xdx2ixbrl1744"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="AsOf2024-02-29_custom_StockAppreciationRightsMember"
      id="xdx2ixbrl1784"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="From2024-03-012025-02-28_custom_StockAppreciationRightsMember"
      id="xdx2ixbrl1786"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="From2024-03-012025-02-28_custom_StockAppreciationRightsMember"
      id="xdx2ixbrl1788"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="From2024-03-012025-02-28_custom_StockAppreciationRightsMember"
      id="xdx2ixbrl1790"
      unitRef="USD"
      xsi:nil="true"/>
    <NTRP:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedorCancelledInPeriodTotalIntrinsicValue
      contextRef="From2024-03-012025-02-28_custom_StockAppreciationRightsMember"
      id="xdx2ixbrl1796"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="AsOf2025-02-28_custom_StockAppreciationRightsMember"
      id="xdx2ixbrl1804"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
      contextRef="AsOf2025-02-28_custom_StockAppreciationRightsMember"
      id="xdx2ixbrl1812"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="AsOf2025-02-28_custom_StockAppreciationRightsMember"
      id="xdx2ixbrl1820"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
      contextRef="AsOf2025-02-28_custom_StockAppreciationRightsMember"
      id="xdx2ixbrl1828"
      unitRef="USD"
      xsi:nil="true"/>
    <NTRP:ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageWeightedAverageExercisePriceWarrantsForfeitedOrCancelled
      contextRef="From2024-03-01to2025-02-28"
      id="xdx2ixbrl1884"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <dei:DocumentType contextRef="From2024-03-01to2025-02-28" id="Fact000013">10-K</dei:DocumentType>
    <dei:DocumentAnnualReport contextRef="From2024-03-01to2025-02-28" id="Fact000014">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate contextRef="From2024-03-01to2025-02-28" id="Fact000015">2025-02-28</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate contextRef="From2024-03-01to2025-02-28" id="Fact000016">--02-28</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus contextRef="From2024-03-01to2025-02-28" id="Fact000017">2025</dei:DocumentFiscalYearFocus>
    <dei:DocumentTransitionReport contextRef="From2024-03-01to2025-02-28" id="Fact000018">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber contextRef="From2024-03-01to2025-02-28" id="Fact000019">001-38015</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="From2024-03-01to2025-02-28" id="Fact000020">NEXTTRIP, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2024-03-01to2025-02-28" id="Fact000021">NV</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="From2024-03-01to2025-02-28" id="Fact000022">27-1865814</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2024-03-01to2025-02-28" id="Fact000023">3900 Paseo del Sol</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="From2024-03-01to2025-02-28" id="Fact000024">Santa Fe</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2024-03-01to2025-02-28" id="Fact000025">NM</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2024-03-01to2025-02-28" id="Fact000026">87507</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2024-03-01to2025-02-28" id="Fact000027">(954)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2024-03-01to2025-02-28" id="Fact000028">526-9688</dei:LocalPhoneNumber>
    <dei:Security12bTitle contextRef="From2024-03-01to2025-02-28" id="Fact000029">Common     Stock, par value $0.001 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2024-03-01to2025-02-28" id="Fact000030">NTRP</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2024-03-01to2025-02-28" id="Fact000031">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityWellKnownSeasonedIssuer contextRef="From2024-03-01to2025-02-28" id="Fact000032">No</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers contextRef="From2024-03-01to2025-02-28" id="Fact000033">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus contextRef="From2024-03-01to2025-02-28" id="Fact000034">No</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="From2024-03-01to2025-02-28" id="Fact000035">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory contextRef="From2024-03-01to2025-02-28" id="Fact000036">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="From2024-03-01to2025-02-28" id="Fact000037">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="From2024-03-01to2025-02-28" id="Fact000038">false</dei:EntityEmergingGrowthCompany>
    <dei:IcfrAuditorAttestationFlag contextRef="From2024-03-01to2025-02-28" id="Fact000039">false</dei:IcfrAuditorAttestationFlag>
    <dei:DocumentFinStmtErrorCorrectionFlag contextRef="From2024-03-01to2025-02-28" id="Fact000040">false</dei:DocumentFinStmtErrorCorrectionFlag>
    <dei:EntityShellCompany contextRef="From2024-03-01to2025-02-28" id="Fact000041">false</dei:EntityShellCompany>
    <dei:EntityPublicFloat
      contextRef="AsOf2024-08-31"
      decimals="0"
      id="Fact000042"
      unitRef="USD">3817106</dei:EntityPublicFloat>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="AsOf2025-05-28"
      decimals="INF"
      id="Fact000043"
      unitRef="Shares">7653525</dei:EntityCommonStockSharesOutstanding>
    <dei:DocumentsIncorporatedByReferenceTextBlock contextRef="From2024-03-01to2025-02-28" id="Fact000044">None</dei:DocumentsIncorporatedByReferenceTextBlock>
    <cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock contextRef="From2024-03-01to2025-02-28" id="Fact000051">&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Risk
Management and Strategy&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Due
to the size of our company, we have not yet developed robust policies and processes for assessing, identifying, and managing material
risk from cybersecurity threats. &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_905_ecyd--CybersecurityRiskManagementProcessesIntegratedTextBlock_c20240301__20250228_zceUsl7Glt9"&gt;We have &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_90F_ecyd--CybersecurityRiskManagementProcessesIntegratedFlag_dbT_c20240301__20250228_zTzF38pbzok1"&gt;implemented&lt;/span&gt; access controls with respect to our systems, which we monitor regularly and audit
annually. We currently rely heavily on products and services provided by &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_90F_ecyd--CybersecurityRiskManagementThirdPartyEngagedFlag_dbT_c20240301__20250228_ztXsSs4RzLcb"&gt;third-party&lt;/span&gt; suppliers to operate certain critical business systems,
including without limitation, cloud-based infrastructure, encryption and authentication technology, email, and other functions&lt;/span&gt;. &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_902_ecyd--CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag_dbT_c20240301__20250228_z1JBgml2CD19"&gt;We rely
on third party providers and outsourced IT services to monitor and address cybersecurity related risks, including installing software
for threat protection and malware&lt;/span&gt;. Such third-party providers are tasked with notifying management of any material risks or cybersecurity
concerns that they identify, which management then assesses and may bring to our Board of Directors to discuss if deemed necessary or
appropriate. Based on the results of our risk assessments, if deemed necessary or appropriate, we take steps to re-design, implement,
and maintain reasonable safeguards to minimize identified risks; reasonably address any identified gaps in existing safeguards; and regularly
monitor the effectiveness of our safeguards.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;We
intend to work with outside counsel and third-party service providers to further develop our expertise, processes and procedures with
respect to cybersecurity protection and our response plan.&lt;/span&gt;&lt;/p&gt;

&#160;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;To
date, we have &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_908_ecyd--CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag_dbF_c20240301__20250228_z9TcUXskhocb"&gt;not&lt;/span&gt; (to our knowledge) encountered cybersecurity challenges that have materially impaired our operations or financial standing.
For additional information regarding risks from cybersecurity threats, please refer to Item 1A, &#x201c;Risk Factors,&#x201d; in this Report.&lt;/span&gt;&lt;/p&gt;

&#160;</cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock>
    <cyd:CybersecurityRiskManagementProcessesIntegratedTextBlock contextRef="From2024-03-01to2025-02-28" id="Fact000052">We have &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_90F_ecyd--CybersecurityRiskManagementProcessesIntegratedFlag_dbT_c20240301__20250228_zTzF38pbzok1"&gt;implemented&lt;/span&gt; access controls with respect to our systems, which we monitor regularly and audit
annually. We currently rely heavily on products and services provided by &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_90F_ecyd--CybersecurityRiskManagementThirdPartyEngagedFlag_dbT_c20240301__20250228_ztXsSs4RzLcb"&gt;third-party&lt;/span&gt; suppliers to operate certain critical business systems,
including without limitation, cloud-based infrastructure, encryption and authentication technology, email, and other functions</cyd:CybersecurityRiskManagementProcessesIntegratedTextBlock>
    <cyd:CybersecurityRiskManagementProcessesIntegratedFlag contextRef="From2024-03-01to2025-02-28" id="Fact000053">true</cyd:CybersecurityRiskManagementProcessesIntegratedFlag>
    <cyd:CybersecurityRiskManagementThirdPartyEngagedFlag contextRef="From2024-03-01to2025-02-28" id="Fact000054">true</cyd:CybersecurityRiskManagementThirdPartyEngagedFlag>
    <cyd:CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag contextRef="From2024-03-01to2025-02-28" id="Fact000055">true</cyd:CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag>
    <cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag contextRef="From2024-03-01to2025-02-28" id="Fact000056">false</cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag>
    <cyd:CybersecurityRiskBoardOfDirectorsOversightTextBlock contextRef="From2024-03-01to2025-02-28" id="Fact000060">&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Governance&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_905_ecyd--CybersecurityRiskRoleOfManagementTextBlock_c20240301__20250228_z1UKx64iKHMi"&gt;Our
management team is primarily responsible for assessing and managing our strategic risk exposures, including material risks from cybersecurity
threats, with assistance from third-party service providers. Management oversees our cybersecurity process on a day-to-day basis, including
those described in &#x201c;Risk Management and Strategy&#x201d; above&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Our
Board of Directors does not have a standing risk management committee. Instead, &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_905_ecyd--CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock_c20240301__20250228_zZm3ycTJbAPj"&gt;our Board of Directors as a whole has oversight responsibility
for risk management, which it administers directly as well as with the assistance of standing committees of the Board of Directors that
will address risks inherent in their respective areas of oversight&lt;/span&gt;. Throughout the year, the board and its committees engage with management
to discuss a wide range of enterprise risks, including cybersecurity.&lt;/span&gt;&lt;/p&gt;

&#160;</cyd:CybersecurityRiskBoardOfDirectorsOversightTextBlock>
    <cyd:CybersecurityRiskRoleOfManagementTextBlock contextRef="From2024-03-01to2025-02-28" id="Fact000061">Our
management team is primarily responsible for assessing and managing our strategic risk exposures, including material risks from cybersecurity
threats, with assistance from third-party service providers. Management oversees our cybersecurity process on a day-to-day basis, including
those described in &#x201c;Risk Management and Strategy&#x201d; above</cyd:CybersecurityRiskRoleOfManagementTextBlock>
    <cyd:CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock contextRef="From2024-03-01to2025-02-28" id="Fact000062">our Board of Directors as a whole has oversight responsibility
for risk management, which it administers directly as well as with the assistance of standing committees of the Board of Directors that
will address risks inherent in their respective areas of oversight</cyd:CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock>
    <ecd:Rule10b51ArrAdoptedFlag contextRef="From2024-12-012025-02-28" id="Fact000063">false</ecd:Rule10b51ArrAdoptedFlag>
    <ecd:NonRule10b51ArrAdoptedFlag contextRef="From2024-12-012025-02-28" id="Fact000064">false</ecd:NonRule10b51ArrAdoptedFlag>
    <ecd:Rule10b51ArrTrmntdFlag contextRef="From2024-12-012025-02-28" id="Fact000065">false</ecd:Rule10b51ArrTrmntdFlag>
    <ecd:NonRule10b51ArrTrmntdFlag contextRef="From2024-12-012025-02-28" id="Fact000066">false</ecd:NonRule10b51ArrTrmntdFlag>
    <dei:AuditorName contextRef="From2024-03-01to2025-02-28" id="Fact000067">Haynie &amp; Company</dei:AuditorName>
    <dei:AuditorLocation contextRef="From2024-03-01to2025-02-28" id="Fact000068">Salt Lake City, Utah</dei:AuditorLocation>
    <dei:AuditorFirmId contextRef="From2024-03-01to2025-02-28" id="Fact000069">457</dei:AuditorFirmId>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="AsOf2025-02-28"
      decimals="0"
      id="Fact000074"
      unitRef="USD">1062367</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="AsOf2024-02-29"
      decimals="0"
      id="Fact000075"
      unitRef="USD">323805</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <NTRP:PromissoryNoteReceivableNet
      contextRef="AsOf2024-02-29"
      decimals="0"
      id="Fact000078"
      unitRef="USD">1000000</NTRP:PromissoryNoteReceivableNet>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="AsOf2025-02-28"
      decimals="0"
      id="Fact000080"
      unitRef="USD">22567</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="AsOf2024-02-29"
      decimals="0"
      id="Fact000081"
      unitRef="USD">34082</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="AsOf2025-02-28"
      decimals="0"
      id="Fact000083"
      unitRef="USD">1380575</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="AsOf2024-02-29"
      decimals="0"
      id="Fact000084"
      unitRef="USD">340921</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="AsOf2025-02-28"
      decimals="0"
      id="Fact000086"
      unitRef="USD">2465509</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="AsOf2024-02-29"
      decimals="0"
      id="Fact000087"
      unitRef="USD">1698808</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2025-02-28"
      decimals="0"
      id="Fact000092"
      unitRef="USD">4119</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2024-02-29"
      decimals="0"
      id="Fact000093"
      unitRef="USD">6642</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="AsOf2025-02-28"
      decimals="0"
      id="Fact000095"
      unitRef="USD">2127368</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="AsOf2024-02-29"
      decimals="0"
      id="Fact000096"
      unitRef="USD">2173420</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:SecurityDeposit
      contextRef="AsOf2025-02-28"
      decimals="0"
      id="Fact000098"
      unitRef="USD">30167</us-gaap:SecurityDeposit>
    <us-gaap:SecurityDeposit
      contextRef="AsOf2024-02-29"
      decimals="0"
      id="Fact000099"
      unitRef="USD">42167</us-gaap:SecurityDeposit>
    <us-gaap:Goodwill
      contextRef="AsOf2025-02-28"
      decimals="0"
      id="Fact000101"
      unitRef="USD">1167805</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="AsOf2024-02-29"
      decimals="0"
      id="Fact000102"
      unitRef="USD">1167805</us-gaap:Goodwill>
    <us-gaap:EquityMethodInvestments
      contextRef="AsOf2025-02-28"
      decimals="0"
      id="Fact000104"
      unitRef="USD">3407610</us-gaap:EquityMethodInvestments>
    <us-gaap:PrepaidExpenseOtherNoncurrent
      contextRef="AsOf2025-02-28"
      decimals="0"
      id="Fact000107"
      unitRef="USD">733575</us-gaap:PrepaidExpenseOtherNoncurrent>
    <us-gaap:AssetsNoncurrent
      contextRef="AsOf2025-02-28"
      decimals="0"
      id="Fact000110"
      unitRef="USD">7470644</us-gaap:AssetsNoncurrent>
    <us-gaap:AssetsNoncurrent
      contextRef="AsOf2024-02-29"
      decimals="0"
      id="Fact000111"
      unitRef="USD">3390034</us-gaap:AssetsNoncurrent>
    <us-gaap:Assets
      contextRef="AsOf2025-02-28"
      decimals="0"
      id="Fact000113"
      unitRef="USD">9936153</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="AsOf2024-02-29"
      decimals="0"
      id="Fact000114"
      unitRef="USD">5088842</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="AsOf2025-02-28"
      decimals="0"
      id="Fact000122"
      unitRef="USD">1184404</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="AsOf2024-02-29"
      decimals="0"
      id="Fact000123"
      unitRef="USD">531847</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="AsOf2025-02-28"
      decimals="0"
      id="Fact000125"
      unitRef="USD">721382</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="AsOf2024-02-29"
      decimals="0"
      id="Fact000126"
      unitRef="USD">460768</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:DeferredRevenueCurrent
      contextRef="AsOf2025-02-28"
      decimals="0"
      id="Fact000128"
      unitRef="USD">97770</us-gaap:DeferredRevenueCurrent>
    <us-gaap:DeferredRevenueCurrent
      contextRef="AsOf2024-02-29"
      decimals="0"
      id="Fact000129"
      unitRef="USD">139921</us-gaap:DeferredRevenueCurrent>
    <us-gaap:NotesPayableCurrent
      contextRef="AsOf2025-02-28_us-gaap_NonrelatedPartyMember"
      decimals="0"
      id="Fact000131"
      unitRef="USD">506004</us-gaap:NotesPayableCurrent>
    <us-gaap:NotesPayableCurrent
      contextRef="AsOf2025-02-28_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact000134"
      unitRef="USD">61526</us-gaap:NotesPayableCurrent>
    <us-gaap:NotesPayableCurrent
      contextRef="AsOf2024-02-29_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact000135"
      unitRef="USD">828277</us-gaap:NotesPayableCurrent>
    <us-gaap:NotesPayableCurrent
      contextRef="AsOf2025-02-28_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact000137"
      unitRef="USD">61526</us-gaap:NotesPayableCurrent>
    <us-gaap:NotesPayableCurrent
      contextRef="AsOf2024-02-29_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact000138"
      unitRef="USD">828277</us-gaap:NotesPayableCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="AsOf2025-02-28"
      decimals="0"
      id="Fact000140"
      unitRef="USD">2571086</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="AsOf2024-02-29"
      decimals="0"
      id="Fact000141"
      unitRef="USD">1960813</us-gaap:LiabilitiesCurrent>
    <us-gaap:Liabilities
      contextRef="AsOf2025-02-28"
      decimals="0"
      id="Fact000143"
      unitRef="USD">2571086</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="AsOf2024-02-29"
      decimals="0"
      id="Fact000144"
      unitRef="USD">1960813</us-gaap:Liabilities>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2025-02-28"
      decimals="INF"
      id="Fact000155"
      unitRef="USDPShares">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2024-02-29"
      decimals="INF"
      id="Fact000157"
      unitRef="USDPShares">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2025-02-28"
      decimals="INF"
      id="Fact000159"
      unitRef="Shares">10000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2024-02-29"
      decimals="INF"
      id="Fact000161"
      unitRef="Shares">10000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2025-02-28"
      decimals="INF"
      id="Fact000163"
      unitRef="Shares">3106616</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2025-02-28"
      decimals="INF"
      id="Fact000165"
      unitRef="Shares">3106616</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2024-02-29"
      decimals="INF"
      id="Fact000167"
      unitRef="Shares">472996</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2024-02-29"
      decimals="INF"
      id="Fact000169"
      unitRef="Shares">472996</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2025-02-28"
      decimals="0"
      id="Fact000152"
      unitRef="USD">3107</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2024-02-29"
      decimals="0"
      id="Fact000153"
      unitRef="USD">474</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2025-02-28"
      decimals="INF"
      id="Fact000174"
      unitRef="USDPShares">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2024-02-29"
      decimals="INF"
      id="Fact000176"
      unitRef="USDPShares">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2025-02-28"
      decimals="INF"
      id="Fact000178"
      unitRef="Shares">250000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2024-02-29"
      decimals="INF"
      id="Fact000180"
      unitRef="Shares">1200000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2025-02-28"
      decimals="INF"
      id="Fact000182"
      unitRef="Shares">1656738</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2025-02-28"
      decimals="INF"
      id="Fact000184"
      unitRef="Shares">1656738</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2024-02-29"
      decimals="INF"
      id="Fact000186"
      unitRef="Shares">936430</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2024-02-29"
      decimals="INF"
      id="Fact000188"
      unitRef="Shares">936430</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="AsOf2025-02-28"
      decimals="0"
      id="Fact000171"
      unitRef="USD">1657</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="AsOf2024-02-29"
      decimals="0"
      id="Fact000172"
      unitRef="USD">936</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="AsOf2025-02-28"
      decimals="0"
      id="Fact000190"
      unitRef="USD">41710126</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="AsOf2024-02-29"
      decimals="0"
      id="Fact000191"
      unitRef="USD">27277758</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="AsOf2025-02-28"
      decimals="0"
      id="Fact000193"
      unitRef="USD">-34349823</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="AsOf2024-02-29"
      decimals="0"
      id="Fact000194"
      unitRef="USD">-24151139</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2025-02-28"
      decimals="0"
      id="Fact000196"
      unitRef="USD">7365067</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-02-29"
      decimals="0"
      id="Fact000197"
      unitRef="USD">3128029</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="AsOf2025-02-28"
      decimals="0"
      id="Fact000199"
      unitRef="USD">9936153</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="AsOf2024-02-29"
      decimals="0"
      id="Fact000200"
      unitRef="USD">5088842</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="From2023-12-292023-12-29_custom_NextTripGroupLLCMember"
      decimals="INF"
      id="Fact000203"
      unitRef="Shares">83371</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <NTRP:PercentageForIssuedAndOutstandingCapitalStock
      contextRef="From2023-12-292023-12-29_custom_NextTripGroupLLCMember"
      decimals="INF"
      id="Fact000205"
      unitRef="Pure">1</NTRP:PercentageForIssuedAndOutstandingCapitalStock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2024-03-01to2025-02-28"
      decimals="0"
      id="Fact000207"
      unitRef="USD">501423</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact000208"
      unitRef="USD">458752</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfRevenue
      contextRef="From2024-03-01to2025-02-28"
      decimals="0"
      id="Fact000210"
      unitRef="USD">498121</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact000211"
      unitRef="USD">397532</us-gaap:CostOfRevenue>
    <us-gaap:GrossProfit
      contextRef="From2024-03-01to2025-02-28"
      decimals="0"
      id="Fact000213"
      unitRef="USD">3302</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact000214"
      unitRef="USD">61220</us-gaap:GrossProfit>
    <us-gaap:LaborAndRelatedExpense
      contextRef="From2024-03-01to2025-02-28"
      decimals="0"
      id="Fact000219"
      unitRef="USD">2630663</us-gaap:LaborAndRelatedExpense>
    <us-gaap:LaborAndRelatedExpense
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact000220"
      unitRef="USD">1604487</us-gaap:LaborAndRelatedExpense>
    <us-gaap:ShareBasedCompensation
      contextRef="From2024-03-01to2025-02-28"
      decimals="0"
      id="Fact000222"
      unitRef="USD">67874</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact000223"
      unitRef="USD">116512</us-gaap:ShareBasedCompensation>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2024-03-01to2025-02-28"
      decimals="0"
      id="Fact000225"
      unitRef="USD">95341</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact000226"
      unitRef="USD">152106</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="From2024-03-01to2025-02-28"
      decimals="0"
      id="Fact000228"
      unitRef="USD">307166</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact000229"
      unitRef="USD">484250</us-gaap:SellingAndMarketingExpense>
    <us-gaap:ProfessionalFees
      contextRef="From2024-03-01to2025-02-28"
      decimals="0"
      id="Fact000231"
      unitRef="USD">2228481</us-gaap:ProfessionalFees>
    <us-gaap:ProfessionalFees
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact000232"
      unitRef="USD">1421508</us-gaap:ProfessionalFees>
    <NTRP:Technology
      contextRef="From2024-03-01to2025-02-28"
      decimals="0"
      id="Fact000234"
      unitRef="USD">843296</NTRP:Technology>
    <NTRP:Technology
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact000235"
      unitRef="USD">311430</NTRP:Technology>
    <NTRP:OrganizationCosts
      contextRef="From2024-03-01to2025-02-28"
      decimals="0"
      id="Fact000237"
      unitRef="USD">213613</NTRP:OrganizationCosts>
    <NTRP:OrganizationCosts
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact000238"
      unitRef="USD">25000</NTRP:OrganizationCosts>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="From2024-03-01to2025-02-28"
      decimals="0"
      id="Fact000240"
      unitRef="USD">713236</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact000241"
      unitRef="USD">1468762</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:OtherExpenses
      contextRef="From2024-03-01to2025-02-28"
      decimals="0"
      id="Fact000243"
      unitRef="USD">317061</us-gaap:OtherExpenses>
    <us-gaap:OtherExpenses
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact000244"
      unitRef="USD">156522</us-gaap:OtherExpenses>
    <us-gaap:OperatingExpenses
      contextRef="From2024-03-01to2025-02-28"
      decimals="0"
      id="Fact000246"
      unitRef="USD">7416731</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact000247"
      unitRef="USD">5740577</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2024-03-01to2025-02-28"
      decimals="0"
      id="Fact000249"
      unitRef="USD">-7413429</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact000250"
      unitRef="USD">-5679357</us-gaap:OperatingIncomeLoss>
    <us-gaap:GainLossOnDispositionOfAssets1
      contextRef="From2024-03-01to2025-02-28"
      decimals="0"
      id="Fact000255"
      unitRef="USD">-90</us-gaap:GainLossOnDispositionOfAssets1>
    <us-gaap:GainLossOnDispositionOfAssets1
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact000256"
      unitRef="USD">-14718</us-gaap:GainLossOnDispositionOfAssets1>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="From2024-03-01to2025-02-28"
      decimals="0"
      id="Fact000258"
      unitRef="USD">-1134579</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact000259"
      unitRef="USD">166890</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <NTRP:LossOnRelatedPartyReceivable
      contextRef="From2024-03-01to2025-02-28"
      decimals="0"
      id="Fact000261"
      unitRef="USD">1000000</NTRP:LossOnRelatedPartyReceivable>
    <NTRP:LossOnRelatedPartyReceivable
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact000262"
      unitRef="USD">1567665</NTRP:LossOnRelatedPartyReceivable>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="From2024-03-01to2025-02-28"
      decimals="0"
      id="Fact000264"
      unitRef="USD">-589039</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact000265"
      unitRef="USD">-48620</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="From2024-03-01to2025-02-28"
      decimals="0"
      id="Fact000267"
      unitRef="USD">16099</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact000268"
      unitRef="USD">486633</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="From2024-03-01to2025-02-28"
      decimals="0"
      id="Fact000270"
      unitRef="USD">-2707609</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact000271"
      unitRef="USD">-977480</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2024-03-01to2025-02-28"
      decimals="0"
      id="Fact000273"
      unitRef="USD">-10121038</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact000274"
      unitRef="USD">-6656837</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <NTRP:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestment
      contextRef="From2024-03-01to2025-02-28"
      decimals="0"
      id="Fact000279"
      unitRef="USD">-10121038</NTRP:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestment>
    <NTRP:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestment
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact000280"
      unitRef="USD">-6656837</NTRP:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestment>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="From2024-03-01to2025-02-28"
      decimals="0"
      id="Fact000282"
      unitRef="USD">-7390</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="From2024-03-01to2025-02-28"
      decimals="0"
      id="Fact000285"
      unitRef="USD">-10128428</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact000286"
      unitRef="USD">-6656837</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="From2024-03-01to2025-02-28"
      decimals="0"
      id="Fact000288"
      unitRef="USD">8344</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact000289"
      unitRef="USD">-675314</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-03-01to2025-02-28"
      decimals="0"
      id="Fact000291"
      unitRef="USD">-10120084</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact000292"
      unitRef="USD">-7332151</us-gaap:NetIncomeLoss>
    <us-gaap:PreferredStockDividendsIncomeStatementImpact
      contextRef="From2024-03-01to2025-02-28"
      decimals="0"
      id="Fact000294"
      unitRef="USD">78600</us-gaap:PreferredStockDividendsIncomeStatementImpact>
    <us-gaap:PreferredStockDividendsIncomeStatementImpact
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact000295"
      unitRef="USD">7125</us-gaap:PreferredStockDividendsIncomeStatementImpact>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2024-03-01to2025-02-28"
      decimals="0"
      id="Fact000297"
      unitRef="USD">-10198684</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact000298"
      unitRef="USD">-7339276</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="From2024-03-01to2025-02-28"
      decimals="INF"
      id="Fact000300"
      unitRef="USDPShares">-2.24</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="From2024-03-01to2025-02-28"
      decimals="INF"
      id="Fact000302"
      unitRef="USDPShares">-2.24</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="From2023-03-012024-02-29"
      decimals="INF"
      id="Fact000304"
      unitRef="USDPShares">-29.16</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="From2023-03-012024-02-29"
      decimals="INF"
      id="Fact000306"
      unitRef="USDPShares">-29.16</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="From2024-03-01to2025-02-28"
      decimals="INF"
      id="Fact000308"
      unitRef="USDPShares">0.01</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
      contextRef="From2024-03-01to2025-02-28"
      decimals="INF"
      id="Fact000310"
      unitRef="USDPShares">0.01</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="From2023-03-012024-02-29"
      decimals="INF"
      id="Fact000312"
      unitRef="USDPShares">-2.96</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
      contextRef="From2023-03-012024-02-29"
      decimals="INF"
      id="Fact000314"
      unitRef="USDPShares">-2.96</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2024-03-01to2025-02-28"
      decimals="INF"
      id="Fact000316"
      unitRef="USDPShares">-2.23</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2024-03-01to2025-02-28"
      decimals="INF"
      id="Fact000318"
      unitRef="USDPShares">-2.23</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2023-03-012024-02-29"
      decimals="INF"
      id="Fact000320"
      unitRef="USDPShares">-32.12</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2023-03-012024-02-29"
      decimals="INF"
      id="Fact000322"
      unitRef="USDPShares">-32.12</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2024-03-01to2025-02-28"
      decimals="INF"
      id="Fact000324"
      unitRef="Shares">4566787</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2024-03-01to2025-02-28"
      decimals="INF"
      id="Fact000326"
      unitRef="Shares">4566787</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2023-03-012024-02-29"
      decimals="INF"
      id="Fact000328"
      unitRef="Shares">228274</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2023-03-012024-02-29"
      decimals="INF"
      id="Fact000330"
      unitRef="Shares">228274</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="From2023-12-292023-12-29_custom_NextTripGroupLLCMember"
      decimals="INF"
      id="Fact000333"
      unitRef="Shares">83371</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <NTRP:PercentageForIssuedAndOutstandingCapitalStock
      contextRef="From2023-12-292023-12-29_custom_NextTripGroupLLCMember"
      decimals="INF"
      id="Fact000335"
      unitRef="Pure">1</NTRP:PercentageForIssuedAndOutstandingCapitalStock>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-02-28_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000345"
      unitRef="Shares">83371</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-02-28_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000338"
      unitRef="USD">83</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-02-28_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000339"
      unitRef="USD">17295890</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-02-28_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000340"
      unitRef="USD">-16811863</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-02-28"
      decimals="0"
      id="Fact000341"
      unitRef="USD">484110</us-gaap:StockholdersEquity>
    <NTRP:StockIssuedDuringPeriodShareOfPreferredShares
      contextRef="From2023-03-012024-02-29_us-gaap_PreferredStockMember"
      decimals="INF"
      id="Fact000353"
      unitRef="USD">472680</NTRP:StockIssuedDuringPeriodShareOfPreferredShares>
    <NTRP:StockIssuedDuringPeriodValueOfPreferredShares
      contextRef="From2023-03-012024-02-29_us-gaap_PreferredStockMember"
      decimals="0"
      id="Fact000347"
      unitRef="USD">473</NTRP:StockIssuedDuringPeriodValueOfPreferredShares>
    <NTRP:StockIssuedDuringPeriodValueOfPreferredShares
      contextRef="From2023-03-012024-02-29_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000349"
      unitRef="USD">1603027</NTRP:StockIssuedDuringPeriodValueOfPreferredShares>
    <NTRP:StockIssuedDuringPeriodValueOfPreferredShares
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact000351"
      unitRef="USD">1603500</NTRP:StockIssuedDuringPeriodValueOfPreferredShares>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="From2023-03-012024-02-29_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000363"
      unitRef="Shares">52818</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2023-03-012024-02-29_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000358"
      unitRef="USD">53</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2023-03-012024-02-29_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000359"
      unitRef="USD">3968507</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact000361"
      unitRef="USD">3968560</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <NTRP:StockIssuedDuringPeriodSharesPurchasesOfCommonShares
      contextRef="From2023-03-012024-02-29_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000371"
      unitRef="Shares">15481</NTRP:StockIssuedDuringPeriodSharesPurchasesOfCommonShares>
    <NTRP:StockIssuedDuringPeriodValuePurchasesOfCommonShares
      contextRef="From2023-03-012024-02-29_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000366"
      unitRef="USD">16</NTRP:StockIssuedDuringPeriodValuePurchasesOfCommonShares>
    <NTRP:StockIssuedDuringPeriodValuePurchasesOfCommonShares
      contextRef="From2023-03-012024-02-29_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000367"
      unitRef="USD">1905954</NTRP:StockIssuedDuringPeriodValuePurchasesOfCommonShares>
    <NTRP:StockIssuedDuringPeriodValuePurchasesOfCommonShares
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact000369"
      unitRef="USD">1905970</NTRP:StockIssuedDuringPeriodValuePurchasesOfCommonShares>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="From2023-03-012024-02-29_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000379"
      unitRef="Shares">4337</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2023-03-012024-02-29_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000374"
      unitRef="USD">4</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2023-03-012024-02-29_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000375"
      unitRef="USD">13106</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact000377"
      unitRef="USD">13110</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <NTRP:StockIssuedDuringPeriodSharesReverseAcquisition
      contextRef="From2023-03-012024-02-29_us-gaap_PreferredStockMember"
      decimals="INF"
      id="Fact000387"
      unitRef="Shares">316</NTRP:StockIssuedDuringPeriodSharesReverseAcquisition>
    <NTRP:StockIssuedDuringPeriodValueReverseAcquisition
      contextRef="From2023-03-012024-02-29_us-gaap_PreferredStockMember"
      decimals="0"
      id="Fact000381"
      unitRef="USD">1</NTRP:StockIssuedDuringPeriodValueReverseAcquisition>
    <NTRP:StockIssuedDuringPeriodSharesReverseAcquisition
      contextRef="From2023-03-012024-02-29_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000389"
      unitRef="Shares">780423</NTRP:StockIssuedDuringPeriodSharesReverseAcquisition>
    <NTRP:StockIssuedDuringPeriodValueReverseAcquisition
      contextRef="From2023-03-012024-02-29_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000382"
      unitRef="USD">780</NTRP:StockIssuedDuringPeriodValueReverseAcquisition>
    <NTRP:StockIssuedDuringPeriodValueReverseAcquisition
      contextRef="From2023-03-012024-02-29_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000383"
      unitRef="USD">2367637</NTRP:StockIssuedDuringPeriodValueReverseAcquisition>
    <NTRP:StockIssuedDuringPeriodValueReverseAcquisition
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact000385"
      unitRef="USD">2368418</NTRP:StockIssuedDuringPeriodValueReverseAcquisition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2023-03-012024-02-29_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000393"
      unitRef="USD">116512</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact000395"
      unitRef="USD">116512</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:DividendsPreferredStock
      contextRef="From2023-03-012024-02-29_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000399"
      unitRef="USD">-7125</us-gaap:DividendsPreferredStock>
    <us-gaap:DividendsPreferredStock
      contextRef="From2023-03-012024-02-29_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000400"
      unitRef="USD">7125</us-gaap:DividendsPreferredStock>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-03-012024-02-29_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000406"
      unitRef="USD">-7332151</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact000407"
      unitRef="USD">-7332151</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2024-02-29_us-gaap_PreferredStockMember"
      decimals="INF"
      id="Fact000415"
      unitRef="Shares">472996</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-02-29_us-gaap_PreferredStockMember"
      decimals="0"
      id="Fact000409"
      unitRef="USD">474</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2024-02-29_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000417"
      unitRef="Shares">936430</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-02-29_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000410"
      unitRef="USD">936</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-02-29_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000411"
      unitRef="USD">27277758</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-02-29_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000412"
      unitRef="USD">-24151139</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-02-29"
      decimals="0"
      id="Fact000413"
      unitRef="USD">3128029</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2024-02-29_us-gaap_PreferredStockMember"
      decimals="INF"
      id="Fact000425"
      unitRef="Shares">472996</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-02-29_us-gaap_PreferredStockMember"
      decimals="0"
      id="Fact000419"
      unitRef="USD">474</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2024-02-29_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000427"
      unitRef="Shares">936430</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-02-29_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000420"
      unitRef="USD">936</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-02-29_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000421"
      unitRef="USD">27277758</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-02-29_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000422"
      unitRef="USD">-24151139</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-02-29"
      decimals="0"
      id="Fact000423"
      unitRef="USD">3128029</us-gaap:StockholdersEquity>
    <NTRP:StockIssuedDuringPeriodSharesOfPreferredSharesInPrivatePlacements
      contextRef="From2024-03-012025-02-28_us-gaap_PreferredStockMember"
      decimals="INF"
      id="Fact000435"
      unitRef="Shares">830284</NTRP:StockIssuedDuringPeriodSharesOfPreferredSharesInPrivatePlacements>
    <NTRP:StockIssuedDuringPeriodValueOfPreferredSharesInPrivatePlacements
      contextRef="From2024-03-012025-02-28_us-gaap_PreferredStockMember"
      decimals="0"
      id="Fact000429"
      unitRef="USD">830</NTRP:StockIssuedDuringPeriodValueOfPreferredSharesInPrivatePlacements>
    <NTRP:StockIssuedDuringPeriodValueOfPreferredSharesInPrivatePlacements
      contextRef="From2024-03-012025-02-28_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000431"
      unitRef="USD">3872104</NTRP:StockIssuedDuringPeriodValueOfPreferredSharesInPrivatePlacements>
    <NTRP:StockIssuedDuringPeriodValueOfPreferredSharesInPrivatePlacements
      contextRef="From2024-03-01to2025-02-28"
      decimals="0"
      id="Fact000433"
      unitRef="USD">3872934</NTRP:StockIssuedDuringPeriodValueOfPreferredSharesInPrivatePlacements>
    <NTRP:StockIssuedDuringPeriodSharesConversionOfPreferredSharesToCommonShares
      contextRef="From2024-03-012025-02-28_us-gaap_PreferredStockMember"
      decimals="INF"
      id="Fact000445"
      unitRef="Shares">-409502</NTRP:StockIssuedDuringPeriodSharesConversionOfPreferredSharesToCommonShares>
    <NTRP:StockIssuedDuringPeriodValueConversionOfPreferredSharesToCommonShares
      contextRef="From2024-03-012025-02-28_us-gaap_PreferredStockMember"
      decimals="0"
      id="Fact000439"
      unitRef="USD">-410</NTRP:StockIssuedDuringPeriodValueConversionOfPreferredSharesToCommonShares>
    <NTRP:StockIssuedDuringPeriodSharesConversionOfPreferredSharesToCommonShares
      contextRef="From2024-03-012025-02-28_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000447"
      unitRef="Shares">409502</NTRP:StockIssuedDuringPeriodSharesConversionOfPreferredSharesToCommonShares>
    <NTRP:StockIssuedDuringPeriodValueConversionOfPreferredSharesToCommonShares
      contextRef="From2024-03-012025-02-28_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000440"
      unitRef="USD">410</NTRP:StockIssuedDuringPeriodValueConversionOfPreferredSharesToCommonShares>
    <NTRP:StockIssuedDuringPeriodSharesIssuanceOfPreferredSharesForDebtConversions
      contextRef="From2024-03-012025-02-28_us-gaap_PreferredStockMember"
      decimals="INF"
      id="Fact000455"
      unitRef="Shares">1459434</NTRP:StockIssuedDuringPeriodSharesIssuanceOfPreferredSharesForDebtConversions>
    <NTRP:StockIssuedDuringPeriodValueIssuanceOfPreferredSharesForDebtConversions
      contextRef="From2024-03-012025-02-28_us-gaap_PreferredStockMember"
      decimals="0"
      id="Fact000449"
      unitRef="USD">1460</NTRP:StockIssuedDuringPeriodValueIssuanceOfPreferredSharesForDebtConversions>
    <NTRP:StockIssuedDuringPeriodValueIssuanceOfPreferredSharesForDebtConversions
      contextRef="From2024-03-012025-02-28_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000451"
      unitRef="USD">4651040</NTRP:StockIssuedDuringPeriodValueIssuanceOfPreferredSharesForDebtConversions>
    <NTRP:StockIssuedDuringPeriodValueIssuanceOfPreferredSharesForDebtConversions
      contextRef="From2024-03-01to2025-02-28"
      decimals="0"
      id="Fact000453"
      unitRef="USD">4652500</NTRP:StockIssuedDuringPeriodValueIssuanceOfPreferredSharesForDebtConversions>
    <NTRP:StockIssuedDuringPeriodSharesIssuanceOfSecuritiesForServices
      contextRef="From2024-03-012025-02-28_us-gaap_PreferredStockMember"
      decimals="INF"
      id="Fact000465"
      unitRef="Shares">109113</NTRP:StockIssuedDuringPeriodSharesIssuanceOfSecuritiesForServices>
    <NTRP:StockIssuedDuringPeriodValueIssuanceOfSecuritiesForServices
      contextRef="From2024-03-012025-02-28_us-gaap_PreferredStockMember"
      decimals="0"
      id="Fact000459"
      unitRef="USD">109</NTRP:StockIssuedDuringPeriodValueIssuanceOfSecuritiesForServices>
    <NTRP:StockIssuedDuringPeriodSharesIssuanceOfSecuritiesForServices
      contextRef="From2024-03-012025-02-28_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000467"
      unitRef="Shares">160990</NTRP:StockIssuedDuringPeriodSharesIssuanceOfSecuritiesForServices>
    <NTRP:StockIssuedDuringPeriodValueIssuanceOfSecuritiesForServices
      contextRef="From2024-03-012025-02-28_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000460"
      unitRef="USD">161</NTRP:StockIssuedDuringPeriodValueIssuanceOfSecuritiesForServices>
    <NTRP:StockIssuedDuringPeriodValueIssuanceOfSecuritiesForServices
      contextRef="From2024-03-012025-02-28_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000461"
      unitRef="USD">2407193</NTRP:StockIssuedDuringPeriodValueIssuanceOfSecuritiesForServices>
    <NTRP:StockIssuedDuringPeriodValueIssuanceOfSecuritiesForServices
      contextRef="From2024-03-01to2025-02-28"
      decimals="0"
      id="Fact000463"
      unitRef="USD">2407463</NTRP:StockIssuedDuringPeriodValueIssuanceOfSecuritiesForServices>
    <NTRP:StockIssuedDuringPeriodSharseSecuritiesIssuedForEquityInvestments
      contextRef="From2024-03-012025-02-28_us-gaap_PreferredStockMember"
      decimals="INF"
      id="Fact000475"
      unitRef="Shares">644291</NTRP:StockIssuedDuringPeriodSharseSecuritiesIssuedForEquityInvestments>
    <NTRP:StockIssuedDuringPeriodValueSecuritiesIssuedForEquityInvestments
      contextRef="From2024-03-012025-02-28_us-gaap_PreferredStockMember"
      decimals="0"
      id="Fact000469"
      unitRef="USD">644</NTRP:StockIssuedDuringPeriodValueSecuritiesIssuedForEquityInvestments>
    <NTRP:StockIssuedDuringPeriodSharseSecuritiesIssuedForEquityInvestments
      contextRef="From2024-03-012025-02-28_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000477"
      unitRef="Shares">8065</NTRP:StockIssuedDuringPeriodSharseSecuritiesIssuedForEquityInvestments>
    <NTRP:StockIssuedDuringPeriodValueSecuritiesIssuedForEquityInvestments
      contextRef="From2024-03-012025-02-28_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000470"
      unitRef="USD">8</NTRP:StockIssuedDuringPeriodValueSecuritiesIssuedForEquityInvestments>
    <NTRP:StockIssuedDuringPeriodValueSecuritiesIssuedForEquityInvestments
      contextRef="From2024-03-012025-02-28_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000471"
      unitRef="USD">2938704</NTRP:StockIssuedDuringPeriodValueSecuritiesIssuedForEquityInvestments>
    <NTRP:StockIssuedDuringPeriodValueSecuritiesIssuedForEquityInvestments
      contextRef="From2024-03-01to2025-02-28"
      decimals="0"
      id="Fact000473"
      unitRef="USD">2939356</NTRP:StockIssuedDuringPeriodValueSecuritiesIssuedForEquityInvestments>
    <NTRP:StockIssuedDuringPeriodSharesIssuanceOfCommitmentSharesForEquityLineOfCredit
      contextRef="From2024-03-012025-02-28_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000487"
      unitRef="Shares">32786</NTRP:StockIssuedDuringPeriodSharesIssuanceOfCommitmentSharesForEquityLineOfCredit>
    <NTRP:StockIssuedDuringPeriodValueIssuanceOfCommitmentSharesForEquityLineOfCredit
      contextRef="From2024-03-012025-02-28_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000480"
      unitRef="USD">33</NTRP:StockIssuedDuringPeriodValueIssuanceOfCommitmentSharesForEquityLineOfCredit>
    <NTRP:StockIssuedDuringPeriodValueIssuanceOfCommitmentSharesForEquityLineOfCredit
      contextRef="From2024-03-012025-02-28_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000481"
      unitRef="USD">99967</NTRP:StockIssuedDuringPeriodValueIssuanceOfCommitmentSharesForEquityLineOfCredit>
    <NTRP:StockIssuedDuringPeriodValueIssuanceOfCommitmentSharesForEquityLineOfCredit
      contextRef="From2024-03-01to2025-02-28"
      decimals="0"
      id="Fact000483"
      unitRef="USD">100000</NTRP:StockIssuedDuringPeriodValueIssuanceOfCommitmentSharesForEquityLineOfCredit>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="From2024-03-012025-02-28_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000497"
      unitRef="Shares">104965</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2024-03-012025-02-28_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000490"
      unitRef="USD">105</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2024-03-012025-02-28_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000491"
      unitRef="USD">316890</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="From2024-03-01to2025-02-28"
      decimals="0"
      id="Fact000493"
      unitRef="USD">316995</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="From2024-03-012025-02-28_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000507"
      unitRef="Shares">4000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2024-03-012025-02-28_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000500"
      unitRef="USD">4</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2024-03-012025-02-28_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000501"
      unitRef="USD">67870</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="From2024-03-01to2025-02-28"
      decimals="0"
      id="Fact000503"
      unitRef="USD">67874</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:DividendsPreferredStock
      contextRef="From2024-03-012025-02-28_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000511"
      unitRef="USD">-78600</us-gaap:DividendsPreferredStock>
    <us-gaap:DividendsPreferredStock
      contextRef="From2024-03-012025-02-28_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000512"
      unitRef="USD">78600</us-gaap:DividendsPreferredStock>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-03-012025-02-28_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000518"
      unitRef="USD">-10120084</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-03-01to2025-02-28"
      decimals="0"
      id="Fact000519"
      unitRef="USD">-10120084</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2025-02-28_us-gaap_PreferredStockMember"
      decimals="INF"
      id="Fact000527"
      unitRef="Shares">3106616</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2025-02-28_us-gaap_PreferredStockMember"
      decimals="0"
      id="Fact000521"
      unitRef="USD">3107</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2025-02-28_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000529"
      unitRef="Shares">1656738</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2025-02-28_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000522"
      unitRef="USD">1657</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2025-02-28_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000523"
      unitRef="USD">41710126</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2025-02-28_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000524"
      unitRef="USD">-34349823</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2025-02-28"
      decimals="0"
      id="Fact000525"
      unitRef="USD">7365067</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2025-02-28_us-gaap_PreferredStockMember"
      decimals="INF"
      id="Fact000537"
      unitRef="Shares">3106616</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2025-02-28_us-gaap_PreferredStockMember"
      decimals="0"
      id="Fact000531"
      unitRef="USD">3107</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2025-02-28_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000539"
      unitRef="Shares">1656738</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2025-02-28_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000532"
      unitRef="USD">1657</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2025-02-28_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000533"
      unitRef="USD">41710126</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2025-02-28_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000534"
      unitRef="USD">-34349823</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2025-02-28"
      decimals="0"
      id="Fact000535"
      unitRef="USD">7365067</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="From2023-12-292023-12-29_custom_NextTripGroupLLCMember"
      decimals="INF"
      id="Fact000542"
      unitRef="Shares">83371</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <NTRP:PercentageForIssuedAndOutstandingCapitalStock
      contextRef="From2023-12-292023-12-29_custom_NextTripGroupLLCMember"
      decimals="INF"
      id="Fact000544"
      unitRef="Pure">1</NTRP:PercentageForIssuedAndOutstandingCapitalStock>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="From2024-03-01to2025-02-28"
      decimals="0"
      id="Fact000549"
      unitRef="USD">-10128428</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact000550"
      unitRef="USD">-6656837</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="From2024-03-01to2025-02-28"
      decimals="0"
      id="Fact000555"
      unitRef="USD">713236</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact000556"
      unitRef="USD">1468762</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="From2024-03-01to2025-02-28"
      decimals="0"
      id="Fact000558"
      unitRef="USD">342935</us-gaap:AmortizationOfDebtDiscountPremium>
    <NTRP:AmortizationOfPrepaidExpenses
      contextRef="From2024-03-01to2025-02-28"
      decimals="0"
      id="Fact000561"
      unitRef="USD">236112</NTRP:AmortizationOfPrepaidExpenses>
    <NTRP:LossOnRelatedPartyReceivable
      contextRef="From2024-03-01to2025-02-28"
      decimals="0"
      id="Fact000564"
      unitRef="USD">1000000</NTRP:LossOnRelatedPartyReceivable>
    <NTRP:LossOnRelatedPartyReceivable
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact000565"
      unitRef="USD">1567665</NTRP:LossOnRelatedPartyReceivable>
    <us-gaap:ShareBasedCompensation
      contextRef="From2024-03-01to2025-02-28"
      decimals="0"
      id="Fact000567"
      unitRef="USD">67874</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact000568"
      unitRef="USD">116512</us-gaap:ShareBasedCompensation>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="From2024-03-01to2025-02-28"
      decimals="0"
      id="Fact000570"
      unitRef="USD">-1134579</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact000571"
      unitRef="USD">166890</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <NTRP:LossOnDispositionOfAssets
      contextRef="From2024-03-01to2025-02-28"
      decimals="0"
      id="Fact000573"
      unitRef="USD">90</NTRP:LossOnDispositionOfAssets>
    <NTRP:LossOnDispositionOfAssets
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact000574"
      unitRef="USD">14718</NTRP:LossOnDispositionOfAssets>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="From2024-03-01to2025-02-28"
      decimals="0"
      id="Fact000576"
      unitRef="USD">-7390</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="From2024-03-01to2025-02-28"
      decimals="0"
      id="Fact000582"
      unitRef="USD">-11515</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact000583"
      unitRef="USD">662939</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInPrepaidExpense
      contextRef="From2024-03-01to2025-02-28"
      decimals="0"
      id="Fact000585"
      unitRef="USD">-159343</us-gaap:IncreaseDecreaseInPrepaidExpense>
    <us-gaap:IncreaseDecreaseInPrepaidExpense
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact000586"
      unitRef="USD">281506</us-gaap:IncreaseDecreaseInPrepaidExpense>
    <us-gaap:IncreaseDecreaseInSecurityDeposits
      contextRef="From2024-03-01to2025-02-28"
      decimals="0"
      id="Fact000588"
      unitRef="USD">12000</us-gaap:IncreaseDecreaseInSecurityDeposits>
    <us-gaap:IncreaseDecreaseInSecurityDeposits
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact000589"
      unitRef="USD">-27167</us-gaap:IncreaseDecreaseInSecurityDeposits>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="From2024-03-01to2025-02-28"
      decimals="0"
      id="Fact000591"
      unitRef="USD">1397007</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact000592"
      unitRef="USD">-531367</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInDeferredRevenue
      contextRef="From2024-03-01to2025-02-28"
      decimals="0"
      id="Fact000594"
      unitRef="USD">-42151</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:IncreaseDecreaseInDeferredRevenue
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact000595"
      unitRef="USD">102954</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
      contextRef="From2024-03-01to2025-02-28"
      decimals="0"
      id="Fact000597"
      unitRef="USD">-5088498</us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations>
    <us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact000598"
      unitRef="USD">-5056095</us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations>
    <us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
      contextRef="From2024-03-01to2025-02-28"
      decimals="0"
      id="Fact000600"
      unitRef="USD">8344</us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations>
    <us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact000601"
      unitRef="USD">-675314</us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2024-03-01to2025-02-28"
      decimals="0"
      id="Fact000603"
      unitRef="USD">-5080154</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact000604"
      unitRef="USD">-5731409</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact000610"
      unitRef="USD">9253</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsForSoftware
      contextRef="From2024-03-01to2025-02-28"
      decimals="0"
      id="Fact000612"
      unitRef="USD">534751</us-gaap:PaymentsForSoftware>
    <us-gaap:PaymentsForSoftware
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact000613"
      unitRef="USD">1016175</us-gaap:PaymentsForSoftware>
    <us-gaap:ProceedsFromSaleOfProductiveAssets
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact000616"
      unitRef="USD">1589241</us-gaap:ProceedsFromSaleOfProductiveAssets>
    <NTRP:InvestmentInEquityMethodInvestee
      contextRef="From2024-03-01to2025-02-28"
      decimals="0"
      id="Fact000618"
      unitRef="USD">500000</NTRP:InvestmentInEquityMethodInvestee>
    <NTRP:ProceedsFromAcquireBusinessesGross
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact000622"
      unitRef="USD">-417122</NTRP:ProceedsFromAcquireBusinessesGross>
    <us-gaap:ProceedsFromSaleOfOtherProductiveAssets
      contextRef="From2024-03-01to2025-02-28"
      decimals="0"
      id="Fact000624"
      unitRef="USD">1000</us-gaap:ProceedsFromSaleOfOtherProductiveAssets>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="From2024-03-01to2025-02-28"
      decimals="0"
      id="Fact000627"
      unitRef="USD">-1033751</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact000628"
      unitRef="USD">980935</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromNotesPayable
      contextRef="From2024-03-01to2025-02-28"
      decimals="0"
      id="Fact000633"
      unitRef="USD">1967224</us-gaap:ProceedsFromNotesPayable>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact000637"
      unitRef="USD">735057</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact000640"
      unitRef="USD">1905970</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
      contextRef="From2024-03-01to2025-02-28"
      decimals="0"
      id="Fact000642"
      unitRef="USD">2450000</us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock>
    <us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact000643"
      unitRef="USD">1603500</us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock>
    <us-gaap:ProceedsFromIssuanceOfWarrants
      contextRef="From2024-03-01to2025-02-28"
      decimals="0"
      id="Fact000645"
      unitRef="USD">316994</us-gaap:ProceedsFromIssuanceOfWarrants>
    <us-gaap:ProceedsFromRelatedPartyDebt
      contextRef="From2024-03-01to2025-02-28"
      decimals="0"
      id="Fact000648"
      unitRef="USD">2118249</us-gaap:ProceedsFromRelatedPartyDebt>
    <us-gaap:ProceedsFromRelatedPartyDebt
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact000649"
      unitRef="USD">547277</us-gaap:ProceedsFromRelatedPartyDebt>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2024-03-01to2025-02-28"
      decimals="0"
      id="Fact000651"
      unitRef="USD">6852467</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact000652"
      unitRef="USD">4791804</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="From2024-03-01to2025-02-28"
      decimals="0"
      id="Fact000654"
      unitRef="USD">738562</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact000655"
      unitRef="USD">41330</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="AsOf2024-02-29"
      decimals="0"
      id="Fact000657"
      unitRef="USD">323805</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="AsOf2023-02-28"
      decimals="0"
      id="Fact000658"
      unitRef="USD">282475</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="AsOf2025-02-28"
      decimals="0"
      id="Fact000660"
      unitRef="USD">1062367</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="AsOf2024-02-29"
      decimals="0"
      id="Fact000661"
      unitRef="USD">323805</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:InterestPaidNet
      contextRef="From2024-03-01to2025-02-28"
      decimals="0"
      id="Fact000666"
      unitRef="USD">91680</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact000667"
      unitRef="USD">4381</us-gaap:InterestPaidNet>
    <NTRP:IssuanceOfPreferredSharesForServices
      contextRef="From2024-03-01to2025-02-28"
      decimals="0"
      id="Fact000675"
      unitRef="USD">329520</NTRP:IssuanceOfPreferredSharesForServices>
    <NTRP:IssuanceOfPreferredSharesForServices
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact000676"
      unitRef="USD">569000</NTRP:IssuanceOfPreferredSharesForServices>
    <NTRP:IssuanceOfCommonSharesForServices
      contextRef="From2024-03-01to2025-02-28"
      decimals="0"
      id="Fact000678"
      unitRef="USD">706870</NTRP:IssuanceOfCommonSharesForServices>
    <NTRP:IssuanceOfCommonSharesForServices
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact000679"
      unitRef="USD">13106</NTRP:IssuanceOfCommonSharesForServices>
    <NTRP:IssuanceOfCommonSharesAsCommitmentShares
      contextRef="From2024-03-01to2025-02-28"
      decimals="0"
      id="Fact000681"
      unitRef="USD">100000</NTRP:IssuanceOfCommonSharesAsCommitmentShares>
    <NTRP:IssuanceOfCommonWarrantsForServices
      contextRef="From2024-03-01to2025-02-28"
      decimals="0"
      id="Fact000684"
      unitRef="USD">1371072</NTRP:IssuanceOfCommonWarrantsForServices>
    <NTRP:IssuanceOfCommonSharesForEquityInvestments
      contextRef="From2024-03-01to2025-02-28"
      decimals="0"
      id="Fact000687"
      unitRef="USD">24356</NTRP:IssuanceOfCommonSharesForEquityInvestments>
    <NTRP:IssuanceOfPreferredSharesForEquityInvestments
      contextRef="From2024-03-01to2025-02-28"
      decimals="0"
      id="Fact000690"
      unitRef="USD">2915000</NTRP:IssuanceOfPreferredSharesForEquityInvestments>
    <NTRP:IssuanceOfPreferredSharesForPerpetualSoftwareLicense
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact000694"
      unitRef="USD">362000</NTRP:IssuanceOfPreferredSharesForPerpetualSoftwareLicense>
    <NTRP:ConversionOfConvertibleNotes
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact000697"
      unitRef="USD">3968507</NTRP:ConversionOfConvertibleNotes>
    <NTRP:PreferredStockDividends
      contextRef="From2024-03-01to2025-02-28"
      decimals="0"
      id="Fact000699"
      unitRef="USD">78600</NTRP:PreferredStockDividends>
    <NTRP:PreferredStockDividends
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact000700"
      unitRef="USD">7125</NTRP:PreferredStockDividends>
    <us-gaap:SubstantialDoubtAboutGoingConcernTextBlock contextRef="From2024-03-01to2025-02-28" id="Fact000702">&lt;p id="xdx_800_eus-gaap--SubstantialDoubtAboutGoingConcernTextBlock_zN1FKlthmUk4" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
1 - &lt;span id="xdx_828_z3J93tCm4t6c"&gt;Business Description and Going Concern&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Sigma
Additive Solutions, Inc. (&#x201c;Sigma&#x201d;), the legal acquiror of NextTrip, was initially incorporated as Messidor Limited in Nevada
on December 23, 1985, and changed its name to Framewaves Inc. in 2001. On September 27, 2010, the name was changed to Sigma Labs, Inc.
On May 17, 2022, Sigma Labs, Inc. began doing business as Sigma Additive Solutions, and on August 9, 2022, changed its name to Sigma
Additive Solutions, Inc.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
March 11, 2024, Sigma filed a Certificate of Amendment to its Amended and Restated Articles of Incorporation, as amended to date, with
the Secretary of State of the State of Nevada, pursuant to which, effective as of 12:01 a.m. Pacific time on March 13, 2024, among other
things, Sigma&#x2019;s corporate name was changed from Sigma Additive Solutions, Inc. to &#x201c;NextTrip, Inc.&#x201d;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s corporate office is located at 3900 Paseo del Sol, Santa Fe NM 87507. The consolidated financial statements include
the accounts of the Company&#x2019;s wholly owned subsidiaries, NextTrip Holdings Inc., incorporated on October 22, 2015, and
Extraordinary Vacations USA, Inc., incorporated on June 24, 2002.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Prior
to the NextPlay Exchange Agreement, as described below, NextTrip Holdings, Inc. (&#x201c;NTH&#x201d;) was a wholly owned subsidiary of
NextTrip Group, LLC (&#x201c;NTG&#x201d;), which in turn, was a wholly owned subsidiary of NextPlay Technologies, Inc.
(&#x201c;NextPlay&#x201d;). All of the business operations of NTG were conducted through its subsidiaries. On January 25, 2023,
NextPlay and NTG entered into an Amended and Restated Separation Agreement, Amended and Restated Operating Agreement, and Exchange
Agreement (the &#x201c;NextPlay Exchange Agreement&#x201d;, whereby NextPlay transferred their interest in the travel business
to NTG. Pursuant to the NextPlay Exchange Agreement, NextPlay exchanged &lt;span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230125__20230125__us-gaap--BusinessAcquisitionAxis__custom--NextPlayTechnologiesIncMember__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__us-gaap--StatementEquityComponentsAxis__custom--MembershipUnitsMember_zjos9diZi93h" title="Number of common stock issued"&gt;1,000,000&lt;/span&gt;
Membership Units of NTG for &lt;span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230125__20230125__us-gaap--BusinessAcquisitionAxis__custom--NextPlayTechnologiesIncMember__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__us-gaap--StatementEquityComponentsAxis__custom--PreferredUnitsMember_ztMgBBiMFbL4" title="Number of common stock issued"&gt;400,000&lt;/span&gt;
Preferred Units of NTG, with a value of $&lt;span id="xdx_905_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20230125__us-gaap--BusinessAcquisitionAxis__custom--NextPlayTechnologiesIncMember__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember_zELcOTaWmJIh" title="Share price per share"&gt;10&lt;/span&gt;
per unit. Prior to the exchange for Preferred Units, NTG had a payable due to NextPlay of $&lt;span id="xdx_905_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pid_c20230125__20230125__us-gaap--BusinessAcquisitionAxis__custom--NextPlayTechnologiesIncMember__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__us-gaap--StatementEquityComponentsAxis__custom--PreferredUnitsMember_zI3yKNrROni" title="Number of common stock issued, value"&gt;17,295,873&lt;/span&gt;,
representing cash advances and payment of expenses by NextPlay on behalf of NTG, while NextPlay had obligations to provide ongoing
support to NTH. Such liability was settled by the issuance of the Preferred Units and the waiver of all of NextPlay&#x2019;s
ongoing support obligations except for a $&lt;span id="xdx_909_eus-gaap--Capital_iI_pn5n6_c20230125__us-gaap--BusinessAcquisitionAxis__custom--NextTripGroupLLCMember_zrZpt7552iM4" title="Contributed capital"&gt;1.5&lt;/span&gt;
million advance remaining under a promissory note and, as such, NTH recorded the payable as contributed capital.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company provides travel technology solutions with sales originating in the United States, with a primary emphasis on hotels, air, and
all-inclusive travel packages. Our proprietary booking engine, branded as NextTrip 2.0, provides travel distributors access to a sizeable
inventory.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company owns &lt;span id="xdx_908_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_dp_uPure_c20241130__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--NextInnovationLLCMember_zwBXrrGEDlol" title="Ownership percentage"&gt;50&lt;/span&gt;%
of Next Innovation LLC, a Joint Venture (&#x201c;Next Innovation&#x201d;), which is dormant. No activities nor operations occurred
through Next Innovation in fiscal years 2024 or 2025 and the Company does not have control of Next Innovation and therefore no minority interest
was recorded.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Reverse
Acquisition&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
October 12, 2023, the Company (then known as Sigma) entered into a Share Exchange Agreement (as amended, the &#x201c;Exchange
Agreement&#x201d;) with NTH, NTG, and William Kerby (the &#x201c;NextTrip Representative&#x201d;). Under the terms of the Exchange
Agreement, the parties agreed that NTG would sell and transfer to the Company all of the issued and outstanding shares of NTH in
exchange for &lt;span id="xdx_90E_eus-gaap--BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_pid_c20231012__20231012__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__us-gaap--BusinessAcquisitionAxis__custom--NextTripGroupLLCMember__us-gaap--StatementClassOfStockAxis__custom--ClosingSharesMember_z1dbqyxiBm58" title="Restricted shares issuable in reverse acquisition"&gt;156,007&lt;/span&gt;
restricted shares of Company common stock (the &#x201c;Closing Shares&#x201d;), issuable at closing, and the right to receive up to an
additional &lt;span id="xdx_908_eus-gaap--BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_pid_c20231012__20231012__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__us-gaap--BusinessAcquisitionAxis__custom--NextTripGroupLLCMember__us-gaap--StatementClassOfStockAxis__custom--ContingentSharesMember_zFZ7ArmJ3rXl" title="Restricted shares issuable in reverse acquisition"&gt;5,843,993&lt;/span&gt;
restricted shares of Company common stock upon satisfaction of certain milestones set forth in the Exchange Agreement (the
&#x201c;Contingent Shares,&#x201d; and together with the Closing Shares, the &#x201c;Restricted Shares&#x201d;), which Restricted Shares
are issuable to the members of NTG, on a pro rata basis, under the terms of the Exchange Agreement, subject to certain closing
conditions (the &#x201c;NextTrip Acquisition&#x201d;). Upon the closing of the NextTrip Acquisition on December 29, 2023, NTH
became a wholly owned subsidiary of the Company.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Contingent Shares, together with the Closing Shares, will not exceed &lt;span id="xdx_907_eus-gaap--BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_pid_c20231012__20231012__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__us-gaap--BusinessAcquisitionAxis__custom--NextTripGroupLLCMember__srt--RangeAxis__srt--MaximumMember_zUcGhlrNAGd9" title="Restricted shares issuable in reverse acquisition"&gt;6,000,000&lt;/span&gt;
shares of Company common stock, or approximately &lt;span id="xdx_90A_ecustom--PercentageForIssuedAndOutstandingCapitalStock_pid_dp_uPure_c20231012__20231012__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__us-gaap--BusinessAcquisitionAxis__custom--NextTripGroupLLCMember_zgpUt3q26oo1" title="Percentage for issued and outstanding capital stock"&gt;90.2&lt;/span&gt;%
of the issued and outstanding shares of Company common stock immediately prior to the closing. The NextTrip Acquisition will likely
result in a change of control, with the members of NTG receiving an aggregate number of shares that exceeds the number of shares
that held by the legacy shareholders of Sigma. As a result, the NextTrip Acquisition is accounted for as a reverse acquisition of
NTH by the Company, whereby the Company is treated as the legal acquirer and NTH is treated as the accounting acquirer. As a result,
the historical financial information for the periods prior to closing of the NextTrip Acquisition presented is that of
NTH.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
accordance with ASC &lt;i&gt;805&lt;/i&gt;-&lt;i&gt;40&lt;/i&gt;-&lt;i&gt;45&lt;/i&gt;-&lt;i&gt;1,&lt;/i&gt; the consolidated financial statements prepared following a reverse acquisition
are issued under the name of the legal parent (NextTrip, Inc., f/k/a Sigma Additive Solutions, Inc.) but described in the notes to the
financial statements as a continuation of the financial statements of the legal subsidiary (NTH), with &lt;i&gt;one&lt;/i&gt; adjustment, which
is to retroactively adjust the accounting acquirer&#x2019;s legal capital to reflect the legal capital of the accounting acquiree. That
adjustment is required to reflect the capital of the legal parent. Comparative information presented in the consolidated financial statements
also is retroactively adjusted to reflect the legal capital of the legal parent.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Under
ASC &lt;i&gt;805&lt;/i&gt;-&lt;i&gt;40&lt;/i&gt;-&lt;i&gt;45&lt;/i&gt;-&lt;i&gt;2,&lt;/i&gt; the consolidated financial statements represent the continuation of the legal subsidiary
except for the capital structure, as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(a)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
    assets and liabilities of the legal subsidiary recognized and measured at their pre-combination carrying amounts;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(b)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
    assets and liabilities of the legal parent recognized and measured in accordance with the guidance in this topic applicable to business
    combinations (ASC 805);&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(c)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
    retained earnings and other equity balances of the legal subsidiary before the business combination;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(d)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
    amount required to be recognized as issued equity interests in the consolidated financial statements determined by adding the issued
    equity interest of the legal subsidiary outstanding immediately before the business combination to the fair value of the legal parent
    determined in accordance with the guidance in ASC 805 applicable to business combinations. However, the equity structure reflects
    the equity structure of the legal parent, including the equity interests the legal parent issued to affect the combination. Accordingly,
    the equity structure of the legal subsidiary is restated using the exchange ratio established in the acquisition agreement to reflect
    the number of shares of the legal parent issued in the reverse acquisition.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
assets and liabilities of Sigma were recognized at fair value under ASC 805 as described in &lt;b&gt;NOTE 8 &#x2013;
Goodwill&lt;/b&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Going
Concern&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of February 28, 2025, and February 29, 2024, the Company had an accumulated deficit of $&lt;span id="xdx_90D_eus-gaap--RetainedEarningsAccumulatedDeficit_iNI_di_c20250228_zsUkhEI6Ady3" title="Accumulated deficit"&gt;34,349,823&lt;/span&gt; and $&lt;span id="xdx_90F_eus-gaap--RetainedEarningsAccumulatedDeficit_iNI_di_c20240229_zUD6hNqCpqLc" title="Accumulated deficit"&gt;24,151,139&lt;/span&gt;, respectively, and
working capital deficit of $&lt;span id="xdx_902_ecustom--WorkingCapitalDeficit_iI_c20250228_zg9XcvXLlAzd" title="Working capital deficit"&gt;105,577&lt;/span&gt; and $&lt;span id="xdx_90F_ecustom--WorkingCapitalDeficit_iI_c20240229_zf4PSoVY4I1j" title="Working capital deficit"&gt;262,005&lt;/span&gt;, respectively, and has incurred losses since incorporation. The Company will need to
raise additional funds through equity or debt financings to support its on-going operations, increase market penetration of its products,
expand the marketing and development of its travel and technology driven products, provide capital expenditures for additional equipment
and development costs, payment obligations, and systems for managing the business including covering other operating costs until the
planned revenue streams are fully implemented and begin to offset the Company&#x2019;s operating costs. In the event the Company is unable to raise adequate
funding in the future for its operations and to pay its outstanding debt obligations, the Company may be forced to scale back its business
plan and/or liquidate some or all of its assets or may be forced to seek bankruptcy protection.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
light of the foregoing, there is substantial doubt about the Company&#x2019;s ability to continue as a going concern for 12 months from the date of the
filing of this Report.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:SubstantialDoubtAboutGoingConcernTextBlock>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2023-01-252023-01-25_custom_NextPlayTechnologiesIncMember_custom_ShareExchangeAgreementMember_custom_MembershipUnitsMember"
      decimals="INF"
      id="Fact000704"
      unitRef="Shares">1000000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2023-01-252023-01-25_custom_NextPlayTechnologiesIncMember_custom_ShareExchangeAgreementMember_custom_PreferredUnitsMember"
      decimals="INF"
      id="Fact000706"
      unitRef="Shares">400000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="AsOf2023-01-25_custom_NextPlayTechnologiesIncMember_custom_ShareExchangeAgreementMember"
      decimals="INF"
      id="Fact000708"
      unitRef="USDPShares">10</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2023-01-252023-01-25_custom_NextPlayTechnologiesIncMember_custom_ShareExchangeAgreementMember_custom_PreferredUnitsMember"
      decimals="INF"
      id="Fact000710"
      unitRef="USD">17295873</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:Capital
      contextRef="AsOf2023-01-25_custom_NextTripGroupLLCMember"
      decimals="-5"
      id="Fact000712"
      unitRef="USD">1500000</us-gaap:Capital>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="AsOf2024-11-30_custom_NextInnovationLLCMember"
      decimals="INF"
      id="Fact000714"
      unitRef="Pure">0.50</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="From2023-10-122023-10-12_custom_ShareExchangeAgreementMember_custom_NextTripGroupLLCMember_custom_ClosingSharesMember"
      decimals="INF"
      id="Fact000716"
      unitRef="Shares">156007</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="From2023-10-122023-10-12_custom_ShareExchangeAgreementMember_custom_NextTripGroupLLCMember_custom_ContingentSharesMember"
      decimals="INF"
      id="Fact000718"
      unitRef="Shares">5843993</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="From2023-10-122023-10-12_custom_ShareExchangeAgreementMember_custom_NextTripGroupLLCMember_srt_MaximumMember"
      decimals="INF"
      id="Fact000720"
      unitRef="Shares">6000000</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <NTRP:PercentageForIssuedAndOutstandingCapitalStock
      contextRef="From2023-10-122023-10-12_custom_ShareExchangeAgreementMember_custom_NextTripGroupLLCMember"
      decimals="INF"
      id="Fact000722"
      unitRef="Pure">0.902</NTRP:PercentageForIssuedAndOutstandingCapitalStock>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="AsOf2025-02-28"
      decimals="0"
      id="Fact000724"
      unitRef="USD">-34349823</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="AsOf2024-02-29"
      decimals="0"
      id="Fact000726"
      unitRef="USD">-24151139</us-gaap:RetainedEarningsAccumulatedDeficit>
    <NTRP:WorkingCapitalDeficit
      contextRef="AsOf2025-02-28"
      decimals="0"
      id="Fact000728"
      unitRef="USD">105577</NTRP:WorkingCapitalDeficit>
    <NTRP:WorkingCapitalDeficit
      contextRef="AsOf2024-02-29"
      decimals="0"
      id="Fact000730"
      unitRef="USD">262005</NTRP:WorkingCapitalDeficit>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="From2024-03-01to2025-02-28" id="Fact000732">&lt;p id="xdx_806_eus-gaap--SignificantAccountingPoliciesTextBlock_z9EOl08QDmLe" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
2 &#x2013; &lt;span id="xdx_82D_zmWRpPg1HyL9"&gt;Summary of Significant Accounting Policies&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_849_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zJ1BUaV0Gyzk" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_86E_zh2Lg2wMOZjl"&gt;Basis
of Presentation and Principles of Consolidation&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
accompanying consolidated financial statements and related disclosures have been prepared pursuant to the rules and regulations of the
Securities and Exchange Commission (&#x201c;SEC&#x201d;). The Financial Statements have been prepared using the accrual basis of accounting
in accordance with Generally Accepted Accounting Principles (&#x201c;GAAP&#x201d;) of the United States.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
financial statements have been prepared on a consolidated basis with those of the Company&#x2019;s wholly owned subsidiaries. All intercompany
transactions and balances have been eliminated in consolidation.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_849_eus-gaap--ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_zSHpdixYhZra" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_86B_zRKXUvJqxDW9"&gt;Functional
and presentation currency&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;These
financial statements are presented in United States dollars (&#x201c;USD&#x201d;), which is the Company&#x2019;s functional and reporting
currency. All financial information has been rounded to the nearest dollar except where otherwise indicated.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_847_eus-gaap--UseOfEstimates_z92xxB7g9Hp6" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_868_zANkfF99EJc3"&gt;Use
of Estimates&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that
affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the consolidated
financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from
those estimates. These differences could have a material effect on the Company&#x2019;s future results of operations and financial position.
Significant items subject to estimates and assumptions include the carrying amounts of intangible assets, depreciation and amortization.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Information
about key assumptions and estimation uncertainty that has a significant risk of resulting in a material adjustment to the carrying amounts
of the Company&#x2019;s assets and liabilities within the next financial year are referenced in the notes to the financial statements
as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;
    &lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
    assessment of the Company to continue as a going concern;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
    assessment of the allowance on the related party promissory note receivable;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Estimates
    of purchase price allocation;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;
    &lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
    measurement and useful life of intangible assets and property and equipment&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Estimates
    of fair value of equity instruments;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;
    &lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Recoverability
    of long lived assets&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84E_eus-gaap--EarningsPerSharePolicyTextBlock_z00E9Pa3SOu7" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_86E_zssQN5TOOKRj"&gt;Loss
Per Share &lt;/span&gt;&#x2013; &lt;/b&gt;The computation of loss per share is based on the weighted average number of shares outstanding during the period
in accordance with ASC Topic No. 260, &#x201c;Earnings Per Share.&#x201d; Shares underlying the Company&#x2019;s outstanding warrants, options, preferred stock
or note conversion features were excluded due to the anti-dilutive effect they would have on the computation. At February 28, 2025 and
February 29, 2024, the Company had the following common shares underlying these instruments:&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_892_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zvqrR8ZG98Q5" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B9_zfcl7inofrn9" style="display: none"&gt;Schedule of Anti-dilutive Securities Excluded
from Computation of Earnings Per Share&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_490_20240301__20250228_zVHxnQOa9wwf" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;2025&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49B_20230301__20240229_zoPHw1J6jZFc" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;Year Ended February 28 and 29,&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;2025&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zqkv5WKfeJ97" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 60%"&gt;Warrants&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;3,015,885&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;486,165&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--StockOptionMember_zAoWQGOKgK8b" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Stock Options&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;76,342&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;85,300&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--PreferredStockMember_zaluQv3R7uv5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"&gt;Preferred Stock&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;3,109,663&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;475,835&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_z7EAhfi3Lt6d" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"&gt;Total Underlying Common Shares&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;6,201,890&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;1,047,300&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A7_zrK2FIOrjfHj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84C_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zhjm7voHXbBg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_86A_z9BMsv76wSO3"&gt;Cash
and Cash Equivalents&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Cash
consists of amounts denominated in USD. The Company has not experienced any losses on such accounts. The Company considers all
highly liquid investments with a maturity of three months or less when purchased to be cash equivalents. There were &lt;span id="xdx_90B_eus-gaap--CashEquivalentsAtCarryingValue_iI_do_c20250228_zuNofbvNxerl" title="Cash equivalents"&gt;&lt;span id="xdx_905_eus-gaap--CashEquivalentsAtCarryingValue_iI_do_c20240229_zQkXA1eQbURh" title="Cash equivalents"&gt;no&lt;/span&gt;&lt;/span&gt; cash equivalents
as of February 28, 2025, or February 29, 2024.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_840_ecustom--PrepaidsPolicyTextBlock_zwgSrGb0Idxj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_865_zDatv27VkZte"&gt;Prepaids&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company records cash paid in advance for goods and/or services to be received in the future as prepaid expenses. Prepaid expenses are
expensed over time according to the terms of the purchase. Other current assets are recognized when it is probable that the future economic
benefits will flow to the Company and the asset has a cost or value that can be measured reliably. It is then charged to expense over
the expected number of periods during which economic benefits will be realized.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_849_eus-gaap--TradeAndOtherAccountsReceivablePolicy_zqPgfmpOk2Yi" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_867_zSrcewP8Ripj"&gt;Accounts
Receivable&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Trade
accounts receivable are recorded at the invoiced amount and do not bear interest. The allowance for credit losses is the Company&#x2019;s
best estimate of the amount of probable losses in its existing accounts receivable.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company considers accounts receivable to be fully collectible; accordingly, no allowance for credit losses is required. If amounts
become uncollectible, they will be charged to operations when that determination is made.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Trade
accounts receivable balances as of February 28, 2025 and February 29, 2024, were $&lt;span id="xdx_909_eus-gaap--AccountsReceivableNet_iI_c20250228_zUbjy98GiaXl" title="Accounts receivable"&gt;22,567&lt;/span&gt; and $&lt;span id="xdx_900_eus-gaap--AccountsReceivableNet_iI_c20240229_zcmT867FEce8" title="Accounts receivable"&gt;34,092&lt;/span&gt;, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_841_eus-gaap--EquityMethodInvestmentsPolicy_zabWDYnrzqte" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_863_zrlX5qfCtnlc"&gt;Investments
in Equity Method Investees&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company holds investments in certain entities that are accounted for under the equity method of accounting, as well as investments that
are accounted for under the fair value method pursuant to ASC 321, &#x201c;Investments - Equity Securities.&#x201d; Under the equity method,
investments in entities in which the Company has significant influence, but not control, are initially recognized at cost and adjusted
thereafter to recognize the Company&#x2019;s share of the investees&#x2019; earnings or losses and other comprehensive income.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company determines the existence of significant influence based on various factors, including representation on the investees&#x2019;
board of directors, participation in policy-making processes, and material intercompany transactions.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s equity method investments are evaluated periodically for impairment by assessing whether events or changes in circumstances
indicate that the carrying value of the investment may not be recoverable. When such indicators exist, the Company performs an impairment
test and recognizes an impairment loss to the extent that the carrying amount of the investment exceeds its fair value.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Distributions
received from equity method investees that exceed cumulative earnings recognized by the Company are considered a return of investment
and are recorded as a reduction in the carrying amount of the investment.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Adjustments
resulting from changes in the Company&#x2019;s ownership interest in equity method investees that do not result in a loss of significant
influence are accounted for prospectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84F_ecustom--BasisDifferencePolicyTextBlock_zIre3wqhViVg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_862_zKhnwIT74bZ1"&gt;Basis
Difference&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
accordance with ASC 323, &#x201c;Investments - Equity Method and Joint Ventures,&#x201d; the Company records a basis difference when the
carrying value of its equity method investment differs from its share of the investee&#x2019;s fair value of net assets at the acquisition
date. This basis difference is allocated to the investee&#x2019;s identifiable assets and liabilities based on their fair values. The
amortization of any basis difference related to depreciable assets, such as property, plant, and equipment, is recognized in the Company&#x2019;s
share of the investee&#x2019;s earnings or losses. Any basis difference related to non-depreciable assets, including goodwill, is generally
not amortized, but is subject to impairment testing as necessary.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company assesses the impact of any basis differences on its earnings and the carrying value of its equity method investments. If a basis
difference is determined to exist, the appropriate adjustments are made to reflect the amortization of such differences in the consolidated
financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84B_eus-gaap--EquitySecuritiesWithoutReadilyDeterminableFairValuePolicyTextBlock_z70CbGD2sAsc" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_865_ziedsQLI2no4"&gt;Investments
in Equity Securities without Readily Determinable Fair Value&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
accordance with ASC 321-10-35-2, the Company holds certain investments in equity securities in which the Company does not have significant
influence or control, and for which fair value is not readily determinable. These investments are primarily accounted for at cost, less
any impairment. The carrying amount is periodically evaluated for impairment, and if necessary, an impairment loss is recognized in the
statement of operations. These investments are not adjusted for unrealized gains or losses unless an impairment is identified.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84C_eus-gaap--EquityMethodInvestmentsIssuancesPolicy_zWGPIxaV2yFe" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_868_zE55pMyDrGlg"&gt;Equity
in Earnings of Equity Method Investees&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s share of earnings or losses from equity method investees is recognized in the consolidated statement of operations within
&#x201c;Equity in share of loss of equity method investees,&#x201d; net of any related income taxes.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_843_eus-gaap--FairValueMeasurementPolicyPolicyTextBlock_zPNgWiw9RGQh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_869_zAp1boL6zgRj"&gt;Fair
Value Measurements&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
fair value of equity method investments is disclosed when available and practical to determine. However, for investments that are not
readily marketable, such as non-public entities, fair value is not typically recognized in the financial statements unless the investment
is impaired.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84C_ecustom--PromissoryNoteReceivablePolicyTextBlock_zpvsQAIGfJNc" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Promissory
Note Receivable&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Receivables
from NextPlay under the promissory note as described in &lt;b&gt;NOTE 1 &#x2013; Business Description and Going Concern&lt;/b&gt; were $&lt;span id="xdx_903_eus-gaap--AccountsReceivableNet_iI_c20250228__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--NextPlayTechnologiesIncMember_z1qGJcY8kUE" title="Accounts receivable"&gt;0&lt;/span&gt; and $&lt;span id="xdx_903_eus-gaap--AccountsReceivableNet_iI_c20240229__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--NextPlayTechnologiesIncMember_zoFhIZVRI9Ab" title="Accounts receivable"&gt;1,000,000&lt;/span&gt;
at February 28, 2025 and February 29, 2024, respectively. Pursuant to the terms of the Promissory Note (the &#x201c;NextPlay Note&#x201d;)
between NTH and NextPlay, the NextPlay Note was due and payable in full on the earlier of September 1, 2023 or the date the Company
completed a financing of $&lt;span id="xdx_90E_eus-gaap--NotesPayable_iI_pn6n6_c20230925__us-gaap--BusinessAcquisitionAxis__custom--NextPlayTechnologiesIncMember_zGhg2DJpWydb" title="Notes payable"&gt;10&lt;/span&gt; million or more. No payments have been made by NextPlay, and as such NextPlay is in default under the terms
of the NextPlay Note.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
January 27, 2025, as creditors of NextPlay, Donald P. Monaco, the Company&#x2019;s Chairman, William Kerby, the Company&#x2019;s Chief
Executive Officer, and Ian Sharpe, the Chief Operating Officer of the Company&#x2019;s Media division, filed a petition to force NextPlay
into involuntary bankruptcy as a result of unpaid fees. The proceedings are ongoing and the outcome at this time is uncertain and cannot
be predicted. As a result, management has determined that the collectability of the NextPlay Note is uncertain and has therefore established
an allowance for doubtful accounts for the entire balance of $&lt;span id="xdx_902_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iI_c20250127__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--NextPlayTechnologiesIncMember_z2SRuRsyeQXk" title="Allowance for doubtful accounts"&gt;2,567,665&lt;/span&gt;. Of this amount, $&lt;span id="xdx_908_ecustom--LossOnRelatedPartyReceivable_c20240301__20250228_z7jiBGEHH9Uc" title="Loss on promissory note receivable"&gt;1,000,000&lt;/span&gt; was recorded as of February 28, 2025,
and $&lt;span id="xdx_900_ecustom--LossOnRelatedPartyReceivable_c20230301__20240229_zmIVjrNPV9Lb" title="Loss on promissory note receivable"&gt;1,567,665&lt;/span&gt; was recorded as of February 29, 2024.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84A_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_z8czT4zfswHh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_86F_z6yCU0h8ggla"&gt;Property
and Equipment&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Recognition
and measurement&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Items
of property and equipment are measured at cost, less accumulated depreciation and accumulated impairment losses. When parts of an item
of property and equipment have different estimated useful lives, they are accounted for as separate items within property and equipment.
The costs of the ongoing regular repairs and maintenance of property and equipment are recognized in the period in which they are incurred.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Depreciation&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Depreciation
is recognized in profit or loss over the estimated useful lives of each part of an item of property and equipment in a manner that most
closely reflects management&#x2019;s estimated future consumption of the future economic benefits embodied in the asset. The estimated
useful lives for the Company&#x2019;s property and equipment are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89A_ecustom--ScheduleOfEstimatedUsefulLivesForPropertyAndEquipmentTableTextBlock_z5CB4ZAtqjM7" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span style="display: none"&gt;&lt;span id="xdx_8BB_zz2yIF2XvmHl"&gt;Schedule
of Estimated
Useful Lives for Property and Equipment&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Category&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Method&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Estimated
    useful life&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Furniture
    &amp;amp; Fixtures&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Straight
    line&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_909_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20250228__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zvTl2fGZ8Eof" title="Estimated useful life"&gt;5&lt;/span&gt;
    years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Computer
    &amp;amp; Equipment&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Straight
    line&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90D_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20250228__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_zUaXzpeVFOQf" title="Estimated useful life"&gt;3&lt;/span&gt;
    years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8A6_zYReKKJGarnl" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84F_eus-gaap--IntangibleAssetsFiniteLivedPolicy_zDoeSolb4H5g" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_86D_z5mvFUmsmmdh"&gt;Intangible
assets&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company measures separately acquired intangible assets at cost, less accumulated amortization and impairment losses. The Company recognizes
internally developed intangible assets when it has determined that the completion of such is technically feasible, and the Company has
sufficient resources to complete the development. Subsequent expenditures are capitalized when they increase the future economic benefits
of the associated asset. All other expenditures are recorded in profit or loss as incurred.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company assesses whether the life of intangible asset is finite or indefinite. The Company reviews the amortization method and period
of use of its intangible assets at least annually. Changes in the expected useful life or period of consumption of future economic benefits
associated with the asset are accounted for prospectively by changing the amortization method or period as a change in accounting estimates
in profit or loss. The Company has assessed the useful life of its trademarks as indefinite.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_891_ecustom--ScheduleOfEstimatedUsefulLivesForFiniteLifeIntangibleAssetsTableTextBlock_zX9Gyyi62dK9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
estimated useful lives for the Company&#x2019;s finite life intangible assets are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B8_zqdpJQVrfANf" style="display: none"&gt;Schedule
of Estimated
Useful Lives for Finite Life Intangible Assets&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Category&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Method&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Estimated
    useful life&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Software&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Straight
    line&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_909_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20250228__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SoftwareMember__srt--RangeAxis__srt--MinimumMember_zAPO9167w9ai" title="Estimated useful life"&gt;1&lt;/span&gt;
    - &lt;span id="xdx_909_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20250228__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SoftwareMember__srt--RangeAxis__srt--MaximumMember_zv66dkLsEoxe" title="Estimated useful life"&gt;3&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Software
    licenses&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Straight
    line&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90D_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20250228__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SoftwareLicensesMember__srt--RangeAxis__srt--MinimumMember_zfNu07ETVGUi" title="Estimated useful life"&gt;0.5&lt;/span&gt;
    - &lt;span id="xdx_902_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20250228__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SoftwareLicensesMember__srt--RangeAxis__srt--MaximumMember_zPU8KANFDz6l" title="Estimated useful life"&gt;4&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8AA_zrmr4KOowcch" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84F_eus-gaap--InternalUseSoftwarePolicy_zPKn11aVP3Sg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_864_zS1UUutOsNbd"&gt;Software
Development Costs&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company capitalizes internal software development costs subsequent to establishing technological feasibility of a software application
in accordance with guidelines established by &#x201c;ASC 985-20-25&#x201d; Accounting for the Costs of Software to Be Sold, Leased, or
Otherwise Marketed, requiring certain software development costs to be capitalized upon the establishment of technological feasibility.
The establishment of technological feasibility and the ongoing assessment of the recoverability of these costs require considerable judgment
by management with respect to certain external factors such as anticipated future revenue, estimated economic life, and changes in software
and hardware technologies. Amortization of the capitalized software development costs begins when the product is available for general
release to customers. Capitalized costs are amortized based on the straight-line method over the remaining estimated economic life of
the product.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_849_eus-gaap--GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_z6Yc1kBv10E4" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_863_zmgLD6BsuqJk"&gt;Impairment
of Intangible Assets&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
accordance with ASC 350-30-65 &#x201c;Goodwill and Other Intangible Assets&#x201d;, the Company assesses the impairment of identifiable
intangible assets whenever events or changes in circumstances indicate that the carrying value may not be recoverable. Factors the Company
considers important, which could trigger an impairment review include the following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1.
Significant underperformance compared to historical or projected future operating results.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2.
Significant changes in the manner or use of the acquired assets or the strategy for the overall business, and&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3.
Significant negative industry or economic trends.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;When
the Company determines that the carrying value of an intangible asset may not be recoverable based upon the existence of one or more
of the above indicators of impairment and the carrying value of the asset cannot be recovered from projected undiscounted cash flows,
the Company records an impairment charge. The Company measures any impairment based on a projected discounted cash flow method using
a discount rate determined by management to be commensurate with the risk inherent to the current business model. Significant management
judgment is required in determining whether an indicator of impairment exists and in projecting cash flows. Intangible assets that have
finite useful lives are amortized over their useful lives.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84F_eus-gaap--LesseeLeasesPolicyTextBlock_zCLGhnMfxjwa" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_86A_zflz7TQmjQ8k"&gt;Leases&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company adopted ASU 2016-02 (Topic ASC 842) Leases, which requires a lessee to recognize a lease asset and a leases liability for operating
leases arrangements greater than twelve (12) months.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;We
determine if an arrangement is a lease at inception. Operating leases are included in operating lease right-of-use (&#x201c;ROU&#x201d;)
assets, operating lease liabilities - current, and operating lease liabilities - noncurrent on the balance sheets.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;ROU
assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease
payments arising from the lease. Operating lease ROU assets and liabilities are recognized at commencement date based on the present
value of lease payments over the lease term. As most of our leases do not provide an implicit rate, we generally use our incremental
borrowing rate based on the estimated rate of interest for collateralized borrowing over a similar term of the lease payments at commencement
date. The operating lease ROU asset also includes any lease payments made and excludes lease incentives. Our lease terms may include
options to extend or terminate the lease when it is reasonably certain that we will exercise that option. Lease expense for lease payments
is recognized on a straight-line basis over the lease term.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_845_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zs0xXffHlI4j" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_861_zQFg4hltGIxf"&gt;Reclassification&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Certain
prior year amounts have been reclassified to conform to the current period presentation. These reclassifications had no impact on the
net earnings (loss) or financial position.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84C_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zYUEOLk4dVve" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_868_zgeN1xwJDHX"&gt;Fair
Value of Financial Instruments&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company follows accounting guidelines on fair value measurements for financial instruments measured on a recurring basis, as well as
for certain assets and liabilities that are initially recorded at their estimated fair values. Fair Value is defined as the exit price,
or the amount that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants
as the measurement date. The Company uses the following three-level hierarchy that maximizes the use of observable inputs and minimizes
the use of unobservable inputs to value its financial instruments:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;
    &lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
    1: Observable inputs such as unadjusted quoted prices in active markets for identical instruments.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;
    &lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
    2: Quoted prices for similar instruments that are directly or indirectly observable in the marketplace.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;
    &lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
    3: Significant unobservable inputs which are supported by little or no market activity and that are financial instruments whose values
    are determined using pricing models, discounted cash flow methodologies, or similar techniques, as well as instruments for which
    the determination of fair value requires a significant judgment or estimation.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Financial
instruments measured at fair value are classified in their entirety based on the lowest level of input that is significant to the fair
value measurement. The Company&#x2019;s assessment of the significance of a particular input to the fair value measurement in its entirety
requires it to make judgments and consider factors specific to the asset or liability. The use of different assumptions and/or estimation
methodologies may have a material effect on estimated fair values. Accordingly, the fair value estimates disclosed, or initial amounts
recorded may not be indicative of the amount that the Company or holders of the instruments could realize in a current market exchange.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
carrying amounts of the Company&#x2019;s financial instruments including cash, accounts receivable, accounts payable, accrued expenses,
convertible notes and notes payable are of approximately fair value due to the short-term maturities of these instruments.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_848_eus-gaap--MarketRiskBenefitPolicyTextBlock_zmy8rbwcLTdf" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_868_zxjb70IvPBf5"&gt;Concentration
of Credit Risk &lt;/span&gt;-&lt;/b&gt; The Company maintains its cash in bank deposit accounts, which, at times, may exceed federally insured limits. The
Company has not experienced any losses in such accounts and believes it is not exposed to any significant credit risk on its cash and
cash equivalents.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_849_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_z3Mq8xR32Ov9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: -0.9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_86A_zGMWX7TRgG6f"&gt;Stock
Based Compensation&lt;/span&gt;&lt;/b&gt; &#x2013; The Company recognizes compensation costs to employees under ASC Topic No. 718, &#x201c;Compensation &#x2013;
Stock Compensation.&#x201d; Under ASC Topic No. 718, companies are required to measure the compensation costs of share-based compensation
arrangements based on the grant-date fair value and recognize the costs in the financial statements over the period during which employees
are required to provide services. Share based compensation arrangements may include stock options, grants of shares of common stock with
and without restrictions, performance-based awards, share appreciation rights and employee share purchase plans. As such, compensation
cost is measured on the date of grant at its fair value. Such compensation amounts, if any, are amortized over the respective vesting
periods of the option or stock grants.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: -0.9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Equity
instruments issued to non-employees are recorded on the basis of the fair value of the instruments, as required by ASC Topic No. 718.
In general, the measurement date is either (a) when a performance commitment, as defined, is reached or (b) the earlier of the date that
(i) the non-employee performance requirement is complete or (ii) the instruments are vested. The measured value related to the instruments
is recognized over a period based on the facts and circumstances of each particular grant as defined in the FASB Accounting Standards
Codification.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_844_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_zrdm3uMmNHhg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_86E_z1a64sRD73ic"&gt;Revenue
Recognition&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company recognizes revenue in accordance with ASC Topic No. 606. In May 2014, the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) issued
Accounting Standards Update (&#x201c;ASU&#x201d;) No. 2014-09, &lt;i&gt;Revenue from Contracts with Customers&lt;/i&gt;. ASU 2014-09 is a comprehensive revenue recognition
standard that superseded nearly all existing revenue recognition guidance under prior GAAP and replaced it with a principles-based
approach for determining revenue recognition. The core principle of the standard is the recognition of revenue upon the transfer of promised
goods or services to customers in an amount that reflects the consideration to which the company expects to be entitled in exchange for
those goods or services. In general, we determine revenue recognition by: (1) identifying the contract, or contracts, with our customer;
(2) identifying the performance obligations in the contract; (3) determining the transaction price; (4) allocating the transaction price
to performance obligations in the contract; and (5) recognizing revenue when, or as, we satisfy performance obligations by transferring
the promised goods or services.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company recognizes revenue when the customer has purchased the product, the occurrence of the earlier of date of travel and the date of
cancellation has expired, as satisfaction of the performance obligation, the sales price is fixed or determinable and collectability
is reasonably assured. Revenue for customer travel packages purchased directly from the Company are recorded gross (the amount paid to
the Company by the customer is shown as revenue and the cost of providing the respective travel package is recorded to cost of revenues).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company generates revenues from sales directly to customers as well as through other distribution channels of tours and activities at
destinations throughout the world.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company controls the specified travel product before it is transferred to the customer and is therefore a principal, based on but not
limited to, the following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;
    &lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
    Company is primarily responsible for fulling the promise to provide such travel product.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;
    &lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
    Company has inventory risk before the specified travel product has been transferred to a customer or after transfer of control to
    a customer.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;
    &lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
    Company has discretion in establishing the price for the specified travel product.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Payments
for tours or activities received in advance of services being rendered are recorded as deferred revenue and recognized as revenue at
the earlier of the date of travel or the last date of cancellation (i.e., the customer&#x2019;s refund privileges lapse).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84D_eus-gaap--SellingGeneralAndAdministrativeExpensesPolicyTextBlock_zJTtpSias568" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_86F_zQ3fcJCgU2ec"&gt;Sales
and Marketing&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Selling
and marketing expenses consist primarily of marketing and promotional expenses, expenses related to our participation in industry
conferences, and public relations expenses.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Sales
and marketing expenses are charged to expense as incurred and are included in selling and promotions expenses in the accompanying consolidated
financial statements. Sales and marketing expense for the years ended February 28, 2025 and February 29, 2024 was $&lt;span id="xdx_907_eus-gaap--SellingAndMarketingExpense_c20240301__20250228_z6vgQuzeHCol" title="Sales and marketing expense"&gt;307,166&lt;/span&gt; and $&lt;span id="xdx_905_eus-gaap--SellingAndMarketingExpense_c20230301__20240229_z4jYH9fDJYtb" title="Sales and marketing expense"&gt;484,250&lt;/span&gt;,
respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84B_eus-gaap--IncomeTaxPolicyTextBlock_zgwGOWd6ekvk" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_86E_zNUHheJDSJmc"&gt;Income
Taxes&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company accounts for income taxes in accordance with ASC Topic No. 740, &#x201c;Accounting for Income Taxes.&#x201d;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Income
taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences
attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective
tax bases and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected
to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred
tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. A valuation
allowance on deferred tax assets is established when management considers it is more likely than not that some portion or all of the
deferred tax assets will not be realized.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Tax
benefits from an uncertain tax position are only recognized if it is more likely than not that the tax position will be sustained on
examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in the consolidated
financial statements from such a position are measured based on the largest benefit that has a greater than fifty percent likelihood
of being realized upon ultimate resolution. Interest and penalties related to unrecognized tax benefits are recorded as incurred as a
component of income tax expense. The Company has not recognized any tax benefits from uncertain tax positions for any of the reporting
periods presented.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company had no tax positions at February 28, 2025 or 2024 for which the ultimate deductibility was highly uncertain but for which there
was uncertainty about the timing of such deductibility.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company recognizes interest accrued related to unrecognized tax benefits in interest expense and penalties in operating expenses.
During the years ended February 28, 2025 and February 29, 2024, the Company recognized no interest and penalties. All tax returns
for years starting with 2021 and thereafter remain open for examination by the IRS.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_849_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zAjDLPXRefc6" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_86D_zo0lewsivXQl"&gt;Recently
adopted accounting pronouncements&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
July 2023, the FASB issued ASU 2023-03, Presentation of Financial Statements (Topic 205), Income Statement&#x2014;Reporting Comprehensive
Income (Topic 220), Distinguishing Liabilities from Equity (Topic 480), Equity (Topic 505), and Compensation&#x2014;Stock Compensation
(Topic 718). The FASB Issued this ASU to amend and align various SEC paragraphs within the Codification with interpretive guidance recently
issued by the Securities and Exchange Commission (SEC). Specifically, this update codifies the guidance from SEC Staff Accounting Bulletin
(SAB) No. 120, which clarifies the application of ASC 718 &#x2013; Compensation&#x2014;Stock Compensation to certain share-based payment
arrangements. SAB No. 120 was issued in response to concerns about so-called &#x201c;spring-loaded&#x201d; awards &#x2014; share-based compensation
arrangements granted shortly before the release of material nonpublic information (MNPI) that is expected to significantly affect the
market price of the issuer&#x2019;s stock. SAB No. 120 does not change the fundamental measurement principles of ASC 718, but it emphasizes
the requirement to include the impact of MNPI in estimating fair value at the grant date when it is reasonable to expect that such information
would be factored into the pricing by a market participant. Under ASC 718, entities must measure the grant-date fair value of equity-classified
awards using an option-pricing model and inputs that reflect assumptions a market participant would make. SAB No. 120 reinforces that
this includes: (i) adjusting expected volatility or stock price to reflect the anticipated impact of MNPI; (ii) documenting the rationale
for assumptions that do not reflect such information, if applicable; and (3) ensuring internal control processes capture relevant information
in determining grant-date fair value. The Company adopted ASU 2023-03 effective January 1, 2024. In conjunction with this adoption, the
Company reviewed its stock compensation grant practices and valuation procedures under ASC 718. While the Company has not historically
granted awards in close proximity to the release of MNPI, it has updated its internal controls to require additional documentation and
review for any future awards that may be subject to this scenario. The adoption of ASU 2023-03 did not result in any changes to the recognition
or measurement of share-based payment expense in the Company&#x2019;s consolidated financial statements. However, the Company enhanced
its internal controls around the timing and valuation of equity awards to ensure compliance with the interpretive guidance of SAB No.
120 and ASC 718.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
November 2023, the FASB issued ASU 2023-07 to improve disclosures about a public entity&#x2019;s reportable segments and address investor
feedback for greater transparency. The amendments are intended to enhance the usefulness of segment information, particularly regarding
expenses, by requiring more detailed disclosures and expanding the scope of interim disclosures. The Company adopted ASU 2023-07 for
its fiscal year beginning March 1, 2024 (i.e., for the fiscal year ending February 28, 2025), as required. The amendments require entities
to disclose, on an annual and interim basis: (i) significant segment expenses that are regularly provided to the chief operating decision
maker (&#x201c;CODM&#x201d;); (ii) an explanation of how reported segment profit or loss is measured, (ii) The title and position of the CODM; (iii)
a description of how the CODM uses reported measures in decision-making; and (iv) expanded disclosures of segment information in interim
periods, consistent with annual disclosures.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;We
manage the Company as one reportable segment, Travel Products and Services. Travel bookings are the source of our revenues and include
the sale of travel products such as airline tickets and hotel rooms as well as travel services such as travel insurance and ground activities.
The segment information aligns with how the Company&#x2019;s CODM reviews and manages our
business. The Company&#x2019;s CODM is the Company&#x2019;s Chief Executive Officer.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Financial
information and annual operating plans and forecasts are prepared and are reviewed by the CODM at a consolidated level. The CODM assesses
performance for the Travel Products and Services segment and decides how to allocate resources based on revenue and net income that is
reported on the Consolidated Statements of Operations. The Company&#x2019;s objective in making resource allocation decisions is to optimize
the financial results. The accounting policies of our Travel Products and Services segment are the same as those described in the summary
of significant accounting policies herein.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
our single reportable segment-level financial information, total assets, and significant non-cash transactions, see the Financial Statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84D_ecustom--RecentlyIssuedAccountingPronouncementsNotYetAdoptedPolicyTextBlock_zTPCxbe6xR06" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_866_zgwQwVdwKsR9"&gt;Recently
issued accounting pronouncements not yet adopted&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
December 2023, the FASB issued ASU 2023-09, &lt;i&gt;Income Taxes (Topic 740): Improvements to Income
Tax Disclosures&lt;/i&gt;, to enhance the transparency and decision-usefulness of income tax information provided to investors. The amendments
focus primarily on expanding the disclosures related to the effective tax rate reconciliation and income taxes paid. Key provisions of
the update include: (i) enhanced disclosure of the effective tax rate reconciliation, using both standardized categories and quantitative
disclosure of individual reconciling items that meet specified thresholds; (ii) required disaggregation of income taxes paid, by federal,
state, and significant foreign jurisdictions; (iii) additional qualitative disclosures about tax-related assumptions and estimation methodologies.
ASU 2023-09 is effective for public business entities for annual periods beginning after December 15, 2024. As a result, the Company
will adopt the standard for its fiscal year beginning March 1, 2025 (ending February 28, 2026). Early adoption is permitted; however,
the Company does not intend to early adopt. The Company is currently evaluating the impact of the new standard on its income tax footnote
disclosures. The adoption is not expected to have an impact on the Company&#x2019;s consolidated financial position, results of operations,
or cash flows, but it will result in expanded and more detailed income tax disclosures beginning in fiscal 2026.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has considered all other recently issued accounting pronouncements and does not believe the adoption of such pronouncements will
have a material impact on its consolidated financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_85D_zmoLoCbHvlrb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="From2024-03-01to2025-02-28" id="Fact000734">&lt;p id="xdx_849_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zJ1BUaV0Gyzk" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_86E_zh2Lg2wMOZjl"&gt;Basis
of Presentation and Principles of Consolidation&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
accompanying consolidated financial statements and related disclosures have been prepared pursuant to the rules and regulations of the
Securities and Exchange Commission (&#x201c;SEC&#x201d;). The Financial Statements have been prepared using the accrual basis of accounting
in accordance with Generally Accepted Accounting Principles (&#x201c;GAAP&#x201d;) of the United States.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
financial statements have been prepared on a consolidated basis with those of the Company&#x2019;s wholly owned subsidiaries. All intercompany
transactions and balances have been eliminated in consolidation.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock contextRef="From2024-03-01to2025-02-28" id="Fact000736">&lt;p id="xdx_849_eus-gaap--ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_zSHpdixYhZra" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_86B_zRKXUvJqxDW9"&gt;Functional
and presentation currency&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;These
financial statements are presented in United States dollars (&#x201c;USD&#x201d;), which is the Company&#x2019;s functional and reporting
currency. All financial information has been rounded to the nearest dollar except where otherwise indicated.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock>
    <us-gaap:UseOfEstimates contextRef="From2024-03-01to2025-02-28" id="Fact000738">&lt;p id="xdx_847_eus-gaap--UseOfEstimates_z92xxB7g9Hp6" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_868_zANkfF99EJc3"&gt;Use
of Estimates&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that
affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the consolidated
financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from
those estimates. These differences could have a material effect on the Company&#x2019;s future results of operations and financial position.
Significant items subject to estimates and assumptions include the carrying amounts of intangible assets, depreciation and amortization.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Information
about key assumptions and estimation uncertainty that has a significant risk of resulting in a material adjustment to the carrying amounts
of the Company&#x2019;s assets and liabilities within the next financial year are referenced in the notes to the financial statements
as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;
    &lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
    assessment of the Company to continue as a going concern;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
    assessment of the allowance on the related party promissory note receivable;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Estimates
    of purchase price allocation;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;
    &lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
    measurement and useful life of intangible assets and property and equipment&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Estimates
    of fair value of equity instruments;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;
    &lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Recoverability
    of long lived assets&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:UseOfEstimates>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="From2024-03-01to2025-02-28" id="Fact000740">&lt;p id="xdx_84E_eus-gaap--EarningsPerSharePolicyTextBlock_z00E9Pa3SOu7" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_86E_zssQN5TOOKRj"&gt;Loss
Per Share &lt;/span&gt;&#x2013; &lt;/b&gt;The computation of loss per share is based on the weighted average number of shares outstanding during the period
in accordance with ASC Topic No. 260, &#x201c;Earnings Per Share.&#x201d; Shares underlying the Company&#x2019;s outstanding warrants, options, preferred stock
or note conversion features were excluded due to the anti-dilutive effect they would have on the computation. At February 28, 2025 and
February 29, 2024, the Company had the following common shares underlying these instruments:&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_892_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zvqrR8ZG98Q5" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B9_zfcl7inofrn9" style="display: none"&gt;Schedule of Anti-dilutive Securities Excluded
from Computation of Earnings Per Share&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_490_20240301__20250228_zVHxnQOa9wwf" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;2025&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49B_20230301__20240229_zoPHw1J6jZFc" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;Year Ended February 28 and 29,&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;2025&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zqkv5WKfeJ97" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 60%"&gt;Warrants&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;3,015,885&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;486,165&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--StockOptionMember_zAoWQGOKgK8b" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Stock Options&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;76,342&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;85,300&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--PreferredStockMember_zaluQv3R7uv5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"&gt;Preferred Stock&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;3,109,663&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;475,835&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_z7EAhfi3Lt6d" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"&gt;Total Underlying Common Shares&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;6,201,890&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;1,047,300&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A7_zrK2FIOrjfHj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock contextRef="From2024-03-01to2025-02-28" id="Fact000742">&lt;p id="xdx_892_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zvqrR8ZG98Q5" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B9_zfcl7inofrn9" style="display: none"&gt;Schedule of Anti-dilutive Securities Excluded
from Computation of Earnings Per Share&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_490_20240301__20250228_zVHxnQOa9wwf" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;2025&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49B_20230301__20240229_zoPHw1J6jZFc" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;Year Ended February 28 and 29,&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;2025&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zqkv5WKfeJ97" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 60%"&gt;Warrants&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;3,015,885&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;486,165&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--StockOptionMember_zAoWQGOKgK8b" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Stock Options&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;76,342&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;85,300&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--PreferredStockMember_zaluQv3R7uv5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"&gt;Preferred Stock&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;3,109,663&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;475,835&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_z7EAhfi3Lt6d" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"&gt;Total Underlying Common Shares&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;6,201,890&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;1,047,300&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2024-03-012025-02-28_us-gaap_WarrantMember"
      decimals="INF"
      id="Fact000744"
      unitRef="Shares">3015885</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2023-03-012024-02-29_us-gaap_WarrantMember"
      decimals="INF"
      id="Fact000745"
      unitRef="Shares">486165</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2024-03-012025-02-28_us-gaap_StockOptionMember"
      decimals="INF"
      id="Fact000747"
      unitRef="Shares">76342</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2023-03-012024-02-29_us-gaap_StockOptionMember"
      decimals="INF"
      id="Fact000748"
      unitRef="Shares">85300</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2024-03-012025-02-28_us-gaap_PreferredStockMember11842375"
      decimals="INF"
      id="Fact000750"
      unitRef="Shares">3109663</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2023-03-012024-02-29_us-gaap_PreferredStockMember11842375"
      decimals="INF"
      id="Fact000751"
      unitRef="Shares">475835</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2024-03-01to2025-02-28"
      decimals="INF"
      id="Fact000753"
      unitRef="Shares">6201890</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2023-03-012024-02-29"
      decimals="INF"
      id="Fact000754"
      unitRef="Shares">1047300</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="From2024-03-01to2025-02-28" id="Fact000756">&lt;p id="xdx_84C_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zhjm7voHXbBg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_86A_z9BMsv76wSO3"&gt;Cash
and Cash Equivalents&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Cash
consists of amounts denominated in USD. The Company has not experienced any losses on such accounts. The Company considers all
highly liquid investments with a maturity of three months or less when purchased to be cash equivalents. There were &lt;span id="xdx_90B_eus-gaap--CashEquivalentsAtCarryingValue_iI_do_c20250228_zuNofbvNxerl" title="Cash equivalents"&gt;&lt;span id="xdx_905_eus-gaap--CashEquivalentsAtCarryingValue_iI_do_c20240229_zQkXA1eQbURh" title="Cash equivalents"&gt;no&lt;/span&gt;&lt;/span&gt; cash equivalents
as of February 28, 2025, or February 29, 2024.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:CashEquivalentsAtCarryingValue
      contextRef="AsOf2025-02-28"
      decimals="0"
      id="Fact000758"
      unitRef="USD">0</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashEquivalentsAtCarryingValue
      contextRef="AsOf2024-02-29"
      decimals="0"
      id="Fact000760"
      unitRef="USD">0</us-gaap:CashEquivalentsAtCarryingValue>
    <NTRP:PrepaidsPolicyTextBlock contextRef="From2024-03-01to2025-02-28" id="Fact000762">&lt;p id="xdx_840_ecustom--PrepaidsPolicyTextBlock_zwgSrGb0Idxj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_865_zDatv27VkZte"&gt;Prepaids&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company records cash paid in advance for goods and/or services to be received in the future as prepaid expenses. Prepaid expenses are
expensed over time according to the terms of the purchase. Other current assets are recognized when it is probable that the future economic
benefits will flow to the Company and the asset has a cost or value that can be measured reliably. It is then charged to expense over
the expected number of periods during which economic benefits will be realized.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</NTRP:PrepaidsPolicyTextBlock>
    <us-gaap:TradeAndOtherAccountsReceivablePolicy contextRef="From2024-03-01to2025-02-28" id="Fact000764">&lt;p id="xdx_849_eus-gaap--TradeAndOtherAccountsReceivablePolicy_zqPgfmpOk2Yi" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_867_zSrcewP8Ripj"&gt;Accounts
Receivable&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Trade
accounts receivable are recorded at the invoiced amount and do not bear interest. The allowance for credit losses is the Company&#x2019;s
best estimate of the amount of probable losses in its existing accounts receivable.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company considers accounts receivable to be fully collectible; accordingly, no allowance for credit losses is required. If amounts
become uncollectible, they will be charged to operations when that determination is made.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Trade
accounts receivable balances as of February 28, 2025 and February 29, 2024, were $&lt;span id="xdx_909_eus-gaap--AccountsReceivableNet_iI_c20250228_zUbjy98GiaXl" title="Accounts receivable"&gt;22,567&lt;/span&gt; and $&lt;span id="xdx_900_eus-gaap--AccountsReceivableNet_iI_c20240229_zcmT867FEce8" title="Accounts receivable"&gt;34,092&lt;/span&gt;, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:TradeAndOtherAccountsReceivablePolicy>
    <us-gaap:AccountsReceivableNet
      contextRef="AsOf2025-02-28"
      decimals="0"
      id="Fact000766"
      unitRef="USD">22567</us-gaap:AccountsReceivableNet>
    <us-gaap:AccountsReceivableNet
      contextRef="AsOf2024-02-29"
      decimals="0"
      id="Fact000768"
      unitRef="USD">34092</us-gaap:AccountsReceivableNet>
    <us-gaap:EquityMethodInvestmentsPolicy contextRef="From2024-03-01to2025-02-28" id="Fact000770">&lt;p id="xdx_841_eus-gaap--EquityMethodInvestmentsPolicy_zabWDYnrzqte" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_863_zrlX5qfCtnlc"&gt;Investments
in Equity Method Investees&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company holds investments in certain entities that are accounted for under the equity method of accounting, as well as investments that
are accounted for under the fair value method pursuant to ASC 321, &#x201c;Investments - Equity Securities.&#x201d; Under the equity method,
investments in entities in which the Company has significant influence, but not control, are initially recognized at cost and adjusted
thereafter to recognize the Company&#x2019;s share of the investees&#x2019; earnings or losses and other comprehensive income.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company determines the existence of significant influence based on various factors, including representation on the investees&#x2019;
board of directors, participation in policy-making processes, and material intercompany transactions.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s equity method investments are evaluated periodically for impairment by assessing whether events or changes in circumstances
indicate that the carrying value of the investment may not be recoverable. When such indicators exist, the Company performs an impairment
test and recognizes an impairment loss to the extent that the carrying amount of the investment exceeds its fair value.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Distributions
received from equity method investees that exceed cumulative earnings recognized by the Company are considered a return of investment
and are recorded as a reduction in the carrying amount of the investment.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Adjustments
resulting from changes in the Company&#x2019;s ownership interest in equity method investees that do not result in a loss of significant
influence are accounted for prospectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:EquityMethodInvestmentsPolicy>
    <NTRP:BasisDifferencePolicyTextBlock contextRef="From2024-03-01to2025-02-28" id="Fact000772">&lt;p id="xdx_84F_ecustom--BasisDifferencePolicyTextBlock_zIre3wqhViVg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_862_zKhnwIT74bZ1"&gt;Basis
Difference&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
accordance with ASC 323, &#x201c;Investments - Equity Method and Joint Ventures,&#x201d; the Company records a basis difference when the
carrying value of its equity method investment differs from its share of the investee&#x2019;s fair value of net assets at the acquisition
date. This basis difference is allocated to the investee&#x2019;s identifiable assets and liabilities based on their fair values. The
amortization of any basis difference related to depreciable assets, such as property, plant, and equipment, is recognized in the Company&#x2019;s
share of the investee&#x2019;s earnings or losses. Any basis difference related to non-depreciable assets, including goodwill, is generally
not amortized, but is subject to impairment testing as necessary.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company assesses the impact of any basis differences on its earnings and the carrying value of its equity method investments. If a basis
difference is determined to exist, the appropriate adjustments are made to reflect the amortization of such differences in the consolidated
financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</NTRP:BasisDifferencePolicyTextBlock>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValuePolicyTextBlock contextRef="From2024-03-01to2025-02-28" id="Fact000774">&lt;p id="xdx_84B_eus-gaap--EquitySecuritiesWithoutReadilyDeterminableFairValuePolicyTextBlock_z70CbGD2sAsc" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_865_ziedsQLI2no4"&gt;Investments
in Equity Securities without Readily Determinable Fair Value&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
accordance with ASC 321-10-35-2, the Company holds certain investments in equity securities in which the Company does not have significant
influence or control, and for which fair value is not readily determinable. These investments are primarily accounted for at cost, less
any impairment. The carrying amount is periodically evaluated for impairment, and if necessary, an impairment loss is recognized in the
statement of operations. These investments are not adjusted for unrealized gains or losses unless an impairment is identified.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValuePolicyTextBlock>
    <us-gaap:EquityMethodInvestmentsIssuancesPolicy contextRef="From2024-03-01to2025-02-28" id="Fact000776">&lt;p id="xdx_84C_eus-gaap--EquityMethodInvestmentsIssuancesPolicy_zWGPIxaV2yFe" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_868_zE55pMyDrGlg"&gt;Equity
in Earnings of Equity Method Investees&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s share of earnings or losses from equity method investees is recognized in the consolidated statement of operations within
&#x201c;Equity in share of loss of equity method investees,&#x201d; net of any related income taxes.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:EquityMethodInvestmentsIssuancesPolicy>
    <us-gaap:FairValueMeasurementPolicyPolicyTextBlock contextRef="From2024-03-01to2025-02-28" id="Fact000778">&lt;p id="xdx_843_eus-gaap--FairValueMeasurementPolicyPolicyTextBlock_zPNgWiw9RGQh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_869_zAp1boL6zgRj"&gt;Fair
Value Measurements&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
fair value of equity method investments is disclosed when available and practical to determine. However, for investments that are not
readily marketable, such as non-public entities, fair value is not typically recognized in the financial statements unless the investment
is impaired.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:FairValueMeasurementPolicyPolicyTextBlock>
    <NTRP:PromissoryNoteReceivablePolicyTextBlock contextRef="From2024-03-01to2025-02-28" id="Fact000780">&lt;p id="xdx_84C_ecustom--PromissoryNoteReceivablePolicyTextBlock_zpvsQAIGfJNc" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Promissory
Note Receivable&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Receivables
from NextPlay under the promissory note as described in &lt;b&gt;NOTE 1 &#x2013; Business Description and Going Concern&lt;/b&gt; were $&lt;span id="xdx_903_eus-gaap--AccountsReceivableNet_iI_c20250228__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--NextPlayTechnologiesIncMember_z1qGJcY8kUE" title="Accounts receivable"&gt;0&lt;/span&gt; and $&lt;span id="xdx_903_eus-gaap--AccountsReceivableNet_iI_c20240229__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--NextPlayTechnologiesIncMember_zoFhIZVRI9Ab" title="Accounts receivable"&gt;1,000,000&lt;/span&gt;
at February 28, 2025 and February 29, 2024, respectively. Pursuant to the terms of the Promissory Note (the &#x201c;NextPlay Note&#x201d;)
between NTH and NextPlay, the NextPlay Note was due and payable in full on the earlier of September 1, 2023 or the date the Company
completed a financing of $&lt;span id="xdx_90E_eus-gaap--NotesPayable_iI_pn6n6_c20230925__us-gaap--BusinessAcquisitionAxis__custom--NextPlayTechnologiesIncMember_zGhg2DJpWydb" title="Notes payable"&gt;10&lt;/span&gt; million or more. No payments have been made by NextPlay, and as such NextPlay is in default under the terms
of the NextPlay Note.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
January 27, 2025, as creditors of NextPlay, Donald P. Monaco, the Company&#x2019;s Chairman, William Kerby, the Company&#x2019;s Chief
Executive Officer, and Ian Sharpe, the Chief Operating Officer of the Company&#x2019;s Media division, filed a petition to force NextPlay
into involuntary bankruptcy as a result of unpaid fees. The proceedings are ongoing and the outcome at this time is uncertain and cannot
be predicted. As a result, management has determined that the collectability of the NextPlay Note is uncertain and has therefore established
an allowance for doubtful accounts for the entire balance of $&lt;span id="xdx_902_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iI_c20250127__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--NextPlayTechnologiesIncMember_z2SRuRsyeQXk" title="Allowance for doubtful accounts"&gt;2,567,665&lt;/span&gt;. Of this amount, $&lt;span id="xdx_908_ecustom--LossOnRelatedPartyReceivable_c20240301__20250228_z7jiBGEHH9Uc" title="Loss on promissory note receivable"&gt;1,000,000&lt;/span&gt; was recorded as of February 28, 2025,
and $&lt;span id="xdx_900_ecustom--LossOnRelatedPartyReceivable_c20230301__20240229_zmIVjrNPV9Lb" title="Loss on promissory note receivable"&gt;1,567,665&lt;/span&gt; was recorded as of February 29, 2024.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</NTRP:PromissoryNoteReceivablePolicyTextBlock>
    <us-gaap:AccountsReceivableNet
      contextRef="AsOf2025-02-28_custom_NextPlayTechnologiesIncMember"
      decimals="0"
      id="Fact000782"
      unitRef="USD">0</us-gaap:AccountsReceivableNet>
    <us-gaap:AccountsReceivableNet
      contextRef="AsOf2024-02-29_custom_NextPlayTechnologiesIncMember"
      decimals="0"
      id="Fact000784"
      unitRef="USD">1000000</us-gaap:AccountsReceivableNet>
    <us-gaap:NotesPayable
      contextRef="AsOf2023-09-25_custom_NextPlayTechnologiesIncMember"
      decimals="-6"
      id="Fact000786"
      unitRef="USD">10000000</us-gaap:NotesPayable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="AsOf2025-01-27_custom_NextPlayTechnologiesIncMember"
      decimals="0"
      id="Fact000788"
      unitRef="USD">2567665</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <NTRP:LossOnRelatedPartyReceivable
      contextRef="From2024-03-01to2025-02-28"
      decimals="0"
      id="Fact000790"
      unitRef="USD">1000000</NTRP:LossOnRelatedPartyReceivable>
    <NTRP:LossOnRelatedPartyReceivable
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact000792"
      unitRef="USD">1567665</NTRP:LossOnRelatedPartyReceivable>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock contextRef="From2024-03-01to2025-02-28" id="Fact000794">&lt;p id="xdx_84A_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_z8czT4zfswHh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_86F_z6yCU0h8ggla"&gt;Property
and Equipment&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Recognition
and measurement&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Items
of property and equipment are measured at cost, less accumulated depreciation and accumulated impairment losses. When parts of an item
of property and equipment have different estimated useful lives, they are accounted for as separate items within property and equipment.
The costs of the ongoing regular repairs and maintenance of property and equipment are recognized in the period in which they are incurred.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Depreciation&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Depreciation
is recognized in profit or loss over the estimated useful lives of each part of an item of property and equipment in a manner that most
closely reflects management&#x2019;s estimated future consumption of the future economic benefits embodied in the asset. The estimated
useful lives for the Company&#x2019;s property and equipment are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89A_ecustom--ScheduleOfEstimatedUsefulLivesForPropertyAndEquipmentTableTextBlock_z5CB4ZAtqjM7" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span style="display: none"&gt;&lt;span id="xdx_8BB_zz2yIF2XvmHl"&gt;Schedule
of Estimated
Useful Lives for Property and Equipment&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Category&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Method&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Estimated
    useful life&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Furniture
    &amp;amp; Fixtures&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Straight
    line&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_909_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20250228__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zvTl2fGZ8Eof" title="Estimated useful life"&gt;5&lt;/span&gt;
    years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Computer
    &amp;amp; Equipment&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Straight
    line&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90D_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20250228__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_zUaXzpeVFOQf" title="Estimated useful life"&gt;3&lt;/span&gt;
    years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8A6_zYReKKJGarnl" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <NTRP:ScheduleOfEstimatedUsefulLivesForPropertyAndEquipmentTableTextBlock contextRef="From2024-03-01to2025-02-28" id="Fact000796">&lt;p id="xdx_89A_ecustom--ScheduleOfEstimatedUsefulLivesForPropertyAndEquipmentTableTextBlock_z5CB4ZAtqjM7" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span style="display: none"&gt;&lt;span id="xdx_8BB_zz2yIF2XvmHl"&gt;Schedule
of Estimated
Useful Lives for Property and Equipment&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Category&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Method&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Estimated
    useful life&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Furniture
    &amp;amp; Fixtures&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Straight
    line&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_909_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20250228__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zvTl2fGZ8Eof" title="Estimated useful life"&gt;5&lt;/span&gt;
    years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Computer
    &amp;amp; Equipment&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Straight
    line&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90D_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20250228__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_zUaXzpeVFOQf" title="Estimated useful life"&gt;3&lt;/span&gt;
    years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</NTRP:ScheduleOfEstimatedUsefulLivesForPropertyAndEquipmentTableTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="AsOf2025-02-28_us-gaap_FurnitureAndFixturesMember"
      id="Fact000798">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="AsOf2025-02-28_us-gaap_ComputerEquipmentMember"
      id="Fact000800">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:IntangibleAssetsFiniteLivedPolicy contextRef="From2024-03-01to2025-02-28" id="Fact000802">&lt;p id="xdx_84F_eus-gaap--IntangibleAssetsFiniteLivedPolicy_zDoeSolb4H5g" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_86D_z5mvFUmsmmdh"&gt;Intangible
assets&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company measures separately acquired intangible assets at cost, less accumulated amortization and impairment losses. The Company recognizes
internally developed intangible assets when it has determined that the completion of such is technically feasible, and the Company has
sufficient resources to complete the development. Subsequent expenditures are capitalized when they increase the future economic benefits
of the associated asset. All other expenditures are recorded in profit or loss as incurred.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company assesses whether the life of intangible asset is finite or indefinite. The Company reviews the amortization method and period
of use of its intangible assets at least annually. Changes in the expected useful life or period of consumption of future economic benefits
associated with the asset are accounted for prospectively by changing the amortization method or period as a change in accounting estimates
in profit or loss. The Company has assessed the useful life of its trademarks as indefinite.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_891_ecustom--ScheduleOfEstimatedUsefulLivesForFiniteLifeIntangibleAssetsTableTextBlock_zX9Gyyi62dK9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
estimated useful lives for the Company&#x2019;s finite life intangible assets are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B8_zqdpJQVrfANf" style="display: none"&gt;Schedule
of Estimated
Useful Lives for Finite Life Intangible Assets&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Category&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Method&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Estimated
    useful life&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Software&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Straight
    line&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_909_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20250228__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SoftwareMember__srt--RangeAxis__srt--MinimumMember_zAPO9167w9ai" title="Estimated useful life"&gt;1&lt;/span&gt;
    - &lt;span id="xdx_909_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20250228__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SoftwareMember__srt--RangeAxis__srt--MaximumMember_zv66dkLsEoxe" title="Estimated useful life"&gt;3&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Software
    licenses&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Straight
    line&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90D_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20250228__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SoftwareLicensesMember__srt--RangeAxis__srt--MinimumMember_zfNu07ETVGUi" title="Estimated useful life"&gt;0.5&lt;/span&gt;
    - &lt;span id="xdx_902_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20250228__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SoftwareLicensesMember__srt--RangeAxis__srt--MaximumMember_zPU8KANFDz6l" title="Estimated useful life"&gt;4&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8AA_zrmr4KOowcch" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:IntangibleAssetsFiniteLivedPolicy>
    <NTRP:ScheduleOfEstimatedUsefulLivesForFiniteLifeIntangibleAssetsTableTextBlock contextRef="From2024-03-01to2025-02-28" id="Fact000804">&lt;p id="xdx_891_ecustom--ScheduleOfEstimatedUsefulLivesForFiniteLifeIntangibleAssetsTableTextBlock_zX9Gyyi62dK9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
estimated useful lives for the Company&#x2019;s finite life intangible assets are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B8_zqdpJQVrfANf" style="display: none"&gt;Schedule
of Estimated
Useful Lives for Finite Life Intangible Assets&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Category&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Method&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Estimated
    useful life&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Software&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Straight
    line&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_909_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20250228__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SoftwareMember__srt--RangeAxis__srt--MinimumMember_zAPO9167w9ai" title="Estimated useful life"&gt;1&lt;/span&gt;
    - &lt;span id="xdx_909_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20250228__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SoftwareMember__srt--RangeAxis__srt--MaximumMember_zv66dkLsEoxe" title="Estimated useful life"&gt;3&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Software
    licenses&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Straight
    line&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90D_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20250228__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SoftwareLicensesMember__srt--RangeAxis__srt--MinimumMember_zfNu07ETVGUi" title="Estimated useful life"&gt;0.5&lt;/span&gt;
    - &lt;span id="xdx_902_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20250228__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SoftwareLicensesMember__srt--RangeAxis__srt--MaximumMember_zPU8KANFDz6l" title="Estimated useful life"&gt;4&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</NTRP:ScheduleOfEstimatedUsefulLivesForFiniteLifeIntangibleAssetsTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="AsOf2025-02-28_custom_SoftwareMember_srt_MinimumMember"
      id="Fact000806">P1Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="AsOf2025-02-28_custom_SoftwareMember_srt_MaximumMember"
      id="Fact000808">P3Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="AsOf2025-02-28_custom_SoftwareLicensesMember_srt_MinimumMember"
      id="Fact000810">P0Y6M</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="AsOf2025-02-28_custom_SoftwareLicensesMember_srt_MaximumMember"
      id="Fact000812">P4Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:InternalUseSoftwarePolicy contextRef="From2024-03-01to2025-02-28" id="Fact000814">&lt;p id="xdx_84F_eus-gaap--InternalUseSoftwarePolicy_zPKn11aVP3Sg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_864_zS1UUutOsNbd"&gt;Software
Development Costs&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company capitalizes internal software development costs subsequent to establishing technological feasibility of a software application
in accordance with guidelines established by &#x201c;ASC 985-20-25&#x201d; Accounting for the Costs of Software to Be Sold, Leased, or
Otherwise Marketed, requiring certain software development costs to be capitalized upon the establishment of technological feasibility.
The establishment of technological feasibility and the ongoing assessment of the recoverability of these costs require considerable judgment
by management with respect to certain external factors such as anticipated future revenue, estimated economic life, and changes in software
and hardware technologies. Amortization of the capitalized software development costs begins when the product is available for general
release to customers. Capitalized costs are amortized based on the straight-line method over the remaining estimated economic life of
the product.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:InternalUseSoftwarePolicy>
    <us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsPolicy contextRef="From2024-03-01to2025-02-28" id="Fact000816">&lt;p id="xdx_849_eus-gaap--GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_z6Yc1kBv10E4" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_863_zmgLD6BsuqJk"&gt;Impairment
of Intangible Assets&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
accordance with ASC 350-30-65 &#x201c;Goodwill and Other Intangible Assets&#x201d;, the Company assesses the impairment of identifiable
intangible assets whenever events or changes in circumstances indicate that the carrying value may not be recoverable. Factors the Company
considers important, which could trigger an impairment review include the following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1.
Significant underperformance compared to historical or projected future operating results.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2.
Significant changes in the manner or use of the acquired assets or the strategy for the overall business, and&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3.
Significant negative industry or economic trends.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;When
the Company determines that the carrying value of an intangible asset may not be recoverable based upon the existence of one or more
of the above indicators of impairment and the carrying value of the asset cannot be recovered from projected undiscounted cash flows,
the Company records an impairment charge. The Company measures any impairment based on a projected discounted cash flow method using
a discount rate determined by management to be commensurate with the risk inherent to the current business model. Significant management
judgment is required in determining whether an indicator of impairment exists and in projecting cash flows. Intangible assets that have
finite useful lives are amortized over their useful lives.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsPolicy>
    <us-gaap:LesseeLeasesPolicyTextBlock contextRef="From2024-03-01to2025-02-28" id="Fact000818">&lt;p id="xdx_84F_eus-gaap--LesseeLeasesPolicyTextBlock_zCLGhnMfxjwa" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_86A_zflz7TQmjQ8k"&gt;Leases&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company adopted ASU 2016-02 (Topic ASC 842) Leases, which requires a lessee to recognize a lease asset and a leases liability for operating
leases arrangements greater than twelve (12) months.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;We
determine if an arrangement is a lease at inception. Operating leases are included in operating lease right-of-use (&#x201c;ROU&#x201d;)
assets, operating lease liabilities - current, and operating lease liabilities - noncurrent on the balance sheets.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;ROU
assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease
payments arising from the lease. Operating lease ROU assets and liabilities are recognized at commencement date based on the present
value of lease payments over the lease term. As most of our leases do not provide an implicit rate, we generally use our incremental
borrowing rate based on the estimated rate of interest for collateralized borrowing over a similar term of the lease payments at commencement
date. The operating lease ROU asset also includes any lease payments made and excludes lease incentives. Our lease terms may include
options to extend or terminate the lease when it is reasonably certain that we will exercise that option. Lease expense for lease payments
is recognized on a straight-line basis over the lease term.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:LesseeLeasesPolicyTextBlock>
    <us-gaap:PriorPeriodReclassificationAdjustmentDescription contextRef="From2024-03-01to2025-02-28" id="Fact000820">&lt;p id="xdx_845_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zs0xXffHlI4j" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_861_zQFg4hltGIxf"&gt;Reclassification&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Certain
prior year amounts have been reclassified to conform to the current period presentation. These reclassifications had no impact on the
net earnings (loss) or financial position.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:PriorPeriodReclassificationAdjustmentDescription>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy contextRef="From2024-03-01to2025-02-28" id="Fact000822">&lt;p id="xdx_84C_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zYUEOLk4dVve" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_868_zgeN1xwJDHX"&gt;Fair
Value of Financial Instruments&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company follows accounting guidelines on fair value measurements for financial instruments measured on a recurring basis, as well as
for certain assets and liabilities that are initially recorded at their estimated fair values. Fair Value is defined as the exit price,
or the amount that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants
as the measurement date. The Company uses the following three-level hierarchy that maximizes the use of observable inputs and minimizes
the use of unobservable inputs to value its financial instruments:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;
    &lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
    1: Observable inputs such as unadjusted quoted prices in active markets for identical instruments.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;
    &lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
    2: Quoted prices for similar instruments that are directly or indirectly observable in the marketplace.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;
    &lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
    3: Significant unobservable inputs which are supported by little or no market activity and that are financial instruments whose values
    are determined using pricing models, discounted cash flow methodologies, or similar techniques, as well as instruments for which
    the determination of fair value requires a significant judgment or estimation.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Financial
instruments measured at fair value are classified in their entirety based on the lowest level of input that is significant to the fair
value measurement. The Company&#x2019;s assessment of the significance of a particular input to the fair value measurement in its entirety
requires it to make judgments and consider factors specific to the asset or liability. The use of different assumptions and/or estimation
methodologies may have a material effect on estimated fair values. Accordingly, the fair value estimates disclosed, or initial amounts
recorded may not be indicative of the amount that the Company or holders of the instruments could realize in a current market exchange.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
carrying amounts of the Company&#x2019;s financial instruments including cash, accounts receivable, accounts payable, accrued expenses,
convertible notes and notes payable are of approximately fair value due to the short-term maturities of these instruments.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <us-gaap:MarketRiskBenefitPolicyTextBlock contextRef="From2024-03-01to2025-02-28" id="Fact000824">&lt;p id="xdx_848_eus-gaap--MarketRiskBenefitPolicyTextBlock_zmy8rbwcLTdf" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_868_zxjb70IvPBf5"&gt;Concentration
of Credit Risk &lt;/span&gt;-&lt;/b&gt; The Company maintains its cash in bank deposit accounts, which, at times, may exceed federally insured limits. The
Company has not experienced any losses in such accounts and believes it is not exposed to any significant credit risk on its cash and
cash equivalents.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:MarketRiskBenefitPolicyTextBlock>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy contextRef="From2024-03-01to2025-02-28" id="Fact000826">&lt;p id="xdx_849_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_z3Mq8xR32Ov9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: -0.9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_86A_zGMWX7TRgG6f"&gt;Stock
Based Compensation&lt;/span&gt;&lt;/b&gt; &#x2013; The Company recognizes compensation costs to employees under ASC Topic No. 718, &#x201c;Compensation &#x2013;
Stock Compensation.&#x201d; Under ASC Topic No. 718, companies are required to measure the compensation costs of share-based compensation
arrangements based on the grant-date fair value and recognize the costs in the financial statements over the period during which employees
are required to provide services. Share based compensation arrangements may include stock options, grants of shares of common stock with
and without restrictions, performance-based awards, share appreciation rights and employee share purchase plans. As such, compensation
cost is measured on the date of grant at its fair value. Such compensation amounts, if any, are amortized over the respective vesting
periods of the option or stock grants.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: -0.9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Equity
instruments issued to non-employees are recorded on the basis of the fair value of the instruments, as required by ASC Topic No. 718.
In general, the measurement date is either (a) when a performance commitment, as defined, is reached or (b) the earlier of the date that
(i) the non-employee performance requirement is complete or (ii) the instruments are vested. The measured value related to the instruments
is recognized over a period based on the facts and circumstances of each particular grant as defined in the FASB Accounting Standards
Codification.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock contextRef="From2024-03-01to2025-02-28" id="Fact000828">&lt;p id="xdx_844_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_zrdm3uMmNHhg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_86E_z1a64sRD73ic"&gt;Revenue
Recognition&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company recognizes revenue in accordance with ASC Topic No. 606. In May 2014, the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) issued
Accounting Standards Update (&#x201c;ASU&#x201d;) No. 2014-09, &lt;i&gt;Revenue from Contracts with Customers&lt;/i&gt;. ASU 2014-09 is a comprehensive revenue recognition
standard that superseded nearly all existing revenue recognition guidance under prior GAAP and replaced it with a principles-based
approach for determining revenue recognition. The core principle of the standard is the recognition of revenue upon the transfer of promised
goods or services to customers in an amount that reflects the consideration to which the company expects to be entitled in exchange for
those goods or services. In general, we determine revenue recognition by: (1) identifying the contract, or contracts, with our customer;
(2) identifying the performance obligations in the contract; (3) determining the transaction price; (4) allocating the transaction price
to performance obligations in the contract; and (5) recognizing revenue when, or as, we satisfy performance obligations by transferring
the promised goods or services.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company recognizes revenue when the customer has purchased the product, the occurrence of the earlier of date of travel and the date of
cancellation has expired, as satisfaction of the performance obligation, the sales price is fixed or determinable and collectability
is reasonably assured. Revenue for customer travel packages purchased directly from the Company are recorded gross (the amount paid to
the Company by the customer is shown as revenue and the cost of providing the respective travel package is recorded to cost of revenues).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company generates revenues from sales directly to customers as well as through other distribution channels of tours and activities at
destinations throughout the world.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company controls the specified travel product before it is transferred to the customer and is therefore a principal, based on but not
limited to, the following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;
    &lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
    Company is primarily responsible for fulling the promise to provide such travel product.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;
    &lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
    Company has inventory risk before the specified travel product has been transferred to a customer or after transfer of control to
    a customer.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;
    &lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
    Company has discretion in establishing the price for the specified travel product.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Payments
for tours or activities received in advance of services being rendered are recorded as deferred revenue and recognized as revenue at
the earlier of the date of travel or the last date of cancellation (i.e., the customer&#x2019;s refund privileges lapse).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
    <us-gaap:SellingGeneralAndAdministrativeExpensesPolicyTextBlock contextRef="From2024-03-01to2025-02-28" id="Fact000830">&lt;p id="xdx_84D_eus-gaap--SellingGeneralAndAdministrativeExpensesPolicyTextBlock_zJTtpSias568" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_86F_zQ3fcJCgU2ec"&gt;Sales
and Marketing&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Selling
and marketing expenses consist primarily of marketing and promotional expenses, expenses related to our participation in industry
conferences, and public relations expenses.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Sales
and marketing expenses are charged to expense as incurred and are included in selling and promotions expenses in the accompanying consolidated
financial statements. Sales and marketing expense for the years ended February 28, 2025 and February 29, 2024 was $&lt;span id="xdx_907_eus-gaap--SellingAndMarketingExpense_c20240301__20250228_z6vgQuzeHCol" title="Sales and marketing expense"&gt;307,166&lt;/span&gt; and $&lt;span id="xdx_905_eus-gaap--SellingAndMarketingExpense_c20230301__20240229_z4jYH9fDJYtb" title="Sales and marketing expense"&gt;484,250&lt;/span&gt;,
respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:SellingGeneralAndAdministrativeExpensesPolicyTextBlock>
    <us-gaap:SellingAndMarketingExpense
      contextRef="From2024-03-01to2025-02-28"
      decimals="0"
      id="Fact000832"
      unitRef="USD">307166</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact000834"
      unitRef="USD">484250</us-gaap:SellingAndMarketingExpense>
    <us-gaap:IncomeTaxPolicyTextBlock contextRef="From2024-03-01to2025-02-28" id="Fact000836">&lt;p id="xdx_84B_eus-gaap--IncomeTaxPolicyTextBlock_zgwGOWd6ekvk" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_86E_zNUHheJDSJmc"&gt;Income
Taxes&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company accounts for income taxes in accordance with ASC Topic No. 740, &#x201c;Accounting for Income Taxes.&#x201d;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Income
taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences
attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective
tax bases and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected
to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred
tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. A valuation
allowance on deferred tax assets is established when management considers it is more likely than not that some portion or all of the
deferred tax assets will not be realized.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Tax
benefits from an uncertain tax position are only recognized if it is more likely than not that the tax position will be sustained on
examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in the consolidated
financial statements from such a position are measured based on the largest benefit that has a greater than fifty percent likelihood
of being realized upon ultimate resolution. Interest and penalties related to unrecognized tax benefits are recorded as incurred as a
component of income tax expense. The Company has not recognized any tax benefits from uncertain tax positions for any of the reporting
periods presented.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company had no tax positions at February 28, 2025 or 2024 for which the ultimate deductibility was highly uncertain but for which there
was uncertainty about the timing of such deductibility.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company recognizes interest accrued related to unrecognized tax benefits in interest expense and penalties in operating expenses.
During the years ended February 28, 2025 and February 29, 2024, the Company recognized no interest and penalties. All tax returns
for years starting with 2021 and thereafter remain open for examination by the IRS.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="From2024-03-01to2025-02-28" id="Fact000838">&lt;p id="xdx_849_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zAjDLPXRefc6" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_86D_zo0lewsivXQl"&gt;Recently
adopted accounting pronouncements&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
July 2023, the FASB issued ASU 2023-03, Presentation of Financial Statements (Topic 205), Income Statement&#x2014;Reporting Comprehensive
Income (Topic 220), Distinguishing Liabilities from Equity (Topic 480), Equity (Topic 505), and Compensation&#x2014;Stock Compensation
(Topic 718). The FASB Issued this ASU to amend and align various SEC paragraphs within the Codification with interpretive guidance recently
issued by the Securities and Exchange Commission (SEC). Specifically, this update codifies the guidance from SEC Staff Accounting Bulletin
(SAB) No. 120, which clarifies the application of ASC 718 &#x2013; Compensation&#x2014;Stock Compensation to certain share-based payment
arrangements. SAB No. 120 was issued in response to concerns about so-called &#x201c;spring-loaded&#x201d; awards &#x2014; share-based compensation
arrangements granted shortly before the release of material nonpublic information (MNPI) that is expected to significantly affect the
market price of the issuer&#x2019;s stock. SAB No. 120 does not change the fundamental measurement principles of ASC 718, but it emphasizes
the requirement to include the impact of MNPI in estimating fair value at the grant date when it is reasonable to expect that such information
would be factored into the pricing by a market participant. Under ASC 718, entities must measure the grant-date fair value of equity-classified
awards using an option-pricing model and inputs that reflect assumptions a market participant would make. SAB No. 120 reinforces that
this includes: (i) adjusting expected volatility or stock price to reflect the anticipated impact of MNPI; (ii) documenting the rationale
for assumptions that do not reflect such information, if applicable; and (3) ensuring internal control processes capture relevant information
in determining grant-date fair value. The Company adopted ASU 2023-03 effective January 1, 2024. In conjunction with this adoption, the
Company reviewed its stock compensation grant practices and valuation procedures under ASC 718. While the Company has not historically
granted awards in close proximity to the release of MNPI, it has updated its internal controls to require additional documentation and
review for any future awards that may be subject to this scenario. The adoption of ASU 2023-03 did not result in any changes to the recognition
or measurement of share-based payment expense in the Company&#x2019;s consolidated financial statements. However, the Company enhanced
its internal controls around the timing and valuation of equity awards to ensure compliance with the interpretive guidance of SAB No.
120 and ASC 718.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
November 2023, the FASB issued ASU 2023-07 to improve disclosures about a public entity&#x2019;s reportable segments and address investor
feedback for greater transparency. The amendments are intended to enhance the usefulness of segment information, particularly regarding
expenses, by requiring more detailed disclosures and expanding the scope of interim disclosures. The Company adopted ASU 2023-07 for
its fiscal year beginning March 1, 2024 (i.e., for the fiscal year ending February 28, 2025), as required. The amendments require entities
to disclose, on an annual and interim basis: (i) significant segment expenses that are regularly provided to the chief operating decision
maker (&#x201c;CODM&#x201d;); (ii) an explanation of how reported segment profit or loss is measured, (ii) The title and position of the CODM; (iii)
a description of how the CODM uses reported measures in decision-making; and (iv) expanded disclosures of segment information in interim
periods, consistent with annual disclosures.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;We
manage the Company as one reportable segment, Travel Products and Services. Travel bookings are the source of our revenues and include
the sale of travel products such as airline tickets and hotel rooms as well as travel services such as travel insurance and ground activities.
The segment information aligns with how the Company&#x2019;s CODM reviews and manages our
business. The Company&#x2019;s CODM is the Company&#x2019;s Chief Executive Officer.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Financial
information and annual operating plans and forecasts are prepared and are reviewed by the CODM at a consolidated level. The CODM assesses
performance for the Travel Products and Services segment and decides how to allocate resources based on revenue and net income that is
reported on the Consolidated Statements of Operations. The Company&#x2019;s objective in making resource allocation decisions is to optimize
the financial results. The accounting policies of our Travel Products and Services segment are the same as those described in the summary
of significant accounting policies herein.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
our single reportable segment-level financial information, total assets, and significant non-cash transactions, see the Financial Statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <NTRP:RecentlyIssuedAccountingPronouncementsNotYetAdoptedPolicyTextBlock contextRef="From2024-03-01to2025-02-28" id="Fact000840">&lt;p id="xdx_84D_ecustom--RecentlyIssuedAccountingPronouncementsNotYetAdoptedPolicyTextBlock_zTPCxbe6xR06" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_866_zgwQwVdwKsR9"&gt;Recently
issued accounting pronouncements not yet adopted&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
December 2023, the FASB issued ASU 2023-09, &lt;i&gt;Income Taxes (Topic 740): Improvements to Income
Tax Disclosures&lt;/i&gt;, to enhance the transparency and decision-usefulness of income tax information provided to investors. The amendments
focus primarily on expanding the disclosures related to the effective tax rate reconciliation and income taxes paid. Key provisions of
the update include: (i) enhanced disclosure of the effective tax rate reconciliation, using both standardized categories and quantitative
disclosure of individual reconciling items that meet specified thresholds; (ii) required disaggregation of income taxes paid, by federal,
state, and significant foreign jurisdictions; (iii) additional qualitative disclosures about tax-related assumptions and estimation methodologies.
ASU 2023-09 is effective for public business entities for annual periods beginning after December 15, 2024. As a result, the Company
will adopt the standard for its fiscal year beginning March 1, 2025 (ending February 28, 2026). Early adoption is permitted; however,
the Company does not intend to early adopt. The Company is currently evaluating the impact of the new standard on its income tax footnote
disclosures. The adoption is not expected to have an impact on the Company&#x2019;s consolidated financial position, results of operations,
or cash flows, but it will result in expanded and more detailed income tax disclosures beginning in fiscal 2026.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has considered all other recently issued accounting pronouncements and does not believe the adoption of such pronouncements will
have a material impact on its consolidated financial statements.&lt;/span&gt;&lt;/p&gt;

</NTRP:RecentlyIssuedAccountingPronouncementsNotYetAdoptedPolicyTextBlock>
    <us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock contextRef="From2024-03-01to2025-02-28" id="Fact000842">&lt;p id="xdx_803_eus-gaap--DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_zc6Ec27lkNVg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
3 &#x2013; &lt;span id="xdx_820_zjAQlsGaqkYc"&gt;Discontinued Operations&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
the fiscal year ended February 29, 2024, the Company completed the sale of certain legacy assets of Sigma,
which has been classified as discontinued operations in accordance with ASC 205-20, &#x201c;Presentation of Financial Statements
&#x2013; Discontinued Operations.&#x201d;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
October 6, 2023, the Company entered into a definitive asset purchase agreement (the &#x201c;Divergent Agreement&#x201d;) with Divergent Technologies,
Inc. (&#x201c;Divergent&#x201d;), pursuant to which the Company agreed to sell to Divergent, and Divergent agreed to purchase from
us, certain assets consisting primarily of patents, software code and other intellectual property for a purchase price of $&lt;span id="xdx_907_eus-gaap--PaymentsToAcquireIntangibleAssets_c20231006__20231006__us-gaap--TypeOfArrangementAxis__custom--AssetPurchaseAgreementMember__dei--LegalEntityAxis__custom--DivergentTechnologiesIncMember_zoTShA3T5C7g" title="Purchase price"&gt;1,626,242&lt;/span&gt;,
including a $&lt;span id="xdx_90B_ecustom--EarnestMoneyDeposit_iI_c20231006__us-gaap--TypeOfArrangementAxis__custom--AssetPurchaseAgreementMember__dei--LegalEntityAxis__custom--DivergentTechnologiesIncMember_zp3ut5lOt7ud" title="Earnest money deposit"&gt;37,000&lt;/span&gt;
earnest-money deposit previously paid to us by Divergent. The closing under the Divergent Agreement occurred subsequent to the
closing of the reverse acquisition with NTH on January 12, 2024. The parties&#x2019; respective obligations to close were
subject to the accuracy of the parties&#x2019; respective representations and warranties and performance of their respective
covenants and satisfaction or waiver of other customary conditions specified in the Divergent Agreement. In the interim,
between the signing date and closing date or termination of the Divergent Agreement, the Company granted Divergent a non-exclusive,
nontransferable, non-sublicensable (except to Divergent customers and affiliates), limited, irrevocable (except in connection with
the termination of the Divergent Agreement), worldwide, royalty-free license to the &#x201c;Licensed IP&#x201d; (as defined therein) for
testing, evaluation, and commercialization purposes. A gain of $&lt;span id="xdx_908_eus-gaap--GainLossOnDispositionOfAssets1_c20231006__20231006__us-gaap--TypeOfArrangementAxis__custom--AssetPurchaseAgreementMember__dei--LegalEntityAxis__custom--DivergentTechnologiesIncMember_z29KsoyPT2Yj" title="Loss on disposal of assets"&gt;30,515 &lt;/span&gt;was
recognized in the asset disposition transaction.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
the year ended February 28, 2025, the Company recorded a gain of $&lt;span id="xdx_90B_eus-gaap--IncomeLossFromDiscontinuedOperationsNetOfTax_c20240301__20250228_znCJ5QuEoQd4" title="Loss of discontinued operations"&gt;8,344&lt;/span&gt; from discontinued operations as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_894_eus-gaap--ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_zFCh736E4fIa" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;span id="xdx_8B1_zhPTT6uD6F5e" style="display: none"&gt;Schedule
of Discontinued Operations&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_495_20240301__20250228_zIpCboDEeHp3" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;February 28,&lt;/p&gt;
                                                                               &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;2025&lt;/p&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--DisposalGroupIncludingDiscontinuedOperationRevenue_maDGIDOzv4w_zShvCX8ho5Rl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 78%"&gt;Revenue&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right"&gt;14,731&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold_msDGIDOzv4w_zJf2TzTzn1Q3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;Cost of revenue&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0856"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss_iT_mtDGIDOzv4w_maDGIDOzv2d_zzYmXroHjHW2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"&gt;Gross profit&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;14,731&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_ecustom--DisposalGroupIncludingDiscontinuedOperationsProfessionalServices_maDGIDOzcGq_zZbST1Jw89Fh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Professional services&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;4,163&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--DisposalGroupIncludingDiscontinuedOperationsInvestorRelationsServices_maDGIDOzcGq_zTrEix5zyql" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Investor relations services&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;4,194&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--DisposalGroupIncludingDiscontinuedOperationsOtherIncome_maDGIDOzcGq_zF8I0kVGhYR6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"&gt;Other income&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(1,970&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--DisposalGroupIncludingDiscontinuedOperationOperatingExpense_iT_mtDGIDOzcGq_msDGIDOzv2d_zYuvubvD1yHg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"&gt;Total Expenses&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;6,387&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--IncomeLossFromDiscontinuedOperationsNetOfTax_iT_mtDGIDOzv2d_zENYlBZnkdX8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"&gt;Gain from Discontinued Operations&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;8,344&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A5_zV0vEq8nfgE3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock>
    <us-gaap:PaymentsToAcquireIntangibleAssets
      contextRef="From2023-10-062023-10-06_custom_AssetPurchaseAgreementMember_custom_DivergentTechnologiesIncMember"
      decimals="0"
      id="Fact000844"
      unitRef="USD">1626242</us-gaap:PaymentsToAcquireIntangibleAssets>
    <NTRP:EarnestMoneyDeposit
      contextRef="AsOf2023-10-06_custom_AssetPurchaseAgreementMember_custom_DivergentTechnologiesIncMember"
      decimals="0"
      id="Fact000846"
      unitRef="USD">37000</NTRP:EarnestMoneyDeposit>
    <us-gaap:GainLossOnDispositionOfAssets1
      contextRef="From2023-10-062023-10-06_custom_AssetPurchaseAgreementMember_custom_DivergentTechnologiesIncMember"
      decimals="0"
      id="Fact000848"
      unitRef="USD">30515</us-gaap:GainLossOnDispositionOfAssets1>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="From2024-03-01to2025-02-28"
      decimals="0"
      id="Fact000850"
      unitRef="USD">8344</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock contextRef="From2024-03-01to2025-02-28" id="Fact000852">&lt;p id="xdx_894_eus-gaap--ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_zFCh736E4fIa" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;span id="xdx_8B1_zhPTT6uD6F5e" style="display: none"&gt;Schedule
of Discontinued Operations&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_495_20240301__20250228_zIpCboDEeHp3" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;February 28,&lt;/p&gt;
                                                                               &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;2025&lt;/p&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--DisposalGroupIncludingDiscontinuedOperationRevenue_maDGIDOzv4w_zShvCX8ho5Rl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 78%"&gt;Revenue&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right"&gt;14,731&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold_msDGIDOzv4w_zJf2TzTzn1Q3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;Cost of revenue&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0856"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss_iT_mtDGIDOzv4w_maDGIDOzv2d_zzYmXroHjHW2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"&gt;Gross profit&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;14,731&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_ecustom--DisposalGroupIncludingDiscontinuedOperationsProfessionalServices_maDGIDOzcGq_zZbST1Jw89Fh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Professional services&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;4,163&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--DisposalGroupIncludingDiscontinuedOperationsInvestorRelationsServices_maDGIDOzcGq_zTrEix5zyql" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Investor relations services&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;4,194&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--DisposalGroupIncludingDiscontinuedOperationsOtherIncome_maDGIDOzcGq_zF8I0kVGhYR6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"&gt;Other income&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(1,970&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--DisposalGroupIncludingDiscontinuedOperationOperatingExpense_iT_mtDGIDOzcGq_msDGIDOzv2d_zYuvubvD1yHg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"&gt;Total Expenses&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;6,387&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--IncomeLossFromDiscontinuedOperationsNetOfTax_iT_mtDGIDOzv2d_zENYlBZnkdX8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"&gt;Gain from Discontinued Operations&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;8,344&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue
      contextRef="From2024-03-01to2025-02-28"
      decimals="0"
      id="Fact000854"
      unitRef="USD">14731</us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss
      contextRef="From2024-03-01to2025-02-28"
      decimals="0"
      id="Fact000858"
      unitRef="USD">14731</us-gaap:DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss>
    <NTRP:DisposalGroupIncludingDiscontinuedOperationsProfessionalServices
      contextRef="From2024-03-01to2025-02-28"
      decimals="0"
      id="Fact000860"
      unitRef="USD">4163</NTRP:DisposalGroupIncludingDiscontinuedOperationsProfessionalServices>
    <NTRP:DisposalGroupIncludingDiscontinuedOperationsInvestorRelationsServices
      contextRef="From2024-03-01to2025-02-28"
      decimals="0"
      id="Fact000862"
      unitRef="USD">4194</NTRP:DisposalGroupIncludingDiscontinuedOperationsInvestorRelationsServices>
    <NTRP:DisposalGroupIncludingDiscontinuedOperationsOtherIncome
      contextRef="From2024-03-01to2025-02-28"
      decimals="0"
      id="Fact000864"
      unitRef="USD">-1970</NTRP:DisposalGroupIncludingDiscontinuedOperationsOtherIncome>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingExpense
      contextRef="From2024-03-01to2025-02-28"
      decimals="0"
      id="Fact000866"
      unitRef="USD">6387</us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingExpense>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="From2024-03-01to2025-02-28"
      decimals="0"
      id="Fact000868"
      unitRef="USD">8344</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:EquityMethodInvestmentsDisclosureTextBlock contextRef="From2024-03-01to2025-02-28" id="Fact000870">&lt;p id="xdx_80D_eus-gaap--EquityMethodInvestmentsDisclosureTextBlock_zbW1I4veE0f2" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
4 - &lt;span id="xdx_82A_zRyuxxMKdLBf"&gt;Investment in Equity Method Investee&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Membership
Purchase Agreement with FSA Travel, LLC&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
February 6, 2025, the Company entered into a Membership Purchase Agreement (the &#x201c;FSA Purchase Agreement&#x201d;) with FSA
Travel, LLC (&#x201c;FSA&#x201d;). Under the terms of the FSA Purchase Agreement, the Company acquired an initial &lt;span id="xdx_90B_eus-gaap--EquityOwnershipPercentageExcludingConsolidatedEntityAndEquityMethodInvestee_iI_pid_dp_uPure_c20250206__us-gaap--TypeOfArrangementAxis__custom--MembershipPurchaseAgreementMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--FSATravelLLCMember_zEcBTYA2ex1a"&gt;49&lt;/span&gt;%
membership interest in FSA for a total of $&lt;span id="xdx_90C_eus-gaap--BusinessAcquisitionPreacquisitionContingencyAmountOfSettlement_iI_c20250206__us-gaap--TypeOfArrangementAxis__custom--MembershipPurchaseAgreementMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--FSATravelLLCMember_zSsW0K191t04" title="Business acquisition amount"&gt;1,000,000&lt;/span&gt;.
The acquisition consideration consisted of $&lt;span id="xdx_90B_eus-gaap--BusinessCombinationContingentConsiderationAsset_iI_c20250206__us-gaap--TypeOfArrangementAxis__custom--MembershipPurchaseAgreementMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--FSATravelLLCMember_zzSu8xqvHChl" title="Business acquisition  consideration cash"&gt;500,000&lt;/span&gt;
in cash and $&lt;span id="xdx_905_eus-gaap--BusinessCombinationContingentConsiderationAsset_iI_c20250206__us-gaap--TypeOfArrangementAxis__custom--MembershipPurchaseAgreementMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--FSATravelLLCMember__us-gaap--StatementClassOfStockAxis__custom--SeriesOPreferredStockMember_zIfy9t8SHmh9" title="Business acquisition  consideration cash"&gt;500,000&lt;/span&gt;
of Series O Preferred shares (&lt;span id="xdx_90E_eus-gaap--SharesIssued_iI_c20250206__us-gaap--TypeOfArrangementAxis__custom--MembershipPurchaseAgreementMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--FSATravelLLCMember__us-gaap--StatementClassOfStockAxis__custom--SeriesOPreferredStockMember_zIyezkG0RZt1" title="Business acquisition shares issued"&gt;161,291&lt;/span&gt;
shares at $&lt;span id="xdx_909_eus-gaap--SharesIssuedPricePerShare_iI_c20250206__us-gaap--TypeOfArrangementAxis__custom--MembershipPurchaseAgreementMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--FSATravelLLCMember__us-gaap--StatementClassOfStockAxis__custom--SeriesOPreferredStockMember_zikqIxv9di4g" title="Business acquisition shares price per share"&gt;3.10&lt;/span&gt;
per share). The investment in FSA is accounted for using the equity method of accounting in accordance with ASC 323 because
the Company has significant influence over the investee due to its &lt;span id="xdx_901_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20250206__us-gaap--TypeOfArrangementAxis__custom--MembershipPurchaseAgreementMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--NextTripMember_zQw3wG4WabA4"&gt;49&lt;/span&gt;%
ownership interest.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Pursuant
to the FSA Purchase Agreement, NextTrip was granted an option to acquire the remaining &lt;span id="xdx_909_eus-gaap--InvestmentInterestRatePaidInCash_iI_pid_dp_uPure_c20250206__us-gaap--TypeOfArrangementAxis__custom--MembershipPurchaseAgreementMember__dei--LegalEntityAxis__custom--FSATravelLLCMember_zA8Z86vKyKSf"&gt;51&lt;/span&gt;%
membership interest in FSA for an additional $&lt;span id="xdx_903_eus-gaap--BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCosts_iI_c20250206__us-gaap--TypeOfArrangementAxis__custom--MembershipPurchaseAgreementMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--FSATravelLLCMember_zYvOcwYUanbl" title="Business acquisition additional amount"&gt;1,000,000&lt;/span&gt;.
The option is exercisable within 60 days from the execution of the FSA Purchase Agreement, subject to the satisfaction of certain
conditions outlined in the FSA Purchase Agreement. The consideration for the remaining interest would consist of $&lt;span id="xdx_90B_eus-gaap--BusinessCombinationContingentConsiderationAsset_iI_c20250206__us-gaap--TypeOfArrangementAxis__custom--MembershipPurchaseAgreementMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--FSATravelLLCMember_zDak6yi2AVzg" title="Business acquisition  consideration cash"&gt;500,000&lt;/span&gt;
in cash and $&lt;span id="xdx_905_eus-gaap--BusinessCombinationContingentConsiderationAsset_iI_c20250206__us-gaap--TypeOfArrangementAxis__custom--MembershipPurchaseAgreementMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--FSATravelLLCMember__us-gaap--StatementClassOfStockAxis__custom--SeriesOPreferredStockMember_z7eHicJCV7Rg" title="Business acquisition  consideration cash"&gt;500,000 &lt;/span&gt;of
Series O Preferred shares (&lt;span id="xdx_90E_eus-gaap--SharesIssued_iI_c20250206__us-gaap--TypeOfArrangementAxis__custom--MembershipPurchaseAgreementMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--FSATravelLLCMember__us-gaap--StatementClassOfStockAxis__custom--SeriesOPreferredStockMember_zWCrdKGwd3Nl" title="Business acquisition shares issued"&gt;161,291&lt;/span&gt;
shares at $&lt;span id="xdx_909_eus-gaap--SharesIssuedPricePerShare_iI_c20250206__us-gaap--TypeOfArrangementAxis__custom--MembershipPurchaseAgreementMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--FSATravelLLCMember__us-gaap--StatementClassOfStockAxis__custom--SeriesOPreferredStockMember_zeCwqzFwvc3b" title="Business acquisition shares price per share"&gt;3.10&lt;/span&gt;
per share).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Pursuant
to the FSA Purchase Agreement, if the Company exercises its option to acquire the remaining &lt;span id="xdx_904_eus-gaap--InvestmentInterestRatePaidInCash_iI_pid_dp_uPure_c20250206__us-gaap--TypeOfArrangementAxis__custom--MembershipPurchaseAgreementMember_z3aqMnqtD3p"&gt;51&lt;/span&gt;%
interest, incremental consideration would include four business milestone payments, payable upon achievement of such milestones. The
achievement of each milestone would result in a payment of $&lt;span id="xdx_904_eus-gaap--BusinessAcquisitionPreacquisitionContingencyAmountOfSettlement_iI_c20250206__us-gaap--TypeOfArrangementAxis__custom--MembershipPurchaseAgreementMember_zgE4X010ITMf" title="Business acquisition amount"&gt;200,000&lt;/span&gt;,
consisting of $&lt;span id="xdx_901_eus-gaap--BusinessCombinationContingentConsiderationAsset_iI_c20250206__us-gaap--TypeOfArrangementAxis__custom--MembershipPurchaseAgreementMember_zo2QpEl46jmd" title="Business acquisition  consideration cash"&gt;100,000&lt;/span&gt;
in cash and $&lt;span id="xdx_90C_eus-gaap--BusinessCombinationContingentConsiderationAsset_iI_c20250206__us-gaap--TypeOfArrangementAxis__custom--MembershipPurchaseAgreementMember_zZaV1pfvSP4i" title="Business acquisition  consideration cash"&gt;100,000&lt;/span&gt;
in Series O Preferred shares (&lt;span id="xdx_906_eus-gaap--SharesIssued_iI_c20250206__us-gaap--TypeOfArrangementAxis__custom--MembershipPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesOPreferredStockMember_zZJiCUG0YA02" title="Business acquisition shares issued"&gt;32,258&lt;/span&gt;
shares at $&lt;span id="xdx_908_eus-gaap--SharesIssuedPricePerShare_iI_c20250206__us-gaap--TypeOfArrangementAxis__custom--MembershipPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesOPreferredStockMember_zJplSBKHtrDc" title="Business acquisition shares price per share"&gt;3.10&lt;/span&gt;
per share). These milestone payments are contingent upon the Company&#x2019;s exercise of the option to acquire the remaining &lt;span id="xdx_908_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20250206__us-gaap--TypeOfArrangementAxis__custom--MembershipPurchaseAgreementMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--FSATravelLLCMember_zng5Ri49qDA4"&gt;51&lt;/span&gt;%
of FSA, and are triggered only if the conditions necessary to exercise the option are satisfied. The total milestone payments
are capped at $&lt;span id="xdx_90B_ecustom--BusinessAcquisitionMilestonePayments_iI_c20250206__us-gaap--TypeOfArrangementAxis__custom--MembershipPurchaseAgreementMember__dei--LegalEntityAxis__custom--FSATravelLLCMember_zMhTirdjALPj" title="Milestone payments"&gt;800,000&lt;/span&gt;
(four milestones at $&lt;span id="xdx_904_ecustom--BusinessAcquisitionPerMilestonePayments_iI_c20250206__us-gaap--TypeOfArrangementAxis__custom--MembershipPurchaseAgreementMember__dei--LegalEntityAxis__custom--FSATravelLLCMember_zbwuYGV0Ob12" title="Per milestone payments"&gt;200,000&lt;/span&gt;
per milestone). These milestone payments are considered performance-based contingent consideration and will be recognized in the
future if and when the related milestones are satisfied, and the payments are made.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of February 28, 2025, the Company recorded its initial &lt;span id="xdx_905_eus-gaap--EquityOwnershipPercentageExcludingConsolidatedEntityAndEquityMethodInvestee_iI_pid_dp_uPure_c20250228__us-gaap--TypeOfArrangementAxis__custom--MembershipPurchaseAgreementMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--FSATravelLLCMember_zqCu082XJZSi"&gt;49&lt;/span&gt;% investment in FSA at $&lt;span id="xdx_901_eus-gaap--BusinessAcquisitionPreacquisitionContingencyAmountOfSettlement_iI_c20250228__us-gaap--TypeOfArrangementAxis__custom--MembershipPurchaseAgreementMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--FSATravelLLCMember_zuhACkyCc3ci" title="Business acquisition amount"&gt;1,000,000&lt;/span&gt;. This amount includes $&lt;span id="xdx_903_eus-gaap--BusinessCombinationContingentConsiderationAsset_iI_c20250228__us-gaap--TypeOfArrangementAxis__custom--MembershipPurchaseAgreementMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--FSATravelLLCMember_zgSP8xRQODil" title="Business acquisition  consideration cash"&gt;500,000&lt;/span&gt; in cash
and $&lt;span id="xdx_900_eus-gaap--BusinessCombinationContingentConsiderationAsset_iI_c20250228__us-gaap--TypeOfArrangementAxis__custom--MembershipPurchaseAgreementMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--FSATravelLLCMember__us-gaap--StatementClassOfStockAxis__custom--SeriesOPreferredStockMember_zl8ndLJ5AvNg" title="Business acquisition  consideration cash"&gt;500,000&lt;/span&gt; in Series O Preferred shares. The carrying amount of the equity method investment will be adjusted based on the Company&#x2019;s
share of FSA&#x2019;s earnings or losses, in accordance with the equity method of accounting. The milestones and contingent consideration
payments, including the additional $&lt;span id="xdx_909_eus-gaap--BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCosts_iI_c20250228__us-gaap--TypeOfArrangementAxis__custom--MembershipPurchaseAgreementMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--FSATravelLLCMember_zyHgXJuKdZ5f" title="Business acquisition additional amount"&gt;1,000,000&lt;/span&gt; to acquire the remaining &lt;span id="xdx_90E_eus-gaap--InvestmentInterestRatePaidInCash_iI_pid_dp_uPure_c20250228__us-gaap--TypeOfArrangementAxis__custom--MembershipPurchaseAgreementMember__dei--LegalEntityAxis__custom--FSATravelLLCMember_zeSYLOpWPy02"&gt;51&lt;/span&gt;% interest, will be recognized in the future if, as, and when
the conditions for such payments are satisfied.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
total potential commitment for the Company under the FSA Purchase Agreement, assuming the satisfaction of all conditions and the
exercise of the option to acquire the remaining &lt;span id="xdx_902_eus-gaap--InvestmentInterestRatePaidInCash_iI_pid_dp_uPure_c20250228__us-gaap--TypeOfArrangementAxis__custom--MembershipPurchaseAgreementMember__dei--LegalEntityAxis__custom--NextTripMember_zzhZ21BWDPSj"&gt;51&lt;/span&gt;%
interest, is $&lt;span id="xdx_90E_eus-gaap--PaymentsToAcquireBusinessesAndInterestInAffiliates_c20250228__20250228__us-gaap--TypeOfArrangementAxis__custom--MembershipPurchaseAgreementMember__dei--LegalEntityAxis__custom--NextTripMember_zEp6yDsJxHtb" title="Business acquisition additional amount"&gt;2,800,000&lt;/span&gt;.
This includes $&lt;span id="xdx_901_eus-gaap--PaymentsToAcquireBusinessesAndInterestInAffiliates_c20250228__20250228__us-gaap--TypeOfArrangementAxis__custom--MembershipPurchaseAgreementMember_z2jaaqCZkEuh" title="Business acquisition additional amount"&gt;1,000,000&lt;/span&gt;
already paid for the &lt;span id="xdx_90B_eus-gaap--EquityOwnershipPercentageExcludingConsolidatedEntityAndEquityMethodInvestee_iI_pid_dp_uPure_c20250228__us-gaap--TypeOfArrangementAxis__custom--MembershipPurchaseAgreementMember_zU2uuJy4lbGb"&gt;49&lt;/span&gt;%
interest in FSA, $&lt;span id="xdx_901_eus-gaap--PaymentsToAcquireBusinessesAndInterestInAffiliates_c20250228__20250228__us-gaap--TypeOfArrangementAxis__custom--MembershipPurchaseAgreementMember__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--NextTripMember_zAakq6b8sXz4" title="Business acquisition additional amount"&gt;1,000,000&lt;/span&gt;
payable by the Company in the event that it exercises its option to acquire the remaining &lt;span id="xdx_905_eus-gaap--InvestmentInterestRatePaidInCash_iI_pid_dp_uPure_c20250228__us-gaap--TypeOfArrangementAxis__custom--MembershipPurchaseAgreementMember__dei--LegalEntityAxis__custom--NextTripMember_zVwV0o3plrbj"&gt;51&lt;/span&gt;%
of interests in FSA, and $&lt;span id="xdx_90D_ecustom--BusinessAcquisitionMilestonePayments_iI_c20250228__us-gaap--TypeOfArrangementAxis__custom--MembershipPurchaseAgreementMember_z1wmXjB9Tgj5" title="Milestone payments"&gt;800,000&lt;/span&gt;
for the milestone payments associated with the acquisition of the remaining interests.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Summarized
Financial Information for FSA Travel, LLC&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89A_eus-gaap--EquityMethodInvestmentsTextBlock_zgVv5JxPm8S8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;FSA
Travel&#x2019;s fiscal year ends on December 31. As of and for the year ended December 31, 2024, unaudited summarized financial
information for FSA is as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BA_zlKZQgby6RVe" style="display: none"&gt;Schedule
of Unaudited Summarized Financial Information&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_493_20241231__dei--LegalEntityAxis__custom--FSATravelLLCMember_zB2Y60wOH5Vi" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;December 31,&lt;/p&gt;
                                                                               &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;2024&lt;/p&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--AssetsCurrent_iI_zCdkziM07QYb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 78%; text-align: left"&gt;Current assets&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right"&gt;13,629&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--AssetsNoncurrent_iI_zNAqslBORhIk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Non-current assets&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;577,776&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--LiabilitiesCurrent_iI_zSXOMmfed4H5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Current liabilities&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;12,452&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--LiabilitiesNoncurrent_iI_zIq6Zjv4hvYa" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Non-current liabilities&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;199,100&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--StockholdersEquity_iI_zZWVpEs6pGl4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Member&#x2019;s equity&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;379,852&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Net revenues&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_907_eus-gaap--Revenues_c20240101__20241231__dei--LegalEntityAxis__custom--FSATravelLLCMember_zWL53lViRExk" title="Net revenues"&gt;374,143&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Gross profit&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90C_eus-gaap--GrossProfit_c20240101__20241231__dei--LegalEntityAxis__custom--FSATravelLLCMember_z6tp6d7RJNI2" title="Gross profit"&gt;374,143&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Net loss&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_905_eus-gaap--NetIncomeLoss_c20240101__20241231__dei--LegalEntityAxis__custom--FSATravelLLCMember_zYKrNYjeG0ni" title="Net loss"&gt;(252,381&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A4_zNyhCz8xN6Mf" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:EquityMethodInvestmentsDisclosureTextBlock>
    <us-gaap:EquityOwnershipPercentageExcludingConsolidatedEntityAndEquityMethodInvestee
      contextRef="AsOf2025-02-06_custom_MembershipPurchaseAgreementMember_custom_FSATravelLLCMember"
      decimals="INF"
      id="Fact000871"
      unitRef="Pure">0.49</us-gaap:EquityOwnershipPercentageExcludingConsolidatedEntityAndEquityMethodInvestee>
    <us-gaap:BusinessAcquisitionPreacquisitionContingencyAmountOfSettlement
      contextRef="AsOf2025-02-06_custom_MembershipPurchaseAgreementMember_custom_FSATravelLLCMember"
      decimals="0"
      id="Fact000873"
      unitRef="USD">1000000</us-gaap:BusinessAcquisitionPreacquisitionContingencyAmountOfSettlement>
    <us-gaap:BusinessCombinationContingentConsiderationAsset
      contextRef="AsOf2025-02-06_custom_MembershipPurchaseAgreementMember_custom_FSATravelLLCMember"
      decimals="0"
      id="Fact000875"
      unitRef="USD">500000</us-gaap:BusinessCombinationContingentConsiderationAsset>
    <us-gaap:BusinessCombinationContingentConsiderationAsset
      contextRef="AsOf2025-02-06_custom_MembershipPurchaseAgreementMember_custom_FSATravelLLCMember_custom_SeriesOPreferredStockMember"
      decimals="0"
      id="Fact000877"
      unitRef="USD">500000</us-gaap:BusinessCombinationContingentConsiderationAsset>
    <us-gaap:SharesIssued
      contextRef="AsOf2025-02-06_custom_MembershipPurchaseAgreementMember_custom_FSATravelLLCMember_custom_SeriesOPreferredStockMember"
      decimals="INF"
      id="Fact000879"
      unitRef="Shares">161291</us-gaap:SharesIssued>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="AsOf2025-02-06_custom_MembershipPurchaseAgreementMember_custom_FSATravelLLCMember_custom_SeriesOPreferredStockMember"
      decimals="INF"
      id="Fact000881"
      unitRef="USDPShares">3.10</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="AsOf2025-02-06_custom_MembershipPurchaseAgreementMember_custom_NextTripMember"
      decimals="INF"
      id="Fact000882"
      unitRef="Pure">0.49</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:InvestmentInterestRatePaidInCash
      contextRef="AsOf2025-02-06_custom_MembershipPurchaseAgreementMember_custom_FSATravelLLCMember11843687"
      decimals="INF"
      id="Fact000883"
      unitRef="Pure">0.51</us-gaap:InvestmentInterestRatePaidInCash>
    <us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCosts
      contextRef="AsOf2025-02-06_custom_MembershipPurchaseAgreementMember_custom_FSATravelLLCMember"
      decimals="0"
      id="Fact000885"
      unitRef="USD">1000000</us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCosts>
    <us-gaap:BusinessCombinationContingentConsiderationAsset
      contextRef="AsOf2025-02-06_custom_MembershipPurchaseAgreementMember_custom_FSATravelLLCMember"
      decimals="0"
      id="Fact000887"
      unitRef="USD">500000</us-gaap:BusinessCombinationContingentConsiderationAsset>
    <us-gaap:BusinessCombinationContingentConsiderationAsset
      contextRef="AsOf2025-02-06_custom_MembershipPurchaseAgreementMember_custom_FSATravelLLCMember_custom_SeriesOPreferredStockMember"
      decimals="0"
      id="Fact000889"
      unitRef="USD">500000</us-gaap:BusinessCombinationContingentConsiderationAsset>
    <us-gaap:SharesIssued
      contextRef="AsOf2025-02-06_custom_MembershipPurchaseAgreementMember_custom_FSATravelLLCMember_custom_SeriesOPreferredStockMember"
      decimals="INF"
      id="Fact000891"
      unitRef="Shares">161291</us-gaap:SharesIssued>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="AsOf2025-02-06_custom_MembershipPurchaseAgreementMember_custom_FSATravelLLCMember_custom_SeriesOPreferredStockMember"
      decimals="INF"
      id="Fact000893"
      unitRef="USDPShares">3.10</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:InvestmentInterestRatePaidInCash
      contextRef="AsOf2025-02-06_custom_MembershipPurchaseAgreementMember"
      decimals="INF"
      id="Fact000894"
      unitRef="Pure">0.51</us-gaap:InvestmentInterestRatePaidInCash>
    <us-gaap:BusinessAcquisitionPreacquisitionContingencyAmountOfSettlement
      contextRef="AsOf2025-02-06_custom_MembershipPurchaseAgreementMember"
      decimals="0"
      id="Fact000896"
      unitRef="USD">200000</us-gaap:BusinessAcquisitionPreacquisitionContingencyAmountOfSettlement>
    <us-gaap:BusinessCombinationContingentConsiderationAsset
      contextRef="AsOf2025-02-06_custom_MembershipPurchaseAgreementMember"
      decimals="0"
      id="Fact000898"
      unitRef="USD">100000</us-gaap:BusinessCombinationContingentConsiderationAsset>
    <us-gaap:BusinessCombinationContingentConsiderationAsset
      contextRef="AsOf2025-02-06_custom_MembershipPurchaseAgreementMember"
      decimals="0"
      id="Fact000900"
      unitRef="USD">100000</us-gaap:BusinessCombinationContingentConsiderationAsset>
    <us-gaap:SharesIssued
      contextRef="AsOf2025-02-06_custom_MembershipPurchaseAgreementMember_custom_SeriesOPreferredStockMember"
      decimals="INF"
      id="Fact000902"
      unitRef="Shares">32258</us-gaap:SharesIssued>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="AsOf2025-02-06_custom_MembershipPurchaseAgreementMember_custom_SeriesOPreferredStockMember"
      decimals="INF"
      id="Fact000904"
      unitRef="USDPShares">3.10</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="AsOf2025-02-06_custom_MembershipPurchaseAgreementMember_custom_FSATravelLLCMember"
      decimals="INF"
      id="Fact000905"
      unitRef="Pure">0.51</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <NTRP:BusinessAcquisitionMilestonePayments
      contextRef="AsOf2025-02-06_custom_MembershipPurchaseAgreementMember_custom_FSATravelLLCMember11843687"
      decimals="0"
      id="Fact000907"
      unitRef="USD">800000</NTRP:BusinessAcquisitionMilestonePayments>
    <NTRP:BusinessAcquisitionPerMilestonePayments
      contextRef="AsOf2025-02-06_custom_MembershipPurchaseAgreementMember_custom_FSATravelLLCMember11843687"
      decimals="0"
      id="Fact000909"
      unitRef="USD">200000</NTRP:BusinessAcquisitionPerMilestonePayments>
    <us-gaap:EquityOwnershipPercentageExcludingConsolidatedEntityAndEquityMethodInvestee
      contextRef="AsOf2025-02-28_custom_MembershipPurchaseAgreementMember_custom_FSATravelLLCMember"
      decimals="INF"
      id="Fact000910"
      unitRef="Pure">0.49</us-gaap:EquityOwnershipPercentageExcludingConsolidatedEntityAndEquityMethodInvestee>
    <us-gaap:BusinessAcquisitionPreacquisitionContingencyAmountOfSettlement
      contextRef="AsOf2025-02-28_custom_MembershipPurchaseAgreementMember_custom_FSATravelLLCMember"
      decimals="0"
      id="Fact000912"
      unitRef="USD">1000000</us-gaap:BusinessAcquisitionPreacquisitionContingencyAmountOfSettlement>
    <us-gaap:BusinessCombinationContingentConsiderationAsset
      contextRef="AsOf2025-02-28_custom_MembershipPurchaseAgreementMember_custom_FSATravelLLCMember"
      decimals="0"
      id="Fact000914"
      unitRef="USD">500000</us-gaap:BusinessCombinationContingentConsiderationAsset>
    <us-gaap:BusinessCombinationContingentConsiderationAsset
      contextRef="AsOf2025-02-28_custom_MembershipPurchaseAgreementMember_custom_FSATravelLLCMember_custom_SeriesOPreferredStockMember"
      decimals="0"
      id="Fact000916"
      unitRef="USD">500000</us-gaap:BusinessCombinationContingentConsiderationAsset>
    <us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCosts
      contextRef="AsOf2025-02-28_custom_MembershipPurchaseAgreementMember_custom_FSATravelLLCMember"
      decimals="0"
      id="Fact000918"
      unitRef="USD">1000000</us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCosts>
    <us-gaap:InvestmentInterestRatePaidInCash
      contextRef="AsOf2025-02-28_custom_MembershipPurchaseAgreementMember_custom_FSATravelLLCMember11843734"
      decimals="INF"
      id="Fact000919"
      unitRef="Pure">0.51</us-gaap:InvestmentInterestRatePaidInCash>
    <us-gaap:InvestmentInterestRatePaidInCash
      contextRef="AsOf2025-02-28_custom_MembershipPurchaseAgreementMember_custom_NextTripMember"
      decimals="INF"
      id="Fact000920"
      unitRef="Pure">0.51</us-gaap:InvestmentInterestRatePaidInCash>
    <us-gaap:PaymentsToAcquireBusinessesAndInterestInAffiliates
      contextRef="From2025-02-282025-02-28_custom_MembershipPurchaseAgreementMember_custom_NextTripMember"
      decimals="0"
      id="Fact000922"
      unitRef="USD">2800000</us-gaap:PaymentsToAcquireBusinessesAndInterestInAffiliates>
    <us-gaap:PaymentsToAcquireBusinessesAndInterestInAffiliates
      contextRef="From2025-02-282025-02-28_custom_MembershipPurchaseAgreementMember"
      decimals="0"
      id="Fact000924"
      unitRef="USD">1000000</us-gaap:PaymentsToAcquireBusinessesAndInterestInAffiliates>
    <us-gaap:EquityOwnershipPercentageExcludingConsolidatedEntityAndEquityMethodInvestee
      contextRef="AsOf2025-02-28_custom_MembershipPurchaseAgreementMember"
      decimals="INF"
      id="Fact000925"
      unitRef="Pure">0.49</us-gaap:EquityOwnershipPercentageExcludingConsolidatedEntityAndEquityMethodInvestee>
    <us-gaap:PaymentsToAcquireBusinessesAndInterestInAffiliates
      contextRef="From2025-02-282025-02-28_custom_MembershipPurchaseAgreementMember_custom_NextTripMember11843750"
      decimals="0"
      id="Fact000927"
      unitRef="USD">1000000</us-gaap:PaymentsToAcquireBusinessesAndInterestInAffiliates>
    <us-gaap:InvestmentInterestRatePaidInCash
      contextRef="AsOf2025-02-28_custom_MembershipPurchaseAgreementMember_custom_NextTripMember"
      decimals="INF"
      id="Fact000928"
      unitRef="Pure">0.51</us-gaap:InvestmentInterestRatePaidInCash>
    <NTRP:BusinessAcquisitionMilestonePayments
      contextRef="AsOf2025-02-28_custom_MembershipPurchaseAgreementMember"
      decimals="0"
      id="Fact000930"
      unitRef="USD">800000</NTRP:BusinessAcquisitionMilestonePayments>
    <us-gaap:EquityMethodInvestmentsTextBlock contextRef="From2024-03-01to2025-02-28" id="Fact000932">&lt;p id="xdx_89A_eus-gaap--EquityMethodInvestmentsTextBlock_zgVv5JxPm8S8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;FSA
Travel&#x2019;s fiscal year ends on December 31. As of and for the year ended December 31, 2024, unaudited summarized financial
information for FSA is as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BA_zlKZQgby6RVe" style="display: none"&gt;Schedule
of Unaudited Summarized Financial Information&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_493_20241231__dei--LegalEntityAxis__custom--FSATravelLLCMember_zB2Y60wOH5Vi" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;December 31,&lt;/p&gt;
                                                                               &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;2024&lt;/p&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--AssetsCurrent_iI_zCdkziM07QYb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 78%; text-align: left"&gt;Current assets&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right"&gt;13,629&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--AssetsNoncurrent_iI_zNAqslBORhIk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Non-current assets&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;577,776&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--LiabilitiesCurrent_iI_zSXOMmfed4H5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Current liabilities&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;12,452&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--LiabilitiesNoncurrent_iI_zIq6Zjv4hvYa" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Non-current liabilities&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;199,100&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--StockholdersEquity_iI_zZWVpEs6pGl4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Member&#x2019;s equity&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;379,852&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Net revenues&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_907_eus-gaap--Revenues_c20240101__20241231__dei--LegalEntityAxis__custom--FSATravelLLCMember_zWL53lViRExk" title="Net revenues"&gt;374,143&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Gross profit&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90C_eus-gaap--GrossProfit_c20240101__20241231__dei--LegalEntityAxis__custom--FSATravelLLCMember_z6tp6d7RJNI2" title="Gross profit"&gt;374,143&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Net loss&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_905_eus-gaap--NetIncomeLoss_c20240101__20241231__dei--LegalEntityAxis__custom--FSATravelLLCMember_zYKrNYjeG0ni" title="Net loss"&gt;(252,381&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:EquityMethodInvestmentsTextBlock>
    <us-gaap:AssetsCurrent
      contextRef="AsOf2024-12-31_custom_FSATravelLLCMember"
      decimals="0"
      id="Fact000934"
      unitRef="USD">13629</us-gaap:AssetsCurrent>
    <us-gaap:AssetsNoncurrent
      contextRef="AsOf2024-12-31_custom_FSATravelLLCMember"
      decimals="0"
      id="Fact000936"
      unitRef="USD">577776</us-gaap:AssetsNoncurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="AsOf2024-12-31_custom_FSATravelLLCMember"
      decimals="0"
      id="Fact000938"
      unitRef="USD">12452</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesNoncurrent
      contextRef="AsOf2024-12-31_custom_FSATravelLLCMember"
      decimals="0"
      id="Fact000940"
      unitRef="USD">199100</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-12-31_custom_FSATravelLLCMember"
      decimals="0"
      id="Fact000942"
      unitRef="USD">379852</us-gaap:StockholdersEquity>
    <us-gaap:Revenues
      contextRef="From2024-01-012024-12-31_custom_FSATravelLLCMember"
      decimals="0"
      id="Fact000944"
      unitRef="USD">374143</us-gaap:Revenues>
    <us-gaap:GrossProfit
      contextRef="From2024-01-012024-12-31_custom_FSATravelLLCMember"
      decimals="0"
      id="Fact000946"
      unitRef="USD">374143</us-gaap:GrossProfit>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-01-012024-12-31_custom_FSATravelLLCMember"
      decimals="0"
      id="Fact000948"
      unitRef="USD">-252381</us-gaap:NetIncomeLoss>
    <us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock contextRef="From2024-03-01to2025-02-28" id="Fact000950">&lt;p id="xdx_803_eus-gaap--InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_zk1spcvuT7k3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
5 - &lt;span id="xdx_820_zRjrY1NKPcH9"&gt;Investment in Equity Securities&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Investment
in Blue Fysh Holdings Inc&lt;/i&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
February 24, 2025, the Company entered into a Share Exchange Agreement with Blue Fysh Holdings Inc. (&#x201c;Blue Fysh&#x201d;), under
which the Company acquired a &lt;span id="xdx_90F_eus-gaap--EquityOwnershipPercentageExcludingConsolidatedEntityAndEquityMethodInvestee_iI_pid_dp_uPure_c20250224__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__dei--LegalEntityAxis__custom--BlueFyshHoldingsIncMember_zaWvJzjAQ25k"&gt;10&lt;/span&gt;% ownership interest in Blue Fysh. As part of the transaction, the Company issued &lt;span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20250224__20250224__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__dei--LegalEntityAxis__custom--BlueFyshHoldingsIncMember__us-gaap--StatementClassOfStockAxis__custom--SeriesNNonvotingConvertiblePreferredStockMember_zRCl6t2mIp1h" title="Number of shares issued"&gt;483,000&lt;/span&gt; shares of Series
N Nonvoting Preferred at an issuance price of $&lt;span id="xdx_903_eus-gaap--SharesIssuedPricePerShare_iI_c20250224__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__dei--LegalEntityAxis__custom--BlueFyshHoldingsIncMember__us-gaap--StatementClassOfStockAxis__custom--SeriesNNonvotingConvertiblePreferredStockMember_zW6i30bGo65b" title="Shares issued price per share"&gt;5.00&lt;/span&gt; per share, totaling $&lt;span id="xdx_906_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20250224__20250224__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__dei--LegalEntityAxis__custom--BlueFyshHoldingsIncMember__us-gaap--StatementClassOfStockAxis__custom--SeriesNNonvotingConvertiblePreferredStockMember_zUrODtjF2Y3c" title="Shares issued value"&gt;2,415,000&lt;/span&gt;, in exchange for &lt;span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20250224__20250224__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__dei--LegalEntityAxis__custom--BlueFyshHoldingsIncMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_z9hh8JaoSN83" title="Number of shares issued"&gt;82&lt;/span&gt; restricted shares
of Blue Fysh common stock. The transaction closed on February 28, 2025.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s investment in Blue Fysh is accounted for under the cost method, as the Company does not have significant influence over
Blue Fysh. No board appointments are contemplated as part of this transaction; however, the Company has the right to appoint a representative
to the Blue Fysh Advisory Committee, which will allow the Company to receive financial updates as needed and to be informed of financial
events that could significantly impact the Company&#x2019;s ownership position.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Since
the Company&#x2019;s ownership interest does not meet the criteria for significant influence pursuant to ASC 323, this investment is classified
as an equity security without a readily determinable fair value and is initially recorded at cost. The Company will assess the investment
for impairment in future periods and recognize any impairment losses as necessary.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock>
    <us-gaap:EquityOwnershipPercentageExcludingConsolidatedEntityAndEquityMethodInvestee
      contextRef="AsOf2025-02-24_custom_ShareExchangeAgreementMember_custom_BlueFyshHoldingsIncMember"
      decimals="INF"
      id="Fact000951"
      unitRef="Pure">0.10</us-gaap:EquityOwnershipPercentageExcludingConsolidatedEntityAndEquityMethodInvestee>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2025-02-242025-02-24_custom_ShareExchangeAgreementMember_custom_BlueFyshHoldingsIncMember_custom_SeriesNNonvotingConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact000953"
      unitRef="Shares">483000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="AsOf2025-02-24_custom_ShareExchangeAgreementMember_custom_BlueFyshHoldingsIncMember_custom_SeriesNNonvotingConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact000955"
      unitRef="USDPShares">5.00</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2025-02-242025-02-24_custom_ShareExchangeAgreementMember_custom_BlueFyshHoldingsIncMember_custom_SeriesNNonvotingConvertiblePreferredStockMember"
      decimals="0"
      id="Fact000957"
      unitRef="USD">2415000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2025-02-242025-02-24_custom_ShareExchangeAgreementMember_custom_BlueFyshHoldingsIncMember_us-gaap_RestrictedStockMember"
      decimals="INF"
      id="Fact000959"
      unitRef="Shares">82</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <NTRP:PrepaidExpensesAndOtherCurrentAssetsTextBlock contextRef="From2024-03-01to2025-02-28" id="Fact000961">&lt;p id="xdx_80A_ecustom--PrepaidExpensesAndOtherCurrentAssetsTextBlock_z3tgxJoRgvZb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
6 - &lt;span id="xdx_821_zMmrmVtuVkN3"&gt;Prepaid and Other Current Assets&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_895_eus-gaap--DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_zzd2qGLq0dEf" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Prepaid
and other current assets consisted of the following as of February 28, 2025 and as of February 29, 2024:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span&gt;&lt;span id="xdx_8B9_zZ9LwnoUVML1" style="display: none"&gt;Schedule
of Prepaid and Other Current Assets&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_493_20250228_zaA7VLr6hEd7" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;February 28,&lt;/p&gt;
                                                                               &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;2025&lt;/p&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49E_20240229_z4C2EE7B1Xm" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;February 29,&lt;/p&gt;
                                                                               &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;2024&lt;/p&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--PrepaidOfferingCosts_iI_maPEAOAzw6s_znFtiZY5Fzd2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: justify"&gt;Offering costs&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;100,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0966"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--PrepaidConsultingContract_iI_maPEAOAzw6s_zAVhaLKZoOG4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;Current portion of two-year strategic consulting contract&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;733,575&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0969"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_ecustom--PrepaidCostOfSales_iI_maPEAOAzw6s_z8dUu9C15iIl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;Cost of sales&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;121,588&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;42,547&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--OtherPrepaidExpenseCurrent_iI_maPEAOAzw6s_zEO9vZ7unnL" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;Other expenses&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;425,412&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;298,274&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--PrepaidAdvertising_iI_maPEAOAzw6s_zpQz10yOyLk8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 1pt"&gt;Marketing expenses&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0977"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;100&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_iTI_mtPEAOAzw6s_z2yNbqhBQOy5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 2.5pt"&gt;Total&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;1,380,575&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;340,921&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A7_zgXt3pMmAJa4" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</NTRP:PrepaidExpensesAndOtherCurrentAssetsTextBlock>
    <us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock contextRef="From2024-03-01to2025-02-28" id="Fact000963">&lt;p id="xdx_895_eus-gaap--DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_zzd2qGLq0dEf" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Prepaid
and other current assets consisted of the following as of February 28, 2025 and as of February 29, 2024:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span&gt;&lt;span id="xdx_8B9_zZ9LwnoUVML1" style="display: none"&gt;Schedule
of Prepaid and Other Current Assets&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_493_20250228_zaA7VLr6hEd7" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;February 28,&lt;/p&gt;
                                                                               &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;2025&lt;/p&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49E_20240229_z4C2EE7B1Xm" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;February 29,&lt;/p&gt;
                                                                               &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;2024&lt;/p&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--PrepaidOfferingCosts_iI_maPEAOAzw6s_znFtiZY5Fzd2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: justify"&gt;Offering costs&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;100,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0966"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--PrepaidConsultingContract_iI_maPEAOAzw6s_zAVhaLKZoOG4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;Current portion of two-year strategic consulting contract&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;733,575&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0969"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_ecustom--PrepaidCostOfSales_iI_maPEAOAzw6s_z8dUu9C15iIl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;Cost of sales&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;121,588&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;42,547&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--OtherPrepaidExpenseCurrent_iI_maPEAOAzw6s_zEO9vZ7unnL" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;Other expenses&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;425,412&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;298,274&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--PrepaidAdvertising_iI_maPEAOAzw6s_zpQz10yOyLk8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 1pt"&gt;Marketing expenses&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0977"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;100&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_iTI_mtPEAOAzw6s_z2yNbqhBQOy5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 2.5pt"&gt;Total&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;1,380,575&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;340,921&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock>
    <NTRP:PrepaidOfferingCosts
      contextRef="AsOf2025-02-28"
      decimals="0"
      id="Fact000965"
      unitRef="USD">100000</NTRP:PrepaidOfferingCosts>
    <NTRP:PrepaidConsultingContract
      contextRef="AsOf2025-02-28"
      decimals="0"
      id="Fact000968"
      unitRef="USD">733575</NTRP:PrepaidConsultingContract>
    <NTRP:PrepaidCostOfSales
      contextRef="AsOf2025-02-28"
      decimals="0"
      id="Fact000971"
      unitRef="USD">121588</NTRP:PrepaidCostOfSales>
    <NTRP:PrepaidCostOfSales
      contextRef="AsOf2024-02-29"
      decimals="0"
      id="Fact000972"
      unitRef="USD">42547</NTRP:PrepaidCostOfSales>
    <us-gaap:OtherPrepaidExpenseCurrent
      contextRef="AsOf2025-02-28"
      decimals="0"
      id="Fact000974"
      unitRef="USD">425412</us-gaap:OtherPrepaidExpenseCurrent>
    <us-gaap:OtherPrepaidExpenseCurrent
      contextRef="AsOf2024-02-29"
      decimals="0"
      id="Fact000975"
      unitRef="USD">298274</us-gaap:OtherPrepaidExpenseCurrent>
    <us-gaap:PrepaidAdvertising
      contextRef="AsOf2024-02-29"
      decimals="0"
      id="Fact000978"
      unitRef="USD">100</us-gaap:PrepaidAdvertising>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="AsOf2025-02-28"
      decimals="0"
      id="Fact000980"
      unitRef="USD">1380575</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="AsOf2024-02-29"
      decimals="0"
      id="Fact000981"
      unitRef="USD">340921</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock contextRef="From2024-03-01to2025-02-28" id="Fact000983">&lt;p id="xdx_80E_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_zMTpp6N84Goh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
7 - &lt;span id="xdx_829_zPDHFk9aODM9"&gt;Property and Equipment&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_891_eus-gaap--PropertyPlantAndEquipmentTextBlock_z6SunUFoOwGj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Property
and equipment as of February 28, 2025 and February 29, 2024 consisted of the following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BF_zEtJj1gNIcbg" style="display: none"&gt;Schedule
of Property and Equipment&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_490_20250228_zWpUUeXWrJNb" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;February 28,&lt;/p&gt;
                                                                               &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;2025&lt;/p&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_497_20240229_zyYAsYQPn3A5" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;February 29,&lt;/p&gt;
                                                                               &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;2024&lt;/p&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zYTS5IqlbML3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left"&gt;Furniture and Fixtures&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;17,018&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;17,018&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_zXutqmKqqjGj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"&gt;Computer and Equipment&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;80,786&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;82,492&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--PropertyPlantAndEquipmentGross_iI_maPPAENzyNw_zvY3v3iwVE74" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;Total&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;97,804&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;99,510&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_di_msPPAENzyNw_zMcYamBJ0cA6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"&gt;Accumulated depreciation&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(93,685&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(92,868&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--PropertyPlantAndEquipmentNet_iTI_mtPPAENzyNw_zs6xEA8hJwX7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"&gt;Property and Equipment, net of depreciation&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;4,119&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;6,642&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AC_zp7QT4rzrdS7" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Depreciation
expense for the years ended February 28, 2025, and February 29, 2024 was $&lt;span id="xdx_904_eus-gaap--Depreciation_c20240301__20250228_zvlqpnbQtuDk" title="Depreciation expense"&gt;1,434&lt;/span&gt; and $&lt;span id="xdx_906_eus-gaap--Depreciation_c20230301__20240229_z4CJhKlIg4hf" title="Depreciation expense"&gt;18,838&lt;/span&gt;, respectively, and is recorded in operating
expenses.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
the years ended February 28, 2025 and February 29, 2024, the Company acquired property and equipment of $&lt;span id="xdx_90D_eus-gaap--PaymentsToAcquirePropertyPlantAndEquipment_dxL_c20240301__20250228_z40WmMzunsv" title="Property and equipment::XDX::-"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1006"&gt;0&lt;/span&gt;&lt;/span&gt; and $&lt;span id="xdx_908_eus-gaap--PaymentsToAcquirePropertyPlantAndEquipment_c20230301__20240229_zbTQ3DkdSAMe" title="Property and equipment"&gt;9,253&lt;/span&gt;, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock contextRef="From2024-03-01to2025-02-28" id="Fact000985">&lt;p id="xdx_891_eus-gaap--PropertyPlantAndEquipmentTextBlock_z6SunUFoOwGj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Property
and equipment as of February 28, 2025 and February 29, 2024 consisted of the following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BF_zEtJj1gNIcbg" style="display: none"&gt;Schedule
of Property and Equipment&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_490_20250228_zWpUUeXWrJNb" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;February 28,&lt;/p&gt;
                                                                               &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;2025&lt;/p&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_497_20240229_zyYAsYQPn3A5" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;February 29,&lt;/p&gt;
                                                                               &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;2024&lt;/p&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zYTS5IqlbML3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left"&gt;Furniture and Fixtures&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;17,018&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;17,018&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_zXutqmKqqjGj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"&gt;Computer and Equipment&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;80,786&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;82,492&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--PropertyPlantAndEquipmentGross_iI_maPPAENzyNw_zvY3v3iwVE74" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;Total&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;97,804&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;99,510&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_di_msPPAENzyNw_zMcYamBJ0cA6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"&gt;Accumulated depreciation&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(93,685&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(92,868&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--PropertyPlantAndEquipmentNet_iTI_mtPPAENzyNw_zs6xEA8hJwX7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"&gt;Property and Equipment, net of depreciation&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;4,119&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;6,642&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2025-02-28_us-gaap_FurnitureAndFixturesMember"
      decimals="0"
      id="Fact000987"
      unitRef="USD">17018</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2024-02-29_us-gaap_FurnitureAndFixturesMember"
      decimals="0"
      id="Fact000988"
      unitRef="USD">17018</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2025-02-28_us-gaap_ComputerEquipmentMember"
      decimals="0"
      id="Fact000990"
      unitRef="USD">80786</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2024-02-29_us-gaap_ComputerEquipmentMember"
      decimals="0"
      id="Fact000991"
      unitRef="USD">82492</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2025-02-28"
      decimals="0"
      id="Fact000993"
      unitRef="USD">97804</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2024-02-29"
      decimals="0"
      id="Fact000994"
      unitRef="USD">99510</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="AsOf2025-02-28"
      decimals="0"
      id="Fact000996"
      unitRef="USD">93685</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="AsOf2024-02-29"
      decimals="0"
      id="Fact000997"
      unitRef="USD">92868</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2025-02-28"
      decimals="0"
      id="Fact000999"
      unitRef="USD">4119</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2024-02-29"
      decimals="0"
      id="Fact001000"
      unitRef="USD">6642</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Depreciation
      contextRef="From2024-03-01to2025-02-28"
      decimals="0"
      id="Fact001002"
      unitRef="USD">1434</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact001004"
      unitRef="USD">18838</us-gaap:Depreciation>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact001008"
      unitRef="USD">9253</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:IntangibleAssetsDisclosureTextBlock contextRef="From2024-03-01to2025-02-28" id="Fact001010">&lt;p id="xdx_808_eus-gaap--IntangibleAssetsDisclosureTextBlock_z4mPR0KbQZAf" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
8 - &lt;span id="xdx_820_zTJZLaMb9ES1"&gt;Intangible Assets&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_897_eus-gaap--ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_zMzuwzsxZmVb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Intangible
assets as of February 28, 2025, and February 29, 2024 consisted of the following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B9_zcVqzSqgiiBl" style="display: none"&gt;Schedule
of Intangible Assets&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_491_20250228_zMGiNaZmXL5b" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;February 28,&lt;/p&gt;
                                                                               &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;2025&lt;/p&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_497_20240229_zetU7acUGT5k" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;February 29,&lt;/p&gt;
                                                                               &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;2024&lt;/p&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_hus-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareDevelopmentMember_zekzs3dSm5ml" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left"&gt;Software Development&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;7,267,778&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;6,602,028&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_hus-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SoftwareLicenseMember_zWrgLBaj59K" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Software Licenses&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;789,576&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;789,576&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_hus-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksMember_z50dLyO1uDDg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;Trademark&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;6,283&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;6,283&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_maIANEGzjZg_zeOpXEg4tvac" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;Total&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;8,063,637&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;7,397,887&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iNI_di_msIANEGzjZg_zOR1s54bfor5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"&gt;Accumulated amortization&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(5,936,269&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(5,224,467&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--IntangibleAssetsNetExcludingGoodwill_iTI_mtIANEGzjZg_zMNY8S7Av56d" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"&gt;Intangible assets, net of amortization&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;2,127,368&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;2,173,420&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AA_ztSc7ffpHbN1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Amortization
expense for the years ended February 28, 2025 and February 29, 2024 was $&lt;span id="xdx_901_eus-gaap--AmortizationOfIntangibleAssets_c20240301__20250228_z1z7BDzi649j" title="Amortization"&gt;711,802&lt;/span&gt;
and $&lt;span id="xdx_90E_eus-gaap--AmortizationOfIntangibleAssets_c20230301__20240229_zBXe78p2Qr8b" title="Amortization"&gt;1,449,925&lt;/span&gt;,
respectively, and is recorded in operating expenses.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
the years ended February 28, 2025 and February 29, 2024, the Company recorded no impairment losses associated with the carrying value
exceeding its recoverable amount.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_890_eus-gaap--ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_zxtda79nCq13" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
estimated aggregate amortization expense for each of the succeeding years ending February 28 is as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;span id="xdx_8BF_zK8DGd5XDLF7" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Schedule
of estimated aggregate amortization expense&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_492_20250228_zvwRmE3Hy06d" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_400_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_iI_maFLIANzgGq_zmX8Le2zIXee" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 78%; text-align: left"&gt;2025&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right"&gt;597,914&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_iI_maFLIANzgGq_zlGpJjXF1bSi" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;2026&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;623,882&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_iI_maFLIANzgGq_zIvT3DmfbQ46" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;2027&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;312,358&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_iI_maFLIANzgGq_zlLijaxGX7W3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;2028&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;528&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour_iI_maFLIANzgGq_zSd01zuCTb31" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"&gt;Thereafter&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1046"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_mtFLIANzgGq_zLFRe29Qm969" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;1,534,682&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A6_zTFjqqWrscsa" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:IntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock contextRef="From2024-03-01to2025-02-28" id="Fact001012">&lt;p id="xdx_897_eus-gaap--ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_zMzuwzsxZmVb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Intangible
assets as of February 28, 2025, and February 29, 2024 consisted of the following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B9_zcVqzSqgiiBl" style="display: none"&gt;Schedule
of Intangible Assets&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_491_20250228_zMGiNaZmXL5b" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;February 28,&lt;/p&gt;
                                                                               &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;2025&lt;/p&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_497_20240229_zetU7acUGT5k" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;February 29,&lt;/p&gt;
                                                                               &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;2024&lt;/p&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_hus-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareDevelopmentMember_zekzs3dSm5ml" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left"&gt;Software Development&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;7,267,778&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;6,602,028&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_hus-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SoftwareLicenseMember_zWrgLBaj59K" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Software Licenses&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;789,576&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;789,576&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_hus-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksMember_z50dLyO1uDDg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;Trademark&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;6,283&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;6,283&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_maIANEGzjZg_zeOpXEg4tvac" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;Total&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;8,063,637&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;7,397,887&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iNI_di_msIANEGzjZg_zOR1s54bfor5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"&gt;Accumulated amortization&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(5,936,269&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(5,224,467&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--IntangibleAssetsNetExcludingGoodwill_iTI_mtIANEGzjZg_zMNY8S7Av56d" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"&gt;Intangible assets, net of amortization&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;2,127,368&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;2,173,420&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2025-02-28_us-gaap_SoftwareDevelopmentMember"
      decimals="0"
      id="Fact001014"
      unitRef="USD">7267778</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2024-02-29_us-gaap_SoftwareDevelopmentMember"
      decimals="0"
      id="Fact001015"
      unitRef="USD">6602028</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2025-02-28_custom_SoftwareLicenseMember"
      decimals="0"
      id="Fact001017"
      unitRef="USD">789576</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2024-02-29_custom_SoftwareLicenseMember"
      decimals="0"
      id="Fact001018"
      unitRef="USD">789576</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2025-02-28_us-gaap_TrademarksMember"
      decimals="0"
      id="Fact001020"
      unitRef="USD">6283</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2024-02-29_us-gaap_TrademarksMember"
      decimals="0"
      id="Fact001021"
      unitRef="USD">6283</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2025-02-28"
      decimals="0"
      id="Fact001023"
      unitRef="USD">8063637</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2024-02-29"
      decimals="0"
      id="Fact001024"
      unitRef="USD">7397887</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="AsOf2025-02-28"
      decimals="0"
      id="Fact001026"
      unitRef="USD">5936269</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="AsOf2024-02-29"
      decimals="0"
      id="Fact001027"
      unitRef="USD">5224467</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="AsOf2025-02-28"
      decimals="0"
      id="Fact001029"
      unitRef="USD">2127368</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="AsOf2024-02-29"
      decimals="0"
      id="Fact001030"
      unitRef="USD">2173420</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="From2024-03-01to2025-02-28"
      decimals="0"
      id="Fact001032"
      unitRef="USD">711802</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact001034"
      unitRef="USD">1449925</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock contextRef="From2024-03-01to2025-02-28" id="Fact001036">&lt;p id="xdx_890_eus-gaap--ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_zxtda79nCq13" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
estimated aggregate amortization expense for each of the succeeding years ending February 28 is as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;span id="xdx_8BF_zK8DGd5XDLF7" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Schedule
of estimated aggregate amortization expense&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_492_20250228_zvwRmE3Hy06d" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_400_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_iI_maFLIANzgGq_zmX8Le2zIXee" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 78%; text-align: left"&gt;2025&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right"&gt;597,914&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_iI_maFLIANzgGq_zlGpJjXF1bSi" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;2026&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;623,882&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_iI_maFLIANzgGq_zIvT3DmfbQ46" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;2027&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;312,358&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_iI_maFLIANzgGq_zlLijaxGX7W3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;2028&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;528&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour_iI_maFLIANzgGq_zSd01zuCTb31" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"&gt;Thereafter&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1046"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_mtFLIANzgGq_zLFRe29Qm969" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;1,534,682&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="AsOf2025-02-28"
      decimals="0"
      id="Fact001038"
      unitRef="USD">597914</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="AsOf2025-02-28"
      decimals="0"
      id="Fact001040"
      unitRef="USD">623882</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="AsOf2025-02-28"
      decimals="0"
      id="Fact001042"
      unitRef="USD">312358</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="AsOf2025-02-28"
      decimals="0"
      id="Fact001044"
      unitRef="USD">528</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="AsOf2025-02-28"
      decimals="0"
      id="Fact001048"
      unitRef="USD">1534682</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:GoodwillDisclosureTextBlock contextRef="From2024-03-01to2025-02-28" id="Fact001050">&lt;p id="xdx_801_eus-gaap--GoodwillDisclosureTextBlock_zWPMFJypXXB3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
9 &#x2013; &lt;span id="xdx_829_zVVnxALhjXHc"&gt;Goodwill&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
discussed in &lt;b&gt;Note 1&#x2013; Business Description and Going Concern&lt;/b&gt;, the legal acquisition of NTH by the Company was determined to be a reverse acquisition, with NTH as the accounting acquirer, using the acquisition method of accounting
in accordance with ASC 805, Business Combinations. Under this method of accounting, the purchase price was allocated to the assets acquired
and liabilities assumed based upon their estimated fair values at the date of consummation of the transaction.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table presents the allocation of the $&lt;span id="xdx_900_eus-gaap--BusinessCombinationConsiderationTransferred1_c20231012__20231012__us-gaap--BusinessAcquisitionAxis__custom--SigmaAdditiveSolutionsIncMember_zW6FAhvFKOug" title="Consideration transferred"&gt;2,368,418&lt;/span&gt;
consideration for the acquisition and summarizes the estimated fair values of the Sigma (the accounting acquiree) assets acquired
and liabilities assumed for NTH (the accounting acquirer). The estimated consideration of approximately $&lt;span id="xdx_904_eus-gaap--BusinessCombinationConsiderationTransferred1_c20231012__20231012__us-gaap--BusinessAcquisitionAxis__custom--SigmaAdditiveSolutionsIncMember_zRSV2kBwEe62" title="Consideration transferred"&gt;2,368,418&lt;/span&gt;
is based on Sigma&#x2019;s closing share price of $&lt;span id="xdx_906_eus-gaap--BusinessAcquisitionSharePrice_iI_pid_c20231012__us-gaap--BusinessAcquisitionAxis__custom--SigmaAdditiveSolutionsIncMember_z8YJRkGf8PSb" title="Share price"&gt;3.0229,&lt;/span&gt;
as reported on Nasdaq on December 29, 2023 multiplied by the &lt;span id="xdx_90A_eus-gaap--CommonStockSharesOutstanding_iI_c20231012_zPDW0LbjsEVg" title="Shares outstanding"&gt;780,423&lt;/span&gt;
shares outstanding as of that date and the fair value of Series E Preferred Stock (on an as converted basis) into &lt;span id="xdx_904_eus-gaap--CommonStockSharesOutstanding_iI_c20231012__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesEPreferredStockMember_zBjDxbkcvl42" title="Shares outstanding"&gt;3,069&lt;/span&gt;
common shares.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89C_eus-gaap--ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_zDnofmYiEA1d" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BB_zX19U9Pi4bTl" style="display: none"&gt;Schedule
of Fair Value of Assets Acquired&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_495_20231012__us-gaap--BusinessAcquisitionAxis__custom--SigmaAdditiveSolutionsIncMember_zzmncsXgk2P3" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td colspan="5" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Fair Value of Net Assets Acquired:&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_iI_maBCRIAzMVe_zYkg02IIjFDb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 78%"&gt;Cash&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right"&gt;417,121&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_iI_maBCRIAzMVe_z15YejLtQxk9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Accounts Receivable, net&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;4,900&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_iI_maBCRIAzMVe_zQWARQWVfXci" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;Inventory&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;257,873&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_iI_maBCRIAzMVe_zL1FXHlImNyg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Prepaid expenses and other current assets&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;50,802&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_iI_maBCRIAzMVe_z3g28zCwuAf4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Property and equipment&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;52,357&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_iI_maBCRIAzMVe_z6ftHVRcBZg7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Intangible assets&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;1,277,919&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_iNI_di_msBCRIAzMVe_zpye9vMBtYE1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Accounts payable&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(837,450&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses_iNI_di_msBCRIAzMVe_zV7kmVYEqlQ7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Accrued expenses&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(61,001&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_iNI_di_msBCRIAzMVe_zEkqA9FU2eYj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"&gt;Deferred revenue&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(14,218&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iTI_mtBCRIAzMVe_maBCRIAzevg_z0KXangQ1Emi" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Total identifiable net assets acquired&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;1,148,303&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--Goodwill_iI_maBCRIAzevg_z0xwSYYEs4Je" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;Goodwill&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;1,220,115&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_iTI_mtBCRIAzevg_zXBJU8hxiP4e" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"&gt;Total Fair Value of Net Assets Acquired&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"&gt;2,368,418&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"&gt;Total Purchase Consideration&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--BusinessCombinationConsiderationTransferred1_c20231012__20231012__us-gaap--BusinessAcquisitionAxis__custom--SigmaAdditiveSolutionsIncMember_zcZftK0JDz8j" style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"&gt;2,368,418&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A0_zczo4MRxO5Hl" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Pursuant
to ASC 350-20, the Company assigned its goodwill to reporting units and is required to test each reporting unit&#x2019;s goodwill for
impairment at least on an annual basis and between annual tests if an event occurs or circumstances change that would more likely
than not reduce the fair value of a reporting unit below its carrying amount. The goodwill resulting from the reverse acquisition is
primarily attributable to NTH&#x2019;s objective to obtain access to public markets to provide funding wherewithal to fund business
growth. NTH&#x2019;s benefit in paying for these synergies in the reverse acquisition transaction are to avoid the time and expense
of organizing and executing an Initial Public Offering transaction. In the reverse acquisition, $&lt;span id="xdx_902_eus-gaap--GoodwillPeriodIncreaseDecrease_c20231012__20231012__us-gaap--BusinessAcquisitionAxis__custom--SigmaAdditiveSolutionsIncMember_zi5bC55rUBYa" title="Goodwill"&gt;52,310&lt;/span&gt;
of goodwill was allocated to the Sigma Reporting Unit (as defined below) and $&lt;span id="xdx_90B_eus-gaap--GoodwillPeriodIncreaseDecrease_c20231012__20231012__us-gaap--BusinessAcquisitionAxis__custom--NextTripHoldingsIncMember_z6OXPWNwWl83" title="Goodwill"&gt;1,167,805&lt;/span&gt;
of goodwill was allocated to the NTH Reporting Unit (as defined below) under the acquisition method of accounting.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
combined Company consists of two reporting units, Sigma (the &#x201c;Sigma Reporting Unit&#x201d;) and NTH (the &#x201c;NTH Reporting
Unit&#x201d;). As the accounting acquirer in the reverse acquisition, NTH is considered to be an existing reporting unit and Sigma is
considered to be a new reporting unit in that it is not in the same business as NTH. Accordingly, the reverse acquisition creates a
new reporting unit which holds the Sigma business, constituting an asset held for sale as a result of the agreement for the sale of
certain legacy Sigma assets to Divergent for a sales price of $&lt;span id="xdx_900_eus-gaap--PaymentsToAcquireIntangibleAssets_c20231012__20231012__dei--LegalEntityAxis__custom--DivergentTechnologiesIncMember_ziJtjLwFy6Zi" title="Purchase price"&gt;1,626,242&lt;/span&gt;.
As such, the fair value of the Sigma Reporting Unit is determined to be $&lt;span id="xdx_900_eus-gaap--PaymentsToAcquireIntangibleAssets_c20231012__20231012__dei--LegalEntityAxis__custom--DivergentTechnologiesIncMember_zBatN4lIfTFe" title="Purchase price"&gt;1,626,242&lt;/span&gt;,
with the difference of $&lt;span id="xdx_90C_eus-gaap--BusinessCombinationConsiderationTransferred1_c20231012__20231012__us-gaap--BusinessAcquisitionAxis__custom--NextTripHoldingsIncMember_zTcxU0mfMXnb" title="Purchase consideration"&gt;742,176&lt;/span&gt;
from the purchase consideration being allocated to the NTH Reporting Unit. The assets sold to Divergent and the
liabilities relieved from the Divergent transaction are assigned to the Sigma Reporting unit with the difference between the
net fair value of those assets and liabilities and the Sigma Reporting Unit being assigned to goodwill. The goodwill being assigned
to the NTH Reporting Unit is determined by the difference between the purchase consideration assigned to the NTH Reporting
Unit and the net acquired Sigma assets and liabilities assumed that are assigned to the NTH Reporting Unit. A gain of $&lt;span id="xdx_906_eus-gaap--GainLossOnDispositionOfAssets_c20231012__20231012_zEoTtbZ4IOCh" title="Gain on disposition transaction"&gt;37,592&lt;/span&gt;
was recognized in the disposition transaction.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:GoodwillDisclosureTextBlock>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="From2023-10-122023-10-12_custom_SigmaAdditiveSolutionsIncMember"
      decimals="0"
      id="Fact001052"
      unitRef="USD">2368418</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="From2023-10-122023-10-12_custom_SigmaAdditiveSolutionsIncMember"
      decimals="0"
      id="Fact001054"
      unitRef="USD">2368418</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessAcquisitionSharePrice
      contextRef="AsOf2023-10-12_custom_SigmaAdditiveSolutionsIncMember"
      decimals="INF"
      id="Fact001056"
      unitRef="USDPShares">3.0229</us-gaap:BusinessAcquisitionSharePrice>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2023-10-12"
      decimals="INF"
      id="Fact001058"
      unitRef="Shares">780423</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2023-10-12_us-gaap_SeriesEPreferredStockMember"
      decimals="INF"
      id="Fact001060"
      unitRef="Shares">3069</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock contextRef="From2024-03-01to2025-02-28" id="Fact001062">&lt;p id="xdx_89C_eus-gaap--ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_zDnofmYiEA1d" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BB_zX19U9Pi4bTl" style="display: none"&gt;Schedule
of Fair Value of Assets Acquired&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_495_20231012__us-gaap--BusinessAcquisitionAxis__custom--SigmaAdditiveSolutionsIncMember_zzmncsXgk2P3" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td colspan="5" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Fair Value of Net Assets Acquired:&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_iI_maBCRIAzMVe_zYkg02IIjFDb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 78%"&gt;Cash&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right"&gt;417,121&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_iI_maBCRIAzMVe_z15YejLtQxk9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Accounts Receivable, net&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;4,900&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_iI_maBCRIAzMVe_zQWARQWVfXci" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;Inventory&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;257,873&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_iI_maBCRIAzMVe_zL1FXHlImNyg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Prepaid expenses and other current assets&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;50,802&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_iI_maBCRIAzMVe_z3g28zCwuAf4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Property and equipment&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;52,357&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_iI_maBCRIAzMVe_z6ftHVRcBZg7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Intangible assets&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;1,277,919&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_iNI_di_msBCRIAzMVe_zpye9vMBtYE1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Accounts payable&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(837,450&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses_iNI_di_msBCRIAzMVe_zV7kmVYEqlQ7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Accrued expenses&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(61,001&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_iNI_di_msBCRIAzMVe_zEkqA9FU2eYj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"&gt;Deferred revenue&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(14,218&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iTI_mtBCRIAzMVe_maBCRIAzevg_z0KXangQ1Emi" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Total identifiable net assets acquired&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;1,148,303&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--Goodwill_iI_maBCRIAzevg_z0xwSYYEs4Je" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;Goodwill&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;1,220,115&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_iTI_mtBCRIAzevg_zXBJU8hxiP4e" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"&gt;Total Fair Value of Net Assets Acquired&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"&gt;2,368,418&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"&gt;Total Purchase Consideration&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--BusinessCombinationConsiderationTransferred1_c20231012__20231012__us-gaap--BusinessAcquisitionAxis__custom--SigmaAdditiveSolutionsIncMember_zcZftK0JDz8j" style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"&gt;2,368,418&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
      contextRef="AsOf2023-10-12_custom_SigmaAdditiveSolutionsIncMember"
      decimals="0"
      id="Fact001064"
      unitRef="USD">417121</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
      contextRef="AsOf2023-10-12_custom_SigmaAdditiveSolutionsIncMember"
      decimals="0"
      id="Fact001066"
      unitRef="USD">4900</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory
      contextRef="AsOf2023-10-12_custom_SigmaAdditiveSolutionsIncMember"
      decimals="0"
      id="Fact001068"
      unitRef="USD">257873</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets
      contextRef="AsOf2023-10-12_custom_SigmaAdditiveSolutionsIncMember"
      decimals="0"
      id="Fact001070"
      unitRef="USD">50802</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="AsOf2023-10-12_custom_SigmaAdditiveSolutionsIncMember"
      decimals="0"
      id="Fact001072"
      unitRef="USD">52357</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="AsOf2023-10-12_custom_SigmaAdditiveSolutionsIncMember"
      decimals="0"
      id="Fact001074"
      unitRef="USD">1277919</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable
      contextRef="AsOf2023-10-12_custom_SigmaAdditiveSolutionsIncMember"
      decimals="0"
      id="Fact001076"
      unitRef="USD">837450</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable>
    <NTRP:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses
      contextRef="AsOf2023-10-12_custom_SigmaAdditiveSolutionsIncMember"
      decimals="0"
      id="Fact001078"
      unitRef="USD">61001</NTRP:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue
      contextRef="AsOf2023-10-12_custom_SigmaAdditiveSolutionsIncMember"
      decimals="0"
      id="Fact001080"
      unitRef="USD">14218</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
      contextRef="AsOf2023-10-12_custom_SigmaAdditiveSolutionsIncMember"
      decimals="0"
      id="Fact001082"
      unitRef="USD">1148303</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
    <us-gaap:Goodwill
      contextRef="AsOf2023-10-12_custom_SigmaAdditiveSolutionsIncMember"
      decimals="0"
      id="Fact001084"
      unitRef="USD">1220115</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="AsOf2023-10-12_custom_SigmaAdditiveSolutionsIncMember"
      decimals="0"
      id="Fact001086"
      unitRef="USD">2368418</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="From2023-10-122023-10-12_custom_SigmaAdditiveSolutionsIncMember"
      decimals="0"
      id="Fact001087"
      unitRef="USD">2368418</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:GoodwillPeriodIncreaseDecrease
      contextRef="From2023-10-122023-10-12_custom_SigmaAdditiveSolutionsIncMember"
      decimals="0"
      id="Fact001089"
      unitRef="USD">52310</us-gaap:GoodwillPeriodIncreaseDecrease>
    <us-gaap:GoodwillPeriodIncreaseDecrease
      contextRef="From2023-10-122023-10-12_custom_NextTripHoldingsIncMember"
      decimals="0"
      id="Fact001091"
      unitRef="USD">1167805</us-gaap:GoodwillPeriodIncreaseDecrease>
    <us-gaap:PaymentsToAcquireIntangibleAssets
      contextRef="From2023-10-122023-10-12_custom_DivergentTechnologiesIncMember"
      decimals="0"
      id="Fact001093"
      unitRef="USD">1626242</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:PaymentsToAcquireIntangibleAssets
      contextRef="From2023-10-122023-10-12_custom_DivergentTechnologiesIncMember"
      decimals="0"
      id="Fact001095"
      unitRef="USD">1626242</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="From2023-10-122023-10-12_custom_NextTripHoldingsIncMember"
      decimals="0"
      id="Fact001097"
      unitRef="USD">742176</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:GainLossOnDispositionOfAssets
      contextRef="From2023-10-122023-10-12"
      decimals="0"
      id="Fact001099"
      unitRef="USD">37592</us-gaap:GainLossOnDispositionOfAssets>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock contextRef="From2024-03-01to2025-02-28" id="Fact001101">&lt;p id="xdx_80D_eus-gaap--AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_z7y9rYBML4o7" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
10 - &lt;span id="xdx_825_zJ9fAe9YNBbf"&gt;Accounts Payable and Accrued Liabilities&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of February 28, 2025, the Company had accounts payable of $&lt;span id="xdx_907_eus-gaap--AccountsPayableCurrentAndNoncurrent_iI_c20250228_zryYUIlMxoT8" title="Accounts payable"&gt;1,184,404&lt;/span&gt; and accrued expenses of $&lt;span id="xdx_90D_eus-gaap--AccruedLiabilitiesCurrentAndNoncurrent_iI_c20250228_zOPT2vJQ7Gq3" title="Accrued expenses"&gt;721,382&lt;/span&gt;, compared to $&lt;span id="xdx_905_eus-gaap--AccountsPayableCurrentAndNoncurrent_iI_c20240229_znbiVZ0aUmH2" title="Accounts payable"&gt;531,847&lt;/span&gt; of accounts
payable and $&lt;span id="xdx_90B_eus-gaap--AccruedLiabilitiesCurrentAndNoncurrent_iI_c20240229_z11rWuyggAGf" title="Accrued expenses"&gt;460,768&lt;/span&gt; of accrued expenses for the year ended February 29, 2024.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock>
    <us-gaap:AccountsPayableCurrentAndNoncurrent
      contextRef="AsOf2025-02-28"
      decimals="0"
      id="Fact001103"
      unitRef="USD">1184404</us-gaap:AccountsPayableCurrentAndNoncurrent>
    <us-gaap:AccruedLiabilitiesCurrentAndNoncurrent
      contextRef="AsOf2025-02-28"
      decimals="0"
      id="Fact001105"
      unitRef="USD">721382</us-gaap:AccruedLiabilitiesCurrentAndNoncurrent>
    <us-gaap:AccountsPayableCurrentAndNoncurrent
      contextRef="AsOf2024-02-29"
      decimals="0"
      id="Fact001107"
      unitRef="USD">531847</us-gaap:AccountsPayableCurrentAndNoncurrent>
    <us-gaap:AccruedLiabilitiesCurrentAndNoncurrent
      contextRef="AsOf2024-02-29"
      decimals="0"
      id="Fact001109"
      unitRef="USD">460768</us-gaap:AccruedLiabilitiesCurrentAndNoncurrent>
    <us-gaap:IncomeTaxDisclosureTextBlock contextRef="From2024-03-01to2025-02-28" id="Fact001111">&lt;p id="xdx_802_eus-gaap--IncomeTaxDisclosureTextBlock_zAMEfinEtRp8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
11 &#x2013; &lt;span id="xdx_821_zRvcjmT4d2N5"&gt;Income Taxes&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company accounts for income taxes in accordance with ASC Topic No. 740. This standard requires the Company to provide a net deferred
tax asset or liability equal to the expected future tax benefit or expense of temporary reporting differences between book and tax
accounting methods and any available net operating loss or tax credit carryforwards. Income tax returns open for examination by the
Internal Revenue Service consist of tax years ended February 28, 2021 through 2023.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company had available at February 28, 2025 unused operating loss carryforwards of approximately $&lt;span id="xdx_90A_eus-gaap--OperatingLossCarryforwards_iI_c20250228_zSA0W3b79QS8" title="Operating loss carryforwards"&gt;54,763,000&lt;/span&gt;, which may be applied against
future taxable income. Losses incurred between 2010 and 2017, which total $&lt;span id="xdx_900_eus-gaap--OperatingLossCarryforwards_iI_c20171231_zmYP2WgUOpP6" title="Operating loss carryforwards"&gt;9,820,000&lt;/span&gt;, expire in various years through 2038, and the remainder
of the losses, which total $&lt;span id="xdx_90A_ecustom--OperatingLossCarryforwardsRemainder_iI_c20250228_z5GAdPXg45Kc" title="Operating loss carryforwards remainder"&gt;44,943,000&lt;/span&gt;, can be carried forward indefinitely. Due to the change in ownership provisions of the Tax Reform
Act of 1986, net operating loss carryforwards for Federal income tax reported purposes are subject to annual limitations. Due to the
change in ownership as a result of the reverse acquisition, the Company&#x2019;s net operating loss carryforwards may be limited as to
use in future years, and any such limitation will be determined on a year-to-year basis. The amount and ultimate realization of the
benefits from the operating loss carryforwards for income tax purposes is dependent, in part, upon the tax laws in effect, the future
earnings of the Company and other future events, the effects of which cannot be determined. Because of the uncertainty surrounding the
realization of the loss carryforwards, the Company has established a valuation allowance equal to the tax effect of the loss carryforwards
and other temporary differences of approximately $&lt;span id="xdx_904_eus-gaap--DeferredTaxAssetsValuationAllowance_iI_c20250228_zXMxl7FIKd6h" title="Valuation allowance loss carryforwards"&gt;11,816,400&lt;/span&gt; and $&lt;span id="xdx_900_eus-gaap--DeferredTaxAssetsValuationAllowance_iI_c20240229_zqO5bIbmUTp" title="Valuation allowance loss carryforwards"&gt;11,250,300&lt;/span&gt; at February 28, 2025, and February 29, 2024, respectively,
and, therefore, no deferred tax asset has been recognized for the loss carryforwards.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89C_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zm5FVERFSJ79" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Deferred
tax assets are comprised of the following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8BA_zjS1RXDG8JMl" style="display: none"&gt;Schedule of Deferred Tax Assets&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_497_20250228_zMJ3N7S1jjIh" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;2025&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49C_20240229_zhx5HdvLifX5" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Deferred tax assets:&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_pp0p0_maDTANzaXy_z7BPBcuMa4j6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left"&gt;NOL carryover&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;11,500,300&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;9,226,100&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--DeferredTaxAssetDepreciation_iI_pp0p0_maDTANzaXy_zpGYk1ZOToF6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Related party accruals&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;12,900&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;173,900&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--DeferredTaxAssetsPayrollAccruals_iI_pp0p0_maDTANzaXy_zwCIXWVDgPE9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Payroll accruals&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;47,800&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;77,800&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Deferred tax liabilities:&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_ecustom--DeferredTaxLiabilitiesDepreciation_iNI_di_msDTANzaXy_z3CrokXutTlk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;Depreciation&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;255,400&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;1,772,500&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_di_msDTANzaXy_zB3Dn34YPKJe" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"&gt;Valuation allowance&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(11,816,400&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(11,250,300&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--DeferredTaxAssetsNet_iTI_pp0p0_mtDTANzaXy_zmyZXff2Z04a" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"&gt;Net deferred tax asset (liability)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1140"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1141"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AD_zLxZyXncLAHj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
reconciliation of the provision for income taxes computed at the U.S. federal statutory tax rate (&lt;span id="xdx_90F_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pid_dp_uPure_c20240301__20250228_zTwd4Tos7Jcj" title="Federal statutory tax rate"&gt;&lt;span id="xdx_908_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pid_dp_uPure_c20230301__20240229_zKEATpMRAFKj" title="Federal statutory tax rate"&gt;21&lt;/span&gt;&lt;/span&gt;%) to the Company&#x2019;s effective
tax rate for the years ended February 28, 2025, and February 29, 2024 is as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_894_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_z1nA8U21pNwd" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8BE_zVTgBR51BTI" style="display: none"&gt;Schedule
of Reconciliation of Provision for Income Taxes&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49E_20240301__20250228_zGywL4iFe0Kh" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;2025&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_498_20230301__20240229_zF6BxogVbtue" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--EffectiveIncomeTaxRateReconciliationBookLoss_maITEBzMQv_zQlIL8hoKUDf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left"&gt;Book loss&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;(2,141,700&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;(1,541,200&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--IncomeTaxReconciliationNondeductibleExpenseDepreciation_maITEBzMQv_zfkiHKDQ2hk7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;Depreciation&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(197,100&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;270,100&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment_maITEBzMQv_zsvIGW2gXn6f" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Meals &amp;amp; entertainment&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1155"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;300&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--IncomeTaxReconciliationNondeductibleExpensePreferredDividends_maITEBzMQv_z5S1j75qjE8g" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Preferred dividends&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;16,506&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;422,842&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--IncomeTaxReconciliationNondeductibleExpenseLossOnNextPlayNoteReceivable_maITEBzMQv_zZHdbst94oE5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Loss on NextPlay note receivable&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;p style="margin: 0"&gt;210,000&lt;/p&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;p style="margin: 0"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1162"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_maITEBzMQv_zBx7diM0508d" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Stock compensation&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;14,254&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;24,468&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--IncomeTaxReconciliationNondeductibleExpenseLossOnAssetDisposal_maITEBzMQv_zIsiJttSawak" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Loss on asset disposal&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;229&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;67,274&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_ecustom--IncomeTaxReconciliationNondeductibleExpenseAccruedPayroll_maITEBzMQv_zl7vdpLM9dDb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Accrued payroll&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(29,991&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;51,857&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--IncomeTaxReconciliationNondeductibleExpenseRelatedPartyAccruals_maITEBzMQv_zSajqfDyM3ac" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Related party accruals&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(161,018&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;114,928&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_maITEBzMQv_z8zXFDg5og7a" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"&gt;Change in valuation allowance&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;2,288,820&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;589,431&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--IncomeTaxExpenseBenefit_iT_pp0p0_mtITEBzMQv_zCxHBGqrRx7a" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"&gt;Provision for Income Taxes&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1179"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1180"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A9_zH8XhtFGojgd" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:OperatingLossCarryforwards
      contextRef="AsOf2025-02-28"
      decimals="0"
      id="Fact001113"
      unitRef="USD">54763000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="AsOf2017-12-31"
      decimals="0"
      id="Fact001115"
      unitRef="USD">9820000</us-gaap:OperatingLossCarryforwards>
    <NTRP:OperatingLossCarryforwardsRemainder
      contextRef="AsOf2025-02-28"
      decimals="0"
      id="Fact001117"
      unitRef="USD">44943000</NTRP:OperatingLossCarryforwardsRemainder>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="AsOf2025-02-28"
      decimals="0"
      id="Fact001119"
      unitRef="USD">11816400</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="AsOf2024-02-29"
      decimals="0"
      id="Fact001121"
      unitRef="USD">11250300</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock contextRef="From2024-03-01to2025-02-28" id="Fact001123">&lt;p id="xdx_89C_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zm5FVERFSJ79" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Deferred
tax assets are comprised of the following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8BA_zjS1RXDG8JMl" style="display: none"&gt;Schedule of Deferred Tax Assets&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_497_20250228_zMJ3N7S1jjIh" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;2025&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49C_20240229_zhx5HdvLifX5" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Deferred tax assets:&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_pp0p0_maDTANzaXy_z7BPBcuMa4j6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left"&gt;NOL carryover&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;11,500,300&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;9,226,100&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--DeferredTaxAssetDepreciation_iI_pp0p0_maDTANzaXy_zpGYk1ZOToF6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Related party accruals&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;12,900&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;173,900&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--DeferredTaxAssetsPayrollAccruals_iI_pp0p0_maDTANzaXy_zwCIXWVDgPE9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Payroll accruals&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;47,800&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;77,800&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Deferred tax liabilities:&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_ecustom--DeferredTaxLiabilitiesDepreciation_iNI_di_msDTANzaXy_z3CrokXutTlk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;Depreciation&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;255,400&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;1,772,500&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_di_msDTANzaXy_zB3Dn34YPKJe" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"&gt;Valuation allowance&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(11,816,400&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(11,250,300&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--DeferredTaxAssetsNet_iTI_pp0p0_mtDTANzaXy_zmyZXff2Z04a" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"&gt;Net deferred tax asset (liability)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1140"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1141"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="AsOf2025-02-28"
      decimals="0"
      id="Fact001125"
      unitRef="USD">11500300</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="AsOf2024-02-29"
      decimals="0"
      id="Fact001126"
      unitRef="USD">9226100</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <NTRP:DeferredTaxAssetDepreciation
      contextRef="AsOf2025-02-28"
      decimals="0"
      id="Fact001128"
      unitRef="USD">12900</NTRP:DeferredTaxAssetDepreciation>
    <NTRP:DeferredTaxAssetDepreciation
      contextRef="AsOf2024-02-29"
      decimals="0"
      id="Fact001129"
      unitRef="USD">173900</NTRP:DeferredTaxAssetDepreciation>
    <NTRP:DeferredTaxAssetsPayrollAccruals
      contextRef="AsOf2025-02-28"
      decimals="0"
      id="Fact001131"
      unitRef="USD">47800</NTRP:DeferredTaxAssetsPayrollAccruals>
    <NTRP:DeferredTaxAssetsPayrollAccruals
      contextRef="AsOf2024-02-29"
      decimals="0"
      id="Fact001132"
      unitRef="USD">77800</NTRP:DeferredTaxAssetsPayrollAccruals>
    <NTRP:DeferredTaxLiabilitiesDepreciation
      contextRef="AsOf2025-02-28"
      decimals="0"
      id="Fact001134"
      unitRef="USD">-255400</NTRP:DeferredTaxLiabilitiesDepreciation>
    <NTRP:DeferredTaxLiabilitiesDepreciation
      contextRef="AsOf2024-02-29"
      decimals="0"
      id="Fact001135"
      unitRef="USD">-1772500</NTRP:DeferredTaxLiabilitiesDepreciation>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="AsOf2025-02-28"
      decimals="0"
      id="Fact001137"
      unitRef="USD">11816400</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="AsOf2024-02-29"
      decimals="0"
      id="Fact001138"
      unitRef="USD">11250300</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="From2024-03-01to2025-02-28"
      decimals="INF"
      id="Fact001143"
      unitRef="Pure">0.21</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="From2023-03-012024-02-29"
      decimals="INF"
      id="Fact001145"
      unitRef="Pure">0.21</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock contextRef="From2024-03-01to2025-02-28" id="Fact001147">&lt;p id="xdx_894_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_z1nA8U21pNwd" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8BE_zVTgBR51BTI" style="display: none"&gt;Schedule
of Reconciliation of Provision for Income Taxes&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49E_20240301__20250228_zGywL4iFe0Kh" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;2025&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_498_20230301__20240229_zF6BxogVbtue" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--EffectiveIncomeTaxRateReconciliationBookLoss_maITEBzMQv_zQlIL8hoKUDf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left"&gt;Book loss&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;(2,141,700&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;(1,541,200&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--IncomeTaxReconciliationNondeductibleExpenseDepreciation_maITEBzMQv_zfkiHKDQ2hk7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;Depreciation&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(197,100&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;270,100&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment_maITEBzMQv_zsvIGW2gXn6f" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Meals &amp;amp; entertainment&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1155"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;300&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--IncomeTaxReconciliationNondeductibleExpensePreferredDividends_maITEBzMQv_z5S1j75qjE8g" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Preferred dividends&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;16,506&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;422,842&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--IncomeTaxReconciliationNondeductibleExpenseLossOnNextPlayNoteReceivable_maITEBzMQv_zZHdbst94oE5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Loss on NextPlay note receivable&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;p style="margin: 0"&gt;210,000&lt;/p&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;p style="margin: 0"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1162"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_maITEBzMQv_zBx7diM0508d" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Stock compensation&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;14,254&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;24,468&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--IncomeTaxReconciliationNondeductibleExpenseLossOnAssetDisposal_maITEBzMQv_zIsiJttSawak" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Loss on asset disposal&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;229&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;67,274&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_ecustom--IncomeTaxReconciliationNondeductibleExpenseAccruedPayroll_maITEBzMQv_zl7vdpLM9dDb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Accrued payroll&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(29,991&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;51,857&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--IncomeTaxReconciliationNondeductibleExpenseRelatedPartyAccruals_maITEBzMQv_zSajqfDyM3ac" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Related party accruals&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(161,018&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;114,928&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_maITEBzMQv_z8zXFDg5og7a" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"&gt;Change in valuation allowance&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;2,288,820&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;589,431&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--IncomeTaxExpenseBenefit_iT_pp0p0_mtITEBzMQv_zCxHBGqrRx7a" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"&gt;Provision for Income Taxes&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1179"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1180"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <NTRP:EffectiveIncomeTaxRateReconciliationBookLoss
      contextRef="From2024-03-01to2025-02-28"
      decimals="0"
      id="Fact001149"
      unitRef="USD">-2141700</NTRP:EffectiveIncomeTaxRateReconciliationBookLoss>
    <NTRP:EffectiveIncomeTaxRateReconciliationBookLoss
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact001150"
      unitRef="USD">-1541200</NTRP:EffectiveIncomeTaxRateReconciliationBookLoss>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseDepreciation
      contextRef="From2024-03-01to2025-02-28"
      decimals="0"
      id="Fact001152"
      unitRef="USD">-197100</us-gaap:IncomeTaxReconciliationNondeductibleExpenseDepreciation>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseDepreciation
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact001153"
      unitRef="USD">270100</us-gaap:IncomeTaxReconciliationNondeductibleExpenseDepreciation>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact001156"
      unitRef="USD">300</us-gaap:IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment>
    <NTRP:IncomeTaxReconciliationNondeductibleExpensePreferredDividends
      contextRef="From2024-03-01to2025-02-28"
      decimals="0"
      id="Fact001158"
      unitRef="USD">16506</NTRP:IncomeTaxReconciliationNondeductibleExpensePreferredDividends>
    <NTRP:IncomeTaxReconciliationNondeductibleExpensePreferredDividends
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact001159"
      unitRef="USD">422842</NTRP:IncomeTaxReconciliationNondeductibleExpensePreferredDividends>
    <NTRP:IncomeTaxReconciliationNondeductibleExpenseLossOnNextPlayNoteReceivable
      contextRef="From2024-03-01to2025-02-28"
      decimals="0"
      id="Fact001161"
      unitRef="USD">210000</NTRP:IncomeTaxReconciliationNondeductibleExpenseLossOnNextPlayNoteReceivable>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
      contextRef="From2024-03-01to2025-02-28"
      decimals="0"
      id="Fact001164"
      unitRef="USD">14254</us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact001165"
      unitRef="USD">24468</us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <NTRP:IncomeTaxReconciliationNondeductibleExpenseLossOnAssetDisposal
      contextRef="From2024-03-01to2025-02-28"
      decimals="0"
      id="Fact001167"
      unitRef="USD">229</NTRP:IncomeTaxReconciliationNondeductibleExpenseLossOnAssetDisposal>
    <NTRP:IncomeTaxReconciliationNondeductibleExpenseLossOnAssetDisposal
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact001168"
      unitRef="USD">67274</NTRP:IncomeTaxReconciliationNondeductibleExpenseLossOnAssetDisposal>
    <NTRP:IncomeTaxReconciliationNondeductibleExpenseAccruedPayroll
      contextRef="From2024-03-01to2025-02-28"
      decimals="0"
      id="Fact001170"
      unitRef="USD">-29991</NTRP:IncomeTaxReconciliationNondeductibleExpenseAccruedPayroll>
    <NTRP:IncomeTaxReconciliationNondeductibleExpenseAccruedPayroll
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact001171"
      unitRef="USD">51857</NTRP:IncomeTaxReconciliationNondeductibleExpenseAccruedPayroll>
    <NTRP:IncomeTaxReconciliationNondeductibleExpenseRelatedPartyAccruals
      contextRef="From2024-03-01to2025-02-28"
      decimals="0"
      id="Fact001173"
      unitRef="USD">-161018</NTRP:IncomeTaxReconciliationNondeductibleExpenseRelatedPartyAccruals>
    <NTRP:IncomeTaxReconciliationNondeductibleExpenseRelatedPartyAccruals
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact001174"
      unitRef="USD">114928</NTRP:IncomeTaxReconciliationNondeductibleExpenseRelatedPartyAccruals>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="From2024-03-01to2025-02-28"
      decimals="0"
      id="Fact001176"
      unitRef="USD">2288820</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact001177"
      unitRef="USD">589431</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:DebtDisclosureTextBlock contextRef="From2024-03-01to2025-02-28" id="Fact001182">&lt;p id="xdx_80B_eus-gaap--DebtDisclosureTextBlock_zJycisDhM7kj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
12 &#x2013; &lt;span id="xdx_82A_zKmZC7DCvcz3"&gt;Notes Payable&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
May 24, 2024, the Company sold a short-term promissory note to a private investor in the aggregate principal amount of $&lt;span id="xdx_90B_eus-gaap--ProceedsFromConvertibleDebt_c20240524__20240524_zBEAX7ZtzvLl" title="Proceeds from convertible debt"&gt;100,000&lt;/span&gt;. The
note bears interest at &lt;span id="xdx_907_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20240524_zrgztgDt5oV6" title="Interest rate"&gt;7.5%&lt;/span&gt; per annum and had a maturity date of the earlier of completion of a public financing or October 31, 2024.
The investor has consented to extend the maturity date on a month-to-month basis and continues to accrue interest. As of February 28,
2025, the full principal amount of $&lt;span id="xdx_902_eus-gaap--ProceedsFromConvertibleDebt_c20250228__20250228_zJMqQv5AfXT5" title="Proceeds from convertible debt"&gt;100,000&lt;/span&gt; was outstanding.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
June 26, 2024, the Company sold a short-term promissory note to a private investor in the aggregate principal amount of $&lt;span id="xdx_902_eus-gaap--ProceedsFromConvertibleDebt_c20240626__20240626_zI2ZfkH51vMd" title="Proceeds from convertible debt"&gt;40,000&lt;/span&gt;. The
note bears interest at &lt;span id="xdx_90E_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20240626_zgfW4BoE5CYb" title="Interest rate"&gt;7.5%&lt;/span&gt; per annum and has a maturity date of June 25, 2025, which may be extended by written consent of the investor.
As of February 28, 2025, the full principal amount of $&lt;span id="xdx_901_eus-gaap--DebtInstrumentFaceAmount_iI_c20250228_zxsaPosbe7Y5" title="Proceeds from convertible debt"&gt;40,000&lt;/span&gt; was outstanding.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
September 19, 2024, the Company sold a short-term promissory note and warrants to Alumni Capital for total consideration of $&lt;span id="xdx_901_eus-gaap--NotesAndLoansPayableCurrent_iI_c20240919__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_z0C93Fxfrkh1"&gt;250,000&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;.
After deducting commissions, net proceeds to the Company were $&lt;span id="xdx_904_eus-gaap--ProceedsFromNotesPayable_c20240919__20240919__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_z4FHdwt6KMi2"&gt;230,000&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;. &lt;/span&gt;The
Alumni Note is in the principal amount of $&lt;span id="xdx_908_eus-gaap--DebtInstrumentFaceAmount_iI_c20240919__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zCWCosv8eXC2"&gt;300,000&lt;/span&gt;
with an original issue discount of $&lt;span id="xdx_90D_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_c20240919__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zeOR7C3q0v5g"&gt;50,000&lt;/span&gt;
and guaranteed interest on the principal amount of &lt;span id="xdx_908_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20240919__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zlVVaRo5Bd4k"&gt;10%&lt;/span&gt;
per annum which shall be due and payable on &lt;span id="xdx_909_eus-gaap--DebtInstrumentMaturityDate_c20240919__20240919__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_z9Ow7VXcrnO4"&gt;December
19, 2024&lt;/span&gt;. In the event of a failure to re-pay the Alumni Note on or before December 19, 2024, the interest rate will increase
to the lesser of twenty-two percent (&lt;span id="xdx_902_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20240919__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--RangeAxis__srt--MaximumMember_zAftHR1QEATh"&gt;22%&lt;/span&gt;)
per annum or the maximum amount permitted under law from the due date thereof until the same is paid. The Alumni Note is convertible
into common stock of the Company only upon an event of default. In accordance with ASC 470-20-25-2, the proceeds of the short-term
promissory note was allocated to the note and the warrant based on the relative fair values of the note without the warrants and of
the warrant itself at time of issuance, with the portion of the proceeds allocated to the warrants accounted for as paid-in capital,
and the remainder of the proceeds allocated to the note. The relative fair value of the warrants at the time of issuance that was
allocated to additional paid-in capital was $&lt;span id="xdx_90C_eus-gaap--AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_c20240919__20240919_zNOGirYXAju4" title="Warrants additional paid in capital"&gt;116,322&lt;/span&gt;. The Alumni note and accrued interest was repaid on December 19, 2024.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
October 18, 2024, the Company sold a short-term promissory note to 1800 Diagonal Lending LLC in the aggregate principal amount of $&lt;span id="xdx_90B_eus-gaap--DebtInstrumentFaceAmount_iI_c20241018__us-gaap--TypeOfArrangementAxis__custom--NoteSecuritiesPurchaseAgreementMember_zWr2I6la4A2c" title="Principal amount"&gt;154,440&lt;/span&gt;.
The note includes an Original Issue Discount of $&lt;span id="xdx_901_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_c20241018__us-gaap--TypeOfArrangementAxis__custom--NoteSecuritiesPurchaseAgreementMember_z51Qe94BOfR4" title="Original issue discount"&gt;22,440&lt;/span&gt;, and bears a one-time interest charge of &lt;span id="xdx_903_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20241018__us-gaap--TypeOfArrangementAxis__custom--NoteSecuritiesPurchaseAgreementMember_zftE50q6jJ9g" title="Interest rate"&gt;13%&lt;/span&gt;, which was applied on the issuance
date to the principal. The note is payable in ten equal installments of $&lt;span id="xdx_902_ecustom--ConvertibleNotesPayableOfInstallments_iI_c20241018_z3eNQ8RVoR6" title="Note payable equal installments"&gt;17,452&lt;/span&gt; beginning on November 15, 2024, and may be prepaid at
any time with no prepayment penalty. Upon the event of default by the Company, any unpaid principal and interest may be converted to
common stock at the election of 1800 Diagonal Lending LLC. As of February 28, 2025, the balance on the note, net of the unamortized debt
discount, was $&lt;span id="xdx_903_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_c20250228_zNLJLhdwZzW6" title="Unamortized debt discount"&gt;80,114&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
November 1, 2024, the Company sold a short-term promissory note to a private investor in the aggregate principal amount of $&lt;span id="xdx_908_eus-gaap--NotesAndLoansPayableCurrent_iI_c20241101__us-gaap--TypeOfArrangementAxis__custom--ShortTermPromissoryNoteMember_z5xR8xUFqdCe" title="Total consideration"&gt;250,000&lt;/span&gt;.
The note bears guaranteed interest of &lt;span id="xdx_909_eus-gaap--DebtInstrumentInterestRateEffectivePercentage_iI_c20241101_zIgqTZj01r95"&gt;15%&lt;/span&gt;, or $&lt;span id="xdx_900_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_c20241101__us-gaap--TypeOfArrangementAxis__custom--ShortTermPromissoryNoteMember_zqK0frNw2T2e" title="Original issue discount"&gt;37,500&lt;/span&gt;, payable in full together with the principal on the maturity date of May 1, 2025.
On November 29, 2024, the Company sold an additional short-term promissory note to the same investor in the aggregate principal amount
of $&lt;span id="xdx_901_eus-gaap--DebtInstrumentFaceAmount_iI_c20241129_zAEeeRAkVMC7" title="Principal amount"&gt;100,000&lt;/span&gt;. The note bears guaranteed interest of &lt;span id="xdx_90C_eus-gaap--DebtInstrumentInterestRateEffectivePercentage_iI_c20241129_zrUST1p7cLU8"&gt;15%&lt;/span&gt;, or $&lt;span id="xdx_906_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_c20241129__us-gaap--TypeOfArrangementAxis__custom--ShortTermPromissoryNoteMember_zrDUCMfH9Q5l" title="Original issue discount"&gt;15,000&lt;/span&gt;, payable in full together with the principal on the maturity date
of May 29, 2025. In connection with the promissory notes, the Company issued warrants to the investor to purchase up to &lt;span id="xdx_900_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20241129_z8JLL4TcD549"&gt;140,000&lt;/span&gt; shares
of common stock at an exercise price of $&lt;span id="xdx_90C_eus-gaap--SaleOfStockPricePerShare_iI_c20241129_zmeaklvS04ci"&gt;3.25&lt;/span&gt; per share with a three-year term. In accordance with ASC 470-20-25-2, the proceeds of the
short-term promissory notes were allocated to the notes and the warrants based on the relative fair values of the notes without the warrants
and of the warrants themselves at time of issuance, with the portion of the proceeds allocated to the warrants accounted for as paid-in
capital, and the remainder of the proceeds allocated to the note. The relative fair value of the warrants at the time of issuance that
was allocated to additional paid-in capital was $&lt;span id="xdx_903_eus-gaap--AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_c20241129__20241129_zpAlDZeU6XUe" title="Warrants additional paid in capital"&gt;120,239&lt;/span&gt;. On December 31, 2024, the Company entered into a Debt Exchange Agreement with
the investor whereby the entire principal balance of $&lt;span id="xdx_904_eus-gaap--DebtConversionConvertedInstrumentAmount1_c20241231__20241231__us-gaap--StatementClassOfStockAxis__custom--SeriesMNonvotingConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--DebtConversionAgreementMember_zgPVpvDII9Y1" title="Debt converted amount"&gt;350,000&lt;/span&gt; plus guaranteed interest of $&lt;span id="xdx_903_ecustom--DebtConversionConvertedInstrumentOfGuaranteedInterest_c20241231__20241231__us-gaap--StatementClassOfStockAxis__custom--SeriesMNonvotingConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--DebtConversionAgreementMember_z81TaBNZutsd"&gt;52,500&lt;/span&gt; was converted into &lt;span id="xdx_90E_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_c20241231__20241231__us-gaap--StatementClassOfStockAxis__custom--SeriesMNonvotingConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--DebtConversionAgreementMember_zIDXPkBPwtZi"&gt;133,278&lt;/span&gt; shares of
the Company&#x2019;s Series M Preferred Stock at a price of $&lt;span id="xdx_908_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20241231__us-gaap--StatementClassOfStockAxis__custom--SeriesMNonvotingConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--DebtConversionAgreementMember_zb6cA43vRrt1"&gt;3.02&lt;/span&gt; per share.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
November 8, 2024&lt;b&gt;, &lt;/b&gt;the Company sold a short-term promissory note to 1800 Diagonal Lending LLC in the aggregate principal amount
of $&lt;span id="xdx_90F_eus-gaap--NotesAndLoansPayableCurrent_iI_c20241108_zNG0R61hGIC" title="Total consideration"&gt;125,190&lt;/span&gt;. The note includes an Original Issue Discount of $&lt;span id="xdx_90F_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_c20241108_zv5cgFneuBe2"&gt;18,190&lt;/span&gt;, and bears a one-time interest charge of &lt;span id="xdx_905_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20241108__us-gaap--TypeOfArrangementAxis__custom--NoteSecuritiesPurchaseAgreementMember_zsS0kZcQyHvc" title="Interest rate"&gt;13%&lt;/span&gt;, which was applied
on the issuance date to the principal. The note is payable in five installments, with the first payment in the amount of $&lt;span id="xdx_900_eus-gaap--DebtInstrumentPeriodicPayment_c20241108__20241108__us-gaap--TypeOfArrangementAxis__custom--NoteTwoSecuritiesPurchaseAgreementMember_z1jKJ62U7ZIb" title="debt instrument periodic payment"&gt;70,732&lt;/span&gt; due
on &lt;span id="xdx_90B_eus-gaap--DebtInstrumentMaturityDate_c20241108__20241108__us-gaap--TypeOfArrangementAxis__custom--ShortTermPromissoryNoteMember_z4mym9CGrcP3" title="Maturity date"&gt;May 15, 2025&lt;/span&gt;, and the remaining four equal installments of $&lt;span id="xdx_90B_ecustom--DebtInstrumentPeriodicOfInstallments_c20241108__20241108_z6TC8sK7qk49"&gt;17,683&lt;/span&gt; are due on the 15&lt;sup&gt;th&lt;/sup&gt; of each of the next four successive
months. The note may be prepaid at any time with no prepayment penalty. Upon the event of default by the Company, any unpaid principal
and interest may be converted to common stock at the election of 1800 Diagonal Lending LLC. As of February 28, 2025, the balance on the
note, net of the unamortized debt discount was $&lt;span id="xdx_900_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_c20250228__us-gaap--TypeOfArrangementAxis__custom--ShortTermPromissoryNoteMember_zt9vJ0AhiUc5" title="Unamortized debt discount"&gt;113,223&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
December 31, 2024, the Company sold a short-term promissory note to a private investor in the aggregate principal amount of $&lt;span id="xdx_901_eus-gaap--DebtInstrumentFaceAmount_iI_c20241231_z5MqTZHU4mC1" title="Principal amount"&gt;220,000&lt;/span&gt;.
The note bears guaranteed interest of &lt;span id="xdx_902_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20241231_zLvfBopacQ82" title="Prepaid interest percentage"&gt;15%&lt;/span&gt;, or $&lt;span id="xdx_900_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_c20241231__us-gaap--TypeOfArrangementAxis__custom--ShortTermPromissoryNoteMember_z1wy7onjpcdi" title="Original issue discount"&gt;33,000&lt;/span&gt;, payable in full on the issue date by the issuance of &lt;span id="xdx_908_eus-gaap--SharesIssued_iI_c20241231_zfgQNQVk3Upd"&gt;10,927&lt;/span&gt; shares of the Company&#x2019;s
Series K Preferred Stock. The note may be prepaid at any time without penalty. Additionally, the Company issued a warrant to the investor
to purchase up to &lt;span id="xdx_901_eus-gaap--DebtInstrumentFaceAmount_iI_c20241231_zwI6QTrfbl39" title="Principal amount"&gt;220,000&lt;/span&gt; shares of common stock with an exercise price of $&lt;span id="xdx_909_eus-gaap--SharesIssuedPricePerShare_iI_c20241231_zWwHNTyoZBO8"&gt;4.00&lt;/span&gt; per share and a three-year term. In accordance with
ASC 470-20-25-2, the proceeds of the short-term promissory note were allocated to the note and the warrant based on the relative fair
values of the note without the warrant and of the warrant itself at time of issuance, with the portion of the proceeds allocated to the
warrants accounted for as paid-in capital, and the remainder of the proceeds allocated to the note. The relative fair value of the warrant
at the time of issuance that was allocated to additional paid-in capital was $&lt;span id="xdx_90A_eus-gaap--AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_c20241231__20241231_zr5av3hXuExh" title="Warrants additional paid in capital"&gt;179,913&lt;/span&gt;. As of February 28, 2025, the balance on the note,
net of the unamortized debt discount, was $&lt;span id="xdx_900_ecustom--DebtInstrumentUnamortizedDebtDiscount_iI_c20250228__us-gaap--TypeOfArrangementAxis__custom--ShortTermPromissoryNoteMember_zJK8Q5c3qlr3" title="Unamortized debt discount"&gt;41,504&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
December 31, 2024, &lt;span id="xdx_901_eus-gaap--DebtInstrumentCovenantDescription_c20241231__20241231_zm6oP8foT3u1"&gt;the Company sold a short-term promissory note to a private investor for $&lt;span id="xdx_90D_ecustom--DebtInstrumentOfInvestor_iI_c20241231_zFZUXAuF8mii" title="Principal amount"&gt;1,000,000&lt;/span&gt;, with $&lt;span id="xdx_904_ecustom--DebtInstrumentOfFunded_iI_c20241231_z7VzIGZ5keAe" title="Principal amount"&gt;500,000&lt;/span&gt; funded on December
15, 2024 and $&lt;span id="xdx_904_ecustom--DebtInstrumentOfFunded_iI_c20241231_z2YtBzjQd928" title="Principal amount"&gt;500,000&lt;/span&gt; funded on January 15, 2025. The note bears prepaid interest of &lt;span id="xdx_90D_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20241231__us-gaap--TypeOfArrangementAxis__custom--OneMillionNoteMember_zmX2kk62B8gk" title="Prepaid interest percentage"&gt;15%&lt;/span&gt;, payable in 49,668 shares of the Company&#x2019;s
Series K Preferred Stock. In addition, the Company issued warrants to the investor to purchase up to &lt;span id="xdx_90A_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20241231_ziblBpt8Seee"&gt;1,000,000&lt;/span&gt; shares of the Company&#x2019;s
common stock at an exercise price of $&lt;span id="xdx_900_eus-gaap--SaleOfStockPricePerShare_iI_c20241231_z34O3oH0JLIk"&gt;4.00&lt;/span&gt; per share with an expiration date of June 30, 2028. Up to 500,000 of the warrants may be exercised
on a cashless basis, at the election of the investor. In accordance with ASC 470-20-25-2, the proceeds of the short-term promissory note
were allocated to the note and the warrant based on the relative fair values of the note without the warrant and of the warrant itself
at time of issuance, with the portion of the proceeds allocated to the warrants accounted for as paid-in capital, and the remainder of
the proceeds allocated to the note. &lt;/span&gt;The relative fair value of the warrant at the time of issuance that was allocated to additional paid-in
capital was $&lt;span id="xdx_901_ecustom--AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCost_c20241231__20241231_zBAf4ZOqGXS6" title="Warrants additional paid in capital"&gt;829,523&lt;/span&gt;. On February 26, 2025, the Company entered into a Debt Exchange Agreement with the investor whereby the entire principal
balance of $&lt;span id="xdx_904_ecustom--DebtInstrumentOfInvestor_iI_c20250226_zRkWv1tOib47" title="Principal amount"&gt;1,000,000&lt;/span&gt; was converted into &lt;span id="xdx_90C_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20250226__20250226__us-gaap--StatementClassOfStockAxis__custom--SeriesPNonvotingConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--DebtExchangeAgreementMember_zkEL8xoqn4A8" title="Sale of stock, shares"&gt;250,000&lt;/span&gt; shares of the Company&#x2019;s Series P Preferred Stock at a price of $&lt;span id="xdx_909_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20250226__us-gaap--StatementClassOfStockAxis__custom--SeriesPNonvotingConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--DebtExchangeAgreementMember_zogRlktljk0g" title="Conversion price"&gt;4.00&lt;/span&gt; per share.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
February 4&lt;b&gt;, &lt;/b&gt;2025, the Company sold a short-term promissory note to 1800 Diagonal Lending LLC in the aggregate principal amount
of $&lt;span id="xdx_904_eus-gaap--DebtInstrumentFaceAmount_iI_c20250204_z1rwk3pZAuzj" title="Principal amount"&gt;152,100&lt;/span&gt;. The note includes an Original Issue Discount of $&lt;span id="xdx_909_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_c20240204__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zlXNvH0LPtCh" title="Original issue discount"&gt;22,100&lt;/span&gt;, and bears a one-time interest charge of &lt;span id="xdx_905_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20250204__us-gaap--TypeOfArrangementAxis__custom--NoteSecuritiesPurchaseAgreementMember_ztGbj94eVLGd" title="Interest rate"&gt;13%&lt;/span&gt;, which was applied
on the issuance date to the principal. The note is payable in five installments, with the first payment in the amount of $&lt;span id="xdx_901_eus-gaap--DebtInstrumentPeriodicPayment_c20250204__20250204__us-gaap--TypeOfArrangementAxis__custom--NoteTwoSecuritiesPurchaseAgreementMember_z04eXxeAYiqg" title="debt instrument periodic payment"&gt;85,937&lt;/span&gt; due
on August 15, 2025, and the remaining four equal installments of $&lt;span id="xdx_90E_ecustom--DebtInstrumentPeriodicOfInstallments_c20250204__20250204_zXNAmsgJYPcl"&gt;21,484&lt;/span&gt; are due on the 15&lt;sup&gt;th&lt;/sup&gt; of each of the next four successive
months. The note may be prepaid at any time with no prepayment penalty. Upon the event of default by the Company, any unpaid principal
and interest may be converted to common stock at the election of 1800 Diagonal Lending LLC. As of February 28, 2025, the balance on the
note, net of the unamortized debt discount was $&lt;span id="xdx_908_ecustom--DebtInstrumentUnamortizedDebtDiscount_iI_c20250228_zZv0YlQrZlqc" title="Unamortized debt discount"&gt;131,163&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="From2024-05-242024-05-24"
      decimals="0"
      id="Fact001184"
      unitRef="USD">100000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2024-05-24"
      decimals="INF"
      id="Fact001186"
      unitRef="Pure">0.075</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="From2025-02-282025-02-28"
      decimals="0"
      id="Fact001188"
      unitRef="USD">100000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="From2024-06-262024-06-26"
      decimals="0"
      id="Fact001190"
      unitRef="USD">40000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2024-06-26"
      decimals="INF"
      id="Fact001192"
      unitRef="Pure">0.075</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2025-02-28"
      decimals="0"
      id="Fact001194"
      unitRef="USD">40000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:NotesAndLoansPayableCurrent
      contextRef="AsOf2024-09-19_custom_SecuritiesPurchaseAgreementMember"
      decimals="0"
      id="Fact001195"
      unitRef="USD">250000</us-gaap:NotesAndLoansPayableCurrent>
    <us-gaap:ProceedsFromNotesPayable
      contextRef="From2024-09-192024-09-19_custom_SecuritiesPurchaseAgreementMember"
      decimals="0"
      id="Fact001196"
      unitRef="USD">230000</us-gaap:ProceedsFromNotesPayable>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2024-09-19_custom_SecuritiesPurchaseAgreementMember"
      decimals="0"
      id="Fact001197"
      unitRef="USD">300000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="AsOf2024-09-19_custom_SecuritiesPurchaseAgreementMember"
      decimals="0"
      id="Fact001198"
      unitRef="USD">50000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2024-09-19_custom_SecuritiesPurchaseAgreementMember"
      decimals="INF"
      id="Fact001199"
      unitRef="Pure">0.10</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentMaturityDate
      contextRef="From2024-09-192024-09-19_custom_SecuritiesPurchaseAgreementMember"
      id="Fact001200">2024-12-19</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2024-09-19_custom_SecuritiesPurchaseAgreementMember_srt_MaximumMember"
      decimals="INF"
      id="Fact001201"
      unitRef="Pure">0.22</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
      contextRef="From2024-09-192024-09-19"
      decimals="0"
      id="Fact001203"
      unitRef="USD">116322</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2024-10-18_custom_NoteSecuritiesPurchaseAgreementMember"
      decimals="0"
      id="Fact001205"
      unitRef="USD">154440</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="AsOf2024-10-18_custom_NoteSecuritiesPurchaseAgreementMember"
      decimals="0"
      id="Fact001207"
      unitRef="USD">22440</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2024-10-18_custom_NoteSecuritiesPurchaseAgreementMember"
      decimals="INF"
      id="Fact001209"
      unitRef="Pure">0.13</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <NTRP:ConvertibleNotesPayableOfInstallments
      contextRef="AsOf2024-10-18"
      decimals="0"
      id="Fact001211"
      unitRef="USD">17452</NTRP:ConvertibleNotesPayableOfInstallments>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="AsOf2025-02-28"
      decimals="0"
      id="Fact001213"
      unitRef="USD">80114</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:NotesAndLoansPayableCurrent
      contextRef="AsOf2024-11-01_custom_ShortTermPromissoryNoteMember"
      decimals="0"
      id="Fact001215"
      unitRef="USD">250000</us-gaap:NotesAndLoansPayableCurrent>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="AsOf2024-11-01"
      decimals="INF"
      id="Fact001216"
      unitRef="Pure">0.15</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="AsOf2024-11-01_custom_ShortTermPromissoryNoteMember"
      decimals="0"
      id="Fact001218"
      unitRef="USD">37500</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2024-11-29"
      decimals="0"
      id="Fact001220"
      unitRef="USD">100000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="AsOf2024-11-29"
      decimals="INF"
      id="Fact001221"
      unitRef="Pure">0.15</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="AsOf2024-11-29_custom_ShortTermPromissoryNoteMember"
      decimals="0"
      id="Fact001223"
      unitRef="USD">15000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2024-11-29"
      decimals="INF"
      id="Fact001224"
      unitRef="Shares">140000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="AsOf2024-11-29"
      decimals="INF"
      id="Fact001225"
      unitRef="USDPShares">3.25</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
      contextRef="From2024-11-292024-11-29"
      decimals="0"
      id="Fact001227"
      unitRef="USD">120239</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <us-gaap:DebtConversionConvertedInstrumentAmount1
      contextRef="From2024-12-312024-12-31_custom_SeriesMNonvotingConvertiblePreferredStockMember_custom_DebtConversionAgreementMember"
      decimals="0"
      id="Fact001229"
      unitRef="USD">350000</us-gaap:DebtConversionConvertedInstrumentAmount1>
    <NTRP:DebtConversionConvertedInstrumentOfGuaranteedInterest
      contextRef="From2024-12-312024-12-31_custom_SeriesMNonvotingConvertiblePreferredStockMember_custom_DebtConversionAgreementMember"
      decimals="0"
      id="Fact001230"
      unitRef="USD">52500</NTRP:DebtConversionConvertedInstrumentOfGuaranteedInterest>
    <us-gaap:DebtConversionConvertedInstrumentSharesIssued1
      contextRef="From2024-12-312024-12-31_custom_SeriesMNonvotingConvertiblePreferredStockMember_custom_DebtConversionAgreementMember"
      decimals="INF"
      id="Fact001231"
      unitRef="Shares">133278</us-gaap:DebtConversionConvertedInstrumentSharesIssued1>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="AsOf2024-12-31_custom_SeriesMNonvotingConvertiblePreferredStockMember_custom_DebtConversionAgreementMember"
      decimals="INF"
      id="Fact001232"
      unitRef="USDPShares">3.02</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:NotesAndLoansPayableCurrent
      contextRef="AsOf2024-11-08"
      decimals="0"
      id="Fact001234"
      unitRef="USD">125190</us-gaap:NotesAndLoansPayableCurrent>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="AsOf2024-11-08"
      decimals="0"
      id="Fact001235"
      unitRef="USD">18190</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2024-11-08_custom_NoteSecuritiesPurchaseAgreementMember"
      decimals="INF"
      id="Fact001237"
      unitRef="Pure">0.13</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentPeriodicPayment
      contextRef="From2024-11-082024-11-08_custom_NoteTwoSecuritiesPurchaseAgreementMember"
      decimals="0"
      id="Fact001239"
      unitRef="USD">70732</us-gaap:DebtInstrumentPeriodicPayment>
    <us-gaap:DebtInstrumentMaturityDate
      contextRef="From2024-11-082024-11-08_custom_ShortTermPromissoryNoteMember"
      id="Fact001241">2025-05-15</us-gaap:DebtInstrumentMaturityDate>
    <NTRP:DebtInstrumentPeriodicOfInstallments
      contextRef="From2024-11-082024-11-08"
      decimals="0"
      id="Fact001242"
      unitRef="USD">17683</NTRP:DebtInstrumentPeriodicOfInstallments>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="AsOf2025-02-28_custom_ShortTermPromissoryNoteMember"
      decimals="0"
      id="Fact001244"
      unitRef="USD">113223</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact001246"
      unitRef="USD">220000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2024-12-31"
      decimals="INF"
      id="Fact001248"
      unitRef="Pure">0.15</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="AsOf2024-12-31_custom_ShortTermPromissoryNoteMember"
      decimals="0"
      id="Fact001250"
      unitRef="USD">33000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:SharesIssued
      contextRef="AsOf2024-12-31"
      decimals="INF"
      id="Fact001251"
      unitRef="Shares">10927</us-gaap:SharesIssued>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact001253"
      unitRef="USD">220000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="AsOf2024-12-31"
      decimals="INF"
      id="Fact001254"
      unitRef="USDPShares">4.00</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
      contextRef="From2024-12-312024-12-31"
      decimals="0"
      id="Fact001256"
      unitRef="USD">179913</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <NTRP:DebtInstrumentUnamortizedDebtDiscount
      contextRef="AsOf2025-02-28_custom_ShortTermPromissoryNoteMember"
      decimals="0"
      id="Fact001258"
      unitRef="USD">41504</NTRP:DebtInstrumentUnamortizedDebtDiscount>
    <us-gaap:DebtInstrumentCovenantDescription contextRef="From2024-12-312024-12-31" id="Fact001259">the Company sold a short-term promissory note to a private investor for $1,000,000, with $500,000 funded on December
15, 2024 and $500,000 funded on January 15, 2025. The note bears prepaid interest of 15%, payable in 49,668 shares of the Company&#x2019;s
Series K Preferred Stock. In addition, the Company issued warrants to the investor to purchase up to 1,000,000 shares of the Company&#x2019;s
common stock at an exercise price of $4.00 per share with an expiration date of June 30, 2028. Up to 500,000 of the warrants may be exercised
on a cashless basis, at the election of the investor. In accordance with ASC 470-20-25-2, the proceeds of the short-term promissory note
were allocated to the note and the warrant based on the relative fair values of the note without the warrant and of the warrant itself
at time of issuance, with the portion of the proceeds allocated to the warrants accounted for as paid-in capital, and the remainder of
the proceeds allocated to the note.</us-gaap:DebtInstrumentCovenantDescription>
    <NTRP:DebtInstrumentOfInvestor
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact001261"
      unitRef="USD">1000000</NTRP:DebtInstrumentOfInvestor>
    <NTRP:DebtInstrumentOfFunded
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact001263"
      unitRef="USD">500000</NTRP:DebtInstrumentOfFunded>
    <NTRP:DebtInstrumentOfFunded
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact001265"
      unitRef="USD">500000</NTRP:DebtInstrumentOfFunded>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2024-12-31_custom_OneMillionNoteMember"
      decimals="INF"
      id="Fact001267"
      unitRef="Pure">0.15</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2024-12-31"
      decimals="INF"
      id="Fact001268"
      unitRef="Shares">1000000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="AsOf2024-12-31"
      decimals="INF"
      id="Fact001269"
      unitRef="USDPShares">4.00</us-gaap:SaleOfStockPricePerShare>
    <NTRP:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCost
      contextRef="From2024-12-312024-12-31"
      decimals="0"
      id="Fact001271"
      unitRef="USD">829523</NTRP:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCost>
    <NTRP:DebtInstrumentOfInvestor
      contextRef="AsOf2025-02-26"
      decimals="0"
      id="Fact001273"
      unitRef="USD">1000000</NTRP:DebtInstrumentOfInvestor>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="From2025-02-262025-02-26_custom_SeriesPNonvotingConvertiblePreferredStockMember_custom_DebtExchangeAgreementMember"
      decimals="INF"
      id="Fact001275"
      unitRef="Shares">250000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="AsOf2025-02-26_custom_SeriesPNonvotingConvertiblePreferredStockMember_custom_DebtExchangeAgreementMember"
      decimals="INF"
      id="Fact001277"
      unitRef="USDPShares">4.00</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2025-02-04"
      decimals="0"
      id="Fact001279"
      unitRef="USD">152100</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="AsOf2024-02-04_custom_SecuritiesPurchaseAgreementMember"
      decimals="0"
      id="Fact001281"
      unitRef="USD">22100</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2025-02-04_custom_NoteSecuritiesPurchaseAgreementMember"
      decimals="INF"
      id="Fact001283"
      unitRef="Pure">0.13</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentPeriodicPayment
      contextRef="From2025-02-042025-02-04_custom_NoteTwoSecuritiesPurchaseAgreementMember"
      decimals="0"
      id="Fact001285"
      unitRef="USD">85937</us-gaap:DebtInstrumentPeriodicPayment>
    <NTRP:DebtInstrumentPeriodicOfInstallments
      contextRef="From2025-02-042025-02-04"
      decimals="0"
      id="Fact001286"
      unitRef="USD">21484</NTRP:DebtInstrumentPeriodicOfInstallments>
    <NTRP:DebtInstrumentUnamortizedDebtDiscount
      contextRef="AsOf2025-02-28"
      decimals="0"
      id="Fact001288"
      unitRef="USD">131163</NTRP:DebtInstrumentUnamortizedDebtDiscount>
    <NTRP:ConvertibleDebtDisclosureTextBlock contextRef="From2024-03-01to2025-02-28" id="Fact001290">&lt;p id="xdx_806_ecustom--ConvertibleDebtDisclosureTextBlock_zcANo5qcnnHa" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
13 - &lt;span id="xdx_825_za9lYQGopFr"&gt;Convertible Notes&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Between
March 13, 2023 and June 9, 2023, the Company issued $&lt;span id="xdx_909_eus-gaap--ProceedsFromConvertibleDebt_c20230313__20230609__dei--LegalEntityAxis__custom--SpecialPurposeAcquisitionCorporationMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SeveralInvestorsMember__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesMember_z0TrXPn1tkdi" title="Convertible note issued"&gt;650,000&lt;/span&gt; in convertible notes upon the receipt of proceeds from several investors.
The notes had an interest at a rate of &lt;span id="xdx_906_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_c20230609__dei--LegalEntityAxis__custom--SpecialPurposeAcquisitionCorporationMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SeveralInvestorsMember__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesMember_z44HX4hk5tzf" title="Interest rate"&gt;8&lt;/span&gt;% per annum and were convertible into shares and warrants in a new public company upon the completion
of a merger with a Special Purpose Acquisition Corporation (&#x201c;SPAC&#x201d;) at a conversion price of $&lt;span id="xdx_906_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_pid_c20230609__dei--LegalEntityAxis__custom--SpecialPurposeAcquisitionCorporationMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SeveralInvestorsMember__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesMember_zf9jm3XdNhq5" title="Conversion price"&gt;3.00&lt;/span&gt; per common share, subject
to certain adjustments.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Between
July 27, 2022 and February 21, 2023, the Company issued a total principal amount of $&lt;span id="xdx_902_eus-gaap--ProceedsFromConvertibleDebt_c20220727__20230221__dei--LegalEntityAxis__custom--SpecialPurposeAcquisitionCorporationMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SeveralInvestorsMember__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesMember_ztwdnKjl5qIg" title="Convertible note issued"&gt;3,012,000&lt;/span&gt; in convertible notes upon the receipt
of proceeds from several investors. The notes had an interest at a rate of &lt;span id="xdx_90E_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_c20230221__dei--LegalEntityAxis__custom--SpecialPurposeAcquisitionCorporationMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SeveralInvestorsMember__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesMember_zxrpswu6nIY1" title="Interest rate"&gt;8&lt;/span&gt;% per annum and were convertible into shares and warrants
in a new public company upon the completion of a merger with a SPAC at a conversion
price of $&lt;span id="xdx_905_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_pid_c20230221__dei--LegalEntityAxis__custom--SpecialPurposeAcquisitionCorporationMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SeveralInvestorsMember__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesMember_zo7R6X7v7QC7" title="Conversion price"&gt;3.00&lt;/span&gt; per common share, subject to certain adjustments.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
December 29, 2023, in connection with, and contingent upon the acquisition of NTH by the Company, each investor in a convertible
note entered into a Debt Assignment and Conversion Agreement with NTG and NTH, whereby the notes and the debt represented thereby
were assigned from NTH to NTG and converted into common units of NTG with the equivalent value on the terms and conditions as set
forth in the Debt Assignment and Conversion Agreements. In exchange for entering into the Debt Assignment and Conversion Agreements,
each investor received the right to receive a number of Restricted Shares, including both Closing Shares and Contingent
Shares, to be distributed by the Company to each such investor following the consummation of the NextTrip Acquisition. The shares were
issued at a price of $&lt;span id="xdx_901_eus-gaap--SharePrice_iI_pid_c20231229__us-gaap--TypeOfArrangementAxis__custom--DebtAssignmentAndConversionAgreementsMember_zqd25b5TLGgf" title="Share price"&gt;3.00&lt;/span&gt;,
and include both principal and accrued interest thereon.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
NextTrip Acquisition closed on December 29, 2023, and as a result, the Company issued to the investors and aggregate of &lt;span id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c20231229__20231229__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zqOOW0RWTYyb" title="Conversion of convertible notes, shares"&gt;52,818&lt;/span&gt;
Closing Shares, and the right to receive an aggregate of &lt;span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c20231229__20231229__us-gaap--StatementEquityComponentsAxis__custom--ContingentSharesMember_zWexfYlJF83g" title="Conversion of convertible notes, shares"&gt;1,978,598&lt;/span&gt;
Contingent Shares, if issued.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
the years ended February 28, 2025 and February 29, 2024, the Company recorded interest expense of $&lt;span id="xdx_90F_eus-gaap--InterestExpenseDebt_c20240301__20250228_zhEGTUfgQNWh" title="Interest expense"&gt;0&lt;/span&gt; and $&lt;span id="xdx_90C_eus-gaap--InterestExpenseDebt_c20230301__20240229_zpmr2iYBE1Kl" title="Interest expense"&gt;234,213&lt;/span&gt;, respectively, related
to the notes.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</NTRP:ConvertibleDebtDisclosureTextBlock>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="From2023-03-132023-06-09_custom_SpecialPurposeAcquisitionCorporationMember_custom_SeveralInvestorsMember_custom_ConvertibleNotesMember"
      decimals="0"
      id="Fact001292"
      unitRef="USD">650000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2023-06-09_custom_SpecialPurposeAcquisitionCorporationMember_custom_SeveralInvestorsMember_custom_ConvertibleNotesMember"
      decimals="INF"
      id="Fact001294"
      unitRef="Pure">0.08</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="AsOf2023-06-09_custom_SpecialPurposeAcquisitionCorporationMember_custom_SeveralInvestorsMember_custom_ConvertibleNotesMember"
      decimals="INF"
      id="Fact001296"
      unitRef="USDPShares">3.00</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="From2022-07-272023-02-21_custom_SpecialPurposeAcquisitionCorporationMember_custom_SeveralInvestorsMember_custom_ConvertibleNotesMember"
      decimals="0"
      id="Fact001298"
      unitRef="USD">3012000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2023-02-21_custom_SpecialPurposeAcquisitionCorporationMember_custom_SeveralInvestorsMember_custom_ConvertibleNotesMember"
      decimals="INF"
      id="Fact001300"
      unitRef="Pure">0.08</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="AsOf2023-02-21_custom_SpecialPurposeAcquisitionCorporationMember_custom_SeveralInvestorsMember_custom_ConvertibleNotesMember"
      decimals="INF"
      id="Fact001302"
      unitRef="USDPShares">3.00</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:SharePrice
      contextRef="AsOf2023-12-29_custom_DebtAssignmentAndConversionAgreementsMember"
      decimals="INF"
      id="Fact001304"
      unitRef="USDPShares">3.00</us-gaap:SharePrice>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="From2023-12-292023-12-29_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact001306"
      unitRef="Shares">52818</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="From2023-12-292023-12-29_custom_ContingentSharesMember"
      decimals="INF"
      id="Fact001308"
      unitRef="Shares">1978598</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:InterestExpenseDebt
      contextRef="From2024-03-01to2025-02-28"
      decimals="0"
      id="Fact001310"
      unitRef="USD">0</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact001312"
      unitRef="USD">234213</us-gaap:InterestExpenseDebt>
    <NTRP:SharePurchaseAgreementsDisclosureTextBlock contextRef="From2024-03-01to2025-02-28" id="Fact001314">&lt;p id="xdx_80A_ecustom--SharePurchaseAgreementsDisclosureTextBlock_zQgD7zi8pgnc" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
14 &#x2013; &lt;span id="xdx_820_zxVVuh2q1wsk"&gt;Share Purchase Agreements&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Between
August 10, 2023 and November 6, 2023, NTH entered into Share Purchase Agreements with several investors to purchase convertible
shares in NTH in exchange for total proceeds of $&lt;span id="xdx_905_eus-gaap--ProceedsFromConvertibleDebt_c20230810__20231106__us-gaap--TypeOfArrangementAxis__custom--SharePurchaseAgreementsMember__srt--TitleOfIndividualAxis__custom--SeveralInvestorsMember_zpjBX0R5bUbc" title="Proceeds from convertible shares"&gt;1,755,970&lt;/span&gt;.
Pursuant to the Share Purchase Agreements, the shares were initially convertible into the common shares of a public company with
which NTH completed a strategic transaction at a price of $&lt;span id="xdx_909_eus-gaap--SharePrice_iI_c20231106__us-gaap--TypeOfArrangementAxis__custom--SharePurchaseAgreementsMember__srt--TitleOfIndividualAxis__custom--SeveralInvestorsMember_zR1y7oIRSJh4" title="Conversion share price"&gt;0.15&lt;/span&gt;
per share. The Share Purchase Agreements further provided that contingent upon the consummation of the legal acquisition of NTH by
the Company, the investors would receive the same number of shares of Company common stock in lieu of NTH common
shares.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;On December 29, 2023, concurrent with the consummation
of the NextTrip Acquisition, each investor entered into an Exchange Agreement (the &#x201c;Pre-Acquisition Exchange Agreements&#x201d;)
with NTG and NTH, whereby such investors exchanged their rights to NTH shares for rights to common units of NTG of the same value, and
NTG distributed to the investors that number of Closing Shares as set forth in the Pre-Acquisition Exchange Agreements. Additionally,
upon the Company&#x2019;s achievement of each of the milestones as set forth in the Exchange Agreement, if ever, NTG will further distribute
the number of Contingent Shares in accordance with the Pre-Acquisition Exchange Agreements.&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
September 19, 2022, the Company entered into a Software as a Service Agreement with a third-party consultant, pursuant to which the Company received
a $&lt;span id="xdx_90A_ecustom--ProceedsFromDownpaymentForContract_c20220919__20220919__us-gaap--TypeOfArrangementAxis__custom--SoftwareAsAServiceAgreementMember__srt--TitleOfIndividualAxis__custom--ThirdPartyMember_zRhEOz43wfSa" title="Proceeds from downpayment for contract"&gt;150,000&lt;/span&gt; down payment upon signing of the contract. On December 31, 2022, the Company entered into an amended agreement with the counterparty,
pursuant which the down payment became a noninterest bearing share issuance obligation and which such amount will be converted to shares in
a new public company upon the completion of a merger at a conversion price of $&lt;span id="xdx_908_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20220919__us-gaap--TypeOfArrangementAxis__custom--SoftwareAsAServiceAgreementMember__srt--TitleOfIndividualAxis__custom--ThirdPartyMember_zq7TiMeqVl1e" title="Conversion share price"&gt;3.00&lt;/span&gt; per common share, subject to adjustments. On December
29, 2023, upon the consummation of the NextTrip Acquisition, the counterparty received &lt;span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c20231229__20231229__us-gaap--TypeOfArrangementAxis__custom--SoftwareAsAServiceAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--TitleOfIndividualAxis__custom--ThirdPartyMember_zySNcOwmPOB6" title="Conversion of convertible notes, shares"&gt;1,996&lt;/span&gt; Closing Shares and
the right to receive an additional &lt;span id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c20231229__20231229__us-gaap--StatementEquityComponentsAxis__custom--ContingentSharesMember__us-gaap--TypeOfArrangementAxis__custom--SoftwareAsAServiceAgreementMember__srt--TitleOfIndividualAxis__custom--ThirdPartyMember_zGj6xEvHIh7" title="Conversion of convertible notes, shares"&gt;74,786&lt;/span&gt; Contingent Shares, if issued.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
total number of Closing Shares issued to investors, inclusive the third-party consultant, on December 29, 2023 was &lt;span id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c20231229__20231229__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--TitleOfIndividualAxis__custom--ThirdPartyConsultantMember_ztLhHtQNDYn6" title="Conversion of convertible notes, shares"&gt;15,481&lt;/span&gt;
Closing Shares, and the Contingent Shares issuable, if ever, totaled an aggregate of &lt;span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c20231229__20231229__us-gaap--StatementEquityComponentsAxis__custom--ContingentSharesMember__srt--TitleOfIndividualAxis__custom--ThirdPartyConsultantMember_zy8pL76pzPT7" title="Conversion of convertible notes, shares"&gt;579,954&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
December 28, 2023, the Company entered into a Consulting Modification Agreement with a third-party consultant, which provided for
the full settlement of $&lt;span id="xdx_90F_ecustom--ConsultingFees_c20231228__20231228__us-gaap--TypeOfArrangementAxis__custom--ConsultingModificationAgreementMember__srt--TitleOfIndividualAxis__custom--ThirdPartyConsultantMember_zvTINfhiX9Bc" title="Consulting fees"&gt;180,000&lt;/span&gt;
in consulting fees by issuing shares of Company common stock contingent upon the closing of the NextTrip acquisition. The NextTrip
Acquisition closed on December 29, 2023, pursuant to which the Company issued &lt;span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c20231229__20231229__us-gaap--TypeOfArrangementAxis__custom--ConsultingModificationAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--TitleOfIndividualAxis__custom--ThirdPartyConsultantMember_z5TLUDwCfJFk" title="Conversion of convertible notes, shares"&gt;4,337&lt;/span&gt;
Closing Shares to the consultant, and the right to receive &lt;span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c20231229__20231229__us-gaap--TypeOfArrangementAxis__custom--ConsultingModificationAgreementMember__us-gaap--StatementEquityComponentsAxis__custom--ContingentSharesMember__srt--TitleOfIndividualAxis__custom--ThirdPartyConsultantMember_zeuqJbpGydkb" title="Conversion of convertible notes, shares"&gt;162,466&lt;/span&gt;
Contingent Shares, if issued.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</NTRP:SharePurchaseAgreementsDisclosureTextBlock>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="From2023-08-102023-11-06_custom_SharePurchaseAgreementsMember_custom_SeveralInvestorsMember"
      decimals="0"
      id="Fact001316"
      unitRef="USD">1755970</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:SharePrice
      contextRef="AsOf2023-11-06_custom_SharePurchaseAgreementsMember_custom_SeveralInvestorsMember"
      decimals="INF"
      id="Fact001318"
      unitRef="USDPShares">0.15</us-gaap:SharePrice>
    <NTRP:ProceedsFromDownpaymentForContract
      contextRef="From2022-09-192022-09-19_custom_SoftwareAsAServiceAgreementMember_custom_ThirdPartyMember"
      decimals="0"
      id="Fact001320"
      unitRef="USD">150000</NTRP:ProceedsFromDownpaymentForContract>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="AsOf2022-09-19_custom_SoftwareAsAServiceAgreementMember_custom_ThirdPartyMember"
      decimals="INF"
      id="Fact001322"
      unitRef="USDPShares">3.00</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="From2023-12-292023-12-29_custom_SoftwareAsAServiceAgreementMember_us-gaap_CommonStockMember_custom_ThirdPartyMember"
      decimals="INF"
      id="Fact001324"
      unitRef="Shares">1996</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="From2023-12-292023-12-29_custom_ContingentSharesMember_custom_SoftwareAsAServiceAgreementMember_custom_ThirdPartyMember"
      decimals="INF"
      id="Fact001326"
      unitRef="Shares">74786</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="From2023-12-292023-12-29_us-gaap_CommonStockMember_custom_ThirdPartyConsultantMember"
      decimals="INF"
      id="Fact001328"
      unitRef="Shares">15481</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="From2023-12-292023-12-29_custom_ContingentSharesMember_custom_ThirdPartyConsultantMember"
      decimals="INF"
      id="Fact001330"
      unitRef="Shares">579954</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <NTRP:ConsultingFees
      contextRef="From2023-12-282023-12-28_custom_ConsultingModificationAgreementMember_custom_ThirdPartyConsultantMember"
      decimals="0"
      id="Fact001332"
      unitRef="USD">180000</NTRP:ConsultingFees>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="From2023-12-292023-12-29_custom_ConsultingModificationAgreementMember_us-gaap_CommonStockMember_custom_ThirdPartyConsultantMember"
      decimals="INF"
      id="Fact001334"
      unitRef="Shares">4337</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="From2023-12-292023-12-29_custom_ConsultingModificationAgreementMember_custom_ContingentSharesMember_custom_ThirdPartyConsultantMember"
      decimals="INF"
      id="Fact001336"
      unitRef="Shares">162466</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="From2024-03-01to2025-02-28" id="Fact001338">&lt;p id="xdx_80E_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zYTv9TEZiO23" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
15 - &lt;span id="xdx_82D_zLEG8HLsV2me"&gt;Related Party Transactions&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
February 28, 2023, the Company entered into an Asset Purchase Agreement with Travel and Media Tech, LLC (&#x201c;TMT&#x201d;),
pursuant to which it purchased the right, title and interest in the &#x201c;Bookit&#x201d; or &#x201c;NextTrip 2.0&#x201d; booking
engine, including customer lists, all current content associated with hotel and destination product in the booking engine (pictures,
hotel descriptions, restaurant descriptions, room descriptions, amenity descriptions, and destination information) and source code
related thereto. TMT is a related entity owned by Donald P. Monaco, the Company&#x2019;s Chairman, and William Kerby, the
Company&#x2019;s Chief Executive Officer.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Amounts
due to related parties at February 28, 2025 and February 29, 2024 was $&lt;span id="xdx_90B_eus-gaap--NotesPayableCurrent_iI_pp0p0_c20250228__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_z8Ao9EYP5eD1" title="Notes payable - related parties"&gt;61,526&lt;/span&gt; and $&lt;span id="xdx_906_eus-gaap--NotesPayableCurrent_c20240229__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_pp0p0" title="Notes payable - related parties"&gt;828,277&lt;/span&gt;, respectively. The amounts due at February
28, 2025 are to Donald P. Monaco, William Kerby, and Gregory Miller, and at February 29, 2024 were to William Kerby and Donald P. Monaco.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company recorded a loss of $&lt;span id="xdx_907_ecustom--LossOnRelatedPartyReceivable_c20240301__20250228__us-gaap--BusinessAcquisitionAxis__custom--NextPlayTechnologiesIncMember_zEymAtR6JJIb" title="Loss on related party receivable"&gt;1,000,000&lt;/span&gt; on the NextPlay related party receivable for the year ended February 28, 2025. The total amount
receivable from NextPlay was $&lt;span id="xdx_909_eus-gaap--ReceivablesNetCurrent_iI_c20250228__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--NextPlayTechnologiesIncMember_z3YA7KBgwUFh" title="Accounts receivable"&gt;2,567,665&lt;/span&gt; at February 28, 2025. NextPlay is in involuntary bankruptcy proceedings and is in default under
the terms of its promissory note and, as a result, the Company established an allowance for doubtful accounts of $&lt;span id="xdx_90E_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iI_c20250228__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--NextPlayTechnologiesIncMember_zcQK8VpCTHw2" title="Allowance for doubtful accounts"&gt;2,567,665&lt;/span&gt; as collectability
of the note is uncertain. As of February 29, 2024, $&lt;span id="xdx_902_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iI_do_c20240229__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--NextPlayTechnologiesIncMember_zctRo65pvGYe" title="Allowance for doubtful accounts"&gt;1,567,665&lt;/span&gt; allowance for credit losses was established.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:NotesPayableCurrent
      contextRef="AsOf2025-02-28_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact001340"
      unitRef="USD">61526</us-gaap:NotesPayableCurrent>
    <us-gaap:NotesPayableCurrent
      contextRef="AsOf2024-02-29_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact001342"
      unitRef="USD">828277</us-gaap:NotesPayableCurrent>
    <NTRP:LossOnRelatedPartyReceivable
      contextRef="From2024-03-012025-02-28_custom_NextPlayTechnologiesIncMember"
      decimals="0"
      id="Fact001344"
      unitRef="USD">1000000</NTRP:LossOnRelatedPartyReceivable>
    <us-gaap:ReceivablesNetCurrent
      contextRef="AsOf2025-02-28_custom_NextPlayTechnologiesIncMember"
      decimals="0"
      id="Fact001346"
      unitRef="USD">2567665</us-gaap:ReceivablesNetCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="AsOf2025-02-28_custom_NextPlayTechnologiesIncMember"
      decimals="0"
      id="Fact001348"
      unitRef="USD">2567665</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="AsOf2024-02-29_custom_NextPlayTechnologiesIncMember"
      decimals="0"
      id="Fact001350"
      unitRef="USD">1567665</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <NTRP:DeferredRevenueTextBlock contextRef="From2024-03-01to2025-02-28" id="Fact001352">&lt;p id="xdx_803_ecustom--DeferredRevenueTextBlock_z2KWmrnN1kLd" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
16 - &lt;span id="xdx_821_zKG1fsISYakd"&gt;Deferred Revenue&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Deferred
revenue as of the years ended February 28, 2025, and February 29, 2024 was $&lt;span id="xdx_905_eus-gaap--DeferredRevenueCurrent_iI_c20250228_zmue3OBk8KNd" title="Deferred revenue"&gt;97,770&lt;/span&gt; and $&lt;span id="xdx_90B_eus-gaap--DeferredRevenueCurrent_iI_c20240229_zqpuCaLJE1d1" title="Deferred revenue"&gt;139,921&lt;/span&gt;, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Deferred
revenue consists of travel deposits received from users in advance of revenue recognition. The deferred revenue balance for the years
ended February 28, 2025 and February 29, 2024 was driven by cash payments from customers in advance of satisfying our performance obligations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</NTRP:DeferredRevenueTextBlock>
    <us-gaap:DeferredRevenueCurrent
      contextRef="AsOf2025-02-28"
      decimals="0"
      id="Fact001354"
      unitRef="USD">97770</us-gaap:DeferredRevenueCurrent>
    <us-gaap:DeferredRevenueCurrent
      contextRef="AsOf2024-02-29"
      decimals="0"
      id="Fact001356"
      unitRef="USD">139921</us-gaap:DeferredRevenueCurrent>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="From2024-03-01to2025-02-28" id="Fact001358">&lt;p id="xdx_800_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zePe41COpDyf" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
17 - &lt;span id="xdx_822_z0jGBGniifL5"&gt;Commitments and Contingencies&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company is involved, from time to time, in litigation, other legal claims and proceedings involving matters associated with or incidental
to our business, including, among other things, matters involving breach of contract claims, intellectual property, employment issues,
and other related claims and vendor matters. The Company believes that the resolution of currently pending matters could, individually
or in the aggregate, have a material adverse effect on our financial condition or results of operations. However, assessment of the current
litigation or other legal claims could change considering the discovery of facts not presently known to the Company or by judges, juries
or other finders of fact, which are not in accord with management&#x2019;s evaluation of the possible liability or outcome of such litigation
or claims.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="From2024-03-01to2025-02-28" id="Fact001360">&lt;p id="xdx_80A_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zIUrNS1iB2Ig" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
18 &#x2013; &lt;span id="xdx_828_zLvcJElMeBJj"&gt;Stockholders&#x2019; Equity&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Common
Stock&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has &lt;span id="xdx_908_eus-gaap--CommonStockSharesAuthorized_iI_c20250228_zJY3vPkCUuU1" title="Common stock, shares authorized"&gt;250,000,000&lt;/span&gt; shares of common stock authorized. As of February 28, 2025 and February 29, 2024, the Company had
&lt;span id="xdx_903_eus-gaap--CommonStockSharesOutstanding_iI_c20250228_zna4o60hVrV9" title="Common stock, shares outstanding"&gt;1,656,738&lt;/span&gt; and &lt;span id="xdx_908_eus-gaap--CommonStockSharesOutstanding_iI_c20240229_zSbHcduuN7ej" title="Common stock, shares outstanding"&gt;936,430&lt;/span&gt; shares of common stock, par value $&lt;span id="xdx_908_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20250228_z4zA75WQagXf" title="Common stock, par value"&gt;&lt;span id="xdx_90B_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20240229_zndi6ZE0anr3" title="Common stock, par value"&gt;0.001&lt;/span&gt;&lt;/span&gt; issued and outstanding, respectively. All shares have equal voting rights,
are fully-paid and non-assessable, and are entitled to one vote per share.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
September 22, 2023, we effected a &lt;span id="xdx_905_eus-gaap--StockholdersEquityReverseStockSplit_c20230921__20230922_z2xDteU60Hu3" title="Reverse stock split"&gt;1-for-20 reverse stock split&lt;/span&gt; of the outstanding shares of our common stock and a corresponding decrease
in the number of shares of our common stock that we are authorized to issue. In connection with the reverse split, we issued &lt;span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesReverseStockSplits_c20230922__20230922_zR9cE8RQxuWb" title="Reverse stock split issued common shares"&gt;40,197&lt;/span&gt; common
shares to round-up fractional shares to the nearest whole share.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
effects of the reverse stock split have been retroactively reflected in all periods presented in this Report.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Fiscal
Year Ended February 28, 2025&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
March 15, 2024, the Company issued &lt;span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c20240315__20240315__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zoHQgPDk8x35" title="Conversion shares issued"&gt;409,502&lt;/span&gt; shares of common stock pursuant to automatic conversions of the Company&#x2019;s Series G,
H, and I Convertible Preferred Stock upon receiving shareholder approval to increase the Company&#x2019;s authorized common shares to
250 million.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
July 2024 and August 2024, the Company issued &lt;span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20240701__20240831__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zdQhOExxWQea" title="Shares issued for services"&gt;42,709&lt;/span&gt;
shares of common stock to Dooya Media Group, Inc. as partial compensation for development work related to Compass.TV, the
Company&#x2019;s Free-Ad Supported TV (&#x201c;FAST&#x201d;) channel.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
September 19, 2024, the Company issued &lt;span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20240919__20240919__dei--LegalEntityAxis__custom--AlumniCapitalLPMember_zTXmv6NkWxtl" title="Number of common stock issued"&gt;32,786&lt;/span&gt;
shares of common stock to Alumni Capital LP (&#x201c;Alumni&#x201d;) as commitment shares for a $&lt;span id="xdx_907_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pn6n6_c20240919__20240919__dei--LegalEntityAxis__custom--AlumniCapitalLPMember_zFlkjOgy8Oia" title="Equity line of credit"&gt;10&lt;/span&gt;
million equity line of credit.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
October 8, 2024, the Company issued &lt;span id="xdx_90D_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_c20241008__20241008__dei--LegalEntityAxis__custom--FSATravelLLCMember_zwpHTsJDSii9" title="Stock deposit acquisition"&gt;8,065&lt;/span&gt;
shares of common stock to FSA upon executing a non-binding letter of intent to acquire interests in FSA. Pursuant to the
terms of the agreement, the shares were to be credited towards the final purchase price if an acquisition occurs, and as a down
payment towards the acquisition price of FSA.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;On December 16, 2024, the Company issued &lt;span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20241216__20241216__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z8KZe2l0kaE9" title="Issuance of shares"&gt;28,281&lt;/span&gt; shares
of common stock to Out of the Box Capital as a prepayment for an Investor Relations consulting contract.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
December 2024 and January 2025, the Company issued &lt;span id="xdx_907_ecustom--StockIssuedDuringPeriodSharesWarrantExercises_c20241201__20250131__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_ztS6QABvdmci" title="Issuance of shares warrant exercises"&gt;an
aggregate of 104,965&lt;/span&gt; shares of common stock pursuant to warrant exercises, resulting in gross proceeds of $&lt;span id="xdx_90E_eus-gaap--ProceedsFromWarrantExercises_c20241201__20250131__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z5FgNxiqzPL5" title="Gross proceeds of warrant exercises"&gt;316,995&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
January 7, 2025, the Company issued &lt;span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20250107__20250107__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zSqjLW2Q6jhj" title="Issuance of shares"&gt;30,000&lt;/span&gt; shares of common stock as a prepayment for a consulting contract with an investor relations
company.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
January 29, 2025, the Company issued &lt;span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20250129__20250129__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zSsKSEKezNie" title="Issuance of shares"&gt;4,000&lt;/span&gt;
shares of common stock to Lyndsey North, the Company&#x2019;s former President, in connection with her separation
agreement.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
February 26, 2025, the Company issued &lt;span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20250226__20250226__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zNOFulTCQf1h" title="Issuance of shares"&gt;60,000&lt;/span&gt; shares of common stock to AOS Holdings, Inc. as a partial prepayment for a two-year consulting
contract to provide investor relations and strategic consulting services.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Fiscal
Year Ended February 29, 2024&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
September 2023 and October 2023, the Company sold &lt;span id="xdx_903_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20230901__20230930__us-gaap--SubsidiarySaleOfStockAxis__custom--AtTheMarketIssuanceSalesAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zyaF72bp2UW5" title="Share issued and sold during period, shares"&gt;72,721&lt;/span&gt;
and &lt;span id="xdx_905_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20231001__20231031__us-gaap--SubsidiarySaleOfStockAxis__custom--AtTheMarketIssuanceSalesAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zxYVWkKBw9U6" title="Share issued and sold during period, shares"&gt;128,887&lt;/span&gt;
shares of common stock, respectively, through our ATM Agreement, resulting in net proceeds of $&lt;span id="xdx_905_eus-gaap--ProceedsFromIssuanceOfCommonStock_c20230901__20230930__us-gaap--SubsidiarySaleOfStockAxis__custom--AtTheMarketIssuanceSalesAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zD8h2PXjJjG7" title="Net proceeds"&gt;364,555&lt;/span&gt;
and $&lt;span id="xdx_90F_eus-gaap--ProceedsFromIssuanceOfCommonStock_c20231001__20231031__us-gaap--SubsidiarySaleOfStockAxis__custom--AtTheMarketIssuanceSalesAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_ztTcgd3Usf24" title="Net proceeds"&gt;772,468&lt;/span&gt;,
respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
December 29, 2023, the Company acquired &lt;span id="xdx_903_eus-gaap--BusinessAcquisitionPercentageOfVotingInterestsAcquired_iI_pid_dp_uPure_c20231229__us-gaap--BusinessAcquisitionAxis__custom--NextTripHoldingsIncMember_zTCR7L3h4Si9" title="Equity interest acquired"&gt;100&lt;/span&gt;%
of the outstanding equity interests of NTH pursuant to the Exchange Agreement in connection with the NextTrip Acquisition. As
consideration for the NextTrip Acquisition, at closing the Company issued &lt;span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20231229__20231229__us-gaap--BusinessAcquisitionAxis__custom--NextTripHoldingsIncMember_z6XeUm1x8hha" title="Restricted shares issued in acquisitions"&gt;156,007&lt;/span&gt;
restricted shares of its common stock as Closing Shares, constituting &lt;span id="xdx_908_eus-gaap--SaleOfStockPercentageOfOwnershipAfterTransaction_pid_dp_uPure_c20231229__20241229__us-gaap--BusinessAcquisitionAxis__custom--NextTripHoldingsIncMember_z8nwLdn84WU4" title="Percentage of issued and outstanding common shares"&gt;19.99&lt;/span&gt;%
of its issued and outstanding shares of common stock immediately prior to execution of the Exchange Agreement, and agreed to
issue up to an aggregate of &lt;span id="xdx_90F_eus-gaap--BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_c20231229__20231229__us-gaap--BusinessAcquisitionAxis__custom--NextTripHoldingsIncMember_zBEYPX4hztel" title="Shares issuable for consideration"&gt;5,843,993&lt;/span&gt;
Contingent Shares as further consideration upon NTH&#x2019;s achievement of certain milestones set forth in the Exchange
Agreement.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Of
the &lt;span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20231229__20231229__us-gaap--BusinessAcquisitionAxis__custom--NextTripHoldingsIncMember_ziKRiLvxb8vd" title="Restricted shares issued in acquisitions"&gt;156,007&lt;/span&gt;
restricted shares issued at closing, &lt;span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_c20231229__20231229__us-gaap--BusinessAcquisitionAxis__custom--NextTripHoldingsIncMember__us-gaap--DeferredRevenueArrangementTypeAxis__custom--DebtAssignmentAndConversionAgreementsMember_zcVxde1Nxxm4" title="Shares issued in acquisitions"&gt;52,818&lt;/span&gt;
shares were issued pursuant to the Debt Assignment and Conversion agreements, &lt;span id="xdx_908_eus-gaap--StockRepurchasedDuringPeriodShares_c20231229__20231229__us-gaap--BusinessAcquisitionAxis__custom--NextTripHoldingsIncMember__us-gaap--DeferredRevenueArrangementTypeAxis__custom--SharePurchaseAndExchangeAgreementsMember_zXmqO1j4HNF9" title="Purchase of shares issued"&gt;15,481&lt;/span&gt;
shares were issued pursuant to the Share Purchase and Pre-Acquisition Exchange Agreements, and &lt;span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20231229__20231229__us-gaap--BusinessAcquisitionAxis__custom--NextTripHoldingsIncMember__us-gaap--RelatedPartyTransactionAxis__custom--ThirdPartyConsultantMember_zWAaO8cs85Il" title="Shares issued during period services"&gt;4,337&lt;/span&gt;
shares were issued to a third-party consultant. Pursuant to ASC 805-40-45-1, the remaining &lt;span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_c20231229__20231229__us-gaap--BusinessAcquisitionAxis__custom--NextTripHoldingsIncMember_zKEQJKuWBoB9" title="Shares issued in acquisitions"&gt;83,371&lt;/span&gt;
Closing Shares are reflected as a retroactive adjustment to adjust the accounting acquirer&#x2019;s legal capital to reflect the
legal capital of the accounting acquiree. That adjustment is required to reflect the capital of the legal parent.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Deferred
Compensation&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
discussed above, during the fiscal year ended February 28, 2025, the Company issued &lt;span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20240301__20250228_zmoUsuE3c0p" title="Number of restricted common shares issued"&gt;4,000&lt;/span&gt;
restricted shares of common stock at a price of $&lt;span id="xdx_90B_eus-gaap--SharePrice_iI_c20250228_za5aZ7S8ciyg" title="Share price"&gt;6.69&lt;/span&gt;
to Lyndsey North, the Company&#x2019;s former President, in connection with her separation agreement. The shares were fully vested on
January 29, 2025, which was the grant date. As a result, the Company recorded share based compensation expense of $&lt;span id="xdx_904_eus-gaap--AllocatedShareBasedCompensationExpense_c20240301__20250228_zBXrJqKFWwKb" title="Share based compensation expense"&gt;26,760&lt;/span&gt;.
The Company did not issue any shares of common stock to employees during the fiscal year ended February 29, 2024.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Preferred
Stock&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Under
our amended and restated articles of incorporation (our &#x201c;Charter&#x201d;), our board of directors has the authority, without further action by
stockholders, to designate one or more series of preferred stock and to fix the voting powers, designations, preferences,
limitations, restrictions and relative rights granted to or imposed upon the preferred stock, including dividend rights, conversion
rights, voting rights, rights and terms of redemption, liquidation preference and sinking fund terms, any or all of which may be
preferential to or greater than the rights of the common stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Our
board of directors may authorize the issuance of preferred stock with voting or conversion rights that could adversely affect the voting
power or other rights of the holders of the common stock. The issuance of preferred stock, while providing flexibility in connection
with possible acquisitions and other corporate purposes, could, among other things, have the effect of delaying, deferring or preventing
a change in our control and may adversely affect the market price of the common stock and the voting and other rights of the holders
of common stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company is authorized to issue &lt;span id="xdx_908_eus-gaap--PreferredStockSharesAuthorized_iI_pid_c20250228_zrlsHaHx2Kig" title="Preferred stock, shares authorized"&gt;&lt;span id="xdx_90C_eus-gaap--PreferredStockSharesAuthorized_iI_pid_c20240229_zmn39j8t6sj9" title="Preferred stock, shares authorized"&gt;10,000,000&lt;/span&gt;&lt;/span&gt; shares of preferred stock, $&lt;span id="xdx_90A_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_c20250228_ztDddnKY9zf5" title="Preferred stock, par value"&gt;&lt;span id="xdx_908_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_c20240229_z1pgoEkOJyXh" title="Preferred stock, par value"&gt;0.001&lt;/span&gt;&lt;/span&gt; par value. &lt;span id="xdx_907_eus-gaap--PreferredStockSharesIssued_iI_c20250228_zAhHboNAMuYh" title="Preferred stock, shares issued"&gt;&lt;span id="xdx_903_eus-gaap--PreferredStockSharesOutstanding_iI_c20250228_zPBQUchr8fPd" title="Preferred stock, shares outstanding"&gt;3,106,616&lt;/span&gt;&lt;/span&gt; and &lt;span id="xdx_908_eus-gaap--PreferredStockSharesIssued_iI_c20240229_zNopltyXIZs" title="Preferred stock, shares issued"&gt;&lt;span id="xdx_900_eus-gaap--PreferredStockSharesOutstanding_iI_c20240229_zxwtZ7Dqslcc" title="Preferred stock, shares outstanding"&gt;472,996&lt;/span&gt;&lt;/span&gt; shares of preferred stock
were issued and outstanding at February 28, 2025 and February 29, 2024, Respectively, as discussed in additional detail below.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Series
E Convertible Preferred Stock&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Under
the Certificate of Designations of the Series E Preferred Stock, the shares of the Company&#x2019;s preferred stock as Series E
Convertible Preferred Stock (the &#x201c;Series E Preferred&#x201d;) have an initial stated value of $&lt;span id="xdx_906_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20250228__us-gaap--StatementClassOfStockAxis__custom--SeriesEConvertiblePreferredStockMember_zUdA0lJ5fYTi" title="Preferred stock, par value"&gt;1,500&lt;/span&gt;
per share (the &#x201c;Stated Value&#x201d;). Dividends at the initial rate of &lt;span id="xdx_90F_eus-gaap--PreferredStockDividendRatePercentage_pid_dp_uPure_c20240301__20250228__us-gaap--StatementClassOfStockAxis__custom--SeriesEConvertiblePreferredStockMember_zVPdL0kaOB6k" title="Dividends percentage"&gt;9&lt;/span&gt;%
per annum will accrue and, on a monthly basis, shall be payable in kind by the increase of the Stated Value of the Series E
Preferred by said amount. The holders of shares of the Series E Preferred have the right at any time to convert all or a portion of
the Series E Preferred (including, without limitation, accrued and unpaid dividends and make-whole dividends through the third
anniversary of the closing date) into shares of the Company&#x2019;s common stock at an initial conversion rate determined by
dividing the Conversion Amount by the conversion price ($&lt;span id="xdx_900_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20250228__us-gaap--StatementClassOfStockAxis__custom--SeriesEConvertiblePreferredStockMember_zdEKRkCpfPYb" title="Conversion price per share"&gt;0.13&lt;/span&gt;
above the consolidated closing bid price for the trading day prior to the execution of the relates stock purchase agreement). The
Conversion Amount is the sum of the Stated Value of the shares of Series E Preferred then being converted plus any other
unpaid amounts payable with respect to the Series E Preferred being converted plus the &#x201c;Make Whole Amount&#x201d; (the
amount of any dividends that, but for the conversion, would have accrued at the dividend rate for the period through the third
anniversary of the initial issuance date). The Conversion Rate is also subject to adjustment for stock splits, dividends
recapitalizations and similar events.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;At
February 28, 2025, &lt;span title="Preferred stock, shares issued"&gt;&lt;span id="xdx_90B_eus-gaap--PreferredStockSharesOutstanding_iI_c20250228__us-gaap--StatementClassOfStockAxis__custom--SeriesEConvertiblePreferredStockMember_zfcxfpP5yLk8" title="Preferred stock, shares outstanding"&gt;316&lt;/span&gt;&lt;/span&gt; shares of Series E Preferred were outstanding, which if converted as of February
28, 2025, including the make-whole dividends, would have resulted in the issuance of &lt;span id="xdx_906_eus-gaap--PreferredStockConvertibleSharesIssuable_iI_c20250228__us-gaap--StatementClassOfStockAxis__custom--SeriesEConvertiblePreferredStockMember_z3PGw85AlSk7" title="Common stock issuable upon conversion"&gt;3,362&lt;/span&gt; shares of common stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Series
F Convertible Preferred Stock&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
January 4, 2024, the Company filed a Certificate of Designation of Series F Convertible Preferred Stock (the &#x201c;Series F
Certificate of Designation&#x201d;) with the Secretary of State of the State of Nevada, designating &lt;span id="xdx_90B_eus-gaap--PreferredStockSharesAuthorized_iI_c20240104__us-gaap--StatementClassOfStockAxis__custom--SeriesFConvertiblePreferredStockMember_zwGeU0lsj9Yb" title="Preferred stock shares authorized"&gt;5,843,993&lt;/span&gt;
shares of the Company&#x2019;s preferred stock as Series F Convertible Preferred Stock, par value $&lt;span id="xdx_90B_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20240104__us-gaap--StatementClassOfStockAxis__custom--SeriesFConvertiblePreferredStockMember_zxN6eeocjlAg" title="Preferred stock, par value"&gt;0.001&lt;/span&gt;
per share (the &#x201c;Series F Preferred&#x201d;). The Series F Preferred was designated by the Company in connection with the NextTrip Acquisition, and, in the event that the Company does not have sufficient shares
of common stock available to fulfill its obligations pursuant to the Exchange Agreement governing the terms of the
NextTrip Acquisition, shares of Series F Preferred shall be issued to the previous equity holders of NTH in lieu of shares of Company
common stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
terms and conditions set forth in the Series F Certificate of Designation are summarized below:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Ranking&lt;/i&gt;&lt;/b&gt;&lt;i&gt;.
&lt;/i&gt;The Series F Preferred rank pari passu to the Company&#x2019;s common stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Dividends&lt;/i&gt;&lt;/b&gt;&lt;i&gt;.
&lt;/i&gt;Holders of Series F Preferred will be entitled to dividends, on an as-converted basis, equal to dividends actually paid, if any,
on shares of Company common stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Voting&lt;/i&gt;&lt;/b&gt;.
Except as provided by the Company&#x2019;s Charter or as otherwise required by the Nevada Revised Statutes, holders of Series F
Preferred are entitled to vote with the holders of outstanding shares of Company common stock, voting together as a single class,
with respect to all matters presented to the Company&#x2019;s stockholders for their action or consideration. In any such vote, each
holder is entitled to a number of votes equal to the number of shares of common stock into which the Series F Preferred held by such
holder is convertible. The Company may not, without the consent of holders of a majority of the outstanding shares of Series F
Preferred, (i) alter or change adversely the powers, preferences or rights given to the Series F Preferred or alter or amend the
Series F Certificate of Designation, (ii) amend its Charter or other charter documents in any manner that adversely effects any
rights of the holders of the Series F Preferred, or (c) enter into any agreement with respect to the foregoing.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Conversion&lt;/i&gt;&lt;/b&gt;.
On such date that the Company amends its Charter to increase the number of shares of common stock authorized for issuance
thereunder, to at least the extent required to convert all of the outstanding Series F Preferred, each outstanding share of Series F
Preferred shall automatically be converted into one share of Company common stock (subject to adjustment under certain limited
circumstances) (the &#x201c;Series F Conversion Ratio&#x201d;).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Liquidation&lt;/i&gt;&lt;/b&gt;.
In the event of any liquidation, dissolution or winding up of the Company, either voluntary or involuntary (each, a
&#x201c;Liquidation&#x201d;), holders of Series F Preferred will be entitled to participate, on an as-converted-to-common stock basis
calculate based on the Series F Conversion Ratio, with holders of Company common stock in any distribution of assets of the Company
to holders of the Company&#x2019;s common stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;At
February 28, 2025, &lt;span id="xdx_901_eus-gaap--PreferredStockSharesOutstanding_iI_do_c20250228__us-gaap--StatementClassOfStockAxis__custom--SeriesFConvertiblePreferredStockMember_zAtQK5X3Ymz9" title="Preferred stock, shares outstanding"&gt;no&lt;/span&gt; shares of the Series F Preferred were outstanding.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Series
G Convertible Preferred Stock&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
January 26, 2024, the Company filed a Certificate of Designation of Series G Convertible Preferred Stock (the &#x201c;Series G
Certificate of Designation&#x201d;) with the Secretary of State of the State of Nevada, designating &lt;span id="xdx_907_eus-gaap--PreferredStockSharesAuthorized_iI_c20240126__us-gaap--StatementClassOfStockAxis__custom--SeriesGConvertiblePreferredStockMember_zheNllniYYnf" title="Preferred stock shares authorized"&gt;100,000&lt;/span&gt;
shares of the Company&#x2019;s preferred stock as Series G Convertible Preferred Stock, par value $&lt;span id="xdx_906_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20240126__us-gaap--StatementClassOfStockAxis__custom--SeriesGConvertiblePreferredStockMember_zOSy2wUglqF5" title="Preferred stock, par value"&gt;0.001&lt;/span&gt;
per share (the &#x201c;Series G Preferred&#x201d;).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
terms and conditions set forth in the Series G Certificate of Designation are summarized below:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Ranking.
&lt;/i&gt;The Series G Preferred rank pari passu to the Company&#x2019;s common stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Dividends.
&lt;/i&gt;Holders of Series G Preferred will be entitled to dividends, on an as-converted basis, equal to dividends actually paid, if any,
on shares of Company common stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Voting&lt;/i&gt;.
Except as provided by the Company&#x2019;s Charter or as otherwise required by the Nevada Revised Statutes, holders of Series G Preferred
are entitled to vote with the holders of outstanding shares of Company common stock, voting together as a single class, with respect
to all matters presented to the Company&#x2019;s stockholders for their action or consideration. In any such vote, each holder is entitled
to a number of votes equal to the number of shares of common stock into which the Series G Preferred held by such holder is convertible.
The Company may not, without the consent of holders of a majority of the outstanding shares of Series G Preferred, (i) alter or change
adversely the powers, preferences or rights given to the Series G Preferred or alter or amend the Series G Certificate of Designation,
(ii) amend its Charter or other charter documents in any manner that adversely effects any rights of the holders of the Series G Preferred,
or (c) enter into any agreement with respect to the foregoing.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Conversion&lt;/i&gt;.
On such date that the Company amends its Charter to increase the number of shares of common stock authorized for issuance thereunder,
to at least the extent required to convert all of the outstanding Series G Preferred, each outstanding share of Series G Preferred shall
automatically be converted into one share of Company common stock (subject to adjustment under certain limited circumstances) (the &#x201c;Series
G Conversion Ratio&#x201d;).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Liquidation&lt;/i&gt;.
In the event of any liquidation, dissolution or winding up of the Company, either voluntary or involuntary, holders of Series G Preferred
will be entitled to participate, on an as-converted-to-common stock basis calculate based on the Series G Conversion Ratio, with holders
of Company common stock in any distribution of assets of the Company to holders of the Company&#x2019;s common stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Redemption
Right&lt;/i&gt;. &lt;span id="xdx_90E_eus-gaap--PreferredStockRedemptionTerms_c20240301__20250228__us-gaap--StatementClassOfStockAxis__custom--SeriesGConvertiblePreferredStockMember_z0OGLpnlv4G" title="Preferred stock redemption right, description"&gt;The
Company shall have the right to redeem up to 50% of the Series G Preferred for an aggregate price of $1.00 in accordance with
the terms of the Perpetual License Agreement&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company did not exercise its option to repurchase up to 50% of the Series G Preferred, and all such shares were converted to common
stock on March 15, 2024. At February 28, 2025, &lt;span id="xdx_906_eus-gaap--PreferredStockSharesOutstanding_iI_do_c20250228__us-gaap--StatementClassOfStockAxis__custom--SeriesGConvertiblePreferredStockMember_zBnO2ylgM36b" title="Preferred stock, shares outstanding"&gt;no&lt;/span&gt; shares of the issued Series G Preferred were outstanding.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Series
H Convertible Preferred Stock&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
January 26, 2024, the Company filed a Certificate of Designation of Series H Convertible Preferred Stock (the &#x201c;Series H
Certificate of Designation&#x201d;) with the Secretary of State of the State of Nevada, designating &lt;span id="xdx_905_eus-gaap--PreferredStockSharesAuthorized_iI_c20240126__us-gaap--StatementClassOfStockAxis__custom--SeriesHConvertiblePreferredStockMember_z6RcaBv2mAu1" title="Preferred stock, shares authorized"&gt;150,000&lt;/span&gt;
shares of the Company&#x2019;s preferred stock as Series H Preferred Stock, par value $&lt;span id="xdx_90C_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20240126__us-gaap--StatementClassOfStockAxis__custom--SeriesHConvertiblePreferredStockMember_zypY5Qw3AED5" title="Preferred stock, par value"&gt;0.001&lt;/span&gt;
per share (the &#x201c;Series H Preferred&#x201d;).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
terms and conditions set forth in the Series H Certificate of Designation are summarized below:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Ranking.
&lt;/i&gt;The Series H Preferred rank pari passu to the Company&#x2019;s common stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Dividends.
&lt;/i&gt;Holders of Series H Preferred will be entitled to dividends, on an as-converted basis, equal to dividends actually paid, if any,
on shares of Company common stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Voting&lt;/i&gt;.
Except as provided by the Company&#x2019;s Charter or as otherwise required by the Nevada Revised Statutes, holders of Series H Preferred
are entitled to vote with the holders of outstanding shares of Company common stock, voting together as a single class, with respect
to all matters presented to the Company&#x2019;s stockholders for their action or consideration. In any such vote, each holder is entitled
to a number of votes equal to the number of shares of common stock into which the Series H Preferred held by such holder is convertible.
The Company may not, without the consent of holders of a majority of the outstanding shares of Series H Preferred, (i) alter or change
adversely the powers, preferences or rights given to the Series H Preferred or alter or amend the Series H Certificate of Designation,
(ii) amend its Charter or other charter documents in any manner that adversely effects any rights of the holders of the Series H Preferred,
or (c) enter into any agreement with respect to the foregoing.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Conversion&lt;/i&gt;.
On such date that the Company amends its Charter to increase the number of shares of common stock authorized for issuance thereunder,
to at least the extent required to convert all of the outstanding Series H Preferred, each outstanding share of Series H Preferred shall
automatically be converted into one share of Company common stock (subject to adjustment under certain limited circumstances) (the &#x201c;Series
H Conversion Ratio&#x201d;).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Liquidation&lt;/i&gt;.
In the event of any liquidation, dissolution or winding up of the Company, either voluntary or involuntary, holders of Series H Preferred
will be entitled to participate, on an as-converted-to-common stock basis calculate based on the Series H Conversion Ratio, with holders
of Company common stock in any distribution of assets of the Company to holders of the Company&#x2019;s common stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;At
February 28, 2025, &lt;span title="Preferred stock, shares issued"&gt;&lt;span id="xdx_90A_eus-gaap--PreferredStockSharesOutstanding_iI_c20250228__us-gaap--StatementClassOfStockAxis__custom--SeriesHConvertiblePreferredStockMember_zPXkajWGz9i3" title="Preferred stock, shares outstanding"&gt;33,000&lt;/span&gt;&lt;/span&gt; shares of the issued Series H Preferred were outstanding, which if converted as of February
28, 2025, would have resulted in the issuance of &lt;span id="xdx_905_eus-gaap--PreferredStockConvertibleSharesIssuable_iI_c20250228__us-gaap--StatementClassOfStockAxis__custom--SeriesHConvertiblePreferredStockMember_zMAiZCl9HXwa" title="Common stock issuable upon conversion"&gt;33,000&lt;/span&gt; shares of common stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Series
I Convertible Preferred Stock&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
February 22, 2024, the Company filed a Certificate of Designation of Series I Convertible Preferred Stock (the &#x201c;Initial Series
I Certificate of Designation&#x201d;) with the Secretary of State of the State of Nevada, designating &lt;span id="xdx_900_eus-gaap--PreferredStockSharesAuthorized_iI_c20240222__us-gaap--StatementClassOfStockAxis__custom--SeriesIConvertiblePreferredStockMember_zjIC8UIJlcK1"&gt;331,124&lt;/span&gt;&lt;/span&gt;
&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares of the Company&#x2019;s preferred stock as Series I Convertible
Preferred Stock, par value $&lt;span id="xdx_904_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20240222__us-gaap--StatementClassOfStockAxis__custom--SeriesIConvertiblePreferredStockMember_zAw72DGiuhC1"&gt;0.001&lt;/span&gt;&lt;/span&gt;
&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;per share (the &#x201c;Series I Preferred&#x201d;). On February
25, 2025, the Company filed an amendment to the Certificate of Designation of Series I Convertible Preferred Stock (the &#x201c;Amendment
to Series I Certificate of Designation,&#x201d; and together with the Initial Series I Certificate of Designation, the &#x201c;Series I
Certificate of Designation&#x201d;) with the Secretary of State of the State of Nevada, to increase the number of shares of the Company&#x2019;s
preferred stock designated as Series I Preferred to &lt;span id="xdx_900_eus-gaap--PreferredStockSharesAuthorized_iI_c20250225__us-gaap--StatementClassOfStockAxis__custom--SeriesIConvertiblePreferredStockMember_zmfPDHYZIMUb"&gt;692,945&lt;/span&gt;&lt;/span&gt;
&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
terms and conditions set forth in the Series I Certificate of Designation are summarized below:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Ranking.
&lt;/i&gt;The Series I Preferred rank pari passu to the Company&#x2019;s common stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Dividends.
&lt;/i&gt;Holders of Series I Preferred will be entitled to dividends, on an as-converted basis, equal to dividends actually paid, if any,
on shares of Company common stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Voting&lt;/i&gt;.
Except as provided by the Charter, or as otherwise required by the Nevada Revised Statutes, holders of Series I Preferred are entitled
to vote with the holders of outstanding shares of Company common stock, voting together as a single class, with respect to all matters
presented to the Company&#x2019;s stockholders for their action or consideration. In any such vote, each holder is entitled to a number
of votes equal to the number of shares of common stock into which the Series I Preferred held by such holder is convertible. The Company
may not, without the consent of holders of a majority of the outstanding shares of Series I Preferred, (i) alter or change adversely
the powers, preferences or rights given to the Series I Preferred or alter or amend the Series I Certificate of Designation, (ii) amend
its Charter or other charter documents in any manner that adversely effects any rights of the holders of the Series I Preferred, or (c)
enter into any agreement with respect to the foregoing.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Conversion&lt;/i&gt;.
On such date that the Company amends its Charter to increase the number of shares of common stock authorized for issuance thereunder,
to at least the extent required to convert all of the outstanding shares of Series I Preferred, each outstanding share of Series I Preferred
shall automatically be converted into one share of Company common stock (subject to adjustment under certain limited circumstances) (the
&#x201c;Series I Conversion Ratio&#x201d;).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Liquidation&lt;/i&gt;.
In the event of any liquidation, dissolution or winding up of the Company, either voluntary or involuntary, holders of Series I Preferred
will be entitled to participate, on an as-converted-to-common stock basis calculated based on the Series I Conversion Ratio, with holders
of Company common stock in any distribution of assets of the Company to holders of the Company&#x2019;s common stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
February 15, 2024, the Company entered into a securities purchase agreement with certain accredited investors, pursuant to which the
Company issued and sold an aggregate of $&lt;span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20240215__20240215__us-gaap--StatementClassOfStockAxis__custom--SeriesIConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zE4U5gt1etga" title="Issuance of shares"&gt;672,500&lt;/span&gt; of the Company&#x2019;s securities, consisting of (i) &lt;span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20240215__20240215__us-gaap--StatementClassOfStockAxis__custom--SeriesIConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zUhxlGTD5jKd" title="Issuance of shares"&gt;222,680&lt;/span&gt; restricted shares of Series I Preferred, and (ii) unregistered warrants
to purchase up to &lt;span id="xdx_905_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20240215__us-gaap--StatementClassOfStockAxis__custom--SeriesIConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zYwR9dgXiJ33" title="Warrants to purchase common stock"&gt;111,340&lt;/span&gt; shares of Company common stock at a combined price of $&lt;span id="xdx_907_eus-gaap--SharePrice_iI_c20240215__us-gaap--StatementClassOfStockAxis__custom--SeriesIConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zHGEKTXDd78i" title="Share price"&gt;3.02&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
August 15, 2024, the Company entered into a securities purchase agreement with an investor for the sale of &lt;span id="xdx_904_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20240815__20240815__us-gaap--StatementClassOfStockAxis__custom--SeriesIConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_z06NpsU1w4y6" title="Sale of stock, shares"&gt;4,967&lt;/span&gt; shares of Series I Preferred, at $&lt;span id="xdx_901_eus-gaap--SaleOfStockPricePerShare_iI_c20240815__us-gaap--StatementClassOfStockAxis__custom--SeriesIConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zDpKxUYtGCEa" title="Sale of stock, shares price"&gt;3.02&lt;/span&gt; per share, resulting in gross proceeds to the Company of $&lt;span id="xdx_905_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_c20240815__20240815__us-gaap--StatementClassOfStockAxis__custom--SeriesIConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_z5x5E7G4Awf6" title="Sale of stock proceeds"&gt;15,000&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
August 31, 2024, the Company entered into a securities purchase agreement with an investor for the sale of &lt;span id="xdx_90E_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20240831__20240831__us-gaap--StatementClassOfStockAxis__custom--SeriesIConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zhY4QXaJPvW7" title="Sale of stock, shares"&gt;24,834&lt;/span&gt; shares of Series I Preferred at $&lt;span id="xdx_904_eus-gaap--SaleOfStockPricePerShare_iI_c20240831__us-gaap--StatementClassOfStockAxis__custom--SeriesIConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zI7UoZbvVzVl" title="Sale of stock, shares price"&gt;3.02&lt;/span&gt; per share, resulting in gross proceeds to the Company of $&lt;span id="xdx_90D_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_c20240831__20240831__us-gaap--StatementClassOfStockAxis__custom--SeriesIConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zmJhDJJyyqN2" title="Sale of stock proceeds"&gt;75,000&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
October 1, 2024, the Company entered into a securities purchase agreement with an investor for the sale of &lt;span id="xdx_908_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20241001__20241001__us-gaap--StatementClassOfStockAxis__custom--SeriesIConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_z7uKfJAZlqKh" title="Sale of stock, shares"&gt;66,225&lt;/span&gt; shares of Series I Preferred at $&lt;span id="xdx_903_eus-gaap--SaleOfStockPricePerShare_iI_c20241001__us-gaap--StatementClassOfStockAxis__custom--SeriesIConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zfPCvEmQkxj" title="Sale of stock, shares price"&gt;3.02&lt;/span&gt; per share, resulting in gross proceeds to the Company of $&lt;span id="xdx_90A_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_c20241001__20241001__us-gaap--StatementClassOfStockAxis__custom--SeriesIConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zOvdrEUweBq6" title="Sale of stock proceeds"&gt;200,000&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
February 24, 2025, the Company entered into a securities purchase agreement (the &#x201c;Series I Purchase Agreement&#x201d;) with
certain accredited investors (the &#x201c;Purchasers&#x201d;), pursuant to which the Company issued and sold an aggregate of &lt;span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20250224__20250224__us-gaap--StatementClassOfStockAxis__custom--SeriesIConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--SeriesIPurchaseAgreementMember_zUIhkjOBdwJ6" title="Restricted shares"&gt;331,125&lt;/span&gt;
restricted shares of Series I Preferred Stock to the Purchasers at a purchase price of $&lt;span id="xdx_904_eus-gaap--SaleOfStockPricePerShare_iI_c20250224__us-gaap--StatementClassOfStockAxis__custom--SeriesIConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zARw9a2FXOF2" title="Sale of stock, shares price"&gt;3.02&lt;/span&gt;
per share (the &#x201c;Series I Offering&#x201d;), resulting in aggregate gross proceeds to the Company of $&lt;span id="xdx_90A_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_c20250224__20250224__us-gaap--StatementClassOfStockAxis__custom--SeriesIConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--SeriesIPurchaseAgreementMember_zwrMGrCZ65p6" title="Sale of stock proceeds"&gt;1,000,000&lt;/span&gt;.
In addition, the Company issued &lt;span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20250224__20250224__us-gaap--StatementClassOfStockAxis__custom--SeriesIPreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--SeriesIPurchaseAgreementMember_zUW6n00Q1BVk" title="Issuance of shares"&gt;10,000&lt;/span&gt;
shares of Series I Preferred at $&lt;span id="xdx_909_eus-gaap--SaleOfStockPricePerShare_iI_c20241001__us-gaap--StatementClassOfStockAxis__custom--SeriesIPreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zBybi1QSKXo8" title="Sale of stock, shares price"&gt;3.02&lt;/span&gt;
per share to an outside contractor as payment for outstanding invoices.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
February 24 2025, the Company entered into a debt conversion agreement with Greg Miller, an independent contractor of the Company,
whereby Mr. Miller and the Company agreed to convert $&lt;span id="xdx_902_eus-gaap--DebtConversionConvertedInstrumentAmount1_c20250224__20250224__us-gaap--TypeOfArrangementAxis__custom--MillerDebtConversionAgreementMember_zoUUqZLZ2R46" title="Converted amount"&gt;100,000&lt;/span&gt;
in deferred consulting fees owed to Mr. Miller into &lt;span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20250224__20250224__us-gaap--TypeOfArrangementAxis__custom--MillerDebtConversionAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesIConvertiblePreferredStockMember_zF3KiLH3tJ11" title="Issuance of shares"&gt;33,113&lt;/span&gt;
shares of Series I Preferred, at a conversion price of $&lt;span id="xdx_90B_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20250224__us-gaap--TypeOfArrangementAxis__custom--MillerDebtConversionAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesIConvertiblePreferredStockMember_zh6vvXLmh4J3" title="Debt conversion price"&gt;3.02&lt;/span&gt;
per share, and a warrant to purchase &lt;span id="xdx_904_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20250224__us-gaap--TypeOfArrangementAxis__custom--MillerDebtConversionAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesIConvertiblePreferredStockMember_zmwVL8rVnyV3" title="Warrants to purchase common stock"&gt;33,113&lt;/span&gt;
shares of common stock (the &#x201c;Miller Warrant&#x201d;). The Miller Warrant has an exercise price of $&lt;span id="xdx_90A_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20250224__us-gaap--TypeOfArrangementAxis__custom--MillerDebtConversionAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesIConvertiblePreferredStockMember_z5GwVjqRpot7" title="Exercise price"&gt;4.00&lt;/span&gt;
per share, becomes exercisable six months from the issuance date (subject to stockholder approval of removal of the Exchange Cap),
and shall expire three years from the initial exercise date (August 24, 2028).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Series I Preferred shall not be convertible and the Miller Warrant shall be not exercisable into shares of common stock until such date
that the Company obtains stockholder approval to remove the Exchange Cap (as described below).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;At
February 28, 2025, &lt;span title="Preferred stock, shares issued"&gt;&lt;span id="xdx_90E_eus-gaap--PreferredStockSharesOutstanding_iI_c20250228__us-gaap--StatementClassOfStockAxis__custom--SeriesIConvertiblePreferredStockMember_zUdgF5jSWgsc" title="Preferred stock, shares outstanding"&gt;500,442&lt;/span&gt;&lt;/span&gt; shares of the Series I Preferred were outstanding, which if converted as of February 28,
2025, would have resulted in the issuance of &lt;span id="xdx_902_eus-gaap--PreferredStockConvertibleSharesIssuable_iI_c20250228__us-gaap--StatementClassOfStockAxis__custom--SeriesIConvertiblePreferredStockMember_zViR1ZgYSmd1" title="Converted issuance of shares of common stock"&gt;500,442&lt;/span&gt; shares of common stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Series
J Nonvoting Convertible Preferred Stock&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
January 3, 2025, the Company filed a Certificate of Designation of Series J Nonvoting Convertible Preferred Stock (the &#x201c;Series
J Certificate of Designation&#x201d;) with the Secretary of State of the State of Nevada, designating &lt;span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20250103__20250103__us-gaap--StatementClassOfStockAxis__custom--SeriesJNonvotingConvertiblePreferredStockMember_zqRBMkqSJcu5" title="Restricted shares"&gt;297,788&lt;/span&gt;
shares of the Company&#x2019;s preferred stock as Series J Nonvoting Convertible Preferred Stock, par value $&lt;span id="xdx_906_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20250103__us-gaap--StatementClassOfStockAxis__custom--SeriesJNonvotingConvertiblePreferredStockMember_zc2zlVEBbpFk" title="Preferred stock, par value"&gt;0.001&lt;/span&gt;
per share (the &#x201c;Series J Preferred&#x201d;).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
terms and conditions set forth in the Series J Certificate of Designation are summarized below:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Ranking.
&lt;/i&gt;The Series J Preferred rank pari passu to the Company&#x2019;s common stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Dividends.
&lt;/i&gt;Holders of Series J Preferred will be entitled to dividends, on an as-converted basis, equal to dividends actually paid, if any,
on shares of Company common stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Voting&lt;/i&gt;.
Except as provided by the Charter, or as otherwise required by the Nevada Revised Statutes, holders of Series J Preferred are not entitled
to voting rights. However, the Company may not, without the consent of holders of a majority of the outstanding shares of Series J Preferred,
(i) alter or change adversely the powers, preferences or rights given to the Series J Preferred or alter or amend the Series J Certificate
of Designation, (ii) amend its Charter or other charter documents in any manner that adversely effects any rights of the holders of the
Series J Preferred, or (c) enter into any agreement with respect to the foregoing.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Conversion&lt;/i&gt;.
On the third business day after the date that the Company&#x2019;s stockholders approve the conversion of Series J Preferred into shares
of Common Stock in accordance with the listing rules of Nasdaq, each outstanding share of Series J Preferred shall automatically be converted
into one share of Company common stock (subject to adjustment under certain limited circumstances) (the &#x201c;Series J Conversion Ratio&#x201d;),
subject to beneficial ownership limitations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Liquidation&lt;/i&gt;.
In the event of any liquidation, dissolution or winding up of the Company, either voluntary or involuntary, holders of Series J Preferred
will be entitled to participate, on an as-converted-to-common stock basis calculated based on the Series J Conversion Ratio, with holders
of Company common stock in any distribution of assets of the Company to holders of the Company&#x2019;s common stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
December 31, 2024, the Company entered into a securities purchase agreement with certain accredited investors, pursuant to which the
Company issued and sold an aggregate of &lt;span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20241231__20241231__us-gaap--StatementClassOfStockAxis__custom--SeriesJNonvotingConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zYp76RjrWlC2" title="Issuance of shares"&gt;231,788&lt;/span&gt; restricted shares of Series J Preferred, at a purchase price of $&lt;span id="xdx_909_eus-gaap--SharePrice_iI_c20241231__us-gaap--StatementClassOfStockAxis__custom--SeriesJNonvotingConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_z5jYfH7uczp6" title="Share price"&gt;3.02&lt;/span&gt; per share, resulting in gross proceeds to the Company
of $&lt;span id="xdx_905_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_c20241231__20241231__us-gaap--StatementClassOfStockAxis__custom--SeriesJNonvotingConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zVAHvSTRWQCi" title="Sale of stock proceeds"&gt;700,000&lt;/span&gt;. In addition, the Company issued a total of &lt;span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20241231__20241231__us-gaap--StatementClassOfStockAxis__custom--SeriesJNonvotingConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zETwHV1wAIUl" title="Issuance of shares for services"&gt;66,000&lt;/span&gt; shares of Series J Preferred to four consultants for investor relations
services.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Series J Preferred shall be convertible into the Company&#x2019;s common stock on such date that the Company obtains stockholder approval
to remove the Exchange Cap.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;At
February 28, 2025, &lt;span title="Preferred stock, shares issued"&gt;&lt;span id="xdx_90F_eus-gaap--PreferredStockSharesOutstanding_iI_c20250228__us-gaap--StatementClassOfStockAxis__custom--SeriesJNonvotingConvertiblePreferredStockMember_z4EO1sdNnv8l" title="Preferred stock, shares outstanding"&gt;297,788&lt;/span&gt;&lt;/span&gt; shares of the Series J Preferred were outstanding, which if converted as of February 28,
2025, would have resulted in the issuance of &lt;span id="xdx_90D_eus-gaap--PreferredStockConvertibleSharesIssuable_iI_c20250228__us-gaap--StatementClassOfStockAxis__custom--SeriesJNonvotingConvertiblePreferredStockMember_zS4BPrzLX3F2" title="Common stock issuable upon conversion"&gt;297,788&lt;/span&gt; shares of common stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Series
K Nonvoting Convertible Preferred Stock&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
January 3, 2025, the Company filed a Certificate of Designation of Series K Nonvoting Convertible Preferred Stock (the &#x201c;Series
K Certificate of Designation&#x201d;) with the Secretary of State of the State of Nevada, designating &lt;span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20250103__20250103__us-gaap--StatementClassOfStockAxis__custom--SeriesKNonvotingConvertiblePreferredStockMember_z8hCFKypgGIc" title="Restricted shares"&gt;60,595&lt;/span&gt;
shares of the Company&#x2019;s preferred stock as Series K Nonvoting Convertible Preferred Stock, par value $&lt;span id="xdx_90E_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20250103__us-gaap--StatementClassOfStockAxis__custom--SeriesKNonvotingConvertiblePreferredStockMember_zxciiO6flLPd" title="Preferred stock, par value"&gt;0.001&lt;/span&gt;
per share (the &#x201c;Series K Preferred&#x201d;).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
terms and conditions set forth in the Series K Certificate of Designation are summarized below:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Ranking.
&lt;/i&gt;The Series K Preferred rank pari passu to the Company&#x2019;s common stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Dividends.
&lt;/i&gt;Holders of Series K Preferred will be entitled to dividends, on an as-converted basis, equal to dividends actually paid, if any,
on shares of Company common stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Voting&lt;/i&gt;.
Except as provided by the Charter, or as otherwise required by the Nevada Revised Statutes, holders of Series K Preferred are not entitled
to voting rights. However, the Company may not, without the consent of holders of a majority of the outstanding shares of Series K Preferred,
(i) alter or change adversely the powers, preferences or rights given to the Series K Preferred or alter or amend the Series K Certificate
of Designation, (ii) amend its Charter or other charter documents in any manner that adversely effects any rights of the holders of the
Series K Preferred, or (c) enter into any agreement with respect to the foregoing.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Conversion&lt;/i&gt;.
On the third business day after the date that the Company&#x2019;s stockholders approve the conversion of Series K Preferred into shares
of Common Stock in accordance with the listing rules of Nasdaq, each outstanding share of Series K Preferred shall automatically be converted
into one share of Company common stock (subject to adjustment under certain limited circumstances) (the &#x201c;Series K Conversion Ratio&#x201d;),
subject to beneficial ownership limitations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Liquidation&lt;/i&gt;.
In the event of any liquidation, dissolution or winding up of the Company, either voluntary or involuntary, holders of Series K Preferred
will be entitled to participate, on an as-converted-to-common stock basis calculated based on the Series K Conversion Ratio, with holders
of Company common stock in any distribution of assets of the Company to holders of the Company&#x2019;s common stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
December 31, 2024, the Company issued an aggregate of &lt;span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20241231__20241231__us-gaap--StatementClassOfStockAxis__custom--SeriesKNonvotingConvertiblePreferredStockMember_zYVNUXGoXWxl" title="Issuance of shares"&gt;60,595&lt;/span&gt; shares of Series K Preferred to a series of investors
at a price of $&lt;span id="xdx_901_eus-gaap--SharePrice_iI_c20241231__us-gaap--StatementClassOfStockAxis__custom--SeriesKNonvotingConvertiblePreferredStockMember_z2DyjOLX6OSf" title="Share price"&gt;3.02&lt;/span&gt; per share as prepaid guaranteed interest in connection with the sale of an aggregate of $&lt;span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20241231__20241231__us-gaap--StatementClassOfStockAxis__custom--SeriesKNonvotingConvertiblePreferredStockMember_z7pGBVoIMrCb" title="Issuance of shares"&gt;1,220,000&lt;/span&gt; in promissory
notes.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Series K Preferred shall be convertible into the Company&#x2019;s common stock on such date that the Company obtains stockholder approval
to remove the Exchange Cap.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;At
February 28, 2025, &lt;span title="Preferred stock, shares issued"&gt;&lt;span id="xdx_90D_eus-gaap--PreferredStockSharesOutstanding_iI_c20250228__us-gaap--StatementClassOfStockAxis__custom--SeriesKNonvotingConvertiblePreferredStockMember_zRtrgYW5oqO4" title="Preferred stock, shares outstanding"&gt;60,595&lt;/span&gt;&lt;/span&gt; shares of the Series K Preferred were outstanding, which if converted as of February 28,
2025, would have resulted in the issuance of &lt;span id="xdx_907_eus-gaap--PreferredStockConvertibleSharesIssuable_iI_c20250228__us-gaap--StatementClassOfStockAxis__custom--SeriesKNonvotingConvertiblePreferredStockMember_zGyKd0UC1YVg" title="Converted issuance of shares of common stock"&gt;60,595&lt;/span&gt; shares of common stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Series
L Nonvoting Convertible Preferred Stock&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
January 3, 2025, the Company filed a Certificate of Designation of Series L Nonvoting Convertible Preferred Stock (the
&#x201c;Initial Series L Certificate of Designation&#x201d;) with the Secretary of State of the State of Nevada, designating &lt;span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20250103__20250103__us-gaap--StatementClassOfStockAxis__custom--SeriesLNonvotingConvertiblePreferredStockMember_zw5J948csBw6" title="Restricted shares"&gt;579,469&lt;/span&gt;
shares of the Company&#x2019;s preferred stock as Series L Nonvoting Convertible Preferred Stock, par value $&lt;span id="xdx_90C_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20250103__us-gaap--StatementClassOfStockAxis__custom--SeriesLNonvotingConvertiblePreferredStockMember_zxFdB69gfp9d" title="Preferred stock, par value"&gt;0.001&lt;/span&gt;
per share(the &#x201c;Series L Preferred&#x201d;). On February 25, 2025, the Company filed an amendment to the Initial Series L Certificate of Designation (the &#x201c;Series
L Preferred Amendment,&#x201d; and together with the Initial Series L Certificate of Designation, the &#x201c;Series L Certificate of Designation&#x201d;)
with the Secretary of State of the State of Nevada, to increase the number of shares of the Company&#x2019;s preferred stock designated
as Series L Preferred to &lt;span id="xdx_904_eus-gaap--PreferredStockSharesAuthorized_iI_c20250225__us-gaap--StatementClassOfStockAxis__custom--SeriesLNonvotingConvertiblePreferredStockMember_zLBhtrDGaLPc" title="Preferred stock, shares authorized"&gt;1,076,158&lt;/span&gt; shares.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
terms and conditions set forth in the Series L Certificate of Designation are summarized below:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Ranking.
&lt;/i&gt;The Series L Preferred rank pari passu to the Company&#x2019;s common stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Dividends.
&lt;/i&gt;Holders of Series L Preferred will be entitled to dividends, if, as and when declared by the Board out of funds at the time legally
available therefor, dividends in the amount of &lt;span id="xdx_90E_eus-gaap--PreferredStockDividendRatePercentage_pid_dp_uPure_c20250103__20250103__us-gaap--StatementClassOfStockAxis__custom--SeriesLNonvotingConvertiblePreferredStockMember_z602A2WHwORb" title="Dividend percentage"&gt;12&lt;/span&gt;% per annum per share of Preferred Stock (subject to appropriate adjustment in the event
of any stock dividend, stock split, combination or other similar recapitalization with respect to the Preferred Stock), and no more.
Dividends on the Preferred Stock shall be fully cumulative, shall accrue without interest and without compounding from the date of first
issuance, and shall, if declared by the Board, be payable quarterly in arrears on March 1, June 1, September 1 and December of each year.
All dividends on the Preferred Stock shall be payable (i) in shares of Common Stock of the Company at the Nasdaq Closing Price; provided,
however, that such prices shall not be less than $&lt;span id="xdx_90F_eus-gaap--SaleOfStockPricePerShare_iI_c20250103__us-gaap--StatementClassOfStockAxis__custom--SeriesLNonvotingConvertiblePreferredStockMember_zG9MtSsxsPNg" title="Purchase price, per share"&gt;3.02&lt;/span&gt; per share, or (ii) cash, at the election of a majority of the independent directors.
Any dividend which shall not be paid on required dividend date on which it shall become due shall be deemed to be &#x201c;past due&#x201d;
until such dividend shall be paid or until the share of Preferred Stock with respect to which such dividend became due shall no longer
be outstanding, whichever is the earlier to occur. In the event that any dividend becomes &#x201c;past due&#x201d; the per annum rate shall
increase to 14%.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Voting&lt;/i&gt;.
Except as provided by the Charter, or as otherwise required by the Nevada Revised Statutes, holders of Series L Preferred are not entitled
to voting rights However, the Company may not, without the consent of holders of a majority of the outstanding shares of Series L Preferred,
(i) alter or change adversely the powers, preferences or rights given to the Series L Preferred or alter or amend the Series L Certificate
of Designation, (ii) amend its Charter or other charter documents in any manner that adversely effects any rights of the holders of the
Series L Preferred, or (c) enter into any agreement with respect to the foregoing.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Conversion&lt;/i&gt;.
On the third business day after the date that the Company&#x2019;s stockholders approve the conversion of Series L Preferred into shares
of Common Stock in accordance with the listing rules of Nasdaq, each outstanding share of Series L Preferred shall automatically be converted
into one share of Company common stock (subject to adjustment under certain limited circumstances) (the &#x201c;Series L Conversion Ratio&#x201d;),
subject to beneficial ownership limitations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Liquidation&lt;/i&gt;.
In the event of any liquidation, dissolution or winding up of the Company, either voluntary or involuntary, holders of Series L Preferred
will be entitled to participate, on an as-converted-to-common stock basis calculated based on the Series L Conversion Ratio, with holders
of Company common stock in any distribution of assets of the Company to holders of the Company&#x2019;s common stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
December 31, 2024, the Company entered into debt conversion agreements with
its chief executive officer, William Kerby, and chairman of the board, Donald P. Monaco (the &#x201c;Related Parties&#x201d;), whereby
the Related Parties and the Company agreed to convert $&lt;span id="xdx_909_eus-gaap--DebtConversionConvertedInstrumentAmount1_pn4n6_c20241231__20241231__srt--TitleOfIndividualAxis__custom--MessrsKerbyAndMonacoMember__us-gaap--TypeOfArrangementAxis__custom--RelatedPartyDebtConversionAgreementsMember_z0bWZk7HXdfh" title="Converted amount"&gt;1.75&lt;/span&gt; million in existing unsecured promissory notes owed to the Related Parties
for monies advanced to the Company into an aggregate of &lt;span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20241231__20241231__srt--TitleOfIndividualAxis__custom--MessrsKerbyAndMonacoMember__us-gaap--StatementClassOfStockAxis__custom--SeriesLNonvotingConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--RelatedPartyDebtConversionAgreementsMember_zs93oHrPKI0f" title="Restricted shares"&gt;579,469&lt;/span&gt; restricted shares of Series L Preferred, at a purchase price of $&lt;span id="xdx_90D_eus-gaap--SaleOfStockPricePerShare_iI_c20241231__srt--TitleOfIndividualAxis__custom--MessrsKerbyAndMonacoMember__us-gaap--StatementClassOfStockAxis__custom--SeriesLNonvotingConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--RelatedPartyDebtConversionAgreementsMember_zoRaJYGTeIjb" title="Purchase price, per share"&gt;3.02&lt;/span&gt; per share.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
February 24, 2025, the Company entered into debt conversion agreements with
its chief executive officer, William Kerby, and chairman of the board, Donald P. Monaco, whereby
the Related Parties and the Company agreed to convert $&lt;span id="xdx_90E_eus-gaap--DebtConversionConvertedInstrumentAmount1_c20250224__20250224__us-gaap--TypeOfArrangementAxis__custom--RelatedPartyDebtConversionAgreementsMember__us-gaap--StatementClassOfStockAxis__custom--SeriesLNonvotingConvertiblePreferredStockMember_ziHxJhrI8nZc" title="Converted amount"&gt;500,000&lt;/span&gt; in deferred salary (Mr. Kerby) and $&lt;span id="xdx_90A_eus-gaap--ProceedsFromUnsecuredNotesPayable_pn5n6_c20250224__20250224__us-gaap--TypeOfArrangementAxis__custom--RelatedPartyDebtConversionAgreementsMember__us-gaap--StatementClassOfStockAxis__custom--SeriesLNonvotingConvertiblePreferredStockMember_zM611ZdNl5ll" title="Unsecured promissory notes"&gt;1.0&lt;/span&gt; million in existing unsecured
promissory notes owed for monies advanced to the Company (Mr. Monaco), respectively, into an aggregate of &lt;span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20250224__20250224__us-gaap--TypeOfArrangementAxis__custom--RelatedPartyDebtConversionAgreementsMember__us-gaap--StatementClassOfStockAxis__custom--SeriesLNonvotingConvertiblePreferredStockMember_zfkF3xJox5Hg" title="Restricted shares"&gt;496,687&lt;/span&gt; restricted shares of
Series L Preferred at a conversion price of $&lt;span id="xdx_902_eus-gaap--SaleOfStockPricePerShare_iI_c20250224__us-gaap--StatementClassOfStockAxis__custom--SeriesLNonvotingConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--RelatedPartyDebtConversionAgreementsMember_zEQYUFXzuhMk" title="Purchase price, per share"&gt;3.02&lt;/span&gt; per
share.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Series L Preferred shall be convertible into the Company&#x2019;s common stock on such date that the Company obtains stockholder approval
to remove the Exchange Cap (as described below), subject to beneficial ownership limitations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;At
February 28, 2025, &lt;span title="Preferred stock, shares issued"&gt;&lt;span id="xdx_900_eus-gaap--PreferredStockSharesOutstanding_iI_c20250228__us-gaap--StatementClassOfStockAxis__custom--SeriesLNonvotingConvertiblePreferredStockMember_zf890FYnq3Vl" title="Preferred stock, shares outstanding"&gt;1,076,156&lt;/span&gt;&lt;/span&gt; shares of the Series L Preferred were outstanding, which if converted as of February 28,
2025, would have resulted in the issuance of &lt;span id="xdx_90F_eus-gaap--PreferredStockConvertibleSharesIssuable_iI_c20250228__us-gaap--StatementClassOfStockAxis__custom--SeriesLNonvotingConvertiblePreferredStockMember_zTTBPSqknx52" title="Converted issuance of shares of common stock"&gt;1,076,156&lt;/span&gt; shares of common stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Series
M Nonvoting Convertible Preferred Stock&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
January 3, 2025, the Company filed a Certificate of Designation of Series M Nonvoting Convertible Preferred Stock (the &#x201c;Series
M Certificate of Designation&#x201d;) with the Secretary of State of the State of Nevada, designating &lt;span id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20250103__20250103__us-gaap--StatementClassOfStockAxis__custom--SeriesMNonvotingConvertiblePreferredStockMember_zOdtJ9ntlIge" title="Restricted shares"&gt;165,562&lt;/span&gt;
shares of the Company&#x2019;s preferred stock as Series M Nonvoting Convertible Preferred Stock, par value $&lt;span id="xdx_901_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20250103__us-gaap--StatementClassOfStockAxis__custom--SeriesMNonvotingConvertiblePreferredStockMember_z2NKN9bwu4Kg" title="Preferred stock, par value"&gt;0.001&lt;/span&gt;
per share (the &#x201c;Series M Preferred&#x201d;).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
terms and conditions set forth in the Series M Certificate of Designation are summarized below:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Ranking.
&lt;/i&gt;The Series M Preferred rank pari passu to the Company&#x2019;s common stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Dividends.
&lt;/i&gt;Holders of Series M Preferred will be entitled to dividends, if, as and when declared by the Board out of funds at the time legally
available therefor, dividends in the amount of &lt;span id="xdx_900_eus-gaap--PreferredStockDividendRatePercentage_pid_dp_uPure_c20250103__20250103__us-gaap--StatementClassOfStockAxis__custom--SeriesMNonvotingConvertiblePreferredStockMember_zZdJb3e6He6k" title="Dividend percentage"&gt;12&lt;/span&gt;% per annum per share of Preferred Stock (subject to appropriate adjustment in the event
of any stock dividend, stock split, combination or other similar recapitalization with respect to the Preferred Stock), and no more.
Dividends on the Preferred Stock shall be fully cumulative, shall accrue without interest and without compounding from the date of first
issuance, and shall, if declared by the Board, be payable quarterly in arrears on March 1, June 1, September 1 and December of each year.
All dividends on the Preferred Stock shall be payable (i) in shares of Common Stock of the Company at the Nasdaq Closing Price; provided,
however, that such prices shall not be less than $&lt;span id="xdx_902_eus-gaap--SaleOfStockPricePerShare_iI_c20250103__us-gaap--StatementClassOfStockAxis__custom--SeriesMNonvotingConvertiblePreferredStockMember_zAOACmj362H2" title="Purchase price, per share"&gt;3.02&lt;/span&gt; per share, or (ii) cash, at the election of a majority of the independent directors.
Any dividend which shall not be paid on required dividend date on which it shall become due shall be deemed to be &#x201c;past due&#x201d;
until such dividend shall be paid or until the share of Preferred Stock with respect to which such dividend became due shall no longer
be outstanding, whichever is the earlier to occur. In the event that any dividend becomes &#x201c;past due&#x201d; the per annum rate shall
increase to 14%.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Voting&lt;/i&gt;.
Except as provided by the Charter, or as otherwise required by the Nevada Revised Statutes, holders of Series M Preferred are not entitled
to voting rights. However, the Company may not, without the consent of holders of a majority of the outstanding shares of Series M Preferred,
(i) alter or change adversely the powers, preferences or rights given to the Series M Preferred or alter or amend the Series M Certificate
of Designation, (ii) amend its Charter or other charter documents in any manner that adversely effects any rights of the holders of the
Series M Preferred, or (c) enter into any agreement with respect to the foregoing.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Conversion&lt;/i&gt;.
On the third business day after the date that the Company&#x2019;s stockholders approve the conversion of Series M Preferred into shares
of Common Stock in accordance with the listing rules of Nasdaq, each outstanding share of Series M Preferred shall automatically be converted
into one share of Company common stock (subject to adjustment under certain limited circumstances) (the &#x201c;Series M Conversion Ratio&#x201d;),
subject to beneficial ownership limitations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Liquidation&lt;/i&gt;.
In the event of any liquidation, dissolution or winding up of the Company, either voluntary or involuntary, holders of Series M Preferred
will be entitled to participate, on an as-converted-to-common stock basis calculated based on the Series M Conversion Ratio, with holders
of Company common stock in any distribution of assets of the Company to holders of the Company&#x2019;s common stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
December 31, 2024, the Company entered into a securities purchase agreement with certain accredited investors, pursuant to which the
Company may issue and sell up to $&lt;span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20241231__20241231__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesMNonvotingConvertiblePreferredStockMember_zZscwvrUyrn4" title="Restricted shares"&gt;500,000&lt;/span&gt; of restricted shares of Series M Preferred, at a purchase price of $&lt;span id="xdx_906_eus-gaap--SaleOfStockPricePerShare_iI_c20241231__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__custom--SeriesMNonvotingConvertiblePreferredStockMember_zVwTLZ977Sw9" title="Purchase price, per share"&gt;3.02&lt;/span&gt; per share.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
addition, as part of the Series M Preferred offering, on December 31, 2024, the Company entered into a debt conversion agreement
with an existing lender whereby the lender and the Company agreed to convert $&lt;span id="xdx_90E_eus-gaap--DebtConversionConvertedInstrumentAmount1_c20241231__20241231__us-gaap--StatementClassOfStockAxis__custom--SeriesMNonvotingConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--DebtConversionAgreementMember_zq7Jb0QNf96c" title="Debt converted amount"&gt;350,000&lt;/span&gt;
in existing unsecured promissory notes plus accrued interest owed to the lender for monies advanced to the Company into shares of
Series M Preferred.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Series M Preferred shall be convertible into the Company&#x2019;s common stock on such date that the Company obtains stockholder approval
to remove the Exchange Cap.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
December 31, 2024, in connection with the foregoing, the Company issued &lt;span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20241231__20241231__us-gaap--StatementClassOfStockAxis__custom--SeriesMNonvotingConvertiblePreferredStockMember_zXOhuFET6MJl" title="Issuance of shares"&gt;133,278&lt;/span&gt;
shares of Series M Preferred to an investor pursuant to a debt conversion agreement.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;At February 28, 2025, all &lt;span id="xdx_901_eus-gaap--PreferredStockSharesIssued_iI_c20250228__us-gaap--StatementClassOfStockAxis__custom--SeriesMNonvotingConvertiblePreferredStockMember_z98tTMXOF478" title="Preferred stock, shares issued"&gt;&lt;span id="xdx_90D_eus-gaap--PreferredStockSharesOutstanding_iI_c20250228__us-gaap--StatementClassOfStockAxis__custom--SeriesMNonvotingConvertiblePreferredStockMember_zBAAKrlUXXF4" title="Preferred stock, shares outstanding"&gt;133,278&lt;/span&gt;&lt;/span&gt;
shares of the Series M Preferred were outstanding, which if converted as of February 28, 2025, would have resulted
in the issuance of &lt;span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesConversionOfUnits_c20240301__20250228__us-gaap--StatementClassOfStockAxis__custom--SeriesMNonvotingConvertiblePreferredStockMember_zxIZ2glL7L3j" title="Common stock issuable upon conversion"&gt;133,278&lt;/span&gt;
shares of common stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Series
N Nonvoting Convertible Preferred Stock&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
January 30, 2025, the Company filed a Certificate of Designation of Series N Convertible Preferred Stock (the &#x201c;Series N
Certificate of Designation&#x201d;) with the Secretary of State of the State of Nevada, designating &lt;span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20250103__20250103__us-gaap--StatementClassOfStockAxis__custom--SeriesNNonvotingConvertiblePreferredStockMember_zOUglbwzLDQf" title="Restricted shares"&gt;500,000&lt;/span&gt;
shares of the Company&#x2019;s preferred stock as Series N Convertible Preferred Stock, par value $&lt;span id="xdx_90E_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20250103__us-gaap--StatementClassOfStockAxis__custom--SeriesNNonvotingConvertiblePreferredStockMember_zMFcuI5CZk1i" title="Preferred stock, par value"&gt;0.001&lt;/span&gt;
per share (the &#x201c;Series N Preferred&#x201d;).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
terms and conditions set forth in the Series N Certificate of Designation are summarized below:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Ranking.
&lt;/i&gt;The Series N Preferred rank pari passu to the Company&#x2019;s common stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Dividends.
&lt;/i&gt;Holders of Series N Preferred will be entitled to dividends, on an as-converted basis, equal to dividends actually paid, if any,
on shares of Company common stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Voting&lt;/i&gt;.
Except as provided by the Series N Certificate of Designation, or as otherwise required by the Nevada Revised Statutes, holders of Series
N Preferred are not entitled to voting rights. However, the Company may not, without the consent of holders of a majority of the outstanding
shares of Series N Preferred, (i) alter or change adversely the powers, preferences or rights given to the Series N Preferred or alter
or amend the Series N Certificate of Designation, (ii) amend its amended and restated articles of incorporation, amended and restated
bylaws or other charter documents in any manner that adversely effects any rights of the holders of the Series N Preferred, or (c) enter
into any agreement with respect to the foregoing.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Conversion&lt;/i&gt;.
On the third business day after the date that the Company&#x2019;s stockholders approve the conversion of Series N Preferred into shares
of common stock in accordance with the listing rules of Nasdaq, each outstanding share of Series N Preferred shall automatically be converted
into one share of Company common stock (subject to adjustment under certain limited circumstances) (the &#x201c;Series N Conversion Ratio&#x201d;),
subject to beneficial ownership limitations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Liquidation&lt;/i&gt;.
In the event of any liquidation, dissolution or winding up of the Company, either voluntary or involuntary, holders of Series N Preferred
will be entitled to participate, on an as-converted-to-common stock basis calculated based on the Series N Conversion Ratio (as defined
in the Series N Certificate of Designation), with holders of Company common stock in any distribution of assets of the Company to holders
of the Company&#x2019;s common stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
January 28, 2025, the Company entered into a securities purchase agreement with an accredited
investor, pursuant to which the Company issued and sold the purchaser (i) &lt;span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20250128__20250128__us-gaap--StatementClassOfStockAxis__custom--SeriesNNonvotingConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zqbnJZQtgAMi" title="Restricted shares"&gt;17,000&lt;/span&gt; restricted shares of Series N Preferred and (ii) warrants to
purchase &lt;span id="xdx_905_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20250128__us-gaap--StatementClassOfStockAxis__custom--SeriesNNonvotingConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zgmwKVtsXA2a" title="Warrants to purchase common stock"&gt;17,000&lt;/span&gt; shares of Company common stock, at a combined purchase price of $&lt;span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20250128__us-gaap--StatementClassOfStockAxis__custom--SeriesNNonvotingConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zXTcVmlFpkxf" title="Warrants purchase price"&gt;5.00&lt;/span&gt; per share and warrant,
resulting in gross proceeds to the Company of $&lt;span id="xdx_906_eus-gaap--ProceedsFromIssuanceOfWarrants_c20250128__20250128__us-gaap--StatementClassOfStockAxis__custom--SeriesNNonvotingConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_z4pSYqAktbg6" title="Gross proceeds"&gt;85,000&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
February 24, 2025, the Company and Blue Fysh Holdings Inc. (&#x201c;Blue Fysh&#x201d;) entered into a share exchange agreement (the &#x201c;BF
Share Exchange Agreement&#x201d;) whereby Blue Fysh agreed to issue &lt;span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20250128__20250128__us-gaap--StatementClassOfStockAxis__custom--SeriesNNonvotingConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__dei--LegalEntityAxis__custom--BlueFyshHoldingsIncMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zISI3Wgnbwf9" title="Restricted shares"&gt;82&lt;/span&gt; restricted shares of its common stock to the Company, representing
a ten percent (&lt;span id="xdx_90A_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20250128__us-gaap--StatementClassOfStockAxis__custom--SeriesNNonvotingConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__dei--LegalEntityAxis__custom--BlueFyshHoldingsIncMember_z8cLbTETA5c9" title="Interest rate"&gt;10&lt;/span&gt;%) interest in Blue Fysh, in exchange for &lt;span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20250128__20250128__us-gaap--StatementClassOfStockAxis__custom--SeriesNNonvotingConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__dei--LegalEntityAxis__custom--BlueFyshHoldingsIncMember_z5vsJPbVCyY7" title="Restricted shares"&gt;483,000&lt;/span&gt; restricted shares of Series N Preferred at an issuance price of $&lt;span id="xdx_909_eus-gaap--SharePrice_iI_pid_c20250128__us-gaap--StatementClassOfStockAxis__custom--SeriesNNonvotingConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__dei--LegalEntityAxis__custom--BlueFyshHoldingsIncMember_z6757XdqSBre" title="Share price"&gt;5.00&lt;/span&gt; per share (the &#x201c;BF Share Exchange&#x201d;).
The BF Share Exchange closed on February 28, 2025.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Series N Preferred shall be convertible into the Company&#x2019;s common stock on such date that the Company obtains stockholder approval
to remove the Exchange Cap.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;At
February 28, 2025, &lt;span id="xdx_905_eus-gaap--PreferredStockSharesOutstanding_iI_c20250228__us-gaap--StatementClassOfStockAxis__custom--SeriesNNonvotingConvertibleConvertiblePreferredStockMember_ztaGf0VmnbGf" title="Preferred stock, shares outstanding"&gt;500,000&lt;/span&gt; shares of the Series N Preferred were outstanding, which if converted as of February 28,
2025, would have resulted in the issuance of &lt;span id="xdx_90F_eus-gaap--PreferredStockConvertibleSharesIssuable_iI_c20250228__us-gaap--StatementClassOfStockAxis__custom--SeriesNNonvotingConvertibleConvertiblePreferredStockMember_z0HYZvaK6ky5" title="Converted issuance of shares of common stock"&gt;500,000&lt;/span&gt; shares of common stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Series
O Nonvoting Convertible Preferred Stock&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
February 6, 2025, the Company filed a Certificate of Designation of Series O Nonvoting Convertible Preferred Stock (the
&#x201c;Series O Certificate of Designation&#x201d;) with the Secretary of State of the State of Nevada, designating &lt;span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20250206__20250206__us-gaap--StatementClassOfStockAxis__custom--SeriesONonvotingConvertiblePreferredStockMember_zpajU4Nv96S" title="Restricted shares"&gt;451,614&lt;/span&gt;
shares of the Company&#x2019;s preferred stock as Series O Nonvoting Convertible Preferred Stock, par value $&lt;span id="xdx_90D_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20250206__us-gaap--StatementClassOfStockAxis__custom--SeriesONonvotingConvertiblePreferredStockMember_ztKyiykfFosd" title="Preferred stock, par value"&gt;0.001&lt;/span&gt;
per share (the &#x201c;Series O Preferred&#x201d;).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
terms and conditions set forth in the Series O Certificate of Designation are summarized below:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Ranking.
&lt;/i&gt;The Series O Preferred rank pari passu to the Company&#x2019;s common stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Dividends.
&lt;/i&gt;Holders of Series O Preferred will be entitled to dividends, on an as-converted basis, equal to dividends actually paid, if any,
on shares of Company common stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Voting&lt;/i&gt;.
Except as provided by the Series O Certificate of Designation, or as otherwise required by the Nevada Revised Statutes, holders of Series
O Preferred are not entitled to voting rights. However, the Company may not, without the consent of holders of a majority of the outstanding
shares of Series O Preferred, (i) alter or change adversely the powers, preferences or rights given to the Series O Preferred or alter
or amend the Series O Certificate of Designation, (ii) amend its amended and restated articles of incorporation, amended and restated
bylaws or other charter documents in any manner that adversely effects any rights of the holders of the Series O Preferred, or (c) enter
into any agreement with respect to the foregoing.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Conversion&lt;/i&gt;.
On the third business day after the date that the Company&#x2019;s stockholders approve the conversion of Series O Preferred into shares
of common stock in accordance with the listing rules of Nasdaq, each outstanding share of Series O Preferred shall automatically be converted
into one share of Company common stock (subject to adjustment under certain limited circumstances) (the &#x201c;Series O Conversion Ratio&#x201d;),
subject to beneficial ownership limitations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Liquidation&lt;/i&gt;.
In the event of any liquidation, dissolution or winding up of the Company, either voluntary or involuntary, holders of Series O Preferred
will be entitled to participate, on an as-converted-to-common stock basis calculated based on the Series O Conversion Ratio (as defined
in the Series O Certificate of Designation), with holders of Company common stock in any distribution of assets of the Company to holders
of the Company&#x2019;s common stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
February 6, 2025, in connection with the initial &lt;span id="xdx_90A_eus-gaap--BusinessAcquisitionPercentageOfVotingInterestsAcquired_iI_pid_dp_uPure_c20250206__us-gaap--BusinessAcquisitionAxis__custom--FSATravelLLCMember_zeI5BSCSrnVa"&gt;49&lt;/span&gt;%
acquisition of FSA, the Company issued &lt;span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20250206__20250206__us-gaap--StatementClassOfStockAxis__custom--SeriesONonvotingConvertiblePreferredStockMember_zEyjzfmhhv7d" title="Shares issued"&gt;161,291&lt;/span&gt;
shares of Series O Preferred to FSA.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
shares of Series O Preferred issued and issuable cannot be converted into shares of Company common stock unless and until the Company&#x2019;s
stockholders approve the conversion of Series O Preferred into shares of common stock in accordance with the listing rules of Nasdaq.
Upon receipt of such approvals, the share of Series O Preferred outstanding as of such date shall automatically convert into shares of
Company common stock, subject to applicable beneficial ownership limitations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;At
February 28, 2025, &lt;span id="xdx_906_eus-gaap--PreferredStockSharesOutstanding_iI_c20250228__us-gaap--StatementClassOfStockAxis__custom--SeriesONonvotingConvertiblePreferredStockMember_zQgI5WxaOB0l" title="Preferred stock, shares outstanding"&gt;161,291&lt;/span&gt; shares of the Series O Preferred were outstanding, which if converted as of February 28,
2025, would have resulted in the issuance of &lt;span id="xdx_905_eus-gaap--PreferredStockConvertibleSharesIssuable_iI_c20250228__us-gaap--StatementClassOfStockAxis__custom--SeriesONonvotingConvertiblePreferredStockMember_zDEy67uEeA41" title="Common stock issuable upon conversion"&gt;161,291&lt;/span&gt; shares of common stock&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Series
P Nonvoting Convertible Preferred Stock&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
February 25, 2025, the Company filed a Certificate of Designation of Series P Nonvoting Convertible Preferred Stock (the
&#x201c;Series P Certificate of Designation&#x201d;) with the Secretary of State of the State of Nevada, designating &lt;span id="xdx_90D_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20250225__20250225__us-gaap--StatementClassOfStockAxis__custom--SeriesPNonvotingConvertiblePreferredStockMember_zjRV5lYzrXP6" title="Restricted shares"&gt;343,750&lt;/span&gt;
shares of the Company&#x2019;s preferred stock as Series P Nonvoting Convertible Preferred Stock, par value $&lt;span id="xdx_90E_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20250225__us-gaap--StatementClassOfStockAxis__custom--SeriesPNonvotingConvertiblePreferredStockMember_zgBVASdwY4Dc" title="Preferred stock, par value"&gt;0.001&lt;/span&gt;
per share (the &#x201c;Series P Preferred&#x201d;).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
terms and conditions set forth in the Series P Certificate of Designation are summarized below:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Ranking.
The Series P Preferred rank pari passu to the Company&#x2019;s common stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Dividends.
Holders of Series P Preferred will be entitled to dividends, on an as-converted basis, equal to dividends actually paid, if any, on shares
of Company common stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Voting.
Except as provided by the Charter, or as otherwise required by the Nevada Revised Statutes, holders of Series P Preferred are not entitled
to voting rights. However, the Company may not, without the consent of holders of a majority of the outstanding shares of Series P Preferred,
(i) alter or change adversely the powers, preferences or rights given to the Series P Preferred or alter or amend the Series P Certificate
of Designation, (ii) amend its Charter or other charter documents in any manner that adversely effects any rights of the holders of the
Series P Preferred, or (c) enter into any agreement with respect to the foregoing.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Conversion.
On the third business day after the date that the Company&#x2019;s stockholders approve the conversion of Series P Preferred into shares
of Common Stock in accordance with the listing rules of Nasdaq, each outstanding share of Series P Preferred shall automatically be converted
into one share of Company common stock (subject to adjustment under certain limited circumstances) (the &#x201c;Series P Conversion Ratio&#x201d;),
subject to beneficial ownership limitations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Liquidation.
In the event of any liquidation, dissolution or winding up of the Company, either voluntary or involuntary, holders of Series P Preferred
will be entitled to participate, on an as-converted-to-common stock basis calculated based on the Series P Conversion Ratio, with holders
of Company common stock in any distribution of assets of the Company to holders of the Company&#x2019;s common stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
February 26, 2025, the Company entered into an Equity Investment Agreement with AOS Holdings
LLC (&#x201c;AOS&#x201d;), pursuant to which the Company issued and sold to AOS (i) &lt;span id="xdx_90F_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20250226__20250226__us-gaap--StatementClassOfStockAxis__custom--SeriesPNonvotingConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--EquityInvestmentAgreementMember_zI1HPWniz502" title="Sale of stock, shares"&gt;93,750&lt;/span&gt; restricted shares of Series P Preferred, (ii) a warrant exercisable in cash to purchase up to &lt;span id="xdx_903_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20250226__us-gaap--StatementClassOfStockAxis__custom--SeriesPNonvotingConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--EquityInvestmentAgreementMember_zEOhxa8c6Qlg" title="Warrants to purchase common stock"&gt;375,000&lt;/span&gt; shares
of common stock (the &#x201c;Cash Warrant&#x201d;), and (iii) a warrant exercisable in either cash or via cashless exercise (the &#x201c;Cashless
Warrant&#x201d;) to purchase up to &lt;span id="xdx_909_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_iI_c20250226__us-gaap--StatementClassOfStockAxis__custom--SeriesPNonvotingConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--EquityInvestmentAgreementMember_z4V7Mi6lcV61" title="Warrants to purchase"&gt;375,000&lt;/span&gt; shares of common stock, for a combined purchase price of $&lt;span id="xdx_906_eus-gaap--SharePrice_iI_c20250226__us-gaap--StatementClassOfStockAxis__custom--SeriesPNonvotingConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--EquityInvestmentAgreementMember_zOaMfIoTxjdj" title="Share price"&gt;4.00&lt;/span&gt; per share, resulting in gross
proceeds to the Company of $&lt;span id="xdx_907_eus-gaap--ProceedsFromIssuanceOfWarrants_c20250226__20250226__us-gaap--StatementClassOfStockAxis__custom--SeriesPNonvotingConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--EquityInvestmentAgreementMember_z9Td9kHZ3iGb" title="Gross proceeds"&gt;375,000&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
February 26, 2025, the Company entered into a Debt Exchange Agreement with AOS whereby
AOS and the Company agreed to convert $&lt;span id="xdx_90B_eus-gaap--DebtConversionConvertedInstrumentAmount1_c20250226__20250226__us-gaap--StatementClassOfStockAxis__custom--SeriesPNonvotingConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--DebtExchangeAgreementMember_zWYcQofGXV23" title="Converted amount"&gt;1,000,000&lt;/span&gt; owed to AOS under an existing unsecured promissory note owed for monies advanced to
the Company into &lt;span id="xdx_90C_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20250226__20250226__us-gaap--StatementClassOfStockAxis__custom--SeriesPNonvotingConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--DebtExchangeAgreementMember_zPyueLqYjVk2" title="Sale of stock, shares"&gt;250,000&lt;/span&gt; shares of Series P Preferred at a conversion price of $&lt;span id="xdx_909_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20250226__us-gaap--StatementClassOfStockAxis__custom--SeriesPNonvotingConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--DebtExchangeAgreementMember_z6TKteeZ1gXg" title="Conversion price"&gt;4.00&lt;/span&gt; per share.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Series P Preferred shall be convertible into the Company&#x2019;s common stock on such date that the Company obtains stockholder approval
to remove the Exchange Cap (as described below), subject to beneficial ownership limitations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;At
February 28, 2025, &lt;span id="xdx_908_eus-gaap--PreferredStockSharesOutstanding_iI_c20250228__us-gaap--StatementClassOfStockAxis__custom--SeriesPNonvotingConvertiblePreferredStockMember_znU2pxliQcJh" title="Preferred stock, shares outstanding"&gt;343,750&lt;/span&gt; shares of the Series P Preferred were outstanding, which if converted as of February 28,
2025, would have resulted in the issuance of &lt;span id="xdx_90F_eus-gaap--PreferredStockConvertibleSharesIssuable_iI_c20250228__us-gaap--StatementClassOfStockAxis__custom--SeriesPNonvotingConvertiblePreferredStockMember_zDzHqs2vaAH6" title="Common stock issuable upon conversion"&gt;343,750&lt;/span&gt; shares of common stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Stock
Options&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
December 28, 2023, at the Annual Meeting of Stockholders of the Company, the Company&#x2019;s stockholders approved the adoption of
the NextTrip 2023 Equity Incentive Plan (the &#x201c;2023 Plan&#x201d;). &lt;span id="xdx_907_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_c20250228__us-gaap--PlanNameAxis__custom--TwoThousandTwentyThreeEquityIncentivePlanMember_zo3mmXkcbxo5" title="Common stock reserved for issuance"&gt;7,000,000&lt;/span&gt;
shares of common stock have been reserved for issuance under the 2023 Plan, and as of February 28, 2025, all such shares are
available for issuance.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of February 28, 2025, we had outstanding options under our 2013 Equity Incentive Plan (the &#x201c;2012 Plan&#x201d;) to purchase an
aggregate of &lt;span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20250228__us-gaap--PlanNameAxis__custom--TwoThousandThirteenEquityIncentivePlanMember_z5lWraltrygh" title="Common stock shares option outstanding"&gt;76,342&lt;/span&gt;
shares of our common stock at a weighted-average exercise price of $&lt;span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20250228__us-gaap--PlanNameAxis__custom--TwoThousandThirteenEquityIncentivePlanMember_zS36WPJG0okh" title="Weighted average exercise price"&gt;52.69&lt;/span&gt;
per share.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
fiscal year 2025, the Company did not grant any options. In fiscal year 2025, &lt;span id="xdx_90B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_c20240301__20250228_zldPJCJcWiw1" title="Share based compensation arrangement by award options vested"&gt;3,101&lt;/span&gt; options vested and $&lt;span id="xdx_906_eus-gaap--CompensationExpenseExcludingCostOfGoodAndServiceSold_c20240301__20250228_zuBpMRIgQca2" title="Compensation cost"&gt;41,114&lt;/span&gt; of compensation cost was
recognized during the year. At February 28, 2025, there are vested options exercisable for &lt;span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20250228__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_z1aCqAmcHwO2" title="Stock issued during Stock options exercised"&gt;75,992&lt;/span&gt; shares of common stock. &lt;span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_do_c20240301__20250228_zXpnLOlY10c5" title="Share based compensation arrangement by award options grants"&gt;No&lt;/span&gt; options
to purchase shares of common stock were exercised during the fiscal year ended February 28, 2025.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company generally grants stock options to employees, consultants and directors at exercise prices equal to the fair market value of the
Company&#x2019;s stock on the dates of grant. Stock options are typically granted throughout the year and generally vest over three years
of service and expire five years from the date of the award, unless otherwise specified. The Company recognizes compensation expense
for the fair value of the stock options over the requisite service period for each stock option award.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Upon
closing of the NextTrip Acquisition on December 29, 2023, the Company assumed options to purchase up to &lt;span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20240301__20250228__srt--RangeAxis__srt--MaximumMember_zOz24DRBl19g" title="Options to purchase of common stock"&gt;86,402&lt;/span&gt; shares of common
stock. Between December 29, 2023 and February 29, 2024, &lt;span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_pid_c20231229__20240229_zlUILpQ5eShi" title="Options to forfeited or expired"&gt;1,342&lt;/span&gt; options were forfeited or expired and no options were issued or exercised.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total
employee share-based compensation expense for the year ended February 28, 2025 was $&lt;span id="xdx_90B_eus-gaap--ShareBasedCompensation_pp0p0_c20240301__20250228_zRSQ1hA9KgM4" title="Allocation share based compensation expense"&gt;67,874&lt;/span&gt;, of which $&lt;span id="xdx_904_eus-gaap--ProceedsFromStockOptionsExercised_pp0p0_c20240301__20250228_zgTHMbIBiPr9" title="Stock options"&gt;41,114&lt;/span&gt; was related to stock options.
There was no capitalized share-based compensation cost as of February 28, 2025, and there were no recognized tax benefits during the
fiscal year ended February 28, 2025.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;To
estimate the value of an option award, the Company uses the Black-Scholes option-pricing model. This model requires inputs such as
expected life, expected volatility and risk-free interest rate. The forfeiture rate also impacts the amount of aggregate
compensation. These inputs are subjective and generally require significant analysis and judgment to develop. While estimates of
expected life, volatility and forfeiture rate are derived primarily from the Company&#x2019;s historical data, the risk-free rate is
based on the yield available on U.S. Treasury constant maturity rates with similar terms to the expected term of the stock option
awards. The fair value of outstanding stock option awards at February 28, 2025 was estimated using the Black-Scholes model with the
following weighted-average assumptions at the date of grant:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_895_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_z7fWqRBOsDU8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Option
activity for the year ended February 28, 2025 was as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8BC_zfQu3JsnJ59" style="display: none"&gt;Schedule of Stock Option Activity&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Weighted Average&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Weighted Average&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Exercise&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Remaining&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Aggregate&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Price&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Contractual&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Intrinsic&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Options&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;($)&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Life (Yrs.)&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Value ($)&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 44%; padding-bottom: 2.5pt"&gt;Options outstanding at February 29, 2024&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20240301__20250228_zPZHtTXqaegk" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Number of Options Outstanding, Balance"&gt;85,300&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20240301__20250228_z9ijAU1jR6H5" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; width: 10%; text-align: right" title="Weighted Average Exercise Price Outstanding, Balance"&gt;60.50&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; width: 10%; text-align: right"&gt;&lt;span id="xdx_90B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20230301__20240229_z7rh1Tw5VOCa" title="Weighted Average Remaining Contractual Life Years, Outstanding Balance"&gt;2.52&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_pp0p0_c20240301__20250228_zzRgZC8N6fuf" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Aggregate Intrinsic Value Outstanding"&gt;&#160;&#160;&#160;&#160;&lt;span style="-sec-ix-hidden: xdx2ixbrl1700"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;Exercised&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_pid_di0_c20240301__20250228_zgwFJ0vHjxqj" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options, Exercised"&gt;-&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20240301__20250228_zb5XDJ5uwvna" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1704"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;-&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_pp0p0_c20240301__20250228_zMmgjk4Asvdf" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1706"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"&gt;Forfeited or cancelled&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_iN_pid_di_c20240301__20250228_zLqMInKaS8x7" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options, Forfeited or cancelled"&gt;(8,958&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_pid_c20240301__20250228_zRGsYFDGyqqa" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right" title="Weighted Average Exercise Price, Forfeited or cancelled"&gt;125.65&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right"&gt;-&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedorCancelledInPeriodTotalIntrinsicValue_pp0p0_c20240301__20250228_zGxxh3VyvZD6" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Forfeited or cancelled"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1712"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;Options outstanding at February 28, 2025&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20240301__20250228_zxxWWJqIBdUc" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options Outstanding, Balance"&gt;76,342&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20240301__20250228_zycMET3eH0s6" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price Outstanding, Balance"&gt;52.69&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"&gt;&lt;span id="xdx_904_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20240301__20250228_z7pTiXutuxa4" title="Weighted Average Remaining Contractual Life Years, Outstanding Balance"&gt;1.60&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iE_pp0p0_c20240301__20250228_zxoBHzrt13Sc" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value Outstanding"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1720"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Options expected to vest in the future as of February 28, 2025&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iE_pid_c20240301__20250228_zRqlghxB8pGb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options, Expected to Vest in the Future Ending Balance"&gt;350&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_iE_pid_c20240301__20250228_zRmsLe0OoOx" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Expected to Vest"&gt;50.00&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_dtY_c20240301__20250228_zVtPqhUUH0Xg" title="Weighted Average Remaining Contractual Life Years, Expected to Vest"&gt;2.34&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_iE_pp0p0_c20240301__20250228_zVuiziQo3bue" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Outstanding, Expected of  Vest"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1728"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;Options exercisable at February 28, 2025&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_pid_c20240301__20250228_zKfkfptkyge6" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options, Exercisable"&gt;75,992&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20240301__20250228_z7d3SzvRF8i6" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right" title="Weighted Average Exercise Price, Exercisable"&gt;52.71&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right"&gt;&lt;span id="xdx_90D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20240301__20250228_zLUR4wKzojMi" title="Weighted Average Remaining Contractual Life Years, Exercisable"&gt;1.59&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iE_pp0p0_c20240301__20250228_zup665Ufk8G" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Outstanding, Exercisable"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1736"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"&gt;Options vested, exercisable, and options expected to vest at February 28, 2025&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_iE_pid_c20230301__20250228_zLyRyLfYBXdb" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options, Vested, Exercisable and Options Expected to Vest, Balance"&gt;76,342&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_iE_c20240301__20250228_zOaTHmRKbjRj" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price, Vested, Exercisable and Options Expected to Vest"&gt;52.69&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"&gt;&lt;span id="xdx_904_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_dtY_c20240301__20250228_z3c1eUlHCHM8" title="Weighted Average Remaining Contractual Life (Yrs.), Vested, Exercisable and Options Expected to Vest"&gt;1.60&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_iE_pp0p0_c20240301__20250228_zetWwG7Azr31" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Outstanding,Exercisable and Options Expected to Vest"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1744"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AA_z4ubeUqz6YUc" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
aggregate intrinsic value is calculated as the difference between the exercise price of the underlying awards and the quoted price of
our common stock for those awards that have an exercise price below the $&lt;span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20240301__20250228_zdDyM65zTIOd" title="Options exercise price"&gt;3.98&lt;/span&gt; closing price of our Common Stock on February 28, 2025.
All of the outstanding option grants have an exercise price above $&lt;span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20240301__20250228_z9fEYjzkqxFf" title="Options exercise price"&gt;3.98&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;At
February 28, 2025, there was $&lt;span id="xdx_906_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_iI_c20250228_zkNsCfHfwop5" title="Unrecognized stock-based compensation expense, stock option"&gt;5,260&lt;/span&gt; of unrecognized share-based compensation expense related to unvested stock options with a weighted
average remaining recognition period of &lt;span id="xdx_901_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_dtY_c20240301__20250228_zyY6aVCYc9n7" title="Weighted average remaining recognition period"&gt;0.34&lt;/span&gt; years.&lt;/span&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Stock
Appreciation Rights&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
purposes of the 2020 Stock Appreciation Rights Plan (the &#x201c;2020 SARs Plan&#x201d;) are to: (i) enable the Company to attract and
retain the types of employees, consultants, and directors (collectively, &#x201c;Service Providers&#x201d;) who will contribute to the
Company&#x2019;s long-range success; (ii) provide incentives that align the interests of Service Providers with those of the
shareholders of the Company; and (iii) promote the success of the Company&#x2019;s business. The 2020 SARs Plan provides for
incentive awards that are only made in the form of stock appreciation rights payable in cash (&#x201c;SARs&#x201d;). No shares of
common stock were reserved in connection with the adoption of the 2020 SARs Plan since no shares will be issued pursuant to the
2020 SARs Plan.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;SARs
may be granted to any Service Provider. A SAR is the right to receive an amount equal to the Spread with respect to a share of the
Company&#x2019;s common stock (a &#x201c;Share&#x201d;) upon the exercise of the SAR. The &#x201c;Spread&#x201d; is the difference
between the exercise price per share specified in a SAR agreement on the date of grant and the fair market value per share on the
date of exercise of the SAR. The exercise price per share will not be less than 100% of the fair market value of a Share on the date
of grant of the SAR. The administrator of the 2020 SARs Plan will have the authority to, among other things, prescribe the terms and
conditions of each SAR, including, without limitation, the exercise price and medium of payment and vesting provisions, and to
specify the provisions of the SAR agreement relating to such grant.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Upon
closing of the NextTrip Acquisition on December 29, 2023, the Company assumed &lt;span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20231229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_z5PCbZEWw0re" title="Reverse acquisition shares outstanding"&gt;40,390&lt;/span&gt; outstanding SARs. Between December 29, 2023
and February 29, 2024, &lt;span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_dn_c20241229__20241229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zHJ6bvYJEXWb" title="Shares forfeited or expired"&gt;none&lt;/span&gt; were forfeited or expired and &lt;span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_do_c20241229__20241229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_z98G3VLCaAd1" title="Shares issued or exercised"&gt;no&lt;/span&gt; SARs were issued or exercised.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company recognizes compensation expense and a corresponding liability for the fair value of the SARs over the requisite service period
for each SAR award. The SAR&#x2019;s are revalued at each reporting date in accordance with ASC 718 &#x201c;Compensation-Stock Compensation&#x201d;,
and any changes in fair value are reflected in income as of the applicable reporting date.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89B_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_hus-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_z2BXlDB1N7Lj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
fair value of outstanding SAR awards was estimated using the Black-Scholes model with the following assumptions for the twelve months
ended February 28, 2025:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Assumptions:&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8BE_zRCuvey8r5x6" style="display: none"&gt;Schedule of Share Based Payments Award Stock Options Valuation Assumptions&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 75%; margin-right: auto"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;2025&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 78%; text-align: left"&gt;Dividend yield&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right"&gt;&lt;span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_uPure_c20240301__20250228__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyStockAppreciationRightsPlanMember_zvTY0812C7Tb" title="Dividend yield"&gt;0.0&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Risk-free interest rate&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_dp_uPure_c20240301__20250228__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyStockAppreciationRightsPlanMember_zKHl8PAoQXla" title="Risk-free interest rate, minimum"&gt;2.3&lt;/span&gt;%-&lt;span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_dp_uPure_c20240301__20250228__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyStockAppreciationRightsPlanMember_zX9fO0EfkiO6" title="Risk-free interest rate, maximum"&gt;5.25&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Expected volatility&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_dp_uPure_c20240301__20250228__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyStockAppreciationRightsPlanMember_zq5yRj9WdE3e" title="Expected volatility, minimum"&gt;96.5&lt;/span&gt;%-&lt;span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_dp_uPure_c20240301__20250228__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyStockAppreciationRightsPlanMember_zq9WsGGxTKmj" title="Expected volatility, maximum"&gt;187.8&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Expected life (in years)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20240301__20250228__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyStockAppreciationRightsPlanMember__srt--RangeAxis__srt--MinimumMember_z86hD1Pm8OR" title="Expected life"&gt;0.16&lt;/span&gt;-&lt;span id="xdx_90B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20240301__20250228__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyStockAppreciationRightsPlanMember__srt--RangeAxis__srt--MaximumMember_z8xRrC63KiZ" title="Expected life"&gt;2.08&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A2_zKoCi2YHf8pl" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89B_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_hus-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zY6pvwKtnjEh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;SARs
activity for the year ended February 28, 2025 was as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8BC_z9W7DSJJXzi3" style="display: none"&gt;Schedule of Stock Option Activity&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Weighted Average&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Weighted Average&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Exercise&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Remaining&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Aggregate&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Price&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Contractual&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Intrinsic&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;SARs&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;($)&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Life (Yrs.)&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Value ($)&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 44%; padding-bottom: 2.5pt"&gt;SARs outstanding at February 29, 2024&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20240301__20250228__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zjkCZZCRAwh8" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Number of Options, Outstanding, Balance"&gt;40,390&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20240301__20250228__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zQ4n6w20TGg5" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Weighted Average Exercise Price, Outstanding Balance"&gt;44.77&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right"&gt;&lt;span id="xdx_90B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20230301__20240228__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zRRT7pE2pkti" title="Weighted Average Remaining Contractual Life, Outstanding Balance"&gt;2.99&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_pp0p0_c20240301__20250228__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zsdfPy788FQj" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Aggregate Intrinsic Value, Outstanding Balance"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&lt;span style="-sec-ix-hidden: xdx2ixbrl1784"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;Exercised&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_pid_di_c20240301__20250228__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_z4IaxQLm7lD8" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options, Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1786"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20240301__20250228__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zSHJCbpGBwW8" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1788"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;-&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_pp0p0_c20240301__20250228__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zceVw30bzj7" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1790"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"&gt;Forfeited or cancelled&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_iN_pid_di_c20240301__20250228__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zYUiseWCIOyj" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options, Forfeited or cancelled"&gt;(167&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageForfeitedOrCancelled_pid_c20240301__20250228__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zKmYsp2iQrNe" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Forfeited or cancelled"&gt;37.4&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;-&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedorCancelledInPeriodTotalIntrinsicValue_pp0p0_c20240301__20250228__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zbjkcFaAlHz8" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Forfeited or cancelled"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1796"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;SARs outstanding February 28, 2025&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20240301__20250228__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zqxsOpD7OZwd" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options, Outstanding, Balance"&gt;40,223&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20240301__20250228__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zC6dAbVaDPBg" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Outstanding Balance"&gt;44.80&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20240301__20250228__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zr4yQGUbcPJ7" title="Weighted Average Remaining Contractual Life, Outstanding Balance"&gt;1.99&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iE_pp0p0_c20240301__20250228__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zGpRxO6pgOQf" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Outstanding Balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1804"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;SARs expected to vest in the future as of February 28, 2025&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iE_pid_c20240301__20250228__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zGGSsgm4v6p9" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options, Expected to vest in the future, Balance"&gt;5,213&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_iE_pid_c20240301__20250228__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zn7Hsp92P6K3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Expected to Vest"&gt;27.66&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_dtY_c20240301__20250228__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zwFy3VfuD7Ta" title="Weighted Average Remaining Contractual Life, Expected to Vest"&gt;1.93&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_iE_pp0p0_c20240301__20250228__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zGQtOUP8Ukwd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Options expected to vest in the future"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1812"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;SARs exercisable at February 28, 2025&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_pid_c20240301__20250228__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zx1loO0OnAHd" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options, Exercisable"&gt;35,010&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20240301__20250228__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zAMuaPcKE2H9" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Exercisable"&gt;47.35&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20240301__20250228__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zD33XKKplyh9" title="Weighted Average Remaining Contractual Life, Exercisable"&gt;2.34&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iE_pp0p0_c20240301__20250228__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zJCSqvoC7hnd" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Options exercisable"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1820"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"&gt;SARs vested, exercisable, and options expected to vest at February 28, 2025&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_iE_pid_c20240301__20250228__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_z0urZVBN5lfj" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options, Vested, Exercisable and Options Expected to Vest Balance"&gt;40,223&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_iE_pid_c20240301__20250228__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zva9jgslCi35" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Vested, Exercisable and Options Expected to Vest"&gt;44.80&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_dtY_c20240301__20250228__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zf1jdG76Rzj6" title="Weighted Average Remaining Contractual Life, Vested, Exercisable and Options Expected to Vest"&gt;1.99&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_iE_pp0p0_c20240301__20250228__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zklpPrAoaHe4" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Options vested, exercisable and options expected to vest"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1828"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A5_z19QDd2hIeyl" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
aggregate intrinsic value is calculated as the difference between the exercise price of the underlying awards and the quoted price of
our common stock for those awards that have an exercise price below the $&lt;span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20240301__20250228__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyStockAppreciationRightsPlanMember_zhEqFikJSe5f" title="Options exercise price"&gt;3.98&lt;/span&gt; closing price of our common stock on February 28, 2025.
All the SARs have an exercise price above $&lt;span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20240301__20250228__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyStockAppreciationRightsPlanMember_zZEZPtWnuHKk" title="Options exercise price"&gt;3.98&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
the year ended February 28, 2025, $&lt;span id="xdx_905_eus-gaap--AllocatedShareBasedCompensationExpense_c20240301__20250228__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyStockAppreciationRightsPlanMember_zf6X6c9CefPk" title="Share based compensation expense"&gt;67,874&lt;/span&gt; of share-based compensation expense was recognized, and at February 28, 2025, there was $&lt;span id="xdx_900_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_iI_c20250228__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyStockAppreciationRightsPlanMember_zRDVDCFMfG3i" title="Unrecognized share based compensation cost"&gt;119&lt;/span&gt;
of unrecognized share-based compensation expense related to unvested SARs with a weighted average remaining recognition period of &lt;span id="xdx_90A_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardWeightedAverageRemainingRecognitionPeriod_dtY_c20240301__20250228__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyStockAppreciationRightsPlanMember_zpvquFCnh26a" title="Weighted average remaining recognition period"&gt;0.26&lt;/span&gt;
years.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Warrants&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;At
February 28, 2025, the Company had outstanding warrants to purchase a total of &lt;span id="xdx_909_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_iI_c20250228__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zpWoyYv4gsfi" title="Purchase of outstanding warrants"&gt;3,015,885&lt;/span&gt; shares of common stock. The warrants have exercise
prices that range from $&lt;span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20250228__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--RangeAxis__srt--MinimumMember_zUVFINpdY1be" title="Warrants exercise price"&gt;3.02&lt;/span&gt; to $&lt;span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20250228__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--RangeAxis__srt--MaximumMember_zbSbYTOWgPnl" title="Warrants exercise price"&gt;350.00&lt;/span&gt;, which if not exercised, will &lt;span id="xdx_904_ecustom--DescriptionForWarrantExpiration_c20240301__20250228__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zbpmzUCaixki" title="Warrant description"&gt;expire between July 26, 2025 and August 24, 2030&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_893_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_zFI411ZI4oWh" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The fair value of warrants issued during the year
was estimated using the Black-Scholes model with the following assumptions for the twelve months ended February 28, 2025:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"&gt;&lt;b&gt;Assumptions:&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B0_zjrLnBZbNBQh" style="display: none"&gt;Schedule of Share Based Payments Award Stock Options Valuation Assumptions&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;2025&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 80%; text-align: left"&gt;Dividend yield&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 18%; text-align: right"&gt;&lt;span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_uPure_c20240301__20250228_zaeQiO9I5h47" title="Dividend yield"&gt;0.0&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Risk-free interest rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_pid_dp_uPure_c20240301__20250228__srt--RangeAxis__srt--MinimumMember_zhLnzXurenHb" title="Risk-free interest rate, minimum"&gt;3.5%&lt;/span&gt;-&lt;span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uPure_c20240301__20250228__srt--RangeAxis__srt--MaximumMember_zPhasS7VGCxb" title="Risk-free interest rate, maximum"&gt;4.3&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Expected volatility&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_dp_uPure_c20240301__20250228__srt--RangeAxis__srt--MinimumMember_zxTUefTGKlD5" title="Expected volatility, minimum"&gt;127.1%&lt;/span&gt;-&lt;span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_dp_uPure_c20240301__20250228__srt--RangeAxis__srt--MaximumMember_zjNy1QocRtUj" title="Expected volatility, maximum"&gt;159.4&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Expected life (in years)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20240301__20250228__srt--RangeAxis__srt--MinimumMember_zWEcePIp2eya" title="Expected life"&gt;1.5&lt;/span&gt;-&lt;span id="xdx_90F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20240301__20250228__srt--RangeAxis__srt--MaximumMember_zE5VvcpgzZzb" title="Expected life"&gt;5.0&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AB_zOXeCzacRYT9" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_896_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zhpRYHcrbv0j" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Warrant
activity for the year ended February 28, 2025 was as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8BB_zjRXwdpkZ8oh" style="display: none"&gt;Schedule of Warranty Activity&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Weighted Average&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Weighted&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Average&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Exercise&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Remaining&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Price&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Contractual&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Warrants&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;($)&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Life (Yrs.)&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 46%; padding-bottom: 2.5pt"&gt;Warrants outstanding at February 29, 2024&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_pid_c20240301__20250228_zIpt1G5hP1Ph" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right" title="Warrants Outstanding, Beginning Balance"&gt;486,165&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20240301__20250228_zgZUaZGSu2Ci" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right" title="Weighted Average Exercise Price Outstanding, Beginning Balance"&gt;9.94&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonOutstandingWeightedAverageRemainingContractualTerm_dtY_c20230301__20240229_zw2bFLwpI3ri" title="Weighted Average Remaining Contractual Life Years, Beginning Balance"&gt;1.96&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;Granted&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_pid_c20240301__20250228_zvn9T6oeWXu2" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants, Granted"&gt;2,637,887&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20240301__20250228_zFHGq4ni9MKc" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price Outstanding, Granted"&gt;4.80&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_901_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonGrantsWeightedAverageRemainingContractualTerm_dtY_c20240301__20250228_zszdofnTORw5" title="Weighted Average Remaining Contractual Life Years, Granted"&gt;4.24&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;Exercised&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_iN_pid_di_c20240301__20250228_ztCL8aXqCXTc" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants,Exercised"&gt;(104,965&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageExercisePrice_pid_c20240301__20250228_zMCjplN3nB72" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price Outstanding,Exercised"&gt;3.02&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;-&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"&gt;Forfeited or cancelled&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_iN_pid_di_c20240301__20250228_zuGRbpcXSw46" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants, Forfeited or cancelled"&gt;(3,202&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageWeightedAverageExercisePriceWarrantsForfeitedOrCancelled_pid_c20240301__20250228_zSjC9Dr7s8jk" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price Outstanding, Forfeited or cancelled"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1884"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;-&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;Warrants outstanding at February 28, 2025&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_pid_c20240301__20250228_ziS5TaRvdfLk" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants Outstanding, Ending Balance"&gt;3,015,885&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20240301__20250228_zHwIq6VlvfIk" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price Outstanding, Ending Balance"&gt;5.36&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonOutstandingWeightedAverageRemainingContractualTerm_dtY_c20240301__20250228_zoWs4z0IxTZb" title="Weighted Average Remaining Contractual Life Years, Ending Balance"&gt;3.84&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A7_zppCWPjkWhq6" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
further information regarding the allocation of the relative fair values of warrants issued in connection with short-term promissory
notes, see &lt;b&gt;NOTE 12- Notes Payable.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2025-02-28"
      decimals="INF"
      id="Fact001362"
      unitRef="Shares">250000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2025-02-28"
      decimals="INF"
      id="Fact001364"
      unitRef="Shares">1656738</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2024-02-29"
      decimals="INF"
      id="Fact001366"
      unitRef="Shares">936430</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2025-02-28"
      decimals="INF"
      id="Fact001368"
      unitRef="USDPShares">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2024-02-29"
      decimals="INF"
      id="Fact001370"
      unitRef="USDPShares">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:StockholdersEquityReverseStockSplit contextRef="From2023-09-212023-09-22" id="Fact001372">1-for-20 reverse stock split</us-gaap:StockholdersEquityReverseStockSplit>
    <us-gaap:StockIssuedDuringPeriodSharesReverseStockSplits
      contextRef="From2023-09-222023-09-22"
      decimals="INF"
      id="Fact001374"
      unitRef="Shares">40197</us-gaap:StockIssuedDuringPeriodSharesReverseStockSplits>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="From2024-03-152024-03-15_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact001376"
      unitRef="Shares">409502</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="From2024-07-012024-08-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact001378"
      unitRef="Shares">42709</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2024-09-192024-09-19_custom_AlumniCapitalLPMember"
      decimals="INF"
      id="Fact001380"
      unitRef="Shares">32786</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2024-09-192024-09-19_custom_AlumniCapitalLPMember"
      decimals="-6"
      id="Fact001382"
      unitRef="USD">10000000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="From2024-10-082024-10-08_custom_FSATravelLLCMember"
      decimals="INF"
      id="Fact001384"
      unitRef="Shares">8065</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2024-12-162024-12-16_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact001386"
      unitRef="Shares">28281</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <NTRP:StockIssuedDuringPeriodSharesWarrantExercises
      contextRef="From2024-12-012025-01-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact001388"
      unitRef="Shares">104965</NTRP:StockIssuedDuringPeriodSharesWarrantExercises>
    <us-gaap:ProceedsFromWarrantExercises
      contextRef="From2024-12-012025-01-31_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact001390"
      unitRef="USD">316995</us-gaap:ProceedsFromWarrantExercises>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2025-01-072025-01-07_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact001392"
      unitRef="Shares">30000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2025-01-292025-01-29_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact001394"
      unitRef="Shares">4000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2025-02-262025-02-26_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact001396"
      unitRef="Shares">60000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="From2023-09-012023-09-30_custom_AtTheMarketIssuanceSalesAgreementMember_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact001398"
      unitRef="Shares">72721</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="From2023-10-012023-10-31_custom_AtTheMarketIssuanceSalesAgreementMember_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact001400"
      unitRef="Shares">128887</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="From2023-09-012023-09-30_custom_AtTheMarketIssuanceSalesAgreementMember_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact001402"
      unitRef="USD">364555</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="From2023-10-012023-10-31_custom_AtTheMarketIssuanceSalesAgreementMember_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact001404"
      unitRef="USD">772468</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="AsOf2023-12-29_custom_NextTripHoldingsIncMember"
      decimals="INF"
      id="Fact001406"
      unitRef="Pure">1</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross
      contextRef="From2023-12-292023-12-29_custom_NextTripHoldingsIncMember"
      decimals="INF"
      id="Fact001408"
      unitRef="Shares">156007</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
    <us-gaap:SaleOfStockPercentageOfOwnershipAfterTransaction
      contextRef="From2023-12-292024-12-29_custom_NextTripHoldingsIncMember"
      decimals="INF"
      id="Fact001410"
      unitRef="Pure">0.1999</us-gaap:SaleOfStockPercentageOfOwnershipAfterTransaction>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="From2023-12-292023-12-29_custom_NextTripHoldingsIncMember"
      decimals="INF"
      id="Fact001412"
      unitRef="Shares">5843993</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross
      contextRef="From2023-12-292023-12-29_custom_NextTripHoldingsIncMember"
      decimals="INF"
      id="Fact001414"
      unitRef="Shares">156007</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="From2023-12-292023-12-29_custom_NextTripHoldingsIncMember_custom_DebtAssignmentAndConversionAgreementsMember"
      decimals="INF"
      id="Fact001416"
      unitRef="Shares">52818</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="From2023-12-292023-12-29_custom_NextTripHoldingsIncMember_custom_SharePurchaseAndExchangeAgreementsMember"
      decimals="INF"
      id="Fact001418"
      unitRef="Shares">15481</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="From2023-12-292023-12-29_custom_NextTripHoldingsIncMember_custom_ThirdPartyConsultantMember"
      decimals="INF"
      id="Fact001420"
      unitRef="Shares">4337</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="From2023-12-292023-12-29_custom_NextTripHoldingsIncMember"
      decimals="INF"
      id="Fact001422"
      unitRef="Shares">83371</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross
      contextRef="From2024-03-01to2025-02-28"
      decimals="INF"
      id="Fact001424"
      unitRef="Shares">4000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
    <us-gaap:SharePrice
      contextRef="AsOf2025-02-28"
      decimals="INF"
      id="Fact001426"
      unitRef="USDPShares">6.69</us-gaap:SharePrice>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2024-03-01to2025-02-28"
      decimals="0"
      id="Fact001428"
      unitRef="USD">26760</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2025-02-28"
      decimals="INF"
      id="Fact001430"
      unitRef="Shares">10000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2024-02-29"
      decimals="INF"
      id="Fact001432"
      unitRef="Shares">10000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2025-02-28"
      decimals="INF"
      id="Fact001434"
      unitRef="USDPShares">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2024-02-29"
      decimals="INF"
      id="Fact001436"
      unitRef="USDPShares">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2025-02-28"
      decimals="INF"
      id="Fact001438"
      unitRef="Shares">3106616</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2025-02-28"
      decimals="INF"
      id="Fact001440"
      unitRef="Shares">3106616</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2024-02-29"
      decimals="INF"
      id="Fact001442"
      unitRef="Shares">472996</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2024-02-29"
      decimals="INF"
      id="Fact001444"
      unitRef="Shares">472996</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2025-02-28_custom_SeriesEConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact001446"
      unitRef="USDPShares">1500</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockDividendRatePercentage
      contextRef="From2024-03-012025-02-28_custom_SeriesEConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact001448"
      unitRef="Pure">0.09</us-gaap:PreferredStockDividendRatePercentage>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="AsOf2025-02-28_custom_SeriesEConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact001450"
      unitRef="USDPShares">0.13</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2025-02-28_custom_SeriesEConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact001452"
      unitRef="Shares">316</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockConvertibleSharesIssuable
      contextRef="AsOf2025-02-28_custom_SeriesEConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact001454"
      unitRef="Shares">3362</us-gaap:PreferredStockConvertibleSharesIssuable>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2024-01-04_custom_SeriesFConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact001456"
      unitRef="Shares">5843993</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2024-01-04_custom_SeriesFConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact001458"
      unitRef="USDPShares">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2025-02-28_custom_SeriesFConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact001460"
      unitRef="Shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2024-01-26_custom_SeriesGConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact001462"
      unitRef="Shares">100000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2024-01-26_custom_SeriesGConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact001464"
      unitRef="USDPShares">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockRedemptionTerms
      contextRef="From2024-03-012025-02-28_custom_SeriesGConvertiblePreferredStockMember"
      id="Fact001466">The
Company shall have the right to redeem up to 50% of the Series G Preferred for an aggregate price of $1.00 in accordance with
the terms of the Perpetual License Agreement</us-gaap:PreferredStockRedemptionTerms>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2025-02-28_custom_SeriesGConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact001468"
      unitRef="Shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2024-01-26_custom_SeriesHConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact001470"
      unitRef="Shares">150000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2024-01-26_custom_SeriesHConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact001472"
      unitRef="USDPShares">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2025-02-28_custom_SeriesHConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact001474"
      unitRef="Shares">33000</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockConvertibleSharesIssuable
      contextRef="AsOf2025-02-28_custom_SeriesHConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact001476"
      unitRef="Shares">33000</us-gaap:PreferredStockConvertibleSharesIssuable>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2024-02-22_custom_SeriesIConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact001477"
      unitRef="Shares">331124</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2024-02-22_custom_SeriesIConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact001478"
      unitRef="USDPShares">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2025-02-25_custom_SeriesIConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact001479"
      unitRef="Shares">692945</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2024-02-152024-02-15_custom_SeriesIConvertiblePreferredStockMember_custom_SecuritiesPurchaseAgreementMember"
      decimals="0"
      id="Fact001481"
      unitRef="USD">672500</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2024-02-152024-02-15_custom_SeriesIConvertiblePreferredStockMember_custom_SecuritiesPurchaseAgreementMember"
      decimals="INF"
      id="Fact001483"
      unitRef="Shares">222680</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2024-02-15_custom_SeriesIConvertiblePreferredStockMember_custom_SecuritiesPurchaseAgreementMember"
      decimals="INF"
      id="Fact001485"
      unitRef="Shares">111340</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:SharePrice
      contextRef="AsOf2024-02-15_custom_SeriesIConvertiblePreferredStockMember_custom_SecuritiesPurchaseAgreementMember"
      decimals="INF"
      id="Fact001487"
      unitRef="USDPShares">3.02</us-gaap:SharePrice>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="From2024-08-152024-08-15_custom_SeriesIConvertiblePreferredStockMember_custom_SecuritiesPurchaseAgreementMember"
      decimals="INF"
      id="Fact001489"
      unitRef="Shares">4967</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="AsOf2024-08-15_custom_SeriesIConvertiblePreferredStockMember_custom_SecuritiesPurchaseAgreementMember"
      decimals="INF"
      id="Fact001491"
      unitRef="USDPShares">3.02</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction
      contextRef="From2024-08-152024-08-15_custom_SeriesIConvertiblePreferredStockMember_custom_SecuritiesPurchaseAgreementMember"
      decimals="0"
      id="Fact001493"
      unitRef="USD">15000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="From2024-08-312024-08-31_custom_SeriesIConvertiblePreferredStockMember_custom_SecuritiesPurchaseAgreementMember"
      decimals="INF"
      id="Fact001495"
      unitRef="Shares">24834</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="AsOf2024-08-31_custom_SeriesIConvertiblePreferredStockMember_custom_SecuritiesPurchaseAgreementMember"
      decimals="INF"
      id="Fact001497"
      unitRef="USDPShares">3.02</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction
      contextRef="From2024-08-312024-08-31_custom_SeriesIConvertiblePreferredStockMember_custom_SecuritiesPurchaseAgreementMember"
      decimals="0"
      id="Fact001499"
      unitRef="USD">75000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="From2024-10-012024-10-01_custom_SeriesIConvertiblePreferredStockMember_custom_SecuritiesPurchaseAgreementMember"
      decimals="INF"
      id="Fact001501"
      unitRef="Shares">66225</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="AsOf2024-10-01_custom_SeriesIConvertiblePreferredStockMember_custom_SecuritiesPurchaseAgreementMember"
      decimals="INF"
      id="Fact001503"
      unitRef="USDPShares">3.02</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction
      contextRef="From2024-10-012024-10-01_custom_SeriesIConvertiblePreferredStockMember_custom_SecuritiesPurchaseAgreementMember"
      decimals="0"
      id="Fact001505"
      unitRef="USD">200000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross
      contextRef="From2025-02-242025-02-24_custom_SeriesIConvertiblePreferredStockMember_custom_SeriesIPurchaseAgreementMember"
      decimals="INF"
      id="Fact001507"
      unitRef="Shares">331125</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="AsOf2025-02-24_custom_SeriesIConvertiblePreferredStockMember_custom_SecuritiesPurchaseAgreementMember"
      decimals="INF"
      id="Fact001509"
      unitRef="USDPShares">3.02</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction
      contextRef="From2025-02-242025-02-24_custom_SeriesIConvertiblePreferredStockMember_custom_SeriesIPurchaseAgreementMember"
      decimals="0"
      id="Fact001511"
      unitRef="USD">1000000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2025-02-242025-02-24_custom_SeriesIPreferredStockMember_custom_SeriesIPurchaseAgreementMember"
      decimals="INF"
      id="Fact001513"
      unitRef="Shares">10000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="AsOf2024-10-01_custom_SeriesIPreferredStockMember_custom_SecuritiesPurchaseAgreementMember"
      decimals="INF"
      id="Fact001515"
      unitRef="USDPShares">3.02</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:DebtConversionConvertedInstrumentAmount1
      contextRef="From2025-02-242025-02-24_custom_MillerDebtConversionAgreementMember"
      decimals="0"
      id="Fact001517"
      unitRef="USD">100000</us-gaap:DebtConversionConvertedInstrumentAmount1>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2025-02-242025-02-24_custom_MillerDebtConversionAgreementMember_custom_SeriesIConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact001519"
      unitRef="Shares">33113</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="AsOf2025-02-24_custom_MillerDebtConversionAgreementMember_custom_SeriesIConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact001521"
      unitRef="USDPShares">3.02</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2025-02-24_custom_MillerDebtConversionAgreementMember_custom_SeriesIConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact001523"
      unitRef="Shares">33113</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2025-02-24_custom_MillerDebtConversionAgreementMember_custom_SeriesIConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact001525"
      unitRef="USDPShares">4.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2025-02-28_custom_SeriesIConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact001527"
      unitRef="Shares">500442</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockConvertibleSharesIssuable
      contextRef="AsOf2025-02-28_custom_SeriesIConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact001529"
      unitRef="Shares">500442</us-gaap:PreferredStockConvertibleSharesIssuable>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross
      contextRef="From2025-01-032025-01-03_custom_SeriesJNonvotingConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact001531"
      unitRef="Shares">297788</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2025-01-03_custom_SeriesJNonvotingConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact001533"
      unitRef="USDPShares">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2024-12-312024-12-31_custom_SeriesJNonvotingConvertiblePreferredStockMember_custom_SecuritiesPurchaseAgreementMember"
      decimals="INF"
      id="Fact001535"
      unitRef="Shares">231788</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SharePrice
      contextRef="AsOf2024-12-31_custom_SeriesJNonvotingConvertiblePreferredStockMember_custom_SecuritiesPurchaseAgreementMember"
      decimals="INF"
      id="Fact001537"
      unitRef="USDPShares">3.02</us-gaap:SharePrice>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction
      contextRef="From2024-12-312024-12-31_custom_SeriesJNonvotingConvertiblePreferredStockMember_custom_SecuritiesPurchaseAgreementMember"
      decimals="0"
      id="Fact001539"
      unitRef="USD">700000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="From2024-12-312024-12-31_custom_SeriesJNonvotingConvertiblePreferredStockMember_custom_SecuritiesPurchaseAgreementMember"
      decimals="INF"
      id="Fact001541"
      unitRef="Shares">66000</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2025-02-28_custom_SeriesJNonvotingConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact001543"
      unitRef="Shares">297788</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockConvertibleSharesIssuable
      contextRef="AsOf2025-02-28_custom_SeriesJNonvotingConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact001545"
      unitRef="Shares">297788</us-gaap:PreferredStockConvertibleSharesIssuable>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross
      contextRef="From2025-01-032025-01-03_custom_SeriesKNonvotingConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact001547"
      unitRef="Shares">60595</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2025-01-03_custom_SeriesKNonvotingConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact001549"
      unitRef="USDPShares">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2024-12-312024-12-31_custom_SeriesKNonvotingConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact001551"
      unitRef="Shares">60595</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SharePrice
      contextRef="AsOf2024-12-31_custom_SeriesKNonvotingConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact001553"
      unitRef="USDPShares">3.02</us-gaap:SharePrice>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2024-12-312024-12-31_custom_SeriesKNonvotingConvertiblePreferredStockMember"
      decimals="0"
      id="Fact001555"
      unitRef="USD">1220000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2025-02-28_custom_SeriesKNonvotingConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact001557"
      unitRef="Shares">60595</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockConvertibleSharesIssuable
      contextRef="AsOf2025-02-28_custom_SeriesKNonvotingConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact001559"
      unitRef="Shares">60595</us-gaap:PreferredStockConvertibleSharesIssuable>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross
      contextRef="From2025-01-032025-01-03_custom_SeriesLNonvotingConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact001561"
      unitRef="Shares">579469</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2025-01-03_custom_SeriesLNonvotingConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact001563"
      unitRef="USDPShares">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2025-02-25_custom_SeriesLNonvotingConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact001565"
      unitRef="Shares">1076158</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockDividendRatePercentage
      contextRef="From2025-01-032025-01-03_custom_SeriesLNonvotingConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact001567"
      unitRef="Pure">0.12</us-gaap:PreferredStockDividendRatePercentage>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="AsOf2025-01-03_custom_SeriesLNonvotingConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact001569"
      unitRef="USDPShares">3.02</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:DebtConversionConvertedInstrumentAmount1
      contextRef="From2024-12-312024-12-31_custom_MessrsKerbyAndMonacoMember_custom_RelatedPartyDebtConversionAgreementsMember"
      decimals="-4"
      id="Fact001571"
      unitRef="USD">1750000</us-gaap:DebtConversionConvertedInstrumentAmount1>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross
      contextRef="From2024-12-312024-12-31_custom_MessrsKerbyAndMonacoMember_custom_SeriesLNonvotingConvertiblePreferredStockMember_custom_RelatedPartyDebtConversionAgreementsMember"
      decimals="INF"
      id="Fact001573"
      unitRef="Shares">579469</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="AsOf2024-12-31_custom_MessrsKerbyAndMonacoMember_custom_SeriesLNonvotingConvertiblePreferredStockMember_custom_RelatedPartyDebtConversionAgreementsMember"
      decimals="INF"
      id="Fact001575"
      unitRef="USDPShares">3.02</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:DebtConversionConvertedInstrumentAmount1
      contextRef="From2025-02-242025-02-24_custom_RelatedPartyDebtConversionAgreementsMember_custom_SeriesLNonvotingConvertiblePreferredStockMember"
      decimals="0"
      id="Fact001577"
      unitRef="USD">500000</us-gaap:DebtConversionConvertedInstrumentAmount1>
    <us-gaap:ProceedsFromUnsecuredNotesPayable
      contextRef="From2025-02-242025-02-24_custom_RelatedPartyDebtConversionAgreementsMember_custom_SeriesLNonvotingConvertiblePreferredStockMember"
      decimals="-5"
      id="Fact001579"
      unitRef="USD">1000000.0</us-gaap:ProceedsFromUnsecuredNotesPayable>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross
      contextRef="From2025-02-242025-02-24_custom_RelatedPartyDebtConversionAgreementsMember_custom_SeriesLNonvotingConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact001581"
      unitRef="Shares">496687</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="AsOf2025-02-24_custom_SeriesLNonvotingConvertiblePreferredStockMember_custom_RelatedPartyDebtConversionAgreementsMember"
      decimals="INF"
      id="Fact001583"
      unitRef="USDPShares">3.02</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2025-02-28_custom_SeriesLNonvotingConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact001585"
      unitRef="Shares">1076156</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockConvertibleSharesIssuable
      contextRef="AsOf2025-02-28_custom_SeriesLNonvotingConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact001587"
      unitRef="Shares">1076156</us-gaap:PreferredStockConvertibleSharesIssuable>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross
      contextRef="From2025-01-032025-01-03_custom_SeriesMNonvotingConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact001589"
      unitRef="Shares">165562</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2025-01-03_custom_SeriesMNonvotingConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact001591"
      unitRef="USDPShares">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockDividendRatePercentage
      contextRef="From2025-01-032025-01-03_custom_SeriesMNonvotingConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact001593"
      unitRef="Pure">0.12</us-gaap:PreferredStockDividendRatePercentage>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="AsOf2025-01-03_custom_SeriesMNonvotingConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact001595"
      unitRef="USDPShares">3.02</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross
      contextRef="From2024-12-312024-12-31_custom_SecuritiesPurchaseAgreementMember_custom_SeriesMNonvotingConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact001597"
      unitRef="Shares">500000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="AsOf2024-12-31_custom_SecuritiesPurchaseAgreementMember_custom_SeriesMNonvotingConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact001599"
      unitRef="USDPShares">3.02</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:DebtConversionConvertedInstrumentAmount1
      contextRef="From2024-12-312024-12-31_custom_SeriesMNonvotingConvertiblePreferredStockMember_custom_DebtConversionAgreementMember"
      decimals="0"
      id="Fact001601"
      unitRef="USD">350000</us-gaap:DebtConversionConvertedInstrumentAmount1>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2024-12-312024-12-31_custom_SeriesMNonvotingConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact001603"
      unitRef="Shares">133278</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2025-02-28_custom_SeriesMNonvotingConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact001605"
      unitRef="Shares">133278</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2025-02-28_custom_SeriesMNonvotingConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact001607"
      unitRef="Shares">133278</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits
      contextRef="From2024-03-012025-02-28_custom_SeriesMNonvotingConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact001609"
      unitRef="Shares">133278</us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross
      contextRef="From2025-01-032025-01-03_custom_SeriesNNonvotingConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact001611"
      unitRef="Shares">500000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2025-01-03_custom_SeriesNNonvotingConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact001613"
      unitRef="USDPShares">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross
      contextRef="From2025-01-282025-01-28_custom_SeriesNNonvotingConvertiblePreferredStockMember_custom_SecuritiesPurchaseAgreementMember"
      decimals="INF"
      id="Fact001615"
      unitRef="Shares">17000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2025-01-28_custom_SeriesNNonvotingConvertiblePreferredStockMember_custom_SecuritiesPurchaseAgreementMember"
      decimals="INF"
      id="Fact001617"
      unitRef="Shares">17000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2025-01-28_custom_SeriesNNonvotingConvertiblePreferredStockMember_custom_SecuritiesPurchaseAgreementMember"
      decimals="INF"
      id="Fact001619"
      unitRef="USDPShares">5.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ProceedsFromIssuanceOfWarrants
      contextRef="From2025-01-282025-01-28_custom_SeriesNNonvotingConvertiblePreferredStockMember_custom_SecuritiesPurchaseAgreementMember"
      decimals="0"
      id="Fact001621"
      unitRef="USD">85000</us-gaap:ProceedsFromIssuanceOfWarrants>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross
      contextRef="From2025-01-282025-01-28_custom_SeriesNNonvotingConvertiblePreferredStockMember_custom_ShareExchangeAgreementMember_custom_BlueFyshHoldingsIncMember_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact001623"
      unitRef="Shares">82</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2025-01-28_custom_SeriesNNonvotingConvertiblePreferredStockMember_custom_ShareExchangeAgreementMember_custom_BlueFyshHoldingsIncMember"
      decimals="INF"
      id="Fact001625"
      unitRef="Pure">0.10</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross
      contextRef="From2025-01-282025-01-28_custom_SeriesNNonvotingConvertiblePreferredStockMember_custom_ShareExchangeAgreementMember_custom_BlueFyshHoldingsIncMember"
      decimals="INF"
      id="Fact001627"
      unitRef="Shares">483000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
    <us-gaap:SharePrice
      contextRef="AsOf2025-01-28_custom_SeriesNNonvotingConvertiblePreferredStockMember_custom_ShareExchangeAgreementMember_custom_BlueFyshHoldingsIncMember"
      decimals="INF"
      id="Fact001629"
      unitRef="USDPShares">5.00</us-gaap:SharePrice>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2025-02-28_custom_SeriesNNonvotingConvertibleConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact001631"
      unitRef="Shares">500000</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockConvertibleSharesIssuable
      contextRef="AsOf2025-02-28_custom_SeriesNNonvotingConvertibleConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact001633"
      unitRef="Shares">500000</us-gaap:PreferredStockConvertibleSharesIssuable>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross
      contextRef="From2025-02-062025-02-06_custom_SeriesONonvotingConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact001635"
      unitRef="Shares">451614</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2025-02-06_custom_SeriesONonvotingConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact001637"
      unitRef="USDPShares">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="AsOf2025-02-06_custom_FSATravelLLCMember"
      decimals="INF"
      id="Fact001638"
      unitRef="Pure">0.49</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2025-02-062025-02-06_custom_SeriesONonvotingConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact001640"
      unitRef="Shares">161291</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2025-02-28_custom_SeriesONonvotingConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact001642"
      unitRef="Shares">161291</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockConvertibleSharesIssuable
      contextRef="AsOf2025-02-28_custom_SeriesONonvotingConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact001644"
      unitRef="Shares">161291</us-gaap:PreferredStockConvertibleSharesIssuable>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross
      contextRef="From2025-02-252025-02-25_custom_SeriesPNonvotingConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact001646"
      unitRef="Shares">343750</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2025-02-25_custom_SeriesPNonvotingConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact001648"
      unitRef="USDPShares">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="From2025-02-262025-02-26_custom_SeriesPNonvotingConvertiblePreferredStockMember_custom_EquityInvestmentAgreementMember"
      decimals="INF"
      id="Fact001650"
      unitRef="Shares">93750</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2025-02-26_custom_SeriesPNonvotingConvertiblePreferredStockMember_custom_EquityInvestmentAgreementMember"
      decimals="INF"
      id="Fact001652"
      unitRef="Shares">375000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
      contextRef="AsOf2025-02-26_custom_SeriesPNonvotingConvertiblePreferredStockMember_custom_EquityInvestmentAgreementMember"
      decimals="INF"
      id="Fact001654"
      unitRef="Shares">375000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight>
    <us-gaap:SharePrice
      contextRef="AsOf2025-02-26_custom_SeriesPNonvotingConvertiblePreferredStockMember_custom_EquityInvestmentAgreementMember"
      decimals="INF"
      id="Fact001656"
      unitRef="USDPShares">4.00</us-gaap:SharePrice>
    <us-gaap:ProceedsFromIssuanceOfWarrants
      contextRef="From2025-02-262025-02-26_custom_SeriesPNonvotingConvertiblePreferredStockMember_custom_EquityInvestmentAgreementMember"
      decimals="0"
      id="Fact001658"
      unitRef="USD">375000</us-gaap:ProceedsFromIssuanceOfWarrants>
    <us-gaap:DebtConversionConvertedInstrumentAmount1
      contextRef="From2025-02-262025-02-26_custom_SeriesPNonvotingConvertiblePreferredStockMember_custom_DebtExchangeAgreementMember"
      decimals="0"
      id="Fact001660"
      unitRef="USD">1000000</us-gaap:DebtConversionConvertedInstrumentAmount1>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="From2025-02-262025-02-26_custom_SeriesPNonvotingConvertiblePreferredStockMember_custom_DebtExchangeAgreementMember"
      decimals="INF"
      id="Fact001662"
      unitRef="Shares">250000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="AsOf2025-02-26_custom_SeriesPNonvotingConvertiblePreferredStockMember_custom_DebtExchangeAgreementMember"
      decimals="INF"
      id="Fact001664"
      unitRef="USDPShares">4.00</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2025-02-28_custom_SeriesPNonvotingConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact001666"
      unitRef="Shares">343750</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockConvertibleSharesIssuable
      contextRef="AsOf2025-02-28_custom_SeriesPNonvotingConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact001668"
      unitRef="Shares">343750</us-gaap:PreferredStockConvertibleSharesIssuable>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="AsOf2025-02-28_custom_TwoThousandTwentyThreeEquityIncentivePlanMember"
      decimals="INF"
      id="Fact001670"
      unitRef="Shares">7000000</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2025-02-28_custom_TwoThousandThirteenEquityIncentivePlanMember"
      decimals="INF"
      id="Fact001672"
      unitRef="Shares">76342</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2025-02-28_custom_TwoThousandThirteenEquityIncentivePlanMember"
      decimals="INF"
      id="Fact001674"
      unitRef="USDPShares">52.69</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
      contextRef="From2024-03-01to2025-02-28"
      decimals="INF"
      id="Fact001676"
      unitRef="Shares">3101</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares>
    <us-gaap:CompensationExpenseExcludingCostOfGoodAndServiceSold
      contextRef="From2024-03-01to2025-02-28"
      decimals="0"
      id="Fact001678"
      unitRef="USD">41114</us-gaap:CompensationExpenseExcludingCostOfGoodAndServiceSold>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="AsOf2025-02-28_us-gaap_StockOptionMember"
      decimals="INF"
      id="Fact001680"
      unitRef="Shares">75992</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="From2024-03-01to2025-02-28"
      decimals="INF"
      id="Fact001682"
      unitRef="Shares">0</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="From2024-03-012025-02-28_srt_MaximumMember"
      decimals="INF"
      id="Fact001684"
      unitRef="Shares">86402</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
      contextRef="From2023-12-292024-02-29"
      decimals="INF"
      id="Fact001686"
      unitRef="Shares">1342</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod>
    <us-gaap:ShareBasedCompensation
      contextRef="From2024-03-01to2025-02-28"
      decimals="0"
      id="Fact001688"
      unitRef="USD">67874</us-gaap:ShareBasedCompensation>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="From2024-03-01to2025-02-28"
      decimals="0"
      id="Fact001690"
      unitRef="USD">41114</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock contextRef="From2024-03-01to2025-02-28" id="Fact001692">&lt;p id="xdx_895_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_z7fWqRBOsDU8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Option
activity for the year ended February 28, 2025 was as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8BC_zfQu3JsnJ59" style="display: none"&gt;Schedule of Stock Option Activity&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Weighted Average&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Weighted Average&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Exercise&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Remaining&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Aggregate&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Price&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Contractual&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Intrinsic&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Options&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;($)&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Life (Yrs.)&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Value ($)&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 44%; padding-bottom: 2.5pt"&gt;Options outstanding at February 29, 2024&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20240301__20250228_zPZHtTXqaegk" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Number of Options Outstanding, Balance"&gt;85,300&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20240301__20250228_z9ijAU1jR6H5" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; width: 10%; text-align: right" title="Weighted Average Exercise Price Outstanding, Balance"&gt;60.50&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; width: 10%; text-align: right"&gt;&lt;span id="xdx_90B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20230301__20240229_z7rh1Tw5VOCa" title="Weighted Average Remaining Contractual Life Years, Outstanding Balance"&gt;2.52&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_pp0p0_c20240301__20250228_zzRgZC8N6fuf" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Aggregate Intrinsic Value Outstanding"&gt;&#160;&#160;&#160;&#160;&lt;span style="-sec-ix-hidden: xdx2ixbrl1700"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;Exercised&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_pid_di0_c20240301__20250228_zgwFJ0vHjxqj" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options, Exercised"&gt;-&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20240301__20250228_zb5XDJ5uwvna" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1704"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;-&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_pp0p0_c20240301__20250228_zMmgjk4Asvdf" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1706"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"&gt;Forfeited or cancelled&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_iN_pid_di_c20240301__20250228_zLqMInKaS8x7" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options, Forfeited or cancelled"&gt;(8,958&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_pid_c20240301__20250228_zRGsYFDGyqqa" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right" title="Weighted Average Exercise Price, Forfeited or cancelled"&gt;125.65&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right"&gt;-&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedorCancelledInPeriodTotalIntrinsicValue_pp0p0_c20240301__20250228_zGxxh3VyvZD6" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Forfeited or cancelled"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1712"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;Options outstanding at February 28, 2025&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20240301__20250228_zxxWWJqIBdUc" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options Outstanding, Balance"&gt;76,342&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20240301__20250228_zycMET3eH0s6" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price Outstanding, Balance"&gt;52.69&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"&gt;&lt;span id="xdx_904_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20240301__20250228_z7pTiXutuxa4" title="Weighted Average Remaining Contractual Life Years, Outstanding Balance"&gt;1.60&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iE_pp0p0_c20240301__20250228_zxoBHzrt13Sc" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value Outstanding"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1720"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Options expected to vest in the future as of February 28, 2025&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iE_pid_c20240301__20250228_zRqlghxB8pGb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options, Expected to Vest in the Future Ending Balance"&gt;350&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_iE_pid_c20240301__20250228_zRmsLe0OoOx" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Expected to Vest"&gt;50.00&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_dtY_c20240301__20250228_zVtPqhUUH0Xg" title="Weighted Average Remaining Contractual Life Years, Expected to Vest"&gt;2.34&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_iE_pp0p0_c20240301__20250228_zVuiziQo3bue" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Outstanding, Expected of  Vest"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1728"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;Options exercisable at February 28, 2025&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_pid_c20240301__20250228_zKfkfptkyge6" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options, Exercisable"&gt;75,992&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20240301__20250228_z7d3SzvRF8i6" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right" title="Weighted Average Exercise Price, Exercisable"&gt;52.71&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right"&gt;&lt;span id="xdx_90D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20240301__20250228_zLUR4wKzojMi" title="Weighted Average Remaining Contractual Life Years, Exercisable"&gt;1.59&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iE_pp0p0_c20240301__20250228_zup665Ufk8G" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Outstanding, Exercisable"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1736"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"&gt;Options vested, exercisable, and options expected to vest at February 28, 2025&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_iE_pid_c20230301__20250228_zLyRyLfYBXdb" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options, Vested, Exercisable and Options Expected to Vest, Balance"&gt;76,342&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_iE_c20240301__20250228_zOaTHmRKbjRj" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price, Vested, Exercisable and Options Expected to Vest"&gt;52.69&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"&gt;&lt;span id="xdx_904_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_dtY_c20240301__20250228_z3c1eUlHCHM8" title="Weighted Average Remaining Contractual Life (Yrs.), Vested, Exercisable and Options Expected to Vest"&gt;1.60&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_iE_pp0p0_c20240301__20250228_zetWwG7Azr31" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Outstanding,Exercisable and Options Expected to Vest"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1744"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2024-02-29"
      decimals="INF"
      id="Fact001694"
      unitRef="Shares">85300</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2024-02-29"
      decimals="INF"
      id="Fact001696"
      unitRef="USDPShares">60.50</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="From2023-03-012024-02-29" id="Fact001698">P2Y6M7D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="From2024-03-01to2025-02-28"
      decimals="INF"
      id="Fact001702"
      unitRef="Shares">0</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
      contextRef="From2024-03-01to2025-02-28"
      decimals="INF"
      id="Fact001708"
      unitRef="Shares">8958</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="From2024-03-01to2025-02-28"
      decimals="INF"
      id="Fact001710"
      unitRef="USDPShares">125.65</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2025-02-28"
      decimals="INF"
      id="Fact001714"
      unitRef="Shares">76342</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2025-02-28"
      decimals="INF"
      id="Fact001716"
      unitRef="USDPShares">52.69</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="From2024-03-01to2025-02-28" id="Fact001718">P1Y7M6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="AsOf2025-02-28"
      decimals="INF"
      id="Fact001722"
      unitRef="Shares">350</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2025-02-28"
      decimals="INF"
      id="Fact001724"
      unitRef="USDPShares">50.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1 contextRef="From2024-03-01to2025-02-28" id="Fact001726">P2Y4M2D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="AsOf2025-02-28"
      decimals="INF"
      id="Fact001730"
      unitRef="Shares">75992</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="AsOf2025-02-28"
      decimals="INF"
      id="Fact001732"
      unitRef="USDPShares">52.71</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1 contextRef="From2024-03-01to2025-02-28" id="Fact001734">P1Y7M2D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
      contextRef="AsOf2025-02-28"
      decimals="INF"
      id="Fact001738"
      unitRef="Shares">76342</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
      contextRef="AsOf2025-02-28"
      decimals="INF"
      id="Fact001740"
      unitRef="USDPShares">52.69</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1 contextRef="From2024-03-01to2025-02-28" id="Fact001742">P1Y7M6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="From2024-03-01to2025-02-28"
      decimals="INF"
      id="Fact001746"
      unitRef="USDPShares">3.98</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="From2024-03-01to2025-02-28"
      decimals="INF"
      id="Fact001748"
      unitRef="USDPShares">3.98</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
      contextRef="AsOf2025-02-28"
      decimals="0"
      id="Fact001750"
      unitRef="USD">5260</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 contextRef="From2024-03-01to2025-02-28" id="Fact001752">P0Y4M2D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2023-12-29_custom_StockAppreciationRightsMember"
      decimals="INF"
      id="Fact001754"
      unitRef="Shares">40390</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
      contextRef="From2024-12-292024-12-29_custom_StockAppreciationRightsMember"
      decimals="INF"
      id="Fact001756"
      unitRef="Shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="From2024-12-292024-12-29_custom_StockAppreciationRightsMember"
      decimals="INF"
      id="Fact001758"
      unitRef="Shares">0</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
      contextRef="From2024-03-012025-02-28_custom_StockAppreciationRightsMember"
      id="Fact001760">&lt;p id="xdx_89B_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_hus-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_z2BXlDB1N7Lj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
fair value of outstanding SAR awards was estimated using the Black-Scholes model with the following assumptions for the twelve months
ended February 28, 2025:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Assumptions:&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8BE_zRCuvey8r5x6" style="display: none"&gt;Schedule of Share Based Payments Award Stock Options Valuation Assumptions&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 75%; margin-right: auto"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;2025&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 78%; text-align: left"&gt;Dividend yield&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right"&gt;&lt;span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_uPure_c20240301__20250228__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyStockAppreciationRightsPlanMember_zvTY0812C7Tb" title="Dividend yield"&gt;0.0&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Risk-free interest rate&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_dp_uPure_c20240301__20250228__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyStockAppreciationRightsPlanMember_zKHl8PAoQXla" title="Risk-free interest rate, minimum"&gt;2.3&lt;/span&gt;%-&lt;span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_dp_uPure_c20240301__20250228__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyStockAppreciationRightsPlanMember_zX9fO0EfkiO6" title="Risk-free interest rate, maximum"&gt;5.25&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Expected volatility&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_dp_uPure_c20240301__20250228__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyStockAppreciationRightsPlanMember_zq5yRj9WdE3e" title="Expected volatility, minimum"&gt;96.5&lt;/span&gt;%-&lt;span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_dp_uPure_c20240301__20250228__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyStockAppreciationRightsPlanMember_zq9WsGGxTKmj" title="Expected volatility, maximum"&gt;187.8&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Expected life (in years)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20240301__20250228__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyStockAppreciationRightsPlanMember__srt--RangeAxis__srt--MinimumMember_z86hD1Pm8OR" title="Expected life"&gt;0.16&lt;/span&gt;-&lt;span id="xdx_90B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20240301__20250228__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyStockAppreciationRightsPlanMember__srt--RangeAxis__srt--MaximumMember_z8xRrC63KiZ" title="Expected life"&gt;2.08&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="From2024-03-012025-02-28_custom_TwoThousandAndTwentyStockAppreciationRightsPlanMember"
      decimals="INF"
      id="Fact001762"
      unitRef="Pure">0.000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
      contextRef="From2024-03-012025-02-28_custom_TwoThousandAndTwentyStockAppreciationRightsPlanMember"
      decimals="INF"
      id="Fact001764"
      unitRef="Pure">0.023</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
      contextRef="From2024-03-012025-02-28_custom_TwoThousandAndTwentyStockAppreciationRightsPlanMember"
      decimals="INF"
      id="Fact001766"
      unitRef="Pure">0.0525</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
      contextRef="From2024-03-012025-02-28_custom_TwoThousandAndTwentyStockAppreciationRightsPlanMember"
      decimals="INF"
      id="Fact001768"
      unitRef="Pure">0.965</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
      contextRef="From2024-03-012025-02-28_custom_TwoThousandAndTwentyStockAppreciationRightsPlanMember"
      decimals="INF"
      id="Fact001770"
      unitRef="Pure">1.878</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="From2024-03-012025-02-28_custom_TwoThousandAndTwentyStockAppreciationRightsPlanMember_srt_MinimumMember"
      id="Fact001772">P0Y1M28D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="From2024-03-012025-02-28_custom_TwoThousandAndTwentyStockAppreciationRightsPlanMember_srt_MaximumMember"
      id="Fact001774">P2Y29D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
      contextRef="From2024-03-012025-02-28_custom_StockAppreciationRightsMember"
      id="Fact001776">&lt;p id="xdx_89B_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_hus-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zY6pvwKtnjEh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;SARs
activity for the year ended February 28, 2025 was as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8BC_z9W7DSJJXzi3" style="display: none"&gt;Schedule of Stock Option Activity&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Weighted Average&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Weighted Average&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Exercise&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Remaining&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Aggregate&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Price&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Contractual&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Intrinsic&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;SARs&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;($)&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Life (Yrs.)&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Value ($)&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 44%; padding-bottom: 2.5pt"&gt;SARs outstanding at February 29, 2024&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20240301__20250228__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zjkCZZCRAwh8" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Number of Options, Outstanding, Balance"&gt;40,390&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20240301__20250228__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zQ4n6w20TGg5" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Weighted Average Exercise Price, Outstanding Balance"&gt;44.77&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right"&gt;&lt;span id="xdx_90B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20230301__20240228__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zRRT7pE2pkti" title="Weighted Average Remaining Contractual Life, Outstanding Balance"&gt;2.99&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_pp0p0_c20240301__20250228__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zsdfPy788FQj" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Aggregate Intrinsic Value, Outstanding Balance"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&lt;span style="-sec-ix-hidden: xdx2ixbrl1784"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;Exercised&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_pid_di_c20240301__20250228__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_z4IaxQLm7lD8" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options, Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1786"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20240301__20250228__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zSHJCbpGBwW8" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1788"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;-&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_pp0p0_c20240301__20250228__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zceVw30bzj7" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1790"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"&gt;Forfeited or cancelled&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_iN_pid_di_c20240301__20250228__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zYUiseWCIOyj" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options, Forfeited or cancelled"&gt;(167&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageForfeitedOrCancelled_pid_c20240301__20250228__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zKmYsp2iQrNe" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Forfeited or cancelled"&gt;37.4&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;-&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedorCancelledInPeriodTotalIntrinsicValue_pp0p0_c20240301__20250228__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zbjkcFaAlHz8" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Forfeited or cancelled"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1796"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;SARs outstanding February 28, 2025&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20240301__20250228__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zqxsOpD7OZwd" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options, Outstanding, Balance"&gt;40,223&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20240301__20250228__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zC6dAbVaDPBg" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Outstanding Balance"&gt;44.80&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20240301__20250228__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zr4yQGUbcPJ7" title="Weighted Average Remaining Contractual Life, Outstanding Balance"&gt;1.99&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iE_pp0p0_c20240301__20250228__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zGpRxO6pgOQf" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Outstanding Balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1804"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;SARs expected to vest in the future as of February 28, 2025&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iE_pid_c20240301__20250228__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zGGSsgm4v6p9" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options, Expected to vest in the future, Balance"&gt;5,213&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_iE_pid_c20240301__20250228__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zn7Hsp92P6K3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Expected to Vest"&gt;27.66&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_dtY_c20240301__20250228__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zwFy3VfuD7Ta" title="Weighted Average Remaining Contractual Life, Expected to Vest"&gt;1.93&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_iE_pp0p0_c20240301__20250228__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zGQtOUP8Ukwd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Options expected to vest in the future"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1812"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;SARs exercisable at February 28, 2025&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_pid_c20240301__20250228__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zx1loO0OnAHd" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options, Exercisable"&gt;35,010&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20240301__20250228__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zAMuaPcKE2H9" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Exercisable"&gt;47.35&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20240301__20250228__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zD33XKKplyh9" title="Weighted Average Remaining Contractual Life, Exercisable"&gt;2.34&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iE_pp0p0_c20240301__20250228__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zJCSqvoC7hnd" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Options exercisable"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1820"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"&gt;SARs vested, exercisable, and options expected to vest at February 28, 2025&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_iE_pid_c20240301__20250228__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_z0urZVBN5lfj" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Options, Vested, Exercisable and Options Expected to Vest Balance"&gt;40,223&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_iE_pid_c20240301__20250228__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zva9jgslCi35" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Vested, Exercisable and Options Expected to Vest"&gt;44.80&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_dtY_c20240301__20250228__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zf1jdG76Rzj6" title="Weighted Average Remaining Contractual Life, Vested, Exercisable and Options Expected to Vest"&gt;1.99&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_iE_pp0p0_c20240301__20250228__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zklpPrAoaHe4" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Options vested, exercisable and options expected to vest"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1828"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2024-02-29_custom_StockAppreciationRightsMember"
      decimals="INF"
      id="Fact001778"
      unitRef="Shares">40390</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2024-02-29_custom_StockAppreciationRightsMember"
      decimals="INF"
      id="Fact001780"
      unitRef="USDPShares">44.77</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="From2023-03-012024-02-28_custom_StockAppreciationRightsMember"
      id="Fact001782">P2Y11M26D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
      contextRef="From2024-03-012025-02-28_custom_StockAppreciationRightsMember"
      decimals="INF"
      id="Fact001792"
      unitRef="Shares">167</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod>
    <NTRP:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageForfeitedOrCancelled
      contextRef="From2024-03-012025-02-28_custom_StockAppreciationRightsMember"
      decimals="INF"
      id="Fact001794"
      unitRef="USDPShares">37.4</NTRP:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageForfeitedOrCancelled>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2025-02-28_custom_StockAppreciationRightsMember"
      decimals="INF"
      id="Fact001798"
      unitRef="Shares">40223</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2025-02-28_custom_StockAppreciationRightsMember"
      decimals="INF"
      id="Fact001800"
      unitRef="USDPShares">44.80</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="From2024-03-012025-02-28_custom_StockAppreciationRightsMember"
      id="Fact001802">P1Y11M26D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="AsOf2025-02-28_custom_StockAppreciationRightsMember"
      decimals="INF"
      id="Fact001806"
      unitRef="Shares">5213</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2025-02-28_custom_StockAppreciationRightsMember"
      decimals="INF"
      id="Fact001808"
      unitRef="USDPShares">27.66</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
      contextRef="From2024-03-012025-02-28_custom_StockAppreciationRightsMember"
      id="Fact001810">P1Y11M4D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="AsOf2025-02-28_custom_StockAppreciationRightsMember"
      decimals="INF"
      id="Fact001814"
      unitRef="Shares">35010</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="AsOf2025-02-28_custom_StockAppreciationRightsMember"
      decimals="INF"
      id="Fact001816"
      unitRef="USDPShares">47.35</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
      contextRef="From2024-03-012025-02-28_custom_StockAppreciationRightsMember"
      id="Fact001818">P2Y4M2D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
      contextRef="AsOf2025-02-28_custom_StockAppreciationRightsMember"
      decimals="INF"
      id="Fact001822"
      unitRef="Shares">40223</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
      contextRef="AsOf2025-02-28_custom_StockAppreciationRightsMember"
      decimals="INF"
      id="Fact001824"
      unitRef="USDPShares">44.80</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
      contextRef="From2024-03-012025-02-28_custom_StockAppreciationRightsMember"
      id="Fact001826">P1Y11M26D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="From2024-03-012025-02-28_custom_TwoThousandAndTwentyStockAppreciationRightsPlanMember"
      decimals="INF"
      id="Fact001830"
      unitRef="USDPShares">3.98</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="From2024-03-012025-02-28_custom_TwoThousandAndTwentyStockAppreciationRightsPlanMember"
      decimals="INF"
      id="Fact001832"
      unitRef="USDPShares">3.98</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2024-03-012025-02-28_custom_TwoThousandAndTwentyStockAppreciationRightsPlanMember"
      decimals="0"
      id="Fact001834"
      unitRef="USD">67874</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="AsOf2025-02-28_custom_TwoThousandAndTwentyStockAppreciationRightsPlanMember"
      decimals="0"
      id="Fact001836"
      unitRef="USD">119</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <NTRP:SharebasedCompensationArrangementBySharebasedPaymentAwardWeightedAverageRemainingRecognitionPeriod
      contextRef="From2024-03-012025-02-28_custom_TwoThousandAndTwentyStockAppreciationRightsPlanMember"
      id="Fact001838">P0Y3M3D</NTRP:SharebasedCompensationArrangementBySharebasedPaymentAwardWeightedAverageRemainingRecognitionPeriod>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
      contextRef="AsOf2025-02-28_us-gaap_WarrantMember"
      decimals="INF"
      id="Fact001840"
      unitRef="Shares">3015885</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2025-02-28_us-gaap_WarrantMember_srt_MinimumMember"
      decimals="INF"
      id="Fact001842"
      unitRef="USDPShares">3.02</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2025-02-28_us-gaap_WarrantMember_srt_MaximumMember"
      decimals="INF"
      id="Fact001844"
      unitRef="USDPShares">350.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <NTRP:DescriptionForWarrantExpiration
      contextRef="From2024-03-012025-02-28_us-gaap_WarrantMember11853671"
      id="Fact001846">expire between July 26, 2025 and August 24, 2030</NTRP:DescriptionForWarrantExpiration>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock contextRef="From2024-03-01to2025-02-28" id="Fact001848">&lt;p id="xdx_893_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_zFI411ZI4oWh" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The fair value of warrants issued during the year
was estimated using the Black-Scholes model with the following assumptions for the twelve months ended February 28, 2025:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"&gt;&lt;b&gt;Assumptions:&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B0_zjrLnBZbNBQh" style="display: none"&gt;Schedule of Share Based Payments Award Stock Options Valuation Assumptions&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;2025&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 80%; text-align: left"&gt;Dividend yield&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 18%; text-align: right"&gt;&lt;span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_uPure_c20240301__20250228_zaeQiO9I5h47" title="Dividend yield"&gt;0.0&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Risk-free interest rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_pid_dp_uPure_c20240301__20250228__srt--RangeAxis__srt--MinimumMember_zhLnzXurenHb" title="Risk-free interest rate, minimum"&gt;3.5%&lt;/span&gt;-&lt;span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uPure_c20240301__20250228__srt--RangeAxis__srt--MaximumMember_zPhasS7VGCxb" title="Risk-free interest rate, maximum"&gt;4.3&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Expected volatility&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_dp_uPure_c20240301__20250228__srt--RangeAxis__srt--MinimumMember_zxTUefTGKlD5" title="Expected volatility, minimum"&gt;127.1%&lt;/span&gt;-&lt;span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_dp_uPure_c20240301__20250228__srt--RangeAxis__srt--MaximumMember_zjNy1QocRtUj" title="Expected volatility, maximum"&gt;159.4&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Expected life (in years)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20240301__20250228__srt--RangeAxis__srt--MinimumMember_zWEcePIp2eya" title="Expected life"&gt;1.5&lt;/span&gt;-&lt;span id="xdx_90F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20240301__20250228__srt--RangeAxis__srt--MaximumMember_zE5VvcpgzZzb" title="Expected life"&gt;5.0&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="From2024-03-01to2025-02-28"
      decimals="INF"
      id="Fact001850"
      unitRef="Pure">0.000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
      contextRef="From2024-03-012025-02-28_srt_MinimumMember"
      decimals="INF"
      id="Fact001852"
      unitRef="Pure">0.035</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
      contextRef="From2024-03-012025-02-28_srt_MaximumMember"
      decimals="INF"
      id="Fact001854"
      unitRef="Pure">0.043</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
      contextRef="From2024-03-012025-02-28_srt_MinimumMember"
      decimals="INF"
      id="Fact001856"
      unitRef="Pure">1.271</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
      contextRef="From2024-03-012025-02-28_srt_MaximumMember"
      decimals="INF"
      id="Fact001858"
      unitRef="Pure">1.594</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="From2024-03-012025-02-28_srt_MinimumMember"
      id="Fact001860">P1Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="From2024-03-012025-02-28_srt_MaximumMember"
      id="Fact001862">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock contextRef="From2024-03-01to2025-02-28" id="Fact001864">&lt;p id="xdx_896_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zhpRYHcrbv0j" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Warrant
activity for the year ended February 28, 2025 was as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8BB_zjRXwdpkZ8oh" style="display: none"&gt;Schedule of Warranty Activity&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Weighted Average&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Weighted&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Average&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Exercise&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Remaining&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Price&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Contractual&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Warrants&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;($)&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Life (Yrs.)&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 46%; padding-bottom: 2.5pt"&gt;Warrants outstanding at February 29, 2024&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_pid_c20240301__20250228_zIpt1G5hP1Ph" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right" title="Warrants Outstanding, Beginning Balance"&gt;486,165&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20240301__20250228_zgZUaZGSu2Ci" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right" title="Weighted Average Exercise Price Outstanding, Beginning Balance"&gt;9.94&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonOutstandingWeightedAverageRemainingContractualTerm_dtY_c20230301__20240229_zw2bFLwpI3ri" title="Weighted Average Remaining Contractual Life Years, Beginning Balance"&gt;1.96&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;Granted&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_pid_c20240301__20250228_zvn9T6oeWXu2" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants, Granted"&gt;2,637,887&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20240301__20250228_zFHGq4ni9MKc" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price Outstanding, Granted"&gt;4.80&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_901_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonGrantsWeightedAverageRemainingContractualTerm_dtY_c20240301__20250228_zszdofnTORw5" title="Weighted Average Remaining Contractual Life Years, Granted"&gt;4.24&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;Exercised&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_iN_pid_di_c20240301__20250228_ztCL8aXqCXTc" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants,Exercised"&gt;(104,965&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageExercisePrice_pid_c20240301__20250228_zMCjplN3nB72" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price Outstanding,Exercised"&gt;3.02&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;-&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"&gt;Forfeited or cancelled&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_iN_pid_di_c20240301__20250228_zuGRbpcXSw46" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants, Forfeited or cancelled"&gt;(3,202&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageWeightedAverageExercisePriceWarrantsForfeitedOrCancelled_pid_c20240301__20250228_zSjC9Dr7s8jk" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price Outstanding, Forfeited or cancelled"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1884"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;-&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;Warrants outstanding at February 28, 2025&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_pid_c20240301__20250228_ziS5TaRvdfLk" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants Outstanding, Ending Balance"&gt;3,015,885&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20240301__20250228_zHwIq6VlvfIk" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price Outstanding, Ending Balance"&gt;5.36&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonOutstandingWeightedAverageRemainingContractualTerm_dtY_c20240301__20250228_zoWs4z0IxTZb" title="Weighted Average Remaining Contractual Life Years, Ending Balance"&gt;3.84&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
      contextRef="AsOf2024-02-29"
      decimals="INF"
      id="Fact001866"
      unitRef="Shares">486165</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <NTRP:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2024-02-29"
      decimals="INF"
      id="Fact001868"
      unitRef="USDPShares">9.94</NTRP:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice>
    <NTRP:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonOutstandingWeightedAverageRemainingContractualTerm contextRef="From2023-03-012024-02-29" id="Fact001870">P1Y11M15D</NTRP:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonOutstandingWeightedAverageRemainingContractualTerm>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
      contextRef="From2024-03-01to2025-02-28"
      decimals="INF"
      id="Fact001872"
      unitRef="Shares">2637887</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted>
    <NTRP:ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="From2024-03-01to2025-02-28"
      decimals="INF"
      id="Fact001874"
      unitRef="USDPShares">4.80</NTRP:ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <NTRP:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonGrantsWeightedAverageRemainingContractualTerm contextRef="From2024-03-01to2025-02-28" id="Fact001876">P4Y2M26D</NTRP:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonGrantsWeightedAverageRemainingContractualTerm>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
      contextRef="From2024-03-01to2025-02-28"
      decimals="INF"
      id="Fact001878"
      unitRef="Shares">104965</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised>
    <NTRP:ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageExercisePrice
      contextRef="From2024-03-01to2025-02-28"
      decimals="INF"
      id="Fact001880"
      unitRef="USDPShares">3.02</NTRP:ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures
      contextRef="From2024-03-01to2025-02-28"
      decimals="INF"
      id="Fact001882"
      unitRef="Shares">3202</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
      contextRef="AsOf2025-02-28"
      decimals="INF"
      id="Fact001886"
      unitRef="Shares">3015885</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <NTRP:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2025-02-28"
      decimals="INF"
      id="Fact001888"
      unitRef="USDPShares">5.36</NTRP:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice>
    <NTRP:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonOutstandingWeightedAverageRemainingContractualTerm contextRef="From2024-03-01to2025-02-28" id="Fact001890">P3Y10M2D</NTRP:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonOutstandingWeightedAverageRemainingContractualTerm>
    <us-gaap:EarningsPerShareTextBlock contextRef="From2024-03-01to2025-02-28" id="Fact001892">&lt;p id="xdx_80B_eus-gaap--EarningsPerShareTextBlock_zDTtQmaqfTp9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
19 &#x2013; &lt;span id="xdx_82F_zpwl32m6pnoc"&gt;Loss Per Share&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89C_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zzRn2OLe8J13" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following data show the amounts used in computing loss per share and the effect on income and the weighted average number of shares of
dilutive potential common stock for the years ended February 28, 2025 and February 29, 2024:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B0_zB5oQ5B78MWg" style="display: none"&gt;Schedule of Earnings Per Share, Basic and Diluted&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_491_20240301__20250228_zIax3Wzc3cCl" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;2025&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_490_20230301__20240229_zea9HjiMcnW9" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;Year Ended February&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;2025&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_zFrF7PIzwta" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left"&gt;Loss from continuing operations&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;(10,128,428&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;(6,656,837&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--PreferredStockDividendsIncomeStatementImpact_iN_di_z9I9ynpTyyy9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"&gt;Preferred dividends&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(78,600&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(7,125&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--IncomeLossFromContinuingOperations_z8bBw63pHCCg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Loss from continuing operations applicable to common stockholders&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(10,207,028&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(6,663,962&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_zhUfm67V8gu5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"&gt;Gain (loss) from discontinued operations applicable to common stockholders&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;8,344&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(675,314&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_zPemkS9ty0b" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"&gt;Net loss applicable to common stockholders&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(10,198,684&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(7,339,276&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_zfw2IISZJTAf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"&gt;Weighted average number of common shares Outstanding used in loss per share during the Period (denominator)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;4,566,787&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;228,274&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A6_zMqJkahZJF4" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
June 10, 2024, the Company determined that three of the four business milestones per the Exchange Agreement had been achieved.
As a result, &lt;span id="xdx_906_eus-gaap--IncrementalCommonSharesAttributableToContingentlyIssuableShares_c20240610__20240610__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__srt--StatementScenarioAxis__custom--AchievedMember_z28SKl9tP20a" title="Contingent shares issuable"&gt;4,393,993&lt;/span&gt; of the total Contingent Shares of &lt;span id="xdx_905_eus-gaap--IncrementalCommonSharesAttributableToContingentlyIssuableShares_pid_c20240610__20240610__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember_zyiZR7FWQkR3" title="Contingent shares issuable"&gt;5,843,993&lt;/span&gt; became eligible for issuance. Pursuant to ASC 260, as there are no
circumstances under which the shares will not be issued, such eligible contingent shares are included in the computation of basic earnings
per share. The following table shows the business milestones and the issuable Contingent Shares:&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89D_eus-gaap--ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock_zwEd4uQAvnFg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8BA_zJ94RHgNtRXe" style="display: none"&gt;Schedule
of Business Milestones and Issuable Contingent Shares&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;Business Milestones&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;Contingent Shares&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: italic 10pt Times New Roman, Times, Serif; text-align: justify"&gt;Achieved&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 78%; text-align: justify"&gt;Launch of leisure travel booking platform&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--IncrementalCommonSharesAttributableToContingentlyIssuableShares_c20240610__20240610__srt--StatementScenarioAxis__custom--AchievedMember__us-gaap--OtherCommitmentsAxis__custom--LeisureTravelBookingPlatformMember_zj7ToOtUlco7" style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right" title="Launch of leisure travel booking platform"&gt;1,450,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;Launch of group travel booking platform&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--IncrementalCommonSharesAttributableToContingentlyIssuableShares_c20240610__20240610__srt--StatementScenarioAxis__custom--AchievedMember__us-gaap--OtherCommitmentsAxis__custom--GroupTravelBookingPlatformMember_zUvg407RUbDg" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Launch of group travel booking platform"&gt;1,450,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 1pt"&gt;Launch of PayDlay technology&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--IncrementalCommonSharesAttributableToContingentlyIssuableShares_c20240610__20240610__srt--StatementScenarioAxis__custom--AchievedMember__us-gaap--OtherCommitmentsAxis__custom--FlexPayTechnologyMember_z8y6ZcZE9Lqb" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Launch of FlexPay technology"&gt;1,493,993&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 1pt"&gt;Total contingent shares issuable on June 10, 2024&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--IncrementalCommonSharesAttributableToContingentlyIssuableShares_c20240610__20240610__srt--StatementScenarioAxis__custom--AchievedMember_zzmq5bWdIYRc" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total contingent shares issuable on June 10, 2024"&gt;4,393,993&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: italic 10pt Times New Roman, Times, Serif; text-align: justify"&gt;Not Achieved&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 1pt"&gt;Launch of travel agent platform&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--IncrementalCommonSharesAttributableToContingentlyIssuableShares_c20240610__20240610__srt--StatementScenarioAxis__custom--NotAchievedMember__us-gaap--OtherCommitmentsAxis__custom--TravelAgentPlatformMember_zis53YyOuZRh" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total contingent shares potentially issuable in future periods"&gt;1,450,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 1pt"&gt;Total contingent shares potentially issuable in future periods&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--IncrementalCommonSharesAttributableToContingentlyIssuableShares_c20240610__20240610__srt--StatementScenarioAxis__custom--NotAchievedMember_zMhks37wI6C4" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total contingent shares potentially issuable in future periods"&gt;1,450,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 2.5pt"&gt;Total contingent shares&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--IncrementalCommonSharesAttributableToContingentlyIssuableShares_c20240610__20240610_zwx7IksCC5M5" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total contingent shares"&gt;5,843,993&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A3_zmC9g7WtLdQa" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_899_eus-gaap--ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_zkFLoYttQsQb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table shows the reconciliation of the weighted average common shares outstanding for the twelve months ended February 28, 2025
to the weighted average common shares used in the computation of basic earnings per share:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8BD_zbSPJ2PEsGaf" style="display: none"&gt;Schedule
of Weighted Average Common Shares&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;February 28,&lt;/p&gt;
                                                                               &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;2025&lt;/p&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 78%"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFdlaWdodGVkIEF2ZXJhZ2UgQ29tbW9uIFNoYXJlcyAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_90D_eus-gaap--CommonStockSharesOutstanding_iI_c20250228_ziMjiQjhAeV9" title="Common stock, shares outstanding"&gt;1,656,738&lt;/span&gt; common shares outstanding&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20240301__20250228__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zoNFLk1YuaVc" style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right" title="1,656,738 common shares outstanding"&gt;1,400,705&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFdlaWdodGVkIEF2ZXJhZ2UgQ29tbW9uIFNoYXJlcyAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_906_eus-gaap--IncrementalCommonSharesAttributableToContingentlyIssuableShares_c20240301__20250228_zKANRDcND0Yf" title="Contingent shares issuable"&gt;4,393,993&lt;/span&gt; issuable contingent shares&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20240301__20250228__us-gaap--StatementClassOfStockAxis__custom--ContingentSharesMember_z5QbJx49MdH7" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="4,393,993 issuable contingent shares"&gt;3,166,083&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;Weighted average common shares outstanding&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20240301__20250228_zL6wAdzc4YJ" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average common shares outstanding"&gt;4,566,787&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A8_zIqBfyY49Km3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
issuable Contingent Shares are of the Company&#x2019;s sole class of common stock, and as such have the same rights and privileges as
existing common stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Dilutive
loss per share was not presented as the Company&#x2019;s outstanding common and preferred warrants, stock options and preferred stock
common equivalent shares for the periods presented would have had an anti-dilutive effect. At February 28, 2025, the Company had outstanding
warrants to purchase &lt;span id="xdx_907_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20250228__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zC1uVTvVAj9i" title="Warrants outstanding to purchase common stock"&gt;3,105,885&lt;/span&gt; shares of common stock; stock options exercisable for &lt;span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20250228__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zY4mdWRCA8R2" title="Shares issuable upon exercisable of options"&gt;76,342&lt;/span&gt; shares of common stock; &lt;span id="xdx_90C_eus-gaap--ConversionOfStockSharesConverted1_c20240301__20250228__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesEPreferredStockMember_zh5W9qUysmQh" title="Number of shares converted"&gt;316&lt;/span&gt; shares of
Series E Preferred, which could be converted into &lt;span id="xdx_90C_eus-gaap--ConversionOfStockSharesIssued1_c20240301__20250228__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesEPreferredStockMember_z5JhoCeB2Rb3" title="Common stock issuable upon conversion"&gt;3,362&lt;/span&gt; shares of common stock; &lt;span id="xdx_90D_eus-gaap--ConversionOfStockSharesConverted1_c20240301__20250228__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesHPreferredStockMember_zNLZxBa501d5" title="Number of shares converted"&gt;33,000&lt;/span&gt; shares of Series H Preferred, convertible
into &lt;span id="xdx_90F_eus-gaap--ConversionOfStockSharesIssued1_c20240301__20250228__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesHPreferredStockMember_zi4TX1YcKCk9" title="Common stock issuable upon conversion"&gt;33,000&lt;/span&gt; shares of common stock; &lt;span id="xdx_903_eus-gaap--ConversionOfStockSharesConverted1_c20240301__20250228__us-gaap--StatementClassOfStockAxis__custom--SeriesIPreferredStockMember_zrW6cm8FCER7" title="Number of shares converted"&gt;500,442&lt;/span&gt; shares of Series I Preferred, convertible into &lt;span id="xdx_90E_eus-gaap--ConversionOfStockSharesIssued1_c20240301__20250228__us-gaap--StatementClassOfStockAxis__custom--SeriesIPreferredStockMember_zRhpP5XqF5p6" title="Common stock issuable upon conversion"&gt;500,442&lt;/span&gt; shares of common stock; &lt;span id="xdx_905_eus-gaap--ConversionOfStockSharesConverted1_c20240301__20250228__us-gaap--StatementClassOfStockAxis__custom--SeriesJPreferredStockMember_zWRY8Z3kyK95" title="Number of shares converted"&gt;297,788&lt;/span&gt;
shares of Series J Preferred, convertible into &lt;span id="xdx_90A_eus-gaap--ConversionOfStockSharesIssued1_c20240301__20250228__us-gaap--StatementClassOfStockAxis__custom--SeriesJPreferredStockMember_zGjMu8V3sE75" title="Common stock issuable upon conversion"&gt;297,788&lt;/span&gt; shares of common stock; &lt;span id="xdx_905_eus-gaap--ConversionOfStockSharesConverted1_c20240301__20250228__us-gaap--StatementClassOfStockAxis__custom--SeriesKPreferredStockMember_z5OxjsaXehr9" title="Number of shares converted"&gt;60,595&lt;/span&gt; shares of Series K Stock, convertible
into &lt;span id="xdx_90F_eus-gaap--ConversionOfStockSharesIssued1_c20240301__20250228__us-gaap--StatementClassOfStockAxis__custom--SeriesKPreferredStockMember_zuFEdBtf2MU3" title="Common stock issuable upon conversion"&gt;60,595&lt;/span&gt; shares of common stock; &lt;span id="xdx_900_eus-gaap--ConversionOfStockSharesConverted1_c20240301__20250228__us-gaap--StatementClassOfStockAxis__custom--SeriesLPreferredStockMember_zljkXPA5OQV7" title="Number of shares converted"&gt;1,076,156&lt;/span&gt; shares of Series L Preferred, convertible into &lt;span id="xdx_906_eus-gaap--ConversionOfStockSharesIssued1_c20240301__20250228__us-gaap--StatementClassOfStockAxis__custom--SeriesLPreferredStockMember_zgkaLd7XJ8V3" title="Common stock issuable upon conversion"&gt;1,076,156&lt;/span&gt; shares of common stock;
&lt;span id="xdx_900_eus-gaap--ConversionOfStockSharesConverted1_c20240301__20250228__us-gaap--StatementClassOfStockAxis__custom--SeriesMPreferredStockMember_zwQrwAAxmBU6" title="Number of shares converted"&gt;133,278&lt;/span&gt; shares of Series M Preferred, convertible into &lt;span id="xdx_904_eus-gaap--ConversionOfStockSharesIssued1_c20240301__20250228__us-gaap--StatementClassOfStockAxis__custom--SeriesMPreferredStockMember_zwsyCupL84Wl" title="Common stock issuable upon conversion"&gt;133,278&lt;/span&gt; shares of common stock; &lt;span id="xdx_900_eus-gaap--ConversionOfStockSharesConverted1_c20240301__20250228__us-gaap--StatementClassOfStockAxis__custom--SeriesNPreferredStockMember_zIxkCjvTHMTi" title="Number of shares converted"&gt;500,000&lt;/span&gt; shares of Series N Preferred,
convertible into &lt;span id="xdx_90A_eus-gaap--ConversionOfStockSharesIssued1_c20240301__20250228__us-gaap--StatementClassOfStockAxis__custom--SeriesNPreferredStockMember_z2OG52knENS7" title="Common stock issuable upon conversion"&gt;500,000&lt;/span&gt; shares of common stock; &lt;span id="xdx_901_eus-gaap--ConversionOfStockSharesConverted1_c20240301__20250228__us-gaap--StatementClassOfStockAxis__custom--SeriesOPreferredStockMember_zWIrpBfIwWj9" title="Number of shares converted"&gt;161,291&lt;/span&gt; shares of Series O Preferred, convertible into &lt;span id="xdx_90E_eus-gaap--ConversionOfStockSharesIssued1_c20240301__20250228__us-gaap--StatementClassOfStockAxis__custom--SeriesOPreferredStockMember_zqjL1H1CNWYc" title="Common stock issuable upon conversion"&gt;161,291&lt;/span&gt; shares of common
stock; and &lt;span id="xdx_906_eus-gaap--ConversionOfStockSharesConverted1_c20240301__20250228__us-gaap--StatementClassOfStockAxis__custom--SeriesOPreferredStockOneMember_z4zt5soCOyWg" title="Number of shares converted"&gt;343,750&lt;/span&gt; shares of Series O Stock, convertible into &lt;span id="xdx_909_eus-gaap--ConversionOfStockSharesIssued1_c20240301__20250228__us-gaap--StatementClassOfStockAxis__custom--SeriesOPreferredStockOneMember_zudvTBRY08c4" title="Common stock issuable upon conversion"&gt;343,750&lt;/span&gt; shares of common stock, resulting in a potential total
additional &lt;span id="xdx_90C_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_c20240301__20250228__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zMwWi7Oo9q03" title="Potentially dilutive securities"&gt;3,109,663&lt;/span&gt; shares of common stock outstanding in the future. At February 29, 2024, the Company had &lt;span id="xdx_902_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_c20230301__20240229__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zLQykkw5cWcf" title="Potentially dilutive securities"&gt;1,047,300&lt;/span&gt; outstanding potentially
dilutive securities.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="From2024-03-01to2025-02-28" id="Fact001894">&lt;p id="xdx_89C_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zzRn2OLe8J13" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following data show the amounts used in computing loss per share and the effect on income and the weighted average number of shares of
dilutive potential common stock for the years ended February 28, 2025 and February 29, 2024:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B0_zB5oQ5B78MWg" style="display: none"&gt;Schedule of Earnings Per Share, Basic and Diluted&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_491_20240301__20250228_zIax3Wzc3cCl" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;2025&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_490_20230301__20240229_zea9HjiMcnW9" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;Year Ended February&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;2025&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_zFrF7PIzwta" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left"&gt;Loss from continuing operations&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;(10,128,428&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;(6,656,837&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--PreferredStockDividendsIncomeStatementImpact_iN_di_z9I9ynpTyyy9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"&gt;Preferred dividends&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(78,600&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(7,125&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--IncomeLossFromContinuingOperations_z8bBw63pHCCg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Loss from continuing operations applicable to common stockholders&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(10,207,028&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(6,663,962&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_zhUfm67V8gu5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"&gt;Gain (loss) from discontinued operations applicable to common stockholders&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;8,344&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(675,314&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_zPemkS9ty0b" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"&gt;Net loss applicable to common stockholders&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(10,198,684&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(7,339,276&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_zfw2IISZJTAf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"&gt;Weighted average number of common shares Outstanding used in loss per share during the Period (denominator)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;4,566,787&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;228,274&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="From2024-03-01to2025-02-28"
      decimals="0"
      id="Fact001896"
      unitRef="USD">-10128428</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact001897"
      unitRef="USD">-6656837</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:PreferredStockDividendsIncomeStatementImpact
      contextRef="From2024-03-01to2025-02-28"
      decimals="0"
      id="Fact001899"
      unitRef="USD">78600</us-gaap:PreferredStockDividendsIncomeStatementImpact>
    <us-gaap:PreferredStockDividendsIncomeStatementImpact
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact001900"
      unitRef="USD">7125</us-gaap:PreferredStockDividendsIncomeStatementImpact>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="From2024-03-01to2025-02-28"
      decimals="0"
      id="Fact001902"
      unitRef="USD">-10207028</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact001903"
      unitRef="USD">-6663962</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
      contextRef="From2024-03-01to2025-02-28"
      decimals="0"
      id="Fact001905"
      unitRef="USD">8344</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact001906"
      unitRef="USD">-675314</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2024-03-01to2025-02-28"
      decimals="0"
      id="Fact001908"
      unitRef="USD">-10198684</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact001909"
      unitRef="USD">-7339276</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2024-03-01to2025-02-28"
      decimals="INF"
      id="Fact001911"
      unitRef="Shares">4566787</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2023-03-012024-02-29"
      decimals="INF"
      id="Fact001912"
      unitRef="Shares">228274</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:IncrementalCommonSharesAttributableToContingentlyIssuableShares
      contextRef="From2024-06-102024-06-10_custom_ShareExchangeAgreementMember_custom_AchievedMember"
      decimals="INF"
      id="Fact001914"
      unitRef="Shares">4393993</us-gaap:IncrementalCommonSharesAttributableToContingentlyIssuableShares>
    <us-gaap:IncrementalCommonSharesAttributableToContingentlyIssuableShares
      contextRef="From2024-06-102024-06-10_custom_ShareExchangeAgreementMember"
      decimals="INF"
      id="Fact001916"
      unitRef="Shares">5843993</us-gaap:IncrementalCommonSharesAttributableToContingentlyIssuableShares>
    <us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock contextRef="From2024-03-01to2025-02-28" id="Fact001918">&lt;p id="xdx_89D_eus-gaap--ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock_zwEd4uQAvnFg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8BA_zJ94RHgNtRXe" style="display: none"&gt;Schedule
of Business Milestones and Issuable Contingent Shares&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;Business Milestones&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;Contingent Shares&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: italic 10pt Times New Roman, Times, Serif; text-align: justify"&gt;Achieved&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 78%; text-align: justify"&gt;Launch of leisure travel booking platform&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--IncrementalCommonSharesAttributableToContingentlyIssuableShares_c20240610__20240610__srt--StatementScenarioAxis__custom--AchievedMember__us-gaap--OtherCommitmentsAxis__custom--LeisureTravelBookingPlatformMember_zj7ToOtUlco7" style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right" title="Launch of leisure travel booking platform"&gt;1,450,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;Launch of group travel booking platform&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--IncrementalCommonSharesAttributableToContingentlyIssuableShares_c20240610__20240610__srt--StatementScenarioAxis__custom--AchievedMember__us-gaap--OtherCommitmentsAxis__custom--GroupTravelBookingPlatformMember_zUvg407RUbDg" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Launch of group travel booking platform"&gt;1,450,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 1pt"&gt;Launch of PayDlay technology&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--IncrementalCommonSharesAttributableToContingentlyIssuableShares_c20240610__20240610__srt--StatementScenarioAxis__custom--AchievedMember__us-gaap--OtherCommitmentsAxis__custom--FlexPayTechnologyMember_z8y6ZcZE9Lqb" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Launch of FlexPay technology"&gt;1,493,993&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 1pt"&gt;Total contingent shares issuable on June 10, 2024&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--IncrementalCommonSharesAttributableToContingentlyIssuableShares_c20240610__20240610__srt--StatementScenarioAxis__custom--AchievedMember_zzmq5bWdIYRc" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total contingent shares issuable on June 10, 2024"&gt;4,393,993&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: italic 10pt Times New Roman, Times, Serif; text-align: justify"&gt;Not Achieved&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 1pt"&gt;Launch of travel agent platform&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--IncrementalCommonSharesAttributableToContingentlyIssuableShares_c20240610__20240610__srt--StatementScenarioAxis__custom--NotAchievedMember__us-gaap--OtherCommitmentsAxis__custom--TravelAgentPlatformMember_zis53YyOuZRh" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total contingent shares potentially issuable in future periods"&gt;1,450,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 1pt"&gt;Total contingent shares potentially issuable in future periods&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--IncrementalCommonSharesAttributableToContingentlyIssuableShares_c20240610__20240610__srt--StatementScenarioAxis__custom--NotAchievedMember_zMhks37wI6C4" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total contingent shares potentially issuable in future periods"&gt;1,450,000&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 2.5pt"&gt;Total contingent shares&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--IncrementalCommonSharesAttributableToContingentlyIssuableShares_c20240610__20240610_zwx7IksCC5M5" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total contingent shares"&gt;5,843,993&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock>
    <us-gaap:IncrementalCommonSharesAttributableToContingentlyIssuableShares
      contextRef="From2024-06-102024-06-10_custom_AchievedMember_custom_LeisureTravelBookingPlatformMember"
      decimals="INF"
      id="Fact001920"
      unitRef="Shares">1450000</us-gaap:IncrementalCommonSharesAttributableToContingentlyIssuableShares>
    <us-gaap:IncrementalCommonSharesAttributableToContingentlyIssuableShares
      contextRef="From2024-06-102024-06-10_custom_AchievedMember_custom_GroupTravelBookingPlatformMember"
      decimals="INF"
      id="Fact001922"
      unitRef="Shares">1450000</us-gaap:IncrementalCommonSharesAttributableToContingentlyIssuableShares>
    <us-gaap:IncrementalCommonSharesAttributableToContingentlyIssuableShares
      contextRef="From2024-06-102024-06-10_custom_AchievedMember_custom_FlexPayTechnologyMember"
      decimals="INF"
      id="Fact001924"
      unitRef="Shares">1493993</us-gaap:IncrementalCommonSharesAttributableToContingentlyIssuableShares>
    <us-gaap:IncrementalCommonSharesAttributableToContingentlyIssuableShares
      contextRef="From2024-06-102024-06-10_custom_AchievedMember"
      decimals="INF"
      id="Fact001926"
      unitRef="Shares">4393993</us-gaap:IncrementalCommonSharesAttributableToContingentlyIssuableShares>
    <us-gaap:IncrementalCommonSharesAttributableToContingentlyIssuableShares
      contextRef="From2024-06-102024-06-10_custom_NotAchievedMember_custom_TravelAgentPlatformMember"
      decimals="INF"
      id="Fact001928"
      unitRef="Shares">1450000</us-gaap:IncrementalCommonSharesAttributableToContingentlyIssuableShares>
    <us-gaap:IncrementalCommonSharesAttributableToContingentlyIssuableShares
      contextRef="From2024-06-102024-06-10_custom_NotAchievedMember"
      decimals="INF"
      id="Fact001930"
      unitRef="Shares">1450000</us-gaap:IncrementalCommonSharesAttributableToContingentlyIssuableShares>
    <us-gaap:IncrementalCommonSharesAttributableToContingentlyIssuableShares
      contextRef="From2024-06-102024-06-10"
      decimals="INF"
      id="Fact001932"
      unitRef="Shares">5843993</us-gaap:IncrementalCommonSharesAttributableToContingentlyIssuableShares>
    <us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock contextRef="From2024-03-01to2025-02-28" id="Fact001934">&lt;p id="xdx_899_eus-gaap--ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_zkFLoYttQsQb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table shows the reconciliation of the weighted average common shares outstanding for the twelve months ended February 28, 2025
to the weighted average common shares used in the computation of basic earnings per share:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8BD_zbSPJ2PEsGaf" style="display: none"&gt;Schedule
of Weighted Average Common Shares&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;February 28,&lt;/p&gt;
                                                                               &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;2025&lt;/p&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 78%"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFdlaWdodGVkIEF2ZXJhZ2UgQ29tbW9uIFNoYXJlcyAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_90D_eus-gaap--CommonStockSharesOutstanding_iI_c20250228_ziMjiQjhAeV9" title="Common stock, shares outstanding"&gt;1,656,738&lt;/span&gt; common shares outstanding&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20240301__20250228__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zoNFLk1YuaVc" style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right" title="1,656,738 common shares outstanding"&gt;1,400,705&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFdlaWdodGVkIEF2ZXJhZ2UgQ29tbW9uIFNoYXJlcyAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_906_eus-gaap--IncrementalCommonSharesAttributableToContingentlyIssuableShares_c20240301__20250228_zKANRDcND0Yf" title="Contingent shares issuable"&gt;4,393,993&lt;/span&gt; issuable contingent shares&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20240301__20250228__us-gaap--StatementClassOfStockAxis__custom--ContingentSharesMember_z5QbJx49MdH7" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="4,393,993 issuable contingent shares"&gt;3,166,083&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;Weighted average common shares outstanding&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20240301__20250228_zL6wAdzc4YJ" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average common shares outstanding"&gt;4,566,787&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2025-02-28"
      decimals="INF"
      id="Fact001936"
      unitRef="Shares">1656738</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2024-03-012025-02-28_us-gaap_CommonStockMember11856671"
      decimals="INF"
      id="Fact001938"
      unitRef="Shares">1400705</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:IncrementalCommonSharesAttributableToContingentlyIssuableShares
      contextRef="From2024-03-01to2025-02-28"
      decimals="INF"
      id="Fact001940"
      unitRef="Shares">4393993</us-gaap:IncrementalCommonSharesAttributableToContingentlyIssuableShares>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2024-03-012025-02-28_custom_ContingentSharesMember"
      decimals="INF"
      id="Fact001942"
      unitRef="Shares">3166083</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2024-03-01to2025-02-28"
      decimals="INF"
      id="Fact001944"
      unitRef="Shares">4566787</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2025-02-28_us-gaap_WarrantMember"
      decimals="INF"
      id="Fact001946"
      unitRef="Shares">3105885</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="AsOf2025-02-28_us-gaap_EmployeeStockOptionMember"
      decimals="INF"
      id="Fact001948"
      unitRef="Shares">76342</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ConversionOfStockSharesConverted1
      contextRef="From2024-03-012025-02-28_us-gaap_SeriesEPreferredStockMember"
      decimals="INF"
      id="Fact001950"
      unitRef="Shares">316</us-gaap:ConversionOfStockSharesConverted1>
    <us-gaap:ConversionOfStockSharesIssued1
      contextRef="From2024-03-012025-02-28_us-gaap_SeriesEPreferredStockMember"
      decimals="INF"
      id="Fact001952"
      unitRef="Shares">3362</us-gaap:ConversionOfStockSharesIssued1>
    <us-gaap:ConversionOfStockSharesConverted1
      contextRef="From2024-03-012025-02-28_us-gaap_SeriesHPreferredStockMember"
      decimals="INF"
      id="Fact001954"
      unitRef="Shares">33000</us-gaap:ConversionOfStockSharesConverted1>
    <us-gaap:ConversionOfStockSharesIssued1
      contextRef="From2024-03-012025-02-28_us-gaap_SeriesHPreferredStockMember"
      decimals="INF"
      id="Fact001956"
      unitRef="Shares">33000</us-gaap:ConversionOfStockSharesIssued1>
    <us-gaap:ConversionOfStockSharesConverted1
      contextRef="From2024-03-012025-02-28_custom_SeriesIPreferredStockMember"
      decimals="INF"
      id="Fact001958"
      unitRef="Shares">500442</us-gaap:ConversionOfStockSharesConverted1>
    <us-gaap:ConversionOfStockSharesIssued1
      contextRef="From2024-03-012025-02-28_custom_SeriesIPreferredStockMember"
      decimals="INF"
      id="Fact001960"
      unitRef="Shares">500442</us-gaap:ConversionOfStockSharesIssued1>
    <us-gaap:ConversionOfStockSharesConverted1
      contextRef="From2024-03-012025-02-28_custom_SeriesJPreferredStockMember"
      decimals="INF"
      id="Fact001962"
      unitRef="Shares">297788</us-gaap:ConversionOfStockSharesConverted1>
    <us-gaap:ConversionOfStockSharesIssued1
      contextRef="From2024-03-012025-02-28_custom_SeriesJPreferredStockMember"
      decimals="INF"
      id="Fact001964"
      unitRef="Shares">297788</us-gaap:ConversionOfStockSharesIssued1>
    <us-gaap:ConversionOfStockSharesConverted1
      contextRef="From2024-03-012025-02-28_custom_SeriesKPreferredStockMember"
      decimals="INF"
      id="Fact001966"
      unitRef="Shares">60595</us-gaap:ConversionOfStockSharesConverted1>
    <us-gaap:ConversionOfStockSharesIssued1
      contextRef="From2024-03-012025-02-28_custom_SeriesKPreferredStockMember"
      decimals="INF"
      id="Fact001968"
      unitRef="Shares">60595</us-gaap:ConversionOfStockSharesIssued1>
    <us-gaap:ConversionOfStockSharesConverted1
      contextRef="From2024-03-012025-02-28_custom_SeriesLPreferredStockMember"
      decimals="INF"
      id="Fact001970"
      unitRef="Shares">1076156</us-gaap:ConversionOfStockSharesConverted1>
    <us-gaap:ConversionOfStockSharesIssued1
      contextRef="From2024-03-012025-02-28_custom_SeriesLPreferredStockMember"
      decimals="INF"
      id="Fact001972"
      unitRef="Shares">1076156</us-gaap:ConversionOfStockSharesIssued1>
    <us-gaap:ConversionOfStockSharesConverted1
      contextRef="From2024-03-012025-02-28_custom_SeriesMPreferredStockMember"
      decimals="INF"
      id="Fact001974"
      unitRef="Shares">133278</us-gaap:ConversionOfStockSharesConverted1>
    <us-gaap:ConversionOfStockSharesIssued1
      contextRef="From2024-03-012025-02-28_custom_SeriesMPreferredStockMember"
      decimals="INF"
      id="Fact001976"
      unitRef="Shares">133278</us-gaap:ConversionOfStockSharesIssued1>
    <us-gaap:ConversionOfStockSharesConverted1
      contextRef="From2024-03-012025-02-28_custom_SeriesNPreferredStockMember"
      decimals="INF"
      id="Fact001978"
      unitRef="Shares">500000</us-gaap:ConversionOfStockSharesConverted1>
    <us-gaap:ConversionOfStockSharesIssued1
      contextRef="From2024-03-012025-02-28_custom_SeriesNPreferredStockMember"
      decimals="INF"
      id="Fact001980"
      unitRef="Shares">500000</us-gaap:ConversionOfStockSharesIssued1>
    <us-gaap:ConversionOfStockSharesConverted1
      contextRef="From2024-03-012025-02-28_custom_SeriesOPreferredStockMember"
      decimals="INF"
      id="Fact001982"
      unitRef="Shares">161291</us-gaap:ConversionOfStockSharesConverted1>
    <us-gaap:ConversionOfStockSharesIssued1
      contextRef="From2024-03-012025-02-28_custom_SeriesOPreferredStockMember"
      decimals="INF"
      id="Fact001984"
      unitRef="Shares">161291</us-gaap:ConversionOfStockSharesIssued1>
    <us-gaap:ConversionOfStockSharesConverted1
      contextRef="From2024-03-012025-02-28_custom_SeriesOPreferredStockOneMember"
      decimals="INF"
      id="Fact001986"
      unitRef="Shares">343750</us-gaap:ConversionOfStockSharesConverted1>
    <us-gaap:ConversionOfStockSharesIssued1
      contextRef="From2024-03-012025-02-28_custom_SeriesOPreferredStockOneMember"
      decimals="INF"
      id="Fact001988"
      unitRef="Shares">343750</us-gaap:ConversionOfStockSharesIssued1>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="From2024-03-012025-02-28_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact001990"
      unitRef="Shares">3109663</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="From2023-03-012024-02-29_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact001992"
      unitRef="Shares">1047300</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:ConcentrationRiskDisclosureTextBlock contextRef="From2024-03-01to2025-02-28" id="Fact001994">&lt;p id="xdx_806_eus-gaap--ConcentrationRiskDisclosureTextBlock_z4zPeoJ5B9ub" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
20 &#x2013; &lt;span id="xdx_827_zbuUqEC1BVk1"&gt;Concentrations&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Revenues
&lt;/b&gt;&#x2013; During the years ended February 28, 2025 and February 29, 2024, the Company did not have any significant customers who accounted
for more than &lt;span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20230301__20240229__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerMember_zeDZHqbZWjC8" title="Concentration of risk percentage"&gt;&lt;span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20240301__20250228__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerMember_zhl4YsKrD3Vi" title="Concentration of risk percentage"&gt;10&lt;/span&gt;&lt;/span&gt;% each of the Company&#x2019;s revenue in at least one of the periods presented.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Accounts
Receivable&lt;/b&gt; &#x2013; The Company had no significant customers who accounted for more than &lt;span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20230301__20240229__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerMember_zVjSBRAFYhH5" title="Concentration of risk percentage"&gt;&lt;span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20240301__20250228__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerMember_zTgRhDTrrEtg" title="Concentration of risk percentage"&gt;10&lt;/span&gt;&lt;/span&gt;% each of the Company&#x2019;s accounts
receivable balance at February 28, 2025 and February 29, 2024, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ConcentrationRiskDisclosureTextBlock>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2023-03-012024-02-29_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerMember"
      decimals="INF"
      id="Fact001996"
      unitRef="Pure">0.10</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2024-03-012025-02-28_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerMember"
      decimals="INF"
      id="Fact001998"
      unitRef="Pure">0.10</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2023-03-012024-02-29_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerMember"
      decimals="INF"
      id="Fact002000"
      unitRef="Pure">0.10</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2024-03-012025-02-28_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerMember"
      decimals="INF"
      id="Fact002002"
      unitRef="Pure">0.10</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:CompensationAndEmployeeBenefitPlansTextBlock contextRef="From2024-03-01to2025-02-28" id="Fact002004">&lt;p id="xdx_80C_eus-gaap--CompensationAndEmployeeBenefitPlansTextBlock_zvEibmnE4U3h" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
21 - &lt;span id="xdx_822_zfN3g2K8OFl6"&gt;Defined Contribution Plans&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has adopted two qualified 401(k) plans (the &#x201c;401(k) Plans&#x201d;), in which all employees over the age of 21 may
participate. Depending on the 401(k) Plan, &lt;span id="xdx_90C_eus-gaap--DescriptionOfDefinedContributionPensionAndOtherPostretirementPlans_c20240301__20250228_zoaePQhxSIsj" title="Contribution plan description"&gt;the
Company makes either a safe Harbor contribution match of 100% of each participant&#x2019;s contribution up to 3% of salary, and 50%
of the next 2% of salary contributed, or a 3% non-elective contribution for all eligible participants&lt;/span&gt;. The matching
contributions were $&lt;span id="xdx_90D_eus-gaap--DefinedContributionPlanCostRecognized_c20240301__20250228_z0tS3FmyBaKb" title="Cost of contribution"&gt;23,628&lt;/span&gt;
in 2025 and $&lt;span id="xdx_90F_eus-gaap--DefinedContributionPlanCostRecognized_c20230301__20240228_zYLUz8bt56ej" title="Cost of contribution"&gt;17,112&lt;/span&gt;
in 2024.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:CompensationAndEmployeeBenefitPlansTextBlock>
    <us-gaap:DescriptionOfDefinedContributionPensionAndOtherPostretirementPlans contextRef="From2024-03-01to2025-02-28" id="Fact002006">the
Company makes either a safe Harbor contribution match of 100% of each participant&#x2019;s contribution up to 3% of salary, and 50%
of the next 2% of salary contributed, or a 3% non-elective contribution for all eligible participants</us-gaap:DescriptionOfDefinedContributionPensionAndOtherPostretirementPlans>
    <us-gaap:DefinedContributionPlanCostRecognized
      contextRef="From2024-03-01to2025-02-28"
      decimals="0"
      id="Fact002008"
      unitRef="USD">23628</us-gaap:DefinedContributionPlanCostRecognized>
    <us-gaap:DefinedContributionPlanCostRecognized
      contextRef="From2023-03-012024-02-28"
      decimals="0"
      id="Fact002010"
      unitRef="USD">17112</us-gaap:DefinedContributionPlanCostRecognized>
    <us-gaap:SubsequentEventsTextBlock contextRef="From2024-03-01to2025-02-28" id="Fact002012">&lt;p id="xdx_80B_eus-gaap--SubsequentEventsTextBlock_zxuIlZY5Qj77" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
22 &#x2013; &lt;span id="xdx_82B_zUTpgECwLQI3"&gt;Subsequent Events&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;Nasdaq &lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
March 3, 2025, the Company received a notification letter from Nasdaq notifying the Company that, because the Company had not held
an annual meeting of shareholders within twelve months of the end of the Company&#x2019;s fiscal year ended February 29, 2024,the
Company was out of compliance with Nasdaq Listing Rule 5620(a) (the &#x201c;Annual Meeting Rule&#x201d;). On March 3, 2025, the
Company also received a notification letter from the Listing Qualifications Staff of Nasdaq (the &#x201c;Staff&#x201d;) notifying the
Company that, based on the Current Report on Form 8-K filed by the Company with the SEC on February 18, 2024, the Staff had
determined the Company had regained compliance with the minimum stockholders&#x2019; equity requirements set forth in Nasdaq Listing
Rule 5550(b)(1) (the &#x201c;Equity Rule&#x201d;). However, if the Company fails to evidence compliance with the Equity Rule upon
filing its next periodic report, the Company may be subject to delisting. At that time, Staff will provide written notification to
the Company, which may then appeal Staff&#x2019;s determination to a Nasdaq Hearings Panel. The notification letters had no immediate effect on the listing of the Company&#x2019;s securities on Nasdaq.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Under
Nasdaq Listing Rule 5810(c)(2)(G), the Company had until April 17, 2025 to provide Nasdaq with a plan to regain compliance with the Annual
Meeting Rule. &lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
April 9, 2025, the Company held its 2025 Annual Meeting of the Stockholders (the &#x201c;Annual Meeting&#x201d;) in a virtual format. On
April 23, 2025, the Company received a letter from the Staff of Nasdaq notifying the Company that, based on the fact that the Company
held its Annual Meeting on April 9, 2025, Nasdaq had determined that the Company has regained compliance with the Annual Meeting Rule
and that the matter is now closed.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;Contingent Shares Issuances and Change in Control
&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
March 26, 2025, the Company issued an aggregate of &lt;span id="xdx_901_eus-gaap--IncrementalCommonSharesAttributableToContingentlyIssuableShares_pid_c20250326__20250326__us-gaap--TypeOfArrangementAxis__custom--ExchangeAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zJ6xP4rbZzpl" title="Number of contingent shares issued"&gt;4,393,993&lt;/span&gt;&lt;/span&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Contingent
Shares to the NextTrip Sellers in satisfaction of its obligations to issue Contingent Shares upon achievement of three of the four
Milestone Events under the Exchange Agreement. The Contingent Shares were issued after the Company received notice from Nasdaq, on
March 25, 2025, that Nasdaq has approved the Company&#x2019;s initial listing application. &lt;/span&gt;Following issuance of the
Contingent Shares, the Company had &lt;span id="xdx_905_eus-gaap--CommonStockSharesIssued_iI_pid_c20250326__us-gaap--TypeOfArrangementAxis__custom--ExchangeAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zYxN3Ugjsf6e" title="Common sock, shares issued"&gt;&lt;span id="xdx_906_eus-gaap--CommonStockSharesOutstanding_iI_pid_c20250326__us-gaap--TypeOfArrangementAxis__custom--ExchangeAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zHksYJ3TSVG9" title="Common sock, shares outstanding"&gt;6,163,525&lt;/span&gt;&lt;/span&gt; shares of common stock issued and outstanding, &lt;span id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20250326__20250326__us-gaap--TypeOfArrangementAxis__custom--ExchangeAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zK5XDanrfaMi" title="Issuance of shares"&gt;4,550,000&lt;/span&gt; of which (or &lt;span id="xdx_902_ecustom--CommonStockIssuedPercentage_iI_pid_dp_uPure_c20250326__us-gaap--TypeOfArrangementAxis__custom--ExchangeAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z2UiBwdezCW2" title="Issued percentage"&gt;73.8&lt;/span&gt;%) were held
by the NextTrip Sellers. As a result, the NextTrip Sellers collectively had ownership and voting control over the Company as of such
date, resulting in a change in control of the Company.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;As a result of the issuance of the Contingent Shares and pursuant to the Exchange Agreement, the NextTrip Representative
now has the right to designate a replacement for three directors of the Company.&#160;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;On May 5, 2025, the Company
issued an aggregate of &lt;span id="xdx_909_eus-gaap--IncrementalCommonSharesAttributableToContingentlyIssuableShares_pid_c20250505__20250505__us-gaap--TypeOfArrangementAxis__custom--ExchangeAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zTFe7Qz4Rr15" title="Number of contingent shares issued"&gt;1,450,000&lt;/span&gt; Contingent Shares to the NextTrip Sellers in satisfaction of its obligation to issue Contingent Shares
upon achievement of the fourth and final Milestone Event under the Exchange Agreement. Immediately following such issuance, all Contingent
Shares issuable pursuant to the Exchange Agreement have been issued, and the Company has no further commitments or obligations to issue
additional shares pursuant to the Exchange Agreement.&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;Alumni Agreements&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
April 1, 2025, the Company entered into a securities purchase agreement (the &#x201c;Alumni Purchase Agreement&#x201d;) with Alumni
for the sale of a short-term promissory note (the &#x201c;Alumni Note&#x201d;) and warrants (the &#x201c;Alumni Warrants&#x201d;) to
Alumni for total consideration of $&lt;span id="xdx_90C_eus-gaap--NotesAndLoansPayableCurrent_iI_c20250401__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zCoMNQphumnj" title="Total consideration"&gt;300,000&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Alumni Note is in the principal amount of $&lt;span id="xdx_90D_eus-gaap--DebtInstrumentFaceAmount_iI_c20250401__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zJveFiDgW6Fa" title="Principal amount"&gt;360,000&lt;/span&gt;
with an original issue discount of $&lt;span id="xdx_907_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_c20250401__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zNdmU5aLYUnd" title="Original issue discount"&gt;60,000&lt;/span&gt;
and guaranteed interest on the principal amount of ten percent (&lt;span id="xdx_909_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20250401__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zQ1cbaz7zEQe" title="Interest rate"&gt;10&lt;/span&gt;%)
per annum, which shall be due and payable on &lt;span id="xdx_909_eus-gaap--DebtInstrumentMaturityDate_dd_c20250401__20250401__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zycytL4IV6rd" title="Maturity date"&gt;July
1, 2025&lt;/span&gt;. In the event of a failure to re-pay the Alumni Note on or before the maturity date, the interest rate will increase
to the lesser of twenty-two percent (&lt;span id="xdx_909_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20250401__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--RangeAxis__srt--MaximumMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zUSE8BnQJTK4" title="Interest rate"&gt;22&lt;/span&gt;%)
per annum or the maximum amount permitted under law from the due date thereof until the same is paid.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Alumni Note is convertible into shares of common stock of the Company only upon an event of default.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_908_eus-gaap--ClassOfWarrantOrRightReasonForIssuingToNonemployees_pid_c20250401__20250401__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zPmjiM1vQwx2" title="Warrant description"&gt;In
conjunction with the issuance of the Alumni Note to Alumni, the Company also issued warrants to purchase &lt;span id="xdx_90C_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20250401__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z6NY4ONNLD6e" title="Warrants outstanding to purchase common stock"&gt;80,000&lt;/span&gt;
shares of common stock at a price per share of $&lt;span id="xdx_906_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20250401__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zpQswI5Itn5c" title="Shares issued price per share"&gt;4.50&lt;/span&gt;,
which represents 100% warrant coverage on the principal amount of the Alumni Note. The Alumni Warrants are exercisable on or prior
to the five (5) year anniversary of the effective date.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin: 0"&gt;&lt;i&gt;Journy.tv Asset Purchase&lt;/i&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
April 1, 2025, the Company entered into an asset purchase agreement (the &#x201c;Journy.tv Purchase Agreement&#x201d;) with Ovation
LLC (&#x201c;Ovation&#x201d;), pursuant to which the Company purchased assets, including without limitation trademarks, domains, apps
and certain agreements, and assumed certain liabilities related to Ovation&#x2019; Journy.tv business (the &#x201c;Journy.tv
Acquisition&#x201d;). The Journy.tv Acquisition closed on April 1, 2025.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Pursuant
to the Purchase Agreement, as consideration for the Journy.tv Acquisition, the Company paid Ovation $&lt;span id="xdx_900_eus-gaap--PaymentsToAcquireBusinessesGross_c20250401__20250401__us-gaap--TypeOfArrangementAxis__custom--AssetPurchaseAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_znitF9Zvx9f4" title="Payments to acquire businesses"&gt;300,000&lt;/span&gt; in cash at closing and issued
Ovation &lt;span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20250401__20250401__us-gaap--TypeOfArrangementAxis__custom--AssetPurchaseAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zSAOMC0wxs06" title="Restricted shares, issued"&gt;20,000&lt;/span&gt; restricted shares of Company common stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
connection with the Journy.tv Acquisition, on April 1, 2025, the Company and Ovation also entered into a License Agreement (the &#x201c;License
Agreement&#x201d;), pursuant to which Ovation granted the Company the non-exclusive right, throughout the territories and for the term
set forth therein, to exhibit, promote, market, advertise, publicize and/or otherwise exploit the programs listed in the License Agreement
in the media of (i) FAST via the Journy.tv Channel and (ii) Video On Demand via the Journy.tv Channel. Pursuant to the License Agreement, Ovation
shall not license any unaffiliated third party the right to exhibit certain of the programs subject to the License Agreement and shall
not use certain of the programs subject to the License Agreement on its owned or operating streaming platforms (subject to certain exceptions).
As consideration for the rights granted under the License Agreement, the Company agreed to pay Ovation an aggregate non-refundable license
fee of $&lt;span id="xdx_904_eus-gaap--PaymentsForFees_c20250401__20250401__us-gaap--TypeOfArrangementAxis__custom--AssetPurchaseAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zpFgbhkGnCEh" title="License fee"&gt;336,801&lt;/span&gt; over thirty months.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;FSA Travel Final Closing and Milestone Payments&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
April 9, 2025 (the &#x201c;Final Closing Date&#x201d;), upon FSA&#x2019;s agreement to waive the capital raise condition to closing,
the Company exercised its option to acquire the remaining &lt;span id="xdx_90A_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20250409__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--FSATravelLLCMember__us-gaap--TypeOfArrangementAxis__custom--PurchaseAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zMUctIfatDld" title="Ownership percentage"&gt;51&lt;/span&gt;%
of FSA outstanding membership units, in satisfaction of its obligations under the FSA Purchase Agreement. In connection with the
Final Closing, the Company paid the the members of FSA (the &#x201c;FSA Members&#x201d;) an aggregate of $&lt;span id="xdx_902_eus-gaap--PaymentsToAcquireBusinessesGross_c20250409__20250409__dei--LegalEntityAxis__custom--FSATravelLLCMember__us-gaap--TypeOfArrangementAxis__custom--PurchaseAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zZ4QHlZsyZ96" title="Payments to acquire businesses"&gt;500,000&lt;/span&gt;
in cash and issued the FSA Members an aggregate of &lt;span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20250409__20250409__dei--LegalEntityAxis__custom--FSATravelLLCMember__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember__us-gaap--StatementClassOfStockAxis__custom--SeriesOPreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--PurchaseAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zYC2BlGq4Snj" title="Shares issued"&gt;161,291&lt;/span&gt;
shares of Series O Preferred. As a result, as of the Final Closing Date, FSA became a wholly owned subsidiary of the
Company.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
April 28, 2025, upon achievement of each of the business milestones pursuant to the FSA Purchase Agreement, the Company made each of
the Milestone Payments to the FSA Members, including payment of $&lt;span id="xdx_900_eus-gaap--PaymentsToAcquireBusinessesGross_c20250428__20250428__dei--LegalEntityAxis__custom--FSATravelLLCMember__us-gaap--TypeOfArrangementAxis__custom--PurchaseAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z4CF8Se9GgIj" title="Payments to acquire businesses"&gt;400,000&lt;/span&gt;
in cash and the issuance of an aggregate of &lt;span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20250428__20250428__dei--LegalEntityAxis__custom--FSATravelLLCMember__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember__us-gaap--StatementClassOfStockAxis__custom--SeriesOPreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--PurchaseAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z0RrCw0Y065c" title="Shares issued"&gt;129,032&lt;/span&gt;
shares of Series O Preferred (the number of shares provided for above, less &lt;span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20250428__20250428__dei--LegalEntityAxis__custom--FSATravelLLCMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--TypeOfArrangementAxis__custom--PurchaseAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z5zYKtv2Huid" title="Shares issued"&gt;8,065&lt;/span&gt;
shares of common stock previously issued to FSA by the Company as a deposit.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;Related Party Notes&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On April 9, 2025, NTH and the Donald P. Monaco Insurance
Trust (the &#x201c;Trust&#x201d;) entered into two promissory notes (together, the &#x201c;Trust Notes&#x201d;) under the Company&#x2019;s
$&lt;span id="xdx_902_eus-gaap--LineOfCredit_iI_pn5n6_c20250409__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zmKe78yprE4d" title="Line of credit"&gt;2.0&lt;/span&gt; million line of credit. Donald Monaco, chairman of the Company&#x2019;s Board of Directors, is the trustee of the Trust. The first
note had a principal balance of $&lt;span id="xdx_900_eus-gaap--DebtInstrumentFaceAmount_iI_c20250409__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--DebtInstrumentAxis__custom--NoteOneMember_zjQvZgFBKAC1" title="Principal amount"&gt;500,000&lt;/span&gt; and was issued in exchange for a new cash payment provided my Mr. Monaco. The second note had
a principal balance of $&lt;span id="xdx_90F_eus-gaap--DebtInstrumentFaceAmount_iI_c20250409__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--DebtInstrumentAxis__custom--NoteTwoMember_zkVBY5TC4mIl" title="Principal amount"&gt;145,000&lt;/span&gt; and was issued in exchange for cash advances previously made by Mr. Monaco to the Company.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
May 6, 2025, the Company entered into a Line of Credit Agreement (the &#x201c;MIP Line of Credit&#x201d;) with Monaco Investment
Partners II, LP (&#x201c;MIP&#x201d;) providing the Company with a $&lt;span id="xdx_90E_eus-gaap--LineOfCredit_iI_c20250506__us-gaap--TypeOfArrangementAxis__custom--LineOfCreditAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zqdYGYbfhWjc" title="Line of credit"&gt;3,000,000&lt;/span&gt;
revolving line of credit. The MIP Line of Credit allows the Company to request advances thereunder from time to time until &lt;span id="xdx_902_eus-gaap--LineOfCreditFacilityExpirationDate1_dd_c20250506__20250506__us-gaap--TypeOfArrangementAxis__custom--LineOfCreditAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zSQVIbLr1hG7" title="Line of credit maturity date"&gt;May
31, 2027&lt;/span&gt;, the maturity date. Advances made under the MIP Line of Credit bear simple interest at a rate of &lt;span id="xdx_908_eus-gaap--LineOfCreditFacilityInterestRateDuringPeriod_pid_dp_c20250506__20250506__us-gaap--TypeOfArrangementAxis__custom--LineOfCreditAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zxLWn1ou9Tq4" title="Line of credit, interest rate"&gt;12&lt;/span&gt;%
per annum, calculated from the date of each respective advance. Accrued interest shall be payable on a monthly basis, no later than
the 10th day of the subsequent month. The full outstanding principal balance, together with any accrued and unpaid interest, shall
be due and payable in full by the Company on the maturity date. The Company may, at its option, prepay any borrowings under the MIP
Line of Credit, in whole or in part, at any time prior to the maturity date, without penalty. Mr. Monaco controls MIP&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90B_eus-gaap--LineOfCreditFacilityDescription_c20250506__20250506__us-gaap--TypeOfArrangementAxis__custom--LineOfCreditAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zljfoUUl9AV6" title="Line of credit advance description"&gt;The
Company received an initial advance of $&lt;span id="xdx_909_eus-gaap--ProceedsFromLinesOfCredit_dd_c20250506__20250506__us-gaap--TypeOfArrangementAxis__custom--LineOfCreditAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z7Y2FX0x9hr7" title="Initial advance of line of credit"&gt;1,045,000&lt;/span&gt;
under the MIP Line of Credit, which was used to repay (i) a $&lt;span id="xdx_901_ecustom--CashAdvance_c20250506__20250506__us-gaap--TypeOfArrangementAxis__custom--LineOfCreditAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zw6gUi5lPRF7" title="Cash advance"&gt;400,000&lt;/span&gt;
cash advance previously made by the Trust to the Company (ii) and all outstanding
indebtedness under the terms of the Trust Notes, totaling $&lt;span id="xdx_907_eus-gaap--DebtInstrumentCarryingAmount_iI_c20250409__us-gaap--TypeOfArrangementAxis__custom--LineOfCreditAgreementMember__us-gaap--DebtInstrumentAxis__custom--TwoPromissoryNotesMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z5Wg2rLyMCjc" title="Cash advance"&gt;645,000&lt;/span&gt;.
Additional advances through May 28, 2025 totaled $&lt;span id="xdx_90B_eus-gaap--LineOfCreditFacilityIncreaseDecreaseForPeriodNet_c20250506__20250506__us-gaap--TypeOfArrangementAxis__custom--LineOfCreditAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zw4plTy3cax" title="Aditional advances"&gt;441,575&lt;/span&gt;,
bringing the total amount advanced under the line to $&lt;span id="xdx_903_eus-gaap--LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod_dd_c20250506__20250506__us-gaap--TypeOfArrangementAxis__custom--LineOfCreditAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zHx7o3dgDMZf" title="Total advances of line of credit"&gt;1,486,575&lt;/span&gt;.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:IncrementalCommonSharesAttributableToContingentlyIssuableShares
      contextRef="From2025-03-262025-03-26_custom_ExchangeAgreementMember_us-gaap_SubsequentEventMember"
      decimals="INF"
      id="Fact002014"
      unitRef="Shares">4393993</us-gaap:IncrementalCommonSharesAttributableToContingentlyIssuableShares>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2025-03-26_custom_ExchangeAgreementMember_us-gaap_SubsequentEventMember"
      decimals="INF"
      id="Fact002016"
      unitRef="Shares">6163525</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2025-03-26_custom_ExchangeAgreementMember_us-gaap_SubsequentEventMember"
      decimals="INF"
      id="Fact002018"
      unitRef="Shares">6163525</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2025-03-262025-03-26_custom_ExchangeAgreementMember_us-gaap_SubsequentEventMember"
      decimals="INF"
      id="Fact002020"
      unitRef="Shares">4550000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <NTRP:CommonStockIssuedPercentage
      contextRef="AsOf2025-03-26_custom_ExchangeAgreementMember_us-gaap_SubsequentEventMember"
      decimals="INF"
      id="Fact002022"
      unitRef="Pure">0.738</NTRP:CommonStockIssuedPercentage>
    <us-gaap:IncrementalCommonSharesAttributableToContingentlyIssuableShares
      contextRef="From2025-05-052025-05-05_custom_ExchangeAgreementMember_us-gaap_SubsequentEventMember"
      decimals="INF"
      id="Fact002024"
      unitRef="Shares">1450000</us-gaap:IncrementalCommonSharesAttributableToContingentlyIssuableShares>
    <us-gaap:NotesAndLoansPayableCurrent
      contextRef="AsOf2025-04-01_custom_SecuritiesPurchaseAgreementMember_us-gaap_SubsequentEventMember"
      decimals="0"
      id="Fact002026"
      unitRef="USD">300000</us-gaap:NotesAndLoansPayableCurrent>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2025-04-01_custom_SecuritiesPurchaseAgreementMember_us-gaap_SubsequentEventMember"
      decimals="0"
      id="Fact002028"
      unitRef="USD">360000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="AsOf2025-04-01_custom_SecuritiesPurchaseAgreementMember_us-gaap_SubsequentEventMember"
      decimals="0"
      id="Fact002030"
      unitRef="USD">60000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2025-04-01_custom_SecuritiesPurchaseAgreementMember_us-gaap_SubsequentEventMember"
      decimals="INF"
      id="Fact002032"
      unitRef="Pure">0.10</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentMaturityDate
      contextRef="From2025-04-012025-04-01_custom_SecuritiesPurchaseAgreementMember_us-gaap_SubsequentEventMember"
      id="Fact002034">2025-07-01</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2025-04-01_custom_SecuritiesPurchaseAgreementMember_srt_MaximumMember_us-gaap_SubsequentEventMember"
      decimals="INF"
      id="Fact002036"
      unitRef="Pure">0.22</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ClassOfWarrantOrRightReasonForIssuingToNonemployees
      contextRef="From2025-04-012025-04-01_custom_SecuritiesPurchaseAgreementMember_us-gaap_SubsequentEventMember"
      id="Fact002038">In
conjunction with the issuance of the Alumni Note to Alumni, the Company also issued warrants to purchase 80,000
shares of common stock at a price per share of $4.50,
which represents 100% warrant coverage on the principal amount of the Alumni Note. The Alumni Warrants are exercisable on or prior
to the five (5) year anniversary of the effective date.</us-gaap:ClassOfWarrantOrRightReasonForIssuingToNonemployees>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2025-04-01_custom_SecuritiesPurchaseAgreementMember_us-gaap_SubsequentEventMember"
      decimals="INF"
      id="Fact002040"
      unitRef="Shares">80000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="AsOf2025-04-01_custom_SecuritiesPurchaseAgreementMember_us-gaap_SubsequentEventMember"
      decimals="INF"
      id="Fact002042"
      unitRef="USDPShares">4.50</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="From2025-04-012025-04-01_custom_AssetPurchaseAgreementMember_us-gaap_SubsequentEventMember"
      decimals="0"
      id="Fact002044"
      unitRef="USD">300000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross
      contextRef="From2025-04-012025-04-01_custom_AssetPurchaseAgreementMember_us-gaap_CommonStockMember_us-gaap_SubsequentEventMember"
      decimals="INF"
      id="Fact002046"
      unitRef="Shares">20000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
    <us-gaap:PaymentsForFees
      contextRef="From2025-04-012025-04-01_custom_AssetPurchaseAgreementMember_us-gaap_SubsequentEventMember"
      decimals="0"
      id="Fact002048"
      unitRef="USD">336801</us-gaap:PaymentsForFees>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="AsOf2025-04-09_custom_FSATravelLLCMember_custom_PurchaseAgreementMember_us-gaap_SubsequentEventMember"
      decimals="INF"
      id="Fact002050"
      unitRef="Pure">0.51</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="From2025-04-092025-04-09_custom_FSATravelLLCMember_custom_PurchaseAgreementMember_us-gaap_SubsequentEventMember"
      decimals="0"
      id="Fact002052"
      unitRef="USD">500000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2025-04-092025-04-09_custom_FSATravelLLCMember_us-gaap_PreferredStockMember_custom_SeriesOPreferredStockMember_custom_PurchaseAgreementMember_us-gaap_SubsequentEventMember"
      decimals="INF"
      id="Fact002054"
      unitRef="Shares">161291</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="From2025-04-282025-04-28_custom_FSATravelLLCMember_custom_PurchaseAgreementMember_us-gaap_SubsequentEventMember"
      decimals="0"
      id="Fact002056"
      unitRef="USD">400000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2025-04-282025-04-28_custom_FSATravelLLCMember_us-gaap_PreferredStockMember_custom_SeriesOPreferredStockMember_custom_PurchaseAgreementMember_us-gaap_SubsequentEventMember"
      decimals="INF"
      id="Fact002058"
      unitRef="Shares">129032</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2025-04-282025-04-28_custom_FSATravelLLCMember_us-gaap_CommonStockMember_custom_PurchaseAgreementMember_us-gaap_SubsequentEventMember"
      decimals="INF"
      id="Fact002060"
      unitRef="Shares">8065</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:LineOfCredit
      contextRef="AsOf2025-04-09_us-gaap_SubsequentEventMember"
      decimals="-5"
      id="Fact002062"
      unitRef="USD">2000000.0</us-gaap:LineOfCredit>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2025-04-09_us-gaap_SubsequentEventMember_custom_NoteOneMember"
      decimals="0"
      id="Fact002064"
      unitRef="USD">500000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2025-04-09_us-gaap_SubsequentEventMember_custom_NoteTwoMember"
      decimals="0"
      id="Fact002066"
      unitRef="USD">145000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:LineOfCredit
      contextRef="AsOf2025-05-06_custom_LineOfCreditAgreementMember_us-gaap_SubsequentEventMember"
      decimals="0"
      id="Fact002068"
      unitRef="USD">3000000</us-gaap:LineOfCredit>
    <us-gaap:LineOfCreditFacilityExpirationDate1
      contextRef="From2025-05-062025-05-06_custom_LineOfCreditAgreementMember_us-gaap_SubsequentEventMember"
      id="Fact002070">2027-05-31</us-gaap:LineOfCreditFacilityExpirationDate1>
    <us-gaap:LineOfCreditFacilityInterestRateDuringPeriod
      contextRef="From2025-05-062025-05-06_custom_LineOfCreditAgreementMember_us-gaap_SubsequentEventMember"
      decimals="INF"
      id="Fact002072"
      unitRef="Pure">0.12</us-gaap:LineOfCreditFacilityInterestRateDuringPeriod>
    <us-gaap:LineOfCreditFacilityDescription
      contextRef="From2025-05-062025-05-06_custom_LineOfCreditAgreementMember_us-gaap_SubsequentEventMember"
      id="Fact002074">The
Company received an initial advance of $1,045,000
under the MIP Line of Credit, which was used to repay (i) a $400,000
cash advance previously made by the Trust to the Company (ii) and all outstanding
indebtedness under the terms of the Trust Notes, totaling $645,000.
Additional advances through May 28, 2025 totaled $441,575,
bringing the total amount advanced under the line to $1,486,575.</us-gaap:LineOfCreditFacilityDescription>
    <us-gaap:ProceedsFromLinesOfCredit
      contextRef="From2025-05-062025-05-06_custom_LineOfCreditAgreementMember_us-gaap_SubsequentEventMember"
      decimals="0"
      id="Fact002076"
      unitRef="USD">1045000</us-gaap:ProceedsFromLinesOfCredit>
    <NTRP:CashAdvance
      contextRef="From2025-05-062025-05-06_custom_LineOfCreditAgreementMember_us-gaap_SubsequentEventMember"
      decimals="0"
      id="Fact002078"
      unitRef="USD">400000</NTRP:CashAdvance>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="AsOf2025-04-09_custom_LineOfCreditAgreementMember_custom_TwoPromissoryNotesMember_us-gaap_SubsequentEventMember"
      decimals="0"
      id="Fact002080"
      unitRef="USD">645000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:LineOfCreditFacilityIncreaseDecreaseForPeriodNet
      contextRef="From2025-05-062025-05-06_custom_LineOfCreditAgreementMember_us-gaap_SubsequentEventMember"
      decimals="0"
      id="Fact002082"
      unitRef="USD">441575</us-gaap:LineOfCreditFacilityIncreaseDecreaseForPeriodNet>
    <us-gaap:LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod
      contextRef="From2025-05-062025-05-06_custom_LineOfCreditAgreementMember_us-gaap_SubsequentEventMember"
      decimals="0"
      id="Fact002084"
      unitRef="USD">1486575</us-gaap:LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#Fact000171"
          xlink:label="Fact000171"
          xlink:type="locator"/>
        <link:footnote id="Footnote000201" xlink:label="Footnote000201" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">On
    December 29, 2023, the Company (then known as Sigma Additive Solutions, Inc.) acquired NextTrip Holdings, Inc. (&#x201c;NTH&#x201d;)
    in a reverse acquisition. NextTrip Group, LLC (&#x201c;NTG&#x201d;) was issued <xhtml:span
  id="xdx_90E_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_pid_c20231229__20231229__us-gaap--BusinessAcquisitionAxis__custom--NextTripGroupLLCMember_zi92mxXMT2Ei"
  title="Number of shares acquired">83,371</xhtml:span> shares of Company common stock in exchange for
    <xhtml:span
  id="xdx_909_ecustom--PercentageForIssuedAndOutstandingCapitalStock_pid_dp_uPure_c20231229__20231229__us-gaap--BusinessAcquisitionAxis__custom--NextTripGroupLLCMember_zUXOGjE4ta79"
  title="Percentage for issued and outstanding capital stock">100</xhtml:span>% of the issued and outstanding capital stock of NTH at the time of the reverse acquisition. The Company has reflected this transaction
    retroactively in these financial statements.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000171"
          xlink:to="Footnote000201"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000172"
          xlink:label="Fact000172"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000172"
          xlink:to="Footnote000201"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000190"
          xlink:label="Fact000190"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000190"
          xlink:to="Footnote000201"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000191"
          xlink:label="Fact000191"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000191"
          xlink:to="Footnote000201"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000300"
          xlink:label="Fact000300"
          xlink:type="locator"/>
        <link:footnote id="Footnote000331" xlink:label="Footnote000331" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">On
    December 29, 2023, the Company (then known as Sigma Additive Solutions, Inc.) acquired NTH in a reverse acquisition. NTG was issued
    <xhtml:span
  id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_pid_c20231229__20231229__us-gaap--BusinessAcquisitionAxis__custom--NextTripGroupLLCMember_zMAWreRRiNcf"
  title="Number of shares acquired">83,371</xhtml:span> shares of Company common stock in exchange for <xhtml:span
  id="xdx_904_ecustom--PercentageForIssuedAndOutstandingCapitalStock_pid_dp_c20231229__20231229__us-gaap--BusinessAcquisitionAxis__custom--NextTripGroupLLCMember_zN7cXzVnhmg1"
  title="Percentage for issued and outstanding capital stock">100</xhtml:span>% of the issued and outstanding capital stock of NTH at the time of the
    reverse acquisition. The Company has reflected this transaction retroactively in these financial statements.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000300"
          xlink:to="Footnote000331"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000302"
          xlink:label="Fact000302"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000302"
          xlink:to="Footnote000331"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000304"
          xlink:label="Fact000304"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000304"
          xlink:to="Footnote000331"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000306"
          xlink:label="Fact000306"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000306"
          xlink:to="Footnote000331"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000308"
          xlink:label="Fact000308"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000308"
          xlink:to="Footnote000331"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000310"
          xlink:label="Fact000310"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000310"
          xlink:to="Footnote000331"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000312"
          xlink:label="Fact000312"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000312"
          xlink:to="Footnote000331"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000314"
          xlink:label="Fact000314"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000314"
          xlink:to="Footnote000331"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000316"
          xlink:label="Fact000316"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000316"
          xlink:to="Footnote000331"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000318"
          xlink:label="Fact000318"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000318"
          xlink:to="Footnote000331"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000320"
          xlink:label="Fact000320"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000320"
          xlink:to="Footnote000331"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000322"
          xlink:label="Fact000322"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000322"
          xlink:to="Footnote000331"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000324"
          xlink:label="Fact000324"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000324"
          xlink:to="Footnote000331"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000326"
          xlink:label="Fact000326"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000326"
          xlink:to="Footnote000331"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000328"
          xlink:label="Fact000328"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000328"
          xlink:to="Footnote000331"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000330"
          xlink:label="Fact000330"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000330"
          xlink:to="Footnote000331"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl0337"
          xlink:label="xdx2ixbrl0337"
          xlink:type="locator"/>
        <link:footnote id="Footnote000540" xlink:label="Footnote000540" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">On
    December 29, 2023, the Company (then known as Sigma Additive Solutions, Inc.) acquired NTH in a reverse acquisition. NTG was issued
    <xhtml:span
  id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_pid_c20231229__20231229__us-gaap--BusinessAcquisitionAxis__custom--NextTripGroupLLCMember_znf0cL99Yexe"
  title="Number of shares acquired">83,371</xhtml:span> shares of Company common stock in exchange for <xhtml:span
  id="xdx_903_ecustom--PercentageForIssuedAndOutstandingCapitalStock_pid_dp_uPure_c20231229__20231229__us-gaap--BusinessAcquisitionAxis__custom--NextTripGroupLLCMember_zJ1ftypKOa1l"
  title="Percentage for issued and outstanding capital stock">100</xhtml:span>% of the issued and outstanding capital stock of NTH at the time of the
    reverse acquisition. The Company has reflected this transaction retroactively in these financial statements.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl0337"
          xlink:to="Footnote000540"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000338"
          xlink:label="Fact000338"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000338"
          xlink:to="Footnote000540"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000339"
          xlink:label="Fact000339"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000339"
          xlink:to="Footnote000540"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000340"
          xlink:label="Fact000340"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000340"
          xlink:to="Footnote000540"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000341"
          xlink:label="Fact000341"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000341"
          xlink:to="Footnote000540"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl0343"
          xlink:label="xdx2ixbrl0343"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl0343"
          xlink:to="Footnote000540"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000345"
          xlink:label="Fact000345"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000345"
          xlink:to="Footnote000540"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000409"
          xlink:label="Fact000409"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000409"
          xlink:to="Footnote000540"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000410"
          xlink:label="Fact000410"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000410"
          xlink:to="Footnote000540"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000411"
          xlink:label="Fact000411"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000411"
          xlink:to="Footnote000540"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000412"
          xlink:label="Fact000412"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000412"
          xlink:to="Footnote000540"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000413"
          xlink:label="Fact000413"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000413"
          xlink:to="Footnote000540"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000415"
          xlink:label="Fact000415"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000415"
          xlink:to="Footnote000540"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000417"
          xlink:label="Fact000417"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000417"
          xlink:to="Footnote000540"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000425"
          xlink:label="Fact000425"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000425"
          xlink:to="Footnote000540"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000427"
          xlink:label="Fact000427"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000427"
          xlink:to="Footnote000540"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000435"
          xlink:label="Fact000435"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000435"
          xlink:to="Footnote000540"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl0437"
          xlink:label="xdx2ixbrl0437"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl0437"
          xlink:to="Footnote000540"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000445"
          xlink:label="Fact000445"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000445"
          xlink:to="Footnote000540"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000447"
          xlink:label="Fact000447"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000447"
          xlink:to="Footnote000540"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000455"
          xlink:label="Fact000455"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000455"
          xlink:to="Footnote000540"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl0457"
          xlink:label="xdx2ixbrl0457"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl0457"
          xlink:to="Footnote000540"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000465"
          xlink:label="Fact000465"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000465"
          xlink:to="Footnote000540"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000467"
          xlink:label="Fact000467"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000467"
          xlink:to="Footnote000540"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000475"
          xlink:label="Fact000475"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000475"
          xlink:to="Footnote000540"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000477"
          xlink:label="Fact000477"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000477"
          xlink:to="Footnote000540"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl0485"
          xlink:label="xdx2ixbrl0485"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl0485"
          xlink:to="Footnote000540"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000487"
          xlink:label="Fact000487"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000487"
          xlink:to="Footnote000540"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl0495"
          xlink:label="xdx2ixbrl0495"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl0495"
          xlink:to="Footnote000540"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000497"
          xlink:label="Fact000497"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000497"
          xlink:to="Footnote000540"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl0505"
          xlink:label="xdx2ixbrl0505"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl0505"
          xlink:to="Footnote000540"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000507"
          xlink:label="Fact000507"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000507"
          xlink:to="Footnote000540"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000527"
          xlink:label="Fact000527"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000527"
          xlink:to="Footnote000540"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000529"
          xlink:label="Fact000529"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000529"
          xlink:to="Footnote000540"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000537"
          xlink:label="Fact000537"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000537"
          xlink:to="Footnote000540"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000539"
          xlink:label="Fact000539"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000539"
          xlink:to="Footnote000540"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
